query accession pident length evalue bitscore title id Reviewed protein_name organism go_ids go_bp go_cc go_mf g7941.t1 O75581 35.514 321 4e-44 167.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g7941.t1 O75581 34.365 323 3.07e-40 155.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g7941.t1 O75581 33.929 336 1.81e-39 153.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g7941.t1 O75581 30.769 312 5.83e-28 119.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g7943.t1 Q14517 39.252 107 1.19e-22 95.5 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g7944.t1 Q7L592 51.683 416 6.85e-148 431.0 sp|Q7L592|NDUF7_HUMAN Protein arginine methyltransferase NDUFAF7, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFAF7 PE=1 SV=1 NDUF7_HUMAN reviewed Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog) Homo sapiens (Human) GO:0005615; GO:0005739; GO:0005759; GO:0008168; GO:0019899; GO:0019918; GO:0032981; GO:0035243 mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918] extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] enzyme binding [GO:0019899]; methyltransferase activity [GO:0008168]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243] g7945.t1 Q80T85 58.01 412 2.5500000000000002e-173 529.0 sp|Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated factor 5 OS=Mus musculus OX=10090 GN=Dcaf5 PE=1 SV=2 g7946.t1 P05094 65.657 891 0.0 1230.0 sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3 g7946.t2 P05094 65.881 891 0.0 1234.0 sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3 g7946.t3 P05094 65.657 891 0.0 1227.0 sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3 g7950.t1 Q9N2A4 37.387 551 9.55e-115 356.0 sp|Q9N2A4|ACM3_PANTR Muscarinic acetylcholine receptor M3 OS=Pan troglodytes OX=9598 GN=CHRM3 PE=3 SV=1 g7951.t1 Q8BI22 26.833 641 8.42e-49 187.0 sp|Q8BI22|CE128_MOUSE Centrosomal protein of 128 kDa OS=Mus musculus OX=10090 GN=Cep128 PE=1 SV=2 CE128_MOUSE reviewed Centrosomal protein 128 (Cep128) (Centrosomal protein of 128 kDa) Mus musculus (Mouse) GO:0000922; GO:0005794; GO:0005813; GO:0005814; GO:0007283; GO:0008104; GO:0010468; GO:0031965; GO:0036064; GO:0044458; GO:0120103; GO:0120212; GO:0120316 intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; sperm head-tail coupling apparatus [GO:0120212]; spindle pole [GO:0000922] g7953.t1 Q6ZU80 29.29 338 1.93e-23 103.0 sp|Q6ZU80|CE128_HUMAN Centrosomal protein of 128 kDa OS=Homo sapiens OX=9606 GN=CEP128 PE=1 SV=2 CE128_HUMAN reviewed Centrosomal protein 128 (Cep128) (Centrosomal protein of 128 kDa) Homo sapiens (Human) GO:0000922; GO:0005794; GO:0005813; GO:0005814; GO:0008104; GO:0010468; GO:0031965; GO:0036064; GO:0044458; GO:0120103; GO:0120212; GO:0120316 intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; sperm head-tail coupling apparatus [GO:0120212]; spindle pole [GO:0000922] g7954.t1 Q8C7Q4 40.323 186 2.64e-47 168.0 sp|Q8C7Q4|RBM4_MOUSE RNA-binding protein 4 OS=Mus musculus OX=10090 GN=Rbm4 PE=1 SV=1 RBM4_MOUSE reviewed RNA-binding protein 4 (Lark homolog) (mLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a) Mus musculus (Mouse) GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006397; GO:0007623; GO:0008270; GO:0008380; GO:0010468; GO:0010494; GO:0016607; GO:0017148; GO:0030332; GO:0031016; GO:0032055; GO:0032922; GO:0035198; GO:0035278; GO:0035773; GO:0035883; GO:0036002; GO:0042593; GO:0043153; GO:0045727; GO:0045947; GO:0046626; GO:0046685; GO:0046822; GO:0048471; GO:0051149; GO:0097157; GO:0097158; GO:0097167 cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g7955.t1 Q6QHC5 69.474 95 1.2199999999999999e-45 152.0 sp|Q6QHC5|DEGS2_HUMAN Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 OS=Homo sapiens OX=9606 GN=DEGS2 PE=1 SV=2 DEGS2_HUMAN reviewed Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 (EC 1.14.18.5) (EC 1.14.19.17) (Degenerative spermatocyte homolog 2) (Sphingolipid 4-desaturase) (Sphingolipid C4-monooxygenase) Homo sapiens (Human) GO:0005789; GO:0006667; GO:0030148; GO:0042284; GO:0046513; GO:0102772 ceramide biosynthetic process [GO:0046513]; sphinganine metabolic process [GO:0006667]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum membrane [GO:0005789] sphingolipid C4-monooxygenase activity [GO:0102772]; sphingolipid delta-4 desaturase activity [GO:0042284] g7956.t1 Q94515 54.023 174 3.28e-69 216.0 sp|Q94515|DEGS1_DROME Sphingolipid delta(4)-desaturase DES1 OS=Drosophila melanogaster OX=7227 GN=ifc PE=1 SV=1 g7957.t1 Q00899 63.93 341 9.05e-136 397.0 sp|Q00899|TYY1_MOUSE Transcriptional repressor protein YY1 OS=Mus musculus OX=10090 GN=Yy1 PE=1 SV=1 g7957.t2 Q00899 64.307 339 6.879999999999999e-138 402.0 sp|Q00899|TYY1_MOUSE Transcriptional repressor protein YY1 OS=Mus musculus OX=10090 GN=Yy1 PE=1 SV=1 g7958.t1 Q5HZE0 53.265 291 1.03e-107 320.0 sp|Q5HZE0|S2529_RAT Mitochondrial basic amino acids transporter OS=Rattus norvegicus OX=10116 GN=Slc25a29 PE=2 SV=1 S2529_RAT reviewed Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29) Rattus norvegicus (Rat) GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0015174; GO:0015227; GO:0015822; GO:0089709; GO:1902616; GO:1903401; GO:1903826; GO:1990575 L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; O-acyl-L-carnitine transmembrane transport [GO:1902616]; ornithine transport [GO:0015822] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227] g7959.t1 Q5M7T4 61.943 247 1.35e-96 288.0 sp|Q5M7T4|YIPF4_RAT Protein YIPF4 OS=Rattus norvegicus OX=10116 GN=Yipf4 PE=2 SV=1 g7960.t1 Q803U7 50.223 448 1.15e-138 439.0 sp|Q803U7|EXO1_DANRE Exonuclease 1 OS=Danio rerio OX=7955 GN=exo1 PE=2 SV=1 g7964.t1 A8E5Y3 41.361 382 6.97e-92 283.0 sp|A8E5Y3|GDPP1_XENLA GDP-D-glucose phosphorylase 1 OS=Xenopus laevis OX=8355 GN=gdpgp1 PE=2 SV=1 GDPP1_XENLA reviewed GDP-D-glucose phosphorylase 1 (EC 2.7.7.78) Xenopus laevis (African clawed frog) GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016787; GO:0080048 glucose metabolic process [GO:0006006] cytoplasm [GO:0005737] GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166] g7964.t2 A8E5Y3 38.916 406 3.29e-86 270.0 sp|A8E5Y3|GDPP1_XENLA GDP-D-glucose phosphorylase 1 OS=Xenopus laevis OX=8355 GN=gdpgp1 PE=2 SV=1 GDPP1_XENLA reviewed GDP-D-glucose phosphorylase 1 (EC 2.7.7.78) Xenopus laevis (African clawed frog) GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016787; GO:0080048 glucose metabolic process [GO:0006006] cytoplasm [GO:0005737] GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166] g7966.t1 Q9UL41 29.712 313 1.33e-32 132.0 sp|Q9UL41|PNMA3_HUMAN Paraneoplastic antigen Ma3 OS=Homo sapiens OX=9606 GN=PNMA3 PE=1 SV=3 PNMA3_HUMAN reviewed Paraneoplastic antigen Ma3 Homo sapiens (Human) GO:0003676; GO:0005730; GO:0008270; GO:0043065 positive regulation of apoptotic process [GO:0043065] nucleolus [GO:0005730] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g7967.t1 Q32PI1 48.925 372 3.5599999999999994e-126 378.0 sp|Q32PI1|VRK1_BOVIN Serine/threonine-protein kinase VRK1 OS=Bos taurus OX=9913 GN=VRK1 PE=2 SV=1 VRK1_BOVIN reviewed Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1) Bos taurus (Bovine) GO:0000785; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005795; GO:0006338; GO:0006468; GO:0006974; GO:0007165; GO:0015030; GO:0030576; GO:0031175; GO:0031492; GO:0046777; GO:0051301; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222 Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165] Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634] ATP binding [GO:0005524]; histone H2AX kinase activity [GO:0141003]; nucleosomal DNA binding [GO:0031492]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7968.t1 Q1L994 52.219 383 1.6499999999999999e-134 423.0 sp|Q1L994|PPR37_DANRE Protein phosphatase 1 regulatory subunit 37 OS=Danio rerio OX=7955 GN=ppp1r37 PE=2 SV=1 g7969.t1 Q8WVM8 66.667 300 7.449999999999999e-138 406.0 sp|Q8WVM8|SCFD1_HUMAN Sec1 family domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SCFD1 PE=1 SV=4 SCFD1_HUMAN reviewed Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2) Homo sapiens (Human) GO:0000139; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0009636; GO:0019905; GO:0032580; GO:0044877; GO:0051223; GO:0060628; GO:1902902 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798] protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905] g7970.t1 Q8BRF7 69.478 249 1.1e-121 363.0 sp|Q8BRF7|SCFD1_MOUSE Sec1 family domain-containing protein 1 OS=Mus musculus OX=10090 GN=Scfd1 PE=1 SV=1 g7972.t1 O09101 43.506 154 5.4299999999999997e-39 137.0 sp|O09101|PIGF_MOUSE GPI ethanolamine phosphate transferase, stabilizing subunit OS=Mus musculus OX=10090 GN=Pigf PE=1 SV=1 g7974.t1 Q5FVJ6 41.259 143 7.420000000000001e-36 133.0 sp|Q5FVJ6|BSCL2_RAT Seipin OS=Rattus norvegicus OX=10116 GN=Bscl2 PE=1 SV=1 BSCL2_RAT reviewed Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein homolog) Rattus norvegicus (Rat) GO:0005543; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0019915; GO:0034389; GO:0045444; GO:0048515; GO:0050995; GO:0060612; GO:0061725; GO:0120162; GO:0140042; GO:1905693 adipose tissue development [GO:0060612]; cytosolic lipolysis [GO:0061725]; fat cell differentiation [GO:0045444]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of phosphatidic acid biosynthetic process [GO:1905693]; spermatid differentiation [GO:0048515] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] phospholipid binding [GO:0005543] g7978.t1 Q8NF91 43.158 380 5.57e-88 294.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7978.t2 Q8NF91 43.045 381 4.3000000000000003e-88 295.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7979.t1 Q8NF91 21.081 2386 1.3e-106 387.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7983.t1 Q6ZWR6 22.715 722 4.66e-34 144.0 sp|Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus OX=10090 GN=Syne1 PE=1 SV=2 SYNE1_MOUSE reviewed Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) Mus musculus (Mouse) GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0007030; GO:0007097; GO:0007283; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090292; GO:0098843; GO:0098871; GO:0098978; GO:0099149; GO:1902017; GO:1903353; GO:2001054 centrosome localization [GO:0051642]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g7983.t1 Q6ZWR6 20.947 697 8.089999999999999e-30 130.0 sp|Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus OX=10090 GN=Syne1 PE=1 SV=2 SYNE1_MOUSE reviewed Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) Mus musculus (Mouse) GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0007030; GO:0007097; GO:0007283; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090292; GO:0098843; GO:0098871; GO:0098978; GO:0099149; GO:1902017; GO:1903353; GO:2001054 centrosome localization [GO:0051642]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g7983.t1 Q6ZWR6 21.642 536 2.6699999999999998e-24 113.0 sp|Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus OX=10090 GN=Syne1 PE=1 SV=2 SYNE1_MOUSE reviewed Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) Mus musculus (Mouse) GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0007030; GO:0007097; GO:0007283; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090292; GO:0098843; GO:0098871; GO:0098978; GO:0099149; GO:1902017; GO:1903353; GO:2001054 centrosome localization [GO:0051642]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g7983.t1 Q6ZWR6 20.968 434 2.9e-22 107.0 sp|Q6ZWR6|SYNE1_MOUSE Nesprin-1 OS=Mus musculus OX=10090 GN=Syne1 PE=1 SV=2 SYNE1_MOUSE reviewed Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) Mus musculus (Mouse) GO:0000932; GO:0002053; GO:0003779; GO:0005102; GO:0005521; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0007030; GO:0007097; GO:0007283; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0043197; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0051642; GO:0061886; GO:0090292; GO:0098843; GO:0098871; GO:0098978; GO:0099149; GO:1902017; GO:1903353; GO:2001054 centrosome localization [GO:0051642]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of cilium assembly [GO:1902017]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g7986.t1 Q8NF91 22.824 517 7.119999999999999e-24 112.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7987.t1 Q8NF91 35.336 3079 0.0 1596.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7987.t1 Q8NF91 20.408 931 2.16e-32 145.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7987.t2 Q8NF91 35.084 3104 0.0 1587.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7987.t2 Q8NF91 20.408 931 2.2e-32 145.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7987.t3 Q8NF91 35.142 3096 0.0 1590.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7987.t3 Q8NF91 20.408 931 1.9400000000000002e-32 145.0 sp|Q8NF91|SYNE1_HUMAN Nesprin-1 OS=Homo sapiens OX=9606 GN=SYNE1 PE=1 SV=4 g7988.t1 Q15573 27.72 386 2.92e-35 140.0 sp|Q15573|TAF1A_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit A OS=Homo sapiens OX=9606 GN=TAF1A PE=1 SV=1 TAF1A_HUMAN reviewed TATA box-binding protein-associated factor RNA polymerase I subunit A (RNA polymerase I-specific TBP-associated factor 48 kDa) (TAFI48) (TATA box-binding protein-associated factor 1A) (TBP-associated factor 1A) (Transcription factor SL1) (Transcription initiation factor SL1/TIF-IB subunit A) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005668; GO:0006360; GO:0006366; GO:0015630 transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668] DNA binding [GO:0003677] g7989.t1 Q8R2K4 45.86 471 5.2300000000000004e-132 404.0 sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1 TAF6L_MOUSE reviewed TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha) Mus musculus (Mouse) GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006355; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:1904672 positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; RNA polymerase II preinitiation complex assembly [GO:0051123] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669] protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713] g7991.t1 Q9H3N1 45.641 195 1.3800000000000001e-65 209.0 sp|Q9H3N1|TMX1_HUMAN Thioredoxin-related transmembrane protein 1 OS=Homo sapiens OX=9606 GN=TMX1 PE=1 SV=1 TMX1_HUMAN reviewed Thioredoxin-related transmembrane protein 1 (Protein disulfide-isomerase TMX1) (EC 5.3.4.1) (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein) Homo sapiens (Human) GO:0003756; GO:0004857; GO:0005576; GO:0005789; GO:0010868; GO:0012505; GO:0015035; GO:0015036; GO:0031966; GO:0034976; GO:0044233; GO:0051924; GO:0090331; GO:1904294 negative regulation of platelet aggregation [GO:0090331]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of ERAD pathway [GO:1904294]; regulation of calcium ion transport [GO:0051924]; response to endoplasmic reticulum stress [GO:0034976] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966] disulfide oxidoreductase activity [GO:0015036]; enzyme inhibitor activity [GO:0004857]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] g7992.t1 Q5R806 54.783 345 1.11e-133 387.0 sp|Q5R806|PTGR2_PONAB Prostaglandin reductase 2 OS=Pongo abelii OX=9601 GN=PTGR2 PE=2 SV=2 PTGR2_PONAB reviewed Prostaglandin reductase 2 (PRG-2) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0006693; GO:0047522 prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522] g7994.t1 O46606 41.736 726 0.0 542.0 sp|O46606|DDHD1_BOVIN Phospholipase DDHD1 OS=Bos taurus OX=9913 GN=DDHD1 PE=1 SV=1 g7995.t1 Q28EM2 53.488 86 4.9900000000000006e-21 82.0 sp|Q28EM2|SIM12_XENTR Small integral membrane protein 12 OS=Xenopus tropicalis OX=8364 GN=smim12 PE=3 SV=1 g7998.t1 P51955 51.471 476 5.27e-155 450.0 sp|P51955|NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens OX=9606 GN=NEK2 PE=1 SV=1 NEK2_HUMAN reviewed Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032206; GO:0032991; GO:0036064; GO:0045171; GO:0046602; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051988; GO:0090307; GO:0106310; GO:1903126 blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of telomere maintenance [GO:0032206]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7999.t1 O35815 51.148 305 2.9200000000000002e-99 302.0 sp|O35815|ATX3_RAT Ataxin-3 OS=Rattus norvegicus OX=10116 GN=Atxn3 PE=1 SV=1 ATX3_RAT reviewed Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog) Rattus norvegicus (Rat) GO:0000226; GO:0000977; GO:0001222; GO:0002181; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0006338; GO:0006511; GO:0006515; GO:0009267; GO:0010810; GO:0016363; GO:0030036; GO:0031625; GO:0031669; GO:0031966; GO:0034198; GO:0034605; GO:0035520; GO:0035640; GO:0038202; GO:0042405; GO:0042802; GO:0042826; GO:0043161; GO:0045104; GO:0045947; GO:0045948; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904262; GO:1904263; GO:1904294; GO:1904327; GO:1990380; GO:2000060 actin cytoskeleton organization [GO:0030036]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; chromatin remodeling [GO:0006338]; cytoplasmic translation [GO:0002181]; exploration behavior [GO:0035640]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex [GO:1904327]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; TORC1 signaling [GO:0038202]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] g8000.t1 Q9WU47 56.048 248 3.28e-94 287.0 sp|Q9WU47|B3GA3_CRIGR Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Cricetulus griseus OX=10029 GN=B3GAT3 PE=2 SV=1 g8001.t1 Q8N801 39.904 208 1.41e-34 127.0 sp|Q8N801|STPG4_HUMAN Protein STPG4 OS=Homo sapiens OX=9606 GN=STPG4 PE=1 SV=2 g8002.t1 Q32M08 64.145 304 7.76e-152 436.0 sp|Q32M08|DUS4L_MOUSE tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Mus musculus OX=10090 GN=Dus4l PE=2 SV=1 g8003.t1 Q96LQ0 33.246 382 9.500000000000001e-59 201.0 sp|Q96LQ0|PPR36_HUMAN Protein phosphatase 1 regulatory subunit 36 OS=Homo sapiens OX=9606 GN=PPP1R36 PE=1 SV=1 g8005.t1 Q5F4A1 36.436 376 1.16e-53 201.0 sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1 g8006.t1 Q8K1Y2 73.952 334 6.57e-172 527.0 sp|Q8K1Y2|KPCD3_MOUSE Serine/threonine-protein kinase D3 OS=Mus musculus OX=10090 GN=Prkd3 PE=1 SV=1 KPCD3_MOUSE reviewed Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (nPKC-nu) Mus musculus (Mouse) GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0007200; GO:0008270; GO:0010647; GO:0016301; GO:0023056; GO:0035556; GO:0036064; GO:0106310 intracellular signal transduction [GO:0035556]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell communication [GO:0010647]; positive regulation of signaling [GO:0023056] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g8006.t1 Q8K1Y2 51.098 501 2.93e-157 489.0 sp|Q8K1Y2|KPCD3_MOUSE Serine/threonine-protein kinase D3 OS=Mus musculus OX=10090 GN=Prkd3 PE=1 SV=1 KPCD3_MOUSE reviewed Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (nPKC-nu) Mus musculus (Mouse) GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0007200; GO:0008270; GO:0010647; GO:0016301; GO:0023056; GO:0035556; GO:0036064; GO:0106310 intracellular signal transduction [GO:0035556]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell communication [GO:0010647]; positive regulation of signaling [GO:0023056] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g8007.t1 Q7ZT47 65.816 196 1.7e-94 276.0 sp|Q7ZT47|PSF1_XENLA DNA replication complex GINS protein PSF1 OS=Xenopus laevis OX=8355 GN=gins1 PE=1 SV=1 PSF1_XENLA reviewed DNA replication complex GINS protein PSF1 (GINS complex subunit 1) Xenopus laevis (African clawed frog) GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902983 DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983] CMG complex [GO:0071162]; GINS complex [GO:0000811] chromatin binding [GO:0003682] g8008.t1 Q9Y5J7 58.974 78 9.55e-30 104.0 sp|Q9Y5J7|TIM9_HUMAN Mitochondrial import inner membrane translocase subunit Tim9 OS=Homo sapiens OX=9606 GN=TIMM9 PE=1 SV=1 TIM9_HUMAN reviewed Mitochondrial import inner membrane translocase subunit Tim9 Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0015031; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0051087; GO:0140318 protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space chaperone complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; zinc ion binding [GO:0008270] g8009.t1 Q55E31 63.102 187 9.3e-83 250.0 sp|Q55E31|RB32B_DICDI Ras-related protein Rab-32B OS=Dictyostelium discoideum OX=44689 GN=rab32B PE=3 SV=1 RB32B_DICDI reviewed Ras-related protein Rab-32B Dictyostelium discoideum (Social amoeba) GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0012505; GO:0016192; GO:0032438; GO:0042470 intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192] endomembrane system [GO:0012505]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g8009.t2 Q55E31 53.153 222 1.27e-76 236.0 sp|Q55E31|RB32B_DICDI Ras-related protein Rab-32B OS=Dictyostelium discoideum OX=44689 GN=rab32B PE=3 SV=1 RB32B_DICDI reviewed Ras-related protein Rab-32B Dictyostelium discoideum (Social amoeba) GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0012505; GO:0016192; GO:0032438; GO:0042470 intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192] endomembrane system [GO:0012505]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g8010.t1 P22027 46.927 179 1.01e-58 186.0 sp|P22027|ATP5S_BOVIN ATP synthase subunit s, mitochondrial OS=Bos taurus OX=9913 GN=DMAC2L PE=1 SV=2 ATP5S_BOVIN reviewed ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B) Bos taurus (Bovine) GO:0005737; GO:0005743; GO:0006754; GO:0045259; GO:0046872; GO:1902600 ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex [GO:0045259] metal ion binding [GO:0046872] g8010.t2 P22027 46.927 179 9.54e-59 187.0 sp|P22027|ATP5S_BOVIN ATP synthase subunit s, mitochondrial OS=Bos taurus OX=9913 GN=DMAC2L PE=1 SV=2 ATP5S_BOVIN reviewed ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B) Bos taurus (Bovine) GO:0005737; GO:0005743; GO:0006754; GO:0045259; GO:0046872; GO:1902600 ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex [GO:0045259] metal ion binding [GO:0046872] g8011.t1 Q4R4Q6 79.339 121 1.5e-69 207.0 sp|Q4R4Q6|YPEL5_MACFA Protein yippee-like 5 OS=Macaca fascicularis OX=9541 GN=YPEL5 PE=2 SV=1 g8013.t1 Q8BW86 24.514 514 4.36e-26 119.0 sp|Q8BW86|ARG33_MOUSE Rho guanine nucleotide exchange factor 33 OS=Mus musculus OX=10090 GN=Arhgef33 PE=1 SV=3 g8014.t1 Q80UF4 32.606 733 1.4600000000000001e-99 326.0 sp|Q80UF4|SDCG8_MOUSE Serologically defined colon cancer antigen 8 homolog OS=Mus musculus OX=10090 GN=Sdccag8 PE=1 SV=1 SDCG8_MOUSE reviewed Serologically defined colon cancer antigen 8 homolog (Centrosomal colon cancer autoantigen protein) (mCCCAP) Mus musculus (Mouse) GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005929; GO:0007098; GO:0030010; GO:0030030; GO:0031023; GO:0034451; GO:0035148; GO:0036064; GO:0097733; GO:1902017 cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; regulation of cilium assembly [GO:1902017]; tube formation [GO:0035148] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733] g8015.t1 Q04864 49.671 304 8.54e-92 301.0 sp|Q04864|REL_HUMAN Proto-oncogene c-Rel OS=Homo sapiens OX=9606 GN=REL PE=1 SV=1 REL_HUMAN reviewed Proto-oncogene c-Rel Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0007249; GO:0010629; GO:0032688; GO:0034097; GO:0038061; GO:0043123; GO:0045087; GO:0045944; GO:0071159 canonical NF-kappaB signal transduction [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g8015.t2 Q04864 49.671 304 1.04e-91 300.0 sp|Q04864|REL_HUMAN Proto-oncogene c-Rel OS=Homo sapiens OX=9606 GN=REL PE=1 SV=1 REL_HUMAN reviewed Proto-oncogene c-Rel Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0007249; GO:0010629; GO:0032688; GO:0034097; GO:0038061; GO:0043123; GO:0045087; GO:0045944; GO:0071159 canonical NF-kappaB signal transduction [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g8016.t1 Q9VZI3 51.052 713 0.0 684.0 sp|Q9VZI3|UN112_DROME Unc-112-related protein OS=Drosophila melanogaster OX=7227 GN=Fit1 PE=1 SV=1 g8017.t1 Q86X10 45.876 1552 0.0 1253.0 sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1 g8017.t2 Q86X10 45.235 1574 0.0 1246.0 sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1 g8017.t3 Q86X10 45.676 1561 0.0 1248.0 sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1 g8018.t1 Q5FWF7 35.172 145 1.21e-21 88.2 sp|Q5FWF7|FBX48_HUMAN F-box only protein 48 OS=Homo sapiens OX=9606 GN=FBXO48 PE=1 SV=1 g8019.t1 O35790 43.694 222 2.0299999999999998e-62 199.0 sp|O35790|PIGL_RAT N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase OS=Rattus norvegicus OX=10116 GN=Pigl PE=1 SV=1 g8021.t1 B6NXD5 49.471 378 2.04e-131 384.0 sp|B6NXD5|BABA2_BRAFL BRISC and BRCA1-A complex member 2 OS=Branchiostoma floridae OX=7739 GN=BABAM2 PE=3 SV=1 BABA2_BRAFL reviewed BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0005634; GO:0005737; GO:0006302; GO:0006325; GO:0006915; GO:0007095; GO:0010212; GO:0031593; GO:0045739; GO:0051301; GO:0070531; GO:0070552 apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634] polyubiquitin modification-dependent protein binding [GO:0031593] g8022.t1 F4IYM4 29.124 491 2.32e-62 226.0 sp|F4IYM4|DEX1_ARATH Protein DEFECTIVE IN EXINE FORMATION 1 OS=Arabidopsis thaliana OX=3702 GN=DEX1 PE=2 SV=1 DEX1_ARATH reviewed Protein DEFECTIVE IN EXINE FORMATION 1 Arabidopsis thaliana (Mouse-ear cress) GO:0000137; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0010208; GO:0010584; GO:0016020; GO:0071555 cell wall organization [GO:0071555]; pollen exine formation [GO:0010584]; pollen wall assembly [GO:0010208] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi cis cisterna [GO:0000137]; membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g8023.t1 A1XQY1 34.552 1450 0.0 789.0 sp|A1XQY1|NR3BA_DANRE Neurexin-3b OS=Danio rerio OX=7955 GN=nrxn3b PE=2 SV=1 NR3BA_DANRE reviewed Neurexin-3b (Neurexin IIIb-alpha) (Neurexin-3b-alpha) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0007155; GO:0016020; GO:0046872 cell adhesion [GO:0007155]; sprouting angiogenesis [GO:0002040] membrane [GO:0016020] metal ion binding [GO:0046872] g8024.t1 Q866F4 32.058 1098 3.6700000000000004e-161 538.0 sp|Q866F4|ADCYA_RABIT Adenylate cyclase type 10 OS=Oryctolagus cuniculus OX=9986 GN=ADCY10 PE=2 SV=1 g8024.t1 Q866F4 23.372 522 6.89e-32 140.0 sp|Q866F4|ADCYA_RABIT Adenylate cyclase type 10 OS=Oryctolagus cuniculus OX=9986 GN=ADCY10 PE=2 SV=1 g8028.t1 G3V801 38.961 154 8.69e-28 112.0 sp|G3V801|NETR_RAT Neurotrypsin OS=Rattus norvegicus OX=10116 GN=Prss12 PE=1 SV=1 NETR_RAT reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Rattus norvegicus (Rat) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g8028.t1 G3V801 32.37 173 2.21e-22 96.3 sp|G3V801|NETR_RAT Neurotrypsin OS=Rattus norvegicus OX=10116 GN=Prss12 PE=1 SV=1 NETR_RAT reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Rattus norvegicus (Rat) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g8044.t1 P49756 52.998 417 7.34e-94 316.0 sp|P49756|RBM25_HUMAN RNA-binding protein 25 OS=Homo sapiens OX=9606 GN=RBM25 PE=1 SV=3 RBM25_HUMAN reviewed RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981 mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g8045.t1 Q05481 30.091 987 5.879999999999999e-135 446.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g8045.t1 Q05481 30.296 911 4.94e-126 422.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g8045.t1 Q05481 29.819 882 3.2e-115 392.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g8045.t1 Q05481 30.889 709 4.13e-91 324.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g8045.t1 Q05481 29.545 264 2.19e-30 134.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g8046.t1 Q90474 76.703 734 0.0 1134.0 sp|Q90474|H90A1_DANRE Heat shock protein HSP 90-alpha 1 OS=Danio rerio OX=7955 GN=hsp90a.1 PE=1 SV=3 g8047.t1 Q9NR09 47.143 420 1.0400000000000001e-123 405.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g8047.t2 Q9NR09 47.143 420 1.2100000000000002e-123 404.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g8049.t1 Q9NR09 36.955 3120 0.0 1682.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g8050.t1 Q9NR09 45.549 1157 0.0 812.0 sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3 BIRC6_HUMAN reviewed Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON) Homo sapiens (Human) GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g8051.t1 Q96L50 34.3 414 1.3e-62 209.0 sp|Q96L50|LLR1_HUMAN Leucine-rich repeat protein 1 OS=Homo sapiens OX=9606 GN=LRR1 PE=1 SV=2 g8052.t1 A2AQ19 50.723 692 4.4599999999999996e-172 511.0 sp|A2AQ19|RTF1_MOUSE RNA polymerase-associated protein RTF1 homolog OS=Mus musculus OX=10090 GN=Rtf1 PE=1 SV=1 RTF1_MOUSE reviewed RNA polymerase-associated protein RTF1 homolog Mus musculus (Mouse) GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0005730; GO:0006325; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:1990269 blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730] RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697] g8054.t1 Q80YR7 40.727 275 1.67e-49 180.0 sp|Q80YR7|CLSPN_MOUSE Claspin OS=Mus musculus OX=10090 GN=Clspn PE=1 SV=2 CLSPN_MOUSE reviewed Claspin Mus musculus (Mouse) GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0033314 DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217] g8055.t1 Q28HE5 48.723 470 6.0499999999999995e-146 429.0 sp|Q28HE5|S38A6_XENTR Probable sodium-coupled neutral amino acid transporter 6 OS=Xenopus tropicalis OX=8364 GN=slc38a6 PE=2 SV=1 S38A6_XENTR reviewed Probable sodium-coupled neutral amino acid transporter 6 (Na(+)-coupled neutral amino acid transporter 6) (Solute carrier family 38 member 6) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003333; GO:0005886; GO:0006814; GO:0006868; GO:0015186 amino acid transmembrane transport [GO:0003333]; glutamine transport [GO:0006868]; sodium ion transport [GO:0006814] plasma membrane [GO:0005886] L-glutamine transmembrane transporter activity [GO:0015186] g8055.t2 Q28HE5 48.62 471 6.979999999999999e-146 429.0 sp|Q28HE5|S38A6_XENTR Probable sodium-coupled neutral amino acid transporter 6 OS=Xenopus tropicalis OX=8364 GN=slc38a6 PE=2 SV=1 S38A6_XENTR reviewed Probable sodium-coupled neutral amino acid transporter 6 (Na(+)-coupled neutral amino acid transporter 6) (Solute carrier family 38 member 6) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003333; GO:0005886; GO:0006814; GO:0006868; GO:0015186 amino acid transmembrane transport [GO:0003333]; glutamine transport [GO:0006868]; sodium ion transport [GO:0006814] plasma membrane [GO:0005886] L-glutamine transmembrane transporter activity [GO:0015186] g8056.t1 Q9CQ46 64.331 157 1.64e-75 226.0 sp|Q9CQ46|DRC8_MOUSE Dynein regulatory complex protein 8 OS=Mus musculus OX=10090 GN=Efcab2 PE=1 SV=1 g8057.t1 O35459 53.791 277 1.43e-108 322.0 sp|O35459|ECH1_MOUSE Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial OS=Mus musculus OX=10090 GN=Ech1 PE=1 SV=1 g8058.t1 Q9HBH5 51.887 318 1.3100000000000002e-97 295.0 sp|Q9HBH5|RDH14_HUMAN Retinol dehydrogenase 14 OS=Homo sapiens OX=9606 GN=RDH14 PE=1 SV=1 RDH14_HUMAN reviewed Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4) Homo sapiens (Human) GO:0001649; GO:0005634; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0052650; GO:0102354 osteoblast differentiation [GO:0001649] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g8059.t1 Q9HBH5 51.701 294 5e-95 288.0 sp|Q9HBH5|RDH14_HUMAN Retinol dehydrogenase 14 OS=Homo sapiens OX=9606 GN=RDH14 PE=1 SV=1 RDH14_HUMAN reviewed Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4) Homo sapiens (Human) GO:0001649; GO:0005634; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0052650; GO:0102354 osteoblast differentiation [GO:0001649] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g8060.t1 Q8NB59 48.64 331 4.3400000000000003e-103 321.0 sp|Q8NB59|SYT14_HUMAN Synaptotagmin-14 OS=Homo sapiens OX=9606 GN=SYT14 PE=1 SV=2 g8063.t1 Q1L9A2 40.397 151 6.1899999999999995e-40 135.0 sp|Q1L9A2|OPA3_DANRE Optic atrophy 3 protein homolog OS=Danio rerio OX=7955 GN=opa3 PE=3 SV=1 OPA3_DANRE reviewed Optic atrophy 3 protein homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005739; GO:0007626; GO:0019216; GO:0031413; GO:0050881 locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216] mitochondrion [GO:0005739] g8064.t1 Q08CF3 42.43 535 2.83e-96 304.0 sp|Q08CF3|CCD61_DANRE Centrosomal protein CCDC61 OS=Danio rerio OX=7955 GN=ccdc61 PE=1 SV=1 CCD61_DANRE reviewed Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005813; GO:0005815; GO:0030030; GO:0034451; GO:0036064; GO:0042802; GO:0090307; GO:0098534; GO:0120103 cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; microtubule organizing center [GO:0005815] identical protein binding [GO:0042802] g8064.t2 Q08CF3 42.537 536 3.98e-96 304.0 sp|Q08CF3|CCD61_DANRE Centrosomal protein CCDC61 OS=Danio rerio OX=7955 GN=ccdc61 PE=1 SV=1 CCD61_DANRE reviewed Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005813; GO:0005815; GO:0030030; GO:0034451; GO:0036064; GO:0042802; GO:0090307; GO:0098534; GO:0120103 cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; microtubule organizing center [GO:0005815] identical protein binding [GO:0042802] g8066.t1 Q14BI7 41.246 1428 0.0 1008.0 sp|Q14BI7|TDRD9_MOUSE ATP-dependent RNA helicase TDRD9 OS=Mus musculus OX=10090 GN=Tdrd9 PE=1 SV=3 g8071.t1 D3YVL2 45.343 1138 0.0 931.0 sp|D3YVL2|CFA70_MOUSE Cilia- and flagella-associated protein 70 OS=Mus musculus OX=10090 GN=Cfap70 PE=1 SV=2 CFA70_MOUSE reviewed Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18) (TPR repeat protein 18) Mus musculus (Mouse) GO:0000902; GO:0002177; GO:0003341; GO:0005737; GO:0005930; GO:0007338; GO:0008104; GO:0010467; GO:0030317; GO:0031514; GO:0036064; GO:0036126; GO:0036157; GO:0044782; GO:0048872; GO:0060271; GO:0065003; GO:0098727; GO:0120316; GO:1905198 cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; intracellular protein localization [GO:0008104]; maintenance of cell number [GO:0098727]; manchette assembly [GO:1905198]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] g8071.t2 D3YVL2 45.965 1140 0.0 947.0 sp|D3YVL2|CFA70_MOUSE Cilia- and flagella-associated protein 70 OS=Mus musculus OX=10090 GN=Cfap70 PE=1 SV=2 CFA70_MOUSE reviewed Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18) (TPR repeat protein 18) Mus musculus (Mouse) GO:0000902; GO:0002177; GO:0003341; GO:0005737; GO:0005930; GO:0007338; GO:0008104; GO:0010467; GO:0030317; GO:0031514; GO:0036064; GO:0036126; GO:0036157; GO:0044782; GO:0048872; GO:0060271; GO:0065003; GO:0098727; GO:0120316; GO:1905198 cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; intracellular protein localization [GO:0008104]; maintenance of cell number [GO:0098727]; manchette assembly [GO:1905198]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] g8072.t1 Q8TEA8 69.799 149 4.930000000000001e-72 224.0 sp|Q8TEA8|DTD1_HUMAN D-aminoacyl-tRNA deacylase 1 OS=Homo sapiens OX=9606 GN=DTD1 PE=1 SV=2 DTD1_HUMAN reviewed D-aminoacyl-tRNA deacylase 1 (DTD) (EC 3.1.1.96) (DNA-unwinding element-binding protein B) (DUE-B) (Gly-tRNA(Ala) deacylase) (Histidyl-tRNA synthase-related) Homo sapiens (Human) GO:0000049; GO:0003677; GO:0005634; GO:0005737; GO:0005739; GO:0006260; GO:0006399; GO:0046872; GO:0051500; GO:0106026 DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; DNA binding [GO:0003677]; Gly-tRNA(Ala) deacylase activity [GO:0106026]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049] g8073.t1 Q8NFF2 51.423 562 0.0 545.0 sp|Q8NFF2|NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 OS=Homo sapiens OX=9606 GN=SLC24A4 PE=1 SV=2 NCKX4_HUMAN reviewed Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4) Homo sapiens (Human) GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834 amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293] g8074.t1 O88350 55.0 140 9.49e-55 172.0 sp|O88350|RBBP9_RAT Serine hydrolase RBBP9 OS=Rattus norvegicus OX=10116 GN=Rbbp9 PE=1 SV=2 g8075.t1 O75884 56.983 179 3.3500000000000003e-77 231.0 sp|O75884|RBBP9_HUMAN Serine hydrolase RBBP9 OS=Homo sapiens OX=9606 GN=RBBP9 PE=1 SV=2 g8076.t1 Q7ZVN5 83.399 506 0.0 885.0 sp|Q7ZVN5|SRP54_DANRE Signal recognition particle subunit SRP54 OS=Danio rerio OX=7955 GN=srp54 PE=2 SV=1 SRP54_DANRE reviewed Signal recognition particle subunit SRP54 (EC 3.6.5.4) (Signal recognition particle 54 kDa protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003924; GO:0005525; GO:0005783; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0016607; GO:0030593; GO:0030851; GO:0030942; GO:0031017 exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786] 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g8077.t1 Q6EV77 53.963 593 0.0 651.0 sp|Q6EV77|FUT8_PANTR Alpha-(1,6)-fucosyltransferase OS=Pan troglodytes OX=9598 GN=FUT8 PE=2 SV=1 FUT8_PANTR reviewed Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase) Pan troglodytes (Chimpanzee) GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0010468; GO:0010761; GO:0017124; GO:0018279; GO:0032580; GO:0043112; GO:0046368; GO:0046921; GO:1900407 fibroblast migration [GO:0010761]; GDP-L-fucose metabolic process [GO:0046368]; integrin-mediated signaling pathway [GO:0007229]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi cisterna membrane [GO:0032580] alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124] g8078.t1 Q75WS4 65.01 523 0.0 723.0 sp|Q75WS4|CRYD_XENLA Cryptochrome DASH OS=Xenopus laevis OX=8355 GN=cry-dash PE=2 SV=1 g8079.t1 Q32Q90 37.989 179 5.79e-33 119.0 sp|Q32Q90|COA8_RAT Cytochrome c oxidase assembly factor 8 OS=Rattus norvegicus OX=10116 GN=Coa8 PE=2 SV=1 g8080.t1 Q5RFE6 48.852 479 1.09e-162 472.0 sp|Q5RFE6|THNS2_PONAB Threonine synthase-like 2 OS=Pongo abelii OX=9601 GN=THNSL2 PE=2 SV=1 g8081.t1 Q6IFY7 54.922 193 7.080000000000001e-66 209.0 sp|Q6IFY7|RTN1A_XENLA Reticulon-1-A OS=Xenopus laevis OX=8355 GN=rtn1-a PE=2 SV=1 g8081.t2 Q6IFY7 56.452 186 1.5900000000000001e-65 208.0 sp|Q6IFY7|RTN1A_XENLA Reticulon-1-A OS=Xenopus laevis OX=8355 GN=rtn1-a PE=2 SV=1 g8082.t1 Q3B7D2 58.661 508 0.0 627.0 sp|Q3B7D2|SPTC2_RAT Serine palmitoyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Sptlc2 PE=1 SV=1 SPTC2_RAT reviewed Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Rattus norvegicus (Rat) GO:0004758; GO:0005789; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0035902; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504 adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; response to immobilization stress [GO:0035902]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] g8083.t1 Q5R7R9 66.912 544 0.0 679.0 sp|Q5R7R9|SNW1_PONAB SNW domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SNW1 PE=2 SV=1 SNW1_PONAB reviewed SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0016363; GO:0016922; GO:0030511; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0070562; GO:0071007 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384] nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear vitamin D receptor binding [GO:0042809]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g8084.t1 Q86TW2 57.143 476 0.0 566.0 sp|Q86TW2|ADCK1_HUMAN AarF domain-containing protein kinase 1 OS=Homo sapiens OX=9606 GN=ADCK1 PE=1 SV=2 g8085.t1 A7SL20 45.228 241 2.37e-62 199.0 sp|A7SL20|RRP36_NEMVE Ribosomal RNA processing protein 36 homolog OS=Nematostella vectensis OX=45351 GN=v1g245966 PE=3 SV=1 g8087.t1 Q6ZMW3 65.566 1969 0.0 2812.0 sp|Q6ZMW3|EMAL6_HUMAN Echinoderm microtubule-associated protein-like 6 OS=Homo sapiens OX=9606 GN=EML6 PE=1 SV=2 g8090.t1 A6NEE1 39.492 433 1.67e-98 311.0 sp|A6NEE1|PLHD1_HUMAN Pleckstrin homology domain-containing family D member 1 OS=Homo sapiens OX=9606 GN=PLEKHD1 PE=1 SV=3 g8091.t1 Q9D0U9 48.095 210 8.96e-53 174.0 sp|Q9D0U9|ARV1_MOUSE Protein ARV1 OS=Mus musculus OX=10090 GN=Arv1 PE=2 SV=1 ARV1_MOUSE reviewed Protein ARV1 Mus musculus (Mouse) GO:0001889; GO:0005789; GO:0005794; GO:0006631; GO:0006641; GO:0006665; GO:0008203; GO:0008206; GO:0009749; GO:0010467; GO:0015721; GO:0015908; GO:0016125; GO:0030301; GO:0031667; GO:0032366; GO:0032383; GO:0032541; GO:0032868; GO:0033344; GO:0033489; GO:0033490; GO:0038185; GO:0090181; GO:0097036; GO:0120015 bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; gene expression [GO:0010467]; intracellular sterol transport [GO:0032366]; liver development [GO:0001889]; nuclear receptor-mediated bile acid signaling pathway [GO:0038185]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125]; triglyceride metabolic process [GO:0006641] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] sterol transfer activity [GO:0120015] g8092.t1 Q8WXG1 62.571 350 1.25e-162 462.0 sp|Q8WXG1|RSAD2_HUMAN S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Homo sapiens OX=9606 GN=RSAD2 PE=1 SV=1 RSAD2_HUMAN reviewed S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (EC 4.2.-.-) (Cytomegalovirus-induced gene 5 protein) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin) Homo sapiens (Human) GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553 CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] 4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872] g8093.t1 Q2HJF9 66.97 330 1.6600000000000001e-164 467.0 sp|Q2HJF9|RSAD2_BOVIN S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Bos taurus OX=9913 GN=RSAD2 PE=2 SV=1 RSAD2_BOVIN reviewed S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (EC 4.2.-.-) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin) Bos taurus (Bovine) GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553 CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] 4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872] g8093.t2 Q2HJF9 68.652 319 8.09e-164 465.0 sp|Q2HJF9|RSAD2_BOVIN S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Bos taurus OX=9913 GN=RSAD2 PE=2 SV=1 RSAD2_BOVIN reviewed S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (EC 4.2.-.-) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin) Bos taurus (Bovine) GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553 CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] 4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872] g8098.t1 Q14995 28.032 503 9.320000000000001e-43 163.0 sp|Q14995|NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens OX=9606 GN=NR1D2 PE=1 SV=4 NR1D2_HUMAN reviewed Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030522; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g8099.t1 Q8VCX6 42.416 356 9.349999999999999e-82 261.0 sp|Q8VCX6|KPTN_MOUSE KICSTOR complex protein kaptin OS=Mus musculus OX=10090 GN=Kptn PE=2 SV=1 g8099.t2 Q8VCX6 42.416 356 5.53e-82 261.0 sp|Q8VCX6|KPTN_MOUSE KICSTOR complex protein kaptin OS=Mus musculus OX=10090 GN=Kptn PE=2 SV=1 g8100.t1 Q6DDB9 74.576 236 1.7599999999999998e-128 366.0 sp|Q6DDB9|PNO1_XENTR RNA-binding protein PNO1 OS=Xenopus tropicalis OX=8364 GN=pno1 PE=2 SV=1 g8101.t1 B2RYN7 46.972 611 2.21e-160 474.0 sp|B2RYN7|SPAST_RAT Spastin OS=Rattus norvegicus OX=10116 GN=Spast PE=1 SV=1 SPAST_RAT reviewed Spastin (EC 5.6.1.1) Rattus norvegicus (Rat) GO:0000281; GO:0000922; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006888; GO:0008017; GO:0008089; GO:0008568; GO:0010458; GO:0015630; GO:0016887; GO:0019896; GO:0021955; GO:0030424; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0071782; GO:0090148; GO:1904115 anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; central nervous system neuron axonogenesis [GO:0021955]; cytokinetic process [GO:0032506]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922] alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568] g8105.t1 Q04865 27.517 298 5.09e-21 99.8 sp|Q04865|TF65_XENLA Putative transcription factor p65 homolog OS=Xenopus laevis OX=8355 GN=rela PE=2 SV=1 g8107.t1 Q8NBN7 58.044 317 3.98e-111 329.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g8107.t2 Q8NBN7 57.68 319 4.9e-109 323.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g8108.t1 Q8CEE7 55.418 323 7.27e-104 311.0 sp|Q8CEE7|RDH13_MOUSE Retinol dehydrogenase 13 OS=Mus musculus OX=10090 GN=Rdh13 PE=1 SV=1 g8109.t1 Q62730 38.591 298 4.32e-66 217.0 sp|Q62730|DHB2_RAT Estradiol 17-beta-dehydrogenase 2 OS=Rattus norvegicus OX=10116 GN=Hsd17b2 PE=1 SV=1 DHB2_RAT reviewed Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) Rattus norvegicus (Rat) GO:0001701; GO:0001890; GO:0004303; GO:0005789; GO:0006702; GO:0006703; GO:0008202; GO:0008209; GO:0032526; GO:0047035; GO:0060348; GO:0071248 androgen biosynthetic process [GO:0006702]; androgen metabolic process [GO:0008209]; bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789] estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035] g8110.t1 Q8NBN7 54.952 313 5.99e-102 306.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g8111.t1 P30825 28.795 639 1.1100000000000001e-66 232.0 sp|P30825|CTR1_HUMAN High affinity cationic amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A1 PE=1 SV=1 CTR1_HUMAN reviewed High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter) Homo sapiens (Human) GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0006865; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:0098655; GO:0150104; GO:1903352; GO:1903401; GO:1903810; GO:1903826 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-lysine transmembrane transport [GO:1903401]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; monoatomic cation transmembrane transport [GO:0098655]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618] g8112.t1 Q5RBF1 59.375 352 1.56e-142 412.0 sp|Q5RBF1|SIR2_PONAB NAD-dependent protein deacetylase sirtuin-2 OS=Pongo abelii OX=9601 GN=SIRT2 PE=1 SV=1 SIR2_PONAB reviewed NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-2) (EC 2.3.1.-) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0006476; GO:0010507; GO:0010801; GO:0016042; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046890; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0062013; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140219; GO:0140228; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378 cell division [GO:0051301]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; lipid catabolic process [GO:0016042]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of small molecule metabolic process [GO:0062013]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of lipid biosynthetic process [GO:0046890]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042] centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819] chromatin binding [GO:0003682]; histone benzoyllysine debenzoylase activity [GO:0140228]; histone deacetylase activity [GO:0004407]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; histone methacryllysine demethacrylase activity [GO:0140219]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903] g8114.t1 P79702 53.012 83 9.48e-22 96.7 sp|P79702|FOS_CYPCA Protein c-Fos OS=Cyprinus carpio OX=7962 GN=fos PE=2 SV=1 g8114.t2 P79702 53.012 83 9.67e-22 97.1 sp|P79702|FOS_CYPCA Protein c-Fos OS=Cyprinus carpio OX=7962 GN=fos PE=2 SV=1 g8115.t1 P18847 43.846 130 7.21e-22 90.5 sp|P18847|ATF3_HUMAN Cyclic AMP-dependent transcription factor ATF-3 OS=Homo sapiens OX=9606 GN=ATF3 PE=1 SV=2 ATF3_HUMAN reviewed Cyclic AMP-dependent transcription factor ATF-3 (cAMP-dependent transcription factor ATF-3) (Activating transcription factor 3) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005813; GO:0006094; GO:0006357; GO:0007179; GO:0008284; GO:0010628; GO:0016604; GO:0030968; GO:0034198; GO:0034341; GO:0034976; GO:0035914; GO:0036064; GO:0042802; GO:0042803; GO:0045944; GO:0046982; GO:0070373; GO:0090575; GO:1903984; GO:1990622; GO:1990837 cellular response to amino acid starvation [GO:0034198]; endoplasmic reticulum unfolded protein response [GO:0030968]; gluconeogenesis [GO:0006094]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to type II interferon [GO:0034341]; skeletal muscle cell differentiation [GO:0035914]; transforming growth factor beta receptor signaling pathway [GO:0007179] centrosome [GO:0005813]; CHOP-ATF3 complex [GO:1990622]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g8118.t1 Q2KIA2 58.537 123 7.55e-47 150.0 sp|Q2KIA2|TR112_BOVIN Multifunctional methyltransferase subunit TRM112-like protein OS=Bos taurus OX=9913 GN=TRMT112 PE=2 SV=1 TR112_BOVIN reviewed Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog) Bos taurus (Bovine) GO:0000470; GO:0005634; GO:0005654; GO:0005737; GO:0018364; GO:0030490; GO:0031167; GO:0043528; GO:0045815; GO:0046982; GO:0048471; GO:0070476; GO:0141106; GO:2000234 maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; transcription initiation-coupled chromatin remodeling [GO:0045815] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA (m2G10) methyltransferase complex [GO:0043528] protein heterodimerization activity [GO:0046982]; tRNA methyltransferase activator activity [GO:0141106] g8119.t1 Q8IMC6 66.304 368 1.5500000000000002e-157 525.0 sp|Q8IMC6|ASATR_DROME Tau-tubulin kinase homolog Asator OS=Drosophila melanogaster OX=7227 GN=Asator PE=1 SV=2 ASATR_DROME reviewed Tau-tubulin kinase homolog Asator (EC 2.7.11.1) Drosophila melanogaster (Fruit fly) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0007165; GO:0106310 signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8120.t1 O75689 35.912 362 4.8999999999999995e-62 219.0 sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2 ADAP1_HUMAN reviewed Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25) Homo sapiens (Human) GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043533; GO:1902936 cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270] g8120.t2 O75689 35.912 362 1.22e-62 219.0 sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2 ADAP1_HUMAN reviewed Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25) Homo sapiens (Human) GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043533; GO:1902936 cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270] g8121.t1 Q99PL5 27.132 774 1.1399999999999999e-45 184.0 sp|Q99PL5|RRBP1_MOUSE Ribosome-binding protein 1 OS=Mus musculus OX=10090 GN=Rrbp1 PE=1 SV=2 g8121.t2 Q99PL5 27.132 774 8.579999999999999e-46 184.0 sp|Q99PL5|RRBP1_MOUSE Ribosome-binding protein 1 OS=Mus musculus OX=10090 GN=Rrbp1 PE=1 SV=2 g8121.t3 Q99PL5 26.533 750 1.1400000000000001e-33 145.0 sp|Q99PL5|RRBP1_MOUSE Ribosome-binding protein 1 OS=Mus musculus OX=10090 GN=Rrbp1 PE=1 SV=2 g8122.t1 C3XR70 57.736 265 8.83e-105 310.0 sp|C3XR70|ENOPH_BRAFL Enolase-phosphatase E1 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_73099 PE=3 SV=1 ENOPH_BRAFL reviewed Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0000287; GO:0005634; GO:0005737; GO:0019509; GO:0043874 L-methionine salvage from methylthioadenosine [GO:0019509] cytoplasm [GO:0005737]; nucleus [GO:0005634] acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287] g8123.t1 Q69ZR2 73.399 1327 0.0 1966.0 sp|Q69ZR2|HECD1_MOUSE E3 ubiquitin-protein ligase HECTD1 OS=Mus musculus OX=10090 GN=Hectd1 PE=1 SV=2 HECD1_MOUSE reviewed E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1) (Protein open mind) Mus musculus (Mouse) GO:0000209; GO:0001779; GO:0001843; GO:0001892; GO:0003170; GO:0003281; GO:0016607; GO:0035904; GO:0043161; GO:0046872; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:1903077 aorta development [GO:0035904]; embryonic placenta development [GO:0001892]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] nuclear speck [GO:0016607] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] g8123.t1 Q69ZR2 60.208 867 0.0 1064.0 sp|Q69ZR2|HECD1_MOUSE E3 ubiquitin-protein ligase HECTD1 OS=Mus musculus OX=10090 GN=Hectd1 PE=1 SV=2 HECD1_MOUSE reviewed E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1) (Protein open mind) Mus musculus (Mouse) GO:0000209; GO:0001779; GO:0001843; GO:0001892; GO:0003170; GO:0003281; GO:0016607; GO:0035904; GO:0043161; GO:0046872; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:1903077 aorta development [GO:0035904]; embryonic placenta development [GO:0001892]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] nuclear speck [GO:0016607] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] g8128.t1 Q05090 81.204 681 0.0 1071.0 sp|Q05090|KLC_STRPU Kinesin light chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g8128.t2 Q05090 80.47 681 0.0 1054.0 sp|Q05090|KLC_STRPU Kinesin light chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g8129.t1 Q78P75 89.773 88 3.11e-55 172.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g8129.t1 Q78P75 82.759 87 2.93e-50 160.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g8130.t1 Q78P75 82.759 87 7.06e-53 165.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g8131.t1 Q78P75 89.412 85 1.5699999999999998e-54 167.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g8132.t1 P27657 42.939 347 2.9299999999999997e-81 257.0 sp|P27657|LIPP_RAT Pancreatic triacylglycerol lipase OS=Rattus norvegicus OX=10116 GN=Pnlip PE=1 SV=1 LIPP_RAT reviewed Pancreatic triacylglycerol lipase (PL) (Pancreatic lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0001523; GO:0004465; GO:0004806; GO:0005615; GO:0006629; GO:0006633; GO:0008970; GO:0009791; GO:0016298; GO:0019433; GO:0030299; GO:0033993; GO:0034375; GO:0042632; GO:0043434; GO:0046872; GO:0047376; GO:0050253 cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; post-embryonic development [GO:0009791]; response to lipid [GO:0033993]; response to peptide hormone [GO:0043434]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; metal ion binding [GO:0046872]; phospholipase A1 activity [GO:0008970]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8133.t1 P81139 43.072 332 6.92e-85 266.0 sp|P81139|LIPR2_CAVPO Pancreatic lipase-related protein 2 OS=Cavia porcellus OX=10141 GN=PNLIPRP2 PE=1 SV=1 LIPR2_CAVPO reviewed Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (GPL) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3) Cavia porcellus (Guinea pig) GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0006644; GO:0009395; GO:0019376; GO:0019433; GO:0042589; GO:0043005; GO:0047372; GO:0047714 galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589] calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806] g8134.t1 P54315 41.525 354 3.49e-87 273.0 sp|P54315|LIPR1_HUMAN Inactive pancreatic lipase-related protein 1 OS=Homo sapiens OX=9606 GN=PNLIPRP1 PE=1 SV=1 LIPR1_HUMAN reviewed Inactive pancreatic lipase-related protein 1 (PL-RP1) Homo sapiens (Human) GO:0004465; GO:0004806; GO:0005509; GO:0005576; GO:0006633; GO:0008970; GO:0019433; GO:0034375; GO:0042632 cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; triglyceride catabolic process [GO:0019433] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; lipoprotein lipase activity [GO:0004465]; phospholipase A1 activity [GO:0008970]; triacylglycerol lipase activity [GO:0004806] g8135.t1 Q504Y2 40.374 374 1.4499999999999999e-84 273.0 sp|Q504Y2|PKDCC_HUMAN Extracellular tyrosine-protein kinase PKDCC OS=Homo sapiens OX=9606 GN=PKDCC PE=1 SV=2 PKDCC_HUMAN reviewed Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase) Homo sapiens (Human) GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] g8137.t1 Q6P2X9 26.45 431 5.850000000000001e-31 127.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g8138.t1 Q6P2X9 26.573 429 1.98e-30 125.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g8139.t1 Q6P2X9 25.581 430 6.85e-29 121.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g8140.t1 Q8BSL4 32.082 293 2.7899999999999998e-46 165.0 sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1 g8141.t1 O75096 38.246 285 7.69e-43 169.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8141.t1 O75096 37.05 278 4.24e-39 157.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8141.t1 O75096 34.926 272 7.69e-38 154.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8141.t1 O75096 32.542 295 1.05e-36 150.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8143.t1 O88572 34.513 339 1.1399999999999998e-42 172.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8143.t1 O88572 35.739 291 8.120000000000001e-37 154.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8143.t1 O88572 32.646 291 3.33e-35 148.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8143.t1 O88572 27.34 406 4.47e-26 119.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8144.t1 Q06807 36.842 437 4.08e-86 291.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g8145.t1 O75096 38.628 277 2.1400000000000002e-47 179.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8145.t1 O75096 35.463 313 1.76e-45 173.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8145.t1 O75096 40.758 211 2.7399999999999998e-42 164.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8145.t1 O75096 33.929 280 2.98e-41 160.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8146.t1 Q9UGM3 43.112 784 3.1700000000000003e-169 550.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8146.t1 Q9UGM3 43.974 755 1.85e-168 548.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8146.t1 Q9UGM3 43.553 760 7.16e-165 538.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8146.t1 Q9UGM3 42.139 776 5.41e-162 530.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8146.t1 Q9UGM3 42.857 763 3.11e-159 522.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8146.t1 Q9UGM3 43.016 630 5.1800000000000007e-132 444.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8146.t1 Q9UGM3 38.494 478 3.67e-78 284.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8146.t1 Q9UGM3 38.136 354 6.91e-49 193.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8147.t1 Q9QYP1 37.764 331 3.64e-44 170.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8147.t1 Q9QYP1 35.612 278 5.810000000000001e-43 167.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8147.t1 Q9QYP1 35.915 284 2.02e-41 162.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8147.t1 Q9QYP1 34.672 274 4.07e-37 149.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g8148.t1 Q9UGM3 38.523 501 1.37e-80 276.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 37.262 526 2.68e-80 275.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 36.59 522 4.62e-80 275.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 36.782 522 6.830000000000001e-80 274.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 36.973 522 7.530000000000001e-79 271.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 36.812 527 1.05e-77 268.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 36.498 474 1.1099999999999999e-67 239.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 34.236 517 2.9000000000000004e-56 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 33.333 513 5.2699999999999996e-52 193.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8148.t1 Q9UGM3 51.961 102 2.8700000000000003e-21 101.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8149.t1 Q9UGM3 37.974 1688 0.0 986.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8149.t1 Q9UGM3 36.241 1857 0.0 947.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8149.t1 Q9UGM3 38.179 1527 0.0 875.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8149.t1 Q9UGM3 37.953 938 1.8700000000000002e-157 544.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8150.t1 Q95218 46.369 358 1.38e-87 291.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g8150.t1 Q95218 42.52 381 1.95e-79 268.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g8150.t1 Q95218 41.818 385 2.92e-78 265.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g8150.t1 Q95218 42.797 236 1.97e-50 184.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g8152.t1 Q7LHG5 30.769 871 8.37e-107 365.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g8153.t1 Q9UGM3 45.484 620 4.39e-141 468.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8153.t1 Q9UGM3 45.234 619 1.44e-138 461.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8153.t1 Q9UGM3 43.918 633 2.36e-136 454.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8153.t1 Q9UGM3 43.444 633 1.3099999999999999e-135 452.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8153.t1 Q9UGM3 45.714 490 6.09e-113 386.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8153.t1 Q9UGM3 45.628 366 3.32e-80 289.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8153.t1 Q9UGM3 35.977 353 1.4099999999999998e-45 182.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8154.t1 Q8BYK4 53.618 304 1.32e-102 306.0 sp|Q8BYK4|RDH12_MOUSE Retinol dehydrogenase 12 OS=Mus musculus OX=10090 GN=Rdh12 PE=2 SV=1 RDH12_MOUSE reviewed Retinol dehydrogenase 12 (EC 1.1.1.300) Mus musculus (Mouse) GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g8155.t1 Q9UGM3 33.797 1654 0.0 808.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8155.t1 Q9UGM3 33.722 1545 0.0 761.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8155.t1 Q9UGM3 33.076 1554 0.0 733.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8155.t1 Q9UGM3 33.067 1503 0.0 714.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8155.t1 Q9UGM3 32.818 905 3.44e-112 403.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8155.t1 Q9UGM3 31.781 494 1.1099999999999999e-55 219.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g8157.t1 Q9MYY0 35.968 506 1.76e-95 303.0 sp|Q9MYY0|HPSE_BOVIN Heparanase OS=Bos taurus OX=9913 GN=HPSE PE=2 SV=2 g8158.t1 Q9Z1K8 45.418 502 6.96e-144 426.0 sp|Q9Z1K8|YLAT1_MOUSE Y+L amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a7 PE=1 SV=1 YLAT1_MOUSE reviewed Y+L amino acid transporter 1 (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1) Mus musculus (Mouse) GO:0000821; GO:0003333; GO:0015174; GO:0015179; GO:0015820; GO:0016323; GO:0061459; GO:1903826 amino acid transmembrane transport [GO:0003333]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; regulation of arginine metabolic process [GO:0000821] basolateral plasma membrane [GO:0016323] basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459] g8158.t2 Q9Z1K8 44.727 512 2.4600000000000002e-145 430.0 sp|Q9Z1K8|YLAT1_MOUSE Y+L amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a7 PE=1 SV=1 YLAT1_MOUSE reviewed Y+L amino acid transporter 1 (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1) Mus musculus (Mouse) GO:0000821; GO:0003333; GO:0015174; GO:0015179; GO:0015820; GO:0016323; GO:0061459; GO:1903826 amino acid transmembrane transport [GO:0003333]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; regulation of arginine metabolic process [GO:0000821] basolateral plasma membrane [GO:0016323] basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459] g8158.t3 Q9Z1K8 45.618 502 1.06e-145 431.0 sp|Q9Z1K8|YLAT1_MOUSE Y+L amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a7 PE=1 SV=1 YLAT1_MOUSE reviewed Y+L amino acid transporter 1 (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1) Mus musculus (Mouse) GO:0000821; GO:0003333; GO:0015174; GO:0015179; GO:0015820; GO:0016323; GO:0061459; GO:1903826 amino acid transmembrane transport [GO:0003333]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; regulation of arginine metabolic process [GO:0000821] basolateral plasma membrane [GO:0016323] basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459] g8158.t4 Q5RAE3 50.294 340 2.69e-98 304.0 sp|Q5RAE3|LAT2_PONAB Large neutral amino acids transporter small subunit 2 OS=Pongo abelii OX=9601 GN=SLC7A8 PE=2 SV=3 LAT2_PONAB reviewed Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0015175; GO:0015180; GO:0015187; GO:0015190; GO:0015297; GO:0015349; GO:0015804; GO:0015827; GO:0015829; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0046982; GO:0070327; GO:1903801; GO:1904273 L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; microvillus membrane [GO:0031528] antiporter activity [GO:0015297]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; protein heterodimerization activity [GO:0046982]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534] g8159.t1 P54921 72.202 277 9.369999999999999e-150 424.0 sp|P54921|SNAA_RAT Alpha-soluble NSF attachment protein OS=Rattus norvegicus OX=10116 GN=Napa PE=1 SV=2 g8160.t1 Q91ZR5 37.901 343 8.82e-63 219.0 sp|Q91ZR5|CTSR1_MOUSE Cation channel sperm-associated protein 1 OS=Mus musculus OX=10090 GN=Catsper1 PE=1 SV=1 CTSR1_MOUSE reviewed Cation channel sperm-associated protein 1 (CatSper1) Mus musculus (Mouse) GO:0005227; GO:0005245; GO:0005886; GO:0006816; GO:0007283; GO:0007342; GO:0030154; GO:0030317; GO:0036126; GO:0036128; GO:0051924; GO:0060296; GO:0097228 calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; regulation of calcium ion transport [GO:0051924]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] calcium-activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245] g8161.t1 Q5SY80 24.479 960 3.69e-62 232.0 sp|Q5SY80|CTSRE_HUMAN Cation channel sperm-associated auxiliary subunit epsilon OS=Homo sapiens OX=9606 GN=CATSPERE PE=1 SV=1 g8162.t1 Q6GN70 66.286 175 1.53e-88 259.0 sp|Q6GN70|B9D2_XENLA B9 domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=b9d2 PE=2 SV=1 g8163.t1 Q9VBW3 43.548 310 2.2399999999999998e-82 288.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g8163.t2 Q9VBW3 43.548 310 2.4899999999999998e-82 288.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g8165.t1 Q8N2M8 57.061 347 8.64e-96 310.0 sp|Q8N2M8|CLASR_HUMAN CLK4-associating serine/arginine rich protein OS=Homo sapiens OX=9606 GN=CLASRP PE=1 SV=5 CLASR_HUMAN reviewed CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2) Homo sapiens (Human) GO:0005654; GO:0006397; GO:0008380 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654] g8167.t1 Q9UIU6 65.426 188 3.13e-85 282.0 sp|Q9UIU6|SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens OX=9606 GN=SIX4 PE=1 SV=2 g8170.t1 Q6NZ04 66.454 313 5.8e-142 404.0 sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1 SIX1B_DANRE reviewed Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146 adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g8172.t1 O95475 82.791 215 5.2100000000000006e-123 353.0 sp|O95475|SIX6_HUMAN Homeobox protein SIX6 OS=Homo sapiens OX=9606 GN=SIX6 PE=1 SV=2 SIX6_HUMAN reviewed Homeobox protein SIX6 (Homeodomain protein OPTX2) (Optic homeobox 2) (Sine oculis homeobox homolog 6) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001654; GO:0005634; GO:0005667; GO:0006357; GO:0007601; GO:0009887; GO:1990837 animal organ morphogenesis [GO:0009887]; eye development [GO:0001654]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g8174.t1 Q9C0K0 40.219 547 1.59e-76 270.0 sp|Q9C0K0|BC11B_HUMAN B-cell lymphoma/leukemia 11B OS=Homo sapiens OX=9606 GN=BCL11B PE=1 SV=1 BC11B_HUMAN reviewed B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0005654; GO:0006366; GO:0008270; GO:0008285; GO:0010837; GO:0016514; GO:0019216; GO:0021773; GO:0021902; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043368; GO:0045664; GO:0045944; GO:0046632; GO:0048538; GO:0070242; GO:0070244; GO:0071678; GO:0097535; GO:1990837 alpha-beta T cell differentiation [GO:0046632]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of thymocyte apoptotic process [GO:0070244]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymocyte apoptotic process [GO:0070242]; thymus development [GO:0048538]; transcription by RNA polymerase II [GO:0006366] neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g8174.t2 Q9C0K0 40.219 547 1.88e-76 270.0 sp|Q9C0K0|BC11B_HUMAN B-cell lymphoma/leukemia 11B OS=Homo sapiens OX=9606 GN=BCL11B PE=1 SV=1 BC11B_HUMAN reviewed B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0005654; GO:0006366; GO:0008270; GO:0008285; GO:0010837; GO:0016514; GO:0019216; GO:0021773; GO:0021902; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043368; GO:0045664; GO:0045944; GO:0046632; GO:0048538; GO:0070242; GO:0070244; GO:0071678; GO:0097535; GO:1990837 alpha-beta T cell differentiation [GO:0046632]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of thymocyte apoptotic process [GO:0070244]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymocyte apoptotic process [GO:0070242]; thymus development [GO:0048538]; transcription by RNA polymerase II [GO:0006366] neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g8177.t1 Q3SZE9 39.481 347 2.5799999999999997e-91 279.0 sp|Q3SZE9|TBCC_BOVIN Tubulin-specific chaperone C OS=Bos taurus OX=9913 GN=TBCC PE=2 SV=1 g8178.t1 P53794 63.542 96 2.88e-32 120.0 sp|P53794|SC5A3_HUMAN Sodium/myo-inositol cotransporter OS=Homo sapiens OX=9606 GN=SLC5A3 PE=1 SV=4 SC5A3_HUMAN reviewed Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) Homo sapiens (Human) GO:0005365; GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0015146; GO:0015150; GO:0015166; GO:0015459; GO:0015750; GO:0015756; GO:0015791; GO:0015798; GO:0016020; GO:0016323; GO:0016324; GO:0044325; GO:0048471; GO:0150104; GO:1903428; GO:1904659; GO:1904679; GO:1905477 D-glucose transmembrane transport [GO:1904659]; fucose transmembrane transport [GO:0015756]; inositol metabolic process [GO:0006020]; myo-inositol import across plasma membrane [GO:1904679]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; polyol transmembrane transport [GO:0015791]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] D-glucose:sodium symporter activity [GO:0005412]; fucose transmembrane transporter activity [GO:0015150]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325] g8179.t1 Q9JKZ2 54.605 304 2.1e-120 368.0 sp|Q9JKZ2|SC5A3_MOUSE Sodium/myo-inositol cotransporter OS=Mus musculus OX=10090 GN=Slc5a3 PE=1 SV=2 SC5A3_MOUSE reviewed Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) Mus musculus (Mouse) GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0008076; GO:0015459; GO:0015798; GO:0016323; GO:0016324; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1905477 inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] D-glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325] g8180.t1 O42282 33.819 343 9.25e-78 244.0 sp|O42282|RDS2_CHICK Photoreceptor outer segment membrane glycoprotein 2 OS=Gallus gallus OX=9031 PE=2 SV=1 g8181.t1 O42282 29.545 308 9.42e-51 182.0 sp|O42282|RDS2_CHICK Photoreceptor outer segment membrane glycoprotein 2 OS=Gallus gallus OX=9031 PE=2 SV=1 g8185.t1 Q9Z129 43.194 551 1.16e-153 457.0 sp|Q9Z129|RECQ1_MOUSE ATP-dependent DNA helicase Q1 OS=Mus musculus OX=10090 GN=Recql PE=1 SV=2 g8189.t1 Q5ZHS3 54.4 125 3.03e-46 150.0 sp|Q5ZHS3|C1D_CHICK Nuclear nucleic acid-binding protein C1D OS=Gallus gallus OX=9031 GN=C1D PE=2 SV=1 g8190.t1 Q3UJK4 61.007 536 0.0 659.0 sp|Q3UJK4|GTPB2_MOUSE GTP-binding protein 2 OS=Mus musculus OX=10090 GN=Gtpbp2 PE=1 SV=1 GTPB2_MOUSE reviewed GTP-binding protein 2 (GTP-binding-like protein 2) Mus musculus (Mouse) GO:0003746; GO:0003924; GO:0005525; GO:0006414; GO:0042802; GO:0070966; GO:0072344; GO:1904678 nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414] alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746] g8192.t1 P62142 87.539 321 0.0 582.0 sp|P62142|PP1B_RAT Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Rattus norvegicus OX=10116 GN=Ppp1cb PE=1 SV=3 PP1B_RAT reviewed Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16) (EC 3.1.3.53) Rattus norvegicus (Rat) GO:0000164; GO:0000781; GO:0004721; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005977; GO:0005979; GO:0005981; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042587; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0072357 cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357] metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722] g8194.t1 P21262 67.105 76 4.94e-34 114.0 sp|P21262|SRP09_CANLF Signal recognition particle 9 kDa protein OS=Canis lupus familiaris OX=9615 GN=SRP9 PE=1 SV=2 g8195.t1 Q5R896 36.142 451 4.43e-54 188.0 sp|Q5R896|EVL_PONAB Ena/VASP-like protein OS=Pongo abelii OX=9601 GN=EVL PE=2 SV=1 EVL_PONAB reviewed Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001725; GO:0003779; GO:0005522; GO:0005737; GO:0008154; GO:0010633; GO:0017124; GO:0030027; GO:0030838; GO:0051289; GO:0051496; GO:1900028 actin polymerization or depolymerization [GO:0008154]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289] cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124] g8195.t2 Q8N8S7 70.796 113 4.4e-47 175.0 sp|Q8N8S7|ENAH_HUMAN Protein enabled homolog OS=Homo sapiens OX=9606 GN=ENAH PE=1 SV=2 ENAH_HUMAN reviewed Protein enabled homolog Homo sapiens (Human) GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030175; GO:0050699; GO:0070358; GO:0098794; GO:0098982; GO:0099188 actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]; postsynaptic cytoskeleton organization [GO:0099188] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699] g8197.t1 Q14739 42.742 620 2.11e-158 469.0 sp|Q14739|LBR_HUMAN Delta(14)-sterol reductase LBR OS=Homo sapiens OX=9606 GN=LBR PE=1 SV=2 LBR_HUMAN reviewed Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005652; GO:0005654; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0030223; GO:0031965; GO:0050613; GO:0060816; GO:0070087; GO:0070402; GO:0140463 cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; random inactivation of X chromosome [GO:0060816] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin-protein adaptor activity [GO:0140463]; chromo shadow domain binding [GO:0070087]; Delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; RNA binding [GO:0003723] g8197.t2 Q14739 42.512 621 9.41e-158 468.0 sp|Q14739|LBR_HUMAN Delta(14)-sterol reductase LBR OS=Homo sapiens OX=9606 GN=LBR PE=1 SV=2 LBR_HUMAN reviewed Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005652; GO:0005654; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0030223; GO:0031965; GO:0050613; GO:0060816; GO:0070087; GO:0070402; GO:0140463 cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; random inactivation of X chromosome [GO:0060816] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin-protein adaptor activity [GO:0140463]; chromo shadow domain binding [GO:0070087]; Delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; RNA binding [GO:0003723] g8198.t1 P23913 55.257 409 8.55e-157 461.0 sp|P23913|LBR_CHICK Delta(14)-sterol reductase LBR OS=Gallus gallus OX=9031 GN=LBR PE=1 SV=1 g8199.t1 P10079 37.097 868 9.99e-121 403.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t1 P10079 37.561 820 1.76e-114 386.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t1 P10079 33.108 888 1.88e-88 313.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t1 P10079 38.303 436 6.41e-57 219.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t1 P10079 31.907 514 7.169999999999999e-42 171.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t2 P10079 37.806 857 4.6300000000000003e-123 409.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t2 P10079 37.319 828 8.47e-116 389.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t2 P10079 33.718 866 3.6399999999999995e-89 315.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t2 P10079 32.089 723 1.4500000000000001e-63 239.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t2 P10079 38.303 436 5.25e-57 219.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t3 P10079 37.806 857 9.600000000000001e-123 409.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t3 P10079 37.319 828 1.7999999999999998e-115 389.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t3 P10079 33.718 866 6.849999999999999e-89 314.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t3 P10079 32.089 723 2.22e-63 239.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t3 P10079 38.303 436 7.39e-57 218.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t4 P10079 37.806 857 4.6300000000000003e-123 409.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t4 P10079 37.319 828 8.47e-116 389.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t4 P10079 33.718 866 3.6399999999999995e-89 315.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t4 P10079 32.089 723 1.4500000000000001e-63 239.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t4 P10079 38.303 436 5.25e-57 219.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t5 P10079 37.806 857 4.6300000000000003e-123 409.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t5 P10079 37.319 828 8.47e-116 389.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t5 P10079 33.718 866 3.6399999999999995e-89 315.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t5 P10079 32.089 723 1.4500000000000001e-63 239.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t5 P10079 38.303 436 5.25e-57 219.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t6 P10079 37.991 866 4.95e-128 424.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t6 P10079 32.756 809 3.71e-86 307.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t6 P10079 37.924 472 9.429999999999999e-62 234.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t7 P10079 37.662 847 1.71e-128 426.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8199.t7 P10079 33.0 800 6.9e-81 292.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8201.t1 Q5R8I2 49.799 249 9.23e-72 222.0 sp|Q5R8I2|RTRAF_PONAB RNA transcription, translation and transport factor protein OS=Pongo abelii OX=9601 GN=RTRAF PE=2 SV=1 RTRAF_PONAB reviewed tRNA-splicing ligase complex subunit RTRAF (RNA transcription, translation and transport factor protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000993; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006469; GO:0042802; GO:0045944; GO:0048471; GO:0072669; GO:0072686 negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993] g8202.t1 P10493 35.621 612 1.68e-91 329.0 sp|P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus OX=10090 GN=Nid1 PE=1 SV=2 NID1_MOUSE reviewed Nidogen-1 (NID-1) (Entactin) Mus musculus (Mouse) GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0007160; GO:0010811; GO:0030198; GO:0031012; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0050840; GO:0051149; GO:0071944; GO:0098637; GO:0110011; GO:2001046 cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein complex involved in cell-matrix adhesion [GO:0098637] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] g8202.t1 P10493 28.603 451 4.55e-49 196.0 sp|P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus OX=10090 GN=Nid1 PE=1 SV=2 NID1_MOUSE reviewed Nidogen-1 (NID-1) (Entactin) Mus musculus (Mouse) GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0007160; GO:0010811; GO:0030198; GO:0031012; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0050840; GO:0051149; GO:0071944; GO:0098637; GO:0110011; GO:2001046 cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein complex involved in cell-matrix adhesion [GO:0098637] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] g8202.t2 P10493 35.621 612 3.43e-91 328.0 sp|P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus OX=10090 GN=Nid1 PE=1 SV=2 NID1_MOUSE reviewed Nidogen-1 (NID-1) (Entactin) Mus musculus (Mouse) GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0007160; GO:0010811; GO:0030198; GO:0031012; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0050840; GO:0051149; GO:0071944; GO:0098637; GO:0110011; GO:2001046 cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein complex involved in cell-matrix adhesion [GO:0098637] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] g8202.t2 P10493 28.0 450 7.93e-49 195.0 sp|P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus OX=10090 GN=Nid1 PE=1 SV=2 NID1_MOUSE reviewed Nidogen-1 (NID-1) (Entactin) Mus musculus (Mouse) GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0007160; GO:0010811; GO:0030198; GO:0031012; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0050840; GO:0051149; GO:0071944; GO:0098637; GO:0110011; GO:2001046 cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein complex involved in cell-matrix adhesion [GO:0098637] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] g8202.t3 P10493 37.031 586 1.5e-88 320.0 sp|P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus OX=10090 GN=Nid1 PE=1 SV=2 NID1_MOUSE reviewed Nidogen-1 (NID-1) (Entactin) Mus musculus (Mouse) GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0007160; GO:0010811; GO:0030198; GO:0031012; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0050840; GO:0051149; GO:0071944; GO:0098637; GO:0110011; GO:2001046 cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein complex involved in cell-matrix adhesion [GO:0098637] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] g8202.t3 P10493 28.0 450 1.12e-48 194.0 sp|P10493|NID1_MOUSE Nidogen-1 OS=Mus musculus OX=10090 GN=Nid1 PE=1 SV=2 NID1_MOUSE reviewed Nidogen-1 (NID-1) (Entactin) Mus musculus (Mouse) GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0007160; GO:0010811; GO:0030198; GO:0031012; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0050840; GO:0051149; GO:0071944; GO:0098637; GO:0110011; GO:2001046 cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein complex involved in cell-matrix adhesion [GO:0098637] calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] g8205.t1 Q26417 54.608 293 3.2000000000000003e-75 238.0 sp|Q26417|OTX_STRPU Homeobox protein OTX OS=Strongylocentrotus purpuratus OX=7668 GN=OTX PE=2 SV=1 g8208.t1 Q8NDI1 37.827 727 1.04e-133 438.0 sp|Q8NDI1|EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens OX=9606 GN=EHBP1 PE=1 SV=3 g8208.t1 Q8NDI1 48.8 250 3.3999999999999994e-52 204.0 sp|Q8NDI1|EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens OX=9606 GN=EHBP1 PE=1 SV=3 g8208.t2 Q8NDI1 37.827 727 7.439999999999999e-134 439.0 sp|Q8NDI1|EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens OX=9606 GN=EHBP1 PE=1 SV=3 g8208.t2 Q8NDI1 48.8 250 3.4599999999999995e-52 203.0 sp|Q8NDI1|EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens OX=9606 GN=EHBP1 PE=1 SV=3 g8209.t1 Q5ZM39 39.45 109 1.07e-21 103.0 sp|Q5ZM39|BCL6_CHICK B-cell lymphoma 6 protein homolog OS=Gallus gallus OX=9031 GN=BCL6 PE=2 SV=1 BCL6_CHICK reviewed B-cell lymphoma 6 protein homolog Gallus gallus (Chicken) GO:0000122; GO:0000902; GO:0000978; GO:0001227; GO:0001817; GO:0001953; GO:0002467; GO:0002682; GO:0002829; GO:0003682; GO:0005634; GO:0005654; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008270; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0043065; GO:0043066; GO:0043380; GO:0043565; GO:0045595; GO:0045597; GO:0045892; GO:0048294; GO:0048821; GO:0050727; GO:1903037 actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; DNA damage response [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell differentiation [GO:0045597]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of leukocyte cell-cell adhesion [GO:1903037]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g8209.t2 Q5ZM39 39.45 109 1.08e-21 103.0 sp|Q5ZM39|BCL6_CHICK B-cell lymphoma 6 protein homolog OS=Gallus gallus OX=9031 GN=BCL6 PE=2 SV=1 BCL6_CHICK reviewed B-cell lymphoma 6 protein homolog Gallus gallus (Chicken) GO:0000122; GO:0000902; GO:0000978; GO:0001227; GO:0001817; GO:0001953; GO:0002467; GO:0002682; GO:0002829; GO:0003682; GO:0005634; GO:0005654; GO:0006954; GO:0006974; GO:0007266; GO:0007283; GO:0008104; GO:0008270; GO:0008285; GO:0030036; GO:0030183; GO:0030308; GO:0030890; GO:0032764; GO:0035024; GO:0042092; GO:0042127; GO:0043065; GO:0043066; GO:0043380; GO:0043565; GO:0045595; GO:0045597; GO:0045892; GO:0048294; GO:0048821; GO:0050727; GO:1903037 actin cytoskeleton organization [GO:0030036]; B cell differentiation [GO:0030183]; cell morphogenesis [GO:0000902]; DNA damage response [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell differentiation [GO:0045597]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of leukocyte cell-cell adhesion [GO:1903037]; regulation of memory T cell differentiation [GO:0043380]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; type 2 immune response [GO:0042092] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g8210.t1 Q8C0Y0 47.067 750 0.0 696.0 sp|Q8C0Y0|PP4R4_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Mus musculus OX=10090 GN=Ppp4r4 PE=1 SV=2 g8210.t2 Q8C0Y0 43.086 875 0.0 695.0 sp|Q8C0Y0|PP4R4_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Mus musculus OX=10090 GN=Ppp4r4 PE=1 SV=2 g8210.t3 Q8C0Y0 46.204 764 0.0 686.0 sp|Q8C0Y0|PP4R4_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Mus musculus OX=10090 GN=Ppp4r4 PE=1 SV=2 g8213.t1 Q80TE4 54.545 704 0.0 766.0 sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3 g8213.t2 Q80TE4 54.545 704 0.0 766.0 sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3 g8215.t1 Q9BXW4 75.424 118 4.7e-62 189.0 sp|Q9BXW4|MLP3C_HUMAN Microtubule-associated protein 1 light chain 3 gamma OS=Homo sapiens OX=9606 GN=MAP1LC3C PE=1 SV=1 MLP3C_HUMAN reviewed Microtubule-associated protein 1 light chain 3 gamma (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (Microtubule-associated proteins 1A/1B light chain 3C) (MAP1A/MAP1B LC3 C) (MAP1A/MAP1B light chain 3 C) Homo sapiens (Human) GO:0000045; GO:0000421; GO:0000423; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008429; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; protein exit from endoplasmic reticulum [GO:0032527] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090] phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625] g8216.t1 Q1G7G9 29.724 1016 5.2299999999999994e-67 253.0 sp|Q1G7G9|TALD3_CHICK TALPID3 protein OS=Gallus gallus OX=9031 GN=TALPID3 PE=2 SV=2 TALD3_CHICK reviewed TALPID3 protein Gallus gallus (Chicken) GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271 centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] g8217.t1 Q6PCG7 45.251 716 1.25e-165 494.0 sp|Q6PCG7|I2BLB_XENLA Interferon regulatory factor 2-binding protein-like B OS=Xenopus laevis OX=8355 GN=irf2bpl-b PE=2 SV=1 g8217.t2 Q6PCG7 45.251 716 7.3e-166 494.0 sp|Q6PCG7|I2BLB_XENLA Interferon regulatory factor 2-binding protein-like B OS=Xenopus laevis OX=8355 GN=irf2bpl-b PE=2 SV=1 g8219.t1 Q99PP2 30.541 370 1.6399999999999999e-40 169.0 sp|Q99PP2|ZN318_MOUSE Zinc finger protein 318 OS=Mus musculus OX=10090 GN=Znf318 PE=1 SV=3 ZN318_MOUSE reviewed Zinc finger protein 318 (Testicular zinc finger protein) Mus musculus (Mouse) GO:0003676; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0046982; GO:0051321 meiotic cell cycle [GO:0051321]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleic acid binding [GO:0003676]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g8219.t2 Q99PP2 30.541 370 1.5899999999999999e-40 169.0 sp|Q99PP2|ZN318_MOUSE Zinc finger protein 318 OS=Mus musculus OX=10090 GN=Znf318 PE=1 SV=3 ZN318_MOUSE reviewed Zinc finger protein 318 (Testicular zinc finger protein) Mus musculus (Mouse) GO:0003676; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0046982; GO:0051321 meiotic cell cycle [GO:0051321]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleic acid binding [GO:0003676]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g8220.t1 Q5T3U5 48.369 1257 0.0 1100.0 sp|Q5T3U5|MRP7_HUMAN ATP-binding cassette sub-family C member 10 OS=Homo sapiens OX=9606 GN=ABCC10 PE=1 SV=1 MRP7_HUMAN reviewed ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7) Homo sapiens (Human) GO:0005524; GO:0005765; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0015711; GO:0016323; GO:0016887; GO:0043225; GO:0055085; GO:0071716; GO:0140359 leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225] g8221.t1 Q5T3U5 44.577 1346 0.0 1043.0 sp|Q5T3U5|MRP7_HUMAN ATP-binding cassette sub-family C member 10 OS=Homo sapiens OX=9606 GN=ABCC10 PE=1 SV=1 MRP7_HUMAN reviewed ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7) Homo sapiens (Human) GO:0005524; GO:0005765; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0015711; GO:0016323; GO:0016887; GO:0043225; GO:0055085; GO:0071716; GO:0140359 leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225] g8221.t1 Q5T3U5 43.673 1383 0.0 1023.0 sp|Q5T3U5|MRP7_HUMAN ATP-binding cassette sub-family C member 10 OS=Homo sapiens OX=9606 GN=ABCC10 PE=1 SV=1 MRP7_HUMAN reviewed ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7) Homo sapiens (Human) GO:0005524; GO:0005765; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0015711; GO:0016323; GO:0016887; GO:0043225; GO:0055085; GO:0071716; GO:0140359 leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225] g8222.t1 P14772 56.098 82 2.03e-26 104.0 sp|P14772|BPT1_YEAST Bile pigment transporter 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=BPT1 PE=1 SV=2 BPT1_YEAST reviewed Bile pigment transporter 1 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0000329; GO:0005524; GO:0005783; GO:0015086; GO:0015127; GO:0015691; GO:0016887; GO:0042144; GO:0055085; GO:0140359 cadmium ion transport [GO:0015691]; transmembrane transport [GO:0055085]; vacuole fusion, non-autophagic [GO:0042144] endoplasmic reticulum [GO:0005783]; fungal-type vacuole membrane [GO:0000329] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bilirubin transmembrane transporter activity [GO:0015127]; cadmium ion transmembrane transporter activity [GO:0015086] g8223.t1 O75586 55.794 233 2.39e-91 273.0 sp|O75586|MED6_HUMAN Mediator of RNA polymerase II transcription subunit 6 OS=Homo sapiens OX=9606 GN=MED6 PE=1 SV=2 g8224.t1 D9IQ16 31.803 305 9.9e-28 118.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g8224.t1 D9IQ16 30.986 284 1.0399999999999998e-23 106.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g8224.t1 D9IQ16 31.933 238 1.86e-22 103.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g8225.t1 D9IQ16 29.375 320 4.0399999999999994e-23 105.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g8225.t2 D9IQ16 29.375 320 5.74e-23 105.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g8225.t3 D9IQ16 29.375 320 4.11e-23 105.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g8225.t4 D9IQ16 29.375 320 3.8199999999999996e-23 105.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g8227.t1 Q91VN0 40.845 213 1.37e-39 158.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8227.t1 Q91VN0 38.028 213 1.48e-36 149.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8227.t1 Q91VN0 32.018 228 4.9599999999999995e-28 123.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8227.t1 Q91VN0 30.705 241 8.56e-24 110.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g8235.t1 P79403 54.31 928 0.0 1068.0 sp|P79403|GANAB_PIG Neutral alpha-glucosidase AB OS=Sus scrofa OX=9823 GN=GANAB PE=1 SV=1 GANAB_PIG reviewed Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) Sus scrofa (Pig) GO:0005794; GO:0005975; GO:0006491; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0090599; GO:0106407 carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491] glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470] alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; Glc2Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0106407]; glucan 1,3-alpha-glucosidase activity [GO:0033919] g8235.t2 P79403 54.095 928 0.0 1065.0 sp|P79403|GANAB_PIG Neutral alpha-glucosidase AB OS=Sus scrofa OX=9823 GN=GANAB PE=1 SV=1 GANAB_PIG reviewed Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) Sus scrofa (Pig) GO:0005794; GO:0005975; GO:0006491; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0090599; GO:0106407 carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491] glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470] alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; Glc2Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0106407]; glucan 1,3-alpha-glucosidase activity [GO:0033919] g8235.t3 P79403 52.169 968 0.0 1051.0 sp|P79403|GANAB_PIG Neutral alpha-glucosidase AB OS=Sus scrofa OX=9823 GN=GANAB PE=1 SV=1 GANAB_PIG reviewed Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) Sus scrofa (Pig) GO:0005794; GO:0005975; GO:0006491; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0090599; GO:0106407 carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491] glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470] alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; Glc2Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0106407]; glucan 1,3-alpha-glucosidase activity [GO:0033919] g8236.t1 Q5E9G1 79.778 450 0.0 752.0 sp|Q5E9G1|P2R3C_BOVIN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma OS=Bos taurus OX=9913 GN=PPP2R3C PE=2 SV=1 P2R3C_BOVIN reviewed Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma Bos taurus (Bovine) GO:0000226; GO:0001782; GO:0005634; GO:0005737; GO:0005813; GO:0030865; GO:0035303; GO:0043029; GO:0045579; GO:0046872 B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of dephosphorylation [GO:0035303]; T cell homeostasis [GO:0043029] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634] metal ion binding [GO:0046872] g8237.t1 Q4R366 40.217 460 1.9e-106 336.0 sp|Q4R366|MRPP3_MACFA Mitochondrial ribonuclease P catalytic subunit OS=Macaca fascicularis OX=9541 GN=PRORP PE=2 SV=2 MRPP3_MACFA reviewed Mitochondrial ribonuclease P catalytic subunit (EC 3.1.26.5) (Mitochondrial ribonuclease P protein 3) (Mitochondrial RNase P protein 3) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001682; GO:0004526; GO:0005759; GO:0030678; GO:0046872; GO:0097745 mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682] mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678] metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526] g8238.t1 Q8TB61 58.824 408 1.57e-155 450.0 sp|Q8TB61|S35B2_HUMAN Adenosine 3'-phospho 5'-phosphosulfate transporter 1 OS=Homo sapiens OX=9606 GN=SLC35B2 PE=1 SV=1 S35B2_HUMAN reviewed Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2) Homo sapiens (Human) GO:0000139; GO:0005789; GO:0005794; GO:0005802; GO:0015297; GO:0016020; GO:0043123; GO:0046963; GO:0046964; GO:0050650; GO:0055085; GO:1902558 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; 5'-adenylyl sulfate transmembrane transport [GO:1902558]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; antiporter activity [GO:0015297] g8239.t1 A7YWS7 60.92 522 0.0 700.0 sp|A7YWS7|DPOE2_BOVIN DNA polymerase epsilon subunit 2 OS=Bos taurus OX=9913 GN=POLE2 PE=2 SV=1 g8239.t2 A7YWS7 60.536 522 0.0 691.0 sp|A7YWS7|DPOE2_BOVIN DNA polymerase epsilon subunit 2 OS=Bos taurus OX=9913 GN=POLE2 PE=2 SV=1 g8239.t3 A7YWS7 60.342 527 0.0 694.0 sp|A7YWS7|DPOE2_BOVIN DNA polymerase epsilon subunit 2 OS=Bos taurus OX=9913 GN=POLE2 PE=2 SV=1 g8240.t1 Q99JB7 28.255 361 1.8800000000000002e-37 146.0 sp|Q99JB7|AMNLS_MOUSE Protein amnionless OS=Mus musculus OX=10090 GN=Amn PE=1 SV=1 AMNLS_MOUSE reviewed Protein amnionless [Cleaved into: Soluble protein amnionless] Mus musculus (Mouse) GO:0005102; GO:0005615; GO:0005905; GO:0006898; GO:0008104; GO:0009235; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0043001; GO:0043235; GO:0045177; GO:0097017 cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]; renal protein absorption [GO:0097017] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] cargo receptor activity [GO:0038024]; signaling receptor binding [GO:0005102] g8241.t1 Q70E20 37.5 368 9.98e-49 188.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t1 Q70E20 32.648 389 1.17e-39 160.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t1 Q70E20 31.075 428 7.41e-36 149.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t1 Q70E20 32.598 408 3.46e-35 146.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t1 Q70E20 32.804 378 3.04e-31 134.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t2 Q70E20 37.47 411 1.26e-55 209.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t2 Q70E20 31.631 509 6.229999999999999e-45 177.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t2 Q70E20 32.34 470 6.62e-44 174.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t2 Q70E20 32.85 414 2.44e-34 144.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t2 Q70E20 32.447 376 2.2e-32 138.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g8241.t3 P10079 37.277 448 2.1599999999999997e-54 206.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8241.t3 P10079 36.364 440 1.09e-49 192.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8241.t3 P10079 36.7 406 6.6700000000000004e-49 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8241.t3 P10079 36.526 449 1.25e-48 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8241.t3 P10079 34.864 479 1.42e-48 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8241.t3 P10079 34.579 428 3.1199999999999996e-45 178.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8245.t1 Q5M8Z0 54.318 359 2.18e-131 385.0 sp|Q5M8Z0|BHMT1_XENTR Betaine--homocysteine S-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=bhmt PE=2 SV=1 g8246.t1 Q32LQ4 53.297 364 1.09e-132 388.0 sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1 g8247.t1 Q8NCA5 47.305 334 6.41e-90 286.0 sp|Q8NCA5|FA98A_HUMAN Protein FAM98A OS=Homo sapiens OX=9606 GN=FAM98A PE=1 SV=2 FA98A_HUMAN reviewed Protein FAM98A Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0006388; GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0032418; GO:0072669; GO:1900029 lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723] g8248.t1 Q5U508 42.72 522 4.82e-139 415.0 sp|Q5U508|TBCE_XENLA Tubulin-specific chaperone E OS=Xenopus laevis OX=8355 GN=tbce PE=2 SV=1 g8249.t1 O82201 57.143 140 4.55e-58 179.0 sp|O82201|AP4S_ARATH AP-4 complex subunit sigma OS=Arabidopsis thaliana OX=3702 GN=At2g19790 PE=1 SV=1 g8250.t1 Q9ERG2 61.538 767 0.0 894.0 sp|Q9ERG2|STRN3_MOUSE Striatin-3 OS=Mus musculus OX=10090 GN=Strn3 PE=1 SV=1 g8258.t1 Q5E951 54.0 250 8e-90 268.0 sp|Q5E951|TBCB_BOVIN Tubulin-folding cofactor B OS=Bos taurus OX=9913 GN=TBCB PE=2 SV=1 TBCB_BOVIN reviewed Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010 cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634] alpha-tubulin binding [GO:0043014]; microtubule plus-end binding [GO:0051010] g8260.t1 Q38SD2 30.116 777 3.68e-80 296.0 sp|Q38SD2|LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3 LRRK1_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8260.t1 Q38SD2 29.841 439 4.49e-36 154.0 sp|Q38SD2|LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3 LRRK1_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8260.t2 Q38SD2 29.811 795 1.46e-81 301.0 sp|Q38SD2|LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3 LRRK1_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8260.t2 Q38SD2 29.841 439 5.94e-36 153.0 sp|Q38SD2|LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3 LRRK1_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8260.t3 Q38SD2 30.116 777 5.4400000000000005e-80 296.0 sp|Q38SD2|LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3 LRRK1_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8260.t3 Q38SD2 29.979 477 6.42e-37 156.0 sp|Q38SD2|LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3 LRRK1_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8262.t1 Q5RDQ2 45.299 702 0.0 546.0 sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1 PALS1_PONAB reviewed Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204 central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204] ATP binding [GO:0005524] g8262.t2 Q5RDQ2 44.29 718 1.29e-177 537.0 sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1 PALS1_PONAB reviewed Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204 central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204] ATP binding [GO:0005524] g8262.t3 Q5RDQ2 44.29 718 5.59e-179 538.0 sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1 PALS1_PONAB reviewed Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204 central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204] ATP binding [GO:0005524] g8263.t1 Q8TBZ3 57.168 565 0.0 631.0 sp|Q8TBZ3|WDR20_HUMAN WD repeat-containing protein 20 OS=Homo sapiens OX=9606 GN=WDR20 PE=1 SV=2 WDR20_HUMAN reviewed WD repeat-containing protein 20 (Protein DMR) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0035800 cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] deubiquitinase activator activity [GO:0035800] g8264.t1 Q9JJ61 59.026 493 0.0 593.0 sp|Q9JJ61|GLT16_MOUSE Polypeptide N-acetylgalactosaminyltransferase 16 OS=Mus musculus OX=10090 GN=Galnt16 PE=2 SV=2 g8266.t1 Q7SZE5 77.083 768 0.0 1282.0 sp|Q7SZE5|SC23A_DANRE Protein transport protein Sec23A OS=Danio rerio OX=7955 GN=sec23a PE=2 SV=1 SC23A_DANRE reviewed Protein transport protein Sec23A (SEC23-related protein A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005096; GO:0005789; GO:0005829; GO:0006605; GO:0006886; GO:0008270; GO:0030127; GO:0035138; GO:0048702; GO:0051216; GO:0070971; GO:0090110 cartilage development [GO:0051216]; COPII-coated vesicle cargo loading [GO:0090110]; embryonic neurocranium morphogenesis [GO:0048702]; intracellular protein transport [GO:0006886]; pectoral fin morphogenesis [GO:0035138]; protein targeting [GO:0006605] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789] GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g8272.t1 P59325 56.364 385 8.86e-146 424.0 sp|P59325|IF5_MOUSE Eukaryotic translation initiation factor 5 OS=Mus musculus OX=10090 GN=Eif5 PE=1 SV=1 g8275.t1 B0BK71 28.468 555 3.75e-44 167.0 sp|B0BK71|MSP1_MYCSO Dye-decolorizing peroxidase msp1 OS=Mycetinis scorodonius OX=182058 GN=msp1 PE=1 SV=1 MSP1_MYCSO reviewed Dye-decolorizing peroxidase msp1 (EC 1.11.1.19) (EC 1.11.1.7) (Peroxidase 1) (MsP1) Mycetinis scorodonius (Garlic mushroom) (Marasmius scorodonius) GO:0004601; GO:0005576; GO:0005829; GO:0016121; GO:0020037; GO:0046872; GO:0140825 carotene catabolic process [GO:0016121] cytosol [GO:0005829]; extracellular region [GO:0005576] heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] g8277.t1 Q5F3Z9 52.027 148 4.85e-46 179.0 sp|Q5F3Z9|ZC3HE_CHICK Zinc finger CCCH domain-containing protein 14 OS=Gallus gallus OX=9031 GN=ZC3H14 PE=2 SV=1 g8277.t1 Q5F3Z9 28.571 574 1.04e-35 148.0 sp|Q5F3Z9|ZC3HE_CHICK Zinc finger CCCH domain-containing protein 14 OS=Gallus gallus OX=9031 GN=ZC3H14 PE=2 SV=1 g8277.t2 Q5F3Z9 51.724 145 1.1e-46 181.0 sp|Q5F3Z9|ZC3HE_CHICK Zinc finger CCCH domain-containing protein 14 OS=Gallus gallus OX=9031 GN=ZC3H14 PE=2 SV=1 g8277.t2 Q5F3Z9 28.571 574 9.42e-36 148.0 sp|Q5F3Z9|ZC3HE_CHICK Zinc finger CCCH domain-containing protein 14 OS=Gallus gallus OX=9031 GN=ZC3H14 PE=2 SV=1 g8278.t1 P51476 33.036 336 1.54e-60 202.0 sp|P51476|OPSP_COLLI Pinopsin OS=Columba livia OX=8932 PE=1 SV=1 g8280.t1 O42266 35.542 332 1.36e-66 220.0 sp|O42266|OPSP_ICTPU Parapinopsin OS=Ictalurus punctatus OX=7998 PE=2 SV=1 g8281.t1 Q94126 58.75 80 1.23e-25 103.0 sp|Q94126|CES2_CAEEL Transcription factor ces-2 OS=Caenorhabditis elegans OX=6239 GN=ces-2 PE=1 SV=1 g8282.t1 Q5RCI5 31.687 243 1.49e-31 120.0 sp|Q5RCI5|CSKMT_PONAB Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial OS=Pongo abelii OX=9601 GN=CSKMT PE=2 SV=1 CSKMT_PONAB reviewed Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial (CS-KMT) (EC 2.1.1.-) (Methyltransferase-like protein 12, mitochondrial) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005739; GO:0006479; GO:0016278; GO:0016279; GO:0018023; GO:0018026; GO:0018027 peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] mitochondrion [GO:0005739] lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279] g8284.t1 Q99NB1 63.838 495 0.0 681.0 sp|Q99NB1|ACS2L_MOUSE Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Mus musculus OX=10090 GN=Acss1 PE=1 SV=1 ACS2L_MOUSE reviewed Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17) Mus musculus (Mouse) GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218 acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218] g8284.t2 Q99NB1 63.783 497 0.0 682.0 sp|Q99NB1|ACS2L_MOUSE Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Mus musculus OX=10090 GN=Acss1 PE=1 SV=1 ACS2L_MOUSE reviewed Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17) Mus musculus (Mouse) GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218 acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218] g8285.t1 A0LG91 62.5 112 1.55e-41 147.0 sp|A0LG91|ACSA_SYNFM Acetyl-coenzyme A synthetase OS=Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB) OX=335543 GN=acsA PE=3 SV=1 g8286.t1 Q868Z9 41.448 649 9.61e-140 495.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 37.565 386 2.2399999999999998e-67 258.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 25.686 1020 1.09e-59 233.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 35.329 334 1.11e-50 203.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 35.714 308 2.78e-50 202.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 32.289 415 1.89e-47 192.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 31.176 340 1.12e-44 183.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 35.045 331 4.75e-44 181.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 28.869 336 1.84e-38 163.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 32.198 323 2.82e-32 142.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8286.t1 Q868Z9 28.07 513 1.52e-31 140.0 sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2 PPN_DROME reviewed Papilin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0005201; GO:0005576; GO:0005604; GO:0030198 extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] g8291.t1 Q28C74 36.123 1362 0.0 835.0 sp|Q28C74|LPPRC_XENTR Leucine-rich PPR motif-containing protein, mitochondrial OS=Xenopus tropicalis OX=8364 GN=lrpprc PE=2 SV=1 g8292.t1 Q5L9Q0 48.485 363 1.4099999999999998e-119 353.0 sp|Q5L9Q0|PHNW_BACFN 2-aminoethylphosphonate--pyruvate transaminase OS=Bacteroides fragilis (strain ATCC 25285 / DSM 2151 / CCUG 4856 / JCM 11019 / LMG 10263 / NCTC 9343 / Onslow / VPI 2553 / EN-2) OX=272559 GN=phnW PE=3 SV=1 g8293.t1 Q9CQ40 47.692 130 6.62e-39 134.0 sp|Q9CQ40|RM49_MOUSE Large ribosomal subunit protein mL49 OS=Mus musculus OX=10090 GN=Mrpl49 PE=1 SV=1 g8293.t2 Q9CQ40 47.692 130 6.56e-39 134.0 sp|Q9CQ40|RM49_MOUSE Large ribosomal subunit protein mL49 OS=Mus musculus OX=10090 GN=Mrpl49 PE=1 SV=1 g8294.t1 P13255 58.667 300 1.83e-123 357.0 sp|P13255|GNMT_RAT Glycine N-methyltransferase OS=Rattus norvegicus OX=10116 GN=Gnmt PE=1 SV=2 GNMT_RAT reviewed Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein) Rattus norvegicus (Rat) GO:0005542; GO:0005829; GO:0005977; GO:0006111; GO:0006544; GO:0006555; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0051289; GO:0098603; GO:1901052; GO:1904047 glycine metabolic process [GO:0006544]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052] cytosol [GO:0005829]; methyltransferase complex [GO:0034708] folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; selenol Se-methyltransferase activity [GO:0098603] g8295.t1 Q8IWX5 37.531 397 3.49e-77 247.0 sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1 g8296.t1 Q8IWX5 35.0 360 8.41e-66 218.0 sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1 g8297.t1 Q6UWX4 52.262 442 2.77e-155 480.0 sp|Q6UWX4|HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens OX=9606 GN=HHIPL2 PE=1 SV=1 g8302.t1 Q8N966 31.474 251 1.17e-37 137.0 sp|Q8N966|ZDH22_HUMAN Palmitoyltransferase ZDHHC22 OS=Homo sapiens OX=9606 GN=ZDHHC22 PE=1 SV=2 ZDH22_HUMAN reviewed Palmitoyltransferase ZDHHC22 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 22) (DHHC-22) (zDHHC22) Homo sapiens (Human) GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0018345; GO:0019706; GO:0072659 protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g8303.t1 Q2TGI8 31.66 259 1.77e-30 118.0 sp|Q2TGI8|ZDH22_RAT Palmitoyltransferase ZDHHC22 OS=Rattus norvegicus OX=10116 GN=Zdhhc22 PE=2 SV=1 g8304.t1 Q3T0C9 60.0 90 1.6e-31 112.0 sp|Q3T0C9|SYJ2B_BOVIN Synaptojanin-2-binding protein OS=Bos taurus OX=9913 GN=SYNJ2BP PE=2 SV=1 SYJ2B_BOVIN reviewed Synaptojanin-2-binding protein (Activin receptor-interacting protein 2) (Mitochondrial outer membrane protein 25) Bos taurus (Bovine) GO:0001937; GO:0005741; GO:0006897; GO:0008593; GO:0010596; GO:0016525; GO:0048471; GO:0070373; GO:1903671 endocytosis [GO:0006897]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Notch signaling pathway [GO:0008593] mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471] g8305.t1 Q8R1K1 33.423 371 5.3799999999999995e-55 187.0 sp|Q8R1K1|UBAC2_MOUSE Ubiquitin-associated domain-containing protein 2 OS=Mus musculus OX=10090 GN=Ubac2 PE=1 SV=1 g8306.t1 Q08EJ0 45.161 93 1.1100000000000001e-21 86.7 sp|Q08EJ0|PL8L1_MOUSE PLAC8-like protein 1 OS=Mus musculus OX=10090 GN=Plac8l1 PE=2 SV=2 g8309.t1 Q9TXQ1 31.297 671 9.609999999999999e-67 256.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g8310.t1 Q6NRL6 55.263 646 0.0 647.0 sp|Q6NRL6|SYVNA_XENLA E3 ubiquitin-protein ligase synoviolin A OS=Xenopus laevis OX=8355 GN=syvn1-a PE=2 SV=1 SYVNA_XENLA reviewed E3 ubiquitin-protein ligase synoviolin A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin A) (Synovial apoptosis inhibitor-1-A) Xenopus laevis (African clawed frog) GO:0005789; GO:0006511; GO:0008270; GO:0012505; GO:0016567; GO:0036503; GO:0043161; GO:0044322; GO:0050821; GO:0061630; GO:1902236 ERAD pathway [GO:0036503]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g8311.t1 Q5IBH7 56.915 188 3.22e-72 229.0 sp|Q5IBH7|SPDYA_MOUSE Speedy protein A OS=Mus musculus OX=10090 GN=Spdya PE=1 SV=2 SPDYA_MOUSE reviewed Speedy protein A (Protein expressed in male leptotene and zygotene spermatocytes 465) (MLZ-465) (Rapid inducer of G2/M progression in oocytes A) (RINGO A) (mSpy/Ringo A) (Speedy-1) (Spy1) Mus musculus (Mouse) GO:0000082; GO:0000781; GO:0001741; GO:0005634; GO:0005635; GO:0005654; GO:0006974; GO:0007140; GO:0007283; GO:0008284; GO:0016233; GO:0019901; GO:0030295; GO:0045737; GO:0048477; GO:0070197; GO:0070200 DNA damage response [GO:0006974]; establishment of protein localization to telomere [GO:0070200]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; spermatogenesis [GO:0007283]; telomere capping [GO:0016233] chromosome, telomeric region [GO:0000781]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; XY body [GO:0001741] protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] g8312.t1 P80147 60.294 68 6.559999999999999e-23 95.5 sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2 GABT_PIG reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Sus scrofa (Pig) GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537 gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877] 4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g8313.t1 P80147 51.844 461 0.0 522.0 sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2 GABT_PIG reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Sus scrofa (Pig) GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537 gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877] 4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g8314.t1 Q9BVS5 37.273 330 1e-62 217.0 sp|Q9BVS5|TR61B_HUMAN tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=TRMT61B PE=1 SV=2 TR61B_HUMAN reviewed tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006397; GO:0016433; GO:0030488; GO:0031515; GO:0061953; GO:0090646; GO:0160107 mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; tRNA methylation [GO:0030488] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tRNA (m1A) methyltransferase complex [GO:0031515] mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; rRNA (adenine) methyltransferase activity [GO:0016433]; tRNA (adenine(58)-N1)-methyltransferase activity [GO:0160107] g8315.t1 A0NLY7 32.701 211 1.72e-25 105.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g8316.t1 A0NLY7 32.227 211 7.040000000000001e-26 106.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g8317.t1 A0NLY7 34.247 219 9.62e-27 108.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g8318.t1 A0NLY7 34.3 207 3.29e-29 115.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g8319.t1 A0NLY7 34.597 211 1.18e-28 113.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g8320.t1 A0NLY7 35.577 208 2.0200000000000002e-27 110.0 sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1 ISAHY_ROSAI reviewed Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b) Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata) GO:0004061; GO:0016812; GO:0019441; GO:0030145 L-tryptophan catabolic process to kynurenine [GO:0019441] arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145] g8321.t1 Q9TXQ1 28.318 1296 7.06e-107 387.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g8321.t1 Q9TXQ1 27.917 720 7.76e-61 236.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g8322.t1 Q52KP5 28.384 458 4.41e-35 141.0 sp|Q52KP5|NXPE4_MOUSE NXPE family member 4 OS=Mus musculus OX=10090 GN=Nxpe4 PE=2 SV=1 g8324.t1 Q99MK2 61.359 515 0.0 627.0 sp|Q99MK2|KAT5_RAT Histone acetyltransferase KAT5 OS=Rattus norvegicus OX=10116 GN=Kat5 PE=1 SV=2 KAT5_RAT reviewed Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-) Rattus norvegicus (Rat) GO:0000122; GO:0000132; GO:0000724; GO:0000729; GO:0000776; GO:0000785; GO:0000786; GO:0000812; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005829; GO:0006289; GO:0006302; GO:0006303; GO:0006357; GO:0006646; GO:0006656; GO:0006915; GO:0006974; GO:0007286; GO:0008270; GO:0010212; GO:0010485; GO:0010508; GO:0010867; GO:0018394; GO:0019432; GO:0021915; GO:0022008; GO:0030330; GO:0032703; GO:0032777; GO:0032991; GO:0035092; GO:0035267; GO:0035861; GO:0035973; GO:0042149; GO:0042753; GO:0043161; GO:0043274; GO:0043998; GO:0043999; GO:0044877; GO:0045087; GO:0045089; GO:0045591; GO:0045662; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0046972; GO:0048471; GO:0051315; GO:0051726; GO:0061733; GO:0062033; GO:0070301; GO:0071211; GO:0071333; GO:0071392; GO:0071481; GO:0097431; GO:0106226; GO:0120300; GO:0140064; GO:0140065; GO:0140297; GO:0140694; GO:0140861; GO:0140896; GO:1902036; GO:1902425; GO:1905168; GO:1905337; GO:1905691; GO:1990166; GO:2000042 aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to X-ray [GO:0071481]; cGAS/STING signaling pathway [GO:0140896]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; membraneless organelle assembly [GO:0140694]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of aggrephagy [GO:1905337]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of innate immune response [GO:0045089]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to site of double-strand break [GO:1990166]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of cell cycle [GO:0051726]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; triglyceride biosynthetic process [GO:0019432] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; piccolo histone acetyltransferase complex [GO:0032777]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; Swr1 complex [GO:0000812]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H2A acetyltransferase activity [GO:0043998]; histone H2AK5 acetyltransferase activity [GO:0043999]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K16 acetyltransferase activity [GO:0046972]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g8325.t1 Q921X6 61.392 316 1.05e-149 426.0 sp|Q921X6|RPC6_MOUSE DNA-directed RNA polymerase III subunit RPC6 OS=Mus musculus OX=10090 GN=Polr3f PE=1 SV=1 g8326.t1 Q9XY07 65.229 371 0.0 528.0 sp|Q9XY07|KARG_STIJA Arginine kinase OS=Stichopus japonicus OX=307972 GN=AK PE=1 SV=1 g8327.t1 P11498 69.88 1162 0.0 1724.0 sp|P11498|PYC_HUMAN Pyruvate carboxylase, mitochondrial OS=Homo sapiens OX=9606 GN=PC PE=1 SV=2 PYC_HUMAN reviewed Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) Homo sapiens (Human) GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006094; GO:0006629; GO:0006739; GO:0009374; GO:0010629; GO:0019074; GO:0019076; GO:0019674; GO:0042802; GO:0044794; GO:0046872 gluconeogenesis [GO:0006094]; host-mediated activation of viral process [GO:0044794]; lipid metabolic process [GO:0006629]; NAD+ metabolic process [GO:0019674]; NADP+ metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736] g8329.t1 Q9TXQ1 32.514 692 1.98e-70 268.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g8329.t1 Q9TXQ1 31.993 572 5.4199999999999996e-67 256.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g8329.t1 Q9TXQ1 25.698 537 1.04e-25 120.0 sp|Q9TXQ1|TNKS1_CAEEL Poly [ADP-ribose] polymerase tankyrase OS=Caenorhabditis elegans OX=6239 GN=tank-1 PE=2 SV=1 g8332.t1 Q9UJM8 52.078 361 1.43e-130 381.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g8333.t1 P20072 30.492 305 2.62e-39 155.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g8333.t2 P20072 30.492 305 2.71e-39 155.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g8335.t1 Q9QXF7 41.551 503 2.35e-127 383.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g8336.t1 Q9WUA6 64.226 478 0.0 639.0 sp|Q9WUA6|AKT3_MOUSE RAC-gamma serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Akt3 PE=1 SV=1 AKT3_MOUSE reviewed RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) Mus musculus (Mouse) GO:0001938; GO:0004672; GO:0004674; GO:0005080; GO:0005524; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0007165; GO:0008286; GO:0010765; GO:0032008; GO:0032869; GO:0035556; GO:0036064; GO:0043066; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1903898; GO:1905564; GO:1905653; GO:2000773 brain morphogenesis [GO:0048854]; cellular response to insulin stimulus [GO:0032869]; homeostasis of number of cells within a tissue [GO:0048873]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; signal transduction [GO:0007165] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8337.t1 P13821 48.208 307 9.289999999999999e-67 226.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.896 309 1.7700000000000001e-66 225.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 48.013 302 8.43e-65 221.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8337.t1 P13821 47.222 288 5.0200000000000004e-57 200.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g8339.t1 Q6NWH0 55.446 101 1.94e-24 102.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g8340.t1 Q62415 64.039 203 1.11e-87 311.0 sp|Q62415|ASPP1_MOUSE Apoptosis-stimulating of p53 protein 1 OS=Mus musculus OX=10090 GN=Ppp1r13b PE=1 SV=2 g8340.t1 Q62415 49.057 318 6.36e-80 288.0 sp|Q62415|ASPP1_MOUSE Apoptosis-stimulating of p53 protein 1 OS=Mus musculus OX=10090 GN=Ppp1r13b PE=1 SV=2 g8341.t1 P62334 89.46 389 0.0 720.0 sp|P62334|PRS10_MOUSE 26S proteasome regulatory subunit 10B OS=Mus musculus OX=10090 GN=Psmc6 PE=1 SV=1 g8342.t1 Q5RE15 66.917 266 2.34e-124 358.0 sp|Q5RE15|PSMD8_PONAB 26S proteasome non-ATPase regulatory subunit 8 (Fragment) OS=Pongo abelii OX=9601 GN=PSMD8 PE=2 SV=2 g8343.t1 Q9TU19 44.294 517 2.2e-146 453.0 sp|Q9TU19|NPHP1_CANLF Nephrocystin-1 (Fragment) OS=Canis lupus familiaris OX=9615 GN=NPHP1 PE=1 SV=1 g8344.t1 Q6GM78 50.962 312 1.02e-93 283.0 sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1 ASGL1_XENLA reviewed Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain] Xenopus laevis (African clawed frog) GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345 L-asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917] asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798] g8345.t1 P33497 42.053 302 4.9400000000000004e-79 254.0 sp|P33497|RYK_AVIR3 Tyrosine-protein kinase transforming protein RYK OS=Avian retrovirus RPL30 OX=31671 GN=V-RYK PE=2 SV=1 g8345.t2 Q98949 43.273 275 1.0300000000000001e-71 244.0 sp|Q98949|TYRO3_CHICK Tyrosine-protein kinase receptor TYRO3 OS=Gallus gallus OX=9031 GN=TYRO3 PE=1 SV=1 g8346.t1 P50867 58.475 354 1.83e-141 409.0 sp|P50867|CYSK_EMENI Cysteine synthase 1 OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=cysB PE=3 SV=2 g8347.t1 A9ULC7 27.24 279 1.09e-32 128.0 sp|A9ULC7|OSTA_XENTR Organic solute transporter subunit alpha OS=Xenopus tropicalis OX=8364 GN=slc51a PE=2 SV=2 OSTA_XENTR reviewed Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005789; GO:0005886; GO:0015721; GO:0016020; GO:0022857; GO:0032991; GO:0042803; GO:0046982 bile acid and bile salt transport [GO:0015721] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857] g8348.t1 A9ULC7 29.618 314 3.6200000000000004e-27 114.0 sp|A9ULC7|OSTA_XENTR Organic solute transporter subunit alpha OS=Xenopus tropicalis OX=8364 GN=slc51a PE=2 SV=2 OSTA_XENTR reviewed Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005789; GO:0005886; GO:0015721; GO:0016020; GO:0022857; GO:0032991; GO:0042803; GO:0046982 bile acid and bile salt transport [GO:0015721] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857] g8349.t1 Q9ESS0 37.709 358 2.9600000000000004e-70 232.0 sp|Q9ESS0|DUS10_MOUSE Dual specificity protein phosphatase 10 OS=Mus musculus OX=10090 GN=Dusp10 PE=2 SV=2 DUS10_MOUSE reviewed Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5) Mus musculus (Mouse) GO:0002819; GO:0004722; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008330; GO:0008432; GO:0010633; GO:0016791; GO:0017017; GO:0032496; GO:0032873; GO:0033549; GO:0033550; GO:0045088; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0048715; GO:0050680; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042 negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; negative regulation of stress-activated MAPK cascade [GO:0032873]; oligodendrocyte differentiation [GO:0048709]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; regulation of innate immune response [GO:0045088]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330] g8350.t1 Q9D3S5 31.503 346 1.1900000000000001e-56 191.0 sp|Q9D3S5|NXRD1_MOUSE NADP-dependent oxidoreductase domain-containing protein 1 OS=Mus musculus OX=10090 GN=Noxred1 PE=2 SV=1 g8351.t1 P18845 30.0 240 1.79e-36 144.0 sp|P18845|ACHA3_CARAU Neuronal acetylcholine receptor subunit alpha-3 OS=Carassius auratus OX=7957 GN=chrna3 PE=2 SV=1 g8352.t1 Q9R0W9 28.358 335 8.010000000000001e-43 159.0 sp|Q9R0W9|ACHA6_MOUSE Neuronal acetylcholine receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Chrna6 PE=1 SV=2 ACHA6_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-6 Mus musculus (Mouse) GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0014059; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098878; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888] g8356.t1 Q7SXA9 46.006 363 1.5099999999999998e-82 281.0 sp|Q7SXA9|MUS81_DANRE Structure-specific endonuclease subunit MUS81 OS=Danio rerio OX=7955 GN=mus81 PE=1 SV=1 g8356.t1 Q7SXA9 48.117 239 1.76e-56 209.0 sp|Q7SXA9|MUS81_DANRE Structure-specific endonuclease subunit MUS81 OS=Danio rerio OX=7955 GN=mus81 PE=1 SV=1 g8357.t1 O43581 24.549 277 1.95e-22 103.0 sp|O43581|SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens OX=9606 GN=SYT7 PE=1 SV=3 SYT7_HUMAN reviewed Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) Homo sapiens (Human) GO:0000149; GO:0001778; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0061891; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:0099502; GO:1900242; GO:1990926; GO:1990927 calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g8358.t1 Q9BUJ2 55.14 214 1.68e-52 192.0 sp|Q9BUJ2|HNRL1_HUMAN Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1 PE=1 SV=2 g8359.t1 Q00839 48.347 242 1.0899999999999999e-74 254.0 sp|Q00839|HNRPU_HUMAN Heterogeneous nuclear ribonucleoprotein U OS=Homo sapiens OX=9606 GN=HNRNPU PE=1 SV=6 HNRPU_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (GRIP120) (Nuclear p120 ribonucleoprotein) (Scaffold-attachment factor A) (SAF-A) (p120) (pp120) Homo sapiens (Human) GO:0000122; GO:0000228; GO:0000380; GO:0000381; GO:0000398; GO:0000776; GO:0000922; GO:0000978; GO:0000993; GO:0001097; GO:0001649; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003714; GO:0003723; GO:0003725; GO:0003727; GO:0003730; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005813; GO:0005829; GO:0006325; GO:0006396; GO:0007346; GO:0008143; GO:0009048; GO:0009986; GO:0016020; GO:0016363; GO:0016607; GO:0017069; GO:0017130; GO:0030218; GO:0030425; GO:0030496; GO:0031048; GO:0031490; GO:0032211; GO:0032922; GO:0032991; GO:0033673; GO:0034046; GO:0034244; GO:0034584; GO:0036002; GO:0036464; GO:0042802; GO:0043021; GO:0044877; GO:0045944; GO:0048255; GO:0050873; GO:0051301; GO:0051457; GO:0055013; GO:0060816; GO:0070034; GO:0070934; GO:0070937; GO:0071013; GO:0071385; GO:0072686; GO:0090336; GO:0098577; GO:0098963; GO:0099122; GO:0106222; GO:1900152; GO:1901673; GO:1902275; GO:1902425; GO:1902889; GO:1990023; GO:1990280; GO:1990498; GO:1990830; GO:1990837; GO:1990841; GO:1990845; GO:1990904; GO:2000373; GO:2000648; GO:2000737; GO:2000767 adaptive thermogenesis [GO:1990845]; alternative mRNA splicing, via spliceosome [GO:0000380]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell development [GO:0055013]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; erythrocyte differentiation [GO:0030218]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; random inactivation of X chromosome [GO:0060816]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]; RNA localization to chromatin [GO:1990280]; RNA processing [GO:0006396] catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697] actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; piRNA binding [GO:0034584]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714] g8363.t1 Q9VXE5 79.264 299 1.71e-167 503.0 sp|Q9VXE5|PAKM_DROME Serine/threonine-protein kinase PAK mbt OS=Drosophila melanogaster OX=7227 GN=mbt PE=1 SV=2 PAKM_DROME reviewed Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein) Drosophila melanogaster (Fruit fly) GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0009267; GO:0016319; GO:0031267; GO:0035556; GO:0043408; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:0106310; GO:2000047 cellular response to starvation [GO:0009267]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] g8364.t1 A8PU71 58.442 77 1.4399999999999997e-23 89.4 sp|A8PU71|SDHF1_BOVIN Succinate dehydrogenase assembly factor 1, mitochondrial OS=Bos taurus OX=9913 GN=SDHAF1 PE=3 SV=1 g8366.t1 Q5RJY2 42.271 317 5.14e-80 279.0 sp|Q5RJY2|G2E3_MOUSE G2/M phase-specific E3 ubiquitin-protein ligase OS=Mus musculus OX=10090 GN=G2e3 PE=2 SV=2 G2E3_MOUSE reviewed G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase) Mus musculus (Mouse) GO:0000209; GO:0001824; GO:0005634; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0008270; GO:0061630; GO:2001243 apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g8367.t1 Q08DB5 65.646 294 4.0699999999999997e-131 382.0 sp|Q08DB5|STX5_BOVIN Syntaxin-5 OS=Bos taurus OX=9913 GN=STX5 PE=2 SV=1 STX5_BOVIN reviewed Syntaxin-5 Bos taurus (Bovine) GO:0000139; GO:0000149; GO:0005484; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0012505; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0045732; GO:0048278; GO:0090166; GO:1903358 early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201]; vesicle [GO:0031982] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g8368.t2 P20825 38.785 214 3.58e-36 153.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g8371.t1 O73755 48.252 143 1.32e-41 142.0 sp|O73755|GREM1_CHICK Gremlin-1 OS=Gallus gallus OX=9031 GN=GREM1 PE=2 SV=1 g8372.t1 Q9JL04 42.601 446 6.68e-98 329.0 sp|Q9JL04|FMN2_MOUSE Formin-2 OS=Mus musculus OX=10090 GN=Fmn2 PE=1 SV=2 FMN2_MOUSE reviewed Formin-2 Mus musculus (Mouse) GO:0003779; GO:0005634; GO:0005730; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0008017; GO:0015031; GO:0015629; GO:0016192; GO:0016344; GO:0016477; GO:0030036; GO:0030659; GO:0040038; GO:0042177; GO:0043066; GO:0045010; GO:0046907; GO:0048471; GO:0048477; GO:0051017; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin nucleation [GO:0045010]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular transport [GO:0046907]; meiotic chromosome movement towards spindle pole [GO:0016344]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819] actin binding [GO:0003779]; microtubule binding [GO:0008017] g8376.t1 P46198 51.74 661 0.0 671.0 sp|P46198|IF2M_BOVIN Translation initiation factor IF-2, mitochondrial OS=Bos taurus OX=9913 GN=MTIF2 PE=1 SV=1 IF2M_BOVIN reviewed Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt)) Bos taurus (Bovine) GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0008135; GO:0032790; GO:0043024; GO:0070124 mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743] g8377.t1 P79781 94.702 151 1.3599999999999998e-91 265.0 sp|P79781|RS27A_CHICK Ubiquitin-ribosomal protein eS31 fusion protein OS=Gallus gallus OX=9031 GN=RPS27A PE=1 SV=3 RS27A_CHICK reviewed Ubiquitin-ribosomal protein eS31 fusion protein (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; Small ribosomal subunit protein eS31 (40S ribosomal protein S27a)] Gallus gallus (Chicken) GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006412; GO:0008270; GO:0016567; GO:0019941; GO:0031386; GO:0031625; GO:0032040; GO:0042274 modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; small-subunit processome [GO:0032040] protein tag activity [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g8378.t1 Q86TV6 44.529 786 0.0 600.0 sp|Q86TV6|TTC7B_HUMAN Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3 g8385.t1 Q8CGC7 59.417 892 0.0 1066.0 sp|Q8CGC7|SYEP_MOUSE Bifunctional glutamate/proline--tRNA ligase OS=Mus musculus OX=10090 GN=Eprs1 PE=1 SV=4 SYEP_MOUSE reviewed Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)] Mus musculus (Mouse) GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904 cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270] g8385.t1 Q8CGC7 58.649 740 0.0 863.0 sp|Q8CGC7|SYEP_MOUSE Bifunctional glutamate/proline--tRNA ligase OS=Mus musculus OX=10090 GN=Eprs1 PE=1 SV=4 SYEP_MOUSE reviewed Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)] Mus musculus (Mouse) GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904 cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270] g8386.t1 Q6F473 73.585 53 9.49e-24 88.6 sp|Q6F473|RS29_PLUXY Small ribosomal subunit protein uS14 OS=Plutella xylostella OX=51655 GN=RpS29 PE=3 SV=1 g8387.t1 Q80U96 80.561 1070 0.0 1825.0 sp|Q80U96|XPO1_RAT Exportin-1 OS=Rattus norvegicus OX=10116 GN=Xpo1 PE=1 SV=1 XPO1_RAT reviewed Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog) Rattus norvegicus (Rat) GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0071401; GO:0140297; GO:1902075; GO:1990904 cellular response to salt [GO:1902075]; cellular response to triglyceride [GO:0071401]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254] annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] DNA-binding transcription factor binding [GO:0140297]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] g8388.t1 Q96MY7 36.18 445 1.83e-65 234.0 sp|Q96MY7|F161B_HUMAN Protein FAM161B OS=Homo sapiens OX=9606 GN=FAM161B PE=1 SV=2 g8389.t1 Q7TPB1 76.236 526 0.0 821.0 sp|Q7TPB1|TCPD_RAT T-complex protein 1 subunit delta OS=Rattus norvegicus OX=10116 GN=Cct4 PE=1 SV=3 TCPD_RAT reviewed T-complex protein 1 subunit delta (TCP-1-delta) (EC 3.6.1.-) (CCT-delta) Rattus norvegicus (Rat) GO:0002199; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0042470; GO:0044183; GO:0044297; GO:0046872; GO:0050821; GO:0051082; GO:0090666; GO:0140662; GO:1904874 binding of sperm to zona pellucida [GO:0007339]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] g8390.t1 Q24498 45.271 3817 0.0 3246.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t1 Q24498 48.969 1503 0.0 1332.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t2 Q24498 45.111 3835 0.0 3232.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t2 Q24498 49.001 1502 0.0 1333.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t3 Q24498 45.136 3824 0.0 3231.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t3 Q24498 48.969 1503 0.0 1333.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t4 Q24498 45.14 3817 0.0 3231.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t4 Q24498 49.064 1496 0.0 1334.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t5 Q24498 46.215 5323 0.0 4564.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t6 Q24498 45.219 3817 0.0 3237.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t6 Q24498 48.969 1503 0.0 1332.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t7 Q24498 45.221 3808 0.0 3238.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t7 Q24498 49.001 1502 0.0 1333.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t8 Q24498 45.219 3817 0.0 3239.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t8 Q24498 49.331 1494 0.0 1343.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t9 Q24498 45.347 3793 0.0 3242.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t9 Q24498 48.969 1503 0.0 1333.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t10 Q24498 45.276 3810 0.0 3247.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t10 Q24498 49.001 1502 0.0 1334.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t11 Q24498 45.481 3784 0.0 3246.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t11 Q24498 48.969 1503 0.0 1333.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t12 Q24498 44.753 3859 0.0 3210.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8390.t12 Q24498 49.064 1496 0.0 1333.0 sp|Q24498|RYR_DROME Ryanodine receptor OS=Drosophila melanogaster OX=7227 GN=RyR PE=1 SV=3 RYR_DROME reviewed Ryanodine receptor (Ryanodine receptor 44F) Drosophila melanogaster (Fruit fly) GO:0005219; GO:0005262; GO:0006816; GO:0006874; GO:0006936; GO:0015279; GO:0016020; GO:0033017; GO:0035206; GO:0051209; GO:0060047; GO:0070588; GO:0072347 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; intracellular calcium ion homeostasis [GO:0006874]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347] membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; store-operated calcium channel activity [GO:0015279] g8392.t1 Q9H7Z3 33.93 1229 0.0 603.0 sp|Q9H7Z3|NRDE2_HUMAN Nuclear exosome regulator NRDE2 OS=Homo sapiens OX=9606 GN=NRDE2 PE=1 SV=3 g8394.t1 Q16769 49.398 332 7.44e-91 280.0 sp|Q16769|QPCT_HUMAN Glutaminyl-peptide cyclotransferase OS=Homo sapiens OX=9606 GN=QPCT PE=1 SV=1 g8395.t1 P23790 60.87 207 3.49e-69 230.0 sp|P23790|SRF_XENLA Serum response factor OS=Xenopus laevis OX=8355 GN=srf PE=2 SV=1 g8398.t1 P97587 37.162 148 1.37e-22 95.5 sp|P97587|CGRF1_RAT Cell growth regulator with RING finger domain protein 1 OS=Rattus norvegicus OX=10116 GN=Cgrrf1 PE=2 SV=1 g8399.t1 Q0IHW3 37.65 749 2.27e-122 383.0 sp|Q0IHW3|SMAG1_XENTR Protein Smaug homolog 1 OS=Xenopus tropicalis OX=8364 GN=samd4a PE=2 SV=1 g8402.t1 P22288 69.34 212 2.07e-107 315.0 sp|P22288|GCH1_RAT GTP cyclohydrolase 1 OS=Rattus norvegicus OX=10116 GN=Gch1 PE=1 SV=1 g8403.t1 Q9CR14 45.822 371 1.41e-118 352.0 sp|Q9CR14|FANCL_MOUSE E3 ubiquitin-protein ligase FANCL OS=Mus musculus OX=10090 GN=Fancl PE=1 SV=1 FANCL_MOUSE reviewed E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein homolog) (Proliferation of germ cells protein) (RING-type E3 ubiquitin transferase FANCL) Mus musculus (Mouse) GO:0000785; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0008270; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043240; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g8404.t1 A7E2I7 48.451 355 2.3700000000000003e-117 363.0 sp|A7E2I7|T151B_DANRE Transmembrane protein 151B OS=Danio rerio OX=7955 GN=tmem151b PE=2 SV=1 g8407.t1 O60232 44.783 230 5.0799999999999996e-52 170.0 sp|O60232|ZNRD2_HUMAN Protein ZNRD2 OS=Homo sapiens OX=9606 GN=ZNRD2 PE=1 SV=1 ZNRD2_HUMAN reviewed Protein ZNRD2 (Autoantigen p27) (Protein zinc ribbon domain type 2) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2) Homo sapiens (Human) GO:0000278; GO:0005737; GO:0042802; GO:0046872; GO:0051301 cell division [GO:0051301]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737] identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g8408.t1 Q9P2K8 39.255 1717 0.0 1079.0 sp|Q9P2K8|E2AK4_HUMAN eIF-2-alpha kinase GCN2 OS=Homo sapiens OX=9606 GN=EIF2AK4 PE=1 SV=3 E2AK4_HUMAN reviewed eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein) Homo sapiens (Human) GO:0000049; GO:0000077; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0006468; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138; GO:1990928 adaptive immune response [GO:0002250]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; GCN2-mediated signaling [GO:0140469]; host-mediated suppression of viral genome replication [GO:0044828]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to amino acid starvation [GO:1990928]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634] ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049] g8408.t2 Q9QZ05 38.77 1723 0.0 1076.0 sp|Q9QZ05|E2AK4_MOUSE eIF-2-alpha kinase GCN2 OS=Mus musculus OX=10090 GN=Eif2ak4 PE=1 SV=2 g8409.t1 Q5RGU1 50.932 644 0.0 623.0 sp|Q5RGU1|COQ8A_DANRE Atypical kinase COQ8A, mitochondrial OS=Danio rerio OX=7955 GN=coq8a PE=2 SV=2 COQ8A_DANRE reviewed Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004672; GO:0005524; GO:0005739; GO:0006744; GO:0016301; GO:0016310; GO:0031966; GO:0043531 phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744] mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672] g8410.t1 Q6DHJ3 47.241 453 7.76e-148 432.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g8411.t1 Q91YE3 43.49 384 5.66e-102 311.0 sp|Q91YE3|EGLN1_MOUSE Egl nine homolog 1 OS=Mus musculus OX=10090 GN=Egln1 PE=1 SV=2 EGLN1_MOUSE reviewed Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20) Mus musculus (Mouse) GO:0001666; GO:0004857; GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0008198; GO:0008270; GO:0014069; GO:0016706; GO:0019899; GO:0031418; GO:0031543; GO:0031545; GO:0032364; GO:0043065; GO:0043523; GO:0043525; GO:0045765; GO:0045944; GO:0055008; GO:0060347; GO:0060412; GO:0060711; GO:0071456; GO:0071731; GO:0098978; GO:0099159; GO:0140252; GO:0160082; GO:1902072; GO:1905290 cardiac muscle tissue morphogenesis [GO:0055008]; cellular response to hypoxia [GO:0071456]; heart trabecula formation [GO:0060347]; intracellular iron ion homeostasis [GO:0006879]; intracellular oxygen homeostasis [GO:0032364]; labyrinthine layer development [GO:0060711]; negative regulation of CAMKK-AMPK signaling cascade [GO:1905290]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron apoptotic process [GO:0043523]; regulation protein catabolic process at postsynapse [GO:0140252]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; zinc ion binding [GO:0008270] g8412.t1 Q8IXF0 50.851 470 2.7199999999999996e-141 447.0 sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1 g8412.t2 Q8IXF0 50.851 470 1.12e-141 448.0 sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1 g8414.t1 Q9WVC7 27.477 444 3.05e-36 154.0 sp|Q9WVC7|AKAP6_RAT A-kinase anchor protein 6 OS=Rattus norvegicus OX=10116 GN=Akap6 PE=1 SV=1 AKAP6_RAT reviewed A-kinase anchor protein 6 (AKAP-6) (Protein kinase A-anchoring protein 6) (PRKA6) (mAKAP) Rattus norvegicus (Rat) GO:0001508; GO:0005634; GO:0005635; GO:0005737; GO:0005901; GO:0008179; GO:0010739; GO:0010880; GO:0014701; GO:0014704; GO:0016529; GO:0019899; GO:0030307; GO:0030315; GO:0031503; GO:0031965; GO:0032991; GO:0034237; GO:0034704; GO:0042383; GO:0043495; GO:0044325; GO:0045727; GO:0048471; GO:0051018; GO:0051281; GO:0051721; GO:0060090; GO:0060306; GO:0061051; GO:0070886; GO:0071320; GO:0071345; GO:0071872; GO:0086004; GO:0141161; GO:1901381; GO:1901897 action potential [GO:0001508]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epinephrine stimulus [GO:0071872]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of translation [GO:0045727]; protein-containing complex localization [GO:0031503]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of membrane repolarization [GO:0060306]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315] adenylate cyclase binding [GO:0008179]; enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2A binding [GO:0051721]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325] g8418.t1 P10894 53.092 469 6.69e-157 513.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t1 P10894 39.641 724 1.29e-135 455.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t2 P10894 53.092 469 6.69e-157 513.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t2 P10894 39.641 724 1.29e-135 455.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t3 P10687 47.119 590 4.31e-158 516.0 sp|P10687|PLCB1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Rattus norvegicus OX=10116 GN=Plcb1 PE=1 SV=1 PLCB1_RAT reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1) Rattus norvegicus (Rat) GO:0000086; GO:0000785; GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0007186; GO:0007200; GO:0007207; GO:0007213; GO:0007215; GO:0007612; GO:0007613; GO:0008277; GO:0010560; GO:0016607; GO:0019899; GO:0021987; GO:0031161; GO:0031965; GO:0032024; GO:0032735; GO:0032957; GO:0032991; GO:0034284; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0043434; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0051209; GO:0060466; GO:0070498; GO:0080154; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:0099524; GO:0120548; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:1990806; GO:2000344; GO:2000438 activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; response to monosaccharide [GO:0034284]; response to peptide hormone [GO:0043434] chromatin [GO:0000785]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t3 P10687 40.611 687 3.77e-137 459.0 sp|P10687|PLCB1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Rattus norvegicus OX=10116 GN=Plcb1 PE=1 SV=1 PLCB1_RAT reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1) Rattus norvegicus (Rat) GO:0000086; GO:0000785; GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0007186; GO:0007200; GO:0007207; GO:0007213; GO:0007215; GO:0007612; GO:0007613; GO:0008277; GO:0010560; GO:0016607; GO:0019899; GO:0021987; GO:0031161; GO:0031965; GO:0032024; GO:0032735; GO:0032957; GO:0032991; GO:0034284; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0043434; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0051209; GO:0060466; GO:0070498; GO:0080154; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:0099524; GO:0120548; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:1990806; GO:2000344; GO:2000438 activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; response to monosaccharide [GO:0034284]; response to peptide hormone [GO:0043434] chromatin [GO:0000785]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t4 P10687 47.119 590 6.92e-158 516.0 sp|P10687|PLCB1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Rattus norvegicus OX=10116 GN=Plcb1 PE=1 SV=1 PLCB1_RAT reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1) Rattus norvegicus (Rat) GO:0000086; GO:0000785; GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0007186; GO:0007200; GO:0007207; GO:0007213; GO:0007215; GO:0007612; GO:0007613; GO:0008277; GO:0010560; GO:0016607; GO:0019899; GO:0021987; GO:0031161; GO:0031965; GO:0032024; GO:0032735; GO:0032957; GO:0032991; GO:0034284; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0043434; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0051209; GO:0060466; GO:0070498; GO:0080154; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:0099524; GO:0120548; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:1990806; GO:2000344; GO:2000438 activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; response to monosaccharide [GO:0034284]; response to peptide hormone [GO:0043434] chromatin [GO:0000785]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t4 P10687 38.95 724 9.069999999999999e-134 450.0 sp|P10687|PLCB1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Rattus norvegicus OX=10116 GN=Plcb1 PE=1 SV=1 PLCB1_RAT reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1) Rattus norvegicus (Rat) GO:0000086; GO:0000785; GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0007186; GO:0007200; GO:0007207; GO:0007213; GO:0007215; GO:0007612; GO:0007613; GO:0008277; GO:0010560; GO:0016607; GO:0019899; GO:0021987; GO:0031161; GO:0031965; GO:0032024; GO:0032735; GO:0032957; GO:0032991; GO:0034284; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0043434; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0051209; GO:0060466; GO:0070498; GO:0080154; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:0099524; GO:0120548; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:1990806; GO:2000344; GO:2000438 activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; response to monosaccharide [GO:0034284]; response to peptide hormone [GO:0043434] chromatin [GO:0000785]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t5 P10894 53.092 469 1.4800000000000002e-156 514.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t5 P10894 39.641 724 1.85e-135 456.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t6 P10894 53.092 469 1.87e-156 514.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8418.t6 P10894 39.641 724 2.2099999999999998e-135 456.0 sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1 PLCB1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1) Bos taurus (Bovine) GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498; GO:0120548 G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g8419.t1 Q15147 62.338 616 0.0 789.0 sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3 g8419.t1 Q15147 58.554 567 0.0 693.0 sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3 g8419.t2 Q15147 62.338 616 0.0 790.0 sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3 g8419.t2 Q15147 62.476 517 0.0 694.0 sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3 g8420.t1 Q9Y3Q0 48.489 695 0.0 662.0 sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1 NALD2_HUMAN reviewed N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II) Homo sapiens (Human) GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129 carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236] g8421.t1 O93603 27.681 401 4.07e-21 97.4 sp|O93603|TRHR_CHICK Thyrotropin-releasing hormone receptor OS=Gallus gallus OX=9031 GN=TRHR PE=2 SV=1 g8422.t1 O93403 30.725 345 3.44e-43 160.0 sp|O93403|CHST3_TETCF Carbohydrate sulfotransferase 3 OS=Tetronarce californica OX=7787 GN=CHST3 PE=1 SV=1 g8423.t1 O93403 33.038 339 9.99e-47 170.0 sp|O93403|CHST3_TETCF Carbohydrate sulfotransferase 3 OS=Tetronarce californica OX=7787 GN=CHST3 PE=1 SV=1 g8424.t1 Q5HZM1 59.036 166 1.95e-58 184.0 sp|Q5HZM1|EIF1A_XENLA Probable RNA-binding protein EIF1AD OS=Xenopus laevis OX=8355 GN=eif1ad PE=2 SV=1 g8425.t1 P16054 60.654 765 0.0 959.0 sp|P16054|KPCE_MOUSE Protein kinase C epsilon type OS=Mus musculus OX=10090 GN=Prkce PE=1 SV=1 KPCE_MOUSE reviewed Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) Mus musculus (Mouse) GO:0000139; GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004699; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007635; GO:0008047; GO:0008270; GO:0009407; GO:0010634; GO:0010763; GO:0010811; GO:0010917; GO:0016020; GO:0017124; GO:0019216; GO:0019899; GO:0019901; GO:0030315; GO:0030546; GO:0030838; GO:0031397; GO:0031594; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0036120; GO:0042178; GO:0043066; GO:0043123; GO:0043278; GO:0043410; GO:0045111; GO:0048471; GO:0050996; GO:0051279; GO:0051280; GO:0051301; GO:0051562; GO:0061178; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0098978; GO:0099171; GO:0099523; GO:0106310; GO:0120283 cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to prostaglandin E stimulus [GO:0071380]; chemosensory behavior [GO:0007635]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; toxin catabolic process [GO:0009407]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]; xenobiotic catabolic process [GO:0042178] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; T-tubule [GO:0030315] 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; SH3 domain binding [GO:0017124]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] g8425.t2 P16054 61.854 755 0.0 965.0 sp|P16054|KPCE_MOUSE Protein kinase C epsilon type OS=Mus musculus OX=10090 GN=Prkce PE=1 SV=1 KPCE_MOUSE reviewed Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) Mus musculus (Mouse) GO:0000139; GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004699; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007635; GO:0008047; GO:0008270; GO:0009407; GO:0010634; GO:0010763; GO:0010811; GO:0010917; GO:0016020; GO:0017124; GO:0019216; GO:0019899; GO:0019901; GO:0030315; GO:0030546; GO:0030838; GO:0031397; GO:0031594; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0036120; GO:0042178; GO:0043066; GO:0043123; GO:0043278; GO:0043410; GO:0045111; GO:0048471; GO:0050996; GO:0051279; GO:0051280; GO:0051301; GO:0051562; GO:0061178; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0098978; GO:0099171; GO:0099523; GO:0106310; GO:0120283 cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to prostaglandin E stimulus [GO:0071380]; chemosensory behavior [GO:0007635]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; toxin catabolic process [GO:0009407]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]; xenobiotic catabolic process [GO:0042178] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; T-tubule [GO:0030315] 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; SH3 domain binding [GO:0017124]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] g8425.t3 Q02156 52.243 379 9.13e-135 405.0 sp|Q02156|KPCE_HUMAN Protein kinase C epsilon type OS=Homo sapiens OX=9606 GN=PRKCE PE=1 SV=1 KPCE_HUMAN reviewed Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) Homo sapiens (Human) GO:0000165; GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0008047; GO:0008270; GO:0009407; GO:0010634; GO:0010763; GO:0010811; GO:0019899; GO:0030073; GO:0030546; GO:0030838; GO:0031397; GO:0031589; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0032930; GO:0032956; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0042178; GO:0043123; GO:0043278; GO:0043410; GO:0045111; GO:0045202; GO:0048471; GO:0050996; GO:0051279; GO:0051301; GO:0051649; GO:0051932; GO:0061178; GO:0070254; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0106310; GO:1902306; GO:1903078 apoptotic process [GO:0006915]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]; toxin catabolic process [GO:0009407]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]; xenobiotic catabolic process [GO:0042178] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; zinc ion binding [GO:0008270] g8426.t1 Q86U28 53.6 125 5.52e-41 137.0 sp|Q86U28|ISCA2_HUMAN Iron-sulfur cluster assembly 2 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=ISCA2 PE=1 SV=2 ISCA2_HUMAN reviewed Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005759; GO:0016226; GO:0042802; GO:0051537; GO:0051539; GO:0051604; GO:0120510 iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604] mitochondrial [4Fe-4S] assembly complex [GO:0120510]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506] g8428.t1 P60899 82.051 117 1.1500000000000001e-73 218.0 sp|P60899|RPB9_PIG DNA-directed RNA polymerase II subunit RPB9 OS=Sus scrofa OX=9823 GN=POLR2I PE=1 SV=1 g8429.t1 Q8IW19 41.406 128 1.0399999999999998e-23 108.0 sp|Q8IW19|APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens OX=9606 GN=APLF PE=1 SV=1 APLF_HUMAN reviewed Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1) Homo sapiens (Human) GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006974; GO:0007566; GO:0008270; GO:0008408; GO:0010717; GO:0035861; GO:0042393; GO:0044183; GO:0045191; GO:0071168; GO:0072572; GO:0090734; GO:0140713; GO:0140861; GO:0160002 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryo implantation [GO:0007566]; protein localization to chromatin [GO:0071168]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] 3'-5' exonuclease activity [GO:0008408]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose binding [GO:0072572]; protein folding chaperone [GO:0044183]; zinc ion binding [GO:0008270] g8429.t2 Q8IW19 41.406 128 1.0699999999999998e-23 108.0 sp|Q8IW19|APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens OX=9606 GN=APLF PE=1 SV=1 APLF_HUMAN reviewed Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1) Homo sapiens (Human) GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006974; GO:0007566; GO:0008270; GO:0008408; GO:0010717; GO:0035861; GO:0042393; GO:0044183; GO:0045191; GO:0071168; GO:0072572; GO:0090734; GO:0140713; GO:0140861; GO:0160002 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryo implantation [GO:0007566]; protein localization to chromatin [GO:0071168]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] 3'-5' exonuclease activity [GO:0008408]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose binding [GO:0072572]; protein folding chaperone [GO:0044183]; zinc ion binding [GO:0008270] g8430.t1 Q6ZMV9 49.891 916 0.0 823.0 sp|Q6ZMV9|KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens OX=9606 GN=KIF6 PE=1 SV=3 g8431.t1 Q95M12 48.028 431 5.500000000000001e-144 420.0 sp|Q95M12|LGMN_BOVIN Legumain OS=Bos taurus OX=9913 GN=LGMN PE=1 SV=1 LGMN_BOVIN reviewed Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) Bos taurus (Bovine) GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0019886; GO:0032801; GO:0043202; GO:0051603; GO:1901185 antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] cysteine-type endopeptidase activity [GO:0004197] g8432.t1 Q9Y4D1 53.506 1084 0.0 1058.0 sp|Q9Y4D1|DAAM1_HUMAN Disheveled-associated activator of morphogenesis 1 OS=Homo sapiens OX=9606 GN=DAAM1 PE=1 SV=2 DAAM1_HUMAN reviewed Disheveled-associated activator of morphogenesis 1 Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0031514; GO:0036064; GO:0042802; GO:0048471; GO:0060071; GO:0098793; GO:0098978; GO:0099140 presynaptic actin cytoskeleton organization [GO:0099140]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; motile cilium [GO:0031514]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; stress fiber [GO:0001725] actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] g8432.t2 Q9Y4D1 54.299 1070 0.0 1068.0 sp|Q9Y4D1|DAAM1_HUMAN Disheveled-associated activator of morphogenesis 1 OS=Homo sapiens OX=9606 GN=DAAM1 PE=1 SV=2 DAAM1_HUMAN reviewed Disheveled-associated activator of morphogenesis 1 Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0031514; GO:0036064; GO:0042802; GO:0048471; GO:0060071; GO:0098793; GO:0098978; GO:0099140 presynaptic actin cytoskeleton organization [GO:0099140]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; motile cilium [GO:0031514]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; stress fiber [GO:0001725] actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] g8433.t1 Q9Y253 37.978 811 2.0700000000000002e-166 501.0 sp|Q9Y253|POLH_HUMAN DNA polymerase eta OS=Homo sapiens OX=9606 GN=POLH PE=1 SV=1 POLH_HUMAN reviewed DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) Homo sapiens (Human) GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0008270; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0070987; GO:0071494 cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; zinc ion binding [GO:0008270] g8434.t1 Q8IV61 50.826 545 0.0 548.0 sp|Q8IV61|GRP3_HUMAN Ras guanyl-releasing protein 3 OS=Homo sapiens OX=9606 GN=RASGRP3 PE=1 SV=1 GRP3_HUMAN reviewed Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1) Homo sapiens (Human) GO:0000165; GO:0005085; GO:0005096; GO:0005509; GO:0005886; GO:0007264; GO:0007265; GO:0008270; GO:0019900; GO:0019992; GO:0031267; GO:0032045; GO:0048471 MAPK cascade [GO:0000165]; Ras protein signal transduction [GO:0007265]; small GTPase-mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor complex [GO:0032045]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g8435.t1 Q6P4F7 36.053 380 5.84e-44 177.0 sp|Q6P4F7|RHGBA_HUMAN Rho GTPase-activating protein 11A OS=Homo sapiens OX=9606 GN=ARHGAP11A PE=1 SV=2 RHGBA_HUMAN reviewed Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A) Homo sapiens (Human) GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056 positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] GTPase activator activity [GO:0005096] g8436.t1 P62744 92.254 142 1.31e-94 272.0 sp|P62744|AP2S1_RAT AP-2 complex subunit sigma OS=Rattus norvegicus OX=10116 GN=Ap2s1 PE=1 SV=1 AP2S1_RAT reviewed AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma-adaptin 3b) (Sigma2-adaptin) Rattus norvegicus (Rat) GO:0005886; GO:0006886; GO:0008021; GO:0016192; GO:0030122; GO:0035615; GO:0045202; GO:0048488; GO:0072583; GO:0098794; GO:0098884; GO:0098894; GO:0098978 clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] clathrin adaptor activity [GO:0035615] g8437.t1 P52432 66.272 338 3.9799999999999995e-170 479.0 sp|P52432|RPAC1_MOUSE DNA-directed RNA polymerases I and III subunit RPAC1 OS=Mus musculus OX=10090 GN=Polr1c PE=1 SV=3 g8438.t1 Q8BKG3 37.604 1077 0.0 724.0 sp|Q8BKG3|PTK7_MOUSE Inactive tyrosine-protein kinase 7 OS=Mus musculus OX=10090 GN=Ptk7 PE=1 SV=1 PTK7_MOUSE reviewed Inactive tyrosine-protein kinase 7 (Protein chuzhoi) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) Mus musculus (Mouse) GO:0001736; GO:0001822; GO:0001843; GO:0003281; GO:0003401; GO:0004672; GO:0005524; GO:0005829; GO:0005886; GO:0005911; GO:0007155; GO:0007507; GO:0010976; GO:0016020; GO:0016055; GO:0016477; GO:0030036; GO:0042060; GO:0045198; GO:0060026; GO:0060484; GO:0060976; GO:0071300; GO:0090103; GO:0090263 actin cytoskeleton organization [GO:0030036]; axis elongation [GO:0003401]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; convergent extension [GO:0060026]; coronary vasculature development [GO:0060976]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; lung-associated mesenchyme development [GO:0060484]; neural tube closure [GO:0001843]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuron projection development [GO:0010976]; ventricular septum development [GO:0003281]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase activity [GO:0004672] g8440.t1 Q6ZUK4 40.173 346 1.9999999999999997e-68 221.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g8442.t1 Q6ZUK4 36.512 367 1.3600000000000002e-57 195.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g8443.t1 Q6ZUK4 39.349 338 7.19e-63 207.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g8444.t1 Q6ZUK4 32.653 343 4.22e-50 177.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g8445.t1 Q5VTE6 46.115 399 3.88e-94 302.0 sp|Q5VTE6|ANGE2_HUMAN Protein angel homolog 2 OS=Homo sapiens OX=9606 GN=ANGEL2 PE=1 SV=1 ANGE2_HUMAN reviewed RNA 2',3'-cyclic phosphatase ANGEL2 (EC 3.-.-.-) Homo sapiens (Human) GO:0000287; GO:0003730; GO:0005737; GO:0005739; GO:0005759; GO:0015030; GO:0033119; GO:0045930; GO:0070935; GO:0090616; GO:0160272; GO:0160273; GO:2000236 3'-UTR-mediated mRNA stabilization [GO:0070935]; mitochondrial mRNA 3'-end processing [GO:0090616]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of RNA splicing [GO:0033119]; negative regulation of tRNA processing [GO:2000236] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] magnesium ion binding [GO:0000287]; mRNA 3'-UTR binding [GO:0003730]; RNA 2',3'-cyclic phosphatase activity [GO:0160272]; RNA 2'-phosphatase activity [GO:0160273] g8452.t1 Q61412 64.286 196 1.6400000000000001e-77 248.0 sp|Q61412|VSX2_MOUSE Visual system homeobox 2 OS=Mus musculus OX=10090 GN=Vsx2 PE=1 SV=1 VSX2_MOUSE reviewed Visual system homeobox 2 (Ceh-10 homeodomain-containing homolog) (Homeobox protein CHX10) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0001227; GO:0005634; GO:0005737; GO:0006357; GO:0007601; GO:0008284; GO:0008285; GO:0043010; GO:0045165; GO:0045944; GO:0060040; GO:0060042; GO:1990837 camera-type eye development [GO:0043010]; cell fate commitment [GO:0045165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina morphogenesis in camera-type eye [GO:0060042]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g8455.t1 Q6PB03 47.732 463 5e-150 439.0 sp|Q6PB03|PLD3_XENLA 5'-3' exonuclease PLD3 OS=Xenopus laevis OX=8355 GN=pld3 PE=2 SV=1 PLD3_XENLA reviewed 5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3) Xenopus laevis (African clawed frog) GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0012505; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015 immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202] single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145] g8455.t2 Q6PB03 48.283 466 1.55e-151 443.0 sp|Q6PB03|PLD3_XENLA 5'-3' exonuclease PLD3 OS=Xenopus laevis OX=8355 GN=pld3 PE=2 SV=1 PLD3_XENLA reviewed 5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3) Xenopus laevis (African clawed frog) GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0012505; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015 immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202] single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145] g8456.t1 Q26534 51.299 308 5.92e-108 324.0 sp|Q26534|CATL_SCHMA Cathepsin L OS=Schistosoma mansoni OX=6183 GN=CL1 PE=2 SV=1 g8458.t1 P98068 43.885 417 7.08e-108 335.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g8459.t1 Q96M11 39.72 214 3.39e-30 120.0 sp|Q96M11|HYLS1_HUMAN Centriolar and ciliogenesis-associated protein HYLS1 OS=Homo sapiens OX=9606 GN=HYLS1 PE=1 SV=1 HYLS1_HUMAN reviewed Centriolar and ciliogenesis-associated protein HYLS1 (Hydrolethalus syndrome protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0060271; GO:0097730 cilium assembly [GO:0060271] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g8460.t1 Q6DFF9 57.297 740 0.0 915.0 sp|Q6DFF9|MABP1_XENLA Mitogen-activated protein kinase-binding protein 1 OS=Xenopus laevis OX=8355 GN=mapkbp1 PE=2 SV=1 g8460.t2 Q6DFF9 57.297 740 0.0 915.0 sp|Q6DFF9|MABP1_XENLA Mitogen-activated protein kinase-binding protein 1 OS=Xenopus laevis OX=8355 GN=mapkbp1 PE=2 SV=1 g8461.t1 A9ULC7 30.108 279 1e-24 105.0 sp|A9ULC7|OSTA_XENTR Organic solute transporter subunit alpha OS=Xenopus tropicalis OX=8364 GN=slc51a PE=2 SV=2 OSTA_XENTR reviewed Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005789; GO:0005886; GO:0015721; GO:0016020; GO:0022857; GO:0032991; GO:0042803; GO:0046982 bile acid and bile salt transport [GO:0015721] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857] g8462.t1 Q8N5C6 46.941 801 0.0 729.0 sp|Q8N5C6|SRBD1_HUMAN S1 RNA-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SRBD1 PE=1 SV=2 g8464.t1 Q6NXA9 43.155 336 4.2e-74 233.0 sp|Q6NXA9|UBXN1_DANRE UBX domain-containing protein 1 OS=Danio rerio OX=7955 GN=ubxn1 PE=2 SV=1 g8465.t1 Q9JI19 51.955 358 6.129999999999999e-138 399.0 sp|Q9JI19|FIBP_MOUSE Acidic fibroblast growth factor intracellular-binding protein OS=Mus musculus OX=10090 GN=Fibp PE=1 SV=1 g8466.t1 O95433 46.307 352 1.26e-112 333.0 sp|O95433|AHSA1_HUMAN Activator of 90 kDa heat shock protein ATPase homolog 1 OS=Homo sapiens OX=9606 GN=AHSA1 PE=1 SV=1 g8467.t1 Q5I0I4 34.503 171 3.3999999999999996e-30 116.0 sp|Q5I0I4|DMAC2_RAT Distal membrane-arm assembly complex protein 2 OS=Rattus norvegicus OX=10116 GN=Dmac2 PE=2 SV=1 g8469.t1 Q9Y6A2 38.716 483 1.12e-109 338.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8471.t1 Q9Y6A2 38.716 483 1.02e-109 338.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8477.t1 Q80TI1 45.667 1027 0.0 891.0 sp|Q80TI1|PKHH1_MOUSE Pleckstrin homology domain-containing family H member 1 OS=Mus musculus OX=10090 GN=Plekhh1 PE=1 SV=2 g8477.t1 Q80TI1 36.025 161 5.049999999999999e-23 111.0 sp|Q80TI1|PKHH1_MOUSE Pleckstrin homology domain-containing family H member 1 OS=Mus musculus OX=10090 GN=Plekhh1 PE=1 SV=2 g8479.t1 Q7Z449 35.8 500 2.04e-112 347.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g8480.t1 Q8VD72 69.472 511 0.0 787.0 sp|Q8VD72|TTC8_MOUSE Tetratricopeptide repeat protein 8 OS=Mus musculus OX=10090 GN=Ttc8 PE=1 SV=1 g8483.t1 G5EDR5 34.201 269 7.7e-33 135.0 sp|G5EDR5|FUTA_CAEEL Alpha-(1,3)-fucosyltransferase fut-1 OS=Caenorhabditis elegans OX=6239 GN=fut-1 PE=1 SV=1 FUTA_CAEEL reviewed Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1) Caenorhabditis elegans GO:0000139; GO:0006487; GO:0006491; GO:0008417; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0046872; GO:0046920; GO:1901137 carbohydrate biosynthetic process [GO:0016051]; carbohydrate derivative biosynthetic process [GO:1901137]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872] g8483.t1 G5EDR5 34.483 232 1.37e-31 132.0 sp|G5EDR5|FUTA_CAEEL Alpha-(1,3)-fucosyltransferase fut-1 OS=Caenorhabditis elegans OX=6239 GN=fut-1 PE=1 SV=1 FUTA_CAEEL reviewed Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1) Caenorhabditis elegans GO:0000139; GO:0006487; GO:0006491; GO:0008417; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0046872; GO:0046920; GO:1901137 carbohydrate biosynthetic process [GO:0016051]; carbohydrate derivative biosynthetic process [GO:1901137]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872] g8484.t1 P79345 35.948 153 5.19e-25 97.1 sp|P79345|NPC2_BOVIN NPC intracellular cholesterol transporter 2 OS=Bos taurus OX=9913 GN=NPC2 PE=1 SV=1 NPC2_BOVIN reviewed NPC intracellular cholesterol transporter 2 (EPV20) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog) Bos taurus (Bovine) GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0015485; GO:0030301; GO:0032367; GO:0033344 cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764] cholesterol binding [GO:0015485] g8486.t1 Q9UQ07 69.492 295 2.7500000000000002e-157 454.0 sp|Q9UQ07|MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens OX=9606 GN=MOK PE=1 SV=1 MOK_HUMAN reviewed MAPK/MAK/MRK overlapping kinase (EC 2.7.11.22) (MOK protein kinase) (Renal tumor antigen 1) (RAGE-1) Homo sapiens (Human) GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0035556; GO:0046872; GO:0097546; GO:0106310 intracellular signal transduction [GO:0035556] ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8487.t1 A7RLE5 60.14 143 8.29e-55 178.0 sp|A7RLE5|DNPH1_NEMVE Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 OS=Nematostella vectensis OX=45351 GN=v1g160099 PE=3 SV=1 DNPH1_NEMVE reviewed Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) Nematostella vectensis (Starlet sea anemone) GO:0005634; GO:0005737; GO:0006163; GO:0009116; GO:0009159; GO:0030307; GO:0042802; GO:0070694 deoxyribonucleoside monophosphate catabolic process [GO:0009159]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide metabolic process [GO:0006163] cytoplasm [GO:0005737]; nucleus [GO:0005634] 5-hydroxymethyl-dUMP N-hydrolase activity [GO:0070694]; identical protein binding [GO:0042802] g8487.t1 A7RLE5 53.147 143 2.87e-39 138.0 sp|A7RLE5|DNPH1_NEMVE Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 OS=Nematostella vectensis OX=45351 GN=v1g160099 PE=3 SV=1 DNPH1_NEMVE reviewed Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) Nematostella vectensis (Starlet sea anemone) GO:0005634; GO:0005737; GO:0006163; GO:0009116; GO:0009159; GO:0030307; GO:0042802; GO:0070694 deoxyribonucleoside monophosphate catabolic process [GO:0009159]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide metabolic process [GO:0006163] cytoplasm [GO:0005737]; nucleus [GO:0005634] 5-hydroxymethyl-dUMP N-hydrolase activity [GO:0070694]; identical protein binding [GO:0042802] g8488.t1 Q9DCX1 28.044 271 9.62e-30 117.0 sp|Q9DCX1|MD2BP_MOUSE MAD2L1-binding protein OS=Mus musculus OX=10090 GN=Mad2l1bp PE=1 SV=2 g8489.t1 O88466 30.0 460 2.11e-50 201.0 sp|O88466|ZN106_MOUSE Zinc finger protein 106 OS=Mus musculus OX=10090 GN=Znf106 PE=1 SV=3 ZN106_MOUSE reviewed Zinc finger protein 106 (Zfp-106) (H3a minor histocompatibility antigen) (Son of insulin receptor mutant) (Zinc finger protein 474) Mus musculus (Mouse) GO:0003723; GO:0005730; GO:0005829; GO:0008270; GO:0008286; GO:0016020; GO:0016607; GO:0017124 insulin receptor signaling pathway [GO:0008286] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270] g8491.t1 O60306 71.637 1368 0.0 2062.0 sp|O60306|AQR_HUMAN RNA helicase aquarius OS=Homo sapiens OX=9606 GN=AQR PE=1 SV=4 AQR_HUMAN reviewed RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] g8502.t1 P80146 44.961 387 1.3e-94 291.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g8503.t1 A6H7E2 40.376 213 9.46e-46 155.0 sp|A6H7E2|CINP_BOVIN Cyclin-dependent kinase 2-interacting protein OS=Bos taurus OX=9913 GN=CINP PE=2 SV=1 g8504.t1 A8K0R7 28.012 332 6.230000000000001e-21 103.0 sp|A8K0R7|ZN839_HUMAN Zinc finger protein 839 OS=Homo sapiens OX=9606 GN=ZNF839 PE=1 SV=1 ZN839_HUMAN reviewed Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50) Homo sapiens (Human) GO:0008270 zinc ion binding [GO:0008270] g8505.t1 B1AT66 24.945 457 4.3100000000000004e-35 142.0 sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1 g8513.t1 Q8BGC3 26.549 452 9.090000000000001e-27 115.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g8516.t1 F1LXS7 51.818 110 3.38e-36 124.0 sp|F1LXS7|LYSET_RAT Lysosomal enzyme trafficking factor OS=Rattus norvegicus OX=10116 GN=Lyset PE=3 SV=2 g8517.t1 Q6NS26 69.508 528 0.0 772.0 sp|Q6NS26|CDKAL_XENLA Threonylcarbamoyladenosine tRNA methylthiotransferase OS=Xenopus laevis OX=8355 GN=cdkal1 PE=2 SV=1 g8521.t1 Q9NRK6 60.441 589 0.0 733.0 sp|Q9NRK6|ABCBA_HUMAN ATP-binding cassette sub-family B member 10, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB10 PE=1 SV=2 ABCBA_HUMAN reviewed ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (EC 7.6.2.-) (Mitochondrial ATP-binding cassette 2) (M-ABC2) Homo sapiens (Human) GO:0005524; GO:0005739; GO:0005743; GO:0006783; GO:0006839; GO:0016887; GO:0031966; GO:0034514; GO:0042803; GO:0045648; GO:0046872; GO:0046985; GO:0048821; GO:0070455; GO:0140359; GO:0170037 erythrocyte development [GO:0048821]; export from the mitochondrion [GO:0170037]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g8529.t1 B3EWY9 30.159 1071 3.96e-118 418.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8529.t1 B3EWY9 35.424 271 2.32e-31 139.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8529.t1 B3EWY9 31.29 310 1.8299999999999999e-25 120.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8529.t1 B3EWY9 34.812 293 1.35e-23 114.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8529.t2 B3EWY9 30.159 1071 5.02e-118 417.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8529.t2 B3EWY9 35.424 271 2.15e-31 139.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8529.t2 B3EWY9 31.29 310 1.68e-25 120.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8529.t2 B3EWY9 34.812 293 1.26e-23 114.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g8533.t1 Q6TYB5 42.265 362 2.12e-63 209.0 sp|Q6TYB5|FEZ2_MOUSE Fasciculation and elongation protein zeta-2 OS=Mus musculus OX=10090 GN=Fez2 PE=2 SV=1 g8542.t1 Q4LDE5 28.584 1102 3.58e-106 385.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g8542.t1 Q4LDE5 41.414 198 1.23e-35 154.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g8542.t1 Q4LDE5 22.773 988 3.97e-25 119.0 sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3 SVEP1_HUMAN reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38) Homo sapiens (Human) GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g8545.t1 P10079 41.488 605 4.64e-140 472.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8545.t1 P10079 41.723 592 1.04e-137 465.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8545.t1 P10079 41.776 608 5.17e-137 462.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8545.t1 P10079 40.031 637 5.01e-136 460.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g8564.t1 Q9P2D8 36.002 1611 0.0 991.0 sp|Q9P2D8|UNC79_HUMAN Protein unc-79 homolog OS=Homo sapiens OX=9606 GN=UNC79 PE=1 SV=4 g8564.t1 Q9P2D8 51.756 655 0.0 623.0 sp|Q9P2D8|UNC79_HUMAN Protein unc-79 homolog OS=Homo sapiens OX=9606 GN=UNC79 PE=1 SV=4 g8564.t2 Q0KK59 51.657 664 0.0 627.0 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g8564.t2 Q0KK59 38.84 569 4.05e-117 415.0 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g8564.t3 Q0KK59 37.411 842 1.27e-178 571.0 sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1 UNC79_MOUSE reviewed Protein unc-79 homolog Mus musculus (Mouse) GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149 adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967] plasma membrane [GO:0005886] g8580.t1 Q96L93 50.565 973 0.0 822.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g8580.t1 Q96L93 45.455 165 6.35e-39 162.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g8580.t2 Q96L93 50.565 973 0.0 823.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g8580.t2 Q96L93 45.455 165 5.47e-39 162.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g8581.t1 Q06HQ7 45.181 332 1.2800000000000001e-86 293.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 PLB1_MONDO reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Monodelphis domestica (Gray short-tailed opossum) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0031526; GO:0050253 phospholipid metabolic process [GO:0006644] brush border membrane [GO:0031526] phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8581.t1 Q06HQ7 42.105 323 2.43e-77 266.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 PLB1_MONDO reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Monodelphis domestica (Gray short-tailed opossum) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0031526; GO:0050253 phospholipid metabolic process [GO:0006644] brush border membrane [GO:0031526] phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8581.t1 Q06HQ7 38.855 332 6.8100000000000004e-65 230.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 PLB1_MONDO reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Monodelphis domestica (Gray short-tailed opossum) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0031526; GO:0050253 phospholipid metabolic process [GO:0006644] brush border membrane [GO:0031526] phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8582.t1 Q4G0X4 56.79 81 6.879999999999999e-23 94.4 sp|Q4G0X4|KCD21_HUMAN BTB/POZ domain-containing protein KCTD21 OS=Homo sapiens OX=9606 GN=KCTD21 PE=1 SV=1 KCD21_HUMAN reviewed BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21) Homo sapiens (Human) GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602 negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cullin family protein binding [GO:0097602]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] g8584.t1 Q7T3H2 36.118 407 5.5700000000000005e-43 159.0 sp|Q7T3H2|INS1B_DANRE Insulinoma-associated protein 1b OS=Danio rerio OX=7955 GN=insm1b PE=2 SV=1 INS1B_DANRE reviewed Insulinoma-associated protein 1b (Insulinoma-associated 1-like protein b) (Zinc finger protein IA-1b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0008270; GO:0010564; GO:0017053; GO:0030182; GO:0031490; GO:0060290 negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; regulation of cell cycle process [GO:0010564]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309] nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g8585.t1 Q9JI70 34.276 601 7.61e-96 308.0 sp|Q9JI70|MKKS_MOUSE Molecular chaperone MKKS OS=Mus musculus OX=10090 GN=Mkks PE=2 SV=2 MKKS_MOUSE reviewed Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog) Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0032502; GO:0033210; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902140; GO:1902636; GO:1905515 artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to inositol [GO:1902140]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634] ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082] g8588.t1 Q5TYV4 36.0 400 8.19e-81 265.0 sp|Q5TYV4|SPE39_DANRE Spermatogenesis-defective protein 39 homolog OS=Danio rerio OX=7955 GN=vipas39 PE=2 SV=1 SPE39_DANRE reviewed Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007034; GO:0007283; GO:0030154; GO:0055037; GO:0061008 cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034] cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; recycling endosome [GO:0055037] g8589.t1 Q6ZQ12 34.101 651 4.71e-81 296.0 sp|Q6ZQ12|NINL_MOUSE Ninein-like protein OS=Mus musculus OX=10090 GN=Ninl PE=1 SV=3 g8589.t2 G9G127 34.052 928 1.07e-102 360.0 sp|G9G127|NINL_DANRE Ninein-like protein OS=Danio rerio OX=7955 GN=Ninl PE=1 SV=1 NINL_DANRE reviewed Ninein-like protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005737; GO:0005813; GO:0005874; GO:0035845; GO:0036064; GO:0042462 eye photoreceptor cell development [GO:0042462]; photoreceptor cell outer segment organization [GO:0035845] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874] calcium ion binding [GO:0005509] g8591.t1 A4IF63 22.741 321 3.84e-21 101.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g8592.t1 O15403 22.941 510 1.2499999999999999e-23 107.0 sp|O15403|MOT7_HUMAN Monocarboxylate transporter 7 OS=Homo sapiens OX=9606 GN=SLC16A6 PE=1 SV=2 g8593.t1 Q8BGC3 25.773 388 7.29e-23 103.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g8595.t1 Q6P2X9 25.758 396 1.5200000000000002e-27 117.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g8596.t1 Q8VEM9 52.713 387 4.92e-149 429.0 sp|Q8VEM9|KLDC3_MOUSE Kelch domain-containing protein 3 OS=Mus musculus OX=10090 GN=Klhdc3 PE=2 SV=1 g8597.t1 Q8BGD7 46.961 181 4.59e-44 162.0 sp|Q8BGD7|NPAS4_MOUSE Neuronal PAS domain-containing protein 4 OS=Mus musculus OX=10090 GN=Npas4 PE=1 SV=1 NPAS4_MOUSE reviewed Neuronal PAS domain-containing protein 4 (Neuronal PAS4) (HLH-PAS transcription factor NXF) (Limbic-enhanced PAS protein) (LE-PAS) Mus musculus (Mouse) GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0033554; GO:0035176; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862 cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to stress [GO:0033554]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g8598.t1 A6H791 51.6 250 1.9000000000000002e-80 246.0 sp|A6H791|TRM61_BOVIN tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A OS=Bos taurus OX=9913 GN=TRMT61A PE=2 SV=1 TRM61_BOVIN reviewed tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A) Bos taurus (Bovine) GO:0005634; GO:0006397; GO:0030488; GO:0031515; GO:0061953; GO:0160107 mRNA processing [GO:0006397]; tRNA methylation [GO:0030488] nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515] mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine(58)-N1)-methyltransferase activity [GO:0160107] g8599.t1 Q8BYM7 61.224 490 0.0 569.0 sp|Q8BYM7|RSH4A_MOUSE Radial spoke head protein 4 homolog A OS=Mus musculus OX=10090 GN=Rsph4a PE=1 SV=2 RSH4A_MOUSE reviewed Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3) Mus musculus (Mouse) GO:0001534; GO:0001535; GO:0003341; GO:0003351; GO:0005576; GO:0005930; GO:0035082; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338] g8600.t1 Q8VEB2 39.216 408 4.25e-76 242.0 sp|Q8VEB2|SAV1_MOUSE Protein salvador homolog 1 OS=Mus musculus OX=10090 GN=Sav1 PE=1 SV=2 SAV1_MOUSE reviewed Protein salvador homolog 1 (45 kDa WW domain protein) (mWW45) Mus musculus (Mouse) GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008285; GO:0030216; GO:0035329; GO:0035331; GO:0035332; GO:0042802; GO:0043065; GO:0043539; GO:0045600; GO:0046620; GO:0050680; GO:0050821; GO:0060044; GO:0060090; GO:0060412; GO:0060487; GO:0060575; GO:0140537; GO:2000036 apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of hippo signaling [GO:0035331]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of organ growth [GO:0046620]; regulation of stem cell population maintenance [GO:2000036]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; transcription regulator activator activity [GO:0140537] g8602.t1 O54728 44.318 352 3.44e-88 297.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8602.t1 O54728 40.237 338 8.99e-76 261.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8602.t1 O54728 38.576 337 5.89e-65 230.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8602.t1 O54728 27.576 330 4.24e-25 112.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8603.t1 O54728 45.797 345 1.66e-89 301.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8603.t1 O54728 39.554 359 1.1e-78 270.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8603.t1 O54728 39.766 342 1.33e-72 252.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8603.t1 O54728 26.857 350 1.5100000000000001e-27 120.0 sp|O54728|PLB1_RAT Phospholipase B1, membrane-associated OS=Rattus norvegicus OX=10116 GN=Plb1 PE=1 SV=1 PLB1_RAT reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0042572; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344 diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinol metabolic process [GO:0042572]; triglyceride catabolic process [GO:0019433] brush border membrane [GO:0031526] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8604.t1 Q06HQ7 44.167 360 3.23e-94 313.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 PLB1_MONDO reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Monodelphis domestica (Gray short-tailed opossum) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0031526; GO:0050253 phospholipid metabolic process [GO:0006644] brush border membrane [GO:0031526] phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8604.t1 Q06HQ7 44.109 331 6.06e-83 281.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 PLB1_MONDO reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Monodelphis domestica (Gray short-tailed opossum) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0031526; GO:0050253 phospholipid metabolic process [GO:0006644] brush border membrane [GO:0031526] phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8604.t1 Q06HQ7 41.441 333 1.6400000000000003e-79 272.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 PLB1_MONDO reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Monodelphis domestica (Gray short-tailed opossum) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0031526; GO:0050253 phospholipid metabolic process [GO:0006644] brush border membrane [GO:0031526] phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8604.t1 Q06HQ7 27.635 351 1.92e-23 107.0 sp|Q06HQ7|PLB1_MONDO Phospholipase B1, membrane-associated OS=Monodelphis domestica OX=13616 GN=PLB1 PE=2 SV=1 PLB1_MONDO reviewed Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3) Monodelphis domestica (Gray short-tailed opossum) GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0031526; GO:0050253 phospholipid metabolic process [GO:0006644] brush border membrane [GO:0031526] phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g8605.t1 Q91X34 36.768 427 1.2899999999999999e-82 263.0 sp|Q91X34|BAAT_MOUSE Bile acid-CoA:amino acid N-acyltransferase OS=Mus musculus OX=10090 GN=Baat PE=1 SV=1 BAAT_MOUSE reviewed Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2) Mus musculus (Mouse) GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817 acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530] cytosol [GO:0005829]; peroxisome [GO:0005777] carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817] g8606.t1 Q91X34 36.744 430 2.62e-77 249.0 sp|Q91X34|BAAT_MOUSE Bile acid-CoA:amino acid N-acyltransferase OS=Mus musculus OX=10090 GN=Baat PE=1 SV=1 BAAT_MOUSE reviewed Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2) Mus musculus (Mouse) GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817 acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530] cytosol [GO:0005829]; peroxisome [GO:0005777] carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817] g8607.t1 A2AKK5 35.597 427 3.61e-78 250.0 sp|A2AKK5|ACNT1_MOUSE Acyl-coenzyme A amino acid N-acyltransferase 1 OS=Mus musculus OX=10090 GN=Acnat1 PE=1 SV=1 ACNT1_MOUSE reviewed Acyl-coenzyme A amino acid N-acyltransferase 1 (EC 2.3.1.-) Mus musculus (Mouse) GO:0005777; GO:0006631; GO:0006637; GO:0016410; GO:0047617 acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] peroxisome [GO:0005777] fatty acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410] g8608.t1 Q63276 37.209 430 2.5200000000000002e-79 254.0 sp|Q63276|BAAT_RAT Bile acid-CoA:amino acid N-acyltransferase OS=Rattus norvegicus OX=10116 GN=Baat PE=1 SV=2 BAAT_RAT reviewed Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Kan-1) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2) Rattus norvegicus (Rat) GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817 acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530] cytosol [GO:0005829]; peroxisome [GO:0005777] carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817] g8609.t1 Q8K5B2 51.786 112 1.1300000000000001e-32 117.0 sp|Q8K5B2|MCFD2_MOUSE Multiple coagulation factor deficiency protein 2 homolog OS=Mus musculus OX=10090 GN=Mcfd2 PE=1 SV=1 g8610.t1 L8E946 63.043 92 1.92e-28 112.0 sp|L8E946|UNC42_CAEEL Homeobox protein unc-42 OS=Caenorhabditis elegans OX=6239 GN=unc-42 PE=1 SV=1 UNC42_CAEEL reviewed Homeobox protein unc-42 (Uncoordinated protein 42) Caenorhabditis elegans GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007411; GO:0008345; GO:0010468; GO:0030182; GO:0045944; GO:0048665; GO:0048666; GO:0050808; GO:0061564 axon development [GO:0061564]; axon guidance [GO:0007411]; larval locomotory behavior [GO:0008345]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse organization [GO:0050808] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g8611.t1 Q9CXI3 35.501 569 3.72e-115 358.0 sp|Q9CXI3|MOXD1_MOUSE DBH-like monooxygenase protein 1 OS=Mus musculus OX=10090 GN=Moxd1 PE=1 SV=1 MOXD1_MOUSE reviewed DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X) Mus musculus (Mouse) GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421 dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; secretory granule membrane [GO:0030667] copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500] g8612.t1 Q86UA1 46.515 660 0.0 577.0 sp|Q86UA1|PRP39_HUMAN Pre-mRNA-processing factor 39 OS=Homo sapiens OX=9606 GN=PRPF39 PE=1 SV=3 g8617.t1 Q86SF2 48.381 525 7.08e-169 500.0 sp|Q86SF2|GALT7_HUMAN N-acetylgalactosaminyltransferase 7 OS=Homo sapiens OX=9606 GN=GALNT7 PE=1 SV=1 GALT7_HUMAN reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0005975; GO:0006493; GO:0016020; GO:0016266; GO:0030246; GO:0046872; GO:0070062 carbohydrate metabolic process [GO:0005975]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g8621.t1 A0A0G2L7I0 57.812 320 5.0199999999999997e-126 386.0 sp|A0A0G2L7I0|SPRTN_DANRE DNA-dependent metalloprotease SPRTN OS=Danio rerio OX=7955 GN=sprtn PE=3 SV=1 SPRTN_DANRE reviewed DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0008270; GO:0016540; GO:0031593; GO:0106300 DNA damage response [GO:0006974]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508] chromatin [GO:0000785]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g8623.t1 Q9U518 42.078 587 3.53e-155 462.0 sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1 g8623.t2 Q9U518 40.886 587 3.2399999999999997e-147 441.0 sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1 g8625.t1 A1A4M4 66.917 266 1.61e-126 363.0 sp|A1A4M4|TATD3_BOVIN Putative deoxyribonuclease TATDN3 OS=Bos taurus OX=9913 GN=TATDN3 PE=2 SV=1 g8628.t1 Q9Y345 43.147 591 1.19e-162 488.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g8632.t1 Q09575 43.81 105 4.26e-26 106.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g8635.t1 Q4KLN8 48.421 95 1.7799999999999998e-23 101.0 sp|Q4KLN8|RNF8_RAT E3 ubiquitin-protein ligase RNF8 OS=Rattus norvegicus OX=10116 GN=Rnf8 PE=2 SV=1 RNF8_RAT reviewed E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8) Rattus norvegicus (Rat) GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0031625; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042770; GO:0042802; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168; GO:1990166 cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g8636.t1 Q6P286 53.326 917 0.0 1031.0 sp|Q6P286|DHTK1_XENLA 2-oxoadipate dehydrogenase complex component E1 OS=Xenopus laevis OX=8355 GN=dhtkd1 PE=2 SV=1 g8639.t1 Q588U8 29.119 261 1.1000000000000001e-27 116.0 sp|Q588U8|CFDP2_TRAJA Craniofacial development protein 2 OS=Tragulus javanicus OX=9849 GN=CFDP2 PE=2 SV=1 g8643.t1 Q24342 45.69 232 2.65e-66 218.0 sp|Q24342|FNG_DROME Fringe glycosyltransferase OS=Drosophila melanogaster OX=7227 GN=fng PE=1 SV=1 FNG_DROME reviewed Fringe glycosyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0001745; GO:0005737; GO:0005795; GO:0005797; GO:0007293; GO:0007450; GO:0007476; GO:0007480; GO:0008587; GO:0008593; GO:0030707; GO:0033829; GO:0035017; GO:0036011; GO:0036066; GO:0036099; GO:0045746; GO:0045747; GO:0046872; GO:0048100; GO:0048190; GO:0048749 compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190] cytoplasm [GO:0005737]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795] metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] g8645.t1 Q8BW94 68.651 252 7.57e-116 368.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 DYH3_MOUSE reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3) Mus musculus (Mouse) GO:0005524; GO:0005874; GO:0008569; GO:0036156; GO:0045505; GO:0051959; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294] 9+2 motile cilium [GO:0097729]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g8646.t1 Q8TD57 70.027 377 1.5699999999999998e-172 536.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g8647.t1 Q8BW94 81.034 174 1.97e-92 298.0 sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2 DYH3_MOUSE reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3) Mus musculus (Mouse) GO:0005524; GO:0005874; GO:0008569; GO:0036156; GO:0045505; GO:0051959; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294] 9+2 motile cilium [GO:0097729]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g8648.t1 Q8IWU5 38.617 839 0.0 552.0 sp|Q8IWU5|SULF2_HUMAN Extracellular sulfatase Sulf-2 OS=Homo sapiens OX=9606 GN=SULF2 PE=1 SV=1 SULF2_HUMAN reviewed Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form] Homo sapiens (Human) GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345 bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] g8650.t1 Q8VHK2 54.348 138 2.0500000000000003e-43 176.0 sp|Q8VHK2|CSKI1_RAT Caskin-1 OS=Rattus norvegicus OX=10116 GN=Caskin1 PE=1 SV=1 CSKI1_RAT reviewed Caskin-1 (CASK-interacting protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0007165; GO:0019904; GO:0042802; GO:0098794; GO:0098978; GO:0099151 regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794] identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] g8652.t1 Q09575 36.482 307 8.2e-56 199.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g8654.t1 Q09575 32.911 158 1.39e-28 117.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g8671.t1 P0CY46 38.38 284 1e-51 186.0 sp|P0CY46|EGFR_APIME Epidermal growth factor receptor OS=Apis mellifera OX=7460 GN=Egfr PE=2 SV=1 g8673.t1 Q62956 43.826 575 8.669999999999999e-138 444.0 sp|Q62956|ERBB4_RAT Receptor tyrosine-protein kinase erbB-4 OS=Rattus norvegicus OX=10116 GN=Erbb4 PE=1 SV=3 g8673.t2 Q62956 43.826 575 5.15e-136 444.0 sp|Q62956|ERBB4_RAT Receptor tyrosine-protein kinase erbB-4 OS=Rattus norvegicus OX=10116 GN=Erbb4 PE=1 SV=3 g8678.t1 Q6YHU6 24.873 985 3.86e-69 263.0 sp|Q6YHU6|THADA_HUMAN tRNA (32-2'-O)-methyltransferase regulator THADA OS=Homo sapiens OX=9606 GN=THADA PE=1 SV=1 THADA_HUMAN reviewed tRNA (32-2'-O)-methyltransferase regulator THADA (Gene inducing thyroid adenomas protein) (Thyroid adenoma-associated protein) Homo sapiens (Human) GO:0002128; GO:0030234; GO:0030488; GO:0032471; GO:0055088; GO:0098554; GO:1990845 adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554] enzyme regulator activity [GO:0030234] g8679.t1 P11216 71.667 840 0.0 1267.0 sp|P11216|PYGB_HUMAN Glycogen phosphorylase, brain form OS=Homo sapiens OX=9606 GN=PYGB PE=1 SV=5 PYGB_HUMAN reviewed Glycogen phosphorylase, brain form (EC 2.4.1.1) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005980; GO:0008184; GO:0016020; GO:0030170; GO:0035578; GO:0070062 glycogen catabolic process [GO:0005980] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020] glycogen phosphorylase activity [GO:0008184]; pyridoxal phosphate binding [GO:0030170] g8681.t1 Q8NFJ9 58.966 580 0.0 722.0 sp|Q8NFJ9|BBS1_HUMAN BBSome complex member BBS1 OS=Homo sapiens OX=9606 GN=BBS1 PE=1 SV=1 g8684.t1 Q8BLY1 38.819 237 3.83e-33 135.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t1 Q8BLY1 43.284 134 3.04e-28 120.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t1 Q8BLY1 34.135 208 2.5e-24 109.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t2 Q8BLY1 35.959 292 3.0400000000000003e-35 141.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t2 Q8BLY1 43.284 134 2.6399999999999998e-28 121.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t2 Q8BLY1 34.615 208 7.84e-24 108.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t3 Q8BLY1 35.959 292 2.94e-35 141.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t3 Q8BLY1 43.284 134 2.44e-28 121.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t3 Q8BLY1 34.135 208 2.38e-24 109.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t4 Q8BLY1 36.09 266 2.58e-32 132.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t4 Q8BLY1 43.284 134 1.9299999999999999e-28 121.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8684.t4 Q8BLY1 34.135 208 2.8099999999999998e-24 109.0 sp|Q8BLY1|SMOC1_MOUSE SPARC-related modular calcium-binding protein 1 OS=Mus musculus OX=10090 GN=Smoc1 PE=2 SV=2 SMOC1_MOUSE reviewed SPARC-related modular calcium-binding protein 1 (SPARC-related gene protein) (Secreted modular calcium-binding protein 1) (SMOC-1) Mus musculus (Mouse) GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010811; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] g8687.t1 Q9NRC6 30.975 2657 0.0 1209.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g8687.t1 Q9NRC6 36.868 811 5.92e-142 506.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g8687.t1 Q9NRC6 26.989 1282 4.0399999999999997e-106 387.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g8687.t1 Q9NRC6 20.293 2252 1.93e-63 246.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g8687.t1 Q9NRC6 20.648 833 1.2200000000000002e-27 128.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g8687.t1 Q9NRC6 26.389 360 3.4999999999999997e-25 120.0 sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2 g8688.t1 Q9Y6A2 39.066 471 8.47e-112 343.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8689.t1 Q9Y6A2 40.421 475 1.8900000000000001e-118 360.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8690.t1 Q9Y6A2 40.764 471 6.029999999999999e-113 346.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8693.t1 Q9Y6A2 43.158 475 1.31e-129 389.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8695.t1 Q9Y6A2 42.094 468 2.71e-125 378.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8696.t1 Q9Y6A2 41.263 475 1.31e-119 362.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8698.t1 Q6R5N8 27.772 929 3.9600000000000002e-59 222.0 sp|Q6R5N8|TLR13_MOUSE Toll-like receptor 13 OS=Mus musculus OX=10090 GN=Tlr13 PE=1 SV=1 TLR13_MOUSE reviewed Toll-like receptor 13 Mus musculus (Mouse) GO:0002224; GO:0002755; GO:0005737; GO:0005768; GO:0005886; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0038023; GO:0042802; GO:0043408; GO:0045087 inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; rRNA binding [GO:0019843]; signaling receptor activity [GO:0038023] g8699.t1 P78540 49.673 306 1.1400000000000001e-110 330.0 sp|P78540|ARGI2_HUMAN Arginase-2, mitochondrial OS=Homo sapiens OX=9606 GN=ARG2 PE=1 SV=1 ARGI2_HUMAN reviewed Arginase-2, mitochondrial (EC 3.5.3.1) (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase) Homo sapiens (Human) GO:0000050; GO:0001657; GO:0002250; GO:0002829; GO:0004053; GO:0005737; GO:0005739; GO:0005759; GO:0006525; GO:0006809; GO:0006941; GO:0030145; GO:0032651; GO:0032696; GO:0032700; GO:0032720; GO:0045087; GO:0071641; GO:0071644; GO:0071650; GO:1900425; GO:1903426; GO:1905403; GO:2000562; GO:2000774 adaptive immune response [GO:0002250]; arginine metabolic process [GO:0006525]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] arginase activity [GO:0004053]; manganese ion binding [GO:0030145] g8700.t1 O93229 40.076 262 3.45e-52 183.0 sp|O93229|CCNB2_RANJA G2/mitotic-specific cyclin-B2 OS=Rana japonica OX=8402 GN=CCNB2 PE=2 SV=1 g8703.t1 Q14919 46.078 204 5.4399999999999995e-48 160.0 sp|Q14919|NC2A_HUMAN Dr1-associated corepressor OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=3 NC2A_HUMAN reviewed Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha) Homo sapiens (Human) GO:0000122; GO:0001046; GO:0001091; GO:0005634; GO:0006366; GO:0016251; GO:0017025; GO:0017054; GO:0042802; GO:0046982; GO:0090575 negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366] negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025] g8704.t1 P53569 40.97 1113 0.0 780.0 sp|P53569|CEBPZ_MOUSE CCAAT/enhancer-binding protein zeta OS=Mus musculus OX=10090 GN=Cebpz PE=1 SV=2 g8704.t2 P53569 41.203 1114 0.0 781.0 sp|P53569|CEBPZ_MOUSE CCAAT/enhancer-binding protein zeta OS=Mus musculus OX=10090 GN=Cebpz PE=1 SV=2 g8708.t1 P53988 29.864 221 3.6799999999999996e-23 103.0 sp|P53988|MOT2_MESAU Monocarboxylate transporter 2 OS=Mesocricetus auratus OX=10036 GN=SLC16A7 PE=1 SV=1 g8711.t1 O60669 25.614 285 3.32e-24 108.0 sp|O60669|MOT2_HUMAN Monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC16A7 PE=1 SV=2 MOT2_HUMAN reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Homo sapiens (Human) GO:0005477; GO:0005654; GO:0005829; GO:0005886; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:0150104; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g8711.t2 O60669 24.912 285 7.28e-22 101.0 sp|O60669|MOT2_HUMAN Monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC16A7 PE=1 SV=2 MOT2_HUMAN reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Homo sapiens (Human) GO:0005477; GO:0005654; GO:0005829; GO:0005886; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:0150104; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g8712.t1 Q2KID9 53.161 348 4.0599999999999997e-115 345.0 sp|Q2KID9|RT05_BOVIN Small ribosomal subunit protein uS5m OS=Bos taurus OX=9913 GN=MRPS5 PE=1 SV=1 g8713.t1 Q9CR63 42.727 110 2.28e-25 95.1 sp|Q9CR63|COX16_MOUSE Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial OS=Mus musculus OX=10090 GN=Cox16 PE=3 SV=1 g8714.t1 Q9N126 45.833 120 5.56e-28 107.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g8717.t1 P83673 52.101 119 2.81e-32 116.0 sp|P83673|LYS1_CRAVI Lysozyme 1 OS=Crassostrea virginica OX=6565 GN=lysoz1 PE=1 SV=3 LYS1_CRAVI reviewed Lysozyme 1 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase 1) (Invertebrate-type lysozyme 1) (cv-lysozyme 1) Crassostrea virginica (Eastern oyster) GO:0003796; GO:0005576; GO:0031640; GO:0050829; GO:0050830 defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] lysozyme activity [GO:0003796] g8718.t1 Q8IU26 46.957 115 1.99e-24 94.4 sp|Q8IU26|LYS_RUDPH Invertebrate-type lysozyme OS=Ruditapes philippinarum OX=129788 PE=1 SV=1 LYS_RUDPH reviewed Invertebrate-type lysozyme (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase) (Destabilase) Ruditapes philippinarum (Japanese carpet shell) (Venerupis philippinarum) GO:0003796; GO:0004568; GO:0005576; GO:0008233; GO:0031640; GO:0042742; GO:0042803; GO:0061929 defense response to bacterium [GO:0042742]; killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] chitinase activity [GO:0004568]; gamma-glutamylaminecyclotransferase activity [GO:0061929]; lysozyme activity [GO:0003796]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803] g8719.t1 P86383 49.58 119 1.9e-27 101.0 sp|P86383|LYS_MERLU Lysozyme OS=Meretrix lusoria OX=74491 PE=1 SV=1 LYS_MERLU reviewed Lysozyme (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase) (Invertebrate-type lysozyme) Meretrix lusoria (Hard clam) (Common Orient clam) GO:0003796; GO:0004568; GO:0005576; GO:0031640; GO:0042742 defense response to bacterium [GO:0042742]; killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] chitinase activity [GO:0004568]; lysozyme activity [GO:0003796] g8721.t1 P30372 31.646 474 2.01e-80 260.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g8722.t1 A3KP37 63.946 294 8.06e-139 398.0 sp|A3KP37|NDUF5_DANRE Arginine-hydroxylase NDUFAF5, mitochondrial OS=Danio rerio OX=7955 GN=ndufaf5 PE=2 SV=1 g8723.t1 P48601 91.61 441 0.0 804.0 sp|P48601|PRS4_DROME 26S proteasome regulatory subunit 4 OS=Drosophila melanogaster OX=7227 GN=Rpt2 PE=1 SV=2 g8724.t1 Q8R4S0 54.118 85 2.54e-21 86.7 sp|Q8R4S0|PP14C_MOUSE Protein phosphatase 1 regulatory subunit 14C OS=Mus musculus OX=10090 GN=Ppp1r14c PE=1 SV=1 g8725.t1 Q5E9R3 65.794 535 0.0 737.0 sp|Q5E9R3|EHD1_BOVIN EH domain-containing protein 1 OS=Bos taurus OX=9913 GN=EHD1 PE=1 SV=1 EHD1_BOVIN reviewed EH domain-containing protein 1 Bos taurus (Bovine) GO:0005509; GO:0005524; GO:0005525; GO:0005737; GO:0005769; GO:0005886; GO:0005929; GO:0006886; GO:0006897; GO:0010008; GO:0020018; GO:0030139; GO:0030674; GO:0031175; GO:0031901; GO:0032456; GO:0048471; GO:0055038; GO:0060271; GO:0061512; GO:0072659; GO:1901741; GO:1990090; GO:2001137 cellular response to nerve growth factor stimulus [GO:1990090]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659] ciliary pocket membrane [GO:0020018]; cilium [GO:0005929]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; protein-macromolecule adaptor activity [GO:0030674] g8727.t1 Q8IUB2 34.518 197 6.16e-21 94.7 sp|Q8IUB2|WFDC3_HUMAN WAP four-disulfide core domain protein 3 OS=Homo sapiens OX=9606 GN=WFDC3 PE=1 SV=1 g8737.t1 Q554S6 32.979 376 2.77e-62 221.0 sp|Q554S6|ACT17_DICDI Actin-17 OS=Dictyostelium discoideum OX=44689 GN=act17 PE=3 SV=1 ACT17_DICDI reviewed Actin-17 (EC 3.6.4.-) (Actin-2-sub 2) Dictyostelium discoideum (Social amoeba) GO:0000902; GO:0001778; GO:0001891; GO:0005200; GO:0005524; GO:0005911; GO:0006909; GO:0015629; GO:0016787; GO:0017022; GO:0030027; GO:0030864; GO:0032009; GO:0032010; GO:0051591; GO:0060187; GO:0061836 cell morphogenesis [GO:0000902]; phagocytosis [GO:0006909]; plasma membrane repair [GO:0001778]; response to cAMP [GO:0051591] actin cytoskeleton [GO:0015629]; cell pole [GO:0060187]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; early phagosome [GO:0032009]; intranuclear rod [GO:0061836]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; phagolysosome [GO:0032010] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200] g8739.t1 Q9Y6A2 41.775 462 2.2500000000000002e-122 370.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8740.t1 Q5VTY9 29.73 481 1.05e-56 201.0 sp|Q5VTY9|HHAT_HUMAN Protein-cysteine N-palmitoyltransferase HHAT OS=Homo sapiens OX=9606 GN=HHAT PE=1 SV=1 HHAT_HUMAN reviewed Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2) (MART-2) (Skinny hedgehog protein 1) Homo sapiens (Human) GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0008374; GO:0016409; GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409] g8742.t1 Q9Y6A2 42.21 353 1.4e-94 294.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g8744.t1 Q02280 52.51 996 0.0 1041.0 sp|Q02280|KCNAE_DROME Potassium voltage-gated channel protein eag OS=Drosophila melanogaster OX=7227 GN=eag PE=1 SV=2 KCNAE_DROME reviewed Potassium voltage-gated channel protein eag (Ether-a-go-go protein) Drosophila melanogaster (Fruit fly) GO:0005249; GO:0005886; GO:0006813; GO:0007608; GO:0007611; GO:0007612; GO:0007619; GO:0008016; GO:0008076; GO:0022843; GO:0042066; GO:0042391; GO:0044325; GO:0048150; GO:0071805 behavioral response to ether [GO:0048150]; courtship behavior [GO:0007619]; learning [GO:0007612]; learning or memory [GO:0007611]; perineurial glial growth [GO:0042066]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart contraction [GO:0008016]; regulation of membrane potential [GO:0042391]; sensory perception of smell [GO:0007608] plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249] g8745.t1 Q8K4M5 46.448 183 1.04e-51 167.0 sp|Q8K4M5|COMD1_MOUSE COMM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Commd1 PE=1 SV=2 COMD1_MOUSE reviewed COMM domain-containing protein 1 (Protein Murr1) Mus musculus (Mouse) GO:0005507; GO:0005546; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006289; GO:0006878; GO:0006893; GO:0010008; GO:0015031; GO:0019871; GO:0031398; GO:0031462; GO:0031648; GO:0032088; GO:0032434; GO:0034383; GO:0042632; GO:0042802; GO:0042803; GO:0043325; GO:0048227; GO:0055037; GO:0055070; GO:0070300; GO:0080025; GO:0097006; GO:1902072; GO:1902306; GO:1904109; GO:1905751; GO:2000009; GO:2000010 cholesterol homeostasis [GO:0042632]; copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; intracellular copper ion homeostasis [GO:0006878]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of cholesterol import [GO:1904109]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of plasma lipoprotein particle levels [GO:0097006]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037] copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871] g8746.t1 F1RAX8 55.102 441 2.31e-166 483.0 sp|F1RAX8|COQ6_DANRE Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Danio rerio OX=7955 GN=coq6 PE=2 SV=1 g8747.t1 Q13395 30.169 1359 4.9000000000000005e-166 541.0 sp|Q13395|TARB1_HUMAN tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 OS=Homo sapiens OX=9606 GN=TARBP1 PE=1 SV=1 TARB1_HUMAN reviewed tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 (EC 2.1.1.34) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488; GO:0141100 regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488] nucleus [GO:0005634] RNA binding [GO:0003723]; tRNA (guanine(18)-2'-O)-methyltransferase activity [GO:0141100]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA binding [GO:0000049] g8749.t1 Q9H477 56.478 301 2.74e-119 348.0 sp|Q9H477|RBSK_HUMAN Ribokinase OS=Homo sapiens OX=9606 GN=RBKS PE=1 SV=1 RBSK_HUMAN reviewed Ribokinase (RK) (EC 2.7.1.15) Homo sapiens (Human) GO:0004747; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872 D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747] g8750.t1 F8WLE0 43.223 1055 0.0 818.0 sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1 KIF28_RAT reviewed Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6) Rattus norvegicus (Rat) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g8751.t1 Q6PCL9 65.217 529 0.0 723.0 sp|Q6PCL9|PAPOG_MOUSE Poly(A) polymerase gamma OS=Mus musculus OX=10090 GN=Papolg PE=1 SV=1 PAPOG_MOUSE reviewed Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme) Mus musculus (Mouse) GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0016604; GO:0031123; GO:0046872; GO:1990817 mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817]; RNA binding [GO:0003723] g8753.t1 Q5E971 67.876 193 7.19e-90 266.0 sp|Q5E971|TMEDA_BOVIN Transmembrane emp24 domain-containing protein 10 OS=Bos taurus OX=9913 GN=TMED10 PE=2 SV=1 TMEDA_BOVIN reviewed Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1) Bos taurus (Bovine) GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008320; GO:0019905; GO:0030134; GO:0030137; GO:0030140; GO:0030658; GO:0030667; GO:0032732; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0045055; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003 COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905] g8754.t1 Q8TD19 51.478 812 0.0 794.0 sp|Q8TD19|NEK9_HUMAN Serine/threonine-protein kinase Nek9 OS=Homo sapiens OX=9606 GN=NEK9 PE=1 SV=2 NEK9_HUMAN reviewed Serine/threonine-protein kinase Nek9 (EC 2.7.11.38) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8) Homo sapiens (Human) GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0007346; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310 cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; regulation of mitotic cell cycle [GO:0007346] cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8760.t1 Q9UHC1 43.169 366 9.27e-92 318.0 sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3 MLH3_HUMAN reviewed DNA mismatch repair protein Mlh3 (MutL protein homolog 3) Homo sapiens (Human) GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664 female meiosis I [GO:0007144]; intracellular protein localization [GO:0008104]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696] g8760.t1 Q9UHC1 38.854 314 3.1e-59 223.0 sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3 MLH3_HUMAN reviewed DNA mismatch repair protein Mlh3 (MutL protein homolog 3) Homo sapiens (Human) GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664 female meiosis I [GO:0007144]; intracellular protein localization [GO:0008104]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696] g8762.t1 Q9HAV4 41.605 1209 0.0 925.0 sp|Q9HAV4|XPO5_HUMAN Exportin-5 OS=Homo sapiens OX=9606 GN=XPO5 PE=1 SV=1 XPO5_HUMAN reviewed Exportin-5 (Exp5) (Ran-binding protein 21) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1905172 miRNA metabolic process [GO:0010586]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565] mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] g8764.t1 A0JM56 44.717 1429 0.0 1155.0 sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2 g8765.t1 Q32KV4 48.968 339 1.92e-109 326.0 sp|Q32KV4|DC2L1_BOVIN Cytoplasmic dynein 2 light intermediate chain 1 OS=Bos taurus OX=9913 GN=DYNC2LI1 PE=2 SV=1 DC2L1_BOVIN reviewed Cytoplasmic dynein 2 light intermediate chain 1 Bos taurus (Bovine) GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005930; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045504; GO:1902017 intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874] dynein heavy chain binding [GO:0045504] g8767.t1 Q4R6I5 30.622 418 1.1799999999999998e-52 197.0 sp|Q4R6I5|CLHC1_MACFA Clathrin heavy chain linker domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=CLHC1 PE=2 SV=1 g8780.t1 Q5R613 67.662 402 0.0 561.0 sp|Q5R613|SNX6_PONAB Sorting nexin-6 OS=Pongo abelii OX=9601 GN=SNX6 PE=2 SV=1 SNX6_PONAB reviewed Sorting nexin-6 [Cleaved into: Sorting nexin-6, N-terminally processed] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005829; GO:0006886; GO:0030904; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0097422 intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; retromer complex [GO:0030904]; tubular endosome [GO:0097422] dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091] g8797.t1 E9Q355 30.678 339 7.790000000000001e-43 165.0 sp|E9Q355|CTSG1_MOUSE Cation channel sperm-associated protein subunit gamma 1 OS=Mus musculus OX=10090 GN=Catsperg1 PE=2 SV=1 g8798.t1 Q70CQ2 51.766 2917 0.0 2904.0 sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2 UBP34_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34) Homo sapiens (Human) GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g8798.t1 Q70CQ2 45.437 526 3.6700000000000006e-132 473.0 sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2 UBP34_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34) Homo sapiens (Human) GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g8798.t2 Q70CQ2 51.766 2917 0.0 2904.0 sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2 UBP34_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34) Homo sapiens (Human) GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g8798.t2 Q70CQ2 45.351 527 9.34e-131 468.0 sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2 UBP34_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34) Homo sapiens (Human) GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g8798.t3 Q70CQ2 51.8 2917 0.0 2899.0 sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2 UBP34_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34) Homo sapiens (Human) GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g8798.t3 Q70CQ2 45.351 527 9.249999999999999e-131 468.0 sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2 UBP34_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34) Homo sapiens (Human) GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g8799.t1 A4IIL4 45.111 450 2.79e-128 380.0 sp|A4IIL4|BROX_XENTR BRO1 domain-containing protein BROX OS=Xenopus tropicalis OX=8364 GN=brox PE=2 SV=1 BROX_XENTR reviewed BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005635; GO:0007084; GO:0031965 mitotic nuclear membrane reassembly [GO:0007084] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] g8802.t1 Q9UJM8 63.231 359 1.31e-162 464.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g8804.t1 Q3B7D2 58.385 483 0.0 607.0 sp|Q3B7D2|SPTC2_RAT Serine palmitoyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Sptlc2 PE=1 SV=1 SPTC2_RAT reviewed Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Rattus norvegicus (Rat) GO:0004758; GO:0005789; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0035902; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504 adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; response to immobilization stress [GO:0035902]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] g8807.t1 O15040 34.3 621 5.900000000000001e-116 403.0 sp|O15040|TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=TECPR2 PE=1 SV=4 TCPR2_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297) Homo sapiens (Human) GO:0005737; GO:0006914; GO:0032527 autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527] cytoplasm [GO:0005737] g8807.t1 O15040 37.905 401 2.49e-69 261.0 sp|O15040|TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=TECPR2 PE=1 SV=4 TCPR2_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297) Homo sapiens (Human) GO:0005737; GO:0006914; GO:0032527 autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527] cytoplasm [GO:0005737] g8809.t1 Q4V8V1 50.926 324 1.8600000000000002e-103 308.0 sp|Q4V8V1|BM1LA_DANRE Breast cancer metastasis-suppressor 1-like protein-A OS=Danio rerio OX=7955 GN=brms1la PE=2 SV=1 g8811.t1 Q5ND34 34.872 1018 3.09e-159 541.0 sp|Q5ND34|WDR81_MOUSE WD repeat-containing protein 81 OS=Mus musculus OX=10090 GN=Wdr81 PE=1 SV=2 WDR81_MOUSE reviewed WD repeat-containing protein 81 Mus musculus (Mouse) GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010008; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0045022; GO:0050821; GO:0070530; GO:0141039 aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol 3-kinase regulator activity [GO:0035014] g8811.t1 Q5ND34 32.102 785 2.73e-113 404.0 sp|Q5ND34|WDR81_MOUSE WD repeat-containing protein 81 OS=Mus musculus OX=10090 GN=Wdr81 PE=1 SV=2 WDR81_MOUSE reviewed WD repeat-containing protein 81 Mus musculus (Mouse) GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010008; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0045022; GO:0050821; GO:0070530; GO:0141039 aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol 3-kinase regulator activity [GO:0035014] g8813.t1 Q9JHU4 75.419 4658 0.0 7359.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g8813.t2 Q9JHU4 75.597 4647 0.0 7367.0 sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2 DYHC1_MOUSE reviewed Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Mus musculus (Mouse) GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832 cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569] g8814.t1 Q6TV19 40.73 356 2.1e-76 261.0 sp|Q6TV19|DICER_DANRE Endoribonuclease Dicer OS=Danio rerio OX=7955 GN=dicer1 PE=2 SV=2 DICER_DANRE reviewed Endoribonuclease Dicer (EC 3.1.26.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0016442; GO:0021591; GO:0030422; GO:0031054; GO:0035195; GO:0035196; GO:0035279; GO:0046872; GO:0050767; GO:0070578; GO:0070883; GO:0098795 apoptotic DNA fragmentation [GO:0006309]; global gene silencing by mRNA cleavage [GO:0098795]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; pre-miRNA processing [GO:0031054]; regulation of neurogenesis [GO:0050767]; siRNA processing [GO:0030422]; ventricular system development [GO:0021591] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723] g8815.t1 Q6TV19 48.533 375 3.09e-104 349.0 sp|Q6TV19|DICER_DANRE Endoribonuclease Dicer OS=Danio rerio OX=7955 GN=dicer1 PE=2 SV=2 DICER_DANRE reviewed Endoribonuclease Dicer (EC 3.1.26.3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0016442; GO:0021591; GO:0030422; GO:0031054; GO:0035195; GO:0035196; GO:0035279; GO:0046872; GO:0050767; GO:0070578; GO:0070883; GO:0098795 apoptotic DNA fragmentation [GO:0006309]; global gene silencing by mRNA cleavage [GO:0098795]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; pre-miRNA processing [GO:0031054]; regulation of neurogenesis [GO:0050767]; siRNA processing [GO:0030422]; ventricular system development [GO:0021591] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723] g8816.t1 B3DLA6 48.598 642 3.37e-178 560.0 sp|B3DLA6|DICER_XENTR Endoribonuclease Dicer OS=Xenopus tropicalis OX=8364 GN=dicer1 PE=2 SV=2 DICER_XENTR reviewed Endoribonuclease Dicer (EC 3.1.26.3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0016442; GO:0030422; GO:0031054; GO:0046872; GO:0051239; GO:0070578; GO:0098795 apoptotic DNA fragmentation [GO:0006309]; global gene silencing by mRNA cleavage [GO:0098795]; pre-miRNA processing [GO:0031054]; regulation of multicellular organismal process [GO:0051239]; siRNA processing [GO:0030422] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723] g8819.t1 C3XRY1 55.656 442 2.3e-180 523.0 sp|C3XRY1|NO66_BRAFL Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_123918 PE=3 SV=1 NO66_BRAFL reviewed Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66) Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0005506; GO:0005634; GO:0005730; GO:0016706; GO:0032453; GO:0034647; GO:0036139; GO:0045892; GO:0051864; GO:0140680 negative regulation of DNA-templated transcription [GO:0045892] nucleolus [GO:0005730]; nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; iron ion binding [GO:0005506]; peptidyl-histidine dioxygenase activity [GO:0036139] g8820.t1 Q8K5B3 40.58 138 9.91e-24 94.0 sp|Q8K5B3|MCFD2_RAT Multiple coagulation factor deficiency protein 2 homolog OS=Rattus norvegicus OX=10116 GN=Mcfd2 PE=1 SV=1 g8821.t1 P35815 62.304 382 3.4799999999999998e-174 493.0 sp|P35815|PPM1B_RAT Protein phosphatase 1B OS=Rattus norvegicus OX=10116 GN=Ppm1b PE=2 SV=1 g8822.t1 Q5PQ59 57.214 201 7.43e-78 236.0 sp|Q5PQ59|ALKB6_XENLA Probable RNA/DNA demethylase ALKBH6 OS=Xenopus laevis OX=8355 GN=alkbh6 PE=2 SV=1 g8823.t1 O60524 56.125 800 0.0 907.0 sp|O60524|NEMF_HUMAN Ribosome quality control complex subunit NEMF OS=Homo sapiens OX=9606 GN=NEMF PE=1 SV=4 g8829.t1 P80146 37.076 383 4.3e-63 210.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g8830.t1 P08594 38.798 366 1.81e-65 219.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g8831.t1 Q6A070 45.065 537 2.99e-144 476.0 sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3 TGRM1_MOUSE reviewed TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B) Mus musculus (Mouse) GO:0000226; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:1905515 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881] microtubule binding [GO:0008017] g8834.t1 Q9Y4F4 38.693 597 8.33e-106 364.0 sp|Q9Y4F4|TGRM1_HUMAN TOG array regulator of axonemal microtubules protein 1 OS=Homo sapiens OX=9606 GN=TOGARAM1 PE=1 SV=4 TGRM1_HUMAN reviewed TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B) Homo sapiens (Human) GO:0000226; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:1905515 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881] microtubule binding [GO:0008017] g8841.t1 A2RRH5 34.792 891 9.19e-172 523.0 sp|A2RRH5|WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens OX=9606 GN=WDR27 PE=1 SV=3 g8848.t1 P35448 54.595 914 0.0 970.0 sp|P35448|TSP1_XENLA Thrombospondin-1 OS=Xenopus laevis OX=8355 GN=thbs1 PE=2 SV=1 g8849.t1 Q9D291 60.0 155 4.89e-71 218.0 sp|Q9D291|DESI2_MOUSE Deubiquitinase DESI2 OS=Mus musculus OX=10090 GN=Desi2 PE=1 SV=1 DESI2_MOUSE reviewed Deubiquitinase DESI2 (EC 3.4.19.12) (Desumoylating isopeptidase 2) (DeSI-2) (PPPDE peptidase domain-containing protein 1) (Palmitoyl protein thioesterase DESI2) (EC 3.1.2.22) (Protein FAM152A) (S-depalmitoylase DESI2) Mus musculus (Mouse) GO:0004843; GO:0005737; GO:0006508; GO:0008474; GO:0052816; GO:0061578; GO:0101005; GO:1990380 proteolysis [GO:0006508] cytoplasm [GO:0005737] cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; palmitoyl-(protein) hydrolase activity [GO:0008474] g8851.t1 O95876 45.289 605 0.0 541.0 sp|O95876|FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens OX=9606 GN=WDPCP PE=1 SV=2 FRITZ_HUMAN reviewed WD repeat-containing and planar cell polarity effector protein fritz homolog (hFRTZ) (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein) Homo sapiens (Human) GO:0001736; GO:0001822; GO:0002093; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0021915; GO:0032185; GO:0032880; GO:0035091; GO:0042073; GO:0042733; GO:0043010; GO:0043587; GO:0044782; GO:0045184; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072359; GO:0090521; GO:0097541; GO:1900027; GO:1902017; GO:2000114 auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; podocyte cell migration [GO:0090521]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587] axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886] phosphatidylinositol binding [GO:0035091] g8853.t1 Q6ZUK4 33.427 356 1.7e-36 143.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g8854.t1 Q9BWU0 50.607 494 7.999999999999999e-138 428.0 sp|Q9BWU0|NADAP_HUMAN Kanadaptin OS=Homo sapiens OX=9606 GN=SLC4A1AP PE=1 SV=2 g8855.t1 Q6PD03 75.705 461 0.0 712.0 sp|Q6PD03|2A5A_MOUSE Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Mus musculus OX=10090 GN=Ppp2r5a PE=1 SV=1 2A5A_MOUSE reviewed Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Mus musculus (Mouse) GO:0000159; GO:0000775; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007165; GO:0019210; GO:0019888; GO:0019900; GO:0030018; GO:0031430; GO:0072542; GO:1903077 negative regulation of protein localization to plasma membrane [GO:1903077]; signal transduction [GO:0007165] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018] kinase binding [GO:0019900]; kinase inhibitor activity [GO:0019210]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] g8856.t1 Q62760 60.15 133 1.85e-46 151.0 sp|Q62760|TOM20_RAT Mitochondrial import receptor subunit TOM20 homolog OS=Rattus norvegicus OX=10116 GN=Tomm20 PE=1 SV=2 TOM20_RAT reviewed Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20) Rattus norvegicus (Rat) GO:0005739; GO:0005740; GO:0005741; GO:0005742; GO:0006626; GO:0006886; GO:0014850; GO:0015450; GO:0016031; GO:0030150; GO:0030943; GO:0044233; GO:0051082; GO:0071944; GO:0097225; GO:0140494; GO:1905242 intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to muscle activity [GO:0014850]; tRNA import into mitochondrion [GO:0016031] cell periphery [GO:0071944]; migrasome [GO:0140494]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225] mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082] g8858.t1 Q8IYT3 35.008 637 2.53e-111 358.0 sp|Q8IYT3|CC170_HUMAN Coiled-coil domain-containing protein 170 OS=Homo sapiens OX=9606 GN=CCDC170 PE=1 SV=3 CC170_HUMAN reviewed Coiled-coil domain-containing protein 170 Homo sapiens (Human) GO:0000226; GO:0005794; GO:0008017; GO:0030054; GO:0036064 microtubule cytoskeleton organization [GO:0000226] cell junction [GO:0030054]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794] microtubule binding [GO:0008017] g8859.t1 Q7SXI1 40.0 120 3.2100000000000004e-21 84.7 sp|Q7SXI1|CO72L_DANRE Cytochrome c oxidase subunit 7A2-like, mitochondrial OS=Danio rerio OX=7955 GN=cox7a2l PE=3 SV=1 g8866.t1 Q8TCS8 66.197 710 0.0 984.0 sp|Q8TCS8|PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2 PNPT1_HUMAN reviewed Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein) Homo sapiens (Human) GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0005840; GO:0006397; GO:0006401; GO:0006402; GO:0007005; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042802; GO:0043457; GO:0045025; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772 cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion organization [GO:0007005]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; rRNA import into mitochondrion [GO:0035928] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosome [GO:0005840] 3'-5'-RNA exonuclease activity [GO:0000175]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723] g8867.t1 Q92784 49.864 367 6.99e-113 337.0 sp|Q92784|DPF3_HUMAN Zinc finger protein DPF3 OS=Homo sapiens OX=9606 GN=DPF3 PE=1 SV=3 DPF3_HUMAN reviewed Zinc finger protein DPF3 (BRG1-associated factor 45C) (BAF45C) (Zinc finger protein cer-d4) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0007399; GO:0007517; GO:0008270; GO:0016514; GO:0030071; GO:0035060; GO:0045597; GO:0045663; GO:0070316; GO:0071565; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] zinc ion binding [GO:0008270] g8868.t1 O08901 40.556 360 9.64e-74 272.0 sp|O08901|BUB1_MOUSE Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Mus musculus OX=10090 GN=Bub1 PE=1 SV=1 BUB1_MOUSE reviewed Mitotic checkpoint serine/threonine-protein kinase BUB1 (mBUB1) (EC 2.7.11.1) (BUB1A) Mus musculus (Mouse) GO:0000775; GO:0000776; GO:0000779; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0007059; GO:0007063; GO:0007094; GO:0051301; GO:0051754; GO:0051983; GO:0106310; GO:0140995; GO:2000720; GO:2001244 apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000720]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063] chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940] ATP binding [GO:0005524]; histone H2A kinase activity [GO:0140995]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8869.t1 Q8SPP9 39.398 731 4.84e-161 496.0 sp|Q8SPP9|TSHR_PIG Thyrotropin receptor OS=Sus scrofa OX=9823 GN=TSHR PE=1 SV=2 g8870.t1 Q8VDM6 51.414 389 4.77e-133 405.0 sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1 g8870.t2 Q8VDM6 44.987 389 8.839999999999999e-104 327.0 sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1 g8871.t1 Q6NWH0 33.19 232 2.16e-36 133.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g8872.t1 Q6NWH0 37.173 191 1.08e-36 134.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g8875.t1 Q6NWH0 34.615 208 3.36e-33 127.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g8876.t1 Q95NI4 80.822 146 7.97e-83 243.0 sp|Q95NI4|CALM_HALOK Calmodulin OS=Halichondria okadai OX=163232 PE=2 SV=3 g8877.t1 P29147 43.871 310 1.18e-77 245.0 sp|P29147|BDH_RAT D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bdh1 PE=1 SV=2 BDH_RAT reviewed D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) Rattus norvegicus (Rat) GO:0001889; GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0007584; GO:0008202; GO:0009410; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617 adipose tissue development [GO:0060612]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543] g8878.t1 Q02337 36.667 330 6.110000000000001e-73 233.0 sp|Q02337|BDH_BOVIN D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=BDH1 PE=1 SV=2 g8879.t1 P62154 98.658 149 2.0000000000000002e-103 295.0 sp|P62154|CALM_LOCMI Calmodulin OS=Locusta migratoria OX=7004 PE=1 SV=2 g8880.t1 P18061 36.986 146 1.33e-28 105.0 sp|P18061|CALM_TRYCR Calmodulin OS=Trypanosoma cruzi OX=5693 GN=CALA2 PE=3 SV=2 g8881.t1 P0DH96 36.986 146 1.71e-28 105.0 sp|P0DH96|CALM4_ARATH Calmodulin-4 OS=Arabidopsis thaliana OX=3702 GN=CAM4 PE=1 SV=1 g8882.t1 P69098 39.041 146 1.48e-27 102.0 sp|P69098|CALM_TRYBG Calmodulin OS=Trypanosoma brucei gambiense OX=31285 PE=3 SV=2 g8883.t1 P62154 97.315 149 1.13e-101 290.0 sp|P62154|CALM_LOCMI Calmodulin OS=Locusta migratoria OX=7004 PE=1 SV=2 g8884.t1 P21251 100.0 149 5.7000000000000004e-105 299.0 sp|P21251|CALM_STIJA Calmodulin OS=Stichopus japonicus OX=307972 PE=1 SV=2 g8886.t1 Q8K212 40.695 892 8.69e-167 512.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g8886.t2 Q8K212 40.471 892 7.28e-167 513.0 sp|Q8K212|PACS1_MOUSE Phosphofurin acidic cluster sorting protein 1 OS=Mus musculus OX=10090 GN=Pacs1 PE=1 SV=2 PACS1_MOUSE reviewed Phosphofurin acidic cluster sorting protein 1 (PACS-1) Mus musculus (Mouse) GO:0002260; GO:0005794; GO:0030137; GO:0034067; GO:0044325; GO:0048471; GO:0072659 lymphocyte homeostasis [GO:0002260]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] transmembrane transporter binding [GO:0044325] g8889.t1 Q6IP59 41.346 728 0.0 565.0 sp|Q6IP59|CTL2_XENLA Choline transporter-like protein 2 OS=Xenopus laevis OX=8355 GN=slc44a2 PE=2 SV=1 CTL2_XENLA reviewed Choline transporter-like protein 2 (Solute carrier family 44 member 2) Xenopus laevis (African clawed frog) GO:0005741; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0022857; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228]; transmembrane transporter activity [GO:0022857] g8890.t1 Q6IP59 41.346 728 0.0 561.0 sp|Q6IP59|CTL2_XENLA Choline transporter-like protein 2 OS=Xenopus laevis OX=8355 GN=slc44a2 PE=2 SV=1 CTL2_XENLA reviewed Choline transporter-like protein 2 (Solute carrier family 44 member 2) Xenopus laevis (African clawed frog) GO:0005741; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0022857; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228]; transmembrane transporter activity [GO:0022857] g8891.t1 P29147 42.014 288 5.6000000000000005e-80 252.0 sp|P29147|BDH_RAT D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bdh1 PE=1 SV=2 BDH_RAT reviewed D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) Rattus norvegicus (Rat) GO:0001889; GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0007584; GO:0008202; GO:0009410; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617 adipose tissue development [GO:0060612]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543] g8892.t1 Q08C93 33.867 375 1.6500000000000002e-79 252.0 sp|Q08C93|ABD12_DANRE Lysophosphatidylserine lipase ABHD12 OS=Danio rerio OX=7955 GN=abhd12 PE=2 SV=1 ABD12_DANRE reviewed Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016020; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651; GO:0120560 acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] monoacylglycerol lipase activity [GO:0047372]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phosphatidylserine lysophospholipase activity [GO:0120560]; phospholipase activity [GO:0004620] g8893.t1 Q7RTY0 25.962 416 7.67e-24 106.0 sp|Q7RTY0|MOT13_HUMAN Monocarboxylate transporter 13 OS=Homo sapiens OX=9606 GN=SLC16A13 PE=1 SV=1 MOT13_HUMAN reviewed Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13) Homo sapiens (Human) GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0008028; GO:0015293 cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] g8894.t1 Q60452 75.395 760 0.0 1215.0 sp|Q60452|ERCC2_CRIGR General transcription and DNA repair factor IIH helicase subunit XPD OS=Cricetulus griseus OX=10029 GN=ERCC2 PE=1 SV=1 g8895.t1 Q99LC9 48.219 730 0.0 626.0 sp|Q99LC9|PEX6_MOUSE Peroxisomal ATPase PEX6 OS=Mus musculus OX=10090 GN=Pex6 PE=1 SV=1 g8896.t1 Q9HB14 51.103 272 1.22e-89 274.0 sp|Q9HB14|KCNKD_HUMAN Potassium channel subfamily K member 13 OS=Homo sapiens OX=9606 GN=KCNK13 PE=1 SV=2 g8897.t1 Q9HB14 46.296 108 3.47e-24 98.6 sp|Q9HB14|KCNKD_HUMAN Potassium channel subfamily K member 13 OS=Homo sapiens OX=9606 GN=KCNK13 PE=1 SV=2 g8898.t1 D4AR77 22.996 948 3.2399999999999997e-34 145.0 sp|D4AR77|A6907_ARTBC Uncharacterized secreted protein ARB_06907 OS=Arthroderma benhamiae (strain ATCC MYA-4681 / CBS 112371) OX=663331 GN=ARB_06907 PE=1 SV=2 g8899.t1 Q8WUJ0 58.252 206 7.29e-80 241.0 sp|Q8WUJ0|STYX_HUMAN Serine/threonine/tyrosine-interacting protein OS=Homo sapiens OX=9606 GN=STYX PE=1 SV=1 STYX_HUMAN reviewed Serine/threonine/tyrosine-interacting protein (Inactive tyrosine-protein phosphatase STYX) (Phosphoserine/threonine/tyrosine interaction protein) Homo sapiens (Human) GO:0001691; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032091; GO:0062026; GO:0070372; GO:1990444 negative regulation of protein binding [GO:0032091]; negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062026]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] F-box domain binding [GO:1990444]; pseudophosphatase activity [GO:0001691] g8901.t1 Q9BQ24 45.763 236 4.28e-62 197.0 sp|Q9BQ24|ZFY21_HUMAN Zinc finger FYVE domain-containing protein 21 OS=Homo sapiens OX=9606 GN=ZFYVE21 PE=1 SV=1 ZFY21_HUMAN reviewed Zinc finger FYVE domain-containing protein 21 (ZF21) Homo sapiens (Human) GO:0005768; GO:0005925; GO:0008270 endosome [GO:0005768]; focal adhesion [GO:0005925] zinc ion binding [GO:0008270] g8902.t1 Q5U2V5 58.919 185 6.86e-70 223.0 sp|Q5U2V5|CRLS1_RAT Cardiolipin synthase (CMP-forming) OS=Rattus norvegicus OX=10116 GN=Crls1 PE=2 SV=1 g8903.t1 Q9VAI0 51.765 170 1.7100000000000002e-59 187.0 sp|Q9VAI0|GNA1_DROME Probable glucosamine 6-phosphate N-acetyltransferase OS=Drosophila melanogaster OX=7227 GN=Gnpnat PE=2 SV=1 g8904.t1 Q0MQ83 47.525 202 3.03e-62 202.0 sp|Q0MQ83|CIA30_GORGO Complex I intermediate-associated protein 30, mitochondrial OS=Gorilla gorilla gorilla OX=9595 GN=NDUFAF1 PE=2 SV=1 CIA30_GORGO reviewed Complex I intermediate-associated protein 30, mitochondrial (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1) Gorilla gorilla gorilla (Western lowland gorilla) GO:0005739; GO:0005759; GO:0006120; GO:0032981; GO:0051082 mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] unfolded protein binding [GO:0051082] g8905.t1 Q9GZT9 40.204 393 2.58e-86 274.0 sp|Q9GZT9|EGLN1_HUMAN Egl nine homolog 1 OS=Homo sapiens OX=9606 GN=EGLN1 PE=1 SV=1 g8911.t1 P50748 32.529 2321 0.0 1085.0 sp|P50748|KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens OX=9606 GN=KNTC1 PE=1 SV=1 KNTC1_HUMAN reviewed Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod) Homo sapiens (Human) GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0051988; GO:0065003; GO:1903394; GO:1990423 cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] small GTPase binding [GO:0031267] g8913.t1 Q8S7M7 35.922 206 1.9499999999999997e-23 102.0 sp|Q8S7M7|PIRL5_ORYSJ Plant intracellular Ras-group-related LRR protein 5 OS=Oryza sativa subsp. japonica OX=39947 GN=IRL5 PE=2 SV=1 g8914.t1 P61023 66.327 196 7.230000000000001e-86 254.0 sp|P61023|CHP1_RAT Calcineurin B homologous protein 1 OS=Rattus norvegicus OX=10116 GN=Chp1 PE=1 SV=2 CHP1_RAT reviewed Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22) Rattus norvegicus (Rat) GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0006469; GO:0006611; GO:0006903; GO:0006906; GO:0008017; GO:0010560; GO:0010923; GO:0015385; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0045121; GO:0048306; GO:0050821; GO:0051222; GO:0051259; GO:0051453; GO:0061024; GO:0061025; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1990351 cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein complex oligomerization [GO:0051259]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; transporter complex [GO:1990351] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; sodium:proton antiporter activity [GO:0015385] g8917.t1 I3LHK5 55.983 234 3.62e-86 265.0 sp|I3LHK5|ARP10_PIG Actin-related protein 10 OS=Sus scrofa OX=9823 GN=ACTR10 PE=1 SV=1 g8920.t1 Q3ZBD2 56.021 191 1.73e-67 216.0 sp|Q3ZBD2|ARP10_BOVIN Actin-related protein 10 OS=Bos taurus OX=9913 GN=ACTR10 PE=2 SV=1 g8924.t1 Q6AXJ9 68.81 311 2.19e-153 440.0 sp|Q6AXJ9|CDKL1_DANRE Cyclin-dependent kinase-like 1 OS=Danio rerio OX=7955 GN=cdkl1 PE=2 SV=1 g8924.t2 Q6AXJ9 64.62 342 1.88e-155 444.0 sp|Q6AXJ9|CDKL1_DANRE Cyclin-dependent kinase-like 1 OS=Danio rerio OX=7955 GN=cdkl1 PE=2 SV=1 g8926.t1 Q924I2 49.306 937 0.0 853.0 sp|Q924I2|M4K3_RAT Mitogen-activated protein kinase kinase kinase kinase 3 OS=Rattus norvegicus OX=10116 GN=Map4k3 PE=1 SV=2 g8926.t2 Q9Y4K4 58.376 394 2.3399999999999998e-147 460.0 sp|Q9Y4K4|M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens OX=9606 GN=MAP4K5 PE=1 SV=3 M4K5_HUMAN reviewed Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0008349; GO:0035556; GO:0106310 intracellular signal transduction [GO:0035556] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8926.t2 Q9Y4K4 53.904 397 3.9e-146 457.0 sp|Q9Y4K4|M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens OX=9606 GN=MAP4K5 PE=1 SV=3 M4K5_HUMAN reviewed Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0008349; GO:0035556; GO:0106310 intracellular signal transduction [GO:0035556] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g8926.t3 Q61161 44.322 907 0.0 714.0 sp|Q61161|M4K2_MOUSE Mitogen-activated protein kinase kinase kinase kinase 2 OS=Mus musculus OX=10090 GN=Map4k2 PE=1 SV=1 g8929.t1 Q6P2X9 23.278 421 1.01e-26 115.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g8930.t1 Q792Q4 78.218 101 4.72e-53 164.0 sp|Q792Q4|CRIPT_RAT Cysteine-rich PDZ-binding protein OS=Rattus norvegicus OX=10116 GN=Cript PE=1 SV=1 CRIPT_RAT reviewed Cysteine-rich PDZ-binding protein (Cysteine-rich interactor of PDZ three) (Cysteine-rich interactor of PDZ3) Rattus norvegicus (Rat) GO:0005681; GO:0005737; GO:0006397; GO:0008017; GO:0008380; GO:0030165; GO:0030425; GO:0031122; GO:0035372; GO:0043025; GO:0043197; GO:0043198; GO:0044877; GO:0097110; GO:0098978; GO:0099092; GO:0099151; GO:1902897 cytoplasmic microtubule organization [GO:0031122]; mRNA processing [GO:0006397]; protein localization to microtubule [GO:0035372]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynaptic density, intracellular component [GO:0099092]; spliceosomal complex [GO:0005681] microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g8932.t1 O88871 29.719 249 3.65e-21 98.6 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g8933.t1 O75899 29.717 636 4.35e-88 298.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g8934.t1 Q6QNK2 41.083 314 6.35e-65 239.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g8935.t1 Q9HAR2 41.776 304 5.58e-62 234.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g8937.t1 Q5RC21 45.775 284 8.48e-81 254.0 sp|Q5RC21|TSNAX_PONAB Translin-associated protein X OS=Pongo abelii OX=9601 GN=TSNAX PE=2 SV=1 TSNAX_PONAB reviewed Translin-associated protein X (Translin-associated factor X) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005654; GO:0005794; GO:0007283; GO:0030154; GO:0030422; GO:0043565; GO:0046872; GO:0048471; GO:1902555 cell differentiation [GO:0030154]; siRNA processing [GO:0030422]; spermatogenesis [GO:0007283] endoribonuclease complex [GO:1902555]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565] g8937.t2 Q5RC21 43.919 296 9.79e-79 250.0 sp|Q5RC21|TSNAX_PONAB Translin-associated protein X OS=Pongo abelii OX=9601 GN=TSNAX PE=2 SV=1 TSNAX_PONAB reviewed Translin-associated protein X (Translin-associated factor X) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005654; GO:0005794; GO:0007283; GO:0030154; GO:0030422; GO:0043565; GO:0046872; GO:0048471; GO:1902555 cell differentiation [GO:0030154]; siRNA processing [GO:0030422]; spermatogenesis [GO:0007283] endoribonuclease complex [GO:1902555]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565] g8938.t1 Q1RMR4 51.429 210 5e-74 225.0 sp|Q1RMR4|RAB15_BOVIN Ras-related protein Rab-15 OS=Bos taurus OX=9913 GN=RAB15 PE=2 SV=1 RAB15_BOVIN reviewed Ras-related protein Rab-15 (EC 3.6.5.2) Bos taurus (Bovine) GO:0003925; GO:0005525; GO:0005886; GO:0006887; GO:0010008; GO:0015031; GO:0032482; GO:0046872 exocytosis [GO:0006887]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482] endosome membrane [GO:0010008]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] g8939.t1 P62862 64.662 133 1.02e-51 163.0 sp|P62862|RS30_MOUSE Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein OS=Mus musculus OX=10090 GN=Fau PE=1 SV=2 RS30_MOUSE reviewed Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein (FAU ubiquitin-like and ribosomal protein S30) [Cleaved into: Ubiquitin-like protein FUBI; Small ribosomal subunit protein eS30 (40S ribosomal protein S30)] Mus musculus (Mouse) GO:0000028; GO:0002181; GO:0002227; GO:0003735; GO:0005615; GO:0005634; GO:0005737; GO:0016567; GO:0019731; GO:0019941; GO:0022626; GO:0022627; GO:0031386; GO:0031625; GO:0050830; GO:0061844 antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; ribosomal small subunit assembly [GO:0000028] cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleus [GO:0005634] protein tag activity [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625] g8940.t1 Q58DU5 73.077 260 1.21e-141 400.0 sp|Q58DU5|PSA3_BOVIN Proteasome subunit alpha type-3 OS=Bos taurus OX=9913 GN=PSMA3 PE=1 SV=3 g8942.t1 Q6ZNE5 36.66 491 1.9899999999999998e-91 290.0 sp|Q6ZNE5|BAKOR_HUMAN Beclin 1-associated autophagy-related key regulator OS=Homo sapiens OX=9606 GN=ATG14 PE=1 SV=1 BAKOR_HUMAN reviewed Beclin 1-associated autophagy-related key regulator (Barkor) (Autophagy-related protein 14-like protein) (Atg14L) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000423; GO:0001933; GO:0001934; GO:0005776; GO:0005789; GO:0005829; GO:0005930; GO:0006622; GO:0008333; GO:0009267; GO:0010608; GO:0016236; GO:0016240; GO:0016241; GO:0034045; GO:0035014; GO:0035032; GO:0036092; GO:0042149; GO:0043491; GO:0043495; GO:0044233; GO:0045022; GO:0045087; GO:0045335; GO:0051020; GO:0051607; GO:0061635; GO:0090207; GO:0097352; GO:0097629; GO:0097632; GO:0098780; GO:0141039 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein phosphorylation [GO:0001933]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of protein phosphorylation [GO:0001934]; post-transcriptional regulation of gene expression [GO:0010608]; protein targeting to lysosome [GO:0006622]; regulation of macroautophagy [GO:0016241]; regulation of protein complex stability [GO:0061635]; regulation of triglyceride metabolic process [GO:0090207]; response to mitochondrial depolarisation [GO:0098780] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol 3-kinase complex, class III [GO:0035032] GTPase binding [GO:0051020]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein-membrane adaptor activity [GO:0043495] g8943.t1 P62489 90.698 172 2.14e-114 324.0 sp|P62489|RPB7_RAT DNA-directed RNA polymerase II subunit RPB7 OS=Rattus norvegicus OX=10116 GN=Polr2g PE=2 SV=1 g8944.t1 Q5ZKL5 36.082 582 2.01e-108 350.0 sp|Q5ZKL5|PPCEL_CHICK Prolyl endopeptidase-like OS=Gallus gallus OX=9031 GN=PREPL PE=2 SV=1 g8945.t1 Q8C0V9 40.23 348 4.46e-80 271.0 sp|Q8C0V9|FRMD6_MOUSE FERM domain-containing protein 6 OS=Mus musculus OX=10090 GN=Frmd6 PE=1 SV=2 FRMD6_MOUSE reviewed FERM domain-containing protein 6 Mus musculus (Mouse) GO:0003383; GO:0005737; GO:0005886; GO:0008104; GO:0032970; GO:0035332; GO:0043296; GO:0098592 apical constriction [GO:0003383]; intracellular protein localization [GO:0008104]; positive regulation of hippo signaling [GO:0035332]; regulation of actin filament-based process [GO:0032970] apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; plasma membrane [GO:0005886] g8946.t1 Q8VDL4 35.198 429 3.53e-66 224.0 sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2 ADPGK_MOUSE reviewed ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147) Mus musculus (Mouse) GO:0005576; GO:0005783; GO:0006006; GO:0006096; GO:0043843; GO:0046872 glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576] ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872] g8950.t1 Q8CBH5 26.514 611 5.329999999999999e-42 164.0 sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1 g8951.t1 Q8CBH5 27.778 576 1.1899999999999999e-48 184.0 sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1 g8952.t1 Q9H1A4 47.026 1967 0.0 1728.0 sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1 APC1_HUMAN reviewed Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein) Homo sapiens (Human) GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070936; GO:0070979; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] molecular adaptor activity [GO:0060090] g8952.t2 Q9H1A4 47.002 1968 0.0 1724.0 sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1 APC1_HUMAN reviewed Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein) Homo sapiens (Human) GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070936; GO:0070979; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] molecular adaptor activity [GO:0060090] g8953.t1 Q02337 41.096 292 1.22e-69 224.0 sp|Q02337|BDH_BOVIN D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=BDH1 PE=1 SV=2 g8958.t1 P27987 61.059 321 9.02e-131 420.0 sp|P27987|IP3KB_HUMAN Inositol-trisphosphate 3-kinase B OS=Homo sapiens OX=9606 GN=ITPKB PE=1 SV=5 IP3KB_HUMAN reviewed Inositol-trisphosphate 3-kinase B (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase B) (IP3 3-kinase B) (IP3K B) (InsP 3-kinase B) Homo sapiens (Human) GO:0000165; GO:0000828; GO:0002262; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005856; GO:0007165; GO:0007166; GO:0008440; GO:0016020; GO:0032957; GO:0032958; GO:0033030; GO:0035726; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0046854; GO:0071277 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440] g8958.t2 P27987 64.068 295 7.569999999999999e-134 410.0 sp|P27987|IP3KB_HUMAN Inositol-trisphosphate 3-kinase B OS=Homo sapiens OX=9606 GN=ITPKB PE=1 SV=5 IP3KB_HUMAN reviewed Inositol-trisphosphate 3-kinase B (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase B) (IP3 3-kinase B) (IP3K B) (InsP 3-kinase B) Homo sapiens (Human) GO:0000165; GO:0000828; GO:0002262; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005856; GO:0007165; GO:0007166; GO:0008440; GO:0016020; GO:0032957; GO:0032958; GO:0033030; GO:0035726; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0046854; GO:0071277 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440] g8960.t1 Q21279 37.689 528 4.9000000000000005e-123 373.0 sp|Q21279|TTL15_CAEEL Probable tubulin polyglutamylase ttll-15 OS=Caenorhabditis elegans OX=6239 GN=ttll-15 PE=2 SV=3 g8961.t1 Q28IH8 43.094 181 2.71e-46 166.0 sp|Q28IH8|CFA36_XENTR Cilia- and flagella-associated protein 36 OS=Xenopus tropicalis OX=8364 GN=cfap36 PE=2 SV=2 g8961.t2 Q28IH8 32.338 402 1.12e-56 192.0 sp|Q28IH8|CFA36_XENTR Cilia- and flagella-associated protein 36 OS=Xenopus tropicalis OX=8364 GN=cfap36 PE=2 SV=2 g8962.t1 Q5SP90 61.159 811 0.0 1001.0 sp|Q5SP90|PP4R3_DANRE Serine/threonine-protein phosphatase 4 regulatory subunit 3 OS=Danio rerio OX=7955 GN=smek1 PE=1 SV=1 g8963.t1 O75899 32.951 698 7.509999999999999e-119 383.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g8964.t1 O75899 32.855 697 5.25e-120 387.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g8965.t1 Q6ZUK4 33.152 368 5.5799999999999995e-45 160.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g8966.t1 Q3B8Q2 87.781 401 0.0 747.0 sp|Q3B8Q2|IF4A3_RAT Eukaryotic initiation factor 4A-III OS=Rattus norvegicus OX=10116 GN=Eif4a3 PE=1 SV=1 IF4A3_RAT reviewed Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed] Rattus norvegicus (Rat) GO:0000184; GO:0000381; GO:0000398; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008143; GO:0008306; GO:0010629; GO:0016607; GO:0016887; GO:0017148; GO:0030425; GO:0035145; GO:0035368; GO:0035613; GO:0035640; GO:0043021; GO:0043025; GO:0045727; GO:0045944; GO:0048026; GO:0048701; GO:0051028; GO:0071006; GO:0071013; GO:0072715; GO:0090394; GO:0098794; GO:0098978; GO:0099578; GO:1904570; GO:1990416; GO:1990904; GO:2000622 associative learning [GO:0008306]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to selenite ion [GO:0072715]; embryonic cranial skeleton morphogenesis [GO:0048701]; exploration behavior [GO:0035640]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of gene expression [GO:0010629]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; rRNA processing [GO:0006364] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 1 spliceosome [GO:0071006] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368] g8967.t1 Q29RQ5 52.77 722 0.0 786.0 sp|Q29RQ5|TRIM9_BOVIN E3 ubiquitin-protein ligase TRIM9 OS=Bos taurus OX=9913 GN=TRIM9 PE=2 SV=1 TRIM9_BOVIN reviewed E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9) Bos taurus (Bovine) GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016567; GO:0030425; GO:0043161; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g8967.t2 Q29RQ5 54.043 705 0.0 796.0 sp|Q29RQ5|TRIM9_BOVIN E3 ubiquitin-protein ligase TRIM9 OS=Bos taurus OX=9913 GN=TRIM9 PE=2 SV=1 TRIM9_BOVIN reviewed E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9) Bos taurus (Bovine) GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016567; GO:0030425; GO:0043161; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g8968.t1 A7SMW7 65.675 437 0.0 601.0 sp|A7SMW7|L2HDH_NEMVE L-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g172254 PE=3 SV=1 g8970.t1 P18426 34.653 202 5.1600000000000005e-37 130.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g8971.t1 Q8NBN7 61.043 326 1.62e-130 379.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g8976.t1 Q5TYP8 46.0 100 1.19e-24 95.5 sp|Q5TYP8|STUM_DANRE Protein stum homolog OS=Danio rerio OX=7955 GN=si:dkeyp-59a8.4 PE=3 SV=1 g8977.t1 P16537 60.0 135 1.1e-44 150.0 sp|P16537|SPC3_STRPU Protein SPEC3 OS=Strongylocentrotus purpuratus OX=7668 GN=SPEC3 PE=3 SV=1 g8978.t1 Q16975 51.471 136 9.45e-44 157.0 sp|Q16975|KPC2_APLCA Calcium-independent protein kinase C OS=Aplysia californica OX=6500 GN=PRKC2 PE=1 SV=1 KPC2_APLCA reviewed Calcium-independent protein kinase C (EC 2.7.11.13) (APL II) Aplysia californica (California sea hare) GO:0004697; GO:0005524; GO:0007611; GO:0008270; GO:0016020; GO:0106310 learning or memory [GO:0007611] membrane [GO:0016020] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270] g8979.t1 Q91WT4 50.847 295 2.7600000000000004e-79 249.0 sp|Q91WT4|DJC17_MOUSE DnaJ homolog subfamily C member 17 OS=Mus musculus OX=10090 GN=Dnajc17 PE=1 SV=2 g8980.t1 P30047 59.524 84 2.45e-34 116.0 sp|P30047|GFRP_HUMAN GTP cyclohydrolase 1 feedback regulatory protein OS=Homo sapiens OX=9606 GN=GCHFR PE=1 SV=3 GFRP_HUMAN reviewed GTP cyclohydrolase 1 feedback regulatory protein (GFRP) (GTP cyclohydrolase I feedback regulatory protein) (p35) Homo sapiens (Human) GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0009890; GO:0030425; GO:0031965; GO:0042470; GO:0044549; GO:0045428; GO:0060308; GO:0062014 negative regulation of biosynthetic process [GO:0009890]; negative regulation of small molecule metabolic process [GO:0062014]; regulation of nitric oxide biosynthetic process [GO:0045428] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome [GO:0042470]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme inhibitor activity [GO:0004857]; GTP cyclohydrolase binding [GO:0044549]; GTP cyclohydrolase I regulator activity [GO:0060308] g8980.t2 P30047 63.855 83 8.050000000000001e-36 121.0 sp|P30047|GFRP_HUMAN GTP cyclohydrolase 1 feedback regulatory protein OS=Homo sapiens OX=9606 GN=GCHFR PE=1 SV=3 GFRP_HUMAN reviewed GTP cyclohydrolase 1 feedback regulatory protein (GFRP) (GTP cyclohydrolase I feedback regulatory protein) (p35) Homo sapiens (Human) GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0009890; GO:0030425; GO:0031965; GO:0042470; GO:0044549; GO:0045428; GO:0060308; GO:0062014 negative regulation of biosynthetic process [GO:0009890]; negative regulation of small molecule metabolic process [GO:0062014]; regulation of nitric oxide biosynthetic process [GO:0045428] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome [GO:0042470]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme inhibitor activity [GO:0004857]; GTP cyclohydrolase binding [GO:0044549]; GTP cyclohydrolase I regulator activity [GO:0060308] g8981.t1 Q5EAU9 36.607 224 5.2900000000000005e-47 169.0 sp|Q5EAU9|RMD3_XENLA Regulator of microtubule dynamics protein 3 OS=Xenopus laevis OX=8355 GN=rmdn3 PE=2 SV=1 RMD3_XENLA reviewed Regulator of microtubule dynamics protein 3 (RMD-3) (Protein FAM82A2) (Protein FAM82C) Xenopus laevis (African clawed frog) GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005876; GO:0008017; GO:0097431 cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle microtubule [GO:0005876] microtubule binding [GO:0008017] g8982.t1 Q6R5J2 50.56 625 0.0 649.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g8986.t1 Q9H2Y9 30.139 720 1.49e-89 301.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g8987.t1 Q96C23 46.233 292 1.37e-78 244.0 sp|Q96C23|GALM_HUMAN Galactose mutarotase OS=Homo sapiens OX=9606 GN=GALM PE=1 SV=1 GALM_HUMAN reviewed Galactose mutarotase (EC 5.1.3.3) (Aldose 1-epimerase) Homo sapiens (Human) GO:0004034; GO:0005829; GO:0005975; GO:0006006; GO:0006012; GO:0030246; GO:0033499; GO:0070062 carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006] cytosol [GO:0005829]; extracellular exosome [GO:0070062] aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246] g8992.t1 Q6P7Q4 65.169 178 8.55e-86 253.0 sp|Q6P7Q4|LGUL_RAT Lactoylglutathione lyase OS=Rattus norvegicus OX=10116 GN=Glo1 PE=1 SV=3 LGUL_RAT reviewed Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase) Rattus norvegicus (Rat) GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066 glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270] g8998.t1 Q08BY1 45.0 660 1.07e-179 528.0 sp|Q08BY1|MED17_DANRE Mediator of RNA polymerase II transcription subunit 17 OS=Danio rerio OX=7955 GN=med17 PE=2 SV=1 g8998.t2 Q8VCD5 44.376 649 0.0 534.0 sp|Q8VCD5|MED17_MOUSE Mediator of RNA polymerase II transcription subunit 17 OS=Mus musculus OX=10090 GN=Med17 PE=1 SV=1 g8999.t1 Q5RBN9 50.256 390 3.28e-122 363.0 sp|Q5RBN9|TAD2B_PONAB Transcriptional adapter 2-beta OS=Pongo abelii OX=9601 GN=TADA2B PE=2 SV=1 TAD2B_PONAB reviewed Transcriptional adapter 2-beta Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003682; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0008270; GO:0070461 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; SAGA-type complex [GO:0070461] chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g8999.t2 Q5RBN9 49.744 390 1.28e-121 362.0 sp|Q5RBN9|TAD2B_PONAB Transcriptional adapter 2-beta OS=Pongo abelii OX=9601 GN=TADA2B PE=2 SV=1 TAD2B_PONAB reviewed Transcriptional adapter 2-beta Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003682; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0008270; GO:0070461 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; SAGA-type complex [GO:0070461] chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g9000.t1 B8JI71 35.922 206 3.18e-26 117.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g9000.t1 B8JI71 35.102 245 1.28e-25 115.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g9000.t1 B8JI71 29.148 223 6.51e-22 103.0 sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2 EYS_DANRE reviewed Protein eyes shut homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005112; GO:0005509; GO:0005886; GO:0005930; GO:0007417; GO:0007601; GO:0033165; GO:0045597; GO:0048589; GO:0051240; GO:0051241; GO:0060218; GO:1901222 central nervous system development [GO:0007417]; developmental growth [GO:0048589]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of multicellular organismal process [GO:0051241]; positive regulation of cell differentiation [GO:0045597]; positive regulation of multicellular organismal process [GO:0051240]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; visual perception [GO:0007601] axoneme [GO:0005930]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g9001.t1 P97878 50.491 713 0.0 724.0 sp|P97878|EXOC5_RAT Exocyst complex component 5 OS=Rattus norvegicus OX=10116 GN=Exoc5 PE=1 SV=1 EXOC5_RAT reviewed Exocyst complex component 5 (71 kDa component of rsec6/8 secretory complex) (Exocyst complex component Sec10) (p71) Rattus norvegicus (Rat) GO:0000145; GO:0001736; GO:0001738; GO:0006887; GO:0006893; GO:0015031; GO:0030496; GO:0031267; GO:0043066; GO:0048873; GO:0072659; GO:1904019; GO:1905515 epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; non-motile cilium assembly [GO:1905515]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031] exocyst [GO:0000145]; midbody [GO:0030496] small GTPase binding [GO:0031267] g9001.t2 P97878 51.429 700 0.0 734.0 sp|P97878|EXOC5_RAT Exocyst complex component 5 OS=Rattus norvegicus OX=10116 GN=Exoc5 PE=1 SV=1 EXOC5_RAT reviewed Exocyst complex component 5 (71 kDa component of rsec6/8 secretory complex) (Exocyst complex component Sec10) (p71) Rattus norvegicus (Rat) GO:0000145; GO:0001736; GO:0001738; GO:0006887; GO:0006893; GO:0015031; GO:0030496; GO:0031267; GO:0043066; GO:0048873; GO:0072659; GO:1904019; GO:1905515 epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of apoptotic process [GO:0043066]; non-motile cilium assembly [GO:1905515]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031] exocyst [GO:0000145]; midbody [GO:0030496] small GTPase binding [GO:0031267] g9002.t1 P52655 62.162 111 3.83e-32 126.0 sp|P52655|TF2AA_HUMAN Transcription initiation factor IIA subunit 1 OS=Homo sapiens OX=9606 GN=GTF2A1 PE=1 SV=1 TF2AA_HUMAN reviewed Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit) (TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit)] Homo sapiens (Human) GO:0000979; GO:0001091; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0016251; GO:0017025; GO:0045944; GO:0046982; GO:0051123; GO:0060261; GO:0061629; GO:0097550 positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025] g9003.t1 Q29463 40.323 248 2.47e-52 174.0 sp|Q29463|TRY2_BOVIN Anionic trypsin OS=Bos taurus OX=9913 PE=2 SV=1 TRY2_BOVIN reviewed Anionic trypsin (EC 3.4.21.4) Bos taurus (Bovine) GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0030574 collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252] g9006.t1 P08217 39.855 276 3.4899999999999995e-54 179.0 sp|P08217|CEL2A_HUMAN Chymotrypsin-like elastase family member 2A OS=Homo sapiens OX=9606 GN=CELA2A PE=1 SV=1 CEL2A_HUMAN reviewed Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2A) Homo sapiens (Human) GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0006508; GO:0017171; GO:0032868; GO:0036457; GO:0050796; GO:0090330; GO:1901143 insulin catabolic process [GO:1901143]; proteolysis [GO:0006508]; regulation of insulin secretion [GO:0050796]; regulation of platelet aggregation [GO:0090330]; response to insulin [GO:0032868] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; keratohyalin granule [GO:0036457] endopeptidase activity [GO:0004175]; serine hydrolase activity [GO:0017171]; serine-type endopeptidase activity [GO:0004252] g9007.t1 Q6ZMI0 47.854 792 0.0 702.0 sp|Q6ZMI0|PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 OS=Homo sapiens OX=9606 GN=PPP1R21 PE=1 SV=1 PPR21_HUMAN reviewed Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (Ferry endosomal RAB5 effector complex subunit 2) (Fy-2) (KLRAQ motif-containing protein 1) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005769; GO:0016020; GO:0030674; GO:0031901; GO:1904580 regulation of intracellular mRNA localization [GO:1904580] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020] mRNA binding [GO:0003729]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] g9008.t1 Q6DC58 35.751 193 1.86e-36 132.0 sp|Q6DC58|TM223_DANRE Transmembrane protein 223 OS=Danio rerio OX=7955 GN=tmem223 PE=2 SV=1 g9009.t1 Q33BP8 35.424 542 1.14e-72 242.0 sp|Q33BP8|FOXN3_PIG Forkhead box protein N3 OS=Sus scrofa OX=9823 GN=FOXN3 PE=2 SV=1 g9011.t1 O15228 40.289 623 1.1899999999999999e-150 455.0 sp|O15228|GNPAT_HUMAN Dihydroxyacetone phosphate acyltransferase OS=Homo sapiens OX=9606 GN=GNPAT PE=1 SV=1 GNPAT_HUMAN reviewed Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DAPAT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase) Homo sapiens (Human) GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006654; GO:0007416; GO:0008611; GO:0016020; GO:0016287; GO:0021587; GO:0030054; GO:0030913; GO:0061024 cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; synapse assembly [GO:0007416] cell junction [GO:0030054]; cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] glycerone-phosphate O-acyltransferase activity [GO:0016287] g9012.t1 Q5U3G6 51.411 319 6.78e-105 311.0 sp|Q5U3G6|YIF1B_DANRE Protein YIF1B OS=Danio rerio OX=7955 GN=yif1b PE=2 SV=2 g9014.t1 Q6NWH0 38.115 244 5.76e-48 165.0 sp|Q6NWH0|CK068_DANRE UPF0696 protein C11orf68 homolog OS=Danio rerio OX=7955 GN=P5436 PE=2 SV=1 g9018.t1 A1L2Y1 32.196 469 3.4200000000000002e-31 131.0 sp|A1L2Y1|FSIP1_XENLA Fibrous sheath-interacting protein 1 OS=Xenopus laevis OX=8355 GN=fsip1 PE=2 SV=2 g9018.t2 A1L2Y1 32.196 469 3.57e-31 131.0 sp|A1L2Y1|FSIP1_XENLA Fibrous sheath-interacting protein 1 OS=Xenopus laevis OX=8355 GN=fsip1 PE=2 SV=2 g9019.t1 Q28727 40.496 121 2.6900000000000002e-21 96.3 sp|Q28727|NTCP2_RABIT Ileal sodium/bile acid cotransporter OS=Oryctolagus cuniculus OX=9986 GN=SLC10A2 PE=2 SV=1 NTCP2_RABIT reviewed Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2) Oryctolagus cuniculus (Rabbit) GO:0008508; GO:0016324 apical plasma membrane [GO:0016324] bile acid:sodium symporter activity [GO:0008508] g9022.t1 Q9C0G6 56.373 204 2.5200000000000003e-77 257.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9023.t1 O54991 35.023 217 3.6300000000000006e-27 122.0 sp|O54991|CNTP1_MOUSE Contactin-associated protein 1 OS=Mus musculus OX=10090 GN=Cntnap1 PE=1 SV=2 CNTP1_MOUSE reviewed Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin) Mus musculus (Mouse) GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227 axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918] SH3 domain binding [GO:0017124] g9023.t2 O54991 35.023 217 3.94e-27 122.0 sp|O54991|CNTP1_MOUSE Contactin-associated protein 1 OS=Mus musculus OX=10090 GN=Cntnap1 PE=1 SV=2 CNTP1_MOUSE reviewed Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin) Mus musculus (Mouse) GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227 axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918] SH3 domain binding [GO:0017124] g9025.t1 F1QMV3 71.154 156 1.49e-83 245.0 sp|F1QMV3|TPC6B_DANRE Trafficking protein particle complex subunit 6b OS=Danio rerio OX=7955 GN=trappc6b PE=2 SV=1 g9026.t1 Q5R5X0 41.121 321 3.58e-46 174.0 sp|Q5R5X0|PININ_PONAB Pinin OS=Pongo abelii OX=9601 GN=PNN PE=2 SV=1 g9027.t1 A6QQD2 38.783 263 1.9599999999999998e-48 169.0 sp|A6QQD2|ACTMP_BOVIN Actin maturation protease OS=Bos taurus OX=9913 GN=ACTMAP PE=2 SV=3 ACTMP_BOVIN reviewed Actin maturation protease (EC 3.4.11.-) (Actin aminopeptidase ACTMAP) Bos taurus (Bovine) GO:0004239; GO:0005737; GO:0006508 proteolysis [GO:0006508] cytoplasm [GO:0005737] initiator methionyl aminopeptidase activity [GO:0004239] g9029.t1 Q90964 60.748 214 5.13e-71 233.0 sp|Q90964|FOXG1_CHICK Forkhead box protein G1 OS=Gallus gallus OX=9031 GN=FOXG1 PE=2 SV=1 FOXG1_CHICK reviewed Forkhead box protein G1 (FoxG1) (Brain factor 1) (BF-1) (BF1) (cBF-1) (CEQ 3-1) (Forkhead-related protein FKHL1) (N-62-5) (Proto-oncogene C-QIN) Gallus gallus (Chicken) GO:0000122; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007346; GO:0007405; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0048664; GO:1990837 axon midline choice point recognition [GO:0016199]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; sequence-specific double-stranded DNA binding [GO:1990837] g9030.t1 Q13231 40.695 489 5.220000000000001e-109 338.0 sp|Q13231|CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens OX=9606 GN=CHIT1 PE=1 SV=1 g9031.t1 Q13231 48.696 460 2.44e-150 440.0 sp|Q13231|CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens OX=9606 GN=CHIT1 PE=1 SV=1 g9033.t1 P51950 82.645 121 2.41e-74 226.0 sp|P51950|MAT1_MARGL CDK-activating kinase assembly factor MAT1 OS=Marthasterias glacialis OX=7609 PE=1 SV=1 g9034.t1 P51950 80.0 190 2.8099999999999998e-106 310.0 sp|P51950|MAT1_MARGL CDK-activating kinase assembly factor MAT1 OS=Marthasterias glacialis OX=7609 PE=1 SV=1 g9035.t1 F6VSS6 47.867 422 1.41e-137 408.0 sp|F6VSS6|TRM5_XENTR tRNA (guanine(37)-N(1))-methyltransferase OS=Xenopus tropicalis OX=8364 GN=trmt5 PE=3 SV=1 g9037.t1 Q08E15 39.098 266 1.09e-58 195.0 sp|Q08E15|SIA7F_BOVIN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 OS=Bos taurus OX=9913 GN=ST6GALNAC6 PE=2 SV=1 SIA7F_BOVIN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI) (ST6GalNAcVI) (Sialyltransferase 7F) (SIAT7-F) Bos taurus (Bovine) GO:0000139; GO:0001574; GO:0001665; GO:0009311; GO:0009988 cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g9038.t1 Q64689 35.241 332 8.029999999999999e-42 154.0 sp|Q64689|SIA8C_MOUSE Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 OS=Mus musculus OX=10090 GN=St8sia3 PE=1 SV=2 SIA8C_MOUSE reviewed Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (Ganglioside GD3 synthase ST8SIA3) (EC 2.4.3.8) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sia alpha 2,3Gal beta 1,4GlcNAc alpha 2,8-sialyltransferase) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0003828; GO:0006491; GO:0008373; GO:0009100; GO:0009311; GO:0042802; GO:0097503 ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialyltransferase activity [GO:0008373] g9040.t1 Q5RCA5 25.49 459 2.3300000000000001e-32 134.0 sp|Q5RCA5|NXPE3_PONAB NXPE family member 3 OS=Pongo abelii OX=9601 GN=NXPE3 PE=2 SV=1 g9041.t1 Q969Y0 27.214 463 7.36e-37 146.0 sp|Q969Y0|NXPE3_HUMAN NXPE family member 3 OS=Homo sapiens OX=9606 GN=NXPE3 PE=1 SV=1 g9041.t2 Q969Y0 27.214 463 3.12e-36 145.0 sp|Q969Y0|NXPE3_HUMAN NXPE family member 3 OS=Homo sapiens OX=9606 GN=NXPE3 PE=1 SV=1 g9044.t1 Q8AWD2 52.146 466 2.51e-161 466.0 sp|Q8AWD2|MOCS3_DANRE Adenylyltransferase and sulfurtransferase MOCS3 OS=Danio rerio OX=7955 GN=mocs3 PE=2 SV=1 MOCS3_DANRE reviewed Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292] g9046.t1 Q86V25 54.545 308 2.7e-112 334.0 sp|Q86V25|VASH2_HUMAN Tubulinyl-Tyr carboxypeptidase 2 OS=Homo sapiens OX=9606 GN=VASH2 PE=1 SV=2 g9047.t1 Q08DV6 46.326 313 5.76e-86 278.0 sp|Q08DV6|ASB3_BOVIN Ankyrin repeat and SOCS box protein 3 OS=Bos taurus OX=9913 GN=ASB3 PE=2 SV=1 g9047.t1 Q08DV6 26.575 508 3.71e-28 121.0 sp|Q08DV6|ASB3_BOVIN Ankyrin repeat and SOCS box protein 3 OS=Bos taurus OX=9913 GN=ASB3 PE=2 SV=1 g9047.t1 Q08DV6 31.878 229 1.6300000000000001e-21 101.0 sp|Q08DV6|ASB3_BOVIN Ankyrin repeat and SOCS box protein 3 OS=Bos taurus OX=9913 GN=ASB3 PE=2 SV=1 g9048.t1 Q3SZW1 56.044 273 1.5299999999999998e-104 314.0 sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus OX=9913 GN=TSSK1B PE=2 SV=1 TSSK1_BOVIN reviewed Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) Bos taurus (Bovine) GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g9049.t1 Q6SA08 43.682 277 3.95e-71 226.0 sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens OX=9606 GN=TSSK4 PE=1 SV=1 TSSK4_HUMAN reviewed Testis-specific serine/threonine-protein kinase 4 (TSK-4) (TSSK-4) (Testis-specific kinase 4) (EC 2.7.11.1) (Serine/threonine-protein kinase 22E) Homo sapiens (Human) GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0030317; GO:0032793; GO:0036126; GO:0042803; GO:0044877; GO:0106310 fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g9050.t1 B1ANS9 30.769 247 4.68e-38 149.0 sp|B1ANS9|WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens OX=9606 GN=WDR64 PE=1 SV=1 g9051.t1 B1ANS9 40.729 329 1.07e-77 262.0 sp|B1ANS9|WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens OX=9606 GN=WDR64 PE=1 SV=1 g9052.t1 Q9D565 39.041 292 8.67e-65 223.0 sp|Q9D565|WDR64_MOUSE WD repeat-containing protein 64 OS=Mus musculus OX=10090 GN=Wdr64 PE=2 SV=2 g9054.t1 Q90ZE4 56.341 481 3.0999999999999997e-172 494.0 sp|Q90ZE4|PSN2_DANRE Presenilin-2 OS=Danio rerio OX=7955 GN=psen2 PE=2 SV=2 PSN2_DANRE reviewed Presenilin-2 (PS-2) (Zf-PS2) (EC 3.4.23.-) (Pre2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0001964; GO:0005789; GO:0006509; GO:0007219; GO:0007420; GO:0010506; GO:0016485; GO:0019896; GO:0022008; GO:0030318; GO:0034205; GO:0042500; GO:0055074; GO:0061053; GO:0070765; GO:1904115 amyloid-beta formation [GO:0034205]; axonal transport of mitochondrion [GO:0019896]; brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; melanocyte differentiation [GO:0030318]; membrane protein ectodomain proteolysis [GO:0006509]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; somite development [GO:0061053]; startle response [GO:0001964] axon cytoplasm [GO:1904115]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi membrane [GO:0000139] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500] g9060.t1 Q9NS73 46.33 218 9.96e-51 174.0 sp|Q9NS73|MBIP1_HUMAN MAP3K12-binding inhibitory protein 1 OS=Homo sapiens OX=9606 GN=MBIP PE=1 SV=2 MBIP1_HUMAN reviewed MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein) Homo sapiens (Human) GO:0000122; GO:0004860; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0010628; GO:0042802; GO:0045995; GO:0046330; GO:0051302; GO:0051726; GO:0072686; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860] g9062.t1 Q15643 38.841 345 1.5699999999999998e-54 201.0 sp|Q15643|TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens OX=9606 GN=TRIP11 PE=1 SV=3 TRIPB_HUMAN reviewed Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230) Homo sapiens (Human) GO:0000139; GO:0002080; GO:0003281; GO:0003413; GO:0003713; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006888; GO:0007030; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0071806; GO:0090161; GO:0099041 cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein transmembrane transport [GO:0071806]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] acrosomal membrane [GO:0002080]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713] g9065.t1 Q15643 31.579 1140 3.6799999999999996e-126 433.0 sp|Q15643|TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens OX=9606 GN=TRIP11 PE=1 SV=3 TRIPB_HUMAN reviewed Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230) Homo sapiens (Human) GO:0000139; GO:0002080; GO:0003281; GO:0003413; GO:0003713; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006888; GO:0007030; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0071806; GO:0090161; GO:0099041 cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein transmembrane transport [GO:0071806]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] acrosomal membrane [GO:0002080]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713] g9066.t1 Q8R081 44.909 550 4.7199999999999996e-147 439.0 sp|Q8R081|HNRPL_MOUSE Heterogeneous nuclear ribonucleoprotein L OS=Mus musculus OX=10090 GN=Hnrnpl PE=1 SV=2 g9068.t1 P49753 38.575 407 1.12e-86 276.0 sp|P49753|ACOT2_HUMAN Acyl-coenzyme A thioesterase 2, mitochondrial OS=Homo sapiens OX=9606 GN=ACOT2 PE=1 SV=6 ACOT2_HUMAN reviewed Acyl-coenzyme A thioesterase 2, mitochondrial (Acyl-CoA thioesterase 2) (EC 3.1.2.2) (Acyl-coenzyme A thioester hydrolase 2a) (CTE-Ia) (Long-chain acyl-CoA thioesterase 2) (ZAP128) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0005739; GO:0005759; GO:0005782; GO:0005829; GO:0006631; GO:0006637; GO:0047617; GO:0052689 acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617] g9069.t1 Q6DDL7 31.498 454 5.66e-65 220.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g9070.t1 Q6ZUK4 31.437 334 1.4600000000000002e-26 112.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g9071.t1 Q6ZUK4 32.889 225 1.25e-26 108.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g9072.t1 H9JIQ1 30.357 896 2.0099999999999997e-104 361.0 sp|H9JIQ1|MESH_BOMMO Protein mesh OS=Bombyx mori OX=7091 PE=1 SV=1 g9074.t1 Q0KHY3 29.369 967 2.85e-88 312.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g9076.t1 Q9UGT4 31.867 750 1.44e-91 312.0 sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1 SUSD2_HUMAN reviewed Sushi domain-containing protein 2 Homo sapiens (Human) GO:0005615; GO:0005886; GO:0051782; GO:0070062; GO:1902807 negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] g9077.t1 Q0KHY3 29.548 951 1.4e-103 357.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g9078.t1 Q0KHY3 29.787 940 8.68e-105 361.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g9080.t1 Q16667 47.872 188 9.94e-55 177.0 sp|Q16667|CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens OX=9606 GN=CDKN3 PE=1 SV=1 CDKN3_HUMAN reviewed Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase) Homo sapiens (Human) GO:0000079; GO:0000082; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0008138; GO:0008285; GO:0048471; GO:0051726 G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] g9081.t1 F1MNN4 33.984 256 6.91e-41 165.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g9081.t1 F1MNN4 34.902 255 5.41e-39 159.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g9081.t1 F1MNN4 33.197 244 5.79e-34 144.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g9083.t1 P21274 47.12 382 2.9400000000000002e-117 350.0 sp|P21274|BMP2_MOUSE Bone morphogenetic protein 2 OS=Mus musculus OX=10090 GN=Bmp2 PE=1 SV=3 BMP2_MOUSE reviewed Bone morphogenetic protein 2 (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A) Mus musculus (Mouse) GO:0000122; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001837; GO:0002062; GO:0003007; GO:0003129; GO:0003133; GO:0003176; GO:0003181; GO:0003203; GO:0003210; GO:0003272; GO:0003331; GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0005929; GO:0006029; GO:0006355; GO:0006954; GO:0007179; GO:0007219; GO:0007507; GO:0008083; GO:0008284; GO:0008285; GO:0009617; GO:0009887; GO:0009986; GO:0010467; GO:0010628; GO:0010629; GO:0010718; GO:0010894; GO:0014898; GO:0019211; GO:0019904; GO:0021537; GO:0021978; GO:0030177; GO:0030282; GO:0030316; GO:0030335; GO:0030501; GO:0030509; GO:0030512; GO:0031648; GO:0031982; GO:0032348; GO:0032991; GO:0033690; GO:0035051; GO:0035054; GO:0035360; GO:0036305; GO:0039706; GO:0042475; GO:0042482; GO:0042487; GO:0042802; GO:0043065; GO:0043410; GO:0043539; GO:0043569; GO:0045165; GO:0045597; GO:0045599; GO:0045600; GO:0045666; GO:0045669; GO:0045778; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0048018; GO:0048662; GO:0048711; GO:0048762; GO:0048839; GO:0050769; GO:0051042; GO:0055007; GO:0055008; GO:0060039; GO:0060128; GO:0060129; GO:0060317; GO:0060348; GO:0060391; GO:0060426; GO:0060485; GO:0061036; GO:0070374; GO:0070700; GO:0070724; GO:0071363; GO:0071773; GO:0072138; GO:0090090; GO:0150005; GO:1900159; GO:1900745; GO:1901331; GO:1902895; GO:1905072; GO:1905222; GO:2000065; GO:2000726 ameloblast differentiation [GO:0036305]; animal organ morphogenesis [GO:0009887]; aortic valve development [GO:0003176]; atrioventricular canal morphogenesis [GO:1905222]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac atrium formation [GO:0003210]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte differentiation [GO:0002062]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endodermal-mesodermal cell signaling [GO:0003133]; epithelial to mesenchymal transition [GO:0001837]; gene expression [GO:0010467]; heart development [GO:0007507]; heart induction [GO:0003129]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; lung vasculature development [GO:0060426]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchyme development [GO:0060485]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of calcium-independent cell-cell adhesion [GO:0051042]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericardium development [GO:0060039]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of bone mineralization [GO:0030501]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of odontogenesis [GO:0042482]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; proteoglycan metabolic process [GO:0006029]; regulation of DNA-templated transcription [GO:0006355]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transforming growth factor beta receptor signaling pathway [GO:0007179] BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; cilium [GO:0005929]; enzyme activator complex [GO:0150005]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982] BMP receptor binding [GO:0070700]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; phosphatase activator activity [GO:0019211]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018] g9084.t1 P48970 46.597 382 5.05e-105 318.0 sp|P48970|UNIV_STRPU Univin OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g9085.t1 P11362 44.937 316 4.94e-76 269.0 sp|P11362|FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens OX=9606 GN=FGFR1 PE=1 SV=3 FGFR1_HUMAN reviewed Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331) Homo sapiens (Human) GO:0000122; GO:0000165; GO:0001501; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001764; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010518; GO:0010966; GO:0010976; GO:0016020; GO:0016477; GO:0017134; GO:0018108; GO:0021847; GO:0030031; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0044344; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048339; GO:0048378; GO:0048469; GO:0048705; GO:0048863; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239 angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; chordate embryonic development [GO:0043009]; diphosphate metabolic process [GO:0071344]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; MAPK cascade [GO:0000165]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169] g9088.t1 Q5UQN4 38.378 185 2.9e-40 139.0 sp|Q5UQN4|YL432_MIMIV Uncharacterized protein L432 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_L432 PE=4 SV=1 g9089.t1 P0DKB4 63.636 330 3.91e-153 436.0 sp|P0DKB4|T3HPD_SACKO Trans-L-3-hydroxyproline dehydratase OS=Saccoglossus kowalevskii OX=10224 GN=l3hypdh PE=1 SV=1 g9090.t1 Q5SPH9 57.463 134 3.76e-51 168.0 sp|Q5SPH9|RT10_DANRE Small ribosomal subunit protein uS10m OS=Danio rerio OX=7955 GN=mrps10 PE=3 SV=1 g9091.t1 Q8T888 73.846 195 2.7e-97 283.0 sp|Q8T888|DNAL1_CIOIN Dynein axonemal light chain 1 OS=Ciona intestinalis OX=7719 GN=DNAL1 PE=2 SV=1 g9092.t1 Q8BXJ2 35.281 445 4.3499999999999994e-54 210.0 sp|Q8BXJ2|TREF1_MOUSE Transcriptional-regulating factor 1 OS=Mus musculus OX=10090 GN=Trerf1 PE=1 SV=1 g9092.t2 Q8BXJ2 35.682 440 5.759999999999999e-54 211.0 sp|Q8BXJ2|TREF1_MOUSE Transcriptional-regulating factor 1 OS=Mus musculus OX=10090 GN=Trerf1 PE=1 SV=1 g9092.t3 Q8BXJ2 35.281 445 8.059999999999999e-54 211.0 sp|Q8BXJ2|TREF1_MOUSE Transcriptional-regulating factor 1 OS=Mus musculus OX=10090 GN=Trerf1 PE=1 SV=1 g9093.t1 Q6PA06 60.474 506 0.0 656.0 sp|Q6PA06|ATLA2_MOUSE Atlastin-2 OS=Mus musculus OX=10090 GN=Atl2 PE=1 SV=1 ATLA2_MOUSE reviewed Atlastin-2 (EC 3.6.5.-) Mus musculus (Mouse) GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0007029; GO:0016320; GO:0046872; GO:0051260; GO:0071346; GO:0098826; GO:0140523; GO:1990809 cellular response to type II interferon [GO:0071346]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network membrane [GO:0098826] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; metal ion binding [GO:0046872] g9094.t1 Q5JTD7 50.394 254 8.99e-77 243.0 sp|Q5JTD7|LRC73_HUMAN Leucine-rich repeat-containing protein 73 OS=Homo sapiens OX=9606 GN=LRRC73 PE=1 SV=1 LRC73_HUMAN reviewed Leucine-rich repeat-containing protein 73 Homo sapiens (Human) g9097.t1 Q9NZM5 34.899 447 6.13e-51 182.0 sp|Q9NZM5|NOP53_HUMAN Ribosome biogenesis protein NOP53 OS=Homo sapiens OX=9606 GN=NOP53 PE=1 SV=2 NOP53_HUMAN reviewed Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (Protein interacting with carboxyl terminus 1) (PICT-1) (p60) Homo sapiens (Human) GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006364; GO:0006974; GO:0007095; GO:0008097; GO:0031333; GO:0032435; GO:0032436; GO:0039535; GO:0042802; GO:0042981; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901796; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173 cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723] g9098.t1 Q3UU96 50.669 1719 0.0 1673.0 sp|Q3UU96|MRCKA_MOUSE Serine/threonine-protein kinase MRCK alpha OS=Mus musculus OX=10090 GN=Cdc42bpa PE=1 SV=2 MRCKA_MOUSE reviewed Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) Mus musculus (Mouse) GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0007010; GO:0007097; GO:0008270; GO:0016477; GO:0030027; GO:0030036; GO:0031032; GO:0031252; GO:0042641; GO:0042802; GO:0051056; GO:0106310 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; nuclear migration [GO:0007097]; regulation of small GTPase mediated signal transduction [GO:0051056] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g9098.t2 Q3UU96 50.698 1718 0.0 1674.0 sp|Q3UU96|MRCKA_MOUSE Serine/threonine-protein kinase MRCK alpha OS=Mus musculus OX=10090 GN=Cdc42bpa PE=1 SV=2 MRCKA_MOUSE reviewed Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) Mus musculus (Mouse) GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005911; GO:0007010; GO:0007097; GO:0008270; GO:0016477; GO:0030027; GO:0030036; GO:0031032; GO:0031252; GO:0042641; GO:0042802; GO:0051056; GO:0106310 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; nuclear migration [GO:0007097]; regulation of small GTPase mediated signal transduction [GO:0051056] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g9099.t1 Q6P5P3 34.737 190 1.98e-33 121.0 sp|Q6P5P3|TTC9C_RAT Tetratricopeptide repeat protein 9C OS=Rattus norvegicus OX=10116 GN=Ttc9c PE=2 SV=1 g9100.t1 Q924S7 37.892 446 3.31e-82 261.0 sp|Q924S7|SPRE2_MOUSE Sprouty-related, EVH1 domain-containing protein 2 OS=Mus musculus OX=10090 GN=Spred2 PE=1 SV=1 g9102.t1 Q4LE39 45.411 414 3.41e-91 328.0 sp|Q4LE39|ARI4B_HUMAN AT-rich interactive domain-containing protein 4B OS=Homo sapiens OX=9606 GN=ARID4B PE=1 SV=2 ARI4B_HUMAN reviewed AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1) Homo sapiens (Human) GO:0000122; GO:0000976; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459 establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822] DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976] g9103.t1 Q5M9F1 44.34 212 1.02e-55 194.0 sp|Q5M9F1|RBM34_RAT RNA-binding protein 34 OS=Rattus norvegicus OX=10116 GN=Rbm34 PE=1 SV=1 g9105.t1 Q8IUQ4 84.615 273 9.04e-174 483.0 sp|Q8IUQ4|SIAH1_HUMAN E3 ubiquitin-protein ligase SIAH1 OS=Homo sapiens OX=9606 GN=SIAH1 PE=1 SV=2 g9106.t1 Q9D7N9 33.411 428 5.24e-81 259.0 sp|Q9D7N9|APMAP_MOUSE Adipocyte plasma membrane-associated protein OS=Mus musculus OX=10090 GN=Apmap PE=1 SV=1 APMAP_MOUSE reviewed Adipocyte plasma membrane-associated protein (Protein DD16) Mus musculus (Mouse) GO:0004064; GO:0009986; GO:0016020 cell surface [GO:0009986]; membrane [GO:0016020] arylesterase activity [GO:0004064] g9107.t1 A2ARS0 44.586 157 6.22e-36 141.0 sp|A2ARS0|ANR63_MOUSE Ankyrin repeat domain-containing protein 63 OS=Mus musculus OX=10090 GN=Ankrd63 PE=1 SV=1 g9111.t1 Q3U1V8 50.501 699 0.0 654.0 sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus OX=10090 GN=Map3k9 PE=2 SV=2 g9111.t2 Q3U1V8 40.849 1060 0.0 660.0 sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus OX=10090 GN=Map3k9 PE=2 SV=2 g9112.t1 Q96RV3 64.609 1150 0.0 1587.0 sp|Q96RV3|PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens OX=9606 GN=PCNX1 PE=1 SV=2 g9112.t1 Q96RV3 45.283 106 2.7e-23 112.0 sp|Q96RV3|PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens OX=9606 GN=PCNX1 PE=1 SV=2 g9112.t2 Q96RV3 64.609 1150 0.0 1585.0 sp|Q96RV3|PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens OX=9606 GN=PCNX1 PE=1 SV=2 g9112.t2 Q96RV3 45.283 106 2.5399999999999997e-23 112.0 sp|Q96RV3|PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens OX=9606 GN=PCNX1 PE=1 SV=2 g9114.t1 P26885 66.667 135 1.49e-64 196.0 sp|P26885|FKBP2_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP2 OS=Homo sapiens OX=9606 GN=FKBP2 PE=1 SV=2 FKBP2_HUMAN reviewed Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Homo sapiens (Human) GO:0003755; GO:0005528; GO:0005783; GO:0005789 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g9115.t1 Q18786 81.356 118 3.56e-59 181.0 sp|Q18786|SMD2_CAEEL Probable small nuclear ribonucleoprotein Sm D2 OS=Caenorhabditis elegans OX=6239 GN=snr-4 PE=1 SV=1 SMD2_CAEEL reviewed Probable small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2) Caenorhabditis elegans GO:0000387; GO:0003723; GO:0005682; GO:0005685; GO:0005686; GO:0005689; GO:0005829; GO:0034715; GO:0046540; GO:0071011; GO:0071013 spliceosomal snRNP assembly [GO:0000387] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] RNA binding [GO:0003723] g9116.t1 Q08170 72.067 179 7.32e-88 273.0 sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2 SRSF4_HUMAN reviewed Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4) Homo sapiens (Human) GO:0000375; GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825 mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] g9116.t2 Q08170 67.188 192 6.85e-85 266.0 sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2 SRSF4_HUMAN reviewed Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4) Homo sapiens (Human) GO:0000375; GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825 mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] g9117.t1 Q9VDY1 48.891 1262 0.0 1093.0 sp|Q9VDY1|INO80_DROME Chromatin-remodeling ATPase INO80 OS=Drosophila melanogaster OX=7227 GN=Ino80 PE=1 SV=2 INO80_DROME reviewed Chromatin-remodeling ATPase INO80 (dINO80) (EC 3.6.4.-) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0000976; GO:0003677; GO:0005524; GO:0005634; GO:0005700; GO:0006281; GO:0006310; GO:0006338; GO:0006351; GO:0008094; GO:0010468; GO:0016887; GO:0031011; GO:0040034; GO:0042393; GO:0045892; GO:0140658 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of development, heterochronic [GO:0040034]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; Ino80 complex [GO:0031011]; nucleus [GO:0005634]; polytene chromosome [GO:0005700] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976] g9119.t1 Q9BUX1 46.701 197 5.750000000000001e-59 189.0 sp|Q9BUX1|CHAC1_HUMAN Glutathione-specific gamma-glutamylcyclotransferase 1 OS=Homo sapiens OX=9606 GN=CHAC1 PE=1 SV=3 CHAC1_HUMAN reviewed Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 4.3.2.7) (Blocks Notch protein) (Botch) (Cation transport regulator-like protein 1) Homo sapiens (Human) GO:0005112; GO:0005737; GO:0005802; GO:0005829; GO:0006749; GO:0006751; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061771; GO:0061928; GO:0070059 glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to caloric restriction [GO:0061771]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802] glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112] g9120.t1 P10041 35.694 692 1e-131 416.0 sp|P10041|DL_DROME Neurogenic locus protein delta OS=Drosophila melanogaster OX=7227 GN=Delta PE=1 SV=2 g9121.t1 A6QNT4 31.058 718 1.77e-90 300.0 sp|A6QNT4|F120B_BOVIN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Bos taurus OX=9913 GN=FAM120B PE=2 SV=1 g9122.t1 Q6NWD4 52.288 306 3.5699999999999996e-114 342.0 sp|Q6NWD4|TIM50_DANRE Mitochondrial import inner membrane translocase subunit TIM50 OS=Danio rerio OX=7955 GN=timm50 PE=2 SV=2 TIM50_DANRE reviewed Mitochondrial import inner membrane translocase subunit TIM50 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004722; GO:0004725; GO:0005743; GO:0005744; GO:0006470; GO:0006915; GO:0007006; GO:0030150 apoptotic process [GO:0006915]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150] mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g9122.t2 Q6NWD4 52.288 306 1.3999999999999999e-114 342.0 sp|Q6NWD4|TIM50_DANRE Mitochondrial import inner membrane translocase subunit TIM50 OS=Danio rerio OX=7955 GN=timm50 PE=2 SV=2 TIM50_DANRE reviewed Mitochondrial import inner membrane translocase subunit TIM50 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004722; GO:0004725; GO:0005743; GO:0005744; GO:0006470; GO:0006915; GO:0007006; GO:0030150 apoptotic process [GO:0006915]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150] mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g9123.t1 Q4R6F2 33.235 680 3.13e-109 348.0 sp|Q4R6F2|EMARD_MACFA Endoplasmic reticulum membrane-associated RNA degradation protein (Fragment) OS=Macaca fascicularis OX=9541 GN=ERMARD PE=2 SV=2 g9123.t2 Q4R6F2 33.138 682 2.87e-108 345.0 sp|Q4R6F2|EMARD_MACFA Endoplasmic reticulum membrane-associated RNA degradation protein (Fragment) OS=Macaca fascicularis OX=9541 GN=ERMARD PE=2 SV=2 g9124.t1 Q9VCZ3 28.613 346 3.7500000000000003e-31 128.0 sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1 OCTB1_DROME reviewed Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R) Drosophila melanogaster (Fruit fly) GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410] membrane [GO:0016020]; plasma membrane [GO:0005886] adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989] g9125.t1 Q9D2H2 50.922 434 9.04e-140 415.0 sp|Q9D2H2|KAD7_MOUSE Adenylate kinase 7 OS=Mus musculus OX=10090 GN=Ak7 PE=1 SV=1 KAD7_MOUSE reviewed Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7) Mus musculus (Mouse) GO:0002437; GO:0003351; GO:0004017; GO:0004550; GO:0005524; GO:0005576; GO:0005737; GO:0005829; GO:0007283; GO:0007420; GO:0031514; GO:0035082; GO:0036431 axoneme assembly [GO:0035082]; brain development [GO:0007420]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; inflammatory response to antigenic stimulus [GO:0002437]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; motile cilium [GO:0031514] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550] g9126.t1 Q96M32 50.633 237 2.19e-73 240.0 sp|Q96M32|KAD7_HUMAN Adenylate kinase 7 OS=Homo sapiens OX=9606 GN=AK7 PE=1 SV=3 KAD7_HUMAN reviewed Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0030030; GO:0036431; GO:0097228 cell projection organization [GO:0030030] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sperm principal piece [GO:0097228] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550] g9127.t1 Q6NYB7 89.268 205 2.23e-137 385.0 sp|Q6NYB7|RAB1A_RAT Ras-related protein Rab-1A OS=Rattus norvegicus OX=10116 GN=Rab1A PE=1 SV=3 RAB1A_RAT reviewed Ras-related protein Rab-1A (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0030252; GO:0032402; GO:0032482; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0043025; GO:0046872; GO:0047496; GO:0070382; GO:0090110; GO:0098793; GO:1903020 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496] cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; presynapse [GO:0098793] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g9128.t1 E1BLZ4 35.362 1216 0.0 657.0 sp|E1BLZ4|ZFY26_BOVIN Zinc finger FYVE domain-containing protein 26 OS=Bos taurus OX=9913 GN=ZFYVE26 PE=3 SV=1 g9128.t2 E1BLZ4 34.752 1269 0.0 653.0 sp|E1BLZ4|ZFY26_BOVIN Zinc finger FYVE domain-containing protein 26 OS=Bos taurus OX=9913 GN=ZFYVE26 PE=3 SV=1 g9128.t2 E1BLZ4 25.786 636 7.06e-25 119.0 sp|E1BLZ4|ZFY26_BOVIN Zinc finger FYVE domain-containing protein 26 OS=Bos taurus OX=9913 GN=ZFYVE26 PE=3 SV=1 g9128.t3 E1BLZ4 34.752 1269 0.0 653.0 sp|E1BLZ4|ZFY26_BOVIN Zinc finger FYVE domain-containing protein 26 OS=Bos taurus OX=9913 GN=ZFYVE26 PE=3 SV=1 g9128.t4 E1BLZ4 33.845 1303 0.0 635.0 sp|E1BLZ4|ZFY26_BOVIN Zinc finger FYVE domain-containing protein 26 OS=Bos taurus OX=9913 GN=ZFYVE26 PE=3 SV=1 g9128.t5 E1BLZ4 33.845 1303 0.0 635.0 sp|E1BLZ4|ZFY26_BOVIN Zinc finger FYVE domain-containing protein 26 OS=Bos taurus OX=9913 GN=ZFYVE26 PE=3 SV=1 g9129.t1 O54891 37.793 299 3.7499999999999997e-54 181.0 sp|O54891|LEG6_MOUSE Galectin-6 OS=Mus musculus OX=10090 GN=Lgals6 PE=2 SV=1 g9130.t1 Q62665 35.032 314 1.6199999999999998e-54 184.0 sp|Q62665|LEG8_RAT Galectin-8 OS=Rattus norvegicus OX=10116 GN=Lgals8 PE=2 SV=1 g9130.t1 Q62665 36.364 143 2.42e-22 99.0 sp|Q62665|LEG8_RAT Galectin-8 OS=Rattus norvegicus OX=10116 GN=Lgals8 PE=2 SV=1 g9131.t1 Q3B8N2 31.332 383 3.6499999999999997e-45 162.0 sp|Q3B8N2|LEG9B_HUMAN Galectin-9B OS=Homo sapiens OX=9606 GN=LGALS9B PE=1 SV=3 LEG9B_HUMAN reviewed Galectin-9B (Gal-9B) (Galectin-9-like protein A) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0010628; GO:0016936; GO:0030246; GO:0032689; GO:2000562 negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of type II interferon production [GO:0032689]; positive regulation of gene expression [GO:0010628] cytosol [GO:0005829]; nucleus [GO:0005634] carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936] g9131.t1 Q3B8N2 37.589 141 1.27e-22 101.0 sp|Q3B8N2|LEG9B_HUMAN Galectin-9B OS=Homo sapiens OX=9606 GN=LGALS9B PE=1 SV=3 LEG9B_HUMAN reviewed Galectin-9B (Gal-9B) (Galectin-9-like protein A) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0010628; GO:0016936; GO:0030246; GO:0032689; GO:2000562 negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of type II interferon production [GO:0032689]; positive regulation of gene expression [GO:0010628] cytosol [GO:0005829]; nucleus [GO:0005634] carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936] g9132.t1 A5A6H9 64.734 414 0.0 566.0 sp|A5A6H9|ODBA_PANTR 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial OS=Pan troglodytes OX=9598 GN=BCKDHA PE=2 SV=1 ODBA_PANTR reviewed 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha) Pan troglodytes (Chimpanzee) GO:0003863; GO:0005759; GO:0009083; GO:0046872; GO:0120552; GO:0160157 branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA [GO:0120552]; branched-chain amino acid catabolic process [GO:0009083] branched-chain alpha-ketoacid dehydrogenase complex [GO:0160157]; mitochondrial matrix [GO:0005759] branched-chain 2-oxo acid dehydrogenase activity [GO:0003863]; metal ion binding [GO:0046872] g9133.t1 Q8HXY4 60.613 424 0.0 541.0 sp|Q8HXY4|ODBA_MACFA 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial OS=Macaca fascicularis OX=9541 GN=BCKDHA PE=2 SV=1 g9134.t1 Q4R8N7 54.856 556 0.0 600.0 sp|Q4R8N7|STIP1_MACFA Stress-induced-phosphoprotein 1 OS=Macaca fascicularis OX=9541 GN=STIP1 PE=2 SV=1 STIP1_MACFA reviewed Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005634; GO:0051879; GO:0120293 dynein axonemal particle [GO:0120293]; nucleus [GO:0005634] Hsp90 protein binding [GO:0051879] g9135.t1 Q99698 45.013 1193 0.0 1034.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t1 Q99698 29.763 971 1.12e-99 366.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t1 Q99698 24.857 873 4.89e-43 179.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t1 Q99698 36.872 179 6.37e-26 122.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t2 Q99698 45.145 1174 0.0 1025.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t2 Q99698 29.763 971 1.28e-99 366.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t2 Q99698 24.857 873 5.620000000000001e-43 179.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t2 Q99698 36.872 179 6.56e-26 122.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t3 Q99698 45.145 1174 0.0 1025.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t3 Q99698 29.763 971 1.47e-99 366.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t3 Q99698 24.857 873 6.52e-43 179.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t3 Q99698 36.872 179 7.23e-26 122.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t4 Q99698 45.145 1174 0.0 1025.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t4 Q99698 29.763 971 1.39e-99 366.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t4 Q99698 24.857 873 7.18e-43 179.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9135.t4 Q99698 36.872 179 7.2e-26 122.0 sp|Q99698|LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens OX=9606 GN=LYST PE=1 SV=3 LYST_HUMAN reviewed Lysosomal-trafficking regulator (Beige homolog) Homo sapiens (Human) GO:0005737; GO:0006909; GO:0015031; GO:0015630; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein transport [GO:0015031] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] g9136.t1 Q8JFW4 42.918 233 1.56e-47 170.0 sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2 g9136.t1 Q8JFW4 71.622 74 7.27e-30 122.0 sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2 g9138.t1 Q1LZH1 42.373 295 1.9e-67 218.0 sp|Q1LZH1|MARC2_BOVIN Mitochondrial amidoxime reducing component 2 OS=Bos taurus OX=9913 GN=MTARC2 PE=2 SV=1 MARC2_BOVIN reviewed Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2) Bos taurus (Bovine) GO:0005741; GO:0005777; GO:0006809; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0070458; GO:0098809 cellular detoxification of nitrogen compound [GO:0070458]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809] mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777] molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; pyridoxal phosphate binding [GO:0030170] g9139.t1 A7RZW4 59.726 730 0.0 897.0 sp|A7RZW4|DPP3_NEMVE Dipeptidyl peptidase 3 OS=Nematostella vectensis OX=45351 GN=dpp3 PE=3 SV=1 DPP3_NEMVE reviewed Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) Nematostella vectensis (Starlet sea anemone) GO:0004177; GO:0005737; GO:0006508; GO:0008235; GO:0008239; GO:0046872 proteolysis [GO:0006508] cytoplasm [GO:0005737] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235] g9140.t1 Q9CPT3 37.705 244 3.63e-46 157.0 sp|Q9CPT3|NANP_MOUSE N-acylneuraminate-9-phosphatase OS=Mus musculus OX=10090 GN=Nanp PE=1 SV=1 NANP_MOUSE reviewed N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (N-acetylneuraminate-9-phosphate phosphatase) (Neu5Ac-9-Pase) Mus musculus (Mouse) GO:0005829; GO:0006045; GO:0006054; GO:0006055; GO:0046380; GO:0046872; GO:0050124 CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380]; N-acetylneuraminate metabolic process [GO:0006054] cytosol [GO:0005829] metal ion binding [GO:0046872]; N-acylneuraminate-9-phosphatase activity [GO:0050124] g9141.t1 Q06609 85.503 338 0.0 595.0 sp|Q06609|RAD51_HUMAN DNA repair protein RAD51 homolog 1 OS=Homo sapiens OX=9606 GN=RAD51 PE=1 SV=1 RAD51_HUMAN reviewed DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (EC 3.6.4.-) (RAD51 homolog A) Homo sapiens (Human) GO:0000150; GO:0000152; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000781; GO:0000785; GO:0000793; GO:0000794; GO:0000800; GO:0001673; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005813; GO:0005829; GO:0006281; GO:0006310; GO:0006312; GO:0006974; GO:0007131; GO:0008094; GO:0009410; GO:0009636; GO:0010165; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019899; GO:0031297; GO:0032991; GO:0032993; GO:0035861; GO:0036297; GO:0042148; GO:0042802; GO:0048471; GO:0051321; GO:0070182; GO:0070192; GO:0071479; GO:0071480; GO:0072711; GO:0072719; GO:0072757; GO:0099182; GO:0140664; GO:1904631; GO:1990414; GO:1990426; GO:1990918; GO:2000001 cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response [GO:0006974]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to glucoside [GO:1904631]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833] centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nuclear ubiquitin ligase complex [GO:0000152]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; presynaptic intermediate filament cytoskeleton [GO:0099182]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116] g9142.t1 Q9DAZ9 37.931 406 3.31e-77 246.0 sp|Q9DAZ9|ANCHR_MOUSE Abscission/NoCut checkpoint regulator OS=Mus musculus OX=10090 GN=Zfyve19 PE=1 SV=2 ANCHR_MOUSE reviewed Abscission/NoCut checkpoint regulator (ANCHR) (Zinc finger FYVE domain-containing protein 19) Mus musculus (Mouse) GO:0005813; GO:0008270; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0061952; GO:0090543 midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; midbody [GO:0030496] phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270] g9143.t1 Q6P823 99.265 136 1.28e-94 271.0 sp|Q6P823|H33_XENTR Histone H3.3 OS=Xenopus tropicalis OX=8364 GN=TGas113e22.1 PE=1 SV=3 H33_XENTR reviewed Histone H3.3 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 nucleosome [GO:0000786]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] g9144.t1 Q9UBU9 44.237 642 5.2600000000000005e-166 494.0 sp|Q9UBU9|NXF1_HUMAN Nuclear RNA export factor 1 OS=Homo sapiens OX=9606 GN=NXF1 PE=1 SV=1 NXF1_HUMAN reviewed Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0010494; GO:0015031; GO:0016607; GO:0016973; GO:0042272; GO:0042405 mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g9144.t2 Q9UBU9 44.237 642 3.3e-166 494.0 sp|Q9UBU9|NXF1_HUMAN Nuclear RNA export factor 1 OS=Homo sapiens OX=9606 GN=NXF1 PE=1 SV=1 NXF1_HUMAN reviewed Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0010494; GO:0015031; GO:0016607; GO:0016973; GO:0042272; GO:0042405 mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g9145.t1 Q2HZX7 38.242 421 1.79e-92 288.0 sp|Q2HZX7|FUZZY_XENTR Protein fuzzy homolog OS=Xenopus tropicalis OX=8364 GN=fuz PE=1 SV=1 FUZZY_XENTR reviewed Protein fuzzy homolog (Xfy) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0048704; GO:0060271; GO:1905515 cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] g9147.t1 Q9W686 28.849 617 1.54e-49 189.0 sp|Q9W686|SE3AB_DANRE Semaphorin-3ab OS=Danio rerio OX=7955 GN=sema3ab PE=2 SV=1 SE3AB_DANRE reviewed Semaphorin-3ab (Semaphorin-1B) (Semaphorin-Z1B) (Sema Z1B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001569; GO:0001755; GO:0001763; GO:0005615; GO:0005886; GO:0008045; GO:0030215; GO:0030335; GO:0030424; GO:0038191; GO:0045499; GO:0048755; GO:0050919; GO:0071526; GO:0098978 branching involved in blood vessel morphogenesis [GO:0001569]; branching morphogenesis of a nerve [GO:0048755]; morphogenesis of a branching structure [GO:0001763]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] axon [GO:0030424]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215] g9148.t1 Q7KRY7 37.931 261 5.2300000000000005e-33 137.0 sp|Q7KRY7|SCRIB_DROME Protein lap4 OS=Drosophila melanogaster OX=7227 GN=scrib PE=1 SV=1 g9148.t1 Q7KRY7 37.838 222 8.440000000000001e-29 125.0 sp|Q7KRY7|SCRIB_DROME Protein lap4 OS=Drosophila melanogaster OX=7227 GN=scrib PE=1 SV=1 g9148.t1 Q7KRY7 33.831 201 5.7699999999999995e-24 110.0 sp|Q7KRY7|SCRIB_DROME Protein lap4 OS=Drosophila melanogaster OX=7227 GN=scrib PE=1 SV=1 g9148.t1 Q7KRY7 33.649 211 2.1599999999999998e-23 108.0 sp|Q7KRY7|SCRIB_DROME Protein lap4 OS=Drosophila melanogaster OX=7227 GN=scrib PE=1 SV=1 g9148.t1 Q7KRY7 34.071 226 3.1399999999999995e-23 107.0 sp|Q7KRY7|SCRIB_DROME Protein lap4 OS=Drosophila melanogaster OX=7227 GN=scrib PE=1 SV=1 g9151.t1 Q9P055 51.827 301 1.7e-108 322.0 sp|Q9P055|JKAMP_HUMAN JNK1/MAPK8-associated membrane protein OS=Homo sapiens OX=9606 GN=JKAMP PE=1 SV=4 g9152.t1 O75899 35.602 382 1.88e-75 268.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g9153.t1 Q6NYB7 89.268 205 2.23e-137 385.0 sp|Q6NYB7|RAB1A_RAT Ras-related protein Rab-1A OS=Rattus norvegicus OX=10116 GN=Rab1A PE=1 SV=3 RAB1A_RAT reviewed Ras-related protein Rab-1A (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0030252; GO:0032402; GO:0032482; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0043025; GO:0046872; GO:0047496; GO:0070382; GO:0090110; GO:0098793; GO:1903020 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496] cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; presynapse [GO:0098793] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g9154.t1 Q9UBS5 36.213 301 2.6e-63 219.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g9154.t2 Q9UBS5 35.548 301 5.6199999999999995e-61 217.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g9155.t1 Q9WV18 41.837 392 8.56e-90 312.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g9155.t1 Q9WV18 31.443 388 1.32e-54 209.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g9155.t2 O75899 41.927 384 4.22e-90 310.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g9155.t2 O75899 34.94 332 4.62e-64 236.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g9158.t1 Q3UJB0 70.225 534 0.0 727.0 sp|Q3UJB0|SF3B2_MOUSE Splicing factor 3B subunit 2 OS=Mus musculus OX=10090 GN=Sf3b2 PE=2 SV=1 g9159.t1 Q9VFJ2 50.0 188 1.17e-63 197.0 sp|Q9VFJ2|RM11_DROME Large ribosomal subunit protein uL11m OS=Drosophila melanogaster OX=7227 GN=mRpL11 PE=2 SV=1 g9161.t1 A6QLH6 54.81 686 0.0 755.0 sp|A6QLH6|SCYL1_BOVIN N-terminal kinase-like protein OS=Bos taurus OX=9913 GN=SCYL1 PE=2 SV=1 SCYL1_BOVIN reviewed N-terminal kinase-like protein (SCY1-like protein 1) Bos taurus (Bovine) GO:0004672; GO:0005524; GO:0005793; GO:0005794; GO:0005801; GO:0005813; GO:0006890; GO:0030126 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; protein kinase activity [GO:0004672] g9163.t1 Q3V1V3 41.121 428 6.02e-74 250.0 sp|Q3V1V3|ESF1_MOUSE ESF1 homolog OS=Mus musculus OX=10090 GN=Esf1 PE=1 SV=1 g9164.t1 Q9H501 53.691 149 1.64e-38 148.0 sp|Q9H501|ESF1_HUMAN ESF1 homolog OS=Homo sapiens OX=9606 GN=ESF1 PE=1 SV=1 g9165.t1 Q0PGG7 34.14 372 3.72e-64 238.0 sp|Q0PGG7|HIF1A_BOSMU Hypoxia-inducible factor 1-alpha OS=Bos mutus grunniens OX=30521 GN=HIF1A PE=2 SV=1 HIF1A_BOSMU reviewed Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) Bos mutus grunniens (Wild yak) (Bos grunniens) GO:0000302; GO:0000977; GO:0000981; GO:0001223; GO:0001666; GO:0001678; GO:0003700; GO:0005634; GO:0005829; GO:0006110; GO:0010468; GO:0010575; GO:0016607; GO:0019896; GO:0043565; GO:0045893; GO:0045944; GO:0046982; GO:0071456; GO:1900017; GO:1904115; GO:2000434 axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; intracellular glucose homeostasis [GO:0001678]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223] g9166.t1 Q497V6 46.392 194 3.79e-44 175.0 sp|Q497V6|BAHD1_MOUSE Bromo adjacent homology domain-containing 1 protein OS=Mus musculus OX=10090 GN=Bahd1 PE=1 SV=1 BAHD1_MOUSE reviewed Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1) Mus musculus (Mouse) GO:0000976; GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892 heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892] chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654] chromatin binding [GO:0003682]; transcription cis-regulatory region binding [GO:0000976] g9167.t1 Q6P632 73.596 178 2.12e-100 289.0 sp|Q6P632|NAA20_XENTR N-alpha-acetyltransferase 20 OS=Xenopus tropicalis OX=8364 GN=naa20 PE=2 SV=1 NAA20_XENTR reviewed N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004596; GO:0005634; GO:0005737; GO:0006474; GO:0017190; GO:0017192; GO:0018002; GO:0031416; GO:0032956; GO:0120518 N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-glutamine acetylation [GO:0017192]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of actin cytoskeleton organization [GO:0032956] cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634] protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g9168.t1 P49355 58.376 394 2.4500000000000002e-166 476.0 sp|P49355|FNTB_BOVIN Protein farnesyltransferase subunit beta OS=Bos taurus OX=9913 GN=FNTB PE=2 SV=1 g9170.t1 P52162 62.222 135 1.28e-49 160.0 sp|P52162|MAX_CHICK Protein max OS=Gallus gallus OX=9031 GN=MAX PE=3 SV=1 g9171.t1 Q07890 54.432 1117 0.0 1159.0 sp|Q07890|SOS2_HUMAN Son of sevenless homolog 2 OS=Homo sapiens OX=9606 GN=SOS2 PE=1 SV=2 SOS2_HUMAN reviewed Son of sevenless homolog 2 (SOS-2) Homo sapiens (Human) GO:0001782; GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0008286; GO:0033081; GO:0042129; GO:0046982; GO:2000973 B cell homeostasis [GO:0001782]; insulin receptor signaling pathway [GO:0008286]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129] cytosol [GO:0005829]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982] g9172.t1 O88384 43.049 223 2.77e-51 169.0 sp|O88384|VTI1B_MOUSE Vesicle transport through interaction with t-SNAREs homolog 1B OS=Mus musculus OX=10090 GN=Vti1b PE=1 SV=1 VTI1B_MOUSE reviewed Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1) Mus musculus (Mouse) GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006891; GO:0006896; GO:0008021; GO:0012507; GO:0016020; GO:0016236; GO:0019869; GO:0031201; GO:0031901; GO:0031902; GO:0031982; GO:0042147; GO:0043025; GO:0048280; GO:0048471; GO:0055037; GO:0055038; GO:0098954; GO:1903076 Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; presynaptic endosome membrane [GO:0098954]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g9180.t1 Q95M12 51.928 389 7.37e-137 402.0 sp|Q95M12|LGMN_BOVIN Legumain OS=Bos taurus OX=9913 GN=LGMN PE=1 SV=1 LGMN_BOVIN reviewed Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) Bos taurus (Bovine) GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0006624; GO:0019886; GO:0032801; GO:0043202; GO:0051603; GO:1901185 antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] cysteine-type endopeptidase activity [GO:0004197] g9181.t1 P40793 52.792 197 9.76e-67 207.0 sp|P40793|CDC42_DROME Cdc42 homolog OS=Drosophila melanogaster OX=7227 GN=Cdc42 PE=1 SV=1 CDC42_DROME reviewed Cdc42 homolog (EC 3.6.5.2) Drosophila melanogaster (Fruit fly) GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0005938; GO:0006897; GO:0006909; GO:0007015; GO:0007165; GO:0007266; GO:0007274; GO:0007286; GO:0007298; GO:0007349; GO:0007391; GO:0007409; GO:0007411; GO:0008045; GO:0008360; GO:0008582; GO:0009611; GO:0010592; GO:0016028; GO:0016192; GO:0016318; GO:0019901; GO:0030010; GO:0030011; GO:0030027; GO:0030030; GO:0030031; GO:0030036; GO:0030041; GO:0030424; GO:0030426; GO:0030833; GO:0030866; GO:0031175; GO:0032794; GO:0035010; GO:0035011; GO:0035099; GO:0035147; GO:0035318; GO:0042060; GO:0045177; GO:0045185; GO:0045200; GO:0045202; GO:0045860; GO:0046330; GO:0046843; GO:0046928; GO:0048010; GO:0048477; GO:0048675; GO:0048812; GO:0048813; GO:0050770; GO:0050975; GO:0051491; GO:0051601; GO:0060446; GO:0072659; GO:0090303; GO:0097206 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cell projection organization [GO:0030030]; cellularization [GO:0007349]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; encapsulation of foreign target [GO:0035010]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; ommatidial rotation [GO:0016318]; oogenesis [GO:0048477]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vesicle-mediated transport [GO:0016192]; wound healing [GO:0042060] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; synapse [GO:0045202] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] g9182.t1 Q75J93 34.308 889 3.4599999999999996e-147 458.0 sp|Q75J93|CPAS1_DICDI Circularly permutated Ras protein 1 OS=Dictyostelium discoideum OX=44689 GN=cpras1 PE=3 SV=1 g9184.t1 Q8CC12 35.988 1017 8.45e-147 485.0 sp|Q8CC12|CDAN1_MOUSE Codanin-1 OS=Mus musculus OX=10090 GN=Cdan1 PE=1 SV=2 CDAN1_MOUSE reviewed Codanin-1 Mus musculus (Mouse) GO:0000902; GO:0001701; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006998; GO:0008104; GO:0010467; GO:0012505; GO:0031507; GO:0048469; GO:0051170; GO:0060319 cell maturation [GO:0048469]; cell morphogenesis [GO:0000902]; chromatin organization [GO:0006325]; gene expression [GO:0010467]; heterochromatin formation [GO:0031507]; import into nucleus [GO:0051170]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; nuclear envelope organization [GO:0006998]; primitive erythrocyte differentiation [GO:0060319] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g9187.t1 A0JM08 58.427 89 1.2900000000000001e-31 119.0 sp|A0JM08|C170B_XENTR Centrosomal protein of 170 kDa protein B OS=Xenopus tropicalis OX=8364 GN=cep170b PE=2 SV=1 g9188.t1 Q7T0V2 63.636 121 2.35e-55 171.0 sp|Q7T0V2|LTR3A_XENLA Ragulator complex protein LAMTOR3-A OS=Xenopus laevis OX=8355 GN=lamtor3-a PE=2 SV=1 g9189.t1 Q5ZL91 43.841 958 0.0 775.0 sp|Q5ZL91|INT7_CHICK Integrator complex subunit 7 OS=Gallus gallus OX=9031 GN=INTS7 PE=2 SV=1 INT7_CHICK reviewed Integrator complex subunit 7 (Int7) Gallus gallus (Chicken) GO:0005634; GO:0005694; GO:0005737; GO:0006974; GO:0032039; GO:0034472; GO:0160232; GO:0160240 DNA damage response [GO:0006974]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472] chromosome [GO:0005694]; cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634] g9190.t1 Q6P1W0 41.895 475 4.06e-106 346.0 sp|Q6P1W0|DTL_XENTR Denticleless protein homolog OS=Xenopus tropicalis OX=8364 GN=dtl PE=1 SV=1 DTL_XENTR reviewed Denticleless protein homolog Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000209; GO:0005634; GO:0005694; GO:0005813; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0007095; GO:0009411; GO:0019985; GO:0030674; GO:0031464; GO:0031465; GO:0031490; GO:0043161; GO:0048511; GO:0051726; GO:2000060 DNA damage response [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; protein-macromolecule adaptor activity [GO:0030674] g9191.t1 Q28D01 62.925 588 0.0 764.0 sp|Q28D01|WDR26_XENTR WD repeat-containing protein 26 OS=Xenopus tropicalis OX=8364 GN=wdr26 PE=2 SV=2 g9192.t1 Q15061 38.806 603 2.38e-140 428.0 sp|Q15061|WDR43_HUMAN WD repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=WDR43 PE=1 SV=3 WDR43_HUMAN reviewed WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog) Homo sapiens (Human) GO:0000462; GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0032040; GO:0034243; GO:0042274; GO:0045943; GO:2000036; GO:2000234 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; ribosomal small subunit biogenesis [GO:0042274] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation factor activity [GO:0003711] g9195.t1 Q8IUS5 46.207 145 8.68e-41 143.0 sp|Q8IUS5|EPHX4_HUMAN Epoxide hydrolase 4 OS=Homo sapiens OX=9606 GN=EPHX4 PE=1 SV=2 g9198.t1 G5E845 31.325 249 1.99e-28 114.0 sp|G5E845|KCNKG_MOUSE Potassium channel, subfamily K, member 16 OS=Mus musculus OX=10090 GN=Kcnk16 PE=1 SV=1 KCNKG_MOUSE reviewed Potassium channel, subfamily K, member 16 (2P domain potassium channel Talk-1) (Potassium channel subfamily K member 16) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1) Mus musculus (Mouse) GO:0005267; GO:0005743; GO:0005789; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0032469; GO:0042802; GO:0046872; GO:0046982; GO:0051279; GO:0061178; GO:0070092; GO:0071805; GO:0086011; GO:0090273; GO:0098900 endoplasmic reticulum calcium ion homeostasis [GO:0032469]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential [GO:0098900]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of somatostatin secretion [GO:0090273] endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g9199.t1 G5E845 30.952 210 5.4400000000000005e-21 94.4 sp|G5E845|KCNKG_MOUSE Potassium channel, subfamily K, member 16 OS=Mus musculus OX=10090 GN=Kcnk16 PE=1 SV=1 KCNKG_MOUSE reviewed Potassium channel, subfamily K, member 16 (2P domain potassium channel Talk-1) (Potassium channel subfamily K member 16) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1) Mus musculus (Mouse) GO:0005267; GO:0005743; GO:0005789; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0032469; GO:0042802; GO:0046872; GO:0046982; GO:0051279; GO:0061178; GO:0070092; GO:0071805; GO:0086011; GO:0090273; GO:0098900 endoplasmic reticulum calcium ion homeostasis [GO:0032469]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential [GO:0098900]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of somatostatin secretion [GO:0090273] endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g9201.t1 O95279 31.6 250 2.96e-35 138.0 sp|O95279|KCNK5_HUMAN Potassium channel subfamily K member 5 OS=Homo sapiens OX=9606 GN=KCNK5 PE=1 SV=1 KCNK5_HUMAN reviewed Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2) Homo sapiens (Human) GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0034702; GO:0046872; GO:0046982; GO:0060075; GO:0071805; GO:0097623; GO:1990573 potassium ion export across plasma membrane [GO:0097623]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g9202.t1 O95279 29.15 247 2.3000000000000003e-31 127.0 sp|O95279|KCNK5_HUMAN Potassium channel subfamily K member 5 OS=Homo sapiens OX=9606 GN=KCNK5 PE=1 SV=1 KCNK5_HUMAN reviewed Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2) Homo sapiens (Human) GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0034702; GO:0046872; GO:0046982; GO:0060075; GO:0071805; GO:0097623; GO:1990573 potassium ion export across plasma membrane [GO:0097623]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g9203.t1 Q96T55 35.918 245 8.84e-39 142.0 sp|Q96T55|KCNKG_HUMAN Potassium channel subfamily K member 16 OS=Homo sapiens OX=9606 GN=KCNK16 PE=1 SV=1 KCNKG_HUMAN reviewed Potassium channel subfamily K member 16 (2P domain potassium channel Talk-1) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1) Homo sapiens (Human) GO:0005267; GO:0005743; GO:0005789; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0032469; GO:0034702; GO:0042802; GO:0046872; GO:0046982; GO:0051279; GO:0061178; GO:0071805; GO:0086011; GO:0098900 endoplasmic reticulum calcium ion homeostasis [GO:0032469]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential [GO:0098900]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279] endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g9210.t1 Q9D1I6 67.5 80 8.850000000000001e-33 115.0 sp|Q9D1I6|RM14_MOUSE Large ribosomal subunit protein uL14m OS=Mus musculus OX=10090 GN=Mrpl14 PE=1 SV=1 g9211.t1 X1WEM4 42.9 662 4.82e-174 520.0 sp|X1WEM4|TM63C_DANRE Osmosensitive cation channel TMEM63C OS=Danio rerio OX=7955 GN=tmem63c PE=3 SV=1 TM63C_DANRE reviewed Osmosensitive cation channel TMEM63C (Calcium permeable stress-gated cation channel 1) (Transmembrane protein 63c) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003094; GO:0005227; GO:0005789; GO:0005886; GO:0032835; GO:1990760 glomerular filtration [GO:0003094]; glomerulus development [GO:0032835] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] calcium-activated cation channel activity [GO:0005227]; osmolarity-sensing monoatomic cation channel activity [GO:1990760] g9211.t2 X1WEM4 43.359 655 2.99e-175 523.0 sp|X1WEM4|TM63C_DANRE Osmosensitive cation channel TMEM63C OS=Danio rerio OX=7955 GN=tmem63c PE=3 SV=1 TM63C_DANRE reviewed Osmosensitive cation channel TMEM63C (Calcium permeable stress-gated cation channel 1) (Transmembrane protein 63c) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003094; GO:0005227; GO:0005789; GO:0005886; GO:0032835; GO:1990760 glomerular filtration [GO:0003094]; glomerulus development [GO:0032835] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] calcium-activated cation channel activity [GO:0005227]; osmolarity-sensing monoatomic cation channel activity [GO:1990760] g9211.t3 X1WEM4 43.511 655 1.52e-175 523.0 sp|X1WEM4|TM63C_DANRE Osmosensitive cation channel TMEM63C OS=Danio rerio OX=7955 GN=tmem63c PE=3 SV=1 TM63C_DANRE reviewed Osmosensitive cation channel TMEM63C (Calcium permeable stress-gated cation channel 1) (Transmembrane protein 63c) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003094; GO:0005227; GO:0005789; GO:0005886; GO:0032835; GO:1990760 glomerular filtration [GO:0003094]; glomerulus development [GO:0032835] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] calcium-activated cation channel activity [GO:0005227]; osmolarity-sensing monoatomic cation channel activity [GO:1990760] g9214.t1 F1MKX4 49.617 1828 0.0 1806.0 sp|F1MKX4|PSME4_BOVIN Proteasome activator complex subunit 4 OS=Bos taurus OX=9913 GN=PSME4 PE=1 SV=1 g9215.t1 P07311 58.333 96 1.79e-36 122.0 sp|P07311|ACYP1_HUMAN Acylphosphatase-1 OS=Homo sapiens OX=9606 GN=ACYP1 PE=1 SV=2 g9216.t1 Q9UBQ5 61.574 216 1.07e-96 283.0 sp|Q9UBQ5|EIF3K_HUMAN Eukaryotic translation initiation factor 3 subunit K OS=Homo sapiens OX=9606 GN=EIF3K PE=1 SV=1 EIF3K_HUMAN reviewed Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28) Homo sapiens (Human) GO:0001732; GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022 formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; membrane [GO:0016020]; nucleus [GO:0005634] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] g9217.t1 P81139 35.548 301 3.8399999999999997e-42 154.0 sp|P81139|LIPR2_CAVPO Pancreatic lipase-related protein 2 OS=Cavia porcellus OX=10141 GN=PNLIPRP2 PE=1 SV=1 LIPR2_CAVPO reviewed Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (GPL) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3) Cavia porcellus (Guinea pig) GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0006644; GO:0009395; GO:0019376; GO:0019433; GO:0042589; GO:0043005; GO:0047372; GO:0047714 galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589] calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806] g9219.t1 J3RZ81 45.6 125 1.62e-26 107.0 sp|J3RZ81|LIPE_CROAD Putative endothelial lipase OS=Crotalus adamanteus OX=8729 PE=2 SV=1 g9220.t1 Q9QYE6 58.163 196 3.6800000000000004e-70 229.0 sp|Q9QYE6|GOGA5_MOUSE Golgin subfamily A member 5 OS=Mus musculus OX=10090 GN=Golga5 PE=1 SV=2 GOGA5_MOUSE reviewed Golgin subfamily A member 5 (Golgin-84) (Protein Ret-II) (Protein Sumiko) Mus musculus (Mouse) GO:0000137; GO:0000138; GO:0000139; GO:0000301; GO:0005794; GO:0005797; GO:0005801; GO:0007030; GO:0016020; GO:0030663; GO:0030674; GO:0031267; GO:0031985; GO:0042803; GO:0048193 Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301] cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna [GO:0031985]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g9221.t1 Q9QYE6 42.183 339 2.9000000000000003e-63 218.0 sp|Q9QYE6|GOGA5_MOUSE Golgin subfamily A member 5 OS=Mus musculus OX=10090 GN=Golga5 PE=1 SV=2 GOGA5_MOUSE reviewed Golgin subfamily A member 5 (Golgin-84) (Protein Ret-II) (Protein Sumiko) Mus musculus (Mouse) GO:0000137; GO:0000138; GO:0000139; GO:0000301; GO:0005794; GO:0005797; GO:0005801; GO:0007030; GO:0016020; GO:0030663; GO:0030674; GO:0031267; GO:0031985; GO:0042803; GO:0048193 Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301] cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna [GO:0031985]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g9222.t1 Q9USQ7 36.634 505 2.14e-101 320.0 sp|Q9USQ7|DPH6_SCHPO Diphthine--ammonia ligase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=mug71 PE=1 SV=1 g9224.t1 P23685 71.711 152 5.59e-69 228.0 sp|P23685|NAC1_CANLF Sodium/calcium exchanger 1 OS=Canis lupus familiaris OX=9615 GN=SLC8A1 PE=1 SV=1 g9225.t1 P57103 56.055 578 0.0 658.0 sp|P57103|NAC3_HUMAN Sodium/calcium exchanger 3 OS=Homo sapiens OX=9606 GN=SLC8A3 PE=1 SV=2 NAC3_HUMAN reviewed Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) Homo sapiens (Human) GO:0001669; GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015630; GO:0016528; GO:0021537; GO:0030424; GO:0030425; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0097229; GO:0098703; GO:0098794; GO:0098815; GO:1902532; GO:1903779; GO:1905060; GO:1990034 calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transport [GO:0006811]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; sperm end piece [GO:0097229]; synapse [GO:0045202] calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g9227.t1 P48039 28.107 338 7.09e-28 114.0 sp|P48039|MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens OX=9606 GN=MTNR1A PE=1 SV=1 MTR1A_HUMAN reviewed Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617] plasma membrane [GO:0005886]; receptor complex [GO:0043235] G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502] g9228.t1 Q24214 85.882 170 9.040000000000001e-105 300.0 sp|Q24214|CANB2_DROME Calcineurin subunit B type 2 OS=Drosophila melanogaster OX=7227 GN=CanB2 PE=1 SV=2 CANB2_DROME reviewed Calcineurin subunit B type 2 (Protein phosphatase 2B regulatory subunit 2) (dCNB2) Drosophila melanogaster (Fruit fly) GO:0005509; GO:0005516; GO:0005955; GO:0007269; GO:0008021; GO:0008597; GO:0016192; GO:0019902; GO:0030431; GO:0045214; GO:0051321; GO:0097720 calcineurin-mediated signaling [GO:0097720]; meiotic cell cycle [GO:0051321]; neurotransmitter secretion [GO:0007269]; sarcomere organization [GO:0045214]; sleep [GO:0030431]; vesicle-mediated transport [GO:0016192] calcineurin complex [GO:0005955]; synaptic vesicle [GO:0008021] calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; calmodulin binding [GO:0005516]; phosphatase binding [GO:0019902] g9229.t1 Q7SX99 74.837 461 0.0 727.0 sp|Q7SX99|FUMH_DANRE Fumarate hydratase, mitochondrial OS=Danio rerio OX=7955 GN=fh PE=2 SV=1 FUMH_DANRE reviewed Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000050; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:2001034 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050] chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] fumarate hydratase activity [GO:0004333] g9230.t1 P08842 46.771 573 4.54e-180 525.0 sp|P08842|STS_HUMAN Steryl-sulfatase OS=Homo sapiens OX=9606 GN=STS PE=1 SV=2 STS_HUMAN reviewed Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) Homo sapiens (Human) GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0043231; GO:0046872 epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484] g9232.t1 Q9ERY9 45.763 118 1.56e-29 107.0 sp|Q9ERY9|ERG28_MOUSE Ergosterol biosynthetic protein 28 homolog OS=Mus musculus OX=10090 GN=Erg28 PE=2 SV=1 g9233.t1 Q8CBH5 27.487 593 3.03e-47 179.0 sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1 g9235.t1 Q8CBH5 27.934 605 5.48e-50 187.0 sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1 g9236.t1 Q9N126 34.737 285 1.2599999999999999e-42 151.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g9237.t1 P08842 47.89 545 8.5e-172 503.0 sp|P08842|STS_HUMAN Steryl-sulfatase OS=Homo sapiens OX=9606 GN=STS PE=1 SV=2 STS_HUMAN reviewed Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) Homo sapiens (Human) GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0043231; GO:0046872 epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484] g9238.t1 A6QLU6 30.208 288 9.550000000000001e-21 101.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g9239.t1 A0A072ULZ1 26.549 339 4.0799999999999996e-23 105.0 sp|A0A072ULZ1|GLB12_MEDTR Anaerobic nitrite reductase Glb1-2 OS=Medicago truncatula OX=3880 GN=Glb1-2 PE=1 SV=1 GLB12_MEDTR reviewed Anaerobic nitrite reductase Glb1-2 (EC 1.7.2.-) (Non-symbiotic hemoglobin 1-2) (MtGlb1-2) (Phytoglobin 1.2) (Phytogb1.2) Medicago truncatula (Barrel medic) (Medicago tribuloides) GO:0001666; GO:0005344; GO:0005634; GO:0005737; GO:0009609; GO:0009877; GO:0010167; GO:0016491; GO:0019825; GO:0020037; GO:0046872; GO:0060359; GO:0071731 nodulation [GO:0009877]; response to ammonium ion [GO:0060359]; response to hypoxia [GO:0001666]; response to nitrate [GO:0010167]; response to nitric oxide [GO:0071731]; response to symbiotic bacterium [GO:0009609] cytoplasm [GO:0005737]; nucleus [GO:0005634] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] g9239.t1 A0A072ULZ1 27.632 304 1.6900000000000001e-21 100.0 sp|A0A072ULZ1|GLB12_MEDTR Anaerobic nitrite reductase Glb1-2 OS=Medicago truncatula OX=3880 GN=Glb1-2 PE=1 SV=1 GLB12_MEDTR reviewed Anaerobic nitrite reductase Glb1-2 (EC 1.7.2.-) (Non-symbiotic hemoglobin 1-2) (MtGlb1-2) (Phytoglobin 1.2) (Phytogb1.2) Medicago truncatula (Barrel medic) (Medicago tribuloides) GO:0001666; GO:0005344; GO:0005634; GO:0005737; GO:0009609; GO:0009877; GO:0010167; GO:0016491; GO:0019825; GO:0020037; GO:0046872; GO:0060359; GO:0071731 nodulation [GO:0009877]; response to ammonium ion [GO:0060359]; response to hypoxia [GO:0001666]; response to nitrate [GO:0010167]; response to nitric oxide [GO:0071731]; response to symbiotic bacterium [GO:0009609] cytoplasm [GO:0005737]; nucleus [GO:0005634] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] g9239.t1 A0A072ULZ1 26.045 311 2.38e-21 100.0 sp|A0A072ULZ1|GLB12_MEDTR Anaerobic nitrite reductase Glb1-2 OS=Medicago truncatula OX=3880 GN=Glb1-2 PE=1 SV=1 GLB12_MEDTR reviewed Anaerobic nitrite reductase Glb1-2 (EC 1.7.2.-) (Non-symbiotic hemoglobin 1-2) (MtGlb1-2) (Phytoglobin 1.2) (Phytogb1.2) Medicago truncatula (Barrel medic) (Medicago tribuloides) GO:0001666; GO:0005344; GO:0005634; GO:0005737; GO:0009609; GO:0009877; GO:0010167; GO:0016491; GO:0019825; GO:0020037; GO:0046872; GO:0060359; GO:0071731 nodulation [GO:0009877]; response to ammonium ion [GO:0060359]; response to hypoxia [GO:0001666]; response to nitrate [GO:0010167]; response to nitric oxide [GO:0071731]; response to symbiotic bacterium [GO:0009609] cytoplasm [GO:0005737]; nucleus [GO:0005634] heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] g9241.t1 Q9NVF7 45.082 244 1.54e-56 191.0 sp|Q9NVF7|FBX28_HUMAN F-box only protein 28 OS=Homo sapiens OX=9606 GN=FBXO28 PE=1 SV=1 FBX28_HUMAN reviewed F-box only protein 28 Homo sapiens (Human) GO:0000209; GO:0000776; GO:0042802 protein polyubiquitination [GO:0000209] kinetochore [GO:0000776] identical protein binding [GO:0042802] g9242.t1 Q2JII9 42.748 131 5.42e-25 112.0 sp|Q2JII9|GLMU_SYNJB Bifunctional protein GlmU OS=Synechococcus sp. (strain JA-2-3B'a(2-13)) OX=321332 GN=glmU PE=3 SV=1 GLMU_SYNJB reviewed Bifunctional protein GlmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridyltransferase); Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157)] Synechococcus sp. (strain JA-2-3B'a(2-13)) (Cyanobacteria bacterium Yellowstone B-Prime) GO:0000287; GO:0000902; GO:0003977; GO:0005737; GO:0006048; GO:0008360; GO:0009245; GO:0009252; GO:0016020; GO:0019134; GO:0031470; GO:0043886; GO:0071555 cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; lipid A biosynthetic process [GO:0009245]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] carboxysome [GO:0031470]; cytoplasm [GO:0005737]; membrane [GO:0016020] glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; structural constituent of carboxysome shell [GO:0043886]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977] g9243.t1 Q5RFQ0 74.129 201 2.12e-107 309.0 sp|Q5RFQ0|FCF1_PONAB rRNA-processing protein FCF1 homolog OS=Pongo abelii OX=9601 GN=FCF1 PE=2 SV=1 g9244.t1 O15033 50.5 800 0.0 771.0 sp|O15033|AREL1_HUMAN Apoptosis-resistant E3 ubiquitin protein ligase 1 OS=Homo sapiens OX=9606 GN=AREL1 PE=1 SV=3 AREL1_HUMAN reviewed Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1) Homo sapiens (Human) GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0050727; GO:0061630; GO:0070979; GO:1990390 apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g9246.t1 Q9UBX8 51.695 236 2.5600000000000002e-73 239.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g9247.t1 Q7PYT9 43.907 517 1.42e-143 432.0 sp|Q7PYT9|MALT_ANOGA Salivary alpha-glucosidase OS=Anopheles gambiae OX=7165 GN=MAL1 PE=1 SV=3 g9248.t1 Q91WV7 37.359 621 3.25e-130 403.0 sp|Q91WV7|SLC31_MOUSE Amino acid transporter heavy chain SLC3A1 OS=Mus musculus OX=10090 GN=Slc3a1 PE=1 SV=1 SLC31_MOUSE reviewed Amino acid transporter heavy chain SLC3A1 (D2) (Neutral and basic amino acid transport protein) (NBAT) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transporter-related heavy chain) (rBAT) Mus musculus (Mouse) GO:0005743; GO:0005774; GO:0005975; GO:0006865; GO:0010467; GO:0015810; GO:0015811; GO:0015813; GO:0016324; GO:0031526; GO:0044877; GO:0046872; GO:0046982 amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; mitochondrial inner membrane [GO:0005743]; vacuolar membrane [GO:0005774] metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877] g9249.t1 Q9P0W8 29.792 433 2.87e-31 129.0 sp|Q9P0W8|SPAT7_HUMAN Spermatogenesis-associated protein 7 OS=Homo sapiens OX=9606 GN=SPATA7 PE=1 SV=3 g9250.t1 Q9JIS4 35.102 245 3.23e-37 147.0 sp|Q9JIS4|KCNKA_RAT Potassium channel subfamily K member 10 OS=Rattus norvegicus OX=10116 GN=Kcnk10 PE=2 SV=1 KCNKA_RAT reviewed Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit) Rattus norvegicus (Rat) GO:0005267; GO:0005886; GO:0007613; GO:0015271; GO:0022841; GO:0034702; GO:0046872; GO:0071805; GO:0098782; GO:1904551 cellular response to arachidonate [GO:1904551]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] mechanosensitive potassium channel activity [GO:0098782]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] g9251.t1 Q5R6P6 58.865 141 7.459999999999999e-54 169.0 sp|Q5R6P6|GMFB_PONAB Glia maturation factor beta OS=Pongo abelii OX=9601 GN=GMFB PE=2 SV=3 g9252.t1 Q561P5 74.56 739 0.0 1179.0 sp|Q561P5|MCM5_XENTR DNA replication licensing factor mcm5 OS=Xenopus tropicalis OX=8364 GN=mcm5 PE=2 SV=1 MCM5_XENTR reviewed DNA replication licensing factor mcm5 (EC 3.6.4.12) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000727; GO:0000785; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162 cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174] chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697] g9255.t1 Q78P75 75.0 88 1.4599999999999998e-45 146.0 sp|Q78P75|DYL2_RAT Dynein light chain 2, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dynll2 PE=1 SV=1 DYL2_RAT reviewed Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2) Rattus norvegicus (Rat) GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978 microtubule-based process [GO:0007017] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] g9256.t1 O02414 79.518 83 9.15e-46 145.0 sp|O02414|DYL1_HELCR Dynein light chain LC6, flagellar outer arm OS=Heliocidaris crassispina OX=1043166 PE=3 SV=1 g9257.t1 Q8IWV8 42.379 1824 0.0 1408.0 sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1 UBR2_HUMAN reviewed E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II) Homo sapiens (Human) GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053 cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g9258.t1 Q9P1Q0 49.062 960 0.0 895.0 sp|Q9P1Q0|VPS54_HUMAN Vacuolar protein sorting-associated protein 54 OS=Homo sapiens OX=9606 GN=VPS54 PE=1 SV=2 g9259.t1 Q9C0G6 47.386 1224 0.0 1214.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t1 Q9C0G6 43.057 1361 0.0 1092.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t1 Q9C0G6 46.405 153 2.8100000000000003e-37 160.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t2 Q9C0G6 47.386 1224 0.0 1214.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t2 Q9C0G6 42.486 1384 0.0 1088.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t2 Q9C0G6 46.405 153 2.8300000000000003e-37 160.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t3 Q9C0G6 47.386 1224 0.0 1214.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t3 Q9C0G6 43.057 1361 0.0 1093.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9259.t3 Q9C0G6 46.405 153 2.57e-37 160.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9262.t1 Q61184 29.545 308 9.580000000000001e-21 94.7 sp|Q61184|MTR1A_MOUSE Melatonin receptor type 1A OS=Mus musculus OX=10090 GN=Mtnr1a PE=2 SV=1 g9264.t1 Q9C0G6 37.341 865 4.81e-170 554.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g9269.t1 P15589 49.466 281 2.13e-85 270.0 sp|P15589|STS_RAT Steryl-sulfatase OS=Rattus norvegicus OX=10116 GN=Sts PE=1 SV=2 STS_RAT reviewed Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) Rattus norvegicus (Rat) GO:0004065; GO:0004773; GO:0005635; GO:0005789; GO:0007565; GO:0007611; GO:0008202; GO:0008284; GO:0008484; GO:0009268; GO:0043434; GO:0043588; GO:0043627; GO:0046872 female pregnancy [GO:0007565]; learning or memory [GO:0007611]; positive regulation of cell population proliferation [GO:0008284]; response to estrogen [GO:0043627]; response to peptide hormone [GO:0043434]; response to pH [GO:0009268]; skin development [GO:0043588]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484] g9270.t1 P08842 60.526 152 1.54e-53 185.0 sp|P08842|STS_HUMAN Steryl-sulfatase OS=Homo sapiens OX=9606 GN=STS PE=1 SV=2 STS_HUMAN reviewed Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) Homo sapiens (Human) GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0043231; GO:0046872 epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484] g9271.t1 Q5HZQ9 38.046 1259 0.0 832.0 sp|Q5HZQ9|PCX4_XENLA Pecanex-like protein 4 OS=Xenopus laevis OX=8355 GN=pcnx4 PE=2 SV=1 g9272.t1 Q9CXR1 44.04 302 4.32e-80 250.0 sp|Q9CXR1|DHRS7_MOUSE Dehydrogenase/reductase SDR family member 7 OS=Mus musculus OX=10090 GN=Dhrs7 PE=1 SV=2 g9273.t1 Q8NBD8 60.479 167 2.49e-72 218.0 sp|Q8NBD8|T229B_HUMAN Transmembrane protein 229B OS=Homo sapiens OX=9606 GN=TMEM229B PE=1 SV=1 T229B_HUMAN reviewed Transmembrane protein 229B Homo sapiens (Human) GO:0009617; GO:0016020; GO:0042116 macrophage activation [GO:0042116]; response to bacterium [GO:0009617] membrane [GO:0016020] g9279.t1 Q96L93 55.763 590 0.0 658.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g9279.t2 Q96L93 56.357 582 0.0 663.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g9279.t3 Q96L93 49.069 752 0.0 684.0 sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2 KI16B_HUMAN reviewed Kinesin-like protein KIF16B (Sorting nexin-23) Homo sapiens (Human) GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025 early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574] g9280.t1 P98068 41.88 117 2.9399999999999998e-24 102.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g9281.t1 P98068 37.743 567 1.1700000000000001e-125 386.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g9282.t1 A5A6N7 57.53 332 9.549999999999999e-138 396.0 sp|A5A6N7|LDHB_PANTR L-lactate dehydrogenase B chain OS=Pan troglodytes OX=9598 GN=LDHB PE=2 SV=1 g9282.t2 A5A6N7 51.771 367 1.9200000000000003e-129 377.0 sp|A5A6N7|LDHB_PANTR L-lactate dehydrogenase B chain OS=Pan troglodytes OX=9598 GN=LDHB PE=2 SV=1 g9283.t1 Q80X66 65.528 322 2.46e-141 414.0 sp|Q80X66|BTBDA_MOUSE BTB/POZ domain-containing protein 10 OS=Mus musculus OX=10090 GN=Btbd10 PE=1 SV=1 g9285.t1 E7F221 32.133 361 1.6699999999999998e-55 194.0 sp|E7F221|FRMD8_DANRE FERM domain-containing protein 8 OS=Danio rerio OX=7955 GN=frmd8 PE=2 SV=1 g9285.t2 Q9BZ67 32.265 437 1.71e-56 196.0 sp|Q9BZ67|FRMD8_HUMAN FERM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=FRMD8 PE=1 SV=1 g9287.t1 Q6ZSM3 25.897 390 1.7400000000000001e-29 124.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g9294.t1 Q5RBX7 62.376 101 1.24e-38 129.0 sp|Q5RBX7|SRP14_PONAB Signal recognition particle 14 kDa protein OS=Pongo abelii OX=9601 GN=SRP14 PE=2 SV=1 g9295.t1 Q8JGT5 53.801 342 7.549999999999999e-126 367.0 sp|Q8JGT5|SAE1_XENLA SUMO-activating enzyme subunit 1 OS=Xenopus laevis OX=8355 GN=sae1 PE=2 SV=1 g9296.t1 Q8SQC1 31.637 452 5.01e-84 272.0 sp|Q8SQC1|SCRB1_PIG Scavenger receptor class B member 1 OS=Sus scrofa OX=9823 GN=SCARB1 PE=2 SV=1 g9297.t1 Q8SQC1 35.141 461 1.55e-98 309.0 sp|Q8SQC1|SCRB1_PIG Scavenger receptor class B member 1 OS=Sus scrofa OX=9823 GN=SCARB1 PE=2 SV=1 g9298.t1 Q9VT65 46.948 688 0.0 639.0 sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2 CANB_DROME reviewed Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2] Drosophila melanogaster (Fruit fly) GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540 border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; membrane [GO:0016020] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g9298.t2 Q9VT65 46.812 690 0.0 634.0 sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2 CANB_DROME reviewed Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2] Drosophila melanogaster (Fruit fly) GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540 border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; membrane [GO:0016020] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g9298.t3 Q9VT65 47.076 684 0.0 639.0 sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2 CANB_DROME reviewed Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2] Drosophila melanogaster (Fruit fly) GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540 border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; membrane [GO:0016020] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g9299.t1 Q6PBN2 50.794 315 6.73e-98 293.0 sp|Q6PBN2|AIDA_DANRE Axin interactor, dorsalization-associated protein OS=Danio rerio OX=7955 GN=aida PE=1 SV=1 AIDA_DANRE reviewed Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0009953; GO:0016020; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264; GO:2000016 determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333] membrane [GO:0016020] phosphatidylinositol binding [GO:0035091] g9301.t1 P39109 51.282 78 1.5300000000000002e-21 90.1 sp|P39109|YCFI_YEAST Metal resistance protein YCF1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YCF1 PE=1 SV=2 YCFI_YEAST reviewed Metal resistance protein YCF1 (ABC-type Cd(2+) transporter) (EC 7.2.2.2) (ABC-type glutathione-S-conjugate transporter) (EC 7.6.2.3) (Yeast cadmium factor 1) Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0000329; GO:0005524; GO:0006749; GO:0008551; GO:0010038; GO:0015127; GO:0015431; GO:0015434; GO:0016887; GO:0042144; GO:0045121; GO:0045454; GO:0046686; GO:0055085; GO:0140359 cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; transmembrane transport [GO:0055085]; vacuole fusion, non-autophagic [GO:0042144] fungal-type vacuole membrane [GO:0000329]; membrane raft [GO:0045121] ABC-type cadmium transporter activity [GO:0015434]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bilirubin transmembrane transporter activity [GO:0015127]; P-type cadmium transporter activity [GO:0008551] g9302.t1 P82451 33.193 1422 0.0 738.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g9303.t1 A1A5F2 59.525 2063 0.0 2377.0 sp|A1A5F2|HTR5B_XENTR HEAT repeat-containing protein 5B OS=Xenopus tropicalis OX=8364 GN=heatr5b PE=2 SV=1 g9304.t1 Q923Y4 29.355 310 5.66e-25 106.0 sp|Q923Y4|TAA7H_RAT Trace amine-associated receptor 7h OS=Rattus norvegicus OX=10116 GN=Taar7h PE=3 SV=1 g9305.t1 A1L2S8 47.147 333 1.0199999999999999e-106 317.0 sp|A1L2S8|ZFPL1_XENLA Zinc finger protein-like 1 OS=Xenopus laevis OX=8355 GN=zfpl1 PE=2 SV=1 g9309.t1 A5PJS2 55.367 177 5.69e-74 229.0 sp|A5PJS2|S5A1_BOVIN 3-oxo-5-alpha-steroid 4-dehydrogenase 1 OS=Bos taurus OX=9913 GN=SRD5A1 PE=2 SV=1 g9311.t1 P91685 29.129 896 5.93e-119 387.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g9312.t1 Q9EQT3 61.187 219 1.62e-92 278.0 sp|Q9EQT3|RHOU_MOUSE Rho-related GTP-binding protein RhoU OS=Mus musculus OX=10090 GN=Rhou PE=2 SV=1 RHOU_MOUSE reviewed Rho-related GTP-binding protein RhoU (Rho GTPase-like protein ARHU) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1) Mus musculus (Mouse) GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0006897; GO:0007010; GO:0007015; GO:0007165; GO:0008360; GO:0016601; GO:0019901; GO:0030010; GO:0030036; GO:0030674; GO:0046872; GO:0120183 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of focal adhesion disassembly [GO:0120183]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165] focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] g9313.t1 Q9BWH6 35.442 1470 0.0 702.0 sp|Q9BWH6|RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens OX=9606 GN=RPAP1 PE=1 SV=3 g9314.t1 Q4R642 51.055 474 1.29e-174 503.0 sp|Q4R642|DRC5_MACFA Dynein regulatory complex subunit 5 OS=Macaca fascicularis OX=9541 GN=TCTE1 PE=2 SV=1 g9315.t1 Q9WTN5 27.716 718 9.150000000000001e-64 232.0 sp|Q9WTN5|TPC1_RAT Two pore calcium channel protein 1 OS=Rattus norvegicus OX=10116 GN=Tpcn1 PE=1 SV=2 TPC1_RAT reviewed Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1) Rattus norvegicus (Rat) GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0022832; GO:0031901; GO:0034702; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682 endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; sodium ion transmembrane transport [GO:0035725] early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated channel activity [GO:0022832]; voltage-gated sodium channel activity [GO:0005248] g9316.t1 G3V8R8 36.137 321 1.3099999999999999e-52 178.0 sp|G3V8R8|KCNK6_RAT Potassium channel subfamily K member 6 OS=Rattus norvegicus OX=10116 GN=Kcnk6 PE=1 SV=1 KCNK6_RAT reviewed Potassium channel subfamily K member 6 Rattus norvegicus (Rat) GO:0003073; GO:0003085; GO:0005267; GO:0005765; GO:0005886; GO:0015271; GO:0022841; GO:0031902; GO:0046872; GO:0060075; GO:0062196; GO:0071805; GO:1900227 negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; potassium ion transmembrane transport [GO:0071805]; regulation of lysosome size [GO:0062196]; regulation of resting membrane potential [GO:0060075]; regulation of systemic arterial blood pressure [GO:0003073] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] g9316.t2 G3V8R8 37.261 314 1.2099999999999998e-54 183.0 sp|G3V8R8|KCNK6_RAT Potassium channel subfamily K member 6 OS=Rattus norvegicus OX=10116 GN=Kcnk6 PE=1 SV=1 KCNK6_RAT reviewed Potassium channel subfamily K member 6 Rattus norvegicus (Rat) GO:0003073; GO:0003085; GO:0005267; GO:0005765; GO:0005886; GO:0015271; GO:0022841; GO:0031902; GO:0046872; GO:0060075; GO:0062196; GO:0071805; GO:1900227 negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; potassium ion transmembrane transport [GO:0071805]; regulation of lysosome size [GO:0062196]; regulation of resting membrane potential [GO:0060075]; regulation of systemic arterial blood pressure [GO:0003073] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] g9317.t1 Q3UK37 33.779 299 6.0700000000000005e-22 101.0 sp|Q3UK37|TEDC1_MOUSE Tubulin epsilon and delta complex protein 1 OS=Mus musculus OX=10090 GN=Tedc1 PE=1 SV=2 g9318.t1 F1RWC3 22.796 3040 3.3100000000000005e-129 463.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 23.093 2949 7.19e-118 426.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 23.78 2540 4.75e-116 420.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 22.69 2543 3.37e-105 384.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 22.636 2792 3.4e-102 374.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 22.473 2394 3.09e-89 332.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 23.362 1832 6.3700000000000006e-80 301.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 23.452 1680 2.04e-77 292.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9318.t1 F1RWC3 22.743 1750 5.61e-65 251.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g9319.t1 Q5F3X0 47.692 260 3.5600000000000003e-88 270.0 sp|Q5F3X0|LCLT1_CHICK Lysocardiolipin acyltransferase 1 OS=Gallus gallus OX=9031 GN=LCLAT1 PE=2 SV=1 LCLT1_CHICK reviewed Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1) Gallus gallus (Chicken) GO:0003841; GO:0005783; GO:0005789; GO:0012505; GO:0016024; GO:0016746; GO:0036149 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidylinositol acyl-chain remodeling [GO:0036149] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] g9320.t1 Q8BH86 42.159 593 3.26e-151 452.0 sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1 g9322.t1 Q9C005 65.882 85 4.34e-36 121.0 sp|Q9C005|DPY30_HUMAN Protein dpy-30 homolog OS=Homo sapiens OX=9606 GN=DPY30 PE=1 SV=1 g9324.t1 Q92797 51.986 1183 0.0 1148.0 sp|Q92797|SYMPK_HUMAN Symplekin OS=Homo sapiens OX=9606 GN=SYMPK PE=1 SV=2 SYMPK_HUMAN reviewed Symplekin Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006397; GO:0007155; GO:0032091; GO:0097165 cell adhesion [GO:0007155]; mRNA processing [GO:0006397]; negative regulation of protein binding [GO:0032091] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g9324.t2 Q92797 50.803 1183 0.0 1112.0 sp|Q92797|SYMPK_HUMAN Symplekin OS=Homo sapiens OX=9606 GN=SYMPK PE=1 SV=2 SYMPK_HUMAN reviewed Symplekin Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006397; GO:0007155; GO:0032091; GO:0097165 cell adhesion [GO:0007155]; mRNA processing [GO:0006397]; negative regulation of protein binding [GO:0032091] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g9325.t1 P47990 57.058 1353 0.0 1571.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g9326.t1 Q9HBF4 57.078 657 0.0 778.0 sp|Q9HBF4|ZFYV1_HUMAN Zinc finger FYVE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZFYVE1 PE=1 SV=1 ZFYV1_HUMAN reviewed Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) Homo sapiens (Human) GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0044829; GO:0048471; GO:0097629; GO:0140042; GO:1990462 cellular response to starvation [GO:0009267]; host-mediated activation of viral genome replication [GO:0044829]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236] autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407] 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270] g9329.t1 Q3MIT2 43.289 529 4.4300000000000004e-145 431.0 sp|Q3MIT2|PUS10_HUMAN tRNA pseudouridine synthase Pus10 OS=Homo sapiens OX=9606 GN=PUS10 PE=1 SV=1 PUS10_HUMAN reviewed tRNA pseudouridine synthase Pus10 (Hup10) (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148 primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(55) synthase activity [GO:0160148] g9330.t1 P56404 32.794 247 6e-35 129.0 sp|P56404|AQP8_MOUSE Aquaporin-8 OS=Mus musculus OX=10090 GN=Aqp8 PE=1 SV=1 AQP8_MOUSE reviewed Aquaporin-8 (AQP-8) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0005790; GO:0005886; GO:0006833; GO:0008519; GO:0015250; GO:0015264; GO:0015265; GO:0015722; GO:0015840; GO:0015843; GO:0016323; GO:0016324; GO:0030183; GO:0030868; GO:0031526; GO:0031966; GO:0035377; GO:0045177; GO:0045540; GO:0046691; GO:0071320; GO:0072488; GO:0072489; GO:0080170; GO:0097708; GO:0140157; GO:1990748 ammonium import across plasma membrane [GO:0140157]; ammonium transmembrane transport [GO:0072488]; B cell differentiation [GO:0030183]; canalicular bile acid transport [GO:0015722]; cellular detoxification [GO:1990748]; cellular response to cAMP [GO:0071320]; hydrogen peroxide transmembrane transport [GO:0080170]; methylammonium transmembrane transport [GO:0072489]; methylammonium transport [GO:0015843]; regulation of cholesterol biosynthetic process [GO:0045540]; transepithelial water transport [GO:0035377]; urea transport [GO:0015840]; water transport [GO:0006833] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; intracellular canaliculus [GO:0046691]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; smooth endoplasmic reticulum membrane [GO:0030868] ammonium channel activity [GO:0008519]; methylammonium channel activity [GO:0015264]; urea channel activity [GO:0015265]; water channel activity [GO:0015250] g9334.t1 Q5BKG8 34.706 340 1.28e-29 125.0 sp|Q5BKG8|NUSAP_XENTR Nucleolar and spindle-associated protein 1 OS=Xenopus tropicalis OX=8364 GN=nusap1 PE=2 SV=2 g9334.t2 Q5BKG8 34.582 347 3.11e-29 124.0 sp|Q5BKG8|NUSAP_XENTR Nucleolar and spindle-associated protein 1 OS=Xenopus tropicalis OX=8364 GN=nusap1 PE=2 SV=2 g9337.t1 Q9H0R1 36.653 502 8.529999999999999e-108 332.0 sp|Q9H0R1|AP5M1_HUMAN AP-5 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP5M1 PE=1 SV=2 AP5M1_HUMAN reviewed AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein) Homo sapiens (Human) GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599 endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] g9338.t1 Q01H84 47.351 302 6.24e-88 281.0 sp|Q01H84|SELN_XENTR Selenoprotein N OS=Xenopus tropicalis OX=8364 GN=selenon PE=2 SV=2 g9343.t1 Q9JKC7 40.263 457 1.83e-113 343.0 sp|Q9JKC7|AP4M1_MOUSE AP-4 complex subunit mu-1 OS=Mus musculus OX=10090 GN=Ap4m1 PE=1 SV=1 AP4M1_MOUSE reviewed AP-4 complex subunit mu-1 (AP-4 adaptor complex mu subunit) (Adaptor-related protein complex 4 subunit mu-1) (Mu subunit of AP-4) (Mu-adaptin-related protein 2) (mu-ARP2) (Mu4-adaptin) (mu4) Mus musculus (Mouse) GO:0000045; GO:0005769; GO:0005802; GO:0005829; GO:0006605; GO:0006622; GO:0006886; GO:0006895; GO:0008104; GO:0016192; GO:0019904; GO:0030124; GO:0030131; GO:0031410; GO:0090160; GO:1903361 autophagosome assembly [GO:0000045]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; intracellular protein localization [GO:0008104]; intracellular protein transport [GO:0006886]; protein localization to basolateral plasma membrane [GO:1903361]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; trans-Golgi network [GO:0005802] protein domain specific binding [GO:0019904] g9346.t1 Q3T145 68.902 328 6.320000000000001e-167 471.0 sp|Q3T145|MDHC_BOVIN Malate dehydrogenase, cytoplasmic OS=Bos taurus OX=9913 GN=MDH1 PE=2 SV=3 MDHC_BOVIN reviewed Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Aromatic alpha-keto acid reductase) (KAR) (Cytosolic malate dehydrogenase) Bos taurus (Bovine) GO:0005813; GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006739; GO:0030060; GO:0043490; GO:0047860; GO:0047995 malate metabolic process [GO:0006108]; malate-aspartate shuttle [GO:0043490]; NADP+ metabolic process [GO:0006739]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099] centrosome [GO:0005813]; cytosol [GO:0005829] (2R)-hydroxyphenylpyruvate reductase [NAD(P)H] activity [GO:0047995]; diiodophenylpyruvate reductase (NAD+) activity [GO:0047860]; L-malate dehydrogenase (NAD+) activity [GO:0030060] g9347.t1 Q07130 67.959 490 0.0 677.0 sp|Q07130|UGPA_BOVIN UTP--glucose-1-phosphate uridylyltransferase OS=Bos taurus OX=9913 GN=UGP2 PE=1 SV=2 g9347.t2 Q07130 67.959 490 0.0 676.0 sp|Q07130|UGPA_BOVIN UTP--glucose-1-phosphate uridylyltransferase OS=Bos taurus OX=9913 GN=UGP2 PE=1 SV=2 g9349.t1 Q9Z2G6 63.576 604 0.0 801.0 sp|Q9Z2G6|SE1L1_MOUSE Protein sel-1 homolog 1 OS=Mus musculus OX=10090 GN=Sel1l PE=1 SV=2 g9349.t2 Q9UBV2 63.576 604 0.0 795.0 sp|Q9UBV2|SE1L1_HUMAN Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L PE=1 SV=3 SE1L1_HUMAN reviewed Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L) Homo sapiens (Human) GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0030970; GO:0036503; GO:0036513; GO:0050821 ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641] Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839] g9350.t1 F1R332 29.107 347 3.8199999999999997e-34 136.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g9351.t1 Q3V6T2 36.133 1929 0.0 909.0 sp|Q3V6T2|GRDN_HUMAN Girdin OS=Homo sapiens OX=9606 GN=CCDC88A PE=1 SV=2 GRDN_HUMAN reviewed Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) Homo sapiens (Human) GO:0001965; GO:0003779; GO:0005080; GO:0005085; GO:0005092; GO:0005154; GO:0005158; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007264; GO:0007399; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032147; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042169; GO:0042803; GO:0043184; GO:0043422; GO:0043539; GO:0045724; GO:0045742; GO:0051496; GO:0051897; GO:0051959; GO:0061024; GO:0072660; GO:1903566 activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of neuron projection development [GO:0010975]; small GTPase-mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activator activity [GO:0043539]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g9351.t2 Q3V6T2 40.275 1527 0.0 919.0 sp|Q3V6T2|GRDN_HUMAN Girdin OS=Homo sapiens OX=9606 GN=CCDC88A PE=1 SV=2 GRDN_HUMAN reviewed Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) Homo sapiens (Human) GO:0001965; GO:0003779; GO:0005080; GO:0005085; GO:0005092; GO:0005154; GO:0005158; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007264; GO:0007399; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032147; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042169; GO:0042803; GO:0043184; GO:0043422; GO:0043539; GO:0045724; GO:0045742; GO:0051496; GO:0051897; GO:0051959; GO:0061024; GO:0072660; GO:1903566 activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of neuron projection development [GO:0010975]; small GTPase-mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activator activity [GO:0043539]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g9351.t3 Q3V6T2 36.397 1915 0.0 919.0 sp|Q3V6T2|GRDN_HUMAN Girdin OS=Homo sapiens OX=9606 GN=CCDC88A PE=1 SV=2 GRDN_HUMAN reviewed Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) Homo sapiens (Human) GO:0001965; GO:0003779; GO:0005080; GO:0005085; GO:0005092; GO:0005154; GO:0005158; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007264; GO:0007399; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032147; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042169; GO:0042803; GO:0043184; GO:0043422; GO:0043539; GO:0045724; GO:0045742; GO:0051496; GO:0051897; GO:0051959; GO:0061024; GO:0072660; GO:1903566 activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of neuron projection development [GO:0010975]; small GTPase-mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activator activity [GO:0043539]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g9351.t4 Q3V6T2 40.275 1527 0.0 921.0 sp|Q3V6T2|GRDN_HUMAN Girdin OS=Homo sapiens OX=9606 GN=CCDC88A PE=1 SV=2 GRDN_HUMAN reviewed Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) Homo sapiens (Human) GO:0001965; GO:0003779; GO:0005080; GO:0005085; GO:0005092; GO:0005154; GO:0005158; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007264; GO:0007399; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032147; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042169; GO:0042803; GO:0043184; GO:0043422; GO:0043539; GO:0045724; GO:0045742; GO:0051496; GO:0051897; GO:0051959; GO:0061024; GO:0072660; GO:1903566 activation of protein kinase activity [GO:0032147]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of neuron projection development [GO:0010975]; small GTPase-mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activator activity [GO:0043539]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g9352.t1 Q8BH86 41.008 595 3.0600000000000003e-144 435.0 sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1 g9353.t1 Q6ULP2 29.981 527 5.1e-38 156.0 sp|Q6ULP2|AFTIN_HUMAN Aftiphilin OS=Homo sapiens OX=9606 GN=AFTPH PE=1 SV=3 AFTIN_HUMAN reviewed Aftiphilin Homo sapiens (Human) GO:0005654; GO:0005794; GO:0005829; GO:0015031; GO:0030121; GO:0030276; GO:0032588; GO:0048471 protein transport [GO:0015031] AP-1 adaptor complex [GO:0030121]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network membrane [GO:0032588] clathrin binding [GO:0030276] g9353.t2 Q6ULP2 28.932 515 1.16e-35 149.0 sp|Q6ULP2|AFTIN_HUMAN Aftiphilin OS=Homo sapiens OX=9606 GN=AFTPH PE=1 SV=3 AFTIN_HUMAN reviewed Aftiphilin Homo sapiens (Human) GO:0005654; GO:0005794; GO:0005829; GO:0015031; GO:0030121; GO:0030276; GO:0032588; GO:0048471 protein transport [GO:0015031] AP-1 adaptor complex [GO:0030121]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network membrane [GO:0032588] clathrin binding [GO:0030276] g9354.t1 P14000 50.509 491 1.98e-172 503.0 sp|P14000|ARS_HEMPU Arylsulfatase OS=Hemicentrotus pulcherrimus OX=7650 PE=1 SV=1 g9355.t1 Q9P203 49.927 687 0.0 682.0 sp|Q9P203|BTBD7_HUMAN BTB/POZ domain-containing protein 7 OS=Homo sapiens OX=9606 GN=BTBD7 PE=1 SV=3 g9356.t1 Q309Z6 45.684 475 8.529999999999999e-135 427.0 sp|Q309Z6|HIF1A_EOSFB Hypoxia-inducible factor 1-alpha OS=Eospalax fontanierii baileyi OX=146132 GN=HIF1A PE=2 SV=1 HIF1A_EOSFB reviewed Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) Eospalax fontanierii baileyi (Plateau zokor) (Eospalax baileyi) GO:0000302; GO:0000977; GO:0000981; GO:0001223; GO:0001666; GO:0001678; GO:0003700; GO:0005634; GO:0005829; GO:0006110; GO:0010468; GO:0016607; GO:0019896; GO:0035295; GO:0043565; GO:0045893; GO:0045944; GO:0046982; GO:0071456; GO:0072359; GO:1900017; GO:1904115; GO:2000434 axonal transport of mitochondrion [GO:0019896]; cellular response to hypoxia [GO:0071456]; circulatory system development [GO:0072359]; intracellular glucose homeostasis [GO:0001678]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of protein neddylation [GO:2000434]; response to hypoxia [GO:0001666]; response to reactive oxygen species [GO:0000302]; tube development [GO:0035295] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223] g9357.t1 I0IUP3 66.208 799 0.0 1098.0 sp|I0IUP3|MCM8_CHICK DNA helicase MCM8 OS=Gallus gallus OX=9031 GN=MCM8 PE=1 SV=1 MCM8_CHICK reviewed DNA helicase MCM8 (EC 5.6.2.4) (DNA 3'-5' helicase MCM8) (Minichromosome maintenance 8) Gallus gallus (Chicken) GO:0000724; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006974; GO:0016887; GO:0042555; GO:0097362 DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724] MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] g9358.t1 P22274 55.294 170 3.9500000000000004e-59 187.0 sp|P22274|ARF_CANAL ADP-ribosylation factor OS=Candida albicans (strain SC5314 / ATCC MYA-2876) OX=237561 GN=ARF1 PE=1 SV=5 g9359.t1 Q75A26 52.326 172 2.1300000000000002e-47 156.0 sp|Q75A26|ARF_EREGS ADP-ribosylation factor OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=ARF1 PE=3 SV=3 g9360.t1 P91924 55.676 185 8.029999999999999e-67 205.0 sp|P91924|ARF_DUGJA ADP-ribosylation factor OS=Dugesia japonica OX=6161 PE=2 SV=3 g9361.t1 P51643 55.319 188 3.0499999999999997e-69 211.0 sp|P51643|ARF1_XENLA ADP-ribosylation factor 1 OS=Xenopus laevis OX=8355 GN=arf1 PE=2 SV=2 g9362.t1 Q68EK7 86.449 214 3.02e-137 385.0 sp|Q68EK7|RAB4B_DANRE Ras-related protein Rab-4B OS=Danio rerio OX=7955 GN=rab4b PE=2 SV=1 RAB4B_DANRE reviewed Ras-related protein Rab-4B (EC 3.6.5.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0015031; GO:0016192; GO:0030100; GO:0031901; GO:0032482; GO:0032593; GO:0046872; GO:0055037 protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] early endosome membrane [GO:0031901]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g9364.t1 P17248 71.537 397 0.0 618.0 sp|P17248|SYWC_BOVIN Tryptophan--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=WARS1 PE=1 SV=3 g9365.t1 P53041 66.126 493 0.0 703.0 sp|P53041|PPP5_HUMAN Serine/threonine-protein phosphatase 5 OS=Homo sapiens OX=9606 GN=PPP5C PE=1 SV=1 PPP5_HUMAN reviewed Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT) Homo sapiens (Human) GO:0000165; GO:0000278; GO:0001965; GO:0003723; GO:0004721; GO:0004722; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006302; GO:0006351; GO:0008017; GO:0008289; GO:0010288; GO:0016791; GO:0030291; GO:0030544; GO:0031435; GO:0032991; GO:0042802; GO:0043066; GO:0043123; GO:0043204; GO:0043278; GO:0043409; GO:0043531; GO:0044877; GO:0046872; GO:0048156; GO:0051879; GO:0070262; GO:0070301; GO:0071276; GO:0101031; GO:1904550; GO:1990635; GO:2000324 cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; DNA-templated transcription [GO:0006351]; double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of apoptotic process [GO:0043066]; negative regulation of MAPK cascade [GO:0043409]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; response to arachidonate [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635] ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; tau protein binding [GO:0048156] g9366.t1 Q9BSD7 63.102 187 8.090000000000001e-73 221.0 sp|Q9BSD7|NTPCR_HUMAN Cancer-related nucleoside-triphosphatase OS=Homo sapiens OX=9606 GN=NTPCR PE=1 SV=1 NTPCR_HUMAN reviewed Cancer-related nucleoside-triphosphatase (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase) Homo sapiens (Human) GO:0003723; GO:0003924; GO:0005524; GO:0005739; GO:0016020; GO:0016887; GO:0017111; GO:0043273 membrane [GO:0016020]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; GTPase activity [GO:0003924]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; RNA binding [GO:0003723] g9367.t1 Q8N9N7 62.185 238 6.21e-102 298.0 sp|Q8N9N7|LRC57_HUMAN Leucine-rich repeat-containing protein 57 OS=Homo sapiens OX=9606 GN=LRRC57 PE=1 SV=1 g9368.t1 O54750 40.719 501 9.48e-129 387.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 CP2J6_MOUSE reviewed Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6) Mus musculus (Mouse) GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0032760; GO:0032966; GO:0035359; GO:0043651; GO:0045722; GO:0071614; GO:1903055 epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of tumor necrosis factor production [GO:0032760]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g9369.t1 Q9Y3Q0 45.551 753 0.0 671.0 sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1 NALD2_HUMAN reviewed N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II) Homo sapiens (Human) GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129 carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236] g9371.t1 P38584 52.736 402 5.76e-144 417.0 sp|P38584|TTL_BOVIN Tubulin--tyrosine ligase OS=Bos taurus OX=9913 GN=TTL PE=1 SV=1 g9372.t1 P17431 43.59 312 4.55e-59 198.0 sp|P17431|TISB_RAT mRNA decay activator protein ZFP36L1 OS=Rattus norvegicus OX=10116 GN=Zfp36l1 PE=1 SV=1 TISB_RAT reviewed mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-inducible protein CMG1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1) Rattus norvegicus (Rat) GO:0000165; GO:0000288; GO:0000932; GO:0001570; GO:0003342; GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006402; GO:0006417; GO:0006915; GO:0007507; GO:0008270; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0048382; GO:0048568; GO:0051028; GO:0060710; GO:0060712; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904 3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; embryonic organ development [GO:0048568]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; regulation of translation [GO:0006417]; response to wounding [GO:0009611]; spongiotrophoblast layer development [GO:0060712]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] 14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g9374.t1 O15315 50.0 110 1.5500000000000001e-27 108.0 sp|O15315|RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens OX=9606 GN=RAD51B PE=1 SV=2 g9376.t1 P06027 40.268 149 1e-28 106.0 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g9377.t1 O15315 54.365 252 2.15e-97 293.0 sp|O15315|RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens OX=9606 GN=RAD51B PE=1 SV=2 g9378.t1 P86397 51.562 128 1.01e-40 137.0 sp|P86397|HTD2_HUMAN Hydroxyacyl-thioester dehydratase type 2, mitochondrial OS=Homo sapiens OX=9606 GN=HTD2 PE=1 SV=1 HTD2_HUMAN reviewed Hydroxyacyl-thioester dehydratase type 2, mitochondrial (HsHTD2) (EC 4.2.1.59) (3-hydroxyacyl-[acyl-carrier-protein] dehydratase) Homo sapiens (Human) GO:0005730; GO:0005739; GO:0005759; GO:0006633; GO:0018812; GO:0019171; GO:0046949 fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] (3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812] g9379.t1 B1AKI9 38.734 395 4.99e-86 279.0 sp|B1AKI9|ISM1_HUMAN Isthmin-1 OS=Homo sapiens OX=9606 GN=ISM1 PE=1 SV=2 ISM1_HUMAN reviewed Isthmin-1 Homo sapiens (Human) GO:0005576; GO:0016525 negative regulation of angiogenesis [GO:0016525] extracellular region [GO:0005576] g9381.t1 D4A039 40.076 791 0.0 548.0 sp|D4A039|DZAN1_RAT Double zinc ribbon and ankyrin repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Dzank1 PE=2 SV=3 g9381.t2 D4A039 40.202 791 0.0 548.0 sp|D4A039|DZAN1_RAT Double zinc ribbon and ankyrin repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Dzank1 PE=2 SV=3 g9381.t3 Q8C008 39.194 819 0.0 546.0 sp|Q8C008|DZAN1_MOUSE Double zinc ribbon and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Dzank1 PE=1 SV=2 g9383.t1 Q5F4B8 24.406 463 3.12e-22 102.0 sp|Q5F4B8|S46A3_CHICK Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 OS=Gallus gallus OX=9031 GN=SLC46A3 PE=2 SV=1 g9384.t1 Q6DCX5 29.604 429 8.429999999999999e-39 150.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9385.t1 Q7ZWG6 23.49 447 1.0899999999999999e-23 106.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9386.t1 Q6DCX5 29.318 440 3.15e-39 151.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9387.t1 Q8BZ60 37.259 518 3.34e-100 343.0 sp|Q8BZ60|STON2_MOUSE Stonin-2 OS=Mus musculus OX=10090 GN=Ston2 PE=1 SV=1 STON2_MOUSE reviewed Stonin-2 (Stoned B) Mus musculus (Mouse) GO:0002244; GO:0005730; GO:0005829; GO:0007268; GO:0008021; GO:0030100; GO:0030122; GO:0030136; GO:0035615; GO:0043005; GO:0048488; GO:0072583; GO:0098793 chemical synaptic transmission [GO:0007268]; clathrin-dependent endocytosis [GO:0072583]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021] clathrin adaptor activity [GO:0035615] g9388.t1 Q8N806 46.018 452 1.88e-126 377.0 sp|Q8N806|UBR7_HUMAN Putative E3 ubiquitin-protein ligase UBR7 OS=Homo sapiens OX=9606 GN=UBR7 PE=1 SV=2 g9389.t1 B1MTJ4 49.064 481 8.409999999999999e-159 472.0 sp|B1MTJ4|SETD3_PLEMO Actin-histidine N-methyltransferase OS=Plecturocebus moloch OX=9523 GN=SETD3 PE=3 SV=2 SETD3_PLEMO reviewed Actin-histidine N-methyltransferase (EC 2.1.1.85) (Protein-L-histidine N-tele-methyltransferase) (SET domain-containing protein 3) Plecturocebus moloch (Dusky titi monkey) (Callicebus moloch) GO:0003713; GO:0003779; GO:0005634; GO:0005737; GO:0016279; GO:0018021; GO:0018064; GO:0030047; GO:0045893; GO:0070472 actin modification [GO:0030047]; peptidyl-histidine methylation [GO:0018021]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472] cytoplasm [GO:0005737]; nucleus [GO:0005634] actin binding [GO:0003779]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription coactivator activity [GO:0003713] g9390.t1 O75909 69.388 245 3.28e-128 394.0 sp|O75909|CCNK_HUMAN Cyclin-K OS=Homo sapiens OX=9606 GN=CCNK PE=1 SV=2 CCNK_HUMAN reviewed Cyclin-K Homo sapiens (Human) GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006366; GO:0006974; GO:0008024; GO:0008353; GO:0009966; GO:0019901; GO:0032786; GO:0032968; GO:0044828; GO:0045944; GO:0051301; GO:0061575 cell division [GO:0051301]; DNA damage response [GO:0006974]; host-mediated suppression of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; transcription by RNA polymerase II [GO:0006366] cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] g9391.t1 Q8NBP0 43.735 846 0.0 691.0 sp|Q8NBP0|TTC13_HUMAN Tetratricopeptide repeat protein 13 OS=Homo sapiens OX=9606 GN=TTC13 PE=1 SV=3 g9391.t2 Q8NBP0 43.787 845 0.0 692.0 sp|Q8NBP0|TTC13_HUMAN Tetratricopeptide repeat protein 13 OS=Homo sapiens OX=9606 GN=TTC13 PE=1 SV=3 g9392.t1 Q1JQD7 49.637 689 0.0 626.0 sp|Q1JQD7|MOCS1_BOVIN Molybdenum cofactor biosynthesis protein 1 OS=Bos taurus OX=9913 GN=MOCS1 PE=2 SV=2 MOCS1_BOVIN reviewed Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (MOCS1A) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (MOCS1B) (Molybdenum cofactor biosynthesis protein C)] Bos taurus (Bovine) GO:0005525; GO:0006777; GO:0046872; GO:0051539; GO:0061798; GO:0061799 Mo-molybdopterin cofactor biosynthetic process [GO:0006777] 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] g9392.t2 Q5RKZ7 69.733 337 3.41e-176 509.0 sp|Q5RKZ7|MOCS1_MOUSE Molybdenum cofactor biosynthesis protein 1 OS=Mus musculus OX=10090 GN=Mocs1 PE=1 SV=2 MOCS1_MOUSE reviewed Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (MOCS1A) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (MOCS1B) (Molybdenum cofactor biosynthesis protein C)] Mus musculus (Mouse) GO:0005525; GO:0005759; GO:0005829; GO:0006777; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799; GO:1904047 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759] 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] g9393.t1 A7MB54 72.289 83 8.830000000000001e-32 129.0 sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1 HLX_BOVIN reviewed H2.0-like homeobox protein (Homeobox protein HLX1) Bos taurus (Bovine) GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679 embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565] g9394.t1 Q9R0I7 53.034 379 2.79e-102 347.0 sp|Q9R0I7|YLPM1_MOUSE YLP motif-containing protein 1 OS=Mus musculus OX=10090 GN=Ylpm1 PE=2 SV=2 g9394.t2 Q9R0I7 53.034 379 2.93e-102 347.0 sp|Q9R0I7|YLPM1_MOUSE YLP motif-containing protein 1 OS=Mus musculus OX=10090 GN=Ylpm1 PE=2 SV=2 g9394.t3 Q9R0I7 53.034 379 2.72e-102 347.0 sp|Q9R0I7|YLPM1_MOUSE YLP motif-containing protein 1 OS=Mus musculus OX=10090 GN=Ylpm1 PE=2 SV=2 g9395.t1 P13821 33.634 333 4.6800000000000005e-21 102.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g9395.t1 P13821 33.634 333 4.6800000000000005e-21 102.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g9395.t1 P13821 33.634 333 4.6800000000000005e-21 102.0 sp|P13821|SANT_PLAFW S-antigen protein OS=Plasmodium falciparum (isolate Wellcome) OX=5848 PE=3 SV=1 g9396.t1 Q0V989 37.5 376 1.51e-64 213.0 sp|Q0V989|CC85C_XENTR Coiled-coil domain-containing protein 85C OS=Xenopus tropicalis OX=8364 GN=ccdc85c PE=2 SV=1 g9398.t1 Q63ZP1 48.017 479 1.03e-136 419.0 sp|Q63ZP1|PHF10_XENLA PHD finger protein 10 OS=Xenopus laevis OX=8355 GN=phf10 PE=2 SV=2 g9398.t2 Q63ZP1 47.599 479 2.3299999999999998e-135 417.0 sp|Q63ZP1|PHF10_XENLA PHD finger protein 10 OS=Xenopus laevis OX=8355 GN=phf10 PE=2 SV=2 g9401.t1 Q68CQ4 48.222 703 0.0 643.0 sp|Q68CQ4|UTP25_HUMAN U3 small nucleolar RNA-associated protein 25 homolog OS=Homo sapiens OX=9606 GN=UTP25 PE=1 SV=2 UTP25_HUMAN reviewed U3 small nucleolar RNA-associated protein 25 homolog (Digestive organ expansion factor homolog) (UTP25 small subunit processor component) Homo sapiens (Human) GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019; GO:0048568; GO:1902570 embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511] g9402.t1 Q0P6H9 41.567 587 2.74e-150 452.0 sp|Q0P6H9|TMM62_HUMAN Transmembrane protein 62 OS=Homo sapiens OX=9606 GN=TMEM62 PE=1 SV=1 g9403.t1 Q8N128 40.789 152 7.18e-31 114.0 sp|Q8N128|F177A_HUMAN Protein FAM177A1 OS=Homo sapiens OX=9606 GN=FAM177A1 PE=1 SV=1 F177A_HUMAN reviewed Protein FAM177A1 Homo sapiens (Human) GO:0005794 Golgi apparatus [GO:0005794] g9404.t1 B2RYG6 62.302 252 1.41e-113 330.0 sp|B2RYG6|OTUB1_RAT Ubiquitin thioesterase OTUB1 OS=Rattus norvegicus OX=10116 GN=Otub1 PE=1 SV=1 OTUB1_RAT reviewed Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (Ubiquitin-specific-processing protease OTUB1) Rattus norvegicus (Rat) GO:0002250; GO:0004843; GO:0005737; GO:0006281; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0031669; GO:0038202; GO:0043130; GO:0043161; GO:0055105; GO:0071108; GO:0071347; GO:1904262; GO:1904263; GO:2000780 adaptive immune response [GO:0002250]; cellular response to interleukin-1 [GO:0071347]; cellular response to nutrient levels [GO:0031669]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737] cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105] g9405.t1 O15381 54.039 916 0.0 896.0 sp|O15381|NVL_HUMAN Nuclear valosin-containing protein-like OS=Homo sapiens OX=9606 GN=NVL PE=1 SV=1 NVL_HUMAN reviewed Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) Homo sapiens (Human) GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0032206; GO:0042254; GO:0042273; GO:1904749; GO:1905323; GO:1990275 positive regulation of protein binding [GO:0032092]; positive regulation of telomere maintenance [GO:0032206]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723] g9406.t1 Q68FR6 57.895 437 0.0 515.0 sp|Q68FR6|EF1G_RAT Elongation factor 1-gamma OS=Rattus norvegicus OX=10116 GN=Eef1g PE=2 SV=3 EF1G_RAT reviewed Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Rattus norvegicus (Rat) GO:0003746; GO:0005634; GO:0005737; GO:0005783; GO:0006414; GO:0009615 response to virus [GO:0009615]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] translation elongation factor activity [GO:0003746] g9408.t1 Q09666 28.713 2734 3.5999999999999996e-106 386.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 28.425 2628 4.82e-105 382.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 28.909 2705 1.94e-101 370.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 28.89 2198 4.28e-94 346.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 28.064 2701 5.16e-94 346.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 28.024 2687 2.7699999999999998e-92 340.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 26.69 2529 4.39e-66 254.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 26.466 2388 5.28e-66 254.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 26.663 2074 1.91e-63 245.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t1 Q09666 27.64 1089 4.6500000000000004e-32 142.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 28.752 2765 1.98e-106 387.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 28.425 2628 3.14e-105 383.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 28.974 2623 2.72e-101 370.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 28.89 2198 3.19e-94 347.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 28.064 2701 3.71e-94 347.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 28.097 2680 1.9799999999999999e-91 338.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 26.648 2518 1.16e-65 253.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 26.933 1979 1.98e-63 245.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 27.289 2184 9.55e-59 230.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 26.708 1595 1.48e-37 160.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9408.t2 Q09666 27.977 1201 3.22e-25 119.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 29.278 1011 6.56e-35 149.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 27.773 1091 1.97e-32 140.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 29.417 1064 2e-32 140.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 28.628 1013 2.4500000000000002e-32 140.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 28.659 1148 9.950000000000002e-32 138.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 29.217 1085 8.31e-30 132.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 29.215 955 1.9100000000000002e-29 131.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 29.192 990 9.240000000000001e-29 129.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 27.309 1007 2.04e-28 127.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 26.909 1074 3.35e-26 120.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9409.t1 Q09666 27.037 1080 3.4e-24 114.0 sp|Q09666|AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens OX=9606 GN=AHNAK PE=1 SV=2 AHNK_HUMAN reviewed Neuroblast differentiation-associated protein AHNAK (Desmoyokin) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1905686 positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] g9413.t1 Q3U2J5 42.16 287 4.34e-78 243.0 sp|Q3U2J5|CMKMT_MOUSE Calmodulin-lysine N-methyltransferase OS=Mus musculus OX=10090 GN=Camkmt PE=1 SV=1 g9416.t1 Q28EW0 50.798 376 2.26e-128 383.0 sp|Q28EW0|TM87A_XENTR Transmembrane protein 87A OS=Xenopus tropicalis OX=8364 GN=tmem87a PE=2 SV=1 TM87A_XENTR reviewed Transmembrane protein 87A (Elkin1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0005794; GO:0005829; GO:0005886; GO:0032580; GO:0042147; GO:0050976; GO:0071260 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] g9417.t1 Q9P2K3 46.591 528 1.06e-142 423.0 sp|Q9P2K3|RCOR3_HUMAN REST corepressor 3 OS=Homo sapiens OX=9606 GN=RCOR3 PE=1 SV=2 RCOR3_HUMAN reviewed REST corepressor 3 Homo sapiens (Human) GO:0000118; GO:0003714; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] transcription corepressor activity [GO:0003714] g9418.t1 Q5RCS8 72.984 248 4.889999999999999e-128 365.0 sp|Q5RCS8|VATD_PONAB V-type proton ATPase subunit D OS=Pongo abelii OX=9601 GN=ATP6V1D PE=2 SV=1 g9419.t1 Q1LWJ6 52.212 226 2.4500000000000002e-77 235.0 sp|Q1LWJ6|ARPIN_DANRE Arpin OS=Danio rerio OX=7955 GN=arpin PE=2 SV=1 g9420.t1 Q6PB93 65.961 567 0.0 788.0 sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1 GALT2_MOUSE reviewed Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] Mus musculus (Mouse) GO:0002639; GO:0004653; GO:0005576; GO:0005794; GO:0005795; GO:0005796; GO:0006493; GO:0016266; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604 positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9421.t1 Q9NUM3 58.716 327 3.32e-115 338.0 sp|Q9NUM3|S39A9_HUMAN Zinc transporter ZIP9 OS=Homo sapiens OX=9606 GN=SLC39A9 PE=1 SV=2 g9422.t1 Q93104 65.0 100 9.25e-45 143.0 sp|Q93104|ERH_AEDAE Enhancer of rudimentary homolog OS=Aedes aegypti OX=7159 PE=3 SV=1 g9422.t2 Q93104 60.748 107 4.4999999999999995e-42 136.0 sp|Q93104|ERH_AEDAE Enhancer of rudimentary homolog OS=Aedes aegypti OX=7159 PE=3 SV=1 g9423.t1 Q2HJG7 52.174 115 1.16e-38 128.0 sp|Q2HJG7|CHUR_BOVIN Protein Churchill OS=Bos taurus OX=9913 GN=CHURC1 PE=3 SV=3 g9424.t1 Q2T9V5 37.263 475 4.75e-94 297.0 sp|Q2T9V5|TRM6_BOVIN tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Bos taurus OX=9913 GN=TRMT6 PE=2 SV=1 g9427.t1 Q9UI42 28.62 297 2.73e-23 105.0 sp|Q9UI42|CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens OX=9606 GN=CPA4 PE=1 SV=2 CBPA4_HUMAN reviewed Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3) Homo sapiens (Human) GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171 hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g9428.t1 Q5RBF1 52.532 316 6.89e-119 349.0 sp|Q5RBF1|SIR2_PONAB NAD-dependent protein deacetylase sirtuin-2 OS=Pongo abelii OX=9601 GN=SIRT2 PE=1 SV=1 SIR2_PONAB reviewed NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-2) (EC 2.3.1.-) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0006476; GO:0010507; GO:0010801; GO:0016042; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046890; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0062013; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140219; GO:0140228; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378 cell division [GO:0051301]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; lipid catabolic process [GO:0016042]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of small molecule metabolic process [GO:0062013]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of lipid biosynthetic process [GO:0046890]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042] centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819] chromatin binding [GO:0003682]; histone benzoyllysine debenzoylase activity [GO:0140228]; histone deacetylase activity [GO:0004407]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; histone methacryllysine demethacrylase activity [GO:0140219]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903] g9429.t1 Q5RBF1 51.242 322 2.82e-114 338.0 sp|Q5RBF1|SIR2_PONAB NAD-dependent protein deacetylase sirtuin-2 OS=Pongo abelii OX=9601 GN=SIRT2 PE=1 SV=1 SIR2_PONAB reviewed NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-2) (EC 2.3.1.-) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0006476; GO:0010507; GO:0010801; GO:0016042; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046890; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0062013; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140219; GO:0140228; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378 cell division [GO:0051301]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; lipid catabolic process [GO:0016042]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of small molecule metabolic process [GO:0062013]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of lipid biosynthetic process [GO:0046890]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042] centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819] chromatin binding [GO:0003682]; histone benzoyllysine debenzoylase activity [GO:0140228]; histone deacetylase activity [GO:0004407]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; histone methacryllysine demethacrylase activity [GO:0140219]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903] g9430.t1 Q5PQZ3 62.687 469 0.0 610.0 sp|Q5PQZ3|ZNT9_DANRE Proton-coupled zinc antiporter SLC30A9, mitochondrial OS=Danio rerio OX=7955 GN=slc30a9 PE=2 SV=1 ZNT9_DANRE reviewed Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005385; GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0010821; GO:0015297; GO:0031410; GO:0031966 intracellular zinc ion homeostasis [GO:0006882]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634] antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385] g9431.t1 Q90Y54 44.454 1208 0.0 1071.0 sp|Q90Y54|JAG1B_DANRE Protein jagged-1b OS=Danio rerio OX=7955 GN=jag1b PE=2 SV=1 JAG1B_DANRE reviewed Protein jagged-1b (Jagged1b) (Jagged3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009913; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:0061008; GO:1904888 auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; hepaticobiliary system development [GO:0061008]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g9432.t1 Q9QUI1 48.438 128 1.36e-29 110.0 sp|Q9QUI1|LRA25_MOUSE Leucine repeat adapter protein 25 OS=Mus musculus OX=10090 GN=Fam89b PE=1 SV=1 LRA25_MOUSE reviewed Leucine repeat adapter protein 25 (C184L ORF2 protein) (C184M protein) (MMTV receptor) Mus musculus (Mouse) GO:0001222; GO:0005737; GO:0009986; GO:0030010; GO:0030027; GO:0030335; GO:0030512; GO:0060392 establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335] cell surface [GO:0009986]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027] transcription corepressor binding [GO:0001222] g9433.t1 Q5RDB5 75.694 144 4.1199999999999995e-74 220.0 sp|Q5RDB5|CNIH1_PONAB Protein cornichon homolog 1 OS=Pongo abelii OX=9601 GN=CNIH1 PE=2 SV=1 CNIH1_PONAB reviewed Protein cornichon homolog 1 (CNIH-1) (Cornichon family AMPA receptor auxiliary protein 1) (Protein cornichon homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005789; GO:0016192 vesicle-mediated transport [GO:0016192] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] g9434.t1 P79937 62.233 421 5.09e-153 441.0 sp|P79937|MEIS1_XENLA Homeobox protein Meis1 OS=Xenopus laevis OX=8355 GN=meis1 PE=1 SV=1 MEIS1_XENLA reviewed Homeobox protein Meis1 (XMeis1) Xenopus laevis (African clawed frog) GO:0001228; GO:0001525; GO:0001654; GO:0005634; GO:0005667; GO:0005737; GO:0007420; GO:0008284; GO:0009880; GO:0009887; GO:0014036; GO:0030097; GO:0043565; GO:0045893; GO:0045944 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; neural crest cell fate specification [GO:0014036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific DNA binding [GO:0043565] g9434.t2 P97367 53.816 511 2.89e-143 421.0 sp|P97367|MEIS2_MOUSE Homeobox protein Meis2 OS=Mus musculus OX=10090 GN=Meis2 PE=1 SV=2 g9439.t1 Q62599 65.729 569 0.0 741.0 sp|Q62599|MTA1_RAT Metastasis-associated protein MTA1 OS=Rattus norvegicus OX=10116 GN=Mta1 PE=1 SV=1 MTA1_RAT reviewed Metastasis-associated protein MTA1 Rattus norvegicus (Rat) GO:0000122; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005794; GO:0005829; GO:0005874; GO:0006302; GO:0006338; GO:0007565; GO:0008270; GO:0010212; GO:0016581; GO:0019899; GO:0032922; GO:0033363; GO:0042588; GO:0042826; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0061629; GO:1902499 chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; female pregnancy [GO:0007565]; locomotor rhythm [GO:0045475]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; rough endoplasmic reticulum [GO:0005791]; zymogen granule [GO:0042588] chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g9439.t2 Q13330 66.257 569 0.0 741.0 sp|Q13330|MTA1_HUMAN Metastasis-associated protein MTA1 OS=Homo sapiens OX=9606 GN=MTA1 PE=1 SV=2 MTA1_HUMAN reviewed Metastasis-associated protein MTA1 Homo sapiens (Human) GO:0000122; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006302; GO:0006338; GO:0007165; GO:0008270; GO:0010212; GO:0016581; GO:0032922; GO:0042659; GO:0042826; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0045892; GO:0045893; GO:0061629; GO:1902499; GO:2000736 chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g9441.t1 P36404 82.609 184 1.62e-113 323.0 sp|P36404|ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS=Homo sapiens OX=9606 GN=ARL2 PE=1 SV=4 ARL2_HUMAN reviewed ADP-ribosylation factor-like protein 2 Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005813; GO:0005814; GO:0005829; GO:0006110; GO:0006457; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0036064; GO:0051457; GO:0070830; GO:0097225; GO:1903715 bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; protein folding [GO:0006457]; regulation of aerobic respiration [GO:1903715]; regulation of glycolytic process [GO:0006110]; regulation of microtubule polymerization [GO:0031113] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm midpiece [GO:0097225] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g9442.t1 Q96S38 43.842 203 3.32e-38 157.0 sp|Q96S38|KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens OX=9606 GN=RPS6KC1 PE=1 SV=2 KS6C1_HUMAN reviewed Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310 signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9442.t1 Q96S38 48.684 152 1.3500000000000002e-32 139.0 sp|Q96S38|KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens OX=9606 GN=RPS6KC1 PE=1 SV=2 KS6C1_HUMAN reviewed Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310 signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9443.t1 Q96S38 48.634 183 1.5999999999999999e-52 198.0 sp|Q96S38|KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens OX=9606 GN=RPS6KC1 PE=1 SV=2 KS6C1_HUMAN reviewed Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0007165; GO:0016020; GO:0035091; GO:0106310 signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9444.t1 A0JMY4 42.213 488 9.800000000000001e-124 377.0 sp|A0JMY4|BBOF1_XENLA Basal body-orientation factor 1 OS=Xenopus laevis OX=8355 GN=ccdc176 PE=2 SV=1 BBOF1_XENLA reviewed Basal body-orientation factor 1 (Coiled-coil domain-containing protein 176) Xenopus laevis (African clawed frog) GO:0036064; GO:0044458 motile cilium assembly [GO:0044458] ciliary basal body [GO:0036064] g9445.t1 O96952 52.941 102 2.1600000000000003e-31 110.0 sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1 g9446.t1 A0JPI9 40.0 430 8.05e-109 340.0 sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1 g9449.t1 Q9H5Q4 29.739 306 2.1999999999999997e-42 154.0 sp|Q9H5Q4|TFB2M_HUMAN Dimethyladenosine transferase 2, mitochondrial OS=Homo sapiens OX=9606 GN=TFB2M PE=1 SV=1 TFB2M_HUMAN reviewed Dimethyladenosine transferase 2, mitochondrial (EC 2.1.1.-) (Hepatitis C virus NS5A-transactivated protein 5) (HCV NS5A-transactivated protein 5) (Mitochondrial 12S rRNA dimethylase 2) (Mitochondrial transcription factor B2) (h-mtTFB) (h-mtTFB2) (hTFB2M) (mtTFB2) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2) Homo sapiens (Human) GO:0000179; GO:0003723; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0008988; GO:0031167; GO:0034246; GO:0042645 mitochondrial transcription [GO:0006390]; rRNA methylation [GO:0031167]; transcription initiation at mitochondrial promoter [GO:0006391] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988] g9450.t1 D9IQ16 27.607 326 1.77e-25 113.0 sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1 g9451.t1 P18293 46.858 732 0.0 659.0 sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2 ANPRA_MOUSE reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Mus musculus (Mouse) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g9452.t1 Q64LD2 39.583 432 1.9500000000000002e-97 308.0 sp|Q64LD2|WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens OX=9606 GN=WDR25 PE=1 SV=3 WDR25_HUMAN reviewed WD repeat-containing protein 25 Homo sapiens (Human) g9454.t1 Q6DCW7 44.602 352 1.02e-97 299.0 sp|Q6DCW7|G137B_XENLA Integral membrane protein GPR137B OS=Xenopus laevis OX=8355 GN=gpr137b PE=2 SV=1 g9455.t1 Q9H2M9 35.915 1136 0.0 613.0 sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1 RBGPR_HUMAN reviewed Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit) Homo sapiens (Human) GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786 establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536] autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g9456.t1 M9PH32 25.22 341 3.1699999999999997e-25 115.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9457.t1 Q9H2M9 54.286 385 5.33e-134 418.0 sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1 RBGPR_HUMAN reviewed Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit) Homo sapiens (Human) GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786 establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536] autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g9458.t1 Q9CXE6 44.134 358 2.8599999999999998e-89 275.0 sp|Q9CXE6|XRCC3_MOUSE DNA repair protein XRCC3 OS=Mus musculus OX=10090 GN=Xrcc3 PE=2 SV=1 g9459.t1 Q9NU02 45.07 781 0.0 669.0 sp|Q9NU02|ANKE1_HUMAN Ankyrin repeat and EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKEF1 PE=1 SV=2 g9460.t1 O00255 50.746 469 6.45e-155 464.0 sp|O00255|MEN1_HUMAN Menin OS=Homo sapiens OX=9606 GN=MEN1 PE=1 SV=5 MEN1_HUMAN reviewed Menin Homo sapiens (Human) GO:0000122; GO:0000165; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001933; GO:0002076; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006357; GO:0006974; GO:0008285; GO:0009411; GO:0010332; GO:0016363; GO:0017053; GO:0030511; GO:0030674; GO:0032154; GO:0032991; GO:0035097; GO:0043433; GO:0044665; GO:0045064; GO:0045668; GO:0045736; GO:0045786; GO:0045815; GO:0045892; GO:0045944; GO:0046329; GO:0051219; GO:0070412; GO:0071339 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to UV [GO:0009411]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; Y-form DNA binding [GO:0000403] g9461.t1 Q9MA55 31.615 291 1.35e-28 124.0 sp|Q9MA55|ACBP4_ARATH Acyl-CoA-binding domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=ACBP4 PE=1 SV=1 ACBP4_ARATH reviewed Acyl-CoA-binding domain-containing protein 4 (Acyl-CoA binding protein 4) Arabidopsis thaliana (Mouse-ear cress) GO:0000062; GO:0005737; GO:0005829; GO:0006869; GO:0009416; GO:0009723; GO:0009753 lipid transport [GO:0006869]; response to ethylene [GO:0009723]; response to jasmonic acid [GO:0009753]; response to light stimulus [GO:0009416] cytoplasm [GO:0005737]; cytosol [GO:0005829] fatty-acyl-CoA binding [GO:0000062] g9462.t1 Q568W0 58.904 73 2.01e-24 90.1 sp|Q568W0|SELW_DANRE Selenoprotein W OS=Danio rerio OX=7955 GN=selenow PE=3 SV=3 g9463.t1 Q568W0 58.571 70 2.1599999999999998e-23 87.4 sp|Q568W0|SELW_DANRE Selenoprotein W OS=Danio rerio OX=7955 GN=selenow PE=3 SV=3 g9465.t1 Q6YHU6 36.943 1459 0.0 871.0 sp|Q6YHU6|THADA_HUMAN tRNA (32-2'-O)-methyltransferase regulator THADA OS=Homo sapiens OX=9606 GN=THADA PE=1 SV=1 THADA_HUMAN reviewed tRNA (32-2'-O)-methyltransferase regulator THADA (Gene inducing thyroid adenomas protein) (Thyroid adenoma-associated protein) Homo sapiens (Human) GO:0002128; GO:0030234; GO:0030488; GO:0032471; GO:0055088; GO:0098554; GO:1990845 adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554] enzyme regulator activity [GO:0030234] g9466.t1 Q6DIZ0 53.069 277 6.08e-100 297.0 sp|Q6DIZ0|3HAO_XENTR 3-hydroxyanthranilate 3,4-dioxygenase OS=Xenopus tropicalis OX=8364 GN=haao PE=2 SV=1 g9467.t1 Q6ZUK4 36.943 314 7.83e-51 179.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g9468.t1 Q6ZUK4 32.162 370 4.990000000000001e-47 167.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g9469.t1 Q8VHF0 57.491 821 0.0 855.0 sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus OX=10116 GN=Mark3 PE=1 SV=1 MARK3_RAT reviewed MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000226; GO:0001764; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0050321; GO:0106310; GO:1900181 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g9469.t2 Q8VHF0 57.543 822 0.0 857.0 sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus OX=10116 GN=Mark3 PE=1 SV=1 MARK3_RAT reviewed MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000226; GO:0001764; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0050321; GO:0106310; GO:1900181 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g9469.t3 Q8VHF0 57.421 822 0.0 859.0 sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus OX=10116 GN=Mark3 PE=1 SV=1 MARK3_RAT reviewed MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000226; GO:0001764; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0050321; GO:0106310; GO:1900181 intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] g9470.t1 P29617 64.138 145 1.79e-66 221.0 sp|P29617|PROS_DROME Homeobox protein prospero OS=Drosophila melanogaster OX=7227 GN=pros PE=1 SV=3 g9472.t1 P11179 66.667 408 1.02e-172 496.0 sp|P11179|ODO2_BOVIN Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial OS=Bos taurus OX=9913 GN=DLST PE=1 SV=2 g9473.t1 Q6GNT9 64.605 291 9.619999999999999e-137 391.0 sp|Q6GNT9|MEMO1_XENLA Protein MEMO1 OS=Xenopus laevis OX=8355 GN=memo1 PE=2 SV=1 g9474.t1 Q5F3K0 43.596 773 0.0 649.0 sp|Q5F3K0|TTC27_CHICK Tetratricopeptide repeat protein 27 OS=Gallus gallus OX=9031 GN=TTC27 PE=2 SV=1 g9475.t1 Q0V9S9 54.34 795 0.0 835.0 sp|Q0V9S9|DRC7_XENTR Dynein regulatory complex subunit 7 OS=Xenopus tropicalis OX=8364 GN=drc7 PE=2 SV=1 g9477.t1 O95861 53.746 307 1.1999999999999999e-119 349.0 sp|O95861|BPNT1_HUMAN 3'(2'),5'-bisphosphate nucleotidase 1 OS=Homo sapiens OX=9606 GN=BPNT1 PE=1 SV=1 BPNT1_HUMAN reviewed 3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (3'-phosphoadenosine 5'-phosphate phosphatase) (PAP phosphatase) (Bisphosphate 3'-nucleotidase 1) (BPntase 1) (HsPIP) (Inositol-polyphosphate 1-phosphatase) (EC 3.1.3.57) Homo sapiens (Human) GO:0004441; GO:0005739; GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046872; GO:0050427 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829]; mitochondrion [GO:0005739] 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872] g9479.t1 Q8K2P6 47.742 155 1.2e-49 159.0 sp|Q8K2P6|RFESD_MOUSE Rieske domain-containing protein OS=Mus musculus OX=10090 GN=Rfesd PE=1 SV=1 g9480.t1 Q6DEL2 59.813 642 0.0 753.0 sp|Q6DEL2|CLPT1_DANRE Putative lipid scramblase CLPTM1 OS=Danio rerio OX=7955 GN=clptm1 PE=2 SV=1 g9481.t1 P60881 65.366 205 7.269999999999999e-89 263.0 sp|P60881|SNP25_RAT Synaptosomal-associated protein 25 OS=Rattus norvegicus OX=10116 GN=Snap25 PE=1 SV=1 SNP25_RAT reviewed Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein) Rattus norvegicus (Rat) GO:0000149; GO:0001917; GO:0005249; GO:0005484; GO:0005737; GO:0005768; GO:0005802; GO:0005856; GO:0005886; GO:0005938; GO:0006887; GO:0007269; GO:0007409; GO:0007616; GO:0007626; GO:0008021; GO:0008076; GO:0008289; GO:0008306; GO:0010975; GO:0015629; GO:0016020; GO:0016079; GO:0016082; GO:0016197; GO:0017022; GO:0017075; GO:0019904; GO:0030027; GO:0030073; GO:0030175; GO:0030182; GO:0030424; GO:0030426; GO:0031083; GO:0031201; GO:0031340; GO:0031629; GO:0031915; GO:0031982; GO:0032024; GO:0035493; GO:0036477; GO:0042734; GO:0043005; GO:0043025; GO:0043195; GO:0044295; GO:0044325; GO:0045202; GO:0046887; GO:0048306; GO:0048471; GO:0048791; GO:0051649; GO:0051963; GO:0060291; GO:0070032; GO:0070033; GO:0070044; GO:0070201; GO:0097470; GO:0098693; GO:0098888; GO:0098978; GO:0099525; GO:1903296; GO:1990926 associative learning [GO:0008306]; axonogenesis [GO:0007409]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of establishment of protein localization [GO:0070201]; regulation of neuron projection development [GO:0010975]; regulation of synapse assembly [GO:0051963]; regulation of synaptic vesicle cycle [GO:0098693]; short-term synaptic potentiation [GO:1990926]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; BLOC-1 complex [GO:0031083]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endosome [GO:0005768]; extrinsic component of presynaptic membrane [GO:0098888]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] calcium-dependent protein binding [GO:0048306]; lipid binding [GO:0008289]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] g9481.t2 P60881 63.902 205 8.3e-88 260.0 sp|P60881|SNP25_RAT Synaptosomal-associated protein 25 OS=Rattus norvegicus OX=10116 GN=Snap25 PE=1 SV=1 SNP25_RAT reviewed Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein) Rattus norvegicus (Rat) GO:0000149; GO:0001917; GO:0005249; GO:0005484; GO:0005737; GO:0005768; GO:0005802; GO:0005856; GO:0005886; GO:0005938; GO:0006887; GO:0007269; GO:0007409; GO:0007616; GO:0007626; GO:0008021; GO:0008076; GO:0008289; GO:0008306; GO:0010975; GO:0015629; GO:0016020; GO:0016079; GO:0016082; GO:0016197; GO:0017022; GO:0017075; GO:0019904; GO:0030027; GO:0030073; GO:0030175; GO:0030182; GO:0030424; GO:0030426; GO:0031083; GO:0031201; GO:0031340; GO:0031629; GO:0031915; GO:0031982; GO:0032024; GO:0035493; GO:0036477; GO:0042734; GO:0043005; GO:0043025; GO:0043195; GO:0044295; GO:0044325; GO:0045202; GO:0046887; GO:0048306; GO:0048471; GO:0048791; GO:0051649; GO:0051963; GO:0060291; GO:0070032; GO:0070033; GO:0070044; GO:0070201; GO:0097470; GO:0098693; GO:0098888; GO:0098978; GO:0099525; GO:1903296; GO:1990926 associative learning [GO:0008306]; axonogenesis [GO:0007409]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of establishment of protein localization [GO:0070201]; regulation of neuron projection development [GO:0010975]; regulation of synapse assembly [GO:0051963]; regulation of synaptic vesicle cycle [GO:0098693]; short-term synaptic potentiation [GO:1990926]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; BLOC-1 complex [GO:0031083]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endosome [GO:0005768]; extrinsic component of presynaptic membrane [GO:0098888]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] calcium-dependent protein binding [GO:0048306]; lipid binding [GO:0008289]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] g9481.t3 P60881 64.151 159 3.38e-65 201.0 sp|P60881|SNP25_RAT Synaptosomal-associated protein 25 OS=Rattus norvegicus OX=10116 GN=Snap25 PE=1 SV=1 SNP25_RAT reviewed Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein) Rattus norvegicus (Rat) GO:0000149; GO:0001917; GO:0005249; GO:0005484; GO:0005737; GO:0005768; GO:0005802; GO:0005856; GO:0005886; GO:0005938; GO:0006887; GO:0007269; GO:0007409; GO:0007616; GO:0007626; GO:0008021; GO:0008076; GO:0008289; GO:0008306; GO:0010975; GO:0015629; GO:0016020; GO:0016079; GO:0016082; GO:0016197; GO:0017022; GO:0017075; GO:0019904; GO:0030027; GO:0030073; GO:0030175; GO:0030182; GO:0030424; GO:0030426; GO:0031083; GO:0031201; GO:0031340; GO:0031629; GO:0031915; GO:0031982; GO:0032024; GO:0035493; GO:0036477; GO:0042734; GO:0043005; GO:0043025; GO:0043195; GO:0044295; GO:0044325; GO:0045202; GO:0046887; GO:0048306; GO:0048471; GO:0048791; GO:0051649; GO:0051963; GO:0060291; GO:0070032; GO:0070033; GO:0070044; GO:0070201; GO:0097470; GO:0098693; GO:0098888; GO:0098978; GO:0099525; GO:1903296; GO:1990926 associative learning [GO:0008306]; axonogenesis [GO:0007409]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of vesicle fusion [GO:0031340]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of establishment of protein localization [GO:0070201]; regulation of neuron projection development [GO:0010975]; regulation of synapse assembly [GO:0051963]; regulation of synaptic vesicle cycle [GO:0098693]; short-term synaptic potentiation [GO:1990926]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; BLOC-1 complex [GO:0031083]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endosome [GO:0005768]; extrinsic component of presynaptic membrane [GO:0098888]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] calcium-dependent protein binding [GO:0048306]; lipid binding [GO:0008289]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] g9482.t1 Q9Y6A2 36.364 484 1.83e-98 309.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g9483.t1 A5D6U8 57.177 418 1.82e-172 493.0 sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1 ACP7_DANRE reviewed Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003993; GO:0005576; GO:0046872 extracellular region [GO:0005576] acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] g9484.t1 A5D6U8 58.554 415 4.69e-174 497.0 sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1 ACP7_DANRE reviewed Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003993; GO:0005576; GO:0046872 extracellular region [GO:0005576] acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] g9485.t1 A5D6U8 58.313 415 4.84e-175 499.0 sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1 ACP7_DANRE reviewed Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003993; GO:0005576; GO:0046872 extracellular region [GO:0005576] acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] g9488.t1 Q80VA0 51.052 523 0.0 550.0 sp|Q80VA0|GALT7_MOUSE N-acetylgalactosaminyltransferase 7 OS=Mus musculus OX=10090 GN=Galnt7 PE=1 SV=2 GALT7_MOUSE reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9488.t2 Q80VA0 51.052 523 0.0 551.0 sp|Q80VA0|GALT7_MOUSE N-acetylgalactosaminyltransferase 7 OS=Mus musculus OX=10090 GN=Galnt7 PE=1 SV=2 GALT7_MOUSE reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9488.t3 Q80VA0 48.05 564 0.0 537.0 sp|Q80VA0|GALT7_MOUSE N-acetylgalactosaminyltransferase 7 OS=Mus musculus OX=10090 GN=Galnt7 PE=1 SV=2 GALT7_MOUSE reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9490.t1 Q2YDC9 48.627 255 2.21e-70 224.0 sp|Q2YDC9|PDCD2_BOVIN Programmed cell death protein 2 OS=Bos taurus OX=9913 GN=PDCD2 PE=2 SV=1 g9491.t1 Q5EAR5 50.246 203 5.1899999999999994e-68 211.0 sp|Q5EAR5|TRPT1_DANRE tRNA 2'-phosphotransferase 1 OS=Danio rerio OX=7955 GN=trpt1 PE=2 SV=2 g9492.t1 Q8R0G9 39.492 1180 0.0 761.0 sp|Q8R0G9|NU133_MOUSE Nuclear pore complex protein Nup133 OS=Mus musculus OX=10090 GN=Nup133 PE=1 SV=2 NU133_MOUSE reviewed Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) Mus musculus (Mouse) GO:0000776; GO:0000972; GO:0005635; GO:0005643; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0016973; GO:0017056; GO:0021915; GO:0022008; GO:0031080; GO:0031965; GO:0048339; GO:0061053; GO:0072006 mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] structural constituent of nuclear pore [GO:0017056] g9494.t1 Q93015 46.809 141 2.16e-42 149.0 sp|Q93015|NAA80_HUMAN N-alpha-acetyltransferase 80 OS=Homo sapiens OX=9606 GN=NAA80 PE=1 SV=2 NAA80_HUMAN reviewed N-alpha-acetyltransferase 80 (HsNAAA80) (EC 2.3.1.-) (N-acetyltransferase 6) (Protein fusion-2) (Protein fus-2) Homo sapiens (Human) GO:0004596; GO:0005737; GO:0005829; GO:0006473; GO:0008064; GO:0008080; GO:0017190; GO:0018002; GO:0030047; GO:1905502 actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064] cytoplasm [GO:0005737]; cytosol [GO:0005829] acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g9495.t1 Q58EM4 50.115 435 3.4899999999999997e-146 427.0 sp|Q58EM4|ARMT1_DANRE Damage-control phosphatase ARMT1 OS=Danio rerio OX=7955 GN=armt1 PE=2 SV=1 ARMT1_DANRE reviewed Damage-control phosphatase 1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0006974; GO:0008757; GO:0016791; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026 DNA damage response [GO:0006974]; methylation [GO:0032259] fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g9496.t1 Q9CQG1 63.842 177 2.4399999999999997e-82 244.0 sp|Q9CQG1|CHAC2_MOUSE Putative glutathione-specific gamma-glutamylcyclotransferase 2 OS=Mus musculus OX=10090 GN=Chac2 PE=1 SV=1 g9498.t1 Q9JJ93 39.13 115 2.3500000000000002e-26 98.6 sp|Q9JJ93|CN119_MOUSE Uncharacterized protein C14orf119 homolog OS=Mus musculus OX=10090 GN=MNCb-2990 PE=2 SV=1 g9502.t1 Q80VA0 46.255 534 7.41e-157 469.0 sp|Q80VA0|GALT7_MOUSE N-acetylgalactosaminyltransferase 7 OS=Mus musculus OX=10090 GN=Galnt7 PE=1 SV=2 GALT7_MOUSE reviewed N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7) Mus musculus (Mouse) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9503.t1 Q9CR40 54.301 558 0.0 632.0 sp|Q9CR40|KLH28_MOUSE Kelch-like protein 28 OS=Mus musculus OX=10090 GN=Klhl28 PE=2 SV=1 g9505.t1 Q6P0F9 41.064 470 7.8e-88 276.0 sp|Q6P0F9|INS1A_DANRE Insulinoma-associated protein 1a OS=Danio rerio OX=7955 GN=insm1a PE=2 SV=1 INS1A_DANRE reviewed Insulinoma-associated protein 1a (Insulinoma-associated 1-like protein a) (Zinc finger protein IA-1a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0008270; GO:0010564; GO:0017053; GO:0021522; GO:0030182; GO:0031490; GO:0035677; GO:0042670; GO:0043565; GO:0043697; GO:0045892; GO:0048920; GO:0060221; GO:0060290; GO:0070654 cell dedifferentiation [GO:0043697]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; posterior lateral line neuromast hair cell development [GO:0035677]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of cell cycle process [GO:0010564]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; sensory epithelium regeneration [GO:0070654]; spinal cord motor neuron differentiation [GO:0021522]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309] nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g9507.t1 Q6GYQ0 41.274 2120 0.0 1505.0 sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1 RGPA1_HUMAN reviewed Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240) Homo sapiens (Human) GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630 activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; nucleus [GO:0005634] GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982] g9511.t1 Q9NBX4 28.94 349 4.16e-28 118.0 sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1 g9513.t1 P53985 33.898 177 1.43e-21 96.7 sp|P53985|MOT1_HUMAN Monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC16A1 PE=1 SV=3 MOT1_HUMAN reviewed Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1) Homo sapiens (Human) GO:0005813; GO:0005886; GO:0006629; GO:0007098; GO:0008028; GO:0009925; GO:0015129; GO:0015130; GO:0015141; GO:0015650; GO:0015718; GO:0015728; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030054; GO:0032094; GO:0035879; GO:0042593; GO:0042802; GO:0042867; GO:0045202; GO:0046943; GO:0050796; GO:0051780; GO:0070062; GO:0071422; GO:0150104; GO:1901475; GO:1905039 behavioral response to nutrient [GO:0051780]; carboxylic acid transmembrane transport [GO:1905039]; centrosome cycle [GO:0007098]; glucose homeostasis [GO:0042593]; lipid metabolic process [GO:0006629]; mevalonate transport [GO:0015728]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475]; regulation of insulin secretion [GO:0050796]; response to food [GO:0032094]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] carboxylic acid transmembrane transporter activity [GO:0046943]; identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; lactate:proton symporter activity [GO:0015650]; mevalonate transmembrane transporter activity [GO:0015130]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; succinate transmembrane transporter activity [GO:0015141] g9514.t1 L7YAI7 34.343 198 5.5e-30 119.0 sp|L7YAI7|B4GA1_DANRE Beta-1,4-glucuronyltransferase 1 OS=Danio rerio OX=7955 GN=b4gat1 PE=1 SV=1 B4GA1_DANRE reviewed Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005794; GO:0015020; GO:0035269; GO:0046872; GO:0055001 muscle cell development [GO:0055001]; protein O-linked glycosylation via mannose [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872] g9515.t1 L7YAI7 39.098 399 1.46e-88 286.0 sp|L7YAI7|B4GA1_DANRE Beta-1,4-glucuronyltransferase 1 OS=Danio rerio OX=7955 GN=b4gat1 PE=1 SV=1 B4GA1_DANRE reviewed Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005794; GO:0015020; GO:0035269; GO:0046872; GO:0055001 muscle cell development [GO:0055001]; protein O-linked glycosylation via mannose [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872] g9516.t1 Q5RAX0 62.014 437 0.0 541.0 sp|Q5RAX0|PAF1_PONAB RNA polymerase II-associated factor 1 homolog OS=Pongo abelii OX=9601 GN=PAF1 PE=2 SV=1 g9517.t1 Q8JHI6 47.887 142 1.52e-42 143.0 sp|Q8JHI6|MED29_DANRE Mediator of RNA polymerase II transcription subunit 29 OS=Danio rerio OX=7955 GN=med29 PE=2 SV=1 g9518.t1 P98133 30.67 1852 1.49e-177 604.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t1 P98133 30.713 1641 7.71e-158 545.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t1 P98133 29.662 1507 1.96e-127 451.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t1 P98133 28.207 1684 1.27e-126 448.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t1 P98133 29.443 1491 3.95e-120 428.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t1 P98133 27.395 1566 2.3e-116 416.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t1 P98133 30.106 1415 5.0900000000000003e-107 386.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t1 P98133 29.313 1252 2.66e-106 384.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 30.562 1852 5.09e-176 599.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 30.506 1639 8.41e-155 535.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 28.426 1671 9.399999999999999e-128 452.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 29.58 1501 8.21e-127 449.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 27.21 1606 1.13e-121 432.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 27.49 1506 5.08e-116 415.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 30.385 1402 2.92e-107 387.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9518.t2 P98133 29.313 1252 5.31e-106 383.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g9519.t1 Q5ZLK8 39.61 154 2.44e-33 119.0 sp|Q5ZLK8|CF120_CHICK UPF0669 protein C6orf120 homolog OS=Gallus gallus OX=9031 GN=RCJMB04_5l6 PE=2 SV=1 g9520.t1 P16157 29.448 652 2.61e-60 231.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9520.t1 P16157 27.16 567 1.21e-34 148.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9520.t1 P16157 28.502 414 6.380000000000001e-27 123.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9520.t1 P16157 28.402 338 6.21e-24 113.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9520.t2 P16157 29.448 652 2.1699999999999999e-60 231.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9520.t2 P16157 27.16 567 1.11e-34 148.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9520.t2 P16157 28.502 414 5.7000000000000004e-27 123.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9520.t2 P16157 28.402 338 6.2899999999999995e-24 113.0 sp|P16157|ANK1_HUMAN Ankyrin-1 OS=Homo sapiens OX=9606 GN=ANK1 PE=1 SV=3 ANK1_HUMAN reviewed Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) Homo sapiens (Human) GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014 cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] ankyrin-1 complex [GO:0170014]; axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018] ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] g9521.t1 P23506 67.111 225 8.92e-106 309.0 sp|P23506|PIMT_MOUSE Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Mus musculus OX=10090 GN=Pcmt1 PE=1 SV=3 PIMT_MOUSE reviewed Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase) Mus musculus (Mouse) GO:0004719; GO:0005615; GO:0005737; GO:0005829; GO:0008757; GO:0010667; GO:0016323; GO:0031526; GO:0032259; GO:0043204; GO:0046498; GO:0046500 methylation [GO:0032259]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500] basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; perikaryon [GO:0043204] protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g9521.t2 P23506 67.111 225 7.69e-106 310.0 sp|P23506|PIMT_MOUSE Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Mus musculus OX=10090 GN=Pcmt1 PE=1 SV=3 PIMT_MOUSE reviewed Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase) Mus musculus (Mouse) GO:0004719; GO:0005615; GO:0005737; GO:0005829; GO:0008757; GO:0010667; GO:0016323; GO:0031526; GO:0032259; GO:0043204; GO:0046498; GO:0046500 methylation [GO:0032259]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500] basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; perikaryon [GO:0043204] protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g9522.t1 Q4VAC9 42.89 429 3.39e-97 348.0 sp|Q4VAC9|PKHG3_MOUSE Pleckstrin homology domain-containing family G member 3 OS=Mus musculus OX=10090 GN=Plekhg3 PE=1 SV=2 PKHG3_MOUSE reviewed Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3) Mus musculus (Mouse) GO:0003779; GO:0005085; GO:0005829; GO:0005856; GO:0030334; GO:0031267; GO:2000114 regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114] cytoskeleton [GO:0005856]; cytosol [GO:0005829] actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g9522.t2 Q4VAC9 43.333 420 5.73e-97 347.0 sp|Q4VAC9|PKHG3_MOUSE Pleckstrin homology domain-containing family G member 3 OS=Mus musculus OX=10090 GN=Plekhg3 PE=1 SV=2 PKHG3_MOUSE reviewed Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3) Mus musculus (Mouse) GO:0003779; GO:0005085; GO:0005829; GO:0005856; GO:0030334; GO:0031267; GO:2000114 regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114] cytoskeleton [GO:0005856]; cytosol [GO:0005829] actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g9523.t1 Q5RDU7 85.345 116 7.37e-72 213.0 sp|Q5RDU7|YPEL5_PONAB Protein yippee-like 5 OS=Pongo abelii OX=9601 GN=YPEL5 PE=2 SV=1 g9524.t1 Q4R4T6 40.996 522 6e-120 367.0 sp|Q4R4T6|DDX28_MACFA Probable ATP-dependent RNA helicase DDX28 OS=Macaca fascicularis OX=9541 GN=DDX28 PE=2 SV=1 g9525.t1 Q9RLV9 30.094 319 4.32e-25 108.0 sp|Q9RLV9|PHLC_LISIV Sphingomyelinase C OS=Listeria ivanovii OX=1638 GN=smcL PE=1 SV=1 g9529.t1 Q6P0D1 50.0 426 2.62e-146 433.0 sp|Q6P0D1|ZNT6_DANRE Zinc transporter 6 OS=Danio rerio OX=7955 GN=slc30a6 PE=2 SV=1 g9530.t1 Q5ZIF1 40.786 407 4.58e-105 319.0 sp|Q5ZIF1|APMAP_CHICK Adipocyte plasma membrane-associated protein OS=Gallus gallus OX=9031 GN=APMAP PE=2 SV=1 g9531.t1 Q26613 66.566 664 0.0 945.0 sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1 g9531.t2 Q26613 66.279 688 0.0 966.0 sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1 g9532.t1 Q60803 38.693 597 3.6899999999999997e-137 416.0 sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2 g9537.t1 O35218 63.752 789 0.0 1018.0 sp|O35218|CPSF2_MOUSE Cleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1 CPSF2_MOUSE reviewed Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit) Mus musculus (Mouse) GO:0003723; GO:0005847; GO:0006398; GO:0098794; GO:0098978 mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398] glutamatergic synapse [GO:0098978]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; postsynapse [GO:0098794] RNA binding [GO:0003723] g9540.t1 G5EFS2 34.649 228 1.01e-33 129.0 sp|G5EFS2|MSI1H_CAEEL RNA-binding protein Musashi homolog 1 OS=Caenorhabditis elegans OX=6239 GN=msi-1 PE=1 SV=1 MSI1H_CAEEL reviewed RNA-binding protein Musashi homolog 1 (Musashi-1) Caenorhabditis elegans GO:0003729; GO:0005737; GO:0006417; GO:0043204; GO:0050877 nervous system process [GO:0050877]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; perikaryon [GO:0043204] mRNA binding [GO:0003729] g9541.t1 P91809 89.655 203 3.23e-130 373.0 sp|P91809|TBP_STRPU TATA-box-binding protein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9542.t1 Q8NHU2 48.074 1298 0.0 1238.0 sp|Q8NHU2|CFA61_HUMAN Cilia- and flagella-associated protein 61 OS=Homo sapiens OX=9606 GN=CFAP61 PE=1 SV=3 g9543.t1 P63155 73.875 689 0.0 1081.0 sp|P63155|CRNL1_RAT Crooked neck-like protein 1 OS=Rattus norvegicus OX=10116 GN=Crnkl1 PE=2 SV=1 CRNL1_RAT reviewed Crooked neck-like protein 1 (Crooked neck homolog) (Crooked neck protein) Rattus norvegicus (Rat) GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005681; GO:0016607; GO:0021987; GO:0071007; GO:0071013; GO:0071014; GO:1990416; GO:1990830 cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebral cortex development [GO:0021987]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] RNA binding [GO:0003723] g9544.t1 Q969Y0 25.111 450 1.83e-28 122.0 sp|Q969Y0|NXPE3_HUMAN NXPE family member 3 OS=Homo sapiens OX=9606 GN=NXPE3 PE=1 SV=1 g9545.t1 Q9UJ37 33.11 299 2.66e-44 160.0 sp|Q9UJ37|SIA7B_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Homo sapiens OX=9606 GN=ST6GALNAC2 PE=1 SV=1 SIA7B_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0006493; GO:0008373; GO:0009101; GO:0016266; GO:0019082; GO:1990743 glycoprotein biosynthetic process [GO:0009101]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; protein sialylation [GO:1990743]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g9546.t1 B3EWZ5 32.11 436 1.66e-61 233.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 30.47 489 7.08e-53 206.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 30.645 434 1.17e-49 196.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 30.698 430 1.9000000000000002e-43 176.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 29.054 444 1.21e-38 160.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 31.043 393 3.92e-37 156.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 29.867 452 9.95e-35 148.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 30.789 393 6.61e-33 142.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 29.487 390 1.3700000000000001e-32 141.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 29.73 407 2.78e-32 140.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 30.894 369 1.63e-31 137.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 30.189 371 1.95e-31 137.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 30.055 366 1.45e-28 128.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 33.333 237 4.34e-28 127.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t1 B3EWZ5 28.571 413 6.41e-28 126.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9546.t2 F1QVU0 31.985 1063 1.49e-106 373.0 sp|F1QVU0|LTK_DANRE Tyrosine-protein kinase receptor OS=Danio rerio OX=7955 GN=ltk PE=1 SV=1 LTK_DANRE reviewed Tyrosine-protein kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase 1) (alk-1) (Protein moonstone) (mne) (Protein shady) (shd) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0030318; GO:0042127; GO:0043235; GO:0043473; GO:0045664; GO:0048066; GO:0048070; GO:0050935; GO:0070285; GO:0097324; GO:0098727 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; developmental pigmentation [GO:0048066]; iridophore differentiation [GO:0050935]; maintenance of cell number [GO:0098727]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; pigment cell development [GO:0070285]; pigmentation [GO:0043473]; regulation of cell population proliferation [GO:0042127]; regulation of developmental pigmentation [GO:0048070]; regulation of neuron differentiation [GO:0045664] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g9547.t1 O43741 52.65 283 2.41e-89 269.0 sp|O43741|AAKB2_HUMAN 5'-AMP-activated protein kinase subunit beta-2 OS=Homo sapiens OX=9606 GN=PRKAB2 PE=1 SV=1 AAKB2_HUMAN reviewed 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0007165; GO:0019901; GO:0031588; GO:0031669; GO:0120162 cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] protein kinase binding [GO:0019901] g9551.t1 P27653 72.67 633 0.0 926.0 sp|P27653|C1TC_RAT C-1-tetrahydrofolate synthase, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Mthfd1 PE=1 SV=3 C1TC_RAT reviewed C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Rattus norvegicus (Rat) GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009086; GO:0009152; GO:0009257; GO:0019346; GO:0035713; GO:0035999; GO:0046655; GO:0061053 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; response to nitrogen dioxide [GO:0035713]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346] cytosol [GO:0005829] ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488] g9552.t1 P11586 59.044 293 1.28e-115 357.0 sp|P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=MTHFD1 PE=1 SV=4 C1TC_HUMAN reviewed C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Homo sapiens (Human) GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0007507; GO:0009086; GO:0009152; GO:0009257; GO:0016020; GO:0019346; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488] g9554.t1 Q6PBM1 73.554 121 3.85e-66 201.0 sp|Q6PBM1|GLRX5_DANRE Glutaredoxin-related protein 5, mitochondrial OS=Danio rerio OX=7955 GN=glrx5 PE=2 SV=1 GLRX5_DANRE reviewed Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0030097; GO:0046872; GO:0051537 hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872] g9555.t1 O76536 27.202 511 3.38e-23 110.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9558.t1 Q32PI6 60.262 229 5.660000000000001e-97 291.0 sp|Q32PI6|RM04_BOVIN Large ribosomal subunit protein uL4m OS=Bos taurus OX=9913 GN=MRPL4 PE=1 SV=1 g9559.t1 Q7ZWG6 28.436 422 1.1300000000000001e-29 123.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9560.t1 Q9JLL0 37.104 442 3.3e-73 251.0 sp|Q9JLL0|CRIM1_MOUSE Cysteine-rich motor neuron 1 protein OS=Mus musculus OX=10090 GN=Crim1 PE=2 SV=2 g9560.t2 Q9JLL0 37.02 443 4.2699999999999994e-74 253.0 sp|Q9JLL0|CRIM1_MOUSE Cysteine-rich motor neuron 1 protein OS=Mus musculus OX=10090 GN=Crim1 PE=2 SV=2 g9561.t1 Q8AWW5 46.296 162 4.38e-44 159.0 sp|Q8AWW5|CRIM1_CHICK Cysteine-rich motor neuron 1 protein OS=Gallus gallus OX=9031 GN=CRIM1 PE=2 SV=1 g9562.t1 Q8AWW5 36.759 253 3.9e-38 147.0 sp|Q8AWW5|CRIM1_CHICK Cysteine-rich motor neuron 1 protein OS=Gallus gallus OX=9031 GN=CRIM1 PE=2 SV=1 g9562.t1 Q8AWW5 34.286 175 5.550000000000001e-21 97.1 sp|Q8AWW5|CRIM1_CHICK Cysteine-rich motor neuron 1 protein OS=Gallus gallus OX=9031 GN=CRIM1 PE=2 SV=1 g9563.t1 Q56A35 89.34 394 0.0 745.0 sp|Q56A35|ARP2B_DANRE Actin-related protein 2-B OS=Danio rerio OX=7955 GN=actr2b PE=2 SV=1 ARP2B_DANRE reviewed Actin-related protein 2-B (Actin-like protein 2-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0005938; GO:0034314; GO:0035861; GO:0042995; GO:0045944; GO:0060319; GO:1905168 Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive erythrocyte differentiation [GO:0060319] Arp2/3 protein complex [GO:0005885]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] actin binding [GO:0003779]; ATP binding [GO:0005524] g9564.t1 Q1JQA5 53.103 145 9.529999999999999e-45 147.0 sp|Q1JQA5|NENF_BOVIN Neudesin OS=Bos taurus OX=9913 GN=NENF PE=2 SV=1 NENF_BOVIN reviewed Neudesin (Neuron-derived neurotrophic factor) (SCIRP10-related protein) (Spinal cord injury-related protein 10) Bos taurus (Bovine) GO:0000165; GO:0005615; GO:0005739; GO:0005783; GO:0008083; GO:0012505; GO:0016020; GO:0032099; GO:0043410; GO:0046872 MAPK cascade [GO:0000165]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739] growth factor activity [GO:0008083]; metal ion binding [GO:0046872] g9567.t1 Q4KLN8 39.759 249 3.17e-36 145.0 sp|Q4KLN8|RNF8_RAT E3 ubiquitin-protein ligase RNF8 OS=Rattus norvegicus OX=10116 GN=Rnf8 PE=2 SV=1 RNF8_RAT reviewed E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8) Rattus norvegicus (Rat) GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0031625; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042770; GO:0042802; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168; GO:1990166 cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9567.t1 Q4KLN8 36.994 173 3.97e-28 122.0 sp|Q4KLN8|RNF8_RAT E3 ubiquitin-protein ligase RNF8 OS=Rattus norvegicus OX=10116 GN=Rnf8 PE=2 SV=1 RNF8_RAT reviewed E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8) Rattus norvegicus (Rat) GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0031625; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042770; GO:0042802; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168; GO:1990166 cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9568.t1 P98068 42.281 570 2.3e-149 447.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g9570.t1 Q8BMN3 34.555 191 3.19e-35 132.0 sp|Q8BMN3|ACHB3_MOUSE Neuronal acetylcholine receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Chrnb3 PE=2 SV=1 ACHB3_MOUSE reviewed Neuronal acetylcholine receptor subunit beta-3 Mus musculus (Mouse) GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0042166; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0099171; GO:1901363 acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; transmembrane signaling receptor activity [GO:0004888] g9571.t1 P36544 35.0 320 2.29e-66 222.0 sp|P36544|ACHA7_HUMAN Neuronal acetylcholine receptor subunit alpha-7 OS=Homo sapiens OX=9606 GN=CHRNA7 PE=1 SV=5 ACHA7_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Homo sapiens (Human) GO:0001540; GO:0001666; GO:0004888; GO:0005216; GO:0005262; GO:0005789; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007611; GO:0007613; GO:0007614; GO:0008284; GO:0015464; GO:0015643; GO:0016020; GO:0017081; GO:0022848; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043124; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045766; GO:0050808; GO:0050890; GO:0050893; GO:0051247; GO:0060079; GO:0060084; GO:0070374; GO:0095500; GO:0097061; GO:0098794; GO:0098815; GO:0140059; GO:1900016; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904645; GO:1905144; GO:1905906; GO:2000463 acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; excitatory postsynaptic potential [GO:0060079]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein metabolic process [GO:0051247]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of membrane potential [GO:0042391]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission involved in micturition [GO:0060084] acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; calcium channel activity [GO:0005262]; chloride channel regulator activity [GO:0017081]; monoatomic ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; transmembrane signaling receptor activity [GO:0004888] g9575.t1 Q0IHH1 79.245 159 4.24e-88 269.0 sp|Q0IHH1|NAA30_XENLA N-alpha-acetyltransferase 30 OS=Xenopus laevis OX=8355 GN=naa30 PE=2 SV=1 NAA30_XENLA reviewed N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit) Xenopus laevis (African clawed frog) GO:0004596; GO:0005634; GO:0005737; GO:0031417; GO:0050821; GO:0120518 protein stabilization [GO:0050821] cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634] protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g9576.t1 O02414 73.864 88 2.1499999999999997e-48 151.0 sp|O02414|DYL1_HELCR Dynein light chain LC6, flagellar outer arm OS=Heliocidaris crassispina OX=1043166 PE=3 SV=1 g9577.t1 Q86YB8 57.732 291 1.51e-106 320.0 sp|Q86YB8|ERO1B_HUMAN ERO1-like protein beta OS=Homo sapiens OX=9606 GN=ERO1B PE=1 SV=2 ERO1B_HUMAN reviewed ERO1-like protein beta (ERO1-L-beta) (EC 1.8.3.2) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta) Homo sapiens (Human) GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006888; GO:0015035; GO:0016491; GO:0016972; GO:0030070; GO:0030198; GO:0034975; GO:0042593; GO:0045454; GO:0051082; GO:0071949 cell redox homeostasis [GO:0045454]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789] FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972]; unfolded protein binding [GO:0051082] g9577.t2 Q86YB8 58.219 292 2.59e-108 325.0 sp|Q86YB8|ERO1B_HUMAN ERO1-like protein beta OS=Homo sapiens OX=9606 GN=ERO1B PE=1 SV=2 ERO1B_HUMAN reviewed ERO1-like protein beta (ERO1-L-beta) (EC 1.8.3.2) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta) Homo sapiens (Human) GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006888; GO:0015035; GO:0016491; GO:0016972; GO:0030070; GO:0030198; GO:0034975; GO:0042593; GO:0045454; GO:0051082; GO:0071949 cell redox homeostasis [GO:0045454]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789] FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972]; unfolded protein binding [GO:0051082] g9578.t1 Q9V3A6 46.457 127 1.12e-33 128.0 sp|Q9V3A6|ERO1L_DROME Ero1-like protein OS=Drosophila melanogaster OX=7227 GN=Ero1L PE=2 SV=2 g9579.t1 O88379 36.166 459 1.31e-71 263.0 sp|O88379|BAZ1A_MOUSE Bromodomain adjacent to zinc finger domain protein 1A OS=Mus musculus OX=10090 GN=Baz1a PE=1 SV=3 BAZ1A_MOUSE reviewed Bromodomain adjacent to zinc finger domain protein 1A (Cbp146) Mus musculus (Mouse) GO:0000228; GO:0003677; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006355; GO:0008270; GO:0008623; GO:0016590; GO:0031445; GO:0045740 chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of heterochromatin formation [GO:0031445] ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g9579.t1 O88379 32.031 256 4.1e-25 116.0 sp|O88379|BAZ1A_MOUSE Bromodomain adjacent to zinc finger domain protein 1A OS=Mus musculus OX=10090 GN=Baz1a PE=1 SV=3 BAZ1A_MOUSE reviewed Bromodomain adjacent to zinc finger domain protein 1A (Cbp146) Mus musculus (Mouse) GO:0000228; GO:0003677; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006355; GO:0008270; GO:0008623; GO:0016590; GO:0031445; GO:0045740 chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of heterochromatin formation [GO:0031445] ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g9581.t1 O88379 45.907 281 1.1399999999999999e-69 249.0 sp|O88379|BAZ1A_MOUSE Bromodomain adjacent to zinc finger domain protein 1A OS=Mus musculus OX=10090 GN=Baz1a PE=1 SV=3 BAZ1A_MOUSE reviewed Bromodomain adjacent to zinc finger domain protein 1A (Cbp146) Mus musculus (Mouse) GO:0000228; GO:0003677; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006355; GO:0008270; GO:0008623; GO:0016590; GO:0031445; GO:0045740 chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of heterochromatin formation [GO:0031445] ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g9582.t1 Q6P9U1 40.278 288 2.46e-76 238.0 sp|Q6P9U1|NUD22_RAT Uridine diphosphate glucose pyrophosphatase NUDT22 OS=Rattus norvegicus OX=10116 GN=Nudt22 PE=2 SV=1 g9583.t1 Q9H1X1 58.755 257 5.16e-114 332.0 sp|Q9H1X1|RSPH9_HUMAN Radial spoke head protein 9 homolog OS=Homo sapiens OX=9606 GN=RSPH9 PE=1 SV=1 RSPH9_HUMAN reviewed Radial spoke head protein 9 homolog Homo sapiens (Human) GO:0001535; GO:0003341; GO:0005930; GO:0031514; GO:0035082; GO:0036126; GO:0044458; GO:0060091; GO:0060294; GO:0062177; GO:0097729; GO:0120336; GO:0120338; GO:1904158 axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126] g9584.t1 Q9NVS2 47.482 139 3.06e-35 124.0 sp|Q9NVS2|RT18A_HUMAN Large ribosomal subunit protein mL66 OS=Homo sapiens OX=9606 GN=MRPS18A PE=1 SV=1 g9585.t1 Q6P6S9 40.481 457 9.210000000000001e-100 309.0 sp|Q6P6S9|ENTP5_RAT Ectonucleoside triphosphate diphosphohydrolase 5 OS=Rattus norvegicus OX=10116 GN=Entpd5 PE=2 SV=1 ENTP5_RAT reviewed Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5) Rattus norvegicus (Rat) GO:0004382; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003 'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134] g9585.t2 Q6P6S9 40.741 459 7.53e-101 312.0 sp|Q6P6S9|ENTP5_RAT Ectonucleoside triphosphate diphosphohydrolase 5 OS=Rattus norvegicus OX=10116 GN=Entpd5 PE=2 SV=1 ENTP5_RAT reviewed Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5) Rattus norvegicus (Rat) GO:0004382; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003 'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134] g9586.t1 Q9R1T1 61.364 88 3.68e-35 118.0 sp|Q9R1T1|BAF_RAT Barrier-to-autointegration factor OS=Rattus norvegicus OX=10116 GN=Banf1 PE=1 SV=1 BAF_RAT reviewed Barrier-to-autointegration factor (LAP2-binding protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed] Rattus norvegicus (Rat) GO:0000785; GO:0000793; GO:0003677; GO:0003690; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006325; GO:0006979; GO:0007084; GO:0010836; GO:0015074; GO:0032480; GO:0032481; GO:0042802; GO:0042803; GO:0045071; GO:0045824; GO:0051276; GO:0140896; GO:0160049 cGAS/STING signaling pathway [GO:0140896]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; DNA integration [GO:0015074]; DNA repair [GO:0006281]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; positive regulation of type I interferon production [GO:0032481]; response to oxidative stress [GO:0006979] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g9587.t1 O16099 31.707 492 2.27e-58 208.0 sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2 g9604.t1 Q8CFK2 71.186 177 9.42e-83 261.0 sp|Q8CFK2|TF3B_MOUSE Transcription factor IIIB 90 kDa subunit OS=Mus musculus OX=10090 GN=Brf1 PE=1 SV=1 g9605.t1 M3XQV7 65.828 477 0.0 637.0 sp|M3XQV7|BTBD3_MUSPF BTB/POZ domain-containing protein 3 OS=Mustela putorius furo OX=9669 GN=BTBD3 PE=2 SV=2 g9606.t1 Q8CFK2 44.802 529 8.97e-111 349.0 sp|Q8CFK2|TF3B_MOUSE Transcription factor IIIB 90 kDa subunit OS=Mus musculus OX=10090 GN=Brf1 PE=1 SV=1 g9607.t1 Q803R5 53.662 751 0.0 849.0 sp|Q803R5|CMTR1_DANRE Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 OS=Danio rerio OX=7955 GN=cmtr1 PE=2 SV=1 g9616.t1 P54366 87.324 71 4.470000000000001e-37 138.0 sp|P54366|GSC_DROME Homeobox protein goosecoid OS=Drosophila melanogaster OX=7227 GN=Gsc PE=2 SV=2 g9619.t1 Q86YW7 36.8 125 1.3400000000000002e-21 86.7 sp|Q86YW7|GPHB5_HUMAN Glycoprotein hormone beta-5 OS=Homo sapiens OX=9606 GN=GPHB5 PE=1 SV=1 GPHB5_HUMAN reviewed Glycoprotein hormone beta-5 (Thyrostimulin subunit beta) Homo sapiens (Human) GO:0002155; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007186; GO:0007189; GO:0031531; GO:0046982 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of thyroid hormone receptor signaling pathway [GO:0002155] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531] g9620.t1 Q86YW7 40.171 117 1.06e-23 92.0 sp|Q86YW7|GPHB5_HUMAN Glycoprotein hormone beta-5 OS=Homo sapiens OX=9606 GN=GPHB5 PE=1 SV=1 GPHB5_HUMAN reviewed Glycoprotein hormone beta-5 (Thyrostimulin subunit beta) Homo sapiens (Human) GO:0002155; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007186; GO:0007189; GO:0031531; GO:0046982 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of thyroid hormone receptor signaling pathway [GO:0002155] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531] g9621.t1 A0A0F7Z3J2 38.835 103 1.06e-22 89.7 sp|A0A0F7Z3J2|CTHA2_CONVC Thyrostimulin alpha-2 subunit OS=Conus victoriae OX=319920 PE=1 SV=1 g9626.t1 A0JPQ7 36.301 292 2.96e-38 147.0 sp|A0JPQ7|CS047_RAT Uncharacterized protein C19orf47 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1 g9629.t1 Q8BYN3 43.275 342 3.78e-101 308.0 sp|Q8BYN3|ITPK1_MOUSE Inositol-tetrakisphosphate 1-kinase OS=Mus musculus OX=10090 GN=Itpk1 PE=2 SV=1 ITPK1_MOUSE reviewed Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159) Mus musculus (Mouse) GO:0000287; GO:0000825; GO:0005524; GO:0016324; GO:0016787; GO:0016853; GO:0021915; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052835; GO:0070266 inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915] apical plasma membrane [GO:0016324] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,5,6-tetrakisphosphate 1-kinase activity [GO:0047325]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287] g9632.t1 A0A1L8HYT7 37.325 501 3.03e-101 330.0 sp|A0A1L8HYT7|CIROP_XENLA Ciliated left-right organizer metallopeptidase OS=Xenopus laevis OX=8355 GN=cirop PE=2 SV=1 g9633.t1 Q9H0D6 56.263 990 0.0 1044.0 sp|Q9H0D6|XRN2_HUMAN 5'-3' exoribonuclease 2 OS=Homo sapiens OX=9606 GN=XRN2 PE=1 SV=1 g9635.t1 P43698 52.365 296 7.420000000000001e-75 239.0 sp|P43698|TITF1_CANLF Thyroid transcription factor 1 OS=Canis lupus familiaris OX=9615 GN=TITF1 PE=2 SV=1 g9637.t1 O95096 46.914 324 4.700000000000001e-72 227.0 sp|O95096|NKX22_HUMAN Homeobox protein Nkx-2.2 OS=Homo sapiens OX=9606 GN=NKX2-2 PE=1 SV=1 g9640.t1 Q90980 49.889 449 5.62e-142 434.0 sp|Q90980|CNG3_CHICK Cyclic nucleotide-gated channel rod photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 CNG3_CHICK reviewed Cyclic nucleotide-gated channel rod photoreceptor subunit alpha (CNG channel 3) (CNG-3) (CNG3) Gallus gallus (Chicken) GO:0005222; GO:0005223; GO:0005886; GO:0007601; GO:0007606; GO:0017071; GO:0030552; GO:0030553; GO:0042622; GO:0098655; GO:0120200 monoatomic cation transmembrane transport [GO:0098655]; sensory perception of chemical stimulus [GO:0007606]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223] g9640.t2 Q28718 44.071 506 5.1e-131 408.0 sp|Q28718|CNGA2_RABIT Cyclic nucleotide-gated channel alpha-2 OS=Oryctolagus cuniculus OX=9986 GN=CNGA2 PE=2 SV=1 CNGA2_RABIT reviewed Cyclic nucleotide-gated channel alpha-2 (CNG channel alpha-2) (CNG-2) (CNG2) (Aorta CNG channel) (RACNG) (Olfactory cyclic nucleotide-gated channel subunit 1) (OCNC1) Oryctolagus cuniculus (Rabbit) GO:0005222; GO:0005223; GO:0005262; GO:0005516; GO:0006813; GO:0006814; GO:0006816; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0044877; GO:0098804 calcium ion transport [GO:0006816]; potassium ion transport [GO:0006813]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877] g9642.t1 P47236 73.43 207 4.2399999999999994e-95 287.0 sp|P47236|PAX1_CHICK Paired box protein Pax-1 (Fragment) OS=Gallus gallus OX=9031 GN=PAX1 PE=3 SV=1 g9642.t2 P47236 72.947 207 1.26e-96 285.0 sp|P47236|PAX1_CHICK Paired box protein Pax-1 (Fragment) OS=Gallus gallus OX=9031 GN=PAX1 PE=3 SV=1 g9646.t1 Q5RFB7 67.014 288 2.9e-137 393.0 sp|Q5RFB7|ODC_PONAB Mitochondrial 2-oxodicarboxylate carrier OS=Pongo abelii OX=9601 GN=SLC25A21 PE=2 SV=1 g9647.t1 Q8TD10 42.254 355 2.5e-76 254.0 sp|Q8TD10|MIPO1_HUMAN Mirror-image polydactyly gene 1 protein OS=Homo sapiens OX=9606 GN=MIPOL1 PE=1 SV=1 MIPO1_HUMAN reviewed Mirror-image polydactyly gene 1 protein Homo sapiens (Human) GO:0005634; GO:0042802 nucleus [GO:0005634] identical protein binding [GO:0042802] g9649.t1 P84961 46.957 345 2.44e-83 266.0 sp|P84961|FXA2B_XENLA Forkhead box protein A2-B OS=Xenopus laevis OX=8355 GN=foxa2-b PE=2 SV=1 g9651.t1 P07850 55.435 460 0.0 527.0 sp|P07850|SUOX_CHICK Sulfite oxidase OS=Gallus gallus OX=9031 GN=SUOX PE=1 SV=3 g9652.t1 Q6GQ29 57.725 466 0.0 555.0 sp|Q6GQ29|CBPQ_XENLA Carboxypeptidase Q OS=Xenopus laevis OX=8355 GN=cpq PE=2 SV=1 CBPQ_XENLA reviewed Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase) Xenopus laevis (African clawed frog) GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0042803; GO:0043171; GO:0046872; GO:0070573 peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764] carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803] g9653.t1 Q32P59 46.753 77 5.6100000000000005e-22 86.3 sp|Q32P59|SLIRP_BOVIN SRA stem-loop-interacting RNA-binding protein, mitochondrial OS=Bos taurus OX=9913 GN=SLIRP PE=3 SV=1 g9654.t1 P0CB42 41.576 368 6.78e-86 272.0 sp|P0CB42|ALKB1_MOUSE Nucleic acid dioxygenase ALKBH1 OS=Mus musculus OX=10090 GN=Alkbh1 PE=1 SV=1 ALKB1_MOUSE reviewed Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1) (EC 1.14.11.51) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase) (EC 1.14.11.-) (tRNA N1-methyl adenine demethylase) (EC 1.14.11.-) Mus musculus (Mouse) GO:0000049; GO:0000791; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0006281; GO:0006446; GO:0006448; GO:0008198; GO:0010468; GO:0016706; GO:0030154; GO:0031175; GO:0035513; GO:0035515; GO:0035516; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0070129; GO:0140078; GO:0141131; GO:0141137; GO:0160290; GO:1990983; GO:1990984 cell differentiation [GO:0030154]; developmental growth [GO:0048589]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative RNA demethylation [GO:0035513]; placenta development [GO:0001890]; positive regulation of gene expression, epigenetic [GO:0141137]; regulation of gene expression [GO:0010468]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by tRNA modification [GO:1990983]; RNA repair [GO:0042245]; tRNA wobble cytosine modification [GO:0002101] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; euchromatin [GO:0000791]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; 2-oxoglutarate-dependent tRNA 5-methylcytidine formyltransferase activity [GO:0160290]; broad specificity oxidative DNA demethylase activity [GO:0035516]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N6-methyladenine demethylase activity [GO:0141131]; ferrous iron binding [GO:0008198]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984] g9655.t1 Q9D2G9 51.707 615 0.0 634.0 sp|Q9D2G9|HIPL2_MOUSE HHIP-like protein 2 OS=Mus musculus OX=10090 GN=Hhipl2 PE=2 SV=2 g9656.t1 Q8BW75 48.462 520 2.6899999999999996e-172 499.0 sp|Q8BW75|AOFB_MOUSE Amine oxidase [flavin-containing] B OS=Mus musculus OX=10090 GN=Maob PE=1 SV=4 AOFB_MOUSE reviewed Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005743; GO:0008131; GO:0014063; GO:0019607; GO:0030425; GO:0042802; GO:0043025; GO:0045964; GO:0048545; GO:0050660; GO:0097621 negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to steroid hormone [GO:0048545] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g9657.t1 Q6P158 50.443 1354 0.0 1287.0 sp|Q6P158|DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens OX=9606 GN=DHX57 PE=1 SV=2 DHX57_HUMAN reviewed Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0008270; GO:0016887; GO:0045727; GO:0070063 positive regulation of translation [GO:0045727] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; zinc ion binding [GO:0008270] g9658.t1 Q9CX53 42.857 161 3.0400000000000004e-37 129.0 sp|Q9CX53|GEMI6_MOUSE Gem-associated protein 6 OS=Mus musculus OX=10090 GN=Gemin6 PE=1 SV=2 g9660.t1 Q28653 72.978 544 0.0 822.0 sp|Q28653|2A5D_RABIT Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Oryctolagus cuniculus OX=9986 GN=PPP2R5D PE=2 SV=1 g9662.t1 P60901 80.894 246 4.7e-153 428.0 sp|P60901|PSA6_RAT Proteasome subunit alpha type-6 OS=Rattus norvegicus OX=10116 GN=Psma6 PE=1 SV=1 PSA6_RAT reviewed Proteasome subunit alpha type-6 (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) (Proteasome subunit alpha-1) (alpha-1) Rattus norvegicus (Rat) GO:0000502; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005839; GO:0005840; GO:0005929; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0043123; GO:0043161; GO:0050727; GO:0051059; GO:0051603 positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of inflammatory response [GO:0050727] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; ribosome [GO:0005840]; sarcomere [GO:0030017] NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723] g9663.t1 A4QNE6 72.316 354 0.0 541.0 sp|A4QNE6|DAA10_XENTR Dynein axonemal assembly factor 10 OS=Xenopus tropicalis OX=8364 GN=dnaaf10 PE=2 SV=1 g9664.t1 O43290 47.239 326 2.56e-76 268.0 sp|O43290|SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1 g9664.t2 O43290 47.239 326 2.6e-76 268.0 sp|O43290|SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1 g9664.t3 O43290 46.951 328 1.43e-76 268.0 sp|O43290|SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens OX=9606 GN=SART1 PE=1 SV=1 g9666.t1 Q8BLD9 28.0 350 9.59e-31 125.0 sp|Q8BLD9|DRD5_MOUSE D(1B) dopamine receptor OS=Mus musculus OX=10090 GN=Drd5 PE=2 SV=1 DRD5_MOUSE reviewed D(1B) dopamine receptor (D(5) dopamine receptor) (Dopamine D5 receptor) Mus musculus (Mouse) GO:0001588; GO:0001965; GO:0001975; GO:0001992; GO:0001994; GO:0004930; GO:0004952; GO:0005886; GO:0005929; GO:0007189; GO:0007191; GO:0007212; GO:0007617; GO:0008306; GO:0008542; GO:0019226; GO:0030336; GO:0030424; GO:0030425; GO:0031526; GO:0035240; GO:0042060; GO:0042220; GO:0043025; GO:0043197; GO:0043410; GO:0045776; GO:0045924; GO:0046960; GO:0060170; GO:0060292; GO:0071870; GO:0071880; GO:0072593; GO:0097730; GO:0097731; GO:0098839; GO:0098978; GO:0099072 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular response to catecholamine stimulus [GO:0071870]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; mating behavior [GO:0007617]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; positive regulation of MAPK cascade [GO:0043410]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; transmission of nerve impulse [GO:0019226]; visual learning [GO:0008542]; wound healing [GO:0042060] 9+0 non-motile cilium [GO:0097731]; axon [GO:0030424]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965] g9667.t1 O70528 26.331 357 5.18e-30 121.0 sp|O70528|5HT4R_CAVPO 5-hydroxytryptamine receptor 4 OS=Cavia porcellus OX=10141 GN=HTR4 PE=2 SV=1 g9668.t1 P25100 27.124 306 7.78e-30 123.0 sp|P25100|ADA1D_HUMAN Alpha-1D adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1D PE=1 SV=2 ADA1D_HUMAN reviewed Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a) Homo sapiens (Human) GO:0004937; GO:0005886; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0008284; GO:0042802; GO:0043410; GO:0045907; GO:0071880; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802] g9669.t1 P25100 28.076 317 2.3000000000000002e-29 122.0 sp|P25100|ADA1D_HUMAN Alpha-1D adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1D PE=1 SV=2 ADA1D_HUMAN reviewed Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a) Homo sapiens (Human) GO:0004937; GO:0005886; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0008284; GO:0042802; GO:0043410; GO:0045907; GO:0071880; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802] g9670.t1 A2ARS0 38.415 164 3.57e-31 128.0 sp|A2ARS0|ANR63_MOUSE Ankyrin repeat domain-containing protein 63 OS=Mus musculus OX=10090 GN=Ankrd63 PE=1 SV=1 g9673.t1 O75582 63.26 773 0.0 979.0 sp|O75582|KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens OX=9606 GN=RPS6KA5 PE=1 SV=1 KS6A5_HUMAN reviewed Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) Homo sapiens (Human) GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0099175; GO:0106310 axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g9674.t1 A1A4Q2 59.006 161 3.65e-64 197.0 sp|A1A4Q2|PRXD1_BOVIN Prolyl-tRNA synthetase associated domain-containing protein 1 OS=Bos taurus OX=9913 GN=PRORSD1 PE=2 SV=1 g9675.t1 Q6DCX5 27.549 461 4.65e-50 180.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9676.t1 Q6DCX5 30.917 469 2.5100000000000002e-57 199.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9677.t1 Q7ZWG6 29.481 424 2.79e-44 165.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9678.t1 Q5BU09 41.818 330 9.2e-64 207.0 sp|Q5BU09|EAPP_MOUSE E2F-associated phosphoprotein OS=Mus musculus OX=10090 GN=Eapp PE=1 SV=2 g9683.t1 Q9VMU8 38.012 342 1.85e-74 236.0 sp|Q9VMU8|SENJU_DROME UDP-galactose transporter senju OS=Drosophila melanogaster OX=7227 GN=senju PE=1 SV=2 SENJU_DROME reviewed UDP-galactose transporter senju Drosophila melanogaster (Fruit fly) GO:0000139; GO:0002225; GO:0005459; GO:0005794; GO:0005797; GO:0010560; GO:0045751; GO:0045824; GO:0055085; GO:0072334 negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; transmembrane transport [GO:0055085]; UDP-galactose transmembrane transport [GO:0072334] Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] UDP-galactose transmembrane transporter activity [GO:0005459] g9684.t1 P57093 61.357 339 3.2e-154 439.0 sp|P57093|PAHX_RAT Phytanoyl-CoA dioxygenase, peroxisomal OS=Rattus norvegicus OX=10116 GN=Phyh PE=1 SV=2 PAHX_RAT reviewed Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH) Rattus norvegicus (Rat) GO:0001561; GO:0003824; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089] 9+0 non-motile cilium [GO:0097731]; peroxisome [GO:0005777] carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244] g9687.t1 B3EWZ5 29.82 389 4.9e-34 137.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 31.339 351 8.98e-33 133.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 29.598 348 2.85e-31 129.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 29.885 348 2.68e-29 123.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 29.867 375 1.51e-28 120.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 27.147 361 6.9499999999999995e-28 119.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 29.275 345 8.47e-28 118.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 27.326 344 7.300000000000001e-27 115.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 27.368 380 2.31e-26 114.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 29.086 361 1.87e-25 111.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 27.374 358 2.38e-25 111.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 29.73 259 3.66e-24 107.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 30.534 262 1.68e-23 105.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 27.457 346 4.22e-22 101.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9687.t1 B3EWZ5 26.893 383 4.58e-22 101.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g9688.t1 O76536 34.831 1157 9.409999999999999e-115 400.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9688.t1 O76536 32.146 1207 5.62e-104 368.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9688.t1 O76536 32.756 1154 2.42e-96 345.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9688.t1 O76536 32.353 1156 3.29e-94 338.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9688.t1 O76536 32.981 1134 1.3799999999999999e-92 333.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g9691.t1 P11103 41.148 1045 0.0 750.0 sp|P11103|PARP1_MOUSE Poly [ADP-ribose] polymerase 1 OS=Mus musculus OX=10090 GN=Parp1 PE=1 SV=3 PARP1_MOUSE reviewed Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (msPARP) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) [Cleaved into: Poly [ADP-ribose] polymerase 1, processed C-terminus (Poly [ADP-ribose] polymerase 1, 89-kDa form); Poly [ADP-ribose] polymerase 1, processed N-terminus (Poly [ADP-ribose] polymerase 1, 24-kDa form)] Mus musculus (Mouse) GO:0000122; GO:0000723; GO:0000724; GO:0000785; GO:0003677; GO:0003682; GO:0003684; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006259; GO:0006281; GO:0006284; GO:0006302; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008047; GO:0008270; GO:0010613; GO:0016051; GO:0016540; GO:0016604; GO:0016779; GO:0019899; GO:0019901; GO:0023019; GO:0030331; GO:0030592; GO:0031491; GO:0031625; GO:0032042; GO:0032700; GO:0032786; GO:0032869; GO:0032880; GO:0032991; GO:0032993; GO:0033148; GO:0034244; GO:0034599; GO:0034644; GO:0035861; GO:0040009; GO:0042802; GO:0042803; GO:0042826; GO:0043123; GO:0043504; GO:0043596; GO:0045087; GO:0045188; GO:0045824; GO:0045892; GO:0045944; GO:0046697; GO:0048148; GO:0051287; GO:0051901; GO:0060391; GO:0060545; GO:0061629; GO:0070212; GO:0070213; GO:0070412; GO:0071168; GO:0071451; GO:0071932; GO:0090734; GO:0140294; GO:0140537; GO:0140805; GO:0140806; GO:0140807; GO:0140808; GO:0140815; GO:0140816; GO:0140817; GO:0140822; GO:0140861; GO:0160049; GO:0160239; GO:1900182; GO:1903376; GO:1903516; GO:1904178; GO:1904357; GO:1904646; GO:1904762; GO:1905051; GO:1905168; GO:1990090; GO:1990166; GO:1990404; GO:1990966; GO:2001170 apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair [GO:0006284]; behavioral response to cocaine [GO:0048148]; carbohydrate biosynthetic process [GO:0016051]; cellular response to amyloid-beta [GO:1904646]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidative stress [GO:0034599]; cellular response to superoxide [GO:0071451]; cellular response to UV [GO:0034644]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of necroptotic process [GO:0060545]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein localization to chromatin [GO:0071168]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of base-excision repair [GO:1905051]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of growth rate [GO:0040009]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of single strand break repair [GO:1903516]; replication fork reversal [GO:0071932]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription pausing by RNA polymerase II [GO:0160239]; transforming growth factor beta receptor signaling pathway [GO:0007179] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity [GO:0140822]; NAD+-histone H2BS6 serine ADP-ribosyltransferase activity [GO:0140816]; NAD+-histone H3S10 serine ADP-ribosyltransferase activity [GO:0140817]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-histidine ADP-ribosyltransferase activity [GO:0140815]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; NAD+-protein-tyrosine ADP-ribosyltransferase activity [GO:0140808]; nuclear estrogen receptor binding [GO:0030331]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator activator activity [GO:0140537]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g9692.t1 Q8IYD8 52.318 755 0.0 795.0 sp|Q8IYD8|FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens OX=9606 GN=FANCM PE=1 SV=2 FANCM_HUMAN reviewed Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog) Homo sapiens (Human) GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0005829; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:1902527 double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724] g9692.t1 Q8IYD8 38.333 240 7.02e-42 174.0 sp|Q8IYD8|FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens OX=9606 GN=FANCM PE=1 SV=2 FANCM_HUMAN reviewed Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog) Homo sapiens (Human) GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0005829; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:1902527 double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724] g9693.t1 Q9GLW7 54.651 172 4.61e-65 202.0 sp|Q9GLW7|PRDX5_CHLAE Peroxiredoxin-5, mitochondrial OS=Chlorocebus aethiops OX=9534 GN=PRDX5 PE=2 SV=1 g9694.t1 Q9CRA8 58.173 208 9.55e-81 244.0 sp|Q9CRA8|EXOS5_MOUSE Exosome complex component RRP46 OS=Mus musculus OX=10090 GN=Exosc5 PE=1 SV=1 EXOS5_MOUSE reviewed Exosome complex component RRP46 (Exosome component 5) (Ribosomal RNA-processing protein 46) Mus musculus (Mouse) GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006402; GO:0016075; GO:0034475; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019 defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; RNA binding [GO:0003723] g9695.t1 Q02401 51.6 500 4.22e-170 531.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9695.t1 Q02401 48.233 481 7.29e-151 478.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9695.t1 Q02401 43.035 481 1.6800000000000001e-133 431.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9696.t1 Q02401 53.892 501 3.33e-173 538.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9696.t1 Q02401 51.351 481 9.78e-158 496.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9696.t1 Q02401 43.902 492 5.3200000000000005e-132 425.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9697.t1 Q02401 51.4 500 1.1199999999999999e-170 532.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9697.t1 Q02401 49.272 481 2.01e-153 485.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9697.t1 Q02401 44.491 481 2.83e-137 441.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9698.t1 Q02401 51.318 493 2.39e-157 495.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9698.t1 Q02401 48.211 475 1.87e-142 454.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9698.t1 Q02401 43.368 475 1.14e-124 404.0 sp|Q02401|LPH_RAT Lactase/phlorizin hydrolase OS=Rattus norvegicus OX=10116 GN=Lct PE=1 SV=2 LPH_RAT reviewed Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] Rattus norvegicus (Rat) GO:0000016; GO:0001666; GO:0004336; GO:0004348; GO:0005903; GO:0005990; GO:0007584; GO:0008422; GO:0009410; GO:0009725; GO:0009744; GO:0010040; GO:0010045; GO:0010288; GO:0016740; GO:0042594; GO:0042803; GO:0043627; GO:0045471; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to nickel cation [GO:0010045]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; response to xenobiotic stimulus [GO:0009410] brush border [GO:0005903]; external side of apical plasma membrane [GO:0098591] beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] g9699.t1 Q5RHR0 47.59 996 0.0 890.0 sp|Q5RHR0|PARP1_DANRE Poly [ADP-ribose] polymerase 1 OS=Danio rerio OX=7955 GN=parp1 PE=2 SV=1 PARP1_DANRE reviewed Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000785; GO:0003677; GO:0003684; GO:0003950; GO:0005634; GO:0005730; GO:0005829; GO:0006281; GO:0006302; GO:0006915; GO:0008270; GO:0016779; GO:0031491; GO:0042803; GO:0043596; GO:0045087; GO:0045187; GO:0045824; GO:0051287; GO:0070213; GO:0071932; GO:0090734; GO:0140805; GO:0140806; GO:0140807; GO:0140808; GO:0140815; GO:1990404 apoptotic process [GO:0006915]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein auto-ADP-ribosylation [GO:0070213]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; replication fork reversal [GO:0071932] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-histidine ADP-ribosyltransferase activity [GO:0140815]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; NAD+-protein-tyrosine ADP-ribosyltransferase activity [GO:0140808]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g9699.t2 Q5RHR0 47.805 1025 0.0 928.0 sp|Q5RHR0|PARP1_DANRE Poly [ADP-ribose] polymerase 1 OS=Danio rerio OX=7955 GN=parp1 PE=2 SV=1 PARP1_DANRE reviewed Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000785; GO:0003677; GO:0003684; GO:0003950; GO:0005634; GO:0005730; GO:0005829; GO:0006281; GO:0006302; GO:0006915; GO:0008270; GO:0016779; GO:0031491; GO:0042803; GO:0043596; GO:0045087; GO:0045187; GO:0045824; GO:0051287; GO:0070213; GO:0071932; GO:0090734; GO:0140805; GO:0140806; GO:0140807; GO:0140808; GO:0140815; GO:1990404 apoptotic process [GO:0006915]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein auto-ADP-ribosylation [GO:0070213]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; replication fork reversal [GO:0071932] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-histidine ADP-ribosyltransferase activity [GO:0140815]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; NAD+-protein-tyrosine ADP-ribosyltransferase activity [GO:0140808]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g9700.t1 Q8NFU1 51.499 367 7.18e-134 403.0 sp|Q8NFU1|BEST2_HUMAN Bestrophin-2a OS=Homo sapiens OX=9606 GN=BEST2 PE=1 SV=1 BEST2_HUMAN reviewed Bestrophin-2a (Vitelliform macular dystrophy 2-like protein 1) Homo sapiens (Human) GO:0005217; GO:0005254; GO:0005886; GO:0005929; GO:0007608; GO:0016323; GO:0034707; GO:0046872; GO:0051899; GO:0099094; GO:0099095; GO:0160133; GO:1902476 chloride transmembrane transport [GO:1902476]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608] basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886] bicarbonate channel activity [GO:0160133]; chloride channel activity [GO:0005254]; intracellularly ligand-gated monoatomic ion channel activity [GO:0005217]; ligand-gated monoatomic anion channel activity [GO:0099095]; ligand-gated monoatomic cation channel activity [GO:0099094]; metal ion binding [GO:0046872] g9700.t2 Q8NFU1 51.499 367 7.13e-134 402.0 sp|Q8NFU1|BEST2_HUMAN Bestrophin-2a OS=Homo sapiens OX=9606 GN=BEST2 PE=1 SV=1 BEST2_HUMAN reviewed Bestrophin-2a (Vitelliform macular dystrophy 2-like protein 1) Homo sapiens (Human) GO:0005217; GO:0005254; GO:0005886; GO:0005929; GO:0007608; GO:0016323; GO:0034707; GO:0046872; GO:0051899; GO:0099094; GO:0099095; GO:0160133; GO:1902476 chloride transmembrane transport [GO:1902476]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608] basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886] bicarbonate channel activity [GO:0160133]; chloride channel activity [GO:0005254]; intracellularly ligand-gated monoatomic ion channel activity [GO:0005217]; ligand-gated monoatomic anion channel activity [GO:0099095]; ligand-gated monoatomic cation channel activity [GO:0099094]; metal ion binding [GO:0046872] g9702.t1 Q9Y3B9 46.667 225 2.93e-43 152.0 sp|Q9Y3B9|RRP15_HUMAN RRP15-like protein OS=Homo sapiens OX=9606 GN=RRP15 PE=1 SV=2 g9703.t1 Q8VEH8 42.222 450 2.28e-124 374.0 sp|Q8VEH8|ERLEC_MOUSE Endoplasmic reticulum lectin 1 OS=Mus musculus OX=10090 GN=Erlec1 PE=1 SV=1 g9704.t1 P27090 35.309 405 7.98e-71 231.0 sp|P27090|TGFB2_MOUSE Transforming growth factor beta-2 proprotein OS=Mus musculus OX=10090 GN=Tgfb2 PE=1 SV=2 TGFB2_MOUSE reviewed Transforming growth factor beta-2 proprotein [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-2 (TGF-beta-2)] Mus musculus (Mouse) GO:0000902; GO:0001501; GO:0001502; GO:0001540; GO:0001568; GO:0001654; GO:0001666; GO:0001822; GO:0001837; GO:0001843; GO:0001942; GO:0001974; GO:0003007; GO:0003148; GO:0003149; GO:0003151; GO:0003179; GO:0003181; GO:0003184; GO:0003203; GO:0003214; GO:0003215; GO:0003222; GO:0003274; GO:0003289; GO:0003407; GO:0005102; GO:0005114; GO:0005125; GO:0005160; GO:0005576; GO:0005604; GO:0005615; GO:0005768; GO:0005802; GO:0007179; GO:0007411; GO:0007435; GO:0007507; GO:0008083; GO:0008284; GO:0008285; GO:0008347; GO:0008584; GO:0009611; GO:0009986; GO:0010002; GO:0010628; GO:0010629; GO:0010634; GO:0010718; GO:0010936; GO:0016477; GO:0016525; GO:0023052; GO:0030097; GO:0030141; GO:0030198; GO:0030199; GO:0030307; GO:0030308; GO:0030326; GO:0030335; GO:0030424; GO:0030593; GO:0030855; GO:0031012; GO:0031069; GO:0032570; GO:0032874; GO:0032909; GO:0032956; GO:0033630; GO:0034714; GO:0035910; GO:0042060; GO:0042127; GO:0042416; GO:0042802; GO:0042803; GO:0042981; GO:0043025; GO:0043065; GO:0043066; GO:0043525; GO:0043627; GO:0044877; GO:0045216; GO:0045617; GO:0045726; GO:0045747; GO:0045787; GO:0045823; GO:0046580; GO:0048103; GO:0048566; GO:0048663; GO:0048666; GO:0048702; GO:0048839; GO:0050680; GO:0050714; GO:0050778; GO:0051280; GO:0051781; GO:0051794; GO:0051795; GO:0051891; GO:0051897; GO:0060038; GO:0060065; GO:0060317; GO:0060325; GO:0060391; GO:0060412; GO:0060413; GO:0061037; GO:0061626; GO:0062009; GO:0062043; GO:0070237; GO:0090091; GO:0097191; GO:1900182; GO:1902256; GO:1902895; GO:1903053; GO:1903701; GO:1904238; GO:1904426; GO:1904888; GO:1905006; GO:1905007; GO:2001241 ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; axon guidance [GO:0007411]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cartilage condensation [GO:0001502]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell junction organization [GO:0045216]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic neurocranium morphogenesis [GO:0048702]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial cell differentiation [GO:0030855]; epithelial to mesenchymal transition [GO:0001837]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; face morphogenesis [GO:0060325]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neuron fate commitment [GO:0048663]; neutrophil chemotaxis [GO:0030593]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pericyte cell differentiation [GO:1904238]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of activation-induced cell death of T cells [GO:0070237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of GTP binding [GO:1904426]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of apoptotic process [GO:0042981]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of extracellular matrix organization [GO:1903053]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; signaling [GO:0023052]; skeletal system development [GO:0001501]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060] axon [GO:0030424]; basement membrane [GO:0005604]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802] amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714] g9705.t1 Q6EEF3 50.271 553 0.0 594.0 sp|Q6EEF3|TTLL5_CHLAE Tubulin polyglutamylase TTLL5 OS=Chlorocebus aethiops OX=9534 GN=TTLL5 PE=2 SV=2 TTLL5_CHLAE reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (SRC1 and TIF2-associated modulatory protein) (STAMP protein) (Tubulin--tyrosine ligase-like protein 5) Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0015631; GO:0036064; GO:0046872; GO:0070740; GO:0106437; GO:0106438 microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g9705.t1 Q6EEF3 33.871 434 3.9400000000000003e-33 143.0 sp|Q6EEF3|TTLL5_CHLAE Tubulin polyglutamylase TTLL5 OS=Chlorocebus aethiops OX=9534 GN=TTLL5 PE=2 SV=2 TTLL5_CHLAE reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (SRC1 and TIF2-associated modulatory protein) (STAMP protein) (Tubulin--tyrosine ligase-like protein 5) Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0015631; GO:0036064; GO:0046872; GO:0070740; GO:0106437; GO:0106438 microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g9705.t2 Q6EEF3 52.399 521 0.0 594.0 sp|Q6EEF3|TTLL5_CHLAE Tubulin polyglutamylase TTLL5 OS=Chlorocebus aethiops OX=9534 GN=TTLL5 PE=2 SV=2 TTLL5_CHLAE reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (SRC1 and TIF2-associated modulatory protein) (STAMP protein) (Tubulin--tyrosine ligase-like protein 5) Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0015631; GO:0036064; GO:0046872; GO:0070740; GO:0106437; GO:0106438 microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g9705.t2 Q6EEF3 33.871 434 4.02e-33 143.0 sp|Q6EEF3|TTLL5_CHLAE Tubulin polyglutamylase TTLL5 OS=Chlorocebus aethiops OX=9534 GN=TTLL5 PE=2 SV=2 TTLL5_CHLAE reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (SRC1 and TIF2-associated modulatory protein) (STAMP protein) (Tubulin--tyrosine ligase-like protein 5) Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0015631; GO:0036064; GO:0046872; GO:0070740; GO:0106437; GO:0106438 microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g9705.t3 Q6EEF3 51.326 528 0.0 593.0 sp|Q6EEF3|TTLL5_CHLAE Tubulin polyglutamylase TTLL5 OS=Chlorocebus aethiops OX=9534 GN=TTLL5 PE=2 SV=2 TTLL5_CHLAE reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (SRC1 and TIF2-associated modulatory protein) (STAMP protein) (Tubulin--tyrosine ligase-like protein 5) Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0015631; GO:0036064; GO:0046872; GO:0070740; GO:0106437; GO:0106438 microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g9705.t3 Q6EEF3 33.871 434 3.37e-33 144.0 sp|Q6EEF3|TTLL5_CHLAE Tubulin polyglutamylase TTLL5 OS=Chlorocebus aethiops OX=9534 GN=TTLL5 PE=2 SV=2 TTLL5_CHLAE reviewed Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (SRC1 and TIF2-associated modulatory protein) (STAMP protein) (Tubulin--tyrosine ligase-like protein 5) Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0000226; GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0015631; GO:0036064; GO:0046872; GO:0070740; GO:0106437; GO:0106438 microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g9706.t1 Q6P2X9 27.368 285 2.7699999999999997e-28 118.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g9707.t1 Q6ZUK4 32.07 343 5.1899999999999997e-45 162.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g9708.t1 Q54KD0 26.135 1079 1.8e-84 311.0 sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1 g9711.t1 Q9VUL9 42.336 137 4.69e-29 115.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g9713.t1 Q9NQX3 54.831 414 6.06e-159 468.0 sp|Q9NQX3|GEPH_HUMAN Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1 GEPH_HUMAN reviewed Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E) (Mo insertase)] Homo sapiens (Human) GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007416; GO:0007529; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0030425; GO:0030674; GO:0042802; GO:0043197; GO:0043546; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098982; GO:0099091; GO:0099572; GO:0099645 establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synapse assembly [GO:0007416] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synaptic membrane [GO:0097060] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102] g9714.t1 Q9PW38 64.072 167 3.7500000000000004e-64 231.0 sp|Q9PW38|GEPH_CHICK Gephyrin OS=Gallus gallus OX=9031 GN=GPHN PE=1 SV=1 g9717.t1 Q5EAC5 53.636 220 3.31e-70 244.0 sp|Q5EAC5|ZN410_BOVIN Zinc finger protein 410 OS=Bos taurus OX=9913 GN=ZNF410 PE=2 SV=1 g9718.t1 Q9QYP1 35.37 311 1.5499999999999999e-46 172.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9718.t1 Q9QYP1 33.099 284 4.4299999999999994e-42 159.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9718.t1 Q9QYP1 33.813 278 3.41e-41 157.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9718.t1 Q9QYP1 30.508 295 3.54e-36 142.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9722.t1 Q9QYP1 35.294 306 4.6999999999999994e-42 167.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9722.t1 Q9QYP1 34.892 278 1.32e-39 160.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9722.t1 Q9QYP1 33.448 290 6.47e-39 158.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9722.t1 Q9QYP1 31.419 296 8.29e-36 148.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9724.t1 Q96Q07 64.634 574 0.0 781.0 sp|Q96Q07|BTBD9_HUMAN BTB/POZ domain-containing protein 9 OS=Homo sapiens OX=9606 GN=BTBD9 PE=1 SV=2 BTBD9_HUMAN reviewed BTB/POZ domain-containing protein 9 Homo sapiens (Human) GO:0005737; GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050804; GO:0050951; GO:0060586; GO:0098978; GO:1900242 adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal-level iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978] g9725.t1 Q4R7U8 50.641 312 1.8900000000000002e-97 293.0 sp|Q4R7U8|ASGL1_MACFA Isoaspartyl peptidase/L-asparaginase OS=Macaca fascicularis OX=9541 GN=ASRGL1 PE=2 SV=1 ASGL1_MACFA reviewed Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain] Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345 L-asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917] asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798] g9726.t1 Q58D06 53.977 352 1.0099999999999999e-135 395.0 sp|Q58D06|WDR74_BOVIN WD repeat-containing protein 74 OS=Bos taurus OX=9913 GN=WDR74 PE=2 SV=1 g9727.t1 Q4JIJ3 70.0 1270 0.0 1859.0 sp|Q4JIJ3|METH_BOVIN Methionine synthase OS=Bos taurus OX=9913 GN=MTR PE=2 SV=1 METH_BOVIN reviewed Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase) Bos taurus (Bovine) GO:0005829; GO:0008270; GO:0008705; GO:0009086; GO:0031419; GO:0032259; GO:0046653; GO:0050667 homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; tetrahydrofolate metabolic process [GO:0046653] cytosol [GO:0005829] cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270] g9728.t1 O14618 56.554 267 1.7e-108 317.0 sp|O14618|CCS_HUMAN Copper chaperone for superoxide dismutase OS=Homo sapiens OX=9606 GN=CCS PE=1 SV=1 CCS_HUMAN reviewed Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone) Homo sapiens (Human) GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0015035; GO:0016532; GO:0019430; GO:0034599; GO:0045296; GO:0051604 cellular response to oxidative stress [GO:0034599]; protein maturation [GO:0051604]; removal of superoxide radicals [GO:0019430] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035]; superoxide dismutase copper chaperone activity [GO:0016532] g9729.t1 Q9Y2U9 40.36 389 8.399999999999999e-95 293.0 sp|Q9Y2U9|KLDC2_HUMAN Kelch domain-containing protein 2 OS=Homo sapiens OX=9606 GN=KLHDC2 PE=1 SV=1 g9731.t1 O46470 57.231 484 0.0 556.0 sp|O46470|RGS7_BOVIN Regulator of G-protein signaling 7 OS=Bos taurus OX=9913 GN=RGS7 PE=1 SV=1 g9731.t2 P49802 56.818 484 0.0 554.0 sp|P49802|RGS7_HUMAN Regulator of G-protein signaling 7 OS=Homo sapiens OX=9606 GN=RGS7 PE=1 SV=3 RGS7_HUMAN reviewed Regulator of G-protein signaling 7 (RGS7) Homo sapiens (Human) GO:0001965; GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0031681; GO:0035556; GO:0042734; GO:0043005; GO:0043547; GO:0044292; GO:0045211; GO:0045744; GO:0051286; GO:0060078; GO:0098978 G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of GTPase activity [GO:0043547]; regulation of postsynaptic membrane potential [GO:0060078] cell tip [GO:0051286]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite terminus [GO:0044292]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] g9731.t3 O46470 58.193 476 0.0 561.0 sp|O46470|RGS7_BOVIN Regulator of G-protein signaling 7 OS=Bos taurus OX=9913 GN=RGS7 PE=1 SV=1 g9734.t1 Q6DGZ0 46.067 267 3.96e-65 207.0 sp|Q6DGZ0|GPT11_DANRE G patch domain-containing protein 11 OS=Danio rerio OX=7955 GN=gpatch11 PE=2 SV=1 g9735.t1 P26884 54.299 221 5.69e-74 226.0 sp|P26884|FKBP3_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP3 OS=Bos taurus OX=9913 GN=FKBP3 PE=1 SV=2 g9736.t1 Q08882 41.176 153 5.15e-24 110.0 sp|Q08882|HR3_MANSE Probable nuclear hormone receptor HR3 OS=Manduca sexta OX=7130 GN=HR3 PE=2 SV=1 g9738.t1 P35398 61.905 84 1.32e-26 117.0 sp|P35398|RORA_HUMAN Nuclear receptor ROR-alpha OS=Homo sapiens OX=9606 GN=RORA PE=1 SV=2 RORA_HUMAN reviewed Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001223; GO:0001525; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006357; GO:0006805; GO:0006809; GO:0008013; GO:0008142; GO:0008270; GO:0008589; GO:0010575; GO:0010906; GO:0019218; GO:0021702; GO:0021930; GO:0030522; GO:0032922; GO:0036315; GO:0042632; GO:0042692; GO:0042753; GO:0043030; GO:0043124; GO:0043565; GO:0045599; GO:0045893; GO:0045944; GO:0046068; GO:0050728; GO:0070328; GO:0071347; GO:0071356; GO:0071456; GO:0072539; GO:0098531 angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to sterol [GO:0036315]; cellular response to tumor necrosis factor [GO:0071356]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell differentiation [GO:0021702]; cGMP metabolic process [GO:0046068]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; intracellular receptor signaling pathway [GO:0030522]; muscle cell differentiation [GO:0042692]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucose metabolic process [GO:0010906]; regulation of macrophage activation [GO:0043030]; regulation of smoothened signaling pathway [GO:0008589]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ligand-modulated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g9739.t1 Q3UYG8 48.851 174 2.0300000000000003e-37 146.0 sp|Q3UYG8|MACD2_MOUSE ADP-ribose glycohydrolase MACROD2 OS=Mus musculus OX=10090 GN=Macrod2 PE=1 SV=1 MACD2_MOUSE reviewed ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0007420; GO:0009617; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0061463; GO:0140291; GO:0140293 brain development [GO:0007420]; DNA damage response [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463] g9740.t1 Q8R4H4 35.867 421 4.72e-97 300.0 sp|Q8R4H4|CBPA5_MOUSE Carboxypeptidase A5 OS=Mus musculus OX=10090 GN=Cpa5 PE=2 SV=1 g9741.t1 P00730 36.468 436 8.84e-78 250.0 sp|P00730|CBPA1_BOVIN Carboxypeptidase A1 OS=Bos taurus OX=9913 GN=CPA1 PE=1 SV=3 CBPA1_BOVIN reviewed Carboxypeptidase A1 (EC 3.4.17.1) Bos taurus (Bovine) GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270 leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g9742.t1 Q9H6P5 47.826 391 1.54e-121 361.0 sp|Q9H6P5|TASP1_HUMAN Threonine aspartase 1 OS=Homo sapiens OX=9606 GN=TASP1 PE=1 SV=1 TASP1_HUMAN reviewed Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta] Homo sapiens (Human) GO:0004298; GO:0005737; GO:0005829; GO:0006508; GO:0042802; GO:0045893; GO:0051604 positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298] g9743.t1 Q9VBW0 32.022 178 2.17e-21 88.6 sp|Q9VBW0|SAYS1_DROME SAYSvFN domain-containing protein 1 OS=Drosophila melanogaster OX=7227 GN=Saysd1 PE=2 SV=1 g9744.t1 Q14746 46.809 752 0.0 681.0 sp|Q14746|COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens OX=9606 GN=COG2 PE=1 SV=1 g9745.t1 Q8BMT9 30.862 499 5.2e-73 244.0 sp|Q8BMT9|HHAT_MOUSE Protein-cysteine N-palmitoyltransferase HHAT OS=Mus musculus OX=10090 GN=Hhat PE=1 SV=1 HHAT_MOUSE reviewed Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Skinny hedgehog protein) Mus musculus (Mouse) GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0016409; GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409] g9747.t1 E7FAM5 24.451 364 1.35e-29 124.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9748.t1 Q8MQW8 34.048 373 7.32e-61 233.0 sp|Q8MQW8|SPRI_DROME Protein sprint OS=Drosophila melanogaster OX=7227 GN=spri PE=2 SV=3 SPRI_DROME reviewed Protein sprint (SH2 poly-proline-containing Ras-interactor protein) Drosophila melanogaster (Fruit fly) GO:0005085; GO:0005096; GO:0005829; GO:0005938; GO:0007165; GO:0016192; GO:0019901; GO:0030139; GO:0030971; GO:0031267; GO:0032483; GO:0048260; GO:0048675; GO:1903688 axon extension [GO:0048675]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of Rab protein signal transduction [GO:0032483]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267] g9749.t1 Q8NBX0 48.941 425 1.26e-151 439.0 sp|Q8NBX0|SCPDL_HUMAN Saccharopine dehydrogenase-like oxidoreductase OS=Homo sapiens OX=9606 GN=SCCPDH PE=1 SV=1 g9750.t1 Q2PFW9 54.114 316 3.65e-94 298.0 sp|Q2PFW9|NOVA1_MACFA RNA-binding protein Nova-1 OS=Macaca fascicularis OX=9541 GN=NOVA1 PE=2 SV=1 g9751.t1 Q62261 57.556 2349 0.0 2672.0 sp|Q62261|SPTB2_MOUSE Spectrin beta chain, non-erythrocytic 1 OS=Mus musculus OX=10090 GN=Sptbn1 PE=1 SV=2 g9752.t1 Q96JC1 57.207 888 0.0 989.0 sp|Q96JC1|VPS39_HUMAN Vam6/Vps39-like protein OS=Homo sapiens OX=9606 GN=VPS39 PE=1 SV=2 g9754.t1 Q5ZQU0 35.443 237 9.530000000000001e-36 151.0 sp|Q5ZQU0|SNED1_RAT Sushi, nidogen and EGF-like domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Sned1 PE=2 SV=2 SNED1_RAT reviewed Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1) Rattus norvegicus (Rat) GO:0005112; GO:0005509; GO:0007160; GO:0031012 cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g9755.t1 Q5ZQU0 45.833 240 7.24e-58 223.0 sp|Q5ZQU0|SNED1_RAT Sushi, nidogen and EGF-like domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Sned1 PE=2 SV=2 SNED1_RAT reviewed Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1) Rattus norvegicus (Rat) GO:0005112; GO:0005509; GO:0007160; GO:0031012 cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g9755.t2 Q5ZQU0 45.833 240 1.88e-57 223.0 sp|Q5ZQU0|SNED1_RAT Sushi, nidogen and EGF-like domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Sned1 PE=2 SV=2 SNED1_RAT reviewed Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1) Rattus norvegicus (Rat) GO:0005112; GO:0005509; GO:0007160; GO:0031012 cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g9756.t1 Q5VT66 41.176 340 6.1799999999999996e-74 234.0 sp|Q5VT66|MARC1_HUMAN Mitochondrial amidoxime-reducing component 1 OS=Homo sapiens OX=9606 GN=MTARC1 PE=1 SV=1 MARC1_HUMAN reviewed Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1) Homo sapiens (Human) GO:0005739; GO:0005741; GO:0006809; GO:0008940; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809; GO:1903958 cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958] molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170] g9757.t1 Q9NP81 45.638 447 1.23e-136 407.0 sp|Q9NP81|SYSM_HUMAN Serine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=SARS2 PE=1 SV=1 SYSM_HUMAN reviewed Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006434; GO:0070158 mitochondrial seryl-tRNA aminoacylation [GO:0070158]; seryl-tRNA aminoacylation [GO:0006434] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049] g9758.t1 Q9P2K2 26.648 728 8.59e-66 238.0 sp|Q9P2K2|TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens OX=9606 GN=TXNDC16 PE=1 SV=4 TXD16_HUMAN reviewed Thioredoxin domain-containing protein 16 Homo sapiens (Human) GO:0005788; GO:0070062 endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] g9758.t2 Q9P2K2 27.2 375 3.09e-35 142.0 sp|Q9P2K2|TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens OX=9606 GN=TXNDC16 PE=1 SV=4 TXD16_HUMAN reviewed Thioredoxin domain-containing protein 16 Homo sapiens (Human) GO:0005788; GO:0070062 endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] g9758.t3 Q7TN22 26.531 343 1.9099999999999997e-24 109.0 sp|Q7TN22|TXD16_MOUSE Thioredoxin domain-containing protein 16 OS=Mus musculus OX=10090 GN=Txndc16 PE=2 SV=1 g9759.t1 A4IFM3 45.486 288 4.0299999999999997e-81 251.0 sp|A4IFM3|DR9C7_BOVIN Short-chain dehydrogenase/reductase family 9C member 7 OS=Bos taurus OX=9913 GN=SDR9C7 PE=2 SV=1 DR9C7_BOVIN reviewed Short-chain dehydrogenase/reductase family 9C member 7 (SDR9C7) (EC 1.1.1.-) (O-acylceramide dehydrogenase) (Orphan short-chain dehydrogenase/reductase) (SDR-O) Bos taurus (Bovine) GO:0004745; GO:0005737; GO:0008202; GO:0042572 retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] cytoplasm [GO:0005737] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745] g9760.t1 P57791 47.876 259 2.59e-63 206.0 sp|P57791|FACE2_MOUSE CAAX prenyl protease 2 OS=Mus musculus OX=10090 GN=Rce1 PE=2 SV=1 FACE2_MOUSE reviewed CAAX prenyl protease 2 (EC 3.4.26.1) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005789; GO:0008238; GO:0071586; GO:0080120 CAAX-box protein maturation [GO:0080120]; CAAX-box protein processing [GO:0071586] endoplasmic reticulum membrane [GO:0005789] endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222] g9762.t1 P31646 47.17 212 1.3e-55 190.0 sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1 S6A13_RAT reviewed Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13) Rattus norvegicus (Rat) GO:0005283; GO:0005308; GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine:sodium symporter activity [GO:0005369] g9763.t1 P23978 46.171 444 2.44e-141 421.0 sp|P23978|SC6A1_RAT Sodium- and chloride-dependent GABA transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc6a1 PE=1 SV=1 SC6A1_RAT reviewed Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1) Rattus norvegicus (Rat) GO:0005283; GO:0005332; GO:0005886; GO:0006865; GO:0007612; GO:0007613; GO:0008306; GO:0009410; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098810; GO:0098982; GO:1902476; GO:1904313 amino acid transport [GO:0006865]; associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to methamphetamine hydrochloride [GO:1904313]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] amino acid:sodium symporter activity [GO:0005283]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] g9764.t1 Q5R8C2 51.556 225 2.3500000000000002e-80 243.0 sp|Q5R8C2|LYPL1_PONAB Lysophospholipase-like protein 1 OS=Pongo abelii OX=9601 GN=LYPLAL1 PE=2 SV=3 g9767.t1 Q9WU19 50.275 364 1.61e-122 360.0 sp|Q9WU19|HAOX1_MOUSE 2-Hydroxyacid oxidase 1 OS=Mus musculus OX=10090 GN=Hao1 PE=1 SV=1 HAOX1_MOUSE reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Mus musculus (Mouse) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g9768.t1 Q9WU19 49.864 367 2.0300000000000003e-117 347.0 sp|Q9WU19|HAOX1_MOUSE 2-Hydroxyacid oxidase 1 OS=Mus musculus OX=10090 GN=Hao1 PE=1 SV=1 HAOX1_MOUSE reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Mus musculus (Mouse) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g9769.t1 Q9UJM8 49.319 367 6.63e-123 361.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g9770.t1 B0BNF9 51.226 367 1.84e-125 368.0 sp|B0BNF9|HAOX1_RAT 2-Hydroxyacid oxidase 1 OS=Rattus norvegicus OX=10116 GN=Hao1 PE=1 SV=1 HAOX1_RAT reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Rattus norvegicus (Rat) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g9771.t1 P02576 58.081 198 2.54e-80 248.0 sp|P02576|ACTA_PHYPO Actin, plasmodial isoform OS=Physarum polycephalum OX=5791 GN=ARDA PE=1 SV=2 g9772.t1 Q5REC2 66.72 622 0.0 852.0 sp|Q5REC2|NEC2_PONAB Neuroendocrine convertase 2 OS=Pongo abelii OX=9601 GN=PCSK2 PE=2 SV=1 NEC2_PONAB reviewed Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Prohormone convertase 2) (Proprotein convertase 2) (PC2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004252; GO:0005615; GO:0005654; GO:0007399; GO:0016020; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0034230; GO:0043005 enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540] extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] serine-type endopeptidase activity [GO:0004252] g9772.t2 Q5REC2 66.506 624 0.0 852.0 sp|Q5REC2|NEC2_PONAB Neuroendocrine convertase 2 OS=Pongo abelii OX=9601 GN=PCSK2 PE=2 SV=1 NEC2_PONAB reviewed Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (Prohormone convertase 2) (Proprotein convertase 2) (PC2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004252; GO:0005615; GO:0005654; GO:0007399; GO:0016020; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0034230; GO:0043005 enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540] extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] serine-type endopeptidase activity [GO:0004252] g9776.t1 Q9N126 43.885 278 2.62e-62 202.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g9782.t1 Q7ZWG6 32.243 428 1.11e-52 188.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9783.t1 Q7ZWG6 32.243 428 1.11e-52 188.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9786.t1 Q6DCX5 30.735 449 5.0000000000000005e-58 202.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g9787.t1 Q9WVL0 63.38 213 1.43e-100 293.0 sp|Q9WVL0|MAAI_MOUSE Maleylacetoacetate isomerase OS=Mus musculus OX=10090 GN=Gstz1 PE=1 SV=1 g9788.t1 Q64280 29.326 341 6.18e-38 143.0 sp|Q64280|LFTY1_MOUSE Left-right determination factor 1 OS=Mus musculus OX=10090 GN=Lefty1 PE=2 SV=1 LFTY1_MOUSE reviewed Left-right determination factor 1 (Protein lefty-1) (Lefty protein) (Stimulated by retinoic acid gene 3 protein) (Transforming growth factor beta-4) (TGF-beta-4) Mus musculus (Mouse) GO:0000122; GO:0003007; GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0007368; GO:0008083; GO:0008285; GO:0009948; GO:0030509; GO:0032526; GO:0038100; GO:0042074; GO:1900108; GO:1900124 anterior/posterior axis specification [GO:0009948]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nodal receptor complex assembly [GO:1900124]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to retinoic acid [GO:0032526] extracellular region [GO:0005576]; extracellular space [GO:0005615] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; transforming growth factor beta receptor binding [GO:0005160] g9791.t1 Q7T293 64.706 68 1.35e-21 94.4 sp|Q7T293|SDE2_DANRE Splicing regulator SDE2 OS=Danio rerio OX=7955 GN=sde2 PE=2 SV=2 SDE2_DANRE reviewed Splicing regulator SDE2 (Replication stress response regulator SDE2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000479; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0030515; GO:0045292; GO:0051301 cell division [GO:0051301]; DNA replication [GO:0006260]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; mRNA cis splicing, via spliceosome [GO:0045292] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; snoRNA binding [GO:0030515] g9792.t1 Q07G43 62.162 74 4.66e-25 102.0 sp|Q07G43|SDE2_XENTR Splicing regulator SDE2 OS=Xenopus tropicalis OX=8364 GN=sde2 PE=2 SV=1 g9794.t1 Q14181 43.863 611 4.3e-158 469.0 sp|Q14181|DPOA2_HUMAN DNA polymerase alpha subunit B OS=Homo sapiens OX=9606 GN=POLA2 PE=1 SV=2 DPOA2_HUMAN reviewed DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005658; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006606; GO:0036064 DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; protein import into nucleus [GO:0006606] alpha DNA polymerase:primase complex [GO:0005658]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA binding [GO:0003677] g9795.t1 Q03017 36.066 305 1.01e-43 162.0 sp|Q03017|CACT_DROME NF-kappa-B inhibitor cactus OS=Drosophila melanogaster OX=7227 GN=cact PE=1 SV=2 g9797.t1 Q16534 54.839 93 2.01e-21 95.9 sp|Q16534|HLF_HUMAN Hepatic leukemia factor OS=Homo sapiens OX=9606 GN=HLF PE=1 SV=1 HLF_HUMAN reviewed Hepatic leukemia factor Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0006357; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:0090575; GO:1990837 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g9798.t1 O35680 63.971 136 1.68e-52 166.0 sp|O35680|RT12_MOUSE Small ribosomal subunit protein uS12m OS=Mus musculus OX=10090 GN=Mrps12 PE=1 SV=1 g9801.t1 Q8WV16 35.23 457 2.7400000000000002e-70 238.0 sp|Q8WV16|DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens OX=9606 GN=DCAF4 PE=1 SV=3 DCAF4_HUMAN reviewed DDB1- and CUL4-associated factor 4 (WD repeat-containing protein 21A) Homo sapiens (Human) GO:0005654; GO:0016567; GO:0080008 protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] g9802.t1 A5PJS2 63.068 176 8.4e-80 242.0 sp|A5PJS2|S5A1_BOVIN 3-oxo-5-alpha-steroid 4-dehydrogenase 1 OS=Bos taurus OX=9913 GN=SRD5A1 PE=2 SV=1 g9805.t1 Q9PTN2 46.0 100 7.9e-25 111.0 sp|Q9PTN2|VDRA_DANRE Vitamin D3 receptor A OS=Danio rerio OX=7955 GN=vdra PE=1 SV=2 VDRA_DANRE reviewed Vitamin D3 receptor A (VDR-A) (1,25-dihydroxyvitamin D3 receptor A) (Nuclear receptor subfamily 1 group I member 1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0001503; GO:0001947; GO:0003146; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0008270; GO:0030154; GO:0030522; GO:0045944; GO:0055074; GO:0071425; GO:1902098; GO:1902121 calcium ion homeostasis [GO:0055074]; cell differentiation [GO:0030154]; DNA-templated transcription [GO:0006351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355] cytoplasm [GO:0005737]; nucleus [GO:0005634] calcitriol binding [GO:1902098]; lithocholic acid binding [GO:1902121]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270] g9806.t1 Q96FA3 57.248 407 1.3399999999999999e-165 474.0 sp|Q96FA3|PELI1_HUMAN E3 ubiquitin-protein ligase pellino homolog 1 OS=Homo sapiens OX=9606 GN=PELI1 PE=1 SV=2 PELI1_HUMAN reviewed E3 ubiquitin-protein ligase pellino homolog 1 (Pellino-1) (EC 2.3.2.27) (Pellino-related intracellular-signaling molecule) (RING-type E3 ubiquitin transferase pellino homolog 1) Homo sapiens (Human) GO:0000209; GO:0001819; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0008592; GO:0030890; GO:0031398; GO:0032496; GO:0034141; GO:0034145; GO:0034450; GO:0035861; GO:0042098; GO:0042130; GO:0043123; GO:0043161; GO:0043331; GO:0060544; GO:0060546; GO:0061630; GO:0070534; GO:0070936; GO:1904262; GO:1905168 DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production [GO:0001819]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of necroptotic process [GO:0060544]; regulation of Toll signaling pathway [GO:0008592]; response to dsRNA [GO:0043331]; response to lipopolysaccharide [GO:0032496]; T cell proliferation [GO:0042098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] g9809.t1 Q0VC16 27.845 826 1.18e-54 215.0 sp|Q0VC16|TGO1_BOVIN Transport and Golgi organization protein 1 homolog OS=Bos taurus OX=9913 GN=MIA3 PE=2 SV=2 TGO1_BOVIN reviewed Transport and Golgi organization protein 1 homolog (TANGO1) Bos taurus (Bovine) GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0009306; GO:0015031; GO:0016020; GO:0035459; GO:0038024; GO:0042953; GO:0048731; GO:0070971; GO:0070973; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; system development [GO:0048731]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] cargo receptor activity [GO:0038024] g9809.t2 Q0VC16 27.845 826 1.1899999999999999e-54 215.0 sp|Q0VC16|TGO1_BOVIN Transport and Golgi organization protein 1 homolog OS=Bos taurus OX=9913 GN=MIA3 PE=2 SV=2 TGO1_BOVIN reviewed Transport and Golgi organization protein 1 homolog (TANGO1) Bos taurus (Bovine) GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0009306; GO:0015031; GO:0016020; GO:0035459; GO:0038024; GO:0042953; GO:0048731; GO:0070971; GO:0070973; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; system development [GO:0048731]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] cargo receptor activity [GO:0038024] g9809.t3 Q0VC16 27.662 817 4.32e-53 210.0 sp|Q0VC16|TGO1_BOVIN Transport and Golgi organization protein 1 homolog OS=Bos taurus OX=9913 GN=MIA3 PE=2 SV=2 TGO1_BOVIN reviewed Transport and Golgi organization protein 1 homolog (TANGO1) Bos taurus (Bovine) GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0009306; GO:0015031; GO:0016020; GO:0035459; GO:0038024; GO:0042953; GO:0048731; GO:0070971; GO:0070973; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; system development [GO:0048731]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] cargo receptor activity [GO:0038024] g9811.t1 O95069 32.493 357 7.25e-40 151.0 sp|O95069|KCNK2_HUMAN Potassium channel subfamily K member 2 OS=Homo sapiens OX=9606 GN=KCNK2 PE=1 SV=2 g9816.t1 Q52KG5 55.172 551 2.02e-162 555.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9816.t1 Q52KG5 43.889 180 6.77e-22 108.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9816.t2 Q52KG5 54.645 549 3.21e-162 555.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9816.t2 Q52KG5 43.889 180 6.24e-22 108.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9816.t3 Q52KG5 55.556 531 1.88e-158 539.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9816.t3 Q52KG5 44.633 177 6.75e-22 108.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9816.t4 Q52KG5 55.493 537 4.769999999999999e-159 541.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9816.t4 Q52KG5 44.633 177 6.41e-22 108.0 sp|Q52KG5|KI26A_MOUSE Kinesin-like protein KIF26A OS=Mus musculus OX=10090 GN=Kif26a PE=1 SV=2 KI26A_MOUSE reviewed Kinesin-like protein KIF26A Mus musculus (Mouse) GO:0001560; GO:0005524; GO:0005874; GO:0008017; GO:0009968; GO:0010975; GO:0021987; GO:0048484; GO:2001222 cerebral cortex development [GO:0021987]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975] microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017] g9817.t1 Q8N5I4 37.544 285 7.94e-46 159.0 sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2 DHRSX_HUMAN reviewed Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase) Homo sapiens (Human) GO:0005576; GO:0005789; GO:0005811; GO:0008106; GO:0010508; GO:0043048; GO:0160196; GO:0160197 dolichyl monophosphate biosynthetic process [GO:0043048]; positive regulation of autophagy [GO:0010508] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; lipid droplet [GO:0005811] alcohol dehydrogenase (NADP+) activity [GO:0008106]; dolichal reductase (NADPH) activity [GO:0160197]; polyprenol dehydrogenase (NAD+) activity [GO:0160196] g9819.t1 Q8K4T1 29.041 365 2.95e-46 169.0 sp|Q8K4T1|SIA8F_MOUSE Alpha-2,8-sialyltransferase 8F OS=Mus musculus OX=10090 GN=St8sia6 PE=1 SV=1 SIA8F_MOUSE reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g9819.t2 Q8K4T1 29.041 365 3.33e-46 169.0 sp|Q8K4T1|SIA8F_MOUSE Alpha-2,8-sialyltransferase 8F OS=Mus musculus OX=10090 GN=St8sia6 PE=1 SV=1 SIA8F_MOUSE reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g9820.t1 Q8K4T1 29.825 342 2.62e-46 167.0 sp|Q8K4T1|SIA8F_MOUSE Alpha-2,8-sialyltransferase 8F OS=Mus musculus OX=10090 GN=St8sia6 PE=1 SV=1 SIA8F_MOUSE reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g9821.t1 Q6ZXC9 34.855 241 4.12e-39 146.0 sp|Q6ZXC9|SIA8D_BOVIN CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Bos taurus OX=9913 GN=ST8SIA4 PE=2 SV=1 g9822.t1 Q9UGM3 32.323 495 1.2700000000000001e-64 231.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9822.t1 Q9UGM3 32.046 518 2.02e-64 230.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9822.t1 Q9UGM3 31.346 520 3.24e-62 224.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9822.t1 Q9UGM3 31.391 532 8.05e-61 219.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9822.t1 Q9UGM3 31.285 537 1.72e-59 216.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9822.t1 Q9UGM3 31.836 512 4.7200000000000005e-59 214.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9824.t1 Q5G265 35.417 336 1.84e-46 173.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g9824.t1 Q5G265 34.32 338 1.14e-44 168.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g9824.t1 Q5G265 34.703 219 6.75e-25 110.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g9825.t1 P13080 29.688 640 4.09e-74 254.0 sp|P13080|MALT_AEDAE Salivary alpha-glucosidase OS=Aedes aegypti OX=7159 GN=MAL1 PE=1 SV=1 g9826.t1 Q9Y597 67.308 624 0.0 850.0 sp|Q9Y597|KCTD3_HUMAN BTB/POZ domain-containing protein KCTD3 OS=Homo sapiens OX=9606 GN=KCTD3 PE=1 SV=2 g9827.t1 O75445 40.212 5287 0.0 3857.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g9827.t2 O75445 40.091 5303 0.0 3850.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g9827.t3 O75445 40.06 5307 0.0 3847.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g9832.t1 Q80XK6 37.461 2269 0.0 1347.0 sp|Q80XK6|ATG2B_MOUSE Autophagy-related protein 2 homolog B OS=Mus musculus OX=10090 GN=Atg2b PE=1 SV=3 ATG2B_MOUSE reviewed Autophagy-related protein 2 homolog B Mus musculus (Mouse) GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005783; GO:0005789; GO:0005811; GO:0032266; GO:0034045; GO:0034727; GO:0043495; GO:0061709; GO:0061723; GO:0061908; GO:0120013 autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; phagophore [GO:0061908]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-membrane adaptor activity [GO:0043495] g9834.t1 Q9NW75 37.193 285 7.57e-39 152.0 sp|Q9NW75|GPTC2_HUMAN G patch domain-containing protein 2 OS=Homo sapiens OX=9606 GN=GPATCH2 PE=1 SV=1 GPTC2_HUMAN reviewed G patch domain-containing protein 2 Homo sapiens (Human) GO:0003676; GO:0005634; GO:0005730; GO:0016607 nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] nucleic acid binding [GO:0003676] g9834.t2 Q9NW75 37.193 285 6.56e-39 152.0 sp|Q9NW75|GPTC2_HUMAN G patch domain-containing protein 2 OS=Homo sapiens OX=9606 GN=GPATCH2 PE=1 SV=1 GPTC2_HUMAN reviewed G patch domain-containing protein 2 Homo sapiens (Human) GO:0003676; GO:0005634; GO:0005730; GO:0016607 nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] nucleic acid binding [GO:0003676] g9835.t1 Q96L03 41.096 365 1.05e-85 266.0 sp|Q96L03|SPT17_HUMAN Spermatogenesis-associated protein 17 OS=Homo sapiens OX=9606 GN=SPATA17 PE=1 SV=1 g9836.t1 P50428 48.998 449 3.81e-148 434.0 sp|P50428|ARSA_MOUSE Arylsulfatase A OS=Mus musculus OX=10090 GN=Arsa PE=1 SV=2 g9837.t1 B5X7E4 49.505 202 9.019999999999999e-55 177.0 sp|B5X7E4|IF43B_SALSA Intraflagellar transport protein 43 homolog B OS=Salmo salar OX=8030 GN=ift43b PE=2 SV=1 g9838.t1 Q7TPD1 69.773 837 0.0 1212.0 sp|Q7TPD1|FBX11_MOUSE F-box only protein 11 OS=Mus musculus OX=10090 GN=Fbxo11 PE=1 SV=3 FBX11_MOUSE reviewed F-box only protein 11 Mus musculus (Mouse) GO:0001837; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756 epithelial to mesenchymal transition [GO:0001837]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9838.t2 Q7TPD1 69.441 841 0.0 1209.0 sp|Q7TPD1|FBX11_MOUSE F-box only protein 11 OS=Mus musculus OX=10090 GN=Fbxo11 PE=1 SV=3 FBX11_MOUSE reviewed F-box only protein 11 Mus musculus (Mouse) GO:0001837; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756 epithelial to mesenchymal transition [GO:0001837]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9838.t3 Q7TPD1 69.773 837 0.0 1215.0 sp|Q7TPD1|FBX11_MOUSE F-box only protein 11 OS=Mus musculus OX=10090 GN=Fbxo11 PE=1 SV=3 FBX11_MOUSE reviewed F-box only protein 11 Mus musculus (Mouse) GO:0001837; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756 epithelial to mesenchymal transition [GO:0001837]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g9839.t1 Q6AXQ2 49.65 143 2.5e-46 151.0 sp|Q6AXQ2|EFC11_RAT EF-hand calcium-binding domain-containing protein 11 OS=Rattus norvegicus OX=10116 GN=Efcab11 PE=2 SV=1 g9841.t1 Q561L1 66.964 448 0.0 635.0 sp|Q561L1|PUA1A_XENLA Adenylosuccinate synthetase isozyme 1 A OS=Xenopus laevis OX=8355 GN=adss1-a PE=2 SV=1 g9842.t1 Q6NUH2 55.932 236 1.4799999999999999e-89 267.0 sp|Q6NUH2|NAA40_XENLA N-alpha-acetyltransferase 40 OS=Xenopus laevis OX=8355 GN=naa40 PE=2 SV=1 g9843.t1 Q9QZS3 43.976 498 6.63e-119 371.0 sp|Q9QZS3|NUMB_MOUSE Protein numb homolog OS=Mus musculus OX=10090 GN=Numb PE=1 SV=1 NUMB_MOUSE reviewed Protein numb homolog (m-Nb) (m-Numb) Mus musculus (Mouse) GO:0005543; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0005905; GO:0007399; GO:0007405; GO:0007409; GO:0008013; GO:0010008; GO:0014069; GO:0016323; GO:0021670; GO:0021849; GO:0030136; GO:0030335; GO:0030900; GO:0031410; GO:0034332; GO:0043197; GO:0045177; GO:0045294; GO:0045296; GO:0045664; GO:0050769; GO:0050775; GO:0098978; GO:0099149; GO:0150052; GO:1903077 adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; forebrain development [GO:0030900]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; neuroblast proliferation [GO:0007405]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse assembly [GO:0150052]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543] g9844.t1 P42674 42.068 561 2.18e-139 419.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g9846.t1 Q86SR1 47.86 257 7.99e-71 234.0 sp|Q86SR1|GLT10_HUMAN Polypeptide N-acetylgalactosaminyltransferase 10 OS=Homo sapiens OX=9606 GN=GALNT10 PE=1 SV=2 GLT10_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g9850.t1 Q8NBN7 55.077 325 1.52e-105 315.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g9851.t1 P11928 30.699 329 2.5699999999999997e-30 121.0 sp|P11928|OAS1A_MOUSE 2'-5'-oligoadenylate synthase 1A OS=Mus musculus OX=10090 GN=Oas1a PE=1 SV=2 OAS1A_MOUSE reviewed 2'-5'-oligoadenylate synthase 1A ((2-5')oligo(A) synthase 1A) (2-5A synthase 1A) (EC 2.7.7.84) (p42 OAS) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0006164; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0048525; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071659; GO:0140374; GO:1901857; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; purine nucleotide biosynthetic process [GO:0006164]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g9852.t1 Q95JY5 51.402 107 8.93e-34 127.0 sp|Q95JY5|SAM15_MACFA Sterile alpha motif domain-containing protein 15 OS=Macaca fascicularis OX=9541 GN=SAMD15 PE=2 SV=2 g9853.t1 P33274 33.611 360 8.87e-58 199.0 sp|P33274|CP4F1_RAT Cytochrome P450 4F1 OS=Rattus norvegicus OX=10116 GN=Cyp4f1 PE=1 SV=1 CP4F1_RAT reviewed Cytochrome P450 4F1 (CYPIVF1) (Cytochrome P450-A3) (Leukotriene-B4 20-monooxygenase) (EC 1.14.14.94) Rattus norvegicus (Rat) GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0009636; GO:0019369; GO:0020037; GO:0036101; GO:0050051; GO:0050544; GO:0052869; GO:0097267 arachidonate metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; omega-hydroxylase P450 pathway [GO:0097267]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789] arachidonate binding [GO:0050544]; arachidonate monooxygenase activity [GO:0008391]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051] g9854.t1 Q8BMP6 50.943 106 4.86e-31 128.0 sp|Q8BMP6|GCP60_MOUSE Golgi resident protein GCP60 OS=Mus musculus OX=10090 GN=Acbd3 PE=1 SV=3 GCP60_MOUSE reviewed Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) Mus musculus (Mouse) GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0034237 steroid biosynthetic process [GO:0006694] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739] fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237] g9859.t1 B1H1W9 34.068 590 1.4999999999999997e-95 321.0 sp|B1H1W9|KTU_XENLA Protein kintoun OS=Xenopus laevis OX=8355 GN=dnaaf2 PE=2 SV=1 g9860.t1 Q92186 33.745 243 4.57e-39 145.0 sp|Q92186|SIA8B_HUMAN Alpha-2,8-sialyltransferase 8B OS=Homo sapiens OX=9606 GN=ST8SIA2 PE=1 SV=1 SIA8B_HUMAN reviewed Alpha-2,8-sialyltransferase 8B (EC 2.4.3.-) (Sialyltransferase 8B) (SIAT8-B) (Sialyltransferase St8Sia II) (ST8SiaII) (Sialyltransferase X) (STX) Homo sapiens (Human) GO:0000139; GO:0000166; GO:0001574; GO:0003828; GO:0005576; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006491; GO:0007399; GO:0009101; GO:0009311; GO:0033691; GO:0036211; GO:0042220; GO:0043525; GO:0048471; GO:0051965; GO:0055037; GO:0097503; GO:1990138 carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; neuron projection extension [GO:1990138]; oligosaccharide metabolic process [GO:0009311]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synapse assembly [GO:0051965]; protein modification process [GO:0036211]; response to cocaine [GO:0042220]; sialylation [GO:0097503] cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; nucleotide binding [GO:0000166]; sialic acid binding [GO:0033691] g9861.t1 Q9UGM3 32.649 536 6.67e-64 229.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t1 Q9UGM3 33.533 501 5.34e-62 223.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t1 Q9UGM3 31.97 538 4.8599999999999997e-60 217.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t1 Q9UGM3 32.7 526 7.799999999999999e-60 217.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t1 Q9UGM3 31.955 532 4.24e-59 214.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t1 Q9UGM3 34.109 387 5.230000000000001e-47 179.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t1 Q9UGM3 32.365 241 3.18e-25 114.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t2 Q9UGM3 32.649 536 6.67e-64 229.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t2 Q9UGM3 33.533 501 5.34e-62 223.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t2 Q9UGM3 31.97 538 4.8599999999999997e-60 217.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t2 Q9UGM3 32.7 526 7.799999999999999e-60 217.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t2 Q9UGM3 31.955 532 4.24e-59 214.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t2 Q9UGM3 34.109 387 5.230000000000001e-47 179.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9861.t2 Q9UGM3 32.365 241 3.18e-25 114.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g9863.t1 P21329 33.01 206 6.26e-22 97.4 sp|P21329|RTJK_DROFU RNA-directed DNA polymerase from mobile element jockey OS=Drosophila funebris OX=7221 GN=jockey\pol PE=1 SV=1 g9865.t1 A1A4N1 29.213 445 7.98e-55 194.0 sp|A1A4N1|S29A3_BOVIN Equilibrative nucleoside transporter 3 OS=Bos taurus OX=9913 GN=SLC29A3 PE=2 SV=1 S29A3_BOVIN reviewed Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3) Bos taurus (Bovine) GO:0005326; GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0006837; GO:0008504; GO:0015101; GO:0015205; GO:0015208; GO:0015210; GO:0015212; GO:0015213; GO:0015851; GO:0015858; GO:0015861; GO:0015862; GO:0015872; GO:0015874; GO:0031902; GO:0031966; GO:0032238; GO:0035340; GO:1901642; GO:1903716; GO:1903791; GO:1904082; GO:1904823 adenosine transport [GO:0032238]; cytidine transport [GO:0015861]; dopamine transport [GO:0015872]; guanine transmembrane transport [GO:1903716]; inosine transport [GO:0035340]; norepinephrine transport [GO:0015874]; nucleobase transport [GO:0015851]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transmembrane transport [GO:1904082]; serotonin transport [GO:0006837]; uracil transmembrane transport [GO:1903791]; uridine transmembrane transport [GO:0015862] Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] cytidine transmembrane transporter activity [GO:0015212]; guanine transmembrane transporter activity [GO:0015208]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleobase transmembrane transporter activity [GO:0015205]; nucleoside transmembrane transporter activity [GO:0005337]; organic cation transmembrane transporter activity [GO:0015101]; uracil transmembrane transporter activity [GO:0015210]; uridine transmembrane transporter activity [GO:0015213] g9867.t1 Q09815 33.609 363 4.21e-46 183.0 sp|Q09815|PPK5_SCHPO Serine/threonine-protein kinase ppk5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ppk5 PE=1 SV=1 PPK5_SCHPO reviewed Serine/threonine-protein kinase ppk5 (EC 2.7.11.1) (Meiotically up-regulated gene 189 protein) Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005739; GO:0005856; GO:0010821; GO:0023052; GO:0032153; GO:0051321; GO:0051445; GO:0106310; GO:0110085; GO:1902412 meiotic cell cycle [GO:0051321]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cytokinesis [GO:1902412]; signaling [GO:0023052] cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; mitotic actomyosin contractile ring [GO:0110085] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9867.t2 Q09815 38.571 210 2.77e-33 142.0 sp|Q09815|PPK5_SCHPO Serine/threonine-protein kinase ppk5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ppk5 PE=1 SV=1 PPK5_SCHPO reviewed Serine/threonine-protein kinase ppk5 (EC 2.7.11.1) (Meiotically up-regulated gene 189 protein) Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005739; GO:0005856; GO:0010821; GO:0023052; GO:0032153; GO:0051321; GO:0051445; GO:0106310; GO:0110085; GO:1902412 meiotic cell cycle [GO:0051321]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cytokinesis [GO:1902412]; signaling [GO:0023052] cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; mitotic actomyosin contractile ring [GO:0110085] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g9868.t1 O13046 44.577 1171 0.0 951.0 sp|O13046|WDHD1_XENLA WD repeat and HMG-box DNA-binding protein 1 OS=Xenopus laevis OX=8355 GN=wdhd1 PE=1 SV=1 g9869.t1 O75159 48.299 294 2.33e-78 260.0 sp|O75159|SOCS5_HUMAN Suppressor of cytokine signaling 5 OS=Homo sapiens OX=9606 GN=SOCS5 PE=1 SV=1 SOCS5_HUMAN reviewed Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2 protein 6) (CIS-6) (Cytokine-inducible SH2-containing protein 5) Homo sapiens (Human) GO:0005154; GO:0005829; GO:0007173; GO:0007175; GO:0007259; GO:0009968; GO:0016567; GO:0019221; GO:0030971; GO:0032436; GO:0032715; GO:0035556; GO:0045627; GO:0045629; GO:0050728; GO:0071404; GO:0071638; GO:0097699 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of signal transduction [GO:0009968]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; protein ubiquitination [GO:0016567]; vascular endothelial cell response to fluid shear stress [GO:0097699] cytosol [GO:0005829] epidermal growth factor receptor binding [GO:0005154]; receptor tyrosine kinase binding [GO:0030971] g9872.t1 Q17M80 75.842 505 0.0 809.0 sp|Q17M80|MMSA_AEDAE Probable methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase [acylating], mitochondrial OS=Aedes aegypti OX=7159 GN=AAEL001134 PE=3 SV=1 g9874.t1 Q5ZJQ3 69.091 110 9.200000000000001e-47 149.0 sp|Q5ZJQ3|LIN52_CHICK Protein lin-52 homolog OS=Gallus gallus OX=9031 GN=LIN52 PE=1 SV=1 g9875.t1 A1A4N1 35.629 421 5.87e-81 259.0 sp|A1A4N1|S29A3_BOVIN Equilibrative nucleoside transporter 3 OS=Bos taurus OX=9913 GN=SLC29A3 PE=2 SV=1 S29A3_BOVIN reviewed Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3) Bos taurus (Bovine) GO:0005326; GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0006837; GO:0008504; GO:0015101; GO:0015205; GO:0015208; GO:0015210; GO:0015212; GO:0015213; GO:0015851; GO:0015858; GO:0015861; GO:0015862; GO:0015872; GO:0015874; GO:0031902; GO:0031966; GO:0032238; GO:0035340; GO:1901642; GO:1903716; GO:1903791; GO:1904082; GO:1904823 adenosine transport [GO:0032238]; cytidine transport [GO:0015861]; dopamine transport [GO:0015872]; guanine transmembrane transport [GO:1903716]; inosine transport [GO:0035340]; norepinephrine transport [GO:0015874]; nucleobase transport [GO:0015851]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transmembrane transport [GO:1904082]; serotonin transport [GO:0006837]; uracil transmembrane transport [GO:1903791]; uridine transmembrane transport [GO:0015862] Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] cytidine transmembrane transporter activity [GO:0015212]; guanine transmembrane transporter activity [GO:0015208]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleobase transmembrane transporter activity [GO:0015205]; nucleoside transmembrane transporter activity [GO:0005337]; organic cation transmembrane transporter activity [GO:0015101]; uracil transmembrane transporter activity [GO:0015210]; uridine transmembrane transporter activity [GO:0015213] g9875.t2 A1A4N1 35.222 406 5.21e-75 243.0 sp|A1A4N1|S29A3_BOVIN Equilibrative nucleoside transporter 3 OS=Bos taurus OX=9913 GN=SLC29A3 PE=2 SV=1 S29A3_BOVIN reviewed Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3) Bos taurus (Bovine) GO:0005326; GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0006837; GO:0008504; GO:0015101; GO:0015205; GO:0015208; GO:0015210; GO:0015212; GO:0015213; GO:0015851; GO:0015858; GO:0015861; GO:0015862; GO:0015872; GO:0015874; GO:0031902; GO:0031966; GO:0032238; GO:0035340; GO:1901642; GO:1903716; GO:1903791; GO:1904082; GO:1904823 adenosine transport [GO:0032238]; cytidine transport [GO:0015861]; dopamine transport [GO:0015872]; guanine transmembrane transport [GO:1903716]; inosine transport [GO:0035340]; norepinephrine transport [GO:0015874]; nucleobase transport [GO:0015851]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transmembrane transport [GO:1904082]; serotonin transport [GO:0006837]; uracil transmembrane transport [GO:1903791]; uridine transmembrane transport [GO:0015862] Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] cytidine transmembrane transporter activity [GO:0015212]; guanine transmembrane transporter activity [GO:0015208]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleobase transmembrane transporter activity [GO:0015205]; nucleoside transmembrane transporter activity [GO:0005337]; organic cation transmembrane transporter activity [GO:0015101]; uracil transmembrane transporter activity [GO:0015210]; uridine transmembrane transporter activity [GO:0015213] g9880.t1 Q8IV35 30.536 727 1.14e-87 311.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g9882.t1 F1Q8R9 57.143 686 0.0 793.0 sp|F1Q8R9|POMT2_DANRE Protein O-mannosyl-transferase 2 OS=Danio rerio OX=7955 GN=pomt2 PE=1 SV=1 POMT2_DANRE reviewed Protein O-mannosyl-transferase 2 (EC 2.4.1.109) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0045494 photoreceptor cell maintenance [GO:0045494]; protein O-linked glycosylation via mannose [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169] g9883.t1 C6KFA3 24.006 654 2.2800000000000002e-33 143.0 sp|C6KFA3|AGRG6_DANRE Adhesion G-protein coupled receptor G6 OS=Danio rerio OX=7955 GN=adgrg6 PE=1 SV=1 AGRG6_DANRE reviewed Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004930; GO:0005518; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007193; GO:0007507; GO:0014037; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0043583; GO:0050840; GO:0051216; GO:0060347 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; regulation of bone mineralization [GO:0030500]; Schwann cell differentiation [GO:0014037] plasma membrane [GO:0005886] collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236] g9884.t1 F7J220 33.073 768 1.88e-107 356.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9884.t1 F7J220 32.678 661 1.26e-80 283.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9884.t1 F7J220 30.607 758 2.04e-79 279.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9884.t1 F7J220 29.803 661 9.83e-69 249.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9884.t2 F7J220 32.169 687 6.62e-91 310.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9884.t2 F7J220 31.004 687 2.56e-72 258.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9884.t2 F7J220 30.015 663 3.07e-69 249.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9884.t2 F7J220 29.446 343 2.56e-31 135.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g9886.t1 Q17QR8 30.634 284 2.2800000000000002e-35 134.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g1736.t1 Q5XGI3 42.89 436 1.05e-103 330.0 sp|Q5XGI3|FBXL5_XENTR F-box/LRR-repeat protein 5 OS=Xenopus tropicalis OX=8364 GN=fbxl5 PE=2 SV=1 g1736.t1 Q5XGI3 46.753 154 4.51e-29 125.0 sp|Q5XGI3|FBXL5_XENTR F-box/LRR-repeat protein 5 OS=Xenopus tropicalis OX=8364 GN=fbxl5 PE=2 SV=1 g1737.t1 Q6ZQX7 38.424 203 8.350000000000001e-43 155.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 38.806 201 1.51e-42 155.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 39.394 198 3.1599999999999995e-42 154.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 39.0 200 3.81e-42 154.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 39.0 200 1.18e-41 152.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 38.889 198 1.35e-41 152.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 39.086 197 1.96e-41 152.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 39.086 197 2.37e-41 152.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 37.143 210 2.71e-41 152.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1737.t1 Q6ZQX7 37.811 201 1.44e-40 150.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g1738.t1 Q5U4C9 67.806 556 0.0 768.0 sp|Q5U4C9|DYRK2_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Mus musculus OX=10090 GN=Dyrk2 PE=2 SV=1 DYRK2_MOUSE reviewed Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) Mus musculus (Mouse) GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007224; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:0106310; GO:1990904 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; smoothened signaling pathway [GO:0007224] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g1739.t1 P47897 63.32 777 0.0 1042.0 sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1 SYQ_HUMAN reviewed Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS) Homo sapiens (Human) GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234 brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] g1740.t1 Q9N0P9 63.258 264 1.85e-123 361.0 sp|Q9N0P9|PIM1_BOVIN Serine/threonine-protein kinase pim-1 OS=Bos taurus OX=9913 GN=PIM1 PE=2 SV=1 g1741.t1 F6S215 26.496 936 3.05e-98 331.0 sp|F6S215|AP5B1_XENTR AP-5 complex subunit beta-1 OS=Xenopus tropicalis OX=8364 GN=ap5b1 PE=3 SV=1 g1741.t2 F6S215 26.574 937 3.55e-97 328.0 sp|F6S215|AP5B1_XENTR AP-5 complex subunit beta-1 OS=Xenopus tropicalis OX=8364 GN=ap5b1 PE=3 SV=1 g1742.t1 A0JNK6 54.455 101 4.0800000000000003e-35 120.0 sp|A0JNK6|TM243_BOVIN Transmembrane protein 243 OS=Bos taurus OX=9913 GN=TMEM243 PE=3 SV=1 g1743.t1 P10079 38.026 618 7.829999999999999e-94 334.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1743.t1 P10079 34.732 691 3.37e-89 320.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1743.t1 P10079 35.231 650 7.15e-86 310.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1743.t1 P10079 36.892 637 7.35e-86 310.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1743.t1 P10079 33.871 620 2.79e-75 278.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1743.t1 P10079 36.58 462 1.32e-67 254.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1743.t1 P10079 41.967 305 1.51e-60 232.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g1744.t1 Q01105 49.772 219 1.3e-73 231.0 sp|Q01105|SET_HUMAN Protein SET OS=Homo sapiens OX=9606 GN=SET PE=1 SV=3 SET_HUMAN reviewed Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003682; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0019888; GO:0032991; GO:0042393; GO:0043524; GO:0045892; GO:0048471 DNA replication [GO:0006260]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888] g1745.t1 Q5I0M0 48.235 255 1.81e-76 238.0 sp|Q5I0M0|SETMR_RAT Histone-lysine N-methyltransferase SETMAR OS=Rattus norvegicus OX=10116 GN=Setmar PE=2 SV=1 SETMR_RAT reviewed Histone-lysine N-methyltransferase SETMAR (EC 2.1.1.357) (SET domain and mariner transposase fusion protein homolog) Rattus norvegicus (Rat) GO:0000014; GO:0000729; GO:0000793; GO:0003677; GO:0003690; GO:0003697; GO:0004519; GO:0005634; GO:0005730; GO:0006303; GO:0006308; GO:0008270; GO:0008283; GO:0015074; GO:0031297; GO:0032259; GO:0035861; GO:0042054; GO:0042800; GO:0042803; GO:0044547; GO:0044774; GO:0045814; GO:0045892; GO:0046975; GO:0140954; GO:2001034; GO:2001251 cell population proliferation [GO:0008283]; DNA catabolic process [GO:0006308]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; methylation [GO:0032259]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297] condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone methyltransferase activity [GO:0042054]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270] g1746.t1 P11029 64.673 2341 0.0 3146.0 sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1 g1746.t2 P11029 64.938 2333 0.0 3153.0 sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1 g1747.t1 Q6PCB5 70.44 159 5.15e-73 239.0 sp|Q6PCB5|RSBNL_HUMAN Lysine-specific demethylase RSBN1L OS=Homo sapiens OX=9606 GN=RSBN1L PE=1 SV=2 g1748.t1 Q14767 34.198 655 4.27e-64 246.0 sp|Q14767|LTBP2_HUMAN Latent-transforming growth factor beta-binding protein 2 OS=Homo sapiens OX=9606 GN=LTBP2 PE=1 SV=3 g1751.t1 O95376 57.112 464 0.0 565.0 sp|O95376|ARI2_HUMAN E3 ubiquitin-protein ligase ARIH2 OS=Homo sapiens OX=9606 GN=ARIH2 PE=1 SV=1 g1752.t1 Q9BXT6 39.404 1208 0.0 756.0 sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1 M10L1_HUMAN reviewed RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1) Homo sapiens (Human) GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196 germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g1752.t2 Q9BXT6 46.231 796 0.0 670.0 sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1 M10L1_HUMAN reviewed RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1) Homo sapiens (Human) GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196 germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g1752.t2 Q9BXT6 29.553 291 9.020000000000001e-22 107.0 sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1 M10L1_HUMAN reviewed RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1) Homo sapiens (Human) GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196 germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g1753.t1 Q9UP83 62.283 806 0.0 1021.0 sp|Q9UP83|COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens OX=9606 GN=COG5 PE=1 SV=4 COG5_HUMAN reviewed Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1) Homo sapiens (Human) GO:0000139; GO:0000301; GO:0005654; GO:0005794; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0048219 Golgi organization [GO:0007030]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588] g1754.t1 Q571C7 39.535 301 9.82e-44 177.0 sp|Q571C7|BDP1_MOUSE Transcription factor TFIIIB component B'' homolog OS=Mus musculus OX=10090 GN=Bdp1 PE=2 SV=2 BDP1_MOUSE reviewed Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator) Mus musculus (Mouse) GO:0000126; GO:0001156; GO:0005634; GO:0005654; GO:0006355; GO:0070898 regulation of DNA-templated transcription [GO:0006355]; RNA polymerase III preinitiation complex assembly [GO:0070898] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126] TFIIIC-class transcription factor complex binding [GO:0001156] g1755.t1 Q9JHW4 59.075 584 0.0 686.0 sp|Q9JHW4|SELB_MOUSE Selenocysteine-specific elongation factor OS=Mus musculus OX=10090 GN=Eefsec PE=1 SV=2 SELB_MOUSE reviewed Selenocysteine-specific elongation factor (EC 3.6.5.-) (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific) (mSelB) Mus musculus (Mouse) GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005739; GO:0005829; GO:0035368; GO:0043021; GO:0046872; GO:1990904 selenocysteine incorporation [GO:0001514] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049] g1757.t1 Q9D1L9 50.562 89 1.19e-28 101.0 sp|Q9D1L9|LTOR5_MOUSE Ragulator complex protein LAMTOR5 OS=Mus musculus OX=10090 GN=Lamtor5 PE=1 SV=1 LTOR5_MOUSE reviewed Ragulator complex protein LAMTOR5 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5) Mus musculus (Mouse) GO:0005764; GO:0005765; GO:0005829; GO:0008361; GO:0010628; GO:0031902; GO:0032008; GO:0032757; GO:0032991; GO:0038202; GO:0043066; GO:0043123; GO:0061462; GO:0071230; GO:0071986; GO:1900182; GO:1904263; GO:1990877 cellular response to amino acid stimulus [GO:0071230]; negative regulation of apoptotic process [GO:0043066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]; TORC1 signaling [GO:0038202] cytosol [GO:0005829]; FNIP-folliculin RagC/D GAP [GO:1990877]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; Ragulator complex [GO:0071986] g1760.t1 P70170 35.683 1617 0.0 954.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 ABCC9_MOUSE reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Mus musculus (Mouse) GO:0000165; GO:0001508; GO:0001568; GO:0001666; GO:0001669; GO:0003007; GO:0003018; GO:0005267; GO:0005524; GO:0005737; GO:0005739; GO:0005886; GO:0006357; GO:0006813; GO:0006950; GO:0007005; GO:0007507; GO:0007519; GO:0008015; GO:0008217; GO:0008281; GO:0008282; GO:0009410; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0019905; GO:0030017; GO:0030315; GO:0032991; GO:0033198; GO:0035864; GO:0035865; GO:0036293; GO:0042311; GO:0042383; GO:0042391; GO:0042542; GO:0042626; GO:0042802; GO:0043066; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0060976; GO:0061337; GO:0062197; GO:0070482; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072359; GO:0072592; GO:0086003; GO:0097746; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:1901363; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel diameter maintenance [GO:0097746]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; circulatory system development [GO:0072359]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of blood pressure [GO:0008217]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to decreased oxygen levels [GO:0036293]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to peptide [GO:1901652]; response to potassium ion [GO:0035864]; response to stress [GO:0006950]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; vascular process in circulatory system [GO:0003018]; vasodilation [GO:0042311] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; T-tubule [GO:0030315] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325] g1763.t1 Q6ITT3 35.021 474 1.83e-100 312.0 sp|Q6ITT3|MGT4C_PIG Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Sus scrofa OX=9823 GN=MGAT4C PE=2 SV=1 g1764.t1 P54289 33.97 1151 0.0 627.0 sp|P54289|CA2D1_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-1 OS=Homo sapiens OX=9606 GN=CACNA2D1 PE=1 SV=3 CA2D1_HUMAN reviewed Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1] Homo sapiens (Human) GO:0005245; GO:0005886; GO:0005891; GO:0006816; GO:0016529; GO:0046872; GO:0048787; GO:0051924; GO:0060307; GO:0060402; GO:0061577; GO:0070062; GO:0086002; GO:0086048; GO:0086091; GO:0098703; GO:0098903; GO:0098982; GO:0098992; GO:1902514; GO:1904646; GO:1990454 calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to amyloid-beta [GO:1904646]; membrane depolarization during bundle of His cell action potential [GO:0086048]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; L-type voltage-gated calcium channel complex [GO:1990454]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; sarcoplasmic reticulum [GO:0016529]; voltage-gated calcium channel complex [GO:0005891] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g1764.t2 Q9NY47 35.246 1098 0.0 619.0 sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2 g1764.t3 Q9NY47 35.695 1101 0.0 632.0 sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2 g1764.t4 Q9NY47 36.022 1091 0.0 640.0 sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2 g1764.t5 Q9NY47 35.78 218 6.2e-31 123.0 sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2 g1765.t1 P25102 26.837 313 1.2200000000000001e-21 97.4 sp|P25102|HRH2_RAT Histamine H2 receptor OS=Rattus norvegicus OX=10116 GN=Hrh2 PE=3 SV=1 HRH2_RAT reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Rattus norvegicus (Rat) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:0071420; GO:1900139; GO:1901363 cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g1771.t1 O75051 38.618 1577 0.0 989.0 sp|O75051|PLXA2_HUMAN Plexin-A2 OS=Homo sapiens OX=9606 GN=PLXNA2 PE=1 SV=4 PLXA2_HUMAN reviewed Plexin-A2 (Semaphorin receptor OCT) Homo sapiens (Human) GO:0001756; GO:0002116; GO:0005886; GO:0007416; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0051642; GO:0060037; GO:0060174; GO:0071526 centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154] g1772.t1 F1R4Y7 38.536 724 4.19e-143 438.0 sp|F1R4Y7|CEP83_DANRE Centrosomal protein of 83 kDa OS=Danio rerio OX=7955 GN=cep83 PE=3 SV=2 g1774.t1 Q9P2N4 43.889 1440 0.0 1195.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g1774.t1 Q9P2N4 33.033 1111 1.2500000000000001e-160 553.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g1774.t1 Q9P2N4 30.164 915 3.11e-103 374.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g1774.t1 Q9P2N4 30.246 896 4.05e-92 338.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g1774.t1 Q9P2N4 29.968 624 3.21e-61 238.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g1775.t1 Q8BFR4 49.706 511 2.23e-174 506.0 sp|Q8BFR4|GNS_MOUSE N-acetylglucosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Gns PE=1 SV=1 GNS_MOUSE reviewed N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Mus musculus (Mouse) GO:0005539; GO:0005764; GO:0008449; GO:0008484; GO:0030200; GO:0030203; GO:0042340; GO:0042582; GO:0043199; GO:0046872 glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan catabolic process [GO:0030200]; keratan sulfate proteoglycan catabolic process [GO:0042340] azurophil granule [GO:0042582]; lysosome [GO:0005764] glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484] g1775.t2 Q8BFR4 52.391 481 4.36e-179 517.0 sp|Q8BFR4|GNS_MOUSE N-acetylglucosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Gns PE=1 SV=1 GNS_MOUSE reviewed N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Mus musculus (Mouse) GO:0005539; GO:0005764; GO:0008449; GO:0008484; GO:0030200; GO:0030203; GO:0042340; GO:0042582; GO:0043199; GO:0046872 glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan catabolic process [GO:0030200]; keratan sulfate proteoglycan catabolic process [GO:0042340] azurophil granule [GO:0042582]; lysosome [GO:0005764] glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484] g1775.t3 Q8BFR4 49.71 517 5.21e-175 508.0 sp|Q8BFR4|GNS_MOUSE N-acetylglucosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Gns PE=1 SV=1 GNS_MOUSE reviewed N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Mus musculus (Mouse) GO:0005539; GO:0005764; GO:0008449; GO:0008484; GO:0030200; GO:0030203; GO:0042340; GO:0042582; GO:0043199; GO:0046872 glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan catabolic process [GO:0030200]; keratan sulfate proteoglycan catabolic process [GO:0042340] azurophil granule [GO:0042582]; lysosome [GO:0005764] glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484] g1776.t1 Q9UJ37 35.235 298 2.87e-41 153.0 sp|Q9UJ37|SIA7B_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Homo sapiens OX=9606 GN=ST6GALNAC2 PE=1 SV=1 SIA7B_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0006493; GO:0008373; GO:0009101; GO:0016266; GO:0019082; GO:1990743 glycoprotein biosynthetic process [GO:0009101]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; protein sialylation [GO:1990743]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g1777.t1 Q92184 30.794 315 2.43e-37 142.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g1778.t1 Q3T0F5 84.541 207 2.09e-130 368.0 sp|Q3T0F5|RAB7A_BOVIN Ras-related protein Rab-7a OS=Bos taurus OX=9913 GN=RAB7A PE=2 SV=1 RAB7A_BOVIN reviewed Ras-related protein Rab-7a (EC 3.6.5.2) Bos taurus (Bovine) GO:0000421; GO:0003925; GO:0005525; GO:0005739; GO:0005764; GO:0005765; GO:0005770; GO:0005811; GO:0005829; GO:0008333; GO:0016042; GO:0030670; GO:0031902; GO:0031966; GO:0033162; GO:0045022; GO:0045335; GO:0046872; GO:0061724; GO:0090383; GO:0090385; GO:0099638 early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670] G protein activity [GO:0003925]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] g1783.t1 Q9NVM9 41.803 732 2.08e-163 488.0 sp|Q9NVM9|INT13_HUMAN Integrator complex subunit 13 OS=Homo sapiens OX=9606 GN=INTS13 PE=1 SV=2 INT13_HUMAN reviewed Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016180; GO:0016604; GO:0030317; GO:0032039; GO:0034243; GO:0051301; GO:0051642; GO:0080154; GO:0090435; GO:0140297; GO:0160232; GO:0160240 cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor binding [GO:0140297] g1784.t1 Q6BEA0 32.489 1973 0.0 896.0 sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1 PLXA4_DANRE reviewed Plexin-A4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526 axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416] membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g1785.t1 Q9HCM2 27.718 1306 2.98e-125 431.0 sp|Q9HCM2|PLXA4_HUMAN Plexin-A4 OS=Homo sapiens OX=9606 GN=PLXNA4 PE=1 SV=4 PLXA4_HUMAN reviewed Plexin-A4 Homo sapiens (Human) GO:0002116; GO:0005886; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g1786.t1 Q9V4A7 30.63 1874 0.0 805.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g1787.t1 Q9V4A7 31.363 1827 0.0 837.0 sp|Q9V4A7|PLXB_DROME Plexin-B OS=Drosophila melanogaster OX=7227 GN=PlexB PE=1 SV=2 PLXB_DROME reviewed Plexin-B Drosophila melanogaster (Fruit fly) GO:0002116; GO:0005886; GO:0007162; GO:0007411; GO:0007416; GO:0008045; GO:0008360; GO:0017154; GO:0030334; GO:0030425; GO:0050772; GO:0070593; GO:0071526; GO:0071678; GO:0097374 axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; motor neuron axon guidance [GO:0008045]; negative regulation of cell adhesion [GO:0007162]; olfactory bulb axon guidance [GO:0071678]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synapse assembly [GO:0007416] dendrite [GO:0030425]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g1788.t1 Q6NZW8 90.86 186 7.46e-127 357.0 sp|Q6NZW8|AR8BA_DANRE ADP-ribosylation factor-like protein 8B-A OS=Danio rerio OX=7955 GN=arl8ba PE=2 SV=1 g1790.t1 O43772 65.203 296 3.9599999999999997e-138 395.0 sp|O43772|MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens OX=9606 GN=SLC25A20 PE=1 SV=1 MCAT_HUMAN reviewed Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20) Homo sapiens (Human) GO:0001701; GO:0005476; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006853; GO:0015227; GO:1902603 carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839] cytosol [GO:0005829]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine:O-acyl-L-carnitine antiporter activity [GO:0005476]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227] g1793.t1 Q9H1K0 34.128 545 4.74e-77 261.0 sp|Q9H1K0|RBNS5_HUMAN Rabenosyn-5 OS=Homo sapiens OX=9606 GN=RBSN PE=1 SV=2 RBNS5_HUMAN reviewed Rabenosyn-5 (110 kDa protein) (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20) Homo sapiens (Human) GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0008270; GO:0010008; GO:0015031; GO:0016197; GO:0031267; GO:0031901; GO:0032266; GO:0034498; GO:0070062; GO:0090160; GO:1903358 early endosome to Golgi transport [GO:0034498]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] phosphatidylinositol-3-phosphate binding [GO:0032266]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g1793.t2 Q9H1K0 34.508 539 1.98e-79 267.0 sp|Q9H1K0|RBNS5_HUMAN Rabenosyn-5 OS=Homo sapiens OX=9606 GN=RBSN PE=1 SV=2 RBNS5_HUMAN reviewed Rabenosyn-5 (110 kDa protein) (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20) Homo sapiens (Human) GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0008270; GO:0010008; GO:0015031; GO:0016197; GO:0031267; GO:0031901; GO:0032266; GO:0034498; GO:0070062; GO:0090160; GO:1903358 early endosome to Golgi transport [GO:0034498]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] phosphatidylinositol-3-phosphate binding [GO:0032266]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g1794.t1 Q9H816 47.977 346 4.66e-102 327.0 sp|Q9H816|DCR1B_HUMAN 5' exonuclease Apollo OS=Homo sapiens OX=9606 GN=DCLRE1B PE=1 SV=1 g1796.t1 P09960 43.092 608 3.82e-163 481.0 sp|P09960|LKHA4_HUMAN Leukotriene A-4 hydrolase OS=Homo sapiens OX=9606 GN=LTA4H PE=1 SV=2 LKHA4_HUMAN reviewed Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4) Homo sapiens (Human) GO:0003723; GO:0004177; GO:0004301; GO:0004463; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0008270; GO:0010043; GO:0019370; GO:0043171; GO:0043434; GO:0045148; GO:0060509; GO:0070006; GO:0070062; GO:1904724; GO:1904813 leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270] g1799.t1 Q8K1C7 24.335 489 3.84e-37 145.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g1804.t1 Q8K1C7 28.647 569 3.36e-44 172.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g1804.t1 Q8K1C7 26.984 504 8.8e-33 139.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g1804.t1 Q8K1C7 25.0 504 1.48e-32 138.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g1805.t1 Q6ZSM3 32.287 223 3.44e-35 134.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g1808.t1 Q6P799 65.302 513 0.0 704.0 sp|Q6P799|SYSC_RAT Serine--tRNA ligase, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Sars1 PE=1 SV=3 SYSC_RAT reviewed Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase) Rattus norvegicus (Rat) GO:0000049; GO:0000122; GO:0000978; GO:0001514; GO:0002181; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006434; GO:0016525; GO:0019899; GO:0042803; GO:0060090; GO:0098619; GO:1904046 cytoplasmic translation [GO:0002181]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteine incorporation [GO:0001514]; seryl-tRNA aminoacylation [GO:0006434]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; selenocysteine-tRNA ligase activity [GO:0098619]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049] g1811.t1 A7Z063 50.412 486 3.86e-119 360.0 sp|A7Z063|WASH1_BOVIN WASH complex subunit 1 OS=Bos taurus OX=9913 GN=WASHC1 PE=1 SV=1 WASH1_BOVIN reviewed WASH complex subunit 1 (WAS protein family homolog 1) Bos taurus (Bovine) GO:0003779; GO:0005769; GO:0005770; GO:0005776; GO:0005814; GO:0005829; GO:0006887; GO:0015031; GO:0016197; GO:0031901; GO:0032456; GO:0034314; GO:0042147; GO:0043014; GO:0043015; GO:0055037; GO:0055038; GO:0071203 Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147] autophagosome [GO:0005776]; centriole [GO:0005814]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015] g1812.t1 Q8N0U4 26.893 383 3.53e-40 151.0 sp|Q8N0U4|F185A_HUMAN Protein FAM185A OS=Homo sapiens OX=9606 GN=FAM185A PE=1 SV=3 g1813.t1 Q640L2 48.554 484 4.63e-165 479.0 sp|Q640L2|SPX3_XENLA Sugar phosphate exchanger 3 OS=Xenopus laevis OX=8355 GN=slc37a3 PE=2 SV=1 g1813.t2 Q640L2 48.76 484 1.48e-164 478.0 sp|Q640L2|SPX3_XENLA Sugar phosphate exchanger 3 OS=Xenopus laevis OX=8355 GN=slc37a3 PE=2 SV=1 g1814.t1 Q9NX05 43.454 909 0.0 627.0 sp|Q9NX05|F120C_HUMAN Constitutive coactivator of PPAR-gamma-like protein 2 OS=Homo sapiens OX=9606 GN=FAM120C PE=1 SV=4 g1815.t1 Q9FN03 33.741 409 9.24e-53 196.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g1815.t1 Q9FN03 33.712 264 3.84e-36 147.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g1815.t1 Q9FN03 36.364 209 2.0099999999999999e-28 124.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g1816.t1 A7S1L6 64.371 334 2.31e-155 444.0 sp|A7S1L6|FUCT1_NEMVE GDP-fucose transporter 1 OS=Nematostella vectensis OX=45351 GN=slc35c1 PE=3 SV=1 FUCT1_NEMVE reviewed GDP-fucose transporter 1 (Solute carrier family 35 member C1 homolog) Nematostella vectensis (Starlet sea anemone) GO:0000139; GO:0005457; GO:0005794; GO:0015297; GO:0036085 GDP-fucose import into Golgi lumen [GO:0036085] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457] g1817.t1 Q8BR07 42.857 819 8.71e-175 528.0 sp|Q8BR07|BICD1_MOUSE Protein bicaudal D homolog 1 OS=Mus musculus OX=10090 GN=Bicd1 PE=1 SV=2 BICD1_MOUSE reviewed Protein bicaudal D homolog 1 (Bic-D 1) Mus musculus (Mouse) GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0008093; GO:0016020; GO:0019068; GO:0019901; GO:0031267; GO:0031410; GO:0031871; GO:0034063; GO:0034452; GO:0045505; GO:0048260; GO:0048471; GO:0070507; GO:0070840; GO:0072385; GO:0072393; GO:0099503; GO:1900737; GO:1904781 microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of microtubule cytoskeleton organization [GO:0070507]; stress granule assembly [GO:0034063]; virion assembly [GO:0019068] centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802] cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267] g1818.t1 A4IHS0 35.659 387 2.07e-59 205.0 sp|A4IHS0|TM10C_XENTR tRNA methyltransferase 10 homolog C OS=Xenopus tropicalis OX=8364 GN=trmt10c PE=2 SV=1 TM10C_XENTR reviewed tRNA methyltransferase 10 homolog C (Mitochondrial ribonuclease P protein 1) (Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase) (EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase) (EC 2.1.1.221) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000049; GO:0005634; GO:0005654; GO:0005739; GO:0006397; GO:0032259; GO:0042645; GO:0052905; GO:0070131; GO:0090646; GO:0097745; GO:0160106 methylation [GO:0032259]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] tRNA (adenine(9)-N1)-methyltransferase activity [GO:0160106]; tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049] g1819.t1 Q7SXW4 72.727 242 3.51e-131 374.0 sp|Q7SXW4|EMC3_DANRE ER membrane protein complex subunit 3 OS=Danio rerio OX=7955 GN=emc3 PE=2 SV=1 g1820.t1 Q29611 47.586 435 3.1199999999999997e-134 396.0 sp|Q29611|CLN3_CANLF Battenin OS=Canis lupus familiaris OX=9615 GN=CLN3 PE=3 SV=1 CLN3_CANLF reviewed Battenin (Protein CLN3) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0016020; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288 amyloid precursor protein catabolic process [GO:0042987]; autophagosome-lysosome fusion [GO:0061909]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; intracellular water homeostasis [GO:0009992]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496] autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146] g1821.t1 Q29611 44.393 428 5.74e-116 349.0 sp|Q29611|CLN3_CANLF Battenin OS=Canis lupus familiaris OX=9615 GN=CLN3 PE=3 SV=1 CLN3_CANLF reviewed Battenin (Protein CLN3) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0016020; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288 amyloid precursor protein catabolic process [GO:0042987]; autophagosome-lysosome fusion [GO:0061909]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; intracellular water homeostasis [GO:0009992]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496] autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146] g1823.t1 O60706 38.834 1406 0.0 943.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g1825.t1 Q7SXF6 44.402 259 1.4200000000000001e-75 236.0 sp|Q7SXF6|CREL2_DANRE Cysteine-rich with EGF-like domain protein 2 OS=Danio rerio OX=7955 GN=creld2 PE=2 SV=2 g1826.t1 O55044 69.421 484 0.0 746.0 sp|O55044|G6PD_CRIGR Glucose-6-phosphate 1-dehydrogenase OS=Cricetulus griseus OX=10029 GN=G6PD PE=2 SV=3 g1826.t2 O55044 69.421 484 0.0 748.0 sp|O55044|G6PD_CRIGR Glucose-6-phosphate 1-dehydrogenase OS=Cricetulus griseus OX=10029 GN=G6PD PE=2 SV=3 g1827.t1 Q8TCT0 40.741 513 2.2800000000000002e-129 393.0 sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1 CERK1_HUMAN reviewed Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4) Homo sapiens (Human) GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020 ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287] g1828.t1 Q55C17 29.492 295 3.8299999999999997e-28 112.0 sp|Q55C17|TECR_DICDI Very-long-chain enoyl-CoA reductase OS=Dictyostelium discoideum OX=44689 GN=gpsn2 PE=3 SV=1 g1829.t1 Q9NU19 54.297 512 0.0 544.0 sp|Q9NU19|TB22B_HUMAN TBC1 domain family member 22B OS=Homo sapiens OX=9606 GN=TBC1D22B PE=1 SV=3 TB22B_HUMAN reviewed TBC1 domain family member 22B Homo sapiens (Human) GO:0005096; GO:0005794; GO:0071889 Golgi apparatus [GO:0005794] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096] g1832.t1 P57789 30.939 181 4.36e-27 112.0 sp|P57789|KCNKA_HUMAN Potassium channel subfamily K member 10 OS=Homo sapiens OX=9606 GN=KCNK10 PE=1 SV=1 KCNKA_HUMAN reviewed Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit) Homo sapiens (Human) GO:0005267; GO:0005886; GO:0007165; GO:0015271; GO:0022841; GO:0034702; GO:0071805; GO:0098782; GO:1904551 cellular response to arachidonate [GO:1904551]; potassium ion transmembrane transport [GO:0071805]; signal transduction [GO:0007165] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] mechanosensitive potassium channel activity [GO:0098782]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] g1833.t1 Q92959 27.656 593 6.0099999999999995e-55 201.0 sp|Q92959|SO2A1_HUMAN Solute carrier organic anion transporter family member 2A1 OS=Homo sapiens OX=9606 GN=SLCO2A1 PE=1 SV=2 SO2A1_HUMAN reviewed Solute carrier organic anion transporter family member 2A1 (SLCO2A1) (OATP2A1) (PHOAR2) (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2) (SLC21A2) Homo sapiens (Human) GO:0005319; GO:0005764; GO:0005886; GO:0006869; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0016020; GO:0016323; GO:0043252 lipid transport [GO:0006869]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] lipid transporter activity [GO:0005319]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g1834.t1 O60669 27.163 416 9.539999999999999e-34 135.0 sp|O60669|MOT2_HUMAN Monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC16A7 PE=1 SV=2 MOT2_HUMAN reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Homo sapiens (Human) GO:0005477; GO:0005654; GO:0005829; GO:0005886; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:0150104; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g1837.t1 O75051 32.997 694 1.9e-96 331.0 sp|O75051|PLXA2_HUMAN Plexin-A2 OS=Homo sapiens OX=9606 GN=PLXNA2 PE=1 SV=4 PLXA2_HUMAN reviewed Plexin-A2 (Semaphorin receptor OCT) Homo sapiens (Human) GO:0001756; GO:0002116; GO:0005886; GO:0007416; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0051642; GO:0060037; GO:0060174; GO:0071526 centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154] g1838.t1 P33497 42.038 314 3.76e-78 256.0 sp|P33497|RYK_AVIR3 Tyrosine-protein kinase transforming protein RYK OS=Avian retrovirus RPL30 OX=31671 GN=V-RYK PE=2 SV=1 g1839.t1 O35490 30.659 349 6.93e-46 164.0 sp|O35490|BHMT1_MOUSE Betaine--homocysteine S-methyltransferase 1 OS=Mus musculus OX=10090 GN=Bhmt PE=1 SV=1 BHMT1_MOUSE reviewed Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5) Mus musculus (Mouse) GO:0005615; GO:0005634; GO:0005829; GO:0006577; GO:0006579; GO:0008168; GO:0008270; GO:0009086; GO:0032259; GO:0032991; GO:0042802; GO:0044877; GO:0047150; GO:0070062; GO:0071266; GO:0071267 'de novo' L-methionine biosynthetic process [GO:0071266]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] betaine-homocysteine S-methyltransferase activity [GO:0047150]; identical protein binding [GO:0042802]; methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270] g1840.t1 Q95218 44.492 236 1.1699999999999999e-46 175.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1840.t1 Q95218 39.831 236 8.55e-41 157.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1840.t1 Q95218 38.889 234 7.0999999999999994e-40 155.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1840.t1 Q95218 37.288 236 8.39e-36 143.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1840.t1 Q95218 49.505 101 8.53e-22 101.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1841.t1 Q5G265 35.498 231 6.82e-43 164.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g1841.t1 Q5G265 38.249 217 6.3699999999999995e-40 155.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g1841.t1 Q5G265 35.407 209 1.35e-38 151.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g1842.t1 Q5G267 44.667 150 8.5e-31 127.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g1842.t1 Q5G267 34.682 173 3.34e-28 120.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g1842.t1 Q5G267 36.667 150 4.39e-26 113.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g1844.t1 O42414 33.038 678 6.859999999999999e-89 306.0 sp|O42414|NFASC_CHICK Neurofascin OS=Gallus gallus OX=9031 GN=NFASC PE=1 SV=1 g1846.t1 O94856 29.951 611 1.05e-63 237.0 sp|O94856|NFASC_HUMAN Neurofascin OS=Homo sapiens OX=9606 GN=NFASC PE=1 SV=4 g1846.t1 O94856 26.21 496 1.12e-24 114.0 sp|O94856|NFASC_HUMAN Neurofascin OS=Homo sapiens OX=9606 GN=NFASC PE=1 SV=4 g1847.t1 P97686 31.733 375 2.19e-39 152.0 sp|P97686|NRCAM_RAT Neuronal cell adhesion molecule OS=Rattus norvegicus OX=10116 GN=Nrcam PE=1 SV=2 g1848.t1 Q2KJ36 50.578 346 1.85e-99 303.0 sp|Q2KJ36|DUS6_BOVIN Dual specificity protein phosphatase 6 OS=Bos taurus OX=9913 GN=DUSP6 PE=2 SV=1 DUS6_BOVIN reviewed Dual specificity protein phosphatase 6 (EC 3.1.3.16) (EC 3.1.3.48) Bos taurus (Bovine) GO:0004722; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008330; GO:0017017; GO:0033550; GO:0043065; GO:0051409; GO:0060420; GO:0070373 negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of apoptotic process [GO:0043065]; regulation of heart growth [GO:0060420]; response to nitrosative stress [GO:0051409]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330] g1849.t1 Q28I85 62.845 471 0.0 592.0 sp|Q28I85|POC1A_XENTR POC1 centriolar protein homolog A OS=Xenopus tropicalis OX=8364 GN=poc1a PE=2 SV=1 POC1A_XENTR reviewed POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005814; GO:0007017; GO:0036064; GO:0048871; GO:0060271 cilium assembly [GO:0060271]; microtubule-based process [GO:0007017]; multicellular organismal-level homeostasis [GO:0048871] centriole [GO:0005814]; ciliary basal body [GO:0036064] g1850.t1 Q9CQH8 49.107 112 2.2099999999999997e-34 118.0 sp|Q9CQH8|RPP14_MOUSE Ribonuclease P protein subunit p14 OS=Mus musculus OX=10090 GN=Rpp14 PE=1 SV=1 g1852.t1 Q8AXZ4 29.665 418 1.64e-38 155.0 sp|Q8AXZ4|CNT1A_DANRE Contactin-1a OS=Danio rerio OX=7955 GN=cntn1a PE=2 SV=1 CNT1A_DANRE reviewed Contactin-1a (F3/F11/contactin) (Neural cell recognition molecule F11) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0007411; GO:0007420; GO:0030424; GO:0098552; GO:0098609; GO:0098632 axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609] axon [GO:0030424]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] cell-cell adhesion mediator activity [GO:0098632] g1853.t1 Q8K1N1 50.774 323 7.429999999999999e-104 337.0 sp|Q8K1N1|PLPL8_MOUSE Calcium-independent phospholipase A2-gamma OS=Mus musculus OX=10090 GN=Pnpla8 PE=1 SV=1 PLPL8_MOUSE reviewed Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8) Mus musculus (Mouse) GO:0001516; GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0006631; GO:0008970; GO:0016020; GO:0019369; GO:0031966; GO:0032048; GO:0034638; GO:0035556; GO:0043651; GO:0046338; GO:0047499; GO:0050482; GO:0055088; GO:0070328; GO:1900407 arachidonate metabolic process [GO:0019369]; arachidonate secretion [GO:0050482]; cardiolipin metabolic process [GO:0032048]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; regulation of cellular response to oxidative stress [GO:1900407]; triglyceride homeostasis [GO:0070328] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970] g1854.t1 D3ZRC4 52.0 100 1.0800000000000001e-27 108.0 sp|D3ZRC4|PLPL8_RAT Calcium-independent phospholipase A2-gamma OS=Rattus norvegicus OX=10116 GN=Pnpla8 PE=3 SV=1 PLPL8_RAT reviewed Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8) Rattus norvegicus (Rat) GO:0001516; GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0006631; GO:0008970; GO:0016020; GO:0019369; GO:0031966; GO:0032048; GO:0034638; GO:0035556; GO:0043651; GO:0046338; GO:0047499; GO:0050482; GO:0055088; GO:0070328; GO:1900407 arachidonate metabolic process [GO:0019369]; arachidonate secretion [GO:0050482]; cardiolipin metabolic process [GO:0032048]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; regulation of cellular response to oxidative stress [GO:1900407]; triglyceride homeostasis [GO:0070328] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] calcium-independent phospholipase A2 activity [GO:0047499]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970] g1857.t1 Q6ZSM3 27.122 483 2.71e-40 155.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g1861.t1 P02740 69.048 126 1.09e-53 167.0 sp|P02740|SAA_ANAPL Serum amyloid A protein OS=Anas platyrhynchos OX=8839 PE=1 SV=2 g1862.t1 Q9BXW9 41.11 703 4.13e-157 493.0 sp|Q9BXW9|FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens OX=9606 GN=FANCD2 PE=1 SV=2 g1863.t1 Q68Y81 44.853 272 9.56e-65 222.0 sp|Q68Y81|FACD2_CHICK Fanconi anemia group D2 protein OS=Gallus gallus OX=9031 GN=FANCD2 PE=1 SV=1 FACD2_CHICK reviewed Fanconi anemia group D2 protein (Protein FACD2) Gallus gallus (Chicken) GO:0005654; GO:0006281 DNA repair [GO:0006281] nucleoplasm [GO:0005654] g1864.t1 Q68Y81 46.631 371 3.06e-101 330.0 sp|Q68Y81|FACD2_CHICK Fanconi anemia group D2 protein OS=Gallus gallus OX=9031 GN=FANCD2 PE=1 SV=1 FACD2_CHICK reviewed Fanconi anemia group D2 protein (Protein FACD2) Gallus gallus (Chicken) GO:0005654; GO:0006281 DNA repair [GO:0006281] nucleoplasm [GO:0005654] g1868.t1 Q9GLY5 36.918 902 0.0 555.0 sp|Q9GLY5|ITIH3_RABIT Inter-alpha-trypsin inhibitor heavy chain H3 OS=Oryctolagus cuniculus OX=9986 GN=ITIH3 PE=2 SV=1 g1873.t1 Q16881 61.065 601 0.0 742.0 sp|Q16881|TRXR1_HUMAN Thioredoxin reductase 1, cytoplasmic OS=Homo sapiens OX=9606 GN=TXNRD1 PE=1 SV=3 g1874.t1 Q96NI6 29.683 347 4.0600000000000004e-35 145.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1875.t1 Q96NI6 31.003 329 9.33e-33 139.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1876.t1 Q8BXA0 30.294 340 4.11e-34 141.0 sp|Q8BXA0|LRFN5_MOUSE Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Mus musculus OX=10090 GN=Lrfn5 PE=1 SV=1 LRFN5_MOUSE reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Mus musculus (Mouse) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1877.t1 Q96NI6 29.683 347 3.9e-32 137.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1878.t1 Q96NI6 29.598 348 1.37e-33 140.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1879.t1 Q96NI6 30.793 328 3.46e-35 143.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1879.t2 Q96NI6 30.793 328 2.18e-34 143.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1880.t1 Q96NI6 29.107 347 5.34e-34 141.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g1881.t1 Q6AZD4 57.669 163 3.7699999999999996e-67 206.0 sp|Q6AZD4|IMP2L_DANRE Mitochondrial inner membrane protease subunit 2 OS=Danio rerio OX=7955 GN=immp2l PE=2 SV=1 g1882.t1 Q9Y5X3 28.534 382 1.7700000000000001e-29 120.0 sp|Q9Y5X3|SNX5_HUMAN Sorting nexin-5 OS=Homo sapiens OX=9606 GN=SNX5 PE=1 SV=1 g1883.t1 P53634 53.957 417 9.86e-159 465.0 sp|P53634|CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens OX=9606 GN=CTSC PE=1 SV=2 CATC_HUMAN reviewed Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] Homo sapiens (Human) GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031012; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0051087; GO:0051603; GO:0070062; GO:1903052; GO:1903980; GO:2001235 immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252] g1883.t1 P53634 66.092 174 3.67e-75 249.0 sp|P53634|CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens OX=9606 GN=CTSC PE=1 SV=2 CATC_HUMAN reviewed Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)] Homo sapiens (Human) GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031012; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0051087; GO:0051603; GO:0070062; GO:1903052; GO:1903980; GO:2001235 immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252] g1884.t1 Q28C33 49.694 654 0.0 598.0 sp|Q28C33|TBC30_XENTR TBC1 domain family member 30 OS=Xenopus tropicalis OX=8364 GN=tbc1d30 PE=2 SV=1 g1885.t1 P70170 38.432 1569 0.0 1036.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 ABCC9_MOUSE reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Mus musculus (Mouse) GO:0000165; GO:0001508; GO:0001568; GO:0001666; GO:0001669; GO:0003007; GO:0003018; GO:0005267; GO:0005524; GO:0005737; GO:0005739; GO:0005886; GO:0006357; GO:0006813; GO:0006950; GO:0007005; GO:0007507; GO:0007519; GO:0008015; GO:0008217; GO:0008281; GO:0008282; GO:0009410; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0019905; GO:0030017; GO:0030315; GO:0032991; GO:0033198; GO:0035864; GO:0035865; GO:0036293; GO:0042311; GO:0042383; GO:0042391; GO:0042542; GO:0042626; GO:0042802; GO:0043066; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0060976; GO:0061337; GO:0062197; GO:0070482; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072359; GO:0072592; GO:0086003; GO:0097746; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:1901363; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel diameter maintenance [GO:0097746]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; circulatory system development [GO:0072359]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of blood pressure [GO:0008217]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to decreased oxygen levels [GO:0036293]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to peptide [GO:1901652]; response to potassium ion [GO:0035864]; response to stress [GO:0006950]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; vascular process in circulatory system [GO:0003018]; vasodilation [GO:0042311] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; T-tubule [GO:0030315] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325] g1886.t1 O60706 38.345 1583 0.0 1050.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g1887.t1 Q5BKN5 48.348 333 7.4e-104 311.0 sp|Q5BKN5|CD123_XENTR Translation initiation factor eIF2 assembly protein OS=Xenopus tropicalis OX=8364 GN=cdc123 PE=2 SV=1 g1888.t1 Q1JQ66 63.88 299 3.1e-136 391.0 sp|Q1JQ66|S35E3_DANRE Solute carrier family 35 member E3 OS=Danio rerio OX=7955 GN=slc35e3 PE=2 SV=1 g1889.t1 D4A734 24.769 432 5.220000000000001e-35 139.0 sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1 MOT12_RAT reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Rattus norvegicus (Rat) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g1891.t1 Q1LZ86 41.967 305 5.37e-76 239.0 sp|Q1LZ86|ABHD6_BOVIN Monoacylglycerol lipase ABHD6 OS=Bos taurus OX=9913 GN=ABHD6 PE=2 SV=1 ABHD6_BOVIN reviewed Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 6) Bos taurus (Bovine) GO:0004620; GO:0005765; GO:0009395; GO:0016020; GO:0030336; GO:0031902; GO:0031966; GO:0032281; GO:0045211; GO:0046464; GO:0046889; GO:0047372; GO:0052651; GO:0060292; GO:0098978; GO:0098982; GO:0099178; GO:0120163; GO:2000124; GO:2001311 acylglycerol catabolic process [GO:0046464]; long-term synaptic depression [GO:0060292]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid catabolic process [GO:0009395]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178] AMPA glutamate receptor complex [GO:0032281]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; postsynaptic membrane [GO:0045211] monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620] g1892.t1 Q6P2X9 25.673 483 5.96e-41 156.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g1894.t1 F6Z5C0 55.848 949 0.0 1042.0 sp|F6Z5C0|UBP15_XENTR Ubiquitin carboxyl-terminal hydrolase 15 OS=Xenopus tropicalis OX=8364 GN=usp15 PE=2 SV=2 g1895.t1 P13154 35.112 356 1.68e-55 193.0 sp|P13154|DHLE_GEOSE Leucine dehydrogenase OS=Geobacillus stearothermophilus OX=1422 GN=ldh PE=1 SV=3 g1895.t2 P13154 35.674 356 2.76e-57 198.0 sp|P13154|DHLE_GEOSE Leucine dehydrogenase OS=Geobacillus stearothermophilus OX=1422 GN=ldh PE=1 SV=3 g1895.t3 P13154 33.798 287 3.5999999999999996e-42 152.0 sp|P13154|DHLE_GEOSE Leucine dehydrogenase OS=Geobacillus stearothermophilus OX=1422 GN=ldh PE=1 SV=3 g1896.t1 Q54MC6 27.925 265 1.19e-25 112.0 sp|Q54MC6|LRLA_DICDI Latrophilin receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=lrlA PE=3 SV=1 g1897.t1 Q91WM3 56.65 406 8.38e-171 492.0 sp|Q91WM3|U3IP2_MOUSE U3 small nucleolar RNA-interacting protein 2 OS=Mus musculus OX=10090 GN=Rrp9 PE=1 SV=1 g1897.t2 Q91WM3 56.79 405 1.45e-172 497.0 sp|Q91WM3|U3IP2_MOUSE U3 small nucleolar RNA-interacting protein 2 OS=Mus musculus OX=10090 GN=Rrp9 PE=1 SV=1 g1898.t1 P25155 38.911 257 9.72e-53 194.0 sp|P25155|FA10_CHICK Coagulation factor X OS=Gallus gallus OX=9031 GN=F10 PE=1 SV=1 g1899.t1 Q98SP7 66.759 722 0.0 1020.0 sp|Q98SP7|BBS2_DANRE BBSome complex member BBS2 OS=Danio rerio OX=7955 GN=bbs2 PE=2 SV=1 g1900.t1 Q9H4K1 47.861 374 1.5199999999999998e-106 321.0 sp|Q9H4K1|RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 OS=Homo sapiens OX=9606 GN=RIBC2 PE=1 SV=2 g1901.t1 Q96DB2 62.099 343 3.8800000000000004e-156 449.0 sp|Q96DB2|HDA11_HUMAN Histone deacetylase 11 OS=Homo sapiens OX=9606 GN=HDAC11 PE=1 SV=1 g1902.t1 Q5M821 44.942 514 9.69e-152 445.0 sp|Q5M821|PPM1H_RAT Protein phosphatase 1H OS=Rattus norvegicus OX=10116 GN=Ppm1h PE=1 SV=2 PPM1H_RAT reviewed Protein phosphatase 1H (EC 3.1.3.16) Rattus norvegicus (Rat) GO:0004721; GO:0004741; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0042802; GO:0045202; GO:0098978 cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase activity [GO:0004741]; identical protein binding [GO:0042802]; phosphoprotein phosphatase activity [GO:0004721] g1903.t1 Q8BFQ4 71.111 315 1.21e-177 496.0 sp|Q8BFQ4|WDR82_MOUSE WD repeat-containing protein 82 OS=Mus musculus OX=10090 GN=Wdr82 PE=1 SV=1 WDR82_MOUSE reviewed WD repeat-containing protein 82 Mus musculus (Mouse) GO:0000781; GO:0000785; GO:0001111; GO:0003682; GO:0005634; GO:0005730; GO:0006353; GO:0010467; GO:0032785; GO:0032968; GO:0035097; GO:0048188; GO:0071027; GO:0072357; GO:0106222; GO:0110064; GO:0140744 DNA-templated transcription termination [GO:0006353]; gene expression [GO:0010467]; lncRNA catabolic process [GO:0110064]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of lncRNA transcription [GO:0140744]; nuclear RNA surveillance [GO:0071027]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188] chromatin binding [GO:0003682]; lncRNA binding [GO:0106222] g1905.t1 Q08BL7 45.562 507 5.28e-145 430.0 sp|Q08BL7|GLCTK_DANRE Glycerate kinase OS=Danio rerio OX=7955 GN=glyctk PE=2 SV=1 g1907.t1 Q29243 33.489 857 3.38e-118 384.0 sp|Q29243|DAG1_PIG Dystroglycan 1 OS=Sus scrofa OX=9823 GN=DAG1 PE=2 SV=2 DAG1_PIG reviewed Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)] Sus scrofa (Pig) GO:0002009; GO:0005055; GO:0005509; GO:0005604; GO:0005615; GO:0005654; GO:0005856; GO:0007411; GO:0016011; GO:0016203; GO:0021675; GO:0035022; GO:0042383; GO:0043236; GO:0045211; GO:1904862 axon guidance [GO:0007411]; inhibitory synapse assembly [GO:1904862]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; nerve development [GO:0021675]; positive regulation of Rac protein signal transduction [GO:0035022] basement membrane [GO:0005604]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383] calcium ion binding [GO:0005509]; laminin binding [GO:0043236]; laminin receptor activity [GO:0005055] g1909.t1 A4D0V7 31.823 971 5.21e-150 479.0 sp|A4D0V7|CPED1_HUMAN Cadherin-like and PC-esterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CPED1 PE=1 SV=1 CPED1_HUMAN reviewed Cadherin-like and PC-esterase domain-containing protein 1 Homo sapiens (Human) GO:0005783 endoplasmic reticulum [GO:0005783] g1910.t1 Q02548 78.571 126 1.91e-65 215.0 sp|Q02548|PAX5_HUMAN Paired box protein Pax-5 OS=Homo sapiens OX=9606 GN=PAX5 PE=1 SV=1 PAX5_HUMAN reviewed Paired box protein Pax-5 (B-cell-specific transcription factor) (BSAP) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0006357; GO:0006366; GO:0007283; GO:0007399; GO:0007423; GO:0021670; GO:0021987; GO:0030183; GO:0030534; GO:0035914; GO:0048701 adult behavior [GO:0030534]; B cell differentiation [GO:0030183]; cerebral cortex development [GO:0021987]; embryonic cranial skeleton morphogenesis [GO:0048701]; lateral ventricle development [GO:0021670]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleoplasm [GO:0005654] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g1911.t1 Q9UBV4 48.819 381 2.1899999999999998e-128 376.0 sp|Q9UBV4|WNT16_HUMAN Protein Wnt-16 OS=Homo sapiens OX=9606 GN=WNT16 PE=1 SV=1 WNT16_HUMAN reviewed Protein Wnt-16 Homo sapiens (Human) GO:0003408; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0010628; GO:0016055; GO:0030182; GO:0030216; GO:0043616; GO:0045165; GO:0046330; GO:0046849; GO:0051897; GO:0060070; GO:0060317; GO:0090399; GO:0090403; GO:2001234 bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of apoptotic signaling pathway [GO:2001234]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; replicative senescence [GO:0090399]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytokine activity [GO:0005125]; frizzled binding [GO:0005109] g1912.t1 Q925H0 38.702 447 1.26e-106 330.0 sp|Q925H0|ASIC2_MOUSE Acid-sensing ion channel 2 OS=Mus musculus OX=10090 GN=Asic2 PE=1 SV=1 g1914.t1 Q16515 37.015 335 7.55e-75 242.0 sp|Q16515|ASIC2_HUMAN Acid-sensing ion channel 2 OS=Homo sapiens OX=9606 GN=ASIC2 PE=1 SV=1 g1915.t1 E1BSI0 52.7 537 9.03e-179 516.0 sp|E1BSI0|PARP3_CHICK Protein mono-ADP-ribosyltransferase PARP3 OS=Gallus gallus OX=9031 GN=PARP3 PE=1 SV=2 PARP3_CHICK reviewed Protein mono-ADP-ribosyltransferase PARP3 (cPARP3) (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) Gallus gallus (Chicken) GO:0003950; GO:0005730; GO:0005813; GO:0005814; GO:0006302; GO:0016779; GO:0035861; GO:0051053; GO:0140804; GO:0140806; GO:0140807 double-strand break repair [GO:0006302]; negative regulation of DNA metabolic process [GO:0051053] centriole [GO:0005814]; centrosome [GO:0005813]; nucleolus [GO:0005730]; site of double-strand break [GO:0035861] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; nucleotidyltransferase activity [GO:0016779] g1916.t1 O60285 57.414 263 4.9e-102 328.0 sp|O60285|NUAK1_HUMAN NUAK family SNF1-like kinase 1 OS=Homo sapiens OX=9606 GN=NUAK1 PE=1 SV=1 NUAK1_HUMAN reviewed NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) Homo sapiens (Human) GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0042127; GO:0046872; GO:0106310; GO:1901796; GO:2000772 cell adhesion [GO:0007155]; DNA damage response [GO:0006974]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of signal transduction by p53 class mediator [GO:1901796] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1917.t1 P70207 38.422 1926 0.0 1222.0 sp|P70207|PLXA2_MOUSE Plexin-A2 OS=Mus musculus OX=10090 GN=Plxna2 PE=1 SV=2 g1918.t1 P70207 32.26 1336 0.0 620.0 sp|P70207|PLXA2_MOUSE Plexin-A2 OS=Mus musculus OX=10090 GN=Plxna2 PE=1 SV=2 g1919.t1 Q14714 32.474 194 7.780000000000001e-22 95.5 sp|Q14714|SSPN_HUMAN Sarcospan OS=Homo sapiens OX=9606 GN=SSPN PE=1 SV=3 SSPN_HUMAN reviewed Sarcospan (K-ras oncogene-associated protein) (Kirsten-ras-associated protein) Homo sapiens (Human) GO:0000139; GO:0005886; GO:0006936; GO:0007155; GO:0016010; GO:0030133; GO:0042383; GO:0045211 cell adhesion [GO:0007155]; muscle contraction [GO:0006936] dystrophin-associated glycoprotein complex [GO:0016010]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133] g1920.t1 Q8WSR4 84.93 1639 0.0 2694.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g1920.t2 Q8WSR4 83.957 1658 0.0 2685.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g1921.t1 Q8WSR4 91.081 1110 0.0 2062.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g1921.t2 Q8WSR4 90.673 1115 0.0 2054.0 sp|Q8WSR4|ITPR_PATPE Inositol 1,4,5-trisphosphate receptor OS=Patiria pectinifera OX=7594 GN=IP3R PE=1 SV=1 g1922.t1 Q0P5L5 71.886 281 3e-154 438.0 sp|Q0P5L5|SUMF1_BOVIN Formylglycine-generating enzyme OS=Bos taurus OX=9913 GN=SUMF1 PE=2 SV=1 SUMF1_BOVIN reviewed Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1) Bos taurus (Bovine) GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135 post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] cupric ion binding [GO:1903135]; formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802] g1923.t1 P34908 49.689 805 0.0 707.0 sp|P34908|BRAF_COTJA Serine/threonine-protein kinase B-raf OS=Coturnix japonica OX=93934 GN=BRAF PE=2 SV=1 g1923.t2 P15056 52.324 753 0.0 719.0 sp|P15056|BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens OX=9606 GN=BRAF PE=1 SV=4 BRAF_HUMAN reviewed Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1) Homo sapiens (Human) GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007173; GO:0008270; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0034451; GO:0035019; GO:0036064; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0097225; GO:0097228; GO:0097229; GO:0098793; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:1900026; GO:2000301; GO:2000352 animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542] cell body [GO:0044297]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; zinc ion binding [GO:0008270] g1924.t1 Q9MYM7 41.25 240 3.28e-56 191.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g1926.t1 P18294 74.219 1121 0.0 1758.0 sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g1927.t1 F1QF89 46.936 718 0.0 680.0 sp|F1QF89|POMT1_DANRE Protein O-mannosyl-transferase 1 OS=Danio rerio OX=7955 GN=pomt1 PE=1 SV=1 POMT1_DANRE reviewed Protein O-mannosyl-transferase 1 (EC 2.4.1.109) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0042478; GO:0048742 protein O-linked glycosylation via mannose [GO:0035269]; regulation of eye photoreceptor cell development [GO:0042478]; regulation of skeletal muscle fiber development [GO:0048742] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169] g1928.t1 Q8VEM8 77.707 314 1.09e-176 498.0 sp|Q8VEM8|S25A3_MOUSE Solute carrier family 25 member 3 OS=Mus musculus OX=10090 GN=Slc25a3 PE=1 SV=1 g1929.t1 P49432 70.64 344 0.0 520.0 sp|P49432|ODPB_RAT Pyruvate dehydrogenase E1 component subunit beta, mitochondrial OS=Rattus norvegicus OX=10116 GN=Pdhb PE=1 SV=2 g1930.t1 Q8BX57 52.749 582 0.0 598.0 sp|Q8BX57|PXK_MOUSE PX domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Pxk PE=1 SV=2 g1930.t2 Q8BX57 53.644 494 0.0 569.0 sp|Q8BX57|PXK_MOUSE PX domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Pxk PE=1 SV=2 g1931.t1 Q0D2E8 53.073 537 0.0 549.0 sp|Q0D2E8|RFT1_XENTR Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 OS=Xenopus tropicalis OX=8364 GN=rft1 PE=2 SV=1 g1933.t1 Q7TQ20 44.607 547 3.49e-130 396.0 sp|Q7TQ20|DNJC2_RAT DnaJ homolog subfamily C member 2 OS=Rattus norvegicus OX=10116 GN=Dnajc2 PE=1 SV=1 DNJC2_RAT reviewed DnaJ homolog subfamily C member 2 (Gliosarcoma-related antigen MIDA1) (Zuotin-related factor 1) Rattus norvegicus (Rat) GO:0003682; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006450; GO:0030308; GO:0030544; GO:0031965; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649; GO:2000279 'de novo' cotranslational protein folding [GO:0051083]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649] g1935.t1 Q3UHX0 41.379 232 2.13e-49 194.0 sp|Q3UHX0|NOL8_MOUSE Nucleolar protein 8 OS=Mus musculus OX=10090 GN=Nol8 PE=1 SV=2 g1936.t1 Q61554 34.707 752 4.82e-80 291.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 31.62 778 3.33e-71 264.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 32.36 788 5.940000000000001e-70 260.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 33.42 772 1.1799999999999998e-69 259.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 33.591 777 7.19e-69 257.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 31.37 832 7.3699999999999996e-68 254.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 31.565 773 6.18e-67 251.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 31.572 776 2.36e-66 249.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 32.51 769 6.8e-63 238.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 30.435 828 3.8299999999999998e-62 236.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 31.219 804 1.0799999999999999e-61 234.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 32.148 675 1.22e-60 231.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 31.72 744 2.01e-59 228.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 33.097 565 2.35e-53 208.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 30.623 738 2.85e-53 208.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 32.411 506 1.52e-36 154.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 39.196 199 9.210000000000001e-27 122.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1936.t1 Q61554 31.788 302 3.63e-24 114.0 sp|Q61554|FBN1_MOUSE Fibrillin-1 OS=Mus musculus OX=10090 GN=Fbn1 PE=1 SV=2 g1938.t1 Q9H8X2 30.348 201 7.02e-24 101.0 sp|Q9H8X2|IPPK_HUMAN Inositol-pentakisphosphate 2-kinase OS=Homo sapiens OX=9606 GN=IPPK PE=1 SV=1 g1940.t1 P34743 49.007 151 1.2e-43 145.0 sp|P34743|BTG1_CHICK Protein BTG1 OS=Gallus gallus OX=9031 GN=BTG1 PE=2 SV=1 g1941.t1 Q5VUG0 44.605 621 2.08e-167 531.0 sp|Q5VUG0|SMBT2_HUMAN Scm-like with four MBT domains protein 2 OS=Homo sapiens OX=9606 GN=SFMBT2 PE=1 SV=1 SMBT2_HUMAN reviewed Scm-like with four MBT domains protein 2 (Scm-like with 4 MBT domains protein 2) Homo sapiens (Human) GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0010629; GO:0016235; GO:0016604; GO:0016607; GO:0042393; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629] aggresome [GO:0016235]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714] g1942.t1 Q86TL2 49.012 253 4.99e-76 238.0 sp|Q86TL2|STIMA_HUMAN Store-operated calcium entry regulator STIMATE OS=Homo sapiens OX=9606 GN=STIMATE PE=1 SV=1 STIMA_HUMAN reviewed Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110) Homo sapiens (Human) GO:0002115; GO:0005246; GO:0005789; GO:0016020; GO:0032237; GO:0032541; GO:0140268 activation of store-operated calcium channel activity [GO:0032237]; store-operated calcium entry [GO:0002115] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020] calcium channel regulator activity [GO:0005246] g1943.t1 Q6DFN1 59.722 144 9.65e-61 189.0 sp|Q6DFN1|NDUF3_XENTR NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 OS=Xenopus tropicalis OX=8364 GN=ndufaf3 PE=2 SV=1 g1944.t1 Q9UNF1 41.981 212 5.48e-55 191.0 sp|Q9UNF1|MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens OX=9606 GN=MAGED2 PE=1 SV=2 MAGD2_HUMAN reviewed Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen) Homo sapiens (Human) GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294 female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294] cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093] g1947.t1 Q32PH7 52.356 382 4.3500000000000004e-130 382.0 sp|Q32PH7|SUV92_BOVIN Histone-lysine N-methyltransferase SUV39H2 OS=Bos taurus OX=9913 GN=SUV39H2 PE=2 SV=1 SUV92_BOVIN reviewed Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.-) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2) Bos taurus (Bovine) GO:0000775; GO:0000976; GO:0005634; GO:0007623; GO:0008270; GO:0030154; GO:0032259; GO:0045814; GO:0045892; GO:0046974; GO:0140949 cell differentiation [GO:0030154]; circadian rhythm [GO:0007623]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814] chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634] histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 trimethyltransferase activity [GO:0140949]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g1949.t1 Q8K4J0 50.258 388 8.46e-122 371.0 sp|Q8K4J0|DCR1C_MOUSE Protein artemis OS=Mus musculus OX=10090 GN=Dclre1c PE=1 SV=2 DCR1C_MOUSE reviewed Protein artemis (mArt) (EC 3.1.-.-) (DNA cross-link repair 1C protein) (SNM1-like protein) Mus musculus (Mouse) GO:0000014; GO:0000723; GO:0002250; GO:0003684; GO:0005634; GO:0005654; GO:0005794; GO:0006302; GO:0006303; GO:0006310; GO:0008409; GO:0010212; GO:0030183; GO:0033151; GO:0035312; GO:0036297; GO:0051276; GO:0070419 adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]; V(D)J recombination [GO:0033151] Golgi apparatus [GO:0005794]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 5'-3' DNA exonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] g1958.t1 P23978 44.719 606 0.0 562.0 sp|P23978|SC6A1_RAT Sodium- and chloride-dependent GABA transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc6a1 PE=1 SV=1 SC6A1_RAT reviewed Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1) Rattus norvegicus (Rat) GO:0005283; GO:0005332; GO:0005886; GO:0006865; GO:0007612; GO:0007613; GO:0008306; GO:0009410; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098810; GO:0098982; GO:1902476; GO:1904313 amino acid transport [GO:0006865]; associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to methamphetamine hydrochloride [GO:1904313]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] amino acid:sodium symporter activity [GO:0005283]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] g1959.t1 P23978 45.724 608 0.0 565.0 sp|P23978|SC6A1_RAT Sodium- and chloride-dependent GABA transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc6a1 PE=1 SV=1 SC6A1_RAT reviewed Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1) Rattus norvegicus (Rat) GO:0005283; GO:0005332; GO:0005886; GO:0006865; GO:0007612; GO:0007613; GO:0008306; GO:0009410; GO:0009636; GO:0009744; GO:0009986; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098810; GO:0098982; GO:1902476; GO:1904313 amino acid transport [GO:0006865]; associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to lead ion [GO:0010288]; response to methamphetamine hydrochloride [GO:1904313]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] amino acid:sodium symporter activity [GO:0005283]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] g1960.t1 Q96QE2 52.273 572 0.0 593.0 sp|Q96QE2|MYCT_HUMAN Proton myo-inositol cotransporter OS=Homo sapiens OX=9606 GN=SLC2A13 PE=1 SV=3 MYCT_HUMAN reviewed Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13) Homo sapiens (Human) GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005794; GO:0005886; GO:0015798; GO:0016020; GO:0016324; GO:0030426; GO:0031090; GO:0042995; GO:0044297; GO:0051117; GO:0055085; GO:0071944; GO:0097450; GO:0150104; GO:1902004 myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020] g1964.t1 Q32LH4 47.122 278 1.51e-90 273.0 sp|Q32LH4|NIT1_BOVIN Deaminated glutathione amidase OS=Bos taurus OX=9913 GN=NIT1 PE=2 SV=1 g1964.t2 Q32LH4 46.552 290 1.3e-90 275.0 sp|Q32LH4|NIT1_BOVIN Deaminated glutathione amidase OS=Bos taurus OX=9913 GN=NIT1 PE=2 SV=1 g1965.t1 Q9UPS8 25.952 1129 2.7e-77 289.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g1965.t1 Q9UPS8 43.396 212 9.43e-41 170.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g1965.t2 Q9UPS8 25.598 1129 1.71e-76 287.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g1965.t2 Q9UPS8 43.396 212 7.85e-41 170.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g1965.t3 Q9UPS8 26.395 1129 4.58e-84 311.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g1965.t3 Q9UPS8 43.396 212 7.49e-41 170.0 sp|Q9UPS8|ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ANKRD26 PE=1 SV=4 ANR26_HUMAN reviewed Ankyrin repeat domain-containing protein 26 Homo sapiens (Human) GO:0005813; GO:0045599 negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] g1966.t1 Q2T9W2 41.834 447 8.690000000000001e-103 316.0 sp|Q2T9W2|THUM3_BOVIN tRNA (guanine(6)-N(2))-methyltransferase THUMP3 OS=Bos taurus OX=9913 GN=THUMPD3 PE=2 SV=1 THUM3_BOVIN reviewed tRNA (guanine(6)-N(2))-methyltransferase THUMP3 (EC 2.1.1.256) (THUMP domain-containing protein 3) (tRNA(Trp) (guanine(7)-N(2))-methyltransferase THUMP3) (EC 2.1.1.-) Bos taurus (Bovine) GO:0000049; GO:0005737; GO:0016423; GO:0030488; GO:0043527; GO:0160117 tRNA methylation [GO:0030488] cytoplasm [GO:0005737]; tRNA methyltransferase complex [GO:0043527] tRNA (guanine(6)-N2)-methyltransferase activity [GO:0160117]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA binding [GO:0000049] g1969.t1 Q5S006 38.593 1578 0.0 1053.0 sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2 LRRK2_MOUSE reviewed Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) Mus musculus (Mouse) GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904644; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377 autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to curcumin [GO:1904644]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887] amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909] actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] g1969.t1 Q5S006 22.25 809 5.57e-32 142.0 sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2 LRRK2_MOUSE reviewed Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) Mus musculus (Mouse) GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904644; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377 autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to curcumin [GO:1904644]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887] amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909] actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] g1969.t2 Q5S006 38.593 1578 0.0 1052.0 sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2 LRRK2_MOUSE reviewed Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) Mus musculus (Mouse) GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904644; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377 autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to curcumin [GO:1904644]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887] amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909] actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] g1969.t2 Q5S006 22.25 809 6.19e-32 141.0 sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2 LRRK2_MOUSE reviewed Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) Mus musculus (Mouse) GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904644; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377 autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to curcumin [GO:1904644]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887] amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909] actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] g1970.t1 Q9DGD1 36.53 219 2.1999999999999997e-42 156.0 sp|Q9DGD1|MGT4C_CHICK Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Gallus gallus OX=9031 GN=MGAT4C PE=1 SV=1 g1971.t1 Q4R4A8 34.685 222 3.4400000000000004e-31 125.0 sp|Q4R4A8|MGT4C_MACFA Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Macaca fascicularis OX=9541 GN=MGAT4C PE=2 SV=1 g1979.t1 Q9UGM3 43.29 231 9.11e-51 187.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 41.379 232 4.34e-49 182.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 38.023 263 1.7999999999999998e-48 181.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 41.048 229 4.9699999999999994e-48 179.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 38.889 252 9.66e-48 179.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 40.693 231 1.2800000000000002e-47 178.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 40.26 231 7.01e-47 176.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 40.175 229 1.02e-46 176.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 40.175 229 1.1699999999999999e-46 175.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 51.485 101 1.6999999999999997e-23 107.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1979.t1 Q9UGM3 49.474 95 4.790000000000001e-21 99.8 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1982.t1 O75795 31.151 504 2.08e-72 243.0 sp|O75795|UDB17_HUMAN UDP-glucuronosyltransferase 2B17 OS=Homo sapiens OX=9606 GN=UGT2B17 PE=1 SV=1 UDB17_HUMAN reviewed UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT) Homo sapiens (Human) GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0015020; GO:0016020 estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g1983.t1 Q99JW2 55.362 401 1.92e-162 466.0 sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1 g1983.t2 Q99JW2 55.112 401 4.76e-162 464.0 sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1 g1983.t3 Q99JW2 51.636 428 2.44e-156 451.0 sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1 g1984.t1 Q922Q6 41.026 195 4.41e-47 160.0 sp|Q922Q6|ABHEA_MOUSE Protein ABHD14A OS=Mus musculus OX=10090 GN=Abhd14a PE=1 SV=2 g1985.t1 Q98SN7 64.201 338 4.3e-168 480.0 sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1 g1985.t2 Q98SN7 64.012 339 3.63e-166 475.0 sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1 g1989.t1 A0M8U1 76.74 546 0.0 870.0 sp|A0M8U1|ST7_CHICK Suppressor of tumorigenicity 7 protein homolog OS=Gallus gallus OX=9031 GN=ST7 PE=3 SV=1 g1989.t2 A0M8U1 72.997 574 0.0 854.0 sp|A0M8U1|ST7_CHICK Suppressor of tumorigenicity 7 protein homolog OS=Gallus gallus OX=9031 GN=ST7 PE=3 SV=1 g1990.t1 Q6NT55 41.684 475 2.23e-131 395.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g1991.t1 O43592 52.758 961 0.0 1095.0 sp|O43592|XPOT_HUMAN Exportin-T OS=Homo sapiens OX=9606 GN=XPOT PE=1 SV=2 XPOT_HUMAN reviewed Exportin-T (Exportin(tRNA)) (tRNA exportin) Homo sapiens (Human) GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0006886; GO:0016363; GO:0031267; GO:0071528 intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] g1992.t1 Q9UHD2 41.282 671 2.19e-149 459.0 sp|Q9UHD2|TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1 TBK1_HUMAN reviewed Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1) Homo sapiens (Human) GO:0002218; GO:0002753; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010508; GO:0010629; GO:0016236; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0042802; GO:0043123; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1902554; GO:1904262; GO:1904263; GO:1904417; GO:1904515 activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g1993.t1 Q5D0E6 32.288 542 1.05e-56 203.0 sp|Q5D0E6|DALD3_HUMAN DALR anticodon-binding domain-containing protein 3 OS=Homo sapiens OX=9606 GN=DALRD3 PE=1 SV=2 DALD3_HUMAN reviewed DALR anticodon-binding domain-containing protein 3 Homo sapiens (Human) GO:0000049; GO:0004814; GO:0005524; GO:0006420; GO:0106217 arginyl-tRNA aminoacylation [GO:0006420]; tRNA C3-cytosine methylation [GO:0106217] arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049] g1993.t2 Q5D0E6 32.288 542 6.25e-57 204.0 sp|Q5D0E6|DALD3_HUMAN DALR anticodon-binding domain-containing protein 3 OS=Homo sapiens OX=9606 GN=DALRD3 PE=1 SV=2 DALD3_HUMAN reviewed DALR anticodon-binding domain-containing protein 3 Homo sapiens (Human) GO:0000049; GO:0004814; GO:0005524; GO:0006420; GO:0106217 arginyl-tRNA aminoacylation [GO:0006420]; tRNA C3-cytosine methylation [GO:0106217] arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049] g1995.t1 Q9MYM7 36.434 258 5.87e-53 181.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g1997.t1 Q8BRG8 42.124 565 1.02e-143 430.0 sp|Q8BRG8|TM209_MOUSE Transmembrane protein 209 OS=Mus musculus OX=10090 GN=Tmem209 PE=2 SV=1 g1999.t1 Q29P71 50.816 429 2.84e-139 443.0 sp|Q29P71|MYO7A_DROPS Myosin-VIIa OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=ck PE=3 SV=1 MYO7A_DROPS reviewed Myosin-VIIa (Protein crinkled) Drosophila pseudoobscura pseudoobscura (Fruit fly) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g1999.t1 Q29P71 28.453 362 1.9100000000000002e-32 134.0 sp|Q29P71|MYO7A_DROPS Myosin-VIIa OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=ck PE=3 SV=1 MYO7A_DROPS reviewed Myosin-VIIa (Protein crinkled) Drosophila pseudoobscura pseudoobscura (Fruit fly) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g1999.t2 Q29P71 51.039 433 4.92e-140 446.0 sp|Q29P71|MYO7A_DROPS Myosin-VIIa OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=ck PE=3 SV=1 MYO7A_DROPS reviewed Myosin-VIIa (Protein crinkled) Drosophila pseudoobscura pseudoobscura (Fruit fly) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g1999.t2 Q29P71 28.997 369 1.2800000000000002e-32 135.0 sp|Q29P71|MYO7A_DROPS Myosin-VIIa OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=ck PE=3 SV=1 MYO7A_DROPS reviewed Myosin-VIIa (Protein crinkled) Drosophila pseudoobscura pseudoobscura (Fruit fly) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005902; GO:0007605; GO:0008407; GO:0016461; GO:0030048; GO:0032027; GO:0035317; GO:0045177; GO:0048800; GO:0071944 actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027] g2001.t1 Q5R5P3 47.832 715 0.0 652.0 sp|Q5R5P3|THNS1_PONAB Threonine synthase-like 1 OS=Pongo abelii OX=9601 GN=THNSL1 PE=2 SV=1 g2002.t1 Q8BIE6 50.0 552 4.1799999999999996e-176 549.0 sp|Q8BIE6|FRM4A_MOUSE FERM domain-containing protein 4A OS=Mus musculus OX=10090 GN=Frmd4a PE=1 SV=2 FRM4A_MOUSE reviewed FERM domain-containing protein 4A Mus musculus (Mouse) GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162 establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] protein-macromolecule adaptor activity [GO:0030674] g2004.t1 D3ZN95 76.883 385 0.0 717.0 sp|D3ZN95|HCFC1_RAT Host cell factor 1 OS=Rattus norvegicus OX=10116 GN=Hcfc1 PE=1 SV=1 HCFC1_RAT reviewed Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] Rattus norvegicus (Rat) GO:0000122; GO:0000123; GO:0000228; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0010628; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0031490; GO:0032991; GO:0035097; GO:0035774; GO:0042802; GO:0043025; GO:0043254; GO:0044545; GO:0044665; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0140297 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713] g2004.t1 D3ZN95 62.447 237 8.050000000000001e-85 311.0 sp|D3ZN95|HCFC1_RAT Host cell factor 1 OS=Rattus norvegicus OX=10116 GN=Hcfc1 PE=1 SV=1 HCFC1_RAT reviewed Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] Rattus norvegicus (Rat) GO:0000122; GO:0000123; GO:0000228; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0010628; GO:0019046; GO:0030424; GO:0030425; GO:0030674; GO:0031490; GO:0032991; GO:0035097; GO:0035774; GO:0042802; GO:0043025; GO:0043254; GO:0044545; GO:0044665; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0140297 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713] g2010.t1 Q7Z6Z7 52.854 2505 0.0 2452.0 sp|Q7Z6Z7|HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3 HUWE1_HUMAN reviewed E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034450; GO:0034774; GO:0035359; GO:0043123; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0070936; GO:0097225; GO:0097228; GO:0097229; GO:0140852; GO:0141198; GO:1903955; GO:1904813; GO:1905091 base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g2010.t1 Q7Z6Z7 72.184 586 0.0 905.0 sp|Q7Z6Z7|HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3 HUWE1_HUMAN reviewed E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034450; GO:0034774; GO:0035359; GO:0043123; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0070936; GO:0097225; GO:0097228; GO:0097229; GO:0140852; GO:0141198; GO:1903955; GO:1904813; GO:1905091 base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g2010.t1 Q7Z6Z7 44.949 594 6.84e-103 377.0 sp|Q7Z6Z7|HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens OX=9606 GN=HUWE1 PE=1 SV=3 HUWE1_HUMAN reviewed E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034450; GO:0034774; GO:0035359; GO:0043123; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0070936; GO:0097225; GO:0097228; GO:0097229; GO:0140852; GO:0141198; GO:1903955; GO:1904813; GO:1905091 base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g2011.t1 Q64692 34.783 276 3.25e-34 134.0 sp|Q64692|SIA8D_MOUSE CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Mus musculus OX=10090 GN=St8sia4 PE=1 SV=1 SIA8D_MOUSE reviewed CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D) (SIAT8-D) (Sialyltransferase St8Sia IV) (ST8SiaIV) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0003828; GO:0005576; GO:0005794; GO:0006491; GO:0008373; GO:0009311; GO:0097503 ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g2012.t1 Q92186 33.621 232 3.95e-35 135.0 sp|Q92186|SIA8B_HUMAN Alpha-2,8-sialyltransferase 8B OS=Homo sapiens OX=9606 GN=ST8SIA2 PE=1 SV=1 SIA8B_HUMAN reviewed Alpha-2,8-sialyltransferase 8B (EC 2.4.3.-) (Sialyltransferase 8B) (SIAT8-B) (Sialyltransferase St8Sia II) (ST8SiaII) (Sialyltransferase X) (STX) Homo sapiens (Human) GO:0000139; GO:0000166; GO:0001574; GO:0003828; GO:0005576; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006491; GO:0007399; GO:0009101; GO:0009311; GO:0033691; GO:0036211; GO:0042220; GO:0043525; GO:0048471; GO:0051965; GO:0055037; GO:0097503; GO:1990138 carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; neuron projection extension [GO:1990138]; oligosaccharide metabolic process [GO:0009311]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synapse assembly [GO:0051965]; protein modification process [GO:0036211]; response to cocaine [GO:0042220]; sialylation [GO:0097503] cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; nucleotide binding [GO:0000166]; sialic acid binding [GO:0033691] g2013.t1 Q7ZZL8 41.667 204 1.6e-45 158.0 sp|Q7ZZL8|LHPL5_CHICK LHFPL tetraspan subfamily member 5 protein OS=Gallus gallus OX=9031 GN=LHFPL5 PE=2 SV=1 g2014.t1 Q09429 37.916 1622 0.0 1021.0 sp|Q09429|ABCC8_RAT ATP-binding cassette sub-family C member 8 OS=Rattus norvegicus OX=10116 GN=Abcc8 PE=1 SV=4 ABCC8_RAT reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Rattus norvegicus (Rat) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0032991; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050768; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of neurogenesis [GO:0050768]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2016.t1 P21856 57.859 439 0.0 523.0 sp|P21856|GDIA_BOVIN Rab GDP dissociation inhibitor alpha OS=Bos taurus OX=9913 GN=GDI1 PE=1 SV=1 GDIA_BOVIN reviewed Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (SMG p25A GDI) Bos taurus (Bovine) GO:0005093; GO:0005096; GO:0005794; GO:0005829; GO:0015031; GO:0016192; GO:0032482; GO:0050771; GO:0090315 negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi apparatus [GO:0005794] GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093] g2017.t1 Q8NHV4 37.383 749 2.01e-137 422.0 sp|Q8NHV4|NEDD1_HUMAN Protein NEDD1 OS=Homo sapiens OX=9606 GN=NEDD1 PE=1 SV=1 NEDD1_HUMAN reviewed Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1) Homo sapiens (Human) GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301 cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278] apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] gamma-tubulin binding [GO:0043015] g2017.t2 P33215 36.605 754 1.48e-135 417.0 sp|P33215|NEDD1_MOUSE Protein NEDD1 OS=Mus musculus OX=10090 GN=Nedd1 PE=1 SV=2 NEDD1_MOUSE reviewed Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1) Mus musculus (Mouse) GO:0000242; GO:0000278; GO:0000922; GO:0000931; GO:0001650; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007019; GO:0007020; GO:0031109; GO:0036064; GO:0043015; GO:0045177; GO:0051301; GO:0070201 cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule nucleation [GO:0007020]; microtubule polymerization or depolymerization [GO:0031109]; mitotic cell cycle [GO:0000278]; regulation of establishment of protein localization [GO:0070201] apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; gamma-tubulin ring complex [GO:0000931]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] gamma-tubulin binding [GO:0043015] g2019.t1 Q2TAR3 86.286 175 2.16e-111 340.0 sp|Q2TAR3|FEZF2_XENLA Fez family zinc finger protein 2 OS=Xenopus laevis OX=8355 GN=fezf2 PE=2 SV=1 g2020.t1 Q9V3G7 70.951 389 0.0 592.0 sp|Q9V3G7|PSMD6_DROME 26S proteasome non-ATPase regulatory subunit 6 OS=Drosophila melanogaster OX=7227 GN=Rpn7 PE=2 SV=1 g2021.t1 P82669 59.146 164 2.27e-72 218.0 sp|P82669|RT25_BOVIN Small ribosomal subunit protein mS25 OS=Bos taurus OX=9913 GN=MRPS25 PE=1 SV=2 g2023.t1 Q8NEE6 39.433 705 3.5e-176 531.0 sp|Q8NEE6|FXL13_HUMAN F-box and leucine-rich repeat protein 13 OS=Homo sapiens OX=9606 GN=FBXL13 PE=1 SV=3 FXL13_HUMAN reviewed F-box and leucine-rich repeat protein 13 (Dynein regulatory complex subunit 6) (F-box/LRR-repeat protein 13) Homo sapiens (Human) GO:0005813; GO:0005829; GO:0019005; GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] g2024.t1 Q96RW7 28.44 545 8.800000000000001e-35 149.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g2025.t1 O88572 33.217 286 4.56e-36 145.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g2025.t1 O88572 28.182 330 3.82e-33 136.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g2025.t1 O88572 33.953 215 1.67e-31 131.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g2025.t1 O88572 28.112 249 2.81e-25 112.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g2027.t1 P11714 36.905 168 5.88e-28 114.0 sp|P11714|CP2D9_MOUSE Cytochrome P450 2D9 OS=Mus musculus OX=10090 GN=Cyp2d9 PE=1 SV=2 CP2D9_MOUSE reviewed Cytochrome P450 2D9 (EC 1.14.14.1) (CYPIID9) (Cytochrome P450-16-alpha) (Cytochrome P450CA) (Testosterone 16-alpha hydroxylase) Mus musculus (Mouse) GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005789; GO:0006805; GO:0016491; GO:0016712; GO:0019369; GO:0020037; GO:0062187; GO:0062188; GO:0062189; GO:0070330 arachidonate metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739] anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g2029.t1 Q8AVH7 42.969 256 5.09e-55 204.0 sp|Q8AVH7|EGFL6_XENLA Epidermal growth factor-like protein 6 OS=Xenopus laevis OX=8355 GN=egfl6 PE=2 SV=1 g2030.t1 Q9D0W5 71.895 153 2.73e-83 245.0 sp|Q9D0W5|PPIL1_MOUSE Peptidyl-prolyl cis-trans isomerase-like 1 OS=Mus musculus OX=10090 GN=Ppil1 PE=1 SV=1 PPIL1_MOUSE reviewed Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1) Mus musculus (Mouse) GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0071007; GO:0071013; GO:0097718; GO:1990403 embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g2032.t1 Q13371 47.333 300 7.93e-84 256.0 sp|Q13371|PHLP_HUMAN Phosducin-like protein OS=Homo sapiens OX=9606 GN=PDCL PE=1 SV=3 PHLP_HUMAN reviewed Phosducin-like protein (PHLP) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005929; GO:0007165; GO:0007601; GO:0008277; GO:0030030; GO:0045880; GO:1902605 cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] g2032.t2 Q13371 46.844 301 1.3599999999999999e-83 256.0 sp|Q13371|PHLP_HUMAN Phosducin-like protein OS=Homo sapiens OX=9606 GN=PDCL PE=1 SV=3 PHLP_HUMAN reviewed Phosducin-like protein (PHLP) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005929; GO:0007165; GO:0007601; GO:0008277; GO:0030030; GO:0045880; GO:1902605 cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] g2035.t1 Q96LD8 49.282 209 1.73e-62 196.0 sp|Q96LD8|SENP8_HUMAN Sentrin-specific protease 8 OS=Homo sapiens OX=9606 GN=SENP8 PE=1 SV=1 SENP8_HUMAN reviewed Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8) Homo sapiens (Human) GO:0000338; GO:0005829; GO:0006508; GO:0008234; GO:0016579; GO:0019784; GO:0043687 post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829] cysteine-type peptidase activity [GO:0008234]; deNEDDylase activity [GO:0019784] g2036.t1 Q9ERZ3 32.084 427 1.37e-50 188.0 sp|Q9ERZ3|ACM3_MOUSE Muscarinic acetylcholine receptor M3 OS=Mus musculus OX=10090 GN=Chrm3 PE=1 SV=1 ACM3_MOUSE reviewed Muscarinic acetylcholine receptor M3 (Mm3 mAChR) Mus musculus (Mouse) GO:0003063; GO:0005789; GO:0005886; GO:0006939; GO:0006940; GO:0007187; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007271; GO:0009925; GO:0016323; GO:0016907; GO:0019722; GO:0030425; GO:0031789; GO:0032279; GO:0042166; GO:0042734; GO:0043679; GO:0045202; GO:0045907; GO:0045987; GO:0046541; GO:0050997; GO:0095500; GO:0098839; GO:0098978; GO:1904695; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of heart rate by acetylcholine [GO:0003063]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; positive regulation of vasoconstriction [GO:0045907]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; saliva secretion [GO:0046541]; smooth muscle contraction [GO:0006939]; synaptic transmission, cholinergic [GO:0007271] asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled acetylcholine receptor binding [GO:0031789]; quaternary ammonium group binding [GO:0050997] g2038.t1 Q8QZZ7 42.69 171 5.52e-45 149.0 sp|Q8QZZ7|TPRKB_MOUSE EKC/KEOPS complex subunit Tprkb OS=Mus musculus OX=10090 GN=Tprkb PE=1 SV=1 g2039.t1 Q5BKT4 43.167 461 1.8900000000000002e-125 375.0 sp|Q5BKT4|AG10A_HUMAN Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG10 PE=1 SV=1 AG10A_HUMAN reviewed Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase A (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006487; GO:0006488; GO:0106073 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073] g2040.t1 Q9DC53 64.595 531 0.0 718.0 sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3 g2040.t2 Q9DC53 64.528 530 0.0 721.0 sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3 g2042.t1 B2GUB3 48.382 618 0.0 610.0 sp|B2GUB3|TTLL3_XENTR Tubulin tyrosine ligase 3 OS=Xenopus tropicalis OX=8364 GN=ttll3 PE=1 SV=1 TTLL3_XENTR reviewed Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005874; GO:0005930; GO:0018094; GO:0046872; GO:0070736 protein polyglycylation [GO:0018094] axoneme [GO:0005930]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity, initiating [GO:0070736] g2042.t2 B2GUB3 48.382 618 0.0 610.0 sp|B2GUB3|TTLL3_XENTR Tubulin tyrosine ligase 3 OS=Xenopus tropicalis OX=8364 GN=ttll3 PE=1 SV=1 TTLL3_XENTR reviewed Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005874; GO:0005930; GO:0018094; GO:0046872; GO:0070736 protein polyglycylation [GO:0018094] axoneme [GO:0005930]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity, initiating [GO:0070736] g2046.t1 Q28106 30.513 390 1.9699999999999997e-40 159.0 sp|Q28106|CNTN1_BOVIN Contactin-1 OS=Bos taurus OX=9913 GN=CNTN1 PE=2 SV=1 g2047.t1 Q5R7A4 43.529 170 1.15e-51 168.0 sp|Q5R7A4|RAB7L_PONAB Ras-related protein Rab-7L1 OS=Pongo abelii OX=9601 GN=RAB29 PE=2 SV=1 RAB7L_PONAB reviewed Ras-related protein Rab-29 (EC 3.6.5.2) (Rab-7-like protein 1) (Ras-related protein Rab-7L1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0001921; GO:0003925; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005770; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0007005; GO:0007030; GO:0007416; GO:0008333; GO:0009617; GO:0010977; GO:0015031; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0042110; GO:0042147; GO:0044788; GO:0045335; GO:0048471; GO:0050862; GO:0055037; GO:0070840; GO:0072657; GO:0090316; GO:0090385; GO:1990748 cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; host-mediated perturbation of viral process [GO:0044788]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; phagosome-lysosome fusion [GO:0090385]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] dynein complex binding [GO:0070840]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] g2048.t1 F1R332 28.939 311 6.58e-31 124.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g2051.t1 Q6ZMW2 29.814 322 3.71e-33 140.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g2051.t1 Q6ZMW2 34.061 229 2.22e-27 122.0 sp|Q6ZMW2|ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens OX=9606 GN=ZNF782 PE=1 SV=1 g2052.t1 Q9Y4C4 34.05 279 2.0499999999999998e-34 142.0 sp|Q9Y4C4|MFHA1_HUMAN Malignant fibrous histiocytoma-amplified sequence 1 OS=Homo sapiens OX=9606 GN=MFHAS1 PE=1 SV=2 MFHA1_HUMAN reviewed Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1) Homo sapiens (Human) GO:0005525; GO:0005737; GO:0006954; GO:0030218; GO:0031625; GO:0034121; GO:0034136; GO:0034137; GO:0034144; GO:0035556; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745 erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121] cytoplasm [GO:0005737] GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625] g2053.t1 Q8CCC3 39.418 378 3.22e-73 251.0 sp|Q8CCC3|CL056_MOUSE Uncharacterized protein C12orf56 homolog OS=Mus musculus OX=10090 PE=2 SV=1 g2054.t1 P33497 41.325 317 1.6500000000000001e-77 253.0 sp|P33497|RYK_AVIR3 Tyrosine-protein kinase transforming protein RYK OS=Avian retrovirus RPL30 OX=31671 GN=V-RYK PE=2 SV=1 g2055.t1 P23049 41.096 292 2.29e-77 249.0 sp|P23049|SEA_AVIET Tyrosine-protein kinase transforming protein SEA OS=Avian erythroblastosis virus (strain S13) OX=11863 GN=V-SEA PE=3 SV=2 g2056.t1 P23049 42.751 269 1.33e-68 226.0 sp|P23049|SEA_AVIET Tyrosine-protein kinase transforming protein SEA OS=Avian erythroblastosis virus (strain S13) OX=11863 GN=V-SEA PE=3 SV=2 g2056.t2 P23049 44.238 269 5.04e-76 245.0 sp|P23049|SEA_AVIET Tyrosine-protein kinase transforming protein SEA OS=Avian erythroblastosis virus (strain S13) OX=11863 GN=V-SEA PE=3 SV=2 g2057.t1 P16056 43.056 288 6.85e-77 266.0 sp|P16056|MET_MOUSE Hepatocyte growth factor receptor OS=Mus musculus OX=10090 GN=Met PE=1 SV=1 MET_MOUSE reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Mus musculus (Mouse) GO:0000122; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0005008; GO:0005524; GO:0005615; GO:0005886; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010828; GO:0010976; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043025; GO:0043235; GO:0043274; GO:0043410; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:0140677; GO:1900407; GO:1900745; GO:1901299; GO:2001028 adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519] basal plasma membrane [GO:0009925]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor receptor activity [GO:0005008]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154] g2058.t1 O97341 71.233 146 1.49e-72 217.0 sp|O97341|CALM_SUBDO Calmodulin OS=Suberites domuncula OX=55567 PE=2 SV=3 g2059.t1 A1X150 33.486 872 5.33e-119 412.0 sp|A1X150|MET_ECHTE Hepatocyte growth factor receptor OS=Echinops telfairi OX=9371 GN=MET PE=3 SV=1 MET_ECHTE reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Echinops telfairi (Lesser hedgehog tenrec) GO:0002116; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0010468; GO:0017154; GO:0048468; GO:0048513; GO:0050918; GO:0071526; GO:2001028 animal organ development [GO:0048513]; cell development [GO:0048468]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; regulation of gene expression [GO:0010468]; semaphorin-plexin signaling pathway [GO:0071526] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] ATP binding [GO:0005524]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g2060.t1 Q80UG2 31.984 1976 0.0 946.0 sp|Q80UG2|PLXA4_MOUSE Plexin-A4 OS=Mus musculus OX=10090 GN=Plxna4 PE=1 SV=3 PLXA4_MOUSE reviewed Plexin-A4 Mus musculus (Mouse) GO:0002116; GO:0005886; GO:0007399; GO:0007411; GO:0007416; GO:0008045; GO:0017154; GO:0021602; GO:0021610; GO:0021612; GO:0021615; GO:0021636; GO:0021637; GO:0021644; GO:0021784; GO:0021785; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0048485; GO:0048812; GO:0048841; GO:0050923; GO:0071526; GO:0097492; GO:0099558; GO:0150053 anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; chemorepulsion of branchiomotor axon [GO:0021793]; cranial nerve morphogenesis [GO:0021602]; embryonic heart tube development [GO:0035050]; facial nerve morphogenesis [GO:0021610]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; maintenance of synapse structure [GO:0099558]; motor neuron axon guidance [GO:0008045]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; synapse assembly [GO:0007416]; trigeminal nerve morphogenesis [GO:0021636]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] semaphorin receptor activity [GO:0017154] g2062.t1 A0A6I8TCE0 33.082 1194 0.0 595.0 sp|A0A6I8TCE0|PTP1_AEDAE Putative receptor-type tyrosine-protein phosphatase mosPTP-1 OS=Aedes aegypti OX=7159 PE=1 SV=1 PTP1_AEDAE reviewed Putative receptor-type tyrosine-protein phosphatase mosPTP-1 (mosPTP-1) (EC 3.1.3.48) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004725; GO:0005886; GO:0009653; GO:0048666 anatomical structure morphogenesis [GO:0009653]; neuron development [GO:0048666] plasma membrane [GO:0005886] protein tyrosine phosphatase activity [GO:0004725] g2062.t1 A0A6I8TCE0 27.875 287 4.3e-22 107.0 sp|A0A6I8TCE0|PTP1_AEDAE Putative receptor-type tyrosine-protein phosphatase mosPTP-1 OS=Aedes aegypti OX=7159 PE=1 SV=1 PTP1_AEDAE reviewed Putative receptor-type tyrosine-protein phosphatase mosPTP-1 (mosPTP-1) (EC 3.1.3.48) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004725; GO:0005886; GO:0009653; GO:0048666 anatomical structure morphogenesis [GO:0009653]; neuron development [GO:0048666] plasma membrane [GO:0005886] protein tyrosine phosphatase activity [GO:0004725] g2062.t2 A0A6I8TCE0 33.531 1178 0.0 600.0 sp|A0A6I8TCE0|PTP1_AEDAE Putative receptor-type tyrosine-protein phosphatase mosPTP-1 OS=Aedes aegypti OX=7159 PE=1 SV=1 PTP1_AEDAE reviewed Putative receptor-type tyrosine-protein phosphatase mosPTP-1 (mosPTP-1) (EC 3.1.3.48) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004725; GO:0005886; GO:0009653; GO:0048666 anatomical structure morphogenesis [GO:0009653]; neuron development [GO:0048666] plasma membrane [GO:0005886] protein tyrosine phosphatase activity [GO:0004725] g2062.t2 A0A6I8TCE0 27.875 287 4.570000000000001e-22 107.0 sp|A0A6I8TCE0|PTP1_AEDAE Putative receptor-type tyrosine-protein phosphatase mosPTP-1 OS=Aedes aegypti OX=7159 PE=1 SV=1 PTP1_AEDAE reviewed Putative receptor-type tyrosine-protein phosphatase mosPTP-1 (mosPTP-1) (EC 3.1.3.48) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004725; GO:0005886; GO:0009653; GO:0048666 anatomical structure morphogenesis [GO:0009653]; neuron development [GO:0048666] plasma membrane [GO:0005886] protein tyrosine phosphatase activity [GO:0004725] g2062.t3 A0A6I8TCE0 31.991 869 2.1600000000000003e-109 369.0 sp|A0A6I8TCE0|PTP1_AEDAE Putative receptor-type tyrosine-protein phosphatase mosPTP-1 OS=Aedes aegypti OX=7159 PE=1 SV=1 PTP1_AEDAE reviewed Putative receptor-type tyrosine-protein phosphatase mosPTP-1 (mosPTP-1) (EC 3.1.3.48) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004725; GO:0005886; GO:0009653; GO:0048666 anatomical structure morphogenesis [GO:0009653]; neuron development [GO:0048666] plasma membrane [GO:0005886] protein tyrosine phosphatase activity [GO:0004725] g2062.t4 A0A6I8TCE0 32.564 1213 0.0 583.0 sp|A0A6I8TCE0|PTP1_AEDAE Putative receptor-type tyrosine-protein phosphatase mosPTP-1 OS=Aedes aegypti OX=7159 PE=1 SV=1 PTP1_AEDAE reviewed Putative receptor-type tyrosine-protein phosphatase mosPTP-1 (mosPTP-1) (EC 3.1.3.48) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004725; GO:0005886; GO:0009653; GO:0048666 anatomical structure morphogenesis [GO:0009653]; neuron development [GO:0048666] plasma membrane [GO:0005886] protein tyrosine phosphatase activity [GO:0004725] g2062.t4 A0A6I8TCE0 27.875 287 4.39e-22 107.0 sp|A0A6I8TCE0|PTP1_AEDAE Putative receptor-type tyrosine-protein phosphatase mosPTP-1 OS=Aedes aegypti OX=7159 PE=1 SV=1 PTP1_AEDAE reviewed Putative receptor-type tyrosine-protein phosphatase mosPTP-1 (mosPTP-1) (EC 3.1.3.48) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0004725; GO:0005886; GO:0009653; GO:0048666 anatomical structure morphogenesis [GO:0009653]; neuron development [GO:0048666] plasma membrane [GO:0005886] protein tyrosine phosphatase activity [GO:0004725] g2064.t1 Q9H6U8 56.441 590 0.0 707.0 sp|Q9H6U8|ALG9_HUMAN Alpha-1,2-mannosyltransferase ALG9 OS=Homo sapiens OX=9606 GN=ALG9 PE=1 SV=2 g2065.t1 Q02543 71.023 176 2.95e-92 269.0 sp|Q02543|RL18A_HUMAN Large ribosomal subunit protein eL20 OS=Homo sapiens OX=9606 GN=RPL18A PE=1 SV=2 RL18A_HUMAN reviewed Large ribosomal subunit protein eL20 (60S ribosomal protein L18a) Homo sapiens (Human) GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626 cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; postsynaptic density [GO:0014069] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g2066.t1 Q9H845 61.333 600 0.0 744.0 sp|Q9H845|ACAD9_HUMAN Complex I assembly factor ACAD9, mitochondrial OS=Homo sapiens OX=9606 GN=ACAD9 PE=1 SV=1 ACAD9_HUMAN reviewed Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.7, EC 1.3.8.8) Homo sapiens (Human) GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991 long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain fatty acyl-CoA dehydrogenase activity [GO:0070991] g2067.t1 Q09428 38.698 1628 0.0 1056.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2068.t1 Q29J90 26.462 359 3.2e-25 110.0 sp|Q29J90|MOODY_DROPS G-protein coupled receptor moody OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=moody PE=3 SV=2 g2069.t1 Q29J90 26.462 359 3.2e-25 110.0 sp|Q29J90|MOODY_DROPS G-protein coupled receptor moody OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=moody PE=3 SV=2 g2070.t1 P82451 64.444 180 2.6e-71 238.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g2071.t1 Q96ME1 35.577 208 7.75e-34 131.0 sp|Q96ME1|FXL18_HUMAN F-box/LRR-repeat protein 18 OS=Homo sapiens OX=9606 GN=FBXL18 PE=1 SV=3 g2072.t1 O60706 38.791 1588 0.0 1085.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2073.t1 Q09428 39.761 1587 0.0 1091.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2073.t2 Q09428 39.723 1591 0.0 1090.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2073.t3 O60706 41.886 1177 0.0 905.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2074.t1 Q9WUV0 58.904 438 0.0 530.0 sp|Q9WUV0|ORC5_MOUSE Origin recognition complex subunit 5 OS=Mus musculus OX=10090 GN=Orc5 PE=2 SV=1 g2075.t1 Q91178 31.32 447 2.28e-55 192.0 sp|Q91178|GPRX_ORYLA Probable G-protein coupled receptor (Fragment) OS=Oryzias latipes OX=8090 PE=3 SV=1 g2077.t1 P21839 72.165 97 9.94e-39 138.0 sp|P21839|ODBB_BOVIN 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial OS=Bos taurus OX=9913 GN=BCKDHB PE=1 SV=2 g2078.t1 P30531 58.182 550 0.0 689.0 sp|P30531|SC6A1_HUMAN Sodium- and chloride-dependent GABA transporter 1 OS=Homo sapiens OX=9606 GN=SLC6A1 PE=1 SV=2 SC6A1_HUMAN reviewed Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1) Homo sapiens (Human) GO:0005332; GO:0005886; GO:0006865; GO:0007268; GO:0007613; GO:0008306; GO:0009986; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0035725; GO:0043025; GO:0046872; GO:0050808; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098982; GO:0150104; GO:1902476 amino acid transport [GO:0006865]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104] axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793] gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] g2079.t1 Q92560 44.603 769 4.13e-174 520.0 sp|Q92560|BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens OX=9606 GN=BAP1 PE=1 SV=2 BAP1_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1) (Cerebral protein 6) Homo sapiens (Human) GO:0000278; GO:0001558; GO:0001701; GO:0001894; GO:0002574; GO:0003682; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006511; GO:0008233; GO:0008285; GO:0010467; GO:0016579; GO:0030223; GO:0031490; GO:0031507; GO:0033028; GO:0035517; GO:0035520; GO:0035726; GO:0036211; GO:0036344; GO:0043249; GO:0043363; GO:0045892; GO:0050727; GO:0051726; GO:0061484; GO:0061519; GO:0070050; GO:0070661; GO:0071108; GO:0140950; GO:1900015; GO:1903955 common myeloid progenitor cell proliferation [GO:0035726]; erythrocyte maturation [GO:0043249]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; leukocyte proliferation [GO:0070661]; macrophage homeostasis [GO:0061519]; mitotic cell cycle [GO:0000278]; monoubiquitinated protein deubiquitination [GO:0035520]; myeloid cell apoptotic process [GO:0033028]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; neuron cellular homeostasis [GO:0070050]; neutrophil differentiation [GO:0030223]; nucleate erythrocyte differentiation [GO:0043363]; platelet morphogenesis [GO:0036344]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; thrombocyte differentiation [GO:0002574]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cysteine-type deubiquitinase activity [GO:0004843]; histone H2A deubiquitinase activity [GO:0140950]; peptidase activity [GO:0008233] g2080.t1 Q60490 42.453 212 4.73e-57 184.0 sp|Q60490|EBP_CAVPO 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Cavia porcellus OX=10141 GN=EBP PE=1 SV=3 g2080.t2 Q60490 44.34 212 2.52e-60 192.0 sp|Q60490|EBP_CAVPO 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Cavia porcellus OX=10141 GN=EBP PE=1 SV=3 g2081.t1 Q60490 39.912 228 2.49e-52 172.0 sp|Q60490|EBP_CAVPO 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Cavia porcellus OX=10141 GN=EBP PE=1 SV=3 g2082.t1 Q60490 40.435 230 2.17e-55 179.0 sp|Q60490|EBP_CAVPO 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase OS=Cavia porcellus OX=10141 GN=EBP PE=1 SV=3 g2083.t1 Q9SXD5 33.333 417 1.86e-65 219.0 sp|Q9SXD5|GSXL3_ARATH Flavin-containing monooxygenase FMO GS-OX-like 3 OS=Arabidopsis thaliana OX=3702 GN=At1g62620 PE=2 SV=2 g2084.t1 Q96GS4 38.15 173 3.32e-29 119.0 sp|Q96GS4|BORC6_HUMAN BLOC-1-related complex subunit 6 OS=Homo sapiens OX=9606 GN=BORCS6 PE=1 SV=2 g2085.t1 Q9H1D0 26.427 613 1.3499999999999998e-54 205.0 sp|Q9H1D0|TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens OX=9606 GN=TRPV6 PE=1 SV=3 g2087.t1 Q9H1D0 26.387 595 9.629999999999999e-54 204.0 sp|Q9H1D0|TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens OX=9606 GN=TRPV6 PE=1 SV=3 g2088.t1 A8Y5T1 48.78 164 1.7899999999999998e-48 157.0 sp|A8Y5T1|CF276_DANRE Protein CFAP276 OS=Danio rerio OX=7955 GN=cfap276 PE=3 SV=1 g2089.t1 Q3UZV7 40.688 988 0.0 766.0 sp|Q3UZV7|ELAP2_MOUSE Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Mus musculus OX=10090 GN=Elapor2 PE=1 SV=1 ELAP2_MOUSE reviewed Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) Mus musculus (Mouse) GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700 negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684] membrane [GO:0016020]; plasma membrane [GO:0005886] BMP receptor binding [GO:0070700] g2089.t2 Q3UZV7 40.692 983 0.0 766.0 sp|Q3UZV7|ELAP2_MOUSE Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Mus musculus OX=10090 GN=Elapor2 PE=1 SV=1 ELAP2_MOUSE reviewed Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) Mus musculus (Mouse) GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700 negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684] membrane [GO:0016020]; plasma membrane [GO:0005886] BMP receptor binding [GO:0070700] g2089.t3 Q3UZV7 40.733 982 0.0 767.0 sp|Q3UZV7|ELAP2_MOUSE Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Mus musculus OX=10090 GN=Elapor2 PE=1 SV=1 ELAP2_MOUSE reviewed Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) Mus musculus (Mouse) GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700 negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684] membrane [GO:0016020]; plasma membrane [GO:0005886] BMP receptor binding [GO:0070700] g2093.t1 E7F654 34.184 588 3.51e-86 297.0 sp|E7F654|NOL9_DANRE Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Danio rerio OX=7955 GN=nol9 PE=3 SV=1 NOL9_DANRE reviewed Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.78) (Nucleolar protein 9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000448; GO:0001889; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0031017; GO:0048565; GO:0051731; GO:0051734; GO:0060216; GO:0061113 cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; definitive hemopoiesis [GO:0060216]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; pancreas morphogenesis [GO:0061113]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent polynucleotide 5'-hydroxyl-kinase activity [GO:0051734]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723] g2093.t2 E7F654 34.3 586 1.5e-86 298.0 sp|E7F654|NOL9_DANRE Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Danio rerio OX=7955 GN=nol9 PE=3 SV=1 NOL9_DANRE reviewed Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.78) (Nucleolar protein 9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000448; GO:0001889; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0031017; GO:0048565; GO:0051731; GO:0051734; GO:0060216; GO:0061113 cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; definitive hemopoiesis [GO:0060216]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; pancreas morphogenesis [GO:0061113]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent polynucleotide 5'-hydroxyl-kinase activity [GO:0051734]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723] g2094.t1 Q9WUN2 41.778 675 1.76e-169 515.0 sp|Q9WUN2|TBK1_MOUSE Serine/threonine-protein kinase TBK1 OS=Mus musculus OX=10090 GN=Tbk1 PE=1 SV=1 TBK1_MOUSE reviewed Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) Mus musculus (Mouse) GO:0002181; GO:0002218; GO:0002753; GO:0003676; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006606; GO:0009299; GO:0010468; GO:0010508; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0031669; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0038202; GO:0038203; GO:0042802; GO:0043123; GO:0043491; GO:0044565; GO:0045087; GO:0045944; GO:0045948; GO:0050830; GO:0051219; GO:0051897; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1904262; GO:1904263; GO:1904417; GO:1904515 activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; cellular response to nutrient levels [GO:0031669]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell proliferation [GO:0044565]; innate immune response [GO:0045087]; mRNA transcription [GO:0009299]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of type I interferon production [GO:0032479]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g2095.t1 Q4VBT5 43.457 405 3.2499999999999997e-115 350.0 sp|Q4VBT5|MKRN1_DANRE Probable E3 ubiquitin-protein ligase makorin-1 OS=Danio rerio OX=7955 GN=mkrn1 PE=2 SV=1 g2097.t1 Q66KD5 51.675 418 1.33e-135 397.0 sp|Q66KD5|ING3_XENTR Inhibitor of growth protein 3 OS=Xenopus tropicalis OX=8364 GN=ing3 PE=2 SV=1 g2098.t1 Q96SB4 72.727 253 3.28e-113 361.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g2098.t1 Q96SB4 63.314 169 3.1200000000000004e-66 236.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g2098.t2 Q96SB4 72.727 253 3.75e-113 362.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g2098.t2 Q96SB4 63.314 169 2.71e-66 236.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g2098.t3 Q96SB4 72.727 253 3.96e-113 362.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g2098.t3 Q96SB4 63.314 169 2.8e-66 236.0 sp|Q96SB4|SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens OX=9606 GN=SRPK1 PE=1 SV=2 SRPK1_HUMAN reviewed SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) Homo sapiens (Human) GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g2105.t1 P20488 33.937 221 1.38e-39 142.0 sp|P20488|SYPH_BOVIN Synaptophysin OS=Bos taurus OX=9913 GN=SYP PE=1 SV=3 SYPH_BOVIN reviewed Synaptophysin (Major synaptic vesicle protein p38) Bos taurus (Bovine) GO:0006897; GO:0030136; GO:0030672; GO:0042584; GO:0042802; GO:0043005; GO:0045920; GO:0048168; GO:0048786; GO:0051020; GO:2000474 endocytosis [GO:0006897]; negative regulation of exocytosis [GO:0045920]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of opioid receptor signaling pathway [GO:2000474] chromaffin granule membrane [GO:0042584]; clathrin-coated vesicle [GO:0030136]; neuron projection [GO:0043005]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672] GTPase binding [GO:0051020]; identical protein binding [GO:0042802] g2106.t1 P53590 66.359 434 0.0 572.0 sp|P53590|SUCB2_PIG Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (Fragment) OS=Sus scrofa OX=9823 GN=SUCLG2 PE=1 SV=2 g2107.t1 O35678 47.727 220 3.06e-69 217.0 sp|O35678|MGLL_MOUSE Monoglyceride lipase OS=Mus musculus OX=10090 GN=Mgll PE=1 SV=1 MGLL_MOUSE reviewed Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL) Mus musculus (Mouse) GO:0005811; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0030424; GO:0030516; GO:0042803; GO:0043196; GO:0045202; GO:0045907; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0060292; GO:0098688; GO:0098793; GO:0099178; GO:0150053; GO:2000124 acylglycerol catabolic process [GO:0046464]; arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433] axon [GO:0030424]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; presynapse [GO:0098793]; synapse [GO:0045202]; varicosity [GO:0043196] hydrolase activity [GO:0016787]; monoacylglycerol lipase activity [GO:0047372]; protein homodimerization activity [GO:0042803] g2108.t1 Q969K4 51.685 89 4.6100000000000006e-21 88.6 sp|Q969K4|ABTB1_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ABTB1 PE=1 SV=1 g2109.t1 Q99LJ2 53.916 332 1.7e-114 344.0 sp|Q99LJ2|ABTB1_MOUSE Ankyrin repeat and BTB/POZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Abtb1 PE=2 SV=1 g2111.t1 Q6P1C6 45.029 855 0.0 698.0 sp|Q6P1C6|LRIG3_MOUSE Leucine-rich repeats and immunoglobulin-like domains protein 3 OS=Mus musculus OX=10090 GN=Lrig3 PE=1 SV=1 LRIG3_MOUSE reviewed Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3) Mus musculus (Mouse) GO:0005886; GO:0030659; GO:0032474 otolith morphogenesis [GO:0032474] cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886] g2113.t1 Q3T052 42.685 581 2.75e-143 449.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g2115.t1 Q3T052 35.359 543 5.839999999999999e-95 312.0 sp|Q3T052|ITIH4_BOVIN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Bos taurus OX=9913 GN=ITIH4 PE=1 SV=1 ITIH4_BOVIN reviewed Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) Bos taurus (Bovine) GO:0004867; GO:0005576; GO:0006953; GO:0030212 acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] serine-type endopeptidase inhibitor activity [GO:0004867] g2117.t1 P97280 34.354 882 1.26e-149 467.0 sp|P97280|ITIH3_MESAU Inter-alpha-trypsin inhibitor heavy chain H3 OS=Mesocricetus auratus OX=10036 GN=ITIH3 PE=1 SV=1 g2119.t1 O35161 28.357 931 9.660000000000001e-77 283.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g2119.t1 O35161 30.086 349 2.3100000000000002e-32 141.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g2119.t1 O35161 26.0 400 2.2000000000000002e-27 125.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g2124.t1 Q6NWG4 43.109 341 9.22e-92 279.0 sp|Q6NWG4|ANM6_DANRE Protein arginine N-methyltransferase 6 OS=Danio rerio OX=7955 GN=prmt6 PE=2 SV=2 ANM6_DANRE reviewed Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0005634; GO:0006281; GO:0006338; GO:0006355; GO:0008757; GO:0010629; GO:0016274; GO:0021782; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0042393; GO:0044020; GO:0045892; GO:0060041; GO:0070611; GO:0070612; GO:2000059 chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; glial cell development [GO:0021782]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; regulation of DNA-templated transcription [GO:0006355]; retina development in camera-type eye [GO:0060041] chromatin [GO:0000785]; nucleus [GO:0005634] histone binding [GO:0042393]; histone H2AR3 methyltransferase activity [GO:0070612]; histone H3R2 methyltransferase activity [GO:0070611]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g2126.t1 Q8YRI1 25.181 691 4.6299999999999996e-38 159.0 sp|Q8YRI1|YY46_NOSS1 Uncharacterized WD repeat-containing protein alr3466 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr3466 PE=4 SV=1 g2126.t1 Q8YRI1 30.854 363 3.67e-26 120.0 sp|Q8YRI1|YY46_NOSS1 Uncharacterized WD repeat-containing protein alr3466 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr3466 PE=4 SV=1 g2126.t1 Q8YRI1 28.682 387 3.06e-25 117.0 sp|Q8YRI1|YY46_NOSS1 Uncharacterized WD repeat-containing protein alr3466 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr3466 PE=4 SV=1 g2126.t1 Q8YRI1 28.756 386 9.15e-25 116.0 sp|Q8YRI1|YY46_NOSS1 Uncharacterized WD repeat-containing protein alr3466 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr3466 PE=4 SV=1 g2126.t1 Q8YRI1 30.053 376 1.26e-24 115.0 sp|Q8YRI1|YY46_NOSS1 Uncharacterized WD repeat-containing protein alr3466 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr3466 PE=4 SV=1 g2126.t1 Q8YRI1 25.896 614 1.3799999999999998e-23 112.0 sp|Q8YRI1|YY46_NOSS1 Uncharacterized WD repeat-containing protein alr3466 OS=Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) OX=103690 GN=alr3466 PE=4 SV=1 g2129.t1 Q9ULI1 29.179 1011 3.57e-133 460.0 sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3 g2130.t1 A6H603 25.68 1176 3.7e-77 285.0 sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2 NWD1_MOUSE reviewed NACHT domain- and WD repeat-containing protein 1 Mus musculus (Mouse) GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088 negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628] cytosol [GO:0005829]; nucleolus [GO:0005730] ATP binding [GO:0005524] g2131.t1 Q9ULI1 28.928 401 1.89e-49 184.0 sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3 g2132.t1 O95243 72.222 54 1.81e-22 94.4 sp|O95243|MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens OX=9606 GN=MBD4 PE=1 SV=1 g2137.t1 Q96DM1 35.329 167 7.49e-21 91.7 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g2138.t1 Q9UBN7 58.75 80 3.0400000000000004e-27 111.0 sp|Q9UBN7|HDAC6_HUMAN Protein deacetylase HDAC6 OS=Homo sapiens OX=9606 GN=HDAC6 PE=1 SV=2 HDAC6_HUMAN reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) Homo sapiens (Human) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0033148; GO:0033558; GO:0034605; GO:0035967; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0071218; GO:0090042; GO:1903146; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of aggrephagy [GO:1905336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of type 2 mitophagy [GO:1905091]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g2139.t1 Q9W534 29.664 327 3.07e-45 167.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g2140.t1 Q9Z2V5 45.704 838 0.0 717.0 sp|Q9Z2V5|HDAC6_MOUSE Protein deacetylase HDAC6 OS=Mus musculus OX=10090 GN=Hdac6 PE=1 SV=3 HDAC6_MOUSE reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) (mHDA2) Mus musculus (Mouse) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006511; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010727; GO:0010821; GO:0010977; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033148; GO:0033558; GO:0035967; GO:0035973; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0044297; GO:0045598; GO:0045814; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070507; GO:0070840; GO:0070842; GO:0070845; GO:0071211; GO:0071218; GO:0090042; GO:0140694; GO:1900409; GO:1904056; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggrephagy [GO:0035973]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; membraneless organelle assembly [GO:0140694]; mitochondrion localization [GO:0051646]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to corticosterone [GO:0051412]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell body [GO:0044297]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g2140.t1 Q9Z2V5 47.774 337 3.03e-100 341.0 sp|Q9Z2V5|HDAC6_MOUSE Protein deacetylase HDAC6 OS=Mus musculus OX=10090 GN=Hdac6 PE=1 SV=3 HDAC6_MOUSE reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) (mHDA2) Mus musculus (Mouse) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006511; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010727; GO:0010821; GO:0010977; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033148; GO:0033558; GO:0035967; GO:0035973; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0044297; GO:0045598; GO:0045814; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070507; GO:0070840; GO:0070842; GO:0070845; GO:0071211; GO:0071218; GO:0090042; GO:0140694; GO:1900409; GO:1904056; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggrephagy [GO:0035973]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; membraneless organelle assembly [GO:0140694]; mitochondrion localization [GO:0051646]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to corticosterone [GO:0051412]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell body [GO:0044297]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g2140.t1 Q9Z2V5 39.443 431 1.78e-89 311.0 sp|Q9Z2V5|HDAC6_MOUSE Protein deacetylase HDAC6 OS=Mus musculus OX=10090 GN=Hdac6 PE=1 SV=3 HDAC6_MOUSE reviewed Protein deacetylase HDAC6 (EC 3.5.1.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) (mHDA2) Mus musculus (Mouse) GO:0000118; GO:0000153; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006511; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010634; GO:0010727; GO:0010821; GO:0010977; GO:0015630; GO:0016234; GO:0016235; GO:0016241; GO:0019213; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0032991; GO:0033148; GO:0033558; GO:0035967; GO:0035973; GO:0036064; GO:0036479; GO:0042030; GO:0042826; GO:0042903; GO:0043005; GO:0043014; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0044297; GO:0045598; GO:0045814; GO:0045861; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051646; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060997; GO:0061523; GO:0061630; GO:0061734; GO:0070201; GO:0070301; GO:0070507; GO:0070840; GO:0070842; GO:0070845; GO:0071211; GO:0071218; GO:0090042; GO:0140694; GO:1900409; GO:1904056; GO:1904115; GO:1905091; GO:1905336 actin filament organization [GO:0007015]; aggrephagy [GO:0035973]; aggresome assembly [GO:0070842]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; membraneless organelle assembly [GO:0140694]; mitochondrion localization [GO:0051646]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein-containing complex disassembly [GO:0032984]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to corticosterone [GO:0051412]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell body [GO:0044297]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; deacetylase activity [GO:0019213]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g2144.t1 Q09165 27.498 5615 6.02e-63 247.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.398 5234 9.94e-58 230.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.096 5569 1.15e-57 229.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 26.992 5435 2.83e-56 225.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.654 5388 6.3899999999999996e-55 220.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 26.892 5801 2.44e-53 215.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.512 4627 5.22e-53 214.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 26.811 5826 2.16e-52 212.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.33 5741 3.9e-50 204.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.184 4521 7.9e-41 174.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.704 1895 1.98e-25 122.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.442 4566 1.5099999999999998e-23 116.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2144.t1 Q09165 27.523 2507 7.07e-21 107.0 sp|Q09165|DIG1_CAEEL Mesocentin OS=Caenorhabditis elegans OX=6239 GN=dig-1 PE=1 SV=2 DIG1_CAEEL reviewed Mesocentin Caenorhabditis elegans GO:0005509; GO:0007155; GO:0007399; GO:0008406; GO:0071711 basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; gonad development [GO:0008406]; nervous system development [GO:0007399] calcium ion binding [GO:0005509] g2145.t1 Q28983 36.885 244 1.7600000000000001e-29 120.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g2145.t1 Q28983 37.751 249 4.89e-29 119.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g2145.t1 Q28983 36.15 213 3.16e-26 111.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g2148.t1 Q60HC7 61.798 623 0.0 811.0 sp|Q60HC7|TKT_MACFA Transketolase OS=Macaca fascicularis OX=9541 GN=TKT PE=2 SV=1 g2148.t2 Q9D4D4 62.379 622 0.0 805.0 sp|Q9D4D4|TKTL2_MOUSE Transketolase-like protein 2 OS=Mus musculus OX=10090 GN=Tktl2 PE=1 SV=1 g2149.t1 P31646 48.899 636 0.0 614.0 sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1 S6A13_RAT reviewed Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13) Rattus norvegicus (Rat) GO:0005283; GO:0005308; GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine:sodium symporter activity [GO:0005369] g2150.t1 Q04791 35.663 558 4.11e-101 319.0 sp|Q04791|SASB_ANAPL Fatty acyl-CoA hydrolase precursor, medium chain OS=Anas platyrhynchos OX=8839 PE=1 SV=1 g2153.t1 G3H0N9 37.308 260 7.87e-40 140.0 sp|G3H0N9|DNJB9_CRIGR DnaJ homolog subfamily B member 9 OS=Cricetulus griseus OX=10029 GN=DNAJB9 PE=1 SV=1 g2154.t1 Q96SW2 49.624 399 1.44e-136 403.0 sp|Q96SW2|CRBN_HUMAN Protein cereblon OS=Homo sapiens OX=9606 GN=CRBN PE=1 SV=1 CRBN_HUMAN reviewed Protein cereblon Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016567; GO:0030177; GO:0031333; GO:0031334; GO:0031464; GO:0034766; GO:0035641; GO:0043161; GO:0044325; GO:0046872; GO:0048471; GO:0060173 limb development [GO:0060173]; locomotory exploration behavior [GO:0035641]; negative regulation of monoatomic ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Wnt signaling pathway [GO:0030177]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325] g2160.t1 Q6DHJ3 36.681 458 4.7999999999999996e-89 281.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g2163.t1 Q6DHJ3 35.652 460 1.43e-87 277.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g2164.t1 Q6DHJ3 42.466 365 2.38e-90 282.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g2165.t1 F7J184 38.037 326 1.38e-63 214.0 sp|F7J184|NVD_XENLA Cholesterol 7-desaturase nvd OS=Xenopus laevis OX=8355 GN=nvd PE=1 SV=1 g2165.t2 F7J184 38.037 326 1.38e-63 214.0 sp|F7J184|NVD_XENLA Cholesterol 7-desaturase nvd OS=Xenopus laevis OX=8355 GN=nvd PE=1 SV=1 g2166.t1 Q6ZUK4 39.189 296 6.53e-61 206.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g2168.t1 Q9UGM3 45.455 220 1.93e-51 189.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 35.393 356 4.51e-50 186.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 42.739 241 1.24e-49 184.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 42.4 250 3.56e-49 183.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 42.739 241 4.15e-49 183.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 42.149 242 7.54e-49 182.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 41.767 249 1.3599999999999999e-48 181.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 41.909 241 4.4399999999999995e-48 180.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 41.909 241 9.119999999999999e-48 179.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 41.803 244 5.21e-47 177.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2168.t1 Q9UGM3 45.614 114 1.8300000000000003e-21 101.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 41.667 168 6.99e-34 136.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 39.062 192 1.5600000000000002e-32 132.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 39.674 184 3.34e-32 131.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 38.22 191 4.5200000000000003e-32 131.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 38.095 189 9.510000000000001e-32 130.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 39.13 184 1.6e-31 129.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 38.22 191 1.8200000000000001e-31 129.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 37.368 190 2.42e-31 129.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 37.566 189 3.87e-31 128.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 37.566 189 4.71e-31 128.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 37.566 189 4.8e-31 128.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 38.021 192 2.4e-30 126.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 48.077 104 8.159999999999999e-24 107.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2169.t1 Q9UGM3 43.86 114 9.430000000000001e-21 97.8 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 43.519 216 4.0999999999999995e-48 176.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 41.991 231 1.38e-46 171.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 41.991 231 1.77e-46 171.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 40.928 237 2.5299999999999998e-46 171.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 40.586 239 7.61e-46 169.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 41.631 233 1.08e-45 169.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 41.202 233 1.93e-45 168.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 41.631 233 3.88e-45 167.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 40.084 237 9.099999999999999e-45 166.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 40.084 237 1.13e-44 166.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 40.084 237 1.81e-44 165.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 41.026 234 1.39e-43 162.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 48.113 106 4.98e-24 105.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2171.t1 Q9UGM3 46.296 108 5.420000000000001e-21 97.1 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 41.841 239 9.939999999999999e-48 177.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 41.176 238 2.8400000000000003e-47 175.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.678 236 5.13e-47 174.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 41.102 236 5.69e-47 174.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.678 236 6.95e-47 174.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.756 238 2.1e-46 173.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.506 237 3.1699999999999997e-46 172.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.254 236 1.3199999999999999e-45 171.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.254 236 2.2799999999999998e-45 170.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.254 236 2.6e-45 169.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 40.167 239 2.17e-44 167.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2172.t1 Q9UGM3 48.077 104 1.43e-23 106.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g2173.t1 Q0VG85 36.14 974 1.35e-177 572.0 sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4 g2173.t2 Q0VG85 36.401 967 1.47e-179 577.0 sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4 g2175.t1 Q08DI8 45.87 569 4.9e-177 527.0 sp|Q08DI8|PUS7_BOVIN Pseudouridylate synthase 7 homolog OS=Bos taurus OX=9913 GN=PUS7 PE=2 SV=1 PUS7_BOVIN reviewed Pseudouridylate synthase 7 homolog (EC 5.4.99.-) Bos taurus (Bovine) GO:0001522; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009982; GO:0017148; GO:0031119; GO:0160150; GO:1902036; GO:1990481; GO:2000380 mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] nucleus [GO:0005634] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(13) synthase activity [GO:0160150] g2177.t1 Q7SXK5 59.954 437 0.0 549.0 sp|Q7SXK5|HUTI_DANRE Probable imidazolonepropionase OS=Danio rerio OX=7955 GN=amdhd1 PE=2 SV=2 g2180.t1 Q95218 44.86 214 1.27e-47 178.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g2180.t1 Q95218 39.834 241 1.18e-44 169.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g2180.t1 Q95218 38.583 254 3.15e-43 165.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g2180.t1 Q95218 35.714 266 3.7599999999999994e-40 156.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g2180.t1 Q95218 38.174 241 1.19e-38 152.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g2180.t1 Q95218 48.148 108 4.27e-23 105.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g2180.t1 Q95218 45.794 107 1.95e-21 100.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g2182.t1 P09215 51.585 694 0.0 724.0 sp|P09215|KPCD_RAT Protein kinase C delta type OS=Rattus norvegicus OX=10116 GN=Prkcd PE=1 SV=1 KPCD_RAT reviewed Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] Rattus norvegicus (Rat) GO:0001666; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006915; GO:0006974; GO:0006979; GO:0008047; GO:0008270; GO:0009410; GO:0009612; GO:0009749; GO:0016020; GO:0016064; GO:0016363; GO:0018105; GO:0019899; GO:0019901; GO:0023021; GO:0030296; GO:0030837; GO:0032869; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0034644; GO:0035556; GO:0036019; GO:0042100; GO:0042119; GO:0042149; GO:0042307; GO:0042325; GO:0042542; GO:0042742; GO:0043065; GO:0043200; GO:0043409; GO:0043410; GO:0043560; GO:0043687; GO:0045471; GO:0046326; GO:0046627; GO:0048471; GO:0050728; GO:0051490; GO:0060326; GO:0070301; GO:0070528; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:0106310; GO:0120283; GO:0141212; GO:1904385; GO:1904627; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235 apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; phospholipase C/protein kinase C signal transduction [GO:0141212]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of D-glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; protein kinase C signaling [GO:0070528]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of phosphorylation [GO:0042325]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to xenobiotic stimulus [GO:0009410]; termination of signal transduction [GO:0023021] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase activity [GO:0004713]; TIR domain binding [GO:0070976]; zinc ion binding [GO:0008270] g2183.t1 O75648 55.362 401 2.49e-165 473.0 sp|O75648|MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens OX=9606 GN=TRMU PE=1 SV=2 g2184.t1 Q8BGC3 25.618 445 7.39e-28 118.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2185.t1 Q8BGC3 27.069 447 2.0599999999999998e-30 125.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2186.t1 Q8BGC3 25.397 441 1.43e-28 120.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2197.t1 Q9D8N6 33.462 260 9.239999999999999e-30 115.0 sp|Q9D8N6|LIN37_MOUSE Protein lin-37 homolog OS=Mus musculus OX=10090 GN=Lin37 PE=1 SV=1 g2200.t1 Q9JJF6 47.656 128 9.87e-28 121.0 sp|Q9JJF6|EFCC1_MOUSE EF-hand and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Efcc1 PE=2 SV=2 g2201.t1 Q9QYP1 31.23 935 1.1e-118 417.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g2201.t1 Q9QYP1 30.185 921 6.88e-102 366.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g2201.t1 Q9QYP1 34.056 323 1.0499999999999999e-38 162.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g2201.t1 Q9QYP1 27.988 343 3e-24 115.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g2205.t1 C6KFA3 27.108 664 8.88e-63 238.0 sp|C6KFA3|AGRG6_DANRE Adhesion G-protein coupled receptor G6 OS=Danio rerio OX=7955 GN=adgrg6 PE=1 SV=1 AGRG6_DANRE reviewed Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004930; GO:0005518; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007193; GO:0007507; GO:0014037; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0043583; GO:0050840; GO:0051216; GO:0060347 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; regulation of bone mineralization [GO:0030500]; Schwann cell differentiation [GO:0014037] plasma membrane [GO:0005886] collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236] g2207.t1 Q3MHX1 51.777 197 1.97e-73 223.0 sp|Q3MHX1|COMD7_BOVIN COMM domain-containing protein 7 OS=Bos taurus OX=9913 GN=COMMD7 PE=2 SV=1 g2208.t1 P56652 31.277 924 5.440000000000001e-129 433.0 sp|P56652|ITIH3_BOVIN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Bos taurus OX=9913 GN=ITIH3 PE=1 SV=2 g2208.t1 P56652 34.304 618 1.83e-95 335.0 sp|P56652|ITIH3_BOVIN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Bos taurus OX=9913 GN=ITIH3 PE=1 SV=2 g2208.t1 P56652 34.561 570 2.64e-86 307.0 sp|P56652|ITIH3_BOVIN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Bos taurus OX=9913 GN=ITIH3 PE=1 SV=2 g2208.t2 P56652 31.277 924 4.650000000000001e-129 433.0 sp|P56652|ITIH3_BOVIN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Bos taurus OX=9913 GN=ITIH3 PE=1 SV=2 g2208.t2 P56652 34.304 618 1.4499999999999998e-95 335.0 sp|P56652|ITIH3_BOVIN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Bos taurus OX=9913 GN=ITIH3 PE=1 SV=2 g2208.t2 P56652 34.561 570 2.1800000000000002e-86 308.0 sp|P56652|ITIH3_BOVIN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Bos taurus OX=9913 GN=ITIH3 PE=1 SV=2 g2209.t1 Q06033 29.352 879 1.58e-108 373.0 sp|Q06033|ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens OX=9606 GN=ITIH3 PE=1 SV=2 ITIH3_HUMAN reviewed Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3) (Serum-derived hyaluronan-associated protein) (SHAP) Homo sapiens (Human) GO:0004866; GO:0004867; GO:0005576; GO:0030212; GO:0031089; GO:0070062 hyaluronan metabolic process [GO:0030212] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] g2209.t1 Q06033 34.753 587 1.47e-93 329.0 sp|Q06033|ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens OX=9606 GN=ITIH3 PE=1 SV=2 ITIH3_HUMAN reviewed Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3) (Serum-derived hyaluronan-associated protein) (SHAP) Homo sapiens (Human) GO:0004866; GO:0004867; GO:0005576; GO:0030212; GO:0031089; GO:0070062 hyaluronan metabolic process [GO:0030212] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] g2209.t1 Q06033 34.256 578 3.23e-87 310.0 sp|Q06033|ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens OX=9606 GN=ITIH3 PE=1 SV=2 ITIH3_HUMAN reviewed Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3) (Serum-derived hyaluronan-associated protein) (SHAP) Homo sapiens (Human) GO:0004866; GO:0004867; GO:0005576; GO:0030212; GO:0031089; GO:0070062 hyaluronan metabolic process [GO:0030212] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] g2210.t1 P17200 24.628 471 7.5e-35 138.0 sp|P17200|ACM4_CHICK Muscarinic acetylcholine receptor M4 OS=Gallus gallus OX=9031 GN=CHRM4 PE=2 SV=1 g2211.t1 Q9DCM0 56.574 251 6.219999999999999e-98 291.0 sp|Q9DCM0|ETHE1_MOUSE Persulfide dioxygenase ETHE1, mitochondrial OS=Mus musculus OX=10090 GN=Ethe1 PE=1 SV=2 ETHE1_MOUSE reviewed Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1 homolog) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1) Mus musculus (Mouse) GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0042802; GO:0050313; GO:0070813 glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313] g2212.t1 Q5FVB0 33.735 415 1.25e-65 223.0 sp|Q5FVB0|ATX10_XENTR Ataxin-10 OS=Xenopus tropicalis OX=8364 GN=atxn10 PE=2 SV=1 g2213.t1 Q3L254 64.327 342 4.85e-170 480.0 sp|Q3L254|WNT7B_CHICK Protein Wnt-7b OS=Gallus gallus OX=9031 GN=WNT7B PE=2 SV=1 WNT7B_CHICK reviewed Protein Wnt-7b Gallus gallus (Chicken) GO:0005109; GO:0005125; GO:0005615; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089 canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089] extracellular space [GO:0005615] cytokine activity [GO:0005125]; frizzled binding [GO:0005109] g2215.t1 Q4V7B1 50.179 279 4.11e-83 285.0 sp|Q4V7B1|CF20D_RAT Protein CFAP20DC OS=Rattus norvegicus OX=10116 GN=Cfap20dc PE=2 SV=1 g2216.t1 Q5U3U3 50.711 633 0.0 667.0 sp|Q5U3U3|CPT2_DANRE Carnitine O-palmitoyltransferase 2, mitochondrial OS=Danio rerio OX=7955 GN=cpt2 PE=2 SV=2 CPT2_DANRE reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g2217.t1 Q6GM59 26.645 304 1.19e-22 102.0 sp|Q6GM59|MOT12_XENLA Monocarboxylate transporter 12 OS=Xenopus laevis OX=8355 GN=slc16a12 PE=2 SV=1 MOT12_XENLA reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Xenopus laevis (African clawed frog) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2218.t1 Q8NCE2 45.383 639 1.81e-171 506.0 sp|Q8NCE2|MTMRE_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 OS=Homo sapiens OX=9606 GN=MTMR14 PE=1 SV=2 MTMRE_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 (EC 3.1.3.95) (HCV NS5A-transactivated protein 4 splice variant A-binding protein 1) (NS5ATP4ABP1) (Myotubularin-related protein 14) (Phosphatidylinositol-3-phosphate phosphatase) (hJumpy) Homo sapiens (Human) GO:0001726; GO:0004438; GO:0004722; GO:0005829; GO:0006661; GO:0016236; GO:0048471; GO:0052629 macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726] phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722] g2219.t1 Q9D581 37.008 127 4.65e-23 90.5 sp|Q9D581|EFC10_MOUSE EF-hand calcium-binding domain-containing protein 10 OS=Mus musculus OX=10090 GN=Efcab10 PE=1 SV=1 g2220.t1 Q80TM9 49.007 453 1.31e-126 430.0 sp|Q80TM9|NISCH_MOUSE Nischarin OS=Mus musculus OX=10090 GN=Nisch PE=1 SV=2 NISCH_MOUSE reviewed Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor I-1-like protein) (Imidazoline-1 receptor) (I1R) Mus musculus (Mouse) GO:0005178; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0045171; GO:0048243; GO:0055037 actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091] g2220.t1 Q80TM9 30.805 435 2.81e-44 179.0 sp|Q80TM9|NISCH_MOUSE Nischarin OS=Mus musculus OX=10090 GN=Nisch PE=1 SV=2 NISCH_MOUSE reviewed Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor I-1-like protein) (Imidazoline-1 receptor) (I1R) Mus musculus (Mouse) GO:0005178; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0045171; GO:0048243; GO:0055037 actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091] g2221.t1 Q86XH1 55.251 838 0.0 855.0 sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1 g2221.t2 Q86XH1 54.343 852 0.0 846.0 sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1 g2223.t1 P21333 45.291 2336 0.0 1816.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g2223.t1 P21333 35.138 2641 0.0 1301.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g2223.t1 P21333 29.628 2096 0.0 647.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g2223.t1 P21333 28.256 906 2.21e-70 268.0 sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4 FLNA_HUMAN reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Homo sapiens (Human) GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g2223.t2 Q14315 42.305 1683 0.0 1191.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 39.045 1424 0.0 832.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 57.053 475 2.45e-154 542.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 30.709 1537 1.61e-149 527.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 38.782 887 1.47e-143 508.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 28.089 1481 7.49e-120 431.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 31.001 1129 8.79e-109 394.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 33.376 773 1.82e-96 354.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 29.945 905 1.14e-91 338.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 30.355 929 1.6e-78 295.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 29.945 905 2.64e-78 295.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 28.902 865 1.12e-74 283.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 27.902 896 5.74e-71 270.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 29.04 885 3.42e-70 268.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 28.619 905 4.6300000000000003e-70 267.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 29.104 859 6.479999999999999e-68 260.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 28.331 893 2.3400000000000002e-66 255.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 41.379 348 2.2199999999999997e-61 239.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 24.647 1063 1.1500000000000001e-58 230.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 28.656 848 4.21e-56 221.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 29.259 499 2.54e-43 179.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t2 Q14315 24.555 786 1.0100000000000001e-31 141.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 42.909 1650 0.0 1202.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 39.7 1398 0.0 843.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 57.053 475 2.63e-154 542.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 31.696 1445 5.11e-151 532.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 38.782 887 1.27e-143 508.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 30.628 1466 2.53e-137 488.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 28.542 1447 2.0700000000000003e-123 442.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 30.303 924 1.3100000000000002e-97 358.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 29.945 905 7.759999999999999e-92 339.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 30.14 929 1.05e-78 296.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 29.945 905 3.05e-78 294.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 28.902 865 1.04e-74 283.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 27.902 896 6.65e-71 270.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 29.04 885 3.0300000000000005e-70 268.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 28.619 905 3.83e-70 268.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 29.104 859 5.84e-68 260.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 28.331 893 2.51e-66 255.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 41.379 348 2.3899999999999998e-61 239.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 24.647 1063 9.210000000000001e-59 230.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 28.656 848 4.61e-56 221.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 29.278 485 1.28e-42 177.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2223.t3 Q14315 24.555 786 6.97e-32 141.0 sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3 FLNC_HUMAN reviewed Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015 sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2225.t1 Q9WUE3 50.0 202 1.1e-51 170.0 sp|Q9WUE3|C56D2_MOUSE Transmembrane reductase CYB561D2 OS=Mus musculus OX=10090 GN=Cyb561d2 PE=1 SV=1 C56D2_MOUSE reviewed Transmembrane reductase CYB561D2 (EC 7.2.1.3) (Cytochrome b561 domain-containing protein 2) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576 ascorbate homeostasis [GO:0140576] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; vesicle [GO:0031982] heme binding [GO:0020037]; metal ion binding [GO:0046872]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575] g2226.t1 Q9WUE4 56.883 385 1.2199999999999999e-159 456.0 sp|Q9WUE4|NPRL2_MOUSE GATOR1 complex protein NPRL2 OS=Mus musculus OX=10090 GN=Nprl2 PE=1 SV=1 NPRL2_MOUSE reviewed GATOR1 complex protein NPRL2 (Gene 21 protein) (G21 protein) (Nitrogen permease regulator 2-like protein) (NPR2-like protein) Mus musculus (Mouse) GO:0002181; GO:0005096; GO:0005765; GO:0005774; GO:0010508; GO:0031669; GO:0034198; GO:0038202; GO:0045947; GO:0045948; GO:0061431; GO:0061462; GO:1904262; GO:1904263; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to methionine [GO:0061431]; cellular response to nutrient levels [GO:0031669]; cytoplasmic translation [GO:0002181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translational initiation [GO:0045947]; positive regulation of autophagy [GO:0010508]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; TORC1 signaling [GO:0038202] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774] GTPase activator activity [GO:0005096] g2227.t1 P41180 29.293 594 7.15e-92 310.0 sp|P41180|CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens OX=9606 GN=CASR PE=1 SV=3 CASR_HUMAN reviewed Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1) Homo sapiens (Human) GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0007635; GO:0008284; GO:0009653; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051924; GO:0060613; GO:0070374; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1900227; GO:1901653; GO:1902476 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311] apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325] g2228.t1 P48442 32.246 276 3.2799999999999997e-40 155.0 sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1 CASR_RAT reviewed Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR) Rattus norvegicus (Rat) GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051649; GO:0051924; GO:0060613; GO:0070374; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1900227; GO:1901653; GO:1902476 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; establishment of localization in cell [GO:0051649]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311] apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325] g2229.t1 Q9QXA6 38.526 475 1.9599999999999997e-104 323.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g2231.t1 Q9QY36 83.133 166 6.21e-103 302.0 sp|Q9QY36|NAA10_MOUSE N-alpha-acetyltransferase 10 OS=Mus musculus OX=10090 GN=Naa10 PE=1 SV=1 g2232.t1 Q95LL8 26.2 500 2.61e-40 155.0 sp|Q95LL8|EFC12_MACFA EF-hand calcium-binding domain-containing protein 12 OS=Macaca fascicularis OX=9541 GN=EFCAB12 PE=2 SV=1 g2236.t1 P07201 72.308 65 2.21e-25 99.0 sp|P07201|RIR2_SPISO Ribonucleoside-diphosphate reductase small chain OS=Spisula solidissima OX=6584 PE=2 SV=2 g2238.t1 Q09575 27.299 348 1.7500000000000001e-29 122.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g2244.t1 P07201 72.308 65 7.329999999999999e-25 99.0 sp|P07201|RIR2_SPISO Ribonucleoside-diphosphate reductase small chain OS=Spisula solidissima OX=6584 PE=2 SV=2 g2247.t1 A1L1M4 46.452 155 2.38e-41 155.0 sp|A1L1M4|P4R2B_DANRE Serine/threonine-protein phosphatase 4 regulatory subunit 2-B OS=Danio rerio OX=7955 GN=ppp4r2b PE=1 SV=2 g2248.t1 P53500 33.773 379 1.44e-55 200.0 sp|P53500|ACT_CYAM1 Actin OS=Cyanidioschyzon merolae (strain NIES-3377 / 10D) OX=280699 GN=CYME_CMM237C PE=3 SV=1 g2249.t1 B0G143 48.232 311 3.39e-99 296.0 sp|B0G143|UCPB_DICDI Mitochondrial substrate carrier family protein ucpB OS=Dictyostelium discoideum OX=44689 GN=ucpB PE=3 SV=1 g2250.t1 O35161 40.663 2747 0.0 2046.0 sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3 CELR1_MOUSE reviewed Cadherin EGF LAG seven-pass G-type receptor 1 Mus musculus (Mouse) GO:0001736; GO:0001764; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007166; GO:0007266; GO:0007409; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0044331; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475 anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion mediated by cadherin [GO:0044331]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g2251.t1 Q5XFW8 76.603 312 0.0 506.0 sp|Q5XFW8|SEC13_RAT Protein SEC13 homolog OS=Rattus norvegicus OX=10116 GN=Sec13 PE=1 SV=1 SEC13_RAT reviewed Protein SEC13 homolog (GATOR2 complex protein SEC13) (SEC13-like protein 1) Rattus norvegicus (Rat) GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005789; GO:0006606; GO:0006888; GO:0030127; GO:0031080; GO:0031669; GO:0032008; GO:0032527; GO:0032991; GO:0042802; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:0090114; GO:1904263 cellular response to nutrient levels [GO:0031669]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein import into nucleus [GO:0006606]; protein localization to plasma membrane [GO:0072659] COPII vesicle coat [GO:0030127]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] g2253.t1 Q5ZLX4 47.857 420 4.72e-136 409.0 sp|Q5ZLX4|ARHG3_CHICK Rho guanine nucleotide exchange factor 3 OS=Gallus gallus OX=9031 GN=Arhgef3 PE=2 SV=1 g2253.t2 Q5ZLX4 47.235 434 3.0099999999999997e-137 407.0 sp|Q5ZLX4|ARHG3_CHICK Rho guanine nucleotide exchange factor 3 OS=Gallus gallus OX=9031 GN=Arhgef3 PE=2 SV=1 g2254.t1 Q91ZT8 39.245 265 3.03e-47 162.0 sp|Q91ZT8|ASB9_MOUSE Ankyrin repeat and SOCS box protein 9 OS=Mus musculus OX=10090 GN=Asb9 PE=1 SV=2 g2254.t2 Q96DX5 38.168 262 1.16e-47 164.0 sp|Q96DX5|ASB9_HUMAN Ankyrin repeat and SOCS box protein 9 OS=Homo sapiens OX=9606 GN=ASB9 PE=1 SV=1 ASB9_HUMAN reviewed Ankyrin repeat and SOCS box protein 9 (ASB-9) Homo sapiens (Human) GO:0005739; GO:0005829; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0045732; GO:1990756 intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; mitochondrion [GO:0005739] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2255.t1 A1L1R5 39.242 660 1.2e-140 434.0 sp|A1L1R5|PTPC1_DANRE Protein tyrosine phosphatase domain-containing protein 1 OS=Danio rerio OX=7955 GN=ptpdc1 PE=2 SV=1 g2256.t1 Q8R146 45.505 723 0.0 623.0 sp|Q8R146|ACPH_MOUSE Acylamino-acid-releasing enzyme OS=Mus musculus OX=10090 GN=Apeh PE=1 SV=3 ACPH_MOUSE reviewed Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) Mus musculus (Mouse) GO:0004252; GO:0005829; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0050435 amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508] cytosol [GO:0005829]; nuclear membrane [GO:0031965] identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252] g2256.t2 Q8R146 45.92 723 0.0 627.0 sp|Q8R146|ACPH_MOUSE Acylamino-acid-releasing enzyme OS=Mus musculus OX=10090 GN=Apeh PE=1 SV=3 ACPH_MOUSE reviewed Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) Mus musculus (Mouse) GO:0004252; GO:0005829; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0050435 amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508] cytosol [GO:0005829]; nuclear membrane [GO:0031965] identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252] g2256.t3 Q8R146 45.109 736 0.0 619.0 sp|Q8R146|ACPH_MOUSE Acylamino-acid-releasing enzyme OS=Mus musculus OX=10090 GN=Apeh PE=1 SV=3 ACPH_MOUSE reviewed Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) Mus musculus (Mouse) GO:0004252; GO:0005829; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0050435 amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508] cytosol [GO:0005829]; nuclear membrane [GO:0031965] identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252] g2257.t1 Q5XGY1 52.612 804 0.0 825.0 sp|Q5XGY1|TSR1_XENLA Pre-rRNA-processing protein TSR1 homolog OS=Xenopus laevis OX=8355 GN=tsr1 PE=2 SV=1 g2258.t1 Q8BH65 62.342 555 0.0 696.0 sp|Q8BH65|DEN6A_MOUSE Protein DENND6A OS=Mus musculus OX=10090 GN=Dennd6a PE=1 SV=1 g2260.t1 P07942 44.63 1797 0.0 1566.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g2261.t1 P0CO88 50.498 301 1.7499999999999998e-104 311.0 sp|P0CO88|NBP35_CRYNJ Cytosolic Fe-S cluster assembly factor NBP35 OS=Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) OX=214684 GN=NBP35 PE=3 SV=1 g2262.t1 Q8K3H0 39.914 694 8.3e-152 466.0 sp|Q8K3H0|DP13A_MOUSE DCC-interacting protein 13-alpha OS=Mus musculus OX=10090 GN=Appl1 PE=1 SV=1 DP13A_MOUSE reviewed DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1) Mus musculus (Mouse) GO:0001726; GO:0001786; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006606; GO:0007179; GO:0008286; GO:0010008; GO:0010762; GO:0012506; GO:0015629; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0032009; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0042802; GO:0042803; GO:0043422; GO:0044354; GO:0044877; GO:0045088; GO:0046324; GO:0046326; GO:0048023; GO:0048487; GO:0097708; GO:0098793; GO:0098794; GO:0098978; GO:0099558; GO:1900017; GO:1903076; GO:1905303; GO:1905450; GO:2000045 adiponectin-activated signaling pathway [GO:0033211]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; insulin receptor signaling pathway [GO:0008286]; maintenance of synapse structure [GO:0099558]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of D-glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of D-glucose import [GO:0046324]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ruffle [GO:0001726]; vesicle membrane [GO:0012506] beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877] g2263.t1 G5E8P0 37.618 848 2.3499999999999997e-170 566.0 sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1 g2263.t1 G5E8P0 51.908 393 7.58e-127 442.0 sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1 g2270.t1 Q07646 49.541 327 5.3599999999999995e-104 311.0 sp|Q07646|MEST_MOUSE Mesoderm-specific transcript protein OS=Mus musculus OX=10090 GN=Mest PE=2 SV=1 MEST_MOUSE reviewed Mesoderm-specific transcript protein (EC 3.-.-.-) (Paternally-expressed gene 1 protein) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0010561; GO:0010883; GO:0016787; GO:0032526; GO:0045444; GO:0048666; GO:0050767; GO:0090090; GO:0140650; GO:1903077 fat cell differentiation [GO:0045444]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of glycoprotein biosynthetic process [GO:0010561]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuron development [GO:0048666]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of lipid storage [GO:0010883]; regulation of neurogenesis [GO:0050767]; response to retinoic acid [GO:0032526] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] hydrolase activity [GO:0016787] g2271.t1 F1MUG2 46.821 346 4.24e-97 296.0 sp|F1MUG2|CEP41_BOVIN Centrosomal protein of 41 kDa OS=Bos taurus OX=9913 GN=CEP41 PE=3 SV=2 g2272.t1 P05631 62.637 273 8.29e-124 357.0 sp|P05631|ATPG_BOVIN ATP synthase F(1) complex subunit gamma, mitochondrial OS=Bos taurus OX=9913 GN=ATP5F1C PE=1 SV=3 g2273.t1 B2KF05 47.344 1280 0.0 1030.0 sp|B2KF05|BRPF3_MOUSE Bromodomain and PHD finger-containing protein 3 OS=Mus musculus OX=10090 GN=Brpf3 PE=1 SV=1 BRPF3_MOUSE reviewed Bromodomain and PHD finger-containing protein 3 Mus musculus (Mouse) GO:0000123; GO:0005634; GO:0006355; GO:0006357; GO:0008270; GO:0036408; GO:0043995; GO:0043996; GO:0043997; GO:0045740; GO:0050793; GO:0070776; GO:1903706 positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleus [GO:0005634] histone H3K14 acetyltransferase activity [GO:0036408]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; zinc ion binding [GO:0008270] g2273.t2 B2KF05 47.114 1282 0.0 1025.0 sp|B2KF05|BRPF3_MOUSE Bromodomain and PHD finger-containing protein 3 OS=Mus musculus OX=10090 GN=Brpf3 PE=1 SV=1 BRPF3_MOUSE reviewed Bromodomain and PHD finger-containing protein 3 Mus musculus (Mouse) GO:0000123; GO:0005634; GO:0006355; GO:0006357; GO:0008270; GO:0036408; GO:0043995; GO:0043996; GO:0043997; GO:0045740; GO:0050793; GO:0070776; GO:1903706 positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleus [GO:0005634] histone H3K14 acetyltransferase activity [GO:0036408]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; zinc ion binding [GO:0008270] g2274.t1 P16056 33.069 1385 0.0 635.0 sp|P16056|MET_MOUSE Hepatocyte growth factor receptor OS=Mus musculus OX=10090 GN=Met PE=1 SV=1 MET_MOUSE reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Mus musculus (Mouse) GO:0000122; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0005008; GO:0005524; GO:0005615; GO:0005886; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010828; GO:0010976; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043025; GO:0043235; GO:0043274; GO:0043410; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:0140677; GO:1900407; GO:1900745; GO:1901299; GO:2001028 adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519] basal plasma membrane [GO:0009925]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor receptor activity [GO:0005008]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154] g2274.t2 P16056 32.924 1385 0.0 635.0 sp|P16056|MET_MOUSE Hepatocyte growth factor receptor OS=Mus musculus OX=10090 GN=Met PE=1 SV=1 MET_MOUSE reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Mus musculus (Mouse) GO:0000122; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0005008; GO:0005524; GO:0005615; GO:0005886; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010828; GO:0010976; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043025; GO:0043235; GO:0043274; GO:0043410; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:0140677; GO:1900407; GO:1900745; GO:1901299; GO:2001028 adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519] basal plasma membrane [GO:0009925]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor receptor activity [GO:0005008]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154] g2278.t1 Q8CE22 44.583 480 5.92e-125 393.0 sp|Q8CE22|DMTF1_MOUSE Cyclin-D-binding Myb-like transcription factor 1 OS=Mus musculus OX=10090 GN=Dmtf1 PE=1 SV=2 DMTF1_MOUSE reviewed Cyclin-D-binding Myb-like transcription factor 1 (Cyclin-D-interacting Myb-like protein 1) (mDmp1) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g2280.t1 Q8TD57 55.009 3394 0.0 3661.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2280.t1 Q8TD57 69.55 578 0.0 858.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2280.t2 Q8TD57 55.009 3394 0.0 3661.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2280.t2 Q8TD57 69.913 575 0.0 863.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2280.t3 Q8TD57 55.009 3394 0.0 3661.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2280.t3 Q8TD57 69.913 575 0.0 863.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2280.t4 Q8TD57 57.407 3942 0.0 4511.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2284.t1 Q6ZVK8 36.392 316 3.6e-49 169.0 sp|Q6ZVK8|NUD18_HUMAN 8-oxo-dGDP phosphatase NUDT18 OS=Homo sapiens OX=9606 GN=NUDT18 PE=1 SV=3 NUD18_HUMAN reviewed 8-oxo-dGDP phosphatase NUDT18 (EC 3.6.1.58) (EC 3.6.1.68) (EC 3.6.1.76) (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (MutT homolog 3) (Nucleoside diphosphate-linked moiety X motif 18) (Nudix motif 18) Homo sapiens (Human) GO:0005829; GO:0044715; GO:0044716; GO:0044717; GO:0046057; GO:0046067; GO:0046712; GO:0046872; GO:0055086; GO:0106405 dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule metabolic process [GO:0055086] cytosol [GO:0005829] 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; isoprenoid diphosphate phosphatase activity [GO:0106405]; metal ion binding [GO:0046872] g2286.t1 Q9Y2M2 33.875 369 6.14e-73 236.0 sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2 g2289.t1 Q6PHU5 37.176 772 8.380000000000001e-169 511.0 sp|Q6PHU5|SORT_MOUSE Sortilin OS=Mus musculus OX=10090 GN=Sort1 PE=1 SV=1 SORT_MOUSE reviewed Sortilin (Neurotensin receptor 3) (NTR3) (mNTR3) Mus musculus (Mouse) GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006622; GO:0006895; GO:0006897; GO:0007186; GO:0007218; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016020; GO:0016050; GO:0019899; GO:0030136; GO:0030140; GO:0030379; GO:0030425; GO:0030659; GO:0031410; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0043025; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0090160; GO:0099558; GO:0150053; GO:1904037; GO:1905394 D-glucose import [GO:0046323]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050] cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140] enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394] g2291.t1 Q9D2R8 56.863 102 1.48e-35 120.0 sp|Q9D2R8|RT33_MOUSE Small ribosomal subunit protein mS33 OS=Mus musculus OX=10090 GN=Mrps33 PE=1 SV=1 g2293.t1 G3V9D0 61.326 362 1.09e-166 476.0 sp|G3V9D0|PGLT1_RAT Protein O-glucosyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Poglut1 PE=3 SV=1 PGLT1_RAT reviewed Protein O-glucosyltransferase 1 (EC 2.4.1.376) (O-glucosyltransferase Rumi homolog) (Protein O-xylosyltransferase) (EC 2.4.2.63) Rattus norvegicus (Rat) GO:0001756; GO:0005783; GO:0005788; GO:0006493; GO:0007369; GO:0008593; GO:0010470; GO:0012505; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537; GO:0072359; GO:0140561; GO:0140562; GO:0180059; GO:0180064 axial mesoderm development [GO:0048318]; circulatory system development [GO:0072359]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via glucose [GO:0180059]; protein O-linked glycosylation via xylose [GO:0180064]; regulation of gastrulation [GO:0010470]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252] g2295.t1 P62311 84.314 102 2.02e-58 177.0 sp|P62311|LSM3_MOUSE U6 snRNA-associated Sm-like protein LSm3 OS=Mus musculus OX=10090 GN=Lsm3 PE=1 SV=2 g2305.t1 Q08874 38.31 509 5.22e-78 257.0 sp|Q08874|MITF_MOUSE Microphthalmia-associated transcription factor OS=Mus musculus OX=10090 GN=Mitf PE=1 SV=4 MITF_MOUSE reviewed Microphthalmia-associated transcription factor Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0006351; GO:0006355; GO:0006357; GO:0010468; GO:0010628; GO:0016055; GO:0030154; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0043066; GO:0043473; GO:0043565; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:2000144; GO:2001141 bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; DNA-templated transcription [GO:0006351]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; pigmentation [GO:0043473]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g2307.t1 P51612 53.216 342 1.05e-125 395.0 sp|P51612|XPC_MOUSE DNA repair protein complementing XP-C cells homolog OS=Mus musculus OX=10090 GN=Xpc PE=1 SV=2 XPC_MOUSE reviewed DNA repair protein complementing XP-C cells homolog (Xeroderma pigmentosum group C-complementing protein homolog) (p125) Mus musculus (Mouse) GO:0000109; GO:0000111; GO:0000720; GO:0003684; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006289; GO:0006298; GO:0006974; GO:0009410; GO:0010224; GO:0010996; GO:0031573; GO:0044877; GO:0045721; GO:0045893; GO:0061629; GO:0070914; GO:0071942; GO:0090734; GO:0140612; GO:1901990 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of gluconeogenesis [GO:0045721]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; UV-damage excision repair [GO:0070914] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of DNA damage [GO:0090734]; XPC complex [GO:0071942] damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g2318.t1 Q07E43 36.216 185 1.5399999999999998e-30 124.0 sp|Q07E43|ASZ1_DASNO Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 OS=Dasypus novemcinctus OX=9361 GN=ASZ1 PE=3 SV=1 g2321.t1 P35831 49.169 301 5.02e-97 327.0 sp|P35831|PTN12_MOUSE Tyrosine-protein phosphatase non-receptor type 12 OS=Mus musculus OX=10090 GN=Ptpn12 PE=1 SV=3 PTN12_MOUSE reviewed Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (MPTP-PEST) (Protein-tyrosine phosphatase P19) (P19-PTP) Mus musculus (Mouse) GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0017124; GO:0035335; GO:0042058; GO:0042246; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; podosome [GO:0002102] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] g2321.t2 P35831 49.169 301 4.43e-97 327.0 sp|P35831|PTN12_MOUSE Tyrosine-protein phosphatase non-receptor type 12 OS=Mus musculus OX=10090 GN=Ptpn12 PE=1 SV=3 PTN12_MOUSE reviewed Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (MPTP-PEST) (Protein-tyrosine phosphatase P19) (P19-PTP) Mus musculus (Mouse) GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0017124; GO:0035335; GO:0042058; GO:0042246; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; podosome [GO:0002102] non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] g2323.t1 Q07984 46.358 151 1.3500000000000002e-43 145.0 sp|Q07984|SSRD_RAT Translocon-associated protein subunit delta OS=Rattus norvegicus OX=10116 GN=Ssr4 PE=2 SV=1 g2324.t1 Q90X38 41.342 462 3e-108 333.0 sp|Q90X38|GPKOW_DANRE G-patch domain and KOW motifs-containing protein OS=Danio rerio OX=7955 GN=gpkow PE=2 SV=2 g2325.t1 Q8W485 38.938 113 2.9599999999999997e-24 96.3 sp|Q8W485|Y5010_ARATH Uncharacterized protein At5g50100, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g50100 PE=1 SV=1 g2326.t1 Q6ZR37 36.703 455 3.3e-97 317.0 sp|Q6ZR37|PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens OX=9606 GN=PLEKHG7 PE=1 SV=2 PKHG7_HUMAN reviewed Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7) Homo sapiens (Human) GO:0005085; GO:0007266 Rho protein signal transduction [GO:0007266] guanyl-nucleotide exchange factor activity [GO:0005085] g2328.t1 Q8W485 38.938 113 2.9599999999999997e-24 96.3 sp|Q8W485|Y5010_ARATH Uncharacterized protein At5g50100, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g50100 PE=1 SV=1 g2329.t1 Q90X38 40.253 554 5.36e-122 372.0 sp|Q90X38|GPKOW_DANRE G-patch domain and KOW motifs-containing protein OS=Danio rerio OX=7955 GN=gpkow PE=2 SV=2 g2330.t1 Q07984 49.007 151 3.51e-49 159.0 sp|Q07984|SSRD_RAT Translocon-associated protein subunit delta OS=Rattus norvegicus OX=10116 GN=Ssr4 PE=2 SV=1 g2331.t1 Q8W485 38.938 113 2.9599999999999997e-24 96.3 sp|Q8W485|Y5010_ARATH Uncharacterized protein At5g50100, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g50100 PE=1 SV=1 g2332.t1 Q6ZR37 36.703 455 6.53e-96 319.0 sp|Q6ZR37|PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens OX=9606 GN=PLEKHG7 PE=1 SV=2 PKHG7_HUMAN reviewed Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7) Homo sapiens (Human) GO:0005085; GO:0007266 Rho protein signal transduction [GO:0007266] guanyl-nucleotide exchange factor activity [GO:0005085] g2335.t1 Q9Y2U8 40.866 531 1.8299999999999998e-115 377.0 sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2 MAN1_HUMAN reviewed Inner nuclear membrane protein Man1 (LEM domain-containing protein 3) Homo sapiens (Human) GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446 negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446] g2336.t1 Q9WTS8 50.235 213 6.190000000000001e-56 187.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g2337.t1 Q6DN90 51.116 448 3.42e-127 423.0 sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1 IQEC1_HUMAN reviewed IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2) Homo sapiens (Human) GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0051549; GO:0060996; GO:0120183 actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] g2337.t2 Q6DN90 52.174 437 1.7600000000000002e-129 429.0 sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1 IQEC1_HUMAN reviewed IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2) Homo sapiens (Human) GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0051549; GO:0060996; GO:0120183 actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] g2340.t1 Q6DFC2 48.577 492 5.560000000000001e-144 425.0 sp|Q6DFC2|CCD77_XENLA Coiled-coil domain-containing protein 77 OS=Xenopus laevis OX=8355 GN=ccdc77 PE=2 SV=1 g2340.t2 Q6DFC2 50.854 527 9.15e-170 492.0 sp|Q6DFC2|CCD77_XENLA Coiled-coil domain-containing protein 77 OS=Xenopus laevis OX=8355 GN=ccdc77 PE=2 SV=1 g2341.t1 P29375 58.828 1365 0.0 1617.0 sp|P29375|KDM5A_HUMAN Lysine-specific demethylase 5A OS=Homo sapiens OX=9606 GN=KDM5A PE=1 SV=3 KDM5A_HUMAN reviewed Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006355; GO:0008270; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0042393; GO:0045815; GO:0045893; GO:0140718 chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g2341.t2 P29375 58.613 1370 0.0 1615.0 sp|P29375|KDM5A_HUMAN Lysine-specific demethylase 5A OS=Homo sapiens OX=9606 GN=KDM5A PE=1 SV=3 KDM5A_HUMAN reviewed Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006355; GO:0008270; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0042393; GO:0045815; GO:0045893; GO:0140718 chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g2343.t1 Q8R4I1 35.843 332 7.22e-28 124.0 sp|Q8R4I1|ATX7_MOUSE Ataxin-7 OS=Mus musculus OX=10090 GN=Atxn7 PE=1 SV=2 ATX7_MOUSE reviewed Ataxin-7 (Spinocerebellar ataxia type 7 protein homolog) Mus musculus (Mouse) GO:0000124; GO:0000226; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006282; GO:0006357; GO:0007026; GO:0015630; GO:0016363; GO:0033276; GO:0043484; GO:0043569; GO:0045893; GO:0045944 microtubule cytoskeleton organization [GO:0000226]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] chromatin binding [GO:0003682] g2343.t2 Q8R4I1 35.952 331 5.1199999999999995e-28 124.0 sp|Q8R4I1|ATX7_MOUSE Ataxin-7 OS=Mus musculus OX=10090 GN=Atxn7 PE=1 SV=2 ATX7_MOUSE reviewed Ataxin-7 (Spinocerebellar ataxia type 7 protein homolog) Mus musculus (Mouse) GO:0000124; GO:0000226; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006282; GO:0006357; GO:0007026; GO:0015630; GO:0016363; GO:0033276; GO:0043484; GO:0043569; GO:0045893; GO:0045944 microtubule cytoskeleton organization [GO:0000226]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] chromatin binding [GO:0003682] g2346.t1 Q91XA8 35.735 347 6.990000000000001e-72 231.0 sp|Q91XA8|KLD8A_MOUSE Kelch domain-containing protein 8A OS=Mus musculus OX=10090 GN=Klhdc8a PE=2 SV=1 g2351.t1 O02751 38.5 200 1.06e-30 128.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g2352.t1 P19221 38.801 317 1.89e-60 217.0 sp|P19221|THRB_MOUSE Prothrombin OS=Mus musculus OX=10090 GN=F2 PE=1 SV=1 THRB_MOUSE reviewed Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] Mus musculus (Mouse) GO:0001530; GO:0004175; GO:0004252; GO:0005102; GO:0005509; GO:0005615; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0008201; GO:0008233; GO:0008284; GO:0008360; GO:0009611; GO:0009897; GO:0010468; GO:0030168; GO:0030194; GO:0030195; GO:0030307; GO:0031012; GO:0032967; GO:0042730; GO:0045861; GO:0048018; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0061844; GO:0070053; GO:0070493; GO:0070945; GO:1900016; GO:1900182; GO:1900738; GO:2000379 acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; response to wounding [GO:0009611]; thrombin-activated receptor signaling pathway [GO:0070493] external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053] g2356.t1 Q6DDT4 48.98 539 5.98e-178 514.0 sp|Q6DDT4|APEX2_XENLA DNA-(apurinic or apyrimidinic site) endonuclease 2 OS=Xenopus laevis OX=8355 GN=apex2.L PE=1 SV=1 APEX2_XENLA reviewed DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.11.2) Xenopus laevis (African clawed frog) GO:0003677; GO:0003906; GO:0005634; GO:0005694; GO:0005739; GO:0006284; GO:0008081; GO:0008270; GO:0008311 base-excision repair [GO:0006284] chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270] g2357.t1 O18404 70.866 254 7.89e-135 383.0 sp|O18404|HCD2_DROME 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Drosophila melanogaster OX=7227 GN=scu PE=1 SV=1 HCD2_DROME reviewed 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51, EC 1.1.1.62) (3-hydroxyacyl-CoA dehydrogenase type II) (Hydroxysteroid dehydrogenase) (EC 1.1.1.-, EC 1.1.1.53) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH) Drosophila melanogaster (Fruit fly) GO:0003857; GO:0004303; GO:0005739; GO:0005759; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0030678; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0090646; GO:0097745; GO:0106282; GO:0106283; GO:0140040 acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial polycistronic RNA processing [GO:0140040]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA processing [GO:0090646]; steroid metabolic process [GO:0008202] mitochondrial matrix [GO:0005759]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283] g2358.t1 Q08879 38.69 504 2.86e-84 287.0 sp|Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus OX=10090 GN=Fbln1 PE=1 SV=2 FBLN1_MOUSE reviewed Fibulin-1 (FIBL-1) (Basement-membrane protein 90) (BM-90) Mus musculus (Mouse) GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0070051; GO:0070373; GO:0071635; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647 blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237] basement membrane [GO:0005604]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein-containing complex binding [GO:0044877] g2358.t1 Q08879 32.338 603 7.170000000000001e-58 214.0 sp|Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus OX=10090 GN=Fbln1 PE=1 SV=2 FBLN1_MOUSE reviewed Fibulin-1 (FIBL-1) (Basement-membrane protein 90) (BM-90) Mus musculus (Mouse) GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0070051; GO:0070373; GO:0071635; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647 blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237] basement membrane [GO:0005604]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein-containing complex binding [GO:0044877] g2359.t1 Q9CU62 63.229 1251 0.0 1518.0 sp|Q9CU62|SMC1A_MOUSE Structural maintenance of chromosomes protein 1A OS=Mus musculus OX=10090 GN=Smc1a PE=1 SV=4 SMC1A_MOUSE reviewed Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Chromosome segregation protein SmcB) (Sb1.8) Mus musculus (Mouse) GO:0000776; GO:0000795; GO:0000800; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007062; GO:0008278; GO:0009314; GO:0016363; GO:0016887; GO:0019827; GO:0030892; GO:0030893; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431 cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827] cohesin complex [GO:0008278]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982] g2360.t1 Q17RP2 33.265 487 2.07e-100 314.0 sp|Q17RP2|TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens OX=9606 GN=TIGD6 PE=1 SV=2 g2360.t2 Q17RP2 31.667 540 1.08e-102 320.0 sp|Q17RP2|TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens OX=9606 GN=TIGD6 PE=1 SV=2 g2363.t1 Q93075 40.977 266 1.84e-63 219.0 sp|Q93075|TATD2_HUMAN 3'-5' RNA nuclease TATDN2 OS=Homo sapiens OX=9606 GN=TATDN2 PE=1 SV=2 g2364.t1 Q8WWW0 39.394 297 1.69e-63 216.0 sp|Q8WWW0|RASF5_HUMAN Ras association domain-containing protein 5 OS=Homo sapiens OX=9606 GN=RASSF5 PE=1 SV=1 RASF5_HUMAN reviewed Ras association domain-containing protein 5 (New ras effector 1) (Regulator for cell adhesion and polarization enriched in lymphoid tissues) (RAPL) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0007165; GO:0008270; GO:0031398; GO:0042802; GO:0046651; GO:0050672; GO:1900180 apoptotic process [GO:0006915]; lymphocyte proliferation [GO:0046651]; negative regulation of lymphocyte proliferation [GO:0050672]; positive regulation of protein ubiquitination [GO:0031398]; regulation of protein localization to nucleus [GO:1900180]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] g2366.t1 Q32P97 59.859 142 9.499999999999999e-55 172.0 sp|Q32P97|UXT_BOVIN Protein UXT OS=Bos taurus OX=9913 GN=UXT PE=2 SV=1 UXT_BOVIN reviewed Protein UXT (Ubiquitously expressed transcript protein) Bos taurus (Bovine) GO:0000122; GO:0000785; GO:0000922; GO:0003682; GO:0003714; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0016592 negative regulation of transcription by RNA polymerase II [GO:0000122] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleus [GO:0005634]; spindle pole [GO:0000922] chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714] g2367.t1 Q7SZ78 58.291 199 3.51e-69 233.0 sp|Q7SZ78|THOC7_XENLA THO complex subunit 7 homolog OS=Xenopus laevis OX=8355 GN=thoc7 PE=2 SV=1 g2367.t2 Q7SZ78 58.291 199 1.73e-71 233.0 sp|Q7SZ78|THOC7_XENLA THO complex subunit 7 homolog OS=Xenopus laevis OX=8355 GN=thoc7 PE=2 SV=1 g2369.t1 Q54MC6 27.099 262 9.1e-24 106.0 sp|Q54MC6|LRLA_DICDI Latrophilin receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=lrlA PE=3 SV=1 g2370.t1 P80146 41.344 387 3.33e-89 278.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g2371.t1 P50579 82.289 367 0.0 653.0 sp|P50579|MAP2_HUMAN Methionine aminopeptidase 2 OS=Homo sapiens OX=9606 GN=METAP2 PE=1 SV=1 MAP2_HUMAN reviewed Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) Homo sapiens (Human) GO:0003723; GO:0004177; GO:0004239; GO:0005737; GO:0005829; GO:0005886; GO:0006446; GO:0008235; GO:0016485; GO:0046872; GO:0070006 protein processing [GO:0016485]; regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] aminopeptidase activity [GO:0004177]; initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723] g2372.t1 Q3UG20 35.636 999 3.0300000000000003e-121 429.0 sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2 KMT2E_MOUSE reviewed Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Mus musculus (Mouse) GO:0000785; GO:0000791; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0008270; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0034967; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:0070210; GO:0140002; GO:1900087 epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of DNA-templated transcription [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384] centrosome [GO:0005813]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g2372.t2 Q3UG20 35.6 1000 2.64e-121 429.0 sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2 KMT2E_MOUSE reviewed Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Mus musculus (Mouse) GO:0000785; GO:0000791; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0008270; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0034967; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:0070210; GO:0140002; GO:1900087 epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of DNA-templated transcription [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384] centrosome [GO:0005813]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g2372.t3 Q3UG20 35.6 1000 1.7300000000000001e-121 429.0 sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2 KMT2E_MOUSE reviewed Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Mus musculus (Mouse) GO:0000785; GO:0000791; GO:0002446; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0008270; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0034967; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:0070210; GO:0140002; GO:1900087 epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of DNA-templated transcription [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384] centrosome [GO:0005813]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g2375.t1 Q62717 69.932 1184 0.0 1741.0 sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1 g2375.t2 Q62717 70.408 1176 0.0 1749.0 sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1 g2375.t3 Q62717 69.899 1186 0.0 1744.0 sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1 g2376.t1 Q7ZXE9 42.921 445 2.7900000000000003e-123 368.0 sp|Q7ZXE9|TES_XENLA Testin OS=Xenopus laevis OX=8355 GN=tes PE=2 SV=1 g2377.t1 D4A734 24.586 362 1.67e-28 120.0 sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1 MOT12_RAT reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Rattus norvegicus (Rat) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2378.t1 Q5RGV1 74.907 538 0.0 820.0 sp|Q5RGV1|IMDH3_DANRE Inosine-5'-monophosphate dehydrogenase 1b OS=Danio rerio OX=7955 GN=impdh1b PE=2 SV=1 IMDH3_DANRE reviewed Inosine-5'-monophosphate dehydrogenase 1b (IMP dehydrogenase 1b) (IMPD 1b) (IMPDH 1b) (EC 1.1.1.205) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872 GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183] cytoplasm [GO:0005737]; nucleus [GO:0005634] IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g2378.t2 Q5RGV1 77.992 518 0.0 832.0 sp|Q5RGV1|IMDH3_DANRE Inosine-5'-monophosphate dehydrogenase 1b OS=Danio rerio OX=7955 GN=impdh1b PE=2 SV=1 IMDH3_DANRE reviewed Inosine-5'-monophosphate dehydrogenase 1b (IMP dehydrogenase 1b) (IMPD 1b) (IMPDH 1b) (EC 1.1.1.205) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0006177; GO:0006183; GO:0046872 GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183] cytoplasm [GO:0005737]; nucleus [GO:0005634] IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g2379.t1 A2RV80 35.078 516 1.36e-89 293.0 sp|A2RV80|GRAM4_XENLA GRAM domain-containing protein 4 OS=Xenopus laevis OX=8355 GN=gramd4 PE=2 SV=1 g2386.t1 Q1JP73 51.632 337 1.48e-125 366.0 sp|Q1JP73|QNG1_BOVIN Queuosine 5'-phosphate N-glycosylase/hydrolase OS=Bos taurus OX=9913 GN=QNG1 PE=2 SV=1 g2387.t1 Q9PU36 40.282 355 1.03e-72 277.0 sp|Q9PU36|PCLO_CHICK Protein piccolo (Fragment) OS=Gallus gallus OX=9031 GN=PCLO PE=2 SV=1 g2387.t1 Q9PU36 48.148 135 2.46e-32 143.0 sp|Q9PU36|PCLO_CHICK Protein piccolo (Fragment) OS=Gallus gallus OX=9031 GN=PCLO PE=2 SV=1 g2387.t2 Q9PU36 40.282 355 1.03e-72 277.0 sp|Q9PU36|PCLO_CHICK Protein piccolo (Fragment) OS=Gallus gallus OX=9031 GN=PCLO PE=2 SV=1 g2387.t2 Q9PU36 48.148 135 2.48e-32 143.0 sp|Q9PU36|PCLO_CHICK Protein piccolo (Fragment) OS=Gallus gallus OX=9031 GN=PCLO PE=2 SV=1 g2388.t1 Q9UKK9 47.739 199 3.59e-59 189.0 sp|Q9UKK9|NUDT5_HUMAN ADP-sugar pyrophosphatase OS=Homo sapiens OX=9606 GN=NUDT5 PE=1 SV=1 NUDT5_HUMAN reviewed ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5) (EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5) (hNUDT5) (YSA1H) Homo sapiens (Human) GO:0000287; GO:0005634; GO:0005829; GO:0006338; GO:0006753; GO:0009117; GO:0009191; GO:0016779; GO:0019144; GO:0019303; GO:0019693; GO:0030515; GO:0042802; GO:0042803; GO:0044715; GO:0047631; GO:0055086; GO:0070062; GO:1990966 ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515] g2388.t2 Q9UKK9 40.851 235 3.24e-52 172.0 sp|Q9UKK9|NUDT5_HUMAN ADP-sugar pyrophosphatase OS=Homo sapiens OX=9606 GN=NUDT5 PE=1 SV=1 NUDT5_HUMAN reviewed ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5) (EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5) (hNUDT5) (YSA1H) Homo sapiens (Human) GO:0000287; GO:0005634; GO:0005829; GO:0006338; GO:0006753; GO:0009117; GO:0009191; GO:0016779; GO:0019144; GO:0019303; GO:0019693; GO:0030515; GO:0042802; GO:0042803; GO:0044715; GO:0047631; GO:0055086; GO:0070062; GO:1990966 ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515] g2394.t1 P23824 52.817 426 4.35e-120 364.0 sp|P23824|GATA2_CHICK GATA-binding factor 2 OS=Gallus gallus OX=9031 GN=GATA2 PE=2 SV=1 g2395.t1 Q90ZM2 89.451 474 0.0 869.0 sp|Q90ZM2|S61A1_DANRE Protein transport protein Sec61 subunit alpha-like 1 OS=Danio rerio OX=7955 GN=sec61al1 PE=2 SV=3 S61A1_DANRE reviewed Protein transport protein Sec61 subunit alpha-like 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0021986; GO:0031204; GO:0039019; GO:0043022; GO:0045048 cotranslational protein targeting to membrane [GO:0006613]; habenula development [GO:0021986]; post-translational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616] endoplasmic reticulum membrane [GO:0005789]; Sec61 translocon complex [GO:0005784] protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048] g2398.t1 P80146 52.174 345 5.899999999999999e-104 313.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g2399.t1 P80146 50.649 385 1.37e-114 342.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g2400.t1 O43581 31.25 240 4.53e-25 109.0 sp|O43581|SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens OX=9606 GN=SYT7 PE=1 SV=3 SYT7_HUMAN reviewed Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) Homo sapiens (Human) GO:0000149; GO:0001778; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0061891; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:0099502; GO:1900242; GO:1990926; GO:1990927 calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g2401.t1 Q7RTX9 24.583 480 1.7e-24 109.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g2402.t1 Q8WPD0 44.311 167 1.38e-39 135.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g2403.t1 Q8WPD0 44.186 172 6.56e-38 130.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g2404.t1 Q58A42 33.782 669 5.37e-101 324.0 sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1 DD3_DICDI reviewed Protein DD3-3 Dictyostelium discoideum (Social amoeba) GO:0016020 membrane [GO:0016020] g2405.t1 Q58A42 38.245 604 5.59e-116 367.0 sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1 DD3_DICDI reviewed Protein DD3-3 Dictyostelium discoideum (Social amoeba) GO:0016020 membrane [GO:0016020] g2408.t1 A2ARI4 29.766 299 1.7699999999999998e-24 107.0 sp|A2ARI4|LGR4_MOUSE Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Mus musculus OX=10090 GN=Lgr4 PE=1 SV=1 LGR4_MOUSE reviewed Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48) Mus musculus (Mouse) GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0005886; GO:0007186; GO:0007283; GO:0007411; GO:0007623; GO:0008201; GO:0016055; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0035239; GO:0036335; GO:0045087; GO:0046849; GO:0048495; GO:0048565; GO:0050673; GO:0050919; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013 axon guidance [GO:0007411]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestive tract development [GO:0048565]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative chemotaxis [GO:0050919]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; spermatogenesis [GO:0007283]; tube morphogenesis [GO:0035239]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888] g2409.t1 Q99PV3 63.562 730 0.0 972.0 sp|Q99PV3|MKLN1_RAT Muskelin OS=Rattus norvegicus OX=10116 GN=Mkln1 PE=1 SV=1 MKLN1_RAT reviewed Muskelin Rattus norvegicus (Rat) GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005737; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042802; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164 actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g2410.t1 Q7ZXE1 44.848 660 0.0 560.0 sp|Q7ZXE1|CPT2_XENLA Carnitine O-palmitoyltransferase 2, mitochondrial OS=Xenopus laevis OX=8355 GN=cpt2 PE=2 SV=1 CPT2_XENLA reviewed Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II) Xenopus laevis (African clawed frog) GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458; GO:0015909 fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid transport [GO:0015909] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] g2411.t1 Q4R4R4 44.828 174 4.5399999999999995e-54 172.0 sp|Q4R4R4|PRAF3_MACFA PRA1 family protein 3 OS=Macaca fascicularis OX=9541 GN=ARL6IP5 PE=2 SV=1 g2412.t1 P07872 46.786 669 0.0 588.0 sp|P07872|ACOX1_RAT Peroxisomal acyl-coenzyme A oxidase 1 OS=Rattus norvegicus OX=10116 GN=Acox1 PE=1 SV=1 ACOX1_RAT reviewed Peroxisomal acyl-coenzyme A oxidase 1 (ACO) (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] Rattus norvegicus (Rat) GO:0000038; GO:0003997; GO:0005504; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0006091; GO:0006629; GO:0006636; GO:0006693; GO:0007283; GO:0009062; GO:0016559; GO:0019395; GO:0030165; GO:0033540; GO:0036109; GO:0042632; GO:0042759; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0120524; GO:0140493; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038] cytoplasm [GO:0005737]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; long-chain fatty acyl-CoA oxidase activity [GO:0120524]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803] g2413.t1 Q8WPD0 43.902 164 3.72e-34 125.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g2413.t1 Q8WPD0 44.138 145 6.97e-29 112.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g2414.t1 Q9H237 45.022 462 8.59e-120 362.0 sp|Q9H237|PORCN_HUMAN Protein-serine O-palmitoleoyltransferase porcupine OS=Homo sapiens OX=9606 GN=PORCN PE=1 SV=2 PORCN_HUMAN reviewed Protein-serine O-palmitoleoyltransferase porcupine (EC 2.3.1.250) (Protein MG61) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006497; GO:0009100; GO:0016020; GO:0016055; GO:0017147; GO:0030258; GO:0032281; GO:0045234; GO:0061355; GO:0098978; GO:0099072; GO:1990698 glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020] palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147] g2415.t1 A0FKN5 40.646 743 0.0 551.0 sp|A0FKN5|S26A5_CHICK Prestin OS=Gallus gallus OX=9031 GN=SLC26A5 PE=1 SV=1 S26A5_CHICK reviewed Prestin (Solute carrier family 26 member 5) Gallus gallus (Chicken) GO:0005886; GO:0046872; GO:0160044; GO:0160046 plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oxalate:chloride antiporter activity [GO:0160046]; sulfate:chloride antiporter activity [GO:0160044] g2415.t2 A0FKN5 39.3 743 1.76e-173 518.0 sp|A0FKN5|S26A5_CHICK Prestin OS=Gallus gallus OX=9031 GN=SLC26A5 PE=1 SV=1 S26A5_CHICK reviewed Prestin (Solute carrier family 26 member 5) Gallus gallus (Chicken) GO:0005886; GO:0046872; GO:0160044; GO:0160046 plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oxalate:chloride antiporter activity [GO:0160046]; sulfate:chloride antiporter activity [GO:0160044] g2416.t1 A0FKN5 38.814 742 3.13e-165 498.0 sp|A0FKN5|S26A5_CHICK Prestin OS=Gallus gallus OX=9031 GN=SLC26A5 PE=1 SV=1 S26A5_CHICK reviewed Prestin (Solute carrier family 26 member 5) Gallus gallus (Chicken) GO:0005886; GO:0046872; GO:0160044; GO:0160046 plasma membrane [GO:0005886] metal ion binding [GO:0046872]; oxalate:chloride antiporter activity [GO:0160046]; sulfate:chloride antiporter activity [GO:0160044] g2428.t1 Q8BR93 37.917 240 4.37e-47 164.0 sp|Q8BR93|HARB1_MOUSE Putative nuclease HARBI1 OS=Mus musculus OX=10090 GN=Harbi1 PE=2 SV=1 g2433.t1 Q8K339 38.496 226 1.3e-34 129.0 sp|Q8K339|KIN17_MOUSE DNA/RNA-binding protein KIN17 OS=Mus musculus OX=10090 GN=Kin PE=1 SV=1 KIN17_MOUSE reviewed DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Mus musculus (Mouse) GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0008270; GO:0016363; GO:0032991 DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397] cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2434.t1 Q8K339 76.761 142 5.31e-81 246.0 sp|Q8K339|KIN17_MOUSE DNA/RNA-binding protein KIN17 OS=Mus musculus OX=10090 GN=Kin PE=1 SV=1 KIN17_MOUSE reviewed DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Mus musculus (Mouse) GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0008270; GO:0016363; GO:0032991 DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397] cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2435.t1 A8E657 50.692 939 0.0 956.0 sp|A8E657|AASS_BOVIN Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Bos taurus OX=9913 GN=AASS PE=2 SV=1 AASS_BOVIN reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Bos taurus (Bovine) GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131 L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753] g2435.t2 A8E657 50.317 946 0.0 954.0 sp|A8E657|AASS_BOVIN Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Bos taurus OX=9913 GN=AASS PE=2 SV=1 AASS_BOVIN reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Bos taurus (Bovine) GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131 L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753] g2435.t3 A8E657 49.895 954 0.0 945.0 sp|A8E657|AASS_BOVIN Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Bos taurus OX=9913 GN=AASS PE=2 SV=1 AASS_BOVIN reviewed Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)] Bos taurus (Bovine) GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131 L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753] g2436.t1 Q5Y4N8 27.835 291 7.08e-22 106.0 sp|Q5Y4N8|AGRE1_RAT Adhesion G protein-coupled receptor E2 OS=Rattus norvegicus OX=10116 GN=Adgre1 PE=2 SV=1 AGRE1_RAT reviewed Adhesion G protein-coupled receptor E2 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor) Rattus norvegicus (Rat) GO:0002250; GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0009897; GO:0071356; GO:0071560; GO:0071944 adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186] cell periphery [GO:0071944]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g2437.t1 Q14656 33.186 226 3.5900000000000003e-37 134.0 sp|Q14656|TM187_HUMAN Transmembrane protein 187 OS=Homo sapiens OX=9606 GN=TMEM187 PE=1 SV=1 g2438.t1 Q14656 38.235 170 6.580000000000001e-27 105.0 sp|Q14656|TM187_HUMAN Transmembrane protein 187 OS=Homo sapiens OX=9606 GN=TMEM187 PE=1 SV=1 g2438.t3 Q0VCM2 32.54 252 2.67e-31 119.0 sp|Q0VCM2|TM187_BOVIN Transmembrane protein 187 OS=Bos taurus OX=9913 GN=TMEM187 PE=2 SV=1 g2439.t1 Q14656 35.227 264 4.680000000000001e-43 150.0 sp|Q14656|TM187_HUMAN Transmembrane protein 187 OS=Homo sapiens OX=9606 GN=TMEM187 PE=1 SV=1 g2444.t1 A8I499 30.673 639 6.83e-96 310.0 sp|A8I499|CTR2_PIG Cationic amino acid transporter 2 OS=Sus scrofa OX=9823 GN=SLC7A2 PE=2 SV=1 CTR2_PIG reviewed Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2) Sus scrofa (Pig) GO:0000064; GO:0005886; GO:0015189; GO:0061459; GO:0097638; GO:1903352; GO:1903826 L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352] plasma membrane [GO:0005886] L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g2451.t1 Q9H944 49.515 206 2.28e-72 221.0 sp|Q9H944|MED20_HUMAN Mediator of RNA polymerase II transcription subunit 20 OS=Homo sapiens OX=9606 GN=MED20 PE=1 SV=1 MED20_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog) (hTRFP) Homo sapiens (Human) GO:0003713; GO:0003899; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0006366; GO:0016592; GO:0032968; GO:0035914; GO:0051123; GO:0060261; GO:0070847 DNA-templated transcription [GO:0006351]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-directed RNA polymerase activity [GO:0003899]; transcription coactivator activity [GO:0003713] g2452.t1 Q24297 74.713 87 1.53e-45 144.0 sp|Q24297|RUXF_DROME Small nuclear ribonucleoprotein F OS=Drosophila melanogaster OX=7227 GN=SmF PE=1 SV=2 RUXF_DROME reviewed Small nuclear ribonucleoprotein F (snRNP-F) (Membrane-associated protein Deb-B) (Sm protein F) (Sm-F) (SmF) Drosophila melanogaster (Fruit fly) GO:0000398; GO:0003723; GO:0005681; GO:0005685; GO:0005829; GO:0030532; GO:0034715; GO:0071011; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685] RNA binding [GO:0003723] g2457.t1 Q9DA39 49.782 229 2.71e-75 231.0 sp|Q9DA39|LFG4_MOUSE Protein lifeguard 4 OS=Mus musculus OX=10090 GN=Tmbim4 PE=2 SV=1 LFG4_MOUSE reviewed Protein lifeguard 4 (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein) Mus musculus (Mouse) GO:0000139; GO:0005262; GO:0005789; GO:0005795; GO:0006915; GO:0007626; GO:0016020; GO:0030968; GO:0043066; GO:0043524; GO:0050848 apoptotic process [GO:0006915]; endoplasmic reticulum unfolded protein response [GO:0030968]; locomotory behavior [GO:0007626]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of calcium-mediated signaling [GO:0050848] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020] calcium channel activity [GO:0005262] g2458.t1 Q05B18 45.721 444 4.41e-135 415.0 sp|Q05B18|SHQ1_XENTR Protein SHQ1 homolog OS=Xenopus tropicalis OX=8364 GN=shq1 PE=2 SV=1 g2460.t1 Q9UBJ2 62.018 674 0.0 854.0 sp|Q9UBJ2|ABCD2_HUMAN ATP-binding cassette sub-family D member 2 OS=Homo sapiens OX=9606 GN=ABCD2 PE=1 SV=1 ABCD2_HUMAN reviewed ATP-binding cassette sub-family D member 2 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR) Homo sapiens (Human) GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0006636; GO:0007031; GO:0009617; GO:0015605; GO:0015910; GO:0015932; GO:0016887; GO:0032000; GO:0036109; GO:0042626; GO:0042759; GO:0042760; GO:0042803; GO:0042887; GO:0043217; GO:0043651; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1901570; GO:1901682; GO:1903427; GO:1990535; GO:2001280 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ABC-type transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleobase-containing compound transmembrane transporter activity [GO:0015932]; organophosphate ester transmembrane transporter activity [GO:0015605]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sulfur compound transmembrane transporter activity [GO:1901682] g2461.t1 P31646 57.895 589 0.0 686.0 sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1 S6A13_RAT reviewed Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13) Rattus norvegicus (Rat) GO:0005283; GO:0005308; GO:0005332; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734] basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine:sodium symporter activity [GO:0005369] g2462.t1 P47990 55.351 1355 0.0 1514.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g2463.t1 P47990 44.718 284 2.62e-60 207.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g2463.t2 Q00519 62.745 153 2.59e-58 201.0 sp|Q00519|XDH_MOUSE Xanthine dehydrogenase/oxidase OS=Mus musculus OX=10090 GN=Xdh PE=1 SV=5 g2464.t1 Q5I0S8 44.416 385 3.85e-103 313.0 sp|Q5I0S8|ILEU_XENTR Leukocyte elastase inhibitor OS=Xenopus tropicalis OX=8364 GN=serpinb1 PE=2 SV=1 g2465.t1 O73790 38.068 176 6.83e-29 113.0 sp|O73790|SPB10_CHICK Heterochromatin-associated protein MENT OS=Gallus gallus OX=9031 GN=SERPINB10 PE=1 SV=1 g2466.t1 Q5SV42 45.383 379 4.88e-105 318.0 sp|Q5SV42|ILEUC_MOUSE Leukocyte elastase inhibitor C OS=Mus musculus OX=10090 GN=Serpinb1c PE=1 SV=1 g2467.t1 P47990 66.102 118 1.7099999999999998e-46 163.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g2468.t1 P47990 57.29 1358 0.0 1591.0 sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1 g2469.t1 Q8BU30 65.339 1180 0.0 1615.0 sp|Q8BU30|SYIC_MOUSE Isoleucine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Iars1 PE=1 SV=2 SYIC_MOUSE reviewed Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) Mus musculus (Mouse) GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006428; GO:0017101; GO:0051020 isoleucyl-tRNA aminoacylation [GO:0006428] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] g2471.t1 Q16720 60.839 1121 0.0 1360.0 sp|Q16720|AT2B3_HUMAN Plasma membrane calcium-transporting ATPase 3 OS=Homo sapiens OX=9606 GN=ATP2B3 PE=1 SV=3 g2471.t2 Q16720 58.824 1173 0.0 1355.0 sp|Q16720|AT2B3_HUMAN Plasma membrane calcium-transporting ATPase 3 OS=Homo sapiens OX=9606 GN=ATP2B3 PE=1 SV=3 g2474.t1 Q29504 58.228 395 2.9300000000000003e-156 471.0 sp|Q29504|UBA1_RABIT Ubiquitin-like modifier-activating enzyme 1 OS=Oryctolagus cuniculus OX=9986 GN=UBA1 PE=1 SV=1 UBA1_RABIT reviewed Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) Oryctolagus cuniculus (Rabbit) GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0006974 DNA damage response [GO:0006974]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839] g2475.t1 A3KMV5 66.719 637 0.0 921.0 sp|A3KMV5|UBA1_BOVIN Ubiquitin-like modifier-activating enzyme 1 OS=Bos taurus OX=9913 GN=UBA1 PE=2 SV=1 UBA1_BOVIN reviewed Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) Bos taurus (Bovine) GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0006974; GO:0016567 DNA damage response [GO:0006974]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839] g2477.t1 Q68FS3 35.217 230 1.0400000000000001e-31 126.0 sp|Q68FS3|FBX7_RAT F-box only protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxo7 PE=2 SV=1 FBX7_RAT reviewed F-box only protein 7 Rattus norvegicus (Rat) GO:0000151; GO:0000422; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0030098; GO:0031625; GO:0031647; GO:0032991; GO:0040012; GO:0043130; GO:0043161; GO:0043524; GO:0045620; GO:0046982; GO:0070936; GO:0097409; GO:0097414; GO:0097462; GO:1901526; GO:1903377; GO:1903599; GO:1990037; GO:1990038; GO:1990756; GO:2000134 autophagy of mitochondrion [GO:0000422]; lymphocyte differentiation [GO:0030098]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of mitophagy [GO:1901526]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2482.t1 Q09428 33.211 1635 0.0 892.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2483.t1 U3NEE3 29.249 253 2.09e-30 120.0 sp|U3NEE3|HNMTL_CHICK Carnosine N-methyltransferase 2 OS=Gallus gallus OX=9031 PE=1 SV=1 g2484.t1 Q76EC5 31.724 290 8.199999999999999e-34 133.0 sp|Q76EC5|CHST9_MOUSE Carbohydrate sulfotransferase 9 OS=Mus musculus OX=10090 GN=Chst9 PE=2 SV=1 g2489.t1 Q9ESJ4 44.632 475 2.6800000000000003e-129 399.0 sp|Q9ESJ4|SPN90_MOUSE NCK-interacting protein with SH3 domain OS=Mus musculus OX=10090 GN=Nckipsd PE=1 SV=2 SPN90_MOUSE reviewed NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (VIP54) (90 kDa N-WASP-interacting protein) (90 kDa SH3 protein interacting with Nck) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-binding protein) (N-WASP-binding protein) Mus musculus (Mouse) GO:0005654; GO:0005886; GO:0006897; GO:0008180; GO:0010976; GO:0017124; GO:0071933; GO:0098794; GO:0098978; GO:0150052 endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976]; regulation of postsynapse assembly [GO:0150052] COP9 signalosome [GO:0008180]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] Arp2/3 complex binding [GO:0071933]; SH3 domain binding [GO:0017124] g2490.t1 A4IHD2 52.169 807 0.0 842.0 sp|A4IHD2|ARIP4_XENTR Helicase ARIP4 OS=Xenopus tropicalis OX=8364 GN=rad54l2 PE=2 SV=1 g2490.t1 A4IHD2 48.896 317 2e-69 261.0 sp|A4IHD2|ARIP4_XENTR Helicase ARIP4 OS=Xenopus tropicalis OX=8364 GN=rad54l2 PE=2 SV=1 g2491.t1 P60123 86.842 456 0.0 815.0 sp|P60123|RUVB1_RAT RuvB-like 1 OS=Rattus norvegicus OX=10116 GN=Ruvbl1 PE=1 SV=1 RUVB1_RAT reviewed RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (DNA helicase p50) (Pontin 52) (TIP49a) Rattus norvegicus (Rat) GO:0000492; GO:0000723; GO:0000786; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0006357; GO:0010756; GO:0016363; GO:0016607; GO:0016887; GO:0017025; GO:0031011; GO:0031965; GO:0032991; GO:0033044; GO:0035267; GO:0036064; GO:0043138; GO:0043531; GO:0045739; GO:0045893; GO:0045995; GO:0051117; GO:0051301; GO:0051726; GO:0060382; GO:0071339; GO:0090263; GO:0097255; GO:0101031; GO:0120293; GO:1904507; GO:1905168; GO:1990062; GO:1990904; GO:2000269 box C/D snoRNP assembly [GO:0000492]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance [GO:0000723] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812] 3'-5' DNA helicase activity [GO:0043138]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713] g2492.t1 Q8IYE0 45.134 935 0.0 756.0 sp|Q8IYE0|CC146_HUMAN Coiled-coil domain-containing protein 146 OS=Homo sapiens OX=9606 GN=CCDC146 PE=1 SV=2 CC146_HUMAN reviewed Coiled-coil domain-containing protein 146 Homo sapiens (Human) GO:0000902; GO:0005813; GO:0005814; GO:0005856; GO:0005930; GO:0006997; GO:0007286; GO:0007288; GO:0007338; GO:0008283; GO:0010467; GO:0030496; GO:0036064; GO:0036126; GO:0044877; GO:0120212; GO:0120316; GO:1905198 cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; gene expression [GO:0010467]; manchette assembly [GO:1905198]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; midbody [GO:0030496]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212] protein-containing complex binding [GO:0044877] g2493.t1 Q7ZT75 38.87 301 5.1000000000000005e-43 154.0 sp|Q7ZT75|FCN1A_XENLA Ficolin-1-A OS=Xenopus laevis OX=8355 GN=fcn1-a PE=1 SV=2 FCN1A_XENLA reviewed Ficolin-1-A Xenopus laevis (African clawed frog) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0033691; GO:0038187; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g2494.t1 O00602 41.85 227 1.6e-45 162.0 sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2 FCN1_HUMAN reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Homo sapiens (Human) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031012; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:0106139; GO:1903028; GO:1904813; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g2495.t1 O15123 38.596 228 1.15e-40 154.0 sp|O15123|ANGP2_HUMAN Angiopoietin-2 OS=Homo sapiens OX=9606 GN=ANGPT2 PE=1 SV=1 ANGP2_HUMAN reviewed Angiopoietin-2 (ANG-2) Homo sapiens (Human) GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007281; GO:0007596; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0048018; GO:0050820; GO:0050928; GO:0060135; GO:0071363; GO:0072012 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; blood coagulation [GO:0007596]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; positive regulation of coagulation [GO:0050820]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014] cell projection [GO:0042995]; extracellular region [GO:0005576]; extracellular space [GO:0005615] metal ion binding [GO:0046872]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] g2496.t1 O75636 50.495 101 1.6399999999999998e-23 99.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g2498.t1 O75636 41.0 200 2.07e-38 137.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g2500.t1 P24628 25.352 426 5.89e-27 115.0 sp|P24628|DRD2A_XENLA D(2) dopamine receptor A OS=Xenopus laevis OX=8355 GN=drd2-a PE=2 SV=1 g2501.t1 P82451 33.936 1273 0.0 733.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g2502.t1 P82451 60.338 237 3.81e-91 297.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g2503.t1 O60706 39.721 1576 0.0 1090.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2504.t1 Q91ZY1 25.532 376 2.55e-22 101.0 sp|Q91ZY1|HRH4_RAT Histamine H4 receptor OS=Rattus norvegicus OX=10116 GN=Hrh4 PE=2 SV=1 g2505.t1 P82451 37.764 1610 0.0 1073.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g2506.t1 O60706 31.844 1209 0.0 600.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2506.t1 O60706 40.561 392 9.32e-80 295.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2507.t1 O60706 39.087 1599 0.0 1138.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g2514.t1 Q58CN9 55.263 342 5.12e-133 387.0 sp|Q58CN9|NAPEP_BOVIN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Bos taurus OX=9913 GN=NAPEPLD PE=2 SV=1 NAPEP_BOVIN reviewed N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54) Bos taurus (Bovine) GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0031901; GO:0043005; GO:0043025; GO:0048874; GO:0050729; GO:0070290; GO:0070291; GO:0070292; GO:0090336 host-mediated modulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270] g2515.t1 Q6IQ20 54.22 391 7.89e-145 430.0 sp|Q6IQ20|NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens OX=9606 GN=NAPEPLD PE=1 SV=2 NAPEP_HUMAN reviewed N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54) Homo sapiens (Human) GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0030868; GO:0031901; GO:0032052; GO:0035900; GO:0042622; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0098686; GO:1903999 host-mediated modulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; smooth endoplasmic reticulum membrane [GO:0030868] bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270] g2518.t1 Q6GP04 56.063 635 0.0 686.0 sp|Q6GP04|MON2_XENLA Protein MON2 homolog OS=Xenopus laevis OX=8355 GN=mon2 PE=2 SV=1 g2519.t1 Q9VLT1 67.755 245 7.089999999999999e-104 335.0 sp|Q9VLT1|MON2_DROME Protein MON2 homolog OS=Drosophila melanogaster OX=7227 GN=mon2 PE=2 SV=4 g2520.t1 Q80TL7 63.223 242 3.6299999999999997e-93 304.0 sp|Q80TL7|MON2_MOUSE Protein MON2 homolog OS=Mus musculus OX=10090 GN=Mon2 PE=1 SV=2 g2521.t1 Q80TL7 49.053 528 4.57e-159 497.0 sp|Q80TL7|MON2_MOUSE Protein MON2 homolog OS=Mus musculus OX=10090 GN=Mon2 PE=1 SV=2 g2522.t1 Q9PSX7 75.0 188 1.73e-97 283.0 sp|Q9PSX7|RHOC_CHICK Rho-related GTP-binding protein RhoC OS=Gallus gallus OX=9031 GN=RHOC PE=1 SV=1 g2523.t1 Q6NUX8 88.601 193 9.42e-125 352.0 sp|Q6NUX8|RHOAA_DANRE Rho-related GTP-binding protein RhoA-A OS=Danio rerio OX=7955 GN=rhoaa PE=1 SV=1 g2525.t1 Q68EY9 72.778 360 0.0 566.0 sp|Q68EY9|GMPBA_XENLA Mannose-1-phosphate guanyltransferase beta-A OS=Xenopus laevis OX=8355 GN=gmppb-a PE=2 SV=1 g2526.t1 Q5F489 61.364 132 1.7799999999999998e-48 190.0 sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1 g2526.t1 Q5F489 52.941 85 3.56e-22 107.0 sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1 g2527.t1 Q7ZVX6 70.362 442 0.0 682.0 sp|Q7ZVX6|UBA3_DANRE NEDD8-activating enzyme E1 catalytic subunit OS=Danio rerio OX=7955 GN=uba3 PE=2 SV=1 g2528.t1 Q3KRG3 36.224 196 1.22e-33 121.0 sp|Q3KRG3|TSR2_DANRE Pre-rRNA-processing protein TSR2 homolog OS=Danio rerio OX=7955 GN=tsr2 PE=2 SV=1 g2529.t1 A6QLI6 47.582 641 0.0 596.0 sp|A6QLI6|HEM1_BOVIN 5-aminolevulinate synthase, non-specific, mitochondrial OS=Bos taurus OX=9913 GN=ALAS1 PE=2 SV=1 HEM1_BOVIN reviewed 5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1) Bos taurus (Bovine) GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0048821; GO:1903412 erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170] g2530.t1 Q96ER9 34.557 327 9.36e-48 169.0 sp|Q96ER9|MITOK_HUMAN Mitochondrial potassium channel OS=Homo sapiens OX=9606 GN=CCDC51 PE=1 SV=2 MITOK_HUMAN reviewed Mitochondrial potassium channel (MITOK) (Coiled-coil domain-containing protein 51) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0006884; GO:0062156; GO:0062157; GO:0071805; GO:0140141 cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805] mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial ATP-gated potassium channel activity [GO:0062156] g2532.t1 Q5E9Q3 44.545 110 2.9599999999999997e-24 100.0 sp|Q5E9Q3|MITOK_BOVIN Mitochondrial potassium channel OS=Bos taurus OX=9913 GN=CCDC51 PE=2 SV=1 g2533.t1 Q8VDB2 53.958 480 3.5400000000000004e-160 468.0 sp|Q8VDB2|ALG12_MOUSE Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase OS=Mus musculus OX=10090 GN=Alg12 PE=2 SV=2 g2536.t1 E9Q7T7 27.212 746 8.649999999999999e-55 209.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g2536.t1 E9Q7T7 27.77 749 9e-54 206.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g2536.t1 E9Q7T7 31.879 298 1.1900000000000001e-29 131.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g2536.t1 E9Q7T7 29.377 337 2.35e-25 117.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g2537.t1 Q45R42 31.863 408 2.5399999999999998e-48 186.0 sp|Q45R42|LRRC4_RAT Leucine-rich repeat-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Lrrc4 PE=1 SV=1 LRRC4_RAT reviewed Leucine-rich repeat-containing protein 4 (Netrin-G2 ligand) (NGL-2) Rattus norvegicus (Rat) GO:0005886; GO:0043197; GO:0044309; GO:0045202; GO:0045211; GO:0050804; GO:0050808; GO:0060076; GO:0097119; GO:0098632; GO:0098685; GO:0098839; GO:0098978; GO:0099560; GO:1904861 excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synapse organization [GO:0050808]; synaptic membrane adhesion [GO:0099560] dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] cell-cell adhesion mediator activity [GO:0098632] g2538.t1 Q3B7H2 50.467 321 2.01e-108 322.0 sp|Q3B7H2|TAM41_DANRE Phosphatidate cytidylyltransferase, mitochondrial OS=Danio rerio OX=7955 GN=tamm41 PE=2 SV=1 g2539.t1 Q1KZG4 57.031 128 8.99e-53 167.0 sp|Q1KZG4|FHIT_BOVIN Bis(5'-adenosyl)-triphosphatase OS=Bos taurus OX=9913 GN=FHIT PE=2 SV=1 FHIT_BOVIN reviewed Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Adenosine 5'-monophosphoramidase FHIT) (EC 3.9.1.-) (Adenylylsulfatase) (EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase) (EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein) Bos taurus (Bovine) GO:0000166; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006163; GO:0015964; GO:0031625; GO:0032435; GO:0043530; GO:0047352; GO:0047627; GO:0047710; GO:0072332 diadenosine triphosphate catabolic process [GO:0015964]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; purine nucleotide metabolic process [GO:0006163] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adenosine 5'-monophosphoramidase activity [GO:0043530]; adenylylsulfatase activity [GO:0047627]; adenylylsulfate-ammonia adenylyltransferase activity [GO:0047352]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; nucleotide binding [GO:0000166]; ubiquitin protein ligase binding [GO:0031625] g2540.t1 P17971 67.679 560 0.0 767.0 sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2 KCNAL_DROME reviewed Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2) Drosophila melanogaster (Fruit fly) GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805 action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260] dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249] g2540.t2 P17971 65.12 582 0.0 754.0 sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2 KCNAL_DROME reviewed Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2) Drosophila melanogaster (Fruit fly) GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805 action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260] dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249] g2541.t1 Q8VD04 38.647 665 3.38e-97 327.0 sp|Q8VD04|GRAP1_MOUSE GRIP1-associated protein 1 OS=Mus musculus OX=10090 GN=Gripap1 PE=1 SV=1 g2541.t1 Q8VD04 51.5 200 2.29e-40 164.0 sp|Q8VD04|GRAP1_MOUSE GRIP1-associated protein 1 OS=Mus musculus OX=10090 GN=Gripap1 PE=1 SV=1 g2541.t2 Q9JHZ4 38.649 696 3.51e-98 331.0 sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1 GRAP1_RAT reviewed GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)] Rattus norvegicus (Rat) GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910 negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255] g2541.t2 Q9JHZ4 52.5 200 6.5e-41 166.0 sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1 GRAP1_RAT reviewed GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)] Rattus norvegicus (Rat) GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910 negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255] g2542.t1 Q91560 50.965 259 1.8e-77 254.0 sp|Q91560|REXO4_XENLA RNA exonuclease 4 OS=Xenopus laevis OX=8355 GN=rexo4 PE=2 SV=2 g2543.t1 P11714 32.544 507 2.5400000000000003e-79 259.0 sp|P11714|CP2D9_MOUSE Cytochrome P450 2D9 OS=Mus musculus OX=10090 GN=Cyp2d9 PE=1 SV=2 CP2D9_MOUSE reviewed Cytochrome P450 2D9 (EC 1.14.14.1) (CYPIID9) (Cytochrome P450-16-alpha) (Cytochrome P450CA) (Testosterone 16-alpha hydroxylase) Mus musculus (Mouse) GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005789; GO:0006805; GO:0016491; GO:0016712; GO:0019369; GO:0020037; GO:0062187; GO:0062188; GO:0062189; GO:0070330 arachidonate metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739] anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g2544.t1 P11714 32.604 503 5.38e-80 261.0 sp|P11714|CP2D9_MOUSE Cytochrome P450 2D9 OS=Mus musculus OX=10090 GN=Cyp2d9 PE=1 SV=2 CP2D9_MOUSE reviewed Cytochrome P450 2D9 (EC 1.14.14.1) (CYPIID9) (Cytochrome P450-16-alpha) (Cytochrome P450CA) (Testosterone 16-alpha hydroxylase) Mus musculus (Mouse) GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005789; GO:0006805; GO:0016491; GO:0016712; GO:0019369; GO:0020037; GO:0062187; GO:0062188; GO:0062189; GO:0070330 arachidonate metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739] anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g2545.t1 Q7Z449 32.544 507 1.1199999999999999e-82 269.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g2546.t1 P17560 55.499 391 7.95e-159 468.0 sp|P17560|RENBP_PIG N-acylglucosamine 2-epimerase OS=Sus scrofa OX=9823 GN=RENBP PE=1 SV=2 g2548.t1 Q149M9 28.249 1416 9.26e-154 510.0 sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3 g2550.t1 Q9CWW7 41.979 667 3.33e-164 489.0 sp|Q9CWW7|CXXC1_MOUSE CXXC-type zinc finger protein 1 OS=Mus musculus OX=10090 GN=Cxxc1 PE=1 SV=1 CXXC1_MOUSE reviewed CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1) Mus musculus (Mouse) GO:0000987; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008270; GO:0016363; GO:0016607; GO:0035097; GO:0045322; GO:0045893; GO:0048188; GO:0140002 positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] cis-regulatory region sequence-specific DNA binding [GO:0000987]; histone H3K4me3 reader activity [GO:0140002]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g2551.t1 Q3SZ22 39.114 271 4.1399999999999997e-54 180.0 sp|Q3SZ22|RM46_BOVIN Large ribosomal subunit protein mL46 OS=Bos taurus OX=9913 GN=MRPL46 PE=2 SV=1 g2552.t1 B2GV05 42.056 428 2.79e-89 307.0 sp|B2GV05|RBM5_RAT RNA-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Rbm5 PE=1 SV=1 RBM5_RAT reviewed RNA-binding protein 5 (RNA-binding motif protein 5) Rattus norvegicus (Rat) GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006915; GO:0008270; GO:0043065 apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2552.t1 B2GV05 35.862 290 4.28e-45 179.0 sp|B2GV05|RBM5_RAT RNA-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Rbm5 PE=1 SV=1 RBM5_RAT reviewed RNA-binding protein 5 (RNA-binding motif protein 5) Rattus norvegicus (Rat) GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006915; GO:0008270; GO:0043065 apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2552.t2 B2GV05 42.056 428 2.89e-89 307.0 sp|B2GV05|RBM5_RAT RNA-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Rbm5 PE=1 SV=1 RBM5_RAT reviewed RNA-binding protein 5 (RNA-binding motif protein 5) Rattus norvegicus (Rat) GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006915; GO:0008270; GO:0043065 apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2552.t2 B2GV05 35.862 290 4.4499999999999995e-45 179.0 sp|B2GV05|RBM5_RAT RNA-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Rbm5 PE=1 SV=1 RBM5_RAT reviewed RNA-binding protein 5 (RNA-binding motif protein 5) Rattus norvegicus (Rat) GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006915; GO:0008270; GO:0043065 apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g2553.t1 Q5XK94 42.788 208 9.200000000000001e-59 189.0 sp|Q5XK94|TIDC1_XENLA Complex I assembly factor TIMMDC1, mitochondrial OS=Xenopus laevis OX=8355 GN=timmdc1 PE=2 SV=1 g2554.t1 Q5R7N2 49.65 286 1.1099999999999999e-101 304.0 sp|Q5R7N2|TWF1_PONAB Twinfilin-1 OS=Pongo abelii OX=9601 GN=TWF1 PE=2 SV=1 g2555.t1 P0C218 62.899 407 6.44e-175 533.0 sp|P0C218|DDX20_DANRE Probable ATP-dependent RNA helicase DDX20 OS=Danio rerio OX=7955 GN=ddx20 PE=3 SV=1 g2556.t1 Q8BFQ2 45.775 142 3.14e-36 128.0 sp|Q8BFQ2|T229B_MOUSE Transmembrane protein 229B OS=Mus musculus OX=10090 GN=TMEM229B PE=2 SV=1 g2557.t1 O08816 45.455 264 5.86e-70 235.0 sp|O08816|WASL_RAT Actin nucleation-promoting factor WASL OS=Rattus norvegicus OX=10116 GN=Wasl PE=1 SV=2 WASL_RAT reviewed Actin nucleation-promoting factor WASL (Neural Wiskott-Aldrich syndrome protein) (N-WASP) Rattus norvegicus (Rat) GO:0000139; GO:0003779; GO:0005634; GO:0005829; GO:0005886; GO:0006900; GO:0008092; GO:0009617; GO:0010324; GO:0016050; GO:0030027; GO:0030036; GO:0030041; GO:0030050; GO:0030478; GO:0031252; GO:0031410; GO:0031503; GO:0032880; GO:0042802; GO:0045944; GO:0050921; GO:0051301; GO:0051491; GO:0051653; GO:0060491; GO:0060997; GO:0097320; GO:0098794; GO:0098974; GO:0098978; GO:0099173; GO:0099175; GO:1903526; GO:2000370; GO:2000402 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cell division [GO:0051301]; dendritic spine morphogenesis [GO:0060997]; membrane invagination [GO:0010324]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; plasma membrane tubulation [GO:0097320]; positive regulation of chemotaxis [GO:0050921]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse organization [GO:0099173]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein-containing complex localization [GO:0031503]; regulation of cell projection assembly [GO:0060491]; regulation of postsynapse organization [GO:0099175]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] actin cap [GO:0030478]; cell leading edge [GO:0031252]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] g2558.t1 Q32KW0 57.426 202 1.05e-65 204.0 sp|Q32KW0|NFYB_BOVIN Nuclear transcription factor Y subunit beta OS=Bos taurus OX=9913 GN=NFYB PE=2 SV=1 g2560.t1 Q9I8E6 76.744 258 1.57e-136 408.0 sp|Q9I8E6|COPG2_TAKRU Coatomer subunit gamma-2 OS=Takifugu rubripes OX=31033 GN=copg2 PE=3 SV=1 g2561.t1 D4ABY2 81.858 226 2.67e-130 386.0 sp|D4ABY2|COPG2_RAT Coatomer subunit gamma-2 OS=Rattus norvegicus OX=10116 GN=Copg2 PE=3 SV=2 COPG2_RAT reviewed Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) Rattus norvegicus (Rat) GO:0000139; GO:0005198; GO:0005783; GO:0005793; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0009306; GO:0030126; GO:0030137; GO:0030426; GO:0072384 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306] COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; growth cone [GO:0030426] structural molecule activity [GO:0005198] g2562.t1 Q9I8E6 55.216 393 9.51e-141 424.0 sp|Q9I8E6|COPG2_TAKRU Coatomer subunit gamma-2 OS=Takifugu rubripes OX=31033 GN=copg2 PE=3 SV=1 g2563.t1 Q9SA71 28.475 446 5.58e-40 152.0 sp|Q9SA71|GLPT3_ARATH Putative glycerol-3-phosphate transporter 3 OS=Arabidopsis thaliana OX=3702 GN=At1g30560 PE=3 SV=1 g2565.t1 P26262 40.249 241 7.25e-46 180.0 sp|P26262|KLKB1_MOUSE Plasma kallikrein OS=Mus musculus OX=10090 GN=Klkb1 PE=1 SV=2 KLKB1_MOUSE reviewed Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain] Mus musculus (Mouse) GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0008236; GO:0031639; GO:0042730; GO:0051919 blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919] extracellular space [GO:0005615] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g2571.t1 P07953 65.647 425 0.0 593.0 sp|P07953|F261_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 OS=Rattus norvegicus OX=10116 GN=Pfkfb1 PE=1 SV=3 g2571.t2 P07953 66.828 413 0.0 585.0 sp|P07953|F261_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 OS=Rattus norvegicus OX=10116 GN=Pfkfb1 PE=1 SV=3 g2572.t1 Q8R4K2 35.714 490 7.52e-75 246.0 sp|Q8R4K2|IRAK4_MOUSE Interleukin-1 receptor-associated kinase 4 OS=Mus musculus OX=10090 GN=Irak4 PE=1 SV=1 IRAK4_MOUSE reviewed Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) Mus musculus (Mouse) GO:0000287; GO:0002446; GO:0004674; GO:0005149; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007254; GO:0008063; GO:0009986; GO:0016301; GO:0019221; GO:0019901; GO:0031663; GO:0034142; GO:0035556; GO:0038061; GO:0038172; GO:0043123; GO:0045087; GO:0048661; GO:0070498; GO:0106310; GO:1990266 cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-33-mediated signaling pathway [GO:0038172]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of smooth muscle cell proliferation [GO:0048661]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2576.t1 Q91YE6 59.238 866 0.0 1079.0 sp|Q91YE6|IPO9_MOUSE Importin-9 OS=Mus musculus OX=10090 GN=Ipo9 PE=1 SV=3 IPO9_MOUSE reviewed Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Mus musculus (Mouse) GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0010498; GO:0031144; GO:0031267; GO:0042254; GO:0042393; GO:0050821; GO:0061608; GO:0140713 proteasomal protein catabolic process [GO:0010498]; proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] g2577.t1 Q96P70 73.333 75 6.52e-31 117.0 sp|Q96P70|IPO9_HUMAN Importin-9 OS=Homo sapiens OX=9606 GN=IPO9 PE=1 SV=3 IPO9_HUMAN reviewed Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9) Homo sapiens (Human) GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0016020; GO:0031144; GO:0031267; GO:0042393; GO:0061608; GO:0140713 proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] g2578.t1 E2RQ08 50.617 567 0.0 561.0 sp|E2RQ08|RPN1_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Canis lupus familiaris OX=9615 GN=RPN1 PE=1 SV=1 RPN1_CANLF reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005791; GO:0005829; GO:0008250; GO:0009101; GO:0018279; GO:0160226; GO:0160227 glycoprotein biosynthetic process [GO:0009101]; protein N-linked glycosylation via asparagine [GO:0018279] cytosol [GO:0005829]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; rough endoplasmic reticulum [GO:0005791] g2579.t1 Q5RCP3 79.167 96 1.3e-52 162.0 sp|Q5RCP3|LSM8_PONAB U6 snRNA-associated Sm-like protein LSm8 OS=Pongo abelii OX=9601 GN=LSM8 PE=3 SV=3 LSM8_PONAB reviewed U6 snRNA-associated Sm-like protein LSm8 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000398; GO:0003729; GO:0005634; GO:0005688; GO:0046540; GO:0071005; GO:0120115 mRNA splicing, via spliceosome [GO:0000398] Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] mRNA binding [GO:0003729] g2580.t1 Q498T4 56.579 304 5.54e-110 324.0 sp|Q498T4|RM02_RAT Large ribosomal subunit protein uL2m OS=Rattus norvegicus OX=10116 GN=Mrpl2 PE=2 SV=1 g2583.t1 A7YWP4 51.311 267 1.43e-85 271.0 sp|A7YWP4|HUTH_BOVIN Histidine ammonia-lyase OS=Bos taurus OX=9913 GN=HAL PE=2 SV=1 HUTH_BOVIN reviewed Histidine ammonia-lyase (Histidase) (EC 4.3.1.3) Bos taurus (Bovine) GO:0004397; GO:0005737; GO:0006548; GO:0019556; GO:0019557 L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557] cytoplasm [GO:0005737] histidine ammonia-lyase activity [GO:0004397] g2584.t1 P42357 75.843 356 0.0 558.0 sp|P42357|HUTH_HUMAN Histidine ammonia-lyase OS=Homo sapiens OX=9606 GN=HAL PE=1 SV=1 HUTH_HUMAN reviewed Histidine ammonia-lyase (Histidase) (EC 4.3.1.3) Homo sapiens (Human) GO:0004397; GO:0005829; GO:0006548; GO:0019556; GO:0019557 L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557] cytosol [GO:0005829] histidine ammonia-lyase activity [GO:0004397] g2585.t1 Q8VC12 50.485 309 9.149999999999999e-93 289.0 sp|Q8VC12|HUTU_MOUSE Urocanate hydratase OS=Mus musculus OX=10090 GN=Uroc1 PE=1 SV=2 g2586.t1 Q8VC12 72.836 335 0.0 532.0 sp|Q8VC12|HUTU_MOUSE Urocanate hydratase OS=Mus musculus OX=10090 GN=Uroc1 PE=1 SV=2 g2587.t1 Q86UL8 49.39 164 5.9699999999999996e-46 163.0 sp|Q86UL8|MAGI2_HUMAN Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MAGI2 PE=1 SV=3 g2588.t1 Q6RHR9 49.11 281 4.9e-71 266.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t1 Q6RHR9 43.774 265 6.24e-47 189.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t1 Q6RHR9 63.529 85 8.35e-26 120.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t1 Q6RHR9 52.041 98 3.6300000000000003e-22 108.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t2 Q6RHR9 48.746 279 4.16e-69 260.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t2 Q6RHR9 43.774 265 6.88e-47 189.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t2 Q6RHR9 63.529 85 9.510000000000001e-26 120.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t2 Q6RHR9 52.041 98 3.74e-22 108.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t3 Q6RHR9 48.746 279 3.73e-69 260.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t3 Q6RHR9 43.774 265 6.8e-47 189.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t3 Q6RHR9 63.529 85 9.15e-26 120.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2588.t3 Q6RHR9 52.041 98 3.6000000000000003e-22 108.0 sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1 MAGI1_MOUSE reviewed Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) Mus musculus (Mouse) GO:0001886; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007165; GO:0016020; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0071944 endothelial cell morphogenesis [GO:0001886]; positive regulation of cell-cell adhesion [GO:0022409]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524] g2589.t1 Q99943 41.87 246 5.789999999999999e-54 179.0 sp|Q99943|PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2 PLCA_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15) Homo sapiens (Human) GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] g2590.t1 F1QN74 54.204 452 0.0 525.0 sp|F1QN74|ZMY10_DANRE Zinc finger MYND domain-containing protein 10 OS=Danio rerio OX=7955 GN=zmynd10 PE=2 SV=1 g2591.t1 Q8MJJ7 54.459 314 1.46e-120 353.0 sp|Q8MJJ7|DCPS_BOVIN m7GpppX diphosphatase OS=Bos taurus OX=9913 GN=DCPS PE=2 SV=1 g2600.t1 Q55GQ5 55.752 113 2.35e-37 131.0 sp|Q55GQ5|SODC1_DICDI Superoxide dismutase [Cu-Zn] 1 OS=Dictyostelium discoideum OX=44689 GN=sodA PE=2 SV=1 SODC1_DICDI reviewed Superoxide dismutase [Cu-Zn] 1 (EC 1.15.1.1) Dictyostelium discoideum (Social amoeba) GO:0004784; GO:0005507; GO:0006801; GO:0006979; GO:0009617; GO:0019430; GO:0031012; GO:0031152; GO:0042542; GO:0045335; GO:0046686; GO:1904643 aggregation involved in sorocarp development [GO:0031152]; removal of superoxide radicals [GO:0019430]; response to bacterium [GO:0009617]; response to cadmium ion [GO:0046686]; response to curcumin [GO:1904643]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; superoxide metabolic process [GO:0006801] extracellular matrix [GO:0031012]; phagocytic vesicle [GO:0045335] copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784] g2602.t1 Q641G7 89.286 168 8.16e-111 315.0 sp|Q641G7|ARPC4_XENLA Actin-related protein 2/3 complex subunit 4 OS=Xenopus laevis OX=8355 GN=arpc4 PE=1 SV=1 g2605.t1 Q5ZKY2 60.083 719 0.0 857.0 sp|Q5ZKY2|ATG7_CHICK Ubiquitin-like modifier-activating enzyme ATG7 OS=Gallus gallus OX=9031 GN=ATG7 PE=2 SV=1 ATG7_CHICK reviewed Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) Gallus gallus (Chicken) GO:0000045; GO:0000407; GO:0000423; GO:0005737; GO:0006914; GO:0006995; GO:0009896; GO:0015031; GO:0019778; GO:0019779; GO:0032446; GO:0034727; GO:0042752; GO:0042981; GO:0048511; GO:0060255; GO:0080090 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of catabolic process [GO:0009896]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of macromolecule metabolic process [GO:0060255]; regulation of primary metabolic process [GO:0080090]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407] Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779] g2606.t1 Q14135 43.885 139 2.9900000000000004e-21 93.6 sp|Q14135|VGLL4_HUMAN Transcription cofactor vestigial-like protein 4 OS=Homo sapiens OX=9606 GN=VGLL4 PE=1 SV=5 g2606.t2 Q14135 43.885 139 3.3500000000000002e-21 93.6 sp|Q14135|VGLL4_HUMAN Transcription cofactor vestigial-like protein 4 OS=Homo sapiens OX=9606 GN=VGLL4 PE=1 SV=5 g2607.t1 B5X2S3 57.966 590 0.0 708.0 sp|B5X2S3|ARP8_SALSA Actin-related protein 8 OS=Salmo salar OX=8030 GN=actr8 PE=2 SV=1 g2608.t1 Q01H83 45.263 95 1.92e-22 86.3 sp|Q01H83|SELK_XENTR Selenoprotein K OS=Xenopus tropicalis OX=8364 GN=selenok PE=3 SV=2 g2612.t1 Q8BLJ3 47.508 301 2.0100000000000002e-99 298.0 sp|Q8BLJ3|PLCX3_MOUSE PI-PLC X domain-containing protein 3 OS=Mus musculus OX=10090 GN=Plcxd3 PE=1 SV=1 g2614.t1 B4LX78 49.123 171 4.55e-55 175.0 sp|B4LX78|ARMET_DROVI Mesencephalic astrocyte-derived neurotrophic factor homolog OS=Drosophila virilis OX=7244 GN=Manf PE=3 SV=1 g2615.t1 Q5RGE6 44.93 503 1.27e-149 441.0 sp|Q5RGE6|HSP7E_DANRE Heat shock 70 kDa protein 14 OS=Danio rerio OX=7955 GN=hspa14 PE=2 SV=1 HSP7E_DANRE reviewed Heat shock 70 kDa protein 14 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016887; GO:0031072; GO:0042026; GO:0044183; GO:0140662 protein refolding [GO:0042026] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183] g2616.t1 Q9HCS2 40.077 519 8.22e-139 414.0 sp|Q9HCS2|CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens OX=9606 GN=CYP4F12 PE=1 SV=3 CP4FC_HUMAN reviewed Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006631; GO:0006805; GO:0008392; GO:0016324; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0043231; GO:0050051; GO:0055078 arachidonate metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; phylloquinone catabolic process [GO:0042376]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] alkane 1-monooxygenase activity [GO:0018685]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497] g2618.t1 P50429 57.287 494 0.0 561.0 sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3 g2619.t1 P50429 57.287 494 0.0 565.0 sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3 g2620.t1 Q3MII6 43.219 671 1.14e-175 521.0 sp|Q3MII6|TBC25_HUMAN TBC1 domain family member 25 OS=Homo sapiens OX=9606 GN=TBC1D25 PE=1 SV=2 TBC25_HUMAN reviewed TBC1 domain family member 25 Homo sapiens (Human) GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:1901096 autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410] GTPase activator activity [GO:0005096] g2621.t1 B5X5D0 45.918 98 2.82e-26 98.6 sp|B5X5D0|PIRC1_SALSA Piercer of microtubule wall 1 protein OS=Salmo salar OX=8030 GN=pierce1 PE=2 SV=1 g2622.t1 Q9BSH3 37.037 216 1.9500000000000001e-47 158.0 sp|Q9BSH3|NICN1_HUMAN Nicolin-1 OS=Homo sapiens OX=9606 GN=NICN1 PE=1 SV=1 g2622.t2 Q9BSH3 36.073 219 1.3899999999999999e-46 156.0 sp|Q9BSH3|NICN1_HUMAN Nicolin-1 OS=Homo sapiens OX=9606 GN=NICN1 PE=1 SV=1 g2624.t1 Q5R8H3 45.714 245 4.9199999999999994e-55 179.0 sp|Q5R8H3|BAP31_PONAB B-cell receptor-associated protein 31 OS=Pongo abelii OX=9601 GN=BCAP31 PE=2 SV=3 BAP31_PONAB reviewed B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0033116; GO:0070973 apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; protein localization to endoplasmic reticulum exit site [GO:0070973] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116] g2625.t1 Q91WC1 34.719 409 7.259999999999999e-69 246.0 sp|Q91WC1|POTE1_MOUSE Protection of telomeres protein 1 OS=Mus musculus OX=10090 GN=Pot1 PE=1 SV=1 POTE1_MOUSE reviewed Protection of telomeres protein 1 (mPot1) (POT1-like telomere end-binding protein) Mus musculus (Mouse) GO:0000781; GO:0000783; GO:0005654; GO:0007004; GO:0010521; GO:0016233; GO:0017151; GO:0032202; GO:0032206; GO:0032210; GO:0032211; GO:0032212; GO:0042162; GO:0043047; GO:0051276; GO:0060383; GO:0061820; GO:0061821; GO:0070187; GO:0070200; GO:0098505; GO:1905773; GO:1905840; GO:1990955; GO:2001032 chromosome organization [GO:0051276]; establishment of protein localization to telomere [GO:0070200]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA strand elongation [GO:0060383]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomeric D-loop disassembly [GO:1905840]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820] chromosome, telomeric region [GO:0000781]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187] 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; DEAD/H-box RNA helicase binding [GO:0017151]; G-rich single-stranded DNA binding [GO:1990955]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded telomeric DNA binding [GO:0043047]; telomerase inhibitor activity [GO:0010521]; telomeric D-loop binding [GO:0061821]; telomeric DNA binding [GO:0042162] g2626.t1 Q96M96 42.699 541 3.7e-138 451.0 sp|Q96M96|FGD4_HUMAN FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=2 g2626.t2 Q96M96 42.699 541 4.8399999999999995e-137 448.0 sp|Q96M96|FGD4_HUMAN FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=2 g2627.t1 A7RK30 53.369 371 3.17e-134 390.0 sp|A7RK30|QORL2_NEMVE Quinone oxidoreductase-like protein 2 homolog OS=Nematostella vectensis OX=45351 GN=v1g238856 PE=3 SV=1 g2628.t1 Q6ZV73 50.49 612 0.0 580.0 sp|Q6ZV73|FGD6_HUMAN FYVE, RhoGEF and PH domain-containing protein 6 OS=Homo sapiens OX=9606 GN=FGD6 PE=1 SV=2 FGD6_HUMAN reviewed FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24) Homo sapiens (Human) GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008270; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g2630.t1 Q810W9 36.957 230 2.2400000000000002e-32 139.0 sp|Q810W9|WHRN_RAT Whirlin OS=Rattus norvegicus OX=10116 GN=Whrn PE=1 SV=1 g2632.t1 Q6GR08 50.0 218 1.6600000000000002e-70 217.0 sp|Q6GR08|I4E3A_XENLA Eukaryotic translation initiation factor 4E type 3-A OS=Xenopus laevis OX=8355 GN=eif4e3-a PE=2 SV=1 g2634.t1 Q9I918 34.584 373 1.0600000000000001e-73 238.0 sp|Q9I918|GP173_DANRE Probable G-protein coupled receptor 173 OS=Danio rerio OX=7955 GN=gpr173 PE=3 SV=1 g2636.t1 P46023 35.052 873 6.64e-155 516.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g2636.t2 P46023 35.068 884 7.13e-154 513.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g2637.t1 Q66H84 68.328 341 3.0799999999999998e-174 493.0 sp|Q66H84|MAPK3_RAT MAP kinase-activated protein kinase 3 OS=Rattus norvegicus OX=10116 GN=Mapkapk3 PE=2 SV=1 MAPK3_RAT reviewed MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) Rattus norvegicus (Rat) GO:0000165; GO:0002224; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0009931; GO:0032496; GO:0034097; GO:0035556; GO:0044351; GO:0051019; GO:0106310 intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2638.t1 Q0VBL3 41.176 323 4.1900000000000005e-59 219.0 sp|Q0VBL3|RBM15_MOUSE RNA-binding protein 15 OS=Mus musculus OX=10090 GN=Rbm15 PE=1 SV=1 RBM15_MOUSE reviewed RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15) Mus musculus (Mouse) GO:0000122; GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674 branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412] nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g2638.t1 Q0VBL3 42.442 172 1.9099999999999997e-24 113.0 sp|Q0VBL3|RBM15_MOUSE RNA-binding protein 15 OS=Mus musculus OX=10090 GN=Rbm15 PE=1 SV=1 RBM15_MOUSE reviewed RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15) Mus musculus (Mouse) GO:0000122; GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674 branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412] nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g2641.t1 Q8IZD9 39.824 683 4.63e-155 509.0 sp|Q8IZD9|DOCK3_HUMAN Dedicator of cytokinesis protein 3 OS=Homo sapiens OX=9606 GN=DOCK3 PE=1 SV=1 DOCK3_HUMAN reviewed Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (PS binding protein) (PBP) (Presenilin-binding protein) Homo sapiens (Human) GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056 neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g2642.t1 Q8IZD9 40.022 907 0.0 658.0 sp|Q8IZD9|DOCK3_HUMAN Dedicator of cytokinesis protein 3 OS=Homo sapiens OX=9606 GN=DOCK3 PE=1 SV=1 DOCK3_HUMAN reviewed Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (PS binding protein) (PBP) (Presenilin-binding protein) Homo sapiens (Human) GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056 neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g2642.t2 Q8IZD9 39.22 923 0.0 651.0 sp|Q8IZD9|DOCK3_HUMAN Dedicator of cytokinesis protein 3 OS=Homo sapiens OX=9606 GN=DOCK3 PE=1 SV=1 DOCK3_HUMAN reviewed Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (PS binding protein) (PBP) (Presenilin-binding protein) Homo sapiens (Human) GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056 neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] g2643.t1 Q9NRM2 45.558 439 9.109999999999999e-126 375.0 sp|Q9NRM2|ZN277_HUMAN Zinc finger protein 277 OS=Homo sapiens OX=9606 GN=ZNF277 PE=1 SV=2 g2644.t1 Q6AZW1 68.919 74 1.81e-35 117.0 sp|Q6AZW1|KISHB_DANRE Protein kish-B OS=Danio rerio OX=7955 GN=tmem167b PE=3 SV=1 g2648.t1 Q96DM1 22.881 590 8.88e-27 119.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g2649.t1 Q96HN2 80.22 455 0.0 791.0 sp|Q96HN2|SAHH3_HUMAN Adenosylhomocysteinase 3 OS=Homo sapiens OX=9606 GN=AHCYL2 PE=1 SV=1 SAHH3_HUMAN reviewed Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.13.2.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2) Homo sapiens (Human) GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005 one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; neuron projection [GO:0043005] hydrolase activity [GO:0016787] g2650.t1 Q04073 55.858 478 3.34e-174 500.0 sp|Q04073|P3A2_STRPU DNA-binding protein P3A2 OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g2650.t2 Q04073 55.858 478 3.27e-174 500.0 sp|Q04073|P3A2_STRPU DNA-binding protein P3A2 OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g2657.t1 Q8NFZ0 37.712 883 2.98e-159 497.0 sp|Q8NFZ0|FBH1_HUMAN F-box DNA helicase 1 OS=Homo sapiens OX=9606 GN=FBH1 PE=1 SV=2 FBH1_HUMAN reviewed F-box DNA helicase 1 (hFBH1) (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18) Homo sapiens (Human) GO:0000724; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006281; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042 DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429] chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] g2660.t1 Q09324 43.048 374 1.74e-97 302.0 sp|Q09324|GCNT1_MOUSE Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=Gcnt1 PE=1 SV=2 GCNT1_MOUSE reviewed Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GlcNAcT) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Leukocyte type core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GnT-L) Mus musculus (Mouse) GO:0000139; GO:0000166; GO:0003829; GO:0005615; GO:0005802; GO:0009101; GO:0016266; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993; GO:1903238 cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729] extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; nucleotide binding [GO:0000166] g2661.t1 Q8IZF6 29.12 625 6.780000000000001e-73 271.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g2662.t1 Q9LJN4 33.889 720 1.2e-99 328.0 sp|Q9LJN4|BXL5_ARATH Probable beta-D-xylosidase 5 OS=Arabidopsis thaliana OX=3702 GN=BXL5 PE=2 SV=2 g2665.t1 Q8BGC3 27.632 380 1.92e-32 133.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2665.t2 Q8BGC3 27.632 380 2.2e-32 133.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2666.t1 Q8BGC3 25.984 381 8.889999999999999e-30 124.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g2667.t1 A8WIP6 81.25 336 0.0 576.0 sp|A8WIP6|CDK20_DANRE Cyclin-dependent kinase 20 OS=Danio rerio OX=7955 GN=cdk20 PE=2 SV=1 CDK20_DANRE reviewed Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0051301; GO:0060271; GO:0106310 cell division [GO:0051301]; cilium assembly [GO:0060271] cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2668.t1 Q58DA6 59.748 318 4.14e-121 359.0 sp|Q58DA6|S35A2_BOVIN UDP-galactose translocator OS=Bos taurus OX=9913 GN=SLC35A2 PE=2 SV=1 S35A2_BOVIN reviewed UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT) Bos taurus (Bovine) GO:0000139; GO:0005459; GO:0015297; GO:0072334 UDP-galactose transmembrane transport [GO:0072334] Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; UDP-galactose transmembrane transporter activity [GO:0005459] g2668.t2 Q58DA6 57.02 349 3.56e-122 360.0 sp|Q58DA6|S35A2_BOVIN UDP-galactose translocator OS=Bos taurus OX=9913 GN=SLC35A2 PE=2 SV=1 S35A2_BOVIN reviewed UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT) Bos taurus (Bovine) GO:0000139; GO:0005459; GO:0015297; GO:0072334 UDP-galactose transmembrane transport [GO:0072334] Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; UDP-galactose transmembrane transporter activity [GO:0005459] g2669.t1 Q5BJN5 66.667 108 2.08e-49 159.0 sp|Q5BJN5|MIA40_RAT Mitochondrial intermembrane space import and assembly protein 40 OS=Rattus norvegicus OX=10116 GN=Chchd4 PE=2 SV=1 MIA40_RAT reviewed Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4) Rattus norvegicus (Rat) GO:0005739; GO:0005758; GO:0015035; GO:0033108; GO:0034599; GO:0043504; GO:0045041; GO:0046825; GO:0051604; GO:0072655; GO:0160203; GO:1901857; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to oxidative stress [GO:0034599]; establishment of protein localization to mitochondrion [GO:0072655]; mitochondrial disulfide relay system [GO:0160203]; mitochondrial DNA repair [GO:0043504]; mitochondrial respiratory chain complex assembly [GO:0033108]; positive regulation of cellular respiration [GO:1901857]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; regulation of protein export from nucleus [GO:0046825] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] protein-disulfide reductase activity [GO:0015035] g2670.t1 Q9ESN5 34.483 232 3.48e-27 109.0 sp|Q9ESN5|CENPK_MOUSE Centromere protein K OS=Mus musculus OX=10090 GN=Cenpk PE=1 SV=2 g2672.t1 Q5E9T9 54.054 185 1.12e-54 181.0 sp|Q5E9T9|RTCB_BOVIN RNA-splicing ligase RtcB homolog OS=Bos taurus OX=9913 GN=RTCB PE=2 SV=1 RTCB_BOVIN reviewed RNA-splicing ligase RTCB (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase) (RNA 2',3'-cyclic phosphate and 5'-OH ligase) Bos taurus (Bovine) GO:0001701; GO:0001890; GO:0005525; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0006388; GO:0046872; GO:0072669; GO:0170057 in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (GTP) activity [GO:0170057] g2673.t1 Q561P3 84.691 307 0.0 553.0 sp|Q561P3|RTCB_XENTR RNA-splicing ligase RtcB homolog OS=Xenopus tropicalis OX=8364 GN=rtcb PE=2 SV=1 RTCB_XENTR reviewed RNA-splicing ligase RTCB (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase) (RNA 2',3'-cyclic phosphate and 5'-OH ligase) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005525; GO:0005634; GO:0005737; GO:0006388; GO:0046872; GO:0072669; GO:0170057 tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (GTP) activity [GO:0170057] g2674.t1 Q6DJI9 58.772 228 3.5399999999999997e-81 244.0 sp|Q6DJI9|ZCRB1_XENLA Zinc finger CCHC-type and RNA-binding motif-containing protein 1 OS=Xenopus laevis OX=8355 GN=zcrb1 PE=2 SV=1 g2675.t1 Q8BUH1 77.181 149 5.0399999999999996e-83 243.0 sp|Q8BUH1|TXN4B_MOUSE Thioredoxin-like protein 4B OS=Mus musculus OX=10090 GN=Txnl4b PE=2 SV=2 g2676.t1 Q7L0Y3 37.931 290 9.42e-62 209.0 sp|Q7L0Y3|TM10C_HUMAN tRNA methyltransferase 10 homolog C OS=Homo sapiens OX=9606 GN=TRMT10C PE=1 SV=2 TM10C_HUMAN reviewed tRNA methyltransferase 10 homolog C (HBV pre-S2 trans-regulated protein 2) (Mitochondrial ribonuclease P protein 1) (Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase) (EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase) (EC 2.1.1.221) Homo sapiens (Human) GO:0000049; GO:0000964; GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0030678; GO:0042645; GO:0042802; GO:0043527; GO:0052905; GO:0070131; GO:0070901; GO:0090646; GO:0097745; GO:0160106; GO:1990180 mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tRNA (adenine(9)-N1)-methyltransferase activity [GO:0160106]; tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049] g2678.t1 Q16635 51.908 262 6.81e-88 265.0 sp|Q16635|TAZ_HUMAN Tafazzin OS=Homo sapiens OX=9606 GN=TAFAZZIN PE=1 SV=2 g2679.t1 A2AS55 46.197 355 8.89e-97 295.0 sp|A2AS55|ANR16_MOUSE Ankyrin repeat domain-containing protein 16 OS=Mus musculus OX=10090 GN=Ankrd16 PE=1 SV=1 ANR16_MOUSE reviewed Ankyrin repeat domain-containing protein 16 Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0006400 tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] g2681.t1 Q2M389 65.732 1141 0.0 1595.0 sp|Q2M389|WASC4_HUMAN WASH complex subunit 4 OS=Homo sapiens OX=9606 GN=WASHC4 PE=1 SV=2 WASC4_HUMAN reviewed WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP) Homo sapiens (Human) GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0050890; GO:0050905; GO:0061635; GO:0071203; GO:0140591; GO:0140894 cognition [GO:0050890]; endolysosomal toll-like receptor signaling pathway [GO:0140894]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; neuromuscular process [GO:0050905]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein complex stability [GO:0061635] early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203] g2681.t2 Q2M389 65.732 1141 0.0 1594.0 sp|Q2M389|WASC4_HUMAN WASH complex subunit 4 OS=Homo sapiens OX=9606 GN=WASHC4 PE=1 SV=2 WASC4_HUMAN reviewed WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP) Homo sapiens (Human) GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0050890; GO:0050905; GO:0061635; GO:0071203; GO:0140591; GO:0140894 cognition [GO:0050890]; endolysosomal toll-like receptor signaling pathway [GO:0140894]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; neuromuscular process [GO:0050905]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein complex stability [GO:0061635] early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203] g2684.t1 A1X150 31.221 852 3.39e-106 370.0 sp|A1X150|MET_ECHTE Hepatocyte growth factor receptor OS=Echinops telfairi OX=9371 GN=MET PE=3 SV=1 MET_ECHTE reviewed Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) Echinops telfairi (Lesser hedgehog tenrec) GO:0002116; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0010468; GO:0017154; GO:0048468; GO:0048513; GO:0050918; GO:0071526; GO:2001028 animal organ development [GO:0048513]; cell development [GO:0048468]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; regulation of gene expression [GO:0010468]; semaphorin-plexin signaling pathway [GO:0071526] plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] ATP binding [GO:0005524]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g2685.t1 F7J220 38.732 142 2.5600000000000002e-26 114.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g2685.t1 F7J220 40.69 145 2.4399999999999997e-24 108.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g2685.t1 F7J220 38.298 141 1.0900000000000001e-21 100.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g2685.t1 F7J220 38.462 143 3.75e-21 99.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g2685.t1 F7J220 35.714 140 8.16e-21 97.8 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g2686.t1 Q5G267 42.13 216 2.8499999999999997e-46 173.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2686.t1 Q5G267 36.866 217 5.1e-44 167.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2686.t1 Q5G267 37.441 211 2.55e-41 159.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g2687.t1 Q6P2S7 35.705 801 2.91e-140 471.0 sp|Q6P2S7|TTC41_HUMAN Putative tetratricopeptide repeat protein 41 OS=Homo sapiens OX=9606 GN=TTC41P PE=5 SV=3 g2688.t1 Q66HD0 64.304 776 0.0 955.0 sp|Q66HD0|ENPL_RAT Endoplasmin OS=Rattus norvegicus OX=10116 GN=Hsp90b1 PE=1 SV=2 ENPL_RAT reviewed Endoplasmin (EC 3.6.4.-) (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) Rattus norvegicus (Rat) GO:0001666; GO:0003723; GO:0004864; GO:0005524; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005829; GO:0006457; GO:0016887; GO:0019903; GO:0030177; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0033018; GO:0034123; GO:0034663; GO:0036503; GO:0042470; GO:0043066; GO:0044183; GO:0048471; GO:0050750; GO:0051082; GO:0071287; GO:0071318; GO:0072659; GO:0097524; GO:0140662 actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; cellular response to manganese ion [GO:0071287]; ERAD pathway [GO:0036503]; negative regulation of apoptotic process [GO:0043066]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of Wnt signaling pathway [GO:0030177]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; sperm plasma membrane [GO:0097524] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; low-density lipoprotein particle receptor binding [GO:0050750]; protein folding chaperone [GO:0044183]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] g2689.t1 Q9UPQ7 43.799 379 2.58e-63 234.0 sp|Q9UPQ7|PZRN3_HUMAN E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens OX=9606 GN=PDZRN3 PE=1 SV=2 g2689.t1 Q9UPQ7 48.636 220 5.819999999999999e-48 188.0 sp|Q9UPQ7|PZRN3_HUMAN E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens OX=9606 GN=PDZRN3 PE=1 SV=2 g2691.t1 E7FDW2 51.792 307 8.879999999999999e-101 321.0 sp|E7FDW2|PZR3B_DANRE E3 ubiquitin-protein ligase PDZRN3-B OS=Danio rerio OX=7955 GN=pdzrn3b PE=1 SV=1 g2692.t1 Q9EPW2 52.809 178 2.13e-52 182.0 sp|Q9EPW2|KLF15_MOUSE Krueppel-like factor 15 OS=Mus musculus OX=10090 GN=Klf15 PE=1 SV=1 KLF15_MOUSE reviewed Krueppel-like factor 15 (Cardiovascular Krueppel-like factor) Mus musculus (Mouse) GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0010001; GO:0010468; GO:0014898; GO:0016607; GO:0030111; GO:0032868; GO:0032966; GO:0045893; GO:0045944; GO:0046326; GO:0071635; GO:0072112; GO:1990837; GO:1990859; GO:2000757 cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to endothelin [GO:1990859]; glial cell differentiation [GO:0010001]; intracellular glucose homeostasis [GO:0001678]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of transforming growth factor beta production [GO:0071635]; podocyte differentiation [GO:0072112]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; response to insulin [GO:0032868] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g2695.t1 Q4R8V8 45.359 571 1.8e-148 444.0 sp|Q4R8V8|CP100_MACFA Cilia- and flagella-associated protein 100 OS=Macaca fascicularis OX=9541 GN=CFAP100 PE=2 SV=2 CP100_MACFA reviewed Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003341; GO:0031514; GO:0036064; GO:0036159; GO:0070840; GO:0097545 cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159] axonemal doublet microtubule [GO:0097545]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] dynein complex binding [GO:0070840] g2695.t2 Q4R8V8 44.983 578 3.9199999999999996e-146 439.0 sp|Q4R8V8|CP100_MACFA Cilia- and flagella-associated protein 100 OS=Macaca fascicularis OX=9541 GN=CFAP100 PE=2 SV=2 CP100_MACFA reviewed Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003341; GO:0031514; GO:0036064; GO:0036159; GO:0070840; GO:0097545 cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159] axonemal doublet microtubule [GO:0097545]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] dynein complex binding [GO:0070840] g2697.t1 Q6ZUG5 38.462 429 2.7e-93 317.0 sp|Q6ZUG5|YC006_HUMAN Uncharacterized protein FLJ43738 OS=Homo sapiens OX=9606 PE=1 SV=1 g2698.t1 Q14831 48.655 855 0.0 859.0 sp|Q14831|GRM7_HUMAN Metabotropic glutamate receptor 7 OS=Homo sapiens OX=9606 GN=GRM7 PE=1 SV=1 g2700.t1 Q14832 53.912 818 0.0 918.0 sp|Q14832|GRM3_HUMAN Metabotropic glutamate receptor 3 OS=Homo sapiens OX=9606 GN=GRM3 PE=1 SV=2 GRM3_HUMAN reviewed Metabotropic glutamate receptor 3 (mGluR3) Homo sapiens (Human) GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0033554; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 cellular response to stress [GO:0033554]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g2702.t1 E9Q137 42.202 218 7.64e-50 168.0 sp|E9Q137|TX264_MOUSE Testis-expressed protein 264 homolog OS=Mus musculus OX=10090 GN=Tex264 PE=2 SV=1 g2703.t1 Q5PQN4 27.066 617 2.95e-33 140.0 sp|Q5PQN4|MDM1_RAT Nuclear protein MDM1 OS=Rattus norvegicus OX=10116 GN=Mdm1 PE=1 SV=2 MDM1_RAT reviewed Nuclear protein MDM1 Rattus norvegicus (Rat) GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0008017; GO:0034451; GO:0046600; GO:0060041; GO:0097730 negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634] microtubule binding [GO:0008017] g2704.t1 A2T806 41.455 275 3.47e-45 155.0 sp|A2T806|PQBP1_PONPY Polyglutamine-binding protein 1 OS=Pongo pygmaeus OX=9600 GN=PQBP1 PE=3 SV=1 PQBP1_PONPY reviewed Polyglutamine-binding protein 1 (PQBP-1) (Polyglutamine tract-binding protein 1) Pongo pygmaeus (Bornean orangutan) GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005737; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0045087; GO:0051607; GO:0071360; GO:0120025 activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; plasma membrane bounded cell projection [GO:0120025] double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021] g2705.t1 Q26619 72.776 371 0.0 563.0 sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2705.t2 Q26619 72.776 371 0.0 568.0 sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g2709.t1 Q96N23 34.02 2040 0.0 1102.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 CFA54_HUMAN reviewed Cilia- and flagella-associated protein 54 Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] g2709.t1 Q96N23 28.835 1408 2.34e-142 505.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 CFA54_HUMAN reviewed Cilia- and flagella-associated protein 54 Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] g2709.t2 Q96N23 34.003 2041 0.0 1103.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 CFA54_HUMAN reviewed Cilia- and flagella-associated protein 54 Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] g2709.t2 Q96N23 28.835 1408 2.49e-142 505.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 CFA54_HUMAN reviewed Cilia- and flagella-associated protein 54 Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] g2709.t3 Q96N23 33.429 2085 0.0 1085.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 CFA54_HUMAN reviewed Cilia- and flagella-associated protein 54 Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] g2709.t3 Q96N23 28.835 1408 1.68e-142 506.0 sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3 CFA54_HUMAN reviewed Cilia- and flagella-associated protein 54 Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] g2710.t1 Q5BIX7 35.529 501 6.210000000000001e-66 231.0 sp|Q5BIX7|SPDLA_XENLA Protein Spindly-A OS=Xenopus laevis OX=8355 GN=spdl1-a PE=2 SV=1 g2711.t1 P41969 73.913 92 2.6600000000000003e-43 161.0 sp|P41969|ELK1_MOUSE ETS domain-containing protein Elk-1 OS=Mus musculus OX=10090 GN=Elk1 PE=1 SV=3 ELK1_MOUSE reviewed ETS domain-containing protein Elk-1 Mus musculus (Mouse) GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0009416; GO:0010467; GO:0030154; GO:0030324; GO:0030425; GO:0031966; GO:0036033; GO:0043025; GO:0043679; GO:0045471; GO:0045893; GO:0045944; GO:0061629; GO:0071394; GO:0071396; GO:0071480; GO:0071774; GO:0110088; GO:0140416; GO:0140537; GO:1990837 cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to lipid [GO:0071396]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; hippocampal neuron apoptotic process [GO:0110088]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416] axon terminus [GO:0043679]; dendrite [GO:0030425]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; mediator complex binding [GO:0036033]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator activator activity [GO:0140537]; transcription regulator inhibitor activity [GO:0140416] g2712.t1 Q1L8I0 34.453 685 9.72e-117 370.0 sp|Q1L8I0|PUS7L_DANRE Pseudouridylate synthase PUS7L OS=Danio rerio OX=7955 GN=pus7l PE=2 SV=1 g2713.t1 Q6IQ86 80.282 71 2.7700000000000003e-37 122.0 sp|Q6IQ86|BRK1_DANRE Probable protein BRICK1 OS=Danio rerio OX=7955 GN=brk1 PE=3 SV=1 g2714.t1 Q7Z3Z2 34.921 189 1.82e-21 90.5 sp|Q7Z3Z2|RD3_HUMAN Protein RD3 OS=Homo sapiens OX=9606 GN=RD3 PE=1 SV=1 RD3_HUMAN reviewed Protein RD3 (Retinal degeneration protein 3) Homo sapiens (Human) GO:0001750; GO:0001917; GO:0005634; GO:0005737; GO:0005768; GO:0007601; GO:0015031; GO:0031283; GO:0048471; GO:0060041; GO:0120199; GO:0120200 negative regulation of guanylate cyclase activity [GO:0031283]; protein transport [GO:0015031]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; rod photoreceptor outer segment [GO:0120200] g2715.t1 Q5EAW4 38.636 704 1.3800000000000002e-132 425.0 sp|Q5EAW4|MCM10_XENLA Protein MCM10 homolog OS=Xenopus laevis OX=8355 GN=mcm10 PE=1 SV=2 MCM10_XENLA reviewed Protein MCM10 homolog Xenopus laevis (African clawed frog) GO:0003688; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0008270; GO:0043596 DNA damage response [GO:0006974]; DNA replication initiation [GO:0006270] nuclear replication fork [GO:0043596]; nucleus [GO:0005634] DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g2716.t1 Q9HAU5 52.659 959 0.0 1042.0 sp|Q9HAU5|RENT2_HUMAN Regulator of nonsense transcripts 2 OS=Homo sapiens OX=9606 GN=UPF2 PE=1 SV=1 g2717.t1 Q2YDU3 51.196 418 3.96e-129 392.0 sp|Q2YDU3|OTUD5_RAT OTU domain-containing protein 5 OS=Rattus norvegicus OX=10116 GN=Otud5 PE=1 SV=2 OTUD5_RAT reviewed OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA) Rattus norvegicus (Rat) GO:0004843; GO:0005634; GO:0014033; GO:0016579; GO:0031647; GO:0032496; GO:0032700; GO:0043161; GO:0043374; GO:0050776; GO:0061578; GO:0070536; GO:0071108; GO:0072540; GO:0090090; GO:0101005; GO:1904263; GO:1904515; GO:1990380; GO:2000316 CD8-positive, alpha-beta T cell differentiation [GO:0043374]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of interleukin-17 production [GO:0032700]; neural crest cell differentiation [GO:0014033]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of immune response [GO:0050776]; regulation of protein stability [GO:0031647]; regulation of T-helper 17 type immune response [GO:2000316]; response to lipopolysaccharide [GO:0032496]; T-helper 17 cell lineage commitment [GO:0072540] nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578] g2718.t1 Q8WWQ8 35.058 2513 0.0 1481.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g2718.t1 Q8WWQ8 30.035 566 4.83e-44 181.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g2718.t2 Q8WWQ8 35.058 2513 0.0 1482.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g2718.t2 Q8WWQ8 30.035 566 4.21e-44 181.0 sp|Q8WWQ8|STAB2_HUMAN Stabilin-2 OS=Homo sapiens OX=9606 GN=STAB2 PE=1 SV=3 STAB2_HUMAN reviewed Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Homo sapiens (Human) GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] g2719.t1 Q803T2 61.207 812 0.0 974.0 sp|Q803T2|STRP1_DANRE Striatin-interacting protein 1 homolog OS=Danio rerio OX=7955 GN=strip1 PE=1 SV=1 g2719.t2 Q803T2 61.501 813 0.0 980.0 sp|Q803T2|STRP1_DANRE Striatin-interacting protein 1 homolog OS=Danio rerio OX=7955 GN=strip1 PE=1 SV=1 g2720.t1 P09623 72.407 511 0.0 764.0 sp|P09623|DLDH_PIG Dihydrolipoyl dehydrogenase, mitochondrial OS=Sus scrofa OX=9823 GN=DLD PE=1 SV=1 g2721.t1 G5ECP4 38.141 312 8.25e-50 187.0 sp|G5ECP4|PIK1_CAEEL Pelle-like serine/threonine-protein kinase pik-1 OS=Caenorhabditis elegans OX=6239 GN=pik-1 PE=1 SV=1 PIK1_CAEEL reviewed Pelle-like serine/threonine-protein kinase pik-1 (EC 2.7.11.1) Caenorhabditis elegans GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0008063; GO:0019221; GO:0031663; GO:0035556; GO:0045087; GO:0106310 cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; Toll signaling pathway [GO:0008063] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2722.t1 B9FAF3 41.419 437 9.85e-97 319.0 sp|B9FAF3|KN14E_ORYSJ Kinesin-like protein KIN-14E OS=Oryza sativa subsp. japonica OX=39947 GN=KIN14E PE=2 SV=1 KN14E_ORYSJ reviewed Kinesin-like protein KIN-14E Oryza sativa subsp. japonica (Rice) GO:0003777; GO:0005524; GO:0005874; GO:0007017; GO:0007018; GO:0008017; GO:0015630 microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017] microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g2724.t1 P19182 47.215 413 2.98e-125 373.0 sp|P19182|IFRD1_MOUSE Interferon-related developmental regulator 1 OS=Mus musculus OX=10090 GN=Ifrd1 PE=1 SV=2 IFRD1_MOUSE reviewed Interferon-related developmental regulator 1 (Nerve growth factor-inducible protein PC4) (TPA-induced sequence 7) (TIS7 protein) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0006357; GO:0014706; GO:0016055; GO:0030517; GO:0042692; GO:0043403; GO:0045444; GO:0045944; GO:0048671; GO:0060612; GO:0061629 adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; muscle cell differentiation [GO:0042692]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; nucleus [GO:0005634] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g2725.t1 Q8IXL7 57.447 141 1.1e-57 181.0 sp|Q8IXL7|MSRB3_HUMAN Methionine-R-sulfoxide reductase B3 OS=Homo sapiens OX=9606 GN=MSRB3 PE=1 SV=2 MSRB3_HUMAN reviewed Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745 protein repair [GO:0030091]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270] g2725.t2 Q8IXL7 60.305 131 3.7e-56 178.0 sp|Q8IXL7|MSRB3_HUMAN Methionine-R-sulfoxide reductase B3 OS=Homo sapiens OX=9606 GN=MSRB3 PE=1 SV=2 MSRB3_HUMAN reviewed Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745 protein repair [GO:0030091]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270] g2726.t1 Q9Y4B6 43.365 731 0.0 598.0 sp|Q9Y4B6|DCAF1_HUMAN DDB1- and CUL4-associated factor 1 OS=Homo sapiens OX=9606 GN=DCAF1 PE=1 SV=3 DCAF1_HUMAN reviewed DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein) Homo sapiens (Human) GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043161; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756 B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2727.t1 Q9Y4B6 53.534 764 0.0 800.0 sp|Q9Y4B6|DCAF1_HUMAN DDB1- and CUL4-associated factor 1 OS=Homo sapiens OX=9606 GN=DCAF1 PE=1 SV=3 DCAF1_HUMAN reviewed DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein) Homo sapiens (Human) GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043161; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756 B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2728.t1 A0JPI9 31.921 354 2.37e-45 171.0 sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1 g2729.t1 P30975 26.144 306 5.1e-22 101.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g2732.t1 O88854 27.011 348 7.270000000000001e-21 95.9 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g2735.t1 Q2T9Z7 37.805 164 2.43e-25 115.0 sp|Q2T9Z7|KLHL9_BOVIN Kelch-like protein 9 OS=Bos taurus OX=9913 GN=KLHL9 PE=2 SV=1 KLHL9_BOVIN reviewed Kelch-like protein 9 Bos taurus (Bovine) GO:0005829; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301; GO:0097602 cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; midbody [GO:0030496] cullin family protein binding [GO:0097602] g2737.t1 Q14CN2 28.405 859 4.17e-106 360.0 sp|Q14CN2|CLCA4_HUMAN Calcium-activated chloride channel regulator 4 OS=Homo sapiens OX=9606 GN=CLCA4 PE=1 SV=2 CLCA4_HUMAN reviewed Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form] Homo sapiens (Human) GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0006508; GO:0016324; GO:0034220; GO:0046872 monoatomic ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g2740.t1 Q08CY9 47.07 512 6.740000000000001e-157 462.0 sp|Q08CY9|EOGT_XENTR EGF domain-specific O-linked N-acetylglucosamine transferase OS=Xenopus tropicalis OX=8364 GN=eogt PE=2 SV=1 g2741.t1 Q26622 62.04 598 0.0 677.0 sp|Q26622|SHR2_STRPU Orphan steroid hormone receptor 2 OS=Strongylocentrotus purpuratus OX=7668 GN=SHR2 PE=1 SV=1 SHR2_STRPU reviewed Orphan steroid hormone receptor 2 (SpSHR2) Strongylocentrotus purpuratus (Purple sea urchin) GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2741.t2 Q26622 60.884 611 0.0 674.0 sp|Q26622|SHR2_STRPU Orphan steroid hormone receptor 2 OS=Strongylocentrotus purpuratus OX=7668 GN=SHR2 PE=1 SV=1 SHR2_STRPU reviewed Orphan steroid hormone receptor 2 (SpSHR2) Strongylocentrotus purpuratus (Purple sea urchin) GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2741.t3 Q26622 62.207 598 0.0 683.0 sp|Q26622|SHR2_STRPU Orphan steroid hormone receptor 2 OS=Strongylocentrotus purpuratus OX=7668 GN=SHR2 PE=1 SV=1 SHR2_STRPU reviewed Orphan steroid hormone receptor 2 (SpSHR2) Strongylocentrotus purpuratus (Purple sea urchin) GO:0000978; GO:0003677; GO:0004879; GO:0005634; GO:0005652; GO:0005737; GO:0006357; GO:0008270; GO:0030154; GO:0045177; GO:0048471 cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] DNA binding [GO:0003677]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g2742.t1 Q9Y5R4 44.884 303 8.870000000000001e-73 231.0 sp|Q9Y5R4|HEMK1_HUMAN MTRF1L release factor glutamine methyltransferase OS=Homo sapiens OX=9606 GN=HEMK1 PE=1 SV=1 g2744.t1 Q6NRK9 50.813 246 2.9e-90 269.0 sp|Q6NRK9|CCNQ_XENLA Cyclin-Q OS=Xenopus laevis OX=8355 GN=ccnq PE=2 SV=2 g2745.t1 Q96I25 64.706 102 1.5200000000000002e-37 146.0 sp|Q96I25|SPF45_HUMAN Splicing factor 45 OS=Homo sapiens OX=9606 GN=RBM17 PE=1 SV=1 SPF45_HUMAN reviewed Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17) Homo sapiens (Human) GO:0000380; GO:0003723; GO:0005654; GO:0005681; GO:0045292 alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA cis splicing, via spliceosome [GO:0045292] nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] RNA binding [GO:0003723] g2746.t1 Q9D8P7 47.475 99 1.5299999999999999e-24 97.1 sp|Q9D8P7|TF3C6_MOUSE General transcription factor 3C polypeptide 6 OS=Mus musculus OX=10090 GN=Gtf3c6 PE=2 SV=1 g2747.t1 P51650 60.425 518 0.0 625.0 sp|P51650|SSDH_RAT Succinate-semialdehyde dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh5a1 PE=1 SV=2 SSDH_RAT reviewed Succinate-semialdehyde dehydrogenase, mitochondrial (SSADH) (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase) Rattus norvegicus (Rat) GO:0004777; GO:0005739; GO:0006105; GO:0006536; GO:0007417; GO:0009448; GO:0009450; GO:0009791; GO:0031406; GO:0042802; GO:0045202; GO:0051287; GO:0051932 central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932] mitochondrion [GO:0005739]; synapse [GO:0045202] carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777] g2749.t1 Q8WZA1 27.542 541 2.47e-53 200.0 sp|Q8WZA1|PMGT1_HUMAN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=POMGNT1 PE=1 SV=2 PMGT1_HUMAN reviewed Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2) Homo sapiens (Human) GO:0000139; GO:0006493; GO:0007605; GO:0008375; GO:0010467; GO:0016020; GO:0016266; GO:0021542; GO:0030145; GO:0030246; GO:0035269; GO:0042552; GO:0047223; GO:0051674; GO:0071711; GO:0150103 basement membrane organization [GO:0071711]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; localization of cell [GO:0051674]; myelination [GO:0042552]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; reactive gliosis [GO:0150103]; sensory perception of sound [GO:0007605] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145] g2749.t2 Q8WZA1 27.523 545 2.41e-53 200.0 sp|Q8WZA1|PMGT1_HUMAN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=POMGNT1 PE=1 SV=2 PMGT1_HUMAN reviewed Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2) Homo sapiens (Human) GO:0000139; GO:0006493; GO:0007605; GO:0008375; GO:0010467; GO:0016020; GO:0016266; GO:0021542; GO:0030145; GO:0030246; GO:0035269; GO:0042552; GO:0047223; GO:0051674; GO:0071711; GO:0150103 basement membrane organization [GO:0071711]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; localization of cell [GO:0051674]; myelination [GO:0042552]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; reactive gliosis [GO:0150103]; sensory perception of sound [GO:0007605] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145] g2752.t1 O97725 52.206 136 2.2199999999999998e-42 140.0 sp|O97725|NDUAC_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Bos taurus OX=9913 GN=NDUFA12 PE=1 SV=1 g2753.t1 A2CI35 60.0 945 0.0 1125.0 sp|A2CI35|DUSTY_STRPU Dual serine/threonine and tyrosine protein kinase OS=Strongylocentrotus purpuratus OX=7668 GN=DSTYK PE=2 SV=1 g2754.t1 Q7ZW46 61.31 336 9.440000000000001e-144 412.0 sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1 g2755.t1 Q00537 63.707 518 0.0 630.0 sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2 CDK17_HUMAN reviewed Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2) Homo sapiens (Human) GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987 protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] g2755.t2 Q00537 63.81 525 0.0 639.0 sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2 CDK17_HUMAN reviewed Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2) Homo sapiens (Human) GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987 protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] g2756.t1 Q5R7J6 84.0 150 2.9399999999999996e-94 272.0 sp|Q5R7J6|UBE2N_PONAB Ubiquitin-conjugating enzyme E2 N OS=Pongo abelii OX=9601 GN=UBE2N PE=2 SV=1 UBE2N_PONAB reviewed Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000151; GO:0004842; GO:0005524; GO:0006281; GO:0031372; GO:0061631; GO:0070534 DNA repair [GO:0006281]; protein K63-linked ubiquitination [GO:0070534] UBC13-MMS2 complex [GO:0031372]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g2757.t1 O00429 69.282 752 0.0 1029.0 sp|O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens OX=9606 GN=DNM1L PE=1 SV=2 DNM1L_HUMAN reviewed Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1) Homo sapiens (Human) GO:0000266; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0160040; GO:1900063; GO:1901524; GO:1903578 calcium ion transport [GO:0006816]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion organization [GO:0007005]; mitocytosis [GO:0160040]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; regulation of peroxisome organization [GO:1900063]; rhythmic process [GO:0048511] brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672] GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] g2758.t1 Q63505 28.571 742 4.08e-79 296.0 sp|Q63505|TF3C1_RAT General transcription factor 3C polypeptide 1 OS=Rattus norvegicus OX=10116 GN=Gtf3c1 PE=1 SV=1 g2758.t1 Q63505 32.0 450 3.36e-39 165.0 sp|Q63505|TF3C1_RAT General transcription factor 3C polypeptide 1 OS=Rattus norvegicus OX=10116 GN=Gtf3c1 PE=1 SV=1 g2759.t1 O18373 57.754 374 1.14e-160 459.0 sp|O18373|SPS1_DROME Inactive selenide, water dikinase-like protein OS=Drosophila melanogaster OX=7227 GN=Sps1 PE=2 SV=1 g2760.t1 O18373 65.823 316 1.6199999999999999e-159 455.0 sp|O18373|SPS1_DROME Inactive selenide, water dikinase-like protein OS=Drosophila melanogaster OX=7227 GN=Sps1 PE=2 SV=1 g2761.t1 Q12893 48.348 333 4.24e-106 318.0 sp|Q12893|TM115_HUMAN Transmembrane protein 115 OS=Homo sapiens OX=9606 GN=TMEM115 PE=1 SV=1 TM115_HUMAN reviewed Transmembrane protein 115 (Placental protein 6) (Protein PL6) Homo sapiens (Human) GO:0000139; GO:0005634; GO:0005794; GO:0006890; GO:0008285; GO:0015031; GO:0032580; GO:0042802 negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] identical protein binding [GO:0042802] g2764.t1 Q8VXZ0 40.304 263 1.0499999999999999e-55 187.0 sp|Q8VXZ0|NUD20_ARATH Nudix hydrolase 20, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=NUDT20 PE=2 SV=1 g2765.t1 P62257 83.607 183 1.89e-105 303.0 sp|P62257|UBE2H_MOUSE Ubiquitin-conjugating enzyme E2 H OS=Mus musculus OX=10090 GN=Ube2h PE=1 SV=1 UBE2H_MOUSE reviewed Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Mus musculus (Mouse) GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g2766.t1 Q5M8S7 35.023 217 1.34e-29 121.0 sp|Q5M8S7|ZC3C1_XENTR Zinc finger C3HC-type protein 1-like OS=Xenopus tropicalis OX=8364 GN=zc3hc1 PE=2 SV=1 g2768.t1 Q5U580 43.75 96 3.9200000000000006e-21 90.9 sp|Q5U580|KLD10_XENLA Kelch domain-containing protein 10 OS=Xenopus laevis OX=8355 GN=klhdc10 PE=2 SV=1 g2769.t1 Q5U3Y0 43.011 186 1.4599999999999998e-48 166.0 sp|Q5U3Y0|KLD10_RAT Kelch domain-containing protein 10 OS=Rattus norvegicus OX=10116 GN=Klhdc10 PE=2 SV=1 g2770.t1 Q5U3Y0 35.733 389 5.2e-81 257.0 sp|Q5U3Y0|KLD10_RAT Kelch domain-containing protein 10 OS=Rattus norvegicus OX=10116 GN=Klhdc10 PE=2 SV=1 g2771.t1 Q28DE7 48.257 373 6.509999999999999e-126 373.0 sp|Q28DE7|KLD10_XENTR Kelch domain-containing protein 10 OS=Xenopus tropicalis OX=8364 GN=klhdc10 PE=2 SV=2 g2772.t1 Q70EX6 26.667 345 2.87e-22 100.0 sp|Q70EX6|SOAT_RAT Sodium-dependent organic anion transporter OS=Rattus norvegicus OX=10116 GN=Slc10a6 PE=1 SV=1 SOAT_RAT reviewed Sodium-dependent organic anion transporter (Soat) (Solute carrier family 10 member 6) (SLC10A6) Rattus norvegicus (Rat) GO:0008508; GO:0015721; GO:0016020; GO:0043250; GO:0043251 bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251] membrane [GO:0016020] bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250] g2773.t1 Q9JIH7 47.455 786 0.0 632.0 sp|Q9JIH7|WNK1_RAT Serine/threonine-protein kinase WNK1 OS=Rattus norvegicus OX=10116 GN=Wnk1 PE=1 SV=2 WNK1_RAT reviewed Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) Rattus norvegicus (Rat) GO:0000287; GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0006884; GO:0007165; GO:0007507; GO:0008217; GO:0010507; GO:0010766; GO:0010793; GO:0010820; GO:0016020; GO:0019870; GO:0019901; GO:0019902; GO:0030291; GO:0030295; GO:0030644; GO:0031397; GO:0032991; GO:0033633; GO:0034115; GO:0035556; GO:0035725; GO:0038116; GO:0043232; GO:0045050; GO:0045766; GO:0050801; GO:0050804; GO:0050852; GO:0051058; GO:0055075; GO:0055080; GO:0071277; GO:0071474; GO:0071805; GO:0072686; GO:0090188; GO:0090263; GO:0097022; GO:0098982; GO:0106310; GO:0140693; GO:0140694; GO:1902305; GO:1903038; GO:1903077; GO:1903288; GO:1903490; GO:1904062; GO:1904595; GO:1990869 cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; heart development [GO:0007507]; intracellular chloride ion homeostasis [GO:0030644]; intracellular signal transduction [GO:0035556]; lymphocyte migration into lymph node [GO:0097022]; membraneless organelle assembly [GO:0140694]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic cation homeostasis [GO:0055080]; monoatomic ion homeostasis [GO:0050801]; monoatomic ion transport [GO:0006811]; negative regulation of autophagy [GO:0010507]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of termination of RNA polymerase II transcription [GO:1904595]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of mRNA export from nucleus [GO:0010793]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; T cell receptor signaling pathway [GO:0050852] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; intracellular membraneless organelle [GO:0043232]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; molecular condensate scaffold activity [GO:0140693]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291] g2774.t1 O70131 50.909 110 5.470000000000001e-29 110.0 sp|O70131|NINJ1_MOUSE Ninjurin-1 OS=Mus musculus OX=10090 GN=Ninj1 PE=1 SV=1 g2775.t1 Q925T6 45.032 1097 0.0 819.0 sp|Q925T6|GRIP1_MOUSE Glutamate receptor-interacting protein 1 OS=Mus musculus OX=10090 GN=Grip1 PE=1 SV=1 g2777.t1 Q6GNL7 67.77 906 0.0 1313.0 sp|Q6GNL7|AL1L1_XENLA Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Xenopus laevis OX=8355 GN=aldh1l1 PE=2 SV=1 AL1L1_XENLA reviewed Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1) Xenopus laevis (African clawed frog) GO:0004029; GO:0005829; GO:0006730; GO:0006740; GO:0009258; GO:0016155 10-formyltetrahydrofolate catabolic process [GO:0009258]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730] cytosol [GO:0005829] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155] g2778.t1 Q08BB2 48.423 444 8.8e-152 446.0 sp|Q08BB2|P2012_DANRE N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 OS=Danio rerio OX=7955 GN=pm20d1.2 PE=2 SV=1 P2012_DANRE reviewed N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 (EC 3.5.1.114) (EC 3.5.1.14) (Peptidase M20 domain-containing protein 1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004046; GO:0004181; GO:0005615; GO:0006508; GO:0006520; GO:0006629; GO:0006631; GO:0016811; GO:0016829; GO:0022904; GO:0043604; GO:0043605; GO:0046872; GO:0097009; GO:1990845 adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; amide catabolic process [GO:0043605]; amino acid metabolic process [GO:0006520]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; respiratory electron transport chain [GO:0022904] extracellular space [GO:0005615] aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181] g2779.t2 Q55E58 27.033 418 1.5500000000000002e-26 121.0 sp|Q55E58|PATS1_DICDI Probable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1 PATS1_DICDI reviewed Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1) Dictyostelium discoideum (Social amoeba) GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310 cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856] actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2781.t1 Q5BIZ0 34.511 481 3.2399999999999997e-81 267.0 sp|Q5BIZ0|MFD4A_XENTR Major facilitator superfamily domain-containing protein 4A OS=Xenopus tropicalis OX=8364 GN=mfsd4a PE=2 SV=1 g2782.t1 Q3ZC71 48.352 91 5.92e-30 105.0 sp|Q3ZC71|DPM3_BOVIN Dolichol-phosphate mannosyltransferase subunit 3 OS=Bos taurus OX=9913 GN=DPM3 PE=3 SV=1 g2783.t1 Q3SZ71 78.492 451 0.0 761.0 sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1 g2786.t1 Q63481 50.244 205 3.6499999999999996e-67 207.0 sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1 RAB7L_RAT reviewed Ras-related protein Rab-29 (EC 3.6.5.2) (Rab-7-like protein 1) (Ras-related protein Rab-7L1) Rattus norvegicus (Rat) GO:0000139; GO:0001921; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0031982; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0060271; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1903441; GO:1905279; GO:1990748 cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; host-mediated perturbation of viral process [GO:0044788]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; vesicle [GO:0031982] dynein complex binding [GO:0070840]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] g2787.t1 A8WGF4 74.264 1189 0.0 1934.0 sp|A8WGF4|IF122_XENTR Intraflagellar transport protein 122 homolog OS=Xenopus tropicalis OX=8364 GN=ift122 PE=2 SV=1 g2788.t1 Q640R7 83.158 190 8.79e-111 317.0 sp|Q640R7|RAP1B_XENTR Ras-related protein Rap-1b OS=Xenopus tropicalis OX=8364 GN=rap1b PE=2 SV=1 g2789.t1 F1MNN4 37.472 443 2.89e-86 292.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g2793.t1 Q7Z2Q7 29.605 304 2.94e-28 124.0 sp|Q7Z2Q7|LRR70_HUMAN Leucine-rich repeat-containing protein 70 OS=Homo sapiens OX=9606 GN=LRRC70 PE=1 SV=1 g2800.t1 Q5R9S8 43.2 250 3.95e-69 221.0 sp|Q5R9S8|TMM43_PONAB Transmembrane protein 43 OS=Pongo abelii OX=9601 GN=TMEM43 PE=2 SV=1 g2802.t1 Q5XIP9 47.656 128 8.120000000000001e-35 131.0 sp|Q5XIP9|TMM43_RAT Transmembrane protein 43 OS=Rattus norvegicus OX=10116 GN=Tmem43 PE=2 SV=1 TMM43_RAT reviewed Transmembrane protein 43 (Protein LUMA) Rattus norvegicus (Rat) GO:0005637; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006629; GO:0006813; GO:0007613; GO:0010650; GO:0042802; GO:0045087; GO:0071763 innate immune response [GO:0045087]; lipid metabolic process [GO:0006629]; memory [GO:0007613]; nuclear membrane organization [GO:0071763]; positive regulation of cell communication by electrical coupling [GO:0010650]; potassium ion transport [GO:0006813] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886] identical protein binding [GO:0042802] g2804.t1 Q13569 63.208 212 4.67e-86 278.0 sp|Q13569|TDG_HUMAN G/T mismatch-specific thymine DNA glycosylase OS=Homo sapiens OX=9606 GN=TDG PE=1 SV=2 TDG_HUMAN reviewed G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG) Homo sapiens (Human) GO:0000122; GO:0000287; GO:0003676; GO:0003677; GO:0003684; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032183; GO:0040029; GO:0043739; GO:0045008; GO:0045995; GO:0140297; GO:0141016; GO:0141167 base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; depyrimidination [GO:0045008]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of embryonic development [GO:0045995] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605] ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; G/T mismatch-specific thymine-DNA glycosylase activity [GO:0141016]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; uracil DNA N-glycosylase activity [GO:0004844] g2805.t1 Q86U86 44.875 1522 0.0 1235.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2805.t1 Q86U86 52.83 106 1.6600000000000002e-26 123.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2805.t2 Q86U86 44.807 1531 0.0 1231.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2805.t2 Q86U86 52.83 106 1.64e-26 123.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2805.t3 Q86U86 44.884 1515 0.0 1230.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2805.t3 Q86U86 52.83 106 1.54e-26 123.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2805.t4 Q86U86 44.875 1522 0.0 1235.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2805.t4 Q86U86 38.462 260 2.79e-30 135.0 sp|Q86U86|PB1_HUMAN Protein polybromo-1 OS=Homo sapiens OX=9606 GN=PBRM1 PE=1 SV=1 PB1_HUMAN reviewed Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D) Homo sapiens (Human) GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g2806.t1 Q21086 49.028 463 4.39e-139 420.0 sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1 GNL3_CAEEL reviewed Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1) Caenorhabditis elegans GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127 germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g2811.t1 Q62845 33.021 960 4.02e-152 478.0 sp|Q62845|CNTN4_RAT Contactin-4 OS=Rattus norvegicus OX=10116 GN=Cntn4 PE=1 SV=1 CNTN4_RAT reviewed Contactin-4 (Brain-derived immunoglobulin superfamily protein 2) (BIG-2) Rattus norvegicus (Rat) GO:0005576; GO:0005886; GO:0007156; GO:0007399; GO:0007411; GO:0007420; GO:0030424; GO:0031175; GO:0045202; GO:0045665; GO:0050808; GO:0070593; GO:0098552; GO:0098632 axon guidance [GO:0007411]; brain development [GO:0007420]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; synapse organization [GO:0050808] axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; synapse [GO:0045202] cell-cell adhesion mediator activity [GO:0098632] g2811.t2 Q69Z26 31.967 976 9.04e-149 469.0 sp|Q69Z26|CNTN4_MOUSE Contactin-4 OS=Mus musculus OX=10090 GN=Cntn4 PE=1 SV=2 CNTN4_MOUSE reviewed Contactin-4 (Brain-derived immunoglobulin superfamily protein 2) (BIG-2) Mus musculus (Mouse) GO:0005576; GO:0005886; GO:0007155; GO:0007399; GO:0007420; GO:0031175; GO:0043005; GO:0045665; GO:0098552 brain development [GO:0007420]; cell adhesion [GO:0007155]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron projection development [GO:0031175] extracellular region [GO:0005576]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] g2812.t1 P41564 67.368 190 1.86e-83 256.0 sp|P41564|IDH3G_MACFA Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Fragment) OS=Macaca fascicularis OX=9541 GN=IDH3G PE=2 SV=1 g2813.t1 P41564 62.406 133 1.81e-53 174.0 sp|P41564|IDH3G_MACFA Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Fragment) OS=Macaca fascicularis OX=9541 GN=IDH3G PE=2 SV=1 g2814.t1 Q5FYB0 52.795 161 3.5199999999999996e-52 179.0 sp|Q5FYB0|ARSJ_HUMAN Arylsulfatase J OS=Homo sapiens OX=9606 GN=ARSJ PE=1 SV=1 ARSJ_HUMAN reviewed Arylsulfatase J (ASJ) (EC 3.1.6.-) Homo sapiens (Human) GO:0004065; GO:0005576; GO:0005788; GO:0008484; GO:0015629; GO:0046872 actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484] g2815.t1 Q32KJ8 42.403 283 7.9e-61 204.0 sp|Q32KJ8|ARSI_RAT Arylsulfatase I OS=Rattus norvegicus OX=10116 GN=Arsi PE=2 SV=1 g2817.t1 Q99LW6 58.621 116 1.8500000000000001e-31 125.0 sp|Q99LW6|YAF2_MOUSE YY1-associated factor 2 OS=Mus musculus OX=10090 GN=Yaf2 PE=1 SV=1 g2818.t1 Q8R3A2 55.446 101 1.6499999999999999e-38 128.0 sp|Q8R3A2|CDPF1_MOUSE Cysteine-rich DPF motif domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cdpf1 PE=3 SV=2 g2819.t1 Q55EX9 31.004 229 1.86e-28 112.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g2821.t1 Q5U374 58.453 556 0.0 700.0 sp|Q5U374|KLH12_DANRE Kelch-like protein 12 OS=Danio rerio OX=7955 GN=klhl12 PE=2 SV=2 KLH12_DANRE reviewed Kelch-like protein 12 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0006513; GO:0006888; GO:0009952; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0043161; GO:0048208; GO:0060028; GO:1990756 anterior/posterior pattern specification [GO:0009952]; convergent extension involved in axis elongation [GO:0060028]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055] COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g2823.t1 Q924Y0 35.31 371 1.07e-76 248.0 sp|Q924Y0|BODG_MOUSE Gamma-butyrobetaine dioxygenase OS=Mus musculus OX=10090 GN=Bbox1 PE=1 SV=1 g2825.t1 Q5R5D8 37.566 189 3.34e-42 148.0 sp|Q5R5D8|BODG_PONAB Gamma-butyrobetaine dioxygenase OS=Pongo abelii OX=9601 GN=BBOX1 PE=2 SV=1 BODG_PONAB reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329 carnitine biosynthetic process [GO:0045329] mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g2831.t1 Q9NSC7 29.208 404 1.23e-39 154.0 sp|Q9NSC7|SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 OS=Homo sapiens OX=9606 GN=ST6GALNAC1 PE=1 SV=1 SIA7A_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAc-I) (ST6GalNAcI) (hST6GalNAc-I) (Sialyltransferase 7A) (SIAT7-A) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0008373; GO:0009101; GO:0009312; GO:0048874 glycoprotein biosynthetic process [GO:0009101]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; oligosaccharide biosynthetic process [GO:0009312] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g2833.t1 Q9NQE7 34.221 488 2.21e-94 300.0 sp|Q9NQE7|TSSP_HUMAN Thymus-specific serine protease OS=Homo sapiens OX=9606 GN=PRSS16 PE=1 SV=2 g2834.t1 Q9CX98 36.289 485 3.05e-94 297.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g2835.t1 O15992 41.444 374 9.440000000000001e-79 260.0 sp|O15992|KARG_ANTJA Arginine kinase OS=Anthopleura japonica OX=67755 PE=1 SV=1 g2835.t1 O15992 40.921 369 1.04e-78 260.0 sp|O15992|KARG_ANTJA Arginine kinase OS=Anthopleura japonica OX=67755 PE=1 SV=1 g2838.t1 Q8IPH9 35.574 357 1.5700000000000001e-56 199.0 sp|Q8IPH9|SLOB_DROME Slowpoke-binding protein OS=Drosophila melanogaster OX=7227 GN=Slob PE=1 SV=2 SLOB_DROME reviewed Slowpoke-binding protein Drosophila melanogaster (Fruit fly) GO:0004672; GO:0005737; GO:0007274; GO:0042391; GO:0042594; GO:0045202; GO:0050804 modulation of chemical synaptic transmission [GO:0050804]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; synapse [GO:0045202] protein kinase activity [GO:0004672] g2840.t1 Q13825 61.29 279 2.67e-112 331.0 sp|Q13825|AUHM_HUMAN Methylglutaconyl-CoA hydratase, mitochondrial OS=Homo sapiens OX=9606 GN=AUH PE=1 SV=1 AUHM_HUMAN reviewed Methylglutaconyl-CoA hydratase, mitochondrial (3-MG-CoA hydratase) (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56) Homo sapiens (Human) GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0050011 fatty acid beta-oxidation [GO:0006635]; L-leucine catabolic process [GO:0006552] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730] g2841.t1 P47812 70.833 336 0.0 515.0 sp|P47812|MK14_XENLA Mitogen-activated protein kinase 14 OS=Xenopus laevis OX=8355 GN=mapk14 PE=2 SV=1 g2842.t1 Q28811 62.183 513 0.0 670.0 sp|Q28811|PHR_POTTR Deoxyribodipyrimidine photo-lyase OS=Potorous tridactylus OX=9310 GN=PHR PE=2 SV=1 g2843.t1 P35400 30.42 858 4.22e-125 401.0 sp|P35400|GRM7_RAT Metabotropic glutamate receptor 7 OS=Rattus norvegicus OX=10116 GN=Grm7 PE=1 SV=1 g2844.t1 P40893 35.359 181 6.410000000000001e-27 104.0 sp|P40893|REE1_YEAST Regulation of enolase protein 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=REE1 PE=1 SV=1 g2844.t2 P40893 35.359 181 7.250000000000001e-27 104.0 sp|P40893|REE1_YEAST Regulation of enolase protein 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=REE1 PE=1 SV=1 g2847.t1 Q5PQR5 68.142 113 5.46e-51 165.0 sp|Q5PQR5|IMP4_RAT U3 small nucleolar ribonucleoprotein protein IMP4 OS=Rattus norvegicus OX=10116 GN=Imp4 PE=2 SV=1 g2848.t1 Q96G21 57.759 116 2.3999999999999998e-39 137.0 sp|Q96G21|IMP4_HUMAN U3 small nucleolar ribonucleoprotein protein IMP4 OS=Homo sapiens OX=9606 GN=IMP4 PE=1 SV=1 IMP4_HUMAN reviewed U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4) (Brix domain-containing protein 4) Homo sapiens (Human) GO:0001650; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042134; GO:0042274 maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040] rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515] g2849.t1 Q6AYB3 70.877 285 3.06e-138 394.0 sp|Q6AYB3|ISY1_RAT Pre-mRNA-splicing factor ISY1 homolog OS=Rattus norvegicus OX=10116 GN=Isy1 PE=2 SV=1 g2850.t1 Q91WM2 43.617 470 3.75e-123 368.0 sp|Q91WM2|HDHD5_MOUSE Haloacid dehalogenase-like hydrolase domain-containing 5 OS=Mus musculus OX=10090 GN=Hdhd5 PE=1 SV=1 g2851.t1 Q86YS6 61.809 199 3e-88 261.0 sp|Q86YS6|RAB43_HUMAN Ras-related protein Rab-43 OS=Homo sapiens OX=9606 GN=RAB43 PE=1 SV=1 RAB43_HUMAN reviewed Ras-related protein Rab-43 (Ras-related protein Rab-41) (EC 3.6.5.2) Homo sapiens (Human) GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0012505; GO:0019068; GO:0030670; GO:0032588; GO:0033106; GO:0033116; GO:0035526; GO:0045335; GO:0070062; GO:0071346; GO:0090382; GO:1903358 autophagosome assembly [GO:0000045]; cellular response to type II interferon [GO:0071346]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068] cis-Golgi network membrane [GO:0033106]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g2852.t1 Q9Z2U1 78.008 241 5.94e-145 407.0 sp|Q9Z2U1|PSA5_MOUSE Proteasome subunit alpha type-5 OS=Mus musculus OX=10090 GN=Psma5 PE=1 SV=1 PSA5_MOUSE reviewed Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome subunit alpha-5) (alpha-5) (Proteasome zeta chain) Mus musculus (Mouse) GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0019773; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773] g2853.t1 A7SMR0 59.551 89 1.3e-34 116.0 sp|A7SMR0|MEIG1_NEMVE Meiosis expressed gene 1 protein homolog OS=Nematostella vectensis OX=45351 GN=v1g237368 PE=3 SV=1 g2854.t1 Q52I78 56.057 487 0.0 538.0 sp|Q52I78|NAMPT_PIG Nicotinamide phosphoribosyltransferase OS=Sus scrofa OX=9823 GN=NAMPT PE=2 SV=2 NAMPT_PIG reviewed Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin) Sus scrofa (Pig) GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0009435; GO:0032922; GO:0042802; GO:0047280 circadian regulation of gene expression [GO:0032922]; NAD+ biosynthetic process [GO:0009435] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280] g2855.t1 Q5F4A1 36.436 376 7.14e-54 201.0 sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1 g2860.t1 Q58DF3 51.456 309 3.57e-98 305.0 sp|Q58DF3|TRABD_BOVIN TraB domain-containing protein OS=Bos taurus OX=9913 GN=TRABD PE=2 SV=1 g2861.t1 P58751 45.072 3490 0.0 2992.0 sp|P58751|RELN_RAT Reelin OS=Rattus norvegicus OX=10116 GN=Reln PE=2 SV=1 g2861.t1 P58751 32.776 1077 1.89e-151 536.0 sp|P58751|RELN_RAT Reelin OS=Rattus norvegicus OX=10116 GN=Reln PE=2 SV=1 g2861.t1 P58751 36.023 694 1.12e-103 379.0 sp|P58751|RELN_RAT Reelin OS=Rattus norvegicus OX=10116 GN=Reln PE=2 SV=1 g2861.t1 P58751 33.134 335 6.519999999999999e-42 175.0 sp|P58751|RELN_RAT Reelin OS=Rattus norvegicus OX=10116 GN=Reln PE=2 SV=1 g2868.t1 Q9Z1J2 74.444 270 1.86e-145 446.0 sp|Q9Z1J2|NEK4_MOUSE Serine/threonine-protein kinase Nek4 OS=Mus musculus OX=10090 GN=Nek4 PE=1 SV=1 NEK4_MOUSE reviewed Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) Mus musculus (Mouse) GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0030145; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:0106310; GO:2000772 cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772] ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2868.t2 Q9Z1J2 74.444 270 1.09e-145 447.0 sp|Q9Z1J2|NEK4_MOUSE Serine/threonine-protein kinase Nek4 OS=Mus musculus OX=10090 GN=Nek4 PE=1 SV=1 NEK4_MOUSE reviewed Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) Mus musculus (Mouse) GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0030145; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:0106310; GO:2000772 cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772] ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g2870.t1 Q9Z1L5 41.989 1086 0.0 835.0 sp|Q9Z1L5|CA2D3_MOUSE Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Mus musculus OX=10090 GN=Cacna2d3 PE=1 SV=1 CA2D3_MOUSE reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Mus musculus (Mouse) GO:0005245; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g2870.t2 Q9Z1L5 41.989 1086 0.0 837.0 sp|Q9Z1L5|CA2D3_MOUSE Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Mus musculus OX=10090 GN=Cacna2d3 PE=1 SV=1 CA2D3_MOUSE reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Mus musculus (Mouse) GO:0005245; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g2870.t3 Q8CFG5 41.515 1096 0.0 825.0 sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1 CA2D3_RAT reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Rattus norvegicus (Rat) GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g2870.t4 Q9Z1L5 47.109 709 0.0 645.0 sp|Q9Z1L5|CA2D3_MOUSE Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Mus musculus OX=10090 GN=Cacna2d3 PE=1 SV=1 CA2D3_MOUSE reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Mus musculus (Mouse) GO:0005245; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g2870.t4 Q9Z1L5 33.609 363 2.2499999999999996e-52 204.0 sp|Q9Z1L5|CA2D3_MOUSE Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Mus musculus OX=10090 GN=Cacna2d3 PE=1 SV=1 CA2D3_MOUSE reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Mus musculus (Mouse) GO:0005245; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g2872.t1 Q8WXK3 46.718 259 1.36e-78 242.0 sp|Q8WXK3|ASB13_HUMAN Ankyrin repeat and SOCS box protein 13 OS=Homo sapiens OX=9606 GN=ASB13 PE=1 SV=2 ASB13_HUMAN reviewed Ankyrin repeat and SOCS box protein 13 (ASB-13) Homo sapiens (Human) GO:0005829; GO:0016567; GO:0035556 intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] g2873.t1 Q69ZR9 38.367 245 1.6499999999999999e-46 190.0 sp|Q69ZR9|TASOR_MOUSE Protein TASOR OS=Mus musculus OX=10090 GN=Tasor PE=1 SV=2 TASOR_MOUSE reviewed Protein TASOR (Transgene activation suppressor protein) Mus musculus (Mouse) GO:0000792; GO:0003682; GO:0005654; GO:0008595; GO:0045814; GO:0060809; GO:0097355; GO:0140283; GO:0140719; GO:0141005 anterior/posterior axis specification, embryo [GO:0008595]; constitutive heterochromatin formation [GO:0140719]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; protein localization to heterochromatin [GO:0097355]; transposable element silencing by heterochromatin formation [GO:0141005] heterochromatin [GO:0000792]; HUSH complex [GO:0140283]; nucleoplasm [GO:0005654] chromatin binding [GO:0003682] g2873.t2 Q69ZR9 38.367 245 1.6799999999999999e-46 190.0 sp|Q69ZR9|TASOR_MOUSE Protein TASOR OS=Mus musculus OX=10090 GN=Tasor PE=1 SV=2 TASOR_MOUSE reviewed Protein TASOR (Transgene activation suppressor protein) Mus musculus (Mouse) GO:0000792; GO:0003682; GO:0005654; GO:0008595; GO:0045814; GO:0060809; GO:0097355; GO:0140283; GO:0140719; GO:0141005 anterior/posterior axis specification, embryo [GO:0008595]; constitutive heterochromatin formation [GO:0140719]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; protein localization to heterochromatin [GO:0097355]; transposable element silencing by heterochromatin formation [GO:0141005] heterochromatin [GO:0000792]; HUSH complex [GO:0140283]; nucleoplasm [GO:0005654] chromatin binding [GO:0003682] g2876.t1 P27012 33.803 213 4.65e-37 131.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g2877.t1 P49013 37.37 289 9.38e-55 193.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g2877.t1 P49013 39.754 244 1.02e-51 185.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g2878.t1 Q4R6T7 54.46 639 0.0 702.0 sp|Q4R6T7|IQUB_MACFA IQ motif and ubiquitin-like domain-containing protein OS=Macaca fascicularis OX=9541 GN=IQUB PE=2 SV=2 IQUB_MACFA reviewed IQ motif and ubiquitin-like domain-containing protein Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001534; GO:0001669; GO:0007618; GO:0030317; GO:0036126; GO:0060271; GO:0097729 cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; mating [GO:0007618] 9+2 motile cilium [GO:0097729]; acrosomal vesicle [GO:0001669]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126] g2879.t1 Q8WXX0 55.11 3963 0.0 4415.0 sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2 DYH7_HUMAN reviewed Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2) Homo sapiens (Human) GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g2880.t1 P40682 29.372 446 4.43e-35 139.0 sp|P40682|VAS1_BOVIN V-type proton ATPase subunit S1 OS=Bos taurus OX=9913 GN=ATP6AP1 PE=1 SV=1 VAS1_BOVIN reviewed V-type proton ATPase subunit S1 (V-ATPase subunit S1) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1) Bos taurus (Bovine) GO:0001671; GO:0005789; GO:0006879; GO:0030641; GO:0030665; GO:0030672; GO:0033116; GO:0033176; GO:0036295; GO:1902600 cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641] clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672] ATPase activator activity [GO:0001671] g2881.t1 Q86FP7 93.662 142 7.15e-93 268.0 sp|Q86FP7|RS23_DERVA Small ribosomal subunit protein uS12 OS=Dermacentor variabilis OX=34621 GN=RpS23 PE=2 SV=1 g2882.t1 Q9Z0V7 70.0 170 1.4e-79 236.0 sp|Q9Z0V7|TI17B_MOUSE Mitochondrial import inner membrane translocase subunit Tim17-B OS=Mus musculus OX=10090 GN=Timm17b PE=1 SV=1 g2883.t1 Q9QXK2 34.468 235 8.93e-34 139.0 sp|Q9QXK2|RAD18_MOUSE E3 ubiquitin-protein ligase RAD18 OS=Mus musculus OX=10090 GN=Rad18 PE=1 SV=2 RAD18_MOUSE reviewed E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (mRAD18Sc) (RING-type E3 ubiquitin transferase RAD18) Mus musculus (Mouse) GO:0000403; GO:0000785; GO:0001741; GO:0003690; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0007283; GO:0008270; GO:0009411; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0043130; GO:0044877; GO:0045910; GO:0051865; GO:0051984; GO:0061630; GO:0097505 DNA damage response [GO:0006974]; DNA damage tolerance [GO:0006301]; DNA repair [GO:0006281]; negative regulation of DNA recombination [GO:0045910]; positive regulation of chromosome segregation [GO:0051984]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; response to UV [GO:0009411]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; XY body [GO:0001741] double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270] g2883.t1 Q9QXK2 51.961 102 1.1200000000000001e-29 127.0 sp|Q9QXK2|RAD18_MOUSE E3 ubiquitin-protein ligase RAD18 OS=Mus musculus OX=10090 GN=Rad18 PE=1 SV=2 RAD18_MOUSE reviewed E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (mRAD18Sc) (RING-type E3 ubiquitin transferase RAD18) Mus musculus (Mouse) GO:0000403; GO:0000785; GO:0001741; GO:0003690; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0007283; GO:0008270; GO:0009411; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0043130; GO:0044877; GO:0045910; GO:0051865; GO:0051984; GO:0061630; GO:0097505 DNA damage response [GO:0006974]; DNA damage tolerance [GO:0006301]; DNA repair [GO:0006281]; negative regulation of DNA recombination [GO:0045910]; positive regulation of chromosome segregation [GO:0051984]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; response to UV [GO:0009411]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; XY body [GO:0001741] double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270] g2884.t1 Q6GMH0 55.848 342 3.05e-133 386.0 sp|Q6GMH0|PRP18_DANRE Pre-mRNA-splicing factor 18 OS=Danio rerio OX=7955 GN=prpf18 PE=2 SV=1 g2887.t1 Q9ERZ3 28.322 286 6.64e-30 129.0 sp|Q9ERZ3|ACM3_MOUSE Muscarinic acetylcholine receptor M3 OS=Mus musculus OX=10090 GN=Chrm3 PE=1 SV=1 ACM3_MOUSE reviewed Muscarinic acetylcholine receptor M3 (Mm3 mAChR) Mus musculus (Mouse) GO:0003063; GO:0005789; GO:0005886; GO:0006939; GO:0006940; GO:0007187; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007271; GO:0009925; GO:0016323; GO:0016907; GO:0019722; GO:0030425; GO:0031789; GO:0032279; GO:0042166; GO:0042734; GO:0043679; GO:0045202; GO:0045907; GO:0045987; GO:0046541; GO:0050997; GO:0095500; GO:0098839; GO:0098978; GO:1904695; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of heart rate by acetylcholine [GO:0003063]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; positive regulation of vasoconstriction [GO:0045907]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; saliva secretion [GO:0046541]; smooth muscle contraction [GO:0006939]; synaptic transmission, cholinergic [GO:0007271] asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled acetylcholine receptor binding [GO:0031789]; quaternary ammonium group binding [GO:0050997] g2889.t1 O42260 47.451 255 1.38e-74 231.0 sp|O42260|GEMI2_XENLA Gem-associated protein 2 OS=Xenopus laevis OX=8355 GN=gemin2 PE=2 SV=1 g2890.t1 O95786 32.902 696 2.38e-97 328.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g2891.t1 P08567 31.818 374 1.8300000000000002e-58 196.0 sp|P08567|PLEK_HUMAN Pleckstrin OS=Homo sapiens OX=9606 GN=PLEK PE=1 SV=3 PLEK_HUMAN reviewed Pleckstrin (Platelet 47 kDa protein) (p47) Homo sapiens (Human) GO:0002244; GO:0002576; GO:0005080; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0006904; GO:0007200; GO:0007229; GO:0010572; GO:0010920; GO:0016020; GO:0019211; GO:0030030; GO:0030036; GO:0030836; GO:0030845; GO:0030866; GO:0031529; GO:0032233; GO:0032587; GO:0033625; GO:0035556; GO:0042803; GO:0043325; GO:0043647; GO:0045744; GO:0050849; GO:0060305; GO:0070493; GO:0070495; GO:0070527; GO:0070560 actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cortical actin cytoskeleton organization [GO:0030866]; hematopoietic progenitor cell differentiation [GO:0002244]; inositol phosphate metabolic process [GO:0043647]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of integrin activation [GO:0033625]; positive regulation of platelet activation [GO:0010572]; protein secretion by platelet [GO:0070560]; regulation of cell diameter [GO:0060305]; ruffle organization [GO:0031529]; thrombin-activated receptor signaling pathway [GO:0070493]; vesicle docking involved in exocytosis [GO:0006904] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] phosphatase activator activity [GO:0019211]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080] g2892.t1 Q6Q899 32.476 622 1.04e-85 300.0 sp|Q6Q899|RIGI_MOUSE Antiviral innate immune response receptor RIG-I OS=Mus musculus OX=10090 GN=Rigi PE=1 SV=2 g2893.t1 P41340 85.294 374 0.0 701.0 sp|P41340|ACT3_LIMPO Actin-3 OS=Limulus polyphemus OX=6850 PE=1 SV=1 g2894.t1 Q964E2 66.4 375 0.0 538.0 sp|Q964E2|ACTC_BIOPF Actin, cytoplasmic OS=Biomphalaria pfeifferi OX=112525 PE=3 SV=1 g2895.t1 P48728 56.417 374 4.89e-149 431.0 sp|P48728|GCST_HUMAN Aminomethyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=AMT PE=1 SV=1 GCST_HUMAN reviewed Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT) Homo sapiens (Human) GO:0004047; GO:0005654; GO:0005739; GO:0005759; GO:0005960; GO:0006546; GO:0008483; GO:0019464 glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483] g2898.t1 B0JZG0 50.915 601 0.0 597.0 sp|B0JZG0|S23A2_XENTR Solute carrier family 23 member 2 OS=Xenopus tropicalis OX=8364 GN=slc23a2 PE=2 SV=1 g2899.t1 B0JZG0 47.866 656 0.0 597.0 sp|B0JZG0|S23A2_XENTR Solute carrier family 23 member 2 OS=Xenopus tropicalis OX=8364 GN=slc23a2 PE=2 SV=1 g2900.t1 Q7RTX9 34.828 290 4.2e-45 173.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g2901.t1 Q7ZWB2 44.366 142 5.75e-35 122.0 sp|Q7ZWB2|UBL4A_DANRE Ubiquitin-like protein 4A OS=Danio rerio OX=7955 GN=ubl4a PE=2 SV=1 g2903.t1 Q8IZF6 29.969 644 2.5e-80 298.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g2904.t1 B7ZCC9 30.721 638 2.08e-76 284.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g2905.t1 Q8IZF6 29.073 626 1.9100000000000002e-66 252.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g2906.t1 Q6N075 33.489 427 2.57e-62 212.0 sp|Q6N075|MFSD5_HUMAN Molybdate-anion transporter OS=Homo sapiens OX=9606 GN=MFSD5 PE=1 SV=2 MFSD5_HUMAN reviewed Solute carrier family 61 member 1 (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2) (Molybdate-anion transporter) Homo sapiens (Human) GO:0005886; GO:0006811; GO:0015098; GO:0015689; GO:0016020; GO:0032094; GO:0042594 molybdate ion transport [GO:0015689]; monoatomic ion transport [GO:0006811]; response to food [GO:0032094]; response to starvation [GO:0042594] membrane [GO:0016020]; plasma membrane [GO:0005886] molybdate ion transmembrane transporter activity [GO:0015098] g2908.t1 Q64692 37.097 248 2.8e-35 136.0 sp|Q64692|SIA8D_MOUSE CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Mus musculus OX=10090 GN=St8sia4 PE=1 SV=1 SIA8D_MOUSE reviewed CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D) (SIAT8-D) (Sialyltransferase St8Sia IV) (ST8SiaIV) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0003828; GO:0005576; GO:0005794; GO:0006491; GO:0008373; GO:0009311; GO:0097503 ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g2909.t1 Q64692 37.097 248 3.17e-35 136.0 sp|Q64692|SIA8D_MOUSE CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Mus musculus OX=10090 GN=St8sia4 PE=1 SV=1 SIA8D_MOUSE reviewed CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D) (SIAT8-D) (Sialyltransferase St8Sia IV) (ST8SiaIV) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0003828; GO:0005576; GO:0005794; GO:0006491; GO:0008373; GO:0009311; GO:0097503 ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g2911.t1 P61643 34.454 238 3.07e-35 132.0 sp|P61643|SIA8B_PANTR Alpha-2,8-sialyltransferase 8B OS=Pan troglodytes OX=9598 GN=ST8SIA2 PE=2 SV=1 g2912.t1 P39022 56.78 236 1.39e-81 268.0 sp|P39022|RAD52_CHICK DNA repair protein RAD52 homolog OS=Gallus gallus OX=9031 GN=RAD52 PE=2 SV=1 g2913.t1 Q99MI1 43.689 1030 0.0 704.0 sp|Q99MI1|RB6I2_MOUSE ELKS/Rab6-interacting/CAST family member 1 OS=Mus musculus OX=10090 GN=Erc1 PE=1 SV=1 g2913.t2 Q99MI1 43.744 1015 0.0 695.0 sp|Q99MI1|RB6I2_MOUSE ELKS/Rab6-interacting/CAST family member 1 OS=Mus musculus OX=10090 GN=Erc1 PE=1 SV=1 g2913.t3 Q99MI1 43.917 1011 0.0 694.0 sp|Q99MI1|RB6I2_MOUSE ELKS/Rab6-interacting/CAST family member 1 OS=Mus musculus OX=10090 GN=Erc1 PE=1 SV=1 g2918.t1 Q8BID8 70.077 391 0.0 564.0 sp|Q8BID8|FXL14_MOUSE F-box/LRR-repeat protein 14 OS=Mus musculus OX=10090 GN=Fbxl14 PE=2 SV=1 g2919.t1 Q27Q52 60.705 369 1.6e-168 479.0 sp|Q27Q52|WNT5A_RABIT Protein Wnt-5a OS=Oryctolagus cuniculus OX=9986 GN=WNT5A PE=2 SV=1 WNT5A_RABIT reviewed Protein Wnt-5a Oryctolagus cuniculus (Rabbit) GO:0001736; GO:0001756; GO:0001822; GO:0001843; GO:0001938; GO:0001947; GO:0002053; GO:0003138; GO:0003139; GO:0003281; GO:0003283; GO:0003323; GO:0003344; GO:0005109; GO:0005115; GO:0005125; GO:0005615; GO:0006954; GO:0007200; GO:0007223; GO:0007254; GO:0007442; GO:0007494; GO:0008104; GO:0008543; GO:0008584; GO:0008595; GO:0009986; GO:0010463; GO:0010595; GO:0010631; GO:0010742; GO:0010820; GO:0010976; GO:0019904; GO:0021891; GO:0030216; GO:0030324; GO:0030509; GO:0030514; GO:0031012; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0032880; GO:0035022; GO:0036342; GO:0036517; GO:0036518; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045944; GO:0046330; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048843; GO:0048846; GO:0048850; GO:0050680; GO:0050729; GO:0051216; GO:0051885; GO:0051897; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060762; GO:0060809; GO:0060907; GO:0061036; GO:0062009; GO:0070242; GO:0070245; GO:0071222; GO:0071277; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090090; GO:0090103; GO:0097325; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0099175; GO:0099566; GO:0140013; GO:0150012; GO:1902035; GO:1902379; GO:1904934; GO:1904948; GO:2000049; GO:2000052; GO:2001235 anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to type II interferon [GO:0071346]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midbrain dopaminergic neuron differentiation [GO:1904948]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; paraxial mesoderm formation [GO:0048341]; pericardium morphogenesis [GO:0003344]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of protein localization [GO:0032880]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventricular septum development [GO:0003281]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685] chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115] g2921.t1 A4IGF3 43.684 190 1.29e-48 164.0 sp|A4IGF3|ATP23_DANRE Mitochondrial inner membrane protease ATP23 homolog OS=Danio rerio OX=7955 GN=atp23 PE=2 SV=1 g2924.t1 M9PBE2 69.643 112 2.02e-51 182.0 sp|M9PBE2|HAKAI_DROME E3 ubiquitin-protein ligase Hakai OS=Drosophila melanogaster OX=7227 GN=Hakai PE=1 SV=1 HAKAI_DROME reviewed E3 ubiquitin-protein ligase Hakai (EC 2.3.2.27) Drosophila melanogaster (Fruit fly) GO:0000381; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0007015; GO:0007391; GO:0007427; GO:0007494; GO:0008258; GO:0008270; GO:0016567; GO:0030155; GO:0030237; GO:0031410; GO:0035282; GO:0036396; GO:0040003; GO:0045296; GO:0048471; GO:0060429; GO:0061630 actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration, open tracheal system [GO:0007427]; epithelium development [GO:0060429]; female sex determination [GO:0030237]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell adhesion [GO:0030155]; segmentation [GO:0035282] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g2925.t1 O94966 42.301 1130 0.0 828.0 sp|O94966|UBP19_HUMAN Ubiquitin carboxyl-terminal hydrolase 19 OS=Homo sapiens OX=9606 GN=USP19 PE=1 SV=2 g2928.t1 O60242 42.568 148 2.43e-22 100.0 sp|O60242|AGRB3_HUMAN Adhesion G protein-coupled receptor B3 OS=Homo sapiens OX=9606 GN=ADGRB3 PE=1 SV=2 AGRB3_HUMAN reviewed Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3) Homo sapiens (Human) GO:0004930; GO:0005096; GO:0005886; GO:0007166; GO:0007186; GO:0007520; GO:0016020; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0090128; GO:0098794; GO:0098839; GO:0099558; GO:0150053; GO:1905806 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814]; regulation of synapse maturation [GO:0090128]; regulation of synapse pruning [GO:1905806] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density membrane [GO:0098839]; synaptic cleft [GO:0043083] G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096] g2929.t1 B3EWZ3 42.13 216 3.9899999999999996e-38 145.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g2929.t1 B3EWZ3 44.624 186 1.3700000000000001e-36 141.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g2929.t1 B3EWZ3 36.916 214 2.3599999999999998e-30 123.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g2930.t1 Q96RW7 37.857 280 2.69e-43 167.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g2930.t1 Q96RW7 35.87 276 1.94e-37 149.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g2931.t1 W0LYS5 69.605 329 2.7700000000000003e-167 473.0 sp|W0LYS5|CAMKI_MACNP Calcium/calmodulin-dependent protein kinase type 1 OS=Macrobrachium nipponense OX=159736 GN=CaMKI PE=2 SV=1 CAMKI_MACNP reviewed Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI) Macrobrachium nipponense (Oriental river shrimp) (Palaemon nipponensis) GO:0004683; GO:0005516; GO:0005524; GO:0022404; GO:0106310 molting cycle process [GO:0022404] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310] g2932.t1 Q8HXG5 36.641 131 1.08e-21 87.4 sp|Q8HXG5|NDUBB_BOVIN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial OS=Bos taurus OX=9913 GN=NDUFB11 PE=1 SV=2 g2934.t1 Q5ZKD7 42.427 1030 0.0 715.0 sp|Q5ZKD7|MOV10_CHICK Putative helicase MOV-10 OS=Gallus gallus OX=9031 GN=MOV10 PE=2 SV=1 MOV10_CHICK reviewed Putative helicase MOV-10 (EC 3.6.4.13) Gallus gallus (Chicken) GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011 3'-UTR-mediated mRNA destabilization [GO:0061158]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; transposable element silencing [GO:0010526] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g2935.t1 Q0V8H6 39.357 1057 0.0 671.0 sp|Q0V8H6|MOV10_BOVIN Putative helicase MOV-10 OS=Bos taurus OX=9913 GN=MOV10 PE=2 SV=1 MOV10_BOVIN reviewed Putative helicase MOV-10 (EC 3.6.4.13) Bos taurus (Bovine) GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0141008; GO:0150011 3'-UTR-mediated mRNA destabilization [GO:0061158]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; transposable element silencing [GO:0010526]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g2936.t1 P23249 50.891 617 0.0 610.0 sp|P23249|MOV10_MOUSE Putative helicase MOV-10 OS=Mus musculus OX=10090 GN=Mov10 PE=1 SV=2 MOV10_MOUSE reviewed Putative helicase MOV-10 (EC 3.6.4.13) (Moloney leukemia virus 10 protein) Mus musculus (Mouse) GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0141008; GO:0150011 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; transposable element silencing [GO:0010526]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g2938.t1 P0CH95 59.709 206 2.37e-77 271.0 sp|P0CH95|PHF8_DANRE Histone lysine demethylase PHF8 OS=Danio rerio OX=7955 GN=phf8 PE=1 SV=1 PHF8_DANRE reviewed Histone lysine demethylase PHF8 (EC 1.14.11.-) (EC 1.14.11.65) (PHD finger protein 8) (zPHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0003682; GO:0003712; GO:0005730; GO:0006338; GO:0006357; GO:0007420; GO:0008270; GO:0032452; GO:0032454; GO:0035575; GO:0042472; GO:0043523; GO:0045893; GO:0045943; GO:0048703; GO:0048922; GO:0051864; GO:0060319; GO:0061188; GO:0071558; GO:0140002; GO:0140680; GO:0140683 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic viscerocranium morphogenesis [GO:0048703]; G1/S transition of mitotic cell cycle [GO:0000082]; inner ear morphogenesis [GO:0042472]; negative regulation of rDNA heterochromatin formation [GO:0061188]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; posterior lateral line neuromast deposition [GO:0048922]; primitive erythrocyte differentiation [GO:0060319]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730] chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; histone H3K4me3 reader activity [GO:0140002]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; histone H4K20 demethylase activity [GO:0035575]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g2938.t2 P0CH95 59.709 206 2.37e-77 271.0 sp|P0CH95|PHF8_DANRE Histone lysine demethylase PHF8 OS=Danio rerio OX=7955 GN=phf8 PE=1 SV=1 PHF8_DANRE reviewed Histone lysine demethylase PHF8 (EC 1.14.11.-) (EC 1.14.11.65) (PHD finger protein 8) (zPHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0003682; GO:0003712; GO:0005730; GO:0006338; GO:0006357; GO:0007420; GO:0008270; GO:0032452; GO:0032454; GO:0035575; GO:0042472; GO:0043523; GO:0045893; GO:0045943; GO:0048703; GO:0048922; GO:0051864; GO:0060319; GO:0061188; GO:0071558; GO:0140002; GO:0140680; GO:0140683 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic viscerocranium morphogenesis [GO:0048703]; G1/S transition of mitotic cell cycle [GO:0000082]; inner ear morphogenesis [GO:0042472]; negative regulation of rDNA heterochromatin formation [GO:0061188]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; posterior lateral line neuromast deposition [GO:0048922]; primitive erythrocyte differentiation [GO:0060319]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730] chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; histone H3K4me3 reader activity [GO:0140002]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; histone H4K20 demethylase activity [GO:0035575]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g2938.t3 P0CH95 56.744 215 2.64e-75 266.0 sp|P0CH95|PHF8_DANRE Histone lysine demethylase PHF8 OS=Danio rerio OX=7955 GN=phf8 PE=1 SV=1 PHF8_DANRE reviewed Histone lysine demethylase PHF8 (EC 1.14.11.-) (EC 1.14.11.65) (PHD finger protein 8) (zPHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0003682; GO:0003712; GO:0005730; GO:0006338; GO:0006357; GO:0007420; GO:0008270; GO:0032452; GO:0032454; GO:0035575; GO:0042472; GO:0043523; GO:0045893; GO:0045943; GO:0048703; GO:0048922; GO:0051864; GO:0060319; GO:0061188; GO:0071558; GO:0140002; GO:0140680; GO:0140683 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic viscerocranium morphogenesis [GO:0048703]; G1/S transition of mitotic cell cycle [GO:0000082]; inner ear morphogenesis [GO:0042472]; negative regulation of rDNA heterochromatin formation [GO:0061188]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; posterior lateral line neuromast deposition [GO:0048922]; primitive erythrocyte differentiation [GO:0060319]; regulation of neuron apoptotic process [GO:0043523]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730] chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; histone H3K4me3 reader activity [GO:0140002]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; histone H4K20 demethylase activity [GO:0035575]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g2939.t1 P0CF52 57.919 221 2.69e-94 290.0 sp|P0CF52|KDM7B_DANRE Lysine-specific demethylase 7B OS=Danio rerio OX=7955 GN=jhdm1db PE=2 SV=1 KDM7B_DANRE reviewed Lysine-specific demethylase 7B (DrKDM7b) (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003712; GO:0005634; GO:0006338; GO:0006357; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0035575; GO:0051864; GO:0071558 chromatin remodeling [GO:0006338]; midbrain development [GO:0030901]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; histone H3K36 demethylase activity [GO:0051864]; histone H3K9 demethylase activity [GO:0032454]; histone H4K20 demethylase activity [GO:0035575]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g2940.t1 O53532 34.435 363 9.239999999999999e-54 188.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g2944.t1 P51644 84.831 178 6.9e-115 326.0 sp|P51644|ARF4_XENLA ADP-ribosylation factor 4 OS=Xenopus laevis OX=8355 GN=arf4 PE=1 SV=2 g2945.t1 Q9WV03 66.471 340 4.93e-147 420.0 sp|Q9WV03|FA50A_MOUSE Protein FAM50A OS=Mus musculus OX=10090 GN=Fam50a PE=1 SV=1 g2946.t1 Q08CD5 41.084 443 3.56e-116 349.0 sp|Q08CD5|RXLT1_DANRE Ribitol-5-phosphate xylosyltransferase 1 OS=Danio rerio OX=7955 GN=rxylt1 PE=2 SV=2 RXLT1_DANRE reviewed Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.61) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005794; GO:0035269; GO:0120053 protein O-linked glycosylation via mannose [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] ribitol beta-1,4-xylosyltransferase activity [GO:0120053] g2947.t1 A6QL50 47.368 133 5.46e-44 144.0 sp|A6QL50|FA72A_BOVIN Protein FAM72A OS=Bos taurus OX=9913 GN=FAM72A PE=1 SV=1 g2948.t1 Q7Z6B7 35.955 801 3.74e-162 504.0 sp|Q7Z6B7|SRGP1_HUMAN SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1 SRGP1_HUMAN reviewed SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0007266; GO:0007399; GO:0016477; GO:0030336; GO:0031267; GO:0051963 cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; nervous system development [GO:0007399]; regulation of synapse assembly [GO:0051963]; Rho protein signal transduction [GO:0007266] cytosol [GO:0005829] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g2949.t1 O15457 59.5 800 0.0 952.0 sp|O15457|MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens OX=9606 GN=MSH4 PE=1 SV=2 MSH4_HUMAN reviewed MutS protein homolog 4 (hMSH4) Homo sapiens (Human) GO:0000795; GO:0001541; GO:0003677; GO:0003690; GO:0005524; GO:0005634; GO:0005694; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0030983; GO:0140664 female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983] g2950.t1 Q8NA31 35.838 346 1.12e-51 198.0 sp|Q8NA31|TERB1_HUMAN Telomere repeats-binding bouquet formation protein 1 OS=Homo sapiens OX=9606 GN=TERB1 PE=1 SV=3 TERB1_HUMAN reviewed Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79) Homo sapiens (Human) GO:0000781; GO:0005635; GO:0005637; GO:0007129; GO:0045141; GO:0070187; GO:0070197; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141] chromosome, telomeric region [GO:0000781]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187] g2951.t1 Q7ZY86 39.459 702 2.07e-176 522.0 sp|Q7ZY86|TM168_XENLA Transmembrane protein 168 OS=Xenopus laevis OX=8355 GN=tmem168 PE=2 SV=1 g2952.t1 Q9D706 41.667 276 5.340000000000001e-59 202.0 sp|Q9D706|RPAP3_MOUSE RNA polymerase II-associated protein 3 OS=Mus musculus OX=10090 GN=Rpap3 PE=1 SV=1 g2952.t1 Q9D706 45.506 178 1.54e-38 147.0 sp|Q9D706|RPAP3_MOUSE RNA polymerase II-associated protein 3 OS=Mus musculus OX=10090 GN=Rpap3 PE=1 SV=1 g2953.t1 Q5ZKQ3 36.97 165 8.01e-22 96.3 sp|Q5ZKQ3|RPAP3_CHICK RNA polymerase II-associated protein 3 OS=Gallus gallus OX=9031 GN=RPAP3 PE=2 SV=1 g2954.t1 Q8IZF6 28.433 619 1.11e-64 248.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g2957.t1 Q6QM28 48.789 289 3e-81 255.0 sp|Q6QM28|SYN_HELPO Synapsin OS=Helix pomatia OX=6536 GN=SYN PE=1 SV=1 g2959.t1 P26652 31.28 211 8.14e-26 103.0 sp|P26652|TIMP3_CHICK Metalloproteinase inhibitor 3 OS=Gallus gallus OX=9031 GN=TIMP3 PE=1 SV=2 g2969.t1 O70441 46.281 242 4.28e-68 222.0 sp|O70441|SYN3_RAT Synapsin-3 OS=Rattus norvegicus OX=10116 GN=Syn3 PE=1 SV=1 g2971.t1 P23935 69.565 115 1.16e-53 166.0 sp|P23935|NDUA5_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Bos taurus OX=9913 GN=NDUFA5 PE=1 SV=3 g2974.t1 Q9Y6G3 54.348 92 1.7500000000000002e-26 100.0 sp|Q9Y6G3|RM42_HUMAN Large ribosomal subunit protein mL42 OS=Homo sapiens OX=9606 GN=MRPL42 PE=1 SV=1 RM42_HUMAN reviewed Large ribosomal subunit protein mL42 (39S ribosomal protein L31, mitochondrial) (L31mt) (MRP-L31) (39S ribosomal protein L42, mitochondrial) (L42mt) (MRP-L42) Homo sapiens (Human) GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0005763; GO:0005886; GO:0006412; GO:0032543 mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g2975.t1 Q04832 49.505 101 1.2500000000000001e-22 95.5 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g2976.t1 Q04832 32.117 274 2.17e-35 129.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g2976.t1 Q04832 31.336 217 2.6900000000000003e-27 107.0 sp|Q04832|HEXP_LEIMA DNA-binding protein HEXBP OS=Leishmania major OX=5664 GN=HEXBP PE=4 SV=1 g2978.t1 Q9W2N0 53.763 279 9.97e-115 335.0 sp|Q9W2N0|CAPZA_DROME F-actin-capping protein subunit alpha OS=Drosophila melanogaster OX=7227 GN=cpa PE=1 SV=1 CAPZA_DROME reviewed F-actin-capping protein subunit alpha Drosophila melanogaster (Fruit fly) GO:0007015; GO:0007294; GO:0008290; GO:0010591; GO:0016324; GO:0030018; GO:0030036; GO:0030837; GO:0030863; GO:0035220; GO:0046329; GO:0046982; GO:0051015; GO:0051016; GO:0051489; GO:0051490; GO:0051491; GO:0071203; GO:0140591 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; germarium-derived oocyte fate determination [GO:0007294]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; nuclear envelope budding [GO:0140591]; positive regulation of filopodium assembly [GO:0051491]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220] apical plasma membrane [GO:0016324]; cortical cytoskeleton [GO:0030863]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; Z disc [GO:0030018] actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982] g2979.t1 Q925U4 60.478 544 0.0 699.0 sp|Q925U4|EDEM1_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 1 OS=Mus musculus OX=10090 GN=Edem1 PE=1 SV=1 g2980.t1 Q96M69 41.693 638 2.3800000000000003e-156 478.0 sp|Q96M69|LRGUK_HUMAN Leucine-rich repeat and guanylate kinase domain-containing protein OS=Homo sapiens OX=9606 GN=LRGUK PE=1 SV=1 g2983.t1 Q15075 38.554 249 1.02e-30 122.0 sp|Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sapiens OX=9606 GN=EEA1 PE=1 SV=2 EEA1_HUMAN reviewed Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) Homo sapiens (Human) GO:0005516; GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0006906; GO:0008270; GO:0016189; GO:0030742; GO:0031901; GO:0042803; GO:0044308; GO:0044788; GO:0045022; GO:0055037; GO:0070062; GO:0098685; GO:0098830; GO:0098842; GO:0098978; GO:0099565 chemical synaptic transmission, postsynaptic [GO:0099565]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; host-mediated perturbation of viral process [GO:0044788]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906] axonal spine [GO:0044308]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; postsynaptic early endosome [GO:0098842]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685] 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g2984.t1 Q15075 45.915 355 2.54e-76 276.0 sp|Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sapiens OX=9606 GN=EEA1 PE=1 SV=2 EEA1_HUMAN reviewed Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) Homo sapiens (Human) GO:0005516; GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0006906; GO:0008270; GO:0016189; GO:0030742; GO:0031901; GO:0042803; GO:0044308; GO:0044788; GO:0045022; GO:0055037; GO:0070062; GO:0098685; GO:0098830; GO:0098842; GO:0098978; GO:0099565 chemical synaptic transmission, postsynaptic [GO:0099565]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; host-mediated perturbation of viral process [GO:0044788]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906] axonal spine [GO:0044308]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; postsynaptic early endosome [GO:0098842]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685] 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g2984.t1 Q15075 32.249 369 7.66e-29 128.0 sp|Q15075|EEA1_HUMAN Early endosome antigen 1 OS=Homo sapiens OX=9606 GN=EEA1 PE=1 SV=2 EEA1_HUMAN reviewed Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) Homo sapiens (Human) GO:0005516; GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0006906; GO:0008270; GO:0016189; GO:0030742; GO:0031901; GO:0042803; GO:0044308; GO:0044788; GO:0045022; GO:0055037; GO:0070062; GO:0098685; GO:0098830; GO:0098842; GO:0098978; GO:0099565 chemical synaptic transmission, postsynaptic [GO:0099565]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; host-mediated perturbation of viral process [GO:0044788]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906] axonal spine [GO:0044308]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; postsynaptic early endosome [GO:0098842]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; Schaffer collateral - CA1 synapse [GO:0098685] 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g2988.t1 P30676 92.09 354 0.0 668.0 sp|P30676|GNAI_PATPE Guanine nucleotide-binding protein G(i) subunit alpha OS=Patiria pectinifera OX=7594 PE=1 SV=3 g2989.t1 P54357 45.205 146 3.3199999999999997e-40 135.0 sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1 g2991.t1 P55861 77.576 165 5.629999999999999e-89 280.0 sp|P55861|MCM2_XENLA DNA replication licensing factor mcm2 OS=Xenopus laevis OX=8355 GN=mcm2 PE=1 SV=2 g2992.t1 P55861 80.841 642 0.0 1054.0 sp|P55861|MCM2_XENLA DNA replication licensing factor mcm2 OS=Xenopus laevis OX=8355 GN=mcm2 PE=1 SV=2 g2993.t1 Q791F6 46.269 335 1.39e-93 287.0 sp|Q791F6|TPRA1_RAT Transmembrane protein adipocyte-associated 1 OS=Rattus norvegicus OX=10116 GN=Tpra1 PE=2 SV=1 g2997.t1 Q9NPI6 51.648 182 7.59e-57 204.0 sp|Q9NPI6|DCP1A_HUMAN mRNA-decapping enzyme 1A OS=Homo sapiens OX=9606 GN=DCP1A PE=1 SV=3 DCP1A_HUMAN reviewed mRNA-decapping enzyme 1A (EC 3.6.1.62) (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF) Homo sapiens (Human) GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0008047; GO:0016020; GO:0019894; GO:0030425; GO:0031087; GO:0036464; GO:0042802; GO:0110156; GO:0140933; GO:1903608 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; mRNA methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein localization to cytoplasmic stress granule [GO:1903608] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932] 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; mRNA binding [GO:0003729] g2998.t1 Q01815 55.851 1991 0.0 2002.0 sp|Q01815|CAC1C_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1C OS=Mus musculus OX=10090 GN=Cacna1c PE=1 SV=1 CAC1C_MOUSE reviewed Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2) Mus musculus (Mouse) GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005654; GO:0005737; GO:0005886; GO:0005891; GO:0005929; GO:0006816; GO:0006874; GO:0006887; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0009986; GO:0010881; GO:0014069; GO:0016020; GO:0017156; GO:0019229; GO:0019899; GO:0019904; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0030424; GO:0030425; GO:0031369; GO:0032024; GO:0032991; GO:0035115; GO:0042383; GO:0042593; GO:0042734; GO:0043010; GO:0043025; GO:0043198; GO:0043204; GO:0044325; GO:0045211; GO:0045762; GO:0045933; GO:0046620; GO:0046872; GO:0051393; GO:0051721; GO:0060083; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086065; GO:0086091; GO:0098703; GO:0098839; GO:0098911; GO:0098912; GO:0098978; GO:1904181; GO:1904879; GO:1990454 adult walking behavior [GO:0007628]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-ion regulated exocytosis [GO:0017156]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication involved in cardiac conduction [GO:0086065]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane depolarization [GO:1904181]; positive regulation of muscle contraction [GO:0045933]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542] axon [GO:0030424]; caveolar macromolecular signaling complex [GO:0002095]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] g2998.t2 Q01815 56.241 1979 0.0 2009.0 sp|Q01815|CAC1C_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1C OS=Mus musculus OX=10090 GN=Cacna1c PE=1 SV=1 CAC1C_MOUSE reviewed Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2) Mus musculus (Mouse) GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005654; GO:0005737; GO:0005886; GO:0005891; GO:0005929; GO:0006816; GO:0006874; GO:0006887; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0009986; GO:0010881; GO:0014069; GO:0016020; GO:0017156; GO:0019229; GO:0019899; GO:0019904; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0030424; GO:0030425; GO:0031369; GO:0032024; GO:0032991; GO:0035115; GO:0042383; GO:0042593; GO:0042734; GO:0043010; GO:0043025; GO:0043198; GO:0043204; GO:0044325; GO:0045211; GO:0045762; GO:0045933; GO:0046620; GO:0046872; GO:0051393; GO:0051721; GO:0060083; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086065; GO:0086091; GO:0098703; GO:0098839; GO:0098911; GO:0098912; GO:0098978; GO:1904181; GO:1904879; GO:1990454 adult walking behavior [GO:0007628]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-ion regulated exocytosis [GO:0017156]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication involved in cardiac conduction [GO:0086065]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane depolarization [GO:1904181]; positive regulation of muscle contraction [GO:0045933]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542] axon [GO:0030424]; caveolar macromolecular signaling complex [GO:0002095]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] g2998.t3 Q01815 55.55 1991 0.0 1994.0 sp|Q01815|CAC1C_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1C OS=Mus musculus OX=10090 GN=Cacna1c PE=1 SV=1 CAC1C_MOUSE reviewed Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2) Mus musculus (Mouse) GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005654; GO:0005737; GO:0005886; GO:0005891; GO:0005929; GO:0006816; GO:0006874; GO:0006887; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0009986; GO:0010881; GO:0014069; GO:0016020; GO:0017156; GO:0019229; GO:0019899; GO:0019904; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0030424; GO:0030425; GO:0031369; GO:0032024; GO:0032991; GO:0035115; GO:0042383; GO:0042593; GO:0042734; GO:0043010; GO:0043025; GO:0043198; GO:0043204; GO:0044325; GO:0045211; GO:0045762; GO:0045933; GO:0046620; GO:0046872; GO:0051393; GO:0051721; GO:0060083; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086065; GO:0086091; GO:0098703; GO:0098839; GO:0098911; GO:0098912; GO:0098978; GO:1904181; GO:1904879; GO:1990454 adult walking behavior [GO:0007628]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-ion regulated exocytosis [GO:0017156]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication involved in cardiac conduction [GO:0086065]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane depolarization [GO:1904181]; positive regulation of muscle contraction [GO:0045933]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542] axon [GO:0030424]; caveolar macromolecular signaling complex [GO:0002095]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] g2999.t1 Q66J91 47.826 414 6.11e-108 340.0 sp|Q66J91|SAMTR_XENLA S-adenosylmethionine sensor upstream of mTORC1 OS=Xenopus laevis OX=8355 GN=samtor PE=2 SV=1 g3000.t1 A4IFD2 49.604 379 5.4e-107 348.0 sp|A4IFD2|FOXP1_BOVIN Forkhead box protein P1 OS=Bos taurus OX=9913 GN=FOXP1 PE=2 SV=1 FOXP1_BOVIN reviewed Forkhead box protein P1 Bos taurus (Bovine) GO:0000978; GO:0001227; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0048513 animal organ development [GO:0048513]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g3000.t2 A4IFD2 49.604 379 5.0000000000000003e-107 349.0 sp|A4IFD2|FOXP1_BOVIN Forkhead box protein P1 OS=Bos taurus OX=9913 GN=FOXP1 PE=2 SV=1 FOXP1_BOVIN reviewed Forkhead box protein P1 Bos taurus (Bovine) GO:0000978; GO:0001227; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0048513 animal organ development [GO:0048513]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g3001.t1 P46530 34.916 948 2.24e-112 390.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t1 P46530 32.146 1039 3.97e-108 377.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t1 P46530 33.011 930 6.92e-103 361.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t1 P46530 33.804 920 4.99e-102 358.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t1 P46530 33.69 935 1.87e-101 357.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t1 P46530 32.887 970 3.2100000000000002e-99 350.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t1 P46530 33.525 871 1.73e-95 339.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t1 P46530 32.28 443 1.6499999999999999e-38 160.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 35.09 949 3.77e-114 395.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 32.212 1040 1.22e-109 382.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 33.913 920 1.51e-103 363.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 33.868 936 2.6e-103 362.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 33.083 931 2.8500000000000003e-103 362.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 32.956 971 1.37e-99 351.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 33.563 870 2.49e-97 345.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t2 P46530 32.28 443 1.57e-38 161.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g3001.t3 P10079 35.762 906 3.41e-115 385.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t3 P10079 36.849 787 3.8599999999999994e-104 354.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t3 P10079 35.792 827 1.0000000000000001e-103 353.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t3 P10079 34.34 894 9.89e-102 348.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t3 P10079 36.31 672 4.6e-83 295.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t4 P10079 35.762 906 3.41e-115 385.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t4 P10079 36.849 787 3.8599999999999994e-104 354.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t4 P10079 35.792 827 1.0000000000000001e-103 353.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t4 P10079 34.34 894 9.89e-102 348.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t4 P10079 36.31 672 4.6e-83 295.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t5 P10079 35.762 906 3.41e-115 385.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t5 P10079 36.849 787 3.8599999999999994e-104 354.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t5 P10079 35.792 827 1.0000000000000001e-103 353.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t5 P10079 34.34 894 9.89e-102 348.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3001.t5 P10079 36.31 672 4.6e-83 295.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g3005.t1 Q28623 58.233 249 3.42e-86 275.0 sp|Q28623|SLMAP_RABIT Sarcolemmal membrane-associated protein OS=Oryctolagus cuniculus OX=9986 GN=SLMAP PE=1 SV=2 SLMAP_RABIT reviewed Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein) Oryctolagus cuniculus (Rabbit) GO:0005615; GO:0005789; GO:0005813; GO:0030018; GO:0030674; GO:0031430; GO:0031966; GO:0035331; GO:0042383; GO:0072659; GO:0090443; GO:1900825 negative regulation of hippo signaling [GO:0035331]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825] centrosome [GO:0005813]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; FAR/SIN/STRIPAK complex [GO:0090443]; M band [GO:0031430]; mitochondrial membrane [GO:0031966]; sarcolemma [GO:0042383]; Z disc [GO:0030018] protein-macromolecule adaptor activity [GO:0030674] g3009.t1 Q6DFC0 54.915 468 5.02e-171 499.0 sp|Q6DFC0|S41A2_XENLA Solute carrier family 41 member 2 OS=Xenopus laevis OX=8355 GN=slc41a2 PE=2 SV=1 S41A2_XENLA reviewed Solute carrier family 41 member 2 Xenopus laevis (African clawed frog) GO:0005886; GO:0006824; GO:0006826; GO:0006828; GO:0008324; GO:0015675; GO:0015693 cobalt ion transport [GO:0006824]; iron ion transport [GO:0006826]; magnesium ion transport [GO:0015693]; manganese ion transport [GO:0006828]; nickel cation transport [GO:0015675] plasma membrane [GO:0005886] monoatomic cation transmembrane transporter activity [GO:0008324] g3011.t1 Q9GLL1 41.509 106 2.33e-21 91.7 sp|Q9GLL1|CP4F_SHEEP Prostaglandin E2 omega-hydroxylase CYP4F21 OS=Ovis aries OX=9940 GN=CYP4F21 PE=1 SV=1 g3012.t1 P51869 40.969 454 4.16e-120 366.0 sp|P51869|CP4F4_RAT Cytochrome P450 4F4 OS=Rattus norvegicus OX=10116 GN=Cyp4f4 PE=1 SV=1 CP4F4_RAT reviewed Cytochrome P450 4F4 (CYPIVF4) (Leukotriene-B4 20-monooxygenase) (EC 1.14.14.94) Rattus norvegicus (Rat) GO:0005506; GO:0005789; GO:0008391; GO:0019369; GO:0020037; GO:0036101; GO:0050051; GO:0052869; GO:0097267; GO:1904681; GO:1905344 arachidonate metabolic process [GO:0019369]; leukotriene B4 catabolic process [GO:0036101]; omega-hydroxylase P450 pathway [GO:0097267]; prostaglandin catabolic process [GO:1905344]; response to 3-methylcholanthrene [GO:1904681] endoplasmic reticulum membrane [GO:0005789] arachidonate monooxygenase activity [GO:0008391]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051] g3013.t1 P78329 45.581 430 1.44e-131 395.0 sp|P78329|CP4F2_HUMAN Cytochrome P450 4F2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1 CP4F2_HUMAN reviewed Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0055078; GO:0097258; GO:0097259; GO:0097267; GO:0102033 arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonate epoxygenase activity [GO:0008392]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g3013.t2 P51869 43.653 449 4.05e-130 391.0 sp|P51869|CP4F4_RAT Cytochrome P450 4F4 OS=Rattus norvegicus OX=10116 GN=Cyp4f4 PE=1 SV=1 CP4F4_RAT reviewed Cytochrome P450 4F4 (CYPIVF4) (Leukotriene-B4 20-monooxygenase) (EC 1.14.14.94) Rattus norvegicus (Rat) GO:0005506; GO:0005789; GO:0008391; GO:0019369; GO:0020037; GO:0036101; GO:0050051; GO:0052869; GO:0097267; GO:1904681; GO:1905344 arachidonate metabolic process [GO:0019369]; leukotriene B4 catabolic process [GO:0036101]; omega-hydroxylase P450 pathway [GO:0097267]; prostaglandin catabolic process [GO:1905344]; response to 3-methylcholanthrene [GO:1904681] endoplasmic reticulum membrane [GO:0005789] arachidonate monooxygenase activity [GO:0008391]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051] g3014.t1 Q7Z3G6 73.312 311 1.57e-175 525.0 sp|Q7Z3G6|PRIC2_HUMAN Prickle-like protein 2 OS=Homo sapiens OX=9606 GN=PRICKLE2 PE=1 SV=2 PRIC2_HUMAN reviewed Prickle-like protein 2 Homo sapiens (Human) GO:0001825; GO:0005634; GO:0005737; GO:0008270; GO:0014069; GO:0030424; GO:0030425; GO:0031965; GO:0043194; GO:0060071; GO:0099612 blastocyst formation [GO:0001825]; protein localization to axon [GO:0099612]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] axon [GO:0030424]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] zinc ion binding [GO:0008270] g3014.t2 Q7Z3G6 63.158 361 1.7e-165 500.0 sp|Q7Z3G6|PRIC2_HUMAN Prickle-like protein 2 OS=Homo sapiens OX=9606 GN=PRICKLE2 PE=1 SV=2 PRIC2_HUMAN reviewed Prickle-like protein 2 Homo sapiens (Human) GO:0001825; GO:0005634; GO:0005737; GO:0008270; GO:0014069; GO:0030424; GO:0030425; GO:0031965; GO:0043194; GO:0060071; GO:0099612 blastocyst formation [GO:0001825]; protein localization to axon [GO:0099612]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] axon [GO:0030424]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] zinc ion binding [GO:0008270] g3016.t1 Q07DZ5 32.687 774 2.59e-120 421.0 sp|Q07DZ5|CTTB2_ORNAN Cortactin-binding protein 2 OS=Ornithorhynchus anatinus OX=9258 GN=CTTNBP2 PE=3 SV=1 g3016.t1 Q07DZ5 31.707 287 3.36e-28 128.0 sp|Q07DZ5|CTTB2_ORNAN Cortactin-binding protein 2 OS=Ornithorhynchus anatinus OX=9258 GN=CTTNBP2 PE=3 SV=1 g14908.t1 Q9C102 61.207 116 1.9e-33 133.0 sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1 GLT1_SCHPO reviewed Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT) Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) GO:0005506; GO:0005759; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054 ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759] 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639] g14909.t1 E1BD59 26.364 330 1.03e-31 134.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g14910.t1 Q9C102 64.557 79 1.11e-22 93.6 sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1 GLT1_SCHPO reviewed Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT) Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) GO:0005506; GO:0005759; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054 ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759] 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639] g14911.t1 F7H9X2 26.144 306 1.11e-22 106.0 sp|F7H9X2|TRIM2_CALJA Tripartite motif-containing protein 2 OS=Callithrix jacchus OX=9483 GN=TRIM2 PE=3 SV=1 g14913.t1 Q9DB15 46.795 156 3.14e-34 123.0 sp|Q9DB15|RM12_MOUSE Large ribosomal subunit protein bL12m OS=Mus musculus OX=10090 GN=Mrpl12 PE=1 SV=2 g14914.t1 Q8QGX4 42.931 4258 0.0 3359.0 sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1 g14916.t1 O95497 38.031 518 7.839999999999999e-104 323.0 sp|O95497|VNN1_HUMAN Pantetheinase OS=Homo sapiens OX=9606 GN=VNN1 PE=1 SV=2 VNN1_HUMAN reviewed Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1) Homo sapiens (Human) GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015938; GO:0015939; GO:0016020; GO:0017159; GO:0033089; GO:0035577; GO:0045087; GO:0098552; GO:0098609; GO:1902177 acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; coenzyme A catabolic process [GO:0015938]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979] azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] pantetheine hydrolase activity [GO:0017159] g14919.t1 Q75T13 39.57 604 1.76e-143 442.0 sp|Q75T13|PGAP1_HUMAN GPI inositol-deacylase OS=Homo sapiens OX=9606 GN=PGAP1 PE=1 SV=1 PGAP1_HUMAN reviewed GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006506; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0016255; GO:0016788; GO:0021871; GO:0050185; GO:0160215; GO:1902953 anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; forebrain regionalization [GO:0021871]; GPI anchor biosynthetic process [GO:0006506]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] deacylase activity [GO:0160215]; hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185] g14920.t1 Q5I2E5 54.976 211 3.67e-72 230.0 sp|Q5I2E5|FCN2_BOVIN Ficolin-2 OS=Bos taurus OX=9913 GN=FCN2 PE=2 SV=1 FCN2_BOVIN reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Bos taurus (Bovine) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g14921.t1 O70165 53.555 211 1.09e-72 234.0 sp|O70165|FCN1_MOUSE Ficolin-1 OS=Mus musculus OX=10090 GN=Fcn1 PE=1 SV=1 g14924.t1 Q6P823 99.265 136 1.28e-94 271.0 sp|Q6P823|H33_XENTR Histone H3.3 OS=Xenopus tropicalis OX=8364 GN=TGas113e22.1 PE=1 SV=3 H33_XENTR reviewed Histone H3.3 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 nucleosome [GO:0000786]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] g14927.t1 Q1JQD2 54.588 425 3.6799999999999997e-168 483.0 sp|Q1JQD2|GRWD1_BOVIN Glutamate-rich WD repeat-containing protein 1 OS=Bos taurus OX=9913 GN=GRWD1 PE=2 SV=1 GRWD1_BOVIN reviewed Glutamate-rich WD repeat-containing protein 1 Bos taurus (Bovine) GO:0003682; GO:0003688; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006334; GO:0006337; GO:0042254; GO:0042393 DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; ribosome biogenesis [GO:0042254] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393] g14928.t1 Q5BK18 45.142 494 8.080000000000001e-129 382.0 sp|Q5BK18|CIAO3_RAT Cytosolic iron-sulfur assembly component 3 OS=Rattus norvegicus OX=10116 GN=Ciao3 PE=2 SV=1 CIAO3_RAT reviewed Cytosolic iron-sulfur assembly component 3 (Cytosolic Fe-S cluster assembly factor NARFL) (Iron-only hydrogenase-like protein 1) (IOP1) (Nuclear prelamin A recognition factor-like protein) Rattus norvegicus (Rat) GO:0001666; GO:0002244; GO:0010468; GO:0016226; GO:0032364; GO:0046872; GO:0051539; GO:0097361 hematopoietic progenitor cell differentiation [GO:0002244]; intracellular oxygen homeostasis [GO:0032364]; iron-sulfur cluster assembly [GO:0016226]; regulation of gene expression [GO:0010468]; response to hypoxia [GO:0001666] cytosolic [4Fe-4S] assembly targeting complex [GO:0097361] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872] g14929.t1 P61214 55.276 199 2.1200000000000002e-77 233.0 sp|P61214|ARL4A_RAT ADP-ribosylation factor-like protein 4A OS=Rattus norvegicus OX=10116 GN=Arl4a PE=2 SV=1 g14930.t1 O95453 43.427 677 0.0 552.0 sp|O95453|PARN_HUMAN Poly(A)-specific ribonuclease PARN OS=Homo sapiens OX=9606 GN=PARN PE=1 SV=1 g14937.t1 Q9QXV1 69.231 65 1.7699999999999998e-23 107.0 sp|Q9QXV1|CBX8_MOUSE Chromobox protein homolog 8 OS=Mus musculus OX=10090 GN=Cbx8 PE=1 SV=1 CBX8_MOUSE reviewed Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (mPc3) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003682; GO:0003727; GO:0005634; GO:0005654; GO:0008284; GO:0031507; GO:0031519; GO:0032967; GO:0035102; GO:0045739; GO:0061628; GO:0070301; GO:0097027 cellular response to hydrogen peroxide [GO:0070301]; heterochromatin formation [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA repair [GO:0045739] chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] chromatin binding [GO:0003682]; histone H3K27me3 reader activity [GO:0061628]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027] g14940.t1 Q7TN88 27.898 742 3.2700000000000005e-86 320.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g14940.t1 Q7TN88 36.224 392 3.25e-68 261.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g14941.t1 Q29476 38.033 305 1.23e-64 209.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g14944.t1 P0DSP1 30.693 606 8.34e-45 180.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g14944.t1 P0DSP1 31.502 619 1.37e-44 179.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g14944.t1 P0DSP1 31.329 632 7.64e-44 177.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g14944.t1 P0DSP1 31.56 564 6.32e-39 161.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g14944.t1 P0DSP1 30.824 558 3.66e-34 146.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g14944.t1 P0DSP1 30.856 444 9.23e-26 119.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g14944.t1 P0DSP1 32.423 293 7.360000000000001e-21 103.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g14945.t1 Q6Q0C0 60.42 667 0.0 806.0 sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1 TRAF7_HUMAN reviewed E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235 apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14945.t2 Q922B6 67.491 566 0.0 804.0 sp|Q922B6|TRAF7_MOUSE E3 ubiquitin-protein ligase TRAF7 OS=Mus musculus OX=10090 GN=Traf7 PE=1 SV=1 TRAF7_MOUSE reviewed E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7) Mus musculus (Mouse) GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006357; GO:0006915; GO:0007249; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0035519; GO:0043410; GO:0043525; GO:0048471; GO:0061630; GO:0070372; GO:0071354; GO:2000060; GO:2001235 apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14946.t1 E1BZR9 41.718 652 2.11e-165 531.0 sp|E1BZR9|TCPR1_CHICK Tectonin beta-propeller repeat-containing protein 1 OS=Gallus gallus OX=9031 GN=TECPR1 PE=3 SV=1 g14946.t1 E1BZR9 45.103 439 4.42e-91 325.0 sp|E1BZR9|TCPR1_CHICK Tectonin beta-propeller repeat-containing protein 1 OS=Gallus gallus OX=9031 GN=TECPR1 PE=3 SV=1 g14946.t1 E1BZR9 31.793 368 1.1999999999999999e-39 164.0 sp|E1BZR9|TCPR1_CHICK Tectonin beta-propeller repeat-containing protein 1 OS=Gallus gallus OX=9031 GN=TECPR1 PE=3 SV=1 g14946.t1 E1BZR9 29.917 361 2.7400000000000003e-32 140.0 sp|E1BZR9|TCPR1_CHICK Tectonin beta-propeller repeat-containing protein 1 OS=Gallus gallus OX=9031 GN=TECPR1 PE=3 SV=1 g14946.t2 Q7Z6L1 43.719 613 5.3400000000000006e-166 533.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g14946.t2 Q7Z6L1 47.815 389 1.0899999999999999e-92 330.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g14946.t2 Q7Z6L1 30.769 403 1.5600000000000002e-37 157.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g14946.t2 Q7Z6L1 32.248 307 3.87e-32 140.0 sp|Q7Z6L1|TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TECPR1 PE=1 SV=1 TCPR1_HUMAN reviewed Tectonin beta-propeller repeat-containing protein 1 Homo sapiens (Human) GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0097352; GO:1901096 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] phosphatidylinositol-3-phosphate binding [GO:0032266] g14947.t1 Q32L83 42.857 126 1.77e-22 88.6 sp|Q32L83|BRI3_BOVIN Membrane protein BRI3 OS=Bos taurus OX=9913 GN=BRI3 PE=2 SV=1 g14948.t1 B6VQA1 74.648 71 7.040000000000001e-27 108.0 sp|B6VQA1|DIMM_DROME Protein dimmed OS=Drosophila melanogaster OX=7227 GN=dimm PE=1 SV=1 DIMM_DROME reviewed Protein dimmed Drosophila melanogaster (Fruit fly) GO:0000981; GO:0002793; GO:0005634; GO:0005737; GO:0006355; GO:0007419; GO:0007423; GO:0045944; GO:0046887; GO:0046983; GO:0061101; GO:0061564; GO:0070888 axon development [GO:0061564]; neuroendocrine cell differentiation [GO:0061101]; positive regulation of hormone secretion [GO:0046887]; positive regulation of peptide secretion [GO:0002793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; sensory organ development [GO:0007423]; ventral cord development [GO:0007419] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983] g14950.t1 Q29476 36.86 293 1.3e-58 191.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g14961.t1 Q6NXC0 26.026 999 9.46e-90 317.0 sp|Q6NXC0|FMNL3_DANRE Formin-like protein 3 OS=Danio rerio OX=7955 GN=fmnl3 PE=2 SV=2 FMNL3_DANRE reviewed Formin-like protein 3 (Formin homology 2 domain-containing protein 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0002040; GO:0005829; GO:0005886; GO:0008360; GO:0016477; GO:0030041; GO:0030866; GO:0031267; GO:0046847; GO:0051015 actin filament polymerization [GO:0030041]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; sprouting angiogenesis [GO:0002040] cytosol [GO:0005829]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; small GTPase binding [GO:0031267] g14963.t1 Q7SZQ0 38.298 470 6.43e-95 297.0 sp|Q7SZQ0|MBOA7_DANRE Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 OS=Danio rerio OX=7955 GN=mboat7 PE=2 SV=1 MBOA7_DANRE reviewed Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Lysophospholipid acyltransferase 7) (LPLAT 7) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617; GO:0090207 lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233] lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374] g14964.t1 Q5U4T9 46.186 472 6.82e-130 387.0 sp|Q5U4T9|MBOA7_XENLA Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 OS=Xenopus laevis OX=8355 GN=mboat7 PE=2 SV=1 g14965.t1 Q9NZS9 41.163 430 5.64e-104 320.0 sp|Q9NZS9|BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens OX=9606 GN=BFAR PE=1 SV=1 g14966.t1 P82929 40.288 139 7e-22 91.3 sp|P82929|RT34_BOVIN Small ribosomal subunit protein mS34 OS=Bos taurus OX=9913 GN=MRPS34 PE=1 SV=2 g14967.t1 A4FV97 39.357 249 9.629999999999999e-61 206.0 sp|A4FV97|RL1D1_BOVIN Ribosomal L1 domain-containing protein 1 OS=Bos taurus OX=9913 GN=RSL1D1 PE=2 SV=1 RL1D1_BOVIN reviewed Ribosomal L1 domain-containing protein 1 Bos taurus (Bovine) GO:0003723; GO:0003730; GO:0005694; GO:0005730; GO:0005829; GO:0005929; GO:0032880; GO:0042981; GO:0048027; GO:2000772 regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880] chromosome [GO:0005694]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleolus [GO:0005730] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723] g14968.t1 Q5SUE8 42.276 123 9.539999999999999e-30 117.0 sp|Q5SUE8|ANR40_MOUSE Ankyrin repeat domain-containing protein 40 OS=Mus musculus OX=10090 GN=Ankrd40 PE=1 SV=1 g14968.t1 Q5SUE8 63.291 79 3.7e-22 96.7 sp|Q5SUE8|ANR40_MOUSE Ankyrin repeat domain-containing protein 40 OS=Mus musculus OX=10090 GN=Ankrd40 PE=1 SV=1 g14968.t2 Q6AI12 63.75 80 7.509999999999999e-24 99.4 sp|Q6AI12|ANR40_HUMAN Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2 ANR40_HUMAN reviewed Ankyrin repeat domain-containing protein 40 Homo sapiens (Human) g14968.t2 Q6AI12 46.067 89 4.63e-23 97.4 sp|Q6AI12|ANR40_HUMAN Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2 ANR40_HUMAN reviewed Ankyrin repeat domain-containing protein 40 Homo sapiens (Human) g14969.t1 Q5SUF2 58.148 270 4.16e-103 322.0 sp|Q5SUF2|LC7L3_MOUSE Luc7-like protein 3 OS=Mus musculus OX=10090 GN=Luc7l3 PE=1 SV=1 g14970.t1 O54983 50.489 307 1.58e-99 299.0 sp|O54983|CRYM_MOUSE Ketimine reductase mu-crystallin OS=Mus musculus OX=10090 GN=Crym PE=1 SV=1 CRYM_MOUSE reviewed Ketimine reductase mu-crystallin (EC 1.5.1.25) (1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase) (P2C/Pyr2C reductase) (EC 1.5.1.1) (NADP-regulated thyroid-hormone-binding protein) Mus musculus (Mouse) GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006839; GO:0007605; GO:0042403; GO:0042562; GO:0042803; GO:0047125; GO:0047127; GO:0050241; GO:0050661; GO:0070324; GO:0070327 mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] delta1-piperideine-2-carboxylate reductase activity [GO:0047125]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; pyrroline-2-carboxylate reductase activity [GO:0050241]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714] g14970.t2 O54983 45.507 345 3.31e-92 282.0 sp|O54983|CRYM_MOUSE Ketimine reductase mu-crystallin OS=Mus musculus OX=10090 GN=Crym PE=1 SV=1 CRYM_MOUSE reviewed Ketimine reductase mu-crystallin (EC 1.5.1.25) (1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase) (P2C/Pyr2C reductase) (EC 1.5.1.1) (NADP-regulated thyroid-hormone-binding protein) Mus musculus (Mouse) GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006839; GO:0007605; GO:0042403; GO:0042562; GO:0042803; GO:0047125; GO:0047127; GO:0050241; GO:0050661; GO:0070324; GO:0070327 mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] delta1-piperideine-2-carboxylate reductase activity [GO:0047125]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; pyrroline-2-carboxylate reductase activity [GO:0050241]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714] g14971.t1 Q9U1M8 27.714 783 1.9899999999999998e-82 298.0 sp|Q9U1M8|MYOI_DICDI Myosin-I heavy chain OS=Dictyostelium discoideum OX=44689 GN=myoI PE=1 SV=1 g14973.t1 Q9ES54 55.556 612 0.0 712.0 sp|Q9ES54|NPL4_RAT Nuclear protein localization protein 4 homolog OS=Rattus norvegicus OX=10116 GN=Nploc4 PE=1 SV=3 NPL4_RAT reviewed Nuclear protein localization protein 4 homolog (Protein NPL4) Rattus norvegicus (Rat) GO:0005634; GO:0005829; GO:0006511; GO:0007030; GO:0008270; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036501; GO:0036503; GO:0039536; GO:0043130; GO:0043161; GO:0044877; GO:0051117 ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] ATPase binding [GO:0051117]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g14975.t1 Q8IWB9 36.903 691 2.98e-131 429.0 sp|Q8IWB9|TEX2_HUMAN Testis-expressed protein 2 OS=Homo sapiens OX=9606 GN=TEX2 PE=1 SV=2 g14975.t2 Q8IWB9 37.592 681 2.6200000000000002e-133 434.0 sp|Q8IWB9|TEX2_HUMAN Testis-expressed protein 2 OS=Homo sapiens OX=9606 GN=TEX2 PE=1 SV=2 g14976.t1 Q9NWF9 38.071 591 6.9e-101 345.0 sp|Q9NWF9|RN216_HUMAN E3 ubiquitin-protein ligase RNF216 OS=Homo sapiens OX=9606 GN=RNF216 PE=1 SV=3 g14978.t1 A4F5G6 50.373 268 4e-56 194.0 sp|A4F5G6|RFOX2_XENLA RNA binding protein fox-1 homolog 2 OS=Xenopus laevis OX=8355 GN=rbfox2 PE=1 SV=1 RFOX2_XENLA reviewed RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (RNA-binding motif protein 9) (RNA-binding protein 9) Xenopus laevis (African clawed frog) GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729] g14978.t2 A4F5G6 50.763 262 1.1e-56 195.0 sp|A4F5G6|RFOX2_XENLA RNA binding protein fox-1 homolog 2 OS=Xenopus laevis OX=8355 GN=rbfox2 PE=1 SV=1 RFOX2_XENLA reviewed RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (RNA-binding motif protein 9) (RNA-binding protein 9) Xenopus laevis (African clawed frog) GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729] g14978.t3 A4F5G6 51.145 262 1.5700000000000001e-56 194.0 sp|A4F5G6|RFOX2_XENLA RNA binding protein fox-1 homolog 2 OS=Xenopus laevis OX=8355 GN=rbfox2 PE=1 SV=1 RFOX2_XENLA reviewed RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (RNA-binding motif protein 9) (RNA-binding protein 9) Xenopus laevis (African clawed frog) GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729] g14978.t4 A4F5G6 50.373 268 2.96e-56 194.0 sp|A4F5G6|RFOX2_XENLA RNA binding protein fox-1 homolog 2 OS=Xenopus laevis OX=8355 GN=rbfox2 PE=1 SV=1 RFOX2_XENLA reviewed RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (RNA-binding motif protein 9) (RNA-binding protein 9) Xenopus laevis (African clawed frog) GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729] g14982.t1 Q9UQB8 33.194 479 8.93e-73 246.0 sp|Q9UQB8|BAIP2_HUMAN BAR/IMD domain-containing adapter protein 2 OS=Homo sapiens OX=9606 GN=BAIAP2 PE=1 SV=1 g14982.t2 Q9UQB8 32.495 477 8.17e-73 246.0 sp|Q9UQB8|BAIP2_HUMAN BAR/IMD domain-containing adapter protein 2 OS=Homo sapiens OX=9606 GN=BAIAP2 PE=1 SV=1 g14984.t1 Q6P963 64.368 261 1.04e-127 370.0 sp|Q6P963|GLO2_DANRE Hydroxyacylglutathione hydrolase, mitochondrial OS=Danio rerio OX=7955 GN=hagh PE=2 SV=2 GLO2_DANRE reviewed Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004416; GO:0005739; GO:0005759; GO:0006749; GO:0019243; GO:0046872 glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] g14986.t1 Q0PV50 30.114 880 1.92e-92 315.0 sp|Q0PV50|TLR3_BOSTR Toll-like receptor 3 OS=Boselaphus tragocamelus OX=9917 GN=TLR3 PE=2 SV=1 TLR3_BOSTR reviewed Toll-like receptor 3 (CD antigen CD283) Boselaphus tragocamelus (Nilgai) GO:0002684; GO:0003723; GO:0004888; GO:0005769; GO:0005789; GO:0005886; GO:0010008; GO:0032722; GO:0032728; GO:0032755; GO:0035556; GO:0038187; GO:0043123; GO:0043330; GO:0045087; GO:0046330; GO:0051607; GO:0090594 defense response to virus [GO:0051607]; inflammatory response to wounding [GO:0090594]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chemokine production [GO:0032722]; positive regulation of immune system process [GO:0002684]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; response to exogenous dsRNA [GO:0043330] early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; transmembrane signaling receptor activity [GO:0004888] g14987.t1 Q24562 63.682 402 0.0 531.0 sp|Q24562|U2AF2_DROME Splicing factor U2AF 50 kDa subunit OS=Drosophila melanogaster OX=7227 GN=U2af50 PE=1 SV=1 U2AF2_DROME reviewed Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit) Drosophila melanogaster (Fruit fly) GO:0000243; GO:0000245; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701 mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245] commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701] mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723] g14988.t1 Q8WVQ1 52.703 370 5.98e-141 414.0 sp|Q8WVQ1|CANT1_HUMAN Soluble calcium-activated nucleotidase 1 OS=Homo sapiens OX=9606 GN=CANT1 PE=1 SV=1 g14989.t1 Q02366 64.567 127 7.389999999999999e-55 170.0 sp|Q02366|NDUA6_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 OS=Bos taurus OX=9913 GN=NDUFA6 PE=1 SV=2 g14990.t1 Q9Y6D9 34.918 736 3.41e-118 374.0 sp|Q9Y6D9|MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens OX=9606 GN=MAD1L1 PE=1 SV=2 MD1L1_HUMAN reviewed Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181) Homo sapiens (Human) GO:0000776; GO:0000922; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] identical protein binding [GO:0042802]; kinetochore binding [GO:0043515] g14991.t1 Q9Y272 55.2 250 1.8900000000000002e-86 262.0 sp|Q9Y272|RASD1_HUMAN Dexamethasone-induced Ras-related protein 1 OS=Homo sapiens OX=9606 GN=RASD1 PE=1 SV=1 RASD1_HUMAN reviewed Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1) Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0031681; GO:0045892; GO:0048471 G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of DNA-templated transcription [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g14992.t1 Q969T9 40.541 259 2.4199999999999998e-42 148.0 sp|Q969T9|WBP2_HUMAN WW domain-binding protein 2 OS=Homo sapiens OX=9606 GN=WBP2 PE=1 SV=1 g14993.t1 Q28CQ4 77.848 158 1.18e-93 272.0 sp|Q28CQ4|UBC9_XENTR SUMO-conjugating enzyme UBC9 OS=Xenopus tropicalis OX=8364 GN=ube2i PE=2 SV=1 UBC9_XENTR reviewed SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005634; GO:0007059; GO:0016925; GO:0051301; GO:0061656 cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein sumoylation [GO:0016925] nucleus [GO:0005634] ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656] g14994.t1 Q5U305 85.849 212 4.07e-133 375.0 sp|Q5U305|ERD22_RAT ER lumen protein-retaining receptor 2 OS=Rattus norvegicus OX=10116 GN=Kdelr2 PE=2 SV=1 g14996.t1 Q9MYM7 39.357 249 4.660000000000001e-56 190.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g14999.t1 A3KPA3 59.596 198 1.7599999999999998e-90 275.0 sp|A3KPA3|NAA60_DANRE N-alpha-acetyltransferase 60 OS=Danio rerio OX=7955 GN=naa60 PE=2 SV=1 NAA60_DANRE reviewed N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004402; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0120518 cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334] Golgi membrane [GO:0000139] histone acetyltransferase activity [GO:0004402]; histone H4 acetyltransferase activity [GO:0010485]; protein homodimerization activity [GO:0042803]; protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g15000.t1 Q4R9F7 32.143 448 8.23e-49 188.0 sp|Q4R9F7|REXO5_MACFA RNA exonuclease 5 OS=Macaca fascicularis OX=9541 GN=REXO5 PE=2 SV=1 g15000.t2 Q4R9F7 32.287 446 1.89e-49 190.0 sp|Q4R9F7|REXO5_MACFA RNA exonuclease 5 OS=Macaca fascicularis OX=9541 GN=REXO5 PE=2 SV=1 g15001.t1 Q5HZL1 60.595 269 2.3400000000000002e-110 338.0 sp|Q5HZL1|ERI2_XENLA ERI1 exoribonuclease 2 OS=Xenopus laevis OX=8355 GN=eri2 PE=2 SV=1 g15003.t1 Q7ZW63 28.319 452 8.540000000000001e-43 160.0 sp|Q7ZW63|NUF2_DANRE Kinetochore protein Nuf2 OS=Danio rerio OX=7955 GN=nuf2 PE=2 SV=1 NUF2_DANRE reviewed Kinetochore protein Nuf2 (Cell division cycle-associated protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0007052; GO:0007507; GO:0008017; GO:0031262; GO:0044877; GO:0045132; GO:0051301; GO:0051315; GO:0051383 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; heart development [GO:0007507]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle organization [GO:0007052] Ndc80 complex [GO:0031262]; nucleus [GO:0005634] microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877] g15004.t1 P08172 31.207 439 2.23e-64 219.0 sp|P08172|ACM2_HUMAN Muscarinic acetylcholine receptor M2 OS=Homo sapiens OX=9606 GN=CHRM2 PE=1 SV=1 ACM2_HUMAN reviewed Muscarinic acetylcholine receptor M2 Homo sapiens (Human) GO:0005730; GO:0005794; GO:0005886; GO:0005929; GO:0006940; GO:0007186; GO:0007187; GO:0007188; GO:0007193; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007399; GO:0008016; GO:0009615; GO:0016020; GO:0016907; GO:0030425; GO:0030669; GO:0036064; GO:0045202; GO:0045211; GO:0098793; GO:0098981; GO:0099171; GO:1990763 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; response to virus [GO:0009615] cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907] g15005.t1 Q6P1M3 47.125 974 0.0 909.0 sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2 L2GL2_HUMAN reviewed LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716 branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165] g15005.t2 Q6P1M3 47.57 967 0.0 915.0 sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2 L2GL2_HUMAN reviewed LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716 branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165] g15005.t3 Q6P1M3 47.812 960 0.0 918.0 sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2 L2GL2_HUMAN reviewed LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716 branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165] g15006.t1 Q8CHD8 30.782 588 1.66e-56 209.0 sp|Q8CHD8|RFIP3_MOUSE Rab11 family-interacting protein 3 OS=Mus musculus OX=10090 GN=Rab11fip3 PE=1 SV=2 RFIP3_MOUSE reviewed Rab11 family-interacting protein 3 (FIP3) (FIP3-Rab11) (Rab11-FIP3) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005654; GO:0005739; GO:0005768; GO:0005813; GO:0005886; GO:0005929; GO:0007018; GO:0016020; GO:0016192; GO:0030139; GO:0030496; GO:0030666; GO:0030674; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0032588; GO:0034451; GO:0036064; GO:0042802; GO:0042803; GO:0043001; GO:0045171; GO:0045724; GO:0051301; GO:0051959; GO:0055037; GO:0055038; GO:0060090; GO:0060627; GO:0061502; GO:0061512; GO:0070164; GO:0098944; GO:1902017; GO:1902954; GO:1903438; GO:1904779; GO:1905345; GO:2001135 cell division [GO:0051301]; early endosome to recycling endosome transport [GO:0061502]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; microtubule-based movement [GO:0007018]; negative regulation of adiponectin secretion [GO:0070164]; positive regulation of cilium assembly [GO:0045724]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein localization to cilium [GO:0061512]; protein localization to cleavage furrow [GO:1905345]; regulation of cilium assembly [GO:1902017]; regulation of cytokinesis [GO:0032465]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to centrosome [GO:1904779]; regulation of vesicle-mediated transport [GO:0060627]; vesicle-mediated transport [GO:0016192] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic recycling endosome membrane [GO:0098944]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g15006.t2 O75154 30.333 600 5.13e-56 205.0 sp|O75154|RFIP3_HUMAN Rab11 family-interacting protein 3 OS=Homo sapiens OX=9606 GN=RAB11FIP3 PE=1 SV=1 RFIP3_HUMAN reviewed Rab11 family-interacting protein 3 (FIP3) (FIP3-Rab11) (Rab11-FIP3) (Arfophilin-1) (EF hands-containing Rab-interacting protein) (Eferin) (MU-MB-17.148) Homo sapiens (Human) GO:0000139; GO:0005509; GO:0005654; GO:0005739; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0016192; GO:0030139; GO:0030496; GO:0030666; GO:0030674; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0032588; GO:0034451; GO:0036064; GO:0042802; GO:0042803; GO:0043001; GO:0045171; GO:0045724; GO:0051301; GO:0051959; GO:0055037; GO:0055038; GO:0060090; GO:0060627; GO:0061502; GO:0061512; GO:0070164; GO:0098944; GO:1902017; GO:1902954; GO:1903438; GO:1904779; GO:1905345; GO:2001135 cell division [GO:0051301]; early endosome to recycling endosome transport [GO:0061502]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; negative regulation of adiponectin secretion [GO:0070164]; positive regulation of cilium assembly [GO:0045724]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein localization to cilium [GO:0061512]; protein localization to cleavage furrow [GO:1905345]; regulation of cilium assembly [GO:1902017]; regulation of cytokinesis [GO:0032465]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to centrosome [GO:1904779]; regulation of vesicle-mediated transport [GO:0060627]; vesicle-mediated transport [GO:0016192] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic recycling endosome membrane [GO:0098944]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g15006.t3 Q3LGD4 29.485 641 8.28e-57 205.0 sp|Q3LGD4|RFP4A_DANRE Rab11 family-interacting protein 4A OS=Danio rerio OX=7955 GN=rab11fip4a PE=2 SV=1 RFP4A_DANRE reviewed Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005768; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048592; GO:0051301; GO:0051726; GO:0055038 cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038] calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g15006.t4 Q3LGD4 30.516 639 7.709999999999999e-60 214.0 sp|Q3LGD4|RFP4A_DANRE Rab11 family-interacting protein 4A OS=Danio rerio OX=7955 GN=rab11fip4a PE=2 SV=1 RFP4A_DANRE reviewed Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005768; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0048592; GO:0051301; GO:0051726; GO:0055038 cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038] calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g15008.t1 Q5ZHN9 48.621 290 4.21e-83 275.0 sp|Q5ZHN9|PGPS1_CHICK CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial OS=Gallus gallus OX=9031 GN=PGS1 PE=2 SV=1 g15008.t1 Q5ZHN9 50.199 251 1.19e-68 237.0 sp|Q5ZHN9|PGPS1_CHICK CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial OS=Gallus gallus OX=9031 GN=PGS1 PE=2 SV=1 g15009.t1 Q8IV35 29.044 847 8.03e-97 337.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g15010.t1 Q8R3P7 64.56 364 2.9300000000000005e-160 461.0 sp|Q8R3P7|CLUA1_MOUSE Clusterin-associated protein 1 OS=Mus musculus OX=10090 GN=Cluap1 PE=1 SV=1 CLUA1_MOUSE reviewed Clusterin-associated protein 1 Mus musculus (Mouse) GO:0001843; GO:0001947; GO:0005654; GO:0005813; GO:0005815; GO:0005929; GO:0007224; GO:0015629; GO:0021508; GO:0030991; GO:0030992; GO:0035082; GO:0035720; GO:0042073; GO:0060271; GO:0060972; GO:0097542; GO:0097546 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; intraciliary transport particle B [GO:0030992]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654] g15011.t1 P25325 41.463 287 3.8199999999999998e-81 250.0 sp|P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3 THTM_HUMAN reviewed 3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2) Homo sapiens (Human) GO:0000098; GO:0001822; GO:0001889; GO:0004792; GO:0005739; GO:0005759; GO:0009440; GO:0009636; GO:0016783; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814 cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202] 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792] g15012.t1 P35406 31.343 335 1.98e-37 142.0 sp|P35406|DRD1_CARAU D(1) dopamine receptor OS=Carassius auratus OX=7957 PE=2 SV=1 g15017.t1 Q21FL9 56.41 273 2.48e-109 321.0 sp|Q21FL9|ISPE_SACD2 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase OS=Saccharophagus degradans (strain 2-40 / ATCC 43961 / DSM 17024) OX=203122 GN=ispE PE=3 SV=1 g15019.t1 P07207 36.826 1336 0.0 740.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15019.t1 P07207 37.353 1277 0.0 736.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15019.t1 P07207 37.164 1227 0.0 701.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15019.t1 P07207 36.289 1094 0.0 646.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15019.t1 P07207 38.199 966 6.04e-177 589.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15019.t1 P07207 34.396 1067 6.35e-165 554.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15019.t1 P07207 36.61 885 1.0899999999999999e-134 465.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15019.t1 P07207 33.208 533 2.35e-63 243.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15020.t1 P21783 40.764 1413 0.0 974.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 40.712 1405 0.0 914.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 39.146 1405 0.0 906.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 39.956 1374 0.0 895.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 40.255 1334 0.0 895.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 38.434 1392 0.0 864.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 38.347 1343 0.0 812.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 37.934 1181 0.0 726.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 35.07 1420 0.0 716.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 38.015 947 1.35e-163 570.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 37.065 804 5.94e-136 482.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 41.066 319 1.69e-48 196.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 35.45 378 6.28e-48 194.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 39.634 328 6.869999999999999e-45 184.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 36.441 354 1.58e-44 183.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 37.5 328 2.29e-44 182.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 36.452 310 4.56e-43 178.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 35.53 349 1.17e-42 177.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 39.297 313 3.9599999999999994e-42 175.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 39.039 333 2.0099999999999998e-40 169.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 35.04 371 3.62e-40 169.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 35.928 334 1.42e-39 167.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 35.693 339 4.9799999999999997e-39 165.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 34.232 371 1e-36 157.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t1 P21783 40.415 193 1.3099999999999999e-23 114.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 40.764 1413 0.0 975.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 40.712 1405 0.0 915.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 39.668 1447 0.0 908.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 39.146 1405 0.0 907.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 40.255 1334 0.0 895.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 38.666 1244 0.0 792.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 36.14 1425 0.0 750.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 37.934 1181 0.0 726.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 38.015 947 1.2100000000000001e-163 570.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 37.065 804 5.8e-136 482.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 41.066 319 1.6299999999999998e-48 196.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 35.45 378 6.11e-48 194.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 39.634 328 6.09e-45 184.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 36.441 354 1.55e-44 183.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 37.5 328 2.03e-44 182.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 36.452 310 4.22e-43 178.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 35.53 349 1.0499999999999999e-42 177.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 39.297 313 3.85e-42 175.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 39.039 333 2.14e-40 169.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 35.04 371 3.52e-40 169.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 35.928 334 1.28e-39 167.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 35.693 339 4.2e-39 165.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 34.232 371 9.35e-37 157.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15020.t2 P21783 40.415 193 1.16e-23 114.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15021.t1 P97819 35.842 837 5.6299999999999994e-170 514.0 sp|P97819|PLPL9_MOUSE 85/88 kDa calcium-independent phospholipase A2 OS=Mus musculus OX=10090 GN=Pla2g6 PE=1 SV=3 PLPL9_MOUSE reviewed 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9) Mus musculus (Mouse) GO:0003847; GO:0004622; GO:0005516; GO:0005615; GO:0005739; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0015630; GO:0016607; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0042311; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0052816; GO:0090200; GO:0090238; GO:1902533; GO:2000304 antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; chemotaxis [GO:0006935]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311] extracellular space [GO:0005615]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; phosphatidylcholine lysophospholipase activity [GO:0004622]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171] g15022.t1 Q90889 51.493 134 9.910000000000001e-35 122.0 sp|Q90889|MAFG_CHICK Transcription factor MafG OS=Gallus gallus OX=9031 GN=MAFG PE=3 SV=1 g15023.t1 Q6PDG8 45.887 547 5.33e-168 491.0 sp|Q6PDG8|MON1A_MOUSE Vacuolar fusion protein MON1 homolog A OS=Mus musculus OX=10090 GN=Mon1a PE=1 SV=3 MON1A_MOUSE reviewed Vacuolar fusion protein MON1 homolog A Mus musculus (Mouse) GO:0005085; GO:0006623; GO:0006879; GO:0009306; GO:0015031; GO:0016192; GO:0035658 intracellular iron ion homeostasis [GO:0006879]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] Mon1-Ccz1 complex [GO:0035658] guanyl-nucleotide exchange factor activity [GO:0005085] g15024.t1 Q3UDE2 46.106 642 0.0 556.0 sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1 g15025.t1 Q8R481 36.101 554 4.75e-96 316.0 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 g15026.t1 Q8R481 36.984 557 2.08e-97 332.0 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 g15026.t1 Q8R481 35.163 583 1.2e-88 307.0 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 g15027.t1 Q8R481 35.59 576 1.37e-96 318.0 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 g15028.t1 Q07192 69.939 326 8.2e-167 478.0 sp|Q07192|MP2K2_XENLA Dual specificity mitogen-activated protein kinase kinase 2 (Fragment) OS=Xenopus laevis OX=8355 GN=map2k2 PE=1 SV=1 g15029.t1 O75636 45.161 217 1.64e-51 176.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g15030.t1 Q3V096 50.816 490 2.2100000000000002e-167 486.0 sp|Q3V096|ANR42_MOUSE Ankyrin repeat domain-containing protein 42 OS=Mus musculus OX=10090 GN=Ankrd42 PE=1 SV=1 g15031.t1 Q5ZL79 26.148 283 2.37e-25 111.0 sp|Q5ZL79|NOL11_CHICK Nucleolar protein 11 OS=Gallus gallus OX=9031 GN=NOL11 PE=2 SV=1 g15032.t1 O89035 62.057 282 3.96e-131 377.0 sp|O89035|DIC_RAT Mitochondrial dicarboxylate carrier OS=Rattus norvegicus OX=10116 GN=Slc25a10 PE=2 SV=1 DIC_RAT reviewed Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10) Rattus norvegicus (Rat) GO:0005310; GO:0005315; GO:0005654; GO:0005739; GO:0005743; GO:0006817; GO:0006869; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015291; GO:0015297; GO:0015709; GO:0015729; GO:0015743; GO:0035435; GO:0046166; GO:0071422; GO:0071423; GO:1902358 glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; malate transport [GO:0015743]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; succinate transmembrane transport [GO:0071422]; sulfate transmembrane transport [GO:1902358]; thiosulfate transport [GO:0015709] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; phosphate transmembrane transporter activity [GO:0005315]; secondary active transmembrane transporter activity [GO:0015291]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117] g15036.t1 Q8BWQ6 57.576 990 0.0 1173.0 sp|Q8BWQ6|VP35L_MOUSE VPS35 endosomal protein-sorting factor-like OS=Mus musculus OX=10090 GN=Vps35l PE=1 SV=2 g15037.t1 P07207 40.224 1340 0.0 916.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 39.347 1408 0.0 907.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 38.792 1374 0.0 899.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 39.229 1323 0.0 855.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 38.238 1237 0.0 826.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 36.587 1178 0.0 707.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 32.274 1007 4.4299999999999996e-108 390.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 34.949 681 5.949999999999999e-90 332.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 36.893 412 1.64e-62 242.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 32.992 488 8.570000000000001e-58 226.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 34.091 440 1.89e-57 225.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 36.562 413 5.290000000000001e-56 220.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 31.05 438 3.2300000000000003e-47 191.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15037.t1 P07207 34.521 365 2.0599999999999997e-40 169.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15038.t1 Q5HZV9 26.814 317 1.8700000000000002e-26 114.0 sp|Q5HZV9|PP1R7_RAT Protein phosphatase 1 regulatory subunit 7 OS=Rattus norvegicus OX=10116 GN=Ppp1r7 PE=1 SV=1 g15041.t1 Q6GV29 63.743 342 3.18e-165 468.0 sp|Q6GV29|QTGAL_RAT Queuosine-tRNA galactosyltransferase OS=Rattus norvegicus OX=10116 GN=B3gntl1 PE=1 SV=1 QTGAL_RAT reviewed Queuosine-tRNA galactosyltransferase (QTGAL) (EC 2.4.1.-) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1) (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) Rattus norvegicus (Rat) GO:0005737; GO:0006400; GO:0006417; GO:0141125 regulation of translation [GO:0006417]; tRNA modification [GO:0006400] cytoplasm [GO:0005737] tRNA-queuosine(34) galactosyltransferase activity [GO:0141125] g15043.t1 P46530 35.122 1472 0.0 639.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 34.636 1510 0.0 626.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 32.863 1488 9.69e-173 600.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 31.868 1751 3.1300000000000005e-166 580.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 32.791 1476 1.16e-164 575.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 33.831 1475 4.77e-164 573.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 33.354 1619 9.75e-164 572.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 32.795 1485 7.72e-154 540.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 33.199 1485 9.7e-154 540.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 32.613 1435 1.65e-151 533.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 33.045 1386 8.66e-142 502.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 33.434 1325 6.42e-137 486.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 32.216 1164 3.6400000000000003e-118 426.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 33.725 851 2.67e-92 341.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 42.407 349 1.17e-61 240.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 41.067 375 1.84e-60 236.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 39.773 352 6.48e-60 234.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 38.439 346 4.49e-58 228.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 35.748 428 7.62e-57 224.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 36.591 399 2.73e-56 223.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 37.245 392 1.1899999999999999e-55 221.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 38.329 347 1.66e-51 207.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 38.793 348 1.71e-51 207.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 37.255 357 5.809999999999999e-48 195.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 37.676 284 2.42e-36 157.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15043.t1 P46530 36.441 236 1.59e-25 121.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15044.t1 Q5M843 47.692 325 3.48e-91 277.0 sp|Q5M843|OGFD3_RAT 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ogfod3 PE=2 SV=1 g15045.t1 P70180 29.254 335 5.56e-34 136.0 sp|P70180|ANPRC_MOUSE Atrial natriuretic peptide receptor 3 OS=Mus musculus OX=10090 GN=Npr3 PE=1 SV=3 ANPRC_MOUSE reviewed Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C) (EF-2) Mus musculus (Mouse) GO:0001501; GO:0001525; GO:0001974; GO:0002158; GO:0002931; GO:0005886; GO:0006182; GO:0007165; GO:0007193; GO:0007200; GO:0007218; GO:0008217; GO:0008528; GO:0016941; GO:0017046; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0042277; GO:0042311; GO:0042562; GO:0042802; GO:0042803; GO:0048662; GO:0090187; GO:0120163; GO:0140319; GO:1901082 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cGMP biosynthetic process [GO:0006182]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; neuropeptide signaling pathway [GO:0007218]; osteoclast proliferation [GO:0002158]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of relaxation of smooth muscle [GO:1901082]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; vasodilation [GO:0042311] plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; receptor decoy activity [GO:0140319] g15046.t1 Q9CZT4 43.879 727 0.0 579.0 sp|Q9CZT4|RPC5_MOUSE DNA-directed RNA polymerase III subunit RPC5 OS=Mus musculus OX=10090 GN=Polr3e PE=1 SV=2 g15047.t1 Q14197 51.724 174 2.47e-57 182.0 sp|Q14197|ICT1_HUMAN Large ribosomal subunit protein mL62 OS=Homo sapiens OX=9606 GN=MRPL58 PE=1 SV=1 ICT1_HUMAN reviewed Large ribosomal subunit protein mL62 (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Digestion substraction 1) (DS-1) (Immature colon carcinoma transcript 1 protein) (Peptidyl-tRNA hydrolase ICT1, mitochondrial) (EC 3.1.1.29) Homo sapiens (Human) GO:0004045; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005762; GO:0005886; GO:0016150; GO:0032543; GO:0070126; GO:0072344 mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126]; rescue of stalled ribosome [GO:0072344] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] peptidyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150] g15048.t1 Q6PHN1 32.502 1083 2.9899999999999997e-119 394.0 sp|Q6PHN1|CCD57_MOUSE Coiled-coil domain-containing protein 57 OS=Mus musculus OX=10090 GN=Ccdc57 PE=1 SV=1 CCD57_MOUSE reviewed Coiled-coil domain-containing protein 57 Mus musculus (Mouse) GO:0000086; GO:0003351; GO:0005576; GO:0005813; GO:0005814; GO:0005876; GO:0007020; GO:0007099; GO:0032053; GO:0034451; GO:0035082; GO:0036064; GO:0045931; GO:0060271; GO:0090162; GO:0090660 axoneme assembly [GO:0035082]; centriole replication [GO:0007099]; cerebrospinal fluid circulation [GO:0090660]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell polarity [GO:0090162]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; spindle microtubule [GO:0005876] g15058.t1 Q29S22 70.11 455 0.0 652.0 sp|Q29S22|DDX47_BOVIN Probable ATP-dependent RNA helicase DDX47 OS=Bos taurus OX=9913 GN=DDX47 PE=2 SV=1 DDX47_BOVIN reviewed Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47) Bos taurus (Bovine) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016887 extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g15059.t1 O15169 35.913 969 2.24e-128 410.0 sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2 AXIN1_HUMAN reviewed Axin-1 (Axis inhibition protein 1) (hAxin) Homo sapiens (Human) GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060 apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605] beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g15061.t1 Q9XT77 36.404 684 3.71e-131 404.0 sp|Q9XT77|SC5A6_RABIT Sodium-dependent multivitamin transporter OS=Oryctolagus cuniculus OX=9986 GN=SLC5A6 PE=2 SV=1 g15062.t1 Q8VCY6 38.843 605 2.15e-139 420.0 sp|Q8VCY6|UTP6_MOUSE U3 small nucleolar RNA-associated protein 6 homolog OS=Mus musculus OX=10090 GN=Utp6 PE=2 SV=1 g15063.t1 Q32PC3 42.4 125 1.8499999999999998e-23 92.8 sp|Q32PC3|RM27_BOVIN Large ribosomal subunit protein bL27m OS=Bos taurus OX=9913 GN=MRPL27 PE=1 SV=1 g15064.t1 Q4R7U0 40.058 689 7.04e-162 490.0 sp|Q4R7U0|TMC7_MACFA Transmembrane channel-like protein 7 OS=Macaca fascicularis OX=9541 GN=TMC7 PE=2 SV=1 g15065.t1 Q6UXY8 33.984 615 2.63e-90 314.0 sp|Q6UXY8|TMC5_HUMAN Transmembrane channel-like protein 5 OS=Homo sapiens OX=9606 GN=TMC5 PE=1 SV=3 g15069.t1 Q7ZWC3 60.265 151 3.47e-67 204.0 sp|Q7ZWC3|8ODP_DANRE Oxidized purine nucleoside triphosphate hydrolase OS=Danio rerio OX=7955 GN=nudt1 PE=1 SV=1 8ODP_DANRE reviewed Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0005634; GO:0005737; GO:0005759; GO:0005829; GO:0008413; GO:0008828; GO:0009151; GO:0016791; GO:0016818; GO:0042262; GO:0046872; GO:0047429 DNA protection [GO:0042262]; purine deoxyribonucleotide metabolic process [GO:0009151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634] 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; dATP diphosphatase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphatase activity [GO:0016791]; RNA binding [GO:0003723] g15070.t1 Q6NRT5 70.65 477 0.0 667.0 sp|Q6NRT5|CSN1_XENLA COP9 signalosome complex subunit 1 OS=Xenopus laevis OX=8355 GN=csn1 PE=2 SV=1 g15072.t1 G1TFE0 71.277 188 1.18e-96 281.0 sp|G1TFE0|RL18_RABIT Large ribosomal subunit protein eL18 OS=Oryctolagus cuniculus OX=9986 GN=RPL18 PE=1 SV=2 g15073.t1 Q9CYH6 45.697 337 7.22e-98 296.0 sp|Q9CYH6|RRS1_MOUSE Ribosome biogenesis regulatory protein homolog OS=Mus musculus OX=10090 GN=Rrs1 PE=1 SV=1 RRS1_MOUSE reviewed Ribosome biogenesis regulatory protein homolog Mus musculus (Mouse) GO:0000027; GO:0000447; GO:0000794; GO:0002244; GO:0005654; GO:0005730; GO:0005783; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570 endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase chromosome alignment [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273] condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687] 5S rRNA binding [GO:0008097] g15074.t1 Q6ZXC9 34.513 226 3e-29 119.0 sp|Q6ZXC9|SIA8D_BOVIN CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Bos taurus OX=9913 GN=ST8SIA4 PE=2 SV=1 g15075.t1 G3C7W6 38.842 587 7.5e-131 399.0 sp|G3C7W6|S2611_CAVPO Sodium-independent sulfate anion transporter OS=Cavia porcellus OX=10141 GN=Slc26a11 PE=2 SV=1 S2611_CAVPO reviewed Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11) Cavia porcellus (Guinea pig) GO:0005254; GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0008271; GO:0016323; GO:0016324; GO:0019532; GO:0140900; GO:1902358 oxalate transport [GO:0019532]; sulfate transmembrane transport [GO:1902358] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; chloride:bicarbonate antiporter activity [GO:0140900]; secondary active sulfate transmembrane transporter activity [GO:0008271] g15076.t1 G3C7W6 42.419 587 4.89e-149 446.0 sp|G3C7W6|S2611_CAVPO Sodium-independent sulfate anion transporter OS=Cavia porcellus OX=10141 GN=Slc26a11 PE=2 SV=1 S2611_CAVPO reviewed Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11) Cavia porcellus (Guinea pig) GO:0005254; GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0008271; GO:0016323; GO:0016324; GO:0019532; GO:0140900; GO:1902358 oxalate transport [GO:0019532]; sulfate transmembrane transport [GO:1902358] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; chloride:bicarbonate antiporter activity [GO:0140900]; secondary active sulfate transmembrane transporter activity [GO:0008271] g15078.t1 Q28FE0 47.811 297 2.11e-101 303.0 sp|Q28FE0|CPPED_XENTR Serine/threonine-protein phosphatase CPPED1 OS=Xenopus tropicalis OX=8364 GN=cpped1 PE=2 SV=1 CPPED_XENTR reviewed Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004722; GO:0005737; GO:0046872 cytoplasm [GO:0005737] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g15078.t2 Q28FE0 47.811 297 5.58e-102 303.0 sp|Q28FE0|CPPED_XENTR Serine/threonine-protein phosphatase CPPED1 OS=Xenopus tropicalis OX=8364 GN=cpped1 PE=2 SV=1 CPPED_XENTR reviewed Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004722; GO:0005737; GO:0046872 cytoplasm [GO:0005737] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g15079.t1 Q28FE0 45.578 294 1.54e-95 287.0 sp|Q28FE0|CPPED_XENTR Serine/threonine-protein phosphatase CPPED1 OS=Xenopus tropicalis OX=8364 GN=cpped1 PE=2 SV=1 CPPED_XENTR reviewed Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004722; GO:0005737; GO:0046872 cytoplasm [GO:0005737] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g15080.t1 P23965 44.882 254 5.54e-74 231.0 sp|P23965|ECI1_RAT Enoyl-CoA delta isomerase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Eci1 PE=1 SV=1 ECI1_RAT reviewed Enoyl-CoA delta isomerase 1, mitochondrial (MECI) (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) Rattus norvegicus (Rat) GO:0004165; GO:0005739; GO:0005759; GO:0006635; GO:0016863; GO:0042802 fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863] g15081.t1 P42125 53.585 265 2.82e-98 293.0 sp|P42125|ECI1_MOUSE Enoyl-CoA delta isomerase 1, mitochondrial OS=Mus musculus OX=10090 GN=Eci1 PE=1 SV=2 ECI1_MOUSE reviewed Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) Mus musculus (Mouse) GO:0004165; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0016863; GO:0042802 fatty acid beta-oxidation [GO:0006635] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863] g15082.t1 P23965 44.828 290 2.27e-81 251.0 sp|P23965|ECI1_RAT Enoyl-CoA delta isomerase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Eci1 PE=1 SV=1 ECI1_RAT reviewed Enoyl-CoA delta isomerase 1, mitochondrial (MECI) (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) Rattus norvegicus (Rat) GO:0004165; GO:0005739; GO:0005759; GO:0006635; GO:0016863; GO:0042802 fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863] g15083.t1 P23965 40.52 269 4.9000000000000005e-65 207.0 sp|P23965|ECI1_RAT Enoyl-CoA delta isomerase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Eci1 PE=1 SV=1 ECI1_RAT reviewed Enoyl-CoA delta isomerase 1, mitochondrial (MECI) (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase) Rattus norvegicus (Rat) GO:0004165; GO:0005739; GO:0005759; GO:0006635; GO:0016863; GO:0042802 fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; identical protein binding [GO:0042802]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863] g15085.t1 A0JP70 47.745 1929 0.0 1786.0 sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1 g15086.t1 Q9NYV6 39.523 587 1.25e-156 467.0 sp|Q9NYV6|RRN3_HUMAN RNA polymerase I-specific transcription initiation factor RRN3 OS=Homo sapiens OX=9606 GN=RRN3 PE=1 SV=1 RRN3_HUMAN reviewed RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) Homo sapiens (Human) GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005634; GO:0005654; GO:0005730; GO:0006361; GO:0007000; GO:0007028; GO:0042254; GO:0045893; GO:0048144; GO:0048872; GO:0072332; GO:1902254; GO:2000142 cytoplasm organization [GO:0007028]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation at RNA polymerase I promoter [GO:0006361] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] g15087.t1 Q13255 31.31 313 1e-44 169.0 sp|Q13255|GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens OX=9606 GN=GRM1 PE=1 SV=3 GRM1_HUMAN reviewed Metabotropic glutamate receptor 1 (mGluR1) Homo sapiens (Human) GO:0001640; GO:0004930; GO:0005634; GO:0005886; GO:0007186; GO:0007200; GO:0007206; GO:0007216; GO:0007268; GO:0007626; GO:0008066; GO:0019233; GO:0038037; GO:0038038; GO:0043410; GO:0044293; GO:0051930; GO:0051966; GO:0071257; GO:0098685; GO:0098712; GO:0098839; GO:0098872; GO:0098978; GO:0099530; GO:0099538; GO:0099583 cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; L-glutamate import across plasma membrane [GO:0098712]; locomotory behavior [GO:0007626]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of MAPK cascade [GO:0043410]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic signaling via neuropeptide [GO:0099538] dendriole [GO:0044293]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor homodimeric complex [GO:0038038]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0098872]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583] g15089.t1 Q68EF4 28.424 679 8.65e-86 291.0 sp|Q68EF4|GRM4_MOUSE Metabotropic glutamate receptor 4 OS=Mus musculus OX=10090 GN=Grm4 PE=1 SV=2 GRM4_MOUSE reviewed Metabotropic glutamate receptor 4 (mGluR4) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0004930; GO:0005516; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007612; GO:0008066; GO:0031410; GO:0043005; GO:0043195; GO:0043198; GO:0043410; GO:0048306; GO:0048787; GO:0051966; GO:0098688; GO:0098978; GO:0099171; GO:0150048 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; positive regulation of MAPK cascade [GO:0043410]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g15090.t1 P41594 30.635 803 1.0499999999999998e-104 353.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g15091.t1 P97772 30.539 835 4.12e-105 354.0 sp|P97772|GRM1_MOUSE Metabotropic glutamate receptor 1 OS=Mus musculus OX=10090 GN=Grm1 PE=1 SV=2 g15092.t1 Q3KQ10 33.125 160 3.7900000000000005e-27 103.0 sp|Q3KQ10|CENPM_XENLA Centromere protein M OS=Xenopus laevis OX=8355 GN=cenpm PE=2 SV=1 g15094.t1 Q9UI43 46.61 236 6.98e-78 238.0 sp|Q9UI43|MRM2_HUMAN rRNA methyltransferase 2, mitochondrial OS=Homo sapiens OX=9606 GN=MRM2 PE=1 SV=1 MRM2_HUMAN reviewed rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (16S rRNA (uridine(1369)-2'-O)-methyltransferase) (16S rRNA [Um1369] 2'-O-methyltransferase) (Protein ftsJ homolog 2) Homo sapiens (Human) GO:0000451; GO:0001510; GO:0005730; GO:0005739; GO:0005759; GO:0006364; GO:0008650; GO:0031167; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775]; RNA methylation [GO:0001510]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650] g15095.t1 Q8K4Q0 62.056 1352 0.0 1699.0 sp|Q8K4Q0|RPTOR_MOUSE Regulatory-associated protein of mTOR OS=Mus musculus OX=10090 GN=Rptor PE=1 SV=1 RPTOR_MOUSE reviewed Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) Mus musculus (Mouse) GO:0000045; GO:0001558; GO:0001932; GO:0001938; GO:0002181; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031267; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045672; GO:0045821; GO:0045945; GO:0045947; GO:0045948; GO:0046676; GO:0046889; GO:0061462; GO:0071230; GO:0071233; GO:0071333; GO:0071456; GO:0071470; GO:0071889; GO:0140767; GO:1900087; GO:1901331; GO:1902554; GO:1904263; GO:1905857 autophagosome assembly [GO:0000045]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; DNA damage response [GO:0006974]; negative regulation of autophagy [GO:0010507]; negative regulation of insulin secretion [GO:0046676]; negative regulation of translational initiation [GO:0045947]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of protein phosphorylation [GO:0001932]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931] 14-3-3 protein binding [GO:0071889]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g15095.t2 Q8K4Q0 62.267 1341 0.0 1700.0 sp|Q8K4Q0|RPTOR_MOUSE Regulatory-associated protein of mTOR OS=Mus musculus OX=10090 GN=Rptor PE=1 SV=1 RPTOR_MOUSE reviewed Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) Mus musculus (Mouse) GO:0000045; GO:0001558; GO:0001932; GO:0001938; GO:0002181; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031267; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045672; GO:0045821; GO:0045945; GO:0045947; GO:0045948; GO:0046676; GO:0046889; GO:0061462; GO:0071230; GO:0071233; GO:0071333; GO:0071456; GO:0071470; GO:0071889; GO:0140767; GO:1900087; GO:1901331; GO:1902554; GO:1904263; GO:1905857 autophagosome assembly [GO:0000045]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; DNA damage response [GO:0006974]; negative regulation of autophagy [GO:0010507]; negative regulation of insulin secretion [GO:0046676]; negative regulation of translational initiation [GO:0045947]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of protein phosphorylation [GO:0001932]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931] 14-3-3 protein binding [GO:0071889]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g15095.t3 Q8K4Q0 61.972 1349 0.0 1701.0 sp|Q8K4Q0|RPTOR_MOUSE Regulatory-associated protein of mTOR OS=Mus musculus OX=10090 GN=Rptor PE=1 SV=1 RPTOR_MOUSE reviewed Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) Mus musculus (Mouse) GO:0000045; GO:0001558; GO:0001932; GO:0001938; GO:0002181; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031267; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045672; GO:0045821; GO:0045945; GO:0045947; GO:0045948; GO:0046676; GO:0046889; GO:0061462; GO:0071230; GO:0071233; GO:0071333; GO:0071456; GO:0071470; GO:0071889; GO:0140767; GO:1900087; GO:1901331; GO:1902554; GO:1904263; GO:1905857 autophagosome assembly [GO:0000045]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; DNA damage response [GO:0006974]; negative regulation of autophagy [GO:0010507]; negative regulation of insulin secretion [GO:0046676]; negative regulation of translational initiation [GO:0045947]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of protein phosphorylation [GO:0001932]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931] 14-3-3 protein binding [GO:0071889]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g15095.t4 Q8K4Q0 62.09 1340 0.0 1691.0 sp|Q8K4Q0|RPTOR_MOUSE Regulatory-associated protein of mTOR OS=Mus musculus OX=10090 GN=Rptor PE=1 SV=1 RPTOR_MOUSE reviewed Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) Mus musculus (Mouse) GO:0000045; GO:0001558; GO:0001932; GO:0001938; GO:0002181; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031267; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045672; GO:0045821; GO:0045945; GO:0045947; GO:0045948; GO:0046676; GO:0046889; GO:0061462; GO:0071230; GO:0071233; GO:0071333; GO:0071456; GO:0071470; GO:0071889; GO:0140767; GO:1900087; GO:1901331; GO:1902554; GO:1904263; GO:1905857 autophagosome assembly [GO:0000045]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; DNA damage response [GO:0006974]; negative regulation of autophagy [GO:0010507]; negative regulation of insulin secretion [GO:0046676]; negative regulation of translational initiation [GO:0045947]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of protein phosphorylation [GO:0001932]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931] 14-3-3 protein binding [GO:0071889]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g15096.t1 A8MT69 55.263 76 1.11e-22 85.9 sp|A8MT69|CENPX_HUMAN Centromere protein X OS=Homo sapiens OX=9606 GN=CENPX PE=1 SV=1 CENPX_HUMAN reviewed Centromere protein X (CENP-X) (FANCM-associated histone fold protein 2) (FANCM-interacting histone fold protein 2) (Fanconi anemia-associated polypeptide of 10 kDa) (Retinoic acid-inducible gene D9 protein homolog) (Stimulated by retinoic acid gene 13 protein homolog) Homo sapiens (Human) GO:0000712; GO:0000785; GO:0000939; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0007059; GO:0031297; GO:0031398; GO:0036297; GO:0043240; GO:0051301; GO:0051382; GO:0071821 cell division [GO:0051301]; chromosome segregation [GO:0007059]; interstrand cross-link repair [GO:0036297]; kinetochore assembly [GO:0051382]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677] g15097.t1 O88637 61.741 379 1.43e-171 489.0 sp|O88637|PCY2_RAT Ethanolamine-phosphate cytidylyltransferase OS=Rattus norvegicus OX=10116 GN=Pcyt2 PE=1 SV=1 g15099.t1 Q96Q15 37.551 3691 0.0 2302.0 sp|Q96Q15|SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens OX=9606 GN=SMG1 PE=1 SV=3 SMG1_HUMAN reviewed Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1) Homo sapiens (Human) GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006974; GO:0018105; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of telomere maintenance [GO:0032204] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] g15099.t2 Q96Q15 37.544 3689 0.0 2304.0 sp|Q96Q15|SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens OX=9606 GN=SMG1 PE=1 SV=3 SMG1_HUMAN reviewed Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1) Homo sapiens (Human) GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006974; GO:0018105; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of telomere maintenance [GO:0032204] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] g15099.t3 Q96Q15 37.551 3691 0.0 2302.0 sp|Q96Q15|SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens OX=9606 GN=SMG1 PE=1 SV=3 SMG1_HUMAN reviewed Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1) Homo sapiens (Human) GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006974; GO:0018105; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of telomere maintenance [GO:0032204] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] g15099.t4 Q96Q15 37.268 3719 0.0 2286.0 sp|Q96Q15|SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens OX=9606 GN=SMG1 PE=1 SV=3 SMG1_HUMAN reviewed Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1) Homo sapiens (Human) GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006974; GO:0018105; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of telomere maintenance [GO:0032204] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] g15101.t1 Q4V832 30.176 454 2.99e-50 189.0 sp|Q4V832|AP4AT_XENLA AP-4 complex accessory subunit tepsin OS=Xenopus laevis OX=8355 GN=tepsin PE=2 SV=2 g15102.t1 P51688 53.521 497 0.0 551.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g15102.t2 P51688 52.8 500 0.0 553.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g15102.t3 P51688 51.488 336 3.31e-121 370.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g15102.t3 P51688 56.17 235 1.31e-82 270.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g15103.t1 B3EWZ3 37.5 424 1.38e-71 269.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g15103.t1 B3EWZ3 36.212 359 3.8100000000000003e-56 219.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g15103.t1 B3EWZ3 33.56 441 4.19e-52 206.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g15103.t1 B3EWZ3 32.268 313 1.6100000000000002e-31 139.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g15103.t1 B3EWZ3 36.957 184 5.99e-26 120.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g15104.t1 F1R8Z9 42.042 333 2.0000000000000002e-66 222.0 sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1 FXJ1B_DANRE reviewed Forkhead box protein J1-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271 auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15105.t1 Q9Y2W2 47.592 353 8.12e-75 254.0 sp|Q9Y2W2|WBP11_HUMAN WW domain-binding protein 11 OS=Homo sapiens OX=9606 GN=WBP11 PE=1 SV=1 WBP11_HUMAN reviewed WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1) Homo sapiens (Human) GO:0001669; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006397; GO:0008380; GO:0050699; GO:0097228; GO:0097229 mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm end piece [GO:0097229]; sperm principal piece [GO:0097228] RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699] g15106.t1 Q8BVV7 34.573 457 2.7599999999999998e-67 246.0 sp|Q8BVV7|CEP95_MOUSE Centrosomal protein of 95 kDa OS=Mus musculus OX=10090 GN=Cep95 PE=1 SV=2 g15106.t2 Q8BVV7 34.573 457 2.62e-67 246.0 sp|Q8BVV7|CEP95_MOUSE Centrosomal protein of 95 kDa OS=Mus musculus OX=10090 GN=Cep95 PE=1 SV=2 g15108.t1 Q6TH15 67.222 540 0.0 759.0 sp|Q6TH15|EIF3D_DANRE Eukaryotic translation initiation factor 3 subunit D OS=Danio rerio OX=7955 GN=eif3d PE=2 SV=1 g15109.t1 Q94519 60.638 94 5.8e-35 122.0 sp|Q94519|ACPM_DROME Acyl carrier protein, mitochondrial OS=Drosophila melanogaster OX=7227 GN=ND-ACP PE=1 SV=1 g15124.t1 F1QAM1 31.768 362 9.479999999999999e-60 199.0 sp|F1QAM1|ZDHC4_DANRE Palmitoyltransferase ZDHHC4 OS=Danio rerio OX=7955 GN=zdhhc4 PE=2 SV=1 g15125.t1 P54922 57.637 347 5.74e-133 386.0 sp|P54922|ADPRH_HUMAN ADP-ribosylhydrolase ARH1 OS=Homo sapiens OX=9606 GN=ADPRH PE=1 SV=1 ADPRH_HUMAN reviewed ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1) Homo sapiens (Human) GO:0000287; GO:0003875; GO:0005615; GO:0030955; GO:0036211; GO:0051725 protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211] extracellular space [GO:0005615] ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955] g15127.t1 Q95108 39.623 159 3.18e-38 130.0 sp|Q95108|THIOM_BOVIN Thioredoxin, mitochondrial OS=Bos taurus OX=9913 GN=TXN2 PE=1 SV=2 g15128.t1 Q90YS3 78.777 278 2.67e-152 429.0 sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1 g15129.t1 Q8IV36 68.545 852 0.0 1161.0 sp|Q8IV36|HID1_HUMAN Protein HID1 OS=Homo sapiens OX=9606 GN=HID1 PE=1 SV=1 HID1_HUMAN reviewed Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog) Homo sapiens (Human) GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0009749; GO:0016020; GO:0030070; GO:0042144; GO:0061792; GO:0070062; GO:0098548 insulin processing [GO:0030070]; response to glucose [GO:0009749]; secretory granule maturation [GO:0061792]; vacuole fusion, non-autophagic [GO:0042144] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic side of Golgi membrane [GO:0098548]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] g15129.t2 Q8IV36 68.353 850 0.0 1154.0 sp|Q8IV36|HID1_HUMAN Protein HID1 OS=Homo sapiens OX=9606 GN=HID1 PE=1 SV=1 HID1_HUMAN reviewed Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog) Homo sapiens (Human) GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0009749; GO:0016020; GO:0030070; GO:0042144; GO:0061792; GO:0070062; GO:0098548 insulin processing [GO:0030070]; response to glucose [GO:0009749]; secretory granule maturation [GO:0061792]; vacuole fusion, non-autophagic [GO:0042144] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic side of Golgi membrane [GO:0098548]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] g15130.t1 U3JAG9 43.421 1216 0.0 776.0 sp|U3JAG9|CP131_DANRE Centrosomal protein of 131 kDa OS=Danio rerio OX=7955 GN=cep131 PE=1 SV=1 CP131_DANRE reviewed Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; extracellular region [GO:0005576] g15131.t1 O75175 57.841 389 1.14e-124 394.0 sp|O75175|CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1 CNOT3_HUMAN reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2) Homo sapiens (Human) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g15131.t1 O75175 73.545 189 2.36e-91 306.0 sp|O75175|CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1 CNOT3_HUMAN reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2) Homo sapiens (Human) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g15131.t2 O75175 57.436 390 2.5400000000000002e-124 394.0 sp|O75175|CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1 CNOT3_HUMAN reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2) Homo sapiens (Human) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g15131.t2 O75175 73.545 189 2.16e-91 306.0 sp|O75175|CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1 CNOT3_HUMAN reviewed CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2) Homo sapiens (Human) GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006402; GO:0006417; GO:0007368; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036 determination of left/right symmetry [GO:0007368]; mRNA catabolic process [GO:0006402]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] g15132.t1 Q9CXB2 30.588 340 5.6499999999999996e-42 159.0 sp|Q9CXB2|SOAT_MOUSE Sodium-dependent organic anion transporter OS=Mus musculus OX=10090 GN=Slc10a6 PE=1 SV=1 SOAT_MOUSE reviewed Sodium-dependent organic anion transporter (SOAT) (Solute carrier family 10 member 6) (SLC10A6) Mus musculus (Mouse) GO:0008508; GO:0015721; GO:0016020; GO:0043250; GO:0043251 bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251] membrane [GO:0016020] bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250] g15134.t1 Q8VCI0 47.409 521 3.01e-160 470.0 sp|Q8VCI0|PLBL1_MOUSE Phospholipase B-like 1 OS=Mus musculus OX=10090 GN=Plbd1 PE=1 SV=1 g15135.t1 Q5U2V4 48.785 494 4.19e-162 475.0 sp|Q5U2V4|PLBL1_RAT Phospholipase B-like 1 OS=Rattus norvegicus OX=10116 GN=Plbd1 PE=2 SV=1 LYLAP_RAT reviewed Lysosomal leucine aminopeptidase (LyLAP) (EC 3.4.11.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) (Phospholipase B-like 1) [Cleaved into: Lysosomal leucine aminopeptidase chain A; Lysosomal leucine aminopeptidase chain B; Lysosomal leucine aminopeptidase chain C] Rattus norvegicus (Rat) GO:0004177; GO:0004620; GO:0005576; GO:0005615; GO:0005764; GO:0009395; GO:1905146 lysosomal protein catabolic process [GO:1905146]; phospholipid catabolic process [GO:0009395] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] aminopeptidase activity [GO:0004177]; phospholipase activity [GO:0004620] g15136.t1 Q5ZIE8 49.265 136 5.82e-28 127.0 sp|Q5ZIE8|MCAF1_CHICK Activating transcription factor 7-interacting protein 1 OS=Gallus gallus OX=9031 GN=ATF7IP PE=2 SV=1 g15137.t1 Q9ET47 37.069 232 7.260000000000001e-27 119.0 sp|Q9ET47|ESPN_MOUSE Espin OS=Mus musculus OX=10090 GN=Espn PE=1 SV=2 g15138.t1 P02288 78.333 120 4.6499999999999994e-61 186.0 sp|P02288|H2BE2_PSAMI Histone H2B.2, embryonic OS=Psammechinus miliaris OX=7660 PE=3 SV=2 g15139.t1 P58872 43.103 232 4.3100000000000003e-57 189.0 sp|P58872|RHBL3_HUMAN Rhomboid-related protein 3 OS=Homo sapiens OX=9606 GN=RHBDL3 PE=1 SV=1 g15141.t1 P07305 46.535 101 9.43e-22 90.9 sp|P07305|H10_HUMAN Histone H1.0 OS=Homo sapiens OX=9606 GN=H1-0 PE=1 SV=3 H10_HUMAN reviewed Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed] Homo sapiens (Human) GO:0000785; GO:0000786; GO:0000791; GO:0003680; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0006334; GO:0015629; GO:0016604; GO:0017053; GO:0030261; GO:0030527; GO:0031490; GO:0031491; GO:0031492; GO:0031507; GO:0045910; GO:2000679 chromosome condensation [GO:0030261]; heterochromatin formation [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; positive regulation of transcription regulatory region DNA binding [GO:2000679] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] g15145.t1 P29506 63.218 87 1.2200000000000001e-31 120.0 sp|P29506|UNC4_CAEEL Homeobox protein unc-4 OS=Caenorhabditis elegans OX=6239 GN=unc-4 PE=1 SV=2 UNC4_CAEEL reviewed Homeobox protein unc-4 (Homeobox protein ceh-4) (Uncoordinated protein 4) Caenorhabditis elegans GO:0000122; GO:0000977; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007400; GO:0007416; GO:0008039; GO:0030424; GO:0040011; GO:0048489; GO:0048666; GO:0050770; GO:0050803; GO:0050807; GO:0090090 cell fate specification [GO:0001708]; locomotion [GO:0040011]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; neuron development [GO:0048666]; regulation of axonogenesis [GO:0050770]; regulation of DNA-templated transcription [GO:0006355]; regulation of synapse organization [GO:0050807]; regulation of synapse structure or activity [GO:0050803]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039]; synaptic vesicle transport [GO:0048489] axon [GO:0030424]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g15146.t1 Q50D79 75.833 120 1.8e-50 182.0 sp|Q50D79|UNC4_DANRE Homeobox protein unc-4 homolog OS=Danio rerio OX=7955 GN=uncx PE=2 SV=2 g15148.t1 Q8K448 24.581 358 1.12e-25 112.0 sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2 ABCA5_MOUSE reviewed Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) Mus musculus (Mouse) GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] g15165.t1 Q9UL41 29.712 313 1.43e-32 132.0 sp|Q9UL41|PNMA3_HUMAN Paraneoplastic antigen Ma3 OS=Homo sapiens OX=9606 GN=PNMA3 PE=1 SV=3 PNMA3_HUMAN reviewed Paraneoplastic antigen Ma3 Homo sapiens (Human) GO:0003676; GO:0005730; GO:0008270; GO:0043065 positive regulation of apoptotic process [GO:0043065] nucleolus [GO:0005730] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g15179.t1 O60290 23.038 586 6.97e-38 155.0 sp|O60290|ZN862_HUMAN Zinc finger protein 862 OS=Homo sapiens OX=9606 GN=ZNF862 PE=1 SV=2 g15183.t1 P60322 65.517 58 4.040000000000001e-21 87.8 sp|P60322|NANO2_MOUSE Nanos homolog 2 OS=Mus musculus OX=10090 GN=Nanos2 PE=1 SV=2 NANO2_MOUSE reviewed Nanos homolog 2 (NOS-2) Mus musculus (Mouse) GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008047; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:0061157 germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] enzyme activator activity [GO:0008047]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g15191.t1 P12027 22.034 354 1.8400000000000002e-27 119.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15191.t1 P12027 22.157 343 1.01e-26 117.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15191.t1 P12027 22.157 343 1.01e-26 117.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15191.t1 P12027 22.157 343 1.01e-26 117.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15191.t1 P12027 22.157 343 1.01e-26 117.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15191.t1 P12027 22.157 343 1.01e-26 117.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15191.t1 P12027 22.157 343 1.01e-26 117.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15191.t1 P12027 22.388 335 1.2900000000000001e-26 117.0 sp|P12027|PSGP_ONCMY Polysialoglycoprotein OS=Oncorhynchus mykiss OX=8022 PE=1 SV=2 g15197.t1 P60322 37.762 143 4.13e-21 87.8 sp|P60322|NANO2_MOUSE Nanos homolog 2 OS=Mus musculus OX=10090 GN=Nanos2 PE=1 SV=2 NANO2_MOUSE reviewed Nanos homolog 2 (NOS-2) Mus musculus (Mouse) GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008047; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:0061157 germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] enzyme activator activity [GO:0008047]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g15206.t1 P16423 36.992 246 6.95e-41 153.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g15215.t1 P21265 75.311 482 0.0 776.0 sp|P21265|PUR8_CHICK Adenylosuccinate lyase OS=Gallus gallus OX=9031 GN=ADSL PE=2 SV=2 g15247.t1 P60322 37.063 143 3.1300000000000002e-21 88.2 sp|P60322|NANO2_MOUSE Nanos homolog 2 OS=Mus musculus OX=10090 GN=Nanos2 PE=1 SV=2 NANO2_MOUSE reviewed Nanos homolog 2 (NOS-2) Mus musculus (Mouse) GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008047; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:0061157 germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] enzyme activator activity [GO:0008047]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g15258.t1 P60322 65.517 58 5.1300000000000004e-21 87.4 sp|P60322|NANO2_MOUSE Nanos homolog 2 OS=Mus musculus OX=10090 GN=Nanos2 PE=1 SV=2 NANO2_MOUSE reviewed Nanos homolog 2 (NOS-2) Mus musculus (Mouse) GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008047; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:0061157 germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] enzyme activator activity [GO:0008047]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g15259.t1 P60322 65.517 58 1.2200000000000001e-21 87.0 sp|P60322|NANO2_MOUSE Nanos homolog 2 OS=Mus musculus OX=10090 GN=Nanos2 PE=1 SV=2 NANO2_MOUSE reviewed Nanos homolog 2 (NOS-2) Mus musculus (Mouse) GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008047; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:0061157 germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] enzyme activator activity [GO:0008047]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g15310.t1 P21265 69.492 59 1.3900000000000001e-21 95.9 sp|P21265|PUR8_CHICK Adenylosuccinate lyase OS=Gallus gallus OX=9031 GN=ADSL PE=2 SV=2 g15313.t1 Q9DEI1 68.056 72 7.84e-25 102.0 sp|Q9DEI1|PRKDC_XENLA DNA-dependent protein kinase catalytic subunit OS=Xenopus laevis OX=8355 GN=prkdc PE=2 SV=1 g15314.t1 Q94AM1 47.783 699 0.0 634.0 sp|Q94AM1|OOPDA_ARATH Organellar oligopeptidase A, chloroplastic/mitochondrial OS=Arabidopsis thaliana OX=3702 GN=OOP PE=1 SV=1 OOPDA_ARATH reviewed Organellar oligopeptidase A, chloroplastic/mitochondrial (AtOOP) (EC 3.4.24.70) (Thimet metalloendopeptidase 1) (Zincin-like metalloproteases family protein 1) Arabidopsis thaliana (Mouse-ear cress) GO:0004222; GO:0005759; GO:0006508; GO:0006518; GO:0009507; GO:0009536; GO:0009570; GO:0046872 peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; mitochondrial matrix [GO:0005759]; plastid [GO:0009536] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g15316.t1 O54922 43.04 704 0.0 569.0 sp|O54922|EXOC7_RAT Exocyst complex component 7 OS=Rattus norvegicus OX=10116 GN=Exoc7 PE=1 SV=1 g15316.t2 O35250 44.778 699 0.0 582.0 sp|O35250|EXOC7_MOUSE Exocyst complex component 7 OS=Mus musculus OX=10090 GN=Exoc7 PE=1 SV=2 EXOC7_MOUSE reviewed Exocyst complex component 7 (Exocyst complex component Exo70) Mus musculus (Mouse) GO:0000145; GO:0000281; GO:0005546; GO:0005815; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0030496; GO:0030674; GO:0032584; GO:0034451; GO:0051963; GO:0071806; GO:0090148; GO:0090522; GO:0090543; GO:0098793; GO:0098794; GO:1903438; GO:2000535 exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein transmembrane transport [GO:0071806]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of synapse assembly [GO:0051963]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-macromolecule adaptor activity [GO:0030674] g15317.t1 Q14344 61.667 360 5.69e-160 456.0 sp|Q14344|GNA13_HUMAN Guanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens OX=9606 GN=GNA13 PE=1 SV=2 g15319.t1 Q9CPY6 79.798 198 5.3700000000000006e-117 334.0 sp|Q9CPY6|GID4_MOUSE Glucose-induced degradation protein 4 homolog OS=Mus musculus OX=10090 GN=Gid4 PE=1 SV=1 g15320.t1 Q1LZ96 59.751 241 1.0200000000000001e-103 306.0 sp|Q1LZ96|ATPF2_BOVIN ATP synthase mitochondrial F1 complex assembly factor 2 OS=Bos taurus OX=9913 GN=ATPAF2 PE=2 SV=1 g15321.t1 Q9D5E4 52.317 518 0.0 548.0 sp|Q9D5E4|DRC3_MOUSE Dynein regulatory complex subunit 3 OS=Mus musculus OX=10090 GN=Drc3 PE=1 SV=1 DRC3_MOUSE reviewed Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48) Mus musculus (Mouse) GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0097545 axonemal doublet microtubule [GO:0097545]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] g15322.t1 Q5SRX1 42.42 653 2.73e-151 449.0 sp|Q5SRX1|TM1L2_MOUSE TOM1-like protein 2 OS=Mus musculus OX=10090 GN=Tom1l2 PE=1 SV=1 g15322.t2 Q5SRX1 43.012 644 6.85e-153 453.0 sp|Q5SRX1|TM1L2_MOUSE TOM1-like protein 2 OS=Mus musculus OX=10090 GN=Tom1l2 PE=1 SV=1 g15323.t1 A5D7N3 63.953 172 6.28e-78 233.0 sp|A5D7N3|TMM11_BOVIN Transmembrane protein 11, mitochondrial OS=Bos taurus OX=9913 GN=TMEM11 PE=2 SV=1 g15324.t1 P55039 80.495 364 0.0 635.0 sp|P55039|DRG2_HUMAN Developmentally-regulated GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=DRG2 PE=1 SV=1 DRG2_HUMAN reviewed Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-) Homo sapiens (Human) GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0046872 cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] g15325.t1 O96530 41.472 299 7e-49 187.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g15325.t1 O96530 39.535 301 7.41e-46 178.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g15325.t1 O96530 36.789 299 1.8600000000000002e-43 171.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g15325.t1 O96530 41.111 270 6.8299999999999995e-34 142.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g15325.t1 O96530 37.104 221 3.02e-26 119.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g15326.t1 P46058 30.747 348 3.03e-39 144.0 sp|P46058|EDSP_CYNPY Epidermal differentiation-specific protein OS=Cynops pyrrhogaster OX=8330 PE=2 SV=1 g15327.t1 O76536 39.526 253 3.73e-40 162.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15327.t1 O76536 36.184 304 7.68e-39 158.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15327.t1 O76536 37.546 269 7.4e-38 155.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15327.t1 O76536 35.548 301 2.9200000000000002e-36 150.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15327.t1 O76536 36.614 254 1.0500000000000001e-32 139.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15327.t1 O76536 37.052 251 1.39e-27 123.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15327.t1 O76536 37.5 256 2.68e-27 122.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15327.t1 O76536 36.709 237 1.8500000000000002e-26 119.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g15329.t1 P46058 31.322 348 6.65e-41 149.0 sp|P46058|EDSP_CYNPY Epidermal differentiation-specific protein OS=Cynops pyrrhogaster OX=8330 PE=2 SV=1 g15330.t1 P30352 77.451 102 5e-50 165.0 sp|P30352|SRSF2_CHICK Serine/arginine-rich splicing factor 2 OS=Gallus gallus OX=9031 GN=SRSF2 PE=2 SV=1 g15331.t1 Q5F364 52.137 1544 0.0 1628.0 sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1 MRP1_CHICK reviewed Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter) Gallus gallus (Chicken) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015431; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0046943; GO:0070729 cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; carboxylic acid transmembrane transporter activity [GO:0046943]; glutathione transmembrane transporter activity [GO:0034634] g15332.t1 Q3KQF0 78.025 314 0.0 535.0 sp|Q3KQF0|NUP1A_XENLA Cytosolic Fe-S cluster assembly factor nubp1-A OS=Xenopus laevis OX=8355 GN=nubp1-A PE=2 SV=1 g15335.t1 Q7Z442 27.976 983 2.8299999999999997e-89 331.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g15335.t1 Q7Z442 28.783 674 8.720000000000001e-86 319.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g15335.t2 Q7Z442 28.753 946 4.56e-90 333.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g15335.t2 Q7Z442 28.783 674 6.97e-86 320.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g15336.t1 Q9NTG1 22.693 1203 6.82e-81 303.0 sp|Q9NTG1|PKDRE_HUMAN Polycystin family receptor for egg jelly OS=Homo sapiens OX=9606 GN=PKDREJ PE=1 SV=2 g15336.t2 Q9NTG1 22.693 1203 7.279999999999999e-81 303.0 sp|Q9NTG1|PKDRE_HUMAN Polycystin family receptor for egg jelly OS=Homo sapiens OX=9606 GN=PKDREJ PE=1 SV=2 g15337.t1 A6H782 51.515 495 5.33e-177 509.0 sp|A6H782|TEKT3_BOVIN Tektin-3 OS=Bos taurus OX=9913 GN=TEKT3 PE=1 SV=1 TEKT3_BOVIN reviewed Tektin-3 Bos taurus (Bovine) GO:0001669; GO:0002080; GO:0002081; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0160111 cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126] g15338.t1 Q5RAM2 33.496 409 7.37e-63 213.0 sp|Q5RAM2|ERR3_PONAB Estrogen-related receptor gamma OS=Pongo abelii OX=9601 GN=ESRRG PE=2 SV=1 g15339.t1 Q5RAM2 35.422 367 2.48e-63 214.0 sp|Q5RAM2|ERR3_PONAB Estrogen-related receptor gamma OS=Pongo abelii OX=9601 GN=ESRRG PE=2 SV=1 g15341.t1 Q6INH1 54.497 378 9.17e-142 431.0 sp|Q6INH1|RN157_XENLA E3 ubiquitin ligase Rnf157 OS=Xenopus laevis OX=8355 GN=rnf157 PE=2 SV=1 g15341.t2 Q6INH1 54.497 378 9.07e-142 431.0 sp|Q6INH1|RN157_XENLA E3 ubiquitin ligase Rnf157 OS=Xenopus laevis OX=8355 GN=rnf157 PE=2 SV=1 g15346.t2 Q9BY77 28.243 478 6.64e-23 103.0 sp|Q9BY77|PDIP3_HUMAN Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=2 PDIP3_HUMAN reviewed Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727 poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723] g15350.t1 Q8TB05 63.158 95 5.18e-33 117.0 sp|Q8TB05|UBAD1_HUMAN UBA-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBALD1 PE=1 SV=1 g15361.t1 Q11212 97.531 81 7.8e-56 173.0 sp|Q11212|ACT_SPOLI Actin (Fragment) OS=Spodoptera littoralis OX=7109 PE=2 SV=1 g15362.t1 Q92193 88.235 68 4.6e-37 132.0 sp|Q92193|ACT_CRAVI Actin (Fragment) OS=Crassostrea virginica OX=6565 PE=2 SV=1 g15366.t1 E1BZ85 65.152 66 2.63e-26 103.0 sp|E1BZ85|MARF1_CHICK Meiosis regulator and mRNA stability factor 1 OS=Gallus gallus OX=9031 GN=MARF1 PE=3 SV=1 g15366.t1 E1BZ85 60.0 65 6.1000000000000005e-22 90.5 sp|E1BZ85|MARF1_CHICK Meiosis regulator and mRNA stability factor 1 OS=Gallus gallus OX=9031 GN=MARF1 PE=3 SV=1 g15369.t1 E1BZ85 60.643 249 2.01e-90 316.0 sp|E1BZ85|MARF1_CHICK Meiosis regulator and mRNA stability factor 1 OS=Gallus gallus OX=9031 GN=MARF1 PE=3 SV=1 g15370.t1 Q66J96 52.201 318 5.22e-93 283.0 sp|Q66J96|NDE1A_XENLA Nuclear distribution protein nudE homolog 1-A OS=Xenopus laevis OX=8355 GN=nde1-a PE=1 SV=1 NDE1A_XENLA reviewed Nuclear distribution protein nudE homolog 1-A (Mitotic phosphoprotein 43) (MP43) Xenopus laevis (African clawed frog) GO:0000132; GO:0000776; GO:0005813; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0016477; GO:0030659; GO:0031616; GO:0032154; GO:0047496; GO:0051298; GO:0051301; GO:0051642 cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; vesicle transport along microtubule [GO:0047496] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616] microtubule binding [GO:0008017] g15371.t1 Q6P7A9 50.304 823 0.0 845.0 sp|Q6P7A9|LYAG_RAT Lysosomal alpha-glucosidase OS=Rattus norvegicus OX=10116 GN=Gaa PE=2 SV=1 LYAG_RAT reviewed Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) Rattus norvegicus (Rat) GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0090599; GO:0120282 aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181] autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246] g15375.t1 Q61656 71.125 471 0.0 714.0 sp|Q61656|DDX5_MOUSE Probable ATP-dependent RNA helicase DDX5 OS=Mus musculus OX=10090 GN=Ddx5 PE=1 SV=2 DDX5_MOUSE reviewed Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Mus musculus (Mouse) GO:0000122; GO:0000380; GO:0000381; GO:0000956; GO:0001837; GO:0003712; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0006606; GO:0007623; GO:0009299; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0045893; GO:0046332; GO:0048306; GO:0050681; GO:0060765; GO:0061614; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014 alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of DNA-templated transcription [GO:0045893]; primary miRNA processing [GO:0031053]; protein import into nucleus [GO:0006606]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712] g15376.t1 Q9Y2Q5 76.8 125 3.02e-69 206.0 sp|Q9Y2Q5|LTOR2_HUMAN Ragulator complex protein LAMTOR2 OS=Homo sapiens OX=9606 GN=LAMTOR2 PE=1 SV=1 LTOR2_HUMAN reviewed Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (MAPBP-interacting protein) (Roadblock domain-containing protein 3) Homo sapiens (Human) GO:0001558; GO:0005085; GO:0005765; GO:0005770; GO:0005886; GO:0008104; GO:0010008; GO:0010761; GO:0031902; GO:0032008; GO:0035579; GO:0038202; GO:0043410; GO:0060090; GO:0070821; GO:0071230; GO:0071986; GO:0150116; GO:1902414; GO:1904263; GO:1990877 cellular response to amino acid stimulus [GO:0071230]; fibroblast migration [GO:0010761]; intracellular protein localization [GO:0008104]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to cell junction [GO:1902414]; regulation of cell growth [GO:0001558]; regulation of cell-substrate junction organization [GO:0150116]; TORC1 signaling [GO:0038202] endosome membrane [GO:0010008]; FNIP-folliculin RagC/D GAP [GO:1990877]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090] g15379.t1 Q5R7A2 49.545 440 8.02e-154 448.0 sp|Q5R7A2|ALG1_PONAB Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Pongo abelii OX=9601 GN=ALG1 PE=2 SV=1 g15380.t1 Q9ER34 72.997 774 0.0 1179.0 sp|Q9ER34|ACON_RAT Aconitate hydratase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aco2 PE=1 SV=2 ACON_RAT reviewed Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) Rattus norvegicus (Rat) GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0051538; GO:0051539 citrate metabolic process [GO:0006101]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron ion binding [GO:0005506] g15382.t1 Q641Z8 49.112 169 3.3499999999999997e-60 196.0 sp|Q641Z8|PEF1_RAT Peflin OS=Rattus norvegicus OX=10116 GN=Pef1 PE=2 SV=1 PEF1_RAT reviewed Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1) Rattus norvegicus (Rat) GO:0005509; GO:0005737; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0042802; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:1902527; GO:1990756 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g15383.t1 Q96D21 46.632 193 1.13e-49 166.0 sp|Q96D21|RHES_HUMAN GTP-binding protein Rhes OS=Homo sapiens OX=9606 GN=RASD2 PE=1 SV=1 RHES_HUMAN reviewed GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) Homo sapiens (Human) GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031681; GO:0033235; GO:0045202; GO:0051897 locomotory behavior [GO:0007626]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963] plasma membrane [GO:0005886]; synapse [GO:0045202] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g15384.t1 Q8N8E3 42.549 557 2.62e-136 422.0 sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2 CE112_HUMAN reviewed Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46) Homo sapiens (Human) GO:0005813; GO:0005886; GO:0060077; GO:0097120; GO:0140693 receptor localization to synapse [GO:0097120] centrosome [GO:0005813]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886] molecular condensate scaffold activity [GO:0140693] g15385.t1 Q8N8E3 44.693 179 1.2200000000000001e-31 123.0 sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2 CE112_HUMAN reviewed Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46) Homo sapiens (Human) GO:0005813; GO:0005886; GO:0060077; GO:0097120; GO:0140693 receptor localization to synapse [GO:0097120] centrosome [GO:0005813]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886] molecular condensate scaffold activity [GO:0140693] g15387.t1 Q8N8E3 40.223 179 6.69e-36 136.0 sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2 CE112_HUMAN reviewed Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46) Homo sapiens (Human) GO:0005813; GO:0005886; GO:0060077; GO:0097120; GO:0140693 receptor localization to synapse [GO:0097120] centrosome [GO:0005813]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886] molecular condensate scaffold activity [GO:0140693] g15388.t1 Q6ZXC9 39.256 242 1.88e-45 162.0 sp|Q6ZXC9|SIA8D_BOVIN CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Bos taurus OX=9913 GN=ST8SIA4 PE=2 SV=1 g15389.t1 Q3UIA2 44.273 454 1.47e-131 412.0 sp|Q3UIA2|RHG17_MOUSE Rho GTPase-activating protein 17 OS=Mus musculus OX=10090 GN=Arhgap17 PE=1 SV=1 g15390.t1 Q5NVA9 40.284 422 2.64e-86 288.0 sp|Q5NVA9|EME1_PONAB Structure-specific endonuclease subunit EME1 OS=Pongo abelii OX=9601 GN=EME1 PE=3 SV=1 g15392.t1 A0JMW2 48.571 700 0.0 687.0 sp|A0JMW2|DAAF5_XENLA Dynein axonemal assembly factor 5 OS=Xenopus laevis OX=8355 GN=dnaaf5 PE=2 SV=1 g15392.t2 A0JMW2 46.678 602 0.0 575.0 sp|A0JMW2|DAAF5_XENLA Dynein axonemal assembly factor 5 OS=Xenopus laevis OX=8355 GN=dnaaf5 PE=2 SV=1 g15394.t1 E2IYB3 55.963 109 9.5e-36 129.0 sp|E2IYB3|FCNV1_VARKO Veficolin-1 (Fragment) OS=Varanus komodoensis OX=61221 PE=2 SV=1 g15394.t2 E2IYB3 57.143 77 7.98e-24 97.4 sp|E2IYB3|FCNV1_VARKO Veficolin-1 (Fragment) OS=Varanus komodoensis OX=61221 PE=2 SV=1 g15395.t1 Q27433 75.0 256 1.74e-127 374.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15396.t1 Q27433 77.273 176 1.61e-75 236.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15397.t1 Q9Y661 49.32 294 2.2e-98 303.0 sp|Q9Y661|HS3S4_HUMAN Heparan sulfate glucosamine 3-O-sulfotransferase 4 OS=Homo sapiens OX=9606 GN=HS3ST4 PE=1 SV=3 g15398.t1 Q29RM1 48.615 325 2.68e-103 308.0 sp|Q29RM1|TPC_BOVIN Mitochondrial thiamine pyrophosphate carrier OS=Bos taurus OX=9913 GN=SLC25A19 PE=2 SV=1 g15399.t1 Q8JZQ9 63.889 684 0.0 956.0 sp|Q8JZQ9|EIF3B_MOUSE Eukaryotic translation initiation factor 3 subunit B OS=Mus musculus OX=10090 GN=Eif3b PE=1 SV=1 g15400.t1 Q27433 72.201 259 5.02e-125 367.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15401.t1 Q27433 71.542 253 2.9e-120 356.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15402.t1 Q27433 69.663 267 2.67e-119 353.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15403.t1 Q27433 72.222 252 1.33e-120 356.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15404.t1 Q27433 71.705 258 2.38e-121 358.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15405.t1 O95639 56.89 283 6.06e-113 330.0 sp|O95639|CPSF4_HUMAN Cleavage and polyadenylation specificity factor subunit 4 OS=Homo sapiens OX=9606 GN=CPSF4 PE=1 SV=1 CPSF4_HUMAN reviewed Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005847; GO:0006397; GO:0008270; GO:1990837 mRNA processing [GO:0006397] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g15406.t1 Q9H633 49.541 109 1.3799999999999999e-30 110.0 sp|Q9H633|RPP21_HUMAN Ribonuclease P protein subunit p21 OS=Homo sapiens OX=9606 GN=RPP21 PE=1 SV=1 g15407.t1 Q8CFY5 50.549 364 4.78e-115 347.0 sp|Q8CFY5|COX10_MOUSE Protoheme IX farnesyltransferase, mitochondrial OS=Mus musculus OX=10090 GN=Cox10 PE=2 SV=1 COX10_MOUSE reviewed Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase) Mus musculus (Mouse) GO:0000266; GO:0002521; GO:0004311; GO:0005730; GO:0005739; GO:0005759; GO:0005829; GO:0006629; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0017004; GO:0031966; GO:0035264; GO:0055070; GO:0070069 aerobic respiration [GO:0009060]; copper ion homeostasis [GO:0055070]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; leukocyte differentiation [GO:0002521]; lipid metabolic process [GO:0006629]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; multicellular organism growth [GO:0035264]; respiratory chain complex IV assembly [GO:0008535] cytochrome complex [GO:0070069]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] geranylgeranyl diphosphate synthase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495] g15408.t1 Q7TN88 30.015 673 4.7099999999999997e-98 359.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g15408.t1 Q7TN88 26.34 858 1.47e-69 266.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g15409.t1 Q8JHF2 53.053 262 5.8499999999999996e-102 310.0 sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2 g15411.t1 Q32KH9 44.378 498 4.7e-149 439.0 sp|Q32KH9|ARSG_CANLF Arylsulfatase G OS=Canis lupus familiaris OX=9615 GN=ARSG PE=2 SV=1 ARSG_CANLF reviewed Arylsulfatase G (ASG) (EC 3.1.6.1) (N-sulfoglucosamine-3-sulfatase) (EC 3.1.6.15) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0033889; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889] g15411.t2 Q32KH9 43.874 506 1.61e-146 433.0 sp|Q32KH9|ARSG_CANLF Arylsulfatase G OS=Canis lupus familiaris OX=9615 GN=ARSG PE=2 SV=1 ARSG_CANLF reviewed Arylsulfatase G (ASG) (EC 3.1.6.1) (N-sulfoglucosamine-3-sulfatase) (EC 3.1.6.15) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0033889; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889] g15412.t1 Q32KH9 49.027 514 4.04e-171 498.0 sp|Q32KH9|ARSG_CANLF Arylsulfatase G OS=Canis lupus familiaris OX=9615 GN=ARSG PE=2 SV=1 ARSG_CANLF reviewed Arylsulfatase G (ASG) (EC 3.1.6.1) (N-sulfoglucosamine-3-sulfatase) (EC 3.1.6.15) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0033889; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889] g15412.t2 Q32KH9 47.472 356 7.8e-105 323.0 sp|Q32KH9|ARSG_CANLF Arylsulfatase G OS=Canis lupus familiaris OX=9615 GN=ARSG PE=2 SV=1 ARSG_CANLF reviewed Arylsulfatase G (ASG) (EC 3.1.6.1) (N-sulfoglucosamine-3-sulfatase) (EC 3.1.6.15) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0033889; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889] g15412.t3 Q32KH9 47.449 196 3.34e-56 189.0 sp|Q32KH9|ARSG_CANLF Arylsulfatase G OS=Canis lupus familiaris OX=9615 GN=ARSG PE=2 SV=1 ARSG_CANLF reviewed Arylsulfatase G (ASG) (EC 3.1.6.1) (N-sulfoglucosamine-3-sulfatase) (EC 3.1.6.15) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004065; GO:0005764; GO:0033889; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889] g15413.t1 Q0V9C9 40.964 332 9.12e-84 264.0 sp|Q0V9C9|ECSIT_XENTR Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial OS=Xenopus tropicalis OX=8364 GN=ecsit PE=2 SV=1 g15414.t1 Q3V2A7 41.87 246 1.44e-49 189.0 sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1 QRIC2_MOUSE reviewed Glutamine-rich protein 2 Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] g15414.t2 Q3V2A7 38.205 390 9.87e-66 233.0 sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1 QRIC2_MOUSE reviewed Glutamine-rich protein 2 Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] g15414.t3 Q3V2A7 39.402 368 1.5800000000000002e-64 232.0 sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1 QRIC2_MOUSE reviewed Glutamine-rich protein 2 Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] g15414.t4 Q3V2A7 39.402 368 1.6000000000000002e-64 232.0 sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1 QRIC2_MOUSE reviewed Glutamine-rich protein 2 Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] g15415.t1 Q70CQ4 40.716 754 1.82e-175 551.0 sp|Q70CQ4|UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens OX=9606 GN=USP31 PE=1 SV=2 UBP31_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0006508; GO:0016579 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g15416.t1 Q58DC5 72.482 556 0.0 813.0 sp|Q58DC5|GTPB1_BOVIN GTP-binding protein 1 OS=Bos taurus OX=9913 GN=GTPBP1 PE=2 SV=2 GTPB1_BOVIN reviewed GTP-binding protein 1 (EC 3.6.5.3) Bos taurus (Bovine) GO:0000049; GO:0000177; GO:0002181; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014; GO:0071025; GO:1904678 cytoplasmic translation [GO:0002181]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; RNA surveillance [GO:0071025]; translational elongation [GO:0006414] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829] alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049] g15417.t1 Q9D3S3 48.462 260 8.01e-75 246.0 sp|Q9D3S3|SNX29_MOUSE Sorting nexin-29 OS=Mus musculus OX=10090 GN=Snx29 PE=1 SV=2 g15418.t1 Q9D3S3 49.817 273 2.0100000000000002e-72 253.0 sp|Q9D3S3|SNX29_MOUSE Sorting nexin-29 OS=Mus musculus OX=10090 GN=Snx29 PE=1 SV=2 g15419.t1 P51570 59.845 386 3.0600000000000003e-169 481.0 sp|P51570|GALK1_HUMAN Galactokinase OS=Homo sapiens OX=9606 GN=GALK1 PE=1 SV=1 GALK1_HUMAN reviewed Galactokinase (EC 2.7.1.6) (Galactose kinase) Homo sapiens (Human) GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019402; GO:0033499; GO:0061623; GO:0070062 galactitol metabolic process [GO:0019402]; galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534] g15420.t1 Q8BMA6 51.695 590 0.0 593.0 sp|Q8BMA6|SRP68_MOUSE Signal recognition particle subunit SRP68 OS=Mus musculus OX=10090 GN=Srp68 PE=1 SV=2 g15421.t1 P23004 41.964 448 3.0700000000000004e-124 372.0 sp|P23004|QCR2_BOVIN Cytochrome b-c1 complex subunit 2, mitochondrial OS=Bos taurus OX=9913 GN=UQCRC2 PE=1 SV=2 g15423.t1 Q7ZXH1 60.851 470 0.0 605.0 sp|Q7ZXH1|DHCR7_XENLA 7-dehydrocholesterol reductase OS=Xenopus laevis OX=8355 GN=dhcr7 PE=2 SV=1 g15426.t1 Q9QZB9 78.571 182 2.84e-107 307.0 sp|Q9QZB9|DCTN5_MOUSE Dynactin subunit 5 OS=Mus musculus OX=10090 GN=Dctn5 PE=1 SV=1 g15432.t1 Q40358 38.122 181 7.28e-26 105.0 sp|Q40358|PRP_MEDSA Repetitive proline-rich cell wall protein OS=Medicago sativa OX=3879 GN=PRP PE=2 SV=1 g15432.t1 Q40358 36.318 201 2.39e-24 101.0 sp|Q40358|PRP_MEDSA Repetitive proline-rich cell wall protein OS=Medicago sativa OX=3879 GN=PRP PE=2 SV=1 g15432.t1 Q40358 38.636 176 8.729999999999999e-24 100.0 sp|Q40358|PRP_MEDSA Repetitive proline-rich cell wall protein OS=Medicago sativa OX=3879 GN=PRP PE=2 SV=1 g15434.t1 Q5XGG5 38.788 660 1.07e-122 390.0 sp|Q5XGG5|CCNF_XENTR Cyclin-F OS=Xenopus tropicalis OX=8364 GN=ccnf PE=2 SV=1 CCNF_XENTR reviewed Cyclin-F Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0005814; GO:0005815; GO:0010826; GO:0016538; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051301 cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centriole [GO:0005814]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005] cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] g15435.t1 Q8N957 40.856 864 0.0 632.0 sp|Q8N957|ANKF1_HUMAN Ankyrin repeat and fibronectin type-III domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKFN1 PE=1 SV=3 g15435.t2 Q8N957 40.856 864 0.0 632.0 sp|Q8N957|ANKF1_HUMAN Ankyrin repeat and fibronectin type-III domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKFN1 PE=1 SV=3 g15437.t1 Q6DJ08 58.571 280 8.040000000000001e-107 315.0 sp|Q6DJ08|S2538_XENTR Mitochondrial glycine transporter OS=Xenopus tropicalis OX=8364 GN=slc25a38 PE=2 SV=1 S2538_XENTR reviewed Mitochondrial glycine transporter (Solute carrier family 25 member 38) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005739; GO:0005743; GO:0015187; GO:0030218; GO:1904983 erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] glycine transmembrane transporter activity [GO:0015187] g15438.t1 Q5ZJ24 59.444 180 1.13e-63 196.0 sp|Q5ZJ24|CEP20_CHICK Centrosomal protein 20 OS=Gallus gallus OX=9031 GN=CEP20 PE=2 SV=1 CEP20_CHICK reviewed Centrosomal protein 20 (FGFR1OP N-terminal-like protein) (LisH domain-containing protein FOPNL) Gallus gallus (Chicken) GO:0005813; GO:0031514; GO:0034451; GO:0034453; GO:0036064; GO:0060271 cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] g15445.t1 O75899 30.124 727 1.14e-92 314.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15459.t1 O75899 29.133 738 5.81e-82 284.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15462.t1 O75899 29.7 734 6.34e-91 317.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15464.t1 O75899 28.88 741 8.14e-89 303.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15466.t1 O75899 30.402 523 1.8100000000000003e-64 228.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15468.t1 O75899 29.893 746 4.969999999999999e-90 307.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g15469.t1 Q80T41 29.504 766 1.45e-89 306.0 sp|Q80T41|GABR2_MOUSE Gamma-aminobutyric acid type B receptor subunit 2 OS=Mus musculus OX=10090 GN=Gabbr2 PE=1 SV=2 GABR2_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Mus musculus (Mouse) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0038039; GO:0042734; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g15470.t1 P46530 43.32 1295 0.0 951.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 39.258 1294 0.0 880.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 37.631 1427 0.0 877.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 41.341 1178 0.0 817.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 42.123 914 0.0 651.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 35.619 452 3.91e-65 250.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 38.916 406 5.04e-62 240.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 35.049 408 3.43e-59 230.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 37.198 414 1.0699999999999999e-55 219.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 37.313 402 3.4999999999999995e-55 217.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 35.452 409 6.88e-55 216.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 34.598 448 3.4599999999999995e-52 207.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 36.603 418 1.95e-50 202.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 33.021 427 1.53e-49 199.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 34.584 373 3.31e-44 181.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 33.531 337 4.79e-39 164.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15470.t1 P46530 32.453 265 1.17e-22 110.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g15475.t1 Q3U4H6 37.284 464 8.21e-93 294.0 sp|Q3U4H6|HEXD_MOUSE Hexosaminidase D OS=Mus musculus OX=10090 GN=Hexd PE=1 SV=1 HEXD_MOUSE reviewed Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase) Mus musculus (Mouse) GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:1903561 carbohydrate metabolic process [GO:0005975] cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634] beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929] g15476.t1 Q99758 46.439 1755 0.0 1512.0 sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2 ABCA3_HUMAN reviewed Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form] Homo sapiens (Human) GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140 lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019] g15477.t1 Q9XUE6 53.878 245 1.0499999999999999e-95 284.0 sp|Q9XUE6|PMM_CAEEL Probable phosphomannomutase OS=Caenorhabditis elegans OX=6239 GN=F52B11.2 PE=3 SV=2 g15478.t1 Q9VVA0 47.368 114 4.59e-29 106.0 sp|Q9VVA0|Y9705_DROME Cold shock domain-containing protein CG9705 OS=Drosophila melanogaster OX=7227 GN=CG9705 PE=1 SV=1 g15479.t1 Q9UBM8 35.135 222 6.34e-32 127.0 sp|Q9UBM8|MGT4C_HUMAN Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Homo sapiens OX=9606 GN=MGAT4C PE=2 SV=2 MGT4C_HUMAN reviewed Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc) Homo sapiens (Human) GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0019082; GO:0046872 protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139] acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872] g15480.t1 O15229 56.951 446 0.0 541.0 sp|O15229|KMO_HUMAN Kynurenine 3-monooxygenase OS=Homo sapiens OX=9606 GN=KMO PE=1 SV=2 KMO_HUMAN reviewed Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase) Homo sapiens (Human) GO:0004502; GO:0005615; GO:0005739; GO:0005741; GO:0005829; GO:0006569; GO:0009651; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1903296 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; L-tryptophan catabolic process [GO:0006569]; NAD+ metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174] g15481.t1 Q5REH1 73.842 367 0.0 588.0 sp|Q5REH1|PICK1_PONAB PRKCA-binding protein OS=Pongo abelii OX=9601 GN=PICK1 PE=2 SV=1 PICK1_PONAB reviewed PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002092; GO:0005080; GO:0005543; GO:0005856; GO:0005886; GO:0006886; GO:0008021; GO:0014069; GO:0019904; GO:0021782; GO:0032588; GO:0034316; GO:0036294; GO:0042149; GO:0043005; GO:0043113; GO:0046872; GO:0048471; GO:0051015; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098842 cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113] cytoskeleton [GO:0005856]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080] g15481.t2 Q9NRD5 73.961 361 0.0 577.0 sp|Q9NRD5|PICK1_HUMAN PRKCA-binding protein OS=Homo sapiens OX=9606 GN=PICK1 PE=1 SV=2 g15483.t1 Q8K448 32.847 822 1.26e-120 405.0 sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2 ABCA5_MOUSE reviewed Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) Mus musculus (Mouse) GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] g15483.t1 Q8K448 25.426 645 3.8000000000000005e-43 174.0 sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2 ABCA5_MOUSE reviewed Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) Mus musculus (Mouse) GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043691; GO:0140359; GO:1903064 cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] g15486.t1 O02751 34.404 218 3.1200000000000003e-27 112.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g15487.t1 Q8WWZ7 35.817 832 6.659999999999999e-147 479.0 sp|Q8WWZ7|ABCA5_HUMAN Cholesterol transporter ABCA5 OS=Homo sapiens OX=9606 GN=ABCA5 PE=1 SV=2 g15487.t1 Q8WWZ7 28.056 638 1.25e-53 208.0 sp|Q8WWZ7|ABCA5_HUMAN Cholesterol transporter ABCA5 OS=Homo sapiens OX=9606 GN=ABCA5 PE=1 SV=2 g15488.t1 Q96D21 45.902 305 1.94e-80 248.0 sp|Q96D21|RHES_HUMAN GTP-binding protein Rhes OS=Homo sapiens OX=9606 GN=RASD2 PE=1 SV=1 RHES_HUMAN reviewed GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) Homo sapiens (Human) GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031681; GO:0033235; GO:0045202; GO:0051897 locomotory behavior [GO:0007626]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963] plasma membrane [GO:0005886]; synapse [GO:0045202] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g15488.t2 Q96D21 47.953 171 3.59e-39 139.0 sp|Q96D21|RHES_HUMAN GTP-binding protein Rhes OS=Homo sapiens OX=9606 GN=RASD2 PE=1 SV=1 RHES_HUMAN reviewed GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) Homo sapiens (Human) GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031681; GO:0033235; GO:0045202; GO:0051897 locomotory behavior [GO:0007626]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963] plasma membrane [GO:0005886]; synapse [GO:0045202] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g15488.t3 Q96D21 47.953 171 2.3e-39 138.0 sp|Q96D21|RHES_HUMAN GTP-binding protein Rhes OS=Homo sapiens OX=9606 GN=RASD2 PE=1 SV=1 RHES_HUMAN reviewed GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) Homo sapiens (Human) GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031681; GO:0033235; GO:0045202; GO:0051897 locomotory behavior [GO:0007626]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963] plasma membrane [GO:0005886]; synapse [GO:0045202] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g15488.t4 Q9JKF8 71.429 91 1.1500000000000001e-43 145.0 sp|Q9JKF8|RASD1_RAT Dexamethasone-induced Ras-related protein 1 OS=Rattus norvegicus OX=10116 GN=Rasd1 PE=1 SV=1 RASD1_RAT reviewed Dexamethasone-induced Ras-related protein 1 Rattus norvegicus (Rat) GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007263; GO:0016529; GO:0031681; GO:0045892; GO:0048471 negative regulation of DNA-templated transcription [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g15491.t1 O96647 78.972 214 4.8e-127 360.0 sp|O96647|RL10_BOMMA Large ribosomal subunit protein uL16 OS=Bombyx mandarina OX=7092 GN=RpL10 PE=2 SV=1 g15492.t1 Q8N5I4 34.395 314 3.62e-40 154.0 sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2 DHRSX_HUMAN reviewed Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase) Homo sapiens (Human) GO:0005576; GO:0005789; GO:0005811; GO:0008106; GO:0010508; GO:0043048; GO:0160196; GO:0160197 dolichyl monophosphate biosynthetic process [GO:0043048]; positive regulation of autophagy [GO:0010508] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; lipid droplet [GO:0005811] alcohol dehydrogenase (NADP+) activity [GO:0008106]; dolichal reductase (NADPH) activity [GO:0160197]; polyprenol dehydrogenase (NAD+) activity [GO:0160196] g15493.t1 P27463 62.346 486 0.0 643.0 sp|P27463|AL1A1_CHICK Aldehyde dehydrogenase 1A1 OS=Gallus gallus OX=9031 GN=ALDH1A1 PE=2 SV=1 g15494.t1 Q6NV34 56.667 270 3.5399999999999997e-115 336.0 sp|Q6NV34|DECR2_DANRE Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] OS=Danio rerio OX=7955 GN=decr2 PE=2 SV=1 g15495.t1 Q6NV34 60.075 268 1.39e-116 342.0 sp|Q6NV34|DECR2_DANRE Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] OS=Danio rerio OX=7955 GN=decr2 PE=2 SV=1 g15496.t1 Q5R6R5 53.708 391 1.0800000000000001e-154 446.0 sp|Q5R6R5|NEUA_PONAB N-acylneuraminate cytidylyltransferase OS=Pongo abelii OX=9601 GN=CMAS PE=2 SV=1 g15497.t1 Q0VCN3 49.457 184 6.510000000000001e-63 196.0 sp|Q0VCN3|IFT27_BOVIN Intraflagellar transport protein 27 homolog OS=Bos taurus OX=9913 GN=IFT27 PE=2 SV=1 IFT27_BOVIN reviewed Intraflagellar transport protein 27 homolog (IFT27) (Putative GTP-binding protein RAY-like) (Rab-like protein 4) Bos taurus (Bovine) GO:0000139; GO:0001822; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016192; GO:0030154; GO:0030992; GO:0036126; GO:0042073 cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g15498.t1 Q803V5 67.183 323 2.6300000000000003e-173 486.0 sp|Q803V5|LST8_DANRE Target of rapamycin complex subunit lst8 OS=Danio rerio OX=7955 GN=mlst8 PE=2 SV=1 g15499.t1 Q6P6S2 66.181 343 3.86e-145 416.0 sp|Q6P6S2|S39AB_RAT Zinc transporter ZIP11 OS=Rattus norvegicus OX=10116 GN=Slc39a11 PE=2 SV=1 g15500.t1 Q8AXX8 43.733 375 4.9e-75 245.0 sp|Q8AXX8|SOX10_XENLA Transcription factor Sox-10 OS=Xenopus laevis OX=8355 GN=sox10 PE=1 SV=1 SOX10_XENLA reviewed Transcription factor Sox-10 (SRY (sex determining region Y)-box 10) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0000981; GO:0001755; GO:0002009; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007422; GO:0014003; GO:0014029; GO:0016055; GO:0019899; GO:0022010; GO:0030318; GO:0045893; GO:0048484; GO:0048709 central nervous system myelination [GO:0022010]; enteric nervous system development [GO:0048484]; melanocyte differentiation [GO:0030318]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neural crest formation [GO:0014029]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system development [GO:0007422]; positive regulation of DNA-templated transcription [GO:0045893]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g15503.t1 Q1T7B7 26.042 288 2.61e-22 97.8 sp|Q1T7B7|CENPP_CHICK Centromere protein P OS=Gallus gallus OX=9031 GN=CENPP PE=1 SV=1 g15507.t1 Q6NVU2 71.854 302 2.5400000000000003e-164 462.0 sp|Q6NVU2|PPIG_XENTR Serine/threonine-protein phosphatase PP1-gamma catalytic subunit OS=Xenopus tropicalis OX=8364 GN=ppp1cc PE=2 SV=1 PPIG_XENTR reviewed Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0004722; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005815; GO:0005977; GO:0006470; GO:0007084; GO:0016607; GO:0030496; GO:0032154; GO:0042752; GO:0046872; GO:0051301 cell division [GO:0051301]; glycogen metabolic process [GO:0005977]; mitotic nuclear membrane reassembly [GO:0007084]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g15509.t1 Q8R0V5 38.305 295 3.3500000000000004e-64 211.0 sp|Q8R0V5|I23O2_MOUSE Indoleamine 2,3-dioxygenase 2 OS=Mus musculus OX=10090 GN=Ido2 PE=1 SV=3 I23O2_MOUSE reviewed Indoleamine 2,3-dioxygenase 2 (IDO-2) (EC 1.13.11.-) (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1) Mus musculus (Mouse) GO:0002376; GO:0004833; GO:0005737; GO:0019441; GO:0020037; GO:0033754; GO:0034354; GO:0046872 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; immune system process [GO:0002376]; L-tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737] heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; L-tryptophan 2,3-dioxygenase activity [GO:0004833]; metal ion binding [GO:0046872] g15510.t1 Q8R0V5 37.968 374 7.220000000000001e-85 266.0 sp|Q8R0V5|I23O2_MOUSE Indoleamine 2,3-dioxygenase 2 OS=Mus musculus OX=10090 GN=Ido2 PE=1 SV=3 I23O2_MOUSE reviewed Indoleamine 2,3-dioxygenase 2 (IDO-2) (EC 1.13.11.-) (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1) Mus musculus (Mouse) GO:0002376; GO:0004833; GO:0005737; GO:0019441; GO:0020037; GO:0033754; GO:0034354; GO:0046872 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; immune system process [GO:0002376]; L-tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737] heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; L-tryptophan 2,3-dioxygenase activity [GO:0004833]; metal ion binding [GO:0046872] g15511.t1 Q3U3R4 57.324 553 0.0 655.0 sp|Q3U3R4|LMF1_MOUSE Lipase maturation factor 1 OS=Mus musculus OX=10090 GN=Lmf1 PE=1 SV=1 LMF1_MOUSE reviewed Lipase maturation factor 1 (Transmembrane protein 112) Mus musculus (Mouse) GO:0005789; GO:0006641; GO:0006888; GO:0009306; GO:0034382; GO:0051604; GO:0090181; GO:0090207 chylomicron remnant clearance [GO:0034382]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein maturation [GO:0051604]; protein secretion [GO:0009306]; regulation of cholesterol metabolic process [GO:0090181]; regulation of triglyceride metabolic process [GO:0090207]; triglyceride metabolic process [GO:0006641] endoplasmic reticulum membrane [GO:0005789] g15512.t1 Q4W5Z4 42.936 906 0.0 700.0 sp|Q4W5Z4|DNM3A_CHICK DNA (cytosine-5)-methyltransferase 3A OS=Gallus gallus OX=9031 GN=DNMT3A PE=2 SV=1 DNM3A_CHICK reviewed DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-) Gallus gallus (Chicken) GO:0000791; GO:0001046; GO:0003886; GO:0005634; GO:0005737; GO:0008270; GO:0009408; GO:0016363; GO:0032259; GO:0044027; GO:0045892; GO:0071774; GO:0106363 methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; response to fibroblast growth factor [GO:0071774]; response to heat [GO:0009408] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear matrix [GO:0016363]; nucleus [GO:0005634] core promoter sequence-specific DNA binding [GO:0001046]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; protein-cysteine methyltransferase activity [GO:0106363]; zinc ion binding [GO:0008270] g15513.t1 Q8BQ47 49.0 200 1.25e-62 201.0 sp|Q8BQ47|CNPY4_MOUSE Protein canopy homolog 4 OS=Mus musculus OX=10090 GN=Cnpy4 PE=1 SV=1 g15514.t1 O75832 52.941 221 4.24e-79 239.0 sp|O75832|PSD10_HUMAN 26S proteasome non-ATPase regulatory subunit 10 OS=Homo sapiens OX=9606 GN=PSMD10 PE=1 SV=1 g15517.t1 Q3UHK8 27.393 1055 1.56e-42 175.0 sp|Q3UHK8|TNR6A_MOUSE Trinucleotide repeat-containing gene 6A protein OS=Mus musculus OX=10090 GN=Tnrc6a PE=1 SV=2 TNR6A_MOUSE reviewed Trinucleotide repeat-containing gene 6A protein Mus musculus (Mouse) GO:0000932; GO:0003723; GO:0005654; GO:0005794; GO:0005829; GO:0007492; GO:0009267; GO:0016442; GO:0031047; GO:0032507; GO:0033962; GO:0035195; GO:0035278; GO:0048471; GO:0060090; GO:0060213; GO:1900153 cellular response to starvation [GO:0009267]; endoderm development [GO:0007492]; maintenance of protein location in cell [GO:0032507]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; P-body assembly [GO:0033962]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulatory ncRNA-mediated gene silencing [GO:0031047] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442] molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723] g15520.t1 P80404 49.603 504 0.0 530.0 sp|P80404|GABT_HUMAN 4-aminobutyrate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=ABAT PE=1 SV=3 GABT_HUMAN reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Homo sapiens (Human) GO:0001666; GO:0005739; GO:0005759; GO:0007620; GO:0007626; GO:0009410; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042220; GO:0042802; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0050877; GO:0051536; GO:0070474; GO:0097151; GO:1902722; GO:1904450 cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; nervous system process [GO:0050877]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g15521.t1 Q8WWZ7 34.537 1717 0.0 879.0 sp|Q8WWZ7|ABCA5_HUMAN Cholesterol transporter ABCA5 OS=Homo sapiens OX=9606 GN=ABCA5 PE=1 SV=2 g15521.t1 Q8WWZ7 30.068 439 4.9199999999999994e-55 216.0 sp|Q8WWZ7|ABCA5_HUMAN Cholesterol transporter ABCA5 OS=Homo sapiens OX=9606 GN=ABCA5 PE=1 SV=2 g15522.t1 P80147 52.754 472 0.0 553.0 sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2 GABT_PIG reviewed 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) Sus scrofa (Pig) GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537 gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877] 4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] g15523.t1 Q8TAC2 57.627 177 5.9399999999999995e-74 223.0 sp|Q8TAC2|JOS2_HUMAN Josephin-2 OS=Homo sapiens OX=9606 GN=JOSD2 PE=1 SV=1 JOS2_HUMAN reviewed Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2) Homo sapiens (Human) GO:0004843; GO:0005829; GO:0006508; GO:0016579 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829] cysteine-type deubiquitinase activity [GO:0004843] g15524.t1 Q575S8 33.113 151 1.5400000000000001e-22 92.4 sp|Q575S8|CYGB2_DANRE Cytoglobin-2 OS=Danio rerio OX=7955 GN=cygb2 PE=2 SV=1 CYGB2_DANRE reviewed Cytoglobin-2 (Nitric oxygen dioxygenase CYGB) (EC 1.14.12.-) (Nitrite reductase CYGB) (EC 1.7.-.-) (Pseudoperoxidase CYGB) (EC 1.11.1.-) (Superoxide dismutase CYGB) (EC 1.15.1.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004784; GO:0005506; GO:0005634; GO:0005737; GO:0015671; GO:0016491; GO:0019430; GO:0019825; GO:0020037; GO:0046210; GO:0098809; GO:0141118 nitric oxide catabolic process [GO:0046210]; oxygen transport [GO:0015671]; removal of superoxide radicals [GO:0019430] cytoplasm [GO:0005737]; nucleus [GO:0005634] heme binding [GO:0020037]; iron ion binding [GO:0005506]; nitric oxide dioxygenase activity, heme protein as donor [GO:0141118]; nitrite reductase activity [GO:0098809]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784] g15524.t2 Q575S8 33.113 151 1.6700000000000001e-22 92.4 sp|Q575S8|CYGB2_DANRE Cytoglobin-2 OS=Danio rerio OX=7955 GN=cygb2 PE=2 SV=1 CYGB2_DANRE reviewed Cytoglobin-2 (Nitric oxygen dioxygenase CYGB) (EC 1.14.12.-) (Nitrite reductase CYGB) (EC 1.7.-.-) (Pseudoperoxidase CYGB) (EC 1.11.1.-) (Superoxide dismutase CYGB) (EC 1.15.1.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004784; GO:0005506; GO:0005634; GO:0005737; GO:0015671; GO:0016491; GO:0019430; GO:0019825; GO:0020037; GO:0046210; GO:0098809; GO:0141118 nitric oxide catabolic process [GO:0046210]; oxygen transport [GO:0015671]; removal of superoxide radicals [GO:0019430] cytoplasm [GO:0005737]; nucleus [GO:0005634] heme binding [GO:0020037]; iron ion binding [GO:0005506]; nitric oxide dioxygenase activity, heme protein as donor [GO:0141118]; nitrite reductase activity [GO:0098809]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784] g15525.t1 Q9VVI1 67.089 237 7.37e-113 341.0 sp|Q9VVI1|LUC7L_DROME Putative RNA-binding protein Alsin2 OS=Drosophila melanogaster OX=7227 GN=Alsin2 PE=1 SV=1 g15526.t1 A2RU67 23.801 542 5.3399999999999996e-24 112.0 sp|A2RU67|F234B_HUMAN Protein FAM234B OS=Homo sapiens OX=9606 GN=FAM234B PE=1 SV=1 g15529.t1 Q14500 42.778 360 7.52e-102 312.0 sp|Q14500|KCJ12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens OX=9606 GN=KCNJ12 PE=1 SV=2 KCJ12_HUMAN reviewed ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12) Homo sapiens (Human) GO:0005242; GO:0005886; GO:0006813; GO:0006936; GO:0008016; GO:0016020; GO:0030315; GO:0034702; GO:0034765; GO:0046872; GO:0051289; GO:1990573 muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of monoatomic ion transmembrane transport [GO:0034765] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] inward rectifier potassium channel activity [GO:0005242]; metal ion binding [GO:0046872] g15530.t1 F1MYR9 45.739 352 5.22e-104 320.0 sp|F1MYR9|KCNJ5_BOVIN G protein-activated inward rectifier potassium channel 4 OS=Bos taurus OX=9913 GN=KCNJ5 PE=1 SV=2 KCNJ5_BOVIN reviewed G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5) Bos taurus (Bovine) GO:0005242; GO:0005886; GO:0015467; GO:0034765; GO:0071805; GO:0086089; GO:0086091; GO:0098914; GO:1990566; GO:1990573 membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of monoatomic ion transmembrane transport [GO:0034765] I(KACh) inward rectifier potassium channel complex [GO:1990566]; plasma membrane [GO:0005886] G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089] g15531.t1 P48542 48.286 350 1.53e-106 327.0 sp|P48542|KCNJ6_MOUSE G protein-activated inward rectifier potassium channel 2 OS=Mus musculus OX=10090 GN=Kcnj6 PE=1 SV=1 g15532.t1 F1NHE9 57.704 331 2.6899999999999997e-134 399.0 sp|F1NHE9|KCJ12_CHICK ATP-sensitive inward rectifier potassium channel 12 OS=Gallus gallus OX=9031 GN=KCNJ12 PE=1 SV=1 KCJ12_CHICK reviewed ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (Potassium channel, inwardly rectifying subfamily J member 12) Gallus gallus (Chicken) GO:0005242; GO:0005886; GO:0006813; GO:0016020; GO:0030315; GO:0034702; GO:0034765; GO:0042802; GO:0051289; GO:1990573 potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of monoatomic ion transmembrane transport [GO:0034765] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242] g15533.t1 Q8TDG4 51.402 856 0.0 897.0 sp|Q8TDG4|HELQ_HUMAN Helicase POLQ-like OS=Homo sapiens OX=9606 GN=HELQ PE=1 SV=2 HELQ_HUMAN reviewed Helicase POLQ-like (EC 5.6.2.4) (Mus308-like helicase) (POLQ-like helicase) Homo sapiens (Human) GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0010792; GO:0016887; GO:0045003; GO:0090734; GO:0097681; GO:1905168; GO:1990518 DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168] nucleus [GO:0005634]; site of DNA damage [GO:0090734] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518] g15534.t1 Q5PNP1 37.858 943 0.0 635.0 sp|Q5PNP1|SNX14_DANRE Sorting nexin-14 OS=Danio rerio OX=7955 GN=snx14 PE=2 SV=3 SNX14_DANRE reviewed Sorting nexin-14 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005764; GO:0005765; GO:0005770; GO:0006914; GO:0021680; GO:0030425; GO:0030902; GO:0031902; GO:0035091; GO:0080025; GO:0097352 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902] dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g15534.t2 Q5PNP1 39.035 912 0.0 644.0 sp|Q5PNP1|SNX14_DANRE Sorting nexin-14 OS=Danio rerio OX=7955 GN=snx14 PE=2 SV=3 SNX14_DANRE reviewed Sorting nexin-14 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005764; GO:0005765; GO:0005770; GO:0006914; GO:0021680; GO:0030425; GO:0030902; GO:0031902; GO:0035091; GO:0080025; GO:0097352 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902] dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g15534.t3 Q5PNP1 37.994 937 0.0 631.0 sp|Q5PNP1|SNX14_DANRE Sorting nexin-14 OS=Danio rerio OX=7955 GN=snx14 PE=2 SV=3 SNX14_DANRE reviewed Sorting nexin-14 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005764; GO:0005765; GO:0005770; GO:0006914; GO:0021680; GO:0030425; GO:0030902; GO:0031902; GO:0035091; GO:0080025; GO:0097352 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cerebellar Purkinje cell layer development [GO:0021680]; hindbrain development [GO:0030902] dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g15535.t1 Q8IYS1 46.489 413 6.41e-109 330.0 sp|Q8IYS1|P20D2_HUMAN Xaa-Arg dipeptidase OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2 P20D2_HUMAN reviewed Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246 proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246] nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] g15535.t2 Q8IYS1 47.238 362 3.92e-97 302.0 sp|Q8IYS1|P20D2_HUMAN Xaa-Arg dipeptidase OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2 P20D2_HUMAN reviewed Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246 proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246] nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] g15535.t3 Q8IYS1 45.507 345 1.31e-86 274.0 sp|Q8IYS1|P20D2_HUMAN Xaa-Arg dipeptidase OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2 P20D2_HUMAN reviewed Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246 proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246] nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] g15536.t1 Q3UNX5 57.292 576 0.0 715.0 sp|Q3UNX5|ACSM3_MOUSE Acyl-coenzyme A synthetase ACSM3, mitochondrial OS=Mus musculus OX=10090 GN=Acsm3 PE=1 SV=2 ACSM3_MOUSE reviewed Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog) Mus musculus (Mouse) GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0018729; GO:0031956; GO:0043759; GO:0046872; GO:0050218 acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 2-methylbutanoate-CoA ligase activity [GO:0043759]; ATP binding [GO:0005524]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218] g15537.t1 Q9DBV3 52.121 1155 0.0 1164.0 sp|Q9DBV3|DHX34_MOUSE Probable ATP-dependent RNA helicase DHX34 OS=Mus musculus OX=10090 GN=Dhx34 PE=1 SV=2 DHX34_MOUSE reviewed Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34) Mus musculus (Mouse) GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0016887; GO:0042327; GO:0044877; GO:2000623 negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g15539.t1 Q08CY4 35.468 203 1.2599999999999999e-34 134.0 sp|Q08CY4|TELO2_XENTR Telomere length regulation protein TEL2 homolog OS=Xenopus tropicalis OX=8364 GN=telo2 PE=2 SV=1 g15540.t1 Q9DC40 37.864 206 5.6e-37 140.0 sp|Q9DC40|TELO2_MOUSE Telomere length regulation protein TEL2 homolog OS=Mus musculus OX=10090 GN=Telo2 PE=1 SV=2 TELO2_MOUSE reviewed Telomere length regulation protein TEL2 homolog Mus musculus (Mouse) GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016604; GO:0019900; GO:0019901; GO:0042162; GO:0044877; GO:0050821; GO:0051083; GO:0051879; GO:0060090; GO:0110078; GO:0140777 'de novo' cotranslational protein folding [GO:0051083]; protein stabilization [GO:0050821] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078] Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-containing complex stabilizing activity [GO:0140777]; telomeric DNA binding [GO:0042162] g15541.t1 Q7T006 45.253 316 4.85e-89 286.0 sp|Q7T006|TELO2_DANRE Telomere length regulation protein TEL2 homolog OS=Danio rerio OX=7955 GN=telo2 PE=2 SV=2 g15542.t1 Q6GPP1 46.35 274 2.4499999999999997e-74 246.0 sp|Q6GPP1|TELO2_XENLA Telomere length regulation protein TEL2 homolog OS=Xenopus laevis OX=8355 GN=telo2 PE=2 SV=2 g15543.t1 Q9DC40 41.176 221 1.07e-50 180.0 sp|Q9DC40|TELO2_MOUSE Telomere length regulation protein TEL2 homolog OS=Mus musculus OX=10090 GN=Telo2 PE=1 SV=2 TELO2_MOUSE reviewed Telomere length regulation protein TEL2 homolog Mus musculus (Mouse) GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016604; GO:0019900; GO:0019901; GO:0042162; GO:0044877; GO:0050821; GO:0051083; GO:0051879; GO:0060090; GO:0110078; GO:0140777 'de novo' cotranslational protein folding [GO:0051083]; protein stabilization [GO:0050821] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078] Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-containing complex stabilizing activity [GO:0140777]; telomeric DNA binding [GO:0042162] g15547.t1 Q99XR4 24.796 367 5.61e-25 106.0 sp|Q99XR4|GLFT_STRP1 Glutamate formimidoyltransferase OS=Streptococcus pyogenes serotype M1 OX=301447 GN=M5005_Spy1772 PE=1 SV=1 g15548.t1 A1L2K1 31.126 302 3.3200000000000002e-49 169.0 sp|A1L2K1|METRL_XENLA Meteorin-like protein OS=Xenopus laevis OX=8355 GN=metrnl PE=2 SV=1 g15551.t1 F1R332 30.128 312 4.36e-43 157.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g15552.t1 Q8C9A2 51.711 263 7.649999999999999e-94 284.0 sp|Q8C9A2|ENDOV_MOUSE Endonuclease V OS=Mus musculus OX=10090 GN=Endov PE=1 SV=2 ENDOV_MOUSE reviewed Endonuclease V (EC 3.1.26.-) Mus musculus (Mouse) GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0010494; GO:0016888; GO:0016891 DNA repair [GO:0006281] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730] DNA binding [GO:0003677]; DNA endonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; RNA endonuclease activity producing 5'-phosphomonoesters, hydrolytic mechanism [GO:0016891]; single-stranded RNA binding [GO:0003727] g15553.t1 Q9DCM4 75.728 103 7.52e-57 174.0 sp|Q9DCM4|DNAL4_MOUSE Dynein axonemal light chain 4 OS=Mus musculus OX=10090 GN=Dnal4 PE=3 SV=2 g15556.t1 Q5XX13 35.862 725 2.5599999999999996e-150 483.0 sp|Q5XX13|FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens OX=9606 GN=FBXW10 PE=1 SV=2 FBW10_HUMAN reviewed F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor) Homo sapiens (Human) GO:0005829 cytosol [GO:0005829] g15557.t1 A4FUW8 30.833 720 1.66e-94 319.0 sp|A4FUW8|TXD11_BOVIN Thioredoxin domain-containing protein 11 OS=Bos taurus OX=9913 GN=TXNDC11 PE=2 SV=1 g15562.t1 Q8WWZ7 32.591 1752 0.0 825.0 sp|Q8WWZ7|ABCA5_HUMAN Cholesterol transporter ABCA5 OS=Homo sapiens OX=9606 GN=ABCA5 PE=1 SV=2 g15566.t1 Q8K582 68.293 205 7.58e-101 301.0 sp|Q8K582|DUS1L_RAT tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like OS=Rattus norvegicus OX=10116 GN=Dus1l PE=2 SV=1 g15567.t1 Q6P1R4 47.511 221 1.22e-62 209.0 sp|Q6P1R4|DUS1L_HUMAN tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like OS=Homo sapiens OX=9606 GN=DUS1L PE=1 SV=1 DUS1L_HUMAN reviewed tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.88) (tRNA-dihydrouridine synthase 1-like) Homo sapiens (Human) GO:0002943; GO:0005634; GO:0005737; GO:0017150; GO:0050660; GO:0102262; GO:0102263 tRNA dihydrouridine synthesis [GO:0002943] cytoplasm [GO:0005737]; nucleus [GO:0005634] flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine16 synthase activity [GO:0102262]; tRNA-dihydrouridine17 synthase activity [GO:0102263] g15568.t1 Q8WWZ7 33.92 1704 0.0 857.0 sp|Q8WWZ7|ABCA5_HUMAN Cholesterol transporter ABCA5 OS=Homo sapiens OX=9606 GN=ABCA5 PE=1 SV=2 g15575.t1 Q7T006 45.428 339 4.34e-90 305.0 sp|Q7T006|TELO2_DANRE Telomere length regulation protein TEL2 homolog OS=Danio rerio OX=7955 GN=telo2 PE=2 SV=2 g15577.t1 P70587 36.041 394 2.09e-53 202.0 sp|P70587|LRRC7_RAT Leucine-rich repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Lrrc7 PE=1 SV=2 LRRC7_RAT reviewed Leucine-rich repeat-containing protein 7 (Densin-180) (Densin) (Protein LAP1) Rattus norvegicus (Rat) GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005912; GO:0010976; GO:0014069; GO:0015629; GO:0016323; GO:0019901; GO:0030175; GO:0043113; GO:0043194; GO:0043197; GO:0045197; GO:0098609; GO:0098839; GO:0098887; GO:0098978; GO:1901424 cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; response to toluene [GO:1901424] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] protein kinase binding [GO:0019901] g15577.t1 P70587 32.09 402 7.73e-39 158.0 sp|P70587|LRRC7_RAT Leucine-rich repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Lrrc7 PE=1 SV=2 LRRC7_RAT reviewed Leucine-rich repeat-containing protein 7 (Densin-180) (Densin) (Protein LAP1) Rattus norvegicus (Rat) GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005912; GO:0010976; GO:0014069; GO:0015629; GO:0016323; GO:0019901; GO:0030175; GO:0043113; GO:0043194; GO:0043197; GO:0045197; GO:0098609; GO:0098839; GO:0098887; GO:0098978; GO:1901424 cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; response to toluene [GO:1901424] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] protein kinase binding [GO:0019901] g15577.t1 P70587 28.346 381 7.15e-29 127.0 sp|P70587|LRRC7_RAT Leucine-rich repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Lrrc7 PE=1 SV=2 LRRC7_RAT reviewed Leucine-rich repeat-containing protein 7 (Densin-180) (Densin) (Protein LAP1) Rattus norvegicus (Rat) GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005912; GO:0010976; GO:0014069; GO:0015629; GO:0016323; GO:0019901; GO:0030175; GO:0043113; GO:0043194; GO:0043197; GO:0045197; GO:0098609; GO:0098839; GO:0098887; GO:0098978; GO:1901424 cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; response to toluene [GO:1901424] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] protein kinase binding [GO:0019901] g15577.t1 P70587 31.268 339 3.72e-24 112.0 sp|P70587|LRRC7_RAT Leucine-rich repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Lrrc7 PE=1 SV=2 LRRC7_RAT reviewed Leucine-rich repeat-containing protein 7 (Densin-180) (Densin) (Protein LAP1) Rattus norvegicus (Rat) GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005912; GO:0010976; GO:0014069; GO:0015629; GO:0016323; GO:0019901; GO:0030175; GO:0043113; GO:0043194; GO:0043197; GO:0045197; GO:0098609; GO:0098839; GO:0098887; GO:0098978; GO:1901424 cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; response to toluene [GO:1901424] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] protein kinase binding [GO:0019901] g15580.t1 Q24524 35.0 520 8.54e-88 281.0 sp|Q24524|SING_DROME Protein singed OS=Drosophila melanogaster OX=7227 GN=sn PE=1 SV=1 SING_DROME reviewed Protein singed Drosophila melanogaster (Fruit fly) GO:0003779; GO:0005737; GO:0007163; GO:0008407; GO:0009913; GO:0015629; GO:0016358; GO:0016477; GO:0030034; GO:0030036; GO:0030674; GO:0035017; GO:0035099; GO:0035317; GO:0042060; GO:0043005; GO:0043025; GO:0046847; GO:0048477; GO:0048800; GO:0048812; GO:0051015; GO:0051017 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; antennal morphogenesis [GO:0048800]; cell migration [GO:0016477]; chaeta morphogenesis [GO:0008407]; cuticle pattern formation [GO:0035017]; dendrite development [GO:0016358]; epidermal cell differentiation [GO:0009913]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair organization [GO:0035317]; microvillar actin bundle assembly [GO:0030034]; neuron projection morphogenesis [GO:0048812]; oogenesis [GO:0048477]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674] g15581.t1 Q6NU40 39.705 1083 0.0 669.0 sp|Q6NU40|CTF18_XENLA Chromosome transmission fidelity protein 18 homolog OS=Xenopus laevis OX=8355 GN=chtf18 PE=2 SV=1 g15582.t1 Q62867 48.601 286 1.5e-85 271.0 sp|Q62867|GGH_RAT Gamma-glutamyl hydrolase OS=Rattus norvegicus OX=10116 GN=Ggh PE=1 SV=1 g15583.t1 Q7ZXX2 54.333 727 0.0 747.0 sp|Q7ZXX2|KIF19_XENLA Kinesin-like protein KIF19 OS=Xenopus laevis OX=8355 GN=kif19 PE=2 SV=1 g15584.t1 Q8N8V4 31.591 440 9.97e-61 206.0 sp|Q8N8V4|ANS4B_HUMAN Ankyrin repeat and SAM domain-containing protein 4B OS=Homo sapiens OX=9606 GN=ANKS4B PE=1 SV=2 ANS4B_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 4B (Harmonin-interacting ankyrin repeat-containing protein) (Harp) Homo sapiens (Human) GO:0005789; GO:0005886; GO:0005902; GO:0005903; GO:0030154; GO:0034976; GO:0065003; GO:1904106; GO:1904970 brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; response to endoplasmic reticulum stress [GO:0034976] brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886] g15588.t1 Q7T006 45.896 268 1.3599999999999999e-67 233.0 sp|Q7T006|TELO2_DANRE Telomere length regulation protein TEL2 homolog OS=Danio rerio OX=7955 GN=telo2 PE=2 SV=2 g15589.t1 P00429 56.322 87 2.58e-33 112.0 sp|P00429|CX6B1_BOVIN Cytochrome c oxidase subunit 6B1 OS=Bos taurus OX=9913 GN=COX6B1 PE=1 SV=2 g15590.t1 O60303 37.547 1606 0.0 882.0 sp|O60303|KATIP_HUMAN Katanin-interacting protein OS=Homo sapiens OX=9606 GN=KATNIP PE=1 SV=4 KATIP_HUMAN reviewed Katanin-interacting protein Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005886; GO:0005929; GO:0005930; GO:0008017; GO:0015631; GO:0034451; GO:0036064; GO:0090660; GO:0097546; GO:0097729; GO:0120170; GO:1905504 cerebrospinal fluid circulation [GO:0090660]; negative regulation of motile cilium assembly [GO:1905504] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631] g15591.t1 A6QNK1 32.995 394 3.68e-55 191.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g15596.t1 Q71MB6 29.972 704 6.03e-85 286.0 sp|Q71MB6|SO4C1_RAT Solute carrier organic anion transporter family member 4C1 OS=Rattus norvegicus OX=10116 GN=Slco4c1 PE=1 SV=1 SO4C1_RAT reviewed Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20) Rattus norvegicus (Rat) GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0016324; GO:0030154; GO:0043252 cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g15596.t2 Q71MB6 30.172 696 1.94e-87 293.0 sp|Q71MB6|SO4C1_RAT Solute carrier organic anion transporter family member 4C1 OS=Rattus norvegicus OX=10116 GN=Slco4c1 PE=1 SV=1 SO4C1_RAT reviewed Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20) Rattus norvegicus (Rat) GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0016324; GO:0030154; GO:0043252 cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g15597.t1 Q5QQ57 47.86 771 0.0 766.0 sp|Q5QQ57|XYLT1_PANTR Xylosyltransferase 1 OS=Pan troglodytes OX=9598 GN=XYLT1 PE=2 SV=1 XYLT1_PANTR reviewed Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) Pan troglodytes (Chimpanzee) GO:0000137; GO:0000139; GO:0005615; GO:0015012; GO:0030158; GO:0030166; GO:0043931; GO:0046872; GO:0048706; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] g15597.t2 Q5QQ57 48.489 761 0.0 774.0 sp|Q5QQ57|XYLT1_PANTR Xylosyltransferase 1 OS=Pan troglodytes OX=9598 GN=XYLT1 PE=2 SV=1 XYLT1_PANTR reviewed Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) Pan troglodytes (Chimpanzee) GO:0000137; GO:0000139; GO:0005615; GO:0015012; GO:0030158; GO:0030166; GO:0043931; GO:0046872; GO:0048706; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] g15598.t1 Q7ZWN9 28.454 485 1.15e-54 197.0 sp|Q7ZWN9|TTYH2_XENLA Protein tweety homolog 2 OS=Xenopus laevis OX=8355 GN=ttyh2 PE=2 SV=1 g15598.t2 Q7ZWN9 27.417 569 3.91e-55 198.0 sp|Q7ZWN9|TTYH2_XENLA Protein tweety homolog 2 OS=Xenopus laevis OX=8355 GN=ttyh2 PE=2 SV=1 g15607.t1 A6H8I2 69.934 755 0.0 1129.0 sp|A6H8I2|SGSM3_XENLA Small G protein signaling modulator 3 homolog OS=Xenopus laevis OX=8355 GN=sgsm3 PE=2 SV=1 g15609.t1 Q7ZT75 33.831 201 1.3400000000000002e-21 97.4 sp|Q7ZT75|FCN1A_XENLA Ficolin-1-A OS=Xenopus laevis OX=8355 GN=fcn1-a PE=1 SV=2 FCN1A_XENLA reviewed Ficolin-1-A Xenopus laevis (African clawed frog) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0033691; GO:0038187; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g15610.t1 O43827 32.618 233 1.4e-23 103.0 sp|O43827|ANGL7_HUMAN Angiopoietin-related protein 7 OS=Homo sapiens OX=9606 GN=ANGPTL7 PE=1 SV=1 ANGL7_HUMAN reviewed Angiopoietin-related protein 7 (Angiopoietin-like factor) (Angiopoietin-like protein 7) (Cornea-derived transcript 6 protein) Homo sapiens (Human) GO:0005576; GO:0005615; GO:0006979; GO:0007596; GO:0042802; GO:1901346; GO:1903053 blood coagulation [GO:0007596]; negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053]; response to oxidative stress [GO:0006979] extracellular region [GO:0005576]; extracellular space [GO:0005615] identical protein binding [GO:0042802] g15617.t1 A8E4L1 74.074 81 7.15e-40 129.0 sp|A8E4L1|COX19_BOVIN Cytochrome c oxidase assembly protein COX19 OS=Bos taurus OX=9913 GN=COX19 PE=3 SV=1 COX19_BOVIN reviewed Cytochrome c oxidase assembly protein COX19 Bos taurus (Bovine) GO:0005739; GO:0005758; GO:0005829; GO:0006878; GO:0033617 intracellular copper ion homeostasis [GO:0006878]; mitochondrial respiratory chain complex IV assembly [GO:0033617] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] g15618.t1 A6QPR9 28.716 296 6.67e-38 142.0 sp|A6QPR9|TEFM_BOVIN Transcription elongation factor, mitochondrial OS=Bos taurus OX=9913 GN=TEFM PE=2 SV=2 g15619.t1 Q9DC40 41.475 217 2.3e-50 178.0 sp|Q9DC40|TELO2_MOUSE Telomere length regulation protein TEL2 homolog OS=Mus musculus OX=10090 GN=Telo2 PE=1 SV=2 TELO2_MOUSE reviewed Telomere length regulation protein TEL2 homolog Mus musculus (Mouse) GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016604; GO:0019900; GO:0019901; GO:0042162; GO:0044877; GO:0050821; GO:0051083; GO:0051879; GO:0060090; GO:0110078; GO:0140777 'de novo' cotranslational protein folding [GO:0051083]; protein stabilization [GO:0050821] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078] Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-containing complex stabilizing activity [GO:0140777]; telomeric DNA binding [GO:0042162] g15621.t1 Q0V9N0 57.825 754 0.0 854.0 sp|Q0V9N0|S14L5_XENTR SEC14-like protein 5 OS=Xenopus tropicalis OX=8364 GN=sec14l1 PE=2 SV=1 g15622.t1 Q8NCG7 35.414 689 3.45e-137 420.0 sp|Q8NCG7|DGLB_HUMAN Diacylglycerol lipase-beta OS=Homo sapiens OX=9606 GN=DAGLB PE=1 SV=2 DGLB_HUMAN reviewed Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta) Homo sapiens (Human) GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0006640; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696 arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727] lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] lipase activity [GO:0016298]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372]; triacylglycerol lipase activity [GO:0004806] g15623.t1 Q7T076 38.71 124 4.53e-25 108.0 sp|Q7T076|LSM11_XENLA U7 snRNA-associated Sm-like protein LSm11 OS=Xenopus laevis OX=8355 GN=lsm11 PE=2 SV=1 g15624.t1 Q9DC40 40.314 191 3.21e-39 149.0 sp|Q9DC40|TELO2_MOUSE Telomere length regulation protein TEL2 homolog OS=Mus musculus OX=10090 GN=Telo2 PE=1 SV=2 TELO2_MOUSE reviewed Telomere length regulation protein TEL2 homolog Mus musculus (Mouse) GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016604; GO:0019900; GO:0019901; GO:0042162; GO:0044877; GO:0050821; GO:0051083; GO:0051879; GO:0060090; GO:0110078; GO:0140777 'de novo' cotranslational protein folding [GO:0051083]; protein stabilization [GO:0050821] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078] Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-containing complex stabilizing activity [GO:0140777]; telomeric DNA binding [GO:0042162] g15627.t1 P0CW27 34.815 270 7.62e-33 128.0 sp|P0CW27|CC166_HUMAN Coiled-coil domain-containing protein 166 OS=Homo sapiens OX=9606 GN=CCDC166 PE=1 SV=1 g15628.t1 Q30PH2 56.115 139 1.35e-51 168.0 sp|Q30PH2|END4_SULDN Probable endonuclease 4 OS=Sulfurimonas denitrificans (strain ATCC 33889 / DSM 1251) OX=326298 GN=nfo PE=3 SV=1 g15629.t1 B8F7D1 54.054 111 5.78e-36 137.0 sp|B8F7D1|END4_GLAP5 Probable endonuclease 4 OS=Glaesserella parasuis serovar 5 (strain SH0165) OX=557723 GN=nfo PE=3 SV=1 g15631.t1 Q8BJQ2 32.889 675 3.95e-80 275.0 sp|Q8BJQ2|UBP1_MOUSE Ubiquitin carboxyl-terminal hydrolase 1 OS=Mus musculus OX=10090 GN=Usp1 PE=1 SV=1 UBP1_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment] Mus musculus (Mouse) GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006282; GO:0006508; GO:0007259; GO:0008233; GO:0009411; GO:0016579; GO:0031647; GO:0035520; GO:0046427 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of DNA repair [GO:0006282]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411]; skeletal system development [GO:0001501] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233] g15632.t1 A4IHR1 81.453 647 0.0 1111.0 sp|A4IHR1|IT70A_XENTR Intraflagellar transport protein 70A OS=Xenopus tropicalis OX=8364 GN=ift70a PE=2 SV=1 IT70A_XENTR reviewed Intraflagellar transport protein 70A (Tetratricopeptide repeat protein 30A) (TPR repeat protein 30A) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001501; GO:0001822; GO:0005879; GO:0005929; GO:0018095; GO:0030992; GO:0042073; GO:0060271; GO:0120170 cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; protein polyglutamylation [GO:0018095]; skeletal system development [GO:0001501] axonemal microtubule [GO:0005879]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] intraciliary transport particle B binding [GO:0120170] g15636.t1 Q9UKN7 42.87 1136 0.0 960.0 sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2 MYO15_HUMAN reviewed Unconventional myosin-XV (Unconventional myosin-15) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g15636.t1 Q9UKN7 30.064 1101 1.2999999999999999e-134 480.0 sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2 MYO15_HUMAN reviewed Unconventional myosin-XV (Unconventional myosin-15) Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g15643.t1 P30937 39.826 344 5.46e-75 241.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g15644.t1 A6HD62 59.857 279 1.66e-114 334.0 sp|A6HD62|CHIP_RAT E3 ubiquitin-protein ligase CHIP OS=Rattus norvegicus OX=10116 GN=Stub1 PE=1 SV=1 CHIP_RAT reviewed E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1) Rattus norvegicus (Rat) GO:0000151; GO:0000165; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006513; GO:0006515; GO:0010614; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030512; GO:0030544; GO:0030911; GO:0030968; GO:0031072; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032436; GO:0034392; GO:0034393; GO:0034450; GO:0034605; GO:0035359; GO:0036503; GO:0042405; GO:0042803; GO:0043066; GO:0043161; GO:0045862; GO:0046332; GO:0050821; GO:0051087; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070412; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031; GO:1901526; GO:1904294; GO:1904694 cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018] enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g15646.t1 Q9DC40 38.816 304 1.24e-59 207.0 sp|Q9DC40|TELO2_MOUSE Telomere length regulation protein TEL2 homolog OS=Mus musculus OX=10090 GN=Telo2 PE=1 SV=2 TELO2_MOUSE reviewed Telomere length regulation protein TEL2 homolog Mus musculus (Mouse) GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016604; GO:0019900; GO:0019901; GO:0042162; GO:0044877; GO:0050821; GO:0051083; GO:0051879; GO:0060090; GO:0110078; GO:0140777 'de novo' cotranslational protein folding [GO:0051083]; protein stabilization [GO:0050821] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078] Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-containing complex stabilizing activity [GO:0140777]; telomeric DNA binding [GO:0042162] g15647.t1 Q6GPP1 42.391 184 8.36e-38 140.0 sp|Q6GPP1|TELO2_XENLA Telomere length regulation protein TEL2 homolog OS=Xenopus laevis OX=8355 GN=telo2 PE=2 SV=2 g15652.t1 Q9DC40 37.71 297 2.9e-60 209.0 sp|Q9DC40|TELO2_MOUSE Telomere length regulation protein TEL2 homolog OS=Mus musculus OX=10090 GN=Telo2 PE=1 SV=2 TELO2_MOUSE reviewed Telomere length regulation protein TEL2 homolog Mus musculus (Mouse) GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016604; GO:0019900; GO:0019901; GO:0042162; GO:0044877; GO:0050821; GO:0051083; GO:0051879; GO:0060090; GO:0110078; GO:0140777 'de novo' cotranslational protein folding [GO:0051083]; protein stabilization [GO:0050821] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078] Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-containing complex stabilizing activity [GO:0140777]; telomeric DNA binding [GO:0042162] g15653.t1 Q9Y535 72.816 206 3.53e-111 319.0 sp|Q9Y535|RPC8_HUMAN DNA-directed RNA polymerase III subunit RPC8 OS=Homo sapiens OX=9606 GN=POLR3H PE=1 SV=1 RPC8_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9) Homo sapiens (Human) GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0045087; GO:0051607 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384] centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899] g15654.t1 Q5MJ12 63.107 412 0.0 529.0 sp|Q5MJ12|FXL16_RAT F-box/LRR-repeat protein 16 OS=Rattus norvegicus OX=10116 GN=Fbxl16 PE=2 SV=1 g15655.t1 O05218 36.832 543 2.38e-97 308.0 sp|O05218|YWRD_BACSU Glutathione hydrolase-like YwrD proenzyme OS=Bacillus subtilis (strain 168) OX=224308 GN=ywrD PE=1 SV=1 g15656.t1 Q6ZS10 35.766 137 8.910000000000001e-21 95.5 sp|Q6ZS10|CL17A_HUMAN C-type lectin domain family 17, member A OS=Homo sapiens OX=9606 GN=CLEC17A PE=1 SV=2 CL17A_HUMAN reviewed C-type lectin domain family 17, member A (Prolectin) Homo sapiens (Human) GO:0005537; GO:0006955; GO:0009897; GO:0009986; GO:0038187; GO:0042802; GO:0042806; GO:0046872 immune response [GO:0006955] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897] D-mannose binding [GO:0005537]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187] g15659.t1 Q6EE22 43.943 842 0.0 621.0 sp|Q6EE22|UNK_CANLF RING finger protein unkempt homolog OS=Canis lupus familiaris OX=9615 GN=UNK PE=2 SV=1 g15660.t1 B5DF45 33.191 470 1.88e-61 212.0 sp|B5DF45|TRAF6_RAT TNF receptor-associated factor 6 OS=Rattus norvegicus OX=10116 GN=Traf6 PE=2 SV=1 TRAF6_RAT reviewed TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6) Rattus norvegicus (Rat) GO:0000045; GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007254; GO:0007416; GO:0008270; GO:0009299; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0023035; GO:0030316; GO:0030674; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0032991; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042742; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043124; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070301; GO:0070498; GO:0070534; GO:0070555; GO:0070936; GO:0071222; GO:0071345; GO:0097400; GO:0098696; GO:0098794; GO:0098978; GO:0140252; GO:0140374; GO:0141198; GO:1904385; GO:1904996 animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cell development [GO:0048468]; cellular response to angiotensin [GO:1904385]; cellular response to cytokine stimulus [GO:0071345]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mRNA transcription [GO:0009299]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation protein catabolic process at postsynapse [GO:0140252]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-macromolecule adaptor activity [GO:0030674]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g15661.t1 Q6P823 99.265 136 1.28e-94 271.0 sp|Q6P823|H33_XENTR Histone H3.3 OS=Xenopus tropicalis OX=8364 GN=TGas113e22.1 PE=1 SV=3 H33_XENTR reviewed Histone H3.3 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 nucleosome [GO:0000786]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] g15663.t1 Q13472 57.877 914 0.0 1075.0 sp|Q13472|TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens OX=9606 GN=TOP3A PE=1 SV=1 g15663.t1 Q13472 42.152 223 3.8100000000000003e-35 149.0 sp|Q13472|TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens OX=9606 GN=TOP3A PE=1 SV=1 g15664.t1 Q0WVL7 30.854 632 1.0299999999999999e-40 167.0 sp|Q0WVL7|GOGC5_ARATH Golgin candidate 5 OS=Arabidopsis thaliana OX=3702 GN=GC5 PE=1 SV=1 GOGC5_ARATH reviewed Golgin candidate 5 (AtGC5) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0005737; GO:0005794 cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] g15665.t1 P13620 48.101 158 1.57e-49 159.0 sp|P13620|ATP5H_BOVIN ATP synthase peripheral stalk subunit d, mitochondrial OS=Bos taurus OX=9913 GN=ATP5PD PE=1 SV=2 g15666.t1 C3Z724 69.953 213 1.36e-107 310.0 sp|C3Z724|UBE2S_BRAFL Ubiquitin-conjugating enzyme E2 S OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_259979 PE=3 SV=1 g15668.t1 Q9ULH7 33.091 550 2.79e-50 198.0 sp|Q9ULH7|MRTFB_HUMAN Myocardin-related transcription factor B OS=Homo sapiens OX=9606 GN=MRTFB PE=1 SV=3 MRTFB_HUMAN reviewed Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005737; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:0098793; GO:0098794; GO:0098978; GO:0099159; GO:1902895 muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of modification of postsynaptic structure [GO:0099159]; smooth muscle cell differentiation [GO:0051145] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713] g15668.t2 Q9ULH7 33.094 556 2.76e-49 195.0 sp|Q9ULH7|MRTFB_HUMAN Myocardin-related transcription factor B OS=Homo sapiens OX=9606 GN=MRTFB PE=1 SV=3 MRTFB_HUMAN reviewed Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005737; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:0098793; GO:0098794; GO:0098978; GO:0099159; GO:1902895 muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of modification of postsynaptic structure [GO:0099159]; smooth muscle cell differentiation [GO:0051145] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713] g15668.t3 Q9ULH7 33.091 550 3.12e-50 198.0 sp|Q9ULH7|MRTFB_HUMAN Myocardin-related transcription factor B OS=Homo sapiens OX=9606 GN=MRTFB PE=1 SV=3 MRTFB_HUMAN reviewed Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005737; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:0098793; GO:0098794; GO:0098978; GO:0099159; GO:1902895 muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of modification of postsynaptic structure [GO:0099159]; smooth muscle cell differentiation [GO:0051145] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713] g15669.t1 Q8IWE4 54.043 235 1.33e-84 261.0 sp|Q8IWE4|DCNL3_HUMAN DCN1-like protein 3 OS=Homo sapiens OX=9606 GN=DCUN1D3 PE=1 SV=1 DCNL3_HUMAN reviewed DCN1-like protein 3 (DCNL3) (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3) (Squamous cell carcinoma-related oncogene 3) Homo sapiens (Human) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0010225; GO:0010332; GO:0010564; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0097602; GO:2000134; GO:2000434; GO:2000435; GO:2000436 negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182] g15670.t1 Q2TA38 54.197 417 1.97e-154 449.0 sp|Q2TA38|TEKT4_BOVIN Tektin-4 OS=Bos taurus OX=9913 GN=TEKT4 PE=1 SV=1 TEKT4_BOVIN reviewed Tektin-4 Bos taurus (Bovine) GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0060378; GO:0097225; GO:0097228; GO:0160111 cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] g15671.t1 Q9DCS9 44.828 145 2.74e-38 131.0 sp|Q9DCS9|NDUBA_MOUSE NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 OS=Mus musculus OX=10090 GN=Ndufb10 PE=1 SV=3 g15676.t1 Q6GPP1 42.857 434 3.3300000000000004e-103 328.0 sp|Q6GPP1|TELO2_XENLA Telomere length regulation protein TEL2 homolog OS=Xenopus laevis OX=8355 GN=telo2 PE=2 SV=2 g15677.t1 P21531 78.908 403 0.0 689.0 sp|P21531|RL3_RAT Large ribosomal subunit protein uL3 OS=Rattus norvegicus OX=10116 GN=Rpl3 PE=1 SV=3 RL3_RAT reviewed Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (L4) Rattus norvegicus (Rat) GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0008097; GO:0022625; GO:0022626; GO:0032991; GO:0045202; GO:0071353 cellular response to interleukin-4 [GO:0071353]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202] 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g15679.t1 Q58EA2 52.347 277 4.16e-64 204.0 sp|Q58EA2|THO4A_XENLA THO complex subunit 4-A OS=Xenopus laevis OX=8355 GN=alyref-a PE=2 SV=1 g15680.t1 Q5XI73 51.031 194 2.1600000000000002e-64 200.0 sp|Q5XI73|GDIR1_RAT Rho GDP-dissociation inhibitor 1 OS=Rattus norvegicus OX=10116 GN=Arhgdia PE=1 SV=1 GDIR1_RAT reviewed Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha) Rattus norvegicus (Rat) GO:0001772; GO:0005094; GO:0005096; GO:0005504; GO:0005615; GO:0005634; GO:0005829; GO:0007266; GO:0008360; GO:0016020; GO:0019901; GO:0030336; GO:0031267; GO:0032880; GO:0035023; GO:0045202; GO:0051879; GO:0071260; GO:0071461; GO:0071526; GO:0097336; GO:0097338; GO:0098685; GO:0098693 cellular response to mechanical stimulus [GO:0071260]; cellular response to redox state [GO:0071461]; negative regulation of cell migration [GO:0030336]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic vesicle cycle [GO:0098693]; response to clozapine [GO:0097338]; response to risperidone [GO:0097336]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526] cytosol [GO:0005829]; extracellular space [GO:0005615]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] fatty acid binding [GO:0005504]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor activity [GO:0005094]; small GTPase binding [GO:0031267] g15681.t1 Q9TU03 51.064 188 3.16e-53 171.0 sp|Q9TU03|GDIR2_BOVIN Rho GDP-dissociation inhibitor 2 OS=Bos taurus OX=9913 GN=ARHGDIB PE=2 SV=3 g15682.t1 P54399 52.866 471 0.0 529.0 sp|P54399|PDI_DROME Protein disulfide-isomerase OS=Drosophila melanogaster OX=7227 GN=Pdi PE=2 SV=1 g15686.t1 Q8K561 25.0 868 9.44e-47 186.0 sp|Q8K561|OTOAN_MOUSE Otoancorin OS=Mus musculus OX=10090 GN=Otoa PE=2 SV=1 g15688.t1 P08172 26.786 448 8.58e-38 146.0 sp|P08172|ACM2_HUMAN Muscarinic acetylcholine receptor M2 OS=Homo sapiens OX=9606 GN=CHRM2 PE=1 SV=1 ACM2_HUMAN reviewed Muscarinic acetylcholine receptor M2 Homo sapiens (Human) GO:0005730; GO:0005794; GO:0005886; GO:0005929; GO:0006940; GO:0007186; GO:0007187; GO:0007188; GO:0007193; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007399; GO:0008016; GO:0009615; GO:0016020; GO:0016907; GO:0030425; GO:0030669; GO:0036064; GO:0045202; GO:0045211; GO:0098793; GO:0098981; GO:0099171; GO:1990763 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; response to virus [GO:0009615] cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907] g15689.t2 P08172 22.993 461 3.79e-26 114.0 sp|P08172|ACM2_HUMAN Muscarinic acetylcholine receptor M2 OS=Homo sapiens OX=9606 GN=CHRM2 PE=1 SV=1 ACM2_HUMAN reviewed Muscarinic acetylcholine receptor M2 Homo sapiens (Human) GO:0005730; GO:0005794; GO:0005886; GO:0005929; GO:0006940; GO:0007186; GO:0007187; GO:0007188; GO:0007193; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007399; GO:0008016; GO:0009615; GO:0016020; GO:0016907; GO:0030425; GO:0030669; GO:0036064; GO:0045202; GO:0045211; GO:0098793; GO:0098981; GO:0099171; GO:1990763 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; response to virus [GO:0009615] cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907] g15690.t1 P17200 24.598 435 4.5199999999999995e-30 125.0 sp|P17200|ACM4_CHICK Muscarinic acetylcholine receptor M4 OS=Gallus gallus OX=9031 GN=CHRM4 PE=2 SV=1 g15691.t1 P30372 23.602 483 4.95e-32 131.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g15692.t1 P56489 24.169 451 6e-32 131.0 sp|P56489|ACM1_MACMU Muscarinic acetylcholine receptor M1 OS=Macaca mulatta OX=9544 GN=CHRM1 PE=2 SV=1 g15693.t1 P17200 23.31 429 1.45e-32 133.0 sp|P17200|ACM4_CHICK Muscarinic acetylcholine receptor M4 OS=Gallus gallus OX=9031 GN=CHRM4 PE=2 SV=1 g15694.t1 O70496 57.82 211 2.15e-71 240.0 sp|O70496|CLCN7_MOUSE H(+)/Cl(-) exchange transporter 7 OS=Mus musculus OX=10090 GN=Clcn7 PE=1 SV=1 CLCN7_MOUSE reviewed H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7) Mus musculus (Mouse) GO:0005524; GO:0005765; GO:0009268; GO:0030321; GO:0034707; GO:0062158; GO:1902476 chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; lysosomal membrane [GO:0005765] ATP binding [GO:0005524]; chloride:proton antiporter activity [GO:0062158] g15695.t1 P51799 53.023 215 7.089999999999999e-67 222.0 sp|P51799|CLCN7_RAT H(+)/Cl(-) exchange transporter 7 OS=Rattus norvegicus OX=10116 GN=Clcn7 PE=2 SV=1 g15696.t1 P51798 57.692 156 9.37e-49 170.0 sp|P51798|CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens OX=9606 GN=CLCN7 PE=1 SV=2 CLCN7_HUMAN reviewed H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7) Homo sapiens (Human) GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0016020; GO:0030321; GO:0034707; GO:0062158; GO:1902476 chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride:proton antiporter activity [GO:0062158] g15701.t1 Q6GQ81 25.282 443 2.41e-28 120.0 sp|Q6GQ81|MID49_XENLA Mitochondrial dynamics protein MID49 OS=Xenopus laevis OX=8355 GN=mief2 PE=2 SV=1 MID49_XENLA reviewed Mitochondrial dynamics protein MID49 (Mitochondrial dynamics protein of 49 kDa homolog) (Mitochondrial elongation factor 2) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein homolog) Xenopus laevis (African clawed frog) GO:0005739; GO:0005741; GO:0007005; GO:0090141; GO:0090314 mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] g15702.t1 A4IG61 30.292 274 2.5699999999999997e-30 125.0 sp|A4IG61|MID51_DANRE Mitochondrial dynamics protein MID51 OS=Danio rerio OX=7955 GN=mief1 PE=2 SV=1 MID51_DANRE reviewed Mitochondrial dynamics protein MID51 (Mitochondrial dynamics protein of 51 kDa homolog) (Mitochondrial elongation factor 1) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000166; GO:0005739; GO:0005741; GO:0007005; GO:0010636; GO:0090141; GO:0090314 mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of protein targeting to membrane [GO:0090314] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] nucleotide binding [GO:0000166] g15703.t1 F8WK50 59.161 1288 0.0 1529.0 sp|F8WK50|FLII_DANRE Protein flightless-1 homolog OS=Danio rerio OX=7955 GN=flii PE=1 SV=1 g15704.t1 Q9CYU6 49.102 334 1.7000000000000001e-100 308.0 sp|Q9CYU6|DPH7_MOUSE Diphthine methyltransferase OS=Mus musculus OX=10090 GN=Dph7 PE=2 SV=1 g15704.t2 Q9CYU6 49.401 334 1.88e-100 308.0 sp|Q9CYU6|DPH7_MOUSE Diphthine methyltransferase OS=Mus musculus OX=10090 GN=Dph7 PE=2 SV=1 g15707.t1 P61643 30.396 227 4.1999999999999996e-30 122.0 sp|P61643|SIA8B_PANTR Alpha-2,8-sialyltransferase 8B OS=Pan troglodytes OX=9598 GN=ST8SIA2 PE=2 SV=1 g15708.t1 Q9UPT9 64.51 541 0.0 704.0 sp|Q9UPT9|UBP22_HUMAN Ubiquitin carboxyl-terminal hydrolase 22 OS=Homo sapiens OX=9606 GN=USP22 PE=1 SV=2 UBP22_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) Homo sapiens (Human) GO:0000086; GO:0000124; GO:0003713; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006282; GO:0006357; GO:0006508; GO:0008270; GO:0009792; GO:0016579; GO:0019899; GO:0032481; GO:0033276; GO:0043484; GO:0045893; GO:0045931; GO:0140936; GO:0140950 embryo development ending in birth or egg hatching [GO:0009792]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of type I interferon production [GO:0032481]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15709.t1 Q7Q732 55.378 251 6.1199999999999996e-89 269.0 sp|Q7Q732|DHRS7_ANOGA Dehydrogenase/reductase SDR family protein 7-like OS=Anopheles gambiae OX=7165 GN=AGAP005532 PE=3 SV=3 g15710.t1 Q8TBP0 58.65 474 0.0 583.0 sp|Q8TBP0|TBC16_HUMAN TBC1 domain family member 16 OS=Homo sapiens OX=9606 GN=TBC1D16 PE=1 SV=1 g15710.t2 Q8TBP0 58.65 474 0.0 583.0 sp|Q8TBP0|TBC16_HUMAN TBC1 domain family member 16 OS=Homo sapiens OX=9606 GN=TBC1D16 PE=1 SV=1 g15712.t1 Q4G0X9 41.321 893 0.0 662.0 sp|Q4G0X9|CCD40_HUMAN Coiled-coil domain-containing protein 40 OS=Homo sapiens OX=9606 GN=CCDC40 PE=1 SV=2 CCD40_HUMAN reviewed Coiled-coil domain-containing protein 40 Homo sapiens (Human) GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0031514; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0044782; GO:0060287; GO:0061512; GO:0070286; GO:0071907; GO:0071910 axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514] g15713.t1 Q9W107 47.09 189 2.98e-56 190.0 sp|Q9W107|SYYM_DROME Tyrosine--tRNA ligase, mitochondrial OS=Drosophila melanogaster OX=7227 GN=TyrRS-m PE=2 SV=1 SYYM_DROME reviewed Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Mitochondrial tyrosyl-tRNA synthetase) (Tyrosyl-tRNA synthetase) (TyrRS) Drosophila melanogaster (Fruit fly) GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006437; GO:0043039; GO:0070184 mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831] g15714.t1 A7SLC8 60.0 150 1.5599999999999999e-60 189.0 sp|A7SLC8|NAT9_NEMVE N-acetyltransferase 9-like protein OS=Nematostella vectensis OX=45351 GN=nat9 PE=3 SV=1 g15715.t1 O75689 42.623 366 2.5e-104 315.0 sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2 ADAP1_HUMAN reviewed Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25) Homo sapiens (Human) GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043533; GO:1902936 cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270] g15716.t1 Q9Z1Z3 42.323 508 2.3600000000000002e-107 337.0 sp|Q9Z1Z3|EPN2_RAT Epsin-2 OS=Rattus norvegicus OX=10116 GN=Epn2 PE=1 SV=1 EPN2_RAT reviewed Epsin-2 (EPS-15-interacting protein 2) Rattus norvegicus (Rat) GO:0001701; GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0007219; GO:0030100; GO:0030125; GO:0030128; GO:0030276; GO:0030948; GO:0045747; GO:0048568; GO:0098843; GO:1903671 embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of endocytosis [GO:0030100] clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843] clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] g15720.t1 P04323 37.22 223 9.239999999999999e-39 145.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g15722.t1 Q07643 31.818 330 2.79e-21 97.8 sp|Q07643|CO9A2_MOUSE Collagen alpha-2(IX) chain OS=Mus musculus OX=10090 GN=Col9a2 PE=2 SV=1 g15723.t1 A0MSJ1 29.222 835 2.14e-45 181.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g15723.t1 A0MSJ1 28.308 869 2.5e-40 165.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g15723.t1 A0MSJ1 28.88 786 3.44e-36 152.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g15725.t1 Q9C0C9 58.079 229 3.74e-77 285.0 sp|Q9C0C9|UBE2O_HUMAN (E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens OX=9606 GN=UBE2O PE=1 SV=3 g15725.t1 Q9C0C9 36.755 302 7.12e-44 179.0 sp|Q9C0C9|UBE2O_HUMAN (E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens OX=9606 GN=UBE2O PE=1 SV=3 g15725.t1 Q9C0C9 44.531 128 7.79e-22 107.0 sp|Q9C0C9|UBE2O_HUMAN (E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens OX=9606 GN=UBE2O PE=1 SV=3 g15726.t1 Q96QU8 57.749 1155 0.0 1350.0 sp|Q96QU8|XPO6_HUMAN Exportin-6 OS=Homo sapiens OX=9606 GN=XPO6 PE=1 SV=1 XPO6_HUMAN reviewed Exportin-6 (Exp6) (Ran-binding protein 20) Homo sapiens (Human) GO:0005049; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0031267; GO:0032991 protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] g15727.t1 Q9D4I2 29.547 1215 2.0800000000000002e-122 414.0 sp|Q9D4I2|MEII1_MOUSE Meiosis inhibitor protein 1 OS=Mus musculus OX=10090 GN=Mei1 PE=2 SV=4 MEII1_MOUSE reviewed Meiosis inhibitor protein 1 (Meiosis defective protein 1) Mus musculus (Mouse) GO:0000212; GO:0007127; GO:0007141; GO:0007276; GO:0007283; GO:0007286; GO:0040038; GO:0045141; GO:0048477; GO:0051321 gamete generation [GO:0007276]; male meiosis I [GO:0007141]; meiosis I [GO:0007127]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] g15727.t2 Q9D4I2 28.912 1259 1.88e-116 398.0 sp|Q9D4I2|MEII1_MOUSE Meiosis inhibitor protein 1 OS=Mus musculus OX=10090 GN=Mei1 PE=2 SV=4 MEII1_MOUSE reviewed Meiosis inhibitor protein 1 (Meiosis defective protein 1) Mus musculus (Mouse) GO:0000212; GO:0007127; GO:0007141; GO:0007276; GO:0007283; GO:0007286; GO:0040038; GO:0045141; GO:0048477; GO:0051321 gamete generation [GO:0007276]; male meiosis I [GO:0007141]; meiosis I [GO:0007127]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] g15728.t1 P24733 57.381 1917 0.0 2201.0 sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1 g15728.t2 P24733 52.768 813 0.0 771.0 sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1 g15729.t1 Q8HYW2 31.674 663 5.65e-96 315.0 sp|Q8HYW2|SO3A1_BOVIN Solute carrier organic anion transporter family member 3A1 OS=Bos taurus OX=9913 GN=SLCO3A1 PE=2 SV=1 SO3A1_BOVIN reviewed Solute carrier organic anion transporter family member 3A1 (Organic anion-transporting polypeptide D) (OATP-D) Bos taurus (Bovine) GO:0006811; GO:0008514; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0015823; GO:0015827; GO:0015828; GO:0016323; GO:0016324; GO:0043252 monoatomic ion transport [GO:0006811]; phenylalanine transport [GO:0015823]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g15731.t1 A7RJI7 54.839 465 0.0 530.0 sp|A7RJI7|CCZ1_NEMVE Vacuolar fusion protein CCZ1 homolog OS=Nematostella vectensis OX=45351 GN=v1g238755 PE=3 SV=1 g15732.t1 Q29RR0 70.37 216 6.94e-111 320.0 sp|Q29RR0|RAB26_BOVIN Ras-related protein Rab-26 OS=Bos taurus OX=9913 GN=RAB26 PE=2 SV=1 RAB26_BOVIN reviewed Ras-related protein Rab-26 (EC 3.6.5.2) Bos taurus (Bovine) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005802; GO:0005886; GO:0007193; GO:0016192; GO:0017157; GO:0019002; GO:0030667; GO:0030672; GO:0031985; GO:0035272; GO:0043001; GO:0045055; GO:0046872; GO:0140251 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; exocrine system development [GO:0035272]; Golgi to plasma membrane protein transport [GO:0043001]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; regulation protein catabolic process at presynapse [GO:0140251]; vesicle-mediated transport [GO:0016192] Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g15734.t1 Q9UBX8 54.348 230 1.57e-83 266.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g15735.t1 Q8CIQ6 33.217 286 2.03e-31 125.0 sp|Q8CIQ6|MTR1B_MOUSE Melatonin receptor type 1B OS=Mus musculus OX=10090 GN=Mtnr1b PE=2 SV=1 MTR1B_MOUSE reviewed Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor) Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007186; GO:0007623; GO:0008502; GO:0010754; GO:0042593; GO:0042753; GO:0043524; GO:0045906; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0098908 circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502] g15736.t1 A7SE07 70.611 262 1.23e-138 394.0 sp|A7SE07|NUBP2_NEMVE Cytosolic Fe-S cluster assembly factor NUBP2 homolog OS=Nematostella vectensis OX=45351 GN=v1g229988 PE=3 SV=1 g15739.t1 Q9DC40 40.724 221 7.42e-50 177.0 sp|Q9DC40|TELO2_MOUSE Telomere length regulation protein TEL2 homolog OS=Mus musculus OX=10090 GN=Telo2 PE=1 SV=2 TELO2_MOUSE reviewed Telomere length regulation protein TEL2 homolog Mus musculus (Mouse) GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016604; GO:0019900; GO:0019901; GO:0042162; GO:0044877; GO:0050821; GO:0051083; GO:0051879; GO:0060090; GO:0110078; GO:0140777 'de novo' cotranslational protein folding [GO:0051083]; protein stabilization [GO:0050821] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078] Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-containing complex stabilizing activity [GO:0140777]; telomeric DNA binding [GO:0042162] g15746.t1 Q96QE3 27.122 1025 1.9e-65 250.0 sp|Q96QE3|ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens OX=9606 GN=ATAD5 PE=1 SV=4 ATAD5_HUMAN reviewed ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0008283; GO:0016887; GO:0030890; GO:0031391; GO:0033260; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:1901990; GO:1902166; GO:1902751 cell population proliferation [GO:0008283]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770] Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860] g15747.t1 P68907 37.368 190 3.62e-32 136.0 sp|P68907|PZRN3_RAT E3 ubiquitin-protein ligase PDZRN3 OS=Rattus norvegicus OX=10116 GN=Pdzrn3 PE=1 SV=1 g15749.t1 Q12788 52.566 799 0.0 915.0 sp|Q12788|TBL3_HUMAN Transducin beta-like protein 3 OS=Homo sapiens OX=9606 GN=TBL3 PE=1 SV=2 TBL3_HUMAN reviewed Transducin beta-like protein 3 (WD repeat-containing protein SAZD) Homo sapiens (Human) GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0030686; GO:0032040; GO:0034511; GO:0042274 endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit biogenesis [GO:0042274] 90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] g15750.t1 O95847 61.921 302 1.71e-143 411.0 sp|O95847|UCP4_HUMAN Mitochondrial uncoupling protein 4 OS=Homo sapiens OX=9606 GN=SLC25A27 PE=1 SV=1 UCP4_HUMAN reviewed Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0015078; GO:0015108; GO:0022857; GO:0031966; GO:0035356; GO:0042803; GO:0043025; GO:0043524; GO:0045177; GO:0046324; GO:0048839; GO:0051562 inner ear development [GO:0048839]; intracellular triglyceride homeostasis [GO:0035356]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; regulation of D-glucose import [GO:0046324]; response to cold [GO:0009409] apical part of cell [GO:0045177]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] chloride transmembrane transporter activity [GO:0015108]; protein homodimerization activity [GO:0042803]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857] g15751.t1 Q9JKW0 37.566 189 3.34e-44 149.0 sp|Q9JKW0|AR6P1_MOUSE ADP-ribosylation factor-like protein 6-interacting protein 1 OS=Mus musculus OX=10090 GN=Arl6ip1 PE=1 SV=1 AR6P1_MOUSE reviewed ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Mus musculus (Mouse) GO:0002038; GO:0005737; GO:0005783; GO:0005784; GO:0005789; GO:0005829; GO:0006613; GO:0006915; GO:0016020; GO:0042802; GO:0043066; GO:0071782; GO:0071787; GO:1903371; GO:1990809 apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; regulation of endoplasmic reticulum tubular network organization [GO:1903371] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784] identical protein binding [GO:0042802] g15752.t1 Q54IT3 33.333 474 3.02e-81 264.0 sp|Q54IT3|AOFA_DICDI Probable flavin-containing monoamine oxidase A OS=Dictyostelium discoideum OX=44689 GN=maoA PE=3 SV=1 g15753.t1 Q54IT3 34.047 467 3.35e-85 274.0 sp|Q54IT3|AOFA_DICDI Probable flavin-containing monoamine oxidase A OS=Dictyostelium discoideum OX=44689 GN=maoA PE=3 SV=1 g15758.t1 Q6PE54 53.94 736 0.0 827.0 sp|Q6PE54|DHX40_MOUSE Probable ATP-dependent RNA helicase DHX40 OS=Mus musculus OX=10090 GN=Dhx40 PE=1 SV=1 g15760.t1 Q9BUU2 34.14 372 2.4499999999999997e-52 181.0 sp|Q9BUU2|MET22_HUMAN Methyltransferase-like protein 22 OS=Homo sapiens OX=9606 GN=METTL22 PE=1 SV=2 MET22_HUMAN reviewed Methyltransferase-like protein 22 (EC 2.1.1.-) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0006479; GO:0008276; GO:0016279; GO:0031072; GO:0032991 protein methylation [GO:0006479] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] g15761.t1 Q4R7Z9 85.149 101 2.22e-60 196.0 sp|Q4R7Z9|IFT56_MACFA Intraflagellar transport protein 56 OS=Macaca fascicularis OX=9541 GN=IFT56 PE=2 SV=1 IFT56_MACFA reviewed Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26) (TPR repeat protein 26) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005813; GO:0005929; GO:0007224; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0043005; GO:0060271; GO:0061512; GO:0097546; GO:0120170; GO:1905198 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005] intraciliary transport particle B binding [GO:0120170] g15762.t1 Q8BS45 74.388 449 0.0 691.0 sp|Q8BS45|IFT56_MOUSE Intraflagellar transport protein 56 OS=Mus musculus OX=10090 GN=Ift56 PE=1 SV=1 IFT56_MOUSE reviewed Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26) Mus musculus (Mouse) GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0046530; GO:0060271; GO:0061512; GO:0097546; GO:0120170; GO:1905198 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] intraciliary transport particle B binding [GO:0120170] g15765.t1 Q8NFG4 47.314 577 2.86e-173 506.0 sp|Q8NFG4|FLCN_HUMAN Folliculin OS=Homo sapiens OX=9606 GN=FLCN PE=1 SV=1 FLCN_HUMAN reviewed Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein) Homo sapiens (Human) GO:0000122; GO:0001701; GO:0004857; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0007179; GO:0009267; GO:0010508; GO:0019899; GO:0030097; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0034198; GO:0035024; GO:0035556; GO:0043065; GO:0043491; GO:0044877; GO:0045820; GO:0046578; GO:0050673; GO:0050680; GO:0051898; GO:0070371; GO:0070373; GO:0072111; GO:0072686; GO:0097009; GO:0097193; GO:0120163; GO:1901723; GO:1901874; GO:1903444; GO:1904263; GO:1905672; GO:1990877; GO:2000973; GO:2001244 cell proliferation involved in kidney development [GO:0072111]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome localization [GO:0032418]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glycolytic process [GO:0045820]; negative regulation of lysosome organization [GO:1905672]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of pro-B cell differentiation [GO:2000973]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]; transforming growth factor beta receptor signaling pathway [GO:0007179] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FNIP-folliculin RagC/D GAP [GO:1990877]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877] g15766.t1 Q6DJF8 52.0 225 7.59e-80 242.0 sp|Q6DJF8|MET23_XENLA Histone-arginine methyltransferase METTL23 OS=Xenopus laevis OX=8355 GN=mettl23 PE=2 SV=1 g15767.t1 Q90ZY4 43.82 267 3.93e-75 241.0 sp|Q90ZY4|SBK1_DANRE Serine/threonine-protein kinase SBK1 OS=Danio rerio OX=7955 GN=sbk1 PE=1 SV=1 SBK1_DANRE reviewed Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (Brain-specific protein kinase BSK146) (SH3 domain-binding kinase 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0106310 cytoplasm [GO:0005737] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g15768.t1 Q5R8Q5 49.423 433 1.98e-126 377.0 sp|Q5R8Q5|SYT17_PONAB Synaptotagmin-17 OS=Pongo abelii OX=9601 GN=SYT17 PE=2 SV=1 g15769.t1 Q8BZ36 40.653 674 1.7699999999999999e-165 496.0 sp|Q8BZ36|RINT1_MOUSE RAD50-interacting protein 1 OS=Mus musculus OX=10090 GN=Rint1 PE=1 SV=2 RINT1_MOUSE reviewed RAD50-interacting protein 1 (RAD50 interactor 1) (RINT-1) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] g15769.t2 Q8BZ36 41.221 655 1.0900000000000001e-167 501.0 sp|Q8BZ36|RINT1_MOUSE RAD50-interacting protein 1 OS=Mus musculus OX=10090 GN=Rint1 PE=1 SV=2 RINT1_MOUSE reviewed RAD50-interacting protein 1 (RAD50 interactor 1) (RINT-1) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] g15771.t1 O88854 38.08 323 4.609999999999999e-68 221.0 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g15773.t1 Q84DC4 34.298 449 2.43e-57 199.0 sp|Q84DC4|MANHY_PSEPU Mandelamide hydrolase OS=Pseudomonas putida OX=303 GN=mdlY PE=1 SV=1 g15774.t1 Q8VHK2 55.797 138 7.799999999999999e-46 186.0 sp|Q8VHK2|CSKI1_RAT Caskin-1 OS=Rattus norvegicus OX=10116 GN=Caskin1 PE=1 SV=1 CSKI1_RAT reviewed Caskin-1 (CASK-interacting protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0007165; GO:0019904; GO:0042802; GO:0098794; GO:0098978; GO:0099151 regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794] identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] g15774.t2 Q8WXD9 49.573 351 9.04e-89 324.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g15774.t2 Q8WXD9 52.448 143 3.14e-44 181.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g15774.t3 Q8WXD9 49.573 351 1.06e-88 323.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g15774.t3 Q8WXD9 52.448 143 3.33e-44 181.0 sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1 g15775.t1 Q9BQA9 35.897 195 2.45e-39 136.0 sp|Q9BQA9|CYBC1_HUMAN Cytochrome b-245 chaperone 1 OS=Homo sapiens OX=9606 GN=CYBC1 PE=1 SV=1 CYBC1_HUMAN reviewed Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0045087; GO:0045728 innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] g15776.t1 P23610 48.397 343 7.85e-75 237.0 sp|P23610|HAP40_HUMAN 40-kDa huntingtin-associated protein OS=Homo sapiens OX=9606 GN=F8A1 PE=1 SV=2 HAP40_HUMAN reviewed 40-kDa huntingtin-associated protein (HAP40) (CpG island protein) (Factor VIII intron 22 protein) Homo sapiens (Human) GO:0005634; GO:0005769; GO:0016604; GO:0099518; GO:1901799 negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518] early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634] g15778.t1 A4D2P6 39.623 371 1.5799999999999998e-82 300.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g15778.t1 A4D2P6 40.088 227 3.46e-38 160.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g15778.t2 A4D2P6 39.623 371 1.3299999999999998e-82 300.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g15778.t2 A4D2P6 40.088 227 3.6e-38 160.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g15778.t3 A4D2P6 39.623 371 7.61e-83 300.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g15778.t3 A4D2P6 40.088 227 3.13e-38 160.0 sp|A4D2P6|GRD2I_HUMAN Delphilin OS=Homo sapiens OX=9606 GN=GRID2IP PE=1 SV=2 GRD2I_HUMAN reviewed Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) Homo sapiens (Human) GO:0045211; GO:0060292; GO:0098688; GO:0099072; GO:0099092; GO:0099566; GO:0150048 long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211] g15783.t1 P10394 28.518 1073 1e-114 392.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g15791.t1 Q7L5D6 56.958 309 2.7399999999999998e-126 367.0 sp|Q7L5D6|GET4_HUMAN Golgi to ER traffic protein 4 homolog OS=Homo sapiens OX=9606 GN=GET4 PE=1 SV=1 GET4_HUMAN reviewed Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35) Homo sapiens (Human) GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0006620; GO:0031647; GO:0036503; GO:0036506; GO:0045048; GO:0051087; GO:0071816; GO:0071818; GO:0140597 ERAD pathway [GO:0036503]; maintenance of unfolded protein [GO:0036506]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] protein carrier chaperone [GO:0140597]; protein-folding chaperone binding [GO:0051087] g15792.t1 Q63344 23.645 406 1.08e-22 103.0 sp|Q63344|MOT2_RAT Monocarboxylate transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc16a7 PE=1 SV=2 MOT2_RAT reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Rattus norvegicus (Rat) GO:0005654; GO:0005829; GO:0005886; GO:0008028; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g15793.t1 O93610 57.639 432 9.41e-173 495.0 sp|O93610|DPOD2_XENLA DNA polymerase delta subunit 2 OS=Xenopus laevis OX=8355 GN=pold2 PE=2 SV=1 g15795.t1 Q8N0W5 41.026 234 6.52e-49 166.0 sp|Q8N0W5|IQCK_HUMAN IQ domain-containing protein K OS=Homo sapiens OX=9606 GN=IQCK PE=1 SV=1 g15796.t1 Q5F3I6 53.557 506 0.0 533.0 sp|Q5F3I6|TM104_CHICK Transmembrane protein 104 OS=Gallus gallus OX=9031 GN=TMEM104 PE=2 SV=1 g15799.t1 Q1JP75 60.656 244 8.54e-105 306.0 sp|Q1JP75|DCXR_BOVIN L-xylulose reductase OS=Bos taurus OX=9913 GN=DCXR PE=2 SV=1 DCXR_BOVIN reviewed L-xylulose reductase (XR) (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase) (DCXR) Bos taurus (Bovine) GO:0004090; GO:0005881; GO:0005997; GO:0006006; GO:0016020; GO:0042732; GO:0050038 D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; xylulose metabolic process [GO:0005997] cytoplasmic microtubule [GO:0005881]; membrane [GO:0016020] carbonyl reductase (NADPH) activity [GO:0004090]; L-xylulose reductase (NADPH) activity [GO:0050038] g15801.t1 E2IYB3 62.857 70 1.47e-23 97.8 sp|E2IYB3|FCNV1_VARKO Veficolin-1 (Fragment) OS=Varanus komodoensis OX=61221 PE=2 SV=1 g15803.t1 Q5I012 36.417 508 1.04e-104 361.0 sp|Q5I012|S38AA_MOUSE Solute carrier family 38 member 10 OS=Mus musculus OX=10090 GN=Slc38a10 PE=1 SV=2 S38AA_MOUSE reviewed Solute carrier family 38 member 10 (Amino acid transporter SLC38A10) Mus musculus (Mouse) GO:0003333; GO:0005794; GO:0015179; GO:0016020; GO:0060348 amino acid transmembrane transport [GO:0003333]; bone development [GO:0060348] Golgi apparatus [GO:0005794]; membrane [GO:0016020] L-amino acid transmembrane transporter activity [GO:0015179] g15804.t1 F1NV61 45.985 274 1.1900000000000001e-77 244.0 sp|F1NV61|CASP7_CHICK Caspase-7 OS=Gallus gallus OX=9031 GN=CASP7 PE=3 SV=2 CASP7_CHICK reviewed Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] Gallus gallus (Chicken) GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0043525; GO:0070227; GO:0097194; GO:1905686 apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723] g15811.t1 O94901 60.697 201 2.82e-76 274.0 sp|O94901|SUN1_HUMAN SUN domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUN1 PE=1 SV=4 g15812.t1 Q14565 84.615 325 0.0 583.0 sp|Q14565|DMC1_HUMAN Meiotic recombination protein DMC1/LIM15 homolog OS=Homo sapiens OX=9606 GN=DMC1 PE=1 SV=2 g15815.t1 Q6P8E9 80.315 127 3.79e-74 219.0 sp|Q6P8E9|NH2L1_XENTR NHP2-like protein 1 OS=Xenopus tropicalis OX=8364 GN=snu13 PE=2 SV=1 NH2L1_XENTR reviewed NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000398; GO:0003723; GO:0005634; GO:0005690; GO:0005730; GO:0030490; GO:0030622; GO:0031428; GO:0032040; GO:0034512; GO:0042274; GO:0046540; GO:0071005; GO:0071011 maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; ribosomal small subunit biogenesis [GO:0042274] box C/D methylation guide snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690] box C/D sno(s)RNA binding [GO:0034512]; RNA binding [GO:0003723]; U4atac snRNA binding [GO:0030622] g15816.t1 P57103 35.238 735 1.6500000000000002e-110 358.0 sp|P57103|NAC3_HUMAN Sodium/calcium exchanger 3 OS=Homo sapiens OX=9606 GN=SLC8A3 PE=1 SV=2 NAC3_HUMAN reviewed Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) Homo sapiens (Human) GO:0001669; GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015630; GO:0016528; GO:0021537; GO:0030424; GO:0030425; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0097229; GO:0098703; GO:0098794; GO:0098815; GO:1902532; GO:1903779; GO:1905060; GO:1990034 calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transport [GO:0006811]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; sperm end piece [GO:0097229]; synapse [GO:0045202] calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g15817.t1 Q54KA7 31.887 461 1.15e-41 164.0 sp|Q54KA7|SECG_DICDI Ankyrin repeat, PH and SEC7 domain containing protein secG OS=Dictyostelium discoideum OX=44689 GN=secG PE=2 SV=1 SECG_DICDI reviewed Ankyrin repeat, PH and SEC7 domain containing protein secG Dictyostelium discoideum (Social amoeba) GO:0005085; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327 actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012] cytosol [GO:0005829]; lysosome [GO:0005764] guanyl-nucleotide exchange factor activity [GO:0005085] g15817.t1 Q54KA7 28.362 409 1.9e-25 114.0 sp|Q54KA7|SECG_DICDI Ankyrin repeat, PH and SEC7 domain containing protein secG OS=Dictyostelium discoideum OX=44689 GN=secG PE=2 SV=1 SECG_DICDI reviewed Ankyrin repeat, PH and SEC7 domain containing protein secG Dictyostelium discoideum (Social amoeba) GO:0005085; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327 actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012] cytosol [GO:0005829]; lysosome [GO:0005764] guanyl-nucleotide exchange factor activity [GO:0005085] g15819.t1 E2IYB3 61.429 70 1.04e-21 90.9 sp|E2IYB3|FCNV1_VARKO Veficolin-1 (Fragment) OS=Varanus komodoensis OX=61221 PE=2 SV=1 g15820.t1 O94812 27.813 1111 1.97e-137 451.0 sp|O94812|BAIP3_HUMAN BAI1-associated protein 3 OS=Homo sapiens OX=9606 GN=BAIAP3 PE=1 SV=2 g15820.t2 O94812 27.813 1111 1.55e-137 451.0 sp|O94812|BAIP3_HUMAN BAI1-associated protein 3 OS=Homo sapiens OX=9606 GN=BAIAP3 PE=1 SV=2 g15821.t1 Q61241 39.844 256 7.630000000000001e-59 203.0 sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Tssk1b PE=1 SV=2 g15822.t1 O08796 48.545 653 0.0 601.0 sp|O08796|EF2K_MOUSE Eukaryotic elongation factor 2 kinase OS=Mus musculus OX=10090 GN=Eef2k PE=1 SV=1 EF2K_MOUSE reviewed Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) Mus musculus (Mouse) GO:0002931; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637 cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; regulation of protein autophosphorylation [GO:0031952]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414] dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; translation factor activity, RNA binding [GO:0008135] g15822.t2 O08796 48.769 650 0.0 600.0 sp|O08796|EF2K_MOUSE Eukaryotic elongation factor 2 kinase OS=Mus musculus OX=10090 GN=Eef2k PE=1 SV=1 EF2K_MOUSE reviewed Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) Mus musculus (Mouse) GO:0002931; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637 cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; regulation of protein autophosphorylation [GO:0031952]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414] dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; translation factor activity, RNA binding [GO:0008135] g15823.t1 Q5ZKJ5 28.067 481 1.53e-46 171.0 sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1 g15824.t1 Q8CF89 49.558 113 2.2500000000000002e-26 110.0 sp|Q8CF89|TAB1_MOUSE TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Mus musculus OX=10090 GN=Tab1 PE=1 SV=2 TAB1_MOUSE reviewed TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1) Mus musculus (Mouse) GO:0001701; GO:0003007; GO:0003279; GO:0004722; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0007165; GO:0007179; GO:0007249; GO:0019209; GO:0030324; GO:0032481; GO:0032527; GO:0032991; GO:0035904; GO:0038061; GO:0043410; GO:0043539; GO:0044877; GO:0048273; GO:0060090; GO:0060976; GO:0140896; GO:0141111 aorta development [GO:0035904]; canonical NF-kappaB signal transduction [GO:0007249]; cardiac septum development [GO:0003279]; cGAS/STING signaling pathway [GO:0140896]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of type I interferon production [GO:0032481]; protein exit from endoplasmic reticulum [GO:0032527]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; protein-containing complex [GO:0032991] kinase activator activity [GO:0019209]; mitogen-activated protein kinase p38 binding [GO:0048273]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877] g15825.t1 Q8CF89 48.954 239 2.07e-71 230.0 sp|Q8CF89|TAB1_MOUSE TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Mus musculus OX=10090 GN=Tab1 PE=1 SV=2 TAB1_MOUSE reviewed TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1) Mus musculus (Mouse) GO:0001701; GO:0003007; GO:0003279; GO:0004722; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0007165; GO:0007179; GO:0007249; GO:0019209; GO:0030324; GO:0032481; GO:0032527; GO:0032991; GO:0035904; GO:0038061; GO:0043410; GO:0043539; GO:0044877; GO:0048273; GO:0060090; GO:0060976; GO:0140896; GO:0141111 aorta development [GO:0035904]; canonical NF-kappaB signal transduction [GO:0007249]; cardiac septum development [GO:0003279]; cGAS/STING signaling pathway [GO:0140896]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of type I interferon production [GO:0032481]; protein exit from endoplasmic reticulum [GO:0032527]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; protein-containing complex [GO:0032991] kinase activator activity [GO:0019209]; mitogen-activated protein kinase p38 binding [GO:0048273]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877] g15826.t1 Q9CQB7 55.932 118 1.69e-45 146.0 sp|Q9CQB7|LYRM1_MOUSE LYR motif-containing protein 1 OS=Mus musculus OX=10090 GN=Lyrm1 PE=1 SV=1 g15827.t1 Q8TD57 66.365 4088 0.0 5585.0 sp|Q8TD57|DYH3_HUMAN Dynein axonemal heavy chain 3 OS=Homo sapiens OX=9606 GN=DNAH3 PE=1 SV=1 DYH3_HUMAN reviewed Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g15828.t1 Q24342 38.873 355 1.0100000000000001e-79 254.0 sp|Q24342|FNG_DROME Fringe glycosyltransferase OS=Drosophila melanogaster OX=7227 GN=fng PE=1 SV=1 FNG_DROME reviewed Fringe glycosyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0001745; GO:0005737; GO:0005795; GO:0005797; GO:0007293; GO:0007450; GO:0007476; GO:0007480; GO:0008587; GO:0008593; GO:0030707; GO:0033829; GO:0035017; GO:0036011; GO:0036066; GO:0036099; GO:0045746; GO:0045747; GO:0046872; GO:0048100; GO:0048190; GO:0048749 compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190] cytoplasm [GO:0005737]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795] metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] g15831.t1 P07207 42.939 1395 0.0 1043.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 41.947 1397 0.0 1008.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 42.835 1312 0.0 1006.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 41.29 1395 0.0 1000.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 40.996 1366 0.0 976.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 41.774 1240 0.0 935.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 43.343 1089 0.0 845.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 36.595 1451 0.0 816.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 39.239 1157 0.0 806.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 42.634 1086 0.0 801.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 40.673 981 0.0 709.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 36.301 584 5.1e-84 313.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 37.5 320 1.44e-52 209.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 37.578 322 1.43e-48 196.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 35.625 320 6.259999999999999e-45 184.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 33.058 363 3.85e-44 182.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 36.164 318 3.9900000000000006e-43 178.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 35.312 320 7.64e-40 167.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 34.985 323 2.36e-39 166.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 34.218 339 2.77e-38 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 33.894 357 3.33e-38 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 35.625 320 1.13e-36 157.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 35.417 336 2.05e-35 153.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t1 P07207 36.19 315 2.1200000000000002e-35 153.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 42.939 1395 0.0 1044.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 41.947 1397 0.0 1009.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 42.715 1311 0.0 1007.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 41.29 1395 0.0 1002.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 40.996 1366 0.0 978.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 41.646 1239 0.0 936.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 43.343 1089 0.0 846.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 36.595 1451 0.0 817.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 39.239 1157 0.0 807.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 42.634 1086 0.0 802.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 40.673 981 0.0 709.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 36.301 584 4.63e-84 313.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 37.5 320 1.22e-52 209.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 37.578 322 1.1499999999999999e-48 196.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 35.625 320 5.3e-45 184.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 33.058 363 3.55e-44 182.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 36.164 318 4.31e-43 178.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 35.312 320 6.749999999999999e-40 167.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 34.985 323 2.32e-39 166.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 34.218 339 2.38e-38 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 33.894 357 3.09e-38 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 35.625 320 1.03e-36 157.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 35.417 336 1.81e-35 153.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15831.t2 P07207 36.19 315 1.89e-35 153.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g15832.t1 P21783 37.825 1499 0.0 790.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 38.25 1417 0.0 778.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 37.373 1279 0.0 741.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 37.189 1366 0.0 741.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 37.069 1508 0.0 721.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 36.371 1295 0.0 711.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 36.251 1371 0.0 669.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 37.421 1272 0.0 653.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 38.564 1198 0.0 643.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 34.948 1528 1.67e-167 585.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 34.839 1240 1.22e-155 547.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 35.02 1008 1.18e-114 415.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 35.571 849 3.88e-106 387.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 35.223 741 5.969999999999999e-84 314.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 37.7 313 5.94e-41 172.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 37.241 290 7.13e-38 162.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 36.102 313 5.29e-34 149.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15832.t1 P21783 34.007 297 1.02e-28 132.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g15833.t1 Q7ZX03 54.681 470 1.67e-148 450.0 sp|Q7ZX03|FOXK2_XENLA Forkhead box protein K2 OS=Xenopus laevis OX=8355 GN=foxk2 PE=2 SV=2 FOXK2_XENLA reviewed Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) Xenopus laevis (African clawed frog) GO:0000287; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0010507; GO:0010906; GO:0042594; GO:0043565; GO:0045892; GO:0045893; GO:0061621 canonical glycolysis [GO:0061621]; intracellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976] g15833.t2 Q7ZX03 54.681 470 1.43e-149 451.0 sp|Q7ZX03|FOXK2_XENLA Forkhead box protein K2 OS=Xenopus laevis OX=8355 GN=foxk2 PE=2 SV=2 FOXK2_XENLA reviewed Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) Xenopus laevis (African clawed frog) GO:0000287; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0010507; GO:0010906; GO:0042594; GO:0043565; GO:0045892; GO:0045893; GO:0061621 canonical glycolysis [GO:0061621]; intracellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976] g15834.t1 Q08DM7 66.553 293 5.1e-146 421.0 sp|Q08DM7|SEPT3_BOVIN Neuronal-specific septin-3 OS=Bos taurus OX=9913 GN=SEPTIN3 PE=2 SV=3 SEPT3_BOVIN reviewed Neuronal-specific septin-3 Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0060090; GO:0061640; GO:0098793 cytoskeleton-dependent cytokinesis [GO:0061640]; intracellular protein localization [GO:0008104] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] g15834.t2 Q08DM7 66.553 293 3.13e-145 421.0 sp|Q08DM7|SEPT3_BOVIN Neuronal-specific septin-3 OS=Bos taurus OX=9913 GN=SEPTIN3 PE=2 SV=3 SEPT3_BOVIN reviewed Neuronal-specific septin-3 Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0060090; GO:0061640; GO:0098793 cytoskeleton-dependent cytokinesis [GO:0061640]; intracellular protein localization [GO:0008104] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] g15835.t1 A7UA95 33.991 862 1.2799999999999999e-126 427.0 sp|A7UA95|RADIL_DANRE Ras-associating and dilute domain-containing protein OS=Danio rerio OX=7955 GN=radil PE=2 SV=1 RADIL_DANRE reviewed Ras-associating and dilute domain-containing protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001755; GO:0005874; GO:0007165; GO:0034446; GO:0051020 neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] microtubule [GO:0005874] GTPase binding [GO:0051020] g15835.t1 A7UA95 59.664 119 8.94e-34 145.0 sp|A7UA95|RADIL_DANRE Ras-associating and dilute domain-containing protein OS=Danio rerio OX=7955 GN=radil PE=2 SV=1 RADIL_DANRE reviewed Ras-associating and dilute domain-containing protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001755; GO:0005874; GO:0007165; GO:0034446; GO:0051020 neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] microtubule [GO:0005874] GTPase binding [GO:0051020] g15836.t1 Q15546 45.536 224 9.58e-62 197.0 sp|Q15546|PAQRB_HUMAN Monocyte to macrophage differentiation factor OS=Homo sapiens OX=9606 GN=MMD PE=1 SV=2 g15837.t1 P97434 53.472 144 3.75e-39 164.0 sp|P97434|MPRIP_MOUSE Myosin phosphatase Rho-interacting protein OS=Mus musculus OX=10090 GN=Mprip PE=1 SV=2 MPRIP_MOUSE reviewed Myosin phosphatase Rho-interacting protein (Rho-interacting protein 3) (RIP3) (p116Rip) Mus musculus (Mouse) GO:0001725; GO:0005829; GO:0015629; GO:0032507; GO:0051015 maintenance of protein location in cell [GO:0032507] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; stress fiber [GO:0001725] actin filament binding [GO:0051015] g15837.t1 P97434 52.336 107 1.61e-25 120.0 sp|P97434|MPRIP_MOUSE Myosin phosphatase Rho-interacting protein OS=Mus musculus OX=10090 GN=Mprip PE=1 SV=2 MPRIP_MOUSE reviewed Myosin phosphatase Rho-interacting protein (Rho-interacting protein 3) (RIP3) (p116Rip) Mus musculus (Mouse) GO:0001725; GO:0005829; GO:0015629; GO:0032507; GO:0051015 maintenance of protein location in cell [GO:0032507] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; stress fiber [GO:0001725] actin filament binding [GO:0051015] g15838.t1 P79401 36.68 518 3.06e-119 363.0 sp|P79401|CP3AT_PIG Cytochrome P450 3A29 OS=Sus scrofa OX=9823 GN=CYP3A29 PE=2 SV=1 g15839.t1 Q80ZD1 44.091 440 1.8e-130 394.0 sp|Q80ZD1|RGS9_TAMST Regulator of G-protein signaling 9 OS=Tamias striatus OX=45474 PE=1 SV=1 g15840.t1 Q96G04 58.824 102 5.34e-34 124.0 sp|Q96G04|EF2KT_HUMAN Protein-lysine N-methyltransferase EEF2KMT OS=Homo sapiens OX=9606 GN=EEF2KMT PE=1 SV=2 EF2KT_HUMAN reviewed Protein-lysine N-methyltransferase EEF2KMT (EC 2.1.1.-) (eEF2-lysine methyltransferase) (eEF2-KMT) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0016279; GO:0018023; GO:0032991 peptidyl-lysine trimethylation [GO:0018023] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] protein-lysine N-methyltransferase activity [GO:0016279] g15843.t1 Q9Y278 33.681 288 6.66e-44 161.0 sp|Q9Y278|HS3S2_HUMAN Heparan sulfate glucosamine 3-O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=HS3ST2 PE=1 SV=1 HS3S2_HUMAN reviewed Heparan sulfate glucosamine 3-O-sulfotransferase 2 (EC 2.8.2.29) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 2) (3-OST-2) (Heparan sulfate 3-O-sulfotransferase 2) (h3-OST-2) Homo sapiens (Human) GO:0000139; GO:0006024; GO:0008146; GO:0008467; GO:0015012; GO:0016020 glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] Golgi membrane [GO:0000139]; membrane [GO:0016020] [heparan sulfate]-glucosamine 3-sulfotransferase activity [GO:0008467]; sulfotransferase activity [GO:0008146] g15844.t1 Q8BSL4 34.667 150 7.35e-21 89.7 sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1 g15846.t1 O46640 40.146 274 8.27e-64 207.0 sp|O46640|ST3A1_RABIT Amine sulfotransferase OS=Oryctolagus cuniculus OX=9986 GN=SULT3A1 PE=1 SV=1 g15847.t1 O00338 39.286 280 3.41e-63 205.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g15848.t1 G3V9R3 36.279 215 2.39e-41 146.0 sp|G3V9R3|ST1D1_RAT Sulfotransferase 1 family member D1 OS=Rattus norvegicus OX=10116 GN=Sult1d1 PE=2 SV=1 g15849.t1 Q24342 43.262 282 6.34e-75 242.0 sp|Q24342|FNG_DROME Fringe glycosyltransferase OS=Drosophila melanogaster OX=7227 GN=fng PE=1 SV=1 FNG_DROME reviewed Fringe glycosyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0001745; GO:0005737; GO:0005795; GO:0005797; GO:0007293; GO:0007450; GO:0007476; GO:0007480; GO:0008587; GO:0008593; GO:0030707; GO:0033829; GO:0035017; GO:0036011; GO:0036066; GO:0036099; GO:0045746; GO:0045747; GO:0046872; GO:0048100; GO:0048190; GO:0048749 compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; cuticle pattern formation [GO:0035017]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; germarium-derived egg chamber formation [GO:0007293]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc dorsal/ventral pattern formation [GO:0048190] cytoplasm [GO:0005737]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795] metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] g15850.t1 Q6S5C2 50.588 255 1.58e-84 258.0 sp|Q6S5C2|GNPTG_MOUSE N-acetylglucosamine-1-phosphotransferase subunit gamma OS=Mus musculus OX=10090 GN=Gnptg PE=1 SV=1 GNPTG_MOUSE reviewed N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (M6PR domain-containing protein 1) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma) Mus musculus (Mouse) GO:0000139; GO:0005576; GO:0005794; GO:0042803; GO:0046835; GO:0070622 carbohydrate phosphorylation [GO:0046835] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex [GO:0070622] protein homodimerization activity [GO:0042803] g15851.t1 O35696 34.513 226 3.5500000000000004e-33 130.0 sp|O35696|SIA8B_MOUSE Alpha-2,8-sialyltransferase 8B OS=Mus musculus OX=10090 GN=St8sia2 PE=1 SV=2 SIA8B_MOUSE reviewed Alpha-2,8-sialyltransferase 8B (EC 2.4.3.-) (Polysialic acid synthase) (Sialyltransferase 8B) (SIAT8-B) (Sialyltransferase St8Sia II) (ST8SiaII) (Sialyltransferase X) (STX) Mus musculus (Mouse) GO:0000139; GO:0000166; GO:0001574; GO:0003828; GO:0005576; GO:0005654; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0006491; GO:0008373; GO:0009311; GO:0042220; GO:0043525; GO:0048471; GO:0051965; GO:0055037; GO:0097503; GO:1990138 ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; neuron projection extension [GO:1990138]; oligosaccharide metabolic process [GO:0009311]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; sialylation [GO:0097503] cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; nucleotide binding [GO:0000166]; sialyltransferase activity [GO:0008373] g15854.t1 P07700 26.19 378 1.67e-29 121.0 sp|P07700|ADRB1_MELGA Beta-1 adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB1 PE=1 SV=1 g15855.t1 Q27433 68.889 270 3.5100000000000004e-122 361.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g15857.t1 P35623 67.756 459 0.0 650.0 sp|P35623|GLYC_SHEEP Serine hydroxymethyltransferase, cytosolic OS=Ovis aries OX=9940 GN=SHMT1 PE=1 SV=3 g15858.t1 P51892 48.471 1079 0.0 929.0 sp|P51892|DNLI1_XENLA DNA ligase 1 OS=Xenopus laevis OX=8355 GN=lig1 PE=2 SV=1 g15858.t2 P51892 48.381 1081 0.0 929.0 sp|P51892|DNLI1_XENLA DNA ligase 1 OS=Xenopus laevis OX=8355 GN=lig1 PE=2 SV=1 g15859.t1 Q14106 36.626 243 7.11e-39 144.0 sp|Q14106|TOB2_HUMAN Protein Tob2 OS=Homo sapiens OX=9606 GN=TOB2 PE=1 SV=2 g15863.t1 Q8CI15 32.286 350 1.34e-51 182.0 sp|Q8CI15|SPHK1_MOUSE Sphingosine kinase 1 OS=Mus musculus OX=10090 GN=Sphk1 PE=1 SV=1 SPHK1_MOUSE reviewed Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-) Mus musculus (Mouse) GO:0000287; GO:0001568; GO:0001956; GO:0003677; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005905; GO:0005929; GO:0006473; GO:0006670; GO:0006954; GO:0007420; GO:0008021; GO:0008284; GO:0008289; GO:0008481; GO:0010803; GO:0010976; GO:0016020; GO:0016310; GO:0016407; GO:0019371; GO:0019722; GO:0030100; GO:0030139; GO:0030307; GO:0030335; GO:0030424; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035924; GO:0038036; GO:0043066; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070301; GO:0071363; GO:0071897; GO:0090520; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364 blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cyclooxygenase pathway [GO:0019371]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingolipid mediated signaling pathway [GO:0090520]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] axon [GO:0030424]; cilium [GO:0005929]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021] acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein phosphatase 2A binding [GO:0051721]; sphingosine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036] g15864.t1 Q7PCJ8 44.444 144 8.05e-33 119.0 sp|Q7PCJ8|SAT2_BOVIN Thialysine N-epsilon-acetyltransferase OS=Bos taurus OX=9913 GN=SAT2 PE=2 SV=1 g15865.t1 O70528 29.052 327 3.38e-37 142.0 sp|O70528|5HT4R_CAVPO 5-hydroxytryptamine receptor 4 OS=Cavia porcellus OX=10141 GN=HTR4 PE=2 SV=1 g15866.t1 Q9Z1L4 36.842 152 5.8e-22 95.1 sp|Q9Z1L4|XLRS1_MOUSE Retinoschisin OS=Mus musculus OX=10090 GN=Rs1 PE=1 SV=1 XLRS1_MOUSE reviewed Retinoschisin (X-linked juvenile retinoschisis protein homolog) Mus musculus (Mouse) GO:0001786; GO:0001917; GO:0005546; GO:0005547; GO:0005576; GO:0005615; GO:0007155; GO:0007601; GO:0009897; GO:0009986; GO:0010314; GO:0010842; GO:0032266; GO:0032991; GO:0043325; GO:0044877; GO:0051260; GO:0070273; GO:0080025; GO:0098984 cell adhesion [GO:0007155]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; protein-containing complex [GO:0032991] phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877] g15867.t1 Q3UST5 31.579 342 2.01e-41 152.0 sp|Q3UST5|CP089_MOUSE UPF0764 protein C16orf89 homolog OS=Mus musculus OX=10090 PE=2 SV=2 g15869.t1 Q5QNV8 26.124 467 9.710000000000001e-36 147.0 sp|Q5QNV8|HEAT9_MOUSE Protein HEATR9 OS=Mus musculus OX=10090 GN=Heatr9 PE=4 SV=1 g15870.t1 P33095 90.769 130 1.21e-86 251.0 sp|P33095|RS15A_STRPU Small ribosomal subunit protein uS8 OS=Strongylocentrotus purpuratus OX=7668 GN=RPS15A PE=2 SV=3 g15871.t1 Q75Q41 58.416 101 3.76e-22 88.2 sp|Q75Q41|TOM22_RAT Mitochondrial import receptor subunit TOM22 homolog OS=Rattus norvegicus OX=10116 GN=Tomm22 PE=1 SV=1 TOM22_RAT reviewed Mitochondrial import receptor subunit TOM22 homolog (rTOM22) (Translocase of outer membrane 22 kDa subunit homolog) Rattus norvegicus (Rat) GO:0005739; GO:0005742; GO:0006626; GO:0006886; GO:0008320; GO:0016020; GO:0030150; GO:0030943; GO:0043065; GO:0051204 intracellular protein transport [GO:0006886]; positive regulation of apoptotic process [GO:0043065]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial membrane [GO:0051204]; protein targeting to mitochondrion [GO:0006626] membrane [GO:0016020]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739] mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320] g15872.t1 Q8MJK1 55.814 129 2.95e-38 129.0 sp|Q8MJK1|CBY1_BOVIN Protein chibby homolog 1 OS=Bos taurus OX=9913 GN=CBY1 PE=2 SV=1 g15873.t1 E9PY46 53.799 1461 0.0 1627.0 sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1 IF140_MOUSE reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Mus musculus (Mouse) GO:0001750; GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] g15873.t2 E9PY46 54.394 1445 0.0 1635.0 sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1 IF140_MOUSE reviewed Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) Mus musculus (Mouse) GO:0001750; GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:1902017; GO:1905515; GO:1990403 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] g15874.t1 F5H4B4 28.881 277 3.52e-32 135.0 sp|F5H4B4|F227A_HUMAN Protein FAM227A OS=Homo sapiens OX=9606 GN=FAM227A PE=1 SV=1 g15875.t1 Q8IWF2 53.783 608 0.0 673.0 sp|Q8IWF2|FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=FOXRED2 PE=1 SV=1 FXRD2_HUMAN reviewed FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation) Homo sapiens (Human) GO:0004497; GO:0005788; GO:0036503; GO:0050660 ERAD pathway [GO:0036503] endoplasmic reticulum lumen [GO:0005788] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497] g15876.t1 Q6PJ21 36.792 212 2.8899999999999997e-38 139.0 sp|Q6PJ21|SPSB3_HUMAN SPRY domain-containing SOCS box protein 3 OS=Homo sapiens OX=9606 GN=SPSB3 PE=1 SV=2 SPSB3_HUMAN reviewed SPRY domain-containing SOCS box protein 3 (SSB-3) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0160049; GO:1990756 negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g15877.t1 Q9P209 49.029 206 6.489999999999999e-54 198.0 sp|Q9P209|CEP72_HUMAN Centrosomal protein of 72 kDa OS=Homo sapiens OX=9606 GN=CEP72 PE=1 SV=2 g15877.t1 Q9P209 31.78 236 1.52e-24 112.0 sp|Q9P209|CEP72_HUMAN Centrosomal protein of 72 kDa OS=Homo sapiens OX=9606 GN=CEP72 PE=1 SV=2 g15878.t1 Q9D1C9 49.064 267 1.22e-78 242.0 sp|Q9D1C9|RRP7A_MOUSE Ribosomal RNA-processing protein 7 homolog A OS=Mus musculus OX=10090 GN=Rrp7a PE=2 SV=1 RRP7A_MOUSE reviewed Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14 homolog) Mus musculus (Mouse) GO:0000028; GO:0001825; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005929; GO:0006364; GO:0030054; GO:0032040; GO:0032545; GO:0034456; GO:0042254; GO:0042274; GO:0061523; GO:1902570 blastocyst formation [GO:0001825]; cilium disassembly [GO:0061523]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364] cell junction [GO:0030054]; centrosome [GO:0005813]; cilium [GO:0005929]; CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456] RNA binding [GO:0003723] g15879.t1 Q96N11 33.894 416 9.960000000000001e-56 194.0 sp|Q96N11|INT15_HUMAN Integrator complex subunit 15 OS=Homo sapiens OX=9606 GN=INTS15 PE=1 SV=1 INT15_HUMAN reviewed Integrator complex subunit 15 Homo sapiens (Human) GO:0000398; GO:0001654; GO:0005634; GO:0005694; GO:0007420; GO:0032039; GO:0160232; GO:0160240 brain development [GO:0007420]; eye development [GO:0001654]; mRNA splicing, via spliceosome [GO:0000398]; RNA polymerase II transcription initiation surveillance [GO:0160240] chromosome [GO:0005694]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634] g15880.t1 Q9WTR0 29.821 560 1.9499999999999998e-60 213.0 sp|Q9WTR0|MMP16_MOUSE Matrix metalloproteinase-16 OS=Mus musculus OX=10090 GN=Mmp16 PE=2 SV=3 MMP16_MOUSE reviewed Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP) Mus musculus (Mouse) GO:0001501; GO:0001503; GO:0001958; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0060348; GO:0070006; GO:0097094 bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g15881.t1 Q6UWM5 41.477 176 7.92e-34 131.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g15882.t1 Q6UWM5 43.333 180 1.31e-39 144.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g15883.t1 O13065 34.325 437 3.7100000000000003e-64 219.0 sp|O13065|MMP18_XENLA Matrix metalloproteinase-18 OS=Xenopus laevis OX=8355 GN=mmp18 PE=2 SV=1 g15885.t1 P28863 35.684 468 1.84e-65 223.0 sp|P28863|MMP3_RABIT Stromelysin-1 OS=Oryctolagus cuniculus OX=9986 GN=MMP3 PE=2 SV=1 g15886.t1 P53690 37.783 442 3.56e-76 253.0 sp|P53690|MMP14_MOUSE Matrix metalloproteinase-14 OS=Mus musculus OX=10090 GN=Mmp14 PE=1 SV=3 MMP14_MOUSE reviewed Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (MT-MMP) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP) Mus musculus (Mouse) GO:0000139; GO:0001501; GO:0001503; GO:0001525; GO:0001541; GO:0001666; GO:0001935; GO:0001958; GO:0004175; GO:0004222; GO:0005178; GO:0005615; GO:0005634; GO:0005829; GO:0005886; GO:0006508; GO:0006979; GO:0008270; GO:0008584; GO:0009612; GO:0009725; GO:0010831; GO:0010954; GO:0016477; GO:0030163; GO:0030198; GO:0030307; GO:0030324; GO:0030335; GO:0030574; GO:0031012; GO:0031410; GO:0031638; GO:0035987; GO:0035988; GO:0042470; GO:0043615; GO:0043627; GO:0044354; GO:0045111; GO:0045579; GO:0045746; GO:0048701; GO:0048754; GO:0048771; GO:0051895; GO:0060322; GO:0060348; GO:0070006; GO:0071412; GO:0097094; GO:0160144; GO:0160145; GO:1903076; GO:1905523; GO:1990834 angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; bone development [GO:0060348]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to genistein [GO:0071412]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; GDF15-GFRAL signaling pathway [GO:0160144]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GDF15-GFRAL signaling pathway [GO:0160145]; negative regulation of Notch signaling pathway [GO:0045746]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g15887.t1 Q8BMI3 41.89 783 1.76e-172 516.0 sp|Q8BMI3|GGA3_MOUSE ADP-ribosylation factor-binding protein GGA3 OS=Mus musculus OX=10090 GN=Gga3 PE=1 SV=2 GGA3_MOUSE reviewed ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3) Mus musculus (Mouse) GO:0005764; GO:0005769; GO:0005794; GO:0005802; GO:0006622; GO:0006893; GO:0031267; GO:0031647; GO:0031648; GO:0031901; GO:0032456; GO:0032991; GO:0034394; GO:0035091; GO:0043001; GO:0043130; GO:0044877; GO:0045732; GO:0055037; GO:0055038; GO:0061462; GO:0140318; GO:1902430 endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein localization to lysosome [GO:0061462]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] phosphatidylinositol binding [GO:0035091]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130] g15888.t1 P80476 40.385 624 2.51e-143 434.0 sp|P80476|HCY6_ANDAU Hemocyanin AA6 chain OS=Androctonus australis OX=6858 PE=1 SV=1 g15889.t1 P79401 34.808 520 2.37e-107 332.0 sp|P79401|CP3AT_PIG Cytochrome P450 3A29 OS=Sus scrofa OX=9823 GN=CYP3A29 PE=2 SV=1 g15889.t2 P79401 33.333 543 7.04e-102 319.0 sp|P79401|CP3AT_PIG Cytochrome P450 3A29 OS=Sus scrofa OX=9823 GN=CYP3A29 PE=2 SV=1 g15892.t1 Q9D8W5 67.834 457 0.0 647.0 sp|Q9D8W5|PSD12_MOUSE 26S proteasome non-ATPase regulatory subunit 12 OS=Mus musculus OX=10090 GN=Psmd12 PE=1 SV=4 PSD12_MOUSE reviewed 26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55) Mus musculus (Mouse) GO:0000502; GO:0005737; GO:0005838; GO:0008541; GO:0022624 cytoplasm [GO:0005737]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541] g15893.t1 Q9R0S2 33.012 518 2.1300000000000002e-72 245.0 sp|Q9R0S2|MMP24_MOUSE Matrix metalloproteinase-24 OS=Mus musculus OX=10090 GN=Mmp24 PE=1 SV=2 MMP24_MOUSE reviewed Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] Mus musculus (Mouse) GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742 cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g15908.t1 P10079 55.832 883 0.0 1004.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g15908.t1 P10079 55.365 932 0.0 994.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g15908.t1 P10079 55.556 495 2.3e-172 540.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g15908.t1 P10079 53.081 422 1.3300000000000001e-129 426.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g15909.t1 O35516 44.581 1467 0.0 1099.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 41.935 1426 0.0 1013.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 40.423 1467 0.0 987.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 41.369 1402 0.0 980.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 42.465 1347 0.0 942.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 39.986 1388 0.0 932.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 41.876 1194 0.0 860.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 39.187 1304 0.0 849.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 41.929 1078 0.0 782.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 40.162 1113 0.0 770.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 39.127 1168 0.0 746.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 39.022 920 4.5100000000000006e-179 607.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15909.t1 O35516 40.228 527 1.39e-100 365.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g15910.t1 P79761 40.833 480 2.76e-129 390.0 sp|P79761|CP1A5_CHICK Cytochrome P450 1A5 OS=Gallus gallus OX=9031 GN=CYP1A5 PE=2 SV=1 CP1A5_CHICK reviewed Cytochrome P450 1A5 (EC 1.14.14.1) (CYPIA5) (Cytochrome P450 TCDDAA) Gallus gallus (Chicken) GO:0005506; GO:0005739; GO:0005789; GO:0006706; GO:0006805; GO:0008210; GO:0008392; GO:0008395; GO:0009404; GO:0016712; GO:0019825; GO:0020037; GO:0036146; GO:0042178; GO:0043231; GO:0046677; GO:1990748 cellular detoxification [GO:1990748]; cellular response to mycotoxin [GO:0036146]; estrogen metabolic process [GO:0008210]; response to antibiotic [GO:0046677]; steroid catabolic process [GO:0006706]; toxin metabolic process [GO:0009404]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395] g15911.t1 O42430 42.825 446 1.54e-126 380.0 sp|O42430|CP1A1_LIMLI Cytochrome P450 1A1 OS=Limanda limanda OX=27771 GN=cyp1a1 PE=2 SV=1 g15912.t1 Q8VIJ8 46.271 590 2.71e-174 508.0 sp|Q8VIJ8|NPRL3_MOUSE GATOR1 complex protein NPRL3 OS=Mus musculus OX=10090 GN=Nprl3 PE=1 SV=1 g15913.t1 Q04841 50.235 213 1.39e-64 208.0 sp|Q04841|3MG_MOUSE DNA-3-methyladenine glycosylase OS=Mus musculus OX=10090 GN=Mpg PE=2 SV=3 g15913.t2 Q04841 44.815 270 1.25e-65 210.0 sp|Q04841|3MG_MOUSE DNA-3-methyladenine glycosylase OS=Mus musculus OX=10090 GN=Mpg PE=2 SV=3 g15914.t1 Q6GMF8 50.181 554 0.0 591.0 sp|Q6GMF8|RHDF1_DANRE Inactive rhomboid protein 1 OS=Danio rerio OX=7955 GN=rhbdf1 PE=2 SV=1 RHDF1_DANRE reviewed Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005789; GO:0008283; GO:0015031; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136 cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] growth factor binding [GO:0019838] g15917.t1 Q6NVC5 56.347 646 0.0 758.0 sp|Q6NVC5|MIRO1_DANRE Mitochondrial Rho GTPase 1-A OS=Danio rerio OX=7955 GN=rhot1a PE=2 SV=1 MIRO1_DANRE reviewed Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0016887; GO:0019003; GO:0019725; GO:0047497; GO:0097345 cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] g15917.t2 Q6NVC5 58.995 617 0.0 773.0 sp|Q6NVC5|MIRO1_DANRE Mitochondrial Rho GTPase 1-A OS=Danio rerio OX=7955 GN=rhot1a PE=2 SV=1 MIRO1_DANRE reviewed Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0016887; GO:0019003; GO:0019725; GO:0047497; GO:0097345 cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] g15919.t1 A2A5Z6 68.509 778 0.0 1095.0 sp|A2A5Z6|SMUF2_MOUSE E3 ubiquitin-protein ligase SMURF2 OS=Mus musculus OX=10090 GN=Smurf2 PE=1 SV=1 SMUF2_MOUSE reviewed E3 ubiquitin-protein ligase SMURF2 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) Mus musculus (Mouse) GO:0000151; GO:0004842; GO:0005160; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016607; GO:0030512; GO:0030514; GO:0042802; GO:0043161; GO:0045121; GO:0046332; GO:0061630; GO:0160020; GO:1901165 negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of ferroptosis [GO:0160020]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g15920.t1 Q61420 50.794 315 3.4400000000000003e-100 301.0 sp|Q61420|S35A1_MOUSE CMP-sialic acid transporter OS=Mus musculus OX=10090 GN=Slc35a1 PE=1 SV=2 S35A1_MOUSE reviewed CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (CST) (Solute carrier family 35 member A1) Mus musculus (Mouse) GO:0000139; GO:0005456; GO:0006054; GO:0015297; GO:0015782; GO:0016020 CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; N-acetylneuraminate metabolic process [GO:0006054] Golgi membrane [GO:0000139]; membrane [GO:0016020] antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456] g15921.t1 Q5SSH7 33.878 1529 0.0 806.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t1 Q5SSH7 35.16 967 2.2300000000000002e-166 582.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t1 Q5SSH7 30.705 482 7.249999999999999e-48 194.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t2 Q5SSH7 34.162 1528 0.0 818.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t2 Q5SSH7 35.16 967 2.94e-166 582.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t2 Q5SSH7 30.705 482 8.569999999999999e-48 194.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t3 Q5SSH7 34.387 1518 0.0 826.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t3 Q5SSH7 35.16 967 3.0700000000000004e-166 582.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15921.t3 Q5SSH7 30.705 482 8.75e-48 194.0 sp|Q5SSH7|ZZEF1_MOUSE Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Mus musculus OX=10090 GN=Zzef1 PE=1 SV=2 ZZEF1_MOUSE reviewed Zinc finger ZZ-type and EF-hand domain-containing protein 1 Mus musculus (Mouse) GO:0005509; GO:0007405; GO:0008270; GO:0008542; GO:0009986; GO:0016567; GO:0035249; GO:0042393; GO:0045202; GO:0048167; GO:0048786; GO:0061659; GO:0098794 neuroblast proliferation [GO:0007405]; protein ubiquitination [GO:0016567]; regulation of synaptic plasticity [GO:0048167]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] cell surface [GO:0009986]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] calcium ion binding [GO:0005509]; histone binding [GO:0042393]; ubiquitin-like protein ligase activity [GO:0061659]; zinc ion binding [GO:0008270] g15922.t1 Q54KD0 23.805 1067 7.77e-84 306.0 sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1 g15923.t1 Q9W740 34.021 194 2.78e-28 109.0 sp|Q9W740|NOGG2_DANRE Noggin-2 OS=Danio rerio OX=7955 GN=nog2 PE=2 SV=1 g15924.t1 Q3UHR0 63.636 176 8.93e-66 253.0 sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2 g15924.t1 Q3UHR0 56.774 155 1.91e-47 193.0 sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2 g15924.t2 Q3UHR0 63.636 176 7.54e-66 253.0 sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2 g15924.t2 Q3UHR0 56.774 155 1.8600000000000002e-47 193.0 sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2 g15926.t1 Q6GR34 50.602 166 1.8600000000000002e-56 176.0 sp|Q6GR34|CP52A_XENLA Uncharacterized protein C16orf52 homolog A OS=Xenopus laevis OX=8355 PE=2 SV=1 g15927.t1 Q99PD4 40.571 175 2.73e-33 123.0 sp|Q99PD4|ARC1A_RAT Actin-related protein 2/3 complex subunit 1A OS=Rattus norvegicus OX=10116 GN=Arpc1a PE=2 SV=1 g15928.t1 Q6GNU1 69.159 107 5.73e-41 142.0 sp|Q6GNU1|AR1BB_XENLA Actin-related protein 2/3 complex subunit 1B-B OS=Xenopus laevis OX=8355 GN=arpc1b-b PE=1 SV=1 g15929.t1 P25325 43.986 291 7.239999999999999e-89 269.0 sp|P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3 THTM_HUMAN reviewed 3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2) Homo sapiens (Human) GO:0000098; GO:0001822; GO:0001889; GO:0004792; GO:0005739; GO:0005759; GO:0009440; GO:0009636; GO:0016783; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814 cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202] 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792] g15930.t1 P24329 46.429 280 4.62e-85 260.0 sp|P24329|THTR_RAT Thiosulfate sulfurtransferase OS=Rattus norvegicus OX=10116 GN=Tst PE=1 SV=3 THTR_RAT reviewed Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese) Rattus norvegicus (Rat) GO:0004792; GO:0005739; GO:0005759; GO:0008097; GO:0016226; GO:0016783; GO:0016784; GO:0030855; GO:0035928; GO:0051029 epithelial cell differentiation [GO:0030855]; iron-sulfur cluster assembly [GO:0016226]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; 5S rRNA binding [GO:0008097]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792] g15931.t1 P25325 40.753 292 4.95e-81 249.0 sp|P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3 THTM_HUMAN reviewed 3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2) Homo sapiens (Human) GO:0000098; GO:0001822; GO:0001889; GO:0004792; GO:0005739; GO:0005759; GO:0009440; GO:0009636; GO:0016783; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814 cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202] 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792] g15932.t1 P25325 41.096 292 1.4e-81 251.0 sp|P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3 THTM_HUMAN reviewed 3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2) Homo sapiens (Human) GO:0000098; GO:0001822; GO:0001889; GO:0004792; GO:0005739; GO:0005759; GO:0009440; GO:0009636; GO:0016783; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814 cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202] 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792] g15933.t1 P02286 99.18 122 3.4000000000000003e-85 246.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g15934.t1 P02269 99.2 125 1.06e-84 246.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g15935.t1 P69079 100.0 136 1.3799999999999998e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g15936.t1 P62783 100.0 103 6.4e-68 201.0 sp|P62783|H4_STRPU Histone H4 OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=2 g15937.t1 Q28CA0 66.667 105 1.02e-46 157.0 sp|Q28CA0|PITC1_XENTR Cytoplasmic phosphatidylinositol transfer protein 1 OS=Xenopus tropicalis OX=8364 GN=pitpnc1 PE=2 SV=1 PITC1_XENTR reviewed Cytoplasmic phosphatidylinositol transfer protein 1 (Retinal degeneration B homolog beta) (RdgBbeta) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005634; GO:0005737; GO:0007165; GO:0008526; GO:0035091; GO:1990050 signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] phosphatidic acid transfer activity [GO:1990050]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526] g15939.t1 O94817 60.87 115 4.55e-47 151.0 sp|O94817|ATG12_HUMAN Ubiquitin-like protein ATG12 OS=Homo sapiens OX=9606 GN=ATG12 PE=1 SV=1 ATG12_HUMAN reviewed Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like) Homo sapiens (Human) GO:0000045; GO:0000421; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0016236; GO:0030670; GO:0031386; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0034727; GO:0045824; GO:0050687; GO:0061723; GO:0097352; GO:1901096; GO:1904973; GO:1990234 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of viral translation [GO:1904973]; regulation of autophagosome maturation [GO:1901096] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234] protein tag activity [GO:0031386] g15940.t1 E1BKF9 56.036 439 0.0 537.0 sp|E1BKF9|CFA52_BOVIN Cilia- and flagella-associated protein 52 OS=Bos taurus OX=9913 GN=CFAP52 PE=1 SV=1 g15941.t1 Q5F201 47.333 150 1.6100000000000001e-37 138.0 sp|Q5F201|CFA52_MOUSE Cilia- and flagella-associated protein 52 OS=Mus musculus OX=10090 GN=Cfap52 PE=1 SV=1 CFA52_MOUSE reviewed Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) Mus musculus (Mouse) GO:0005879; GO:0007283; GO:0007286; GO:0007338; GO:0010467; GO:0030317; GO:0036126; GO:0051012; GO:0061966; GO:0097225; GO:0160112 establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; microtubule sliding [GO:0051012]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g15943.t1 Q8LGG0 55.556 108 4.7e-36 122.0 sp|Q8LGG0|FKB12_ARATH Peptidyl-prolyl cis-trans isomerase FKBP12 OS=Arabidopsis thaliana OX=3702 GN=FKBP12 PE=1 SV=2 g15946.t1 Q9NJG9 46.61 118 2.07e-30 118.0 sp|Q9NJG9|SUZ12_DROME Polycomb protein Su(z)12 OS=Drosophila melanogaster OX=7227 GN=Su(z)12 PE=1 SV=1 SUZ12_DROME reviewed Polycomb protein Su(z)12 (Suppressor 12 of zeste protein) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0003677; GO:0005634; GO:0008270; GO:0016586; GO:0022008; GO:0031490; GO:0035097; GO:0035098; GO:0045892; GO:0140718; GO:2001229 facultative heterochromatin formation [GO:0140718]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of response to gamma radiation [GO:2001229]; neurogenesis [GO:0022008] chromatin [GO:0000785]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; RSC-type complex [GO:0016586] chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g15947.t1 Q0VA03 44.425 565 1.78e-143 433.0 sp|Q0VA03|SUZ12_XENTR Polycomb protein suz12 OS=Xenopus tropicalis OX=8364 GN=suz12 PE=2 SV=1 g15955.t1 P04047 64.894 188 1.07e-85 256.0 sp|P04047|KITH_CHICK Thymidine kinase, cytosolic OS=Gallus gallus OX=9031 GN=TK1 PE=1 SV=1 g15956.t1 Q9CR92 48.318 327 1.3599999999999999e-83 276.0 sp|Q9CR92|CF184_MOUSE Cilia- and flagella-associated protein 184 OS=Mus musculus OX=10090 GN=Cfap184 PE=2 SV=1 g15957.t1 O70201 48.855 131 4.72e-45 147.0 sp|O70201|BIRC5_MOUSE Baculoviral IAP repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Birc5 PE=1 SV=1 g15959.t1 P18762 26.912 353 3.01e-35 137.0 sp|P18762|ADRB2_MOUSE Beta-2 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb2 PE=1 SV=2 g15960.t1 Q56FC8 87.143 70 5.32e-37 121.0 sp|Q56FC8|RL38_LYSTE Large ribosomal subunit protein eL38 OS=Lysiphlebus testaceipes OX=77504 GN=RpL38 PE=3 SV=1 g15964.t1 Q03468 44.188 1514 0.0 1125.0 sp|Q03468|ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens OX=9606 GN=ERCC6 PE=1 SV=1 ERCC6_HUMAN reviewed DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB) Homo sapiens (Human) GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006366; GO:0006979; GO:0007254; GO:0008023; GO:0008094; GO:0008630; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032784; GO:0032786; GO:0034243; GO:0035264; GO:0042262; GO:0045494; GO:0045739; GO:0045943; GO:0045944; GO:0045945; GO:0060261; GO:0070063; GO:0071168; GO:0090734; GO:0097680; GO:0110016; GO:0140463; GO:0140658; GO:0140664; GO:1905168; GO:2001033 base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein localization to chromatin [GO:0071168]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283] B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein tyrosine kinase activator activity [GO:0030296]; RNA polymerase binding [GO:0070063] g15965.t1 Q5I4F8 34.926 272 1.8e-49 166.0 sp|Q5I4F8|AQP8_NOTAL Aquaporin-8 OS=Notomys alexis OX=184396 GN=AQP8 PE=2 SV=1 AQP8_NOTAL reviewed Aquaporin-8 (AQP-8) Notomys alexis (Spinifex hopping mouse) GO:0005739; GO:0005743; GO:0005790; GO:0005886; GO:0006833; GO:0008519; GO:0015250; GO:0015264; GO:0015265; GO:0015840; GO:0015843; GO:0016323; GO:0016324; GO:0030183; GO:0030868; GO:0031526; GO:0031966; GO:0035377; GO:0045540; GO:0046691; GO:0072488; GO:0072489; GO:0080170; GO:0097708; GO:0140157; GO:1990748 ammonium import across plasma membrane [GO:0140157]; ammonium transmembrane transport [GO:0072488]; B cell differentiation [GO:0030183]; cellular detoxification [GO:1990748]; hydrogen peroxide transmembrane transport [GO:0080170]; methylammonium transmembrane transport [GO:0072489]; methylammonium transport [GO:0015843]; regulation of cholesterol biosynthetic process [GO:0045540]; transepithelial water transport [GO:0035377]; urea transport [GO:0015840]; water transport [GO:0006833] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; intracellular canaliculus [GO:0046691]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; smooth endoplasmic reticulum membrane [GO:0030868] ammonium channel activity [GO:0008519]; methylammonium channel activity [GO:0015264]; urea channel activity [GO:0015265]; water channel activity [GO:0015250] g15967.t1 Q9JMK2 74.209 411 0.0 620.0 sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus OX=10090 GN=Csnk1e PE=1 SV=2 KC1E_MOUSE reviewed Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006897; GO:0007165; GO:0007623; GO:0008104; GO:0030177; GO:0030178; GO:0030426; GO:0032436; GO:0032880; GO:0032922; GO:0035567; GO:0042752; GO:0043025; GO:0048512; GO:0051058; GO:0060070; GO:0090263; GO:0106310; GO:1902004; GO:1990090; GO:1990904; GO:2000052 canonical Wnt signaling pathway [GO:0060070]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; endocytosis [GO:0006897]; intracellular protein localization [GO:0008104]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of Wnt signaling pathway [GO:0030178]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g15968.t1 Q5ZMU0 44.49 245 2.58e-64 202.0 sp|Q5ZMU0|RT07_CHICK Small ribosomal subunit protein uS7m OS=Gallus gallus OX=9031 GN=MRPS7 PE=2 SV=2 RT07_CHICK reviewed Small ribosomal subunit protein uS7m (28S ribosomal protein S7, mitochondrial) (MRP-S7) (S7mt) Gallus gallus (Chicken) GO:0003729; GO:0003735; GO:0005743; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543 mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840] mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] g15969.t1 Q7TSH8 34.625 800 2.05e-132 448.0 sp|Q7TSH8|TMM94_MOUSE Transmembrane protein 94 OS=Mus musculus OX=10090 GN=Tmem94 PE=1 SV=1 g15969.t1 Q7TSH8 42.488 426 1.69e-87 317.0 sp|Q7TSH8|TMM94_MOUSE Transmembrane protein 94 OS=Mus musculus OX=10090 GN=Tmem94 PE=1 SV=1 g15970.t1 Q9D9S1 41.475 217 8.589999999999999e-46 154.0 sp|Q9D9S1|EVG1_MOUSE UPF0193 protein EVG1 homolog OS=Mus musculus OX=10090 PE=2 SV=1 g15972.t1 O14981 54.895 1900 0.0 2020.0 sp|O14981|BTAF1_HUMAN TATA-binding protein-associated factor 172 OS=Homo sapiens OX=9606 GN=BTAF1 PE=1 SV=2 g15973.t1 Q66II3 44.958 238 3.24e-60 192.0 sp|Q66II3|GRB2_XENTR Growth factor receptor-bound protein 2 OS=Xenopus tropicalis OX=8364 GN=grb2 PE=2 SV=1 g15974.t1 P87379 41.86 258 1.57e-60 193.0 sp|P87379|GRB2A_XENLA Growth factor receptor-bound protein 2-A OS=Xenopus laevis OX=8355 GN=grb2-a PE=1 SV=2 GRB2A_XENLA reviewed Growth factor receptor-bound protein 2-A (Adapter protein GRB2-A) (SH2/SH3 adapter GRB2-A) Xenopus laevis (African clawed frog) GO:0001784; GO:0005154; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005794; GO:0005886; GO:0007143; GO:0007165; GO:0008180; GO:0008286; GO:0043408; GO:0043560 female meiotic nuclear division [GO:0007143]; insulin receptor signaling pathway [GO:0008286]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] epidermal growth factor receptor binding [GO:0005154]; insulin receptor substrate binding [GO:0043560]; phosphotyrosine residue binding [GO:0001784] g15975.t1 Q8IY33 42.484 153 8.89e-26 117.0 sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1 MILK2_HUMAN reviewed MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Homo sapiens (Human) GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] g15975.t2 Q8IY33 40.12 167 6.72e-25 114.0 sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1 MILK2_HUMAN reviewed MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Homo sapiens (Human) GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] g15976.t1 D3ZEN0 43.165 278 3.1899999999999996e-69 235.0 sp|D3ZEN0|MILK2_RAT MICAL-like protein 2 OS=Rattus norvegicus OX=10116 GN=Micall2 PE=1 SV=2 MILK2_RAT reviewed MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Rattus norvegicus (Rat) GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032432; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446] actin filament bundle [GO:0032432]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725] actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] g15977.t1 Q8IVD9 33.903 351 5.85e-57 191.0 sp|Q8IVD9|NUDC3_HUMAN NudC domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NUDCD3 PE=1 SV=3 NUDC3_HUMAN reviewed NudC domain-containing protein 3 Homo sapiens (Human) GO:0005737; GO:0005868; GO:0006457; GO:0051082; GO:0060271; GO:1905793 cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868] unfolded protein binding [GO:0051082] g15978.t1 Q8HY87 43.214 560 1.74e-154 468.0 sp|Q8HY87|RNZ2_MACFA Zinc phosphodiesterase ELAC protein 2 OS=Macaca fascicularis OX=9541 GN=ELAC2 PE=2 SV=1 g15979.t1 Q9BQ52 43.571 140 1.1900000000000002e-31 127.0 sp|Q9BQ52|RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens OX=9606 GN=ELAC2 PE=1 SV=2 RNZ2_HUMAN reviewed Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Heredity prostate cancer protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2) Homo sapiens (Human) GO:0003723; GO:0004521; GO:0004549; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0016078; GO:0042645; GO:0042780; GO:0042781; GO:0046872; GO:0090646; GO:1990180 mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA processing [GO:0090646]; tRNA 3'-end processing [GO:0042780]; tRNA decay [GO:0016078] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; tRNA-specific ribonuclease activity [GO:0004549] g15980.t1 Q9W0T1 36.134 357 2.31e-66 254.0 sp|Q9W0T1|NU301_DROME Nucleosome-remodeling factor subunit NURF301 OS=Drosophila melanogaster OX=7227 GN=E(bx) PE=1 SV=2 NU301_DROME reviewed Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215) Drosophila melanogaster (Fruit fly) GO:0000978; GO:0003713; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0034728; GO:0045824; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048515; GO:0140002 chromatin remodeling [GO:0006338]; hemopoiesis [GO:0030097]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome organization [GO:0034728]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515] nucleus [GO:0005634]; NURF complex [GO:0016589] histone H3K4me3 reader activity [GO:0140002]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15980.t1 Q9W0T1 33.01 309 1.4e-36 157.0 sp|Q9W0T1|NU301_DROME Nucleosome-remodeling factor subunit NURF301 OS=Drosophila melanogaster OX=7227 GN=E(bx) PE=1 SV=2 NU301_DROME reviewed Nucleosome-remodeling factor subunit NURF301 (Enhancer of bithorax) (Nucleosome-remodeling factor 215 kDa subunit) (NURF-215) Drosophila melanogaster (Fruit fly) GO:0000978; GO:0003713; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0010468; GO:0016589; GO:0016922; GO:0030097; GO:0034728; GO:0045824; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048515; GO:0140002 chromatin remodeling [GO:0006338]; hemopoiesis [GO:0030097]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of innate immune response [GO:0045824]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; nucleosome organization [GO:0034728]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515] nucleus [GO:0005634]; NURF complex [GO:0016589] histone H3K4me3 reader activity [GO:0140002]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g15981.t1 Q12830 53.286 426 1.07e-137 469.0 sp|Q12830|BPTF_HUMAN Nucleosome-remodeling factor subunit BPTF OS=Homo sapiens OX=9606 GN=BPTF PE=1 SV=3 g15981.t1 Q12830 46.064 343 2.19e-75 280.0 sp|Q12830|BPTF_HUMAN Nucleosome-remodeling factor subunit BPTF OS=Homo sapiens OX=9606 GN=BPTF PE=1 SV=3 g15982.t1 Q0II26 38.318 321 2.46e-49 168.0 sp|Q0II26|AIMP2_BOVIN Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Bos taurus OX=9913 GN=AIMP2 PE=2 SV=1 AIMP2_BOVIN reviewed Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1) Bos taurus (Bovine) GO:0005634; GO:0005829; GO:0006412; GO:0006915; GO:0008285; GO:0016567; GO:0017101; GO:0030674; GO:0031398; GO:0060510; GO:0065003 apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleus [GO:0005634] protein-macromolecule adaptor activity [GO:0030674] g15984.t1 Q9Y2H8 40.828 169 6.21e-37 140.0 sp|Q9Y2H8|ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens OX=9606 GN=ZNF510 PE=1 SV=1 g15984.t1 Q9Y2H8 44.056 143 1.47e-33 130.0 sp|Q9Y2H8|ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens OX=9606 GN=ZNF510 PE=1 SV=1 g15984.t1 Q9Y2H8 43.056 144 1.74e-32 127.0 sp|Q9Y2H8|ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens OX=9606 GN=ZNF510 PE=1 SV=1 g15984.t1 Q9Y2H8 36.646 161 3.54e-31 124.0 sp|Q9Y2H8|ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens OX=9606 GN=ZNF510 PE=1 SV=1 g15984.t1 Q9Y2H8 40.373 161 5.48e-31 123.0 sp|Q9Y2H8|ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens OX=9606 GN=ZNF510 PE=1 SV=1 g15984.t1 Q9Y2H8 42.5 120 1.52e-24 105.0 sp|Q9Y2H8|ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens OX=9606 GN=ZNF510 PE=1 SV=1 g15984.t1 Q9Y2H8 40.171 117 4.9399999999999994e-23 100.0 sp|Q9Y2H8|ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens OX=9606 GN=ZNF510 PE=1 SV=1 g15987.t1 Q9D0M1 74.016 127 2.6e-58 186.0 sp|Q9D0M1|KPRA_MOUSE Phosphoribosyl pyrophosphate synthase-associated protein 1 OS=Mus musculus OX=10090 GN=Prpsap1 PE=1 SV=1 g15988.t1 Q5ZL26 68.306 183 1.87e-90 271.0 sp|Q5ZL26|KPRB_CHICK Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Gallus gallus OX=9031 GN=PRPSAP2 PE=2 SV=1 g15989.t1 A7M7B9 66.518 224 6.13e-112 331.0 sp|A7M7B9|NTH_CHICK Endonuclease III-like protein 1 OS=Gallus gallus OX=9031 GN=NTHL1 PE=2 SV=1 NTH_CHICK reviewed Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase) Gallus gallus (Chicken) GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078 base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289] mitochondrion [GO:0005739]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703] g15990.t1 Q6V4S5 34.074 270 4.4200000000000004e-29 117.0 sp|Q6V4S5|SDK2_MOUSE Protein sidekick-2 OS=Mus musculus OX=10090 GN=Sdk2 PE=1 SV=1 SDK2_MOUSE reviewed Protein sidekick-2 Mus musculus (Mouse) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219 camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] g15990.t2 Q7Z5N4 33.054 239 1.14e-27 114.0 sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3 SDK1_HUMAN reviewed Protein sidekick-1 Homo sapiens (Human) GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998 behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] plasma membrane [GO:0005886]; synapse [GO:0045202] identical protein binding [GO:0042802] g15991.t1 Q8AV57 40.61 1901 0.0 1333.0 sp|Q8AV57|SDK2_CHICK Protein sidekick-2 OS=Gallus gallus OX=9031 GN=SDK2 PE=1 SV=2 g15991.t1 Q8AV57 29.518 996 5.81e-98 356.0 sp|Q8AV57|SDK2_CHICK Protein sidekick-2 OS=Gallus gallus OX=9031 GN=SDK2 PE=1 SV=2 g15992.t1 A3KMZ6 72.671 161 3.6e-83 254.0 sp|A3KMZ6|COX11_BOVIN Cytochrome c oxidase assembly protein COX11, mitochondrial OS=Bos taurus OX=9913 GN=COX11 PE=2 SV=1 g15995.t1 P97868 51.603 343 3.23e-105 369.0 sp|P97868|RBBP6_MOUSE E3 ubiquitin-protein ligase RBBP6 OS=Mus musculus OX=10090 GN=Rbbp6 PE=1 SV=5 g15996.t1 Q6NYU2 55.41 989 0.0 1095.0 sp|Q6NYU2|HELZ_DANRE Probable helicase with zinc finger domain OS=Danio rerio OX=7955 GN=helz PE=2 SV=1 HELZ_DANRE reviewed ATP-dependent RNA helicase with zinc finger domain (EC 3.6.4.13) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0003700; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008284; GO:0016787; GO:0017148; GO:0035194; GO:0043186; GO:1900153 negative regulation of translation [GO:0017148]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16001.t1 C3YWU0 60.592 439 0.0 559.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g16002.t1 C3YWU0 67.431 436 0.0 598.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g16003.t1 C3YWU0 65.991 444 0.0 589.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g16004.t1 Q5ZHN3 63.445 476 0.0 579.0 sp|Q5ZHN3|WIPI2_CHICK WD repeat domain phosphoinositide-interacting protein 2 OS=Gallus gallus OX=9031 GN=WIPI2 PE=2 SV=1 WIPI2_CHICK reviewed WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2) Gallus gallus (Chicken) GO:0000045; GO:0000422; GO:0000425; GO:0005829; GO:0009267; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025 autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045] phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-macromolecule adaptor activity [GO:0030674] g16005.t1 C3YWU0 69.452 347 7.680000000000001e-179 507.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g16006.t1 Q9QYT7 33.173 624 8.33e-78 260.0 sp|Q9QYT7|PIGQ_MOUSE Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Mus musculus OX=10090 GN=Pigq PE=1 SV=3 g16007.t1 Q8BYA0 53.754 1172 0.0 1271.0 sp|Q8BYA0|TBCD_MOUSE Tubulin-specific chaperone D OS=Mus musculus OX=10090 GN=Tbcd PE=1 SV=1 g16008.t1 Q5MJS3 61.272 346 5.669999999999999e-147 438.0 sp|Q5MJS3|FA20C_MOUSE Extracellular serine/threonine protein kinase FAM20C OS=Mus musculus OX=10090 GN=Fam20c PE=1 SV=1 FA20C_MOUSE reviewed Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK) Mus musculus (Mouse) GO:0000139; GO:0001501; GO:0002020; GO:0004672; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0006468; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0051174; GO:0070166; GO:0071895; GO:0097187; GO:0106310 biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16012.t1 A4IG53 51.515 198 9.88e-65 205.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g16014.t1 Q962X9 88.889 144 2.41e-96 276.0 sp|Q962X9|BUD31_BRABE Protein BUD31 homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1 g16015.t1 Q9Y519 59.579 428 1.3000000000000001e-167 482.0 sp|Q9Y519|T184B_HUMAN Transmembrane protein 184B OS=Homo sapiens OX=9606 GN=TMEM184B PE=1 SV=2 g16016.t1 Q93009 63.139 1115 0.0 1439.0 sp|Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2 UBP7_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7) Homo sapiens (Human) GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006307; GO:0006508; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031647; GO:0032435; GO:0032991; GO:0035520; GO:0042752; GO:0044027; GO:0045721; GO:0048511; GO:0050821; GO:0051090; GO:0070203; GO:0075342; GO:0101005; GO:1901796; GO:1904262; GO:1904353; GO:1905279; GO:1990380 DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of establishment of protein localization to telomere [GO:0070203]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283] chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039] g16017.t1 Q6PAX8 44.043 277 4.59e-63 201.0 sp|Q6PAX8|HAPR1_XENLA HUWE1-associated protein modifying stress responses OS=Xenopus laevis OX=8355 GN=hapstr1 PE=2 SV=1 g16019.t1 Q29476 39.781 274 8.04e-64 206.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g16019.t2 Q29476 39.781 274 8.04e-64 206.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g16020.t1 P80146 36.752 351 4.35e-50 176.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g16023.t1 Q6PGL7 37.357 787 2.3200000000000002e-85 313.0 sp|Q6PGL7|WASC2_MOUSE WASH complex subunit 2 OS=Mus musculus OX=10090 GN=Washc2 PE=1 SV=1 WASC2_MOUSE reviewed WASH complex subunit 2 Mus musculus (Mouse) GO:0005546; GO:0005547; GO:0005730; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0015031; GO:0016197; GO:0031901; GO:0032266; GO:0034315; GO:0036010; GO:0042147; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1901981; GO:1905394 endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203] phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394] g16024.t1 Q5HZH2 55.804 224 3.72e-84 264.0 sp|Q5HZH2|TSR3_MOUSE 18S rRNA aminocarboxypropyltransferase OS=Mus musculus OX=10090 GN=Tsr3 PE=1 SV=1 g16025.t1 P07992 62.389 226 4.18e-106 318.0 sp|P07992|ERCC1_HUMAN DNA excision repair protein ERCC-1 OS=Homo sapiens OX=9606 GN=ERCC1 PE=1 SV=1 ERCC1_HUMAN reviewed DNA excision repair protein ERCC-1 Homo sapiens (Human) GO:0000109; GO:0000110; GO:0000720; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006303; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0008283; GO:0008340; GO:0008584; GO:0009650; GO:0010165; GO:0032205; GO:0035166; GO:0035264; GO:0036297; GO:0045190; GO:0048009; GO:0048477; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090399; GO:0090656; GO:1904431; GO:1905765; GO:1990841 cell population proliferation [GO:0008283]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; mitotic recombination [GO:0006312]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110] damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094] g16026.t1 Q6DBY0 48.25 657 0.0 625.0 sp|Q6DBY0|NUP85_DANRE Nuclear pore complex protein Nup85 OS=Danio rerio OX=7955 GN=nup85 PE=2 SV=1 g16028.t1 A1L272 49.458 461 4.62e-147 436.0 sp|A1L272|S29A4_DANRE Equilibrative nucleoside transporter 4 OS=Danio rerio OX=7955 GN=slc29a4 PE=2 SV=1 g16030.t1 Q8N436 35.542 166 1.57e-22 98.6 sp|Q8N436|CPXM2_HUMAN Inactive carboxypeptidase-like protein X2 OS=Homo sapiens OX=9606 GN=CPXM2 PE=1 SV=3 g16039.t1 Q5XG24 60.36 111 4.69e-43 151.0 sp|Q5XG24|RNP1A_XENLA RNA-binding protein with serine-rich domain 1-A OS=Xenopus laevis OX=8355 GN=rnps1-a PE=2 SV=1 g16040.t1 Q9EQY0 63.636 132 1.82e-49 172.0 sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus OX=10090 GN=Ern1 PE=1 SV=1 ERN1_MOUSE reviewed Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)] Mus musculus (Mouse) GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006468; GO:0010629; GO:0016787; GO:0019899; GO:0030544; GO:0030968; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036498; GO:0042802; GO:0042803; GO:0043531; GO:0046330; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0106310; GO:1900103; GO:1901142; GO:1904707; GO:1990597; GO:1990604; GO:1990630 cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; negative regulation of gene expression [GO:0010629]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of JNK cascade [GO:0046330]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976] AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637] ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521]; unfolded protein binding [GO:0051082] g16041.t1 Q09499 40.28 715 1.1300000000000001e-167 511.0 sp|Q09499|IRE1_CAEEL Serine/threonine-protein kinase/endoribonuclease ire-1 OS=Caenorhabditis elegans OX=6239 GN=ire-1 PE=1 SV=2 IRE1_CAEEL reviewed Serine/threonine-protein kinase/endoribonuclease ire-1 (Inositol-requiring protein 2) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)] Caenorhabditis elegans GO:0002119; GO:0004521; GO:0004674; GO:0005524; GO:0005783; GO:0005789; GO:0006397; GO:0016787; GO:0030968; GO:0035966; GO:0036498; GO:0043025; GO:0045944; GO:0051082; GO:0070059; GO:0106310 endoplasmic reticulum unfolded protein response [GO:0030968]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; nematode larval development [GO:0002119]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to topologically incorrect protein [GO:0035966] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521]; unfolded protein binding [GO:0051082] g16045.t1 Q17QR8 30.986 284 9.34e-36 135.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g16055.t1 Q9PW70 39.13 207 5.02e-34 126.0 sp|Q9PW70|CISH_CHICK Cytokine-inducible SH2-containing protein OS=Gallus gallus OX=9031 GN=CISH PE=2 SV=1 g16056.t1 Q2KHT3 58.471 850 0.0 973.0 sp|Q2KHT3|CL16A_HUMAN Protein CLEC16A OS=Homo sapiens OX=9606 GN=CLEC16A PE=1 SV=2 CL16A_HUMAN reviewed Protein CLEC16A (C-type lectin domain family 16 member A) Homo sapiens (Human) GO:0000423; GO:0005765; GO:0005794; GO:0005829; GO:0007034; GO:0009267; GO:0010008; GO:0016197; GO:0031982; GO:1901096; GO:1901097; GO:1904263 cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; mitophagy [GO:0000423]; negative regulation of autophagosome maturation [GO:1901097]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagosome maturation [GO:1901096]; vacuolar transport [GO:0007034] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; vesicle [GO:0031982] g16057.t1 Q8RXU4 47.278 349 1.25e-109 328.0 sp|Q8RXU4|THA1_ARATH Low-specificity L-threonine aldolase 1 OS=Arabidopsis thaliana OX=3702 GN=THA1 PE=1 SV=1 g16058.t1 Q8R050 62.218 577 0.0 707.0 sp|Q8R050|ERF3A_MOUSE Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Mus musculus OX=10090 GN=Gspt1 PE=1 SV=2 g16060.t1 Q920A6 57.869 413 4.02e-165 475.0 sp|Q920A6|RISC_RAT Retinoid-inducible serine carboxypeptidase OS=Rattus norvegicus OX=10116 GN=Scpep1 PE=2 SV=1 g16063.t1 Q91559 34.021 291 6.76e-45 161.0 sp|Q91559|5HT7R_XENLA 5-hydroxytryptamine receptor 7 OS=Xenopus laevis OX=8355 GN=htr7 PE=2 SV=1 5HT7R_XENLA reviewed 5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (Serotonin receptor 7) Xenopus laevis (African clawed frog) GO:0004993; GO:0005886; GO:0006939; GO:0007192; GO:0007268; GO:0007623; GO:0042310; GO:0043410; GO:0045202; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; positive regulation of MAPK cascade [GO:0043410]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310] plasma membrane [GO:0005886]; synapse [GO:0045202] G protein-coupled serotonin receptor activity [GO:0004993] g16065.t1 O43808 57.655 307 5.6e-119 347.0 sp|O43808|PM34_HUMAN Peroxisomal membrane protein PMP34 OS=Homo sapiens OX=9606 GN=SLC25A17 PE=1 SV=1 PM34_HUMAN reviewed Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17) Homo sapiens (Human) GO:0000295; GO:0001561; GO:0005347; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015297; GO:0015867; GO:0015908; GO:0016020; GO:0044610; GO:0051087; GO:0051724; GO:0080122; GO:1901679 ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; nucleotide transmembrane transport [GO:1901679] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; antiporter activity [GO:0015297]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724]; protein-folding chaperone binding [GO:0051087] g16066.t1 P49842 46.154 221 2.89e-65 206.0 sp|P49842|WHR1_HUMAN Winged helix repair factor 1 OS=Homo sapiens OX=9606 GN=WHR1 PE=1 SV=3 WHR1_HUMAN reviewed Winged helix repair factor 1 (Inactive serine/threonine-protein kinase 19) (Protein G11) (Protein RP1) (Tandem winged helix protein formerly known as STK19) Homo sapiens (Human) GO:0003690; GO:0003725; GO:0005634; GO:0005737; GO:0006281; GO:0016607; GO:0042803; GO:0046579; GO:1903518 DNA repair [GO:0006281]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of single strand break repair [GO:1903518] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803] g16067.t1 Q5E9Y5 42.64 394 2.89e-100 307.0 sp|Q5E9Y5|DXO_BOVIN Decapping and exoribonuclease protein OS=Bos taurus OX=9913 GN=DXO PE=2 SV=1 DXO_BOVIN reviewed Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-) Bos taurus (Bovine) GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005829; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090304; GO:0110152; GO:0110155 mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid metabolic process [GO:0090304]; RNA destabilization [GO:0050779] cytosol [GO:0005829]; nucleus [GO:0005634] 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA 5'-diphosphatase activity [GO:0034353]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152] g16068.t1 Q9V7A7 32.533 375 7.6e-49 171.0 sp|Q9V7A7|GPAN1_DROME G patch domain and ankyrin repeat-containing protein 1 homolog OS=Drosophila melanogaster OX=7227 GN=CG8152 PE=2 SV=1 g16069.t1 Q8TBZ9 36.522 230 9.83e-47 159.0 sp|Q8TBZ9|TEX47_HUMAN Testis-expressed protein 47 OS=Homo sapiens OX=9606 GN=TEX47 PE=1 SV=1 g16069.t2 Q8TBZ9 36.916 214 1.17e-44 154.0 sp|Q8TBZ9|TEX47_HUMAN Testis-expressed protein 47 OS=Homo sapiens OX=9606 GN=TEX47 PE=1 SV=1 g16072.t1 Q8C2E4 39.381 678 2.18e-142 437.0 sp|Q8C2E4|PTCD1_MOUSE Pentatricopeptide repeat-containing protein 1, mitochondrial OS=Mus musculus OX=10090 GN=Ptcd1 PE=2 SV=2 g16073.t1 Q9XZV3 54.875 359 5.64e-144 414.0 sp|Q9XZV3|GNAO_GEOCY Guanine nucleotide-binding protein G(o) subunit alpha OS=Geodia cydonium OX=6047 PE=2 SV=3 g16074.t1 A2VE58 43.723 231 1.2399999999999998e-54 177.0 sp|A2VE58|SNG3_BOVIN Synaptogyrin-3 OS=Bos taurus OX=9913 GN=SYNGR3 PE=2 SV=1 g16076.t1 P31319 73.112 331 6.31e-174 492.0 sp|P31319|KAPR_APLCA cAMP-dependent protein kinase regulatory subunit OS=Aplysia californica OX=6500 PE=2 SV=2 g16076.t2 P31319 72.468 385 0.0 571.0 sp|P31319|KAPR_APLCA cAMP-dependent protein kinase regulatory subunit OS=Aplysia californica OX=6500 PE=2 SV=2 g16077.t1 A4QNR8 51.2 375 9.12e-117 381.0 sp|A4QNR8|LENG8_DANRE Leukocyte receptor cluster member 8 homolog OS=Danio rerio OX=7955 GN=leng8 PE=2 SV=1 g16080.t1 Q16960 86.288 598 0.0 1077.0 sp|Q16960|DYI3_HELCR Dynein intermediate chain 3, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1 g16081.t1 O43299 33.983 821 7.9199999999999995e-140 436.0 sp|O43299|AP5Z1_HUMAN AP-5 complex subunit zeta-1 OS=Homo sapiens OX=9606 GN=AP5Z1 PE=1 SV=2 AP5Z1_HUMAN reviewed AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5) Homo sapiens (Human) GO:0000045; GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005770; GO:0006886; GO:0007030; GO:0007040; GO:0010467; GO:0016192; GO:0016197; GO:0016607; GO:0030119; GO:0034499; GO:0044599; GO:0061564; GO:1905146 autophagosome assembly [GO:0000045]; axon development [GO:0061564]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; late endosome to Golgi transport [GO:0034499]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g16081.t2 O43299 33.983 821 5.59e-140 436.0 sp|O43299|AP5Z1_HUMAN AP-5 complex subunit zeta-1 OS=Homo sapiens OX=9606 GN=AP5Z1 PE=1 SV=2 AP5Z1_HUMAN reviewed AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5) Homo sapiens (Human) GO:0000045; GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005770; GO:0006886; GO:0007030; GO:0007040; GO:0010467; GO:0016192; GO:0016197; GO:0016607; GO:0030119; GO:0034499; GO:0044599; GO:0061564; GO:1905146 autophagosome assembly [GO:0000045]; axon development [GO:0061564]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; late endosome to Golgi transport [GO:0034499]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g16083.t1 Q25378 73.344 649 0.0 1027.0 sp|Q25378|KPC1_LYTPI Protein kinase C OS=Lytechinus pictus OX=7653 GN=PKC1 PE=2 SV=1 g16083.t2 Q25378 72.881 649 0.0 1014.0 sp|Q25378|KPC1_LYTPI Protein kinase C OS=Lytechinus pictus OX=7653 GN=PKC1 PE=2 SV=1 g16084.t1 A6NCI4 43.649 1173 0.0 967.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 VWA3A_HUMAN reviewed von Willebrand factor A domain-containing protein 3A Homo sapiens (Human) GO:0005576 extracellular region [GO:0005576] g16084.t2 A6NCI4 43.353 1181 0.0 960.0 sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3 VWA3A_HUMAN reviewed von Willebrand factor A domain-containing protein 3A Homo sapiens (Human) GO:0005576 extracellular region [GO:0005576] g16086.t1 Q5ZIB2 31.15 565 3.62e-66 249.0 sp|Q5ZIB2|FBF1_CHICK Fas-binding factor 1 homolog OS=Gallus gallus OX=9031 GN=FBF1 PE=2 SV=1 g16087.t1 Q68F62 34.731 167 7.78e-39 135.0 sp|Q68F62|MP17L_XENLA Mpv17-like protein OS=Xenopus laevis OX=8355 GN=mpv17l PE=2 SV=1 g16088.t1 Q5XGZ9 34.943 352 1.3700000000000001e-64 229.0 sp|Q5XGZ9|MF6LB_XENLA Major facilitator superfamily domain-containing protein 6-like protein B OS=Xenopus laevis OX=8355 GN=mfsd6l-b PE=2 SV=1 g16089.t1 A7MBC2 42.198 737 0.0 583.0 sp|A7MBC2|PDXD1_BOVIN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PDXDC1 PE=2 SV=1 g16089.t2 A7MBC2 41.918 730 0.0 569.0 sp|A7MBC2|PDXD1_BOVIN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PDXDC1 PE=2 SV=1 g16090.t1 Q6P8D1 64.856 313 1.43e-143 410.0 sp|Q6P8D1|RSSA_XENTR Small ribosomal subunit protein uS2 OS=Xenopus tropicalis OX=8364 GN=rpsa PE=2 SV=1 RSSA_XENTR reviewed Small ribosomal subunit protein uS2 (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (40S ribosomal protein SA) (67 kDa laminin receptor) (67LR) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000028; GO:0002181; GO:0003735; GO:0005055; GO:0005634; GO:0005886; GO:0006364; GO:0022627; GO:0043236; GO:0048536 cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; rRNA processing [GO:0006364]; spleen development [GO:0048536] cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; plasma membrane [GO:0005886] laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; structural constituent of ribosome [GO:0003735] g16092.t1 Q9Y5X2 46.305 406 3.7500000000000004e-129 387.0 sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1 g16092.t2 Q9Y5X2 47.135 384 7.190000000000001e-129 387.0 sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1 g16093.t1 Q1LZC5 44.978 229 1.57e-55 185.0 sp|Q1LZC5|ANR54_BOVIN Ankyrin repeat domain-containing protein 54 OS=Bos taurus OX=9913 GN=ANKRD54 PE=2 SV=1 g16094.t1 Q3TSG4 69.778 225 3.09e-114 342.0 sp|Q3TSG4|ALKB5_MOUSE RNA demethylase ALKBH5 OS=Mus musculus OX=10090 GN=Alkbh5 PE=1 SV=2 ALKB5_MOUSE reviewed RNA demethylase ALKBH5 (EC 1.14.11.53) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5) Mus musculus (Mouse) GO:0001666; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006417; GO:0007283; GO:0010793; GO:0016607; GO:0016706; GO:0030154; GO:0035515; GO:0042382; GO:0043488; GO:0046630; GO:0046872; GO:0050684; GO:0061157; GO:0140693; GO:0140694; GO:1990931 cell differentiation [GO:0030154]; gamma-delta T cell proliferation [GO:0046630]; membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515] g16095.t1 Q92184 29.176 425 6.02e-39 147.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g16096.t1 Q9JL56 46.875 256 7.21e-74 234.0 sp|Q9JL56|GDE1_MOUSE Glycerophosphodiester phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Gde1 PE=1 SV=1 g16097.t1 P29314 84.574 188 8.879999999999999e-108 309.0 sp|P29314|RS9_RAT Small ribosomal subunit protein uS4 OS=Rattus norvegicus OX=10116 GN=Rps9 PE=1 SV=4 g16098.t1 Q6ICB0 56.962 158 9.780000000000001e-58 192.0 sp|Q6ICB0|DESI1_HUMAN Desumoylating isopeptidase 1 OS=Homo sapiens OX=9606 GN=DESI1 PE=1 SV=1 DESI1_HUMAN reviewed Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Palmitoyl protein thioesterase DESI1) (EC 3.1.2.22) (Polyubiquitinated substrate transporter) (POST) (S-depalmitoylase DESI1) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0006508; GO:0006611; GO:0008474; GO:0016926; GO:0016929; GO:0032434; GO:0032991; GO:0042802; GO:0052816; GO:0061676 protein desumoylation [GO:0016926]; protein export from nucleus [GO:0006611]; proteolysis [GO:0006508]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434] cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] deSUMOylase activity [GO:0016929]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; palmitoyl-(protein) hydrolase activity [GO:0008474] g16099.t1 Q96S21 69.295 241 6.32e-121 349.0 sp|Q96S21|RB40C_HUMAN Ras-related protein Rab-40C OS=Homo sapiens OX=9606 GN=RAB40C PE=1 SV=1 RB40C_HUMAN reviewed Ras-related protein Rab-40C (EC 3.6.5.2) (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3) Homo sapiens (Human) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005811; GO:0005829; GO:0005886; GO:0006887; GO:0008021; GO:0016477; GO:0016567; GO:0031466; GO:0035556; GO:0043161; GO:0046872; GO:0051895; GO:0140042; GO:1990756 cell migration [GO:0016477]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; lipid droplet formation [GO:0140042]; negative regulation of focal adhesion assembly [GO:0051895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16100.t1 Q9UIC8 51.282 312 5.53e-121 353.0 sp|Q9UIC8|LCMT1_HUMAN Leucine carboxyl methyltransferase 1 OS=Homo sapiens OX=9606 GN=LCMT1 PE=1 SV=2 g16101.t1 Q6PCQ0 29.602 679 2.99e-53 200.0 sp|Q6PCQ0|IQCE_MOUSE IQ domain-containing protein E OS=Mus musculus OX=10090 GN=Iqce PE=1 SV=1 IQCE_MOUSE reviewed IQ domain-containing protein E Mus musculus (Mouse) GO:0005739; GO:0008589; GO:0009898; GO:0035108; GO:0045944; GO:0060170; GO:0098797; GO:0120229 limb morphogenesis [GO:0035108]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to motile cilium [GO:0120229]; regulation of smoothened signaling pathway [GO:0008589] ciliary membrane [GO:0060170]; cytoplasmic side of plasma membrane [GO:0009898]; mitochondrion [GO:0005739]; plasma membrane protein complex [GO:0098797] g16101.t2 Q6PCQ0 29.602 679 2.53e-53 201.0 sp|Q6PCQ0|IQCE_MOUSE IQ domain-containing protein E OS=Mus musculus OX=10090 GN=Iqce PE=1 SV=1 IQCE_MOUSE reviewed IQ domain-containing protein E Mus musculus (Mouse) GO:0005739; GO:0008589; GO:0009898; GO:0035108; GO:0045944; GO:0060170; GO:0098797; GO:0120229 limb morphogenesis [GO:0035108]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to motile cilium [GO:0120229]; regulation of smoothened signaling pathway [GO:0008589] ciliary membrane [GO:0060170]; cytoplasmic side of plasma membrane [GO:0009898]; mitochondrion [GO:0005739]; plasma membrane protein complex [GO:0098797] g16105.t1 Q8NBI5 31.843 559 1.9599999999999999e-81 266.0 sp|Q8NBI5|S43A3_HUMAN Equilibrative nucleobase transporter 1 OS=Homo sapiens OX=9606 GN=SLC43A3 PE=1 SV=2 S43A3_HUMAN reviewed Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3) Homo sapiens (Human) GO:0015207; GO:0015208; GO:0015245; GO:0016323; GO:0035344; GO:0042910 hypoxanthine transport [GO:0035344] basolateral plasma membrane [GO:0016323] adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910] g16106.t1 G3M4F8 34.53 362 2.9999999999999998e-55 189.0 sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 OCTB2_CHISP reviewed Octopamine receptor beta-2R (CsOA2B2) Chilo suppressalis (Asiatic rice borer moth) GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0043410; GO:0071418; GO:0071880; GO:0071927; GO:0071928 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; positive regulation of MAPK cascade [GO:0043410]; tyramine signaling pathway [GO:0071928] membrane [GO:0016020]; plasma membrane [GO:0005886] octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226] g16108.t1 Q8BGC3 25.464 377 6.099999999999999e-23 104.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g16108.t2 Q8BGC3 25.405 370 9.21e-22 100.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g16110.t1 Q8BGC3 23.896 385 3.52e-22 103.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g16112.t1 Q6P4S8 46.126 2233 0.0 1714.0 sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2 INT1_MOUSE reviewed Integrator complex subunit 1 (Int1) Mus musculus (Mouse) GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0016180; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240 blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] g16113.t1 Q17RP2 44.526 137 8.68e-38 140.0 sp|Q17RP2|TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens OX=9606 GN=TIGD6 PE=1 SV=2 g16125.t1 Q5ZI11 43.804 694 0.0 538.0 sp|Q5ZI11|LRC45_CHICK Leucine-rich repeat-containing protein 45 OS=Gallus gallus OX=9031 GN=LRRC45 PE=2 SV=1 g16126.t1 Q80YR4 46.883 401 2.39e-102 343.0 sp|Q80YR4|ZN598_MOUSE E3 ubiquitin-protein ligase ZNF598 OS=Mus musculus OX=10090 GN=Znf598 PE=1 SV=1 ZN598_MOUSE reviewed E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598) Mus musculus (Mouse) GO:0005829; GO:0006513; GO:0008270; GO:0016567; GO:0022626; GO:0032790; GO:0043022; GO:0045947; GO:0055106; GO:0061630; GO:0070534; GO:0072344; GO:0140517; GO:0170011; GO:1990116 negative regulation of translational initiation [GO:0045947]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626] protein-RNA adaptor activity [GO:0140517]; ribosome binding [GO:0043022]; stalled ribosome sensor activity [GO:0170011]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase regulator activity [GO:0055106]; zinc ion binding [GO:0008270] g16126.t1 Q80YR4 33.333 210 8.49e-24 112.0 sp|Q80YR4|ZN598_MOUSE E3 ubiquitin-protein ligase ZNF598 OS=Mus musculus OX=10090 GN=Znf598 PE=1 SV=1 ZN598_MOUSE reviewed E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598) Mus musculus (Mouse) GO:0005829; GO:0006513; GO:0008270; GO:0016567; GO:0022626; GO:0032790; GO:0043022; GO:0045947; GO:0055106; GO:0061630; GO:0070534; GO:0072344; GO:0140517; GO:0170011; GO:1990116 negative regulation of translational initiation [GO:0045947]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626] protein-RNA adaptor activity [GO:0140517]; ribosome binding [GO:0043022]; stalled ribosome sensor activity [GO:0170011]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase regulator activity [GO:0055106]; zinc ion binding [GO:0008270] g16127.t1 Q6RUV5 88.601 193 8.120000000000001e-125 352.0 sp|Q6RUV5|RAC1_RAT Ras-related C3 botulinum toxin substrate 1 OS=Rattus norvegicus OX=10116 GN=Rac1 PE=1 SV=1 RAC1_RAT reviewed Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1) Rattus norvegicus (Rat) GO:0000139; GO:0000242; GO:0001764; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003015; GO:0003376; GO:0003382; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005938; GO:0006897; GO:0006911; GO:0006935; GO:0006972; GO:0007010; GO:0007015; GO:0007155; GO:0007163; GO:0007167; GO:0007186; GO:0007264; GO:0007411; GO:0008045; GO:0008360; GO:0010591; GO:0010592; GO:0010595; GO:0010762; GO:0010764; GO:0010811; GO:0014041; GO:0016020; GO:0016358; GO:0016477; GO:0016601; GO:0019805; GO:0019899; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0022604; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030425; GO:0030672; GO:0030742; GO:0030838; GO:0030865; GO:0030900; GO:0031116; GO:0031267; GO:0031410; GO:0031901; GO:0031996; GO:0032496; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035567; GO:0035774; GO:0036464; GO:0042470; GO:0042554; GO:0042734; GO:0042826; GO:0042995; GO:0043020; GO:0043131; GO:0043652; GO:0044877; GO:0045211; GO:0045216; GO:0045428; GO:0045453; GO:0045740; GO:0046425; GO:0048012; GO:0048168; GO:0048532; GO:0048812; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051117; GO:0051491; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051897; GO:0051932; GO:0055038; GO:0060071; GO:0060091; GO:0060263; GO:0060326; GO:0060999; GO:0061344; GO:0070376; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0086098; GO:0090023; GO:0090103; GO:0097178; GO:0098794; GO:0098974; GO:0098978; GO:0098982; GO:0150052; GO:1900026; GO:1900029; GO:1900242; GO:1902622; GO:1903348; GO:1904395; GO:1904936; GO:1904948; GO:2000386; GO:2001222 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell-cell junction organization [GO:0045216]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton organization [GO:0007010]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; endocytosis [GO:0006897]; engulfment of apoptotic cell [GO:0043652]; enzyme-linked receptor protein signaling pathway [GO:0007167]; epithelial cell morphogenesis [GO:0003382]; erythrocyte enucleation [GO:0043131]; establishment or maintenance of cell polarity [GO:0007163]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; interneuron migration [GO:1904936]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; midbrain dopaminergic neuron differentiation [GO:1904948]; motor neuron axon guidance [GO:0008045]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; non-canonical Wnt signaling pathway [GO:0035567]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; quinolinate biosynthetic process [GO:0019805]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of ERK5 cascade [GO:0070376]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of neuron maturation [GO:0014041]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of postsynapse assembly [GO:0150052]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of respiratory burst [GO:0060263]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to lipopolysaccharide [GO:0032496]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; small GTPase-mediated signal transduction [GO:0007264]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; substrate adhesion-dependent cell spreading [GO:0034446]; superoxide anion generation [GO:0042554]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; kinocilium [GO:0060091]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rho GDP-dissociation inhibitor binding [GO:0051022]; small GTPase binding [GO:0031267]; thioesterase binding [GO:0031996] g16128.t1 Q6RUV5 81.771 192 4.93e-119 338.0 sp|Q6RUV5|RAC1_RAT Ras-related C3 botulinum toxin substrate 1 OS=Rattus norvegicus OX=10116 GN=Rac1 PE=1 SV=1 RAC1_RAT reviewed Ras-related C3 botulinum toxin substrate 1 (EC 3.6.5.2) (p21-Rac1) Rattus norvegicus (Rat) GO:0000139; GO:0000242; GO:0001764; GO:0001891; GO:0001934; GO:0002093; GO:0002551; GO:0003015; GO:0003376; GO:0003382; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005938; GO:0006897; GO:0006911; GO:0006935; GO:0006972; GO:0007010; GO:0007015; GO:0007155; GO:0007163; GO:0007167; GO:0007186; GO:0007264; GO:0007411; GO:0008045; GO:0008360; GO:0010591; GO:0010592; GO:0010595; GO:0010762; GO:0010764; GO:0010811; GO:0014041; GO:0016020; GO:0016358; GO:0016477; GO:0016601; GO:0019805; GO:0019899; GO:0019901; GO:0021799; GO:0021831; GO:0021894; GO:0022604; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0030041; GO:0030334; GO:0030425; GO:0030672; GO:0030742; GO:0030838; GO:0030865; GO:0030900; GO:0031116; GO:0031267; GO:0031410; GO:0031901; GO:0031996; GO:0032496; GO:0032587; GO:0032707; GO:0032956; GO:0034446; GO:0035567; GO:0035774; GO:0036464; GO:0042470; GO:0042554; GO:0042734; GO:0042826; GO:0042995; GO:0043020; GO:0043131; GO:0043652; GO:0044877; GO:0045211; GO:0045216; GO:0045428; GO:0045453; GO:0045740; GO:0046425; GO:0048012; GO:0048168; GO:0048532; GO:0048812; GO:0048813; GO:0048870; GO:0048873; GO:0051022; GO:0051117; GO:0051491; GO:0051492; GO:0051496; GO:0051668; GO:0051894; GO:0051897; GO:0051932; GO:0055038; GO:0060071; GO:0060091; GO:0060263; GO:0060326; GO:0060999; GO:0061344; GO:0070376; GO:0071260; GO:0071526; GO:0071542; GO:0072659; GO:0086098; GO:0090023; GO:0090103; GO:0097178; GO:0098794; GO:0098974; GO:0098978; GO:0098982; GO:0150052; GO:1900026; GO:1900029; GO:1900242; GO:1902622; GO:1903348; GO:1904395; GO:1904936; GO:1904948; GO:2000386; GO:2001222 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; anatomical structure arrangement [GO:0048532]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; auditory receptor cell morphogenesis [GO:0002093]; axon guidance [GO:0007411]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell-cell junction organization [GO:0045216]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex GABAergic interneuron development [GO:0021894]; cerebral cortex radially oriented cell migration [GO:0021799]; chemotaxis [GO:0006935]; cochlea morphogenesis [GO:0090103]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton organization [GO:0007010]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dopaminergic neuron differentiation [GO:0071542]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; endocytosis [GO:0006897]; engulfment of apoptotic cell [GO:0043652]; enzyme-linked receptor protein signaling pathway [GO:0007167]; epithelial cell morphogenesis [GO:0003382]; erythrocyte enucleation [GO:0043131]; establishment or maintenance of cell polarity [GO:0007163]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; heart process [GO:0003015]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; homeostasis of number of cells within a tissue [GO:0048873]; hyperosmotic response [GO:0006972]; interneuron migration [GO:1904936]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; midbrain dopaminergic neuron differentiation [GO:1904948]; motor neuron axon guidance [GO:0008045]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; non-canonical Wnt signaling pathway [GO:0035567]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; quinolinate biosynthetic process [GO:0019805]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of ERK5 cascade [GO:0070376]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of neuron maturation [GO:0014041]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neutrophil migration [GO:1902622]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of postsynapse assembly [GO:0150052]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of respiratory burst [GO:0060263]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to lipopolysaccharide [GO:0032496]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; small GTPase-mediated signal transduction [GO:0007264]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; substrate adhesion-dependent cell spreading [GO:0034446]; superoxide anion generation [GO:0042554]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; kinocilium [GO:0060091]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rho GDP-dissociation inhibitor binding [GO:0051022]; small GTPase binding [GO:0031267]; thioesterase binding [GO:0031996] g16129.t1 Q3TYD6 36.865 453 1.44e-86 314.0 sp|Q3TYD6|LMTK2_MOUSE Serine/threonine-protein kinase LMTK2 OS=Mus musculus OX=10090 GN=Lmtk2 PE=1 SV=3 LMTK2_MOUSE reviewed Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Brain-enriched kinase) (Lemur tyrosine kinase 2) Mus musculus (Mouse) GO:0001881; GO:0004672; GO:0004674; GO:0004864; GO:0005524; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0007411; GO:0016020; GO:0030426; GO:0032456; GO:0033572; GO:0043025; GO:0045022; GO:0048011; GO:0048471; GO:0055037; GO:0070853; GO:0106310 axon guidance [GO:0007411]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; nervous system development [GO:0007399]; neurotrophin TRK receptor signaling pathway [GO:0048011]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572] cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein kinase activity [GO:0004672]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16129.t2 Q3TYD6 36.784 454 3.0700000000000004e-85 310.0 sp|Q3TYD6|LMTK2_MOUSE Serine/threonine-protein kinase LMTK2 OS=Mus musculus OX=10090 GN=Lmtk2 PE=1 SV=3 LMTK2_MOUSE reviewed Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Brain-enriched kinase) (Lemur tyrosine kinase 2) Mus musculus (Mouse) GO:0001881; GO:0004672; GO:0004674; GO:0004864; GO:0005524; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0007411; GO:0016020; GO:0030426; GO:0032456; GO:0033572; GO:0043025; GO:0045022; GO:0048011; GO:0048471; GO:0055037; GO:0070853; GO:0106310 axon guidance [GO:0007411]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; nervous system development [GO:0007399]; neurotrophin TRK receptor signaling pathway [GO:0048011]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572] cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein kinase activity [GO:0004672]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16130.t1 Q6DKP5 58.607 488 0.0 585.0 sp|Q6DKP5|WDR13_PANTR WD repeat-containing protein 13 OS=Pan troglodytes OX=9598 GN=WDR13 PE=3 SV=1 g16130.t2 Q6DKP5 58.316 487 0.0 583.0 sp|Q6DKP5|WDR13_PANTR WD repeat-containing protein 13 OS=Pan troglodytes OX=9598 GN=WDR13 PE=3 SV=1 g16131.t1 Q15438 72.843 394 0.0 603.0 sp|Q15438|CYH1_HUMAN Cytohesin-1 OS=Homo sapiens OX=9606 GN=CYTH1 PE=1 SV=1 CYH1_HUMAN reviewed Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1) Homo sapiens (Human) GO:0000139; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008289; GO:0009898; GO:0016192; GO:0030155; GO:0032012; GO:0090162 establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] g16132.t1 P97478 74.419 172 4.94e-94 276.0 sp|P97478|COQ7_MOUSE NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial OS=Mus musculus OX=10090 GN=Coq7 PE=1 SV=3 g16149.t1 O43497 48.169 1065 0.0 790.0 sp|O43497|CAC1G_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1G OS=Homo sapiens OX=9606 GN=CACNA1G PE=1 SV=3 g16149.t1 O43497 60.383 626 0.0 700.0 sp|O43497|CAC1G_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1G OS=Homo sapiens OX=9606 GN=CACNA1G PE=1 SV=3 g16149.t1 O43497 24.165 389 8.89e-25 118.0 sp|O43497|CAC1G_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1G OS=Homo sapiens OX=9606 GN=CACNA1G PE=1 SV=3 g16149.t1 O43497 27.645 293 8.89e-24 114.0 sp|O43497|CAC1G_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1G OS=Homo sapiens OX=9606 GN=CACNA1G PE=1 SV=3 g16149.t1 O43497 28.137 263 1.31e-22 110.0 sp|O43497|CAC1G_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1G OS=Homo sapiens OX=9606 GN=CACNA1G PE=1 SV=3 g16149.t2 O88427 45.077 2214 0.0 1459.0 sp|O88427|CAC1H_MOUSE Voltage-dependent T-type calcium channel subunit alpha-1H OS=Mus musculus OX=10090 GN=Cacna1h PE=1 SV=3 CAC1H_MOUSE reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2) Mus musculus (Mouse) GO:0001518; GO:0005244; GO:0005245; GO:0005248; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016020; GO:0030425; GO:0032342; GO:0034651; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0106134; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of membrane potential [GO:0042391] caveola [GO:0005901]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] g16149.t3 O88427 45.43 2210 0.0 1474.0 sp|O88427|CAC1H_MOUSE Voltage-dependent T-type calcium channel subunit alpha-1H OS=Mus musculus OX=10090 GN=Cacna1h PE=1 SV=3 CAC1H_MOUSE reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2) Mus musculus (Mouse) GO:0001518; GO:0005244; GO:0005245; GO:0005248; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016020; GO:0030425; GO:0032342; GO:0034651; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0106134; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of membrane potential [GO:0042391] caveola [GO:0005901]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] g16149.t4 O88427 45.348 2214 0.0 1472.0 sp|O88427|CAC1H_MOUSE Voltage-dependent T-type calcium channel subunit alpha-1H OS=Mus musculus OX=10090 GN=Cacna1h PE=1 SV=3 CAC1H_MOUSE reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2) Mus musculus (Mouse) GO:0001518; GO:0005244; GO:0005245; GO:0005248; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016020; GO:0030425; GO:0032342; GO:0034651; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0106134; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of membrane potential [GO:0042391] caveola [GO:0005901]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] g16149.t5 O88427 45.612 2199 0.0 1476.0 sp|O88427|CAC1H_MOUSE Voltage-dependent T-type calcium channel subunit alpha-1H OS=Mus musculus OX=10090 GN=Cacna1h PE=1 SV=3 CAC1H_MOUSE reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2) Mus musculus (Mouse) GO:0001518; GO:0005244; GO:0005245; GO:0005248; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016020; GO:0030425; GO:0032342; GO:0034651; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0106134; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of membrane potential [GO:0042391] caveola [GO:0005901]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] g16149.t6 O88427 44.722 2245 0.0 1453.0 sp|O88427|CAC1H_MOUSE Voltage-dependent T-type calcium channel subunit alpha-1H OS=Mus musculus OX=10090 GN=Cacna1h PE=1 SV=3 CAC1H_MOUSE reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2) Mus musculus (Mouse) GO:0001518; GO:0005244; GO:0005245; GO:0005248; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016020; GO:0030425; GO:0032342; GO:0034651; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0106134; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of membrane potential [GO:0042391] caveola [GO:0005901]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] g16149.t7 O88427 47.681 2005 0.0 1474.0 sp|O88427|CAC1H_MOUSE Voltage-dependent T-type calcium channel subunit alpha-1H OS=Mus musculus OX=10090 GN=Cacna1h PE=1 SV=3 CAC1H_MOUSE reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2) Mus musculus (Mouse) GO:0001518; GO:0005244; GO:0005245; GO:0005248; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016020; GO:0030425; GO:0032342; GO:0034651; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0106134; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of membrane potential [GO:0042391] caveola [GO:0005901]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] g16149.t8 O88427 48.272 1939 0.0 1457.0 sp|O88427|CAC1H_MOUSE Voltage-dependent T-type calcium channel subunit alpha-1H OS=Mus musculus OX=10090 GN=Cacna1h PE=1 SV=3 CAC1H_MOUSE reviewed Voltage-dependent T-type calcium channel subunit alpha-1H (Voltage-gated calcium channel subunit alpha Cav3.2) Mus musculus (Mouse) GO:0001518; GO:0005244; GO:0005245; GO:0005248; GO:0005886; GO:0005891; GO:0005901; GO:0006816; GO:0008332; GO:0016020; GO:0030425; GO:0032342; GO:0034651; GO:0042383; GO:0042391; GO:0043005; GO:0043204; GO:0045211; GO:0045956; GO:0046872; GO:0048787; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:0098978; GO:0106134; GO:2000344 aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of cardiac muscle cell contraction [GO:0106134]; regulation of membrane potential [GO:0042391] caveola [GO:0005901]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; sarcolemma [GO:0042383]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated monoatomic ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] g16151.t1 Q8TB22 51.687 741 0.0 793.0 sp|Q8TB22|SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens OX=9606 GN=SPATA20 PE=1 SV=3 g16152.t1 Q0P595 55.348 374 1.04e-146 428.0 sp|Q0P595|SIR7_BOVIN NAD-dependent protein deacetylase sirtuin-7 OS=Bos taurus OX=9913 GN=SIRT7 PE=2 SV=1 SIR7_BOVIN reviewed NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7) Bos taurus (Bovine) GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006281; GO:0006357; GO:0006476; GO:0007129; GO:0009303; GO:0010526; GO:0010821; GO:0031397; GO:0034979; GO:0035861; GO:0036055; GO:0040029; GO:0045722; GO:0045943; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0097372; GO:0106230; GO:0106231; GO:0140861; GO:1901836; GO:2000234 DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; epigenetic regulation of gene expression [GO:0040029]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop processing [GO:0062176]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]; transposable element silencing [GO:0010526] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] chromatin binding [GO:0003682]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-succinyllysine desuccinylase activity [GO:0036055] g16153.t1 B1AQJ2 51.923 416 1.16e-140 464.0 sp|B1AQJ2|UBP36_MOUSE Ubiquitin carboxyl-terminal hydrolase 36 OS=Mus musculus OX=10090 GN=Usp36 PE=1 SV=1 UBP36_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36) Mus musculus (Mouse) GO:0003723; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0042981; GO:0050821; GO:0140936; GO:1990380; GO:2000232 chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; histone H2B deubiquitinase activity [GO:0140936]; K48-linked deubiquitinase activity [GO:1990380]; RNA binding [GO:0003723]; transferase activity [GO:0016740] g16156.t1 Q9SXD5 33.521 355 5.0199999999999996e-52 181.0 sp|Q9SXD5|GSXL3_ARATH Flavin-containing monooxygenase FMO GS-OX-like 3 OS=Arabidopsis thaliana OX=3702 GN=At1g62620 PE=2 SV=2 g16157.t1 Q99943 41.624 197 1.15e-44 155.0 sp|Q99943|PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2 PLCA_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15) Homo sapiens (Human) GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] g16160.t1 Q8CG09 50.064 1560 0.0 1559.0 sp|Q8CG09|MRP1_RAT Multidrug resistance-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Abcc1 PE=1 SV=2 MRP1_RAT reviewed Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter) Rattus norvegicus (Rat) GO:0001894; GO:0002432; GO:0002437; GO:0003158; GO:0005324; GO:0005524; GO:0005886; GO:0006691; GO:0006749; GO:0006954; GO:0006955; GO:0006979; GO:0007613; GO:0008211; GO:0008559; GO:0009410; GO:0009636; GO:0009925; GO:0010001; GO:0010467; GO:0015127; GO:0015420; GO:0015431; GO:0015562; GO:0015723; GO:0015889; GO:0015911; GO:0016323; GO:0016324; GO:0016328; GO:0016491; GO:0016887; GO:0019370; GO:0021764; GO:0021766; GO:0022008; GO:0030335; GO:0033284; GO:0033700; GO:0034040; GO:0034341; GO:0034394; GO:0034405; GO:0034634; GO:0034775; GO:0035264; GO:0035640; GO:0042116; GO:0042391; GO:0042554; GO:0042887; GO:0042908; GO:0042910; GO:0043476; GO:0045332; GO:0045454; GO:0046943; GO:0048003; GO:0048708; GO:0050435; GO:0050665; GO:0050729; GO:0050830; GO:0051132; GO:0051384; GO:0051649; GO:0055082; GO:0055085; GO:0060326; GO:0070633; GO:0070729; GO:0071346; GO:0071716; GO:0072577; GO:0072676; GO:0097242; GO:0097719; GO:0097746; GO:0099039; GO:0140115; GO:0140352; GO:0140359; GO:0141067; GO:1903409; GO:1904646; GO:1905039; GO:1990961; GO:1990962; GO:2001038 amygdala development [GO:0021764]; amyloid-beta clearance [GO:0097242]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of lipid antigen via MHC class Ib [GO:0048003]; astrocyte differentiation [GO:0048708]; bilirubin transport [GO:0015723]; blood vessel diameter maintenance [GO:0097746]; carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cell redox homeostasis [GO:0045454]; cellular response to amyloid-beta [GO:1904646]; cellular response to type II interferon [GO:0071346]; cobalamin transport [GO:0015889]; cyclic nucleotide transport [GO:0070729]; defense response to Gram-positive bacterium [GO:0050830]; endothelial cell apoptotic process [GO:0072577]; endothelium development [GO:0003158]; establishment of localization in cell [GO:0051649]; exploration behavior [GO:0035640]; export across plasma membrane [GO:0140115]; export from cell [GO:0140352]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glucocorticoid metabolic process [GO:0008211]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; granuloma formation [GO:0002432]; hippocampus development [GO:0021766]; hydrogen peroxide biosynthetic process [GO:0050665]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular chemical homeostasis [GO:0055082]; intracellular nitrogen homeostasis [GO:0141067]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; lymphocyte migration [GO:0072676]; macrophage activation [GO:0042116]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; neural tissue regeneration [GO:0097719]; neurogenesis [GO:0022008]; NK T cell activation [GO:0051132]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; pigment accumulation [GO:0043476]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; protein localization to cell surface [GO:0034394]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of cellular response to drug [GO:2001038]; regulation of membrane potential [GO:0042391]; response to fluid shear stress [GO:0034405]; response to glucocorticoid [GO:0051384]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to type II interferon [GO:0034341]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; superoxide anion generation [GO:0042554]; tissue homeostasis [GO:0001894]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled carboxylic acid transmembrane transporter activity [GO:0033284]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; bilirubin transmembrane transporter activity [GO:0015127]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; xenobiotic transmembrane transporter activity [GO:0042910] g16160.t2 Q8CG09 50.064 1560 0.0 1555.0 sp|Q8CG09|MRP1_RAT Multidrug resistance-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Abcc1 PE=1 SV=2 MRP1_RAT reviewed Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter) Rattus norvegicus (Rat) GO:0001894; GO:0002432; GO:0002437; GO:0003158; GO:0005324; GO:0005524; GO:0005886; GO:0006691; GO:0006749; GO:0006954; GO:0006955; GO:0006979; GO:0007613; GO:0008211; GO:0008559; GO:0009410; GO:0009636; GO:0009925; GO:0010001; GO:0010467; GO:0015127; GO:0015420; GO:0015431; GO:0015562; GO:0015723; GO:0015889; GO:0015911; GO:0016323; GO:0016324; GO:0016328; GO:0016491; GO:0016887; GO:0019370; GO:0021764; GO:0021766; GO:0022008; GO:0030335; GO:0033284; GO:0033700; GO:0034040; GO:0034341; GO:0034394; GO:0034405; GO:0034634; GO:0034775; GO:0035264; GO:0035640; GO:0042116; GO:0042391; GO:0042554; GO:0042887; GO:0042908; GO:0042910; GO:0043476; GO:0045332; GO:0045454; GO:0046943; GO:0048003; GO:0048708; GO:0050435; GO:0050665; GO:0050729; GO:0050830; GO:0051132; GO:0051384; GO:0051649; GO:0055082; GO:0055085; GO:0060326; GO:0070633; GO:0070729; GO:0071346; GO:0071716; GO:0072577; GO:0072676; GO:0097242; GO:0097719; GO:0097746; GO:0099039; GO:0140115; GO:0140352; GO:0140359; GO:0141067; GO:1903409; GO:1904646; GO:1905039; GO:1990961; GO:1990962; GO:2001038 amygdala development [GO:0021764]; amyloid-beta clearance [GO:0097242]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of lipid antigen via MHC class Ib [GO:0048003]; astrocyte differentiation [GO:0048708]; bilirubin transport [GO:0015723]; blood vessel diameter maintenance [GO:0097746]; carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cell redox homeostasis [GO:0045454]; cellular response to amyloid-beta [GO:1904646]; cellular response to type II interferon [GO:0071346]; cobalamin transport [GO:0015889]; cyclic nucleotide transport [GO:0070729]; defense response to Gram-positive bacterium [GO:0050830]; endothelial cell apoptotic process [GO:0072577]; endothelium development [GO:0003158]; establishment of localization in cell [GO:0051649]; exploration behavior [GO:0035640]; export across plasma membrane [GO:0140115]; export from cell [GO:0140352]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glucocorticoid metabolic process [GO:0008211]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; granuloma formation [GO:0002432]; hippocampus development [GO:0021766]; hydrogen peroxide biosynthetic process [GO:0050665]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular chemical homeostasis [GO:0055082]; intracellular nitrogen homeostasis [GO:0141067]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; long-chain fatty acid import across plasma membrane [GO:0015911]; lymphocyte migration [GO:0072676]; macrophage activation [GO:0042116]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; neural tissue regeneration [GO:0097719]; neurogenesis [GO:0022008]; NK T cell activation [GO:0051132]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; pigment accumulation [GO:0043476]; positive regulation of cell migration [GO:0030335]; positive regulation of inflammatory response [GO:0050729]; protein localization to cell surface [GO:0034394]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of cellular response to drug [GO:2001038]; regulation of membrane potential [GO:0042391]; response to fluid shear stress [GO:0034405]; response to glucocorticoid [GO:0051384]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to type II interferon [GO:0034341]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; superoxide anion generation [GO:0042554]; tissue homeostasis [GO:0001894]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled carboxylic acid transmembrane transporter activity [GO:0033284]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; bilirubin transmembrane transporter activity [GO:0015127]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; xenobiotic transmembrane transporter activity [GO:0042910] g16161.t1 O14562 66.667 228 1.99e-113 334.0 sp|O14562|UBFD1_HUMAN Ubiquitin domain-containing protein UBFD1 OS=Homo sapiens OX=9606 GN=UBFD1 PE=1 SV=2 g16162.t1 Q9NZV6 70.213 94 2.92e-39 129.0 sp|Q9NZV6|MSRB1_HUMAN Methionine-R-sulfoxide reductase B1 OS=Homo sapiens OX=9606 GN=MSRB1 PE=1 SV=3 MSRB1_HUMAN reviewed Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X) (SelX) Homo sapiens (Human) GO:0003779; GO:0005634; GO:0005829; GO:0008270; GO:0015629; GO:0030041; GO:0030091; GO:0033743; GO:0033745; GO:0045087 actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleus [GO:0005634] actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270] g16163.t1 Q24K03 38.352 352 2.9e-72 231.0 sp|Q24K03|THUM1_BOVIN THUMP domain-containing protein 1 OS=Bos taurus OX=9913 GN=THUMPD1 PE=2 SV=1 g16164.t1 Q7ZXV8 75.676 111 7.59e-56 196.0 sp|Q7ZXV8|ZN207_XENLA BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Xenopus laevis OX=8355 GN=znf207 PE=1 SV=1 ZN207_XENLA reviewed BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (xBuGZ) (Zinc finger protein 207) Xenopus laevis (African clawed frog) GO:0000070; GO:0000776; GO:0001578; GO:0005634; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047 attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983] kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047] microtubule binding [GO:0008017]; zinc ion binding [GO:0008270] g16168.t1 Q96FZ7 62.319 207 1.4e-81 244.0 sp|Q96FZ7|CHMP6_HUMAN Charged multivesicular body protein 6 OS=Homo sapiens OX=9606 GN=CHMP6 PE=1 SV=3 CHMP6_HUMAN reviewed Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20) (Vps20) (hVps20) Homo sapiens (Human) GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0007175; GO:0010008; GO:0015031; GO:0016020; GO:0016236; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0051469; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904902; GO:1904930 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] protein-containing complex binding [GO:0044877] g16169.t1 P56213 53.488 172 1.66e-62 194.0 sp|P56213|ALR_MOUSE FAD-linked sulfhydryl oxidase ALR OS=Mus musculus OX=10090 GN=Gfer PE=1 SV=2 ALR_MOUSE reviewed FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) Mus musculus (Mouse) GO:0001889; GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0097421; GO:0160203; GO:2000573 liver development [GO:0001889]; liver regeneration [GO:0097421]; mitochondrial disulfide relay system [GO:0160203]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of DNA biosynthetic process [GO:2000573] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; flavin-dependent sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035] g16170.t1 F1NQJ3 57.906 449 9.82e-174 529.0 sp|F1NQJ3|PMS2_CHICK Mismatch repair endonuclease PMS2 OS=Gallus gallus OX=9031 GN=PMS2 PE=2 SV=3 PMS2_CHICK reviewed Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2) Gallus gallus (Chicken) GO:0003697; GO:0004519; GO:0005524; GO:0005654; GO:0005829; GO:0006298; GO:0007095; GO:0016446; GO:0016447; GO:0016887; GO:0030890; GO:0032138; GO:0032389; GO:0032407; GO:0048298; GO:0048304; GO:0140664 mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447] cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697] g16170.t1 F1NQJ3 67.206 247 1.1700000000000001e-110 364.0 sp|F1NQJ3|PMS2_CHICK Mismatch repair endonuclease PMS2 OS=Gallus gallus OX=9031 GN=PMS2 PE=2 SV=3 PMS2_CHICK reviewed Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2) Gallus gallus (Chicken) GO:0003697; GO:0004519; GO:0005524; GO:0005654; GO:0005829; GO:0006298; GO:0007095; GO:0016446; GO:0016447; GO:0016887; GO:0030890; GO:0032138; GO:0032389; GO:0032407; GO:0048298; GO:0048304; GO:0140664 mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447] cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; endonuclease activity [GO:0004519]; MutSalpha complex binding [GO:0032407]; single base insertion or deletion binding [GO:0032138]; single-stranded DNA binding [GO:0003697] g16171.t1 Q8VBT9 48.276 174 8.089999999999999e-42 163.0 sp|Q8VBT9|ASPC1_MOUSE Tether containing UBX domain for GLUT4 OS=Mus musculus OX=10090 GN=Aspscr1 PE=1 SV=1 g16171.t1 Q8VBT9 40.351 228 2.83e-38 152.0 sp|Q8VBT9|ASPC1_MOUSE Tether containing UBX domain for GLUT4 OS=Mus musculus OX=10090 GN=Aspscr1 PE=1 SV=1 g16172.t1 Q99758 44.302 1799 0.0 1472.0 sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2 ABCA3_HUMAN reviewed Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form] Homo sapiens (Human) GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140 lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019] g16173.t1 Q9UNK0 40.807 223 1.36e-41 145.0 sp|Q9UNK0|STX8_HUMAN Syntaxin-8 OS=Homo sapiens OX=9606 GN=STX8 PE=1 SV=2 STX8_HUMAN reviewed Syntaxin-8 Homo sapiens (Human) GO:0000149; GO:0005484; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005802; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0019869; GO:0019905; GO:0031201; GO:0031625; GO:0031982; GO:0045022; GO:0045335; GO:0048278; GO:0048471; GO:0055037; GO:0071346; GO:1903076 cellular response to type II interferon [GO:0071346]; early endosome to late endosome transport [GO:0045022]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625] g16174.t1 O95631 61.462 602 0.0 776.0 sp|O95631|NET1_HUMAN Netrin-1 OS=Homo sapiens OX=9606 GN=NTN1 PE=1 SV=2 NET1_HUMAN reviewed Netrin-1 (Epididymis tissue protein Li 131P) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0014009; GO:0015629; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147 anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; regulation of transcription by RNA polymerase II [GO:0006357]; substrate-dependent cell migration, cell extension [GO:0006930] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16174.t2 O95631 61.77 599 0.0 777.0 sp|O95631|NET1_HUMAN Netrin-1 OS=Homo sapiens OX=9606 GN=NTN1 PE=1 SV=2 NET1_HUMAN reviewed Netrin-1 (Epididymis tissue protein Li 131P) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0014009; GO:0015629; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147 anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; regulation of transcription by RNA polymerase II [GO:0006357]; substrate-dependent cell migration, cell extension [GO:0006930] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16174.t3 O95631 63.527 584 0.0 787.0 sp|O95631|NET1_HUMAN Netrin-1 OS=Homo sapiens OX=9606 GN=NTN1 PE=1 SV=2 NET1_HUMAN reviewed Netrin-1 (Epididymis tissue protein Li 131P) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0014009; GO:0015629; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147 anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; regulation of transcription by RNA polymerase II [GO:0006357]; substrate-dependent cell migration, cell extension [GO:0006930] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16175.t1 Q7JQ32 41.705 1079 0.0 791.0 sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1 GC76C_DROME reviewed Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1) Drosophila melanogaster (Fruit fly) GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830 axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435] plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023] g16178.t1 Q07553 42.636 1032 0.0 775.0 sp|Q07553|GCY3E_DROME Guanylate cyclase 32E OS=Drosophila melanogaster OX=7227 GN=Gyc32E PE=1 SV=4 g16179.t1 P82861 55.487 483 0.0 545.0 sp|P82861|ADRO_SALFO NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Salvelinus fontinalis OX=8038 GN=fdxr PE=2 SV=1 g16180.t1 Q6DFD7 71.038 183 4.06e-98 286.0 sp|Q6DFD7|B9D1_XENLA B9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=b9d1 PE=2 SV=1 g16187.t1 Q9NXV2 79.29 169 1.8e-96 283.0 sp|Q9NXV2|KCTD5_HUMAN BTB/POZ domain-containing protein KCTD5 OS=Homo sapiens OX=9606 GN=KCTD5 PE=1 SV=1 KCTD5_HUMAN reviewed BTB/POZ domain-containing protein KCTD5 Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] g16188.t1 O55173 60.261 536 0.0 632.0 sp|O55173|PDPK1_RAT 3-phosphoinositide-dependent protein kinase 1 OS=Rattus norvegicus OX=10116 GN=Pdpk1 PE=1 SV=2 PDPK1_RAT reviewed 3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) (Protein kinase B kinase) (PkB kinase) Rattus norvegicus (Rat) GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006972; GO:0007173; GO:0008286; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0019722; GO:0019901; GO:0030512; GO:0031410; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043491; GO:0043524; GO:0043536; GO:0045766; GO:0048009; GO:0048041; GO:0051281; GO:0051897; GO:0071364; GO:0097191; GO:0106310; GO:0141124; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352 calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; intracellular signaling cassette [GO:0141124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of endothelial cell migration [GO:0010594]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16200.t1 Q29611 41.084 443 1.35e-103 318.0 sp|Q29611|CLN3_CANLF Battenin OS=Canis lupus familiaris OX=9615 GN=CLN3 PE=3 SV=1 CLN3_CANLF reviewed Battenin (Protein CLN3) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0016020; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288 amyloid precursor protein catabolic process [GO:0042987]; autophagosome-lysosome fusion [GO:0061909]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; intracellular water homeostasis [GO:0009992]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496] autolysosome [GO:0044754]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146] g16201.t1 P0DMN0 40.351 285 2.92e-66 213.0 sp|P0DMN0|ST1A4_HUMAN Sulfotransferase 1A4 OS=Homo sapiens OX=9606 GN=SULT1A4 PE=1 SV=1 ST1A4_HUMAN reviewed Sulfotransferase 1A4 (ST1A4) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005829; GO:0008146; GO:0008202; GO:0042403; GO:0042414; GO:0042415; GO:0042417; GO:0042428; GO:0051923 dopamine metabolic process [GO:0042417]; epinephrine metabolic process [GO:0042414]; norepinephrine metabolic process [GO:0042415]; serotonin metabolic process [GO:0042428]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g16203.t1 Q8JG30 42.125 273 1.19e-71 227.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g16211.t1 Q6IMI6 41.812 287 5.2e-68 218.0 sp|Q6IMI6|ST1C3_HUMAN Sulfotransferase 1C3 OS=Homo sapiens OX=9606 GN=SULT1C3 PE=1 SV=1 ST1C3_HUMAN reviewed Sulfotransferase 1C3 (ST1C3) (EC 2.8.2.1) (EC 2.8.2.2) Homo sapiens (Human) GO:0004027; GO:0004062; GO:0005737; GO:0006629; GO:0006790; GO:0006805; GO:0008203; GO:0047704; GO:0050427; GO:0050656; GO:0051923 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; sulfation [GO:0051923]; sulfur compound metabolic process [GO:0006790]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; alcohol sulfotransferase activity [GO:0004027]; aryl sulfotransferase activity [GO:0004062]; bile-salt sulfotransferase activity [GO:0047704] g16213.t1 P19217 39.085 284 7.92e-67 214.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g16216.t1 Q6ZSM3 25.641 390 1.8e-31 130.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g16219.t1 Q9TSV7 32.796 372 1.24e-36 139.0 sp|Q9TSV7|IKBL1_PIG NF-kappa-B inhibitor-like protein 1 OS=Sus scrofa OX=9823 GN=NFKBIL1 PE=3 SV=1 g16220.t1 Q91V92 40.333 781 0.0 600.0 sp|Q91V92|ACLY_MOUSE ATP-citrate synthase OS=Mus musculus OX=10090 GN=Acly PE=1 SV=1 ACLY_MOUSE reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme) Mus musculus (Mouse) GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0036064; GO:0046872; GO:0071616; GO:0110076; GO:2001295 acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; acyl-CoA biosynthetic process [GO:0071616]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g16220.t2 Q91V92 40.385 780 0.0 604.0 sp|Q91V92|ACLY_MOUSE ATP-citrate synthase OS=Mus musculus OX=10090 GN=Acly PE=1 SV=1 ACLY_MOUSE reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme) Mus musculus (Mouse) GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0036064; GO:0046872; GO:0071616; GO:0110076; GO:2001295 acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; acyl-CoA biosynthetic process [GO:0071616]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g16223.t1 P49109 38.716 545 1.3700000000000001e-132 399.0 sp|P49109|FMO5_CAVPO Flavin-containing monooxygenase 5 OS=Cavia porcellus OX=10141 GN=FMO5 PE=1 SV=2 g16226.t1 Q7SXM7 67.131 502 0.0 642.0 sp|Q7SXM7|PRP31_DANRE U4/U6 small nuclear ribonucleoprotein Prp31 OS=Danio rerio OX=7955 GN=prpf31 PE=2 SV=1 PRP31_DANRE reviewed U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000244; GO:0000381; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0060041; GO:0071005; GO:0071011; GO:0071339; GO:0097526 mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244] Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690] U4atac snRNA binding [GO:0030622] g16227.t1 Q7T2A5 67.033 546 0.0 782.0 sp|Q7T2A5|EIF3L_DANRE Eukaryotic translation initiation factor 3 subunit L OS=Danio rerio OX=7955 GN=eif3l PE=2 SV=1 g16228.t1 Q13442 47.826 138 7.289999999999999e-30 110.0 sp|Q13442|HAP28_HUMAN 28 kDa heat- and acid-stable phosphoprotein OS=Homo sapiens OX=9606 GN=PDAP1 PE=1 SV=1 g16229.t1 P13804 68.639 338 3.0499999999999996e-170 479.0 sp|P13804|ETFA_HUMAN Electron transfer flavoprotein subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=ETFA PE=1 SV=1 ETFA_HUMAN reviewed Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0022904; GO:0033539; GO:0045251; GO:0050660 amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491] g16230.t1 P23098 84.083 4467 0.0 7922.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g16231.t1 D4A734 26.076 395 9.440000000000001e-26 111.0 sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1 MOT12_RAT reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Rattus norvegicus (Rat) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g16235.t1 Q9QYZ9 37.919 298 4.9700000000000003e-51 183.0 sp|Q9QYZ9|PRS30_MOUSE Serine protease 30 OS=Mus musculus OX=10090 GN=Prss30 PE=2 SV=2 g16238.t1 Q9W6G7 32.265 437 4.960000000000001e-72 237.0 sp|Q9W6G7|DPOG2_XENLA DNA polymerase subunit gamma-2, mitochondrial OS=Xenopus laevis OX=8355 GN=polg2 PE=1 SV=1 g16239.t1 A8DZE7 48.315 356 8.95e-113 338.0 sp|A8DZE7|D42E1_DANRE Short-chain dehydrogenase/reductase family 42E member 1 OS=Danio rerio OX=7955 GN=sdr42e1 PE=2 SV=1 g16241.t1 Q8BJ51 52.315 216 8.130000000000001e-66 213.0 sp|Q8BJ51|MFS11_MOUSE UNC93-like protein MFSD11 OS=Mus musculus OX=10090 GN=Mfsd11 PE=1 SV=1 g16243.t1 O43934 55.157 223 6.76e-82 254.0 sp|O43934|MFS11_HUMAN UNC93-like protein MFSD11 OS=Homo sapiens OX=9606 GN=MFSD11 PE=1 SV=2 g16245.t1 Q29S14 52.885 208 5.84e-77 233.0 sp|Q29S14|TV23B_BOVIN Golgi apparatus membrane protein TVP23 homolog B OS=Bos taurus OX=9913 GN=TVP23B PE=2 SV=1 g16245.t2 Q29S14 53.202 203 9.65e-76 229.0 sp|Q29S14|TV23B_BOVIN Golgi apparatus membrane protein TVP23 homolog B OS=Bos taurus OX=9913 GN=TVP23B PE=2 SV=1 g16246.t1 P07207 42.498 1273 0.0 988.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 40.319 1317 0.0 941.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 40.44 1318 0.0 930.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 40.982 1242 0.0 925.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 39.966 1176 0.0 832.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 37.164 931 3.95e-168 578.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 39.099 821 1.04e-159 553.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 39.192 421 5.25e-69 263.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 38.914 442 1.23e-65 252.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 37.264 424 5.98e-64 246.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 38.318 428 1.24e-61 239.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 37.448 478 2.6099999999999997e-61 238.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 36.17 470 4.18e-61 237.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 36.674 469 3.81e-59 231.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 35.669 471 3.32e-55 218.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 36.658 371 2.53e-49 198.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 35.025 394 1.91e-48 195.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t1 P07207 35.016 317 2.8e-38 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 42.498 1273 0.0 987.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 40.319 1317 0.0 941.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 40.44 1318 0.0 930.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 40.982 1242 0.0 924.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 39.966 1176 0.0 832.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 37.164 931 3.13e-168 578.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 39.099 821 7.42e-160 553.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 39.895 381 9.62e-64 246.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 38.421 380 4.6900000000000005e-59 230.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 39.793 387 3.1000000000000003e-58 228.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 35.682 440 5.89e-58 226.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 36.923 390 1.0600000000000001e-56 223.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 35.897 429 3.07e-52 208.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 37.789 389 1.11e-51 206.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 35.516 397 4.32e-50 201.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 36.99 392 1.09e-49 199.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 36.658 371 2.43e-49 198.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t2 P07207 34.916 358 1.74e-40 169.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 42.498 1273 0.0 989.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 40.319 1317 0.0 942.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 40.44 1318 0.0 931.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 40.982 1242 0.0 926.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 39.966 1176 0.0 833.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 37.164 931 1.7299999999999998e-168 579.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 38.956 824 5.27e-160 554.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 39.192 421 3.9099999999999997e-69 263.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 38.914 442 9.42e-66 252.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 37.264 424 5.2900000000000005e-64 246.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 38.318 428 9.18e-62 239.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 37.448 478 1.7e-61 238.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 36.17 470 3.1199999999999996e-61 238.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 36.674 469 3.12e-59 231.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 35.669 471 2.5699999999999998e-55 218.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 36.658 371 1.93e-49 199.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 35.025 394 1.5399999999999998e-48 196.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16246.t3 P07207 35.016 317 2.32e-38 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16247.t1 Q9NXH9 50.645 543 0.0 555.0 sp|Q9NXH9|TRM1_HUMAN tRNA (guanine(26)-N(2))-dimethyltransferase OS=Homo sapiens OX=9606 GN=TRMT1 PE=1 SV=1 g16248.t1 Q80W66 34.409 279 1.7e-43 161.0 sp|Q80W66|HS3S2_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 2 OS=Rattus norvegicus OX=10116 GN=Hs3st2 PE=1 SV=1 g16248.t2 Q80W66 34.409 279 1.74e-43 161.0 sp|Q80W66|HS3S2_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 2 OS=Rattus norvegicus OX=10116 GN=Hs3st2 PE=1 SV=1 g16249.t1 P83871 99.091 110 1.4299999999999999e-74 219.0 sp|P83871|PHF5A_RAT PHD finger-like domain-containing protein 5A OS=Rattus norvegicus OX=10116 GN=Phf5a PE=2 SV=1 PHF5A_RAT reviewed PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b) Rattus norvegicus (Rat) GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011 mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863] nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g16251.t1 Q06248 79.403 636 0.0 1062.0 sp|Q06248|HSP74_PARLI Heat shock 70 kDa protein IV OS=Paracentrotus lividus OX=7656 GN=HSP70IV PE=3 SV=1 g16252.t1 Q4R8G6 41.758 455 4.8599999999999996e-119 360.0 sp|Q4R8G6|MEIOB_MACFA Meiosis-specific with OB domain-containing protein OS=Macaca fascicularis OX=9541 GN=MEIOB PE=2 SV=1 MEIOB_MACFA reviewed Meiosis-specific with OB domain-containing protein (EC 3.1.-.-) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000712; GO:0000724; GO:0003682; GO:0003697; GO:0005634; GO:0005694; GO:0005737; GO:0007129; GO:0007140; GO:0007144; GO:0008310; GO:0009566 double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin binding [GO:0003682]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697] g16253.t1 Q9CYI0 34.739 403 6.990000000000001e-64 213.0 sp|Q9CYI0|NJMU_MOUSE Protein Njmu-R1 OS=Mus musculus OX=10090 PE=1 SV=2 g16254.t1 Q66JJ3 44.411 331 1.4e-89 275.0 sp|Q66JJ3|ADPRM_XENTR Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Xenopus tropicalis OX=8364 GN=adprm PE=2 SV=1 g16255.t1 O43303 29.655 435 4.96e-36 151.0 sp|O43303|CP110_HUMAN Centriolar coiled-coil protein of 110 kDa OS=Homo sapiens OX=9606 GN=CCP110 PE=1 SV=3 CP110_HUMAN reviewed Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (CP110) (Cep110) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018 centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] microtubule binding [GO:0008017] g16255.t2 O43303 29.977 437 3.94e-36 152.0 sp|O43303|CP110_HUMAN Centriolar coiled-coil protein of 110 kDa OS=Homo sapiens OX=9606 GN=CCP110 PE=1 SV=3 CP110_HUMAN reviewed Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (CP110) (Cep110) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018 centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] microtubule binding [GO:0008017] g16260.t1 Q8C2A2 39.884 173 5.76e-32 131.0 sp|Q8C2A2|SEN54_MOUSE tRNA-splicing endonuclease subunit Sen54 OS=Mus musculus OX=10090 GN=Tsen54 PE=2 SV=2 g16261.t1 G3C7W6 41.638 586 2.92e-140 424.0 sp|G3C7W6|S2611_CAVPO Sodium-independent sulfate anion transporter OS=Cavia porcellus OX=10141 GN=Slc26a11 PE=2 SV=1 S2611_CAVPO reviewed Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11) Cavia porcellus (Guinea pig) GO:0005254; GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0008271; GO:0016323; GO:0016324; GO:0019532; GO:0140900; GO:1902358 oxalate transport [GO:0019532]; sulfate transmembrane transport [GO:1902358] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; chloride:bicarbonate antiporter activity [GO:0140900]; secondary active sulfate transmembrane transporter activity [GO:0008271] g16262.t1 Q0P5N6 47.34 188 8.509999999999999e-52 167.0 sp|Q0P5N6|ARL16_HUMAN ADP-ribosylation factor-like protein 16 OS=Homo sapiens OX=9606 GN=ARL16 PE=1 SV=1 ARL16_HUMAN reviewed ADP-ribosylation factor-like protein 16 Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005737 cytoplasm [GO:0005737] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g16263.t1 Q99LI8 46.77 836 0.0 627.0 sp|Q99LI8|HGS_MOUSE Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Mus musculus OX=10090 GN=Hgs PE=1 SV=2 HGS_MOUSE reviewed Hepatocyte growth factor-regulated tyrosine kinase substrate Mus musculus (Mouse) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0008270; GO:0008333; GO:0010324; GO:0010628; GO:0010642; GO:0016525; GO:0019904; GO:0030141; GO:0030948; GO:0031623; GO:0031901; GO:0032456; GO:0032585; GO:0033565; GO:0035091; GO:0042802; GO:0043130; GO:0044389; GO:0046426; GO:0072657; GO:0140036; GO:1903543 endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; receptor internalization [GO:0031623] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; secretory granule [GO:0030141] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270] g16264.t1 Q8NFI3 37.448 721 5.86e-151 460.0 sp|Q8NFI3|ENASE_HUMAN Cytosolic endo-beta-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=ENGASE PE=1 SV=1 g16265.t1 P98161 22.222 702 2.19e-23 112.0 sp|P98161|PKD1_HUMAN Polycystin-1 OS=Homo sapiens OX=9606 GN=PKD1 PE=1 SV=3 PKD1_HUMAN reviewed Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein) Homo sapiens (Human) GO:0000139; GO:0001502; GO:0001701; GO:0001822; GO:0001889; GO:0001892; GO:0002133; GO:0005262; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006611; GO:0006816; GO:0007156; GO:0007160; GO:0007161; GO:0007166; GO:0007204; GO:0007259; GO:0007507; GO:0009653; GO:0009986; GO:0016020; GO:0016055; GO:0016323; GO:0016328; GO:0019901; GO:0019904; GO:0021510; GO:0021915; GO:0030010; GO:0030155; GO:0030246; GO:0030660; GO:0031514; GO:0034405; GO:0034703; GO:0034704; GO:0036303; GO:0042813; GO:0043588; GO:0044325; GO:0045944; GO:0048565; GO:0048754; GO:0048806; GO:0050982; GO:0051216; GO:0051290; GO:0051726; GO:0060170; GO:0060236; GO:0060428; GO:0060674; GO:0061136; GO:0070062; GO:0070588; GO:0071941; GO:0072164; GO:0072177; GO:0072205; GO:0072218; GO:0072237; GO:0072287; GO:0140416; GO:0140494; GO:0160040; GO:2000045 anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of cell polarity [GO:0030010]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; mitocytosis [GO:0160040]; neural tube development [GO:0021915]; nitrogen cycle metabolic process [GO:0071941]; placenta blood vessel development [GO:0060674]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510]; Wnt signaling pathway [GO:0016055] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; migrasome [GO:0140494]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133] calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription regulator inhibitor activity [GO:0140416]; transmembrane transporter binding [GO:0044325]; Wnt receptor activity [GO:0042813] g16266.t1 Q7TN88 30.325 953 1.1699999999999999e-91 337.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g16266.t1 Q7TN88 27.326 688 1.02e-75 285.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g16267.t1 P14604 69.663 267 1.07e-137 393.0 sp|P14604|ECHM_RAT Enoyl-CoA hydratase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Echs1 PE=1 SV=1 ECHM_RAT reviewed Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH) Rattus norvegicus (Rat) GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092 fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (2E)-butenoyl-CoA hydratase activity [GO:0120092]; 3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300] g16268.t1 Q4GZT3 31.364 220 6.820000000000001e-31 127.0 sp|Q4GZT3|PKD2_BOVIN Polycystin-2 OS=Bos taurus OX=9913 GN=PKD2 PE=2 SV=1 PKD2_BOVIN reviewed Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2) Bos taurus (Bovine) GO:0001822; GO:0001889; GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006813; GO:0006814; GO:0006816; GO:0007166; GO:0007368; GO:0007507; GO:0015271; GO:0016020; GO:0016323; GO:0030659; GO:0034703; GO:0036064; GO:0043009; GO:0045180; GO:0045429; GO:0048568; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0061333; GO:0070062; GO:0070588; GO:0071277; GO:0071498; GO:0071805; GO:0072686; GO:0098662; GO:0140494 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; chordate embryonic development [GO:0043009]; detection of mechanical stimulus [GO:0050982]; determination of left/right symmetry [GO:0007368]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; liver development [GO:0001889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; renal tubule morphogenesis [GO:0061333]; sodium ion transport [GO:0006814] basal cortex [GO:0045180]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; migrasome [GO:0140494]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248] g16269.t1 Q8BH95 67.87 277 1.5199999999999999e-137 393.0 sp|Q8BH95|ECHM_MOUSE Enoyl-CoA hydratase, mitochondrial OS=Mus musculus OX=10090 GN=Echs1 PE=1 SV=1 ECHM_MOUSE reviewed Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH) Mus musculus (Mouse) GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092 fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] (2E)-butenoyl-CoA hydratase activity [GO:0120092]; 3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300] g16271.t1 Q5ZL16 80.523 344 0.0 599.0 sp|Q5ZL16|WIPI3_CHICK WD repeat domain phosphoinositide-interacting protein 3 OS=Gallus gallus OX=9031 GN=WDR45B PE=2 SV=1 WIPI3_CHICK reviewed WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45B) Gallus gallus (Chicken) GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005764; GO:0005829; GO:0009267; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025 autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-macromolecule adaptor activity [GO:0030674] g16273.t1 Q7Z5P9 27.846 729 1.03e-41 174.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.11 619 1.82e-41 173.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.951 639 7.499999999999999e-40 168.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.084 557 1.14e-39 167.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 30.274 621 2.1e-39 166.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 30.017 573 2.8099999999999997e-38 162.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 30.481 561 3.96e-38 162.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 27.053 828 6.339999999999999e-38 161.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.517 559 6.5e-38 161.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 31.065 573 7.13e-38 161.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.353 603 8.94e-38 161.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 30.619 565 1.89e-37 160.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.877 569 5.24e-37 158.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.257 637 5.660000000000001e-37 158.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 25.637 667 9.12e-37 157.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 25.483 777 9.75e-37 157.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 27.032 566 1e-36 157.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.46 805 1.3200000000000001e-36 157.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.527 645 1.74e-36 157.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.28 625 2.13e-36 156.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.814 590 2.95e-36 156.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.73 636 3.21e-36 155.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.531 588 3.86e-36 155.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.976 635 5.53e-36 155.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.352 522 6.07e-36 155.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.189 555 7.240000000000001e-36 154.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.369 555 1.4e-35 154.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 29.735 565 2.34e-35 153.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 27.477 757 2.48e-35 153.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.884 584 2.91e-35 152.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 27.531 563 4.4700000000000005e-35 152.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 27.994 618 2.18e-34 150.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.838 585 2.56e-34 149.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.988 583 9.689999999999999e-34 147.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 24.694 571 1.09e-33 147.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 23.618 868 1.1400000000000001e-33 147.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.079 579 1.45e-33 147.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 28.482 639 2.01e-33 146.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.343 577 3.53e-33 145.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 25.039 643 1.23e-32 144.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 24.966 741 1.66e-32 144.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.75 643 3.91e-32 142.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.496 702 1.9600000000000001e-31 140.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 25.036 699 2.03e-30 137.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 24.228 615 4.28e-30 135.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.115 628 5.8399999999999995e-30 135.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 24.578 533 1.32e-29 134.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 27.531 563 1.7800000000000001e-29 134.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 25.44 511 1.7800000000000001e-29 134.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16273.t1 Q7Z5P9 26.325 547 3.69e-29 132.0 sp|Q7Z5P9|MUC19_HUMAN Mucin-19 OS=Homo sapiens OX=9606 GN=MUC19 PE=1 SV=3 MUC19_HUMAN reviewed Mucin-19 (MUC-19) Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886 extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] g16275.t1 P49219 27.554 323 1.5400000000000002e-27 115.0 sp|P49219|MTR1C_XENLA Melatonin receptor type 1C OS=Xenopus laevis OX=8355 GN=mtnr1c PE=2 SV=1 g16277.t1 P10587 62.043 1968 0.0 2400.0 sp|P10587|MYH11_CHICK Myosin-11 OS=Gallus gallus OX=9031 GN=MYH11 PE=1 SV=4 g16277.t2 P10587 62.099 1963 0.0 2399.0 sp|P10587|MYH11_CHICK Myosin-11 OS=Gallus gallus OX=9031 GN=MYH11 PE=1 SV=4 g16278.t1 Q7Z5J4 31.439 264 3.9800000000000003e-29 130.0 sp|Q7Z5J4|RAI1_HUMAN Retinoic acid-induced protein 1 OS=Homo sapiens OX=9606 GN=RAI1 PE=1 SV=2 RAI1_HUMAN reviewed Retinoic acid-induced protein 1 Homo sapiens (Human) GO:0001501; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0008270; GO:0032922; GO:0040015; GO:0045893 circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] zinc ion binding [GO:0008270] g16279.t1 P49816 39.634 1365 0.0 935.0 sp|P49816|TSC2_RAT Tuberin OS=Rattus norvegicus OX=10116 GN=Tsc2 PE=1 SV=1 g16279.t1 P49816 44.501 391 3.68e-89 327.0 sp|P49816|TSC2_RAT Tuberin OS=Rattus norvegicus OX=10116 GN=Tsc2 PE=1 SV=1 g16279.t2 P49816 39.634 1365 0.0 935.0 sp|P49816|TSC2_RAT Tuberin OS=Rattus norvegicus OX=10116 GN=Tsc2 PE=1 SV=1 g16279.t2 P49816 44.501 391 2.2799999999999997e-89 328.0 sp|P49816|TSC2_RAT Tuberin OS=Rattus norvegicus OX=10116 GN=Tsc2 PE=1 SV=1 g16280.t1 Q9BVH7 39.592 245 5.4299999999999995e-48 168.0 sp|Q9BVH7|SIA7E_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Homo sapiens OX=9606 GN=ST6GALNAC5 PE=1 SV=1 g16284.t1 A2ARI4 29.74 269 1.1699999999999998e-23 111.0 sp|A2ARI4|LGR4_MOUSE Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Mus musculus OX=10090 GN=Lgr4 PE=1 SV=1 LGR4_MOUSE reviewed Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48) Mus musculus (Mouse) GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0005886; GO:0007186; GO:0007283; GO:0007411; GO:0007623; GO:0008201; GO:0016055; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0035239; GO:0036335; GO:0045087; GO:0046849; GO:0048495; GO:0048565; GO:0050673; GO:0050919; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013 axon guidance [GO:0007411]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestive tract development [GO:0048565]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative chemotaxis [GO:0050919]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; spermatogenesis [GO:0007283]; tube morphogenesis [GO:0035239]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888] g6867.t1 P81458 38.519 135 1.29e-21 87.8 sp|P81458|PA2B_DABRR Basic phospholipase A2 RVV-VD OS=Daboia russelii OX=8707 PE=1 SV=1 g6871.t1 Q571H0 29.412 833 6.01e-85 314.0 sp|Q571H0|NPA1P_MOUSE Nucleolar pre-ribosomal-associated protein 1 OS=Mus musculus OX=10090 GN=Urb1 PE=1 SV=2 g6871.t1 Q571H0 36.752 468 1.62e-75 283.0 sp|Q571H0|NPA1P_MOUSE Nucleolar pre-ribosomal-associated protein 1 OS=Mus musculus OX=10090 GN=Urb1 PE=1 SV=2 g6872.t1 Q99741 45.255 548 3.76e-148 443.0 sp|Q99741|CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens OX=9606 GN=CDC6 PE=1 SV=1 CDC6_HUMAN reviewed Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6) Homo sapiens (Human) GO:0000076; GO:0000079; GO:0000166; GO:0000922; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:0120283; GO:1904117; GO:1904385 cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; protein serine/threonine kinase binding [GO:0120283] g6872.t2 Q99741 47.876 518 8.83e-151 449.0 sp|Q99741|CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens OX=9606 GN=CDC6 PE=1 SV=1 CDC6_HUMAN reviewed Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6) Homo sapiens (Human) GO:0000076; GO:0000079; GO:0000166; GO:0000922; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:0120283; GO:1904117; GO:1904385 cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; protein serine/threonine kinase binding [GO:0120283] g6874.t1 Q86TI4 43.658 339 6.13e-107 326.0 sp|Q86TI4|WDR86_HUMAN WD repeat-containing protein 86 OS=Homo sapiens OX=9606 GN=WDR86 PE=2 SV=3 g6877.t1 P80146 35.696 395 1.64e-59 201.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g6878.t1 P62071 68.844 199 1.98e-89 264.0 sp|P62071|RRAS2_MOUSE Ras-related protein R-Ras2 OS=Mus musculus OX=10090 GN=Rras2 PE=1 SV=1 g6879.t1 P53352 37.126 501 6.25e-58 219.0 sp|P53352|INCE_CHICK Inner centromere protein OS=Gallus gallus OX=9031 GN=INCENP PE=1 SV=1 g6879.t2 P53352 38.641 471 1.19e-59 224.0 sp|P53352|INCE_CHICK Inner centromere protein OS=Gallus gallus OX=9031 GN=INCENP PE=1 SV=1 g6879.t3 P53352 34.393 535 2.63e-52 202.0 sp|P53352|INCE_CHICK Inner centromere protein OS=Gallus gallus OX=9031 GN=INCENP PE=1 SV=1 g6880.t1 Q5ZIA5 77.077 951 0.0 1543.0 sp|Q5ZIA5|COPB_CHICK Coatomer subunit beta OS=Gallus gallus OX=9031 GN=COPB1 PE=2 SV=1 COPB_CHICK reviewed Coatomer subunit beta (Beta-coat protein) (Beta-COP) Gallus gallus (Chicken) GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139] structural molecule activity [GO:0005198] g6882.t1 Q3T0V9 68.025 319 4.82e-168 472.0 sp|Q3T0V9|DEOC_BOVIN Deoxyribose-phosphate aldolase OS=Bos taurus OX=9913 GN=DERA PE=2 SV=1 g6883.t1 Q9NPI0 60.993 141 3.08e-58 181.0 sp|Q9NPI0|TM138_HUMAN Transmembrane protein 138 OS=Homo sapiens OX=9606 GN=TMEM138 PE=1 SV=1 g6883.t2 Q9NPI0 56.579 152 9.39e-55 173.0 sp|Q9NPI0|TM138_HUMAN Transmembrane protein 138 OS=Homo sapiens OX=9606 GN=TMEM138 PE=1 SV=1 g6884.t1 P16273 30.698 215 1.21e-22 94.7 sp|P16273|PRPX_HORVU Pathogen-related protein OS=Hordeum vulgare OX=4513 PE=2 SV=2 g6885.t1 P16257 40.606 165 1e-38 132.0 sp|P16257|TSPO_RAT Translocator protein OS=Rattus norvegicus OX=10116 GN=Tspo PE=1 SV=1 TSPO_RAT reviewed Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR) Rattus norvegicus (Rat) GO:0005497; GO:0005739; GO:0005741; GO:0005829; GO:0006694; GO:0006811; GO:0006821; GO:0006869; GO:0008347; GO:0008503; GO:0009410; GO:0010042; GO:0010266; GO:0014012; GO:0016020; GO:0030325; GO:0031397; GO:0032570; GO:0032720; GO:0033574; GO:0042632; GO:0043065; GO:0044325; GO:0045019; GO:0048265; GO:0048266; GO:0048678; GO:0050810; GO:0051901; GO:0051928; GO:0060242; GO:0060252; GO:0060253; GO:0062100; GO:0071222; GO:0071294; GO:0071476; GO:0072655; GO:0072656; GO:1901525; GO:1903579; GO:1905144; GO:2000379; GO:2000853 adrenal gland development [GO:0030325]; behavioral response to pain [GO:0048266]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; cholesterol homeostasis [GO:0042632]; contact inhibition [GO:0060242]; establishment of protein localization to mitochondrion [GO:0072655]; glial cell migration [GO:0008347]; lipid transport [GO:0006869]; maintenance of protein location in mitochondrion [GO:0072656]; monoatomic ion transport [GO:0006811]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of corticosterone secretion [GO:2000853]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitophagy [GO:1901525]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of steroid biosynthetic process [GO:0050810]; response to acetylcholine [GO:1905144]; response to axon injury [GO:0048678]; response to manganese ion [GO:0010042]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; response to xenobiotic stimulus [GO:0009410]; steroid biosynthetic process [GO:0006694] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; transmembrane transporter binding [GO:0044325] g6886.t1 Q9NP50 45.299 234 1.01e-57 187.0 sp|Q9NP50|SHCAF_HUMAN SIN3-HDAC complex-associated factor OS=Homo sapiens OX=9606 GN=SINHCAF PE=1 SV=1 SHCAF_HUMAN reviewed SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein homolog) Homo sapiens (Human) GO:0000122; GO:0005634; GO:0008284; GO:0030336; GO:0030512; GO:0045596; GO:0070822; GO:1902455; GO:1902459 negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459] nucleus [GO:0005634]; Sin3-type complex [GO:0070822] g6887.t1 Q5H9R7 46.867 798 0.0 713.0 sp|Q5H9R7|PP6R3_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Homo sapiens OX=9606 GN=PPP6R3 PE=1 SV=2 PP6R3_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0009966; GO:0019888; GO:0019903 regulation of signal transduction [GO:0009966] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] g6887.t2 Q5H9R7 46.46 805 0.0 707.0 sp|Q5H9R7|PP6R3_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Homo sapiens OX=9606 GN=PPP6R3 PE=1 SV=2 PP6R3_HUMAN reviewed Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0009966; GO:0019888; GO:0019903 regulation of signal transduction [GO:0009966] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] g6887.t3 Q6NRI0 47.594 748 0.0 689.0 sp|Q6NRI0|P6R3A_XENLA Serine/threonine-protein phosphatase 6 regulatory subunit 3-A OS=Xenopus laevis OX=8355 GN=ppp6r3-a PE=2 SV=1 g6888.t1 A0A096X8J7 44.5 1200 0.0 943.0 sp|A0A096X8J7|B3A3_DANRE Anion exchange protein 3 OS=Danio rerio OX=7955 GN=Slc4a3 PE=2 SV=1 B3A3_DANRE reviewed Anion exchange protein 3 (AE 3) (Solute carrier family 4 member 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005452; GO:0005886; GO:0008509; GO:0015701; GO:0022857; GO:0051453; GO:0055085; GO:0086001 bicarbonate transport [GO:0015701]; cardiac muscle cell action potential [GO:0086001]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] plasma membrane [GO:0005886] monoatomic anion transmembrane transporter activity [GO:0008509]; solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857] g6888.t2 A0A096X8J7 45.47 1159 0.0 942.0 sp|A0A096X8J7|B3A3_DANRE Anion exchange protein 3 OS=Danio rerio OX=7955 GN=Slc4a3 PE=2 SV=1 B3A3_DANRE reviewed Anion exchange protein 3 (AE 3) (Solute carrier family 4 member 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005452; GO:0005886; GO:0008509; GO:0015701; GO:0022857; GO:0051453; GO:0055085; GO:0086001 bicarbonate transport [GO:0015701]; cardiac muscle cell action potential [GO:0086001]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] plasma membrane [GO:0005886] monoatomic anion transmembrane transporter activity [GO:0008509]; solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857] g6889.t1 P13808 40.538 1041 0.0 714.0 sp|P13808|B3A2_MOUSE Anion exchange protein 2 OS=Mus musculus OX=10090 GN=Slc4a2 PE=1 SV=1 B3A2_MOUSE reviewed Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein) (B3RP) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2) Mus musculus (Mouse) GO:0005886; GO:0006821; GO:0007283; GO:0015108; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0022857; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0055085; GO:0070175; GO:0097186; GO:0140900; GO:2000565 amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; positive regulation of enamel mineralization [GO:0070175]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; transmembrane transporter activity [GO:0022857] g6889.t2 P13808 40.538 1041 0.0 714.0 sp|P13808|B3A2_MOUSE Anion exchange protein 2 OS=Mus musculus OX=10090 GN=Slc4a2 PE=1 SV=1 B3A2_MOUSE reviewed Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Band 3-related protein) (B3RP) (Non-erythroid band 3-like protein) (Solute carrier family 4 member 2) Mus musculus (Mouse) GO:0005886; GO:0006821; GO:0007283; GO:0015108; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0019899; GO:0022857; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0055085; GO:0070175; GO:0097186; GO:0140900; GO:2000565 amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; positive regulation of enamel mineralization [GO:0070175]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; transmembrane transporter activity [GO:0022857] g6890.t1 Q6AXQ5 36.741 626 2.72e-130 398.0 sp|Q6AXQ5|PDE12_RAT 2',5'-phosphodiesterase 12 OS=Rattus norvegicus OX=10116 GN=Pde12 PE=2 SV=1 PDE12_RAT reviewed 2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4) Rattus norvegicus (Rat) GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0071346; GO:0071359; GO:0140374 antiviral innate immune response [GO:0140374]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to type II interferon [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3'-5'-RNA exonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535] g6891.t1 A8DYP0 29.609 537 3.0599999999999997e-68 248.0 sp|A8DYP0|OBSCN_DROME Protein Obscurin OS=Drosophila melanogaster OX=7227 GN=Obsc PE=1 SV=1 OBSCN_DROME reviewed Protein Obscurin (Inactive serine/threonine-protein kinase obscurin) (Muscle M-line assembly protein Unc-89) Drosophila melanogaster (Fruit fly) GO:0005085; GO:0005523; GO:0005524; GO:0007527; GO:0019901; GO:0031430; GO:0036309; GO:0045214 adult somatic muscle development [GO:0007527]; protein localization to M-band [GO:0036309]; sarcomere organization [GO:0045214] M band [GO:0031430] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523] g6891.t1 A8DYP0 29.119 261 1.2099999999999999e-30 133.0 sp|A8DYP0|OBSCN_DROME Protein Obscurin OS=Drosophila melanogaster OX=7227 GN=Obsc PE=1 SV=1 OBSCN_DROME reviewed Protein Obscurin (Inactive serine/threonine-protein kinase obscurin) (Muscle M-line assembly protein Unc-89) Drosophila melanogaster (Fruit fly) GO:0005085; GO:0005523; GO:0005524; GO:0007527; GO:0019901; GO:0031430; GO:0036309; GO:0045214 adult somatic muscle development [GO:0007527]; protein localization to M-band [GO:0036309]; sarcomere organization [GO:0045214] M band [GO:0031430] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; tropomyosin binding [GO:0005523] g6892.t1 Q15772 28.089 1303 3.2899999999999996e-134 465.0 sp|Q15772|SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens OX=9606 GN=SPEG PE=1 SV=4 g6892.t1 Q15772 32.624 282 5.74e-42 173.0 sp|Q15772|SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens OX=9606 GN=SPEG PE=1 SV=4 g6893.t1 P29294 45.543 516 6.52e-137 427.0 sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2 g6894.t1 Q86VW2 37.224 317 1.61e-55 207.0 sp|Q86VW2|ARHGP_HUMAN Rho guanine nucleotide exchange factor 25 OS=Homo sapiens OX=9606 GN=ARHGEF25 PE=1 SV=2 ARHGP_HUMAN reviewed Rho guanine nucleotide exchange factor 25 (Guanine nucleotide exchange factor GEFT) (Rac/Cdc42/Rho exchange factor GEFT) (RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT) (p63RhoGEF) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0030016; GO:0030017; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] guanyl-nucleotide exchange factor activity [GO:0005085] g6894.t2 Q86VW2 37.224 317 2.2999999999999998e-55 207.0 sp|Q86VW2|ARHGP_HUMAN Rho guanine nucleotide exchange factor 25 OS=Homo sapiens OX=9606 GN=ARHGEF25 PE=1 SV=2 ARHGP_HUMAN reviewed Rho guanine nucleotide exchange factor 25 (Guanine nucleotide exchange factor GEFT) (Rac/Cdc42/Rho exchange factor GEFT) (RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT) (p63RhoGEF) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0030016; GO:0030017; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] guanyl-nucleotide exchange factor activity [GO:0005085] g6896.t1 O01761 28.646 384 9.04e-25 116.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6897.t1 Q28824 44.774 842 0.0 699.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g6897.t1 Q28824 54.865 370 7.06e-127 436.0 sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1 MYLK_BOVIN reviewed Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] Bos taurus (Bovine) GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872 tonic smooth muscle contraction [GO:0014820] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687] g6898.t1 Q8WZ42 30.235 9942 0.0 3561.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.528 9018 0.0 3206.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 32.096 7652 0.0 3187.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.877 7441 0.0 2966.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 32.024 6670 0.0 2838.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.644 6927 0.0 2791.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.093 7246 0.0 2781.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.374 7044 0.0 2761.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 32.04 6445 0.0 2582.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.399 6462 0.0 2530.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.369 6806 0.0 2529.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.377 6237 0.0 2485.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.814 6166 0.0 2339.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 32.029 5776 0.0 2325.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.281 5409 0.0 2090.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.992 4798 0.0 1853.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.651 4610 0.0 1751.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 34.436 2721 0.0 1523.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.928 4150 0.0 1415.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.404 4010 0.0 1314.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.96 2781 0.0 1022.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.377 2368 0.0 941.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.336 2410 0.0 833.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.37 2081 0.0 811.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.947 2067 0.0 772.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.366 1011 1.07e-106 393.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.937 1109 2.9e-106 392.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.686 1364 1.9599999999999997e-104 386.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.474 950 4.0299999999999994e-104 385.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.971 1041 2.41e-101 375.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.577 1065 1.26e-98 366.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.182 1203 7.049999999999999e-94 351.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.417 1047 1.11e-93 350.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.761 1005 7.54e-89 334.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.454 1093 1.94e-87 329.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.392 1066 1.3999999999999998e-82 313.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.691 955 5.14e-79 301.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.895 950 1.44e-76 293.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.252 714 3.24e-75 289.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.075 805 5.48e-75 288.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.793 969 4.44e-71 275.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.513 1446 6.870000000000001e-70 271.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.367 1461 4.979999999999999e-68 265.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.644 1010 1.02e-67 264.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.896 661 4.9899999999999996e-67 261.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.315 1168 9.91e-66 257.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.123 730 3.61e-65 255.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.312 1488 1.05e-64 254.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.828 1322 4.03e-64 252.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.847 966 2.55e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.91 1471 3.63e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.107 560 8.87e-62 244.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.063 702 1.11e-60 240.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.572 729 1.36e-60 240.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.647 683 9.049999999999999e-60 238.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.515 1479 3.8999999999999995e-55 222.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 21.678 1490 1.31e-54 220.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.037 644 1.9499999999999998e-54 220.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 32.681 511 1.9999999999999998e-54 220.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.982 1214 2.5499999999999998e-54 219.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.161 1278 3.81e-53 215.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.843 1145 3.63e-52 212.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.324 1205 2.38e-50 206.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.606 1148 5.58e-50 205.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.64 1489 5.6700000000000005e-50 205.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.807 664 1.05e-48 201.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.213 1220 1.99e-48 200.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.803 1491 2.6399999999999997e-48 199.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.915 566 4.23e-46 192.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.501 749 2.84e-45 189.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.942 539 4.3399999999999995e-45 189.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.027 565 6.869999999999999e-45 188.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 32.115 383 7.24e-44 185.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.471 1181 9.78e-44 184.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.325 566 2.5799999999999996e-42 179.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.218 486 2.14e-38 166.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.309 498 7.369999999999999e-38 165.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.568 528 9.55e-38 164.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.618 524 2.76e-37 163.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.127 630 2.4600000000000002e-36 160.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.247 507 3.18e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.579 712 5.52e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.333 637 1.2600000000000001e-35 157.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.411 547 1.81e-35 157.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.206 408 2.46e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.601 572 2.5900000000000003e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.805 512 3.03e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.885 628 4.1300000000000004e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.074 594 7.29e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.119 413 7.990000000000001e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 21.645 1155 1.14e-34 154.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.728 412 1.84e-34 153.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.522 431 3.0399999999999997e-34 153.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.768 396 4.81e-34 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.205 566 5.59e-34 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.341 513 8.7e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.048 578 9.61e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.508 559 9.689999999999999e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.248 541 1.46e-33 150.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.112 535 1.57e-33 150.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.733 494 2.85e-33 149.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.856 361 7.01e-33 148.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.131 518 3.48e-32 146.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.619 420 5.200000000000001e-32 145.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.042 480 5.610000000000001e-32 145.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.738 535 1.1e-31 144.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.232 586 1.2e-31 144.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.521 522 4.230000000000001e-31 142.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.19 420 7.4000000000000004e-31 141.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.041 392 8.450000000000001e-31 141.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.401 668 1.27e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 26.891 476 1.82e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.96 621 2.19e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.248 404 4.23e-30 139.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.581 620 7.16e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.506 494 8.33e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.974 390 1.31e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.273 385 1.58e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.832 447 2.75e-29 136.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.409 467 2.79e-29 136.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.384 406 6.77e-29 135.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 21.5 1093 1.2799999999999999e-28 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.41 488 1.53e-28 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 21.39 1122 2.68e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.626 546 3.02e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.843 432 3.12e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 21.251 1247 9.39e-28 131.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 40.588 170 2.2800000000000001e-26 127.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 21.032 504 2.4800000000000002e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.675 604 2.74e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 21.865 622 3.43e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.531 640 5.08e-26 125.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.615 390 1.1e-25 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.515 412 1.81e-25 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.961 409 2.44e-25 123.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.919 393 3.27e-25 123.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.27 445 8.9e-25 121.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.189 265 1.25e-24 121.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 34.091 176 3.4099999999999995e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 29.911 224 5.0099999999999994e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 36.022 186 5.0999999999999995e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.783 258 4.1799999999999995e-23 116.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.112 394 4.5399999999999993e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 32.85 207 5.6e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.991 446 5.98e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 36.471 170 6.669999999999999e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.557 244 9.549999999999999e-23 114.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 36.628 172 1.39e-22 114.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.919 393 2.15e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 22.424 495 2.31e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 23.573 543 2.43e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 33.173 208 2.92e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 38.75 160 3.6000000000000003e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 25.352 355 6.3e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.639 521 7.7e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 27.619 315 1.0100000000000002e-21 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.633 196 1.13e-21 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 24.01 404 1.65e-21 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 35.088 171 1.85e-21 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 28.522 291 3.0500000000000004e-21 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 30.612 196 3.3200000000000002e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.633 196 4.59e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 31.633 196 4.59e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 34.118 170 5.3800000000000005e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 37.5 176 5.5700000000000004e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 34.706 170 6.6300000000000006e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t1 Q8WZ42 35.106 188 8.170000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.785 9485 0.0 3601.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.576 8364 0.0 3338.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.772 8953 0.0 3256.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.271 8193 0.0 3188.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.469 8243 0.0 3167.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.693 7601 0.0 3086.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 32.038 7388 0.0 3032.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 32.024 6670 0.0 2838.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.167 7338 0.0 2836.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.902 6846 0.0 2765.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.291 6887 0.0 2695.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.95 7389 0.0 2617.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.772 6405 0.0 2552.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.377 6237 0.0 2485.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.855 6112 0.0 2456.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.831 6189 0.0 2442.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.177 6585 0.0 2427.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.408 6107 0.0 2216.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.412 5363 0.0 1949.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.992 4798 0.0 1853.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 34.436 2721 0.0 1523.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.377 2368 0.0 941.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.699 2531 0.0 910.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.336 2410 0.0 833.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.456 2085 0.0 811.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.947 2067 0.0 772.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.156 2056 0.0 761.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.366 1011 1.12e-106 393.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.937 1109 3.05e-106 392.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.686 1364 2.1199999999999998e-104 385.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.474 950 4.2499999999999994e-104 385.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.393 1048 3.2300000000000003e-103 382.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.971 1041 2.32e-101 375.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.577 1065 1.21e-98 367.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.182 1203 7.07e-94 351.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.417 1047 1.08e-93 350.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.761 1005 7.56e-89 334.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.136 1148 2.99e-84 319.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.392 1066 1.4199999999999998e-82 313.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.691 955 5.33e-79 301.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.895 950 1.43e-76 293.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.252 714 3.47e-75 288.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.075 805 5.23e-75 288.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.793 969 4.49e-71 275.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.513 1446 7.18e-70 271.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.367 1461 5.2499999999999996e-68 265.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.644 1010 1.02e-67 264.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.896 661 5.04e-67 261.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.315 1168 9.77e-66 257.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.123 730 3.5e-65 255.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.312 1488 1.0800000000000001e-64 254.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.828 1322 4.1100000000000004e-64 252.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.847 966 2.67e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.91 1471 3.79e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.107 560 8.82e-62 244.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.063 702 1.1e-60 240.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.572 729 1.41e-60 240.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.647 683 8.929999999999999e-60 238.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.583 1479 3.91e-55 222.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 21.678 1490 1.47e-54 220.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.037 644 1.86e-54 220.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 32.681 511 2.02e-54 219.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.161 1278 3.95e-53 215.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.843 1145 3.7e-52 212.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.245 1054 2.16e-50 206.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.324 1205 2.51e-50 206.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.606 1148 5.28e-50 205.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.64 1489 6.08e-50 205.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.807 664 1.0599999999999999e-48 201.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.213 1220 2.0299999999999998e-48 200.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.928 1448 2.6499999999999997e-48 199.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.915 566 4.35e-46 192.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.501 749 2.94e-45 189.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.942 539 4.39e-45 189.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.027 565 6.95e-45 188.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.593 383 4.82e-44 185.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.471 1181 1.01e-43 184.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.325 566 2.61e-42 179.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.218 486 2.17e-38 166.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.309 498 7.519999999999999e-38 165.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.568 528 9.58e-38 164.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.618 524 2.74e-37 163.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.127 630 2.57e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.247 507 3.22e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.579 712 5.49e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.333 637 1.32e-35 157.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.411 547 1.8700000000000001e-35 157.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.206 408 2.49e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.601 572 2.6e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.805 512 3.0200000000000004e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.885 628 4.18e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.074 594 7.490000000000001e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.119 413 8.14e-35 154.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 21.645 1155 1.23e-34 154.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.728 412 1.88e-34 153.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.522 431 3.2e-34 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.768 396 4.8599999999999995e-34 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.205 566 5.37e-34 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.341 513 8.94e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.048 578 9.639999999999999e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.508 559 9.89e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.248 541 1.45e-33 150.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.112 535 1.58e-33 150.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.733 494 2.95e-33 149.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.856 361 7.03e-33 148.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.423 520 3.58e-32 146.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.619 420 5.480000000000001e-32 145.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.042 480 5.58e-32 145.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.738 535 1.14e-31 144.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.232 586 1.1900000000000002e-31 144.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.521 522 4.28e-31 142.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.19 420 7.48e-31 141.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.041 392 8.84e-31 141.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.401 668 1.3099999999999999e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 26.891 476 1.8599999999999997e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.96 621 2.25e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.248 404 4.3199999999999995e-30 139.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.581 620 7.43e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.506 494 8.63e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.974 390 1.31e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.273 385 1.66e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.409 467 2.69e-29 136.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.832 447 2.95e-29 136.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.384 406 6.9e-29 135.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 21.5 1093 1.49e-28 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.41 488 1.59e-28 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 21.39 1122 2.8499999999999997e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.626 546 3.08e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.843 432 3.26e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 21.251 1247 9.82e-28 131.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.655 580 2.1200000000000003e-27 130.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 40.588 170 2.2500000000000002e-26 127.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 21.032 504 2.61e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.675 604 3.09e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 21.865 622 3.44e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.531 640 5.18e-26 125.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.615 390 1.15e-25 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.515 412 1.95e-25 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.716 409 2.62e-25 123.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.919 393 3.42e-25 123.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.27 445 9e-25 121.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.189 265 1.25e-24 121.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 34.091 176 3.42e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 29.911 224 4.78e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 36.022 186 5.07e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.783 258 4.1899999999999995e-23 116.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.112 394 4.6699999999999993e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 32.85 207 5.799999999999999e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.991 446 6.2e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 36.471 170 6.74e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.557 244 9.82e-23 114.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 36.628 172 1.35e-22 114.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.919 393 2.19e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 22.424 495 2.46e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 23.573 543 2.74e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 33.173 208 3.01e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 38.75 160 3.52e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 25.352 355 6.21e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.639 521 7.6600000000000005e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 27.619 315 9.83e-22 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.633 196 1.1200000000000002e-21 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.483 580 1.24e-21 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 24.01 404 1.7400000000000003e-21 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 35.088 171 1.82e-21 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 28.522 291 3.11e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 30.612 196 3.3e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.633 196 4.57e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 31.633 196 4.57e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 34.118 170 5.27e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 37.5 176 5.540000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 34.706 170 6.4400000000000006e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t2 Q8WZ42 35.106 188 8.000000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.231 9940 0.0 3560.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.52 9017 0.0 3205.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.07 7652 0.0 3186.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.877 7441 0.0 2966.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.024 6670 0.0 2838.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.645 6930 0.0 2791.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.093 7246 0.0 2780.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.374 7044 0.0 2761.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.04 6445 0.0 2581.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.399 6462 0.0 2529.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.369 6806 0.0 2528.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.377 6237 0.0 2485.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.814 6166 0.0 2339.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.029 5776 0.0 2325.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.281 5409 0.0 2090.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.992 4798 0.0 1853.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.651 4610 0.0 1751.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 34.436 2721 0.0 1523.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.928 4150 0.0 1415.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.404 4010 0.0 1313.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.032 2781 0.0 1022.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.377 2368 0.0 941.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.336 2410 0.0 833.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.456 2085 0.0 811.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.947 2067 0.0 772.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.409 1003 1.0299999999999999e-106 393.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.937 1109 3.14e-106 392.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.686 1364 2.1499999999999997e-104 385.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.474 950 3.9099999999999995e-104 385.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.971 1041 2.47e-101 375.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.577 1065 1.28e-98 366.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.182 1203 8.03e-94 350.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.417 1047 1.18e-93 350.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.96 1005 7.51e-89 334.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.454 1093 2.14e-87 329.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.392 1066 1.69e-82 313.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.691 955 6.1e-79 301.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.895 950 1.47e-76 293.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.252 714 3.4200000000000003e-75 288.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.075 805 6.3e-75 288.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.793 969 5.06e-71 275.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.513 1446 7.63e-70 271.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.367 1461 5.48e-68 265.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.644 1010 1.03e-67 264.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.896 661 4.8499999999999996e-67 261.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.315 1168 9.63e-66 257.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.123 730 4.15e-65 255.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.312 1488 9.56e-65 254.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.828 1322 4.05e-64 252.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.278 1108 2.77e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.847 966 2.88e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.758 1472 3.35e-63 249.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.107 560 8.92e-62 244.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.063 702 1.08e-60 241.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.572 729 1.31e-60 240.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.647 683 8.95e-60 238.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.515 1479 3.79e-55 222.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 21.678 1490 1.2799999999999999e-54 220.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.681 511 2.03e-54 219.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.037 644 2.13e-54 219.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.982 1214 2.2199999999999998e-54 219.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.161 1278 3.58e-53 216.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.843 1145 3.1099999999999996e-52 213.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.606 1148 4.82e-50 205.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.64 1489 5.42e-50 205.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.807 664 1.17e-48 201.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.213 1220 1.8699999999999998e-48 200.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.803 1491 2.2999999999999998e-48 199.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.915 566 3.88e-46 192.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.501 749 2.85e-45 189.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.027 565 6.91e-45 188.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.115 383 7.04e-44 185.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.471 1181 1.09e-43 184.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.325 566 2.3299999999999997e-42 180.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.82 532 8.44e-40 171.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.218 486 2.26e-38 166.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.309 498 7.41e-38 165.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.568 528 9.13e-38 164.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.618 524 2.49e-37 163.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.127 630 2.29e-36 160.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.247 507 3.1500000000000004e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.579 712 4.94e-36 159.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.333 637 1.21e-35 157.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.411 547 1.83e-35 157.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.206 408 2.49e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.601 572 2.49e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.805 512 3.15e-35 156.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.885 628 3.9200000000000003e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.074 594 6.68e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.119 413 7.83e-35 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 21.645 1155 9.49e-35 154.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.728 412 1.93e-34 153.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.522 431 2.83e-34 153.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.768 396 4.87e-34 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.205 566 5.43e-34 152.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.341 513 8.31e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.508 559 9.19e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.048 578 9.42e-34 151.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.248 541 1.47e-33 150.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.112 535 1.56e-33 150.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.733 494 3.3e-33 149.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.856 361 6.82e-33 148.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.131 518 3.59e-32 146.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.619 420 5.23e-32 145.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.042 480 5.31e-32 145.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.738 535 1.05e-31 144.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.232 586 1.2200000000000001e-31 144.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.138 696 2.3300000000000002e-31 143.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.521 522 4.010000000000001e-31 142.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.19 420 7.690000000000001e-31 141.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.041 392 8.080000000000001e-31 141.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.891 476 1.71e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.96 621 2.0599999999999998e-30 140.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.248 404 4.36e-30 139.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.581 620 6.46e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.43 507 7.14e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.506 494 8.099999999999999e-30 138.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.974 390 1.34e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.027 584 1.46e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.273 385 1.63e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.866 469 1.8300000000000002e-29 137.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.409 467 2.79e-29 136.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.832 447 2.88e-29 136.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.619 394 6.86e-29 135.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 21.5 1093 1.1199999999999999e-28 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.41 488 1.59e-28 134.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 21.39 1122 2.3e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.626 546 3.11e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.843 432 3.19e-28 133.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 21.251 1247 8.54e-28 131.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 40.588 170 2.31e-26 127.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 21.032 504 2.49e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.675 604 2.9200000000000003e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 21.865 622 3.66e-26 126.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.531 640 4.7000000000000005e-26 125.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.615 390 1.06e-25 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 26.539 471 1.38e-25 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.515 412 1.88e-25 124.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.716 409 2.45e-25 123.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.919 393 3.18e-25 123.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.27 445 8.44e-25 121.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.189 265 1.24e-24 121.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.84 474 2.8099999999999998e-24 120.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 34.091 176 3.35e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 29.911 224 4.91e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 36.022 186 5.17e-24 119.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.783 258 4.1999999999999996e-23 116.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.112 394 4.64e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.85 207 5.579999999999999e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.991 446 6.059999999999999e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 36.471 170 6.87e-23 115.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.557 244 9.599999999999999e-23 114.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 36.628 172 1.39e-22 114.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.919 393 2.03e-22 114.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 22.424 495 2.21e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 23.573 543 2.31e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 33.173 208 2.96e-22 113.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 38.75 160 3.62e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 25.352 355 6.33e-22 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.619 315 1.05e-21 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.633 196 1.0600000000000001e-21 111.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 24.01 404 1.57e-21 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 35.088 171 1.86e-21 110.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 30.612 196 3.0900000000000003e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 28.522 291 3.0900000000000003e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.633 196 4.32e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 31.633 196 4.32e-21 109.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 34.118 170 5.3200000000000004e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 37.5 176 5.980000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 34.706 170 6.560000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 27.07 314 7.69e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 35.106 188 8.220000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6898.t3 Q8WZ42 32.51 243 8.500000000000001e-21 108.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g6901.t1 Q9I7U4 30.204 245 1.17e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6901.t1 Q9I7U4 28.033 239 7.94e-21 105.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.009 2919 0.0 690.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.235 2085 7.94e-164 580.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 30.48 1145 3.1199999999999997e-153 545.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 29.732 1120 3.24e-118 429.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 29.65 1113 5.1700000000000005e-118 428.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 22.63 2342 9.06e-118 427.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 30.026 1139 3.44e-116 422.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 27.763 1131 5.87e-112 408.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.525 1131 1.39e-100 370.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.087 1173 4.0900000000000003e-88 329.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 24.455 1423 3.25e-76 290.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 21.897 1571 9.73e-76 288.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.473 1572 1.2200000000000001e-73 281.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 22.843 1576 2.0599999999999998e-69 267.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 36.867 415 4.93e-65 253.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.15 998 5.54e-53 213.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.263 792 1.22e-50 205.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 24.314 765 1.1799999999999999e-48 199.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.744 796 2.75e-47 194.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.287 696 1.26e-45 189.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 22.208 770 1.46e-41 175.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.681 777 1.84e-40 171.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.887 424 1.13e-36 159.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 27.294 425 2.26e-36 158.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.732 1163 8.04e-36 156.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 21.286 1104 1.11e-34 152.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 22.537 812 1.8e-32 145.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 21.595 815 6.26e-32 143.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 22.293 628 6.26e-32 143.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 28.831 385 3.2800000000000002e-31 140.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.52 625 7.820000000000001e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.0 436 7.950000000000001e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.536 513 9.76e-30 136.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.231 432 1.7700000000000001e-29 135.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.908 413 1.34e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.842 380 1.63e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.834 579 3.67e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 24.474 380 4.09e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 28.218 404 4.72e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 24.895 474 6.32e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 22.862 573 1.0100000000000001e-27 129.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.316 380 6.460000000000001e-27 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.6 375 9.18e-27 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 22.756 479 1.9600000000000002e-26 125.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.75 400 9.69e-26 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.582 395 1.41e-25 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.11 383 2.56e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 27.559 381 2.58e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 36.683 199 7.58e-25 120.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.765 324 1.79e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 23.831 449 2.77e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 28.871 381 7.55e-24 116.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.258 388 2.4899999999999998e-23 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.0 408 2.99e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 25.364 343 3.33e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 32.627 236 1.5600000000000002e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t1 Q9I7U4 26.78 295 2.16e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.052 2902 0.0 696.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.235 2085 5.940000000000001e-164 581.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 30.48 1145 2.78e-153 545.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.667 2325 2.97e-119 432.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 29.732 1120 3.12e-118 429.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 29.65 1113 5.15e-118 428.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 30.026 1139 2.98e-116 422.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 27.763 1131 5.0699999999999995e-112 409.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.525 1131 1.18e-100 371.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.087 1173 3.8800000000000004e-88 329.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.094 1557 6.93e-78 295.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.086 1716 5.14e-76 289.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.684 1558 4.750000000000001e-75 286.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 36.867 415 4.87e-65 253.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.407 984 6.05e-55 219.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.316 779 6.08e-52 209.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 24.501 751 3.99e-51 207.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.744 796 2.9600000000000003e-47 194.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.287 696 1.21e-45 189.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.208 770 1.56e-41 175.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.791 765 4.05e-41 174.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.847 1149 4.7900000000000004e-37 160.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.887 424 1.15e-36 159.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 27.294 425 2.33e-36 158.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 21.286 1104 1.05e-34 152.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 21.723 801 8.72e-34 149.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.537 812 1.86e-32 145.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.293 628 6.14e-32 143.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 28.831 385 3.3000000000000004e-31 140.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.52 625 7.17e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.0 436 7.93e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.536 513 8.52e-30 136.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.231 432 1.7900000000000001e-29 135.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.908 413 1.37e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.842 380 1.47e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.834 579 3.5399999999999997e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 24.474 380 3.92e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 28.218 404 4.63e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 24.895 474 6.36e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.862 573 1.0300000000000001e-27 129.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.316 380 6.080000000000001e-27 127.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.6 375 9.38e-27 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 22.756 479 2.13e-26 125.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.75 400 1.02e-25 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.582 395 1.35e-25 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 27.559 381 2.44e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.11 383 2.49e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 36.683 199 7.68e-25 120.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.765 324 1.71e-24 119.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.831 449 2.8299999999999997e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 28.871 381 7.28e-24 116.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.258 388 2.4699999999999997e-23 115.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 30.597 268 2.68e-23 114.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.0 408 2.93e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 25.364 343 3.26e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 32.627 236 1.5800000000000001e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 23.868 486 1.6900000000000001e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t2 Q9I7U4 26.78 295 2.16e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.116 2795 0.0 650.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.087 2599 1.0400000000000001e-160 570.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 30.48 1145 4.29e-153 545.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 29.732 1120 3.79e-118 429.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 29.65 1113 7.2100000000000005e-118 428.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 30.026 1139 4.84e-116 422.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 27.763 1131 7.6e-112 408.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.525 1131 1.85e-100 370.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 22.142 2222 2.55e-100 370.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.087 1173 4.88e-88 329.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 22.259 1523 1.01e-74 285.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 21.662 1468 1.1699999999999998e-67 261.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 22.2 1500 1.06e-65 255.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 36.867 415 4.77e-65 253.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.263 792 1.23e-50 205.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.913 876 9.3e-50 202.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 23.609 809 1.8299999999999998e-46 191.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 22.649 808 6.799999999999999e-42 176.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 23.058 811 2.93e-38 164.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.887 424 1.22e-36 159.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 27.294 425 2.24e-36 158.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 21.286 1104 1.38e-34 152.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 23.397 889 1.36e-32 145.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 21.595 815 7.12e-32 143.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 22.293 628 7.68e-32 143.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 28.831 385 3.6400000000000003e-31 140.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 23.68 625 7.720000000000001e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.0 436 8.25e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.536 513 8.57e-30 136.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.231 432 1.9100000000000002e-29 135.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 24.463 838 7.22e-29 133.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.908 413 1.31e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 22.615 933 1.33e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.842 380 1.78e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 23.834 579 3.69e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 24.474 380 4.36e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 28.218 404 5.37e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 24.895 474 5.94e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.316 380 6.760000000000001e-27 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.6 375 1.02e-26 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.263 380 7.020000000000001e-26 123.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.75 400 1.14e-25 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.582 395 1.62e-25 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.11 383 2.91e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 27.559 381 2.91e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 36.683 199 7.6e-25 120.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 23.765 324 1.83e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 23.831 449 2.62e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 28.871 381 8.23e-24 116.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.258 388 2.9099999999999996e-23 114.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.364 343 3.48e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 25.0 408 3.51e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 32.627 236 1.6600000000000001e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t3 Q9I7U4 26.78 295 2.1200000000000003e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.179 2819 0.0 726.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 24.307 2740 0.0 638.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.323 2907 3.56e-173 611.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.728 2849 1.24e-167 593.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 29.938 1296 8.890000000000001e-167 590.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 29.732 1120 4.29e-118 429.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.525 1131 1.39e-100 370.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 21.85 1730 7.43e-75 285.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.473 1572 1.47e-73 281.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 36.867 415 4.77e-65 253.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.15 998 7.02e-53 213.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.263 792 1.33e-50 205.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 24.115 763 1.43e-48 198.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.744 796 3.7e-47 194.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.114 822 2.37e-46 191.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.287 696 1.48e-45 188.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 29.216 421 5.36e-43 180.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 28.478 460 1.2399999999999998e-42 179.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 22.208 770 1.92e-41 174.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.459 1006 3.14e-41 174.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.681 777 2.5e-40 171.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 27.293 447 1.71e-37 161.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.887 424 1.25e-36 159.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 27.294 425 2.4600000000000002e-36 157.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.732 1163 1.0600000000000001e-35 155.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 22.146 1016 3.34e-35 154.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.617 402 7.12e-34 149.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 22.293 628 7.94e-32 143.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 21.595 815 8.28e-32 143.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 28.831 385 3.52e-31 140.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.0 436 8.68e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.52 625 8.820000000000001e-31 139.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.536 513 1.0500000000000001e-29 135.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.231 432 2.0400000000000002e-29 135.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.908 413 1.29e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.842 380 1.72e-28 132.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.834 579 4.18e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 28.218 404 5.2799999999999995e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 24.895 474 6.7899999999999995e-28 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 22.862 573 1.1000000000000001e-27 129.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.316 380 7.05e-27 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.6 375 1.06e-26 126.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.75 400 1.11e-25 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.582 395 1.44e-25 122.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.11 383 2.8399999999999998e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 27.559 381 2.88e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.467 428 3.38e-25 121.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 36.683 199 7.8e-25 119.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.765 324 2.11e-24 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 23.831 449 3.2299999999999997e-24 117.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 28.871 381 7.899999999999999e-24 116.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.258 388 2.74e-23 114.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.606 327 1.2500000000000001e-22 112.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.0 408 2.92e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 25.364 343 3.3700000000000003e-22 111.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 32.627 236 1.6200000000000002e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6907.t4 Q9I7U4 26.78 295 2.2700000000000004e-21 108.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g6908.t1 Q80UK0 32.097 701 1.0100000000000001e-110 374.0 sp|Q80UK0|SESD1_MOUSE SEC14 domain and spectrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Sestd1 PE=1 SV=1 g6908.t2 Q80UK0 32.097 701 7.94e-111 374.0 sp|Q80UK0|SESD1_MOUSE SEC14 domain and spectrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Sestd1 PE=1 SV=1 g6908.t3 O01761 30.407 934 9.229999999999999e-95 348.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 30.402 921 2.4e-93 343.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 32.156 793 2.3199999999999998e-83 311.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 28.633 922 2.23e-78 295.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 29.124 879 8.350000000000001e-75 283.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 26.802 985 6.74e-72 273.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 28.475 885 2.04e-70 268.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 28.059 809 1.53e-64 249.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 26.889 900 5.93e-60 234.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 23.978 905 1.6300000000000002e-59 233.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 28.31 710 1.41e-58 229.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 25.616 933 1.2799999999999999e-54 216.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 25.0 876 3.0999999999999995e-54 215.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 25.729 960 1.03e-51 207.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 26.136 792 1.82e-48 196.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 25.484 879 1.01e-47 194.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 23.92 903 7.87e-46 187.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 26.48 642 3.86e-43 178.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 26.677 671 1.83e-40 169.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 26.087 552 1.95e-32 143.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 24.613 581 3.91e-27 125.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6908.t3 O01761 29.644 253 5.6300000000000005e-21 105.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g6909.t1 P27169 35.737 319 1.2499999999999999e-55 188.0 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens OX=9606 GN=PON1 PE=1 SV=3 PON1_HUMAN reviewed Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1) Homo sapiens (Human) GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005789; GO:0008203; GO:0009636; GO:0010875; GO:0034364; GO:0034366; GO:0042803; GO:0046395; GO:0046434; GO:0046470; GO:0070062; GO:0072562; GO:0102007; GO:1901335 carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lactone catabolic process [GO:1901335]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to toxic substance [GO:0009636] blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366] acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] g6910.t1 P27169 33.856 319 5.3900000000000004e-49 170.0 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens OX=9606 GN=PON1 PE=1 SV=3 PON1_HUMAN reviewed Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1) Homo sapiens (Human) GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005789; GO:0008203; GO:0009636; GO:0010875; GO:0034364; GO:0034366; GO:0042803; GO:0046395; GO:0046434; GO:0046470; GO:0070062; GO:0072562; GO:0102007; GO:1901335 carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lactone catabolic process [GO:1901335]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to toxic substance [GO:0009636] blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366] acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] g6911.t1 P27169 38.17 317 2.6e-65 213.0 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens OX=9606 GN=PON1 PE=1 SV=3 PON1_HUMAN reviewed Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1) Homo sapiens (Human) GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005789; GO:0008203; GO:0009636; GO:0010875; GO:0034364; GO:0034366; GO:0042803; GO:0046395; GO:0046434; GO:0046470; GO:0070062; GO:0072562; GO:0102007; GO:1901335 carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lactone catabolic process [GO:1901335]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to toxic substance [GO:0009636] blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366] acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] g6912.t1 P31285 49.441 358 2.5e-128 375.0 sp|P31285|WNT3A_XENLA Protein Wnt-3a OS=Xenopus laevis OX=8355 GN=wnt3a PE=1 SV=1 g6914.t1 Q90ZK6 58.455 479 0.0 561.0 sp|Q90ZK6|ACVR1_CHICK Activin receptor type-1 OS=Gallus gallus OX=9031 GN=ACVR1 PE=2 SV=1 ACVR1_CHICK reviewed Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor) Gallus gallus (Chicken) GO:0000082; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003272; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009953; GO:0009968; GO:0010694; GO:0010718; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030154; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060412; GO:0060923; GO:0061445; GO:0062043; GO:0070724; GO:0071363; GO:0071773; GO:2000017; GO:2001237 activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412] activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; membrane [GO:0016020]; plasma membrane [GO:0005886] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025] g6914.t2 Q90ZK6 58.455 479 0.0 561.0 sp|Q90ZK6|ACVR1_CHICK Activin receptor type-1 OS=Gallus gallus OX=9031 GN=ACVR1 PE=2 SV=1 ACVR1_CHICK reviewed Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (Type I TGF B receptor) Gallus gallus (Chicken) GO:0000082; GO:0001569; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003272; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007369; GO:0007498; GO:0007507; GO:0009953; GO:0009968; GO:0010694; GO:0010718; GO:0016020; GO:0016361; GO:0016477; GO:0018107; GO:0019838; GO:0030154; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0030513; GO:0032924; GO:0032926; GO:0035556; GO:0042118; GO:0042803; GO:0045177; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0051145; GO:0060037; GO:0060317; GO:0060412; GO:0060923; GO:0061445; GO:0062043; GO:0070724; GO:0071363; GO:0071773; GO:2000017; GO:2001237 activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell fate commitment [GO:0060923]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; endothelial cell activation [GO:0042118]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412] activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; membrane [GO:0016020]; plasma membrane [GO:0005886] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025] g6915.t1 Q96H86 41.04 173 8.9e-37 144.0 sp|Q96H86|ZN764_HUMAN Zinc finger protein 764 OS=Homo sapiens OX=9606 GN=ZNF764 PE=1 SV=2 ZN764_HUMAN reviewed Zinc finger protein 764 Homo sapiens (Human) GO:0000977; GO:0000981; GO:0003712; GO:0005634; GO:0006357; GO:0008270; GO:0071385 cellular response to glucocorticoid stimulus [GO:0071385]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g6916.t1 Q8IYN0 40.58 276 5.440000000000001e-57 209.0 sp|Q8IYN0|ZN100_HUMAN Zinc finger protein 100 OS=Homo sapiens OX=9606 GN=ZNF100 PE=1 SV=2 g6916.t1 Q8IYN0 37.367 281 3.79e-52 195.0 sp|Q8IYN0|ZN100_HUMAN Zinc finger protein 100 OS=Homo sapiens OX=9606 GN=ZNF100 PE=1 SV=2 g6916.t1 Q8IYN0 31.439 264 7.59e-35 144.0 sp|Q8IYN0|ZN100_HUMAN Zinc finger protein 100 OS=Homo sapiens OX=9606 GN=ZNF100 PE=1 SV=2 g6916.t1 Q8IYN0 40.404 198 9.46e-35 144.0 sp|Q8IYN0|ZN100_HUMAN Zinc finger protein 100 OS=Homo sapiens OX=9606 GN=ZNF100 PE=1 SV=2 g6916.t1 Q8IYN0 31.481 216 1.1e-26 119.0 sp|Q8IYN0|ZN100_HUMAN Zinc finger protein 100 OS=Homo sapiens OX=9606 GN=ZNF100 PE=1 SV=2 g6917.t1 Q0VAW7 33.476 233 8.89e-34 139.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6917.t1 Q0VAW7 30.418 263 1.14e-25 114.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6918.t1 Q91740 25.265 1512 4.68e-45 186.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 25.408 1287 2.52e-32 144.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 23.265 1470 3.21e-30 137.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 24.132 1152 6.82e-25 120.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 22.753 1402 1.85e-24 118.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 22.066 1423 2.4099999999999997e-23 115.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 23.219 1137 2.6199999999999998e-23 115.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 23.071 1400 3.35e-22 111.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 22.498 1089 6.22e-22 110.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6918.t1 Q91740 21.668 1583 7.61e-22 110.0 sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1 g6921.t1 Q9UQP3 24.855 861 4.56e-41 170.0 sp|Q9UQP3|TENN_HUMAN Tenascin-N OS=Homo sapiens OX=9606 GN=TNN PE=1 SV=2 g6921.t1 Q9UQP3 23.944 852 1.44e-25 119.0 sp|Q9UQP3|TENN_HUMAN Tenascin-N OS=Homo sapiens OX=9606 GN=TNN PE=1 SV=2 g6921.t1 Q9UQP3 24.788 827 1.0499999999999999e-23 113.0 sp|Q9UQP3|TENN_HUMAN Tenascin-N OS=Homo sapiens OX=9606 GN=TNN PE=1 SV=2 g6923.t1 B2RU80 27.773 1289 6.32e-102 369.0 sp|B2RU80|PTPRB_MOUSE Receptor-type tyrosine-protein phosphatase beta OS=Mus musculus OX=10090 GN=Ptprb PE=1 SV=1 PTPRB_MOUSE reviewed Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP) Mus musculus (Mouse) GO:0001525; GO:0001649; GO:0004725; GO:0008347; GO:0016020; GO:0016311; GO:0043235; GO:0045296; GO:0045668 angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; glial cell migration [GO:0008347]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast differentiation [GO:0001649] membrane [GO:0016020]; receptor complex [GO:0043235] cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725] g6924.t1 Q8WY64 29.495 495 9.309999999999999e-68 227.0 sp|Q8WY64|MYLIP_HUMAN E3 ubiquitin-protein ligase MYLIP OS=Homo sapiens OX=9606 GN=MYLIP PE=1 SV=2 g6925.t1 G8HTB6 29.297 256 6.06e-28 121.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g6926.t1 G8HTB6 29.297 256 1.76e-28 123.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g6928.t1 Q06AK6 46.339 833 0.0 735.0 sp|Q06AK6|TFP11_PIG Tuftelin-interacting protein 11 OS=Sus scrofa OX=9823 GN=TFIP11 PE=2 SV=1 g6929.t1 P50416 52.75 800 0.0 875.0 sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2 CPT1A_HUMAN reviewed Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-) Homo sapiens (Human) GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772 aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674] g6929.t2 P50416 54.592 773 0.0 883.0 sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2 CPT1A_HUMAN reviewed Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-) Homo sapiens (Human) GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772 aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674] g6930.t1 A0A2R9YJI3 31.461 356 2.4899999999999998e-39 151.0 sp|A0A2R9YJI3|GPR22_DANRE G-protein coupled receptor 22 OS=Danio rerio OX=7955 GN=gpr22a PE=2 SV=1 GPR22_DANRE reviewed G-protein coupled receptor 22 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0003140; GO:0004930; GO:0005886; GO:0007186; GO:0007368; GO:0030030; GO:0032870; GO:0061371; GO:0070121; GO:0071907; GO:0071910 cell projection organization [GO:0030030]; cellular response to hormone stimulus [GO:0032870]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; G protein-coupled receptor signaling pathway [GO:0007186]; heart looping [GO:0001947]; Kupffer's vesicle development [GO:0070121] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g6931.t1 O45870 34.699 415 3.38e-64 214.0 sp|O45870|NSMA_CAEEL Putative neutral sphingomyelinase OS=Caenorhabditis elegans OX=6239 GN=T27F6.6 PE=3 SV=2 g6932.t1 P84169 59.309 376 5.6600000000000004e-167 474.0 sp|P84169|PSD13_CHICK 26S proteasome non-ATPase regulatory subunit 13 OS=Gallus gallus OX=9031 GN=PSMD13 PE=1 SV=1 g6933.t1 P40307 67.01 194 4.11e-92 270.0 sp|P40307|PSB2_RAT Proteasome subunit beta type-2 OS=Rattus norvegicus OX=10116 GN=Psmb2 PE=1 SV=1 g6934.t1 Q5R573 72.193 187 9.81e-102 297.0 sp|Q5R573|RBL2A_PONAB Rab-like protein 2A OS=Pongo abelii OX=9601 GN=RABL2A PE=2 SV=1 g6936.t1 Q8NFH4 49.221 321 1.67e-115 339.0 sp|Q8NFH4|NUP37_HUMAN Nucleoporin Nup37 OS=Homo sapiens OX=9606 GN=NUP37 PE=1 SV=1 NUP37_HUMAN reviewed Nucleoporin Nup37 (p37) (Nup107-160 subcomplex subunit Nup37) Homo sapiens (Human) GO:0000776; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301 cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g6937.t1 Q16540 41.139 158 2.16e-33 118.0 sp|Q16540|RM23_HUMAN Large ribosomal subunit protein uL23m OS=Homo sapiens OX=9606 GN=MRPL23 PE=1 SV=1 RM23_HUMAN reviewed Large ribosomal subunit protein uL23m (39S ribosomal protein L23, mitochondrial) (L23mt) (MRP-L23) (L23 mitochondrial-related protein) (Ribosomal protein L23-like) Homo sapiens (Human) GO:0001650; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 mitochondrial translation [GO:0032543]; translation [GO:0006412] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g6939.t1 P22758 44.035 679 0.0 591.0 sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2 g6939.t2 P22758 43.713 684 0.0 590.0 sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2 g6940.t1 Q86SS6 57.576 330 2.9700000000000002e-123 374.0 sp|Q86SS6|SYT9_HUMAN Synaptotagmin-9 OS=Homo sapiens OX=9606 GN=SYT9 PE=1 SV=1 SYT9_HUMAN reviewed Synaptotagmin-9 (Synaptotagmin IX) (SytIX) Homo sapiens (Human) GO:0000149; GO:0001786; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0016192; GO:0017158; GO:0030669; GO:0030672; GO:0031045; GO:0031340; GO:0042802; GO:0046872; GO:0061891; GO:0070382; GO:0098686; GO:0099502 calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; chemical synaptic transmission [GO:0007268]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192] clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g6941.t1 P04176 44.337 309 1.92e-85 268.0 sp|P04176|PH4H_RAT Phenylalanine-4-hydroxylase OS=Rattus norvegicus OX=10116 GN=Pah PE=1 SV=3 g6942.t1 P17276 64.387 424 0.0 580.0 sp|P17276|PH4H_DROME Protein henna OS=Drosophila melanogaster OX=7227 GN=Hn PE=2 SV=3 PH4H_DROME reviewed Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase) Drosophila melanogaster (Fruit fly) GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006587; GO:0006726; GO:0007377; GO:0007616; GO:0042416 dopamine biosynthetic process [GO:0042416]; eye pigment biosynthetic process [GO:0006726]; germ-band extension [GO:0007377]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process from tryptophan [GO:0006587]; tyrosine biosynthetic process [GO:0006571] iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510] g6942.t2 P17276 64.169 427 0.0 581.0 sp|P17276|PH4H_DROME Protein henna OS=Drosophila melanogaster OX=7227 GN=Hn PE=2 SV=3 PH4H_DROME reviewed Protein henna (EC 1.14.16.1) (EC 1.14.16.4) (Phe-4-monooxygenase) (Phenylalanine-4-hydroxylase) (PAH) (Tryptophan 5-hydroxylase) (TRH) (Tryptophan 5-monooxygenase) Drosophila melanogaster (Fruit fly) GO:0004505; GO:0004510; GO:0005506; GO:0006559; GO:0006571; GO:0006587; GO:0006726; GO:0007377; GO:0007616; GO:0042416 dopamine biosynthetic process [GO:0042416]; eye pigment biosynthetic process [GO:0006726]; germ-band extension [GO:0007377]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process from tryptophan [GO:0006587]; tyrosine biosynthetic process [GO:0006571] iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510] g6944.t1 P31423 28.69 481 2.08e-57 208.0 sp|P31423|GRM4_RAT Metabotropic glutamate receptor 4 OS=Rattus norvegicus OX=10116 GN=Grm4 PE=1 SV=1 g6945.t1 P47743 34.043 282 2.7700000000000003e-43 161.0 sp|P47743|GRM8_MOUSE Metabotropic glutamate receptor 8 OS=Mus musculus OX=10090 GN=Grm8 PE=1 SV=2 GRM8_MOUSE reviewed Metabotropic glutamate receptor 8 (mGluR8) Mus musculus (Mouse) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0035249; GO:0042734; GO:0043025; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g6947.t1 Q6P2X9 26.439 469 1.34e-36 144.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g6948.t1 Q149M9 27.621 1593 6.09e-148 498.0 sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3 g6955.t1 Q6DCX5 26.959 434 8.81e-30 123.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g6960.t1 Q7ZWG6 29.431 299 6.72e-22 99.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g6962.t1 P54360 33.75 320 2.67e-57 196.0 sp|P54360|FOJO_DROME Extracellular serine/threonine protein kinase four-jointed OS=Drosophila melanogaster OX=7227 GN=fj PE=1 SV=2 g6968.t1 Q9JMH7 30.733 423 1.51e-40 153.0 sp|Q9JMH7|NEUR3_MOUSE Sialidase-3 OS=Mus musculus OX=10090 GN=Neu3 PE=1 SV=1 NEUR3_MOUSE reviewed Sialidase-3 (EC 3.2.1.18) (Ganglioside sialidase) (Membrane sialidase) (N-acetyl-alpha-neuraminidase 3) Mus musculus (Mouse) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0005901; GO:0005975; GO:0006689; GO:0009313; GO:0009897; GO:0016020; GO:0016997; GO:0031901; GO:0045742; GO:0055038; GO:1900186 carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; oligosaccharide catabolic process [GO:0009313]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742] caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] alpha-sialidase activity [GO:0016997]; exo-alpha-sialidase activity [GO:0004308] g6969.t1 Q8BUG5 36.468 521 5.1900000000000006e-110 345.0 sp|Q8BUG5|CAYP2_MOUSE Calcyphosin-2 OS=Mus musculus OX=10090 GN=Caps2 PE=2 SV=2 g6970.t1 Q5T440 42.771 332 6.61e-73 234.0 sp|Q5T440|CAF17_HUMAN Iron-sulfur cluster assembly factor IBA57, mitochondrial OS=Homo sapiens OX=9606 GN=IBA57 PE=1 SV=1 CAF17_HUMAN reviewed Iron-sulfur cluster assembly factor IBA57, mitochondrial (Iron-sulfur cluster assembly factor homolog) Homo sapiens (Human) GO:0003723; GO:0005739; GO:0005759; GO:0006783; GO:0016226 heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] RNA binding [GO:0003723] g6975.t1 Q4KWL2 29.139 302 8.42e-26 110.0 sp|Q4KWL2|ADRB2_TSCTR Beta-2 adrenergic receptor OS=Tscherskia triton OX=329627 GN=ADRB2 PE=2 SV=1 ADRB2_TSCTR reviewed Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) Tscherskia triton (Greater long-tailed hamster) GO:0002025; GO:0004941; GO:0005769; GO:0005794; GO:0005886; GO:0006940; GO:0010666; GO:0010667; GO:0043410; GO:0048638; GO:0051240; GO:0051241; GO:0051380; GO:0071880; GO:0071881; GO:0106134; GO:1901098; GO:1904504 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of multicellular organismal process [GO:0051241]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of multicellular organismal process [GO:0051240]; regulation of developmental growth [GO:0048638]; regulation of smooth muscle contraction [GO:0006940] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] beta2-adrenergic receptor activity [GO:0004941]; norepinephrine binding [GO:0051380] g6976.t1 Q1LZD0 26.688 311 2.9400000000000003e-21 96.3 sp|Q1LZD0|AA2BR_BOVIN Adenosine receptor A2b OS=Bos taurus OX=9913 GN=ADORA2B PE=2 SV=1 g6977.t1 Q9UQ49 29.343 426 4.29e-39 151.0 sp|Q9UQ49|NEUR3_HUMAN Sialidase-3 OS=Homo sapiens OX=9606 GN=NEU3 PE=1 SV=1 NEUR3_HUMAN reviewed Sialidase-3 (EC 3.2.1.18) (Ganglioside sialidasedis) (Membrane sialidase) (N-acetyl-alpha-neuraminidase 3) Homo sapiens (Human) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0005901; GO:0005975; GO:0006689; GO:0009313; GO:0016020; GO:0016997; GO:0031901; GO:0045742; GO:0046479; GO:0055038; GO:1900186 carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; glycosphingolipid catabolic process [GO:0046479]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; oligosaccharide catabolic process [GO:0009313]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742] caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] alpha-sialidase activity [GO:0016997]; exo-alpha-sialidase activity [GO:0004308] g6977.t2 Q9UQ49 29.343 426 4.68e-39 151.0 sp|Q9UQ49|NEUR3_HUMAN Sialidase-3 OS=Homo sapiens OX=9606 GN=NEU3 PE=1 SV=1 NEUR3_HUMAN reviewed Sialidase-3 (EC 3.2.1.18) (Ganglioside sialidasedis) (Membrane sialidase) (N-acetyl-alpha-neuraminidase 3) Homo sapiens (Human) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0005901; GO:0005975; GO:0006689; GO:0009313; GO:0016020; GO:0016997; GO:0031901; GO:0045742; GO:0046479; GO:0055038; GO:1900186 carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; glycosphingolipid catabolic process [GO:0046479]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; oligosaccharide catabolic process [GO:0009313]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742] caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] alpha-sialidase activity [GO:0016997]; exo-alpha-sialidase activity [GO:0004308] g6985.t1 Q32LP4 51.244 1085 0.0 1058.0 sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1 S4A10_BOVIN reviewed Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10) Bos taurus (Bovine) GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982 bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202] monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452] g6987.t1 O46385 41.894 1172 0.0 889.0 sp|O46385|SVIL_BOVIN Supervillin OS=Bos taurus OX=9913 GN=SVIL PE=1 SV=2 g6988.t1 O76536 37.363 1183 6.41e-120 416.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 36.909 1184 3.95e-119 413.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 37.109 1183 6.109999999999999e-119 413.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 37.056 1182 7.09e-119 412.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 36.94 1183 2.96e-116 405.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 36.851 1175 2.38e-115 402.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 36.549 1223 4.64e-115 401.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 36.559 1116 1.49e-108 382.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 36.086 1114 8.11e-107 376.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6988.t1 O76536 35.452 598 9.96e-53 209.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6990.t1 Q8BGC3 27.845 413 1.04e-34 138.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g6991.t1 P58421 70.307 522 0.0 754.0 sp|P58421|FZD5_XENLA Frizzled-5 OS=Xenopus laevis OX=8355 GN=fzd5 PE=2 SV=1 g6993.t1 Q6DJM7 52.349 447 2.44e-154 448.0 sp|Q6DJM7|CDK14_XENLA Cyclin-dependent kinase 14 OS=Xenopus laevis OX=8355 GN=cdk14 PE=2 SV=1 CDK14_XENLA reviewed Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) Xenopus laevis (African clawed frog) GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310; GO:1901987 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle phase transition [GO:1901987]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] g6994.t1 Q9UP38 62.5 112 3.11e-43 153.0 sp|Q9UP38|FZD1_HUMAN Frizzled-1 OS=Homo sapiens OX=9606 GN=FZD1 PE=1 SV=2 g6997.t1 A7YY35 36.255 251 7.430000000000001e-27 123.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t1 A7YY35 35.319 235 2.0899999999999997e-23 112.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t2 A7YY35 36.255 251 5.9000000000000005e-27 124.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t2 A7YY35 35.319 235 2.0199999999999997e-23 112.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t3 A7YY35 36.255 251 6.2100000000000006e-27 124.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t3 A7YY35 35.319 235 2.2799999999999997e-23 112.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t4 A7YY35 36.255 251 5.81e-27 124.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t4 A7YY35 35.319 235 1.9099999999999998e-23 112.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t5 A7YY35 36.255 251 5.160000000000001e-27 124.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g6997.t5 A7YY35 35.319 235 1.56e-23 112.0 sp|A7YY35|K2012_BOVIN Uncharacterized protein KIAA2012 homolog OS=Bos taurus OX=9913 GN=KIAA2012 PE=2 SV=2 g7001.t1 Q63421 49.527 529 2.03e-180 538.0 sp|Q63421|PDE1C_RAT Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C OS=Rattus norvegicus OX=10116 GN=Pde1c PE=1 SV=1 PDE1C_RAT reviewed Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) Rattus norvegicus (Rat) GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005929; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0051592; GO:0061179; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cilium [GO:0005929]; lysosome [GO:0005764]; neuronal cell body [GO:0043025] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872] g7001.t2 Q63421 51.677 507 0.0 545.0 sp|Q63421|PDE1C_RAT Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C OS=Rattus norvegicus OX=10116 GN=Pde1c PE=1 SV=1 PDE1C_RAT reviewed Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) Rattus norvegicus (Rat) GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005929; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0051592; GO:0061179; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cilium [GO:0005929]; lysosome [GO:0005764]; neuronal cell body [GO:0043025] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872] g7001.t3 Q63421 51.779 506 0.0 545.0 sp|Q63421|PDE1C_RAT Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C OS=Rattus norvegicus OX=10116 GN=Pde1c PE=1 SV=1 PDE1C_RAT reviewed Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) Rattus norvegicus (Rat) GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005929; GO:0007165; GO:0007608; GO:0030552; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0051592; GO:0061179; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; response to calcium ion [GO:0051592]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cilium [GO:0005929]; lysosome [GO:0005764]; neuronal cell body [GO:0043025] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872] g7002.t1 Q3C2C2 42.308 156 4.6800000000000004e-29 107.0 sp|Q3C2C2|PA21_ACAPL Phospholipase A2 AP-PLA2-I OS=Acanthaster planci OX=133434 PE=1 SV=1 PA21_ACAPL reviewed Phospholipase A2 AP-PLA2-I (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) Acanthaster planci (Crown-of-thorns starfish) GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0031640; GO:0047498; GO:0050482; GO:0090729 arachidonate secretion [GO:0050482]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729] g7004.t1 P61166 83.117 77 6.429999999999999e-42 134.0 sp|P61166|TM258_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258 OS=Mus musculus OX=10090 GN=Tmem258 PE=1 SV=1 TM258_MOUSE reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258 (Oligosaccharyl transferase subunit TMEM258) (Transmembrane protein 258) Mus musculus (Mouse) GO:0005737; GO:0005783; GO:0005789; GO:0006487; GO:0006954; GO:0008250; GO:0009306; GO:0016020; GO:0034976; GO:0062062; GO:0160226; GO:0160227; GO:1904019 epithelial cell apoptotic process [GO:1904019]; inflammatory response [GO:0006954]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227] oligosaccharyltransferase complex binding [GO:0062062] g7005.t1 Q3ZBH0 73.614 523 0.0 780.0 sp|Q3ZBH0|TCPB_BOVIN T-complex protein 1 subunit beta OS=Bos taurus OX=9913 GN=CCT2 PE=1 SV=3 TCPB_BOVIN reviewed T-complex protein 1 subunit beta (TCP-1-beta) (EC 3.6.1.-) (CCT-beta) Bos taurus (Bovine) GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044297; GO:0046872; GO:0050821; GO:0051082; GO:0051131; GO:0090666; GO:0140662; GO:1904874 binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] g7007.t1 Q6ZQQ6 27.33 633 2.1399999999999997e-48 195.0 sp|Q6ZQQ6|WDR87_HUMAN WD repeat-containing protein 87 OS=Homo sapiens OX=9606 GN=WDR87 PE=1 SV=4 g7008.t1 A9ULE9 32.044 362 3.7700000000000003e-47 166.0 sp|A9ULE9|DJC22_XENTR DnaJ homolog subfamily C member 22 OS=Xenopus tropicalis OX=8364 GN=dnajc22 PE=2 SV=1 g7009.t1 Q93092 67.5 320 1.23e-156 444.0 sp|Q93092|TALDO_MOUSE Transaldolase OS=Mus musculus OX=10090 GN=Taldo1 PE=1 SV=2 g7011.t1 A5D7F5 39.011 182 2.53e-40 141.0 sp|A5D7F5|DJC27_BOVIN DnaJ homolog subfamily C member 27 OS=Bos taurus OX=9913 GN=DNAJC27 PE=2 SV=1 g7012.t1 Q5BKY9 59.524 84 3.17e-30 114.0 sp|Q5BKY9|F133B_HUMAN Protein FAM133B OS=Homo sapiens OX=9606 GN=FAM133B PE=1 SV=1 g7013.t1 Q9W770 36.728 599 6.18e-111 355.0 sp|Q9W770|SPON1_CHICK Spondin-1 OS=Gallus gallus OX=9031 GN=SPON1 PE=2 SV=1 g7014.t1 Q5ZMA6 67.514 708 0.0 1012.0 sp|Q5ZMA6|NADE_CHICK Glutamine-dependent NAD(+) synthetase OS=Gallus gallus OX=9031 GN=NADSYN1 PE=2 SV=1 NADE_CHICK reviewed Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase) Gallus gallus (Chicken) GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0034354 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; NAD+ biosynthetic process [GO:0009435] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952] g7019.t1 Q9H2Y9 32.902 696 2.93e-111 362.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g7019.t2 Q9H2Y9 32.615 696 5.23e-111 360.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g7020.t1 Q6NU18 44.444 144 4.83e-33 127.0 sp|Q6NU18|CUE2A_XENLA CUE domain-containing protein 2-A OS=Xenopus laevis OX=8355 GN=cuedc2-a PE=1 SV=1 g7027.t1 A2VDP6 33.265 487 4.82e-80 267.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g7028.t1 O88413 48.98 490 1.48e-148 436.0 sp|O88413|TULP3_MOUSE Tubby-related protein 3 OS=Mus musculus OX=10090 GN=Tulp3 PE=1 SV=1 TULP3_MOUSE reviewed Tubby-related protein 3 (Tubby-like protein 3) Mus musculus (Mouse) GO:0001664; GO:0001841; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007420; GO:0008277; GO:0008589; GO:0009952; GO:0019899; GO:0021904; GO:0021915; GO:0021953; GO:0031076; GO:0035091; GO:0036064; GO:0042733; GO:0044877; GO:0045879; GO:0048702; GO:0060173; GO:0060348; GO:0060434; GO:0061512; GO:0061548; GO:0097546; GO:0097731; GO:0120160 anterior/posterior pattern specification [GO:0009952]; bone development [GO:0060348]; brain development [GO:0007420]; bronchus morphogenesis [GO:0060434]; central nervous system neuron differentiation [GO:0021953]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; ganglion development [GO:0061548]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; protein localization to cilium [GO:0061512]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of smoothened signaling pathway [GO:0008589]; smoothened signaling pathway [GO:0007224] 9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877] g7029.t1 Q8K3X2 68.454 317 9.32e-165 464.0 sp|Q8K3X2|FCL_CRIGR GDP-L-fucose synthase OS=Cricetulus griseus OX=10029 GN=GFUS PE=2 SV=1 g7040.t1 A2AKX3 33.333 474 7.58e-55 212.0 sp|A2AKX3|SETX_MOUSE Probable helicase senataxin OS=Mus musculus OX=10090 GN=Setx PE=1 SV=1 SETX_MOUSE reviewed Helicase senataxin (EC 3.6.4.12) (EC 3.6.4.13) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog) Mus musculus (Mouse) GO:0000228; GO:0000781; GO:0001147; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0033677; GO:0034599; GO:0042802; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:2000144; GO:2000806 cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; mRNA splice site recognition [GO:0006376]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369] axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA/RNA helicase activity [GO:0033677]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147] g7041.t1 Q66HL2 55.075 532 0.0 545.0 sp|Q66HL2|SRC8_RAT Src substrate cortactin OS=Rattus norvegicus OX=10116 GN=Cttn PE=1 SV=1 SRC8_RAT reviewed Src substrate cortactin Rattus norvegicus (Rat) GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0016477; GO:0030027; GO:0030036; GO:0030054; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0043197; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0051015; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098794; GO:0098871; GO:0098885; GO:0098978; GO:0099010; GO:1901524; GO:1990023; GO:2001237 actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modification of postsynaptic structure [GO:0099010]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; substrate-dependent cell migration, cell extension [GO:0006930] actin filament [GO:0005884]; cell cortex [GO:0005938]; cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076] actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064] g7042.t1 Q9HBI1 62.5 352 5.16e-153 438.0 sp|Q9HBI1|PARVB_HUMAN Beta-parvin OS=Homo sapiens OX=9606 GN=PARVB PE=1 SV=1 g7044.t1 P28347 69.869 458 0.0 619.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g7044.t2 P28347 67.292 480 0.0 610.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g7044.t3 P28347 67.015 479 0.0 608.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g7044.t4 P28347 66.598 482 0.0 603.0 sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2 TEAD1_HUMAN reviewed Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g7045.t1 Q5ZJW6 54.211 190 4.88e-71 217.0 sp|Q5ZJW6|KBRS2_CHICK NF-kappa-B inhibitor-interacting Ras-like protein 2 OS=Gallus gallus OX=9031 GN=NKIRAS2 PE=2 SV=1 g7047.t1 Q5UQ13 31.538 910 5.7599999999999995e-68 256.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t1 Q5UQ13 31.479 899 2.69e-59 228.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t1 Q5UQ13 31.935 858 5.3e-58 224.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t1 Q5UQ13 31.579 874 7.62e-53 207.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t1 Q5UQ13 30.937 779 2.1600000000000003e-43 177.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t1 Q5UQ13 36.261 444 3.89e-41 170.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t1 Q5UQ13 30.769 572 4.3500000000000003e-35 150.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t1 Q5UQ13 28.897 571 7.04e-25 117.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 31.648 910 2.17e-68 258.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 31.479 899 1.2900000000000001e-59 229.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 31.935 858 2.35e-58 225.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 31.579 874 3.76e-53 209.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 30.937 779 1.32e-43 177.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 36.261 444 3.05e-41 170.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 30.769 572 2.36e-35 151.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t2 Q5UQ13 28.897 571 3.71e-25 117.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 31.538 910 2.2599999999999997e-67 254.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 31.479 899 1.07e-58 227.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 31.228 855 1.15e-56 220.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 31.579 874 2.6699999999999997e-52 206.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 31.194 779 7.350000000000001e-43 175.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 36.261 444 8.41e-41 169.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 30.769 572 1.19e-34 149.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7047.t3 Q5UQ13 28.897 571 1.4599999999999999e-24 115.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g7048.t1 P39059 38.519 270 4.4500000000000005e-56 202.0 sp|P39059|COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens OX=9606 GN=COL15A1 PE=1 SV=2 COFA1_HUMAN reviewed Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV)] Homo sapiens (Human) GO:0001525; GO:0005576; GO:0005582; GO:0005604; GO:0005615; GO:0005783; GO:0005788; GO:0007155; GO:0007165; GO:0016020; GO:0030020; GO:0030154; GO:0031012; GO:0070062 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; signal transduction [GO:0007165] basement membrane [GO:0005604]; collagen type XV trimer [GO:0005582]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] extracellular matrix structural constituent conferring tensile strength [GO:0030020] g7050.t1 P70168 66.856 878 0.0 1194.0 sp|P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus musculus OX=10090 GN=Kpnb1 PE=1 SV=2 IMB1_MOUSE reviewed Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG) Mus musculus (Mouse) GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0010494; GO:0019894; GO:0019899; GO:0019904; GO:0030953; GO:0031267; GO:0031965; GO:0032991; GO:0035332; GO:0040001; GO:0042564; GO:0044877; GO:0045542; GO:0045893; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307 astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hippo signaling [GO:0035332]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; kinesin binding [GO:0019894]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g7053.t1 O08684 43.548 992 0.0 784.0 sp|O08684|PLD1_CRIGR Phospholipase D1 OS=Cricetulus griseus OX=10029 GN=PLD1 PE=2 SV=1 g7053.t2 O08684 43.056 1008 0.0 782.0 sp|O08684|PLD1_CRIGR Phospholipase D1 OS=Cricetulus griseus OX=10029 GN=PLD1 PE=2 SV=1 g7055.t1 Q92738 56.381 431 3.54e-167 493.0 sp|Q92738|US6NL_HUMAN USP6 N-terminal-like protein OS=Homo sapiens OX=9606 GN=USP6NL PE=1 SV=3 US6NL_HUMAN reviewed USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0005886; GO:0007030; GO:0019068; GO:0031267; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:1903358 Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g7056.t1 Q16611 44.554 101 5.05e-24 98.6 sp|Q16611|BAK_HUMAN Bcl-2 homologous antagonist/killer OS=Homo sapiens OX=9606 GN=BAK1 PE=1 SV=1 BAK_HUMAN reviewed Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK) (Bcl-2-like protein 7) (Bcl2-L-7) Homo sapiens (Human) GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006915; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0015267; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0032469; GO:0032471; GO:0034620; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0050673; GO:0051087; GO:0051400; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097136; GO:0097145; GO:0097190; GO:0097192; GO:0097193; GO:1901029; GO:1901030; GO:1902262; GO:1903896 animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068] BAK complex [GO:0097145]; Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930] BH domain binding [GO:0051400]; channel activity [GO:0015267]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325] g7059.t1 Q5RFH9 45.565 248 5.24e-77 236.0 sp|Q5RFH9|AT5F1_PONAB ATP synthase peripheral stalk subunit b, mitochondrial OS=Pongo abelii OX=9601 GN=ATP5PB PE=2 SV=1 g7060.t1 D4A7U2 44.444 342 5.77e-91 300.0 sp|D4A7U2|CARTF_RAT Calcium-responsive transcription factor OS=Rattus norvegicus OX=10116 GN=Carf PE=1 SV=1 CARTF_RAT reviewed Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor) (CaRF) Rattus norvegicus (Rat) GO:0000978; GO:0000981; GO:0001228; GO:0001652; GO:0003677; GO:0005634; GO:0006357; GO:0045944; GO:0071277 cellular response to calcium ion [GO:0071277]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] granular component [GO:0001652]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g7063.t1 Q7ZYS8 81.395 215 9.88e-115 329.0 sp|Q7ZYS8|RL10A_XENLA Large ribosomal subunit protein uL1 OS=Xenopus laevis OX=8355 GN=rpl10a PE=2 SV=1 g7064.t1 Q96K76 45.778 1433 0.0 1169.0 sp|Q96K76|UBP47_HUMAN Ubiquitin carboxyl-terminal hydrolase 47 OS=Homo sapiens OX=9606 GN=USP47 PE=1 SV=3 UBP47_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006508; GO:0006974; GO:0008630; GO:0016579; GO:0019005; GO:0031647; GO:0035520; GO:0071987; GO:0090263; GO:0101005; GO:1902230 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987] g7065.t1 Q16543 58.242 364 5.31e-143 414.0 sp|Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1 g7066.t1 P24638 43.503 354 1.98e-93 291.0 sp|P24638|PPAL_MOUSE Lysosomal acid phosphatase OS=Mus musculus OX=10090 GN=Acp2 PE=1 SV=2 g7066.t2 P24638 43.503 354 5.8099999999999996e-93 291.0 sp|P24638|PPAL_MOUSE Lysosomal acid phosphatase OS=Mus musculus OX=10090 GN=Acp2 PE=1 SV=2 g7067.t1 Q00492 75.849 265 2.88e-138 392.0 sp|Q00492|SUM1_LYTVA Transcription factor SUM-1 OS=Lytechinus variegatus OX=7654 GN=SUM-1 PE=2 SV=1 g7068.t1 Q00492 51.744 172 3.73e-41 146.0 sp|Q00492|SUM1_LYTVA Transcription factor SUM-1 OS=Lytechinus variegatus OX=7654 GN=SUM-1 PE=2 SV=1 g7069.t1 E7EYQ9 44.056 143 2.18e-32 115.0 sp|E7EYQ9|TM216_DANRE Transmembrane protein 216 OS=Danio rerio OX=7955 GN=tmem216 PE=3 SV=1 g7070.t1 Q0VCJ7 40.704 199 3.3600000000000004e-43 147.0 sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1 g7071.t1 A2RRV3 35.949 395 1.1099999999999999e-67 244.0 sp|A2RRV3|PATL1_DANRE Protein PAT1 homolog 1 OS=Danio rerio OX=7955 GN=patl1 PE=1 SV=1 g7072.t1 Q24180 61.404 114 2.7299999999999998e-46 172.0 sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1 DEAF1_DROME reviewed Deformed epidermal autoregulatory factor 1 (Protein DEAF-1) Drosophila melanogaster (Fruit fly) GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776 embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; polytene chromosome [GO:0005700] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g7075.t1 C3YZ51 73.58 405 0.0 561.0 sp|C3YZ51|UBA5_BRAFL Ubiquitin-like modifier-activating enzyme 5 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_113714 PE=3 SV=1 g7080.t1 Q6AZT7 43.331 1327 0.0 978.0 sp|Q6AZT7|NPHP3_XENLA Nephrocystin-3 OS=Xenopus laevis OX=8355 GN=nphp3 PE=2 SV=1 NPHP3_XENLA reviewed Nephrocystin-3 Xenopus laevis (African clawed frog) GO:0001822; GO:0005929; GO:0007368; GO:0016055; GO:0060026; GO:0060027; GO:0060271; GO:0090090; GO:0097543; GO:0097546; GO:2000095 cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of left/right symmetry [GO:0007368]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055] ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929] g7081.t1 Q9Y2E4 63.359 1572 0.0 1966.0 sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2 g7084.t1 Q9ES30 39.306 173 2.9e-28 110.0 sp|Q9ES30|C1QT3_MOUSE Complement C1q tumor necrosis factor-related protein 3 OS=Mus musculus OX=10090 GN=C1qtnf3 PE=2 SV=1 g7085.t1 Q9ES30 39.306 173 1.23e-28 112.0 sp|Q9ES30|C1QT3_MOUSE Complement C1q tumor necrosis factor-related protein 3 OS=Mus musculus OX=10090 GN=C1qtnf3 PE=2 SV=1 g7091.t1 Q6NT55 47.679 474 3.33e-160 468.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g7091.t2 Q6NT55 47.158 475 3.57e-159 466.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g7091.t3 Q6NT55 44.487 517 6.96e-155 456.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g7092.t1 Q11011 64.971 865 0.0 1190.0 sp|Q11011|PSA_MOUSE Puromycin-sensitive aminopeptidase OS=Mus musculus OX=10090 GN=Npepps PE=1 SV=2 PSA_MOUSE reviewed Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S) Mus musculus (Mouse) GO:0004177; GO:0005576; GO:0005634; GO:0005829; GO:0006508; GO:0008270; GO:0016285; GO:0043171; GO:0070006; GO:0071456 cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] g7093.t1 Q99759 45.768 697 9.78e-177 521.0 sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP3K3 PE=1 SV=2 M3K3_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3) Homo sapiens (Human) GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0106310; GO:1900745 blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7093.t2 Q99759 46.098 692 7.190000000000001e-179 526.0 sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP3K3 PE=1 SV=2 M3K3_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3) Homo sapiens (Human) GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0106310; GO:1900745 blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7094.t1 Q6GMD3 39.326 178 1.48e-28 113.0 sp|Q6GMD3|SHFL_XENLA Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog OS=Xenopus laevis OX=8355 GN=shfl PE=2 SV=1 SHFL_XENLA reviewed Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog (SHFL) (Repressor of yield of DENV protein homolog) Xenopus laevis (African clawed frog) GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0006449; GO:0035456; GO:0043022; GO:0045087; GO:0075523; GO:1990825; GO:2001125 innate immune response [GO:0045087]; negative regulation of translational frameshifting [GO:2001125]; regulation of translational termination [GO:0006449]; response to interferon-beta [GO:0035456]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] g7095.t1 P98158 39.924 2640 0.0 1904.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 28.571 1526 3.75e-164 575.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 32.237 760 2.59e-91 337.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 32.34 705 1.09e-88 329.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 26.341 1063 7.16e-84 313.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 31.186 776 9.64e-83 309.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 31.638 708 1.0299999999999999e-69 266.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 26.569 685 3.28e-47 192.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 28.028 710 4.1599999999999997e-45 185.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 39.789 284 5.5400000000000006e-43 178.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 34.959 246 9.36e-31 138.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 30.233 258 2.24e-30 136.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 26.154 390 7.949999999999999e-30 135.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 26.332 319 7.819999999999999e-23 112.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t1 P98158 25.0 344 3.4900000000000005e-21 106.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t2 P98158 40.719 4676 0.0 3391.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7095.t3 P98164 44.584 1911 0.0 1509.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 32.39 1201 1.08e-155 538.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 38.608 733 9.58e-122 433.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 36.054 735 1.02e-114 411.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 33.238 698 5.019999999999999e-91 335.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 31.274 793 8.84e-87 321.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 32.116 657 6.3e-77 289.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 39.286 336 3.8899999999999997e-38 161.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 27.945 365 5.7e-35 151.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 38.384 297 1.3100000000000001e-33 146.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 29.464 336 4.68e-31 138.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 37.544 285 1.5600000000000002e-26 123.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7095.t3 P98164 39.303 201 4.59e-22 108.0 sp|P98164|LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens OX=9606 GN=LRP2 PE=1 SV=3 LRP2_HUMAN reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Homo sapiens (Human) GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0015889; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1904888; GO:1905167 amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cobalamin transport [GO:0015889]; coronary artery morphogenesis [GO:0060982]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7096.t1 P08594 39.175 388 4.0200000000000004e-73 240.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g7098.t1 Q91XT5 42.471 518 2.98e-131 396.0 sp|Q91XT5|BCDO1_RAT Beta,beta-carotene 15,15'-dioxygenase OS=Rattus norvegicus OX=10116 GN=Bco1 PE=2 SV=1 g7099.t1 Q55GU0 36.957 276 8.97e-46 176.0 sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267514 PE=3 SV=1 g7101.t1 Q55GU0 35.172 290 5.550000000000001e-47 175.0 sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267514 PE=3 SV=1 g7102.t1 Q9JLB0 48.036 560 1.47e-180 523.0 sp|Q9JLB0|PALS2_MOUSE Protein PALS2 OS=Mus musculus OX=10090 GN=Pals2 PE=1 SV=1 g7102.t2 Q9JLB0 48.036 560 1.1e-179 520.0 sp|Q9JLB0|PALS2_MOUSE Protein PALS2 OS=Mus musculus OX=10090 GN=Pals2 PE=1 SV=1 g7103.t1 Q924H7 50.794 126 1.74e-27 121.0 sp|Q924H7|WAC_MOUSE WW domain-containing adapter protein with coiled-coil OS=Mus musculus OX=10090 GN=Wac PE=1 SV=2 WAC_MOUSE reviewed WW domain-containing adapter protein with coiled-coil Mus musculus (Mouse) GO:0000993; GO:0003682; GO:0005634; GO:0005654; GO:0005681; GO:0006338; GO:0006974; GO:0010506; GO:0016239; GO:0016607; GO:0031571; GO:0032435; GO:0045893; GO:1904263 chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993] g7103.t1 Q924H7 40.526 190 6.16e-23 107.0 sp|Q924H7|WAC_MOUSE WW domain-containing adapter protein with coiled-coil OS=Mus musculus OX=10090 GN=Wac PE=1 SV=2 WAC_MOUSE reviewed WW domain-containing adapter protein with coiled-coil Mus musculus (Mouse) GO:0000993; GO:0003682; GO:0005634; GO:0005654; GO:0005681; GO:0006338; GO:0006974; GO:0010506; GO:0016239; GO:0016607; GO:0031571; GO:0032435; GO:0045893; GO:1904263 chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993] g7105.t1 Q8BVD5 42.241 580 3.68e-160 473.0 sp|Q8BVD5|MPP7_MOUSE MAGUK p55 subfamily member 7 OS=Mus musculus OX=10090 GN=Mpp7 PE=1 SV=2 g7105.t2 Q8BVD5 42.609 575 4.4200000000000004e-163 480.0 sp|Q8BVD5|MPP7_MOUSE MAGUK p55 subfamily member 7 OS=Mus musculus OX=10090 GN=Mpp7 PE=1 SV=2 g7106.t1 P22727 51.143 350 7.37e-137 396.0 sp|P22727|WNT6_MOUSE Protein Wnt-6 OS=Mus musculus OX=10090 GN=Wnt6 PE=1 SV=2 WNT6_MOUSE reviewed Protein Wnt-6 Mus musculus (Mouse) GO:0001658; GO:0005102; GO:0005109; GO:0005125; GO:0005615; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0030182; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060070; GO:0060684; GO:0070172; GO:0072079; GO:0072080 animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102] g7108.t1 P21551 52.284 394 5.31e-155 444.0 sp|P21551|WNT1_AMBME Protein Wnt-1 OS=Ambystoma mexicanum OX=8296 GN=WNT-1 PE=2 SV=1 g7109.t1 Q9MYM7 39.506 243 1.74e-60 201.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g7110.t1 Q9MYM7 40.53 264 3.7e-57 193.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g7111.t1 Q9MYM7 37.5 288 2.4199999999999997e-61 203.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g7112.t1 O42280 50.752 266 4.47e-85 261.0 sp|O42280|WNT9A_CHICK Protein Wnt-9a OS=Gallus gallus OX=9031 GN=WNT9A PE=2 SV=1 g7114.t1 P04176 49.441 447 9.919999999999999e-147 429.0 sp|P04176|PH4H_RAT Phenylalanine-4-hydroxylase OS=Rattus norvegicus OX=10116 GN=Pah PE=1 SV=3 g7115.t1 Q8N394 53.623 276 1.1600000000000001e-79 260.0 sp|Q8N394|TMTC2_HUMAN Protein O-mannosyl-transferase TMTC2 OS=Homo sapiens OX=9606 GN=TMTC2 PE=1 SV=1 TMTC2_HUMAN reviewed Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2) Homo sapiens (Human) GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0055074 calcium ion homeostasis [GO:0055074]; protein O-linked glycosylation via mannose [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g7116.t1 Q56A06 44.983 598 1.81e-158 478.0 sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1 TMTC2_MOUSE reviewed Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0055074 calcium ion homeostasis [GO:0055074]; protein O-linked glycosylation via mannose [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g7117.t1 Q9DC63 30.137 438 6.05e-49 176.0 sp|Q9DC63|FBX3_MOUSE F-box only protein 3 OS=Mus musculus OX=10090 GN=Fbxo3 PE=1 SV=1 g7119.t1 Q7ZVC9 46.729 107 4.43e-28 103.0 sp|Q7ZVC9|SMAP_DANRE Small acidic protein OS=Danio rerio OX=7955 GN=smap PE=1 SV=1 g7126.t1 Q9UA35 49.751 603 0.0 570.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g7126.t1 Q9UA35 43.22 118 3.7400000000000005e-21 102.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g7126.t2 Q9UA35 49.751 603 0.0 570.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g7126.t2 Q9UA35 43.22 118 3.69e-21 102.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g7126.t3 Q9UA35 49.669 604 0.0 560.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g7126.t3 Q9UA35 43.22 118 3.82e-21 102.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g7127.t1 Q14432 44.956 803 0.0 581.0 sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3 PDE3A_HUMAN reviewed cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE) Homo sapiens (Human) GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162 apoptotic signaling pathway [GO:0097190]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; membrane [GO:0016020] 3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284] g7127.t2 Q14432 41.061 1018 0.0 627.0 sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3 PDE3A_HUMAN reviewed cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE) Homo sapiens (Human) GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162 apoptotic signaling pathway [GO:0097190]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; membrane [GO:0016020] 3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284] g7129.t1 P25786 71.705 258 3.88e-142 403.0 sp|P25786|PSA1_HUMAN Proteasome subunit alpha type-1 OS=Homo sapiens OX=9606 GN=PSMA1 PE=1 SV=1 PSA1_HUMAN reviewed Proteasome subunit alpha type-1 (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain) (Proteasome subunit alpha-6) (alpha-6) Homo sapiens (Human) GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0019773; GO:0043161; GO:0070062 immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773] lipopolysaccharide binding [GO:0001530] g7135.t1 O15050 34.07 2442 0.0 1197.0 sp|O15050|TRNK1_HUMAN TPR and ankyrin repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=TRANK1 PE=1 SV=4 g7136.t1 Q8BJZ4 56.69 284 5.47e-111 329.0 sp|Q8BJZ4|RT35_MOUSE Small ribosomal subunit protein mS35 OS=Mus musculus OX=10090 GN=Mrps35 PE=1 SV=2 g7138.t1 Q9QX15 32.251 893 6.31e-129 418.0 sp|Q9QX15|CA3A1_MOUSE Calcium-activated chloride channel regulator 3A-1 OS=Mus musculus OX=10090 GN=Clca3a1 PE=1 SV=1 CA3A1_MOUSE reviewed Calcium-activated chloride channel regulator 3A-1 (EC 3.4.-.-) Mus musculus (Mouse) GO:0005229; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0046872 chloride transport [GO:0006821]; proteolysis [GO:0006508] plasma membrane [GO:0005886] intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g7139.t1 Q99JB0 54.922 193 1.4700000000000001e-64 203.0 sp|Q99JB0|KLF7_MOUSE Krueppel-like factor 7 OS=Mus musculus OX=10090 GN=Klf7 PE=1 SV=1 KLF7_MOUSE reviewed Krueppel-like factor 7 Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007409; GO:0007411; GO:0008270; GO:0042593; GO:0045604; GO:0045893; GO:0045944; GO:0048813; GO:0061179; GO:1904178 axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g7140.t1 O08584 54.118 85 5.610000000000001e-21 86.7 sp|O08584|KLF6_MOUSE Krueppel-like factor 6 OS=Mus musculus OX=10090 GN=Klf6 PE=2 SV=3 KLF6_MOUSE reviewed Krueppel-like factor 6 (Core promoter element-binding protein) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0008270; GO:0019221; GO:0045944; GO:1905205; GO:1990837 cytokine-mediated signaling pathway [GO:0019221]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g7141.t1 Q9NYL2 36.667 270 2.83e-51 183.0 sp|Q9NYL2|M3K20_HUMAN Mitogen-activated protein kinase kinase kinase 20 OS=Homo sapiens OX=9606 GN=MAP3K20 PE=1 SV=3 M3K20_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK) Homo sapiens (Human) GO:0000077; GO:0000165; GO:0000287; GO:0003723; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007010; GO:0007059; GO:0007254; GO:0008219; GO:0030071; GO:0030154; GO:0030295; GO:0031098; GO:0038066; GO:0042733; GO:0043022; GO:0043065; GO:0043068; GO:0046777; GO:0051403; GO:0060173; GO:0070181; GO:0070269; GO:0070303; GO:0071480; GO:0071493; GO:0106310; GO:0140469; GO:0170011; GO:1902010; GO:1904291 cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV-B [GO:0071493]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; GCN2-mediated signaling [GO:0140469]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; limb development [GO:0060173]; MAPK cascade [GO:0000165]; negative regulation of stress-activated protein kinase signaling cascade [GO:0070303]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; positive regulation of programmed cell death [GO:0043068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; stalled ribosome sensor activity [GO:0170011] g7146.t1 Q76IQ3 48.636 440 1.12e-145 428.0 sp|Q76IQ3|TY3H_CANLF Tyrosine 3-monooxygenase OS=Canis lupus familiaris OX=9615 GN=TH PE=2 SV=1 g7147.t1 Q8WV83 53.086 486 9.07e-174 502.0 sp|Q8WV83|S35F5_HUMAN Solute carrier family 35 member F5 OS=Homo sapiens OX=9606 GN=SLC35F5 PE=1 SV=1 g7151.t1 Q5ZHW4 85.648 216 1.1400000000000001e-132 374.0 sp|Q5ZHW4|RAB5B_CHICK Ras-related protein Rab-5B OS=Gallus gallus OX=9031 GN=RAB5B PE=2 SV=1 RAB5B_CHICK reviewed Ras-related protein Rab-5B (EC 3.6.5.2) Gallus gallus (Chicken) GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0016197; GO:0019003; GO:0030139; GO:0031901; GO:0046872; GO:0048227 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g7152.t1 F1MMV1 40.767 574 1.35e-147 448.0 sp|F1MMV1|EFHB_BOVIN EF-hand domain-containing family member B OS=Bos taurus OX=9913 GN=EFHB PE=1 SV=3 g7153.t1 Q9Y2I7 51.705 528 9.219999999999999e-150 503.0 sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3 FYV1_HUMAN reviewed 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) Homo sapiens (Human) GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506] 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g7153.t1 Q9Y2I7 33.852 514 2.17e-77 286.0 sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3 FYV1_HUMAN reviewed 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) Homo sapiens (Human) GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506] 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g7154.t1 Q9Y2I7 48.562 313 5.04e-89 300.0 sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3 FYV1_HUMAN reviewed 1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1) Homo sapiens (Human) GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506] 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g7158.t1 Q9Z1T6 41.103 399 1.33e-77 271.0 sp|Q9Z1T6|FYV1_MOUSE 1-phosphatidylinositol 3-phosphate 5-kinase OS=Mus musculus OX=10090 GN=Pikfyve PE=1 SV=3 g7159.t1 P54729 33.649 633 2.1600000000000002e-88 288.0 sp|P54729|NUB1_MOUSE NEDD8 ultimate buster 1 OS=Mus musculus OX=10090 GN=Nub1 PE=1 SV=2 NUB1_MOUSE reviewed NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Protein BS4) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0010498; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:0097413; GO:2000058 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Lewy body [GO:0097413]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g7160.t1 A2A6Q5 50.865 867 0.0 848.0 sp|A2A6Q5|CDC27_MOUSE Cell division cycle protein 27 homolog OS=Mus musculus OX=10090 GN=Cdc27 PE=1 SV=1 CDC27_MOUSE reviewed Cell division cycle protein 27 homolog Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0007091; GO:0016567; GO:0019903; GO:0031145; GO:0031175; GO:0051301; GO:0070936; GO:0070979; GO:0072686; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; neuron projection development [GO:0031175]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] protein phosphatase binding [GO:0019903] g7161.t1 Q9R2B6 36.082 194 2.63e-37 140.0 sp|Q9R2B6|SIA7D_MOUSE Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Mus musculus OX=10090 GN=St6galnac4 PE=1 SV=1 g7162.t1 O42131 31.939 526 1.72e-32 135.0 sp|O42131|TOP2B_CHICK DNA topoisomerase 2-beta OS=Gallus gallus OX=9031 GN=TOP2B PE=2 SV=1 TOP2B_CHICK reviewed DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme) Gallus gallus (Chicken) GO:0000712; GO:0000819; GO:0003677; GO:0003916; GO:0003918; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006265; GO:0030183; GO:0046872; GO:1990904 B cell differentiation [GO:0030183]; DNA topological change [GO:0006265]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872] g7163.t1 O42130 72.976 1025 0.0 1610.0 sp|O42130|TOP2A_CHICK DNA topoisomerase 2-alpha OS=Gallus gallus OX=9031 GN=TOP2A PE=2 SV=2 TOP2A_CHICK reviewed DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme) Gallus gallus (Chicken) GO:0000287; GO:0000712; GO:0000792; GO:0000793; GO:0000819; GO:0003677; GO:0003918; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006260; GO:0006265; GO:0006974; GO:0007059; GO:0008094; GO:0008301; GO:0009330; GO:0030263; GO:0030332; GO:0043065; GO:0048511; GO:0051301; GO:1990904 apoptotic chromosome condensation [GO:0030263]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; positive regulation of apoptotic process [GO:0043065]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819] chromosome [GO:0005694]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287] g7164.t1 Q17QG5 84.848 165 3.39e-101 291.0 sp|Q17QG5|UB2G2_BOVIN Ubiquitin-conjugating enzyme E2 G2 OS=Bos taurus OX=9913 GN=UBE2G2 PE=2 SV=1 UB2G2_BOVIN reviewed Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0036503; GO:0061631; GO:0070936 ERAD pathway [GO:0036503]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g7166.t1 C0HL13 39.925 1866 0.0 1180.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 30.787 1296 1.6399999999999998e-134 471.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 33.862 694 6.17e-106 382.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 33.729 759 3.44e-104 377.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 32.63 711 5.9599999999999995e-84 311.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 31.325 747 8.14e-76 285.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 29.437 693 8.39e-65 249.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 36.426 291 8.660000000000001e-35 150.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 33.542 319 6.36e-28 127.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 26.765 340 3.72e-27 125.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7166.t1 C0HL13 30.53 321 3.98e-26 122.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g7167.t1 Q14995 38.506 174 1.2499999999999999e-34 144.0 sp|Q14995|NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens OX=9606 GN=NR1D2 PE=1 SV=4 NR1D2_HUMAN reviewed Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030522; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g7167.t1 Q14995 54.545 88 7.329999999999999e-25 114.0 sp|Q14995|NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens OX=9606 GN=NR1D2 PE=1 SV=4 NR1D2_HUMAN reviewed Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0030522; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; lipid homeostasis [GO:0055088]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g7168.t1 P70701 44.687 367 3.41e-101 309.0 sp|P70701|WN10A_MOUSE Protein Wnt-10a OS=Mus musculus OX=10090 GN=Wnt10a PE=2 SV=1 WN10A_MOUSE reviewed Protein Wnt-10a Mus musculus (Mouse) GO:0001942; GO:0005102; GO:0005109; GO:0005125; GO:0005615; GO:0007165; GO:0007267; GO:0009887; GO:0010628; GO:0014033; GO:0030182; GO:0031069; GO:0042476; GO:0042487; GO:0043586; GO:0043588; GO:0045165; GO:0048018; GO:0048730; GO:0048733; GO:0060070; GO:0071560 animal organ morphogenesis [GO:0009887]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skin development [GO:0043588]; tongue development [GO:0043586] extracellular space [GO:0005615] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102] g7169.t1 Q14596 33.793 435 7.9e-55 211.0 sp|Q14596|NBR1_HUMAN Next to BRCA1 gene 1 protein OS=Homo sapiens OX=9606 GN=NBR1 PE=1 SV=3 NBR1_HUMAN reviewed Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B) Homo sapiens (Human) GO:0000407; GO:0005654; GO:0005758; GO:0005764; GO:0005770; GO:0005776; GO:0005778; GO:0005829; GO:0008270; GO:0016020; GO:0016236; GO:0016604; GO:0030500; GO:0031430; GO:0032872; GO:0043130; GO:0043235; GO:0045668; GO:0051019 macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872] autophagosome [GO:0005776]; cytosol [GO:0005829]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235] mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g7172.t1 F1MNN4 31.193 436 5.3099999999999995e-55 204.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g7173.t1 Q8WPD0 35.673 171 1.23e-25 103.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g7182.t1 Q08E43 50.877 285 4.79e-103 305.0 sp|Q08E43|ASB8_BOVIN Ankyrin repeat and SOCS box protein 8 OS=Bos taurus OX=9913 GN=ASB8 PE=2 SV=1 g7186.t1 Q9JMH7 32.506 443 1.0099999999999999e-55 193.0 sp|Q9JMH7|NEUR3_MOUSE Sialidase-3 OS=Mus musculus OX=10090 GN=Neu3 PE=1 SV=1 NEUR3_MOUSE reviewed Sialidase-3 (EC 3.2.1.18) (Ganglioside sialidase) (Membrane sialidase) (N-acetyl-alpha-neuraminidase 3) Mus musculus (Mouse) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0005901; GO:0005975; GO:0006689; GO:0009313; GO:0009897; GO:0016020; GO:0016997; GO:0031901; GO:0045742; GO:0055038; GO:1900186 carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; oligosaccharide catabolic process [GO:0009313]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742] caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] alpha-sialidase activity [GO:0016997]; exo-alpha-sialidase activity [GO:0004308] g7188.t1 Q9IBG7 36.967 798 5.39e-136 471.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t1 Q9IBG7 34.395 785 4e-99 358.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t1 Q9IBG7 34.332 801 1.81e-96 350.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t1 Q9IBG7 35.032 785 1.78e-92 337.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t1 Q9IBG7 34.071 813 3.49e-92 336.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t1 Q9IBG7 35.797 690 2.4899999999999998e-89 327.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t1 Q9IBG7 33.057 723 5.86e-83 306.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t2 Q9IBG7 36.967 798 3.5699999999999997e-134 471.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t2 Q9IBG7 34.395 785 1.49e-98 358.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t2 Q9IBG7 35.032 785 3.38e-92 338.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t2 Q9IBG7 34.071 813 8.43e-92 337.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t2 Q9IBG7 33.057 723 1.2999999999999999e-82 307.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t3 Q9IBG7 39.175 2037 0.0 1295.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t3 Q9IBG7 34.436 1632 0.0 783.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t3 Q9IBG7 35.283 1573 0.0 776.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t3 Q9IBG7 34.038 852 2.09e-90 334.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t3 Q9IBG7 34.235 739 3.76e-83 310.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t4 Q9IBG7 41.146 1536 0.0 1071.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t4 Q9IBG7 33.119 1244 6.84e-145 496.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t4 Q9IBG7 32.572 1139 6.460000000000001e-129 448.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7188.t4 Q9IBG7 33.27 1049 5.5200000000000005e-118 415.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g7192.t1 Q9W725 65.484 310 5.249999999999999e-140 400.0 sp|Q9W725|UCP2_CYPCA Dicarboxylate carrier UCP2 OS=Cyprinus carpio OX=7962 GN=ucp2 PE=2 SV=1 g7193.t1 Q9BYK8 31.489 1645 0.0 686.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7193.t1 Q9BYK8 29.94 1169 6.43e-110 399.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7193.t1 Q9BYK8 32.797 311 1.72e-27 127.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7194.t1 Q9BYK8 33.302 1063 3.5199999999999997e-147 489.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7195.t1 Q9BYK8 27.784 1832 9.170000000000001e-163 567.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7195.t1 Q9BYK8 29.739 306 8.199999999999999e-23 111.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7196.t1 Q9BYK8 31.481 1674 0.0 713.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7196.t1 Q9BYK8 29.601 1179 1.05e-121 438.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g7197.t1 Q5VXM1 28.086 324 1.23e-25 117.0 sp|Q5VXM1|CDCP2_HUMAN CUB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CDCP2 PE=2 SV=2 g7198.t1 O70244 25.487 616 5.6e-29 131.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7198.t1 O70244 23.577 615 1.1799999999999999e-23 114.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7198.t1 O70244 23.871 620 5.0899999999999995e-23 111.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7198.t1 O70244 23.748 619 3.14e-21 105.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7198.t1 O70244 23.153 609 4.47e-21 105.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g7201.t1 O54750 28.977 528 2.16e-59 208.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 CP2J6_MOUSE reviewed Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6) Mus musculus (Mouse) GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0032760; GO:0032966; GO:0035359; GO:0043651; GO:0045722; GO:0071614; GO:1903055 epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of tumor necrosis factor production [GO:0032760]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g7202.t1 Q5U3N0 38.768 552 1.9500000000000002e-122 373.0 sp|Q5U3N0|PKHA8_DANRE Pleckstrin homology domain-containing family A member 8 OS=Danio rerio OX=7955 GN=plekha8 PE=2 SV=1 g7205.t1 A7J1T0 46.779 947 0.0 701.0 sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis OX=8355 GN=map3k13-b PE=2 SV=1 M313B_XENLA reviewed Mitogen-activated protein kinase kinase kinase 13-B (EC 2.7.11.25) Xenopus laevis (African clawed frog) GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0007254; GO:0016020; GO:0051403; GO:0106310 JNK cascade [GO:0007254]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; membrane [GO:0016020] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7207.t1 Q9UM22 41.808 177 5.23e-46 157.0 sp|Q9UM22|EPDR1_HUMAN Mammalian ependymin-related protein 1 OS=Homo sapiens OX=9606 GN=EPDR1 PE=1 SV=2 g7209.t1 Q9NSI2 40.0 130 1.8000000000000003e-21 91.7 sp|Q9NSI2|SLX9_HUMAN Ribosome biogenesis protein SLX9 homolog OS=Homo sapiens OX=9606 GN=SLX9 PE=1 SV=2 g7211.t1 P31327 62.958 1474 0.0 1951.0 sp|P31327|CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia], mitochondrial OS=Homo sapiens OX=9606 GN=CPS1 PE=1 SV=2 CPSM_HUMAN reviewed Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I) Homo sapiens (Human) GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341; GO:0097225; GO:0097228; GO:0097305 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to alcohol [GO:0097305]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; potassium ion binding [GO:0030955]; protein-containing complex binding [GO:0044877]; small molecule binding [GO:0036094] g7212.t1 O75165 61.712 2267 0.0 2840.0 sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5 DJC13_HUMAN reviewed DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8) Homo sapiens (Human) GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0070062; GO:1902954; GO:2000641 endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] g7212.t2 O75165 61.684 2268 0.0 2838.0 sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5 DJC13_HUMAN reviewed DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8) Homo sapiens (Human) GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0070062; GO:1902954; GO:2000641 endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] g7217.t1 Q5RC02 40.961 874 0.0 669.0 sp|Q5RC02|SYAC_PONAB Alanine--tRNA ligase, cytoplasmic OS=Pongo abelii OX=9601 GN=AARS1 PE=2 SV=1 SYAC_PONAB reviewed Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein lactyltransferase AARS1) (EC 6.-.-.-) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0035332; GO:0141207; GO:1901797 alanyl-tRNA aminoacylation [GO:0006419]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of hippo signaling [GO:0035332]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] alanine-tRNA ligase activity [GO:0004813]; aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; peptide lactyltransferase (ATP-dependent) activity [GO:0141207]; Ser-tRNA(Ala) deacylase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g7220.t1 Q8N2E2 34.988 1612 0.0 942.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g7220.t2 Q8N2E2 35.918 1612 0.0 992.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g7222.t1 Q9GZR5 55.144 243 7.25e-95 284.0 sp|Q9GZR5|ELOV4_HUMAN Very long chain fatty acid elongase 4 OS=Homo sapiens OX=9606 GN=ELOVL4 PE=1 SV=1 ELOV4_HUMAN reviewed Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761 fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020] g7225.t1 P97411 63.929 280 5.9e-124 373.0 sp|P97411|ICA69_MOUSE Islet cell autoantigen 1 OS=Mus musculus OX=10090 GN=Ica1 PE=1 SV=3 ICA69_MOUSE reviewed Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69) Mus musculus (Mouse) GO:0000139; GO:0005795; GO:0005829; GO:0006836; GO:0019904; GO:0030425; GO:0030667; GO:0030672; GO:0043254; GO:0046928; GO:0048471; GO:0051046; GO:0097753; GO:0140090 membrane bending [GO:0097753]; neurotransmitter transport [GO:0006836]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein-containing complex assembly [GO:0043254]; regulation of secretion [GO:0051046] cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] membrane curvature sensor activity [GO:0140090]; protein domain specific binding [GO:0019904] g7226.t1 Q9WV76 38.005 742 0.0 547.0 sp|Q9WV76|AP4B1_MOUSE AP-4 complex subunit beta-1 OS=Mus musculus OX=10090 GN=Ap4b1 PE=1 SV=2 AP4B1_MOUSE reviewed AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin) Mus musculus (Mouse) GO:0005802; GO:0005829; GO:0006605; GO:0006886; GO:0016192; GO:0030124; GO:0030131; GO:0030276; GO:0061938; GO:0098541 intracellular protein transport [GO:0006886]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic side of trans-Golgi network transport vesicle membrane [GO:0098541]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802] clathrin binding [GO:0030276] g7227.t1 Q03637 34.037 379 5.879999999999999e-38 149.0 sp|Q03637|COLQ_TORMA Acetylcholinesterase collagenic tail peptide OS=Torpedo marmorata OX=7788 PE=1 SV=1 g7229.t1 Q96PY6 50.943 265 2.5e-81 281.0 sp|Q96PY6|NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens OX=9606 GN=NEK1 PE=1 SV=2 NEK1_HUMAN reviewed Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) Homo sapiens (Human) GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310 cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g7231.t1 Q93092 68.807 327 1.9e-168 474.0 sp|Q93092|TALDO_MOUSE Transaldolase OS=Mus musculus OX=10090 GN=Taldo1 PE=1 SV=2 g7232.t1 Q9WUW8 38.267 277 3.65e-56 187.0 sp|Q9WUW8|ST1C2_RAT Sulfotransferase 1C2 OS=Rattus norvegicus OX=10116 GN=Sult1c2 PE=1 SV=2 ST1C2_RAT reviewed Sulfotransferase 1C2 (ST1C2) (rSULT1C2) (EC 2.8.2.1) (Sulfotransferase K1) Rattus norvegicus (Rat) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0051922; GO:0051923 sulfation [GO:0051923] cytoplasm [GO:0005737]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922] g7233.t1 Q8JG30 38.462 273 1.9600000000000002e-59 195.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g7234.t1 Q9H0E2 47.586 290 4.95e-78 240.0 sp|Q9H0E2|TOLIP_HUMAN Toll-interacting protein OS=Homo sapiens OX=9606 GN=TOLLIP PE=1 SV=1 TOLIP_HUMAN reviewed Toll-interacting protein Homo sapiens (Human) GO:0005150; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019897; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0045087; GO:0045321; GO:0048471; GO:0060090; GO:0070062; GO:0070498 autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of plasma membrane [GO:0019897]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625] g7236.t1 Q5RF10 67.984 506 0.0 734.0 sp|Q5RF10|CATA_PONAB Catalase OS=Pongo abelii OX=9601 GN=CAT PE=2 SV=3 CATA_PONAB reviewed Catalase (EC 1.11.1.6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004046; GO:0004096; GO:0005739; GO:0005778; GO:0005782; GO:0006641; GO:0008203; GO:0009060; GO:0009650; GO:0019899; GO:0020027; GO:0020037; GO:0042744; GO:0042803; GO:0043066; GO:0046872; GO:0050661; GO:0051781; GO:0051897; GO:0061692; GO:0062151 aerobic respiration [GO:0009060]; cellular detoxification of hydrogen peroxide [GO:0061692]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell division [GO:0051781]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650] catalase complex [GO:0062151]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778] aminoacylase activity [GO:0004046]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803] g7237.t1 Q3HNM7 36.449 535 3.32e-98 312.0 sp|Q3HNM7|INSC_MOUSE Protein inscuteable homolog OS=Mus musculus OX=10090 GN=Insc PE=1 SV=2 INSC_MOUSE reviewed Protein inscuteable homolog (Minsc) Mus musculus (Mouse) GO:0005886; GO:0007399; GO:0008093; GO:0008356; GO:0009786; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991; GO:0045176; GO:0045179 apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647] apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674] g7238.t1 A0A1L8F5J9 48.463 846 0.0 835.0 sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1 NMDZ1_XENLA reviewed Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1) Xenopus laevis (African clawed frog) GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015276; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839 calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725] neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated monoatomic ion channel activity [GO:0015276]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023] g7240.t1 Q0IIF9 34.653 505 6.44e-94 298.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g7248.t1 Q91827 32.468 154 9.930000000000001e-21 89.0 sp|Q91827|AR1_XENLA Apoptosis regulator R1 (Fragment) OS=Xenopus laevis OX=8355 PE=2 SV=1 g7251.t1 Q8VDV3 44.272 323 4.6200000000000004e-77 248.0 sp|Q8VDV3|R3GEF_MOUSE Guanine nucleotide exchange factor for Rab-3A OS=Mus musculus OX=10090 GN=Rab3il1 PE=1 SV=1 g7261.t1 Q08289 70.522 441 0.0 595.0 sp|Q08289|CACB2_HUMAN Voltage-dependent L-type calcium channel subunit beta-2 OS=Homo sapiens OX=9606 GN=CACNB2 PE=1 SV=3 CACB2_HUMAN reviewed Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2) (Lambert-Eaton myasthenic syndrome antigen B) (MYSB) Homo sapiens (Human) GO:0005245; GO:0005262; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0007528; GO:0007601; GO:0045933; GO:0051015; GO:0051928; GO:0070509; GO:0070588; GO:0072659; GO:0086045; GO:0086091; GO:0098684; GO:0098793; GO:0098912; GO:0099626; GO:1904879; GO:1990454 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; neuromuscular junction development [GO:0007528]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of muscle contraction [GO:0045933]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; visual perception [GO:0007601] L-type voltage-gated calcium channel complex [GO:1990454]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891] actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g7261.t2 Q08289 70.522 441 0.0 594.0 sp|Q08289|CACB2_HUMAN Voltage-dependent L-type calcium channel subunit beta-2 OS=Homo sapiens OX=9606 GN=CACNB2 PE=1 SV=3 CACB2_HUMAN reviewed Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2) (Lambert-Eaton myasthenic syndrome antigen B) (MYSB) Homo sapiens (Human) GO:0005245; GO:0005262; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0007528; GO:0007601; GO:0045933; GO:0051015; GO:0051928; GO:0070509; GO:0070588; GO:0072659; GO:0086045; GO:0086091; GO:0098684; GO:0098793; GO:0098912; GO:0099626; GO:1904879; GO:1990454 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; neuromuscular junction development [GO:0007528]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of muscle contraction [GO:0045933]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; visual perception [GO:0007601] L-type voltage-gated calcium channel complex [GO:1990454]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891] actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g7261.t3 Q08289 64.135 474 0.0 570.0 sp|Q08289|CACB2_HUMAN Voltage-dependent L-type calcium channel subunit beta-2 OS=Homo sapiens OX=9606 GN=CACNB2 PE=1 SV=3 CACB2_HUMAN reviewed Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2) (Lambert-Eaton myasthenic syndrome antigen B) (MYSB) Homo sapiens (Human) GO:0005245; GO:0005262; GO:0005886; GO:0005891; GO:0006816; GO:0007268; GO:0007528; GO:0007601; GO:0045933; GO:0051015; GO:0051928; GO:0070509; GO:0070588; GO:0072659; GO:0086045; GO:0086091; GO:0098684; GO:0098793; GO:0098912; GO:0099626; GO:1904879; GO:1990454 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; neuromuscular junction development [GO:0007528]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of muscle contraction [GO:0045933]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; visual perception [GO:0007601] L-type voltage-gated calcium channel complex [GO:1990454]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891] actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g7262.t1 Q5ZKX6 63.636 187 1.2700000000000001e-86 255.0 sp|Q5ZKX6|UBE2F_CHICK NEDD8-conjugating enzyme UBE2F OS=Gallus gallus OX=9031 GN=UBE2F PE=2 SV=1 UBE2F_CHICK reviewed NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F) Gallus gallus (Chicken) GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654 protein neddylation [GO:0045116] cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788] g7264.t1 Q6NWF4 61.272 173 1.82e-82 244.0 sp|Q6NWF4|VPS25_DANRE Vacuolar protein-sorting-associated protein 25 OS=Danio rerio OX=7955 GN=vps25 PE=2 SV=2 g7273.t1 G8JYB2 48.767 730 0.0 682.0 sp|G8JYB2|CTNL1_CAEEL Alpha-catulin OS=Caenorhabditis elegans OX=6239 GN=ctn-1 PE=1 SV=1 CTNL1_CAEEL reviewed Alpha-catulin Caenorhabditis elegans GO:0005886; GO:0007155; GO:0007266; GO:0040012; GO:0045296; GO:0051015; GO:0055120 cell adhesion [GO:0007155]; regulation of locomotion [GO:0040012]; Rho protein signal transduction [GO:0007266] plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120] actin filament binding [GO:0051015]; cadherin binding [GO:0045296] g7273.t2 G8JYB2 48.435 735 0.0 676.0 sp|G8JYB2|CTNL1_CAEEL Alpha-catulin OS=Caenorhabditis elegans OX=6239 GN=ctn-1 PE=1 SV=1 CTNL1_CAEEL reviewed Alpha-catulin Caenorhabditis elegans GO:0005886; GO:0007155; GO:0007266; GO:0040012; GO:0045296; GO:0051015; GO:0055120 cell adhesion [GO:0007155]; regulation of locomotion [GO:0040012]; Rho protein signal transduction [GO:0007266] plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120] actin filament binding [GO:0051015]; cadherin binding [GO:0045296] g7273.t3 G8JYB2 48.831 727 0.0 677.0 sp|G8JYB2|CTNL1_CAEEL Alpha-catulin OS=Caenorhabditis elegans OX=6239 GN=ctn-1 PE=1 SV=1 CTNL1_CAEEL reviewed Alpha-catulin Caenorhabditis elegans GO:0005886; GO:0007155; GO:0007266; GO:0040012; GO:0045296; GO:0051015; GO:0055120 cell adhesion [GO:0007155]; regulation of locomotion [GO:0040012]; Rho protein signal transduction [GO:0007266] plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120] actin filament binding [GO:0051015]; cadherin binding [GO:0045296] g7278.t1 P24053 29.836 305 2.3300000000000004e-27 114.0 sp|P24053|NMBR_RAT Neuromedin-B receptor OS=Rattus norvegicus OX=10116 GN=Nmbr PE=2 SV=1 g7279.t1 P24053 30.492 305 4.3200000000000004e-29 118.0 sp|P24053|NMBR_RAT Neuromedin-B receptor OS=Rattus norvegicus OX=10116 GN=Nmbr PE=2 SV=1 g7283.t1 P04058 36.38 558 6.660000000000001e-110 343.0 sp|P04058|ACES_TETCF Acetylcholinesterase OS=Tetronarce californica OX=7787 GN=ache PE=1 SV=2 g7284.t1 P04058 35.728 529 3.26e-101 320.0 sp|P04058|ACES_TETCF Acetylcholinesterase OS=Tetronarce californica OX=7787 GN=ache PE=1 SV=2 g7285.t1 Q8WXX0 69.056 4004 0.0 5796.0 sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2 DYH7_HUMAN reviewed Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2) Homo sapiens (Human) GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g7285.t2 Q8WXX0 68.935 4011 0.0 5792.0 sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2 DYH7_HUMAN reviewed Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2) Homo sapiens (Human) GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g7287.t1 D4A6L0 30.978 736 7.16e-96 329.0 sp|D4A6L0|MGLYR_RAT Metabotropic glycine receptor OS=Rattus norvegicus OX=10116 GN=Gpr158 PE=1 SV=1 MGLYR_RAT reviewed Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158) Rattus norvegicus (Rat) GO:0001956; GO:0004888; GO:0005634; GO:0005886; GO:0007186; GO:0007420; GO:0008047; GO:0008277; GO:0016020; GO:0042734; GO:0045211; GO:0045744; GO:0050807; GO:0050890; GO:0072659; GO:0098839; GO:0160079 brain development [GO:0007420]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of neurotransmitter secretion [GO:0001956]; protein localization to plasma membrane [GO:0072659]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synapse organization [GO:0050807] membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] enzyme activator activity [GO:0008047]; G protein-coupled glycine receptor activity [GO:0160079]; transmembrane signaling receptor activity [GO:0004888] g7294.t1 P46023 33.68 481 7.75e-74 258.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g7296.t1 Q9WV04 52.963 793 0.0 818.0 sp|Q9WV04|KIF9_MOUSE Kinesin-like protein KIF9 OS=Mus musculus OX=10090 GN=Kif9 PE=1 SV=2 KIF9_MOUSE reviewed Kinesin-like protein KIF9 Mus musculus (Mouse) GO:0002102; GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005879; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0036126; GO:0042802; GO:0071801; GO:1901317; GO:1903008 extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801] axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; sperm flagellum [GO:0036126]; vesicle [GO:0031982] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g7304.t1 P0C5Y8 25.256 586 5.05e-39 157.0 sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1 ALS2_RAT reviewed Alsin (Amyotrophic lateral sclerosis 2 protein homolog) Rattus norvegicus (Rat) GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072 axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] g7304.t1 P0C5Y8 47.541 122 7.82e-27 120.0 sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1 ALS2_RAT reviewed Alsin (Amyotrophic lateral sclerosis 2 protein homolog) Rattus norvegicus (Rat) GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072 axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] g7305.t1 Q920R0 35.061 328 1.76e-53 195.0 sp|Q920R0|ALS2_MOUSE Alsin OS=Mus musculus OX=10090 GN=Als2 PE=1 SV=3 ALS2_MOUSE reviewed Alsin (Amyotrophic lateral sclerosis 2 protein homolog) Mus musculus (Mouse) GO:0001662; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072 axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] g7305.t2 Q920R0 34.024 338 9.19e-51 187.0 sp|Q920R0|ALS2_MOUSE Alsin OS=Mus musculus OX=10090 GN=Als2 PE=1 SV=3 ALS2_MOUSE reviewed Alsin (Amyotrophic lateral sclerosis 2 protein homolog) Mus musculus (Mouse) GO:0001662; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072 axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] g7307.t1 Q96Q42 41.612 608 7.82e-135 433.0 sp|Q96Q42|ALS2_HUMAN Alsin OS=Homo sapiens OX=9606 GN=ALS2 PE=1 SV=2 g7308.t1 O00522 37.338 308 1.3099999999999999e-61 211.0 sp|O00522|KRIT1_HUMAN Krev interaction trapped protein 1 OS=Homo sapiens OX=9606 GN=KRIT1 PE=1 SV=2 KRIT1_HUMAN reviewed Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein) Homo sapiens (Human) GO:0001525; GO:0001937; GO:0003158; GO:0005546; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0007264; GO:0008017; GO:0010596; GO:0016525; GO:0030695; GO:0032991; GO:0033622; GO:0045454; GO:0045765; GO:2000114; GO:2000352 angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; endothelium development [GO:0003158]; integrin activation [GO:0033622]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; regulation of angiogenesis [GO:0045765]; regulation of establishment of cell polarity [GO:2000114]; small GTPase-mediated signal transduction [GO:0007264] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g7309.t1 Q6S5J6 43.723 231 3.71e-53 186.0 sp|Q6S5J6|KRIT1_MOUSE Krev interaction trapped protein 1 OS=Mus musculus OX=10090 GN=Krit1 PE=1 SV=1 KRIT1_MOUSE reviewed Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein homolog) Mus musculus (Mouse) GO:0001525; GO:0001937; GO:0003158; GO:0005546; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0008017; GO:0010596; GO:0016525; GO:0030695; GO:0032991; GO:0033622; GO:0045454; GO:0045765; GO:2000114; GO:2000352 angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; endothelium development [GO:0003158]; integrin activation [GO:0033622]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; regulation of angiogenesis [GO:0045765]; regulation of establishment of cell polarity [GO:2000114] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g7310.t1 Q6ZS30 42.435 2710 0.0 2120.0 sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3 g7310.t2 Q6ZS30 42.435 2710 0.0 2120.0 sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3 g7310.t3 Q6ZS30 42.498 2706 0.0 2123.0 sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3 g7311.t1 Q9HCG8 62.47 413 2.31e-171 516.0 sp|Q9HCG8|CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog OS=Homo sapiens OX=9606 GN=CWC22 PE=1 SV=3 g7312.t1 Q52KN9 52.885 208 5.49e-50 181.0 sp|Q52KN9|CWC22_XENLA Pre-mRNA-splicing factor CWC22 homolog OS=Xenopus laevis OX=8355 GN=cwc22 PE=2 SV=1 g7314.t1 Q9ESN6 31.472 197 1.2999999999999998e-23 106.0 sp|Q9ESN6|TRIM2_MOUSE Tripartite motif-containing protein 2 OS=Mus musculus OX=10090 GN=Trim2 PE=1 SV=1 TRIM2_MOUSE reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (Neural activity-related RING finger protein) (RING-type E3 ubiquitin transferase TRIM2) Mus musculus (Mouse) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0017022; GO:0043161; GO:0043523; GO:0061630; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g7316.t1 Q9JIP7 42.247 632 4.88e-156 474.0 sp|Q9JIP7|S15A1_MOUSE Solute carrier family 15 member 1 OS=Mus musculus OX=10090 GN=Slc15a1 PE=1 SV=2 S15A1_MOUSE reviewed Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1) (Proton-coupled dipeptide cotransporter) Mus musculus (Mouse) GO:0005427; GO:0005886; GO:0005903; GO:0006857; GO:0015031; GO:0015333; GO:0016020; GO:0016248; GO:0016324; GO:0042937; GO:0051956; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; negative regulation of amino acid transport [GO:0051956]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; membrane [GO:0016020]; plasma membrane [GO:0005886] channel inhibitor activity [GO:0016248]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; tripeptide transmembrane transporter activity [GO:0042937] g7316.t2 Q9JIP7 42.247 632 4.78e-156 473.0 sp|Q9JIP7|S15A1_MOUSE Solute carrier family 15 member 1 OS=Mus musculus OX=10090 GN=Slc15a1 PE=1 SV=2 S15A1_MOUSE reviewed Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1) (Proton-coupled dipeptide cotransporter) Mus musculus (Mouse) GO:0005427; GO:0005886; GO:0005903; GO:0006857; GO:0015031; GO:0015333; GO:0016020; GO:0016248; GO:0016324; GO:0042937; GO:0051956; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; negative regulation of amino acid transport [GO:0051956]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; membrane [GO:0016020]; plasma membrane [GO:0005886] channel inhibitor activity [GO:0016248]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; tripeptide transmembrane transporter activity [GO:0042937] g7316.t3 Q9JIP7 42.247 632 2.6200000000000003e-156 473.0 sp|Q9JIP7|S15A1_MOUSE Solute carrier family 15 member 1 OS=Mus musculus OX=10090 GN=Slc15a1 PE=1 SV=2 S15A1_MOUSE reviewed Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1) (Proton-coupled dipeptide cotransporter) Mus musculus (Mouse) GO:0005427; GO:0005886; GO:0005903; GO:0006857; GO:0015031; GO:0015333; GO:0016020; GO:0016248; GO:0016324; GO:0042937; GO:0051956; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; negative regulation of amino acid transport [GO:0051956]; oligopeptide transport [GO:0006857]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; membrane [GO:0016020]; plasma membrane [GO:0005886] channel inhibitor activity [GO:0016248]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; tripeptide transmembrane transporter activity [GO:0042937] g7317.t1 Q8N3P4 38.209 335 1.32e-57 203.0 sp|Q8N3P4|VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens OX=9606 GN=VPS8 PE=1 SV=3 VPS8_HUMAN reviewed Vacuolar protein sorting-associated protein 8 homolog Homo sapiens (Human) GO:0005769; GO:0005770; GO:0006623; GO:0008270; GO:0030897; GO:0033263; GO:0034058; GO:0035542 endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542] CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770] zinc ion binding [GO:0008270] g7318.t1 Q0P5W1 51.003 1047 0.0 1075.0 sp|Q0P5W1|VPS8_MOUSE Vacuolar protein sorting-associated protein 8 homolog OS=Mus musculus OX=10090 GN=Vps8 PE=1 SV=1 VPS8_MOUSE reviewed Vacuolar protein sorting-associated protein 8 homolog Mus musculus (Mouse) GO:0005769; GO:0005770; GO:0006623; GO:0008270; GO:0030897; GO:0033263; GO:0034058 endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623] CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770] zinc ion binding [GO:0008270] g7319.t1 Q9DBR3 57.099 655 0.0 748.0 sp|Q9DBR3|ARMC8_MOUSE Armadillo repeat-containing protein 8 OS=Mus musculus OX=10090 GN=Armc8 PE=1 SV=2 g7321.t1 Q8K1N4 36.612 183 6.5e-25 111.0 sp|Q8K1N4|SPAS2_MOUSE Spermatogenesis-associated serine-rich protein 2 OS=Mus musculus OX=10090 GN=Spats2 PE=1 SV=1 g7322.t1 Q96EZ8 61.239 436 0.0 532.0 sp|Q96EZ8|MCRS1_HUMAN Microspherule protein 1 OS=Homo sapiens OX=9606 GN=MCRS1 PE=1 SV=1 MCRS1_HUMAN reviewed Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2) Homo sapiens (Human) GO:0000123; GO:0000723; GO:0000776; GO:0000922; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005764; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008266; GO:0010521; GO:0016604; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0034451; GO:0036211; GO:0043204; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051726; GO:0060382; GO:0071339; GO:1904357; GO:1904507; GO:1904751 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; kinetochore [GO:0000776]; lysosome [GO:0005764]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; spindle pole [GO:0000922] G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521] g7326.t1 Q9PTJ6 64.706 272 1.24e-116 338.0 sp|Q9PTJ6|CTDSL_CHICK CTD small phosphatase-like protein OS=Gallus gallus OX=9031 GN=NFI1 PE=2 SV=2 g7326.t2 Q9PTJ6 64.945 271 5.3e-116 336.0 sp|Q9PTJ6|CTDSL_CHICK CTD small phosphatase-like protein OS=Gallus gallus OX=9031 GN=NFI1 PE=2 SV=2 g7327.t1 Q62468 44.994 829 0.0 706.0 sp|Q62468|VILI_MOUSE Villin-1 OS=Mus musculus OX=10090 GN=Vil1 PE=1 SV=3 g7327.t1 Q62468 30.607 379 2.0100000000000002e-32 139.0 sp|Q62468|VILI_MOUSE Villin-1 OS=Mus musculus OX=10090 GN=Vil1 PE=1 SV=3 g7327.t2 P02640 45.048 828 0.0 707.0 sp|P02640|VILI_CHICK Villin-1 OS=Gallus gallus OX=9031 GN=VIL1 PE=1 SV=2 g7327.t2 P02640 32.727 385 6.48e-38 155.0 sp|P02640|VILI_CHICK Villin-1 OS=Gallus gallus OX=9031 GN=VIL1 PE=1 SV=2 g7329.t1 Q769J6 33.204 774 7.55e-105 359.0 sp|Q769J6|ATS13_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Mus musculus OX=10090 GN=Adamts13 PE=1 SV=1 ATS13_MOUSE reviewed A disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAM-TS 13) (ADAM-TS13) (ADAMTS-13) (EC 3.4.24.87) (von Willebrand factor-cleaving protease) (vWF-CP) (vWF-cleaving protease) Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0007596; GO:0008233; GO:0009636; GO:0014075; GO:0030163; GO:0030198; GO:0031012; GO:0035864; GO:0043171; GO:0046872; GO:0071222; GO:0071346; GO:0071353; GO:0071356 blood coagulation [GO:0007596]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; extracellular matrix organization [GO:0030198]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to amine [GO:0014075]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233] g7330.t1 P35992 28.007 1089 2.05e-94 347.0 sp|P35992|PTP10_DROME Tyrosine-protein phosphatase 10D OS=Drosophila melanogaster OX=7227 GN=Ptp10D PE=1 SV=4 PTP10_DROME reviewed Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D) Drosophila melanogaster (Fruit fly) GO:0004725; GO:0005001; GO:0007165; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016020; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446; GO:0099156; GO:0140177 axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; cell-cell signaling via exosome [GO:0099156]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; signal transduction [GO:0007165] apical part of cell [GO:0045177]; axon [GO:0030424]; membrane [GO:0016020] membrane-membrane adaptor activity [GO:0140177]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g7331.t1 Q68US5 30.317 221 2.7000000000000004e-26 108.0 sp|Q68US5|EVA1C_PANTR Protein eva-1 homolog C OS=Pan troglodytes OX=9598 GN=EVA1C PE=3 SV=1 g7331.t2 Q68US5 31.818 198 2.27e-25 107.0 sp|Q68US5|EVA1C_PANTR Protein eva-1 homolog C OS=Pan troglodytes OX=9598 GN=EVA1C PE=3 SV=1 g7332.t1 Q9PVW8 34.459 296 1.96e-36 141.0 sp|Q9PVW8|SAL_SILAS Rhamnose-binding lectin OS=Silurus asotus OX=30991 PE=1 SV=1 g7334.t1 Q62981 26.415 424 4.5e-32 134.0 sp|Q62981|ZN260_RAT Zinc finger protein 260 OS=Rattus norvegicus OX=10116 GN=Znf260 PE=1 SV=1 g7334.t2 Q62981 26.415 424 5.31e-32 134.0 sp|Q62981|ZN260_RAT Zinc finger protein 260 OS=Rattus norvegicus OX=10116 GN=Znf260 PE=1 SV=1 g7335.t1 Q32KN7 52.174 138 7.180000000000001e-33 127.0 sp|Q32KN7|ZC21B_BOVIN Zinc finger C2HC domain-containing protein 1B OS=Bos taurus OX=9913 GN=ZC2HC1B PE=2 SV=1 g7336.t1 F1MS15 28.685 251 6.79e-29 120.0 sp|F1MS15|PKHA8_BOVIN Pleckstrin homology domain-containing family A member 8 OS=Bos taurus OX=9913 GN=PLEKHA8 PE=3 SV=2 g7340.t1 O76536 29.837 734 2.16e-38 160.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7340.t1 O76536 30.385 780 1.54e-35 151.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7340.t1 O76536 29.474 760 3.93e-34 146.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7340.t1 O76536 29.759 746 7.5899999999999996e-34 145.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7340.t1 O76536 28.465 671 2.08e-21 105.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7341.t1 O76536 30.584 994 3.71e-59 228.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7341.t1 O76536 28.858 998 5.2999999999999996e-55 215.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7341.t1 O76536 28.911 1010 1.15e-52 207.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7341.t1 O76536 29.885 957 1.25e-44 181.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7341.t1 O76536 30.174 517 2.0299999999999998e-24 115.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7342.t1 P35223 75.921 814 0.0 1229.0 sp|P35223|CTNB_TRIGR Catenin beta OS=Tripneustes gratilla OX=7673 PE=2 SV=1 g7344.t1 Q6DHJ3 42.563 437 1.58e-109 334.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g7345.t1 Q8CH62 46.721 122 1.64e-29 107.0 sp|Q8CH62|LTO1_MOUSE Protein LTO1 homolog OS=Mus musculus OX=10090 GN=Lto1 PE=1 SV=1 g7346.t1 B1WAX6 50.676 148 3.52e-36 135.0 sp|B1WAX6|TIGAR_XENTR Fructose-2,6-bisphosphatase TIGAR OS=Xenopus tropicalis OX=8364 GN=tigar PE=2 SV=1 TIGAR_XENTR reviewed Fructose-2,6-bisphosphatase TIGAR (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004331; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006914; GO:0006915; GO:0006950; GO:0043067; GO:0043456; GO:0045820; GO:0045935; GO:0045937 apoptotic process [GO:0006915]; autophagy [GO:0006914]; negative regulation of glycolytic process [GO:0045820]; positive regulation of nucleobase-containing compound metabolic process [GO:0045935]; positive regulation of phosphate metabolic process [GO:0045937]; regulation of pentose-phosphate shunt [GO:0043456]; regulation of programmed cell death [GO:0043067]; response to stress [GO:0006950] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331] g7348.t1 Q9DEE9 62.374 396 0.0 529.0 sp|Q9DEE9|ARP6_CHICK Actin-related protein 6 OS=Gallus gallus OX=9031 GN=ACTR6 PE=1 SV=1 g7349.t1 Q4QR86 30.061 326 1.22e-33 139.0 sp|Q4QR86|DEPD7_RAT DEP domain-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Depdc7 PE=2 SV=1 g7349.t2 Q4QR86 30.094 319 3.4300000000000004e-32 134.0 sp|Q4QR86|DEPD7_RAT DEP domain-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Depdc7 PE=2 SV=1 g7350.t1 O43581 57.534 292 1.42e-116 352.0 sp|O43581|SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens OX=9606 GN=SYT7 PE=1 SV=3 SYT7_HUMAN reviewed Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) Homo sapiens (Human) GO:0000149; GO:0001778; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0061891; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:0099502; GO:1900242; GO:1990926; GO:1990927 calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g7350.t2 O43581 57.045 291 1.1900000000000001e-116 353.0 sp|O43581|SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens OX=9606 GN=SYT7 PE=1 SV=3 SYT7_HUMAN reviewed Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) Homo sapiens (Human) GO:0000149; GO:0001778; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0061891; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:0099502; GO:1900242; GO:1990926; GO:1990927 calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g7351.t1 A1L520 46.57 554 9.73e-131 393.0 sp|A1L520|ARFG2_BOVIN ADP-ribosylation factor GTPase-activating protein 2 OS=Bos taurus OX=9913 GN=ARFGAP2 PE=2 SV=1 g7352.t1 Q06234 56.0 175 3.92e-44 147.0 sp|Q06234|ASCL1_XENLA Achaete-scute homolog 1 OS=Xenopus laevis OX=8355 GN=ascl1 PE=2 SV=1 g7356.t1 G3MWR8 66.304 184 8.46e-60 231.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g7356.t1 G3MWR8 34.169 439 1.41e-28 129.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g7356.t2 G3MWR8 66.471 170 8.37e-54 211.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g7356.t2 G3MWR8 33.937 442 2.6e-28 128.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g7356.t3 G3MWR8 65.761 184 2.3000000000000002e-59 229.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g7356.t3 G3MWR8 34.169 439 1.6499999999999999e-28 129.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g7357.t1 G3MWR8 66.123 552 0.0 774.0 sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1 MICA3_BOVIN reviewed [F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3) Bos taurus (Bovine) GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0120501 actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g7359.t1 O60237 31.926 592 1.66e-33 141.0 sp|O60237|MYPT2_HUMAN Protein phosphatase 1 regulatory subunit 12B OS=Homo sapiens OX=9606 GN=PPP1R12B PE=1 SV=2 g7359.t2 O14974 49.045 157 4.87e-29 117.0 sp|O14974|MYPT1_HUMAN Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens OX=9606 GN=PPP1R12A PE=1 SV=1 g7359.t3 O60237 31.926 592 1.6200000000000002e-33 141.0 sp|O60237|MYPT2_HUMAN Protein phosphatase 1 regulatory subunit 12B OS=Homo sapiens OX=9606 GN=PPP1R12B PE=1 SV=2 g7359.t4 O60237 31.926 592 1.35e-33 142.0 sp|O60237|MYPT2_HUMAN Protein phosphatase 1 regulatory subunit 12B OS=Homo sapiens OX=9606 GN=PPP1R12B PE=1 SV=2 g7359.t5 O60237 31.897 580 2.9700000000000002e-33 140.0 sp|O60237|MYPT2_HUMAN Protein phosphatase 1 regulatory subunit 12B OS=Homo sapiens OX=9606 GN=PPP1R12B PE=1 SV=2 g7359.t6 Q8BG95 34.279 458 2.46e-32 137.0 sp|Q8BG95|MYPT2_MOUSE Protein phosphatase 1 regulatory subunit 12B OS=Mus musculus OX=10090 GN=Ppp1r12b PE=1 SV=2 g7360.t1 Q9DBR7 62.759 290 7.6e-120 371.0 sp|Q9DBR7|MYPT1_MOUSE Protein phosphatase 1 regulatory subunit 12A OS=Mus musculus OX=10090 GN=Ppp1r12a PE=1 SV=2 MYPT1_MOUSE reviewed Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) Mus musculus (Mouse) GO:0000278; GO:0000776; GO:0001725; GO:0004721; GO:0004857; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007098; GO:0007165; GO:0015629; GO:0017020; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0048812; GO:0071466; GO:0071889; GO:0072357 cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; neuron projection morphogenesis [GO:0048812]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; stress fiber [GO:0001725]; Z disc [GO:0030018] 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901] g7364.t1 Q1L8G6 50.781 768 0.0 803.0 sp|Q1L8G6|AKIB1_DANRE Ankyrin repeat and IBR domain-containing protein 1 OS=Danio rerio OX=7955 GN=ankib1 PE=3 SV=1 AKIB1_DANRE reviewed Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g7368.t1 Q8BIA3 46.711 152 1.52e-33 127.0 sp|Q8BIA3|MKX_MOUSE Homeobox protein Mohawk OS=Mus musculus OX=10090 GN=Mkx PE=2 SV=1 MKX_MOUSE reviewed Homeobox protein Mohawk Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002932; GO:0005634; GO:0005667; GO:0006357; GO:0007517; GO:0010468; GO:0010628; GO:0030199; GO:0030279; GO:0032331; GO:0032967; GO:0035990; GO:0035992; GO:0036077; GO:0045599; GO:0045662; GO:0045944; GO:0048468; GO:0061629; GO:0071260 cell development [GO:0048468]; cellular response to mechanical stimulus [GO:0071260]; collagen fibril organization [GO:0030199]; intratendonous ossification [GO:0036077]; muscle organ development [GO:0007517]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; tendon cell differentiation [GO:0035990]; tendon formation [GO:0035992]; tendon sheath development [GO:0002932] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g7369.t1 Q8NEV4 50.794 1134 0.0 1138.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7372.t1 Q6BEB4 41.889 413 2.2499999999999997e-67 221.0 sp|Q6BEB4|SP5_HUMAN Transcription factor Sp5 OS=Homo sapiens OX=9606 GN=SP5 PE=1 SV=1 SP5_HUMAN reviewed Transcription factor Sp5 Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0008270; GO:0036342; GO:0060349 bone morphogenesis [GO:0060349]; post-anal tail morphogenesis [GO:0036342]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g7374.t1 P49013 48.475 295 9.579999999999999e-84 269.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g7376.t1 Q01705 58.904 73 1.0100000000000002e-21 96.3 sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus OX=10090 GN=Notch1 PE=1 SV=3 g7383.t1 Q0VA40 46.078 408 2.02e-96 305.0 sp|Q0VA40|SP9_XENTR Transcription factor Sp9 OS=Xenopus tropicalis OX=8364 GN=sp9 PE=2 SV=1 g7391.t1 Q61527 51.626 492 2.6e-158 494.0 sp|Q61527|ERBB4_MOUSE Receptor tyrosine-protein kinase erbB-4 OS=Mus musculus OX=10090 GN=Erbb4 PE=1 SV=5 g7392.t1 P04412 35.414 785 3.2699999999999996e-140 451.0 sp|P04412|EGFR_DROME Epidermal growth factor receptor OS=Drosophila melanogaster OX=7227 GN=Egfr PE=1 SV=3 EGFR_DROME reviewed Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) (Drosophila relative of ERBB) (Gurken receptor) (Protein torpedo) Drosophila melanogaster (Fruit fly) GO:0001654; GO:0001742; GO:0001751; GO:0002009; GO:0003015; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0007173; GO:0007298; GO:0007309; GO:0007367; GO:0007390; GO:0007391; GO:0007395; GO:0007422; GO:0007426; GO:0007431; GO:0007443; GO:0007444; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007477; GO:0007479; GO:0007482; GO:0008071; GO:0008284; GO:0008340; GO:0008355; GO:0008406; GO:0008586; GO:0009792; GO:0009880; GO:0009925; GO:0010628; GO:0010629; GO:0016318; GO:0016324; GO:0016330; GO:0016333; GO:0022008; GO:0030031; GO:0030182; GO:0030381; GO:0030718; GO:0035088; GO:0035149; GO:0035159; GO:0035160; GO:0035225; GO:0035277; GO:0035309; GO:0035310; GO:0042327; GO:0042675; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043703; GO:0045198; GO:0045199; GO:0045465; GO:0045572; GO:0046530; GO:0046673; GO:0046843; GO:0048149; GO:0048546; GO:0048749; GO:0048865; GO:0050679; GO:0051781; GO:0061331; GO:0070374; GO:0090303; GO:1903688; GO:2000134; GO:2001234 behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; R8 cell differentiation [GO:0045465]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7392.t2 P04412 32.822 847 8.689999999999999e-126 414.0 sp|P04412|EGFR_DROME Epidermal growth factor receptor OS=Drosophila melanogaster OX=7227 GN=Egfr PE=1 SV=3 EGFR_DROME reviewed Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) (Drosophila relative of ERBB) (Gurken receptor) (Protein torpedo) Drosophila melanogaster (Fruit fly) GO:0001654; GO:0001742; GO:0001751; GO:0002009; GO:0003015; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0007173; GO:0007298; GO:0007309; GO:0007367; GO:0007390; GO:0007391; GO:0007395; GO:0007422; GO:0007426; GO:0007431; GO:0007443; GO:0007444; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007477; GO:0007479; GO:0007482; GO:0008071; GO:0008284; GO:0008340; GO:0008355; GO:0008406; GO:0008586; GO:0009792; GO:0009880; GO:0009925; GO:0010628; GO:0010629; GO:0016318; GO:0016324; GO:0016330; GO:0016333; GO:0022008; GO:0030031; GO:0030182; GO:0030381; GO:0030718; GO:0035088; GO:0035149; GO:0035159; GO:0035160; GO:0035225; GO:0035277; GO:0035309; GO:0035310; GO:0042327; GO:0042675; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043703; GO:0045198; GO:0045199; GO:0045465; GO:0045572; GO:0046530; GO:0046673; GO:0046843; GO:0048149; GO:0048546; GO:0048749; GO:0048865; GO:0050679; GO:0051781; GO:0061331; GO:0070374; GO:0090303; GO:1903688; GO:2000134; GO:2001234 behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; R8 cell differentiation [GO:0045465]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7393.t1 P27085 84.615 117 4.84e-65 196.0 sp|P27085|RS26_OCTVU Small ribosomal subunit protein eS26 OS=Octopus vulgaris OX=6645 GN=RPS26 PE=2 SV=1 g7395.t1 Q61527 47.285 571 3.71e-154 511.0 sp|Q61527|ERBB4_MOUSE Receptor tyrosine-protein kinase erbB-4 OS=Mus musculus OX=10090 GN=Erbb4 PE=1 SV=5 g7395.t1 Q61527 35.994 639 8.23e-112 391.0 sp|Q61527|ERBB4_MOUSE Receptor tyrosine-protein kinase erbB-4 OS=Mus musculus OX=10090 GN=Erbb4 PE=1 SV=5 g7397.t1 P04412 35.203 713 4.9100000000000005e-123 405.0 sp|P04412|EGFR_DROME Epidermal growth factor receptor OS=Drosophila melanogaster OX=7227 GN=Egfr PE=1 SV=3 EGFR_DROME reviewed Epidermal growth factor receptor (Egfr) (EC 2.7.10.1) (Drosophila relative of ERBB) (Gurken receptor) (Protein torpedo) Drosophila melanogaster (Fruit fly) GO:0001654; GO:0001742; GO:0001751; GO:0002009; GO:0003015; GO:0004714; GO:0005006; GO:0005524; GO:0005886; GO:0007173; GO:0007298; GO:0007309; GO:0007367; GO:0007390; GO:0007391; GO:0007395; GO:0007422; GO:0007426; GO:0007431; GO:0007443; GO:0007444; GO:0007455; GO:0007472; GO:0007474; GO:0007476; GO:0007477; GO:0007479; GO:0007482; GO:0008071; GO:0008284; GO:0008340; GO:0008355; GO:0008406; GO:0008586; GO:0009792; GO:0009880; GO:0009925; GO:0010628; GO:0010629; GO:0016318; GO:0016324; GO:0016330; GO:0016333; GO:0022008; GO:0030031; GO:0030182; GO:0030381; GO:0030718; GO:0035088; GO:0035149; GO:0035159; GO:0035160; GO:0035225; GO:0035277; GO:0035309; GO:0035310; GO:0042327; GO:0042675; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043703; GO:0045198; GO:0045199; GO:0045465; GO:0045572; GO:0046530; GO:0046673; GO:0046843; GO:0048149; GO:0048546; GO:0048749; GO:0048865; GO:0050679; GO:0051781; GO:0061331; GO:0070374; GO:0090303; GO:1903688; GO:2000134; GO:2001234 behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cell projection assembly [GO:0030031]; chorion-containing eggshell pattern formation [GO:0030381]; compound eye cone cell differentiation [GO:0042675]; compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; determination of adult lifespan [GO:0008340]; determination of genital disc primordium [GO:0035225]; digestive tract morphogenesis [GO:0048546]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; eye development [GO:0001654]; eye-antennal disc morphogenesis [GO:0007455]; germ-band shortening [GO:0007390]; germ-line stem cell population maintenance [GO:0030718]; gonad development [GO:0008406]; haltere development [GO:0007482]; heart process [GO:0003015]; imaginal disc development [GO:0007444]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; leg disc proximal/distal pattern formation [GO:0007479]; lumen formation, open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; Malpighian tubule morphogenesis [GO:0007443]; maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded [GO:0008071]; morphogenesis of an epithelium [GO:0002009]; morphogenesis of follicular epithelium [GO:0016333]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of compound eye retinal cell programmed cell death [GO:0046673]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; notum cell fate specification [GO:0035310]; notum development [GO:0007477]; oenocyte differentiation [GO:0001742]; olfactory learning [GO:0008355]; ommatidial rotation [GO:0016318]; oocyte axis specification [GO:0007309]; peripheral nervous system development [GO:0007422]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell fate determination [GO:0043703]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of imaginal disc growth [GO:0045572]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphorylation [GO:0042327]; positive regulation of wound healing [GO:0090303]; R8 cell differentiation [GO:0045465]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland development [GO:0007431]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; stem cell fate commitment [GO:0048865]; tracheal outgrowth, open tracheal system [GO:0007426]; wing and notum subfield formation [GO:0035309]; wing disc morphogenesis [GO:0007472] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g7398.t1 Q9CWV0 52.174 115 1.99e-40 139.0 sp|Q9CWV0|MASU1_MOUSE Mitochondrial assembly of ribosomal large subunit protein 1 OS=Mus musculus OX=10090 GN=Malsu1 PE=1 SV=1 g7399.t1 P49917 48.957 911 0.0 902.0 sp|P49917|DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens OX=9606 GN=LIG4 PE=1 SV=2 DNLI4_HUMAN reviewed DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4) Homo sapiens (Human) GO:0000012; GO:0000287; GO:0000781; GO:0000793; GO:0001701; GO:0002328; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005958; GO:0006284; GO:0006297; GO:0006302; GO:0006303; GO:0007417; GO:0008283; GO:0010165; GO:0010332; GO:0016208; GO:0016874; GO:0022008; GO:0032807; GO:0033077; GO:0033151; GO:0033152; GO:0033153; GO:0035019; GO:0043524; GO:0045190; GO:0048144; GO:0048146; GO:0050769; GO:0051276; GO:0051301; GO:0051402; GO:0070419; GO:0071285; GO:0071479; GO:0071897; GO:0072089; GO:0075713; GO:0097680; GO:1904155; GO:2001252 base-excision repair [GO:0006284]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DN2 thymocyte differentiation [GO:1904155]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; fibroblast proliferation [GO:0048144]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151] chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] AMP binding [GO:0016208]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; magnesium ion binding [GO:0000287] g7400.t1 Q7Z6J2 45.517 145 1.22e-34 130.0 sp|Q7Z6J2|GRASP_HUMAN Protein TAMALIN OS=Homo sapiens OX=9606 GN=TAMALIN PE=1 SV=1 GRASP_HUMAN reviewed Protein TAMALIN (General receptor for phosphoinositides 1-associated scaffold protein) (GRP1-associated scaffold protein) Homo sapiens (Human) GO:0005886; GO:0007165; GO:0014069; GO:0030165; GO:0031267; GO:0042802; GO:0045211; GO:0048471; GO:0098978; GO:0099149 regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; signal transduction [GO:0007165] glutamatergic synapse [GO:0098978]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267] g7401.t1 P37287 58.94 453 0.0 558.0 sp|P37287|PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens OX=9606 GN=PIGA PE=1 SV=1 PIGA_HUMAN reviewed Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) Homo sapiens (Human) GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0016020; GO:0017176; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; membrane [GO:0016020] phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194] g7402.t1 Q9D8U2 56.71 231 1.18e-80 246.0 sp|Q9D8U2|TM41A_MOUSE Transmembrane protein 41A OS=Mus musculus OX=10090 GN=Tmem41a PE=2 SV=1 g7403.t1 Q6P2X9 30.29 449 4.01e-50 181.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g7404.t1 A4IGU3 47.222 216 3.7100000000000003e-64 203.0 sp|A4IGU3|MT21A_XENTR Protein N-lysine methyltransferase METTL21A OS=Xenopus tropicalis OX=8364 GN=mettl21a PE=2 SV=1 g7406.t1 F1N5V1 32.391 849 1.07e-88 311.0 sp|F1N5V1|UBP37_BOVIN Ubiquitin carboxyl-terminal hydrolase 37 OS=Bos taurus OX=9913 GN=USP37 PE=3 SV=1 UBP37_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) Bos taurus (Bovine) GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005694; GO:0005829; GO:0006275; GO:0006508; GO:0016579; GO:0019901; GO:0031647; GO:0035871; GO:0051301; GO:0071108 cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of DNA replication [GO:0006275]; regulation of protein stability [GO:0031647] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901] g7406.t1 F1N5V1 54.478 134 1.29e-34 147.0 sp|F1N5V1|UBP37_BOVIN Ubiquitin carboxyl-terminal hydrolase 37 OS=Bos taurus OX=9913 GN=USP37 PE=3 SV=1 UBP37_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) Bos taurus (Bovine) GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005694; GO:0005829; GO:0006275; GO:0006508; GO:0016579; GO:0019901; GO:0031647; GO:0035871; GO:0051301; GO:0071108 cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of DNA replication [GO:0006275]; regulation of protein stability [GO:0031647] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901] g7408.t1 Q503I8 47.752 467 1.0899999999999999e-141 432.0 sp|Q503I8|NGLY1_DANRE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Danio rerio OX=7955 GN=ngly1 PE=2 SV=1 NGLY1_DANRE reviewed Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0007519; GO:0030513; GO:0036269; GO:0042176; GO:0046872; GO:0048936; GO:1903332 glycoprotein catabolic process [GO:0006516]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of protein catabolic process [GO:0042176]; regulation of protein folding [GO:1903332]; skeletal muscle tissue development [GO:0007519]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] g7409.t1 Q503I8 34.01 197 1.4300000000000001e-31 124.0 sp|Q503I8|NGLY1_DANRE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Danio rerio OX=7955 GN=ngly1 PE=2 SV=1 NGLY1_DANRE reviewed Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0007519; GO:0030513; GO:0036269; GO:0042176; GO:0046872; GO:0048936; GO:1903332 glycoprotein catabolic process [GO:0006516]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of protein catabolic process [GO:0042176]; regulation of protein folding [GO:1903332]; skeletal muscle tissue development [GO:0007519]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] g7410.t1 Q503I8 33.702 181 4.34e-30 119.0 sp|Q503I8|NGLY1_DANRE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Danio rerio OX=7955 GN=ngly1 PE=2 SV=1 NGLY1_DANRE reviewed Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0007519; GO:0030513; GO:0036269; GO:0042176; GO:0046872; GO:0048936; GO:1903332 glycoprotein catabolic process [GO:0006516]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of protein catabolic process [GO:0042176]; regulation of protein folding [GO:1903332]; skeletal muscle tissue development [GO:0007519]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] g7410.t2 Q503I8 33.702 181 3.46e-30 119.0 sp|Q503I8|NGLY1_DANRE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Danio rerio OX=7955 GN=ngly1 PE=2 SV=1 NGLY1_DANRE reviewed Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006516; GO:0007519; GO:0030513; GO:0036269; GO:0042176; GO:0046872; GO:0048936; GO:1903332 glycoprotein catabolic process [GO:0006516]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of protein catabolic process [GO:0042176]; regulation of protein folding [GO:1903332]; skeletal muscle tissue development [GO:0007519]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] g7412.t1 P21860 35.088 171 7.579999999999999e-23 104.0 sp|P21860|ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens OX=9606 GN=ERBB3 PE=1 SV=1 ERBB3_HUMAN reviewed Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3) Homo sapiens (Human) GO:0003197; GO:0004672; GO:0004888; GO:0005524; GO:0005615; GO:0005886; GO:0007162; GO:0007165; GO:0007169; GO:0007173; GO:0007422; GO:0007507; GO:0009925; GO:0009968; GO:0010628; GO:0014037; GO:0014044; GO:0016323; GO:0016324; GO:0016328; GO:0019838; GO:0021545; GO:0030182; GO:0030296; GO:0031625; GO:0038131; GO:0038132; GO:0038133; GO:0038143; GO:0042060; GO:0042127; GO:0042552; GO:0042802; GO:0043066; GO:0043125; GO:0043235; GO:0043410; GO:0043491; GO:0043524; GO:0046982; GO:0050679; GO:0051048; GO:0051402; GO:0051897; GO:0055025; GO:0070886; GO:0097049; GO:0097192; GO:2000672 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; motor neuron apoptotic process [GO:0097049]; myelination [GO:0042552]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell population proliferation [GO:0042127]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; wound healing [GO:0042060] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625] g7413.t1 Q9IA79 57.589 224 7e-90 268.0 sp|Q9IA79|BI1_PAROL Probable Bax inhibitor 1 OS=Paralichthys olivaceus OX=8255 GN=tmbim6 PE=2 SV=1 g7417.t1 Q9JME2 30.831 373 1.78e-45 163.0 sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1 CHSTB_MOUSE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g7418.t1 P69478 33.333 294 1.69e-47 167.0 sp|P69478|CHSTB_RAT Carbohydrate sulfotransferase 11 OS=Rattus norvegicus OX=10116 GN=Chst11 PE=1 SV=1 CHSTB_RAT reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Rattus norvegicus (Rat) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g7419.t1 Q7T3S3 37.37 289 2.21e-55 189.0 sp|Q7T3S3|CHSTB_DANRE Carbohydrate sulfotransferase 11 OS=Danio rerio OX=7955 GN=chst11 PE=2 SV=1 CHSTB_DANRE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016051; GO:0030166; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146] g7420.t1 P33610 31.347 386 2.3699999999999998e-48 181.0 sp|P33610|PRI2_MOUSE DNA primase large subunit OS=Mus musculus OX=10090 GN=Prim2 PE=1 SV=1 g7421.t1 Q9UPV9 44.237 321 1.24e-67 233.0 sp|Q9UPV9|TRAK1_HUMAN Trafficking kinesin-binding protein 1 OS=Homo sapiens OX=9606 GN=TRAK1 PE=1 SV=1 g7421.t2 Q6PD31 46.883 369 7.97e-90 296.0 sp|Q6PD31|TRAK1_MOUSE Trafficking kinesin-binding protein 1 OS=Mus musculus OX=10090 GN=Trak1 PE=1 SV=1 TRAK1_MOUSE reviewed Trafficking kinesin-binding protein 1 (Protein Milton) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005938; GO:0006605; GO:0008333; GO:0017022; GO:0019896; GO:0022008; GO:0030425; GO:0030911; GO:0031410; GO:0031966; GO:0044295; GO:0047496; GO:0048311; GO:0048471; GO:0048813; GO:0050772; GO:0050811; GO:1904115 axonal transport of mitochondrion [GO:0019896]; dendrite morphogenesis [GO:0048813]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; positive regulation of axonogenesis [GO:0050772]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; TPR domain binding [GO:0030911] g7421.t3 Q9UPV9 44.237 321 1.6399999999999998e-67 238.0 sp|Q9UPV9|TRAK1_HUMAN Trafficking kinesin-binding protein 1 OS=Homo sapiens OX=9606 GN=TRAK1 PE=1 SV=1 g7422.t1 Q9UPV9 37.589 282 2.26e-35 143.0 sp|Q9UPV9|TRAK1_HUMAN Trafficking kinesin-binding protein 1 OS=Homo sapiens OX=9606 GN=TRAK1 PE=1 SV=1 g7424.t1 B2RY50 58.46 987 0.0 1070.0 sp|B2RY50|ODAD2_MOUSE Outer dynein arm-docking complex subunit 2 OS=Mus musculus OX=10090 GN=Odad2 PE=1 SV=1 ODAD2_MOUSE reviewed Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4) Mus musculus (Mouse) GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546 cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary base [GO:0097546] g7425.t1 Q99615 53.719 484 1.65e-169 490.0 sp|Q99615|DNJC7_HUMAN DnaJ homolog subfamily C member 7 OS=Homo sapiens OX=9606 GN=DNAJC7 PE=1 SV=2 DNJC7_HUMAN reviewed DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2) Homo sapiens (Human) GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0070062; GO:1900034 protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072] g7426.t1 P52485 77.576 165 7.78e-97 284.0 sp|P52485|UBCD2_DROME Ubiquitin-conjugating enzyme E2-24 kDa OS=Drosophila melanogaster OX=7227 GN=Ubc2 PE=2 SV=1 g7427.t1 A4FV48 47.523 444 3.6099999999999997e-147 428.0 sp|A4FV48|FADS2_BOVIN Acyl-CoA 6-desaturase OS=Bos taurus OX=9913 GN=FADS2 PE=2 SV=1 FADS2_BOVIN reviewed Acyl-CoA 6-desaturase (EC 1.14.19.3) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) (Fatty acid desaturase 2) Bos taurus (Bovine) GO:0004768; GO:0005789; GO:0006629; GO:0006636; GO:0016020; GO:0016213; GO:0016717; GO:0036109; GO:0042759; GO:0043651; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] acyl-CoA 6-desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; stearoyl-CoA 9-desaturase activity [GO:0004768] g7428.t1 Q9DEX7 52.672 393 4.76e-155 447.0 sp|Q9DEX7|FADS2_DANRE Acyl-CoA 6-desaturase OS=Danio rerio OX=7955 GN=fads2 PE=1 SV=1 FADS2_DANRE reviewed Acyl-CoA 6-desaturase (EC 1.14.19.3) (EC 1.14.19.44) (Delta(5)/Delta(6) fatty acid desaturase) (D5D/D6D fatty acid desaturase) (Delta-5/Delta-6 fatty acid desaturase) (Fatty acid desaturase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001889; GO:0005789; GO:0006629; GO:0006636; GO:0016020; GO:0016213; GO:0016717; GO:0062076 lipid metabolic process [GO:0006629]; liver development [GO:0001889]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] acyl-CoA (8-3)-desaturase activity [GO:0062076]; acyl-CoA 6-desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717] g7429.t1 Q6DDK2 54.525 442 0.0 518.0 sp|Q6DDK2|FADS2_XENLA Fatty acid desaturase 2 OS=Xenopus laevis OX=8355 GN=fads2 PE=2 SV=1 FADS2_XENLA reviewed Fatty acid desaturase 2 (EC 1.14.19.-) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase) Xenopus laevis (African clawed frog) GO:0005789; GO:0006629; GO:0006636; GO:0016020; GO:0016717 lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717] g7431.t1 Q28EL0 61.667 360 6.76e-149 426.0 sp|Q28EL0|CCYL1_XENTR Cyclin-Y-like protein 1 OS=Xenopus tropicalis OX=8364 GN=ccnyl1 PE=2 SV=1 g7432.t1 Q9Z0R9 50.664 452 3.01e-166 478.0 sp|Q9Z0R9|FADS2_MOUSE Acyl-CoA 6-desaturase OS=Mus musculus OX=10090 GN=Fads2 PE=1 SV=1 g7434.t1 P57081 40.526 380 4.21e-85 269.0 sp|P57081|WDR4_HUMAN tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 OS=Homo sapiens OX=9606 GN=WDR4 PE=1 SV=2 WDR4_HUMAN reviewed tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 (Protein Wuho homolog) (hWH) (WD repeat-containing protein 4) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006400; GO:0006974; GO:0008047; GO:0043527; GO:0106004; GO:0106143 DNA damage response [GO:0006974]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m7G46) methyltransferase complex [GO:0106143]; tRNA methyltransferase complex [GO:0043527] enzyme activator activity [GO:0008047] g7436.t1 O70237 30.651 261 9.570000000000001e-31 121.0 sp|O70237|GFI1B_MOUSE Zinc finger protein Gfi-1b OS=Mus musculus OX=10090 GN=Gfi1b PE=1 SV=1 GFI1B_MOUSE reviewed Zinc finger protein Gfi-1b (Growth factor independent protein 1B) Mus musculus (Mouse) GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005886; GO:0006357; GO:0008270; GO:0016363; GO:0030854; GO:0045646; GO:0061629; GO:1903706; GO:1990837 positive regulation of granulocyte differentiation [GO:0030854]; regulation of erythrocyte differentiation [GO:0045646]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g7437.t1 Q8C0R9 29.442 394 2.52e-47 179.0 sp|Q8C0R9|LRRD1_MOUSE Leucine-rich repeat and death domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrrd1 PE=2 SV=2 g7437.t1 Q8C0R9 30.67 388 1.82e-43 168.0 sp|Q8C0R9|LRRD1_MOUSE Leucine-rich repeat and death domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrrd1 PE=2 SV=2 g7437.t1 Q8C0R9 29.428 367 4.46e-35 143.0 sp|Q8C0R9|LRRD1_MOUSE Leucine-rich repeat and death domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrrd1 PE=2 SV=2 g7437.t1 Q8C0R9 30.128 312 2.4100000000000003e-32 135.0 sp|Q8C0R9|LRRD1_MOUSE Leucine-rich repeat and death domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrrd1 PE=2 SV=2 g7437.t1 Q8C0R9 29.45 309 9.96e-28 121.0 sp|Q8C0R9|LRRD1_MOUSE Leucine-rich repeat and death domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrrd1 PE=2 SV=2 g7438.t1 A4D1F6 31.752 274 1.69e-40 152.0 sp|A4D1F6|LRRD1_HUMAN Leucine-rich repeat and death domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LRRD1 PE=1 SV=2 g7441.t1 Q5ZID6 47.649 319 2.86e-102 306.0 sp|Q5ZID6|5NT3A_CHICK Cytosolic 5'-nucleotidase 3A OS=Gallus gallus OX=9031 GN=NT5C3A PE=1 SV=3 5NT3A_CHICK reviewed Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (7-methylguanosine phosphate-specific 5'-nucleotidase) (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I) Gallus gallus (Chicken) GO:0000166; GO:0000287; GO:0005737; GO:0005783; GO:0005829; GO:0006248; GO:0008253; GO:0016604; GO:0016740 CMP catabolic process [GO:0006248] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604] 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; transferase activity [GO:0016740] g7443.t1 Q3UV71 41.463 246 1.6299999999999998e-48 173.0 sp|Q3UV71|TMTC1_MOUSE Protein O-mannosyl-transferase TMTC1 OS=Mus musculus OX=10090 GN=Tmtc1 PE=2 SV=2 TMTC1_MOUSE reviewed Protein O-mannosyl-transferase TMTC1 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 1) (Transmembrane and tetratricopeptide repeat-containing 1) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005739; GO:0005783; GO:0006396; GO:0016020; GO:0035269 protein O-linked glycosylation via mannose [GO:0035269]; RNA processing [GO:0006396] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739] dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g7444.t1 Q8IUR5 36.156 307 7.34e-50 180.0 sp|Q8IUR5|TMTC1_HUMAN Protein O-mannosyl-transferase TMTC1 OS=Homo sapiens OX=9606 GN=TMTC1 PE=1 SV=3 g7446.t1 F1LMN3 43.287 432 7.409999999999999e-92 313.0 sp|F1LMN3|E2F8_RAT Transcription factor E2F8 OS=Rattus norvegicus OX=10116 GN=E2f8 PE=1 SV=2 E2F8_RAT reviewed Transcription factor E2F8 (E2F-8) Rattus norvegicus (Rat) GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837 cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g7447.t1 Q66S03 34.839 155 1.9800000000000002e-29 108.0 sp|Q66S03|LECG_THANI Galactose-specific lectin nattectin OS=Thalassophryne nattereri OX=289382 PE=1 SV=1 LECG_THANI reviewed Galactose-specific lectin nattectin (CTL) Thalassophryne nattereri (Copper Joe toadfish) GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729 inflammatory response [GO:0006954] extracellular region [GO:0005576] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729] g7450.t1 B2RU80 32.771 830 1.08e-104 360.0 sp|B2RU80|PTPRB_MOUSE Receptor-type tyrosine-protein phosphatase beta OS=Mus musculus OX=10090 GN=Ptprb PE=1 SV=1 PTPRB_MOUSE reviewed Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP) Mus musculus (Mouse) GO:0001525; GO:0001649; GO:0004725; GO:0008347; GO:0016020; GO:0016311; GO:0043235; GO:0045296; GO:0045668 angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; glial cell migration [GO:0008347]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast differentiation [GO:0001649] membrane [GO:0016020]; receptor complex [GO:0043235] cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725] g7451.t1 Q5RDQ0 44.371 151 3.39e-38 130.0 sp|Q5RDQ0|SSBP_PONAB Single-stranded DNA-binding protein, mitochondrial OS=Pongo abelii OX=9601 GN=SSBP1 PE=2 SV=1 SSBP_PONAB reviewed Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003682; GO:0003697; GO:0005739; GO:0006264; GO:0042645; GO:0051289; GO:0090297 mitochondrial DNA replication [GO:0006264]; positive regulation of mitochondrial DNA replication [GO:0090297]; protein homotetramerization [GO:0051289] mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697] g7452.t1 Q9UKN5 39.309 463 5.39e-96 330.0 sp|Q9UKN5|PRDM4_HUMAN PR domain zinc finger protein 4 OS=Homo sapiens OX=9606 GN=PRDM4 PE=1 SV=3 PRDM4_HUMAN reviewed PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006366; GO:0008168; GO:0008270; GO:0010468; GO:0032259; GO:0035097; GO:0045944; GO:1990226; GO:1990837 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; transcription by RNA polymerase II [GO:0006366] histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g7453.t1 Q0MQC7 57.895 76 2.06e-24 91.3 sp|Q0MQC7|NDUB2_PONPY NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial OS=Pongo pygmaeus OX=9600 GN=NDUFB2 PE=3 SV=1 g7454.t1 Q6P2X9 32.243 214 4.3100000000000004e-26 108.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g7457.t1 Q13702 44.819 415 3.62e-118 353.0 sp|Q13702|RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens OX=9606 GN=RAPSN PE=1 SV=4 g7458.t1 A0A125YHX7 36.842 152 2.5100000000000004e-27 105.0 sp|A0A125YHX7|CETN1_TOXGM Centrin-1 OS=Toxoplasma gondii (strain ATCC 50611 / Me49) OX=508771 GN=CEN1 PE=1 SV=1 g7466.t1 P04634 45.669 381 4.91e-117 351.0 sp|P04634|LIPF_RAT Gastric triacylglycerol lipase OS=Rattus norvegicus OX=10116 GN=Lipf PE=1 SV=1 LIPF_RAT reviewed Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Lingual lipase) Rattus norvegicus (Rat) GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006629; GO:0016042; GO:0016298; GO:0016615 lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; malate metabolic process [GO:0006108] extracellular region [GO:0005576]; mitochondrion [GO:0005739] lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806] g7466.t2 P04634 45.669 381 2.66e-116 350.0 sp|P04634|LIPF_RAT Gastric triacylglycerol lipase OS=Rattus norvegicus OX=10116 GN=Lipf PE=1 SV=1 LIPF_RAT reviewed Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) (Lingual lipase) Rattus norvegicus (Rat) GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006629; GO:0016042; GO:0016298; GO:0016615 lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; malate metabolic process [GO:0006108] extracellular region [GO:0005576]; mitochondrion [GO:0005739] lipase activity [GO:0016298]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806] g7467.t1 E9Q7E2 44.057 631 3.94e-165 560.0 sp|E9Q7E2|ARID2_MOUSE AT-rich interactive domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arid2 PE=1 SV=1 ARID2_MOUSE reviewed AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0035060; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:0072359; GO:1905168; GO:2000045; GO:2000781; GO:2000819 cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g7467.t1 E9Q7E2 38.614 202 1.99e-33 146.0 sp|E9Q7E2|ARID2_MOUSE AT-rich interactive domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arid2 PE=1 SV=1 ARID2_MOUSE reviewed AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0035060; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:0072359; GO:1905168; GO:2000045; GO:2000781; GO:2000819 cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g7469.t1 O80668 23.902 410 2.31e-24 108.0 sp|O80668|AVT1A_ARATH Amino acid transporter AVT1A OS=Arabidopsis thaliana OX=3702 GN=AVT1A PE=2 SV=2 g7470.t1 Q12912 34.348 230 2.81e-31 135.0 sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3 IRAG2_HUMAN reviewed Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2] Homo sapiens (Human) GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577 immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] microtubule binding [GO:0008017] g7470.t2 Q12912 38.172 186 6.01e-31 134.0 sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3 IRAG2_HUMAN reviewed Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2] Homo sapiens (Human) GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577 immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] microtubule binding [GO:0008017] g7470.t3 Q12912 38.172 186 6.18e-31 134.0 sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3 IRAG2_HUMAN reviewed Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2] Homo sapiens (Human) GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577 immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] microtubule binding [GO:0008017] g7470.t4 Q12912 36.279 215 1.1500000000000001e-31 136.0 sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3 IRAG2_HUMAN reviewed Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2] Homo sapiens (Human) GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577 immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] microtubule binding [GO:0008017] g7471.t1 O43903 43.729 295 2.59e-81 250.0 sp|O43903|GAS2_HUMAN Growth arrest-specific protein 2 OS=Homo sapiens OX=9606 GN=GAS2 PE=1 SV=1 GAS2_HUMAN reviewed Growth arrest-specific protein 2 (GAS-2) Homo sapiens (Human) GO:0001544; GO:0001547; GO:0001725; GO:0005829; GO:0005884; GO:0006915; GO:0008017; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051726; GO:0051764; GO:0071711 actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; stress fiber [GO:0001725] actin filament binding [GO:0051015]; microtubule binding [GO:0008017] g7473.t1 Q92621 45.382 2003 0.0 1692.0 sp|Q92621|NU205_HUMAN Nuclear pore complex protein Nup205 OS=Homo sapiens OX=9606 GN=NUP205 PE=1 SV=3 NU205_HUMAN reviewed Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) Homo sapiens (Human) GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292 mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g7476.t1 Q8R367 49.091 165 6.76e-45 150.0 sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1 g7477.t1 Q8R367 39.791 191 3.32e-39 139.0 sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1 g7478.t1 Q8R367 40.104 192 1.76e-44 150.0 sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1 g7479.t1 Q6P2B1 54.162 925 0.0 1042.0 sp|Q6P2B1|TNPO3_MOUSE Transportin-3 OS=Mus musculus OX=10090 GN=Tnpo3 PE=1 SV=1 g7480.t1 Q9R0N9 46.254 307 2.1199999999999998e-89 282.0 sp|Q9R0N9|SYT9_MOUSE Synaptotagmin-9 OS=Mus musculus OX=10090 GN=Syt9 PE=1 SV=2 SYT9_MOUSE reviewed Synaptotagmin-9 (Synaptotagmin IX) (SytIX) (Synaptotagmin V) Mus musculus (Mouse) GO:0000149; GO:0001786; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0016192; GO:0017158; GO:0030141; GO:0030672; GO:0031045; GO:0031340; GO:0042802; GO:0045956; GO:0046872; GO:0050796; GO:0061891; GO:0070382; GO:0098686; GO:0099502 calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192] dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g7484.t1 P83883 79.245 106 2.72e-55 169.0 sp|P83883|RL36A_RAT Large ribosomal subunit protein eL42 OS=Rattus norvegicus OX=10116 GN=Rpl36a PE=1 SV=2 g7485.t1 Q6P0B1 56.371 259 1.66e-87 285.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7485.t1 Q6P0B1 60.622 193 4.18e-56 201.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7485.t2 Q6P0B1 56.371 259 1.04e-87 285.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7485.t2 Q6P0B1 60.622 193 3.73e-56 201.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7485.t3 Q6P0B1 56.371 259 1.33e-87 284.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7485.t3 Q6P0B1 60.622 193 3.24e-56 201.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7485.t4 Q792H5 58.635 249 2.8e-89 288.0 sp|Q792H5|CELF2_RAT CUGBP Elav-like family member 2 OS=Rattus norvegicus OX=10116 GN=Celf2 PE=2 SV=1 CELF2_RAT reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Protein ETR-R3) (Neuroblastoma apoptosis-related RNA-binding protein) (rNapor) (RNA-binding protein BRUNOL-3) Rattus norvegicus (Rat) GO:0000381; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0016441; GO:0036002; GO:0090543; GO:0106222; GO:1990904 mRNA splice site recognition [GO:0006376]; post-transcriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] g7485.t4 Q792H5 63.584 173 3.08e-57 204.0 sp|Q792H5|CELF2_RAT CUGBP Elav-like family member 2 OS=Rattus norvegicus OX=10116 GN=Celf2 PE=2 SV=1 CELF2_RAT reviewed CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Protein ETR-R3) (Neuroblastoma apoptosis-related RNA-binding protein) (rNapor) (RNA-binding protein BRUNOL-3) Rattus norvegicus (Rat) GO:0000381; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0016441; GO:0036002; GO:0090543; GO:0106222; GO:1990904 mRNA splice site recognition [GO:0006376]; post-transcriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] g7485.t5 Q6P0B1 56.371 259 8.460000000000001e-88 284.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7485.t5 Q6P0B1 60.622 193 2.15e-56 201.0 sp|Q6P0B1|CELF2_DANRE CUGBP Elav-like family member 2 OS=Danio rerio OX=7955 GN=celf2 PE=2 SV=1 g7486.t1 Q8BGC3 23.223 422 2.55e-25 111.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g7487.t1 Q9BYT3 58.033 305 1.2999999999999998e-126 380.0 sp|Q9BYT3|STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens OX=9606 GN=STK33 PE=1 SV=1 g7488.t1 Q8C5H1 43.054 943 0.0 723.0 sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2 ANO4_MOUSE reviewed Anoctamin-4 (Transmembrane protein 16D) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:0017128; GO:0046983; GO:0061589; GO:0061590; GO:0061591; GO:1902476 calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] g7488.t2 A6QLE6 45.023 884 0.0 722.0 sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1 ANO4_BOVIN reviewed Anoctamin-4 (Transmembrane protein 16D) Bos taurus (Bovine) GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869] plasma membrane [GO:0005886] intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g7488.t3 A6QLE6 44.092 914 0.0 722.0 sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1 ANO4_BOVIN reviewed Anoctamin-4 (Transmembrane protein 16D) Bos taurus (Bovine) GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869] plasma membrane [GO:0005886] intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g7488.t4 A6QLE6 44.004 909 0.0 709.0 sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1 ANO4_BOVIN reviewed Anoctamin-4 (Transmembrane protein 16D) Bos taurus (Bovine) GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869] plasma membrane [GO:0005886] intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g7488.t5 A6QLE6 43.784 909 0.0 707.0 sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1 ANO4_BOVIN reviewed Anoctamin-4 (Transmembrane protein 16D) Bos taurus (Bovine) GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476 chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869] plasma membrane [GO:0005886] intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] g7490.t1 Q7ZXL5 36.529 824 4.3e-173 523.0 sp|Q7ZXL5|NELL2_XENLA Protein kinase C-binding protein NELL2 OS=Xenopus laevis OX=8355 GN=nell2.L PE=2 SV=1 g7490.t2 Q7ZXL5 36.114 839 4.2699999999999994e-172 521.0 sp|Q7ZXL5|NELL2_XENLA Protein kinase C-binding protein NELL2 OS=Xenopus laevis OX=8355 GN=nell2.L PE=2 SV=1 g7491.t1 Q15431 25.858 932 2.16e-28 127.0 sp|Q15431|SYCP1_HUMAN Synaptonemal complex protein 1 OS=Homo sapiens OX=9606 GN=SYCP1 PE=1 SV=2 SYCP1_HUMAN reviewed Synaptonemal complex protein 1 (SCP-1) (Cancer/testis antigen 8) (CT8) Homo sapiens (Human) GO:0000711; GO:0000775; GO:0000795; GO:0000801; GO:0000802; GO:0001673; GO:0003677; GO:0003690; GO:0005694; GO:0007129; GO:0007130; GO:0007131; GO:0007283; GO:0030849; GO:0032880; GO:0035092; GO:0051026; GO:0051289; GO:0051301; GO:0051878 cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] autosome [GO:0030849]; central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802] DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690] g7492.t1 Q8AVY1 58.065 248 2.23e-96 285.0 sp|Q8AVY1|CMA1A_XENLA Ciliary microtubule associated protein 1A OS=Xenopus laevis OX=8355 GN=cimap1a PE=2 SV=1 g7493.t1 P47810 50.097 517 3.72e-155 464.0 sp|P47810|WEE1_MOUSE Wee1-like protein kinase OS=Mus musculus OX=10090 GN=Wee1 PE=1 SV=2 WEE1_MOUSE reviewed Wee1-like protein kinase (EC 2.7.10.2) (Wee1A kinase) Mus musculus (Mouse) GO:0000086; GO:0000226; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006998; GO:0007077; GO:0010971; GO:0010972; GO:0030010; GO:0048812; GO:0051301 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; neuron projection morphogenesis [GO:0048812]; nuclear envelope organization [GO:0006998]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713] g7494.t1 Q9NUJ3 44.04 495 2.01e-134 401.0 sp|Q9NUJ3|T11L1_HUMAN T-complex protein 11-like protein 1 OS=Homo sapiens OX=9606 GN=TCP11L1 PE=1 SV=1 T11L1_HUMAN reviewed T-complex protein 11-like protein 1 Homo sapiens (Human) GO:0005874; GO:0007165 signal transduction [GO:0007165] microtubule [GO:0005874] g7496.t1 Q2HJ56 46.23 504 1.63e-154 453.0 sp|Q2HJ56|PWP1_BOVIN Periodic tryptophan protein 1 homolog OS=Bos taurus OX=9913 GN=PWP1 PE=2 SV=1 g7497.t1 Q6AX60 52.342 854 0.0 908.0 sp|Q6AX60|PTHB1_XENLA Protein PTHB1 OS=Xenopus laevis OX=8355 GN=bbs9 PE=2 SV=1 g7498.t1 Q28BR5 55.0 1000 0.0 1134.0 sp|Q28BR5|PREP_XENTR Presequence protease, mitochondrial OS=Xenopus tropicalis OX=8364 GN=pitrm1 PE=2 SV=1 PREP_XENTR reviewed Presequence protease, mitochondrial (EC 3.4.24.-) (Pitrilysin metalloproteinase 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004222; GO:0005759; GO:0006508; GO:0016485; GO:0046872 protein processing [GO:0016485]; proteolysis [GO:0006508] mitochondrial matrix [GO:0005759] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g7501.t1 P24529 50.844 474 4.510000000000001e-163 474.0 sp|P24529|TY3H_MOUSE Tyrosine 3-monooxygenase OS=Mus musculus OX=10090 GN=Th PE=1 SV=3 TY3H_MOUSE reviewed Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH) Mus musculus (Mouse) GO:0001666; GO:0001963; GO:0004497; GO:0004511; GO:0005634; GO:0005737; GO:0005739; GO:0005790; GO:0006585; GO:0007507; GO:0007601; GO:0007612; GO:0007613; GO:0007617; GO:0007626; GO:0008016; GO:0008021; GO:0008198; GO:0008199; GO:0009887; GO:0009898; GO:0015842; GO:0016597; GO:0019825; GO:0019899; GO:0019904; GO:0030424; GO:0030425; GO:0030659; GO:0031410; GO:0033162; GO:0034617; GO:0035240; GO:0036094; GO:0042416; GO:0042418; GO:0042421; GO:0042423; GO:0042427; GO:0042462; GO:0042755; GO:0042802; GO:0043005; GO:0043025; GO:0043195; GO:0043204; GO:0045471; GO:0048471; GO:0048596; GO:0050890; GO:1990384 aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; animal organ morphogenesis [GO:0009887]; catecholamine biosynthetic process [GO:0042423]; cognition [GO:0050890]; dopamine biosynthetic process [GO:0042416]; dopamine biosynthetic process from tyrosine [GO:0006585]; eating behavior [GO:0042755]; embryonic camera-type eye morphogenesis [GO:0048596]; epinephrine biosynthetic process [GO:0042418]; eye photoreceptor cell development [GO:0042462]; heart development [GO:0007507]; hyaloid vascular plexus regression [GO:1990384]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; regulation of heart contraction [GO:0008016]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; serotonin biosynthetic process [GO:0042427]; synaptic transmission, dopaminergic [GO:0001963]; visual perception [GO:0007601] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; melanosome membrane [GO:0033162]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] amino acid binding [GO:0016597]; dopamine binding [GO:0035240]; enzyme binding [GO:0019899]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; protein domain specific binding [GO:0019904]; small molecule binding [GO:0036094]; tetrahydrobiopterin binding [GO:0034617]; tyrosine 3-monooxygenase activity [GO:0004511] g7502.t1 Q8BR93 36.508 315 1.53e-57 193.0 sp|Q8BR93|HARB1_MOUSE Putative nuclease HARBI1 OS=Mus musculus OX=10090 GN=Harbi1 PE=2 SV=1 g7503.t1 O42574 27.097 310 1.2499999999999999e-23 103.0 sp|O42574|ADRB1_XENLA Beta-1 adrenergic receptor OS=Xenopus laevis OX=8355 GN=adrb1 PE=2 SV=1 g7504.t1 P84173 76.493 268 3.01e-158 444.0 sp|P84173|PHB1_CHICK Prohibitin 1 OS=Gallus gallus OX=9031 GN=PHB1 PE=1 SV=1 g7505.t1 P10881 47.47 415 9.36e-105 318.0 sp|P10881|LA_BOVIN Lupus La protein homolog OS=Bos taurus OX=9913 GN=SSB PE=2 SV=2 g7506.t1 Q9H3S7 41.111 360 1.1600000000000001e-70 267.0 sp|Q9H3S7|PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1 PTN23_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0034451; GO:0036064; GO:0043162; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0097225; GO:0120238; GO:1903387; GO:1903393; GO:2000643 cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238]; sperm midpiece [GO:0097225] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g7506.t1 Q9H3S7 40.841 333 2.11e-62 240.0 sp|Q9H3S7|PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1 PTN23_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0034451; GO:0036064; GO:0043162; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0097225; GO:0120238; GO:1903387; GO:1903393; GO:2000643 cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238]; sperm midpiece [GO:0097225] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g7507.t1 Q9H3S7 55.949 395 3.85e-145 453.0 sp|Q9H3S7|PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens OX=9606 GN=PTPN23 PE=1 SV=1 PTN23_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0034451; GO:0036064; GO:0043162; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:0097225; GO:0120238; GO:1903387; GO:1903393; GO:2000643 cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238]; sperm midpiece [GO:0097225] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g7508.t1 Q9W6N4 48.32 387 2.1800000000000002e-117 350.0 sp|Q9W6N4|THA_HIPHI Thyroid hormone receptor alpha OS=Hippoglossus hippoglossus OX=8267 GN=thra PE=2 SV=1 g7511.t1 Q8UVC3 52.174 713 0.0 693.0 sp|Q8UVC3|INVS_CHICK Inversin OS=Gallus gallus OX=9031 GN=INVS PE=2 SV=2 g7511.t2 Q8UVC3 52.174 713 0.0 692.0 sp|Q8UVC3|INVS_CHICK Inversin OS=Gallus gallus OX=9031 GN=INVS PE=2 SV=2 g7512.t1 Q5BJB7 30.705 241 6.600000000000001e-31 117.0 sp|Q5BJB7|RM10_DANRE Large ribosomal subunit protein uL10m OS=Danio rerio OX=7955 GN=mrpl10 PE=2 SV=1 g7513.t1 O14512 59.281 167 1.32e-62 226.0 sp|O14512|SOCS7_HUMAN Suppressor of cytokine signaling 7 OS=Homo sapiens OX=9606 GN=SOCS7 PE=1 SV=2 SOCS7_HUMAN reviewed Suppressor of cytokine signaling 7 (SOCS-7) (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4) (NAP-4) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0009968; GO:0016567; GO:0017124; GO:0021819; GO:0031466; GO:0035556; GO:0035591; GO:0043161; GO:0140031; GO:1990756; GO:2001222 insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; layer formation in cerebral cortex [GO:0021819]; negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of neuron migration [GO:2001222] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] phosphorylation-dependent protein binding [GO:0140031]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g7514.t1 Q0VFM6 62.233 421 0.0 533.0 sp|Q0VFM6|GMPPA_XENTR Mannose-1-phosphate guanylyltransferase regulatory subunit alpha OS=Xenopus tropicalis OX=8364 GN=gmppa PE=2 SV=1 g7515.t1 Q15542 61.296 602 0.0 795.0 sp|Q15542|TAF5_HUMAN Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3 g7518.t1 Q9N126 38.71 124 1.9599999999999997e-23 95.5 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g7523.t1 Q9BZF3 43.848 894 0.0 717.0 sp|Q9BZF3|OSBL6_HUMAN Oxysterol-binding protein-related protein 6 OS=Homo sapiens OX=9606 GN=OSBPL6 PE=1 SV=1 g7523.t2 Q9BZF3 44.072 894 0.0 719.0 sp|Q9BZF3|OSBL6_HUMAN Oxysterol-binding protein-related protein 6 OS=Homo sapiens OX=9606 GN=OSBPL6 PE=1 SV=1 g7523.t3 Q9BZF3 44.533 878 0.0 721.0 sp|Q9BZF3|OSBL6_HUMAN Oxysterol-binding protein-related protein 6 OS=Homo sapiens OX=9606 GN=OSBPL6 PE=1 SV=1 g7523.t4 Q9BZF3 42.291 934 0.0 704.0 sp|Q9BZF3|OSBL6_HUMAN Oxysterol-binding protein-related protein 6 OS=Homo sapiens OX=9606 GN=OSBPL6 PE=1 SV=1 g7524.t1 Q3TV65 41.235 405 1.35e-93 292.0 sp|Q3TV65|MPND_MOUSE MPN domain-containing protein OS=Mus musculus OX=10090 GN=Mpnd PE=1 SV=2 MPND_MOUSE reviewed MPN domain-containing protein (EC 3.4.-.-) Mus musculus (Mouse) GO:0006302; GO:0006508; GO:0008237; GO:0031593; GO:0046872; GO:0070531; GO:0070552 double-strand break repair [GO:0006302]; proteolysis [GO:0006508] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552] metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593] g7525.t1 Q5RF54 46.535 202 3.0500000000000003e-56 178.0 sp|Q5RF54|CSN8_PONAB COP9 signalosome complex subunit 8 OS=Pongo abelii OX=9601 GN=COPS8 PE=2 SV=1 g7526.t1 A8T6P4 40.972 144 2.45e-34 144.0 sp|A8T6P4|MYRIP_DANRE Rab effector MyRIP OS=Danio rerio OX=7955 GN=myrip PE=1 SV=1 MYRIP_DANRE reviewed Rab effector MyRIP (Exophilin-8) (Myosin VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003779; GO:0006886; GO:0008270; GO:0017022; GO:0030133; GO:0030864; GO:0031267; GO:0048471 intracellular protein transport [GO:0006886] cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133] actin binding [GO:0003779]; myosin binding [GO:0017022]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g7526.t2 A8T6P4 40.972 144 2.2099999999999997e-34 144.0 sp|A8T6P4|MYRIP_DANRE Rab effector MyRIP OS=Danio rerio OX=7955 GN=myrip PE=1 SV=1 MYRIP_DANRE reviewed Rab effector MyRIP (Exophilin-8) (Myosin VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003779; GO:0006886; GO:0008270; GO:0017022; GO:0030133; GO:0030864; GO:0031267; GO:0048471 intracellular protein transport [GO:0006886] cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133] actin binding [GO:0003779]; myosin binding [GO:0017022]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g7532.t1 Q5RF00 68.286 391 0.0 546.0 sp|Q5RF00|ALDH2_PONAB Aldehyde dehydrogenase, mitochondrial OS=Pongo abelii OX=9601 GN=ALDH2 PE=2 SV=1 ALDH2_PONAB reviewed Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004029; GO:0005739; GO:0005759; GO:0008957; GO:0018937; GO:0046185; GO:0106435; GO:1903179; GO:1905627 aldehyde catabolic process [GO:0046185]; nitroglycerin metabolic process [GO:0018937]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; carboxylesterase activity [GO:0106435]; phenylacetaldehyde dehydrogenase (NAD+) activity [GO:0008957] g7533.t1 A2RUC4 62.333 300 8.83e-143 408.0 sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1 TYW5_HUMAN reviewed tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase) Homo sapiens (Human) GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524 wybutosine biosynthetic process [GO:0031591] cytoplasm [GO:0005737] iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524] g7534.t1 Q6AY04 33.816 207 1.0200000000000001e-35 132.0 sp|Q6AY04|MAIP1_RAT m-AAA protease-interacting protein 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Maip1 PE=2 SV=1 g7546.t1 P81942 44.498 209 4.51e-56 180.0 sp|P81942|GSTP1_BUFBU Glutathione S-transferase P 1 OS=Bufo bufo OX=8384 PE=1 SV=1 g7548.t1 P46426 44.974 189 1.0499999999999999e-54 176.0 sp|P46426|GSTP_DIRIM Glutathione S-transferase OS=Dirofilaria immitis OX=6287 PE=2 SV=1 g7549.t1 Q32L00 51.653 242 6.99e-75 236.0 sp|Q32L00|ALKB3_BOVIN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 OS=Bos taurus OX=9913 GN=ALKBH3 PE=2 SV=1 ALKB3_BOVIN reviewed Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (EC 1.14.11.33) (EC 1.14.11.54) (Alkylated DNA repair protein alkB homolog 3) Bos taurus (Bovine) GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006307; GO:0008198; GO:0008283; GO:0035516; GO:1990930; GO:2000766 cell population proliferation [GO:0008283]; DNA alkylation repair [GO:0006307]; DNA repair [GO:0006281]; negative regulation of cytoplasmic translation [GO:2000766] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] broad specificity oxidative DNA demethylase activity [GO:0035516]; ferrous iron binding [GO:0008198]; mRNA N1-methyladenosine dioxygenase activity [GO:1990930] g7550.t1 Q7ZWG6 28.539 445 2.5500000000000004e-47 174.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g7554.t1 B0BLT0 62.5 112 2.67e-47 152.0 sp|B0BLT0|ZN593_XENTR Zinc finger protein 593 OS=Xenopus tropicalis OX=8364 GN=znf593 PE=2 SV=1 g7559.t1 Q3C2C2 58.75 160 1.38e-55 174.0 sp|Q3C2C2|PA21_ACAPL Phospholipase A2 AP-PLA2-I OS=Acanthaster planci OX=133434 PE=1 SV=1 PA21_ACAPL reviewed Phospholipase A2 AP-PLA2-I (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) Acanthaster planci (Crown-of-thorns starfish) GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0031640; GO:0047498; GO:0050482; GO:0090729 arachidonate secretion [GO:0050482]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729] g7560.t1 Q3C2C2 57.5 160 6.679999999999999e-54 170.0 sp|Q3C2C2|PA21_ACAPL Phospholipase A2 AP-PLA2-I OS=Acanthaster planci OX=133434 PE=1 SV=1 PA21_ACAPL reviewed Phospholipase A2 AP-PLA2-I (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) Acanthaster planci (Crown-of-thorns starfish) GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0031640; GO:0047498; GO:0050482; GO:0090729 arachidonate secretion [GO:0050482]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729] g7565.t1 Q15648 46.009 213 2.82e-49 176.0 sp|Q15648|MED1_HUMAN Mediator of RNA polymerase II transcription subunit 1 OS=Homo sapiens OX=9606 GN=MED1 PE=1 SV=4 MED1_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A) Homo sapiens (Human) GO:0000122; GO:0000151; GO:0000785; GO:0000902; GO:0000978; GO:0001223; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003682; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006590; GO:0006606; GO:0006702; GO:0007420; GO:0007595; GO:0010628; GO:0010839; GO:0016020; GO:0016567; GO:0016592; GO:0016922; GO:0030216; GO:0030224; GO:0030331; GO:0030518; GO:0031100; GO:0031490; GO:0032968; GO:0032993; GO:0033148; GO:0035035; GO:0035050; GO:0035116; GO:0035162; GO:0035357; GO:0035729; GO:0035855; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0044877; GO:0045023; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0051123; GO:0060218; GO:0060261; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0061630; GO:0070318; GO:0070562; GO:0070847; GO:0071364; GO:0071383; GO:0097067; GO:0140296; GO:0140297; GO:1990841; GO:2000347; GO:2001141 androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G0 to G1 transition [GO:0045023]; hematopoietic stem cell differentiation [GO:0060218]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear receptor-mediated steroid hormone signaling pathway [GO:0030518]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; positive regulation of type II interferon-mediated signaling pathway [GO:0060335]; protein import into nucleus [GO:0006606]; protein ubiquitination [GO:0016567]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone receptor signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222] chromatin [GO:0000785]; core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; LBD domain binding [GO:0050693]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630] g7566.t1 Q15648 33.586 396 2.02e-49 192.0 sp|Q15648|MED1_HUMAN Mediator of RNA polymerase II transcription subunit 1 OS=Homo sapiens OX=9606 GN=MED1 PE=1 SV=4 MED1_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A) Homo sapiens (Human) GO:0000122; GO:0000151; GO:0000785; GO:0000902; GO:0000978; GO:0001223; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003682; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006590; GO:0006606; GO:0006702; GO:0007420; GO:0007595; GO:0010628; GO:0010839; GO:0016020; GO:0016567; GO:0016592; GO:0016922; GO:0030216; GO:0030224; GO:0030331; GO:0030518; GO:0031100; GO:0031490; GO:0032968; GO:0032993; GO:0033148; GO:0035035; GO:0035050; GO:0035116; GO:0035162; GO:0035357; GO:0035729; GO:0035855; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0044877; GO:0045023; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0051123; GO:0060218; GO:0060261; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0061630; GO:0070318; GO:0070562; GO:0070847; GO:0071364; GO:0071383; GO:0097067; GO:0140296; GO:0140297; GO:1990841; GO:2000347; GO:2001141 androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G0 to G1 transition [GO:0045023]; hematopoietic stem cell differentiation [GO:0060218]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear receptor-mediated steroid hormone signaling pathway [GO:0030518]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; positive regulation of type II interferon-mediated signaling pathway [GO:0060335]; protein import into nucleus [GO:0006606]; protein ubiquitination [GO:0016567]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone receptor signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222] chromatin [GO:0000785]; core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; LBD domain binding [GO:0050693]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630] g7570.t1 Q14457 61.573 445 0.0 548.0 sp|Q14457|BECN1_HUMAN Beclin-1 OS=Homo sapiens OX=9606 GN=BECN1 PE=1 SV=2 BECN1_HUMAN reviewed Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa] Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000423; GO:0001666; GO:0002753; GO:0005737; GO:0005768; GO:0005776; GO:0005783; GO:0005789; GO:0005802; GO:0005829; GO:0006622; GO:0006914; GO:0006915; GO:0006968; GO:0006995; GO:0007040; GO:0007080; GO:0007254; GO:0007623; GO:0008285; GO:0009306; GO:0009410; GO:0010008; GO:0010040; GO:0010288; GO:0010506; GO:0010508; GO:0010613; GO:0016236; GO:0016241; GO:0016604; GO:0019901; GO:0030425; GO:0030674; GO:0031625; GO:0032465; GO:0032473; GO:0032801; GO:0033197; GO:0034198; GO:0034271; GO:0034272; GO:0035032; GO:0036092; GO:0038066; GO:0042149; GO:0042802; GO:0043066; GO:0043069; GO:0043548; GO:0043652; GO:0045022; GO:0045324; GO:0045335; GO:0048666; GO:0050435; GO:0051020; GO:0051301; GO:0051607; GO:0051897; GO:0060090; GO:0060348; GO:0060395; GO:0062029; GO:0065003; GO:0070301; GO:0071275; GO:0071280; GO:0071364; GO:0090650; GO:0097352; GO:0098780; GO:1902425; GO:1902902; GO:1905672; GO:2000786; GO:2001244 amyloid-beta metabolic process [GO:0050435]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; bone development [GO:0060348]; cell division [GO:0051301]; cellular defense response [GO:0006968]; cellular response to aluminum ion [GO:0071275]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian rhythm [GO:0007623]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; engulfment of apoptotic cell [GO:0043652]; JNK cascade [GO:0007254]; late endosome to vacuole transport [GO:0045324]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of programmed cell death [GO:0043069]; neuron development [GO:0048666]; p38MAPK cascade [GO:0038066]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress granule assembly [GO:0062029]; protein secretion [GO:0009306]; protein targeting to lysosome [GO:0006622]; protein-containing complex assembly [GO:0065003]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to mitochondrial depolarisation [GO:0098780]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nuclear body [GO:0016604]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; trans-Golgi network [GO:0005802] GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] g7571.t1 Q64520 55.135 185 1.9000000000000002e-70 216.0 sp|Q64520|KGUA_MOUSE Guanylate kinase OS=Mus musculus OX=10090 GN=Guk1 PE=1 SV=2 KGUA_MOUSE reviewed Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1) Mus musculus (Mouse) GO:0001917; GO:0004385; GO:0005524; GO:0005739; GO:0005829; GO:0006163; GO:0006185; GO:0006805; GO:0019673; GO:0034436; GO:0046037; GO:0046054; GO:0046060; GO:0046711 dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917] ATP binding [GO:0005524]; GMP kinase activity [GO:0004385] g7571.t2 Q64520 57.447 188 1.91e-75 229.0 sp|Q64520|KGUA_MOUSE Guanylate kinase OS=Mus musculus OX=10090 GN=Guk1 PE=1 SV=2 KGUA_MOUSE reviewed Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1) Mus musculus (Mouse) GO:0001917; GO:0004385; GO:0005524; GO:0005739; GO:0005829; GO:0006163; GO:0006185; GO:0006805; GO:0019673; GO:0034436; GO:0046037; GO:0046054; GO:0046060; GO:0046711 dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; GMP metabolic process [GO:0046037]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917] ATP binding [GO:0005524]; GMP kinase activity [GO:0004385] g7572.t1 C3YEM5 50.459 327 3.3e-98 296.0 sp|C3YEM5|EFTS_BRAFL Elongation factor Ts, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_84221 PE=3 SV=1 g7578.t1 Q8IV01 44.194 310 4.98e-85 269.0 sp|Q8IV01|SYT12_HUMAN Synaptotagmin-12 OS=Homo sapiens OX=9606 GN=SYT12 PE=1 SV=1 g7579.t1 Q5IS51 29.197 411 4.5799999999999996e-52 185.0 sp|Q5IS51|ACHA5_PANTR Neuronal acetylcholine receptor subunit alpha-5 OS=Pan troglodytes OX=9598 GN=CHRNA5 PE=2 SV=1 ACHA5_PANTR reviewed Neuronal acetylcholine receptor subunit alpha-5 Pan troglodytes (Chimpanzee) GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0022848; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098793; GO:0098878; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888] g7581.t1 Q5IS51 28.307 378 6.179999999999999e-48 173.0 sp|Q5IS51|ACHA5_PANTR Neuronal acetylcholine receptor subunit alpha-5 OS=Pan troglodytes OX=9598 GN=CHRNA5 PE=2 SV=1 ACHA5_PANTR reviewed Neuronal acetylcholine receptor subunit alpha-5 Pan troglodytes (Chimpanzee) GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0022848; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098793; GO:0098878; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888] g7583.t1 A5D7H5 39.264 163 1.31e-24 113.0 sp|A5D7H5|CASC3_BOVIN Protein CASC3 OS=Bos taurus OX=9913 GN=CASC3 PE=2 SV=1 CASC3_BOVIN reviewed Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein homolog) (MLN 51 homolog) (Protein barentsz) (Btz) Bos taurus (Bovine) GO:0000184; GO:0000398; GO:0003729; GO:0005634; GO:0006417; GO:0008298; GO:0010494; GO:0016607; GO:0030425; GO:0031625; GO:0031965; GO:0035145; GO:0042802; GO:0048471; GO:0051028; GO:0071006; GO:2000622 intracellular mRNA localization [GO:0008298]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417] cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006] identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; ubiquitin protein ligase binding [GO:0031625] g7583.t2 A0JMU8 37.374 198 1.16e-23 110.0 sp|A0JMU8|CASC3_XENLA Protein CASC3 OS=Xenopus laevis OX=8355 GN=casc3 PE=2 SV=1 CASC3_XENLA reviewed Protein CASC3 (Cancer susceptibility candidate gene 3 protein homolog) (Metastatic lymph node protein 51 homolog) (Protein MLN 51 homolog) (XlMLN51) Xenopus laevis (African clawed frog) GO:0000184; GO:0000398; GO:0003729; GO:0005634; GO:0006417; GO:0010494; GO:0016607; GO:0030425; GO:0035145; GO:0048471; GO:0051028; GO:0071006 mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417] cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006] mRNA binding [GO:0003729] g7584.t1 P24340 76.271 59 2.53e-25 98.2 sp|P24340|HXD9_CHICK Homeobox protein Hox-D9 (Fragment) OS=Gallus gallus OX=9031 GN=HOXD9 PE=2 SV=1 g7585.t1 F6UF99 32.095 296 1.28e-38 148.0 sp|F6UF99|TM237_XENTR Transmembrane protein 237 OS=Xenopus tropicalis OX=8364 GN=tmem237 PE=3 SV=1 g7591.t1 Q9JHE4 35.049 408 3.9e-71 233.0 sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2 G3ST1_MOUSE reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Mus musculus (Mouse) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020] galactosylceramide sulfotransferase activity [GO:0001733] g7592.t1 Q99999 35.629 334 4.96e-64 217.0 sp|Q99999|G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1 G3ST1_HUMAN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Homo sapiens (Human) GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146] g7595.t1 A6QNK1 38.17 317 5.09e-69 224.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g7596.t1 Q571I9 43.58 810 0.0 637.0 sp|Q571I9|A16A1_MOUSE Aldehyde dehydrogenase family 16 member A1 OS=Mus musculus OX=10090 GN=Aldh16a1 PE=1 SV=2 g7597.t1 P41823 64.965 431 0.0 519.0 sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2 g7599.t1 G8HTB6 29.43 316 7.08e-25 112.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g7600.t1 Q5THR3 30.384 1379 0.0 648.0 sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1 EFCB6_HUMAN reviewed EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP) Homo sapiens (Human) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g7600.t1 Q5THR3 19.867 1052 1.18e-38 161.0 sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1 EFCB6_HUMAN reviewed EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP) Homo sapiens (Human) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g7600.t2 Q5THR3 29.764 719 1.33e-91 318.0 sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1 EFCB6_HUMAN reviewed EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP) Homo sapiens (Human) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g7600.t2 Q5THR3 20.471 679 3.55e-25 116.0 sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1 EFCB6_HUMAN reviewed EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP) Homo sapiens (Human) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g7600.t2 Q5THR3 19.608 561 4.28e-22 106.0 sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1 EFCB6_HUMAN reviewed EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP) Homo sapiens (Human) GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126] calcium ion binding [GO:0005509] g7601.t1 P63047 49.225 258 2.02e-85 260.0 sp|P63047|ST4A1_RAT Sulfotransferase 4A1 OS=Rattus norvegicus OX=10116 GN=Sult4a1 PE=1 SV=1 g7602.t1 A0A411L030 32.534 292 3.01e-36 135.0 sp|A0A411L030|BUAE_PETAA Proline hydroxylase buaE OS=Petromyces alliaceus OX=209559 GN=buaE PE=3 SV=1 g7604.t1 A1L224 42.537 402 2.71e-68 233.0 sp|A1L224|CR3L2_DANRE Cyclic AMP-responsive element-binding protein 3-like protein 2 OS=Danio rerio OX=7955 GN=creb3l2 PE=2 SV=1 CR3L2_DANRE reviewed Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000976; GO:0000981; GO:0002062; GO:0003330; GO:0005634; GO:0005783; GO:0005789; GO:0006357; GO:0006986; GO:0034976; GO:0035497; GO:0051216; GO:0060628 cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of extracellular matrix constituent secretion [GO:0003330]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976] g7606.t1 Q8AVJ1 50.532 188 5.92e-49 172.0 sp|Q8AVJ1|PRR5_XENLA Proline-rich protein 5 OS=Xenopus laevis OX=8355 GN=prr5 PE=2 SV=1 g7608.t1 Q791V5 46.128 297 4.81e-93 281.0 sp|Q791V5|MTCH2_MOUSE Mitochondrial carrier homolog 2 OS=Mus musculus OX=10090 GN=Mtch2 PE=1 SV=1 MTCH2_MOUSE reviewed Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005743; GO:0006089; GO:0010635; GO:0010917; GO:0016020; GO:0032977; GO:0035701; GO:0042775; GO:0043065; GO:0045040; GO:0045820; GO:0055088; GO:0061484; GO:0070585; GO:0071478; GO:0090152; GO:0097284; GO:1902108; GO:1902231; GO:2000738 cellular response to radiation [GO:0071478]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration [GO:0035701]; hepatocyte apoptotic process [GO:0097284]; lactate metabolic process [GO:0006089]; lipid homeostasis [GO:0055088]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] membrane insertase activity [GO:0032977] g7609.t1 Q99999 37.425 334 7.15e-67 223.0 sp|Q99999|G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1 G3ST1_HUMAN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Homo sapiens (Human) GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146] g7610.t1 A6QNK1 38.024 334 3.4500000000000003e-66 228.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g7611.t1 Q4R8T1 22.314 726 1.93e-34 144.0 sp|Q4R8T1|EFCB6_MACFA EF-hand calcium-binding domain-containing protein 6 (Fragment) OS=Macaca fascicularis OX=9541 GN=EFCAB6 PE=2 SV=2 g7612.t1 A1XQR9 85.393 89 5.2e-50 155.0 sp|A1XQR9|RUXE_PIG Small nuclear ribonucleoprotein E OS=Sus scrofa OX=9823 GN=SNRPE PE=3 SV=1 RUXE_PIG reviewed Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE) Sus scrofa (Pig) GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011 mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387] cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683] RNA binding [GO:0003723] g7613.t1 Q9CXP4 42.289 402 5.55e-114 347.0 sp|Q9CXP4|RHG08_MOUSE Rho GTPase-activating protein 8 OS=Mus musculus OX=10090 GN=Arhgap8 PE=2 SV=3 g7618.t1 O73925 49.094 552 4.87e-159 474.0 sp|O73925|KCNQ1_SQUAC Potassium voltage-gated channel subfamily KQT member 1 OS=Squalus acanthias OX=7797 GN=KCNQ1 PE=2 SV=1 g7631.t1 Q8BZK4 38.095 357 1.12e-76 251.0 sp|Q8BZK4|S35F4_MOUSE Solute carrier family 35 member F4 OS=Mus musculus OX=10090 GN=Slc35f4 PE=2 SV=1 g7633.t1 Q5REU4 58.509 899 0.0 1060.0 sp|Q5REU4|SND1_PONAB Staphylococcal nuclease domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SND1 PE=2 SV=1 g7634.t1 Q5RBZ2 46.154 312 5.51e-92 280.0 sp|Q5RBZ2|MEP50_PONAB Methylosome protein WDR77 OS=Pongo abelii OX=9601 GN=WDR77 PE=2 SV=1 g7641.t1 D3YWQ0 52.419 992 0.0 1006.0 sp|D3YWQ0|DGKI_MOUSE Diacylglycerol kinase iota OS=Mus musculus OX=10090 GN=Dgki PE=1 SV=2 DGKI_MOUSE reviewed Diacylglycerol kinase iota (DAG kinase iota) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005095; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0007265; GO:0007269; GO:0008021; GO:0014069; GO:0030672; GO:0031267; GO:0032045; GO:0032991; GO:0035556; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046339; GO:0046579; GO:0046834; GO:0046959; GO:0048471; GO:0048786; GO:0051966; GO:0060076; GO:0060079; GO:0097060; GO:0098685; GO:0098891; GO:0098978; GO:0099147; GO:0099171; GO:1900452 diacylglycerol metabolic process [GO:0046339]; excitatory postsynaptic potential [GO:0060079]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; neurotransmitter secretion [GO:0007269]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of Ras protein signal transduction [GO:0046579]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; Ras protein signal transduction [GO:0007265]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extrinsic component of postsynaptic density membrane [GO:0099147]; extrinsic component of presynaptic active zone membrane [GO:0098891]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267] g7641.t2 D3YWQ0 52.467 993 0.0 1009.0 sp|D3YWQ0|DGKI_MOUSE Diacylglycerol kinase iota OS=Mus musculus OX=10090 GN=Dgki PE=1 SV=2 DGKI_MOUSE reviewed Diacylglycerol kinase iota (DAG kinase iota) (EC 2.7.1.107) Mus musculus (Mouse) GO:0004143; GO:0005095; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0007265; GO:0007269; GO:0008021; GO:0014069; GO:0030672; GO:0031267; GO:0032045; GO:0032991; GO:0035556; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0046339; GO:0046579; GO:0046834; GO:0046959; GO:0048471; GO:0048786; GO:0051966; GO:0060076; GO:0060079; GO:0097060; GO:0098685; GO:0098891; GO:0098978; GO:0099147; GO:0099171; GO:1900452 diacylglycerol metabolic process [GO:0046339]; excitatory postsynaptic potential [GO:0060079]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; neurotransmitter secretion [GO:0007269]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of Ras protein signal transduction [GO:0046579]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; Ras protein signal transduction [GO:0007265]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extrinsic component of postsynaptic density membrane [GO:0099147]; extrinsic component of presynaptic active zone membrane [GO:0098891]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267] g7641.t3 Q13574 57.159 908 0.0 1045.0 sp|Q13574|DGKZ_HUMAN Diacylglycerol kinase zeta OS=Homo sapiens OX=9606 GN=DGKZ PE=1 SV=4 g7648.t1 P17200 27.578 446 6.89e-49 176.0 sp|P17200|ACM4_CHICK Muscarinic acetylcholine receptor M4 OS=Gallus gallus OX=9031 GN=CHRM4 PE=2 SV=1 g7653.t1 Q95SX7 33.205 259 7.570000000000001e-32 129.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g7654.t1 Q6GPB8 80.531 113 3.43e-63 203.0 sp|Q6GPB8|DBR1A_XENLA Lariat debranching enzyme A OS=Xenopus laevis OX=8355 GN=dbr1-a PE=2 SV=1 DBR1A_XENLA reviewed Lariat debranching enzyme A (EC 3.1.4.-) Xenopus laevis (African clawed frog) GO:0000375; GO:0000398; GO:0005634; GO:0008419; GO:0046872 mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375] nucleus [GO:0005634] metal ion binding [GO:0046872]; RNA lariat debranching enzyme activity [GO:0008419] g7657.t1 Q6GPB8 48.731 591 0.0 528.0 sp|Q6GPB8|DBR1A_XENLA Lariat debranching enzyme A OS=Xenopus laevis OX=8355 GN=dbr1-a PE=2 SV=1 DBR1A_XENLA reviewed Lariat debranching enzyme A (EC 3.1.4.-) Xenopus laevis (African clawed frog) GO:0000375; GO:0000398; GO:0005634; GO:0008419; GO:0046872 mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375] nucleus [GO:0005634] metal ion binding [GO:0046872]; RNA lariat debranching enzyme activity [GO:0008419] g7658.t1 Q96L42 57.204 701 0.0 796.0 sp|Q96L42|KCNH8_HUMAN Voltage-gated delayed rectifier potassium channel KCNH8 OS=Homo sapiens OX=9606 GN=KCNH8 PE=1 SV=2 g7658.t2 Q96L42 56.98 702 0.0 795.0 sp|Q96L42|KCNH8_HUMAN Voltage-gated delayed rectifier potassium channel KCNH8 OS=Homo sapiens OX=9606 GN=KCNH8 PE=1 SV=2 g7659.t1 F1N2K1 41.758 455 2.26e-109 338.0 sp|F1N2K1|PCYOX_BOVIN Prenylcysteine oxidase 1 OS=Bos taurus OX=9913 GN=PCYOX1 PE=1 SV=2 g7661.t1 Q8BGQ2 55.649 239 4.24e-84 278.0 sp|Q8BGQ2|CSRN2_MOUSE Cysteine/serine-rich nuclear protein 2 OS=Mus musculus OX=10090 GN=Csrnp2 PE=2 SV=1 CSRN2_MOUSE reviewed Cysteine/serine-rich nuclear protein 2 (CSRNP-2) (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12) (TAIP-12) Mus musculus (Mouse) GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0019902; GO:0043565; GO:0045944 apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565] g7662.t1 Q28EM8 26.513 347 1.21e-28 117.0 sp|Q28EM8|LTMD1_XENTR LETM1 domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=letmd1 PE=2 SV=1 g7663.t1 Q8TC26 33.473 239 1.3500000000000002e-43 152.0 sp|Q8TC26|TM163_HUMAN Transmembrane protein 163 OS=Homo sapiens OX=9606 GN=TMEM163 PE=1 SV=1 g7665.t1 Q28709 39.834 241 6.64e-62 196.0 sp|Q28709|CD63_RABIT CD63 antigen OS=Oryctolagus cuniculus OX=9986 GN=CD63 PE=2 SV=2 g7666.t1 Q49A88 36.481 233 9.06e-33 141.0 sp|Q49A88|CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens OX=9606 GN=CCDC14 PE=1 SV=3 CCD14_HUMAN reviewed Coiled-coil domain-containing protein 14 Homo sapiens (Human) GO:0005813; GO:0005929; GO:0015630; GO:0021762; GO:0034451; GO:0036064; GO:0071539 protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule cytoskeleton [GO:0015630] g7667.t1 Q5RDC7 38.498 213 2.31e-43 151.0 sp|Q5RDC7|RWDD3_PONAB RWD domain-containing protein 3 OS=Pongo abelii OX=9601 GN=RWDD3 PE=2 SV=1 g7672.t1 Q60614 30.097 309 7.39e-25 106.0 sp|Q60614|AA2BR_MOUSE Adenosine receptor A2b OS=Mus musculus OX=10090 GN=Adora2b PE=2 SV=2 AA2BR_MOUSE reviewed Adenosine receptor A2b Mus musculus (Mouse) GO:0001609; GO:0001938; GO:0001973; GO:0002882; GO:0004930; GO:0005886; GO:0007189; GO:0008284; GO:0008285; GO:0009986; GO:0010575; GO:0010595; GO:0010701; GO:0010753; GO:0010893; GO:0010906; GO:0032722; GO:0032755; GO:0032966; GO:0033605; GO:0042311; GO:0043306; GO:0045202; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171; GO:0141163; GO:1990776 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of glucose metabolic process [GO:0010906]; relaxation of vascular associated smooth muscle [GO:0060087]; response to angiotensin [GO:1990776]; vasodilation [GO:0042311] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930] g7673.t1 Q8C180 58.427 89 5.97e-27 117.0 sp|Q8C180|FRS2_MOUSE Fibroblast growth factor receptor substrate 2 OS=Mus musculus OX=10090 GN=Frs2 PE=1 SV=3 FRS2_MOUSE reviewed Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (FRS2-alpha) (Suc1-associated neurotrophic factor target 1) (SNT-1) Mus musculus (Mouse) GO:0001702; GO:0001759; GO:0002088; GO:0003281; GO:0005068; GO:0005104; GO:0005168; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007169; GO:0007405; GO:0008543; GO:0008595; GO:0030900; GO:0042981; GO:0043410; GO:0044344; GO:0046619; GO:0050678; GO:0060527; GO:0070307; GO:0070372; GO:1904707; GO:2000726 anterior/posterior axis specification, embryo [GO:0008595]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to fibroblast growth factor stimulus [GO:0044344]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; gastrulation with mouth forming second [GO:0001702]; lens development in camera-type eye [GO:0002088]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ventricular septum development [GO:0003281] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g7674.t1 P49706 56.164 292 6.089999999999999e-104 308.0 sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1 g7675.t1 A0JMD4 41.383 824 0.0 594.0 sp|A0JMD4|TPC2_DANRE Two pore channel protein 2 OS=Danio rerio OX=7955 GN=tpcn2 PE=2 SV=1 TPC2_DANRE reviewed Two pore channel protein 2 (Two pore calcium channel protein 2) (Voltage-dependent calcium channel protein TPC2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005245; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0015280; GO:0019722; GO:0031902; GO:0034702; GO:0035725; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0097682; GO:2000290 calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; monoatomic ion channel complex [GO:0034702] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; voltage-gated calcium channel activity [GO:0005245] g7675.t2 A0JMD4 42.131 807 0.0 603.0 sp|A0JMD4|TPC2_DANRE Two pore channel protein 2 OS=Danio rerio OX=7955 GN=tpcn2 PE=2 SV=1 TPC2_DANRE reviewed Two pore channel protein 2 (Two pore calcium channel protein 2) (Voltage-dependent calcium channel protein TPC2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005245; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0015280; GO:0019722; GO:0031902; GO:0034702; GO:0035725; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0097682; GO:2000290 calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; monoatomic ion channel complex [GO:0034702] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; voltage-gated calcium channel activity [GO:0005245] g7677.t1 C9K4X8 73.729 118 1.1999999999999999e-54 169.0 sp|C9K4X8|GSS_PATPE Gonad-stimulating substance OS=Patiria pectinifera OX=7594 GN=GSS PE=1 SV=1 GSS_PATPE reviewed Gonad-stimulating substance (Relaxin-like gonad-stimulating peptide) [Cleaved into: Gonad-stimulating substance B chain; Gonad-stimulating substance A chain] Patiria pectinifera (Starfish) (Asterina pectinifera) GO:0005179; GO:0005615; GO:0005886; GO:0007189; GO:0060279; GO:1900195 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of ovulation [GO:0060279] extracellular space [GO:0005615]; plasma membrane [GO:0005886] hormone activity [GO:0005179] g7678.t1 O15078 42.631 2524 0.0 1795.0 sp|O15078|CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens OX=9606 GN=CEP290 PE=1 SV=2 CE290_HUMAN reviewed Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2) Homo sapiens (Human) GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515 camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] identical protein binding [GO:0042802] g7679.t1 Q5RFD2 38.356 219 4.4e-40 149.0 sp|Q5RFD2|S47A1_PONAB Multidrug and toxin extrusion protein 1 OS=Pongo abelii OX=9601 GN=SLC47A1 PE=2 SV=1 S47A1_PONAB reviewed Multidrug and toxin extrusion protein 1 (MATE-1) (Solute carrier family 47 member 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0015101; GO:0015234; GO:0015297; GO:0015489; GO:0015695; GO:0015847; GO:0016324; GO:0042910; GO:1990961 organic cation transport [GO:0015695]; putrescine transport [GO:0015847]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] apical plasma membrane [GO:0016324] antiporter activity [GO:0015297]; organic cation transmembrane transporter activity [GO:0015101]; putrescine transmembrane transporter activity [GO:0015489]; thiamine transmembrane transporter activity [GO:0015234]; xenobiotic transmembrane transporter activity [GO:0042910] g7682.t1 Q96FL8 31.25 288 1.2299999999999999e-40 155.0 sp|Q96FL8|S47A1_HUMAN Multidrug and toxin extrusion protein 1 OS=Homo sapiens OX=9606 GN=SLC47A1 PE=1 SV=1 g7683.t1 P54611 63.717 226 2.25e-102 298.0 sp|P54611|VATE_DROME V-type proton ATPase subunit E OS=Drosophila melanogaster OX=7227 GN=Vha26 PE=1 SV=1 g7684.t1 Q9DB41 57.188 320 3.37e-130 377.0 sp|Q9DB41|GHC2_MOUSE Mitochondrial glutamate carrier 2 OS=Mus musculus OX=10090 GN=Slc25a18 PE=1 SV=4 g7684.t2 Q9DB41 57.098 317 4.71e-128 372.0 sp|Q9DB41|GHC2_MOUSE Mitochondrial glutamate carrier 2 OS=Mus musculus OX=10090 GN=Slc25a18 PE=1 SV=4 g7685.t1 Q5ZKA2 52.88 955 0.0 1048.0 sp|Q5ZKA2|SYIM_CHICK Isoleucine--tRNA ligase, mitochondrial OS=Gallus gallus OX=9031 GN=IARS2 PE=2 SV=1 g7686.t1 Q96HJ3 35.0 200 7.12e-28 117.0 sp|Q96HJ3|CCD34_HUMAN Coiled-coil domain-containing protein 34 OS=Homo sapiens OX=9606 GN=CCDC34 PE=1 SV=2 g7687.t1 Q96HH6 45.846 325 6.75e-108 321.0 sp|Q96HH6|TMM19_HUMAN Transmembrane protein 19 OS=Homo sapiens OX=9606 GN=TMEM19 PE=1 SV=1 TMM19_HUMAN reviewed Transmembrane protein 19 Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g7688.t1 Q9BY84 56.164 292 1.46e-106 349.0 sp|Q9BY84|DUS16_HUMAN Dual specificity protein phosphatase 16 OS=Homo sapiens OX=9606 GN=DUSP16 PE=1 SV=1 g7688.t2 Q9BY84 58.904 219 8.480000000000001e-85 290.0 sp|Q9BY84|DUS16_HUMAN Dual specificity protein phosphatase 16 OS=Homo sapiens OX=9606 GN=DUSP16 PE=1 SV=1 g7691.t1 Q9ULM3 31.364 220 3.7e-24 103.0 sp|Q9ULM3|YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens OX=9606 GN=YEATS2 PE=1 SV=2 YETS2_HUMAN reviewed YEATS domain-containing protein 2 Homo sapiens (Human) GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0017025; GO:0035267; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140030; GO:0140566; GO:0140672 chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone binding [GO:0042393]; histone reader activity [GO:0140566]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714] g7692.t1 Q3TUF7 67.692 65 7.61e-26 105.0 sp|Q3TUF7|YETS2_MOUSE YEATS domain-containing protein 2 OS=Mus musculus OX=10090 GN=Yeats2 PE=1 SV=2 YETS2_MOUSE reviewed YEATS domain-containing protein 2 Mus musculus (Mouse) GO:0000122; GO:0003714; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0017025; GO:0035267; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140030; GO:0140566; GO:0140672 chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634] histone binding [GO:0042393]; histone reader activity [GO:0140566]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714] g7694.t1 Q7T0L7 39.583 288 2.3e-63 202.0 sp|Q7T0L7|BN3D2_XENLA Pre-miRNA 5'-monophosphate methyltransferase OS=Xenopus laevis OX=8355 GN=bcdin3d PE=2 SV=1 g7696.t1 O35166 58.962 212 2.21e-90 267.0 sp|O35166|GOSR2_MOUSE Golgi SNAP receptor complex member 2 OS=Mus musculus OX=10090 GN=Gosr2 PE=1 SV=2 GOSR2_MOUSE reviewed Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin) Mus musculus (Mouse) GO:0000139; GO:0000149; GO:0005484; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006891; GO:0006906; GO:0012507; GO:0015031; GO:0016192; GO:0031201; GO:0031902 intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g7698.t1 Q5ZHT1 55.23 784 0.0 877.0 sp|Q5ZHT1|ACD11_CHICK Acyl-CoA dehydrogenase family member 11 OS=Gallus gallus OX=9031 GN=ACAD11 PE=2 SV=1 ACD11_CHICK reviewed Acyl-CoA dehydrogenase family member 11 (ACAD-11) (EC 1.3.8.8) Gallus gallus (Chicken) GO:0003995; GO:0005737; GO:0005739; GO:0005777; GO:0031966; GO:0033539; GO:0050660 fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660] g7699.t1 Q9W534 24.185 368 1.2500000000000001e-21 100.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g7700.t1 Q9HBL0 48.193 498 6.04e-139 485.0 sp|Q9HBL0|TENS1_HUMAN Tensin-1 OS=Homo sapiens OX=9606 GN=TNS1 PE=1 SV=3 g7700.t1 Q9HBL0 57.047 298 6.58e-95 347.0 sp|Q9HBL0|TENS1_HUMAN Tensin-1 OS=Homo sapiens OX=9606 GN=TNS1 PE=1 SV=3 g7700.t2 Q9HBL0 48.2 500 3.78e-139 486.0 sp|Q9HBL0|TENS1_HUMAN Tensin-1 OS=Homo sapiens OX=9606 GN=TNS1 PE=1 SV=3 g7700.t2 Q9HBL0 57.047 298 8.169999999999999e-95 347.0 sp|Q9HBL0|TENS1_HUMAN Tensin-1 OS=Homo sapiens OX=9606 GN=TNS1 PE=1 SV=3 g7701.t1 Q6RVG2 49.251 1135 0.0 999.0 sp|Q6RVG2|S4A8_RAT Electroneutral sodium bicarbonate exchanger 1 OS=Rattus norvegicus OX=10116 GN=Slc4a8 PE=1 SV=2 S4A8_RAT reviewed Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na+-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3) Rattus norvegicus (Rat) GO:0005886; GO:0008021; GO:0008270; GO:0008510; GO:0015081; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016323; GO:0016324; GO:0030425; GO:0030672; GO:0032279; GO:0032280; GO:0032809; GO:0035725; GO:0042391; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0043679; GO:0050804; GO:0051453; GO:0055085; GO:0097386; GO:0097457; GO:0098793; GO:0098978; GO:0110010; GO:0140892; GO:1902476; GO:2000300; GO:2000302 basolateral protein secretion [GO:0110010]; bicarbonate transport [GO:0015701]; chloride transmembrane transport [GO:1902476]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber [GO:0097457]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; symmetric synapse [GO:0032280]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; sodium ion transmembrane transporter activity [GO:0015081]; sodium,bicarbonate:chloride antiporter activity [GO:0140892]; sodium:bicarbonate symporter activity [GO:0008510]; zinc ion binding [GO:0008270] g7703.t1 Q8BWW4 48.943 331 2.21e-78 273.0 sp|Q8BWW4|LARP4_MOUSE La-related protein 4 OS=Mus musculus OX=10090 GN=Larp4 PE=1 SV=2 g7704.t1 Q94JV4 52.885 104 6.960000000000001e-29 103.0 sp|Q94JV4|SUI12_ARATH Protein translation factor SUI1 homolog 2 OS=Arabidopsis thaliana OX=3702 GN=At1g54290 PE=3 SV=1 g7705.t1 P18519 30.896 424 8.06e-49 174.0 sp|P18519|TNR16_CHICK Tumor necrosis factor receptor superfamily member 16 OS=Gallus gallus OX=9031 GN=NGFR PE=2 SV=1 g7706.t1 Q04833 35.211 213 1.24e-21 104.0 sp|Q04833|LRP_CAEEL Low-density lipoprotein receptor-related protein OS=Caenorhabditis elegans OX=6239 GN=lrp-1 PE=1 SV=1 LRP_CAEEL reviewed Low-density lipoprotein receptor-related protein (LRP) Caenorhabditis elegans GO:0002119; GO:0005509; GO:0005886; GO:0005905; GO:0006897; GO:0015918; GO:0016324; GO:0030139; GO:0030228; GO:0030334; GO:0040017; GO:0040018; GO:0042395 ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; endocytosis [GO:0006897]; nematode larval development [GO:0002119]; positive regulation of locomotion [GO:0040017]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cell migration [GO:0030334]; sterol transport [GO:0015918] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; lipoprotein particle receptor activity [GO:0030228] g7707.t1 Q9BYW2 50.808 433 9.279999999999999e-126 449.0 sp|Q9BYW2|SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens OX=9606 GN=SETD2 PE=1 SV=3 g7707.t1 Q9BYW2 51.751 257 1.49e-62 242.0 sp|Q9BYW2|SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens OX=9606 GN=SETD2 PE=1 SV=3 g7708.t1 Q5FWL3 63.323 319 1.6900000000000002e-157 446.0 sp|Q5FWL3|RNF41_XENLA E3 ubiquitin-protein ligase NRDP1 OS=Xenopus laevis OX=8355 GN=rnf41 PE=2 SV=1 g7709.t1 Q14790 39.35 277 4.91e-56 202.0 sp|Q14790|CASP8_HUMAN Caspase-8 OS=Homo sapiens OX=9606 GN=CASP8 PE=1 SV=1 g7710.t1 Q8N159 43.387 431 7.89e-124 373.0 sp|Q8N159|NAGS_HUMAN N-acetylglutamate synthase, mitochondrial OS=Homo sapiens OX=9606 GN=NAGS PE=1 SV=1 NAGS_HUMAN reviewed N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form] Homo sapiens (Human) GO:0000050; GO:0004042; GO:0005739; GO:0005759; GO:0006526; GO:0006536 glutamate metabolic process [GO:0006536]; L-arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] L-glutamate N-acetyltransferase activity [GO:0004042] g7712.t1 F1P4W9 38.814 1770 0.0 1247.0 sp|F1P4W9|CFA65_CHICK Cilia- and flagella-associated protein 65 OS=Gallus gallus OX=9031 GN=CFAP65 PE=2 SV=2 g7714.t1 Q9BYI3 42.604 338 2.56e-83 269.0 sp|Q9BYI3|HYCCI_HUMAN Hyccin OS=Homo sapiens OX=9606 GN=HYCC1 PE=1 SV=2 g7722.t1 P46460 68.065 739 0.0 1020.0 sp|P46460|NSF_MOUSE Vesicle-fusing ATPase OS=Mus musculus OX=10090 GN=Nsf PE=1 SV=2 g7723.t1 Q6DIM3 29.211 469 4.75e-46 167.0 sp|Q6DIM3|TBD_XENTR Tubulin delta chain OS=Xenopus tropicalis OX=8364 GN=tubd1 PE=2 SV=1 g7735.t1 Q01484 27.238 525 6.97e-25 116.0 sp|Q01484|ANK2_HUMAN Ankyrin-2 OS=Homo sapiens OX=9606 GN=ANK2 PE=1 SV=4 ANK2_HUMAN reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin) Homo sapiens (Human) GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g7739.t1 E9Q8T7 45.366 205 1.16e-45 171.0 sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1 DYH1_MOUSE reviewed Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7) Mus musculus (Mouse) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g7742.t1 E9Q8T7 68.586 3890 0.0 5615.0 sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1 DYH1_MOUSE reviewed Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7) Mus musculus (Mouse) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g7743.t1 Q63164 72.727 66 6.43e-29 110.0 sp|Q63164|DYH1_RAT Dynein axonemal heavy chain 1 OS=Rattus norvegicus OX=10116 GN=Dnah1 PE=2 SV=2 DYH1_RAT reviewed Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) Rattus norvegicus (Rat) GO:0003351; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g7744.t1 Q9UQF2 50.794 252 5.3e-84 268.0 sp|Q9UQF2|JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens OX=9606 GN=MAPK8IP1 PE=1 SV=1 JIP1_HUMAN reviewed C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1) Homo sapiens (Human) GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043025; GO:0043508; GO:0044294; GO:0044295; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243 JNK cascade [GO:0007254]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of DNA-templated transcription [GO:0006355]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192] axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860] g7746.t1 O75691 39.551 2852 0.0 1977.0 sp|O75691|UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3 UTP20_HUMAN reviewed Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6) Homo sapiens (Human) GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274 endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] 90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g7746.t2 O75691 39.572 2853 0.0 1977.0 sp|O75691|UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3 UTP20_HUMAN reviewed Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6) Homo sapiens (Human) GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274 endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] 90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g7747.t1 P98157 36.834 619 1.57e-104 352.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g7747.t1 P98157 34.082 267 4.16e-37 152.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g7747.t1 P98157 32.955 264 3.66e-33 140.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g7747.t1 P98157 28.755 233 2.2e-22 106.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g7747.t1 P98157 28.302 265 4.1500000000000003e-22 105.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g7748.t1 Q91ZX7 47.122 3909 0.0 3487.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 33.549 1234 1.69e-168 593.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 35.2 750 5.56e-108 394.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 30.584 873 2.84e-102 375.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 32.963 540 2.47e-67 259.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 29.879 579 4.8300000000000004e-57 225.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 31.781 365 2.63e-37 160.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 29.679 374 6.43e-33 145.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7748.t1 Q91ZX7 28.371 356 9.76e-26 122.0 sp|Q91ZX7|LRP1_MOUSE Prolow-density lipoprotein receptor-related protein 1 OS=Mus musculus OX=10090 GN=Lrp1 PE=1 SV=1 LRP1_MOUSE reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Mus musculus (Mouse) GO:0002020; GO:0002265; GO:0003151; GO:0003171; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0006915; GO:0007041; GO:0007167; GO:0007204; GO:0007507; GO:0008203; GO:0008283; GO:0009897; GO:0010467; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016477; GO:0016964; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0032050; GO:0032370; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0048870; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; apoptotic process [GO:0006915]; astrocyte activation involved in immune response [GO:0002265]; atrioventricular valve development [GO:0003171]; cardiac septum development [GO:0003279]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; gene expression [GO:0010467]; heart development [GO:0007507]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g7755.t1 Q5RAJ6 68.839 353 1.87e-172 486.0 sp|Q5RAJ6|DJB11_PONAB DnaJ homolog subfamily B member 11 OS=Pongo abelii OX=9601 GN=DNAJB11 PE=2 SV=1 g7756.t1 Q15042 50.232 1077 0.0 1021.0 sp|Q15042|RB3GP_HUMAN Rab3 GTPase-activating protein catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP1 PE=1 SV=3 g7761.t1 Q9CR23 36.066 183 4.76e-24 95.9 sp|Q9CR23|TMEM9_MOUSE Proton-transporting V-type ATPase complex assembly regulator TMEM9 OS=Mus musculus OX=10090 GN=Tmem9 PE=1 SV=1 TMEM9_MOUSE reviewed Proton-transporting V-type ATPase complex assembly regulator TMEM9 (v-ATPase assembly regulator TMEM9) (Transmembrane protein 9) (Protein TMEM9) Mus musculus (Mouse) GO:0005764; GO:0005765; GO:0005770; GO:0007042; GO:0015031; GO:0015630; GO:0032585; GO:0042176; GO:0045171; GO:0048388; GO:0070070; GO:0072686; GO:0090263 endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176] intercellular bridge [GO:0045171]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585] g7762.t1 Q5E959 65.815 313 6.42e-148 423.0 sp|Q5E959|STRAP_BOVIN Serine-threonine kinase receptor-associated protein OS=Bos taurus OX=9913 GN=STRAP PE=2 SV=1 STRAP_BOVIN reviewed Serine-threonine kinase receptor-associated protein Bos taurus (Bovine) GO:0000122; GO:0000380; GO:0000387; GO:0003723; GO:0003729; GO:0005102; GO:0005634; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034653; GO:0034719; GO:0048384; GO:1990447 alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; retinoic acid catabolic process [GO:0034653]; retinoic acid receptor signaling pathway [GO:0048384]; spliceosomal snRNP assembly [GO:0000387] cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447] g7764.t1 Q9Z0Y9 41.176 493 5.28e-116 353.0 sp|Q9Z0Y9|NR1H3_MOUSE Oxysterols receptor LXR-alpha OS=Mus musculus OX=10090 GN=Nr1h3 PE=1 SV=3 g7769.t1 P43006 48.161 571 6.39e-163 478.0 sp|P43006|EAA2_MOUSE Excitatory amino acid transporter 2 OS=Mus musculus OX=10090 GN=Slc1a2 PE=1 SV=1 EAA2_MOUSE reviewed Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2) Mus musculus (Mouse) GO:0005313; GO:0005314; GO:0005886; GO:0006750; GO:0007399; GO:0007632; GO:0008509; GO:0009410; GO:0009416; GO:0009611; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030424; GO:0030534; GO:0030673; GO:0031982; GO:0033229; GO:0035264; GO:0042734; GO:0043197; GO:0043198; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0045202; GO:0046326; GO:0046872; GO:0070207; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098656; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0140009 adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; monoatomic anion transmembrane transport [GO:0098656]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of D-glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; visual behavior [GO:0007632] astrocyte projection [GO:0097449]; axolemma [GO:0030673]; axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; vesicle [GO:0031982] cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; monoatomic anion transmembrane transporter activity [GO:0008509]; neutral L-amino acid transmembrane transporter activity [GO:0015175] g7773.t1 Q8IVL1 54.675 909 0.0 893.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t2 Q8IVL1 54.675 909 0.0 907.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t2 Q8IVL1 54.0 150 1.57e-36 157.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t3 Q8IVL1 54.496 912 0.0 909.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t3 Q8IVL1 54.0 150 1.55e-36 157.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t4 Q8IVL1 54.675 909 0.0 906.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t4 Q8IVL1 54.0 150 1.55e-36 157.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t5 Q8IVL1 54.636 906 0.0 904.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t5 Q8IVL1 54.0 150 1.59e-36 157.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7773.t6 Q8IVL1 57.997 769 0.0 827.0 sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3 g7777.t1 Q6IQ26 48.105 1372 0.0 1219.0 sp|Q6IQ26|DEN5A_HUMAN DENN domain-containing protein 5A OS=Homo sapiens OX=9606 GN=DENND5A PE=1 SV=2 DEN5A_HUMAN reviewed DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1) Homo sapiens (Human) GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147 negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g7778.t1 Q5E9L5 30.837 227 2.4999999999999998e-23 100.0 sp|Q5E9L5|ANM6_BOVIN Protein arginine N-methyltransferase 6 OS=Bos taurus OX=9913 GN=PRMT6 PE=2 SV=1 ANM6_BOVIN reviewed Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT6) Bos taurus (Bovine) GO:0000122; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006338; GO:0006355; GO:0010821; GO:0016274; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0042393; GO:0044020; GO:0045892; GO:0070611; GO:0070612; GO:0090398; GO:1901796; GO:2000059 cellular senescence [GO:0090398]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H2AR3 methyltransferase activity [GO:0070612]; histone H3R2 methyltransferase activity [GO:0070611]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241] g7779.t1 Q8CGC6 38.382 680 8.96e-120 382.0 sp|Q8CGC6|RBM28_MOUSE RNA-binding protein 28 OS=Mus musculus OX=10090 GN=Rbm28 PE=1 SV=4 g7780.t1 P97259 49.491 786 0.0 743.0 sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1 MGT5A_CRIGR reviewed Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1904894 positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279] extracellular region [GO:0005576]; Golgi membrane [GO:0000139] alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864] g7780.t2 P97259 49.872 780 0.0 740.0 sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1 MGT5A_CRIGR reviewed Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)] Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1904894 positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279] extracellular region [GO:0005576]; Golgi membrane [GO:0000139] alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864] g7781.t1 P98158 33.048 351 4.08e-34 141.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7781.t1 P98158 30.919 359 4.61e-28 123.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7781.t1 P98158 36.965 257 6.28e-27 119.0 sp|P98158|LRP2_RAT Low-density lipoprotein receptor-related protein 2 OS=Rattus norvegicus OX=10116 GN=Lrp2 PE=1 SV=1 g7782.t1 P56962 38.828 273 9.019999999999999e-55 184.0 sp|P56962|STX17_HUMAN Syntaxin-17 OS=Homo sapiens OX=9606 GN=STX17 PE=1 SV=2 STX17_HUMAN reviewed Syntaxin-17 Homo sapiens (Human) GO:0000149; GO:0000421; GO:0005484; GO:0005739; GO:0005776; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007030; GO:0012505; GO:0012507; GO:0016240; GO:0019901; GO:0019903; GO:0030134; GO:0030868; GO:0031201; GO:0033116; GO:0034497; GO:0044233; GO:0048278; GO:0061909; GO:0097111; GO:0097352; GO:0120281 autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; autophagosome-lysosome fusion [GO:0061909]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] autolysosome membrane [GO:0120281]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201] protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g7783.t1 P37234 32.308 390 1.98e-54 191.0 sp|P37234|PPARG_XENLA Peroxisome proliferator-activated receptor gamma OS=Xenopus laevis OX=8355 GN=pparg PE=1 SV=1 PPARG_XENLA reviewed Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0001227; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0006631; GO:0008270; GO:0009755; GO:0010629; GO:0010887; GO:0030154; GO:0030522; GO:0032869; GO:0045923; GO:0045944; GO:0048511; GO:0050728; GO:0051049; GO:0090575 cell differentiation [GO:0030154]; cellular response to insulin stimulus [GO:0032869]; fatty acid metabolic process [GO:0006631]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transport [GO:0051049]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g7785.t1 Q9WTV9 37.156 436 7.91e-80 256.0 sp|Q9WTV9|V1AR_MICOH Vasopressin V1a receptor OS=Microtus ochrogaster OX=79684 GN=Avpr1a PE=3 SV=1 g7786.t1 Q868T3 37.921 356 6.66e-69 230.0 sp|Q868T3|CCAPR_DROME Cardioacceleratory peptide receptor OS=Drosophila melanogaster OX=7227 GN=CCAP-R PE=2 SV=4 g7786.t2 Q868T3 37.883 359 9.24e-69 229.0 sp|Q868T3|CCAPR_DROME Cardioacceleratory peptide receptor OS=Drosophila melanogaster OX=7227 GN=CCAP-R PE=2 SV=4 g7788.t1 Q8N8U9 44.479 652 0.0 549.0 sp|Q8N8U9|BMPER_HUMAN BMP-binding endothelial regulator protein OS=Homo sapiens OX=9606 GN=BMPER PE=1 SV=3 BMPER_HUMAN reviewed BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) Homo sapiens (Human) GO:0001568; GO:0001657; GO:0002043; GO:0005201; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0031012; GO:0032880; GO:0042118; GO:0045765; GO:0048839; GO:0060391; GO:0060395; GO:0070374; GO:1903672 blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201] g7789.t1 P07207 44.237 321 6.96e-54 213.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 39.851 404 1.08e-51 206.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 37.5 408 5.63e-49 197.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 40.432 324 1.4899999999999999e-46 189.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 35.941 409 1.8300000000000003e-43 179.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 34.123 422 1.8499999999999998e-42 176.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 33.71 442 9.41e-42 173.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 34.097 393 2.54e-39 165.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 34.711 363 4.1699999999999996e-39 165.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 37.778 315 8.39e-39 164.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 36.842 323 4.2e-37 158.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t1 P07207 38.163 283 5.41e-34 148.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g7789.t2 P49013 40.881 318 3.3200000000000002e-49 189.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g7789.t2 P49013 41.079 241 5.79e-39 158.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g7789.t3 Q6DI48 43.75 256 8.88e-49 192.0 sp|Q6DI48|DLLA_DANRE Delta-like protein A OS=Danio rerio OX=7955 GN=dla PE=1 SV=1 DLLA_DANRE reviewed Delta-like protein A (DeltaA) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0005112; GO:0005509; GO:0005886; GO:0005938; GO:0007219; GO:0008593; GO:0009880; GO:0014032; GO:0021514; GO:0021536; GO:0022008; GO:0030901; GO:0033504; GO:0045746; GO:0055016; GO:0060034; GO:0060113 angiogenesis [GO:0001525]; diencephalon development [GO:0021536]; embryonic pattern specification [GO:0009880]; floor plate development [GO:0033504]; hypochord development [GO:0055016]; inner ear receptor cell differentiation [GO:0060113]; midbrain development [GO:0030901]; negative regulation of Notch signaling pathway [GO:0045746]; neural crest cell development [GO:0014032]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; notochord cell differentiation [GO:0060034]; regulation of Notch signaling pathway [GO:0008593]; ventral spinal cord interneuron differentiation [GO:0021514] cell cortex [GO:0005938]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g7789.t3 Q6DI48 45.833 240 9.14e-47 185.0 sp|Q6DI48|DLLA_DANRE Delta-like protein A OS=Danio rerio OX=7955 GN=dla PE=1 SV=1 DLLA_DANRE reviewed Delta-like protein A (DeltaA) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0005112; GO:0005509; GO:0005886; GO:0005938; GO:0007219; GO:0008593; GO:0009880; GO:0014032; GO:0021514; GO:0021536; GO:0022008; GO:0030901; GO:0033504; GO:0045746; GO:0055016; GO:0060034; GO:0060113 angiogenesis [GO:0001525]; diencephalon development [GO:0021536]; embryonic pattern specification [GO:0009880]; floor plate development [GO:0033504]; hypochord development [GO:0055016]; inner ear receptor cell differentiation [GO:0060113]; midbrain development [GO:0030901]; negative regulation of Notch signaling pathway [GO:0045746]; neural crest cell development [GO:0014032]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; notochord cell differentiation [GO:0060034]; regulation of Notch signaling pathway [GO:0008593]; ventral spinal cord interneuron differentiation [GO:0021514] cell cortex [GO:0005938]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g7792.t1 O76536 30.401 1148 9.14e-82 301.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 29.773 1189 1.1100000000000001e-80 297.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 31.034 1073 1.01e-75 282.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 28.959 1181 1.13e-75 282.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 29.443 1114 3.98e-74 277.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 29.163 1159 2e-73 275.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 29.904 1147 1.6799999999999998e-69 263.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 27.547 1158 2.7599999999999998e-67 256.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 29.83 999 1.51e-63 244.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 29.4 1000 6.29e-60 232.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7792.t1 O76536 28.259 1051 1.36e-59 231.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g7793.t1 P55345 49.624 399 5.84e-139 407.0 sp|P55345|ANM2_HUMAN Protein arginine N-methyltransferase 2 OS=Homo sapiens OX=9606 GN=PRMT2 PE=1 SV=1 ANM2_HUMAN reviewed Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007165; GO:0016274; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0043124; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0050728; GO:0060765; GO:0140592; GO:0140938; GO:2000134 chromatin remodeling [GO:0006338]; developmental cell growth [GO:0048588]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3 methyltransferase activity [GO:0140938]; histone H3R8 methyltransferase activity [GO:0140592]; histone methyltransferase activity [GO:0042054]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713] g7793.t2 P55345 51.829 328 9.76e-116 346.0 sp|P55345|ANM2_HUMAN Protein arginine N-methyltransferase 2 OS=Homo sapiens OX=9606 GN=PRMT2 PE=1 SV=1 ANM2_HUMAN reviewed Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007165; GO:0016274; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0043124; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0050728; GO:0060765; GO:0140592; GO:0140938; GO:2000134 chromatin remodeling [GO:0006338]; developmental cell growth [GO:0048588]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3 methyltransferase activity [GO:0140938]; histone H3R8 methyltransferase activity [GO:0140592]; histone methyltransferase activity [GO:0042054]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713] g7794.t1 Q7ZU45 52.857 490 4.02e-174 511.0 sp|Q7ZU45|ODAD4_DANRE Outer dynein arm-docking complex subunit 4 OS=Danio rerio OX=7955 GN=odad4 PE=2 SV=2 ODAD4_DANRE reviewed Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25) (TPR repeat protein 25) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003341; GO:0005737; GO:0005930; GO:0032474; GO:0036158; GO:0060271; GO:0061371 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; cytoplasm [GO:0005737] g7795.t1 Q9BS26 50.49 408 2.57e-147 427.0 sp|Q9BS26|ERP44_HUMAN Endoplasmic reticulum resident protein 44 OS=Homo sapiens OX=9606 GN=ERP44 PE=1 SV=1 ERP44_HUMAN reviewed Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4) Homo sapiens (Human) GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0045454; GO:0070062 cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580] protein disulfide isomerase activity [GO:0003756] g7796.t1 Q5RB31 65.686 102 1.03e-33 115.0 sp|Q5RB31|SC61B_PONAB Protein transport protein Sec61 subunit beta OS=Pongo abelii OX=9601 GN=SEC61B PE=3 SV=3 SC61B_PONAB reviewed Protein transport protein Sec61 subunit beta Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005784; GO:0005789; GO:0030970; GO:0031205; GO:0043022; GO:0044322; GO:0048408 retrograde protein transport, ER to cytosol [GO:0030970] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; Sec61 translocon complex [GO:0005784] epidermal growth factor binding [GO:0048408]; ribosome binding [GO:0043022] g7797.t1 P43304 61.708 726 0.0 928.0 sp|P43304|GPDM_HUMAN Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=GPD2 PE=1 SV=3 GPDM_HUMAN reviewed Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (mitochondrial glycerophosphate dehydrogenase gene) (mGDH) (mtGPD) Homo sapiens (Human) GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006127; GO:0019563; GO:0035264; GO:0043010; GO:0047952 camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952] g7798.t1 Q08E53 62.722 338 1.39e-141 434.0 sp|Q08E53|NR4A2_BOVIN Nuclear receptor subfamily 4 group A member 2 OS=Bos taurus OX=9913 GN=NR4A2 PE=2 SV=1 NR4A2_BOVIN reviewed Nuclear receptor subfamily 4 group A member 2 Bos taurus (Bovine) GO:0000978; GO:0000981; GO:0001228; GO:0004879; GO:0005634; GO:0005667; GO:0005737; GO:0006351; GO:0006357; GO:0008270; GO:0021953; GO:0035259; GO:0045444; GO:0045944; GO:0046982; GO:0071376; GO:0071542 cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; central nervous system neuron differentiation [GO:0021953]; DNA-templated transcription [GO:0006351]; dopaminergic neuron differentiation [GO:0071542]; fat cell differentiation [GO:0045444]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g7798.t2 Q07917 63.018 338 5.85e-142 434.0 sp|Q07917|NR4A2_RAT Nuclear receptor subfamily 4 group A member 2 OS=Rattus norvegicus OX=10116 GN=Nr4a2 PE=1 SV=3 NR4A2_RAT reviewed Nuclear receptor subfamily 4 group A member 2 (NUR-related factor 1) (Nuclear orphan receptor HZF-3) (Orphan nuclear receptor NURR1) (Regenerating liver nuclear receptor 1) (RNR-1) (SL-322) Rattus norvegicus (Rat) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0001764; GO:0001975; GO:0003677; GO:0004879; GO:0005634; GO:0005667; GO:0005737; GO:0006351; GO:0006355; GO:0006357; GO:0007399; GO:0007611; GO:0008270; GO:0008344; GO:0009791; GO:0010467; GO:0010468; GO:0016607; GO:0017085; GO:0021952; GO:0021953; GO:0021986; GO:0021987; GO:0034599; GO:0035259; GO:0042053; GO:0042416; GO:0042417; GO:0042551; GO:0043524; GO:0043565; GO:0043576; GO:0045444; GO:0045893; GO:0045944; GO:0046982; GO:0051866; GO:0060041; GO:0071376; GO:0071542; GO:1990837; GO:2001234 adult locomotory behavior [GO:0008344]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to oxidative stress [GO:0034599]; central nervous system neuron differentiation [GO:0021953]; central nervous system projection neuron axonogenesis [GO:0021952]; cerebral cortex development [GO:0021987]; DNA-templated transcription [GO:0006351]; dopamine biosynthetic process [GO:0042416]; dopamine metabolic process [GO:0042417]; dopaminergic neuron differentiation [GO:0071542]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; general adaptation syndrome [GO:0051866]; habenula development [GO:0021986]; learning or memory [GO:0007611]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; regulation of dopamine metabolic process [GO:0042053]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to insecticide [GO:0017085]; retina development in camera-type eye [GO:0060041] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g7799.t1 A0A8M9Q308 48.041 485 2.6000000000000002e-157 459.0 sp|A0A8M9Q308|FLC2B_DANRE Choline/ethanolamine transporter flvcr2b OS=Danio rerio OX=7955 GN=flvcr2b PE=3 SV=1 FLC2B_DANRE reviewed Choline/ethanolamine transporter flvcr2b (Feline leukemia virus subgroup C receptor-related protein 2 homolog B) (Heme transporter flvcr2b) (Major facilitator superfamily domain containing 7C-b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0005886; GO:0015220; GO:0031966; GO:0034228; GO:0150104 transport across blood-brain barrier [GO:0150104] endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228] g7799.t2 A0A8M9Q308 48.041 485 2.52e-157 460.0 sp|A0A8M9Q308|FLC2B_DANRE Choline/ethanolamine transporter flvcr2b OS=Danio rerio OX=7955 GN=flvcr2b PE=3 SV=1 FLC2B_DANRE reviewed Choline/ethanolamine transporter flvcr2b (Feline leukemia virus subgroup C receptor-related protein 2 homolog B) (Heme transporter flvcr2b) (Major facilitator superfamily domain containing 7C-b) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0005886; GO:0015220; GO:0031966; GO:0034228; GO:0150104 transport across blood-brain barrier [GO:0150104] endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228] g7800.t1 P25155 36.437 247 8.53e-50 184.0 sp|P25155|FA10_CHICK Coagulation factor X OS=Gallus gallus OX=9031 GN=F10 PE=1 SV=1 g7801.t1 Q4R381 59.274 744 0.0 874.0 sp|Q4R381|EZH2_MACFA Histone-lysine N-methyltransferase EZH2 OS=Macaca fascicularis OX=9541 GN=EZH2 PE=2 SV=1 EZH2_MACFA reviewed Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (Enhancer of zeste homolog 2) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000122; GO:0003682; GO:0010718; GO:0031491; GO:0031507; GO:0032259; GO:0035098; GO:0042752; GO:0043406; GO:0043547; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048511; GO:0071902; GO:0140951; GO:1990841 heterochromatin formation [GO:0031507]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511] ESC/E(Z) complex [GO:0035098] chromatin binding [GO:0003682]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K27 trimethyltransferase activity [GO:0140951]; nucleosome binding [GO:0031491]; promoter-specific chromatin binding [GO:1990841] g7803.t1 Q9Y2X3 70.264 454 0.0 666.0 sp|Q9Y2X3|NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1 NOP58_HUMAN reviewed Nucleolar protein 58 (Nucleolar protein 5) Homo sapiens (Human) GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0048254; GO:0051117; GO:0070761 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254] box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094] g7804.t1 Q08BY5 55.49 337 5.1399999999999995e-136 404.0 sp|Q08BY5|JMJD4_DANRE 2-oxoglutarate and iron-dependent oxygenase JMJD4 OS=Danio rerio OX=7955 GN=jmjd4 PE=2 SV=1 g7805.t1 Q1L8Y7 34.359 195 5.0000000000000005e-21 94.0 sp|Q1L8Y7|SHOC2_DANRE Leucine-rich repeat protein SHOC-2 OS=Danio rerio OX=7955 GN=shoc2 PE=2 SV=1 g7806.t1 P80204 65.206 388 3.46e-179 518.0 sp|P80204|TGFR1_RAT TGF-beta receptor type-1 OS=Rattus norvegicus OX=10116 GN=Tgfbr1 PE=1 SV=1 TGFR1_RAT reviewed TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) Rattus norvegicus (Rat) GO:0001501; GO:0001525; GO:0001666; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006355; GO:0006915; GO:0007165; GO:0007179; GO:0007399; GO:0007507; GO:0007566; GO:0008284; GO:0008354; GO:0008584; GO:0009636; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016323; GO:0016324; GO:0016361; GO:0030199; GO:0030307; GO:0030324; GO:0030335; GO:0030336; GO:0031100; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0032991; GO:0034695; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043235; GO:0043542; GO:0043627; GO:0044877; GO:0045121; GO:0045602; GO:0045893; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048538; GO:0048565; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051491; GO:0051496; GO:0051602; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071363; GO:0071560; GO:0101023; GO:1901203; GO:1902462; GO:1902894; GO:1902895; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237 activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of miRNA transcription [GO:1902894]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to prostaglandin E [GO:0034695]; response to toxic substance [GO:0009636]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; vascular endothelial cell proliferation [GO:0101023]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] activin receptor complex [GO:0048179]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625] g7810.t1 Q13685 51.397 358 1.64e-128 380.0 sp|Q13685|AAMP_HUMAN Angio-associated migratory cell protein OS=Homo sapiens OX=9606 GN=AAMP PE=1 SV=2 AAMP_HUMAN reviewed Angio-associated migratory cell protein Homo sapiens (Human) GO:0001525; GO:0005829; GO:0005886; GO:0008201; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0045171 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909] cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] heparin binding [GO:0008201] g7812.t1 Q8AYS8 37.173 191 1.51e-34 132.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g7814.t1 O15442 58.268 254 7.17e-109 322.0 sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3 g7814.t2 O15442 57.647 255 1.06e-107 320.0 sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3 g7814.t3 O15442 57.647 255 4.51e-108 318.0 sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3 g7814.t4 O15442 52.027 296 1.2199999999999998e-104 313.0 sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3 g7815.t1 Q7ZW25 77.778 225 1.43e-106 308.0 sp|Q7ZW25|CHM2A_DANRE Charged multivesicular body protein 2a OS=Danio rerio OX=7955 GN=chmp2a PE=2 SV=1 CHM2A_DANRE reviewed Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000815; GO:0005635; GO:0005771; GO:0010458; GO:0015031; GO:0031468; GO:0031902; GO:0032509; GO:0045324 endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear membrane reassembly [GO:0031468]; protein transport [GO:0015031] ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635] g7817.t1 B3EWZ6 32.566 869 3.8700000000000005e-124 415.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 31.995 872 1.64e-120 404.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 31.884 897 3.97e-120 404.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 30.44 864 9.429999999999999e-106 361.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 31.157 873 7.91e-105 358.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 33.894 714 4.0199999999999995e-104 357.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 31.328 881 3.85e-100 345.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 31.093 878 6.82e-98 338.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 30.76 842 8.88e-98 338.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 28.352 910 2.25e-92 322.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 30.286 733 3.26e-86 304.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 33.648 529 1.8600000000000002e-66 245.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 27.586 812 1.62e-65 242.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 26.316 969 1.44e-63 236.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 28.659 813 2.68e-63 235.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 27.652 792 2.04e-62 233.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 28.094 808 1.9e-60 227.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 25.097 1028 1.24e-58 221.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 30.962 520 9.25e-58 219.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 24.186 1013 1.94e-53 206.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7817.t1 B3EWZ6 26.145 524 1.21e-27 124.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g7818.t1 Q9D7B6 70.604 381 0.0 590.0 sp|Q9D7B6|ACAD8_MOUSE Isobutyryl-CoA dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Acad8 PE=1 SV=2 ACAD8_MOUSE reviewed Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.5) (Acyl-CoA dehydrogenase family member 8) (ACAD-8) Mus musculus (Mouse) GO:0003853; GO:0005739; GO:0006574; GO:0006635; GO:0050660 fatty acid beta-oxidation [GO:0006635]; L-valine catabolic process [GO:0006574] mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; short-chain 2-methyl fatty acyl-CoA dehydrogenase activity [GO:0003853] g7819.t1 Q9D0S9 50.694 144 7e-50 161.0 sp|Q9D0S9|HINT2_MOUSE Adenosine 5'-monophosphoramidase HINT2 OS=Mus musculus OX=10090 GN=Hint2 PE=1 SV=1 HINT2_MOUSE reviewed Adenosine 5'-monophosphoramidase HINT2 (EC 3.9.1.-) (HINT-3) (Histidine triad nucleotide-binding protein 2, mitochondrial) (HINT-2) Mus musculus (Mouse) GO:0000166; GO:0005737; GO:0005739; GO:0005759; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:0043530 apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; steroid biosynthetic process [GO:0006694] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] adenosine 5'-monophosphoramidase activity [GO:0043530]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166] g7820.t1 Q9UL25 79.024 205 6.47e-118 337.0 sp|Q9UL25|RAB21_HUMAN Ras-related protein Rab-21 OS=Homo sapiens OX=9606 GN=RAB21 PE=1 SV=3 RAB21_HUMAN reviewed Ras-related protein Rab-21 (EC 3.6.5.2) Homo sapiens (Human) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005769; GO:0005789; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0008089; GO:0009898; GO:0012505; GO:0012506; GO:0017157; GO:0019003; GO:0030516; GO:0031901; GO:0032154; GO:0032482; GO:0032580; GO:0045202; GO:0048260; GO:0050775; GO:0050821; GO:0070062; GO:0098559; GO:1904115; GO:2000643 anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157] axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g7821.t1 O77245 62.617 107 2.49e-38 154.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g7821.t1 O77245 36.994 173 9.800000000000001e-26 115.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g7822.t1 Q9D9P2 47.739 199 1.94e-56 183.0 sp|Q9D9P2|DAA19_MOUSE Dynein axonemal assembly factor 19 OS=Mus musculus OX=10090 GN=Dnaaf19 PE=1 SV=1 g7823.t1 Q9W6B3 48.337 451 2.76e-140 416.0 sp|Q9W6B3|RARB_COTJA Retinoic acid receptor beta OS=Coturnix japonica OX=93934 GN=RARB PE=2 SV=1 g7823.t2 P22448 52.53 415 1.7100000000000002e-144 426.0 sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2 g7823.t3 Q9W6B3 52.53 415 5.1000000000000005e-144 426.0 sp|Q9W6B3|RARB_COTJA Retinoic acid receptor beta OS=Coturnix japonica OX=93934 GN=RARB PE=2 SV=1 g7824.t1 Q6NRT6 42.041 823 0.0 678.0 sp|Q6NRT6|DJC10_XENLA DnaJ homolog subfamily C member 10 OS=Xenopus laevis OX=8355 GN=dnajc10 PE=2 SV=1 g7825.t1 Q6U6G5 54.567 427 2.1300000000000002e-123 368.0 sp|Q6U6G5|ZC3HF_RAT Zinc finger CCCH domain-containing protein 15 OS=Rattus norvegicus OX=10116 GN=Zc3h15 PE=1 SV=1 g7826.t1 Q66K94 63.768 138 7.75e-61 192.0 sp|Q66K94|SOSB1_XENTR SOSS complex subunit B1 OS=Xenopus tropicalis OX=8364 GN=nabp2 PE=2 SV=1 SOSB1_XENTR reviewed SOSS complex subunit B1 (Nucleic acid-binding protein 2) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B) (Sensor of single-strand DNA complex subunit B1) (Sensor of ssDNA subunit B1) (SOSS-B1) (Single-stranded DNA-binding protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000724; GO:0003677; GO:0003697; GO:0005634; GO:0005694; GO:0006281; GO:0006974; GO:0010212; GO:0044818; GO:0070876 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212] chromosome [GO:0005694]; nucleus [GO:0005634]; SOSS complex [GO:0070876] DNA binding [GO:0003677]; single-stranded DNA binding [GO:0003697] g7828.t1 Q5R8R1 86.842 418 0.0 759.0 sp|Q5R8R1|ARP3_PONAB Actin-related protein 3 OS=Pongo abelii OX=9601 GN=ACTR3 PE=2 SV=3 ARP3_PONAB reviewed Actin-related protein 3 (Actin-like protein 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005885; GO:0005903; GO:0005911; GO:0007163; GO:0008356; GO:0010592; GO:0016344; GO:0030027; GO:0033206; GO:0034314; GO:0035861; GO:0045944; GO:0051015; GO:0051653; GO:0060271; GO:0071346 Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to type II interferon [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653] Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200] g7832.t1 P42659 35.513 780 1e-175 530.0 sp|P42659|DPP6_BOVIN A-type potassium channel modulatory protein DPP6 OS=Bos taurus OX=9913 GN=DPP6 PE=1 SV=1 g7832.t2 P42659 36.026 780 7.32e-179 539.0 sp|P42659|DPP6_BOVIN A-type potassium channel modulatory protein DPP6 OS=Bos taurus OX=9913 GN=DPP6 PE=1 SV=1 g7834.t1 Q08DG8 39.801 201 4.2e-35 141.0 sp|Q08DG8|ZN135_BOVIN Zinc finger protein 135 OS=Bos taurus OX=9913 GN=ZNF135 PE=2 SV=1 g7834.t1 Q08DG8 32.889 225 4.1899999999999995e-28 120.0 sp|Q08DG8|ZN135_BOVIN Zinc finger protein 135 OS=Bos taurus OX=9913 GN=ZNF135 PE=2 SV=1 g7834.t1 Q08DG8 38.579 197 1.34e-27 119.0 sp|Q08DG8|ZN135_BOVIN Zinc finger protein 135 OS=Bos taurus OX=9913 GN=ZNF135 PE=2 SV=1 g7834.t1 Q08DG8 31.02 245 3.55e-27 118.0 sp|Q08DG8|ZN135_BOVIN Zinc finger protein 135 OS=Bos taurus OX=9913 GN=ZNF135 PE=2 SV=1 g7834.t1 Q08DG8 37.956 137 1.14e-22 104.0 sp|Q08DG8|ZN135_BOVIN Zinc finger protein 135 OS=Bos taurus OX=9913 GN=ZNF135 PE=2 SV=1 g7835.t1 P90666 58.388 769 0.0 868.0 sp|P90666|TXND3_HELCR Thioredoxin domain-containing protein 3 homolog OS=Heliocidaris crassispina OX=1043166 GN=NME8 PE=1 SV=1 g7835.t2 P90666 60.954 776 0.0 894.0 sp|P90666|TXND3_HELCR Thioredoxin domain-containing protein 3 homolog OS=Heliocidaris crassispina OX=1043166 GN=NME8 PE=1 SV=1 g7836.t1 Q5ZJH7 38.189 254 7.29e-57 199.0 sp|Q5ZJH7|CNPD1_CHICK Protein CNPPD1 OS=Gallus gallus OX=9031 GN=CNPPD1 PE=2 SV=1 g7837.t1 O77245 38.109 349 1.27e-71 236.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g7838.t1 P20664 58.981 412 5.67e-178 506.0 sp|P20664|PRI1_MOUSE DNA primase small subunit OS=Mus musculus OX=10090 GN=Prim1 PE=1 SV=1 g7839.t1 Q02446 68.595 121 2.3099999999999997e-48 183.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g7839.t1 Q02446 40.361 166 2.63e-29 127.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g7840.t1 Q02446 75.168 149 6.44e-77 267.0 sp|Q02446|SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens OX=9606 GN=SP4 PE=1 SV=2 SP4_HUMAN reviewed Transcription factor Sp4 (SPR-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0042802; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g7841.t1 Q9NTK5 72.494 389 0.0 585.0 sp|Q9NTK5|OLA1_HUMAN Obg-like ATPase 1 OS=Homo sapiens OX=9606 GN=OLA1 PE=1 SV=2 OLA1_HUMAN reviewed Obg-like ATPase 1 (DNA damage-regulated overexpressed in cancer 45) (DOC45) (GTP-binding protein 9) Homo sapiens (Human) GO:0005524; GO:0005525; GO:0005576; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0016020; GO:0016887; GO:0031093; GO:0043023; GO:0045296; GO:0046034; GO:0046872; GO:0070062 ATP metabolic process [GO:0046034] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023] g7843.t1 Q9DBF7 42.529 174 6.07e-33 134.0 sp|Q9DBF7|CWC25_MOUSE Pre-mRNA-splicing factor CWC25 homolog OS=Mus musculus OX=10090 GN=Cwc25 PE=2 SV=2 g7844.t1 Q9H8Y8 59.062 320 4.05e-127 376.0 sp|Q9H8Y8|GORS2_HUMAN Golgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3 g7846.t1 P83852 45.641 390 3.09e-109 330.0 sp|P83852|CBPD_LOPSP Carboxypeptidase D (Fragment) OS=Lophonetta specularioides OX=75873 GN=CPD PE=1 SV=1 CBPD_LOPSP reviewed Carboxypeptidase D (EC 3.4.17.22) (CPD-2) (Metallocarboxypeptidase D) Lophonetta specularioides (Crested duck) (Anas specularioides) GO:0004181; GO:0005615; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485 peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508] extracellular space [GO:0005615]; membrane [GO:0016020] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g7847.t1 Q6AYD3 59.89 364 6.030000000000001e-161 460.0 sp|Q6AYD3|PA2G4_RAT Proliferation-associated protein 2G4 OS=Rattus norvegicus OX=10116 GN=Pa2g4 PE=1 SV=1 PA2G4_RAT reviewed Proliferation-associated protein 2G4 Rattus norvegicus (Rat) GO:0003676; GO:0003714; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904 negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625] g7848.t1 Q29S03 30.571 350 4.2e-43 160.0 sp|Q29S03|SGCE_BOVIN Epsilon-sarcoglycan OS=Bos taurus OX=9913 GN=SGCE PE=2 SV=3 g7850.t1 P35346 31.077 325 1.7e-47 168.0 sp|P35346|SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens OX=9606 GN=SSTR5 PE=1 SV=3 SSR5_HUMAN reviewed Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R) (SST5) Homo sapiens (Human) GO:0004994; GO:0005886; GO:0007186; GO:0007187; GO:0007218; GO:0008285; GO:0032467; GO:0042593; GO:0042923; GO:0043005; GO:0050796; GO:0071385 cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose homeostasis [GO:0042593]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g7851.t1 Q9ULJ8 43.452 336 1.0599999999999999e-67 247.0 sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2 g7851.t2 Q9ULJ8 43.452 336 2.65e-67 246.0 sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2 g7852.t1 Q6UXS0 37.589 141 9.139999999999999e-23 92.0 sp|Q6UXS0|CL19A_HUMAN C-type lectin domain family 19 member A OS=Homo sapiens OX=9606 GN=CLEC19A PE=1 SV=2 g7854.t1 Q5ZLS8 35.493 710 9.829999999999999e-141 432.0 sp|Q5ZLS8|INT10_CHICK Integrator complex subunit 10 OS=Gallus gallus OX=9031 GN=INTS10 PE=2 SV=1 g7860.t1 Q96NJ6 26.978 493 1.3999999999999999e-45 171.0 sp|Q96NJ6|ZFP3_HUMAN Zinc finger protein 3 homolog OS=Homo sapiens OX=9606 GN=ZFP3 PE=1 SV=1 g7860.t1 Q96NJ6 30.996 271 4.2e-28 121.0 sp|Q96NJ6|ZFP3_HUMAN Zinc finger protein 3 homolog OS=Homo sapiens OX=9606 GN=ZFP3 PE=1 SV=1 g7861.t1 Q96N22 46.243 173 5.8e-37 151.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g7861.t1 Q96N22 43.931 173 3.63e-30 130.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g7861.t1 Q96N22 41.071 168 4.08e-28 124.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g7861.t1 Q96N22 37.5 192 3.0100000000000004e-27 121.0 sp|Q96N22|ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens OX=9606 GN=ZNF681 PE=1 SV=2 g7862.t1 Q9NYT6 31.502 273 1.0700000000000001e-33 141.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g7862.t1 Q9NYT6 44.371 151 7.600000000000001e-31 132.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g7862.t1 Q9NYT6 35.556 225 9.070000000000001e-31 132.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g7862.t1 Q9NYT6 40.123 162 2.17e-28 125.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g7862.t1 Q9NYT6 40.491 163 3.65e-28 124.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g7862.t1 Q9NYT6 41.29 155 2.3700000000000003e-27 122.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g7862.t1 Q9NYT6 39.877 163 1.0800000000000001e-26 119.0 sp|Q9NYT6|ZN226_HUMAN Zinc finger protein 226 OS=Homo sapiens OX=9606 GN=ZNF226 PE=1 SV=2 g7863.t1 Q29RZ4 39.205 176 2.57e-27 117.0 sp|Q29RZ4|ZNF2_BOVIN Zinc finger protein 2 OS=Bos taurus OX=9913 GN=ZNF2 PE=2 SV=1 g7863.t1 Q29RZ4 40.146 137 5.600000000000001e-21 99.0 sp|Q29RZ4|ZNF2_BOVIN Zinc finger protein 2 OS=Bos taurus OX=9913 GN=ZNF2 PE=2 SV=1 g7864.t1 Q6GNP2 30.303 330 3.12e-31 132.0 sp|Q6GNP2|Z652A_XENLA Zinc finger protein 652-A OS=Xenopus laevis OX=8355 GN=znf652-a PE=2 SV=1 Z652A_XENLA reviewed Zinc finger protein 652-A Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0008270 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g7865.t1 Q6DCW1 43.056 144 2.6000000000000003e-32 132.0 sp|Q6DCW1|GFI1B_XENLA Zinc finger protein Gfi-1b OS=Xenopus laevis OX=8355 GN=gfi1b PE=2 SV=1 g7867.t1 Q75J93 27.425 536 2.5299999999999998e-48 187.0 sp|Q75J93|CPAS1_DICDI Circularly permutated Ras protein 1 OS=Dictyostelium discoideum OX=44689 GN=cpras1 PE=3 SV=1 g7867.t2 Q75J93 27.425 536 3.5899999999999996e-48 187.0 sp|Q75J93|CPAS1_DICDI Circularly permutated Ras protein 1 OS=Dictyostelium discoideum OX=44689 GN=cpras1 PE=3 SV=1 g7867.t3 Q75J93 27.425 536 2.51e-48 187.0 sp|Q75J93|CPAS1_DICDI Circularly permutated Ras protein 1 OS=Dictyostelium discoideum OX=44689 GN=cpras1 PE=3 SV=1 g7868.t1 Q7Z5V6 33.626 455 6.12e-73 239.0 sp|Q7Z5V6|SAXO4_HUMAN Stabilizer of axonemal microtubules 4 OS=Homo sapiens OX=9606 GN=SAXO4 PE=1 SV=1 SAXO4_HUMAN reviewed Stabilizer of axonemal microtubules 4 (Protein phosphatase 1 regulatory subunit 32) Homo sapiens (Human) GO:0005737; GO:0019902; GO:0030317; GO:0036064; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] phosphatase binding [GO:0019902] g7869.t1 Q6WQJ1 45.199 677 0.0 632.0 sp|Q6WQJ1|DGLA_MOUSE Diacylglycerol lipase-alpha OS=Mus musculus OX=10090 GN=Dagla PE=1 SV=2 DGLA_MOUSE reviewed Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.116) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha) Mus musculus (Mouse) GO:0004465; GO:0005737; GO:0005886; GO:0007405; GO:0016787; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0047372; GO:0098839; GO:0098921; GO:0150077; GO:1901696 arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921] cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196] hydrolase activity [GO:0016787]; lipoprotein lipase activity [GO:0004465]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372] g7869.t2 Q9Y4D2 37.657 478 6.030000000000001e-97 336.0 sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3 g7869.t2 Q9Y4D2 45.402 348 1.82e-85 304.0 sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3 g7870.t1 P70428 61.918 709 0.0 914.0 sp|P70428|EXT2_MOUSE Exostosin-2 OS=Mus musculus OX=10090 GN=Ext2 PE=1 SV=2 g7871.t1 Q8N6Q8 42.657 286 2.2699999999999997e-67 231.0 sp|Q8N6Q8|MET25_HUMAN Probable methyltransferase-like protein 25 OS=Homo sapiens OX=9606 GN=METTL25 PE=1 SV=2 g7872.t1 Q8TCG1 41.667 924 0.0 682.0 sp|Q8TCG1|CIP2A_HUMAN Protein CIP2A OS=Homo sapiens OX=9606 GN=CIP2A PE=1 SV=2 g7873.t1 Q9Y5X5 27.119 295 1.53e-28 119.0 sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2 NPFF2_HUMAN reviewed Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408 cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408] actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628] g7875.t1 Q02372 49.39 164 4.67e-47 155.0 sp|Q02372|NDUB8_BOVIN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial OS=Bos taurus OX=9913 GN=NDUFB8 PE=1 SV=1 g7878.t1 Q5R628 90.0 90 4.25e-55 168.0 sp|Q5R628|LSM5_PONAB U6 snRNA-associated Sm-like protein LSm5 OS=Pongo abelii OX=9601 GN=LSM5 PE=3 SV=3 g7879.t1 O60229 40.981 693 5.07e-150 515.0 sp|O60229|KALRN_HUMAN Kalirin OS=Homo sapiens OX=9606 GN=KALRN PE=1 SV=3 KALRN_HUMAN reviewed Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain) Homo sapiens (Human) GO:0004674; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310 axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7879.t1 O60229 38.907 604 3.05e-98 355.0 sp|O60229|KALRN_HUMAN Kalirin OS=Homo sapiens OX=9606 GN=KALRN PE=1 SV=3 KALRN_HUMAN reviewed Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain) Homo sapiens (Human) GO:0004674; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310 axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7879.t1 O60229 33.333 369 3.8e-49 197.0 sp|O60229|KALRN_HUMAN Kalirin OS=Homo sapiens OX=9606 GN=KALRN PE=1 SV=3 KALRN_HUMAN reviewed Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain) Homo sapiens (Human) GO:0004674; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310 axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7880.t1 F1M0Z1 51.82 1154 0.0 1130.0 sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4 TRIO_RAT reviewed Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein) Rattus norvegicus (Rat) GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310 axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170] cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7880.t1 F1M0Z1 36.34 377 4.98e-59 227.0 sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4 TRIO_RAT reviewed Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein) Rattus norvegicus (Rat) GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310 axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170] cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7880.t1 F1M0Z1 25.571 438 1.06e-30 135.0 sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4 TRIO_RAT reviewed Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein) Rattus norvegicus (Rat) GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310 axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170] cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7881.t1 O60229 52.041 588 0.0 671.0 sp|O60229|KALRN_HUMAN Kalirin OS=Homo sapiens OX=9606 GN=KALRN PE=1 SV=3 KALRN_HUMAN reviewed Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain) Homo sapiens (Human) GO:0004674; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310 axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7881.t1 O60229 25.686 401 2.1200000000000003e-21 103.0 sp|O60229|KALRN_HUMAN Kalirin OS=Homo sapiens OX=9606 GN=KALRN PE=1 SV=3 KALRN_HUMAN reviewed Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain) Homo sapiens (Human) GO:0004674; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310 axon guidance [GO:0007411]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g7882.t1 P80146 43.229 384 6.060000000000001e-88 274.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g7884.t1 P08594 42.803 264 3.1199999999999996e-54 187.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g7885.t1 P08594 41.841 239 7.39e-48 170.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g7886.t1 P08594 45.879 364 2.98e-94 294.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g7899.t2 O14513 78.75 80 1.7699999999999999e-28 129.0 sp|O14513|NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens OX=9606 GN=NCKAP5 PE=1 SV=2 NCKP5_HUMAN reviewed Nck-associated protein 5 (NAP-5) (Peripheral clock protein) Homo sapiens (Human) GO:0001578; GO:0007019; GO:0035371 microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] microtubule plus-end [GO:0035371] g7901.t1 Q96PB1 41.192 772 0.0 635.0 sp|Q96PB1|CASD1_HUMAN N-acetylneuraminate (7)9-O-acetyltransferase OS=Homo sapiens OX=9606 GN=CASD1 PE=1 SV=1 g7901.t2 Q1LW89 42.481 798 0.0 632.0 sp|Q1LW89|CASD1_DANRE N-acetylneuraminate (7)9-O-acetyltransferase OS=Danio rerio OX=7955 GN=casd1 PE=2 SV=2 g7909.t1 P08594 45.017 291 1.0800000000000001e-64 216.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g7910.t1 Q9H2S9 30.228 483 2.84e-54 195.0 sp|Q9H2S9|IKZF4_HUMAN Zinc finger protein Eos OS=Homo sapiens OX=9606 GN=IKZF4 PE=1 SV=2 IKZF4_HUMAN reviewed Zinc finger protein Eos (Ikaros family zinc finger protein 4) Homo sapiens (Human) GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0016604; GO:0019904; GO:0032991; GO:0043425; GO:0045892; GO:0045944; GO:0051260 negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g7911.t1 Q2TA17 37.273 220 3.57e-30 130.0 sp|Q2TA17|ZN668_BOVIN Zinc finger protein 668 OS=Bos taurus OX=9913 GN=ZNF668 PE=2 SV=2 ZN668_BOVIN reviewed Zinc finger protein 668 Bos taurus (Bovine) GO:0003677; GO:0005634; GO:0006281; GO:0006357; GO:0008270 DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g7914.t1 Q5RFQ8 25.876 371 2.4600000000000003e-21 100.0 sp|Q5RFQ8|ATS4_PONAB A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Pongo abelii OX=9601 GN=ADAMTS4 PE=2 SV=1 ATS4_PONAB reviewed A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAM-TS 4) (ADAM-TS4) (ADAMTS-4) (EC 3.4.24.82) (Aggrecanase-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004222; GO:0006508; GO:0008233; GO:0008237; GO:0030198; GO:0031012; GO:0046872 extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233] g7917.t1 Q9UPX8 41.926 675 3.7300000000000004e-157 528.0 sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4 g7917.t2 Q9UPX8 41.926 675 8.210000000000001e-157 527.0 sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4 g7920.t1 Q8BGR8 42.991 107 1.06e-28 105.0 sp|Q8BGR8|GSKIP_MOUSE GSK3B-interacting protein OS=Mus musculus OX=10090 GN=Gskip PE=2 SV=1 g7921.t1 Q6NTS7 42.945 163 3.6399999999999996e-45 150.0 sp|Q6NTS7|PRLD2_XENLA PRELI domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=prelid2 PE=2 SV=1 g7922.t1 Q29471 53.642 302 5.6e-107 336.0 sp|Q29471|ANX13_CANLF Annexin A13 OS=Canis lupus familiaris OX=9615 GN=ANXA13 PE=1 SV=2 ANX13_CANLF reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506; GO:0016323; GO:0016324; GO:0042997; GO:0042998; GO:0045121; GO:0070382 negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] g7922.t2 Q29471 53.642 302 5.36e-107 337.0 sp|Q29471|ANX13_CANLF Annexin A13 OS=Canis lupus familiaris OX=9615 GN=ANXA13 PE=1 SV=2 ANX13_CANLF reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506; GO:0016323; GO:0016324; GO:0042997; GO:0042998; GO:0045121; GO:0070382 negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] g7924.t1 P70080 61.449 428 0.0 576.0 sp|P70080|TPH1_CHICK Tryptophan 5-hydroxylase 1 OS=Gallus gallus OX=9031 GN=TPH1 PE=1 SV=1 g7925.t1 P35992 32.439 1193 6.78e-156 528.0 sp|P35992|PTP10_DROME Tyrosine-protein phosphatase 10D OS=Drosophila melanogaster OX=7227 GN=Ptp10D PE=1 SV=4 PTP10_DROME reviewed Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D) Drosophila melanogaster (Fruit fly) GO:0004725; GO:0005001; GO:0007165; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016020; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446; GO:0099156; GO:0140177 axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; cell-cell signaling via exosome [GO:0099156]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; signal transduction [GO:0007165] apical part of cell [GO:0045177]; axon [GO:0030424]; membrane [GO:0016020] membrane-membrane adaptor activity [GO:0140177]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g7925.t2 P35992 32.282 1205 1.25e-154 528.0 sp|P35992|PTP10_DROME Tyrosine-protein phosphatase 10D OS=Drosophila melanogaster OX=7227 GN=Ptp10D PE=1 SV=4 PTP10_DROME reviewed Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D) Drosophila melanogaster (Fruit fly) GO:0004725; GO:0005001; GO:0007165; GO:0007411; GO:0007417; GO:0007424; GO:0007616; GO:0008045; GO:0016020; GO:0030424; GO:0030948; GO:0040037; GO:0042059; GO:0045177; GO:0060446; GO:0099156; GO:0140177 axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; cell-cell signaling via exosome [GO:0099156]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; open tracheal system development [GO:0007424]; signal transduction [GO:0007165] apical part of cell [GO:0045177]; axon [GO:0030424]; membrane [GO:0016020] membrane-membrane adaptor activity [GO:0140177]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g7926.t1 B1H1P9 42.424 429 1.82e-107 327.0 sp|B1H1P9|PPAL_XENLA Lysosomal acid phosphatase OS=Xenopus laevis OX=8355 GN=acp2 PE=2 SV=1 g7929.t1 Q91W89 50.093 1072 0.0 980.0 sp|Q91W89|MA2C1_MOUSE Alpha-mannosidase 2C1 OS=Mus musculus OX=10090 GN=Man2c1 PE=1 SV=1 MA2C1_MOUSE reviewed Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1) (Neutral/cytosolic alpha-mannosidase) Mus musculus (Mouse) GO:0004559; GO:0005654; GO:0005737; GO:0006013; GO:0009313; GO:0030246; GO:0046872 mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g7931.t1 Q8QG61 62.069 493 0.0 644.0 sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1 g7932.t1 Q5RGJ6 52.973 185 2.82e-62 194.0 sp|Q5RGJ6|WASC3_DANRE WASH complex subunit 3 OS=Danio rerio OX=7955 GN=washc3 PE=2 SV=1 g7933.t1 Q99LI7 68.073 711 0.0 1008.0 sp|Q99LI7|CSTF3_MOUSE Cleavage stimulation factor subunit 3 OS=Mus musculus OX=10090 GN=Cstf3 PE=1 SV=1 g7935.t1 Q17DK5 49.813 536 0.0 547.0 sp|Q17DK5|CRY1_AEDAE Cryptochrome-1 OS=Aedes aegypti OX=7159 GN=cry PE=3 SV=1 g20946.t1 E1BD59 24.932 365 6.56e-30 129.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g20948.t1 Q9NWU1 61.995 421 0.0 531.0 sp|Q9NWU1|OXSM_HUMAN 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial OS=Homo sapiens OX=9606 GN=OXSM PE=1 SV=1 g20949.t1 Q9NZN5 49.871 389 2.92e-102 367.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t1 Q9NZN5 48.705 193 1.3300000000000001e-43 179.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t2 Q9NZN5 49.871 389 3.06e-102 367.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t2 Q9NZN5 48.705 193 1.65e-43 178.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t2 Q9NZN5 30.508 236 2.5500000000000004e-21 105.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t3 Q9NZN5 49.871 389 2.36e-102 367.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t3 Q9NZN5 48.705 193 1.3100000000000001e-43 179.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t4 Q9NZN5 49.871 389 2.04e-102 367.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20949.t4 Q9NZN5 48.705 193 1.29e-43 179.0 sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1 ARHGC_HUMAN reviewed Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) Homo sapiens (Human) GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221 G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g20951.t1 O94826 53.24 571 0.0 592.0 sp|O94826|TOM70_HUMAN Mitochondrial import receptor subunit TOM70 OS=Homo sapiens OX=9606 GN=TOMM70 PE=1 SV=1 TOM70_HUMAN reviewed Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70) Homo sapiens (Human) GO:0002218; GO:0002230; GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0008320; GO:0016020; GO:0030150; GO:0030674; GO:0030943; GO:0031966; GO:0032728; GO:0042981; GO:0045039; GO:0045040; GO:0061052; GO:0070062; GO:0097068; GO:0098586; GO:0140596; GO:1903955 activation of innate immune response [GO:0002218]; cellular response to virus [GO:0098586]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068] extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; TOM complex [GO:0140596] mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674] g20952.t1 Q66IH2 41.254 303 9.11e-66 229.0 sp|Q66IH2|TBRG1_XENTR Transforming growth factor beta regulator 1 OS=Xenopus tropicalis OX=8364 GN=tbrg1 PE=2 SV=1 g20953.t1 Q178A5 81.657 169 6.05e-106 303.0 sp|Q178A5|UFC1_AEDAE Ubiquitin-fold modifier-conjugating enzyme 1 OS=Aedes aegypti OX=7159 GN=AAEL005968 PE=3 SV=1 g20954.t1 Q0IHV9 72.506 411 0.0 641.0 sp|Q0IHV9|DDX6_XENTR Probable ATP-dependent RNA helicase ddx6 OS=Xenopus tropicalis OX=8364 GN=ddx6 PE=2 SV=1 DDX6_XENTR reviewed Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000932; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0009408; GO:0010494; GO:0016887; GO:0017148; GO:0033962; GO:0034063; GO:0035278; GO:1990904 miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; response to heat [GO:0009408]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724] g20955.t1 O57429 43.539 356 4.66e-84 281.0 sp|O57429|UBP2_CHICK Ubiquitin carboxyl-terminal hydrolase 2 OS=Gallus gallus OX=9031 GN=USP2 PE=2 SV=1 g20957.t1 Q63665 52.174 345 2.5e-111 329.0 sp|Q63665|USF2_RAT Upstream stimulatory factor 2 OS=Rattus norvegicus OX=10116 GN=Usf2 PE=1 SV=2 USF2_RAT reviewed Upstream stimulatory factor 2 (Major late transcription factor 2) (Upstream transcription factor 2) Rattus norvegicus (Rat) GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0010255; GO:0042802; GO:0042803; GO:0043425; GO:0043565; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0055088; GO:0070888; GO:0071333; GO:1990837 cellular response to glucose stimulus [GO:0071333]; glucose mediated signaling pathway [GO:0010255]; lactation [GO:0007595]; lipid homeostasis [GO:0055088]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g20958.t1 Q9EST8 29.268 328 2.01e-25 117.0 sp|Q9EST8|IKBZ_MOUSE NF-kappa-B inhibitor zeta OS=Mus musculus OX=10090 GN=Nfkbiz PE=1 SV=1 g20960.t1 Q7ZUW2 59.014 588 0.0 701.0 sp|Q7ZUW2|HYOU1_DANRE Hypoxia up-regulated protein 1 OS=Danio rerio OX=7955 GN=hyou1 PE=2 SV=1 g20960.t1 Q7ZUW2 36.508 315 1.33e-36 154.0 sp|Q7ZUW2|HYOU1_DANRE Hypoxia up-regulated protein 1 OS=Danio rerio OX=7955 GN=hyou1 PE=2 SV=1 g20961.t1 Q9DBG7 58.974 663 0.0 719.0 sp|Q9DBG7|SRPRA_MOUSE Signal recognition particle receptor subunit alpha OS=Mus musculus OX=10090 GN=Srpra PE=1 SV=1 SRPRA_MOUSE reviewed Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha) Mus musculus (Mouse) GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006617; GO:0006886; GO:0016020; GO:0045047 intracellular protein transport [GO:0006886]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047] g20966.t1 F7H9X2 26.797 306 3.21e-25 114.0 sp|F7H9X2|TRIM2_CALJA Tripartite motif-containing protein 2 OS=Callithrix jacchus OX=9483 GN=TRIM2 PE=3 SV=1 g20972.t1 Q90678 40.796 402 3.6e-97 300.0 sp|Q90678|PAFA_CHICK Platelet-activating factor acetylhydrolase OS=Gallus gallus OX=9031 GN=PLA2G7 PE=2 SV=1 g20973.t1 Q6ZNA1 25.097 777 1.16e-55 214.0 sp|Q6ZNA1|ZN836_HUMAN Zinc finger protein 836 OS=Homo sapiens OX=9606 GN=ZNF836 PE=1 SV=2 g20973.t1 Q6ZNA1 24.754 610 1.34e-41 170.0 sp|Q6ZNA1|ZN836_HUMAN Zinc finger protein 836 OS=Homo sapiens OX=9606 GN=ZNF836 PE=1 SV=2 g20973.t1 Q6ZNA1 23.367 689 6.87e-35 148.0 sp|Q6ZNA1|ZN836_HUMAN Zinc finger protein 836 OS=Homo sapiens OX=9606 GN=ZNF836 PE=1 SV=2 g20973.t1 Q6ZNA1 23.604 555 4.34e-31 136.0 sp|Q6ZNA1|ZN836_HUMAN Zinc finger protein 836 OS=Homo sapiens OX=9606 GN=ZNF836 PE=1 SV=2 g20975.t1 Q5PQP2 36.402 239 7.99e-34 124.0 sp|Q5PQP2|RCAS1_RAT Receptor-binding cancer antigen expressed on SiSo cells OS=Rattus norvegicus OX=10116 GN=Ebag9 PE=1 SV=1 g20976.t1 Q9ESL4 37.549 253 3.3299999999999995e-42 171.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g20976.t2 Q9ESL4 37.549 253 3.31e-42 171.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g20976.t3 Q9ESL4 37.549 253 3.5599999999999994e-42 171.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g20976.t4 Q9ESL4 37.549 253 3.44e-42 171.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g20976.t5 Q9ESL4 37.549 253 3.2899999999999994e-42 171.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g20976.t6 Q9ESL4 37.549 253 3.44e-42 171.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g20980.t1 Q9EPB1 46.25 320 1.04e-83 266.0 sp|Q9EPB1|DPP2_RAT Dipeptidyl peptidase 2 OS=Rattus norvegicus OX=10116 GN=Dpp7 PE=1 SV=1 DPP2_RAT reviewed Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) Rattus norvegicus (Rat) GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0006508; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0070008; GO:1905146 lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008] g20985.t1 Q9EPB1 54.386 114 1.4e-37 135.0 sp|Q9EPB1|DPP2_RAT Dipeptidyl peptidase 2 OS=Rattus norvegicus OX=10116 GN=Dpp7 PE=1 SV=1 DPP2_RAT reviewed Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) Rattus norvegicus (Rat) GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0006508; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0070008; GO:1905146 lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008] g20986.t1 Q9EPB1 51.955 179 1.18e-57 192.0 sp|Q9EPB1|DPP2_RAT Dipeptidyl peptidase 2 OS=Rattus norvegicus OX=10116 GN=Dpp7 PE=1 SV=1 DPP2_RAT reviewed Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) Rattus norvegicus (Rat) GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0006508; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0070008; GO:1905146 lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008] g20992.t1 Q9EPB1 47.188 320 2.66e-87 275.0 sp|Q9EPB1|DPP2_RAT Dipeptidyl peptidase 2 OS=Rattus norvegicus OX=10116 GN=Dpp7 PE=1 SV=1 DPP2_RAT reviewed Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) Rattus norvegicus (Rat) GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0006508; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0070008; GO:1905146 lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008] g20994.t1 Q5G235 59.406 101 3.16e-41 134.0 sp|Q5G235|PEN2_BOVIN Gamma-secretase subunit PEN-2 OS=Bos taurus OX=9913 GN=PSENEN PE=3 SV=1 g20995.t1 Q7TP17 84.158 202 7.049999999999999e-126 358.0 sp|Q7TP17|U2AF4_RAT Splicing factor U2AF 26 kDa subunit OS=Rattus norvegicus OX=10116 GN=U2af1l4 PE=2 SV=1 g20997.t1 Q21565 50.119 419 6.33e-136 414.0 sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2 g21000.t1 G8HTB6 27.665 394 2.39e-31 131.0 sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1 g21014.t1 P31404 84.715 615 0.0 1105.0 sp|P31404|VATA_BOVIN V-type proton ATPase catalytic subunit A OS=Bos taurus OX=9913 GN=ATP6V1A PE=1 SV=2 VATA_BOVIN reviewed V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Bos taurus (Bovine) GO:0000221; GO:0005524; GO:0005764; GO:0005829; GO:0005886; GO:0006879; GO:0016887; GO:0030133; GO:0030665; GO:0036295; GO:0045851; GO:0046034; GO:0046961; GO:1902600 ATP metabolic process [GO:0046034]; cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; pH reduction [GO:0045851]; proton transmembrane transport [GO:1902600] clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proton-transporting ATPase activity, rotational mechanism [GO:0046961] g21015.t1 Q9NHD5 76.923 156 2.3699999999999997e-89 261.0 sp|Q9NHD5|SAN_DROME Probable N-acetyltransferase san OS=Drosophila melanogaster OX=7227 GN=san PE=1 SV=1 SAN_DROME reviewed Probable N-acetyltransferase san (EC 2.3.1.258) (N-epsilon-acetyltransferase san) (EC 2.3.1.-) (Protein atado) (Protein separation anxiety) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0004596; GO:0005737; GO:0005829; GO:0006474; GO:0007064; GO:0008080; GO:0031248; GO:0031415; GO:0120518 mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; N-terminal protein amino acid acetylation [GO:0006474] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; protein acetyltransferase complex [GO:0031248] N-acetyltransferase activity [GO:0008080]; protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596] g21016.t1 Q8IW92 47.315 596 1.05e-178 526.0 sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1 g21016.t2 Q8IW92 46.458 607 4.96e-175 517.0 sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1 g21018.t1 E1BD59 30.0 290 6.36e-33 131.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21020.t1 Q86BN8 46.893 177 2.12e-51 168.0 sp|Q86BN8|PTPM1_DROME Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 OS=Drosophila melanogaster OX=7227 GN=PTPMT1 PE=2 SV=1 PTPM1_DROME reviewed Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (PTEN-like protein) (Protein-tyrosine phosphatase mitochondrial 1-like protein) (EC 3.1.3.16, EC 3.1.3.48) Drosophila melanogaster (Fruit fly) GO:0004439; GO:0004722; GO:0004725; GO:0005739; GO:0005743; GO:0008962; GO:0032049; GO:0102091 cardiolipin biosynthetic process [GO:0032049] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-5-phosphate phosphatase activity [GO:0102091]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g21021.t1 Q6AZV0 48.673 113 1.04e-33 119.0 sp|Q6AZV0|DHSDB_XENLA Succinate dehydrogenase [ubiquinone] cytochrome b small subunit B, mitochondrial OS=Xenopus laevis OX=8355 GN=sdhd-b PE=2 SV=1 g21022.t1 Q93ZC9 49.383 324 1.71e-107 333.0 sp|Q93ZC9|GLAK1_ARATH Glucuronokinase 1 OS=Arabidopsis thaliana OX=3702 GN=GLCAK1 PE=1 SV=1 g21023.t1 Q08DJ7 46.842 380 9.79e-124 365.0 sp|Q08DJ7|AAR2_BOVIN Protein AAR2 homolog OS=Bos taurus OX=9913 GN=AAR2 PE=2 SV=1 g21025.t1 P41243 41.007 278 5.85e-49 176.0 sp|P41243|MATK_RAT Megakaryocyte-associated tyrosine-protein kinase OS=Rattus norvegicus OX=10116 GN=Matk PE=2 SV=1 g21026.t1 Q9NY30 45.299 117 1.31e-34 125.0 sp|Q9NY30|BTG4_HUMAN Protein BTG4 OS=Homo sapiens OX=9606 GN=BTG4 PE=1 SV=1 g21027.t1 Q5U1Y0 29.643 280 4.7200000000000004e-26 106.0 sp|Q5U1Y0|TM192_RAT Transmembrane protein 192 OS=Rattus norvegicus OX=10116 GN=Tmem192 PE=2 SV=1 g21029.t1 Q63470 78.024 496 0.0 758.0 sp|Q63470|DYR1A_RAT Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Rattus norvegicus OX=10116 GN=Dyrk1a PE=1 SV=2 DYR1A_RAT reviewed Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.11.23) (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) Rattus norvegicus (Rat) GO:0000381; GO:0000724; GO:0003300; GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0005883; GO:0005884; GO:0006303; GO:0006468; GO:0006606; GO:0007623; GO:0008092; GO:0008353; GO:0015631; GO:0016607; GO:0018105; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0031452; GO:0033120; GO:0033173; GO:0042802; GO:0043518; GO:0045786; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0060043; GO:0061050; GO:0106310; GO:0140857; GO:1902003; GO:1902996; GO:1990904; GO:1990935 calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle hypertrophy [GO:0003300]; circadian rhythm [GO:0007623]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of heterochromatin formation [GO:0031452]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of amyloid-beta formation [GO:1902003]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell growth involved in cardiac muscle cell development [GO:0061050]; regulation of neurofibrillary tangle assembly [GO:1902996] actin filament [GO:0005884]; axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; neurofilament [GO:0005883]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; histone H3T45 kinase activity [GO:0140857]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; splicing factor binding [GO:1990935]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631] g21030.t1 P22232 86.864 236 1.17e-153 436.0 sp|P22232|FBRL_XENLA rRNA 2'-O-methyltransferase fibrillarin OS=Xenopus laevis OX=8355 GN=fbl PE=2 SV=1 g21032.t1 Q75R65 28.21 1145 4.1e-121 404.0 sp|Q75R65|JAK2_CHICK Tyrosine-protein kinase JAK2 OS=Gallus gallus OX=9031 GN=JAK2 PE=2 SV=1 g21033.t1 Q08DJ7 47.606 376 5.6200000000000004e-124 365.0 sp|Q08DJ7|AAR2_BOVIN Protein AAR2 homolog OS=Bos taurus OX=9913 GN=AAR2 PE=2 SV=1 g21054.t1 Q6DFR2 57.663 522 0.0 602.0 sp|Q6DFR2|CBLB_XENTR E3 ubiquitin-protein ligase CBL-B OS=Xenopus tropicalis OX=8364 GN=cblb PE=2 SV=1 CBLB_XENTR reviewed E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001784; GO:0005509; GO:0005737; GO:0007166; GO:0008270; GO:0050821; GO:0050860; GO:0050868; GO:0061630; GO:0070534; GO:2000583 cell surface receptor signaling pathway [GO:0007166]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583] cytoplasm [GO:0005737] calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21054.t2 Q6DFR2 57.663 522 0.0 602.0 sp|Q6DFR2|CBLB_XENTR E3 ubiquitin-protein ligase CBL-B OS=Xenopus tropicalis OX=8364 GN=cblb PE=2 SV=1 CBLB_XENTR reviewed E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001784; GO:0005509; GO:0005737; GO:0007166; GO:0008270; GO:0050821; GO:0050860; GO:0050868; GO:0061630; GO:0070534; GO:2000583 cell surface receptor signaling pathway [GO:0007166]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583] cytoplasm [GO:0005737] calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21054.t3 Q6DFR2 58.447 515 0.0 609.0 sp|Q6DFR2|CBLB_XENTR E3 ubiquitin-protein ligase CBL-B OS=Xenopus tropicalis OX=8364 GN=cblb PE=2 SV=1 CBLB_XENTR reviewed E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001784; GO:0005509; GO:0005737; GO:0007166; GO:0008270; GO:0050821; GO:0050860; GO:0050868; GO:0061630; GO:0070534; GO:2000583 cell surface receptor signaling pathway [GO:0007166]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583] cytoplasm [GO:0005737] calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21055.t1 Q5R8I6 51.42 669 0.0 671.0 sp|Q5R8I6|TBC23_PONAB TBC1 domain family member 23 OS=Pongo abelii OX=9601 GN=TBC1D23 PE=2 SV=1 TBC23_PONAB reviewed TBC1 domain family member 23 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005802; GO:0005829; GO:0007420; GO:0016192; GO:0031175; GO:0031410; GO:0042147; GO:0099041; GO:1990403 brain development [GO:0007420]; embryonic brain development [GO:1990403]; neuron projection development [GO:0031175]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle tethering to Golgi [GO:0099041]; vesicle-mediated transport [GO:0016192] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; trans-Golgi network [GO:0005802] g21057.t1 Q9VBW3 45.367 313 7.08e-84 291.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21058.t1 Q9VBW3 45.223 314 2.24e-85 288.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21059.t1 Q9VBW3 44.268 314 4.96e-82 279.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21076.t1 Q9VBW3 41.584 303 1.03e-76 260.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21080.t1 Q29041 47.926 217 1.2399999999999999e-52 180.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g21082.t1 Q9VBW3 41.196 301 2.88e-75 258.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21083.t1 Q8JG38 39.155 355 1.39e-64 237.0 sp|Q8JG38|FGFR2_DANRE Fibroblast growth factor receptor 2 OS=Danio rerio OX=7955 GN=fgfr2 PE=1 SV=1 g21085.t1 Q5RFH0 50.515 97 6.5600000000000005e-31 108.0 sp|Q5RFH0|ATP5L_PONAB ATP synthase F(0) complex subunit g, mitochondrial OS=Pongo abelii OX=9601 GN=ATP5MG PE=3 SV=1 g21087.t1 Q9DED6 56.19 105 4.27e-28 112.0 sp|Q9DED6|BAX1B_CHICK Homeobox protein BarH-like 1b OS=Gallus gallus OX=9031 GN=BARX1B PE=2 SV=1 g21087.t2 Q9DED6 63.81 105 3.32e-35 131.0 sp|Q9DED6|BAX1B_CHICK Homeobox protein BarH-like 1b OS=Gallus gallus OX=9031 GN=BARX1B PE=2 SV=1 g21089.t1 Q9VBW3 44.295 298 4.5599999999999994e-89 288.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21092.t1 Q9VBW3 44.631 298 2.96e-85 289.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21095.t1 E2IYB3 49.123 114 3.9400000000000003e-26 104.0 sp|E2IYB3|FCNV1_VARKO Veficolin-1 (Fragment) OS=Varanus komodoensis OX=61221 PE=2 SV=1 g21097.t1 Q9WTS8 54.167 120 1.25e-33 129.0 sp|Q9WTS8|FCN1_RAT Ficolin-1 OS=Rattus norvegicus OX=10116 GN=Fcn1 PE=2 SV=2 FCN1_RAT reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Rattus norvegicus (Rat) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0005886; GO:0007186; GO:0030246; GO:0032757; GO:0033691; GO:0038187; GO:0046872; GO:0097367; GO:0106139 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of interleukin-8 production [GO:0032757] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g21098.t1 A2VDQ7 48.469 392 6.94e-117 378.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 47.583 393 5.719999999999999e-113 368.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 45.478 387 2.15e-108 355.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 46.056 393 4.17e-108 355.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 43.781 402 1.2199999999999999e-106 351.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 46.316 380 1.14e-105 348.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 46.176 353 6.76e-98 327.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 43.066 274 1.69e-64 234.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21098.t1 A2VDQ7 40.23 174 2.0900000000000002e-29 129.0 sp|A2VDQ7|ZN420_BOVIN Zinc finger protein 420 OS=Bos taurus OX=9913 GN=ZNF420 PE=2 SV=1 g21099.t1 Q8NDA2 26.474 933 1.68e-26 123.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g21105.t1 Q9QZS7 23.523 982 4.04e-30 134.0 sp|Q9QZS7|NPHN_MOUSE Nephrin OS=Mus musculus OX=10090 GN=Nphs1 PE=1 SV=2 g21105.t1 Q9QZS7 23.182 949 3.64e-27 125.0 sp|Q9QZS7|NPHN_MOUSE Nephrin OS=Mus musculus OX=10090 GN=Nphs1 PE=1 SV=2 g21107.t1 E1BD59 24.784 347 5.94e-29 126.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21113.t1 Q9ZSJ2 29.699 266 2.05e-22 100.0 sp|Q9ZSJ2|RGXT1_ARATH UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase 1 OS=Arabidopsis thaliana OX=3702 GN=RGXT1 PE=1 SV=1 RGXT1_ARATH reviewed UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase 1 (EC 2.4.2.-) (Rhamnogalacturonan xylosyltransferase 1) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005794; GO:0010306; GO:0035252 rhamnogalacturonan II biosynthetic process [GO:0010306] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] UDP-xylosyltransferase activity [GO:0035252] g21114.t1 O62809 40.179 448 3.39e-97 305.0 sp|O62809|OX2R_PIG Orexin receptor type 2 OS=Sus scrofa OX=9823 GN=HCRTR2 PE=2 SV=2 g21115.t1 P0DSP1 38.211 2269 0.0 1393.0 sp|P0DSP1|SORL_RAT Sortilin-related receptor OS=Rattus norvegicus OX=10116 GN=Sorl1 PE=1 SV=1 SORL_RAT reviewed Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) Rattus norvegicus (Rat) GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0009986; GO:0010897; GO:0014910; GO:0016020; GO:0016477; GO:0019828; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032585; GO:0034067; GO:0034205; GO:0038020; GO:0042147; GO:0042923; GO:0043025; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0055037; GO:0055038; GO:0070863; GO:0097356; GO:0099638; GO:0140318; GO:1900168; GO:1902430; GO:1902953; GO:1902955; GO:1902966; GO:1902992; GO:1902997; GO:1904179; GO:1990845; GO:2001137 adaptive thermogenesis [GO:1990845]; amyloid-beta formation [GO:0034205]; cell migration [GO:0016477]; diet induced thermogenesis [GO:0002024]; endosome to plasma membrane protein transport [GO:0099638]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]; retrograde transport, endosome to Golgi [GO:0042147] cell surface [GO:0009986]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; low-density lipoprotein particle binding [GO:0030169]; neuropeptide binding [GO:0042923]; protein transporter activity [GO:0140318]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] g21116.t1 Q91WA9 60.519 347 2.19e-132 412.0 sp|Q91WA9|ABCG4_MOUSE ATP-binding cassette subfamily G member 4 OS=Mus musculus OX=10090 GN=Abcg4 PE=1 SV=2 ABCG4_MOUSE reviewed ATP-binding cassette subfamily G member 4 (EC 7.6.2.-) (ATP-binding cassette transporter White2) Mus musculus (Mouse) GO:0005524; GO:0005768; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0015918; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830 cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of DNA-templated transcription [GO:0006355]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085] cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g21116.t1 Q91WA9 62.458 301 1.05e-125 395.0 sp|Q91WA9|ABCG4_MOUSE ATP-binding cassette subfamily G member 4 OS=Mus musculus OX=10090 GN=Abcg4 PE=1 SV=2 ABCG4_MOUSE reviewed ATP-binding cassette subfamily G member 4 (EC 7.6.2.-) (ATP-binding cassette transporter White2) Mus musculus (Mouse) GO:0005524; GO:0005768; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0015918; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830 cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of DNA-templated transcription [GO:0006355]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085] cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g21116.t2 P45844 41.421 746 3.47e-157 477.0 sp|P45844|ABCG1_HUMAN ATP-binding cassette sub-family G member 1 OS=Homo sapiens OX=9606 GN=ABCG1 PE=1 SV=3 ABCG1_HUMAN reviewed ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog) Homo sapiens (Human) GO:0000139; GO:0005524; GO:0005543; GO:0005654; GO:0005739; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0008203; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016887; GO:0019534; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0050714; GO:0055037; GO:0055085; GO:0055091; GO:0071403; GO:0090181; GO:0090554; GO:0120020; GO:0140328; GO:1902004; GO:1990961 amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol metabolic process [GO:0090181]; response to lipid [GO:0033993]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] ABC-type sterol transporter activity [GO:0034041]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534] g21117.t1 Q01433 58.755 771 0.0 926.0 sp|Q01433|AMPD2_HUMAN AMP deaminase 2 OS=Homo sapiens OX=9606 GN=AMPD2 PE=1 SV=3 AMPD2_HUMAN reviewed AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L) Homo sapiens (Human) GO:0003876; GO:0005829; GO:0006188; GO:0032263; GO:0032264; GO:0042632; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009 AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; GMP salvage [GO:0032263]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; podocyte development [GO:0072015] cytosol [GO:0005829] AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g21117.t2 Q02356 59.763 758 0.0 927.0 sp|Q02356|AMPD2_RAT AMP deaminase 2 OS=Rattus norvegicus OX=10116 GN=Ampd2 PE=1 SV=2 AMPD2_RAT reviewed AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L) Rattus norvegicus (Rat) GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032264; GO:0042632; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009 AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]; podocyte development [GO:0072015] cytosol [GO:0005829] AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g21117.t3 Q02356 58.355 778 0.0 920.0 sp|Q02356|AMPD2_RAT AMP deaminase 2 OS=Rattus norvegicus OX=10116 GN=Ampd2 PE=1 SV=2 AMPD2_RAT reviewed AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L) Rattus norvegicus (Rat) GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032264; GO:0042632; GO:0042802; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009 AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]; podocyte development [GO:0072015] cytosol [GO:0005829] AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g21118.t1 Q5R9J9 64.22 218 1.27e-111 321.0 sp|Q5R9J9|TPPC4_PONAB Trafficking protein particle complex subunit 4 OS=Pongo abelii OX=9601 GN=TRAPPC4 PE=2 SV=1 TPPC4_PONAB reviewed Trafficking protein particle complex subunit 4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005783; GO:0005795; GO:0006888; GO:0006914; GO:0008021; GO:0016358; GO:0030008; GO:0030425; GO:0048786; GO:0098839 autophagy [GO:0006914]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; postsynaptic density membrane [GO:0098839]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008] g21121.t1 P18101 97.656 128 9.61e-90 258.0 sp|P18101|RL40_DROME Ubiquitin-ribosomal protein eL40 fusion protein OS=Drosophila melanogaster OX=7227 GN=RpL40 PE=1 SV=2 RL40_DROME reviewed Ubiquitin-ribosomal protein eL40 fusion protein (CEP52) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40)] Drosophila melanogaster (Fruit fly) GO:0002181; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0016567; GO:0019941; GO:0022625; GO:0031386; GO:0031625 cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634] protein tag activity [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625] g21122.t1 Q9QYP0 38.408 2864 0.0 1736.0 sp|Q9QYP0|MEGF8_RAT Multiple epidermal growth factor-like domains protein 8 OS=Rattus norvegicus OX=10116 GN=Megf8 PE=1 SV=2 MEGF8_RAT reviewed Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4) Rattus norvegicus (Rat) GO:0000151; GO:0003143; GO:0005509; GO:0005604; GO:0005634; GO:0007224; GO:0007368; GO:0007411; GO:0007507; GO:0009887; GO:0009888; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060173; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0071907; GO:0097094; GO:0097155; GO:1990403 animal organ morphogenesis [GO:0009887]; aorta development [GO:0035904]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; heart development [GO:0007507]; left/right pattern formation [GO:0060972]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888] basement membrane [GO:0005604]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] calcium ion binding [GO:0005509] g21123.t1 P50336 40.365 493 7.17e-113 345.0 sp|P50336|PPOX_HUMAN Protoporphyrinogen oxidase OS=Homo sapiens OX=9606 GN=PPOX PE=1 SV=1 PPOX_HUMAN reviewed Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4) Homo sapiens (Human) GO:0004729; GO:0005739; GO:0005743; GO:0005758; GO:0006779; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0031966; GO:0050660 heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to xenobiotic stimulus [GO:0009410] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729] g21124.t1 Q9U0E6 75.714 140 1.5600000000000002e-72 216.0 sp|Q9U0E6|PROF_SUBDO Profilin OS=Suberites domuncula OX=55567 PE=2 SV=1 g21129.t1 E1BD59 24.793 363 2e-28 124.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21133.t1 Q9VBW3 40.864 301 2.29e-69 254.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21136.t1 P40859 31.606 386 1.0500000000000001e-58 199.0 sp|P40859|MSOX_BACB0 Monomeric sarcosine oxidase OS=Bacillus sp. (strain B-0618) OX=69000 GN=soxA PE=1 SV=2 g21137.t1 P06027 35.417 144 1.13e-21 88.6 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g21142.t1 Q9H0K1 46.53 879 0.0 648.0 sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1 SIK2_HUMAN reviewed Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310 intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g21143.t1 Q5BJX1 48.649 111 2.6699999999999997e-30 108.0 sp|Q5BJX1|RM41_RAT Large ribosomal subunit protein mL41 OS=Rattus norvegicus OX=10116 GN=Mrpl41 PE=1 SV=1 g21147.t1 Q9Y2K2 49.714 700 0.0 605.0 sp|Q9Y2K2|SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens OX=9606 GN=SIK3 PE=1 SV=4 g21148.t1 Q5ZIJ0 39.841 630 5.22e-94 303.0 sp|Q5ZIJ0|BUD13_CHICK BUD13 homolog OS=Gallus gallus OX=9031 GN=BUD13 PE=2 SV=1 g21149.t1 Q9QYU1 33.987 306 1.99e-45 160.0 sp|Q9QYU1|PEX19_RAT Peroxisomal biogenesis factor 19 OS=Rattus norvegicus OX=10116 GN=Pex19 PE=1 SV=1 PEX19_RAT reviewed Peroxisomal biogenesis factor 19 (Peroxin-19) (Peroxisomal farnesylated protein) Rattus norvegicus (Rat) GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006457; GO:0006625; GO:0007031; GO:0016020; GO:0016557; GO:0016559; GO:0031526; GO:0032991; GO:0033328; GO:0036105; GO:0045046; GO:0050821; GO:0051117; GO:0072663; GO:0140597 establishment of protein localization to peroxisome [GO:0072663]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein folding [GO:0006457]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; peroxisome membrane targeting sequence binding [GO:0033328]; protein carrier chaperone [GO:0140597] g21149.t2 Q9QYU1 33.441 311 5.340000000000001e-43 154.0 sp|Q9QYU1|PEX19_RAT Peroxisomal biogenesis factor 19 OS=Rattus norvegicus OX=10116 GN=Pex19 PE=1 SV=1 PEX19_RAT reviewed Peroxisomal biogenesis factor 19 (Peroxin-19) (Peroxisomal farnesylated protein) Rattus norvegicus (Rat) GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006457; GO:0006625; GO:0007031; GO:0016020; GO:0016557; GO:0016559; GO:0031526; GO:0032991; GO:0033328; GO:0036105; GO:0045046; GO:0050821; GO:0051117; GO:0072663; GO:0140597 establishment of protein localization to peroxisome [GO:0072663]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein folding [GO:0006457]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; peroxisome membrane targeting sequence binding [GO:0033328]; protein carrier chaperone [GO:0140597] g21150.t1 P06276 35.195 591 6.64e-105 332.0 sp|P06276|CHLE_HUMAN Cholinesterase OS=Homo sapiens OX=9606 GN=BCHE PE=1 SV=1 CHLE_HUMAN reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) Homo sapiens (Human) GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0006805; GO:0007612; GO:0008285; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050784; GO:0050805; GO:0051384; GO:0051593; GO:0072562 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine catabolic process [GO:0050784]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802] g21151.t1 Q32NT4 51.807 332 3.66e-102 308.0 sp|Q32NT4|LRC58_XENLA Leucine-rich repeat-containing protein 58 OS=Xenopus laevis OX=8355 GN=lrrc58 PE=2 SV=1 g21153.t1 Q8WWB5 33.538 325 2.8999999999999996e-54 183.0 sp|Q8WWB5|PIHD2_HUMAN PIH1 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PIH1D2 PE=1 SV=1 PIHD2_HUMAN reviewed PIH1 domain-containing protein 2 Homo sapiens (Human) GO:0000492; GO:0005737; GO:0006364; GO:0031267; GO:0050821; GO:0097255; GO:0101031; GO:1990904 box C/D snoRNP assembly [GO:0000492]; protein stabilization [GO:0050821]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; protein folding chaperone complex [GO:0101031]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904] small GTPase binding [GO:0031267] g21156.t1 P35556 32.033 1077 5.18e-97 350.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 33.207 1057 7.06e-95 344.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 32.103 1165 3.82e-94 342.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 31.487 975 3.29e-87 320.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 30.824 1129 1.49e-76 286.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 29.809 1097 3.82e-76 284.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 28.612 1426 3.7299999999999995e-74 278.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 30.699 873 7.259999999999999e-69 261.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 35.743 498 8.23e-65 248.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21156.t1 P35556 29.868 683 2.5500000000000002e-59 230.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g21158.t1 P24821 40.511 274 3.8399999999999996e-45 184.0 sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3 TENA_HUMAN reviewed Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C) Homo sapiens (Human) GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0031012; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098965; GO:0098966; GO:0098978 bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545] g21158.t1 P24821 40.288 278 8.35e-45 183.0 sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3 TENA_HUMAN reviewed Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C) Homo sapiens (Human) GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0031012; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098965; GO:0098966; GO:0098978 bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545] g21158.t1 P24821 37.755 294 4.51e-40 168.0 sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3 TENA_HUMAN reviewed Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C) Homo sapiens (Human) GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0031012; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098965; GO:0098966; GO:0098978 bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545] g21158.t1 P24821 40.31 258 1.28e-38 163.0 sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3 TENA_HUMAN reviewed Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C) Homo sapiens (Human) GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0031012; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098965; GO:0098966; GO:0098978 bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545] g21158.t1 P24821 39.394 264 8.54e-37 157.0 sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3 TENA_HUMAN reviewed Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C) Homo sapiens (Human) GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0031012; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098965; GO:0098966; GO:0098978 bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545] g21158.t1 P24821 37.5 232 3.17e-29 132.0 sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3 TENA_HUMAN reviewed Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C) Homo sapiens (Human) GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0031012; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098965; GO:0098966; GO:0098978 bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; syndecan binding [GO:0045545] g21160.t2 Q9IBG7 33.546 1255 5.8299999999999996e-170 590.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t2 Q9IBG7 31.761 869 1.1500000000000001e-88 329.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t2 Q9IBG7 30.709 889 1.57e-80 303.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t2 Q9IBG7 31.773 897 3.57e-80 301.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t2 Q9IBG7 30.972 833 2.8e-75 285.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t2 Q9IBG7 32.289 734 1.71e-71 273.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t2 Q9IBG7 29.63 621 1.8899999999999998e-46 190.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t3 Q9IBG7 33.466 1255 1.11e-176 592.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t3 Q9IBG7 31.761 869 2.97e-90 330.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t3 Q9IBG7 30.778 887 2.09e-82 305.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t3 Q9IBG7 31.224 964 1.61e-81 302.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t3 Q9IBG7 32.7 789 1.33e-76 286.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21160.t3 Q9IBG7 32.289 734 4.1100000000000003e-72 272.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g21170.t1 Q8VBW5 45.545 202 5.55e-35 148.0 sp|Q8VBW5|BBX_MOUSE HMG box transcription factor BBX OS=Mus musculus OX=10090 GN=Bbx PE=1 SV=2 g21171.t1 Q8TC21 50.0 162 4.5e-46 169.0 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21171.t1 Q8TC21 48.171 164 7.820000000000001e-43 160.0 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21171.t1 Q8TC21 49.068 161 2.45e-41 156.0 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21171.t1 Q8TC21 40.933 193 9.36e-40 152.0 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21171.t1 Q8TC21 49.254 134 1.11e-33 135.0 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21171.t1 Q8TC21 42.581 155 1.25e-30 126.0 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21171.t1 Q8TC21 40.127 157 3.770000000000001e-27 116.0 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21171.t1 Q8TC21 51.546 97 3.2800000000000003e-21 99.4 sp|Q8TC21|ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens OX=9606 GN=ZNF596 PE=1 SV=2 g21172.t1 P11475 32.546 381 4.7e-53 186.0 sp|P11475|ERR2_RAT Steroid hormone receptor ERR2 OS=Rattus norvegicus OX=10116 GN=Esrrb PE=2 SV=1 ERR2_RAT reviewed Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2) Rattus norvegicus (Rat) GO:0000785; GO:0000793; GO:0000978; GO:0000981; GO:0000987; GO:0000993; GO:0001228; GO:0001701; GO:0001831; GO:0001834; GO:0001892; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0032039; GO:0034056; GO:0035019; GO:0043565; GO:0043697; GO:0045494; GO:0045725; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0048839; GO:0061629; GO:0140001; GO:1902459; GO:1990837; GO:2000035; GO:2000737 cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; morula formation [GO:0140001]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell differentiation [GO:2000737]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270] g21174.t1 P53355 24.656 1018 6.149999999999999e-54 211.0 sp|P53355|DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=DAPK1 PE=1 SV=6 DAPK1_HUMAN reviewed Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) Homo sapiens (Human) GO:0002357; GO:0002834; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1904094; GO:1990722; GO:2000310 apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075] g21174.t1 P53355 32.377 244 7.11e-26 120.0 sp|P53355|DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=DAPK1 PE=1 SV=6 DAPK1_HUMAN reviewed Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) Homo sapiens (Human) GO:0002357; GO:0002834; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1904094; GO:1990722; GO:2000310 apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075] g21175.t1 Q9HCK4 36.671 859 5.21e-162 532.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21175.t1 Q9HCK4 28.48 941 4.3400000000000004e-66 251.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21175.t2 Q9HCK4 37.089 852 1.2400000000000002e-163 537.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21175.t2 Q9HCK4 28.512 961 1.87e-67 255.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21175.t3 Q9HCK4 37.089 852 5.9700000000000004e-164 537.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21175.t3 Q9HCK4 28.617 933 2.3399999999999997e-67 254.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21177.t1 Q9HCK4 38.313 830 6.77e-175 566.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21177.t1 Q9HCK4 25.872 344 9.15e-24 113.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21177.t2 Q9HCK4 38.313 830 1.05e-174 566.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21177.t2 Q9HCK4 25.872 344 9.589999999999999e-24 113.0 sp|Q9HCK4|ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens OX=9606 GN=ROBO2 PE=1 SV=2 ROBO2_HUMAN reviewed Roundabout homolog 2 Homo sapiens (Human) GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802] g21178.t1 Q924A2 40.476 504 1.27e-74 282.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t1 Q924A2 45.205 219 3.2800000000000003e-37 159.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t1 Q924A2 39.161 286 3.02e-33 146.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t2 Q924A2 40.557 503 5.5e-75 283.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t2 Q924A2 45.205 219 3.31e-37 159.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t2 Q924A2 39.161 286 3.02e-33 146.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t3 Q924A2 40.476 504 2.66e-74 281.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t3 Q924A2 45.205 219 3.95e-37 159.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21178.t3 Q924A2 39.161 286 4.12e-33 145.0 sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2 g21179.t1 P70097 42.857 161 3.82e-40 136.0 sp|P70097|C560_CRIGR Succinate dehydrogenase cytochrome b560 subunit, mitochondrial OS=Cricetulus griseus OX=10029 GN=SDHC PE=2 SV=1 g21180.t1 Q24152 69.643 56 2.18e-25 91.7 sp|Q24152|CKS1_DROME Cyclin-dependent kinases regulatory subunit OS=Drosophila melanogaster OX=7227 GN=Cks30A PE=3 SV=1 CKS1_DROME reviewed Cyclin-dependent kinases regulatory subunit Drosophila melanogaster (Fruit fly) GO:0000307; GO:0007057; GO:0007143; GO:0007144; GO:0007346; GO:0007488; GO:0019005; GO:0019901; GO:0031145; GO:0035186; GO:0042393; GO:0043130; GO:0051225; GO:0051301; GO:0061575 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; female meiosis I [GO:0007144]; female meiotic nuclear division [GO:0007143]; histoblast morphogenesis [GO:0007488]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225]; spindle assembly involved in female meiosis I [GO:0007057]; syncytial blastoderm mitotic cell cycle [GO:0035186] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005] cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130] g21182.t1 P54612 80.952 588 0.0 990.0 sp|P54612|2AAA_PIG Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform OS=Sus scrofa OX=9823 GN=PPP2R1A PE=2 SV=2 g21183.t1 O35162 54.757 473 1.72e-159 461.0 sp|O35162|HSP13_RAT Heat shock 70 kDa protein 13 OS=Rattus norvegicus OX=10116 GN=Hspa13 PE=1 SV=2 g21184.t1 Q9NXL6 47.155 791 0.0 701.0 sp|Q9NXL6|SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens OX=9606 GN=SIDT1 PE=1 SV=2 g21187.t1 Q92542 38.034 702 1.72e-149 454.0 sp|Q92542|NICA_HUMAN Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2 NICA_HUMAN reviewed Nicastrin Homo sapiens (Human) GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0061133; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926 adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098] azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; endopeptidase activator activity [GO:0061133]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674] g21188.t1 Q96KN3 51.059 425 1.28e-114 350.0 sp|Q96KN3|PKNX2_HUMAN Homeobox protein PKNOX2 OS=Homo sapiens OX=9606 GN=PKNOX2 PE=1 SV=2 g21196.t1 Q9JHA8 26.98 808 3.64e-64 239.0 sp|Q9JHA8|VWA7_MOUSE von Willebrand factor A domain-containing protein 7 OS=Mus musculus OX=10090 GN=Vwa7 PE=2 SV=1 g21225.t1 Q7LHG5 45.139 144 2.66e-36 135.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g21239.t1 P10394 29.744 195 1.5699999999999997e-23 104.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g21253.t1 P10394 28.953 860 1.18e-90 325.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g21259.t1 P20825 37.627 295 2.64e-60 212.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g21276.t1 P04323 33.99 406 5.07e-66 236.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g21277.t1 P10394 26.648 349 2.31e-36 150.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g21346.t1 P10394 29.187 209 1.86e-28 119.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g21357.t1 P50729 31.909 351 1.0499999999999999e-42 160.0 sp|P50729|RECS_BACSU Probable ATP-dependent DNA helicase RecS OS=Bacillus subtilis (strain 168) OX=224308 GN=recS PE=1 SV=1 g21375.t1 B0BN95 37.5 168 2.6800000000000003e-21 93.2 sp|B0BN95|HARB1_RAT Putative nuclease HARBI1 OS=Rattus norvegicus OX=10116 GN=Harbi1 PE=2 SV=1 g21381.t1 Q09575 33.813 278 1.05e-37 149.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g21382.t1 P04323 32.389 247 1.09e-38 147.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g21386.t1 P04323 34.362 486 1.55e-75 267.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g21389.t1 P10394 28.534 382 2.24e-37 152.0 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g21456.t1 A6QLU6 38.024 334 8.59e-59 218.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g21459.t1 Q68CR1 31.858 1039 3.52e-157 501.0 sp|Q68CR1|SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens OX=9606 GN=SEL1L3 PE=1 SV=2 SE1L3_HUMAN reviewed Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3) Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g21460.t1 Q10651 31.894 417 6.87e-58 212.0 sp|Q10651|A4_CAEEL Amyloid-beta-like protein OS=Caenorhabditis elegans OX=6239 GN=apl-1 PE=1 SV=2 A4_CAEEL reviewed Amyloid-beta-like protein Caenorhabditis elegans GO:0002119; GO:0005769; GO:0007409; GO:0007417; GO:0008201; GO:0010171; GO:0016020; GO:0031410; GO:0042395; GO:0043005; GO:0043025; GO:0046914 axonogenesis [GO:0007409]; body morphogenesis [GO:0010171]; central nervous system development [GO:0007417]; ecdysis, collagen and cuticulin-based cuticle [GO:0042395]; nematode larval development [GO:0002119] cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] heparin binding [GO:0008201]; transition metal ion binding [GO:0046914] g21462.t1 Q9VBW3 46.358 302 2.31e-92 311.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21462.t2 Q9VBW3 46.358 302 2.38e-92 311.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21463.t1 Q29496 34.6 500 3.1e-91 290.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g21476.t1 O75845 49.135 289 7.23e-105 310.0 sp|O75845|SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens OX=9606 GN=SC5D PE=1 SV=2 g21477.t1 A2VDB3 49.593 246 2.63e-66 214.0 sp|A2VDB3|RBM42_XENLA RNA-binding protein 42 OS=Xenopus laevis OX=8355 GN=rbm42 PE=2 SV=1 g21479.t1 A2RUV0 38.045 1033 0.0 606.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 41.667 660 4.38e-149 504.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 40.252 713 3.35e-146 496.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 38.462 780 5.99e-145 492.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 36.565 722 2.65e-122 425.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 37.393 698 5.61e-120 418.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 32.138 697 6.11e-86 314.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 38.618 492 1.04e-77 288.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 41.277 235 4.210000000000001e-43 176.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 39.241 237 1.41e-41 171.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 34.4 250 2.1100000000000002e-33 145.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 43.005 193 4.88e-33 144.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 35.484 248 5.340000000000001e-32 140.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 39.048 210 9.99e-32 139.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21479.t1 A2RUV0 32.558 258 3.0800000000000003e-31 137.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g21480.t1 P07207 42.336 274 1.53e-53 209.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 33.989 356 2.53e-47 189.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 37.342 316 2.24e-44 180.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 36.538 312 8.94e-43 174.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 39.427 279 1.7799999999999997e-42 174.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 38.545 275 6.36e-41 169.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 38.043 276 1.7899999999999998e-38 160.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 35.106 282 2.72e-37 157.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 36.525 282 1.42e-34 148.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 30.247 324 4.21e-31 137.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t1 P07207 31.93 285 1.2099999999999999e-24 115.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 42.238 277 2.7499999999999997e-54 211.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 33.708 356 6.030000000000001e-47 188.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 36.859 312 3.3100000000000003e-43 176.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 39.427 279 1.8699999999999998e-42 174.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 38.909 275 1.7e-41 171.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 38.406 276 4.22e-39 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 35.849 265 2.91e-38 160.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 34.752 282 1.61e-36 154.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 36.17 282 3.57e-34 147.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 29.938 324 5.7099999999999994e-30 133.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21480.t2 P07207 31.93 285 1.37e-24 115.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g21481.t1 P10079 48.307 443 1.32e-111 378.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21481.t1 P10079 47.146 473 9.4e-111 375.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21481.t1 P10079 54.201 369 1.0700000000000001e-105 362.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21481.t1 P10079 52.532 316 7.06e-86 305.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21481.t1 P10079 49.682 314 7.52e-80 288.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g21487.t1 Q4W1X2 39.494 514 3.46e-118 367.0 sp|Q4W1X2|GLFA_ASPFM UDP-galactopyranose mutase OS=Aspergillus fumigatus OX=746128 GN=glfA PE=1 SV=1 GLFA_ASPFM reviewed UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) Aspergillus fumigatus (Neosartorya fumigata) GO:0000166; GO:0008767; GO:0071555 cell wall organization [GO:0071555] nucleotide binding [GO:0000166]; UDP-galactopyranose mutase activity [GO:0008767] g21495.t1 Q9H1I8 41.069 711 6.49e-164 493.0 sp|Q9H1I8|ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens OX=9606 GN=ASCC2 PE=1 SV=3 g21497.t1 P48039 25.714 350 2.16e-22 100.0 sp|P48039|MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens OX=9606 GN=MTNR1A PE=1 SV=1 MTR1A_HUMAN reviewed Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617] plasma membrane [GO:0005886]; receptor complex [GO:0043235] G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502] g21498.t1 Q9UHP3 42.419 1141 0.0 817.0 sp|Q9UHP3|UBP25_HUMAN Ubiquitin carboxyl-terminal hydrolase 25 OS=Homo sapiens OX=9606 GN=USP25 PE=1 SV=4 g21499.t1 B5X1G3 69.011 455 0.0 650.0 sp|B5X1G3|GPHR_SALSA Golgi pH regulator OS=Salmo salar OX=8030 GN=gpr89 PE=2 SV=1 g21503.t1 Q09575 28.541 466 1.02e-37 155.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g21507.t1 Q9UPX0 38.024 739 2.38e-157 519.0 sp|Q9UPX0|TUTLB_HUMAN Protein turtle homolog B OS=Homo sapiens OX=9606 GN=IGSF9B PE=1 SV=2 TUTLB_HUMAN reviewed Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B) Homo sapiens (Human) GO:0007155; GO:0007399; GO:0014069; GO:0043005; GO:0045211; GO:0098982 cell adhesion [GO:0007155]; nervous system development [GO:0007399] GABA-ergic synapse [GO:0098982]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] g21508.t1 E1BD59 32.174 230 2.4700000000000002e-26 119.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21509.t1 Q9BRZ2 27.437 277 1.68e-29 125.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21509.t2 Q9BRZ2 27.465 284 1.9900000000000002e-29 125.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21510.t1 Q9BRZ2 27.076 277 1.19e-28 123.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21510.t2 Q9BRZ2 27.113 284 1.04e-28 123.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21511.t1 Q9BRZ2 27.437 277 5.88e-29 124.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21512.t1 Q9BRZ2 27.076 277 1.0800000000000001e-27 120.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21513.t1 Q9BRZ2 27.076 277 1.0800000000000001e-27 120.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21514.t1 Q9BRZ2 27.437 277 9.81e-29 124.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g21517.t1 Q80VI1 27.273 286 9.57e-24 110.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21518.t1 Q6P4R8 40.544 698 2.3e-149 492.0 sp|Q6P4R8|NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein OS=Homo sapiens OX=9606 GN=NFRKB PE=1 SV=2 NFRKB_HUMAN reviewed Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G) Homo sapiens (Human) GO:0000723; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; protease binding [GO:0002020] g21519.t1 Q28FY5 69.863 146 2.08e-74 224.0 sp|Q28FY5|TM147_XENTR BOS complex subunit TMEM147 OS=Xenopus tropicalis OX=8364 GN=tmem147 PE=2 SV=1 TM147_XENTR reviewed BOS complex subunit TMEM147 (Transmembrane protein 147) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005789; GO:0005886; GO:0031965; GO:0036228; GO:0043022; GO:0160063 multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein localization to nuclear inner membrane [GO:0036228] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] ribosome binding [GO:0043022] g21521.t1 A1A4P5 57.616 151 1.4299999999999998e-52 166.0 sp|A1A4P5|PFD2_BOVIN Prefoldin subunit 2 OS=Bos taurus OX=9913 GN=PFDN2 PE=2 SV=1 PFD2_BOVIN reviewed Prefoldin subunit 2 Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082 protein folding [GO:0006457] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272] protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] g21524.t1 Q9HAR2 33.242 364 3.2899999999999995e-48 189.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g21531.t1 A6QLU6 35.233 193 8.590000000000001e-27 120.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g21536.t1 Q0SZ31 36.678 289 1.7900000000000001e-59 197.0 sp|Q0SZ31|TATD_SHIF8 3'-5' ssDNA/RNA exonuclease TatD OS=Shigella flexneri serotype 5b (strain 8401) OX=373384 GN=tatD PE=3 SV=1 g21537.t1 Q5EA95 64.81 395 0.0 530.0 sp|Q5EA95|IFT57_BOVIN Intraflagellar transport protein 57 homolog OS=Bos taurus OX=9913 GN=IFT57 PE=1 SV=1 g21541.t1 Q9H892 31.389 720 5.52e-94 310.0 sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2 TTC12_HUMAN reviewed Tetratricopeptide repeat protein 12 (TPR repeat protein 12) Homo sapiens (Human) GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007288; GO:0031965; GO:0070286 axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] g21542.t1 Q5E9H9 44.622 251 6.79e-70 226.0 sp|Q5E9H9|ABHDA_BOVIN Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Bos taurus OX=9913 GN=ABHD10 PE=2 SV=1 g21546.t1 Q810T5 56.383 564 0.0 616.0 sp|Q810T5|KAT7_RAT Histone acetyltransferase KAT7 OS=Rattus norvegicus OX=10116 GN=Kat7 PE=1 SV=1 g21547.t1 Q8WPD0 36.31 168 1.1300000000000001e-29 108.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g21549.t1 P27118 47.598 229 2.79e-64 211.0 sp|P27118|DCOR_CHICK Ornithine decarboxylase (Fragment) OS=Gallus gallus OX=9031 GN=ODC1 PE=2 SV=1 g21550.t1 P14019 39.098 133 7.52e-22 93.6 sp|P14019|DCOR_CRIGR Ornithine decarboxylase OS=Cricetulus griseus OX=10029 GN=ODC1 PE=2 SV=3 g21553.t1 Q5CZR5 32.353 306 2.6499999999999997e-42 152.0 sp|Q5CZR5|AEP1_DANRE Aerolysin-like protein OS=Danio rerio OX=7955 GN=aep1 PE=1 SV=1 AEP1_DANRE reviewed Aerolysin-like protein (Jacalin-type lectin domain-containing protein 5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005537; GO:0005886; GO:0042742; GO:0042802; GO:0046930; GO:0048030 defense response to bacterium [GO:0042742] plasma membrane [GO:0005886]; pore complex [GO:0046930] D-mannose binding [GO:0005537]; disaccharide binding [GO:0048030]; identical protein binding [GO:0042802] g21557.t1 Q8WPD0 36.257 171 3.02e-26 100.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g21558.t1 Q5CZR5 32.441 299 3.4e-43 154.0 sp|Q5CZR5|AEP1_DANRE Aerolysin-like protein OS=Danio rerio OX=7955 GN=aep1 PE=1 SV=1 AEP1_DANRE reviewed Aerolysin-like protein (Jacalin-type lectin domain-containing protein 5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005537; GO:0005886; GO:0042742; GO:0042802; GO:0046930; GO:0048030 defense response to bacterium [GO:0042742] plasma membrane [GO:0005886]; pore complex [GO:0046930] D-mannose binding [GO:0005537]; disaccharide binding [GO:0048030]; identical protein binding [GO:0042802] g21559.t1 Q5CZR5 31.773 299 2.19e-42 152.0 sp|Q5CZR5|AEP1_DANRE Aerolysin-like protein OS=Danio rerio OX=7955 GN=aep1 PE=1 SV=1 AEP1_DANRE reviewed Aerolysin-like protein (Jacalin-type lectin domain-containing protein 5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005537; GO:0005886; GO:0042742; GO:0042802; GO:0046930; GO:0048030 defense response to bacterium [GO:0042742] plasma membrane [GO:0005886]; pore complex [GO:0046930] D-mannose binding [GO:0005537]; disaccharide binding [GO:0048030]; identical protein binding [GO:0042802] g21561.t1 Q8WPD0 36.257 171 1.6900000000000003e-27 103.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g21562.t1 Q8WPD0 50.588 170 3.95e-57 179.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g21594.t1 E1BD59 25.287 348 3.1e-29 127.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21595.t1 Q06546 45.431 394 4.3599999999999994e-104 318.0 sp|Q06546|GABPA_HUMAN GA-binding protein alpha chain OS=Homo sapiens OX=9606 GN=GABPA PE=1 SV=1 GABPA_HUMAN reviewed GA-binding protein alpha chain (GABP subunit alpha) (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001825; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045653; GO:0045944; GO:1990837 blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g21596.t1 Q8BX09 73.016 504 0.0 758.0 sp|Q8BX09|RBBP5_MOUSE Retinoblastoma-binding protein 5 OS=Mus musculus OX=10090 GN=Rbbp5 PE=1 SV=2 RBBP5_MOUSE reviewed Retinoblastoma-binding protein 5 (RBBP-5) Mus musculus (Mouse) GO:0000976; GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0010467; GO:0035097; GO:0042393; GO:0043627; GO:0044665; GO:0044666; GO:0045815; GO:0048188; GO:0071339 DNA damage response [GO:0006974]; gene expression [GO:0010467]; response to estrogen [GO:0043627]; transcription initiation-coupled chromatin remodeling [GO:0045815] histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976] g21597.t1 O18638 46.46 226 3.96e-62 199.0 sp|O18638|OAF_DROVI Out at first protein OS=Drosophila virilis OX=7244 GN=oaf PE=3 SV=1 g21597.t2 O18638 49.048 210 1.8000000000000001e-65 207.0 sp|O18638|OAF_DROVI Out at first protein OS=Drosophila virilis OX=7244 GN=oaf PE=3 SV=1 g21598.t1 O01359 56.25 112 1.83e-32 112.0 sp|O01359|RLA1_OSCTI Large ribosomal subunit protein P1 OS=Oscheius tipulae OX=141969 GN=rpl-21 PE=3 SV=1 g21599.t1 Q8BGC3 29.712 451 1.06e-55 197.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g21600.t1 Q62685 34.197 193 3.03e-28 122.0 sp|Q62685|NR1H3_RAT Oxysterols receptor LXR-alpha OS=Rattus norvegicus OX=10116 GN=Nr1h3 PE=1 SV=1 g21600.t2 Q9PTN2 29.34 409 2.48e-46 168.0 sp|Q9PTN2|VDRA_DANRE Vitamin D3 receptor A OS=Danio rerio OX=7955 GN=vdra PE=1 SV=2 VDRA_DANRE reviewed Vitamin D3 receptor A (VDR-A) (1,25-dihydroxyvitamin D3 receptor A) (Nuclear receptor subfamily 1 group I member 1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0001503; GO:0001947; GO:0003146; GO:0004879; GO:0005499; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0008270; GO:0030154; GO:0030522; GO:0045944; GO:0055074; GO:0071425; GO:1902098; GO:1902121 calcium ion homeostasis [GO:0055074]; cell differentiation [GO:0030154]; DNA-templated transcription [GO:0006351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355] cytoplasm [GO:0005737]; nucleus [GO:0005634] calcitriol binding [GO:1902098]; lithocholic acid binding [GO:1902121]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270] g21601.t1 Q9N126 41.115 287 4.74e-55 183.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g21603.t1 Q07864 65.508 2302 0.0 3169.0 sp|Q07864|DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens OX=9606 GN=POLE PE=1 SV=5 DPOE1_HUMAN reviewed DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A) Homo sapiens (Human) GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539 base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297] epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; zinc ion binding [GO:0008270] g21603.t2 Q07864 64.749 2329 0.0 3156.0 sp|Q07864|DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens OX=9606 GN=POLE PE=1 SV=5 DPOE1_HUMAN reviewed DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A) Homo sapiens (Human) GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539 base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297] epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310]; zinc ion binding [GO:0008270] g21610.t1 P21571 42.453 106 1.4000000000000002e-21 85.1 sp|P21571|ATP5J_RAT ATP synthase peripheral stalk subunit F6, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5pf PE=1 SV=1 ATP5J_RAT reviewed ATP synthase peripheral stalk subunit F6, mitochondrial (ATPase subunit F6) (ATP synthase peripheral stalk subunit F6) Rattus norvegicus (Rat) GO:0005615; GO:0005739; GO:0005743; GO:0009986; GO:0010460; GO:0014850; GO:0015078; GO:0032307; GO:0042776; GO:0044877; GO:0045259; GO:0045777; GO:1900139 negative regulation of arachidonate secretion [GO:1900139]; negative regulation of prostaglandin secretion [GO:0032307]; positive regulation of blood pressure [GO:0045777]; positive regulation of heart rate [GO:0010460]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to muscle activity [GO:0014850] cell surface [GO:0009986]; extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259] protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078] g21611.t1 Q6NRH1 61.905 420 0.0 559.0 sp|Q6NRH1|DCAF8_XENLA DDB1- and CUL4-associated factor 8 OS=Xenopus laevis OX=8355 GN=dcaf8 PE=2 SV=1 g21612.t1 Q9WTV5 48.515 202 2.92e-66 206.0 sp|Q9WTV5|PSMD9_RAT 26S proteasome non-ATPase regulatory subunit 9 OS=Rattus norvegicus OX=10116 GN=Psmd9 PE=1 SV=1 g21620.t1 Q5R4G2 54.054 222 1.84e-86 258.0 sp|Q5R4G2|PA1B2_PONAB Platelet-activating factor acetylhydrolase IB subunit alpha2 OS=Pongo abelii OX=9601 GN=PAFAH1B2 PE=2 SV=1 PA1B2_PONAB reviewed Platelet-activating factor acetylhydrolase IB subunit alpha2 (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001650; GO:0003847; GO:0005829; GO:0005886; GO:0007283; GO:0008247; GO:0016042; GO:0016239; GO:0042803; GO:0046982; GO:0047179 lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; plasma membrane [GO:0005886] 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g21623.t1 Q7ZX53 39.596 495 5.9e-115 351.0 sp|Q7ZX53|S22FL_XENLA Solute carrier family 22 member 15-like OS=Xenopus laevis OX=8355 GN=slc22a15b PE=2 SV=1 g21625.t1 P13607 75.766 1044 0.0 1666.0 sp|P13607|ATNA_DROME Sodium/potassium-transporting ATPase subunit alpha OS=Drosophila melanogaster OX=7227 GN=Atpalpha PE=1 SV=3 ATNA_DROME reviewed Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha) Drosophila melanogaster (Fruit fly) GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0016887; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573 adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; monoatomic cation transport [GO:0006812]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; sodium:potassium-exchanging ATPase complex [GO:0005890]; synapse [GO:0045202] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; P-type sodium:potassium-exchanging transporter activity [GO:0005391] g21626.t1 Q5QJ74 38.498 426 1.13e-92 289.0 sp|Q5QJ74|TBCEL_HUMAN Tubulin-specific chaperone cofactor E-like protein OS=Homo sapiens OX=9606 GN=TBCEL PE=1 SV=2 TBCEL_HUMAN reviewed Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35) Homo sapiens (Human) GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014 microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] alpha-tubulin binding [GO:0043014] g21627.t1 Q9Z0S9 43.429 175 2.4100000000000002e-49 161.0 sp|Q9Z0S9|PRAF1_MOUSE Prenylated Rab acceptor protein 1 OS=Mus musculus OX=10090 GN=Rabac1 PE=1 SV=1 g21628.t1 Q4W1X2 43.21 243 5.04e-57 195.0 sp|Q4W1X2|GLFA_ASPFM UDP-galactopyranose mutase OS=Aspergillus fumigatus OX=746128 GN=glfA PE=1 SV=1 GLFA_ASPFM reviewed UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) Aspergillus fumigatus (Neosartorya fumigata) GO:0000166; GO:0008767; GO:0071555 cell wall organization [GO:0071555] nucleotide binding [GO:0000166]; UDP-galactopyranose mutase activity [GO:0008767] g21629.t1 Q4W1X2 38.207 513 2.41e-111 352.0 sp|Q4W1X2|GLFA_ASPFM UDP-galactopyranose mutase OS=Aspergillus fumigatus OX=746128 GN=glfA PE=1 SV=1 GLFA_ASPFM reviewed UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) Aspergillus fumigatus (Neosartorya fumigata) GO:0000166; GO:0008767; GO:0071555 cell wall organization [GO:0071555] nucleotide binding [GO:0000166]; UDP-galactopyranose mutase activity [GO:0008767] g21630.t1 Q4W1X2 40.467 514 7.750000000000001e-122 378.0 sp|Q4W1X2|GLFA_ASPFM UDP-galactopyranose mutase OS=Aspergillus fumigatus OX=746128 GN=glfA PE=1 SV=1 GLFA_ASPFM reviewed UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) Aspergillus fumigatus (Neosartorya fumigata) GO:0000166; GO:0008767; GO:0071555 cell wall organization [GO:0071555] nucleotide binding [GO:0000166]; UDP-galactopyranose mutase activity [GO:0008767] g21631.t1 Q4W1X2 41.245 514 5.9900000000000004e-123 380.0 sp|Q4W1X2|GLFA_ASPFM UDP-galactopyranose mutase OS=Aspergillus fumigatus OX=746128 GN=glfA PE=1 SV=1 GLFA_ASPFM reviewed UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) Aspergillus fumigatus (Neosartorya fumigata) GO:0000166; GO:0008767; GO:0071555 cell wall organization [GO:0071555] nucleotide binding [GO:0000166]; UDP-galactopyranose mutase activity [GO:0008767] g21633.t1 Q6ZRR5 32.787 244 3.28e-33 124.0 sp|Q6ZRR5|TLCD5_HUMAN TLC domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TLCD5 PE=2 SV=2 g21634.t1 Q0VD42 37.229 231 7.41e-46 156.0 sp|Q0VD42|TLCD5_BOVIN TLC domain-containing protein 5 OS=Bos taurus OX=9913 GN=TLCD5 PE=2 SV=1 g21640.t1 Q1LXV8 39.888 178 1.4e-37 134.0 sp|Q1LXV8|TLCD5_DANRE TLC domain-containing protein 5 OS=Danio rerio OX=7955 GN=tlcd5 PE=2 SV=1 g21641.t1 Q6ZRR5 43.145 248 8.200000000000001e-70 218.0 sp|Q6ZRR5|TLCD5_HUMAN TLC domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TLCD5 PE=2 SV=2 g21648.t1 Q28IW8 51.351 74 2.66e-22 84.3 sp|Q28IW8|APC13_XENTR Anaphase-promoting complex subunit 13 OS=Xenopus tropicalis OX=8364 GN=anapc13 PE=3 SV=1 g21651.t1 Q9Y2C2 37.308 260 2.77e-46 166.0 sp|Q9Y2C2|UST_HUMAN Uronyl 2-sulfotransferase OS=Homo sapiens OX=9606 GN=UST PE=1 SV=1 UST_HUMAN reviewed Uronyl 2-sulfotransferase (EC 2.8.2.-) (Chondroitin sulfate 2-O-sulfotransferase) (CS-2OST) Homo sapiens (Human) GO:0000139; GO:0008146; GO:0016020; GO:0030010; GO:0034482; GO:0050650; GO:0050651; GO:0050656; GO:0050770; GO:0102142 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; establishment of cell polarity [GO:0030010]; regulation of axonogenesis [GO:0050770] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 2-sulfotransferase activity [GO:0034482]; dermatan 2-sulfotransferase activity [GO:0102142]; sulfotransferase activity [GO:0008146] g21653.t1 Q9BQA5 47.689 411 1.3300000000000001e-129 389.0 sp|Q9BQA5|HINFP_HUMAN Histone H4 transcription factor OS=Homo sapiens OX=9606 GN=HINFP PE=1 SV=2 HINFP_HUMAN reviewed Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein) Homo sapiens (Human) GO:0000077; GO:0000082; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0006357; GO:0008270; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044843; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0045944 cell cycle G1/S phase transition [GO:0044843]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g21654.t1 P57071 25.933 1099 6.87e-73 267.0 sp|P57071|PRD15_HUMAN PR domain zinc finger protein 15 OS=Homo sapiens OX=9606 GN=PRDM15 PE=1 SV=5 PRD15_HUMAN reviewed PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008168; GO:0008270; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0090263; GO:1990841; GO:2000035 methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21656.t1 Q91XQ0 45.3 883 0.0 767.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g21659.t1 Q96JB1 60.153 655 0.0 772.0 sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2 g21660.t1 Q96JB1 81.289 636 0.0 1104.0 sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2 g21661.t1 Q96JB1 70.872 2235 0.0 3296.0 sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2 g21668.t1 Q95LR0 56.983 716 0.0 806.0 sp|Q95LR0|CFA91_MACFA Cilia- and flagella-associated protein 91 OS=Macaca fascicularis OX=9541 GN=CFAP91 PE=2 SV=3 CFA91_MACFA reviewed Cilia- and flagella-associated protein 91 (CFAP91) (AMY-1-associating protein expressed in testis 1) (AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003341; GO:0005739; GO:0005930; GO:0007283; GO:0030154; GO:0031514; GO:1904158 axonemal central apparatus assembly [GO:1904158]; cell differentiation [GO:0030154]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514] g21674.t1 Q08D62 31.045 335 1.7e-40 149.0 sp|Q08D62|MAEL_XENTR Protein maelstrom homolog OS=Xenopus tropicalis OX=8364 GN=mael PE=2 SV=1 g21676.t1 Q708S4 30.149 471 6.04e-72 240.0 sp|Q708S4|ASI4A_DANRE Acid-sensing ion channel 4-A OS=Danio rerio OX=7955 GN=asic4a PE=1 SV=1 g21678.t1 Q62962 31.579 456 5.36e-72 239.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 g21681.t1 Q9UGM3 36.004 1086 6.36e-153 507.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g21681.t1 Q9UGM3 36.433 1043 1.09e-149 498.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g21681.t1 Q9UGM3 36.18 1042 8.38e-148 493.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g21681.t1 Q9UGM3 35.789 1045 1.33e-145 486.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g21681.t1 Q9UGM3 35.749 1035 5.55e-145 484.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g21681.t1 Q9UGM3 36.735 686 6.069999999999999e-95 337.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g21681.t1 Q9UGM3 34.071 678 6.74e-80 291.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g21683.t1 Q9HCN4 66.007 303 5.21e-141 408.0 sp|Q9HCN4|GPN1_HUMAN GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1 PE=1 SV=1 g21687.t1 Q86UT8 29.948 384 8.38e-41 150.0 sp|Q86UT8|CATAC_HUMAN Centrosomal AT-AC splicing factor OS=Homo sapiens OX=9606 GN=CENATAC PE=1 SV=1 CATAC_HUMAN reviewed Centrosomal AT-AC splicing factor (Coiled-coil domain-containing protein 84) Homo sapiens (Human) GO:0000398; GO:0005813; GO:0010826; GO:0042176; GO:0051304 chromosome separation [GO:0051304]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centrosome duplication [GO:0010826]; regulation of protein catabolic process [GO:0042176] centrosome [GO:0005813] g21693.t1 Q708S4 30.29 482 3.3800000000000004e-70 236.0 sp|Q708S4|ASI4A_DANRE Acid-sensing ion channel 4-A OS=Danio rerio OX=7955 GN=asic4a PE=1 SV=1 g21703.t1 Q2TBF2 30.226 354 2.26e-50 182.0 sp|Q2TBF2|WSCD2_HUMAN Sialate:O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=WSCD2 PE=1 SV=2 WSCD2_HUMAN reviewed Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) Homo sapiens (Human) GO:0000139; GO:0008146 Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g21705.t1 Q80T41 33.616 354 2.0099999999999997e-61 223.0 sp|Q80T41|GABR2_MOUSE Gamma-aminobutyric acid type B receptor subunit 2 OS=Mus musculus OX=10090 GN=Gabbr2 PE=1 SV=2 GABR2_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Mus musculus (Mouse) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0038039; GO:0042734; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g21706.t1 Q6PBI5 71.429 119 1.1999999999999999e-42 139.0 sp|Q6PBI5|RS25_DANRE Small ribosomal subunit protein eS25 OS=Danio rerio OX=7955 GN=rps25 PE=1 SV=1 g21707.t1 Q8BVN4 35.865 237 5.98e-39 145.0 sp|Q8BVN4|MTEF4_MOUSE Transcription termination factor 4, mitochondrial OS=Mus musculus OX=10090 GN=Mterf4 PE=2 SV=1 MTEF4_MOUSE reviewed Transcription termination factor 4, mitochondrial (Mitochondrial transcription termination factor 4) (mTERF domain-containing protein 2) Mus musculus (Mouse) GO:0005739; GO:0005829; GO:0006364; GO:0007507; GO:0019843; GO:0043010; GO:0061668; GO:1903108 camera-type eye development [GO:0043010]; heart development [GO:0007507]; mitochondrial ribosome assembly [GO:0061668]; regulation of mitochondrial transcription [GO:1903108]; rRNA processing [GO:0006364] cytosol [GO:0005829]; mitochondrion [GO:0005739] rRNA binding [GO:0019843] g21709.t1 Q8TAA9 53.346 508 1.78e-173 503.0 sp|Q8TAA9|VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens OX=9606 GN=VANGL1 PE=1 SV=1 VANG1_HUMAN reviewed Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) Homo sapiens (Human) GO:0005576; GO:0005886; GO:0016328; GO:0043473; GO:0060071; GO:0120197 mucociliary clearance [GO:0120197]; pigmentation [GO:0043473]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] extracellular region [GO:0005576]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] g21712.t1 Q9JHE4 33.607 366 3.96e-57 198.0 sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2 G3ST1_MOUSE reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Mus musculus (Mouse) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020] galactosylceramide sulfotransferase activity [GO:0001733] g21713.t1 Q0VFV6 35.802 162 2.51e-24 97.1 sp|Q0VFV6|SELS_DANRE Selenoprotein S OS=Danio rerio OX=7955 GN=vimp PE=2 SV=2 g21714.t1 P20749 45.714 245 1.5e-57 203.0 sp|P20749|BCL3_HUMAN B-cell lymphoma 3 protein OS=Homo sapiens OX=9606 GN=BCL3 PE=1 SV=2 BCL3_HUMAN reviewed B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3) Homo sapiens (Human) GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0036064; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222 antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064] Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g21714.t2 P20749 45.714 245 1.2200000000000002e-56 204.0 sp|P20749|BCL3_HUMAN B-cell lymphoma 3 protein OS=Homo sapiens OX=9606 GN=BCL3 PE=1 SV=2 BCL3_HUMAN reviewed B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3) Homo sapiens (Human) GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0036064; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222 antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064] Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g21715.t1 Q5FVL4 36.634 202 2.34e-35 126.0 sp|Q5FVL4|DRC12_RAT Dynein regulatory complex protein 12 OS=Rattus norvegicus OX=10116 GN=Drc12 PE=2 SV=1 g21716.t1 P38117 73.2 250 3.4799999999999997e-134 381.0 sp|P38117|ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens OX=9606 GN=ETFB PE=1 SV=3 ETFB_HUMAN reviewed Electron transfer flavoprotein subunit beta (Beta-ETF) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251 amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] electron transfer activity [GO:0009055] g21717.t1 Q4R7L3 85.68 419 0.0 738.0 sp|Q4R7L3|PRS6B_MACFA 26S proteasome regulatory subunit 6B OS=Macaca fascicularis OX=9541 GN=PSMC4 PE=2 SV=1 PRS6B_MACFA reviewed 26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001824; GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0022624; GO:0036064 blastocyst development [GO:0001824] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g21724.t1 Q14409 60.721 555 0.0 689.0 sp|Q14409|GLPK3_HUMAN Glycerol kinase 3 OS=Homo sapiens OX=9606 GN=GK3 PE=1 SV=2 g21727.t1 Q08879 39.749 239 4.27e-34 134.0 sp|Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus OX=10090 GN=Fbln1 PE=1 SV=2 FBLN1_MOUSE reviewed Fibulin-1 (FIBL-1) (Basement-membrane protein 90) (BM-90) Mus musculus (Mouse) GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0070051; GO:0070373; GO:0071635; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647 blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237] basement membrane [GO:0005604]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein-containing complex binding [GO:0044877] g21729.t1 O08746 33.463 257 5.3e-29 124.0 sp|O08746|MATN2_MOUSE Matrilin-2 OS=Mus musculus OX=10090 GN=Matn2 PE=2 SV=2 MATN2_MOUSE reviewed Matrilin-2 Mus musculus (Mouse) GO:0001764; GO:0005509; GO:0005604; GO:0005615; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0031175; GO:0048678; GO:0120216 axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; matrilin complex [GO:0120216] calcium ion binding [GO:0005509] g21731.t1 Q9VBW3 49.505 303 2.41e-93 308.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21732.t1 P98064 32.329 365 8.93e-52 186.0 sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2 g21733.t1 P48740 40.514 311 1.77e-73 242.0 sp|P48740|MASP1_HUMAN Mannan-binding lectin serine protease 1 OS=Homo sapiens OX=9606 GN=MASP1 PE=1 SV=3 MASP1_HUMAN reviewed Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain] Homo sapiens (Human) GO:0001867; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0006957; GO:0008233; GO:0031638; GO:0042802; GO:0042803; GO:0045916; GO:0048306; GO:0051604; GO:0106139 complement activation, alternative pathway [GO:0006957]; complement activation, lectin pathway [GO:0001867]; negative regulation of complement activation [GO:0045916]; protein maturation [GO:0051604]; zymogen activation [GO:0031638] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; symbiont cell surface [GO:0106139] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252] g21734.t1 Q9VBW3 45.574 305 6.04e-84 285.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21736.t1 O14757 59.034 476 0.0 578.0 sp|O14757|CHK1_HUMAN Serine/threonine-protein kinase Chk1 OS=Homo sapiens OX=9606 GN=CHEK1 PE=1 SV=2 CHK1_HUMAN reviewed Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) Homo sapiens (Human) GO:0000077; GO:0000086; GO:0000785; GO:0000794; GO:0001833; GO:0004672; GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005829; GO:0006260; GO:0006281; GO:0006338; GO:0006468; GO:0006915; GO:0006974; GO:0006997; GO:0007095; GO:0010569; GO:0018107; GO:0019904; GO:0032991; GO:0035402; GO:0042127; GO:0042770; GO:0044818; GO:0045787; GO:0045814; GO:0045839; GO:0046602; GO:0070317; GO:0071260; GO:0090399; GO:0106310; GO:1901796; GO:1902742 apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; cellular response to mechanical stimulus [GO:0071260]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G2/M transition of mitotic cell cycle [GO:0000086]; inner cell mass cell proliferation [GO:0001833]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of mitotic nuclear division [GO:0045839]; nucleus organization [GO:0006997]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle [GO:0045787]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mitotic centrosome separation [GO:0046602]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; signal transduction in response to DNA damage [GO:0042770] centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; replication fork [GO:0005657] ATP binding [GO:0005524]; histone H3T11 kinase activity [GO:0035402]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g21737.t1 Q24372 27.157 313 8.44e-25 109.0 sp|Q24372|LACH_DROME Lachesin OS=Drosophila melanogaster OX=7227 GN=Lac PE=1 SV=2 LACH_DROME reviewed Lachesin Drosophila melanogaster (Fruit fly) GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343; GO:0098552 cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991] neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; side of membrane [GO:0098552] protein homodimerization activity [GO:0042803] g21741.t1 Q8HW98 30.743 296 1.6e-31 128.0 sp|Q8HW98|IGLO5_MOUSE IgLON family member 5 OS=Mus musculus OX=10090 GN=Iglon5 PE=2 SV=2 g21741.t2 Q8HW98 30.743 296 2.21e-31 128.0 sp|Q8HW98|IGLO5_MOUSE IgLON family member 5 OS=Mus musculus OX=10090 GN=Iglon5 PE=2 SV=2 g21743.t1 D3ZQG6 23.887 494 1.05e-21 105.0 sp|D3ZQG6|TRIM2_RAT Tripartite motif-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Trim2 PE=1 SV=2 g21746.t1 Q13263 25.641 351 4.95e-21 103.0 sp|Q13263|TIF1B_HUMAN Transcription intermediary factor 1-beta OS=Homo sapiens OX=9606 GN=TRIM28 PE=1 SV=5 TIF1B_HUMAN reviewed Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28) Homo sapiens (Human) GO:0000122; GO:0000791; GO:0000792; GO:0001837; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006346; GO:0007566; GO:0008270; GO:0016925; GO:0019789; GO:0031625; GO:0032991; GO:0035851; GO:0042307; GO:0043161; GO:0044790; GO:0045087; GO:0045739; GO:0045869; GO:0045892; GO:0045893; GO:0060028; GO:0060669; GO:0061630; GO:0070087; GO:0071514; GO:0090575; GO:1990841 chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; genomic imprinting [GO:0071514]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein sumoylation [GO:0016925]; suppression of viral release by host [GO:0044790] euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g21750.t1 Q62962 31.111 450 2.8999999999999996e-68 229.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 g21751.t1 Q08431 41.29 155 2.0300000000000002e-21 94.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g21755.t1 Q6NV12 52.612 268 4.86e-89 291.0 sp|Q6NV12|S20AA_DANRE Sodium-dependent phosphate transporter 1-A OS=Danio rerio OX=7955 GN=slc20a1a PE=2 SV=1 g21755.t1 Q6NV12 59.77 174 6.22e-62 219.0 sp|Q6NV12|S20AA_DANRE Sodium-dependent phosphate transporter 1-A OS=Danio rerio OX=7955 GN=slc20a1a PE=2 SV=1 g21757.t1 Q7SY29 51.907 472 3.65e-166 483.0 sp|Q7SY29|G6PT3_DANRE Glucose-6-phosphate exchanger SLC37A2 OS=Danio rerio OX=7955 GN=slc37a2 PE=2 SV=1 g21757.t2 Q7SY29 51.907 472 1.99e-166 483.0 sp|Q7SY29|G6PT3_DANRE Glucose-6-phosphate exchanger SLC37A2 OS=Danio rerio OX=7955 GN=slc37a2 PE=2 SV=1 g21759.t1 Q8HW98 33.223 301 2.52e-36 142.0 sp|Q8HW98|IGLO5_MOUSE IgLON family member 5 OS=Mus musculus OX=10090 GN=Iglon5 PE=2 SV=2 g21759.t2 Q8HW98 33.223 301 2.84e-36 142.0 sp|Q8HW98|IGLO5_MOUSE IgLON family member 5 OS=Mus musculus OX=10090 GN=Iglon5 PE=2 SV=2 g21759.t3 Q8HW98 33.673 294 5.19e-38 146.0 sp|Q8HW98|IGLO5_MOUSE IgLON family member 5 OS=Mus musculus OX=10090 GN=Iglon5 PE=2 SV=2 g21759.t4 Q8HW98 33.223 301 2.4e-36 142.0 sp|Q8HW98|IGLO5_MOUSE IgLON family member 5 OS=Mus musculus OX=10090 GN=Iglon5 PE=2 SV=2 g21759.t5 Q8HW98 33.223 301 3.32e-36 142.0 sp|Q8HW98|IGLO5_MOUSE IgLON family member 5 OS=Mus musculus OX=10090 GN=Iglon5 PE=2 SV=2 g21761.t1 F7H9X2 24.752 505 1.17e-25 117.0 sp|F7H9X2|TRIM2_CALJA Tripartite motif-containing protein 2 OS=Callithrix jacchus OX=9483 GN=TRIM2 PE=3 SV=1 g21772.t1 Q9BRP0 56.757 111 1.05e-36 135.0 sp|Q9BRP0|OVOL2_HUMAN Transcription factor Ovo-like 2 OS=Homo sapiens OX=9606 GN=OVOL2 PE=1 SV=1 g21773.t1 G5EDU6 65.468 139 1.41e-55 197.0 sp|G5EDU6|OVOLH_CAEEL Transcription factor ovo-like homolog lin-48 OS=Caenorhabditis elegans OX=6239 GN=lin-48 PE=1 SV=1 OVOLH_CAEEL reviewed Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48) Caenorhabditis elegans GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007442; GO:0008270; GO:0009651; GO:0009887; GO:0009913; GO:0045138 animal organ morphogenesis [GO:0009887]; epidermal cell differentiation [GO:0009913]; hindgut morphogenesis [GO:0007442]; nematode male tail tip morphogenesis [GO:0045138]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to salt stress [GO:0009651] nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21773.t2 G5EDU6 66.929 127 2.16e-51 183.0 sp|G5EDU6|OVOLH_CAEEL Transcription factor ovo-like homolog lin-48 OS=Caenorhabditis elegans OX=6239 GN=lin-48 PE=1 SV=1 OVOLH_CAEEL reviewed Transcription factor ovo-like homolog lin-48 (Abnormal cell lineage protein 48) Caenorhabditis elegans GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007442; GO:0008270; GO:0009651; GO:0009887; GO:0009913; GO:0045138 animal organ morphogenesis [GO:0009887]; epidermal cell differentiation [GO:0009913]; hindgut morphogenesis [GO:0007442]; nematode male tail tip morphogenesis [GO:0045138]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to salt stress [GO:0009651] nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g21774.t1 Q6RFL5 48.905 137 9.82e-30 115.0 sp|Q6RFL5|BSH_CHICK Brain-specific homeobox protein homolog OS=Gallus gallus OX=9031 GN=BSX PE=2 SV=1 g21776.t1 P23098 27.033 1894 0.0 734.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g21776.t1 P23098 25.505 1584 3.89e-121 438.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g21776.t1 P23098 34.661 251 7.63e-38 162.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g21776.t2 P23098 26.98 1894 0.0 734.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g21776.t2 P23098 25.505 1584 4.81e-121 438.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g21776.t2 P23098 35.06 251 3.02e-38 164.0 sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1 g21777.t1 Q02576 95.946 74 2.1100000000000003e-37 127.0 sp|Q02576|HEN1_MOUSE Helix-loop-helix protein 1 OS=Mus musculus OX=10090 GN=Nhlh1 PE=2 SV=1 g21778.t1 Q9UGT4 29.075 681 1.28e-88 309.0 sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1 SUSD2_HUMAN reviewed Sushi domain-containing protein 2 Homo sapiens (Human) GO:0005615; GO:0005886; GO:0051782; GO:0070062; GO:1902807 negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] g21781.t1 Q9DBX3 28.655 684 1.68e-83 293.0 sp|Q9DBX3|SUSD2_MOUSE Sushi domain-containing protein 2 OS=Mus musculus OX=10090 GN=Susd2 PE=1 SV=1 g21782.t1 Q0KHY3 26.639 961 2.5e-78 286.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g21782.t2 Q0KHY3 26.598 970 1.91e-76 281.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g21783.t1 Q9DBX3 27.075 783 9.22e-65 240.0 sp|Q9DBX3|SUSD2_MOUSE Sushi domain-containing protein 2 OS=Mus musculus OX=10090 GN=Susd2 PE=1 SV=1 g21784.t1 A6QLU6 39.308 318 2.5e-56 214.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g21789.t1 Q923G2 80.795 151 2.86e-86 251.0 sp|Q923G2|RPAB3_MOUSE DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Mus musculus OX=10090 GN=Polr2h PE=1 SV=3 g21790.t1 B6LI37 41.29 155 3.19e-23 93.6 sp|B6LI37|HOATZ_BRAFL Cilia- and flagella-associated protein HOATZ OS=Branchiostoma floridae OX=7739 GN=HOATZ PE=3 SV=1 g21791.t1 Q9NS40 56.093 517 0.0 615.0 sp|Q9NS40|KCNH7_HUMAN Voltage-gated inwardly rectifying potassium channel KCNH7 OS=Homo sapiens OX=9606 GN=KCNH7 PE=1 SV=2 KCNH7_HUMAN reviewed Voltage-gated inwardly rectifying potassium channel KCNH7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Potassium voltage-gated channel subfamily H member 7) (Voltage-gated potassium channel subunit Kv11.3) Homo sapiens (Human) GO:0005242; GO:0005886; GO:0006813; GO:0020037; GO:0034702; GO:0042391; GO:0071805 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] heme binding [GO:0020037]; inward rectifier potassium channel activity [GO:0005242] g21793.t1 Q8BGG7 45.024 633 3.26e-180 529.0 sp|Q8BGG7|UBS3B_MOUSE Ubiquitin-associated and SH3 domain-containing protein B OS=Mus musculus OX=10090 GN=Ubash3b PE=1 SV=1 UBS3B_MOUSE reviewed Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2) Mus musculus (Mouse) GO:0004725; GO:0005634; GO:0005737; GO:0009968; GO:0030168; GO:0031625; GO:0038063; GO:0038065; GO:0042802; GO:0045670; GO:0045671; GO:0045779; GO:0051219; GO:0051279; GO:0070527; GO:0090331 collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of signal transduction [GO:0009968]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of release of sequestered calcium ion into cytosol [GO:0051279] cytoplasm [GO:0005737]; nucleus [GO:0005634] identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625] g21795.t1 Q16880 34.677 496 8.729999999999999e-91 292.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g21796.t1 Q16880 35.029 511 1.6799999999999999e-93 299.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g21805.t1 Q9CQT2 37.234 282 5.27e-38 138.0 sp|Q9CQT2|RBM7_MOUSE RNA-binding protein 7 OS=Mus musculus OX=10090 GN=Rbm7 PE=1 SV=1 RBM7_MOUSE reviewed RNA-binding protein 7 (RNA-binding motif protein 7) Mus musculus (Mouse) GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0016076; GO:0017069; GO:0051321; GO:0071889; GO:0097157 meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; snRNA catabolic process [GO:0016076] nucleoplasm [GO:0005654]; nucleus [GO:0005634] 14-3-3 protein binding [GO:0071889]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069] g21806.t1 Q96RW7 28.021 960 4.2800000000000004e-80 298.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 26.581 933 2.18e-75 283.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 27.047 965 1.19e-72 274.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 28.776 768 5.94e-69 262.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 27.965 919 2.89e-68 260.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 25.405 925 2.6999999999999998e-67 256.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 26.819 921 3.77e-66 253.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 26.646 972 5.75e-65 249.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 26.217 904 1.29e-63 244.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 25.48 989 6.78e-63 242.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 25.392 957 6.83e-63 242.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 25.227 991 1.21e-62 241.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 25.451 943 2.09e-60 234.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 25.135 923 3.8999999999999996e-60 233.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 24.872 973 1.05e-56 222.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t1 Q96RW7 27.193 570 5.49e-46 187.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 28.021 960 7.19e-80 298.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 26.581 933 3.4e-75 282.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 27.047 965 1.8700000000000002e-72 273.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 28.776 768 8.689999999999999e-69 261.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 27.965 919 4.64e-68 259.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 25.405 925 5.0099999999999995e-67 256.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 26.819 921 5.09e-66 253.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 26.646 972 1.04e-64 248.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 26.217 904 2e-63 244.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 25.392 957 9.5e-63 242.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 25.48 989 1.27e-62 241.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 25.227 991 1.84e-62 241.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 25.451 943 2.57e-60 234.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 24.919 927 4.9699999999999996e-60 233.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 24.872 973 1.49e-56 221.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21806.t2 Q96RW7 27.193 570 7.4e-46 186.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g21807.t1 E1BD59 28.383 303 1.0100000000000001e-27 118.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21808.t1 Q155Q3 39.887 707 1.7299999999999998e-146 448.0 sp|Q155Q3|DIXC1_HUMAN Dixin OS=Homo sapiens OX=9606 GN=DIXDC1 PE=1 SV=2 DIXC1_HUMAN reviewed Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0098794; GO:0098885; GO:0098978 canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507] cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; stress fiber [GO:0001725] actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904] g21811.t1 Q03164 63.422 339 1.57e-131 471.0 sp|Q03164|KMT2A_HUMAN Histone-lysine N-methyltransferase 2A OS=Homo sapiens OX=9606 GN=KMT2A PE=1 SV=5 KMT2A_HUMAN reviewed Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] Homo sapiens (Human) GO:0003680; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0008542; GO:0009791; GO:0009952; GO:0032259; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0045064; GO:0045322; GO:0045815; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0048172; GO:0048536; GO:0048873; GO:0051899; GO:0060216; GO:0065003; GO:0071339; GO:0071560; GO:0090310; GO:0106363; GO:0140945; GO:0140999 anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g21811.t1 Q03164 45.025 402 1.38e-100 369.0 sp|Q03164|KMT2A_HUMAN Histone-lysine N-methyltransferase 2A OS=Homo sapiens OX=9606 GN=KMT2A PE=1 SV=5 KMT2A_HUMAN reviewed Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] Homo sapiens (Human) GO:0003680; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0008542; GO:0009791; GO:0009952; GO:0032259; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0045064; GO:0045322; GO:0045815; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0048172; GO:0048536; GO:0048873; GO:0051899; GO:0060216; GO:0065003; GO:0071339; GO:0071560; GO:0090310; GO:0106363; GO:0140945; GO:0140999 anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g21811.t1 Q03164 51.961 102 4.7e-24 116.0 sp|Q03164|KMT2A_HUMAN Histone-lysine N-methyltransferase 2A OS=Homo sapiens OX=9606 GN=KMT2A PE=1 SV=5 KMT2A_HUMAN reviewed Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] Homo sapiens (Human) GO:0003680; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0008542; GO:0009791; GO:0009952; GO:0032259; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0045064; GO:0045322; GO:0045815; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0048172; GO:0048536; GO:0048873; GO:0051899; GO:0060216; GO:0065003; GO:0071339; GO:0071560; GO:0090310; GO:0106363; GO:0140945; GO:0140999 anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g21812.t1 P55200 64.286 84 1.63e-33 135.0 sp|P55200|KMT2A_MOUSE Histone-lysine N-methyltransferase 2A OS=Mus musculus OX=10090 GN=Kmt2a PE=1 SV=3 KMT2A_MOUSE reviewed Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] Mus musculus (Mouse) GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0008285; GO:0008542; GO:0009416; GO:0009791; GO:0009952; GO:0010468; GO:0010628; GO:0032259; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0040029; GO:0042800; GO:0042802; GO:0042803; GO:0045064; GO:0045322; GO:0045815; GO:0045893; GO:0045944; GO:0048172; GO:0048536; GO:0048873; GO:0050890; GO:0051899; GO:0060216; GO:0065003; GO:0071339; GO:0071560; GO:0090310; GO:0106363; GO:0140297; GO:0140945; GO:0140999 anterior/posterior pattern specification [GO:0009952]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; cognition [GO:0050890]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; epigenetic regulation of gene expression [GO:0040029]; exploration behavior [GO:0035640]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] g21816.t1 E1BD59 27.2 375 6.04e-36 147.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21818.t1 O00338 40.767 287 5.72e-71 226.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g21820.t1 O00338 40.418 287 6.74e-72 227.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g21821.t1 Q8JG30 39.925 268 6.37e-67 214.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g21823.t1 P63016 44.886 352 7.09e-87 273.0 sp|P63016|PAX6_RAT Paired box protein Pax-6 OS=Rattus norvegicus OX=10116 GN=Pax6 PE=2 SV=1 PAX6_RAT reviewed Paired box protein Pax-6 (Oculorhombin) Rattus norvegicus (Rat) GO:0000122; GO:0000132; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001227; GO:0001228; GO:0001568; GO:0001709; GO:0001755; GO:0001764; GO:0002052; GO:0002064; GO:0002088; GO:0003002; GO:0003309; GO:0003310; GO:0003322; GO:0003677; GO:0003680; GO:0003682; GO:0003690; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0007224; GO:0007399; GO:0007406; GO:0007409; GO:0007411; GO:0007420; GO:0007423; GO:0007435; GO:0007601; GO:0009611; GO:0009786; GO:0009950; GO:0009952; GO:0009953; GO:0010467; GO:0010468; GO:0010628; GO:0010975; GO:0019901; GO:0021510; GO:0021517; GO:0021520; GO:0021521; GO:0021543; GO:0021549; GO:0021593; GO:0021772; GO:0021778; GO:0021796; GO:0021798; GO:0021902; GO:0021905; GO:0021917; GO:0021953; GO:0021978; GO:0021983; GO:0021986; GO:0021987; GO:0022027; GO:0023019; GO:0030154; GO:0030182; GO:0030216; GO:0030334; GO:0030858; GO:0030900; GO:0030902; GO:0031490; GO:0031625; GO:0032808; GO:0032869; GO:0035035; GO:0042462; GO:0042593; GO:0042660; GO:0043010; GO:0043565; GO:0044344; GO:0045165; GO:0045471; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0048505; GO:0048596; GO:0048708; GO:0050680; GO:0050767; GO:0060041; GO:0061034; GO:0061072; GO:0061303; GO:0061351; GO:0070410; GO:0070412; GO:0071333; GO:0071380; GO:0071466; GO:0071837; GO:0098598; GO:0120008; GO:1901142; GO:1902895; GO:1904937; GO:1990830; GO:1990837; GO:2000178; GO:2001224 anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; central nervous system neuron differentiation [GO:0021953]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cerebral cortex regionalization [GO:0021796]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epithelial cell development [GO:0002064]; establishment of mitotic spindle orientation [GO:0000132]; eye photoreceptor cell development [GO:0042462]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; hindbrain development [GO:0030902]; insulin metabolic process [GO:1901142]; interkinetic nuclear migration [GO:0022027]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; learned vocalization behavior or vocal learning [GO:0098598]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; olfactory bulb mitral cell layer development [GO:0061034]; oligodendrocyte cell fate specification [GO:0021778]; pallium development [GO:0021543]; pancreatic A cell development [GO:0003322]; pancreatic A cell differentiation [GO:0003310]; pituitary gland development [GO:0021983]; positive regulation of cell fate specification [GO:0042660]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamatergic neuron differentiation [GO:0120008]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regionalization [GO:0003002]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of neuron projection development [GO:0010975]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; rhombomere morphogenesis [GO:0021593]; salivary gland morphogenesis [GO:0007435]; sensory neuron migration [GO:1904937]; sensory organ development [GO:0007423]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; somatic motor neuron fate commitment [GO:0021917]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; telencephalon regionalization [GO:0021978]; type B pancreatic cell differentiation [GO:0003309]; ventral spinal cord development [GO:0021517]; ventral spinal cord interneuron specification [GO:0021521]; visual perception [GO:0007601] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; HMG box domain binding [GO:0071837]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; ubiquitin protein ligase binding [GO:0031625] g21823.t2 P63016 45.17 352 5.82e-90 281.0 sp|P63016|PAX6_RAT Paired box protein Pax-6 OS=Rattus norvegicus OX=10116 GN=Pax6 PE=2 SV=1 PAX6_RAT reviewed Paired box protein Pax-6 (Oculorhombin) Rattus norvegicus (Rat) GO:0000122; GO:0000132; GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001227; GO:0001228; GO:0001568; GO:0001709; GO:0001755; GO:0001764; GO:0002052; GO:0002064; GO:0002088; GO:0003002; GO:0003309; GO:0003310; GO:0003322; GO:0003677; GO:0003680; GO:0003682; GO:0003690; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0007224; GO:0007399; GO:0007406; GO:0007409; GO:0007411; GO:0007420; GO:0007423; GO:0007435; GO:0007601; GO:0009611; GO:0009786; GO:0009950; GO:0009952; GO:0009953; GO:0010467; GO:0010468; GO:0010628; GO:0010975; GO:0019901; GO:0021510; GO:0021517; GO:0021520; GO:0021521; GO:0021543; GO:0021549; GO:0021593; GO:0021772; GO:0021778; GO:0021796; GO:0021798; GO:0021902; GO:0021905; GO:0021917; GO:0021953; GO:0021978; GO:0021983; GO:0021986; GO:0021987; GO:0022027; GO:0023019; GO:0030154; GO:0030182; GO:0030216; GO:0030334; GO:0030858; GO:0030900; GO:0030902; GO:0031490; GO:0031625; GO:0032808; GO:0032869; GO:0035035; GO:0042462; GO:0042593; GO:0042660; GO:0043010; GO:0043565; GO:0044344; GO:0045165; GO:0045471; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0048505; GO:0048596; GO:0048708; GO:0050680; GO:0050767; GO:0060041; GO:0061034; GO:0061072; GO:0061303; GO:0061351; GO:0070410; GO:0070412; GO:0071333; GO:0071380; GO:0071466; GO:0071837; GO:0098598; GO:0120008; GO:1901142; GO:1902895; GO:1904937; GO:1990830; GO:1990837; GO:2000178; GO:2001224 anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; central nervous system neuron differentiation [GO:0021953]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; cerebral cortex regionalization [GO:0021796]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; cornea development in camera-type eye [GO:0061303]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epithelial cell development [GO:0002064]; establishment of mitotic spindle orientation [GO:0000132]; eye photoreceptor cell development [GO:0042462]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain-midbrain boundary formation [GO:0021905]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; habenula development [GO:0021986]; hindbrain development [GO:0030902]; insulin metabolic process [GO:1901142]; interkinetic nuclear migration [GO:0022027]; iris morphogenesis [GO:0061072]; keratinocyte differentiation [GO:0030216]; lacrimal gland development [GO:0032808]; learned vocalization behavior or vocal learning [GO:0098598]; lens development in camera-type eye [GO:0002088]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; olfactory bulb mitral cell layer development [GO:0061034]; oligodendrocyte cell fate specification [GO:0021778]; pallium development [GO:0021543]; pancreatic A cell development [GO:0003322]; pancreatic A cell differentiation [GO:0003310]; pituitary gland development [GO:0021983]; positive regulation of cell fate specification [GO:0042660]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamatergic neuron differentiation [GO:0120008]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regionalization [GO:0003002]; regulation of asymmetric cell division [GO:0009786]; regulation of cell migration [GO:0030334]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of neuron projection development [GO:0010975]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; retina development in camera-type eye [GO:0060041]; rhombomere morphogenesis [GO:0021593]; salivary gland morphogenesis [GO:0007435]; sensory neuron migration [GO:1904937]; sensory organ development [GO:0007423]; signal transduction involved in regulation of gene expression [GO:0023019]; smoothened signaling pathway [GO:0007224]; somatic motor neuron fate commitment [GO:0021917]; spinal cord development [GO:0021510]; spinal cord motor neuron cell fate specification [GO:0021520]; telencephalon regionalization [GO:0021978]; type B pancreatic cell differentiation [GO:0003309]; ventral spinal cord development [GO:0021517]; ventral spinal cord interneuron specification [GO:0021521]; visual perception [GO:0007601] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; HMG box domain binding [GO:0071837]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; ubiquitin protein ligase binding [GO:0031625] g21830.t1 Q9VBW3 48.582 282 2.61e-85 298.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21832.t1 Q26614 41.848 184 2.3600000000000003e-37 141.0 sp|Q26614|FGFR_STRPU Fibroblast growth factor receptor OS=Strongylocentrotus purpuratus OX=7668 GN=FGFR PE=2 SV=1 FGFR_STRPU reviewed Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005007; GO:0005524; GO:0005886; GO:0008284; GO:0008543; GO:0017134; GO:0043235; GO:0043410 fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007] g21838.t1 Q6ZW76 49.85 333 1.21e-88 298.0 sp|Q6ZW76|ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ANKS3 PE=1 SV=1 ANKS3_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 3 Homo sapiens (Human) GO:0005737; GO:0005929 cilium [GO:0005929]; cytoplasm [GO:0005737] g21838.t1 Q6ZW76 50.829 181 8.289999999999999e-45 175.0 sp|Q6ZW76|ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ANKS3 PE=1 SV=1 ANKS3_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 3 Homo sapiens (Human) GO:0005737; GO:0005929 cilium [GO:0005929]; cytoplasm [GO:0005737] g21839.t1 A0A1L8EYB2 34.385 1300 0.0 629.0 sp|A0A1L8EYB2|DAAF8_XENLA Dynein axonemal assembly factor 8 OS=Xenopus laevis OX=8355 GN=dnaaf8 PE=1 SV=1 g21846.t1 P36425 43.871 155 9.41e-32 124.0 sp|P36425|SP17_RABIT Sperm surface protein Sp17 OS=Oryctolagus cuniculus OX=9986 GN=SPA17 PE=1 SV=2 g21847.t1 Q8VDD5 23.487 975 1.1500000000000001e-33 149.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t1 Q8VDD5 22.878 966 2.96e-26 125.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t1 Q8VDD5 21.528 1073 2.97e-24 118.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t2 Q8VDD5 23.487 975 1.1500000000000001e-33 149.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t2 Q8VDD5 22.878 966 2.97e-26 125.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t2 Q8VDD5 21.528 1073 2.98e-24 118.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t3 Q8VDD5 23.487 975 1.1500000000000001e-33 149.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t3 Q8VDD5 22.878 966 2.98e-26 125.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t3 Q8VDD5 21.528 1073 2.98e-24 118.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t4 Q8VDD5 23.487 975 1.1500000000000001e-33 149.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t4 Q8VDD5 22.878 966 2.98e-26 125.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t4 Q8VDD5 21.528 1073 2.98e-24 118.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t5 Q8VDD5 23.487 975 1.16e-33 149.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t5 Q8VDD5 22.878 966 2.99e-26 125.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t5 Q8VDD5 21.528 1073 3e-24 118.0 sp|Q8VDD5|MYH9_MOUSE Myosin-9 OS=Mus musculus OX=10090 GN=Myh9 PE=1 SV=4 MYH9_MOUSE reviewed Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) Mus musculus (Mouse) GO:0000146; GO:0000212; GO:0000902; GO:0001525; GO:0001618; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0001965; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005819; GO:0005826; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005912; GO:0005938; GO:0006509; GO:0006911; GO:0007155; GO:0007200; GO:0007520; GO:0008180; GO:0008360; GO:0009898; GO:0009986; GO:0015031; GO:0015629; GO:0016324; GO:0016328; GO:0016459; GO:0016460; GO:0016604; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030048; GO:0030154; GO:0030220; GO:0030224; GO:0030863; GO:0031032; GO:0031252; GO:0031594; GO:0031762; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032962; GO:0032982; GO:0032991; GO:0035774; GO:0042641; GO:0042699; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045335; GO:0045745; GO:0045807; GO:0046718; GO:0048870; GO:0050766; GO:0051015; GO:0051017; GO:0051295; GO:0051894; GO:0060327; GO:0060471; GO:0060473; GO:0070374; GO:0070650; GO:0097110; GO:0097513; GO:0098609; GO:0110053; GO:1903919; GO:1903923; GO:1904753; GO:1905684 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; follicle-stimulating hormone signaling pathway [GO:0042699]; in utero embryonic development [GO:0001701]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; phagocytosis, engulfment [GO:0006911]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; plasma membrane repair [GO:0001778]; platelet formation [GO:0030220]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of actin filament organization [GO:0110053]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; symbiont entry into host cell [GO:0046718]; uropod organization [GO:0032796] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cleavage furrow [GO:0032154]; COP9 signalosome [GO:0008180]; cortical cytoskeleton [GO:0030863]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; follicle-stimulating hormone receptor binding [GO:0031762]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495]; scaffold protein binding [GO:0097110]; virus receptor activity [GO:0001618] g21847.t6 P08799 22.901 1227 4.2200000000000005e-33 147.0 sp|P08799|MYS2_DICDI Myosin-2 heavy chain OS=Dictyostelium discoideum OX=44689 GN=mhcA PE=1 SV=3 MYS2_DICDI reviewed Myosin-2 heavy chain (Myosin II heavy chain) Dictyostelium discoideum (Social amoeba) GO:0000146; GO:0000281; GO:0001931; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005826; GO:0005829; GO:0005856; GO:0005938; GO:0006930; GO:0006935; GO:0006971; GO:0008104; GO:0008360; GO:0009612; GO:0016460; GO:0030038; GO:0030554; GO:0030837; GO:0030864; GO:0030866; GO:0030899; GO:0031012; GO:0031034; GO:0031143; GO:0031152; GO:0031154; GO:0031254; GO:0031270; GO:0031410; GO:0032009; GO:0032060; GO:0032154; GO:0032982; GO:0033275; GO:0033298; GO:0034461; GO:0042542; GO:0042641; GO:0042802; GO:0045179; GO:0046847; GO:0048870; GO:0050982; GO:0051015; GO:0051591; GO:0060328; GO:0071889; GO:0097204; GO:0140220; GO:1903013; GO:1990753 actin-myosin filament sliding [GO:0033275]; aggregation involved in sorocarp development [GO:0031152]; bleb assembly [GO:0032060]; cell motility [GO:0048870]; chemotaxis [GO:0006935]; contractile actin filament bundle assembly [GO:0030038]; contractile vacuole organization [GO:0033298]; cortical actin cytoskeleton organization [GO:0030866]; culmination involved in sorocarp development [GO:0031154]; cytoplasmic actin-based contraction involved in forward cell motility [GO:0060328]; detection of mechanical stimulus [GO:0050982]; filopodium assembly [GO:0046847]; hypotonic response [GO:0006971]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; myosin filament assembly [GO:0031034]; negative regulation of actin filament polymerization [GO:0030837]; pseudopodium retraction [GO:0031270]; regulation of cell shape [GO:0008360]; response to cAMP [GO:0051591]; response to differentiation-inducing factor 1 [GO:1903013]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; substrate-dependent cell migration, cell extension [GO:0006930]; uropod retraction [GO:0034461] actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell trailing edge [GO:0031254]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early phagosome [GO:0032009]; equatorial cell cortex [GO:1990753]; extracellular matrix [GO:0031012]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; pathogen-containing vacuole [GO:0140220]; phagocytic cup base [GO:0097204]; pseudopodium [GO:0031143]; uropod [GO:0001931] 14-3-3 protein binding [GO:0071889]; actin filament binding [GO:0051015]; adenyl nucleotide binding [GO:0030554]; ATP binding [GO:0005524]; calcium-dependent ATPase activity [GO:0030899]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146] g21848.t1 P49959 50.866 635 0.0 613.0 sp|P49959|MRE11_HUMAN Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11 PE=1 SV=3 MRE11_HUMAN reviewed Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A) Homo sapiens (Human) GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008283; GO:0008296; GO:0008408; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0032206; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0062176; GO:0070533; GO:0097552; GO:0098687; GO:0110025; GO:2000781; GO:2001033 cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; R-loop processing [GO:0062176]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860] BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; cadherin binding [GO:0045296]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] g21849.t1 O88923 23.913 644 1.04e-24 114.0 sp|O88923|AGRL2_RAT Adhesion G protein-coupled receptor L2 OS=Rattus norvegicus OX=10116 GN=Adgrl2 PE=1 SV=2 g21850.t1 P98086 35.808 229 6.319999999999999e-23 97.4 sp|P98086|C1QA_MOUSE Complement C1q subcomponent subunit A OS=Mus musculus OX=10090 GN=C1qa PE=1 SV=2 g21853.t1 P0C8L6 69.149 94 4.01e-45 144.0 sp|P0C8L6|PHS_HYPEX Probable pterin-4-alpha-carbinolamine dehydratase OS=Hypsibius exemplaris OX=2072580 GN=Pcd PE=3 SV=1 g21853.t2 P0C8L6 69.149 94 3.06e-45 144.0 sp|P0C8L6|PHS_HYPEX Probable pterin-4-alpha-carbinolamine dehydratase OS=Hypsibius exemplaris OX=2072580 GN=Pcd PE=3 SV=1 g21854.t1 D3YXG0 29.609 537 2.26e-51 199.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 27.21 577 6.57e-43 173.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 27.338 556 4.01e-42 171.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 27.178 574 6.799999999999999e-42 170.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 27.256 554 1.08e-41 169.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.071 560 2.29e-39 162.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.585 568 9.2e-39 160.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 27.395 595 1.6e-38 159.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.888 543 2.7100000000000004e-37 155.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 27.172 541 3.6700000000000002e-37 155.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.104 521 2.5e-36 152.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 25.783 543 1.44e-35 150.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 27.941 612 6.68e-35 148.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.344 558 1.3100000000000001e-33 144.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.415 530 4.08e-32 139.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.178 573 5.1600000000000005e-31 135.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 26.894 528 2.82e-29 130.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21854.t1 D3YXG0 24.082 490 3.660000000000001e-21 103.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g21855.t1 Q8T674 33.333 660 2.99e-115 366.0 sp|Q8T674|ABCGK_DICDI ABC transporter G family member 20 OS=Dictyostelium discoideum OX=44689 GN=abcG20 PE=3 SV=1 g21856.t1 P43141 30.312 320 9.12e-22 97.8 sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 g21857.t1 A2AV25 48.261 230 2.52e-58 197.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g21858.t1 A2AV25 47.391 230 2.95e-58 197.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g21860.t1 P16588 35.323 402 2.3800000000000003e-56 197.0 sp|P16588|PROA_VIBAL Alkaline serine exoprotease A OS=Vibrio alginolyticus OX=663 GN=proA PE=3 SV=1 g21861.t1 Q9UPV0 64.706 102 1.51e-38 161.0 sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3 CE164_HUMAN reviewed Centrosomal protein of 164 kDa (Cep164) Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0035869; GO:0051301; GO:0060271; GO:0097228; GO:0097539 cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228] g21861.t1 Q9UPV0 28.868 433 2.65e-32 141.0 sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3 CE164_HUMAN reviewed Centrosomal protein of 164 kDa (Cep164) Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0035869; GO:0051301; GO:0060271; GO:0097228; GO:0097539 cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228] g21861.t2 Q9UPV0 64.706 102 1.35e-38 162.0 sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3 CE164_HUMAN reviewed Centrosomal protein of 164 kDa (Cep164) Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0035869; GO:0051301; GO:0060271; GO:0097228; GO:0097539 cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228] g21861.t2 Q9UPV0 28.868 433 2.3800000000000002e-32 141.0 sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3 CE164_HUMAN reviewed Centrosomal protein of 164 kDa (Cep164) Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0035869; GO:0051301; GO:0060271; GO:0097228; GO:0097539 cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; sperm principal piece [GO:0097228] g21863.t1 Q63312 35.693 678 7.749999999999999e-91 310.0 sp|Q63312|PHLB1_RAT Pleckstrin homology-like domain family B member 1 (Fragment) OS=Rattus norvegicus OX=10116 GN=Phldb1 PE=1 SV=2 g21863.t2 Q63312 34.825 715 5.49e-92 315.0 sp|Q63312|PHLB1_RAT Pleckstrin homology-like domain family B member 1 (Fragment) OS=Rattus norvegicus OX=10116 GN=Phldb1 PE=1 SV=2 g21863.t3 Q63312 35.704 703 2.8799999999999997e-95 323.0 sp|Q63312|PHLB1_RAT Pleckstrin homology-like domain family B member 1 (Fragment) OS=Rattus norvegicus OX=10116 GN=Phldb1 PE=1 SV=2 g21864.t1 Q86UU1 42.735 234 4.05e-42 158.0 sp|Q86UU1|PHLB1_HUMAN Pleckstrin homology-like domain family B member 1 OS=Homo sapiens OX=9606 GN=PHLDB1 PE=1 SV=1 g21868.t1 A7MBP4 72.247 227 5.79e-119 350.0 sp|A7MBP4|IFT46_DANRE Intraflagellar transport protein 46 homolog OS=Danio rerio OX=7955 GN=ift46 PE=2 SV=2 IFT46_DANRE reviewed Intraflagellar transport protein 46 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005815; GO:0030992; GO:0031514; GO:0036064; GO:0042073; GO:0048264; GO:0048793; GO:0060041; GO:0060271 cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041] ciliary basal body [GO:0036064]; intraciliary transport particle B [GO:0030992]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514] g21868.t2 Q9NQC8 71.875 224 2.34e-117 345.0 sp|Q9NQC8|IFT46_HUMAN Intraflagellar transport protein 46 homolog OS=Homo sapiens OX=9606 GN=IFT46 PE=1 SV=1 g21872.t1 Q3KR37 35.052 679 2e-122 386.0 sp|Q3KR37|ASTRB_HUMAN Protein Aster-B OS=Homo sapiens OX=9606 GN=GRAMD1B PE=1 SV=1 ASTRB_HUMAN reviewed Protein Aster-B (GRAM domain-containing protein 1B) Homo sapiens (Human) GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0032366; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268 cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786] g21874.t1 Q5CZR5 31.455 213 2.1300000000000002e-27 111.0 sp|Q5CZR5|AEP1_DANRE Aerolysin-like protein OS=Danio rerio OX=7955 GN=aep1 PE=1 SV=1 AEP1_DANRE reviewed Aerolysin-like protein (Jacalin-type lectin domain-containing protein 5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005537; GO:0005886; GO:0042742; GO:0042802; GO:0046930; GO:0048030 defense response to bacterium [GO:0042742] plasma membrane [GO:0005886]; pore complex [GO:0046930] D-mannose binding [GO:0005537]; disaccharide binding [GO:0048030]; identical protein binding [GO:0042802] g21876.t1 Q5ZQU0 43.22 118 4.0600000000000004e-21 95.1 sp|Q5ZQU0|SNED1_RAT Sushi, nidogen and EGF-like domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Sned1 PE=2 SV=2 SNED1_RAT reviewed Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1) Rattus norvegicus (Rat) GO:0005112; GO:0005509; GO:0007160; GO:0031012 cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g21877.t1 O05527 39.016 305 1.09e-62 209.0 sp|O05527|PHB_DELAC Poly(3-hydroxybutyrate) depolymerase OS=Delftia acidovorans OX=80866 GN=phaZCac PE=1 SV=1 g21878.t1 Q6P825 48.137 322 6.43e-110 326.0 sp|Q6P825|TOM40_XENTR Mitochondrial import receptor subunit TOM40 homolog OS=Xenopus tropicalis OX=8364 GN=tomm40 PE=2 SV=1 g21879.t1 Q9VBW3 43.689 309 1.67e-94 309.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21882.t1 O00338 39.249 293 5.02e-69 220.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g21884.t1 P19217 40.686 204 1.25e-46 158.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g21885.t1 O00338 38.754 289 2.4100000000000002e-70 223.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g21886.t1 O00338 39.175 291 1.67e-70 224.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g21887.t1 O00338 42.424 198 8.73e-51 168.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g21889.t1 P19217 40.364 275 1.98e-67 216.0 sp|P19217|ST1E1_BOVIN Sulfotransferase 1E1 OS=Bos taurus OX=9913 GN=SULT1E1 PE=1 SV=1 ST1E1_BOVIN reviewed Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring) Bos taurus (Bovine) GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0008210; GO:0050294; GO:0051923 estrogen metabolic process [GO:0008210]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294] g21891.t1 B3EWZ5 40.123 162 6.85e-23 111.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t1 B3EWZ5 31.724 290 7.16e-21 105.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t2 B3EWZ5 40.0 165 1.8e-23 113.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t2 B3EWZ5 35.152 165 7.810000000000001e-22 108.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t2 B3EWZ5 39.877 163 3.04e-21 106.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t2 B3EWZ5 35.165 182 7.66e-21 104.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t2 B3EWZ5 36.207 174 8.26e-21 104.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t3 B3EWZ5 40.0 165 1.8299999999999997e-23 113.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t3 B3EWZ5 35.152 165 7.94e-22 108.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t3 B3EWZ5 39.877 163 3.0900000000000003e-21 106.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t3 B3EWZ5 35.165 182 7.530000000000001e-21 104.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21891.t3 B3EWZ5 36.207 174 8.26e-21 104.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21892.t1 Q9VBW3 46.584 322 3.08e-92 315.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g21894.t1 P35520 62.089 517 0.0 657.0 sp|P35520|CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens OX=9606 GN=CBS PE=1 SV=2 CBS_HUMAN reviewed Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase) Homo sapiens (Human) GO:0001958; GO:0001974; GO:0004122; GO:0005634; GO:0005737; GO:0005829; GO:0006535; GO:0006563; GO:0006565; GO:0006801; GO:0010749; GO:0019343; GO:0019344; GO:0019346; GO:0019448; GO:0019825; GO:0019899; GO:0020037; GO:0021587; GO:0030170; GO:0031625; GO:0042262; GO:0042802; GO:0042803; GO:0043066; GO:0043418; GO:0046328; GO:0046872; GO:0050421; GO:0050667; GO:0051593; GO:0060135; GO:0060351; GO:0070025; GO:0070026; GO:0070814; GO:0071456; GO:0072341; GO:0097746; GO:1904047 blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of JNK cascade [GO:0046328]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625] g21896.t1 Q8BGC3 27.467 375 5.24e-31 127.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g21897.t1 B3EWZ5 37.918 269 1.92e-33 144.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 35.274 292 6.600000000000001e-31 136.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 38.281 256 1.76e-30 135.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 34.286 280 2.14e-30 134.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 32.89 301 3.08e-28 127.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 34.944 269 1.14e-27 125.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 34.601 263 3.84e-27 124.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 34.815 270 6.0100000000000005e-27 123.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 32.107 299 1.41e-26 122.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 36.576 257 5.91e-26 120.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 34.766 256 4.21e-25 117.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 36.471 255 1.38e-24 115.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 41.714 175 3.37e-24 114.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 34.1 261 6.459999999999999e-24 113.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 31.395 258 1.6399999999999998e-23 112.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t1 B3EWZ5 29.897 291 3.22e-23 111.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 37.918 269 3.37e-33 145.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 35.274 292 1.3299999999999999e-30 136.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 38.281 256 2.8699999999999997e-30 135.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 34.286 280 3.1199999999999998e-30 135.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 32.89 301 3.88e-28 128.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 34.944 269 2.4100000000000003e-27 125.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 34.601 263 5.06e-27 124.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 34.815 270 9.430000000000001e-27 124.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 32.107 299 2.68e-26 122.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 36.576 257 9.54e-26 120.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 34.766 256 5.73e-25 117.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 36.471 255 2.2999999999999997e-24 115.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 41.714 175 5.42e-24 114.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 34.1 261 1.0499999999999999e-23 114.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 31.66 259 2.4199999999999998e-23 112.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t2 B3EWZ5 29.897 291 4.63e-23 111.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 37.918 269 3.2100000000000004e-33 145.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 35.274 292 1.32e-30 136.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 34.286 280 3.05e-30 135.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 38.281 256 3.1999999999999996e-30 135.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 32.89 301 4.57e-28 128.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 34.944 269 2.36e-27 125.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 34.601 263 4.660000000000001e-27 124.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 34.815 270 9.370000000000001e-27 124.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 32.441 299 3.5400000000000003e-26 122.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 36.576 257 9.65e-26 120.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 34.766 256 5.94e-25 117.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 36.471 255 2.4e-24 115.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 41.714 175 5.8599999999999996e-24 114.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 34.1 261 9.54e-24 114.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 31.395 258 2.4699999999999997e-23 112.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21897.t3 B3EWZ5 29.897 291 4.4899999999999997e-23 111.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g21900.t1 H2N0D4 53.529 510 0.0 542.0 sp|H2N0D4|AMY_ORYLA Alpha-amylase OS=Oryzias latipes OX=8090 PE=1 SV=1 AMY_ORYLA reviewed Alpha-amylase (EC 3.2.1.1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004556; GO:0005615; GO:0005975; GO:0046872 carbohydrate metabolic process [GO:0005975] extracellular space [GO:0005615] alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872] g21901.t1 O35075 65.068 292 1.38e-152 431.0 sp|O35075|VP26C_MOUSE Vacuolar protein sorting-associated protein 26C OS=Mus musculus OX=10090 GN=Vps26c PE=1 SV=1 g21902.t1 P56182 39.521 334 3.6e-71 245.0 sp|P56182|RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens OX=9606 GN=RRP1 PE=1 SV=1 RRP1_HUMAN reviewed Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0006364; GO:0030688 rRNA processing [GO:0006364] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688] RNA binding [GO:0003723] g21904.t1 P34082 25.502 498 4.09e-29 130.0 sp|P34082|FAS2_DROME Fasciclin-2 OS=Drosophila melanogaster OX=7227 GN=Fas2 PE=1 SV=1 g21905.t1 Q14146 24.107 1008 2.61e-50 200.0 sp|Q14146|URB2_HUMAN Unhealthy ribosome biogenesis protein 2 homolog OS=Homo sapiens OX=9606 GN=URB2 PE=1 SV=2 g21905.t1 Q14146 28.39 236 3.53e-21 105.0 sp|Q14146|URB2_HUMAN Unhealthy ribosome biogenesis protein 2 homolog OS=Homo sapiens OX=9606 GN=URB2 PE=1 SV=2 g21911.t1 Q5EB73 31.078 399 3.5999999999999995e-48 172.0 sp|Q5EB73|PGAP4_RAT GPI-N-acetylgalactosamine transferase PGAP4 OS=Rattus norvegicus OX=10116 GN=Pgap4 PE=2 SV=1 g21912.t1 Q5E9T8 46.336 423 8.699999999999999e-95 312.0 sp|Q5E9T8|KIME_BOVIN Mevalonate kinase OS=Bos taurus OX=9913 GN=MVK PE=2 SV=1 KIME_BOVIN reviewed Mevalonate kinase (MK) (EC 2.7.1.36) Bos taurus (Bovine) GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0019287; GO:0042802 cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287] cytosol [GO:0005829]; peroxisome [GO:0005777] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496] g21913.t1 P18887 37.285 582 2.89e-107 338.0 sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3 XRCC1_HUMAN reviewed DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) Homo sapiens (Human) GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599 base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572] g21913.t2 P18887 37.05 583 1.8899999999999999e-106 335.0 sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3 XRCC1_HUMAN reviewed DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) Homo sapiens (Human) GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599 base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572] g21914.t1 Q9ESZ0 62.857 70 2.55e-25 100.0 sp|Q9ESZ0|XRCC1_RAT DNA repair protein XRCC1 OS=Rattus norvegicus OX=10116 GN=Xrcc1 PE=1 SV=2 XRCC1_RAT reviewed DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) Rattus norvegicus (Rat) GO:0000012; GO:0000781; GO:0000785; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0006303; GO:0006974; GO:0009410; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572] g21917.t1 Q4R5B8 57.358 265 5.08e-111 327.0 sp|Q4R5B8|EIF3F_MACFA Eukaryotic translation initiation factor 3 subunit F OS=Macaca fascicularis OX=9541 GN=EIF3F PE=2 SV=1 EIF3F_MACFA reviewed Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001732; GO:0003743; GO:0004843; GO:0005852; GO:0006413; GO:0006508; GO:0008237; GO:0016282; GO:0031369; GO:0033290; GO:0071541 formation of cytoplasmic translation initiation complex [GO:0001732]; proteolysis [GO:0006508]; translational initiation [GO:0006413] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541] cysteine-type deubiquitinase activity [GO:0004843]; metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g21918.t1 A7RR34 42.021 188 6.909999999999999e-42 141.0 sp|A7RR34|FLTOP_NEMVE Protein Flattop homolog OS=Nematostella vectensis OX=45351 GN=v1g200856 PE=3 SV=1 g21919.t1 Q2YDD2 44.167 120 6.21e-25 101.0 sp|Q2YDD2|SMG9_BOVIN Nonsense-mediated mRNA decay factor SMG9 OS=Bos taurus OX=9913 GN=SMG9 PE=2 SV=1 g21923.t1 B5X165 37.037 405 2.57e-82 264.0 sp|B5X165|SMG9_SALSA Nonsense-mediated mRNA decay factor SMG9 OS=Salmo salar OX=8030 GN=smg9 PE=2 SV=1 g21925.t1 P54310 38.095 819 3.0499999999999998e-176 529.0 sp|P54310|LIPS_MOUSE Hormone-sensitive lipase OS=Mus musculus OX=10090 GN=Lipe PE=1 SV=2 LIPS_MOUSE reviewed Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH) Mus musculus (Mouse) GO:0004771; GO:0004806; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0016298; GO:0016788; GO:0017171; GO:0019433; GO:0019901; GO:0042134; GO:0042758; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0070417; GO:0120516 cellular response to cold [GO:0070417]; cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; long-chain fatty acid catabolic process [GO:0042758]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diacylglycerol lipase activity [GO:0120516]; hydrolase activity, acting on ester bonds [GO:0016788]; lipase activity [GO:0016298]; monoacylglycerol lipase activity [GO:0047372]; protein kinase binding [GO:0019901]; retinyl-palmitate esterase activity [GO:0050253]; rRNA primary transcript binding [GO:0042134]; serine hydrolase activity [GO:0017171]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806] g21926.t1 Q6GPD0 53.931 636 0.0 657.0 sp|Q6GPD0|RHG32_XENLA Rho GTPase-activating protein 32 OS=Xenopus laevis OX=8355 GN=arhgap32 PE=2 SV=1 RHG32_XENLA reviewed Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) Xenopus laevis (African clawed frog) GO:0001650; GO:0005096; GO:0005654; GO:0005794; GO:0005886; GO:0005938; GO:0007264; GO:0014069; GO:0015629; GO:1901981 small GTPase-mediated signal transduction [GO:0007264] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981] g21927.t1 Q9UKI9 48.58 352 1.69e-87 276.0 sp|Q9UKI9|PO2F3_HUMAN POU domain, class 2, transcription factor 3 OS=Homo sapiens OX=9606 GN=POU2F3 PE=1 SV=3 PO2F3_HUMAN reviewed POU domain, class 2, transcription factor 3 (Octamer-binding protein 11) (Oct-11) (Octamer-binding transcription factor 11) (OTF-11) (Transcription factor PLA-1) (Transcription factor Skn-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008544; GO:0016604; GO:0030216; GO:0042060; GO:0042802; GO:0043565; GO:0043922; GO:0045944; GO:1990837 epidermis development [GO:0008544]; host-mediated suppression of viral transcription [GO:0043922]; keratinocyte differentiation [GO:0030216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g21932.t1 Q9QX29 35.648 432 1.93e-58 220.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g21932.t1 Q9QX29 32.286 350 1.05e-49 193.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g21933.t1 Q9QX29 31.545 466 2.3999999999999998e-60 226.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g21934.t1 D3ZQG6 30.189 265 1.51e-28 117.0 sp|D3ZQG6|TRIM2_RAT Tripartite motif-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Trim2 PE=1 SV=2 g21936.t1 A8J4S9 52.133 211 1.24e-73 239.0 sp|A8J4S9|TREA_APIME Trehalase OS=Apis mellifera OX=7460 PE=1 SV=1 TREA_APIME reviewed Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase) Apis mellifera (Honeybee) GO:0004555; GO:0005993; GO:0016020 trehalose catabolic process [GO:0005993] membrane [GO:0016020] alpha,alpha-trehalase activity [GO:0004555] g21937.t1 O43280 49.462 279 5.89e-85 269.0 sp|O43280|TREA_HUMAN Trehalase OS=Homo sapiens OX=9606 GN=TREH PE=1 SV=2 g21938.t1 P83565 37.438 203 2.9e-28 107.0 sp|P83565|RM40_RAT Large ribosomal subunit protein mL40 OS=Rattus norvegicus OX=10116 GN=Mrpl40 PE=1 SV=2 g21939.t1 Q8NCU4 27.856 998 1.63e-76 273.0 sp|Q8NCU4|CC191_HUMAN Coiled-coil domain-containing protein 191 OS=Homo sapiens OX=9606 GN=CCDC191 PE=1 SV=1 g21939.t2 Q8NCU4 27.884 997 1.14e-76 273.0 sp|Q8NCU4|CC191_HUMAN Coiled-coil domain-containing protein 191 OS=Homo sapiens OX=9606 GN=CCDC191 PE=1 SV=1 g21944.t1 P53804 32.4 250 3.4e-33 145.0 sp|P53804|TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens OX=9606 GN=TTC3 PE=1 SV=2 TTC3_HUMAN reviewed E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0008270; GO:0061630; GO:0070936 protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g21944.t1 P53804 32.877 219 3.03e-22 109.0 sp|P53804|TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens OX=9606 GN=TTC3 PE=1 SV=2 TTC3_HUMAN reviewed E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0008270; GO:0061630; GO:0070936 protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g21945.t1 Q32LN4 49.728 551 3.3e-147 437.0 sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2 CFA45_BOVIN reviewed Cilia- and flagella-associated protein 45 Bos taurus (Bovine) GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112 cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] 9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126] AMP binding [GO:0016208] g21946.t1 Q9NYK5 45.395 304 1.88e-84 261.0 sp|Q9NYK5|RM39_HUMAN Large ribosomal subunit protein mL39 OS=Homo sapiens OX=9606 GN=MRPL39 PE=1 SV=3 RM39_HUMAN reviewed Large ribosomal subunit protein mL39 (39S ribosomal protein L39, mitochondrial) (L39mt) (MRP-L39) (39S ribosomal protein L5, mitochondrial) (L5mt) (MRP-L5) Homo sapiens (Human) GO:0000166; GO:0003723; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] nucleotide binding [GO:0000166]; RNA binding [GO:0003723] g21948.t1 F1NY98 38.898 1234 0.0 879.0 sp|F1NY98|DSCAM_CHICK Cell adhesion molecule DSCAM OS=Gallus gallus OX=9031 GN=DSCAM PE=1 SV=3 DSCAM_CHICK reviewed Cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule homolog) Gallus gallus (Chicken) GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030425; GO:0030426; GO:0035176; GO:0035249; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0060996; GO:0070593; GO:1990782; GO:1990890 axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; dendritic spine development [GO:0060996]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] dendrite [GO:0030425]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782] g21948.t1 F1NY98 25.042 1182 1.31e-58 226.0 sp|F1NY98|DSCAM_CHICK Cell adhesion molecule DSCAM OS=Gallus gallus OX=9031 GN=DSCAM PE=1 SV=3 DSCAM_CHICK reviewed Cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule homolog) Gallus gallus (Chicken) GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030425; GO:0030426; GO:0035176; GO:0035249; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0060996; GO:0070593; GO:1990782; GO:1990890 axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; dendritic spine development [GO:0060996]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] dendrite [GO:0030425]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782] g21949.t1 F1NY98 34.897 341 3.34e-56 216.0 sp|F1NY98|DSCAM_CHICK Cell adhesion molecule DSCAM OS=Gallus gallus OX=9031 GN=DSCAM PE=1 SV=3 DSCAM_CHICK reviewed Cell adhesion molecule DSCAM (Down syndrome cell adhesion molecule homolog) Gallus gallus (Chicken) GO:0005886; GO:0007156; GO:0007162; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0030425; GO:0030426; GO:0035176; GO:0035249; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0060996; GO:0070593; GO:1990782; GO:1990890 axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; dendritic spine development [GO:0060996]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] dendrite [GO:0030425]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782] g21950.t1 P22717 46.965 626 0.0 551.0 sp|P22717|GCYB2_RAT Guanylate cyclase soluble subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gucy1b2 PE=2 SV=1 GCYB2_RAT reviewed Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2) Rattus norvegicus (Rat) GO:0004383; GO:0005525; GO:0005829; GO:0008074; GO:0019934; GO:0020037; GO:0046872; GO:0070026; GO:0070482 cGMP-mediated signaling [GO:0019934]; response to oxygen levels [GO:0070482] cytosol [GO:0005829]; guanylate cyclase complex, soluble [GO:0008074] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026] g21951.t1 E1BD59 27.707 314 5.31e-30 129.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g21955.t1 Q90837 46.946 573 1.75e-153 451.0 sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1 g21955.t2 Q01414 90.286 175 1.28e-103 303.0 sp|Q01414|ERG_LYTVA Transcriptional regulator ERG homolog (Fragment) OS=Lytechinus variegatus OX=7654 GN=ERG PE=3 SV=1 g21955.t3 Q01414 90.286 175 8.32e-104 303.0 sp|Q01414|ERG_LYTVA Transcriptional regulator ERG homolog (Fragment) OS=Lytechinus variegatus OX=7654 GN=ERG PE=3 SV=1 g21955.t4 Q90837 43.382 272 3.13e-51 182.0 sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1 g21956.t1 P70490 34.831 178 7.4e-22 97.1 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g21957.t1 P15062 47.89 474 3.0800000000000004e-122 370.0 sp|P15062|ETS1B_CHICK Transforming protein p68/c-ets-1 OS=Gallus gallus OX=9031 GN=ETS1 PE=2 SV=1 g21958.t1 Q6INI7 68.03 269 1.55e-145 412.0 sp|Q6INI7|NIT2B_XENLA Omega-amidase NIT2-B OS=Xenopus laevis OX=8355 GN=nit2b PE=2 SV=1 g21959.t1 P14198 45.695 151 1.01e-32 129.0 sp|P14198|AAC4_DICDI AAC-rich mRNA clone AAC4 protein OS=Dictyostelium discoideum OX=44689 GN=AAC4 PE=2 SV=3 g21961.t1 P97499 34.0 200 9.030000000000001e-32 127.0 sp|P97499|TEP1_MOUSE Telomerase protein component 1 OS=Mus musculus OX=10090 GN=Tep1 PE=1 SV=1 TEP1_MOUSE reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Mus musculus (Mouse) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g21986.t1 Q9NYG2 36.071 280 2.32e-52 176.0 sp|Q9NYG2|ZDHC3_HUMAN Palmitoyltransferase ZDHHC3 OS=Homo sapiens OX=9606 GN=ZDHHC3 PE=1 SV=2 g21987.t1 Q4V8D1 32.389 494 8.48e-87 280.0 sp|Q4V8D1|CP2U1_RAT Cytochrome P450 2U1 OS=Rattus norvegicus OX=10116 GN=Cyp2u1 PE=1 SV=1 CP2U1_RAT reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Rattus norvegicus (Rat) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g21988.t1 P49013 36.585 410 8.32e-73 246.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g21988.t1 P49013 51.456 103 2.2799999999999998e-24 110.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g21989.t1 O01635 29.565 345 9.59e-38 157.0 sp|O01635|ASIC1_CAEEL Degenerin-like protein asic-1 OS=Caenorhabditis elegans OX=6239 GN=asic-1 PE=3 SV=2 g21990.t1 Q0P6D6 45.763 177 5.55e-31 131.0 sp|Q0P6D6|CCD15_HUMAN Coiled-coil domain-containing protein 15 OS=Homo sapiens OX=9606 GN=CCDC15 PE=1 SV=2 CCD15_HUMAN reviewed Coiled-coil domain-containing protein 15 Homo sapiens (Human) GO:0005813; GO:0005814; GO:0034451; GO:0060271; GO:1903724 cilium assembly [GO:0060271]; positive regulation of centriole elongation [GO:1903724] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813] g21990.t2 Q0P6D6 45.763 177 5.630000000000001e-31 131.0 sp|Q0P6D6|CCD15_HUMAN Coiled-coil domain-containing protein 15 OS=Homo sapiens OX=9606 GN=CCDC15 PE=1 SV=2 CCD15_HUMAN reviewed Coiled-coil domain-containing protein 15 Homo sapiens (Human) GO:0005813; GO:0005814; GO:0034451; GO:0060271; GO:1903724 cilium assembly [GO:0060271]; positive regulation of centriole elongation [GO:1903724] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813] g21992.t1 Q5U239 55.963 109 4.22e-36 131.0 sp|Q5U239|TM145_XENLA Transmembrane protein 145 OS=Xenopus laevis OX=8355 GN=tmem145 PE=2 SV=1 g21993.t1 Q8C4U2 45.13 308 2.22e-77 255.0 sp|Q8C4U2|TM145_MOUSE Transmembrane protein 145 OS=Mus musculus OX=10090 GN=Tmem145 PE=1 SV=1 g21994.t1 Q16549 54.133 617 0.0 655.0 sp|Q16549|PCSK7_HUMAN Proprotein convertase subtilisin/kexin type 7 OS=Homo sapiens OX=9606 GN=PCSK7 PE=1 SV=2 PCSK7_HUMAN reviewed Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) Homo sapiens (Human) GO:0000139; GO:0004252; GO:0005802; GO:0008233; GO:0016485; GO:0016486 peptide hormone processing [GO:0016486]; protein processing [GO:0016485] Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g21996.t1 O75899 32.615 742 8.55e-135 426.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g21997.t1 O75899 32.774 775 7.68e-136 429.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g21998.t1 Q4G059 42.908 282 2.6599999999999997e-62 206.0 sp|Q4G059|CDA7L_RAT Cell division cycle-associated 7-like protein OS=Rattus norvegicus OX=10116 GN=Cdca7l PE=1 SV=1 g22002.t1 Q7Z3Q1 25.74 338 3.06e-23 103.0 sp|Q7Z3Q1|S46A3_HUMAN Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 OS=Homo sapiens OX=9606 GN=SLC46A3 PE=1 SV=1 S46A3_HUMAN reviewed Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 (Solute carrier family 46 member 3) Homo sapiens (Human) GO:0005375; GO:0005765; GO:0015293; GO:0022857; GO:0034486; GO:0070062; GO:1904613 cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; vacuolar transmembrane transport [GO:0034486] extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765] copper ion transmembrane transporter activity [GO:0005375]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g22003.t1 Q6DCX5 27.617 449 3.71e-40 153.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g22004.t1 Q7ZWG6 26.281 449 2.67e-41 157.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g22005.t1 Q7ZZ00 39.241 237 5e-51 173.0 sp|Q7ZZ00|ZN511_DANRE Zinc finger protein 511 OS=Danio rerio OX=7955 GN=znf511 PE=2 SV=1 g22007.t1 Q90YQ4 68.707 147 9.37e-71 212.0 sp|Q90YQ4|RS19_ICTPU Small ribosomal subunit protein eS19 OS=Ictalurus punctatus OX=7998 GN=rps19 PE=2 SV=1 g22008.t1 O76536 32.997 991 1.12e-84 306.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22008.t1 O76536 31.619 1050 4.43e-79 290.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22008.t1 O76536 34.124 885 2.85e-76 281.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22008.t1 O76536 33.041 799 3.84e-59 227.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22009.t1 O76536 32.685 1080 3.05e-103 365.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22009.t1 O76536 30.687 1209 4.68e-98 349.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22009.t1 O76536 31.389 1166 1.61e-97 348.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22009.t1 O76536 31.049 1153 5.81e-96 343.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22009.t1 O76536 31.22 1230 1.3599999999999999e-90 327.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g22010.t1 Q9BRP7 29.685 667 3.01e-75 255.0 sp|Q9BRP7|FDXA1_HUMAN Ferredoxin-fold anticodon-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FDXACB1 PE=1 SV=3 g22011.t1 O60500 31.361 1014 1.1299999999999999e-137 454.0 sp|O60500|NPHN_HUMAN Nephrin OS=Homo sapiens OX=9606 GN=NPHS1 PE=1 SV=1 g22012.t1 Q8BR86 33.09 547 1.15e-79 275.0 sp|Q8BR86|KIRR3_MOUSE Kin of IRRE-like protein 3 OS=Mus musculus OX=10090 GN=Kirrel3 PE=1 SV=1 KIRR3_MOUSE reviewed Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) (mKirre) [Cleaved into: Processed kin of IRRE-like protein 3] Mus musculus (Mouse) GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0005911; GO:0007156; GO:0007416; GO:0008021; GO:0016020; GO:0021740; GO:0021766; GO:0030097; GO:0030165; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0050839; GO:0072102; GO:0098609 cell-cell adhesion [GO:0098609]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416] axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165] g22013.t1 P19356 53.561 351 1.8e-127 373.0 sp|P19356|HEM3_RAT Porphobilinogen deaminase OS=Rattus norvegicus OX=10116 GN=Hmbs PE=1 SV=2 HEM3_RAT reviewed Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase) Rattus norvegicus (Rat) GO:0000793; GO:0001666; GO:0001889; GO:0004418; GO:0004852; GO:0005737; GO:0005829; GO:0006778; GO:0006779; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009725; GO:0009743; GO:0010038; GO:0010043; GO:0010288; GO:0030424; GO:0031100; GO:0031406; GO:0031667; GO:0032025; GO:0032355; GO:0033014; GO:0033273; GO:0043176; GO:0043200; GO:0048471; GO:0048708; GO:0051597; GO:0071236; GO:0071243; GO:0071284; GO:0071345; GO:0071418; GO:0071549 animal organ regeneration [GO:0031100]; astrocyte differentiation [GO:0048708]; cellular response to amine stimulus [GO:0071418]; cellular response to antibiotic [GO:0071236]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cytokine stimulus [GO:0071345]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to lead ion [GO:0071284]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; liver development [GO:0001889]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to amino acid [GO:0043200]; response to carbohydrate [GO:0009743]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lead ion [GO:0010288]; response to metal ion [GO:0010038]; response to methylmercury [GO:0051597]; response to nutrient levels [GO:0031667]; response to vitamin [GO:0033273]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; tetrapyrrole biosynthetic process [GO:0033014] axon [GO:0030424]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] amine binding [GO:0043176]; carboxylic acid binding [GO:0031406]; hydroxymethylbilane synthase activity [GO:0004418]; uroporphyrinogen-III synthase activity [GO:0004852] g22014.t1 P53619 67.829 516 0.0 730.0 sp|P53619|COPD_BOVIN Coatomer subunit delta OS=Bos taurus OX=9913 GN=ARCN1 PE=1 SV=1 COPD_BOVIN reviewed Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP) Bos taurus (Bovine) GO:0000139; GO:0005783; GO:0006888; GO:0006890; GO:0006891; GO:0008344; GO:0015031; GO:0021691; GO:0030126; GO:0043473; GO:0051645 adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intra-Golgi vesicle-mediated transport [GO:0006891]; pigmentation [GO:0043473]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139] g22015.t1 Q9NRX2 46.711 152 8.930000000000001e-44 147.0 sp|Q9NRX2|RM17_HUMAN Large ribosomal subunit protein bL17m OS=Homo sapiens OX=9606 GN=MRPL17 PE=1 SV=1 RM17_HUMAN reviewed Large ribosomal subunit protein bL17m (39S ribosomal protein L17, mitochondrial) (L17mt) (MRP-L17) (LYST-interacting protein 2) Homo sapiens (Human) GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019904; GO:0032543 mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735] g22016.t1 Q56A55 58.295 645 0.0 738.0 sp|Q56A55|MITOS_DANRE Mitochondrial potassium channel ATP-binding subunit OS=Danio rerio OX=7955 GN=abcb8 PE=2 SV=2 MITOS_DANRE reviewed Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005739; GO:0005743; GO:0016020; GO:0016887; GO:0042626; GO:0055085; GO:0062157; GO:0071805; GO:0140359 potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626] g22019.t1 Q5EA65 62.469 405 9.94e-178 504.0 sp|Q5EA65|GPT_BOVIN UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase OS=Bos taurus OX=9913 GN=DPAGT1 PE=1 SV=1 GPT_BOVIN reviewed UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase) Bos taurus (Bovine) GO:0003975; GO:0005789; GO:0006487; GO:0006488; GO:0016020; GO:0016757; GO:0042802; GO:0046872 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975] g22022.t1 A0A1W2PQ73 63.889 144 4.01e-51 184.0 sp|A0A1W2PQ73|ERFL_HUMAN ETS domain-containing transcription factor ERF-like OS=Homo sapiens OX=9606 GN=ERFL PE=3 SV=1 g22022.t2 A0A1W2PQ73 63.889 144 5.76e-51 184.0 sp|A0A1W2PQ73|ERFL_HUMAN ETS domain-containing transcription factor ERF-like OS=Homo sapiens OX=9606 GN=ERFL PE=3 SV=1 g22024.t1 Q9JJA2 57.353 612 0.0 690.0 sp|Q9JJA2|COG8_MOUSE Conserved oligomeric Golgi complex subunit 8 OS=Mus musculus OX=10090 GN=Cog8 PE=1 SV=3 g22028.t1 Q6VTH5 63.861 202 4.66e-84 252.0 sp|Q6VTH5|RSPH1_CYPCA Radial spoke head 1 homolog OS=Cyprinus carpio OX=7962 GN=rsph1 PE=1 SV=1 g22031.t1 Q69D48 52.318 453 3.29e-157 458.0 sp|Q69D48|RHBGA_XENLA Ammonium transporter Rh type B-A OS=Xenopus laevis OX=8355 GN=rhbg-a PE=2 SV=1 g22032.t1 A5PKG6 43.123 1076 0.0 892.0 sp|A5PKG6|UBE4A_BOVIN Ubiquitin conjugation factor E4 A OS=Bos taurus OX=9913 GN=UBE4A PE=2 SV=1 g22034.t1 Q9R0W9 24.947 469 2.3999999999999997e-42 160.0 sp|Q9R0W9|ACHA6_MOUSE Neuronal acetylcholine receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Chrna6 PE=1 SV=2 ACHA6_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-6 Mus musculus (Mouse) GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0014059; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098878; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888] g22035.t1 Q15155 47.294 1201 0.0 1124.0 sp|Q15155|NOMO1_HUMAN BOS complex subunit NOMO1 OS=Homo sapiens OX=9606 GN=NOMO1 PE=1 SV=5 NOMO1_HUMAN reviewed BOS complex subunit NOMO1 (Nodal modulator 1) (pM5 protein) Homo sapiens (Human) GO:0005789; GO:0016020; GO:0030246; GO:0043022; GO:0160063; GO:0160064 multi-pass transmembrane protein insertion into ER membrane [GO:0160063] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; multi-pass translocon complex [GO:0160064] carbohydrate binding [GO:0030246]; ribosome binding [GO:0043022] g22036.t1 Q5RAX9 49.75 400 2.5399999999999997e-128 430.0 sp|Q5RAX9|PRD10_PONAB PR domain zinc finger protein 10 OS=Pongo abelii OX=9601 GN=PRDM10 PE=2 SV=1 PRD10_PONAB reviewed PR domain zinc finger protein 10 (PR domain-containing protein 10) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000785; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045893; GO:0045944 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270] g22036.t1 Q5RAX9 46.392 194 5.35e-46 185.0 sp|Q5RAX9|PRD10_PONAB PR domain zinc finger protein 10 OS=Pongo abelii OX=9601 GN=PRDM10 PE=2 SV=1 PRD10_PONAB reviewed PR domain zinc finger protein 10 (PR domain-containing protein 10) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000785; GO:0003677; GO:0003700; GO:0005634; GO:0008270; GO:0045893; GO:0045944 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270] g22038.t1 M9PH32 24.808 391 3.57e-28 124.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g22047.t1 E1BD59 24.119 369 1.0900000000000001e-29 128.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g22051.t1 Q9VBW3 44.586 314 1.53e-86 304.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22052.t1 Q9VBW3 48.0 300 2.37e-90 314.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22053.t1 Q9VBW3 47.667 300 8.34e-90 313.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22054.t1 Q9VBW3 47.667 300 1.2099999999999999e-92 313.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22055.t1 Q9VBW3 47.0 300 1.37e-91 310.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22057.t1 Q9VBW3 46.486 185 1.0999999999999999e-42 169.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22058.t1 Q9VBW3 44.681 94 1.8499999999999998e-23 97.1 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22062.t1 Q9VBW3 48.387 279 9.909999999999999e-95 300.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g22068.t1 Q24372 30.333 300 2.12e-28 116.0 sp|Q24372|LACH_DROME Lachesin OS=Drosophila melanogaster OX=7227 GN=Lac PE=1 SV=2 LACH_DROME reviewed Lachesin Drosophila melanogaster (Fruit fly) GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343; GO:0098552 cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991] neuron projection [GO:0043005]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; side of membrane [GO:0098552] protein homodimerization activity [GO:0042803] g22070.t1 Q6AZB0 34.951 309 8.85e-39 154.0 sp|Q6AZB0|BOC_MOUSE Brother of CDO OS=Mus musculus OX=10090 GN=Boc PE=1 SV=2 BOC_MOUSE reviewed Brother of CDO (Protein BOC) Mus musculus (Mouse) GO:0005886; GO:0007224; GO:0007399; GO:0007411; GO:0009986; GO:0016202; GO:0030030; GO:0030424; GO:0030426; GO:0043025; GO:0044295; GO:0045663; GO:0098609 axon guidance [GO:0007411]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; regulation of striated muscle tissue development [GO:0016202]; smoothened signaling pathway [GO:0007224] axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] g22070.t2 Q6AZB0 29.485 563 1.42e-41 163.0 sp|Q6AZB0|BOC_MOUSE Brother of CDO OS=Mus musculus OX=10090 GN=Boc PE=1 SV=2 BOC_MOUSE reviewed Brother of CDO (Protein BOC) Mus musculus (Mouse) GO:0005886; GO:0007224; GO:0007399; GO:0007411; GO:0009986; GO:0016202; GO:0030030; GO:0030424; GO:0030426; GO:0043025; GO:0044295; GO:0045663; GO:0098609 axon guidance [GO:0007411]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; regulation of striated muscle tissue development [GO:0016202]; smoothened signaling pathway [GO:0007224] axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] g22072.t1 Q6ZQX7 32.039 206 8.51e-39 151.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 34.0 200 2.09e-38 150.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 32.524 206 3.08e-38 149.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 32.039 206 6.27e-38 149.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 32.195 205 1.93e-37 147.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 32.039 206 2.2100000000000002e-37 147.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 32.308 195 5.01e-37 146.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 31.553 206 4.7400000000000004e-36 143.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 31.553 206 8.050000000000001e-36 142.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 31.019 216 1.51e-33 136.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22072.t1 Q6ZQX7 32.609 184 7.38e-32 131.0 sp|Q6ZQX7|LIAT1_HUMAN Protein LIAT1 OS=Homo sapiens OX=9606 GN=LIAT1 PE=1 SV=2 LIAT1_HUMAN reviewed Protein LIAT1 (Ligand of ATE1 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0016598; GO:0140693; GO:0140694 membraneless organelle assembly [GO:0140694]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleolus [GO:0005730] molecular condensate scaffold activity [GO:0140693] g22073.t1 Q91WD5 74.447 497 0.0 758.0 sp|Q91WD5|NDUS2_MOUSE NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial OS=Mus musculus OX=10090 GN=Ndufs2 PE=1 SV=1 NDUS2_MOUSE reviewed NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit) Mus musculus (Mouse) GO:0003954; GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0019826; GO:0022008; GO:0031625; GO:0032981; GO:0042063; GO:0042775; GO:0042776; GO:0045271; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0061351; GO:0071453 aerobic respiration [GO:0009060]; cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; oxygen sensor activity [GO:0019826]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625] g22073.t2 Q91WD5 68.691 527 0.0 716.0 sp|Q91WD5|NDUS2_MOUSE NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial OS=Mus musculus OX=10090 GN=Ndufs2 PE=1 SV=1 NDUS2_MOUSE reviewed NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit) Mus musculus (Mouse) GO:0003954; GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0019826; GO:0022008; GO:0031625; GO:0032981; GO:0042063; GO:0042775; GO:0042776; GO:0045271; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0061351; GO:0071453 aerobic respiration [GO:0009060]; cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; oxygen sensor activity [GO:0019826]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625] g22074.t1 Q2TBW5 29.374 463 6.589999999999999e-48 172.0 sp|Q2TBW5|ZNHI2_BOVIN Zinc finger HIT domain-containing protein 2 OS=Bos taurus OX=9913 GN=ZNHIT2 PE=2 SV=1 g22077.t1 P49841 73.684 418 0.0 627.0 sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2 GSK3B_HUMAN reviewed Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) Homo sapiens (Human) GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0003170; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007005; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0019082; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030154; GO:0030336; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031398; GO:0031625; GO:0032007; GO:0032092; GO:0032436; GO:0032481; GO:0032886; GO:0034236; GO:0034452; GO:0034976; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043161; GO:0043525; GO:0045597; GO:0045668; GO:0045719; GO:0045724; GO:0045732; GO:0046777; GO:0046825; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060070; GO:0060079; GO:0061629; GO:0070507; GO:0070885; GO:0071109; GO:0071300; GO:0090090; GO:0097110; GO:0097191; GO:0097192; GO:0098793; GO:0098794; GO:0098978; GO:0099171; GO:0106027; GO:0106310; GO:0150101; GO:0160213; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1902042; GO:1903566; GO:1903940; GO:1904339; GO:1904646; GO:1904781; GO:1990909; GO:2000077; GO:2000466; GO:2000740 beta-arrestin-dependent dopamine receptor signaling pathway [GO:0160213]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of type I interferon production [GO:0032481]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; response to endoplasmic reticulum stress [GO:0034976]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909] ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625] g22078.t1 Q6AXT0 33.773 379 3.9200000000000004e-64 215.0 sp|Q6AXT0|RM37_RAT Large ribosomal subunit protein mL37 OS=Rattus norvegicus OX=10116 GN=Mrpl37 PE=2 SV=1 g22079.t1 Q5R9Y1 41.199 267 3.86e-65 213.0 sp|Q5R9Y1|FSTL1_PONAB Follistatin-related protein 1 OS=Pongo abelii OX=9601 GN=FSTL1 PE=2 SV=2 g22085.t1 Q17QR8 30.986 284 9.34e-36 135.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g17083.t1 P00920 48.289 263 6.17e-79 242.0 sp|P00920|CAH2_MOUSE Carbonic anhydrase 2 OS=Mus musculus OX=10090 GN=Ca2 PE=1 SV=4 CAH2_MOUSE reviewed Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69) Mus musculus (Mouse) GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0018820; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0044849; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:1904404; GO:2001150; GO:2001225 angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; estrous cycle [GO:0044849]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to formaldehyde [GO:1904404]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903] apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886] arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270] g17083.t2 P00920 47.909 263 6.909999999999999e-76 234.0 sp|P00920|CAH2_MOUSE Carbonic anhydrase 2 OS=Mus musculus OX=10090 GN=Ca2 PE=1 SV=4 CAH2_MOUSE reviewed Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69) Mus musculus (Mouse) GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006885; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0018820; GO:0030424; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0044849; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0071498; GO:1904404; GO:2001150; GO:2001225 angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; estrous cycle [GO:0044849]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to formaldehyde [GO:1904404]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903] apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886] arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270] g17084.t1 Q5R9K8 59.589 146 2.59e-55 176.0 sp|Q5R9K8|AR2BP_PONAB ADP-ribosylation factor-like protein 2-binding protein OS=Pongo abelii OX=9601 GN=ARL2BP PE=2 SV=1 AR2BP_PONAB reviewed ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003713; GO:0005654; GO:0005758; GO:0005813; GO:0005819; GO:0005829; GO:0030496; GO:0036064; GO:0042531; GO:0051457 maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrial intermembrane space [GO:0005758]; nucleoplasm [GO:0005654]; spindle [GO:0005819] transcription coactivator activity [GO:0003713] g17085.t1 Q7ZU29 54.897 827 0.0 931.0 sp|Q7ZU29|NUP93_DANRE Nuclear pore complex protein Nup93 OS=Danio rerio OX=7955 GN=dye PE=2 SV=1 g17086.t1 Q8NCN5 46.324 857 0.0 771.0 sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2 g17087.t1 Q9UBT2 56.765 680 0.0 743.0 sp|Q9UBT2|SAE2_HUMAN SUMO-activating enzyme subunit 2 OS=Homo sapiens OX=9606 GN=UBA2 PE=1 SV=2 SAE2_HUMAN reviewed SUMO-activating enzyme subunit 2 (EC 2.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0033235; GO:0044388; GO:0044390; GO:0046982 positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] g17088.t1 Q7ZV00 50.0 292 6.42e-93 280.0 sp|Q7ZV00|OTU6B_DANRE Deubiquitinase OTUD6B OS=Danio rerio OX=7955 GN=otud6b PE=2 SV=1 g17088.t2 Q7ZV00 45.768 319 2.75e-87 267.0 sp|Q7ZV00|OTU6B_DANRE Deubiquitinase OTUD6B OS=Danio rerio OX=7955 GN=otud6b PE=2 SV=1 g17089.t1 Q5NVK5 49.47 566 0.0 535.0 sp|Q5NVK5|PGTA_PONAB Geranylgeranyl transferase type-2 subunit alpha OS=Pongo abelii OX=9601 GN=RABGGTA PE=2 SV=1 g17090.t1 Q587J7 33.88 732 3.26e-112 391.0 sp|Q587J7|TDR12_HUMAN Putative ATP-dependent RNA helicase TDRD12 OS=Homo sapiens OX=9606 GN=TDRD12 PE=1 SV=2 TDR12_HUMAN reviewed Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12) Homo sapiens (Human) GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923 fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] PET complex [GO:1990923] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] g17090.t2 Q587J7 33.88 732 3.89e-112 391.0 sp|Q587J7|TDR12_HUMAN Putative ATP-dependent RNA helicase TDRD12 OS=Homo sapiens OX=9606 GN=TDRD12 PE=1 SV=2 TDR12_HUMAN reviewed Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12) Homo sapiens (Human) GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923 fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] PET complex [GO:1990923] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] g17092.t1 Q3U145 44.279 201 4.8799999999999997e-45 162.0 sp|Q3U145|TMM64_MOUSE Transmembrane protein 64 OS=Mus musculus OX=10090 GN=Tmem64 PE=1 SV=1 TMM64_MOUSE reviewed Transmembrane protein 64 Mus musculus (Mouse) GO:0005783; GO:0016020; GO:0045600; GO:0045668; GO:0045672; GO:0045780; GO:0051480; GO:0090090 negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of bone resorption [GO:0045780]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] g17093.t1 Q0VCC1 60.09 223 1.24e-96 286.0 sp|Q0VCC1|S66A2_BOVIN Solute carrier family 66 member 2 OS=Bos taurus OX=9913 GN=SLC66A2 PE=2 SV=1 g17093.t2 Q5M880 50.923 271 4.75e-96 287.0 sp|Q5M880|S66A2_RAT Solute carrier family 66 member 2 OS=Rattus norvegicus OX=10116 GN=Slc66a2 PE=1 SV=2 g17094.t1 Q5XKA2 43.913 230 1.33e-58 188.0 sp|Q5XKA2|TIM21_XENLA Mitochondrial import inner membrane translocase subunit Tim21 OS=Xenopus laevis OX=8355 GN=timm21 PE=2 SV=1 g17095.t1 F7B645 41.358 324 3.28e-93 283.0 sp|F7B645|TM231_XENTR Transmembrane protein 231 OS=Xenopus tropicalis OX=8364 GN=tmem231 PE=2 SV=1 g17096.t1 P60522 72.414 116 1.05e-60 184.0 sp|P60522|GBRL2_RAT Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Rattus norvegicus OX=10116 GN=Gabarapl2 PE=3 SV=1 g17097.t1 P18426 39.048 210 2.8300000000000003e-47 157.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g17098.t1 Q9QXF7 38.294 504 2.6e-114 350.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g17099.t1 A0A481NSZ4 31.602 462 3.14e-79 258.0 sp|A0A481NSZ4|BPI_SEBSC Bactericidal permeability-increasing protein OS=Sebastes schlegelii OX=214486 GN=BPI PE=1 SV=1 BPI_SEBSC reviewed Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP) Sebastes schlegelii (Korean rockfish) GO:0005615; GO:0008289; GO:0042742; GO:0045087 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular space [GO:0005615] lipid binding [GO:0008289] g17100.t1 A0A481NSZ4 31.197 468 2.7800000000000003e-72 239.0 sp|A0A481NSZ4|BPI_SEBSC Bactericidal permeability-increasing protein OS=Sebastes schlegelii OX=214486 GN=BPI PE=1 SV=1 BPI_SEBSC reviewed Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP) Sebastes schlegelii (Korean rockfish) GO:0005615; GO:0008289; GO:0042742; GO:0045087 defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular space [GO:0005615] lipid binding [GO:0008289] g17101.t1 Q7XJJ7 37.847 613 9.13e-109 342.0 sp|Q7XJJ7|FAAH_ARATH Fatty acid amide hydrolase OS=Arabidopsis thaliana OX=3702 GN=FAAH PE=1 SV=1 FAAH_ARATH reviewed Fatty acid amide hydrolase (AtFAAH) (EC 3.5.1.99) (N-acylethanolamine amidohydrolase) Arabidopsis thaliana (Mouse-ear cress) GO:0000325; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0009536; GO:0016020; GO:0016042; GO:0017064; GO:0042742; GO:0047412; GO:0070291 defense response to bacterium [GO:0042742]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plant-type vacuole [GO:0000325]; plasma membrane [GO:0005886]; plastid [GO:0009536] fatty acid amide hydrolase activity [GO:0017064]; N-(long-chain-acyl)ethanolamine deacylase activity [GO:0047412] g17102.t1 Q75QI0 41.935 310 3.34e-48 166.0 sp|Q75QI0|CFDP1_CHICK Craniofacial development protein 1 OS=Gallus gallus OX=9031 GN=CFDP1 PE=2 SV=1 g17104.t1 Q9R049 43.668 687 2.36e-164 492.0 sp|Q9R049|AMFR_MOUSE E3 ubiquitin-protein ligase AMFR OS=Mus musculus OX=10090 GN=Amfr PE=1 SV=2 AMFR_MOUSE reviewed E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING-type E3 ubiquitin transferase AMFR) Mus musculus (Mouse) GO:0000151; GO:0000166; GO:0000209; GO:0004842; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006511; GO:0007249; GO:0007611; GO:0008270; GO:0016055; GO:0030425; GO:0030426; GO:0030674; GO:0030968; GO:0032991; GO:0034450; GO:0036503; GO:0036513; GO:0038023; GO:0038061; GO:0042802; GO:0043025; GO:0043130; GO:0044314; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1990381; GO:2000638 canonical NF-kappaB signal transduction [GO:0007249]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical NF-kappaB signal transduction [GO:0038061]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of SREBP signaling pathway [GO:2000638]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein-folding chaperone binding [GO:0051087]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g17104.t2 Q9R049 43.977 689 7.13e-165 493.0 sp|Q9R049|AMFR_MOUSE E3 ubiquitin-protein ligase AMFR OS=Mus musculus OX=10090 GN=Amfr PE=1 SV=2 AMFR_MOUSE reviewed E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING-type E3 ubiquitin transferase AMFR) Mus musculus (Mouse) GO:0000151; GO:0000166; GO:0000209; GO:0004842; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006511; GO:0007249; GO:0007611; GO:0008270; GO:0016055; GO:0030425; GO:0030426; GO:0030674; GO:0030968; GO:0032991; GO:0034450; GO:0036503; GO:0036513; GO:0038023; GO:0038061; GO:0042802; GO:0043025; GO:0043130; GO:0044314; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1990381; GO:2000638 canonical NF-kappaB signal transduction [GO:0007249]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical NF-kappaB signal transduction [GO:0038061]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of SREBP signaling pathway [GO:2000638]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein-folding chaperone binding [GO:0051087]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g17105.t1 Q9UL36 42.82 1901 0.0 1364.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g17105.t1 Q9UL36 32.281 285 7.57e-30 134.0 sp|Q9UL36|ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens OX=9606 GN=ZNF236 PE=1 SV=2 g17107.t1 P14555 41.803 122 3.3400000000000003e-22 88.6 sp|P14555|PA2GA_HUMAN Phospholipase A2, membrane associated OS=Homo sapiens OX=9606 GN=PLA2G2A PE=1 SV=2 PA2GA_HUMAN reviewed Phospholipase A2, membrane associated (EC 3.1.1.4) (GIIC sPLA2) (Group IIA phospholipase A2) (Non-pancreatic secretory phospholipase A2) (NPS-PLA2) (Phosphatidylcholine 2-acylhydrolase 2A) Homo sapiens (Human) GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0006644; GO:0006954; GO:0010744; GO:0016042; GO:0030141; GO:0031640; GO:0034374; GO:0036335; GO:0038166; GO:0042130; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0047498; GO:0048471; GO:0050482; GO:0050729; GO:0050830; GO:0070062; GO:0070374; GO:1902563 angiotensin-activated signaling pathway [GO:0038166]; arachidonate secretion [GO:0050482]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; intestinal stem cell homeostasis [GO:0036335]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of T cell proliferation [GO:0042130]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid metabolic process [GO:0006644]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; regulation of neutrophil activation [GO:1902563] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543] g17108.t1 Q3C2C2 38.788 165 4.4199999999999994e-23 92.4 sp|Q3C2C2|PA21_ACAPL Phospholipase A2 AP-PLA2-I OS=Acanthaster planci OX=133434 PE=1 SV=1 PA21_ACAPL reviewed Phospholipase A2 AP-PLA2-I (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) Acanthaster planci (Crown-of-thorns starfish) GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0031640; GO:0047498; GO:0050482; GO:0090729 arachidonate secretion [GO:0050482]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729] g17109.t1 Q99M85 80.986 142 1.61e-83 259.0 sp|Q99M85|SCRT1_MOUSE Transcriptional repressor scratch 1 OS=Mus musculus OX=10090 GN=Scrt1 PE=1 SV=1 SCRT1_MOUSE reviewed Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (mScrt) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043565; GO:1990837; GO:2001222 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron migration [GO:2001222] nuclear body [GO:0016604]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g17111.t1 P05689 69.708 274 3.24e-138 397.0 sp|P05689|CATZ_BOVIN Cathepsin Z OS=Bos taurus OX=9913 GN=CTSZ PE=2 SV=2 g17114.t1 A4VCH0 56.369 369 3.6399999999999996e-136 403.0 sp|A4VCH0|SAC1A_DANRE Phosphatidylinositol-3-phosphatase SAC1-A OS=Danio rerio OX=7955 GN=sacm1la PE=2 SV=2 SAC1A_DANRE reviewed Phosphatidylinositol-3-phosphatase SAC1-A (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0016791; GO:0043812; GO:0046856; GO:0140268 phosphatidylinositol dephosphorylation [GO:0046856] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi membrane [GO:0000139] phosphatase activity [GO:0016791]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812] g17115.t1 A1L244 54.359 195 2.24e-72 232.0 sp|A1L244|SAC1B_DANRE Phosphatidylinositol-3-phosphatase SAC1-B OS=Danio rerio OX=7955 GN=sacm1lb PE=2 SV=1 SAC1B_DANRE reviewed Phosphatidylinositol-3-phosphatase SAC1-B (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0016791; GO:0043812; GO:0046856; GO:0140268 phosphatidylinositol dephosphorylation [GO:0046856] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi membrane [GO:0000139] phosphatase activity [GO:0016791]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812] g17116.t1 Q92766 43.478 345 3.33e-69 262.0 sp|Q92766|RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens OX=9606 GN=RREB1 PE=1 SV=3 g17116.t1 Q92766 39.45 218 2.94e-46 187.0 sp|Q92766|RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens OX=9606 GN=RREB1 PE=1 SV=3 g17118.t1 P10076 31.469 286 4.39e-28 123.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g17118.t1 P10076 27.797 295 5.4499999999999996e-24 110.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g17118.t1 P10076 27.365 296 3.67e-22 104.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g17118.t1 P10076 27.532 316 8.430000000000001e-21 100.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g17119.t1 Q96GQ7 55.409 758 0.0 745.0 sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=3 g17120.t1 Q8TB96 40.299 603 3.1599999999999998e-142 429.0 sp|Q8TB96|TIP_HUMAN T-cell immunomodulatory protein OS=Homo sapiens OX=9606 GN=ITFG1 PE=1 SV=1 g17121.t1 Q9BYN7 30.847 295 1.73e-35 149.0 sp|Q9BYN7|ZN341_HUMAN Zinc finger protein 341 OS=Homo sapiens OX=9606 GN=ZNF341 PE=1 SV=2 ZN341_HUMAN reviewed Zinc finger protein 341 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0008270 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g17122.t1 Q502P7 37.9 438 2.17e-77 253.0 sp|Q502P7|BANP_DANRE Protein BANP OS=Danio rerio OX=7955 GN=banp PE=2 SV=1 g17122.t2 Q0VCW3 36.203 453 1.73e-78 255.0 sp|Q0VCW3|BANP_BOVIN Protein BANP OS=Bos taurus OX=9913 GN=BANP PE=2 SV=1 BANP_BOVIN reviewed Protein BANP Bos taurus (Bovine) GO:0003677; GO:0003723; GO:0005737; GO:0006325; GO:0016607 chromatin organization [GO:0006325] cytoplasm [GO:0005737]; nuclear speck [GO:0016607] DNA binding [GO:0003677]; RNA binding [GO:0003723] g17127.t1 P10076 37.195 164 1.58e-22 105.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g17128.t1 Q9VM35 29.293 198 8.880000000000001e-21 94.4 sp|Q9VM35|U2QL1_DROME Ubiquitin-conjugating enzyme E2Q-like protein CG4502 OS=Drosophila melanogaster OX=7227 GN=CG4502 PE=2 SV=1 g17129.t1 B2RYN2 36.111 432 2.5e-84 269.0 sp|B2RYN2|FBX31_RAT F-box only protein 31 OS=Rattus norvegicus OX=10116 GN=Fbxo31 PE=1 SV=1 FBX31_RAT reviewed F-box only protein 31 Rattus norvegicus (Rat) GO:0005737; GO:0005813; GO:0006974; GO:0016567; GO:0019005; GO:0030330; GO:0030332; GO:0031145; GO:0031146; GO:0031571; GO:0034599; GO:0038066; GO:0042770; GO:0043025; GO:0043161; GO:0046872; GO:0050775; GO:1901797; GO:1990756; GO:2001224 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to oxidative stress [GO:0034599]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; p38MAPK cascade [GO:0038066]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron migration [GO:2001224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction in response to DNA damage [GO:0042770] centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; metal ion binding [GO:0046872]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17130.t1 B2RYD2 45.876 691 0.0 598.0 sp|B2RYD2|ESRP1_RAT Epithelial splicing regulatory protein 1 OS=Rattus norvegicus OX=10116 GN=Esrp1 PE=2 SV=2 ESRP1_RAT reviewed Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A) Rattus norvegicus (Rat) GO:0000380; GO:0003729; GO:0005634; GO:0005654; GO:0016604; GO:0042669; GO:0043484; GO:0050673; GO:0050679; GO:0060441; GO:0060445; GO:1990904 alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial cell proliferation [GO:0050673]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA binding [GO:0003729] g17132.t1 Q7Z4Q2 39.092 683 1.37e-133 410.0 sp|Q7Z4Q2|HEAT3_HUMAN HEAT repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=HEATR3 PE=1 SV=2 HEAT3_HUMAN reviewed HEAT repeat-containing protein 3 (Symportin Syo1) (hsSyo1) Homo sapiens (Human) GO:0006606; GO:0042273; GO:0043249; GO:0051082 erythrocyte maturation [GO:0043249]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273] unfolded protein binding [GO:0051082] g17133.t1 Q12908 33.923 339 1.24e-41 156.0 sp|Q12908|NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens OX=9606 GN=SLC10A2 PE=1 SV=2 NTCP2_HUMAN reviewed Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2) Homo sapiens (Human) GO:0005886; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016324 bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] apical plasma membrane [GO:0016324]; microvillus [GO:0005902]; plasma membrane [GO:0005886] bile acid:sodium symporter activity [GO:0008508] g17134.t1 Q12908 34.808 339 1.0600000000000001e-43 161.0 sp|Q12908|NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens OX=9606 GN=SLC10A2 PE=1 SV=2 NTCP2_HUMAN reviewed Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2) Homo sapiens (Human) GO:0005886; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016324 bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] apical plasma membrane [GO:0016324]; microvillus [GO:0005902]; plasma membrane [GO:0005886] bile acid:sodium symporter activity [GO:0008508] g17135.t1 P57709 65.48 927 0.0 1239.0 sp|P57709|AT2C1_BOVIN Calcium-transporting ATPase type 2C member 1 OS=Bos taurus OX=9913 GN=ATP2C1 PE=2 SV=1 AT2C1_BOVIN reviewed Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1) (SPCA1) Bos taurus (Bovine) GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0016339; GO:0016887; GO:0030026; GO:0030036; GO:0030145; GO:0032468; GO:0032472; GO:0032580; GO:0033106; GO:0042998; GO:0043123; GO:0070588; GO:0098629; GO:0140613 actin cytoskeleton organization [GO:0030036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; intracellular manganese ion homeostasis [GO:0030026]; manganese ion transport [GO:0006828]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; trans-Golgi network membrane organization [GO:0098629] cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; P-type calcium transporter activity [GO:0005388]; P-type manganese transporter activity [GO:0140613] g17136.t1 Q2HJF3 36.8 250 9.7e-50 167.0 sp|Q2HJF3|ORC6_BOVIN Origin recognition complex subunit 6 OS=Bos taurus OX=9913 GN=ORC6 PE=2 SV=1 g17136.t2 Q2HJF3 36.948 249 4.18e-50 167.0 sp|Q2HJF3|ORC6_BOVIN Origin recognition complex subunit 6 OS=Bos taurus OX=9913 GN=ORC6 PE=2 SV=1 g17137.t1 Q3SZH6 66.82 434 0.0 606.0 sp|Q3SZH6|TTLL9_BOVIN Probable tubulin polyglutamylase TTLL9 OS=Bos taurus OX=9913 GN=TTLL9 PE=2 SV=1 TTLL9_BOVIN reviewed Probable tubulin polyglutamylase TTLL9 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 9) Bos taurus (Bovine) GO:0000226; GO:0005524; GO:0005874; GO:0015631; GO:0030317; GO:0036064; GO:0046872; GO:0070740; GO:0106438 flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g17138.t1 P59048 48.855 131 1.51e-36 124.0 sp|P59048|PDRG1_MOUSE p53 and DNA damage-regulated protein 1 OS=Mus musculus OX=10090 GN=Pdrg1 PE=2 SV=1 g17139.t1 Q9Y5B9 63.269 1040 0.0 1337.0 sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1 g17140.t1 Q9VT00 36.007 611 9.21e-110 387.0 sp|Q9VT00|JARD2_DROME Jumonji, AT rich interactive domain protein 2 OS=Drosophila melanogaster OX=7227 GN=Jarid2 PE=1 SV=3 JARD2_DROME reviewed Jumonji, AT rich interactive domain protein 2 (Protein jumonji) (dJmj) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0000791; GO:0003677; GO:0005634; GO:0005737; GO:0006338; GO:0010468; GO:0044877; GO:0045893 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877] g17140.t2 Q9VT00 35.352 611 5.809999999999999e-106 375.0 sp|Q9VT00|JARD2_DROME Jumonji, AT rich interactive domain protein 2 OS=Drosophila melanogaster OX=7227 GN=Jarid2 PE=1 SV=3 JARD2_DROME reviewed Jumonji, AT rich interactive domain protein 2 (Protein jumonji) (dJmj) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0000791; GO:0003677; GO:0005634; GO:0005737; GO:0006338; GO:0010468; GO:0044877; GO:0045893 chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877] g17141.t1 Q969N2 49.367 553 0.0 527.0 sp|Q969N2|PIGT_HUMAN GPI-anchor transamidase component PIGT OS=Homo sapiens OX=9606 GN=PIGT PE=1 SV=1 g17142.t1 Q8IYS1 40.816 392 7.08e-100 307.0 sp|Q8IYS1|P20D2_HUMAN Xaa-Arg dipeptidase OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2 P20D2_HUMAN reviewed Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246 proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246] nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] g17143.t1 Q5RED8 43.87 522 1.61e-126 422.0 sp|Q5RED8|CYLD_PONAB Ubiquitin carboxyl-terminal hydrolase CYLD OS=Pongo abelii OX=9601 GN=CYLD PE=2 SV=1 CYLD_PONAB reviewed Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0043124; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493 innate immune response [GO:0045087]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; protein deubiquitination [GO:0016579]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819] cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; zinc ion binding [GO:0008270] g17144.t1 Q6PGU2 53.913 230 5.89e-78 238.0 sp|Q6PGU2|MAF1_DANRE Repressor of RNA polymerase III transcription MAF1 homolog OS=Danio rerio OX=7955 GN=maf1 PE=2 SV=1 g17145.t1 A9JTG5 41.653 605 1.28e-141 436.0 sp|A9JTG5|HOIL1_DANRE RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Danio rerio OX=7955 GN=rbck1 PE=2 SV=1 HOIL1_DANRE reviewed RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004842; GO:0008270; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0048701; GO:0061630; GO:0071600; GO:0071797; GO:0097039 defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039] LUBAC complex [GO:0071797] ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17145.t2 Q9BYM8 32.963 270 6.100000000000001e-27 117.0 sp|Q9BYM8|HOIL1_HUMAN RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=RBCK1 PE=1 SV=2 HOIL1_HUMAN reviewed RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3) Homo sapiens (Human) GO:0000209; GO:0003713; GO:0004842; GO:0005829; GO:0007249; GO:0008270; GO:0032088; GO:0042742; GO:0042802; GO:0043123; GO:0043124; GO:0043130; GO:0043161; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0071797; GO:0097039; GO:0140311; GO:1901224; GO:1990757; GO:2001238 canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; LUBAC complex [GO:0071797] identical protein binding [GO:0042802]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17145.t3 Q9BYM8 33.579 271 1.2900000000000002e-27 118.0 sp|Q9BYM8|HOIL1_HUMAN RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=RBCK1 PE=1 SV=2 HOIL1_HUMAN reviewed RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3) Homo sapiens (Human) GO:0000209; GO:0003713; GO:0004842; GO:0005829; GO:0007249; GO:0008270; GO:0032088; GO:0042742; GO:0042802; GO:0043123; GO:0043124; GO:0043130; GO:0043161; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0071797; GO:0097039; GO:0140311; GO:1901224; GO:1990757; GO:2001238 canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; LUBAC complex [GO:0071797] identical protein binding [GO:0042802]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17145.t4 A9JTG5 55.894 263 1.8e-109 334.0 sp|A9JTG5|HOIL1_DANRE RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Danio rerio OX=7955 GN=rbck1 PE=2 SV=1 HOIL1_DANRE reviewed RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004842; GO:0008270; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0048701; GO:0061630; GO:0071600; GO:0071797; GO:0097039 defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039] LUBAC complex [GO:0071797] ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17148.t1 Q99J78 48.951 429 1.58e-147 439.0 sp|Q99J78|DEFI8_MOUSE Differentially expressed in FDCP 8 OS=Mus musculus OX=10090 GN=Def8 PE=1 SV=1 g17148.t2 Q4V8I4 50.966 414 9.91e-152 449.0 sp|Q4V8I4|DEFI8_RAT Differentially expressed in FDCP 8 homolog OS=Rattus norvegicus OX=10116 GN=Def8 PE=1 SV=1 g17149.t1 P50260 51.462 342 3.7400000000000003e-97 296.0 sp|P50260|TBB2_OOMCK Tubulin beta-2 chain (Fragment) OS=Oomycete-like sp. (strain MacKay2000) OX=129195 GN=TUBB2 PE=2 SV=1 g17149.t1 P50260 65.541 148 8.719999999999999e-45 160.0 sp|P50260|TBB2_OOMCK Tubulin beta-2 chain (Fragment) OS=Oomycete-like sp. (strain MacKay2000) OX=129195 GN=TUBB2 PE=2 SV=1 g17150.t1 P18700 96.316 190 1.1299999999999999e-137 389.0 sp|P18700|TBB_STRPU Tubulin beta chain (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17150.t2 P02556 95.495 111 1.54e-76 228.0 sp|P02556|TBB_LYTPI Tubulin beta chain (Fragment) OS=Lytechinus pictus OX=7653 PE=2 SV=1 g17151.t1 P11833 96.637 446 0.0 914.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g17152.t1 P11833 97.534 446 0.0 919.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g17153.t1 Q9HYH5 27.928 222 1.03e-24 102.0 sp|Q9HYH5|Y3430_PSEAE Putative aldolase class 2 protein PA3430 OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=PA3430 PE=3 SV=1 g17154.t1 P11833 96.644 447 0.0 915.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g17155.t1 P86221 66.465 331 6.58e-143 408.0 sp|P86221|TBB4B_MESAU Tubulin beta-4B chain (Fragments) OS=Mesocricetus auratus OX=10036 GN=TUBB4B PE=1 SV=1 g17156.t1 P11833 97.309 446 0.0 919.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g17157.t1 P86221 69.728 294 3.56e-127 367.0 sp|P86221|TBB4B_MESAU Tubulin beta-4B chain (Fragments) OS=Mesocricetus auratus OX=10036 GN=TUBB4B PE=1 SV=1 g17158.t1 Q5JS54 45.833 120 2.71e-32 113.0 sp|Q5JS54|PSMG4_HUMAN Proteasome assembly chaperone 4 OS=Homo sapiens OX=9606 GN=PSMG4 PE=1 SV=2 g17160.t1 Q9TST5 26.531 343 4.41e-21 97.4 sp|Q9TST5|ADRB2_FELCA Beta-2 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB2 PE=3 SV=1 g17161.t1 Q149F1 55.793 328 2.64e-130 395.0 sp|Q149F1|RUSD2_MOUSE Pseudouridylate synthase RPUSD2 OS=Mus musculus OX=10090 GN=Rpusd2 PE=1 SV=2 g17162.t1 Q8VDC0 48.84 905 0.0 913.0 sp|Q8VDC0|SYLM_MOUSE Probable leucine--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Lars2 PE=1 SV=1 g17163.t1 Q90Z10 68.421 209 4.81e-93 274.0 sp|Q90Z10|RL13_DANRE Large ribosomal subunit protein eL13 OS=Danio rerio OX=7955 GN=rpl13 PE=1 SV=3 g17165.t1 Q8L0X4 41.787 347 2.09e-91 283.0 sp|Q8L0X4|MEGL_FUSNP L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. polymorphum OX=76857 GN=mgl PE=1 SV=1 g17166.t1 Q8RDT4 49.28 347 5.4400000000000004e-124 368.0 sp|Q8RDT4|MEGL_FUSNN L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=FN1419 PE=1 SV=1 g17166.t2 Q8RDT4 49.153 295 2.9999999999999997e-106 318.0 sp|Q8RDT4|MEGL_FUSNN L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=FN1419 PE=1 SV=1 g17168.t1 Q9IBG7 28.03 1873 1.52e-128 454.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17168.t1 Q9IBG7 28.918 1812 1.2100000000000002e-124 442.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17168.t1 Q9IBG7 28.195 1784 1.3800000000000002e-124 442.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17168.t1 Q9IBG7 28.343 1750 2.66e-121 432.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17168.t1 Q9IBG7 27.854 1393 2.17e-92 339.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17168.t1 Q9IBG7 27.338 1251 3.77e-78 293.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17168.t1 Q9IBG7 28.474 1173 1.37e-74 281.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17168.t1 Q9IBG7 28.881 876 1.87e-64 248.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 28.683 1154 2.6499999999999998e-92 330.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 29.473 1062 5.11e-88 317.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 29.872 1098 1.73e-85 309.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 29.248 1077 7.79e-85 307.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 28.189 1082 1.13e-81 297.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 28.103 1160 5.3100000000000005e-80 292.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 28.14 828 6.010000000000001e-73 270.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 28.85 1026 4.0600000000000003e-66 249.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 28.684 889 3.97e-57 221.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 27.422 609 2.24e-35 150.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17170.t1 Q9IBG7 27.11 782 8.38e-35 149.0 sp|Q9IBG7|KCP_XENLA Kielin/chordin-like protein OS=Xenopus laevis OX=8355 GN=kcp PE=2 SV=1 g17172.t1 Q92636 44.527 941 0.0 800.0 sp|Q92636|FAN_HUMAN Protein FAN OS=Homo sapiens OX=9606 GN=NSMAF PE=1 SV=2 FAN_HUMAN reviewed Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016020; GO:0033209; GO:0034250; GO:0045834; GO:1905038 ceramide metabolic process [GO:0006672]; positive regulation of amide metabolic process [GO:0034250]; positive regulation of lipid metabolic process [GO:0045834]; regulation of membrane lipid metabolic process [GO:1905038]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] g17173.t1 Q3KPT5 85.106 94 3.0899999999999997e-54 166.0 sp|Q3KPT5|ENY2_XENLA Transcription and mRNA export factor ENY2 OS=Xenopus laevis OX=8355 GN=eny2 PE=3 SV=1 g17174.t1 O62703 60.105 574 0.0 696.0 sp|O62703|CTBL1_BOVIN Beta-catenin-like protein 1 OS=Bos taurus OX=9913 GN=CTNNBL1 PE=2 SV=3 g17175.t1 O23300 33.129 163 1.4e-25 103.0 sp|O23300|ECI3_ARATH Enoyl-CoA delta isomerase 3 OS=Arabidopsis thaliana OX=3702 GN=ECI3 PE=1 SV=1 g17176.t1 O95363 58.255 424 0.0 523.0 sp|O95363|SYFM_HUMAN Phenylalanine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=FARS2 PE=1 SV=1 SYFM_HUMAN reviewed Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS) Homo sapiens (Human) GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006418; GO:0006432; GO:0008033 phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049] g17177.t1 Q9P243 34.097 393 7.72e-58 222.0 sp|Q9P243|ZFAT_HUMAN Zinc finger protein ZFAT OS=Homo sapiens OX=9606 GN=ZFAT PE=1 SV=2 g17177.t1 Q9P243 31.275 502 3.38e-54 211.0 sp|Q9P243|ZFAT_HUMAN Zinc finger protein ZFAT OS=Homo sapiens OX=9606 GN=ZFAT PE=1 SV=2 g17178.t1 A0A1D5NSM8 50.442 113 3.11e-28 122.0 sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1 SVEP1_DANRE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136 cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509] g17179.t1 O76536 31.493 489 3.59e-39 158.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17179.t1 O76536 31.643 414 9.72e-33 138.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17179.t1 O76536 32.367 414 1.0500000000000001e-32 138.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17179.t1 O76536 31.579 437 3.18e-32 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17179.t1 O76536 30.0 410 2.3199999999999997e-28 124.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17179.t1 O76536 39.344 244 3.87e-22 105.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17180.t1 P10079 31.342 1021 9.83e-84 298.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17180.t1 P10079 28.918 453 4.45e-26 120.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17180.t2 P10079 31.226 1060 9.23e-82 293.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17180.t2 P10079 35.041 488 1.5599999999999997e-48 192.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17180.t2 P10079 29.58 524 1.33e-25 118.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17181.t1 Q8K078 34.844 640 1.41e-133 412.0 sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2 SO4A1_MOUSE reviewed Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12) Mus musculus (Mouse) GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0015711; GO:0016323; GO:0042403; GO:0043252 monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] g17182.t1 Q7Z449 49.296 142 6.19e-43 156.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g17183.t1 Q0IIF9 50.345 145 2.1499999999999998e-46 165.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g17184.t1 Q0IIF9 47.917 144 4.09e-43 156.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g17185.t1 Q0IIF9 52.542 118 2.94e-34 132.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g17187.t1 Q8CHJ0 44.393 428 3.6400000000000004e-122 365.0 sp|Q8CHJ0|PIGU_CRIGR GPI-anchor transamidase component PIGU OS=Cricetulus griseus OX=10029 GN=PIGU PE=1 SV=3 g17188.t1 Q9UGM3 38.107 391 8.88e-65 234.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 38.649 370 4.61e-64 232.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 37.692 390 6.84e-64 231.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 37.275 389 7.31e-64 231.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 38.42 367 4.3999999999999995e-62 226.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 37.887 388 7.73e-62 226.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 37.209 387 1.2799999999999999e-61 225.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 36.79 405 8.58e-60 219.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17188.t1 Q9UGM3 32.153 367 4.89e-41 164.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17189.t1 P09487 45.643 482 4.4999999999999995e-134 402.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g17190.t1 Q29486 45.098 510 3.9699999999999996e-146 434.0 sp|Q29486|PPBT_FELCA Alkaline phosphatase, tissue-nonspecific isozyme OS=Felis catus OX=9685 GN=ALPL PE=1 SV=1 PPBT_FELCA reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Felis catus (Cat) (Felis silvestris catus) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016311; GO:0016462; GO:0016887; GO:0030282; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0098552; GO:0120162 bone mineralization [GO:0030282]; dephosphorylation [GO:0016311]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g17191.t1 P05186 45.04 504 6.440000000000001e-144 429.0 sp|P05186|PPBT_HUMAN Alkaline phosphatase, tissue-nonspecific isozyme OS=Homo sapiens OX=9606 GN=ALPL PE=1 SV=4 PPBT_HUMAN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNS-ALP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Homo sapiens (Human) GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005576; GO:0005758; GO:0005886; GO:0016020; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031966; GO:0032496; GO:0032868; GO:0033280; GO:0033883; GO:0034516; GO:0036005; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0070062; GO:0071529; GO:0098552; GO:0120162; GO:0140651; GO:0140928; GO:1904383 bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; inhibition of non-skeletal tissue mineralization [GO:0140928]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to macrophage colony-stimulating factor [GO:0036005]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g17192.t1 P05186 44.643 504 2.91e-142 424.0 sp|P05186|PPBT_HUMAN Alkaline phosphatase, tissue-nonspecific isozyme OS=Homo sapiens OX=9606 GN=ALPL PE=1 SV=4 PPBT_HUMAN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNS-ALP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Homo sapiens (Human) GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005576; GO:0005758; GO:0005886; GO:0016020; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031966; GO:0032496; GO:0032868; GO:0033280; GO:0033883; GO:0034516; GO:0036005; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0070062; GO:0071529; GO:0098552; GO:0120162; GO:0140651; GO:0140928; GO:1904383 bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; inhibition of non-skeletal tissue mineralization [GO:0140928]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to macrophage colony-stimulating factor [GO:0036005]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g17193.t1 P09487 44.444 207 3.25e-51 176.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g17194.t1 P09242 48.747 439 5.72e-131 393.0 sp|P09242|PPBT_MOUSE Alkaline phosphatase, tissue-nonspecific isozyme OS=Mus musculus OX=10090 GN=Alpl PE=1 SV=2 PPBT_MOUSE reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase 2) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Mus musculus (Mouse) GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005615; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031012; GO:0031966; GO:0032496; GO:0032868; GO:0033280; GO:0033883; GO:0034516; GO:0036005; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0065010; GO:0071529; GO:0098552; GO:0120162; GO:0140651; GO:0140928; GO:1904383 bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; inhibition of non-skeletal tissue mineralization [GO:0140928]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to macrophage colony-stimulating factor [GO:0036005]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280] extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g17197.t1 O70513 44.348 115 3.13e-29 119.0 sp|O70513|LG3BP_RAT Galectin-3-binding protein OS=Rattus norvegicus OX=10116 GN=Lgals3bp PE=1 SV=2 g17198.t1 Q2VLG4 30.982 326 1.1999999999999998e-38 151.0 sp|Q2VLG4|C163A_CHLAE Scavenger receptor cysteine-rich type 1 protein M130 OS=Chlorocebus aethiops OX=9534 GN=CD163 PE=1 SV=1 C163A_CHLAE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0005576; GO:0005737; GO:0005886; GO:0006953 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] g17198.t1 Q2VLG4 31.098 328 3.5e-34 138.0 sp|Q2VLG4|C163A_CHLAE Scavenger receptor cysteine-rich type 1 protein M130 OS=Chlorocebus aethiops OX=9534 GN=CD163 PE=1 SV=1 C163A_CHLAE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0005576; GO:0005737; GO:0005886; GO:0006953 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] g17198.t1 Q2VLG4 28.08 349 1.13e-28 122.0 sp|Q2VLG4|C163A_CHLAE Scavenger receptor cysteine-rich type 1 protein M130 OS=Chlorocebus aethiops OX=9534 GN=CD163 PE=1 SV=1 C163A_CHLAE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0005576; GO:0005737; GO:0005886; GO:0006953 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] g17198.t1 Q2VLG4 28.108 370 9.31e-26 113.0 sp|Q2VLG4|C163A_CHLAE Scavenger receptor cysteine-rich type 1 protein M130 OS=Chlorocebus aethiops OX=9534 GN=CD163 PE=1 SV=1 C163A_CHLAE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0005576; GO:0005737; GO:0005886; GO:0006953 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] g17198.t1 Q2VLG4 25.532 376 7.72e-23 104.0 sp|Q2VLG4|C163A_CHLAE Scavenger receptor cysteine-rich type 1 protein M130 OS=Chlorocebus aethiops OX=9534 GN=CD163 PE=1 SV=1 C163A_CHLAE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0005576; GO:0005737; GO:0005886; GO:0006953 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] g17198.t1 Q2VLG4 25.698 358 2.85e-22 102.0 sp|Q2VLG4|C163A_CHLAE Scavenger receptor cysteine-rich type 1 protein M130 OS=Chlorocebus aethiops OX=9534 GN=CD163 PE=1 SV=1 C163A_CHLAE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops) GO:0005576; GO:0005737; GO:0005886; GO:0006953 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] g17199.t1 P41044 41.989 181 2.41e-41 144.0 sp|P41044|CAB32_DROME Calbindin-32 OS=Drosophila melanogaster OX=7227 GN=Cbp53E PE=2 SV=1 g17201.t1 P08684 38.552 511 3.21e-114 350.0 sp|P08684|CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens OX=9606 GN=CYP3A4 PE=1 SV=4 CP3A4_HUMAN reviewed Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55) Homo sapiens (Human) GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006629; GO:0006706; GO:0006805; GO:0008202; GO:0008203; GO:0008209; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019825; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0042759; GO:0043231; GO:0046222; GO:0050591; GO:0050649; GO:0062181; GO:0062187; GO:0062188; GO:0062189; GO:0070576; GO:0070989; GO:0101020; GO:0101021; GO:0102320 aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] 1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343] g17202.t1 P11707 41.429 490 6.82e-136 405.0 sp|P11707|CP3A6_RABIT Cytochrome P450 3A6 OS=Oryctolagus cuniculus OX=9986 GN=CYP3A6 PE=2 SV=2 g17203.t1 O43312 42.705 658 9.44e-133 421.0 sp|O43312|MTSS1_HUMAN Protein MTSS 1 OS=Homo sapiens OX=9606 GN=MTSS1 PE=1 SV=2 g17205.t1 Q8J025 41.775 462 3.42e-128 386.0 sp|Q8J025|APCD1_HUMAN Protein APCDD1 OS=Homo sapiens OX=9606 GN=APCDD1 PE=1 SV=1 APCD1_HUMAN reviewed Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein) Homo sapiens (Human) GO:0001942; GO:0005886; GO:0016055; GO:0017147; GO:0030178; GO:0042487; GO:0042802; GO:0043615 astrocyte cell migration [GO:0043615]; hair follicle development [GO:0001942]; negative regulation of Wnt signaling pathway [GO:0030178]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147] g17207.t1 Q7M767 53.147 143 3.81e-47 152.0 sp|Q7M767|UB2V2_RAT Ubiquitin-conjugating enzyme E2 variant 2 OS=Rattus norvegicus OX=10116 GN=Ube2v2 PE=1 SV=3 UB2V2_RAT reviewed Ubiquitin-conjugating enzyme E2 variant 2 (Ubiquitin-conjugating enzyme variant MMS2) Rattus norvegicus (Rat) GO:0000729; GO:0005634; GO:0005654; GO:0006301; GO:0010976; GO:0031371; GO:0031372; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0070534; GO:1902523; GO:2000781 DNA damage tolerance [GO:0006301]; DNA double-strand break processing [GO:0000729]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of synapse assembly [GO:0051965]; protein K63-linked ubiquitination [GO:0070534] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371] g17208.t1 Q9DAG6 34.737 190 2.54e-29 120.0 sp|Q9DAG6|GPRL1_MOUSE GLIPR1-like protein 1 OS=Mus musculus OX=10090 GN=Glipr1l1 PE=1 SV=1 GPRL1_MOUSE reviewed GLIPR1-like protein 1 Mus musculus (Mouse) GO:0001669; GO:0002081; GO:0005615; GO:0005886; GO:0007339; GO:0007342; GO:0045121; GO:0060090; GO:0060476; GO:0098635; GO:0120212 binding of sperm to zona pellucida [GO:0007339]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; protein localization involved in acrosome reaction [GO:0060476] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; outer acrosomal membrane [GO:0002081]; plasma membrane [GO:0005886]; protein complex involved in cell-cell adhesion [GO:0098635]; sperm head-tail coupling apparatus [GO:0120212] molecular adaptor activity [GO:0060090] g17210.t1 A0A1D9BZF0 52.542 177 1.05e-27 122.0 sp|A0A1D9BZF0|GCNA_MOUSE Germ cell nuclear acidic protein OS=Mus musculus OX=10090 GN=Gcna PE=1 SV=1 GCNA_MOUSE reviewed Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear antigen) Mus musculus (Mouse) GO:0000793; GO:0006974; GO:0007129; GO:0010032; GO:0016605; GO:0031570; GO:0035825; GO:0106300 DNA damage response [GO:0006974]; DNA integrity checkpoint signaling [GO:0031570]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic chromosome condensation [GO:0010032]; protein-DNA covalent cross-linking repair [GO:0106300] condensed chromosome [GO:0000793]; PML body [GO:0016605] g17210.t1 A0A1D9BZF0 51.724 174 2.03e-25 115.0 sp|A0A1D9BZF0|GCNA_MOUSE Germ cell nuclear acidic protein OS=Mus musculus OX=10090 GN=Gcna PE=1 SV=1 GCNA_MOUSE reviewed Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear antigen) Mus musculus (Mouse) GO:0000793; GO:0006974; GO:0007129; GO:0010032; GO:0016605; GO:0031570; GO:0035825; GO:0106300 DNA damage response [GO:0006974]; DNA integrity checkpoint signaling [GO:0031570]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic chromosome condensation [GO:0010032]; protein-DNA covalent cross-linking repair [GO:0106300] condensed chromosome [GO:0000793]; PML body [GO:0016605] g17210.t1 A0A1D9BZF0 49.302 215 3.16e-25 114.0 sp|A0A1D9BZF0|GCNA_MOUSE Germ cell nuclear acidic protein OS=Mus musculus OX=10090 GN=Gcna PE=1 SV=1 GCNA_MOUSE reviewed Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear antigen) Mus musculus (Mouse) GO:0000793; GO:0006974; GO:0007129; GO:0010032; GO:0016605; GO:0031570; GO:0035825; GO:0106300 DNA damage response [GO:0006974]; DNA integrity checkpoint signaling [GO:0031570]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic chromosome condensation [GO:0010032]; protein-DNA covalent cross-linking repair [GO:0106300] condensed chromosome [GO:0000793]; PML body [GO:0016605] g17210.t1 A0A1D9BZF0 41.135 282 5.58e-25 113.0 sp|A0A1D9BZF0|GCNA_MOUSE Germ cell nuclear acidic protein OS=Mus musculus OX=10090 GN=Gcna PE=1 SV=1 GCNA_MOUSE reviewed Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear antigen) Mus musculus (Mouse) GO:0000793; GO:0006974; GO:0007129; GO:0010032; GO:0016605; GO:0031570; GO:0035825; GO:0106300 DNA damage response [GO:0006974]; DNA integrity checkpoint signaling [GO:0031570]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic chromosome condensation [GO:0010032]; protein-DNA covalent cross-linking repair [GO:0106300] condensed chromosome [GO:0000793]; PML body [GO:0016605] g17210.t1 A0A1D9BZF0 48.571 210 1.4399999999999997e-23 109.0 sp|A0A1D9BZF0|GCNA_MOUSE Germ cell nuclear acidic protein OS=Mus musculus OX=10090 GN=Gcna PE=1 SV=1 GCNA_MOUSE reviewed Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear antigen) Mus musculus (Mouse) GO:0000793; GO:0006974; GO:0007129; GO:0010032; GO:0016605; GO:0031570; GO:0035825; GO:0106300 DNA damage response [GO:0006974]; DNA integrity checkpoint signaling [GO:0031570]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic chromosome condensation [GO:0010032]; protein-DNA covalent cross-linking repair [GO:0106300] condensed chromosome [GO:0000793]; PML body [GO:0016605] g17211.t1 Q9QXA6 60.377 318 3.3199999999999995e-128 379.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g17211.t2 Q9N1R6 59.574 329 1.4e-128 380.0 sp|Q9N1R6|BAT1_RABIT b(0,+)-type amino acid transporter 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A9 PE=2 SV=1 BAT1_RABIT reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT) (4F2-LC6) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Oryctolagus cuniculus (Rabbit) GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016020; GO:0016324; GO:0031526; GO:0042605; GO:0180009 L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane [GO:0016020]; plasma membrane [GO:0005886] broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605] g17211.t3 Q9N1R6 57.246 414 1.54e-155 461.0 sp|Q9N1R6|BAT1_RABIT b(0,+)-type amino acid transporter 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A9 PE=2 SV=1 BAT1_RABIT reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT) (4F2-LC6) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Oryctolagus cuniculus (Rabbit) GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016020; GO:0016324; GO:0031526; GO:0042605; GO:0180009 L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane [GO:0016020]; plasma membrane [GO:0005886] broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605] g17211.t3 Q9N1R6 54.375 160 1.8699999999999998e-45 172.0 sp|Q9N1R6|BAT1_RABIT b(0,+)-type amino acid transporter 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A9 PE=2 SV=1 BAT1_RABIT reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT) (4F2-LC6) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Oryctolagus cuniculus (Rabbit) GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016020; GO:0016324; GO:0031526; GO:0042605; GO:0180009 L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane [GO:0016020]; plasma membrane [GO:0005886] broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605] g17211.t4 Q9N1R6 58.213 414 1.64e-158 469.0 sp|Q9N1R6|BAT1_RABIT b(0,+)-type amino acid transporter 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A9 PE=2 SV=1 BAT1_RABIT reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT) (4F2-LC6) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Oryctolagus cuniculus (Rabbit) GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016020; GO:0016324; GO:0031526; GO:0042605; GO:0180009 L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane [GO:0016020]; plasma membrane [GO:0005886] broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605] g17211.t4 Q9N1R6 54.375 160 1.25e-45 172.0 sp|Q9N1R6|BAT1_RABIT b(0,+)-type amino acid transporter 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A9 PE=2 SV=1 BAT1_RABIT reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT) (4F2-LC6) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Oryctolagus cuniculus (Rabbit) GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016020; GO:0016324; GO:0031526; GO:0042605; GO:0180009 L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane [GO:0016020]; plasma membrane [GO:0005886] broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605] g17211.t5 Q9QXA6 62.302 252 6.8e-96 302.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g17211.t5 Q9QXA6 57.718 149 1.0099999999999999e-46 172.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g17211.t6 P82251 53.234 201 2.7699999999999998e-67 216.0 sp|P82251|BAT1_HUMAN b(0,+)-type amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A9 PE=1 SV=1 BAT1_HUMAN reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0065003; GO:0180009 amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g17214.t1 Q32KL5 45.455 198 6.76e-58 184.0 sp|Q32KL5|EMC8_BOVIN ER membrane protein complex subunit 8 OS=Bos taurus OX=9913 GN=EMC8 PE=2 SV=1 g17215.t1 D3ZMM8 48.723 509 2.91e-171 496.0 sp|D3ZMM8|YLAT2_RAT Y+L amino acid transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc7a6 PE=1 SV=1 YLAT2_RAT reviewed Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Rattus norvegicus (Rat) GO:0003333; GO:0005886; GO:0006809; GO:0015174; GO:0015179; GO:0015804; GO:0015820; GO:0015822; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809]; ornithine transport [GO:0015822] plasma membrane [GO:0005886] arginine binding [GO:0034618]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g17216.t1 Q9R0S5 56.522 138 5.04e-44 156.0 sp|Q9R0S5|YLAT1_RAT Y+L amino acid transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc7a7 PE=1 SV=1 YLAT1_RAT reviewed Y+L amino acid transporter 1 (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1) Rattus norvegicus (Rat) GO:0000821; GO:0003333; GO:0015174; GO:0015179; GO:0015820; GO:0016323; GO:0061459; GO:1903826 amino acid transmembrane transport [GO:0003333]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; regulation of arginine metabolic process [GO:0000821] basolateral plasma membrane [GO:0016323] basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459] g17216.t2 Q9R0S5 60.169 118 5.08e-41 147.0 sp|Q9R0S5|YLAT1_RAT Y+L amino acid transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc7a7 PE=1 SV=1 YLAT1_RAT reviewed Y+L amino acid transporter 1 (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1) Rattus norvegicus (Rat) GO:0000821; GO:0003333; GO:0015174; GO:0015179; GO:0015820; GO:0016323; GO:0061459; GO:1903826 amino acid transmembrane transport [GO:0003333]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; regulation of arginine metabolic process [GO:0000821] basolateral plasma membrane [GO:0016323] basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459] g17217.t1 Q9R0S5 54.545 154 1.87e-46 162.0 sp|Q9R0S5|YLAT1_RAT Y+L amino acid transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc7a7 PE=1 SV=1 YLAT1_RAT reviewed Y+L amino acid transporter 1 (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1) Rattus norvegicus (Rat) GO:0000821; GO:0003333; GO:0015174; GO:0015179; GO:0015820; GO:0016323; GO:0061459; GO:1903826 amino acid transmembrane transport [GO:0003333]; L-arginine transmembrane transport [GO:1903826]; L-leucine transport [GO:0015820]; regulation of arginine metabolic process [GO:0000821] basolateral plasma membrane [GO:0016323] basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459] g17218.t1 Q8MH63 50.35 143 1.7699999999999998e-45 151.0 sp|Q8MH63|LAT1N_HUMAN Putative L-type amino acid transporter 1-like protein MLAS OS=Homo sapiens OX=9606 GN=SLC7A5P1 PE=5 SV=1 g17219.t1 Q96ME1 26.467 733 1.72e-44 174.0 sp|Q96ME1|FXL18_HUMAN F-box/LRR-repeat protein 18 OS=Homo sapiens OX=9606 GN=FBXL18 PE=1 SV=3 g17220.t1 Q96BZ8 44.792 192 5.45e-33 127.0 sp|Q96BZ8|LENG1_HUMAN Leukocyte receptor cluster member 1 OS=Homo sapiens OX=9606 GN=LENG1 PE=1 SV=2 LENG1_HUMAN reviewed Leukocyte receptor cluster member 1 Homo sapiens (Human) GO:0005654 nucleoplasm [GO:0005654] g17221.t1 Q3T077 46.386 166 1.84e-45 150.0 sp|Q3T077|TPPP2_BOVIN Tubulin polymerization-promoting protein family member 2 OS=Bos taurus OX=9913 GN=TPPP2 PE=2 SV=1 g17222.t1 P00125 67.73 282 3.78e-131 379.0 sp|P00125|CY1_BOVIN Cytochrome c1, heme protein, mitochondrial OS=Bos taurus OX=9913 GN=CYC1 PE=1 SV=2 g17223.t1 Q8NCC3 46.277 376 1.47e-113 342.0 sp|Q8NCC3|PAG15_HUMAN Lysosomal phospholipase A and acyltransferase OS=Homo sapiens OX=9606 GN=PLA2G15 PE=1 SV=2 PAG15_HUMAN reviewed Lysosomal phospholipase A and acyltransferase (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2) (Phospholipase A2 group XV) (PLA2G15) Homo sapiens (Human) GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006644; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0009062; GO:0016020; GO:0016411; GO:0034638; GO:0046338; GO:0046470; GO:0046471; GO:0047499; GO:0070062 ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; O-acyltransferase activity [GO:0008374]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g17224.t1 Q9NQP4 54.098 122 9.67e-38 127.0 sp|Q9NQP4|PFD4_HUMAN Prefoldin subunit 4 OS=Homo sapiens OX=9606 GN=PFDN4 PE=1 SV=1 PFD4_HUMAN reviewed Prefoldin subunit 4 (Protein C-1) Homo sapiens (Human) GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087; GO:1905907 negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272] amyloid-beta binding [GO:0001540]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] g17225.t1 Q5R875 33.985 409 1.85e-81 262.0 sp|Q5R875|TMX3_PONAB Protein disulfide-isomerase TMX3 OS=Pongo abelii OX=9601 GN=TMX3 PE=2 SV=1 TMX3_PONAB reviewed Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003756; GO:0005789; GO:0009986 cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789] protein disulfide isomerase activity [GO:0003756] g17226.t1 Q8IZU8 39.289 1153 0.0 831.0 sp|Q8IZU8|DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens OX=9606 GN=DSEL PE=1 SV=2 g17227.t1 Q5ZML6 50.0 120 6.42e-30 117.0 sp|Q5ZML6|F210A_CHICK Protein FAM210A OS=Gallus gallus OX=9031 GN=FAM210A PE=2 SV=1 F210A_CHICK reviewed Protein FAM210A Gallus gallus (Chicken) GO:0005737; GO:0005739; GO:0016020 cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739] g17227.t2 Q5ZML6 53.488 86 2.32e-21 94.4 sp|Q5ZML6|F210A_CHICK Protein FAM210A OS=Gallus gallus OX=9031 GN=FAM210A PE=2 SV=1 F210A_CHICK reviewed Protein FAM210A Gallus gallus (Chicken) GO:0005737; GO:0005739; GO:0016020 cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739] g17228.t1 A0JMQ0 64.882 635 0.0 899.0 sp|A0JMQ0|BOP1_DANRE Ribosome biogenesis protein bop1 OS=Danio rerio OX=7955 GN=bop1 PE=2 SV=1 g17230.t1 Q60414 36.103 349 1.01e-66 218.0 sp|Q60414|NTCP2_CRIGR Ileal sodium/bile acid cotransporter OS=Cricetulus griseus OX=10029 GN=SLC10A2 PE=1 SV=1 g17233.t1 Q9NRH2 49.289 633 0.0 545.0 sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SNRK PE=1 SV=2 g17234.t1 Q921M3 81.183 1217 0.0 2079.0 sp|Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS=Mus musculus OX=10090 GN=Sf3b3 PE=1 SV=1 g17236.t1 Q5R7R6 58.785 757 0.0 907.0 sp|Q5R7R6|COG4_PONAB Conserved oligomeric Golgi complex subunit 4 OS=Pongo abelii OX=9601 GN=COG4 PE=2 SV=1 COG4_PONAB reviewed Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119 Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119] g17240.t1 Q9NW15 44.081 642 8.76e-168 500.0 sp|Q9NW15|ANO10_HUMAN Anoctamin-10 OS=Homo sapiens OX=9606 GN=ANO10 PE=1 SV=2 g17241.t1 Q68DL7 39.552 268 1.16e-58 211.0 sp|Q68DL7|CR063_HUMAN Uncharacterized protein C18orf63 OS=Homo sapiens OX=9606 GN=C18orf63 PE=1 SV=2 g17244.t1 Q54F23 45.185 135 4.13e-29 114.0 sp|Q54F23|MROH1_DICDI Maestro heat-like repeat-containing protein family member 1 OS=Dictyostelium discoideum OX=44689 GN=mroh1 PE=3 SV=1 g17245.t1 Q8NDA8 34.926 1423 0.0 936.0 sp|Q8NDA8|MROH1_HUMAN Maestro heat-like repeat-containing protein family member 1 OS=Homo sapiens OX=9606 GN=MROH1 PE=1 SV=3 g17246.t1 O76536 37.849 1218 5.15e-151 508.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 38.825 1226 2.35e-148 500.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 38.814 1113 2.06e-145 491.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 38.183 1244 9.1e-145 489.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 37.954 1183 2.5100000000000002e-144 488.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 37.931 1189 1.54e-142 483.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 37.902 1182 7.9e-142 481.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 43.932 585 8.63e-98 349.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 37.381 527 2.09e-58 227.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 36.673 529 2.6e-56 220.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 36.062 513 1.97e-50 201.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 33.199 497 1.03e-46 189.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 34.274 496 6.37e-45 183.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t1 O76536 33.696 460 1.69e-36 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 37.849 1218 1.33e-151 509.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 38.694 1225 6.07e-149 502.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 38.814 1113 6.31e-146 493.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 38.183 1244 2.6e-145 491.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 37.954 1183 6.01e-145 490.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 37.931 1189 4.14e-143 484.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 37.902 1182 2.02e-142 483.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 43.932 585 4.58e-98 350.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 37.291 539 1.02e-61 237.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 37.248 545 8.82e-59 228.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 36.636 535 3.96e-57 223.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 36.062 513 1.4e-50 202.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 33.266 496 8.2e-47 189.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 34.436 514 1.02e-45 186.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17246.t2 O76536 33.691 466 5.22e-37 157.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 39.037 789 2.3500000000000003e-110 386.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 37.335 908 2.27e-106 374.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 37.033 829 2.3e-93 335.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 37.571 708 6.98e-76 281.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 40.884 362 5.16e-41 170.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 41.436 362 1.56e-40 168.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 39.84 374 2.79e-40 167.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 40.563 355 7.07e-40 166.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 38.701 354 1.33e-36 155.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 38.438 333 1.19e-30 136.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17247.t1 O76536 37.329 292 1.1400000000000001e-21 107.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17248.t1 Q24K12 53.261 184 5.15e-51 179.0 sp|Q24K12|GPTC1_BOVIN G patch domain-containing protein 1 OS=Bos taurus OX=9913 GN=GPATCH1 PE=2 SV=1 g17249.t1 Q24K12 36.476 647 8.31e-97 322.0 sp|Q24K12|GPTC1_BOVIN G patch domain-containing protein 1 OS=Bos taurus OX=9913 GN=GPATCH1 PE=2 SV=1 g17249.t2 Q24K12 36.476 647 8.26e-97 322.0 sp|Q24K12|GPTC1_BOVIN G patch domain-containing protein 1 OS=Bos taurus OX=9913 GN=GPATCH1 PE=2 SV=1 g17250.t1 O76536 39.013 1256 7.41e-169 561.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 39.856 1252 3.3999999999999997e-168 559.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 37.853 1239 9.34e-168 558.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 38.805 1255 7.42e-166 552.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 38.321 1203 6.6e-160 535.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 38.057 1235 1.4300000000000001e-157 528.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 36.772 1270 1.21e-153 516.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 37.646 1113 7e-151 508.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 37.073 1230 1.87e-149 504.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 36.431 1216 2.25e-145 492.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 37.217 884 7.83e-107 377.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 35.355 577 1.76e-63 244.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 32.606 687 2.3000000000000002e-59 231.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 37.021 470 4.64e-58 226.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 32.456 684 6.07e-55 216.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 32.796 683 6.889999999999999e-52 206.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 32.239 670 1.37e-49 199.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 32.079 611 1.57e-36 157.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 33.523 528 6.87e-36 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 30.476 525 3.04e-28 129.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17250.t1 O76536 33.155 374 2.26e-22 110.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17252.t1 Q5R9W3 53.968 252 9.52e-91 270.0 sp|Q5R9W3|DERL1_PONAB Derlin-1 OS=Pongo abelii OX=9601 GN=DERL1 PE=2 SV=1 DERL1_PONAB reviewed Derlin-1 (Der1-like protein 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005047; GO:0005769; GO:0005770; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0036502; GO:0036513; GO:0042288; GO:0042802; GO:0043161; GO:0044322; GO:0051117; GO:0071218; GO:1990381 cellular response to misfolded protein [GO:0071218]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; retrograde protein transport, ER to cytosol [GO:0030970] Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum quality control compartment [GO:0044322]; late endosome [GO:0005770] ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; signal recognition particle binding [GO:0005047]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] g17253.t1 Q6DEY8 62.432 370 5.46e-168 501.0 sp|Q6DEY8|TBC31_XENTR TBC1 domain family member 31 OS=Xenopus tropicalis OX=8364 GN=tbc1d31 PE=2 SV=1 TBC31_XENTR reviewed TBC1 domain family member 31 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005813; GO:0034451; GO:0036064; GO:0060090; GO:0060271 cilium assembly [GO:0060271] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064] molecular adaptor activity [GO:0060090] g17254.t1 Q6DDI6 45.414 676 0.0 546.0 sp|Q6DDI6|TBC31_XENLA TBC1 domain family member 31 OS=Xenopus laevis OX=8355 GN=tbc1d31 PE=2 SV=1 g17256.t1 P21894 71.429 133 3.8699999999999998e-62 209.0 sp|P21894|SYAC_BOMMO Alanine--tRNA ligase, cytoplasmic OS=Bombyx mori OX=7091 PE=1 SV=1 g17257.t1 P49588 60.784 765 0.0 973.0 sp|P49588|SYAC_HUMAN Alanine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=AARS1 PE=1 SV=2 SYAC_HUMAN reviewed Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Protein lactyltransferase AARS1) (EC 6.-.-.-) (Renal carcinoma antigen NY-REN-42) Homo sapiens (Human) GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0021680; GO:0035332; GO:0043524; GO:0050885; GO:0051402; GO:0070062; GO:0140018; GO:0141207; GO:1901797 alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of hippo signaling [GO:0035332]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; peptide lactyltransferase (ATP-dependent) activity [GO:0141207]; Ser-tRNA(Ala) deacylase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g17258.t1 Q922B6 34.259 216 9.04e-33 128.0 sp|Q922B6|TRAF7_MOUSE E3 ubiquitin-protein ligase TRAF7 OS=Mus musculus OX=10090 GN=Traf7 PE=1 SV=1 TRAF7_MOUSE reviewed E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7) Mus musculus (Mouse) GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006357; GO:0006915; GO:0007249; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0035519; GO:0043410; GO:0043525; GO:0048471; GO:0061630; GO:0070372; GO:0071354; GO:2000060; GO:2001235 apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17258.t2 Q922B6 37.755 196 4.25e-37 139.0 sp|Q922B6|TRAF7_MOUSE E3 ubiquitin-protein ligase TRAF7 OS=Mus musculus OX=10090 GN=Traf7 PE=1 SV=1 TRAF7_MOUSE reviewed E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7) Mus musculus (Mouse) GO:0000122; GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0006357; GO:0006915; GO:0007249; GO:0008270; GO:0016567; GO:0031410; GO:0032880; GO:0033235; GO:0035519; GO:0043410; GO:0043525; GO:0048471; GO:0061630; GO:0070372; GO:0071354; GO:2000060; GO:2001235 apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to interleukin-6 [GO:0071354]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17259.t1 Q6Q0C0 30.946 391 8.02e-45 166.0 sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1 TRAF7_HUMAN reviewed E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235 apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17260.t1 Q9NR16 33.996 453 2.75e-57 211.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g17260.t1 Q9NR16 31.187 497 5.91e-47 181.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g17260.t1 Q9NR16 31.789 475 2.0199999999999998e-45 176.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g17260.t1 Q9NR16 28.521 568 2.12e-39 158.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g17260.t1 Q9NR16 29.306 447 2.73e-35 145.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g17260.t1 Q9NR16 26.786 448 4.3199999999999995e-30 129.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g17260.t1 Q9NR16 33.469 245 1.8700000000000002e-29 127.0 sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2 g17261.t1 Q4R5S9 53.297 182 1.97e-70 215.0 sp|Q4R5S9|PLD3B_MACFA PRELI domain containing protein 3B OS=Macaca fascicularis OX=9541 GN=PRELID3B PE=2 SV=1 g17262.t1 Q4G0P3 54.971 684 0.0 803.0 sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3 HYDIN_HUMAN reviewed Hydrocephalus-inducing protein homolog Homo sapiens (Human) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0030036; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 actin cytoskeleton organization [GO:0030036]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g17263.t1 Q4G0P3 35.521 259 7.22e-43 158.0 sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3 HYDIN_HUMAN reviewed Hydrocephalus-inducing protein homolog Homo sapiens (Human) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0030036; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 actin cytoskeleton organization [GO:0030036]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g17264.t1 Q80W93 41.935 1147 0.0 828.0 sp|Q80W93|HYDIN_MOUSE Hydrocephalus-inducing protein OS=Mus musculus OX=10090 GN=Hydin PE=1 SV=2 HYDIN_MOUSE reviewed Hydrocephalus-inducing protein (Protein Hy-3) Mus musculus (Mouse) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0007420; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 axonemal central apparatus assembly [GO:1904158]; brain development [GO:0007420]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g17265.t1 Q4G0P3 41.058 548 9.830000000000001e-123 401.0 sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3 HYDIN_HUMAN reviewed Hydrocephalus-inducing protein homolog Homo sapiens (Human) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0030036; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 actin cytoskeleton organization [GO:0030036]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g17266.t1 Q4G0P3 42.598 716 2.01e-172 555.0 sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3 HYDIN_HUMAN reviewed Hydrocephalus-inducing protein homolog Homo sapiens (Human) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0030036; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 actin cytoskeleton organization [GO:0030036]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g17267.t1 Q4G0P3 48.671 1317 0.0 1273.0 sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3 HYDIN_HUMAN reviewed Hydrocephalus-inducing protein homolog Homo sapiens (Human) GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0030036; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718 actin cytoskeleton organization [GO:0030036]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126] g17268.t1 Q6NRW0 26.427 806 1.05e-48 189.0 sp|Q6NRW0|MTBP_XENLA Mdm2-binding protein OS=Xenopus laevis OX=8355 GN=mtbp PE=2 SV=1 g17268.t2 Q6NRW0 26.394 807 3.02e-47 185.0 sp|Q6NRW0|MTBP_XENLA Mdm2-binding protein OS=Xenopus laevis OX=8355 GN=mtbp PE=2 SV=1 g17269.t1 G1SZ12 62.411 141 7.84e-57 179.0 sp|G1SZ12|RL14_RABIT Large ribosomal subunit protein eL14 OS=Oryctolagus cuniculus OX=9986 GN=RPL14 PE=1 SV=1 g17270.t1 Q9EPL4 52.258 155 7.86e-47 158.0 sp|Q9EPL4|METL9_MOUSE Protein-L-histidine N-pros-methyltransferase OS=Mus musculus OX=10090 GN=Mettl9 PE=1 SV=1 METL9_MOUSE reviewed Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (DORA reverse strand protein) (DREV) (Methyltransferase-like protein 9) (mMETTL9) Mus musculus (Mouse) GO:0005739; GO:0005783; GO:0032259; GO:0106370 methylation [GO:0032259] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] protein-L-histidine N-pros-methyltransferase activity [GO:0106370] g17272.t1 P0C024 35.526 228 4.91e-38 137.0 sp|P0C024|NUDT7_HUMAN Peroxisomal coenzyme A diphosphatase NUDT7 OS=Homo sapiens OX=9606 GN=NUDT7 PE=1 SV=1 NUDT7_HUMAN reviewed Peroxisomal coenzyme A diphosphatase NUDT7 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 7) (Nudix motif 7) Homo sapiens (Human) GO:0000287; GO:0005777; GO:0005782; GO:0005829; GO:0009132; GO:0010945; GO:0015938; GO:0030145; GO:0030515; GO:0036114; GO:0044580; GO:0046356; GO:0050873; GO:1901289; GO:1902858; GO:1902859; GO:2001294 acetyl-CoA catabolic process [GO:0046356]; brown fat cell differentiation [GO:0050873]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; nucleoside diphosphate metabolic process [GO:0009132]; propionyl-CoA catabolic process [GO:1902859]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] coenzyme A diphosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; snoRNA binding [GO:0030515] g17273.t1 Q9WV30 59.766 256 1.6e-96 327.0 sp|Q9WV30|NFAT5_MOUSE Nuclear factor of activated T-cells 5 OS=Mus musculus OX=10090 GN=Nfat5 PE=1 SV=2 g17273.t2 D3ZGB1 59.766 256 1.3599999999999999e-95 327.0 sp|D3ZGB1|NFAT5_RAT Nuclear factor of activated T-cells 5 OS=Rattus norvegicus OX=10116 GN=Nfat5 PE=1 SV=1 NFAT5_RAT reviewed Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) Rattus norvegicus (Rat) GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005737; GO:0005829; GO:0006351; GO:0006974; GO:0010628; GO:0033173; GO:0043123; GO:0045944; GO:0062176; GO:0070884; GO:0071345; GO:1904996; GO:1990837 calcineurin-NFAT signaling cascade [GO:0033173]; cellular response to cytokine stimulus [GO:0071345]; DNA damage response [GO:0006974]; DNA-templated transcription [GO:0006351]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R-loop processing [GO:0062176]; regulation of calcineurin-NFAT signaling cascade [GO:0070884] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g17274.t1 Q86U44 52.381 588 0.0 560.0 sp|Q86U44|MTA70_HUMAN N(6)-adenosine-methyltransferase catalytic subunit METTL3 OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2 MTA70_HUMAN reviewed N(6)-adenosine-methyltransferase catalytic subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N(6)-adenosine-methyltransferase 70 kDa subunit) (MT-A70) Homo sapiens (Human) GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047 cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047] g17275.t1 Q80W03 44.948 287 5.59e-47 176.0 sp|Q80W03|TOX3_MOUSE TOX high mobility group box family member 3 OS=Mus musculus OX=10090 GN=Tox3 PE=1 SV=1 g17275.t2 Q80W03 44.948 287 5.43e-47 176.0 sp|Q80W03|TOX3_MOUSE TOX high mobility group box family member 3 OS=Mus musculus OX=10090 GN=Tox3 PE=1 SV=1 g17275.t3 Q80W03 44.948 287 9.550000000000001e-47 176.0 sp|Q80W03|TOX3_MOUSE TOX high mobility group box family member 3 OS=Mus musculus OX=10090 GN=Tox3 PE=1 SV=1 g17275.t4 Q80W03 44.948 287 4.52e-47 176.0 sp|Q80W03|TOX3_MOUSE TOX high mobility group box family member 3 OS=Mus musculus OX=10090 GN=Tox3 PE=1 SV=1 g17291.t1 Q6DJE4 78.475 223 1.21e-125 357.0 sp|Q6DJE4|CPSF5_XENLA Cleavage and polyadenylation specificity factor subunit 5 OS=Xenopus laevis OX=8355 GN=nudt21 PE=2 SV=1 CPSF5_XENLA reviewed Cleavage and polyadenylation specificity factor subunit 5 (Nudix hydrolase 21) Xenopus laevis (African clawed frog) GO:0003729; GO:0005634; GO:0005737; GO:0005849; GO:0006397; GO:0010608; GO:0030154; GO:0031124; GO:0035925; GO:0042382; GO:0042802; GO:0051290; GO:0110104; GO:0180010; GO:2000738; GO:2000975 cell differentiation [GO:0030154]; co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; post-transcriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290] cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382] identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729] g17292.t1 Q8BTH6 70.504 139 1.77e-68 222.0 sp|Q8BTH6|SCRT2_MOUSE Transcriptional repressor scratch 2 OS=Mus musculus OX=10090 GN=Scrt2 PE=2 SV=2 g17293.t1 Q62737 45.806 155 2.39e-38 133.0 sp|Q62737|CY24A_RAT Cytochrome b-245 light chain OS=Rattus norvegicus OX=10116 GN=Cyba PE=1 SV=3 CY24A_RAT reviewed Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox) Rattus norvegicus (Rat) GO:0001666; GO:0001725; GO:0001938; GO:0003106; GO:0005737; GO:0005768; GO:0005886; GO:0005925; GO:0006801; GO:0006954; GO:0009055; GO:0009410; GO:0014823; GO:0014895; GO:0016175; GO:0016324; GO:0017004; GO:0017124; GO:0020037; GO:0030307; GO:0030425; GO:0031667; GO:0032755; GO:0032760; GO:0032930; GO:0034137; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0045777; GO:0046872; GO:0046982; GO:0048661; GO:0050665; GO:0050766; GO:0051279; GO:0051649; GO:0070254; GO:0070257; GO:0070555; GO:0071260; GO:0071333; GO:0071356; GO:0071480; GO:0072593; GO:0097038; GO:1900426; GO:1903428; GO:1904044; GO:1904385; GO:1904628; GO:1904845 cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; establishment of localization in cell [GO:0051649]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; reactive oxygen species metabolic process [GO:0072593]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; focal adhesion [GO:0005925]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] g17294.t1 F1QXM5 64.544 471 0.0 638.0 sp|F1QXM5|LDHD_DANRE Probable D-lactate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=ldhd PE=2 SV=1 LDHD_DANRE reviewed D-lactate dehydrogenase, mitochondrial (DLD) (Lactate dehydrogenase D) (EC 1.1.98.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004458; GO:0005739; GO:0008720; GO:0050660; GO:0071949; GO:0140170; GO:0140174; GO:1903457 lactate catabolic process [GO:1903457] mitochondrion [GO:0005739] (2R)-2-hydroxycarboxylate dehydrogenase activity [GO:0140174]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase (FAD) activity [GO:0140170]; D-lactate dehydrogenase (NAD+) activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660] g17296.t1 Q3MI05 43.524 471 8.49e-133 396.0 sp|Q3MI05|PPGB_BOVIN Lysosomal protective protein OS=Bos taurus OX=9913 GN=CTSA PE=2 SV=1 g17296.t2 Q3MI05 43.524 471 4.38e-133 396.0 sp|Q3MI05|PPGB_BOVIN Lysosomal protective protein OS=Bos taurus OX=9913 GN=CTSA PE=2 SV=1 g17298.t1 Q8BGA9 48.397 343 1.06e-116 351.0 sp|Q8BGA9|OXA1L_MOUSE Mitochondrial inner membrane protein OXA1L OS=Mus musculus OX=10090 GN=Oxa1l PE=1 SV=1 OXA1L_MOUSE reviewed Mitochondrial inner membrane protein OXA1L (Oxidase assembly 1-like protein) (OXA1-like protein) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0009060; GO:0031966; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0042803; GO:0051262; GO:0097177; GO:0141164 aerobic respiration [GO:0009060]; mitochondrial protein quality control [GO:0141164]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803] g17299.t1 Q5BK48 48.843 432 3.84e-146 426.0 sp|Q5BK48|TTC5_RAT Tetratricopeptide repeat protein 5 OS=Rattus norvegicus OX=10116 GN=Ttc5 PE=2 SV=1 TTC5_RAT reviewed Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap) Rattus norvegicus (Rat) GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410; GO:0043022; GO:0045944; GO:0061014 cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022] g17300.t1 Q9Y3D0 71.333 150 2.3400000000000003e-75 225.0 sp|Q9Y3D0|CIA2B_HUMAN Cytosolic iron-sulfur assembly component 2B OS=Homo sapiens OX=9606 GN=CIAO2B PE=1 SV=1 CIA2B_HUMAN reviewed Cytosolic iron-sulfur assembly component 2B (MSS19-interacting protein of 18 kDa) (Mitotic spindle-associated MMXD complex subunit MIP18) (Protein FAM96B) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0030496; GO:0051604; GO:0071817; GO:0097361 chromosome segregation [GO:0007059]; protein maturation [GO:0051604] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic [4Fe-4S] assembly targeting complex [GO:0097361]; midbody [GO:0030496]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] g17301.t1 Q92556 49.863 732 0.0 719.0 sp|Q92556|ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2 ELMO1_HUMAN reviewed Engulfment and cell motility protein 1 (Protein ced-12 homolog) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0098794; GO:0098978; GO:0150052 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] SH3 domain binding [GO:0017124] g17302.t1 Q9GKY8 51.002 449 8.569999999999999e-138 427.0 sp|Q9GKY8|JPH1_RABIT Junctophilin-1 OS=Oryctolagus cuniculus OX=9986 GN=JPH1 PE=2 SV=1 g17302.t2 Q9HDC5 43.648 614 5.229999999999999e-140 432.0 sp|Q9HDC5|JPH1_HUMAN Junctophilin-1 OS=Homo sapiens OX=9606 GN=JPH1 PE=1 SV=2 JPH1_HUMAN reviewed Junctophilin-1 (JP-1) (Junctophilin type 1) Homo sapiens (Human) GO:0005654; GO:0005789; GO:0005886; GO:0007517; GO:0008307; GO:0010880; GO:0010882; GO:0014701; GO:0016529; GO:0030018; GO:0030314; GO:0060402 calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018] structural constituent of muscle [GO:0008307] g17303.t1 Q6DCX5 27.361 413 3.7e-21 99.8 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g17305.t1 Q8N0W3 47.502 1101 0.0 978.0 sp|Q8N0W3|FCSK_HUMAN L-fucose kinase OS=Homo sapiens OX=9606 GN=FCSK PE=1 SV=2 FCSK_HUMAN reviewed L-fucose kinase (Fucokinase) (EC 2.7.1.52) Homo sapiens (Human) GO:0005524; GO:0005829; GO:0042350; GO:0042352; GO:0046835; GO:0050201 carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose biosynthetic process [GO:0042350]; GDP-L-fucose salvage [GO:0042352] cytosol [GO:0005829] ATP binding [GO:0005524]; fucokinase activity [GO:0050201] g17306.t1 A2RUV9 40.26 154 3.47e-27 111.0 sp|A2RUV9|AEBP1_RAT Adipocyte enhancer-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Aebp1 PE=2 SV=1 AEBP1_RAT reviewed Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein) Rattus norvegicus (Rat) GO:0000122; GO:0000977; GO:0001227; GO:0004180; GO:0005516; GO:0005518; GO:0005576; GO:0006355; GO:0006508; GO:0008270; GO:1904026 negative regulation of transcription by RNA polymerase II [GO:0000122]; proteolysis [GO:0006508]; regulation of collagen fibril organization [GO:1904026]; regulation of DNA-templated transcription [GO:0006355] extracellular region [GO:0005576] calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g17307.t1 Q5QJU3 49.805 257 7.89e-85 258.0 sp|Q5QJU3|ACER2_HUMAN Alkaline ceramidase 2 OS=Homo sapiens OX=9606 GN=ACER2 PE=1 SV=2 ACER2_HUMAN reviewed Alkaline ceramidase 2 (AlkCDase 2) (Alkaline CDase 2) (haCER2) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like) Homo sapiens (Human) GO:0000139; GO:0001953; GO:0005794; GO:0006974; GO:0008284; GO:0010506; GO:0010559; GO:0017040; GO:0030149; GO:0030330; GO:0032526; GO:0033629; GO:0042981; GO:0046512; GO:0046514; GO:0046872; GO:0071466 cellular response to xenobiotic stimulus [GO:0071466]; ceramide catabolic process [GO:0046514]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of glycoprotein biosynthetic process [GO:0010559]; response to retinoic acid [GO:0032526]; sphingolipid catabolic process [GO:0030149]; sphingosine biosynthetic process [GO:0046512] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040] g17308.t1 Q640F2 28.746 327 2.68e-29 128.0 sp|Q640F2|SHCBB_XENLA SHC SH2 domain-binding protein 1 homolog B OS=Xenopus laevis OX=8355 GN=shcbp1-b PE=2 SV=1 g17309.t1 Q6PDL0 53.924 497 1.33e-172 497.0 sp|Q6PDL0|DC1L2_MOUSE Cytoplasmic dynein 1 light intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync1li2 PE=1 SV=2 DC1L2_MOUSE reviewed Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) Mus musculus (Mouse) GO:0000226; GO:0000776; GO:0005524; GO:0005770; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090 cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802] g17309.t2 Q6PDL0 53.722 497 3.4e-172 496.0 sp|Q6PDL0|DC1L2_MOUSE Cytoplasmic dynein 1 light intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync1li2 PE=1 SV=2 DC1L2_MOUSE reviewed Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) Mus musculus (Mouse) GO:0000226; GO:0000776; GO:0005524; GO:0005770; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090 cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802] g17310.t1 A9UMG5 52.303 304 7.8e-105 311.0 sp|A9UMG5|IMPTB_XENTR Protein IMPACT-B OS=Xenopus tropicalis OX=8364 GN=impact-B PE=2 SV=1 g17311.t1 Q80V03 50.373 536 2.77e-165 486.0 sp|Q80V03|ADCK5_MOUSE Uncharacterized aarF domain-containing protein kinase 5 OS=Mus musculus OX=10090 GN=Adck5 PE=2 SV=2 g17312.t1 Q708S6 30.227 440 8.79e-57 200.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 g17313.t1 Q708S6 28.829 444 2.0599999999999997e-48 177.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 g17316.t1 P46197 55.2 250 3.72e-71 253.0 sp|P46197|ANPRB_BOVIN Atrial natriuretic peptide receptor 2 OS=Bos taurus OX=9913 GN=NPR2 PE=2 SV=1 g17317.t1 Q9Z1J3 76.471 408 0.0 688.0 sp|Q9Z1J3|NFS1_MOUSE Cysteine desulfurase OS=Mus musculus OX=10090 GN=Nfs1 PE=1 SV=3 NFS1_MOUSE reviewed Cysteine desulfurase (m-Nfs1) (EC 2.8.1.7) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005813; GO:0005829; GO:0006777; GO:0016226; GO:0030170; GO:0031071; GO:0032324; GO:0042803; GO:0044571; GO:0044572; GO:0046872; GO:0051536; GO:0097163; GO:0099128; GO:1990229 [2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] centrosome [GO:0005813]; cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial [2Fe-2S] assembly complex [GO:0099128]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; sulfur carrier activity [GO:0097163] g17318.t1 Q9P0J1 42.636 516 4.6300000000000003e-123 375.0 sp|Q9P0J1|PDP1_HUMAN [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PDP1 PE=1 SV=3 g17319.t1 A2RT91 31.614 756 6.87e-101 346.0 sp|A2RT91|ANKAR_MOUSE Ankyrin and armadillo repeat-containing protein OS=Mus musculus OX=10090 GN=Ankar PE=2 SV=1 g17320.t1 Q4AEI0 44.865 185 2.53e-47 160.0 sp|Q4AEI0|GPX2_PONPY Glutathione peroxidase 2 OS=Pongo pygmaeus OX=9600 GN=GPX2 PE=2 SV=2 GPX2_PONPY reviewed Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI) (Phospholipid hydroperoxide glutathione peroxidase GPX2) (EC 1.11.1.12) Pongo pygmaeus (Bornean orangutan) GO:0004602; GO:0005829; GO:0006979; GO:0047066 response to oxidative stress [GO:0006979] cytosol [GO:0005829] glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066] g17322.t1 Q9Y3Z3 49.831 590 0.0 568.0 sp|Q9Y3Z3|SAMH1_HUMAN Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Homo sapiens OX=9606 GN=SAMHD1 PE=1 SV=2 g17323.t1 B5X4H8 43.45 458 2.3399999999999998e-101 314.0 sp|B5X4H8|RFT2_SALSA Riboflavin transporter 2 OS=Salmo salar OX=8030 GN=rft2 PE=2 SV=1 g17325.t1 Q29496 43.158 285 1.86e-78 249.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g17326.t1 P33268 35.028 177 3.66e-28 114.0 sp|P33268|CP3A8_MACFA Cytochrome P450 3A8 OS=Macaca fascicularis OX=9541 GN=CYP3A8 PE=1 SV=1 g17329.t1 Q9ET66 44.324 185 1.9700000000000002e-43 167.0 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g17329.t2 Q9ET66 44.324 185 2.07e-43 167.0 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g17330.t1 Q29496 33.135 504 5.1499999999999996e-98 308.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g17332.t1 Q6PEH5 57.447 141 1.26e-53 168.0 sp|Q6PEH5|UB2V2_DANRE Ubiquitin-conjugating enzyme E2 variant 2 OS=Danio rerio OX=7955 GN=ube2v2 PE=2 SV=1 g17333.t1 Q5RAA9 33.862 189 9.29e-22 92.4 sp|Q5RAA9|NPS3A_PONAB Protein NipSnap homolog 3A OS=Pongo abelii OX=9601 GN=NIPSNAP3A PE=2 SV=1 g17334.t1 P28075 77.295 207 3.0400000000000003e-116 337.0 sp|P28075|PSB5_RAT Proteasome subunit beta type-5 OS=Rattus norvegicus OX=10116 GN=Psmb5 PE=1 SV=3 PSB5_RAT reviewed Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit X) (Proteasome subunit beta-5) (beta-5) Rattus norvegicus (Rat) GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0006508; GO:0006979; GO:0008233; GO:0019774; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; response to oxidative stress [GO:0006979] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774] endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298] g17335.t1 Q9Y0H4 55.767 945 0.0 1009.0 sp|Q9Y0H4|SUDX_DROME E3 ubiquitin-protein ligase Su(dx) OS=Drosophila melanogaster OX=7227 GN=Su(dx) PE=1 SV=1 g17336.t1 Q9Y6V0 45.6 125 7.98e-23 105.0 sp|Q9Y6V0|PCLO_HUMAN Protein piccolo OS=Homo sapiens OX=9606 GN=PCLO PE=1 SV=5 PCLO_HUMAN reviewed Protein piccolo (Aczonin) Homo sapiens (Human) GO:0005509; GO:0005522; GO:0005544; GO:0005856; GO:0007010; GO:0008270; GO:0014069; GO:0016079; GO:0017157; GO:0030073; GO:0030424; GO:0035418; GO:0045202; GO:0048788; GO:0070062; GO:0097091; GO:0098882; GO:0098978; GO:0098982; GO:0099140; GO:1904071 cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; presynaptic actin cytoskeleton organization [GO:0099140]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of exocytosis [GO:0017157]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079] axon [GO:0030424]; cytoskeleton [GO:0005856]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synapse [GO:0045202] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882]; zinc ion binding [GO:0008270] g17338.t1 Q9Y6V0 41.296 247 1.17e-41 164.0 sp|Q9Y6V0|PCLO_HUMAN Protein piccolo OS=Homo sapiens OX=9606 GN=PCLO PE=1 SV=5 PCLO_HUMAN reviewed Protein piccolo (Aczonin) Homo sapiens (Human) GO:0005509; GO:0005522; GO:0005544; GO:0005856; GO:0007010; GO:0008270; GO:0014069; GO:0016079; GO:0017157; GO:0030073; GO:0030424; GO:0035418; GO:0045202; GO:0048788; GO:0070062; GO:0097091; GO:0098882; GO:0098978; GO:0098982; GO:0099140; GO:1904071 cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; presynaptic actin cytoskeleton organization [GO:0099140]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of exocytosis [GO:0017157]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079] axon [GO:0030424]; cytoskeleton [GO:0005856]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synapse [GO:0045202] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882]; zinc ion binding [GO:0008270] g17338.t1 Q9Y6V0 42.553 235 4.33e-41 162.0 sp|Q9Y6V0|PCLO_HUMAN Protein piccolo OS=Homo sapiens OX=9606 GN=PCLO PE=1 SV=5 PCLO_HUMAN reviewed Protein piccolo (Aczonin) Homo sapiens (Human) GO:0005509; GO:0005522; GO:0005544; GO:0005856; GO:0007010; GO:0008270; GO:0014069; GO:0016079; GO:0017157; GO:0030073; GO:0030424; GO:0035418; GO:0045202; GO:0048788; GO:0070062; GO:0097091; GO:0098882; GO:0098978; GO:0098982; GO:0099140; GO:1904071 cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; presynaptic actin cytoskeleton organization [GO:0099140]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of exocytosis [GO:0017157]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079] axon [GO:0030424]; cytoskeleton [GO:0005856]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synapse [GO:0045202] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882]; zinc ion binding [GO:0008270] g17338.t1 Q9Y6V0 41.202 233 2.06e-34 142.0 sp|Q9Y6V0|PCLO_HUMAN Protein piccolo OS=Homo sapiens OX=9606 GN=PCLO PE=1 SV=5 PCLO_HUMAN reviewed Protein piccolo (Aczonin) Homo sapiens (Human) GO:0005509; GO:0005522; GO:0005544; GO:0005856; GO:0007010; GO:0008270; GO:0014069; GO:0016079; GO:0017157; GO:0030073; GO:0030424; GO:0035418; GO:0045202; GO:0048788; GO:0070062; GO:0097091; GO:0098882; GO:0098978; GO:0098982; GO:0099140; GO:1904071 cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; presynaptic actin cytoskeleton organization [GO:0099140]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of exocytosis [GO:0017157]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079] axon [GO:0030424]; cytoskeleton [GO:0005856]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synapse [GO:0045202] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882]; zinc ion binding [GO:0008270] g17341.t1 Q8IY22 51.385 325 2e-106 342.0 sp|Q8IY22|CMIP_HUMAN C-Maf-inducing protein OS=Homo sapiens OX=9606 GN=CMIP PE=1 SV=3 CMIP_HUMAN reviewed C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip) Homo sapiens (Human) GO:0001701; GO:0005654; GO:0005829 in utero embryonic development [GO:0001701] cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17341.t1 Q8IY22 51.724 290 9.02e-96 314.0 sp|Q8IY22|CMIP_HUMAN C-Maf-inducing protein OS=Homo sapiens OX=9606 GN=CMIP PE=1 SV=3 CMIP_HUMAN reviewed C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip) Homo sapiens (Human) GO:0001701; GO:0005654; GO:0005829 in utero embryonic development [GO:0001701] cytosol [GO:0005829]; nucleoplasm [GO:0005654] g17343.t1 Q91XU0 52.071 338 4.300000000000001e-109 336.0 sp|Q91XU0|WRIP1_MOUSE ATPase WRNIP1 OS=Mus musculus OX=10090 GN=Wrnip1 PE=1 SV=2 g17347.t1 Q8NG66 44.898 392 6.63e-120 373.0 sp|Q8NG66|NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens OX=9606 GN=NEK11 PE=1 SV=2 NEK11_HUMAN reviewed Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990 intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17348.t1 Q2TB18 28.173 717 1.58e-74 257.0 sp|Q2TB18|ASTE1_HUMAN Single-strand DNA endonuclease ASTE1 OS=Homo sapiens OX=9606 GN=ASTE1 PE=1 SV=1 ASTE1_HUMAN reviewed Single-strand DNA endonuclease ASTE1 (EC 3.1.-.-) (Protein asteroid homolog 1) Homo sapiens (Human) GO:0000014; GO:0000724; GO:0006303; GO:1990599 double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303] 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] g17350.t1 Q9BZ19 34.545 220 8.910000000000001e-27 113.0 sp|Q9BZ19|ANR60_HUMAN Ankyrin repeat domain-containing protein 60 OS=Homo sapiens OX=9606 GN=ANKRD60 PE=1 SV=3 g17351.t1 Q6ZQ89 62.885 617 0.0 747.0 sp|Q6ZQ89|MARH6_MOUSE E3 ubiquitin-protein ligase MARCHF6 OS=Mus musculus OX=10090 GN=Marchf6 PE=2 SV=2 g17351.t1 Q6ZQ89 53.495 329 7.07e-106 356.0 sp|Q6ZQ89|MARH6_MOUSE E3 ubiquitin-protein ligase MARCHF6 OS=Mus musculus OX=10090 GN=Marchf6 PE=2 SV=2 g17352.t1 Q6ZMY6 40.453 309 2.53e-77 246.0 sp|Q6ZMY6|WDR88_HUMAN WD repeat-containing protein 88 OS=Homo sapiens OX=9606 GN=WDR88 PE=1 SV=2 g17356.t1 Q5RKH1 76.658 377 0.0 632.0 sp|Q5RKH1|PRP4K_RAT Serine/threonine-protein kinase PRP4 homolog OS=Rattus norvegicus OX=10116 GN=Prp4k PE=1 SV=1 PRP4K_RAT reviewed Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog) Rattus norvegicus (Rat) GO:0000244; GO:0000387; GO:0000776; GO:0004674; GO:0005524; GO:0005634; GO:0005694; GO:0016607; GO:0035329; GO:0035332; GO:0045292; GO:0046827; GO:0071013; GO:0090266; GO:0106310 hippo signaling [GO:0035329]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244] catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17363.t1 A6QLM0 53.6 125 2.36e-42 143.0 sp|A6QLM0|PEDS1_BOVIN Plasmanylethanolamine desaturase 1 OS=Bos taurus OX=9913 GN=PEDS1 PE=2 SV=1 g17364.t1 A5PLL7 65.546 119 9.21e-53 169.0 sp|A5PLL7|PEDS1_HUMAN Plasmanylethanolamine desaturase 1 OS=Homo sapiens OX=9606 GN=PEDS1 PE=1 SV=3 PEDS1_HUMAN reviewed Plasmanylethanolamine desaturase 1 (EC 1.14.19.77) (Transmembrane protein 189) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0050207 ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] plasmanylethanolamine desaturase activity [GO:0050207] g17367.t1 Q9HD34 52.874 87 1.1999999999999999e-28 101.0 sp|Q9HD34|LYRM4_HUMAN LYR motif-containing protein 4 OS=Homo sapiens OX=9606 GN=LYRM4 PE=1 SV=1 LYRM4_HUMAN reviewed LYR motif-containing protein 4 Homo sapiens (Human) GO:0005198; GO:0005634; GO:0005739; GO:0005759; GO:0016226; GO:0016604; GO:0042803; GO:0044571; GO:0044572; GO:0060090; GO:0099128; GO:1990221; GO:1990229 [2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; iron-sulfur cluster assembly [GO:0016226] iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial [2Fe-2S] assembly complex [GO:0099128]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleus [GO:0005634] molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g17368.t1 Q8WVE7 50.0 110 1.0100000000000001e-29 107.0 sp|Q8WVE7|T170A_HUMAN Transmembrane protein 170A OS=Homo sapiens OX=9606 GN=TMEM170A PE=1 SV=1 T170A_HUMAN reviewed Transmembrane protein 170A Homo sapiens (Human) GO:0005635; GO:0005789; GO:0006998; GO:0051292; GO:0071786 endoplasmic reticulum tubular network organization [GO:0071786]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292] endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635] g17369.t1 Q9PVZ4 33.594 384 1.05e-49 197.0 sp|Q9PVZ4|INSR_XENLA Insulin receptor OS=Xenopus laevis OX=8355 GN=insr PE=1 SV=1 g17370.t1 P36514 36.133 512 3.38e-108 336.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g17371.t1 P23342 31.854 383 8.41e-59 199.0 sp|P23342|MSOX_BACSN Monomeric sarcosine oxidase OS=Bacillus sp. (strain NS-129) OX=1419 GN=soxA PE=1 SV=1 g17372.t1 P36514 36.914 512 3.09e-112 346.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g17373.t1 Q9HYH5 30.189 212 3.6599999999999995e-23 98.6 sp|Q9HYH5|Y3430_PSEAE Putative aldolase class 2 protein PA3430 OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=PA3430 PE=3 SV=1 g17374.t1 Q9HYH5 34.634 205 5.41e-29 114.0 sp|Q9HYH5|Y3430_PSEAE Putative aldolase class 2 protein PA3430 OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=PA3430 PE=3 SV=1 g17375.t1 Q75QN2 32.583 1022 4.95e-164 510.0 sp|Q75QN2|INT8_HUMAN Integrator complex subunit 8 OS=Homo sapiens OX=9606 GN=INTS8 PE=1 SV=1 INT8_HUMAN reviewed Integrator complex subunit 8 (Int8) (Protein kaonashi-1) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243; GO:0034472; GO:0071168; GO:0160232; GO:0160240 protein localization to chromatin [GO:0071168]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] chromatin [GO:0000785]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g17376.t1 Q9UGM3 53.469 245 1.24e-71 249.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 55.602 241 1.6600000000000002e-70 246.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 53.937 254 1.76e-70 245.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 53.252 246 2.55e-70 245.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 50.965 259 7.249999999999999e-68 238.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 50.388 258 4.41e-67 236.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 50.973 257 1.01e-66 234.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 50.388 258 1.37e-66 234.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 48.889 270 1.41e-66 234.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 50.195 257 1.74e-66 234.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 49.057 265 9.1e-66 232.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 52.941 119 2.32e-31 131.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 61.111 90 1.3100000000000002e-27 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17376.t1 Q9UGM3 54.545 99 4.05e-24 109.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17380.t1 O75636 41.81 232 2.85e-38 143.0 sp|O75636|FCN3_HUMAN Ficolin-3 OS=Homo sapiens OX=9606 GN=FCN3 PE=1 SV=2 FCN3_HUMAN reviewed Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (H-ficolin) (Hakata antigen) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0030246; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0051607; GO:0072562; GO:0097367; GO:0106139; GO:1902679; GO:1903028; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g17381.t1 A2AV25 38.272 243 9.479999999999999e-42 155.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g17382.t1 Q92750 53.004 283 4.16e-90 311.0 sp|Q92750|TAF4B_HUMAN Transcription initiation factor TFIID subunit 4B OS=Homo sapiens OX=9606 GN=TAF4B PE=1 SV=2 TAF4B_HUMAN reviewed Transcription initiation factor TFIID subunit 4B (Transcription initiation factor TFIID 105 kDa subunit) (TAF(II)105) (TAFII-105) (TAFII105) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006367; GO:0007283; GO:0016251; GO:0042789; GO:0046982; GO:0048477; GO:0051059; GO:0051123; GO:0060261 mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]; transcription initiation at RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251] g17382.t1 Q92750 32.776 299 1.36e-25 117.0 sp|Q92750|TAF4B_HUMAN Transcription initiation factor TFIID subunit 4B OS=Homo sapiens OX=9606 GN=TAF4B PE=1 SV=2 TAF4B_HUMAN reviewed Transcription initiation factor TFIID subunit 4B (Transcription initiation factor TFIID 105 kDa subunit) (TAF(II)105) (TAFII-105) (TAFII105) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006367; GO:0007283; GO:0016251; GO:0042789; GO:0046982; GO:0048477; GO:0051059; GO:0051123; GO:0060261 mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283]; transcription initiation at RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251] g17383.t1 Q5XJ34 56.126 253 2.4400000000000003e-100 296.0 sp|Q5XJ34|KC15L_DANRE BTB/POZ domain-containing protein kctd15-like OS=Danio rerio OX=7955 GN=kctd15l PE=1 SV=1 g17384.t1 Q3MI05 44.346 451 1.2599999999999998e-128 384.0 sp|Q3MI05|PPGB_BOVIN Lysosomal protective protein OS=Bos taurus OX=9913 GN=CTSA PE=2 SV=1 g17385.t1 P16675 48.775 449 1.42e-151 442.0 sp|P16675|PPGB_MOUSE Lysosomal protective protein OS=Mus musculus OX=10090 GN=Ctsa PE=1 SV=1 PPGB_MOUSE reviewed Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain] Mus musculus (Mouse) GO:0004185; GO:0005739; GO:0005764; GO:0006508; GO:0031647; GO:1904715 negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] lysosome [GO:0005764]; mitochondrion [GO:0005739] serine-type carboxypeptidase activity [GO:0004185] g17386.t1 Q7TSH2 53.832 1057 0.0 1115.0 sp|Q7TSH2|KPBB_MOUSE Phosphorylase b kinase regulatory subunit beta OS=Mus musculus OX=10090 GN=Phkb PE=1 SV=1 g17387.t1 Q5M8Z2 52.326 86 1.74e-25 95.9 sp|Q5M8Z2|PREY_XENTR Protein preY, mitochondrial OS=Xenopus tropicalis OX=8364 GN=pyurf PE=2 SV=1 g17388.t1 Q10570 56.653 1488 0.0 1716.0 sp|Q10570|CPSF1_HUMAN Cleavage and polyadenylation specificity factor subunit 1 OS=Homo sapiens OX=9606 GN=CPSF1 PE=1 SV=2 CPSF1_HUMAN reviewed Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005847; GO:0006397; GO:0019899; GO:0035925; GO:0180012 co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180012]; mRNA processing [GO:0006397] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925] g17389.t1 Q5XH29 24.148 352 6.07e-30 120.0 sp|Q5XH29|CENNA_XENLA Centromere protein N-A OS=Xenopus laevis OX=8355 GN=cenpn-a PE=2 SV=2 g17390.t1 Q32P85 86.458 96 2.2200000000000002e-57 174.0 sp|Q32P85|DLRB2_BOVIN Dynein light chain roadblock-type 2 OS=Bos taurus OX=9913 GN=DYNLRB2 PE=3 SV=1 g17391.t1 Q9D9I4 59.429 350 4.7e-144 419.0 sp|Q9D9I4|TBC20_MOUSE TBC1 domain family member 20 OS=Mus musculus OX=10090 GN=Tbc1d20 PE=1 SV=1 TBC20_MOUSE reviewed TBC1 domain family member 20 Mus musculus (Mouse) GO:0000139; GO:0001675; GO:0002088; GO:0005096; GO:0005783; GO:0005789; GO:0006888; GO:0007030; GO:0007283; GO:0008584; GO:0019068; GO:0031267; GO:0031965; GO:0034389; GO:0043010; GO:0044829; GO:0046726; GO:0070309; GO:0072520; GO:0090110; GO:1902953 acrosome assembly [GO:0001675]; camera-type eye development [GO:0043010]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; host-mediated activation of viral genome replication [GO:0044829]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; male gonad development [GO:0008584]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]; virion assembly [GO:0019068] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g17392.t1 E7F4Z4 55.491 173 1.57e-62 224.0 sp|E7F4Z4|ZDHC1_DANRE Palmitoyltransferase ZDHHC1 OS=Danio rerio OX=7955 GN=zdhhc1 PE=2 SV=2 g17393.t1 P85971 47.436 234 3.23e-67 211.0 sp|P85971|6PGL_RAT 6-phosphogluconolactonase OS=Rattus norvegicus OX=10116 GN=Pgls PE=1 SV=1 g17396.t1 Q5HYA8 42.331 978 0.0 748.0 sp|Q5HYA8|MKS3_HUMAN Meckelin OS=Homo sapiens OX=9606 GN=TMEM67 PE=1 SV=2 MKS3_HUMAN reviewed Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67) Homo sapiens (Human) GO:0005789; GO:0005813; GO:0010826; GO:0030659; GO:0031005; GO:0035567; GO:0035869; GO:0036038; GO:0036503; GO:0051082; GO:0060170; GO:0060271 cilium assembly [GO:0060271]; ERAD pathway [GO:0036503]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567] centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; MKS complex [GO:0036038] filamin binding [GO:0031005]; unfolded protein binding [GO:0051082] g17397.t1 O08999 31.811 657 4.88e-65 243.0 sp|O08999|LTBP2_MOUSE Latent-transforming growth factor beta-binding protein 2 OS=Mus musculus OX=10090 GN=Ltbp2 PE=1 SV=2 g17397.t1 O08999 38.337 493 7.83e-59 224.0 sp|O08999|LTBP2_MOUSE Latent-transforming growth factor beta-binding protein 2 OS=Mus musculus OX=10090 GN=Ltbp2 PE=1 SV=2 g17398.t1 Q0VCA2 26.761 355 5.09e-25 109.0 sp|Q0VCA2|ARRD3_BOVIN Arrestin domain-containing protein 3 OS=Bos taurus OX=9913 GN=ARRDC3 PE=2 SV=1 ARRD3_BOVIN reviewed Arrestin domain-containing protein 3 Bos taurus (Bovine) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0035332; GO:0043588; GO:0060613; GO:0071878; GO:0090327; GO:0120163 fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031]; skin development [GO:0043588] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] beta-3 adrenergic receptor binding [GO:0031699] g17398.t2 Q0VCA2 28.939 311 5.840000000000001e-26 111.0 sp|Q0VCA2|ARRD3_BOVIN Arrestin domain-containing protein 3 OS=Bos taurus OX=9913 GN=ARRDC3 PE=2 SV=1 ARRD3_BOVIN reviewed Arrestin domain-containing protein 3 Bos taurus (Bovine) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0035332; GO:0043588; GO:0060613; GO:0071878; GO:0090327; GO:0120163 fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031]; skin development [GO:0043588] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] beta-3 adrenergic receptor binding [GO:0031699] g17399.t1 Q9VJ33 94.737 76 7.64e-46 144.0 sp|Q9VJ33|NEDD8_DROME Ubiquitin-like protein NEDD8 OS=Drosophila melanogaster OX=7227 GN=Nedd8 PE=1 SV=1 NEDD8_DROME reviewed Ubiquitin-like protein NEDD8 (Neddylin) Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005737; GO:0008283; GO:0008589; GO:0019941; GO:0030162; GO:0030431; GO:0031386; GO:0031625; GO:0031647; GO:0036099; GO:0045116; GO:0045879; GO:0051438 cell population proliferation [GO:0008283]; female germ-line stem cell population maintenance [GO:0036099]; modification-dependent protein catabolic process [GO:0019941]; negative regulation of smoothened signaling pathway [GO:0045879]; protein neddylation [GO:0045116]; regulation of protein stability [GO:0031647]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]; regulation of ubiquitin-protein transferase activity [GO:0051438]; sleep [GO:0030431] cytoplasm [GO:0005737]; nucleus [GO:0005634] protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] g17400.t1 P36959 74.709 344 0.0 562.0 sp|P36959|GMPR1_HUMAN GMP reductase 1 OS=Homo sapiens OX=9606 GN=GMPR PE=1 SV=1 GMPR1_HUMAN reviewed GMP reductase 1 (GMPR 1) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 1) (Guanosine monophosphate reductase 1) Homo sapiens (Human) GO:0003920; GO:0005829; GO:0006144; GO:0006163; GO:0009409; GO:0046872; GO:1902560 purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409] cytosol [GO:0005829]; GMP reductase complex [GO:1902560] GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872] g17401.t1 Q9Y236 42.974 491 2.38e-128 386.0 sp|Q9Y236|OSGI2_HUMAN Oxidative stress-induced growth inhibitor 2 OS=Homo sapiens OX=9606 GN=OSGIN2 PE=1 SV=1 g17402.t1 Q9H6D7 32.249 338 5.38e-51 177.0 sp|Q9H6D7|HAUS4_HUMAN HAUS augmin-like complex subunit 4 OS=Homo sapiens OX=9606 GN=HAUS4 PE=1 SV=1 g17403.t1 Q8NA66 31.28 422 3.4299999999999995e-52 186.0 sp|Q8NA66|CNBD1_HUMAN Cyclic nucleotide-binding domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CNBD1 PE=1 SV=1 g17404.t1 Q14028 43.706 572 6.989999999999999e-147 476.0 sp|Q14028|CNGB1_HUMAN Cyclic nucleotide-gated channel beta-1 OS=Homo sapiens OX=9606 GN=CNGB1 PE=1 SV=2 g17405.t1 P15428 37.918 269 7.210000000000001e-56 183.0 sp|P15428|PGDH_HUMAN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Homo sapiens OX=9606 GN=HPGD PE=1 SV=1 PGDH_HUMAN reviewed 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) Homo sapiens (Human) GO:0001822; GO:0004957; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0019372; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0047034; GO:0051287; GO:0070062; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828 ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] 15-hydroxyicosatetraenoate dehydrogenase activity [GO:0047034]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957] g17407.t1 Q9JK83 54.037 322 5.91e-106 319.0 sp|Q9JK83|PAR6B_MOUSE Partitioning defective 6 homolog beta OS=Mus musculus OX=10090 GN=Pard6b PE=1 SV=2 PAR6B_MOUSE reviewed Partitioning defective 6 homolog beta (PAR-6 beta) (PAR-6B) Mus musculus (Mouse) GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0016324; GO:0030054; GO:0032991; GO:0045177; GO:0051301; GO:0060341; GO:0065003 cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] g17408.t1 Q9BZ19 42.593 216 3.6499999999999994e-52 182.0 sp|Q9BZ19|ANR60_HUMAN Ankyrin repeat domain-containing protein 60 OS=Homo sapiens OX=9606 GN=ANKRD60 PE=1 SV=3 g17409.t1 Q0MQI9 74.672 229 3.66e-126 360.0 sp|Q0MQI9|NDUV2_PANTR NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial OS=Pan troglodytes OX=9598 GN=NDUFV2 PE=2 SV=1 NDUV2_PANTR reviewed NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit) Pan troglodytes (Chimpanzee) GO:0005743; GO:0006120; GO:0008137; GO:0016491; GO:0045271; GO:0046872; GO:0051537 mitochondrial electron transport, NADH to ubiquinone [GO:0006120] mitochondrial inner membrane [GO:0005743]; respiratory chain complex I [GO:0045271] 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity [GO:0016491] g17410.t1 Q0VFG3 45.848 277 1.27e-70 222.0 sp|Q0VFG3|SEGN_XENTR Secretagogin OS=Xenopus tropicalis OX=8364 GN=scgn PE=2 SV=1 g17410.t2 Q0VFG3 46.763 278 1.98e-74 232.0 sp|Q0VFG3|SEGN_XENTR Secretagogin OS=Xenopus tropicalis OX=8364 GN=scgn PE=2 SV=1 g17411.t1 Q32PH2 33.621 348 1.85e-49 179.0 sp|Q32PH2|TM143_BOVIN Transmembrane protein 143 OS=Bos taurus OX=9913 GN=TMEM143 PE=2 SV=1 g17412.t1 Q8R0A7 46.825 126 1.02e-31 123.0 sp|Q8R0A7|K0513_MOUSE Uncharacterized protein KIAA0513 OS=Mus musculus OX=10090 GN=Kiaa0513 PE=1 SV=1 g17412.t1 Q8R0A7 55.435 92 2.3100000000000002e-27 111.0 sp|Q8R0A7|K0513_MOUSE Uncharacterized protein KIAA0513 OS=Mus musculus OX=10090 GN=Kiaa0513 PE=1 SV=1 g17414.t1 O13016 56.554 267 2.7599999999999998e-108 328.0 sp|O13016|PTN1_CHICK Tyrosine-protein phosphatase non-receptor type 1 OS=Gallus gallus OX=9031 GN=PTPN1 PE=1 SV=1 g17414.t2 O13016 56.767 266 2.44e-108 327.0 sp|O13016|PTN1_CHICK Tyrosine-protein phosphatase non-receptor type 1 OS=Gallus gallus OX=9031 GN=PTPN1 PE=1 SV=1 g17415.t1 Q9M571 54.453 494 0.0 545.0 sp|Q9M571|PEAMT_SPIOL Phosphoethanolamine N-methyltransferase OS=Spinacia oleracea OX=3562 GN=PEAMT PE=1 SV=1 g17416.t1 Q9M571 55.306 490 0.0 548.0 sp|Q9M571|PEAMT_SPIOL Phosphoethanolamine N-methyltransferase OS=Spinacia oleracea OX=3562 GN=PEAMT PE=1 SV=1 g17417.t1 Q9M571 55.061 494 0.0 550.0 sp|Q9M571|PEAMT_SPIOL Phosphoethanolamine N-methyltransferase OS=Spinacia oleracea OX=3562 GN=PEAMT PE=1 SV=1 g17418.t1 Q9M571 55.061 494 0.0 550.0 sp|Q9M571|PEAMT_SPIOL Phosphoethanolamine N-methyltransferase OS=Spinacia oleracea OX=3562 GN=PEAMT PE=1 SV=1 g17419.t1 O77750 42.966 263 5.37e-72 229.0 sp|O77750|AQP4_BOVIN Aquaporin-4 OS=Bos taurus OX=9913 GN=AQP4 PE=2 SV=3 AQP4_BOVIN reviewed Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4) Bos taurus (Bovine) GO:0005576; GO:0005886; GO:0006833; GO:0009992; GO:0010008; GO:0015250; GO:0016323; GO:0042383; GO:0050891; GO:0051289; GO:0090660; GO:0097450 cerebrospinal fluid circulation [GO:0090660]; intracellular water homeostasis [GO:0009992]; multicellular organismal-level water homeostasis [GO:0050891]; protein homotetramerization [GO:0051289]; water transport [GO:0006833] astrocyte end-foot [GO:0097450]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] water channel activity [GO:0015250] g17420.t1 F1PLN3 41.339 508 3.99e-118 360.0 sp|F1PLN3|FTO_CANLF Alpha-ketoglutarate-dependent dioxygenase FTO OS=Canis lupus familiaris OX=9615 GN=FTO PE=3 SV=3 FTO_CANLF reviewed Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO) (EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (m6A(m)-demethylase FTO) (EC 1.14.11.-) (mRNA N(6)-methyladenosine demethylase FTO) (EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO) (EC 1.14.11.-) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005634; GO:0005737; GO:0006307; GO:0010883; GO:0016607; GO:0016740; GO:0035516; GO:0040014; GO:0042245; GO:0046872; GO:1990931 DNA alkylation repair [GO:0006307]; regulation of lipid storage [GO:0010883]; regulation of multicellular organism growth [GO:0040014]; RNA repair [GO:0042245] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] broad specificity oxidative DNA demethylase activity [GO:0035516]; metal ion binding [GO:0046872]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; transferase activity [GO:0016740] g17421.t1 Q68CZ1 47.276 1028 0.0 908.0 sp|Q68CZ1|FTM_HUMAN Protein fantom OS=Homo sapiens OX=9606 GN=RPGRIP1L PE=1 SV=2 FTM_HUMAN reviewed Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein) Homo sapiens (Human) GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0016607; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0090102; GO:1905515 cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548] axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] thromboxane A2 receptor binding [GO:0031870] g17421.t1 Q68CZ1 45.625 160 2.9400000000000004e-32 140.0 sp|Q68CZ1|FTM_HUMAN Protein fantom OS=Homo sapiens OX=9606 GN=RPGRIP1L PE=1 SV=2 FTM_HUMAN reviewed Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein) Homo sapiens (Human) GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0016607; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0090102; GO:1905515 cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548] axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] thromboxane A2 receptor binding [GO:0031870] g17425.t1 Q9N1Q0 77.397 146 1.2e-69 216.0 sp|Q9N1Q0|RSMB_NOTEU Small nuclear ribonucleoprotein-associated protein B' OS=Notamacropus eugenii OX=9315 GN=SNRPB PE=2 SV=1 g17426.t1 A5GFY4 63.122 583 0.0 795.0 sp|A5GFY4|NELFD_PIG Negative elongation factor D OS=Sus scrofa OX=9823 GN=NELFCD PE=3 SV=1 g17427.t1 A8WGA0 37.525 509 8.93e-121 370.0 sp|A8WGA0|C27C1_DANRE Cytochrome P450 27C1 OS=Danio rerio OX=7955 GN=cyp27c1 PE=1 SV=2 C27C1_DANRE reviewed Cytochrome P450 27C1 (EC 1.14.19.53) (All-trans retinol 3,4-desaturase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001972; GO:0004497; GO:0005506; GO:0005739; GO:0006629; GO:0016020; GO:0020037; GO:0061896; GO:0061897; GO:0061898; GO:1904768 lipid metabolic process [GO:0006629] membrane [GO:0016020]; mitochondrion [GO:0005739] all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972] g17428.t1 P56395 54.4 125 8.36e-43 140.0 sp|P56395|CYB5_MOUSE Cytochrome b5 OS=Mus musculus OX=10090 GN=Cyb5a PE=1 SV=2 CYB5_MOUSE reviewed Cytochrome b5 Mus musculus (Mouse) GO:0004768; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0006631; GO:0016020; GO:0019899; GO:0020037; GO:0046872 fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrion [GO:0005739] enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768] g17429.t1 Q8QZR1 55.754 391 3.61e-167 479.0 sp|Q8QZR1|ATTY_MOUSE Tyrosine aminotransferase OS=Mus musculus OX=10090 GN=Tat PE=1 SV=1 g17430.t1 Q6AX73 31.047 277 3.75e-33 125.0 sp|Q6AX73|FITM2_XENLA Acyl-coenzyme A diphosphatase FITM2 OS=Xenopus laevis OX=8355 GN=fitm2 PE=2 SV=1 FITM2_XENLA reviewed Acyl-coenzyme A diphosphatase FITM2 (EC 3.6.1.-) (Fat storage-inducing transmembrane protein 2) (Fat-inducing protein 2) Xenopus laevis (African clawed frog) GO:0005789; GO:0007010; GO:0008654; GO:0010945; GO:0017129; GO:0019915; GO:0019992; GO:0022604; GO:0034389; GO:0036115; GO:0055088; GO:0140042 cytoskeleton organization [GO:0007010]; fatty-acyl-CoA catabolic process [GO:0036115]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of cell morphogenesis [GO:0022604] endoplasmic reticulum membrane [GO:0005789] coenzyme A diphosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129] g17431.t1 Q8TB36 31.889 323 1.29e-51 177.0 sp|Q8TB36|GDAP1_HUMAN Ganglioside-induced differentiation-associated protein 1 OS=Homo sapiens OX=9606 GN=GDAP1 PE=1 SV=3 GDAP1_HUMAN reviewed Ganglioside-induced differentiation-associated protein 1 (GDAP1) Homo sapiens (Human) GO:0000266; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005829; GO:0006626; GO:0008053; GO:0016020; GO:0032526; GO:0071305 cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778] g17432.t1 Q96S44 58.333 228 3.79e-90 269.0 sp|Q96S44|PRPK_HUMAN EKC/KEOPS complex subunit TP53RK OS=Homo sapiens OX=9606 GN=TP53RK PE=1 SV=2 PRPK_HUMAN reviewed EKC/KEOPS complex subunit TP53RK (EC 3.6.-.-) (Atypical serine/threonine protein kinase TP53RK) (Nori-2) (TP53-regulating kinase) (EC 2.7.11.1) (p53-related protein kinase) Homo sapiens (Human) GO:0000408; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0008033; GO:0016787; GO:0070525; GO:0106310; GO:1901796 protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17433.t1 Q8BGC3 27.027 407 1.1599999999999999e-34 137.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g17435.t1 P61132 43.478 276 8.34e-83 261.0 sp|P61132|SIAT6_PANTR CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST3GAL3 PE=2 SV=1 g17436.t1 A5PJK1 56.489 262 2.14e-93 285.0 sp|A5PJK1|TMPPE_BOVIN Transmembrane protein with metallophosphoesterase domain OS=Bos taurus OX=9913 GN=TMPPE PE=2 SV=1 g17437.t1 Q9Z2A7 53.488 473 3.26e-177 512.0 sp|Q9Z2A7|DGAT1_MOUSE Diacylglycerol O-acyltransferase 1 OS=Mus musculus OX=10090 GN=Dgat1 PE=1 SV=1 DGAT1_MOUSE reviewed Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase) Mus musculus (Mouse) GO:0001523; GO:0003846; GO:0004144; GO:0005504; GO:0005789; GO:0006640; GO:0010867; GO:0016020; GO:0016746; GO:0019432; GO:0019915; GO:0019992; GO:0030073; GO:0034379; GO:0035336; GO:0042802; GO:0046321; GO:0046339; GO:0046486; GO:0050252; GO:0055089; GO:1901738; GO:1902224; GO:1903998; GO:1904729; GO:2000491 diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; glycerolipid metabolic process [GO:0046486]; insulin secretion [GO:0030073]; ketone body metabolic process [GO:1902224]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; monoacylglycerol biosynthetic process [GO:0006640]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of eating behavior [GO:1903998]; regulation of intestinal lipid absorption [GO:1904729]; regulation of vitamin A metabolic process [GO:1901738]; retinoid metabolic process [GO:0001523]; triglyceride biosynthetic process [GO:0019432]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 2-acylglycerol O-acyltransferase activity [GO:0003846]; acyltransferase activity [GO:0016746]; diacylglycerol binding [GO:0019992]; diacylglycerol O-acyltransferase activity [GO:0004144]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; retinol O-fatty-acyltransferase activity [GO:0050252] g17438.t1 Q76LL6 65.846 325 9.14e-149 466.0 sp|Q76LL6|FHOD3_MOUSE FH1/FH2 domain-containing protein 3 OS=Mus musculus OX=10090 GN=Fhod3 PE=1 SV=1 FHOD3_MOUSE reviewed FH1/FH2 domain-containing protein 3 (Formin homolog overexpressed in spleen 2) (mFHOS2) Mus musculus (Mouse) GO:0005737; GO:0005856; GO:0005865; GO:0007015; GO:0030017; GO:0030018; GO:0030837; GO:0045214; GO:0051015; GO:0051496; GO:0051639; GO:0055003 actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018] actin filament binding [GO:0051015] g17441.t1 Q6PF45 33.551 459 1.1900000000000001e-79 259.0 sp|Q6PF45|VIAAT_XENLA Vesicular inhibitory amino acid transporter OS=Xenopus laevis OX=8355 GN=slc32a1 PE=2 SV=1 VIAAT_XENLA reviewed Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (xVIAAT) Xenopus laevis (African clawed frog) GO:0001762; GO:0003333; GO:0005774; GO:0006836; GO:0008021; GO:0015179; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0051939; GO:0060077; GO:0098793; GO:0140799; GO:0140800 amino acid transmembrane transport [GO:0003333]; beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836] cytoplasmic vesicle membrane [GO:0030659]; inhibitory synapse [GO:0060077]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774] gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799]; L-amino acid transmembrane transporter activity [GO:0015179] g17442.t1 Q9UGM3 40.245 1963 0.0 1185.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 38.937 1975 0.0 1167.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 40.476 1890 0.0 1146.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 38.132 1917 0.0 1114.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 41.846 1723 0.0 1084.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 41.024 1699 0.0 1082.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 41.047 1720 0.0 1075.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 40.917 1723 0.0 1068.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 38.526 1682 0.0 1007.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 40.494 1457 0.0 884.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 36.218 1687 0.0 884.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t1 Q9UGM3 34.966 1450 0.0 686.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 40.182 1981 0.0 1221.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 41.221 1982 0.0 1211.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 40.262 1987 0.0 1202.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 40.286 1956 0.0 1184.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 39.018 1976 0.0 1167.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 38.132 1917 0.0 1114.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 42.366 1657 0.0 1097.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 41.439 1723 0.0 1087.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 38.526 1682 0.0 1006.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 36.218 1687 0.0 884.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 40.395 1468 0.0 870.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t2 Q9UGM3 34.966 1450 0.0 686.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 40.101 1980 0.0 1222.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 41.221 1982 0.0 1212.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 40.181 1986 0.0 1203.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 40.286 1956 0.0 1185.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 38.937 1975 0.0 1169.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 38.132 1917 0.0 1115.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 42.366 1657 0.0 1098.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 41.347 1722 0.0 1088.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 38.526 1682 0.0 1008.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 36.218 1687 0.0 885.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 40.395 1468 0.0 871.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t3 Q9UGM3 34.966 1450 0.0 686.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 40.101 1980 0.0 1222.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 41.221 1982 0.0 1212.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 40.181 1986 0.0 1203.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 40.286 1956 0.0 1185.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 38.937 1975 0.0 1169.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 38.132 1917 0.0 1115.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 42.366 1657 0.0 1098.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 41.347 1722 0.0 1088.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 38.526 1682 0.0 1008.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 36.218 1687 0.0 885.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 40.395 1468 0.0 871.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17442.t4 Q9UGM3 34.966 1450 0.0 686.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 37.5 680 2.3e-109 368.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 36.107 709 2.1500000000000002e-107 363.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 35.949 701 1.88e-105 357.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 35.235 701 2.57e-103 351.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 35.976 656 6.05e-103 350.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 35.338 399 2.4899999999999997e-54 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 31.538 520 3.84e-50 193.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17448.t1 Q9UGM3 32.162 370 1.19e-33 142.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17449.t1 Q5G267 43.668 229 3.52e-50 179.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g17449.t1 Q5G267 40.254 236 5.9e-46 167.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g17449.t1 Q5G267 36.404 228 1.37e-31 125.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g17452.t1 Q8C5T8 48.387 372 1.43e-104 316.0 sp|Q8C5T8|CF263_MOUSE Cilia- and flagella-associated protein 263 OS=Mus musculus OX=10090 GN=Cfap263 PE=2 SV=1 g17453.t1 P28020 83.11 373 0.0 608.0 sp|P28020|CSK21_XENLA Casein kinase II subunit alpha OS=Xenopus laevis OX=8355 GN=csnk2a1 PE=2 SV=2 g17454.t1 Q8BTU1 91.623 191 7.279999999999999e-131 368.0 sp|Q8BTU1|CFA20_MOUSE Cilia- and flagella-associated protein 20 OS=Mus musculus OX=10090 GN=Cfap20 PE=1 SV=1 g17455.t1 P16444 55.118 381 7.380000000000001e-144 419.0 sp|P16444|DPEP1_HUMAN Dipeptidase 1 OS=Homo sapiens OX=9606 GN=DPEP1 PE=1 SV=3 DPEP1_HUMAN reviewed Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP) Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005886; GO:0006508; GO:0006749; GO:0006751; GO:0006954; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0030593; GO:0031528; GO:0034235; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071732; GO:0072340; GO:0072341; GO:0098552; GO:1901749 antibiotic metabolic process [GO:0016999]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; lactam catabolic process [GO:0072340]; leukotriene D4 catabolic process [GO:1901749]; negative regulation of cell migration [GO:0030336]; neutrophil chemotaxis [GO:0030593]; proteolysis [GO:0006508] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] beta-lactamase activity [GO:0008800]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270] g17456.t1 P48416 30.019 513 5.96e-62 215.0 sp|P48416|CP10_LYMST Cytochrome P450 10 OS=Lymnaea stagnalis OX=6523 GN=CYP10 PE=2 SV=1 g17457.t1 P48416 34.308 513 6e-97 308.0 sp|P48416|CP10_LYMST Cytochrome P450 10 OS=Lymnaea stagnalis OX=6523 GN=CYP10 PE=2 SV=1 g17458.t1 D3YXS5 40.522 881 0.0 621.0 sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1 g17459.t1 Q9GYZ0 46.879 1442 0.0 1200.0 sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1 g17460.t1 Q5RKH3 50.323 155 7.96e-39 132.0 sp|Q5RKH3|K1143_RAT Uncharacterized protein KIAA1143 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1 g17461.t1 Q9Y2L5 42.474 1528 0.0 1165.0 sp|Q9Y2L5|TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens OX=9606 GN=TRAPPC8 PE=1 SV=2 TPPC8_HUMAN reviewed Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0032964; GO:0048208; GO:0099022; GO:1990072 collagen biosynthetic process [GO:0032964]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] g17462.t1 Q9UGM3 31.396 1067 4.21e-118 405.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17462.t1 Q9UGM3 32.083 1066 1.21e-116 401.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17462.t1 Q9UGM3 30.748 1096 6.139999999999999e-113 390.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17462.t1 Q9UGM3 29.925 1066 1.0399999999999999e-95 339.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17463.t1 F7J220 34.175 594 1.19e-76 272.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g17463.t1 F7J220 31.366 593 8.21e-60 223.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g17464.t1 Q9UGM3 32.741 1069 1.69e-129 438.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17464.t1 Q9UGM3 32.617 1070 2.13e-128 435.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17464.t1 Q9UGM3 32.311 1043 1.3e-127 433.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17464.t1 Q9UGM3 32.35 1085 8.66e-127 431.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17464.t1 Q9UGM3 32.364 1032 4.0199999999999994e-126 428.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17464.t1 Q9UGM3 34.469 499 2.67e-64 242.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17464.t1 Q9UGM3 36.111 252 1.1199999999999999e-28 129.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17464.t2 Q95218 35.306 507 1.21e-70 266.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 34.942 518 1.2e-68 259.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 35.211 497 8.330000000000001e-66 250.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 32.197 528 4.5e-64 244.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 31.875 480 2.17e-48 194.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 31.373 510 1.63e-45 184.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 30.709 508 1.96e-45 184.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 32.905 389 9.52e-41 169.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 31.552 393 2.69e-38 160.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17464.t2 Q95218 30.0 360 3.0899999999999998e-28 128.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g17465.t1 Q0P4J6 45.361 194 2.76e-47 160.0 sp|Q0P4J6|MCUR1_XENTR Mitochondrial calcium uniporter regulator 1 OS=Xenopus tropicalis OX=8364 GN=mcur1 PE=2 SV=1 g17466.t1 A4FUC9 46.167 574 0.0 537.0 sp|A4FUC9|RHPN2_BOVIN Rhophilin-2 OS=Bos taurus OX=9913 GN=RHPN2 PE=2 SV=1 RHPN2_BOVIN reviewed Rhophilin-2 (GTP-Rho-binding protein 2) Bos taurus (Bovine) GO:0003094; GO:0005886; GO:0007165; GO:0048471; GO:0051497 glomerular filtration [GO:0003094]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] g17467.t1 Q64591 57.962 314 1.2100000000000002e-123 361.0 sp|Q64591|DECR_RAT 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial OS=Rattus norvegicus OX=10116 GN=Decr1 PE=1 SV=2 DECR_RAT reviewed 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial (EC 1.3.1.124) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) Rattus norvegicus (Rat) GO:0005654; GO:0005739; GO:0005829; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494 fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402] g17476.t1 Q9UGM3 32.681 1481 1.0100000000000001e-173 578.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17476.t1 Q9UGM3 32.452 1513 1.4000000000000001e-173 577.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17476.t1 Q9UGM3 50.0 106 3.18e-22 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17479.t1 P0C6T1 44.218 147 7.130000000000001e-35 120.0 sp|P0C6T1|CTF8_RAT Chromosome transmission fidelity protein 8 homolog OS=Rattus norvegicus OX=10116 GN=Chtf8 PE=3 SV=1 g17480.t1 Q8R2N2 37.429 708 1.1999999999999999e-165 494.0 sp|Q8R2N2|UTP4_MOUSE U3 small nucleolar RNA-associated protein 4 homolog OS=Mus musculus OX=10090 GN=Utp4 PE=2 SV=3 g17482.t2 Q9DA42 39.098 133 2.7300000000000003e-27 101.0 sp|Q9DA42|CMIP1_MOUSE Ciliary microtubule inner protein 1 OS=Mus musculus OX=10090 GN=Cimip1 PE=2 SV=2 g17483.t1 Q8TEP8 34.414 401 8.27e-57 204.0 sp|Q8TEP8|CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens OX=9606 GN=CEP192 PE=1 SV=3 CE192_HUMAN reviewed Centrosomal protein of 192 kDa (Cep192) (Cep192/SPD-2) Homo sapiens (Human) GO:0000242; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007098; GO:0007099; GO:0009617; GO:0019902; GO:0071539; GO:0090222; GO:0090307; GO:0120098; GO:0120099 centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099] phosphatase binding [GO:0019902] g17484.t1 Q8TEP8 33.294 847 4.26e-111 401.0 sp|Q8TEP8|CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens OX=9606 GN=CEP192 PE=1 SV=3 CE192_HUMAN reviewed Centrosomal protein of 192 kDa (Cep192) (Cep192/SPD-2) Homo sapiens (Human) GO:0000242; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007098; GO:0007099; GO:0009617; GO:0019902; GO:0071539; GO:0090222; GO:0090307; GO:0120098; GO:0120099 centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099] phosphatase binding [GO:0019902] g17487.t1 P53990 43.878 392 6.629999999999999e-82 257.0 sp|P53990|IST1_HUMAN IST1 homolog OS=Homo sapiens OX=9606 GN=IST1 PE=1 SV=1 IST1_HUMAN reviewed IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28) Homo sapiens (Human) GO:0000785; GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0015031; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0061952; GO:0070062; GO:0090541; GO:0090543; GO:1904903 cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; intracellular protein localization [GO:0008104]; midbody abscission [GO:0061952]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein transport [GO:0015031] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; midbody [GO:0030496]; nuclear envelope [GO:0005635] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] g17487.t2 P53990 45.822 371 7.519999999999999e-82 256.0 sp|P53990|IST1_HUMAN IST1 homolog OS=Homo sapiens OX=9606 GN=IST1 PE=1 SV=1 IST1_HUMAN reviewed IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28) Homo sapiens (Human) GO:0000785; GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0015031; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0061952; GO:0070062; GO:0090541; GO:0090543; GO:1904903 cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; intracellular protein localization [GO:0008104]; midbody abscission [GO:0061952]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein transport [GO:0015031] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; midbody [GO:0030496]; nuclear envelope [GO:0005635] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] g17491.t1 Q7L5A8 44.886 352 3.7100000000000004e-105 316.0 sp|Q7L5A8|FA2H_HUMAN Fatty acid 2-hydroxylase OS=Homo sapiens OX=9606 GN=FA2H PE=1 SV=1 FA2H_HUMAN reviewed Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase) (Fatty acid hydroxylase domain-containing protein 1) Homo sapiens (Human) GO:0001949; GO:0005506; GO:0005783; GO:0005789; GO:0006631; GO:0006633; GO:0006679; GO:0006682; GO:0016020; GO:0020037; GO:0030148; GO:0030258; GO:0032286; GO:0032287; GO:0042634; GO:0044857; GO:0046513; GO:0061436; GO:0080132; GO:0120520; GO:0120521; GO:1904002; GO:1904697 central nervous system myelin maintenance [GO:0032286]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; galactosylceramide biosynthetic process [GO:0006682]; glucosylceramide biosynthetic process [GO:0006679]; lipid modification [GO:0030258]; peripheral nervous system myelin maintenance [GO:0032287]; plasma membrane raft organization [GO:0044857]; regulation of acinar cell proliferation [GO:1904697]; regulation of hair cycle [GO:0042634]; regulation of sebum secreting cell proliferation [GO:1904002]; sebaceous gland cell differentiation [GO:0001949]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase activity [GO:0120521]; fatty acid 2-hydroxylase activity [GO:0080132]; free fatty acid 2-hydroxylase activity [GO:0120520]; heme binding [GO:0020037]; iron ion binding [GO:0005506] g17492.t1 Q499U4 71.49 463 0.0 666.0 sp|Q499U4|DRC4_RAT Dynein regulatory complex subunit 4 OS=Rattus norvegicus OX=10116 GN=Gas8 PE=2 SV=1 DRC4_RAT reviewed Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11) (GAS-11) (Growth arrest-specific protein 8) (GAS-8) Rattus norvegicus (Rat) GO:0000226; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0005930; GO:0007368; GO:0007420; GO:0008017; GO:0008104; GO:0015630; GO:0030317; GO:0031267; GO:0031514; GO:0035082; GO:0036064; GO:0036126; GO:0045880; GO:0051649; GO:0060294; GO:0097386; GO:0097729; GO:1903566 axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; intracellular protein localization [GO:0008104]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126] microtubule binding [GO:0008017]; small GTPase binding [GO:0031267] g17493.t1 Q9ET66 42.162 185 2.79e-36 145.0 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g17494.t1 Q8R4Y8 32.481 2152 0.0 951.0 sp|Q8R4Y8|RTTN_MOUSE Rotatin OS=Mus musculus OX=10090 GN=Rttn PE=1 SV=2 g17495.t1 Q86VV8 52.336 107 1.57e-28 112.0 sp|Q86VV8|RTTN_HUMAN Rotatin OS=Homo sapiens OX=9606 GN=RTTN PE=1 SV=3 RTTN_HUMAN reviewed Rotatin Homo sapiens (Human) GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0032053; GO:0036064 centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064] g17496.t1 O04486 35.227 176 1.81e-24 99.8 sp|O04486|RAA2A_ARATH Ras-related protein RABA2a OS=Arabidopsis thaliana OX=3702 GN=RABA2A PE=2 SV=1 g17497.t1 O75489 61.776 259 1.8e-118 342.0 sp|O75489|NDUS3_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=NDUFS3 PE=1 SV=1 NDUS3_HUMAN reviewed NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit) Homo sapiens (Human) GO:0003954; GO:0005739; GO:0005743; GO:0005759; GO:0006120; GO:0008137; GO:0009055; GO:0009060; GO:0016604; GO:0021762; GO:0031966; GO:0032981; GO:0042776; GO:0045271; GO:0072593; GO:0097228 aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; respiratory chain complex I [GO:0045271]; sperm principal piece [GO:0097228] electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954] g17498.t1 Q08CN9 57.792 154 2.03e-50 167.0 sp|Q08CN9|ZNRF2_DANRE E3 ubiquitin-protein ligase znrf2 OS=Danio rerio OX=7955 GN=znrf2 PE=2 SV=1 ZNRF2_DANRE reviewed E3 ubiquitin-protein ligase znrf2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase znrf2) (Zinc/RING finger protein 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005765; GO:0008270; GO:0010008; GO:0016020; GO:0042734; GO:0043161; GO:0061630; GO:0070936 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; presynaptic membrane [GO:0042734] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g17499.t1 Q3SX23 61.565 869 0.0 1060.0 sp|Q3SX23|LONP2_BOVIN Lon protease homolog 2, peroxisomal OS=Bos taurus OX=9913 GN=LONP2 PE=2 SV=1 LONP2_BOVIN reviewed Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) Bos taurus (Bovine) GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005782; GO:0006515; GO:0006625; GO:0016485; GO:0016558; GO:0016887; GO:0031998 protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998] nucleus [GO:0005634]; peroxisomal matrix [GO:0005782] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252] g17499.t2 Q3SX23 61.778 866 0.0 1060.0 sp|Q3SX23|LONP2_BOVIN Lon protease homolog 2, peroxisomal OS=Bos taurus OX=9913 GN=LONP2 PE=2 SV=1 LONP2_BOVIN reviewed Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) Bos taurus (Bovine) GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005782; GO:0006515; GO:0006625; GO:0016485; GO:0016558; GO:0016887; GO:0031998 protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998] nucleus [GO:0005634]; peroxisomal matrix [GO:0005782] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252] g17501.t1 O08954 37.698 252 5.85e-36 131.0 sp|O08954|SNAI2_RAT Zinc finger protein SNAI2 OS=Rattus norvegicus OX=10116 GN=Snai2 PE=2 SV=2 g17502.t1 Q1ZXJ0 33.006 815 1.55e-118 387.0 sp|Q1ZXJ0|CLCD_DICDI Chloride channel protein D OS=Dictyostelium discoideum OX=44689 GN=clcD PE=3 SV=1 g17506.t1 Q9NSV4 34.135 208 1.2600000000000002e-31 129.0 sp|Q9NSV4|DIAP3_HUMAN Protein diaphanous homolog 3 OS=Homo sapiens OX=9606 GN=DIAPH3 PE=1 SV=4 DIAP3_HUMAN reviewed Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (MDia2) Homo sapiens (Human) GO:0000813; GO:0000922; GO:0001701; GO:0003779; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0007010; GO:0007026; GO:0007059; GO:0007229; GO:0007605; GO:0008017; GO:0010467; GO:0016197; GO:0030010; GO:0030030; GO:0030036; GO:0030041; GO:0030225; GO:0031267; GO:0031941; GO:0032154; GO:0032432; GO:0034367; GO:0042803; GO:0043131; GO:0045010; GO:0045296; GO:0046785; GO:0051017; GO:0051764; GO:0060113; GO:0060322; GO:0061909; GO:0071800; GO:0097470; GO:1990427 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; autophagosome-lysosome fusion [GO:0061909]; cell projection organization [GO:0030030]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; endosomal transport [GO:0016197]; erythrocyte enucleation [GO:0043131]; establishment of cell polarity [GO:0030010]; gene expression [GO:0010467]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; inner ear receptor cell differentiation [GO:0060113]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; podosome assembly [GO:0071800]; protein-containing complex remodeling [GO:0034367]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ribbon synapse [GO:0097470]; spindle pole [GO:0000922]; stereocilia tip-link density [GO:1990427] actin binding [GO:0003779]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g17515.t1 Q15131 73.256 344 0.0 533.0 sp|Q15131|CDK10_HUMAN Cyclin-dependent kinase 10 OS=Homo sapiens OX=9606 GN=CDK10 PE=1 SV=1 g17516.t1 F1Q4S1 65.333 1125 0.0 1523.0 sp|F1Q4S1|ATP9B_DANRE Probable phospholipid-transporting ATPase IIB OS=Danio rerio OX=7955 GN=atp9b PE=3 SV=1 g17519.t1 O54750 38.228 395 3.19e-96 299.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 CP2J6_MOUSE reviewed Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6) Mus musculus (Mouse) GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0032760; GO:0032966; GO:0035359; GO:0043651; GO:0045722; GO:0071614; GO:1903055 epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of tumor necrosis factor production [GO:0032760]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g17523.t1 Q61909 47.708 589 5.21e-159 473.0 sp|Q61909|MTG8_MOUSE Protein CBFA2T1 OS=Mus musculus OX=10090 GN=Runx1t1 PE=2 SV=1 MTG8_MOUSE reviewed Protein CBFA2T1 (Protein MTG8) Mus musculus (Mouse) GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0008270; GO:0010977; GO:0016363; GO:0017053; GO:0042802; GO:0045444; GO:0045599; GO:0045892; GO:0140297 DNA-templated transcription [GO:0006351]; fat cell differentiation [GO:0045444]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; regulation of DNA-templated transcription [GO:0006355] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g17523.t2 Q61909 47.708 589 4.1500000000000004e-160 472.0 sp|Q61909|MTG8_MOUSE Protein CBFA2T1 OS=Mus musculus OX=10090 GN=Runx1t1 PE=2 SV=1 MTG8_MOUSE reviewed Protein CBFA2T1 (Protein MTG8) Mus musculus (Mouse) GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0008270; GO:0010977; GO:0016363; GO:0017053; GO:0042802; GO:0045444; GO:0045599; GO:0045892; GO:0140297 DNA-templated transcription [GO:0006351]; fat cell differentiation [GO:0045444]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; regulation of DNA-templated transcription [GO:0006355] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g17525.t1 P27592 41.096 438 2.11e-118 355.0 sp|P27592|EF1A_ONCVO Elongation factor 1-alpha OS=Onchocerca volvulus OX=6282 PE=2 SV=1 g17527.t1 P12815 63.905 169 2.03e-81 242.0 sp|P12815|PDCD6_MOUSE Programmed cell death protein 6 OS=Mus musculus OX=10090 GN=Pdcd6 PE=1 SV=2 PDCD6_MOUSE reviewed Programmed cell death protein 6 (ALG-257) (Apoptosis-linked gene 2 protein) (ALG-2) (PMP41) Mus musculus (Mouse) GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006915; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043065; GO:0043495; GO:0045766; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0048471; GO:0051592; GO:0051898; GO:0070971; GO:1902527; GO:1990756 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17528.t1 Q9VY77 75.546 229 6.17e-120 381.0 sp|Q9VY77|AJUBA_DROME LIM domain-containing protein jub OS=Drosophila melanogaster OX=7227 GN=jub PE=1 SV=3 AJUBA_DROME reviewed LIM domain-containing protein jub Drosophila melanogaster (Fruit fly) GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311 cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666] adherens junction [GO:0005912]; apical cortex [GO:0045179]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667] metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714] g17528.t2 Q9VY77 76.419 229 3.2400000000000004e-123 390.0 sp|Q9VY77|AJUBA_DROME LIM domain-containing protein jub OS=Drosophila melanogaster OX=7227 GN=jub PE=1 SV=3 AJUBA_DROME reviewed LIM domain-containing protein jub Drosophila melanogaster (Fruit fly) GO:0000278; GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0030707; GO:0035331; GO:0045179; GO:0045572; GO:0046872; GO:0071539; GO:0140311 cytoskeleton organization [GO:0007010]; follicle cell of egg chamber development [GO:0030707]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666] adherens junction [GO:0005912]; apical cortex [GO:0045179]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667] metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription corepressor activity [GO:0003714] g17529.t1 P10825 77.966 354 0.0 588.0 sp|P10825|GNAO_XENLA Guanine nucleotide-binding protein G(o) subunit alpha OS=Xenopus laevis OX=8355 GN=gna0 PE=2 SV=5 g17530.t1 O75818 39.153 378 7.94e-81 254.0 sp|O75818|RPP40_HUMAN Ribonuclease P protein subunit p40 OS=Homo sapiens OX=9606 GN=RPP40 PE=1 SV=3 g17531.t1 B5XB24 58.523 176 2.63e-71 216.0 sp|B5XB24|EMC4_SALSA ER membrane protein complex subunit 4 OS=Salmo salar OX=8030 GN=emc4 PE=2 SV=1 g17532.t1 Q28IV8 50.545 275 3.4900000000000004e-88 269.0 sp|Q28IV8|NGDN_XENTR Neuroguidin OS=Xenopus tropicalis OX=8364 GN=ngdn PE=2 SV=1 g17535.t1 Q8R0M8 24.624 532 2.69e-38 151.0 sp|Q8R0M8|MOT5_MOUSE Monocarboxylate transporter 5 OS=Mus musculus OX=10090 GN=Slc16a4 PE=2 SV=1 g17536.t1 Q9H0J4 24.441 671 6.6e-48 195.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 24.441 671 1.64e-47 194.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.942 685 4.11e-46 189.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.883 582 6.33e-43 179.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 22.606 637 1.46e-42 178.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.22 646 2.01e-42 177.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 22.973 592 6.47e-42 176.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.238 667 2.6e-41 174.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.484 643 1.34e-40 171.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.053 642 5.25e-38 163.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 22.409 656 5.39e-38 163.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 22.409 714 1.38e-37 161.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.25 800 1.1000000000000001e-35 155.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.022 556 1.01e-34 152.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 23.699 519 1.51e-34 151.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 21.06 736 1.18e-33 148.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 22.872 564 1.52e-33 148.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17536.t1 Q9H0J4 21.731 566 1.08e-32 145.0 sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1 QRIC2_HUMAN reviewed Glutamine-rich protein 2 Homo sapiens (Human) GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] g17539.t1 P35858 27.326 344 7.44e-21 101.0 sp|P35858|ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens OX=9606 GN=IGFALS PE=1 SV=1 ALS_HUMAN reviewed Insulin-like growth factor-binding protein complex acid labile subunit (ALS) Homo sapiens (Human) GO:0005520; GO:0005576; GO:0005615; GO:0007155; GO:0007165; GO:0038023; GO:0042567; GO:0070062 cell adhesion [GO:0007155]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567] insulin-like growth factor binding [GO:0005520]; signaling receptor activity [GO:0038023] g17540.t1 O15374 25.865 549 3.17e-36 146.0 sp|O15374|MOT5_HUMAN Monocarboxylate transporter 5 OS=Homo sapiens OX=9606 GN=SLC16A4 PE=1 SV=1 g17541.t1 Q5VZK9 44.369 888 0.0 757.0 sp|Q5VZK9|CARL1_HUMAN F-actin-uncapping protein LRRC16A OS=Homo sapiens OX=9606 GN=CARMIL1 PE=1 SV=1 CARL1_HUMAN reviewed F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0007015; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0034315; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813 actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] protein-containing complex binding [GO:0044877] g17541.t2 Q5VZK9 44.832 861 0.0 757.0 sp|Q5VZK9|CARL1_HUMAN F-actin-uncapping protein LRRC16A OS=Homo sapiens OX=9606 GN=CARMIL1 PE=1 SV=1 CARL1_HUMAN reviewed F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0007015; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0034315; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000813 actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] protein-containing complex binding [GO:0044877] g17542.t1 Q9JLV2 42.617 772 0.0 620.0 sp|Q9JLV2|TP4AP_MOUSE Short transient receptor potential channel 4-associated protein OS=Mus musculus OX=10090 GN=Trpc4ap PE=1 SV=2 TP4AP_MOUSE reviewed Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (Rabex-5/Rin2-interacting protein) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS) Mus musculus (Mouse) GO:0005829; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0080008; GO:0140627; GO:1990756 hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] phosphatase binding [GO:0019902]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17543.t1 Q2HJ94 58.637 411 5.93e-168 479.0 sp|Q2HJ94|DNJA2_BOVIN DnaJ homolog subfamily A member 2 OS=Bos taurus OX=9913 GN=DNAJA2 PE=2 SV=1 DNJA2_BOVIN reviewed DnaJ homolog subfamily A member 2 Bos taurus (Bovine) GO:0001671; GO:0005524; GO:0005737; GO:0005829; GO:0008270; GO:0009408; GO:0016020; GO:0030544; GO:0042026; GO:0051082; GO:0051087 protein refolding [GO:0042026]; response to heat [GO:0009408] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; Hsp70 protein binding [GO:0030544]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] g17544.t1 O43313 38.012 171 2.2000000000000002e-27 122.0 sp|O43313|ATMIN_HUMAN ATM interactor OS=Homo sapiens OX=9606 GN=ATMIN PE=1 SV=2 g17545.t1 P48764 42.018 783 0.0 557.0 sp|P48764|SL9A3_HUMAN Sodium/hydrogen exchanger 3 OS=Homo sapiens OX=9606 GN=SLC9A3 PE=1 SV=2 SL9A3_HUMAN reviewed Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3) Homo sapiens (Human) GO:0005769; GO:0005886; GO:0005903; GO:0006811; GO:0009986; GO:0015385; GO:0015386; GO:0016324; GO:0030165; GO:0031526; GO:0031901; GO:0035091; GO:0042802; GO:0051453; GO:0055038; GO:0070062; GO:0071805; GO:0098719 monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; phosphatidylinositol binding [GO:0035091]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g17548.t1 Q68DC2 37.811 804 4.849999999999999e-140 440.0 sp|Q68DC2|ANKS6_HUMAN Ankyrin repeat and SAM domain-containing protein 6 OS=Homo sapiens OX=9606 GN=ANKS6 PE=1 SV=2 ANKS6_HUMAN reviewed Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6) Homo sapiens (Human) GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0097543 determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822] ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737] g17549.t1 Q6QNK2 35.512 459 1.8200000000000002e-71 249.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g17549.t2 Q6QNK2 35.512 459 1.8200000000000002e-71 249.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g17549.t3 Q6QNK2 36.471 425 6.31e-67 249.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g17551.t1 Q9Z173 25.935 428 4.38e-30 134.0 sp|Q9Z173|AGRL3_RAT Adhesion G protein-coupled receptor L3 OS=Rattus norvegicus OX=10116 GN=Adgrl3 PE=1 SV=1 g17551.t2 Q9Z173 25.576 434 1.4299999999999999e-30 135.0 sp|Q9Z173|AGRL3_RAT Adhesion G protein-coupled receptor L3 OS=Rattus norvegicus OX=10116 GN=Adgrl3 PE=1 SV=1 g17553.t1 Q7ZVE6 61.853 464 0.0 636.0 sp|Q7ZVE6|PLGT2_DANRE Protein O-glucosyltransferase 2 OS=Danio rerio OX=7955 GN=poglut2 PE=2 SV=1 PLGT2_DANRE reviewed Protein O-glucosyltransferase 2 (EC 2.4.1.-) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005788; GO:0007399; GO:0012505; GO:0035251; GO:0035252; GO:0046527; GO:0140561; GO:0140562; GO:0180059 nervous system development [GO:0007399]; protein O-linked glycosylation via glucose [GO:0180059] endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788] EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252] g17558.t1 O14841 64.701 1306 0.0 1671.0 sp|O14841|OPLA_HUMAN 5-oxoprolinase OS=Homo sapiens OX=9606 GN=OPLAH PE=1 SV=3 g17559.t1 Q7YRA3 70.0 240 1.83e-125 358.0 sp|Q7YRA3|EXOS4_BOVIN Exosome complex component RRP41 OS=Bos taurus OX=9913 GN=EXOSC4 PE=2 SV=3 g17560.t1 A0A8M2 34.707 461 1.26e-49 179.0 sp|A0A8M2|L14AA_XENLA Protein LSM14 homolog A-A OS=Xenopus laevis OX=8355 GN=lsm14a-a PE=1 SV=1 L14AA_XENLA reviewed Protein LSM14 homolog A-A (RNA-associated protein 55A-A) (RAP55A-A) (xRAP55) (xRAP55A) Xenopus laevis (African clawed frog) GO:0000932; GO:0003723; GO:0003729; GO:0005737; GO:0010494; GO:0017148; GO:0017151; GO:0032991; GO:0033962; GO:0034063; GO:1990904 negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] DEAD/H-box RNA helicase binding [GO:0017151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g17560.t2 A0A8M2 34.273 461 1.61e-49 179.0 sp|A0A8M2|L14AA_XENLA Protein LSM14 homolog A-A OS=Xenopus laevis OX=8355 GN=lsm14a-a PE=1 SV=1 L14AA_XENLA reviewed Protein LSM14 homolog A-A (RNA-associated protein 55A-A) (RAP55A-A) (xRAP55) (xRAP55A) Xenopus laevis (African clawed frog) GO:0000932; GO:0003723; GO:0003729; GO:0005737; GO:0010494; GO:0017148; GO:0017151; GO:0032991; GO:0033962; GO:0034063; GO:1990904 negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] DEAD/H-box RNA helicase binding [GO:0017151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g17561.t1 Q9VKA4 24.317 366 1.5e-24 110.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g17564.t1 Q9VKA4 28.4 250 5.66e-26 112.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g17565.t1 Q9VKA4 28.013 307 2.71e-33 134.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g17567.t1 Q9VKA4 34.932 146 1.72e-24 102.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g17570.t1 Q9VKA4 26.868 562 2.9100000000000002e-58 218.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g17574.t1 Q6NT55 38.462 455 1.08e-100 315.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g17575.t1 S4R2K0 45.39 141 7.489999999999999e-42 144.0 sp|S4R2K0|DEFM_MOUSE Peptide deformylase, mitochondrial OS=Mus musculus OX=10090 GN=Pdf PE=3 SV=1 g17576.t1 Q2HJ57 41.935 124 2.3600000000000002e-29 107.0 sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3 g17577.t1 Q2HJ57 51.128 133 3.17e-39 132.0 sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3 g17579.t1 P10079 49.219 128 1.4200000000000002e-35 136.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g17580.t1 Q9WTR6 39.487 195 1.46e-41 148.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g17580.t2 Q9WTR6 37.019 208 5.35e-34 129.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g17581.t1 Q9WTR6 40.0 135 8.29e-29 112.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g17585.t1 Q9WTR6 41.4 500 6.76e-131 390.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g17586.t1 Q9WTR6 48.98 490 6.32e-161 471.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g17589.t1 F1QWW8 52.025 321 1.3100000000000001e-123 361.0 sp|F1QWW8|KDSR_DANRE 3-dehydrosphinganine reductase OS=Danio rerio OX=7955 GN=kdsr PE=1 SV=2 g17590.t1 A5D6U8 43.256 430 7.470000000000001e-103 317.0 sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1 ACP7_DANRE reviewed Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003993; GO:0005576; GO:0046872 extracellular region [GO:0005576] acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] g17591.t1 Q96RK4 63.462 468 0.0 602.0 sp|Q96RK4|BBS4_HUMAN BBSome complex member BBS4 OS=Homo sapiens OX=9606 GN=BBS4 PE=1 SV=2 BBS4_HUMAN reviewed BBSome complex member BBS4 (Bardet-Biedl syndrome 4 protein) Homo sapiens (Human) GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001782; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010467; GO:0010629; GO:0015031; GO:0016055; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0034101; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:0120316; GO:1902855; GO:1903546; GO:1905515 adult behavior [GO:0030534]; B cell homeostasis [GO:0001782]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; erythrocyte homeostasis [GO:0034101]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g17592.t1 Q9EP75 28.932 515 4.67e-73 241.0 sp|Q9EP75|CP4FE_MOUSE Leukotriene-B4 omega-hydroxylase 3 OS=Mus musculus OX=10090 GN=Cyp4f14 PE=1 SV=1 g17593.t1 P78329 34.008 494 8.369999999999999e-94 297.0 sp|P78329|CP4F2_HUMAN Cytochrome P450 4F2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1 CP4F2_HUMAN reviewed Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0055078; GO:0097258; GO:0097259; GO:0097267; GO:0102033 arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonate epoxygenase activity [GO:0008392]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g17595.t1 P33274 34.476 496 2.96e-97 306.0 sp|P33274|CP4F1_RAT Cytochrome P450 4F1 OS=Rattus norvegicus OX=10116 GN=Cyp4f1 PE=1 SV=1 CP4F1_RAT reviewed Cytochrome P450 4F1 (CYPIVF1) (Cytochrome P450-A3) (Leukotriene-B4 20-monooxygenase) (EC 1.14.14.94) Rattus norvegicus (Rat) GO:0005506; GO:0005789; GO:0006690; GO:0008391; GO:0009636; GO:0019369; GO:0020037; GO:0036101; GO:0050051; GO:0050544; GO:0052869; GO:0097267 arachidonate metabolic process [GO:0019369]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; omega-hydroxylase P450 pathway [GO:0097267]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789] arachidonate binding [GO:0050544]; arachidonate monooxygenase activity [GO:0008391]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051] g17596.t1 P07858 47.557 307 1.97e-91 279.0 sp|P07858|CATB_HUMAN Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3 CATB_HUMAN reviewed Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Homo sapiens (Human) GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0031012; GO:0036021; GO:0042470; GO:0042981; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0070062; GO:0097067; GO:1904090; GO:1904813 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394] g17597.t1 P83205 39.701 335 1.36e-78 246.0 sp|P83205|CATB_SHEEP Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2 CATB_SHEEP reviewed Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Ovis aries (Sheep) GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394] g17599.t1 Q4R8E0 42.085 259 7.939999999999999e-54 201.0 sp|Q4R8E0|E2AK1_MACFA Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Macaca fascicularis OX=9541 GN=EIF2AK1 PE=2 SV=1 E2AK1_MACFA reviewed Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Hemin-sensitive initiation factor 2-alpha kinase) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0017148; GO:0106310; GO:0140467; GO:0140468; GO:1901526 HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; negative regulation of translation [GO:0017148]; positive regulation of mitophagy [GO:1901526] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein serine kinase activity [GO:0106310] g17599.t1 Q4R8E0 35.714 182 2.6699999999999998e-24 112.0 sp|Q4R8E0|E2AK1_MACFA Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Macaca fascicularis OX=9541 GN=EIF2AK1 PE=2 SV=1 E2AK1_MACFA reviewed Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Hemin-sensitive initiation factor 2-alpha kinase) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0017148; GO:0106310; GO:0140467; GO:0140468; GO:1901526 HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; negative regulation of translation [GO:0017148]; positive regulation of mitophagy [GO:1901526] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein serine kinase activity [GO:0106310] g17600.t1 Q6NTW6 63.118 526 0.0 721.0 sp|Q6NTW6|ULA1_XENLA NEDD8-activating enzyme E1 regulatory subunit OS=Xenopus laevis OX=8355 GN=nae1 PE=2 SV=1 g17601.t1 Q69BK3 59.124 274 8.19e-115 333.0 sp|Q69BK3|UCRI_PONPY Cytochrome b-c1 complex subunit Rieske, mitochondrial OS=Pongo pygmaeus OX=9600 GN=UQCRFS1 PE=3 SV=1 UCRI_PONPY reviewed Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)] Pongo pygmaeus (Bornean orangutan) GO:0005739; GO:0005743; GO:0008121; GO:0022904; GO:0045275; GO:0046872; GO:0051537 respiratory electron transport chain [GO:0022904] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex III [GO:0045275] 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; quinol-cytochrome-c reductase activity [GO:0008121] g17602.t1 Q86VM9 38.942 208 8.32e-30 132.0 sp|Q86VM9|ZCH18_HUMAN Zinc finger CCCH domain-containing protein 18 OS=Homo sapiens OX=9606 GN=ZC3H18 PE=1 SV=2 ZCH18_HUMAN reviewed Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0008270; GO:0016607; GO:0030674; GO:0032991; GO:0050779; GO:0140262; GO:1990904 RNA destabilization [GO:0050779] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g17605.t1 Q96T60 51.768 396 2.05e-144 437.0 sp|Q96T60|PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens OX=9606 GN=PNKP PE=1 SV=1 g17606.t1 Q6PIP5 41.584 606 1.41e-154 459.0 sp|Q6PIP5|NUDC1_MOUSE NudC domain-containing protein 1 OS=Mus musculus OX=10090 GN=Nudcd1 PE=1 SV=2 g17608.t1 O94761 47.305 501 1.17e-129 439.0 sp|O94761|RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens OX=9606 GN=RECQL4 PE=1 SV=2 RECQ4_HUMAN reviewed ATP-dependent DNA helicase Q4 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ4) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4) Homo sapiens (Human) GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0046872; GO:0061820; GO:0061821; GO:1990814 DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820] chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821] g17608.t1 O94761 43.762 505 3.37e-108 378.0 sp|O94761|RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens OX=9606 GN=RECQL4 PE=1 SV=2 RECQ4_HUMAN reviewed ATP-dependent DNA helicase Q4 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ4) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4) Homo sapiens (Human) GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0046872; GO:0061820; GO:0061821; GO:1990814 DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820] chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821] g17609.t1 Q8TE57 47.867 1172 0.0 1167.0 sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3 ATS16_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-) Homo sapiens (Human) GO:0001658; GO:0003073; GO:0004222; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017 branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g17610.t1 Q5R601 46.122 245 7.950000000000001e-73 224.0 sp|Q5R601|VAPA_PONAB Vesicle-associated membrane protein-associated protein A OS=Pongo abelii OX=9601 GN=VAPA PE=2 SV=2 VAPA_PONAB reviewed Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005783; GO:0005789; GO:0005886; GO:0005923; GO:0007029; GO:0008017; GO:0019076; GO:0030301; GO:0031175; GO:0031965; GO:0033149; GO:0044828; GO:0044829; GO:0070972; GO:0090114 cholesterol transport [GO:0030301]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum organization [GO:0007029]; host-mediated activation of viral genome replication [GO:0044829]; host-mediated suppression of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; protein localization to endoplasmic reticulum [GO:0070972]; viral release from host cell [GO:0019076] bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017] g17613.t1 Q5F389 60.741 405 0.0 516.0 sp|Q5F389|WWOX_CHICK WW domain-containing oxidoreductase OS=Gallus gallus OX=9031 GN=WWOX PE=2 SV=2 WWOX_CHICK reviewed WW domain-containing oxidoreductase (EC 1.1.1.-) Gallus gallus (Chicken) GO:0001649; GO:0003713; GO:0005739; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001241 cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; transcription coactivator activity [GO:0003713] g17622.t1 O35929 43.145 248 8.99e-53 178.0 sp|O35929|REM1_MOUSE GTP-binding protein REM 1 OS=Mus musculus OX=10090 GN=Rem1 PE=1 SV=1 REM1_MOUSE reviewed GTP-binding protein REM 1 (Rad and Gem-like GTP-binding protein 1) Mus musculus (Mouse) GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:0014722; GO:0030315; GO:0031674; GO:0044325; GO:1904878 negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722] I band [GO:0031674]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transmembrane transporter binding [GO:0044325] g17623.t1 P28651 57.143 273 1.05e-113 334.0 sp|P28651|CAH8_MOUSE Carbonic anhydrase-related protein OS=Mus musculus OX=10090 GN=Ca8 PE=1 SV=5 CAH8_MOUSE reviewed Carbonic anhydrase-related protein (CARP) (Carbonic anhydrase VIII) (CA-VIII) Mus musculus (Mouse) GO:0004089; GO:0005737; GO:0008270; GO:0050850 positive regulation of calcium-mediated signaling [GO:0050850] cytoplasm [GO:0005737] carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270] g17625.t1 Q503Z8 51.685 267 6.06e-77 253.0 sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1 g17628.t1 Q503Z8 41.408 355 2.41e-53 189.0 sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1 g17632.t1 Q28F67 70.238 420 0.0 646.0 sp|Q28F67|AATM_XENTR Aspartate aminotransferase, mitochondrial OS=Xenopus tropicalis OX=8364 GN=got2 PE=2 SV=1 AATM_XENTR reviewed Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004069; GO:0005739; GO:0005759; GO:0006103; GO:0006531; GO:0006533; GO:0006536; GO:0016212; GO:0030170 2-oxoglutarate metabolic process [GO:0006103]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]; L-aspartate catabolic process [GO:0006533] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170] g17633.t1 A7YVD7 58.214 280 6.4e-121 353.0 sp|A7YVD7|NDUF6_BOVIN NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Bos taurus OX=9913 GN=NDUFAF6 PE=2 SV=1 g17634.t1 Q7ZT01 57.672 189 2.11e-76 232.0 sp|Q7ZT01|PSF3_XENLA DNA replication complex GINS protein PSF3 OS=Xenopus laevis OX=8355 GN=gins3 PE=1 SV=1 PSF3_XENLA reviewed DNA replication complex GINS protein PSF3 (GINS complex subunit 3) Xenopus laevis (African clawed frog) GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902975 DNA replication [GO:0006260]; mitotic DNA replication initiation [GO:1902975] CMG complex [GO:0071162]; GINS complex [GO:0000811] chromatin binding [GO:0003682] g17635.t1 Q28HN9 32.267 344 8.6e-56 189.0 sp|Q28HN9|CENPL_XENTR Centromere protein L OS=Xenopus tropicalis OX=8364 GN=cenpl PE=2 SV=1 g17636.t1 Q9Y5B0 43.349 436 1.79e-97 327.0 sp|Q9Y5B0|CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens OX=9606 GN=CTDP1 PE=1 SV=3 g17636.t1 Q9Y5B0 32.412 398 1.95e-36 151.0 sp|Q9Y5B0|CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens OX=9606 GN=CTDP1 PE=1 SV=3 g17637.t1 P82916 50.0 110 1.0100000000000001e-35 122.0 sp|P82916|RT17_BOVIN Small ribosomal subunit protein uS17m OS=Bos taurus OX=9913 GN=MRPS17 PE=1 SV=3 g17638.t1 Q8N987 42.202 327 2.28e-83 259.0 sp|Q8N987|NECA1_HUMAN N-terminal EF-hand calcium-binding protein 1 OS=Homo sapiens OX=9606 GN=NECAB1 PE=1 SV=1 NECA1_HUMAN reviewed N-terminal EF-hand calcium-binding protein 1 (EF-hand calcium-binding protein 1) (Neuronal calcium-binding protein 1) Homo sapiens (Human) GO:0001835; GO:0005509; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0042802; GO:0042984 blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g17638.t2 Q8N987 41.194 335 4.62e-81 253.0 sp|Q8N987|NECA1_HUMAN N-terminal EF-hand calcium-binding protein 1 OS=Homo sapiens OX=9606 GN=NECAB1 PE=1 SV=1 NECA1_HUMAN reviewed N-terminal EF-hand calcium-binding protein 1 (EF-hand calcium-binding protein 1) (Neuronal calcium-binding protein 1) Homo sapiens (Human) GO:0001835; GO:0005509; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0042802; GO:0042984 blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g17641.t1 Q9EQH3 70.301 798 0.0 1166.0 sp|Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-associated protein 35 OS=Mus musculus OX=10090 GN=Vps35 PE=1 SV=1 VPS35_MOUSE reviewed Vacuolar protein sorting-associated protein 35 (Maternal-embryonic 3) (Vesicle protein sorting 35) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006624; GO:0006886; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016020; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032456; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045202; GO:0045732; GO:0048471; GO:0050728; GO:0050804; GO:0050882; GO:0051246; GO:0060161; GO:0061357; GO:0090128; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098691; GO:0098793; GO:0098794; GO:0098887; GO:0098978; GO:0099073; GO:0099074; GO:0099639; GO:0150052; GO:1902823; GO:1902950; GO:1903181; GO:1903828; GO:1904377; GO:1905166; GO:2000331 endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of mitochondrion organization [GO:0010821]; regulation of postsynapse assembly [GO:0150052]; regulation of protein metabolic process [GO:0051246]; regulation of protein stability [GO:0031647]; regulation of synapse maturation [GO:0090128]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; voluntary musculoskeletal movement [GO:0050882] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; synapse [GO:0045202]; tubular endosome [GO:0097422] D1 dopamine receptor binding [GO:0031748] g17642.t1 Q9WTR6 30.608 477 5.1799999999999994e-74 246.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g17643.t1 P08594 44.839 310 2.55e-66 221.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g17650.t1 A0A0X1KHF9 27.73 934 7.84e-80 285.0 sp|A0A0X1KHF9|RPH_LISMF Rifampicin phosphotransferase OS=Listeria monocytogenes serotype 4b (strain F2365) OX=265669 GN=rph PE=1 SV=2 RPH_LISMF reviewed Rifampicin phosphotransferase (EC 2.7.9.6) (LmRPH) (Rifampin phosphotransferase) (RIF phosphotransferase) Listeria monocytogenes serotype 4b (strain F2365) GO:0005524; GO:0016301; GO:0046677 response to antibiotic [GO:0046677] ATP binding [GO:0005524]; kinase activity [GO:0016301] g17651.t1 P62315 85.263 95 2.82e-56 173.0 sp|P62315|SMD1_MOUSE Small nuclear ribonucleoprotein Sm D1 OS=Mus musculus OX=10090 GN=Snrpd1 PE=1 SV=1 SMD1_MOUSE reviewed Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (Sm-D autoantigen) (snRNP core protein D1) Mus musculus (Mouse) GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005737; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526; GO:1990446 mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387] catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446] g17652.t1 C3YFB4 54.221 308 2.08e-91 276.0 sp|C3YFB4|DRE2_BRAFL Anamorsin homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_58504 PE=3 SV=1 g17653.t1 E2RYF8 78.251 892 0.0 1416.0 sp|E2RYF8|TPX2_PATPE Targeting protein for Xklp2 homolog OS=Patiria pectinifera OX=7594 GN=TPX2 PE=2 SV=1 g17656.t1 Q2YDM5 40.884 181 2.01e-36 129.0 sp|Q2YDM5|SMIP8_BOVIN Sperm microtubule inner protein 8 OS=Bos taurus OX=9913 GN=SPMIP8 PE=1 SV=2 SMIP8_BOVIN reviewed Sperm microtubule inner protein 8 (Testis, prostate and placenta-expressed protein) Bos taurus (Bovine) GO:0160111 axonemal A tubule inner sheath [GO:0160111] g17657.t1 Q7ZXT3 37.705 305 1.87e-58 206.0 sp|Q7ZXT3|EDC4_XENLA Enhancer of mRNA-decapping protein 4 OS=Xenopus laevis OX=8355 GN=edc4 PE=2 SV=1 g17658.t1 Q5ZLG9 43.337 1013 0.0 791.0 sp|Q5ZLG9|WDR59_CHICK GATOR2 complex protein WDR59 OS=Gallus gallus OX=9031 GN=WDR59 PE=2 SV=1 WDR59_CHICK reviewed GATOR2 complex protein WDR59 Gallus gallus (Chicken) GO:0005765; GO:0005774; GO:0008270; GO:0031669; GO:0034198; GO:0035591; GO:0035859; GO:0061700; GO:1904263 cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of TORC1 signaling [GO:1904263] GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774] signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270] g17659.t1 Q8N0V3 34.653 202 3.84e-33 129.0 sp|Q8N0V3|RBFA_HUMAN Putative ribosome-binding factor A, mitochondrial OS=Homo sapiens OX=9606 GN=RBFA PE=1 SV=3 RBFA_HUMAN reviewed Putative ribosome-binding factor A, mitochondrial Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006364; GO:0019843; GO:0043024; GO:0180026 mitochondrial small ribosomal subunit assembly [GO:0180026]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843] g17660.t1 F1NPG5 54.902 102 1.45e-30 130.0 sp|F1NPG5|CENPT_CHICK Centromere protein T OS=Gallus gallus OX=9031 GN=CENPT PE=1 SV=2 g17662.t1 O42242 52.756 127 1.93e-40 134.0 sp|O42242|NTF2_XENLA Nuclear transport factor 2 OS=Xenopus laevis OX=8355 GN=ntf2 PE=2 SV=1 g17663.t1 Q62280 74.359 78 8.539999999999999e-30 125.0 sp|Q62280|SSXT_MOUSE Protein SSXT OS=Mus musculus OX=10090 GN=Ss18 PE=1 SV=2 SSXT_MOUSE reviewed Protein SSXT (Protein SYT) (Synovial sarcoma-associated Ss18-alpha) Mus musculus (Mouse) GO:0000226; GO:0000785; GO:0000902; GO:0003713; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0007010; GO:0008284; GO:0009410; GO:0015630; GO:0016514; GO:0035556; GO:0045596; GO:0045944; GO:0048013; GO:0071564; GO:0097150; GO:0140288; GO:1902459 cell morphogenesis [GO:0000902]; chromatin remodeling [GO:0006338]; cytoskeleton organization [GO:0007010]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cell differentiation [GO:0045596]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410] chromatin [GO:0000785]; GBAF complex [GO:0140288]; microtubule cytoskeleton [GO:0015630]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] transcription coactivator activity [GO:0003713] g17664.t1 Q6J1I7 50.718 209 7.32e-76 231.0 sp|Q6J1I7|RN166_RAT E3 ubiquitin-protein ligase RNF166 OS=Rattus norvegicus OX=10116 GN=Rnf166 PE=2 SV=1 RN166_RAT reviewed E3 ubiquitin-protein ligase RNF166 (EC 2.3.2.27) (RING finger protein 166) (RING-type E3 ubiquitin transferase RNF166) Rattus norvegicus (Rat) GO:0000209; GO:0005737; GO:0006511; GO:0006914; GO:0008270; GO:0045087; GO:0061630 autophagy [GO:0006914]; innate immune response [GO:0045087]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g17665.t1 E9Q876 33.616 1767 0.0 880.0 sp|E9Q876|ABCAC_MOUSE Glucosylceramide transporter ABCA12 OS=Mus musculus OX=10090 GN=Abca12 PE=1 SV=1 ABCAC_MOUSE reviewed Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) Mus musculus (Mouse) GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005743; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016887; GO:0030216; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033700; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010 ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102] g17665.t1 E9Q876 25.088 857 7.06e-53 209.0 sp|E9Q876|ABCAC_MOUSE Glucosylceramide transporter ABCA12 OS=Mus musculus OX=10090 GN=Abca12 PE=1 SV=1 ABCAC_MOUSE reviewed Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) Mus musculus (Mouse) GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005743; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016887; GO:0030216; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033700; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010 ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102] g17665.t1 E9Q876 27.879 660 3.82e-49 197.0 sp|E9Q876|ABCAC_MOUSE Glucosylceramide transporter ABCA12 OS=Mus musculus OX=10090 GN=Abca12 PE=1 SV=1 ABCAC_MOUSE reviewed Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) Mus musculus (Mouse) GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005743; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016887; GO:0030216; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033700; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010 ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102] g17666.t1 Q96NW4 40.543 920 0.0 637.0 sp|Q96NW4|ANR27_HUMAN Ankyrin repeat domain-containing protein 27 OS=Homo sapiens OX=9606 GN=ANKRD27 PE=1 SV=2 g17668.t1 Q9VKA4 31.341 552 7.45e-84 285.0 sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3 g17672.t1 Q16880 33.333 525 1.69e-92 295.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g17674.t1 P36514 34.127 504 1.45e-87 284.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g17675.t1 Q9PTW9 84.348 230 1.9199999999999998e-147 414.0 sp|Q9PTW9|PSA7_CARAU Proteasome subunit alpha type-7 OS=Carassius auratus OX=7957 GN=psma7 PE=2 SV=1 g17676.t1 Q5E9W3 56.345 394 2.3e-153 441.0 sp|Q5E9W3|PYRD_BOVIN Dihydroorotate dehydrogenase (quinone), mitochondrial OS=Bos taurus OX=9913 GN=DHODH PE=1 SV=1 PYRD_BOVIN reviewed Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase) Bos taurus (Bovine) GO:0004152; GO:0005743; GO:0006207; GO:0009220; GO:0044205; GO:0106430 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; pyrimidine ribonucleotide biosynthetic process [GO:0009220] mitochondrial inner membrane [GO:0005743] dihydroorotate dehydrogenase (quinone) activity [GO:0106430]; dihydroorotate dehydrogenase activity [GO:0004152] g17677.t1 A2VD92 64.151 742 0.0 934.0 sp|A2VD92|DDX1_XENLA ATP-dependent RNA helicase DDX1 OS=Xenopus laevis OX=8355 GN=ddx1 PE=2 SV=1 DDX1_XENLA reviewed ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) Xenopus laevis (African clawed frog) GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0003729; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006364; GO:0006388; GO:0006397; GO:0008143; GO:0010494; GO:0016887; GO:0033677; GO:0072669 double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712] g17678.t1 P02722 76.923 299 1.1299999999999999e-172 482.0 sp|P02722|ADT1_BOVIN ADP/ATP translocase 1 OS=Bos taurus OX=9913 GN=SLC25A4 PE=1 SV=3 ADT1_BOVIN reviewed ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4) Bos taurus (Bovine) GO:0005471; GO:0005743; GO:0005757; GO:0015866; GO:0017077; GO:0031966; GO:0046902; GO:0140021; GO:1901029; GO:1901526; GO:1990544; GO:1990845 adaptive thermogenesis [GO:1990845]; ADP transport [GO:0015866]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of mitophagy [GO:1901526]; regulation of mitochondrial membrane permeability [GO:0046902] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial permeability transition pore complex [GO:0005757] ATP:ADP antiporter activity [GO:0005471]; oxidative phosphorylation uncoupler activity [GO:0017077] g17679.t1 Q5ZLV4 55.963 436 1.46e-166 510.0 sp|Q5ZLV4|NSUN2_CHICK RNA cytosine-C(5)-methyltransferase NSUN2 OS=Gallus gallus OX=9031 GN=NSUN2 PE=2 SV=1 NSUN2_CHICK reviewed RNA cytosine-C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) Gallus gallus (Chicken) GO:0000049; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0010793; GO:0016428; GO:0030488; GO:0036416; GO:0062152; GO:0070062; GO:2000736 regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] g17679.t1 Q5ZLV4 42.969 256 5.8e-55 208.0 sp|Q5ZLV4|NSUN2_CHICK RNA cytosine-C(5)-methyltransferase NSUN2 OS=Gallus gallus OX=9031 GN=NSUN2 PE=2 SV=1 NSUN2_CHICK reviewed RNA cytosine-C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) Gallus gallus (Chicken) GO:0000049; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0010793; GO:0016428; GO:0030488; GO:0036416; GO:0062152; GO:0070062; GO:2000736 regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] g17680.t1 P34711 23.341 437 3.11e-24 108.0 sp|P34711|UNC17_CAEEL Vesicular acetylcholine transporter unc-17 OS=Caenorhabditis elegans OX=6239 GN=unc-17 PE=1 SV=1 UNC17_CAEEL reviewed Vesicular acetylcholine transporter unc-17 (Uncoordinated protein 17) Caenorhabditis elegans GO:0002119; GO:0005277; GO:0005886; GO:0006937; GO:0007268; GO:0007271; GO:0008021; GO:0015870; GO:0030121; GO:0030122; GO:0030672; GO:0031090; GO:0040012; GO:0042910; GO:0043005; GO:0043051; GO:0043195; GO:0045202; GO:0046928; GO:0060076 acetylcholine transport [GO:0015870]; chemical synaptic transmission [GO:0007268]; nematode larval development [GO:0002119]; regulation of locomotion [GO:0040012]; regulation of muscle contraction [GO:0006937]; regulation of nematode pharyngeal pumping [GO:0043051]; regulation of neurotransmitter secretion [GO:0046928]; synaptic transmission, cholinergic [GO:0007271] AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] acetylcholine transmembrane transporter activity [GO:0005277]; xenobiotic transmembrane transporter activity [GO:0042910] g17681.t1 Q95114 32.85 207 1.2000000000000002e-21 96.7 sp|Q95114|MFGM_BOVIN Lactadherin OS=Bos taurus OX=9913 GN=MFGE8 PE=1 SV=2 MFGM_BOVIN reviewed Lactadherin (BP47) (Components 15/16) (MFGM) (MGP57/53) (Milk fat globule-EGF factor 8) (MFG-E8) (PAS-6/PAS-7 glycoprotein) (SED1) (Sperm surface protein SP47) Bos taurus (Bovine) GO:0001525; GO:0001786; GO:0002080; GO:0005615; GO:0007155; GO:0007338 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; extracellular space [GO:0005615] phosphatidylserine binding [GO:0001786] g17682.t1 Q6UWM5 41.808 177 2.97e-36 139.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g17684.t1 P23975 54.976 613 0.0 698.0 sp|P23975|SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens OX=9606 GN=SLC6A2 PE=1 SV=1 SC6A2_HUMAN reviewed Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) Homo sapiens (Human) GO:0003779; GO:0005326; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0006836; GO:0006865; GO:0007268; GO:0008504; GO:0009410; GO:0009986; GO:0015844; GO:0015874; GO:0016020; GO:0030424; GO:0030672; GO:0032809; GO:0035725; GO:0042734; GO:0043014; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0051620; GO:0070050 amino acid transport [GO:0006865]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; cell surface [GO:0009986]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334] g17685.t1 Q8R4E9 42.444 450 5.36e-106 340.0 sp|Q8R4E9|CDT1_MOUSE DNA replication factor Cdt1 OS=Mus musculus OX=10090 GN=Cdt1 PE=1 SV=1 CDT1_MOUSE reviewed DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein) Mus musculus (Mouse) GO:0000076; GO:0000278; GO:0000776; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0016604; GO:0030174; GO:0033262; GO:0045740; GO:0045786; GO:0051315; GO:0070182; GO:0071163; GO:0072708; GO:2000104; GO:2000105 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated DNA replication [GO:2000104]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated DNA replication [GO:2000105]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708] kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182] g17686.t1 Q8K4C0 51.215 535 0.0 568.0 sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3 FMO5_RAT reviewed Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1) Rattus norvegicus (Rat) GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016174; GO:0050660; GO:0050661; GO:0090181 lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661] g17687.t1 Q99N95 46.97 330 1.66e-91 280.0 sp|Q99N95|RM03_MOUSE Large ribosomal subunit protein uL3m OS=Mus musculus OX=10090 GN=Mrpl3 PE=1 SV=1 g17688.t1 Q3B7M7 57.823 147 6.03e-49 178.0 sp|Q3B7M7|RMP_BOVIN Unconventional prefoldin RPB5 interactor OS=Bos taurus OX=9913 GN=URI1 PE=2 SV=1 RMP_BOVIN reviewed Unconventional prefoldin RPB5 interactor (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein) Bos taurus (Bovine) GO:0000122; GO:0000993; GO:0001558; GO:0003682; GO:0003714; GO:0004864; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0009615; GO:0010923; GO:0019212; GO:0030425; GO:0042771; GO:0071363; GO:0071383; GO:2001243 cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634] chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714] g17689.t1 P20456 50.741 270 1.5800000000000002e-97 290.0 sp|P20456|IMPA1_BOVIN Inositol monophosphatase 1 OS=Bos taurus OX=9913 GN=IMPA1 PE=1 SV=1 IMPA1_BOVIN reviewed Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) Bos taurus (Bovine) GO:0000287; GO:0004346; GO:0005737; GO:0006020; GO:0006021; GO:0007165; GO:0008877; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0047954; GO:0052832; GO:0052833; GO:0052834; GO:0103026 inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165] cytoplasm [GO:0005737] fructose-1-phosphatase activity [GO:0103026]; glucose-1-phosphatase activity [GO:0008877]; glucose-6-phosphatase activity [GO:0004346]; glycerol-2-phosphatase activity [GO:0047954]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g17690.t1 Q9D1Q1 49.359 156 2.97e-44 146.0 sp|Q9D1Q1|MPH6_MOUSE M-phase phosphoprotein 6 OS=Mus musculus OX=10090 GN=Mphosph6 PE=1 SV=1 g17691.t1 Q9BVG8 45.543 718 0.0 564.0 sp|Q9BVG8|KIFC3_HUMAN Kinesin-like protein KIFC3 OS=Homo sapiens OX=9606 GN=KIFC3 PE=1 SV=4 g17702.t1 P00491 52.92 274 1.11e-102 304.0 sp|P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens OX=9606 GN=PNP PE=1 SV=2 PNPH_HUMAN reviewed Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase) Homo sapiens (Human) GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813 allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731] g17704.t1 Q14703 64.41 1034 0.0 1356.0 sp|Q14703|MBTP1_HUMAN Membrane-bound transcription factor site-1 protease OS=Homo sapiens OX=9606 GN=MBTPS1 PE=1 SV=1 MBTP1_HUMAN reviewed Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1) Homo sapiens (Human) GO:0000139; GO:0004252; GO:0005739; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0007095; GO:0008203; GO:0016485; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0051604; GO:0060627 ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein import into nucleus [GO:0006606]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; mitochondrion [GO:0005739] serine-type endopeptidase activity [GO:0004252] g17705.t1 P41044 40.441 272 9.509999999999999e-54 179.0 sp|P41044|CAB32_DROME Calbindin-32 OS=Drosophila melanogaster OX=7227 GN=Cbp53E PE=2 SV=1 g17706.t1 Q9H4F1 36.934 287 1.3099999999999999e-48 175.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g17706.t1 Q9H4F1 35.256 312 9.22e-46 167.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g17707.t1 Q9H4F1 36.462 277 5.900000000000001e-47 162.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g17709.t1 Q6GQJ8 46.465 198 7.99e-59 186.0 sp|Q6GQJ8|DUS22_XENLA Dual specificity protein phosphatase 22 OS=Xenopus laevis OX=8355 GN=dusp22 PE=2 SV=1 DUS22_XENLA reviewed Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48) Xenopus laevis (African clawed frog) GO:0004722; GO:0004725; GO:0005634; GO:0005829; GO:0007165; GO:0030155; GO:0050860; GO:0071363; GO:1990782 cellular response to growth factor stimulus [GO:0071363]; negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of cell adhesion [GO:0030155]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725] g17710.t1 Q5ZI16 38.628 554 1.34e-116 357.0 sp|Q5ZI16|ADAT1_CHICK tRNA-specific adenosine deaminase 1 OS=Gallus gallus OX=9031 GN=ADAT1 PE=2 SV=1 ADAT1_CHICK reviewed tRNA-specific adenosine deaminase 1 (EC 3.5.4.34) (tRNA-specific adenosine-37 deaminase) Gallus gallus (Chicken) GO:0003723; GO:0008033; GO:0008251; GO:0043829; GO:0046872 tRNA processing [GO:0008033] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; tRNA-specific adenosine-37 deaminase activity [GO:0043829] g17711.t1 Q96LJ7 47.761 335 2.23e-101 303.0 sp|Q96LJ7|DHRS1_HUMAN Dehydrogenase/reductase SDR family member 1 OS=Homo sapiens OX=9606 GN=DHRS1 PE=1 SV=1 DHRS1_HUMAN reviewed Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1) Homo sapiens (Human) GO:0004090; GO:0005783; GO:0016616; GO:0047045; GO:0047881 endoplasmic reticulum [GO:0005783] carbonyl reductase (NADPH) activity [GO:0004090]; estradiol 17-alpha-dehydrogenase [NAD(P)+] activity [GO:0047881]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone dehydrogenase (NADP+) activity [GO:0047045] g17712.t1 Q96LJ7 58.621 174 6.89e-66 208.0 sp|Q96LJ7|DHRS1_HUMAN Dehydrogenase/reductase SDR family member 1 OS=Homo sapiens OX=9606 GN=DHRS1 PE=1 SV=1 DHRS1_HUMAN reviewed Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1) Homo sapiens (Human) GO:0004090; GO:0005783; GO:0016616; GO:0047045; GO:0047881 endoplasmic reticulum [GO:0005783] carbonyl reductase (NADPH) activity [GO:0004090]; estradiol 17-alpha-dehydrogenase [NAD(P)+] activity [GO:0047881]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone dehydrogenase (NADP+) activity [GO:0047045] g17713.t1 Q96LJ7 46.182 275 1.39e-79 246.0 sp|Q96LJ7|DHRS1_HUMAN Dehydrogenase/reductase SDR family member 1 OS=Homo sapiens OX=9606 GN=DHRS1 PE=1 SV=1 DHRS1_HUMAN reviewed Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1) Homo sapiens (Human) GO:0004090; GO:0005783; GO:0016616; GO:0047045; GO:0047881 endoplasmic reticulum [GO:0005783] carbonyl reductase (NADPH) activity [GO:0004090]; estradiol 17-alpha-dehydrogenase [NAD(P)+] activity [GO:0047881]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone dehydrogenase (NADP+) activity [GO:0047045] g17714.t1 Q99L04 50.629 318 4.06e-111 328.0 sp|Q99L04|DHRS1_MOUSE Dehydrogenase/reductase SDR family member 1 OS=Mus musculus OX=10090 GN=Dhrs1 PE=1 SV=1 g17715.t1 Q96LJ7 48.125 320 1.4e-98 296.0 sp|Q96LJ7|DHRS1_HUMAN Dehydrogenase/reductase SDR family member 1 OS=Homo sapiens OX=9606 GN=DHRS1 PE=1 SV=1 DHRS1_HUMAN reviewed Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1) Homo sapiens (Human) GO:0004090; GO:0005783; GO:0016616; GO:0047045; GO:0047881 endoplasmic reticulum [GO:0005783] carbonyl reductase (NADPH) activity [GO:0004090]; estradiol 17-alpha-dehydrogenase [NAD(P)+] activity [GO:0047881]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone dehydrogenase (NADP+) activity [GO:0047045] g17716.t1 O75506 75.806 62 2.0200000000000002e-27 97.4 sp|O75506|HSBP1_HUMAN Heat shock factor-binding protein 1 OS=Homo sapiens OX=9606 GN=HSBP1 PE=1 SV=1 g17717.t1 Q9MYM7 39.331 239 2.48e-49 176.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g17719.t1 Q92058 46.813 502 8.36e-143 427.0 sp|Q92058|PPBT_CHICK Alkaline phosphatase, tissue-nonspecific isozyme OS=Gallus gallus OX=9031 GN=ALPL PE=1 SV=1 g17723.t1 O46585 44.444 135 1.82e-35 123.0 sp|O46585|COX41_PITPI Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Fragment) OS=Pithecia pithecia OX=43777 GN=COX4I1 PE=3 SV=1 g17725.t1 Q78S06 50.0 156 1.5800000000000001e-57 179.0 sp|Q78S06|SYS1_MOUSE Protein SYS1 homolog OS=Mus musculus OX=10090 GN=Sys1 PE=2 SV=1 g17726.t1 A9BJC1 28.228 457 3.17e-36 147.0 sp|A9BJC1|MGGB_PETMO Mannosylglucosyl-3-phosphoglycerate phosphatase OS=Petrotoga mobilis (strain DSM 10674 / SJ95) OX=403833 GN=mggB PE=1 SV=1 MGGB_PETMO reviewed Mannosylglucosyl-3-phosphoglycerate phosphatase (MGPG phosphatase) (EC 3.1.3.-) Petrotoga mobilis (strain DSM 10674 / SJ95) GO:0008253; GO:0008768; GO:0009166; GO:0030288 nucleotide catabolic process [GO:0009166] outer membrane-bounded periplasmic space [GO:0030288] 5'-nucleotidase activity [GO:0008253]; UDP-sugar diphosphatase activity [GO:0008768] g17727.t1 Q9UGM3 33.589 783 1.7400000000000001e-109 370.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t1 Q9UGM3 33.009 821 4.75e-106 360.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t1 Q9UGM3 33.376 785 3.72e-104 355.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t1 Q9UGM3 32.789 796 4.9799999999999994e-104 355.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t1 Q9UGM3 33.042 802 1.21e-102 350.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t1 Q9UGM3 33.485 660 3.11e-90 314.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t1 Q9UGM3 31.812 767 4.4199999999999996e-89 311.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t1 Q9UGM3 29.873 395 6.92e-38 156.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 34.256 759 4.0599999999999995e-108 367.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 32.968 822 1.2599999999999998e-104 356.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 33.376 785 2.82e-104 355.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 32.748 797 8.36e-103 351.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 32.918 802 4.91e-102 349.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 34.385 634 6.83e-90 313.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 31.592 785 2.2999999999999998e-89 311.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17727.t2 Q9UGM3 30.051 396 5.3300000000000006e-37 154.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 37.439 617 2.39e-99 340.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 37.821 624 3.46e-99 340.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 37.152 646 2.29e-97 334.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 36.672 649 1.55e-96 332.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 37.025 632 1.02e-95 329.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 37.743 514 1.96e-72 261.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 34.875 519 9.66e-72 259.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 38.564 376 4.15e-57 215.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t1 Q9UGM3 31.423 506 6.02e-46 181.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t2 Q9UGM3 37.243 486 1.12e-75 267.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t2 Q9UGM3 36.008 511 8.539999999999999e-74 261.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t2 Q9UGM3 35.812 511 4.3700000000000004e-73 259.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t2 Q9UGM3 34.875 519 4.67e-73 259.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t2 Q9UGM3 35.827 508 9.79e-71 253.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t2 Q9UGM3 38.564 376 4.41e-58 215.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17728.t2 Q9UGM3 36.148 379 2.3999999999999997e-48 186.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g17731.t1 Q91766 60.648 432 0.0 517.0 sp|Q91766|HNF4A_XENLA Hepatocyte nuclear factor 4-alpha OS=Xenopus laevis OX=8355 GN=hnf4a PE=2 SV=2 g17731.t2 Q91766 60.277 433 5.49e-179 510.0 sp|Q91766|HNF4A_XENLA Hepatocyte nuclear factor 4-alpha OS=Xenopus laevis OX=8355 GN=hnf4a PE=2 SV=2 g17732.t1 Q0P6D2 29.839 372 3.12e-47 169.0 sp|Q0P6D2|DIK1C_HUMAN Divergent protein kinase domain 1C OS=Homo sapiens OX=9606 GN=DIPK1C PE=1 SV=3 DIK1C_HUMAN reviewed Divergent protein kinase domain 1C (Protein FAM69C) Homo sapiens (Human) GO:0005789 endoplasmic reticulum membrane [GO:0005789] g17733.t1 Q99973 28.119 537 5.18e-41 168.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g17733.t2 Q99973 27.818 550 4.45e-39 162.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g17734.t1 P32007 72.355 293 2.2e-144 409.0 sp|P32007|ADT3_BOVIN ADP/ATP translocase 3 OS=Bos taurus OX=9913 GN=SLC25A6 PE=1 SV=3 ADT3_BOVIN reviewed ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed] Bos taurus (Bovine) GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0140021; GO:1901029; GO:1990544 apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] ATP:ADP antiporter activity [GO:0005471] g17735.t1 Q6GLK6 48.58 634 0.0 563.0 sp|Q6GLK6|ACSF3_XENLA Malonate--CoA ligase ACSF3, mitochondrial OS=Xenopus laevis OX=8355 GN=acsf3 PE=2 SV=1 g17736.t1 Q6TEQ0 39.591 538 3.8e-120 369.0 sp|Q6TEQ0|EEPD1_DANRE Endonuclease/exonuclease/phosphatase family domain-containing protein 1 OS=Danio rerio OX=7955 GN=eepd1 PE=2 SV=1 g17737.t1 O55131 69.318 440 0.0 600.0 sp|O55131|SEPT7_MOUSE Septin-7 OS=Mus musculus OX=10090 GN=Septin7 PE=1 SV=1 SEPT7_MOUSE reviewed Septin-7 (CDC10 protein homolog) Mus musculus (Mouse) GO:0000281; GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016020; GO:0016192; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0031982; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046323; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0098978; GO:0099173; GO:0099186; GO:0150050 cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; D-glucose import [GO:0046323]; dendritic spine morphogenesis [GO:0060997]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic septin cytoskeleton [GO:0150050]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; vesicle [GO:0031982] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural constituent of postsynapse [GO:0099186] g17737.t2 O55131 68.934 441 0.0 597.0 sp|O55131|SEPT7_MOUSE Septin-7 OS=Mus musculus OX=10090 GN=Septin7 PE=1 SV=1 SEPT7_MOUSE reviewed Septin-7 (CDC10 protein homolog) Mus musculus (Mouse) GO:0000281; GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016020; GO:0016192; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0031982; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046323; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0098978; GO:0099173; GO:0099186; GO:0150050 cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; D-glucose import [GO:0046323]; dendritic spine morphogenesis [GO:0060997]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic septin cytoskeleton [GO:0150050]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; vesicle [GO:0031982] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural constituent of postsynapse [GO:0099186] g17737.t3 O55131 70.439 433 0.0 603.0 sp|O55131|SEPT7_MOUSE Septin-7 OS=Mus musculus OX=10090 GN=Septin7 PE=1 SV=1 SEPT7_MOUSE reviewed Septin-7 (CDC10 protein homolog) Mus musculus (Mouse) GO:0000281; GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016020; GO:0016192; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0031982; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046323; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0098978; GO:0099173; GO:0099186; GO:0150050 cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; D-glucose import [GO:0046323]; dendritic spine morphogenesis [GO:0060997]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic septin cytoskeleton [GO:0150050]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; vesicle [GO:0031982] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural constituent of postsynapse [GO:0099186] g17737.t4 O55131 71.698 424 0.0 604.0 sp|O55131|SEPT7_MOUSE Septin-7 OS=Mus musculus OX=10090 GN=Septin7 PE=1 SV=1 SEPT7_MOUSE reviewed Septin-7 (CDC10 protein homolog) Mus musculus (Mouse) GO:0000281; GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005938; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016020; GO:0016192; GO:0016476; GO:0030496; GO:0030865; GO:0031105; GO:0031270; GO:0031982; GO:0032153; GO:0032154; GO:0032156; GO:0032160; GO:0032991; GO:0042734; GO:0042802; GO:0043005; GO:0043209; GO:0043679; GO:0044297; GO:0045202; GO:0046323; GO:0048668; GO:0060090; GO:0060271; GO:0060997; GO:0061640; GO:0097227; GO:0098978; GO:0099173; GO:0099186; GO:0150050 cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton-dependent cytokinesis [GO:0061640]; D-glucose import [GO:0046323]; dendritic spine morphogenesis [GO:0060997]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; postsynapse organization [GO:0099173]; pseudopodium retraction [GO:0031270]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] axon terminus [GO:0043679]; axoneme [GO:0005930]; cell body [GO:0044297]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic septin cytoskeleton [GO:0150050]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; septin complex [GO:0031105]; septin cytoskeleton [GO:0032156]; septin filament array [GO:0032160]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; synapse [GO:0045202]; vesicle [GO:0031982] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural constituent of postsynapse [GO:0099186] g17738.t1 D3YXG0 46.479 355 1.53e-91 323.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g17738.t1 D3YXG0 41.103 399 1.3e-90 320.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g17738.t1 D3YXG0 43.288 365 5.63e-88 312.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g17742.t1 Q4SBY6 32.862 283 6.220000000000001e-35 130.0 sp|Q4SBY6|HNMT_TETNG Histamine N-methyltransferase OS=Tetraodon nigroviridis OX=99883 GN=hnmt PE=3 SV=1 g17744.t1 Q9Y3Z3 54.73 444 6.41e-163 476.0 sp|Q9Y3Z3|SAMH1_HUMAN Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Homo sapiens OX=9606 GN=SAMHD1 PE=1 SV=2 g17745.t1 Q4SBY6 34.061 229 1.82e-37 138.0 sp|Q4SBY6|HNMT_TETNG Histamine N-methyltransferase OS=Tetraodon nigroviridis OX=99883 GN=hnmt PE=3 SV=1 g17746.t1 Q4SBY6 31.633 294 1.12e-46 161.0 sp|Q4SBY6|HNMT_TETNG Histamine N-methyltransferase OS=Tetraodon nigroviridis OX=99883 GN=hnmt PE=3 SV=1 g17747.t1 Q6DEL1 46.897 145 1.9e-35 132.0 sp|Q6DEL1|S38A7_DANRE Sodium-coupled neutral amino acid transporter 7 OS=Danio rerio OX=7955 GN=slc38a7 PE=2 SV=1 S38A7_DANRE reviewed Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003333; GO:0005765; GO:0006867; GO:0006868; GO:0015182; GO:0015186; GO:0016020; GO:0030424; GO:0140901; GO:0140902 amino acid transmembrane transport [GO:0003333]; asparagine transport [GO:0006867]; glutamine transport [GO:0006868] axon [GO:0030424]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] L-asparagine transmembrane transporter activity [GO:0015182]; L-asparagine:sodium symporter activity [GO:0140901]; L-glutamine transmembrane transporter activity [GO:0015186]; L-glutamine:sodium symporter activity [GO:0140902] g17748.t1 Q6JWR2 44.495 218 2.6299999999999996e-54 183.0 sp|Q6JWR2|S38A7_RAT Sodium-coupled neutral amino acid transporter 7 OS=Rattus norvegicus OX=10116 GN=Slc38a7 PE=2 SV=1 S38A7_RAT reviewed Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7) Rattus norvegicus (Rat) GO:0003333; GO:0005765; GO:0006814; GO:0006867; GO:0006868; GO:0015182; GO:0015186; GO:0016020; GO:0030424; GO:0043025; GO:0140901; GO:0140902 amino acid transmembrane transport [GO:0003333]; asparagine transport [GO:0006867]; glutamine transport [GO:0006868]; sodium ion transport [GO:0006814] axon [GO:0030424]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025] L-asparagine transmembrane transporter activity [GO:0015182]; L-asparagine:sodium symporter activity [GO:0140901]; L-glutamine transmembrane transporter activity [GO:0015186]; L-glutamine:sodium symporter activity [GO:0140902] g17749.t1 P50135 32.203 236 3.47e-34 127.0 sp|P50135|HNMT_HUMAN Histamine N-methyltransferase OS=Homo sapiens OX=9606 GN=HNMT PE=1 SV=1 HNMT_HUMAN reviewed Histamine N-methyltransferase (HMT) (EC 2.1.1.8) Homo sapiens (Human) GO:0001692; GO:0001695; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006548; GO:0007268; GO:0007585; GO:0032259; GO:0045202; GO:0046539; GO:0070062 chemical synaptic transmission [GO:0007268]; histamine catabolic process [GO:0001695]; histamine metabolic process [GO:0001692]; L-histidine catabolic process [GO:0006548]; methylation [GO:0032259]; respiratory gaseous exchange by respiratory system [GO:0007585] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; synapse [GO:0045202] histamine N-methyltransferase activity [GO:0046539] g17750.t1 P58137 37.716 289 4.09e-63 204.0 sp|P58137|ACOT8_MOUSE Acyl-coenzyme A thioesterase 8 OS=Mus musculus OX=10090 GN=Acot8 PE=1 SV=1 ACOT8_MOUSE reviewed Acyl-coenzyme A thioesterase 8 (Acyl-CoA thioesterase 8) (EC 3.1.2.1) (EC 3.1.2.11) (EC 3.1.2.2) (EC 3.1.2.3) (EC 3.1.2.5) (Choloyl-coenzyme A thioesterase) (EC 3.1.2.27) (Peroxisomal acyl-CoA thioesterase 2) (PTE-2) (Peroxisomal acyl-coenzyme A thioester hydrolase 1) (PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1) Mus musculus (Mouse) GO:0003986; GO:0004778; GO:0005739; GO:0005777; GO:0005782; GO:0006633; GO:0006637; GO:0009062; GO:0010561; GO:0016559; GO:0033882; GO:0043649; GO:0047603; GO:0047617; GO:0047994; GO:0052689; GO:0052815; GO:0052816 acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; fatty acid biosynthetic process [GO:0006633]; fatty acid catabolic process [GO:0009062]; negative regulation of glycoprotein biosynthetic process [GO:0010561]; peroxisome fission [GO:0016559] mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] acetoacetyl-CoA hydrolase activity [GO:0047603]; acetyl-CoA hydrolase activity [GO:0003986]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; hydroxymethylglutaryl-CoA hydrolase activity [GO:0047994]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; succinyl-CoA hydrolase activity [GO:0004778] g17751.t1 Q5ZJX5 43.417 357 1e-95 299.0 sp|Q5ZJX5|MEAK7_CHICK MTOR-associated protein MEAK7 OS=Gallus gallus OX=9031 GN=MEAK7 PE=2 SV=1 MEAK7_CHICK reviewed MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1) Gallus gallus (Chicken) GO:0005634; GO:0005737; GO:0005765; GO:0006979; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032 positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634] g17752.t1 Q9CWZ7 46.349 315 9.869999999999999e-89 270.0 sp|Q9CWZ7|SNAG_MOUSE Gamma-soluble NSF attachment protein OS=Mus musculus OX=10090 GN=Napg PE=1 SV=1 g17753.t1 O75208 43.172 227 4.45e-62 202.0 sp|O75208|COQ9_HUMAN Ubiquinone biosynthesis protein COQ9, mitochondrial OS=Homo sapiens OX=9606 GN=COQ9 PE=1 SV=1 COQ9_HUMAN reviewed Ubiquinone biosynthesis protein COQ9, mitochondrial Homo sapiens (Human) GO:0005739; GO:0005743; GO:0006120; GO:0006744; GO:0008047; GO:0008289; GO:0019840; GO:0042803; GO:0110142 mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142] enzyme activator activity [GO:0008047]; isoprenoid binding [GO:0019840]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803] g17754.t1 Q5RCM6 58.537 164 1.92e-56 200.0 sp|Q5RCM6|SOCS6_PONAB Suppressor of cytokine signaling 6 OS=Pongo abelii OX=9601 GN=SOCS6 PE=2 SV=1 g17755.t1 P43307 45.74 223 8.01e-63 203.0 sp|P43307|SSRA_HUMAN Translocon-associated protein subunit alpha OS=Homo sapiens OX=9606 GN=SSR1 PE=1 SV=3 SSRA_HUMAN reviewed Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006613; GO:0008284; GO:0016020 cotranslational protein targeting to membrane [GO:0006613]; positive regulation of cell population proliferation [GO:0008284] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] g17756.t1 Q2TAD9 53.939 330 1.42e-133 388.0 sp|Q2TAD9|ZFT1B_XENLA Zinc finger TRAF-type-containing protein 1-B OS=Xenopus laevis OX=8355 GN=zftraf1-b PE=2 SV=2 g17756.t2 Q6GNX1 50.746 201 7.5e-75 233.0 sp|Q6GNX1|ZFT1A_XENLA Zinc finger TRAF-type-containing protein 1-A OS=Xenopus laevis OX=8355 GN=zftraf1-a PE=2 SV=2 g17758.t1 Q92508 32.086 2565 0.0 1203.0 sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4 PIEZ1_HUMAN reviewed Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A) Homo sapiens (Human) GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g17758.t2 Q92508 32.239 2559 0.0 1204.0 sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4 PIEZ1_HUMAN reviewed Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A) Homo sapiens (Human) GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g17758.t3 Q92508 32.34 2551 0.0 1203.0 sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4 PIEZ1_HUMAN reviewed Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A) Homo sapiens (Human) GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g17758.t4 Q92508 32.295 2567 0.0 1215.0 sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4 PIEZ1_HUMAN reviewed Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A) Homo sapiens (Human) GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135 cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261] g17759.t1 Q9DE07 41.104 326 6.41e-76 264.0 sp|Q9DE07|NBN_CHICK Nibrin OS=Gallus gallus OX=9031 GN=NBN PE=1 SV=1 g17761.t1 Q9NX04 33.333 204 2.9000000000000004e-27 105.0 sp|Q9NX04|AIRIM_HUMAN AFG2-interacting ribosome maturation factor OS=Homo sapiens OX=9606 GN=AIRIM PE=1 SV=1 g17762.t1 Q9H5Z1 69.841 693 0.0 1033.0 sp|Q9H5Z1|DHX35_HUMAN Probable ATP-dependent RNA helicase DHX35 OS=Homo sapiens OX=9606 GN=DHX35 PE=1 SV=2 DHX35_HUMAN reviewed Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35) Homo sapiens (Human) GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005654; GO:0016887; GO:0071013 in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g17763.t1 Q5ZJJ5 56.159 276 4.36e-105 311.0 sp|Q5ZJJ5|AKTIP_CHICK AKT-interacting protein OS=Gallus gallus OX=9031 GN=AKTIP PE=2 SV=1 g17764.t1 Q6P1X6 50.259 193 8.88e-70 215.0 sp|Q6P1X6|CH082_HUMAN UPF0598 protein C8orf82 OS=Homo sapiens OX=9606 GN=C8orf82 PE=1 SV=2 g17765.t1 O61585 59.0 700 0.0 851.0 sp|O61585|KTNB1_STRPU Katanin p80 WD40 repeat-containing subunit B1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNB1 PE=1 SV=1 g17770.t1 Q8R151 40.231 1387 0.0 1009.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g17770.t1 Q8R151 37.6 250 2.96e-41 171.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g17771.t1 P57768 61.006 159 1.0999999999999999e-67 220.0 sp|P57768|SNX16_HUMAN Sorting nexin-16 OS=Homo sapiens OX=9606 GN=SNX16 PE=1 SV=2 SNX16_HUMAN reviewed Sorting nexin-16 Homo sapiens (Human) GO:0001881; GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022 early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]; receptor recycling [GO:0001881] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] g17771.t2 Q5R6Q7 60.377 159 1.4099999999999999e-67 220.0 sp|Q5R6Q7|SNX16_PONAB Sorting nexin-16 OS=Pongo abelii OX=9601 GN=SNX16 PE=2 SV=1 SNX16_PONAB reviewed Sorting nexin-16 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0045022 early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764] phosphatidylinositol binding [GO:0035091] g17772.t1 Q5U4I3 34.769 325 7.59e-58 192.0 sp|Q5U4I3|CCDB1_XENLA Cyclin-D1-binding protein 1 homolog OS=Xenopus laevis OX=8355 GN=ccndbp1 PE=2 SV=2 g17773.t1 P56812 56.349 126 7.769999999999999e-42 137.0 sp|P56812|PDCD5_MOUSE Programmed cell death protein 5 OS=Mus musculus OX=10090 GN=Pdcd5 PE=1 SV=3 g17774.t1 Q5ZKJ0 53.053 524 0.0 594.0 sp|Q5ZKJ0|CLP1L_CHICK Lipid scramblase CLPTM1L OS=Gallus gallus OX=9031 GN=CLPTM1L PE=2 SV=1 CLP1L_CHICK reviewed Lipid scramblase CLPTM1L (Cisplatin resistance-related protein 9) (CRR9p) (Cleft lip and palate transmembrane protein 1-like protein) (CLPTM1-like protein) Gallus gallus (Chicken) GO:0005789; GO:0006915; GO:0012505; GO:0016020; GO:0017128 apoptotic process [GO:0006915] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] phospholipid scramblase activity [GO:0017128] g17776.t1 Q29036 67.257 113 1.51e-55 171.0 sp|Q29036|DAD1_PIG Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 OS=Sus scrofa OX=9823 GN=DAD1 PE=3 SV=3 g17777.t1 Q5XF04 27.182 401 2.74e-29 124.0 sp|Q5XF04|GT15_ARATH Probable xyloglucan galactosyltransferase GT15 OS=Arabidopsis thaliana OX=3702 GN=GT15 PE=2 SV=1 g17778.t1 O75521 52.604 384 2e-140 409.0 sp|O75521|ECI2_HUMAN Enoyl-CoA delta isomerase 2 OS=Homo sapiens OX=9606 GN=ECI2 PE=1 SV=4 ECI2_HUMAN reviewed Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1) Homo sapiens (Human) GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0009062; GO:0016020 fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062] g17779.t1 Q6AYK9 43.233 266 3.61e-74 250.0 sp|Q6AYK9|CDYL_RAT Chromodomain Y-like protein OS=Rattus norvegicus OX=10116 GN=Cdyl PE=1 SV=1 CDYL_RAT reviewed Chromodomain Y-like protein (CDY-like) (Crotonyl-CoA hydratase) (EC 4.2.1.-) (Putative tubulin acetyltransferase Cdyl) (EC 2.3.1.-) Rattus norvegicus (Rat) GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0005737; GO:0007286; GO:0016607; GO:0016746; GO:0030674; GO:0042802; GO:0060816; GO:0120092; GO:0120094 negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] (2E)-butenoyl-CoA hydratase activity [GO:0120092]; acyltransferase activity [GO:0016746]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor activity [GO:0003714] g17781.t1 Q9BR09 41.611 149 9.15e-28 108.0 sp|Q9BR09|NEUL2_HUMAN Neuralized-like protein 2 OS=Homo sapiens OX=9606 GN=NEURL2 PE=1 SV=1 g17782.t1 Q4FZW5 71.045 335 1.3e-179 507.0 sp|Q4FZW5|SEH1A_XENLA Nucleoporin SEH1-A OS=Xenopus laevis OX=8355 GN=seh1l-a PE=1 SV=1 SEH1A_XENLA reviewed Nucleoporin SEH1-A (GATOR2 complex protein SEH1-A) (Nup107-160 subcomplex subunit seh1-A) Xenopus laevis (African clawed frog) GO:0000776; GO:0005198; GO:0005765; GO:0005829; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0031669; GO:0034198; GO:0035859; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904263 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859] structural molecule activity [GO:0005198] g17783.t1 O16118 75.198 379 0.0 598.0 sp|O16118|GNAS_HOMAM Guanine nucleotide-binding protein G(s) subunit alpha OS=Homarus americanus OX=6706 PE=2 SV=1 g17783.t2 O16118 80.475 379 0.0 652.0 sp|O16118|GNAS_HOMAM Guanine nucleotide-binding protein G(s) subunit alpha OS=Homarus americanus OX=6706 PE=2 SV=1 g17784.t1 Q96DB5 56.637 226 3.69e-92 277.0 sp|Q96DB5|RMD1_HUMAN Regulator of microtubule dynamics protein 1 OS=Homo sapiens OX=9606 GN=RMDN1 PE=1 SV=1 g17785.t1 Q96DB5 58.407 226 8.009999999999999e-94 284.0 sp|Q96DB5|RMD1_HUMAN Regulator of microtubule dynamics protein 1 OS=Homo sapiens OX=9606 GN=RMDN1 PE=1 SV=1 g17789.t1 Q566Y9 47.594 374 1.3700000000000001e-124 367.0 sp|Q566Y9|MPPE1_DANRE Metallophosphoesterase 1 OS=Danio rerio OX=7955 GN=mppe1 PE=2 SV=1 g17790.t1 P00173 47.126 87 8.790000000000001e-21 84.7 sp|P00173|CYB5_RAT Cytochrome b5 OS=Rattus norvegicus OX=10116 GN=Cyb5a PE=1 SV=2 g17793.t1 Q9Y248 63.006 173 5.98e-82 243.0 sp|Q9Y248|PSF2_HUMAN DNA replication complex GINS protein PSF2 OS=Homo sapiens OX=9606 GN=GINS2 PE=1 SV=1 g17794.t1 Q801E2 40.998 461 2.73e-101 349.0 sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1 ANLN_XENLA reviewed Anillin Xenopus laevis (African clawed frog) GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172 actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106] actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634] actin binding [GO:0003779] g17797.t1 Q66JZ4 34.096 481 3.41e-78 256.0 sp|Q66JZ4|TCAIM_MOUSE T-cell activation inhibitor, mitochondrial OS=Mus musculus OX=10090 GN=TCAIM PE=1 SV=1 g17798.t1 Q61164 38.728 173 1.09e-34 138.0 sp|Q61164|CTCF_MOUSE Transcriptional repressor CTCF OS=Mus musculus OX=10090 GN=Ctcf PE=1 SV=2 CTCF_MOUSE reviewed Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) Mus musculus (Mouse) GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0000987; GO:0001221; GO:0001227; GO:0001651; GO:0001652; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006346; GO:0006355; GO:0006357; GO:0007005; GO:0007059; GO:0007507; GO:0008270; GO:0008285; GO:0010467; GO:0010628; GO:0010629; GO:0040029; GO:0043035; GO:0043565; GO:0044027; GO:0045892; GO:0045893; GO:0045944; GO:0055007; GO:0055013; GO:0060816; GO:0071459; GO:0071514; GO:0140297; GO:0140587; GO:0140588; GO:1902895; GO:1990837 cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; chromatin looping [GO:0140588]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; random inactivation of X chromosome [GO:0060816]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; dense fibrillar component [GO:0001651]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; chromatin loop anchoring activity [GO:0140587]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g17798.t1 Q61164 32.941 170 2.51e-24 107.0 sp|Q61164|CTCF_MOUSE Transcriptional repressor CTCF OS=Mus musculus OX=10090 GN=Ctcf PE=1 SV=2 CTCF_MOUSE reviewed Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) Mus musculus (Mouse) GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0000987; GO:0001221; GO:0001227; GO:0001651; GO:0001652; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006346; GO:0006355; GO:0006357; GO:0007005; GO:0007059; GO:0007507; GO:0008270; GO:0008285; GO:0010467; GO:0010628; GO:0010629; GO:0040029; GO:0043035; GO:0043565; GO:0044027; GO:0045892; GO:0045893; GO:0045944; GO:0055007; GO:0055013; GO:0060816; GO:0071459; GO:0071514; GO:0140297; GO:0140587; GO:0140588; GO:1902895; GO:1990837 cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; chromatin looping [GO:0140588]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; random inactivation of X chromosome [GO:0060816]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; dense fibrillar component [GO:0001651]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; chromatin loop anchoring activity [GO:0140587]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g17801.t1 Q08705 50.36 278 6.7799999999999995e-93 316.0 sp|Q08705|CTCF_CHICK Transcriptional repressor CTCF OS=Gallus gallus OX=9031 GN=CTCF PE=1 SV=1 g17802.t1 Q9BXA9 44.592 453 7.95e-96 342.0 sp|Q9BXA9|SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens OX=9606 GN=SALL3 PE=1 SV=2 SALL3_HUMAN reviewed Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3) Homo sapiens (Human) GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0009966; GO:0021772; GO:0030154; GO:0035108 cell differentiation [GO:0030154]; limb morphogenesis [GO:0035108]; olfactory bulb development [GO:0021772]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g17802.t1 Q9BXA9 55.245 143 2.38e-34 148.0 sp|Q9BXA9|SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens OX=9606 GN=SALL3 PE=1 SV=2 SALL3_HUMAN reviewed Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3) Homo sapiens (Human) GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0009966; GO:0021772; GO:0030154; GO:0035108 cell differentiation [GO:0030154]; limb morphogenesis [GO:0035108]; olfactory bulb development [GO:0021772]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g17802.t1 Q9BXA9 52.326 86 3.71e-21 105.0 sp|Q9BXA9|SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens OX=9606 GN=SALL3 PE=1 SV=2 SALL3_HUMAN reviewed Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3) Homo sapiens (Human) GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0009966; GO:0021772; GO:0030154; GO:0035108 cell differentiation [GO:0030154]; limb morphogenesis [GO:0035108]; olfactory bulb development [GO:0021772]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g17802.t2 Q9BXA9 44.592 453 6.87e-96 343.0 sp|Q9BXA9|SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens OX=9606 GN=SALL3 PE=1 SV=2 SALL3_HUMAN reviewed Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3) Homo sapiens (Human) GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0009966; GO:0021772; GO:0030154; GO:0035108 cell differentiation [GO:0030154]; limb morphogenesis [GO:0035108]; olfactory bulb development [GO:0021772]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g17802.t2 Q9BXA9 55.245 143 2.22e-34 148.0 sp|Q9BXA9|SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens OX=9606 GN=SALL3 PE=1 SV=2 SALL3_HUMAN reviewed Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3) Homo sapiens (Human) GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0009966; GO:0021772; GO:0030154; GO:0035108 cell differentiation [GO:0030154]; limb morphogenesis [GO:0035108]; olfactory bulb development [GO:0021772]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g17802.t2 Q9BXA9 52.326 86 3.82e-21 105.0 sp|Q9BXA9|SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens OX=9606 GN=SALL3 PE=1 SV=2 SALL3_HUMAN reviewed Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3) Homo sapiens (Human) GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0009966; GO:0021772; GO:0030154; GO:0035108 cell differentiation [GO:0030154]; limb morphogenesis [GO:0035108]; olfactory bulb development [GO:0021772]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270] g17805.t1 Q99KE8 46.687 332 6.61e-89 301.0 sp|Q99KE8|ZFP64_MOUSE Zinc finger protein 64 OS=Mus musculus OX=10090 GN=Zfp64 PE=1 SV=1 g17805.t1 Q99KE8 33.654 416 2.1699999999999998e-54 204.0 sp|Q99KE8|ZFP64_MOUSE Zinc finger protein 64 OS=Mus musculus OX=10090 GN=Zfp64 PE=1 SV=1 g17806.t1 Q8TBZ8 27.473 273 9.600000000000002e-27 120.0 sp|Q8TBZ8|ZN564_HUMAN Zinc finger protein 564 OS=Homo sapiens OX=9606 GN=ZNF564 PE=1 SV=1 ZN564_HUMAN reviewed Zinc finger protein 564 Homo sapiens (Human) GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g17807.t1 Q9C0G0 34.653 404 6.42e-65 239.0 sp|Q9C0G0|ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens OX=9606 GN=ZNF407 PE=1 SV=2 ZN407_HUMAN reviewed Zinc finger protein 407 Homo sapiens (Human) GO:0003677; GO:0005634; GO:0008270; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g17809.t1 P23934 46.825 126 4.8599999999999995e-34 117.0 sp|P23934|NDUS6_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS6 PE=1 SV=2 g17815.t1 Q5E9I8 52.823 496 0.0 544.0 sp|Q5E9I8|DCA11_BOVIN DDB1- and CUL4-associated factor 11 OS=Bos taurus OX=9913 GN=DCAF11 PE=2 SV=1 g17817.t1 Q53S33 62.821 78 1.0500000000000001e-32 113.0 sp|Q53S33|BOLA3_HUMAN BolA-like protein 3 OS=Homo sapiens OX=9606 GN=BOLA3 PE=1 SV=1 BOLA3_HUMAN reviewed BolA-like protein 3 Homo sapiens (Human) GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006879; GO:0009249; GO:0016226; GO:0016604; GO:0045454; GO:0051604; GO:0097009; GO:1903442; GO:1990229; GO:1990845 adaptive thermogenesis [GO:1990845]; cell redox homeostasis [GO:0045454]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; intracellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; protein lipoylation [GO:0009249]; protein maturation [GO:0051604]; response to lipoic acid [GO:1903442] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] g17821.t1 P26270 71.988 332 1.1900000000000001e-167 473.0 sp|P26270|PSMD7_DROME 26S proteasome non-ATPase regulatory subunit 7 OS=Drosophila melanogaster OX=7227 GN=Rpn8 PE=1 SV=6 PSMD7_DROME reviewed 26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Proteasome subunit p39B) (Proteasome subunit p40) (Protein Mov34) Drosophila melanogaster (Fruit fly) GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0030425; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541] g17826.t1 O73590 29.383 616 1.3e-49 190.0 sp|O73590|ZFHX4_CHICK Zinc finger homeobox protein 4 OS=Gallus gallus OX=9031 GN=ZFHX4 PE=2 SV=2 g17827.t1 Q15911 46.761 849 0.0 686.0 sp|Q15911|ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens OX=9606 GN=ZFHX3 PE=1 SV=2 g17829.t1 O73590 47.872 188 1.14e-34 143.0 sp|O73590|ZFHX4_CHICK Zinc finger homeobox protein 4 OS=Gallus gallus OX=9031 GN=ZFHX4 PE=2 SV=2 g17830.t1 O73590 42.373 236 5.8399999999999994e-52 187.0 sp|O73590|ZFHX4_CHICK Zinc finger homeobox protein 4 OS=Gallus gallus OX=9031 GN=ZFHX4 PE=2 SV=2 g17831.t1 O73590 75.362 69 5.8e-30 114.0 sp|O73590|ZFHX4_CHICK Zinc finger homeobox protein 4 OS=Gallus gallus OX=9031 GN=ZFHX4 PE=2 SV=2 g17831.t2 Q15911 44.444 144 1.8800000000000002e-29 121.0 sp|Q15911|ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens OX=9606 GN=ZFHX3 PE=1 SV=2 g17833.t1 Q58EX7 55.313 367 1.3300000000000001e-125 426.0 sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1 PKHG4_HUMAN reviewed Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g17833.t1 Q58EX7 27.663 582 5.97e-45 182.0 sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1 PKHG4_HUMAN reviewed Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g17833.t2 Q58EX7 55.313 367 2e-125 425.0 sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1 PKHG4_HUMAN reviewed Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g17833.t2 Q58EX7 28.435 524 4.13e-44 179.0 sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1 PKHG4_HUMAN reviewed Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056 axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g17834.t1 Q95SS8 40.606 165 3.8e-26 105.0 sp|Q95SS8|TMM70_DROME Transmembrane protein 70 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Tmem70 PE=1 SV=1 g17835.t1 O35615 26.19 546 9.290000000000001e-21 102.0 sp|O35615|FOG1_MOUSE Zinc finger protein ZFPM1 OS=Mus musculus OX=10090 GN=Zfpm1 PE=1 SV=1 FOG1_MOUSE reviewed Zinc finger protein ZFPM1 (Friend of GATA protein 1) (FOG-1) (Friend of GATA 1) (Zinc finger protein multitype 1) Mus musculus (Mouse) GO:0000122; GO:0003151; GO:0003181; GO:0003192; GO:0003195; GO:0003677; GO:0003714; GO:0005634; GO:0005667; GO:0005737; GO:0007507; GO:0008270; GO:0010724; GO:0017053; GO:0030218; GO:0030219; GO:0030220; GO:0030851; GO:0032642; GO:0032713; GO:0032729; GO:0035162; GO:0035855; GO:0045944; GO:0048872; GO:0055008; GO:0060318; GO:0060319; GO:0060377; GO:0060412; GO:0060413; GO:0061629 atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cardiac muscle tissue morphogenesis [GO:0055008]; definitive erythrocyte differentiation [GO:0060318]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; homeostasis of number of cells [GO:0048872]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; mitral valve formation [GO:0003192]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of mast cell differentiation [GO:0060377]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; primitive erythrocyte differentiation [GO:0060319]; regulation of chemokine production [GO:0032642]; regulation of definitive erythrocyte differentiation [GO:0010724]; tricuspid valve formation [GO:0003195]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g17836.t1 Q64012 49.524 105 6.88e-27 107.0 sp|Q64012|RALY_MOUSE RNA-binding protein Raly OS=Mus musculus OX=10090 GN=Raly PE=1 SV=3 RALY_MOUSE reviewed RNA-binding protein Raly (Maternally-expressed hnRNP C-related protein) (hnRNP associated with lethal yellow protein) Mus musculus (Mouse) GO:0000122; GO:0003712; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0042632; GO:0071013 cholesterol homeostasis [GO:0042632]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] g17837.t1 P54254 60.938 128 2.9e-43 172.0 sp|P54254|ATX1_MOUSE Ataxin-1 OS=Mus musculus OX=10090 GN=Atxn1 PE=1 SV=2 ATX1_MOUSE reviewed Ataxin-1 (Spinocerebellar ataxia type 1 protein homolog) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007420; GO:0007612; GO:0007613; GO:0008266; GO:0008344; GO:0008542; GO:0016363; GO:0031208; GO:0032991; GO:0034046; GO:0035176; GO:0042405; GO:0042802; GO:0043569; GO:0045892; GO:0045944; GO:0048286; GO:0051168; GO:0060079; GO:0060252; GO:0098794 adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; social behavior [GO:0035176]; visual learning [GO:0008542] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; POZ domain binding [GO:0031208]; RNA binding [GO:0003723] g17838.t1 Q64012 59.048 105 1.1699999999999999e-34 128.0 sp|Q64012|RALY_MOUSE RNA-binding protein Raly OS=Mus musculus OX=10090 GN=Raly PE=1 SV=3 RALY_MOUSE reviewed RNA-binding protein Raly (Maternally-expressed hnRNP C-related protein) (hnRNP associated with lethal yellow protein) Mus musculus (Mouse) GO:0000122; GO:0003712; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0042632; GO:0071013 cholesterol homeostasis [GO:0042632]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] g17838.t2 Q64012 59.048 105 1.7999999999999998e-34 129.0 sp|Q64012|RALY_MOUSE RNA-binding protein Raly OS=Mus musculus OX=10090 GN=Raly PE=1 SV=3 RALY_MOUSE reviewed RNA-binding protein Raly (Maternally-expressed hnRNP C-related protein) (hnRNP associated with lethal yellow protein) Mus musculus (Mouse) GO:0000122; GO:0003712; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0042632; GO:0071013 cholesterol homeostasis [GO:0042632]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] g17839.t1 Q3U2U7 39.955 448 2.8100000000000003e-116 353.0 sp|Q3U2U7|MET17_MOUSE Ribosome assembly protein METTL17, mitochondrial OS=Mus musculus OX=10090 GN=Mettl17 PE=1 SV=2 MET17_MOUSE reviewed Ribosome assembly protein METTL17, mitochondrial (Methyltransferase-like protein 17) Mus musculus (Mouse) GO:0005654; GO:0005739; GO:0005759; GO:0006412; GO:0008168; GO:0042274; GO:0046872; GO:0051539; GO:0097177; GO:0180026; GO:1904047 mitochondrial small ribosomal subunit assembly [GO:0180026]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047] g17840.t1 Q5RHR6 41.291 1332 0.0 983.0 sp|Q5RHR6|BROMI_DANRE Protein broad-minded OS=Danio rerio OX=7955 GN=tbc1d32 PE=3 SV=2 BROMI_DANRE reviewed Protein broad-minded (TBC1 domain family member 32) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005929; GO:0035082; GO:0060271; GO:1905515 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515] cilium [GO:0005929]; cytoplasm [GO:0005737] g17841.t1 Q9Y2B5 36.716 335 3.2400000000000003e-47 182.0 sp|Q9Y2B5|VP9D1_HUMAN VPS9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=VPS9D1 PE=1 SV=2 g17841.t1 Q9Y2B5 41.176 238 4.79e-44 173.0 sp|Q9Y2B5|VP9D1_HUMAN VPS9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=VPS9D1 PE=1 SV=2 g17843.t1 Q9JIX8 45.946 259 7.28e-48 190.0 sp|Q9JIX8|ACINU_MOUSE Apoptotic chromatin condensation inducer in the nucleus OS=Mus musculus OX=10090 GN=Acin1 PE=1 SV=3 g17843.t2 Q9JIX8 45.946 259 7.38e-48 190.0 sp|Q9JIX8|ACINU_MOUSE Apoptotic chromatin condensation inducer in the nucleus OS=Mus musculus OX=10090 GN=Acin1 PE=1 SV=3 g17843.t3 Q9JIX8 45.946 259 3.53e-48 184.0 sp|Q9JIX8|ACINU_MOUSE Apoptotic chromatin condensation inducer in the nucleus OS=Mus musculus OX=10090 GN=Acin1 PE=1 SV=3 g17844.t1 Q7Z442 31.573 1894 0.0 851.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g17847.t2 Q9W707 56.391 266 1.8600000000000003e-73 238.0 sp|Q9W707|FXF1B_XENLA Forkhead box protein F1-B OS=Xenopus laevis OX=8355 GN=foxf1-b PE=2 SV=1 g17850.t1 Q9PVY8 40.417 527 2.93e-87 279.0 sp|Q9PVY8|FXC2B_XENLA Forkhead box protein C2-B OS=Xenopus laevis OX=8355 GN=foxc2-b PE=2 SV=2 g17854.t1 Q8K3X3 75.143 350 0.0 564.0 sp|Q8K3X3|GMDS_CRIGR GDP-mannose 4,6 dehydratase OS=Cricetulus griseus OX=10029 GN=GMDS PE=2 SV=1 g17856.t1 Q63244 58.889 90 3.04e-29 120.0 sp|Q63244|FOXQ1_RAT Forkhead box protein Q1 OS=Rattus norvegicus OX=10116 GN=Foxq1 PE=1 SV=3 g17859.t1 Q6BD04 28.66 321 1.9400000000000002e-35 136.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g17861.t1 O96530 39.722 360 1.22e-49 187.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g17861.t1 O96530 39.244 344 3.58e-46 177.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g17861.t1 O96530 41.358 324 4.769999999999999e-41 162.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g17861.t1 O96530 34.125 337 1.63e-31 133.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g17861.t1 O96530 35.821 268 2.8499999999999997e-25 114.0 sp|O96530|HYAL_LYTVA Hyalin (Fragment) OS=Lytechinus variegatus OX=7654 PE=2 SV=1 g17864.t1 O76536 31.915 470 2.05e-35 146.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17864.t1 O76536 34.318 440 7e-33 139.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17864.t1 O76536 32.265 468 1.2300000000000001e-29 129.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17866.t1 O76536 37.198 414 7.23e-46 179.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17866.t1 O76536 34.802 454 1.3399999999999998e-42 169.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17866.t1 O76536 35.532 470 5.04e-40 161.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17866.t1 O76536 34.454 476 5.48e-39 158.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17866.t1 O76536 35.778 450 5.19e-37 152.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17866.t1 O76536 34.367 387 8.56e-26 117.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17868.t1 Q96EV8 35.088 285 4.25e-42 154.0 sp|Q96EV8|DTBP1_HUMAN Dysbindin OS=Homo sapiens OX=9606 GN=DTNBP1 PE=1 SV=1 g17868.t2 Q96EV8 35.192 287 9.319999999999999e-42 153.0 sp|Q96EV8|DTBP1_HUMAN Dysbindin OS=Homo sapiens OX=9606 GN=DTNBP1 PE=1 SV=1 g17869.t1 Q9CZX2 33.647 532 3.37e-86 295.0 sp|Q9CZX2|CEP89_MOUSE Centrosomal protein of 89 kDa OS=Mus musculus OX=10090 GN=Cep89 PE=1 SV=1 CEP89_MOUSE reviewed Centrosomal protein of 89 kDa (Cep89) (Coiled-coil domain-containing protein 123) Mus musculus (Mouse) GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007005; GO:0007268; GO:0016604; GO:0031514; GO:0033617; GO:0036064; GO:0045202; GO:0060271; GO:0097539; GO:0097730; GO:1905515 chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrial respiratory chain complex IV assembly [GO:0033617]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; spindle pole [GO:0000922]; synapse [GO:0045202] g17872.t1 Q8BJT9 60.892 381 3.43e-160 467.0 sp|Q8BJT9|EDEM2_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 2 OS=Mus musculus OX=10090 GN=Edem2 PE=1 SV=1 g17873.t1 Q9UGV2 44.218 294 1.22e-84 265.0 sp|Q9UGV2|NDRG3_HUMAN Protein NDRG3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=2 g17874.t1 Q63244 74.59 122 4.5899999999999996e-55 189.0 sp|Q63244|FOXQ1_RAT Forkhead box protein Q1 OS=Rattus norvegicus OX=10116 GN=Foxq1 PE=1 SV=3 g17875.t1 Q20191 36.074 377 1.08e-62 213.0 sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5 g17876.t1 Q20191 37.255 306 8.19e-58 198.0 sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5 g17878.t1 P55115 36.207 290 8.4e-51 184.0 sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2 g17880.t1 Q9N126 43.525 278 1.33e-60 197.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g17881.t1 Q81BR3 27.536 828 3.47e-77 270.0 sp|Q81BR3|RPH_BACCR Rifampicin phosphotransferase OS=Bacillus cereus (strain ATCC 14579 / DSM 31 / CCUG 7414 / JCM 2152 / NBRC 15305 / NCIMB 9373 / NCTC 2599 / NRRL B-3711) OX=226900 GN=rph PE=1 SV=1 g17883.t1 Q5FWL3 33.716 261 4e-35 131.0 sp|Q5FWL3|RNF41_XENLA E3 ubiquitin-protein ligase NRDP1 OS=Xenopus laevis OX=8355 GN=rnf41 PE=2 SV=1 g17886.t1 A2AIV2 35.68 1250 0.0 640.0 sp|A2AIV2|VIR_MOUSE Protein virilizer homolog OS=Mus musculus OX=10090 GN=Virma PE=1 SV=1 VIR_MOUSE reviewed Protein virilizer homolog Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] g17886.t1 A2AIV2 51.587 126 4.38e-30 134.0 sp|A2AIV2|VIR_MOUSE Protein virilizer homolog OS=Mus musculus OX=10090 GN=Virma PE=1 SV=1 VIR_MOUSE reviewed Protein virilizer homolog Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] g17887.t1 Q29RZ5 40.996 261 1.11e-59 194.0 sp|Q29RZ5|TNG2_BOVIN Transport and Golgi organization protein 2 homolog OS=Bos taurus OX=9913 GN=TANGO2 PE=2 SV=1 g17888.t1 Q8CJ61 36.994 173 1.04e-22 94.0 sp|Q8CJ61|CKLF4_MOUSE CKLF-like MARVEL transmembrane domain-containing protein 4 OS=Mus musculus OX=10090 GN=Cmtm4 PE=1 SV=1 g17891.t1 Q9D8B6 48.333 120 3.86e-32 122.0 sp|Q9D8B6|F210B_MOUSE Protein FAM210B, mitochondrial OS=Mus musculus OX=10090 GN=Fam210b PE=1 SV=3 F210B_MOUSE reviewed Protein FAM210B, mitochondrial Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0006954; GO:0016020; GO:0030218; GO:0043249; GO:0043588; GO:0045648; GO:0048536; GO:0071392; GO:0072593 cellular response to estradiol stimulus [GO:0071392]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; inflammatory response [GO:0006954]; positive regulation of erythrocyte differentiation [GO:0045648]; reactive oxygen species metabolic process [GO:0072593]; skin development [GO:0043588]; spleen development [GO:0048536] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] g17892.t1 D7UQM5 84.428 411 0.0 657.0 sp|D7UQM5|AURK_PATPE Aurora kinase OS=Patiria pectinifera OX=7594 GN=aur PE=1 SV=1 AURK_PATPE reviewed Aurora kinase (EC 2.7.11.1) (ApAurora) Patiria pectinifera (Starfish) (Asterina pectinifera) GO:0000775; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0030496; GO:0051301; GO:0051321; GO:0106310 cell division [GO:0051301]; meiotic cell cycle [GO:0051321] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g17893.t1 Q32KJ6 68.219 494 0.0 728.0 sp|Q32KJ6|GALNS_RAT N-acetylgalactosamine-6-sulfatase OS=Rattus norvegicus OX=10116 GN=Galns PE=1 SV=1 GALNS_RAT reviewed N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase) Rattus norvegicus (Rat) GO:0004065; GO:0005764; GO:0008484; GO:0043890; GO:0046872 lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] g17894.t1 Q8BNJ6 37.143 385 1.08e-62 219.0 sp|Q8BNJ6|NETO2_MOUSE Neuropilin and tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Neto2 PE=1 SV=1 NETO2_MOUSE reviewed Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) Mus musculus (Mouse) GO:0014069; GO:0035255; GO:0045202; GO:0098696; GO:0098839; GO:0098978; GO:0099645 neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ionotropic glutamate receptor binding [GO:0035255] g17894.t2 Q8BNJ6 37.047 386 1.34e-63 219.0 sp|Q8BNJ6|NETO2_MOUSE Neuropilin and tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Neto2 PE=1 SV=1 NETO2_MOUSE reviewed Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) Mus musculus (Mouse) GO:0014069; GO:0035255; GO:0045202; GO:0098696; GO:0098839; GO:0098978; GO:0099645 neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ionotropic glutamate receptor binding [GO:0035255] g17895.t1 O76536 37.617 1284 4.09e-164 546.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 36.909 1268 9.64e-158 528.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.145 1268 1e-155 522.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.206 1274 2.97e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.675 1213 3.0000000000000002e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.327 1227 1.4e-152 513.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 36.926 1262 1.48e-151 509.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 36.203 1243 4.17e-143 485.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.389 1126 4.88e-138 470.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 35.383 1122 3.46e-128 441.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 36.212 1019 1.46e-122 424.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 35.989 753 5.93e-86 313.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 38.01 613 8.970000000000001e-79 291.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.188 640 6.3e-78 288.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.598 641 2.0599999999999997e-74 278.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.043 629 9.18e-71 266.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 35.804 715 2.49e-70 265.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 35.912 685 5.47e-69 261.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 35.368 639 4.92e-67 254.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 36.481 540 1.16e-63 244.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t1 O76536 37.919 298 6.2600000000000005e-27 125.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.461 1284 1.62e-163 545.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 36.83 1268 2.05e-157 527.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.066 1268 1.98e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.675 1213 2.07e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.206 1274 3.05e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.245 1227 3.0399999999999998e-152 512.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 36.926 1262 1.05e-151 510.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 36.174 1244 1.74e-142 483.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.389 1126 3.45e-138 470.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 35.383 1122 2.9199999999999996e-128 441.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 36.212 1019 1.09e-122 424.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 35.989 753 4.6500000000000004e-86 313.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 38.01 613 7.700000000000001e-79 291.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.188 640 5.61e-78 288.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.598 641 1.7799999999999998e-74 278.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.043 629 7.970000000000001e-71 266.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 35.804 715 2.22e-70 265.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 35.912 685 4.3899999999999997e-69 261.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 35.368 639 4.35e-67 254.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 36.481 540 1.01e-63 244.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t2 O76536 37.919 298 5.7100000000000006e-27 125.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.617 1284 5.59e-164 546.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 36.83 1268 2.6900000000000003e-157 526.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.066 1268 2.83e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.675 1213 2.97e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.206 1274 4.09e-155 520.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.245 1227 3.95e-152 511.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 36.926 1262 1.48e-151 509.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 36.122 1243 1.17e-142 483.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.389 1126 4.88e-138 470.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 35.383 1122 3.69e-128 441.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 36.212 1019 1.47e-122 424.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 35.989 753 5.93e-86 313.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 38.01 613 8.970000000000001e-79 291.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.188 640 6.3e-78 288.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.598 641 2.0599999999999997e-74 278.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.043 629 9.1e-71 266.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 35.804 715 2.49e-70 265.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 35.912 685 5.47e-69 261.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 35.368 639 4.92e-67 254.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 36.481 540 1.16e-63 244.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t3 O76536 37.919 298 6.2600000000000005e-27 125.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.461 1284 1.62e-163 545.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 36.83 1268 2.05e-157 527.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.066 1268 1.98e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.675 1213 2.07e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.206 1274 3.05e-155 521.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.245 1227 3.0399999999999998e-152 512.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 36.926 1262 1.05e-151 510.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 36.174 1244 1.74e-142 483.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.389 1126 3.45e-138 470.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 35.383 1122 2.9199999999999996e-128 441.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 36.212 1019 1.09e-122 424.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 35.989 753 4.6500000000000004e-86 313.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 38.01 613 7.700000000000001e-79 291.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.188 640 5.61e-78 288.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.598 641 1.7799999999999998e-74 278.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.043 629 7.970000000000001e-71 266.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 35.804 715 2.22e-70 265.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 35.912 685 4.3899999999999997e-69 261.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 35.368 639 4.35e-67 254.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 36.481 540 1.01e-63 244.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17895.t4 O76536 37.919 298 5.7100000000000006e-27 125.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17896.t1 Q8BNJ6 38.596 342 3.1700000000000002e-58 209.0 sp|Q8BNJ6|NETO2_MOUSE Neuropilin and tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Neto2 PE=1 SV=1 NETO2_MOUSE reviewed Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) Mus musculus (Mouse) GO:0014069; GO:0035255; GO:0045202; GO:0098696; GO:0098839; GO:0098978; GO:0099645 neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ionotropic glutamate receptor binding [GO:0035255] g17896.t1 Q8BNJ6 38.71 341 4.9e-57 206.0 sp|Q8BNJ6|NETO2_MOUSE Neuropilin and tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Neto2 PE=1 SV=1 NETO2_MOUSE reviewed Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) Mus musculus (Mouse) GO:0014069; GO:0035255; GO:0045202; GO:0098696; GO:0098839; GO:0098978; GO:0099645 neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ionotropic glutamate receptor binding [GO:0035255] g17896.t2 Q8BNJ6 38.596 342 3.1700000000000002e-58 209.0 sp|Q8BNJ6|NETO2_MOUSE Neuropilin and tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Neto2 PE=1 SV=1 NETO2_MOUSE reviewed Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) Mus musculus (Mouse) GO:0014069; GO:0035255; GO:0045202; GO:0098696; GO:0098839; GO:0098978; GO:0099645 neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ionotropic glutamate receptor binding [GO:0035255] g17896.t2 Q8BNJ6 38.71 341 4.9e-57 206.0 sp|Q8BNJ6|NETO2_MOUSE Neuropilin and tolloid-like protein 2 OS=Mus musculus OX=10090 GN=Neto2 PE=1 SV=1 NETO2_MOUSE reviewed Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) Mus musculus (Mouse) GO:0014069; GO:0035255; GO:0045202; GO:0098696; GO:0098839; GO:0098978; GO:0099645 neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synapse [GO:0045202] ionotropic glutamate receptor binding [GO:0035255] g17897.t1 P34059 74.648 71 1.35e-29 112.0 sp|P34059|GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens OX=9606 GN=GALNS PE=1 SV=1 GALNS_HUMAN reviewed N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (GalN6S) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase) Homo sapiens (Human) GO:0003943; GO:0004065; GO:0005576; GO:0008484; GO:0030207; GO:0035578; GO:0043202; GO:0043890; GO:0046872; GO:0070062 chondroitin sulfate proteoglycan catabolic process [GO:0030207] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484] g17898.t1 O76536 29.892 1201 5.85e-71 265.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17898.t1 O76536 29.191 1175 4.88e-63 240.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17898.t1 O76536 31.66 976 5.73e-51 201.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17899.t1 O76536 35.646 1052 2.77e-110 382.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17899.t1 O76536 32.951 1220 6.7e-106 369.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17899.t1 O76536 32.207 1273 2.98e-104 364.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17899.t1 O76536 33.366 1025 8.920000000000001e-103 360.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17899.t1 O76536 31.95 1205 3.09e-89 320.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t1 O76536 36.348 1194 7.73e-114 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t1 O76536 34.435 1240 1.44e-101 360.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t1 O76536 34.913 1203 9.43e-99 352.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t1 O76536 35.284 1128 4.46e-97 347.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t1 O76536 33.984 1230 3.2e-91 329.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t1 O76536 33.867 1125 4.7699999999999995e-89 323.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t1 O76536 32.314 1275 2.31e-87 317.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t2 O76536 36.692 1191 1.97e-116 405.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t2 O76536 35.245 1203 3.2300000000000002e-99 353.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t2 O76536 35.372 1128 2.93e-98 351.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t2 O76536 32.931 1242 3.6e-91 329.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t2 O76536 32.339 1274 9.769999999999999e-90 325.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t2 O76536 33.36 1238 1.5e-87 318.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t2 O76536 33.63 1124 7.83e-86 313.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t3 O76536 36.692 1191 8.24e-117 407.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t3 O76536 35.245 1203 1.2600000000000001e-99 355.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t3 O76536 35.372 1128 1.26e-98 352.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t3 O76536 32.931 1242 1.31e-91 330.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t3 O76536 32.339 1274 3.32e-90 326.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t3 O76536 33.36 1238 5.39e-88 319.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t3 O76536 33.63 1124 2.95e-86 314.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t4 O76536 36.692 1191 8.24e-117 407.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t4 O76536 35.245 1203 1.2600000000000001e-99 355.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t4 O76536 35.372 1128 1.26e-98 352.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t4 O76536 32.931 1242 1.31e-91 330.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t4 O76536 32.339 1274 3.32e-90 326.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t4 O76536 33.36 1238 5.39e-88 319.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17900.t4 O76536 33.63 1124 2.95e-86 314.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g17901.t1 Q08705 28.114 281 1.1999999999999998e-23 110.0 sp|Q08705|CTCF_CHICK Transcriptional repressor CTCF OS=Gallus gallus OX=9031 GN=CTCF PE=1 SV=1 g17901.t1 Q08705 30.769 208 7.97e-21 102.0 sp|Q08705|CTCF_CHICK Transcriptional repressor CTCF OS=Gallus gallus OX=9031 GN=CTCF PE=1 SV=1 g17902.t1 Q6GR45 81.967 244 1.52e-153 429.0 sp|Q6GR45|IF6_XENLA Eukaryotic translation initiation factor 6 OS=Xenopus laevis OX=8355 GN=eif6 PE=2 SV=1 g17903.t1 Q3UJP5 43.721 215 1.08e-60 191.0 sp|Q3UJP5|CF418_MOUSE Cilia- and flagella-associated protein 418 OS=Mus musculus OX=10090 GN=Cfap418 PE=1 SV=1 g17905.t1 Q969T3 32.817 323 1.7999999999999998e-42 154.0 sp|Q969T3|SNX21_HUMAN Sorting nexin-21 OS=Homo sapiens OX=9606 GN=SNX21 PE=1 SV=1 g17906.t1 O95490 32.2 500 7.89e-66 248.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g17906.t2 O95490 32.2 500 5.75e-66 248.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g17907.t1 O94910 30.966 507 3.7e-67 250.0 sp|O94910|AGRL1_HUMAN Adhesion G protein-coupled receptor L1 OS=Homo sapiens OX=9606 GN=ADGRL1 PE=1 SV=1 AGRL1_HUMAN reviewed Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0016020; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] axon [GO:0030424]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524] g17907.t2 O94910 30.966 507 4.15e-67 250.0 sp|O94910|AGRL1_HUMAN Adhesion G protein-coupled receptor L1 OS=Homo sapiens OX=9606 GN=ADGRL1 PE=1 SV=1 AGRL1_HUMAN reviewed Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0016020; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839 cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] axon [GO:0030424]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524] g17909.t1 Q90268 54.726 201 5.07e-62 208.0 sp|Q90268|PAX2A_DANRE Paired box protein Pax-2a OS=Danio rerio OX=7955 GN=pax2a PE=2 SV=2 g17911.t1 A6QQJ8 47.642 212 2.1399999999999998e-53 198.0 sp|A6QQJ8|ZC12A_BOVIN Ribonuclease ZC3H12A OS=Bos taurus OX=9913 GN=ZC3H12A PE=2 SV=1 ZC12A_BOVIN reviewed Ribonuclease ZC3H12A (EC 3.1.-.-) (Zinc finger CCCH domain-containing protein 12A) Bos taurus (Bovine) GO:0000122; GO:0000932; GO:0001525; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003729; GO:0003730; GO:0004518; GO:0004521; GO:0004532; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006402; GO:0006915; GO:0006974; GO:0008270; GO:0010508; GO:0010587; GO:0010595; GO:0010628; GO:0010656; GO:0010884; GO:0016579; GO:0030154; GO:0030867; GO:0032689; GO:0032691; GO:0032715; GO:0032720; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0036464; GO:0042149; GO:0042307; GO:0043022; GO:0043031; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0050852; GO:0051259; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071356; GO:0098586; GO:1900016; GO:1900119; GO:1900745; GO:1901223; GO:1903003; GO:1903936; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to glucose starvation [GO:0042149]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; DNA damage response [GO:0006974]; host-mediated suppression of viral genome replication [GO:0044828]; immune response-activating signaling pathway [GO:0002757]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage activation [GO:0043031]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; T cell receptor signaling pathway [GO:0050852] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum membrane [GO:0030867] chromatin binding [GO:0003682]; cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; ribosome binding [GO:0043022]; RNA endonuclease activity [GO:0004521]; RNA exonuclease activity [GO:0004532]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270] g17913.t1 Q9NQQ7 49.249 333 2.58e-99 301.0 sp|Q9NQQ7|S35C2_HUMAN Solute carrier family 35 member C2 OS=Homo sapiens OX=9606 GN=SLC35C2 PE=1 SV=2 g17914.t1 Q28DH9 68.209 670 0.0 967.0 sp|Q28DH9|CEP76_XENTR Centrosomal protein of 76 kDa OS=Xenopus tropicalis OX=8364 GN=cep76 PE=2 SV=1 g17915.t1 Q3ZBF3 51.02 294 1.22e-105 318.0 sp|Q3ZBF3|RM38_BOVIN Large ribosomal subunit protein mL38 OS=Bos taurus OX=9913 GN=MRPL38 PE=1 SV=2 g17916.t1 A4D1U4 60.25 400 7.910000000000001e-164 473.0 sp|A4D1U4|DEN11_HUMAN DENN domain-containing protein 11 OS=Homo sapiens OX=9606 GN=DENND11 PE=1 SV=1 DEN11_HUMAN reviewed DENN domain-containing protein 11 (DENND11) (Protein LCHN) Homo sapiens (Human) GO:0005085; GO:0005737 cytoplasm [GO:0005737] guanyl-nucleotide exchange factor activity [GO:0005085] g17917.t1 Q9GKV7 33.566 286 1.2200000000000001e-43 159.0 sp|Q9GKV7|FBX15_MACFA F-box only protein 15 OS=Macaca fascicularis OX=9541 GN=FBXO15 PE=2 SV=1 g17917.t2 Q9GKV7 33.566 286 1.32e-43 159.0 sp|Q9GKV7|FBX15_MACFA F-box only protein 15 OS=Macaca fascicularis OX=9541 GN=FBXO15 PE=2 SV=1 g17919.t1 Q13636 41.206 199 3.48e-43 146.0 sp|Q13636|RAB31_HUMAN Ras-related protein Rab-31 OS=Homo sapiens OX=9606 GN=RAB31 PE=1 SV=2 RAB31_HUMAN reviewed Ras-related protein Rab-31 (EC 3.6.5.2) (Ras-related protein Rab-22B) Homo sapiens (Human) GO:0001891; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0019003; GO:0030667; GO:0031623; GO:0031901; GO:0032588; GO:0032869; GO:0036186; GO:0043001; GO:0045055; GO:0045335; GO:0060100; GO:0090382 cellular response to insulin stimulus [GO:0032869]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome membrane [GO:0036186]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g17920.t1 P31582 43.979 191 1.11e-45 154.0 sp|P31582|RAF2A_ARATH Ras-related protein RABF2a OS=Arabidopsis thaliana OX=3702 GN=RABF2A PE=1 SV=1 g17921.t1 Q0ILQ6 42.515 167 3.7899999999999993e-42 144.0 sp|Q0ILQ6|RAB5A_ORYSJ Ras-related protein Rab5A OS=Oryza sativa subsp. japonica OX=39947 GN=RAB5A PE=1 SV=1 RAB5A_ORYSJ reviewed Ras-related protein Rab5A (OsRab5A) (Protein GLUTELIN PRECURSOR 4) (Protein GLUTELIN PRECURSOR ACCUMULATION 1) Oryza sativa subsp. japonica (Rice) GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006886; GO:0009705; GO:0010256; GO:0012505; GO:0030139; GO:0032586; GO:0051028 endomembrane system organization [GO:0010256]; intracellular protein transport [GO:0006886]; mRNA transport [GO:0051028] endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; plant-type vacuole membrane [GO:0009705]; plasma membrane [GO:0005886]; protein storage vacuole membrane [GO:0032586] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g17922.t1 Q9VVY3 40.976 205 9.47e-39 149.0 sp|Q9VVY3|GBS76_DROME Glycogen-binding subunit 76A OS=Drosophila melanogaster OX=7227 GN=Gbs-76A PE=1 SV=1 g17925.t1 Q62077 49.73 1112 0.0 1071.0 sp|Q62077|PLCG1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Mus musculus OX=10090 GN=Plcg1 PE=1 SV=2 PLCG1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1) Mus musculus (Mouse) GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005085; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030335; GO:0030971; GO:0031161; GO:0032587; GO:0032957; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0045793; GO:0046488; GO:0048015; GO:0050429; GO:0050804; GO:0050852; GO:0051209; GO:0051219; GO:0051281; GO:0071364; GO:0090303; GO:0098685; GO:0098978; GO:0120548; GO:1904643; GO:1905564; GO:2000353 calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; inositol trisphosphate metabolic process [GO:0032957]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of wound healing [GO:0090303]; release of sequestered calcium ion into cytosol [GO:0051209]; response to curcumin [GO:1904643]; T cell receptor signaling pathway [GO:0050852] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] g17925.t2 Q62077 50.405 1111 0.0 1092.0 sp|Q62077|PLCG1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Mus musculus OX=10090 GN=Plcg1 PE=1 SV=2 PLCG1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-gamma-1) (PLC-gamma-1) Mus musculus (Mouse) GO:0001701; GO:0001726; GO:0004435; GO:0004629; GO:0005085; GO:0005158; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006816; GO:0007173; GO:0008180; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0030136; GO:0030335; GO:0030971; GO:0031161; GO:0032587; GO:0032957; GO:0032959; GO:0035254; GO:0042995; GO:0043536; GO:0045766; GO:0045793; GO:0046488; GO:0048015; GO:0050429; GO:0050804; GO:0050852; GO:0051209; GO:0051219; GO:0051281; GO:0071364; GO:0090303; GO:0098685; GO:0098978; GO:0120548; GO:1904643; GO:1905564; GO:2000353 calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; inositol trisphosphate metabolic process [GO:0032957]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of wound healing [GO:0090303]; release of sequestered calcium ion into cytosol [GO:0051209]; response to curcumin [GO:1904643]; T cell receptor signaling pathway [GO:0050852] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] g17925.t3 P08487 45.072 761 0.0 622.0 sp|P08487|PLCG1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Bos taurus OX=9913 GN=PLCG1 PE=1 SV=1 PLCG1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1) Bos taurus (Bovine) GO:0001701; GO:0001726; GO:0004435; GO:0005085; GO:0005509; GO:0005737; GO:0005886; GO:0007173; GO:0008180; GO:0009395; GO:0010634; GO:0030027; GO:0032587; GO:0035924; GO:0046488; GO:0048015; GO:0050429; GO:0051209; GO:0071364; GO:0120548 cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; release of sequestered calcium ion into cytosol [GO:0051209] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g17925.t3 P08487 50.669 523 6.79e-168 534.0 sp|P08487|PLCG1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Bos taurus OX=9913 GN=PLCG1 PE=1 SV=1 PLCG1_BOVIN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1) Bos taurus (Bovine) GO:0001701; GO:0001726; GO:0004435; GO:0005085; GO:0005509; GO:0005737; GO:0005886; GO:0007173; GO:0008180; GO:0009395; GO:0010634; GO:0030027; GO:0032587; GO:0035924; GO:0046488; GO:0048015; GO:0050429; GO:0051209; GO:0071364; GO:0120548 cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; release of sequestered calcium ion into cytosol [GO:0051209] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phospholipase C activity [GO:0120548]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g17926.t1 O60762 68.201 239 1.4799999999999999e-115 332.0 sp|O60762|DPM1_HUMAN Dolichol-phosphate mannosyltransferase subunit 1 OS=Homo sapiens OX=9606 GN=DPM1 PE=1 SV=1 DPM1_HUMAN reviewed Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1) Homo sapiens (Human) GO:0004582; GO:0005537; GO:0005634; GO:0005783; GO:0005789; GO:0006488; GO:0006506; GO:0016020; GO:0019673; GO:0033185; GO:0035269; GO:0043048; GO:0043178; GO:0046872; GO:0070482; GO:0180047 dolichol phosphate mannose biosynthetic process [GO:0180047]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl monophosphate biosynthetic process [GO:0043048]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein O-linked glycosylation via mannose [GO:0035269]; response to oxygen levels [GO:0070482] dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634] alcohol binding [GO:0043178]; D-mannose binding [GO:0005537]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; metal ion binding [GO:0046872] g17927.t1 Q9NX74 51.739 460 2.97e-161 471.0 sp|Q9NX74|DUS2_HUMAN tRNA-dihydrouridine(20) synthase [NAD(P)+]-like OS=Homo sapiens OX=9606 GN=DUS2 PE=1 SV=1 g17928.t1 Q502J0 43.719 199 2.75e-46 163.0 sp|Q502J0|PCAT2_DANRE Lysophosphatidylcholine acyltransferase 2 OS=Danio rerio OX=7955 GN=lpcat2 PE=2 SV=1 PCAT2_DANRE reviewed Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0008654; GO:0042171; GO:0047159; GO:0047184; GO:0047192 phospholipid biosynthetic process [GO:0008654] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; lysophosphatidic acid acyltransferase activity [GO:0042171]; plasmalogen synthase activity [GO:0047159] g17929.t1 Q1HAQ0 44.922 256 8.32e-71 230.0 sp|Q1HAQ0|PCAT1_RAT Lysophosphatidylcholine acyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Lpcat1 PE=1 SV=2 PCAT1_RAT reviewed Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) Rattus norvegicus (Rat) GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006656; GO:0008654; GO:0016020; GO:0030163; GO:0036151; GO:0042171; GO:0043129; GO:0045732; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0060041; GO:2001246 negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; calcium ion binding [GO:0005509]; lysophosphatidic acid acyltransferase activity [GO:0042171]; plasmalogen synthase activity [GO:0047159] g17929.t2 Q1HAQ0 56.41 156 4.8399999999999995e-55 191.0 sp|Q1HAQ0|PCAT1_RAT Lysophosphatidylcholine acyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Lpcat1 PE=1 SV=2 PCAT1_RAT reviewed Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) Rattus norvegicus (Rat) GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006656; GO:0008654; GO:0016020; GO:0030163; GO:0036151; GO:0042171; GO:0043129; GO:0045732; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0060041; GO:2001246 negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; calcium ion binding [GO:0005509]; lysophosphatidic acid acyltransferase activity [GO:0042171]; plasmalogen synthase activity [GO:0047159] g17930.t1 O08654 57.82 422 4.41e-171 488.0 sp|O08654|PHAF1_RAT Phagosome assembly factor 1 OS=Rattus norvegicus OX=10116 GN=Phaf1 PE=2 SV=1 g17932.t1 Q148V7 48.08 1198 0.0 1045.0 sp|Q148V7|RELCH_MOUSE RAB11-binding protein RELCH OS=Mus musculus OX=10090 GN=Relch PE=1 SV=1 g17934.t1 Q7LFX5 33.642 324 3.2499999999999996e-48 176.0 sp|Q7LFX5|CHSTF_HUMAN Carbohydrate sulfotransferase 15 OS=Homo sapiens OX=9606 GN=CHST15 PE=1 SV=1 CHSTF_HUMAN reviewed Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST) Homo sapiens (Human) GO:0000139; GO:0016020; GO:0019319; GO:0050650; GO:0050651; GO:0050656; GO:0050659 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] g17935.t1 Q08E15 40.574 244 1.93e-50 173.0 sp|Q08E15|SIA7F_BOVIN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 OS=Bos taurus OX=9913 GN=ST6GALNAC6 PE=2 SV=1 SIA7F_BOVIN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI) (ST6GalNAcVI) (Sialyltransferase 7F) (SIAT7-F) Bos taurus (Bovine) GO:0000139; GO:0001574; GO:0001665; GO:0009311; GO:0009988 cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g17936.t1 A2AV36 46.784 684 0.0 641.0 sp|A2AV36|ANM7_DANRE Protein arginine N-methyltransferase 7 OS=Danio rerio OX=7955 GN=prmt7 PE=2 SV=1 g17937.t1 Q0P570 61.307 398 1.36e-171 488.0 sp|Q0P570|MVD1_BOVIN Diphosphomevalonate decarboxylase OS=Bos taurus OX=9913 GN=MVD PE=2 SV=1 MVD1_BOVIN reviewed Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase) Bos taurus (Bovine) GO:0004163; GO:0005524; GO:0005829; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803 cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284] cytosol [GO:0005829] ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803] g17937.t2 Q0P570 60.794 403 6.6e-172 489.0 sp|Q0P570|MVD1_BOVIN Diphosphomevalonate decarboxylase OS=Bos taurus OX=9913 GN=MVD PE=2 SV=1 MVD1_BOVIN reviewed Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase) Bos taurus (Bovine) GO:0004163; GO:0005524; GO:0005829; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803 cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284] cytosol [GO:0005829] ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803] g17940.t1 Q99315 27.88 868 4.689999999999999e-90 325.0 sp|Q99315|YG31B_YEAST Transposon Ty3-G Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-G PE=1 SV=3 g17942.t1 Q8IZF6 34.375 320 1.9899999999999997e-54 197.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g17944.t1 Q8IZF6 28.478 611 5.68e-59 228.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g17945.t1 Q9D411 48.475 295 2.07e-101 305.0 sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus OX=10090 GN=Tssk4 PE=1 SV=1 TSSK4_MOUSE reviewed Testis-specific serine/threonine-protein kinase 4 (TSK-4) (TSSK-4) (Testis-specific kinase 4) (EC 2.7.11.1) Mus musculus (Mouse) GO:0000287; GO:0001669; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0031514; GO:0032793; GO:0036126; GO:0042802; GO:0042803; GO:0044877; GO:0106310; GO:1990443 fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g17946.t1 Q6NUD8 61.307 199 1.23e-82 246.0 sp|Q6NUD8|CHM1A_XENLA Charged multivesicular body protein 1a OS=Xenopus laevis OX=8355 GN=chmp1a PE=2 SV=1 g17947.t1 Q3T042 41.176 340 3.37e-69 230.0 sp|Q3T042|NOB1_BOVIN RNA-binding protein NOB1 OS=Bos taurus OX=9913 GN=NOB1 PE=2 SV=1 g17947.t1 Q3T042 45.912 159 1.01e-34 137.0 sp|Q3T042|NOB1_BOVIN RNA-binding protein NOB1 OS=Bos taurus OX=9913 GN=NOB1 PE=2 SV=1 g17948.t1 Q99L45 59.71 345 3.2300000000000003e-116 342.0 sp|Q99L45|IF2B_MOUSE Eukaryotic translation initiation factor 2 subunit 2 OS=Mus musculus OX=10090 GN=Eif2s2 PE=1 SV=1 IF2B_MOUSE reviewed Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta) Mus musculus (Mouse) GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008270; GO:0008584; GO:0031369; GO:0045202 cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202] mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270] g17949.t1 Q6YHK3 32.465 1497 0.0 735.0 sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2 CD109_HUMAN reviewed CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109) Homo sapiens (Human) GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647 hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552] serine-type endopeptidase inhibitor activity [GO:0004867] g17950.t1 Q28ES8 41.7 506 8.31e-121 366.0 sp|Q28ES8|CTU2_XENTR Cytoplasmic tRNA 2-thiolation protein 2 OS=Xenopus tropicalis OX=8364 GN=ctu2 PE=2 SV=1 CTU2_XENTR reviewed Cytoplasmic tRNA 2-thiolation protein 2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016779; GO:0016783; GO:0032447; GO:0034227 protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] cytosol [GO:0005829] nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049] g17951.t1 Q6TFL4 31.655 556 5.91e-84 276.0 sp|Q6TFL4|KLH24_HUMAN Kelch-like protein 24 OS=Homo sapiens OX=9606 GN=KLHL24 PE=1 SV=1 KLH24_HUMAN reviewed Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1) Homo sapiens (Human) GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:0045109; GO:0051865; GO:1990756 intermediate filament organization [GO:0045109]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g17952.t1 Q9BSJ2 58.39 882 0.0 1055.0 sp|Q9BSJ2|GCP2_HUMAN Gamma-tubulin complex component 2 OS=Homo sapiens OX=9606 GN=TUBGCP2 PE=1 SV=2 g17952.t2 Q9BSJ2 58.39 882 0.0 1055.0 sp|Q9BSJ2|GCP2_HUMAN Gamma-tubulin complex component 2 OS=Homo sapiens OX=9606 GN=TUBGCP2 PE=1 SV=2 g17953.t1 Q8SQ27 31.818 242 1.1500000000000002e-27 125.0 sp|Q8SQ27|RBM12_MACMU RNA-binding protein 12 OS=Macaca mulatta OX=9544 GN=RBM12 PE=2 SV=1 g17955.t1 Q2VR06 50.19 263 2.69e-86 263.0 sp|Q2VR06|CBR1A_XENLA CBY1-interacting BAR domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=cibar1-a PE=2 SV=1 CBR1A_XENLA reviewed CBY1-interacting BAR domain-containing protein 1-A Xenopus laevis (African clawed frog) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0030154; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227] g17957.t1 A4QMS7 49.123 114 8.97e-29 105.0 sp|A4QMS7|CFA90_HUMAN Cilia- and flagella-associated protein 90 OS=Homo sapiens OX=9606 GN=CFAP90 PE=1 SV=1 CFA90_HUMAN reviewed Cilia- and flagella-associated protein 90 Homo sapiens (Human) GO:0005930; GO:0030317; GO:0036064; GO:0036126; GO:0160112 flagellated sperm motility [GO:0030317] axonemal B tubule inner sheath [GO:0160112]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; sperm flagellum [GO:0036126] g17960.t1 Q924T7 41.917 532 8.79e-125 394.0 sp|Q924T7|RNF31_MOUSE E3 ubiquitin-protein ligase RNF31 OS=Mus musculus OX=10090 GN=Rnf31 PE=1 SV=2 RNF31_MOUSE reviewed E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (Putative Ariadne-like ubiquitin ligase) (PAUL) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) Mus musculus (Mouse) GO:0000209; GO:0004842; GO:0005829; GO:0007249; GO:0008270; GO:0009898; GO:0016567; GO:0023035; GO:0031625; GO:0033209; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043124; GO:0043130; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1904417; GO:1990450 canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797] identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17961.t1 Q96EP0 44.094 127 1.31e-24 115.0 sp|Q96EP0|RNF31_HUMAN E3 ubiquitin-protein ligase RNF31 OS=Homo sapiens OX=9606 GN=RNF31 PE=1 SV=1 g17963.t1 P35668 43.1 471 1.9099999999999998e-134 399.0 sp|P35668|GSHB_XENLA Glutathione synthetase OS=Xenopus laevis OX=8355 GN=gss PE=2 SV=1 g17964.t1 P35668 42.857 357 6.44e-91 284.0 sp|P35668|GSHB_XENLA Glutathione synthetase OS=Xenopus laevis OX=8355 GN=gss PE=2 SV=1 g17966.t1 Q9NY59 32.122 688 2.1499999999999997e-104 335.0 sp|Q9NY59|NSMA2_HUMAN Sphingomyelin phosphodiesterase 3 OS=Homo sapiens OX=9606 GN=SMPD3 PE=1 SV=1 NSMA2_HUMAN reviewed Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II) Homo sapiens (Human) GO:0000137; GO:0000139; GO:0001786; GO:0001958; GO:0002244; GO:0002685; GO:0003433; GO:0004767; GO:0005576; GO:0005737; GO:0005886; GO:0006672; GO:0006684; GO:0006685; GO:0008081; GO:0015774; GO:0030072; GO:0030282; GO:0030509; GO:0032963; GO:0035264; GO:0042802; GO:0045840; GO:0046872; GO:0048008; GO:0048286; GO:0048661; GO:0051898; GO:0061035; GO:0061751; GO:0070300; GO:0070301; GO:0070314; GO:0071286; GO:0071356; GO:0071461; GO:0071897; GO:0085029; GO:0090520; GO:0097187; GO:0098868; GO:0140014; GO:0140052; GO:1900126; GO:1901653; GO:1903543 BMP signaling pathway [GO:0030509]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of cartilage development [GO:0061035]; regulation of leukocyte migration [GO:0002685]; sphingolipid mediated signaling pathway [GO:0090520]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767] g17968.t1 Q8IXZ2 55.914 186 6.07e-63 228.0 sp|Q8IXZ2|ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ZC3H3 PE=1 SV=3 ZC3H3_HUMAN reviewed Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0005847; GO:0008270; GO:0031124; GO:0032927; GO:0051028; GO:0070412 mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; zinc ion binding [GO:0008270] g17969.t1 Q9Y5Q3 50.442 113 5.43e-30 119.0 sp|Q9Y5Q3|MAFB_HUMAN Transcription factor MafB OS=Homo sapiens OX=9606 GN=MAFB PE=1 SV=2 MAFB_HUMAN reviewed Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0005634; GO:0006355; GO:0006357; GO:0007379; GO:0007423; GO:0007584; GO:0007585; GO:0016485; GO:0021571; GO:0021572; GO:0021599; GO:0030216; GO:0033077; GO:0035284; GO:0042472; GO:0042802; GO:0043565; GO:0044877; GO:0045444; GO:0045637; GO:0045647; GO:0045671; GO:0045893; GO:0048538; GO:0090575; GO:0140467; GO:1903575 abducens nerve formation [GO:0021599]; brain segmentation [GO:0035284]; cornified envelope assembly [GO:1903575]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; integrated stress response signaling [GO:0140467]; keratinocyte differentiation [GO:0030216]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; protein processing [GO:0016485]; regulation of DNA-templated transcription [GO:0006355]; regulation of myeloid cell differentiation [GO:0045637]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to nutrient [GO:0007584]; rhombomere 5 development [GO:0021571]; rhombomere 6 development [GO:0021572]; segment specification [GO:0007379]; sensory organ development [GO:0007423]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538] chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g17970.t1 Q9HCD5 30.347 547 7.93e-42 165.0 sp|Q9HCD5|NCOA5_HUMAN Nuclear receptor coactivator 5 OS=Homo sapiens OX=9606 GN=NCOA5 PE=1 SV=2 NCOA5_HUMAN reviewed Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) Homo sapiens (Human) GO:0000122; GO:0003682; GO:0003714; GO:0003723; GO:0005615; GO:0005654; GO:0008286; GO:0009966; GO:0015629; GO:0042593; GO:0046627 glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966] actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] g17971.t1 Q5M8F7 66.379 116 7.53e-53 165.0 sp|Q5M8F7|NEPR1_XENTR Nuclear envelope phosphatase-regulatory subunit 1 OS=Xenopus tropicalis OX=8364 GN=cnep1r1 PE=2 SV=1 g17972.t1 Q0VIA1 65.891 129 1.88e-58 180.0 sp|Q0VIA1|MED10_DANRE Mediator of RNA polymerase II transcription subunit 10 OS=Danio rerio OX=7955 GN=med10 PE=2 SV=1 MED10_DANRE reviewed Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10) (Protein tennis match) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003712; GO:0006357; GO:0007507; GO:0016055; GO:0016592; GO:0036302; GO:1905072 atrioventricular canal development [GO:0036302]; cardiac jelly development [GO:1905072]; heart development [GO:0007507]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055] mediator complex [GO:0016592] transcription coregulator activity [GO:0003712] g17976.t1 P41154 37.443 438 2.9599999999999998e-68 229.0 sp|P41154|HSF_XENLA Heat shock factor protein OS=Xenopus laevis OX=8355 GN=hsf1 PE=2 SV=1 g17977.t1 O35604 40.973 1274 0.0 935.0 sp|O35604|NPC1_MOUSE NPC intracellular cholesterol transporter 1 OS=Mus musculus OX=10090 GN=Npc1 PE=1 SV=2 NPC1_MOUSE reviewed NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein) Mus musculus (Mouse) GO:0001889; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0015918; GO:0016020; GO:0016125; GO:0016242; GO:0022008; GO:0030299; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032365; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0071383; GO:0071404; GO:0090150; GO:0120020; GO:1904036; GO:1904262; GO:2000900 adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol metabolic process [GO:0016125]; sterol transport [GO:0015918]; symbiont entry into host cell [GO:0046718] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020] g17978.t1 Q91W78 35.793 271 1.2e-43 151.0 sp|Q91W78|USB1_MOUSE U6 snRNA phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Usb1 PE=2 SV=1 g17980.t1 Q9VQQ9 46.364 220 6.79e-55 194.0 sp|Q9VQQ9|EXOC2_DROME Exocyst complex component 2 OS=Drosophila melanogaster OX=7227 GN=Sec5 PE=2 SV=1 EXOC2_DROME reviewed Exocyst complex component 2 (Exocyst complex component Sec5) Drosophila melanogaster (Fruit fly) GO:0000145; GO:0005642; GO:0005737; GO:0005886; GO:0005938; GO:0006887; GO:0006893; GO:0007269; GO:0007298; GO:0007349; GO:0016028; GO:0016080; GO:0016081; GO:0016192; GO:0030136; GO:0031267; GO:0031594; GO:0032456; GO:0035003; GO:0035147; GO:0043001; GO:0045056; GO:0045087; GO:0048215; GO:0048599; GO:0055037; GO:0071896; GO:0072657; GO:0072659; GO:0072697; GO:0090128; GO:0098793; GO:0099641; GO:1904115 anterograde axonal protein transport [GO:0099641]; border follicle cell migration [GO:0007298]; branch fusion, open tracheal system [GO:0035147]; cellularization [GO:0007349]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; innate immune response [GO:0045087]; neurotransmitter secretion [GO:0007269]; oocyte development [GO:0048599]; positive regulation of Golgi vesicle fusion to target membrane [GO:0048215]; protein localization to adherens junction [GO:0071896]; protein localization to cell cortex [GO:0072697]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; regulation of synapse maturation [GO:0090128]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; transcytosis [GO:0045056]; vesicle-mediated transport [GO:0016192] annulate lamellae [GO:0005642]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; exocyst [GO:0000145]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; rhabdomere [GO:0016028]; subapical complex [GO:0035003] small GTPase binding [GO:0031267] g17980.t2 O54921 45.2 250 3.19e-51 185.0 sp|O54921|EXOC2_RAT Exocyst complex component 2 OS=Rattus norvegicus OX=10116 GN=Exoc2 PE=1 SV=1 g17980.t3 O54921 40.711 506 5.46e-103 333.0 sp|O54921|EXOC2_RAT Exocyst complex component 2 OS=Rattus norvegicus OX=10116 GN=Exoc2 PE=1 SV=1 g17981.t1 Q9D4H1 36.422 313 3.62e-58 203.0 sp|Q9D4H1|EXOC2_MOUSE Exocyst complex component 2 OS=Mus musculus OX=10090 GN=Exoc2 PE=1 SV=1 EXOC2_MOUSE reviewed Exocyst complex component 2 (Exocyst complex component Sec5) Mus musculus (Mouse) GO:0000145; GO:0000281; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0019901; GO:0031267; GO:0045921; GO:0090148; GO:0090522; GO:0090543; GO:2000535 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145]; Flemming body [GO:0090543]; plasma membrane [GO:0005886] protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] g17982.t1 Q7ZXR7 45.098 510 4.8300000000000006e-123 383.0 sp|Q7ZXR7|UB10B_XENLA Ubiquitin carboxyl-terminal hydrolase 10-B OS=Xenopus laevis OX=8355 GN=usp10-b PE=2 SV=1 UB10B_XENLA reviewed Ubiquitin carboxyl-terminal hydrolase 10-B (EC 3.4.19.12) (Deubiquitinating enzyme 10-B) (Ubiquitin thioesterase 10-B) (Ubiquitin-specific-processing protease 10-B) Xenopus laevis (African clawed frog) GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0031647; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344 autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of protein stability [GO:0031647]; rescue of stalled ribosome [GO:0072344] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325] g17984.t1 Q9DC53 65.524 525 0.0 726.0 sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3 g17985.t1 Q9DC53 63.258 528 0.0 696.0 sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3 g17986.t1 Q86YQ8 63.258 528 0.0 702.0 sp|Q86YQ8|CPNE8_HUMAN Copine-8 OS=Homo sapiens OX=9606 GN=CPNE8 PE=1 SV=2 g17986.t2 Q86YQ8 64.03 531 0.0 711.0 sp|Q86YQ8|CPNE8_HUMAN Copine-8 OS=Homo sapiens OX=9606 GN=CPNE8 PE=1 SV=2 g17988.t1 P55088 45.763 118 4.39e-33 122.0 sp|P55088|AQP4_MOUSE Aquaporin-4 OS=Mus musculus OX=10090 GN=Aqp4 PE=1 SV=2 g17989.t1 P70665 41.731 520 3.24e-128 387.0 sp|P70665|SIAE_MOUSE Sialate O-acetylesterase OS=Mus musculus OX=10090 GN=Siae PE=1 SV=3 SIAE_MOUSE reviewed Sialate O-acetylesterase (SIAE) (EC 3.1.1.53) (Sialic acid-specific 9-O-acetylesterase) (Yolk sac protein 2) [Cleaved into: Sialate O-acetylesterase small subunit; Sialate O-acetylesterase large subunit] Mus musculus (Mouse) GO:0001681; GO:0002682; GO:0005764; GO:0005975; GO:0106330 carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682] lysosome [GO:0005764] sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681] g17993.t1 Q95NR9 100.0 149 1.3099999999999999e-104 298.0 sp|Q95NR9|CALM_METSE Calmodulin OS=Metridium senile OX=6116 PE=1 SV=3 g17994.t1 Q7T3T2 95.495 111 9.570000000000001e-73 216.0 sp|Q7T3T2|CALM_EPIAK Calmodulin OS=Epinephelus akaara OX=215347 GN=calm PE=2 SV=3 g17995.t1 P62154 97.973 148 1.58e-101 290.0 sp|P62154|CALM_LOCMI Calmodulin OS=Locusta migratoria OX=7004 PE=1 SV=2 g17996.t1 Q95NI4 96.622 148 8.32e-101 288.0 sp|Q95NI4|CALM_HALOK Calmodulin OS=Halichondria okadai OX=163232 PE=2 SV=3 g17997.t1 Q95NI4 96.599 147 2.91e-100 287.0 sp|Q95NI4|CALM_HALOK Calmodulin OS=Halichondria okadai OX=163232 PE=2 SV=3 g17998.t1 P52014 56.311 206 3.79e-78 236.0 sp|P52014|CYP6_CAEEL Peptidyl-prolyl cis-trans isomerase 6 OS=Caenorhabditis elegans OX=6239 GN=cyn-6 PE=2 SV=1 g17999.t1 Q5ZIW2 46.685 739 0.0 630.0 sp|Q5ZIW2|CNO10_CHICK CCR4-NOT transcription complex subunit 10 OS=Gallus gallus OX=9031 GN=CNOT10 PE=1 SV=1 CNO10_CHICK reviewed CCR4-NOT transcription complex subunit 10 Gallus gallus (Chicken) GO:0005634; GO:0005829; GO:0006402; GO:0017148; GO:0030014; GO:0031047 mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] g18000.t1 Q9CYH5 52.128 376 1.92e-137 400.0 sp|Q9CYH5|GFOD2_MOUSE Glucose-fructose oxidoreductase domain-containing protein 2 OS=Mus musculus OX=10090 GN=Gfod2 PE=2 SV=1 g18001.t1 Q9JIX5 52.683 1640 0.0 1640.0 sp|Q9JIX5|CHD8_RAT Chromodomain-helicase-DNA-binding protein 8 OS=Rattus norvegicus OX=10116 GN=Chd8 PE=1 SV=2 CHD8_RAT reviewed ATP-dependent chromatin remodeler CHD8 (EC 3.6.4.-) (Axis duplication inhibitor) (Duplin) (Chromo domain-containing protein 8) (CHD-8) Rattus norvegicus (Rat) GO:0000122; GO:0000785; GO:0001701; GO:0001964; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006397; GO:0007420; GO:0007616; GO:0008013; GO:0010468; GO:0016055; GO:0016887; GO:0030178; GO:0032991; GO:0035176; GO:0042393; GO:0043066; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:0140002; GO:0140658; GO:2000270 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; long-term memory [GO:0007616]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prepulse inhibition [GO:0060134]; regulation of gene expression [GO:0010468]; social behavior [GO:0035176]; startle response [GO:0001964]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; histone H3K4me3 reader activity [GO:0140002]; p53 binding [GO:0002039] g18002.t1 Q05975 91.981 212 1.66e-142 399.0 sp|Q05975|RAB2_LYMST Ras-related protein Rab-2 OS=Lymnaea stagnalis OX=6523 GN=RAB2 PE=2 SV=1 g18004.t1 Q08999 47.853 1141 0.0 1001.0 sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3 RBL2_HUMAN reviewed Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0005694; GO:0005730; GO:0005829; GO:0006325; GO:0006357; GO:0010629; GO:0030154; GO:0043550; GO:0070062; GO:1990841; GO:2000134 cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g18004.t2 Q08999 47.765 1141 0.0 1003.0 sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3 RBL2_HUMAN reviewed Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0005694; GO:0005730; GO:0005829; GO:0006325; GO:0006357; GO:0010629; GO:0030154; GO:0043550; GO:0070062; GO:1990841; GO:2000134 cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g18005.t1 Q5NDE3 46.49 527 7.500000000000001e-166 486.0 sp|Q5NDE3|PMGT2_TETNG Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 OS=Tetraodon nigroviridis OX=99883 GN=pomgnt2 PE=2 SV=1 PMGT2_TETNG reviewed Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.312) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2) Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0007420; GO:0008375; GO:0035269; GO:0055001; GO:0060041; GO:0097363 brain development [GO:0007420]; muscle cell development [GO:0055001]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; retina development in camera-type eye [GO:0060041] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] acetylglucosaminyltransferase activity [GO:0008375]; protein O-acetylglucosaminyltransferase activity [GO:0097363] g18006.t1 Q9HCJ6 50.928 377 1.84e-143 417.0 sp|Q9HCJ6|VAT1L_HUMAN Synaptic vesicle membrane protein VAT-1 homolog-like OS=Homo sapiens OX=9606 GN=VAT1L PE=1 SV=2 g18007.t1 O14744 56.583 638 0.0 763.0 sp|O14744|ANM5_HUMAN Protein arginine N-methyltransferase 5 OS=Homo sapiens OX=9606 GN=PRMT5 PE=1 SV=4 g18008.t1 Q8BGC1 38.523 501 1.06e-109 336.0 sp|Q8BGC1|CE022_MOUSE UPF0489 protein C5orf22 homolog OS=Mus musculus OX=10090 PE=1 SV=1 g18009.t1 Q86U38 31.24 605 5.38e-75 258.0 sp|Q86U38|NOP9_HUMAN Nucleolar protein 9 OS=Homo sapiens OX=9606 GN=NOP9 PE=1 SV=1 g18010.t1 Q9W369 33.071 381 4.4199999999999994e-54 186.0 sp|Q9W369|TANN_DROME Beta-alanyl-dopamine/carcinine hydrolase OS=Drosophila melanogaster OX=7227 GN=t PE=1 SV=1 TANN_DROME reviewed Beta-alanyl-dopamine/carcinine hydrolase (EC 3.5.1.-) (NBAD/carcinine hydrolase) (Protein tan) [Cleaved into: Beta-alanyl-dopamine/carcinine hydrolase alpha subunit; Beta-alanyl-dopamine/carcinine hydrolase beta subunit] Drosophila melanogaster (Fruit fly) GO:0001692; GO:0001694; GO:0003832; GO:0005737; GO:0005829; GO:0007601; GO:0016787; GO:0030424; GO:0031964; GO:0042416; GO:0048067 cuticle pigmentation [GO:0048067]; dopamine biosynthetic process [GO:0042416]; histamine biosynthetic process [GO:0001694]; histamine metabolic process [GO:0001692]; visual perception [GO:0007601] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829] beta-alanyl-dopamine hydrolase activity [GO:0003832]; beta-alanyl-histamine hydrolase activity [GO:0031964]; hydrolase activity [GO:0016787] g18011.t1 Q02391 47.064 1090 0.0 1038.0 sp|Q02391|GSLG1_CHICK Golgi apparatus protein 1 OS=Gallus gallus OX=9031 GN=GLG1 PE=1 SV=1 g18011.t2 Q02391 47.412 1082 0.0 1045.0 sp|Q02391|GSLG1_CHICK Golgi apparatus protein 1 OS=Gallus gallus OX=9031 GN=GLG1 PE=1 SV=1 g18012.t1 Q5R662 36.137 642 3.81e-110 363.0 sp|Q5R662|LRP12_PONAB Low-density lipoprotein receptor-related protein 12 OS=Pongo abelii OX=9601 GN=LRP12 PE=2 SV=2 LRP12_PONAB reviewed Low-density lipoprotein receptor-related protein 12 (LRP-12) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001764; GO:0005178; GO:0005886; GO:0005905; GO:0006897; GO:0007155; GO:0031175; GO:0033622; GO:0097021 cell adhesion [GO:0007155]; endocytosis [GO:0006897]; integrin activation [GO:0033622]; lymphocyte migration into lymphoid organs [GO:0097021]; neuron migration [GO:0001764]; neuron projection development [GO:0031175] clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886] integrin binding [GO:0005178] g18013.t1 Q63244 51.818 110 2.48e-30 124.0 sp|Q63244|FOXQ1_RAT Forkhead box protein Q1 OS=Rattus norvegicus OX=10116 GN=Foxq1 PE=1 SV=3 g18014.t1 Q9CR96 55.696 158 1.1299999999999999e-55 176.0 sp|Q9CR96|TM208_MOUSE Transmembrane protein 208 OS=Mus musculus OX=10090 GN=Tmem208 PE=2 SV=1 g18015.t1 Q17QF0 59.743 467 0.0 603.0 sp|Q17QF0|AGT2_BOVIN Alanine--glyoxylate aminotransferase 2, mitochondrial OS=Bos taurus OX=9913 GN=AGXT2 PE=2 SV=1 AGT2_BOVIN reviewed Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (EC 2.6.1.18) (D-3-aminoisobutyrate-pyruvate aminotransferase) (D-AIBAT) (D-beta-aminoisobutyrate-pyruvate aminotransferase) Bos taurus (Bovine) GO:0005739; GO:0008453; GO:0009436; GO:0016223; GO:0019481; GO:0030170; GO:0047305; GO:2001299 glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; N(omega),N(omega)-dimethyl-L-arginine catabolic process [GO:2001299] mitochondrion [GO:0005739] (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; beta-alanine:pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170] g18029.t1 Q9UHW9 56.032 1119 0.0 1216.0 sp|Q9UHW9|S12A6_HUMAN Solute carrier family 12 member 6 OS=Homo sapiens OX=9606 GN=SLC12A6 PE=1 SV=2 g18029.t2 Q63632 58.41 1082 0.0 1215.0 sp|Q63632|S12A4_RAT Solute carrier family 12 member 4 OS=Rattus norvegicus OX=10116 GN=Slc12a4 PE=1 SV=1 S12A4_RAT reviewed Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (rKCC1) (Furosemide-sensitive K-Cl cotransporter) Rattus norvegicus (Rat) GO:0005524; GO:0005886; GO:0006884; GO:0007268; GO:0015379; GO:0016020; GO:0045202; GO:0046872; GO:0055064; GO:0055075; GO:0071805; GO:0120283; GO:1902476; GO:1990573 cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805] membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; potassium:chloride symporter activity [GO:0015379]; protein serine/threonine kinase binding [GO:0120283] g18030.t1 A5PLK6 29.111 371 8.61e-41 168.0 sp|A5PLK6|RGSL_HUMAN Regulator of G-protein signaling protein-like OS=Homo sapiens OX=9606 GN=RGSL1 PE=1 SV=1 RGSL_HUMAN reviewed Regulator of G-protein signaling protein-like Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g18032.t1 Q6R8F2 58.163 98 4.9600000000000006e-27 106.0 sp|Q6R8F2|CADH1_BOVIN Cadherin-1 OS=Bos taurus OX=9913 GN=CDH1 PE=2 SV=1 CADH1_BOVIN reviewed Cadherin-1 (Epithelial cadherin) (E-cadherin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3] Bos taurus (Bovine) GO:0000902; GO:0002159; GO:0005509; GO:0005737; GO:0005768; GO:0005794; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007156; GO:0007416; GO:0008013; GO:0010468; GO:0016339; GO:0016342; GO:0016477; GO:0016600; GO:0030054; GO:0030057; GO:0034332; GO:0043296; GO:0044331; GO:0045296; GO:1903829 adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; desmosome assembly [GO:0002159]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of protein localization [GO:1903829]; regulation of gene expression [GO:0010468]; synapse assembly [GO:0007416] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; endosome [GO:0005768]; flotillin complex [GO:0016600]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g18033.t1 O15943 37.818 825 3e-153 501.0 sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2 g18034.t1 O15943 33.991 1571 0.0 630.0 sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2 g18034.t1 O15943 27.878 2059 2.87e-119 429.0 sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2 g18034.t1 O15943 24.658 1606 1.55e-61 239.0 sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2 g18036.t1 Q5R7G6 67.429 525 0.0 701.0 sp|Q5R7G6|PEPL1_PONAB Probable aminopeptidase NPEPL1 OS=Pongo abelii OX=9601 GN=NPEPL1 PE=3 SV=2 PEPL1_PONAB reviewed Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0006508; GO:0030145; GO:0070006 proteolysis [GO:0006508] cytoplasm [GO:0005737] manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006] g18037.t1 O75351 72.135 445 0.0 667.0 sp|O75351|VPS4B_HUMAN Vacuolar protein sorting-associated protein 4B OS=Homo sapiens OX=9606 GN=VPS4B PE=1 SV=2 VPS4B_HUMAN reviewed Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1) Homo sapiens (Human) GO:0000922; GO:0001525; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006813; GO:0006914; GO:0006997; GO:0007033; GO:0007080; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0030301; GO:0030496; GO:0031468; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0046761; GO:0051261; GO:0060070; GO:0060856; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1903542; GO:1903543; GO:1903724; GO:1904903; GO:1904949 angiogenesis [GO:0001525]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; canonical Wnt signaling pathway [GO:0060070]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; establishment of blood-brain barrier [GO:0060856]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] g18038.t1 P26928 43.085 188 4.86e-38 156.0 sp|P26928|HGFL_MOUSE Hepatocyte growth factor-like protein OS=Mus musculus OX=10090 GN=Mst1 PE=2 SV=2 HGFL_MOUSE reviewed Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain] Mus musculus (Mouse) GO:0005615; GO:0005773; GO:0006508; GO:0007566; GO:0010628; GO:0010758; GO:0019899; GO:0030879; GO:0030971; GO:0033601; GO:0035173; GO:0043065; GO:0045721; GO:0046425; GO:0060763; GO:1904036; GO:2000479 embryo implantation [GO:0007566]; mammary duct terminal end bud growth [GO:0060763]; mammary gland development [GO:0030879]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of macrophage chemotaxis [GO:0010758]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] extracellular space [GO:0005615]; vacuole [GO:0005773] enzyme binding [GO:0019899]; histone kinase activity [GO:0035173]; receptor tyrosine kinase binding [GO:0030971] g18038.t1 P26928 40.291 206 1.27e-30 133.0 sp|P26928|HGFL_MOUSE Hepatocyte growth factor-like protein OS=Mus musculus OX=10090 GN=Mst1 PE=2 SV=2 HGFL_MOUSE reviewed Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain] Mus musculus (Mouse) GO:0005615; GO:0005773; GO:0006508; GO:0007566; GO:0010628; GO:0010758; GO:0019899; GO:0030879; GO:0030971; GO:0033601; GO:0035173; GO:0043065; GO:0045721; GO:0046425; GO:0060763; GO:1904036; GO:2000479 embryo implantation [GO:0007566]; mammary duct terminal end bud growth [GO:0060763]; mammary gland development [GO:0030879]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of macrophage chemotaxis [GO:0010758]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] extracellular space [GO:0005615]; vacuole [GO:0005773] enzyme binding [GO:0019899]; histone kinase activity [GO:0035173]; receptor tyrosine kinase binding [GO:0030971] g18038.t1 P26928 40.341 176 6.9e-29 127.0 sp|P26928|HGFL_MOUSE Hepatocyte growth factor-like protein OS=Mus musculus OX=10090 GN=Mst1 PE=2 SV=2 HGFL_MOUSE reviewed Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain] Mus musculus (Mouse) GO:0005615; GO:0005773; GO:0006508; GO:0007566; GO:0010628; GO:0010758; GO:0019899; GO:0030879; GO:0030971; GO:0033601; GO:0035173; GO:0043065; GO:0045721; GO:0046425; GO:0060763; GO:1904036; GO:2000479 embryo implantation [GO:0007566]; mammary duct terminal end bud growth [GO:0060763]; mammary gland development [GO:0030879]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of macrophage chemotaxis [GO:0010758]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] extracellular space [GO:0005615]; vacuole [GO:0005773] enzyme binding [GO:0019899]; histone kinase activity [GO:0035173]; receptor tyrosine kinase binding [GO:0030971] g18039.t1 P47224 51.754 114 5.5700000000000004e-37 126.0 sp|P47224|MSS4_HUMAN Guanine nucleotide exchange factor MSS4 OS=Homo sapiens OX=9606 GN=RABIF PE=1 SV=2 MSS4_HUMAN reviewed Guanine nucleotide exchange factor MSS4 (Rab-interacting factor) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0006892; GO:0007264; GO:0008270; GO:0015031; GO:0016020; GO:0061025 membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264] cytosol [GO:0005829]; membrane [GO:0016020] guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270] g18040.t1 A0JNH6 42.914 501 2.27e-115 357.0 sp|A0JNH6|C102A_BOVIN Coiled-coil domain-containing protein 102A OS=Bos taurus OX=9913 GN=CCDC102A PE=2 SV=1 g18041.t1 Q0MQF0 61.538 130 2.9e-49 159.0 sp|Q0MQF0|NDUB9_PANTR NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Pan troglodytes OX=9598 GN=NDUFB9 PE=2 SV=3 g18042.t1 P35285 57.143 196 2.16e-80 240.0 sp|P35285|RB22A_MOUSE Ras-related protein Rab-22A OS=Mus musculus OX=10090 GN=Rab22a PE=1 SV=2 RB22A_MOUSE reviewed Ras-related protein Rab-22A (Rab-22) (EC 3.6.5.2) (Rab-14) Mus musculus (Mouse) GO:0001726; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0010008; GO:0012505; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0097494 endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g18043.t1 Q91WE2 40.586 239 7.07e-39 139.0 sp|Q91WE2|PIP30_MOUSE PSME3-interacting protein OS=Mus musculus OX=10090 GN=Psme3ip1 PE=1 SV=1 g18045.t1 Q5R881 64.059 473 0.0 650.0 sp|Q5R881|RSPRY_PONAB RING finger and SPRY domain-containing protein 1 OS=Pongo abelii OX=9601 GN=RSPRY1 PE=2 SV=1 g18046.t1 A0A0P0XM10 36.929 482 2.63e-87 280.0 sp|A0A0P0XM10|PAO6_ORYSJ Polyamine oxidase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=PAO6 PE=2 SV=1 g18049.t1 Q28ZX3 60.894 179 1.29e-69 213.0 sp|Q28ZX3|PABP2_DROPS Polyadenylate-binding protein 2 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=Pabp2 PE=3 SV=1 g18050.t1 B5XGE7 74.453 137 5.53e-77 227.0 sp|B5XGE7|TPC2L_SALSA Trafficking protein particle complex subunit 2-like protein OS=Salmo salar OX=8030 GN=trappc2l PE=2 SV=1 g18051.t1 Q16842 54.093 281 3.94e-106 318.0 sp|Q16842|SIA4B_HUMAN CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 OS=Homo sapiens OX=9606 GN=ST3GAL2 PE=1 SV=1 SIA4B_HUMAN reviewed CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B) Homo sapiens (Human) GO:0000139; GO:0001574; GO:0001576; GO:0003836; GO:0005576; GO:0006688; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0016266; GO:0018146; GO:0019082; GO:0032580; GO:0042803; GO:0047288; GO:0097503 ganglioside biosynthetic process [GO:0001574]; globoside biosynthetic process [GO:0001576]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; keratan sulfate proteoglycan biosynthetic process [GO:0018146]; oligosaccharide biosynthetic process [GO:0009312]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; sialylation [GO:0097503]; viral protein processing [GO:0019082] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373] g18053.t1 Q9DBI2 26.209 393 9.11e-25 109.0 sp|Q9DBI2|BBS10_MOUSE BBSome complex assembly protein BBS10 OS=Mus musculus OX=10090 GN=Bbs10 PE=2 SV=2 BBS10_MOUSE reviewed BBSome complex assembly protein BBS10 (Bardet-Biedl syndrome 10 protein homolog) Mus musculus (Mouse) GO:0005524; GO:0005929; GO:0006974; GO:0007601; GO:0008104; GO:0009416; GO:0019228; GO:0034976; GO:0042670; GO:0043254; GO:0043524; GO:0045494; GO:0046530; GO:0051131; GO:0060041; GO:0060221; GO:0061629; GO:1904390; GO:1905515 chaperone-mediated protein complex assembly [GO:0051131]; cone retinal bipolar cell differentiation [GO:1904390]; DNA damage response [GO:0006974]; intracellular protein localization [GO:0008104]; negative regulation of neuron apoptotic process [GO:0043524]; neuronal action potential [GO:0019228]; non-motile cilium assembly [GO:1905515]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; retinal cone cell differentiation [GO:0042670]; retinal rod cell differentiation [GO:0060221]; visual perception [GO:0007601] cilium [GO:0005929] ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g18054.t1 Q86WA6 54.054 259 5.81e-102 303.0 sp|Q86WA6|BPHL_HUMAN Serine hydrolase BPHL OS=Homo sapiens OX=9606 GN=BPHL PE=1 SV=1 BPHL_HUMAN reviewed Serine hydrolase BPHL (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA) (L-homocysteine-thiolactonase BPHL) (Valacyclovir hydrolase) (VACVase) (Valacyclovirase) Homo sapiens (Human) GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0017171; GO:0046872; GO:0047658; GO:0050667 amino acid metabolic process [GO:0006520]; homocysteine metabolic process [GO:0050667]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] alpha-amino-acid esterase activity [GO:0047658]; metal ion binding [GO:0046872]; serine hydrolase activity [GO:0017171] g18055.t1 A9JR78 46.781 699 0.0 603.0 sp|A9JR78|TONSL_DANRE Tonsoku-like protein OS=Danio rerio OX=7955 GN=tonsl PE=2 SV=1 TONSL_DANRE reviewed Tonsoku-like protein (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000724; GO:0005737; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566 double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; site of double-strand break [GO:0035861] histone binding [GO:0042393]; histone reader activity [GO:0140566] g18055.t1 A9JR78 35.778 668 5.08e-83 304.0 sp|A9JR78|TONSL_DANRE Tonsoku-like protein OS=Danio rerio OX=7955 GN=tonsl PE=2 SV=1 TONSL_DANRE reviewed Tonsoku-like protein (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000724; GO:0005737; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566 double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; site of double-strand break [GO:0035861] histone binding [GO:0042393]; histone reader activity [GO:0140566] g18056.t1 Q32LE4 38.75 160 6.42e-30 111.0 sp|Q32LE4|GGCT_BOVIN Gamma-glutamylcyclotransferase OS=Bos taurus OX=9913 GN=GGCT PE=2 SV=1 g18057.t1 Q32LE4 51.176 170 5.63e-47 154.0 sp|Q32LE4|GGCT_BOVIN Gamma-glutamylcyclotransferase OS=Bos taurus OX=9913 GN=GGCT PE=2 SV=1 g18058.t1 Q2TAA8 35.674 712 1.7e-135 419.0 sp|Q2TAA8|TXIP1_HUMAN Translin-associated factor X-interacting protein 1 OS=Homo sapiens OX=9606 GN=TSNAXIP1 PE=1 SV=1 TXIP1_HUMAN reviewed Translin-associated factor X-interacting protein 1 (Trax-interacting protein 1) Homo sapiens (Human) GO:0005737; GO:0007283; GO:0030154; GO:0048471 cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] g18059.t1 P69566 56.41 624 0.0 678.0 sp|P69566|RANB9_MOUSE Ran-binding protein 9 OS=Mus musculus OX=10090 GN=Ranbp9 PE=1 SV=1 RANB9_MOUSE reviewed Ran-binding protein 9 (RanBP9) (B-cell antigen receptor Ig beta-associated protein 1) (IBAP-1) (Ran-binding protein M) (RanBPM) Mus musculus (Mouse) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007010; GO:0016604; GO:0019899; GO:0031267; GO:0070373; GO:1902993 cytoskeleton organization [GO:0007010]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] enzyme binding [GO:0019899]; small GTPase binding [GO:0031267] g18059.t2 P69566 56.501 623 0.0 680.0 sp|P69566|RANB9_MOUSE Ran-binding protein 9 OS=Mus musculus OX=10090 GN=Ranbp9 PE=1 SV=1 RANB9_MOUSE reviewed Ran-binding protein 9 (RanBP9) (B-cell antigen receptor Ig beta-associated protein 1) (IBAP-1) (Ran-binding protein M) (RanBPM) Mus musculus (Mouse) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007010; GO:0016604; GO:0019899; GO:0031267; GO:0070373; GO:1902993 cytoskeleton organization [GO:0007010]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] enzyme binding [GO:0019899]; small GTPase binding [GO:0031267] g18060.t1 P56616 55.738 183 3.9800000000000004e-70 213.0 sp|P56616|UBE2C_XENLA Ubiquitin-conjugating enzyme E2 C OS=Xenopus laevis OX=8355 GN=ube2c PE=1 SV=1 g18061.t1 A0A8I3S9V6 55.725 131 1.77e-48 154.0 sp|A0A8I3S9V6|RCAF1_CANLF GEL complex subunit OPTI OS=Canis lupus familiaris OX=9615 GN=RAB5IF PE=1 SV=1 RCAF1_CANLF reviewed GEL complex subunit OPTI (Obligate partner of TMCO1 insertase) (Rab5-interacting protein) (RIP5) (Respirasome Complex Assembly Factor 1) (RCAF1) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005743; GO:0005789; GO:0097250; GO:0160063; GO:0160064 mitochondrial respirasome assembly [GO:0097250]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063] endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; multi-pass translocon complex [GO:0160064] g18062.t1 Q8TB40 51.198 334 3.6099999999999994e-126 369.0 sp|Q8TB40|ABHD4_HUMAN (Lyso)-N-acylphosphatidylethanolamine lipase OS=Homo sapiens OX=9606 GN=ABHD4 PE=1 SV=1 ABHD4_HUMAN reviewed (Lyso)-N-acylphosphatidylethanolamine lipase (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4) Homo sapiens (Human) GO:0004622; GO:0005789; GO:0005811; GO:0006654; GO:0016042; GO:0016787; GO:0036152; GO:0042171; GO:0055088; GO:0070292 lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] hydrolase activity [GO:0016787]; lysophosphatidic acid acyltransferase activity [GO:0042171]; phosphatidylcholine lysophospholipase activity [GO:0004622] g18063.t1 Q6ZQ08 67.076 1628 0.0 2227.0 sp|Q6ZQ08|CNOT1_MOUSE CCR4-NOT transcription complex subunit 1 OS=Mus musculus OX=10090 GN=Cnot1 PE=1 SV=2 g18063.t1 Q6ZQ08 58.873 834 0.0 949.0 sp|Q6ZQ08|CNOT1_MOUSE CCR4-NOT transcription complex subunit 1 OS=Mus musculus OX=10090 GN=Cnot1 PE=1 SV=2 g18064.t1 Q9MYM7 43.704 270 2.13e-76 258.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g18066.t1 P41512 73.655 539 0.0 865.0 sp|P41512|TOP1_XENLA DNA topoisomerase 1 OS=Xenopus laevis OX=8355 GN=top1 PE=2 SV=1 g18067.t1 Q9D0L8 58.453 349 1.26e-147 428.0 sp|Q9D0L8|MCES_MOUSE mRNA cap guanine-N(7) methyltransferase OS=Mus musculus OX=10090 GN=Rnmt PE=1 SV=1 MCES_MOUSE reviewed mRNA cap guanine-N(7) methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase) Mus musculus (Mouse) GO:0001650; GO:0003723; GO:0004482; GO:0005634; GO:0005654; GO:0006370; GO:0031533; GO:0043235; GO:0160130; GO:1990830 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830] fibrillar center [GO:0001650]; mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; mRNA capping enzyme complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235] mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723] g18068.t1 Q8BT60 61.524 525 0.0 628.0 sp|Q8BT60|CPNE3_MOUSE Copine-3 OS=Mus musculus OX=10090 GN=Cpne3 PE=1 SV=2 CPNE3_MOUSE reviewed Copine-3 (Copine III) Mus musculus (Mouse) GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0038128; GO:0046872; GO:0048306; GO:0071277; GO:0071363 cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971] g18068.t2 H1UBN0 54.69 565 0.0 612.0 sp|H1UBN0|CPNE7_RAT Copine-7 OS=Rattus norvegicus OX=10116 GN=Cpne7 PE=1 SV=1 g18069.t1 Q17R09 64.724 1287 0.0 1613.0 sp|Q17R09|PRP16_BOVIN Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Bos taurus OX=9913 GN=DHX38 PE=2 SV=1 PRP16_BOVIN reviewed Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) Bos taurus (Bovine) GO:0000398; GO:0003723; GO:0005524; GO:0005681; GO:0016887; GO:0034458; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] catalytic step 2 spliceosome [GO:0071013]; spliceosomal complex [GO:0005681] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] g18070.t1 Q3KQF4 48.688 343 6.72e-102 306.0 sp|Q3KQF4|LRC69_XENLA Leucine-rich repeat-containing protein 69 OS=Xenopus laevis OX=8355 GN=lrrc69 PE=2 SV=1 g18070.t2 Q3KQF4 46.389 360 7.02e-98 297.0 sp|Q3KQF4|LRC69_XENLA Leucine-rich repeat-containing protein 69 OS=Xenopus laevis OX=8355 GN=lrrc69 PE=2 SV=1 g18071.t1 A7RRJ0 74.142 379 0.0 590.0 sp|A7RRJ0|FEN1_NEMVE Flap endonuclease 1 OS=Nematostella vectensis OX=45351 GN=FEN1 PE=3 SV=1 FEN1_NEMVE reviewed Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1) Nematostella vectensis (Starlet sea anemone) GO:0000287; GO:0003677; GO:0004523; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006284; GO:0008409; GO:0017108; GO:0030145; GO:0043137 base-excision repair [GO:0006284]; DNA replication, removal of RNA primer [GO:0043137] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523] g18072.t1 Q9R1S3 53.205 936 0.0 966.0 sp|Q9R1S3|PIGN_MOUSE GPI ethanolamine phosphate transferase 1 OS=Mus musculus OX=10090 GN=Pign PE=1 SV=2 g18073.t1 Q08024 57.895 190 8.37e-73 221.0 sp|Q08024|PEBB_MOUSE Core-binding factor subunit beta OS=Mus musculus OX=10090 GN=Cbfb PE=1 SV=1 PEBB_MOUSE reviewed Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) Mus musculus (Mouse) GO:0000122; GO:0000209; GO:0001503; GO:0001649; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016513; GO:0030098; GO:0030099; GO:0032991; GO:0043371; GO:0043378; GO:0045944; GO:0048469; GO:0060216 cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357] core-binding factor complex [GO:0016513]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g18073.t2 Q13951 61.31 168 1.9e-71 217.0 sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2 g18074.t1 O35276 37.19 242 2.04e-33 140.0 sp|O35276|NRP2_RAT Neuropilin-2 OS=Rattus norvegicus OX=10116 GN=Nrp2 PE=2 SV=1 NRP2_RAT reviewed Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2) Rattus norvegicus (Rat) GO:0001525; GO:0001764; GO:0003148; GO:0005021; GO:0005886; GO:0007411; GO:0007507; GO:0008201; GO:0017154; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036484; GO:0036486; GO:0042802; GO:0045211; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0071526; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1903375; GO:1904835; GO:1990830 angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trunk neural crest cell migration [GO:0036484]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor receptor activity [GO:0005021] g18075.t1 Q8R4D1 61.959 531 0.0 661.0 sp|Q8R4D1|SL9A8_MOUSE Sodium/hydrogen exchanger 8 OS=Mus musculus OX=10090 GN=Slc9a8 PE=1 SV=1 SL9A8_MOUSE reviewed Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8) Mus musculus (Mouse) GO:0000139; GO:0001669; GO:0001675; GO:0005794; GO:0006813; GO:0006814; GO:0015385; GO:0015386; GO:0016324; GO:0032585; GO:0032588; GO:0035725; GO:0051453; GO:0071805; GO:1902600; GO:1905526 acrosome assembly [GO:0001675]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; trans-Golgi network membrane [GO:0032588] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g18077.t1 Q09225 27.552 715 5.53e-69 246.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g18079.t1 Q09225 27.456 743 1.29e-65 236.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g18080.t1 Q68F38 53.836 769 0.0 820.0 sp|Q68F38|VAC14_XENLA Protein VAC14 homolog OS=Xenopus laevis OX=8355 GN=vac14 PE=2 SV=1 g18081.t1 Q9WTR6 50.205 488 7.3e-171 494.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g18083.t1 Q7YQK4 55.814 473 1.57e-173 501.0 sp|Q7YQK4|LAT1_RABIT Large neutral amino acids transporter small subunit 1 OS=Oryctolagus cuniculus OX=9986 GN=SLC7A5 PE=1 SV=1 g18085.t1 Q9NVR0 28.822 628 2.04e-71 246.0 sp|Q9NVR0|KLH11_HUMAN Kelch-like protein 11 OS=Homo sapiens OX=9606 GN=KLHL11 PE=1 SV=1 g18086.t1 Q6DGQ4 37.107 159 2.82e-26 100.0 sp|Q6DGQ4|CP087_DANRE UPF0547 protein C16orf87 homolog OS=Danio rerio OX=7955 GN=zgc:92818 PE=2 SV=1 g18087.t1 Q6NYL5 63.636 484 0.0 665.0 sp|Q6NYL5|ALAT2_DANRE Alanine aminotransferase 2-like OS=Danio rerio OX=7955 GN=gpt2l PE=2 SV=2 ALAT2_DANRE reviewed Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004021; GO:0005737; GO:0006103; GO:0030170; GO:0042851; GO:0042853 2-oxoglutarate metabolic process [GO:0006103]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851] cytoplasm [GO:0005737] L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170] g18090.t1 Q9GKX2 60.385 260 1.2100000000000001e-110 323.0 sp|Q9GKX2|DHRS4_RABIT Dehydrogenase/reductase SDR family member 4 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=DHRS4 PE=1 SV=1 g18091.t1 Q9W369 31.633 392 3.2099999999999997e-55 189.0 sp|Q9W369|TANN_DROME Beta-alanyl-dopamine/carcinine hydrolase OS=Drosophila melanogaster OX=7227 GN=t PE=1 SV=1 TANN_DROME reviewed Beta-alanyl-dopamine/carcinine hydrolase (EC 3.5.1.-) (NBAD/carcinine hydrolase) (Protein tan) [Cleaved into: Beta-alanyl-dopamine/carcinine hydrolase alpha subunit; Beta-alanyl-dopamine/carcinine hydrolase beta subunit] Drosophila melanogaster (Fruit fly) GO:0001692; GO:0001694; GO:0003832; GO:0005737; GO:0005829; GO:0007601; GO:0016787; GO:0030424; GO:0031964; GO:0042416; GO:0048067 cuticle pigmentation [GO:0048067]; dopamine biosynthetic process [GO:0042416]; histamine biosynthetic process [GO:0001694]; histamine metabolic process [GO:0001692]; visual perception [GO:0007601] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829] beta-alanyl-dopamine hydrolase activity [GO:0003832]; beta-alanyl-histamine hydrolase activity [GO:0031964]; hydrolase activity [GO:0016787] g18092.t1 Q9N0C5 39.394 198 3.41e-44 152.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g18093.t1 Q9N0C5 47.826 207 2.78e-66 209.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g18094.t1 Q9N0C5 47.761 201 2.4e-66 211.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g18095.t1 Q8T0Q4 53.07 228 3.97e-73 224.0 sp|Q8T0Q4|CHM4_DROME Charged multivesicular body protein 4 OS=Drosophila melanogaster OX=7227 GN=shrb PE=1 SV=1 g18096.t1 Q9BSE4 38.106 433 6.15e-76 245.0 sp|Q9BSE4|HERP2_HUMAN Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein OS=Homo sapiens OX=9606 GN=HERPUD2 PE=1 SV=2 HERP2_HUMAN reviewed Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein Homo sapiens (Human) GO:0007283; GO:0016020; GO:0030968 endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283] membrane [GO:0016020] g18097.t1 P05689 64.437 284 2.96e-130 375.0 sp|P05689|CATZ_BOVIN Cathepsin Z OS=Bos taurus OX=9913 GN=CTSZ PE=2 SV=2 g18099.t1 P08761 46.296 108 1.84e-24 96.3 sp|P08761|MSRA_DROME Peptide methionine sulfoxide reductase OS=Drosophila melanogaster OX=7227 GN=MsrA PE=1 SV=2 g18100.t1 Q91WK5 39.286 168 2.0500000000000003e-43 145.0 sp|Q91WK5|GCSH_MOUSE Glycine cleavage system H protein, mitochondrial OS=Mus musculus OX=10090 GN=Gcsh PE=1 SV=2 g18101.t1 Q6TEM9 39.091 440 3.34e-97 302.0 sp|Q6TEM9|MYLIA_DANRE E3 ubiquitin-protein ligase MYLIP-A OS=Danio rerio OX=7955 GN=mylipa PE=1 SV=2 MYLIA_DANRE reviewed E3 ubiquitin-protein ligase MYLIP-A (EC 2.3.2.27) (Myosin regulatory light chain-interacting protein A) (MIR-A) (RING-type E3 ubiquitin transferase MYLIP-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007369; GO:0008270; GO:0016567; GO:0030178; GO:0061630 gastrulation [GO:0007369]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18102.t1 Q2KJI7 68.054 745 0.0 1015.0 sp|Q2KJI7|AFG32_BOVIN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Bos taurus OX=9913 GN=AFG3L2 PE=2 SV=1 AFG32_BOVIN reviewed Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) Bos taurus (Bovine) GO:0004176; GO:0004222; GO:0005524; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0030163; GO:0034982; GO:0036444; GO:0051560; GO:0072753; GO:0110097; GO:0140567; GO:0141164 axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097] m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; membrane protein dislocase activity [GO:0140567]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g18104.t1 Q15024 55.862 290 2.64e-116 339.0 sp|Q15024|EXOS7_HUMAN Exosome complex component RRP42 OS=Homo sapiens OX=9606 GN=EXOSC7 PE=1 SV=3 EXOS7_HUMAN reviewed Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8) Homo sapiens (Human) GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0071028; GO:0071035; GO:0071038; GO:0101019 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723] g18105.t1 Q2TGK3 57.143 280 1.31e-114 336.0 sp|Q2TGK3|ZDHC3_RAT Palmitoyltransferase ZDHHC3 OS=Rattus norvegicus OX=10116 GN=Zdhhc3 PE=2 SV=1 ZDHC3_RAT reviewed Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 3) Rattus norvegicus (Rat) GO:0000139; GO:0005783; GO:0005794; GO:0006605; GO:0006612; GO:0008277; GO:0016409; GO:0019705; GO:0019706; GO:0031669; GO:0032230; GO:0034165; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:0140439; GO:0150032; GO:1902685; GO:1903546; GO:1904263 cellular response to nutrient levels [GO:0031669]; lipoprotein localization to membrane [GO:0044873]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein targeting [GO:0006605]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g18113.t1 Q8HY33 45.076 264 2.57e-81 248.0 sp|Q8HY33|CAH1_MONDO Carbonic anhydrase 1 OS=Monodelphis domestica OX=13616 GN=CA1 PE=2 SV=1 g18114.t1 Q8TE73 68.54 4644 0.0 6675.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18117.t1 Q9DBN1 25.196 639 1.4200000000000002e-35 145.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g18117.t2 Q9DBN1 24.804 637 1.23e-35 145.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g18118.t1 Q9DBN1 25.723 657 2.51e-45 174.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g18119.t1 Q9DBN1 26.994 652 7.75e-53 195.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g18120.t1 Q9H227 50.429 466 6.56e-171 493.0 sp|Q9H227|GBA3_HUMAN Cytosolic beta-glucosidase OS=Homo sapiens OX=9606 GN=GBA3 PE=1 SV=2 GBA3_HUMAN reviewed Cytosolic beta-glucosidase (EC 3.2.1.21) (Cytosolic beta-glucosidase-like protein 1) (Cytosolic galactosylceramidase) (EC 3.2.1.46) (Cytosolic glucosylceramidase) (EC 3.2.1.45) (Cytosolic glycosylceramidase) (Cytosolic GCase) (Glucosidase beta acid 3) (Glucosylceramidase beta 3) (Klotho-related protein) (KLrP) Homo sapiens (Human) GO:0004336; GO:0004348; GO:0004565; GO:0005829; GO:0006680; GO:0006683; GO:0008422; GO:0009313; GO:0016020; GO:0016139; GO:0017042; GO:0046477; GO:0046479; GO:0050821; GO:1901805; GO:1902494 beta-glucoside catabolic process [GO:1901805]; galactosylceramide catabolic process [GO:0006683]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide catabolic process [GO:0009313]; protein stabilization [GO:0050821] catalytic complex [GO:1902494]; cytosol [GO:0005829]; membrane [GO:0016020] beta-galactosidase activity [GO:0004565]; beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glycosylceramidase activity [GO:0017042] g18122.t1 Q5FVP5 42.249 329 8.66e-83 261.0 sp|Q5FVP5|WDR89_RAT WD repeat-containing protein 89 OS=Rattus norvegicus OX=10116 GN=Wdr89 PE=2 SV=1 g18122.t2 Q5FVP5 41.246 337 6.75e-80 254.0 sp|Q5FVP5|WDR89_RAT WD repeat-containing protein 89 OS=Rattus norvegicus OX=10116 GN=Wdr89 PE=2 SV=1 g18123.t1 Q0V7M1 50.0 280 5.59e-78 243.0 sp|Q0V7M1|KPSH1_BOVIN Serine/threonine-protein kinase H1 OS=Bos taurus OX=9913 GN=PSKH1 PE=2 SV=1 KPSH1_BOVIN reviewed Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1) Bos taurus (Bovine) GO:0004674; GO:0005524; GO:0005737; GO:0005789; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007368; GO:0007507; GO:0016607; GO:0106310 determination of left/right symmetry [GO:0007368]; heart development [GO:0007507] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g18124.t1 Q4KTY1 55.725 131 3e-44 152.0 sp|Q4KTY1|KPSH1_PINFU Serine/threonine-protein kinase H1 homolog OS=Pinctada fucata OX=50426 GN=PSKH1 PE=2 SV=1 g18125.t1 Q7TSQ8 52.688 93 6.83e-21 89.4 sp|Q7TSQ8|PDPR_MOUSE Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Mus musculus OX=10090 GN=Pdpr PE=1 SV=1 g18126.t1 Q8NCN5 40.568 599 4.57e-145 446.0 sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2 g18127.t1 Q8NCN5 44.393 856 0.0 732.0 sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2 g18130.t1 Q3SA46 56.955 381 9.92e-135 394.0 sp|Q3SA46|TBX20_XENTR T-box transcription factor TBX20 OS=Xenopus tropicalis OX=8364 GN=tbx20 PE=2 SV=1 g18131.t1 Q9JMK0 57.391 230 1e-90 285.0 sp|Q9JMK0|B4GT5_MOUSE Beta-1,4-galactosyltransferase 5 OS=Mus musculus OX=10090 GN=B4galt5 PE=1 SV=2 B4GT5_MOUSE reviewed Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5) Mus musculus (Mouse) GO:0001574; GO:0003945; GO:0005794; GO:0005975; GO:0008489; GO:0009101; GO:0021955; GO:0022010; GO:0030311; GO:0031647; GO:0032580; GO:0040019; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; neuron maturation [GO:0042551]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; regulation of protein stability [GO:0031647] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g18132.t1 Q9UBX8 53.68 231 1.54e-83 266.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g18134.t1 Q9UBX8 57.759 116 1.99e-44 159.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g18135.t1 Q9UBX8 46.383 235 2.56e-57 196.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g18136.t1 Q9UBX8 52.743 237 2.44e-79 252.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g18136.t2 Q9UBX8 52.743 237 4.5400000000000006e-79 253.0 sp|Q9UBX8|B4GT6_HUMAN Beta-1,4-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B4GALT6 PE=1 SV=1 B4GT6_HUMAN reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Homo sapiens (Human) GO:0000139; GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g18137.t1 O14718 34.68 297 2.05e-55 189.0 sp|O14718|OPSX_HUMAN Visual pigment-like receptor peropsin OS=Homo sapiens OX=9606 GN=RRH PE=1 SV=1 g18139.t1 Q96PQ7 32.447 564 3.71e-99 320.0 sp|Q96PQ7|KLHL5_HUMAN Kelch-like protein 5 OS=Homo sapiens OX=9606 GN=KLHL5 PE=1 SV=3 g18140.t1 P59114 53.333 660 0.0 706.0 sp|P59114|CAPAM_MOUSE mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase OS=Mus musculus OX=10090 GN=Pcif1 PE=1 SV=1 g18142.t1 Q9BQ70 41.737 714 7.55e-176 520.0 sp|Q9BQ70|TCF25_HUMAN Ribosome quality control complex subunit TCF25 OS=Homo sapiens OX=9606 GN=TCF25 PE=1 SV=1 TCF25_HUMAN reviewed Ribosome quality control complex subunit TCF25 (Nuclear localized protein 1) (Transcription factor 25) (TCF-25) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0061945; GO:0072344; GO:1990112 regulation of protein K48-linked ubiquitination [GO:0061945]; rescue of stalled ribosome [GO:0072344] cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112] g18145.t1 Q66IJ4 56.091 394 1.25e-143 418.0 sp|Q66IJ4|PIGM_XENTR GPI alpha-1,4-mannosyltransferase I, catalytic subunit OS=Xenopus tropicalis OX=8364 GN=pigm PE=2 SV=1 g18146.t1 Q8VI02 45.372 994 0.0 755.0 sp|Q8VI02|PP4R1_RAT Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Rattus norvegicus OX=10116 GN=Ppp4r1 PE=1 SV=1 g18146.t2 Q8VI02 45.372 994 0.0 758.0 sp|Q8VI02|PP4R1_RAT Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Rattus norvegicus OX=10116 GN=Ppp4r1 PE=1 SV=1 g18147.t1 Q9ULI1 24.717 1060 9.9e-71 266.0 sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3 g18149.t1 Q8VED2 40.268 149 2.35e-27 105.0 sp|Q8VED2|BL1S4_MOUSE Biogenesis of lysosome-related organelles complex 1 subunit 4 OS=Mus musculus OX=10090 GN=Bloc1s4 PE=1 SV=1 BL1S4_MOUSE reviewed Biogenesis of lysosome-related organelles complex 1 subunit 4 (BLOC-1 subunit 4) (Protein cappuccino homolog) Mus musculus (Mouse) GO:0005737; GO:0008089; GO:0031083; GO:0031175; GO:0032438; GO:0048490; GO:0050885; GO:0070527; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737] g18151.t1 Q5RDW1 57.062 354 3.5500000000000004e-116 347.0 sp|Q5RDW1|MTG2_PONAB Mitochondrial ribosome-associated GTPase 2 OS=Pongo abelii OX=9601 GN=MTG2 PE=2 SV=1 g18152.t1 O88554 55.597 536 0.0 627.0 sp|O88554|PARP2_MOUSE Poly [ADP-ribose] polymerase 2 OS=Mus musculus OX=10090 GN=Parp2 PE=1 SV=3 PARP2_MOUSE reviewed Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-) Mus musculus (Mouse) GO:0003682; GO:0003684; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016779; GO:0030592; GO:0031491; GO:0046697; GO:0061051; GO:0070212; GO:0070213; GO:0071168; GO:0072572; GO:0090649; GO:0090734; GO:0097191; GO:0110088; GO:0140294; GO:0140805; GO:0140806; GO:0140807; GO:0140861; GO:0160004; GO:1990404 base-excision repair [GO:0006284]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; hippocampal neuron apoptotic process [GO:0110088]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromatin [GO:0071168]; protein poly-ADP-ribosylation [GO:0070212]; response to oxygen-glucose deprivation [GO:0090649] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; poly-ADP-D-ribose binding [GO:0072572]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004] g18153.t1 Q9UGM3 43.473 766 2.55e-161 526.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18153.t1 Q9UGM3 43.86 741 1.49e-159 521.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18153.t1 Q9UGM3 43.57 762 5.91e-159 520.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18153.t1 Q9UGM3 41.805 842 1.63e-157 516.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18153.t1 Q9UGM3 42.474 784 2.01e-155 509.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18153.t1 Q9UGM3 42.476 638 4.67e-126 425.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18153.t1 Q9UGM3 38.162 642 9.71e-94 330.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18153.t1 Q9UGM3 57.273 110 1.41e-26 121.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18157.t1 Q64459 39.504 524 1.55e-119 363.0 sp|Q64459|CP3AB_MOUSE Cytochrome P450 3A11 OS=Mus musculus OX=10090 GN=Cyp3a11 PE=1 SV=1 CP3AB_MOUSE reviewed Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT) Mus musculus (Mouse) GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008210; GO:0008401; GO:0009617; GO:0009822; GO:0016491; GO:0020037; GO:0032451; GO:0042178; GO:0042573; GO:0050649; GO:0070989; GO:0101020 alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; response to bacterium [GO:0009617]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178] endoplasmic reticulum membrane [GO:0005789] demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; testosterone 6-beta-hydroxylase activity [GO:0050649] g18158.t1 Q96DM1 25.833 480 2.4e-35 144.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g18159.t1 Q29496 35.857 502 1e-114 351.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g18160.t1 A6NE52 27.296 784 4.57e-84 308.0 sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2 WDR97_HUMAN reviewed WD repeat-containing protein 97 Homo sapiens (Human) g18160.t2 A6NE52 27.296 784 3.37e-84 309.0 sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2 WDR97_HUMAN reviewed WD repeat-containing protein 97 Homo sapiens (Human) g18160.t3 A6NE52 27.296 784 3.86e-84 308.0 sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2 WDR97_HUMAN reviewed WD repeat-containing protein 97 Homo sapiens (Human) g18161.t1 Q6DE14 50.4 375 7.75e-107 320.0 sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1 E2F4_XENLA reviewed Transcription factor E2F4 (E2F-4) Xenopus laevis (African clawed frog) GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251 centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g18162.t1 P22892 61.548 840 0.0 1021.0 sp|P22892|AP1G1_MOUSE AP-1 complex subunit gamma-1 OS=Mus musculus OX=10090 GN=Ap1g1 PE=1 SV=3 AP1G1_MOUSE reviewed AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin adaptor protein 1 core) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Mus musculus (Mouse) GO:0005518; GO:0005765; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0005905; GO:0006886; GO:0006896; GO:0016182; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030742; GO:0031267; GO:0032588; GO:0035615; GO:0035646; GO:0043323; GO:0045954; GO:0048471; GO:0048488; GO:0055037; GO:0060155; GO:0090160; GO:0098793; GO:0110010; GO:1903232 basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] clathrin adaptor activity [GO:0035615]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] g18163.t1 Q17QH8 57.095 296 1.31e-122 355.0 sp|Q17QH8|D39U1_BOVIN Epimerase family protein SDR39U1 OS=Bos taurus OX=9913 GN=SDR39U1 PE=2 SV=1 g18164.t1 Q9C0B7 35.033 902 5.72e-162 516.0 sp|Q9C0B7|TNG6_HUMAN Transport and Golgi organization protein 6 homolog OS=Homo sapiens OX=9606 GN=TANGO6 PE=1 SV=2 g18164.t2 Q9C0B7 35.144 902 1.08e-162 518.0 sp|Q9C0B7|TNG6_HUMAN Transport and Golgi organization protein 6 homolog OS=Homo sapiens OX=9606 GN=TANGO6 PE=1 SV=2 g18165.t1 Q9BYN7 46.279 739 0.0 612.0 sp|Q9BYN7|ZN341_HUMAN Zinc finger protein 341 OS=Homo sapiens OX=9606 GN=ZNF341 PE=1 SV=2 ZN341_HUMAN reviewed Zinc finger protein 341 Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0008270 regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g18169.t1 Q11136 61.099 473 0.0 613.0 sp|Q11136|PEPD_MOUSE Xaa-Pro dipeptidase OS=Mus musculus OX=10090 GN=Pepd PE=1 SV=3 PEPD_MOUSE reviewed Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase 4) (Peptidase D) (Proline dipeptidase) (Prolidase) Mus musculus (Mouse) GO:0006508; GO:0008233; GO:0030145; GO:0030574; GO:0043069; GO:0070006; GO:0102009; GO:0140633 CARD8 inflammasome complex assembly [GO:0140633]; collagen catabolic process [GO:0030574]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508] manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009] g18170.t1 Q8BW75 51.852 405 1.55e-142 419.0 sp|Q8BW75|AOFB_MOUSE Amine oxidase [flavin-containing] B OS=Mus musculus OX=10090 GN=Maob PE=1 SV=4 AOFB_MOUSE reviewed Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005743; GO:0008131; GO:0014063; GO:0019607; GO:0030425; GO:0042802; GO:0043025; GO:0045964; GO:0048545; GO:0050660; GO:0097621 negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to steroid hormone [GO:0048545] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g18171.t1 Q6PLK3 61.25 80 1.87e-24 98.2 sp|Q6PLK3|AOFB_PIG Amine oxidase [flavin-containing] B OS=Sus scrofa OX=9823 GN=MAOB PE=2 SV=3 g18173.t1 P49253 50.25 400 3.0099999999999996e-140 413.0 sp|P49253|AOF_ONCMY Amine oxidase [flavin-containing] OS=Oncorhynchus mykiss OX=8022 GN=mao PE=2 SV=2 g18174.t1 Q63767 31.658 935 1.19e-93 318.0 sp|Q63767|BCAR1_RAT Breast cancer anti-estrogen resistance protein 1 OS=Rattus norvegicus OX=10116 GN=Bcar1 PE=1 SV=1 BCAR1_RAT reviewed Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (p130cas) Rattus norvegicus (Rat) GO:0001726; GO:0005737; GO:0005886; GO:0005925; GO:0007015; GO:0007155; GO:0007169; GO:0007173; GO:0007186; GO:0007229; GO:0008286; GO:0010595; GO:0015629; GO:0016020; GO:0016477; GO:0017124; GO:0019901; GO:0019904; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0035729; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050853; GO:0060326; GO:0071732; GO:0086100; GO:1900025; GO:1990859 actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to endothelin [GO:1990859]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to nitric oxide [GO:0071732]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726] protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] g18179.t1 Q9P2E3 37.217 1545 0.0 898.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g18180.t1 Q8R151 45.833 672 2.08e-173 573.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g18181.t1 Q9P2E3 49.407 253 1.14e-64 220.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g18183.t1 Q8R151 42.158 1900 0.0 1427.0 sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3 ZNFX1_MOUSE reviewed NFX1-type zinc finger-containing protein 1 Mus musculus (Mouse) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g18184.t1 Q9P2E3 40.782 1893 0.0 1291.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g18186.t1 Q8TEX9 43.065 1031 0.0 721.0 sp|Q8TEX9|IPO4_HUMAN Importin-4 OS=Homo sapiens OX=9606 GN=IPO4 PE=1 SV=2 IPO4_HUMAN reviewed Importin-4 (Imp4) (Importin-4b) (Imp4b) (Ran-binding protein 4) (RanBP4) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0016020; GO:0031267; GO:0032991; GO:0034504; GO:0061608 protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] g18186.t2 Q8TEX9 43.065 1031 0.0 721.0 sp|Q8TEX9|IPO4_HUMAN Importin-4 OS=Homo sapiens OX=9606 GN=IPO4 PE=1 SV=2 IPO4_HUMAN reviewed Importin-4 (Imp4) (Importin-4b) (Imp4b) (Ran-binding protein 4) (RanBP4) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0016020; GO:0031267; GO:0032991; GO:0034504; GO:0061608 protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] g18187.t1 Q8CIG9 26.4 375 5.120000000000001e-32 127.0 sp|Q8CIG9|FBXL8_MOUSE F-box/LRR-repeat protein 8 OS=Mus musculus OX=10090 GN=Fbxl8 PE=1 SV=1 g18188.t1 Q95N27 47.801 341 1.41e-107 341.0 sp|Q95N27|PP16B_BOVIN Protein phosphatase 1 regulatory inhibitor subunit 16B OS=Bos taurus OX=9913 GN=PPP1R16B PE=1 SV=1 PP16B_BOVIN reviewed Protein phosphatase 1 regulatory inhibitor subunit 16B (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (bTIMAP) Bos taurus (Bovine) GO:0004857; GO:0005634; GO:0005737; GO:0005886; GO:0016607; GO:0017020; GO:0042995; GO:0048471; GO:0051489; GO:0051896; GO:0061028; GO:1903589; GO:1903670 establishment of endothelial barrier [GO:0061028]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of sprouting angiogenesis [GO:1903670] cell projection [GO:0042995]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020] g18189.t1 A7SXZ6 82.09 335 0.0 568.0 sp|A7SXZ6|OSGEP_NEMVE Probable tRNA N6-adenosine threonylcarbamoyltransferase OS=Nematostella vectensis OX=45351 GN=osgep PE=3 SV=1 OSGEP_NEMVE reviewed Probable tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgep) (tRNA threonylcarbamoyladenosine biosynthesis protein osgep) Nematostella vectensis (Starlet sea anemone) GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0046872; GO:0061711 tRNA threonylcarbamoyladenosine modification [GO:0002949] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634] metal ion binding [GO:0046872]; tRNA N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711] g18190.t1 P70691 33.809 491 2.16e-91 293.0 sp|P70691|UD12_MOUSE UDP-glucuronosyltransferase 1-2 OS=Mus musculus OX=10090 GN=Ugt1a2 PE=1 SV=1 g18191.t1 Q9Y5Y6 31.139 562 2.39e-64 229.0 sp|Q9Y5Y6|ST14_HUMAN Suppressor of tumorigenicity 14 protein OS=Homo sapiens OX=9606 GN=ST14 PE=1 SV=2 ST14_HUMAN reviewed Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein) Homo sapiens (Human) GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0009897; GO:0016323; GO:0030163; GO:0030216; GO:0060672 epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g18193.t1 Q2M1K9 33.459 1324 0.0 664.0 sp|Q2M1K9|ZN423_HUMAN Zinc finger protein 423 OS=Homo sapiens OX=9606 GN=ZNF423 PE=1 SV=1 ZN423_HUMAN reviewed Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0008270; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0061512; GO:0120163 cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g18193.t1 Q2M1K9 22.805 763 1.35e-21 106.0 sp|Q2M1K9|ZN423_HUMAN Zinc finger protein 423 OS=Homo sapiens OX=9606 GN=ZNF423 PE=1 SV=1 ZN423_HUMAN reviewed Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0008270; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0061512; GO:0120163 cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g18195.t1 O88822 51.027 292 1.3799999999999998e-95 286.0 sp|O88822|SC5D_MOUSE Lathosterol oxidase OS=Mus musculus OX=10090 GN=Sc5d PE=2 SV=2 SC5D_MOUSE reviewed Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase) Mus musculus (Mouse) GO:0000248; GO:0005506; GO:0005789; GO:0006695; GO:0016020; GO:0033489; GO:0033490; GO:0050046; GO:0070704; GO:0110076 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; negative regulation of ferroptosis [GO:0110076] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] C-5 sterol desaturase activity [GO:0000248]; delta7-sterol 5(6)-desaturase activity [GO:0050046]; iron ion binding [GO:0005506]; sterol desaturase activity [GO:0070704] g18196.t1 O88822 54.212 273 4.58e-96 288.0 sp|O88822|SC5D_MOUSE Lathosterol oxidase OS=Mus musculus OX=10090 GN=Sc5d PE=2 SV=2 SC5D_MOUSE reviewed Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase) Mus musculus (Mouse) GO:0000248; GO:0005506; GO:0005789; GO:0006695; GO:0016020; GO:0033489; GO:0033490; GO:0050046; GO:0070704; GO:0110076 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; negative regulation of ferroptosis [GO:0110076] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] C-5 sterol desaturase activity [GO:0000248]; delta7-sterol 5(6)-desaturase activity [GO:0050046]; iron ion binding [GO:0005506]; sterol desaturase activity [GO:0070704] g18198.t1 O88822 55.973 293 2.56e-111 327.0 sp|O88822|SC5D_MOUSE Lathosterol oxidase OS=Mus musculus OX=10090 GN=Sc5d PE=2 SV=2 SC5D_MOUSE reviewed Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase) Mus musculus (Mouse) GO:0000248; GO:0005506; GO:0005789; GO:0006695; GO:0016020; GO:0033489; GO:0033490; GO:0050046; GO:0070704; GO:0110076 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; negative regulation of ferroptosis [GO:0110076] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] C-5 sterol desaturase activity [GO:0000248]; delta7-sterol 5(6)-desaturase activity [GO:0050046]; iron ion binding [GO:0005506]; sterol desaturase activity [GO:0070704] g18199.t1 O88822 56.997 293 2.1e-111 327.0 sp|O88822|SC5D_MOUSE Lathosterol oxidase OS=Mus musculus OX=10090 GN=Sc5d PE=2 SV=2 SC5D_MOUSE reviewed Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase) Mus musculus (Mouse) GO:0000248; GO:0005506; GO:0005789; GO:0006695; GO:0016020; GO:0033489; GO:0033490; GO:0050046; GO:0070704; GO:0110076 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; negative regulation of ferroptosis [GO:0110076] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] C-5 sterol desaturase activity [GO:0000248]; delta7-sterol 5(6)-desaturase activity [GO:0050046]; iron ion binding [GO:0005506]; sterol desaturase activity [GO:0070704] g18200.t1 P27604 76.347 427 0.0 682.0 sp|P27604|SAHH_CAEEL Adenosylhomocysteinase OS=Caenorhabditis elegans OX=6239 GN=ahcy-1 PE=3 SV=1 g18201.t1 P10819 77.855 429 0.0 697.0 sp|P10819|SAHH_DICDI Adenosylhomocysteinase OS=Dictyostelium discoideum OX=44689 GN=sahA PE=1 SV=2 SAHH_DICDI reviewed Adenosylhomocysteinase (AdoHcyase) (EC 3.13.2.1) (S-adenosyl-L-homocysteine hydrolase) Dictyostelium discoideum (Social amoeba) GO:0004013; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006730; GO:0007163; GO:0030552; GO:0031002; GO:0031012; GO:0033353; GO:0045335 establishment or maintenance of cell polarity [GO:0007163]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] actin rod [GO:0031002]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335] adenosylhomocysteinase activity [GO:0004013]; cAMP binding [GO:0030552] g18202.t1 O93477 77.442 430 0.0 714.0 sp|O93477|SAHHB_XENLA Adenosylhomocysteinase B OS=Xenopus laevis OX=8355 GN=ahcy-b PE=2 SV=1 g18203.t1 Q9W4P5 82.507 343 0.0 605.0 sp|Q9W4P5|VA0D1_DROME V-type proton ATPase subunit d 1 OS=Drosophila melanogaster OX=7227 GN=VhaAC39-1 PE=2 SV=1 g18204.t1 Q5RC80 61.951 410 4.74e-175 508.0 sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1 RBM39_PONAB reviewed RNA-binding protein 39 (RNA-binding motif protein 39) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733 mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380] centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991] RNA binding [GO:0003723]; RS domain binding [GO:0050733] g18205.t1 Q9EQS5 62.5 280 4.24e-124 358.0 sp|Q9EQS5|SC5D_RAT Lathosterol oxidase OS=Rattus norvegicus OX=10116 GN=Sc5d PE=1 SV=1 SC5D_RAT reviewed Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase) Rattus norvegicus (Rat) GO:0000248; GO:0005506; GO:0005789; GO:0006631; GO:0006695; GO:0016020; GO:0033489; GO:0033490; GO:0050046; GO:0070704; GO:0110076 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; fatty acid metabolic process [GO:0006631]; negative regulation of ferroptosis [GO:0110076] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] C-5 sterol desaturase activity [GO:0000248]; delta7-sterol 5(6)-desaturase activity [GO:0050046]; iron ion binding [GO:0005506]; sterol desaturase activity [GO:0070704] g18208.t1 Q1LYM3 34.639 664 2.4e-101 333.0 sp|Q1LYM3|SPIR1_DANRE Protein spire homolog 1 OS=Danio rerio OX=7955 GN=spire1 PE=2 SV=1 SPIR1_DANRE reviewed Protein spire homolog 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003779; GO:0005829; GO:0005856; GO:0005938; GO:0008017; GO:0015031; GO:0030659; GO:0032154; GO:0036089; GO:0040038; GO:0045010; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:2000781 actin filament network formation [GO:0051639]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; microtubule binding [GO:0008017] g18209.t1 O14662 60.323 310 3.3200000000000006e-129 374.0 sp|O14662|STX16_HUMAN Syntaxin-16 OS=Homo sapiens OX=9606 GN=STX16 PE=1 SV=3 STX16_HUMAN reviewed Syntaxin-16 (Syn16) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0019905; GO:0030672; GO:0031201; GO:0031985; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471 endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g18214.t1 P47952 55.556 171 3.32e-59 185.0 sp|P47952|APT_CRIGR Adenine phosphoribosyltransferase OS=Cricetulus griseus OX=10029 GN=APRT PE=3 SV=2 g18215.t1 Q7TQE7 50.15 333 1.34e-125 381.0 sp|Q7TQE7|MACA2_MOUSE Putative tyrosine carboxypeptidase MATCAP2 OS=Mus musculus OX=10090 GN=Matcap2 PE=2 SV=2 g18216.t1 Q9N1F5 41.176 221 1.29e-48 163.0 sp|Q9N1F5|GSTO1_PIG Glutathione S-transferase omega-1 OS=Sus scrofa OX=9823 GN=GSTO1 PE=1 SV=2 GSTO1_PIG reviewed Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R) Sus scrofa (Pig) GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0071243 cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; cytosol [GO:0005829] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491] g18217.t1 Q09225 28.917 702 3.9499999999999996e-74 260.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g18218.t1 Q9DGH0 40.415 193 4.100000000000001e-37 132.0 sp|Q9DGH0|TWS1A_DANRE Twisted gastrulation protein homolog 1-A OS=Danio rerio OX=7955 GN=twsg1a PE=2 SV=1 g18219.t1 P22770 32.661 496 1.04e-73 246.0 sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1 g18219.t2 P22770 33.131 495 1.2500000000000001e-73 245.0 sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1 g18220.t1 Q64287 42.424 165 2e-35 142.0 sp|Q64287|IRF4_MOUSE Interferon regulatory factor 4 OS=Mus musculus OX=10090 GN=Irf4 PE=1 SV=1 IRF4_MOUSE reviewed Interferon regulatory factor 4 (IRF-4) (Lymphocyte-specific interferon regulatory factor) (LSIRF) (NF-EM5) (PU.1 interaction partner) (Transcriptional activator PIP) Mus musculus (Mouse) GO:0000786; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0002376; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0032733; GO:0032736; GO:0032743; GO:0032753; GO:0034122; GO:0042832; GO:0043011; GO:0043565; GO:0045893; GO:0045944; GO:0072540; GO:0120162; GO:1990837 chromatin remodeling [GO:0006338]; defense response to protozoan [GO:0042832]; immune system process [GO:0002376]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell lineage commitment [GO:0072540] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713] g18224.t1 O15995 58.513 417 6.19e-174 496.0 sp|O15995|CCNE_HEMPU G1/S-specific cyclin-E OS=Hemicentrotus pulcherrimus OX=7650 GN=CYCE PE=2 SV=1 g18225.t1 Q1NZ26 46.125 271 1.59e-79 244.0 sp|Q1NZ26|YSMU_CAEEL Uncharacterized protein F13E9.13, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=F13E9.13 PE=3 SV=1 g18228.t1 Q8BJ48 45.455 341 4.2300000000000003e-88 276.0 sp|Q8BJ48|NAGPA_MOUSE N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase OS=Mus musculus OX=10090 GN=Nagpa PE=1 SV=2 g18230.t1 Q9UGM3 44.186 301 1.3900000000000001e-58 213.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 40.06 332 2.27e-56 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 40.741 324 2.6e-56 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 40.06 332 4.62e-56 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 39.94 333 1.72e-55 204.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 39.755 327 1.7499999999999998e-55 204.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 39.198 324 8.32e-55 202.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 36.827 353 1.9299999999999999e-53 198.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 38.344 326 4.02e-53 197.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 42.231 251 5.11e-47 179.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t1 Q9UGM3 51.852 108 8.9e-22 103.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 44.186 301 1.24e-58 213.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 40.06 332 2.16e-56 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 40.741 324 2.31e-56 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 40.06 332 4.19e-56 205.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 39.755 327 1.5799999999999999e-55 204.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 39.94 333 1.61e-55 204.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 39.198 324 7.5e-55 202.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 36.827 353 1.84e-53 197.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 38.344 326 3.93e-53 197.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 42.231 251 4.74e-47 179.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18230.t2 Q9UGM3 51.852 108 8.87e-22 103.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g18231.t1 Q95218 42.818 362 2.01e-70 243.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g18231.t1 Q95218 39.13 391 1.7699999999999999e-62 219.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g18231.t1 Q95218 47.718 241 2.02e-56 202.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g18231.t1 Q95218 48.718 234 1.07e-54 197.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g18232.t1 Q5G265 38.926 149 4.28e-26 113.0 sp|Q5G265|NETR_SAGLB Neurotrypsin OS=Saguinus labiatus OX=78454 GN=PRSS12 PE=3 SV=1 NETR_SAGLB reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Saguinus labiatus (Red-chested mustached tamarin) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g18235.t1 Q09225 27.083 720 3.0799999999999997e-69 246.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g18235.t2 Q09225 26.38 743 7.46e-65 234.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g18236.t1 O15063 23.658 503 1.0400000000000002e-27 125.0 sp|O15063|GRRE1_HUMAN Granule associated Rac and RHOG effector protein 1 OS=Homo sapiens OX=9606 GN=GARRE1 PE=1 SV=2 g18236.t2 O15063 23.459 503 2.09e-24 114.0 sp|O15063|GRRE1_HUMAN Granule associated Rac and RHOG effector protein 1 OS=Homo sapiens OX=9606 GN=GARRE1 PE=1 SV=2 g18238.t1 Q7TT47 61.224 196 3e-81 261.0 sp|Q7TT47|SPG7_RAT Mitochondrial inner membrane m-AAA protease component paraplegin OS=Rattus norvegicus OX=10116 GN=Spg7 PE=2 SV=2 g18239.t1 Q9UQ90 53.816 511 6.240000000000001e-161 479.0 sp|Q9UQ90|SPG7_HUMAN Mitochondrial inner membrane m-AAA protease component paraplegin OS=Homo sapiens OX=9606 GN=SPG7 PE=1 SV=2 SPG7_HUMAN reviewed Mitochondrial inner membrane m-AAA protease component paraplegin (EC 3.4.24.-) (EC 3.6.-.-) (Cell matrix adhesion regulator) (Paraplegin) (Spastic paraplegia 7 protein) Homo sapiens (Human) GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0006508; GO:0007399; GO:0008089; GO:0008233; GO:0008270; GO:0016887; GO:0034982; GO:0046902; GO:0051082; GO:0110097; GO:1902686; GO:1904115 anterograde axonal transport [GO:0008089]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of mitochondrial membrane permeability [GO:0046902] axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] g18241.t1 Q6UB99 51.128 266 6.72e-61 234.0 sp|Q6UB99|ANR11_HUMAN Ankyrin repeat domain-containing protein 11 OS=Homo sapiens OX=9606 GN=ANKRD11 PE=1 SV=3 ANR11_HUMAN reviewed Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0042475; GO:0048705; GO:0060325 face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g18241.t1 Q6UB99 37.867 375 2.4100000000000002e-57 222.0 sp|Q6UB99|ANR11_HUMAN Ankyrin repeat domain-containing protein 11 OS=Homo sapiens OX=9606 GN=ANKRD11 PE=1 SV=3 ANR11_HUMAN reviewed Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005829; GO:0042475; GO:0048705; GO:0060325 face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g18243.t1 Q13884 47.07 529 5.33e-160 468.0 sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3 SNTB1_HUMAN reviewed Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005516; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202 muscle contraction [GO:0006936] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202] actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] g18243.t2 Q13884 47.801 523 9.36e-162 472.0 sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3 SNTB1_HUMAN reviewed Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005516; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202 muscle contraction [GO:0006936] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202] actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] g18244.t1 Q8IVS2 43.333 330 1.31e-88 276.0 sp|Q8IVS2|FABD_HUMAN Malonyl-CoA-acyl carrier protein transacylase, mitochondrial OS=Homo sapiens OX=9606 GN=MCAT PE=1 SV=2 FABD_HUMAN reviewed Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyl CoA:ACP acyltransferase) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase) Homo sapiens (Human) GO:0003723; GO:0004314; GO:0005739; GO:0005759; GO:0006633; GO:0006635; GO:0140691; GO:0180026 fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; mitochondrial small ribosomal subunit assembly [GO:0180026] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; RNA binding [GO:0003723]; RNA folding chaperone [GO:0140691] g18245.t1 Q68ED3 52.094 382 4.44e-120 378.0 sp|Q68ED3|PAPD5_MOUSE Terminal nucleotidyltransferase 4B OS=Mus musculus OX=10090 GN=Tent4b PE=1 SV=2 PAPD5_MOUSE reviewed Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2) Mus musculus (Mouse) GO:0003677; GO:0003887; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006364; GO:0010587; GO:0031123; GO:0031124; GO:0031499; GO:0032211; GO:0033500; GO:0043634; GO:0046872; GO:0051301; GO:0060212; GO:0070034; GO:0070568; GO:0071044; GO:0071051; GO:1905870; GO:1990817 carbohydrate homeostasis [GO:0033500]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA 3'-end processing [GO:0031124]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; polyadenylation-dependent ncRNA catabolic process [GO:0043634]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817]; telomerase RNA binding [GO:0070034] g18246.t1 Q8BHL6 46.341 205 1.24e-58 187.0 sp|Q8BHL6|FAP24_MOUSE Fanconi anemia core complex-associated protein 24 OS=Mus musculus OX=10090 GN=Faap24 PE=2 SV=1 g18247.t1 P30664 68.367 882 0.0 1219.0 sp|P30664|MCM4B_XENLA DNA replication licensing factor mcm4-B OS=Xenopus laevis OX=8355 GN=mcm4-b PE=1 SV=3 g18248.t1 E7FAM5 57.847 771 0.0 885.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18249.t1 P97760 73.091 275 2.1300000000000003e-157 442.0 sp|P97760|RPB3_MOUSE DNA-directed RNA polymerase II subunit RPB3 OS=Mus musculus OX=10090 GN=Polr2c PE=1 SV=2 g18250.t1 Q9CSU0 47.696 369 6.829999999999999e-104 311.0 sp|Q9CSU0|RPR1B_MOUSE Regulation of nuclear pre-mRNA domain-containing protein 1B OS=Mus musculus OX=10090 GN=Rprd1b PE=1 SV=2 RPR1B_MOUSE reviewed Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor) Mus musculus (Mouse) GO:0000993; GO:0001111; GO:0005634; GO:0005654; GO:0008284; GO:0010564; GO:0031124; GO:0042802; GO:0045944; GO:0097550; GO:0099122 mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; RNA polymerase II promoter clearance [GO:0001111] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription preinitiation complex [GO:0097550] identical protein binding [GO:0042802]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993] g18251.t1 Q3ZBD7 70.344 553 0.0 825.0 sp|Q3ZBD7|G6PI_BOVIN Glucose-6-phosphate isomerase OS=Bos taurus OX=9913 GN=GPI PE=2 SV=4 G6PI_BOVIN reviewed Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (D-hexose-6-phosphate anomerase) (Glucose-6-phosphate C2-epimerase) (EC 5.1.3.-) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) Bos taurus (Bovine) GO:0004347; GO:0005125; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0016857; GO:0048029; GO:0051156; GO:0097367 gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096] cytosol [GO:0005829]; extracellular space [GO:0005615] carbohydrate derivative binding [GO:0097367]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; monosaccharide binding [GO:0048029]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857] g18252.t1 Q5PPM8 54.091 220 6.65e-76 235.0 sp|Q5PPM8|PP4P1_RAT Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Rattus norvegicus OX=10116 GN=Pip4p1 PE=1 SV=1 PP4P1_RAT reviewed Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B) Rattus norvegicus (Rat) GO:0005765; GO:0005886; GO:0006991; GO:0008203; GO:0030670; GO:0031902; GO:0032418; GO:0034597; GO:0046856; GO:0070070; GO:1904263 cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; response to sterol depletion [GO:0006991] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597] g18253.t1 Q9VSL3 39.655 232 3.1699999999999997e-46 157.0 sp|Q9VSL3|SEPIA_DROME Pyrimidodiazepine synthase OS=Drosophila melanogaster OX=7227 GN=se PE=1 SV=1 SEPIA_DROME reviewed Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia) Drosophila melanogaster (Fruit fly) GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0042803; GO:0045174 eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; pteridine biosynthetic process [GO:0006728] cytoplasm [GO:0005737] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734] g18254.t1 Q9VSL3 46.154 195 3.66e-49 162.0 sp|Q9VSL3|SEPIA_DROME Pyrimidodiazepine synthase OS=Drosophila melanogaster OX=7227 GN=se PE=1 SV=1 SEPIA_DROME reviewed Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia) Drosophila melanogaster (Fruit fly) GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0042803; GO:0045174 eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; pteridine biosynthetic process [GO:0006728] cytoplasm [GO:0005737] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734] g18255.t1 Q16822 66.503 612 0.0 874.0 sp|Q16822|PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Homo sapiens OX=9606 GN=PCK2 PE=1 SV=4 g18256.t1 P05153 58.007 612 0.0 720.0 sp|P05153|PCKGC_CHICK Phosphoenolpyruvate carboxykinase, cytosolic [GTP] OS=Gallus gallus OX=9031 GN=PCK1 PE=2 SV=1 g18257.t1 Q1LXS2 43.382 272 1.1900000000000001e-80 246.0 sp|Q1LXS2|PSMG2_DANRE Proteasome assembly chaperone 2 OS=Danio rerio OX=7955 GN=psmg2 PE=2 SV=1 g18258.t1 Q8BFR6 50.207 241 2.78e-75 233.0 sp|Q8BFR6|ZFAN1_MOUSE AN1-type zinc finger protein 1 OS=Mus musculus OX=10090 GN=Zfand1 PE=1 SV=1 g18259.t1 Q08462 43.027 337 2.3399999999999997e-81 274.0 sp|Q08462|ADCY2_HUMAN Adenylate cyclase type 2 OS=Homo sapiens OX=9606 GN=ADCY2 PE=1 SV=5 ADCY2_HUMAN reviewed Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) Homo sapiens (Human) GO:0000287; GO:0003091; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0030145; GO:0030425; GO:0035556; GO:0045121; GO:0071377; GO:0097700; GO:1904322 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; intracellular signal transduction [GO:0035556]; renal water homeostasis [GO:0003091]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g18260.t1 Q80TL1 47.383 745 0.0 686.0 sp|Q80TL1|ADCY2_MOUSE Adenylate cyclase type 2 OS=Mus musculus OX=10090 GN=Adcy2 PE=1 SV=2 ADCY2_MOUSE reviewed Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) Mus musculus (Mouse) GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0030145; GO:0030425; GO:0031683; GO:0032991; GO:0035556; GO:0045121; GO:1904322 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; G-protein beta/gamma-subunit complex binding [GO:0031683]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g18260.t2 Q80TL1 46.763 695 0.0 635.0 sp|Q80TL1|ADCY2_MOUSE Adenylate cyclase type 2 OS=Mus musculus OX=10090 GN=Adcy2 PE=1 SV=2 ADCY2_MOUSE reviewed Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) Mus musculus (Mouse) GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0030145; GO:0030425; GO:0031683; GO:0032991; GO:0035556; GO:0045121; GO:1904322 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; G-protein beta/gamma-subunit complex binding [GO:0031683]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g18260.t2 Q80TL1 59.0 100 1.06e-24 114.0 sp|Q80TL1|ADCY2_MOUSE Adenylate cyclase type 2 OS=Mus musculus OX=10090 GN=Adcy2 PE=1 SV=2 ADCY2_MOUSE reviewed Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) Mus musculus (Mouse) GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0030145; GO:0030425; GO:0031683; GO:0032991; GO:0035556; GO:0045121; GO:1904322 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; G-protein beta/gamma-subunit complex binding [GO:0031683]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g18261.t1 Q9CR08 42.857 196 1.8e-52 172.0 sp|Q9CR08|RPP29_MOUSE Ribonuclease P protein subunit p29 OS=Mus musculus OX=10090 GN=Pop4 PE=2 SV=1 g18262.t1 F1R8P4 40.509 432 4.36e-101 315.0 sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2 GLRA2_DANRE reviewed Glycine receptor subunit alpha-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004888; GO:0005231; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872; GO:1902476 chloride transmembrane transport [GO:1902476] cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211] chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824] g18265.t1 Q6NRC9 41.92 1052 0.0 736.0 sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1 g18265.t2 Q6NRC9 40.778 1079 0.0 727.0 sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1 g3880.t1 O75899 29.88 753 1.31e-89 307.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g3881.t1 A8MV24 47.482 139 8.54e-34 127.0 sp|A8MV24|SPMA1_HUMAN Sperm microtubule associated protein 1 OS=Homo sapiens OX=9606 GN=SPMAP1 PE=1 SV=1 g3882.t1 Q98879 42.222 225 2.31e-38 140.0 sp|Q98879|DLX4A_DANRE Homeobox protein Dlx4a OS=Danio rerio OX=7955 GN=dlx4a PE=2 SV=1 g3883.t1 Q04896 50.0 230 3.67e-63 200.0 sp|Q04896|HME1A_DANRE Homeobox protein engrailed-1a OS=Danio rerio OX=7955 GN=eng1a PE=2 SV=1 g3884.t1 Q9N126 36.395 294 9.7e-49 167.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g3885.t1 Q63008 30.161 620 1.3300000000000002e-88 290.0 sp|Q63008|SC5A5_RAT Sodium/iodide cotransporter OS=Rattus norvegicus OX=10116 GN=Slc5a5 PE=1 SV=1 SC5A5_RAT reviewed Sodium/iodide cotransporter (Na(+)/I(-) cotransporter) (Sodium-iodide symporter) (Na(+)/I(-) symporter) (Solute carrier family 5 member 5) Rattus norvegicus (Rat) GO:0005634; GO:0005737; GO:0005886; GO:0006590; GO:0006814; GO:0008507; GO:0015111; GO:0015293; GO:0015373; GO:0015705; GO:0042803; GO:0046872; GO:0071320; GO:0071371; GO:1904200; GO:1904322; GO:1904401 cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to Thyroid stimulating hormone [GO:1904401]; iodide transmembrane transport [GO:1904200]; iodide transport [GO:0015705]; sodium ion transport [GO:0006814]; thyroid hormone generation [GO:0006590] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] iodide transmembrane transporter activity [GO:0015111]; metal ion binding [GO:0046872]; monoatomic anion:sodium symporter activity [GO:0015373]; protein homodimerization activity [GO:0042803]; sodium:iodide symporter activity [GO:0008507]; symporter activity [GO:0015293] g3886.t1 Q3ZMH1 32.68 612 1.01e-108 342.0 sp|Q3ZMH1|SC5A8_DANRE Sodium-coupled monocarboxylate transporter 1 OS=Danio rerio OX=7955 GN=slc5a8 PE=1 SV=1 SC5A8_DANRE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0015355; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0140161; GO:2001142 acetate transport [GO:0006846]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324] monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355] g3888.t1 Q80T79 34.903 361 7.71e-41 167.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g3888.t1 Q80T79 35.799 338 4.88e-39 161.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g3888.t1 Q80T79 33.333 342 6.79e-39 161.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g3888.t1 Q80T79 31.594 345 4.29e-36 152.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g3888.t1 Q80T79 30.952 378 4.96e-34 145.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g3888.t1 Q80T79 30.623 369 7.5599999999999995e-28 125.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g3889.t1 Q07929 35.0 260 3.91e-32 135.0 sp|Q07929|SP63_STRPU 63 kDa sperm flagellar membrane protein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3889.t2 Q07929 34.884 258 2.61e-32 136.0 sp|Q07929|SP63_STRPU 63 kDa sperm flagellar membrane protein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3889.t3 Q07929 35.156 256 2.68e-32 135.0 sp|Q07929|SP63_STRPU 63 kDa sperm flagellar membrane protein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g3890.t1 Q13416 42.787 610 2.07e-149 445.0 sp|Q13416|ORC2_HUMAN Origin recognition complex subunit 2 OS=Homo sapiens OX=9606 GN=ORC2 PE=1 SV=2 ORC2_HUMAN reviewed Origin recognition complex subunit 2 Homo sapiens (Human) GO:0000122; GO:0000781; GO:0000792; GO:0000808; GO:0000939; GO:0003688; GO:0005634; GO:0005654; GO:0005664; GO:0005813; GO:0006270; GO:0016020 DNA replication initiation [GO:0006270]; negative regulation of transcription by RNA polymerase II [GO:0000122] centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; inner kinetochore [GO:0000939]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808] DNA replication origin binding [GO:0003688] g3891.t1 Q6DJ13 39.096 376 1.02e-61 203.0 sp|Q6DJ13|ZN830_XENTR Zinc finger protein 830 OS=Xenopus tropicalis OX=8364 GN=znf830 PE=2 SV=1 g3892.t1 Q96EN8 40.745 967 0.0 670.0 sp|Q96EN8|MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens OX=9606 GN=MOCOS PE=1 SV=2 MOCOS_HUMAN reviewed Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (hMCS) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase) Homo sapiens (Human) GO:0005829; GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0032324; GO:0043545 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545] cytosol [GO:0005829] lyase activity [GO:0016829]; molybdenum cofactor sulfurtransferase activity [GO:0008265]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170] g3893.t1 A2A5I3 36.041 197 1.03e-33 123.0 sp|A2A5I3|CRSPL_MOUSE Peptidase inhibitor R3HDML OS=Mus musculus OX=10090 GN=R3hdml PE=3 SV=1 g3894.t1 Q8BYF6 45.205 146 4.2600000000000003e-35 133.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g3895.t1 Q8BYF6 33.333 558 2.25e-90 295.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g3897.t1 P57721 61.35 326 8.69e-127 374.0 sp|P57721|PCBP3_HUMAN Poly(rC)-binding protein 3 OS=Homo sapiens OX=9606 GN=PCBP3 PE=1 SV=2 PCBP3_HUMAN reviewed Poly(rC)-binding protein 3 (Alpha-CP3) (PCBP3-overlapping transcript) (PCBP3-overlapping transcript 1) Homo sapiens (Human) GO:0000122; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0016071; GO:0039694; GO:0070062; GO:1990829; GO:1990904 mRNA metabolic process [GO:0016071]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; viral RNA genome replication [GO:0039694] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] C-rich single-stranded DNA binding [GO:1990829]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g3899.t1 Q80T91 39.429 175 1.25e-26 117.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 MEG11_MOUSE reviewed Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11) Mus musculus (Mouse) GO:0005044; GO:0010842; GO:0016323; GO:0034109 homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842] basolateral plasma membrane [GO:0016323] scavenger receptor activity [GO:0005044] g3899.t1 Q80T91 36.453 203 2.23e-24 110.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 MEG11_MOUSE reviewed Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11) Mus musculus (Mouse) GO:0005044; GO:0010842; GO:0016323; GO:0034109 homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842] basolateral plasma membrane [GO:0016323] scavenger receptor activity [GO:0005044] g3899.t1 Q80T91 37.853 177 5.5200000000000005e-22 102.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 MEG11_MOUSE reviewed Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11) Mus musculus (Mouse) GO:0005044; GO:0010842; GO:0016323; GO:0034109 homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842] basolateral plasma membrane [GO:0016323] scavenger receptor activity [GO:0005044] g3899.t1 Q80T91 36.364 198 4.03e-21 100.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 MEG11_MOUSE reviewed Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11) Mus musculus (Mouse) GO:0005044; GO:0010842; GO:0016323; GO:0034109 homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842] basolateral plasma membrane [GO:0016323] scavenger receptor activity [GO:0005044] g3901.t1 Q80V70 39.695 262 7.17e-47 181.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 36.68 259 1.8199999999999999e-40 161.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 35.581 267 1.14e-38 156.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 36.63 273 6.46e-38 154.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 39.394 264 1.4e-35 146.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 32.903 310 2.46e-35 146.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 36.68 259 6.2e-35 144.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 36.397 272 9.68e-34 141.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3901.t1 Q80V70 37.302 252 6.47e-30 129.0 sp|Q80V70|MEGF6_MOUSE Multiple epidermal growth factor-like domains protein 6 OS=Mus musculus OX=10090 GN=Megf6 PE=2 SV=3 g3904.t1 A4IGM4 43.885 278 8.560000000000001e-72 226.0 sp|A4IGM4|DHI1L_XENTR Hydroxysteroid 11-beta-dehydrogenase 1-like protein OS=Xenopus tropicalis OX=8364 GN=hsd11b1l PE=2 SV=1 g3906.t1 Q8C1A3 47.318 727 0.0 626.0 sp|Q8C1A3|MTRR_MOUSE Methionine synthase reductase OS=Mus musculus OX=10090 GN=Mtrr PE=1 SV=2 MTRR_MOUSE reviewed Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase) Mus musculus (Mouse) GO:0003958; GO:0005654; GO:0005829; GO:0009086; GO:0009235; GO:0010181; GO:0016723; GO:0030586; GO:0033353; GO:0043418; GO:0045111; GO:0046655; GO:0050660; GO:0050667; GO:0050821; GO:0070402; GO:0071949; GO:0140104 cobalamin metabolic process [GO:0009235]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; protein stabilization [GO:0050821]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654] [methionine synthase] reductase (NADPH) activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; molecular carrier activity [GO:0140104]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723] g3907.t1 Q4G012 56.989 93 3.83e-25 94.0 sp|Q4G012|FMC1_RAT Protein FMC1 homolog OS=Rattus norvegicus OX=10116 GN=Fmc1 PE=3 SV=1 g3908.t1 Q61458 47.249 309 1.55e-94 286.0 sp|Q61458|CCNH_MOUSE Cyclin-H OS=Mus musculus OX=10090 GN=Ccnh PE=1 SV=2 g3909.t1 Q9K7A0 26.95 423 1.2799999999999999e-23 107.0 sp|Q9K7A0|CSD_HALH5 Probable cysteine desulfurase OS=Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) OX=272558 GN=csd PE=3 SV=2 g3910.t1 Q8CBH5 37.156 654 2.82e-138 427.0 sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1 g3912.t1 P07207 39.556 225 1.57e-38 157.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 32.011 353 1.1400000000000001e-33 142.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 38.743 191 5.58e-30 130.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 32.51 243 1.03e-28 126.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 33.203 256 4.270000000000001e-27 121.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 34.286 245 4.6200000000000004e-27 121.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 33.6 250 3.88e-26 118.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 34.156 243 8.240000000000001e-26 117.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 35.644 202 1.59e-25 116.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 32.422 256 1.88e-22 107.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 33.333 213 8.11e-22 104.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3912.t1 P07207 32.87 216 1.97e-21 103.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g3914.t1 Q9D0I6 45.859 495 2.9299999999999996e-141 417.0 sp|Q9D0I6|WSDU1_MOUSE WD repeat, SAM and U-box domain-containing protein 1 OS=Mus musculus OX=10090 GN=Wdsub1 PE=2 SV=1 g3915.t1 O57478 77.241 145 4.19e-80 247.0 sp|O57478|HEMH_XENLA Ferrochelatase, mitochondrial OS=Xenopus laevis OX=8355 GN=fech PE=1 SV=1 g3916.t1 O57478 70.098 204 8.59e-107 315.0 sp|O57478|HEMH_XENLA Ferrochelatase, mitochondrial OS=Xenopus laevis OX=8355 GN=fech PE=1 SV=1 g3917.t1 Q9VCA2 42.993 421 5.19e-105 329.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3917.t2 Q9VCA2 42.518 421 9.18e-106 331.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3919.t1 Q9NPH0 36.785 367 5.8e-69 227.0 sp|Q9NPH0|PPA6_HUMAN Lysophosphatidic acid phosphatase type 6 OS=Homo sapiens OX=9606 GN=ACP6 PE=1 SV=3 PPA6_HUMAN reviewed Lysophosphatidic acid phosphatase type 6 (EC 3.1.3.2) (Acid phosphatase 6, lysophosphatidic) (Acid phosphatase-like protein 1) (PACPL1) Homo sapiens (Human) GO:0002244; GO:0003993; GO:0005737; GO:0005739; GO:0005759; GO:0006644; GO:0006654; GO:0052642; GO:2001311 hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642] g3921.t1 Q90610 37.056 788 2.66e-141 468.0 sp|Q90610|NEO1_CHICK Neogenin (Fragment) OS=Gallus gallus OX=9031 PE=2 SV=1 g3921.t2 P97603 36.724 757 1.07e-137 457.0 sp|P97603|NEO1_RAT Neogenin (Fragment) OS=Rattus norvegicus OX=10116 GN=Neo1 PE=1 SV=1 NEO1_RAT reviewed Neogenin Rattus norvegicus (Rat) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g3921.t2 P97603 30.309 518 2.75e-28 127.0 sp|P97603|NEO1_RAT Neogenin (Fragment) OS=Rattus norvegicus OX=10116 GN=Neo1 PE=1 SV=1 NEO1_RAT reviewed Neogenin Rattus norvegicus (Rat) GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007411; GO:0007520; GO:0009986; GO:0016020; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0043025; GO:0045296; GO:0048679; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550 axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550] cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839] BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023] g3921.t3 Q90610 37.056 788 6.59e-141 469.0 sp|Q90610|NEO1_CHICK Neogenin (Fragment) OS=Gallus gallus OX=9031 PE=2 SV=1 g3921.t4 Q90610 32.55 553 2.46e-70 262.0 sp|Q90610|NEO1_CHICK Neogenin (Fragment) OS=Gallus gallus OX=9031 PE=2 SV=1 g3921.t4 Q90610 31.134 591 1.26e-65 248.0 sp|Q90610|NEO1_CHICK Neogenin (Fragment) OS=Gallus gallus OX=9031 PE=2 SV=1 g3926.t1 Q7Z4L5 63.057 785 0.0 1041.0 sp|Q7Z4L5|TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens OX=9606 GN=TTC21B PE=1 SV=2 TT21B_HUMAN reviewed Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog) Homo sapiens (Human) GO:0003682; GO:0005929; GO:0005930; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799 Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] chromatin binding [GO:0003682] g3927.t1 Q7Z4L5 49.797 492 4.32e-177 535.0 sp|Q7Z4L5|TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens OX=9606 GN=TTC21B PE=1 SV=2 TT21B_HUMAN reviewed Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog) Homo sapiens (Human) GO:0003682; GO:0005929; GO:0005930; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799 Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] chromatin binding [GO:0003682] g3928.t1 Q2EY13 28.797 1014 1.74e-92 324.0 sp|Q2EY13|PRTGB_DANRE Protogenin B (Fragment) OS=Danio rerio OX=7955 GN=prtgb PE=2 SV=1 g3929.t1 Q5R4M2 60.428 187 1.1e-71 239.0 sp|Q5R4M2|ULK4_PONAB Serine/threonine-protein kinase ULK4 OS=Pongo abelii OX=9601 GN=ULK4 PE=2 SV=1 g3930.t1 Q3V129 41.039 943 0.0 676.0 sp|Q3V129|ULK4_MOUSE Serine/threonine-protein kinase ULK4 OS=Mus musculus OX=10090 GN=Ulk4 PE=1 SV=2 ULK4_MOUSE reviewed Serine/threonine-protein kinase ULK4 (EC 2.7.11.1) (Unc-51-like kinase 4) Mus musculus (Mouse) GO:0000226; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005929; GO:0007224; GO:0007420; GO:0007600; GO:0007611; GO:0007613; GO:0007628; GO:0009966; GO:0010467; GO:0010975; GO:0021591; GO:0021819; GO:0021859; GO:0021987; GO:0022008; GO:0022010; GO:0022038; GO:0030534; GO:0032053; GO:0035082; GO:0035176; GO:0036445; GO:0042313; GO:0043254; GO:0043408; GO:0043491; GO:0044458; GO:0046328; GO:0050890; GO:0060996; GO:0090660; GO:0097154; GO:0106310; GO:0150076; GO:1900744; GO:2001222 adult behavior [GO:0030534]; adult walking behavior [GO:0007628]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; central nervous system myelination [GO:0022010]; cerebral cortex development [GO:0021987]; cerebrospinal fluid circulation [GO:0090660]; ciliary basal body organization [GO:0032053]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; GABAergic neuron differentiation [GO:0097154]; gene expression [GO:0010467]; layer formation in cerebral cortex [GO:0021819]; learning or memory [GO:0007611]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; motile cilium assembly [GO:0044458]; neurogenesis [GO:0022008]; neuroinflammatory response [GO:0150076]; neuronal stem cell division [GO:0036445]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein kinase C deactivation [GO:0042313]; pyramidal neuron differentiation [GO:0021859]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966]; sensory perception [GO:0007600]; smoothened signaling pathway [GO:0007224]; social behavior [GO:0035176]; ventricular system development [GO:0021591] cilium [GO:0005929]; extracellular region [GO:0005576] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3931.t1 Q96C45 39.333 150 6.79e-24 100.0 sp|Q96C45|ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens OX=9606 GN=ULK4 PE=1 SV=2 ULK4_HUMAN reviewed Serine/threonine-protein kinase ULK4 (EC 2.7.11.1) (Unc-51-like kinase 4) Homo sapiens (Human) GO:0000226; GO:0004674; GO:0005524; GO:0010975; GO:0042313; GO:0043408; GO:0046328; GO:0106310; GO:1900744; GO:2001222 microtubule cytoskeleton organization [GO:0000226]; protein kinase C deactivation [GO:0042313]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of p38MAPK cascade [GO:1900744] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3933.t1 Q5ZL42 52.871 418 8.180000000000001e-156 449.0 sp|Q5ZL42|5MP1_CHICK eIF5-mimic protein 1 OS=Gallus gallus OX=9031 GN=BZW2 PE=2 SV=1 g3937.t1 Q63699 76.471 289 1.31e-171 479.0 sp|Q63699|CDK2_RAT Cyclin-dependent kinase 2 OS=Rattus norvegicus OX=10116 GN=Cdk2 PE=1 SV=1 CDK2_RAT reviewed Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) Rattus norvegicus (Rat) GO:0000082; GO:0000122; GO:0000287; GO:0000307; GO:0000723; GO:0000781; GO:0000793; GO:0000805; GO:0000806; GO:0001673; GO:0001741; GO:0002088; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005737; GO:0005768; GO:0005813; GO:0006281; GO:0006338; GO:0006813; GO:0006974; GO:0007099; GO:0007165; GO:0007265; GO:0008284; GO:0009410; GO:0009636; GO:0010389; GO:0010468; GO:0015030; GO:0016301; GO:0019904; GO:0030332; GO:0031453; GO:0031848; GO:0032298; GO:0032355; GO:0032869; GO:0042177; GO:0043247; GO:0043687; GO:0044877; GO:0045471; GO:0045893; GO:0046686; GO:0051301; GO:0051321; GO:0051591; GO:0051602; GO:0097123; GO:0097124; GO:0097134; GO:0097135; GO:0097421; GO:0097472; GO:0106310; GO:1904146; GO:1904860 cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; centriole replication [GO:0007099]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA synthesis involved in mitotic DNA replication [GO:1904860]; G1/S transition of mitotic cell cycle [GO:0000082]; lens development in camera-type eye [GO:0002088]; liver regeneration [GO:0097421]; meiotic cell cycle [GO:0051321]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated DNA replication initiation [GO:0032298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; post-translational protein modification [GO:0043687]; potassium ion transport [GO:0006813]; protection from non-homologous end joining at telomere [GO:0031848]; Ras protein signal transduction [GO:0007265]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to cAMP [GO:0051591]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247] Cajal body [GO:0015030]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; endosome [GO:0005768]; male germ cell nucleus [GO:0001673]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g3938.t1 Q8R344 57.895 152 3.82e-49 159.0 sp|Q8R344|CCD12_MOUSE Coiled-coil domain-containing protein 12 OS=Mus musculus OX=10090 GN=Ccdc12 PE=1 SV=2 g3939.t1 Q95JR6 29.814 483 5.17e-65 231.0 sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1 g3941.t1 Q80WP8 53.719 484 0.0 552.0 sp|Q80WP8|GADL1_MOUSE Acidic amino acid decarboxylase GADL1 OS=Mus musculus OX=10090 GN=Gadl1 PE=1 SV=3 GADL1_MOUSE reviewed Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1) Mus musculus (Mouse) GO:0004068; GO:0004782; GO:0005737; GO:0016831; GO:0019752; GO:0030170 carboxylic acid metabolic process [GO:0019752] cytoplasm [GO:0005737] aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782] g3941.t2 Q80WP8 54.316 475 0.0 559.0 sp|Q80WP8|GADL1_MOUSE Acidic amino acid decarboxylase GADL1 OS=Mus musculus OX=10090 GN=Gadl1 PE=1 SV=3 GADL1_MOUSE reviewed Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1) Mus musculus (Mouse) GO:0004068; GO:0004782; GO:0005737; GO:0016831; GO:0019752; GO:0030170 carboxylic acid metabolic process [GO:0019752] cytoplasm [GO:0005737] aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782] g3942.t1 P34275 47.34 188 3.57e-52 174.0 sp|P34275|IVD_CAEEL Probable acyl-CoA dehydrogenase 6 OS=Caenorhabditis elegans OX=6239 GN=acdh-6 PE=3 SV=2 g3943.t1 P34275 54.717 106 1.2300000000000001e-37 136.0 sp|P34275|IVD_CAEEL Probable acyl-CoA dehydrogenase 6 OS=Caenorhabditis elegans OX=6239 GN=acdh-6 PE=3 SV=2 g3944.t1 Q32KP1 30.729 192 9.869999999999999e-23 93.6 sp|Q32KP1|TSN31_BOVIN Tetraspanin-31 OS=Bos taurus OX=9913 GN=TSPAN31 PE=2 SV=1 g3945.t1 Q7ZUB3 52.778 216 3e-72 221.0 sp|Q7ZUB3|TSN31_DANRE Tetraspanin-31 OS=Danio rerio OX=7955 GN=tspan31 PE=2 SV=2 g3945.t2 Q7ZUB3 55.093 216 6.12e-76 230.0 sp|Q7ZUB3|TSN31_DANRE Tetraspanin-31 OS=Danio rerio OX=7955 GN=tspan31 PE=2 SV=2 g3946.t1 Q8BS35 46.485 441 2.73e-144 422.0 sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1 g3947.t1 Q1L8G7 48.148 243 2.8500000000000005e-73 226.0 sp|Q1L8G7|GATD1_DANRE GATA zinc finger domain-containing protein 1 OS=Danio rerio OX=7955 GN=gatad1 PE=2 SV=1 g3948.t1 Q6P316 54.896 337 3.88e-135 392.0 sp|Q6P316|S2540_XENTR Mitochondrial glutathione transporter SLC25A40 OS=Xenopus tropicalis OX=8364 GN=slc25a40 PE=2 SV=1 g3949.t1 Q6DHC3 42.286 350 8.45e-86 270.0 sp|Q6DHC3|S2540_DANRE Mitochondrial glutathione transporter SLC25A40 OS=Danio rerio OX=7955 GN=slc25a40 PE=2 SV=1 g3950.t1 Q0V9S3 32.544 169 1.55e-25 109.0 sp|Q0V9S3|CTIF_XENTR CBP80/20-dependent translation initiation factor OS=Xenopus tropicalis OX=8364 GN=ctif PE=2 SV=1 g3951.t1 Q2KHY7 36.557 424 2.26e-71 237.0 sp|Q2KHY7|TTC23_BOVIN Tetratricopeptide repeat protein 23 OS=Bos taurus OX=9913 GN=TTC23 PE=2 SV=1 g3953.t1 P83111 47.708 480 2.3e-143 428.0 sp|P83111|LACTB_HUMAN Serine beta-lactamase-like protein LACTB, mitochondrial OS=Homo sapiens OX=9606 GN=LACTB PE=1 SV=2 LACTB_HUMAN reviewed Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-) Homo sapiens (Human) GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802 lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216] cytosol [GO:0005829]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; peptidase activity [GO:0008233] g3954.t1 Q969G6 64.138 145 5.95e-70 210.0 sp|Q969G6|RIFK_HUMAN Riboflavin kinase OS=Homo sapiens OX=9606 GN=RFK PE=1 SV=2 RIFK_HUMAN reviewed Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase) Homo sapiens (Human) GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072388; GO:0072593 apoptotic process [GO:0006915]; flavin adenine dinucleotide biosynthetic process [GO:0072388]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531] g3955.t1 Q9BYD2 43.814 194 5.94e-41 144.0 sp|Q9BYD2|RM09_HUMAN Large ribosomal subunit protein bL9m OS=Homo sapiens OX=9606 GN=MRPL9 PE=1 SV=2 g3956.t1 Q5E9V6 62.312 199 3.6799999999999997e-91 268.0 sp|Q5E9V6|COMD4_BOVIN COMM domain-containing protein 4 OS=Bos taurus OX=9913 GN=COMMD4 PE=2 SV=2 g3957.t1 P34897 63.052 498 0.0 657.0 sp|P34897|GLYM_HUMAN Serine hydroxymethyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=SHMT2 PE=1 SV=3 GLYM_HUMAN reviewed Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) Homo sapiens (Human) GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006231; GO:0006544; GO:0006563; GO:0006564; GO:0006730; GO:0008284; GO:0008732; GO:0015630; GO:0015943; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0046653; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0120567; GO:1903715 dTMP biosynthetic process [GO:0006231]; formate biosynthetic process [GO:0015943]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; hydroxytrimethyllysine aldolase activity [GO:0120567]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170] g3958.t1 Q99K85 59.89 364 4.4500000000000003e-169 479.0 sp|Q99K85|SERC_MOUSE Phosphoserine aminotransferase OS=Mus musculus OX=10090 GN=Psat1 PE=1 SV=1 g3959.t1 Q28C98 65.517 174 5.58e-79 236.0 sp|Q28C98|MESH1_XENTR Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 OS=Xenopus tropicalis OX=8364 GN=hddc3 PE=2 SV=1 MESH1_XENTR reviewed Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0008893; GO:0046872 guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872] g3960.t1 Q92828 44.792 480 5.45e-143 431.0 sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2 g3960.t2 Q92828 44.792 480 5.01e-143 431.0 sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2 g3960.t3 Q92828 44.792 480 5.82e-143 431.0 sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2 g3961.t1 Q8HY67 64.744 156 3.77e-53 177.0 sp|Q8HY67|AN32A_CANLF Acidic leucine-rich nuclear phosphoprotein 32 family member A OS=Canis lupus familiaris OX=9615 GN=ANP32A PE=2 SV=1 g3962.t1 Q7Z449 37.5 496 3.37e-112 346.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g3963.t1 O60678 52.562 527 0.0 536.0 sp|O60678|ANM3_HUMAN Protein arginine N-methyltransferase 3 OS=Homo sapiens OX=9606 GN=PRMT3 PE=1 SV=4 ANM3_HUMAN reviewed Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0008168; GO:0008270; GO:0016274; GO:0031397; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0044020; GO:0045669; GO:0045815; GO:1900053 chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; zinc ion binding [GO:0008270] g3964.t1 P18395 47.139 804 0.0 714.0 sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1 g3965.t1 Q28BM0 50.578 692 0.0 675.0 sp|Q28BM0|DYM_XENTR Dymeclin OS=Xenopus tropicalis OX=8364 GN=dym PE=2 SV=1 g3967.t1 Q9W734 51.289 349 3.83e-114 342.0 sp|Q9W734|SMAD6_CHICK Mothers against decapentaplegic homolog 6 OS=Gallus gallus OX=9031 GN=SMAD6 PE=2 SV=1 SMAD6_CHICK reviewed SMAD family member 6 (SMAD 6) (Mothers against decapentaplegic homolog 6) (MAD homolog 6) (Mothers against DPP homolog 6) Gallus gallus (Chicken) GO:0000976; GO:0003682; GO:0005634; GO:0005768; GO:0006357; GO:0009653; GO:0010693; GO:0030154; GO:0030509; GO:0030514; GO:0031589; GO:0032331; GO:0046872; GO:0050767; GO:0060395; GO:0070411; GO:0071144; GO:0090090; GO:0140416; GO:1902832 anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in dorsal spinal cord [GO:1902832]; negative regulation of chondrocyte differentiation [GO:0032331]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395] endosome [GO:0005768]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634] chromatin binding [GO:0003682]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416] g3968.t1 Q90YG6 73.585 106 1.44e-53 166.0 sp|Q90YG6|T2AG_ONCMY Transcription initiation factor IIA subunit 2 OS=Oncorhynchus mykiss OX=8022 GN=gtf2a2 PE=3 SV=1 g3970.t1 O70436 72.163 467 0.0 676.0 sp|O70436|SMAD2_RAT Mothers against decapentaplegic homolog 2 OS=Rattus norvegicus OX=10116 GN=Smad2 PE=1 SV=1 SMAD2_RAT reviewed SMAD family member 2 (SMAD 2) (Mad-related protein 2) (Mothers against decapentaplegic homolog 2) (MAD homolog 2) (Mothers against DPP homolog 2) Rattus norvegicus (Rat) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003140; GO:0003180; GO:0003184; GO:0003203; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0007179; GO:0007352; GO:0007369; GO:0007389; GO:0007492; GO:0007507; GO:0008283; GO:0008285; GO:0009653; GO:0009749; GO:0009791; GO:0009880; GO:0009952; GO:0010628; GO:0010629; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030154; GO:0030279; GO:0030324; GO:0030325; GO:0030513; GO:0031016; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042802; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048156; GO:0048340; GO:0048589; GO:0048617; GO:0048701; GO:0060039; GO:0060395; GO:0061450; GO:0061629; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0071141; GO:0071142; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071895; GO:0097718; GO:0140297 activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endocardial cushion morphogenesis [GO:0003203]; endoderm development [GO:0007492]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of ossification [GO:0030279]; nodal signaling pathway [GO:0038092]; odontoblast differentiation [GO:0071895]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pattern specification process [GO:0007389]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pulmonary valve morphogenesis [GO:0003184]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; response to transforming growth factor beta [GO:0071559]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ureteric bud development [GO:0001657]; zygotic specification of dorsal/ventral axis [GO:0007352] activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625] g3970.t2 P84023 76.581 427 0.0 682.0 sp|P84023|SMAD3_CHICK Mothers against decapentaplegic homolog 3 OS=Gallus gallus OX=9031 GN=SMAD3 PE=2 SV=1 g3971.t1 Q9I9P9 70.588 255 9.32e-127 370.0 sp|Q9I9P9|SMAD2_DANRE Mothers against decapentaplegic homolog 2 OS=Danio rerio OX=7955 GN=smad2 PE=2 SV=1 SMAD2_DANRE reviewed SMAD family member 2 (SMAD 2) (Mothers against decapentaplegic homolog 2) (MAD homolog 2) (Mothers against DPP homolog 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007179; GO:0009653; GO:0009880; GO:0021999; GO:0030154; GO:0032924; GO:0035556; GO:0043565; GO:0045944; GO:0046872; GO:0060028; GO:0060282; GO:0060395; GO:0070411; GO:0071144 activin receptor signaling pathway [GO:0032924]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; convergent extension involved in axis elongation [GO:0060028]; embryonic pattern specification [GO:0009880]; intracellular signal transduction [GO:0035556]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate anterior/posterior regionalization [GO:0021999]; positive regulation of oocyte development [GO:0060282]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] chromatin [GO:0000785]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g3972.t1 D3Z902 32.02 406 1.13e-65 227.0 sp|D3Z902|FBXW7_RAT F-box/WD repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxw7 PE=1 SV=2 FBXW7_RAT reviewed F-box/WD repeat-containing protein 7 Rattus norvegicus (Rat) GO:0000082; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0007346; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032435; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0045944; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570] chromosome [GO:0005694]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g3972.t1 D3Z902 31.034 261 1.29e-32 134.0 sp|D3Z902|FBXW7_RAT F-box/WD repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxw7 PE=1 SV=2 FBXW7_RAT reviewed F-box/WD repeat-containing protein 7 Rattus norvegicus (Rat) GO:0000082; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0007346; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032435; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0045944; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570] chromosome [GO:0005694]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g3978.t1 P34322 27.055 669 1.49e-70 246.0 sp|P34322|NCX7_CAEEL Putative sodium/calcium exchanger 7 OS=Caenorhabditis elegans OX=6239 GN=ncx-7 PE=3 SV=3 g3979.t1 Q9GKL8 55.689 334 1.44e-124 363.0 sp|Q9GKL8|CATL1_CHLAE Procathepsin L OS=Chlorocebus aethiops OX=9534 GN=CTSL PE=2 SV=1 g3980.t1 Q9GKL8 53.03 330 2.7500000000000003e-123 360.0 sp|Q9GKL8|CATL1_CHLAE Procathepsin L OS=Chlorocebus aethiops OX=9534 GN=CTSL PE=2 SV=1 g3981.t1 Q8N2E2 37.991 229 1.02e-42 174.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g3981.t1 Q8N2E2 44.654 159 2.47e-35 150.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g3982.t1 Q9Z2I6 24.0 700 1.1099999999999999e-41 165.0 sp|Q9Z2I6|SV2C_RAT Synaptic vesicle glycoprotein 2C OS=Rattus norvegicus OX=10116 GN=Sv2c PE=1 SV=1 g3982.t2 Q9Z2I6 23.966 701 1.1599999999999999e-41 165.0 sp|Q9Z2I6|SV2C_RAT Synaptic vesicle glycoprotein 2C OS=Rattus norvegicus OX=10116 GN=Sv2c PE=1 SV=1 g3983.t1 E1BNS0 26.336 262 1.5799999999999998e-23 99.4 sp|E1BNS0|FXL15_BOVIN F-box/LRR-repeat protein 15 OS=Bos taurus OX=9913 GN=FBXL15 PE=3 SV=1 g3984.t1 Q8VEE0 64.732 224 5.179999999999999e-106 308.0 sp|Q8VEE0|RPE_MOUSE Ribulose-phosphate 3-epimerase OS=Mus musculus OX=10090 GN=Rpe PE=1 SV=1 RPE_MOUSE reviewed Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-epimerase) Mus musculus (Mouse) GO:0004750; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0030246; GO:0042802; GO:0042803; GO:0046872; GO:0048029 carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052] cytosol [GO:0005829] carbohydrate binding [GO:0030246]; D-ribulose-phosphate 3-epimerase activity [GO:0004750]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein homodimerization activity [GO:0042803] g3992.t1 Q92058 45.114 481 7.91e-128 389.0 sp|Q92058|PPBT_CHICK Alkaline phosphatase, tissue-nonspecific isozyme OS=Gallus gallus OX=9031 GN=ALPL PE=1 SV=1 g3993.t1 Q9CQW0 65.0 100 4.7e-38 127.0 sp|Q9CQW0|EMC6_MOUSE ER membrane protein complex subunit 6 OS=Mus musculus OX=10090 GN=Emc6 PE=1 SV=1 g3994.t1 Q91660 40.592 1047 4.2300000000000005e-163 532.0 sp|Q91660|GLI3_XENLA Zinc finger protein GLI3 OS=Xenopus laevis OX=8355 GN=gli3 PE=2 SV=1 g3996.t1 Q9NVQ4 67.797 177 1.9499999999999998e-83 246.0 sp|Q9NVQ4|FAIM1_HUMAN Fas apoptotic inhibitory molecule 1 OS=Homo sapiens OX=9606 GN=FAIM PE=1 SV=1 g3997.t1 Q5PQQ9 40.945 127 2.35e-24 107.0 sp|Q5PQQ9|CEP70_RAT Centrosomal protein of 70 kDa OS=Rattus norvegicus OX=10116 GN=Cep70 PE=2 SV=1 g3998.t1 Q9CZV8 64.871 427 0.0 563.0 sp|Q9CZV8|FXL20_MOUSE F-box/LRR-repeat protein 20 OS=Mus musculus OX=10090 GN=Fbxl20 PE=1 SV=3 FXL20_MOUSE reviewed F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like) Mus musculus (Mouse) GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300 behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] g3999.t1 Q8TAQ2 60.823 1021 0.0 1130.0 sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1 SMRC2_HUMAN reviewed SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2) Homo sapiens (Human) GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] histone binding [GO:0042393]; transcription coactivator activity [GO:0003713] g4000.t1 Q13591 39.784 1018 0.0 714.0 sp|Q13591|SEM5A_HUMAN Semaphorin-5A OS=Homo sapiens OX=9606 GN=SEMA5A PE=1 SV=3 SEM5A_HUMAN reviewed Semaphorin-5A (Semaphorin-F) (Sema F) Homo sapiens (Human) GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007411; GO:0007413; GO:0016020; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0071526; GO:0090263; GO:1990256; GO:2000352; GO:2001028 axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256] extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545] g4000.t2 Q13591 39.551 1024 0.0 712.0 sp|Q13591|SEM5A_HUMAN Semaphorin-5A OS=Homo sapiens OX=9606 GN=SEMA5A PE=1 SV=3 SEM5A_HUMAN reviewed Semaphorin-5A (Semaphorin-F) (Sema F) Homo sapiens (Human) GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007411; GO:0007413; GO:0016020; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0071526; GO:0090263; GO:1990256; GO:2000352; GO:2001028 axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256] extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545] g4000.t3 Q13591 39.551 1024 0.0 711.0 sp|Q13591|SEM5A_HUMAN Semaphorin-5A OS=Homo sapiens OX=9606 GN=SEMA5A PE=1 SV=3 SEM5A_HUMAN reviewed Semaphorin-5A (Semaphorin-F) (Sema F) Homo sapiens (Human) GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007411; GO:0007413; GO:0016020; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0071526; GO:0090263; GO:1990256; GO:2000352; GO:2001028 axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256] extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545] g4000.t4 Q13591 39.648 1024 0.0 711.0 sp|Q13591|SEM5A_HUMAN Semaphorin-5A OS=Homo sapiens OX=9606 GN=SEMA5A PE=1 SV=3 SEM5A_HUMAN reviewed Semaphorin-5A (Semaphorin-F) (Sema F) Homo sapiens (Human) GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007411; GO:0007413; GO:0016020; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0071526; GO:0090263; GO:1990256; GO:2000352; GO:2001028 axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256] extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545] g4001.t1 O95045 54.545 264 3.61e-101 301.0 sp|O95045|UPP2_HUMAN Uridine phosphorylase 2 OS=Homo sapiens OX=9606 GN=UPP2 PE=1 SV=1 g4002.t1 O60921 51.786 280 4.24e-107 315.0 sp|O60921|HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens OX=9606 GN=HUS1 PE=1 SV=1 HUS1_HUMAN reviewed Checkpoint protein HUS1 (hHUS1) Homo sapiens (Human) GO:0000077; GO:0000723; GO:0000724; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006289; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479 cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; telomere maintenance [GO:0000723] checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] g4003.t1 Q15032 44.0 450 9.99e-83 298.0 sp|Q15032|R3HD1_HUMAN R3H domain-containing protein 1 OS=Homo sapiens OX=9606 GN=R3HDM1 PE=1 SV=3 g4004.t1 Q8CI43 51.37 146 6.3e-48 157.0 sp|Q8CI43|MYL6B_MOUSE Myosin light chain 6B OS=Mus musculus OX=10090 GN=Myl6b PE=1 SV=1 MYL6B_MOUSE reviewed Myosin light chain 6B (Smooth muscle and nonmuscle myosin light chain alkali 6B) Mus musculus (Mouse) GO:0003774; GO:0005509; GO:0006936; GO:0007519; GO:0008307; GO:0016459; GO:0016460; GO:0016461; GO:0030049 muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519] myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461] calcium ion binding [GO:0005509]; cytoskeletal motor activity [GO:0003774]; structural constituent of muscle [GO:0008307] g4009.t1 P48319 66.733 499 0.0 711.0 sp|P48319|DCE1_PIG Glutamate decarboxylase 1 OS=Sus scrofa OX=9823 GN=GAD1 PE=2 SV=1 g4009.t2 P48319 64.165 533 0.0 716.0 sp|P48319|DCE1_PIG Glutamate decarboxylase 1 OS=Sus scrofa OX=9823 GN=GAD1 PE=2 SV=1 g4010.t1 P18293 36.263 899 0.0 569.0 sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2 ANPRA_MOUSE reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Mus musculus (Mouse) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g4020.t1 A2A6A1 62.238 143 7.85e-51 202.0 sp|A2A6A1|GPTC8_MOUSE G patch domain-containing protein 8 OS=Mus musculus OX=10090 GN=Gpatch8 PE=1 SV=1 g4021.t1 Q9Y576 37.288 295 2.17e-48 167.0 sp|Q9Y576|ASB1_HUMAN Ankyrin repeat and SOCS box protein 1 OS=Homo sapiens OX=9606 GN=ASB1 PE=1 SV=1 g4027.t1 Q9Y2W6 36.235 494 3.47e-93 297.0 sp|Q9Y2W6|TDRKH_HUMAN Tudor and KH domain-containing protein OS=Homo sapiens OX=9606 GN=TDRKH PE=1 SV=2 TDRKH_HUMAN reviewed Tudor and KH domain-containing protein (Tudor domain-containing protein 2) Homo sapiens (Human) GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030719; GO:0034587; GO:0043186; GO:0071546; GO:0071547 fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283] mitochondrion [GO:0005739]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547] RNA binding [GO:0003723] g4028.t1 Q9Y4E6 50.965 777 0.0 801.0 sp|Q9Y4E6|WDR7_HUMAN WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=WDR7 PE=1 SV=2 g4029.t1 Q920I9 46.143 726 0.0 573.0 sp|Q920I9|WDR7_MOUSE WD repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Wdr7 PE=1 SV=3 g4029.t2 Q920I9 46.919 714 0.0 582.0 sp|Q920I9|WDR7_MOUSE WD repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Wdr7 PE=1 SV=3 g4030.t1 Q9UBG0 23.223 633 8.000000000000001e-21 102.0 sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2 MRC2_HUMAN reviewed C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280) Homo sapiens (Human) GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023 collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649] focal adhesion [GO:0005925]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023] g4031.t1 P61644 40.067 297 1.08e-71 232.0 sp|P61644|SIA8C_PANTR Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 OS=Pan troglodytes OX=9598 GN=ST8SIA3 PE=2 SV=1 SIA8C_PANTR reviewed Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase ST8SIA3 (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (Ganglioside GD3 synthase ST8SIA3) (EC 2.4.3.8) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sia-a2,3-Gal-b1,4-Glc-NAc-R:a2,8-sialyltransferase) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII) Pan troglodytes (Chimpanzee) GO:0000139; GO:0003828; GO:0006491; GO:0008373; GO:0009311; GO:0097503 N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g4035.t1 Q96HA9 41.228 228 2.22e-53 175.0 sp|Q96HA9|PX11C_HUMAN Peroxisomal membrane protein 11C OS=Homo sapiens OX=9606 GN=PEX11G PE=1 SV=1 PX11C_HUMAN reviewed Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma) Homo sapiens (Human) GO:0005777; GO:0005778; GO:0016559; GO:0032991; GO:0044375 peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375] peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] g4036.t1 Q6RT24 55.99 409 6.27e-128 426.0 sp|Q6RT24|CENPE_MOUSE Centromere-associated protein E OS=Mus musculus OX=10090 GN=Cenpe PE=1 SV=1 CENPE_MOUSE reviewed Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10) Mus musculus (Mouse) GO:0000278; GO:0000775; GO:0000776; GO:0000779; GO:0000940; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005828; GO:0005874; GO:0007018; GO:0007052; GO:0007057; GO:0007059; GO:0007079; GO:0007080; GO:0007088; GO:0007094; GO:0008017; GO:0008608; GO:0015630; GO:0019901; GO:0030071; GO:0030496; GO:0031647; GO:0043515; GO:0045171; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0051984; GO:0051987; GO:0072686; GO:0099606; GO:0099607; GO:1990023 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of protein localization [GO:0045184]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057] chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle midzone [GO:0051233] ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901] g4040.t1 Q99471 54.483 145 1.58e-53 169.0 sp|Q99471|PFD5_HUMAN Prefoldin subunit 5 OS=Homo sapiens OX=9606 GN=PFDN5 PE=1 SV=2 g4041.t1 F8WLE0 38.71 806 1.15e-159 498.0 sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1 KIF28_RAT reviewed Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6) Rattus norvegicus (Rat) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g4041.t2 F8WLE0 38.452 814 3.56e-158 494.0 sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1 KIF28_RAT reviewed Kinesin-like protein KIF28 (Kinesin family member 28) (Kinesin-like protein 6) Rattus norvegicus (Rat) GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007005; GO:0008017; GO:0016887; GO:0031966; GO:0047496; GO:0072384 mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g4046.t1 P31335 68.412 592 0.0 872.0 sp|P31335|PUR9_CHICK Bifunctional purine biosynthesis protein ATIC OS=Gallus gallus OX=9031 GN=ATIC PE=1 SV=1 g4047.t1 Q5ZI74 45.429 722 0.0 600.0 sp|Q5ZI74|DHX30_CHICK ATP-dependent RNA helicase DHX30 OS=Gallus gallus OX=9031 GN=DHX30 PE=2 SV=1 DHX30_CHICK reviewed ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30) Gallus gallus (Chicken) GO:0002151; GO:0003678; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0007417; GO:0016887; GO:0042254; GO:0042645 central nervous system development [GO:0007417]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g4047.t2 Q5ZI74 45.429 722 0.0 600.0 sp|Q5ZI74|DHX30_CHICK ATP-dependent RNA helicase DHX30 OS=Gallus gallus OX=9031 GN=DHX30 PE=2 SV=1 DHX30_CHICK reviewed ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30) Gallus gallus (Chicken) GO:0002151; GO:0003678; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0007417; GO:0016887; GO:0042254; GO:0042645 central nervous system development [GO:0007417]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g4048.t1 Q5ZI74 28.879 232 6.519999999999999e-23 101.0 sp|Q5ZI74|DHX30_CHICK ATP-dependent RNA helicase DHX30 OS=Gallus gallus OX=9031 GN=DHX30 PE=2 SV=1 DHX30_CHICK reviewed ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30) Gallus gallus (Chicken) GO:0002151; GO:0003678; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0007417; GO:0016887; GO:0042254; GO:0042645 central nervous system development [GO:0007417]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g4051.t1 Q8IZJ3 54.936 233 4.31e-84 279.0 sp|Q8IZJ3|CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens OX=9606 GN=CPAMD8 PE=1 SV=2 CPMD8_HUMAN reviewed C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 Homo sapiens (Human) GO:0001654; GO:0004867; GO:0005615; GO:0005886 eye development [GO:0001654] extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase inhibitor activity [GO:0004867] g4052.t1 Q8IZJ3 51.196 209 5.170000000000001e-66 223.0 sp|Q8IZJ3|CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens OX=9606 GN=CPAMD8 PE=1 SV=2 CPMD8_HUMAN reviewed C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 Homo sapiens (Human) GO:0001654; GO:0004867; GO:0005615; GO:0005886 eye development [GO:0001654] extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase inhibitor activity [GO:0004867] g4053.t1 Q8IZJ3 49.601 1252 0.0 1201.0 sp|Q8IZJ3|CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens OX=9606 GN=CPAMD8 PE=1 SV=2 CPMD8_HUMAN reviewed C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 Homo sapiens (Human) GO:0001654; GO:0004867; GO:0005615; GO:0005886 eye development [GO:0001654] extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase inhibitor activity [GO:0004867] g4054.t1 O60318 32.288 319 3.01e-51 187.0 sp|O60318|GANP_HUMAN Germinal-center associated nuclear protein OS=Homo sapiens OX=9606 GN=MCM3AP PE=1 SV=2 g4055.t1 Q5RCP1 46.356 494 1.87e-146 432.0 sp|Q5RCP1|TSTD2_PONAB Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 OS=Pongo abelii OX=9601 GN=TSTD2 PE=2 SV=1 g4062.t1 Q6P0C6 41.434 251 1.37e-53 176.0 sp|Q6P0C6|LHPL2_DANRE LHFPL tetraspan subfamily member 2a protein OS=Danio rerio OX=7955 GN=lhfpl2a PE=2 SV=1 g4063.t1 A0A2R8QP51 56.764 377 8.14e-146 437.0 sp|A0A2R8QP51|DPP9_DANRE Dipeptidyl peptidase 9 OS=Danio rerio OX=7955 GN=dpp9 PE=3 SV=1 DPP9_DANRE reviewed Dipeptidyl peptidase 9 (EC 3.4.14.5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004177; GO:0005634; GO:0006508; GO:0008236; GO:0008239; GO:0050727 proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727] nucleus [GO:0005634] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] g4064.t1 A0A2R8QP51 50.192 261 2.68e-78 256.0 sp|A0A2R8QP51|DPP9_DANRE Dipeptidyl peptidase 9 OS=Danio rerio OX=7955 GN=dpp9 PE=3 SV=1 DPP9_DANRE reviewed Dipeptidyl peptidase 9 (EC 3.4.14.5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004177; GO:0005634; GO:0006508; GO:0008236; GO:0008239; GO:0050727 proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727] nucleus [GO:0005634] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] g4066.t1 Q9R0C0 55.385 130 3.1499999999999997e-34 124.0 sp|Q9R0C0|BL1S6_MOUSE Biogenesis of lysosome-related organelles complex 1 subunit 6 OS=Mus musculus OX=10090 GN=Bloc1s6 PE=1 SV=1 BL1S6_MOUSE reviewed Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein) (Pallidin) (Syntaxin 13-interacting protein) Mus musculus (Mouse) GO:0001725; GO:0001726; GO:0001822; GO:0002936; GO:0003016; GO:0003158; GO:0005737; GO:0005768; GO:0005925; GO:0006520; GO:0006536; GO:0006541; GO:0006605; GO:0006629; GO:0006644; GO:0006904; GO:0006906; GO:0007596; GO:0007613; GO:0008089; GO:0009306; GO:0009410; GO:0010467; GO:0014823; GO:0016020; GO:0021542; GO:0021854; GO:0030133; GO:0030318; GO:0030324; GO:0031083; GO:0031175; GO:0031941; GO:0032402; GO:0032438; GO:0032816; GO:0033299; GO:0033484; GO:0035264; GO:0035646; GO:0042311; GO:0042745; GO:0042802; GO:0042803; GO:0043473; GO:0044291; GO:0046034; GO:0046085; GO:0048286; GO:0048490; GO:0048872; GO:0050942; GO:0051015; GO:0051017; GO:0055088; GO:0060090; GO:0060271; GO:0061025; GO:0070938; GO:0071364; GO:0071806; GO:1904115; GO:1905144; GO:1990742 actin filament bundle assembly [GO:0051017]; adenosine metabolic process [GO:0046085]; amino acid metabolic process [GO:0006520]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; ATP metabolic process [GO:0046034]; blood coagulation [GO:0007596]; bradykinin biosynthetic process [GO:0002936]; cellular response to epidermal growth factor stimulus [GO:0071364]; cilium assembly [GO:0060271]; circadian sleep/wake cycle [GO:0042745]; dentate gyrus development [GO:0021542]; endosome to melanosome transport [GO:0035646]; endothelium development [GO:0003158]; gene expression [GO:0010467]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; homeostasis of number of cells [GO:0048872]; hypothalamus development [GO:0021854]; intracellular nitric oxide homeostasis [GO:0033484]; kidney development [GO:0001822]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; neuron projection development [GO:0031175]; phospholipid metabolic process [GO:0006644]; pigmentation [GO:0043473]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; protein secretion [GO:0009306]; protein targeting [GO:0006605]; protein transmembrane transport [GO:0071806]; respiratory system process [GO:0003016]; response to acetylcholine [GO:1905144]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; secretion of lysosomal enzymes [GO:0033299]; vasodilation [GO:0042311]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell-cell contact zone [GO:0044291]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; endosome [GO:0005768]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microvesicle [GO:1990742]; ruffle [GO:0001726]; stress fiber [GO:0001725]; transport vesicle [GO:0030133] actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803] g4067.t1 Q62902 43.504 508 5.11e-142 422.0 sp|Q62902|LMAN1_RAT Protein ERGIC-53 OS=Rattus norvegicus OX=10116 GN=Lman1 PE=1 SV=1 LMAN1_RAT reviewed Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Lectin mannose-binding 1) (p58) Rattus norvegicus (Rat) GO:0000139; GO:0001701; GO:0005509; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0007029; GO:0007030; GO:0010467; GO:0015031; GO:0030017; GO:0030134; GO:0033116; GO:0042802; GO:0046872; GO:0098978; GO:0150051 endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; in utero embryonic development [GO:0001701]; protein transport [GO:0015031] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; postsynaptic Golgi apparatus [GO:0150051]; sarcomere [GO:0030017] calcium ion binding [GO:0005509]; D-mannose binding [GO:0005537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g4068.t1 P97471 73.913 299 2.67e-142 414.0 sp|P97471|SMAD4_MOUSE Mothers against decapentaplegic homolog 4 OS=Mus musculus OX=10090 GN=Smad4 PE=1 SV=2 SMAD4_MOUSE reviewed SMAD family member 4 (SMAD 4) (Deletion target in pancreatic carcinoma 4 homolog) (Mothers against decapentaplegic homolog 4) (MAD homolog 4) (Mothers against DPP homolog 4) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001822; GO:0001837; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003279; GO:0003360; GO:0003677; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0008584; GO:0008585; GO:0009653; GO:0009952; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0032991; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042127; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046881; GO:0048589; GO:0048663; GO:0048665; GO:0048729; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0090575; GO:0097191; GO:1901203; GO:1902895; GO:1905305 activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412] activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222] g4069.t1 Q9GKQ9 89.172 157 1.51e-88 279.0 sp|Q9GKQ9|SMAD4_PIG Mothers against decapentaplegic homolog 4 OS=Sus scrofa OX=9823 GN=SMAD4 PE=2 SV=1 g4074.t1 Q7TQK0 65.116 301 5.55e-126 412.0 sp|Q7TQK0|CCNT2_MOUSE Cyclin-T2 OS=Mus musculus OX=10090 GN=Ccnt2 PE=1 SV=1 g4074.t2 Q7TQK0 62.903 310 1.24e-122 404.0 sp|Q7TQK0|CCNT2_MOUSE Cyclin-T2 OS=Mus musculus OX=10090 GN=Ccnt2 PE=1 SV=1 g4075.t1 Q2NL14 44.35 354 1.43e-85 272.0 sp|Q2NL14|KANL2_BOVIN KAT8 regulatory NSL complex subunit 2 OS=Bos taurus OX=9913 GN=KANSL2 PE=2 SV=1 KANL2_BOVIN reviewed KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog) Bos taurus (Bovine) GO:0000123; GO:0005634; GO:0005739; GO:0006325; GO:0044545 chromatin organization [GO:0006325] histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleus [GO:0005634] g4076.t1 Q9Z1G4 56.847 869 0.0 989.0 sp|Q9Z1G4|VPP1_MOUSE V-type proton ATPase 116 kDa subunit a 1 OS=Mus musculus OX=10090 GN=Atp6v0a1 PE=1 SV=3 VPP1_MOUSE reviewed V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1) Mus musculus (Mouse) GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0016020; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0046961; GO:0048471; GO:0051117; GO:0097401 regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961] g4076.t2 Q9Z1G4 57.159 859 0.0 991.0 sp|Q9Z1G4|VPP1_MOUSE V-type proton ATPase 116 kDa subunit a 1 OS=Mus musculus OX=10090 GN=Atp6v0a1 PE=1 SV=3 VPP1_MOUSE reviewed V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1) Mus musculus (Mouse) GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0016020; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0046961; GO:0048471; GO:0051117; GO:0097401 regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961] g4077.t1 P25286 65.166 844 0.0 1135.0 sp|P25286|VPP1_RAT V-type proton ATPase 116 kDa subunit a 1 OS=Rattus norvegicus OX=10116 GN=Atp6v0a1 PE=1 SV=1 VPP1_RAT reviewed V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1) Rattus norvegicus (Rat) GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0016020; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0043195; GO:0046961; GO:0048471; GO:0051117; GO:0097401 regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961] g4077.t2 Q9Z1G4 65.335 851 0.0 1147.0 sp|Q9Z1G4|VPP1_MOUSE V-type proton ATPase 116 kDa subunit a 1 OS=Mus musculus OX=10090 GN=Atp6v0a1 PE=1 SV=3 VPP1_MOUSE reviewed V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1) Mus musculus (Mouse) GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0016020; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0046961; GO:0048471; GO:0051117; GO:0097401 regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961] g4078.t1 Q94887 34.885 1310 0.0 698.0 sp|Q94887|NRX4_DROME Neurexin-4 OS=Drosophila melanogaster OX=7227 GN=Nrx-IV PE=1 SV=2 NRX4_DROME reviewed Neurexin-4 (Neurexin IV) Drosophila melanogaster (Fruit fly) GO:0003015; GO:0005886; GO:0005919; GO:0007391; GO:0008039; GO:0008104; GO:0008366; GO:0019991; GO:0021682; GO:0035151; GO:0045202; GO:0045216; GO:0048786; GO:0060857; GO:0061343; GO:0072553; GO:0097105 axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; heart process [GO:0003015]; intracellular protein localization [GO:0008104]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; terminal button organization [GO:0072553] plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] g4079.t1 P23508 53.061 882 0.0 703.0 sp|P23508|CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens OX=9606 GN=MCC PE=1 SV=2 CRCM_HUMAN reviewed Colorectal mutant cancer protein (Protein MCC) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090 establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] signaling receptor activity [GO:0038023] g4079.t2 P23508 53.054 884 0.0 705.0 sp|P23508|CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens OX=9606 GN=MCC PE=1 SV=2 CRCM_HUMAN reviewed Colorectal mutant cancer protein (Protein MCC) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090 establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] signaling receptor activity [GO:0038023] g4079.t3 P23508 52.941 884 0.0 704.0 sp|P23508|CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens OX=9606 GN=MCC PE=1 SV=2 CRCM_HUMAN reviewed Colorectal mutant cancer protein (Protein MCC) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090 establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] signaling receptor activity [GO:0038023] g4080.t1 Q6P859 53.191 188 6.930000000000001e-58 195.0 sp|Q6P859|GPTC4_XENTR G patch domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=gpatch4 PE=2 SV=1 g4081.t1 P43935 32.576 264 2.51e-31 124.0 sp|P43935|Y077_HAEIN Uncharacterized protein HI_0077 OS=Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) OX=71421 GN=HI_0077 PE=4 SV=1 g4082.t1 Q7ZY18 72.738 818 0.0 1231.0 sp|Q7ZY18|MC6ZB_XENLA Zygotic DNA replication licensing factor mcm6-B OS=Xenopus laevis OX=8355 GN=zmcm6-b PE=1 SV=1 MC6ZB_XENLA reviewed Zygotic DNA replication licensing factor mcm6-B (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6-B) (zMCM6-B) (zMCM6b) Xenopus laevis (African clawed frog) GO:0000727; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006279; GO:0008270; GO:0016887; GO:0030174; GO:0042555; GO:1902969; GO:1990518 DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; premeiotic DNA replication [GO:0006279]; regulation of DNA-templated DNA replication initiation [GO:0030174] MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g4085.t1 Q8VHI3 55.862 435 7.62e-172 491.0 sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1 OFUT2_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2) Mus musculus (Mouse) GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046; GO:1903334 fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g4085.t2 Q8VHI3 55.632 435 2.5599999999999997e-170 488.0 sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1 OFUT2_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2) Mus musculus (Mouse) GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046; GO:1903334 fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g4085.t3 Q8VHI3 55.0 440 2.5e-168 483.0 sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1 OFUT2_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2) Mus musculus (Mouse) GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046; GO:1903334 fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g4086.t1 Q95115 52.982 721 0.0 750.0 sp|Q95115|STA5A_BOVIN Signal transducer and activator of transcription 5A OS=Bos taurus OX=9913 GN=STAT5A PE=2 SV=2 STA5A_BOVIN reviewed Signal transducer and activator of transcription 5A (Mammary gland factor) Bos taurus (Bovine) GO:0000978; GO:0000981; GO:0001553; GO:0001779; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0030879; GO:0032743; GO:0040018; GO:0042104; GO:0042127; GO:0043029; GO:0043066; GO:0043434; GO:0045579; GO:0045647; GO:0045931; GO:0045944; GO:0046543; GO:0050729; GO:0060397; GO:0090575 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; T cell homeostasis [GO:0043029] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g4086.t2 Q95115 52.982 721 0.0 751.0 sp|Q95115|STA5A_BOVIN Signal transducer and activator of transcription 5A OS=Bos taurus OX=9913 GN=STAT5A PE=2 SV=2 STA5A_BOVIN reviewed Signal transducer and activator of transcription 5A (Mammary gland factor) Bos taurus (Bovine) GO:0000978; GO:0000981; GO:0001553; GO:0001779; GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0030879; GO:0032743; GO:0040018; GO:0042104; GO:0042127; GO:0043029; GO:0043066; GO:0043434; GO:0045579; GO:0045647; GO:0045931; GO:0045944; GO:0046543; GO:0050729; GO:0060397; GO:0090575 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; T cell homeostasis [GO:0043029] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g4087.t1 P60330 41.636 269 1.33e-65 225.0 sp|P60330|ESPL1_MOUSE Separin OS=Mus musculus OX=10090 GN=Espl1 PE=1 SV=1 g4088.t1 P55006 41.956 317 2.24e-84 260.0 sp|P55006|RDH7_RAT Retinol dehydrogenase 7 OS=Rattus norvegicus OX=10116 GN=Rdh7 PE=1 SV=1 g4089.t1 Q14674 23.404 1410 1.6400000000000002e-43 179.0 sp|Q14674|ESPL1_HUMAN Separin OS=Homo sapiens OX=9606 GN=ESPL1 PE=1 SV=3 ESPL1_HUMAN reviewed Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase) Homo sapiens (Human) GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051306; GO:0051307; GO:0072686 apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic sister chromatid separation [GO:0051306]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] catalytic activity [GO:0003824]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] g4089.t1 Q14674 26.462 359 9.920000000000001e-27 124.0 sp|Q14674|ESPL1_HUMAN Separin OS=Homo sapiens OX=9606 GN=ESPL1 PE=1 SV=3 ESPL1_HUMAN reviewed Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase) Homo sapiens (Human) GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051306; GO:0051307; GO:0072686 apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic sister chromatid separation [GO:0051306]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] catalytic activity [GO:0003824]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] g4090.t1 O43822 41.129 248 2.74e-59 191.0 sp|O43822|CF410_HUMAN Cilia- and flagella-associated protein 410 OS=Homo sapiens OX=9606 GN=CFAP410 PE=1 SV=1 g4091.t1 Q61830 29.536 1185 1.0400000000000001e-144 495.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 30.067 1051 1.53e-118 416.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 25.85 1176 4.69e-103 369.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 26.298 1194 3.83e-102 366.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 27.001 1037 4.25e-81 300.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 25.376 930 2.62e-59 230.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 24.169 902 1.73e-57 224.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 29.005 593 1.97e-53 211.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 24.874 595 1.0899999999999999e-41 173.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4091.t1 Q61830 28.956 297 3.93e-30 135.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4092.t1 P22897 30.742 1132 5.94e-149 503.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4092.t1 P22897 27.101 1059 1.07e-85 314.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4092.t1 P22897 26.944 939 1.94e-63 243.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4092.t1 P22897 23.873 754 2.64e-49 197.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4092.t1 P22897 25.521 768 1.7099999999999998e-48 194.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4092.t1 P22897 25.56 759 2.44e-41 171.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4092.t1 P22897 31.229 301 2.26e-31 139.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4092.t1 P22897 26.714 423 1.4899999999999998e-30 136.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4095.t1 Q8R409 35.294 272 1.32e-26 110.0 sp|Q8R409|HEXI1_MOUSE Protein HEXIM1 OS=Mus musculus OX=10090 GN=Hexim1 PE=1 SV=1 HEXI1_MOUSE reviewed Protein HEXIM1 (Cardiac lineage protein 1) Mus musculus (Mouse) GO:0000122; GO:0002218; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0007507; GO:0017069; GO:0032897; GO:0034244; GO:0042802; GO:0045087; GO:0045892; GO:0097322; GO:0106140; GO:0120259; GO:0140416; GO:1901798 activation of innate immune response [GO:0002218]; heart development [GO:0007507]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of signal transduction by p53 class mediator [GO:1901798] 7SK snRNP [GO:0120259]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; P-TEFb complex binding [GO:0106140]; protein kinase inhibitor activity [GO:0004860]; snRNA binding [GO:0017069]; transcription regulator inhibitor activity [GO:0140416] g4096.t1 Q8WUM4 47.404 886 0.0 771.0 sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1 g4096.t2 Q8WUM4 47.545 896 0.0 768.0 sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1 g4097.t1 P27545 43.158 285 1.7200000000000002e-72 231.0 sp|P27545|CERS1_MOUSE Ceramide synthase 1 OS=Mus musculus OX=10090 GN=Cers1 PE=1 SV=1 CERS1_MOUSE reviewed Ceramide synthase 1 (CerS1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016410; GO:0030148; GO:0036146; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526 brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] g4098.t1 Q5T1A1 27.858 761 1.2900000000000002e-97 328.0 sp|Q5T1A1|DCST2_HUMAN DC-STAMP domain-containing protein 2 OS=Homo sapiens OX=9606 GN=DCST2 PE=1 SV=2 g4099.t1 Q5BJJ5 65.637 259 1.93e-122 352.0 sp|Q5BJJ5|HDHD2_DANRE Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Danio rerio OX=7955 GN=hdhd2 PE=2 SV=1 g4100.t1 Q8WTP8 46.377 207 1.13e-56 190.0 sp|Q8WTP8|AEN_HUMAN Apoptosis-enhancing nuclease OS=Homo sapiens OX=9606 GN=AEN PE=1 SV=2 AEN_HUMAN reviewed Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Homo sapiens (Human) GO:0003676; GO:0004527; GO:0004529; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0010212; GO:0031965; GO:0042771 intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; response to ionizing radiation [GO:0010212]; RNA processing [GO:0006396] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA exonuclease activity [GO:0004529]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] g4101.t1 Q9CR41 58.036 112 4.47e-36 122.0 sp|Q9CR41|HYPK_MOUSE Huntingtin-interacting protein K OS=Mus musculus OX=10090 GN=Hypk PE=1 SV=3 HYPK_MOUSE reviewed Huntingtin-interacting protein K (Huntingtin yeast partner K) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0044183; GO:0050821 negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] protein folding chaperone [GO:0044183] g4102.t1 P00430 70.175 57 1.84e-25 91.7 sp|P00430|COX7C_BOVIN Cytochrome c oxidase subunit 7C, mitochondrial OS=Bos taurus OX=9913 GN=COX7C PE=1 SV=3 g4103.t1 Q498L2 32.063 446 4.2e-36 152.0 sp|Q498L2|SLTM_XENLA SAFB-like transcription modulator OS=Xenopus laevis OX=8355 GN=sltm PE=2 SV=1 g4104.t1 Q14151 35.872 499 2.19e-51 200.0 sp|Q14151|SAFB2_HUMAN Scaffold attachment factor B2 OS=Homo sapiens OX=9606 GN=SAFB2 PE=1 SV=1 g4105.t1 Q5F3Z7 45.116 430 1.42e-106 325.0 sp|Q5F3Z7|CTSL2_CHICK CTD small phosphatase-like protein 2 OS=Gallus gallus OX=9031 GN=CTDSPL2 PE=2 SV=2 g4114.t1 P10079 36.553 818 3.96e-145 463.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4114.t1 P10079 41.536 638 7e-140 449.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4114.t1 P10079 43.261 601 7.77e-140 449.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4114.t1 P10079 40.501 479 2.72e-88 309.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4114.t1 P10079 42.548 416 1.21e-78 281.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4115.t1 O00548 28.197 649 5.940000000000001e-47 180.0 sp|O00548|DLL1_HUMAN Delta-like protein 1 OS=Homo sapiens OX=9606 GN=DLL1 PE=1 SV=2 DLL1_HUMAN reviewed Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1) Homo sapiens (Human) GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002085; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007368; GO:0007386; GO:0008217; GO:0008284; GO:0008285; GO:0009954; GO:0010628; GO:0014002; GO:0014807; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030097; GO:0030099; GO:0030154; GO:0030155; GO:0030857; GO:0030947; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0042491; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045638; GO:0045662; GO:0045665; GO:0045746; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048018; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060563; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726 astrocyte development [GO:0014002]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; myeloid cell differentiation [GO:0030099]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; nephron development [GO:0072006]; neuroepithelial cell differentiation [GO:0060563]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957] g4115.t3 O00548 28.328 646 1.51e-49 187.0 sp|O00548|DLL1_HUMAN Delta-like protein 1 OS=Homo sapiens OX=9606 GN=DLL1 PE=1 SV=2 DLL1_HUMAN reviewed Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1) Homo sapiens (Human) GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002085; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007368; GO:0007386; GO:0008217; GO:0008284; GO:0008285; GO:0009954; GO:0010628; GO:0014002; GO:0014807; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030097; GO:0030099; GO:0030154; GO:0030155; GO:0030857; GO:0030947; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0042491; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045638; GO:0045662; GO:0045665; GO:0045746; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048018; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060563; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726 astrocyte development [GO:0014002]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; myeloid cell differentiation [GO:0030099]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; nephron development [GO:0072006]; neuroepithelial cell differentiation [GO:0060563]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957] g4116.t1 P07207 34.624 1782 0.0 887.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g4116.t1 P07207 40.352 1249 0.0 830.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g4116.t1 P07207 38.576 941 1.18e-179 608.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g4116.t2 O35516 40.015 1312 0.0 848.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4116.t2 O35516 38.069 1295 0.0 783.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4116.t2 O35516 34.694 735 1.32e-112 401.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4116.t2 O35516 35.492 386 4.2700000000000004e-36 154.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t1 O35516 40.573 1257 0.0 856.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t1 O35516 39.165 1269 0.0 798.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t1 O35516 40.415 1158 0.0 767.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t1 O35516 41.574 1080 0.0 676.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t1 O35516 40.161 996 0.0 606.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t1 O35516 37.216 970 6.58e-169 569.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t2 O35516 39.643 1231 0.0 790.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t2 O35516 39.539 1128 0.0 728.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t2 O35516 39.082 1177 0.0 711.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t2 O35516 37.608 1154 0.0 671.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4117.t2 O35516 39.815 1080 0.0 644.0 sp|O35516|NOTC2_MOUSE Neurogenic locus notch homolog protein 2 OS=Mus musculus OX=10090 GN=Notch2 PE=1 SV=2 NOTC2_MOUSE reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (Motch B) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4118.t1 Q9W436 31.06 689 6.21e-116 371.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g4119.t1 Q9W436 34.384 698 7.119999999999999e-138 429.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g4120.t1 O94889 60.177 565 0.0 738.0 sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3 KLH18_HUMAN reviewed Kelch-like protein 18 Homo sapiens (Human) GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756 cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g4120.t2 O94889 59.649 570 0.0 732.0 sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3 KLH18_HUMAN reviewed Kelch-like protein 18 Homo sapiens (Human) GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756 cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g4124.t1 Q5ZJN2 86.239 218 2.35e-137 386.0 sp|Q5ZJN2|RB11A_CHICK Ras-related protein Rab-11A OS=Gallus gallus OX=9031 GN=RAB11A PE=2 SV=1 RB11A_CHICK reviewed Ras-related protein Rab-11A (EC 3.6.5.2) Gallus gallus (Chicken) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0006887; GO:0030133; GO:0030666; GO:0032154; GO:0032402; GO:0032588; GO:0045335; GO:0046872; GO:0055038; GO:0061512; GO:0098837; GO:0098887; GO:1902017; GO:1902954; GO:1904779; GO:2001135 exocytosis [GO:0006887]; melanosome transport [GO:0032402]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to centrosome [GO:1904779] cleavage furrow [GO:0032154]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g4126.t1 Q96KG7 47.431 837 0.0 747.0 sp|Q96KG7|MEG10_HUMAN Multiple epidermal growth factor-like domains protein 10 OS=Homo sapiens OX=9606 GN=MEGF10 PE=1 SV=1 g4126.t1 Q96KG7 38.435 882 2.0100000000000002e-164 521.0 sp|Q96KG7|MEG10_HUMAN Multiple epidermal growth factor-like domains protein 10 OS=Homo sapiens OX=9606 GN=MEGF10 PE=1 SV=1 g4126.t1 Q96KG7 40.072 277 1.15e-46 186.0 sp|Q96KG7|MEG10_HUMAN Multiple epidermal growth factor-like domains protein 10 OS=Homo sapiens OX=9606 GN=MEGF10 PE=1 SV=1 g4126.t2 A0JM12 46.476 837 0.0 746.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g4126.t2 A0JM12 38.318 856 1.55e-162 514.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g4126.t2 A0JM12 37.812 320 1.3e-47 189.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g4128.t1 Q6ZNA1 28.47 281 1.96e-24 107.0 sp|Q6ZNA1|ZN836_HUMAN Zinc finger protein 836 OS=Homo sapiens OX=9606 GN=ZNF836 PE=1 SV=2 g4129.t1 Q93073 47.921 457 8.95e-107 369.0 sp|Q93073|SBP2L_HUMAN Selenocysteine insertion sequence-binding protein 2-like OS=Homo sapiens OX=9606 GN=SECISBP2L PE=1 SV=3 g4129.t2 Q93073 47.921 457 9.78e-107 369.0 sp|Q93073|SBP2L_HUMAN Selenocysteine insertion sequence-binding protein 2-like OS=Homo sapiens OX=9606 GN=SECISBP2L PE=1 SV=3 g4130.t1 P21399 67.306 939 0.0 1306.0 sp|P21399|ACOHC_HUMAN Cytoplasmic aconitate hydratase OS=Homo sapiens OX=9606 GN=ACO1 PE=1 SV=3 ACOHC_HUMAN reviewed Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1) Homo sapiens (Human) GO:0000900; GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0030350; GO:0046872; GO:0050892; GO:0051536; GO:0051538; GO:0051539; GO:0070062 citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723] g4130.t2 P21399 72.109 882 0.0 1358.0 sp|P21399|ACOHC_HUMAN Cytoplasmic aconitate hydratase OS=Homo sapiens OX=9606 GN=ACO1 PE=1 SV=3 ACOHC_HUMAN reviewed Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1) Homo sapiens (Human) GO:0000900; GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0030350; GO:0046872; GO:0050892; GO:0051536; GO:0051538; GO:0051539; GO:0070062 citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723] g4131.t1 Q66H56 38.922 334 6.829999999999999e-69 232.0 sp|Q66H56|TTI2_RAT TELO2-interacting protein 2 OS=Rattus norvegicus OX=10116 GN=Tti2 PE=2 SV=1 g4132.t1 Q6PUF4 44.151 265 6.3499999999999995e-74 231.0 sp|Q6PUF4|DHI1L_CHICK Hydroxysteroid 11-beta-dehydrogenase 1-like protein OS=Gallus gallus OX=9031 GN=HSD11B1L PE=2 SV=1 g4133.t1 Q6PUF3 43.798 258 6.120000000000001e-72 226.0 sp|Q6PUF3|DHI1L_DANRE Hydroxysteroid 11-beta-dehydrogenase 1-like protein OS=Danio rerio OX=7955 GN=hsd11b1l PE=2 SV=1 g4134.t1 Q7ZWG6 26.233 446 9.570000000000001e-36 142.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g4134.t2 Q7ZWG6 26.339 448 8.2e-36 142.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g4135.t1 Q7ZWG6 27.972 429 5.1e-38 148.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g4136.t1 Q96PH1 45.443 823 0.0 628.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4138.t1 Q920Q4 53.659 533 0.0 562.0 sp|Q920Q4|VPS16_MOUSE Vacuolar protein sorting-associated protein 16 homolog OS=Mus musculus OX=10090 GN=Vps16 PE=1 SV=3 VPS16_MOUSE reviewed Vacuolar protein sorting-associated protein 16 homolog (mVPS16) Mus musculus (Mouse) GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031901; GO:0031902; GO:0033263; GO:0042144; GO:0043025; GO:0046718; GO:0051015; GO:0055037; GO:0097352; GO:0098793 autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; symbiont entry into host cell [GO:0046718]; vacuole fusion, non-autophagic [GO:0042144] actin filament [GO:0005884]; autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; recycling endosome [GO:0055037] actin binding [GO:0003779]; actin filament binding [GO:0051015] g4139.t1 Q920Q4 45.0 300 4.87e-80 261.0 sp|Q920Q4|VPS16_MOUSE Vacuolar protein sorting-associated protein 16 homolog OS=Mus musculus OX=10090 GN=Vps16 PE=1 SV=3 VPS16_MOUSE reviewed Vacuolar protein sorting-associated protein 16 homolog (mVPS16) Mus musculus (Mouse) GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031901; GO:0031902; GO:0033263; GO:0042144; GO:0043025; GO:0046718; GO:0051015; GO:0055037; GO:0097352; GO:0098793 autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; symbiont entry into host cell [GO:0046718]; vacuole fusion, non-autophagic [GO:0042144] actin filament [GO:0005884]; autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; recycling endosome [GO:0055037] actin binding [GO:0003779]; actin filament binding [GO:0051015] g4140.t1 E7F7V7 28.125 288 8.4e-22 98.6 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g4141.t1 Q9Y251 39.692 519 1.21e-114 353.0 sp|Q9Y251|HPSE_HUMAN Heparanase OS=Homo sapiens OX=9606 GN=HPSE PE=1 SV=2 g4143.t1 P15178 74.896 482 0.0 769.0 sp|P15178|SYDC_RAT Aspartate--tRNA ligase, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dars1 PE=1 SV=1 g4149.t1 P18910 43.713 1018 0.0 791.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g4150.t1 B1H1X1 35.052 194 4.73e-41 150.0 sp|B1H1X1|FXL17_XENLA F-box/LRR-repeat protein 17 OS=Xenopus laevis OX=8355 GN=fbxl17 PE=2 SV=1 FXL17_XENLA reviewed F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) Xenopus laevis (African clawed frog) GO:0000209; GO:0005634; GO:0005737; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043161 nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] g4154.t1 P70451 42.686 834 0.0 693.0 sp|P70451|FER_MOUSE Tyrosine-protein kinase Fer OS=Mus musculus OX=10090 GN=Fer PE=1 SV=2 g4156.t1 P27808 50.327 459 3.15e-161 466.0 sp|P27808|MGAT1_MOUSE Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=Mgat1 PE=1 SV=1 MGAT1_MOUSE reviewed Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mus musculus (Mouse) GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006487; GO:0008375; GO:0018279; GO:0030145; GO:0033499; GO:0048471 galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; in utero embryonic development [GO:0001701]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471] acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145] g4157.t1 Q56232 29.121 364 2.4500000000000003e-43 159.0 sp|Q56232|AAPAT_THET8 Aspartate/prephenate aminotransferase OS=Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) OX=300852 GN=aspC PE=1 SV=1 AAPAT_THET8 reviewed Aspartate/prephenate aminotransferase (AspAT / PAT) (EC 2.6.1.1) (EC 2.6.1.78) (Transaminase A) Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) GO:0004069; GO:0005737; GO:0006520; GO:0030170; GO:0033853 amino acid metabolic process [GO:0006520] cytoplasm [GO:0005737] aspartate-prephenate aminotransferase activity [GO:0033853]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170] g4158.t1 Q8VID6 61.25 80 1.8300000000000002e-29 113.0 sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1 PDE11_RAT reviewed Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A) Rattus norvegicus (Rat) GO:0004115; GO:0004118; GO:0005829; GO:0007165; GO:0010754; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165] cytosol [GO:0005829]; perikaryon [GO:0043204] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872] g4159.t1 Q8VID6 42.818 731 0.0 545.0 sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1 PDE11_RAT reviewed Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A) Rattus norvegicus (Rat) GO:0004115; GO:0004118; GO:0005829; GO:0007165; GO:0010754; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162 negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165] cytosol [GO:0005829]; perikaryon [GO:0043204] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872] g4161.t1 E1B9R1 44.583 240 3.49e-57 194.0 sp|E1B9R1|SMIP4_BOVIN Sperm-associated microtubule inner protein 4 OS=Bos taurus OX=9913 GN=SPMIP4 PE=3 SV=4 g4161.t2 Q6AYM0 41.758 182 6.910000000000001e-27 109.0 sp|Q6AYM0|SMIP4_RAT Sperm-associated microtubule inner protein 4 OS=Rattus norvegicus OX=10116 GN=Spmip4 PE=1 SV=1 g4163.t1 P55814 39.2 125 2.8799999999999995e-23 95.5 sp|P55814|OAZ1_XENLA Ornithine decarboxylase antizyme 1 OS=Xenopus laevis OX=8355 GN=oaz1 PE=2 SV=2 g4164.t1 O75191 62.9 531 0.0 688.0 sp|O75191|XYLB_HUMAN Xylulose kinase OS=Homo sapiens OX=9606 GN=XYLB PE=1 SV=3 XYLB_HUMAN reviewed Xylulose kinase (Xylulokinase) (EC 2.7.1.17) Homo sapiens (Human) GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0019640; GO:0042732 carbohydrate metabolic process [GO:0005975]; D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997] cytosol [GO:0005829] ATP binding [GO:0005524]; D-xylulokinase activity [GO:0004856] g4166.t1 Q26613 48.276 145 1.1400000000000001e-35 146.0 sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1 g4167.t1 Q6P6T4 29.237 472 2.12e-63 220.0 sp|Q6P6T4|EMAL2_RAT Echinoderm microtubule-associated protein-like 2 OS=Rattus norvegicus OX=10116 GN=Eml2 PE=1 SV=1 EMAL2_RAT reviewed Echinoderm microtubule-associated protein-like 2 (EMAP-2) Rattus norvegicus (Rat) GO:0000226; GO:0005874; GO:0008017; GO:0010968; GO:0015631; GO:0031115; GO:0035255; GO:0072686 microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968] microtubule [GO:0005874]; mitotic spindle [GO:0072686] ionotropic glutamate receptor binding [GO:0035255]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631] g4171.t1 Q06055 61.074 149 5.92e-51 162.0 sp|Q06055|AT5G2_HUMAN ATP synthase F(0) complex subunit C2, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5MC2 PE=1 SV=1 AT5G2_HUMAN reviewed ATP synthase F(0) complex subunit C2, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 2) (ATP synthase proteolipid P2) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C2) (ATPase protein 9) (ATPase subunit c) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0008289; GO:0015078; GO:0015986; GO:0033177; GO:0045259 proton motive force-driven ATP synthesis [GO:0015986] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting two-sector ATPase complex, proton-transporting domain [GO:0033177] lipid binding [GO:0008289]; proton transmembrane transporter activity [GO:0015078] g4172.t1 Q80ZQ5 47.881 236 1.08e-63 204.0 sp|Q80ZQ5|JAZF1_MOUSE Juxtaposed with another zinc finger protein 1 OS=Mus musculus OX=10090 GN=Jazf1 PE=1 SV=2 g4172.t2 Q80ZQ5 48.927 233 8.3e-65 207.0 sp|Q80ZQ5|JAZF1_MOUSE Juxtaposed with another zinc finger protein 1 OS=Mus musculus OX=10090 GN=Jazf1 PE=1 SV=2 g4173.t1 Q99LM2 49.112 507 6.5e-166 482.0 sp|Q99LM2|CK5P3_MOUSE CDK5 regulatory subunit-associated protein 3 OS=Mus musculus OX=10090 GN=Cdk5rap3 PE=1 SV=1 CK5P3_MOUSE reviewed CDK5 regulatory subunit-associated protein 3 Mus musculus (Mouse) GO:0000079; GO:0001889; GO:0001933; GO:0005634; GO:0005730; GO:0005737; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0007095; GO:0007346; GO:0008283; GO:0010921; GO:0012505; GO:0019901; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032790; GO:0032991; GO:0034976; GO:0042177; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0044877; GO:0045944; GO:0051019; GO:0051059; GO:0060318; GO:0071569; GO:0071901; GO:0072344; GO:0097371; GO:0140501; GO:1900182; GO:1901798; GO:1903052; GO:1990756 apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of reticulophagy [GO:0140501]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921]; rescue of stalled ribosome [GO:0072344]; response to endoplasmic reticulum stress [GO:0034976]; ribosome disassembly [GO:0032790] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-like protein ligase binding [GO:0044389] g4174.t1 P80146 48.011 377 9.760000000000001e-100 304.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4175.t1 P80146 49.836 305 3.55e-89 275.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4176.t1 Q8VCK5 39.044 251 4.5e-56 199.0 sp|Q8VCK5|KLH20_MOUSE Kelch-like protein 20 OS=Mus musculus OX=10090 GN=Klhl20 PE=2 SV=2 KLH20_MOUSE reviewed Kelch-like protein 20 (Kelch-like ECT2-interacting protein) Mus musculus (Mouse) GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756 Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802] actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] g4177.t1 Q9C0H6 36.612 183 1.1700000000000001e-29 120.0 sp|Q9C0H6|KLHL4_HUMAN Kelch-like protein 4 OS=Homo sapiens OX=9606 GN=KLHL4 PE=1 SV=2 KLHL4_HUMAN reviewed Kelch-like protein 4 Homo sapiens (Human) GO:0003779; GO:0005737; GO:0005929; GO:0015630; GO:0031463; GO:0034451; GO:0036064; GO:0043161; GO:1990756 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] actin binding [GO:0003779]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g4178.t1 Q502L1 50.0 114 1.22e-33 129.0 sp|Q502L1|ACB5A_DANRE Acyl-CoA-binding domain-containing protein 5A OS=Danio rerio OX=7955 GN=acbd5a PE=2 SV=1 ACB5A_DANRE reviewed Acyl-CoA-binding domain-containing protein 5A Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000062; GO:0000425; GO:0005737; GO:0005777; GO:0006631; GO:0016020 fatty acid metabolic process [GO:0006631]; pexophagy [GO:0000425] cytoplasm [GO:0005737]; membrane [GO:0016020]; peroxisome [GO:0005777] fatty-acyl-CoA binding [GO:0000062] g4178.t2 Q502L1 44.186 129 3.4999999999999996e-30 120.0 sp|Q502L1|ACB5A_DANRE Acyl-CoA-binding domain-containing protein 5A OS=Danio rerio OX=7955 GN=acbd5a PE=2 SV=1 ACB5A_DANRE reviewed Acyl-CoA-binding domain-containing protein 5A Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000062; GO:0000425; GO:0005737; GO:0005777; GO:0006631; GO:0016020 fatty acid metabolic process [GO:0006631]; pexophagy [GO:0000425] cytoplasm [GO:0005737]; membrane [GO:0016020]; peroxisome [GO:0005777] fatty-acyl-CoA binding [GO:0000062] g4180.t1 Q9UIF8 42.331 652 1.14e-130 454.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g4180.t1 Q9UIF8 34.532 695 4.51e-105 376.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g4180.t2 Q9UIF8 42.331 652 1.28e-130 454.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g4180.t2 Q9UIF8 30.886 722 1.99e-78 291.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g4180.t3 Q9UIF8 43.058 641 3.67e-133 461.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g4180.t3 Q9UIF8 30.886 722 1.69e-78 292.0 sp|Q9UIF8|BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens OX=9606 GN=BAZ2B PE=1 SV=3 BAZ2B_HUMAN reviewed Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0008270 chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g4183.t1 Q9D1E5 55.286 454 3.4000000000000005e-167 485.0 sp|Q9D1E5|LMBRL_MOUSE Protein LMBR1L OS=Mus musculus OX=10090 GN=Lmbr1l PE=1 SV=1 LMBRL_MOUSE reviewed Protein LMBR1L (Lipocalin-1-interacting membrane receptor) (LIMR) (Uteroglobin receptor) Mus musculus (Mouse) GO:0004888; GO:0005789; GO:0005886; GO:0006898; GO:0007165; GO:0016055; GO:0030217; GO:0042098; GO:0060218; GO:0070231; GO:0090090 hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] transmembrane signaling receptor activity [GO:0004888] g4184.t1 Q9NQR9 35.0 340 2.7e-65 213.0 sp|Q9NQR9|G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens OX=9606 GN=G6PC2 PE=1 SV=1 G6PC2_HUMAN reviewed Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 3.1.3.9) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein) Homo sapiens (Human) GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0042593; GO:0050796; GO:0051156 gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucose-6-phosphatase activity [GO:0004346] g4186.t1 Q8IV38 52.174 322 1.25e-111 335.0 sp|Q8IV38|ANKY2_HUMAN Ankyrin repeat and MYND domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKMY2 PE=1 SV=1 g4188.t1 A1L1K4 64.789 71 2.2000000000000002e-27 98.6 sp|A1L1K4|C42S2_RAT CDC42 small effector protein 2 OS=Rattus norvegicus OX=10116 GN=Cdc42se2 PE=3 SV=2 C42S2_RAT reviewed CDC42 small effector protein 2 Rattus norvegicus (Rat) GO:0001891; GO:0005856; GO:0005886; GO:0006909; GO:0008360; GO:0009966; GO:0031267; GO:0035023; GO:0035591 phagocytosis [GO:0006909]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of signal transduction [GO:0009966] cytoskeleton [GO:0005856]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267] g4189.t1 Q3TD49 39.08 435 2.94e-93 298.0 sp|Q3TD49|SPP2B_MOUSE Signal peptide peptidase-like 2B OS=Mus musculus OX=10090 GN=Sppl2b PE=1 SV=2 SPP2B_MOUSE reviewed Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) Mus musculus (Mouse) GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0098553; GO:0098554 membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803] g4191.t1 Q62908 57.143 91 3.0800000000000003e-31 111.0 sp|Q62908|CSRP2_RAT Cysteine and glycine-rich protein 2 OS=Rattus norvegicus OX=10116 GN=Csrp2 PE=1 SV=3 g4193.t1 C3N775 29.83 352 7.470000000000001e-37 138.0 sp|C3N775|METE_SACI7 Methionine synthase OS=Saccharolobus islandicus (strain Y.G.57.14 / Yellowstone #1) OX=439386 GN=metE PE=3 SV=1 g4196.t1 P15145 34.924 922 2.0000000000000003e-164 511.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g4198.t1 P32007 80.678 295 2.7099999999999997e-170 476.0 sp|P32007|ADT3_BOVIN ADP/ATP translocase 3 OS=Bos taurus OX=9913 GN=SLC25A6 PE=1 SV=3 ADT3_BOVIN reviewed ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed] Bos taurus (Bovine) GO:0005471; GO:0005743; GO:0006915; GO:0016020; GO:0140021; GO:1901029; GO:1990544 apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] ATP:ADP antiporter activity [GO:0005471] g4199.t1 Q8BRT1 46.83 1183 0.0 956.0 sp|Q8BRT1|CLAP2_MOUSE CLIP-associating protein 2 OS=Mus musculus OX=10090 GN=Clasp2 PE=1 SV=1 CLAP2_MOUSE reviewed CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) Mus musculus (Mouse) GO:0000226; GO:0000776; GO:0000922; GO:0002162; GO:0005794; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010634; GO:0015630; GO:0016477; GO:0030010; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051321; GO:0051497; GO:0051895; GO:0071711; GO:0072686; GO:0090091; GO:0090307; GO:0098978; GO:0099187; GO:1903690; GO:1903754; GO:1905477; GO:1990782 basement membrane organization [GO:0071711]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of protein localization to membrane [GO:1905477]; presynaptic cytoskeleton organization [GO:0099187]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903] axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cortical microtubule plus-end [GO:1903754]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782] g4199.t2 A1A5G0 48.534 1160 0.0 967.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g4199.t3 A1A5G0 48.22 1180 0.0 972.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g4199.t4 A1A5G0 48.498 1165 0.0 961.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g4199.t5 A1A5G0 47.639 1165 0.0 931.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g4199.t6 A1A5G0 42.932 764 2.2599999999999998e-172 536.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g4199.t7 A1A5G0 53.306 242 3.43e-77 258.0 sp|A1A5G0|CLAP1_XENTR CLIP-associating protein 1 OS=Xenopus tropicalis OX=8364 GN=clasp1 PE=1 SV=1 CLAP1_XENTR reviewed CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0007026; GO:0008017; GO:0030010; GO:0031023; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307 cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026] basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] kinetochore binding [GO:0043515]; microtubule binding [GO:0008017] g4200.t1 Q9NZI7 45.917 551 3.9099999999999997e-150 442.0 sp|Q9NZI7|UBIP1_HUMAN Upstream-binding protein 1 OS=Homo sapiens OX=9606 GN=UBP1 PE=1 SV=1 UBIP1_HUMAN reviewed Upstream-binding protein 1 (Transcription factor LBP-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:0045944; GO:1990837 angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g4201.t1 Q6FIF0 38.5 200 4.52e-37 130.0 sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2 ZFAN6_HUMAN reviewed AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3) Homo sapiens (Human) GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356 apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122] cytosol [GO:0005829] DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270] g4204.t1 P22897 25.844 1215 1.5699999999999999e-89 325.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4204.t1 P22897 23.678 1229 6.35e-65 247.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4204.t1 P22897 24.545 1210 8.730000000000001e-59 227.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4205.t1 O88487 65.905 613 0.0 785.0 sp|O88487|DC1I2_MOUSE Cytoplasmic dynein 1 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync1i2 PE=1 SV=1 DC1I2_MOUSE reviewed Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) Mus musculus (Mouse) GO:0005813; GO:0005868; GO:0005874; GO:0010970; GO:0010977; GO:0030286; GO:0031982; GO:0036157; GO:0044877; GO:0045503; GO:0045504 negative regulation of neuron projection development [GO:0010977]; transport along microtubule [GO:0010970] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; vesicle [GO:0031982] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; protein-containing complex binding [GO:0044877] g4206.t1 P10079 46.105 475 2.7900000000000003e-117 387.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4206.t1 P10079 45.148 474 8.55e-114 377.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4206.t1 P10079 44.025 477 4.83e-112 372.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4206.t1 P10079 42.969 512 7.94e-111 369.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4206.t1 P10079 43.671 474 2.02e-102 346.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4206.t1 P10079 42.737 475 4.19e-102 345.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4206.t1 P10079 42.459 431 5.05e-98 334.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4207.t1 Q9C098 57.827 313 3.75e-114 367.0 sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2 DCLK3_HUMAN reviewed Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310 protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g4207.t2 Q9C098 58.766 308 1.25e-116 373.0 sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2 DCLK3_HUMAN reviewed Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310 protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g4208.t1 P70182 55.027 547 0.0 565.0 sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2 g4208.t2 P70182 56.061 528 0.0 569.0 sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2 g4208.t3 P70182 55.027 547 0.0 565.0 sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2 g4209.t1 Q059Y8 28.71 620 1.33e-80 274.0 sp|Q059Y8|DCST1_MOUSE E3 ubiquitin-protein ligase DCST1 OS=Mus musculus OX=10090 GN=Dcst1 PE=1 SV=1 DCST1_MOUSE reviewed E3 ubiquitin-protein ligase DCST1 (EC 2.3.2.27) (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase) Mus musculus (Mouse) GO:0002080; GO:0005886; GO:0006511; GO:0007342; GO:0008270; GO:0016567; GO:0035036; GO:0045087; GO:0060339; GO:0061630 fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein ubiquitination [GO:0016567]; sperm-egg recognition [GO:0035036]; ubiquitin-dependent protein catabolic process [GO:0006511] acrosomal membrane [GO:0002080]; plasma membrane [GO:0005886] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4210.t1 Q32MH5 55.477 283 5.789999999999999e-82 292.0 sp|Q32MH5|ATOSA_HUMAN Atos homolog protein A OS=Homo sapiens OX=9606 GN=ATOSA PE=1 SV=2 ATOSA_HUMAN reviewed Atos homolog protein A Homo sapiens (Human) GO:0005634 nucleus [GO:0005634] g4210.t1 Q32MH5 41.949 236 1.07e-44 179.0 sp|Q32MH5|ATOSA_HUMAN Atos homolog protein A OS=Homo sapiens OX=9606 GN=ATOSA PE=1 SV=2 ATOSA_HUMAN reviewed Atos homolog protein A Homo sapiens (Human) GO:0005634 nucleus [GO:0005634] g4211.t1 Q9D845 43.602 422 1.38e-103 316.0 sp|Q9D845|TEX9_MOUSE Testis-expressed protein 9 OS=Mus musculus OX=10090 GN=Tex9 PE=2 SV=1 g4211.t2 Q9D845 43.23 421 1.4400000000000002e-103 316.0 sp|Q9D845|TEX9_MOUSE Testis-expressed protein 9 OS=Mus musculus OX=10090 GN=Tex9 PE=2 SV=1 g4215.t1 Q26627 24.51 1020 5.4200000000000004e-58 227.0 sp|Q26627|SUREJ_STRPU Sperm receptor for egg jelly OS=Strongylocentrotus purpuratus OX=7668 GN=REJ PE=1 SV=1 SUREJ_STRPU reviewed Sperm receptor for egg jelly (suREJ) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g4215.t2 Q26627 23.81 1050 5.22e-53 211.0 sp|Q26627|SUREJ_STRPU Sperm receptor for egg jelly OS=Strongylocentrotus purpuratus OX=7668 GN=REJ PE=1 SV=1 SUREJ_STRPU reviewed Sperm receptor for egg jelly (suREJ) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g4216.t1 O08762 32.308 325 2.37e-32 133.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g4218.t1 Q95218 44.34 212 9.73e-47 172.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g4218.t1 Q95218 39.754 244 7.95e-44 164.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g4218.t1 Q95218 39.056 233 6.21e-43 161.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g4218.t1 Q95218 38.723 235 3.54e-39 150.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g4218.t1 Q95218 38.197 233 3.5299999999999997e-38 147.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g4218.t1 Q95218 46.491 114 2.7899999999999997e-23 104.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g4218.t1 Q95218 45.794 107 2.2500000000000002e-21 98.6 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g4219.t1 P22897 30.864 1053 3.0699999999999997e-140 482.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 26.852 1296 8.92e-106 377.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 25.247 1216 5.43e-93 338.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 25.88 1221 5.01e-90 328.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 25.605 1199 3.41e-86 317.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 27.273 748 7.01e-53 209.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 26.991 741 1.57e-51 205.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 25.068 730 3.1000000000000003e-47 191.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 27.226 584 3.78e-41 171.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 24.074 756 1.9199999999999998e-40 169.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 23.74 615 2.75e-33 145.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 24.948 481 2.03e-31 139.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4219.t1 P22897 26.009 446 2.5599999999999998e-30 135.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 28.775 1053 6.07e-115 405.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 27.294 1253 5.3200000000000004e-107 381.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 26.277 1214 1.03e-86 318.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 26.476 1186 7.56e-83 306.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 24.354 1199 5.8300000000000004e-77 287.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 23.757 905 3.7999999999999997e-54 214.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 26.606 763 1.1e-53 212.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 28.217 645 9.79e-52 206.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 25.672 744 1.63e-47 192.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 25.201 746 1.56e-42 176.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4220.t1 P22897 24.007 579 1.13e-28 130.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4221.t1 Q61830 27.988 979 1.24e-99 348.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4221.t1 Q61830 26.504 981 2.37e-70 261.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4221.t1 Q61830 25.325 770 8.67e-60 228.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4221.t1 Q61830 24.318 917 1.1399999999999998e-52 206.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4221.t1 Q61830 26.769 523 1.88e-46 186.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4221.t1 Q61830 24.256 672 2.1799999999999999e-41 169.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4221.t2 Q61830 28.215 1042 1.49e-104 363.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4221.t2 Q61830 25.967 1086 1.4100000000000001e-73 271.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4222.t1 P22897 30.25 1081 1.5600000000000002e-122 429.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 25.886 1213 3.5e-86 317.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 26.825 1219 6.19e-85 313.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 25.945 1191 3.25e-81 301.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 26.618 1221 2.1200000000000002e-77 289.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 24.569 1217 1.94e-67 257.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 28.185 628 6.409999999999999e-52 206.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 24.703 757 6.15e-49 197.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 28.723 564 1.67e-48 195.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 24.934 762 1.3399999999999999e-45 186.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 24.114 734 1.86e-44 182.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 24.661 738 1.0299999999999999e-38 163.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 24.828 580 5.58e-38 161.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t1 P22897 26.667 390 8.8e-22 108.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 30.25 1081 1.53e-122 429.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 25.886 1213 3.43e-86 317.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 26.825 1219 6.29e-85 313.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 25.945 1191 3.1299999999999997e-81 301.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 26.618 1221 2.23e-77 289.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 23.908 1305 1.89e-67 257.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 28.185 628 6.349999999999999e-52 206.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 24.703 757 6.41e-49 197.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 28.723 564 1.74e-48 195.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 24.934 762 1.2899999999999999e-45 186.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 24.114 734 1.76e-44 182.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 24.661 738 9.93e-39 163.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 24.828 580 5.569999999999999e-38 161.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t2 P22897 26.667 390 8.87e-22 108.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 30.25 1081 1.24e-122 429.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 25.886 1213 2.87e-86 317.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 26.825 1219 4.94e-85 313.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 25.945 1191 2.42e-81 301.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 26.618 1221 1.82e-77 289.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 24.077 1300 2.81e-68 259.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 28.185 628 5.7099999999999995e-52 207.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 24.703 757 5.3900000000000004e-49 197.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 28.723 564 1.66e-48 195.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 24.934 762 1.2e-45 186.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 24.114 734 1.58e-44 182.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 24.661 738 8.86e-39 164.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 24.828 580 4.849999999999999e-38 161.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t3 P22897 26.667 390 8.26e-22 108.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 30.25 1081 1.1100000000000001e-122 429.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 25.886 1213 2.38e-86 317.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 26.825 1219 4.29e-85 313.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 25.945 1191 2.08e-81 301.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 26.618 1221 1.62e-77 289.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 23.938 1295 1.4999999999999998e-68 261.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 28.185 628 5.3299999999999996e-52 207.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 24.703 757 4.99e-49 197.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 28.723 564 1.5399999999999998e-48 196.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 24.934 762 1.0399999999999999e-45 186.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 24.114 734 1.43e-44 182.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 24.661 738 7.67e-39 164.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 24.828 580 4.72e-38 161.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4222.t4 P22897 26.667 390 7.780000000000001e-22 108.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g4224.t1 Q61249 40.361 332 6.22e-72 229.0 sp|Q61249|IGBP1_MOUSE Immunoglobulin-binding protein 1 OS=Mus musculus OX=10090 GN=Igbp1 PE=1 SV=1 g4225.t1 Q8BXK8 52.485 825 0.0 800.0 sp|Q8BXK8|AGAP1_MOUSE Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Agap1 PE=1 SV=1 AGAP1_MOUSE reviewed Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2) Mus musculus (Mouse) GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005829; GO:0008270; GO:0015031; GO:0098845; GO:0099159 protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159] cytosol [GO:0005829]; postsynaptic endosome [GO:0098845] GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g4225.t2 Q8BXK8 53.318 874 0.0 874.0 sp|Q8BXK8|AGAP1_MOUSE Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Agap1 PE=1 SV=1 AGAP1_MOUSE reviewed Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2) Mus musculus (Mouse) GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005829; GO:0008270; GO:0015031; GO:0098845; GO:0099159 protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159] cytosol [GO:0005829]; postsynaptic endosome [GO:0098845] GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g4225.t3 Q8BXK8 53.211 872 0.0 869.0 sp|Q8BXK8|AGAP1_MOUSE Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Agap1 PE=1 SV=1 AGAP1_MOUSE reviewed Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2) Mus musculus (Mouse) GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005829; GO:0008270; GO:0015031; GO:0098845; GO:0099159 protein transport [GO:0015031]; regulation of modification of postsynaptic structure [GO:0099159] cytosol [GO:0005829]; postsynaptic endosome [GO:0098845] GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g4226.t1 A7RHL5 80.488 82 1.23e-43 139.0 sp|A7RHL5|COSA_NEMVE Costars family protein v1g158749 OS=Nematostella vectensis OX=45351 GN=v1g158749 PE=3 SV=1 g4227.t1 Q9DBC0 55.556 657 0.0 699.0 sp|Q9DBC0|SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4 g4230.t1 Q9GNE2 92.143 140 1.81e-90 261.0 sp|Q9GNE2|RL23_AEDAE Large ribosomal subunit protein uL14 OS=Aedes aegypti OX=7159 GN=RpL23-A PE=2 SV=1 g4231.t1 Q68EF4 32.178 808 1.67e-123 397.0 sp|Q68EF4|GRM4_MOUSE Metabotropic glutamate receptor 4 OS=Mus musculus OX=10090 GN=Grm4 PE=1 SV=2 GRM4_MOUSE reviewed Metabotropic glutamate receptor 4 (mGluR4) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0004930; GO:0005516; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007612; GO:0008066; GO:0031410; GO:0043005; GO:0043195; GO:0043198; GO:0043410; GO:0048306; GO:0048787; GO:0051966; GO:0098688; GO:0098978; GO:0099171; GO:0150048 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; positive regulation of MAPK cascade [GO:0043410]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g4232.t1 Q9Y2M2 36.554 383 6.6299999999999994e-74 241.0 sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2 g4233.t1 Q91ZS8 57.342 647 0.0 715.0 sp|Q91ZS8|RED1_MOUSE Double-stranded RNA-specific editase 1 OS=Mus musculus OX=10090 GN=Adarb1 PE=1 SV=1 RED1_MOUSE reviewed Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase) Mus musculus (Mouse) GO:0003723; GO:0003725; GO:0003726; GO:0004000; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0016556; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050685; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251] g4234.t1 Q8CBE3 55.4 500 0.0 555.0 sp|Q8CBE3|WDR37_MOUSE WD repeat-containing protein 37 OS=Mus musculus OX=10090 GN=Wdr37 PE=1 SV=1 g4235.t1 Q66JY2 31.952 748 6.529999999999999e-68 251.0 sp|Q66JY2|IN80D_MOUSE INO80 complex subunit D OS=Mus musculus OX=10090 GN=Ino80d PE=2 SV=4 IN80D_MOUSE reviewed INO80 complex subunit D Mus musculus (Mouse) GO:0000723; GO:0005634; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] Ino80 complex [GO:0031011]; nucleus [GO:0005634] g4236.t1 Q7Z1B8 85.294 68 3.72e-39 126.0 sp|Q7Z1B8|S61G1_GRYOR Protein transport protein Sec61 subunit gamma OS=Gryllotalpa orientalis OX=213494 GN=SEC61G PE=3 SV=1 g4237.t1 Q9R0M5 51.948 231 3.61e-82 252.0 sp|Q9R0M5|TPK1_MOUSE Thiamine pyrophosphokinase 1 OS=Mus musculus OX=10090 GN=Tpk1 PE=1 SV=1 TPK1_MOUSE reviewed Thiamine pyrophosphokinase 1 (mTPK1) (EC 2.7.6.-) (Thiamin pyrophosphokinase 1) Mus musculus (Mouse) GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0010510; GO:0016301; GO:0030975; GO:0042802; GO:0141200 regulation of pyruvate decarboxylation to acetyl-CoA [GO:0010510]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772] cytosol [GO:0005829] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; UTP thiamine diphosphokinase activity [GO:0141200] g4238.t1 Q8K2A1 42.652 279 1.3499999999999999e-68 223.0 sp|Q8K2A1|GULP1_MOUSE PTB domain-containing engulfment adapter protein 1 OS=Mus musculus OX=10090 GN=Gulp1 PE=1 SV=1 g4238.t2 Q5PQS4 46.4 250 5.78e-69 223.0 sp|Q5PQS4|GULP1_RAT PTB domain-containing engulfment adapter protein 1 OS=Rattus norvegicus OX=10116 GN=Gulp1 PE=1 SV=1 GULP1_RAT reviewed PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP) Rattus norvegicus (Rat) GO:0005737; GO:0006869; GO:0006911; GO:0006915 apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911] cytoplasm [GO:0005737] g4241.t1 B0BN95 27.731 238 1.71e-22 101.0 sp|B0BN95|HARB1_RAT Putative nuclease HARBI1 OS=Rattus norvegicus OX=10116 GN=Harbi1 PE=2 SV=1 g4242.t1 O42350 47.018 1291 3.61e-179 580.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4242.t1 O42350 41.912 952 2.61e-70 264.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4242.t1 O42350 43.438 960 7.66e-68 256.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4242.t1 O42350 41.417 734 1.62e-42 174.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4243.t1 Q28668 38.544 371 3.93e-47 182.0 sp|Q28668|CO1A2_RABIT Collagen alpha-2(I) chain (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=COL1A2 PE=2 SV=1 g4243.t1 Q28668 39.925 268 5.860000000000001e-21 103.0 sp|Q28668|CO1A2_RABIT Collagen alpha-2(I) chain (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=COL1A2 PE=2 SV=1 g4244.t1 A2AX52 35.354 396 1.32e-35 152.0 sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2 CO6A4_MOUSE reviewed Collagen alpha-4(VI) chain Mus musculus (Mouse) GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991 cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] collagen type VI trimer [GO:0005589]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991] collagen binding [GO:0005518] g4244.t1 A2AX52 35.117 299 7.700000000000001e-27 124.0 sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2 CO6A4_MOUSE reviewed Collagen alpha-4(VI) chain Mus musculus (Mouse) GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991 cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] collagen type VI trimer [GO:0005589]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991] collagen binding [GO:0005518] g4244.t1 A2AX52 37.247 247 3.25e-23 112.0 sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2 CO6A4_MOUSE reviewed Collagen alpha-4(VI) chain Mus musculus (Mouse) GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991 cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] collagen type VI trimer [GO:0005589]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991] collagen binding [GO:0005518] g4245.t1 O42350 38.136 944 8.47e-105 357.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4245.t1 O42350 41.033 658 7.390000000000001e-47 186.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4245.t1 O42350 41.093 567 5.05e-41 167.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4245.t1 O42350 39.634 656 5.51e-41 167.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4245.t1 O42350 37.554 695 1.84e-39 162.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4245.t1 O42350 41.481 405 2.9300000000000003e-26 120.0 sp|O42350|CO1A2_AQUCT Collagen alpha-2(I) chain OS=Aquarana catesbeiana OX=8400 GN=COL1A2 PE=2 SV=1 g4246.t1 P02466 37.785 1318 8.1e-121 422.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 41.183 896 6.21e-75 280.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 40.537 819 1.7699999999999998e-61 237.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 41.704 892 3.34e-57 223.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 41.727 695 5.26e-55 216.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 39.704 879 9.019999999999999e-54 212.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 40.102 783 5.99e-53 209.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 41.86 602 7.15e-44 180.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 38.33 587 9.640000000000001e-31 137.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4246.t1 P02466 37.16 514 2.5e-30 135.0 sp|P02466|CO1A2_RAT Collagen alpha-2(I) chain OS=Rattus norvegicus OX=10116 GN=Col1a2 PE=1 SV=3 CO1A2_RAT reviewed Collagen alpha-2(I) chain (Alpha-2 type I collagen) Rattus norvegicus (Rat) GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096 blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen trimer [GO:0005581]; collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] g4247.t1 P25787 80.085 236 2.64e-141 397.0 sp|P25787|PSA2_HUMAN Proteasome subunit alpha type-2 OS=Homo sapiens OX=9606 GN=PSMA2 PE=1 SV=2 PSA2_HUMAN reviewed Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3) (Proteasome subunit alpha-2) (alpha-2) Homo sapiens (Human) GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0009615; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774] g4248.t1 Q2TBI6 42.424 165 7.6e-38 131.0 sp|Q2TBI6|RM32_BOVIN Large ribosomal subunit protein bL32m OS=Bos taurus OX=9913 GN=MRPL32 PE=1 SV=1 g4249.t1 Q96BD0 36.593 634 4.66e-130 404.0 sp|Q96BD0|SO4A1_HUMAN Solute carrier organic anion transporter family member 4A1 OS=Homo sapiens OX=9606 GN=SLCO4A1 PE=1 SV=2 g4253.t1 Q7ZXG7 68.261 230 1.4e-120 345.0 sp|Q7ZXG7|GAMTA_XENLA Guanidinoacetate N-methyltransferase A OS=Xenopus laevis OX=8355 GN=gamt-a PE=2 SV=1 g4257.t1 Q7ZXG7 70.614 228 3.3900000000000003e-124 354.0 sp|Q7ZXG7|GAMTA_XENLA Guanidinoacetate N-methyltransferase A OS=Xenopus laevis OX=8355 GN=gamt-a PE=2 SV=1 g4258.t1 Q60571 26.062 353 2.0299999999999998e-23 102.0 sp|Q60571|CRHBP_MOUSE Corticotropin-releasing factor-binding protein OS=Mus musculus OX=10090 GN=Crhbp PE=2 SV=1 CRHBP_MOUSE reviewed Corticotropin-releasing factor-binding protein (CRF-BP) (CRF-binding protein) (Corticotropin-releasing hormone-binding protein) (CRH-BP) Mus musculus (Mouse) GO:0001659; GO:0001963; GO:0002125; GO:0005615; GO:0005634; GO:0005737; GO:0005767; GO:0005771; GO:0005874; GO:0006954; GO:0007565; GO:0007613; GO:0009755; GO:0030141; GO:0030425; GO:0031045; GO:0035865; GO:0035903; GO:0042277; GO:0042445; GO:0042711; GO:0043196; GO:0043204; GO:0043679; GO:0045055; GO:0048149; GO:0051424; GO:0051459; GO:0051460; GO:0071277; GO:0071314; GO:0071320; GO:0071356; GO:0071391; GO:0071392; GO:0071466; GO:0071965; GO:0080135; GO:0097211; GO:1900011; GO:1903076; GO:2000310 behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to immobilization stress [GO:0035903]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inflammatory response [GO:0006954]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal locomotion [GO:0071965]; negative regulation of corticotropin secretion [GO:0051460]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; regulation of protein localization to plasma membrane [GO:1903076]; synaptic transmission, dopaminergic [GO:0001963]; temperature homeostasis [GO:0001659] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196] corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277] g4260.t1 Q6GNV7 30.837 454 8.34e-68 228.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g4261.t1 P54071 71.082 453 0.0 667.0 sp|P54071|IDHP_MOUSE Isocitrate dehydrogenase [NADP], mitochondrial OS=Mus musculus OX=10090 GN=Idh2 PE=1 SV=3 IDHP_MOUSE reviewed Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) Mus musculus (Mouse) GO:0000287; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006741; GO:0051287; GO:0060253; GO:1903976; GO:1904465 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP+ biosynthetic process [GO:0006741]; NADP+ metabolic process [GO:0006739]; negative regulation of glial cell migration [GO:1903976]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] g4262.t1 Q13423 65.903 1091 0.0 1417.0 sp|Q13423|NNTM_HUMAN NAD(P) transhydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=NNT PE=1 SV=3 NNTM_HUMAN reviewed NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) Homo sapiens (Human) GO:0003957; GO:0005739; GO:0005743; GO:0006099; GO:0006740; GO:0008750; GO:0010918; GO:0016020; GO:0032364; GO:0033273; GO:0043066; GO:0045454; GO:0050661; GO:0051287; GO:0072593; GO:0098803; GO:0098869; GO:1902600; GO:1903285 cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; intracellular oxygen homeostasis [GO:0032364]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex [GO:0098803] NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (Si-specific) activity [GO:0003957]; NADP binding [GO:0050661]; proton-translocating NAD(P)+ transhydrogenase activity [GO:0008750] g4263.t1 O15541 56.231 329 3.73e-127 370.0 sp|O15541|R113A_HUMAN E3 ubiquitin-protein ligase RNF113A OS=Homo sapiens OX=9606 GN=RNF113A PE=1 SV=1 R113A_HUMAN reviewed E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183) Homo sapiens (Human) GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0006281; GO:0008270; GO:0016567; GO:0016607; GO:0034247; GO:0061630; GO:0070100; GO:0071005 DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4264.t1 E1BD52 42.252 826 0.0 575.0 sp|E1BD52|TM245_BOVIN Transmembrane protein 245 OS=Bos taurus OX=9913 GN=TMEM245 PE=3 SV=1 g4264.t2 E1BD52 42.252 826 0.0 574.0 sp|E1BD52|TM245_BOVIN Transmembrane protein 245 OS=Bos taurus OX=9913 GN=TMEM245 PE=3 SV=1 g4266.t1 Q68FQ0 76.836 177 2.0499999999999997e-90 276.0 sp|Q68FQ0|TCPE_RAT T-complex protein 1 subunit epsilon OS=Rattus norvegicus OX=10116 GN=Cct5 PE=1 SV=1 TCPE_RAT reviewed T-complex protein 1 subunit epsilon (TCP-1-epsilon) (EC 3.6.1.-) (CCT-epsilon) Rattus norvegicus (Rat) GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0046872; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0140662 binding of sperm to zona pellucida [GO:0007339]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] g4267.t1 Q4R6V2 80.112 357 0.0 624.0 sp|Q4R6V2|TCPE_MACFA T-complex protein 1 subunit epsilon OS=Macaca fascicularis OX=9541 GN=CCT5 PE=2 SV=1 TCPE_MACFA reviewed T-complex protein 1 subunit epsilon (TCP-1-epsilon) (EC 3.6.1.-) (CCT-epsilon) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044297; GO:0046872; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0140662 binding of sperm to zona pellucida [GO:0007339]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; response to virus [GO:0009615] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082] g4270.t1 P22771 36.842 418 7.34e-84 266.0 sp|P22771|GLRA2_RAT Glycine receptor subunit alpha-2 OS=Rattus norvegicus OX=10116 GN=Glra2 PE=1 SV=1 g4271.t1 F1R8P4 41.566 166 1.55e-38 141.0 sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2 GLRA2_DANRE reviewed Glycine receptor subunit alpha-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004888; GO:0005231; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872; GO:1902476 chloride transmembrane transport [GO:1902476] cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211] chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824] g4272.t1 F1R8P4 38.095 189 3.0200000000000004e-35 130.0 sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2 GLRA2_DANRE reviewed Glycine receptor subunit alpha-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004888; GO:0005231; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872; GO:1902476 chloride transmembrane transport [GO:1902476] cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211] chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824] g4273.t1 Q640N1 37.662 154 1.79e-24 103.0 sp|Q640N1|AEBP1_MOUSE Adipocyte enhancer-binding protein 1 OS=Mus musculus OX=10090 GN=Aebp1 PE=1 SV=1 AEBP1_MOUSE reviewed Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0001227; GO:0004180; GO:0005516; GO:0005518; GO:0005615; GO:0005634; GO:0005737; GO:0006355; GO:0006508; GO:0008270; GO:1904026 negative regulation of transcription by RNA polymerase II [GO:0000122]; proteolysis [GO:0006508]; regulation of collagen fibril organization [GO:1904026]; regulation of DNA-templated transcription [GO:0006355] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g4274.t1 Q8N0X2 47.145 613 0.0 594.0 sp|Q8N0X2|SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens OX=9606 GN=SPAG16 PE=1 SV=2 SPG16_HUMAN reviewed Sperm-associated antigen 16 protein (Pf20 protein homolog) Homo sapiens (Human) GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716 axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288] axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126] g4276.t1 P32749 34.615 572 3.88e-101 322.0 sp|P32749|CHLE_BOVIN Cholinesterase OS=Bos taurus OX=9913 GN=BCHE PE=2 SV=2 g4277.t1 O75899 29.389 786 4.21e-99 332.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g4282.t1 O60494 40.468 3677 0.0 2677.0 sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5 CUBN_HUMAN reviewed Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Homo sapiens (Human) GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g4285.t1 P39021 80.488 82 3.21e-38 140.0 sp|P39021|MEOX2_XENLA Homeobox protein MOX-2 OS=Xenopus laevis OX=8355 GN=meox2 PE=2 SV=2 g4286.t1 Q8NEZ4 46.865 973 0.0 864.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g4286.t1 Q8NEZ4 40.044 899 5.64e-155 550.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g4286.t1 Q8NEZ4 40.858 536 1.3e-114 416.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g4286.t1 Q8NEZ4 35.751 193 3.98e-33 147.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g4286.t1 Q8NEZ4 36.066 183 2.14e-32 144.0 sp|Q8NEZ4|KMT2C_HUMAN Histone-lysine N-methyltransferase 2C OS=Homo sapiens OX=9606 GN=KMT2C PE=1 SV=3 KMT2C_HUMAN reviewed Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Homo sapiens (Human) GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0140945 methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g4287.t1 Q8BG39 35.227 352 1.46e-57 207.0 sp|Q8BG39|SV2B_MOUSE Synaptic vesicle glycoprotein 2B OS=Mus musculus OX=10090 GN=Sv2b PE=1 SV=1 SV2B_MOUSE reviewed Synaptic vesicle glycoprotein 2B (Synaptic vesicle protein 2B) Mus musculus (Mouse) GO:0001669; GO:0006836; GO:0007268; GO:0008021; GO:0022857; GO:0030672; GO:0098978; GO:0099509; GO:2000300 chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300] acrosomal vesicle [GO:0001669]; glutamatergic synapse [GO:0098978]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] transmembrane transporter activity [GO:0022857] g4287.t1 Q8BG39 37.356 174 4e-23 107.0 sp|Q8BG39|SV2B_MOUSE Synaptic vesicle glycoprotein 2B OS=Mus musculus OX=10090 GN=Sv2b PE=1 SV=1 SV2B_MOUSE reviewed Synaptic vesicle glycoprotein 2B (Synaptic vesicle protein 2B) Mus musculus (Mouse) GO:0001669; GO:0006836; GO:0007268; GO:0008021; GO:0022857; GO:0030672; GO:0098978; GO:0099509; GO:2000300 chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300] acrosomal vesicle [GO:0001669]; glutamatergic synapse [GO:0098978]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] transmembrane transporter activity [GO:0022857] g4289.t1 Q5NVI9 66.584 401 0.0 520.0 sp|Q5NVI9|DNJA1_PONAB DnaJ homolog subfamily A member 1 OS=Pongo abelii OX=9601 GN=DNAJA1 PE=2 SV=1 DNJA1_PONAB reviewed DnaJ homolog subfamily A member 1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0006457; GO:0008270; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585 negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408] membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; Hsp70 protein binding [GO:0030544]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] g4290.t1 Q9R1X4 46.982 1143 0.0 1011.0 sp|Q9R1X4|TIM_MOUSE Protein timeless homolog OS=Mus musculus OX=10090 GN=Timeless PE=1 SV=3 g4291.t1 P24524 35.782 422 1.6999999999999999e-84 269.0 sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1 GLRA3_RAT reviewed Glycine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0004888; GO:0005231; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099171; GO:0099634; GO:1902476 cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260] dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734] excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888] g4291.t2 P24524 37.94 398 9.75e-90 281.0 sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1 GLRA3_RAT reviewed Glycine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0004888; GO:0005231; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099171; GO:0099634; GO:1902476 cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260] dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734] excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888] g4292.t1 Q711G3 49.785 233 4.98e-78 238.0 sp|Q711G3|IAH1_RAT Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Rattus norvegicus OX=10116 GN=Iah1 PE=2 SV=2 g4292.t2 Q711G3 49.573 234 2.38e-71 220.0 sp|Q711G3|IAH1_RAT Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Rattus norvegicus OX=10116 GN=Iah1 PE=2 SV=2 g4295.t1 P23640 72.727 220 4.96e-116 333.0 sp|P23640|RB27A_RAT Ras-related protein Rab-27A OS=Rattus norvegicus OX=10116 GN=Rab27a PE=1 SV=1 RB27A_RAT reviewed Ras-related protein Rab-27A (Rab-27) (EC 3.6.5.2) (GTP-binding protein Ram) (Ram p25) Rattus norvegicus (Rat) GO:0001750; GO:0003924; GO:0003925; GO:0005525; GO:0005764; GO:0005770; GO:0005794; GO:0006887; GO:0007596; GO:0009306; GO:0010628; GO:0016192; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0031489; GO:0032400; GO:0032402; GO:0032585; GO:0033093; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0043473; GO:0045921; GO:0050766; GO:0051875; GO:0051904; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182 antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; pigment granule localization [GO:0051875]; pigment granule transport [GO:0051904]; pigmentation [GO:0043473]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; Weibel-Palade body [GO:0033093] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904] g4296.t1 Q32N87 50.0 202 1.67e-40 162.0 sp|Q32N87|HDGR2_XENLA Hepatoma-derived growth factor-related protein 2 OS=Xenopus laevis OX=8355 GN=hdgfl2 PE=2 SV=1 g4297.t1 O35589 36.785 367 1.72e-57 203.0 sp|O35589|NAB1_MESAU NGFI-A-binding protein 1 OS=Mesocricetus auratus OX=10036 GN=NAB1 PE=2 SV=1 g4297.t2 O35589 38.554 332 1e-56 202.0 sp|O35589|NAB1_MESAU NGFI-A-binding protein 1 OS=Mesocricetus auratus OX=10036 GN=NAB1 PE=2 SV=1 g4298.t1 A0ZSK3 29.808 520 3.91e-62 230.0 sp|A0ZSK3|STXA_SYNVE Neoverrucotoxin subunit alpha OS=Synanceia verrucosa OX=51996 PE=1 SV=1 STXA_SYNVE reviewed Neoverrucotoxin subunit alpha (NeoVTX subunit alpha) Synanceia verrucosa (Reef stonefish) GO:0005576; GO:0031640; GO:0090729 killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] toxin activity [GO:0090729] g4299.t2 P70039 40.243 1563 0.0 799.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t2 P70039 43.621 243 1.29e-33 147.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t2 P70039 31.004 458 2.1e-21 107.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t3 P70039 40.243 1563 0.0 798.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t3 P70039 43.621 243 1.3200000000000001e-33 147.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t3 P70039 31.004 458 2.32e-21 107.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t4 P70039 40.243 1563 0.0 798.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t4 P70039 43.852 244 1.02e-32 144.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4299.t4 P70039 31.004 458 2.36e-21 107.0 sp|P70039|APC_XENLA Adenomatous polyposis coli homolog OS=Xenopus laevis OX=8355 GN=apc PE=1 SV=2 APC_XENLA reviewed Adenomatous polyposis coli homolog (Protein APC) Xenopus laevis (African clawed frog) GO:0000776; GO:0001708; GO:0005634; GO:0005737; GO:0005813; GO:0005881; GO:0006974; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0016055; GO:0016342; GO:0016477; GO:0019887; GO:0030054; GO:0030877; GO:0044877; GO:0045295; GO:0045736; GO:0065003; GO:0090090; GO:0120025; GO:1902807 cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; protein-containing complex assembly [GO:0065003]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; nucleus [GO:0005634]; plasma membrane bounded cell projection [GO:0120025] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] g4301.t1 A5PKH3 69.784 417 0.0 625.0 sp|A5PKH3|FAAA_BOVIN Fumarylacetoacetase OS=Bos taurus OX=9913 GN=FAH PE=2 SV=1 g4303.t1 Q9BZV1 33.438 317 1.16e-53 186.0 sp|Q9BZV1|UBXN6_HUMAN UBX domain-containing protein 6 OS=Homo sapiens OX=9606 GN=UBXN6 PE=1 SV=1 UBXN6_HUMAN reviewed UBX domain-containing protein 6 (UBX domain-containing protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005813; GO:0005829; GO:0016020; GO:0016236; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503; GO:0051117; GO:0070062 endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATPase binding [GO:0051117] g4304.t1 Q99PL6 41.943 453 2.06e-96 300.0 sp|Q99PL6|UBXN6_MOUSE UBX domain-containing protein 6 OS=Mus musculus OX=10090 GN=Ubxn6 PE=1 SV=1 g4305.t1 P11980 63.83 517 0.0 684.0 sp|P11980|KPYM_RAT Pyruvate kinase PKM OS=Rattus norvegicus OX=10116 GN=Pkm PE=1 SV=3 KPYM_RAT reviewed Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) Rattus norvegicus (Rat) GO:0000287; GO:0001666; GO:0001889; GO:0001917; GO:0003713; GO:0003729; GO:0004713; GO:0004715; GO:0004743; GO:0005524; GO:0005634; GO:0005737; GO:0005791; GO:0005829; GO:0005929; GO:0006006; GO:0006096; GO:0007584; GO:0009629; GO:0012501; GO:0014870; GO:0030955; GO:0031100; GO:0032868; GO:0032869; GO:0035402; GO:0042802; GO:0042803; GO:0042866; GO:0043403; GO:0043531; GO:0045944; GO:0046983; GO:0051262; GO:0051289; GO:0061621; GO:0070324; GO:1902912; GO:1903672; GO:2000767 animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791] ADP binding [GO:0043531]; ATP binding [GO:0005524]; histone H3T11 kinase activity [GO:0035402]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; potassium ion binding [GO:0030955]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]; transcription coactivator activity [GO:0003713] g4306.t1 P11980 62.863 517 0.0 672.0 sp|P11980|KPYM_RAT Pyruvate kinase PKM OS=Rattus norvegicus OX=10116 GN=Pkm PE=1 SV=3 KPYM_RAT reviewed Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) Rattus norvegicus (Rat) GO:0000287; GO:0001666; GO:0001889; GO:0001917; GO:0003713; GO:0003729; GO:0004713; GO:0004715; GO:0004743; GO:0005524; GO:0005634; GO:0005737; GO:0005791; GO:0005829; GO:0005929; GO:0006006; GO:0006096; GO:0007584; GO:0009629; GO:0012501; GO:0014870; GO:0030955; GO:0031100; GO:0032868; GO:0032869; GO:0035402; GO:0042802; GO:0042803; GO:0042866; GO:0043403; GO:0043531; GO:0045944; GO:0046983; GO:0051262; GO:0051289; GO:0061621; GO:0070324; GO:1902912; GO:1903672; GO:2000767 animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; liver development [GO:0001889]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; pyruvate biosynthetic process [GO:0042866]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; pyruvate kinase complex [GO:1902912]; rough endoplasmic reticulum [GO:0005791] ADP binding [GO:0043531]; ATP binding [GO:0005524]; histone H3T11 kinase activity [GO:0035402]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; potassium ion binding [GO:0030955]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; thyroid hormone binding [GO:0070324]; transcription coactivator activity [GO:0003713] g4307.t1 Q6PBH5 50.0 82 1.12e-25 93.6 sp|Q6PBH5|NDUA4_DANRE Cytochrome c oxidase subunit NDUFA4 OS=Danio rerio OX=7955 GN=ndufa4 PE=3 SV=1 g4308.t1 O94880 47.162 687 0.0 614.0 sp|O94880|PHF14_HUMAN PHD finger protein 14 OS=Homo sapiens OX=9606 GN=PHF14 PE=1 SV=3 PHF14_HUMAN reviewed PHD finger protein 14 Homo sapiens (Human) GO:0000122; GO:0000785; GO:0002314; GO:0005634; GO:0005694; GO:0005737; GO:0008270; GO:0008285; GO:0042393; GO:0048286; GO:0060916; GO:0072201; GO:0140566; GO:2000584; GO:2000791 germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; mesenchymal cell proliferation involved in lung development [GO:0060916]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] histone binding [GO:0042393]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270] g4309.t1 Q5U3W3 38.235 442 1.32e-76 251.0 sp|Q5U3W3|RUN3B_DANRE RUN domain-containing protein 3B OS=Danio rerio OX=7955 GN=rundc3b PE=2 SV=1 g4310.t1 Q7T330 80.939 362 0.0 596.0 sp|Q7T330|SPOP_DANRE Speckle-type POZ protein OS=Danio rerio OX=7955 GN=spop PE=2 SV=1 g4310.t2 Q7T330 81.163 361 0.0 600.0 sp|Q7T330|SPOP_DANRE Speckle-type POZ protein OS=Danio rerio OX=7955 GN=spop PE=2 SV=1 g4311.t1 P22303 35.088 570 9.149999999999999e-94 303.0 sp|P22303|ACES_HUMAN Acetylcholinesterase OS=Homo sapiens OX=9606 GN=ACHE PE=1 SV=1 ACES_HUMAN reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Homo sapiens (Human) GO:0001507; GO:0001540; GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007399; GO:0007416; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0031594; GO:0031623; GO:0032223; GO:0042166; GO:0042803; GO:0042982; GO:0043083; GO:0043236; GO:0045202; GO:0048471; GO:0050714; GO:0060041; GO:0095500; GO:0098552; GO:0120162 acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416] basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; synapse [GO:0045202]; synaptic cleft [GO:0043083] acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; serine hydrolase activity [GO:0017171] g4312.t1 Q869C3 35.409 562 7.699999999999999e-104 332.0 sp|Q869C3|ACES_ANOGA Acetylcholinesterase OS=Anopheles gambiae OX=7165 GN=Ace PE=1 SV=3 g4313.t1 O62763 36.299 562 7.95e-99 316.0 sp|O62763|ACES_FELCA Acetylcholinesterase OS=Felis catus OX=9685 GN=ACHE PE=3 SV=1 g4314.t1 P04058 36.803 538 3.38e-99 316.0 sp|P04058|ACES_TETCF Acetylcholinesterase OS=Tetronarce californica OX=7787 GN=ache PE=1 SV=2 g4315.t1 P06276 32.472 619 2.3399999999999998e-104 330.0 sp|P06276|CHLE_HUMAN Cholinesterase OS=Homo sapiens OX=9606 GN=BCHE PE=1 SV=1 CHLE_HUMAN reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) Homo sapiens (Human) GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0006805; GO:0007612; GO:0008285; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050784; GO:0050805; GO:0051384; GO:0051593; GO:0072562 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine catabolic process [GO:0050784]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802] g4316.t1 P21836 34.744 567 3.3199999999999994e-95 306.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 g4316.t2 P21836 34.744 567 8.87e-95 305.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 g4318.t1 P81908 35.428 573 6.84e-107 336.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 CHLE_HORSE reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase) Equus caballus (Horse) GO:0003990; GO:0004104; GO:0005615; GO:0005886; GO:0006581; GO:0019695 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695] extracellular space [GO:0005615]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104] g4320.t1 P81908 35.602 573 1.66e-107 338.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 CHLE_HORSE reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase) Equus caballus (Horse) GO:0003990; GO:0004104; GO:0005615; GO:0005886; GO:0006581; GO:0019695 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695] extracellular space [GO:0005615]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104] g4321.t1 P21836 35.355 577 3.83e-100 329.0 sp|P21836|ACES_MOUSE Acetylcholinesterase OS=Mus musculus OX=10090 GN=Ache PE=1 SV=1 g4323.t1 O62761 34.238 479 4.96e-81 265.0 sp|O62761|CHLE_PANTT Cholinesterase OS=Panthera tigris tigris OX=74535 GN=BCHE PE=2 SV=1 g4324.t1 Q6PHD9 69.684 475 0.0 701.0 sp|Q6PHD9|SBP1_DANRE Methanethiol oxidase OS=Danio rerio OX=7955 GN=selenbp1 PE=2 SV=1 g4325.t1 Q60520 60.981 856 0.0 1059.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g4325.t1 Q60520 57.613 243 8.76e-58 223.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g4325.t1 Q60520 48.182 110 2.4099999999999998e-24 115.0 sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3 SIN3A_MOUSE reviewed Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351 activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g4326.t1 Q9ERE7 56.477 193 1.73e-67 214.0 sp|Q9ERE7|MESD_MOUSE LRP chaperone MESD OS=Mus musculus OX=10090 GN=Mesd PE=1 SV=1 MESD_MOUSE reviewed LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) Mus musculus (Mouse) GO:0001503; GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0010561; GO:0016055; GO:0030177; GO:0034394; GO:0042802; GO:0044183; GO:0050750; GO:0072659; GO:1904395 mesoderm development [GO:0007498]; negative regulation of glycoprotein biosynthetic process [GO:0010561]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of Wnt signaling pathway [GO:0030177]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; protein folding chaperone [GO:0044183] g4327.t1 Q7TQ95 42.623 366 8.19e-86 270.0 sp|Q7TQ95|LNP_MOUSE Endoplasmic reticulum junction formation protein lunapark OS=Mus musculus OX=10090 GN=Lnpk PE=1 SV=1 LNP_MOUSE reviewed Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark) (Protein ulnaless) Mus musculus (Mouse) GO:0005654; GO:0005783; GO:0005789; GO:0007029; GO:0007596; GO:0008270; GO:0032330; GO:0035115; GO:0042733; GO:0042802; GO:0071782; GO:0071786; GO:0071788; GO:0098826; GO:1903373 blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] g4327.t2 Q7TQ95 42.35 366 4.21e-85 268.0 sp|Q7TQ95|LNP_MOUSE Endoplasmic reticulum junction formation protein lunapark OS=Mus musculus OX=10090 GN=Lnpk PE=1 SV=1 LNP_MOUSE reviewed Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark) (Protein ulnaless) Mus musculus (Mouse) GO:0005654; GO:0005783; GO:0005789; GO:0007029; GO:0007596; GO:0008270; GO:0032330; GO:0035115; GO:0042733; GO:0042802; GO:0071782; GO:0071786; GO:0071788; GO:0098826; GO:1903373 blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] g4328.t1 P31937 69.957 233 7.14e-115 339.0 sp|P31937|3HIDH_HUMAN 3-hydroxyisobutyrate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HIBADH PE=1 SV=2 3HIDH_HUMAN reviewed 3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0050661; GO:0051287 L-valine catabolic process [GO:0006574] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661] g4329.t1 A7T1N0 40.72 1611 0.0 1112.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g4329.t2 A7T1N0 40.589 1631 0.0 1113.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g4330.t1 A7T1N0 39.641 1617 0.0 1083.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g4331.t1 Q6GNV7 34.924 461 6.39e-80 260.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g4332.t1 P11936 45.211 261 2.4700000000000002e-70 221.0 sp|P11936|DNAS1_PIG Deoxyribonuclease-1 OS=Sus scrofa OX=9823 GN=DNASE1 PE=1 SV=2 g4333.t1 Q9D1G0 42.912 261 3.1400000000000005e-73 228.0 sp|Q9D1G0|DNSL2_MOUSE Deoxyribonuclease-1-like 2 OS=Mus musculus OX=10090 GN=Dnase1l2 PE=2 SV=1 DNSL2_MOUSE reviewed Deoxyribonuclease-1-like 2 (EC 3.1.21.-) (Deoxyribonuclease I-like 2) (DNase I-like 2) Mus musculus (Mouse) GO:0001942; GO:0003335; GO:0003677; GO:0004530; GO:0004536; GO:0005576; GO:0005634; GO:0005737; GO:0006308; GO:0046872 corneocyte development [GO:0003335]; DNA catabolic process [GO:0006308]; hair follicle development [GO:0001942] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634] deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; DNA nuclease activity [GO:0004536]; metal ion binding [GO:0046872] g4334.t1 P00639 48.837 258 5.1499999999999997e-82 251.0 sp|P00639|DNAS1_BOVIN Deoxyribonuclease-1 OS=Bos taurus OX=9913 GN=DNASE1 PE=1 SV=3 DNAS1_BOVIN reviewed Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) Bos taurus (Bovine) GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0042588; GO:0070948 apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948] extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588] actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677] g4337.t1 P49165 66.321 386 0.0 524.0 sp|P49165|RL4_URECA Large ribosomal subunit protein uL4 OS=Urechis caupo OX=6431 GN=RPL4 PE=2 SV=1 g4338.t1 Q0IJ01 31.712 514 3.31e-69 238.0 sp|Q0IJ01|ZWILC_XENTR Protein zwilch homolog OS=Xenopus tropicalis OX=8364 GN=zwilch PE=2 SV=1 g4343.t1 Q5T2R2 59.475 343 3.06e-145 422.0 sp|Q5T2R2|DPS1_HUMAN All trans-polyprenyl-diphosphate synthase PDSS1 OS=Homo sapiens OX=9606 GN=PDSS1 PE=1 SV=1 DPS1_HUMAN reviewed All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1) Homo sapiens (Human) GO:0004659; GO:0005739; GO:0005759; GO:0006744; GO:0008299; GO:0032476; GO:0032478; GO:0046872; GO:0046982; GO:0052923; GO:0097269; GO:0110142 isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; ubiquinone biosynthesis complex [GO:0110142] all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982] g4344.t1 Q9Y490 60.246 2601 0.0 2992.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g4344.t2 Q9Y490 60.409 2594 0.0 3000.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g4344.t3 Q9Y490 60.996 2569 0.0 3008.0 sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3 TLN1_HUMAN reviewed Talin-1 Homo sapiens (Human) GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030036; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0043622; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] g4345.t1 B7NLA1 29.502 261 5.2e-30 119.0 sp|B7NLA1|GHRA_ECO7I Glyoxylate/hydroxypyruvate reductase A OS=Escherichia coli O7:K1 (strain IAI39 / ExPEC) OX=585057 GN=ghrA PE=3 SV=1 GHRA_ECO7I reviewed Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase) Escherichia coli O7:K1 (strain IAI39 / ExPEC) GO:0005829; GO:0008465; GO:0030267; GO:0051287; GO:0120509 cytosol [GO:0005829] glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; NAD binding [GO:0051287] g4345.t3 B7NLA1 29.461 241 1.1700000000000001e-27 112.0 sp|B7NLA1|GHRA_ECO7I Glyoxylate/hydroxypyruvate reductase A OS=Escherichia coli O7:K1 (strain IAI39 / ExPEC) OX=585057 GN=ghrA PE=3 SV=1 GHRA_ECO7I reviewed Glyoxylate/hydroxypyruvate reductase A (EC 1.1.1.79) (EC 1.1.1.81) (2-ketoacid reductase) Escherichia coli O7:K1 (strain IAI39 / ExPEC) GO:0005829; GO:0008465; GO:0030267; GO:0051287; GO:0120509 cytosol [GO:0005829] glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; NAD binding [GO:0051287] g4346.t1 A7T1N0 29.264 1196 2.03e-139 481.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g4346.t1 A7T1N0 28.754 1172 3.97e-122 429.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g4348.t1 Q9NZQ8 29.863 1095 5.51e-133 440.0 sp|Q9NZQ8|TRPM5_HUMAN Transient receptor potential cation channel subfamily M member 5 OS=Homo sapiens OX=9606 GN=TRPM5 PE=1 SV=1 g4355.t1 P34147 37.24 529 8.89e-106 337.0 sp|P34147|RACA_DICDI Rho-related protein racA OS=Dictyostelium discoideum OX=44689 GN=racA PE=1 SV=2 g4355.t1 P34147 40.223 179 3.15e-35 145.0 sp|P34147|RACA_DICDI Rho-related protein racA OS=Dictyostelium discoideum OX=44689 GN=racA PE=1 SV=2 g4356.t1 P34147 45.868 593 9.929999999999999e-170 500.0 sp|P34147|RACA_DICDI Rho-related protein racA OS=Dictyostelium discoideum OX=44689 GN=racA PE=1 SV=2 g4357.t1 Q9IA18 56.081 148 1.13e-40 151.0 sp|Q9IA18|EVX2_HETFR Homeobox even-skipped homolog protein 2 OS=Heterodontus francisci OX=7792 GN=EVX2 PE=3 SV=1 g4360.t1 Q08821 56.154 130 2.56e-39 142.0 sp|Q08821|HXA1_XENLA Homeobox protein Hox-A1 (Fragment) OS=Xenopus laevis OX=8355 GN=hoxa1 PE=2 SV=1 g4363.t1 P31245 53.175 126 9.88e-35 129.0 sp|P31245|HXA2_MOUSE Homeobox protein Hox-A2 OS=Mus musculus OX=10090 GN=Hoxa2 PE=2 SV=1 HXA2_MOUSE reviewed Homeobox protein Hox-A2 (Homeobox protein Hox-1.11) (Hox1.11) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0002076; GO:0005634; GO:0005654; GO:0006357; GO:0007379; GO:0007389; GO:0008045; GO:0009952; GO:0009953; GO:0021568; GO:0021569; GO:0021658; GO:0035284; GO:0042474; GO:0043565; GO:0045165; GO:0045665; GO:0045668; GO:0045944; GO:0048703; GO:0048704; GO:0048706; GO:0060037; GO:0061061; GO:0071300; GO:1990837 anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system development [GO:0048706]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; muscle structure development [GO:0061061]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 2 development [GO:0021568]; rhombomere 3 development [GO:0021569]; rhombomere 3 morphogenesis [GO:0021658]; segment specification [GO:0007379] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g4364.t1 Q3V5Z9 62.81 121 1.1e-40 149.0 sp|Q3V5Z9|HXD3_ORYLA Homeobox protein Hox-D3 OS=Oryzias latipes OX=8090 GN=hoxd3a PE=3 SV=1 g4365.t1 Q9PWM3 48.43 223 8.5e-52 173.0 sp|Q9PWM3|HXC4A_DANRE Homeobox protein Hox-C4a OS=Danio rerio OX=7955 GN=hoxc4a PE=2 SV=1 g4367.t1 P09077 67.593 108 3.6499999999999997e-45 159.0 sp|P09077|SCR_DROME Homeotic protein Sex combs reduced OS=Drosophila melanogaster OX=7227 GN=Scr PE=1 SV=5 SCR_DROME reviewed Homeotic protein Sex combs reduced Drosophila melanogaster (Fruit fly) GO:0000977; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0007432; GO:0007494; GO:0009952; GO:0042803; GO:0043565; GO:0045498; GO:0045944 anterior/posterior pattern specification [GO:0009952]; midgut development [GO:0007494]; positive regulation of transcription by RNA polymerase II [GO:0045944]; salivary gland boundary specification [GO:0007432]; sex comb development [GO:0045498] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565] g4370.t1 P13545 48.669 263 5.0200000000000004e-58 190.0 sp|P13545|HMB1_STRPU Homeobox protein HB1 OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g4371.t1 P09071 34.875 281 5.32e-39 139.0 sp|P09071|HXA7_XENLA Homeobox protein Hox-A7 OS=Xenopus laevis OX=8355 GN=hoxa7 PE=2 SV=1 g4374.t1 P10179 87.671 73 1.9299999999999997e-42 145.0 sp|P10179|HMB4_TRIGR Homeobox protein HB4 (Fragment) OS=Tripneustes gratilla OX=7673 PE=3 SV=1 g4376.t1 P24340 81.034 58 2.58e-28 107.0 sp|P24340|HXD9_CHICK Homeobox protein Hox-D9 (Fragment) OS=Gallus gallus OX=9031 GN=HOXD9 PE=2 SV=1 g4377.t1 P24340 67.797 59 7.35e-23 92.4 sp|P24340|HXD9_CHICK Homeobox protein Hox-D9 (Fragment) OS=Gallus gallus OX=9031 GN=HOXD9 PE=2 SV=1 g4378.t1 P23459 47.321 112 2.0200000000000003e-21 91.7 sp|P23459|HXD8_CHICK Homeobox protein Hox-D8 OS=Gallus gallus OX=9031 GN=HOXD8 PE=2 SV=1 g4384.t1 P35604 61.413 184 1.1900000000000001e-77 231.0 sp|P35604|COPZ1_BOVIN Coatomer subunit zeta-1 OS=Bos taurus OX=9913 GN=COPZ1 PE=1 SV=2 g4384.t2 Q5R5F2 61.446 166 8.97e-71 213.0 sp|Q5R5F2|COPZ1_PONAB Coatomer subunit zeta-1 OS=Pongo abelii OX=9601 GN=COPZ1 PE=2 SV=1 g4386.t1 Q5ZL67 31.542 577 2.49e-53 197.0 sp|Q5ZL67|NF2L1_CHICK Endoplasmic reticulum membrane sensor NFE2L1 OS=Gallus gallus OX=9031 GN=NFE2L1 PE=2 SV=1 NF2L1_CHICK reviewed Endoplasmic reticulum membrane sensor NFE2L1 (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) [Cleaved into: Transcription factor NRF1] Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0005634; GO:0005789; GO:0006357; GO:0008203; GO:0008289 cholesterol metabolic process [GO:0008203]; regulation of transcription by RNA polymerase II [GO:0006357] endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lipid binding [GO:0008289]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g4387.t1 A7MBC7 34.336 399 1.59e-57 197.0 sp|A7MBC7|NEMP1_BOVIN Nuclear envelope integral membrane protein 1 OS=Bos taurus OX=9913 GN=NEMP1 PE=2 SV=1 g4389.t1 Q4KMD7 35.569 641 6.3e-116 376.0 sp|Q4KMD7|STPAP_DANRE Speckle targeted PIP5K1A-regulated poly(A) polymerase OS=Danio rerio OX=7955 GN=tut1 PE=2 SV=1 STPAP_DANRE reviewed Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003730; GO:0005524; GO:0005730; GO:0005847; GO:0008270; GO:0016180; GO:0016607; GO:0031123; GO:0050265; GO:0140767; GO:0180010; GO:1990817 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; RNA 3'-end processing [GO:0031123]; snRNA processing [GO:0016180] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; mRNA 3'-UTR binding [GO:0003730]; poly(A) RNA polymerase activity [GO:1990817]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270] g4390.t1 O15973 36.232 207 1.84e-28 122.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g4391.t1 P54357 56.944 144 7.53e-57 177.0 sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1 g4392.t1 O02828 56.643 143 1.2999999999999998e-42 159.0 sp|O02828|TAU_CAPHI Microtubule-associated protein tau OS=Capra hircus OX=9925 GN=MAPT PE=2 SV=3 g4392.t1 O02828 54.412 136 8.430000000000001e-35 137.0 sp|O02828|TAU_CAPHI Microtubule-associated protein tau OS=Capra hircus OX=9925 GN=MAPT PE=2 SV=3 g4392.t1 O02828 31.227 269 2.18e-26 114.0 sp|O02828|TAU_CAPHI Microtubule-associated protein tau OS=Capra hircus OX=9925 GN=MAPT PE=2 SV=3 g4392.t1 O02828 54.082 98 7e-22 100.0 sp|O02828|TAU_CAPHI Microtubule-associated protein tau OS=Capra hircus OX=9925 GN=MAPT PE=2 SV=3 g4392.t2 Q6TS35 53.642 151 2.4500000000000003e-43 162.0 sp|Q6TS35|TAU_SPECI Microtubule-associated protein tau OS=Spermophilus citellus OX=9997 GN=MAPT PE=1 SV=3 TAU_SPECI reviewed Microtubule-associated protein tau Spermophilus citellus (European ground squirrel) (Citellus citellus) GO:0000226; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425; GO:0031175; GO:0042750 hibernation [GO:0042750]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886] microtubule binding [GO:0008017] g4392.t2 Q6TS35 54.412 136 1.37e-34 138.0 sp|Q6TS35|TAU_SPECI Microtubule-associated protein tau OS=Spermophilus citellus OX=9997 GN=MAPT PE=1 SV=3 TAU_SPECI reviewed Microtubule-associated protein tau Spermophilus citellus (European ground squirrel) (Citellus citellus) GO:0000226; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425; GO:0031175; GO:0042750 hibernation [GO:0042750]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886] microtubule binding [GO:0008017] g4392.t2 Q6TS35 40.506 158 5.32e-28 119.0 sp|Q6TS35|TAU_SPECI Microtubule-associated protein tau OS=Spermophilus citellus OX=9997 GN=MAPT PE=1 SV=3 TAU_SPECI reviewed Microtubule-associated protein tau Spermophilus citellus (European ground squirrel) (Citellus citellus) GO:0000226; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425; GO:0031175; GO:0042750 hibernation [GO:0042750]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886] microtubule binding [GO:0008017] g4392.t2 Q6TS35 46.099 141 1.43e-27 118.0 sp|Q6TS35|TAU_SPECI Microtubule-associated protein tau OS=Spermophilus citellus OX=9997 GN=MAPT PE=1 SV=3 TAU_SPECI reviewed Microtubule-associated protein tau Spermophilus citellus (European ground squirrel) (Citellus citellus) GO:0000226; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425; GO:0031175; GO:0042750 hibernation [GO:0042750]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886] microtubule binding [GO:0008017] g4392.t2 Q6TS35 54.082 98 7.1e-22 101.0 sp|Q6TS35|TAU_SPECI Microtubule-associated protein tau OS=Spermophilus citellus OX=9997 GN=MAPT PE=1 SV=3 TAU_SPECI reviewed Microtubule-associated protein tau Spermophilus citellus (European ground squirrel) (Citellus citellus) GO:0000226; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0008017; GO:0030424; GO:0030425; GO:0031175; GO:0042750 hibernation [GO:0042750]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; plasma membrane [GO:0005886] microtubule binding [GO:0008017] g4393.t1 Q9H777 48.343 362 5.8499999999999995e-108 331.0 sp|Q9H777|RNZ1_HUMAN Zinc phosphodiesterase ELAC protein 1 OS=Homo sapiens OX=9606 GN=ELAC1 PE=1 SV=2 g4394.t1 Q5BJ29 45.0 500 6.51e-143 422.0 sp|Q5BJ29|FBXL7_MOUSE F-box/LRR-repeat protein 7 OS=Mus musculus OX=10090 GN=Fbxl7 PE=1 SV=1 FBXL7_MOUSE reviewed F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) Mus musculus (Mouse) GO:0000086; GO:0000209; GO:0000278; GO:0005813; GO:0016567; GO:0019005; GO:0031146; GO:0051301 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; SCF ubiquitin ligase complex [GO:0019005] g4395.t1 Q96HH4 39.306 173 5.43e-41 145.0 sp|Q96HH4|TM169_HUMAN Transmembrane protein 169 OS=Homo sapiens OX=9606 GN=TMEM169 PE=1 SV=1 g4396.t1 Q9UH92 61.966 234 2.39e-87 263.0 sp|Q9UH92|MLX_HUMAN Max-like protein X OS=Homo sapiens OX=9606 GN=MLX PE=1 SV=2 MLX_HUMAN reviewed Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837] g4397.t1 Q4LBC6 50.0 206 1.5799999999999998e-61 196.0 sp|Q4LBC6|MYD88_ONCMY Myeloid differentiation primary response protein MyD88 OS=Oncorhynchus mykiss OX=8022 GN=myd88 PE=2 SV=1 g4400.t1 Q2TAW0 34.436 1179 0.0 681.0 sp|Q2TAW0|CNDG2_XENLA Condensin-2 complex subunit G2 OS=Xenopus laevis OX=8355 GN=ncapg2 PE=1 SV=1 g4401.t1 Q6TXF1 29.642 307 1.01e-36 141.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g4402.t1 Q9Z2W0 60.991 464 0.0 611.0 sp|Q9Z2W0|DNPEP_MOUSE Aspartyl aminopeptidase OS=Mus musculus OX=10090 GN=Dnpep PE=1 SV=2 g4403.t1 O77245 33.962 159 7.379999999999999e-24 107.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g4406.t1 Q6DFB7 35.714 616 5.04e-100 317.0 sp|Q6DFB7|POC5_XENLA Centrosomal protein POC5 OS=Xenopus laevis OX=8355 GN=poc5 PE=2 SV=1 POC5_XENLA reviewed Centrosomal protein POC5 (Protein of centriole 5) Xenopus laevis (African clawed frog) GO:0005813; GO:0005814; GO:0032391; GO:0042462; GO:0061511; GO:1903723 centriole elongation [GO:0061511]; eye photoreceptor cell development [GO:0042462]; negative regulation of centriole elongation [GO:1903723] centriole [GO:0005814]; centrosome [GO:0005813]; photoreceptor connecting cilium [GO:0032391] g4408.t1 Q05733 62.839 479 0.0 662.0 sp|Q05733|DCHS_DROME Histidine decarboxylase OS=Drosophila melanogaster OX=7227 GN=Hdc PE=1 SV=2 g4410.t1 Q8TAK5 43.5 400 1.65e-83 265.0 sp|Q8TAK5|GABP2_HUMAN GA-binding protein subunit beta-2 OS=Homo sapiens OX=9606 GN=GABPB2 PE=1 SV=1 g4411.t1 Q9IBD1 56.867 517 0.0 537.0 sp|Q9IBD1|CELF3_DANRE CUGBP Elav-like family member 3 OS=Danio rerio OX=7955 GN=celf3 PE=2 SV=2 g4411.t2 Q91579 56.214 523 0.0 541.0 sp|Q91579|CEL3A_XENLA CUGBP Elav-like family member 3-A OS=Xenopus laevis OX=8355 GN=tnrc4-a PE=2 SV=2 g4411.t3 Q9IBD1 59.229 493 0.0 549.0 sp|Q9IBD1|CELF3_DANRE CUGBP Elav-like family member 3 OS=Danio rerio OX=7955 GN=celf3 PE=2 SV=2 g4412.t1 P40818 48.269 520 1.85e-146 475.0 sp|P40818|UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens OX=9606 GN=USP8 PE=1 SV=1 UBP8_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8) Homo sapiens (Human) GO:0000281; GO:0002080; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006508; GO:0007032; GO:0007265; GO:0010008; GO:0014069; GO:0016579; GO:0017124; GO:0030496; GO:0031647; GO:0032880; GO:0045296; GO:0061578; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1905166; GO:1905908; GO:1990090; GO:1990380 cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647] acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; SH3 domain binding [GO:0017124] g4412.t1 P40818 38.889 414 3.41e-69 257.0 sp|P40818|UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens OX=9606 GN=USP8 PE=1 SV=1 UBP8_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8) Homo sapiens (Human) GO:0000281; GO:0002080; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006508; GO:0007032; GO:0007265; GO:0010008; GO:0014069; GO:0016579; GO:0017124; GO:0030496; GO:0031647; GO:0032880; GO:0045296; GO:0061578; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1905166; GO:1905908; GO:1990090; GO:1990380 cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647] acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; SH3 domain binding [GO:0017124] g4414.t1 Q4QQQ4 54.63 216 3.51e-87 267.0 sp|Q4QQQ4|RM45_XENTR Large ribosomal subunit protein mL45 OS=Xenopus tropicalis OX=8364 GN=mrpl45 PE=2 SV=1 g4415.t1 Q6DG60 69.112 259 2.4100000000000002e-132 381.0 sp|Q6DG60|UBE2Z_DANRE Ubiquitin-conjugating enzyme E2 Z OS=Danio rerio OX=7955 GN=ube2z PE=2 SV=2 UBE2Z_DANRE reviewed Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0043066; GO:0061631 apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g4420.t1 Q5SUV2 36.02 608 5.47e-100 335.0 sp|Q5SUV2|MYBPP_MOUSE MYCBP-associated protein OS=Mus musculus OX=10090 GN=Mycbpap PE=1 SV=1 MYBPP_MOUSE reviewed MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1) (AMAP-1) Mus musculus (Mouse) GO:0001669; GO:0001675; GO:0005737; GO:0007268; GO:0007283; GO:0016020; GO:0030317; GO:0036126; GO:0045202; GO:0097225; GO:0120316; GO:1990716 acrosome assembly [GO:0001675]; chemical synaptic transmission [GO:0007268]; flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; cytoplasm [GO:0005737]; membrane [GO:0016020]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; synapse [GO:0045202] g4424.t1 P70566 46.512 344 7.26e-98 296.0 sp|P70566|TMOD2_RAT Tropomodulin-2 OS=Rattus norvegicus OX=10116 GN=Tmod2 PE=1 SV=1 g4426.t1 Q5R9C7 83.799 179 2.49e-102 295.0 sp|Q5R9C7|SC11A_PONAB Signal peptidase complex catalytic subunit SEC11A OS=Pongo abelii OX=9601 GN=SEC11A PE=2 SV=1 SC11A_PONAB reviewed Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004252; GO:0005787; GO:0006465; GO:0009003 signal peptide processing [GO:0006465] signal peptidase complex [GO:0005787] serine-type endopeptidase activity [GO:0004252]; signal peptidase activity [GO:0009003] g4428.t1 Q9CQQ8 83.673 98 2.6099999999999998e-55 169.0 sp|Q9CQQ8|LSM7_MOUSE U6 snRNA-associated Sm-like protein LSm7 OS=Mus musculus OX=10090 GN=Lsm7 PE=1 SV=1 LSM7_MOUSE reviewed U6 snRNA-associated Sm-like protein LSm7 Mus musculus (Mouse) GO:0000398; GO:0000956; GO:0003723; GO:0005634; GO:0005681; GO:0005688; GO:0005689; GO:0005737; GO:0006402; GO:0046540; GO:0046982; GO:0071004; GO:0071005; GO:0071013; GO:0097526; GO:0120115; GO:1990726 mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] g4431.t2 Q09575 30.769 234 7.469999999999999e-34 137.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g4432.t1 Q7LHG5 24.886 438 1.4000000000000001e-33 137.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g4433.t1 P32198 42.237 760 0.0 585.0 sp|P32198|CPT1A_RAT Carnitine O-palmitoyltransferase 1, liver isoform OS=Rattus norvegicus OX=10116 GN=Cpt1a PE=1 SV=2 CPT1A_RAT reviewed Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-) Rattus norvegicus (Rat) GO:0001666; GO:0001676; GO:0002753; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0030674; GO:0030855; GO:0031667; GO:0031998; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772 carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674] g4444.t1 O13082 62.338 77 1.2000000000000001e-29 105.0 sp|O13082|COX6A_CYPCA Cytochrome c oxidase subunit 6A, mitochondrial OS=Cyprinus carpio OX=7962 PE=3 SV=1 g4452.t1 Q5E9J9 52.252 333 1.32e-116 346.0 sp|Q5E9J9|STRAA_BOVIN STE20-related kinase adapter protein alpha OS=Bos taurus OX=9913 GN=STRADA PE=2 SV=1 g4456.t1 Q13438 35.258 658 1.17e-96 315.0 sp|Q13438|OS9_HUMAN Protein OS-9 OS=Homo sapiens OX=9606 GN=OS9 PE=1 SV=1 g4461.t1 Q9HCD6 51.567 1117 0.0 1177.0 sp|Q9HCD6|TANC2_HUMAN Protein TANC2 OS=Homo sapiens OX=9606 GN=TANC2 PE=1 SV=3 g4462.t1 F1M5F3 65.131 651 0.0 928.0 sp|F1M5F3|MCM9_RAT DNA helicase MCM9 OS=Rattus norvegicus OX=10116 GN=Mcm9 PE=3 SV=2 MCM9_RAT reviewed DNA helicase MCM9 (EC 5.6.2.4) (DNA 3'-5' helicase MCM9) (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9) Rattus norvegicus (Rat) GO:0000724; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007276; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0036298; GO:0044877; GO:0070716; GO:0071168; GO:0097362 DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; gamete generation [GO:0007276]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298] chromosome [GO:0005694]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; protein-containing complex binding [GO:0044877] g4463.t1 P18735 41.379 145 1.04e-30 116.0 sp|P18735|ZG7_XENLA Gastrula zinc finger protein XlCGF7.1 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g4464.t1 O97758 33.112 903 9.38e-121 424.0 sp|O97758|ZO1_CANLF Tight junction protein 1 OS=Canis lupus familiaris OX=9615 GN=TJP1 PE=1 SV=1 g4464.t1 O97758 57.778 180 2.3e-54 214.0 sp|O97758|ZO1_CANLF Tight junction protein 1 OS=Canis lupus familiaris OX=9615 GN=TJP1 PE=1 SV=1 g4464.t2 O97758 33.112 903 6.4e-121 424.0 sp|O97758|ZO1_CANLF Tight junction protein 1 OS=Canis lupus familiaris OX=9615 GN=TJP1 PE=1 SV=1 g4464.t2 O97758 65.409 159 3.3900000000000005e-58 226.0 sp|O97758|ZO1_CANLF Tight junction protein 1 OS=Canis lupus familiaris OX=9615 GN=TJP1 PE=1 SV=1 g4465.t1 O93602 38.877 463 2.39e-76 249.0 sp|O93602|ATF2_CHICK Cyclic AMP-dependent transcription factor ATF-2 OS=Gallus gallus OX=9031 GN=ATF2 PE=2 SV=1 g4465.t2 O93602 38.646 458 6.3200000000000005e-77 250.0 sp|O93602|ATF2_CHICK Cyclic AMP-dependent transcription factor ATF-2 OS=Gallus gallus OX=9031 GN=ATF2 PE=2 SV=1 g4467.t1 Q91WQ9 40.132 152 7.480000000000001e-35 121.0 sp|Q91WQ9|CALL4_MOUSE Calmodulin-like protein 4 OS=Mus musculus OX=10090 GN=Calml4 PE=1 SV=2 g4468.t1 Q0P483 56.711 298 1.24e-120 353.0 sp|Q0P483|S2542_DANRE Mitochondrial coenzyme A transporter SLC25A42 OS=Danio rerio OX=7955 GN=slc25a42 PE=2 SV=1 S2542_DANRE reviewed Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0035349; GO:0043262; GO:0080121; GO:0080122 ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] ADP phosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228] g4469.t1 Q9GKL8 54.627 335 6.16e-128 372.0 sp|Q9GKL8|CATL1_CHLAE Procathepsin L OS=Chlorocebus aethiops OX=9534 GN=CTSL PE=2 SV=1 g4470.t1 Q9QXF7 39.919 496 5.790000000000001e-110 337.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g4470.t2 Q9QXF7 52.336 107 1.22e-25 108.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g4471.t1 Q4R5T4 53.242 293 1.77e-100 307.0 sp|Q4R5T4|RNF32_MACFA RING finger protein 32 OS=Macaca fascicularis OX=9541 GN=RNF32 PE=2 SV=1 g4472.t1 P79769 59.912 227 5.77e-102 298.0 sp|P79769|TSN_CHICK Translin OS=Gallus gallus OX=9031 GN=TSN PE=1 SV=1 g4473.t1 P30415 49.73 370 4.27e-92 328.0 sp|P30415|NKTR_MOUSE NK-tumor recognition protein OS=Mus musculus OX=10090 GN=Nktr PE=1 SV=4 g4475.t1 Q00534 60.959 292 4.3500000000000006e-129 374.0 sp|Q00534|CDK6_HUMAN Cyclin-dependent kinase 6 OS=Homo sapiens OX=9606 GN=CDK6 PE=1 SV=1 CDK6_HUMAN reviewed Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) Homo sapiens (Human) GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006974; GO:0007165; GO:0007219; GO:0008285; GO:0009615; GO:0010389; GO:0010468; GO:0010628; GO:0014002; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097131; GO:0097132; GO:0097133; GO:0098770; GO:0106310; GO:1902036; GO:2000145; GO:2000773 astrocyte development [GO:0014002]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323] centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; protein serine kinase activity [GO:0106310] g4476.t1 P27545 43.564 303 3.24e-83 260.0 sp|P27545|CERS1_MOUSE Ceramide synthase 1 OS=Mus musculus OX=10090 GN=Cers1 PE=1 SV=1 CERS1_MOUSE reviewed Ceramide synthase 1 (CerS1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016410; GO:0030148; GO:0036146; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526 brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] g4477.t1 Q9W6I1 57.895 171 1.5000000000000002e-56 186.0 sp|Q9W6I1|RBPS2_CHICK RNA-binding protein with multiple splicing 2 OS=Gallus gallus OX=9031 GN=RBPMS2 PE=1 SV=1 RBPS2_CHICK reviewed RNA-binding protein with multiple splicing 2 (Heart and RRM expressed sequence) (Hermes) Gallus gallus (Chicken) GO:0000381; GO:0003713; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0010494; GO:0030514; GO:0042803; GO:0048557; GO:0048565; GO:0048661; GO:0051151; GO:0060395 digestive tract development [GO:0048565]; embryonic digestive tract morphogenesis [GO:0048557]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; SMAD protein signal transduction [GO:0060395] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713] g4479.t1 Q148G7 66.484 182 1.1599999999999999e-83 248.0 sp|Q148G7|DCTN6_BOVIN Dynactin subunit 6 OS=Bos taurus OX=9913 GN=DCTN6 PE=2 SV=1 g4480.t1 Q641X2 52.695 501 2.58e-140 433.0 sp|Q641X2|LEO1_RAT RNA polymerase-associated protein LEO1 OS=Rattus norvegicus OX=10116 GN=Leo1 PE=1 SV=1 g4481.t1 Q8IV35 43.522 1096 0.0 894.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g4483.t1 O75899 30.946 740 4.28e-106 351.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g4483.t2 O75899 30.567 759 9.51e-106 350.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g4491.t1 Q99973 33.109 2232 0.0 1066.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g4492.t1 Q6GNV7 34.773 463 3.61e-84 270.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g4493.t1 Q6GNV7 34.171 398 1.2e-70 233.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g4494.t1 Q6GNV7 35.88 432 8.03e-84 269.0 sp|Q6GNV7|DIRC2_XENLA Solute carrier family 49 member 4 homolog OS=Xenopus laevis OX=8355 GN=slc49a4 PE=2 SV=1 DIRC2_XENLA reviewed Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog) Xenopus laevis (African clawed frog) GO:0005765; GO:0016020; GO:0022857; GO:0031923 pyridoxine transport [GO:0031923] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g4495.t1 Q6GL69 46.154 156 2.7399999999999997e-40 149.0 sp|Q6GL69|MK67I_XENTR MKI67 FHA domain-interacting nucleolar phosphoprotein-like OS=Xenopus tropicalis OX=8364 GN=nifk PE=2 SV=1 g4496.t1 Q8T773 46.626 489 5.67e-162 472.0 sp|Q8T773|MDH1B_BRAFL Putative malate dehydrogenase 1B OS=Branchiostoma floridae OX=7739 GN=MDH1B PE=3 SV=1 g4497.t1 P79143 31.124 996 7.019999999999999e-126 409.0 sp|P79143|AMPN_CANLF Aminopeptidase N OS=Canis lupus familiaris OX=9615 GN=ANPEP PE=1 SV=2 g4499.t1 Q8AVS6 40.796 201 2.3899999999999998e-42 147.0 sp|Q8AVS6|RSLBB_XENLA Ras-like protein family member 11B OS=Xenopus laevis OX=8355 GN=rasl11b PE=2 SV=1 g4501.t1 Q5I0K7 57.407 162 2.27e-61 190.0 sp|Q5I0K7|ALG13_RAT UDP-N-acetylglucosamine transferase subunit ALG13 OS=Rattus norvegicus OX=10116 GN=Alg13 PE=1 SV=1 g4502.t1 Q9BQS8 45.946 296 1.24e-69 262.0 sp|Q9BQS8|FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FYCO1 PE=1 SV=3 g4503.t1 F4KD71 34.457 682 4.15e-102 332.0 sp|F4KD71|DUR3_ARATH Urea-proton symporter DUR3 OS=Arabidopsis thaliana OX=3702 GN=DUR3 PE=1 SV=1 DUR3_ARATH reviewed Urea-proton symporter DUR3 (AtDUR3) (High-affinity urea active transporter DUR3) Arabidopsis thaliana (Mouse-ear cress) GO:0005886; GO:0006995; GO:0015204; GO:0015293; GO:0033219; GO:0071918 cellular response to nitrogen starvation [GO:0006995]; urea transmembrane transport [GO:0071918] plasma membrane [GO:0005886] symporter activity [GO:0015293]; urea binding [GO:0033219]; urea transmembrane transporter activity [GO:0015204] g4506.t1 O43586 36.145 415 9.03e-91 283.0 sp|O43586|PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens OX=9606 GN=PSTPIP1 PE=1 SV=1 PPIP1_HUMAN reviewed Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP) Homo sapiens (Human) GO:0001931; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0032154; GO:0042802; GO:0045087; GO:0048471 cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931] identical protein binding [GO:0042802] g4508.t1 Q8BMN4 46.284 592 0.0 569.0 sp|Q8BMN4|LMLN_MOUSE Leishmanolysin-like peptidase OS=Mus musculus OX=10090 GN=Lmln PE=2 SV=1 g4509.t1 Q9BZE4 65.987 638 0.0 840.0 sp|Q9BZE4|GTPB4_HUMAN GTP-binding protein 4 OS=Homo sapiens OX=9606 GN=GTPBP4 PE=1 SV=3 GTPB4_HUMAN reviewed GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1) Homo sapiens (Human) GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0010972; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0042273; GO:0048471; GO:0050821; GO:1990275 maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA replication [GO:0008156]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; ribosomal large subunit biogenesis [GO:0042273] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; preribosome binding [GO:1990275]; RNA binding [GO:0003723] g4510.t1 Q61686 54.118 170 3.76e-57 182.0 sp|Q61686|CBX5_MOUSE Chromobox protein homolog 5 OS=Mus musculus OX=10090 GN=Cbx5 PE=1 SV=1 CBX5_MOUSE reviewed Chromobox protein homolog 5 (Heterochromatin protein 1 homolog alpha) (HP1 alpha) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000776; GO:0000781; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006974; GO:0010369; GO:0016605; GO:0017053; GO:0030674; GO:0031507; GO:0032991; GO:0035097; GO:0042802; GO:0042826; GO:0043021; GO:0044877; GO:0045892; GO:0062072; GO:0090734; GO:0097355; GO:0140297; GO:0140566; GO:1990904 DNA damage response [GO:0006974]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to heterochromatin [GO:0097355] chromocenter [GO:0010369]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; histone H3K9me2/3 reader activity [GO:0062072]; histone reader activity [GO:0140566]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021] g4511.t1 Q3UND0 32.0 250 4.37e-24 107.0 sp|Q3UND0|SKAP2_MOUSE Src kinase-associated phosphoprotein 2 OS=Mus musculus OX=10090 GN=Skap2 PE=1 SV=2 SKAP2_MOUSE reviewed Src kinase-associated phosphoprotein 2 (Pyk2/RAFTK-associated protein) (SKAP55 homolog) (SKAP-HOM) (Src family-associated phosphoprotein 2) (Src kinase-associated phosphoprotein 55-related protein) (Src-associated adapter protein with PH and SH3 domains) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0042113 B cell activation [GO:0042113]; negative regulation of cell population proliferation [GO:0008285] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g4512.t1 Q9YGN6 52.4 250 4.69e-93 280.0 sp|Q9YGN6|SMUG1_XENLA Single-strand selective monofunctional uracil DNA glycosylase OS=Xenopus laevis OX=8355 GN=smug1 PE=1 SV=1 g4513.t1 Q8BP00 37.133 579 2.95e-120 371.0 sp|Q8BP00|IQCB1_MOUSE IQ calmodulin-binding motif-containing protein 1 OS=Mus musculus OX=10090 GN=Iqcb1 PE=1 SV=2 IQCB1_MOUSE reviewed IQ calmodulin-binding motif-containing protein 1 Mus musculus (Mouse) GO:0001750; GO:0005516; GO:0005813; GO:0005929; GO:0019899; GO:0030674; GO:0032391; GO:0045494; GO:0048496; GO:0060271; GO:0061824; GO:0062063 cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494] centrosome [GO:0005813]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] BBSome binding [GO:0062063]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674] g4515.t1 Q3ULD5 70.902 543 0.0 829.0 sp|Q3ULD5|MCCB_MOUSE Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Mus musculus OX=10090 GN=Mccc2 PE=1 SV=1 g4516.t1 A0A1L8H0H2 42.795 229 3.47e-49 196.0 sp|A0A1L8H0H2|RFX7_XENLA DNA-binding protein RFX7 OS=Xenopus laevis OX=8355 GN=rfx7.L PE=2 SV=1 g4517.t1 Q6A4L0 32.857 560 7.690000000000001e-97 309.0 sp|Q6A4L0|S22AD_MOUSE Solute carrier family 22 member 13 OS=Mus musculus OX=10090 GN=Slc22a13 PE=1 SV=3 S22AD_MOUSE reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) Mus musculus (Mouse) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0045922; GO:0090416; GO:2001142 negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g4518.t1 P18910 45.222 1015 0.0 868.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g4521.t1 Q96DP5 44.11 365 2.16e-89 278.0 sp|Q96DP5|FMT_HUMAN Methionyl-tRNA formyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=MTFMT PE=1 SV=2 g4523.t1 Q61830 24.698 1077 1.66e-79 290.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4523.t1 Q61830 24.561 1083 1.21e-56 219.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4523.t2 Q61830 24.698 1077 1.24e-79 290.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4523.t2 Q61830 24.561 1083 8.43e-57 219.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4525.t1 P51968 49.519 208 3.1599999999999998e-55 192.0 sp|P51968|RO31_XENLA Heterogeneous nuclear ribonucleoprotein A3 homolog 1 OS=Xenopus laevis OX=8355 PE=2 SV=1 g4526.t1 Q6PGZ3 46.677 647 3.63e-160 475.0 sp|Q6PGZ3|MIPT3_DANRE TRAF3-interacting protein 1 OS=Danio rerio OX=7955 GN=traf3ip1 PE=2 SV=1 MIPT3_DANRE reviewed TRAF3-interacting protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005576; GO:0005930; GO:0008017; GO:0021549; GO:0030992; GO:0031113; GO:0035845; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0061524; GO:0070507; GO:0090660 camera-type eye development [GO:0043010]; central canal development [GO:0061524]; cerebellum development [GO:0021549]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell outer segment organization [GO:0035845]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; intraciliary transport particle B [GO:0030992] microtubule binding [GO:0008017] g4526.t2 Q6PGZ3 47.352 642 3.5e-159 472.0 sp|Q6PGZ3|MIPT3_DANRE TRAF3-interacting protein 1 OS=Danio rerio OX=7955 GN=traf3ip1 PE=2 SV=1 MIPT3_DANRE reviewed TRAF3-interacting protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005576; GO:0005930; GO:0008017; GO:0021549; GO:0030992; GO:0031113; GO:0035845; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0061524; GO:0070507; GO:0090660 camera-type eye development [GO:0043010]; central canal development [GO:0061524]; cerebellum development [GO:0021549]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell outer segment organization [GO:0035845]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; intraciliary transport particle B [GO:0030992] microtubule binding [GO:0008017] g4526.t3 Q6PGZ3 47.205 644 1.4000000000000002e-161 478.0 sp|Q6PGZ3|MIPT3_DANRE TRAF3-interacting protein 1 OS=Danio rerio OX=7955 GN=traf3ip1 PE=2 SV=1 MIPT3_DANRE reviewed TRAF3-interacting protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005576; GO:0005930; GO:0008017; GO:0021549; GO:0030992; GO:0031113; GO:0035845; GO:0036064; GO:0042073; GO:0043010; GO:0048793; GO:0060271; GO:0061524; GO:0070507; GO:0090660 camera-type eye development [GO:0043010]; central canal development [GO:0061524]; cerebellum development [GO:0021549]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell outer segment organization [GO:0035845]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; intraciliary transport particle B [GO:0030992] microtubule binding [GO:0008017] g4528.t1 Q61830 25.724 863 1.09e-72 264.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4528.t1 Q61830 24.407 885 8.55e-49 191.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4528.t1 Q61830 26.936 594 7.919999999999999e-42 169.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4530.t1 O08838 37.107 318 4.7600000000000006e-64 221.0 sp|O08838|AMPH_RAT Amphiphysin OS=Rattus norvegicus OX=10116 GN=Amph PE=1 SV=1 AMPH_RAT reviewed Amphiphysin Rattus norvegicus (Rat) GO:0005543; GO:0005856; GO:0005886; GO:0007612; GO:0008021; GO:0019902; GO:0031256; GO:0043195; GO:0043679; GO:0044877; GO:0045807; GO:0048488; GO:0098684; GO:0098793; GO:0098833; GO:0098843; GO:0098850; GO:0098978 learning [GO:0007612]; positive regulation of endocytosis [GO:0045807]; synaptic vesicle endocytosis [GO:0048488] axon terminus [GO:0043679]; cytoskeleton [GO:0005856]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; presynapse [GO:0098793]; presynaptic endocytic zone [GO:0098833]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877] g4531.t1 Q66PG4 36.789 299 1.0600000000000001e-44 172.0 sp|Q66PG4|LARG2_CHICK Xylosyl- and glucuronyltransferase LARGE2s OS=Gallus gallus OX=9031 GN=LARGE2 PE=2 SV=1 LARG2_CHICK reviewed Xylosyl- and glucuronyltransferase LARGE2s (EC 2.4.-.-) (Glycosyltransferase-like 1B) (LARGE xylosyl- and glucuronyltransferase 2) [Includes: Alpha-1,3-xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)] Gallus gallus (Chicken) GO:0000139; GO:0005794; GO:0015020; GO:0035269; GO:0042285; GO:0046872 protein O-linked glycosylation via mannose [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; xylosyltransferase activity [GO:0042285] g4532.t1 Q4QQV8 69.863 219 8.63e-112 322.0 sp|Q4QQV8|CHMP5_RAT Charged multivesicular body protein 5 OS=Rattus norvegicus OX=10116 GN=Chmp5 PE=2 SV=1 CHMP5_RAT reviewed Charged multivesicular body protein 5 (Chromatin-modifying protein 5) Rattus norvegicus (Rat) GO:0000421; GO:0000776; GO:0001778; GO:0001919; GO:0005634; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007040; GO:0007080; GO:0008333; GO:0010824; GO:0015031; GO:0030218; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0039702; GO:0043162; GO:0046761; GO:0061952; GO:0071222; GO:0071225; GO:0071985; GO:0097352; GO:1901673; GO:1902774; GO:1904930 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; erythrocyte differentiation [GO:0030218]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g4541.t1 Q96H78 52.681 317 4.45e-118 345.0 sp|Q96H78|S2544_HUMAN Solute carrier family 25 member 44 OS=Homo sapiens OX=9606 GN=SLC25A44 PE=1 SV=1 g4542.t1 Q2L969 54.357 241 4.2800000000000005e-86 260.0 sp|Q2L969|MTX2_PIG Metaxin-2 OS=Sus scrofa OX=9823 GN=MTX2 PE=2 SV=1 g4545.t1 O22943 32.188 320 2.22e-46 170.0 sp|O22943|STL1_ARATH Probable glycosyltransferase STELLO1 OS=Arabidopsis thaliana OX=3702 GN=STL1 PE=1 SV=1 STL1_ARATH reviewed Probable glycosyltransferase STELLO1 (EC 2.4.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0008104; GO:0016757; GO:0042802; GO:0052324; GO:2001009 intracellular protein localization [GO:0008104]; plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802] g4546.t1 Q8BLB8 56.085 189 2e-52 192.0 sp|Q8BLB8|AN34C_MOUSE Ankyrin repeat domain-containing protein 34C OS=Mus musculus OX=10090 GN=Ankrd34c PE=1 SV=1 g4547.t1 Q96CG8 39.881 168 1.68e-33 122.0 sp|Q96CG8|CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=CTHRC1 PE=1 SV=1 CTHR1_HUMAN reviewed Collagen triple helix repeat-containing protein 1 Homo sapiens (Human) GO:0001649; GO:0004666; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033687; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g4548.t1 Q8CG08 39.216 204 2.89e-39 137.0 sp|Q8CG08|CTHR1_RAT Collagen triple helix repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Cthrc1 PE=1 SV=1 CTHR1_RAT reviewed Collagen triple helix repeat-containing protein 1 Rattus norvegicus (Rat) GO:0004666; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g4549.t1 Q8CG08 39.706 204 2.66e-39 137.0 sp|Q8CG08|CTHR1_RAT Collagen triple helix repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Cthrc1 PE=1 SV=1 CTHR1_RAT reviewed Collagen triple helix repeat-containing protein 1 Rattus norvegicus (Rat) GO:0004666; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g4550.t1 Q28620 55.159 504 4.840000000000001e-179 526.0 sp|Q28620|NPT2A_RABIT Sodium-dependent phosphate transport protein 2A OS=Oryctolagus cuniculus OX=9986 GN=SLC34A1 PE=2 SV=1 NPT2A_RABIT reviewed Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-6) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1) Oryctolagus cuniculus (Rabbit) GO:0005436; GO:0005886; GO:0005903; GO:0006817; GO:0016036; GO:0016324; GO:0030643; GO:0031982; GO:0044341; GO:0055062 cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; plasma membrane [GO:0005886]; vesicle [GO:0031982] sodium:phosphate symporter activity [GO:0005436] g4551.t1 Q9JJ09 52.909 550 0.0 569.0 sp|Q9JJ09|NPT2B_RAT Sodium-dependent phosphate transport protein 2B OS=Rattus norvegicus OX=10116 GN=Slc34a2 PE=1 SV=1 NPT2B_RAT reviewed Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) (rNaPi IIb) Rattus norvegicus (Rat) GO:0001701; GO:0005436; GO:0005903; GO:0006817; GO:0009750; GO:0016020; GO:0016324; GO:0019904; GO:0030643; GO:0031402; GO:0031526; GO:0031528; GO:0031982; GO:0032355; GO:0042301; GO:0043627; GO:0044341 in utero embryonic development [GO:0001701]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; vesicle [GO:0031982] phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436] g4552.t1 Q9FXA7 29.811 265 1.29e-32 127.0 sp|Q9FXA7|RGXT3_ARATH UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase 3 OS=Arabidopsis thaliana OX=3702 GN=RGXT3 PE=1 SV=1 g4553.t1 Q95SX7 30.394 431 7.510000000000001e-36 147.0 sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1 g4555.t1 Q8N565 35.429 175 6.7e-26 104.0 sp|Q8N565|MREG_HUMAN Melanoregulin OS=Homo sapiens OX=9606 GN=MREG PE=1 SV=1 MREG_HUMAN reviewed Melanoregulin (Dilute suppressor protein homolog) Homo sapiens (Human) GO:0005765; GO:0016324; GO:0030318; GO:0030659; GO:0031090; GO:0031902; GO:0032400; GO:0032402; GO:0032991; GO:0033162; GO:0035091; GO:0042470; GO:0072385; GO:0090382 melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; minus-end-directed organelle transport along microtubule [GO:0072385]; phagosome maturation [GO:0090382] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; organelle membrane [GO:0031090]; protein-containing complex [GO:0032991] phosphatidylinositol binding [GO:0035091] g4556.t1 Q9QZW9 37.188 320 1.5699999999999999e-40 150.0 sp|Q9QZW9|MNX1_MOUSE Motor neuron and pancreas homeobox protein 1 OS=Mus musculus OX=10090 GN=Mnx1 PE=1 SV=2 MNX1_MOUSE reviewed Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0001227; GO:0001764; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007417; GO:0008045; GO:0009791; GO:0021520; GO:0021675; GO:0021904; GO:0021953; GO:0030182; GO:0031016; GO:0031018; GO:0048667; GO:0048812; GO:0060539; GO:0060541; GO:1990837 cell morphogenesis involved in neuron differentiation [GO:0048667]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; diaphragm development [GO:0060539]; dorsal/ventral neural tube patterning [GO:0021904]; endocrine pancreas development [GO:0031018]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nerve development [GO:0021675]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; pancreas development [GO:0031016]; post-embryonic development [GO:0009791]; respiratory system development [GO:0060541]; spinal cord motor neuron cell fate specification [GO:0021520] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific double-stranded DNA binding [GO:1990837] g4557.t1 Q7M3K2 23.968 630 1.06e-36 152.0 sp|Q7M3K2|PELET_DROME Transposable element P transposase OS=Drosophila melanogaster OX=7227 GN=T PE=1 SV=2 PELET_DROME reviewed Transposable element P transposase (P-element transposase) (EC 2.7.7.-) (THAP domain-containing protein) (DmTHAP) Drosophila melanogaster (Fruit fly) GO:0003693; GO:0004803; GO:0006313; GO:0008270; GO:0015074; GO:0016740 DNA integration [GO:0015074]; DNA transposition [GO:0006313] P-element binding [GO:0003693]; transferase activity [GO:0016740]; transposase activity [GO:0004803]; zinc ion binding [GO:0008270] g4558.t1 P10181 77.273 66 7.91e-29 115.0 sp|P10181|ROUGH_DROME Homeobox protein rough OS=Drosophila melanogaster OX=7227 GN=ro PE=2 SV=4 ROUGH_DROME reviewed Homeobox protein rough Drosophila melanogaster (Fruit fly) GO:0000977; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007463; GO:0007601; GO:0042067; GO:0045944; GO:0048054 establishment of ommatidial planar polarity [GO:0042067]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R2/R5 cell differentiation [GO:0048054]; R2/R5 cell fate commitment [GO:0007463]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g4559.t1 Q9N295 39.623 265 8.299999999999999e-52 177.0 sp|Q9N295|B3GT5_PANTR Beta-1,3-galactosyltransferase 5 (Fragment) OS=Pan troglodytes OX=9598 GN=B3GALT5 PE=3 SV=1 g4560.t1 Q8CDN6 48.592 284 1.15e-96 289.0 sp|Q8CDN6|TXNL1_MOUSE Thioredoxin-like protein 1 OS=Mus musculus OX=10090 GN=Txnl1 PE=1 SV=3 g4561.t1 Q9D902 54.895 286 1.68e-106 314.0 sp|Q9D902|T2EB_MOUSE General transcription factor IIE subunit 2 OS=Mus musculus OX=10090 GN=Gtf2e2 PE=1 SV=2 g4562.t1 Q66IC8 37.313 134 3.16e-28 105.0 sp|Q66IC8|DYLT5_DANRE Dynein light chain Tctex-type 5 OS=Danio rerio OX=7955 GN=dynlt5 PE=2 SV=1 g4563.t1 Q55CB7 37.179 156 8.760000000000001e-32 119.0 sp|Q55CB7|RASY_DICDI Ras-like protein rasY OS=Dictyostelium discoideum OX=44689 GN=rasY PE=3 SV=1 g4566.t1 Q9WTX6 80.983 773 0.0 1325.0 sp|Q9WTX6|CUL1_MOUSE Cullin-1 OS=Mus musculus OX=10090 GN=Cul1 PE=1 SV=1 CUL1_MOUSE reviewed Cullin-1 (CUL-1) Mus musculus (Mouse) GO:0000045; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006915; GO:0007040; GO:0008283; GO:0009887; GO:0010507; GO:0010508; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031625; GO:0031669; GO:0034599; GO:0038202; GO:0043123; GO:0043124; GO:0043161; GO:0070936; GO:0140374; GO:0160072; GO:1904037; GO:1904262; GO:1990452 animal organ morphogenesis [GO:0009887]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; cell population proliferation [GO:0008283]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of epithelial cell apoptotic process [GO:1904037]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; TORC1 signaling [GO:0038202]; ubiquitin-dependent protein catabolic process [GO:0006511] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005] protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625] g4568.t1 Q8TCJ2 77.056 754 0.0 1201.0 sp|Q8TCJ2|STT3B_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Homo sapiens OX=9606 GN=STT3B PE=1 SV=1 STT3B_HUMAN reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog) Homo sapiens (Human) GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0018279; GO:0032991; GO:0036503; GO:0043687; GO:0046872; GO:0160227 ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex B [GO:0160227]; protein-containing complex [GO:0032991] dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872] g4569.t1 B1H2T2 27.483 433 5.95e-28 119.0 sp|B1H2T2|DIK2A_XENTR Divergent protein kinase domain 2A OS=Xenopus tropicalis OX=8364 GN=dipk2a PE=2 SV=1 g4570.t1 Q9NZ08 35.47 936 0.0 604.0 sp|Q9NZ08|ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens OX=9606 GN=ERAP1 PE=1 SV=3 g4571.t1 Q5BKC6 46.984 315 5.66e-91 290.0 sp|Q5BKC6|HBAP1_RAT HSPB1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Hspbap1 PE=1 SV=1 HBAP1_RAT reviewed HSPB1-associated protein 1 (27 kDa heat shock protein-associated protein 1) (Protein associated with small stress protein 1) Rattus norvegicus (Rat) GO:0005737; GO:0016706 cytoplasm [GO:0005737] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706] g4573.t1 A1ZAX0 31.392 309 7.25e-28 117.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 CCH1R_DROME reviewed Neuropeptide CCHamide-1 receptor Drosophila melanogaster (Fruit fly) GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016020 G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] membrane [GO:0016020]; plasma membrane [GO:0005886] allatostatin receptor activity [GO:0008261]; neuropeptide receptor activity [GO:0008188] g4575.t1 Q9ESQ4 31.818 352 1.8300000000000002e-29 121.0 sp|Q9ESQ4|NMUR2_RAT Neuromedin-U receptor 2 OS=Rattus norvegicus OX=10116 GN=Nmur2 PE=1 SV=2 NMUR2_RAT reviewed Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4) Rattus norvegicus (Rat) GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930 arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g4576.t1 Q10751 56.293 588 0.0 705.0 sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2 ACE_CHICK reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) Gallus gallus (Chicken) GO:0001822; GO:0002003; GO:0003084; GO:0004180; GO:0004222; GO:0005615; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573 angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; substance P catabolic process [GO:0010814] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270] g4576.t1 Q10751 52.318 604 0.0 662.0 sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2 ACE_CHICK reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) Gallus gallus (Chicken) GO:0001822; GO:0002003; GO:0003084; GO:0004180; GO:0004222; GO:0005615; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573 angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; substance P catabolic process [GO:0010814] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270] g4577.t1 Q9GLN7 48.893 587 0.0 616.0 sp|Q9GLN7|ACE_PANTR Angiotensin-converting enzyme OS=Pan troglodytes OX=9598 GN=ACE PE=3 SV=1 g4577.t1 Q9GLN7 46.01 589 0.0 565.0 sp|Q9GLN7|ACE_PANTR Angiotensin-converting enzyme OS=Pan troglodytes OX=9598 GN=ACE PE=3 SV=1 g4578.t1 Q9NPF2 34.247 219 2.49e-34 131.0 sp|Q9NPF2|CHSTB_HUMAN Carbohydrate sulfotransferase 11 OS=Homo sapiens OX=9606 GN=CHST11 PE=1 SV=1 g4579.t1 P97858 62.706 303 9.340000000000001e-130 375.0 sp|P97858|S35B1_MOUSE Solute carrier family 35 member B1 OS=Mus musculus OX=10090 GN=Slc35b1 PE=1 SV=1 g4580.t1 Q8NET6 34.643 280 1.0399999999999999e-45 163.0 sp|Q8NET6|CHSTD_HUMAN Carbohydrate sulfotransferase 13 OS=Homo sapiens OX=9606 GN=CHST13 PE=1 SV=1 CHSTD_HUMAN reviewed Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g4581.t1 Q5VY43 32.941 340 2.11e-32 134.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g4581.t1 Q5VY43 30.69 290 9.629999999999999e-28 120.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g4584.t1 Q8BGD9 39.568 278 2.3900000000000002e-35 145.0 sp|Q8BGD9|IF4B_MOUSE Eukaryotic translation initiation factor 4B OS=Mus musculus OX=10090 GN=Eif4b PE=1 SV=1 g4584.t2 P23588 33.607 732 3.46e-58 211.0 sp|P23588|IF4B_HUMAN Eukaryotic translation initiation factor 4B OS=Homo sapiens OX=9606 GN=EIF4B PE=1 SV=2 IF4B_HUMAN reviewed Eukaryotic translation initiation factor 4B (eIF-4B) Homo sapiens (Human) GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0016281; GO:0033592; GO:0034057; GO:0043024; GO:0097010 eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281] ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743] g4585.t1 Q9NQ48 53.512 299 1.71e-103 307.0 sp|Q9NQ48|LZTL1_HUMAN Leucine zipper transcription factor-like protein 1 OS=Homo sapiens OX=9606 GN=LZTFL1 PE=1 SV=1 g4587.t1 Q5R476 44.554 202 4.2600000000000005e-37 151.0 sp|Q5R476|RN111_PONAB E3 ubiquitin-protein ligase Arkadia OS=Pongo abelii OX=9601 GN=RNF111 PE=2 SV=1 RN111_PONAB reviewed E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (RING-type E3 ubiquitin transferase Arkadia) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0006281; GO:0008270; GO:0016567; GO:0016605; GO:0032184; GO:0061630 DNA repair [GO:0006281]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; PML body [GO:0016605] SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g4588.t1 Q1LWX3 57.843 102 1.5800000000000002e-37 128.0 sp|Q1LWX3|NTAQ1_DANRE Protein N-terminal glutamine amidohydrolase OS=Danio rerio OX=7955 GN=ntaq1 PE=2 SV=1 g4589.t1 Q6P824 65.341 352 6.17e-168 474.0 sp|Q6P824|GPD1L_XENTR Glycerol-3-phosphate dehydrogenase 1-like protein OS=Xenopus tropicalis OX=8364 GN=gpd1l PE=2 SV=1 g4592.t1 Q86SG6 40.735 653 9.61e-138 441.0 sp|Q86SG6|NEK8_HUMAN Serine/threonine-protein kinase Nek8 OS=Homo sapiens OX=9606 GN=NEK8 PE=1 SV=1 NEK8_HUMAN reviewed Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) (Nima-related protein kinase 12a) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005813; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310 animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g4593.t1 Q8C761 32.136 1030 1.46e-147 465.0 sp|Q8C761|DC2I1_MOUSE Cytoplasmic dynein 2 intermediate chain 1 OS=Mus musculus OX=10090 GN=Dync2i1 PE=1 SV=1 DC2I1_MOUSE reviewed Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60) Mus musculus (Mouse) GO:0000242; GO:0000922; GO:0005813; GO:0005829; GO:0005868; GO:0005929; GO:0031021; GO:0035721; GO:0036064; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097546 cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g4595.t1 Q9DCJ5 57.31 171 8.21e-67 204.0 sp|Q9DCJ5|NDUA8_MOUSE NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 OS=Mus musculus OX=10090 GN=Ndufa8 PE=1 SV=3 NDUA8_MOUSE reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (Complex I-PGIV) (CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0005758; GO:0006120; GO:0009060; GO:0042776; GO:0044877; GO:0045271 aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] protein-containing complex binding [GO:0044877] g4596.t1 Q7YRH6 50.0 186 5.9200000000000006e-58 184.0 sp|Q7YRH6|PEMT_BOVIN Phosphatidylethanolamine N-methyltransferase OS=Bos taurus OX=9913 GN=PEMT PE=2 SV=1 g4597.t1 Q99081 38.22 764 6.58e-98 321.0 sp|Q99081|HTF4_HUMAN Transcription factor 12 OS=Homo sapiens OX=9606 GN=TCF12 PE=1 SV=1 g4597.t2 Q99081 38.793 696 5.99e-91 301.0 sp|Q99081|HTF4_HUMAN Transcription factor 12 OS=Homo sapiens OX=9606 GN=TCF12 PE=1 SV=1 g4598.t1 Q15382 62.842 183 1.92e-83 247.0 sp|Q15382|RHEB_HUMAN GTP-binding protein Rheb OS=Homo sapiens OX=9606 GN=RHEB PE=1 SV=1 g4605.t1 Q5R4I3 41.204 216 4.25e-40 147.0 sp|Q5R4I3|UBXN4_PONAB UBX domain-containing protein 4 OS=Pongo abelii OX=9601 GN=UBXN4 PE=2 SV=1 g4607.t1 Q92575 36.934 287 2.45e-45 163.0 sp|Q92575|UBXN4_HUMAN UBX domain-containing protein 4 OS=Homo sapiens OX=9606 GN=UBXN4 PE=1 SV=2 UBXN4_HUMAN reviewed UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2) Homo sapiens (Human) GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006986; GO:0036503 ERAD pathway [GO:0036503]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635] g4610.t1 B3TP03 28.771 643 2.19e-81 272.0 sp|B3TP03|CTR2_CHICK Cationic amino acid transporter 2 OS=Gallus gallus OX=9031 GN=SLC7A2 PE=2 SV=1 CTR2_CHICK reviewed Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2) Gallus gallus (Chicken) GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352 L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g4612.t1 P52951 59.184 147 2.57e-45 161.0 sp|P52951|GBX2_HUMAN Homeobox protein GBX-2 OS=Homo sapiens OX=9606 GN=GBX2 PE=1 SV=3 GBX2_HUMAN reviewed Homeobox protein GBX-2 (Gastrulation and brain-specific homeobox protein 2) Homo sapiens (Human) GO:0000785; GO:0000977; GO:0000979; GO:0000981; GO:0001228; GO:0001569; GO:0001755; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007411; GO:0021549; GO:0021555; GO:0021568; GO:0021794; GO:0021884; GO:0021930; GO:0042472; GO:0048483; GO:0051960; GO:0061629; GO:1990837 autonomic nervous system development [GO:0048483]; axon guidance [GO:0007411]; branching involved in blood vessel morphogenesis [GO:0001569]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellum development [GO:0021549]; forebrain neuron development [GO:0021884]; inner ear morphogenesis [GO:0042472]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; regulation of nervous system development [GO:0051960]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 2 development [GO:0021568]; thalamus development [GO:0021794] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837] g4613.t1 Q61542 36.344 454 5.08e-77 253.0 sp|Q61542|STAR3_MOUSE StAR-related lipid transfer protein 3 OS=Mus musculus OX=10090 GN=Stard3 PE=1 SV=1 g4616.t1 B1AZP2 32.039 206 3.45e-24 113.0 sp|B1AZP2|DLGP4_MOUSE Disks large-associated protein 4 OS=Mus musculus OX=10090 GN=Dlgap4 PE=1 SV=1 DLGP4_MOUSE reviewed Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4) Mus musculus (Mouse) GO:0016020; GO:0019904; GO:0023052; GO:0030425; GO:0031594; GO:0043025; GO:0045202; GO:0050804; GO:0060090; GO:0090128; GO:0098978; GO:0098981; GO:0099010; GO:0099572 modification of postsynaptic structure [GO:0099010]; modulation of chemical synaptic transmission [GO:0050804]; regulation of synapse maturation [GO:0090128]; signaling [GO:0023052] cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; postsynaptic specialization [GO:0099572]; synapse [GO:0045202] molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904] g4617.t1 A2VDC2 61.702 376 1.3e-165 471.0 sp|A2VDC2|HIBCH_XENLA 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Xenopus laevis OX=8355 GN=hibch PE=2 SV=1 g4619.t1 D0FH76 46.44 323 4.22e-97 301.0 sp|D0FH76|VPS4_BOMMO Vacuolar protein sorting-associated protein 4 OS=Bombyx mori OX=7091 GN=VPS4 PE=1 SV=1 VPS4_BOMMO reviewed Vacuolar protein sorting-associated protein 4 (EC 3.6.4.6) (BmVps4) (Vacuolar protein sorting 4) Bombyx mori (Silk moth) GO:0002165; GO:0005524; GO:0005737; GO:0005774; GO:0007033; GO:0007552; GO:0010008; GO:0015031; GO:0016197; GO:0016887; GO:0030496; GO:0031902; GO:0043162; GO:0051259; GO:0051301; GO:0140545 cell division [GO:0051301]; endosomal transport [GO:0016197]; instar larval or pupal development [GO:0002165]; metamorphosis [GO:0007552]; protein complex oligomerization [GO:0051259]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vacuole organization [GO:0007033] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; vacuolar membrane [GO:0005774] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545] g4620.t1 J9PAS6 58.73 126 1.11e-49 159.0 sp|J9PAS6|SRP19_CANLF Signal recognition particle 19 kDa protein OS=Canis lupus familiaris OX=9615 GN=SRP19 PE=1 SV=1 g4621.t1 Q80T91 31.905 210 4.14e-23 100.0 sp|Q80T91|MEG11_MOUSE Multiple epidermal growth factor-like domains protein 11 OS=Mus musculus OX=10090 GN=Megf11 PE=1 SV=3 MEG11_MOUSE reviewed Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11) Mus musculus (Mouse) GO:0005044; GO:0010842; GO:0016323; GO:0034109 homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842] basolateral plasma membrane [GO:0016323] scavenger receptor activity [GO:0005044] g4622.t1 Q5H8C4 34.936 3306 0.0 1867.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g4622.t2 Q5H8C4 34.854 3311 0.0 1863.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g4622.t3 Q5H8C4 35.002 3297 0.0 1874.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g4622.t4 Q5H8C4 35.11 3284 0.0 1879.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g4622.t5 Q5H8C4 34.83 3296 0.0 1863.0 sp|Q5H8C4|VP13A_MOUSE Intermembrane lipid transfer protein VPS13A OS=Mus musculus OX=10090 GN=Vps13a PE=1 SV=1 VP13A_MOUSE reviewed Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein homolog) (Chorein) (Vacuolar protein sorting-associated protein 13A) Mus musculus (Mouse) GO:0000902; GO:0005739; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0006623; GO:0006869; GO:0006914; GO:0007399; GO:0007626; GO:0008344; GO:0009306; GO:0010008; GO:0010467; GO:0014004; GO:0030218; GO:0030317; GO:0030382; GO:0031045; GO:0031547; GO:0031966; GO:0035176; GO:0035264; GO:0035640; GO:0043005; GO:0043025; GO:0044233; GO:0045053; GO:0048167; GO:0050885; GO:0050905; GO:0060292; GO:0061744; GO:0071470; GO:0090648; GO:0097225; GO:0099013; GO:0140058; GO:0150076; GO:1905146 adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell morphogenesis [GO:0000902]; cellular response to osmotic stress [GO:0071470]; erythrocyte differentiation [GO:0030218]; exploration behavior [GO:0035640]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; lysosomal protein catabolic process [GO:1905146]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neuroinflammatory response [GO:0150076]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron projection arborization [GO:0140058]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; regulation of synaptic plasticity [GO:0048167]; response to environmental enrichment [GO:0090648]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] dense core granule [GO:0031045]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] g4624.t1 O43314 55.683 1223 0.0 1210.0 sp|O43314|VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens OX=9606 GN=PPIP5K2 PE=1 SV=3 g4624.t2 O43314 56.457 1208 0.0 1217.0 sp|O43314|VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens OX=9606 GN=PPIP5K2 PE=1 SV=3 g4624.t3 O43314 55.583 1227 0.0 1210.0 sp|O43314|VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens OX=9606 GN=PPIP5K2 PE=1 SV=3 g4624.t4 O43314 56.658 1209 0.0 1218.0 sp|O43314|VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens OX=9606 GN=PPIP5K2 PE=1 SV=3 g4627.t1 P46735 53.49 1103 0.0 1177.0 sp|P46735|MYO1B_MOUSE Unconventional myosin-Ib OS=Mus musculus OX=10090 GN=Myo1b PE=1 SV=3 MYO1B_MOUSE reviewed Unconventional myosin-Ib (MIH-L) (Myosin I alpha) (MMI-alpha) (MMIa) Mus musculus (Mouse) GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0006897; GO:0007015; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030175; GO:0033572; GO:0045177; GO:0048471; GO:0051015; GO:0051017; GO:0071944 actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g4628.t1 Q69ZU6 34.385 317 8.230000000000001e-43 160.0 sp|Q69ZU6|THS7A_MOUSE Thrombospondin type-1 domain-containing protein 7A OS=Mus musculus OX=10090 GN=Thsd7a PE=1 SV=2 THS7A_MOUSE reviewed Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form] Mus musculus (Mouse) GO:0001525; GO:0005576; GO:0005886; GO:0030036; GO:0030154; GO:0098846 actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846] g4630.t1 Q9UPZ6 35.634 1333 0.0 765.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g4630.t1 Q9UPZ6 27.528 1246 1.88e-84 307.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g4630.t1 Q9UPZ6 28.737 1124 1.36e-78 289.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g4630.t1 Q9UPZ6 27.558 606 2.34e-35 150.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g4630.t1 Q9UPZ6 26.942 412 7.2e-24 113.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g4634.t1 P16066 55.231 822 0.0 942.0 sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens OX=9606 GN=NPR1 PE=1 SV=1 ANPRA_HUMAN reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Homo sapiens (Human) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g4636.t1 P10730 32.796 186 6.95e-22 97.4 sp|P10730|ANPRC_BOVIN Atrial natriuretic peptide receptor 3 OS=Bos taurus OX=9913 GN=NPR3 PE=1 SV=2 g4640.t1 P60322 67.241 58 1.04e-21 89.4 sp|P60322|NANO2_MOUSE Nanos homolog 2 OS=Mus musculus OX=10090 GN=Nanos2 PE=1 SV=2 NANO2_MOUSE reviewed Nanos homolog 2 (NOS-2) Mus musculus (Mouse) GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008047; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:0061157 germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] enzyme activator activity [GO:0008047]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g4642.t1 Q6P8G1 62.42 314 1.61e-150 432.0 sp|Q6P8G1|ILF2_XENTR Interleukin enhancer-binding factor 2 homolog OS=Xenopus tropicalis OX=8364 GN=ilf2 PE=2 SV=1 g4645.t1 Q7ZYJ9 55.224 402 1.4000000000000003e-163 468.0 sp|Q7ZYJ9|AASDB_XENLA Alanyl-tRNA editing protein Aarsd1-B OS=Xenopus laevis OX=8355 GN=aarsd1-b PE=2 SV=1 g4646.t1 A8JR92 46.281 121 3.47e-23 112.0 sp|A8JR92|MBD56_DROME Methyl-CpG-binding domain protein 5/6 homolog sba OS=Drosophila melanogaster OX=7227 GN=sba PE=1 SV=1 MBD56_DROME reviewed Methyl-CpG-binding domain protein 5/6 homolog sba (dMBD5/6) (Protein six-banded) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0003682; GO:0005634 nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677] g4646.t2 Q9P267 48.544 103 8.979999999999999e-23 111.0 sp|Q9P267|MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens OX=9606 GN=MBD5 PE=1 SV=3 g4647.t1 Q8C9X6 54.174 539 1.4899999999999999e-171 520.0 sp|Q8C9X6|EPC1_MOUSE Enhancer of polycomb homolog 1 OS=Mus musculus OX=10090 GN=Epc1 PE=1 SV=1 EPC1_MOUSE reviewed Enhancer of polycomb homolog 1 Mus musculus (Mouse) GO:0000122; GO:0000724; GO:0000786; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006303; GO:0006357; GO:0016604; GO:0031965; GO:0032777; GO:0035092; GO:0035267; GO:0035861; GO:0035886; GO:0042981; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0051155; GO:0051726; GO:0140463; GO:0140767; GO:1902275; GO:1905168; GO:2000779 double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromatin organization [GO:1902275]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; vascular associated smooth muscle cell differentiation [GO:0035886] cytoplasm [GO:0005737]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; piccolo histone acetyltransferase complex [GO:0032777]; site of double-strand break [GO:0035861] chromatin-protein adaptor activity [GO:0140463]; enzyme-substrate adaptor activity [GO:0140767] g4647.t2 Q8C9X6 53.803 539 4.07e-172 521.0 sp|Q8C9X6|EPC1_MOUSE Enhancer of polycomb homolog 1 OS=Mus musculus OX=10090 GN=Epc1 PE=1 SV=1 EPC1_MOUSE reviewed Enhancer of polycomb homolog 1 Mus musculus (Mouse) GO:0000122; GO:0000724; GO:0000786; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006303; GO:0006357; GO:0016604; GO:0031965; GO:0032777; GO:0035092; GO:0035267; GO:0035861; GO:0035886; GO:0042981; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0051155; GO:0051726; GO:0140463; GO:0140767; GO:1902275; GO:1905168; GO:2000779 double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromatin organization [GO:1902275]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; vascular associated smooth muscle cell differentiation [GO:0035886] cytoplasm [GO:0005737]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; piccolo histone acetyltransferase complex [GO:0032777]; site of double-strand break [GO:0035861] chromatin-protein adaptor activity [GO:0140463]; enzyme-substrate adaptor activity [GO:0140767] g4648.t1 Q5R733 61.682 107 3.8e-32 132.0 sp|Q5R733|CPEB1_PONAB Cytoplasmic polyadenylation element-binding protein 1 OS=Pongo abelii OX=9601 GN=CPEB1 PE=2 SV=1 CPEB1_PONAB reviewed Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0031440; GO:0032869; GO:0035925; GO:0043022; GO:0046872; GO:0071230; GO:0071456; GO:1990904; GO:2000766 cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; regulation of mRNA 3'-end processing [GO:0031440] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135] g4649.t1 Q9BZB8 79.775 178 2.4099999999999997e-104 313.0 sp|Q9BZB8|CPEB1_HUMAN Cytoplasmic polyadenylation element-binding protein 1 OS=Homo sapiens OX=9606 GN=CPEB1 PE=1 SV=1 CPEB1_HUMAN reviewed Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (h-CPEB) (hCPEB-1) Homo sapiens (Human) GO:0000900; GO:0000932; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0031440; GO:0032869; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0046872; GO:0071230; GO:0071456; GO:1990904; GO:2000766 cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; regulation of mRNA 3'-end processing [GO:0031440] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135] g4649.t2 Q5R733 67.886 246 1.64e-116 347.0 sp|Q5R733|CPEB1_PONAB Cytoplasmic polyadenylation element-binding protein 1 OS=Pongo abelii OX=9601 GN=CPEB1 PE=2 SV=1 CPEB1_PONAB reviewed Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0031440; GO:0032869; GO:0035925; GO:0043022; GO:0046872; GO:0071230; GO:0071456; GO:1990904; GO:2000766 cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; regulation of mRNA 3'-end processing [GO:0031440] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135] g4649.t3 Q5R733 74.888 223 7.020000000000001e-122 360.0 sp|Q5R733|CPEB1_PONAB Cytoplasmic polyadenylation element-binding protein 1 OS=Pongo abelii OX=9601 GN=CPEB1 PE=2 SV=1 CPEB1_PONAB reviewed Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0031440; GO:0032869; GO:0035925; GO:0043022; GO:0046872; GO:0071230; GO:0071456; GO:1990904; GO:2000766 cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; regulation of mRNA 3'-end processing [GO:0031440] cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135] g4650.t1 Q66IM5 45.918 98 1.3299999999999999e-24 94.7 sp|Q66IM5|NATD1_XENTR Protein NATD1 OS=Xenopus tropicalis OX=8364 GN=natd1 PE=3 SV=1 g4651.t1 A2RRS8 38.545 646 7.49e-137 429.0 sp|A2RRS8|CEP78_XENTR Centrosomal protein of 78 kDa OS=Xenopus tropicalis OX=8364 GN=cep78 PE=2 SV=1 g4652.t1 Q6PGC1 48.766 1378 0.0 1283.0 sp|Q6PGC1|DHX29_MOUSE ATP-dependent RNA helicase DHX29 OS=Mus musculus OX=10090 GN=Dhx29 PE=1 SV=1 DHX29_MOUSE reviewed ATP-dependent RNA helicase DHX29 (EC 3.6.4.13) (DEAH box protein 29) Mus musculus (Mouse) GO:0001731; GO:0003723; GO:0003724; GO:0003743; GO:0004386; GO:0005524; GO:0005739; GO:0008494; GO:0016282; GO:0016887; GO:0017111; GO:0022627; GO:0042255; GO:0043024; GO:0045948 formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255] cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743] g4653.t1 Q5ZLL6 64.925 268 3.74e-136 389.0 sp|Q5ZLL6|MSMO1_CHICK Methylsterol monooxygenase 1 OS=Gallus gallus OX=9031 GN=MSMO1 PE=2 SV=1 MSMO1_CHICK reviewed Methylsterol monooxygenase 1 (EC 1.14.18.9) (C-4 methylsterol oxidase) Gallus gallus (Chicken) GO:0000254; GO:0005506; GO:0005789; GO:0016126 sterol biosynthetic process [GO:0016126] endoplasmic reticulum membrane [GO:0005789] C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506] g4654.t1 Q5RBC8 61.919 667 0.0 846.0 sp|Q5RBC8|S2512_PONAB Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial OS=Pongo abelii OX=9601 GN=SLC25A12 PE=2 SV=1 S2512_PONAB reviewed Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial (Solute carrier family 25 member 12) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000514; GO:0000515; GO:0005509; GO:0005739; GO:0005743; GO:0006754; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592 aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] 3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g4655.t1 Q5M939 49.383 405 1.22e-134 395.0 sp|Q5M939|HAT1_RAT Histone acetyltransferase type B catalytic subunit OS=Rattus norvegicus OX=10116 GN=Hat1 PE=2 SV=1 HAT1_RAT reviewed Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1) (Histone methacryltransferase HAT1) (EC 2.3.1.-) Rattus norvegicus (Rat) GO:0000781; GO:0000785; GO:0005654; GO:0005739; GO:0006334; GO:0007584; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043997; GO:0140218 nucleosome assembly [GO:0006334]; response to nutrient [GO:0007584]; subtelomeric heterochromatin formation [GO:0031509] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] histone binding [GO:0042393]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997]; histone methacryltransferase activity [GO:0140218] g4656.t1 Q15404 69.091 275 2.9099999999999997e-141 401.0 sp|Q15404|RSU1_HUMAN Ras suppressor protein 1 OS=Homo sapiens OX=9606 GN=RSU1 PE=1 SV=3 g4658.t1 Q6P4K6 29.643 840 4.0899999999999994e-67 252.0 sp|Q6P4K6|S11IP_XENTR Serine/threonine-protein kinase 11-interacting protein OS=Xenopus tropicalis OX=8364 GN=stk11ip PE=2 SV=1 g4658.t2 Q6P4K6 29.643 840 5.5199999999999996e-67 251.0 sp|Q6P4K6|S11IP_XENTR Serine/threonine-protein kinase 11-interacting protein OS=Xenopus tropicalis OX=8364 GN=stk11ip PE=2 SV=1 g4660.t1 Q7Z3B3 31.423 541 1.0300000000000001e-47 190.0 sp|Q7Z3B3|KANL1_HUMAN KAT8 regulatory NSL complex subunit 1 OS=Homo sapiens OX=9606 GN=KANSL1 PE=1 SV=3 KANL1_HUMAN reviewed KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog) Homo sapiens (Human) GO:0000123; GO:0000776; GO:0000922; GO:0005634; GO:0005654; GO:0005739; GO:0005874; GO:0006325; GO:0035035; GO:0044545; GO:0045893; GO:0071339; GO:1903108 chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108] histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] histone acetyltransferase binding [GO:0035035] g4662.t1 Q86VP1 27.114 686 5.54e-51 196.0 sp|Q86VP1|TAXB1_HUMAN Tax1-binding protein 1 OS=Homo sapiens OX=9606 GN=TAX1BP1 PE=1 SV=2 TAXB1_HUMAN reviewed Tax1-binding protein 1 (TRAF6-binding protein) Homo sapiens (Human) GO:0000407; GO:0005737; GO:0005739; GO:0005776; GO:0005829; GO:0006914; GO:0006915; GO:0008270; GO:0010804; GO:0019900; GO:0030674; GO:0031410; GO:0034144; GO:0035591; GO:0039532; GO:0043066; GO:0043124; GO:0045087; GO:0070062; GO:1905161; GO:2000660 apoptotic process [GO:0006915]; autophagy [GO:0006914]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein localization to phagocytic vesicle [GO:1905161] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407] kinase binding [GO:0019900]; protein-macromolecule adaptor activity [GO:0030674]; signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270] g4663.t1 P09057 37.355 431 5.09e-94 293.0 sp|P09057|DCOR_RAT Ornithine decarboxylase OS=Rattus norvegicus OX=10116 GN=Odc1 PE=1 SV=1 DCOR_RAT reviewed Ornithine decarboxylase (ODC) (EC 4.1.1.17) Rattus norvegicus (Rat) GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471 cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803] g4665.t1 Q15119 60.714 364 5.33e-152 438.0 sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2 PDK2_HUMAN reviewed [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII) Homo sapiens (Human) GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332 cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885]; regulation of pyruvate decarboxylation to acetyl-CoA [GO:0010510] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254] ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] g4667.t1 A3KNL6 44.156 154 4.28e-36 125.0 sp|A3KNL6|GGACC_DANRE Gamma-glutamylaminecyclotransferase C OS=Danio rerio OX=7955 GN=ggact.3 PE=2 SV=1 GGACC_DANRE reviewed Gamma-glutamylaminecyclotransferase C (GGACT C) (EC 4.3.2.8) (AIG2-like domain-containing protein 1-C) (Gamma-glutamylamine cyclotransferase C) (Gamma-glutamylamine cyclotransferase, tandem duplicate 3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0042219; GO:0061929 modified amino acid catabolic process [GO:0042219] cytosol [GO:0005829] gamma-glutamylaminecyclotransferase activity [GO:0061929] g4670.t1 Q90999 36.767 563 1.2e-106 335.0 sp|Q90999|TGFR2_CHICK TGF-beta receptor type-2 OS=Gallus gallus OX=9031 GN=TGFBR2 PE=1 SV=1 TGFR2_CHICK reviewed TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II) Gallus gallus (Chicken) GO:0001654; GO:0001666; GO:0001775; GO:0004675; GO:0005024; GO:0005026; GO:0005524; GO:0005539; GO:0005886; GO:0005901; GO:0006468; GO:0006915; GO:0007179; GO:0007399; GO:0007507; GO:0009410; GO:0009897; GO:0010628; GO:0010718; GO:0010936; GO:0016020; GO:0016361; GO:0016477; GO:0030324; GO:0030335; GO:0031012; GO:0032570; GO:0032924; GO:0034713; GO:0034714; GO:0043235; GO:0045121; GO:0045216; GO:0046872; GO:0048179; GO:0048185; GO:0048568; GO:0048762; GO:0050431; GO:0050714; GO:0051496; GO:0060317; GO:0060325; GO:0070483; GO:0070723; GO:0071363; GO:1905075; GO:2000379 activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell activation [GO:0001775]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to growth factor stimulus [GO:0071363]; detection of hypoxia [GO:0070483]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; lung development [GO:0030324]; mesenchymal cell differentiation [GO:0048762]; negative regulation of macrophage cytokine production [GO:0010936]; nervous system development [GO:0007399]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; protein phosphorylation [GO:0006468]; response to cholesterol [GO:0070723]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; transforming growth factor beta receptor signaling pathway [GO:0007179] activin receptor complex [GO:0048179]; caveola [GO:0005901]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type II [GO:0005026]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type I transforming growth factor beta receptor binding [GO:0034713]; type III transforming growth factor beta receptor binding [GO:0034714] g4671.t1 Q91YJ2 52.582 426 5.06e-161 465.0 sp|Q91YJ2|SNX4_MOUSE Sorting nexin-4 OS=Mus musculus OX=10090 GN=Snx4 PE=1 SV=1 SNX4_MOUSE reviewed Sorting nexin-4 Mus musculus (Mouse) GO:0005154; GO:0005158; GO:0005737; GO:0005769; GO:0005868; GO:0005886; GO:0015031; GO:0016020; GO:0031201; GO:0031901; GO:0032266; GO:0032456; GO:0032991; GO:0035091; GO:0098830; GO:1903595; GO:1990459; GO:1990460; GO:2000786 endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic endosome [GO:0098830]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201] epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459] g4672.t1 O54941 54.874 277 1.19e-90 287.0 sp|O54941|SMCE1_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Mus musculus OX=10090 GN=Smarce1 PE=1 SV=1 SMCE1_MOUSE reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016363; GO:0016514; GO:0016586; GO:0016922; GO:0022008; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723] g4672.t2 O54941 54.874 277 3.6999999999999997e-90 286.0 sp|O54941|SMCE1_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Mus musculus OX=10090 GN=Smarce1 PE=1 SV=1 SMCE1_MOUSE reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57) Mus musculus (Mouse) GO:0000776; GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016363; GO:0016514; GO:0016586; GO:0016922; GO:0022008; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723] g4673.t1 Q800K6 37.321 1672 0.0 1016.0 sp|Q800K6|TOB1A_XENLA DNA topoisomerase 2-binding protein 1-A OS=Xenopus laevis OX=8355 GN=topbp1-A PE=1 SV=2 TOB1A_XENLA reviewed DNA topoisomerase 2-binding protein 1-A (Cut5 protein) (DNA topoisomerase II-binding protein 1-A) (TopBP1-A) (XtopBP) Xenopus laevis (African clawed frog) GO:0000076; GO:0000724; GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0005634; GO:0005813; GO:0006270; GO:0006277; GO:0006974; GO:0007095; GO:0019900; GO:0030174; GO:0033138; GO:0033314; GO:0035563; GO:0035861; GO:0043539; GO:0045860; GO:0051276; GO:0071163; GO:0071165; GO:0071168; GO:0097681; GO:0140031; GO:0140463 chromosome organization [GO:0051276]; DNA amplification [GO:0006277]; DNA damage response [GO:0006974]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; DNA replication preinitiation complex assembly [GO:0071163]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; GINS complex assembly [GO:0071165]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of chromatin binding [GO:0035563]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated DNA replication initiation [GO:0030174] centrosome [GO:0005813]; chromatin [GO:0000785]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922] chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; kinase binding [GO:0019900]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539] g4674.t1 Q8C2L6 45.0 500 1.4e-155 454.0 sp|Q8C2L6|T161B_MOUSE Transmembrane protein 161B OS=Mus musculus OX=10090 GN=Tmem161b PE=2 SV=1 g4675.t1 Q6P832 65.647 425 0.0 590.0 sp|Q6P832|GATM_XENTR Glycine amidinotransferase, mitochondrial OS=Xenopus tropicalis OX=8364 GN=gatm PE=2 SV=1 g4688.t1 Q9Y6H5 28.696 230 2.4399999999999997e-24 114.0 sp|Q9Y6H5|SNCAP_HUMAN Synphilin-1 OS=Homo sapiens OX=9606 GN=SNCAIP PE=1 SV=2 SNCAP_HUMAN reviewed Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein) Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083 cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021] identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625] g4690.t1 A0JM12 37.607 234 5.45e-29 129.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g4690.t1 A0JM12 34.568 243 2.97e-25 117.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g4690.t1 A0JM12 33.588 262 1.52e-24 114.0 sp|A0JM12|MEG10_XENTR Multiple epidermal growth factor-like domains protein 10 OS=Xenopus tropicalis OX=8364 GN=megf10 PE=2 SV=1 g4695.t1 P21279 84.419 353 0.0 627.0 sp|P21279|GNAQ_MOUSE Guanine nucleotide-binding protein G(q) subunit alpha OS=Mus musculus OX=10090 GN=Gnaq PE=1 SV=4 g4696.t1 Q5ZIL9 44.19 611 4.88e-167 492.0 sp|Q5ZIL9|KBP_CHICK KIF-binding protein OS=Gallus gallus OX=9031 GN=Kifbp PE=2 SV=1 g4697.t1 Q9QYF3 53.077 260 7.71e-86 282.0 sp|Q9QYF3|MYO5A_RAT Unconventional myosin-Va OS=Rattus norvegicus OX=10116 GN=Myo5a PE=1 SV=1 MYO5A_RAT reviewed Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) Rattus norvegicus (Rat) GO:0000146; GO:0000149; GO:0001726; GO:0001750; GO:0003774; GO:0003779; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005777; GO:0005783; GO:0005790; GO:0005794; GO:0005829; GO:0005882; GO:0005884; GO:0006582; GO:0006887; GO:0006892; GO:0006897; GO:0007015; GO:0007268; GO:0007601; GO:0008021; GO:0015629; GO:0016020; GO:0016192; GO:0016236; GO:0016459; GO:0016461; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030048; GO:0030050; GO:0030073; GO:0030141; GO:0030318; GO:0030424; GO:0030425; GO:0031267; GO:0031982; GO:0031987; GO:0032252; GO:0032400; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0033602; GO:0042417; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042642; GO:0042759; GO:0042802; GO:0043008; GO:0043025; GO:0043473; GO:0044877; GO:0048066; GO:0048306; GO:0048820; GO:0050808; GO:0051015; GO:0051643; GO:0051967; GO:0055037; GO:0065003; GO:0072659; GO:0097718; GO:0098685; GO:0098794; GO:0098871; GO:0098978; GO:0099089; GO:0099566; GO:0099640; GO:0150103; GO:1900078; GO:1903078; GO:1904754; GO:1990904 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; axo-dendritic protein transport [GO:0099640]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; developmental pigmentation [GO:0048066]; dopamine metabolic process [GO:0042417]; endocytosis [GO:0006897]; endoplasmic reticulum localization [GO:0051643]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; macroautophagy [GO:0016236]; melanin biosynthetic process [GO:0042438]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; myelination [GO:0042552]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; odontogenesis [GO:0042476]; pigmentation [GO:0043473]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin, myosin complex part [GO:0042642]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; recycling endosome [GO:0055037]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075] g4698.t1 Q02440 56.25 96 5.08e-31 120.0 sp|Q02440|MYO5A_CHICK Unconventional myosin-Va OS=Gallus gallus OX=9031 GN=MYO5A PE=1 SV=1 g4699.t1 Q9ULV0 52.073 1375 0.0 1372.0 sp|Q9ULV0|MYO5B_HUMAN Unconventional myosin-Vb OS=Homo sapiens OX=9606 GN=MYO5B PE=1 SV=3 g4699.t2 Q9ULV0 52.419 1364 0.0 1367.0 sp|Q9ULV0|MYO5B_HUMAN Unconventional myosin-Vb OS=Homo sapiens OX=9606 GN=MYO5B PE=1 SV=3 g4699.t3 Q9ULV0 52.52 1369 0.0 1373.0 sp|Q9ULV0|MYO5B_HUMAN Unconventional myosin-Vb OS=Homo sapiens OX=9606 GN=MYO5B PE=1 SV=3 g4700.t1 P33316 72.143 140 1.3800000000000001e-65 204.0 sp|P33316|DUT_HUMAN Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial OS=Homo sapiens OX=9606 GN=DUT PE=1 SV=4 DUT_HUMAN reviewed Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase) Homo sapiens (Human) GO:0000287; GO:0001889; GO:0003723; GO:0004170; GO:0005634; GO:0005654; GO:0005739; GO:0006139; GO:0006226; GO:0006231; GO:0006260; GO:0030547; GO:0032556; GO:0042802; GO:0042975; GO:0043254; GO:0046081; GO:0070062 DNA replication [GO:0006260]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of protein-containing complex assembly [GO:0043254] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] dUTP diphosphatase activity [GO:0004170]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; peroxisome proliferator activated receptor binding [GO:0042975]; pyrimidine deoxyribonucleotide binding [GO:0032556]; RNA binding [GO:0003723]; signaling receptor inhibitor activity [GO:0030547] g4706.t1 Q4KLF3 53.846 130 6.749999999999999e-42 143.0 sp|Q4KLF3|KTI12_XENLA Protein KTI12 homolog OS=Xenopus laevis OX=8355 GN=kti12 PE=2 SV=1 g4707.t1 Q5ZJ85 46.475 766 0.0 605.0 sp|Q5ZJ85|PRPF3_CHICK U4/U6 small nuclear ribonucleoprotein Prp3 OS=Gallus gallus OX=9031 GN=PRPF3 PE=2 SV=1 PRPF3_CHICK reviewed U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3) Gallus gallus (Chicken) GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540 mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244] nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540] g4709.t1 Q0IHU5 65.426 188 1.31e-86 260.0 sp|Q0IHU5|ISOC1_XENTR Isochorismatase domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=isoc1 PE=2 SV=1 g4711.t1 O32164 27.436 390 3.73e-28 120.0 sp|O32164|SUFS_BACSU Cysteine desulfurase SufS OS=Bacillus subtilis (strain 168) OX=224308 GN=sufS PE=1 SV=1 SUFS_BACSU reviewed Cysteine desulfurase SufS (EC 2.8.1.7) Bacillus subtilis (strain 168) GO:0006534; GO:0030170; GO:0031071 cysteine metabolic process [GO:0006534] cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170] g4713.t1 Q10743 41.586 719 5.5699999999999995e-180 536.0 sp|Q10743|ADA10_RAT Disintegrin and metalloproteinase domain-containing protein 10 OS=Rattus norvegicus OX=10116 GN=Adam10 PE=1 SV=2 ADA10_RAT reviewed Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c) Rattus norvegicus (Rat) GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005794; GO:0005798; GO:0005802; GO:0005886; GO:0005912; GO:0006509; GO:0007162; GO:0007173; GO:0007219; GO:0007283; GO:0008021; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0010976; GO:0014069; GO:0016485; GO:0017124; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0032760; GO:0034205; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0043025; GO:0043065; GO:0043197; GO:0045211; GO:0045670; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0061001; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0097327; GO:0098696; GO:0098794; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945; GO:1903265 adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of osteoclast differentiation [GO:0045670]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448]; spermatogenesis [GO:0007283] adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124] g4714.t1 O14672 45.604 728 0.0 646.0 sp|O14672|ADA10_HUMAN Disintegrin and metalloproteinase domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ADAM10 PE=1 SV=1 ADA10_HUMAN reviewed Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c) Homo sapiens (Human) GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005178; GO:0005788; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0005925; GO:0006509; GO:0007162; GO:0007173; GO:0007219; GO:0007229; GO:0007267; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016485; GO:0017124; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0032760; GO:0034332; GO:0034612; GO:0035579; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070062; GO:0070573; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:1901342; GO:1902945; GO:1903265 adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612] adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197] endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124] g4715.t1 Q921X9 45.098 510 1.45e-139 424.0 sp|Q921X9|PDIA5_MOUSE Protein disulfide-isomerase A5 OS=Mus musculus OX=10090 GN=Pdia5 PE=1 SV=1 g4715.t1 Q921X9 38.657 432 1.5e-73 251.0 sp|Q921X9|PDIA5_MOUSE Protein disulfide-isomerase A5 OS=Mus musculus OX=10090 GN=Pdia5 PE=1 SV=1 g4717.t1 Q9CPW9 47.302 315 1.19e-97 298.0 sp|Q9CPW9|MAP12_MOUSE Methionine aminopeptidase 1D, mitochondrial OS=Mus musculus OX=10090 GN=Metap1d PE=2 SV=1 MAP12_MOUSE reviewed Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D) Mus musculus (Mouse) GO:0004239; GO:0005739; GO:0006508; GO:0043687; GO:0046872; GO:0070006 post-translational protein modification [GO:0043687]; proteolysis [GO:0006508] mitochondrion [GO:0005739] initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006] g4719.t1 Q93126 24.27 445 1.02e-22 103.0 sp|Q93126|GPR9_AMPAM Probable G-protein coupled receptor No9 OS=Amphibalanus amphitrite OX=1232801 PE=3 SV=1 g4721.t1 Q96PH1 40.11 546 3.2e-113 369.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4721.t1 Q96PH1 49.123 228 5.75e-67 243.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4721.t2 Q96PH1 41.165 532 9.75e-117 378.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4721.t2 Q96PH1 49.123 228 5.06e-67 243.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4721.t3 Q96PH1 41.165 532 4.23e-117 379.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4721.t3 Q96PH1 49.123 228 4.5599999999999995e-67 243.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4722.t1 Q0D4Z6 29.204 565 3.69e-47 178.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g4723.t1 Q96PH1 46.951 164 2.3799999999999998e-48 169.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4724.t1 Q99J23 30.518 367 8.4700000000000005e-47 176.0 sp|Q99J23|GHDC_MOUSE GH3 domain-containing protein OS=Mus musculus OX=10090 GN=Ghdc PE=2 SV=2 g4725.t1 Q0D4Z6 28.829 555 4.68e-51 189.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g4726.t1 Q9D3W5 39.488 547 7.94e-110 342.0 sp|Q9D3W5|LRC71_MOUSE Leucine-rich repeat-containing protein 71 OS=Mus musculus OX=10090 GN=Lrrc71 PE=2 SV=1 g4726.t2 Q9D3W5 39.781 548 2.3900000000000003e-109 341.0 sp|Q9D3W5|LRC71_MOUSE Leucine-rich repeat-containing protein 71 OS=Mus musculus OX=10090 GN=Lrrc71 PE=2 SV=1 g4726.t3 Q9D3W5 40.187 535 4.6500000000000004e-110 342.0 sp|Q9D3W5|LRC71_MOUSE Leucine-rich repeat-containing protein 71 OS=Mus musculus OX=10090 GN=Lrrc71 PE=2 SV=1 g4727.t1 Q9DC33 52.353 340 5.7700000000000006e-117 346.0 sp|Q9DC33|HM20A_MOUSE High mobility group protein 20A OS=Mus musculus OX=10090 GN=Hmg20a PE=1 SV=1 HM20A_MOUSE reviewed High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein HMGX1) (Inhibitor of BRAF35) (iBRAF) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0005634; GO:0006325; GO:0010468; GO:0033234; GO:0042802; GO:0045665 chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] DNA binding [GO:0003677]; identical protein binding [GO:0042802] g4729.t1 Q02241 50.0 752 0.0 698.0 sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3 KIF23_HUMAN reviewed Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) Homo sapiens (Human) GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149; GO:0097225; GO:0097227; GO:0097228 microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm annulus [GO:0097227]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g4729.t1 Q02241 48.466 163 1.21e-35 149.0 sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3 KIF23_HUMAN reviewed Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) Homo sapiens (Human) GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149; GO:0097225; GO:0097227; GO:0097228 microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm annulus [GO:0097227]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g4730.t1 D3ZMK9 28.25 400 1.71e-32 142.0 sp|D3ZMK9|PRAG1_RAT Inactive tyrosine-protein kinase PRAG1 OS=Rattus norvegicus OX=10116 GN=Prag1 PE=1 SV=1 PRAG1_RAT reviewed Inactive tyrosine-protein kinase PRAG1 (PEAK1-related kinase-activating pseudokinase 1) (Pragma of Rnd2) Rattus norvegicus (Rat) GO:0004672; GO:0005634; GO:0005737; GO:0005925; GO:0008360; GO:0008593; GO:0010977; GO:0016477; GO:0035025; GO:0042802; GO:2000145 cell migration [GO:0016477]; negative regulation of neuron projection development [GO:0010977]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634] identical protein binding [GO:0042802]; protein kinase activity [GO:0004672] g4732.t1 Q9H1K6 45.317 331 2.22e-88 273.0 sp|Q9H1K6|TLRN1_HUMAN Talin rod domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TLNRD1 PE=1 SV=1 g4733.t1 Q9HCE0 32.705 2651 0.0 1274.0 sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2 EPG5_HUMAN reviewed Ectopic P granules protein 5 homolog Homo sapiens (Human) GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786 autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] g4733.t2 Q9HCE0 32.74 2642 0.0 1278.0 sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2 EPG5_HUMAN reviewed Ectopic P granules protein 5 homolog Homo sapiens (Human) GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786 autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] g4733.t3 Q9HCE0 32.605 2656 0.0 1275.0 sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2 EPG5_HUMAN reviewed Ectopic P granules protein 5 homolog Homo sapiens (Human) GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786 autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] g4734.t1 P09503 43.646 181 3.81e-39 135.0 sp|P09503|DYR_SHV21 Viral dihydrofolate reductase OS=Saimiriine herpesvirus 2 (strain 11) OX=10383 GN=DHFR PE=3 SV=1 g4735.t1 P00378 50.0 182 3.55e-61 191.0 sp|P00378|DYR_CHICK Dihydrofolate reductase OS=Gallus gallus OX=9031 GN=DHFR PE=1 SV=1 g4738.t1 A1ZAX0 28.571 315 3.2700000000000004e-31 127.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 CCH1R_DROME reviewed Neuropeptide CCHamide-1 receptor Drosophila melanogaster (Fruit fly) GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016020 G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] membrane [GO:0016020]; plasma membrane [GO:0005886] allatostatin receptor activity [GO:0008261]; neuropeptide receptor activity [GO:0008188] g4740.t1 Q9VCA2 38.349 545 8.739999999999999e-113 350.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g4741.t1 Q5BJZ6 48.087 366 2.37e-128 378.0 sp|Q5BJZ6|CARME_RAT Carnosine N-methyltransferase OS=Rattus norvegicus OX=10116 GN=Carnmt1 PE=1 SV=1 CARME_RAT reviewed Carnosine N-methyltransferase (EC 2.1.1.22) (Anserine-producing methyltransferase) Rattus norvegicus (Rat) GO:0005634; GO:0005829; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803 carnosine metabolic process [GO:0035498]; methylation [GO:0032259] cytosol [GO:0005829]; nucleus [GO:0005634] carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g4742.t1 Q8VDR5 36.916 214 1.35e-38 135.0 sp|Q8VDR5|TM267_MOUSE Transmembrane protein 267 OS=Mus musculus OX=10090 GN=Tmem267 PE=2 SV=1 g4744.t1 P15145 44.004 909 0.0 754.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g4744.t2 P15145 44.994 909 0.0 770.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g4746.t1 P15145 34.907 911 6.58e-160 499.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g4747.t1 P15541 33.298 949 4.38e-161 502.0 sp|P15541|AMPN_RABIT Aminopeptidase N OS=Oryctolagus cuniculus OX=9986 GN=ANPEP PE=1 SV=4 g4748.t1 Q3TZZ7 38.323 835 0.0 568.0 sp|Q3TZZ7|ESYT2_MOUSE Extended synaptotagmin-2 OS=Mus musculus OX=10090 GN=Esyt2 PE=1 SV=1 ESYT2_MOUSE reviewed Extended synaptotagmin-2 (E-Syt2) Mus musculus (Mouse) GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268 endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091] g4748.t2 Q3TZZ7 39.146 820 0.0 573.0 sp|Q3TZZ7|ESYT2_MOUSE Extended synaptotagmin-2 OS=Mus musculus OX=10090 GN=Esyt2 PE=1 SV=1 ESYT2_MOUSE reviewed Extended synaptotagmin-2 (E-Syt2) Mus musculus (Mouse) GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0042802; GO:0044232; GO:0061817; GO:0140268 endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091] g4750.t1 Q8MYF2 46.746 169 4.3e-51 169.0 sp|Q8MYF2|RABJ_DICDI Ras-related protein RabJ OS=Dictyostelium discoideum OX=44689 GN=rabJ PE=3 SV=1 g4751.t1 Q5R5D2 43.382 136 4.77e-32 119.0 sp|Q5R5D2|SOSD1_PONAB Sclerostin domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SOSTDC1 PE=2 SV=1 SOSD1_PONAB reviewed Sclerostin domain-containing protein 1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005615; GO:0007389; GO:0010454; GO:0030514; GO:0031069; GO:0036122; GO:0042475; GO:0045662; GO:0060070; GO:0060648; GO:0072148; GO:0090090; GO:0098821; GO:2000016 canonical Wnt signaling pathway [GO:0060070]; epithelial cell fate commitment [GO:0072148]; hair follicle morphogenesis [GO:0031069]; mammary gland bud morphogenesis [GO:0060648]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of myoblast differentiation [GO:0045662]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389] extracellular space [GO:0005615] BMP binding [GO:0036122]; BMP receptor activity [GO:0098821] g4752.t1 Q5RJG7 38.072 415 5.48e-77 248.0 sp|Q5RJG7|ISPD_MOUSE D-ribitol-5-phosphate cytidylyltransferase OS=Mus musculus OX=10090 GN=Crppa PE=2 SV=1 ISPD_MOUSE reviewed D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein) Mus musculus (Mouse) GO:0005829; GO:0007411; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0070567 axon guidance [GO:0007411]; isoprenoid biosynthetic process [GO:0008299]; protein O-linked glycosylation via mannose [GO:0035269] cytosol [GO:0005829] cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803] g4756.t1 P50549 45.401 511 4.5200000000000005e-105 326.0 sp|P50549|ETV1_HUMAN ETS translocation variant 1 OS=Homo sapiens OX=9606 GN=ETV1 PE=1 SV=2 g4757.t1 Q6NS52 66.37 675 0.0 971.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4757.t1 Q6NS52 57.471 87 1.19e-22 108.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4757.t2 Q6NS52 66.37 675 0.0 967.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4757.t2 Q6NS52 57.471 87 1.4100000000000001e-22 107.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4757.t3 Q6NS52 67.218 665 0.0 968.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4757.t3 Q6NS52 57.471 87 1.16e-22 108.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4757.t4 Q6NS52 65.786 681 0.0 963.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4757.t4 Q6NS52 57.471 87 1.23e-22 108.0 sp|Q6NS52|DGKB_MOUSE Diacylglycerol kinase beta OS=Mus musculus OX=10090 GN=Dgkb PE=1 SV=2 DGKB_MOUSE reviewed Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta) Mus musculus (Mouse) GO:0004143; GO:0005509; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0008289; GO:0009617; GO:0016607; GO:0035556; GO:0046339; GO:0046473; GO:0046486; GO:0046834; GO:0050804; GO:0098685; GO:0098978; GO:0099147; GO:0099175 diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of postsynapse organization [GO:0099175]; response to bacterium [GO:0009617] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g4760.t1 Q9HAB8 52.555 137 4.33e-45 152.0 sp|Q9HAB8|PPCS_HUMAN Phosphopantothenate--cysteine ligase OS=Homo sapiens OX=9606 GN=PPCS PE=1 SV=2 g4762.t1 Q91XQ5 28.719 484 2.4300000000000003e-56 197.0 sp|Q91XQ5|CHSTF_MOUSE Carbohydrate sulfotransferase 15 OS=Mus musculus OX=10090 GN=Chst15 PE=2 SV=1 g4764.t1 P97275 59.544 482 0.0 612.0 sp|P97275|ADAS_CAVPO Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Cavia porcellus OX=10141 GN=AGPS PE=1 SV=1 ADAS_CAVPO reviewed Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Alkylglycerone-phosphate synthase) Cavia porcellus (Guinea pig) GO:0005777; GO:0005778; GO:0008609; GO:0008611; GO:0071949 ether lipid biosynthetic process [GO:0008611] peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949] g4765.t1 Q9EQR2 60.811 74 2.64e-26 103.0 sp|Q9EQR2|ADAS_RAT Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Rattus norvegicus OX=10116 GN=Agps PE=1 SV=1 ADAS_RAT reviewed Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Alkylglycerone-phosphate synthase) Rattus norvegicus (Rat) GO:0005777; GO:0005778; GO:0008609; GO:0008610; GO:0008611; GO:0071949 ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610] peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949] g4769.t1 P53808 48.529 204 1.36e-69 214.0 sp|P53808|PPCT_MOUSE Phosphatidylcholine transfer protein OS=Mus musculus OX=10090 GN=Pctp PE=1 SV=2 g4771.t1 Q9QXM0 45.685 394 8.5e-130 383.0 sp|Q9QXM0|ABHD2_MOUSE Monoacylglycerol lipase ABHD2 OS=Mus musculus OX=10090 GN=Abhd2 PE=1 SV=1 g4772.t1 Q7Z429 41.597 238 8.33e-56 185.0 sp|Q7Z429|LFG1_HUMAN Protein lifeguard 1 OS=Homo sapiens OX=9606 GN=GRINA PE=1 SV=1 LFG1_HUMAN reviewed Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3) Homo sapiens (Human) GO:0000139; GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0032469; GO:0043524; GO:0044325; GO:0097190; GO:1902042; GO:1902236 apoptotic signaling pathway [GO:0097190]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium channel activity [GO:0005262]; transmembrane transporter binding [GO:0044325] g4773.t1 Q91WN1 51.737 259 2.1899999999999997e-89 268.0 sp|Q91WN1|DNJC9_MOUSE DnaJ homolog subfamily C member 9 OS=Mus musculus OX=10090 GN=Dnajc9 PE=1 SV=2 g4775.t1 A2AG06 39.241 158 3.5000000000000003e-29 125.0 sp|A2AG06|MEIOC_MOUSE Meiosis-specific coiled-coil domain-containing protein MEIOC OS=Mus musculus OX=10090 GN=Meioc PE=1 SV=1 MEIOC_MOUSE reviewed Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192 chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] cytoplasm [GO:0005737]; nucleus [GO:0005634] g4777.t1 Q9DAA6 62.903 186 5.12e-83 247.0 sp|Q9DAA6|EXOS1_MOUSE Exosome complex component CSL4 OS=Mus musculus OX=10090 GN=Exosc1 PE=1 SV=1 EXOS1_MOUSE reviewed Exosome complex component CSL4 (Exosome component 1) Mus musculus (Mouse) GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0101019 RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleus [GO:0005634] RNA binding [GO:0003723] g4783.t1 Q9VCA2 38.207 513 3.2699999999999998e-111 345.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g4783.t2 Q9VCA2 38.153 498 8.42e-107 333.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g4784.t1 Q7Z429 44.91 334 5.78e-78 246.0 sp|Q7Z429|LFG1_HUMAN Protein lifeguard 1 OS=Homo sapiens OX=9606 GN=GRINA PE=1 SV=1 LFG1_HUMAN reviewed Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3) Homo sapiens (Human) GO:0000139; GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0032469; GO:0043524; GO:0044325; GO:0097190; GO:1902042; GO:1902236 apoptotic signaling pathway [GO:0097190]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium channel activity [GO:0005262]; transmembrane transporter binding [GO:0044325] g4784.t2 Q7Z429 44.012 334 1.3e-75 239.0 sp|Q7Z429|LFG1_HUMAN Protein lifeguard 1 OS=Homo sapiens OX=9606 GN=GRINA PE=1 SV=1 LFG1_HUMAN reviewed Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3) Homo sapiens (Human) GO:0000139; GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0032469; GO:0043524; GO:0044325; GO:0097190; GO:1902042; GO:1902236 apoptotic signaling pathway [GO:0097190]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium channel activity [GO:0005262]; transmembrane transporter binding [GO:0044325] g4785.t1 Q8JIU7 64.977 217 5.01e-77 233.0 sp|Q8JIU7|NACA_DANRE Nascent polypeptide-associated complex subunit alpha OS=Danio rerio OX=7955 GN=naca PE=1 SV=1 g4788.t1 Q9R0G7 45.402 348 3.05e-60 229.0 sp|Q9R0G7|ZEB2_MOUSE Zinc finger E-box-binding homeobox 2 OS=Mus musculus OX=10090 GN=Zeb2 PE=1 SV=2 ZEB2_MOUSE reviewed Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1) (Zinc finger homeobox protein 1b) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001755; GO:0001756; GO:0001843; GO:0001935; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0006357; GO:0007417; GO:0008270; GO:0010764; GO:0021540; GO:0021766; GO:0021846; GO:0021957; GO:0030177; GO:0030511; GO:0036446; GO:0043149; GO:0043542; GO:0045636; GO:0045944; GO:0048023; GO:0048066; GO:0048143; GO:0048598; GO:0048668; GO:0050772; GO:0061373; GO:0070269; GO:0070412; GO:0072537; GO:0090263; GO:0090649; GO:0097324; GO:1902748; GO:1903056; GO:1904330; GO:1904520; GO:1905603 astrocyte activation [GO:0048143]; cell proliferation in forebrain [GO:0021846]; central nervous system development [GO:0007417]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; developmental pigmentation [GO:0048066]; embryonic morphogenesis [GO:0048598]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; fibroblast activation [GO:0072537]; hippocampus development [GO:0021766]; mammillary axonal complex development [GO:0061373]; melanocyte migration [GO:0097324]; myofibroblast differentiation [GO:0036446]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of axonogenesis [GO:0050772]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myofibroblast contraction [GO:1904330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of Wnt signaling pathway [GO:0030177]; pyroptotic inflammatory response [GO:0070269]; regulation of blood-brain barrier permeability [GO:1905603]; regulation of melanosome organization [GO:1903056]; regulation of myofibroblast cell apoptotic process [GO:1904520]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxygen-glucose deprivation [GO:0090649]; somitogenesis [GO:0001756]; stress fiber assembly [GO:0043149] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g4788.t1 Q9R0G7 71.717 99 1.98e-38 160.0 sp|Q9R0G7|ZEB2_MOUSE Zinc finger E-box-binding homeobox 2 OS=Mus musculus OX=10090 GN=Zeb2 PE=1 SV=2 ZEB2_MOUSE reviewed Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1) (Zinc finger homeobox protein 1b) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001755; GO:0001756; GO:0001843; GO:0001935; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0006357; GO:0007417; GO:0008270; GO:0010764; GO:0021540; GO:0021766; GO:0021846; GO:0021957; GO:0030177; GO:0030511; GO:0036446; GO:0043149; GO:0043542; GO:0045636; GO:0045944; GO:0048023; GO:0048066; GO:0048143; GO:0048598; GO:0048668; GO:0050772; GO:0061373; GO:0070269; GO:0070412; GO:0072537; GO:0090263; GO:0090649; GO:0097324; GO:1902748; GO:1903056; GO:1904330; GO:1904520; GO:1905603 astrocyte activation [GO:0048143]; cell proliferation in forebrain [GO:0021846]; central nervous system development [GO:0007417]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; developmental pigmentation [GO:0048066]; embryonic morphogenesis [GO:0048598]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; fibroblast activation [GO:0072537]; hippocampus development [GO:0021766]; mammillary axonal complex development [GO:0061373]; melanocyte migration [GO:0097324]; myofibroblast differentiation [GO:0036446]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of axonogenesis [GO:0050772]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myofibroblast contraction [GO:1904330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of Wnt signaling pathway [GO:0030177]; pyroptotic inflammatory response [GO:0070269]; regulation of blood-brain barrier permeability [GO:1905603]; regulation of melanosome organization [GO:1903056]; regulation of myofibroblast cell apoptotic process [GO:1904520]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxygen-glucose deprivation [GO:0090649]; somitogenesis [GO:0001756]; stress fiber assembly [GO:0043149] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g4788.t2 Q9R0G7 45.402 348 3.3199999999999996e-60 229.0 sp|Q9R0G7|ZEB2_MOUSE Zinc finger E-box-binding homeobox 2 OS=Mus musculus OX=10090 GN=Zeb2 PE=1 SV=2 ZEB2_MOUSE reviewed Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1) (Zinc finger homeobox protein 1b) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001755; GO:0001756; GO:0001843; GO:0001935; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0006357; GO:0007417; GO:0008270; GO:0010764; GO:0021540; GO:0021766; GO:0021846; GO:0021957; GO:0030177; GO:0030511; GO:0036446; GO:0043149; GO:0043542; GO:0045636; GO:0045944; GO:0048023; GO:0048066; GO:0048143; GO:0048598; GO:0048668; GO:0050772; GO:0061373; GO:0070269; GO:0070412; GO:0072537; GO:0090263; GO:0090649; GO:0097324; GO:1902748; GO:1903056; GO:1904330; GO:1904520; GO:1905603 astrocyte activation [GO:0048143]; cell proliferation in forebrain [GO:0021846]; central nervous system development [GO:0007417]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; developmental pigmentation [GO:0048066]; embryonic morphogenesis [GO:0048598]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; fibroblast activation [GO:0072537]; hippocampus development [GO:0021766]; mammillary axonal complex development [GO:0061373]; melanocyte migration [GO:0097324]; myofibroblast differentiation [GO:0036446]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of axonogenesis [GO:0050772]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myofibroblast contraction [GO:1904330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of Wnt signaling pathway [GO:0030177]; pyroptotic inflammatory response [GO:0070269]; regulation of blood-brain barrier permeability [GO:1905603]; regulation of melanosome organization [GO:1903056]; regulation of myofibroblast cell apoptotic process [GO:1904520]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxygen-glucose deprivation [GO:0090649]; somitogenesis [GO:0001756]; stress fiber assembly [GO:0043149] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g4788.t2 Q9R0G7 74.737 95 3.3699999999999997e-40 166.0 sp|Q9R0G7|ZEB2_MOUSE Zinc finger E-box-binding homeobox 2 OS=Mus musculus OX=10090 GN=Zeb2 PE=1 SV=2 ZEB2_MOUSE reviewed Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1) (Zinc finger homeobox protein 1b) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001755; GO:0001756; GO:0001843; GO:0001935; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0006357; GO:0007417; GO:0008270; GO:0010764; GO:0021540; GO:0021766; GO:0021846; GO:0021957; GO:0030177; GO:0030511; GO:0036446; GO:0043149; GO:0043542; GO:0045636; GO:0045944; GO:0048023; GO:0048066; GO:0048143; GO:0048598; GO:0048668; GO:0050772; GO:0061373; GO:0070269; GO:0070412; GO:0072537; GO:0090263; GO:0090649; GO:0097324; GO:1902748; GO:1903056; GO:1904330; GO:1904520; GO:1905603 astrocyte activation [GO:0048143]; cell proliferation in forebrain [GO:0021846]; central nervous system development [GO:0007417]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; developmental pigmentation [GO:0048066]; embryonic morphogenesis [GO:0048598]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; fibroblast activation [GO:0072537]; hippocampus development [GO:0021766]; mammillary axonal complex development [GO:0061373]; melanocyte migration [GO:0097324]; myofibroblast differentiation [GO:0036446]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of axonogenesis [GO:0050772]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myofibroblast contraction [GO:1904330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of Wnt signaling pathway [GO:0030177]; pyroptotic inflammatory response [GO:0070269]; regulation of blood-brain barrier permeability [GO:1905603]; regulation of melanosome organization [GO:1903056]; regulation of myofibroblast cell apoptotic process [GO:1904520]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxygen-glucose deprivation [GO:0090649]; somitogenesis [GO:0001756]; stress fiber assembly [GO:0043149] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g4790.t1 Q92609 41.456 673 1.13e-170 515.0 sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1 TBCD5_HUMAN reviewed TBC1 domain family member 5 Homo sapiens (Human) GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0044877; GO:1905394 autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; retromer complex [GO:0030904] AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394] g4790.t2 Q92609 41.892 666 2.28e-173 522.0 sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1 TBCD5_HUMAN reviewed TBC1 domain family member 5 Homo sapiens (Human) GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0044877; GO:1905394 autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; retromer complex [GO:0030904] AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394] g4791.t1 O88967 53.815 734 0.0 738.0 sp|O88967|YMEL1_MOUSE ATP-dependent zinc metalloprotease YME1L1 OS=Mus musculus OX=10090 GN=Yme1l1 PE=1 SV=1 YMEL1_MOUSE reviewed ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (EC 3.6.-.-) (ATP-dependent metalloprotease FtsH1) (YME1-like protein 1) Mus musculus (Mouse) GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006515; GO:0007005; GO:0008283; GO:0009267; GO:0010636; GO:0016604; GO:0016887; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872; GO:0097150; GO:2000035 cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mitochondrial fusion [GO:0010636]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of stem cell division [GO:2000035] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g4792.t1 Q9NVV4 38.298 517 1.68e-114 360.0 sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1 PAPD1_HUMAN reviewed Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP) Homo sapiens (Human) GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0071044; GO:0097222; GO:1990817 histone mRNA catabolic process [GO:0071044]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134] g4793.t1 Q8IS64 39.81 736 0.0 543.0 sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1 g4794.t1 Q9Y2T3 52.135 445 3.0199999999999997e-159 461.0 sp|Q9Y2T3|GUAD_HUMAN Guanine deaminase OS=Homo sapiens OX=9606 GN=GDA PE=1 SV=1 g4794.t2 Q9Y2T3 51.011 445 8.29e-152 441.0 sp|Q9Y2T3|GUAD_HUMAN Guanine deaminase OS=Homo sapiens OX=9606 GN=GDA PE=1 SV=1 g4794.t3 Q9Y2T3 48.637 477 4.3099999999999996e-152 444.0 sp|Q9Y2T3|GUAD_HUMAN Guanine deaminase OS=Homo sapiens OX=9606 GN=GDA PE=1 SV=1 g4796.t1 P80146 47.48 377 8.7e-99 302.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g4797.t2 Q4N4N8 35.928 167 1.1500000000000002e-21 94.7 sp|Q4N4N8|TXND_THEPA Thioredoxin domain-containing protein OS=Theileria parva OX=5875 GN=TP02_0602 PE=1 SV=1 g4798.t1 Q9JIQ8 31.401 414 2.84e-45 174.0 sp|Q9JIQ8|TMPS2_MOUSE Transmembrane protease serine 2 OS=Mus musculus OX=10090 GN=Tmprss2 PE=2 SV=3 TMPS2_MOUSE reviewed Transmembrane protease serine 2 (EC 3.4.21.122) (Epitheliasin) (Plasmic transmembrane protein X) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain] Mus musculus (Mouse) GO:0004252; GO:0005576; GO:0005654; GO:0005886; GO:0006508; GO:0008236; GO:0016540; GO:0046598; GO:0046872; GO:0098670 entry receptor-mediated virion attachment to host cell [GO:0098670]; positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g4801.t1 Q8N6U8 31.28 211 2.4600000000000002e-29 120.0 sp|Q8N6U8|GP161_HUMAN G-protein coupled receptor 161 OS=Homo sapiens OX=9606 GN=GPR161 PE=1 SV=1 GP161_HUMAN reviewed G-protein coupled receptor 161 (G-protein coupled receptor RE2) Homo sapiens (Human) GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0030666; GO:0055037; GO:0060170; GO:1901621 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] ciliary membrane [GO:0060170]; cilium [GO:0005929]; endocytic vesicle membrane [GO:0030666]; recycling endosome [GO:0055037] G protein-coupled receptor activity [GO:0004930] g4802.t1 E9PYK3 40.522 997 0.0 688.0 sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1 PARP4_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0140806; GO:0140807; GO:1990404; GO:1990904 inflammatory response [GO:0006954] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876] enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779] g4802.t2 Q9UKK3 40.957 188 6.240000000000001e-27 122.0 sp|Q9UKK3|PARP4_HUMAN Protein mono-ADP-ribosyltransferase PARP4 OS=Homo sapiens OX=9606 GN=PARP4 PE=1 SV=3 PARP4_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) Homo sapiens (Human) GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005876; GO:0006281; GO:0006954; GO:0006974; GO:0009410; GO:0016020; GO:0016779; GO:0019899; GO:0036211; GO:0070062; GO:0140806; GO:0140807; GO:1990404; GO:1990904 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein modification process [GO:0036211]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876] DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779] g4805.t1 Q96MT7 44.864 662 1.77e-168 530.0 sp|Q96MT7|CFA44_HUMAN Cilia- and flagella-associated protein 44 OS=Homo sapiens OX=9606 GN=CFAP44 PE=1 SV=2 CFA44_HUMAN reviewed Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) Homo sapiens (Human) GO:0000226; GO:0000902; GO:0006997; GO:0007288; GO:0008233; GO:0031514 cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288] motile cilium [GO:0031514] peptidase activity [GO:0008233] g4806.t1 Q96MT7 41.942 1061 0.0 712.0 sp|Q96MT7|CFA44_HUMAN Cilia- and flagella-associated protein 44 OS=Homo sapiens OX=9606 GN=CFAP44 PE=1 SV=2 CFA44_HUMAN reviewed Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) Homo sapiens (Human) GO:0000226; GO:0000902; GO:0006997; GO:0007288; GO:0008233; GO:0031514 cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288] motile cilium [GO:0031514] peptidase activity [GO:0008233] g4806.t2 Q96MT7 42.18 1055 0.0 717.0 sp|Q96MT7|CFA44_HUMAN Cilia- and flagella-associated protein 44 OS=Homo sapiens OX=9606 GN=CFAP44 PE=1 SV=2 CFA44_HUMAN reviewed Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) Homo sapiens (Human) GO:0000226; GO:0000902; GO:0006997; GO:0007288; GO:0008233; GO:0031514 cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288] motile cilium [GO:0031514] peptidase activity [GO:0008233] g4806.t3 Q96MT7 42.22 1054 0.0 722.0 sp|Q96MT7|CFA44_HUMAN Cilia- and flagella-associated protein 44 OS=Homo sapiens OX=9606 GN=CFAP44 PE=1 SV=2 CFA44_HUMAN reviewed Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) Homo sapiens (Human) GO:0000226; GO:0000902; GO:0006997; GO:0007288; GO:0008233; GO:0031514 cell morphogenesis [GO:0000902]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288] motile cilium [GO:0031514] peptidase activity [GO:0008233] g4807.t1 Q5Y5T3 29.056 413 9.159999999999999e-38 143.0 sp|Q5Y5T3|ZDH23_MOUSE Palmitoyltransferase ZDHHC23 OS=Mus musculus OX=10090 GN=Zdhhc23 PE=2 SV=1 ZDH23_MOUSE reviewed Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (DHHC-containing protein 11) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23) Mus musculus (Mouse) GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0019706; GO:0072659 protein localization to plasma membrane [GO:0072659]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g4808.t1 Q61070 52.396 313 2.63e-109 324.0 sp|Q61070|EI24_MOUSE Etoposide-induced protein 2.4 OS=Mus musculus OX=10090 GN=Ei24 PE=1 SV=3 EI24_MOUSE reviewed Etoposide-induced protein 2.4 (p53-induced gene 8 protein) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006914; GO:0008630; GO:0009410; GO:0016236; GO:0030308; GO:0031965; GO:0042308; GO:0050885; GO:0061676; GO:0071494; GO:2001244 autophagy [GO:0006914]; cellular response to UV-C [GO:0071494]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308]; negative regulation of protein import into nucleus [GO:0042308]; neuromuscular process controlling balance [GO:0050885]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965] importin-alpha family protein binding [GO:0061676] g4809.t1 Q9Y2M2 33.779 299 5.06e-62 209.0 sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2 g4812.t1 P56818 48.104 501 1.5e-159 466.0 sp|P56818|BACE1_MOUSE Beta-secretase 1 OS=Mus musculus OX=10090 GN=Bace1 PE=1 SV=2 g4813.t1 Q6NWZ9 57.823 147 1.1500000000000001e-59 187.0 sp|Q6NWZ9|CDO1_DANRE Cysteine dioxygenase type 1 OS=Danio rerio OX=7955 GN=cdo1 PE=2 SV=1 g4814.t1 O14672 32.012 681 1.7e-89 298.0 sp|O14672|ADA10_HUMAN Disintegrin and metalloproteinase domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ADAM10 PE=1 SV=1 ADA10_HUMAN reviewed Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c) Homo sapiens (Human) GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005178; GO:0005788; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0005925; GO:0006509; GO:0007162; GO:0007173; GO:0007219; GO:0007229; GO:0007267; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016485; GO:0017124; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0032760; GO:0034332; GO:0034612; GO:0035579; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070062; GO:0070573; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:1901342; GO:1902945; GO:1903265 adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612] adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197] endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124] g4817.t1 Q498G2 30.986 497 5.22e-50 196.0 sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1 g4818.t1 Q15311 47.309 353 1.63e-92 307.0 sp|Q15311|RBP1_HUMAN RalA-binding protein 1 OS=Homo sapiens OX=9606 GN=RALBP1 PE=1 SV=3 RBP1_HUMAN reviewed RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (EC 7.6.2.2, EC 7.6.2.3) (Ral-interacting protein 1) Homo sapiens (Human) GO:0000922; GO:0001934; GO:0005096; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006898; GO:0006935; GO:0007264; GO:0008559; GO:0015431; GO:0016020; GO:0016604; GO:0022857; GO:0031267; GO:0032489; GO:0042626; GO:0042910; GO:0043087; GO:0043547; GO:0051056; GO:0055085; GO:0090141; GO:1900753; GO:1990961 chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; receptor-mediated endocytosis [GO:0006898]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910] g4819.t1 Q5K6N0 31.443 388 8.170000000000001e-47 182.0 sp|Q5K6N0|TM232_MOUSE Transmembrane protein 232 OS=Mus musculus OX=10090 GN=Tmem232 PE=2 SV=2 TM232_MOUSE reviewed Transmembrane protein 232 (Testis-specific protein 13) Mus musculus (Mouse) GO:0001520; GO:0007283; GO:0016020; GO:0030030; GO:0030317; GO:0098544; GO:0160087 cell projection organization [GO:0030030]; flagellated sperm motility [GO:0030317]; maintenance of protein complex location [GO:0098544]; spermatid cytoplasm removal during spermiation of flagellated sperm [GO:0160087]; spermatogenesis [GO:0007283] membrane [GO:0016020]; outer dense fiber [GO:0001520] g4820.t1 B4F7A1 47.826 92 1.46e-22 87.4 sp|B4F7A1|LYRM7_RAT Complex III assembly factor LYRM7 OS=Rattus norvegicus OX=10116 GN=Lyrm7 PE=3 SV=1 g4821.t1 B2RQR8 39.168 697 5.92e-171 512.0 sp|B2RQR8|ECE2_MOUSE Endothelin-converting enzyme 2 OS=Mus musculus OX=10090 GN=Ece2 PE=1 SV=1 ECE2_MOUSE reviewed Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71) Mus musculus (Mouse) GO:0000139; GO:0004222; GO:0016486; GO:0030658; GO:0046872 peptide hormone processing [GO:0016486] Golgi membrane [GO:0000139]; transport vesicle membrane [GO:0030658] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g4822.t1 Q9Y3B3 64.444 135 1.61e-56 182.0 sp|Q9Y3B3|TMED7_HUMAN Transmembrane emp24 domain-containing protein 7 OS=Homo sapiens OX=9606 GN=TMED7 PE=1 SV=2 g4824.t1 P26797 68.493 73 1.5e-29 115.0 sp|P26797|HM19_CAEEL Homeobox protein ceh-19 OS=Caenorhabditis elegans OX=6239 GN=ceh-19 PE=2 SV=2 g4833.t1 Q91612 52.941 374 4.71e-125 370.0 sp|Q91612|IHH_XENLA Indian hedgehog protein OS=Xenopus laevis OX=8355 GN=ihh PE=2 SV=1 IHH_XENLA reviewed Indian hedgehog protein (IHH) (EC 3.1.-.-) (Banded hedgehog protein) (X-BHH) [Cleaved into: Indian hedgehog protein N-product] Xenopus laevis (African clawed frog) GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0016540; GO:0034189; GO:0045880; GO:0048731; GO:0097264; GO:0140853 cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; system development [GO:0048731] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; very-low-density lipoprotein particle binding [GO:0034189] g4835.t1 Q3T0B7 91.667 84 1.7999999999999998e-48 151.0 sp|Q3T0B7|RS27L_BOVIN Small ribosomal subunit protein eS27-like OS=Bos taurus OX=9913 GN=RPS27L PE=3 SV=3 g4837.t1 P35280 79.808 208 6.99e-120 341.0 sp|P35280|RAB8A_RAT Ras-related protein Rab-8A OS=Rattus norvegicus OX=10116 GN=Rab8a PE=1 SV=2 RAB8A_RAT reviewed Ras-related protein Rab-8A (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005730; GO:0005764; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006887; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0010008; GO:0010506; GO:0015629; GO:0019003; GO:0019901; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031410; GO:0031489; GO:0032456; GO:0032869; GO:0032880; GO:0034451; GO:0036064; GO:0042593; GO:0043005; GO:0043025; GO:0045202; GO:0045335; GO:0046326; GO:0046872; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0070382; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:1990782 autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of D-glucose import [GO:0046326]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; regulation of autophagy [GO:0010506]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904] actin cytoskeleton [GO:0015629]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome membrane [GO:0010008]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782] g4838.t1 P80912 62.4 125 2.14e-57 177.0 sp|P80912|HINT1_RABIT Adenosine 5'-monophosphoramidase HINT1 OS=Oryctolagus cuniculus OX=9986 GN=HINT1 PE=1 SV=2 HINT1_RABIT reviewed Adenosine 5'-monophosphoramidase HINT1 (EC 3.9.1.-) (Desumoylating isopeptidase HINT1) (EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (P13.7) Oryctolagus cuniculus (Rabbit) GO:0000118; GO:0000166; GO:0005634; GO:0005737; GO:0006355; GO:0006508; GO:0009154; GO:0016787; GO:0016926; GO:0016929; GO:0043530; GO:0072332 intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508]; purine ribonucleotide catabolic process [GO:0009154]; regulation of DNA-templated transcription [GO:0006355] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634] adenosine 5'-monophosphoramidase activity [GO:0043530]; deSUMOylase activity [GO:0016929]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166] g4840.t1 O15182 83.133 166 5.05e-98 283.0 sp|O15182|CETN3_HUMAN Centrin-3 OS=Homo sapiens OX=9606 GN=CETN3 PE=1 SV=2 CETN3_HUMAN reviewed Centrin-3 Homo sapiens (Human) GO:0000226; GO:0005509; GO:0005730; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390 cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mRNA transport [GO:0051028]; protein transport [GO:0015031] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390] calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; microtubule binding [GO:0008017] g4841.t1 Q8BZH4 33.179 431 6.76e-54 209.0 sp|Q8BZH4|POGZ_MOUSE Pogo transposable element with ZNF domain OS=Mus musculus OX=10090 GN=Pogz PE=1 SV=2 POGZ_MOUSE reviewed Pogo transposable element with ZNF domain Mus musculus (Mouse) GO:0000724; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007064; GO:0008270; GO:0036064; GO:0045944; GO:0051301; GO:0051382 cell division [GO:0051301]; double-strand break repair via homologous recombination [GO:0000724]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g4843.t1 Q5BJR4 46.263 281 7.19e-80 270.0 sp|Q5BJR4|PRUN2_RAT Protein prune homolog 2 OS=Rattus norvegicus OX=10116 GN=Prune2 PE=1 SV=1 g4844.t1 P28494 46.303 1190 0.0 1088.0 sp|P28494|MA2A1_RAT Alpha-mannosidase 2 OS=Rattus norvegicus OX=10116 GN=Man2a1 PE=1 SV=2 MA2A1_RAT reviewed Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Rattus norvegicus (Rat) GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005794; GO:0005797; GO:0005801; GO:0006013; GO:0006491; GO:0007005; GO:0007033; GO:0007585; GO:0008270; GO:0015923; GO:0016787; GO:0016799; GO:0030246; GO:0042802; GO:0042803; GO:0048286; GO:0050769; GO:0060042 in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033] cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; identical protein binding [GO:0042802]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g4844.t2 P28494 46.147 1207 0.0 1083.0 sp|P28494|MA2A1_RAT Alpha-mannosidase 2 OS=Rattus norvegicus OX=10116 GN=Man2a1 PE=1 SV=2 MA2A1_RAT reviewed Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Rattus norvegicus (Rat) GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005794; GO:0005797; GO:0005801; GO:0006013; GO:0006491; GO:0007005; GO:0007033; GO:0007585; GO:0008270; GO:0015923; GO:0016787; GO:0016799; GO:0030246; GO:0042802; GO:0042803; GO:0048286; GO:0050769; GO:0060042 in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033] cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; identical protein binding [GO:0042802]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g4845.t1 Q5NVM9 84.236 609 0.0 1078.0 sp|Q5NVM9|HSP7C_PONAB Heat shock cognate 71 kDa protein OS=Pongo abelii OX=9601 GN=HSPA8 PE=2 SV=2 HSP7C_PONAB reviewed Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005765; GO:0005886; GO:0006397; GO:0008380; GO:0016787; GO:0030674; GO:0042470; GO:0045892; GO:0061740; GO:0072318; GO:0140662; GO:1990904 clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; RNA splicing [GO:0008380] lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; hydrolase activity [GO:0016787]; protein-macromolecule adaptor activity [GO:0030674] g4846.t1 Q5NVM9 83.744 609 0.0 1071.0 sp|Q5NVM9|HSP7C_PONAB Heat shock cognate 71 kDa protein OS=Pongo abelii OX=9601 GN=HSPA8 PE=2 SV=2 HSP7C_PONAB reviewed Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005765; GO:0005886; GO:0006397; GO:0008380; GO:0016787; GO:0030674; GO:0042470; GO:0045892; GO:0061740; GO:0072318; GO:0140662; GO:1990904 clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; RNA splicing [GO:0008380] lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; hydrolase activity [GO:0016787]; protein-macromolecule adaptor activity [GO:0030674] g4847.t1 Q8IYE1 36.472 754 1.34e-110 354.0 sp|Q8IYE1|CCD13_HUMAN Coiled-coil domain-containing protein 13 OS=Homo sapiens OX=9606 GN=CCDC13 PE=1 SV=2 CCD13_HUMAN reviewed Coiled-coil domain-containing protein 13 Homo sapiens (Human) GO:0005813; GO:0006974; GO:0031122; GO:0034451; GO:1905515 cytoplasmic microtubule organization [GO:0031122]; DNA damage response [GO:0006974]; non-motile cilium assembly [GO:1905515] centriolar satellite [GO:0034451]; centrosome [GO:0005813] g4848.t1 Q9ULF5 33.71 531 1.89e-74 259.0 sp|Q9ULF5|S39AA_HUMAN Zinc transporter ZIP10 OS=Homo sapiens OX=9606 GN=SLC39A10 PE=1 SV=2 S39AA_HUMAN reviewed Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10) Homo sapiens (Human) GO:0001837; GO:0002903; GO:0005385; GO:0005886; GO:0006882; GO:0008160; GO:0016324; GO:0030003; GO:0030890; GO:0050861; GO:0071577; GO:0071578; GO:0140410 epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] monoatomic cation:bicarbonate symporter activity [GO:0140410]; protein tyrosine phosphatase activator activity [GO:0008160]; zinc ion transmembrane transporter activity [GO:0005385] g4849.t1 Q2HJ10 46.419 377 4.86e-109 332.0 sp|Q2HJ10|ZNT2_MOUSE Proton-coupled zinc antiporter SLC30A2 OS=Mus musculus OX=10090 GN=Slc30a2 PE=1 SV=1 ZNT2_MOUSE reviewed Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2) Mus musculus (Mouse) GO:0005385; GO:0005737; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006829; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0046872; GO:0062111; GO:0071577; GO:0099503; GO:0140826; GO:0140882; GO:0140914; GO:0140915; GO:0140916; GO:0140917 intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc export across plasma membrane [GO:0140882]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into organelle [GO:0062111]; zinc ion import into secretory vesicle [GO:0140914]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g4850.t1 Q9VCA2 40.037 547 1.85e-123 377.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g4851.t1 Q80V94 40.564 816 1.0600000000000001e-167 535.0 sp|Q80V94|AP4E1_MOUSE AP-4 complex subunit epsilon-1 OS=Mus musculus OX=10090 GN=Ap4e1 PE=1 SV=3 AP4E1_MOUSE reviewed AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin) Mus musculus (Mouse) GO:0005802; GO:0006886; GO:0016192; GO:0030124; GO:0140312 intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; trans-Golgi network [GO:0005802] cargo adaptor activity [GO:0140312] g4852.t1 Q6DHK1 65.992 247 3.94e-120 349.0 sp|Q6DHK1|NNRE_DANRE NAD(P)H-hydrate epimerase OS=Danio rerio OX=7955 GN=naxe PE=1 SV=1 NNRE_DANRE reviewed NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000166; GO:0005576; GO:0005739; GO:0006869; GO:0046872; GO:0052856 lipid transport [GO:0006869] extracellular region [GO:0005576]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; NAD(P)HX epimerase activity [GO:0052856]; nucleotide binding [GO:0000166] g4853.t1 Q80T74 30.298 571 3.54e-84 286.0 sp|Q80T74|KLH29_MOUSE Kelch-like protein 29 OS=Mus musculus OX=10090 GN=Klhl29 PE=2 SV=3 g4854.t1 Q8N2Y8 44.444 252 1.1899999999999999e-45 185.0 sp|Q8N2Y8|RUSC2_HUMAN AP-4 complex accessory subunit RUSC2 OS=Homo sapiens OX=9606 GN=RUSC2 PE=1 SV=3 RUSC2_HUMAN reviewed AP-4 complex accessory subunit RUSC2 (Interacting protein of Rab1) (Iporin) (RUN and SH3 domain-containing protein 2) Homo sapiens (Human) GO:0005829; GO:0005886; GO:0031267; GO:0031410; GO:0070062 cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] small GTPase binding [GO:0031267] g4857.t1 Q9XT77 50.0 552 4.5e-171 503.0 sp|Q9XT77|SC5A6_RABIT Sodium-dependent multivitamin transporter OS=Oryctolagus cuniculus OX=9986 GN=SLC5A6 PE=2 SV=1 g4859.t1 O60320 39.706 204 2.32e-40 150.0 sp|O60320|EREP2_HUMAN Protein ENTREP2 OS=Homo sapiens OX=9606 GN=ENTREP2 PE=1 SV=4 g4860.t1 Q28DE0 32.721 272 3.69e-35 140.0 sp|Q28DE0|FAKD1_XENTR FAST kinase domain-containing protein 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=fastkd1 PE=2 SV=1 g4862.t1 Q6DI86 38.028 213 1.63e-44 163.0 sp|Q6DI86|FAKD1_MOUSE FAST kinase domain-containing protein 1, mitochondrial OS=Mus musculus OX=10090 GN=Fastkd1 PE=2 SV=1 FAKD1_MOUSE reviewed FAST kinase domain-containing protein 1, mitochondrial Mus musculus (Mouse) GO:0000959; GO:0000963; GO:0003723; GO:0005654; GO:0005739; GO:0005759; GO:0035770; GO:0044528 mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] RNA binding [GO:0003723] g4865.t1 Q8TDY8 29.669 664 1.48e-77 274.0 sp|Q8TDY8|IGDC4_HUMAN Immunoglobulin superfamily DCC subclass member 4 OS=Homo sapiens OX=9606 GN=IGDCC4 PE=1 SV=1 g4866.t1 Q2VWP7 34.615 234 2.65e-36 140.0 sp|Q2VWP7|PRTG_HUMAN Protogenin OS=Homo sapiens OX=9606 GN=PRTG PE=1 SV=1 PRTG_HUMAN reviewed Protogenin (Protein Shen-Dan) Homo sapiens (Human) GO:0005615; GO:0005886; GO:0038023; GO:0042802; GO:0050768; GO:0098609 cell-cell adhesion [GO:0098609]; negative regulation of neurogenesis [GO:0050768] extracellular space [GO:0005615]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] g4867.t1 Q6PF21 57.002 914 0.0 1058.0 sp|Q6PF21|SYMC_XENLA Methionine--tRNA ligase, cytoplasmic OS=Xenopus laevis OX=8355 GN=mars1 PE=2 SV=1 g4868.t1 Q61830 31.949 867 7.33e-123 409.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4868.t1 Q61830 28.862 738 9.789999999999999e-68 250.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4868.t1 Q61830 25.701 891 8.92e-65 241.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4868.t1 Q61830 26.636 871 1.87e-61 231.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4868.t1 Q61830 28.053 303 9.419999999999999e-24 112.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t1 Q61830 27.711 747 1.42e-65 244.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t1 Q61830 27.5 720 2.7900000000000003e-56 216.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t1 Q61830 24.707 769 3.9100000000000003e-56 216.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t1 Q61830 26.005 746 1.0899999999999999e-55 214.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t1 Q61830 27.215 474 1.13e-37 157.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t1 Q61830 25.664 452 3.16e-28 127.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t2 Q61830 26.98 745 6.71e-64 239.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t2 Q61830 26.28 742 9.89e-56 214.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t2 Q61830 26.891 714 3.3099999999999997e-54 209.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t2 Q61830 24.374 759 5.989999999999999e-54 208.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t2 Q61830 27.564 468 3.07e-38 159.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t2 Q61830 25.664 452 2.37e-28 127.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t3 Q61830 27.48 746 4.72e-63 237.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t3 Q61830 24.577 769 9.62e-56 214.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t3 Q61830 27.083 720 7.77e-55 211.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t3 Q61830 25.606 742 2.1799999999999998e-54 210.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t3 Q61830 26.85 473 2.12e-36 153.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4869.t3 Q61830 25.977 435 5e-28 126.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4870.t1 Q61830 24.897 1217 6.95e-87 316.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4870.t1 Q61830 22.473 1197 3.7e-57 222.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4870.t1 Q61830 21.352 1021 3.7200000000000004e-43 176.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4870.t1 Q61830 25.299 585 3.26e-36 154.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4870.t1 Q61830 25.0 408 1.7800000000000001e-31 138.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g4873.t1 P97677 29.155 367 2.2800000000000002e-29 122.0 sp|P97677|DLL1_RAT Delta-like protein 1 OS=Rattus norvegicus OX=10116 GN=Dll1 PE=1 SV=1 g4873.t1 P97677 35.802 162 1.19e-21 99.4 sp|P97677|DLL1_RAT Delta-like protein 1 OS=Rattus norvegicus OX=10116 GN=Dll1 PE=1 SV=1 g4874.t1 Q04721 52.632 76 1.7e-21 90.1 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g4875.t1 P10079 50.638 235 1.24e-70 238.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 48.927 233 1.1300000000000001e-66 227.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 45.29 276 1.1e-65 224.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 49.372 239 1.72e-65 224.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 47.66 235 8.45e-65 222.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 46.809 235 1.5800000000000002e-64 221.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 45.833 240 1.75e-63 218.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 46.473 241 2.22e-63 218.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 46.154 234 4.55e-63 217.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 48.511 235 1.36e-62 216.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 47.234 235 1.9e-60 209.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 43.75 240 2.22e-60 209.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 43.404 235 1.35e-57 201.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 47.959 196 7.01e-50 179.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4875.t1 P10079 46.452 155 6.210000000000001e-36 139.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g4876.t1 Q9ESQ4 31.611 329 1.04e-28 119.0 sp|Q9ESQ4|NMUR2_RAT Neuromedin-U receptor 2 OS=Rattus norvegicus OX=10116 GN=Nmur2 PE=1 SV=2 NMUR2_RAT reviewed Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4) Rattus norvegicus (Rat) GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930 arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g4877.t1 P00639 42.412 257 2.76e-69 222.0 sp|P00639|DNAS1_BOVIN Deoxyribonuclease-1 OS=Bos taurus OX=9913 GN=DNASE1 PE=1 SV=3 DNAS1_BOVIN reviewed Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) Bos taurus (Bovine) GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0042588; GO:0070948 apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948] extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588] actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677] g4879.t1 P49183 45.0 260 9.5e-68 216.0 sp|P49183|DNAS1_MOUSE Deoxyribonuclease-1 OS=Mus musculus OX=10090 GN=Dnase1 PE=1 SV=2 DNAS1_MOUSE reviewed Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) Mus musculus (Mouse) GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0004536; GO:0005576; GO:0005634; GO:0005635; GO:0005737; GO:0006308; GO:0006915; GO:0042588; GO:0070948 apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588] actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; DNA nuclease activity [GO:0004536] g4880.t1 P62484 64.744 156 5.68e-63 213.0 sp|P62484|ABI2_MOUSE Abl interactor 2 OS=Mus musculus OX=10090 GN=Abi2 PE=1 SV=1 ABI2_MOUSE reviewed Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1) Mus musculus (Mouse) GO:0000423; GO:0001764; GO:0005829; GO:0005912; GO:0007611; GO:0010592; GO:0016358; GO:0016477; GO:0016601; GO:0030027; GO:0030425; GO:0031209; GO:0031625; GO:0032433; GO:0035591; GO:0042802; GO:0043010; GO:0043197; GO:0045186; GO:0048858; GO:0061001; GO:0070309; GO:0098858; GO:0098871; GO:0098974; GO:0098978; GO:0099173; GO:2000601 camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; dendrite development [GO:0016358]; learning or memory [GO:0007611]; lens fiber cell morphogenesis [GO:0070309]; mitophagy [GO:0000423]; neuron migration [GO:0001764]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynapse organization [GO:0099173]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; zonula adherens assembly [GO:0045186] actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynaptic actin cytoskeleton [GO:0098871]; SCAR complex [GO:0031209] identical protein binding [GO:0042802]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625] g4881.t1 P62484 62.179 156 3.2400000000000002e-59 202.0 sp|P62484|ABI2_MOUSE Abl interactor 2 OS=Mus musculus OX=10090 GN=Abi2 PE=1 SV=1 ABI2_MOUSE reviewed Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1) Mus musculus (Mouse) GO:0000423; GO:0001764; GO:0005829; GO:0005912; GO:0007611; GO:0010592; GO:0016358; GO:0016477; GO:0016601; GO:0030027; GO:0030425; GO:0031209; GO:0031625; GO:0032433; GO:0035591; GO:0042802; GO:0043010; GO:0043197; GO:0045186; GO:0048858; GO:0061001; GO:0070309; GO:0098858; GO:0098871; GO:0098974; GO:0098978; GO:0099173; GO:2000601 camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; dendrite development [GO:0016358]; learning or memory [GO:0007611]; lens fiber cell morphogenesis [GO:0070309]; mitophagy [GO:0000423]; neuron migration [GO:0001764]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynapse organization [GO:0099173]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; zonula adherens assembly [GO:0045186] actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynaptic actin cytoskeleton [GO:0098871]; SCAR complex [GO:0031209] identical protein binding [GO:0042802]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625] g4882.t1 O93479 55.425 424 4.59e-172 491.0 sp|O93479|ORC4_XENLA Origin recognition complex subunit 4 OS=Xenopus laevis OX=8355 GN=orc4 PE=2 SV=1 g4883.t1 P27041 54.881 461 7.520000000000001e-179 512.0 sp|P27041|AVR2B_XENLA Activin receptor type-2B OS=Xenopus laevis OX=8355 GN=acvr2b PE=2 SV=1 g4884.t1 Q9NPI1 37.329 292 1.4299999999999999e-46 169.0 sp|Q9NPI1|BRD7_HUMAN Bromodomain-containing protein 7 OS=Homo sapiens OX=9606 GN=BRD7 PE=1 SV=1 g4885.t1 Q7ZUF2 42.381 210 1e-44 163.0 sp|Q7ZUF2|BRD9_DANRE Bromodomain-containing protein 9 OS=Danio rerio OX=7955 GN=brd9 PE=2 SV=1 g4888.t1 Q9R112 51.264 435 7.79e-161 465.0 sp|Q9R112|SQOR_MOUSE Sulfide:quinone oxidoreductase, mitochondrial OS=Mus musculus OX=10090 GN=Sqor PE=1 SV=3 g4889.t1 Q9R112 51.724 348 2.55e-124 369.0 sp|Q9R112|SQOR_MOUSE Sulfide:quinone oxidoreductase, mitochondrial OS=Mus musculus OX=10090 GN=Sqor PE=1 SV=3 g4890.t1 Q9DCR2 82.99 194 1.08e-115 329.0 sp|Q9DCR2|AP3S1_MOUSE AP-3 complex subunit sigma-1 OS=Mus musculus OX=10090 GN=Ap3s1 PE=1 SV=2 AP3S1_MOUSE reviewed AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Mus musculus (Mouse) GO:0005769; GO:0005802; GO:0006886; GO:0006896; GO:0008021; GO:0008089; GO:0016020; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0048490; GO:0060155; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192] AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; membrane [GO:0016020]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] g4895.t1 Q9H4G4 37.662 154 3.29e-28 105.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g4896.t1 O70628 58.252 515 0.0 637.0 sp|O70628|PDE9A_MOUSE High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Mus musculus OX=10090 GN=Pde9a PE=1 SV=1 PDE9A_MOUSE reviewed High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) Mus musculus (Mouse) GO:0004115; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010613; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0141162; GO:1900273; GO:2000178 cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of neural precursor cell proliferation [GO:2000178]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of long-term synaptic potentiation [GO:1900273]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g4897.t1 P49283 50.299 501 1.25e-162 480.0 sp|P49283|MVL_DROME Protein Malvolio OS=Drosophila melanogaster OX=7227 GN=Mvl PE=2 SV=2 MVL_DROME reviewed Protein Malvolio Drosophila melanogaster (Fruit fly) GO:0000041; GO:0005375; GO:0005381; GO:0005384; GO:0005768; GO:0005886; GO:0006828; GO:0006879; GO:0010008; GO:0015293; GO:0015677; GO:0016020; GO:0030001; GO:0030026; GO:0034755; GO:0034761; GO:0046718; GO:0050916; GO:0055070 copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; intracellular iron ion homeostasis [GO:0006879]; intracellular manganese ion homeostasis [GO:0030026]; iron ion transmembrane transport [GO:0034755]; manganese ion transport [GO:0006828]; metal ion transport [GO:0030001]; positive regulation of iron ion transmembrane transport [GO:0034761]; sensory perception of sweet taste [GO:0050916]; symbiont entry into host cell [GO:0046718]; transition metal ion transport [GO:0000041] endosome [GO:0005768]; endosome membrane [GO:0010008]; membrane [GO:0016020]; plasma membrane [GO:0005886] copper ion transmembrane transporter activity [GO:0005375]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; symporter activity [GO:0015293] g4898.t1 Q9C0G6 65.723 4169 0.0 5669.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g4898.t2 Q9C0G6 65.66 4173 0.0 5670.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g4898.t3 Q9C0G6 65.543 4182 0.0 5663.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g4900.t1 Q711G3 54.545 231 5.23e-85 255.0 sp|Q711G3|IAH1_RAT Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Rattus norvegicus OX=10116 GN=Iah1 PE=2 SV=2 g4901.t1 P28024 59.671 243 9.88e-117 337.0 sp|P28024|PSB4_XENLA Proteasome subunit beta type-4 (Fragment) OS=Xenopus laevis OX=8355 GN=psmb4 PE=2 SV=2 g4902.t1 A4IJ21 51.406 498 1.45e-138 411.0 sp|A4IJ21|MNS1_XENTR Meiosis-specific nuclear structural protein 1 OS=Xenopus tropicalis OX=8364 GN=mns1 PE=2 SV=1 g4903.t1 Q5R5V9 42.898 352 2.81e-72 231.0 sp|Q5R5V9|VPS72_PONAB Vacuolar protein sorting-associated protein 72 homolog OS=Pongo abelii OX=9601 GN=VPS72 PE=2 SV=1 VPS72_PONAB reviewed Vacuolar protein sorting-associated protein 72 homolog (Transcription factor-like 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000786; GO:0003677; GO:0016607; GO:0032991; GO:0035019; GO:0035267; GO:0042393; GO:0045815; GO:0051726; GO:0140713; GO:1905168 positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of cell cycle [GO:0051726]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815] NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleosome [GO:0000786]; protein-containing complex [GO:0032991] DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g4905.t1 O74180 53.556 239 6.18e-87 270.0 sp|O74180|AOX_ASPNG Alternative oxidase, mitochondrial OS=Aspergillus niger OX=5061 GN=aox1 PE=2 SV=2 g4912.t1 P35556 33.007 715 2.22e-78 287.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 33.144 703 1.09e-60 232.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 31.714 700 2.04e-60 231.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 31.571 681 1.03e-59 229.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 33.111 601 2.9000000000000004e-56 218.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 33.224 611 6.12e-53 207.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 31.499 727 7.36e-51 201.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 30.515 544 2.62e-44 180.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4912.t1 P35556 29.272 632 9.1e-36 152.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 30.793 971 3.87e-86 318.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 30.165 1031 3.9499999999999995e-82 305.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 32.789 735 2.27e-74 280.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 32.979 752 5.41e-74 279.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 31.183 744 6.7e-67 256.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 31.921 755 1.1100000000000001e-66 255.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 28.814 1121 5.71e-63 243.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 31.658 736 5.4499999999999994e-61 236.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 32.749 742 1.4900000000000002e-59 231.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 29.929 705 4.04e-54 214.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 28.728 731 7.84e-41 170.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 33.962 318 7.560000000000001e-32 140.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4913.t1 Q61555 30.258 466 5.2300000000000004e-27 124.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g4918.t1 Q9WVK3 57.565 271 1.55e-107 317.0 sp|Q9WVK3|PECR_RAT Peroxisomal trans-2-enoyl-CoA reductase OS=Rattus norvegicus OX=10116 GN=Pecr PE=2 SV=1 PECR_RAT reviewed Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) (PX-2,4-DCR1) (Peroxisomal 2,4-dienoyl-CoA reductase) (RLF98) Rattus norvegicus (Rat) GO:0005102; GO:0005739; GO:0005777; GO:0005778; GO:0006633; GO:0019166; GO:0033306; GO:0043231 fatty acid biosynthetic process [GO:0006633]; phytol metabolic process [GO:0033306] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166] g4921.t1 G5EDR5 35.484 217 6.300000000000001e-32 125.0 sp|G5EDR5|FUTA_CAEEL Alpha-(1,3)-fucosyltransferase fut-1 OS=Caenorhabditis elegans OX=6239 GN=fut-1 PE=1 SV=1 FUTA_CAEEL reviewed Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1) Caenorhabditis elegans GO:0000139; GO:0006487; GO:0006491; GO:0008417; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0046872; GO:0046920; GO:1901137 carbohydrate biosynthetic process [GO:0016051]; carbohydrate derivative biosynthetic process [GO:1901137]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872] g4924.t1 Q5XIY4 53.774 106 3.73e-35 120.0 sp|Q5XIY4|SDHF3_DANRE Succinate dehydrogenase assembly factor 3, mitochondrial OS=Danio rerio OX=7955 GN=sdhaf3 PE=2 SV=1 g4925.t1 P93159 25.234 535 7.49e-29 127.0 sp|P93159|ENG1_SOYBN Glucan endo-1,3-beta-D-glucosidase OS=Glycine max OX=3847 GN=GBP PE=1 SV=2 ENG1_SOYBN reviewed Glucan endo-1,3-beta-D-glucosidase (Endo-1,3-beta-glucanase) (EC 3.2.1.39) (Beta-glucan elicitor-binding protein) (GEBP) (Laminarinase) Glycine max (Soybean) (Glycine hispida) GO:0009505; GO:0009603; GO:0030247; GO:0042973; GO:0044347; GO:0052861; GO:0071555 cell wall organization [GO:0071555]; cell wall polysaccharide catabolic process [GO:0044347]; detection of symbiotic fungus [GO:0009603] plant-type cell wall [GO:0009505] endo-1,3(4)-beta-glucanase activity [GO:0052861]; glucan endo-1,3-beta-D-glucosidase activity [GO:0042973]; polysaccharide binding [GO:0030247] g4931.t1 Q96PH1 31.2 750 2.18e-95 314.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4931.t2 Q96PH1 32.905 389 8.31e-57 207.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g4932.t1 Q13873 45.387 542 3.04e-155 490.0 sp|Q13873|BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens OX=9606 GN=BMPR2 PE=1 SV=2 BMPR2_HUMAN reviewed Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) Homo sapiens (Human) GO:0000165; GO:0001525; GO:0001568; GO:0001649; GO:0001707; GO:0001708; GO:0001893; GO:0001935; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005901; GO:0005905; GO:0005912; GO:0006606; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010628; GO:0010634; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030154; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0048863; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060426; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; MAPK cascade [GO:0000165]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; stem cell differentiation [GO:0048863]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235] activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024] g4934.t1 Q17029 74.359 117 1.0699999999999999e-60 185.0 sp|Q17029|VATF_ANOGA V-type proton ATPase subunit F OS=Anopheles gambiae OX=7165 GN=Vha14 PE=2 SV=2 g4935.t1 Q6P135 36.31 168 6.36e-30 119.0 sp|Q6P135|TMUB1_DANRE Transmembrane and ubiquitin-like domain-containing protein 1 OS=Danio rerio OX=7955 GN=tmub1 PE=2 SV=1 g4936.t1 Q99MZ8 45.725 269 9.75e-68 213.0 sp|Q99MZ8|LASP1_RAT LIM and SH3 domain protein 1 OS=Rattus norvegicus OX=10116 GN=Lasp1 PE=1 SV=1 LASP1_RAT reviewed LIM and SH3 domain protein 1 (LASP-1) Rattus norvegicus (Rat) GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0046872; GO:0051015; GO:0098794 monoatomic ion transport [GO:0006811] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; postsynapse [GO:0098794] actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075] g4936.t2 Q99MZ8 44.361 266 6.13e-67 210.0 sp|Q99MZ8|LASP1_RAT LIM and SH3 domain protein 1 OS=Rattus norvegicus OX=10116 GN=Lasp1 PE=1 SV=1 LASP1_RAT reviewed LIM and SH3 domain protein 1 (LASP-1) Rattus norvegicus (Rat) GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0046872; GO:0051015; GO:0098794 monoatomic ion transport [GO:0006811] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; postsynapse [GO:0098794] actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075] g4937.t1 P14685 65.868 501 0.0 640.0 sp|P14685|PSMD3_MOUSE 26S proteasome non-ATPase regulatory subunit 3 OS=Mus musculus OX=10090 GN=Psmd3 PE=1 SV=3 PSMD3_MOUSE reviewed 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen) Mus musculus (Mouse) GO:0000502; GO:0005654; GO:0005829; GO:0005838; GO:0006511; GO:0008541; GO:0022624; GO:0030234; GO:0042176 regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541] enzyme regulator activity [GO:0030234] g4938.t1 P70550 50.82 183 1.87e-62 196.0 sp|P70550|RAB8B_RAT Ras-related protein Rab-8B OS=Rattus norvegicus OX=10116 GN=Rab8b PE=1 SV=1 g4939.t1 Q6NZP1 48.75 160 2.46e-44 162.0 sp|Q6NZP1|ZRAB3_MOUSE DNA annealing helicase and endonuclease ZRANB3 OS=Mus musculus OX=10090 GN=Zranb3 PE=1 SV=1 ZRAB3_MOUSE reviewed DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-) (EC 5.6.2.-); Endonuclease ZRANB3 (EC 3.1.-.-)] Mus musculus (Mouse) GO:0004386; GO:0004520; GO:0005524; GO:0005654; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0016787; GO:0031297; GO:0036310; GO:0043596; GO:0070530; GO:0071932 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; response to UV [GO:0009411] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270] g4940.t1 E1BB03 54.545 528 0.0 572.0 sp|E1BB03|ZRAB3_BOVIN DNA annealing helicase and endonuclease ZRANB3 OS=Bos taurus OX=9913 GN=ZRANB3 PE=3 SV=3 ZRAB3_BOVIN reviewed DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-) (EC 5.6.2.-); Endonuclease ZRANB3 (EC 3.1.-.-)] Bos taurus (Bovine) GO:0004386; GO:0004520; GO:0005524; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0016787; GO:0031297; GO:0036310; GO:0043596; GO:0070530 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; response to UV [GO:0009411] nuclear replication fork [GO:0043596] ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270] g4940.t1 E1BB03 34.177 237 2.94e-30 133.0 sp|E1BB03|ZRAB3_BOVIN DNA annealing helicase and endonuclease ZRANB3 OS=Bos taurus OX=9913 GN=ZRANB3 PE=3 SV=3 ZRAB3_BOVIN reviewed DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-) (EC 5.6.2.-); Endonuclease ZRANB3 (EC 3.1.-.-)] Bos taurus (Bovine) GO:0004386; GO:0004520; GO:0005524; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0016787; GO:0031297; GO:0036310; GO:0043596; GO:0070530 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; response to UV [GO:0009411] nuclear replication fork [GO:0043596] ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270] g4941.t1 Q54KD0 26.381 1050 4.9299999999999994e-89 326.0 sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1 g11320.t1 Q9UJ37 39.308 318 1.3699999999999999e-67 226.0 sp|Q9UJ37|SIA7B_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Homo sapiens OX=9606 GN=ST6GALNAC2 PE=1 SV=1 SIA7B_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0006493; GO:0008373; GO:0009101; GO:0016266; GO:0019082; GO:1990743 glycoprotein biosynthetic process [GO:0009101]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; protein sialylation [GO:1990743]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g11321.t1 Q92184 41.29 310 1.59e-78 252.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g11324.t1 Q3T8J9 33.752 717 1.1e-65 252.0 sp|Q3T8J9|GON4L_HUMAN GON-4-like protein OS=Homo sapiens OX=9606 GN=GON4L PE=1 SV=1 GON4L_HUMAN reviewed GON-4-like protein (GON-4 homolog) (Yin Yang 1-associated-related protein) Homo sapiens (Human) GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0016604 regulation of DNA-templated transcription [GO:0006355] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coregulator activity [GO:0003712] g11324.t1 Q3T8J9 35.739 291 3.5000000000000003e-47 191.0 sp|Q3T8J9|GON4L_HUMAN GON-4-like protein OS=Homo sapiens OX=9606 GN=GON4L PE=1 SV=1 GON4L_HUMAN reviewed GON-4-like protein (GON-4 homolog) (Yin Yang 1-associated-related protein) Homo sapiens (Human) GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0016604 regulation of DNA-templated transcription [GO:0006355] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coregulator activity [GO:0003712] g11324.t2 Q3T8J9 33.939 716 1.26e-66 255.0 sp|Q3T8J9|GON4L_HUMAN GON-4-like protein OS=Homo sapiens OX=9606 GN=GON4L PE=1 SV=1 GON4L_HUMAN reviewed GON-4-like protein (GON-4 homolog) (Yin Yang 1-associated-related protein) Homo sapiens (Human) GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0016604 regulation of DNA-templated transcription [GO:0006355] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coregulator activity [GO:0003712] g11324.t2 Q3T8J9 35.739 291 3.4600000000000004e-47 191.0 sp|Q3T8J9|GON4L_HUMAN GON-4-like protein OS=Homo sapiens OX=9606 GN=GON4L PE=1 SV=1 GON4L_HUMAN reviewed GON-4-like protein (GON-4 homolog) (Yin Yang 1-associated-related protein) Homo sapiens (Human) GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0016604 regulation of DNA-templated transcription [GO:0006355] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coregulator activity [GO:0003712] g11325.t1 Q28DG6 35.965 228 9.06e-31 119.0 sp|Q28DG6|LYSM3_XENTR LysM and putative peptidoglycan-binding domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=lysmd3 PE=2 SV=1 g11326.t1 Q1RMR0 51.707 205 7.41e-51 167.0 sp|Q1RMR0|RPC7L_BOVIN DNA-directed RNA polymerase III subunit RPC7-like OS=Bos taurus OX=9913 GN=POLR3GL PE=2 SV=1 g11327.t1 Q5R7N3 69.216 510 0.0 675.0 sp|Q5R7N3|CLPX_PONAB ATP-dependent clpX-like chaperone, mitochondrial OS=Pongo abelii OX=9601 GN=CLPX PE=2 SV=1 CLPX_PONAB reviewed ATP-dependent clpX-like chaperone, mitochondrial (EC 3.6.4.10) (ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005524; GO:0005759; GO:0008270; GO:0009368; GO:0016887; GO:0042645; GO:0046983; GO:0051082; GO:0051603; GO:0140662 proteolysis involved in protein catabolic process [GO:0051603] endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] g11328.t1 Q8TF21 29.536 474 8.42e-51 198.0 sp|Q8TF21|ANR24_HUMAN Ankyrin repeat domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ANKRD24 PE=1 SV=2 g11330.t1 Q2T9K6 55.916 524 0.0 617.0 sp|Q2T9K6|FEM1C_XENLA Protein fem-1 homolog C OS=Xenopus laevis OX=8355 GN=fem1c PE=2 SV=1 g11331.t1 Q6TFL3 31.789 1101 8.150000000000001e-160 510.0 sp|Q6TFL3|CC171_HUMAN Coiled-coil domain-containing protein 171 OS=Homo sapiens OX=9606 GN=CCDC171 PE=1 SV=1 g11334.t1 Q5UQ13 36.649 734 8.070000000000001e-70 251.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t1 Q5UQ13 36.228 737 1.31e-64 235.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t1 Q5UQ13 37.147 673 2.1700000000000002e-64 234.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t1 Q5UQ13 36.483 688 1.9499999999999998e-60 223.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t1 Q5UQ13 40.898 423 1.6200000000000001e-43 172.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t1 Q5UQ13 37.562 402 1.14e-37 154.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t1 Q5UQ13 36.944 360 1.23e-31 135.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t2 Q5UQ13 38.321 929 1.3e-102 355.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t2 Q5UQ13 38.419 911 1.2099999999999999e-92 327.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t2 Q5UQ13 36.105 914 6.82e-83 298.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11334.t2 Q5UQ13 35.954 776 1.14e-70 261.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g11335.t1 Q0II24 34.659 352 9.78e-33 127.0 sp|Q0II24|C1QT9_BOVIN Complement C1q and tumor necrosis factor-related protein 9 OS=Bos taurus OX=9913 GN=C1QTNF9 PE=2 SV=1 g11336.t1 B2RNN3 31.124 347 3.62e-31 122.0 sp|B2RNN3|C1T9B_HUMAN Complement C1q and tumor necrosis factor-related protein 9B OS=Homo sapiens OX=9606 GN=C1QTNF9B PE=1 SV=1 C1T9B_HUMAN reviewed Complement C1q and tumor necrosis factor-related protein 9B (C1q/TNF-related protein 9B) (CTRP9B) (Complement C1q and tumor necrosis factor-related protein 9-like) Homo sapiens (Human) GO:0005576; GO:0005581 collagen trimer [GO:0005581]; extracellular region [GO:0005576] g11337.t1 Q9NXG0 31.304 805 3.25e-81 295.0 sp|Q9NXG0|CNTLN_HUMAN Centlein OS=Homo sapiens OX=9606 GN=CNTLN PE=1 SV=6 g11337.t1 Q9NXG0 30.868 311 1.27e-30 135.0 sp|Q9NXG0|CNTLN_HUMAN Centlein OS=Homo sapiens OX=9606 GN=CNTLN PE=1 SV=6 g11338.t1 Q6ZN30 64.972 177 1.77e-67 249.0 sp|Q6ZN30|BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens OX=9606 GN=BNC2 PE=1 SV=1 BNC2_HUMAN reviewed Zinc finger protein basonuclin-2 Homo sapiens (Human) GO:0000182; GO:0000785; GO:0001650; GO:0003416; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043586; GO:0060021; GO:0060485 endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] rDNA binding [GO:0000182]; zinc ion binding [GO:0008270] g11338.t1 Q6ZN30 45.07 142 2.99e-24 114.0 sp|Q6ZN30|BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens OX=9606 GN=BNC2 PE=1 SV=1 BNC2_HUMAN reviewed Zinc finger protein basonuclin-2 Homo sapiens (Human) GO:0000182; GO:0000785; GO:0001650; GO:0003416; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043586; GO:0060021; GO:0060485 endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] rDNA binding [GO:0000182]; zinc ion binding [GO:0008270] g11338.t1 Q6ZN30 76.271 59 1.42e-22 108.0 sp|Q6ZN30|BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens OX=9606 GN=BNC2 PE=1 SV=1 BNC2_HUMAN reviewed Zinc finger protein basonuclin-2 Homo sapiens (Human) GO:0000182; GO:0000785; GO:0001650; GO:0003416; GO:0005634; GO:0006355; GO:0008270; GO:0016604; GO:0043586; GO:0060021; GO:0060485 endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] rDNA binding [GO:0000182]; zinc ion binding [GO:0008270] g11342.t1 Q8C8V1 37.374 198 7.38e-36 141.0 sp|Q8C8V1|ZXDC_MOUSE Zinc finger protein ZXDC OS=Mus musculus OX=10090 GN=Zxdc PE=2 SV=1 g11343.t1 Q8C8V1 48.855 131 1.9600000000000002e-32 134.0 sp|Q8C8V1|ZXDC_MOUSE Zinc finger protein ZXDC OS=Mus musculus OX=10090 GN=Zxdc PE=2 SV=1 g11343.t1 Q8C8V1 40.146 137 1.84e-24 110.0 sp|Q8C8V1|ZXDC_MOUSE Zinc finger protein ZXDC OS=Mus musculus OX=10090 GN=Zxdc PE=2 SV=1 g11344.t1 Q8R2R5 44.355 248 7.490000000000001e-59 190.0 sp|Q8R2R5|LRC61_MOUSE Leucine-rich repeat-containing protein 61 OS=Mus musculus OX=10090 GN=Lrrc61 PE=2 SV=1 g11346.t1 A0AVT1 52.913 412 1.54e-148 451.0 sp|A0AVT1|UBA6_HUMAN Ubiquitin-like modifier-activating enzyme 6 OS=Homo sapiens OX=9606 GN=UBA6 PE=1 SV=1 UBA6_HUMAN reviewed Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2) Homo sapiens (Human) GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0019780; GO:0046872 DNA damage response [GO:0006974]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; metal ion binding [GO:0046872]; ubiquitin activating enzyme activity [GO:0004839] g11347.t1 A0AVT1 52.712 590 0.0 624.0 sp|A0AVT1|UBA6_HUMAN Ubiquitin-like modifier-activating enzyme 6 OS=Homo sapiens OX=9606 GN=UBA6 PE=1 SV=1 UBA6_HUMAN reviewed Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2) Homo sapiens (Human) GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0019780; GO:0046872 DNA damage response [GO:0006974]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; metal ion binding [GO:0046872]; ubiquitin activating enzyme activity [GO:0004839] g11349.t1 P55199 42.478 113 5.97e-21 100.0 sp|P55199|ELL_HUMAN RNA polymerase II elongation factor ELL OS=Homo sapiens OX=9606 GN=ELL PE=1 SV=1 ELL_HUMAN reviewed RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Homo sapiens (Human) GO:0000791; GO:0000987; GO:0001701; GO:0005654; GO:0005829; GO:0006368; GO:0008023; GO:0015030; GO:0016604; GO:0016607; GO:0019902; GO:0032786; GO:0032968; GO:0035363; GO:0042795; GO:0042796; GO:0045945 in utero embryonic development [GO:0001701]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription elongation by RNA polymerase II [GO:0006368] Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] cis-regulatory region sequence-specific DNA binding [GO:0000987]; phosphatase binding [GO:0019902] g11350.t1 Q21565 47.257 474 3.1999999999999996e-134 407.0 sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2 g11351.t1 Q21565 39.305 547 4.2799999999999994e-126 395.0 sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2 g11352.t1 P51171 26.471 612 1.24e-59 214.0 sp|P51171|SCNNG_XENLA Epithelial sodium channel subunit gamma OS=Xenopus laevis OX=8355 GN=scnn1g-a PE=1 SV=1 g11354.t1 Q5R5L7 43.237 414 3.97e-112 337.0 sp|Q5R5L7|ARRD3_PONAB Arrestin domain-containing protein 3 OS=Pongo abelii OX=9601 GN=ARRDC3 PE=2 SV=1 g11357.t1 Q803I4 56.647 346 7.52e-125 364.0 sp|Q803I4|RING2_DANRE E3 ubiquitin-protein ligase RING2 OS=Danio rerio OX=7955 GN=rnf2 PE=2 SV=1 RING2_DANRE reviewed E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING-type E3 ubiquitin transferase RING2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000151; GO:0003161; GO:0003682; GO:0005634; GO:0005694; GO:0005737; GO:0007417; GO:0008270; GO:0016567; GO:0031519; GO:0032330; GO:0033339; GO:0035102; GO:0040029; GO:0048484; GO:0048701; GO:0060042; GO:0061630; GO:0071339; GO:0140862; GO:1902254; GO:1905292; GO:1905295; GO:1905304 cardiac conduction system development [GO:0003161]; central nervous system development [GO:0007417]; embryonic cranial skeleton morphogenesis [GO:0048701]; enteric nervous system development [GO:0048484]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pectoral fin development [GO:0033339]; protein ubiquitination [GO:0016567]; regulation of cardiac myofibril assembly [GO:1905304]; regulation of chondrocyte differentiation [GO:0032330]; regulation of neural crest cell differentiation [GO:1905292]; regulation of neural crest cell fate specification [GO:1905295]; retina morphogenesis in camera-type eye [GO:0060042] chromosome [GO:0005694]; cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151] chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g11358.t1 B3EWZ6 32.115 1286 2.42e-170 568.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 34.423 1101 2.5900000000000003e-161 541.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 35.3 1085 1.2800000000000001e-160 539.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 32.713 1290 1.1500000000000001e-156 527.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 31.599 1307 1.39e-154 521.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 30.495 1292 4.51e-146 496.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 30.666 1262 7.07e-142 484.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 32.821 1106 1.28e-141 483.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 33.856 957 2.19e-124 431.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 29.766 1280 8.759999999999999e-115 402.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 28.381 1198 1.43e-109 387.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 27.721 1277 9.06e-106 375.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 27.685 1257 6.91e-102 363.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 27.843 1275 1.1e-99 356.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 27.236 1252 2.03e-86 315.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 27.109 1055 1.28e-60 234.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11358.t1 B3EWZ6 30.885 531 1.9e-44 181.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g11360.t1 Q5D018 72.727 88 8.14e-44 143.0 sp|Q5D018|RBM8A_DANRE RNA-binding protein 8A OS=Danio rerio OX=7955 GN=rbm8a PE=2 SV=1 RBM8A_DANRE reviewed RNA-binding protein 8A (RNA-binding motif protein 8A) (Ribonucleoprotein RBM8A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000184; GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005737; GO:0006417; GO:0008380; GO:0010468; GO:0016607; GO:0035145; GO:0051028; GO:0071006 mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006] mRNA binding [GO:0003729] g11361.t1 O53532 45.352 355 2.14e-98 298.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11362.t1 O60749 58.685 213 3.3000000000000003e-77 250.0 sp|O60749|SNX2_HUMAN Sorting nexin-2 OS=Homo sapiens OX=9606 GN=SNX2 PE=1 SV=2 SNX2_HUMAN reviewed Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9) Homo sapiens (Human) GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0045296; GO:0046982; GO:0072673; GO:1990459; GO:1990460 early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905] cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459] g11363.t1 Q5EAD5 63.388 366 6.23e-172 486.0 sp|Q5EAD5|PGTB1_BOVIN Geranylgeranyl transferase type-1 subunit beta OS=Bos taurus OX=9913 GN=PGGT1B PE=2 SV=1 PGTB1_BOVIN reviewed Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta) Bos taurus (Bovine) GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018344 protein geranylgeranylation [GO:0018344] CAAX-protein geranylgeranyltransferase complex [GO:0005953] CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270] g11364.t1 Q8TEQ8 34.077 1165 0.0 583.0 sp|Q8TEQ8|PIGO_HUMAN GPI ethanolamine phosphate transferase 3, catalytic subunit OS=Homo sapiens OX=9606 GN=PIGO PE=1 SV=3 PIGO_HUMAN reviewed GPI ethanolamine phosphate transferase 3, catalytic subunit (EC 2.-.-.-) (Phosphatidylinositol-glycan biosynthesis class O protein) (PIG-O) (hGPCR43) Homo sapiens (Human) GO:0005789; GO:0006506; GO:0016020; GO:0051377 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] mannose-ethanolamine phosphotransferase activity [GO:0051377] g11365.t1 Q9XZC8 31.378 341 5.190000000000001e-29 122.0 sp|Q9XZC8|SEM2A_SCHGR Semaphorin-2A OS=Schistocerca gregaria OX=7010 GN=SEMA-2A PE=2 SV=1 g11367.t1 Q96M27 53.501 357 2.01e-111 335.0 sp|Q96M27|PRRC1_HUMAN Protein PRRC1 OS=Homo sapiens OX=9606 GN=PRRC1 PE=1 SV=1 g11369.t1 E9Q9W4 38.291 632 2.9399999999999997e-146 439.0 sp|E9Q9W4|S27A6_MOUSE Long-chain fatty acid transport protein 6 OS=Mus musculus OX=10090 GN=Slc27a6 PE=1 SV=1 S27A6_MOUSE reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLACS2) (VLCSH1) (mVLCS-H1) (EC 6.2.1.-) Mus musculus (Mouse) GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g11370.t1 O35488 44.504 564 2.18e-165 489.0 sp|O35488|S27A2_MOUSE Long-chain fatty acid transport protein 2 OS=Mus musculus OX=10090 GN=Slc27a2 PE=1 SV=2 S27A2_MOUSE reviewed Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (Slc27a2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase) Mus musculus (Mouse) GO:0000038; GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0006635; GO:0006699; GO:0008206; GO:0015245; GO:0015908; GO:0019899; GO:0031957; GO:0042760; GO:0044539; GO:0047676; GO:0047747; GO:0050197; GO:0070251; GO:0097089 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g11371.t1 Q9Y2P4 32.778 180 6.77e-25 106.0 sp|Q9Y2P4|S27A6_HUMAN Long-chain fatty acid transport protein 6 OS=Homo sapiens OX=9606 GN=SLC27A6 PE=1 SV=1 S27A6_HUMAN reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLCSH1) (hVLCS-H1) (EC 6.2.1.-) Homo sapiens (Human) GO:0000038; GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005789; GO:0005886; GO:0015245; GO:0015909; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; very long-chain fatty acid metabolic process [GO:0000038] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g11372.t1 P97524 44.083 338 1.24e-93 293.0 sp|P97524|S27A2_RAT Long-chain fatty acid transport protein 2 OS=Rattus norvegicus OX=10116 GN=Slc27a2 PE=1 SV=1 S27A2_RAT reviewed Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase) Rattus norvegicus (Rat) GO:0000038; GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005783; GO:0005788; GO:0005789; GO:0005886; GO:0006635; GO:0006699; GO:0008206; GO:0015245; GO:0015908; GO:0019899; GO:0031957; GO:0042760; GO:0044539; GO:0047676; GO:0047747; GO:0050197; GO:0070251; GO:0097089 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g11373.t1 E9Q9W4 42.289 629 6.95e-167 493.0 sp|E9Q9W4|S27A6_MOUSE Long-chain fatty acid transport protein 6 OS=Mus musculus OX=10090 GN=Slc27a6 PE=1 SV=1 S27A6_MOUSE reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLACS2) (VLCSH1) (mVLCS-H1) (EC 6.2.1.-) Mus musculus (Mouse) GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g11374.t1 Q9Y2P4 42.827 467 1.8099999999999998e-126 385.0 sp|Q9Y2P4|S27A6_HUMAN Long-chain fatty acid transport protein 6 OS=Homo sapiens OX=9606 GN=SLC27A6 PE=1 SV=1 S27A6_HUMAN reviewed Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLCSH1) (hVLCS-H1) (EC 6.2.1.-) Homo sapiens (Human) GO:0000038; GO:0000166; GO:0001676; GO:0004467; GO:0005324; GO:0005789; GO:0005886; GO:0015245; GO:0015909; GO:0031957; GO:0042383; GO:0044539; GO:0047676 long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; very long-chain fatty acid metabolic process [GO:0000038] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g11376.t1 A5PK63 85.496 131 3.38e-77 227.0 sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1 g11378.t1 O35465 33.005 203 3.13e-28 114.0 sp|O35465|FKBP8_MOUSE Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Mus musculus OX=10090 GN=Fkbp8 PE=1 SV=2 FKBP8_MOUSE reviewed Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (mFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) Mus musculus (Mouse) GO:0001708; GO:0003755; GO:0005516; GO:0005739; GO:0005740; GO:0005783; GO:0005789; GO:0005829; GO:0006457; GO:0006915; GO:0007224; GO:0009953; GO:0010468; GO:0012505; GO:0016020; GO:0021904; GO:0021915; GO:0030510; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0042802; GO:0043010; GO:0043066; GO:0044183; GO:0070585; GO:0097718; GO:1901524 apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube development [GO:0021915]; positive regulation of BMP signaling pathway [GO:0030513]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of BMP signaling pathway [GO:0030510]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; smoothened signaling pathway [GO:0007224] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183] g11379.t1 Q3B7U9 44.531 128 7.750000000000001e-27 107.0 sp|Q3B7U9|FKBP8_RAT Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Rattus norvegicus OX=10116 GN=Fkbp8 PE=2 SV=1 FKBP8_RAT reviewed Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (FK506-binding protein 8) (FKBP-8) (Rotamase) Rattus norvegicus (Rat) GO:0001708; GO:0003755; GO:0005516; GO:0005739; GO:0005740; GO:0005783; GO:0005789; GO:0005829; GO:0006457; GO:0006915; GO:0007224; GO:0009953; GO:0010468; GO:0012505; GO:0016020; GO:0021904; GO:0021915; GO:0030509; GO:0030510; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0042802; GO:0043010; GO:0043066; GO:0044183; GO:0048665; GO:0070585; GO:0097718; GO:1901524 apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube development [GO:0021915]; neuron fate specification [GO:0048665]; positive regulation of BMP signaling pathway [GO:0030513]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of BMP signaling pathway [GO:0030510]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; smoothened signaling pathway [GO:0007224] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183] g11380.t1 Q6TXF1 26.346 353 2.42e-22 101.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g11381.t1 B0BNL6 27.491 291 1.1700000000000001e-21 98.6 sp|B0BNL6|ARRD1_RAT Arrestin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Arrdc1 PE=1 SV=1 ARRD1_RAT reviewed Arrestin domain-containing protein 1 (Alpha-arrestin 1) Rattus norvegicus (Rat) GO:0005737; GO:0005886; GO:0006511; GO:0006858; GO:0015031; GO:0016567; GO:0031410; GO:0031625; GO:0042802; GO:0045746; GO:0140112; GO:1903561; GO:1990756; GO:1990763 extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886] arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g11382.t1 Q96B67 28.767 365 4.5100000000000005e-22 100.0 sp|Q96B67|ARRD3_HUMAN Arrestin domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ARRDC3 PE=1 SV=1 g11383.t1 Q1LWH4 45.634 710 0.0 600.0 sp|Q1LWH4|FAN1_DANRE Fanconi-associated nuclease 1 OS=Danio rerio OX=7955 GN=fan1 PE=2 SV=2 FAN1_DANRE reviewed Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (Myotubularin-related protein 15) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000724; GO:0004528; GO:0005634; GO:0006281; GO:0006289; GO:0008270; GO:0008409; GO:0017108; GO:0036297; GO:0070336; GO:0140036 DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289] nucleus [GO:0005634] 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; phosphodiesterase I activity [GO:0004528]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270] g11383.t2 Q1LWH4 43.862 725 0.0 569.0 sp|Q1LWH4|FAN1_DANRE Fanconi-associated nuclease 1 OS=Danio rerio OX=7955 GN=fan1 PE=2 SV=2 FAN1_DANRE reviewed Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (Myotubularin-related protein 15) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000724; GO:0004528; GO:0005634; GO:0006281; GO:0006289; GO:0008270; GO:0008409; GO:0017108; GO:0036297; GO:0070336; GO:0140036 DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289] nucleus [GO:0005634] 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; phosphodiesterase I activity [GO:0004528]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270] g11384.t1 Q9CPT4 41.304 138 4.630000000000001e-27 103.0 sp|Q9CPT4|MYDGF_MOUSE Myeloid-derived growth factor OS=Mus musculus OX=10090 GN=Mydgf PE=1 SV=1 MYDGF_MOUSE reviewed Myeloid-derived growth factor (MYDGF) Mus musculus (Mouse) GO:0001525; GO:0001934; GO:0001938; GO:0005576; GO:0005615; GO:0005783; GO:0005793; GO:0005794; GO:0006915; GO:0043066; GO:0043410; GO:0045766; GO:0045944; GO:0051897 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] g11386.t1 Q9QXD6 66.269 335 7.899999999999999e-170 478.0 sp|Q9QXD6|F16P1_MOUSE Fructose-1,6-bisphosphatase 1 OS=Mus musculus OX=10090 GN=Fbp1 PE=1 SV=3 g11388.t1 O60140 34.483 290 2.44e-44 170.0 sp|O60140|YNS9_SCHPO Uncharacterized protein C18H10.09 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC18H10.09 PE=4 SV=2 g11389.t1 Q86VS3 43.659 1104 0.0 914.0 sp|Q86VS3|IQCH_HUMAN IQ domain-containing protein H OS=Homo sapiens OX=9606 GN=IQCH PE=1 SV=2 g11391.t1 Q7RTX9 24.477 478 2.29e-27 117.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g11393.t1 Q9VUL9 39.048 210 7.53e-38 147.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g11394.t1 Q9QXE5 36.639 363 5.59e-67 225.0 sp|Q9QXE5|TSSP_MOUSE Thymus-specific serine protease OS=Mus musculus OX=10090 GN=Prss16 PE=2 SV=1 g11395.t1 Q9NQE7 47.368 133 3.27e-33 125.0 sp|Q9NQE7|TSSP_HUMAN Thymus-specific serine protease OS=Homo sapiens OX=9606 GN=PRSS16 PE=1 SV=2 g11396.t1 Q9QXE5 37.885 454 1.7799999999999998e-95 301.0 sp|Q9QXE5|TSSP_MOUSE Thymus-specific serine protease OS=Mus musculus OX=10090 GN=Prss16 PE=2 SV=1 g11397.t1 O53532 36.885 366 9e-63 207.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11398.t1 O53532 34.807 362 3.6e-63 208.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11399.t1 O53532 32.312 359 1.2700000000000002e-56 191.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11400.t1 O53532 31.831 355 6.4900000000000005e-56 189.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11401.t1 Q5XIS7 26.134 551 8.810000000000001e-32 131.0 sp|Q5XIS7|UBAP1_RAT Ubiquitin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Ubap1 PE=2 SV=1 g11401.t2 Q5XIS7 26.335 543 1.74e-31 130.0 sp|Q5XIS7|UBAP1_RAT Ubiquitin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Ubap1 PE=2 SV=1 g11402.t1 P04058 36.266 557 3.13e-106 335.0 sp|P04058|ACES_TETCF Acetylcholinesterase OS=Tetronarce californica OX=7787 GN=ache PE=1 SV=2 g11403.t1 P06276 33.71 620 5.16e-107 337.0 sp|P06276|CHLE_HUMAN Cholinesterase OS=Homo sapiens OX=9606 GN=BCHE PE=1 SV=1 CHLE_HUMAN reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) Homo sapiens (Human) GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0006805; GO:0007612; GO:0008285; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050784; GO:0050805; GO:0051384; GO:0051593; GO:0072562 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine catabolic process [GO:0050784]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802] g11404.t1 P27540 46.386 761 0.0 603.0 sp|P27540|ARNT_HUMAN Aryl hydrocarbon receptor nuclear translocator OS=Homo sapiens OX=9606 GN=ARNT PE=1 SV=1 ARNT_HUMAN reviewed Aryl hydrocarbon receptor nuclear translocator (ARNT protein) (Class E basic helix-loop-helix protein 2) (bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta) (HIF-1-beta) (HIF1-beta) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001666; GO:0001892; GO:0001938; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010575; GO:0016604; GO:0017162; GO:0030154; GO:0030949; GO:0033235; GO:0034599; GO:0034751; GO:0034753; GO:0042803; GO:0043565; GO:0045648; GO:0045821; GO:0045944; GO:0046886; GO:0046982; GO:0050728; GO:0061629; GO:0090575; GO:1990837 cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; embryonic placenta development [GO:0001892]; negative regulation of inflammatory response [GO:0050728]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666] aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g11405.t1 Q9QWW1 41.823 373 6.22e-90 277.0 sp|Q9QWW1|HOME2_MOUSE Homer protein homolog 2 OS=Mus musculus OX=10090 GN=Homer2 PE=1 SV=1 HOME2_MOUSE reviewed Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2) Mus musculus (Mouse) GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014048; GO:0014069; GO:0019722; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0042220; GO:0042802; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0051966; GO:0070885; GO:0098978; GO:2001256 behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of glutamate secretion [GO:0014048]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160] g11405.t2 Q9QWW1 41.509 371 6.64e-88 272.0 sp|Q9QWW1|HOME2_MOUSE Homer protein homolog 2 OS=Mus musculus OX=10090 GN=Homer2 PE=1 SV=1 HOME2_MOUSE reviewed Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2) Mus musculus (Mouse) GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014048; GO:0014069; GO:0019722; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0042220; GO:0042802; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0051966; GO:0070885; GO:0098978; GO:2001256 behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of glutamate secretion [GO:0014048]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160] g11406.t1 Q8C854 35.906 596 1.37e-75 256.0 sp|Q8C854|MYEF2_MOUSE Myelin expression factor 2 OS=Mus musculus OX=10090 GN=Myef2 PE=1 SV=1 MYEF2_MOUSE reviewed Myelin expression factor 2 (MEF-2) (MyEF-2) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0003729; GO:0005634; GO:0005737; GO:1990904 negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g11407.t1 Q8C854 35.915 284 9.06e-40 154.0 sp|Q8C854|MYEF2_MOUSE Myelin expression factor 2 OS=Mus musculus OX=10090 GN=Myef2 PE=1 SV=1 MYEF2_MOUSE reviewed Myelin expression factor 2 (MEF-2) (MyEF-2) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0003729; GO:0005634; GO:0005737; GO:1990904 negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g11407.t2 Q8C854 34.859 284 6.28e-36 144.0 sp|Q8C854|MYEF2_MOUSE Myelin expression factor 2 OS=Mus musculus OX=10090 GN=Myef2 PE=1 SV=1 MYEF2_MOUSE reviewed Myelin expression factor 2 (MEF-2) (MyEF-2) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0003729; GO:0005634; GO:0005737; GO:1990904 negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g11408.t1 Q91W36 54.389 524 0.0 551.0 sp|Q91W36|UBP3_MOUSE Ubiquitin carboxyl-terminal hydrolase 3 OS=Mus musculus OX=10090 GN=Usp3 PE=2 SV=1 UBP3_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000978; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006508; GO:0008270; GO:0016579; GO:0036464; GO:0042393; GO:0090543; GO:0140861; GO:0140936; GO:0140950; GO:1990841 DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g11409.t1 C0H906 60.25 800 0.0 1006.0 sp|C0H906|NCBP1_SALSA Nuclear cap-binding protein subunit 1 OS=Salmo salar OX=8030 GN=ncbp1 PE=2 SV=1 NCBP1_SALSA reviewed Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit) Salmo salar (Atlantic salmon) GO:0000184; GO:0000339; GO:0003729; GO:0005634; GO:0005737; GO:0005846; GO:0006370; GO:0006406; GO:0006417; GO:0008380; GO:0031047; GO:0050684 7-methylguanosine mRNA capping [GO:0006370]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA cap binding [GO:0000339] g11410.t1 Q6UVK1 28.114 2216 0.0 821.0 sp|Q6UVK1|CSPG4_HUMAN Chondroitin sulfate proteoglycan 4 OS=Homo sapiens OX=9606 GN=CSPG4 PE=1 SV=2 CSPG4_HUMAN reviewed Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan) Homo sapiens (Human) GO:0001525; GO:0001726; GO:0005576; GO:0005654; GO:0005796; GO:0005886; GO:0005925; GO:0006929; GO:0008347; GO:0009986; GO:0015026; GO:0016324; GO:0019901; GO:0031012; GO:0031258; GO:0035556; GO:0043202; GO:0043410; GO:0048008; GO:0048771; GO:0050731; GO:0070062; GO:0097178 angiogenesis [GO:0001525]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; tissue remodeling [GO:0048771] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726] coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901] g11411.t1 Q8NEV4 44.914 757 0.0 616.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11411.t2 Q8NEV4 45.178 757 0.0 616.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11412.t1 P41239 58.465 443 0.0 538.0 sp|P41239|CSK_CHICK Tyrosine-protein kinase CSK OS=Gallus gallus OX=9031 GN=CSK PE=2 SV=1 g11415.t1 O01404 41.667 384 7.730000000000001e-86 267.0 sp|O01404|PHM_DROME Peptidylglycine alpha-hydroxylating monooxygenase OS=Drosophila melanogaster OX=7227 GN=Phm PE=1 SV=2 g11416.t1 Q6AZN0 51.1 409 4.02e-140 409.0 sp|Q6AZN0|DAAF4_XENLA Dynein axonemal assembly factor 4 OS=Xenopus laevis OX=8355 GN=dnaaf4 PE=2 SV=1 g11417.t1 Q9UJZ1 64.023 353 3.35e-151 433.0 sp|Q9UJZ1|STML2_HUMAN Stomatin-like protein 2, mitochondrial OS=Homo sapiens OX=9606 GN=STOML2 PE=1 SV=1 g11418.t1 P0C5J4 29.712 313 3.89e-26 110.0 sp|P0C5J4|GPR52_MOUSE G-protein coupled receptor 52 OS=Mus musculus OX=10090 GN=Gpr52 PE=2 SV=1 g11419.t1 P0C872 55.806 310 1.76e-132 382.0 sp|P0C872|JMJD7_MOUSE Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 OS=Mus musculus OX=10090 GN=Jmjd7 PE=1 SV=1 g11421.t1 Q9UGM3 33.468 496 3.3e-64 229.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11421.t1 Q9UGM3 33.14 516 3.7499999999999997e-62 223.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11421.t1 Q9UGM3 32.386 528 4.26e-60 217.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11421.t1 Q9UGM3 32.177 519 2.6900000000000003e-58 212.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11421.t1 Q9UGM3 32.29 511 2.8400000000000003e-57 209.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11421.t1 Q9UGM3 30.132 531 3.46e-57 209.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11421.t1 Q9UGM3 31.792 519 2.8000000000000004e-56 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11421.t1 Q9UGM3 32.143 252 1.32e-24 112.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11422.t1 Q9UGM3 32.228 543 9.08e-62 223.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11422.t1 Q9UGM3 31.887 530 1.5599999999999998e-61 222.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11422.t1 Q9UGM3 31.783 516 9.17e-59 214.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11422.t1 Q9UGM3 30.902 521 5.54e-57 209.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11422.t1 Q9UGM3 29.782 413 2.56e-39 156.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11423.t1 Q9UGM3 30.443 542 1.76e-57 210.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11423.t1 Q9UGM3 31.262 515 9.75e-57 208.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11423.t1 Q9UGM3 28.864 537 6.500000000000001e-56 205.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11423.t1 Q9UGM3 30.019 533 7.08e-56 205.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11423.t1 Q9UGM3 29.502 522 3.4099999999999998e-53 197.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11423.t1 Q9UGM3 29.581 382 1.16e-36 148.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11423.t1 Q9UGM3 31.707 246 1.94e-23 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11424.t1 Q90891 70.635 378 0.0 537.0 sp|Q90891|MP2K2_CHICK Dual specificity mitogen-activated protein kinase kinase 2 OS=Gallus gallus OX=9031 GN=MAP2K2 PE=2 SV=1 MP2K2_CHICK reviewed Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK2) Gallus gallus (Chicken) GO:0000165; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005739; GO:0005769; GO:0005770; GO:0005829; GO:0005925; GO:0032872; GO:0090170; GO:0106310; GO:2000641 MAPK cascade [GO:0000165]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872] cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; late endosome [GO:0005770]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g11425.t1 Q8TDJ6 41.129 2604 0.0 1739.0 sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2 DMXL2_HUMAN reviewed DmX-like protein 2 (Rabconnectin-3) Homo sapiens (Human) GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992 vacuolar acidification [GO:0007035] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g11425.t1 Q8TDJ6 40.836 742 1.94e-139 496.0 sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2 DMXL2_HUMAN reviewed DmX-like protein 2 (Rabconnectin-3) Homo sapiens (Human) GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992 vacuolar acidification [GO:0007035] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g11425.t2 Q8TDJ6 41.228 2605 0.0 1743.0 sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2 DMXL2_HUMAN reviewed DmX-like protein 2 (Rabconnectin-3) Homo sapiens (Human) GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992 vacuolar acidification [GO:0007035] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g11425.t2 Q8TDJ6 40.836 742 2.04e-139 496.0 sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2 DMXL2_HUMAN reviewed DmX-like protein 2 (Rabconnectin-3) Homo sapiens (Human) GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992 vacuolar acidification [GO:0007035] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g11425.t3 Q8TDJ6 40.893 2619 0.0 1728.0 sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2 DMXL2_HUMAN reviewed DmX-like protein 2 (Rabconnectin-3) Homo sapiens (Human) GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992 vacuolar acidification [GO:0007035] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g11425.t3 Q8TDJ6 40.836 742 2.27e-139 496.0 sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2 DMXL2_HUMAN reviewed DmX-like protein 2 (Rabconnectin-3) Homo sapiens (Human) GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0098992 vacuolar acidification [GO:0007035] extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] small GTPase binding [GO:0031267] g11427.t1 Q8N6L1 58.955 134 1.28e-42 140.0 sp|Q8N6L1|KTAP2_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2 OS=Homo sapiens OX=9606 GN=KRTCAP2 PE=1 SV=2 KTAP2_HUMAN reviewed Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit KCP2 (Oligosaccharyl transferase subunit KCP2) (Keratinocyte-associated protein 2) (KCP-2) Homo sapiens (Human) GO:0005789; GO:0006487; GO:0008047; GO:0008250; GO:0018279; GO:0030674; GO:0160226 protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226] enzyme activator activity [GO:0008047]; protein-macromolecule adaptor activity [GO:0030674] g11428.t1 Q9DCN1 45.474 475 4.66e-137 405.0 sp|Q9DCN1|NUD12_MOUSE NAD-capped RNA hydrolase NUDT12 OS=Mus musculus OX=10090 GN=Nudt12 PE=1 SV=1 NUD12_MOUSE reviewed NAD-capped RNA hydrolase NUDT12 (DeNADding enzyme NUDT12) (EC 3.6.1.-) (NADH pyrophosphatase NUDT12) (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12) (Nudix motif 12) Mus musculus (Mouse) GO:0000210; GO:0000287; GO:0005634; GO:0005737; GO:0005777; GO:0006402; GO:0006742; GO:0008270; GO:0010943; GO:0019677; GO:0032922; GO:0035529; GO:0110153; GO:0110155; GO:0110156; GO:1990174 circadian regulation of gene expression [GO:0032922]; mRNA catabolic process [GO:0006402]; mRNA methylguanosine-cap decapping [GO:0110156]; NAD+ catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADP+ catabolic process [GO:0006742] cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisome [GO:0005777] magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NADPH pyrophosphatase activity [GO:0010943]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270] g11429.t1 Q3U3Q1 52.599 481 3.76e-177 508.0 sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus OX=10090 GN=Ulk3 PE=2 SV=1 ULK3_MOUSE reviewed Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) Mus musculus (Mouse) GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0007224; GO:0010506; GO:0034045; GO:0034727; GO:0042594; GO:0045879; GO:0045880; GO:0046777; GO:0061709; GO:0072537; GO:0106310 autophagosome assembly [GO:0000045]; fibroblast activation [GO:0072537]; mitophagy [GO:0000423]; negative regulation of smoothened signaling pathway [GO:0045879]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; smoothened signaling pathway [GO:0007224] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11434.t1 Q7Z401 51.417 953 0.0 1016.0 sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2 MYCPP_HUMAN reviewed C-myc promoter-binding protein (DENN domain-containing protein 4A) Homo sapiens (Human) GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483 regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] g11434.t1 Q7Z401 42.105 266 1.08e-53 212.0 sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2 MYCPP_HUMAN reviewed C-myc promoter-binding protein (DENN domain-containing protein 4A) Homo sapiens (Human) GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483 regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] g11435.t1 P31674 78.082 146 2.18e-81 239.0 sp|P31674|RS15_ORYSJ Small ribosomal subunit protein uS19 OS=Oryza sativa subsp. japonica OX=39947 GN=RPS15 PE=2 SV=2 g11436.t1 Q9DC70 89.744 156 3.6699999999999997e-106 308.0 sp|Q9DC70|NDUS7_MOUSE NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial OS=Mus musculus OX=10090 GN=Ndufs7 PE=1 SV=1 NDUS7_MOUSE reviewed NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) Mus musculus (Mouse) GO:0002020; GO:0003954; GO:0004497; GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0042776; GO:0043025; GO:0045271; GO:0046872; GO:0048038; GO:0051539; GO:0097060 aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; respiratory chain complex I [GO:0045271]; synaptic membrane [GO:0097060] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protease binding [GO:0002020]; quinone binding [GO:0048038] g11437.t1 Q0VCA2 27.855 359 6.7e-24 105.0 sp|Q0VCA2|ARRD3_BOVIN Arrestin domain-containing protein 3 OS=Bos taurus OX=9913 GN=ARRDC3 PE=2 SV=1 ARRD3_BOVIN reviewed Arrestin domain-containing protein 3 Bos taurus (Bovine) GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0035332; GO:0043588; GO:0060613; GO:0071878; GO:0090327; GO:0120163 fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031]; skin development [GO:0043588] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] beta-3 adrenergic receptor binding [GO:0031699] g11437.t2 Q6TXF1 28.638 426 3.2800000000000002e-31 126.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g11437.t3 Q6TXF1 28.873 426 1.1e-30 125.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g11438.t1 Q6TXF1 31.975 319 9.079999999999999e-42 155.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g11439.t1 Q5R5L7 28.487 337 4.34e-38 144.0 sp|Q5R5L7|ARRD3_PONAB Arrestin domain-containing protein 3 OS=Pongo abelii OX=9601 GN=ARRDC3 PE=2 SV=1 g11440.t1 Q5R5L7 30.53 321 1.83e-37 143.0 sp|Q5R5L7|ARRD3_PONAB Arrestin domain-containing protein 3 OS=Pongo abelii OX=9601 GN=ARRDC3 PE=2 SV=1 g11441.t1 Q6TXF1 31.677 322 1.97e-41 156.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g11443.t1 A4UTP7 75.484 155 2.04e-71 238.0 sp|A4UTP7|MEF2C_PIG Myocyte-specific enhancer factor 2C OS=Sus scrofa OX=9823 GN=MEF2C PE=2 SV=1 MEF2C_PIG reviewed Myocyte-specific enhancer factor 2C Sus scrofa (Pig) GO:0000122; GO:0000165; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006959; GO:0007507; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0014033; GO:0016528; GO:0016607; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035051; GO:0035984; GO:0042100; GO:0043524; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046983; GO:0048643; GO:0048666; GO:0050853; GO:0051145; GO:0055012; GO:0060025; GO:0060045; GO:0061333; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:2000111; GO:2000727; GO:2000987; GO:2001013; GO:2001016 B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cardiocyte differentiation [GO:0035051]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule epithelial cell differentiation [GO:0072160]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary heart field specification [GO:0003138]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of synaptic activity [GO:0060025]; renal tubule morphogenesis [GO:0061333]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976] g11443.t2 Q03414 39.521 501 2.12e-75 249.0 sp|Q03414|MEF2A_XENLA Myocyte-specific enhancer factor 2A homolog OS=Xenopus laevis OX=8355 GN=mef2a PE=1 SV=2 g11444.t1 C0IN03 35.734 361 5.41e-75 240.0 sp|C0IN03|HENMT_XENTR Small RNA 2'-O-methyltransferase OS=Xenopus tropicalis OX=8364 GN=henmt1 PE=2 SV=1 HENMT_XENTR reviewed Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1) (piRNA methyltransferase 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0043186; GO:0046872; GO:0090486 piRNA processing [GO:0034587]; RNA methylation [GO:0001510]; siRNA processing [GO:0030422] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186] metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486] g11445.t1 Q9Z1N3 45.115 1177 0.0 988.0 sp|Q9Z1N3|MYO9A_RAT Unconventional myosin-IXa OS=Rattus norvegicus OX=10116 GN=Myo9a PE=1 SV=1 MYO9A_RAT reviewed Unconventional myosin-IXa (Myr 7) (Unconventional myosin-9a) Rattus norvegicus (Rat) GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0008270; GO:0016020; GO:0016459; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0051015; GO:0098685; GO:0098794; GO:0098978; GO:0099084; GO:0150011 cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; postsynaptic specialization organization [GO:0099084]; regulation of neuron projection arborization [GO:0150011] actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270] g11445.t1 Q9Z1N3 35.172 580 2e-95 349.0 sp|Q9Z1N3|MYO9A_RAT Unconventional myosin-IXa OS=Rattus norvegicus OX=10116 GN=Myo9a PE=1 SV=1 MYO9A_RAT reviewed Unconventional myosin-IXa (Myr 7) (Unconventional myosin-9a) Rattus norvegicus (Rat) GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0008270; GO:0016020; GO:0016459; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0051015; GO:0098685; GO:0098794; GO:0098978; GO:0099084; GO:0150011 cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; postsynaptic specialization organization [GO:0099084]; regulation of neuron projection arborization [GO:0150011] actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270] g11445.t2 Q9Z1N3 45.115 1177 0.0 987.0 sp|Q9Z1N3|MYO9A_RAT Unconventional myosin-IXa OS=Rattus norvegicus OX=10116 GN=Myo9a PE=1 SV=1 MYO9A_RAT reviewed Unconventional myosin-IXa (Myr 7) (Unconventional myosin-9a) Rattus norvegicus (Rat) GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0008270; GO:0016020; GO:0016459; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0051015; GO:0098685; GO:0098794; GO:0098978; GO:0099084; GO:0150011 cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; postsynaptic specialization organization [GO:0099084]; regulation of neuron projection arborization [GO:0150011] actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270] g11445.t2 Q9Z1N3 35.172 580 2.1099999999999997e-95 349.0 sp|Q9Z1N3|MYO9A_RAT Unconventional myosin-IXa OS=Rattus norvegicus OX=10116 GN=Myo9a PE=1 SV=1 MYO9A_RAT reviewed Unconventional myosin-IXa (Myr 7) (Unconventional myosin-9a) Rattus norvegicus (Rat) GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0008270; GO:0016020; GO:0016459; GO:0034329; GO:0035556; GO:0044295; GO:0045198; GO:0051015; GO:0098685; GO:0098794; GO:0098978; GO:0099084; GO:0150011 cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; postsynaptic specialization organization [GO:0099084]; regulation of neuron projection arborization [GO:0150011] actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; myosin complex [GO:0016459]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270] g11449.t1 O13262 30.682 352 5.42e-49 181.0 sp|O13262|SCNNC_XENLA Epithelial sodium channel subunit beta-2 OS=Xenopus laevis OX=8355 GN=scnn1b-b PE=1 SV=1 g11450.t1 Q708S6 29.278 485 2.2599999999999997e-54 195.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 g11451.t1 Q925H0 28.994 507 7.52e-53 192.0 sp|Q925H0|ASIC2_MOUSE Acid-sensing ion channel 2 OS=Mus musculus OX=10090 GN=Asic2 PE=1 SV=1 g11453.t1 Q8WND5 47.166 1376 0.0 1186.0 sp|Q8WND5|ELP1_RABIT Elongator complex protein 1 OS=Oryctolagus cuniculus OX=9986 GN=ELP1 PE=2 SV=1 g11454.t1 P07207 35.206 534 1.04e-67 256.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 33.514 552 9.77e-62 237.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 34.411 526 1.2600000000000001e-59 230.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 29.89 639 4.49e-57 222.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 33.776 527 2.03e-55 216.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 32.197 528 5.16e-51 202.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 32.824 524 2.31e-50 200.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 31.679 524 3.69e-47 190.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 31.366 322 1.2400000000000001e-29 132.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11454.t1 P07207 31.488 289 1.1699999999999998e-23 113.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g11460.t1 Q5T1C6 34.667 150 4.12e-24 98.2 sp|Q5T1C6|THEM4_HUMAN Acyl-coenzyme A thioesterase THEM4 OS=Homo sapiens OX=9606 GN=THEM4 PE=1 SV=1 THEM4_HUMAN reviewed Acyl-coenzyme A thioesterase THEM4 (Acyl-CoA thioesterase THEM4) (EC 3.1.2.2) (Carboxyl-terminal modulator protein) (Thioesterase superfamily member 4) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0005886; GO:0006631; GO:0032587; GO:0051898; GO:0052816; GO:1902108 fatty acid metabolic process [GO:0006631]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] long-chain fatty acyl-CoA hydrolase activity [GO:0052816] g11462.t1 D3IUT5 28.505 642 2.03e-27 126.0 sp|D3IUT5|TICRR_XENLA Treslin OS=Xenopus laevis OX=8355 GN=ticrr PE=1 SV=1 g11465.t1 Q5RFI6 28.656 677 7.44e-61 221.0 sp|Q5RFI6|FAKD5_PONAB FAST kinase domain-containing protein 5, mitochondrial OS=Pongo abelii OX=9601 GN=FASTKD5 PE=2 SV=1 g11467.t1 Q568D2 46.691 272 1e-82 254.0 sp|Q568D2|CF161_DANRE Cilia- and flagella-associated protein 161 OS=Danio rerio OX=7955 GN=cfap161 PE=2 SV=1 g11470.t1 O62666 41.224 245 1.0499999999999999e-42 171.0 sp|O62666|IL16_PANTR Pro-interleukin-16 OS=Pan troglodytes OX=9598 GN=IL16 PE=2 SV=1 g11470.t2 O62666 41.224 245 1.02e-42 171.0 sp|O62666|IL16_PANTR Pro-interleukin-16 OS=Pan troglodytes OX=9598 GN=IL16 PE=2 SV=1 g11471.t1 Q9ERE4 57.047 298 6.87e-107 313.0 sp|Q9ERE4|GOLP3_RAT Golgi phosphoprotein 3 OS=Rattus norvegicus OX=10116 GN=Golph3 PE=1 SV=1 GOLP3_RAT reviewed Golgi phosphoprotein 3 (Coat protein GPP34) (Trans-Golgi protein GMx33) Rattus norvegicus (Rat) GO:0000139; GO:0005739; GO:0005758; GO:0005768; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006890; GO:0007030; GO:0009101; GO:0009306; GO:0010467; GO:0010821; GO:0016477; GO:0019899; GO:0030032; GO:0031985; GO:0032008; GO:0032580; GO:0043001; GO:0043066; GO:0045053; GO:0048194; GO:0050714; GO:0050901; GO:0060352; GO:0070273; GO:0072752; GO:0090161; GO:0090164; GO:0140312; GO:0140450 asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to Golgi apparatus [GO:0140450]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cargo adaptor activity [GO:0140312]; enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273] g11473.t1 Q8VHN7 43.75 128 5.910000000000001e-27 109.0 sp|Q8VHN7|AGRV1_MOUSE Adhesion G-protein coupled receptor V1 OS=Mus musculus OX=10090 GN=Adgrv1 PE=1 SV=1 AGRV1_MOUSE reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1) (MASS1) (Neurepin) (Protein rueda) (Very large G-protein coupled receptor 1) (VLGR1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta (VLGR1 subunit beta) (Vbeta)] Mus musculus (Mouse) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0017022; GO:0030501; GO:0031647; GO:0032391; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048471; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0071277; GO:0097264; GO:0098609; GO:0141163; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; myosin binding [GO:0017022] g11474.t1 Q8WXG9 37.584 596 1.19e-101 342.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11474.t1 Q8WXG9 27.612 536 1.96e-27 122.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11475.t1 Q9ERE4 73.77 122 4.3099999999999997e-60 193.0 sp|Q9ERE4|GOLP3_RAT Golgi phosphoprotein 3 OS=Rattus norvegicus OX=10116 GN=Golph3 PE=1 SV=1 GOLP3_RAT reviewed Golgi phosphoprotein 3 (Coat protein GPP34) (Trans-Golgi protein GMx33) Rattus norvegicus (Rat) GO:0000139; GO:0005739; GO:0005758; GO:0005768; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006890; GO:0007030; GO:0009101; GO:0009306; GO:0010467; GO:0010821; GO:0016477; GO:0019899; GO:0030032; GO:0031985; GO:0032008; GO:0032580; GO:0043001; GO:0043066; GO:0045053; GO:0048194; GO:0050714; GO:0050901; GO:0060352; GO:0070273; GO:0072752; GO:0090161; GO:0090164; GO:0140312; GO:0140450 asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; protein targeting to Golgi apparatus [GO:0140450]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cargo adaptor activity [GO:0140312]; enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273] g11476.t1 Q8WXG9 37.88 2698 0.0 1589.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 23.985 1922 8.99e-70 267.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 24.654 1302 4.77e-61 238.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 25.778 1028 2.22e-60 236.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 27.542 944 2.67e-58 229.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 27.313 681 6.28e-45 185.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 25.31 1047 9.31e-43 177.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 23.992 942 2.9599999999999995e-42 176.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 30.22 546 1.34e-39 167.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 24.488 927 1.23e-38 164.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 25.895 950 2.04e-38 163.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 24.962 1322 1.32e-37 160.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 26.971 723 2.07e-34 150.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11476.t1 Q8WXG9 24.502 1204 9.100000000000001e-32 141.0 sp|Q8WXG9|AGRV1_HUMAN Adhesion G-protein coupled receptor V1 OS=Homo sapiens OX=9606 GN=ADGRV1 PE=1 SV=2 AGRV1_HUMAN reviewed Adhesion G-protein coupled receptor V1 (ADGRV1) (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta] Homo sapiens (Human) GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010855; GO:0016020; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0097264; GO:0098609; GO:1990075; GO:1990696 cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 34.287 2027 0.0 940.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 31.912 633 2.77e-56 221.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 26.507 962 3.35e-53 211.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 24.882 1266 3.7699999999999995e-46 188.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 23.913 1104 1.0399999999999998e-42 176.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 25.242 1034 4.85e-41 171.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 23.968 1139 1.51e-37 159.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 25.308 893 6.22e-37 157.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 24.667 900 1.13e-35 153.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 23.569 891 2.92e-33 145.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 27.039 699 1.1700000000000001e-32 143.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 28.019 621 1.35e-31 140.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 34.125 337 1.15e-28 130.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 25.921 760 3.1300000000000002e-27 125.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 30.303 330 1.32e-25 120.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11477.t1 Q6JAN0 23.678 908 5e-25 118.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11479.t1 Q6JAN0 30.667 1275 1.83e-160 533.0 sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1 AGRV1_DANRE reviewed Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] g11484.t1 Q6XK22 32.231 242 2.2e-30 117.0 sp|Q6XK22|R9BP_CHICK Regulator of G-protein signaling 9-binding protein OS=Gallus gallus OX=9031 GN=RGS9BP PE=2 SV=1 g11488.t1 J9SQF3 45.547 887 0.0 764.0 sp|J9SQF3|TRPM3_MOUSE Transient receptor potential cation channel subfamily M member 3 OS=Mus musculus OX=10090 GN=Trpm3 PE=1 SV=1 TRPM3_MOUSE reviewed Transient receptor potential cation channel subfamily M member 3 Mus musculus (Mouse) GO:0005262; GO:0005385; GO:0005516; GO:0005546; GO:0005886; GO:0006812; GO:0006814; GO:0031683; GO:0051289; GO:0070588; GO:0071577; GO:0097603 calcium ion transmembrane transport [GO:0070588]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; sodium ion transport [GO:0006814]; zinc ion transmembrane transport [GO:0071577] plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; temperature-gated ion channel activity [GO:0097603]; zinc ion transmembrane transporter activity [GO:0005385] g11489.t1 Q2TV84 50.955 314 3.56e-101 328.0 sp|Q2TV84|TRPM1_MOUSE Transient receptor potential cation channel subfamily M member 1 OS=Mus musculus OX=10090 GN=Trpm1 PE=1 SV=2 TRPM1_MOUSE reviewed Transient receptor potential cation channel subfamily M member 1 (Long transient receptor potential channel 1) (LTrpC1) (Melastatin-1) Mus musculus (Mouse) GO:0005216; GO:0005261; GO:0005262; GO:0005783; GO:0005789; GO:0005886; GO:0006816; GO:0007165; GO:0007216; GO:0007601; GO:0008104; GO:0008324; GO:0030424; GO:0030425; GO:0035841; GO:0046548; GO:0051262; GO:0051286; GO:0071482; GO:0098655; GO:0098703 calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to light stimulus [GO:0071482]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; intracellular protein localization [GO:0008104]; monoatomic cation transmembrane transport [GO:0098655]; protein tetramerization [GO:0051262]; retinal rod cell development [GO:0046548]; signal transduction [GO:0007165]; visual perception [GO:0007601] axon [GO:0030424]; cell tip [GO:0051286]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; new growing cell tip [GO:0035841]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; monoatomic cation channel activity [GO:0005261]; monoatomic cation transmembrane transporter activity [GO:0008324]; monoatomic ion channel activity [GO:0005216] g11490.t1 Q6PB70 51.515 462 1.16e-169 521.0 sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3 ANO8_MOUSE reviewed Anoctamin-8 (Transmembrane protein 16H) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:1902476 chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229] g11490.t1 Q6PB70 54.106 207 3.16e-63 233.0 sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3 ANO8_MOUSE reviewed Anoctamin-8 (Transmembrane protein 16H) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:1902476 chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229] g11490.t2 Q6PB70 51.515 462 1.36e-169 521.0 sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3 ANO8_MOUSE reviewed Anoctamin-8 (Transmembrane protein 16H) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:1902476 chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229] g11490.t2 Q6PB70 54.106 207 3.62e-63 233.0 sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3 ANO8_MOUSE reviewed Anoctamin-8 (Transmembrane protein 16H) Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005886; GO:1902476 chloride transmembrane transport [GO:1902476] plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229] g11494.t1 P20585 49.635 959 0.0 965.0 sp|P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4 MSH3_HUMAN reviewed DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1) Homo sapiens (Human) GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0140664 DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; somatic recombination of immunoglobulin gene segments [GO:0016447] membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] g11495.t1 Q17QS1 43.293 164 3.18e-36 126.0 sp|Q17QS1|SNX24_BOVIN Sorting nexin-24 OS=Bos taurus OX=9913 GN=SNX24 PE=2 SV=1 g11497.t1 Q6BD04 36.646 322 3.34e-57 193.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g11498.t1 Q6BD04 54.321 81 3.0299999999999996e-23 96.3 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g11499.t1 Q6BD04 28.395 243 3.12e-24 102.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g11500.t1 J9SQF3 36.769 1300 0.0 778.0 sp|J9SQF3|TRPM3_MOUSE Transient receptor potential cation channel subfamily M member 3 OS=Mus musculus OX=10090 GN=Trpm3 PE=1 SV=1 TRPM3_MOUSE reviewed Transient receptor potential cation channel subfamily M member 3 Mus musculus (Mouse) GO:0005262; GO:0005385; GO:0005516; GO:0005546; GO:0005886; GO:0006812; GO:0006814; GO:0031683; GO:0051289; GO:0070588; GO:0071577; GO:0097603 calcium ion transmembrane transport [GO:0070588]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; sodium ion transport [GO:0006814]; zinc ion transmembrane transport [GO:0071577] plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; temperature-gated ion channel activity [GO:0097603]; zinc ion transmembrane transporter activity [GO:0005385] g11501.t1 Q8MQH7 64.495 307 8.18e-112 345.0 sp|Q8MQH7|DRI_STRPU Protein dead ringer homolog OS=Strongylocentrotus purpuratus OX=7668 GN=dri PE=2 SV=1 g11501.t2 Q8MQH7 63.548 310 3.1499999999999998e-111 343.0 sp|Q8MQH7|DRI_STRPU Protein dead ringer homolog OS=Strongylocentrotus purpuratus OX=7668 GN=dri PE=2 SV=1 g11503.t1 P55013 51.965 1018 0.0 1016.0 sp|P55013|S12A2_SQUAC Solute carrier family 12 member 2 OS=Squalus acanthias OX=7797 GN=SLC12A2 PE=1 SV=1 g11504.t1 Q9XZC8 30.973 452 4.16e-38 154.0 sp|Q9XZC8|SEM2A_SCHGR Semaphorin-2A OS=Schistocerca gregaria OX=7010 GN=SEMA-2A PE=2 SV=1 g11505.t1 Q4R708 58.71 310 1.98e-117 358.0 sp|Q4R708|NAA35_MACFA N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Macaca fascicularis OX=9541 GN=NAA35 PE=2 SV=1 g11505.t2 Q5RBT3 55.488 328 1.31e-114 352.0 sp|Q5RBT3|NAA35_PONAB N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Pongo abelii OX=9601 GN=NAA35 PE=2 SV=1 NAA35_PONAB reviewed N-alpha-acetyltransferase 35, NatC auxiliary subunit (Protein MAK10 homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031417; GO:0043066; GO:0048659 negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g11506.t1 Q5ZHV2 54.938 324 1.0100000000000002e-124 379.0 sp|Q5ZHV2|NAA35_CHICK N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Gallus gallus OX=9031 GN=NAA35 PE=2 SV=1 g11507.t1 O02466 44.233 1422 0.0 1134.0 sp|O02466|ILPR_BRALA Insulin-like peptide receptor OS=Branchiostoma lanceolatum OX=7740 PE=2 SV=1 g11509.t1 Q8K3W2 34.171 199 1.4099999999999999e-24 105.0 sp|Q8K3W2|LRC10_MOUSE Leucine-rich repeat-containing protein 10 OS=Mus musculus OX=10090 GN=Lrrc10 PE=1 SV=1 g11510.t1 Q6DIP8 48.665 337 6.87e-100 311.0 sp|Q6DIP8|ARB2A_XENTR Cotranscriptional regulator ARB2A homolog OS=Xenopus tropicalis OX=8364 GN=arb2a PE=2 SV=2 g11512.t1 Q9JII5 43.005 193 8.59e-44 163.0 sp|Q9JII5|DAZP1_MOUSE DAZ-associated protein 1 OS=Mus musculus OX=10090 GN=Dazap1 PE=1 SV=2 DAZP1_MOUSE reviewed DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1) Mus musculus (Mouse) GO:0001893; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008266; GO:0008283; GO:0030154; GO:0032991; GO:0034046; GO:0035613; GO:0048026; GO:1990904 cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613] g11512.t2 Q9JII5 43.005 193 9.1e-44 163.0 sp|Q9JII5|DAZP1_MOUSE DAZ-associated protein 1 OS=Mus musculus OX=10090 GN=Dazap1 PE=1 SV=2 DAZP1_MOUSE reviewed DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1) Mus musculus (Mouse) GO:0001893; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008266; GO:0008283; GO:0030154; GO:0032991; GO:0034046; GO:0035613; GO:0048026; GO:1990904 cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613] g11513.t1 Q32P51 28.319 226 5.9e-25 106.0 sp|Q32P51|RA1L2_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 2 OS=Homo sapiens OX=9606 GN=HNRNPA1L2 PE=1 SV=2 RA1L2_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2) Homo sapiens (Human) GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737] mRNA 3'-UTR binding [GO:0003730] g11515.t1 Q7Z4H7 28.319 452 3.26e-39 162.0 sp|Q7Z4H7|HAUS6_HUMAN HAUS augmin-like complex subunit 6 OS=Homo sapiens OX=9606 GN=HAUS6 PE=1 SV=2 HAUS6_HUMAN reviewed HAUS augmin-like complex subunit 6 Homo sapiens (Human) GO:0000226; GO:0005813; GO:0005829; GO:0007098; GO:0008017; GO:0010968; GO:0051225; GO:0051301; GO:0070652; GO:1990498 cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] microtubule binding [GO:0008017] g11516.t1 Q5VUM1 64.835 91 1.03e-31 111.0 sp|Q5VUM1|SDHF4_HUMAN Succinate dehydrogenase assembly factor 4, mitochondrial OS=Homo sapiens OX=9606 GN=SDHAF4 PE=1 SV=1 SDHF4_HUMAN reviewed Succinate dehydrogenase assembly factor 4, mitochondrial (SDH assembly factor 4) (SDHAF4) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006099; GO:0008047; GO:0034553; GO:0044183; GO:0045087; GO:0045333 cellular respiration [GO:0045333]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex II assembly [GO:0034553]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] enzyme activator activity [GO:0008047]; protein folding chaperone [GO:0044183] g11519.t1 Q6DH02 50.893 224 2.1400000000000002e-72 222.0 sp|Q6DH02|RM24_DANRE Large ribosomal subunit protein uL24m OS=Danio rerio OX=7955 GN=mrpl24 PE=2 SV=1 RM24_DANRE reviewed Large ribosomal subunit protein uL24m (39S ribosomal protein L24, mitochondrial) (L24mt) (MRP-L24) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0006754; GO:0045333 ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; translation [GO:0006412] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] g11520.t1 Q24323 29.381 565 3.12e-40 161.0 sp|Q24323|SEM2A_DROME Semaphorin-2A OS=Drosophila melanogaster OX=7227 GN=Sema2a PE=1 SV=2 SEM2A_DROME reviewed Semaphorin-2A (Semaphorin-II) (Sema II) Drosophila melanogaster (Fruit fly) GO:0001755; GO:0005576; GO:0005829; GO:0005886; GO:0007411; GO:0007629; GO:0007632; GO:0012505; GO:0016201; GO:0030215; GO:0030335; GO:0030534; GO:0042756; GO:0045499; GO:0050919; GO:0070983; GO:0071526; GO:0071678; GO:0097374 adult behavior [GO:0030534]; axon guidance [GO:0007411]; dendrite guidance [GO:0070983]; drinking behavior [GO:0042756]; flight behavior [GO:0007629]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; olfactory bulb axon guidance [GO:0071678]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; synaptic target inhibition [GO:0016201]; visual behavior [GO:0007632] cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] g11521.t1 Q6GMK6 37.339 233 2.03e-41 144.0 sp|Q6GMK6|TSN9_DANRE Tetraspanin-9 OS=Danio rerio OX=7955 GN=tspan9 PE=2 SV=1 g11522.t1 Q6INR1 45.85 253 9.32e-49 164.0 sp|Q6INR1|EIF3J_XENLA Eukaryotic translation initiation factor 3 subunit J OS=Xenopus laevis OX=8355 GN=eif3j PE=2 SV=1 g11523.t1 Q3ZBV8 69.571 700 0.0 1048.0 sp|Q3ZBV8|SYTC_BOVIN Threonine--tRNA ligase 1, cytoplasmic OS=Bos taurus OX=9913 GN=TARS1 PE=2 SV=1 SYTC_BOVIN reviewed Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1) Bos taurus (Bovine) GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0008270; GO:0042802 threonyl-tRNA aminoacylation [GO:0006435] cytoplasm [GO:0005737] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270] g11528.t1 Q9WU02 27.089 347 1.2000000000000001e-29 120.0 sp|Q9WU02|V1BR_MOUSE Vasopressin V1b receptor OS=Mus musculus OX=10090 GN=Avpr1b PE=3 SV=1 V1BR_MOUSE reviewed Vasopressin V1b receptor (V1bR) (AVPR V1b) (AVPR V3) (Antidiuretic hormone receptor 1b) (Vasopressin V3 receptor) Mus musculus (Mouse) GO:0001992; GO:0005000; GO:0005794; GO:0005886; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0008217; GO:0014049; GO:0017046; GO:0030425; GO:0032849; GO:0032870; GO:0042127; GO:0042802; GO:0043410; GO:0045907; GO:0046718; GO:0060732; GO:0090238 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; symbiont entry into host cell [GO:0046718] dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000] g11529.t1 Q2VL90 29.596 1115 6.45e-92 327.0 sp|Q2VL90|C163A_PIG Scavenger receptor cysteine-rich type 1 protein M130 OS=Sus scrofa OX=9823 GN=CD163 PE=1 SV=1 C163A_PIG reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Sus scrofa (Pig) GO:0001618; GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] virus receptor activity [GO:0001618] g11529.t1 Q2VL90 32.103 813 1.45e-72 268.0 sp|Q2VL90|C163A_PIG Scavenger receptor cysteine-rich type 1 protein M130 OS=Sus scrofa OX=9823 GN=CD163 PE=1 SV=1 C163A_PIG reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Sus scrofa (Pig) GO:0001618; GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] virus receptor activity [GO:0001618] g11529.t1 Q2VL90 44.361 133 2.7100000000000004e-21 105.0 sp|Q2VL90|C163A_PIG Scavenger receptor cysteine-rich type 1 protein M130 OS=Sus scrofa OX=9823 GN=CD163 PE=1 SV=1 C163A_PIG reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Sus scrofa (Pig) GO:0001618; GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] virus receptor activity [GO:0001618] g11529.t2 Q2VLH6 29.63 945 3.48e-75 276.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g11529.t2 Q2VLH6 30.93 860 3.86e-72 267.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g11529.t2 Q2VLH6 30.256 585 1.21e-50 200.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g11529.t2 Q2VLH6 35.775 355 1.61e-44 180.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g11529.t2 Q2VLH6 32.635 334 2.92e-37 157.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g11530.t1 Q9Y6N7 35.0 320 8.72e-43 164.0 sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1 ROBO1_HUMAN reviewed Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1) Homo sapiens (Human) GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g11530.t1 Q9Y6N7 31.385 325 3.99e-36 145.0 sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1 ROBO1_HUMAN reviewed Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1) Homo sapiens (Human) GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g11530.t1 Q9Y6N7 30.065 306 3.05e-26 115.0 sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1 ROBO1_HUMAN reviewed Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1) Homo sapiens (Human) GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g11530.t1 Q9Y6N7 32.794 247 2.34e-22 103.0 sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1 ROBO1_HUMAN reviewed Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1) Homo sapiens (Human) GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748 aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886] axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] g11531.t1 Q9QXF7 39.92 501 1.06e-120 366.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g11532.t1 Q9QXF7 39.521 501 4.1e-117 357.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g11532.t2 Q7Z449 49.58 119 1.43e-33 130.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g11533.t1 Q8R317 52.5 600 0.0 544.0 sp|Q8R317|UBQL1_MOUSE Ubiquilin-1 OS=Mus musculus OX=10090 GN=Ubqln1 PE=1 SV=1 UBQL1_MOUSE reviewed Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) Mus musculus (Mouse) GO:0000045; GO:0000502; GO:0005102; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016241; GO:0019215; GO:0019900; GO:0019904; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0036503; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1904294 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ERAD pathway [GO:0036503]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511] aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991] identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102] g11535.t1 P24524 45.181 332 9.16e-96 297.0 sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1 GLRA3_RAT reviewed Glycine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0004888; GO:0005231; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0097688; GO:0098690; GO:0098978; GO:0098982; GO:0099171; GO:0099634; GO:1902476 cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; glutamate receptor clustering [GO:0097688]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260] dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734] excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888] g11536.t1 A2AV25 50.0 226 1.3099999999999999e-61 206.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g11537.t1 Q91ZU0 57.377 305 2.37e-124 362.0 sp|Q91ZU0|ASB7_MOUSE Ankyrin repeat and SOCS box protein 7 OS=Mus musculus OX=10090 GN=Asb7 PE=2 SV=2 ASB7_MOUSE reviewed Ankyrin repeat and SOCS box protein 7 (ASB-7) Mus musculus (Mouse) GO:0000212; GO:0000792; GO:0001556; GO:0005634; GO:0005737; GO:0007010; GO:0008608; GO:0016567; GO:0030866; GO:0031466; GO:0035556; GO:0043161; GO:0051276; GO:0051310; GO:0051321; GO:0090306; GO:0120261; GO:1990756 attachment of spindle microtubules to kinetochore [GO:0008608]; chromosome organization [GO:0051276]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; meiotic cell cycle [GO:0051321]; meiotic spindle assembly [GO:0090306]; meiotic spindle organization [GO:0000212]; metaphase chromosome alignment [GO:0051310]; oocyte maturation [GO:0001556]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of heterochromatin organization [GO:0120261] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g11540.t1 Q9H2E6 36.964 560 2.13e-103 337.0 sp|Q9H2E6|SEM6A_HUMAN Semaphorin-6A OS=Homo sapiens OX=9606 GN=SEMA6A PE=1 SV=3 SEM6A_HUMAN reviewed Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1) Homo sapiens (Human) GO:0001755; GO:0005886; GO:0006915; GO:0007010; GO:0007166; GO:0007399; GO:0007411; GO:0009887; GO:0016020; GO:0016525; GO:0030215; GO:0030424; GO:0035924; GO:0045499; GO:0070373; GO:0071526; GO:0106089; GO:1900747; GO:1903671; GO:2001224 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526] axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886] chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] g11543.t1 Q9Y6G5 50.761 197 6.56e-53 169.0 sp|Q9Y6G5|COMDA_HUMAN COMM domain-containing protein 10 OS=Homo sapiens OX=9606 GN=COMMD10 PE=1 SV=1 g11544.t1 Q3UPC7 23.057 1145 6.83e-66 249.0 sp|Q3UPC7|K0825_MOUSE Uncharacterized protein KIAA0825 homolog OS=Mus musculus OX=10090 PE=2 SV=3 g11545.t1 Q3ZCC4 51.176 170 1.7e-47 169.0 sp|Q3ZCC4|TIPIN_BOVIN TIMELESS-interacting protein OS=Bos taurus OX=9913 GN=TIPIN PE=2 SV=1 g11546.t1 A2RV18 53.876 1045 0.0 1138.0 sp|A2RV18|DI3L1_DANRE DIS3-like exonuclease 1 OS=Danio rerio OX=7955 GN=dis3l PE=2 SV=1 DI3L1_DANRE reviewed DIS3-like exonuclease 1 (EC 3.1.13.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000175; GO:0000177; GO:0003723; GO:0006402; GO:0008859; GO:0010467; GO:0016075; GO:0019899 gene expression [GO:0010467]; mRNA catabolic process [GO:0006402]; rRNA catabolic process [GO:0016075] cytoplasmic exosome (RNase complex) [GO:0000177] 3'-5'-RNA exonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; exoribonuclease II activity [GO:0008859]; RNA binding [GO:0003723] g11547.t1 Q6PEC1 53.922 102 1.2e-34 118.0 sp|Q6PEC1|TBCA_RAT Tubulin-specific chaperone A OS=Rattus norvegicus OX=10116 GN=Tbca PE=1 SV=1 g11548.t1 Q6SR68 50.131 383 4.31e-87 270.0 sp|Q6SR68|OTP_HELTB Homeobox protein orthopedia OS=Heliocidaris tuberculata OX=7635 GN=Otp PE=2 SV=1 g11548.t2 Q6SR68 49.869 383 1.75e-84 263.0 sp|Q6SR68|OTP_HELTB Homeobox protein orthopedia OS=Heliocidaris tuberculata OX=7635 GN=Otp PE=2 SV=1 g11549.t1 Q9I9A2 49.533 214 4.15e-58 196.0 sp|Q9I9A2|RX2_ORYLA Retinal homeobox protein Rx2 OS=Oryzias latipes OX=8090 GN=rx2 PE=2 SV=1 g11550.t1 Q26602 64.179 67 7.429999999999999e-24 102.0 sp|Q26602|SMOX3_SCHMA Homeobox protein SMOX-3 (Fragment) OS=Schistosoma mansoni OX=6183 GN=SMOX-3 PE=2 SV=1 g11551.t1 Q9UI26 54.321 972 0.0 1051.0 sp|Q9UI26|IPO11_HUMAN Importin-11 OS=Homo sapiens OX=9606 GN=IPO11 PE=1 SV=1 g11552.t1 A0JMI9 54.26 763 0.0 784.0 sp|A0JMI9|RRF2M_DANRE Ribosome-releasing factor 2, mitochondrial OS=Danio rerio OX=7955 GN=gfm2 PE=2 SV=2 g11553.t1 Q4ZJN1 34.146 246 5.510000000000001e-29 116.0 sp|Q4ZJN1|C1QT9_MOUSE Complement C1q and tumor necrosis factor-related protein 9 OS=Mus musculus OX=10090 GN=C1qtnf9 PE=1 SV=1 C1QT9_MOUSE reviewed Complement C1q and tumor necrosis factor-related protein 9 Mus musculus (Mouse) GO:0005179; GO:0005581; GO:0005615; GO:0019395; GO:0042802; GO:0045792; GO:0097009; GO:1900078 energy homeostasis [GO:0097009]; fatty acid oxidation [GO:0019395]; negative regulation of cell size [GO:0045792]; positive regulation of cellular response to insulin stimulus [GO:1900078] collagen trimer [GO:0005581]; extracellular space [GO:0005615] hormone activity [GO:0005179]; identical protein binding [GO:0042802] g11554.t1 Q4SBY6 35.498 231 2.38e-40 143.0 sp|Q4SBY6|HNMT_TETNG Histamine N-methyltransferase OS=Tetraodon nigroviridis OX=99883 GN=hnmt PE=3 SV=1 g11555.t1 Q2V2K5 31.977 344 7.88e-49 173.0 sp|Q2V2K5|GNRHR_OCTVU Gonadotropin-releasing hormone receptor OS=Octopus vulgaris OX=6645 GN=GNRHR PE=2 SV=1 g11557.t1 P11031 51.471 68 1.3299999999999998e-23 91.3 sp|P11031|TCP4_MOUSE Activated RNA polymerase II transcriptional coactivator p15 OS=Mus musculus OX=10090 GN=Sub1 PE=1 SV=3 TCP4_MOUSE reviewed Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14) Mus musculus (Mouse) GO:0000978; GO:0001111; GO:0003678; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0042802; GO:0051053; GO:0051260; GO:0060261; GO:0140297 negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II promoter clearance [GO:0001111] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA helicase activity [GO:0003678]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g11559.t1 Q94KD8 35.543 709 1.85e-108 350.0 sp|Q94KD8|BXL2_ARATH Probable beta-D-xylosidase 2 OS=Arabidopsis thaliana OX=3702 GN=BXL2 PE=2 SV=1 g11560.t1 Q94KD8 36.479 710 9.29e-113 362.0 sp|Q94KD8|BXL2_ARATH Probable beta-D-xylosidase 2 OS=Arabidopsis thaliana OX=3702 GN=BXL2 PE=2 SV=1 g11561.t1 Q94KD8 35.833 720 7.59e-117 372.0 sp|Q94KD8|BXL2_ARATH Probable beta-D-xylosidase 2 OS=Arabidopsis thaliana OX=3702 GN=BXL2 PE=2 SV=1 g11562.t1 Q94KD8 34.214 719 2.8500000000000003e-103 336.0 sp|Q94KD8|BXL2_ARATH Probable beta-D-xylosidase 2 OS=Arabidopsis thaliana OX=3702 GN=BXL2 PE=2 SV=1 g11564.t1 Q9BY12 41.131 1539 0.0 1005.0 sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2 SCAPE_HUMAN reviewed S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) Homo sapiens (Human) GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917 antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g11564.t2 Q9BY12 41.307 1530 0.0 1008.0 sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2 SCAPE_HUMAN reviewed S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) Homo sapiens (Human) GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917 antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g11564.t3 Q9BY12 41.965 1506 0.0 1019.0 sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2 SCAPE_HUMAN reviewed S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) Homo sapiens (Human) GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917 antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g11568.t1 P50211 65.659 364 6.180000000000001e-166 471.0 sp|P50211|ISL1_CHICK Insulin gene enhancer protein ISL-1 OS=Gallus gallus OX=9031 GN=ISL1 PE=1 SV=1 g11574.t1 Q7Z2Z2 54.646 1173 0.0 1276.0 sp|Q7Z2Z2|EFL1_HUMAN Elongation factor-like GTPase 1 OS=Homo sapiens OX=9606 GN=EFL1 PE=1 SV=2 EFL1_HUMAN reviewed Elongation factor-like GTPase 1 (EC 3.6.5.-) (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A) Homo sapiens (Human) GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904 cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039] cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746] g11575.t1 Q9QXF7 38.264 507 3.8199999999999995e-126 380.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g11575.t2 Q4V8D1 47.682 151 6.54e-44 159.0 sp|Q4V8D1|CP2U1_RAT Cytochrome P450 2U1 OS=Rattus norvegicus OX=10116 GN=Cyp2u1 PE=1 SV=1 CP2U1_RAT reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Rattus norvegicus (Rat) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g11576.t1 Q0IIF9 48.387 155 2.0699999999999998e-45 165.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g11579.t1 O35186 40.323 310 2.8999999999999997e-67 216.0 sp|O35186|CATK_RAT Cathepsin K OS=Rattus norvegicus OX=10116 GN=Ctsk PE=2 SV=1 CATK_RAT reviewed Cathepsin K (EC 3.4.22.38) Rattus norvegicus (Rat) GO:0001957; GO:0001968; GO:0004197; GO:0005518; GO:0005615; GO:0005654; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0032868; GO:0034224; GO:0043394; GO:0045453; GO:0045471; GO:0051603; GO:0061037; GO:0071356; GO:0071560; GO:1903131 bone resorption [GO:0045453]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to zinc ion starvation [GO:0034224]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; mononuclear cell differentiation [GO:1903131]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394] g11580.t1 P14732 39.898 589 1.8499999999999998e-147 440.0 sp|P14732|LMNB2_CHICK Lamin-B2 OS=Gallus gallus OX=9031 GN=LMNB2 PE=1 SV=1 g11581.t1 Q9D1I5 61.333 150 2.73e-61 190.0 sp|Q9D1I5|MCEE_MOUSE Methylmalonyl-CoA epimerase, mitochondrial OS=Mus musculus OX=10090 GN=Mcee PE=1 SV=1 g11582.t1 Q4R3I0 46.667 315 1.49e-90 276.0 sp|Q4R3I0|MTX1_MACFA Metaxin-1 OS=Macaca fascicularis OX=9541 GN=MTX1 PE=2 SV=1 g11583.t1 Q8VDL4 44.695 443 1.1700000000000001e-125 378.0 sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2 ADPGK_MOUSE reviewed ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147) Mus musculus (Mouse) GO:0005576; GO:0005783; GO:0006006; GO:0006096; GO:0043843; GO:0046872 glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576] ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872] g11585.t1 O08700 70.567 547 0.0 809.0 sp|O08700|VPS45_RAT Vacuolar protein sorting-associated protein 45 OS=Rattus norvegicus OX=10116 GN=Vps45 PE=1 SV=1 g11586.t1 Q40784 41.199 267 4.6800000000000004e-65 209.0 sp|Q40784|AAPC_CENCI Putative glucose-6-phosphate 1-epimerase OS=Cenchrus ciliaris OX=35872 PE=2 SV=1 g11587.t1 Q9BX70 79.398 432 0.0 738.0 sp|Q9BX70|BTBD2_HUMAN BTB/POZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=BTBD2 PE=1 SV=1 BTBD2_HUMAN reviewed BTB/POZ domain-containing protein 2 Homo sapiens (Human) GO:0000932; GO:0005829; GO:0022008 neurogenesis [GO:0022008] cytosol [GO:0005829]; P-body [GO:0000932] g11588.t1 Q5RDU4 49.688 640 0.0 586.0 sp|Q5RDU4|PARP6_PONAB Protein mono-ADP-ribosyltransferase PARP6 OS=Pongo abelii OX=9601 GN=PARP6 PE=2 SV=1 PARP6_PONAB reviewed Protein mono-ADP-ribosyltransferase PARP6 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17) (Poly [ADP-ribose] polymerase 6) (PARP-6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003950; GO:0016779; GO:0070213; GO:0140803; GO:0140806 protein auto-ADP-ribosylation [GO:0070213] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779] g11588.t2 Q5RDU4 51.56 609 0.0 592.0 sp|Q5RDU4|PARP6_PONAB Protein mono-ADP-ribosyltransferase PARP6 OS=Pongo abelii OX=9601 GN=PARP6 PE=2 SV=1 PARP6_PONAB reviewed Protein mono-ADP-ribosyltransferase PARP6 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17) (Poly [ADP-ribose] polymerase 6) (PARP-6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003950; GO:0016779; GO:0070213; GO:0140803; GO:0140806 protein auto-ADP-ribosylation [GO:0070213] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779] g11589.t1 O00566 39.155 710 3.2e-115 364.0 sp|O00566|MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens OX=9606 GN=MPHOSPH10 PE=1 SV=2 MPP10_HUMAN reviewed U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) Homo sapiens (Human) GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006396; GO:0008380; GO:0030490; GO:0032040; GO:0034457; GO:0042274 maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375] chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] RNA binding [GO:0003723] g11590.t1 P13060 77.396 845 0.0 1399.0 sp|P13060|EF2_DROME Eukaryotic translation elongation factor 2 OS=Drosophila melanogaster OX=7227 GN=eEF2 PE=1 SV=4 g11591.t1 Q6GLE8 39.227 362 4.0900000000000004e-64 212.0 sp|Q6GLE8|LRC28_XENTR Leucine-rich repeat-containing protein 28 OS=Xenopus tropicalis OX=8364 GN=lrrc28 PE=2 SV=1 g11592.t1 Q96HH9 28.929 280 8.04e-25 110.0 sp|Q96HH9|GRM2B_HUMAN GRAM domain-containing protein 2B OS=Homo sapiens OX=9606 GN=GRAMD2B PE=1 SV=1 GRM2B_HUMAN reviewed GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2) Homo sapiens (Human) GO:0005881; GO:0042802 cytoplasmic microtubule [GO:0005881] identical protein binding [GO:0042802] g11593.t1 Q99MY8 50.701 856 0.0 943.0 sp|Q99MY8|ASH1L_MOUSE Histone-lysine N-methyltransferase ASH1L OS=Mus musculus OX=10090 GN=Ash1l PE=1 SV=3 ASH1L_MOUSE reviewed Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (Absent small and homeotic disks protein 1 homolog) Mus musculus (Mouse) GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0006355; GO:0007338; GO:0008270; GO:0009791; GO:0010468; GO:0030317; GO:0032259; GO:0042800; GO:0043409; GO:0045944; GO:0046697; GO:0046974; GO:0046975; GO:0048733; GO:0050728; GO:0061038; GO:0140948; GO:0140955; GO:1903699; GO:1903709 decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; methylation [GO:0032259]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; sebaceous gland development [GO:0048733]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038] bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; zinc ion binding [GO:0008270] g11593.t2 Q99MY8 50.701 856 0.0 942.0 sp|Q99MY8|ASH1L_MOUSE Histone-lysine N-methyltransferase ASH1L OS=Mus musculus OX=10090 GN=Ash1l PE=1 SV=3 ASH1L_MOUSE reviewed Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (Absent small and homeotic disks protein 1 homolog) Mus musculus (Mouse) GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0006355; GO:0007338; GO:0008270; GO:0009791; GO:0010468; GO:0030317; GO:0032259; GO:0042800; GO:0043409; GO:0045944; GO:0046697; GO:0046974; GO:0046975; GO:0048733; GO:0050728; GO:0061038; GO:0140948; GO:0140955; GO:1903699; GO:1903709 decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; methylation [GO:0032259]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; sebaceous gland development [GO:0048733]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038] bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; zinc ion binding [GO:0008270] g11594.t1 P82922 45.6 375 6.07e-121 359.0 sp|P82922|RT29_BOVIN Small ribosomal subunit protein mS29 OS=Bos taurus OX=9913 GN=DAP3 PE=1 SV=3 RT29_BOVIN reviewed Small ribosomal subunit protein mS29 (EC 3.6.5.-) (28S ribosomal protein S29, mitochondrial) (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) Bos taurus (Bovine) GO:0003735; GO:0003924; GO:0005739; GO:0005743; GO:0005763; GO:0006915; GO:0032543 apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] GTPase activity [GO:0003924]; structural constituent of ribosome [GO:0003735] g11595.t1 Q5VW36 31.317 1852 0.0 908.0 sp|Q5VW36|FOCAD_HUMAN Focadhesin OS=Homo sapiens OX=9606 GN=FOCAD PE=1 SV=2 FOCAD_HUMAN reviewed Focadhesin Homo sapiens (Human) GO:0005829; GO:0005925; GO:0060147 regulation of post-transcriptional gene silencing [GO:0060147] cytosol [GO:0005829]; focal adhesion [GO:0005925] g11596.t1 P27089 57.529 259 3.08e-91 273.0 sp|P27089|XPA_CHICK DNA repair protein complementing XP-A cells homolog OS=Gallus gallus OX=9031 GN=XPA PE=2 SV=1 g11597.t1 Q8TBF8 27.54 374 3.08e-28 117.0 sp|Q8TBF8|FA81A_HUMAN Protein FAM81A OS=Homo sapiens OX=9606 GN=FAM81A PE=1 SV=3 g11598.t1 P63240 49.829 584 0.0 577.0 sp|P63240|NEC1_MUSCO Neuroendocrine convertase 1 OS=Mus cookii OX=10098 GN=Pcsk1 PE=2 SV=1 NEC1_MUSCO reviewed Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Furin homolog) (PC3) (Prohormone convertase 1) (Propeptide-processing protease) (Proprotein convertase 1) (PC1) Mus cookii (Cook's mouse) GO:0004252; GO:0005615; GO:0005788; GO:0016020; GO:0016486; GO:0030133; GO:0034774; GO:0043005 peptide hormone processing [GO:0016486] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133] serine-type endopeptidase activity [GO:0004252] g11600.t1 B3DM66 32.323 297 1.47e-40 156.0 sp|B3DM66|GP161_XENTR G-protein coupled receptor 161 OS=Xenopus tropicalis OX=8364 GN=gpr161 PE=2 SV=1 g11601.t1 Q60445 66.443 298 2.14e-151 429.0 sp|Q60445|COPE_CRIGR Coatomer subunit epsilon OS=Cricetulus griseus OX=10029 GN=COPE PE=2 SV=2 g11602.t1 A8CVX7 57.014 556 0.0 659.0 sp|A8CVX7|TTLL6_DANRE Tubulin polyglutamylase ttll6 OS=Danio rerio OX=7955 GN=ttll6 PE=2 SV=1 TTLL6_DANRE reviewed Tubulin polyglutamylase ttll6 (EC 6.3.2.-) (Protein polyglutamylase TTLL6) (Tubulin tyrosine ligase-like family member 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001578; GO:0003341; GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015631; GO:0018095; GO:0035082; GO:0036064; GO:0046872; GO:0060296; GO:0070739; GO:0070740; GO:0106437; GO:0106438 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; microtubule bundle formation [GO:0001578]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g11602.t2 A8CVX7 57.014 556 0.0 659.0 sp|A8CVX7|TTLL6_DANRE Tubulin polyglutamylase ttll6 OS=Danio rerio OX=7955 GN=ttll6 PE=2 SV=1 TTLL6_DANRE reviewed Tubulin polyglutamylase ttll6 (EC 6.3.2.-) (Protein polyglutamylase TTLL6) (Tubulin tyrosine ligase-like family member 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001578; GO:0003341; GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015631; GO:0018095; GO:0035082; GO:0036064; GO:0046872; GO:0060296; GO:0070739; GO:0070740; GO:0106437; GO:0106438 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; microtubule bundle formation [GO:0001578]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g11603.t1 Q23939 41.197 284 9.41e-49 166.0 sp|Q23939|TPM_DERFA Tropomyosin OS=Dermatophagoides farinae OX=6954 PE=1 SV=2 g11603.t2 Q23939 40.876 274 8.47e-43 150.0 sp|Q23939|TPM_DERFA Tropomyosin OS=Dermatophagoides farinae OX=6954 PE=1 SV=2 g11603.t3 P86704 41.063 207 1.54e-28 112.0 sp|P86704|TPM_PANBO Tropomyosin OS=Pandalus borealis OX=6703 GN=TM1 PE=1 SV=1 g11605.t1 Q6NSJ0 43.077 195 4.24e-49 178.0 sp|Q6NSJ0|MYORG_HUMAN Myogenesis-regulating glycosidase OS=Homo sapiens OX=9606 GN=MYORG PE=1 SV=2 MYORG_HUMAN reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Homo sapiens (Human) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g11605.t1 Q6NSJ0 47.101 138 3.26e-30 124.0 sp|Q6NSJ0|MYORG_HUMAN Myogenesis-regulating glycosidase OS=Homo sapiens OX=9606 GN=MYORG PE=1 SV=2 MYORG_HUMAN reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Homo sapiens (Human) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g11608.t1 Q6NSJ0 35.824 455 4.35e-86 283.0 sp|Q6NSJ0|MYORG_HUMAN Myogenesis-regulating glycosidase OS=Homo sapiens OX=9606 GN=MYORG PE=1 SV=2 MYORG_HUMAN reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Homo sapiens (Human) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g11609.t1 P19965 36.752 117 1.97e-21 91.7 sp|P19965|SP15_TETCF SITS-binding protein OS=Tetronarce californica OX=7787 PE=1 SV=2 g11610.t1 Q6NSJ0 36.535 531 8.4e-120 378.0 sp|Q6NSJ0|MYORG_HUMAN Myogenesis-regulating glycosidase OS=Homo sapiens OX=9606 GN=MYORG PE=1 SV=2 MYORG_HUMAN reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Homo sapiens (Human) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g11611.t1 Q96KR1 44.253 1105 0.0 764.0 sp|Q96KR1|ZFR_HUMAN Zinc finger RNA-binding protein OS=Homo sapiens OX=9606 GN=ZFR PE=1 SV=2 g11612.t1 Q6NSJ0 41.483 634 1.67e-173 516.0 sp|Q6NSJ0|MYORG_HUMAN Myogenesis-regulating glycosidase OS=Homo sapiens OX=9606 GN=MYORG PE=1 SV=2 MYORG_HUMAN reviewed Alpha-galactosidase MYORG (EC 3.2.1.22) (Myogenesis regulating glycosidase) (Nuclear envelope transmembrane protein 37) Homo sapiens (Human) GO:0004557; GO:0005789; GO:0005975; GO:0031965; GO:0043568; GO:0048741; GO:0051897 carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] alpha-galactosidase activity [GO:0004557] g11614.t1 Q8K2C9 35.236 403 2.48e-83 262.0 sp|Q8K2C9|HACD3_MOUSE Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 OS=Mus musculus OX=10090 GN=Hacd3 PE=1 SV=2 HACD3_MOUSE reviewed Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0007254; GO:0007266; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:1902532 fatty acid elongation [GO:0030497]; JNK cascade [GO:0007254]; negative regulation of intracellular signal transduction [GO:1902532]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rho protein signal transduction [GO:0007266]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965] 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158] g11616.t1 A0A2I4HXH5 42.885 520 5.2600000000000005e-124 379.0 sp|A0A2I4HXH5|V5NTD_NAJAT Snake venom 5'-nucleotidase (Fragment) OS=Naja atra OX=8656 PE=1 SV=1 g11617.t1 A6QQM4 47.991 448 6.37e-127 385.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g11617.t1 A6QQM4 51.429 105 2.59e-28 122.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g11617.t1 A6QQM4 51.485 101 4.380000000000001e-27 118.0 sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1 g11618.t1 Q8BHJ6 35.876 485 1.05e-91 290.0 sp|Q8BHJ6|SERC5_MOUSE Serine incorporator 5 OS=Mus musculus OX=10090 GN=Serinc5 PE=2 SV=1 g11618.t2 Q8BHJ6 37.121 132 8.410000000000001e-21 91.7 sp|Q8BHJ6|SERC5_MOUSE Serine incorporator 5 OS=Mus musculus OX=10090 GN=Serinc5 PE=2 SV=1 g11619.t1 Q6ZMM2 37.5 280 5.24e-62 214.0 sp|Q6ZMM2|ATL5_HUMAN ADAMTS-like protein 5 OS=Homo sapiens OX=9606 GN=ADAMTSL5 PE=1 SV=3 ATL5_HUMAN reviewed ADAMTS-like protein 5 (ADAMTSL-5) (Thrombospondin type-1 domain-containing protein 6) Homo sapiens (Human) GO:0001527; GO:0005576; GO:0008201; GO:0030198; GO:0031012; GO:0050436 extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] heparin binding [GO:0008201]; microfibril binding [GO:0050436] g11622.t1 Q80YE7 35.7 1000 0.0 606.0 sp|Q80YE7|DAPK1_MOUSE Death-associated protein kinase 1 OS=Mus musculus OX=10090 GN=Dapk1 PE=1 SV=3 DAPK1_MOUSE reviewed Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0002357; GO:0002834; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0043065; GO:0043066; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1902042; GO:1904094; GO:1990722; GO:2000310 apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075] g11622.t2 Q80YE7 38.483 1424 0.0 952.0 sp|Q80YE7|DAPK1_MOUSE Death-associated protein kinase 1 OS=Mus musculus OX=10090 GN=Dapk1 PE=1 SV=3 DAPK1_MOUSE reviewed Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0002357; GO:0002834; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0043065; GO:0043066; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1902042; GO:1904094; GO:1990722; GO:2000310 apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075] g11622.t3 Q9UIK4 53.185 314 1.44e-118 350.0 sp|Q9UIK4|DAPK2_HUMAN Death-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=DAPK2 PE=1 SV=1 g11625.t1 Q12888 33.333 516 3.1099999999999997e-68 246.0 sp|Q12888|TP53B_HUMAN TP53-binding protein 1 OS=Homo sapiens OX=9606 GN=TP53BP1 PE=1 SV=2 TP53B_HUMAN reviewed TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) Homo sapiens (Human) GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006303; GO:0006974; GO:0016604; GO:0035861; GO:0042162; GO:0042393; GO:0045830; GO:0045893; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0140005; GO:0140566; GO:0140941; GO:1902255; GO:1990166; GO:1990391; GO:2000042 cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; histone reader activity [GO:0140566]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649] g11630.t1 Q96B86 38.028 426 7.44e-84 268.0 sp|Q96B86|RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens OX=9606 GN=RGMA PE=1 SV=4 g11631.t1 Q503I9 36.562 413 8.67e-74 249.0 sp|Q503I9|GLD2_DANRE Poly(A) RNA polymerase GLD2 OS=Danio rerio OX=7955 GN=tent2 PE=2 SV=1 g11632.t1 Q92900 67.331 1154 0.0 1541.0 sp|Q92900|RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2 RENT1_HUMAN reviewed Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1) Homo sapiens (Human) GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0060816; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; random inactivation of X chromosome [GO:0060816]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270] g11633.t1 O01727 67.623 244 3.64e-108 313.0 sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1 g11634.t1 Q4J781 31.525 387 6.6e-39 145.0 sp|Q4J781|ADH_SULAC NAD-dependent alcohol dehydrogenase OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=adh PE=3 SV=1 g11639.t1 P13234 60.328 305 3.2100000000000003e-133 392.0 sp|P13234|KCC4_RAT Calcium/calmodulin-dependent protein kinase type IV OS=Rattus norvegicus OX=10116 GN=Camk4 PE=1 SV=3 KCC4_RAT reviewed Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) (Calspermin) Rattus norvegicus (Rat) GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006913; GO:0006954; GO:0007165; GO:0007270; GO:0007616; GO:0009931; GO:0035556; GO:0043011; GO:0045893; GO:0046827; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099527; GO:0106310 adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; neuron-neuron synaptic transmission [GO:0007270]; nucleocytoplasmic transport [GO:0006913]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; postsynapse to nucleus signaling pathway [GO:0099527]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310] g11641.t1 Q92733 32.533 375 5.719999999999999e-34 141.0 sp|Q92733|PRCC_HUMAN Proline-rich protein PRCC OS=Homo sapiens OX=9606 GN=PRCC PE=1 SV=1 PRCC_HUMAN reviewed Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0016607; GO:0051726 regulation of cell cycle [GO:0051726] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g11646.t1 P10669 40.667 300 1.3999999999999999e-67 221.0 sp|P10669|FST_PIG Follistatin OS=Sus scrofa OX=9823 GN=FST PE=1 SV=1 g11647.t1 Q95R48 36.589 604 4.11e-113 352.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g11650.t1 Q21974 32.249 338 1.1999999999999999e-46 182.0 sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1 UNC8_CAEEL reviewed Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8) Caenorhabditis elegans GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025 locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725] neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261] g11651.t1 O97742 31.776 321 6.88e-42 166.0 sp|O97742|SCNNB_RABIT Epithelial sodium channel subunit beta OS=Oryctolagus cuniculus OX=9986 GN=SCNN1B PE=2 SV=1 g11652.t1 A5D7U4 27.478 575 1.24e-62 222.0 sp|A5D7U4|SCNNB_BOVIN Epithelial sodium channel subunit beta OS=Bos taurus OX=9913 GN=SCNN1B PE=2 SV=1 SCNNB_BOVIN reviewed Epithelial sodium channel subunit beta (Amiloride-sensitive sodium channel subunit beta) (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB) Bos taurus (Bovine) GO:0005886; GO:0006883; GO:0015280; GO:0016324; GO:0030659; GO:0034706; GO:0035725; GO:0050699; GO:0098719 intracellular sodium ion homeostasis [GO:0006883]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699] g11654.t1 Q13972 50.267 1313 0.0 1202.0 sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2 RGRF1_HUMAN reviewed Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168 long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085] g11654.t2 P28818 51.351 1295 0.0 1214.0 sp|P28818|RGRF1_RAT Ras-specific guanine nucleotide-releasing factor 1 OS=Rattus norvegicus OX=10116 GN=Rasgrf1 PE=1 SV=1 RGRF1_RAT reviewed Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (P140 Ras-GRF) Rattus norvegicus (Rat) GO:0001975; GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0007265; GO:0016323; GO:0016327; GO:0030426; GO:0030971; GO:0031175; GO:0031267; GO:0032869; GO:0034976; GO:0035022; GO:0035254; GO:0043025; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048146; GO:0048167; GO:0048168; GO:0071236; GO:0097440; GO:0098794; GO:0098978; GO:0099170 cellular response to antibiotic [GO:0071236]; cellular response to insulin stimulus [GO:0032869]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to endoplasmic reticulum stress [GO:0034976]; type B pancreatic cell proliferation [GO:0044342] apical dendrite [GO:0097440]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] glutamate receptor binding [GO:0035254]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267] g11657.t1 Q5QJU3 47.727 264 3.14e-93 279.0 sp|Q5QJU3|ACER2_HUMAN Alkaline ceramidase 2 OS=Homo sapiens OX=9606 GN=ACER2 PE=1 SV=2 ACER2_HUMAN reviewed Alkaline ceramidase 2 (AlkCDase 2) (Alkaline CDase 2) (haCER2) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like) Homo sapiens (Human) GO:0000139; GO:0001953; GO:0005794; GO:0006974; GO:0008284; GO:0010506; GO:0010559; GO:0017040; GO:0030149; GO:0030330; GO:0032526; GO:0033629; GO:0042981; GO:0046512; GO:0046514; GO:0046872; GO:0071466 cellular response to xenobiotic stimulus [GO:0071466]; ceramide catabolic process [GO:0046514]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of glycoprotein biosynthetic process [GO:0010559]; response to retinoic acid [GO:0032526]; sphingolipid catabolic process [GO:0030149]; sphingosine biosynthetic process [GO:0046512] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040] g11658.t1 Q9UGJ1 55.786 674 0.0 728.0 sp|Q9UGJ1|GCP4_HUMAN Gamma-tubulin complex component 4 OS=Homo sapiens OX=9606 GN=TUBGCP4 PE=1 SV=1 GCP4_HUMAN reviewed Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) Homo sapiens (Human) GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003 cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922] gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200] g11659.t1 P23188 56.0 650 0.0 726.0 sp|P23188|FURIN_MOUSE Furin OS=Mus musculus OX=10090 GN=Furin PE=1 SV=2 FURIN_MOUSE reviewed Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Prohormone convertase 3) Mus musculus (Mouse) GO:0000139; GO:0001825; GO:0002020; GO:0004175; GO:0004252; GO:0004867; GO:0005576; GO:0005769; GO:0005783; GO:0005788; GO:0005789; GO:0005796; GO:0005802; GO:0005886; GO:0006465; GO:0008201; GO:0008233; GO:0008236; GO:0009003; GO:0009966; GO:0009986; GO:0010008; GO:0012510; GO:0016020; GO:0016485; GO:0016486; GO:0030140; GO:0030335; GO:0030511; GO:0031638; GO:0031985; GO:0032374; GO:0032804; GO:0032902; GO:0032911; GO:0032940; GO:0042176; GO:0042277; GO:0043043; GO:0045121; GO:0046598; GO:0046718; GO:0046872; GO:0048406; GO:0051604; GO:0061133; GO:0090472; GO:0097341; GO:0140447; GO:1904399 blastocyst formation [GO:0001825]; cytokine precursor processing [GO:0140447]; dibasic protein processing [GO:0090472]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of cell migration [GO:0030335]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of viral entry into host cell [GO:0046598]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of cholesterol transport [GO:0032374]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; symbiont entry into host cell [GO:0046718]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341] cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi cisterna [GO:0031985]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; trans-Golgi network transport vesicle membrane [GO:0012510] endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; serine-type peptidase activity [GO:0008236]; signal peptidase activity [GO:0009003] g11659.t2 P23188 54.396 671 0.0 716.0 sp|P23188|FURIN_MOUSE Furin OS=Mus musculus OX=10090 GN=Furin PE=1 SV=2 FURIN_MOUSE reviewed Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Prohormone convertase 3) Mus musculus (Mouse) GO:0000139; GO:0001825; GO:0002020; GO:0004175; GO:0004252; GO:0004867; GO:0005576; GO:0005769; GO:0005783; GO:0005788; GO:0005789; GO:0005796; GO:0005802; GO:0005886; GO:0006465; GO:0008201; GO:0008233; GO:0008236; GO:0009003; GO:0009966; GO:0009986; GO:0010008; GO:0012510; GO:0016020; GO:0016485; GO:0016486; GO:0030140; GO:0030335; GO:0030511; GO:0031638; GO:0031985; GO:0032374; GO:0032804; GO:0032902; GO:0032911; GO:0032940; GO:0042176; GO:0042277; GO:0043043; GO:0045121; GO:0046598; GO:0046718; GO:0046872; GO:0048406; GO:0051604; GO:0061133; GO:0090472; GO:0097341; GO:0140447; GO:1904399 blastocyst formation [GO:0001825]; cytokine precursor processing [GO:0140447]; dibasic protein processing [GO:0090472]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of cell migration [GO:0030335]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of viral entry into host cell [GO:0046598]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of cholesterol transport [GO:0032374]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; symbiont entry into host cell [GO:0046718]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341] cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi cisterna [GO:0031985]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; trans-Golgi network transport vesicle membrane [GO:0012510] endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; serine-type peptidase activity [GO:0008236]; signal peptidase activity [GO:0009003] g11660.t1 P91685 28.751 873 4.62e-108 358.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g11661.t1 Q9H5U6 51.392 467 8.8e-163 472.0 sp|Q9H5U6|ZCHC4_HUMAN rRNA N(6)-adenosine-methyltransferase ZCCHC4 OS=Homo sapiens OX=9606 GN=ZCCHC4 PE=1 SV=3 g11664.t1 Q9UGM3 34.51 510 1.8700000000000001e-65 249.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11664.t1 Q9UGM3 34.077 493 3.13e-65 249.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11664.t1 Q9UGM3 32.957 531 2.56e-63 243.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11664.t1 Q9UGM3 33.078 523 4e-63 242.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11664.t1 Q9UGM3 34.63 514 1.2e-62 240.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11664.t1 Q9UGM3 34.077 493 1.21e-62 240.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11664.t1 Q9UGM3 33.719 519 4.27e-61 235.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11664.t1 Q9UGM3 33.73 504 2.36e-60 233.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g11665.t1 Q5G268 38.346 266 3.18e-45 166.0 sp|Q5G268|NETR_NOMLE Neurotrypsin OS=Nomascus leucogenys OX=61853 GN=PRSS12 PE=3 SV=1 NETR_NOMLE reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Nomascus leucogenys (Northern white-cheeked gibbon) (Hylobates leucogenys) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g11665.t1 Q5G268 34.717 265 7.480000000000001e-35 136.0 sp|Q5G268|NETR_NOMLE Neurotrypsin OS=Nomascus leucogenys OX=61853 GN=PRSS12 PE=3 SV=1 NETR_NOMLE reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Nomascus leucogenys (Northern white-cheeked gibbon) (Hylobates leucogenys) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g11665.t1 Q5G268 34.634 205 2.25e-28 117.0 sp|Q5G268|NETR_NOMLE Neurotrypsin OS=Nomascus leucogenys OX=61853 GN=PRSS12 PE=3 SV=1 NETR_NOMLE reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Nomascus leucogenys (Northern white-cheeked gibbon) (Hylobates leucogenys) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g11666.t1 Q9QXF7 40.12 501 1.74e-117 357.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g11667.t1 P24369 65.198 227 2.1799999999999998e-92 273.0 sp|P24369|PPIB_MOUSE Peptidyl-prolyl cis-trans isomerase B OS=Mus musculus OX=10090 GN=Ppib PE=1 SV=2 PPIB_MOUSE reviewed Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP) Mus musculus (Mouse) GO:0003755; GO:0005654; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0016018; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0044794; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0070063 bone development [GO:0060348]; host-mediated activation of viral genome replication [GO:0044829]; host-mediated activation of viral process [GO:0044794]; neutrophil chemotaxis [GO:0030593]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790] cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063] g11669.t1 P10079 40.536 634 2.33e-114 379.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11669.t1 P10079 39.296 682 2.9299999999999998e-114 379.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11669.t1 P10079 38.686 685 2.05e-112 374.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11669.t1 P10079 37.887 710 4.38e-112 373.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11670.t1 P49914 52.525 198 2.92e-71 218.0 sp|P49914|MTHFS_HUMAN 5-formyltetrahydrofolate cyclo-ligase OS=Homo sapiens OX=9606 GN=MTHFS PE=1 SV=2 MTHFS_HUMAN reviewed 5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase) Homo sapiens (Human) GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006536; GO:0009396; GO:0015942; GO:0030272; GO:0035999; GO:0046653; GO:0046655; GO:0046657; GO:0046872 folic acid catabolic process [GO:0046657]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; formate metabolic process [GO:0015942]; glutamate metabolic process [GO:0006536]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872] g11676.t1 Q9W534 25.197 381 1.83e-22 102.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g11677.t1 Q62862 60.093 431 0.0 528.0 sp|Q62862|MP2K5_RAT Dual specificity mitogen-activated protein kinase kinase 5 OS=Rattus norvegicus OX=10116 GN=Map2k5 PE=1 SV=1 MP2K5_RAT reviewed Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5) Rattus norvegicus (Rat) GO:0000122; GO:0000165; GO:0004672; GO:0004707; GO:0004708; GO:0004713; GO:0005524; GO:0005819; GO:0005829; GO:0007507; GO:0016020; GO:0030307; GO:0032717; GO:0034115; GO:0034392; GO:0043124; GO:0045944; GO:0046872; GO:0048009; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0090051; GO:0106310; GO:2000342; GO:2001240 cellular response to growth factor stimulus [GO:0071363]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; MAPK cascade [GO:0000165]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; membrane [GO:0016020]; spindle [GO:0005819] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein tyrosine kinase activity [GO:0004713] g11678.t1 P0C862 30.38 237 5.670000000000001e-21 94.0 sp|P0C862|C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A OS=Homo sapiens OX=9606 GN=C1QTNF9 PE=1 SV=1 g11679.t1 Q8NEF9 36.184 152 1.0600000000000001e-21 100.0 sp|Q8NEF9|SRFB1_HUMAN Serum response factor-binding protein 1 OS=Homo sapiens OX=9606 GN=SRFBP1 PE=1 SV=1 g11680.t1 P20936 49.835 907 0.0 864.0 sp|P20936|RASA1_HUMAN Ras GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RASA1 PE=1 SV=1 RASA1_HUMAN reviewed Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP) Homo sapiens (Human) GO:0000281; GO:0001525; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0048013; GO:0048514; GO:0051020; GO:0051252; GO:1902531 angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of intracellular signal transduction [GO:1902531]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102] g11681.t1 Q6P5H6 41.043 441 2.34e-109 340.0 sp|Q6P5H6|FRMD5_MOUSE FERM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Frmd5 PE=1 SV=1 g11681.t2 Q6P5H6 42.523 428 8.71e-114 351.0 sp|Q6P5H6|FRMD5_MOUSE FERM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Frmd5 PE=1 SV=1 g11682.t1 B0BML1 44.211 190 1.4e-47 157.0 sp|B0BML1|GNTK_XENTR Probable gluconokinase OS=Xenopus tropicalis OX=8364 GN=idnk PE=2 SV=1 g11683.t1 Q6R3M4 39.377 706 3.4499999999999997e-140 434.0 sp|Q6R3M4|POLI_MOUSE DNA polymerase iota OS=Mus musculus OX=10090 GN=Poli PE=1 SV=1 POLI_MOUSE reviewed DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) Mus musculus (Mouse) GO:0003684; GO:0003887; GO:0006260; GO:0006281; GO:0016607; GO:0019985; GO:0036464; GO:0046872; GO:0071494 cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607] damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g11684.t1 Q9CWB7 54.023 87 1.17e-30 108.0 sp|Q9CWB7|YD286_MOUSE Glutaredoxin-like protein C5orf63 homolog OS=Mus musculus OX=10090 PE=1 SV=1 g11686.t1 Q5FWH7 34.82 471 2.29e-68 238.0 sp|Q5FWH7|S39AC_MOUSE Zinc transporter ZIP12 OS=Mus musculus OX=10090 GN=Slc39a12 PE=1 SV=1 S39AC_MOUSE reviewed Zinc transporter ZIP12 (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12) Mus musculus (Mouse) GO:0001841; GO:0005385; GO:0005886; GO:0007165; GO:0010975; GO:0030003; GO:0031113; GO:0048471; GO:0071578; GO:0140410; GO:1903672; GO:1990138 intracellular monoatomic cation homeostasis [GO:0030003]; neural tube formation [GO:0001841]; neuron projection extension [GO:1990138]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g11689.t1 Q6PEM6 29.503 322 8.14e-33 132.0 sp|Q6PEM6|GRM2B_MOUSE GRAM domain-containing protein 2B OS=Mus musculus OX=10090 GN=Gramd2b PE=1 SV=2 g11689.t2 Q5FVG8 29.268 328 2.1e-33 132.0 sp|Q5FVG8|GRM2B_RAT GRAM domain-containing protein 2B OS=Rattus norvegicus OX=10116 GN=Gramd2b PE=1 SV=1 g11690.t1 Q94KD8 34.535 721 1.0600000000000001e-110 357.0 sp|Q94KD8|BXL2_ARATH Probable beta-D-xylosidase 2 OS=Arabidopsis thaliana OX=3702 GN=BXL2 PE=2 SV=1 g11691.t1 Q9LXA8 31.83 776 8.13e-99 326.0 sp|Q9LXA8|BXL6_ARATH Probable beta-D-xylosidase 6 OS=Arabidopsis thaliana OX=3702 GN=BXL6 PE=2 SV=1 g11692.t1 Q94KD8 34.189 740 2e-108 350.0 sp|Q94KD8|BXL2_ARATH Probable beta-D-xylosidase 2 OS=Arabidopsis thaliana OX=3702 GN=BXL2 PE=2 SV=1 g11694.t1 Q7ZVZ7 78.746 287 6.79e-175 488.0 sp|Q7ZVZ7|AB17C_DANRE Alpha/beta hydrolase domain-containing protein 17C OS=Danio rerio OX=7955 GN=abhd17c PE=2 SV=1 g11697.t1 Q9V9J3 42.712 295 2.26e-61 218.0 sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1 SRC42_DROME reviewed Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0009611; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136 actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] g11698.t1 P00521 39.274 303 1.87e-62 227.0 sp|P00521|ABL_MLVAB Tyrosine-protein kinase transforming protein Abl OS=Abelson murine leukemia virus OX=11788 GN=ABL PE=3 SV=1 g11699.t1 P04757 54.865 483 0.0 525.0 sp|P04757|ACHA3_RAT Neuronal acetylcholine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Chrna3 PE=1 SV=1 ACHA3_RAT reviewed Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007507; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034465; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; heart development [GO:0007507]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to carbon monoxide [GO:0034465]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g11700.t1 P54131 43.08 513 3.63e-127 385.0 sp|P54131|ACHA7_BOVIN Neuronal acetylcholine receptor subunit alpha-7 OS=Bos taurus OX=9913 GN=CHRNA7 PE=1 SV=1 ACHA7_BOVIN reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Bos taurus (Bovine) GO:0001540; GO:0001666; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007271; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043410; GO:0045202; GO:0045211; GO:0045766; GO:0046872; GO:0050890; GO:1900016 calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; chloride channel regulator activity [GO:0017081]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] g11700.t2 P22770 43.992 491 8.989999999999999e-128 385.0 sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1 g11702.t1 Q9Z2E1 57.854 261 3.6100000000000003e-103 309.0 sp|Q9Z2E1|MBD2_MOUSE Methyl-CpG-binding domain protein 2 OS=Mus musculus OX=10090 GN=Mbd2 PE=1 SV=2 g11704.t1 Q9Z160 38.739 999 0.0 648.0 sp|Q9Z160|COG1_MOUSE Conserved oligomeric Golgi complex subunit 1 OS=Mus musculus OX=10090 GN=Cog1 PE=1 SV=3 g11708.t1 Q0V8T4 29.798 198 2.67e-23 104.0 sp|Q0V8T4|CTP5C_RAT Contactin-associated protein like 5-3 OS=Rattus norvegicus OX=10116 GN=Cntnap5c PE=2 SV=1 CTP5C_RAT reviewed Contactin-associated protein like 5-3 (Cell recognition molecule Caspr5-3) (Cell recognition molecule Caspr5c) (Contactin-associated protein-like 5c) Rattus norvegicus (Rat) GO:0001895; GO:0005509; GO:0005604; GO:0007155; GO:0016020; GO:0030054 cell adhesion [GO:0007155]; retina homeostasis [GO:0001895] basement membrane [GO:0005604]; cell junction [GO:0030054]; membrane [GO:0016020] calcium ion binding [GO:0005509] g11709.t1 Q9QXD6 65.766 333 1.39e-165 468.0 sp|Q9QXD6|F16P1_MOUSE Fructose-1,6-bisphosphatase 1 OS=Mus musculus OX=10090 GN=Fbp1 PE=1 SV=3 g11710.t1 O53532 36.723 354 4.18e-75 241.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g11711.t1 Q6P2X9 24.937 397 4.24e-26 113.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g11712.t1 Q8K021 54.908 326 6.450000000000001e-110 327.0 sp|Q8K021|SCAM1_MOUSE Secretory carrier-associated membrane protein 1 OS=Mus musculus OX=10090 GN=Scamp1 PE=1 SV=1 g11713.t1 Q13367 59.543 1095 0.0 1256.0 sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2 g11713.t2 Q13367 59.435 1097 0.0 1254.0 sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2 g11714.t1 Q21565 47.137 454 2.9e-142 432.0 sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2 g11715.t1 Q99L28 75.484 155 7.569999999999999e-82 241.0 sp|Q99L28|RLP24_MOUSE Probable ribosome biogenesis protein RLP24 OS=Mus musculus OX=10090 GN=Rsl24d1 PE=2 SV=1 g11716.t1 Q5M8Z0 72.222 396 0.0 606.0 sp|Q5M8Z0|BHMT1_XENTR Betaine--homocysteine S-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=bhmt PE=2 SV=1 g11717.t1 Q9NPC3 42.913 254 1.3599999999999999e-67 214.0 sp|Q9NPC3|CIP1_HUMAN E3 ubiquitin-protein ligase CCNB1IP1 OS=Homo sapiens OX=9606 GN=CCNB1IP1 PE=1 SV=1 CIP1_HUMAN reviewed E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1) Homo sapiens (Human) GO:0000795; GO:0001825; GO:0007131; GO:0007286; GO:0008270; GO:0016567; GO:0042802; GO:0051026; GO:0061630 blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286] synaptonemal complex [GO:0000795] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g11718.t1 Q9VTY4 45.872 109 1.9500000000000002e-29 109.0 sp|Q9VTY4|KXDL1_DROME KxDL motif-containing protein CG10681 OS=Drosophila melanogaster OX=7227 GN=CG10681 PE=1 SV=1 g11720.t1 Q1KYK5 40.0 360 2.45e-84 263.0 sp|Q1KYK5|WNT7A_PONPY Protein Wnt-7a OS=Pongo pygmaeus OX=9600 GN=WNT7A PE=3 SV=1 g11721.t1 Q7ZTY7 47.442 215 2.92e-61 194.0 sp|Q7ZTY7|USE1_DANRE Vesicle transport protein USE1 OS=Danio rerio OX=7955 GN=use1 PE=2 SV=1 USE1_DANRE reviewed Vesicle transport protein USE1 (USE1-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005484; GO:0005783; GO:0005789; GO:0006890; GO:0015031; GO:0031201 protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484] g11723.t1 Q16959 77.551 735 0.0 1116.0 sp|Q16959|DYI2_HELCR Dynein intermediate chain 2, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1 g11723.t2 Q16959 77.162 740 0.0 1123.0 sp|Q16959|DYI2_HELCR Dynein intermediate chain 2, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1 g11724.t1 Q6DC60 40.609 197 3.1199999999999998e-30 112.0 sp|Q6DC60|F219A_DANRE Protein FAM219A OS=Danio rerio OX=7955 GN=fam219a PE=2 SV=1 g11725.t1 Q6IQT4 86.456 443 0.0 793.0 sp|Q6IQT4|CSN2_DANRE COP9 signalosome complex subunit 2 OS=Danio rerio OX=7955 GN=cops2 PE=2 SV=1 g11726.t1 Q8AVY1 50.207 241 1.73e-75 233.0 sp|Q8AVY1|CMA1A_XENLA Ciliary microtubule associated protein 1A OS=Xenopus laevis OX=8355 GN=cimap1a PE=2 SV=1 g11727.t1 P61025 83.333 72 6.31e-40 129.0 sp|P61025|CKS1_MOUSE Cyclin-dependent kinases regulatory subunit 1 OS=Mus musculus OX=10090 GN=Cks1b PE=3 SV=1 g11728.t1 P62313 98.667 75 3.2e-50 155.0 sp|P62313|LSM6_MOUSE U6 snRNA-associated Sm-like protein LSm6 OS=Mus musculus OX=10090 GN=Lsm6 PE=1 SV=1 g11729.t1 Q61838 32.704 1535 0.0 697.0 sp|Q61838|PZP_MOUSE Pregnancy zone protein OS=Mus musculus OX=10090 GN=Pzp PE=1 SV=3 PZP_MOUSE reviewed Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit] Mus musculus (Mouse) GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007566; GO:0031012; GO:0044877; GO:0048403; GO:0048406 embryo implantation [GO:0007566] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867] g11729.t2 Q61838 32.704 1535 0.0 697.0 sp|Q61838|PZP_MOUSE Pregnancy zone protein OS=Mus musculus OX=10090 GN=Pzp PE=1 SV=3 PZP_MOUSE reviewed Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit] Mus musculus (Mouse) GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007566; GO:0031012; GO:0044877; GO:0048403; GO:0048406 embryo implantation [GO:0007566] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] brain-derived neurotrophic factor binding [GO:0048403]; endopeptidase inhibitor activity [GO:0004866]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase inhibitor activity [GO:0004867] g11730.t1 Q5R4N8 36.004 986 5.57e-170 571.0 sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1 g11730.t1 Q5R4N8 25.641 507 1.3699999999999999e-42 176.0 sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1 g11730.t2 Q5R4N8 36.004 986 6.74e-170 571.0 sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1 g11730.t2 Q5R4N8 25.641 507 1.1399999999999998e-42 176.0 sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1 g11731.t1 O94788 63.093 485 0.0 684.0 sp|O94788|AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens OX=9606 GN=ALDH1A2 PE=1 SV=3 g11732.t1 O94788 61.649 485 0.0 636.0 sp|O94788|AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens OX=9606 GN=ALDH1A2 PE=1 SV=3 g11735.t1 Q9ERS2 49.296 142 4.63e-45 147.0 sp|Q9ERS2|NDUAD_MOUSE NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Mus musculus OX=10090 GN=Ndufa13 PE=1 SV=3 NDUAD_MOUSE reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein) (GRIM-19) (Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit) Mus musculus (Mouse) GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0009060; GO:0031966; GO:0032981; GO:0035458; GO:0042776; GO:0045039; GO:0045202; GO:0045271; GO:0045732; GO:0045892; GO:0071300; GO:0097191; GO:0098803; GO:1900119 aerobic respiration [GO:0009060]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; respiratory chain complex [GO:0098803]; respiratory chain complex I [GO:0045271]; synapse [GO:0045202] ATP binding [GO:0005524] g11741.t1 Q0IHB3 31.765 340 8.38e-41 154.0 sp|Q0IHB3|PTR1A_XENLA Protein prenyltransferase alpha subunit repeat-containing protein 1-A OS=Xenopus laevis OX=8355 GN=ptar1-a PE=2 SV=1 g11742.t1 Q9WTY1 41.284 218 7.76e-37 148.0 sp|Q9WTY1|PDCD7_MOUSE Programmed cell death protein 7 OS=Mus musculus OX=10090 GN=Pdcd7 PE=1 SV=1 g11744.t1 Q3MHH0 42.484 459 3.1e-113 343.0 sp|Q3MHH0|DCA12_BOVIN DDB1- and CUL4-associated factor 12 OS=Bos taurus OX=9913 GN=DCAF12 PE=2 SV=2 DCA12_BOVIN reviewed DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A) Bos taurus (Bovine) GO:0005634; GO:0005813; GO:0005829; GO:0007283; GO:0010506; GO:0016567; GO:0035279; GO:0042110; GO:0080008; GO:0140627; GO:1990756 miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g11745.t1 Q75D00 33.594 384 2.63e-60 201.0 sp|Q75D00|ACT_EREGS Actin OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=ACT1 PE=2 SV=1 g11746.t1 Q63429 100.0 684 0.0 1350.0 sp|Q63429|UBC_RAT Polyubiquitin-C OS=Rattus norvegicus OX=10116 GN=Ubc PE=1 SV=1 g11746.t1 Q63429 100.0 684 0.0 1350.0 sp|Q63429|UBC_RAT Polyubiquitin-C OS=Rattus norvegicus OX=10116 GN=Ubc PE=1 SV=1 g11746.t1 Q63429 99.213 635 0.0 1240.0 sp|Q63429|UBC_RAT Polyubiquitin-C OS=Rattus norvegicus OX=10116 GN=Ubc PE=1 SV=1 g11747.t1 Q61555 44.706 2550 0.0 1985.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t1 Q61555 29.885 2513 0.0 756.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t1 Q61555 46.479 284 4.3799999999999995e-61 238.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t1 Q61555 34.634 410 6.17e-38 162.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t1 Q61555 29.493 434 1.04e-28 131.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t2 Q61555 44.706 2550 0.0 1985.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t2 Q61555 29.885 2513 0.0 757.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t2 Q61555 42.638 326 1.5e-59 233.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t2 Q61555 34.634 410 4.3499999999999997e-38 162.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11747.t2 Q61555 29.111 450 6.41e-29 132.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g11748.t1 Q9BZW5 50.712 351 5.199999999999999e-126 369.0 sp|Q9BZW5|TM6S1_HUMAN Transmembrane 6 superfamily member 1 OS=Homo sapiens OX=9606 GN=TM6SF1 PE=1 SV=2 g11751.t1 E9Q394 38.868 530 4.47e-100 348.0 sp|E9Q394|AKP13_MOUSE A-kinase anchor protein 13 OS=Mus musculus OX=10090 GN=Akap13 PE=1 SV=1 AKP13_MOUSE reviewed A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) Mus musculus (Mouse) GO:0005078; GO:0005085; GO:0005634; GO:0005829; GO:0005856; GO:0005938; GO:0007186; GO:0007507; GO:0008270; GO:0016020; GO:0031267; GO:0035023; GO:0035025; GO:0043123; GO:0048471; GO:0051018; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:2000322 adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000322]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g11751.t2 E9Q394 38.899 527 1.18e-99 347.0 sp|E9Q394|AKP13_MOUSE A-kinase anchor protein 13 OS=Mus musculus OX=10090 GN=Akap13 PE=1 SV=1 AKP13_MOUSE reviewed A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) Mus musculus (Mouse) GO:0005078; GO:0005085; GO:0005634; GO:0005829; GO:0005856; GO:0005938; GO:0007186; GO:0007507; GO:0008270; GO:0016020; GO:0031267; GO:0035023; GO:0035025; GO:0043123; GO:0048471; GO:0051018; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:2000322 adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000322]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g11751.t3 E9Q394 38.868 530 3.5200000000000003e-100 348.0 sp|E9Q394|AKP13_MOUSE A-kinase anchor protein 13 OS=Mus musculus OX=10090 GN=Akap13 PE=1 SV=1 AKP13_MOUSE reviewed A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) Mus musculus (Mouse) GO:0005078; GO:0005085; GO:0005634; GO:0005829; GO:0005856; GO:0005938; GO:0007186; GO:0007507; GO:0008270; GO:0016020; GO:0031267; GO:0035023; GO:0035025; GO:0043123; GO:0048471; GO:0051018; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:2000322 adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000322]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g11755.t1 Q8BWA5 32.061 524 7.4699999999999995e-84 277.0 sp|Q8BWA5|KLH31_MOUSE Kelch-like protein 31 OS=Mus musculus OX=10090 GN=Klhl31 PE=1 SV=1 g11759.t1 Q68FU8 38.312 462 1.2300000000000001e-79 268.0 sp|Q68FU8|SUGP1_RAT SURP and G-patch domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Sugp1 PE=1 SV=1 g11760.t1 Q6DFB8 35.504 783 7.33e-115 381.0 sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1 g11760.t2 Q6DFB8 37.713 586 1.86e-100 340.0 sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1 g11760.t3 Q6DFB8 37.713 586 2.14e-100 340.0 sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1 g11761.t1 Q6DFB8 42.045 352 1.95e-77 263.0 sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1 g11763.t1 Q6PGP7 34.646 381 8.48e-51 185.0 sp|Q6PGP7|SKI3_HUMAN Superkiller complex protein 3 OS=Homo sapiens OX=9606 GN=SKIC3 PE=1 SV=1 SKI3_HUMAN reviewed Superkiller complex protein 3 (Ski3) (Tetratricopeptide repeat protein 37) (TPR repeat protein 37) (Tricho-hepatic-enteric syndrome protein) (Thespin) Homo sapiens (Human) GO:0000791; GO:0000956; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0055087; GO:0070478; GO:0072344 nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344] cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087] g11764.t1 Q9DCA2 59.259 135 3.79e-39 137.0 sp|Q9DCA2|RT11_MOUSE Small ribosomal subunit protein uS11m OS=Mus musculus OX=10090 GN=Mrps11 PE=1 SV=2 g11765.t1 Q8JG64 53.404 470 3.14e-168 487.0 sp|Q8JG64|PDIA3_CHICK Protein disulfide-isomerase A3 OS=Gallus gallus OX=9031 GN=PDIA3 PE=2 SV=1 g11766.t1 Q5VYJ5 41.848 184 2.23e-33 134.0 sp|Q5VYJ5|MALR1_HUMAN MAM and LDL-receptor class A domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MALRD1 PE=1 SV=4 MALR1_HUMAN reviewed MAM and LDL-receptor class A domain-containing protein 1 Homo sapiens (Human) GO:0005794; GO:0030659; GO:0042632; GO:0070858 cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794] g11766.t1 Q5VYJ5 37.342 158 7.31e-22 100.0 sp|Q5VYJ5|MALR1_HUMAN MAM and LDL-receptor class A domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MALRD1 PE=1 SV=4 MALR1_HUMAN reviewed MAM and LDL-receptor class A domain-containing protein 1 Homo sapiens (Human) GO:0005794; GO:0030659; GO:0042632; GO:0070858 cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794] g11767.t1 Q63616 46.623 607 0.0 538.0 sp|Q63616|VP33B_RAT Vacuolar protein sorting-associated protein 33B OS=Rattus norvegicus OX=10116 GN=Vps33b PE=2 SV=1 VP33B_RAT reviewed Vacuolar protein sorting-associated protein 33B (r-vps33b) Rattus norvegicus (Rat) GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0006886; GO:0007032; GO:0008021; GO:0015031; GO:0016192; GO:0030136; GO:0030199; GO:0030897; GO:0031091; GO:0031901; GO:0031902; GO:0032400; GO:0032418; GO:0032963; GO:0033263; GO:0035855; GO:0043589; GO:0044877; GO:0048471; GO:0055037; GO:0061025; GO:0070889; GO:0090330; GO:0099023 collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; megakaryocyte development [GO:0035855]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; regulation of platelet aggregation [GO:0090330]; skin morphogenesis [GO:0043589]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; vesicle tethering complex [GO:0099023] protein-containing complex binding [GO:0044877] g11768.t1 Q008S8 35.067 596 1.2399999999999998e-115 368.0 sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2 g11769.t1 Q008S8 51.397 179 5.3800000000000006e-58 209.0 sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2 g11770.t1 P70605 68.831 385 0.0 571.0 sp|P70605|KCNN3_RAT Small conductance calcium-activated potassium channel protein 3 OS=Rattus norvegicus OX=10116 GN=Kcnn3 PE=1 SV=3 KCNN3_RAT reviewed Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3) Rattus norvegicus (Rat) GO:0005242; GO:0005516; GO:0005737; GO:0005886; GO:0006813; GO:0016286; GO:0030018; GO:0030175; GO:0031594; GO:0043005; GO:0043025; GO:0044297; GO:0044877; GO:0071805 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813] cell body [GO:0044297]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018] calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; small conductance calcium-activated potassium channel activity [GO:0016286] g11770.t2 P70605 68.831 385 0.0 571.0 sp|P70605|KCNN3_RAT Small conductance calcium-activated potassium channel protein 3 OS=Rattus norvegicus OX=10116 GN=Kcnn3 PE=1 SV=3 KCNN3_RAT reviewed Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3) Rattus norvegicus (Rat) GO:0005242; GO:0005516; GO:0005737; GO:0005886; GO:0006813; GO:0016286; GO:0030018; GO:0030175; GO:0031594; GO:0043005; GO:0043025; GO:0044297; GO:0044877; GO:0071805 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813] cell body [GO:0044297]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018] calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; small conductance calcium-activated potassium channel activity [GO:0016286] g11773.t1 A4IHW3 46.906 307 2.47e-84 260.0 sp|A4IHW3|S35A4_XENTR Probable UDP-sugar transporter protein SLC35A4 OS=Xenopus tropicalis OX=8364 GN=slc35a4 PE=2 SV=1 g11774.t1 Q8R2Y3 31.569 510 2.21e-59 208.0 sp|Q8R2Y3|DOLK_MOUSE Dolichol kinase OS=Mus musculus OX=10090 GN=Dolk PE=1 SV=1 g11775.t1 Q8C627 53.061 196 1.11e-76 247.0 sp|Q8C627|F221B_MOUSE Protein FAM221B OS=Mus musculus OX=10090 GN=Fam221b PE=2 SV=1 g11776.t1 Q15751 51.855 2507 0.0 2405.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 g11776.t1 Q15751 53.93 2303 0.0 2271.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 g11776.t1 Q15751 46.612 369 8.5e-91 338.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 g11776.t1 Q15751 40.998 461 1.35e-87 327.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 g11776.t1 Q15751 30.769 273 1.38e-29 135.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 g11776.t1 Q15751 49.18 122 1.91e-26 125.0 sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2 g11779.t1 Q71RS6 38.934 488 5.26e-117 358.0 sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1 NCKX5_HUMAN reviewed Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5) Homo sapiens (Human) GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022] melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g11780.t1 Q7Z7E8 54.455 404 3.2e-150 434.0 sp|Q7Z7E8|UB2Q1_HUMAN Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1 UB2Q1_HUMAN reviewed Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1) Homo sapiens (Human) GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459 embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967] cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g11780.t2 Q7Z7E8 54.591 403 5.82e-152 438.0 sp|Q7Z7E8|UB2Q1_HUMAN Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1 UB2Q1_HUMAN reviewed Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1) Homo sapiens (Human) GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459 embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967] cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g11781.t1 Q66H58 52.682 522 0.0 545.0 sp|Q66H58|INT14_RAT Integrator complex subunit 14 OS=Rattus norvegicus OX=10116 GN=Ints14 PE=2 SV=1 g11782.t1 O54701 49.117 623 0.0 553.0 sp|O54701|NCKX2_RAT Sodium/potassium/calcium exchanger 2 OS=Rattus norvegicus OX=10116 GN=Slc24a2 PE=1 SV=1 NCKX2_RAT reviewed Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2) Rattus norvegicus (Rat) GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007602; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016020; GO:0034220; GO:0035725; GO:0036368; GO:0051649; GO:0060291; GO:0060292; GO:0065003; GO:0070050; GO:0070509; GO:0070588; GO:0071486; GO:0071805; GO:0098703; GO:0098793; GO:0098794 calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; establishment of localization in cell [GO:0051649]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; neuron cellular homeostasis [GO:0070050]; phototransduction [GO:0007602]; potassium ion transmembrane transport [GO:0071805]; protein-containing complex assembly [GO:0065003]; sodium ion transmembrane transport [GO:0035725] membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g11783.t1 Q712U5 53.211 109 3.1300000000000002e-21 86.7 sp|Q712U5|ARP19_RAT cAMP-regulated phosphoprotein 19 OS=Rattus norvegicus OX=10116 GN=Arpp19 PE=1 SV=3 ARP19_RAT reviewed cAMP-regulated phosphoprotein 19 (ARPP-19) Rattus norvegicus (Rat) GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005737; GO:0005829; GO:0015459; GO:0019212; GO:0019888; GO:0030425; GO:0045202; GO:0045722; GO:0046579; GO:0051301; GO:0051721 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of Ras protein signal transduction [GO:0046579] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; synapse [GO:0045202] phosphatase inhibitor activity [GO:0019212]; potassium channel regulator activity [GO:0015459]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102] g11785.t1 O96007 66.949 118 2.13e-54 172.0 sp|O96007|MOC2B_HUMAN Molybdopterin synthase catalytic subunit OS=Homo sapiens OX=9606 GN=MOCS2 PE=1 SV=1 MOC2B_HUMAN reviewed Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B) (Molybdopterin-synthase large subunit) (MPT synthase large subunit) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0006777; GO:0016607; GO:0030366; GO:0032324; GO:1990140 Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] cytosol [GO:0005829]; molybdopterin synthase complex [GO:1990140]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] molybdopterin synthase activity [GO:0030366] g11787.t1 Q6AXS8 44.795 317 2.3e-87 266.0 sp|Q6AXS8|TPGS2_RAT Tubulin polyglutamylase complex subunit 2 OS=Rattus norvegicus OX=10116 GN=Tpgs2 PE=2 SV=2 g11789.t1 Q642M9 43.438 320 2.69e-87 268.0 sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2 g11790.t1 Q62463 27.182 401 1.1900000000000001e-32 130.0 sp|Q62463|V1AR_MOUSE Vasopressin V1a receptor OS=Mus musculus OX=10090 GN=Avpr1a PE=1 SV=1 V1AR_MOUSE reviewed Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor) Mus musculus (Mouse) GO:0001992; GO:0002125; GO:0003084; GO:0005000; GO:0005768; GO:0005886; GO:0007186; GO:0007204; GO:0007621; GO:0007625; GO:0008217; GO:0008284; GO:0010460; GO:0014049; GO:0014902; GO:0017046; GO:0019722; GO:0021537; GO:0030139; GO:0030307; GO:0031394; GO:0031894; GO:0032849; GO:0032870; GO:0035176; GO:0042631; GO:0042711; GO:0042713; GO:0045777; GO:0045907; GO:0051412; GO:0051970 calcium-mediated signaling [GO:0019722]; cellular response to hormone stimulus [GO:0032870]; cellular response to water deprivation [GO:0042631]; G protein-coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537] endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886] peptide hormone binding [GO:0017046]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000] g11792.t1 Q868T3 33.651 315 2.94e-42 157.0 sp|Q868T3|CCAPR_DROME Cardioacceleratory peptide receptor OS=Drosophila melanogaster OX=7227 GN=CCAP-R PE=2 SV=4 g11793.t1 Q08DE6 45.489 266 2.13e-73 231.0 sp|Q08DE6|AQP3_BOVIN Aquaporin-3 OS=Bos taurus OX=9913 GN=AQP3 PE=2 SV=1 AQP3_BOVIN reviewed Aquaporin-3 (AQP-3) (Aquaglyceroporin-3) Bos taurus (Bovine) GO:0002684; GO:0002931; GO:0005654; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0016323; GO:0032526; GO:0042476; GO:0042802; GO:0051649; GO:0070295; GO:0071456 cellular response to hypoxia [GO:0071456]; establishment of localization in cell [GO:0051649]; glycerol transmembrane transport [GO:0015793]; odontogenesis [GO:0042476]; polyol transmembrane transport [GO:0015791]; positive regulation of immune system process [GO:0002684]; renal water absorption [GO:0070295]; response to ischemia [GO:0002931]; response to retinoic acid [GO:0032526]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] glycerol channel activity [GO:0015254]; identical protein binding [GO:0042802]; polyol transmembrane transporter activity [GO:0015166]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] g11794.t1 Q64732 51.957 281 7.88e-80 248.0 sp|Q64732|FOXB1_MOUSE Forkhead box protein B1 OS=Mus musculus OX=10090 GN=Foxb1 PE=2 SV=2 FOXB1_MOUSE reviewed Forkhead box protein B1 (Transcription factor FKH-5) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001655; GO:0001756; GO:0005634; GO:0006357; GO:0007412; GO:0007595; GO:0008542; GO:0009653; GO:0021510; GO:0021767; GO:0021794; GO:0021855; GO:0022029; GO:0030154; GO:0030901; GO:0033504; GO:0043524; GO:0043565; GO:0061030; GO:0061374; GO:0061377; GO:0061379; GO:0061381; GO:1990837 anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g11795.t1 P36544 36.475 488 3.4e-111 341.0 sp|P36544|ACHA7_HUMAN Neuronal acetylcholine receptor subunit alpha-7 OS=Homo sapiens OX=9606 GN=CHRNA7 PE=1 SV=5 ACHA7_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Homo sapiens (Human) GO:0001540; GO:0001666; GO:0004888; GO:0005216; GO:0005262; GO:0005789; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007611; GO:0007613; GO:0007614; GO:0008284; GO:0015464; GO:0015643; GO:0016020; GO:0017081; GO:0022848; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043124; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045766; GO:0050808; GO:0050890; GO:0050893; GO:0051247; GO:0060079; GO:0060084; GO:0070374; GO:0095500; GO:0097061; GO:0098794; GO:0098815; GO:0140059; GO:1900016; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904645; GO:1905144; GO:1905906; GO:2000463 acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; excitatory postsynaptic potential [GO:0060079]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein metabolic process [GO:0051247]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of membrane potential [GO:0042391]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission involved in micturition [GO:0060084] acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; calcium channel activity [GO:0005262]; chloride channel regulator activity [GO:0017081]; monoatomic ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; transmembrane signaling receptor activity [GO:0004888] g11798.t1 Q9VQG2 45.565 248 4.43e-67 211.0 sp|Q9VQG2|APH1_DROME Gamma-secretase subunit Aph-1 OS=Drosophila melanogaster OX=7227 GN=aph-1 PE=1 SV=1 APH1_DROME reviewed Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor) Drosophila melanogaster (Fruit fly) GO:0005770; GO:0005783; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0030674; GO:0034205; GO:0035333; GO:0050821; GO:0055037; GO:0070765 amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; protein stabilization [GO:0050821] endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] protein-macromolecule adaptor activity [GO:0030674] g11810.t1 B2RR83 59.483 1160 0.0 1443.0 sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1 YTDC2_MOUSE reviewed 3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2) Mus musculus (Mouse) GO:0003723; GO:0004386; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247 germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; host-mediated activation of viral genome replication [GO:0044829]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; helicase activity [GO:0004386]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063] g11811.t1 Q2KIU2 47.594 187 2.02e-53 170.0 sp|Q2KIU2|PMVK_BOVIN Phosphomevalonate kinase OS=Bos taurus OX=9913 GN=PMVK PE=2 SV=3 g11814.t1 Q92184 41.083 314 1.0300000000000001e-79 255.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g11816.t1 O95478 82.692 260 2.6700000000000002e-163 455.0 sp|O95478|NSA2_HUMAN Ribosome biogenesis protein NSA2 homolog OS=Homo sapiens OX=9606 GN=NSA2 PE=1 SV=1 g11817.t1 Q68CJ9 39.946 373 2.1e-56 197.0 sp|Q68CJ9|CR3L3_HUMAN Cyclic AMP-responsive element-binding protein 3-like protein 3 OS=Homo sapiens OX=9606 GN=CREB3L3 PE=1 SV=2 CR3L3_HUMAN reviewed Cyclic AMP-responsive element-binding protein 3-like protein 3 (cAMP-responsive element-binding protein 3-like protein 3) (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3] Homo sapiens (Human) GO:0000139; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002675; GO:0005634; GO:0005654; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006986; GO:0016020; GO:0034976; GO:0042802; GO:0042803; GO:0045944; GO:0046982 positive regulation of acute inflammatory response [GO:0002675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976] g11819.t1 P18841 32.537 335 4.74e-32 130.0 sp|P18841|ADA1B_MESAU Alpha-1B adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRA1B PE=1 SV=1 g11821.t1 P18841 29.882 338 8.88e-28 117.0 sp|P18841|ADA1B_MESAU Alpha-1B adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRA1B PE=1 SV=1 g11825.t1 P18841 30.088 339 5.91e-28 118.0 sp|P18841|ADA1B_MESAU Alpha-1B adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRA1B PE=1 SV=1 g11826.t1 O15973 29.487 312 1.73e-23 105.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g11826.t2 P15823 29.552 335 4.92e-24 106.0 sp|P15823|ADA1B_RAT Alpha-1B adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1b PE=2 SV=2 ADA1B_RAT reviewed Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor) Rattus norvegicus (Rat) GO:0001974; GO:0001975; GO:0001987; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007267; GO:0007512; GO:0007626; GO:0008217; GO:0008542; GO:0009410; GO:0009725; GO:0014704; GO:0016020; GO:0019229; GO:0030315; GO:0031965; GO:0035024; GO:0035265; GO:0042593; GO:0043278; GO:0043410; GO:0043627; GO:0045818; GO:0045819; GO:0046982; GO:0048148; GO:0048545; GO:0055117; GO:0061049; GO:0071880; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; locomotory behavior [GO:0007626]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]; response to amphetamine [GO:0001975]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542] caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982] g11830.t1 A6NNX1 51.25 80 1.99e-22 86.7 sp|A6NNX1|RIAD1_HUMAN RIIa domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RIIAD1 PE=1 SV=1 g11831.t1 A8WGB1 37.063 286 3.46e-32 130.0 sp|A8WGB1|CCBE1_DANRE Collagen and calcium-binding EGF domain-containing protein 1 OS=Danio rerio OX=7955 GN=ccbe1 PE=1 SV=2 CCBE1_DANRE reviewed Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001945; GO:0001946; GO:0002040; GO:0005509; GO:0005576; GO:0005581; GO:0038084; GO:0048514; GO:0048845; GO:0060855 blood vessel morphogenesis [GO:0048514]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor signaling pathway [GO:0038084]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell migration involved in lymph vessel development [GO:0060855] collagen trimer [GO:0005581]; extracellular region [GO:0005576] calcium ion binding [GO:0005509] g11832.t1 Q6NZ07 53.659 574 0.0 602.0 sp|Q6NZ07|NCLN_DANRE BOS complex subunit ncln OS=Danio rerio OX=7955 GN=ncln PE=2 SV=1 NCLN_DANRE reviewed BOS complex subunit ncln (Nicalin-1) (Nicastrin-like protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003140; GO:0005789; GO:0009966; GO:0043022; GO:0048484; GO:0160063; GO:0160064; GO:1900108 determination of left/right asymmetry in lateral mesoderm [GO:0003140]; enteric nervous system development [GO:0048484]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; negative regulation of nodal signaling pathway [GO:1900108]; regulation of signal transduction [GO:0009966] endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064] ribosome binding [GO:0043022] g11838.t1 Q1LZA0 45.219 502 2.4500000000000002e-145 433.0 sp|Q1LZA0|PIGB_BOVIN GPI alpha-1,2-mannosyltransferase 3 OS=Bos taurus OX=9913 GN=PIGB PE=2 SV=1 PIGB_BOVIN reviewed GPI alpha-1,2-mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B) Bos taurus (Bovine) GO:0000026; GO:0005789; GO:0006506 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789] alpha-1,2-mannosyltransferase activity [GO:0000026] g11838.t2 Q1LZA0 47.222 504 8.65e-155 458.0 sp|Q1LZA0|PIGB_BOVIN GPI alpha-1,2-mannosyltransferase 3 OS=Bos taurus OX=9913 GN=PIGB PE=2 SV=1 PIGB_BOVIN reviewed GPI alpha-1,2-mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B) Bos taurus (Bovine) GO:0000026; GO:0005789; GO:0006506 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789] alpha-1,2-mannosyltransferase activity [GO:0000026] g11840.t1 Q06248 75.587 639 0.0 1011.0 sp|Q06248|HSP74_PARLI Heat shock 70 kDa protein IV OS=Paracentrotus lividus OX=7656 GN=HSP70IV PE=3 SV=1 g11841.t1 Q96S82 36.104 385 1.22e-44 161.0 sp|Q96S82|UBL7_HUMAN Ubiquitin-like protein 7 OS=Homo sapiens OX=9606 GN=UBL7 PE=1 SV=2 UBL7_HUMAN reviewed Ubiquitin-like protein 7 (Bone marrow stromal cell ubiquitin-like protein) (BMSC-UbP) (Ubiquitin-like protein SB132) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006511; GO:0030674; GO:0031593; GO:0140374 antiviral innate immune response [GO:0140374]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] polyubiquitin modification-dependent protein binding [GO:0031593]; protein-macromolecule adaptor activity [GO:0030674] g11843.t1 Q9EPQ7 35.545 211 6.3599999999999996e-46 156.0 sp|Q9EPQ7|STAR5_MOUSE StAR-related lipid transfer protein 5 OS=Mus musculus OX=10090 GN=Stard5 PE=1 SV=2 g11843.t2 Q9EPQ7 36.946 203 1.2399999999999999e-48 163.0 sp|Q9EPQ7|STAR5_MOUSE StAR-related lipid transfer protein 5 OS=Mus musculus OX=10090 GN=Stard5 PE=1 SV=2 g11845.t1 Q13535 42.004 2764 0.0 2049.0 sp|Q13535|ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens OX=9606 GN=ATR PE=1 SV=3 g11846.t1 Q5U581 32.436 817 3.56e-130 409.0 sp|Q5U581|MTRAA_XENLA Myotubularin-related protein 10-A OS=Xenopus laevis OX=8355 GN=mtmr10-a PE=2 SV=1 g11847.t1 P23438 58.201 189 3.21e-76 229.0 sp|P23438|SSRB_CANLF Translocon-associated protein subunit beta OS=Canis lupus familiaris OX=9615 GN=SSR2 PE=1 SV=1 g11848.t1 A2A3L6 27.681 401 1.55e-23 109.0 sp|A2A3L6|TTC24_HUMAN Tetratricopeptide repeat protein 24 OS=Homo sapiens OX=9606 GN=TTC24 PE=1 SV=1 g11848.t2 A2A3L6 27.681 401 1.19e-23 109.0 sp|A2A3L6|TTC24_HUMAN Tetratricopeptide repeat protein 24 OS=Homo sapiens OX=9606 GN=TTC24 PE=1 SV=1 g11849.t1 A1L271 72.754 334 0.0 524.0 sp|A1L271|GNB5A_DANRE Guanine nucleotide-binding protein subunit beta-5a OS=Danio rerio OX=7955 GN=gnb5a PE=2 SV=1 GNB5A_DANRE reviewed Guanine nucleotide-binding protein subunit beta-5a Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005834; GO:0007212; GO:0007634; GO:0030159; GO:0036269; GO:0060047 G protein-coupled dopamine receptor signaling pathway [GO:0007212]; heart contraction [GO:0060047]; optokinetic behavior [GO:0007634]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834] signaling receptor complex adaptor activity [GO:0030159] g11849.t2 A1L271 67.5 360 0.0 511.0 sp|A1L271|GNB5A_DANRE Guanine nucleotide-binding protein subunit beta-5a OS=Danio rerio OX=7955 GN=gnb5a PE=2 SV=1 GNB5A_DANRE reviewed Guanine nucleotide-binding protein subunit beta-5a Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005834; GO:0007212; GO:0007634; GO:0030159; GO:0036269; GO:0060047 G protein-coupled dopamine receptor signaling pathway [GO:0007212]; heart contraction [GO:0060047]; optokinetic behavior [GO:0007634]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834] signaling receptor complex adaptor activity [GO:0030159] g11856.t1 Q9Y3Q4 54.44 518 0.0 604.0 sp|Q9Y3Q4|HCN4_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Homo sapiens OX=9606 GN=HCN4 PE=1 SV=1 HCN4_HUMAN reviewed Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Homo sapiens (Human) GO:0002027; GO:0003163; GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0006812; GO:0006936; GO:0008015; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0048471; GO:0055117; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086015; GO:0086041; GO:0086046; GO:0086091; GO:0098719; GO:0098855; GO:0098907; GO:0098909; GO:1990573 blood circulation [GO:0008015]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; monoatomic cation transport [GO:0006812]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; sinoatrial node development [GO:0003163]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248] g11857.t1 Q99932 34.426 183 1.9000000000000003e-21 93.2 sp|Q99932|SPAG8_HUMAN Sperm-associated antigen 8 OS=Homo sapiens OX=9606 GN=SPAG8 PE=1 SV=3 SPAG8_HUMAN reviewed Sperm-associated antigen 8 (HSD-1) (Sperm membrane protein 1) (SMP-1) (Sperm membrane protein BS-84) Homo sapiens (Human) GO:0001669; GO:0001673; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0005879; GO:0005929; GO:0007283; GO:0007338; GO:0008017; GO:0016020; GO:0030154; GO:0030317; GO:0036126; GO:0045944; GO:0097228; GO:0097229; GO:0160111 cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm end piece [GO:0097229]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; spindle [GO:0005819] microtubule binding [GO:0008017] g11858.t1 Q4R8R3 46.231 199 3.65e-57 192.0 sp|Q4R8R3|CC112_MACFA Coiled-coil domain-containing protein 112 OS=Macaca fascicularis OX=9541 GN=CCDC112 PE=2 SV=1 g11858.t2 A0AUP1 46.078 204 3.18e-57 192.0 sp|A0AUP1|CC112_MOUSE Coiled-coil domain-containing protein 112 OS=Mus musculus OX=10090 GN=Ccdc112 PE=2 SV=2 g11859.t1 Q8NEF3 37.5 232 4.0800000000000003e-35 132.0 sp|Q8NEF3|CC112_HUMAN Coiled-coil domain-containing protein 112 OS=Homo sapiens OX=9606 GN=CCDC112 PE=1 SV=2 g11859.t2 Q8NEF3 35.537 242 1.82e-33 128.0 sp|Q8NEF3|CC112_HUMAN Coiled-coil domain-containing protein 112 OS=Homo sapiens OX=9606 GN=CCDC112 PE=1 SV=2 g11860.t1 P15206 80.72 389 0.0 665.0 sp|P15206|CCNB_MARGL G2/mitotic-specific cyclin-B OS=Marthasterias glacialis OX=7609 PE=2 SV=1 g11861.t1 Q2KI79 41.558 231 1.5899999999999999e-46 162.0 sp|Q2KI79|ANRA2_BOVIN Ankyrin repeat family A protein 2 OS=Bos taurus OX=9913 GN=ANKRA2 PE=2 SV=1 g11862.t1 P41239 49.871 389 2.8299999999999996e-126 373.0 sp|P41239|CSK_CHICK Tyrosine-protein kinase CSK OS=Gallus gallus OX=9031 GN=CSK PE=2 SV=1 g11863.t1 Q96M60 31.315 479 3.48e-58 206.0 sp|Q96M60|F227B_HUMAN Protein FAM227B OS=Homo sapiens OX=9606 GN=FAM227B PE=1 SV=2 g11863.t2 Q96M60 31.315 479 2.3600000000000003e-58 206.0 sp|Q96M60|F227B_HUMAN Protein FAM227B OS=Homo sapiens OX=9606 GN=FAM227B PE=1 SV=2 g11863.t3 Q96M60 31.933 476 1.1800000000000001e-58 207.0 sp|Q96M60|F227B_HUMAN Protein FAM227B OS=Homo sapiens OX=9606 GN=FAM227B PE=1 SV=2 g11864.t1 Q5XIG6 59.925 267 2.59e-116 344.0 sp|Q5XIG6|GALK2_RAT N-acetylgalactosamine kinase OS=Rattus norvegicus OX=10116 GN=Galk2 PE=2 SV=1 g11864.t2 Q68FH4 56.071 280 2.59e-112 335.0 sp|Q68FH4|GALK2_MOUSE N-acetylgalactosamine kinase OS=Mus musculus OX=10090 GN=Galk2 PE=1 SV=1 g11865.t1 Q5XIG6 51.899 79 2.19e-24 98.2 sp|Q5XIG6|GALK2_RAT N-acetylgalactosamine kinase OS=Rattus norvegicus OX=10116 GN=Galk2 PE=2 SV=1 g11866.t1 P82924 29.63 432 2.2699999999999997e-54 189.0 sp|P82924|RT30_BOVIN Large ribosomal subunit protein mL65 OS=Bos taurus OX=9913 GN=MRPS30 PE=1 SV=4 g11867.t1 A1ZAX0 29.474 380 6.88e-43 159.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 CCH1R_DROME reviewed Neuropeptide CCHamide-1 receptor Drosophila melanogaster (Fruit fly) GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016020 G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] membrane [GO:0016020]; plasma membrane [GO:0005886] allatostatin receptor activity [GO:0008261]; neuropeptide receptor activity [GO:0008188] g11869.t1 Q9NVE4 45.029 171 4.5400000000000005e-32 134.0 sp|Q9NVE4|CCD87_HUMAN Coiled-coil domain-containing protein 87 OS=Homo sapiens OX=9606 GN=CCDC87 PE=1 SV=2 g11871.t1 Q9BU70 41.951 410 1.91e-94 294.0 sp|Q9BU70|TRMO_HUMAN tRNA (adenine(37)-N6)-methyltransferase OS=Homo sapiens OX=9606 GN=TRMO PE=1 SV=2 g11871.t2 Q9BU70 41.951 410 6.25e-95 295.0 sp|Q9BU70|TRMO_HUMAN tRNA (adenine(37)-N6)-methyltransferase OS=Homo sapiens OX=9606 GN=TRMO PE=1 SV=2 g11872.t1 P98156 33.579 271 1.3e-29 128.0 sp|P98156|VLDLR_MOUSE Very low-density lipoprotein receptor OS=Mus musculus OX=10090 GN=Vldlr PE=1 SV=1 VLDLR_MOUSE reviewed Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) Mus musculus (Mouse) GO:0005509; GO:0005615; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0009986; GO:0016020; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045177; GO:0045202; GO:0048306; GO:0048471; GO:0048813; GO:0051963; GO:0071456; GO:0098978; GO:1900006 cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; regulation of synapse assembly [GO:0051963]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] g11873.t1 O08762 40.23 174 6.52e-25 111.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g11874.t1 Q71RS6 39.248 479 7.69e-108 335.0 sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1 NCKX5_HUMAN reviewed Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5) Homo sapiens (Human) GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022] melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g11875.t1 Q8N6T7 70.312 192 5.98e-96 293.0 sp|Q8N6T7|SIR6_HUMAN NAD-dependent protein deacylase sirtuin-6 OS=Homo sapiens OX=9606 GN=SIRT6 PE=1 SV=2 SIR6_HUMAN reviewed NAD-dependent protein deacylase sirtuin-6 (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-6) (EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6) (EC 2.4.2.-) (Regulatory protein SIR2 homolog 6) (hSIRT6) (SIR2-like protein 6) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003677; GO:0003682; GO:0003684; GO:0003714; GO:0003950; GO:0005634; GO:0005654; GO:0005721; GO:0005783; GO:0006284; GO:0006302; GO:0006338; GO:0006476; GO:0006606; GO:0008270; GO:0008285; GO:0008340; GO:0009411; GO:0010526; GO:0010569; GO:0016779; GO:0017136; GO:0019216; GO:0031490; GO:0031491; GO:0031508; GO:0031509; GO:0031648; GO:0032024; GO:0032129; GO:0032206; GO:0032436; GO:0032922; GO:0034244; GO:0034979; GO:0035861; GO:0042181; GO:0042308; GO:0042593; GO:0042752; GO:0042803; GO:0045600; GO:0045721; GO:0045814; GO:0045820; GO:0046325; GO:0046827; GO:0046969; GO:0048146; GO:0050708; GO:0050994; GO:0051697; GO:0055007; GO:0070403; GO:0090734; GO:0097372; GO:0099115; GO:0106222; GO:0106274; GO:0120162; GO:0120186; GO:0120187; GO:0140612; GO:0140765; GO:0140773; GO:0140774; GO:0140804; GO:0140861; GO:1902459; GO:1902732; GO:1903076; GO:1904841; GO:1905555; GO:1905564; GO:1990166; GO:1990404; GO:2000648; GO:2000738; GO:2000773; GO:2000781 base-excision repair [GO:0006284]; cardiac muscle cell differentiation [GO:0055007]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; glucose homeostasis [GO:0042593]; ketone biosynthetic process [GO:0042181]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of D-glucose import [GO:0046325]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; pericentric heterochromatin formation [GO:0031508]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin secretion [GO:0032024]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein deacetylation [GO:0006476]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; protein import into nucleus [GO:0006606]; protein localization to site of double-strand break [GO:1990166]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein secretion [GO:0050708]; response to UV [GO:0009411]; subtelomeric heterochromatin formation [GO:0031509]; transposable element silencing [GO:0010526] chromatin [GO:0000785]; chromosome, subtelomeric region [GO:0099115]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA damage sensor activity [GO:0140612]; histone deacetylase activity, NAD-dependent [GO:0017136]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; histone H3K56 deacetylase activity, NAD-dependent [GO:0140765]; histone H3K9 deacetylase activity, hydrolytic mechanism [GO:0032129]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; lncRNA binding [GO:0106222]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; TORC2 complex binding [GO:1904841]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g11876.t1 Q96MD7 57.658 111 1.41e-39 136.0 sp|Q96MD7|CI085_HUMAN Uncharacterized protein C9orf85 OS=Homo sapiens OX=9606 GN=C9orf85 PE=1 SV=1 g11877.t1 O35857 55.738 427 3.0600000000000004e-173 496.0 sp|O35857|TIM44_MOUSE Mitochondrial import inner membrane translocase subunit TIM44 OS=Mus musculus OX=10090 GN=Timm44 PE=1 SV=2 g11878.t1 Q9DBN9 49.464 560 0.0 561.0 sp|Q9DBN9|DDX59_MOUSE Probable ATP-dependent RNA helicase DDX59 OS=Mus musculus OX=10090 GN=Ddx59 PE=1 SV=1 DDX59_MOUSE reviewed Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5) Mus musculus (Mouse) GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0008270; GO:0016887 cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270] g11879.t1 P35381 82.292 192 7.4e-108 322.0 sp|P35381|ATPA_DROME ATP synthase subunit alpha, mitochondrial OS=Drosophila melanogaster OX=7227 GN=blw PE=1 SV=2 g11880.t1 Q5R546 82.09 335 0.0 548.0 sp|Q5R546|ATPA_PONAB ATP synthase F(1) complex subunit alpha, mitochondrial OS=Pongo abelii OX=9601 GN=ATP5F1A PE=2 SV=1 ATPA_PONAB reviewed ATP synthase F(1) complex subunit alpha, mitochondrial (ATP synthase F1 subunit alpha) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001937; GO:0005524; GO:0005743; GO:0005886; GO:0006629; GO:0015986; GO:0042288; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045259; GO:0046872; GO:0046933 lipid metabolic process [GO:0006629]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259] ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933] g11881.t1 Q8N8R7 44.853 136 3.0800000000000003e-31 115.0 sp|Q8N8R7|AL14E_HUMAN ARL14 effector protein OS=Homo sapiens OX=9606 GN=ARL14EP PE=1 SV=1 AL14E_HUMAN reviewed ARL14 effector protein (ARF7 effector protein) Homo sapiens (Human) GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0005925 cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g11882.t1 Q9LNB6 34.066 182 4.1800000000000003e-22 98.2 sp|Q9LNB6|HSOP1_ARATH Hsp70-Hsp90 organizing protein 1 OS=Arabidopsis thaliana OX=3702 GN=HOP1 PE=2 SV=1 g11883.t1 Q9JMB0 40.079 252 3.74e-50 175.0 sp|Q9JMB0|GKAP1_MOUSE G kinase-anchoring protein 1 OS=Mus musculus OX=10090 GN=Gkap1 PE=1 SV=1 GKAP1_MOUSE reviewed G kinase-anchoring protein 1 (cGMP-dependent protein kinase-anchoring protein of 42 kDa) Mus musculus (Mouse) GO:0005794; GO:0007165; GO:0007199; GO:0019934; GO:0042802; GO:0046628 cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; positive regulation of insulin receptor signaling pathway [GO:0046628]; signal transduction [GO:0007165] Golgi apparatus [GO:0005794] identical protein binding [GO:0042802] g11884.t1 Q1HG43 32.378 349 4.05e-41 153.0 sp|Q1HG43|DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens OX=9606 GN=DUOXA1 PE=1 SV=1 DOXA1_HUMAN reviewed Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0019899; GO:0031252; GO:0042743; GO:0045666; GO:0050727; GO:2000609 hydrogen peroxide metabolic process [GO:0042743]; intracellular protein localization [GO:0008104]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] enzyme binding [GO:0019899] g11885.t1 Q9ES45 76.471 85 1.79e-42 149.0 sp|Q9ES45|DUOX2_RAT Dual oxidase 2 OS=Rattus norvegicus OX=10116 GN=Duox2 PE=2 SV=1 g11886.t1 Q8HZK2 59.459 333 1.6799999999999998e-128 404.0 sp|Q8HZK2|DUOX2_PIG Dual oxidase 2 OS=Sus scrofa OX=9823 GN=DUOX2 PE=1 SV=2 DUOX2_PIG reviewed Dual oxidase 2 (EC 1.-.-.-) (EC 1.11.1.-) (EC 1.6.3.1) (NADH/NADPH thyroid oxidase p138-tox) Sus scrofa (Pig) GO:0004601; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0045177; GO:0051591; GO:0070161 cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590] anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] g11887.t1 Q9VQH2 38.638 1087 0.0 720.0 sp|Q9VQH2|DUOX_DROME Dual oxidase OS=Drosophila melanogaster OX=7227 GN=Duox PE=1 SV=2 DUOX_DROME reviewed Dual oxidase (EC 1.11.1.-) (EC 1.6.3.1) Drosophila melanogaster (Fruit fly) GO:0002385; GO:0004601; GO:0005509; GO:0005886; GO:0006952; GO:0006979; GO:0007476; GO:0008365; GO:0009611; GO:0012505; GO:0016174; GO:0016175; GO:0019221; GO:0020037; GO:0035220; GO:0042335; GO:0042554; GO:0042742; GO:0042744; GO:0043020; GO:0043066; GO:0048085; GO:0051591; GO:0072593; GO:0106292 adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to wounding [GO:0009611]; superoxide anion generation [GO:0042554]; wing disc development [GO:0035220] endomembrane system [GO:0012505]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activity [GO:0106292] g11888.t1 Q1HG43 36.424 302 3.38e-46 165.0 sp|Q1HG43|DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens OX=9606 GN=DUOXA1 PE=1 SV=1 DOXA1_HUMAN reviewed Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0019899; GO:0031252; GO:0042743; GO:0045666; GO:0050727; GO:2000609 hydrogen peroxide metabolic process [GO:0042743]; intracellular protein localization [GO:0008104]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] enzyme binding [GO:0019899] g11888.t2 Q1HG43 36.424 302 3.69e-46 164.0 sp|Q1HG43|DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens OX=9606 GN=DUOXA1 PE=1 SV=1 DOXA1_HUMAN reviewed Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0019899; GO:0031252; GO:0042743; GO:0045666; GO:0050727; GO:2000609 hydrogen peroxide metabolic process [GO:0042743]; intracellular protein localization [GO:0008104]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] enzyme binding [GO:0019899] g11889.t1 Q6VVX2 50.162 618 0.0 571.0 sp|Q6VVX2|CERT_CRIGR Ceramide transfer protein OS=Cricetulus griseus OX=10029 GN=CERT1 PE=1 SV=1 CERT_CRIGR reviewed Ceramide transfer protein (CERT) (Collagen type IV alpha-3-binding protein) Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0005783; GO:0005794; GO:0005829; GO:0035621; GO:0070273; GO:0120017 ER to Golgi ceramide transport [GO:0035621] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794] ceramide transfer activity [GO:0120017]; phosphatidylinositol-4-phosphate binding [GO:0070273] g11890.t1 Q9QUG2 56.034 580 0.0 615.0 sp|Q9QUG2|POLK_MOUSE DNA polymerase kappa OS=Mus musculus OX=10090 GN=Polk PE=1 SV=1 POLK_MOUSE reviewed DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) Mus musculus (Mouse) GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0008270; GO:0016604; GO:0034644; GO:0042276; GO:0060090; GO:0090734 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270] g11891.t1 Q9BVS4 51.087 552 0.0 544.0 sp|Q9BVS4|RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens OX=9606 GN=RIOK2 PE=1 SV=2 RIOK2_HUMAN reviewed Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234 maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11892.t1 Q8N9B5 31.707 492 5.96e-71 254.0 sp|Q8N9B5|JMY_HUMAN Junction-mediating and -regulatory protein OS=Homo sapiens OX=9606 GN=JMY PE=1 SV=2 JMY_HUMAN reviewed Junction-mediating and -regulatory protein Homo sapiens (Human) GO:0000421; GO:0003713; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006281; GO:0006357; GO:0008017; GO:0009267; GO:0012505; GO:0031252; GO:0031410; GO:0034314; GO:0043065; GO:0070060; GO:0070358; GO:0071933; GO:0072332 'de novo' actin filament nucleation [GO:0070060]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; regulation of transcription by RNA polymerase II [GO:0006357] autophagosome membrane [GO:0000421]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; microtubule binding [GO:0008017]; transcription coactivator activity [GO:0003713] g11893.t1 P46940 54.371 1670 0.0 1790.0 sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1 IQGA1_HUMAN reviewed Ras GTPase-activating-like protein IQGAP1 (p195) Homo sapiens (Human) GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990904 caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165] actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267] g11894.t1 Q157S1 43.417 357 3.06e-62 222.0 sp|Q157S1|CRTC1_RAT CREB-regulated transcription coactivator 1 OS=Rattus norvegicus OX=10116 GN=Crtc1 PE=1 SV=1 g11894.t2 Q157S1 43.417 357 3.71e-62 222.0 sp|Q157S1|CRTC1_RAT CREB-regulated transcription coactivator 1 OS=Rattus norvegicus OX=10116 GN=Crtc1 PE=1 SV=1 g11895.t1 Q7Z6M2 24.699 498 3.7300000000000003e-26 115.0 sp|Q7Z6M2|FBX33_HUMAN F-box only protein 33 OS=Homo sapiens OX=9606 GN=FBXO33 PE=1 SV=1 FBX33_HUMAN reviewed F-box only protein 33 Homo sapiens (Human) GO:0016567; GO:0031398 positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567] g11911.t1 P10079 40.704 710 3.75e-146 474.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11911.t1 P10079 39.015 751 4.19e-137 449.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11911.t1 P10079 39.189 740 1.03e-136 448.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11911.t1 P10079 47.699 239 1.0799999999999999e-54 212.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g11913.t1 Q9D0C1 32.8 250 3.51e-28 112.0 sp|Q9D0C1|RN115_MOUSE E3 ubiquitin-protein ligase RNF115 OS=Mus musculus OX=10090 GN=Rnf115 PE=1 SV=1 RN115_MOUSE reviewed E3 ubiquitin-protein ligase RNF115 (EC 2.3.2.27) (RING finger protein 115) (RING-type E3 ubiquitin transferase RNF115) (Rab7-interacting RING finger protein) (Rabring 7) (Zinc finger protein 364) Mus musculus (Mouse) GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006893; GO:0008270; GO:0016567; GO:0034122; GO:0034123; GO:0034142; GO:0042059; GO:0043162; GO:0045335; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0070979 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; toll-like receptor 4 signaling pathway [GO:0034142]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g11914.t1 Q8BGR6 45.503 189 4.1400000000000005e-56 179.0 sp|Q8BGR6|ARL15_MOUSE ADP-ribosylation factor-like protein 15 OS=Mus musculus OX=10090 GN=Arl15 PE=1 SV=1 g11915.t1 P0CB96 65.753 146 1.37e-66 203.0 sp|P0CB96|NDUS4_PONPY NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial OS=Pongo pygmaeus OX=9600 GN=NDUFS4 PE=2 SV=1 g11917.t1 Q92546 50.39 385 7.38e-122 361.0 sp|Q92546|RGP1_HUMAN RAB6A-GEF complex partner protein 2 OS=Homo sapiens OX=9606 GN=RGP1 PE=1 SV=1 RGP1_HUMAN reviewed RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog) Homo sapiens (Human) GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547 negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g11918.t1 Q9HCG7 50.364 824 0.0 802.0 sp|Q9HCG7|GBA2_HUMAN Non-lysosomal glucosylceramidase OS=Homo sapiens OX=9606 GN=GBA2 PE=1 SV=2 GBA2_HUMAN reviewed Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase) Homo sapiens (Human) GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0009247; GO:0016020; GO:0016139; GO:0021954; GO:0030833; GO:0031113; GO:0046479; GO:0046527; GO:0050295; GO:0097035 bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycolipid biosynthetic process [GO:0009247]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295] g11919.t1 O35239 52.778 180 1.44e-59 199.0 sp|O35239|PTN9_MOUSE Tyrosine-protein phosphatase non-receptor type 9 OS=Mus musculus OX=10090 GN=Ptpn9 PE=1 SV=2 g11920.t1 Q641Z2 53.465 303 2.1699999999999998e-104 335.0 sp|Q641Z2|PTN9_RAT Tyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1 g11920.t1 Q641Z2 47.881 236 2.1799999999999997e-68 239.0 sp|Q641Z2|PTN9_RAT Tyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1 g11920.t2 Q641Z2 53.465 303 7.039999999999999e-104 335.0 sp|Q641Z2|PTN9_RAT Tyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1 g11920.t2 Q641Z2 47.345 226 6.16e-65 231.0 sp|Q641Z2|PTN9_RAT Tyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1 g11921.t1 Q56A24 38.908 568 9.75e-119 366.0 sp|Q56A24|KLH24_RAT Kelch-like protein 24 OS=Rattus norvegicus OX=10116 GN=Klhl24 PE=1 SV=1 KLH24_RAT reviewed Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1) Rattus norvegicus (Rat) GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:0045109; GO:0051865; GO:1990756 intermediate filament organization [GO:0045109]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g11922.t1 P07902 66.087 345 1.55e-178 503.0 sp|P07902|GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens OX=9606 GN=GALT PE=1 SV=3 GALT_HUMAN reviewed Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0008108; GO:0008270; GO:0033499 galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-alpha-D-glucose metabolic process [GO:0006011] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270] g11923.t1 P49427 73.913 161 9.080000000000001e-79 236.0 sp|P49427|UB2R1_HUMAN Ubiquitin-conjugating enzyme E2 R1 OS=Homo sapiens OX=9606 GN=CDC34 PE=1 SV=2 UB2R1_HUMAN reviewed Ubiquitin-conjugating enzyme E2 R1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme R1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (Ubiquitin-conjugating enzyme E2-CDC34) (Ubiquitin-protein ligase R1) Homo sapiens (Human) GO:0000082; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006270; GO:0006511; GO:0016567; GO:0016607; GO:0035458; GO:0036211; GO:0043161; GO:0061631; GO:0070936 cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] g11924.t1 Q9W0Y8 52.324 753 0.0 795.0 sp|Q9W0Y8|SCN60_DROME Sodium channel protein 60E OS=Drosophila melanogaster OX=7227 GN=NaCP60E PE=2 SV=6 SCN60_DROME reviewed Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2) Drosophila melanogaster (Fruit fly) GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0035725; GO:0042048; GO:0086010 membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518] voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248] g11925.t1 P15390 54.245 212 2.31e-64 220.0 sp|P15390|SCN4A_RAT Sodium channel protein type 4 subunit alpha OS=Rattus norvegicus OX=10116 GN=Scn4a PE=1 SV=1 SCN4A_RAT reviewed Sodium channel protein type 4 subunit alpha (Mu-1) (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4) Rattus norvegicus (Rat) GO:0001518; GO:0005248; GO:0005886; GO:0006812; GO:0006813; GO:0006814; GO:0015871; GO:0019228; GO:0019233; GO:0030424; GO:0035725; GO:0086010; GO:0100001 choline transport [GO:0015871]; membrane depolarization during action potential [GO:0086010]; monoatomic cation transport [GO:0006812]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518] voltage-gated sodium channel activity [GO:0005248] g11926.t1 P35500 45.814 430 3.51e-108 357.0 sp|P35500|SCNA_DROME Sodium channel protein para OS=Drosophila melanogaster OX=7227 GN=para PE=2 SV=3 g11927.t1 Q8NAG6 45.29 276 4.5699999999999996e-69 228.0 sp|Q8NAG6|ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKLE1 PE=1 SV=2 ANKL1_HUMAN reviewed Structure-specific endonuclease ANKLE1 (Ankyrin repeat and LEM domain-containing protein 1) (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3) Homo sapiens (Human) GO:0000287; GO:0000712; GO:0000724; GO:0004519; GO:0004520; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0006974; GO:0016787; GO:0030145; GO:0030496; GO:0045950; GO:0050897; GO:0090304; GO:1905453; GO:1905456 DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of mitotic recombination [GO:0045950]; nucleic acid metabolic process [GO:0090304]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453]; resolution of meiotic recombination intermediates [GO:0000712] cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654] cobalt ion binding [GO:0050897]; DNA endonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g11930.t1 P17439 52.823 496 1.72e-177 531.0 sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1 GBA1_MOUSE reviewed Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase) Mus musculus (Mouse) GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009247; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:0098773; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146 antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; glycolipid biosynthetic process [GO:0009247]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin epidermis development [GO:0098773]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] g11930.t1 P17439 47.579 475 8.91e-144 443.0 sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1 GBA1_MOUSE reviewed Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase) Mus musculus (Mouse) GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009247; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:0098773; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146 antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; glycolipid biosynthetic process [GO:0009247]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin epidermis development [GO:0098773]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] g11931.t1 Q7ZYC4 58.631 643 0.0 815.0 sp|Q7ZYC4|ACBG2_XENLA Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Xenopus laevis OX=8355 GN=acsbg2 PE=2 SV=1 g11931.t2 Q7ZYC4 57.273 660 0.0 807.0 sp|Q7ZYC4|ACBG2_XENLA Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Xenopus laevis OX=8355 GN=acsbg2 PE=2 SV=1 g11932.t1 Q06441 50.165 909 0.0 830.0 sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1 TSP4_XENLA reviewed Thrombospondin-4 Xenopus laevis (African clawed frog) GO:0005509; GO:0005615; GO:0005783; GO:0006986; GO:0007155; GO:0008083; GO:0016529; GO:0031012; GO:0034976; GO:0051781 cell adhesion [GO:0007155]; positive regulation of cell division [GO:0051781]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529] calcium ion binding [GO:0005509]; growth factor activity [GO:0008083] g11933.t1 Q6TXF1 33.036 336 1.17e-48 173.0 sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1 g11934.t1 Q6AZN6 67.002 894 0.0 1198.0 sp|Q6AZN6|PK3C3_XENLA Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Xenopus laevis OX=8355 GN=pik3c3 PE=2 SV=1 PK3C3_XENLA reviewed Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3) Xenopus laevis (African clawed frog) GO:0000045; GO:0000407; GO:0000425; GO:0005524; GO:0005737; GO:0005768; GO:0005777; GO:0006897; GO:0016020; GO:0016303; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0036092; GO:0048015; GO:0051301 autophagosome assembly [GO:0000045]; cell division [GO:0051301]; endocytosis [GO:0006897]; pexophagy [GO:0000425]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465] cytoplasm [GO:0005737]; endosome [GO:0005768]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524] g11935.t1 Q5MCW4 27.767 497 4.6000000000000003e-35 146.0 sp|Q5MCW4|ZN569_HUMAN Zinc finger protein 569 OS=Homo sapiens OX=9606 GN=ZNF569 PE=1 SV=1 g11935.t1 Q5MCW4 25.397 441 1.15e-28 127.0 sp|Q5MCW4|ZN569_HUMAN Zinc finger protein 569 OS=Homo sapiens OX=9606 GN=ZNF569 PE=1 SV=1 g11936.t1 Q5ZL54 43.297 455 6.73e-92 298.0 sp|Q5ZL54|KHDC4_CHICK KH homology domain-containing protein 4 OS=Gallus gallus OX=9031 GN=KHDC4 PE=2 SV=1 g11937.t1 O95263 53.716 888 0.0 930.0 sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2 g11937.t2 O95263 53.664 887 0.0 932.0 sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2 g11939.t1 Q6NWW5 55.583 403 3.53e-134 450.0 sp|Q6NWW5|KIF24_MOUSE Kinesin-like protein KIF24 OS=Mus musculus OX=10090 GN=Kif24 PE=1 SV=2 KIF24_MOUSE reviewed Kinesin-like protein KIF24 Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018 cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018] centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g11940.t1 P50583 41.135 141 3.27e-33 117.0 sp|P50583|AP4A_HUMAN Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] OS=Homo sapiens OX=9606 GN=NUDT2 PE=1 SV=3 AP4A_HUMAN reviewed Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.17) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2) (Nudix motif 2) Homo sapiens (Human) GO:0004081; GO:0005525; GO:0005759; GO:0006139; GO:0006167; GO:0006754; GO:0006915; GO:0008803; GO:0034599 AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; cellular response to oxidative stress [GO:0034599]; nucleobase-containing compound metabolic process [GO:0006139] mitochondrial matrix [GO:0005759] bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [GO:0008803]; GTP binding [GO:0005525] g11941.t1 Q91X34 40.278 216 1.44e-41 148.0 sp|Q91X34|BAAT_MOUSE Bile acid-CoA:amino acid N-acyltransferase OS=Mus musculus OX=10090 GN=Baat PE=1 SV=1 BAAT_MOUSE reviewed Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2) Mus musculus (Mouse) GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817 acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530] cytosol [GO:0005829]; peroxisome [GO:0005777] carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817] g11941.t2 Q91X34 36.085 424 3.2e-78 252.0 sp|Q91X34|BAAT_MOUSE Bile acid-CoA:amino acid N-acyltransferase OS=Mus musculus OX=10090 GN=Baat PE=1 SV=1 BAAT_MOUSE reviewed Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2) Mus musculus (Mouse) GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817 acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530] cytosol [GO:0005829]; peroxisome [GO:0005777] carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817] g11941.t3 Q8BGG9 33.493 209 1.26e-28 115.0 sp|Q8BGG9|ACNT2_MOUSE Acyl-coenzyme A amino acid N-acyltransferase 2 OS=Mus musculus OX=10090 GN=Acnat2 PE=1 SV=1 g11945.t1 P12890 49.045 314 1.3700000000000001e-86 291.0 sp|P12890|AMDB_XENLA Peptidyl-glycine alpha-amidating monooxygenase B OS=Xenopus laevis OX=8355 GN=pam-b PE=2 SV=1 g11950.t1 Q4R6I1 26.267 217 1.71e-26 114.0 sp|Q4R6I1|GIN1_MACFA Gypsy retrotransposon integrase-like protein 1 OS=Macaca fascicularis OX=9541 GN=GIN1 PE=2 SV=1 g11958.t1 P10731 34.995 983 0.0 568.0 sp|P10731|AMD_BOVIN Peptidyl-glycine alpha-amidating monooxygenase OS=Bos taurus OX=9913 GN=PAM PE=1 SV=2 AMD_BOVIN reviewed Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)] Bos taurus (Bovine) GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0005576; GO:0008270; GO:0030658; GO:0030667; GO:0031418; GO:0062112 fatty acid primary amide biosynthetic process [GO:0062112]; peptide amidation [GO:0001519] extracellular region [GO:0005576]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; zinc ion binding [GO:0008270] g11966.t1 Q9VWH4 74.926 339 0.0 530.0 sp|Q9VWH4|IDH3A_DROME Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Idh3a PE=2 SV=1 g11967.t1 Q04592 35.467 1937 0.0 1002.0 sp|Q04592|PCSK5_MOUSE Proprotein convertase subtilisin/kexin type 5 OS=Mus musculus OX=10090 GN=Pcsk5 PE=1 SV=3 PCSK5_MOUSE reviewed Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (Subtilisin-like proprotein convertase 6) (SPC6) (Subtilisin/kexin-like protease PC5) Mus musculus (Mouse) GO:0000139; GO:0001822; GO:0003279; GO:0004175; GO:0004252; GO:0005615; GO:0005788; GO:0005794; GO:0005797; GO:0005802; GO:0006465; GO:0007368; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016485; GO:0016486; GO:0019058; GO:0030141; GO:0030323; GO:0031410; GO:0033625; GO:0035108; GO:0042277; GO:0043043; GO:0043204; GO:0048566; GO:0048706; GO:0060976; GO:0140447; GO:1904754; GO:1905609; GO:1990635; GO:2001046 anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; cytokine precursor processing [GO:0140447]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of integrin activation [GO:0033625]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; protein processing [GO:0016485]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802] endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252] g11968.t1 Q5F3W3 54.971 342 4.1e-123 388.0 sp|Q5F3W3|MK06_CHICK Mitogen-activated protein kinase 6 OS=Gallus gallus OX=9031 GN=MAPK6 PE=2 SV=1 MK06_CHICK reviewed Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) Gallus gallus (Chicken) GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0019901; GO:0032156; GO:0032991; GO:0035556; GO:0046982; GO:0060999; GO:0106310 intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11971.t1 Q91YK0 47.45 647 0.0 572.0 sp|Q91YK0|LRC49_MOUSE Leucine-rich repeat-containing protein 49 OS=Mus musculus OX=10090 GN=Lrrc49 PE=1 SV=1 g11971.t2 Q91YK0 47.176 655 0.0 574.0 sp|Q91YK0|LRC49_MOUSE Leucine-rich repeat-containing protein 49 OS=Mus musculus OX=10090 GN=Lrrc49 PE=1 SV=1 g11972.t1 Q00765 52.174 184 1.9699999999999999e-69 213.0 sp|Q00765|REEP5_HUMAN Receptor expression-enhancing protein 5 OS=Homo sapiens OX=9606 GN=REEP5 PE=1 SV=3 REEP5_HUMAN reviewed Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2) Homo sapiens (Human) GO:0005783; GO:0007029; GO:0033017; GO:0071782; GO:0090158 endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; sarcoplasmic reticulum membrane [GO:0033017] g11973.t1 Q9Y6V7 61.745 447 0.0 581.0 sp|Q9Y6V7|DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens OX=9606 GN=DDX49 PE=1 SV=1 DDX49_HUMAN reviewed Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016887; GO:0030307; GO:0044357 positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g11974.t1 A5PLF5 50.725 207 4.1199999999999996e-69 217.0 sp|A5PLF5|TM2D3_DANRE TM2 domain-containing protein 3 OS=Danio rerio OX=7955 GN=tm2d3 PE=2 SV=2 g11975.t1 Q64350 43.586 686 0.0 569.0 sp|Q64350|EI2BE_RAT Translation initiation factor eIF2B subunit epsilon OS=Rattus norvegicus OX=10116 GN=Eif2b5 PE=1 SV=2 EI2BE_RAT reviewed Translation initiation factor eIF2B subunit epsilon (eIF2B GDP-GTP exchange factor subunit epsilon) Rattus norvegicus (Rat) GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708; GO:0050852 astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634] guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g11977.t1 Q5F3T9 71.245 466 0.0 690.0 sp|Q5F3T9|UGDH_CHICK UDP-glucose 6-dehydrogenase OS=Gallus gallus OX=9031 GN=UGDH PE=2 SV=1 UGDH_CHICK reviewed UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22) Gallus gallus (Chicken) GO:0001702; GO:0003979; GO:0005634; GO:0006024; GO:0006065; GO:0015012; GO:0034214; GO:0050650; GO:0051287 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065] nucleus [GO:0005634] NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979] g11979.t1 Q8IU60 40.179 448 7.35e-102 313.0 sp|Q8IU60|DCP2_HUMAN m7GpppN-mRNA hydrolase OS=Homo sapiens OX=9606 GN=DCP2 PE=1 SV=3 DCP2_HUMAN reviewed m7GpppN-mRNA hydrolase (EC 3.6.1.62) (Nucleoside diphosphate-linked moiety X motif 20) (Nudix motif 20) (mRNA-decapping enzyme 2) (hDpc) Homo sapiens (Human) GO:0000184; GO:0000288; GO:0000290; GO:0000932; GO:0004534; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0016896; GO:0030054; GO:0030145; GO:0032211; GO:0036464; GO:0043488; GO:0070034; GO:0071044; GO:0140933; GO:1904872 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442] 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; 5'-3' RNA exonuclease activity [GO:0004534]; manganese ion binding [GO:0030145]; RNA exonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; telomerase RNA binding [GO:0070034] g11979.t2 Q8IU60 58.442 231 4.6e-100 306.0 sp|Q8IU60|DCP2_HUMAN m7GpppN-mRNA hydrolase OS=Homo sapiens OX=9606 GN=DCP2 PE=1 SV=3 DCP2_HUMAN reviewed m7GpppN-mRNA hydrolase (EC 3.6.1.62) (Nucleoside diphosphate-linked moiety X motif 20) (Nudix motif 20) (mRNA-decapping enzyme 2) (hDpc) Homo sapiens (Human) GO:0000184; GO:0000288; GO:0000290; GO:0000932; GO:0004534; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0016896; GO:0030054; GO:0030145; GO:0032211; GO:0036464; GO:0043488; GO:0070034; GO:0071044; GO:0140933; GO:1904872 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442] 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; 5'-3' RNA exonuclease activity [GO:0004534]; manganese ion binding [GO:0030145]; RNA exonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; telomerase RNA binding [GO:0070034] g11981.t1 Q8BQ86 35.231 281 3.48e-48 174.0 sp|Q8BQ86|CHST8_MOUSE Carbohydrate sulfotransferase 8 OS=Mus musculus OX=10090 GN=Chst8 PE=2 SV=1 CHST8_MOUSE reviewed Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016051; GO:0016486; GO:0030166; GO:0042446 carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g11982.t1 Q9CPX9 82.353 85 3.04e-47 148.0 sp|Q9CPX9|APC11_MOUSE Anaphase-promoting complex subunit 11 OS=Mus musculus OX=10090 GN=Anapc11 PE=3 SV=1 APC11_MOUSE reviewed Anaphase-promoting complex subunit 11 (APC11) (Cyclosome subunit 11) Mus musculus (Mouse) GO:0001664; GO:0005634; GO:0005654; GO:0005680; GO:0005730; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031145; GO:0031146; GO:0034450; GO:0045842; GO:0051301; GO:0061630; GO:0070936; GO:0070979; GO:0097602; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cullin family protein binding [GO:0097602]; G protein-coupled receptor binding [GO:0001664]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g11983.t1 P46821 35.072 556 1.34e-101 369.0 sp|P46821|MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens OX=9606 GN=MAP1B PE=1 SV=2 MAP1B_HUMAN reviewed Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1] Homo sapiens (Human) GO:0000226; GO:0001578; GO:0001750; GO:0001764; GO:0003779; GO:0005198; GO:0005543; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0007026; GO:0007409; GO:0007416; GO:0008017; GO:0009410; GO:0009612; GO:0009743; GO:0014012; GO:0014069; GO:0016358; GO:0017085; GO:0021700; GO:0030424; GO:0030425; GO:0030426; GO:0031114; GO:0031116; GO:0031175; GO:0032355; GO:0032387; GO:0033189; GO:0036477; GO:0043025; GO:0043196; GO:0043197; GO:0043204; GO:0044877; GO:0045202; GO:0045666; GO:0045773; GO:0047497; GO:0048471; GO:0048675; GO:0051915; GO:0061162; GO:0071363; GO:0071375; GO:0071895; GO:0097440; GO:0097441; GO:0097457; GO:0098978; GO:0150052 axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; regulation of postsynapse assembly [GO:0150052]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196] actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] g11983.t1 P46821 46.212 132 5.58e-26 121.0 sp|P46821|MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens OX=9606 GN=MAP1B PE=1 SV=2 MAP1B_HUMAN reviewed Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1] Homo sapiens (Human) GO:0000226; GO:0001578; GO:0001750; GO:0001764; GO:0003779; GO:0005198; GO:0005543; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0007026; GO:0007409; GO:0007416; GO:0008017; GO:0009410; GO:0009612; GO:0009743; GO:0014012; GO:0014069; GO:0016358; GO:0017085; GO:0021700; GO:0030424; GO:0030425; GO:0030426; GO:0031114; GO:0031116; GO:0031175; GO:0032355; GO:0032387; GO:0033189; GO:0036477; GO:0043025; GO:0043196; GO:0043197; GO:0043204; GO:0044877; GO:0045202; GO:0045666; GO:0045773; GO:0047497; GO:0048471; GO:0048675; GO:0051915; GO:0061162; GO:0071363; GO:0071375; GO:0071895; GO:0097440; GO:0097441; GO:0097457; GO:0098978; GO:0150052 axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; regulation of postsynapse assembly [GO:0150052]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196] actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] g11984.t1 Q4PLW0 32.668 401 3.63e-58 201.0 sp|Q4PLW0|PLIN2_PIG Perilipin-2 OS=Sus scrofa OX=9823 GN=PLIN2 PE=2 SV=1 PLIN2_PIG reviewed Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) Sus scrofa (Pig) GO:0005622; GO:0005811; GO:0005829; GO:0010890; GO:0016020; GO:0019915; GO:0042149; GO:1905691 cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; positive regulation of triglyceride storage [GO:0010890] cytosol [GO:0005829]; intracellular anatomical structure [GO:0005622]; lipid droplet [GO:0005811]; membrane [GO:0016020] g11986.t1 Q8HXX9 44.221 199 1.7e-43 147.0 sp|Q8HXX9|FRDA_MACFA Frataxin, mitochondrial OS=Macaca fascicularis OX=9541 GN=FXN PE=2 SV=2 g11987.t1 Q8BG93 53.543 127 7.29e-49 158.0 sp|Q8BG93|NUD15_MOUSE Nucleotide triphosphate diphosphatase NUDT15 OS=Mus musculus OX=10090 GN=Nudt15 PE=1 SV=1 NUD15_MOUSE reviewed Nucleotide triphosphate diphosphatase NUDT15 (EC 3.6.1.68) (EC 3.6.1.76) (EC 3.6.1.9) (MutT homolog 2) (mMTH2) (Nucleoside diphosphate-linked moiety X motif 15) (Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15) (Nudix hydrolase 15) Mus musculus (Mouse) GO:0000278; GO:0000302; GO:0005829; GO:0006195; GO:0006203; GO:0008413; GO:0009217; GO:0035539; GO:0042178; GO:0042262; GO:0044715; GO:0046872; GO:0047429; GO:0061136; GO:0106405; GO:1901292 dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; mitotic cell cycle [GO:0000278]; nucleoside phosphate catabolic process [GO:1901292]; purine deoxyribonucleoside triphosphate catabolic process [GO:0009217]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]; response to reactive oxygen species [GO:0000302]; xenobiotic catabolic process [GO:0042178] cytosol [GO:0005829] 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; 8-oxo-dGDP phosphatase activity [GO:0044715]; isoprenoid diphosphate phosphatase activity [GO:0106405]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429] g11989.t1 Q2TBK8 48.302 265 1.3299999999999998e-82 262.0 sp|Q2TBK8|SPN1_BOVIN Snurportin-1 OS=Bos taurus OX=9913 GN=SNUPN PE=2 SV=1 SPN1_BOVIN reviewed Snurportin-1 (RNA U transporter 1) Bos taurus (Bovine) GO:0000339; GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0005886; GO:0006404; GO:0006606; GO:0007010; GO:0042564; GO:0051259; GO:0051262; GO:0061015; GO:0061608 cytoskeleton organization [GO:0007010]; protein complex oligomerization [GO:0051259]; protein import into nucleus [GO:0006606]; protein tetramerization [GO:0051262]; RNA import into nucleus [GO:0006404]; snRNA import into nucleus [GO:0061015] cytosol [GO:0005829]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339] g11990.t1 P20060 47.251 491 1.6e-154 453.0 sp|P20060|HEXB_MOUSE Beta-hexosaminidase subunit beta OS=Mus musculus OX=10090 GN=Hexb PE=1 SV=2 HEXB_MOUSE reviewed Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta) Mus musculus (Mouse) GO:0001501; GO:0001669; GO:0004563; GO:0005615; GO:0005764; GO:0006044; GO:0006491; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0015929; GO:0016020; GO:0016231; GO:0016787; GO:0019915; GO:0030203; GO:0030207; GO:0030209; GO:0030214; GO:0030246; GO:0042552; GO:0042582; GO:0042802; GO:0043202; GO:0043615; GO:0044877; GO:0045944; GO:0048477; GO:0050885; GO:0050905; GO:0060473; GO:1905379 astrocyte cell migration [GO:0043615]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; intracellular calcium ion homeostasis [GO:0006874]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; N-glycan processing [GO:0006491]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; skeletal system development [GO:0001501] acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cortical granule [GO:0060473]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; hexosaminidase activity [GO:0015929]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] g11990.t2 P20060 43.527 533 8.58e-146 432.0 sp|P20060|HEXB_MOUSE Beta-hexosaminidase subunit beta OS=Mus musculus OX=10090 GN=Hexb PE=1 SV=2 HEXB_MOUSE reviewed Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta) Mus musculus (Mouse) GO:0001501; GO:0001669; GO:0004563; GO:0005615; GO:0005764; GO:0006044; GO:0006491; GO:0006687; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0015929; GO:0016020; GO:0016231; GO:0016787; GO:0019915; GO:0030203; GO:0030207; GO:0030209; GO:0030214; GO:0030246; GO:0042552; GO:0042582; GO:0042802; GO:0043202; GO:0043615; GO:0044877; GO:0045944; GO:0048477; GO:0050885; GO:0050905; GO:0060473; GO:1905379 astrocyte cell migration [GO:0043615]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; intracellular calcium ion homeostasis [GO:0006874]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; N-acetylglucosamine metabolic process [GO:0006044]; N-glycan processing [GO:0006491]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; skeletal system development [GO:0001501] acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cortical granule [GO:0060473]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylglucosaminidase activity [GO:0016231]; beta-N-acetylhexosaminidase activity [GO:0004563]; carbohydrate binding [GO:0030246]; hexosaminidase activity [GO:0015929]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] g11990.t3 Q641X3 42.463 544 2.49e-141 421.0 sp|Q641X3|HEXA_RAT Beta-hexosaminidase subunit alpha OS=Rattus norvegicus OX=10116 GN=Hexa PE=2 SV=1 HEXA_RAT reviewed Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha) Rattus norvegicus (Rat) GO:0001501; GO:0004563; GO:0005764; GO:0005829; GO:0005975; GO:0006024; GO:0006491; GO:0006689; GO:0007040; GO:0007605; GO:0007626; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0030203; GO:0030209; GO:0030214; GO:0042552; GO:0042582; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:1905379 adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; hyaluronan catabolic process [GO:0030214]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; myelination [GO:0042552]; N-glycan processing [GO:0006491]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501] azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cytosol [GO:0005829]; lysosome [GO:0005764]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; protein heterodimerization activity [GO:0046982] g11993.t1 Q26486 60.36 111 4.99e-33 136.0 sp|Q26486|FKBP4_SPOFR 46 kDa FK506-binding nuclear protein OS=Spodoptera frugiperda OX=7108 GN=FKBP46 PE=2 SV=1 FKBP4_SPOFR reviewed 46 kDa FK506-binding nuclear protein (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase) Spodoptera frugiperda (Fall armyworm) GO:0000785; GO:0003677; GO:0003755; GO:0005730 chromatin [GO:0000785]; nucleolus [GO:0005730] DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g11994.t1 Q4JK73 41.606 274 3.73e-78 243.0 sp|Q4JK73|DHB11_MACFA Estradiol 17-beta-dehydrogenase 11 OS=Macaca fascicularis OX=9541 GN=HSD17B11 PE=2 SV=1 g11995.t1 Q6GQQ9 47.598 458 9.25e-117 381.0 sp|Q6GQQ9|OTU7B_HUMAN OTU domain-containing protein 7B OS=Homo sapiens OX=9606 GN=OTUD7B PE=1 SV=1 OTU7B_HUMAN reviewed OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne) Homo sapiens (Human) GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1904262; GO:1904515; GO:1990380 adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270] g11998.t1 F1Q8W0 52.568 740 0.0 707.0 sp|F1Q8W0|CATIN_DANRE Splicing factor Cactin OS=Danio rerio OX=7955 GN=cactin PE=2 SV=1 g12013.t1 Q0II24 38.017 242 8.800000000000001e-29 115.0 sp|Q0II24|C1QT9_BOVIN Complement C1q and tumor necrosis factor-related protein 9 OS=Bos taurus OX=9913 GN=C1QTNF9 PE=2 SV=1 g12021.t1 F4JTS8 31.702 940 1.2400000000000002e-103 370.0 sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1 NOV_ARATH reviewed Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597) Arabidopsis thaliana (Mouse-ear cress) GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364 auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634] g12024.t1 F4JTS8 31.725 1078 2.1399999999999998e-119 428.0 sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1 NOV_ARATH reviewed Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597) Arabidopsis thaliana (Mouse-ear cress) GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364 auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634] g12025.t1 Q7SZE8 50.829 181 5.400000000000001e-59 191.0 sp|Q7SZE8|TP8L1_DANRE Tumor necrosis factor alpha-induced protein 8-like protein 1 OS=Danio rerio OX=7955 GN=tnfaip8l1 PE=1 SV=1 g12026.t1 Q58D31 60.0 350 9.98e-153 436.0 sp|Q58D31|DHSO_BOVIN Sorbitol dehydrogenase OS=Bos taurus OX=9913 GN=SORD PE=1 SV=3 DHSO_BOVIN reviewed Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9) Bos taurus (Bovine) GO:0003939; GO:0006062; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526 flagellated sperm motility [GO:0030317]; sorbitol catabolic process [GO:0006062] mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514] D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; zinc ion binding [GO:0008270] g12027.t1 Q58D31 57.637 347 2.1e-138 400.0 sp|Q58D31|DHSO_BOVIN Sorbitol dehydrogenase OS=Bos taurus OX=9913 GN=SORD PE=1 SV=3 DHSO_BOVIN reviewed Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9) Bos taurus (Bovine) GO:0003939; GO:0006062; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526 flagellated sperm motility [GO:0030317]; sorbitol catabolic process [GO:0006062] mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514] D-xylulose reductase activity [GO:0046526]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; zinc ion binding [GO:0008270] g12028.t1 P0DMQ6 61.85 346 4.37e-161 457.0 sp|P0DMQ6|DHSO_CHICK Sorbitol dehydrogenase OS=Gallus gallus OX=9031 GN=SORD PE=1 SV=1 g12029.t1 P16393 59.936 941 0.0 1107.0 sp|P16393|HMDH_STRPU 3-hydroxy-3-methylglutaryl-coenzyme A reductase OS=Strongylocentrotus purpuratus OX=7668 GN=HMGCR PE=2 SV=2 g12030.t1 Q09JW2 79.032 186 1.68e-99 288.0 sp|Q09JW2|RL17_ARGMO Large ribosomal subunit protein uL22 OS=Argas monolakensis OX=34602 GN=RpL17 PE=2 SV=1 g12031.t1 Q4R7M4 54.545 220 1.47e-74 232.0 sp|Q4R7M4|DTWD2_MACFA tRNA-uridine aminocarboxypropyltransferase 2 OS=Macaca fascicularis OX=9541 GN=DTWD2 PE=2 SV=1 DTWD2_MACFA reviewed tRNA-uridine aminocarboxypropyltransferase 2 (EC 2.5.1.25) (DTW domain-containing protein 2) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005634; GO:0005737; GO:0006400; GO:0016432; GO:0141217 glycoRNA biosynthetic process [GO:0141217]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] tRNA-uridine aminocarboxypropyltransferase activity [GO:0016432] g12032.t1 Q5UQ13 36.767 767 7.95e-77 282.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g12032.t1 Q5UQ13 33.933 834 2.18e-76 281.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g12032.t1 Q5UQ13 35.593 767 5.85e-75 276.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g12032.t1 Q5UQ13 34.644 814 8.319999999999999e-68 254.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g12032.t1 Q5UQ13 38.432 523 1.76e-54 212.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g12032.t1 Q5UQ13 40.0 560 2.0899999999999997e-54 212.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g12032.t1 Q5UQ13 34.435 363 4.77e-24 114.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g12034.t1 Q5U5V2 28.46 383 2.08e-50 177.0 sp|Q5U5V2|HYKK_MOUSE Hydroxylysine kinase OS=Mus musculus OX=10090 GN=Hykk PE=1 SV=2 g12035.t1 Q6PB06 30.864 405 1.62e-52 183.0 sp|Q6PB06|HYKK_XENLA Hydroxylysine kinase OS=Xenopus laevis OX=8355 GN=hykk PE=2 SV=1 g12036.t1 Q4V9P6 54.131 351 8.83e-139 400.0 sp|Q4V9P6|ADAL_DANRE N6-Methyl-AMP deaminase OS=Danio rerio OX=7955 GN=mapda PE=2 SV=1 ADAL_DANRE reviewed N6-Methyl-AMP deaminase (EC 3.5.4.-) (Adenosine deaminase-like protein) (N6,N6-dimethyl-AMP deaminase) (EC 3.5.4.-) (N6-isopentenyl-AMP deaminase) (EC 3.5.4.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004000; GO:0006154; GO:0009117; GO:0043010; GO:0046103; GO:0046872; GO:0062154 adenosine catabolic process [GO:0006154]; camera-type eye development [GO:0043010]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117] adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-methyl-AMP deaminase activity [GO:0062154] g12037.t1 Q9D0A0 73.937 541 0.0 830.0 sp|Q9D0A0|DET1_MOUSE DET1 homolog OS=Mus musculus OX=10090 GN=Det1 PE=2 SV=2 g12038.t1 Q5ZIQ3 43.662 426 1.44e-79 255.0 sp|Q5ZIQ3|HNRPK_CHICK Heterogeneous nuclear ribonucleoprotein K OS=Gallus gallus OX=9031 GN=HNRNPK PE=2 SV=1 HNRPK_CHICK reviewed Heterogeneous nuclear ribonucleoprotein K (hnRNP K) Gallus gallus (Chicken) GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0010629; GO:0042981; GO:0045892; GO:1990904 mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] DNA binding [GO:0003677]; RNA binding [GO:0003723] g12038.t2 Q5ZIQ3 43.662 426 4.52e-79 254.0 sp|Q5ZIQ3|HNRPK_CHICK Heterogeneous nuclear ribonucleoprotein K OS=Gallus gallus OX=9031 GN=HNRNPK PE=2 SV=1 HNRPK_CHICK reviewed Heterogeneous nuclear ribonucleoprotein K (hnRNP K) Gallus gallus (Chicken) GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0010629; GO:0042981; GO:0045892; GO:1990904 mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] DNA binding [GO:0003677]; RNA binding [GO:0003723] g12040.t1 P70473 58.225 383 2.22e-164 468.0 sp|P70473|AMACR_RAT Alpha-methylacyl-CoA racemase OS=Rattus norvegicus OX=10116 GN=Amacr PE=1 SV=3 AMACR_RAT reviewed Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase) Rattus norvegicus (Rat) GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005886; GO:0006631; GO:0006699; GO:0008111; GO:0008206 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886] alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102] g12041.t1 Q6AYU1 59.429 350 4.09e-144 413.0 sp|Q6AYU1|MO4L1_RAT Mortality factor 4-like protein 1 OS=Rattus norvegicus OX=10116 GN=Morf4l1 PE=2 SV=1 g12042.t1 Q5BK68 39.276 387 1.6e-78 250.0 sp|Q5BK68|SNPC3_RAT snRNA-activating protein complex subunit 3 OS=Rattus norvegicus OX=10116 GN=Snapc3 PE=2 SV=1 g12043.t1 Q96JI7 29.423 2549 0.0 901.0 sp|Q96JI7|SPTCS_HUMAN Spatacsin OS=Homo sapiens OX=9606 GN=SPG11 PE=1 SV=3 SPTCS_HUMAN reviewed Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein) Homo sapiens (Human) GO:0005730; GO:0005737; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256 autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202] protein kinase binding [GO:0019901] g12044.t1 Q6NRY2 47.242 1124 0.0 1041.0 sp|Q6NRY2|NOL6_XENLA Nucleolar protein 6 OS=Xenopus laevis OX=8355 GN=nol6 PE=2 SV=2 NOL6_XENLA reviewed Nucleolar protein 6 Xenopus laevis (African clawed frog) GO:0003723; GO:0005694; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409] chromosome [GO:0005694]; CURI complex [GO:0032545]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456] RNA binding [GO:0003723] g12045.t1 Q8R2R3 33.509 379 4.69e-52 178.0 sp|Q8R2R3|AAGAB_MOUSE Alpha- and gamma-adaptin-binding protein p34 OS=Mus musculus OX=10090 GN=Aagab PE=1 SV=2 g12046.t1 O43451 49.596 867 0.0 879.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g12046.t1 O43451 49.826 861 0.0 868.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g12046.t1 O43451 46.092 870 0.0 792.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g12049.t1 Q6PD21 46.032 189 9.28e-45 167.0 sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2 SHB_MOUSE reviewed SH2 domain-containing adapter protein B Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159] g12049.t2 Q6PD21 46.032 189 4.92e-44 166.0 sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2 SHB_MOUSE reviewed SH2 domain-containing adapter protein B Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159] g12050.t1 Q5EA03 40.11 182 2.5699999999999998e-42 146.0 sp|Q5EA03|TM186_BOVIN Transmembrane protein 186 OS=Bos taurus OX=9913 GN=TMEM186 PE=2 SV=1 g12051.t1 Q9JJ09 51.613 558 0.0 531.0 sp|Q9JJ09|NPT2B_RAT Sodium-dependent phosphate transport protein 2B OS=Rattus norvegicus OX=10116 GN=Slc34a2 PE=1 SV=1 NPT2B_RAT reviewed Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2) (rNaPi IIb) Rattus norvegicus (Rat) GO:0001701; GO:0005436; GO:0005903; GO:0006817; GO:0009750; GO:0016020; GO:0016324; GO:0019904; GO:0030643; GO:0031402; GO:0031526; GO:0031528; GO:0031982; GO:0032355; GO:0042301; GO:0043627; GO:0044341 in utero embryonic development [GO:0001701]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fructose [GO:0009750]; sodium-dependent phosphate transport [GO:0044341] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; vesicle [GO:0031982] phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436] g12054.t1 O42329 33.041 342 6.0400000000000005e-59 199.0 sp|O42329|GNRR2_CLAGA Gonadotropin-releasing hormone II receptor OS=Clarias gariepinus OX=13013 PE=2 SV=2 g12056.t1 Q495B1 31.471 537 6.12e-82 268.0 sp|Q495B1|AKD1A_HUMAN Ankyrin repeat and death domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ANKDD1A PE=1 SV=2 AKD1A_HUMAN reviewed Ankyrin repeat and death domain-containing protein 1A Homo sapiens (Human) GO:0007165 signal transduction [GO:0007165] g12056.t2 Q495B1 29.032 496 3.91e-63 221.0 sp|Q495B1|AKD1A_HUMAN Ankyrin repeat and death domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ANKDD1A PE=1 SV=2 AKD1A_HUMAN reviewed Ankyrin repeat and death domain-containing protein 1A Homo sapiens (Human) GO:0007165 signal transduction [GO:0007165] g12056.t3 Q495B1 29.597 571 7.120000000000001e-75 251.0 sp|Q495B1|AKD1A_HUMAN Ankyrin repeat and death domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ANKDD1A PE=1 SV=2 AKD1A_HUMAN reviewed Ankyrin repeat and death domain-containing protein 1A Homo sapiens (Human) GO:0007165 signal transduction [GO:0007165] g12058.t1 Q8TAD4 45.039 766 0.0 593.0 sp|Q8TAD4|ZNT5_HUMAN Proton-coupled zinc antiporter SLC30A5 OS=Homo sapiens OX=9606 GN=SLC30A5 PE=1 SV=1 ZNT5_HUMAN reviewed Proton-coupled zinc antiporter SLC30A5 (Solute carrier family 30 member 5) (Zinc transporter 5) (ZnT-5) (ZnT-like transporter 1) (hZTL1) Homo sapiens (Human) GO:0000139; GO:0005385; GO:0005654; GO:0005730; GO:0005789; GO:0005794; GO:0005886; GO:0006506; GO:0006824; GO:0006829; GO:0006882; GO:0010043; GO:0012507; GO:0015297; GO:0016020; GO:0016324; GO:0022883; GO:0030070; GO:0030141; GO:0030667; GO:0031410; GO:0032588; GO:0046872; GO:0062111; GO:0071577; GO:0071578; GO:0140826; GO:1904257; GO:1990674 cobalt ion transport [GO:0006824]; GPI anchor biosynthetic process [GO:0006506]; insulin processing [GO:0030070]; intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc ion import across plasma membrane [GO:0071578]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588] antiporter activity [GO:0015297]; metal ion binding [GO:0046872]; zinc efflux transmembrane transporter activity [GO:0022883]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g12060.t1 Q5ZM55 53.016 630 0.0 678.0 sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1 FEM1B_CHICK reviewed Protein fem-1 homolog B (FEM1b) (FEM1-beta) Gallus gallus (Chicken) GO:0000151; GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001 apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g12061.t1 Q96CD2 62.437 197 1.61e-83 249.0 sp|Q96CD2|COAC_HUMAN Phosphopantothenoylcysteine decarboxylase OS=Homo sapiens OX=9606 GN=PPCDC PE=1 SV=2 COAC_HUMAN reviewed Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC) Homo sapiens (Human) GO:0004633; GO:0005829; GO:0010181; GO:0015937; GO:0042802; GO:0071513 coenzyme A biosynthetic process [GO:0015937] cytosol [GO:0005829]; phosphopantothenoylcysteine decarboxylase complex [GO:0071513] FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633] g12062.t1 O02833 31.293 441 1.81e-37 150.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g12063.t1 P35859 28.076 577 1.22e-34 142.0 sp|P35859|ALS_RAT Insulin-like growth factor-binding protein complex acid labile subunit OS=Rattus norvegicus OX=10116 GN=Igfals PE=1 SV=1 g12064.t1 P35858 30.738 488 6.420000000000001e-33 138.0 sp|P35858|ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens OX=9606 GN=IGFALS PE=1 SV=1 ALS_HUMAN reviewed Insulin-like growth factor-binding protein complex acid labile subunit (ALS) Homo sapiens (Human) GO:0005520; GO:0005576; GO:0005615; GO:0007155; GO:0007165; GO:0038023; GO:0042567; GO:0070062 cell adhesion [GO:0007155]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567] insulin-like growth factor binding [GO:0005520]; signaling receptor activity [GO:0038023] g12065.t1 Q9DBY4 30.625 480 3.86e-35 145.0 sp|Q9DBY4|TRIL_MOUSE TLR4 interactor with leucine rich repeats OS=Mus musculus OX=10090 GN=Tril PE=2 SV=1 TRIL_MOUSE reviewed TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644) Mus musculus (Mouse) GO:0001530; GO:0002718; GO:0005886; GO:0006954; GO:0034142; GO:0038023; GO:0045087; GO:0046696 inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142] lipopolysaccharide receptor complex [GO:0046696]; plasma membrane [GO:0005886] lipopolysaccharide binding [GO:0001530]; signaling receptor activity [GO:0038023] g12066.t1 P70389 30.488 492 1.33e-33 139.0 sp|P70389|ALS_MOUSE Insulin-like growth factor-binding protein complex acid labile subunit OS=Mus musculus OX=10090 GN=Igfals PE=1 SV=1 g12066.t1 P70389 30.851 376 2.6200000000000003e-21 101.0 sp|P70389|ALS_MOUSE Insulin-like growth factor-binding protein complex acid labile subunit OS=Mus musculus OX=10090 GN=Igfals PE=1 SV=1 g12067.t1 O02833 28.876 516 2.38e-39 154.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g12071.t1 Q96CS2 37.175 269 4.79e-49 166.0 sp|Q96CS2|HAUS1_HUMAN HAUS augmin-like complex subunit 1 OS=Homo sapiens OX=9606 GN=HAUS1 PE=1 SV=1 HAUS1_HUMAN reviewed HAUS augmin-like complex subunit 1 (Coiled-coil domain-containing protein 5) (Enhancer of invasion-cluster) (HEI-C) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0005829; GO:0007098; GO:0010968; GO:0051225; GO:0051301; GO:0070652; GO:1990498 cell division [GO:0051301]; centrosome cycle [GO:0007098]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; spindle pole [GO:0000922] g12072.t1 P31722 32.314 229 8.11e-21 90.9 sp|P31722|C1QC_RAT Complement C1q subcomponent subunit C OS=Rattus norvegicus OX=10116 GN=C1qc PE=1 SV=2 C1QC_RAT reviewed Complement C1q subcomponent subunit C Rattus norvegicus (Rat) GO:0001786; GO:0001791; GO:0005576; GO:0005581; GO:0005602; GO:0006958; GO:0009986; GO:0019864; GO:0030853; GO:0045087; GO:0045202; GO:0045650; GO:0062167; GO:0098794; GO:0098883; GO:0098888; GO:0098890; GO:0098978; GO:0106139 complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; synapse pruning [GO:0098883] cell surface [GO:0009986]; collagen trimer [GO:0005581]; complement component C1 complex [GO:0005602]; complement component C1q complex [GO:0062167]; extracellular region [GO:0005576]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; symbiont cell surface [GO:0106139]; synapse [GO:0045202] IgG binding [GO:0019864]; IgM binding [GO:0001791]; phosphatidylserine binding [GO:0001786] g12073.t1 Q9DBN1 27.767 533 1.36e-45 175.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g12075.t1 Q9DBN1 29.091 660 2.2799999999999999e-69 243.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g12076.t1 Q8BNU0 45.662 438 6.0599999999999996e-120 360.0 sp|Q8BNU0|ARMC6_MOUSE Armadillo repeat-containing protein 6 OS=Mus musculus OX=10090 GN=Armc6 PE=1 SV=1 g12078.t1 B3EWZ6 35.6 250 4.91e-28 119.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 32.922 243 5.8e-25 110.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 35.616 219 1.56e-24 108.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 32.218 239 1.72e-24 108.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 34.894 235 2.59e-24 108.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 34.199 231 1.8399999999999998e-23 105.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 34.545 220 6.24e-23 103.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 34.419 215 8.729999999999999e-23 103.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 30.645 248 1.5300000000000002e-21 99.8 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 33.929 224 2.4600000000000003e-21 99.4 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12078.t1 B3EWZ6 34.742 213 3.23e-21 99.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12079.t1 B3EWZ6 30.04 253 6.980000000000001e-21 100.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g12082.t1 Q9PUK8 56.198 121 2.8099999999999998e-34 140.0 sp|Q9PUK8|FZD7A_XENLA Frizzled-7-A OS=Xenopus laevis OX=8355 GN=fzd7-a PE=1 SV=2 g12082.t1 Q9PUK8 43.86 114 2.42e-22 104.0 sp|Q9PUK8|FZD7A_XENLA Frizzled-7-A OS=Xenopus laevis OX=8355 GN=fzd7-a PE=1 SV=2 g12086.t1 Q6ZQ11 49.241 725 0.0 741.0 sp|Q6ZQ11|CHSS1_MOUSE Chondroitin sulfate synthase 1 OS=Mus musculus OX=10090 GN=Chsy1 PE=2 SV=2 g12090.t1 Q6ZQ11 57.08 226 1.28e-88 281.0 sp|Q6ZQ11|CHSS1_MOUSE Chondroitin sulfate synthase 1 OS=Mus musculus OX=10090 GN=Chsy1 PE=2 SV=2 g12091.t1 Q5VT52 41.127 355 6.280000000000001e-73 273.0 sp|Q5VT52|RPRD2_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RPRD2 PE=1 SV=1 RPRD2_HUMAN reviewed Regulation of nuclear pre-mRNA domain-containing protein 2 Homo sapiens (Human) GO:0000993; GO:0005654; GO:0031124; GO:0097550; GO:0099122 mRNA 3'-end processing [GO:0031124] nucleoplasm [GO:0005654]; transcription preinitiation complex [GO:0097550] RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993] g12092.t1 Q5F3D7 49.197 498 0.0 530.0 sp|Q5F3D7|UTP15_CHICK U3 small nucleolar RNA-associated protein 15 homolog OS=Gallus gallus OX=9031 GN=UTP15 PE=2 SV=1 g12093.t1 Q5E9V4 41.284 218 5.249999999999999e-41 159.0 sp|Q5E9V4|MT25B_BOVIN Methyltransferase-like protein 25B OS=Bos taurus OX=9913 GN=METTL25B PE=2 SV=1 g12094.t1 Q03147 74.194 341 0.0 530.0 sp|Q03147|CDK7_MOUSE Cyclin-dependent kinase 7 OS=Mus musculus OX=10090 GN=Cdk7 PE=1 SV=2 CDK7_MOUSE reviewed Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit) Mus musculus (Mouse) GO:0000307; GO:0000439; GO:0001111; GO:0001650; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0006368; GO:0008094; GO:0008353; GO:0016301; GO:0032968; GO:0043161; GO:0044877; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0051726; GO:0070516; GO:0070985; GO:0106310; GO:0140836; GO:0160239; GO:0160240; GO:2000045 cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA polymerase II promoter clearance [GO:0001111]; RNA polymerase II transcription initiation surveillance [GO:0160240]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription pausing by RNA polymerase II [GO:0160239] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein-containing complex binding [GO:0044877]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II CTD heptapeptide repeat S5 kinase activity [GO:0140836] g12096.t1 Q8N6G6 35.775 942 1.9899999999999999e-171 554.0 sp|Q8N6G6|ATL1_HUMAN ADAMTS-like protein 1 OS=Homo sapiens OX=9606 GN=ADAMTSL1 PE=1 SV=4 ATL1_HUMAN reviewed ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1) Homo sapiens (Human) GO:0005788; GO:0016787; GO:0030198 extracellular matrix organization [GO:0030198] endoplasmic reticulum lumen [GO:0005788] hydrolase activity [GO:0016787] g12096.t1 Q8N6G6 36.916 214 5.470000000000001e-32 139.0 sp|Q8N6G6|ATL1_HUMAN ADAMTS-like protein 1 OS=Homo sapiens OX=9606 GN=ADAMTSL1 PE=1 SV=4 ATL1_HUMAN reviewed ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1) Homo sapiens (Human) GO:0005788; GO:0016787; GO:0030198 extracellular matrix organization [GO:0030198] endoplasmic reticulum lumen [GO:0005788] hydrolase activity [GO:0016787] g12097.t1 Q60928 34.495 574 1.03e-93 303.0 sp|Q60928|GGT1_MOUSE Glutathione hydrolase 1 proenzyme OS=Mus musculus OX=10090 GN=Ggt1 PE=1 SV=1 GGT1_MOUSE reviewed Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain] Mus musculus (Mouse) GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005783; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0048471; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068 cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] g12098.t1 P20735 41.101 545 2.94e-122 377.0 sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1 g12099.t1 P20735 41.068 543 1.64e-117 362.0 sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1 g12100.t1 Q9DBT9 60.187 854 0.0 1107.0 sp|Q9DBT9|M2GD_MOUSE Dimethylglycine dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Dmgdh PE=1 SV=1 g12101.t1 Q5XGM3 71.827 394 0.0 592.0 sp|Q5XGM3|BHMT1_XENLA Betaine--homocysteine S-methyltransferase 1 OS=Xenopus laevis OX=8355 GN=bhmt PE=2 SV=1 g12104.t1 Q8BGC3 26.637 443 8.17e-36 140.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g12105.t1 B7ZCC9 25.223 674 1.0800000000000001e-44 181.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g12111.t1 Q3B8G7 73.171 82 3.3299999999999997e-40 130.0 sp|Q3B8G7|IR3IP_XENLA Immediate early response 3-interacting protein 1 OS=Xenopus laevis OX=8355 GN=ier3ip1 PE=3 SV=1 g12112.t1 Q62217 30.418 526 1.12e-43 174.0 sp|Q62217|SEM5A_MOUSE Semaphorin-5A OS=Mus musculus OX=10090 GN=Sema5a PE=2 SV=1 g12113.t1 Q8BK72 31.565 377 2.52e-39 149.0 sp|Q8BK72|RT27_MOUSE Small ribosomal subunit protein mS27 OS=Mus musculus OX=10090 GN=Mrps27 PE=1 SV=2 g12114.t1 P51659 57.019 691 0.0 820.0 sp|P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3 DHB4_HUMAN reviewed Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Homo sapiens (Human) GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0006636; GO:0008209; GO:0008210; GO:0016020; GO:0016853; GO:0018812; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042759; GO:0042803; GO:0044594; GO:0060009; GO:0106386; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] (3R)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803] g12116.t1 A0A974E306 47.206 519 3.9299999999999996e-119 363.0 sp|A0A974E306|CFA53_XENLA Cilia- and flagella-associated protein 53 OS=Xenopus laevis OX=8355 GN=cfap53.L PE=2 SV=1 CFA53_XENLA reviewed Cilia- and flagella-associated protein 53 (Coiled-coil domain-containing protein 11) (xCcdc11) Xenopus laevis (African clawed frog) GO:0003341; GO:0005930; GO:0007368; GO:0030030; GO:0034451 cell projection organization [GO:0030030]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368] axoneme [GO:0005930]; centriolar satellite [GO:0034451] g12117.t1 P98198 53.17 1183 0.0 1233.0 sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2 AT8B2_HUMAN reviewed Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531 Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] g12117.t2 P98198 52.667 1200 0.0 1233.0 sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2 AT8B2_HUMAN reviewed Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531 Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] g12117.t3 P98198 53.13 1182 0.0 1233.0 sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2 AT8B2_HUMAN reviewed Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531 Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] g12118.t1 Q9NXJ5 43.781 201 3.68e-48 158.0 sp|Q9NXJ5|PGPI_HUMAN Pyroglutamyl-peptidase 1 OS=Homo sapiens OX=9606 GN=PGPEP1 PE=1 SV=1 PGPI_HUMAN reviewed Pyroglutamyl-peptidase 1 (EC 3.4.19.3) (5-oxoprolyl-peptidase) (Pyroglutamyl aminopeptidase I) (PAP-I) (Pyroglutamyl-peptidase I) (PGP-I) (Pyrrolidone-carboxylate peptidase) Homo sapiens (Human) GO:0005829; GO:0006508; GO:0016920; GO:0030163 protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytosol [GO:0005829] pyroglutamyl-peptidase activity [GO:0016920] g12119.t1 Q501Z5 54.257 505 4.4500000000000004e-173 502.0 sp|Q501Z5|GTPB3_DANRE 5-taurinomethyluridine-[tRNA] synthase subunit GTPB3, mitochondrial OS=Danio rerio OX=7955 GN=gtpbp3 PE=2 SV=1 GTPB3_DANRE reviewed 5-taurinomethyluridine-[tRNA] synthase subunit GTPB3, mitochondrial (EC 3.6.1.-) (GTP-binding protein 3) (tRNA modification GTPase GTPBP3, mitochondrial) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002098; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0030488; GO:0036416; GO:0046872; GO:0048568; GO:0070143; GO:0070153; GO:0070154; GO:0070155; GO:0070183; GO:0070184; GO:0070899; GO:0070900 embryonic organ development [GO:0048568]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; mitochondrial leucyl-tRNA aminoacylation [GO:0070153]; mitochondrial lysyl-tRNA aminoacylation [GO:0070154]; mitochondrial methionyl-tRNA aminoacylation [GO:0070155]; mitochondrial tRNA modification [GO:0070900]; mitochondrial tRNA wobble uridine modification [GO:0070899]; mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g12124.t1 Q1LXZ9 59.15 306 5.64e-114 362.0 sp|Q1LXZ9|SKR1B_DANRE SKI family transcriptional corepressor 1 homolog-B OS=Danio rerio OX=7955 GN=skor1b PE=2 SV=1 g12125.t1 Q62422 57.561 205 5.569999999999999e-82 246.0 sp|Q62422|OSTF1_MOUSE Osteoclast-stimulating factor 1 OS=Mus musculus OX=10090 GN=Ostf1 PE=1 SV=2 g12132.t1 E1C3P4 59.494 553 0.0 707.0 sp|E1C3P4|CBPC1_CHICK Cytosolic carboxypeptidase 1 OS=Gallus gallus OX=9031 GN=AGTPBP1 PE=3 SV=1 CBPC1_CHICK reviewed Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Protein deglutamylase CCP1) Gallus gallus (Chicken) GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0007005; GO:0008270; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0050905 C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g12132.t1 E1C3P4 42.735 468 6.329999999999999e-95 335.0 sp|E1C3P4|CBPC1_CHICK Cytosolic carboxypeptidase 1 OS=Gallus gallus OX=9031 GN=AGTPBP1 PE=3 SV=1 CBPC1_CHICK reviewed Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Protein deglutamylase CCP1) Gallus gallus (Chicken) GO:0001754; GO:0004181; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0007005; GO:0008270; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0050905 C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g12133.t1 Q63604 39.659 822 6.7300000000000005e-177 532.0 sp|Q63604|NTRK2_RAT BDNF/NT-3 growth factors receptor OS=Rattus norvegicus OX=10116 GN=Ntrk2 PE=1 SV=1 NTRK2_RAT reviewed BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) Rattus norvegicus (Rat) GO:0000139; GO:0001570; GO:0001764; GO:0002020; GO:0004675; GO:0004713; GO:0004714; GO:0005030; GO:0005524; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0007169; GO:0007528; GO:0007612; GO:0007616; GO:0007623; GO:0007631; GO:0008284; GO:0009416; GO:0009986; GO:0010628; GO:0010976; GO:0010996; GO:0014047; GO:0014069; GO:0019227; GO:0021954; GO:0021987; GO:0022011; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0030971; GO:0031547; GO:0031594; GO:0031901; GO:0042490; GO:0042803; GO:0043025; GO:0043066; GO:0043087; GO:0043121; GO:0043195; GO:0043197; GO:0043204; GO:0043235; GO:0043408; GO:0043410; GO:0043524; GO:0043679; GO:0045211; GO:0045471; GO:0046548; GO:0046777; GO:0046928; GO:0048403; GO:0048471; GO:0048709; GO:0048786; GO:0048935; GO:0050772; GO:0050773; GO:0051480; GO:0051896; GO:0051897; GO:0051965; GO:0051968; GO:0060041; GO:0060076; GO:0060175; GO:0060291; GO:0071230; GO:0071356; GO:0098793; GO:0098794; GO:0098978; GO:0099183; GO:1900454; GO:1902430; GO:1990090; GO:1990416; GO:2000324; GO:2000463; GO:2000811 brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein autophosphorylation [GO:0046777]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter secretion [GO:0046928]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; response to auditory stimulus [GO:0010996]; response to ethanol [GO:0045471]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vasculogenesis [GO:0001570] axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g12133.t2 Q63604 39.105 849 1.22e-175 530.0 sp|Q63604|NTRK2_RAT BDNF/NT-3 growth factors receptor OS=Rattus norvegicus OX=10116 GN=Ntrk2 PE=1 SV=1 NTRK2_RAT reviewed BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) Rattus norvegicus (Rat) GO:0000139; GO:0001570; GO:0001764; GO:0002020; GO:0004675; GO:0004713; GO:0004714; GO:0005030; GO:0005524; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0007169; GO:0007528; GO:0007612; GO:0007616; GO:0007623; GO:0007631; GO:0008284; GO:0009416; GO:0009986; GO:0010628; GO:0010976; GO:0010996; GO:0014047; GO:0014069; GO:0019227; GO:0021954; GO:0021987; GO:0022011; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0030971; GO:0031547; GO:0031594; GO:0031901; GO:0042490; GO:0042803; GO:0043025; GO:0043066; GO:0043087; GO:0043121; GO:0043195; GO:0043197; GO:0043204; GO:0043235; GO:0043408; GO:0043410; GO:0043524; GO:0043679; GO:0045211; GO:0045471; GO:0046548; GO:0046777; GO:0046928; GO:0048403; GO:0048471; GO:0048709; GO:0048786; GO:0048935; GO:0050772; GO:0050773; GO:0051480; GO:0051896; GO:0051897; GO:0051965; GO:0051968; GO:0060041; GO:0060076; GO:0060175; GO:0060291; GO:0071230; GO:0071356; GO:0098793; GO:0098794; GO:0098978; GO:0099183; GO:1900454; GO:1902430; GO:1990090; GO:1990416; GO:2000324; GO:2000463; GO:2000811 brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein autophosphorylation [GO:0046777]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter secretion [GO:0046928]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; response to auditory stimulus [GO:0010996]; response to ethanol [GO:0045471]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vasculogenesis [GO:0001570] axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g12134.t1 Q02410 68.957 393 1.31e-174 549.0 sp|Q02410|APBA1_HUMAN Amyloid-beta A4 precursor protein-binding family A member 1 OS=Homo sapiens OX=9606 GN=APBA1 PE=1 SV=3 APBA1_HUMAN reviewed Amyloid-beta A4 precursor protein-binding family A member 1 (Adapter protein X11alpha) (Neuron-specific X11 protein) (Neuronal Munc18-1-interacting protein 1) (Mint-1) Homo sapiens (Human) GO:0001540; GO:0001701; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007155; GO:0007268; GO:0007399; GO:0007626; GO:0008021; GO:0008088; GO:0010468; GO:0014047; GO:0014051; GO:0035264; GO:0043197; GO:0048471; GO:0048787; GO:0065003; GO:0098685; GO:0098978; GO:0099171 axo-dendritic transport [GO:0008088]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] amyloid-beta binding [GO:0001540] g12134.t2 Q02410 68.702 393 1.9e-172 543.0 sp|Q02410|APBA1_HUMAN Amyloid-beta A4 precursor protein-binding family A member 1 OS=Homo sapiens OX=9606 GN=APBA1 PE=1 SV=3 APBA1_HUMAN reviewed Amyloid-beta A4 precursor protein-binding family A member 1 (Adapter protein X11alpha) (Neuron-specific X11 protein) (Neuronal Munc18-1-interacting protein 1) (Mint-1) Homo sapiens (Human) GO:0001540; GO:0001701; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007155; GO:0007268; GO:0007399; GO:0007626; GO:0008021; GO:0008088; GO:0010468; GO:0014047; GO:0014051; GO:0035264; GO:0043197; GO:0048471; GO:0048787; GO:0065003; GO:0098685; GO:0098978; GO:0099171 axo-dendritic transport [GO:0008088]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] amyloid-beta binding [GO:0001540] g12136.t1 O53532 34.746 354 3.37e-60 200.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g12137.t1 Q6PC62 57.605 309 3.2799999999999996e-135 390.0 sp|Q6PC62|SPG21_DANRE Maspardin OS=Danio rerio OX=7955 GN=spg21 PE=2 SV=1 g12138.t1 Q6AX59 46.502 243 6.44e-76 246.0 sp|Q6AX59|ABHD8_XENLA Protein ABHD8 OS=Xenopus laevis OX=8355 GN=abhd8 PE=2 SV=1 g12139.t1 Q5U550 55.102 98 1.48e-36 122.0 sp|Q5U550|DDA1_XENLA DET1- and DDB1-associated protein 1 OS=Xenopus laevis OX=8355 GN=dda1 PE=3 SV=1 g12140.t1 P27715 45.318 267 1.0499999999999999e-55 208.0 sp|P27715|UNC13_CAEEL Phorbol ester/diacylglycerol-binding protein unc-13 OS=Caenorhabditis elegans OX=6239 GN=unc-13 PE=1 SV=4 g12140.t1 P27715 52.893 121 3.08e-26 118.0 sp|P27715|UNC13_CAEEL Phorbol ester/diacylglycerol-binding protein unc-13 OS=Caenorhabditis elegans OX=6239 GN=unc-13 PE=1 SV=4 g12140.t2 P27715 45.318 267 1.1699999999999999e-55 208.0 sp|P27715|UNC13_CAEEL Phorbol ester/diacylglycerol-binding protein unc-13 OS=Caenorhabditis elegans OX=6239 GN=unc-13 PE=1 SV=4 g12140.t2 P27715 52.846 123 7.11e-27 120.0 sp|P27715|UNC13_CAEEL Phorbol ester/diacylglycerol-binding protein unc-13 OS=Caenorhabditis elegans OX=6239 GN=unc-13 PE=1 SV=4 g12141.t1 Q62769 60.455 220 3.07e-75 250.0 sp|Q62769|UN13B_RAT Protein unc-13 homolog B OS=Rattus norvegicus OX=10116 GN=Unc13b PE=1 SV=2 UN13B_RAT reviewed Protein unc-13 homolog B (Munc13-2) Rattus norvegicus (Rat) GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0008270; GO:0010807; GO:0010808; GO:0016020; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0019992; GO:0030672; GO:0030742; GO:0031594; GO:0031914; GO:0032009; GO:0035249; GO:0042734; GO:0043065; GO:0043195; GO:0044305; GO:0045921; GO:0048172; GO:0048786; GO:0050714; GO:0060384; GO:0060478; GO:0061669; GO:0061789; GO:0071333; GO:0090382; GO:0097060; GO:0097151; GO:0097470; GO:0098686; GO:0098793; GO:0098978; GO:0099011; GO:0099161; GO:1900426 acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; phagosome maturation [GO:0090382]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of exocytosis [GO:0045921]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082] calyx of Held [GO:0044305]; cytosol [GO:0005829]; early phagosome [GO:0032009]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; zinc ion binding [GO:0008270] g12142.t1 Q9Z1N9 64.576 813 0.0 1082.0 sp|Q9Z1N9|UN13B_MOUSE Protein unc-13 homolog B OS=Mus musculus OX=10090 GN=Unc13b PE=1 SV=2 g12142.t2 Q9Z1N9 64.815 810 0.0 1086.0 sp|Q9Z1N9|UN13B_MOUSE Protein unc-13 homolog B OS=Mus musculus OX=10090 GN=Unc13b PE=1 SV=2 g12142.t3 Q9Z1N9 64.321 810 0.0 1070.0 sp|Q9Z1N9|UN13B_MOUSE Protein unc-13 homolog B OS=Mus musculus OX=10090 GN=Unc13b PE=1 SV=2 g12151.t1 Q9V9W8 46.316 95 1.2399999999999999e-23 102.0 sp|Q9V9W8|PYGO_DROME Protein pygopus OS=Drosophila melanogaster OX=7227 GN=pygo PE=1 SV=1 PYGO_DROME reviewed Protein pygopus (Protein gammy legs) Drosophila melanogaster (Fruit fly) GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0007367; GO:0007472; GO:0008270; GO:0009880; GO:0035214; GO:0035293; GO:0045944; GO:0048526; GO:0060070; GO:0060232; GO:0140002; GO:1990907 canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment polarity determination [GO:0007367]; wing disc morphogenesis [GO:0007472] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3K4me3 reader activity [GO:0140002]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g12152.t1 Q2TBL4 52.06 534 0.0 560.0 sp|Q2TBL4|RPC3_BOVIN DNA-directed RNA polymerase III subunit RPC3 OS=Bos taurus OX=9913 GN=POLR3C PE=2 SV=1 g12153.t1 Q4V8V2 45.704 291 3.68e-81 250.0 sp|Q4V8V2|NUD17_DANRE m7GpppN-mRNA hydrolase NUDT17 OS=Danio rerio OX=7955 GN=nudt17 PE=2 SV=1 g12155.t1 Q06725 79.75 400 0.0 640.0 sp|Q06725|N2F1A_DANRE Nuclear receptor subfamily 2 group F member 1-A OS=Danio rerio OX=7955 GN=nr2f1a PE=2 SV=1 N2F1A_DANRE reviewed Nuclear receptor subfamily 2 group F member 1-A (COUP transcription factor 1-A) (COUP-TFalpha-A) (zCOUP-TFI) (Seven-up related 44) (Svp[44]) (zSvp[44]) (Steroid receptor homolog SVP 44) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0001935; GO:0001944; GO:0003209; GO:0004879; GO:0005634; GO:0007399; GO:0008270; GO:0030154; GO:0035284; GO:0043010; GO:0048738; GO:0055011 atrial cardiac muscle cell differentiation [GO:0055011]; brain segmentation [GO:0035284]; camera-type eye development [GO:0043010]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue development [GO:0048738]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; vasculature development [GO:0001944] nucleus [GO:0005634] nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g12155.t2 Q06725 80.0 400 0.0 646.0 sp|Q06725|N2F1A_DANRE Nuclear receptor subfamily 2 group F member 1-A OS=Danio rerio OX=7955 GN=nr2f1a PE=2 SV=1 N2F1A_DANRE reviewed Nuclear receptor subfamily 2 group F member 1-A (COUP transcription factor 1-A) (COUP-TFalpha-A) (zCOUP-TFI) (Seven-up related 44) (Svp[44]) (zSvp[44]) (Steroid receptor homolog SVP 44) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0000978; GO:0001935; GO:0001944; GO:0003209; GO:0004879; GO:0005634; GO:0007399; GO:0008270; GO:0030154; GO:0035284; GO:0043010; GO:0048738; GO:0055011 atrial cardiac muscle cell differentiation [GO:0055011]; brain segmentation [GO:0035284]; camera-type eye development [GO:0043010]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue development [GO:0048738]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; vasculature development [GO:0001944] nucleus [GO:0005634] nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g12158.t1 Q9FN03 30.542 406 5.81e-38 151.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g12158.t1 Q9FN03 28.44 327 5.100000000000001e-31 130.0 sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1 UVR8_ARATH reviewed Ultraviolet-B receptor UVR8 (Protein UV-B RESISTANCE 8) (RCC1 domain-containing protein UVR8) Arabidopsis thaliana (Mouse-ear cress) GO:0000785; GO:0003682; GO:0005085; GO:0005634; GO:0005829; GO:0009411; GO:0009536; GO:0009649; GO:0009881; GO:0010224; GO:0042802; GO:0042803 entrainment of circadian clock [GO:0009649]; response to UV [GO:0009411]; response to UV-B [GO:0010224] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plastid [GO:0009536] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; photoreceptor activity [GO:0009881]; protein homodimerization activity [GO:0042803] g12159.t1 Q7TN31 44.34 318 2.51e-67 245.0 sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1 AGGF1_MOUSE reviewed Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q) Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676] g12159.t1 Q7TN31 60.0 70 3.0700000000000002e-21 103.0 sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1 AGGF1_MOUSE reviewed Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q) Mus musculus (Mouse) GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676] g12160.t1 O88907 54.681 470 1.16e-164 489.0 sp|O88907|PIAS1_MOUSE E3 SUMO-protein ligase PIAS1 OS=Mus musculus OX=10090 GN=Pias1 PE=1 SV=2 PIAS1_MOUSE reviewed E3 SUMO-protein ligase PIAS1 (EC 2.3.2.27) (DEAD/H box-binding protein 1) (Protein inhibitor of activated STAT protein 1) (RING-type E3 ubiquitin transferase PIAS1) Mus musculus (Mouse) GO:0000082; GO:0000122; GO:0000724; GO:0000729; GO:0000785; GO:0000976; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005856; GO:0006357; GO:0006974; GO:0007259; GO:0007283; GO:0008270; GO:0008542; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0019904; GO:0031625; GO:0032436; GO:0033235; GO:0034399; GO:0042127; GO:0043066; GO:0045444; GO:0045893; GO:0051152; GO:0061630; GO:0061665; GO:0065004; GO:0098978; GO:0099523; GO:0099524; GO:0140297; GO:1904377 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542] chromatin [GO:0000785]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g12161.t1 A0JMA9 60.563 568 0.0 663.0 sp|A0JMA9|KATL2_XENTR Katanin p60 ATPase-containing subunit A-like 2 OS=Xenopus tropicalis OX=8364 GN=katnal2 PE=2 SV=1 g12165.t1 Q6AXP6 40.988 405 1.26e-88 283.0 sp|Q6AXP6|CTSR2_RAT Cation channel sperm-associated protein 2 OS=Rattus norvegicus OX=10116 GN=Catsper2 PE=2 SV=1 g12166.t1 Q9UDY8 33.171 615 1.0099999999999999e-81 282.0 sp|Q9UDY8|MALT1_HUMAN Mucosa-associated lymphoid tissue lymphoma translocation protein 1 OS=Homo sapiens OX=9606 GN=MALT1 PE=1 SV=1 MALT1_HUMAN reviewed Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase) Homo sapiens (Human) GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051168; GO:0051603; GO:0061133; GO:2000321 B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991] cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842] g12168.t1 Q8BHZ4 29.953 424 9.07e-40 164.0 sp|Q8BHZ4|ZN592_MOUSE Zinc finger protein 592 OS=Mus musculus OX=10090 GN=Znf592 PE=1 SV=3 g12169.t1 Q9HCS5 38.889 648 2.33e-140 441.0 sp|Q9HCS5|E41LA_HUMAN Band 4.1-like protein 4A OS=Homo sapiens OX=9606 GN=EPB41L4A PE=1 SV=2 g12169.t2 Q9HCS5 40.887 609 3.3e-144 451.0 sp|Q9HCS5|E41LA_HUMAN Band 4.1-like protein 4A OS=Homo sapiens OX=9606 GN=EPB41L4A PE=1 SV=2 g12169.t3 Q9HCS5 40.887 609 1.38e-144 451.0 sp|Q9HCS5|E41LA_HUMAN Band 4.1-like protein 4A OS=Homo sapiens OX=9606 GN=EPB41L4A PE=1 SV=2 g12171.t1 Q1L908 38.917 591 1.55e-127 389.0 sp|Q1L908|MSTO1_DANRE Protein misato homolog 1 OS=Danio rerio OX=7955 GN=msto1 PE=2 SV=1 g12172.t1 Q6BD04 31.915 282 2.75e-30 121.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g12179.t1 Q6P2C0 25.282 708 9.93e-58 211.0 sp|Q6P2C0|WDR93_HUMAN WD repeat-containing protein 93 OS=Homo sapiens OX=9606 GN=WDR93 PE=1 SV=1 g12179.t2 Q6P2C0 25.174 719 2.96e-56 207.0 sp|Q6P2C0|WDR93_HUMAN WD repeat-containing protein 93 OS=Homo sapiens OX=9606 GN=WDR93 PE=1 SV=1 g12180.t1 Q5RDU9 36.38 547 1.03e-99 313.0 sp|Q5RDU9|EDC3_PONAB Enhancer of mRNA-decapping protein 3 OS=Pongo abelii OX=9601 GN=EDC3 PE=2 SV=1 g12182.t1 Q3UTY6 49.627 268 1.77e-71 258.0 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g12182.t2 Q3UTY6 49.814 269 1.4000000000000002e-72 259.0 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g12182.t3 Q3UTY6 48.295 176 3.4e-40 161.0 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g12184.t1 Q3UTY6 41.603 262 7.07e-61 210.0 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g12184.t1 Q3UTY6 32.068 237 7.05e-25 107.0 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g12184.t1 Q3UTY6 34.091 176 9.37e-21 95.1 sp|Q3UTY6|THSD4_MOUSE Thrombospondin type-1 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Thsd4 PE=1 SV=2 THSD4_MOUSE reviewed Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6) (ADAMTS-like protein 4) (ADAMTSL-4) Mus musculus (Mouse) GO:0001527; GO:0005576; GO:0016787; GO:0031012; GO:0048251; GO:0160054 elastic fiber assembly [GO:0048251]; microfibril assembly [GO:0160054] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] hydrolase activity [GO:0016787] g12185.t1 Q21313 23.819 2498 4.630000000000001e-167 586.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 30.566 530 1.01e-57 227.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 33.976 415 3.98e-42 176.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 30.892 437 6.53e-42 175.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 32.533 375 7.36e-36 155.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 33.636 330 1.17e-35 154.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 39.109 202 4.540000000000001e-31 139.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 39.409 203 1.4500000000000002e-27 127.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 31.325 332 5.0100000000000005e-27 125.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 34.286 210 1.6e-25 120.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12185.t1 Q21313 33.333 219 2.2e-23 114.0 sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1 EPI1_CAEEL reviewed Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1) Caenorhabditis elegans GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0040017; GO:0042127; GO:0051788; GO:0071711 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] extracellular matrix structural constituent [GO:0005201] g12187.t1 O15229 53.864 440 1.16e-165 488.0 sp|O15229|KMO_HUMAN Kynurenine 3-monooxygenase OS=Homo sapiens OX=9606 GN=KMO PE=1 SV=2 KMO_HUMAN reviewed Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase) Homo sapiens (Human) GO:0004502; GO:0005615; GO:0005739; GO:0005741; GO:0005829; GO:0006569; GO:0009651; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1903296 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; L-tryptophan catabolic process [GO:0006569]; NAD+ metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174] g12189.t1 P97288 31.034 319 1.5400000000000002e-32 127.0 sp|P97288|5HT4R_MOUSE 5-hydroxytryptamine receptor 4 OS=Mus musculus OX=10090 GN=Htr4 PE=1 SV=3 5HT4R_MOUSE reviewed 5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4) Mus musculus (Mouse) GO:0004993; GO:0005737; GO:0005886; GO:0007186; GO:0007187; GO:0007189; GO:0007192; GO:0007198; GO:0007214; GO:0007268; GO:0010008; GO:0016020; GO:0030277; GO:0030425; GO:0030594; GO:0032098; GO:0051378; GO:0070254; GO:0098794; GO:0098978; GO:0099589; GO:0120056; GO:0150052 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; large intestinal transit [GO:0120056]; maintenance of gastrointestinal epithelium [GO:0030277]; mucus secretion [GO:0070254]; regulation of appetite [GO:0032098]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589] g12190.t1 P29275 33.77 305 3.28e-32 125.0 sp|P29275|AA2BR_HUMAN Adenosine receptor A2b OS=Homo sapiens OX=9606 GN=ADORA2B PE=1 SV=1 AA2BR_HUMAN reviewed Adenosine receptor A2b Homo sapiens (Human) GO:0001609; GO:0002882; GO:0005886; GO:0007186; GO:0007189; GO:0007190; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0042311; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171 activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685] G protein-coupled adenosine receptor activity [GO:0001609] g12193.t1 Q642M9 40.634 347 3.1000000000000002e-86 266.0 sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2 g12193.t2 Q642M9 42.651 347 9.749999999999999e-95 288.0 sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2 g12194.t1 Q6GM59 23.697 422 7.03e-29 121.0 sp|Q6GM59|MOT12_XENLA Monocarboxylate transporter 12 OS=Xenopus laevis OX=8355 GN=slc16a12 PE=2 SV=1 MOT12_XENLA reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Xenopus laevis (African clawed frog) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g12195.t1 B0TYR8 25.0 356 1.99e-23 102.0 sp|B0TYR8|TDH_FRAP2 L-threonine 3-dehydrogenase OS=Francisella philomiragia subsp. philomiragia (strain ATCC 25017 / CCUG 19701 / FSC 153 / O#319-036) OX=484022 GN=tdh PE=3 SV=1 g12196.t1 O93529 68.182 110 4.39e-53 179.0 sp|O93529|FOXB1_XENLA Forkhead box protein B1 OS=Xenopus laevis OX=8355 GN=foxb1 PE=2 SV=1 g12197.t1 P22770 34.471 293 2.85e-51 178.0 sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1 g12198.t1 P09479 43.373 166 2.05e-41 148.0 sp|P09479|ACHA_CHICK Acetylcholine receptor subunit alpha OS=Gallus gallus OX=9031 GN=CHRNA1 PE=1 SV=1 ACHA_CHICK reviewed Acetylcholine receptor subunit alpha Gallus gallus (Chicken) GO:0003009; GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0022848; GO:0034220; GO:0035094; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098793; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888] g12198.t2 Q98880 50.0 138 1.14e-41 149.0 sp|Q98880|ACHA_DANRE Acetylcholine receptor subunit alpha OS=Danio rerio OX=7955 GN=chrna1 PE=2 SV=1 g12199.t1 Q9I8C7 45.183 436 8.63e-142 417.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g12200.t1 Q9I8C7 41.475 434 1e-120 363.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g12201.t1 Q9I8C7 33.012 415 2.2900000000000002e-79 255.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g12202.t1 Q9I8C7 42.978 356 1.67e-100 313.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g12202.t2 Q9I8C7 41.24 371 1.58e-96 303.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g12203.t1 O76387 33.846 260 7.740000000000001e-27 108.0 sp|O76387|PTH2_CAEEL Probable peptidyl-tRNA hydrolase 2 OS=Caenorhabditis elegans OX=6239 GN=C24G6.8 PE=3 SV=1 g12204.t1 P30874 37.383 321 9.55e-57 194.0 sp|P30874|SSR2_HUMAN Somatostatin receptor type 2 OS=Homo sapiens OX=9606 GN=SSTR2 PE=1 SV=1 SSR2_HUMAN reviewed Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SST2) (SRIF-1) Homo sapiens (Human) GO:0004994; GO:0005654; GO:0005829; GO:0005886; GO:0007187; GO:0007193; GO:0007218; GO:0008285; GO:0030165; GO:0042923; GO:0043005; GO:0071385; GO:0071392 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218] cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994] g12205.t1 Q6BD04 35.423 319 1.66e-57 193.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g12205.t2 Q6BD04 37.647 255 5.73e-46 167.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g12208.t1 Q6BD04 33.197 244 3.19e-37 137.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g12211.t1 Q6BD04 34.226 336 3.05e-51 178.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g12213.t1 Q2KJC9 67.899 514 0.0 771.0 sp|Q2KJC9|AL7A1_BOVIN Alpha-aminoadipic semialdehyde dehydrogenase OS=Bos taurus OX=9913 GN=ALDH7A1 PE=2 SV=4 AL7A1_BOVIN reviewed Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase) Bos taurus (Bovine) GO:0000139; GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006554; GO:0008802; GO:0019285; GO:0042802; GO:0042997; GO:0097009; GO:0110076; GO:1905750 energy homeostasis [GO:0097009]; glycine betaine biosynthetic process from choline [GO:0019285]; lysine catabolic process [GO:0006554]; negative regulation of endosome to plasma membrane protein transport [GO:1905750]; negative regulation of ferroptosis [GO:0110076]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase (NAD+) activity [GO:0008802]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0004043] g12214.t1 Q8WY98 52.294 109 5.81e-38 129.0 sp|Q8WY98|TM234_HUMAN Transmembrane protein 234 OS=Homo sapiens OX=9606 GN=TMEM234 PE=1 SV=1 TM234_HUMAN reviewed Transmembrane protein 234 Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g12215.t1 O43315 42.205 263 1.47e-68 218.0 sp|O43315|AQP9_HUMAN Aquaporin-9 OS=Homo sapiens OX=9606 GN=AQP9 PE=1 SV=2 AQP9_HUMAN reviewed Aquaporin-9 (AQP-9) (Aquaglyceroporin-9) (Small solute channel 1) Homo sapiens (Human) GO:0005345; GO:0005350; GO:0005886; GO:0006833; GO:0006863; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015267; GO:0015793; GO:0015837; GO:0015855; GO:0016323; GO:0043231; GO:0071320; GO:0071722; GO:0071918; GO:0140070 amine transport [GO:0015837]; cellular response to cAMP [GO:0071320]; detoxification of arsenic-containing substance [GO:0071722]; glycerol transmembrane transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] channel activity [GO:0015267]; glycerol channel activity [GO:0015254]; hydrogen peroxide channel activity [GO:0140070]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] g12216.t1 O43315 48.54 274 4.7699999999999995e-90 272.0 sp|O43315|AQP9_HUMAN Aquaporin-9 OS=Homo sapiens OX=9606 GN=AQP9 PE=1 SV=2 AQP9_HUMAN reviewed Aquaporin-9 (AQP-9) (Aquaglyceroporin-9) (Small solute channel 1) Homo sapiens (Human) GO:0005345; GO:0005350; GO:0005886; GO:0006833; GO:0006863; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015267; GO:0015793; GO:0015837; GO:0015855; GO:0016323; GO:0043231; GO:0071320; GO:0071722; GO:0071918; GO:0140070 amine transport [GO:0015837]; cellular response to cAMP [GO:0071320]; detoxification of arsenic-containing substance [GO:0071722]; glycerol transmembrane transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] channel activity [GO:0015267]; glycerol channel activity [GO:0015254]; hydrogen peroxide channel activity [GO:0140070]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] g12218.t1 P46935 54.976 824 0.0 876.0 sp|P46935|NEDD4_MOUSE E3 ubiquitin-protein ligase NEDD4 OS=Mus musculus OX=10090 GN=Nedd4 PE=1 SV=3 NEDD4_MOUSE reviewed E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4) Mus musculus (Mouse) GO:0000122; GO:0000151; GO:0000785; GO:0002250; GO:0003151; GO:0003197; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006366; GO:0006511; GO:0006513; GO:0006622; GO:0006974; GO:0007041; GO:0007528; GO:0010766; GO:0016020; GO:0016248; GO:0016567; GO:0019870; GO:0019871; GO:0019899; GO:0019904; GO:0030948; GO:0031175; GO:0031623; GO:0031698; GO:0032801; GO:0032991; GO:0034644; GO:0035255; GO:0042110; GO:0042391; GO:0042921; GO:0043130; GO:0043162; GO:0044111; GO:0044325; GO:0045087; GO:0045732; GO:0046755; GO:0046824; GO:0048471; GO:0048514; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0050847; GO:0051897; GO:0061630; GO:0070063; GO:0070064; GO:0070534; GO:0098978; GO:0099149; GO:0099524; GO:0099576; GO:0140252; GO:1903765 adaptive immune response [GO:0002250]; blood vessel morphogenesis [GO:0048514]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; endocardial cushion development [GO:0003197]; formation of structure involved in a symbiotic process [GO:0044111]; innate immune response [GO:0045087]; lysosomal transport [GO:0007041]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; nuclear receptor-mediated glucocorticoid signaling pathway [GO:0042921]; outflow tract morphogenesis [GO:0003151]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; regulation protein catabolic process at postsynapse [GO:0140252]; T cell activation [GO:0042110]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755] cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] beta-2 adrenergic receptor binding [GO:0031698]; channel inhibitor activity [GO:0016248]; enzyme binding [GO:0019899]; ionotropic glutamate receptor binding [GO:0035255]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; potassium channel inhibitor activity [GO:0019870]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; transmembrane transporter binding [GO:0044325]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g12219.t1 Q86YP4 36.878 583 1.27e-70 249.0 sp|Q86YP4|P66A_HUMAN Transcriptional repressor p66-alpha OS=Homo sapiens OX=9606 GN=GATAD2A PE=1 SV=1 P66A_HUMAN reviewed Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A) Homo sapiens (Human) GO:0000122; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016581; GO:0016607; GO:0030674; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:2000736 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g12220.t1 B4ZIX8 67.347 588 0.0 827.0 sp|B4ZIX8|SCC4_XENLA MAU2 chromatid cohesion factor homolog OS=Xenopus laevis OX=8355 GN=mau2 PE=1 SV=1 g12221.t1 Q08DA7 64.205 176 2.48e-73 245.0 sp|Q08DA7|QTMAN_BOVIN tRNA-queuosine alpha-mannosyltransferase OS=Bos taurus OX=9913 GN=GTDC1 PE=2 SV=1 g12222.t1 Q3UHD6 55.769 520 0.0 598.0 sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2 SNX27_MOUSE reviewed Sorting nexin-27 Mus musculus (Mouse) GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0035091; GO:0035255; GO:0048306; GO:0061951; GO:0071203; GO:0090128; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098877; GO:0098978; GO:0099072; GO:0099638; GO:1904719 endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; establishment of protein localization to plasma membrane [GO:0061951]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to plasma membrane [GO:0098877]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; postsynapse [GO:0098794]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203] calcium-dependent protein binding [GO:0048306]; ionotropic glutamate receptor binding [GO:0035255]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] g12222.t2 Q3UHD6 56.36 511 0.0 599.0 sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2 SNX27_MOUSE reviewed Sorting nexin-27 Mus musculus (Mouse) GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0035091; GO:0035255; GO:0048306; GO:0061951; GO:0071203; GO:0090128; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098877; GO:0098978; GO:0099072; GO:0099638; GO:1904719 endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; establishment of protein localization to plasma membrane [GO:0061951]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to plasma membrane [GO:0098877]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; postsynapse [GO:0098794]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203] calcium-dependent protein binding [GO:0048306]; ionotropic glutamate receptor binding [GO:0035255]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] g12224.t1 Q5ZIG3 48.034 356 1.25e-120 358.0 sp|Q5ZIG3|S2546_CHICK Mitochondrial outer membrane protein SLC25A46 OS=Gallus gallus OX=9031 GN=SLC25A46 PE=2 SV=1 g12225.t1 P25789 79.747 237 9.15e-143 404.0 sp|P25789|PSA4_HUMAN Proteasome subunit alpha type-4 OS=Homo sapiens OX=9606 GN=PSMA4 PE=1 SV=1 PSA4_HUMAN reviewed Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L) (Proteasome subunit alpha-3) (alpha-3) Homo sapiens (Human) GO:0000502; GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005839; GO:0019773; GO:0043161; GO:0070062; GO:0097225; GO:0120212 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sperm head-tail coupling apparatus [GO:0120212]; sperm midpiece [GO:0097225] g12226.t1 Q4R7D3 28.009 457 2.5600000000000003e-47 172.0 sp|Q4R7D3|SAXO1_MACFA Stabilizer of axonemal microtubules 1 OS=Macaca fascicularis OX=9541 GN=SAXO1 PE=2 SV=2 g12227.t1 Q90W95 60.432 139 5.2599999999999994e-61 188.0 sp|Q90W95|PTPS_POERE 6-pyruvoyl tetrahydrobiopterin synthase OS=Poecilia reticulata OX=8081 GN=pts PE=2 SV=1 g12228.t1 Q28HN4 52.361 233 2.4e-65 204.0 sp|Q28HN4|CC124_XENTR Coiled-coil domain-containing protein 124 OS=Xenopus tropicalis OX=8364 GN=ccdc124 PE=2 SV=1 g12229.t1 Q9DBN1 30.21 619 3.34e-66 234.0 sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1 g12231.t1 O77469 34.615 260 5.48e-24 112.0 sp|O77469|FBLN1_CAEEL Fibulin-1 OS=Caenorhabditis elegans OX=6239 GN=fbl-1 PE=1 SV=3 g12232.t1 Q96PS8 36.491 285 2.7500000000000003e-64 207.0 sp|Q96PS8|AQP10_HUMAN Aquaporin-10 OS=Homo sapiens OX=9606 GN=AQP10 PE=1 SV=2 g12233.t1 O42115 58.586 99 5.61e-28 118.0 sp|O42115|ARX_DANRE Aristaless-related homeobox protein OS=Danio rerio OX=7955 GN=arx PE=2 SV=1 g12235.t1 A5PJA1 61.446 166 1.9e-75 226.0 sp|A5PJA1|KAD6_BOVIN Adenylate kinase isoenzyme 6 OS=Bos taurus OX=9913 GN=AK6 PE=2 SV=1 KAD6_BOVIN reviewed Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Coilin-interacting nuclear ATPase protein) (Dual activity adenylate kinase/ATPase) (AK/ATPase) Bos taurus (Bovine) GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006364; GO:0015030; GO:0016887; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g12236.t1 Q8R092 36.1 241 3.34e-39 142.0 sp|Q8R092|CA043_MOUSE Protein C1orf43 homolog OS=Mus musculus OX=10090 PE=2 SV=1 g12238.t1 Q5EAL3 30.435 207 2.7700000000000004e-32 119.0 sp|Q5EAL3|SWET1_XENTR Sugar transporter SWEET1 OS=Xenopus tropicalis OX=8364 GN=slc50a1 PE=2 SV=1 g12239.t1 F1R7R1 32.944 1114 2.2e-171 533.0 sp|F1R7R1|SMG5_DANRE Nonsense-mediated mRNA decay factor SMG5 OS=Danio rerio OX=7955 GN=smg5 PE=2 SV=1 g12239.t2 F1R7R1 32.915 1115 7.13e-170 529.0 sp|F1R7R1|SMG5_DANRE Nonsense-mediated mRNA decay factor SMG5 OS=Danio rerio OX=7955 GN=smg5 PE=2 SV=1 g12240.t1 O13168 69.231 793 0.0 1017.0 sp|O13168|TLE3B_DANRE Transducin-like enhancer protein 3-B OS=Danio rerio OX=7955 GN=tle3b PE=1 SV=2 g12240.t2 O13168 69.466 786 0.0 1013.0 sp|O13168|TLE3B_DANRE Transducin-like enhancer protein 3-B OS=Danio rerio OX=7955 GN=tle3b PE=1 SV=2 g12240.t3 O13168 70.0 780 0.0 1020.0 sp|O13168|TLE3B_DANRE Transducin-like enhancer protein 3-B OS=Danio rerio OX=7955 GN=tle3b PE=1 SV=2 g12240.t4 O13168 70.09 779 0.0 1019.0 sp|O13168|TLE3B_DANRE Transducin-like enhancer protein 3-B OS=Danio rerio OX=7955 GN=tle3b PE=1 SV=2 g12242.t1 P55143 46.078 102 1.23e-24 92.4 sp|P55143|GLRX_RICCO Glutaredoxin OS=Ricinus communis OX=3988 PE=3 SV=1 g12243.t1 A8WH34 33.077 390 2.92e-60 203.0 sp|A8WH34|GLMPB_XENLA Glycosylated lysosomal membrane protein B OS=Xenopus laevis OX=8355 GN=glmp-b PE=2 SV=2 g12249.t1 Q62132 30.769 299 1.56e-35 147.0 sp|Q62132|PTPRR_MOUSE Receptor-type tyrosine-protein phosphatase R OS=Mus musculus OX=10090 GN=Ptprr PE=1 SV=1 PTPRR_MOUSE reviewed Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Phosphotyrosine phosphatase 13) (Protein-tyrosine-phosphatase SL) Mus musculus (Mouse) GO:0001701; GO:0004725; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0019901; GO:0030054; GO:0038128; GO:0070373 ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886] protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g12250.t1 Q3U481 46.695 469 1.26e-126 380.0 sp|Q3U481|MFS12_MOUSE Major facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1 MFS12_MOUSE reviewed Major facilitator superfamily domain-containing protein 12 (Protein grizzled) Mus musculus (Mouse) GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712 carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021] late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886] cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293] g12251.t1 P20742 30.335 1523 0.0 662.0 sp|P20742|PZP_HUMAN Pregnancy zone protein OS=Homo sapiens OX=9606 GN=PZP PE=1 SV=4 PZP_HUMAN reviewed Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6) Homo sapiens (Human) GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0007565; GO:0070062; GO:0072562 female pregnancy [GO:0007565] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] g12252.t1 Q15650 44.5 600 7.21e-171 500.0 sp|Q15650|TRIP4_HUMAN Activating signal cointegrator 1 OS=Homo sapiens OX=9606 GN=TRIP4 PE=1 SV=4 g12254.t1 Q9Y6M4 70.698 430 0.0 620.0 sp|Q9Y6M4|KC1G3_HUMAN Casein kinase I isoform gamma-3 OS=Homo sapiens OX=9606 GN=CSNK1G3 PE=1 SV=2 KC1G3_HUMAN reviewed Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006897; GO:0007165; GO:0016055; GO:0036211; GO:0090263; GO:0106310 endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein modification process [GO:0036211]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12255.t1 B1H2P5 52.255 377 1.27e-123 383.0 sp|B1H2P5|CE120_XENTR Centrosomal protein of 120 kDa OS=Xenopus tropicalis OX=8364 GN=cep120 PE=2 SV=1 g12256.t1 Q8N960 50.709 564 0.0 543.0 sp|Q8N960|CE120_HUMAN Centrosomal protein of 120 kDa OS=Homo sapiens OX=9606 GN=CEP120 PE=1 SV=2 CE120_HUMAN reviewed Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0007098; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951 astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951] centriole [GO:0005814]; centrosome [GO:0005813] g12257.t1 Q56A10 52.632 285 3.83e-71 268.0 sp|Q56A10|ZN608_MOUSE Zinc finger protein 608 OS=Mus musculus OX=10090 GN=Znf608 PE=1 SV=1 ZN608_MOUSE reviewed Zinc finger protein 608 Mus musculus (Mouse) GO:0000122; GO:0005634; GO:0006357; GO:0008270; GO:0033085 negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] zinc ion binding [GO:0008270] g12261.t1 Q9VCY8 50.0 364 2.8499999999999998e-120 361.0 sp|Q9VCY8|ADRL_DROME Adiponectin receptor protein OS=Drosophila melanogaster OX=7227 GN=AdipoR PE=1 SV=2 g12262.t1 Q5U2Q4 50.311 322 3.69e-101 303.0 sp|Q5U2Q4|PAR16_RAT Protein mono-ADP-ribosyltransferase PARP16 OS=Rattus norvegicus OX=10116 GN=Parp16 PE=2 SV=1 PAR16_RAT reviewed Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16) Rattus norvegicus (Rat) GO:0002181; GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0016020; GO:0016779; GO:0019900; GO:0030968; GO:0036498; GO:0043539; GO:0070213; GO:0071782; GO:0140804; GO:0140806; GO:0140807; GO:1990404; GO:1990830; GO:2000766 cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cytoplasmic translation [GO:2000766]; protein auto-ADP-ribosylation [GO:0070213] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; membrane [GO:0016020]; nuclear envelope [GO:0005635] kinase binding [GO:0019900]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; nucleotidyltransferase activity [GO:0016779]; protein serine/threonine kinase activator activity [GO:0043539] g12263.t1 Q924S5 65.204 980 0.0 1256.0 sp|Q924S5|LONM_RAT Lon protease homolog, mitochondrial OS=Rattus norvegicus OX=10116 GN=Lonp1 PE=2 SV=1 g12266.t1 Q08431 35.777 341 1.21e-46 176.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g12266.t1 Q08431 32.317 328 2.44e-33 137.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g12266.t1 Q08431 30.671 313 8.320000000000001e-29 123.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g12266.t1 Q08431 29.494 356 1.8e-25 113.0 sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3 MFGM_HUMAN reviewed Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin] Homo sapiens (Human) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0031012; GO:0043277; GO:0070062; GO:1903561 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020] integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786] g12270.t1 Q9JJZ6 74.59 122 1.2100000000000002e-59 194.0 sp|Q9JJZ6|KLF13_MOUSE Krueppel-like factor 13 OS=Mus musculus OX=10090 GN=Klf13 PE=1 SV=2 KLF13_MOUSE reviewed Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Erythroid transcription factor FKLF-2) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0008285; GO:0045647; GO:0045944; GO:1990837 negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g12271.t1 Q8W4Q3 36.771 223 7.03e-28 115.0 sp|Q8W4Q3|PIRL3_ARATH Plant intracellular Ras-group-related LRR protein 3 OS=Arabidopsis thaliana OX=3702 GN=PIRL3 PE=2 SV=1 g12272.t1 Q8K596 33.942 931 2.2e-144 454.0 sp|Q8K596|NAC2_MOUSE Sodium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc8a2 PE=1 SV=1 NAC2_MOUSE reviewed Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2) Mus musculus (Mouse) GO:0002931; GO:0005432; GO:0005516; GO:0005874; GO:0005886; GO:0006814; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0016323; GO:0030424; GO:0030425; GO:0035725; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0060402; GO:0070050; GO:0070588; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099608; GO:0106056; GO:1902533; GO:1905060; GO:1990034 calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of intracellular signal transduction [GO:1902533]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808] axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202] calcium ion transmembrane transporter activity [GO:0015085]; calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081] g12272.t2 Q8K596 33.333 942 2.46e-143 452.0 sp|Q8K596|NAC2_MOUSE Sodium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc8a2 PE=1 SV=1 NAC2_MOUSE reviewed Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2) Mus musculus (Mouse) GO:0002931; GO:0005432; GO:0005516; GO:0005874; GO:0005886; GO:0006814; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0016323; GO:0030424; GO:0030425; GO:0035725; GO:0042383; GO:0042995; GO:0043025; GO:0043197; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0060402; GO:0070050; GO:0070588; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099608; GO:0106056; GO:1902533; GO:1905060; GO:1990034 calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of intracellular signal transduction [GO:1902533]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; synapse organization [GO:0050808] axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202] calcium ion transmembrane transporter activity [GO:0015085]; calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081] g12273.t1 E9PV86 69.697 66 5.98e-26 102.0 sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1 g12275.t1 Q03111 48.973 292 1.66e-74 252.0 sp|Q03111|ENL_HUMAN Protein ENL OS=Homo sapiens OX=9606 GN=MLLT1 PE=1 SV=2 ENL_HUMAN reviewed Protein ENL (Eleven-nineteen-leukeumia) (YEATS domain-containing protein 1) Homo sapiens (Human) GO:0001650; GO:0003682; GO:0005654; GO:0005829; GO:0008023; GO:0045893 positive regulation of DNA-templated transcription [GO:0045893] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] chromatin binding [GO:0003682] g12275.t2 Q03111 48.973 292 6.0499999999999996e-74 249.0 sp|Q03111|ENL_HUMAN Protein ENL OS=Homo sapiens OX=9606 GN=MLLT1 PE=1 SV=2 ENL_HUMAN reviewed Protein ENL (Eleven-nineteen-leukeumia) (YEATS domain-containing protein 1) Homo sapiens (Human) GO:0001650; GO:0003682; GO:0005654; GO:0005829; GO:0008023; GO:0045893 positive regulation of DNA-templated transcription [GO:0045893] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] chromatin binding [GO:0003682] g12276.t1 O00160 60.548 1095 0.0 1346.0 sp|O00160|MYO1F_HUMAN Unconventional myosin-If OS=Homo sapiens OX=9606 GN=MYO1F PE=1 SV=3 MYO1F_HUMAN reviewed Unconventional myosin-If (Myosin-Ie) Homo sapiens (Human) GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006897; GO:0007015; GO:0015629; GO:0016461; GO:0051015 actin filament organization [GO:0007015]; endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] g12281.t1 O43776 82.031 256 3.74e-163 466.0 sp|O43776|SYNC_HUMAN Asparagine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=NARS1 PE=1 SV=1 SYNC_HUMAN reviewed Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) (Asparaginyl-tRNA synthetase 1) Homo sapiens (Human) GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0016477; GO:0021987; GO:0031728; GO:0046983; GO:0070062 asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983] g12281.t2 O43776 70.37 297 2.5e-153 443.0 sp|O43776|SYNC_HUMAN Asparagine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=NARS1 PE=1 SV=1 SYNC_HUMAN reviewed Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) (Asparaginyl-tRNA synthetase 1) Homo sapiens (Human) GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0016477; GO:0021987; GO:0031728; GO:0046983; GO:0070062 asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983] g12282.t1 Q2KJG3 62.462 325 2.74e-155 451.0 sp|Q2KJG3|SYNC_BOVIN Asparagine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=NARS PE=2 SV=3 g12282.t2 Q2KJG3 62.462 325 4.65e-154 447.0 sp|Q2KJG3|SYNC_BOVIN Asparagine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=NARS PE=2 SV=3 g12283.t1 E9PZM4 51.713 1284 0.0 1117.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g12283.t2 E9PZM4 51.482 1282 0.0 1117.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g12283.t3 E9PZM4 52.219 1262 0.0 1121.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g12284.t1 E9PZM4 46.19 420 1.1299999999999999e-95 326.0 sp|E9PZM4|CHD2_MOUSE Chromodomain-helicase-DNA-binding protein 2 OS=Mus musculus OX=10090 GN=Chd2 PE=1 SV=1 CHD2_MOUSE reviewed ATP-dependent chromatin remodeler CHD2 (EC 3.6.4.-) (Chromo domain-containing protein 2) (CHD-2) Mus musculus (Mouse) GO:0000785; GO:0000978; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728] chromatin [GO:0000785]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g12285.t1 Q6NTJ7 42.289 201 1.76e-55 178.0 sp|Q6NTJ7|SWET1_XENLA Sugar transporter SWEET1 OS=Xenopus laevis OX=8355 GN=slc50a1 PE=2 SV=1 g12285.t2 Q6NTJ7 41.706 211 1.9199999999999999e-53 174.0 sp|Q6NTJ7|SWET1_XENLA Sugar transporter SWEET1 OS=Xenopus laevis OX=8355 GN=slc50a1 PE=2 SV=1 g12289.t1 Q9DEY9 43.556 900 0.0 701.0 sp|Q9DEY9|BLM_XENLA RecQ-like DNA helicase BLM OS=Xenopus laevis OX=8355 GN=blm PE=2 SV=1 g12290.t1 G1TTQ5 68.085 94 9.909999999999999e-38 125.0 sp|G1TTQ5|RL36_RABIT Large ribosomal subunit protein eL36 OS=Oryctolagus cuniculus OX=9986 GN=RPL36 PE=1 SV=3 g12291.t1 E9PV86 49.282 696 0.0 655.0 sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1 g12292.t1 Q6P502 73.247 542 0.0 852.0 sp|Q6P502|TCPG_RAT T-complex protein 1 subunit gamma OS=Rattus norvegicus OX=10116 GN=Cct3 PE=1 SV=1 TCPG_RAT reviewed T-complex protein 1 subunit gamma (TCP-1-gamma) (EC 3.6.1.-) (CCT-gamma) Rattus norvegicus (Rat) GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0046872; GO:0050821; GO:0051082; GO:0140662 binding of sperm to zona pellucida [GO:0007339]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] g12293.t1 Q6VAB6 33.013 312 3.6499999999999995e-46 179.0 sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2 KSR2_HUMAN reviewed Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162 calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g12295.t1 Q8AXV1 54.875 359 3.9000000000000004e-132 384.0 sp|Q8AXV1|SH3G2_CHICK Endophilin-A1 OS=Gallus gallus OX=9031 GN=SH3GL2 PE=1 SV=1 g12296.t1 A6QLA6 33.946 598 1.17e-38 161.0 sp|A6QLA6|CAF1A_BOVIN Chromatin assembly factor 1 subunit A OS=Bos taurus OX=9913 GN=CHAF1A PE=2 SV=1 g12303.t1 Q5ZLY0 30.458 371 3.5600000000000003e-35 137.0 sp|Q5ZLY0|PHAX_CHICK Phosphorylated adapter RNA export protein OS=Gallus gallus OX=9031 GN=PHAX PE=2 SV=1 PHAX_CHICK reviewed Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein) Gallus gallus (Chicken) GO:0003723; GO:0005634; GO:0005737; GO:0006408; GO:0015031 protein transport [GO:0015031]; snRNA export from nucleus [GO:0006408] cytoplasm [GO:0005737]; nucleus [GO:0005634] RNA binding [GO:0003723] g12306.t1 Q9BRS8 38.724 439 1.4999999999999998e-74 247.0 sp|Q9BRS8|LARP6_HUMAN La-related protein 6 OS=Homo sapiens OX=9606 GN=LARP6 PE=1 SV=1 LARP6_HUMAN reviewed La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Homo sapiens (Human) GO:0003729; GO:0005634; GO:0005737; GO:0006396; GO:0006417; GO:0017022; GO:0032967; GO:0035613; GO:0048027; GO:1990825; GO:1990904 positive regulation of collagen biosynthetic process [GO:0032967]; regulation of translation [GO:0006417]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825] g12307.t1 Q0P5A1 35.294 187 1.45e-32 118.0 sp|Q0P5A1|DCTN3_BOVIN Dynactin subunit 3 OS=Bos taurus OX=9913 GN=DCTN3 PE=2 SV=1 DCTN3_BOVIN reviewed Dynactin subunit 3 Bos taurus (Bovine) GO:0000776; GO:0005737; GO:0005813; GO:0005819; GO:0005869; GO:0030496; GO:0032154; GO:0061640 cytoskeleton-dependent cytokinesis [GO:0061640] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]; midbody [GO:0030496]; spindle [GO:0005819] g12308.t1 Q9UKP4 43.927 988 0.0 775.0 sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2 ATS7_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) Homo sapiens (Human) GO:0002062; GO:0004222; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773 cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g12309.t1 P24367 53.846 182 2.84e-65 204.0 sp|P24367|PPIB_CHICK Peptidyl-prolyl cis-trans isomerase B OS=Gallus gallus OX=9031 GN=PPIB PE=2 SV=1 g12310.t1 Q9NY26 35.647 317 1.37e-46 164.0 sp|Q9NY26|S39A1_HUMAN Zinc transporter ZIP1 OS=Homo sapiens OX=9606 GN=SLC39A1 PE=1 SV=1 S39A1_HUMAN reviewed Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1) (ZIP-1) (hZIP1) Homo sapiens (Human) GO:0001701; GO:0005102; GO:0005385; GO:0005789; GO:0005886; GO:0006812; GO:0016020; GO:0022890; GO:0048701; GO:0060173; GO:0071577 embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; monoatomic cation transport [GO:0006812]; zinc ion transmembrane transport [GO:0071577] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] inorganic cation transmembrane transporter activity [GO:0022890]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385] g12311.t1 Q5E960 31.043 393 1.04e-48 171.0 sp|Q5E960|S39A3_BOVIN Zinc transporter ZIP3 OS=Bos taurus OX=9913 GN=SLC39A3 PE=2 SV=2 S39A3_BOVIN reviewed Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3) Bos taurus (Bovine) GO:0000902; GO:0001701; GO:0005385; GO:0005886; GO:0016324; GO:0043029; GO:0048701; GO:0060173; GO:0071577; GO:0098686 cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886] zinc ion transmembrane transporter activity [GO:0005385] g12313.t1 P82915 52.586 116 1.5199999999999998e-38 129.0 sp|P82915|RT16_BOVIN Small ribosomal subunit protein bS16m OS=Bos taurus OX=9913 GN=MRPS16 PE=1 SV=2 g12314.t1 Q5TYW4 42.828 2433 0.0 1848.0 sp|Q5TYW4|NBAS_DANRE NBAS subunit of NRZ tethering complex OS=Danio rerio OX=7955 GN=nbas PE=2 SV=1 NBAS_DANRE reviewed NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein homolog) (Neuroblastoma-amplified sequence) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000149; GO:0000184; GO:0000956; GO:0006890; GO:0015031; GO:0043009; GO:0048703; GO:0070939; GO:2000623 chordate embryonic development [GO:0043009]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] Dsl1/NZR complex [GO:0070939] SNARE binding [GO:0000149] g12315.t1 Q38PU8 28.338 794 4.7e-86 298.0 sp|Q38PU8|GRIA1_MACFA Glutamate receptor 1 OS=Macaca fascicularis OX=9541 GN=GRIA1 PE=2 SV=1 GRIA1_MACFA reviewed Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004970; GO:0004971; GO:0005789; GO:0014069; GO:0022849; GO:0030425; GO:0030666; GO:0031901; GO:0032281; GO:0043197; GO:0045202; GO:0045211; GO:0055038; GO:0098793; GO:0098794; GO:0098839 AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202] AMPA glutamate receptor activity [GO:0004971]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970] g12316.t1 P23818 28.457 752 2.84e-87 301.0 sp|P23818|GRIA1_MOUSE Glutamate receptor 1 OS=Mus musculus OX=10090 GN=Gria1 PE=1 SV=1 GRIA1_MOUSE reviewed Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1) Mus musculus (Mouse) GO:0001540; GO:0001919; GO:0001965; GO:0004970; GO:0004971; GO:0005769; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005911; GO:0007268; GO:0007416; GO:0007616; GO:0008021; GO:0008179; GO:0008328; GO:0009410; GO:0009636; GO:0009744; GO:0009897; GO:0009986; GO:0010226; GO:0010628; GO:0014069; GO:0016020; GO:0019228; GO:0019865; GO:0019901; GO:0019904; GO:0021510; GO:0021987; GO:0022849; GO:0030165; GO:0030425; GO:0030672; GO:0031267; GO:0031489; GO:0031594; GO:0031623; GO:0031667; GO:0031681; GO:0031698; GO:0031901; GO:0032279; GO:0032281; GO:0032355; GO:0032590; GO:0032591; GO:0032809; GO:0032991; GO:0034765; GO:0035249; GO:0035254; GO:0035255; GO:0036477; GO:0042220; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0044297; GO:0044308; GO:0044309; GO:0045202; GO:0045211; GO:0045471; GO:0045838; GO:0046685; GO:0048167; GO:0048266; GO:0048787; GO:0050804; GO:0050806; GO:0051018; GO:0051428; GO:0051602; GO:0055037; GO:0055038; GO:0060076; GO:0060291; GO:0060292; GO:0060992; GO:0071242; GO:0071359; GO:0071375; GO:0071418; GO:0090326; GO:0097060; GO:0097110; GO:0098793; GO:0098794; GO:0098839; GO:0098978; GO:0099092; GO:0099507; GO:0099544; GO:0099604; GO:1904315; GO:1905232; GO:1990416; GO:1990635; GO:1990708; GO:1990911; GO:2000463 behavioral response to pain [GO:0048266]; cellular response to amine stimulus [GO:0071418]; cellular response to ammonium ion [GO:0071242]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to dsRNA [GO:0071359]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; conditioned place preference [GO:1990708]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to arsenic-containing substance [GO:0046685]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to psychosocial stress [GO:1990911]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; spinal cord development [GO:0021510]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell body [GO:0044297]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; glutamate receptor binding [GO:0035254]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; myosin V binding [GO:0031489]; PDZ domain binding [GO:0030165]; peptide hormone receptor binding [GO:0051428]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g12317.t1 P23818 30.429 769 6.15e-113 371.0 sp|P23818|GRIA1_MOUSE Glutamate receptor 1 OS=Mus musculus OX=10090 GN=Gria1 PE=1 SV=1 GRIA1_MOUSE reviewed Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1) Mus musculus (Mouse) GO:0001540; GO:0001919; GO:0001965; GO:0004970; GO:0004971; GO:0005769; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005911; GO:0007268; GO:0007416; GO:0007616; GO:0008021; GO:0008179; GO:0008328; GO:0009410; GO:0009636; GO:0009744; GO:0009897; GO:0009986; GO:0010226; GO:0010628; GO:0014069; GO:0016020; GO:0019228; GO:0019865; GO:0019901; GO:0019904; GO:0021510; GO:0021987; GO:0022849; GO:0030165; GO:0030425; GO:0030672; GO:0031267; GO:0031489; GO:0031594; GO:0031623; GO:0031667; GO:0031681; GO:0031698; GO:0031901; GO:0032279; GO:0032281; GO:0032355; GO:0032590; GO:0032591; GO:0032809; GO:0032991; GO:0034765; GO:0035249; GO:0035254; GO:0035255; GO:0036477; GO:0042220; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0044297; GO:0044308; GO:0044309; GO:0045202; GO:0045211; GO:0045471; GO:0045838; GO:0046685; GO:0048167; GO:0048266; GO:0048787; GO:0050804; GO:0050806; GO:0051018; GO:0051428; GO:0051602; GO:0055037; GO:0055038; GO:0060076; GO:0060291; GO:0060292; GO:0060992; GO:0071242; GO:0071359; GO:0071375; GO:0071418; GO:0090326; GO:0097060; GO:0097110; GO:0098793; GO:0098794; GO:0098839; GO:0098978; GO:0099092; GO:0099507; GO:0099544; GO:0099604; GO:1904315; GO:1905232; GO:1990416; GO:1990635; GO:1990708; GO:1990911; GO:2000463 behavioral response to pain [GO:0048266]; cellular response to amine stimulus [GO:0071418]; cellular response to ammonium ion [GO:0071242]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to dsRNA [GO:0071359]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; conditioned place preference [GO:1990708]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuronal action potential [GO:0019228]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of membrane potential [GO:0045838]; positive regulation of synaptic transmission [GO:0050806]; receptor internalization [GO:0031623]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of receptor recycling [GO:0001919]; regulation of synaptic plasticity [GO:0048167]; response to arsenic-containing substance [GO:0046685]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to psychosocial stress [GO:1990911]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; spinal cord development [GO:0021510]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; axonal spine [GO:0044308]; cell body [GO:0044297]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; ionotropic glutamate receptor complex [GO:0008328]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] adenylate cyclase binding [GO:0008179]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; beta-2 adrenergic receptor binding [GO:0031698]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; glutamate receptor binding [GO:0035254]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; myosin V binding [GO:0031489]; PDZ domain binding [GO:0030165]; peptide hormone receptor binding [GO:0051428]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g12321.t1 Q9H2B2 57.194 278 1.71e-111 337.0 sp|Q9H2B2|SYT4_HUMAN Synaptotagmin-4 OS=Homo sapiens OX=9606 GN=SYT4 PE=1 SV=1 SYT4_HUMAN reviewed Synaptotagmin-4 (Synaptotagmin IV) (SytIV) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0005509; GO:0005544; GO:0005886; GO:0006906; GO:0007613; GO:0014049; GO:0014059; GO:0016192; GO:0017158; GO:0030100; GO:0030154; GO:0030424; GO:0030425; GO:0030672; GO:0032127; GO:0033604; GO:0043025; GO:0045202; GO:0045955; GO:0045956; GO:0048174; GO:0048471; GO:0050709; GO:0061891; GO:0070382; GO:0097449; GO:0098978; GO:0098992; GO:0099012; GO:0099502; GO:0099519; GO:0150035; GO:0150044; GO:1903861; GO:1905415; GO:1905433; GO:1990742; GO:2000301 calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; cell differentiation [GO:0030154]; dense core granule cytoskeletal transport [GO:0099519]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic dense core vesicle exocytosis [GO:0150044]; regulation of trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0150035]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; dense core granule membrane [GO:0032127]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; microvesicle [GO:1990742]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; neuronal dense core vesicle membrane [GO:0099012]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149] g12322.t1 Q92963 67.164 201 3.6e-92 273.0 sp|Q92963|RIT1_HUMAN GTP-binding protein Rit1 OS=Homo sapiens OX=9606 GN=RIT1 PE=1 SV=1 RIT1_HUMAN reviewed GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1) Homo sapiens (Human) GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003 Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] plasma membrane [GO:0005886] calmodulin binding [GO:0005516]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g12323.t1 Q5RE70 52.284 1029 0.0 1038.0 sp|Q5RE70|INT3_PONAB Integrator complex subunit 3 OS=Pongo abelii OX=9601 GN=INTS3 PE=2 SV=1 g12325.t1 Q5RFI6 28.547 585 1.33e-66 239.0 sp|Q5RFI6|FAKD5_PONAB FAST kinase domain-containing protein 5, mitochondrial OS=Pongo abelii OX=9601 GN=FASTKD5 PE=2 SV=1 g12326.t1 Q9VSL3 42.5 240 1.2900000000000001e-56 183.0 sp|Q9VSL3|SEPIA_DROME Pyrimidodiazepine synthase OS=Drosophila melanogaster OX=7227 GN=se PE=1 SV=1 SEPIA_DROME reviewed Pyrimidodiazepine synthase (EC 1.5.4.1) (Protein sepia) Drosophila melanogaster (Fruit fly) GO:0004364; GO:0004734; GO:0005737; GO:0006726; GO:0006728; GO:0006749; GO:0042803; GO:0045174 eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; pteridine biosynthetic process [GO:0006728] cytoplasm [GO:0005737] glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734] g12327.t1 Q9H5X1 58.084 167 1.5699999999999998e-61 191.0 sp|Q9H5X1|CIA2A_HUMAN Cytosolic iron-sulfur assembly component 2A OS=Homo sapiens OX=9606 GN=CIAO2A PE=1 SV=1 CIA2A_HUMAN reviewed Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A) Homo sapiens (Human) GO:0005654; GO:0005829; GO:0007059; GO:0046872; GO:0051604; GO:0097361 chromosome segregation [GO:0007059]; protein maturation [GO:0051604] cytosol [GO:0005829]; cytosolic [4Fe-4S] assembly targeting complex [GO:0097361]; nucleoplasm [GO:0005654] metal ion binding [GO:0046872] g12328.t1 B0VYY3 66.165 133 1.2200000000000001e-58 182.0 sp|B0VYY3|COX5A_OTOCR Cytochrome c oxidase subunit 5A, mitochondrial OS=Otolemur crassicaudatus OX=9463 GN=COX5A PE=2 SV=1 g12329.t1 Q6PFJ9 75.316 474 0.0 758.0 sp|Q6PFJ9|ARI1_DANRE E3 ubiquitin-protein ligase arih1 OS=Danio rerio OX=7955 GN=arih1 PE=2 SV=1 ARI1_DANRE reviewed E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000151; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0016604; GO:0031624; GO:0061630; GO:0097413 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12333.t1 Q642M9 43.266 349 2.98e-99 300.0 sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2 g12334.t1 Q642M9 43.84 349 6.99e-102 306.0 sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2 g12335.t1 Q8CG46 42.871 1052 0.0 852.0 sp|Q8CG46|SMC5_MOUSE Structural maintenance of chromosomes protein 5 OS=Mus musculus OX=10090 GN=Smc5 PE=1 SV=1 SMC5_MOUSE reviewed Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453) Mus musculus (Mouse) GO:0000217; GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003697; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0044828; GO:0051301; GO:0051984; GO:0071459; GO:0090398 cell division [GO:0051301]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of viral genome replication [GO:0044828]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722] cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] ATP binding [GO:0005524]; DNA secondary structure binding [GO:0000217]; single-stranded DNA binding [GO:0003697] g12336.t1 A1L1C5 32.716 162 2.18e-26 108.0 sp|A1L1C5|URAD_XENLA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Xenopus laevis OX=8355 GN=urad PE=2 SV=1 g12337.t1 A1L1C5 46.341 164 1.49e-48 158.0 sp|A1L1C5|URAD_XENLA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Xenopus laevis OX=8355 GN=urad PE=2 SV=1 g12338.t1 Q8AY68 51.793 251 1.4e-74 248.0 sp|Q8AY68|SHC1_XENLA SHC-transforming protein 1 OS=Xenopus laevis OX=8355 GN=shc1 PE=1 SV=2 g12338.t1 Q8AY68 39.764 254 3.56e-36 144.0 sp|Q8AY68|SHC1_XENLA SHC-transforming protein 1 OS=Xenopus laevis OX=8355 GN=shc1 PE=1 SV=2 g12339.t1 Q8N567 40.741 297 8.850000000000001e-65 207.0 sp|Q8N567|ZCHC9_HUMAN Zinc finger CCHC domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZCCHC9 PE=1 SV=2 g12340.t1 Q38SD2 28.903 1851 0.0 639.0 sp|Q38SD2|LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=LRRK1 PE=1 SV=3 LRRK1_HUMAN reviewed Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533 bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12341.t1 Q66H33 34.274 248 1.4900000000000001e-33 127.0 sp|Q66H33|CC038_RAT Uncharacterized protein C3orf38 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1 g12342.t1 Q8K4Q6 43.119 218 1.18e-57 194.0 sp|Q8K4Q6|NEIL1_MOUSE Endonuclease 8-like 1 OS=Mus musculus OX=10090 GN=Neil1 PE=2 SV=3 NEIL1_MOUSE reviewed Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1) Mus musculus (Mouse) GO:0003684; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0006281; GO:0006284; GO:0006979; GO:0008270; GO:0016798; GO:0016829; GO:0019104; GO:0140078 base-excision repair [GO:0006284]; DNA repair [GO:0006281]; response to oxidative stress [GO:0006979] centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; lyase activity [GO:0016829]; zinc ion binding [GO:0008270] g12344.t1 Q91VX2 29.97 337 1.76e-22 108.0 sp|Q91VX2|UBAP2_MOUSE Ubiquitin-associated protein 2 OS=Mus musculus OX=10090 GN=Ubap2 PE=1 SV=1 g12345.t1 Q5T6F2 40.0 300 4.55e-28 116.0 sp|Q5T6F2|UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo sapiens OX=9606 GN=UBAP2 PE=1 SV=1 UBAP2_HUMAN reviewed Ubiquitin-associated protein 2 (UBAP-2) (RNA polymerase II degradation factor UBAP2) Homo sapiens (Human) GO:0000932; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0010468; GO:0045296; GO:0061484 hematopoietic stem cell homeostasis [GO:0061484]; regulation of gene expression [GO:0010468] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cadherin binding [GO:0045296]; RNA binding [GO:0003723] g12345.t2 Q5T6F2 40.845 284 8.21e-28 115.0 sp|Q5T6F2|UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo sapiens OX=9606 GN=UBAP2 PE=1 SV=1 UBAP2_HUMAN reviewed Ubiquitin-associated protein 2 (UBAP-2) (RNA polymerase II degradation factor UBAP2) Homo sapiens (Human) GO:0000932; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0010468; GO:0045296; GO:0061484 hematopoietic stem cell homeostasis [GO:0061484]; regulation of gene expression [GO:0010468] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cadherin binding [GO:0045296]; RNA binding [GO:0003723] g12346.t1 P0C862 29.798 396 2.34e-26 111.0 sp|P0C862|C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A OS=Homo sapiens OX=9606 GN=C1QTNF9 PE=1 SV=1 g12347.t1 Q7SZ59 45.703 256 3.41e-68 213.0 sp|Q7SZ59|RASLC_DANRE Ras-like protein family member 12 OS=Danio rerio OX=7955 GN=RASL12 PE=2 SV=1 g12348.t1 Q9UGM3 31.951 1061 2.0299999999999999e-115 410.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g12348.t1 Q9UGM3 31.434 1053 2.65e-114 406.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g12348.t1 Q9UGM3 30.85 1047 4.72e-112 399.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g12348.t1 Q9UGM3 32.781 543 1.01e-53 212.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g12348.t1 Q9UGM3 33.907 407 1.57e-46 188.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g12348.t2 F7J220 34.615 780 2.03e-100 353.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g12348.t2 F7J220 33.492 839 8.549999999999999e-91 325.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g12348.t2 F7J220 32.21 801 4.75e-88 317.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g12348.t2 F7J220 32.377 732 4.84e-73 271.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g12348.t2 F7J220 33.264 478 7.93e-49 194.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g12348.t2 F7J220 29.396 381 1.59e-30 135.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g12348.t2 F7J220 32.653 294 1.2799999999999999e-24 116.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g12350.t1 Q6DHG8 32.5 280 1.63e-41 146.0 sp|Q6DHG8|SKA1_DANRE SKA complex subunit 1 OS=Danio rerio OX=7955 GN=ska1 PE=2 SV=1 SKA1_DANRE reviewed SKA complex subunit 1 (Spindle and kinetochore-associated protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000070; GO:0000278; GO:0000940; GO:0005876; GO:0007059; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072686; GO:0072687 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110] meiotic spindle [GO:0072687]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876] microtubule binding [GO:0008017] g12351.t1 Q9Y5X4 59.548 398 4.29e-158 455.0 sp|Q9Y5X4|NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens OX=9606 GN=NR2E3 PE=1 SV=1 NR2E3_HUMAN reviewed Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0007165; GO:0007601; GO:0007602; GO:0008270; GO:0008283; GO:0008285; GO:0010628; GO:0030182; GO:0042462; GO:0043565; GO:0045944; GO:0060041 cell population proliferation [GO:0008283]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g12354.t1 O15146 33.594 384 1.68e-58 217.0 sp|O15146|MUSK_HUMAN Muscle, skeletal receptor tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=MUSK PE=1 SV=1 g12357.t1 Q9QYV8 53.974 1208 0.0 1244.0 sp|Q9QYV8|DPOG1_RAT DNA polymerase subunit gamma-1 OS=Rattus norvegicus OX=10116 GN=Polg PE=2 SV=1 DPOG1_RAT reviewed DNA polymerase subunit gamma-1 (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (5'-deoxyribose-phosphate lyase) (EC 4.2.99.-) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha) Rattus norvegicus (Rat) GO:0000262; GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005759; GO:0005760; GO:0006261; GO:0006264; GO:0006284; GO:0006287; GO:0008310; GO:0008340; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0045004; GO:0046872; GO:0051575; GO:0055093; GO:0071333 base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; determination of adult lifespan [GO:0008340]; DNA replication proofreading [GO:0045004]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416] gamma DNA polymerase complex [GO:0005760]; mitochondrial chromosome [GO:0000262]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195] 3'-5' exonuclease activity [GO:0008408]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310] g12358.t1 Q49SH1 39.062 448 1.4499999999999997e-104 326.0 sp|Q49SH1|NCKX5_DANRE Sodium/potassium/calcium exchanger 5 OS=Danio rerio OX=7955 GN=slc24a5 PE=2 SV=1 NCKX5_DANRE reviewed Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Protein golden) (Solute carrier family 24 member 5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005262; GO:0005802; GO:0006874; GO:0008273; GO:0015293; GO:0016020; GO:0030318; GO:0042470; GO:0043473; GO:0048066; GO:0048069; GO:0070588; GO:0097324 calcium ion transmembrane transport [GO:0070588]; developmental pigmentation [GO:0048066]; eye pigmentation [GO:0048069]; intracellular calcium ion homeostasis [GO:0006874]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; pigmentation [GO:0043473] melanosome [GO:0042470]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293] g12363.t1 Q5R5L7 26.884 398 7.690000000000001e-27 113.0 sp|Q5R5L7|ARRD3_PONAB Arrestin domain-containing protein 3 OS=Pongo abelii OX=9601 GN=ARRDC3 PE=2 SV=1 g17.t1 Q17QR8 30.634 284 2.6100000000000003e-35 134.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g28.t1 Q503Q1 43.558 489 4.85e-133 397.0 sp|Q503Q1|MIEAP_DANRE Mitochondria-eating protein OS=Danio rerio OX=7955 GN=spata18 PE=2 SV=2 g29.t1 P56489 36.018 447 9.43e-84 268.0 sp|P56489|ACM1_MACMU Muscarinic acetylcholine receptor M1 OS=Macaca mulatta OX=9544 GN=CHRM1 PE=2 SV=1 g30.t1 Q5RFQ3 57.77 888 0.0 1103.0 sp|Q5RFQ3|PWP2_PONAB Periodic tryptophan protein 2 homolog OS=Pongo abelii OX=9601 GN=PWP2 PE=2 SV=1 g32.t1 Q9UBG0 32.567 261 2.78e-25 114.0 sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2 MRC2_HUMAN reviewed C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280) Homo sapiens (Human) GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023 collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649] focal adhesion [GO:0005925]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023] g35.t1 O94762 47.026 723 0.0 639.0 sp|O94762|RECQ5_HUMAN ATP-dependent DNA helicase Q5 OS=Homo sapiens OX=9606 GN=RECQL5 PE=1 SV=2 RECQ5_HUMAN reviewed ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5) Homo sapiens (Human) GO:0000278; GO:0000724; GO:0000993; GO:0003677; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006281; GO:0009378; GO:0016887; GO:0034244; GO:0042802; GO:0043138; GO:0046872; GO:0051301; GO:0051304; GO:0071466; GO:0072757; GO:0097550; GO:1990414; GO:1990506; GO:2000042 cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; mitotic DNA-templated DNA replication [GO:1990506]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; transcription preinitiation complex [GO:0097550] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993] g36.t1 Q13123 65.015 343 1.88e-127 389.0 sp|Q13123|RED_HUMAN Protein Red OS=Homo sapiens OX=9606 GN=IK PE=1 SV=3 RED_HUMAN reviewed Protein Red (Cytokine IK) (IK factor) (Protein RER) Homo sapiens (Human) GO:0000278; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0007094; GO:0016607; GO:0034501; GO:0042802; GO:0071005 mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501] chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005] identical protein binding [GO:0042802] g37.t1 Q5XIU9 55.03 169 2.48e-61 192.0 sp|Q5XIU9|PGRC2_RAT Membrane-associated progesterone receptor component 2 OS=Rattus norvegicus OX=10116 GN=Pgrmc2 PE=1 SV=1 PGRC2_RAT reviewed Membrane-associated progesterone receptor component 2 Rattus norvegicus (Rat) GO:0005496; GO:0005576; GO:0005635; GO:0005783; GO:0012505; GO:0015232; GO:0015886; GO:0016020; GO:0020037; GO:0045202; GO:0060612; GO:0098978 adipose tissue development [GO:0060612]; heme transport [GO:0015886] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; synapse [GO:0045202] heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; steroid binding [GO:0005496] g39.t1 Q99M03 40.924 303 9.49e-80 246.0 sp|Q99M03|RWD2B_MOUSE RWD domain-containing protein 2B OS=Mus musculus OX=10090 GN=Rwdd2b PE=2 SV=1 g44.t1 P28606 53.237 278 9.629999999999999e-104 307.0 sp|P28606|Y1628_PICP2 Uncharacterized protein SYNPCC7002_A1628 OS=Picosynechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) OX=32049 GN=SYNPCC7002_A1628 PE=3 SV=2 g59.t1 Q24292 35.587 281 3.2e-26 110.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g61.t1 Q8TDW7 29.141 326 2.32e-26 114.0 sp|Q8TDW7|FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens OX=9606 GN=FAT3 PE=1 SV=3 FAT3_HUMAN reviewed Protocadherin Fat 3 (hFat3) (Cadherin family member 15) (FAT tumor suppressor homolog 3) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0035881; GO:0044331; GO:0048667; GO:1904936; GO:2000171 amacrine cell differentiation [GO:0035881]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cell-cell adhesion mediated by cadherin [GO:0044331]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842] adherens junction [GO:0005912]; dendrite [GO:0030425]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 39.239 2156 0.0 1405.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 28.884 2195 0.0 674.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 27.988 2083 0.0 620.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 29.231 1820 1.5900000000000002e-163 566.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 27.4 1781 2.19e-125 447.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 28.286 1651 5.3700000000000005e-121 432.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 28.244 786 6.649999999999999e-45 184.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 27.454 703 1.27e-38 163.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g62.t1 Q24292 26.395 663 3.47e-27 125.0 sp|Q24292|DS_DROME Protein dachsous OS=Drosophila melanogaster OX=7227 GN=ds PE=1 SV=3 DS_DROME reviewed Protein dachsous (Adherin) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007409; GO:0007560; GO:0016327; GO:0030855; GO:0035331; GO:0035332; GO:0042067; GO:0044331; GO:0090251 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc morphogenesis [GO:0007560]; negative regulation of hippo signaling [GO:0035331]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251] adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g63.t1 Q99JT1 52.444 532 0.0 584.0 sp|Q99JT1|GATB_MOUSE Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial OS=Mus musculus OX=10090 GN=Gatb PE=1 SV=1 g63.t2 Q99JT1 53.204 515 0.0 582.0 sp|Q99JT1|GATB_MOUSE Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial OS=Mus musculus OX=10090 GN=Gatb PE=1 SV=1 g64.t1 P51903 76.886 411 0.0 640.0 sp|P51903|PGK_CHICK Phosphoglycerate kinase OS=Gallus gallus OX=9031 GN=PGK PE=2 SV=2 g65.t1 Q64573 34.552 547 3.59e-86 293.0 sp|Q64573|EST1F_RAT Liver carboxylesterase 1F OS=Rattus norvegicus OX=10116 GN=Ces1f PE=1 SV=2 EST1F_RAT reviewed Liver carboxylesterase 1F (EC 3.1.1.1) (Carboxyesterase ES-4) (Kidney microsomal carboxylesterase) (Microsomal palmitoyl-CoA hydrolase) Rattus norvegicus (Rat) GO:0001523; GO:0005783; GO:0005811; GO:0005829; GO:0016042; GO:0036116; GO:0043231; GO:0047376; GO:0050253; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; retinyl-palmitate esterase activity [GO:0050253] g65.t1 Q64573 31.073 531 2.72e-54 202.0 sp|Q64573|EST1F_RAT Liver carboxylesterase 1F OS=Rattus norvegicus OX=10116 GN=Ces1f PE=1 SV=2 EST1F_RAT reviewed Liver carboxylesterase 1F (EC 3.1.1.1) (Carboxyesterase ES-4) (Kidney microsomal carboxylesterase) (Microsomal palmitoyl-CoA hydrolase) Rattus norvegicus (Rat) GO:0001523; GO:0005783; GO:0005811; GO:0005829; GO:0016042; GO:0036116; GO:0043231; GO:0047376; GO:0050253; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; retinyl-palmitate esterase activity [GO:0050253] g66.t1 P23953 35.348 546 1.85e-86 295.0 sp|P23953|EST1C_MOUSE Carboxylesterase 1C OS=Mus musculus OX=10090 GN=Ces1c PE=1 SV=4 EST1C_MOUSE reviewed Carboxylesterase 1C (EC 3.1.1.1) (Liver carboxylesterase N) (Lung surfactant convertase) (PES-N) Mus musculus (Mouse) GO:0004771; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0009617; GO:0016042; GO:0016788; GO:0042803; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; protein homodimerization activity [GO:0042803]; sterol ester esterase activity [GO:0004771] g66.t1 P23953 32.305 486 2.9299999999999997e-55 206.0 sp|P23953|EST1C_MOUSE Carboxylesterase 1C OS=Mus musculus OX=10090 GN=Ces1c PE=1 SV=4 EST1C_MOUSE reviewed Carboxylesterase 1C (EC 3.1.1.1) (Liver carboxylesterase N) (Lung surfactant convertase) (PES-N) Mus musculus (Mouse) GO:0004771; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0009617; GO:0016042; GO:0016788; GO:0042803; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; protein homodimerization activity [GO:0042803]; sterol ester esterase activity [GO:0004771] g67.t1 Q29550 35.8 581 4.07e-87 295.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g67.t1 Q29550 32.735 501 3e-58 214.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g67.t2 Q29550 35.254 590 2.53e-84 288.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g67.t2 Q29550 32.735 501 2.7800000000000002e-58 214.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g70.t1 Q8I034 31.843 559 6.730000000000001e-72 242.0 sp|Q8I034|EST5A_FELCA Carboxylesterase 5A OS=Felis catus OX=9685 GN=CES5A PE=1 SV=1 EST5A_FELCA reviewed Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein) (Cauxin) Felis catus (Cat) (Felis silvestris catus) GO:0005576; GO:0106435 extracellular region [GO:0005576] carboxylesterase activity [GO:0106435] g71.t1 P81908 54.839 124 4.61e-35 134.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 CHLE_HORSE reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase) Equus caballus (Horse) GO:0003990; GO:0004104; GO:0005615; GO:0005886; GO:0006581; GO:0019695 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695] extracellular space [GO:0005615]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104] g73.t1 Q8N0W4 34.556 518 1.2e-75 256.0 sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1 NLGNX_HUMAN reviewed Neuroligin-4, X-linked (Neuroligin X) (HNLX) Homo sapiens (Human) GO:0003360; GO:0005886; GO:0007158; GO:0007416; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098631; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634 adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625] asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202] cell adhesion mediator activity [GO:0098631]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g73.t2 Q8N0W4 32.911 474 3.1599999999999997e-68 247.0 sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1 NLGNX_HUMAN reviewed Neuroligin-4, X-linked (Neuroligin X) (HNLX) Homo sapiens (Human) GO:0003360; GO:0005886; GO:0007158; GO:0007416; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098631; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634 adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625] asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202] cell adhesion mediator activity [GO:0098631]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g73.t2 Q8N0W4 34.292 487 8.120000000000001e-65 237.0 sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1 NLGNX_HUMAN reviewed Neuroligin-4, X-linked (Neuroligin X) (HNLX) Homo sapiens (Human) GO:0003360; GO:0005886; GO:0007158; GO:0007416; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098631; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634 adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625] asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202] cell adhesion mediator activity [GO:0098631]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] g76.t1 Q9NV70 48.234 906 0.0 837.0 sp|Q9NV70|EXOC1_HUMAN Exocyst complex component 1 OS=Homo sapiens OX=9606 GN=EXOC1 PE=1 SV=4 EXOC1_HUMAN reviewed Exocyst complex component 1 (Exocyst complex component Sec3) Homo sapiens (Human) GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048471; GO:0051607; GO:0090148; GO:0090522; GO:0090543 defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g76.t2 Q9NV70 47.562 923 0.0 833.0 sp|Q9NV70|EXOC1_HUMAN Exocyst complex component 1 OS=Homo sapiens OX=9606 GN=EXOC1 PE=1 SV=4 EXOC1_HUMAN reviewed Exocyst complex component 1 (Exocyst complex component Sec3) Homo sapiens (Human) GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048471; GO:0051607; GO:0090148; GO:0090522; GO:0090543 defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g76.t3 Q9NV70 47.174 920 0.0 834.0 sp|Q9NV70|EXOC1_HUMAN Exocyst complex component 1 OS=Homo sapiens OX=9606 GN=EXOC1 PE=1 SV=4 EXOC1_HUMAN reviewed Exocyst complex component 1 (Exocyst complex component Sec3) Homo sapiens (Human) GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048471; GO:0051607; GO:0090148; GO:0090522; GO:0090543 defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g80.t1 Q8BZ05 30.876 1085 2.43e-139 483.0 sp|Q8BZ05|ARAP2_MOUSE Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arap2 PE=1 SV=2 g80.t2 Q4LDD4 30.427 1101 5.56e-139 477.0 sp|Q4LDD4|ARAP1_MOUSE Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Arap1 PE=1 SV=2 ARAP1_MOUSE reviewed Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2) Mus musculus (Mouse) GO:0000976; GO:0001726; GO:0001921; GO:0002090; GO:0002102; GO:0003700; GO:0005096; GO:0005547; GO:0005654; GO:0005737; GO:0005769; GO:0005771; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007179; GO:0008270; GO:0008360; GO:0019897; GO:0031344; GO:0031702; GO:0032580; GO:0032956; GO:0045124; GO:0045494; GO:0045893; GO:0050766; GO:0051491; GO:0051497; GO:0061629; GO:0070412 negative regulation of stress fiber assembly [GO:0051497]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of phagocytosis [GO:0050766]; positive regulation of receptor recycling [GO:0001921]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of cell projection organization [GO:0031344]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of plasma membrane [GO:0019897]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802] DNA-binding transcription factor activity [GO:0003700]; GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; type 1 angiotensin receptor binding [GO:0031702]; zinc ion binding [GO:0008270] g81.t1 P59889 32.993 294 2.55e-45 159.0 sp|P59889|S39A1_DANRE Zinc transporter ZIP1 OS=Danio rerio OX=7955 GN=slc39a1 PE=2 SV=1 g82.t1 Q62962 32.727 440 7.4e-67 226.0 sp|Q62962|ASIC2_RAT Acid-sensing ion channel 2 OS=Rattus norvegicus OX=10116 GN=Asic2 PE=1 SV=1 g83.t1 A0A0P0XM10 35.391 486 2.5299999999999998e-92 293.0 sp|A0A0P0XM10|PAO6_ORYSJ Polyamine oxidase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=PAO6 PE=2 SV=1 g84.t1 O64411 36.147 462 8.16e-92 291.0 sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1 g86.t1 P35846 43.83 235 5.16e-64 203.0 sp|P35846|FOLR1_MOUSE Folate receptor alpha OS=Mus musculus OX=10090 GN=Folr1 PE=1 SV=2 g87.t1 O43678 56.383 94 3.31e-34 116.0 sp|O43678|NDUA2_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 OS=Homo sapiens OX=9606 GN=NDUFA2 PE=1 SV=3 NDUA2_HUMAN reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit) Homo sapiens (Human) GO:0001835; GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0042776; GO:0045271 aerobic respiration [GO:0009060]; blastocyst hatching [GO:0001835]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] NADH dehydrogenase (ubiquinone) activity [GO:0008137] g88.t1 P51954 38.477 1011 0.0 577.0 sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2 NEK1_MOUSE reviewed Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) Mus musculus (Mouse) GO:0000242; GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006974; GO:0007283; GO:0010212; GO:0016301; GO:0034451; GO:0035264; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310; GO:2000001 cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g89.t1 Q96PY6 39.179 268 3.09e-38 147.0 sp|Q96PY6|NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens OX=9606 GN=NEK1 PE=1 SV=2 NEK1_HUMAN reviewed Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) Homo sapiens (Human) GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310 cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] g90.t1 Q9UHC3 31.277 470 5.96e-77 254.0 sp|Q9UHC3|ASIC3_HUMAN Acid-sensing ion channel 3 OS=Homo sapiens OX=9606 GN=ASIC3 PE=1 SV=2 g91.t1 Q5E9N4 37.408 409 1.31e-94 294.0 sp|Q5E9N4|AADAT_BOVIN Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=AADAT PE=2 SV=1 AADAT_BOVIN reviewed Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Glycine transaminase AADAT) (EC 2.6.1.4) (Kynurenine aminotransferase II) (Kynurenine--glyoxylate transaminase AADAT) (EC 2.6.1.63) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II) (Methionine--glyoxylate transaminase AADAT) (EC 2.6.1.73) Bos taurus (Bovine) GO:0005759; GO:0006103; GO:0006536; GO:0016212; GO:0030170; GO:0033512; GO:0047315; GO:0047536; GO:0047958; GO:0050094; GO:0070189; GO:1901605 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512] mitochondrial matrix [GO:0005759] 2-aminoadipate transaminase activity [GO:0047536]; glycine:2-oxoglutarate aminotransferase activity [GO:0047958]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; methionine-glyoxylate transaminase activity [GO:0050094]; pyridoxal phosphate binding [GO:0030170] g92.t1 P78348 32.743 452 2.06e-78 256.0 sp|P78348|ASIC1_HUMAN Acid-sensing ion channel 1 OS=Homo sapiens OX=9606 GN=ASIC1 PE=1 SV=3 ASIC1_HUMAN reviewed Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) Homo sapiens (Human) GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0006814; GO:0007269; GO:0007613; GO:0008306; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0030425; GO:0035725; GO:0042391; GO:0046929; GO:0050915; GO:0070588; GO:0071467; GO:0098793; GO:0098839; GO:0098978; GO:0150052; GO:0160128 associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; neurotransmitter secretion [GO:0007269]; regulation of membrane potential [GO:0042391]; regulation of postsynapse assembly [GO:0150052]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] cell surface [GO:0009986]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated monoatomic ion channel activity [GO:0160128] g93.t1 Q8N5Z0 38.106 433 3.67e-95 295.0 sp|Q8N5Z0|AADAT_HUMAN Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=AADAT PE=1 SV=2 AADAT_HUMAN reviewed Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Glycine transaminase AADAT) (EC 2.6.1.4) (Kynurenine aminotransferase II) (Kynurenine--glyoxylate transaminase AADAT) (EC 2.6.1.63) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II) (Methionine--glyoxylate transaminase AADAT) (EC 2.6.1.73) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0006103; GO:0006536; GO:0016212; GO:0030170; GO:0033512; GO:0042803; GO:0047315; GO:0047536; GO:0047958; GO:0050094; GO:0070189; GO:1901605 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 2-aminoadipate transaminase activity [GO:0047536]; glycine:2-oxoglutarate aminotransferase activity [GO:0047958]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; methionine-glyoxylate transaminase activity [GO:0050094]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] g94.t1 Q3EC11 28.676 544 7.81e-67 227.0 sp|Q3EC11|ZDHC2_ARATH Probable protein S-acyltransferase 23 OS=Arabidopsis thaliana OX=3702 GN=PAT23 PE=2 SV=2 ZDHC2_ARATH reviewed Probable protein S-acyltransferase 23 (EC 2.3.1.225) (Probable palmitoyltransferase At2g14255) (Zinc finger DHHC domain-containing protein At2g14255) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005794; GO:0019706 Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g94.t2 Q3EC11 28.676 544 7.81e-67 227.0 sp|Q3EC11|ZDHC2_ARATH Probable protein S-acyltransferase 23 OS=Arabidopsis thaliana OX=3702 GN=PAT23 PE=2 SV=2 ZDHC2_ARATH reviewed Probable protein S-acyltransferase 23 (EC 2.3.1.225) (Probable palmitoyltransferase At2g14255) (Zinc finger DHHC domain-containing protein At2g14255) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005794; GO:0019706 Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g96.t1 G3V7J5 36.044 541 8.34e-88 295.0 sp|G3V7J5|EST2E_RAT Pyrethroid hydrolase Ces2e OS=Rattus norvegicus OX=10116 GN=Ces2e PE=1 SV=2 EST2E_RAT reviewed Pyrethroid hydrolase Ces2e (EC 3.1.1.88) (Carboxylic ester hydrolase) (EC 3.1.1.-) Rattus norvegicus (Rat) GO:0001523; GO:0043231; GO:0047376; GO:0050253; GO:0052689; GO:0102209; GO:0106435 retinoid metabolic process [GO:0001523] intracellular membrane-bounded organelle [GO:0043231] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; retinyl-palmitate esterase activity [GO:0050253]; trans-permethrin hydrolase activity [GO:0102209] g96.t1 G3V7J5 32.948 346 1.28e-36 150.0 sp|G3V7J5|EST2E_RAT Pyrethroid hydrolase Ces2e OS=Rattus norvegicus OX=10116 GN=Ces2e PE=1 SV=2 EST2E_RAT reviewed Pyrethroid hydrolase Ces2e (EC 3.1.1.88) (Carboxylic ester hydrolase) (EC 3.1.1.-) Rattus norvegicus (Rat) GO:0001523; GO:0043231; GO:0047376; GO:0050253; GO:0052689; GO:0102209; GO:0106435 retinoid metabolic process [GO:0001523] intracellular membrane-bounded organelle [GO:0043231] all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; retinyl-palmitate esterase activity [GO:0050253]; trans-permethrin hydrolase activity [GO:0102209] g99.t1 Q9NZJ4 30.627 2710 0.0 1041.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g99.t1 Q9NZJ4 30.366 573 3.53e-50 202.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g99.t1 Q9NZJ4 33.487 433 1.08e-47 194.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g99.t1 Q9NZJ4 57.447 141 2.84e-41 172.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g99.t1 Q9NZJ4 40.268 149 3.35e-23 113.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g102.t1 Q9JLC8 30.749 374 9.1e-39 153.0 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g103.t1 Q9NZJ4 56.738 141 1.68e-44 168.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g103.t1 Q9NZJ4 32.184 174 1.13e-23 107.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g103.t1 Q9NZJ4 39.597 149 1.3299999999999998e-23 107.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g103.t1 Q9NZJ4 40.441 136 2.79e-21 100.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g105.t1 Q9JLC8 27.536 276 9.54e-21 95.5 sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2 g106.t1 Q9NZJ4 28.258 3323 0.0 1088.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g106.t1 Q9NZJ4 31.876 549 1.14e-50 204.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g106.t1 Q9NZJ4 25.534 936 4.7899999999999994e-48 195.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g106.t1 Q9NZJ4 33.933 445 3.29e-47 192.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g108.t1 Q6DJ95 44.386 570 2.38e-160 473.0 sp|Q6DJ95|SYCM_XENTR Probable cysteine--tRNA ligase, mitochondrial OS=Xenopus tropicalis OX=8364 GN=cars2 PE=2 SV=1 SYCM_XENTR reviewed Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004817; GO:0005524; GO:0005737; GO:0005739; GO:0006423; GO:0046872 cysteinyl-tRNA aminoacylation [GO:0006423] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872] g109.t1 Q9QXV3 49.237 262 2.6500000000000002e-79 243.0 sp|Q9QXV3|ING1_MOUSE Inhibitor of growth protein 1 OS=Mus musculus OX=10090 GN=Ing1 PE=2 SV=1 g112.t1 Q9NQM4 42.077 183 1.1599999999999999e-42 145.0 sp|Q9NQM4|DAAF6_HUMAN Dynein axonemal assembly factor 6 OS=Homo sapiens OX=9606 GN=DNAAF6 PE=1 SV=1 DAAF6_HUMAN reviewed Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3) (Sarcoma antigen NY-SAR-97) Homo sapiens (Human) GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286 axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802] dynein intermediate chain binding [GO:0045505]; protein-folding chaperone binding [GO:0051087] g113.t1 A7Y2W8 47.183 284 4.75e-83 267.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 SC6A9_XENLA reviewed Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9) Xenopus laevis (African clawed frog) GO:0005283; GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0060092; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375] g113.t2 A7Y2W8 47.887 284 3.65e-85 272.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 SC6A9_XENLA reviewed Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9) Xenopus laevis (African clawed frog) GO:0005283; GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0060092; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375] g114.t1 P31649 47.917 240 3.2e-74 241.0 sp|P31649|S6A13_MOUSE Sodium- and chloride-dependent GABA transporter 2 OS=Mus musculus OX=10090 GN=Slc6a13 PE=1 SV=1 g117.t1 Q5RG49 54.464 224 3.35e-78 260.0 sp|Q5RG49|ACSF4_DANRE Beta-alanine-activating enzyme OS=Danio rerio OX=7955 GN=aasdh PE=3 SV=1 ACSF4_DANRE reviewed Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0006631; GO:0016874; GO:0043041 amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; fatty acid metabolic process [GO:0006631] ATP binding [GO:0005524]; ligase activity [GO:0016874] g118.t1 Q5RG49 32.493 674 3.25e-87 301.0 sp|Q5RG49|ACSF4_DANRE Beta-alanine-activating enzyme OS=Danio rerio OX=7955 GN=aasdh PE=3 SV=1 ACSF4_DANRE reviewed Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0006631; GO:0016874; GO:0043041 amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; fatty acid metabolic process [GO:0006631] ATP binding [GO:0005524]; ligase activity [GO:0016874] g121.t1 Q94K49 28.136 295 5.51e-30 121.0 sp|Q94K49|ALP1_ARATH Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1 ALP1_ARATH reviewed Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 (EC 3.1.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0003682; GO:0004518; GO:0005634; GO:0016787; GO:0035098; GO:0035102; GO:0040029; GO:0046872 epigenetic regulation of gene expression [GO:0040029] ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; PRC1 complex [GO:0035102] chromatin binding [GO:0003682]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g122.t1 Q8WWI1 51.049 143 8.36e-40 157.0 sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3 LMO7_HUMAN reviewed LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP) Homo sapiens (Human) GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] g129.t1 D2GXS7 58.657 283 1.12e-109 340.0 sp|D2GXS7|TRIM2_AILME Tripartite motif-containing protein 2 OS=Ailuropoda melanoleuca OX=9646 GN=TRIM2 PE=3 SV=1 g130.t1 O75382 49.091 220 8.57e-72 236.0 sp|O75382|TRIM3_HUMAN Tripartite motif-containing protein 3 OS=Homo sapiens OX=9606 GN=TRIM3 PE=1 SV=2 TRIM3_HUMAN reviewed Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97) Homo sapiens (Human) GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008270; GO:0015031; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061351; GO:0061630; GO:0070534 nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g133.t1 Q96NL6 32.402 358 9.329999999999999e-45 166.0 sp|Q96NL6|SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2 SCLT1_HUMAN reviewed Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0015630; GO:0017080; GO:0030276; GO:0036064; GO:0045162; GO:0060271; GO:0071439; GO:0097539 cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080] g134.t1 Q96PQ7 63.359 131 3.11e-51 176.0 sp|Q96PQ7|KLHL5_HUMAN Kelch-like protein 5 OS=Homo sapiens OX=9606 GN=KLHL5 PE=1 SV=3 g135.t1 Q96PQ7 69.47 321 1.99e-169 493.0 sp|Q96PQ7|KLHL5_HUMAN Kelch-like protein 5 OS=Homo sapiens OX=9606 GN=KLHL5 PE=1 SV=3 g135.t1 Q96PQ7 44.737 190 1.92e-43 162.0 sp|Q96PQ7|KLHL5_HUMAN Kelch-like protein 5 OS=Homo sapiens OX=9606 GN=KLHL5 PE=1 SV=3 g136.t1 A8WHP3 46.708 638 0.0 533.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g137.t1 Q28728 51.0 100 1.83e-27 109.0 sp|Q28728|SC5AB_RABIT Sodium/myo-inositol cotransporter 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC5A11 PE=1 SV=2 SC5AB_RABIT reviewed Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (rKST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11) Oryctolagus cuniculus (Rabbit) GO:0005365; GO:0005412; GO:0005886; GO:0006915; GO:0015798; GO:0016324 apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] D-glucose:sodium symporter activity [GO:0005412]; myo-inositol transmembrane transporter activity [GO:0005365] g138.t1 A8WHP3 47.98 396 6.28e-125 380.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g139.t1 Q5U4V2 30.556 288 8.89e-34 128.0 sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1 g140.t1 P97454 78.618 463 0.0 712.0 sp|P97454|SMAD5_MOUSE Mothers against decapentaplegic homolog 5 OS=Mus musculus OX=10090 GN=Smad5 PE=1 SV=2 SMAD5_MOUSE reviewed SMAD family member 5 (SMAD 5) (mSmad5) (Dwarfin-C) (Dwf-C) (Mothers against decapentaplegic homolog 5) (MAD homolog 5) (Mothers against DPP homolog 5) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001525; GO:0001649; GO:0001657; GO:0001880; GO:0002051; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006879; GO:0007179; GO:0007281; GO:0009653; GO:0009880; GO:0010629; GO:0017151; GO:0030154; GO:0030218; GO:0030509; GO:0031625; GO:0032991; GO:0043066; GO:0045669; GO:0045944; GO:0046872; GO:0048863; GO:0051216; GO:0060048; GO:0060348; GO:0060395; GO:0070411; GO:0071144; GO:1902045; GO:1990262; GO:1990837 anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; anti-Mullerian hormone receptor signaling pathway [GO:1990262]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; embryonic pattern specification [GO:0009880]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; intracellular iron ion homeostasis [GO:0006879]; Mullerian duct regression [GO:0001880]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; osteoblast fate commitment [GO:0002051]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; stem cell differentiation [GO:0048863]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657] cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin protein ligase binding [GO:0031625] g142.t1 Q5JR59 30.023 433 1.15e-40 169.0 sp|Q5JR59|MTUS2_HUMAN Microtubule-associated tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=MTUS2 PE=1 SV=3 MTUS2_HUMAN reviewed Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa) Homo sapiens (Human) GO:0005634; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171 intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g142.t2 Q5JR59 30.575 435 1.2799999999999998e-40 168.0 sp|Q5JR59|MTUS2_HUMAN Microtubule-associated tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=MTUS2 PE=1 SV=3 MTUS2_HUMAN reviewed Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa) Homo sapiens (Human) GO:0005634; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171 intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g142.t3 Q5JR59 30.023 433 1.33e-40 168.0 sp|Q5JR59|MTUS2_HUMAN Microtubule-associated tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=MTUS2 PE=1 SV=3 MTUS2_HUMAN reviewed Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa) Homo sapiens (Human) GO:0005634; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171 intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g145.t1 Q8BYI9 50.0 216 4.16e-55 196.0 sp|Q8BYI9|TENR_MOUSE Tenascin-R OS=Mus musculus OX=10090 GN=Tnr PE=1 SV=2 TENR_MOUSE reviewed Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin) Mus musculus (Mouse) GO:0005178; GO:0005615; GO:0007158; GO:0007162; GO:0007399; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030155; GO:0030198; GO:0030334; GO:0030517; GO:0031012; GO:0031103; GO:0035641; GO:0045121; GO:0045595; GO:0046625; GO:0048692; GO:0050804; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0072534; GO:0090733; GO:0098685; GO:0098686; GO:0098966; GO:0098978 associative learning [GO:0008306]; axon regeneration [GO:0031103]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733] integrin binding [GO:0005178]; sphingolipid binding [GO:0046625] g146.t1 Q6IQ85 61.244 209 1.01e-88 265.0 sp|Q6IQ85|YIPF6_DANRE Protein YIPF6 OS=Danio rerio OX=7955 GN=yipf6 PE=2 SV=1 g147.t1 Q29550 34.629 566 5.86e-85 291.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g147.t1 Q29550 34.375 512 2.72e-58 215.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g148.t1 Q708S6 30.065 459 5.12e-59 207.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 g152.t1 Q9C0D6 39.698 398 2.85e-85 309.0 sp|Q9C0D6|FHDC1_HUMAN FH2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHDC1 PE=1 SV=2 FHDC1_HUMAN reviewed FH2 domain-containing protein 1 (Inverted formin-1) Homo sapiens (Human) GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005884; GO:0005929; GO:0008017; GO:0030041; GO:0043149; GO:0060271; GO:0090161 actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] actin filament [GO:0005884]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] actin binding [GO:0003779]; microtubule binding [GO:0008017] g152.t2 Q9C0D6 39.698 398 2.59e-85 310.0 sp|Q9C0D6|FHDC1_HUMAN FH2 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHDC1 PE=1 SV=2 FHDC1_HUMAN reviewed FH2 domain-containing protein 1 (Inverted formin-1) Homo sapiens (Human) GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005884; GO:0005929; GO:0008017; GO:0030041; GO:0043149; GO:0060271; GO:0090161 actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] actin filament [GO:0005884]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] actin binding [GO:0003779]; microtubule binding [GO:0008017] g154.t1 Q08857 33.193 476 2.73e-85 275.0 sp|Q08857|CD36_MOUSE Platelet glycoprotein 4 OS=Mus musculus OX=10090 GN=Cd36 PE=1 SV=2 CD36_MOUSE reviewed Platelet glycoprotein 4 (Glycoprotein IIIb) (GPIIIB) (PAS IV) (PAS-4) (Platelet glycoprotein IV) (GPIV) (CD antigen CD36) Mus musculus (Mouse) GO:0000122; GO:0001540; GO:0001676; GO:0001819; GO:0001954; GO:0003085; GO:0005041; GO:0005044; GO:0005324; GO:0005794; GO:0005886; GO:0005901; GO:0006631; GO:0006641; GO:0006898; GO:0006910; GO:0007155; GO:0007166; GO:0007204; GO:0008035; GO:0008289; GO:0009612; GO:0009617; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010744; GO:0010886; GO:0015636; GO:0015908; GO:0015909; GO:0015911; GO:0015912; GO:0016020; GO:0016525; GO:0019395; GO:0019915; GO:0019934; GO:0030169; GO:0030194; GO:0030299; GO:0030301; GO:0031526; GO:0031623; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0032991; GO:0033993; GO:0034121; GO:0034197; GO:0034378; GO:0034381; GO:0034383; GO:0034599; GO:0035325; GO:0035634; GO:0038024; GO:0038060; GO:0042308; GO:0042383; GO:0042755; GO:0042953; GO:0043123; GO:0043235; GO:0043254; GO:0043277; GO:0043410; GO:0044539; GO:0044877; GO:0045121; GO:0045177; GO:0045429; GO:0045725; GO:0045766; GO:0050431; GO:0050766; GO:0050830; GO:0050892; GO:0050909; GO:0055096; GO:0060100; GO:0060907; GO:0070053; GO:0070374; GO:0070508; GO:0070538; GO:0070542; GO:0070543; GO:0070892; GO:0071221; GO:0071222; GO:0071223; GO:0071404; GO:0071447; GO:0071726; GO:0071813; GO:0071944; GO:0090208; GO:0097009; GO:0098900; GO:0120162; GO:0140052; GO:0150024; GO:0150025; GO:0150094; GO:1900227; GO:1901480; GO:1903078; GO:1903428; GO:1904646; GO:1990000; GO:1990379; GO:2000121; GO:2000334; GO:2000379 amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidative stress [GO:0034599]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; chylomicron assembly [GO:0034378]; defense response to Gram-positive bacterium [GO:0050830]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; fatty acid oxidation [GO:0019395]; fatty acid transport [GO:0015908]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid storage [GO:0019915]; lipid transport across blood-brain barrier [GO:1990379]; lipoprotein transport [GO:0042953]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitric oxide-cGMP-mediated signaling [GO:0038060]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of triglyceride metabolic process [GO:0090208]; positive regulation of tumor necrosis factor production [GO:0032760]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of protein-containing complex assembly [GO:0043254]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to bacterium [GO:0009617]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to mechanical stimulus [GO:0009612]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; short-chain fatty acid transport [GO:0015912]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197] apical part of cell [GO:0045177]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell periphery [GO:0071944]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; sarcolemma [GO:0042383] amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid immune receptor activity [GO:0070892]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; oleate transmembrane transporter activity [GO:1901480]; oleic acid binding [GO:0070538]; oxidised low-density lipoprotein particle receptor activity [GO:0150025]; protein-containing complex binding [GO:0044877]; scavenger receptor activity [GO:0005044]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; thrombospondin receptor activity [GO:0070053]; Toll-like receptor binding [GO:0035325]; transforming growth factor beta binding [GO:0050431] g155.t1 Q5U241 49.956 1125 0.0 1143.0 sp|Q5U241|PD5BB_XENLA Sister chromatid cohesion protein PDS5 homolog B-B OS=Xenopus laevis OX=8355 GN=pds5b-b PE=2 SV=2 g157.t1 Q8NEN9 29.441 1216 2.82e-131 431.0 sp|Q8NEN9|PDZD8_HUMAN PDZ domain-containing protein 8 OS=Homo sapiens OX=9606 GN=PDZD8 PE=1 SV=1 PDZD8_HUMAN reviewed PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104) Homo sapiens (Human) GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008270; GO:0008289; GO:0016020; GO:0022604; GO:0044233; GO:0051560; GO:1990456 cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739] lipid binding [GO:0008289]; zinc ion binding [GO:0008270] g158.t1 P97376 62.835 261 2.9999999999999997e-106 311.0 sp|P97376|FRG1_MOUSE Protein FRG1 OS=Mus musculus OX=10090 GN=Frg1 PE=1 SV=2 g159.t1 Q9R1C0 44.606 343 2.3299999999999997e-74 240.0 sp|Q9R1C0|TAF7_MOUSE Transcription initiation factor TFIID subunit 7 OS=Mus musculus OX=10090 GN=Taf7 PE=1 SV=1 TAF7_MOUSE reviewed Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit) (TAF(II)55) (TAFII-55) (TAFII55) Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0001097; GO:0005634; GO:0005667; GO:0005669; GO:0005737; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0016251; GO:0030520; GO:0033276; GO:0035035; GO:0042789; GO:0042809; GO:0045344; GO:0045347; GO:0045892; GO:0045893; GO:0045944; GO:0046966; GO:0046982; GO:0051123; GO:0060261; GO:0061628; GO:0071339; GO:0106140; GO:0140297 DNA-templated transcription initiation [GO:0006352]; estrogen receptor signaling pathway [GO:0030520]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of MHC class I biosynthetic process [GO:0045344]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667] DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone H3K27me3 reader activity [GO:0061628]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; P-TEFb complex binding [GO:0106140]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription cis-regulatory region binding [GO:0000976] g160.t1 Q3SWX0 60.87 322 1.7199999999999998e-138 403.0 sp|Q3SWX0|NIPA2_BOVIN Magnesium transporter NIPA2 OS=Bos taurus OX=9913 GN=NIPA2 PE=2 SV=1 g161.t1 Q95LU3 48.165 218 2.68e-55 189.0 sp|Q95LU3|FBCD1_MACFA Fibrinogen C domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=FIBCD1 PE=2 SV=1 g162.t1 Q6DC37 30.534 262 3.95e-31 120.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g163.t1 Q5U4V2 30.201 298 2.4700000000000002e-31 121.0 sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1 g168.t1 Q5M9N0 25.085 590 1.24e-22 108.0 sp|Q5M9N0|CD158_HUMAN Coiled-coil domain-containing protein 158 OS=Homo sapiens OX=9606 GN=CCDC158 PE=1 SV=2 CD158_HUMAN reviewed Coiled-coil domain-containing protein 158 Homo sapiens (Human) GO:0005769; GO:0006898; GO:0030136; GO:0030276 receptor-mediated endocytosis [GO:0006898] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769] clathrin binding [GO:0030276] g169.t1 Q28CA1 68.75 80 1.0600000000000001e-33 113.0 sp|Q28CA1|COA5_XENTR Cytochrome c oxidase assembly factor 5 OS=Xenopus tropicalis OX=8364 GN=coa5 PE=3 SV=1 g170.t1 O55227 60.078 258 5.37e-105 308.0 sp|O55227|UNC50_RAT Protein unc-50 homolog OS=Rattus norvegicus OX=10116 GN=Unc50 PE=1 SV=1 g171.t1 Q08BG7 58.12 117 1.6200000000000002e-33 116.0 sp|Q08BG7|SCOCA_DANRE Short coiled-coil protein A OS=Danio rerio OX=7955 GN=scoca PE=3 SV=1 g177.t1 P58295 54.776 513 0.0 560.0 sp|P58295|SC6A5_RAT Sodium- and chloride-dependent glycine transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a5 PE=1 SV=2 g178.t1 Q28039 27.466 659 1.13e-69 244.0 sp|Q28039|SC6A9_BOVIN Sodium- and chloride-dependent glycine transporter 1 OS=Bos taurus OX=9913 GN=SLC6A9 PE=2 SV=1 SC6A9_BOVIN reviewed Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9) Bos taurus (Bovine) GO:0005283; GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0060092; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375] g179.t1 Q7T3S3 36.62 284 4.99e-51 178.0 sp|Q7T3S3|CHSTB_DANRE Carbohydrate sulfotransferase 11 OS=Danio rerio OX=7955 GN=chst11 PE=2 SV=1 CHSTB_DANRE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4ST-1) (C4ST1) (zC4ST-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007517; GO:0008045; GO:0008146; GO:0016051; GO:0030166; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; motor neuron axon guidance [GO:0008045]; muscle organ development [GO:0007517]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146] g182.t1 Q66HC7 33.613 476 6.76e-62 222.0 sp|Q66HC7|SP20H_RAT Transcription factor SPT20 homolog OS=Rattus norvegicus OX=10116 GN=Supt20h PE=2 SV=1 g183.t1 Q96B26 60.949 274 2.9600000000000002e-121 350.0 sp|Q96B26|EXOS8_HUMAN Exosome complex component RRP43 OS=Homo sapiens OX=9606 GN=EXOSC8 PE=1 SV=1 EXOS8_HUMAN reviewed Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9) Homo sapiens (Human) GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0071028; GO:0071035; GO:0071038; GO:0101019 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925] g184.t1 Q6VUC1 72.368 76 1.51e-36 120.0 sp|Q6VUC1|DPH3_CRIGR Diphthamide biosynthesis protein 3 OS=Cricetulus griseus OX=10029 GN=DPH3 PE=3 SV=1 g189.t1 Q9H7F4 55.319 235 1.3200000000000001e-88 268.0 sp|Q9H7F4|T185B_HUMAN Transmembrane protein 185B OS=Homo sapiens OX=9606 GN=TMEM185B PE=1 SV=2 g190.t1 Q8NFB2 67.857 84 6.82e-26 101.0 sp|Q8NFB2|T185A_HUMAN Transmembrane protein 185A OS=Homo sapiens OX=9606 GN=TMEM185A PE=1 SV=3 T185A_HUMAN reviewed Transmembrane protein 185A (Protein FAM11A) Homo sapiens (Human) GO:0016020; GO:0030425 dendrite [GO:0030425]; membrane [GO:0016020] g192.t1 Q6P0U0 53.465 404 7.41e-158 452.0 sp|Q6P0U0|NAGA_DANRE N-acetylglucosamine-6-phosphate deacetylase OS=Danio rerio OX=7955 GN=amdhd2 PE=2 SV=1 g193.t1 Q4G0Z9 34.489 519 1.38e-81 271.0 sp|Q4G0Z9|MCMD2_HUMAN Minichromosome maintenance domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MCMDC2 PE=1 SV=3 MCMD2_HUMAN reviewed Minichromosome maintenance domain-containing protein 2 (MCM domain-containing protein 2) Homo sapiens (Human) GO:0000727; GO:0003677; GO:0005524; GO:0005634; GO:0007130; GO:0007283; GO:0042140; GO:0048477; GO:1990918 double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via break-induced replication [GO:0000727]; late meiotic recombination nodule assembly [GO:0042140]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677] g199.t1 P24347 36.947 452 2.42e-78 256.0 sp|P24347|MMP11_HUMAN Stromelysin-3 OS=Homo sapiens OX=9606 GN=MMP11 PE=1 SV=3 MMP11_HUMAN reviewed Stromelysin-3 (SL-3) (ST3) (EC 3.4.24.-) (Matrix metalloproteinase-11) (MMP-11) Homo sapiens (Human) GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005796; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0045599; GO:0071711 basement membrane organization [GO:0071711]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of fat cell differentiation [GO:0045599]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g200.t1 P22758 38.849 695 4.49e-156 476.0 sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2 g201.t1 Q54KA7 31.301 246 1.75e-22 103.0 sp|Q54KA7|SECG_DICDI Ankyrin repeat, PH and SEC7 domain containing protein secG OS=Dictyostelium discoideum OX=44689 GN=secG PE=2 SV=1 SECG_DICDI reviewed Ankyrin repeat, PH and SEC7 domain containing protein secG Dictyostelium discoideum (Social amoeba) GO:0005085; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327 actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012] cytosol [GO:0005829]; lysosome [GO:0005764] guanyl-nucleotide exchange factor activity [GO:0005085] g205.t1 Q6XL69 29.276 304 1.65e-21 98.2 sp|Q6XL69|OPN4_RUTRU Melanopsin OS=Rutilus rutilus OX=48668 GN=opn4 PE=2 SV=1 g207.t1 P61642 31.173 324 1.16e-37 142.0 sp|P61642|SIA8A_PANTR Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST8SIA1 PE=2 SV=1 SIA8A_PANTR reviewed Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase (EC 2.4.3.8) (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Ganglioside GT3 synthase) (Sialyltransferase 8A) (SIAT8-A) (Sialyltransferase St8Sia I) (ST8SiaI) Pan troglodytes (Chimpanzee) GO:0000139; GO:0003828; GO:0006491; GO:0006665; GO:0009311 N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828] g207.t2 P61642 30.641 359 1.94e-38 144.0 sp|P61642|SIA8A_PANTR Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST8SIA1 PE=2 SV=1 SIA8A_PANTR reviewed Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase (EC 2.4.3.8) (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Ganglioside GT3 synthase) (Sialyltransferase 8A) (SIAT8-A) (Sialyltransferase St8Sia I) (ST8SiaI) Pan troglodytes (Chimpanzee) GO:0000139; GO:0003828; GO:0006491; GO:0006665; GO:0009311 N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828] g208.t1 O15466 34.944 269 1.4799999999999999e-40 150.0 sp|O15466|SIA8E_HUMAN Alpha-2,8-sialyltransferase 8E OS=Homo sapiens OX=9606 GN=ST8SIA5 PE=1 SV=2 SIA8E_HUMAN reviewed Alpha-2,8-sialyltransferase 8E (EC 2.4.99.-) (Sialyltransferase 8E) (SIAT8-E) (Sialyltransferase St8Sia V) (ST8SiaV) Homo sapiens (Human) GO:0000139; GO:0003828; GO:0005975; GO:0006491; GO:0006688; GO:0008373; GO:0009311 carbohydrate metabolic process [GO:0005975]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g209.t1 P09470 47.351 604 0.0 603.0 sp|P09470|ACE_MOUSE Angiotensin-converting enzyme OS=Mus musculus OX=10090 GN=Ace PE=1 SV=3 ACE_MOUSE reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Mus musculus (Mouse) GO:0001822; GO:0002003; GO:0002034; GO:0002446; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005886; GO:0006518; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031711; GO:0031982; GO:0032496; GO:0038166; GO:0042310; GO:0042311; GO:0042445; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045777; GO:0045907; GO:0046325; GO:0048167; GO:0048286; GO:0050435; GO:0050482; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060978; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:0090281; GO:0097225; GO:1901363; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; animal organ regeneration [GO:0031100]; arachidonate secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; male gonad development [GO:0008584]; negative regulation of calcium ion import [GO:0090281]; negative regulation of D-glucose import [GO:0046325]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of neurogenesis [GO:0050769]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to lipopolysaccharide [GO:0032496]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311] basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g209.t1 P09470 44.371 604 0.0 560.0 sp|P09470|ACE_MOUSE Angiotensin-converting enzyme OS=Mus musculus OX=10090 GN=Ace PE=1 SV=3 ACE_MOUSE reviewed Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Mus musculus (Mouse) GO:0001822; GO:0002003; GO:0002034; GO:0002446; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004181; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005768; GO:0005886; GO:0006518; GO:0007283; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031711; GO:0031982; GO:0032496; GO:0038166; GO:0042310; GO:0042311; GO:0042445; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045777; GO:0045907; GO:0046325; GO:0048167; GO:0048286; GO:0050435; GO:0050482; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060978; GO:0070062; GO:0070573; GO:0071838; GO:0086091; GO:0090281; GO:0097225; GO:1901363; GO:1902033; GO:1903597 amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; angiotensin-activated signaling pathway [GO:0038166]; animal organ regeneration [GO:0031100]; arachidonate secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; male gonad development [GO:0008584]; negative regulation of calcium ion import [GO:0090281]; negative regulation of D-glucose import [GO:0046325]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of neurogenesis [GO:0050769]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to lipopolysaccharide [GO:0032496]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311] basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; calmodulin binding [GO:0005516]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallocarboxypeptidase activity [GO:0004181]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] g210.t1 Q16515 28.7 446 2.3500000000000002e-57 202.0 sp|Q16515|ASIC2_HUMAN Acid-sensing ion channel 2 OS=Homo sapiens OX=9606 GN=ASIC2 PE=1 SV=1 g211.t1 Q9CXF4 30.612 294 9.990000000000002e-27 117.0 sp|Q9CXF4|TBC15_MOUSE TBC1 domain family member 15 OS=Mus musculus OX=10090 GN=Tbc1d15 PE=1 SV=1 g212.t1 Q91998 52.432 370 1.55e-106 318.0 sp|Q91998|BRN3_CHICK Brain-specific homeobox/POU domain protein 3 OS=Gallus gallus OX=9031 GN=BRN3 PE=2 SV=1 g215.t1 Q8K2Y0 54.622 119 1.0499999999999999e-38 155.0 sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2 g216.t1 Q6DHK8 63.095 336 9.770000000000001e-155 441.0 sp|Q6DHK8|NTCP7_DANRE Sodium/bile acid cotransporter 7 OS=Danio rerio OX=7955 GN=slc10a7 PE=2 SV=1 NTCP7_DANRE reviewed Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005789; GO:0005886; GO:0006814; GO:0015293; GO:0030282; GO:0051216 bone mineralization [GO:0030282]; cartilage development [GO:0051216]; sodium ion transport [GO:0006814] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] symporter activity [GO:0015293] g222.t1 Q9Z286 29.418 979 1.3799999999999999e-108 375.0 sp|Q9Z286|ADCYA_RAT Adenylate cyclase type 10 OS=Rattus norvegicus OX=10116 GN=Adcy10 PE=1 SV=1 ADCYA_RAT reviewed Adenylate cyclase type 10 (EC 4.6.1.1) (Germ cell soluble adenylyl cyclase) (sAC) (Testicular soluble adenylyl cyclase) Rattus norvegicus (Rat) GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006007; GO:0006171; GO:0007286; GO:0010613; GO:0010666; GO:0010917; GO:0015630; GO:0016020; GO:0016324; GO:0030145; GO:0030424; GO:0030425; GO:0030426; GO:0031514; GO:0035556; GO:0043025; GO:0043065; GO:0045177; GO:0045178; GO:0045773; GO:0045778; GO:0045819; GO:0048471; GO:0051117; GO:0051901; GO:0060306; GO:0071890; GO:0090724; GO:0097450; GO:0106028; GO:0106135; GO:1901524; GO:1903378; GO:1903427; GO:1903428; GO:1903955; GO:1905461; GO:1990138; GO:1990535; GO:1990544; GO:2001171; GO:2001244 cAMP biosynthetic process [GO:0006171]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; glucose catabolic process [GO:0006007]; intracellular signal transduction [GO:0035556]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of cardiac muscle cell contraction [GO:0106135]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection extension [GO:1990138]; neuron projection maintenance [GO:1990535]; neuron projection retraction [GO:0106028]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of ossification [GO:0045778]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of membrane repolarization [GO:0060306]; regulation of mitophagy [GO:1901524]; spermatid development [GO:0007286] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; axon [GO:0030424]; basal part of cell [GO:0045178]; central region of growth cone [GO:0090724]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g223.t1 Q5TBA9 42.285 2599 0.0 1770.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g223.t1 Q5TBA9 34.895 427 2.5499999999999998e-53 213.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g223.t2 Q5TBA9 42.28 2597 0.0 1770.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g223.t2 Q5TBA9 34.713 435 8.35e-53 211.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g223.t3 Q5TBA9 42.285 2599 0.0 1769.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g223.t3 Q5TBA9 34.713 435 8.42e-53 211.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g223.t4 Q5TBA9 41.784 2635 0.0 1757.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g223.t4 Q5TBA9 34.713 435 5.9599999999999995e-53 211.0 sp|Q5TBA9|FRY_HUMAN Protein furry homolog OS=Homo sapiens OX=9606 GN=FRY PE=1 SV=1 FRY_HUMAN reviewed Protein furry homolog Homo sapiens (Human) GO:0000902; GO:0000922; GO:0004857; GO:0005813; GO:0005938; GO:0030427; GO:0031175; GO:1904428 cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; centrosome [GO:0005813]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] enzyme inhibitor activity [GO:0004857] g224.t1 Q9BVK2 58.269 520 0.0 612.0 sp|Q9BVK2|ALG8_HUMAN Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG8 PE=1 SV=2 ALG8_HUMAN reviewed Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase) Homo sapiens (Human) GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0018279; GO:0042283; GO:0098553 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583] g225.t1 Q8IZU2 55.471 1307 0.0 1505.0 sp|Q8IZU2|WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens OX=9606 GN=WDR17 PE=1 SV=2 g226.t1 Q6DMN8 36.397 272 3.55e-62 201.0 sp|Q6DMN8|SPAT4_PANTR Spermatogenesis-associated protein 4 OS=Pan troglodytes OX=9598 GN=SPATA4 PE=2 SV=1 g227.t1 Q5I0J5 58.475 236 4.68e-98 289.0 sp|Q5I0J5|MITD1_RAT MIT domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Mitd1 PE=2 SV=1 g228.t1 P15823 29.226 349 2.48e-32 130.0 sp|P15823|ADA1B_RAT Alpha-1B adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1b PE=2 SV=2 ADA1B_RAT reviewed Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor) Rattus norvegicus (Rat) GO:0001974; GO:0001975; GO:0001987; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007267; GO:0007512; GO:0007626; GO:0008217; GO:0008542; GO:0009410; GO:0009725; GO:0014704; GO:0016020; GO:0019229; GO:0030315; GO:0031965; GO:0035024; GO:0035265; GO:0042593; GO:0043278; GO:0043410; GO:0043627; GO:0045818; GO:0045819; GO:0046982; GO:0048148; GO:0048545; GO:0055117; GO:0061049; GO:0071880; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; locomotory behavior [GO:0007626]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]; response to amphetamine [GO:0001975]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542] caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982] g229.t1 P49596 65.232 302 1.38e-151 432.0 sp|P49596|PP2C2_CAEEL Probable protein phosphatase 2C T23F11.1 OS=Caenorhabditis elegans OX=6239 GN=ppm-2 PE=3 SV=2 g230.t1 Q96LD1 43.537 294 5.31e-75 234.0 sp|Q96LD1|SGCZ_HUMAN Zeta-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCZ PE=1 SV=1 g231.t1 Q8BTV1 68.197 305 1.27e-160 455.0 sp|Q8BTV1|TUSC3_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 OS=Mus musculus OX=10090 GN=Tusc3 PE=1 SV=1 g232.t1 Q9H8P0 37.681 276 3.8000000000000005e-58 192.0 sp|Q9H8P0|SR5A3_HUMAN Polyprenal reductase OS=Homo sapiens OX=9606 GN=SRD5A3 PE=1 SV=1 SR5A3_HUMAN reviewed Polyprenal reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3) Homo sapiens (Human) GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0006702; GO:0016095; GO:0016628; GO:0043048; GO:0047751; GO:0102389; GO:0160198 androgen biosynthetic process [GO:0006702]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl monophosphate biosynthetic process [GO:0043048]; polyprenol catabolic process [GO:0016095] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity [GO:0047751]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenal reductase activity [GO:0160198]; polyprenol reductase activity [GO:0102389] g233.t1 Q9Y345 41.404 285 1.11e-71 240.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g234.t1 P28573 49.555 337 6.52e-104 322.0 sp|P28573|SC6A7_RAT Sodium-dependent proline transporter OS=Rattus norvegicus OX=10116 GN=Slc6a7 PE=1 SV=2 SC6A7_RAT reviewed Sodium-dependent proline transporter (Solute carrier family 6 member 7) Rattus norvegicus (Rat) GO:0005298; GO:0005886; GO:0006836; GO:0015193; GO:0015824; GO:0030163; GO:0030672; GO:0035524; GO:0035725; GO:0042734; GO:0045202; GO:0098685; GO:0098978; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; protein catabolic process [GO:0030163]; sodium ion transmembrane transport [GO:0035725] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672] L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298] g235.t1 Q9Y345 43.845 593 2.09e-178 532.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g236.t1 Q9P272 61.783 157 8.22e-65 225.0 sp|Q9P272|TRM9B_HUMAN Probable tRNA methyltransferase 9B OS=Homo sapiens OX=9606 GN=TRMT9B PE=1 SV=3 TRM9B_HUMAN reviewed Probable tRNA methyltransferase 9B (Probable tRNA methyltransferase 9-like protein) (EC 2.1.1.-) Homo sapiens (Human) GO:0000049; GO:0002098; GO:0005634; GO:0005737; GO:0006400; GO:0008175; GO:0008757; GO:0030488; GO:0106335 tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; nucleus [GO:0005634] S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA (5-carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA binding [GO:0000049]; tRNA methyltransferase activity [GO:0008175] g237.t1 C3Y3G4 67.671 365 0.0 526.0 sp|C3Y3G4|LIAS_BRAFL Lipoyl synthase, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_125969 PE=3 SV=1 g239.t1 Q90744 50.785 382 5.43e-135 395.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g240.t1 P06280 54.955 222 8.84e-88 268.0 sp|P06280|AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens OX=9606 GN=GLA PE=1 SV=1 AGAL_HUMAN reviewed Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (Melibiase) (Agalsidase) Homo sapiens (Human) GO:0003824; GO:0004557; GO:0005102; GO:0005576; GO:0005737; GO:0005764; GO:0005794; GO:0009311; GO:0016020; GO:0016139; GO:0016787; GO:0035578; GO:0042803; GO:0043202; GO:0045019; GO:0046477; GO:0046479; GO:0051001; GO:0070062 glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; oligosaccharide metabolic process [GO:0009311] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g241.t1 Q90744 44.371 151 3.66e-34 126.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g242.t1 Q90744 44.872 390 3.83e-119 354.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g243.t1 Q9CSH3 59.275 965 0.0 1165.0 sp|Q9CSH3|RRP44_MOUSE Exosome complex exonuclease RRP44 OS=Mus musculus OX=10090 GN=Dis3 PE=1 SV=4 RRP44_MOUSE reviewed Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44) Mus musculus (Mouse) GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0071031; GO:0071034 CUT catabolic process [GO:0071034]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] g244.t1 Q27HV0 84.375 576 0.0 1001.0 sp|Q27HV0|OGT1_PIG UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Sus scrofa OX=9823 GN=OGT PE=2 SV=1 OGT1_PIG reviewed UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) Sus scrofa (Pig) GO:0000123; GO:0005547; GO:0005634; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0016757; GO:0031397; GO:0032922; GO:0045862; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263 apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteolysis [GO:0045862]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110] cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886] glycosyltransferase activity [GO:0016757]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363] g244.t2 P81436 82.935 586 0.0 992.0 sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2 OGT1_RABIT reviewed UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) Oryctolagus cuniculus (Rabbit) GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263 apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110] cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122] phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363] g245.t1 P81436 63.111 450 0.0 591.0 sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2 OGT1_RABIT reviewed UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) Oryctolagus cuniculus (Rabbit) GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263 apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110] cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122] phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363] g246.t1 Q9QYJ1 34.979 243 3.92e-40 146.0 sp|Q9QYJ1|SIA7E_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Mus musculus OX=10090 GN=St6galnac5 PE=1 SV=1 SIA7E_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g248.t1 Q9GZS1 36.552 145 2.96e-25 102.0 sp|Q9GZS1|RPA49_HUMAN DNA-directed RNA polymerase I subunit RPA49 OS=Homo sapiens OX=9606 GN=POLR1E PE=1 SV=3 RPA49_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53) Homo sapiens (Human) GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0005654; GO:0005730; GO:0005736; GO:0006361; GO:0006362; GO:0042790 nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] DNA binding [GO:0003677]; RNA polymerase I general transcription initiation factor binding [GO:0001179] g249.t1 Q5RFI8 43.826 413 5.6499999999999996e-111 343.0 sp|Q5RFI8|PGM2_PONAB Phosphopentomutase OS=Pongo abelii OX=9601 GN=PGM2 PE=2 SV=3 PGM2_PONAB reviewed Phosphopentomutase (EC 5.4.2.7) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphoglucomutase-2) (PGM 2) (EC 5.4.2.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000287; GO:0004614; GO:0005634; GO:0005829; GO:0006006; GO:0006166; GO:0008973 glucose metabolic process [GO:0006006]; purine ribonucleoside salvage [GO:0006166] cytosol [GO:0005829]; nucleus [GO:0005634] magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973] g250.t1 Q5RFI8 64.444 90 1.1100000000000001e-31 119.0 sp|Q5RFI8|PGM2_PONAB Phosphopentomutase OS=Pongo abelii OX=9601 GN=PGM2 PE=2 SV=3 PGM2_PONAB reviewed Phosphopentomutase (EC 5.4.2.7) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphoglucomutase-2) (PGM 2) (EC 5.4.2.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000287; GO:0004614; GO:0005634; GO:0005829; GO:0006006; GO:0006166; GO:0008973 glucose metabolic process [GO:0006006]; purine ribonucleoside salvage [GO:0006166] cytosol [GO:0005829]; nucleus [GO:0005634] magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973] g251.t1 Q0GNC1 47.892 332 4.75e-83 303.0 sp|Q0GNC1|INF2_MOUSE Inverted formin-2 OS=Mus musculus OX=10090 GN=Inf2 PE=1 SV=1 INF2_MOUSE reviewed Inverted formin-2 Mus musculus (Mouse) GO:0003779; GO:0010467; GO:0031267; GO:0032535; GO:0045010; GO:0048471; GO:0090140 actin nucleation [GO:0045010]; gene expression [GO:0010467]; regulation of cellular component size [GO:0032535]; regulation of mitochondrial fission [GO:0090140] perinuclear region of cytoplasm [GO:0048471] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g255.t1 Q9JMD3 43.825 251 3.18e-75 234.0 sp|Q9JMD3|STA10_MOUSE START domain-containing protein 10 OS=Mus musculus OX=10090 GN=Stard10 PE=1 SV=1 STA10_MOUSE reviewed START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10) Mus musculus (Mouse) GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581 bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360] cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514] lipid binding [GO:0008289] g257.t1 G1SS70 92.208 77 1.39e-37 129.0 sp|G1SS70|RS3A_RABIT Small ribosomal subunit protein eS1 OS=Oryctolagus cuniculus OX=9986 GN=RPS3A PE=1 SV=1 g258.t1 Q4T8S6 76.344 93 4.18e-48 156.0 sp|Q4T8S6|RS3A_TETNG Small ribosomal subunit protein eS1 OS=Tetraodon nigroviridis OX=99883 GN=rps3a PE=3 SV=3 g259.t1 Q6PBY1 62.903 62 6.8e-21 85.9 sp|Q6PBY1|RS3A_DANRE Small ribosomal subunit protein eS1 OS=Danio rerio OX=7955 GN=rps3a PE=1 SV=3 g260.t1 P46869 32.977 561 1.6799999999999998e-69 245.0 sp|P46869|FLA10_CHLRE Kinesin-like protein FLA10 OS=Chlamydomonas reinhardtii OX=3055 GN=FLA10 PE=1 SV=1 g261.t1 Q2KID6 58.891 523 0.0 622.0 sp|Q2KID6|PLRG1_BOVIN Pleiotropic regulator 1 OS=Bos taurus OX=9913 GN=PLRG1 PE=2 SV=1 g262.t1 Q6V0I7 34.634 2691 0.0 1408.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 30.391 1382 3.07e-134 478.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 29.913 1384 1.87e-126 453.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 30.301 1264 7.870000000000001e-124 444.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 28.749 1287 4.91e-114 412.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 30.469 1385 1.1700000000000001e-110 401.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 28.884 1371 1.21e-109 398.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 29.035 1388 1.4e-106 388.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 30.125 1039 4.95e-86 320.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g262.t1 Q6V0I7 29.491 963 4.87e-78 294.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 43.993 566 8.589999999999999e-137 443.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 35.387 568 1.95e-89 306.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 34.021 582 1.55e-77 271.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 36.155 567 3.18e-77 270.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 34.38 573 3.2599999999999997e-74 261.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 33.063 617 8.860000000000001e-72 254.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 31.469 572 2.35e-71 253.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 34.783 575 5.94e-71 252.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 32.702 581 6.1799999999999996e-68 243.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 35.638 564 2.96e-65 235.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 34.386 570 6.3000000000000005e-65 234.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 32.702 581 2.9000000000000002e-64 232.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 34.69 565 2.9300000000000003e-64 232.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 32.821 585 5.15e-64 231.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 33.04 569 3.07e-62 226.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 31.944 576 8.17e-60 219.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g263.t1 Q2PZL6 31.44 493 1.44e-47 183.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 39.044 1652 0.0 1063.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 31.25 1568 4.72e-157 536.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 30.234 1581 1.2e-149 514.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 29.811 1533 4.8e-147 506.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 29.685 1617 1.59e-145 501.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 30.358 1535 3.21e-140 485.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 30.928 776 1.11e-76 287.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t1 Q2PZL6 29.221 462 2.08e-26 122.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 41.807 1184 0.0 867.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 31.284 1106 2.26e-120 416.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 31.086 1142 5.1e-120 415.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 29.72 1070 2.6899999999999997e-115 401.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 31.513 1117 2.59e-113 395.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 31.457 1119 1.66e-106 375.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 31.515 1063 2.1199999999999998e-104 369.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 29.159 1118 2.84e-102 362.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 31.018 835 3.03e-92 332.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 30.0 750 9.54e-66 249.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g264.t2 Q2PZL6 29.221 462 1.59e-26 122.0 sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2 FAT4_MOUSE reviewed Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Mus musculus (Mouse) GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0005912; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0007409; GO:0008543; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0043931; GO:0044331; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307 axonogenesis [GO:0007409]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; epithelial cell differentiation [GO:0030855]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g265.t1 Q9Y673 56.954 302 4.03e-128 371.0 sp|Q9Y673|ALG5_HUMAN Dolichyl-phosphate beta-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG5 PE=1 SV=1 ALG5_HUMAN reviewed Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog) Homo sapiens (Human) GO:0004581; GO:0005789; GO:0006487; GO:0006488; GO:0007368; GO:0016020; GO:0018279; GO:0098554; GO:0098556 determination of left/right symmetry [GO:0007368]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581] g266.t1 Q14AW5 41.031 524 4.9200000000000005e-123 384.0 sp|Q14AW5|NSUN7_MOUSE Putative methyltransferase NSUN7 OS=Mus musculus OX=10090 GN=Nsun7 PE=2 SV=2 g267.t1 P63081 85.256 156 8.230000000000001e-85 248.0 sp|P63081|VATL_RAT V-type proton ATPase 16 kDa proteolipid subunit c OS=Rattus norvegicus OX=10116 GN=Atp6v0c PE=1 SV=1 VATL_RAT reviewed V-type proton ATPase 16 kDa proteolipid subunit c (V-ATPase 16 kDa proteolipid subunit c) (Vacuolar proton pump 16 kDa proteolipid subunit c) Rattus norvegicus (Rat) GO:0000220; GO:0008021; GO:0016020; GO:0030177; GO:0030665; GO:0030672; GO:0031625; GO:0033176; GO:0046961; GO:0070374; GO:0097401; GO:1904093 negative regulation of autophagic cell death [GO:1904093]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Wnt signaling pathway [GO:0030177]; synaptic vesicle lumen acidification [GO:0097401] clathrin-coated vesicle membrane [GO:0030665]; membrane [GO:0016020]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625] g268.t1 A4FUF0 39.518 539 4.66e-117 359.0 sp|A4FUF0|GLYR1_BOVIN Cytokine-like nuclear factor N-PAC OS=Bos taurus OX=9913 GN=GLYR1 PE=2 SV=1 GLYR1_BOVIN reviewed Cytokine-like nuclear factor N-PAC (NPAC) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60) (Putative oxidoreductase GLYR1) Bos taurus (Bovine) GO:0000785; GO:0000786; GO:0003677; GO:0005654; GO:0005829; GO:0031491; GO:0042393; GO:0045815; GO:0050661; GO:0051287; GO:0140463; GO:0140673 transcription elongation-coupled chromatin remodeling [GO:0140673]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786] chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; histone binding [GO:0042393]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; nucleosome binding [GO:0031491] g270.t1 Q9UHB7 40.278 288 1.63e-49 196.0 sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1 g270.t2 Q9UHB7 36.392 316 3.6499999999999995e-46 186.0 sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1 g271.t1 Q9Y6R7 28.162 2443 0.0 822.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 28.111 2451 0.0 803.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 27.533 2517 0.0 790.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 28.229 2423 0.0 786.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 28.094 2481 0.0 786.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 27.374 2506 0.0 769.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 26.859 2461 0.0 743.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 27.61 2213 0.0 696.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 27.411 1970 0.0 650.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 27.875 1991 1.8999999999999998e-180 632.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 26.849 1095 8.97e-92 340.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g271.t1 Q9Y6R7 25.865 665 4.49e-41 172.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g272.t1 Q9Y493 31.908 304 6.580000000000001e-35 138.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g273.t1 Q9Y493 27.632 1292 4.66e-113 405.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g273.t1 Q9Y493 29.095 983 2.24e-84 313.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g273.t1 Q9Y493 24.344 1372 1.3699999999999999e-67 258.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g273.t1 Q9Y493 28.322 572 7.37e-49 196.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g273.t1 Q9Y493 23.395 919 6.709999999999999e-46 187.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g276.t1 Q9NRY5 37.931 464 1.71e-78 263.0 sp|Q9NRY5|F1142_HUMAN Protein FAM114A2 OS=Homo sapiens OX=9606 GN=FAM114A2 PE=1 SV=4 g278.t1 Q8WXW3 47.582 765 0.0 683.0 sp|Q8WXW3|PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens OX=9606 GN=PIBF1 PE=1 SV=2 PIBF1_HUMAN reviewed Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90) Homo sapiens (Human) GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0036064; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515 activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634] interleukin-4 receptor binding [GO:0005136] g279.t1 Q96CM8 48.115 557 0.0 575.0 sp|Q96CM8|ACSF2_HUMAN Medium-chain acyl-CoA ligase ACSF2, mitochondrial OS=Homo sapiens OX=9606 GN=ACSF2 PE=1 SV=2 ACSF2_HUMAN reviewed Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2) Homo sapiens (Human) GO:0004467; GO:0005524; GO:0005739; GO:0005759; GO:0006631; GO:0006637; GO:0031956 acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956] g280.t1 Q0P4F7 48.885 583 0.0 592.0 sp|Q0P4F7|ACSF2_DANRE Medium-chain acyl-CoA ligase ACSF2, mitochondrial OS=Danio rerio OX=7955 GN=acsf2 PE=2 SV=1 ACSF2_DANRE reviewed Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005739; GO:0006631; GO:0031956 fatty acid metabolic process [GO:0006631] mitochondrion [GO:0005739] ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956] g282.t1 Q5G271 33.761 234 6.64e-31 128.0 sp|Q5G271|NETR_PANTR Neurotrypsin OS=Pan troglodytes OX=9598 GN=PRSS12 PE=3 SV=1 g282.t1 Q5G271 36.25 240 5.64e-27 116.0 sp|Q5G271|NETR_PANTR Neurotrypsin OS=Pan troglodytes OX=9598 GN=PRSS12 PE=3 SV=1 g282.t1 Q5G271 32.099 243 3.89e-25 111.0 sp|Q5G271|NETR_PANTR Neurotrypsin OS=Pan troglodytes OX=9598 GN=PRSS12 PE=3 SV=1 g286.t1 Q5SUR0 58.333 1356 0.0 1576.0 sp|Q5SUR0|PUR4_MOUSE Phosphoribosylformylglycinamidine synthase OS=Mus musculus OX=10090 GN=Pfas PE=1 SV=1 g287.t1 Q8NB91 23.435 687 1.58e-26 119.0 sp|Q8NB91|FANCB_HUMAN Fanconi anemia group B protein OS=Homo sapiens OX=9606 GN=FANCB PE=1 SV=1 FANCB_HUMAN reviewed Fanconi anemia group B protein (Protein FACB) (Fanconi anemia-associated polypeptide of 95 kDa) (FAAP95) Homo sapiens (Human) GO:0000785; GO:0005654; GO:0005829; GO:0036297; GO:0043240; GO:1905168; GO:1990414; GO:2000042 interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] g288.t1 Q9CWP6 31.335 517 7.5e-78 257.0 sp|Q9CWP6|MSPD2_MOUSE Motile sperm domain-containing protein 2 OS=Mus musculus OX=10090 GN=Mospd2 PE=1 SV=2 MSPD2_MOUSE reviewed Motile sperm domain-containing protein 2 Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0005886; GO:0006935; GO:0012505; GO:0033149; GO:0044232; GO:0051260; GO:0090023; GO:0090026; GO:0140042; GO:0140284 chemotaxis [GO:0006935]; lipid droplet formation [GO:0140042]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein homooligomerization [GO:0051260] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] FFAT motif binding [GO:0033149] g289.t1 Q7T163 45.44 1294 0.0 1117.0 sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3 KDISB_DANRE reviewed Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005770; GO:0007399; GO:0019887; GO:0030165; GO:0031902; GO:0038180 nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399] late endosome [GO:0005770]; late endosome membrane [GO:0031902] PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887] g291.t1 Q8VHT8 43.682 277 2.1e-70 227.0 sp|Q8VHT8|TF3A_RAT Transcription factor IIIA OS=Rattus norvegicus OX=10116 GN=Gtf3a PE=2 SV=2 g292.t1 Q9CZD5 34.759 187 1.04e-26 110.0 sp|Q9CZD5|IF3M_MOUSE Translation initiation factor IF-3, mitochondrial OS=Mus musculus OX=10090 GN=Mtif3 PE=1 SV=1 g295.t1 Q2KIQ4 55.901 322 3.46e-123 366.0 sp|Q2KIQ4|COQ2_BOVIN 4-hydroxybenzoate polyprenyltransferase, mitochondrial OS=Bos taurus OX=9913 GN=COQ2 PE=2 SV=1 g296.t1 O95671 53.456 217 4.65e-67 219.0 sp|O95671|ASML_HUMAN Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein OS=Homo sapiens OX=9606 GN=ASMTL PE=1 SV=3 ASML_HUMAN reviewed Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)] Homo sapiens (Human) GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0036218; GO:0036221; GO:0046983; GO:0047429 methylation [GO:0032259]; nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] dTTP diphosphatase activity [GO:0036218]; nucleoside triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; protein dimerization activity [GO:0046983]; UTP diphosphatase activity [GO:0036221] g297.t1 Q9JHW5 65.138 218 7.19e-100 291.0 sp|Q9JHW5|VAMP7_RAT Vesicle-associated membrane protein 7 OS=Rattus norvegicus OX=10116 GN=Vamp7 PE=1 SV=1 VAMP7_RAT reviewed Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1) Rattus norvegicus (Rat) GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008333; GO:0009986; GO:0016020; GO:0016079; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030133; GO:0030141; GO:0030175; GO:0030667; GO:0030670; GO:0030672; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595 calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192] apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g298.t1 Q9DF58 62.222 450 0.0 619.0 sp|Q9DF58|ILK_CHICK Scaffold protein ILK OS=Gallus gallus OX=9031 GN=ILK PE=1 SV=1 g299.t1 Q9DB85 50.622 241 2.89e-80 263.0 sp|Q9DB85|RRP8_MOUSE Ribosomal RNA-processing protein 8 OS=Mus musculus OX=10090 GN=Rrp8 PE=1 SV=1 g300.t1 O94868 40.24 666 6.929999999999999e-146 453.0 sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3 g300.t2 O94868 39.852 675 9.32e-145 450.0 sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3 g301.t1 Q7ZW24 57.724 492 0.0 567.0 sp|Q7ZW24|ALG11_DANRE GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase OS=Danio rerio OX=7955 GN=alg11 PE=2 SV=2 g310.t1 Q29449 59.259 1134 0.0 1408.0 sp|Q29449|AT8A1_BOVIN Probable phospholipid-transporting ATPase IA OS=Bos taurus OX=9913 GN=ATP8A1 PE=1 SV=2 AT8A1_BOVIN reviewed Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) Bos taurus (Bovine) GO:0000287; GO:0005524; GO:0005783; GO:0005802; GO:0005886; GO:0016887; GO:0031090; GO:0031410; GO:0042584; GO:0045332; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531 aminophospholipid translocation [GO:0140331]; phospholipid translocation [GO:0045332] chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] g310.t2 Q29449 60.018 1123 0.0 1417.0 sp|Q29449|AT8A1_BOVIN Probable phospholipid-transporting ATPase IA OS=Bos taurus OX=9913 GN=ATP8A1 PE=1 SV=2 AT8A1_BOVIN reviewed Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) Bos taurus (Bovine) GO:0000287; GO:0005524; GO:0005783; GO:0005802; GO:0005886; GO:0016887; GO:0031090; GO:0031410; GO:0042584; GO:0045332; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531 aminophospholipid translocation [GO:0140331]; phospholipid translocation [GO:0045332] chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] g310.t3 Q29449 60.018 1123 0.0 1416.0 sp|Q29449|AT8A1_BOVIN Probable phospholipid-transporting ATPase IA OS=Bos taurus OX=9913 GN=ATP8A1 PE=1 SV=2 AT8A1_BOVIN reviewed Probable phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) Bos taurus (Bovine) GO:0000287; GO:0005524; GO:0005783; GO:0005802; GO:0005886; GO:0016887; GO:0031090; GO:0031410; GO:0042584; GO:0045332; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531 aminophospholipid translocation [GO:0140331]; phospholipid translocation [GO:0045332] chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] g310.t4 Q9Y2Q0 57.899 1171 0.0 1399.0 sp|Q9Y2Q0|AT8A1_HUMAN Phospholipid-transporting ATPase IA OS=Homo sapiens OX=9606 GN=ATP8A1 PE=1 SV=1 AT8A1_HUMAN reviewed Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007612; GO:0016020; GO:0016887; GO:0019829; GO:0030335; GO:0030672; GO:0031090; GO:0031410; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0045332; GO:0048488; GO:0061092; GO:0070062; GO:0090556; GO:0098978; GO:0140326; GO:0140331; GO:0140346; GO:0150104; GO:1990531 aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; synaptic vesicle endocytosis [GO:0048488]; transport across blood-brain barrier [GO:0150104] azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] g311.t1 P24861 51.843 407 7.8e-133 392.0 sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1 g313.t1 P14099 56.356 763 0.0 883.0 sp|P14099|PDE2A_BOVIN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Bos taurus OX=9913 GN=PDE2A PE=1 SV=2 PDE2A_BOVIN reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Bos taurus (Bovine) GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010628; GO:0010754; GO:0010821; GO:0019934; GO:0030553; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011; GO:0097060; GO:0106072; GO:0141162 cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g313.t2 P14099 56.596 758 0.0 882.0 sp|P14099|PDE2A_BOVIN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Bos taurus OX=9913 GN=PDE2A PE=1 SV=2 PDE2A_BOVIN reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Bos taurus (Bovine) GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010628; GO:0010754; GO:0010821; GO:0019934; GO:0030553; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011; GO:0097060; GO:0106072; GO:0141162 cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g313.t3 P14099 55.805 758 0.0 861.0 sp|P14099|PDE2A_BOVIN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Bos taurus OX=9913 GN=PDE2A PE=1 SV=2 PDE2A_BOVIN reviewed cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) Bos taurus (Bovine) GO:0000122; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010628; GO:0010754; GO:0010821; GO:0019934; GO:0030553; GO:0036006; GO:0042734; GO:0042803; GO:0043116; GO:0043117; GO:0046038; GO:0046069; GO:0046872; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071321; GO:0097011; GO:0097060; GO:0106072; GO:0141162 cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g314.t1 Q5T8P6 36.641 524 4.64e-75 273.0 sp|Q5T8P6|RBM26_HUMAN RNA-binding protein 26 OS=Homo sapiens OX=9606 GN=RBM26 PE=1 SV=3 RBM26_HUMAN reviewed RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005654; GO:0008270 nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g314.t1 Q5T8P6 60.256 78 1.49e-22 108.0 sp|Q5T8P6|RBM26_HUMAN RNA-binding protein 26 OS=Homo sapiens OX=9606 GN=RBM26 PE=1 SV=3 RBM26_HUMAN reviewed RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005654; GO:0008270 nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g316.t1 Q6ZQ58 52.984 687 0.0 674.0 sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3 g316.t2 Q6ZQ58 52.984 687 0.0 674.0 sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3 g317.t1 Q02040 54.054 444 7.21e-131 399.0 sp|Q02040|AK17A_HUMAN A-kinase anchor protein 17A OS=Homo sapiens OX=9606 GN=AKAP17A PE=1 SV=2 AK17A_HUMAN reviewed A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018 B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; signal transduction [GO:0007165] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] protein kinase A binding [GO:0051018]; RNA binding [GO:0003723] g318.t2 Q9P270 34.13 293 4.22e-22 103.0 sp|Q9P270|SLAI2_HUMAN SLAIN motif-containing protein 2 OS=Homo sapiens OX=9606 GN=SLAIN2 PE=1 SV=2 SLAI2_HUMAN reviewed SLAIN motif-containing protein 2 Homo sapiens (Human) GO:0005813; GO:0005829; GO:0007020; GO:0015630; GO:0031116; GO:0031122 cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] g320.t1 A8WHP3 49.045 628 0.0 643.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g321.t1 Q761V0 46.179 602 0.0 569.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g323.t1 Q5ZME8 87.524 513 0.0 959.0 sp|Q5ZME8|SMU1_CHICK WD40 repeat-containing protein SMU1 OS=Gallus gallus OX=9031 GN=SMU1 PE=2 SV=1 SMU1_CHICK reviewed WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) Gallus gallus (Chicken) GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011 mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005] g324.t1 Q6P5M2 75.748 301 1.63e-175 490.0 sp|Q6P5M2|SKI8_DANRE Superkiller complex protein 8 OS=Danio rerio OX=7955 GN=skic8 PE=2 SV=1 g325.t1 Q9D9B4 34.416 154 1.21e-21 92.0 sp|Q9D9B4|LRMDA_MOUSE Leucine-rich melanocyte differentiation-associated protein OS=Mus musculus OX=10090 GN=Lrmda PE=1 SV=1 g326.t1 Q17QV3 49.485 97 1.64e-28 102.0 sp|Q17QV3|SUMO3_BOVIN Small ubiquitin-related modifier 3 OS=Bos taurus OX=9913 GN=SUMO3 PE=3 SV=1 SUMO3_BOVIN reviewed Small ubiquitin-related modifier 3 (SUMO-3) Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0016605; GO:0016925; GO:0031386; GO:0044389 protein sumoylation [GO:0016925] cytoplasm [GO:0005737]; nucleus [GO:0005634]; PML body [GO:0016605] protein tag activity [GO:0031386]; ubiquitin-like protein ligase binding [GO:0044389] g327.t1 Q5M823 58.667 150 5.28e-64 196.0 sp|Q5M823|NUDC2_RAT NudC domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Nudcd2 PE=2 SV=1 g328.t1 Q8BX17 35.806 1483 0.0 860.0 sp|Q8BX17|GEMI5_MOUSE Gem-associated protein 5 OS=Mus musculus OX=10090 GN=Gemin5 PE=1 SV=2 GEMI5_MOUSE reviewed Gem-associated protein 5 (Gemin5) Mus musculus (Mouse) GO:0000340; GO:0000387; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504 regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719] mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] g329.t1 Q5BJ48 54.31 232 6.44e-90 267.0 sp|Q5BJ48|MED7_XENTR Mediator of RNA polymerase II transcription subunit 7 OS=Xenopus tropicalis OX=8364 GN=med7 PE=2 SV=1 g330.t1 P08630 41.71 772 0.0 548.0 sp|P08630|BTKL_DROME Tyrosine-protein kinase Btk OS=Drosophila melanogaster OX=7227 GN=Btk PE=2 SV=2 g330.t2 P08630 41.71 772 0.0 547.0 sp|P08630|BTKL_DROME Tyrosine-protein kinase Btk OS=Drosophila melanogaster OX=7227 GN=Btk PE=2 SV=2 g338.t1 Q9WTS5 35.753 1653 0.0 1035.0 sp|Q9WTS5|TEN2_MOUSE Teneurin-2 OS=Mus musculus OX=10090 GN=Tenm2 PE=1 SV=1 TEN2_MOUSE reviewed Teneurin-2 (Ten-2) (Protein Odd Oz/ten-m homolog 2) (Tenascin-M2) (Ten-m2) (Teneurin transmembrane protein 2) [Cleaved into: Ten-2, soluble form; Ten-2 intracellular domain (Ten-2 ICD)] Mus musculus (Mouse) GO:0000122; GO:0005102; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0005911; GO:0007165; GO:0016605; GO:0030054; GO:0030175; GO:0030425; GO:0030426; GO:0042734; GO:0042802; GO:0042803; GO:0043005; GO:0043197; GO:0045202; GO:0045211; GO:0046982; GO:0048666; GO:0050839; GO:0051491; GO:0098609; GO:0098890; GO:0098942; GO:0098978 cell-cell adhesion [GO:0098609]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; positive regulation of filopodium assembly [GO:0051491]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; signal transduction [GO:0007165] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] g343.t1 Q8C827 37.156 436 8.29e-87 285.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g343.t1 Q8C827 37.871 404 1.4699999999999998e-82 274.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g343.t1 Q8C827 37.374 396 1.2e-77 260.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g343.t1 Q8C827 36.683 398 2.5000000000000002e-77 259.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g343.t1 Q8C827 35.891 404 1.65e-76 257.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g343.t1 Q8C827 35.224 335 4.9e-58 207.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g343.t1 Q8C827 33.718 347 1.47e-50 186.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g343.t1 Q8C827 37.209 258 3.74e-46 173.0 sp|Q8C827|ZFP62_MOUSE Zinc finger protein 62 OS=Mus musculus OX=10090 GN=Zfp62 PE=1 SV=1 g344.t1 Q28F39 34.021 194 1.07e-31 120.0 sp|Q28F39|CC134_XENTR Coiled-coil domain-containing protein 134 OS=Xenopus tropicalis OX=8364 GN=ccdc134 PE=2 SV=1 g345.t1 Q5RED7 38.462 364 6.41e-76 245.0 sp|Q5RED7|AGK_PONAB Acylglycerol kinase, mitochondrial OS=Pongo abelii OX=9601 GN=AGK PE=2 SV=1 AGK_PONAB reviewed Acylglycerol kinase, mitochondrial (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (MuLK) (Multi-substrate lipid kinase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001729; GO:0004143; GO:0005524; GO:0005743; GO:0005758; GO:0031966; GO:0042721; GO:0045039; GO:0046486; GO:0046512; GO:0046513; GO:0046834; GO:0047620 ceramide biosynthetic process [GO:0046513]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; protein insertion into mitochondrial inner membrane [GO:0045039]; sphingosine biosynthetic process [GO:0046512] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; ceramide kinase activity [GO:0001729] g346.t1 Q6GPQ3 32.702 581 6.569999999999999e-94 303.0 sp|Q6GPQ3|MFSD8_XENLA Major facilitator superfamily domain-containing protein 8 OS=Xenopus laevis OX=8355 GN=mfsd8 PE=2 SV=1 g349.t1 Q9GZQ4 27.362 307 5.7000000000000004e-21 96.3 sp|Q9GZQ4|NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens OX=9606 GN=NMUR2 PE=1 SV=2 NMUR2_HUMAN reviewed Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1) Homo sapiens (Human) GO:0001607; GO:0002023; GO:0004930; GO:0005229; GO:0005525; GO:0005886; GO:0006940; GO:0007200; GO:0007218; GO:0007267; GO:0007417; GO:0007625; GO:0007631; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0050850 arachidonate secretion [GO:0050482]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium-mediated signaling [GO:0050850]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g351.t1 Q6ZWB6 46.975 281 6.3299999999999995e-74 235.0 sp|Q6ZWB6|KCTD8_HUMAN BTB/POZ domain-containing protein KCTD8 OS=Homo sapiens OX=9606 GN=KCTD8 PE=1 SV=1 g352.t1 F6U5F9 37.692 979 0.0 611.0 sp|F6U5F9|INTU_XENTR Protein inturned OS=Xenopus tropicalis OX=8364 GN=intu PE=3 SV=1 g352.t2 F6U5F9 37.736 954 0.0 608.0 sp|F6U5F9|INTU_XENTR Protein inturned OS=Xenopus tropicalis OX=8364 GN=intu PE=3 SV=1 g353.t1 P70582 38.333 240 4.83e-34 130.0 sp|P70582|NUP54_RAT Nuclear pore complex protein Nup54 OS=Rattus norvegicus OX=10116 GN=Nup54 PE=1 SV=1 g354.t1 P70582 64.444 90 2.6400000000000002e-33 130.0 sp|P70582|NUP54_RAT Nuclear pore complex protein Nup54 OS=Rattus norvegicus OX=10116 GN=Nup54 PE=1 SV=1 g355.t1 E7F587 47.308 260 2.1800000000000002e-73 233.0 sp|E7F587|ZD20B_DANRE Palmitoyltransferase ZDHHC20-B OS=Danio rerio OX=7955 GN=zdhhc20b PE=3 SV=3 ZD20B_DANRE reviewed Palmitoyltransferase ZDHHC20-B (EC 2.3.1.225) (Acyltransferase ZDHHC20-B) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 20-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0016188; GO:0018345; GO:0019705; GO:0019706; GO:0033116; GO:0046872; GO:0048471; GO:0140439 protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g355.t2 F1QXD3 58.772 114 1.34e-44 152.0 sp|F1QXD3|ZH15B_DANRE Palmitoyltransferase ZDHHC15B OS=Danio rerio OX=7955 GN=zdhhc15b PE=1 SV=1 ZH15B_DANRE reviewed Palmitoyltransferase ZDHHC15B (EC 2.3.1.225) (Acyltransferase ZDHHC15B) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 15B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008270; GO:0014069; GO:0016188; GO:0019705; GO:0019706; GO:0072657; GO:0140439; GO:0140450 protein localization to membrane [GO:0072657]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069] protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270] g355.t3 E7F587 51.25 240 1.9000000000000002e-80 250.0 sp|E7F587|ZD20B_DANRE Palmitoyltransferase ZDHHC20-B OS=Danio rerio OX=7955 GN=zdhhc20b PE=3 SV=3 ZD20B_DANRE reviewed Palmitoyltransferase ZDHHC20-B (EC 2.3.1.225) (Acyltransferase ZDHHC20-B) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 20-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0016188; GO:0018345; GO:0019705; GO:0019706; GO:0033116; GO:0046872; GO:0048471; GO:0140439 protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g357.t1 Q6UPE1 66.833 600 0.0 845.0 sp|Q6UPE1|ETFD_RAT Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Etfdh PE=1 SV=1 ETFD_RAT reviewed Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase) Rattus norvegicus (Rat) GO:0004174; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0022900; GO:0031966; GO:0033539; GO:0046872; GO:0048038; GO:0048039; GO:0050660; GO:0051536; GO:0051539 electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039] g358.t1 O09167 63.58 162 5.96e-72 216.0 sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4 RL21_MOUSE reviewed Large ribosomal subunit protein eL21 (60S ribosomal protein L21) Mus musculus (Mouse) GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0022626; GO:0045202; GO:0098794 cytoplasmic translation [GO:0002181] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202] structural constituent of ribosome [GO:0003735] g359.t1 A5D9H7 71.081 370 0.0 541.0 sp|A5D9H7|UBP12_BOVIN Ubiquitin carboxyl-terminal hydrolase 12 OS=Bos taurus OX=9913 GN=USP12 PE=2 SV=1 UBP12_BOVIN reviewed Ubiquitin carboxyl-terminal hydrolase 12 (EC 3.4.19.12) (Deubiquitinating enzyme 12) (Ubiquitin specific peptidase 12) (Ubiquitin thioesterase 12) (Ubiquitin-specific-processing protease 12) Bos taurus (Bovine) GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0016579; GO:0031647; GO:0046872 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872] g360.t1 Q9VCA9 57.542 179 7.89e-68 207.0 sp|Q9VCA9|SPCS3_DROME Signal peptidase complex subunit 3 OS=Drosophila melanogaster OX=7227 GN=Spase22-23 PE=2 SV=1 g361.t1 P10079 43.434 594 8.84e-142 467.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g361.t1 P10079 48.776 490 1.1499999999999998e-140 464.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g361.t1 P10079 47.451 510 1.29e-136 453.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g362.t1 Q9P2G9 53.287 578 0.0 661.0 sp|Q9P2G9|KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens OX=9606 GN=KLHL8 PE=1 SV=4 KLHL8_HUMAN reviewed Kelch-like protein 8 Homo sapiens (Human) GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:1990756 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g362.t2 Q9P2G9 53.287 578 0.0 661.0 sp|Q9P2G9|KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens OX=9606 GN=KLHL8 PE=1 SV=4 KLHL8_HUMAN reviewed Kelch-like protein 8 Homo sapiens (Human) GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:1990756 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g363.t1 O76536 33.402 488 4.2400000000000003e-44 177.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g363.t1 O76536 30.205 586 7.4e-37 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g363.t1 O76536 32.157 510 2.74e-34 145.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g363.t1 O76536 31.957 460 2.09e-33 143.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g363.t1 O76536 31.569 510 1.45e-31 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g363.t1 O76536 30.769 507 9.93e-31 134.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g363.t1 O76536 32.506 443 4.91e-29 129.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t1 O76536 28.536 1216 2.73e-56 219.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t1 O76536 29.264 1155 2.57e-54 213.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t1 O76536 29.465 1103 3.45e-53 209.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t1 O76536 28.061 980 6.79e-37 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t2 O76536 29.264 1155 2.77e-54 213.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t2 O76536 28.766 1175 9.39e-51 201.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t2 O76536 29.212 1003 3.66e-48 193.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g365.t2 O76536 28.061 980 7.55e-37 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g366.t1 P27615 39.18 439 1.45e-102 319.0 sp|P27615|SCRB2_RAT Lysosome membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Scarb2 PE=1 SV=2 SCRB2_RAT reviewed Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36) Rattus norvegicus (Rat) GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0006914; GO:0007605; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638 aminophospholipid transport [GO:0015917]; autophagy [GO:0006914]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; sensory perception of sound [GO:0007605] endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044] g366.t2 P27615 39.18 439 1.91e-102 319.0 sp|P27615|SCRB2_RAT Lysosome membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Scarb2 PE=1 SV=2 SCRB2_RAT reviewed Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36) Rattus norvegicus (Rat) GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0006914; GO:0007605; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638 aminophospholipid transport [GO:0015917]; autophagy [GO:0006914]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; sensory perception of sound [GO:0007605] endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044] g367.t1 Q96DM1 24.59 488 6.1e-38 152.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g368.t1 Q9HD15 39.234 209 1.58e-32 124.0 sp|Q9HD15|SRA1_HUMAN Steroid receptor RNA activator 1 OS=Homo sapiens OX=9606 GN=SRA1 PE=1 SV=2 g368.t2 Q9HD15 39.234 209 1.3700000000000001e-32 124.0 sp|Q9HD15|SRA1_HUMAN Steroid receptor RNA activator 1 OS=Homo sapiens OX=9606 GN=SRA1 PE=1 SV=2 g369.t1 Q13586 50.342 439 7.07e-149 452.0 sp|Q13586|STIM1_HUMAN Stromal interaction molecule 1 OS=Homo sapiens OX=9606 GN=STIM1 PE=1 SV=3 g369.t2 Q13586 45.385 520 1.34e-149 453.0 sp|Q13586|STIM1_HUMAN Stromal interaction molecule 1 OS=Homo sapiens OX=9606 GN=STIM1 PE=1 SV=3 g370.t1 Q96IG2 26.142 394 1.67e-28 120.0 sp|Q96IG2|FXL20_HUMAN F-box/LRR-repeat protein 20 OS=Homo sapiens OX=9606 GN=FBXL20 PE=1 SV=2 g371.t1 O54799 35.574 357 9.67e-56 189.0 sp|O54799|NMBR_MOUSE Neuromedin-B receptor OS=Mus musculus OX=10090 GN=Nmbr PE=1 SV=1 NMBR_MOUSE reviewed Neuromedin-B receptor (NMB-R) (Neuromedin-B-preferring bombesin receptor) Mus musculus (Mouse) GO:0004946; GO:0005829; GO:0005886; GO:0007186; GO:0008188; GO:0032715; GO:0032727; GO:0090290; GO:0140374; GO:0160023; GO:1903942 antiviral innate immune response [GO:0140374]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of interleukin-6 production [GO:0032715]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; sneeze reflex [GO:0160023] cytosol [GO:0005829]; plasma membrane [GO:0005886] bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188] g373.t1 Q7TN88 26.237 667 2.9200000000000003e-59 231.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g373.t1 Q7TN88 25.556 900 1.2399999999999999e-48 196.0 sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1 PK1L2_MOUSE reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Mus musculus (Mouse) GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G-protein alpha-subunit binding [GO:0001965] g374.t1 A1ZAX0 29.101 378 2.65e-25 110.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 CCH1R_DROME reviewed Neuropeptide CCHamide-1 receptor Drosophila melanogaster (Fruit fly) GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016020 G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] membrane [GO:0016020]; plasma membrane [GO:0005886] allatostatin receptor activity [GO:0008261]; neuropeptide receptor activity [GO:0008188] g375.t1 Q12904 39.628 323 1.64e-59 196.0 sp|Q12904|AIMP1_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens OX=9606 GN=AIMP1 PE=1 SV=2 AIMP1_HUMAN reviewed Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)] Homo sapiens (Human) GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0042803; GO:0050900; GO:0051020; GO:0051607; GO:0070094 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634] cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049] g376.t1 Q9GKT2 45.136 257 4.19e-75 233.0 sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1 g378.t1 Q9GKT2 50.0 320 1.59e-111 331.0 sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1 g379.t1 P30937 29.412 289 6.47e-25 108.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g380.t1 P70085 36.424 453 3.26e-93 304.0 sp|P70085|CP17A_ORYLA Steroid 17-alpha-hydroxylase/17,20 lyase OS=Oryzias latipes OX=8090 GN=cyp17a1 PE=2 SV=1 g382.t1 O73853 35.639 477 9.94e-94 305.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g384.t1 O73853 34.402 468 1.78e-87 288.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g385.t1 Q6F6U3 35.514 214 2.06e-33 127.0 sp|Q6F6U3|PNCA_ACIAD Nicotinamidase OS=Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1) OX=62977 GN=pncA PE=1 SV=1 g386.t1 Q6F6U3 38.974 195 5.55e-34 128.0 sp|Q6F6U3|PNCA_ACIAD Nicotinamidase OS=Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1) OX=62977 GN=pncA PE=1 SV=1 g389.t1 P10041 41.333 150 1.01e-28 124.0 sp|P10041|DL_DROME Neurogenic locus protein delta OS=Drosophila melanogaster OX=7227 GN=Delta PE=1 SV=2 g395.t1 Q10138 32.99 194 2.1499999999999998e-24 103.0 sp|Q10138|YAS2_SCHPO CRAL-TRIO domain-containing protein C3H8.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC3H8.02 PE=1 SV=1 g396.t1 Q2HJG4 28.998 838 1.02e-76 265.0 sp|Q2HJG4|TDRD3_BOVIN Tudor domain-containing protein 3 OS=Bos taurus OX=9913 GN=TDRD3 PE=2 SV=1 g397.t1 Q9HC07 59.044 293 2.09e-113 335.0 sp|Q9HC07|TM165_HUMAN Putative divalent cation/proton antiporter TMEM165 OS=Homo sapiens OX=9606 GN=TMEM165 PE=1 SV=1 TM165_HUMAN reviewed Putative divalent cation/proton antiporter TMEM165 (Transmembrane protein 165) (Transmembrane protein PT27) (Transmembrane protein TPARL) Homo sapiens (Human) GO:0000139; GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006816; GO:0006828; GO:0006874; GO:0010008; GO:0015085; GO:0015297; GO:0032468; GO:0032472; GO:0032588; GO:0033106; GO:0035751; GO:0070588; GO:0071421 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751] cis-Golgi network membrane [GO:0033106]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] antiporter activity [GO:0015297]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384] g397.t2 Q9HC07 56.688 314 1.82e-110 328.0 sp|Q9HC07|TM165_HUMAN Putative divalent cation/proton antiporter TMEM165 OS=Homo sapiens OX=9606 GN=TMEM165 PE=1 SV=1 TM165_HUMAN reviewed Putative divalent cation/proton antiporter TMEM165 (Transmembrane protein 165) (Transmembrane protein PT27) (Transmembrane protein TPARL) Homo sapiens (Human) GO:0000139; GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006816; GO:0006828; GO:0006874; GO:0010008; GO:0015085; GO:0015297; GO:0032468; GO:0032472; GO:0032588; GO:0033106; GO:0035751; GO:0070588; GO:0071421 calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751] cis-Golgi network membrane [GO:0033106]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] antiporter activity [GO:0015297]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384] g398.t1 A6QLU6 36.136 440 8.91e-81 287.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g399.t1 Q96M89 41.26 492 6.32e-115 361.0 sp|Q96M89|CC138_HUMAN Coiled-coil domain-containing protein 138 OS=Homo sapiens OX=9606 GN=CCDC138 PE=1 SV=1 g400.t1 Q9Z142 51.417 247 1.0399999999999998e-89 269.0 sp|Q9Z142|TMM33_RAT Transmembrane protein 33 OS=Rattus norvegicus OX=10116 GN=Tmem33 PE=2 SV=1 g401.t1 Q9UI36 72.059 136 1.06e-61 221.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g401.t1 Q9UI36 57.037 135 4.57e-25 114.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g401.t2 Q9UI36 72.059 136 1.62e-61 220.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g401.t2 Q9UI36 57.463 134 4.97e-25 113.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g401.t3 Q9UI36 72.059 136 7.959999999999999e-62 221.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g401.t3 Q9UI36 58.779 131 7.470000000000001e-27 119.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g401.t4 Q9UI36 72.059 136 1.15e-61 221.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g401.t4 Q9UI36 57.463 134 3.9e-25 114.0 sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4 DACH1_HUMAN reviewed Dachshund homolog 1 (Dach1) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g402.t1 Q99LB6 52.027 296 2.08e-101 303.0 sp|Q99LB6|MAT2B_MOUSE Methionine adenosyltransferase 2 subunit beta OS=Mus musculus OX=10090 GN=Mat2b PE=1 SV=1 g403.t1 Q99M87 55.473 402 1.02e-157 459.0 sp|Q99M87|DNJA3_MOUSE DnaJ homolog subfamily A member 3, mitochondrial OS=Mus musculus OX=10090 GN=Dnaja3 PE=1 SV=1 DNJA3_MOUSE reviewed DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (mTid-1) (Tumorous imaginal discs protein Tid56 homolog) Mus musculus (Mouse) GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005884; GO:0005886; GO:0006264; GO:0006457; GO:0006915; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008270; GO:0008285; GO:0009408; GO:0009898; GO:0019901; GO:0030544; GO:0030695; GO:0030971; GO:0031398; GO:0031594; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0044877; GO:0045211; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297 activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase-mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; type II interferon receptor binding [GO:0005133]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] g403.t2 Q96EY1 55.86 401 3.02e-157 459.0 sp|Q96EY1|DNJA3_HUMAN DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2 DNJA3_HUMAN reviewed DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog) Homo sapiens (Human) GO:0000122; GO:0005102; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008270; GO:0008285; GO:0009408; GO:0009898; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0044877; GO:0045211; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297 activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase-mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; type II interferon receptor binding [GO:0005133]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] g404.t1 Q9HC56 35.287 836 2.2899999999999997e-137 453.0 sp|Q9HC56|PCDH9_HUMAN Protocadherin-9 OS=Homo sapiens OX=9606 GN=PCDH9 PE=1 SV=2 g405.t1 Q0V8F1 44.56 965 0.0 803.0 sp|Q0V8F1|CORO7_BOVIN Coronin-7 OS=Bos taurus OX=9913 GN=CORO7 PE=2 SV=1 CORO7_BOVIN reviewed Coronin-7 (Crn7) Bos taurus (Bovine) GO:0000139; GO:0003779; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0030041; GO:0031410 actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] actin binding [GO:0003779] g406.t1 P34661 89.412 85 1.63e-51 159.0 sp|P34661|UFM1_CAEEL Ubiquitin-fold modifier 1 OS=Caenorhabditis elegans OX=6239 GN=ufm-1 PE=1 SV=1 g409.t1 Q5ZIV1 69.11 573 0.0 870.0 sp|Q5ZIV1|MTMR2_CHICK Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2 OS=Gallus gallus OX=9031 GN=MTMR2 PE=2 SV=1 MTMR2_CHICK reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2 (EC 3.1.3.95) (Myotubularin-related protein 2) (Phosphatidylinositol-3-phosphate phosphatase) Gallus gallus (Chicken) GO:0004438; GO:0005737; GO:0005829; GO:0016020; GO:0031901; GO:0046856; GO:0052629 phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; membrane [GO:0016020] phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438] g410.t1 Q2KJG4 41.912 136 4.48e-33 117.0 sp|Q2KJG4|MGST2_BOVIN Microsomal glutathione S-transferase 2 OS=Bos taurus OX=9913 GN=MGST2 PE=2 SV=1 MGST2_BOVIN reviewed Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Glutathione peroxidase MGST2) (EC 1.11.1.-) (Leukotriene C4 synthase MGST2) (EC 4.4.1.20) (Microsomal glutathione S-transferase II) (Microsomal GST-II) Bos taurus (Bovine) GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0008047; GO:0019370; GO:0042802; GO:0043295 leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635] enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464] g411.t1 Q90YW0 70.053 187 1.48e-95 278.0 sp|Q90YW0|RL9_ICTPU Large ribosomal subunit protein uL6 OS=Ictalurus punctatus OX=7998 GN=rpl9 PE=2 SV=1 g412.t1 Q4R5M4 60.079 253 1.6e-100 296.0 sp|Q4R5M4|YIPF5_MACFA Protein YIPF5 OS=Macaca fascicularis OX=9541 GN=YIPF5 PE=2 SV=1 YIPF5_MACFA reviewed Protein YIPF5 (YIP1 family member 5) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005654; GO:0005789; GO:0005802; GO:0006888; GO:0015031; GO:0030070; GO:0030134; GO:0048280; GO:0060628; GO:0070971 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; insulin processing [GO:0030070]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; vesicle fusion with Golgi apparatus [GO:0048280] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] g413.t1 Q9NVU7 61.727 695 0.0 861.0 sp|Q9NVU7|SDA1_HUMAN Protein SDA1 homolog OS=Homo sapiens OX=9606 GN=SDAD1 PE=1 SV=3 g414.t1 F4ILY9 31.51 457 1.22e-57 199.0 sp|F4ILY9|AVT3B_ARATH Amino acid transporter AVT3B OS=Arabidopsis thaliana OX=3702 GN=AVT3B PE=2 SV=1 g415.t1 Q4AC94 35.239 1609 0.0 834.0 sp|Q4AC94|C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=C2CD3 PE=1 SV=4 C2CD3_HUMAN reviewed C2 domain-containing protein 3 Homo sapiens (Human) GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515 brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815] g416.t1 A0JM13 54.128 109 1.3000000000000001e-32 122.0 sp|A0JM13|C2CD3_XENTR C2 domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=c2cd3 PE=2 SV=2 g418.t1 A0A1B0GV85 36.957 184 4.76e-24 102.0 sp|A0A1B0GV85|RELD1_HUMAN Reelin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=REELD1 PE=2 SV=2 g419.t1 Q8QG64 90.991 111 6.71e-69 204.0 sp|Q8QG64|RBX1_SALSA E3 ubiquitin-protein ligase RBX1 OS=Salmo salar OX=8030 GN=rbx1 PE=2 SV=2 g420.t1 Q3V1U8 47.635 296 1.2099999999999999e-92 280.0 sp|Q3V1U8|ELMD1_MOUSE ELMO domain-containing protein 1 OS=Mus musculus OX=10090 GN=Elmod1 PE=1 SV=2 g421.t1 O70472 34.81 1738 0.0 855.0 sp|O70472|TM131_MOUSE Transmembrane protein 131 OS=Mus musculus OX=10090 GN=Tmem131 PE=2 SV=2 g421.t2 O70472 34.81 1738 0.0 855.0 sp|O70472|TM131_MOUSE Transmembrane protein 131 OS=Mus musculus OX=10090 GN=Tmem131 PE=2 SV=2 g422.t1 Q95114 35.542 166 1.1200000000000002e-21 102.0 sp|Q95114|MFGM_BOVIN Lactadherin OS=Bos taurus OX=9913 GN=MFGE8 PE=1 SV=2 MFGM_BOVIN reviewed Lactadherin (BP47) (Components 15/16) (MFGM) (MGP57/53) (Milk fat globule-EGF factor 8) (MFG-E8) (PAS-6/PAS-7 glycoprotein) (SED1) (Sperm surface protein SP47) Bos taurus (Bovine) GO:0001525; GO:0001786; GO:0002080; GO:0005615; GO:0007155; GO:0007338 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; extracellular space [GO:0005615] phosphatidylserine binding [GO:0001786] g422.t2 Q95114 35.542 166 1.1100000000000001e-21 102.0 sp|Q95114|MFGM_BOVIN Lactadherin OS=Bos taurus OX=9913 GN=MFGE8 PE=1 SV=2 MFGM_BOVIN reviewed Lactadherin (BP47) (Components 15/16) (MFGM) (MGP57/53) (Milk fat globule-EGF factor 8) (MFG-E8) (PAS-6/PAS-7 glycoprotein) (SED1) (Sperm surface protein SP47) Bos taurus (Bovine) GO:0001525; GO:0001786; GO:0002080; GO:0005615; GO:0007155; GO:0007338 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; extracellular space [GO:0005615] phosphatidylserine binding [GO:0001786] g423.t1 Q9VCZ3 31.343 335 9.4e-44 160.0 sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1 OCTB1_DROME reviewed Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R) Drosophila melanogaster (Fruit fly) GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410] membrane [GO:0016020]; plasma membrane [GO:0005886] adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989] g424.t1 P97288 32.0 325 3.95e-40 148.0 sp|P97288|5HT4R_MOUSE 5-hydroxytryptamine receptor 4 OS=Mus musculus OX=10090 GN=Htr4 PE=1 SV=3 5HT4R_MOUSE reviewed 5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4) Mus musculus (Mouse) GO:0004993; GO:0005737; GO:0005886; GO:0007186; GO:0007187; GO:0007189; GO:0007192; GO:0007198; GO:0007214; GO:0007268; GO:0010008; GO:0016020; GO:0030277; GO:0030425; GO:0030594; GO:0032098; GO:0051378; GO:0070254; GO:0098794; GO:0098978; GO:0099589; GO:0120056; GO:0150052 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; large intestinal transit [GO:0120056]; maintenance of gastrointestinal epithelium [GO:0030277]; mucus secretion [GO:0070254]; regulation of appetite [GO:0032098]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589] g425.t1 F1RB95 39.754 488 1.72e-112 343.0 sp|F1RB95|RNF14_DANRE E3 ubiquitin-protein ligase RNF14 OS=Danio rerio OX=7955 GN=rnf14 PE=2 SV=1 g426.t1 Q9JI90 45.267 486 1.86e-143 423.0 sp|Q9JI90|RNF14_MOUSE E3 ubiquitin-protein ligase RNF14 OS=Mus musculus OX=10090 GN=Rnf14 PE=1 SV=2 RNF14_MOUSE reviewed E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (RING finger protein 14) Mus musculus (Mouse) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006414; GO:0006415; GO:0006511; GO:0008270; GO:0019787; GO:0022626; GO:0031624; GO:0045893; GO:0050681; GO:0060765; GO:0060828; GO:0061630; GO:0072344; GO:0085020; GO:0160127 positive regulation of DNA-templated transcription [GO:0045893]; protein K6-linked ubiquitination [GO:0085020]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA-templated transcription [GO:0006355]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; translational termination [GO:0006415]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] nuclear androgen receptor binding [GO:0050681]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; zinc ion binding [GO:0008270] g434.t1 Q86TZ1 45.833 408 7.78e-120 393.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g434.t1 Q86TZ1 25.191 524 5.270000000000001e-27 121.0 sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1 g435.t1 Q68EV6 50.427 234 4.42e-69 218.0 sp|Q68EV6|RM28_XENLA Large ribosomal subunit protein bL28m OS=Xenopus laevis OX=8355 GN=mrpl28 PE=2 SV=1 g436.t1 Q504N0 40.187 428 1.06e-97 302.0 sp|Q504N0|CBPA2_MOUSE Carboxypeptidase A2 OS=Mus musculus OX=10090 GN=Cpa2 PE=1 SV=1 g438.t1 Q9CQ79 57.282 206 9.960000000000001e-87 258.0 sp|Q9CQ79|TXND9_MOUSE Thioredoxin domain-containing protein 9 OS=Mus musculus OX=10090 GN=Txndc9 PE=1 SV=1 TXND9_MOUSE reviewed Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) Mus musculus (Mouse) GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0030496 microtubule cytoskeleton organization [GO:0000226] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634] g439.t1 P70581 41.416 466 4.5e-84 277.0 sp|P70581|NUP58_RAT Nucleoporin p58/p45 OS=Rattus norvegicus OX=10116 GN=Nup58 PE=1 SV=1 g439.t2 P70581 42.927 410 5.1599999999999995e-82 271.0 sp|P70581|NUP58_RAT Nucleoporin p58/p45 OS=Rattus norvegicus OX=10116 GN=Nup58 PE=1 SV=1 g440.t1 Q5F452 61.296 540 0.0 706.0 sp|Q5F452|MTMR8_CHICK Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 OS=Gallus gallus OX=9031 GN=MTMR8 PE=2 SV=1 MTMR8_CHICK reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 (EC 3.1.3.95) (Myotubularin-related protein 8) (Phosphatidylinositol-3-phosphate phosphatase) Gallus gallus (Chicken) GO:0004438; GO:0005635; GO:0005737; GO:0046856; GO:0052629; GO:0106018 phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; nuclear envelope [GO:0005635] phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438] g441.t1 Q80T79 34.239 184 9.229999999999999e-23 98.6 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g442.t1 Q1ZZS1 28.019 414 7.93e-36 141.0 sp|Q1ZZS1|LGSN_CANLF Lengsin OS=Canis lupus familiaris OX=9615 GN=LGSN PE=2 SV=1 g443.t1 Q1ZZS1 27.389 314 1.39e-25 112.0 sp|Q1ZZS1|LGSN_CANLF Lengsin OS=Canis lupus familiaris OX=9615 GN=LGSN PE=2 SV=1 g444.t1 Q7TT51 36.062 452 3.85e-85 274.0 sp|Q7TT51|LGSN_RAT Lengsin OS=Rattus norvegicus OX=10116 GN=Lgsn PE=2 SV=1 g445.t1 Q66GS9 40.459 1221 0.0 845.0 sp|Q66GS9|CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2 CP135_HUMAN reviewed Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0010457; GO:0015631; GO:0042802; GO:0042803; GO:1902857; GO:1904951 centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631] g446.t1 B0UYT5 28.986 345 3.93e-36 149.0 sp|B0UYT5|MFD6B_DANRE Major facilitator superfamily domain-containing protein 6-B OS=Danio rerio OX=7955 GN=mfsd6b PE=3 SV=1 g450.t1 Q08890 42.735 585 2.1100000000000003e-157 467.0 sp|Q08890|IDS_MOUSE Iduronate 2-sulfatase OS=Mus musculus OX=10090 GN=Ids PE=2 SV=3 IDS_MOUSE reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) Mus musculus (Mouse) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484] g452.t1 O93603 27.139 339 8.07e-21 96.7 sp|O93603|TRHR_CHICK Thyrotropin-releasing hormone receptor OS=Gallus gallus OX=9031 GN=TRHR PE=2 SV=1 g453.t1 Q9Z207 40.846 1016 0.0 735.0 sp|Q9Z207|DIAP3_MOUSE Protein diaphanous homolog 3 OS=Mus musculus OX=10090 GN=Diaph3 PE=1 SV=1 DIAP3_MOUSE reviewed Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (p134mDIA2) (mDIA2) Mus musculus (Mouse) GO:0000226; GO:0000813; GO:0000922; GO:0001701; GO:0003779; GO:0005634; GO:0005737; GO:0005815; GO:0005884; GO:0007010; GO:0007015; GO:0007026; GO:0007059; GO:0007229; GO:0007605; GO:0008017; GO:0008092; GO:0010467; GO:0016197; GO:0030010; GO:0030030; GO:0030036; GO:0030041; GO:0030182; GO:0030218; GO:0030225; GO:0031267; GO:0031941; GO:0032154; GO:0032432; GO:0034367; GO:0042803; GO:0043131; GO:0045010; GO:0046785; GO:0051017; GO:0051764; GO:0060113; GO:0060322; GO:0061909; GO:0071800; GO:0097470; GO:1990427 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; autophagosome-lysosome fusion [GO:0061909]; cell projection organization [GO:0030030]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; endosomal transport [GO:0016197]; erythrocyte differentiation [GO:0030218]; erythrocyte enucleation [GO:0043131]; establishment of cell polarity [GO:0030010]; gene expression [GO:0010467]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; inner ear receptor cell differentiation [GO:0060113]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron differentiation [GO:0030182]; podosome assembly [GO:0071800]; protein-containing complex remodeling [GO:0034367]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; ESCRT I complex [GO:0000813]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ribbon synapse [GO:0097470]; spindle pole [GO:0000922]; stereocilia tip-link density [GO:1990427] actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g454.t1 Q9NWZ8 28.571 238 1.23e-24 102.0 sp|Q9NWZ8|GEMI8_HUMAN Gem-associated protein 8 OS=Homo sapiens OX=9606 GN=GEMIN8 PE=1 SV=1 g455.t1 Q8BGC3 26.087 414 1.8500000000000002e-35 139.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g456.t1 Q8BGC3 27.105 380 1.9400000000000002e-32 130.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g457.t1 P70031 38.684 380 1.77e-88 279.0 sp|P70031|CCKAR_XENLA Cholecystokinin receptor OS=Xenopus laevis OX=8355 GN=cckar PE=2 SV=1 g458.t1 Q8N5T2 62.089 517 0.0 659.0 sp|Q8N5T2|TBC19_HUMAN TBC1 domain family member 19 OS=Homo sapiens OX=9606 GN=TBC1D19 PE=1 SV=2 g461.t1 Q95JR6 29.123 285 4.95e-25 114.0 sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1 g461.t2 Q95JR6 29.123 285 4.92e-25 114.0 sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1 g469.t1 Q8N442 67.267 611 0.0 882.0 sp|Q8N442|GUF1_HUMAN Translation factor GUF1, mitochondrial OS=Homo sapiens OX=9606 GN=GUF1 PE=1 SV=1 g471.t1 Q9Z0U4 33.795 361 7.27e-55 197.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 g472.t1 O75899 40.0 345 2.46e-85 283.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g474.t1 Q9Z1M7 65.339 753 0.0 1041.0 sp|Q9Z1M7|LARG1_MOUSE Xylosyl- and glucuronyltransferase LARGE1 OS=Mus musculus OX=10090 GN=Large1 PE=1 SV=1 LARG1_MOUSE reviewed Xylosyl- and glucuronyltransferase LARGE1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) (LARGE xylosyl- and glucuronyltransferase 1) [Includes: Alpha-1,3-xylosyltransferase LARGE1 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE1 (EC 2.4.1.-)] Mus musculus (Mouse) GO:0000139; GO:0001568; GO:0001662; GO:0001764; GO:0005794; GO:0005886; GO:0006493; GO:0006612; GO:0006833; GO:0006886; GO:0006941; GO:0007009; GO:0007010; GO:0007268; GO:0007274; GO:0007420; GO:0007507; GO:0007517; GO:0007528; GO:0007605; GO:0007613; GO:0008104; GO:0008340; GO:0009100; GO:0009101; GO:0009416; GO:0009612; GO:0010467; GO:0010842; GO:0014902; GO:0015020; GO:0016757; GO:0016758; GO:0021542; GO:0021675; GO:0021740; GO:0030145; GO:0030225; GO:0031594; GO:0032991; GO:0035129; GO:0035264; GO:0035269; GO:0042285; GO:0042552; GO:0043403; GO:0043687; GO:0046716; GO:0048167; GO:0048708; GO:0048738; GO:0048741; GO:0050808; GO:0050884; GO:0050905; GO:0051124; GO:0051674; GO:0055002; GO:0055013; GO:0055085; GO:0060041; GO:0060173; GO:0060291; GO:0060348; GO:0060538; GO:0061298; GO:0061448; GO:0065003; GO:0071711; GO:0071805; GO:0072657; GO:0072659; GO:0090659; GO:0095500; GO:0098528; GO:0150103 acetylcholine receptor signaling pathway [GO:0095500]; astrocyte differentiation [GO:0048708]; basement membrane organization [GO:0071711]; behavioral fear response [GO:0001662]; blood vessel development [GO:0001568]; bone development [GO:0060348]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle tissue development [GO:0048738]; chemical synaptic transmission [GO:0007268]; connective tissue development [GO:0061448]; cytoskeleton organization [GO:0007010]; dentate gyrus development [GO:0021542]; determination of adult lifespan [GO:0008340]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; glycoprotein metabolic process [GO:0009100]; heart development [GO:0007507]; intracellular protein localization [GO:0008104]; intracellular protein transport [GO:0006886]; limb development [GO:0060173]; localization of cell [GO:0051674]; long-term synaptic potentiation [GO:0060291]; macrophage differentiation [GO:0030225]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myelination [GO:0042552]; myotube differentiation [GO:0014902]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; neuron migration [GO:0001764]; plasma membrane organization [GO:0007009]; post-embryonic hindlimb morphogenesis [GO:0035129]; post-translational protein modification [GO:0043687]; potassium ion transmembrane transport [GO:0071805]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of synaptic plasticity [GO:0048167]; response to light stimulus [GO:0009416]; response to mechanical stimulus [GO:0009612]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842]; retina vasculature development in camera-type eye [GO:0061298]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; transmembrane transport [GO:0055085]; walking behavior [GO:0090659]; water transport [GO:0006833] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; manganese ion binding [GO:0030145]; xylosyltransferase activity [GO:0042285] g477.t1 Q5F361 57.348 905 0.0 1052.0 sp|Q5F361|TBCK_CHICK TBC domain-containing protein kinase-like protein OS=Gallus gallus OX=9031 GN=TBCK PE=2 SV=2 g479.t1 Q969H0 78.764 518 0.0 862.0 sp|Q969H0|FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=FBXW7 PE=1 SV=1 FBXW7_HUMAN reviewed F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4) Homo sapiens (Human) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045742; GO:0045746; GO:0048511; GO:0050816; GO:0050821; GO:0055088; GO:0070374; GO:0097027; GO:1901524; GO:1901800; GO:1902806; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2000346; GO:2000639; GO:2001205 cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g480.t1 Q5RL51 34.365 646 2.08e-102 332.0 sp|Q5RL51|GSTCD_MOUSE Glutathione S-transferase C-terminal domain-containing protein OS=Mus musculus OX=10090 GN=Gstcd PE=2 SV=1 g482.t1 P96202 26.594 2290 4.95e-171 586.0 sp|P96202|PPSC_MYCTU Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=ppsC PE=1 SV=2 PPSC_MYCTU reviewed Phenolphthiocerol/phthiocerol polyketide synthase subunit C (EC 2.3.1.292) ((Phenol)carboxyphthiodiolenone synthase subunit C) (Beta-ketoacyl-acyl-carrier-protein synthase I) (Phthiocerol synthesis polyketide synthase type I PpsC) Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) GO:0004312; GO:0004315; GO:0005737; GO:0005829; GO:0005886; GO:0006633; GO:0016491; GO:0031177; GO:0034081; GO:0071766; GO:0071770; GO:0097040; GO:0097041 Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177] g483.t1 Q9P2J5 63.861 1176 0.0 1578.0 sp|Q9P2J5|SYLC_HUMAN Leucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=LARS1 PE=1 SV=2 SYLC_HUMAN reviewed Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) (cLRS) Homo sapiens (Human) GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0012505; GO:0016604; GO:0017101; GO:0034198; GO:0071230; GO:0071233; GO:1904263; GO:1990253 cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of TORC1 signaling [GO:1904263]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604] aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823] g484.t1 G5EBX9 46.802 641 0.0 620.0 sp|G5EBX9|PPE_CAEEL Serine/threonine-protein phosphatase with EF-hands pef-1 OS=Caenorhabditis elegans OX=6239 GN=pef-1 PE=1 SV=1 PPE_CAEEL reviewed Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1) Caenorhabditis elegans GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906 detection of stimulus involved in sensory perception [GO:0050906] axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] g485.t1 P53367 58.333 276 2.41e-113 340.0 sp|P53367|ARFP1_HUMAN Arfaptin-1 OS=Homo sapiens OX=9606 GN=ARFIP1 PE=1 SV=2 ARFP1_HUMAN reviewed Arfaptin-1 (ADP-ribosylation factor-interacting protein 1) Homo sapiens (Human) GO:0000139; GO:0005543; GO:0005829; GO:0006886; GO:0019904; GO:0032588; GO:0034315; GO:0050708; GO:0070273; GO:1905280 intracellular protein transport [GO:0006886]; negative regulation of retrograde transport, endosome to Golgi [GO:1905280]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein secretion [GO:0050708] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904] g486.t1 Q9WVA1 56.338 71 2.14e-25 93.6 sp|Q9WVA1|TIM8A_RAT Mitochondrial import inner membrane translocase subunit Tim8 A OS=Rattus norvegicus OX=10116 GN=Timm8a PE=1 SV=1 g487.t1 Q5EAN7 33.333 258 2.73e-28 119.0 sp|Q5EAN7|TE2IP_RAT Telomeric repeat-binding factor 2-interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Terf2ip PE=1 SV=1 TE2IP_RAT reviewed Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog) (RAP1 homolog) Rattus norvegicus (Rat) GO:0000781; GO:0001673; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010569; GO:0010833; GO:0031848; GO:0042162; GO:0043123; GO:0048239; GO:0070187 negative regulation of DNA recombination at telomere [GO:0048239]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protection from non-homologous end joining at telomere [GO:0031848]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance via telomere lengthening [GO:0010833] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187] telomeric DNA binding [GO:0042162] g488.t1 Q5R824 55.519 308 1.16e-124 365.0 sp|Q5R824|NNRD_PONAB ATP-dependent (S)-NAD(P)H-hydrate dehydratase OS=Pongo abelii OX=9601 GN=NAXD PE=2 SV=1 g491.t1 P04323 30.585 376 6.5499999999999996e-52 191.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g491.t2 P04323 29.327 416 3.7699999999999996e-52 194.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g493.t1 P04323 35.676 185 2.8e-29 124.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g497.t1 A0A1B0GVH7 29.004 231 5.8700000000000005e-27 120.0 sp|A0A1B0GVH7|IQCM_HUMAN IQ domain-containing protein M OS=Homo sapiens OX=9606 GN=IQCM PE=4 SV=1 g498.t1 Q6P1D7 35.081 248 9.370000000000001e-27 123.0 sp|Q6P1D7|SLX4_MOUSE Structure-specific endonuclease subunit SLX4 OS=Mus musculus OX=10090 GN=Slx4 PE=1 SV=1 SLX4_MOUSE reviewed Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12) Mus musculus (Mouse) GO:0000712; GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0008270; GO:0010792; GO:0032206; GO:0033557; GO:0048476; GO:0061820; GO:0070522; GO:0072429; GO:0090656; GO:1904357; GO:1904431 DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557] DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; zinc ion binding [GO:0008270] g502.t1 Q7L985 27.184 618 1.42e-41 164.0 sp|Q7L985|LIGO2_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 OS=Homo sapiens OX=9606 GN=LINGO2 PE=1 SV=1 LIGO2_HUMAN reviewed Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C) Homo sapiens (Human) GO:0005886; GO:0038023; GO:0051965; GO:0097060; GO:0098978 positive regulation of synapse assembly [GO:0051965] glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060] signaling receptor activity [GO:0038023] g504.t1 Q5E9N4 48.0 425 1.75e-160 462.0 sp|Q5E9N4|AADAT_BOVIN Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=AADAT PE=2 SV=1 AADAT_BOVIN reviewed Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Glycine transaminase AADAT) (EC 2.6.1.4) (Kynurenine aminotransferase II) (Kynurenine--glyoxylate transaminase AADAT) (EC 2.6.1.63) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II) (Methionine--glyoxylate transaminase AADAT) (EC 2.6.1.73) Bos taurus (Bovine) GO:0005759; GO:0006103; GO:0006536; GO:0016212; GO:0030170; GO:0033512; GO:0047315; GO:0047536; GO:0047958; GO:0050094; GO:0070189; GO:1901605 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512] mitochondrial matrix [GO:0005759] 2-aminoadipate transaminase activity [GO:0047536]; glycine:2-oxoglutarate aminotransferase activity [GO:0047958]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; methionine-glyoxylate transaminase activity [GO:0050094]; pyridoxal phosphate binding [GO:0030170] g505.t1 A1A4L5 45.293 733 0.0 629.0 sp|A1A4L5|ALKB8_BOVIN tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8 OS=Bos taurus OX=9913 GN=ALKBH8 PE=2 SV=1 ALKB8_BOVIN reviewed tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8 (EC 2.1.1.229) (Alkylated DNA repair protein alkB homolog 8) (Alpha-ketoglutarate-dependent dioxygenase ALKBH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ALKBH8) Bos taurus (Bovine) GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0006974; GO:0008270; GO:0008757; GO:0016300; GO:0016706; GO:0030488; GO:0106335 DNA damage response [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA (5-carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uridine) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g506.t1 P07207 41.331 1413 0.0 1004.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g506.t1 P07207 38.573 1514 0.0 955.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g506.t1 P07207 40.296 1283 0.0 919.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g506.t1 P07207 40.499 1242 0.0 876.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g506.t1 P07207 41.224 980 0.0 716.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g506.t1 P07207 40.102 783 3.89e-157 550.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g506.t1 P07207 33.639 654 1.1900000000000001e-88 328.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g506.t2 P10079 43.924 790 0.0 635.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 44.301 772 0.0 605.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 44.218 735 0.0 593.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 43.575 716 4.08e-176 565.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 43.333 660 4.25e-156 511.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 44.097 576 2.46e-134 451.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 41.401 628 3.01e-132 445.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 38.035 631 1.38e-107 374.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 41.787 347 1.38e-70 263.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 39.286 168 3.76e-22 108.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 46.309 149 6.42e-22 107.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t2 P10079 43.046 151 2.9300000000000004e-21 105.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 45.57 790 0.0 648.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 43.302 739 0.0 577.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 43.096 659 6e-153 501.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 37.636 643 8.560000000000001e-105 365.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 41.787 347 1.03e-70 263.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 39.286 168 3.3400000000000003e-22 108.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 46.309 149 5.32e-22 107.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t3 P10079 43.046 151 2.54e-21 105.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 43.924 790 0.0 640.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 44.301 772 0.0 610.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 44.218 735 0.0 598.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 43.515 717 6.59e-174 570.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 43.333 660 5.16e-155 515.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 44.097 576 4.569999999999999e-134 454.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 41.401 628 3.85e-132 448.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 38.035 631 1.76e-107 375.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 41.787 347 6.35e-71 265.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 39.286 168 3.95e-22 108.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 46.309 149 5.41e-22 108.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g506.t4 P10079 43.333 150 3.4e-21 105.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g509.t1 A4IIJ3 31.218 1166 6.7800000000000006e-133 435.0 sp|A4IIJ3|KIBRA_XENTR Protein KIBRA OS=Xenopus tropicalis OX=8364 GN=wwc1 PE=2 SV=1 g509.t2 A4IIJ3 31.046 1166 3.1500000000000005e-132 433.0 sp|A4IIJ3|KIBRA_XENTR Protein KIBRA OS=Xenopus tropicalis OX=8364 GN=wwc1 PE=2 SV=1 g511.t1 Q5M9G0 67.442 172 4.19e-83 247.0 sp|Q5M9G0|DCTD_RAT Deoxycytidylate deaminase OS=Rattus norvegicus OX=10116 GN=Dctd PE=2 SV=1 DCTD_RAT reviewed Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase) Rattus norvegicus (Rat) GO:0004132; GO:0005737; GO:0006226; GO:0006231; GO:0008270; GO:0042802; GO:0043174; GO:0070694 dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; nucleoside salvage [GO:0043174] cytoplasm [GO:0005737] 5-hydroxymethyl-dUMP N-hydrolase activity [GO:0070694]; dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] g512.t1 Q9QXN0 36.325 234 6.2300000000000005e-37 157.0 sp|Q9QXN0|SHRM3_MOUSE Protein Shroom3 OS=Mus musculus OX=10090 GN=Shroom3 PE=1 SV=2 g512.t2 Q9QXN0 36.325 234 6.5600000000000005e-37 157.0 sp|Q9QXN0|SHRM3_MOUSE Protein Shroom3 OS=Mus musculus OX=10090 GN=Shroom3 PE=1 SV=2 g512.t3 Q9QXN0 36.325 234 6.02e-37 157.0 sp|Q9QXN0|SHRM3_MOUSE Protein Shroom3 OS=Mus musculus OX=10090 GN=Shroom3 PE=1 SV=2 g515.t1 Q5R806 54.441 349 1.33e-135 393.0 sp|Q5R806|PTGR2_PONAB Prostaglandin reductase 2 OS=Pongo abelii OX=9601 GN=PTGR2 PE=2 SV=2 PTGR2_PONAB reviewed Prostaglandin reductase 2 (PRG-2) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005737; GO:0006693; GO:0047522 prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522] g516.t1 Q8BY02 29.041 365 4.5100000000000004e-26 116.0 sp|Q8BY02|NKRF_MOUSE NF-kappa-B-repressing factor OS=Mus musculus OX=10090 GN=Nkrf PE=2 SV=3 g517.t1 Q8CDF7 32.831 332 1.2600000000000001e-37 152.0 sp|Q8CDF7|EXD1_MOUSE piRNA biogenesis protein EXD1 OS=Mus musculus OX=10090 GN=Exd1 PE=1 SV=1 EXD1_MOUSE reviewed piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1) Mus musculus (Mouse) GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:1990923 meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated gene silencing [GO:0031047] P granule [GO:0043186]; PET complex [GO:1990923] protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] g518.t1 Q9CZV8 31.206 282 2.2899999999999998e-24 109.0 sp|Q9CZV8|FXL20_MOUSE F-box/LRR-repeat protein 20 OS=Mus musculus OX=10090 GN=Fbxl20 PE=1 SV=3 FXL20_MOUSE reviewed F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like) Mus musculus (Mouse) GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300 behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] g519.t1 P31754 55.485 474 0.0 538.0 sp|P31754|UMPS_BOVIN Uridine 5'-monophosphate synthase OS=Bos taurus OX=9913 GN=UMPS PE=2 SV=1 g521.t1 Q8K2G4 67.972 715 0.0 1038.0 sp|Q8K2G4|BBS7_MOUSE BBSome complex member BBS7 OS=Mus musculus OX=10090 GN=Bbs7 PE=1 SV=1 BBS7_MOUSE reviewed BBSome complex member BBS7 (BBS2-like protein 1) (Bardet-Biedl syndrome 7 protein homolog) Mus musculus (Mouse) GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034451; GO:0034464; GO:0036064; GO:0043005; GO:0045444; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515 brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular protein localization [GO:0008104]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g522.t1 Q99J23 34.135 416 8.85e-62 216.0 sp|Q99J23|GHDC_MOUSE GH3 domain-containing protein OS=Mus musculus OX=10090 GN=Ghdc PE=2 SV=2 g523.t1 Q2KJ97 36.494 696 5.43e-115 366.0 sp|Q2KJ97|NCDN_BOVIN Neurochondrin OS=Bos taurus OX=9913 GN=NCDN PE=2 SV=1 NCDN_BOVIN reviewed Neurochondrin Bos taurus (Bovine) GO:0005829; GO:0010008; GO:0030425; GO:0031175; GO:0043025; GO:0048168; GO:0098794 neuron projection development [GO:0031175]; regulation of neuronal synaptic plasticity [GO:0048168] cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794] g524.t1 F1R345 53.268 918 0.0 974.0 sp|F1R345|DDX11_DANRE ATP-dependent DNA helicase DDX11 OS=Danio rerio OX=7955 GN=ddx11 PE=2 SV=1 DDX11_DANRE reviewed ATP-dependent DNA helicase DDX11 (EC 5.6.2.3) (DEAD/H-box protein 11) (DNA 5'-3' helicase DDX11) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000922; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005813; GO:0006260; GO:0006281; GO:0009303; GO:0016887; GO:0030496; GO:0034085; GO:0043139; GO:0046872; GO:0051539; GO:1901836; GO:1990700 DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of sister chromatid cohesion [GO:0034085]; nucleolar chromatin organization [GO:1990700]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303] centrosome [GO:0005813]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922] 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] g527.t1 Q8N2E2 45.385 130 1.35e-33 133.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g527.t1 Q8N2E2 41.221 131 7.56e-33 131.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g527.t1 Q8N2E2 43.511 131 2.85e-31 126.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g527.t1 Q8N2E2 41.844 141 3.86e-30 123.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g527.t1 Q8N2E2 42.222 135 4.9400000000000004e-29 120.0 sp|Q8N2E2|VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens OX=9606 GN=VWDE PE=1 SV=4 g531.t1 Q9R0Y1 32.164 171 1.6100000000000001e-21 95.1 sp|Q9R0Y1|ASIC5_MOUSE Bile acid-sensitive ion channel OS=Mus musculus OX=10090 GN=Asic5 PE=1 SV=1 ASIC5_MOUSE reviewed Bile acid-sensitive ion channel (BASIC) (Acid-sensing ion channel subunit family member 5) (Amiloride-sensitive cation channel 5) (Brain-liver-intestine amiloride-sensitive Na(+) channel) (BLINaC) Mus musculus (Mouse) GO:0005272; GO:0005886; GO:0015252; GO:0015280; GO:0016020; GO:0016324; GO:0019228; GO:0035725; GO:0098719; GO:0160228 neuronal action potential [GO:0019228]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; membrane [GO:0016020]; plasma membrane [GO:0005886] bile acid-gated sodium channel activity [GO:0160228]; ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium channel activity [GO:0005272] g532.t1 P78348 33.673 490 4.31e-92 292.0 sp|P78348|ASIC1_HUMAN Acid-sensing ion channel 1 OS=Homo sapiens OX=9606 GN=ASIC1 PE=1 SV=3 ASIC1_HUMAN reviewed Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) Homo sapiens (Human) GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0006814; GO:0007269; GO:0007613; GO:0008306; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0030425; GO:0035725; GO:0042391; GO:0046929; GO:0050915; GO:0070588; GO:0071467; GO:0098793; GO:0098839; GO:0098978; GO:0150052; GO:0160128 associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; neurotransmitter secretion [GO:0007269]; regulation of membrane potential [GO:0042391]; regulation of postsynapse assembly [GO:0150052]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] cell surface [GO:0009986]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated monoatomic ion channel activity [GO:0160128] g533.t1 Q708S6 33.55 462 4.1600000000000003e-88 283.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 g534.t1 Q16515 37.251 451 3.17e-96 303.0 sp|Q16515|ASIC2_HUMAN Acid-sensing ion channel 2 OS=Homo sapiens OX=9606 GN=ASIC2 PE=1 SV=1 g535.t1 Q16515 35.477 451 2.54e-93 295.0 sp|Q16515|ASIC2_HUMAN Acid-sensing ion channel 2 OS=Homo sapiens OX=9606 GN=ASIC2 PE=1 SV=1 g536.t1 P78348 34.674 522 2.46e-94 299.0 sp|P78348|ASIC1_HUMAN Acid-sensing ion channel 1 OS=Homo sapiens OX=9606 GN=ASIC1 PE=1 SV=3 ASIC1_HUMAN reviewed Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) Homo sapiens (Human) GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0006814; GO:0007269; GO:0007613; GO:0008306; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0030425; GO:0035725; GO:0042391; GO:0046929; GO:0050915; GO:0070588; GO:0071467; GO:0098793; GO:0098839; GO:0098978; GO:0150052; GO:0160128 associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; neurotransmitter secretion [GO:0007269]; regulation of membrane potential [GO:0042391]; regulation of postsynapse assembly [GO:0150052]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] cell surface [GO:0009986]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic ion-gated channel activity [GO:0022839]; pH-gated monoatomic ion channel activity [GO:0160128] g537.t1 B3FL73 36.908 401 2.51e-83 266.0 sp|B3FL73|FXL21_SHEEP F-box/LRR-repeat protein 21 OS=Ovis aries OX=9940 GN=Fbxl21 PE=1 SV=1 g538.t1 Q12931 58.982 668 0.0 815.0 sp|Q12931|TRAP1_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3 g541.t1 Q5G267 40.183 219 3.53e-41 158.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g541.t1 Q5G267 37.838 222 3.57e-39 152.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g541.t1 Q5G267 35.981 214 2.06e-35 141.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g542.t1 Q92179 37.615 218 8.56e-37 138.0 sp|Q92179|CHST3_CHICK Carbohydrate sulfotransferase 3 OS=Gallus gallus OX=9031 GN=CHST3 PE=1 SV=1 g543.t1 Q9H920 62.162 333 7.72e-164 462.0 sp|Q9H920|RN121_HUMAN E3 ubiquitin ligase RNF121 OS=Homo sapiens OX=9606 GN=RNF121 PE=1 SV=1 g547.t1 P51792 55.718 822 0.0 899.0 sp|P51792|CLCN3_RAT H(+)/Cl(-) exchange transporter 3 OS=Rattus norvegicus OX=10116 GN=Clcn3 PE=2 SV=2 CLCN3_RAT reviewed H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3) Rattus norvegicus (Rat) GO:0005216; GO:0005244; GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006811; GO:0006821; GO:0006911; GO:0008021; GO:0008344; GO:0009897; GO:0010008; GO:0012506; GO:0015297; GO:0016324; GO:0030141; GO:0030165; GO:0030672; GO:0031410; GO:0031901; GO:0031902; GO:0035249; GO:0042581; GO:0043679; GO:0045202; GO:0045211; GO:0045335; GO:0045494; GO:0045794; GO:0051932; GO:0055037; GO:0055038; GO:0060077; GO:0062158; GO:0070050; GO:0072320; GO:0097401; GO:0098978; GO:0098982; GO:1902476; GO:1903428 adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; monoatomic ion transport [GO:0006811]; negative regulation of cell volume [GO:0045794]; neuron cellular homeostasis [GO:0070050]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401] apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle membrane [GO:0012506] antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride:proton antiporter activity [GO:0062158]; monoatomic ion channel activity [GO:0005216]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated monoatomic ion channel activity [GO:0005244]; volume-sensitive chloride channel activity [GO:0072320] g548.t1 Q3V1H1 30.385 260 4.49e-22 104.0 sp|Q3V1H1|CKAP2_MOUSE Cytoskeleton-associated protein 2 OS=Mus musculus OX=10090 GN=Ckap2 PE=1 SV=1 CKAP2_MOUSE reviewed Cytoskeleton-associated protein 2 Mus musculus (Mouse) GO:0000281; GO:0000922; GO:0005730; GO:0005813; GO:0005874; GO:0005929; GO:0006915; GO:0007026; GO:0015630; GO:0036064; GO:0045944; GO:0072686 apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922] g549.t1 Q8N1A6 50.82 183 8.73e-58 183.0 sp|Q8N1A6|CD033_HUMAN UPF0462 protein C4orf33 OS=Homo sapiens OX=9606 GN=C4orf33 PE=1 SV=2 g551.t1 A8MXD5 42.918 233 1.45e-57 192.0 sp|A8MXD5|GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens OX=9606 GN=GRXCR1 PE=1 SV=1 GRCR1_HUMAN reviewed Glutaredoxin domain-containing cysteine-rich protein 1 Homo sapiens (Human) GO:0005902; GO:0006887; GO:0007009; GO:0007605; GO:0032420; GO:0051592; GO:0051649; GO:0060088; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0070588; GO:0090102; GO:1905144 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transmembrane transport [GO:0070588]; cochlea development [GO:0090102]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; plasma membrane organization [GO:0007009]; response to acetylcholine [GO:1905144]; response to calcium ion [GO:0051592]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118] kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420] g552.t1 Q8HXX6 41.718 163 9.68e-33 119.0 sp|Q8HXX6|SAP3_MACFA Ganglioside GM2 activator OS=Macaca fascicularis OX=9541 GN=GM2A PE=2 SV=2 g553.t1 Q4R5V2 56.818 176 5.2399999999999994e-68 211.0 sp|Q4R5V2|EMC7_MACFA Endoplasmic reticulum membrane protein complex subunit 7 OS=Macaca fascicularis OX=9541 GN=EMC7 PE=2 SV=1 EMC7_MACFA reviewed Endoplasmic reticulum membrane protein complex subunit 7 (ER membrane protein complex subunit 7) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005789; GO:0016020; GO:0030246; GO:0045050; GO:0071816; GO:0072546 protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carbohydrate binding [GO:0030246] g554.t1 Q61687 51.452 861 0.0 847.0 sp|Q61687|ATRX_MOUSE Transcriptional regulator ATRX OS=Mus musculus OX=10090 GN=Atrx PE=1 SV=3 g554.t1 Q61687 46.97 198 8.43e-51 203.0 sp|Q61687|ATRX_MOUSE Transcriptional regulator ATRX OS=Mus musculus OX=10090 GN=Atrx PE=1 SV=3 g556.t1 P46872 77.525 703 0.0 1084.0 sp|P46872|KRP85_STRPU Kinesin-II 85 kDa subunit OS=Strongylocentrotus purpuratus OX=7668 GN=KRP85 PE=1 SV=1 g559.t1 Q923Q2 46.685 724 0.0 642.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g559.t1 Q923Q2 36.237 287 1.9600000000000001e-35 150.0 sp|Q923Q2|STA13_MOUSE StAR-related lipid transfer protein 13 OS=Mus musculus OX=10090 GN=Stard13 PE=1 SV=5 g561.t1 Q9D711 68.276 290 3.15e-148 422.0 sp|Q9D711|PIR_MOUSE Pirin OS=Mus musculus OX=10090 GN=Pir PE=1 SV=1 PIR_MOUSE reviewed Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase) Mus musculus (Mouse) GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008127; GO:0016604; GO:0030099; GO:0030224; GO:0046872 monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712] g563.t1 Q8BVQ5 57.181 376 2.44e-149 430.0 sp|Q8BVQ5|PPME1_MOUSE Protein phosphatase methylesterase 1 OS=Mus musculus OX=10090 GN=Ppme1 PE=1 SV=5 g564.t1 O95831 52.396 647 0.0 645.0 sp|O95831|AIFM1_HUMAN Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1 g564.t2 O95831 63.279 433 0.0 581.0 sp|O95831|AIFM1_HUMAN Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1 g575.t1 P16423 23.112 874 8.73e-41 167.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g576.t1 P16423 23.749 859 4.46e-46 182.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g576.t2 P16423 23.744 876 1.4700000000000002e-47 189.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g577.t1 P16423 26.511 513 2.9299999999999997e-41 169.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g578.t1 P14381 30.803 909 2.21e-110 377.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g578.t4 P14381 34.703 438 3.8900000000000003e-66 239.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g580.t1 P16423 26.511 513 2.9299999999999997e-41 169.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g581.t1 P14381 30.803 909 2.21e-110 377.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g583.t1 P02269 94.4 125 2.9799999999999996e-82 239.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g584.t1 P07794 90.385 104 7.95e-64 192.0 sp|P07794|H2BL1_PSAMI Late histone H2B.2.1 OS=Psammechinus miliaris OX=7660 PE=3 SV=2 g585.t1 P69079 100.0 136 1.3799999999999998e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g586.t1 P62783 100.0 103 6.4e-68 201.0 sp|P62783|H4_STRPU Histone H4 OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=2 g587.t1 P14381 30.811 912 2.54e-123 413.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g590.t1 P14381 31.322 779 7.67e-102 350.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g592.t1 P02269 94.4 125 2.9799999999999996e-82 239.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g593.t1 P07794 90.385 104 7.95e-64 192.0 sp|P07794|H2BL1_PSAMI Late histone H2B.2.1 OS=Psammechinus miliaris OX=7660 PE=3 SV=2 g594.t1 P69079 100.0 136 1.3799999999999998e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g595.t1 P62783 100.0 103 6.4e-68 201.0 sp|P62783|H4_STRPU Histone H4 OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=2 g596.t1 P14381 30.803 909 2.21e-110 377.0 sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1 g598.t1 P02269 94.4 125 2.9799999999999996e-82 239.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g599.t1 Q7M4G7 96.296 81 5.279999999999999e-52 161.0 sp|Q7M4G7|H2B_PATPE Histone H2B OS=Patiria pectinifera OX=7594 PE=1 SV=2 H2B_PATPE reviewed Histone H2B Patiria pectinifera (Starfish) (Asterina pectinifera) GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0044877; GO:0046982 nucleosome [GO:0000786]; nucleus [GO:0005634] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; structural constituent of chromatin [GO:0030527] g606.t1 O76039 77.027 296 7.37e-168 523.0 sp|O76039|CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens OX=9606 GN=CDKL5 PE=1 SV=2 CDKL5_HUMAN reviewed Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) Homo sapiens (Human) GO:0001764; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0016301; GO:0031267; GO:0032839; GO:0035022; GO:0036064; GO:0044294; GO:0045773; GO:0050773; GO:0050775; GO:0050804; GO:0097542; GO:0098978; GO:0099175; GO:0106310; GO:1902017 modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] g610.t1 A0A8I6A2H6 46.819 393 2.34e-107 330.0 sp|A0A8I6A2H6|MICU3_RAT Calcium uptake protein 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Micu3 PE=3 SV=1 MICU3_RAT reviewed Calcium uptake protein 3, mitochondrial Rattus norvegicus (Rat) GO:0001956; GO:0005246; GO:0005509; GO:0005739; GO:0005758; GO:0036444; GO:0046982; GO:0051560; GO:0061891; GO:0071277; GO:1990246 calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of neurotransmitter secretion [GO:0001956] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g610.t2 A0A8I6A2H6 42.748 393 1.54e-96 301.0 sp|A0A8I6A2H6|MICU3_RAT Calcium uptake protein 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Micu3 PE=3 SV=1 MICU3_RAT reviewed Calcium uptake protein 3, mitochondrial Rattus norvegicus (Rat) GO:0001956; GO:0005246; GO:0005509; GO:0005739; GO:0005758; GO:0036444; GO:0046982; GO:0051560; GO:0061891; GO:0071277; GO:1990246 calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of neurotransmitter secretion [GO:0001956] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g611.t1 Q28HC7 38.421 190 1.61e-40 139.0 sp|Q28HC7|COMD6_XENTR COMM domain-containing protein 6 OS=Xenopus tropicalis OX=8364 GN=commd6 PE=2 SV=1 g612.t1 Q8WV99 47.5 280 5.320000000000001e-85 258.0 sp|Q8WV99|ZFN2B_HUMAN AN1-type zinc finger protein 2B OS=Homo sapiens OX=9606 GN=ZFAND2B PE=1 SV=1 ZFN2B_HUMAN reviewed AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein) Homo sapiens (Human) GO:0000502; GO:0005737; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; proteasome complex [GO:0000502] K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g613.t1 O02467 55.66 318 1.2899999999999999e-126 369.0 sp|O02467|ASPG_SPOFR N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (Fragment) OS=Spodoptera frugiperda OX=7108 PE=1 SV=1 g620.t1 P21675 52.193 1870 0.0 1726.0 sp|P21675|TAF1_HUMAN Transcription initiation factor TFIID subunit 1 OS=Homo sapiens OX=9606 GN=TAF1 PE=1 SV=3 TAF1_HUMAN reviewed Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) Homo sapiens (Human) GO:0000122; GO:0000209; GO:0000785; GO:0000979; GO:0001091; GO:0001181; GO:0002039; GO:0004402; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005669; GO:0006361; GO:0006366; GO:0006367; GO:0006511; GO:0006974; GO:0010629; GO:0016251; GO:0016301; GO:0016922; GO:0017025; GO:0030901; GO:0032436; GO:0034644; GO:0042789; GO:0043565; GO:0045944; GO:0046777; GO:0046982; GO:0050821; GO:0051123; GO:0060261; GO:0061629; GO:0061631; GO:0071318; GO:0071339; GO:0106310; GO:0140046; GO:0140416; GO:0160207; GO:1901796; GO:1901797; GO:1902806; GO:1905524; GO:2000059 cellular response to ATP [GO:0071318]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; midbrain development [GO:0030901]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of androgen receptor signaling pathway [GO:0160207]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein autophosphorylation [GO:0046777]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase I promoter [GO:0006361]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription regulator complex [GO:0005667] ATP binding [GO:0005524]; histone acetyltransferase activity [GO:0004402]; histone H4K16ac reader activity [GO:0140046]; kinase activity [GO:0016301]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin conjugating enzyme activity [GO:0061631] g625.t1 Q8K458 34.354 294 1.61e-56 193.0 sp|Q8K458|PKR2_MOUSE Prokineticin receptor 2 OS=Mus musculus OX=10090 GN=Prokr2 PE=2 SV=1 g625.t2 Q8K458 41.964 112 4.6200000000000005e-21 90.5 sp|Q8K458|PKR2_MOUSE Prokineticin receptor 2 OS=Mus musculus OX=10090 GN=Prokr2 PE=2 SV=1 g627.t1 Q9H5L6 33.668 398 3.14e-74 251.0 sp|Q9H5L6|THAP9_HUMAN DNA transposase THAP9 OS=Homo sapiens OX=9606 GN=THAP9 PE=1 SV=2 g629.t1 Q9Y5X5 41.176 102 9.310000000000001e-21 90.1 sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2 NPFF2_HUMAN reviewed Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408 cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408] actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628] g633.t1 P97846 34.975 203 3.43e-28 119.0 sp|P97846|CNTP1_RAT Contactin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Cntnap1 PE=1 SV=1 CNTP1_RAT reviewed Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (Paranodin) (p190) Rattus norvegicus (Rat) GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227 axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone [GO:0048786] SH3 domain binding [GO:0017124] g634.t1 Q812E9 28.352 261 1.06e-22 98.2 sp|Q812E9|GPM6A_RAT Neuronal membrane glycoprotein M6-a OS=Rattus norvegicus OX=10116 GN=Gpm6a PE=1 SV=1 GPM6A_RAT reviewed Neuronal membrane glycoprotein M6-a (M6a) Rattus norvegicus (Rat) GO:0001764; GO:0003407; GO:0005262; GO:0005886; GO:0007416; GO:0009617; GO:0030175; GO:0031175; GO:0043005; GO:0043025; GO:0043197; GO:0044295; GO:0048787; GO:0048812; GO:0048863; GO:0050807; GO:0051491; GO:0098688; GO:0098793; GO:0098978 neural retina development [GO:0003407]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; positive regulation of filopodium assembly [GO:0051491]; regulation of synapse organization [GO:0050807]; response to bacterium [GO:0009617]; stem cell differentiation [GO:0048863]; synapse assembly [GO:0007416] axonal growth cone [GO:0044295]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787] calcium channel activity [GO:0005262] g638.t1 Q55GU0 45.382 249 5.559999999999999e-54 207.0 sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267514 PE=3 SV=1 g641.t1 A4IG53 47.642 212 2.94e-61 195.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g642.t1 A4IG53 46.512 215 1.7800000000000002e-64 204.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g643.t1 A4IG53 46.512 215 1.7800000000000002e-64 204.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g644.t1 A4IG53 47.393 211 5.9200000000000007e-64 201.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g645.t1 A4IG53 46.512 215 1.7800000000000002e-64 204.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g646.t1 A4IG53 46.512 215 1.7800000000000002e-64 204.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g647.t1 A4IG53 46.512 215 1.7800000000000002e-64 204.0 sp|A4IG53|COMTB_DANRE Catechol O-methyltransferase B OS=Danio rerio OX=7955 GN=comtb PE=2 SV=1 COMTB_DANRE reviewed Catechol O-methyltransferase B (EC 2.1.1.6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0005576; GO:0016206; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259] extracellular region [GO:0005576] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g648.t1 A7RNG8 58.075 644 0.0 754.0 sp|A7RNG8|CCD22_NEMVE Coiled-coil domain-containing protein 22 homolog OS=Nematostella vectensis OX=45351 GN=v1g180167 PE=3 SV=1 g649.t1 Q8R1X6 33.255 427 1.5599999999999998e-69 238.0 sp|Q8R1X6|SPART_MOUSE Spartin OS=Mus musculus OX=10090 GN=Spart PE=1 SV=1 SPART_MOUSE reviewed Spartin Mus musculus (Mouse) GO:0005737; GO:0005741; GO:0005811; GO:0005829; GO:0005886; GO:0006869; GO:0008289; GO:0016042; GO:0030496; GO:0030514; GO:0031625; GO:0034389; GO:0045202; GO:0048698; GO:0050905; GO:0051301; GO:0051881; GO:0060612; GO:0061724; GO:0061952 adipose tissue development [GO:0060612]; cell division [GO:0051301]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid transport [GO:0006869]; lipophagy [GO:0061724]; midbody abscission [GO:0061952]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of collateral sprouting in absence of injury [GO:0048698]; neuromuscular process [GO:0050905]; regulation of mitochondrial membrane potential [GO:0051881] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; synapse [GO:0045202] lipid binding [GO:0008289]; ubiquitin protein ligase binding [GO:0031625] g650.t1 Q5ZMP3 40.556 360 1.01e-80 264.0 sp|Q5ZMP3|T184C_CHICK Transmembrane protein 184C OS=Gallus gallus OX=9031 GN=TMEM184C PE=2 SV=1 g651.t1 Q6GQE1 36.842 361 5.7e-63 218.0 sp|Q6GQE1|T184C_XENLA Transmembrane protein 184C OS=Xenopus laevis OX=8355 GN=tmem184c PE=2 SV=1 g652.t1 Q3U3W5 31.514 898 9.79e-131 417.0 sp|Q3U3W5|ANM9_MOUSE Protein arginine N-methyltransferase 9 OS=Mus musculus OX=10090 GN=Prmt9 PE=2 SV=2 g654.t1 Q3KPT0 39.286 168 1.65e-27 107.0 sp|Q3KPT0|CC169_XENLA Coiled-coil domain-containing protein 169 OS=Xenopus laevis OX=8355 GN=ccdc169 PE=2 SV=2 g657.t1 Q08E15 39.024 246 1.54e-51 176.0 sp|Q08E15|SIA7F_BOVIN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 OS=Bos taurus OX=9913 GN=ST6GALNAC6 PE=2 SV=1 SIA7F_BOVIN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI) (ST6GalNAcVI) (Sialyltransferase 7F) (SIAT7-F) Bos taurus (Bovine) GO:0000139; GO:0001574; GO:0001665; GO:0009311; GO:0009988 cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g658.t1 G3X9Z4 39.062 320 1.97e-49 194.0 sp|G3X9Z4|PCF11_MOUSE Pre-mRNA cleavage complex 2 protein Pcf11 OS=Mus musculus OX=10090 GN=Pcf11 PE=2 SV=1 g660.t1 G3X9Z4 50.622 241 7.58e-60 231.0 sp|G3X9Z4|PCF11_MOUSE Pre-mRNA cleavage complex 2 protein Pcf11 OS=Mus musculus OX=10090 GN=Pcf11 PE=2 SV=1 g661.t1 Q923S9 69.697 198 8.800000000000001e-100 290.0 sp|Q923S9|RAB30_MOUSE Ras-related protein Rab-30 OS=Mus musculus OX=10090 GN=Rab30 PE=1 SV=1 RAB30_MOUSE reviewed Ras-related protein Rab-30 (EC 3.6.5.2) Mus musculus (Mouse) GO:0000139; GO:0000421; GO:0003924; GO:0003925; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016192; GO:0031410; GO:0031985; GO:0032482; GO:0033106; GO:0046872; GO:0055088; GO:0120281 Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] autolysosome membrane [GO:0120281]; autophagosome membrane [GO:0000421]; cis-Golgi network [GO:0005801]; cis-Golgi network membrane [GO:0033106]; cytoplasmic vesicle [GO:0031410]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g662.t1 Q8C7H1 59.697 330 1.01e-144 421.0 sp|Q8C7H1|MMAA_MOUSE Methylmalonic aciduria type A homolog, mitochondrial OS=Mus musculus OX=10090 GN=Mmaa PE=1 SV=1 g669.t1 P04323 41.509 265 3.0599999999999997e-52 197.0 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g675.t1 Q09575 35.498 231 2.11e-47 171.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g677.t1 Q95ZS2 52.697 482 0.0 556.0 sp|Q95ZS2|TDC1_CAEEL Tyrosine decarboxylase OS=Caenorhabditis elegans OX=6239 GN=tdc-1 PE=2 SV=1 TDC1_CAEEL reviewed Tyrosine decarboxylase (EC 4.1.1.25) Caenorhabditis elegans GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0016831; GO:0019752; GO:0030170; GO:0030424; GO:0043025; GO:0043204 amino acid metabolic process [GO:0006520]; carboxylic acid metabolic process [GO:0019752]; octopamine biosynthetic process [GO:0006589] axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837] g680.t1 Q6NSR3 44.796 538 2.5e-149 449.0 sp|Q6NSR3|ADCK2_MOUSE Uncharacterized aarF domain-containing protein kinase 2 OS=Mus musculus OX=10090 GN=Adck2 PE=2 SV=1 ADCK2_MOUSE reviewed Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005739; GO:0010795; GO:0016020 regulation of ubiquinone biosynthetic process [GO:0010795] membrane [GO:0016020]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] g681.t1 P24408 63.768 207 1.57e-95 279.0 sp|P24408|RAB9A_CANLF Ras-related protein Rab-9A OS=Canis lupus familiaris OX=9615 GN=RAB9A PE=1 SV=2 g682.t1 Q566M8 41.691 343 1.1899999999999999e-82 263.0 sp|Q566M8|RN150_DANRE RING finger protein 150 OS=Danio rerio OX=7955 GN=rnf150 PE=2 SV=1 g683.t1 Q8IV35 24.945 906 8.72e-83 296.0 sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2 g684.t1 Q00547 44.103 195 1.1e-26 121.0 sp|Q00547|HMMR_MOUSE Hyaluronan mediated motility receptor OS=Mus musculus OX=10090 GN=Hmmr PE=1 SV=4 g684.t2 O75330 31.119 286 1.6400000000000002e-21 101.0 sp|O75330|HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens OX=9606 GN=HMMR PE=1 SV=2 HMMR_HUMAN reviewed Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168) Homo sapiens (Human) GO:0005540; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0006898; GO:0009986; GO:0015630; GO:0016020; GO:0030214; GO:0038024 hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819] cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540] g685.t1 Q49A17 49.735 565 0.0 557.0 sp|Q49A17|GLTL6_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like 6 OS=Homo sapiens OX=9606 GN=GALNTL6 PE=2 SV=2 GLTL6_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17) Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g686.t1 Q86UW6 33.556 450 7.08e-53 210.0 sp|Q86UW6|N4BP2_HUMAN NEDD4-binding protein 2 OS=Homo sapiens OX=9606 GN=N4BP2 PE=1 SV=2 N4BP2_HUMAN reviewed NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein) Homo sapiens (Human) GO:0004519; GO:0004520; GO:0005524; GO:0005829; GO:0016787; GO:0043130; GO:0046404; GO:0070481 nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481] cytosol [GO:0005829] ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; DNA endonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; hydrolase activity [GO:0016787]; ubiquitin binding [GO:0043130] g686.t1 Q86UW6 52.055 146 4.57e-38 161.0 sp|Q86UW6|N4BP2_HUMAN NEDD4-binding protein 2 OS=Homo sapiens OX=9606 GN=N4BP2 PE=1 SV=2 N4BP2_HUMAN reviewed NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein) Homo sapiens (Human) GO:0004519; GO:0004520; GO:0005524; GO:0005829; GO:0016787; GO:0043130; GO:0046404; GO:0070481 nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481] cytosol [GO:0005829] ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; DNA endonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; hydrolase activity [GO:0016787]; ubiquitin binding [GO:0043130] g687.t1 Q8NB90 49.215 892 0.0 853.0 sp|Q8NB90|AFG2A_HUMAN ATPase family gene 2 protein homolog A OS=Homo sapiens OX=9606 GN=AFG2A PE=1 SV=3 g689.t1 Q08E39 51.261 119 5.089999999999999e-34 127.0 sp|Q08E39|SPY2_BOVIN Protein sprouty homolog 2 OS=Bos taurus OX=9913 GN=SPRY2 PE=2 SV=1 SPY2_BOVIN reviewed Protein sprouty homolog 2 (Spry-2) Bos taurus (Bovine) GO:0000132; GO:0005634; GO:0005829; GO:0007605; GO:0008285; GO:0008543; GO:0010628; GO:0010719; GO:0015629; GO:0016525; GO:0019901; GO:0030291; GO:0030335; GO:0030512; GO:0031345; GO:0031397; GO:0032587; GO:0035924; GO:0040037; GO:0042059; GO:0042472; GO:0043066; GO:0043539; GO:0045165; GO:0045742; GO:0046580; GO:0048513; GO:0051387; GO:0051897; GO:0055105; GO:0060437; GO:0060449; GO:0070371; GO:0070373; GO:0070374; GO:1900747; GO:1902747; GO:1990752; GO:1990830 animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung growth [GO:0060437]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell migration [GO:0030335]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; microtubule end [GO:1990752]; nucleus [GO:0005634]; ruffle membrane [GO:0032587] protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ubiquitin-protein transferase inhibitor activity [GO:0055105] g692.t1 Q8R0W6 32.227 211 3.6e-24 98.2 sp|Q8R0W6|NFIP1_MOUSE NEDD4 family-interacting protein 1 OS=Mus musculus OX=10090 GN=Ndfip1 PE=1 SV=1 NFIP1_MOUSE reviewed NEDD4 family-interacting protein 1 (NEDD4 WW domain-binding protein 5) Mus musculus (Mouse) GO:0000139; GO:0002761; GO:0002829; GO:0005576; GO:0005783; GO:0005794; GO:0005938; GO:0006511; GO:0006879; GO:0007034; GO:0010008; GO:0010629; GO:0016020; GO:0030001; GO:0030425; GO:0031398; GO:0032713; GO:0042130; GO:0045202; GO:0045619; GO:0045732; GO:0048294; GO:0048302; GO:0048471; GO:0050699; GO:0050728; GO:0051224 intracellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034] cell cortex [GO:0005938]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] WW domain binding [GO:0050699] g693.t1 P53370 48.485 264 2.67e-82 254.0 sp|P53370|NUDT6_HUMAN Nucleoside diphosphate-linked moiety X motif 6 OS=Homo sapiens OX=9606 GN=NUDT6 PE=1 SV=2 NUDT6_HUMAN reviewed Nudix hydrolase 6 (Antisense basic fibroblast growth factor) (FAD diphosphatase NUDT6) (EC 3.6.1.18) (NADH pyrophosphatase NUDT6) (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 6) (Nudix motif 6) (Protein GFG) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0047884; GO:0051287 negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ADP-ribose diphosphatase activity [GO:0047631]; FAD diphosphatase activity [GO:0047884]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529] g697.t2 Q09575 30.709 254 1.92e-31 134.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g698.t1 P04323 38.931 131 3.6599999999999995e-23 98.2 sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g701.t1 Q9GV77 65.378 3131 0.0 4175.0 sp|Q9GV77|FREM2_LYTVA Extracellular matrix protein 3 OS=Lytechinus variegatus OX=7654 GN=ECM3 PE=1 SV=1 g703.t1 Q91784 46.609 1150 0.0 954.0 sp|Q91784|KIF4_XENLA Chromosome-associated kinesin KIF4 OS=Xenopus laevis OX=8355 GN=kif4 PE=2 SV=1 KIF4_XENLA reviewed Chromosome-associated kinesin KIF4 (Chromokinesin) (Chromosome-associated kinesin KLP1) Xenopus laevis (African clawed frog) GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0005874; GO:0005875; GO:0007018; GO:0007052; GO:0008017; GO:0046872; GO:0051231; GO:0051536 microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; spindle elongation [GO:0051231] chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g705.t1 A7SNN5 67.667 300 3.89e-139 447.0 sp|A7SNN5|PLK4_NEMVE Serine/threonine-protein kinase PLK4 OS=Nematostella vectensis OX=45351 GN=v1g246408 PE=3 SV=1 PLK4_NEMVE reviewed Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) Nematostella vectensis (Starlet sea anemone) GO:0004674; GO:0005524; GO:0005634; GO:0005814; GO:0106310 centriole [GO:0005814]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g705.t1 A7SNN5 37.177 503 3.58e-91 317.0 sp|A7SNN5|PLK4_NEMVE Serine/threonine-protein kinase PLK4 OS=Nematostella vectensis OX=45351 GN=v1g246408 PE=3 SV=1 PLK4_NEMVE reviewed Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) Nematostella vectensis (Starlet sea anemone) GO:0004674; GO:0005524; GO:0005634; GO:0005814; GO:0106310 centriole [GO:0005814]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g715.t1 Q3UA06 68.396 424 0.0 577.0 sp|Q3UA06|PCH2_MOUSE Pachytene checkpoint protein 2 homolog OS=Mus musculus OX=10090 GN=Trip13 PE=1 SV=1 PCH2_MOUSE reviewed Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13) Mus musculus (Mouse) GO:0001556; GO:0001673; GO:0005524; GO:0005634; GO:0005694; GO:0006302; GO:0007094; GO:0007130; GO:0007131; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0016887; GO:0042802; GO:0048477; GO:0051598 double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] g717.t1 Q06AB3 52.212 226 9.59e-83 249.0 sp|Q06AB3|UCHL3_PIG Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Sus scrofa OX=9823 GN=UCHL3 PE=2 SV=1 g717.t2 Q06AB3 51.77 226 1.49e-81 246.0 sp|Q06AB3|UCHL3_PIG Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Sus scrofa OX=9823 GN=UCHL3 PE=2 SV=1 g717.t3 Q06AB3 43.542 271 5.55e-73 226.0 sp|Q06AB3|UCHL3_PIG Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Sus scrofa OX=9823 GN=UCHL3 PE=2 SV=1 g718.t1 Q5ZHV1 70.286 175 1.36e-92 274.0 sp|Q5ZHV1|RB33B_CHICK Ras-related protein Rab-33B OS=Gallus gallus OX=9031 GN=RAB33B PE=2 SV=1 RB33B_CHICK reviewed Ras-related protein Rab-33B (EC 3.6.5.2) Gallus gallus (Chicken) GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005794; GO:0005796; GO:0006891; GO:0015031; GO:0017157; GO:0032482; GO:0034045; GO:0034067; GO:0034497; GO:0046872; GO:0048705; GO:1903358; GO:1903434; GO:2000156 autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; phagophore assembly site membrane [GO:0034045] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g719.t1 P95329 40.952 525 1.61e-120 369.0 sp|P95329|MASY_MYXXD Malate synthase OS=Myxococcus xanthus (strain DK1622) OX=246197 GN=mls PE=3 SV=2 g720.t1 P18749 39.211 380 6.780000000000001e-73 246.0 sp|P18749|ZO6_XENLA Oocyte zinc finger protein XlCOF6 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g720.t1 P18749 38.529 340 1.86e-62 218.0 sp|P18749|ZO6_XENLA Oocyte zinc finger protein XlCOF6 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g720.t1 P18749 31.538 260 1.34e-26 117.0 sp|P18749|ZO6_XENLA Oocyte zinc finger protein XlCOF6 (Fragment) OS=Xenopus laevis OX=8355 PE=3 SV=1 g721.t1 Q80UM3 59.7 866 0.0 1045.0 sp|Q80UM3|NAA15_MOUSE N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Mus musculus OX=10090 GN=Naa15 PE=1 SV=1 NAA15_MOUSE reviewed N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1) Mus musculus (Mouse) GO:0001525; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0008080; GO:0010698; GO:0016604; GO:0030154; GO:0031415; GO:0043022; GO:0043066; GO:0045893; GO:0048471; GO:0050821 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-templated transcription [GO:0045893]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667] acetyltransferase activator activity [GO:0010698]; N-acetyltransferase activity [GO:0008080]; ribosome binding [GO:0043022] g722.t1 Q28E95 43.898 549 1.2700000000000002e-125 410.0 sp|Q28E95|SH3R1_XENTR E3 ubiquitin-protein ligase SH3RF1 OS=Xenopus tropicalis OX=8364 GN=sh3rf1 PE=2 SV=1 SH3R1_XENTR reviewed E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564 negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471] MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g722.t1 Q28E95 80.357 56 1.43e-21 105.0 sp|Q28E95|SH3R1_XENTR E3 ubiquitin-protein ligase SH3RF1 OS=Xenopus tropicalis OX=8364 GN=sh3rf1 PE=2 SV=1 SH3R1_XENTR reviewed E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564 negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471] MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g724.t1 Q499N4 55.224 335 5.6e-130 384.0 sp|Q499N4|COQ2_RAT 4-hydroxybenzoate polyprenyltransferase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Coq2 PE=1 SV=1 COQ2_RAT reviewed 4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase) Rattus norvegicus (Rat) GO:0004659; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0031314 glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743] 4-hydroxybenzoate polyprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659] g726.t1 Q9Z1S8 47.414 116 1.38e-29 129.0 sp|Q9Z1S8|GAB2_MOUSE GRB2-associated-binding protein 2 OS=Mus musculus OX=10090 GN=Gab2 PE=1 SV=2 g726.t2 Q9Z1S8 47.414 116 1.36e-29 129.0 sp|Q9Z1S8|GAB2_MOUSE GRB2-associated-binding protein 2 OS=Mus musculus OX=10090 GN=Gab2 PE=1 SV=2 g727.t1 P27398 49.185 675 0.0 645.0 sp|P27398|CAND_DROME Calpain-D OS=Drosophila melanogaster OX=7227 GN=sol PE=1 SV=2 CAND_DROME reviewed Calpain-D (EC 3.4.22.-) (Calcium-activated neutral proteinase D) (CANP D) (Small optic lobes protein) Drosophila melanogaster (Fruit fly) GO:0004198; GO:0005737; GO:0006508; GO:0007399; GO:0007601; GO:0008270 nervous system development [GO:0007399]; proteolysis [GO:0006508]; visual perception [GO:0007601] cytoplasm [GO:0005737] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; zinc ion binding [GO:0008270] g728.t1 Q922Q8 57.727 220 8.850000000000001e-75 234.0 sp|Q922Q8|LRC59_MOUSE Leucine-rich repeat-containing protein 59 OS=Mus musculus OX=10090 GN=Lrrc59 PE=1 SV=1 g729.t1 Q6NTU3 70.27 111 4.77e-50 158.0 sp|Q6NTU3|TI16A_XENLA Mitochondrial import inner membrane translocase subunit tim16-A OS=Xenopus laevis OX=8355 GN=pam16-a PE=2 SV=1 g730.t1 Q8VDL9 70.701 157 1.5e-79 260.0 sp|Q8VDL9|GLIS2_MOUSE Zinc finger protein GLIS2 OS=Mus musculus OX=10090 GN=Glis2 PE=1 SV=1 GLIS2_MOUSE reviewed Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) (Zinc finger protein GLI5) Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007417; GO:0008270; GO:0016607; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0061005; GO:0061484; GO:0097730; GO:1900182; GO:1990837 cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; kidney development [GO:0001822]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g731.t1 Q6NYV5 62.044 137 6.0499999999999996e-52 164.0 sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1 SP30L_DANRE reviewed Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273 heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355] histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730] DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g731.t2 Q6NYV5 64.964 137 1.34e-59 184.0 sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1 SP30L_DANRE reviewed Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273 heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355] histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730] DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g732.t1 Q24537 52.41 166 9.92e-55 181.0 sp|Q24537|HMG2_DROME High mobility group protein DSP1 OS=Drosophila melanogaster OX=7227 GN=Dsp1 PE=2 SV=1 HMG2_DROME reviewed High mobility group protein DSP1 (Protein dorsal switch 1) Drosophila melanogaster (Fruit fly) GO:0000122; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0007379; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0045892; GO:0140297 chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; segment specification [GO:0007379] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700] DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025] g733.t1 Q24537 56.364 165 1.7899999999999997e-61 199.0 sp|Q24537|HMG2_DROME High mobility group protein DSP1 OS=Drosophila melanogaster OX=7227 GN=Dsp1 PE=2 SV=1 HMG2_DROME reviewed High mobility group protein DSP1 (Protein dorsal switch 1) Drosophila melanogaster (Fruit fly) GO:0000122; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005700; GO:0006338; GO:0007379; GO:0008301; GO:0008348; GO:0017025; GO:0017055; GO:0032502; GO:0035218; GO:0045892; GO:0140297 chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; segment specification [GO:0007379] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700] DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025] g734.t1 Q5XJQ5 58.182 385 1.78e-157 454.0 sp|Q5XJQ5|EXOS9_DANRE Exosome complex component RRP45 OS=Danio rerio OX=7955 GN=exosc9 PE=2 SV=1 EXOS9_DANRE reviewed Exosome complex component RRP45 (Exosome component 9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000176; GO:0000177; GO:0000467; GO:0005654; GO:0005730; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0071028; GO:0071035; GO:0071038 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; rRNA catabolic process [GO:0016075]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476] cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mRNA 3'-UTR AU-rich region binding [GO:0035925] g734.t2 Q5XJQ5 58.182 385 2.33e-157 454.0 sp|Q5XJQ5|EXOS9_DANRE Exosome complex component RRP45 OS=Danio rerio OX=7955 GN=exosc9 PE=2 SV=1 EXOS9_DANRE reviewed Exosome complex component RRP45 (Exosome component 9) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000176; GO:0000177; GO:0000467; GO:0005654; GO:0005730; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0071028; GO:0071035; GO:0071038 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; rRNA catabolic process [GO:0016075]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476] cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mRNA 3'-UTR AU-rich region binding [GO:0035925] g735.t1 Q01664 50.0 262 1.37e-66 216.0 sp|Q01664|TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens OX=9606 GN=TFAP4 PE=1 SV=2 TFAP4_HUMAN reviewed Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41) Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008285; GO:0010629; GO:0017053; GO:0030330; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837 cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; host-mediated activation of viral transcription [GO:0043923]; host-mediated suppression of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g740.t1 Q9UJU3 36.585 205 1.35e-39 149.0 sp|Q9UJU3|ZN112_HUMAN Zinc finger protein 112 OS=Homo sapiens OX=9606 GN=ZNF112 PE=1 SV=2 g740.t1 Q9UJU3 34.568 243 3.2400000000000003e-37 142.0 sp|Q9UJU3|ZN112_HUMAN Zinc finger protein 112 OS=Homo sapiens OX=9606 GN=ZNF112 PE=1 SV=2 g744.t1 P62909 73.577 246 1.14e-115 334.0 sp|P62909|RS3_RAT Small ribosomal subunit protein uS3 OS=Rattus norvegicus OX=10116 GN=Rps3 PE=1 SV=1 RS3_RAT reviewed Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3) Rattus norvegicus (Rat) GO:0003677; GO:0003684; GO:0003723; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0006281; GO:0006284; GO:0006412; GO:0006915; GO:0006974; GO:0007059; GO:0008017; GO:0010628; GO:0014069; GO:0015631; GO:0017148; GO:0019899; GO:0019900; GO:0019901; GO:0022626; GO:0022627; GO:0030425; GO:0030544; GO:0031116; GO:0031334; GO:0031397; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0034614; GO:0042104; GO:0042981; GO:0044390; GO:0044877; GO:0045202; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051225; GO:0051301; GO:0051879; GO:0061481; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0098556; GO:0140078; GO:0140297; GO:1901224; GO:1902231; GO:1905053; GO:1990090; GO:1990904; GO:2001235 apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; cell division [GO:0051301]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; synapse [GO:0045202] class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] g745.t1 O60841 56.434 544 0.0 624.0 sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4 IF2P_HUMAN reviewed Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872 regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] g758.t1 O60841 64.706 102 6.21e-32 131.0 sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4 IF2P_HUMAN reviewed Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2) Homo sapiens (Human) GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872 regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] g760.t1 Q8VEH0 52.586 348 1.22e-121 359.0 sp|Q8VEH0|TM144_MOUSE Transmembrane protein 144 OS=Mus musculus OX=10090 GN=Tmem144 PE=2 SV=1 g760.t2 Q8VEH0 50.278 360 1.6e-117 350.0 sp|Q8VEH0|TM144_MOUSE Transmembrane protein 144 OS=Mus musculus OX=10090 GN=Tmem144 PE=2 SV=1 g760.t3 Q8VEH0 46.65 403 1.32e-116 349.0 sp|Q8VEH0|TM144_MOUSE Transmembrane protein 144 OS=Mus musculus OX=10090 GN=Tmem144 PE=2 SV=1 g762.t1 Q80U35 36.276 929 6.3e-142 483.0 sp|Q80U35|ARHGH_MOUSE Rho guanine nucleotide exchange factor 17 OS=Mus musculus OX=10090 GN=Arhgef17 PE=1 SV=2 g762.t1 Q80U35 52.247 356 3.05e-102 365.0 sp|Q80U35|ARHGH_MOUSE Rho guanine nucleotide exchange factor 17 OS=Mus musculus OX=10090 GN=Arhgef17 PE=1 SV=2 g762.t2 Q80U35 36.276 929 6.74e-142 483.0 sp|Q80U35|ARHGH_MOUSE Rho guanine nucleotide exchange factor 17 OS=Mus musculus OX=10090 GN=Arhgef17 PE=1 SV=2 g762.t2 Q80U35 52.247 356 3.19e-102 365.0 sp|Q80U35|ARHGH_MOUSE Rho guanine nucleotide exchange factor 17 OS=Mus musculus OX=10090 GN=Arhgef17 PE=1 SV=2 g762.t3 Q96PE2 36.364 935 1.5699999999999998e-141 482.0 sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1 ARHGH_HUMAN reviewed Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056 actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829] guanyl-nucleotide exchange factor activity [GO:0005085] g762.t3 Q96PE2 53.352 358 6.74e-105 373.0 sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1 ARHGH_HUMAN reviewed Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056 actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829] guanyl-nucleotide exchange factor activity [GO:0005085] g763.t1 Q9D9G3 59.88 167 1.03e-59 186.0 sp|Q9D9G3|CHIC2_MOUSE Cysteine-rich hydrophobic domain-containing protein 2 OS=Mus musculus OX=10090 GN=Chic2 PE=2 SV=1 g765.t1 Q0KHY3 29.792 960 1e-93 334.0 sp|Q0KHY3|MESH_DROME Protein mesh OS=Drosophila melanogaster OX=7227 GN=mesh PE=1 SV=2 MESH_DROME reviewed Protein mesh Drosophila melanogaster (Fruit fly) GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528 cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528] apicolateral plasma membrane [GO:0016327]; extracellular space [GO:0005615]; smooth septate junction [GO:0005920] g769.t1 P38024 59.951 412 0.0 540.0 sp|P38024|PUR6_CHICK Multifunctional protein ADE2 OS=Gallus gallus OX=9031 GN=AIRC PE=2 SV=1 g770.t1 P28173 69.625 507 0.0 733.0 sp|P28173|PUR1_CHICK Amidophosphoribosyltransferase OS=Gallus gallus OX=9031 GN=PPAT PE=1 SV=1 g771.t1 Q5R9W8 49.145 468 6.3700000000000004e-173 500.0 sp|Q5R9W8|XPP3_PONAB Xaa-Pro aminopeptidase 3 OS=Pongo abelii OX=9601 GN=XPNPEP3 PE=2 SV=1 g772.t1 P97929 42.723 639 5.62e-149 528.0 sp|P97929|BRCA2_MOUSE Breast cancer type 2 susceptibility protein homolog OS=Mus musculus OX=10090 GN=Brca2 PE=1 SV=2 g773.t1 P31316 66.667 111 3.61e-38 139.0 sp|P31316|GSX2_MOUSE GS homeobox 2 OS=Mus musculus OX=10090 GN=Gsx2 PE=1 SV=2 g775.t1 P70118 53.529 170 3.16e-45 159.0 sp|P70118|PDX1_MESAU Pancreas/duodenum homeobox protein 1 OS=Mesocricetus auratus OX=10036 GN=PDX1 PE=1 SV=1 g776.t1 Q9DEB6 47.639 233 1.6199999999999998e-40 146.0 sp|Q9DEB6|CDX1_CHICK Homeobox protein CDX-1 OS=Gallus gallus OX=9031 GN=CDX1 PE=2 SV=2 g778.t1 P10079 35.294 748 2.38e-119 410.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g778.t1 P10079 41.578 469 1.12e-105 370.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g778.t1 P10079 42.683 410 1.79e-91 327.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g778.t1 P10079 46.176 340 1.34e-81 298.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g778.t1 P10079 37.681 414 3.03e-76 281.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g778.t1 P10079 40.55 291 1.86e-54 213.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g783.t1 P24643 54.809 551 0.0 585.0 sp|P24643|CALX_CANLF Calnexin OS=Canis lupus familiaris OX=9615 GN=CANX PE=1 SV=3 g786.t1 A4IID1 42.589 533 3.11e-141 419.0 sp|A4IID1|MGT4A_XENTR Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A OS=Xenopus tropicalis OX=8364 GN=mgat4a PE=2 SV=1 MGT4A_XENTR reviewed Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa) (GlcNAc-T IVa) (GnT-IVa) (N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0005576; GO:0005777; GO:0006491; GO:0008453; GO:0008454; GO:0042803; GO:0046487; GO:0046872 glyoxylate metabolic process [GO:0046487]; N-glycan processing [GO:0006491] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; peroxisome [GO:0005777] alanine-glyoxylate transaminase activity [GO:0008453]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] g787.t1 Q62398 54.934 679 0.0 731.0 sp|Q62398|CNGA2_MOUSE Cyclic nucleotide-gated channel alpha-2 OS=Mus musculus OX=10090 GN=Cnga2 PE=2 SV=2 g788.t1 G5E8F4 37.647 595 1.5900000000000002e-124 382.0 sp|G5E8F4|FPGT_MOUSE Fucose-1-phosphate guanylyltransferase OS=Mus musculus OX=10090 GN=Fpgt PE=1 SV=1 g789.t1 Q13887 38.021 384 2.04e-57 197.0 sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2 KLF5_HUMAN reviewed Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1990830; GO:1990837; GO:1990859 angiogenesis [GO:0001525]; cellular response to endothelin [GO:1990859]; cellular response to leukemia inhibitory factor [GO:1990830]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816] chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g790.t1 O35738 56.875 160 7.72e-51 177.0 sp|O35738|KLF12_MOUSE Krueppel-like factor 12 OS=Mus musculus OX=10090 GN=Klf12 PE=1 SV=2 KLF12_MOUSE reviewed Krueppel-like factor 12 (Transcriptional repressor AP-2rep) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0008270; GO:0045944; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g790.t2 O35738 56.875 160 3.96e-51 177.0 sp|O35738|KLF12_MOUSE Krueppel-like factor 12 OS=Mus musculus OX=10090 GN=Klf12 PE=1 SV=2 KLF12_MOUSE reviewed Krueppel-like factor 12 (Transcriptional repressor AP-2rep) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0008270; GO:0045944; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g790.t3 O35738 56.875 160 4.51e-51 177.0 sp|O35738|KLF12_MOUSE Krueppel-like factor 12 OS=Mus musculus OX=10090 GN=Klf12 PE=1 SV=2 KLF12_MOUSE reviewed Krueppel-like factor 12 (Transcriptional repressor AP-2rep) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0008270; GO:0045944; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g792.t1 A4FUM1 74.201 407 0.0 631.0 sp|A4FUM1|SEP8B_DANRE Septin-8-B OS=Danio rerio OX=7955 GN=sept8b PE=2 SV=1 SEP8B_DANRE reviewed Septin-8-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0060090; GO:0061640 cytoskeleton-dependent cytokinesis [GO:0061640]; intracellular protein localization [GO:0008104] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] g793.t1 Q5U317 39.545 220 1.3600000000000002e-26 118.0 sp|Q5U317|FIP1_RAT Pre-mRNA 3'-end-processing factor FIP1 OS=Rattus norvegicus OX=10116 GN=Fip1l1 PE=1 SV=1 g794.t1 A4FV08 78.521 284 2.4800000000000003e-173 483.0 sp|A4FV08|GNPI1_BOVIN Glucosamine-6-phosphate deaminase 1 OS=Bos taurus OX=9913 GN=GNPDA1 PE=1 SV=1 GNPI1_BOVIN reviewed Glucosamine-6-phosphate deaminase 1 (GlcN6P deaminase 1) (EC 3.5.99.6) (Glucosamine-6-phosphate isomerase 1) (Protein oscillin) Bos taurus (Bovine) GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0016853; GO:0019262; GO:0042802 carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytoplasm [GO:0005737] glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853] g795.t1 O35690 47.706 218 2.5e-51 176.0 sp|O35690|PHX2B_MOUSE Paired mesoderm homeobox protein 2B OS=Mus musculus OX=10090 GN=Phox2b PE=1 SV=1 PHX2B_MOUSE reviewed Paired mesoderm homeobox protein 2B (Neuroblastoma Phox) (NBPhox) (PHOX2B homeodomain protein) (Paired-like homeobox 2B) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001764; GO:0002087; GO:0003357; GO:0003358; GO:0003360; GO:0005634; GO:0005654; GO:0006357; GO:0008285; GO:0010001; GO:0010468; GO:0014823; GO:0021533; GO:0021723; GO:0021934; GO:0030182; GO:0035914; GO:0045665; GO:0045666; GO:0045944; GO:0048468; GO:0048483; GO:0048484; GO:0048485; GO:0048486; GO:0048666; GO:0048839; GO:0048894; GO:0051899; GO:0060541; GO:0061452; GO:0061549; GO:0071244; GO:0071542; GO:0071773; GO:0120162; GO:1901166; GO:1990837 autonomic nervous system development [GO:0048483]; brainstem development [GO:0003360]; cell development [GO:0048468]; cell differentiation in hindbrain [GO:0021533]; cellular response to BMP stimulus [GO:0071773]; cellular response to carbon dioxide [GO:0071244]; dopaminergic neuron differentiation [GO:0071542]; efferent axon development in a lateral line nerve [GO:0048894]; enteric nervous system development [GO:0048484]; glial cell differentiation [GO:0010001]; hindbrain tangential cell migration [GO:0021934]; inner ear development [GO:0048839]; medullary reticular formation development [GO:0021723]; membrane depolarization [GO:0051899]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron differentiation [GO:0003357]; parasympathetic nervous system development [GO:0048486]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system development [GO:0060541]; response to activity [GO:0014823]; retrotrapezoid nucleus neuron differentiation [GO:0061452]; skeletal muscle cell differentiation [GO:0035914]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g798.t1 Q5E9N5 67.222 540 0.0 717.0 sp|Q5E9N5|CLPB_BOVIN Mitochondrial disaggregase OS=Bos taurus OX=9913 GN=CLPB PE=2 SV=1 CLPB_BOVIN reviewed Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form] Bos taurus (Bovine) GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0034605 cellular response to heat [GO:0034605] cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g801.t1 Q99P50 25.393 382 7.97e-21 95.9 sp|Q99P50|GHSR_MOUSE Growth hormone secretagogue receptor type 1 OS=Mus musculus OX=10090 GN=Ghsr PE=2 SV=3 g804.t1 P60924 35.683 227 3.39e-30 127.0 sp|P60924|DELE1_RAT DAP3-binding cell death enhancer 1 OS=Rattus norvegicus OX=10116 GN=Dele1 PE=2 SV=2 DELE1_RAT reviewed DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)] Rattus norvegicus (Rat) GO:0000423; GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0006413; GO:0006974; GO:0008625; GO:0019901; GO:0033554; GO:0043539; GO:0051260; GO:0070585; GO:0140467; GO:0140468; GO:1901526; GO:1990641 cellular response to stress [GO:0033554]; DNA damage response [GO:0006974]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; mitophagy [GO:0000423]; positive regulation of mitophagy [GO:1901526]; protein homooligomerization [GO:0051260]; protein localization to mitochondrion [GO:0070585]; response to iron ion starvation [GO:1990641]; translational initiation [GO:0006413] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] g805.t1 Q9NWY4 55.519 308 8.289999999999999e-126 370.0 sp|Q9NWY4|HPF1_HUMAN Histone PARylation factor 1 OS=Homo sapiens OX=9606 GN=HPF1 PE=1 SV=2 HPF1_HUMAN reviewed Histone PARylation factor 1 Homo sapiens (Human) GO:0000785; GO:0003682; GO:0005634; GO:0006281; GO:0006302; GO:0006974; GO:0010835; GO:0042393; GO:0072572; GO:0090734; GO:0140768; GO:0140861 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; regulation of protein ADP-ribosylation [GO:0010835] chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768] g805.t2 Q9NWY4 55.519 308 7.559999999999999e-126 370.0 sp|Q9NWY4|HPF1_HUMAN Histone PARylation factor 1 OS=Homo sapiens OX=9606 GN=HPF1 PE=1 SV=2 HPF1_HUMAN reviewed Histone PARylation factor 1 Homo sapiens (Human) GO:0000785; GO:0003682; GO:0005634; GO:0006281; GO:0006302; GO:0006974; GO:0010835; GO:0042393; GO:0072572; GO:0090734; GO:0140768; GO:0140861 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; regulation of protein ADP-ribosylation [GO:0010835] chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768] g806.t1 Q0VFH6 53.125 192 4.5900000000000003e-66 207.0 sp|Q0VFH6|RM22_XENTR Large ribosomal subunit protein uL22m OS=Xenopus tropicalis OX=8364 GN=mrpl22 PE=2 SV=1 g808.t1 Q5RBU7 57.019 463 0.0 558.0 sp|Q5RBU7|PCP_PONAB Lysosomal Pro-X carboxypeptidase OS=Pongo abelii OX=9601 GN=PRCP PE=2 SV=1 PCP_PONAB reviewed Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003085; GO:0004185; GO:0005764; GO:0006508; GO:0008239; GO:0043535; GO:0060055 angiogenesis involved in wound healing [GO:0060055]; negative regulation of systemic arterial blood pressure [GO:0003085]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535] lysosome [GO:0005764] dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185] g809.t1 Q5F457 30.377 451 3.0399999999999997e-38 145.0 sp|Q5F457|WBP4_CHICK WW domain-binding protein 4 OS=Gallus gallus OX=9031 GN=WBP4 PE=2 SV=1 WBP4_CHICK reviewed WW domain-binding protein 4 (WBP-4) Gallus gallus (Chicken) GO:0000398; GO:0003676; GO:0005634; GO:0008270; GO:0016607; GO:0071005 mRNA splicing, via spliceosome [GO:0000398] nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g810.t1 Q6DIN3 44.395 446 4.3399999999999995e-115 384.0 sp|Q6DIN3|MBTD1_XENTR MBT domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=mbtd1 PE=2 SV=1 g813.t1 P18841 25.915 355 1.43e-24 107.0 sp|P18841|ADA1B_MESAU Alpha-1B adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRA1B PE=1 SV=1 g814.t1 Q14CM0 45.518 569 4.82e-145 491.0 sp|Q14CM0|FRPD4_HUMAN FERM and PDZ domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FRMPD4 PE=1 SV=1 FRPD4_HUMAN reviewed FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso) Homo sapiens (Human) GO:0005546; GO:0032991; GO:0043197; GO:0051835 positive regulation of synapse structural plasticity [GO:0051835] dendritic spine [GO:0043197]; protein-containing complex [GO:0032991] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g814.t2 Q14CM0 45.246 568 2.0000000000000001e-143 486.0 sp|Q14CM0|FRPD4_HUMAN FERM and PDZ domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FRMPD4 PE=1 SV=1 FRPD4_HUMAN reviewed FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso) Homo sapiens (Human) GO:0005546; GO:0032991; GO:0043197; GO:0051835 positive regulation of synapse structural plasticity [GO:0051835] dendritic spine [GO:0043197]; protein-containing complex [GO:0032991] phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g816.t1 Q8AV28 30.807 1636 9.89e-140 487.0 sp|Q8AV28|PCM1_CHICK Pericentriolar material 1 protein OS=Gallus gallus OX=9031 GN=PCM1 PE=2 SV=1 g816.t2 Q8AV28 30.933 1639 1.4299999999999999e-139 486.0 sp|Q8AV28|PCM1_CHICK Pericentriolar material 1 protein OS=Gallus gallus OX=9031 GN=PCM1 PE=2 SV=1 g817.t1 Q5RES6 72.028 143 1.1599999999999999e-74 221.0 sp|Q5RES6|TPPC2_PONAB Trafficking protein particle complex subunit 2 OS=Pongo abelii OX=9601 GN=TRAPPC2 PE=2 SV=1 g819.t1 Q66L32 62.195 82 5.6699999999999995e-34 115.0 sp|Q66L32|TIM8A_XENLA Mitochondrial import inner membrane translocase subunit Tim8 A OS=Xenopus laevis OX=8355 GN=timm8a PE=3 SV=1 g820.t1 Q96M20 31.163 215 2e-25 114.0 sp|Q96M20|CNBD2_HUMAN Cyclic nucleotide-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CNBD2 PE=1 SV=2 g821.t1 Q8C6C9 33.631 336 4.7099999999999995e-52 180.0 sp|Q8C6C9|LEG1H_MOUSE Protein LEG1 homolog OS=Mus musculus OX=10090 GN=Leg1 PE=2 SV=2 g822.t1 Q9H8H3 43.421 228 6.1e-53 174.0 sp|Q9H8H3|TMT1A_HUMAN Thiol S-methyltransferase TMT1A OS=Homo sapiens OX=9606 GN=TMT1A PE=1 SV=1 TMT1A_HUMAN reviewed Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A) Homo sapiens (Human) GO:0001649; GO:0001734; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0008168; GO:0008173; GO:0016020; GO:0018708; GO:0032259; GO:0042476; GO:0180035; GO:1904724 lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724] methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708] g823.t1 Q9H8H3 42.609 230 9.41e-53 174.0 sp|Q9H8H3|TMT1A_HUMAN Thiol S-methyltransferase TMT1A OS=Homo sapiens OX=9606 GN=TMT1A PE=1 SV=1 TMT1A_HUMAN reviewed Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A) Homo sapiens (Human) GO:0001649; GO:0001734; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0008168; GO:0008173; GO:0016020; GO:0018708; GO:0032259; GO:0042476; GO:0180035; GO:1904724 lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724] methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708] g824.t1 B0V207 45.315 587 1.05e-152 492.0 sp|B0V207|FHI1B_DANRE FHF complex subunit HOOK-interacting protein 1B OS=Danio rerio OX=7955 GN=fhip1b PE=3 SV=1 g824.t1 B0V207 41.6 250 3.14e-45 182.0 sp|B0V207|FHI1B_DANRE FHF complex subunit HOOK-interacting protein 1B OS=Danio rerio OX=7955 GN=fhip1b PE=3 SV=1 g824.t2 B0V207 46.248 573 2.98e-156 501.0 sp|B0V207|FHI1B_DANRE FHF complex subunit HOOK-interacting protein 1B OS=Danio rerio OX=7955 GN=fhip1b PE=3 SV=1 g824.t2 B0V207 41.6 250 2.7499999999999998e-45 182.0 sp|B0V207|FHI1B_DANRE FHF complex subunit HOOK-interacting protein 1B OS=Danio rerio OX=7955 GN=fhip1b PE=3 SV=1 g826.t1 Q5EAD8 46.739 184 3.5899999999999994e-54 174.0 sp|Q5EAD8|LRC51_BOVIN Leucine-rich repeat-containing protein 51 OS=Bos taurus OX=9913 GN=LRRC51 PE=2 SV=1 g827.t1 Q6P791 40.361 166 5.270000000000001e-32 115.0 sp|Q6P791|LTOR1_RAT Ragulator complex protein LAMTOR1 OS=Rattus norvegicus OX=10116 GN=Lamtor1 PE=1 SV=1 LTOR1_RAT reviewed Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) Rattus norvegicus (Rat) GO:0000045; GO:0001558; GO:0001919; GO:0002181; GO:0005764; GO:0005765; GO:0007032; GO:0007040; GO:0008104; GO:0010507; GO:0010874; GO:0016197; GO:0031669; GO:0031902; GO:0032008; GO:0032418; GO:0038202; GO:0042632; GO:0043410; GO:0043495; GO:0045121; GO:0045947; GO:0045948; GO:0051020; GO:0060620; GO:0061462; GO:0071230; GO:0071986; GO:0072657; GO:0150032; GO:1904263; GO:1990877 autophagosome assembly [GO:0000045]; cellular response to amino acid stimulus [GO:0071230]; cellular response to nutrient levels [GO:0031669]; cholesterol homeostasis [GO:0042632]; cytoplasmic translation [GO:0002181]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein localization [GO:0008104]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of translational initiation [GO:0045947]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]; TORC1 signaling [GO:0038202] FNIP-folliculin RagC/D GAP [GO:1990877]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; Ragulator complex [GO:0071986] GTPase binding [GO:0051020]; protein-membrane adaptor activity [GO:0043495] g828.t1 Q9CPW7 70.149 201 7.61e-86 255.0 sp|Q9CPW7|ZMAT2_MOUSE Zinc finger matrin-type protein 2 OS=Mus musculus OX=10090 GN=Zmat2 PE=2 SV=1 g828.t2 Q9CPW7 70.149 201 6.28e-86 255.0 sp|Q9CPW7|ZMAT2_MOUSE Zinc finger matrin-type protein 2 OS=Mus musculus OX=10090 GN=Zmat2 PE=2 SV=1 g830.t1 Q17QB3 48.843 389 1.69e-139 406.0 sp|Q17QB3|ASAH1_BOVIN Acid ceramidase OS=Bos taurus OX=9913 GN=ASAH1 PE=2 SV=3 ASAH1_BOVIN reviewed Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta] Bos taurus (Bovine) GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0016020; GO:0017040; GO:0017064; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356 cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512] extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634] fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040] g831.t1 B2ZZS9 40.909 374 2.04e-101 308.0 sp|B2ZZS9|WDR55_ORYLA WD repeat-containing protein 55 OS=Oryzias latipes OX=8090 GN=wdr55 PE=1 SV=1 WDR55_ORYLA reviewed WD repeat-containing protein 55 (Protein hokecha) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0001654; GO:0001889; GO:0005730; GO:0006364; GO:0048536; GO:0048538; GO:0060322; GO:0160093 chordate pharynx development [GO:0160093]; eye development [GO:0001654]; head development [GO:0060322]; liver development [GO:0001889]; rRNA processing [GO:0006364]; spleen development [GO:0048536]; thymus development [GO:0048538] nucleolus [GO:0005730] g832.t1 Q2ABP2 35.021 237 1.4999999999999998e-42 148.0 sp|Q2ABP2|PGAP2_CRIGR Acyltransferase PGAP2 OS=Cricetulus griseus OX=10029 GN=Pgap2 PE=1 SV=1 g833.t1 Q8BYJ6 40.801 1348 0.0 831.0 sp|Q8BYJ6|TBCD4_MOUSE TBC1 domain family member 4 OS=Mus musculus OX=10090 GN=Tbc1d4 PE=1 SV=2 g834.t1 Q5SQX6 66.107 1251 0.0 1796.0 sp|Q5SQX6|CYFP2_MOUSE Cytoplasmic FMR1-interacting protein 2 OS=Mus musculus OX=10090 GN=Cyfip2 PE=1 SV=2 CYFP2_MOUSE reviewed Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121) Mus musculus (Mouse) GO:0000902; GO:0005634; GO:0005737; GO:0006915; GO:0007411; GO:0030031; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609; GO:0150052 apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202] small GTPase binding [GO:0031267] g839.t1 Q06S87 50.355 141 1.93e-43 142.0 sp|Q06S87|HIUH_DANRE 5-hydroxyisourate hydrolase OS=Danio rerio OX=7955 GN=urah PE=1 SV=1 g840.t1 B2KI97 50.668 1573 0.0 1451.0 sp|B2KI97|THOC2_RHIFE THO complex subunit 2 OS=Rhinolophus ferrumequinum OX=59479 GN=THOC2 PE=3 SV=1 g841.t1 Q8N3Z3 48.511 235 2.1500000000000002e-72 229.0 sp|Q8N3Z3|GTPB8_HUMAN GTP-binding protein 8 OS=Homo sapiens OX=9606 GN=GTPBP8 PE=1 SV=1 g842.t1 O89016 46.87 623 0.0 570.0 sp|O89016|ABCD4_MOUSE Lysosomal cobalamin transporter ABCD4 OS=Mus musculus OX=10090 GN=Abcd4 PE=1 SV=2 ABCD4_MOUSE reviewed Lysosomal cobalamin transporter ABCD4 (EC 7.6.2.8) (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) Mus musculus (Mouse) GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016887; GO:0042626; GO:0042760; GO:0042802; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; very long-chain fatty acid catabolic process [GO:0042760] endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324] g843.t1 A7Y2W8 48.631 621 0.0 606.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 SC6A9_XENLA reviewed Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9) Xenopus laevis (African clawed frog) GO:0005283; GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0060092; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375] g845.t1 O13076 28.66 321 1.6100000000000001e-21 96.7 sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1 g846.t1 Q92878 45.004 1311 0.0 1113.0 sp|Q92878|RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens OX=9606 GN=RAD50 PE=1 SV=1 RAD50_HUMAN reviewed DNA repair protein RAD50 (hRAD50) (EC 3.6.-.-) Homo sapiens (Human) GO:0000019; GO:0000722; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0000794; GO:0003677; GO:0003691; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007131; GO:0016020; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0032206; GO:0035825; GO:0035861; GO:0042802; GO:0043047; GO:0043539; GO:0044818; GO:0046872; GO:0051880; GO:0062176; GO:0070192; GO:0070533; GO:0098687; GO:0110025; GO:1904354; GO:2000781 chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; R-loop processing [GO:0062176]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860] BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; membrane [GO:0016020]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activator activity [GO:0043539]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047] g848.t1 Q80VI1 27.66 329 1.61e-25 115.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g849.t1 O42385 23.733 434 4.88e-26 112.0 sp|O42385|5H1AA_TAKRU 5-hydroxytryptamine receptor 1A-alpha OS=Takifugu rubripes OX=31033 GN=htr1aa PE=3 SV=1 g850.t1 Q9MYM7 47.212 269 1.5999999999999998e-82 257.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g851.t1 Q9MYM7 44.689 273 1.22e-77 244.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g853.t1 P07742 72.34 799 0.0 1155.0 sp|P07742|RIR1_MOUSE Ribonucleoside-diphosphate reductase large subunit OS=Mus musculus OX=10090 GN=Rrm1 PE=1 SV=2 g856.t1 Q8NEZ2 34.532 417 1.01e-51 181.0 sp|Q8NEZ2|VP37A_HUMAN Vacuolar protein sorting-associated protein 37A OS=Homo sapiens OX=9606 GN=VPS37A PE=1 SV=1 VP37A_HUMAN reviewed Vacuolar protein sorting-associated protein 37A (hVps37A) (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1) Homo sapiens (Human) GO:0000813; GO:0001669; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0033011; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0090148; GO:0097225; GO:0097228; GO:0097229 macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; perinuclear theca [GO:0033011]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] g857.t1 Q9UIV1 69.825 285 1.48e-149 422.0 sp|Q9UIV1|CNOT7_HUMAN CCR4-NOT transcription complex subunit 7 OS=Homo sapiens OX=9606 GN=CNOT7 PE=1 SV=3 g858.t1 Q9Y5J1 44.262 427 2.41e-121 370.0 sp|Q9Y5J1|UTP18_HUMAN U3 small nucleolar RNA-associated protein 18 homolog OS=Homo sapiens OX=9606 GN=UTP18 PE=1 SV=3 g859.t1 P70010 71.622 148 9.42e-78 230.0 sp|P70010|NDKA1_XENLA Nucleoside diphosphate kinase A1 OS=Xenopus laevis OX=8355 PE=2 SV=1 g860.t1 Q9H3E2 38.843 847 0.0 580.0 sp|Q9H3E2|SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens OX=9606 GN=SNX25 PE=1 SV=2 g861.t1 Q9ERR2 45.854 205 3.9e-58 186.0 sp|Q9ERR2|COMD5_RAT COMM domain-containing protein 5 OS=Rattus norvegicus OX=10116 GN=Commd5 PE=2 SV=1 g862.t1 D3YY23 48.048 333 1.72e-104 343.0 sp|D3YY23|LONF1_MOUSE LON peptidase N-terminal domain and RING finger protein 1 OS=Mus musculus OX=10090 GN=Lonrf1 PE=1 SV=2 g862.t1 D3YY23 30.798 263 9.629999999999999e-23 108.0 sp|D3YY23|LONF1_MOUSE LON peptidase N-terminal domain and RING finger protein 1 OS=Mus musculus OX=10090 GN=Lonrf1 PE=1 SV=2 g863.t1 Q58DV5 52.525 99 1.11e-26 102.0 sp|Q58DV5|RM30_BOVIN Large ribosomal subunit protein uL30m OS=Bos taurus OX=9913 GN=MRPL30 PE=1 SV=1 g867.t1 B3EWY9 28.599 1028 6.67e-93 338.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g869.t1 Q9Y6R7 31.075 1284 1.2200000000000001e-148 511.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 30.7 1228 2.99e-141 489.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 30.692 1287 1.1e-135 472.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 30.519 1232 1.58e-135 471.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 30.571 1279 2.03e-135 471.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 30.614 1287 2.1399999999999998e-135 471.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 30.601 1232 5.67e-131 457.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 30.471 1211 5.24e-128 449.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 32.017 962 2.87e-120 425.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 29.061 1139 1.31e-108 389.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 29.086 777 9.33e-78 291.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 35.484 248 8.89e-38 160.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 34.016 244 2.87e-31 139.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 34.016 244 2.99e-31 138.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 28.142 366 1.42e-30 136.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 33.772 228 5.66e-29 131.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 33.582 268 2.43e-27 125.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 34.008 247 4.53e-27 125.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 32.576 264 3.7400000000000003e-26 122.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 32.576 264 6.250000000000001e-26 121.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 32.806 253 5.96e-24 114.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 34.413 247 6.5e-23 111.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g869.t1 Q9Y6R7 34.413 247 6.5e-23 111.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 27.733 750 5.94e-69 260.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 30.495 364 1.47e-37 158.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 31.42 331 7.11e-35 149.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 27.052 329 1.1300000000000001e-26 123.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 30.488 246 6.37e-25 117.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 28.269 283 9.809999999999999e-24 113.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 30.204 245 1.4599999999999998e-23 112.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t1 Q28983 33.696 184 1.02e-21 106.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t2 Q28983 27.733 750 3.82e-69 261.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t2 Q28983 26.006 696 1.02e-42 175.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t2 Q28983 31.42 331 5.38e-35 150.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t2 Q28983 27.052 329 1.0300000000000001e-26 123.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t2 Q28983 30.488 246 5.6999999999999995e-25 117.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t2 Q28983 30.204 245 1.2499999999999999e-23 113.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t2 Q28983 33.696 184 8.68e-22 107.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 27.867 750 1.0399999999999999e-68 259.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 30.495 364 1.14e-37 159.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 31.42 331 6.34e-35 150.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 27.052 329 8.84e-27 123.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 30.488 246 4.88e-25 117.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 29.032 279 7.509999999999999e-24 114.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 30.204 245 1.1399999999999999e-23 113.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g871.t3 Q28983 33.696 184 7.92e-22 107.0 sp|Q28983|ZAN_PIG Zonadhesin OS=Sus scrofa OX=9823 GN=ZAN PE=1 SV=1 ZAN_PIG reviewed Zonadhesin Sus scrofa (Pig) GO:0005201; GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840 binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] g873.t1 Q9HBX9 41.595 702 0.0 546.0 sp|Q9HBX9|RXFP1_HUMAN Relaxin receptor 1 OS=Homo sapiens OX=9606 GN=RXFP1 PE=1 SV=2 g874.t1 Q8AVH7 46.288 229 7.56e-62 224.0 sp|Q8AVH7|EGFL6_XENLA Epidermal growth factor-like protein 6 OS=Xenopus laevis OX=8355 GN=egfl6 PE=2 SV=1 g876.t1 Q8AVH7 42.857 280 9.53e-66 231.0 sp|Q8AVH7|EGFL6_XENLA Epidermal growth factor-like protein 6 OS=Xenopus laevis OX=8355 GN=egfl6 PE=2 SV=1 g878.t1 Q9MYV9 50.065 775 0.0 775.0 sp|Q9MYV9|TRPC5_BOVIN Short transient receptor potential channel 5 OS=Bos taurus OX=9913 GN=TRPC5 PE=2 SV=2 TRPC5_BOVIN reviewed Short transient receptor potential channel 5 (TrpC5) Bos taurus (Bovine) GO:0005262; GO:0005886; GO:0046872; GO:0051402; GO:0070782 neuron apoptotic process [GO:0051402]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; metal ion binding [GO:0046872] g879.t1 Q8VC30 45.378 595 4.5200000000000005e-161 475.0 sp|Q8VC30|TKFC_MOUSE Triokinase/FMN cyclase OS=Mus musculus OX=10090 GN=Tkfc PE=1 SV=1 g880.t1 Q95218 47.321 224 1.08e-52 191.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g880.t1 Q95218 42.642 265 3.6099999999999995e-48 178.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g880.t1 Q95218 41.7 247 2.9400000000000004e-47 176.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g880.t1 Q95218 42.8 250 4.03e-45 169.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g880.t1 Q95218 51.786 112 8.379999999999999e-24 107.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g880.t1 Q95218 49.123 114 1.86e-23 105.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g882.t1 E7F7V7 22.554 368 1.6200000000000002e-21 98.2 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g885.t1 P0C6B8 34.041 1789 0.0 915.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g886.t1 P35556 31.052 599 3.87e-48 193.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 30.337 712 5.680000000000001e-47 189.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 29.872 703 3.6900000000000005e-43 177.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 30.137 657 4.22e-41 170.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 29.463 689 1.02e-39 166.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 31.569 529 1.24e-39 165.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 31.111 540 3.9e-39 164.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 27.822 762 9.16e-39 162.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g886.t1 P35556 29.539 738 1.83e-33 145.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g887.t1 P0C6B8 34.81 1580 0.0 861.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g888.t1 P0C6B8 33.958 1228 0.0 635.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g889.t1 Q5R949 28.074 431 4.08e-41 154.0 sp|Q5R949|ACM1_PONAB Muscarinic acetylcholine receptor M1 OS=Pongo abelii OX=9601 GN=CHRM1 PE=2 SV=1 ACM1_PONAB reviewed Muscarinic acetylcholine receptor M1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004435; GO:0004993; GO:0007187; GO:0007197; GO:0016907; GO:0030425; GO:0040012; GO:0045211; GO:0046541; GO:0050890 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of locomotion [GO:0040012]; saliva secretion [GO:0046541] dendrite [GO:0030425]; postsynaptic membrane [GO:0045211] G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g890.t1 P43141 28.743 334 4.32e-25 108.0 sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 g891.t1 Q9W391 49.774 1326 0.0 1229.0 sp|Q9W391|KPBA_DROME Probable phosphorylase b kinase regulatory subunit alpha OS=Drosophila melanogaster OX=7227 GN=CG7766 PE=1 SV=2 g891.t2 Q9W391 50.774 1292 0.0 1241.0 sp|Q9W391|KPBA_DROME Probable phosphorylase b kinase regulatory subunit alpha OS=Drosophila melanogaster OX=7227 GN=CG7766 PE=1 SV=2 g892.t1 Q2L897 51.852 81 4.04e-25 92.0 sp|Q2L897|QCR8_AILME Cytochrome b-c1 complex subunit 8 OS=Ailuropoda melanoleuca OX=9646 GN=UQCRQ PE=3 SV=3 g897.t1 Q9W534 25.731 342 1.5199999999999998e-23 105.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g898.t1 Q6P1H6 37.161 627 5.07e-107 359.0 sp|Q6P1H6|ANKL2_MOUSE Ankyrin repeat and LEM domain-containing protein 2 OS=Mus musculus OX=10090 GN=Ankle2 PE=1 SV=2 ANKL2_MOUSE reviewed Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) Mus musculus (Mouse) GO:0004860; GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0042326; GO:0043066; GO:0051301; GO:0051721 cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] protein kinase inhibitor activity [GO:0004860]; protein phosphatase 2A binding [GO:0051721] g899.t1 Q6XPS3 43.897 467 2.3999999999999997e-126 385.0 sp|Q6XPS3|TPTE2_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens OX=9606 GN=TPTE2 PE=1 SV=2 TPTE2_HUMAN reviewed Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase) Homo sapiens (Human) GO:0000139; GO:0005216; GO:0005737; GO:0005789; GO:0005829; GO:0006661; GO:0016314; GO:0051800 phosphatidylinositol biosynthetic process [GO:0006661] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] monoatomic ion channel activity [GO:0005216]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800] g900.t1 Q8R323 78.652 356 0.0 610.0 sp|Q8R323|RFC3_MOUSE Replication factor C subunit 3 OS=Mus musculus OX=10090 GN=Rfc3 PE=1 SV=1 g901.t1 Q9WVS9 42.589 587 5.1600000000000005e-132 417.0 sp|Q9WVS9|CLOCK_RAT Circadian locomoter output cycles protein kaput OS=Rattus norvegicus OX=10116 GN=Clock PE=2 SV=1 g902.t1 E9QI36 70.588 510 0.0 725.0 sp|E9QI36|HARS1_DANRE Histidine--tRNA ligase OS=Danio rerio OX=7955 GN=hars PE=3 SV=2 g902.t2 P70076 70.378 503 0.0 708.0 sp|P70076|HARS1_TAKRU Histidine--tRNA ligase, cytoplasmic OS=Takifugu rubripes OX=31033 GN=hars1 PE=3 SV=1 g903.t1 O75592 45.763 2207 0.0 1808.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g903.t1 O75592 55.485 1586 0.0 1687.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g903.t2 O75592 45.651 2219 0.0 1806.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g903.t2 O75592 55.485 1586 0.0 1687.0 sp|O75592|MYCB2_HUMAN E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens OX=9606 GN=MYCBP2 PE=1 SV=4 MYCB2_HUMAN reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0050905; GO:0051493; GO:0061630; GO:0070936; GO:1902667 axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g905.t1 F1RD40 42.035 521 3.55e-119 392.0 sp|F1RD40|MYCB2_DANRE E3 ubiquitin-protein ligase MYCBP2 OS=Danio rerio OX=7955 GN=mycbp2 PE=2 SV=1 MYCB2_DANRE reviewed E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein Esrom) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004842; GO:0005085; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0016198; GO:0016567; GO:0021952; GO:0021986; GO:0030424; GO:0031267; GO:0031290; GO:0032922; GO:0042068; GO:0048066; GO:0048677; GO:0050905; GO:0061630; GO:1902667 axon choice point recognition [GO:0016198]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; retinal ganglion cell axon guidance [GO:0031290] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g906.t1 O43451 46.021 867 0.0 803.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g906.t1 O43451 45.061 901 0.0 758.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g906.t1 O43451 45.676 902 0.0 753.0 sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6 MGA_HUMAN reviewed Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) Homo sapiens (Human) GO:0000025; GO:0003824; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027 dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; oligo-1,6-glucosidase activity [GO:0004574] g907.t1 Q5MD89 40.673 713 4.97e-143 480.0 sp|Q5MD89|VGFR3_DANRE Vascular endothelial growth factor receptor 3 OS=Danio rerio OX=7955 GN=flt4 PE=2 SV=1 VGFR3_DANRE reviewed Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0005021; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0008045; GO:0008284; GO:0016477; GO:0019838; GO:0030335; GO:0030947; GO:0035474; GO:0036302; GO:0036303; GO:0038084; GO:0042802; GO:0043235; GO:0043410; GO:0046777; GO:0048010; GO:0060836; GO:0060841; GO:0060855; GO:0061026; GO:1900746; GO:1901207 angiogenesis [GO:0001525]; atrioventricular canal development [GO:0036302]; cardiac muscle tissue regeneration [GO:0061026]; cell migration [GO:0016477]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; regulation of heart looping [GO:1901207]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; selective angioblast sprouting [GO:0035474]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]; venous blood vessel development [GO:0060841]; venous endothelial cell migration involved in lymph vessel development [GO:0060855] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; vascular endothelial growth factor receptor activity [GO:0005021] g907.t1 Q5MD89 22.949 841 1.1399999999999999e-45 185.0 sp|Q5MD89|VGFR3_DANRE Vascular endothelial growth factor receptor 3 OS=Danio rerio OX=7955 GN=flt4 PE=2 SV=1 VGFR3_DANRE reviewed Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0005021; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0008045; GO:0008284; GO:0016477; GO:0019838; GO:0030335; GO:0030947; GO:0035474; GO:0036302; GO:0036303; GO:0038084; GO:0042802; GO:0043235; GO:0043410; GO:0046777; GO:0048010; GO:0060836; GO:0060841; GO:0060855; GO:0061026; GO:1900746; GO:1901207 angiogenesis [GO:0001525]; atrioventricular canal development [GO:0036302]; cardiac muscle tissue regeneration [GO:0061026]; cell migration [GO:0016477]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; regulation of heart looping [GO:1901207]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; selective angioblast sprouting [GO:0035474]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]; venous blood vessel development [GO:0060841]; venous endothelial cell migration involved in lymph vessel development [GO:0060855] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; vascular endothelial growth factor receptor activity [GO:0005021] g911.t1 Q3SZV5 52.137 117 2.7199999999999998e-34 119.0 sp|Q3SZV5|POMP_BOVIN Proteasome maturation protein OS=Bos taurus OX=9913 GN=POMP PE=2 SV=1 g912.t1 Q9XT50 48.535 1399 0.0 1198.0 sp|Q9XT50|ATP7B_SHEEP Copper-transporting ATPase 2 OS=Ovis aries OX=9940 GN=ATP7B PE=2 SV=1 g912.t1 Q9XT50 34.06 596 9.71e-81 297.0 sp|Q9XT50|ATP7B_SHEEP Copper-transporting ATPase 2 OS=Ovis aries OX=9940 GN=ATP7B PE=2 SV=1 g912.t1 Q9XT50 32.635 573 4.1e-75 280.0 sp|Q9XT50|ATP7B_SHEEP Copper-transporting ATPase 2 OS=Ovis aries OX=9940 GN=ATP7B PE=2 SV=1 g918.t1 Q8BQN6 50.739 203 3.8000000000000003e-66 209.0 sp|Q8BQN6|OZF_MOUSE Zinc finger protein OZF OS=Mus musculus OX=10090 GN=Znf146 PE=2 SV=2 g918.t1 Q8BQN6 45.146 206 2.69e-60 194.0 sp|Q8BQN6|OZF_MOUSE Zinc finger protein OZF OS=Mus musculus OX=10090 GN=Znf146 PE=2 SV=2 g918.t1 Q8BQN6 46.86 207 5.7800000000000006e-58 188.0 sp|Q8BQN6|OZF_MOUSE Zinc finger protein OZF OS=Mus musculus OX=10090 GN=Znf146 PE=2 SV=2 g918.t1 Q8BQN6 42.347 196 1.48e-52 174.0 sp|Q8BQN6|OZF_MOUSE Zinc finger protein OZF OS=Mus musculus OX=10090 GN=Znf146 PE=2 SV=2 g918.t1 Q8BQN6 44.91 167 1.26e-48 164.0 sp|Q8BQN6|OZF_MOUSE Zinc finger protein OZF OS=Mus musculus OX=10090 GN=Znf146 PE=2 SV=2 g918.t1 Q8BQN6 42.778 180 8.810000000000001e-47 159.0 sp|Q8BQN6|OZF_MOUSE Zinc finger protein OZF OS=Mus musculus OX=10090 GN=Znf146 PE=2 SV=2 g918.t1 Q8BQN6 44.805 154 1.62e-35 130.0 sp|Q8BQN6|OZF_MOUSE Zinc finger protein OZF OS=Mus musculus OX=10090 GN=Znf146 PE=2 SV=2 g921.t1 Q805E5 40.87 345 2.69e-90 281.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g923.t1 Q5XK67 56.14 114 8.99e-43 139.0 sp|Q5XK67|RPAC2_XENLA DNA-directed RNA polymerases I and III subunit RPAC2 OS=Xenopus laevis OX=8355 GN=polr1d PE=3 SV=1 g924.t1 Q4V7A8 47.571 494 8.530000000000001e-160 464.0 sp|Q4V7A8|ABD18_RAT Protein ABHD18 OS=Rattus norvegicus OX=10116 GN=Abhd18 PE=2 SV=2 g925.t1 Q6P1S4 63.636 671 0.0 894.0 sp|Q6P1S4|SYRC_XENTR Arginine--tRNA ligase, cytoplasmic OS=Xenopus tropicalis OX=8364 GN=rars1 PE=2 SV=1 g926.t1 A4IF63 33.333 276 6.5900000000000006e-43 162.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g930.t1 Q9R2B6 41.224 245 1.11e-59 200.0 sp|Q9R2B6|SIA7D_MOUSE Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Mus musculus OX=10090 GN=St6galnac4 PE=1 SV=1 g932.t1 Q14094 38.847 399 7.59e-79 249.0 sp|Q14094|CCNI_HUMAN Cyclin-I OS=Homo sapiens OX=9606 GN=CCNI PE=1 SV=1 g933.t1 O15075 58.078 718 0.0 796.0 sp|O15075|DCLK1_HUMAN Serine/threonine-protein kinase DCLK1 OS=Homo sapiens OX=9606 GN=DCLK1 PE=1 SV=2 g937.t1 Q6ZQ82 53.31 574 0.0 625.0 sp|Q6ZQ82|RHG26_MOUSE Rho GTPase-activating protein 26 OS=Mus musculus OX=10090 GN=Arhgap26 PE=1 SV=3 g937.t2 Q6ZQ82 53.229 573 0.0 629.0 sp|Q6ZQ82|RHG26_MOUSE Rho GTPase-activating protein 26 OS=Mus musculus OX=10090 GN=Arhgap26 PE=1 SV=3 g937.t3 Q6ZQ82 52.962 574 0.0 626.0 sp|Q6ZQ82|RHG26_MOUSE Rho GTPase-activating protein 26 OS=Mus musculus OX=10090 GN=Arhgap26 PE=1 SV=3 g938.t1 Q32LC9 58.104 327 3.22e-127 369.0 sp|Q32LC9|ZN330_BOVIN Zinc finger protein 330 OS=Bos taurus OX=9913 GN=ZNF330 PE=2 SV=1 g940.t1 Q05187 38.817 693 3.28e-157 477.0 sp|Q05187|TGMH_TACTR Hemocyte protein-glutamine gamma-glutamyltransferase OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g941.t1 Q96EQ9 36.585 410 8.72e-72 248.0 sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2 g943.t1 E1BD59 29.804 255 3.75e-28 121.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g944.t1 E1BD59 27.389 314 1.0300000000000001e-29 125.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g947.t1 B2FU61 39.171 217 6.3699999999999995e-40 152.0 sp|B2FU61|TTCA_STRMK tRNA-cytidine(32) 2-sulfurtransferase OS=Stenotrophomonas maltophilia (strain K279a) OX=522373 GN=ttcA PE=3 SV=2 TTCA_STRMK reviewed tRNA-cytidine(32) 2-sulfurtransferase (EC 2.8.1.-) (Two-thiocytidine biosynthesis protein A) (tRNA 2-thiocytidine biosynthesis protein TtcA) Stenotrophomonas maltophilia (strain K279a) GO:0000049; GO:0000287; GO:0005524; GO:0005737; GO:0016783; GO:0034227; GO:0051539 tRNA thio-modification [GO:0034227] cytoplasm [GO:0005737] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049] g949.t1 P46060 45.769 579 1.7e-150 447.0 sp|P46060|RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RANGAP1 PE=1 SV=1 RAGP1_HUMAN reviewed Ran GTPase-activating protein 1 (RanGAP1) Homo sapiens (Human) GO:0000776; GO:0003723; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0007165; GO:0016235; GO:0016925; GO:0030425; GO:0031267; GO:0031625; GO:0031965; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0051168; GO:0072686; GO:0090630; GO:0106068; GO:1904115; GO:1904117; GO:1990723 activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; nuclear export [GO:0051168]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165] aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SUMO ligase complex [GO:0106068] cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] g949.t2 P46060 44.706 595 2.34e-149 445.0 sp|P46060|RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RANGAP1 PE=1 SV=1 RAGP1_HUMAN reviewed Ran GTPase-activating protein 1 (RanGAP1) Homo sapiens (Human) GO:0000776; GO:0003723; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0007165; GO:0016235; GO:0016925; GO:0030425; GO:0031267; GO:0031625; GO:0031965; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0051168; GO:0072686; GO:0090630; GO:0106068; GO:1904115; GO:1904117; GO:1990723 activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; nuclear export [GO:0051168]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165] aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SUMO ligase complex [GO:0106068] cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] g950.t1 P24386 35.815 712 4.19e-143 438.0 sp|P24386|RAE1_HUMAN Rab proteins geranylgeranyltransferase component A 1 OS=Homo sapiens OX=9606 GN=CHM PE=1 SV=3 RAE1_HUMAN reviewed Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein) (Rab escort protein 1) (REP-1) (TCD protein) Homo sapiens (Human) GO:0004663; GO:0005092; GO:0005096; GO:0005634; GO:0005829; GO:0005968; GO:0006612; GO:0006886; GO:0007264; GO:0007601; GO:0016192; GO:0018344; GO:0031267 intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968] GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267] g951.t1 Q9H720 42.614 704 0.0 575.0 sp|Q9H720|PG2IP_HUMAN PGAP2-interacting protein OS=Homo sapiens OX=9606 GN=CWH43 PE=1 SV=2 g952.t1 Q7ZVK4 59.115 384 1.2300000000000001e-163 466.0 sp|Q7ZVK4|VPS36_DANRE Vacuolar protein-sorting-associated protein 36 OS=Danio rerio OX=7955 GN=vps36 PE=2 SV=1 g953.t1 Q95NN1 55.844 385 7.22e-143 416.0 sp|Q95NN1|T23O_TRICA Tryptophan 2,3-dioxygenase OS=Tribolium castaneum OX=7070 PE=2 SV=1 g954.t1 Q8BM88 41.275 298 3.1100000000000005e-79 248.0 sp|Q8BM88|CATO_MOUSE Cathepsin O OS=Mus musculus OX=10090 GN=Ctso PE=2 SV=1 g956.t1 Q8NEZ3 59.732 149 1.58e-60 204.0 sp|Q8NEZ3|WDR19_HUMAN WD repeat-containing protein 19 OS=Homo sapiens OX=9606 GN=WDR19 PE=1 SV=2 WDR19_HUMAN reviewed WD repeat-containing protein 19 (Intraflagellar transport 144 homolog) Homo sapiens (Human) GO:0000902; GO:0001701; GO:0001750; GO:0005886; GO:0005929; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0043113; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060831; GO:0061055; GO:0065003; GO:0097542; GO:0097730; GO:1903441 cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] g957.t1 Q3UGF1 65.152 198 3.32e-90 292.0 sp|Q3UGF1|WDR19_MOUSE WD repeat-containing protein 19 OS=Mus musculus OX=10090 GN=Wdr19 PE=1 SV=1 g958.t1 Q8NEZ3 68.55 531 0.0 784.0 sp|Q8NEZ3|WDR19_HUMAN WD repeat-containing protein 19 OS=Homo sapiens OX=9606 GN=WDR19 PE=1 SV=2 WDR19_HUMAN reviewed WD repeat-containing protein 19 (Intraflagellar transport 144 homolog) Homo sapiens (Human) GO:0000902; GO:0001701; GO:0001750; GO:0005886; GO:0005929; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0043113; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060831; GO:0061055; GO:0065003; GO:0097542; GO:0097730; GO:1903441 cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] g959.t1 Q3UGF1 79.643 280 5.3599999999999996e-158 477.0 sp|Q3UGF1|WDR19_MOUSE WD repeat-containing protein 19 OS=Mus musculus OX=10090 GN=Wdr19 PE=1 SV=1 g961.t1 Q8WWT9 45.238 588 8.58e-165 487.0 sp|Q8WWT9|S13A3_HUMAN Na(+)/dicarboxylate cotransporter 3 OS=Homo sapiens OX=9606 GN=SLC13A3 PE=1 SV=1 g963.t1 O75899 31.928 783 1.48e-127 410.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g964.t1 Q9Z2W8 44.506 901 0.0 724.0 sp|Q9Z2W8|GRIA4_MOUSE Glutamate receptor 4 OS=Mus musculus OX=10090 GN=Gria4 PE=1 SV=2 g965.t1 Q16445 37.06 483 5.98e-96 301.0 sp|Q16445|GBRA6_HUMAN Gamma-aminobutyric acid receptor subunit alpha-6 OS=Homo sapiens OX=9606 GN=GABRA6 PE=1 SV=2 GBRA6_HUMAN reviewed Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) (GABAAR subunit alpha-6) Homo sapiens (Human) GO:0004890; GO:0005886; GO:0007165; GO:0007214; GO:0008503; GO:0022851; GO:0032590; GO:0034707; GO:0051932; GO:0098794; GO:0099192; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862 chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932] cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic specialization membrane [GO:0099634] benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g965.t2 Q16445 37.06 483 2.09e-96 302.0 sp|Q16445|GBRA6_HUMAN Gamma-aminobutyric acid receptor subunit alpha-6 OS=Homo sapiens OX=9606 GN=GABRA6 PE=1 SV=2 GBRA6_HUMAN reviewed Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) (GABAAR subunit alpha-6) Homo sapiens (Human) GO:0004890; GO:0005886; GO:0007165; GO:0007214; GO:0008503; GO:0022851; GO:0032590; GO:0034707; GO:0051932; GO:0098794; GO:0099192; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862 chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932] cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic specialization membrane [GO:0099634] benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g966.t1 P42262 39.845 906 0.0 615.0 sp|P42262|GRIA2_HUMAN Glutamate receptor 2 OS=Homo sapiens OX=9606 GN=GRIA2 PE=1 SV=3 GRIA2_HUMAN reviewed Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) Homo sapiens (Human) GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0009897; GO:0014069; GO:0030425; GO:0030666; GO:0032279; GO:0032281; GO:0035235; GO:0035249; GO:0043025; GO:0043197; GO:0050804; GO:0060076; GO:0098794; GO:0098839; GO:0098843; GO:0099094; GO:1904315 ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843] AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate-gated receptor activity [GO:0004970]; ligand-gated monoatomic cation channel activity [GO:0099094]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g966.t2 P42262 39.563 915 0.0 617.0 sp|P42262|GRIA2_HUMAN Glutamate receptor 2 OS=Homo sapiens OX=9606 GN=GRIA2 PE=1 SV=3 GRIA2_HUMAN reviewed Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) Homo sapiens (Human) GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0009897; GO:0014069; GO:0030425; GO:0030666; GO:0032279; GO:0032281; GO:0035235; GO:0035249; GO:0043025; GO:0043197; GO:0050804; GO:0060076; GO:0098794; GO:0098839; GO:0098843; GO:0099094; GO:1904315 ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249] AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843] AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate-gated receptor activity [GO:0004970]; ligand-gated monoatomic cation channel activity [GO:0099094]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g967.t1 P24045 46.748 492 2.2699999999999998e-149 440.0 sp|P24045|GBRB4_CHICK Gamma-aminobutyric acid receptor subunit beta-4 OS=Gallus gallus OX=9031 GN=GABRB4 PE=2 SV=1 g967.t2 P24045 47.817 481 6.579999999999999e-153 448.0 sp|P24045|GBRB4_CHICK Gamma-aminobutyric acid receptor subunit beta-4 OS=Gallus gallus OX=9031 GN=GABRB4 PE=2 SV=1 g968.t1 P28471 43.721 215 7.580000000000001e-58 195.0 sp|P28471|GBRA4_RAT Gamma-aminobutyric acid receptor subunit alpha-4 OS=Rattus norvegicus OX=10116 GN=Gabra4 PE=1 SV=1 GBRA4_RAT reviewed Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) (GABAAR subunit alpha-4) Rattus norvegicus (Rat) GO:0004890; GO:0007214; GO:0007417; GO:0022851; GO:0032590; GO:0034707; GO:0051932; GO:0098794; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862 central nervous system development [GO:0007417]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; synaptic transmission, GABAergic [GO:0051932] chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; postsynapse [GO:0098794]; postsynaptic specialization membrane [GO:0099634] GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g969.t1 Q16445 36.111 180 4.6899999999999994e-23 97.4 sp|Q16445|GBRA6_HUMAN Gamma-aminobutyric acid receptor subunit alpha-6 OS=Homo sapiens OX=9606 GN=GABRA6 PE=1 SV=2 GBRA6_HUMAN reviewed Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) (GABAAR subunit alpha-6) Homo sapiens (Human) GO:0004890; GO:0005886; GO:0007165; GO:0007214; GO:0008503; GO:0022851; GO:0032590; GO:0034707; GO:0051932; GO:0098794; GO:0099192; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862 chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932] cerebellar Golgi cell to granule cell synapse [GO:0099192]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic specialization membrane [GO:0099634] benzodiazepine receptor activity [GO:0008503]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g970.t1 D3Z8N4 43.761 585 4.44e-169 497.0 sp|D3Z8N4|KLH20_RAT Kelch-like protein 20 OS=Rattus norvegicus OX=10116 GN=Klhl20 PE=3 SV=1 KLH20_RAT reviewed Kelch-like protein 20 Rattus norvegicus (Rat) GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756 Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802] actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] g971.t1 P34586 45.582 996 0.0 827.0 sp|P34586|TRPL_CAEEL Transient-receptor-potential-like protein OS=Caenorhabditis elegans OX=6239 GN=trp-1 PE=2 SV=3 g972.t1 Q58A65 49.529 1379 0.0 1184.0 sp|Q58A65|JIP4_MOUSE C-Jun-amino-terminal kinase-interacting protein 4 OS=Mus musculus OX=10090 GN=Spag9 PE=1 SV=2 JIP4_MOUSE reviewed C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (JNK-associated leucine-zipper protein) (JLP) (JNK/SAPK-associated protein 2) (JSAP2) (Mitogen-activated protein kinase 8-interacting protein 4) (Sperm-associated antigen 9) Mus musculus (Mouse) GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0043410; GO:0045665; GO:0045666; GO:0048273; GO:0048471; GO:0051146; GO:1903860 JNK cascade [GO:0007254]; lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase p38 binding [GO:0048273]; signaling receptor complex adaptor activity [GO:0030159] g972.t2 Q58A65 49.564 1376 0.0 1187.0 sp|Q58A65|JIP4_MOUSE C-Jun-amino-terminal kinase-interacting protein 4 OS=Mus musculus OX=10090 GN=Spag9 PE=1 SV=2 JIP4_MOUSE reviewed C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (JNK-associated leucine-zipper protein) (JLP) (JNK/SAPK-associated protein 2) (JSAP2) (Mitogen-activated protein kinase 8-interacting protein 4) (Sperm-associated antigen 9) Mus musculus (Mouse) GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0043410; GO:0045665; GO:0045666; GO:0048273; GO:0048471; GO:0051146; GO:1903860 JNK cascade [GO:0007254]; lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase p38 binding [GO:0048273]; signaling receptor complex adaptor activity [GO:0030159] g972.t3 Q58A65 50.555 1351 0.0 1200.0 sp|Q58A65|JIP4_MOUSE C-Jun-amino-terminal kinase-interacting protein 4 OS=Mus musculus OX=10090 GN=Spag9 PE=1 SV=2 JIP4_MOUSE reviewed C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (JNK-associated leucine-zipper protein) (JLP) (JNK/SAPK-associated protein 2) (JSAP2) (Mitogen-activated protein kinase 8-interacting protein 4) (Sperm-associated antigen 9) Mus musculus (Mouse) GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0043410; GO:0045665; GO:0045666; GO:0048273; GO:0048471; GO:0051146; GO:1903860 JNK cascade [GO:0007254]; lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase p38 binding [GO:0048273]; signaling receptor complex adaptor activity [GO:0030159] g973.t1 Q9DGG6 39.686 1212 0.0 795.0 sp|Q9DGG6|ADCY9_CHICK Adenylate cyclase type 9 OS=Gallus gallus OX=9031 GN=ADCY9 PE=1 SV=1 g974.t1 Q6JHU9 68.293 820 0.0 1165.0 sp|Q6JHU9|CBP_RAT Histone lysine acetyltransferase CREBBP OS=Rattus norvegicus OX=10116 GN=Crebbp PE=1 SV=1 CBP_RAT reviewed Histone lysine acetyltransferase CREBBP (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-) Rattus norvegicus (Rat) GO:0000122; GO:0000123; GO:0000724; GO:0000785; GO:0000940; GO:0000977; GO:0001093; GO:0001223; GO:0002039; GO:0002931; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007249; GO:0007616; GO:0008140; GO:0008270; GO:0010628; GO:0016407; GO:0016479; GO:0016604; GO:0019904; GO:0030511; GO:0030718; GO:0031490; GO:0031648; GO:0031669; GO:0032688; GO:0032991; GO:0034644; GO:0035729; GO:0042975; GO:0043426; GO:0043993; GO:0044017; GO:0044877; GO:0045893; GO:0045944; GO:0046332; GO:0048148; GO:0048511; GO:0048525; GO:0050821; GO:0060090; GO:0060325; GO:0060355; GO:0060999; GO:0061629; GO:0061733; GO:0070555; GO:0071108; GO:0090575; GO:0097009; GO:0097718; GO:0098586; GO:0120300; GO:0140297; GO:1900087; GO:1900182; GO:1901224; GO:1905168 behavioral response to cocaine [GO:0048148]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; double-strand break repair via homologous recombination [GO:0000724]; energy homeostasis [GO:0097009]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; long-term memory [GO:0007616]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein destabilization [GO:0031648]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; rhythmic process [GO:0048511] chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] acetyltransferase activity [GO:0016407]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; molecular adaptor activity [GO:0060090]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g974.t1 Q6JHU9 56.215 354 1.78e-84 314.0 sp|Q6JHU9|CBP_RAT Histone lysine acetyltransferase CREBBP OS=Rattus norvegicus OX=10116 GN=Crebbp PE=1 SV=1 CBP_RAT reviewed Histone lysine acetyltransferase CREBBP (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-) Rattus norvegicus (Rat) GO:0000122; GO:0000123; GO:0000724; GO:0000785; GO:0000940; GO:0000977; GO:0001093; GO:0001223; GO:0002039; GO:0002931; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007249; GO:0007616; GO:0008140; GO:0008270; GO:0010628; GO:0016407; GO:0016479; GO:0016604; GO:0019904; GO:0030511; GO:0030718; GO:0031490; GO:0031648; GO:0031669; GO:0032688; GO:0032991; GO:0034644; GO:0035729; GO:0042975; GO:0043426; GO:0043993; GO:0044017; GO:0044877; GO:0045893; GO:0045944; GO:0046332; GO:0048148; GO:0048511; GO:0048525; GO:0050821; GO:0060090; GO:0060325; GO:0060355; GO:0060999; GO:0061629; GO:0061733; GO:0070555; GO:0071108; GO:0090575; GO:0097009; GO:0097718; GO:0098586; GO:0120300; GO:0140297; GO:1900087; GO:1900182; GO:1901224; GO:1905168 behavioral response to cocaine [GO:0048148]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; double-strand break repair via homologous recombination [GO:0000724]; energy homeostasis [GO:0097009]; face morphogenesis [GO:0060325]; germ-line stem cell population maintenance [GO:0030718]; long-term memory [GO:0007616]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral process [GO:0048525]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein destabilization [GO:0031648]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; rhythmic process [GO:0048511] chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] acetyltransferase activity [GO:0016407]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; molecular adaptor activity [GO:0060090]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g976.t1 Q9ESL4 39.683 252 1.1299999999999999e-41 166.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g980.t1 P79942 49.848 329 7.970000000000001e-110 330.0 sp|P79942|NOCT_XENLA Nocturnin OS=Xenopus laevis OX=8355 GN=noct PE=2 SV=1 g981.t1 B2GV77 37.956 137 7.280000000000001e-29 104.0 sp|B2GV77|NXT2_RAT NTF2-related export protein 2 OS=Rattus norvegicus OX=10116 GN=Nxt2 PE=2 SV=1 g982.t1 Q2KIK0 49.0 200 1.14e-55 182.0 sp|Q2KIK0|SGT1_BOVIN Protein SGT1 homolog OS=Bos taurus OX=9913 GN=SUGT1 PE=2 SV=1 g983.t1 Q14517 34.831 267 4.19e-29 129.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 36.523 1024 0.0 635.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 31.111 585 5.3e-65 244.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 28.391 634 1.69e-53 208.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 29.279 666 1.37e-51 202.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 27.104 701 2.3599999999999998e-48 192.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 28.834 652 2.88e-48 192.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 27.198 728 1.71e-47 189.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 28.814 708 4.41e-44 179.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 27.669 665 1.74e-41 170.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 27.534 661 2.42e-38 160.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 25.557 673 3.94e-34 146.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 26.723 595 2.32e-33 144.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 27.223 551 2.39e-31 137.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g984.t1 Q14517 26.212 557 3.5e-28 127.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g985.t1 Q14517 35.747 221 2.69e-33 130.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g985.t1 Q14517 33.333 225 6.730000000000001e-21 95.1 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 48.841 604 2.14e-168 537.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 29.874 636 2.09e-62 229.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 28.974 604 3.0099999999999998e-52 198.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 27.804 633 1.73e-51 196.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 27.987 636 3.9900000000000002e-50 192.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 27.695 603 2.08e-49 190.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 26.448 639 8.47e-46 179.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 29.317 498 1.1599999999999999e-41 166.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 26.023 611 1.02e-36 151.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 27.08 613 1.28e-34 145.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 24.224 644 3.27e-24 112.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 26.276 392 2.31e-22 106.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g987.t1 Q14517 27.763 389 7.030000000000001e-21 102.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 41.839 1697 0.0 1192.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 28.58 1627 9.219999999999999e-128 450.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 28.151 1563 1.07e-113 406.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 26.517 1648 2.88e-110 395.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 26.74 1724 3.1299999999999994e-104 376.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 27.846 1379 5.100000000000001e-103 372.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 25.588 1700 2.52e-96 351.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 27.605 1315 5.78e-91 334.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t1 Q14517 26.222 1064 1.24e-55 219.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 42.04 1696 0.0 1197.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 28.387 1624 3.06e-131 460.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 26.626 1645 3.35e-110 395.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 26.856 1724 8.7e-105 378.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 26.07 1565 5.97e-96 350.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 28.082 1314 2.05e-95 348.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 25.517 1693 1.1899999999999999e-94 345.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 31.424 646 2.8000000000000002e-70 266.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 26.246 1063 5.21e-55 217.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 26.947 809 1.2999999999999999e-46 189.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g988.t2 Q14517 27.599 558 3.4599999999999998e-34 148.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g990.t1 Q94738 59.235 758 0.0 900.0 sp|Q94738|HSP97_MESFR 97 kDa heat shock protein OS=Mesocentrotus franciscanus OX=1328066 GN=HSP110 PE=2 SV=1 g991.t1 P61087 63.317 199 3.3e-80 240.0 sp|P61087|UBE2K_MOUSE Ubiquitin-conjugating enzyme E2 K OS=Mus musculus OX=10090 GN=Ube2k PE=1 SV=3 UBE2K_MOUSE reviewed Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase) Mus musculus (Mouse) GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0010994; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0060337; GO:0060340; GO:0061631; GO:0070059; GO:0070936; GO:1903265 cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g992.t1 Q5XGI0 89.623 318 0.0 596.0 sp|Q5XGI0|PRPS2_XENTR Ribose-phosphate pyrophosphokinase 2 OS=Xenopus tropicalis OX=8364 GN=prps2 PE=2 SV=1 PRPS2_XENTR reviewed Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000287; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0009156; GO:0016301; GO:0042803 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156] cytoplasm [GO:0005737] ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749] g994.t1 Q96PE3 34.068 998 1.1e-177 550.0 sp|Q96PE3|INP4A_HUMAN Inositol polyphosphate-4-phosphatase type I A OS=Homo sapiens OX=9606 GN=INPP4A PE=1 SV=1 g994.t2 Q96PE3 34.321 979 4.76e-180 556.0 sp|Q96PE3|INP4A_HUMAN Inositol polyphosphate-4-phosphatase type I A OS=Homo sapiens OX=9606 GN=INPP4A PE=1 SV=1 g995.t1 O95714 56.114 4997 0.0 5269.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g995.t2 O95714 56.796 4944 0.0 5308.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 54.979 1195 0.0 1213.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 66.957 345 7.94e-136 464.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 40.449 445 6.31e-83 304.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 54.506 233 6.410000000000001e-70 263.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 38.154 325 5.44e-56 218.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 44.017 234 1.21e-51 204.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 39.316 234 1.75e-36 155.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 34.643 280 8.27e-35 149.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 37.5 240 2.47e-32 141.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 33.913 230 7.47e-30 133.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g996.t1 Q4U2R1 33.043 230 1.1100000000000001e-21 106.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g997.t1 O95714 80.172 116 2.05e-57 194.0 sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2 HERC2_HUMAN reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Homo sapiens (Human) GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0050821; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g998.t1 Q4U2R1 80.07 286 5.100000000000001e-156 485.0 sp|Q4U2R1|HERC2_MOUSE E3 ubiquitin-protein ligase HERC2 OS=Mus musculus OX=10090 GN=Herc2 PE=1 SV=3 HERC2_MOUSE reviewed E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886] SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g999.t1 Q5ZLF0 47.717 438 9.3e-120 357.0 sp|Q5ZLF0|F10A1_CHICK Hsc70-interacting protein OS=Gallus gallus OX=9031 GN=ST13 PE=2 SV=1 F10A1_CHICK reviewed Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog) Gallus gallus (Chicken) GO:0005737; GO:0030544; GO:0046983 cytoplasm [GO:0005737] Hsp70 protein binding [GO:0030544]; protein dimerization activity [GO:0046983] g1000.t1 Q16589 33.651 315 8.41e-51 176.0 sp|Q16589|CCNG2_HUMAN Cyclin-G2 OS=Homo sapiens OX=9606 GN=CCNG2 PE=1 SV=1 g1003.t1 Q5R4U0 39.13 299 2.06e-70 224.0 sp|Q5R4U0|CAH10_PONAB Carbonic anhydrase-related protein 10 OS=Pongo abelii OX=9601 GN=CA10 PE=2 SV=1 g1004.t1 D4A666 38.779 606 2.11e-99 348.0 sp|D4A666|UBN2_RAT Ubinuclein-2 OS=Rattus norvegicus OX=10116 GN=Ubn2 PE=1 SV=1 g1005.t1 A0A0R4IWG9 56.667 240 1.81e-87 291.0 sp|A0A0R4IWG9|GCNA_DANRE Germ cell nuclear acidic protein OS=Danio rerio OX=7955 GN=gcna PE=3 SV=1 g1006.t1 A1L1C7 60.245 571 0.0 676.0 sp|A1L1C7|PAN3_XENTR PAN2-PAN3 deadenylation complex subunit pan3 OS=Xenopus tropicalis OX=8364 GN=pan3 PE=2 SV=1 PAN3_XENTR reviewed PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000289; GO:0000932; GO:0004672; GO:0005524; GO:0006397; GO:0008143; GO:0008270; GO:0010606; GO:0031251 mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] P-body [GO:0000932]; PAN complex [GO:0031251] ATP binding [GO:0005524]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270] g1008.t1 Q3ZBE9 66.366 333 9.360000000000001e-173 486.0 sp|Q3ZBE9|NSDHL_BOVIN Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating OS=Bos taurus OX=9913 GN=NSDHL PE=2 SV=1 NSDHL_BOVIN reviewed Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (EC 1.1.1.170) Bos taurus (Bovine) GO:0005783; GO:0005789; GO:0005811; GO:0006695; GO:0008203; GO:0016616; GO:0102175 cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] 3-beta-hydroxysteroid dehydrogenase (NAD+)/C4-decarboxylase activity [GO:0102175]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616] g1009.t1 Q9R1K9 82.558 172 3.23e-97 281.0 sp|Q9R1K9|CETN2_MOUSE Centrin-2 OS=Mus musculus OX=10090 GN=Cetn2 PE=1 SV=1 CETN2_MOUSE reviewed Centrin-2 (Caltractin isoform 1) Mus musculus (Mouse) GO:0000226; GO:0005509; GO:0005634; GO:0005813; GO:0005814; GO:0005929; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0045177; GO:0051028; GO:0051301; GO:0070390; GO:0071942; GO:0097729 cell division [GO:0051301]; centriole replication [GO:0007099]; microtubule cytoskeleton organization [GO:0000226]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283] 9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942] calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017] g1010.t1 Q92870 48.571 455 1.48e-138 433.0 sp|Q92870|APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 OS=Homo sapiens OX=9606 GN=APBB2 PE=1 SV=3 APBB2_HUMAN reviewed Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1) Homo sapiens (Human) GO:0000122; GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0007411; GO:0016020; GO:0030027; GO:0030198; GO:0030426; GO:0035556; GO:0036438; GO:0043065; GO:0043066; GO:0045202; GO:0045944; GO:0050808; GO:0060090; GO:1901988 axon guidance [GO:0007411]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202] amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090] g1011.t1 Q08890 47.628 548 8.75e-174 506.0 sp|Q08890|IDS_MOUSE Iduronate 2-sulfatase OS=Mus musculus OX=10090 GN=Ids PE=2 SV=3 IDS_MOUSE reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) Mus musculus (Mouse) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0008484; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484] g1012.t1 A2A3V2 47.692 325 2.33e-103 309.0 sp|A2A3V2|S2543_MOUSE Solute carrier family 25 member 43 OS=Mus musculus OX=10090 GN=Slc25a43 PE=2 SV=1 g1013.t1 Q9NUQ7 45.824 467 1.5700000000000002e-144 430.0 sp|Q9NUQ7|UFSP2_HUMAN Ufm1-specific protease 2 OS=Homo sapiens OX=9606 GN=UFSP2 PE=1 SV=3 UFSP2_HUMAN reviewed Ufm1-specific protease 2 (UfSP2) (EC 3.4.22.-) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0032649; GO:0032790; GO:0033146; GO:0071567; GO:0072344; GO:1903051 negative regulation of proteolysis involved in protein catabolic process [GO:1903051]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of type II interferon production [GO:0032649]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] deUFMylase activity [GO:0071567] g1014.t1 Q9Z255 89.404 151 1.44e-101 290.0 sp|Q9Z255|UBE2A_MOUSE Ubiquitin-conjugating enzyme E2 A OS=Mus musculus OX=10090 GN=Ube2a PE=1 SV=1 UBE2A_MOUSE reviewed Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (mHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A) Mus musculus (Mouse) GO:0000086; GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0001835; GO:0004842; GO:0005524; GO:0005764; GO:0005770; GO:0006281; GO:0006338; GO:0009411; GO:0016567; GO:0031625; GO:0033503; GO:0043161; GO:0060135; GO:0061631; GO:0070936; GO:0070979; GO:1901526 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of mitophagy [GO:1901526]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411] chromatin [GO:0000785]; HULC complex [GO:0033503]; late endosome [GO:0005770]; lysosome [GO:0005764]; XY body [GO:0001741] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g1015.t1 Q9EPN1 60.486 658 0.0 864.0 sp|Q9EPN1|NBEA_MOUSE Neurobeachin OS=Mus musculus OX=10090 GN=Nbea PE=1 SV=1 NBEA_MOUSE reviewed Neurobeachin (Lysosomal-trafficking regulator 2) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005802; GO:0005829; GO:0005886; GO:0006605; GO:0006892; GO:0008104; GO:0012505; GO:0016020; GO:0019901; GO:0045211; GO:0050808; GO:0051018; GO:0061484; GO:0098696; GO:0098890; GO:0098978; GO:0098982; GO:0099192 hematopoietic stem cell homeostasis [GO:0061484]; intracellular protein localization [GO:0008104]; post-Golgi vesicle-mediated transport [GO:0006892]; protein targeting [GO:0006605]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; synapse organization [GO:0050808] cerebellar Golgi cell to granule cell synapse [GO:0099192]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extrinsic component of postsynaptic membrane [GO:0098890]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t1 Q9ESE1 64.052 1071 0.0 1492.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t1 Q9ESE1 43.519 432 1.02e-86 321.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t1 Q9ESE1 39.785 372 6.26e-64 246.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t2 Q9ESE1 64.052 1071 0.0 1492.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t2 Q9ESE1 43.519 432 1.21e-86 321.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t2 Q9ESE1 39.267 382 6.77e-62 239.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t3 Q9ESE1 64.0 1075 0.0 1493.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t3 Q9ESE1 43.519 432 1.05e-86 321.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1016.t3 Q9ESE1 39.267 382 6.46e-62 240.0 sp|Q9ESE1|LRBA_MOUSE Lipopolysaccharide-responsive and beige-like anchor protein OS=Mus musculus OX=10090 GN=Lrba PE=1 SV=1 LRBA_MOUSE reviewed Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) Mus musculus (Mouse) GO:0000423; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0016020; GO:0016197; GO:0019901; GO:0031410; GO:0034497; GO:0051018; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901] g1018.t1 A4IIW0 80.278 360 0.0 613.0 sp|A4IIW0|MB212_XENTR Protein mab-21-like 2 OS=Xenopus tropicalis OX=8364 GN=mab21l2 PE=2 SV=1 g1020.t1 Q96RY5 38.603 272 1.74e-52 205.0 sp|Q96RY5|CRML_HUMAN Protein cramped-like OS=Homo sapiens OX=9606 GN=CRAMP1 PE=1 SV=3 CRML_HUMAN reviewed Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein) Homo sapiens (Human) GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0007389; GO:0035363; GO:0045893 pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893] histone locus body [GO:0035363]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] g1020.t2 Q96RY5 38.603 272 1.4899999999999999e-52 205.0 sp|Q96RY5|CRML_HUMAN Protein cramped-like OS=Homo sapiens OX=9606 GN=CRAMP1 PE=1 SV=3 CRML_HUMAN reviewed Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein) Homo sapiens (Human) GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0007389; GO:0035363; GO:0045893 pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893] histone locus body [GO:0035363]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] g1021.t1 Q9ULJ7 56.547 1222 0.0 1354.0 sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4 g1022.t1 Q03442 40.125 319 2.48e-73 232.0 sp|Q03442|CRJ1A_TRICY Crystallin J1A OS=Tripedalia cystophora OX=6141 PE=1 SV=1 g1024.t1 Q03442 39.048 315 4.8100000000000006e-73 231.0 sp|Q03442|CRJ1A_TRICY Crystallin J1A OS=Tripedalia cystophora OX=6141 PE=1 SV=1 g1025.t1 Q7Z2H8 43.902 451 9.25e-121 365.0 sp|Q7Z2H8|S36A1_HUMAN Proton-coupled amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC36A1 PE=1 SV=1 S36A1_HUMAN reviewed Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1) Homo sapiens (Human) GO:0005280; GO:0005297; GO:0005765; GO:0005774; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015411; GO:0015734; GO:0015808; GO:0015816; GO:0015824; GO:0016324; GO:0022858; GO:0032328; GO:0035524; GO:0089718; GO:1902600 alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; monoatomic ion transport [GO:0006811]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; taurine transmembrane transport [GO:0015734] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] ABC-type taurine transporter transporter activity [GO:0015411]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297] g1025.t2 Q7Z2H8 43.902 451 6.16e-121 366.0 sp|Q7Z2H8|S36A1_HUMAN Proton-coupled amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC36A1 PE=1 SV=1 S36A1_HUMAN reviewed Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1) Homo sapiens (Human) GO:0005280; GO:0005297; GO:0005765; GO:0005774; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015171; GO:0015180; GO:0015187; GO:0015193; GO:0015411; GO:0015734; GO:0015808; GO:0015816; GO:0015824; GO:0016324; GO:0022858; GO:0032328; GO:0035524; GO:0089718; GO:1902600 alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; monoatomic ion transport [GO:0006811]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; taurine transmembrane transport [GO:0015734] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] ABC-type taurine transporter transporter activity [GO:0015411]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297] g1026.t1 O60264 77.522 1001 0.0 1551.0 sp|O60264|SMCA5_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Homo sapiens OX=9606 GN=SMARCA5 PE=1 SV=1 SMCA5_HUMAN reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H) Homo sapiens (Human) GO:0000183; GO:0000785; GO:0000793; GO:0001650; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005730; GO:0006275; GO:0006281; GO:0006325; GO:0006334; GO:0006338; GO:0006346; GO:0006352; GO:0006355; GO:0006357; GO:0006974; GO:0008623; GO:0016479; GO:0016589; GO:0016590; GO:0016887; GO:0031213; GO:0031491; GO:0031507; GO:0035861; GO:0045740; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0090536; GO:0090537; GO:0110016; GO:0140374; GO:0140658; GO:0140750; GO:0140751; GO:1905213; GO:1990830 antiviral innate immune response [GO:0140374]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; DNA-templated transcription initiation [GO:0006352]; heterochromatin formation [GO:0031507]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin formation [GO:0000183]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CERF complex [GO:0090537]; CHRAC [GO:0008623]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; site of double-strand break [GO:0035861]; WICH complex [GO:0090535] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone octamer slider activity [GO:0140751]; nucleosome array spacer activity [GO:0140750]; nucleosome binding [GO:0031491] g1027.t1 P52948 46.319 326 4.86e-44 170.0 sp|P52948|NUP98_HUMAN Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens OX=9606 GN=NUP98 PE=1 SV=4 NUP98_HUMAN reviewed Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Homo sapiens (Human) GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006508; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042405; GO:0044614; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:0140693; GO:1990841; GO:1990904 mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713] g1027.t2 P52948 46.319 326 4.56e-44 170.0 sp|P52948|NUP98_HUMAN Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens OX=9606 GN=NUP98 PE=1 SV=4 NUP98_HUMAN reviewed Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Homo sapiens (Human) GO:0000973; GO:0003713; GO:0003723; GO:0003729; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006508; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034398; GO:0034399; GO:0042405; GO:0044614; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:0140693; GO:1990841; GO:1990904 mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713] g1028.t1 Q6NRJ7 66.851 181 5.5399999999999996e-92 268.0 sp|Q6NRJ7|MCS1B_XENLA Malignant T-cell-amplified sequence 1-B OS=Xenopus laevis OX=8355 GN=mcts1-b PE=2 SV=1 g1029.t1 Q3LSS0 40.855 1006 0.0 631.0 sp|Q3LSS0|C19L2_DANRE CWF19-like protein 2 OS=Danio rerio OX=7955 GN=cwf19l2 PE=2 SV=1 g1030.t1 Q0P4I1 45.161 124 2.2700000000000003e-31 129.0 sp|Q0P4I1|CEP44_XENTR Centrosomal protein of 44 kDa OS=Xenopus tropicalis OX=8364 GN=cep44 PE=2 SV=1 g1031.t1 Q9QZN3 50.0 252 1.9800000000000002e-80 248.0 sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2 g1032.t1 P57102 46.89 209 8.68e-48 159.0 sp|P57102|HAND2_DANRE Heart- and neural crest derivatives-expressed protein 2 OS=Danio rerio OX=7955 GN=hand2 PE=2 SV=1 HAND2_DANRE reviewed Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0005634; GO:0006357; GO:0007507; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0039008; GO:0046983; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908; GO:0072015; GO:0072158 cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; podocyte development [GO:0072015]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; pronephric nephron tubule morphogenesis [GO:0039008]; proximal tubule morphogenesis [GO:0072158]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g1033.t1 Q6IFT6 27.93 802 3.03e-75 269.0 sp|Q6IFT6|ANO7_RAT Anoctamin-7 OS=Rattus norvegicus OX=10116 GN=Ano7 PE=2 SV=1 ANO7_RAT reviewed Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G) Rattus norvegicus (Rat) GO:0005229; GO:0005254; GO:0005634; GO:0005783; GO:0005886; GO:0006821; GO:0017128; GO:0046983; GO:0051649; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476 calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] g1034.t1 Q90744 54.404 386 2.9799999999999998e-165 472.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g1035.t1 Q90744 55.125 361 4.47e-149 436.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g1035.t2 Q90744 57.267 344 2.84e-150 440.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g1036.t1 Q90744 49.482 386 3.38e-146 424.0 sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1 NAGAB_CHICK reviewed Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B) Gallus gallus (Chicken) GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016020; GO:0016139; GO:0019377 glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456] g1037.t1 Q502W6 38.676 1042 0.0 716.0 sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3 VWA3B_HUMAN reviewed von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B) Homo sapiens (Human) GO:0005654; GO:0005829 cytosol [GO:0005829]; nucleoplasm [GO:0005654] g1038.t1 P33402 38.515 431 4.1299999999999996e-83 275.0 sp|P33402|GCYA2_HUMAN Guanylate cyclase soluble subunit alpha-2 OS=Homo sapiens OX=9606 GN=GUCY1A2 PE=1 SV=1 GCYA2_HUMAN reviewed Guanylate cyclase soluble subunit alpha-2 (GCS-alpha-2) (EC 4.6.1.2) Homo sapiens (Human) GO:0004383; GO:0005525; GO:0005829; GO:0007165; GO:0007263; GO:0008074; GO:0010750; GO:0019934; GO:0020037; GO:0070482 cGMP-mediated signaling [GO:0019934]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; response to oxygen levels [GO:0070482]; signal transduction [GO:0007165] cytosol [GO:0005829]; guanylate cyclase complex, soluble [GO:0008074] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037] g1039.t1 Q4ZHS0 62.577 163 2.46e-66 217.0 sp|Q4ZHS0|GCYA1_CANLF Guanylate cyclase soluble subunit alpha-1 OS=Canis lupus familiaris OX=9615 GN=GUCY1A1 PE=2 SV=1 g1040.t1 P16068 62.197 619 0.0 798.0 sp|P16068|GCYB1_BOVIN Guanylate cyclase soluble subunit beta-1 OS=Bos taurus OX=9913 GN=GUCY1B1 PE=1 SV=1 GCYB1_BOVIN reviewed Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit) Bos taurus (Bovine) GO:0004383; GO:0005525; GO:0005737; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0038060; GO:0046872; GO:0070482; GO:0071732 cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482] cytoplasm [GO:0005737]; guanylate cyclase complex, soluble [GO:0008074] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872] g1041.t1 Q5NVE1 51.007 298 5.9e-94 283.0 sp|Q5NVE1|ADPPT_PONAB L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase OS=Pongo abelii OX=9601 GN=AASDHPPT PE=2 SV=1 g1042.t1 Q761V0 42.07 744 0.0 592.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g1043.t1 Q5ZLC6 47.321 224 7.51e-57 194.0 sp|Q5ZLC6|ANR10_CHICK Ankyrin repeat domain-containing protein 10 OS=Gallus gallus OX=9031 GN=ANKRD10 PE=2 SV=1 g1043.t2 Q5ZLC6 45.455 253 1.01e-57 194.0 sp|Q5ZLC6|ANR10_CHICK Ankyrin repeat domain-containing protein 10 OS=Gallus gallus OX=9031 GN=ANKRD10 PE=2 SV=1 g1045.t1 Q8BW70 48.219 421 2.9e-129 415.0 sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2 UBP38_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38) Mus musculus (Mouse) GO:0000082; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0031647; GO:0032435; GO:0043161; GO:0045824; GO:0070936; GO:0140374; GO:1990168 antiviral innate immune response [GO:0140374]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g1045.t1 Q8BW70 35.683 227 3.48e-24 112.0 sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2 UBP38_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38) Mus musculus (Mouse) GO:0000082; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0031647; GO:0032435; GO:0043161; GO:0045824; GO:0070936; GO:0140374; GO:1990168 antiviral innate immune response [GO:0140374]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of innate immune response [GO:0045824]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g1046.t1 Q9P2H5 49.64 139 3.3500000000000002e-21 92.8 sp|Q9P2H5|UBP35_HUMAN Ubiquitin carboxyl-terminal hydrolase 35 OS=Homo sapiens OX=9606 GN=USP35 PE=1 SV=3 UBP35_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 35 (EC 3.4.19.12) (Deubiquitinating enzyme 35) (Ubiquitin thioesterase 35) (Ubiquitin-specific-processing protease 35) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005739; GO:0005829; GO:0006508; GO:0016579; GO:0031647 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g1047.t1 P49793 40.061 1972 0.0 1164.0 sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2 g1047.t2 P49793 39.959 1972 0.0 1160.0 sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2 g1047.t3 P49793 40.061 1972 0.0 1165.0 sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2 g1050.t1 Q04671 60.349 459 0.0 557.0 sp|Q04671|P_HUMAN P protein OS=Homo sapiens OX=9606 GN=OCA2 PE=1 SV=2 P_HUMAN reviewed P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog) Homo sapiens (Human) GO:0005254; GO:0005765; GO:0005789; GO:0006583; GO:0007286; GO:0008283; GO:0010008; GO:0030318; GO:0033162; GO:0035752; GO:0042438 cell population proliferation [GO:0008283]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process [GO:0042438]; melanin biosynthetic process from tyrosine [GO:0006583]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286] endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162] chloride channel activity [GO:0005254] g1051.t1 Q8BZ39 27.049 366 1.76e-22 101.0 sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1 NMUR2_MOUSE reviewed Neuromedin-U receptor 2 (NMU-R2) Mus musculus (Mouse) GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930 arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g1053.t1 Q9WTN3 46.404 862 0.0 638.0 sp|Q9WTN3|SRBP1_MOUSE Sterol regulatory element-binding protein 1 OS=Mus musculus OX=10090 GN=Srebf1 PE=1 SV=4 SRBP1_MOUSE reviewed Sterol regulatory element-binding protein 1 (SREBP-1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)] Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0006355; GO:0006357; GO:0007584; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009410; GO:0009749; GO:0009750; GO:0010867; GO:0012507; GO:0016020; GO:0019217; GO:0019901; GO:0030324; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032933; GO:0032991; GO:0033762; GO:0042789; GO:0043565; GO:0044877; GO:0045089; GO:0045444; GO:0045471; GO:0045542; GO:0045723; GO:0045893; GO:0045944; GO:0046676; GO:0046889; GO:0046983; GO:0050796; GO:0051591; GO:0071398; GO:0090209; GO:1901524; GO:1902895; GO:1903214; GO:1990837 cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of innate immune response [GO:0045089]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of DNA-templated transcription [GO:0006355]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of insulin secretion [GO:0050796]; regulation of mitophagy [GO:1901524]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to fructose [GO:0009750]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221] g1054.t1 O08623 31.809 503 4.1e-61 209.0 sp|O08623|SQSTM_RAT Sequestosome-1 OS=Rattus norvegicus OX=10116 GN=Sqstm1 PE=1 SV=1 g1055.t1 Q32NR4 39.54 435 2.92e-94 296.0 sp|Q32NR4|TTC29_XENLA Tetratricopeptide repeat protein 29 OS=Xenopus laevis OX=8355 GN=ttc29 PE=2 SV=1 g1056.t1 Q9NP73 44.744 371 1.25e-94 330.0 sp|Q9NP73|ALG13_HUMAN UDP-N-acetylglucosamine transferase subunit ALG13 OS=Homo sapiens OX=9606 GN=ALG13 PE=1 SV=2 ALG13_HUMAN reviewed UDP-N-acetylglucosamine transferase subunit ALG13 (EC 2.4.1.141) (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) Homo sapiens (Human) GO:0004577; GO:0005789; GO:0006487; GO:0006488; GO:0006508; GO:0008234; GO:0043541; GO:0098554 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; proteolysis [GO:0006508] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; UDP-N-acetylglucosamine transferase complex [GO:0043541] cysteine-type peptidase activity [GO:0008234]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577] g1056.t2 Q9NP73 43.666 371 5.57e-91 319.0 sp|Q9NP73|ALG13_HUMAN UDP-N-acetylglucosamine transferase subunit ALG13 OS=Homo sapiens OX=9606 GN=ALG13 PE=1 SV=2 ALG13_HUMAN reviewed UDP-N-acetylglucosamine transferase subunit ALG13 (EC 2.4.1.141) (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) Homo sapiens (Human) GO:0004577; GO:0005789; GO:0006487; GO:0006488; GO:0006508; GO:0008234; GO:0043541; GO:0098554 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; proteolysis [GO:0006508] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; UDP-N-acetylglucosamine transferase complex [GO:0043541] cysteine-type peptidase activity [GO:0008234]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577] g1058.t1 P61222 81.5 600 0.0 1042.0 sp|P61222|ABCE1_MOUSE ATP-binding cassette sub-family E member 1 OS=Mus musculus OX=10090 GN=Abce1 PE=1 SV=1 ABCE1_MOUSE reviewed ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (EC 3.6.5.-) (Ribonuclease 4 inhibitor) (RNS4I) Mus musculus (Mouse) GO:0003924; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006415; GO:0006417; GO:0016887; GO:0017111; GO:0022626; GO:0032790; GO:0043024; GO:0043273; GO:0051539; GO:0060698; GO:0071569; GO:0072344; GO:0140708; GO:1990116 CAT tailing [GO:0140708]; protein ufmylation [GO:0071569]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; translational initiation [GO:0006413]; translational termination [GO:0006415] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; mitochondrion [GO:0005739] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; endoribonuclease inhibitor activity [GO:0060698]; GTPase activity [GO:0003924]; iron ion binding [GO:0005506]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024] g1059.t1 Q8CCA0 61.475 244 1.14e-104 307.0 sp|Q8CCA0|DCNL4_MOUSE DCN1-like protein 4 OS=Mus musculus OX=10090 GN=Dcun1d4 PE=2 SV=1 g1060.t1 Q27802 73.387 744 0.0 1174.0 sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2 g1061.t1 Q27802 73.276 348 6.11e-176 545.0 sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2 g1062.t1 Q27802 79.13 3196 0.0 5294.0 sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2 g1062.t2 Q27802 79.193 3196 0.0 5306.0 sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2 g1063.t1 A6H7B8 39.592 245 6.06e-54 177.0 sp|A6H7B8|PGAP2_BOVIN Acyltransferase PGAP2 OS=Bos taurus OX=9913 GN=PGAP2 PE=2 SV=1 PGAP2_BOVIN reviewed Acyltransferase PGAP2 (EC 2.3.-.-) (Post-GPI attachment to proteins factor 2) Bos taurus (Bovine) GO:0000139; GO:0005789; GO:0006506; GO:0016740 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] transferase activity [GO:0016740] g1064.t1 Q05086 56.414 764 0.0 868.0 sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4 UBE3A_HUMAN reviewed Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54) Homo sapiens (Human) GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058 androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021] transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g1070.t1 Q6Q2C2 47.016 553 0.0 546.0 sp|Q6Q2C2|HYES_PIG Bifunctional epoxide hydrolase 2 OS=Sus scrofa OX=9823 GN=EPHX2 PE=2 SV=1 g1071.t1 P34913 46.76 571 0.0 532.0 sp|P34913|HYES_HUMAN Bifunctional epoxide hydrolase 2 OS=Homo sapiens OX=9606 GN=EPHX2 PE=1 SV=2 HYES_HUMAN reviewed Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)] Homo sapiens (Human) GO:0000287; GO:0001558; GO:0004301; GO:0005777; GO:0005782; GO:0005829; GO:0009636; GO:0010628; GO:0015643; GO:0016311; GO:0016791; GO:0033885; GO:0042577; GO:0042632; GO:0042803; GO:0046272; GO:0046839; GO:0052642; GO:0070062; GO:0090181; GO:0097176 cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cell growth [GO:0001558]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] g1076.t1 G3V9R3 42.403 283 1.34e-68 218.0 sp|G3V9R3|ST1D1_RAT Sulfotransferase 1 family member D1 OS=Rattus norvegicus OX=10116 GN=Sult1d1 PE=2 SV=1 g1077.t1 Q6ZV65 30.933 375 1.33e-39 149.0 sp|Q6ZV65|FA47E_HUMAN Protein FAM47E OS=Homo sapiens OX=9606 GN=FAM47E PE=1 SV=3 FA47E_HUMAN reviewed Protein FAM47E Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0045815; GO:0071168 protein localization to chromatin [GO:0071168]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] enzyme activator activity [GO:0008047] g1080.t1 O54834 39.683 504 1.15e-86 305.0 sp|O54834|RHG06_MOUSE Rho GTPase-activating protein 6 OS=Mus musculus OX=10090 GN=Arhgap6 PE=1 SV=3 g1080.t2 O54834 37.594 532 8.3e-82 291.0 sp|O54834|RHG06_MOUSE Rho GTPase-activating protein 6 OS=Mus musculus OX=10090 GN=Arhgap6 PE=1 SV=3 g1080.t3 O54834 37.594 532 8.3e-82 291.0 sp|O54834|RHG06_MOUSE Rho GTPase-activating protein 6 OS=Mus musculus OX=10090 GN=Arhgap6 PE=1 SV=3 g1083.t1 Q9IA76 77.966 118 1.78e-65 197.0 sp|Q9IA76|RL31_PAROL Large ribosomal subunit protein eL31 OS=Paralichthys olivaceus OX=8255 GN=rpl31 PE=2 SV=1 g1084.t1 Q16534 50.826 242 7.020000000000001e-70 221.0 sp|Q16534|HLF_HUMAN Hepatic leukemia factor OS=Homo sapiens OX=9606 GN=HLF PE=1 SV=1 HLF_HUMAN reviewed Hepatic leukemia factor Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0006357; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:0090575; GO:1990837 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g1084.t2 Q8BW74 49.206 252 1.2800000000000001e-70 223.0 sp|Q8BW74|HLF_MOUSE Hepatic leukemia factor OS=Mus musculus OX=10090 GN=Hlf PE=2 SV=1 g1085.t1 O95164 70.0 120 8.170000000000001e-56 172.0 sp|O95164|UBL3_HUMAN Ubiquitin-like protein 3 OS=Homo sapiens OX=9606 GN=UBL3 PE=1 SV=1 g1086.t1 Q6ZWJ1 35.815 497 2.34e-88 294.0 sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2 STXB4_HUMAN reviewed Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip) Homo sapiens (Human) GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808 cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335] syntaxin binding [GO:0019905] g1086.t2 Q6ZWJ1 36.795 443 2.2e-88 293.0 sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2 STXB4_HUMAN reviewed Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip) Homo sapiens (Human) GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808 cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335] syntaxin binding [GO:0019905] g1086.t3 Q6ZWJ1 35.815 497 2.1600000000000002e-88 294.0 sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2 STXB4_HUMAN reviewed Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip) Homo sapiens (Human) GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808 cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335] syntaxin binding [GO:0019905] g1088.t1 Q1XA76 30.905 453 1.8999999999999998e-68 231.0 sp|Q1XA76|ASIC1_CHICK Acid-sensing ion channel 1 OS=Gallus gallus OX=9031 GN=ASIC1 PE=1 SV=1 ASIC1_CHICK reviewed Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) Gallus gallus (Chicken) GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0042802; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; pH-gated monoatomic ion channel activity [GO:0160128] g1089.t1 Q708S6 28.543 501 8.58e-63 216.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 g1090.t1 Q708S6 34.529 446 8.409999999999999e-69 233.0 sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1 g1091.t1 A7Y2W8 48.065 620 0.0 603.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 SC6A9_XENLA reviewed Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9) Xenopus laevis (African clawed frog) GO:0005283; GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0060092; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375] g1092.t1 A7Y2W8 49.416 599 0.0 602.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 SC6A9_XENLA reviewed Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9) Xenopus laevis (African clawed frog) GO:0005283; GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0060092; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375] g1093.t1 A7Y2W8 50.087 577 0.0 575.0 sp|A7Y2W8|SC6A9_XENLA Sodium- and chloride-dependent glycine transporter 1 OS=Xenopus laevis OX=8355 GN=slc6a9 PE=2 SV=1 SC6A9_XENLA reviewed Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (xGlyT1) (Solute carrier family 6 member 9) Xenopus laevis (African clawed frog) GO:0005283; GO:0005886; GO:0006836; GO:0015375; GO:0035725; GO:0060092; GO:1903804 glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375] g1094.t1 A0A1U8QWA2 38.258 1320 0.0 804.0 sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1 ATR12_EMENI reviewed Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)] Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans) GO:0016616; GO:0031177 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; phosphopantetheine binding [GO:0031177] g1095.t1 Q9Y619 53.793 290 2e-104 311.0 sp|Q9Y619|ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens OX=9606 GN=SLC25A15 PE=1 SV=1 ORNT1_HUMAN reviewed Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15) Homo sapiens (Human) GO:0000050; GO:0000064; GO:0005739; GO:0005743; GO:0015189; GO:0015297; GO:0016020; GO:0061459; GO:1903401; GO:1903826; GO:1990575 L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g1096.t1 P20105 80.769 104 4.32e-56 199.0 sp|P20105|E74EA_DROME Ecdysone-induced protein 74EF isoform A OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2 g1097.t1 A0JMY5 54.249 706 0.0 690.0 sp|A0JMY5|NFXL1_XENLA NF-X1-type zinc finger protein NFXL1 OS=Xenopus laevis OX=8355 GN=nfxl1 PE=2 SV=1 g1100.t1 Q80Z25 29.83 704 1.81e-79 283.0 sp|Q80Z25|OFD1_MOUSE Centriole and centriolar satellite protein OFD1 OS=Mus musculus OX=10090 GN=Ofd1 PE=1 SV=1 OFD1_MOUSE reviewed Centriole and centriolar satellite protein OFD1 (Oral-facial-digital syndrome 1 protein homolog) Mus musculus (Mouse) GO:0005576; GO:0005634; GO:0005813; GO:0005814; GO:0005929; GO:0010172; GO:0031514; GO:0034451; GO:0035082; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060090; GO:0060271; GO:0060287; GO:2000314 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; nucleus [GO:0005634] alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] g1100.t2 Q80Z25 29.83 704 3.4700000000000005e-79 282.0 sp|Q80Z25|OFD1_MOUSE Centriole and centriolar satellite protein OFD1 OS=Mus musculus OX=10090 GN=Ofd1 PE=1 SV=1 OFD1_MOUSE reviewed Centriole and centriolar satellite protein OFD1 (Oral-facial-digital syndrome 1 protein homolog) Mus musculus (Mouse) GO:0005576; GO:0005634; GO:0005813; GO:0005814; GO:0005929; GO:0010172; GO:0031514; GO:0034451; GO:0035082; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060090; GO:0060271; GO:0060287; GO:2000314 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; nucleus [GO:0005634] alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] g19083.t1 Q9JME2 31.93 285 3.44e-43 157.0 sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1 CHSTB_MOUSE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g19083.t2 Q9JME2 31.93 285 2.87e-43 157.0 sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1 CHSTB_MOUSE reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g19087.t1 Q5R7W3 53.267 505 5.8200000000000004e-157 457.0 sp|Q5R7W3|CWC27_PONAB Spliceosome-associated protein CWC27 homolog OS=Pongo abelii OX=9601 GN=CWC27 PE=2 SV=1 g19089.t1 O73823 60.92 87 5.6800000000000006e-27 114.0 sp|O73823|TAL1_XENLA T-cell acute lymphocytic leukemia protein 1 OS=Xenopus laevis OX=8355 GN=tal1 PE=2 SV=1 g19090.t1 Q6ITT3 38.073 218 4.39e-46 166.0 sp|Q6ITT3|MGT4C_PIG Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Sus scrofa OX=9823 GN=MGAT4C PE=2 SV=1 g19090.t2 Q6ITT3 38.073 218 4.2e-46 166.0 sp|Q6ITT3|MGT4C_PIG Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Sus scrofa OX=9823 GN=MGAT4C PE=2 SV=1 g19091.t1 Q9DGD1 38.528 231 6.96e-48 171.0 sp|Q9DGD1|MGT4C_CHICK Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Gallus gallus OX=9031 GN=MGAT4C PE=1 SV=1 g19094.t1 Q9WV18 40.256 390 5.6e-83 294.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g19094.t1 Q9WV18 33.512 373 6.88e-55 211.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g19095.t1 Q6WKW9 49.223 193 9.83e-44 169.0 sp|Q6WKW9|HMGX4_XENLA HMG box-containing protein 4 OS=Xenopus laevis OX=8355 GN=hmgxb4 PE=1 SV=1 g19099.t1 Q9H799 26.694 1978 7.79e-158 551.0 sp|Q9H799|CPLN1_HUMAN Ciliogenesis and planar polarity effector 1 OS=Homo sapiens OX=9606 GN=CPLANE1 PE=1 SV=4 CPLN1_HUMAN reviewed Ciliogenesis and planar polarity effector 1 (Protein JBTS17) Homo sapiens (Human) GO:0016020; GO:0035869; GO:0060271 cilium assembly [GO:0060271] ciliary transition zone [GO:0035869]; membrane [GO:0016020] g19101.t1 P54802 48.494 697 0.0 695.0 sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2 ANAG_HUMAN reviewed Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form] Homo sapiens (Human) GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097009; GO:0097696; GO:0099022; GO:0140315; GO:1904389; GO:1904390 adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; energy homeostasis [GO:0097009]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-N-acetylglucosaminidase activity [GO:0004561]; iron ion sequestering activity [GO:0140315] g19106.t1 Q0D2K2 26.869 495 1.4800000000000001e-58 207.0 sp|Q0D2K2|KLH30_HUMAN Kelch-like protein 30 OS=Homo sapiens OX=9606 GN=KLHL30 PE=1 SV=3 g19107.t1 P41214 44.481 607 9.89e-154 457.0 sp|P41214|EIF2D_HUMAN Eukaryotic translation initiation factor 2D OS=Homo sapiens OX=9606 GN=EIF2D PE=1 SV=3 EIF2D_HUMAN reviewed Eukaryotic translation initiation factor 2D (eIF2d) (Hepatocellular carcinoma-associated antigen 56) (Ligatin) Homo sapiens (Human) GO:0001731; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006886; GO:0016604; GO:0032790; GO:0038023; GO:0075522 formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604] RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743] g19108.t1 Q6KCD5 50.653 1607 0.0 1534.0 sp|Q6KCD5|NIPBL_MOUSE Nipped-B-like protein OS=Mus musculus OX=10090 GN=Nipbl PE=1 SV=1 NIPBL_MOUSE reviewed Nipped-B-like protein (Delangin homolog) (SCC2 homolog) Mus musculus (Mouse) GO:0000070; GO:0000122; GO:0000785; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007064; GO:0007420; GO:0007507; GO:0007605; GO:0008104; GO:0019827; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224 brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intracellular protein localization [GO:0008104]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038] chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714] g19108.t1 Q6KCD5 46.798 203 4.89e-38 161.0 sp|Q6KCD5|NIPBL_MOUSE Nipped-B-like protein OS=Mus musculus OX=10090 GN=Nipbl PE=1 SV=1 NIPBL_MOUSE reviewed Nipped-B-like protein (Delangin homolog) (SCC2 homolog) Mus musculus (Mouse) GO:0000070; GO:0000122; GO:0000785; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007064; GO:0007420; GO:0007507; GO:0007605; GO:0008104; GO:0019827; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224 brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intracellular protein localization [GO:0008104]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038] chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714] g19108.t2 Q6KCD5 50.247 1620 0.0 1533.0 sp|Q6KCD5|NIPBL_MOUSE Nipped-B-like protein OS=Mus musculus OX=10090 GN=Nipbl PE=1 SV=1 NIPBL_MOUSE reviewed Nipped-B-like protein (Delangin homolog) (SCC2 homolog) Mus musculus (Mouse) GO:0000070; GO:0000122; GO:0000785; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007064; GO:0007420; GO:0007507; GO:0007605; GO:0008104; GO:0019827; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224 brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intracellular protein localization [GO:0008104]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038] chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714] g19108.t2 Q6KCD5 46.798 203 4.57e-38 161.0 sp|Q6KCD5|NIPBL_MOUSE Nipped-B-like protein OS=Mus musculus OX=10090 GN=Nipbl PE=1 SV=1 NIPBL_MOUSE reviewed Nipped-B-like protein (Delangin homolog) (SCC2 homolog) Mus musculus (Mouse) GO:0000070; GO:0000122; GO:0000785; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006974; GO:0007064; GO:0007420; GO:0007507; GO:0007605; GO:0008104; GO:0019827; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048701; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224 brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; intracellular protein localization [GO:0008104]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; uterus morphogenesis [GO:0061038] chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714] g19109.t1 Q9TU53 31.418 261 3.7899999999999995e-23 112.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19110.t1 P54802 42.286 700 0.0 553.0 sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2 ANAG_HUMAN reviewed Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form] Homo sapiens (Human) GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097009; GO:0097696; GO:0099022; GO:0140315; GO:1904389; GO:1904390 adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; energy homeostasis [GO:0097009]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] alpha-N-acetylglucosaminidase activity [GO:0004561]; iron ion sequestering activity [GO:0140315] g19111.t1 Q95135 52.686 484 5.59e-172 499.0 sp|Q95135|EAA3_BOVIN Excitatory amino acid transporter 3 OS=Bos taurus OX=9913 GN=SLC1A1 PE=2 SV=1 EAA3_BOVIN reviewed Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Renal high affinity glutamate transporter EAAC1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Bos taurus (Bovine) GO:0005313; GO:0005314; GO:0005886; GO:0015108; GO:0015501; GO:0015813; GO:0016324; GO:0031901; GO:0031902; GO:0033229; GO:0042883; GO:0043005; GO:0045202; GO:0046872; GO:0055038; GO:0070633; GO:0070778; GO:0071944; GO:0098712; GO:0140009; GO:0150104; GO:1902476 chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202] chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872] g19114.t1 Q8VHT6 37.248 298 7.4e-63 206.0 sp|Q8VHT6|AS3MT_RAT Arsenite methyltransferase OS=Rattus norvegicus OX=10116 GN=As3mt PE=1 SV=1 AS3MT_RAT reviewed Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase) Rattus norvegicus (Rat) GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685 arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404] cytosol [GO:0005829] arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] g19115.t1 Q6AXK4 38.43 242 1.91e-51 179.0 sp|Q6AXK4|BABA1_DANRE BRISC and BRCA1-A complex member 1 OS=Danio rerio OX=7955 GN=babam1 PE=1 SV=2 BABA1_DANRE reviewed BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0006302; GO:0007095; GO:0010212; GO:0016604; GO:0045739; GO:0051301; GO:0070531; GO:0070552; GO:0140861 cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634] g19116.t1 Q8CIV2 58.511 564 0.0 611.0 sp|Q8CIV2|MBRL_MOUSE Membralin OS=Mus musculus OX=10090 GN=Tmem259 PE=1 SV=2 MBRL_MOUSE reviewed Membralin (Transmembrane protein 259) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0034976; GO:1904294 positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] g19117.t1 Q3U487 53.143 875 0.0 917.0 sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2 HECD3_MOUSE reviewed E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3) Mus musculus (Mouse) GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] perinuclear region of cytoplasm [GO:0048471] syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g19118.t1 Q5H8A4 42.691 602 1.13e-141 451.0 sp|Q5H8A4|PIGG_HUMAN GPI ethanolamine phosphate transferase 2, catalytic subunit OS=Homo sapiens OX=9606 GN=PIGG PE=1 SV=1 PIGG_HUMAN reviewed GPI ethanolamine phosphate transferase 2, catalytic subunit (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016740; GO:0016780; GO:0051267 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; transferase activity [GO:0016740] g19118.t1 Q5H8A4 38.872 337 1.1699999999999999e-46 184.0 sp|Q5H8A4|PIGG_HUMAN GPI ethanolamine phosphate transferase 2, catalytic subunit OS=Homo sapiens OX=9606 GN=PIGG PE=1 SV=1 PIGG_HUMAN reviewed GPI ethanolamine phosphate transferase 2, catalytic subunit (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016740; GO:0016780; GO:0051267 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; transferase activity [GO:0016740] g19119.t1 Q0V8M0 45.925 638 3.1100000000000002e-167 512.0 sp|Q0V8M0|KRI1_BOVIN Protein KRI1 homolog OS=Bos taurus OX=9913 GN=KRI1 PE=2 SV=3 g19119.t2 Q0V8M0 45.925 638 2.31e-168 510.0 sp|Q0V8M0|KRI1_BOVIN Protein KRI1 homolog OS=Bos taurus OX=9913 GN=KRI1 PE=2 SV=3 g19120.t1 Q5ZLR1 50.0 556 0.0 548.0 sp|Q5ZLR1|WLS_CHICK Protein wntless homolog OS=Gallus gallus OX=9031 GN=WLS PE=2 SV=1 WLS_CHICK reviewed Protein wntless homolog (Integral membrane protein GPR177) Gallus gallus (Chicken) GO:0000139; GO:0006886; GO:0012505; GO:0016055; GO:0017147; GO:0030177; GO:0030659; GO:0031090; GO:0061355; GO:0061357 intracellular protein transport [GO:0006886]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] cytoplasmic vesicle membrane [GO:0030659]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090] Wnt-protein binding [GO:0017147] g19123.t1 Q6IQE5 66.859 347 3.06e-165 467.0 sp|Q6IQE5|GET3_DANRE ATPase GET3 OS=Danio rerio OX=7955 GN=get3 PE=1 SV=1 GET3_DANRE reviewed ATPase GET3 (EC 3.6.4.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005730; GO:0006620; GO:0007416; GO:0016887; GO:0043529; GO:0046872; GO:0071816 post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; synapse assembly [GO:0007416]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GET complex [GO:0043529]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872] g19124.t1 P56719 27.419 434 1.2e-35 140.0 sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 OX2R_RAT reviewed Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2) Rattus norvegicus (Rat) GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0040011; GO:0042593; GO:0051480 cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046] g19125.t1 P69527 36.118 850 1.27e-161 491.0 sp|P69527|AMPO_RAT Aminopeptidase O OS=Rattus norvegicus OX=10116 GN=Aopep PE=2 SV=2 g19126.t1 Q66KC4 64.029 417 0.0 536.0 sp|Q66KC4|HSDL2_XENTR Hydroxysteroid dehydrogenase-like protein 2 OS=Xenopus tropicalis OX=8364 GN=hsdl2 PE=2 SV=1 g19128.t1 Q9NPF2 34.219 301 2.32e-55 189.0 sp|Q9NPF2|CHSTB_HUMAN Carbohydrate sulfotransferase 11 OS=Homo sapiens OX=9606 GN=CHST11 PE=1 SV=1 g19129.t1 Q8VCT9 41.589 428 6.05e-99 317.0 sp|Q8VCT9|TESK2_MOUSE Dual specificity testis-specific protein kinase 2 OS=Mus musculus OX=10090 GN=Tesk2 PE=1 SV=1 g19130.t1 Q9MYM7 33.333 258 5.94e-43 155.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g19131.t1 P18433 44.648 654 0.0 599.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19134.t1 Q06807 47.138 297 1.96e-84 293.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19138.t1 P49446 42.208 308 1.35e-66 243.0 sp|P49446|PTPRE_MOUSE Receptor-type tyrosine-protein phosphatase epsilon OS=Mus musculus OX=10090 GN=Ptpre PE=1 SV=3 g19138.t1 P49446 34.979 243 2.12e-39 161.0 sp|P49446|PTPRE_MOUSE Receptor-type tyrosine-protein phosphatase epsilon OS=Mus musculus OX=10090 GN=Ptpre PE=1 SV=3 g19144.t1 P11617 33.333 303 3.0900000000000002e-43 157.0 sp|P11617|AA2AR_CANLF Adenosine receptor A2a OS=Canis lupus familiaris OX=9615 GN=ADORA2A PE=2 SV=1 g19145.t1 Q6DIY8 38.776 196 3.6e-46 154.0 sp|Q6DIY8|M17L2_XENTR Mpv17-like protein 2 OS=Xenopus tropicalis OX=8364 GN=mpv17l2 PE=2 SV=1 g19145.t2 Q6DGV7 39.594 197 7.12e-49 161.0 sp|Q6DGV7|M17L2_DANRE Mpv17-like protein 2 OS=Danio rerio OX=7955 GN=mpv17l2 PE=2 SV=1 g19150.t1 Q66KE8 34.343 495 1.28e-72 251.0 sp|Q66KE8|CCD78_XENLA Coiled-coil domain-containing protein 78 OS=Xenopus laevis OX=8355 GN=ccdc78 PE=2 SV=1 g19156.t1 P81139 40.635 315 1.24e-68 226.0 sp|P81139|LIPR2_CAVPO Pancreatic lipase-related protein 2 OS=Cavia porcellus OX=10141 GN=PNLIPRP2 PE=1 SV=1 LIPR2_CAVPO reviewed Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (GPL) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3) Cavia porcellus (Guinea pig) GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0006644; GO:0009395; GO:0019376; GO:0019433; GO:0042589; GO:0043005; GO:0047372; GO:0047714 galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589] calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806] g19157.t1 Q8R4F0 43.203 537 1.04e-151 450.0 sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1 MCLN3_MOUSE reviewed Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3) Mus musculus (Mouse) GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171; GO:0072345 inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626] autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171] lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; NAADP-sensitive calcium-release channel activity [GO:0072345]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272] g19158.t1 Q5VYK3 45.939 1859 0.0 1623.0 sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2 ECM29_HUMAN reviewed Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) Homo sapiens (Human) GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628 ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502] molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] g19158.t2 Q5VYK3 45.737 1865 0.0 1617.0 sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2 ECM29_HUMAN reviewed Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) Homo sapiens (Human) GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628 ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502] molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] g19159.t1 P49013 45.815 227 4.8800000000000005e-70 251.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g19159.t1 P49013 43.668 229 3.59e-65 237.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g19159.t1 P49013 36.538 156 1.92e-31 137.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g19159.t1 P49013 44.167 120 1.9e-25 118.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g19161.t1 B1H283 39.928 278 1.0999999999999999e-52 181.0 sp|B1H283|CMAP2_RAT Ciliary microtubule-associated protein 2 OS=Rattus norvegicus OX=10116 GN=Cimap2 PE=2 SV=1 g19162.t1 Q9NPF5 61.062 452 0.0 526.0 sp|Q9NPF5|DMAP1_HUMAN DNA methyltransferase 1-associated protein 1 OS=Homo sapiens OX=9606 GN=DMAP1 PE=1 SV=1 DMAP1_HUMAN reviewed DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1) Homo sapiens (Human) GO:0000122; GO:0000786; GO:0000812; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006338; GO:0006355; GO:0035267; GO:0042307; GO:0042981; GO:0045471; GO:0045892; GO:0045893; GO:0051726; GO:0061629; GO:1905168; GO:2000779 chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; response to ethanol [GO:0045471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812] RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g19165.t1 Q8HY31 59.557 361 2.49e-157 462.0 sp|Q8HY31|DCUP_SHEEP Uroporphyrinogen decarboxylase OS=Ovis aries OX=9940 GN=UROD PE=1 SV=1 g19167.t1 Q0V9J0 46.763 139 1.02e-25 105.0 sp|Q0V9J0|TMM69_XENTR Transmembrane protein 69 OS=Xenopus tropicalis OX=8364 GN=tmem69 PE=2 SV=1 g19172.t1 Q9R1K5 69.88 498 0.0 668.0 sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1 FZR1_MOUSE reviewed Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005680; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0046105; GO:0051301; GO:0051603; GO:0070306; GO:1904668; GO:1904860; GO:1905786; GO:1990756; GO:1990757; GO:2000773 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA synthesis involved in mitotic DNA replication [GO:1904860]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020]; thymidine biosynthetic process [GO:0046105] anaphase-promoting complex [GO:0005680]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g19176.t1 F1P3Y5 47.015 134 1.3e-34 120.0 sp|F1P3Y5|CF144_CHICK Cilia- and flagella-associated protein 144 OS=Gallus gallus OX=9031 GN=CFAP144 PE=1 SV=2 g19177.t1 Q9D903 50.318 157 8.419999999999999e-24 98.2 sp|Q9D903|EBP2_MOUSE Probable rRNA-processing protein EBP2 OS=Mus musculus OX=10090 GN=Ebna1bp2 PE=2 SV=1 g19178.t1 Q99848 48.0 100 1.81e-23 95.5 sp|Q99848|EBP2_HUMAN Probable rRNA-processing protein EBP2 OS=Homo sapiens OX=9606 GN=EBNA1BP2 PE=1 SV=2 EBP2_HUMAN reviewed Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40) Homo sapiens (Human) GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273 ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687] RNA binding [GO:0003723] g19180.t1 Q4R3J0 60.388 361 3.63e-149 427.0 sp|Q4R3J0|RTCA_MACFA RNA 3'-terminal phosphate cyclase OS=Macaca fascicularis OX=9541 GN=RTCA PE=2 SV=1 g19181.t1 P11181 55.233 516 0.0 563.0 sp|P11181|ODB2_BOVIN Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial OS=Bos taurus OX=9913 GN=DBT PE=1 SV=2 ODB2_BOVIN reviewed Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase) Bos taurus (Bovine) GO:0005739; GO:0005759; GO:0005829; GO:0043754; GO:0120552; GO:0160157 branched-chain alpha-keto acid decarboxylation to branched-chain acyl-CoA [GO:0120552] branched-chain alpha-ketoacid dehydrogenase complex [GO:0160157]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] dihydrolipoamide branched chain acyltransferase activity [GO:0043754] g19184.t1 Q9UGM3 40.994 644 5.19e-122 407.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19184.t1 Q9UGM3 41.204 648 3.21e-121 404.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19184.t1 Q9UGM3 39.939 656 5.31e-117 392.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19184.t1 Q9UGM3 40.546 513 4.19e-90 313.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19184.t1 Q9UGM3 39.779 543 1.7099999999999997e-89 311.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19187.t1 Q8BM89 44.949 198 6.2099999999999995e-46 162.0 sp|Q8BM89|ARSJ_MOUSE Arylsulfatase J OS=Mus musculus OX=10090 GN=Arsj PE=2 SV=1 g19188.t1 P15848 50.185 271 9.850000000000001e-79 250.0 sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1 ARSB_HUMAN reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Homo sapiens (Human) GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484] g19190.t1 P50429 46.693 514 7.560000000000001e-156 459.0 sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3 g19191.t1 X1WGX5 42.636 645 1.5500000000000002e-166 493.0 sp|X1WGX5|PUM3_DANRE Pumilio homolog 3 OS=Danio rerio OX=7955 GN=pum3 PE=2 SV=2 PUM3_DANRE reviewed Pumilio homolog 3 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0006417; GO:0008354 germ cell migration [GO:0008354]; regulation of translation [GO:0006417] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; mRNA binding [GO:0003729] g19192.t1 Q8NE22 42.478 339 2.12e-82 254.0 sp|Q8NE22|SETD9_HUMAN SET domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SETD9 PE=1 SV=2 g19193.t1 Q9HBL7 45.652 138 1e-38 131.0 sp|Q9HBL7|PLRKT_HUMAN Plasminogen receptor (KT) OS=Homo sapiens OX=9606 GN=PLGRKT PE=1 SV=1 g19194.t1 P35822 45.113 133 1.33e-29 119.0 sp|P35822|PTPRK_MOUSE Receptor-type tyrosine-protein phosphatase kappa OS=Mus musculus OX=10090 GN=Ptprk PE=1 SV=1 PTPRK_MOUSE reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001750; GO:0004725; GO:0005886; GO:0005911; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0045295; GO:0045786; GO:0045892; GO:0048041 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g19195.t1 Q99M80 32.407 1151 2.02e-151 510.0 sp|Q99M80|PTPRT_MOUSE Receptor-type tyrosine-protein phosphatase T OS=Mus musculus OX=10090 GN=Ptprt PE=1 SV=2 g19195.t2 O14522 38.587 736 6.81e-149 504.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19195.t3 Q99M80 31.424 1152 3.1699999999999997e-150 509.0 sp|Q99M80|PTPRT_MOUSE Receptor-type tyrosine-protein phosphatase T OS=Mus musculus OX=10090 GN=Ptprt PE=1 SV=2 g19196.t1 O14522 39.024 738 6.69e-155 513.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19197.t1 Q6INU7 25.0 460 2.1500000000000002e-32 137.0 sp|Q6INU7|FRRS1_XENLA Putative ferric-chelate reductase 1 OS=Xenopus laevis OX=8355 GN=frrs1 PE=2 SV=1 g19197.t2 Q8MSU3 28.148 405 8.01e-32 135.0 sp|Q8MSU3|FRRS1_DROME Putative ferric-chelate reductase 1 homolog OS=Drosophila melanogaster OX=7227 GN=CG8399 PE=2 SV=1 g19198.t1 Q9V9A7 55.508 236 1.1200000000000001e-73 238.0 sp|Q9V9A7|MCCB_DROME Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Mccc2 PE=2 SV=1 g19199.t1 Q9V9A7 48.319 238 2.8399999999999997e-69 225.0 sp|Q9V9A7|MCCB_DROME Probable methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Mccc2 PE=2 SV=1 g19200.t1 O95477 45.013 762 0.0 638.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19200.t1 O95477 35.0 220 7.840000000000001e-29 128.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19201.t1 P41233 37.211 1212 0.0 705.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19201.t1 P41233 39.474 266 2e-48 194.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19201.t1 P41233 30.469 256 1.88e-25 119.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19205.t1 Q8BG58 38.519 405 5.12e-76 249.0 sp|Q8BG58|P4HTM_MOUSE Transmembrane prolyl 4-hydroxylase OS=Mus musculus OX=10090 GN=P4htm PE=1 SV=1 P4HTM_MOUSE reviewed Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4) Mus musculus (Mouse) GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0008270; GO:0016706; GO:0031418; GO:0045646; GO:0160082 regulation of erythrocyte differentiation [GO:0045646] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; zinc ion binding [GO:0008270] g19206.t1 Q9NXG6 43.048 374 9.51e-86 278.0 sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2 g19208.t1 Q6NXW6 41.244 611 3.8699999999999997e-153 461.0 sp|Q6NXW6|RAD17_MOUSE Cell cycle checkpoint protein RAD17 OS=Mus musculus OX=10090 GN=Rad17 PE=1 SV=2 RAD17_MOUSE reviewed Cell cycle checkpoint protein RAD17 Mus musculus (Mouse) GO:0000077; GO:0000781; GO:0003682; GO:0003689; GO:0005524; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0008156; GO:0031389; GO:0031573; GO:0033314; GO:0035861; GO:0140463; GO:1990166 DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; protein localization to site of double-strand break [GO:1990166] chromosome, telomeric region [GO:0000781]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rad17 RFC-like complex [GO:0031389]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA clamp loader activity [GO:0003689] g19210.t1 Q28024 58.065 62 3.46e-23 86.3 sp|Q28024|GBG12_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 OS=Bos taurus OX=9913 GN=GNG12 PE=1 SV=2 GBG12_BOVIN reviewed Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 (Gamma-S1) Bos taurus (Bovine) GO:0005834; GO:0007186; GO:0030165; GO:0031681 G protein-coupled receptor signaling pathway [GO:0007186] heterotrimeric G-protein complex [GO:0005834] G-protein beta-subunit binding [GO:0031681]; PDZ domain binding [GO:0030165] g19211.t1 O14522 47.323 579 3.2699999999999995e-176 540.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19212.t1 P35590 27.191 445 6.12e-32 139.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19215.t1 P35590 35.714 252 4.34e-36 145.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19216.t1 Q06806 30.099 505 5.34e-49 184.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19217.t1 O73792 50.893 112 4.44e-30 120.0 sp|O73792|TIE1_DANRE Tyrosine-protein kinase receptor Tie-1 (Fragment) OS=Danio rerio OX=7955 GN=tie1 PE=1 SV=1 g19218.t1 Q06807 31.544 447 9.740000000000001e-58 218.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19220.t1 P35590 25.708 424 3.9499999999999996e-30 131.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19221.t1 Q06805 39.041 146 2.4900000000000002e-27 120.0 sp|Q06805|TIE1_BOVIN Tyrosine-protein kinase receptor Tie-1 OS=Bos taurus OX=9913 GN=TIE1 PE=2 SV=1 g19222.t1 O73792 48.76 121 8.13e-37 126.0 sp|O73792|TIE1_DANRE Tyrosine-protein kinase receptor Tie-1 (Fragment) OS=Danio rerio OX=7955 GN=tie1 PE=1 SV=1 g19223.t1 Q8AVP1 67.143 280 3.36e-139 398.0 sp|Q8AVP1|RPF1_XENLA Ribosome production factor 1 OS=Xenopus laevis OX=8355 GN=rpf1 PE=2 SV=1 g19224.t1 Q5R5L7 25.141 354 2.3999999999999998e-28 120.0 sp|Q5R5L7|ARRD3_PONAB Arrestin domain-containing protein 3 OS=Pongo abelii OX=9601 GN=ARRDC3 PE=2 SV=1 g19227.t1 O95490 35.318 739 9.380000000000001e-125 414.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g19228.t1 O97831 37.676 783 1.21e-144 473.0 sp|O97831|AGRL1_BOVIN Adhesion G protein-coupled receptor L1 OS=Bos taurus OX=9913 GN=ADGRL1 PE=2 SV=1 g19228.t2 O97831 38.163 773 8.319999999999999e-147 478.0 sp|O97831|AGRL1_BOVIN Adhesion G protein-coupled receptor L1 OS=Bos taurus OX=9913 GN=ADGRL1 PE=2 SV=1 g19229.t1 Q06807 47.826 299 4.33e-81 295.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19229.t1 Q06807 32.819 259 1.21e-33 145.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19230.t1 Q06807 33.861 632 7.03e-86 309.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19230.t1 Q06807 34.884 258 4.2200000000000006e-37 156.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19231.t1 P0C5E4 23.653 1577 2.37e-49 199.0 sp|P0C5E4|PTPRQ_MOUSE Phosphatidylinositol phosphatase PTPRQ OS=Mus musculus OX=10090 GN=Ptprq PE=1 SV=1 PTPRQ_MOUSE reviewed Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) Mus musculus (Mouse) GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044 detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421] phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725] g19231.t1 P0C5E4 23.474 1606 5.53e-41 171.0 sp|P0C5E4|PTPRQ_MOUSE Phosphatidylinositol phosphatase PTPRQ OS=Mus musculus OX=10090 GN=Ptprq PE=1 SV=1 PTPRQ_MOUSE reviewed Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) Mus musculus (Mouse) GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044 detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421] phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725] g19231.t1 P0C5E4 23.042 1328 8.139999999999999e-38 160.0 sp|P0C5E4|PTPRQ_MOUSE Phosphatidylinositol phosphatase PTPRQ OS=Mus musculus OX=10090 GN=Ptprq PE=1 SV=1 PTPRQ_MOUSE reviewed Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) Mus musculus (Mouse) GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044 detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421] phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725] g19231.t1 P0C5E4 25.836 538 2.64e-24 116.0 sp|P0C5E4|PTPRQ_MOUSE Phosphatidylinositol phosphatase PTPRQ OS=Mus musculus OX=10090 GN=Ptprq PE=1 SV=1 PTPRQ_MOUSE reviewed Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) Mus musculus (Mouse) GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044 detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421] phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725] g19232.t1 O73792 48.413 126 2.91e-36 138.0 sp|O73792|TIE1_DANRE Tyrosine-protein kinase receptor Tie-1 (Fragment) OS=Danio rerio OX=7955 GN=tie1 PE=1 SV=1 g19233.t1 P28828 30.192 1146 1.74e-143 478.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19234.t1 F1NWE3 30.462 1300 6.94e-152 501.0 sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3 g19235.t1 P28828 33.304 1129 7.24e-161 535.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19235.t2 P28828 33.304 1129 1.09e-160 534.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19236.t1 Q90YY5 41.509 159 5.0099999999999997e-23 106.0 sp|Q90YY5|MED26_XENLA Mediator of RNA polymerase II transcription subunit 26 OS=Xenopus laevis OX=8355 GN=med26 PE=2 SV=1 g19237.t1 Q24799 47.872 188 1.2799999999999999e-54 174.0 sp|Q24799|MYPH_ECHGR Myophilin OS=Echinococcus granulosus OX=6210 PE=2 SV=1 g19238.t1 Q24799 46.701 197 3.06e-50 164.0 sp|Q24799|MYPH_ECHGR Myophilin OS=Echinococcus granulosus OX=6210 PE=2 SV=1 g19239.t1 Q5VU97 44.794 1239 0.0 1113.0 sp|Q5VU97|CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACHD1 PE=1 SV=2 CAHD1_HUMAN reviewed VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1) Homo sapiens (Human) GO:0005245; GO:0005891 voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel activity [GO:0005245] g19240.t1 P37193 68.657 134 3.98e-67 206.0 sp|P37193|ADXH1_DROME Adrenodoxin-like protein 1, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Fdx1 PE=2 SV=3 g19241.t1 Q9C0D3 45.2 750 0.0 576.0 sp|Q9C0D3|ZY11B_HUMAN Protein zyg-11 homolog B OS=Homo sapiens OX=9606 GN=ZYG11B PE=1 SV=2 g19243.t1 A2VDD2 56.818 176 2.33e-65 201.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g19243.t2 A2VDD2 58.993 139 8.04e-57 179.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g19244.t1 Q69ZJ7 41.481 1485 0.0 1126.0 sp|Q69ZJ7|RIC1_MOUSE Guanine nucleotide exchange factor subunit RIC1 OS=Mus musculus OX=10090 GN=Ric1 PE=1 SV=2 RIC1_MOUSE reviewed Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1) Mus musculus (Mouse) GO:0000139; GO:0003330; GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547; GO:1904888 cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g19247.t1 Q684M4 55.142 564 0.0 636.0 sp|Q684M4|KEAP1_PIG Kelch-like ECH-associated protein 1 OS=Sus scrofa OX=9823 GN=KEAP1 PE=3 SV=1 KEAP1_PIG reviewed Kelch-like ECH-associated protein 1 Sus scrofa (Pig) GO:0000122; GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0034451; GO:0034599; GO:0042802; GO:0043161; GO:0045604; GO:0061629; GO:0070936; GO:0071353; GO:0097718; GO:0140416; GO:1902883; GO:1990756 cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511] actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654] disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g19253.t1 P81908 32.155 566 1.64e-87 285.0 sp|P81908|CHLE_HORSE Cholinesterase OS=Equus caballus OX=9796 GN=BCHE PE=1 SV=1 CHLE_HORSE reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase) Equus caballus (Horse) GO:0003990; GO:0004104; GO:0005615; GO:0005886; GO:0006581; GO:0019695 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695] extracellular space [GO:0005615]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; cholinesterase activity [GO:0004104] g19260.t1 Q9UBC2 41.801 933 0.0 599.0 sp|Q9UBC2|EP15R_HUMAN Epidermal growth factor receptor substrate 15-like 1 OS=Homo sapiens OX=9606 GN=EPS15L1 PE=1 SV=1 EP15R_HUMAN reviewed Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R) Homo sapiens (Human) GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0030674; GO:0045296; GO:0048488; GO:0098793 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; synaptic vesicle endocytosis [GO:0048488] clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein-macromolecule adaptor activity [GO:0030674] g19262.t1 Q9HCJ5 62.066 1036 0.0 1283.0 sp|Q9HCJ5|ZSWM6_HUMAN Zinc finger SWIM domain-containing protein 6 OS=Homo sapiens OX=9606 GN=ZSWIM6 PE=1 SV=2 g19263.t1 B0BNE2 83.412 211 4.0699999999999997e-131 370.0 sp|B0BNE2|RPAB1_RAT DNA-directed RNA polymerases I, II, and III subunit RPABC1 OS=Rattus norvegicus OX=10116 GN=Polr2e PE=2 SV=1 RPAB1_RAT reviewed DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) Rattus norvegicus (Rat) GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0006362; GO:0006366; GO:0042797; GO:1990062 transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; tRNA transcription by RNA polymerase III [GO:0042797] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899] g19264.t1 Q28DB0 45.804 572 0.0 549.0 sp|Q28DB0|TT39B_XENTR Tetratricopeptide repeat protein 39B OS=Xenopus tropicalis OX=8364 GN=ttc39b PE=2 SV=1 g19264.t2 Q28DB0 45.471 552 0.0 540.0 sp|Q28DB0|TT39B_XENTR Tetratricopeptide repeat protein 39B OS=Xenopus tropicalis OX=8364 GN=ttc39b PE=2 SV=1 g19265.t1 Q28DB0 45.109 552 0.0 540.0 sp|Q28DB0|TT39B_XENTR Tetratricopeptide repeat protein 39B OS=Xenopus tropicalis OX=8364 GN=ttc39b PE=2 SV=1 g19266.t1 P54646 64.374 567 0.0 717.0 sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2 AAPK2_HUMAN reviewed 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) Homo sapiens (Human) GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044 autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] g19266.t2 P54646 64.716 564 0.0 722.0 sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2 AAPK2_HUMAN reviewed 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) Homo sapiens (Human) GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044 autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] g19267.t1 Q9H6L4 60.963 187 9.14e-72 219.0 sp|Q9H6L4|ARMC7_HUMAN Armadillo repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=ARMC7 PE=1 SV=1 ARMC7_HUMAN reviewed Armadillo repeat-containing protein 7 Homo sapiens (Human) GO:0005681; GO:0006397; GO:0008380 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] spliceosomal complex [GO:0005681] g19268.t1 Q9VXX8 79.348 92 8.18e-49 152.0 sp|Q9VXX8|RL371_DROME Large ribosomal subunit protein eL37A OS=Drosophila melanogaster OX=7227 GN=RpL37-1 PE=1 SV=1 g19269.t1 Q3T0J1 28.614 339 2.6e-36 140.0 sp|Q3T0J1|FBX4_BOVIN F-box only protein 4 OS=Bos taurus OX=9913 GN=FBXO4 PE=2 SV=1 g19269.t2 Q3T0J1 28.614 339 3.7200000000000004e-35 137.0 sp|Q3T0J1|FBX4_BOVIN F-box only protein 4 OS=Bos taurus OX=9913 GN=FBXO4 PE=2 SV=1 g19270.t1 O35704 55.983 468 0.0 547.0 sp|O35704|SPTC1_MOUSE Serine palmitoyltransferase 1 OS=Mus musculus OX=10090 GN=Sptlc1 PE=1 SV=2 SPTC1_MOUSE reviewed Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1) Mus musculus (Mouse) GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:1904504; GO:1904649 ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; regulation of fat cell apoptotic process [GO:1904649]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059] pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] g19271.t1 Q9HCN3 29.918 732 2.61e-81 279.0 sp|Q9HCN3|PGAP6_HUMAN Post-GPI attachment to proteins factor 6 OS=Homo sapiens OX=9606 GN=PGAP6 PE=1 SV=3 PGAP6_HUMAN reviewed Post-GPI attachment to proteins factor 6 (EC 3.1.1.4) (GPI processing phospholipase A2) (GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A) Homo sapiens (Human) GO:0004623; GO:0005765; GO:0005886; GO:0006629; GO:0070062 lipid metabolic process [GO:0006629] extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] phospholipase A2 activity [GO:0004623] g19272.t1 Q2T9T9 40.108 369 1.43e-93 293.0 sp|Q2T9T9|FBXW9_BOVIN F-box/WD repeat-containing protein 9 OS=Bos taurus OX=9913 GN=FBXW9 PE=2 SV=1 g19273.t1 Q92973 80.877 889 0.0 1472.0 sp|Q92973|TNPO1_HUMAN Transportin-1 OS=Homo sapiens OX=9606 GN=TNPO1 PE=1 SV=2 TNPO1_HUMAN reviewed Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein) (MIP) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005929; GO:0006606; GO:0008139; GO:0031267; GO:0061608; GO:0070062 protein import into nucleus [GO:0006606] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] g19274.t1 Q5PR73 79.397 199 7.94e-117 335.0 sp|Q5PR73|DIRA2_MOUSE GTP-binding protein Di-Ras2 OS=Mus musculus OX=10090 GN=Diras2 PE=1 SV=1 g19278.t1 P24293 37.5 136 1.5100000000000002e-21 87.8 sp|P24293|PA2A1_ERIMA Acidic phospholipase A2 PLA-1 OS=Eristicophis macmahoni OX=110227 PE=1 SV=1 g19279.t1 P23787 85.422 782 0.0 1375.0 sp|P23787|TERA_XENLA Transitional endoplasmic reticulum ATPase OS=Xenopus laevis OX=8355 GN=vcp PE=1 SV=3 g19280.t1 Q5U4S8 49.347 383 3.48e-135 395.0 sp|Q5U4S8|CEGTB_XENLA Ceramide glucosyltransferase-B OS=Xenopus laevis OX=8355 GN=ugcg-b PE=2 SV=1 g19281.t1 Q7ZYD9 58.391 435 0.0 526.0 sp|Q7ZYD9|A13CB_XENLA Ankyrin repeat domain-containing protein 13C-B OS=Xenopus laevis OX=8355 GN=ankrd13c-b PE=2 SV=1 g19282.t1 B6CHA3 62.255 612 0.0 802.0 sp|B6CHA3|UHRF1_XENLA E3 ubiquitin-protein ligase UHRF1 OS=Xenopus laevis OX=8355 GN=uhrf1 PE=2 SV=1 UHRF1_XENLA reviewed E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Nuclear zinc finger protein Np95) (XNp95) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0004842; GO:0005634; GO:0005657; GO:0006511; GO:0008270; GO:0016567; GO:0031507; GO:0042393; GO:0044027; GO:0044729; GO:0061630; GO:0062072; GO:0140234; GO:0140248; GO:0140851; GO:0141119 chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; heterochromatin formation [GO:0031507]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; replication fork [GO:0005657] hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; histone H3K14 ubiquitin ligase activity [GO:0140851]; histone H3K18 ubiquitin ligase activity [GO:0140248]; histone H3K23 ubiquitin ligase activity [GO:0140234]; histone H3K9me2/3 reader activity [GO:0062072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19282.t1 B6CHA3 42.857 182 4.72e-33 140.0 sp|B6CHA3|UHRF1_XENLA E3 ubiquitin-protein ligase UHRF1 OS=Xenopus laevis OX=8355 GN=uhrf1 PE=2 SV=1 UHRF1_XENLA reviewed E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Nuclear zinc finger protein Np95) (XNp95) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (Ubiquitin-like-containing PHD and RING finger domains protein 1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0004842; GO:0005634; GO:0005657; GO:0006511; GO:0008270; GO:0016567; GO:0031507; GO:0042393; GO:0044027; GO:0044729; GO:0061630; GO:0062072; GO:0140234; GO:0140248; GO:0140851; GO:0141119 chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; heterochromatin formation [GO:0031507]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; replication fork [GO:0005657] hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; histone H3K14 ubiquitin ligase activity [GO:0140851]; histone H3K18 ubiquitin ligase activity [GO:0140248]; histone H3K23 ubiquitin ligase activity [GO:0140234]; histone H3K9me2/3 reader activity [GO:0062072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19284.t1 Q5R5D8 36.911 382 4.78e-83 265.0 sp|Q5R5D8|BODG_PONAB Gamma-butyrobetaine dioxygenase OS=Pongo abelii OX=9601 GN=BBOX1 PE=2 SV=1 BODG_PONAB reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329 carnitine biosynthetic process [GO:0045329] mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g19285.t1 Q8NI36 52.227 898 0.0 975.0 sp|Q8NI36|WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens OX=9606 GN=WDR36 PE=1 SV=2 WDR36_HUMAN reviewed WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g19286.t1 P42739 29.577 284 4.13e-23 107.0 sp|P42739|UBIQP_ACEPE Polyubiquitin (Fragment) OS=Acetabularia peniculus OX=35862 PE=3 SV=2 g19286.t1 P42739 29.93 284 7.839999999999999e-23 106.0 sp|P42739|UBIQP_ACEPE Polyubiquitin (Fragment) OS=Acetabularia peniculus OX=35862 PE=3 SV=2 g19288.t1 Q9Y272 40.0 165 3.44e-32 120.0 sp|Q9Y272|RASD1_HUMAN Dexamethasone-induced Ras-related protein 1 OS=Homo sapiens OX=9606 GN=RASD1 PE=1 SV=1 RASD1_HUMAN reviewed Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1) Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0031681; GO:0045892; GO:0048471 G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of DNA-templated transcription [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g19294.t1 Q4R3D4 49.65 286 1.83e-81 249.0 sp|Q4R3D4|EF1D_MACFA Elongation factor 1-delta OS=Macaca fascicularis OX=9541 GN=EEF1D PE=2 SV=2 g19294.t2 P29693 52.874 261 4.18e-75 231.0 sp|P29693|EF1D_XENLA Elongation factor 1-delta OS=Xenopus laevis OX=8355 GN=eef1d PE=1 SV=1 g19295.t1 Q0II91 52.044 367 1.84e-125 382.0 sp|Q0II91|DJC21_BOVIN DnaJ homolog subfamily C member 21 OS=Bos taurus OX=9913 GN=DNAJC21 PE=2 SV=2 DJC21_BOVIN reviewed DnaJ homolog subfamily C member 21 Bos taurus (Bovine) GO:0003676; GO:0005730; GO:0005737; GO:0008270 cytoplasm [GO:0005737]; nucleolus [GO:0005730] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g19296.t1 Q1WG82 38.953 172 9.68e-28 111.0 sp|Q1WG82|ZGLP1_MOUSE GATA-type zinc finger protein 1 OS=Mus musculus OX=10090 GN=Zglp1 PE=2 SV=1 ZGLP1_MOUSE reviewed GATA-type zinc finger protein 1 (GATA-like protein 1) (GLP-1) Mus musculus (Mouse) GO:0000122; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0043565; GO:0045944; GO:0048599 negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g19297.t1 Q9Z139 50.994 704 0.0 743.0 sp|Q9Z139|ROR1_MOUSE Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Mus musculus OX=10090 GN=Ror1 PE=2 SV=2 ROR1_MOUSE reviewed Inactive tyrosine-protein kinase transmembrane receptor ROR1 (mROR1) (Neurotrophic tyrosine kinase, receptor-related 1) Mus musculus (Mouse) GO:0001725; GO:0004714; GO:0005524; GO:0005886; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092 astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605] axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725] ATP binding [GO:0005524]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g19297.t1 Q9Z139 34.559 272 2.57e-45 181.0 sp|Q9Z139|ROR1_MOUSE Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Mus musculus OX=10090 GN=Ror1 PE=2 SV=2 ROR1_MOUSE reviewed Inactive tyrosine-protein kinase transmembrane receptor ROR1 (mROR1) (Neurotrophic tyrosine kinase, receptor-related 1) Mus musculus (Mouse) GO:0001725; GO:0004714; GO:0005524; GO:0005886; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092 astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605] axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725] ATP binding [GO:0005524]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g19299.t1 Q9NXK8 28.125 256 2.5699999999999997e-30 120.0 sp|Q9NXK8|FXL12_HUMAN F-box/LRR-repeat protein 12 OS=Homo sapiens OX=9606 GN=FBXL12 PE=1 SV=1 FXL12_HUMAN reviewed F-box/LRR-repeat protein 12 (F-box and leucine-rich repeat protein 12) (F-box protein FBL12) Homo sapiens (Human) GO:0000151; GO:0005829; GO:0006511; GO:0016567 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] g19300.t1 Q95LM1 32.07 343 3.56e-51 175.0 sp|Q95LM1|UBE2U_MACFA Ubiquitin-conjugating enzyme E2 U OS=Macaca fascicularis OX=9541 GN=UBE2U PE=2 SV=1 g19302.t1 O70528 31.858 339 1.1699999999999999e-34 135.0 sp|O70528|5HT4R_CAVPO 5-hydroxytryptamine receptor 4 OS=Cavia porcellus OX=10141 GN=HTR4 PE=2 SV=1 g19303.t1 Q9WYJ1 43.367 392 3.24e-88 278.0 sp|Q9WYJ1|TSAL_THEMA L-threonine ammonia-lyase OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0356 PE=1 SV=1 g19304.t1 Q1L987 41.532 248 1.75e-57 189.0 sp|Q1L987|ATPF1_DANRE ATP synthase mitochondrial F1 complex assembly factor 1 OS=Danio rerio OX=7955 GN=atpaf1 PE=2 SV=2 g19305.t1 O77592 67.29 321 1.24e-153 437.0 sp|O77592|S35A3_CANLF UDP-N-acetylglucosamine transporter OS=Canis lupus familiaris OX=9615 GN=SLC35A3 PE=2 SV=1 g19306.t1 Q8RWD9 29.762 252 9.44e-31 127.0 sp|Q8RWD9|ACBP5_ARATH Acyl-CoA-binding domain-containing protein 5 OS=Arabidopsis thaliana OX=3702 GN=ACBP5 PE=1 SV=1 g19306.t1 Q8RWD9 28.881 277 3.92e-25 110.0 sp|Q8RWD9|ACBP5_ARATH Acyl-CoA-binding domain-containing protein 5 OS=Arabidopsis thaliana OX=3702 GN=ACBP5 PE=1 SV=1 g19307.t1 Q6P6G5 43.464 306 8.230000000000001e-79 245.0 sp|Q6P6G5|YIPF1_RAT Protein YIPF1 OS=Rattus norvegicus OX=10116 GN=Yipf1 PE=2 SV=1 g19308.t1 Q1JPX3 72.289 498 0.0 730.0 sp|Q1JPX3|SYFA_DANRE Phenylalanine--tRNA ligase alpha subunit OS=Danio rerio OX=7955 GN=farsa PE=2 SV=2 g19310.t1 Q96MR6 61.458 1248 0.0 1587.0 sp|Q96MR6|CFA57_HUMAN Cilia- and flagella-associated protein 57 OS=Homo sapiens OX=9606 GN=CFAP57 PE=1 SV=3 CFA57_HUMAN reviewed Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65) Homo sapiens (Human) GO:0005930; GO:0007338; GO:0036126; GO:0070286; GO:0120316 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] axoneme [GO:0005930]; sperm flagellum [GO:0036126] g19311.t1 Q3B8G0 58.599 157 1.7099999999999998e-68 207.0 sp|Q3B8G0|CZIB_XENLA CXXC motif containing zinc binding protein OS=Xenopus laevis OX=8355 GN=czib PE=2 SV=1 g19312.t1 Q5E960 35.89 365 3.04e-60 201.0 sp|Q5E960|S39A3_BOVIN Zinc transporter ZIP3 OS=Bos taurus OX=9913 GN=SLC39A3 PE=2 SV=2 S39A3_BOVIN reviewed Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3) Bos taurus (Bovine) GO:0000902; GO:0001701; GO:0005385; GO:0005886; GO:0016324; GO:0043029; GO:0048701; GO:0060173; GO:0071577; GO:0098686 cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886] zinc ion transmembrane transporter activity [GO:0005385] g19313.t1 Q5R4R3 46.606 545 6.58e-174 505.0 sp|Q5R4R3|OGFD1_PONAB Prolyl 3-hydroxylase OGFOD1 OS=Pongo abelii OX=9601 GN=OGFOD1 PE=2 SV=1 OGFD1_PONAB reviewed Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (uS12 prolyl 3-hydroxylase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005506; GO:0005634; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0031418; GO:0031543; GO:0031544; GO:0034063 cell population proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543] g19317.t1 Q8NBN7 45.763 295 1.4400000000000001e-64 210.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g19320.t1 Q8BGC3 23.043 447 1.5500000000000001e-21 100.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g19321.t1 A6QLY2 54.73 148 2.52e-51 166.0 sp|A6QLY2|GPX7_BOVIN Glutathione peroxidase 7 OS=Bos taurus OX=9913 GN=GPX7 PE=2 SV=1 g19322.t1 Q12834 56.237 489 0.0 559.0 sp|Q12834|CDC20_HUMAN Cell division cycle protein 20 homolog OS=Homo sapiens OX=9606 GN=CDC20 PE=1 SV=2 CDC20_HUMAN reviewed Cell division cycle protein 20 homolog (p55CDC) Homo sapiens (Human) GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008284; GO:0010997; GO:0016567; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922] anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g19324.t1 Q9D3D9 58.779 131 7.519999999999999e-48 156.0 sp|Q9D3D9|ATPD_MOUSE ATP synthase F(1) complex subunit delta, mitochondrial OS=Mus musculus OX=10090 GN=Atp5f1d PE=1 SV=1 ATPD_MOUSE reviewed ATP synthase F(1) complex subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit) Mus musculus (Mouse) GO:0005198; GO:0005739; GO:0005740; GO:0005743; GO:0009060; GO:0015078; GO:0015986; GO:0033615; GO:0042776; GO:0044877; GO:0045259; GO:0046933; GO:1902600 aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600] mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259] protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; structural molecule activity [GO:0005198] g19325.t1 Q6R327 45.465 849 0.0 716.0 sp|Q6R327|RICTR_HUMAN Rapamycin-insensitive companion of mTOR OS=Homo sapiens OX=9606 GN=RICTOR PE=1 SV=1 RICTR_HUMAN reviewed Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3) Homo sapiens (Human) GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0060090; GO:0140767; GO:2000114 actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; TORC2 signaling [GO:0038203] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270] g19325.t1 Q6R327 43.919 148 2.7200000000000003e-31 138.0 sp|Q6R327|RICTR_HUMAN Rapamycin-insensitive companion of mTOR OS=Homo sapiens OX=9606 GN=RICTOR PE=1 SV=1 RICTR_HUMAN reviewed Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3) Homo sapiens (Human) GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0060090; GO:0140767; GO:2000114 actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; TORC2 signaling [GO:0038203] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270] g19325.t1 Q6R327 31.613 310 2.01e-25 119.0 sp|Q6R327|RICTR_HUMAN Rapamycin-insensitive companion of mTOR OS=Homo sapiens OX=9606 GN=RICTOR PE=1 SV=1 RICTR_HUMAN reviewed Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3) Homo sapiens (Human) GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0060090; GO:0140767; GO:2000114 actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; TORC2 signaling [GO:0038203] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270] g19326.t1 Q5H8C1 38.462 351 4.09e-73 249.0 sp|Q5H8C1|FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens OX=9606 GN=FREM1 PE=1 SV=3 FREM1_HUMAN reviewed FRAS1-related extracellular matrix protein 1 (Protein QBRICK) Homo sapiens (Human) GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016020; GO:0030246; GO:0046872; GO:0097094 anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g19327.t1 Q5H8C1 39.561 1413 0.0 1048.0 sp|Q5H8C1|FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens OX=9606 GN=FREM1 PE=1 SV=3 FREM1_HUMAN reviewed FRAS1-related extracellular matrix protein 1 (Protein QBRICK) Homo sapiens (Human) GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016020; GO:0030246; GO:0046872; GO:0097094 anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g19327.t1 Q5H8C1 24.894 1414 5.1300000000000005e-59 229.0 sp|Q5H8C1|FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens OX=9606 GN=FREM1 PE=1 SV=3 FREM1_HUMAN reviewed FRAS1-related extracellular matrix protein 1 (Protein QBRICK) Homo sapiens (Human) GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016020; GO:0030246; GO:0046872; GO:0097094 anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g19327.t1 Q5H8C1 23.759 846 1.3599999999999999e-34 149.0 sp|Q5H8C1|FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens OX=9606 GN=FREM1 PE=1 SV=3 FREM1_HUMAN reviewed FRAS1-related extracellular matrix protein 1 (Protein QBRICK) Homo sapiens (Human) GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016020; GO:0030246; GO:0046872; GO:0097094 anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g19328.t1 Q5H8C1 29.603 277 7.84e-24 108.0 sp|Q5H8C1|FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens OX=9606 GN=FREM1 PE=1 SV=3 FREM1_HUMAN reviewed FRAS1-related extracellular matrix protein 1 (Protein QBRICK) Homo sapiens (Human) GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016020; GO:0030246; GO:0046872; GO:0097094 anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; membrane [GO:0016020] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] g19331.t1 P50533 62.72 1191 0.0 1523.0 sp|P50533|SMC2_XENLA Structural maintenance of chromosomes protein 2 OS=Xenopus laevis OX=8355 GN=smc2 PE=1 SV=1 g19333.t1 A4QN59 50.877 513 0.0 519.0 sp|A4QN59|DPH2_DANRE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 OS=Danio rerio OX=7955 GN=dph2 PE=2 SV=1 DPH2_DANRE reviewed 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513 protein histidyl modification to diphthamide [GO:0017183] 2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513] 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872] g19334.t1 Q66JF3 59.391 394 8.8e-161 466.0 sp|Q66JF3|MKNK1_XENTR MAP kinase-interacting serine/threonine-protein kinase 1 OS=Xenopus tropicalis OX=8364 GN=mknk1 PE=2 SV=1 MKNK1_XENTR reviewed MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006417; GO:0009931; GO:0035556; GO:0046872; GO:0106310 intracellular signal transduction [GO:0035556]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] g19335.t1 Q8HXX8 72.43 428 0.0 668.0 sp|Q8HXX8|GCDH_MACFA Glutaryl-CoA dehydrogenase, mitochondrial OS=Macaca fascicularis OX=9541 GN=GCDH PE=2 SV=1 GCDH_MACFA reviewed Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000062; GO:0004361; GO:0005743; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660 fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; L-tryptophan metabolic process [GO:0006568] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759] fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361] g19335.t2 Q8HXX8 73.759 423 0.0 669.0 sp|Q8HXX8|GCDH_MACFA Glutaryl-CoA dehydrogenase, mitochondrial OS=Macaca fascicularis OX=9541 GN=GCDH PE=2 SV=1 GCDH_MACFA reviewed Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000062; GO:0004361; GO:0005743; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660 fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; L-tryptophan metabolic process [GO:0006568] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759] fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361] g19337.t1 B1AY13 48.282 2678 0.0 2420.0 sp|B1AY13|UBP24_MOUSE Ubiquitin carboxyl-terminal hydrolase 24 OS=Mus musculus OX=10090 GN=Usp24 PE=1 SV=1 UBP24_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24) Mus musculus (Mouse) GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579; GO:0031647 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g19337.t2 B1AY13 48.049 2691 0.0 2410.0 sp|B1AY13|UBP24_MOUSE Ubiquitin carboxyl-terminal hydrolase 24 OS=Mus musculus OX=10090 GN=Usp24 PE=1 SV=1 UBP24_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24) Mus musculus (Mouse) GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579; GO:0031647 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g19338.t1 Q28DS3 46.35 274 3.73e-85 258.0 sp|Q28DS3|RN170_XENTR E3 ubiquitin-protein ligase RNF170 OS=Xenopus tropicalis OX=8364 GN=rnf170 PE=2 SV=1 RN170_XENTR reviewed E3 ubiquitin-protein ligase RNF170 (EC 2.3.2.27) (RING finger protein 170) (RING-type E3 ubiquitin transferase RNF170) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005789; GO:0008270; GO:0016567; GO:0061630 protein ubiquitination [GO:0016567] endoplasmic reticulum membrane [GO:0005789] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g19338.t2 Q28DS3 45.421 273 5.56e-85 258.0 sp|Q28DS3|RN170_XENTR E3 ubiquitin-protein ligase RNF170 OS=Xenopus tropicalis OX=8364 GN=rnf170 PE=2 SV=1 RN170_XENTR reviewed E3 ubiquitin-protein ligase RNF170 (EC 2.3.2.27) (RING finger protein 170) (RING-type E3 ubiquitin transferase RNF170) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005789; GO:0008270; GO:0016567; GO:0061630 protein ubiquitination [GO:0016567] endoplasmic reticulum membrane [GO:0005789] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g19339.t1 Q6GQ73 57.618 722 0.0 788.0 sp|Q6GQ73|HOOK3_XENLA Protein Hook homolog 3 OS=Xenopus laevis OX=8355 GN=hook3 PE=2 SV=1 HOOK3_XENLA reviewed Protein Hook homolog 3 Xenopus laevis (African clawed frog) GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0045022; GO:0051959 cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein transport [GO:0015031] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017] g19339.t2 Q6GQ73 58.123 714 0.0 788.0 sp|Q6GQ73|HOOK3_XENLA Protein Hook homolog 3 OS=Xenopus laevis OX=8355 GN=hook3 PE=2 SV=1 HOOK3_XENLA reviewed Protein Hook homolog 3 Xenopus laevis (African clawed frog) GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0045022; GO:0051959 cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein transport [GO:0015031] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017] g19340.t1 Q15B89 55.864 324 2.71e-130 378.0 sp|Q15B89|S35DL_PIG Solute carrier family 35 member D2-like protein (Fragment) OS=Sus scrofa OX=9823 PE=2 SV=1 g19341.t1 P81458 40.299 134 3.8000000000000005e-21 86.7 sp|P81458|PA2B_DABRR Basic phospholipase A2 RVV-VD OS=Daboia russelii OX=8707 PE=1 SV=1 g19342.t1 P14419 38.017 121 1.4500000000000002e-21 88.2 sp|P14419|PA21B_SHEEP Phospholipase A2 OS=Ovis aries OX=9940 GN=PLA2G1B PE=1 SV=1 g19343.t1 P80966 40.881 159 1.11e-28 107.0 sp|P80966|PA2A1_OPHHA Acidic phospholipase A2 1 OS=Ophiophagus hannah OX=8665 PE=1 SV=2 PA2A1_OPHHA reviewed Acidic phospholipase A2 1 (svPLA2) (EC 3.1.1.4) (APLA2-1) (OHV A-PLA2) (OHV-APLA2) (Phosphatidylcholine 2-acylhydrolase) Ophiophagus hannah (King cobra) (Naja hannah) GO:0005102; GO:0005509; GO:0005543; GO:0005576; GO:0006633; GO:0006644; GO:0016042; GO:0047498; GO:0048146; GO:0050482; GO:0090729 arachidonate secretion [GO:0050482]; fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; positive regulation of fibroblast proliferation [GO:0048146] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; toxin activity [GO:0090729] g19345.t1 O76536 34.946 1199 5.07e-131 437.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t1 O76536 34.336 1130 3.1600000000000004e-124 418.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t1 O76536 34.245 1206 8.85e-117 397.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t1 O76536 34.897 1023 7.33e-112 384.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t1 O76536 33.606 1101 2.58e-105 365.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t1 O76536 36.246 698 2.13e-76 280.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 34.946 1199 1.67e-126 436.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 34.336 1130 3.7e-120 417.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 34.897 1023 8.18e-109 383.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 33.525 1044 4.38e-92 332.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 31.388 1131 2.23e-91 330.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 31.724 1201 4.45e-90 326.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 31.083 1200 1.26e-89 325.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 31.193 1215 1.68e-85 312.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 31.8 1217 7.25e-83 304.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 30.187 1176 7.15e-75 279.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 36.246 698 7.35e-75 279.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 30.896 1094 5.37e-68 258.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t2 O76536 33.566 429 6.579999999999999e-23 112.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 34.946 1199 1.67e-126 436.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 34.336 1130 3.7e-120 417.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 34.897 1023 8.18e-109 383.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 33.525 1044 4.38e-92 332.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 31.388 1131 2.23e-91 330.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 31.724 1201 4.45e-90 326.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 31.083 1200 1.26e-89 325.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 31.193 1215 1.68e-85 312.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 31.8 1217 7.25e-83 304.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 30.187 1176 7.15e-75 279.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 36.246 698 7.35e-75 279.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 30.896 1094 5.37e-68 258.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19345.t3 O76536 33.566 429 6.579999999999999e-23 112.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19346.t1 Q09575 29.268 246 6.89e-25 107.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g19347.t1 O76536 39.7 267 3.0500000000000003e-27 122.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 39.405 269 3.5200000000000004e-26 119.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 36.704 267 9.83e-25 114.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 38.824 255 1.12e-24 114.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 37.815 238 2.3499999999999997e-23 109.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 36.508 252 6.35e-23 108.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 37.97 266 1.26e-22 107.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 36.508 252 1.63e-22 107.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 38.577 267 2.23e-21 103.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 35.955 267 5.58e-21 102.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19347.t1 O76536 35.223 247 8.290000000000001e-21 101.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19348.t1 Q6AZB8 28.188 298 1.5e-28 117.0 sp|Q6AZB8|HARB1_DANRE Putative nuclease HARBI1 OS=Danio rerio OX=7955 GN=harbi1 PE=2 SV=1 g19350.t1 Q6NVD0 25.517 580 1.0699999999999998e-23 112.0 sp|Q6NVD0|FREM2_MOUSE FRAS1-related extracellular matrix protein 2 OS=Mus musculus OX=10090 GN=Frem2 PE=1 SV=2 FREM2_MOUSE reviewed FRAS1-related extracellular matrix protein 2 (ECM3 homolog) (NV domain-containing protein 1) Mus musculus (Mouse) GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0031012; GO:0042733; GO:0046872; GO:0048839 anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] metal ion binding [GO:0046872] g19352.t1 B1WAV2 79.167 144 1.38e-78 250.0 sp|B1WAV2|RFX2_XENTR DNA-binding protein RFX2 OS=Xenopus tropicalis OX=8364 GN=rfx2 PE=2 SV=1 g19353.t1 P0C6B8 38.012 171 7.88e-21 102.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g19356.t1 Q7T3H9 49.064 267 1.0299999999999999e-92 278.0 sp|Q7T3H9|HYI_DANRE Putative hydroxypyruvate isomerase OS=Danio rerio OX=7955 GN=hyi PE=2 SV=2 g19357.t1 P48381 57.095 592 0.0 632.0 sp|P48381|RFX3_MOUSE Transcription factor RFX3 OS=Mus musculus OX=10090 GN=Rfx3 PE=1 SV=2 RFX3_MOUSE reviewed Transcription factor RFX3 (Regulatory factor X 3) Mus musculus (Mouse) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005576; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0006357; GO:0007368; GO:0031018; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0050796; GO:0060271; GO:0060285; GO:0060287; GO:0072560; GO:1990837; GO:2000078 cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; DNA-templated transcription [GO:0006351]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of DNA-templated transcription [GO:0006355]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell maturation [GO:0072560] chromatin [GO:0000785]; extracellular region [GO:0005576]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g19357.t2 P48381 60.612 523 0.0 615.0 sp|P48381|RFX3_MOUSE Transcription factor RFX3 OS=Mus musculus OX=10090 GN=Rfx3 PE=1 SV=2 RFX3_MOUSE reviewed Transcription factor RFX3 (Regulatory factor X 3) Mus musculus (Mouse) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005576; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0006357; GO:0007368; GO:0031018; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0050796; GO:0060271; GO:0060285; GO:0060287; GO:0072560; GO:1990837; GO:2000078 cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; DNA-templated transcription [GO:0006351]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of DNA-templated transcription [GO:0006355]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell maturation [GO:0072560] chromatin [GO:0000785]; extracellular region [GO:0005576]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g19358.t1 Q6AX31 37.5 368 2.53e-53 190.0 sp|Q6AX31|NDC1_XENLA Nucleoporin NDC1 OS=Xenopus laevis OX=8355 GN=ndc1 PE=1 SV=1 g19359.t1 Q8VCB1 35.0 180 5.7300000000000004e-27 110.0 sp|Q8VCB1|NDC1_MOUSE Nucleoporin NDC1 OS=Mus musculus OX=10090 GN=Ndc1 PE=1 SV=1 NDC1_MOUSE reviewed Nucleoporin NDC1 (Transmembrane protein 48) Mus musculus (Mouse) GO:0005635; GO:0005643; GO:0005737; GO:0005886; GO:0006913; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0015629; GO:0017056; GO:0030674; GO:0031965; GO:0051028; GO:0051292; GO:0051664; GO:0070762 homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886] protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056] g19360.t1 Q1HCL7 50.378 397 2.33e-142 416.0 sp|Q1HCL7|NADK2_RAT NAD kinase 2, mitochondrial OS=Rattus norvegicus OX=10116 GN=Nadk2 PE=1 SV=1 NADK2_RAT reviewed NAD kinase 2, mitochondrial (EC 2.7.1.23) (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial) Rattus norvegicus (Rat) GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0019674; GO:0042803 NAD+ metabolic process [GO:0019674]; NADP+ biosynthetic process [GO:0006741] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803] g19361.t1 Q13233 38.07 746 5.61e-138 461.0 sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens OX=9606 GN=MAP3K1 PE=1 SV=4 M3K1_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) (EC 2.3.2.27) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0038095; GO:0061630; GO:0070160; GO:0071260; GO:0106310 cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; tight junction [GO:0070160] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g19361.t1 Q13233 50.995 402 3.67e-116 399.0 sp|Q13233|M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens OX=9606 GN=MAP3K1 PE=1 SV=4 M3K1_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) (EC 2.3.2.27) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0038095; GO:0061630; GO:0070160; GO:0071260; GO:0106310 cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; tight junction [GO:0070160] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g19363.t1 Q90384 77.273 198 2.05e-115 329.0 sp|Q90384|TDX_CYNPY Peroxiredoxin OS=Cynops pyrrhogaster OX=8330 PE=2 SV=1 g19364.t1 Q12882 70.103 97 1.0399999999999998e-42 151.0 sp|Q12882|DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP(+)] OS=Homo sapiens OX=9606 GN=DPYD PE=1 SV=2 g19365.t1 Q28943 71.285 895 0.0 1362.0 sp|Q28943|DPYD_PIG Dihydropyrimidine dehydrogenase [NADP(+)] OS=Sus scrofa OX=9823 GN=DPYD PE=1 SV=1 DPYD_PIG reviewed Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) Sus scrofa (Pig) GO:0002058; GO:0005737; GO:0005829; GO:0006210; GO:0006212; GO:0006214; GO:0010181; GO:0017113; GO:0019483; GO:0042803; GO:0046872; GO:0050660; GO:0050661; GO:0051539 beta-alanine biosynthetic process [GO:0019483]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212] cytoplasm [GO:0005737]; cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058] g19366.t1 P57784 72.308 195 2.59e-100 293.0 sp|P57784|RU2A_MOUSE U2 small nuclear ribonucleoprotein A' OS=Mus musculus OX=10090 GN=Snrpa1 PE=1 SV=2 g19367.t1 O95477 42.613 995 0.0 773.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19367.t1 O95477 37.546 269 1.47e-44 181.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19367.t1 O95477 30.165 242 8.23e-24 113.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19368.t1 P41233 33.875 431 6.63e-47 184.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19369.t1 O35600 53.333 375 9.140000000000001e-122 390.0 sp|O35600|ABCA4_MOUSE Retinal-specific phospholipid-transporting ATPase ABCA4 OS=Mus musculus OX=10090 GN=Abca4 PE=1 SV=1 ABCA4_MOUSE reviewed Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter) Mus musculus (Mouse) GO:0001523; GO:0001750; GO:0003924; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005548; GO:0005783; GO:0005886; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0031410; GO:0042574; GO:0042626; GO:0045332; GO:0045494; GO:0046872; GO:0090555; GO:0120202; GO:0140326; GO:0140327; GO:0140347; GO:0140359 lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; rod photoreceptor disc membrane [GO:0120202] 11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501] g19369.t1 O35600 34.375 224 3.3300000000000003e-26 114.0 sp|O35600|ABCA4_MOUSE Retinal-specific phospholipid-transporting ATPase ABCA4 OS=Mus musculus OX=10090 GN=Abca4 PE=1 SV=1 ABCA4_MOUSE reviewed Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Retinal-specific ATP-binding cassette transporter) Mus musculus (Mouse) GO:0001523; GO:0001750; GO:0003924; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005548; GO:0005783; GO:0005886; GO:0006649; GO:0006869; GO:0007601; GO:0016887; GO:0031410; GO:0042574; GO:0042626; GO:0045332; GO:0045494; GO:0046872; GO:0090555; GO:0120202; GO:0140326; GO:0140327; GO:0140347; GO:0140359 lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; rod photoreceptor disc membrane [GO:0120202] 11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501] g19370.t1 P41233 57.658 111 2.6e-38 147.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19371.t1 O95477 40.602 963 0.0 696.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19371.t1 O95477 36.759 253 9.07e-39 163.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19371.t1 O95477 38.164 207 5.18e-22 108.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19372.t1 O95477 53.107 676 0.0 752.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19372.t1 O95477 28.376 585 5.52e-49 193.0 sp|O95477|ABCA1_HUMAN Phospholipid-transporting ATPase ABCA1 OS=Homo sapiens OX=9606 GN=ABCA1 PE=1 SV=3 ABCA1_HUMAN reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) Homo sapiens (Human) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071404; GO:0071466; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g19384.t1 Q96DT6 41.993 281 1.88e-68 237.0 sp|Q96DT6|ATG4C_HUMAN Cysteine protease ATG4C OS=Homo sapiens OX=9606 GN=ATG4C PE=1 SV=1 ATG4C_HUMAN reviewed Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3) (Autophagin-3) (Autophagy-related protein 4 homolog C) (HsAPG4C) Homo sapiens (Human) GO:0000045; GO:0000423; GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016485; GO:0019786; GO:0034727; GO:0035973; GO:0051697 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; protein delipidation [GO:0051697]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786] g19384.t1 Q96DT6 48.276 145 3.2199999999999997e-41 160.0 sp|Q96DT6|ATG4C_HUMAN Cysteine protease ATG4C OS=Homo sapiens OX=9606 GN=ATG4C PE=1 SV=1 ATG4C_HUMAN reviewed Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3) (Autophagin-3) (Autophagy-related protein 4 homolog C) (HsAPG4C) Homo sapiens (Human) GO:0000045; GO:0000423; GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016485; GO:0019786; GO:0034727; GO:0035973; GO:0051697 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; protein delipidation [GO:0051697]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786] g19385.t1 Q5W5U4 63.502 474 0.0 600.0 sp|Q5W5U4|DDX4_BOVIN Probable ATP-dependent RNA helicase DDX4 OS=Bos taurus OX=9913 GN=DDX4 PE=2 SV=1 DDX4_BOVIN reviewed Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) Bos taurus (Bovine) GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007276; GO:0007281; GO:0007283; GO:0016887; GO:0030154; GO:0033391; GO:0034587; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:0141006; GO:0141196 cell differentiation [GO:0030154]; gamete generation [GO:0007276]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724] g19386.t1 Q90XC2 57.692 702 0.0 817.0 sp|Q90XC2|NEK8_DANRE Serine/threonine-protein kinase Nek8 OS=Danio rerio OX=7955 GN=nek8 PE=2 SV=1 NEK8_DANRE reviewed Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0004674; GO:0005524; GO:0005813; GO:0005929; GO:0005930; GO:0009887; GO:0046872; GO:0048793; GO:0051301; GO:0061326; GO:0061371; GO:0072116; GO:0106310 animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; pronephros development [GO:0048793]; pronephros formation [GO:0072116]; renal tubule development [GO:0061326] axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19389.t1 Q9VZF4 23.517 472 7.030000000000001e-26 115.0 sp|Q9VZF4|FBXW7_DROME F-box/WD repeat-containing protein 7 OS=Drosophila melanogaster OX=7227 GN=ago PE=1 SV=1 FBXW7_DROME reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago) Drosophila melanogaster (Fruit fly) GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1990381 branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419] nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381] g19390.t1 O14522 46.718 259 5.180000000000001e-66 248.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19390.t2 O14522 46.718 259 1.43e-65 248.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19390.t3 O14522 46.718 259 8.81e-66 247.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19391.t1 O14522 33.694 1018 1.6899999999999998e-159 526.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19392.t1 Q8AXY6 36.095 845 1.2400000000000001e-161 501.0 sp|Q8AXY6|MUSK_CHICK Muscle, skeletal receptor tyrosine protein kinase OS=Gallus gallus OX=9031 GN=MUSK PE=2 SV=1 MUSK_CHICK reviewed Muscle, skeletal receptor tyrosine protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) Gallus gallus (Chicken) GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007528; GO:0008582; GO:0010604; GO:0017147; GO:0030154; GO:0043235; GO:0045211 cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; neuromuscular junction development [GO:0007528]; positive regulation of macromolecule metabolic process [GO:0010604]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147] g19393.t1 B1H1H3 41.036 251 8.11e-66 209.0 sp|B1H1H3|ZDH21_DANRE Palmitoyltransferase ZDHHC21 OS=Danio rerio OX=7955 GN=zdhhc21 PE=2 SV=2 ZDH21_DANRE reviewed Palmitoyltransferase ZDHHC21 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 21) (Zinc finger DHHC domain-containing protein 21) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0018230; GO:0019706 peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] protein-cysteine S-palmitoyltransferase activity [GO:0019706] g19394.t1 P13623 55.932 354 2.91e-118 357.0 sp|P13623|NFIX_MESAU Nuclear factor 1 X-type OS=Mesocricetus auratus OX=10036 GN=NFIX PE=2 SV=1 g19396.t1 Q5ZMV2 45.896 536 5.5599999999999996e-136 412.0 sp|Q5ZMV2|SAS6_CHICK Spindle assembly abnormal protein 6 homolog OS=Gallus gallus OX=9031 GN=SASS6 PE=2 SV=1 g19398.t1 Q6P2X9 24.533 428 9e-24 106.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g19399.t1 Q7RTX9 24.576 472 1.43e-25 112.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g19400.t1 Q28034 43.275 513 1.2300000000000002e-125 382.0 sp|Q28034|GLU2B_BOVIN Glucosidase 2 subunit beta OS=Bos taurus OX=9913 GN=PRKCSH PE=2 SV=1 GLU2B_BOVIN reviewed Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) (Vacuolar system-associated protein 60) (VASAP-60) Bos taurus (Bovine) GO:0001889; GO:0005509; GO:0006491; GO:0016787; GO:0017177; GO:0043231 liver development [GO:0001889]; N-glycan processing [GO:0006491] glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231] calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787] g19400.t2 Q28034 42.578 512 1.1300000000000001e-123 377.0 sp|Q28034|GLU2B_BOVIN Glucosidase 2 subunit beta OS=Bos taurus OX=9913 GN=PRKCSH PE=2 SV=1 GLU2B_BOVIN reviewed Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) (Vacuolar system-associated protein 60) (VASAP-60) Bos taurus (Bovine) GO:0001889; GO:0005509; GO:0006491; GO:0016787; GO:0017177; GO:0043231 liver development [GO:0001889]; N-glycan processing [GO:0006491] glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231] calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787] g19401.t1 Q8VBX6 37.158 1647 0.0 850.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t1 Q8VBX6 44.071 506 5.809999999999999e-106 382.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t1 Q8VBX6 28.6 500 4.570000000000001e-22 108.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t1 Q8VBX6 25.573 524 7.23e-21 104.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t2 Q8VBX6 37.158 1647 0.0 850.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t2 Q8VBX6 44.071 506 5.809999999999999e-106 382.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t2 Q8VBX6 28.6 500 4.570000000000001e-22 108.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t2 Q8VBX6 25.573 524 7.23e-21 104.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t3 Q8VBX6 36.647 1670 0.0 837.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t3 Q8VBX6 44.664 506 6.629999999999999e-106 382.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t3 Q8VBX6 28.6 500 5.77e-22 108.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t3 Q8VBX6 25.573 524 8.810000000000001e-21 104.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t4 Q8VBX6 36.647 1670 0.0 838.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t4 Q8VBX6 44.664 506 8.03e-106 382.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t4 Q8VBX6 28.288 403 9.079999999999999e-23 111.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t4 Q8VBX6 28.6 500 5.59e-22 108.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19401.t4 Q8VBX6 25.573 524 8.550000000000001e-21 104.0 sp|Q8VBX6|MPDZ_MOUSE Multiple PDZ domain protein OS=Mus musculus OX=10090 GN=Mpdz PE=1 SV=2 g19402.t1 Q9W2H1 48.171 164 4.44e-47 155.0 sp|Q9W2H1|TM2D1_DROME TM2 domain-containing protein biscotti OS=Drosophila melanogaster OX=7227 GN=bisc PE=2 SV=1 g19403.t1 Q96RT1 52.092 478 1.62e-155 496.0 sp|Q96RT1|ERBIN_HUMAN Erbin OS=Homo sapiens OX=9606 GN=ERBIN PE=1 SV=2 g19404.t1 F1MCA7 54.348 92 1.3100000000000002e-21 103.0 sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3 g19405.t1 Q9CZU3 74.305 1043 0.0 1634.0 sp|Q9CZU3|MTREX_MOUSE Exosome RNA helicase MTR4 OS=Mus musculus OX=10090 GN=Mtrex PE=1 SV=1 MTREX_MOUSE reviewed Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase) Mus musculus (Mouse) GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0006974; GO:0008380; GO:0016607; GO:0016887; GO:0031499; GO:0071013 DNA damage response [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g19406.t1 P51869 46.25 480 5.51e-154 452.0 sp|P51869|CP4F4_RAT Cytochrome P450 4F4 OS=Rattus norvegicus OX=10116 GN=Cyp4f4 PE=1 SV=1 CP4F4_RAT reviewed Cytochrome P450 4F4 (CYPIVF4) (Leukotriene-B4 20-monooxygenase) (EC 1.14.14.94) Rattus norvegicus (Rat) GO:0005506; GO:0005789; GO:0008391; GO:0019369; GO:0020037; GO:0036101; GO:0050051; GO:0052869; GO:0097267; GO:1904681; GO:1905344 arachidonate metabolic process [GO:0019369]; leukotriene B4 catabolic process [GO:0036101]; omega-hydroxylase P450 pathway [GO:0097267]; prostaglandin catabolic process [GO:1905344]; response to 3-methylcholanthrene [GO:1904681] endoplasmic reticulum membrane [GO:0005789] arachidonate monooxygenase activity [GO:0008391]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051] g19407.t1 P07201 67.949 78 2.96e-29 109.0 sp|P07201|RIR2_SPISO Ribonucleoside-diphosphate reductase small chain OS=Spisula solidissima OX=6584 PE=2 SV=2 g19408.t1 Q4KLN6 77.169 219 1.38e-127 376.0 sp|Q4KLN6|RIR2_RAT Ribonucleoside-diphosphate reductase subunit M2 OS=Rattus norvegicus OX=10116 GN=Rrm2 PE=2 SV=1 RIR2_RAT reviewed Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit) Rattus norvegicus (Rat) GO:0001824; GO:0004748; GO:0005635; GO:0005654; GO:0005829; GO:0005971; GO:0006206; GO:0008199; GO:0008284; GO:0009185; GO:0009262; GO:0009263; GO:0009265; GO:0042802; GO:0042803; GO:0051290; GO:1900087 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; deoxyribonucleotide metabolic process [GO:0009262]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; ribonucleoside diphosphate metabolic process [GO:0009185] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; ribonucleoside-diphosphate reductase complex [GO:0005971] ferric iron binding [GO:0008199]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748] g19409.t1 A3KN33 42.73 674 0.0 571.0 sp|A3KN33|EGFLA_BOVIN Pikachurin OS=Bos taurus OX=9913 GN=EGFLAM PE=2 SV=1 EGFLA_BOVIN reviewed Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein) Bos taurus (Bovine) GO:0005509; GO:0005604; GO:0043083; GO:0048786 basement membrane [GO:0005604]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083] calcium ion binding [GO:0005509] g19410.t1 Q5XIN7 57.492 654 0.0 799.0 sp|Q5XIN7|PMGT1_RAT Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Pomgnt1 PE=2 SV=1 PMGT1_RAT reviewed Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) Rattus norvegicus (Rat) GO:0000139; GO:0006493; GO:0007420; GO:0007605; GO:0008375; GO:0010467; GO:0016020; GO:0016266; GO:0021542; GO:0030145; GO:0030246; GO:0035269; GO:0042552; GO:0047223; GO:0051674; GO:0071711; GO:0150103 basement membrane organization [GO:0071711]; brain development [GO:0007420]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; localization of cell [GO:0051674]; myelination [GO:0042552]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; reactive gliosis [GO:0150103]; sensory perception of sound [GO:0007605] Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145] g19412.t1 Q9BT30 60.69 145 7.96e-60 188.0 sp|Q9BT30|ALKB7_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial OS=Homo sapiens OX=9606 GN=ALKBH7 PE=1 SV=1 g19412.t2 Q9BT30 59.146 164 1.3499999999999999e-67 207.0 sp|Q9BT30|ALKB7_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial OS=Homo sapiens OX=9606 GN=ALKBH7 PE=1 SV=1 g19413.t1 P54318 39.441 322 5.61e-56 192.0 sp|P54318|LIPR2_RAT Pancreatic lipase-related protein 2 OS=Rattus norvegicus OX=10116 GN=Pnliprp2 PE=1 SV=1 LIPR2_RAT reviewed Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (Galactolipase) (EC 3.1.1.26) (Secretory glycoprotein GP-3) (Triacylglycerol lipase) (EC 3.1.1.3) Rattus norvegicus (Rat) GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006633; GO:0006644; GO:0006968; GO:0008970; GO:0009395; GO:0009617; GO:0009791; GO:0016298; GO:0019376; GO:0019433; GO:0032094; GO:0033993; GO:0034375; GO:0034638; GO:0042589; GO:0042632; GO:0043005; GO:0043434; GO:0044258; GO:0047372; GO:0047714; GO:0051384 cellular defense response [GO:0006968]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; galactolipid catabolic process [GO:0019376]; high-density lipoprotein particle remodeling [GO:0034375]; intestinal lipid catabolic process [GO:0044258]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; post-embryonic development [GO:0009791]; response to bacterium [GO:0009617]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to lipid [GO:0033993]; response to peptide hormone [GO:0043434]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589] calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806] g19419.t1 Q9H3R0 68.75 336 4.62e-165 523.0 sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2 g19419.t1 Q9H3R0 41.727 417 4.17e-96 335.0 sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2 g19420.t1 P16621 46.755 2049 0.0 1741.0 sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2 LAR_DROME reviewed Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR) Drosophila melanogaster (Fruit fly) GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007165; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386 axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124] axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925] heparin binding [GO:0008201]; insulin receptor binding [GO:0005158]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19421.t1 P0C6F1 71.279 4011 0.0 6125.0 sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1 DYH2_MOUSE reviewed Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) Mus musculus (Mouse) GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g19421.t1 P0C6F1 57.143 315 5.27e-101 371.0 sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1 DYH2_MOUSE reviewed Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) Mus musculus (Mouse) GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729 cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g19423.t1 Q32PD8 50.388 129 3.2999999999999997e-38 129.0 sp|Q32PD8|LERL1_BOVIN Leptin receptor overlapping transcript-like 1 OS=Bos taurus OX=9913 GN=LEPROTL1 PE=2 SV=1 g19432.t1 B2RX14 40.94 745 2.63e-153 516.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g19432.t1 B2RX14 33.08 263 2.0500000000000003e-43 178.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g19432.t1 B2RX14 27.609 297 3.18e-30 135.0 sp|B2RX14|TUT4_MOUSE Terminal uridylyltransferase 4 OS=Mus musculus OX=10090 GN=Tut4 PE=1 SV=2 TUT4_MOUSE reviewed Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Mus musculus (Mouse) GO:0001556; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0031664; GO:0032755; GO:0035198; GO:0036464; GO:0050265; GO:0070102; GO:0070569; GO:0141008; GO:1990074 interleukin-6-mediated signaling pathway [GO:0070102]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; positive regulation of interleukin-6 production [GO:0032755]; pre-miRNA processing [GO:0031054]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] g19434.t1 Q8WXA9 62.567 187 1.4300000000000001e-70 239.0 sp|Q8WXA9|SREK1_HUMAN Splicing regulatory glutamine/lysine-rich protein 1 OS=Homo sapiens OX=9606 GN=SREK1 PE=1 SV=1 SREK1_HUMAN reviewed Splicing regulatory glutamine/lysine-rich protein 1 (Serine/arginine-rich-splicing regulatory protein 86) (SRrp86) (Splicing factor, arginine/serine-rich 12) (Splicing regulatory protein 508) (SRrp508) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0016607 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] RNA binding [GO:0003723] g19437.t1 Q09575 37.288 177 3.89e-27 111.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g19437.t2 Q09575 37.288 177 3.8e-27 111.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g19445.t1 B1ATG9 56.713 432 8.01e-164 478.0 sp|B1ATG9|TIKI2_MOUSE Metalloprotease TIKI2 OS=Mus musculus OX=10090 GN=Trabd2b PE=2 SV=1 TIKI2_MOUSE reviewed Metalloprotease TIKI2 (EC 3.4.-.-) (Heart, kidney and adipose-enriched transmembrane protein) (TRAB domain-containing protein 2B) Mus musculus (Mouse) GO:0004222; GO:0005654; GO:0005886; GO:0006508; GO:0016055; GO:0017147; GO:0030178; GO:0031090; GO:0031334; GO:0046872 negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] nucleoplasm [GO:0005654]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147] g19445.t2 B1ATG9 58.333 432 8.83e-173 499.0 sp|B1ATG9|TIKI2_MOUSE Metalloprotease TIKI2 OS=Mus musculus OX=10090 GN=Trabd2b PE=2 SV=1 TIKI2_MOUSE reviewed Metalloprotease TIKI2 (EC 3.4.-.-) (Heart, kidney and adipose-enriched transmembrane protein) (TRAB domain-containing protein 2B) Mus musculus (Mouse) GO:0004222; GO:0005654; GO:0005886; GO:0006508; GO:0016055; GO:0017147; GO:0030178; GO:0031090; GO:0031334; GO:0046872 negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] nucleoplasm [GO:0005654]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147] g19445.t3 B1ATG9 58.333 432 6.969999999999999e-172 499.0 sp|B1ATG9|TIKI2_MOUSE Metalloprotease TIKI2 OS=Mus musculus OX=10090 GN=Trabd2b PE=2 SV=1 TIKI2_MOUSE reviewed Metalloprotease TIKI2 (EC 3.4.-.-) (Heart, kidney and adipose-enriched transmembrane protein) (TRAB domain-containing protein 2B) Mus musculus (Mouse) GO:0004222; GO:0005654; GO:0005886; GO:0006508; GO:0016055; GO:0017147; GO:0030178; GO:0031090; GO:0031334; GO:0046872 negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] nucleoplasm [GO:0005654]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147] g19448.t1 Q9QXA5 90.625 96 2.5899999999999998e-61 186.0 sp|Q9QXA5|LSM4_MOUSE U6 snRNA-associated Sm-like protein LSm4 OS=Mus musculus OX=10090 GN=Lsm4 PE=1 SV=1 g19449.t1 Q7TQK4 48.347 242 6.399999999999999e-82 249.0 sp|Q7TQK4|EXOS3_MOUSE Exosome complex component RRP40 OS=Mus musculus OX=10090 GN=Exosc3 PE=1 SV=3 EXOS3_MOUSE reviewed Exosome complex component RRP40 (EC 3.1.13.-) (Exosome component 3) (Ribosomal RNA-processing protein 40) Mus musculus (Mouse) GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0000791; GO:0000956; GO:0003723; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006402; GO:0034475; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071051; GO:0101019 CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; mRNA catabolic process [GO:0006402]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U4 snRNA 3'-end processing [GO:0034475] cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] exonuclease activity [GO:0004527]; RNA binding [GO:0003723] g19451.t1 P51907 59.93 287 2.19e-109 349.0 sp|P51907|EAA3_RAT Excitatory amino acid transporter 3 OS=Rattus norvegicus OX=10116 GN=Slc1a1 PE=1 SV=1 g19451.t1 P51907 52.991 117 1.5599999999999999e-30 130.0 sp|P51907|EAA3_RAT Excitatory amino acid transporter 3 OS=Rattus norvegicus OX=10116 GN=Slc1a1 PE=1 SV=1 g19457.t1 Q07598 65.019 526 0.0 711.0 sp|Q07598|SCP2_CHICK Sterol carrier protein 2 (Fragment) OS=Gallus gallus OX=9031 GN=SCP2 PE=2 SV=1 SCP2_CHICK reviewed Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X) Gallus gallus (Chicken) GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0033814; GO:0050633; GO:0120019; GO:0120020 bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; lipid transport [GO:0006869] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylcholine transfer activity [GO:0120019]; propanoyl-CoA C-acyltransferase activity [GO:0033814] g19458.t1 Q2F7Z7 39.931 288 4.28e-66 213.0 sp|Q2F7Z7|TMM59_PIG Transmembrane protein 59 OS=Sus scrofa OX=9823 GN=TMEM59 PE=2 SV=1 g19460.t1 Q15386 48.228 1072 0.0 924.0 sp|Q15386|UBE3C_HUMAN Ubiquitin-protein ligase E3C OS=Homo sapiens OX=9606 GN=UBE3C PE=1 SV=3 UBE3C_HUMAN reviewed Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2) (HectH2) (RTA-associated ubiquitin ligase) (RAUL) Homo sapiens (Human) GO:0000209; GO:0000502; GO:0006511; GO:0035519; GO:0061630; GO:0070936 protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] proteasome complex [GO:0000502] ubiquitin protein ligase activity [GO:0061630] g19464.t1 Q2M2T6 74.286 105 9.46e-52 160.0 sp|Q2M2T6|ASTER_BOVIN PAT complex subunit Asterix OS=Bos taurus OX=9913 GN=WDR83OS PE=3 SV=1 ASTER_BOVIN reviewed PAT complex subunit Asterix (Protein WDR83OS homolog) (Protein associated with the ER translocon of 10kDa) (PAT-10) (PAT10) Bos taurus (Bovine) GO:0005789; GO:0044183; GO:0045048; GO:0160063; GO:0160064 multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein insertion into ER membrane [GO:0045048] endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064] protein folding chaperone [GO:0044183] g19465.t1 Q00277 50.314 159 1.79e-42 143.0 sp|Q00277|GPX1_SCHMA Glutathione peroxidase OS=Schistosoma mansoni OX=6183 GN=GPX1 PE=1 SV=2 g19466.t1 Q02368 53.846 104 1.4399999999999999e-34 119.0 sp|Q02368|NDUB7_BOVIN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 OS=Bos taurus OX=9913 GN=NDUFB7 PE=1 SV=2 g19467.t1 Q9D2Y9 52.158 278 2.19e-101 300.0 sp|Q9D2Y9|ELOV7_MOUSE Very long chain fatty acid elongase 7 OS=Mus musculus OX=10090 GN=Elovl7 PE=2 SV=1 ELOV7_MOUSE reviewed Very long chain fatty acid elongase 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Elongation of very long chain fatty acids protein 7) (Very long chain 3-ketoacyl-CoA synthase 7) (Very long chain 3-oxoacyl-CoA synthase 7) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761 fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g19468.t1 Q5M7W7 52.74 438 1.09e-165 479.0 sp|Q5M7W7|SYPM_RAT Probable proline--tRNA ligase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Pars2 PE=2 SV=1 g19469.t1 P70541 46.467 467 2.47e-140 413.0 sp|P70541|EI2BG_RAT Translation initiation factor eIF2B subunit gamma OS=Rattus norvegicus OX=10116 GN=Eif2b3 PE=2 SV=2 EI2BG_RAT reviewed Translation initiation factor eIF2B subunit gamma (eIF2B GDP-GTP exchange factor subunit gamma) Rattus norvegicus (Rat) GO:0002183; GO:0003743; GO:0005085; GO:0005737; GO:0005829; GO:0005851; GO:0006412; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0021766; GO:0043434; GO:0050852 cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851] guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743] g19471.t1 P28575 42.535 576 1.96e-170 499.0 sp|P28575|IPP_MOUSE Actin-binding protein IPP OS=Mus musculus OX=10090 GN=Ipp PE=2 SV=3 g19472.t1 Q9NA75 35.094 265 3.06e-55 182.0 sp|Q9NA75|T38B1_CAEEL Trimeric intracellular cation channel type 1B.1 OS=Caenorhabditis elegans OX=6239 GN=tric-1B.1 PE=1 SV=2 T38B1_CAEEL reviewed Trimeric intracellular cation channel type 1B.1 (TRIC-1B.1) (TRIC-B1) Caenorhabditis elegans GO:0005267; GO:0005789; GO:0042802 endoplasmic reticulum membrane [GO:0005789] identical protein binding [GO:0042802]; potassium channel activity [GO:0005267] g19481.t1 Q9R1M7 30.535 822 1.6900000000000002e-117 389.0 sp|Q9R1M7|NMD3A_RAT Glutamate receptor ionotropic, NMDA 3A OS=Rattus norvegicus OX=10116 GN=Grin3a PE=1 SV=1 NMD3A_RAT reviewed Glutamate receptor ionotropic, NMDA 3A (GluN3A) (Glutamate receptor chi-1) (N-methyl-D-aspartate receptor) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) (NMDAR-L1) Rattus norvegicus (Rat) GO:0004970; GO:0004972; GO:0005262; GO:0005737; GO:0005789; GO:0005886; GO:0006816; GO:0008066; GO:0016020; GO:0016358; GO:0016594; GO:0017146; GO:0022824; GO:0034702; GO:0035235; GO:0035249; GO:0042802; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0045471; GO:0048167; GO:0048511; GO:0048666; GO:0050804; GO:0051721; GO:0060134; GO:0061000; GO:0070905; GO:0098655; GO:0098793; GO:0098839; GO:0098878; GO:0098978; GO:0099171; GO:1904315 calcium ion transport [GO:0006816]; dendrite development [GO:0016358]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of dendritic spine development [GO:0061000]; neuron development [GO:0048666]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; rhythmic process [GO:0048511]; synaptic transmission, glutamatergic [GO:0035249] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] calcium channel activity [GO:0005262]; glutamate receptor activity [GO:0008066]; glutamate-gated receptor activity [GO:0004970]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; NMDA glutamate receptor activity [GO:0004972]; protein phosphatase 2A binding [GO:0051721]; serine binding [GO:0070905]; transmitter-gated monoatomic ion channel activity [GO:0022824]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g19487.t1 Q98TB4 29.211 380 1.1300000000000001e-32 132.0 sp|Q98TB4|GDF8_OREMO Growth/differentiation factor 8 OS=Oreochromis mossambicus OX=8127 GN=gdf-8 PE=2 SV=1 g19488.t1 Q4R5D4 44.559 680 4.85e-177 521.0 sp|Q4R5D4|ASND1_MACFA Asparagine synthetase domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=ASNSD1 PE=2 SV=1 g19489.t1 P41985 26.049 453 4.17e-33 133.0 sp|P41985|ACM2_BOVIN Muscarinic acetylcholine receptor M2 OS=Bos taurus OX=9913 GN=CHRM2 PE=2 SV=2 g19490.t1 Q9Y2P8 69.312 378 0.0 526.0 sp|Q9Y2P8|RCL1_HUMAN RNA 3'-terminal phosphate cyclase-like protein OS=Homo sapiens OX=9606 GN=RCL1 PE=1 SV=3 g19492.t1 O14976 44.942 1384 0.0 1087.0 sp|O14976|GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens OX=9606 GN=GAK PE=1 SV=2 g19493.t1 Q68CZ6 29.984 617 1.92e-78 263.0 sp|Q68CZ6|HAUS3_HUMAN HAUS augmin-like complex subunit 3 OS=Homo sapiens OX=9606 GN=HAUS3 PE=1 SV=1 HAUS3_HUMAN reviewed HAUS augmin-like complex subunit 3 Homo sapiens (Human) GO:0005654; GO:0005739; GO:0005813; GO:0005815; GO:0005829; GO:0005929; GO:0007098; GO:0010968; GO:0015630; GO:0031023; GO:0036064; GO:0045171; GO:0051225; GO:0051301; GO:0070652; GO:0072686; GO:1990498 cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule organizing center organization [GO:0031023]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; nucleoplasm [GO:0005654] g19494.t1 P49453 38.605 215 2.68e-31 131.0 sp|P49453|CENPC_SHEEP Centromere protein C (Fragment) OS=Ovis aries OX=9940 GN=CENPC PE=2 SV=1 g19496.t1 Q9CR59 42.282 149 7.22e-36 129.0 sp|Q9CR59|G45IP_MOUSE Large ribosomal subunit protein mL64 OS=Mus musculus OX=10090 GN=Gadd45gip1 PE=1 SV=1 g19498.t1 Q5ZKV8 56.841 709 0.0 803.0 sp|Q5ZKV8|KIF2A_CHICK Kinesin-like protein KIF2A OS=Gallus gallus OX=9031 GN=KIF2A PE=2 SV=2 KIF2A_CHICK reviewed Kinesin-like protein KIF2A Gallus gallus (Chicken) GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016887; GO:0030154; GO:0051301 cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g19498.t2 Q5ZKV8 55.74 723 0.0 792.0 sp|Q5ZKV8|KIF2A_CHICK Kinesin-like protein KIF2A OS=Gallus gallus OX=9031 GN=KIF2A PE=2 SV=2 KIF2A_CHICK reviewed Kinesin-like protein KIF2A Gallus gallus (Chicken) GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016887; GO:0030154; GO:0051301 cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g19498.t3 Q5ZKV8 55.74 723 0.0 792.0 sp|Q5ZKV8|KIF2A_CHICK Kinesin-like protein KIF2A OS=Gallus gallus OX=9031 GN=KIF2A PE=2 SV=2 KIF2A_CHICK reviewed Kinesin-like protein KIF2A Gallus gallus (Chicken) GO:0000922; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0007052; GO:0007399; GO:0008017; GO:0016887; GO:0030154; GO:0051301 cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g19502.t1 Q61115 49.785 1165 0.0 1092.0 sp|Q61115|PTC1_MOUSE Protein patched homolog 1 OS=Mus musculus OX=10090 GN=Ptch1 PE=1 SV=1 PTC1_MOUSE reviewed Protein patched homolog 1 (PTC) (PTC1) Mus musculus (Mouse) GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001841; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005576; GO:0005794; GO:0005886; GO:0005901; GO:0005929; GO:0007165; GO:0007286; GO:0007346; GO:0007389; GO:0007420; GO:0008158; GO:0008201; GO:0008270; GO:0008285; GO:0008544; GO:0009410; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010875; GO:0015485; GO:0016485; GO:0021522; GO:0021532; GO:0021904; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030850; GO:0030879; GO:0032355; GO:0032526; GO:0032880; GO:0035108; GO:0035137; GO:0040008; GO:0040015; GO:0042127; GO:0042593; GO:0043279; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045177; GO:0045211; GO:0045606; GO:0045668; GO:0045879; GO:0045892; GO:0045893; GO:0048471; GO:0048568; GO:0048745; GO:0050680; GO:0051782; GO:0060037; GO:0060603; GO:0060644; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072203; GO:0072205; GO:0072659; GO:0097108; GO:0097421 animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube formation [GO:0001841]; neural tube patterning [GO:0021532]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal cell differentiation [GO:0045606]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of cell population proliferation [GO:0042127]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; response to alkaloid [GO:0043279]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spermatid development [GO:0007286]; spinal cord motor neuron differentiation [GO:0021522] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; cilium [GO:0005929]; dendritic growth cone [GO:0044294]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]; zinc ion binding [GO:0008270] g19503.t1 Q8C1A5 63.678 658 0.0 890.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 THOP1_MOUSE reviewed Thimet oligopeptidase (EC 3.4.24.15) Mus musculus (Mouse) GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0043171; GO:0046872 intracellular signal transduction [GO:0035556]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] mitochondrial intermembrane space [GO:0005758] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277] g19503.t2 Q8C1A5 63.83 658 0.0 894.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 THOP1_MOUSE reviewed Thimet oligopeptidase (EC 3.4.24.15) Mus musculus (Mouse) GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0043171; GO:0046872 intracellular signal transduction [GO:0035556]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] mitochondrial intermembrane space [GO:0005758] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277] g19503.t3 Q8C1A5 62.918 658 0.0 881.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 THOP1_MOUSE reviewed Thimet oligopeptidase (EC 3.4.24.15) Mus musculus (Mouse) GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0043171; GO:0046872 intracellular signal transduction [GO:0035556]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] mitochondrial intermembrane space [GO:0005758] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277] g19503.t4 Q8C1A5 61.976 668 0.0 872.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 THOP1_MOUSE reviewed Thimet oligopeptidase (EC 3.4.24.15) Mus musculus (Mouse) GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0043171; GO:0046872 intracellular signal transduction [GO:0035556]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] mitochondrial intermembrane space [GO:0005758] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277] g19503.t5 Q8C1A5 61.504 678 0.0 877.0 sp|Q8C1A5|THOP1_MOUSE Thimet oligopeptidase OS=Mus musculus OX=10090 GN=Thop1 PE=1 SV=1 THOP1_MOUSE reviewed Thimet oligopeptidase (EC 3.4.24.15) Mus musculus (Mouse) GO:0004222; GO:0005758; GO:0006508; GO:0006518; GO:0008233; GO:0035556; GO:0042277; GO:0043171; GO:0046872 intracellular signal transduction [GO:0035556]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] mitochondrial intermembrane space [GO:0005758] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277] g19504.t1 Q9H4F1 38.846 260 1.96e-53 189.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g19506.t1 Q6VVW5 45.752 612 1.68e-162 505.0 sp|Q6VVW5|ANPRB_MOUSE Atrial natriuretic peptide receptor 2 OS=Mus musculus OX=10090 GN=Npr2 PE=1 SV=2 ANPRB_MOUSE reviewed Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) Mus musculus (Mouse) GO:0000165; GO:0001541; GO:0001549; GO:0001568; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007281; GO:0007283; GO:0007338; GO:0007409; GO:0007605; GO:0008015; GO:0009611; GO:0009725; GO:0010641; GO:0010753; GO:0016941; GO:0017046; GO:0019228; GO:0019934; GO:0021562; GO:0021647; GO:0021675; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042060; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0046068; GO:0048546; GO:0048565; GO:0048599; GO:0048668; GO:0048745; GO:0050872; GO:0051216; GO:0051276; GO:0051402; GO:0051447; GO:0060173; GO:0060348; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537 activation of meiosis involved in egg activation [GO:0060466]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cartilage development [GO:0051216]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract development [GO:0048565]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; germ cell development [GO:0007281]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to fibroblast growth factor [GO:0071774]; response to hormone [GO:0009725]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve development [GO:0021562]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060] cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672] g19508.t1 Q96MU7 51.94 335 7.679999999999999e-94 311.0 sp|Q96MU7|YTDC1_HUMAN YTH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=YTHDC1 PE=1 SV=3 YTDC1_HUMAN reviewed YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B) Homo sapiens (Human) GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0050873; GO:0110104; GO:0140313; GO:1990247 brown fat cell differentiation [GO:0050873]; dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723] g19509.t1 P08045 27.438 1097 9.37e-88 318.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 24.927 1376 1.37e-84 309.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 25.602 1246 8.69e-81 297.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 24.608 1276 5.51e-80 294.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 26.942 1017 1.17e-71 268.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 25.461 1139 2.85e-71 267.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 24.119 1078 1.5599999999999998e-61 236.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 28.244 524 2.82e-37 157.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19509.t1 P08045 23.362 702 2.5600000000000004e-32 141.0 sp|P08045|XFIN_XENLA Zinc finger protein Xfin OS=Xenopus laevis OX=8355 PE=1 SV=1 g19514.t1 Q03168 52.405 395 8.71e-146 422.0 sp|Q03168|ASPP_AEDAE Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2 g19515.t1 Q0ZDF7 46.061 165 2.8000000000000002e-43 145.0 sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1 g19519.t1 B3EWZ3 37.872 470 1.6199999999999998e-81 296.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g19519.t1 B3EWZ3 35.932 526 3.76e-78 285.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g19519.t1 B3EWZ3 39.202 426 1.07e-76 281.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g19519.t1 B3EWZ3 39.303 201 4.48e-31 136.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g19520.t1 A2AJL3 60.766 548 0.0 704.0 sp|A2AJL3|FGGY_MOUSE FGGY carbohydrate kinase domain-containing protein OS=Mus musculus OX=10090 GN=Fggy PE=1 SV=1 g19522.t1 Q05117 46.557 305 6.23e-100 300.0 sp|Q05117|PPA5_MOUSE Tartrate-resistant acid phosphatase type 5 OS=Mus musculus OX=10090 GN=Acp5 PE=1 SV=2 PPA5_MOUSE reviewed Tartrate-resistant acid phosphatase type 5 (TR-AP) (EC 3.1.3.2) (Tartrate-resistant acid ATPase) (TrATPase) (Type 5 acid phosphatase) Mus musculus (Mouse) GO:0003993; GO:0005615; GO:0005764; GO:0007162; GO:0008198; GO:0008199; GO:0016787; GO:0030335; GO:0032496; GO:0032691; GO:0032695; GO:0032720; GO:0032929; GO:0034097; GO:0045019; GO:0045453; GO:0050728; GO:0050830; GO:0060349 bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cell adhesion [GO:0007162]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cell migration [GO:0030335]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496] extracellular space [GO:0005615]; lysosome [GO:0005764] acid phosphatase activity [GO:0003993]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; hydrolase activity [GO:0016787] g19523.t1 Q5ZLX5 56.842 190 1.66e-48 167.0 sp|Q5ZLX5|ZRAB2_CHICK Zinc finger Ran-binding domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ZRANB2 PE=2 SV=1 g19524.t1 P35556 34.013 932 1.31e-95 339.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 33.519 898 4.58e-87 313.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 34.048 840 3.79e-82 298.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 32.822 847 9.379999999999999e-82 297.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 32.436 817 7.090000000000001e-80 291.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 31.962 851 6.04e-69 258.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 30.347 893 5.43e-68 255.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 32.258 806 8.96e-64 242.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t1 P35556 33.031 772 1.82e-58 225.0 sp|P35556|FBN2_HUMAN Fibrillin-2 OS=Homo sapiens OX=9606 GN=FBN2 PE=1 SV=3 FBN2_HUMAN reviewed Fibrillin-2 [Cleaved into: Placensin] Homo sapiens (Human) GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0006006; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g19524.t2 P98133 35.287 802 1.35e-87 314.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 35.062 810 1.39e-87 314.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 32.202 972 5.71e-78 285.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 34.309 752 5.9e-76 279.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 34.217 792 9.130000000000001e-75 275.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 33.101 861 1.61e-74 274.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 33.29 769 9.010000000000001e-73 269.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 32.118 878 3.48e-72 267.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 30.725 869 6.5e-65 244.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 33.25 797 5.49e-63 239.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 33.519 540 1.4400000000000002e-43 177.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19524.t2 P98133 35.26 346 5.7800000000000005e-37 155.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g19525.t1 Q06806 39.74 385 1.37e-82 295.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19525.t2 Q06806 39.74 385 1.63e-82 294.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19525.t3 Q06806 39.74 385 2.34e-83 294.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19526.t1 Q95ZS2 50.207 482 4.19e-178 522.0 sp|Q95ZS2|TDC1_CAEEL Tyrosine decarboxylase OS=Caenorhabditis elegans OX=6239 GN=tdc-1 PE=2 SV=1 TDC1_CAEEL reviewed Tyrosine decarboxylase (EC 4.1.1.25) Caenorhabditis elegans GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0016831; GO:0019752; GO:0030170; GO:0030424; GO:0043025; GO:0043204 amino acid metabolic process [GO:0006520]; carboxylic acid metabolic process [GO:0019752]; octopamine biosynthetic process [GO:0006589] axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837] g19527.t1 Q95ZS2 53.053 475 0.0 558.0 sp|Q95ZS2|TDC1_CAEEL Tyrosine decarboxylase OS=Caenorhabditis elegans OX=6239 GN=tdc-1 PE=2 SV=1 TDC1_CAEEL reviewed Tyrosine decarboxylase (EC 4.1.1.25) Caenorhabditis elegans GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0016831; GO:0019752; GO:0030170; GO:0030424; GO:0043025; GO:0043204 amino acid metabolic process [GO:0006520]; carboxylic acid metabolic process [GO:0019752]; octopamine biosynthetic process [GO:0006589] axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837] g19528.t1 P08760 59.624 213 4.66e-94 277.0 sp|P08760|KAD3_BOVIN GTP:AMP phosphotransferase AK3, mitochondrial OS=Bos taurus OX=9913 GN=AK3 PE=1 SV=3 g19531.t1 P54315 33.784 444 4.82e-76 249.0 sp|P54315|LIPR1_HUMAN Inactive pancreatic lipase-related protein 1 OS=Homo sapiens OX=9606 GN=PNLIPRP1 PE=1 SV=1 LIPR1_HUMAN reviewed Inactive pancreatic lipase-related protein 1 (PL-RP1) Homo sapiens (Human) GO:0004465; GO:0004806; GO:0005509; GO:0005576; GO:0006633; GO:0008970; GO:0019433; GO:0034375; GO:0042632 cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; triglyceride catabolic process [GO:0019433] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; lipoprotein lipase activity [GO:0004465]; phospholipase A1 activity [GO:0008970]; triacylglycerol lipase activity [GO:0004806] g19532.t1 P06857 33.921 454 1.3599999999999999e-74 244.0 sp|P06857|LIPR1_CANLF Inactive pancreatic lipase-related protein 1 OS=Canis lupus familiaris OX=9615 GN=PNLIPRP1 PE=1 SV=2 g19533.t1 Q9CQ36 43.269 104 4.65e-28 102.0 sp|Q9CQ36|DPOE4_MOUSE DNA polymerase epsilon subunit 4 OS=Mus musculus OX=10090 GN=Pole4 PE=1 SV=1 g19534.t1 Q9DGI3 50.962 104 4.7400000000000004e-36 122.0 sp|Q9DGI3|THIO_ICTPU Thioredoxin OS=Ictalurus punctatus OX=7998 GN=txn PE=3 SV=1 g19535.t1 Q01581 71.237 372 0.0 565.0 sp|Q01581|HMCS1_HUMAN Hydroxymethylglutaryl-CoA synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=HMGCS1 PE=1 SV=2 HMCS1_HUMAN reviewed Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase) Homo sapiens (Human) GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0010142; GO:0042803 acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629] cytoplasm [GO:0005737]; cytosol [GO:0005829] hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803] g19544.t1 Q5M7L9 51.701 294 6.829999999999999e-68 221.0 sp|Q5M7L9|FOXD3_XENTR Forkhead box protein D3 OS=Xenopus tropicalis OX=8364 GN=foxd3 PE=2 SV=1 FOXD3_XENTR reviewed Forkhead box protein D3 (FoxD3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000978; GO:0000981; GO:0001755; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0007422; GO:0009653; GO:0010629; GO:0014034; GO:0030154; GO:0030318; GO:0045892; GO:0048484; GO:0048485; GO:0048937; GO:0050768; GO:0050769; GO:0050935; GO:0060351; GO:0097066 anatomical structure morphogenesis [GO:0009653]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell differentiation [GO:0030154]; enteric nervous system development [GO:0048484]; iridophore differentiation [GO:0050935]; lateral line nerve glial cell development [GO:0048937]; melanocyte differentiation [GO:0030318]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of neurogenesis [GO:0050768]; neural crest cell fate commitment [GO:0014034]; neural crest cell migration [GO:0001755]; peripheral nervous system development [GO:0007422]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]; response to thyroid hormone [GO:0097066]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g19545.t1 Q8VEH6 60.484 372 3.0900000000000004e-157 450.0 sp|Q8VEH6|ZNG1_MOUSE Zinc-regulated GTPase metalloprotein activator 1 OS=Mus musculus OX=10090 GN=Zng1 PE=1 SV=1 ZNG1_MOUSE reviewed Zinc-regulated GTPase metalloprotein activator 1 (EC 3.6.5.-) (Cobalamin synthase W domain-containing protein 1) (COBW domain-containing protein 1) Mus musculus (Mouse) GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0006882; GO:0051604; GO:0140827 intracellular zinc ion homeostasis [GO:0006882]; kidney development [GO:0001822]; protein maturation [GO:0051604] cytoplasm [GO:0005737]; nucleus [GO:0005634] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc chaperone activity [GO:0140827] g19546.t1 Q8K0C1 44.69 951 0.0 815.0 sp|Q8K0C1|IPO13_MOUSE Importin-13 OS=Mus musculus OX=10090 GN=Ipo13 PE=1 SV=1 g19547.t1 Q7TMA5 28.865 1119 2.61e-111 405.0 sp|Q7TMA5|APOB_RAT Apolipoprotein B-100 OS=Rattus norvegicus OX=10116 GN=Apob PE=1 SV=1 APOB_RAT reviewed Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)] Rattus norvegicus (Rat) GO:0001701; GO:0005543; GO:0005615; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009743; GO:0009791; GO:0010269; GO:0010628; GO:0010744; GO:0010884; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0031983; GO:0032355; GO:0032496; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034364; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042627; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071356; GO:0071379; GO:0071402; GO:0120020; GO:1904646 artery morphogenesis [GO:0048844]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipoprotein particle stimulus [GO:0071402]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642] chylomicron [GO:0042627]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983] cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018] g19555.t1 P17225 56.02 407 9.28e-141 418.0 sp|P17225|PTBP1_MOUSE Polypyrimidine tract-binding protein 1 OS=Mus musculus OX=10090 GN=Ptbp1 PE=1 SV=3 g19555.t2 P17225 57.037 405 5.9999999999999995e-142 421.0 sp|P17225|PTBP1_MOUSE Polypyrimidine tract-binding protein 1 OS=Mus musculus OX=10090 GN=Ptbp1 PE=1 SV=3 g19556.t1 Q6DJC8 36.071 280 1.64e-45 158.0 sp|Q6DJC8|TM53B_XENLA Transmembrane protein 53-B OS=Xenopus laevis OX=8355 GN=tmem53-b PE=2 SV=1 g19557.t1 A7MBF6 55.362 401 2.09e-161 464.0 sp|A7MBF6|ARMD1_BOVIN Armadillo-like helical domain containing protein 1 OS=Bos taurus OX=9913 GN=ARMH1 PE=2 SV=1 g19558.t1 Q90243 21.655 1039 1.8800000000000001e-47 191.0 sp|Q90243|VIT_ACITR Vitellogenin (Fragment) OS=Acipenser transmontanus OX=7904 PE=2 SV=1 g19558.t2 Q90243 21.655 1039 1.91e-47 191.0 sp|Q90243|VIT_ACITR Vitellogenin (Fragment) OS=Acipenser transmontanus OX=7904 PE=2 SV=1 g19560.t1 Q8BHG1 50.0 962 0.0 989.0 sp|Q8BHG1|NRDC_MOUSE Nardilysin OS=Mus musculus OX=10090 GN=Nrdc PE=1 SV=1 NRDC_MOUSE reviewed Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase) Mus musculus (Mouse) GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0032760; GO:0046872; GO:0050772; GO:0051044; GO:0061133; GO:0120163; GO:1903265 negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508] dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] endopeptidase activator activity [GO:0061133]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233] g19561.t1 P23378 66.184 967 0.0 1337.0 sp|P23378|GCSP_HUMAN Glycine dehydrogenase (decarboxylating), mitochondrial OS=Homo sapiens OX=9606 GN=GLDC PE=1 SV=2 GCSP_HUMAN reviewed Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring)) Homo sapiens (Human) GO:0004375; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0005960; GO:0006546; GO:0009055; GO:0016594; GO:0016829; GO:0019464; GO:0030170; GO:0036255; GO:0042803; GO:0070280; GO:1903442; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170] g19561.t2 P23378 64.718 992 0.0 1326.0 sp|P23378|GCSP_HUMAN Glycine dehydrogenase (decarboxylating), mitochondrial OS=Homo sapiens OX=9606 GN=GLDC PE=1 SV=2 GCSP_HUMAN reviewed Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring)) Homo sapiens (Human) GO:0004375; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0005960; GO:0006546; GO:0009055; GO:0016594; GO:0016829; GO:0019464; GO:0030170; GO:0036255; GO:0042803; GO:0070280; GO:1903442; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170] g19562.t1 Q60HG7 63.918 388 0.0 513.0 sp|Q60HG7|CGL_MACFA Cystathionine gamma-lyase OS=Macaca fascicularis OX=9541 GN=CTH PE=2 SV=1 g19566.t1 Q8BFZ2 37.075 294 1.31e-56 191.0 sp|Q8BFZ2|PLPR1_MOUSE Phospholipid phosphatase-related protein type 1 OS=Mus musculus OX=10090 GN=Plppr1 PE=1 SV=1 g19567.t1 Q8BJ52 36.861 274 6.3299999999999994e-46 162.0 sp|Q8BJ52|PLPR5_MOUSE Phospholipid phosphatase-related protein type 5 OS=Mus musculus OX=10090 GN=Plppr5 PE=2 SV=1 PLPR5_MOUSE reviewed Phospholipid phosphatase-related protein type 5 (Lipid phosphate phosphatase-related protein type 5) (Plasticity-related gene 5 protein) (PRG-5) Mus musculus (Mouse) GO:0005886; GO:0006644; GO:0007165; GO:0008195; GO:0010976; GO:0046839; GO:0051491 phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165] plasma membrane [GO:0005886] phosphatidate phosphatase activity [GO:0008195] g19568.t1 Q99437 63.235 204 2.22e-84 251.0 sp|Q99437|VATO_HUMAN V-type proton ATPase 21 kDa proteolipid subunit c'' OS=Homo sapiens OX=9606 GN=ATP6V0B PE=1 SV=1 VATO_HUMAN reviewed V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (Vacuolar proton pump 21 kDa proteolipid subunit c'') (hATPL) Homo sapiens (Human) GO:0000139; GO:0000220; GO:0005765; GO:0005886; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0030665; GO:0030670; GO:0033176; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:1902600 endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] clathrin-coated vesicle membrane [GO:0030665]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] proton-transporting ATPase activity, rotational mechanism [GO:0046961] g19569.t1 F7E540 49.878 822 0.0 838.0 sp|F7E540|TTLL7_XENTR Tubulin polyglutamylase TTLL7 OS=Xenopus tropicalis OX=8364 GN=ttll7 PE=1 SV=2 TTLL7_XENTR reviewed Tubulin polyglutamylase TTLL7 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 7) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005874; GO:0005929; GO:0007399; GO:0018095; GO:0030154; GO:0030425; GO:0043204; GO:0046872; GO:0070740; GO:0106437; GO:0106438 cell differentiation [GO:0030154]; nervous system development [GO:0007399]; protein polyglutamylation [GO:0018095] cilium [GO:0005929]; dendrite [GO:0030425]; microtubule [GO:0005874]; perikaryon [GO:0043204] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740] g19570.t1 Q8NEA6 48.321 536 1.33e-131 422.0 sp|Q8NEA6|GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens OX=9606 GN=GLIS3 PE=1 SV=5 GLIS3_HUMAN reviewed Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g19571.t1 Q9DBG9 51.163 86 1.69e-24 92.8 sp|Q9DBG9|TX1B3_MOUSE Tax1-binding protein 3 OS=Mus musculus OX=10090 GN=Tax1bp3 PE=1 SV=1 TX1B3_MOUSE reviewed Tax1-binding protein 3 (Tax interaction protein 1) (TIP-1) Mus musculus (Mouse) GO:0001650; GO:0005634; GO:0005737; GO:0005886; GO:0007266; GO:0008013; GO:0008285; GO:0015629; GO:0016055; GO:0030178; GO:0032489; GO:2000009 negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of Wnt signaling pathway [GO:0030178]; regulation of Cdc42 protein signal transduction [GO:0032489]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway [GO:0016055] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; plasma membrane [GO:0005886] beta-catenin binding [GO:0008013] g19572.t1 Q5MNV6 64.286 378 1.04e-164 468.0 sp|Q5MNV6|ZNT7_CHICK Zinc transporter 7 OS=Gallus gallus OX=9031 GN=SLC30A7 PE=2 SV=1 ZNT7_CHICK reviewed Zinc transporter 7 (Solute carrier family 30 member 7) Gallus gallus (Chicken) GO:0000139; GO:0005385; GO:0005739; GO:0005794; GO:0006882; GO:0031410; GO:0033017; GO:0042802; GO:0048471; GO:1904257; GO:1990674 intracellular zinc ion homeostasis [GO:0006882]; zinc ion import into Golgi lumen [GO:1904257] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017] identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385] g19573.t1 Q9CWQ0 68.953 277 4.36e-146 414.0 sp|Q9CWQ0|DPH5_MOUSE Diphthine methyl ester synthase OS=Mus musculus OX=10090 GN=Dph5 PE=1 SV=2 DPH5_MOUSE reviewed Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase) Mus musculus (Mouse) GO:0004164; GO:0005829; GO:0017183; GO:0032259; GO:0141133 methylation [GO:0032259]; protein histidyl modification to diphthamide [GO:0017183] cytosol [GO:0005829] diphthine methyl ester synthase activity [GO:0141133]; diphthine synthase activity [GO:0004164] g19576.t1 Q5RKS2 64.103 78 6.49e-29 101.0 sp|Q5RKS2|SMIM7_MOUSE Small integral membrane protein 7 OS=Mus musculus OX=10090 GN=Smim7 PE=3 SV=1 g19577.t1 P28288 67.069 662 0.0 934.0 sp|P28288|ABCD3_HUMAN ATP-binding cassette sub-family D member 3 OS=Homo sapiens OX=9606 GN=ABCD3 PE=1 SV=1 ABCD3_HUMAN reviewed ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70) Homo sapiens (Human) GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0015721; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0047617; GO:0140359; GO:1903512 bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803] g19577.t2 P16970 62.629 388 1.53e-172 499.0 sp|P16970|ABCD3_RAT ATP-binding cassette sub-family D member 3 OS=Rattus norvegicus OX=10116 GN=Abcd3 PE=1 SV=3 ABCD3_RAT reviewed ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70) Rattus norvegicus (Rat) GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0006633; GO:0006635; GO:0006699; GO:0006869; GO:0007031; GO:0009410; GO:0015721; GO:0015910; GO:0016887; GO:0042626; GO:0042760; GO:0042802; GO:0042803; GO:0047617; GO:0140359; GO:1903512 bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; lipid transport [GO:0006869]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803] g19577.t3 P28288 73.826 298 6.47e-164 473.0 sp|P28288|ABCD3_HUMAN ATP-binding cassette sub-family D member 3 OS=Homo sapiens OX=9606 GN=ABCD3 PE=1 SV=1 ABCD3_HUMAN reviewed ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70) Homo sapiens (Human) GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0015721; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0047617; GO:0140359; GO:1903512 bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803] g19578.t1 Q6VZZ7 38.462 299 1.52e-64 216.0 sp|Q6VZZ7|OPN5_MOUSE Opsin-5 OS=Mus musculus OX=10090 GN=Opn5 PE=1 SV=1 OPN5_MOUSE reviewed Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin) Mus musculus (Mouse) GO:0001750; GO:0004930; GO:0005502; GO:0005737; GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0007604; GO:0008020; GO:0043153; GO:0071482; GO:0071492; GO:1990384 cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930] g19579.t1 O75072 42.737 475 2e-133 396.0 sp|O75072|FKTN_HUMAN Ribitol-5-phosphate transferase FKTN OS=Homo sapiens OX=9606 GN=FKTN PE=1 SV=2 FKTN_HUMAN reviewed Ribitol-5-phosphate transferase FKTN (EC 2.7.8.-) (Fukutin) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005801; GO:0006493; GO:0007399; GO:0007517; GO:0008285; GO:0016780; GO:0021695; GO:0021987; GO:0035269; GO:0046329; GO:0071711; GO:0098528 basement membrane organization [GO:0071711]; cerebellar cortex development [GO:0021695]; cerebral cortex development [GO:0021987]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of JNK cascade [GO:0046329]; nervous system development [GO:0007399]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via mannose [GO:0035269]; skeletal muscle fiber differentiation [GO:0098528] cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] phosphotransferase activity, for other substituted phosphate groups [GO:0016780] g19585.t1 Q9U943 24.867 1130 6.55e-84 312.0 sp|Q9U943|APLP_LOCMI Apolipophorins OS=Locusta migratoria OX=7004 PE=1 SV=2 g19586.t1 A0JMR6 39.362 470 4.54e-98 333.0 sp|A0JMR6|MYSM1_XENLA Histone H2A deubiquitinase MYSM1 OS=Xenopus laevis OX=8355 GN=mysm1 PE=2 SV=1 MYSM1_XENLA reviewed Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1) Xenopus laevis (African clawed frog) GO:0003677; GO:0003713; GO:0005634; GO:0006302; GO:0006338; GO:0006508; GO:0008237; GO:0031593; GO:0042393; GO:0045944; GO:0046872; GO:0070531; GO:0070552; GO:0140492; GO:0140950 chromatin remodeling [GO:0006338]; double-strand break repair [GO:0006302]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; transcription coactivator activity [GO:0003713] g19588.t1 Q04870 43.178 535 8.220000000000001e-100 314.0 sp|Q04870|T2FA_XENLA General transcription factor IIF subunit 1 OS=Xenopus laevis OX=8355 GN=gtf2f1 PE=2 SV=1 g19589.t1 Q9Z254 56.818 308 2.93e-112 332.0 sp|Q9Z254|GIPC1_RAT PDZ domain-containing protein GIPC1 OS=Rattus norvegicus OX=10116 GN=Gipc1 PE=1 SV=2 g19590.t1 Q9QZU7 32.161 398 2.3199999999999997e-67 224.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g19591.t1 P80003 41.221 131 2.33e-34 127.0 sp|P80003|PA2A2_HELSU Acidic phospholipase A2 PA4 OS=Heloderma suspectum OX=8554 PE=1 SV=2 g19593.t1 P70490 37.888 161 1.25e-28 112.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g19596.t1 Q7ZWX9 39.303 402 3.48e-64 216.0 sp|Q7ZWX9|MIDNB_XENLA Midnolin-B OS=Xenopus laevis OX=8355 GN=midn-b PE=2 SV=1 g19597.t1 Q8IY84 61.205 415 0.0 516.0 sp|Q8IY84|NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens OX=9606 GN=NIM1K PE=1 SV=1 NIM1_HUMAN reviewed Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0035556; GO:0106310 intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19597.t2 Q8IY84 58.661 433 9.05e-177 504.0 sp|Q8IY84|NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens OX=9606 GN=NIM1K PE=1 SV=1 NIM1_HUMAN reviewed Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase) Homo sapiens (Human) GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0035556; GO:0106310 intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19599.t1 Q4FZQ6 77.934 213 7.8e-118 345.0 sp|Q4FZQ6|PR38A_XENLA Pre-mRNA-splicing factor 38A OS=Xenopus laevis OX=8355 GN=prpf38a PE=2 SV=1 g19600.t1 Q13415 54.98 502 2.25e-160 495.0 sp|Q13415|ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens OX=9606 GN=ORC1 PE=1 SV=2 g19603.t1 Q28DV3 77.934 426 0.0 719.0 sp|Q28DV3|HDAC3_XENTR Histone deacetylase 3 OS=Xenopus tropicalis OX=8364 GN=hdac3 PE=2 SV=1 HDAC3_XENTR reviewed Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000118; GO:0000122; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0017053; GO:0032922; GO:0033558; GO:0040029; GO:0042752; GO:0046872; GO:0140229; GO:0141221; GO:0160008; GO:0160009; GO:0160010; GO:0160216 circadian regulation of gene expression [GO:0032922]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; histone isonicotinyllysine deisonicotinylase activity [GO:0140229]; metal ion binding [GO:0046872]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein decrotonylase activity [GO:0160008]; protein lysine deacetylase activity [GO:0033558]; protein lysine delactylase activity [GO:0160216]; transcription corepressor activity [GO:0003714] g19603.t2 Q28DV3 77.934 426 0.0 719.0 sp|Q28DV3|HDAC3_XENTR Histone deacetylase 3 OS=Xenopus tropicalis OX=8364 GN=hdac3 PE=2 SV=1 HDAC3_XENTR reviewed Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000118; GO:0000122; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0017053; GO:0032922; GO:0033558; GO:0040029; GO:0042752; GO:0046872; GO:0140229; GO:0141221; GO:0160008; GO:0160009; GO:0160010; GO:0160216 circadian regulation of gene expression [GO:0032922]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; histone isonicotinyllysine deisonicotinylase activity [GO:0140229]; metal ion binding [GO:0046872]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein decrotonylase activity [GO:0160008]; protein lysine deacetylase activity [GO:0033558]; protein lysine delactylase activity [GO:0160216]; transcription corepressor activity [GO:0003714] g19606.t1 Q9H074 28.065 367 2.41e-39 150.0 sp|Q9H074|PAIP1_HUMAN Polyadenylate-binding protein-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAIP1 PE=1 SV=1 g19607.t1 Q6DJK9 62.637 273 6.989999999999999e-128 380.0 sp|Q6DJK9|YJU2B_XENLA Probable splicing factor YJU2B OS=Xenopus laevis OX=8355 GN=yju2b PE=2 SV=1 g19608.t1 Q924Y0 36.053 380 1.94e-84 267.0 sp|Q924Y0|BODG_MOUSE Gamma-butyrobetaine dioxygenase OS=Mus musculus OX=10090 GN=Bbox1 PE=1 SV=1 g19610.t1 Q7TT28 43.056 648 9.8e-148 488.0 sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1 g19610.t2 Q7TT28 40.634 694 7.5e-142 473.0 sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1 g19611.t1 A2VDD2 40.496 121 5.230000000000001e-29 107.0 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g19612.t1 Q6P2X9 28.541 466 2.36e-47 172.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g19613.t1 Q99P88 48.929 1400 0.0 1342.0 sp|Q99P88|NU155_MOUSE Nuclear pore complex protein Nup155 OS=Mus musculus OX=10090 GN=Nup155 PE=1 SV=1 NU155_MOUSE reviewed Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155) Mus musculus (Mouse) GO:0000972; GO:0005635; GO:0005643; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0017056; GO:0031965; GO:0034504; GO:0035196; GO:0036228; GO:0044611; GO:0086014 atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; protein localization to nucleus [GO:0034504]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g19618.t1 Q9W4S9 57.642 229 1.88e-70 238.0 sp|Q9W4S9|PDE4C_DROME 3',5'-cyclic-AMP phosphodiesterase, isoforms N/G OS=Drosophila melanogaster OX=7227 GN=dnc PE=3 SV=2 PDE4C_DROME reviewed 3',5'-cyclic-AMP phosphodiesterase, isoforms N/G (EC 3.1.4.53) (Learning/memory process protein) (Protein dunce) (cAMP-specific phosphodiesterase, isoforms N/G) Drosophila melanogaster (Fruit fly) GO:0001661; GO:0004115; GO:0006198; GO:0007165; GO:0007268; GO:0007612; GO:0007613; GO:0007614; GO:0007615; GO:0007617; GO:0007619; GO:0007623; GO:0008306; GO:0008355; GO:0040040; GO:0045202; GO:0046872; GO:0046958; GO:0048675 anesthesia-resistant memory [GO:0007615]; associative learning [GO:0008306]; axon extension [GO:0048675]; cAMP catabolic process [GO:0006198]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; conditioned taste aversion [GO:0001661]; courtship behavior [GO:0007619]; learning [GO:0007612]; mating behavior [GO:0007617]; memory [GO:0007613]; nonassociative learning [GO:0046958]; olfactory learning [GO:0008355]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; thermosensory behavior [GO:0040040] synapse [GO:0045202] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; metal ion binding [GO:0046872] g19619.t1 Q01063 69.565 276 8.3e-144 427.0 sp|Q01063|PDE4D_MOUSE 3',5'-cyclic-AMP phosphodiesterase 4D OS=Mus musculus OX=10090 GN=Pde4d PE=1 SV=2 g19620.t1 Q66IC8 34.503 171 1.45e-30 112.0 sp|Q66IC8|DYLT5_DANRE Dynein light chain Tctex-type 5 OS=Danio rerio OX=7955 GN=dynlt5 PE=2 SV=1 g19621.t1 P98166 37.017 751 2.46e-131 438.0 sp|P98166|VLDLR_RAT Very low-density lipoprotein receptor OS=Rattus norvegicus OX=10116 GN=Vldlr PE=2 SV=1 VLDLR_RAT reviewed Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) Rattus norvegicus (Rat) GO:0001666; GO:0005509; GO:0005615; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007166; GO:0007507; GO:0007584; GO:0008203; GO:0009410; GO:0009725; GO:0009986; GO:0016020; GO:0021517; GO:0021987; GO:0030229; GO:0030296; GO:0032496; GO:0032869; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0042149; GO:0043235; GO:0045177; GO:0045202; GO:0048306; GO:0048471; GO:0048813; GO:0051963; GO:0071222; GO:0071347; GO:0071456; GO:0098978; GO:1900006 cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex development [GO:0021987]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; heart development [GO:0007507]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; regulation of synapse assembly [GO:0051963]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; protein tyrosine kinase activator activity [GO:0030296]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] g19621.t1 P98166 27.921 505 1.08e-52 205.0 sp|P98166|VLDLR_RAT Very low-density lipoprotein receptor OS=Rattus norvegicus OX=10116 GN=Vldlr PE=2 SV=1 VLDLR_RAT reviewed Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) Rattus norvegicus (Rat) GO:0001666; GO:0005509; GO:0005615; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007166; GO:0007507; GO:0007584; GO:0008203; GO:0009410; GO:0009725; GO:0009986; GO:0016020; GO:0021517; GO:0021987; GO:0030229; GO:0030296; GO:0032496; GO:0032869; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0042149; GO:0043235; GO:0045177; GO:0045202; GO:0048306; GO:0048471; GO:0048813; GO:0051963; GO:0071222; GO:0071347; GO:0071456; GO:0098978; GO:1900006 cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex development [GO:0021987]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; heart development [GO:0007507]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; regulation of synapse assembly [GO:0051963]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; protein tyrosine kinase activator activity [GO:0030296]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] g19621.t1 P98166 28.877 374 6.55e-37 155.0 sp|P98166|VLDLR_RAT Very low-density lipoprotein receptor OS=Rattus norvegicus OX=10116 GN=Vldlr PE=2 SV=1 VLDLR_RAT reviewed Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) Rattus norvegicus (Rat) GO:0001666; GO:0005509; GO:0005615; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007166; GO:0007507; GO:0007584; GO:0008203; GO:0009410; GO:0009725; GO:0009986; GO:0016020; GO:0021517; GO:0021987; GO:0030229; GO:0030296; GO:0032496; GO:0032869; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0042149; GO:0043235; GO:0045177; GO:0045202; GO:0048306; GO:0048471; GO:0048813; GO:0051963; GO:0071222; GO:0071347; GO:0071456; GO:0098978; GO:1900006 cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex development [GO:0021987]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; heart development [GO:0007507]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; regulation of synapse assembly [GO:0051963]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; protein tyrosine kinase activator activity [GO:0030296]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] g19621.t1 P98166 27.979 386 1.58e-34 148.0 sp|P98166|VLDLR_RAT Very low-density lipoprotein receptor OS=Rattus norvegicus OX=10116 GN=Vldlr PE=2 SV=1 VLDLR_RAT reviewed Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) Rattus norvegicus (Rat) GO:0001666; GO:0005509; GO:0005615; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007166; GO:0007507; GO:0007584; GO:0008203; GO:0009410; GO:0009725; GO:0009986; GO:0016020; GO:0021517; GO:0021987; GO:0030229; GO:0030296; GO:0032496; GO:0032869; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0042149; GO:0043235; GO:0045177; GO:0045202; GO:0048306; GO:0048471; GO:0048813; GO:0051963; GO:0071222; GO:0071347; GO:0071456; GO:0098978; GO:1900006 cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex development [GO:0021987]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; heart development [GO:0007507]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; regulation of synapse assembly [GO:0051963]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; protein tyrosine kinase activator activity [GO:0030296]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] g19622.t1 Q6UWH4 35.474 327 1.13e-39 157.0 sp|Q6UWH4|GAK1B_HUMAN Golgi-associated kinase 1B OS=Homo sapiens OX=9606 GN=GASK1B PE=1 SV=1 g19623.t1 Q9QZU7 36.579 380 2.44e-85 270.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g19624.t1 Q5R5D8 37.815 119 1.82e-25 102.0 sp|Q5R5D8|BODG_PONAB Gamma-butyrobetaine dioxygenase OS=Pongo abelii OX=9601 GN=BBOX1 PE=2 SV=1 BODG_PONAB reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329 carnitine biosynthetic process [GO:0045329] mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g19625.t1 Q9QZU7 36.022 372 2.5599999999999998e-84 268.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g19626.t1 Q9UNH5 63.599 489 0.0 657.0 sp|Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens OX=9606 GN=CDC14A PE=1 SV=1 g19626.t2 Q9UNH5 64.389 483 0.0 661.0 sp|Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens OX=9606 GN=CDC14A PE=1 SV=1 g19626.t3 Q9UNH5 63.599 489 0.0 657.0 sp|Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens OX=9606 GN=CDC14A PE=1 SV=1 g19627.t1 Q8N183 40.881 159 1.41e-26 101.0 sp|Q8N183|NDUF2_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 OS=Homo sapiens OX=9606 GN=NDUFAF2 PE=1 SV=1 NDUF2_HUMAN reviewed NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 (B17.2-like) (B17.2L) (Mimitin) (Myc-induced mitochondrial protein) (MMTN) (NDUFA12-like protein) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0032981; GO:0044877; GO:0045271; GO:0060271; GO:0061179 cilium assembly [GO:0060271]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] protein-containing complex binding [GO:0044877] g19628.t1 Q8CFD5 56.897 232 3.55e-99 297.0 sp|Q8CFD5|ERCC8_MOUSE DNA excision repair protein ERCC-8 OS=Mus musculus OX=10090 GN=Ercc8 PE=1 SV=2 ERCC8_MOUSE reviewed DNA excision repair protein ERCC-8 (Cockayne syndrome WD repeat protein CSA homolog) Mus musculus (Mouse) GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0010165; GO:0010996; GO:0016363; GO:0016567; GO:0031464; GO:0032991; GO:0043161; GO:0043204; GO:0045739; GO:0051865; GO:0080008; GO:0090262; GO:0090734; GO:0097680; GO:1990756 DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to auditory stimulus [GO:0010996]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g19629.t1 Q5BIM8 49.091 165 1.0099999999999999e-46 159.0 sp|Q5BIM8|ERCC8_BOVIN DNA excision repair protein ERCC-8 OS=Bos taurus OX=9913 GN=ERCC8 PE=2 SV=1 ERCC8_BOVIN reviewed DNA excision repair protein ERCC-8 Bos taurus (Bovine) GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0045739; GO:0051865; GO:0080008; GO:0090734; GO:0097680; GO:1990756 DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g19634.t1 Q9Y547 45.185 135 6.41e-41 136.0 sp|Q9Y547|IFT25_HUMAN Intraflagellar transport protein 25 homolog OS=Homo sapiens OX=9606 GN=IFT25 PE=1 SV=1 IFT25_HUMAN reviewed Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Heat shock protein family B member 11) (Placental protein 25) (PP25) Homo sapiens (Human) GO:0001501; GO:0001822; GO:0005813; GO:0005929; GO:0007224; GO:0007283; GO:0007507; GO:0015031; GO:0030154; GO:0030324; GO:0030991; GO:0030992; GO:0035720; GO:0046872; GO:0060271; GO:0070986; GO:0097542 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; intraciliary transport particle B [GO:0030992] metal ion binding [GO:0046872] g19635.t1 Q99N42 50.111 451 3.78e-142 418.0 sp|Q99N42|TYPH_MOUSE Thymidine phosphorylase OS=Mus musculus OX=10090 GN=Tymp PE=2 SV=1 TYPH_MOUSE reviewed Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase) Mus musculus (Mouse) GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0009032; GO:0009887; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333 animal organ morphogenesis [GO:0009887]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969] cytosol [GO:0005829] 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; thymidine phosphorylase activity [GO:0009032] g19636.t1 Q6DCF6 37.811 402 5.8399999999999996e-98 308.0 sp|Q6DCF6|EFCB7_XENLA EF-hand calcium-binding domain-containing protein 7 OS=Xenopus laevis OX=8355 GN=efcab7 PE=2 SV=1 g19638.t1 Q9NXG6 36.951 387 3.47e-76 248.0 sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2 g19639.t1 Q2NKS3 40.984 122 1.5400000000000002e-27 100.0 sp|Q2NKS3|PSMG3_BOVIN Proteasome assembly chaperone 3 OS=Bos taurus OX=9913 GN=PSMG3 PE=2 SV=1 g19640.t1 P10949 55.702 228 6.47e-76 230.0 sp|P10949|RAB3C_BOVIN Ras-related protein Rab-3C OS=Bos taurus OX=9913 GN=RAB3C PE=1 SV=3 RAB3C_BOVIN reviewed Ras-related protein Rab-3C (EC 3.6.5.2) (SMG P25C) Bos taurus (Bovine) GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0015031; GO:0031489 exocytosis [GO:0006887]; protein transport [GO:0015031] endosome [GO:0005768]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] g19642.t1 Q5U2Z0 44.34 318 1.11e-72 229.0 sp|Q5U2Z0|ZN367_RAT Zinc finger protein 367 OS=Rattus norvegicus OX=10116 GN=Znf367 PE=2 SV=1 g19643.t1 Q8NBS3 45.375 800 0.0 654.0 sp|Q8NBS3|S4A11_HUMAN Solute carrier family 4 member 11 OS=Homo sapiens OX=9606 GN=SLC4A11 PE=1 SV=3 g19645.t1 D3ZYR1 43.653 898 0.0 653.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g19645.t2 Q0JRZ9 44.764 869 0.0 665.0 sp|Q0JRZ9|FCHO2_HUMAN F-BAR domain only protein 2 OS=Homo sapiens OX=9606 GN=FCHO2 PE=1 SV=2 FCHO2_HUMAN reviewed F-BAR domain only protein 2 Homo sapiens (Human) GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynapse [GO:0098793] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g19645.t3 D3ZYR1 45.946 851 0.0 681.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g19645.t4 D3ZYR1 41.561 551 9.14e-113 369.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g19645.t4 D3ZYR1 53.571 308 2.15e-94 320.0 sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1 FCHO2_RAT reviewed F-BAR domain only protein 2 Rattus norvegicus (Rat) GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793 clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786] g19646.t1 P46530 40.59 1424 0.0 935.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 37.474 1465 0.0 868.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 40.316 1265 0.0 867.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 39.489 1175 0.0 805.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 33.44 1558 6.830000000000001e-166 579.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 34.188 1287 3.87e-163 570.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 34.544 1459 4.98e-162 566.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 32.568 1480 5.3e-162 566.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 31.818 1540 3.52e-157 551.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 32.292 960 1.71e-103 378.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t1 P46530 35.032 471 1.93e-52 210.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 40.59 1424 0.0 936.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 37.474 1465 0.0 868.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 40.316 1265 0.0 867.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 39.489 1175 0.0 805.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 31.905 1727 2.6700000000000003e-166 580.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 34.544 1459 4.21e-162 567.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 32.568 1480 4.52e-162 567.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 31.818 1540 2.7500000000000002e-157 552.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19646.t2 P46530 35.032 471 1.93e-52 210.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g19664.t1 Q96K37 50.867 346 3.86e-113 338.0 sp|Q96K37|S35E1_HUMAN Solute carrier family 35 member E1 OS=Homo sapiens OX=9606 GN=SLC35E1 PE=1 SV=2 g19665.t1 Q92889 54.143 881 0.0 953.0 sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3 g19667.t1 F1N9Y5 41.796 646 8.53e-161 479.0 sp|F1N9Y5|KSYK_CHICK Tyrosine-protein kinase SYK OS=Gallus gallus OX=9031 GN=SYK PE=1 SV=2 KSYK_CHICK reviewed Tyrosine-protein kinase SYK (EC 2.7.10.2) Gallus gallus (Chicken) GO:0001945; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0005886; GO:0007159; GO:0007229; GO:0010543; GO:0018108; GO:0030593; GO:0032009; GO:0032928; GO:0033630; GO:0035556; GO:0042742; GO:0043313; GO:0045087; GO:0045780; GO:0048514; GO:0050764; GO:0050853; GO:0070301; GO:0070372; GO:0071226; GO:0090237; GO:0090330 adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; regulation of arachidonate secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554] cytosol [GO:0005829]; early phagosome [GO:0032009]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] g19667.t2 F1N9Y5 41.731 647 1.67e-160 479.0 sp|F1N9Y5|KSYK_CHICK Tyrosine-protein kinase SYK OS=Gallus gallus OX=9031 GN=SYK PE=1 SV=2 KSYK_CHICK reviewed Tyrosine-protein kinase SYK (EC 2.7.10.2) Gallus gallus (Chicken) GO:0001945; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0005886; GO:0007159; GO:0007229; GO:0010543; GO:0018108; GO:0030593; GO:0032009; GO:0032928; GO:0033630; GO:0035556; GO:0042742; GO:0043313; GO:0045087; GO:0045780; GO:0048514; GO:0050764; GO:0050853; GO:0070301; GO:0070372; GO:0071226; GO:0090237; GO:0090330 adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; regulation of arachidonate secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554] cytosol [GO:0005829]; early phagosome [GO:0032009]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] g19668.t1 Q19425 44.404 545 2.8e-143 431.0 sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2 g19668.t2 Q8NBW4 48.43 223 4.67e-66 216.0 sp|Q8NBW4|S38A9_HUMAN Neutral amino acid transporter 9 OS=Homo sapiens OX=9606 GN=SLC38A9 PE=1 SV=2 g19670.t1 Q9Y5W3 88.776 98 1.9000000000000002e-58 196.0 sp|Q9Y5W3|KLF2_HUMAN Krueppel-like factor 2 OS=Homo sapiens OX=9606 GN=KLF2 PE=1 SV=2 g19672.t1 Q29550 36.648 543 1.12e-90 307.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g19672.t1 Q29550 31.919 542 1.48e-59 218.0 sp|Q29550|EST1_PIG Liver carboxylesterase OS=Sus scrofa OX=9823 PE=1 SV=1 EST1_PIG reviewed Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH) Sus scrofa (Pig) GO:0005783; GO:0005788; GO:0005811; GO:0016042; GO:0052689; GO:0106435 lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689] g19674.t1 O73791 33.333 372 2.68e-36 148.0 sp|O73791|TIE2_DANRE Angiopoietin-1 receptor OS=Danio rerio OX=7955 GN=tek PE=1 SV=1 g19675.t1 Q95J56 39.207 227 7.060000000000001e-43 171.0 sp|Q95J56|DJC14_BOVIN DnaJ homolog subfamily C member 14 OS=Bos taurus OX=9913 GN=DNAJC14 PE=1 SV=1 g19676.t1 Q14678 57.143 273 9.57e-83 304.0 sp|Q14678|KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KANK1 PE=1 SV=3 KANK1_HUMAN reviewed KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030674; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0043622; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393 actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; cortical microtubule organization [GO:0043622]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] beta-catenin binding [GO:0008013]; protein-macromolecule adaptor activity [GO:0030674] g19676.t2 Q14678 57.091 275 1.9699999999999998e-82 303.0 sp|Q14678|KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KANK1 PE=1 SV=3 KANK1_HUMAN reviewed KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030674; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0043622; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393 actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; cortical microtubule organization [GO:0043622]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] beta-catenin binding [GO:0008013]; protein-macromolecule adaptor activity [GO:0030674] g19677.t1 Q3U6K5 34.737 285 3.07e-34 138.0 sp|Q3U6K5|SPAT6_MOUSE Spermatogenesis-associated protein 6 OS=Mus musculus OX=10090 GN=Spata6 PE=1 SV=2 SPAT6_MOUSE reviewed Spermatogenesis-associated protein 6 (Kinesin-related protein) Mus musculus (Mouse) GO:0005576; GO:0007283; GO:0030154; GO:0031514; GO:0032027; GO:0044458; GO:0120212 cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] extracellular region [GO:0005576]; motile cilium [GO:0031514]; sperm head-tail coupling apparatus [GO:0120212] myosin light chain binding [GO:0032027] g19678.t1 Q7Z7F7 33.058 121 3.95e-21 85.1 sp|Q7Z7F7|RM55_HUMAN Large ribosomal subunit protein mL55 OS=Homo sapiens OX=9606 GN=MRPL55 PE=1 SV=1 RM55_HUMAN reviewed Large ribosomal subunit protein mL55 (39S ribosomal protein L55, mitochondrial) (L55mt) (MRP-L55) (Mitochondrial large ribosomal subunit protein bL31m) Homo sapiens (Human) GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] structural constituent of ribosome [GO:0003735] g19679.t1 Q8R1P4 35.47 234 6.83e-38 134.0 sp|Q8R1P4|ATG10_MOUSE Ubiquitin-like-conjugating enzyme ATG10 OS=Mus musculus OX=10090 GN=Atg10 PE=1 SV=1 g19679.t2 Q8R1P4 35.622 233 2.19e-38 135.0 sp|Q8R1P4|ATG10_MOUSE Ubiquitin-like-conjugating enzyme ATG10 OS=Mus musculus OX=10090 GN=Atg10 PE=1 SV=1 g19680.t1 Q9D032 55.672 476 6.05e-112 339.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19680.t2 Q9D032 53.689 488 2.75e-109 333.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19680.t3 Q9D032 56.025 473 1.38e-111 338.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19680.t4 Q9D032 56.503 469 3.13e-112 340.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19680.t5 Q9D032 58.889 450 9.800000000000001e-117 350.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19680.t6 Q9D032 57.955 440 9.6e-109 329.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19680.t7 Q9D032 53.731 469 7.84e-110 333.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19680.t8 Q9D032 57.5 440 1.63e-108 328.0 sp|Q9D032|SSBP3_MOUSE Single-stranded DNA-binding protein 3 OS=Mus musculus OX=10090 GN=Ssbp3 PE=1 SV=2 SSBP3_MOUSE reviewed Single-stranded DNA-binding protein 3 (Lck-associated signal transducer) (Sequence-specific single-stranded-DNA-binding protein) Mus musculus (Mouse) GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0030154; GO:0032991; GO:0045893; GO:0045944; GO:0060322; GO:0060323; GO:0065003; GO:2000744 cell differentiation [GO:0030154]; head development [GO:0060322]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] g19681.t1 P28828 40.541 592 1.21e-128 443.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19683.t1 Q06806 45.033 302 1.3e-78 283.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19683.t1 Q06806 28.932 515 1.03e-36 154.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19684.t1 Q02858 34.824 425 1.0400000000000001e-70 256.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19685.t1 Q06806 45.033 302 3.74e-78 284.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19685.t1 Q06806 32.609 322 1.92e-33 144.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19686.t1 O76536 25.296 759 9.72e-28 124.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19686.t1 O76536 27.133 715 7.640000000000001e-27 122.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g19687.t1 Q02763 42.339 248 4.35e-65 234.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19687.t2 Q02763 42.339 248 4.71e-65 233.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19688.t1 P54727 45.045 333 3.43e-77 245.0 sp|P54727|RD23B_HUMAN UV excision repair protein RAD23 homolog B OS=Homo sapiens OX=9606 GN=RAD23B PE=1 SV=1 RD23B_HUMAN reviewed Lysine-specific demethylase RAD23B (EC 1.14.11.-) (UV excision repair protein RAD23 homolog B) (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58) Homo sapiens (Human) GO:0000502; GO:0000978; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006289; GO:0007283; GO:0031593; GO:0032434; GO:0035575; GO:0043130; GO:0043161; GO:0048568; GO:0061629; GO:0070628; GO:0070914; GO:0071942; GO:0098761; GO:0140612 cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283]; UV-damage excision repair [GO:0070914] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942] damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; histone H4K20 demethylase activity [GO:0035575]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130] g19690.t1 Q6AY22 36.875 160 3.22e-23 107.0 sp|Q6AY22|SPAT1_RAT Spermatogenesis-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Spata1 PE=2 SV=1 g19691.t1 P55809 72.277 202 8.380000000000001e-105 314.0 sp|P55809|SCOT1_HUMAN Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=OXCT1 PE=1 SV=1 SCOT1_HUMAN reviewed Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0007507; GO:0007584; GO:0008260; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046952; GO:0060612; GO:1902224 adipose tissue development [GO:0060612]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; succinyl-CoA:3-oxo-acid CoA-transferase activity [GO:0008260] g19692.t1 P55809 72.961 233 1.22e-119 355.0 sp|P55809|SCOT1_HUMAN Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=OXCT1 PE=1 SV=1 SCOT1_HUMAN reviewed Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0007507; GO:0007584; GO:0008260; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046952; GO:0060612; GO:1902224 adipose tissue development [GO:0060612]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; succinyl-CoA:3-oxo-acid CoA-transferase activity [GO:0008260] g19693.t1 Q5XJN2 45.992 237 8.18e-73 225.0 sp|Q5XJN2|GILT_DANRE Gamma-interferon-inducible lysosomal thiol reductase OS=Danio rerio OX=7955 GN=ifi30 PE=1 SV=1 GILT_DANRE reviewed Gamma-interferon-inducible lysosomal thiol reductase (zGILT) (EC 1.8.4.-) (Gamma-interferon-inducible protein IP-30) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425 cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376] extracellular region [GO:0005576]; lysosome [GO:0005764] oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134] g19694.t1 Q5XJN2 45.148 237 7.13e-72 223.0 sp|Q5XJN2|GILT_DANRE Gamma-interferon-inducible lysosomal thiol reductase OS=Danio rerio OX=7955 GN=ifi30 PE=1 SV=1 GILT_DANRE reviewed Gamma-interferon-inducible lysosomal thiol reductase (zGILT) (EC 1.8.4.-) (Gamma-interferon-inducible protein IP-30) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425 cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376] extracellular region [GO:0005576]; lysosome [GO:0005764] oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134] g19695.t1 Q5RFU5 44.706 85 2.1e-21 87.0 sp|Q5RFU5|MMAC_DANRE Cyanocobalamin reductase / alkylcobalamin dealkylase OS=Danio rerio OX=7955 GN=mmachc PE=3 SV=2 MMAC_DANRE reviewed Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase) (EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)) (EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein) (MMACHC) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0005829; GO:0009235; GO:0016740; GO:0031419; GO:0032451; GO:0033787; GO:0048703; GO:0061181; GO:0071949 cobalamin metabolic process [GO:0009235]; embryonic viscerocranium morphogenesis [GO:0048703]; regulation of chondrocyte development [GO:0061181] cytoplasm [GO:0005737]; cytosol [GO:0005829] cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) (NADP+) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; transferase activity [GO:0016740] g19696.t1 Q08DP0 63.093 569 0.0 714.0 sp|Q08DP0|PGM1_BOVIN Phosphoglucomutase-1 OS=Bos taurus OX=9913 GN=PGM1 PE=2 SV=1 g19697.t1 Q96PH1 45.681 521 4.06e-128 408.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g19697.t1 Q96PH1 50.787 254 9.320000000000001e-77 270.0 sp|Q96PH1|NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens OX=9606 GN=NOX5 PE=1 SV=1 g19700.t1 Q9Y5Q9 41.138 773 0.0 567.0 sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1 g19701.t1 Q4R4T9 38.095 420 4.12e-58 205.0 sp|Q4R4T9|RANB3_MACFA Ran-binding protein 3 OS=Macaca fascicularis OX=9541 GN=RANBP3 PE=2 SV=1 g19701.t2 Q9CT10 35.141 461 1.35e-56 201.0 sp|Q9CT10|RANB3_MOUSE Ran-binding protein 3 OS=Mus musculus OX=10090 GN=Ranbp3 PE=1 SV=2 g19701.t3 Q9CT10 35.699 465 7.01e-57 202.0 sp|Q9CT10|RANB3_MOUSE Ran-binding protein 3 OS=Mus musculus OX=10090 GN=Ranbp3 PE=1 SV=2 g19702.t1 Q9Y672 51.697 501 2.78e-166 483.0 sp|Q9Y672|ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG6 PE=1 SV=2 ALG6_HUMAN reviewed Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase) Homo sapiens (Human) GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0016020; GO:0042281; GO:0046527; GO:0098553 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020] dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527] g19705.t1 A7S5D9 54.694 245 3.26e-94 282.0 sp|A7S5D9|IYD_NEMVE Iodotyrosine deiodinase OS=Nematostella vectensis OX=45351 GN=v1g105379 PE=1 SV=1 IYD_NEMVE reviewed Iodotyrosine deiodinase (EC 1.21.1.1) (Halotyrosine dehalogenase) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0006570; GO:0010181; GO:0016491; GO:0140616 tyrosine metabolic process [GO:0006570] plasma membrane [GO:0005886] FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491] g19706.t1 A7S5D9 54.321 243 3.46e-92 276.0 sp|A7S5D9|IYD_NEMVE Iodotyrosine deiodinase OS=Nematostella vectensis OX=45351 GN=v1g105379 PE=1 SV=1 IYD_NEMVE reviewed Iodotyrosine deiodinase (EC 1.21.1.1) (Halotyrosine dehalogenase) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0006570; GO:0010181; GO:0016491; GO:0140616 tyrosine metabolic process [GO:0006570] plasma membrane [GO:0005886] FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491] g19707.t1 P35590 43.0 300 1.45e-76 262.0 sp|P35590|TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens OX=9606 GN=TIE1 PE=1 SV=1 TIE1_HUMAN reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Homo sapiens (Human) GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19708.t1 Q02858 36.864 236 6.78e-47 174.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19709.t1 Q02858 32.082 293 9.12e-32 129.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19710.t1 Q7ZV22 63.869 274 2.8999999999999997e-131 375.0 sp|Q7ZV22|MTAP_DANRE S-methyl-5'-thioadenosine phosphorylase OS=Danio rerio OX=7955 GN=mtap PE=2 SV=2 g19711.t1 O12944 67.881 741 0.0 1037.0 sp|O12944|RAD54_CHICK DNA repair and recombination protein RAD54-like (Fragment) OS=Gallus gallus OX=9031 GN=RAD54L PE=2 SV=1 g19713.t1 D2YVH7 34.118 170 4.03e-21 87.8 sp|D2YVH7|LECM_OXYSU C-type lectin mannose-binding isoform OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1 g19714.t1 P06027 35.172 145 1.6299999999999997e-23 93.6 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g19716.t1 Q9Y345 50.317 630 0.0 610.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g19716.t2 Q9Y345 49.158 653 0.0 611.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g19717.t1 Q761V0 50.338 592 0.0 600.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g19719.t1 Q96LT7 31.544 447 5.479999999999999e-81 261.0 sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange factor C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2 CI072_HUMAN reviewed Guanine nucleotide exchange factor C9orf72 Homo sapiens (Human) GO:0000932; GO:0001933; GO:0005085; GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0044295; GO:0044304; GO:0044754; GO:0045920; GO:0048675; GO:0050777; GO:0061909; GO:0090543; GO:0098686; GO:0098693; GO:0098794; GO:0098978; GO:0099523; GO:0110053; GO:1902774; GO:1903432; GO:2000785 autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063] autolysosome [GO:0044754]; autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g19722.t1 Q9BU89 58.609 302 2.73e-120 350.0 sp|Q9BU89|DOHH_HUMAN Deoxyhypusine hydroxylase OS=Homo sapiens OX=9606 GN=DOHH PE=1 SV=1 DOHH_HUMAN reviewed Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1) Homo sapiens (Human) GO:0005506; GO:0005829; GO:0008612; GO:0019135 peptidyl-lysine modification to peptidyl-hypusine [GO:0008612] cytosol [GO:0005829] deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506] g19722.t1 Q9BU89 38.889 126 1.8300000000000003e-21 95.5 sp|Q9BU89|DOHH_HUMAN Deoxyhypusine hydroxylase OS=Homo sapiens OX=9606 GN=DOHH PE=1 SV=1 DOHH_HUMAN reviewed Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1) Homo sapiens (Human) GO:0005506; GO:0005829; GO:0008612; GO:0019135 peptidyl-lysine modification to peptidyl-hypusine [GO:0008612] cytosol [GO:0005829] deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506] g19723.t1 Q6IR74 45.039 635 0.0 547.0 sp|Q6IR74|CTL1_XENLA Choline transporter-like protein 1 OS=Xenopus laevis OX=8355 GN=slc44a1 PE=2 SV=2 g19732.t1 Q06807 37.5 256 1.31e-44 175.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19734.t1 A2AVA0 35.352 3352 0.0 1949.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g19734.t1 A2AVA0 30.355 1802 0.0 794.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g19734.t2 A2AVA0 34.875 3352 0.0 1903.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g19734.t2 A2AVA0 30.355 1802 0.0 795.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g19735.t1 B1AS42 42.14 299 2.2e-82 254.0 sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1 g19737.t1 Q9R095 36.832 2001 0.0 1134.0 sp|Q9R095|SPEF2_RAT Sperm flagellar protein 2 OS=Rattus norvegicus OX=10116 GN=Spef2 PE=1 SV=2 g19737.t2 Q9R095 36.721 2007 0.0 1128.0 sp|Q9R095|SPEF2_RAT Sperm flagellar protein 2 OS=Rattus norvegicus OX=10116 GN=Spef2 PE=1 SV=2 g19739.t1 Q8CDY7 34.928 209 2.1200000000000003e-27 106.0 sp|Q8CDY7|DYLT4_MOUSE Dynein light chain Tctex-type 4 OS=Mus musculus OX=10090 GN=Dynlt4 PE=1 SV=1 g19742.t1 Q9VCR7 47.11 346 4.320000000000001e-109 329.0 sp|Q9VCR7|CTNS_DROME Cystinosin OS=Drosophila melanogaster OX=7227 GN=Ctns PE=1 SV=2 g19743.t1 Q6DC04 53.559 590 0.0 615.0 sp|Q6DC04|CARM1_DANRE Histone-arginine methyltransferase CARM1 OS=Danio rerio OX=7955 GN=carm1 PE=2 SV=1 CARM1_DANRE reviewed Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000976; GO:0003713; GO:0005634; GO:0005829; GO:0006338; GO:0006355; GO:0008757; GO:0016274; GO:0032259; GO:0033146; GO:0035242; GO:0035642; GO:0043596; GO:0045600; GO:0048742; GO:0070611; GO:0071932; GO:0140903 chromatin remodeling [GO:0006338]; methylation [GO:0032259]; positive regulation of fat cell differentiation [GO:0045600]; regulation of DNA-templated transcription [GO:0006355]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]; replication fork reversal [GO:0071932] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634] histone H3R17 methyltransferase activity [GO:0035642]; histone H3R2 methyltransferase activity [GO:0070611]; histone H3R26 methyltransferase activity [GO:0140903]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g19744.t1 A2A9C3 33.164 1972 0.0 949.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g19744.t1 A2A9C3 32.529 1740 0.0 723.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g19744.t2 A2A9C3 33.215 1972 0.0 948.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g19744.t2 A2A9C3 31.991 1763 0.0 714.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g19744.t3 A2A9C3 33.215 1972 0.0 948.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g19744.t3 A2A9C3 31.192 1074 5.38e-125 449.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g19744.t3 A2A9C3 36.193 641 3.31e-74 282.0 sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1 SZT2_MOUSE reviewed KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR) Mus musculus (Mouse) GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667] GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] g19751.t1 Q23835 55.152 495 4.82e-180 536.0 sp|Q23835|AMY1_DROAN Alpha-amylase 1 OS=Drosophila ananassae OX=7217 GN=Amy35 PE=3 SV=3 g19751.t1 Q23835 54.545 495 3.48e-178 532.0 sp|Q23835|AMY1_DROAN Alpha-amylase 1 OS=Drosophila ananassae OX=7217 GN=Amy35 PE=3 SV=3 g19752.t1 P91778 53.846 104 1.21e-31 119.0 sp|P91778|AMY_PECMA Alpha-amylase OS=Pecten maximus OX=6579 PE=2 SV=1 g19753.t1 P00690 60.0 235 2.02e-87 270.0 sp|P00690|AMYP_PIG Pancreatic alpha-amylase OS=Sus scrofa OX=9823 GN=AMY2 PE=1 SV=3 g19754.t1 H2N0D4 58.994 517 0.0 605.0 sp|H2N0D4|AMY_ORYLA Alpha-amylase OS=Oryzias latipes OX=8090 PE=1 SV=1 AMY_ORYLA reviewed Alpha-amylase (EC 3.2.1.1) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0004556; GO:0005615; GO:0005975; GO:0046872 carbohydrate metabolic process [GO:0005975] extracellular space [GO:0005615] alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872] g19755.t1 P29957 40.113 708 1.59e-151 483.0 sp|P29957|AMY_PSEHA Alpha-amylase OS=Pseudoalteromonas haloplanktis OX=228 GN=amy PE=1 SV=3 g19755.t1 P29957 45.37 216 3.42e-44 176.0 sp|P29957|AMY_PSEHA Alpha-amylase OS=Pseudoalteromonas haloplanktis OX=228 GN=amy PE=1 SV=3 g19755.t1 P29957 44.724 199 3.31e-40 163.0 sp|P29957|AMY_PSEHA Alpha-amylase OS=Pseudoalteromonas haloplanktis OX=228 GN=amy PE=1 SV=3 g19755.t1 P29957 44.724 199 3.66e-39 160.0 sp|P29957|AMY_PSEHA Alpha-amylase OS=Pseudoalteromonas haloplanktis OX=228 GN=amy PE=1 SV=3 g19755.t1 P29957 44.221 199 1.62e-38 158.0 sp|P29957|AMY_PSEHA Alpha-amylase OS=Pseudoalteromonas haloplanktis OX=228 GN=amy PE=1 SV=3 g19756.t1 P18709 23.326 956 1.0999999999999999e-48 195.0 sp|P18709|VITA2_XENLA Vitellogenin-A2 OS=Xenopus laevis OX=8355 PE=1 SV=1 g19757.t1 P18709 23.326 956 2e-49 197.0 sp|P18709|VITA2_XENLA Vitellogenin-A2 OS=Xenopus laevis OX=8355 PE=1 SV=1 g19758.t1 P18709 23.67 959 6.36e-51 202.0 sp|P18709|VITA2_XENLA Vitellogenin-A2 OS=Xenopus laevis OX=8355 PE=1 SV=1 g19759.t1 Q9NRA2 32.035 462 1.12e-66 224.0 sp|Q9NRA2|S17A5_HUMAN Sialin OS=Homo sapiens OX=9606 GN=SLC17A5 PE=1 SV=2 g19761.t1 Q96CW9 32.578 353 6.58e-47 179.0 sp|Q96CW9|NTNG2_HUMAN Netrin-G2 OS=Homo sapiens OX=9606 GN=NTNG2 PE=1 SV=2 g19761.t2 Q96CW9 32.123 358 4.41e-47 180.0 sp|Q96CW9|NTNG2_HUMAN Netrin-G2 OS=Homo sapiens OX=9606 GN=NTNG2 PE=1 SV=2 g19763.t1 Q6PCS4 39.121 933 0.0 611.0 sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1 g19763.t2 Q6PCS4 39.121 933 0.0 610.0 sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1 g19764.t1 Q3SZD5 37.548 261 6.26e-40 160.0 sp|Q3SZD5|DCA15_BOVIN DDB1- and CUL4-associated factor 15 OS=Bos taurus OX=9913 GN=DCAF15 PE=2 SV=1 DCA15_BOVIN reviewed DDB1- and CUL4-associated factor 15 Bos taurus (Bovine) GO:0000209; GO:0002376; GO:0016567; GO:0032814; GO:0046872; GO:0080008 immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] metal ion binding [GO:0046872] g19764.t1 Q3SZD5 34.184 196 2.8499999999999997e-25 115.0 sp|Q3SZD5|DCA15_BOVIN DDB1- and CUL4-associated factor 15 OS=Bos taurus OX=9913 GN=DCAF15 PE=2 SV=1 DCA15_BOVIN reviewed DDB1- and CUL4-associated factor 15 Bos taurus (Bovine) GO:0000209; GO:0002376; GO:0016567; GO:0032814; GO:0046872; GO:0080008 immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] metal ion binding [GO:0046872] g19765.t1 Q8CE50 43.717 382 1.65e-111 339.0 sp|Q8CE50|SNX30_MOUSE Sorting nexin-30 OS=Mus musculus OX=10090 GN=Snx30 PE=1 SV=1 g19765.t2 Q8CE50 43.947 380 1.24e-113 345.0 sp|Q8CE50|SNX30_MOUSE Sorting nexin-30 OS=Mus musculus OX=10090 GN=Snx30 PE=1 SV=1 g19767.t1 Q15831 59.799 398 4.3e-160 461.0 sp|Q15831|STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens OX=9606 GN=STK11 PE=1 SV=1 g19769.t1 P70187 61.992 492 0.0 598.0 sp|P70187|MF14A_MOUSE Hippocampus abundant transcript 1 protein OS=Mus musculus OX=10090 GN=Mfsd14a PE=2 SV=3 S71A1_MOUSE reviewed Solute carrier family 71 member 1 (Hippocampus abundant transcript 1 protein) (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein) Mus musculus (Mouse) GO:0000139; GO:0001675; GO:0007283; GO:0007286; GO:0007289; GO:0022857; GO:0030382 acrosome assembly [GO:0001675]; sperm mitochondrion organization [GO:0030382]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283] Golgi membrane [GO:0000139] transmembrane transporter activity [GO:0022857] g19770.t1 A0A1I9LN01 26.296 540 4.14e-32 134.0 sp|A0A1I9LN01|LAF3_ARATH Protein LONG AFTER FAR-RED 3 OS=Arabidopsis thaliana OX=3702 GN=LAF3 PE=2 SV=1 LAF3_ARATH reviewed Protein LONG AFTER FAR-RED 3 (EC 3.5.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0005783; GO:0009704; GO:0009845; GO:0010218; GO:0016020; GO:0016810; GO:0048471 de-etiolation [GO:0009704]; response to far red light [GO:0010218]; seed germination [GO:0009845] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810] g19771.t1 Q3B8D7 36.691 139 1.66e-28 110.0 sp|Q3B8D7|DYL5A_XENLA Dynein light chain Tctex-type 5-A OS=Xenopus laevis OX=8355 GN=Dynlt5-a PE=2 SV=1 g19772.t1 Q5RJI4 31.387 274 8.55e-36 139.0 sp|Q5RJI4|PKDCC_MOUSE Extracellular tyrosine-protein kinase PKDCC OS=Mus musculus OX=10090 GN=Pkdcc PE=1 SV=2 PKDCC_MOUSE reviewed Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase) Mus musculus (Mouse) GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] g19774.t1 O95405 51.827 739 0.0 815.0 sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2 ZFYV9_HUMAN reviewed Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation) Homo sapiens (Human) GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0008270; GO:0016197; GO:0019904; GO:0031901; GO:0032991 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; protein-containing complex [GO:0032991] 1-phosphatidylinositol binding [GO:0005545]; protein domain specific binding [GO:0019904]; zinc ion binding [GO:0008270] g19775.t1 Q90511 64.957 351 1.45e-163 464.0 sp|Q90511|EI2BB_TAKRU Translation initiation factor eIF2B subunit beta OS=Takifugu rubripes OX=31033 GN=eif2b2 PE=3 SV=1 g19776.t1 A3KMX0 48.738 634 0.0 632.0 sp|A3KMX0|ER6L2_BOVIN DNA excision repair protein ERCC-6-like 2 OS=Bos taurus OX=9913 GN=ERCC6L2 PE=2 SV=4 ER6L2_BOVIN reviewed DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) Bos taurus (Bovine) GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0036297; GO:0097680 DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297] centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787] g19777.t1 Q6GPB9 48.201 778 0.0 717.0 sp|Q6GPB9|DNAI4_XENLA Dynein axonemal intermediate chain 4 OS=Xenopus laevis OX=8355 GN=dnai4 PE=2 SV=1 g19777.t2 Q6GPB9 48.201 778 0.0 717.0 sp|Q6GPB9|DNAI4_XENLA Dynein axonemal intermediate chain 4 OS=Xenopus laevis OX=8355 GN=dnai4 PE=2 SV=1 g19777.t3 Q6GPB9 48.201 778 0.0 717.0 sp|Q6GPB9|DNAI4_XENLA Dynein axonemal intermediate chain 4 OS=Xenopus laevis OX=8355 GN=dnai4 PE=2 SV=1 g19779.t1 Q9VCZ3 29.664 327 7.15e-31 125.0 sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1 OCTB1_DROME reviewed Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R) Drosophila melanogaster (Fruit fly) GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410] membrane [GO:0016020]; plasma membrane [GO:0005886] adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989] g19783.t1 Q6AXP1 42.593 162 5.05e-26 117.0 sp|Q6AXP1|CS044_RAT Uncharacterized protein C19orf44 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1 g19783.t2 Q6AXP1 42.593 162 4.85e-26 117.0 sp|Q6AXP1|CS044_RAT Uncharacterized protein C19orf44 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1 g19784.t1 P36406 64.937 559 0.0 770.0 sp|P36406|TRI23_HUMAN E3 ubiquitin-protein ligase TRIM23 OS=Homo sapiens OX=9606 GN=TRIM23 PE=1 SV=1 TRI23_HUMAN reviewed E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING finger protein 46) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23) Homo sapiens (Human) GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005886; GO:0006886; GO:0008047; GO:0008270; GO:0010508; GO:0016192; GO:0016567; GO:0019003; GO:0042802; GO:0045087; GO:0061630 innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; positive regulation of autophagy [GO:0010508]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g19785.t1 A4QNP7 39.69 451 9.12e-77 249.0 sp|A4QNP7|DMTA2_XENTR Doublesex- and mab-3-related transcription factor A2 OS=Xenopus tropicalis OX=8364 GN=dmrta2 PE=2 SV=1 DMTA2_XENTR reviewed Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0021537; GO:0046872; GO:0060128 corticotropin hormone secreting cell differentiation [GO:0060128]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; telencephalon development [GO:0021537] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g19787.t1 Q18248 44.019 209 1.03e-44 159.0 sp|Q18248|DMD4_CAEEL Doublesex- and mab-3-related transcription factor dmd-4 OS=Caenorhabditis elegans OX=6239 GN=dmd-4 PE=1 SV=2 DMD4_CAEEL reviewed Doublesex- and mab-3-related transcription factor dmd-4 Caenorhabditis elegans GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0043130; GO:0046872; GO:0098883 regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; synapse pruning [GO:0098883] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin binding [GO:0043130] g19790.t1 E9QBI7 42.157 306 1.66e-76 248.0 sp|E9QBI7|OMA1_DANRE Metalloendopeptidase OMA1, mitochondrial OS=Danio rerio OX=7955 GN=oma1 PE=3 SV=1 OMA1_DANRE reviewed Metalloendopeptidase OMA1, mitochondrial (zfoma1) (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0010637; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0043065; GO:0046872; GO:0097009; GO:0140467; GO:0140468; GO:1903850 diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g19791.t1 Q7SXV2 47.778 90 4.4399999999999995e-23 94.7 sp|Q7SXV2|AEBP2_DANRE Zinc finger protein AEBP2 OS=Danio rerio OX=7955 GN=aebp2 PE=2 SV=2 g19792.t1 Q9Z248 48.872 133 2.64e-35 131.0 sp|Q9Z248|AEBP2_MOUSE Zinc finger protein AEBP2 OS=Mus musculus OX=10090 GN=Aebp2 PE=1 SV=2 AEBP2_MOUSE reviewed Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0035098 chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g19793.t1 O35134 46.503 1787 0.0 1516.0 sp|O35134|RPA1_MOUSE DNA-directed RNA polymerase I subunit RPA1 OS=Mus musculus OX=10090 GN=Polr1a PE=1 SV=2 RPA1_MOUSE reviewed DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194) Mus musculus (Mouse) GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005694; GO:0005736; GO:0006360; GO:0008270; GO:0009303; GO:0042790; GO:0071667; GO:1904750 negative regulation of protein localization to nucleolus [GO:1904750]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; rRNA transcription [GO:0009303]; transcription by RNA polymerase I [GO:0006360] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] g19794.t1 Q5VU57 67.026 464 0.0 691.0 sp|Q5VU57|CBPC6_HUMAN Cytosolic carboxypeptidase 6 OS=Homo sapiens OX=9606 GN=AGBL4 PE=1 SV=3 CBPC6_HUMAN reviewed Cytosolic carboxypeptidase 6 (EC 3.4.17.24) (ATP/GTP-binding protein-like 4) (Protein deglutamylase CCP6) Homo sapiens (Human) GO:0004181; GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607; GO:0098957; GO:0098958; GO:0120222; GO:1904115; GO:2000060 anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule cytoskeleton [GO:0015630] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g19795.t1 A0A0R4IEW8 57.88 349 1.33e-136 399.0 sp|A0A0R4IEW8|ELAV4_DANRE ELAV-like protein 4 OS=Danio rerio OX=7955 GN=elavl4 PE=1 SV=2 ELAV4_DANRE reviewed ELAV-like protein 4 (Protein elrD) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0005737; GO:0006397; GO:0007409; GO:0008380; GO:0030424; GO:0030425; GO:0030426; GO:0032991; GO:0043204; GO:1990904 axonogenesis [GO:0007409]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] RNA binding [GO:0003723] g19795.t2 A0A0R4IEW8 58.651 341 4.51e-136 397.0 sp|A0A0R4IEW8|ELAV4_DANRE ELAV-like protein 4 OS=Danio rerio OX=7955 GN=elavl4 PE=1 SV=2 ELAV4_DANRE reviewed ELAV-like protein 4 (Protein elrD) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0005737; GO:0006397; GO:0007409; GO:0008380; GO:0030424; GO:0030425; GO:0030426; GO:0032991; GO:0043204; GO:1990904 axonogenesis [GO:0007409]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] RNA binding [GO:0003723] g19799.t1 Q96D70 36.94 268 6.939999999999999e-42 147.0 sp|Q96D70|R3HD4_HUMAN R3H domain-containing protein 4 OS=Homo sapiens OX=9606 GN=R3HDM4 PE=1 SV=3 g19800.t1 Q6P5J6 32.181 376 5.730000000000001e-43 162.0 sp|Q6P5J6|LRC42_DANRE Leucine-rich repeat-containing protein 42 OS=Danio rerio OX=7955 GN=lrrc42 PE=2 SV=1 g19801.t1 Q3UVK0 40.855 842 0.0 634.0 sp|Q3UVK0|ERMP1_MOUSE Endoplasmic reticulum metallopeptidase 1 OS=Mus musculus OX=10090 GN=Ermp1 PE=1 SV=2 ERMP1_MOUSE reviewed Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina) Mus musculus (Mouse) GO:0001541; GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872 cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ovarian follicle development [GO:0001541]; proteolysis [GO:0006508] endoplasmic reticulum membrane [GO:0005789] metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235] g19802.t1 Q7YU29 35.135 592 4.69e-101 338.0 sp|Q7YU29|DMDE_DROME Dystrophin, isoform E OS=Drosophila melanogaster OX=7227 GN=Dys PE=1 SV=1 g19802.t2 Q7YU29 35.304 592 3.52e-101 339.0 sp|Q7YU29|DMDE_DROME Dystrophin, isoform E OS=Drosophila melanogaster OX=7227 GN=Dys PE=1 SV=1 g19803.t1 O88587 47.222 216 3.95e-64 204.0 sp|O88587|COMT_MOUSE Catechol O-methyltransferase OS=Mus musculus OX=10090 GN=Comt PE=1 SV=2 COMT_MOUSE reviewed Catechol O-methyltransferase (EC 2.1.1.6) Mus musculus (Mouse) GO:0000287; GO:0001662; GO:0001666; GO:0001822; GO:0001963; GO:0001964; GO:0001975; GO:0002001; GO:0005739; GO:0005829; GO:0005977; GO:0006584; GO:0006693; GO:0006950; GO:0006979; GO:0007565; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0008210; GO:0008217; GO:0008542; GO:0009266; GO:0009410; GO:0009611; GO:0009636; GO:0009712; GO:0010467; GO:0014046; GO:0016020; GO:0016036; GO:0016206; GO:0021696; GO:0030424; GO:0030425; GO:0031982; GO:0032094; GO:0032259; GO:0032502; GO:0032835; GO:0033344; GO:0033555; GO:0034097; GO:0035264; GO:0035640; GO:0035812; GO:0042415; GO:0042417; GO:0042420; GO:0042424; GO:0042596; GO:0043197; GO:0044297; GO:0045211; GO:0045963; GO:0046959; GO:0048243; GO:0048265; GO:0048662; GO:0050668; GO:0050890; GO:0050965; GO:0051412; GO:0060840; GO:0071314; GO:0071626; GO:0097018; GO:0097205; GO:0098794; GO:0098978; GO:1902074; GO:1903350; GO:1990776 artery development [GO:0060840]; behavioral fear response [GO:0001662]; catechol-containing compound metabolic process [GO:0009712]; catecholamine catabolic process [GO:0042424]; catecholamine metabolic process [GO:0006584]; cellular response to cocaine [GO:0071314]; cellular response to phosphate starvation [GO:0016036]; cerebellar cortex morphogenesis [GO:0021696]; cholesterol efflux [GO:0033344]; cognition [GO:0050890]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; dopamine secretion [GO:0014046]; estrogen metabolic process [GO:0008210]; exploration behavior [GO:0035640]; fear response [GO:0042596]; female pregnancy [GO:0007565]; gene expression [GO:0010467]; glomerulus development [GO:0032835]; glycogen metabolic process [GO:0005977]; habituation [GO:0046959]; kidney development [GO:0001822]; learning [GO:0007612]; learning or memory [GO:0007611]; mastication [GO:0071626]; memory [GO:0007613]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; multicellular organismal response to stress [GO:0033555]; negative regulation of dopamine metabolic process [GO:0045963]; negative regulation of smooth muscle cell proliferation [GO:0048662]; norepinephrine metabolic process [GO:0042415]; norepinephrine secretion [GO:0048243]; positive regulation of homocysteine metabolic process [GO:0050668]; prostaglandin metabolic process [GO:0006693]; regulation of blood pressure [GO:0008217]; renal albumin absorption [GO:0097018]; renal filtration [GO:0097205]; renal sodium excretion [GO:0035812]; renin secretion into blood stream [GO:0002001]; response to amphetamine [GO:0001975]; response to angiotensin [GO:1990776]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to dopamine [GO:1903350]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to pain [GO:0048265]; response to salt [GO:1902074]; response to stress [GO:0006950]; response to temperature stimulus [GO:0009266]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; short-term memory [GO:0007614]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; visual learning [GO:0008542] axon [GO:0030424]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; vesicle [GO:0031982] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g19804.t1 Q1LZF8 26.842 380 1.06e-31 134.0 sp|Q1LZF8|CLCC1_BOVIN Chloride channel CLIC-like protein 1 OS=Bos taurus OX=9913 GN=CLCC1 PE=2 SV=1 CLCC1_BOVIN reviewed Chloride channel CLIC-like protein 1 (ER anion channel 1) (ERAC1) Bos taurus (Bovine) GO:0005254; GO:0005783; GO:0005789; GO:0016020; GO:0032469; GO:0034707; GO:0044233 endoplasmic reticulum calcium ion homeostasis [GO:0032469] chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233] chloride channel activity [GO:0005254] g19806.t1 Q71S21 30.805 435 2.11e-41 166.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g19806.t1 Q71S21 27.655 452 5.870000000000001e-26 117.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g19806.t1 Q71S21 27.859 341 8.4e-26 117.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g19806.t1 Q71S21 25.522 431 3.78e-25 115.0 sp|Q71S21|INVSB_XENLA Inversin-B OS=Xenopus laevis OX=8355 GN=invs-b PE=1 SV=1 g19807.t1 Q8BH88 44.444 306 1.74e-69 245.0 sp|Q8BH88|DEP1B_MOUSE DEP domain-containing protein 1B OS=Mus musculus OX=10090 GN=Depdc1b PE=2 SV=1 g19807.t1 Q8BH88 49.074 216 1.7e-43 170.0 sp|Q8BH88|DEP1B_MOUSE DEP domain-containing protein 1B OS=Mus musculus OX=10090 GN=Depdc1b PE=2 SV=1 g19808.t1 Q0IJ05 55.42 738 0.0 805.0 sp|Q0IJ05|OSBL9_XENTR Oxysterol-binding protein-related protein 9 OS=Xenopus tropicalis OX=8364 GN=osbpl9 PE=2 SV=1 g19808.t2 Q0IJ05 55.556 738 0.0 799.0 sp|Q0IJ05|OSBL9_XENTR Oxysterol-binding protein-related protein 9 OS=Xenopus tropicalis OX=8364 GN=osbpl9 PE=2 SV=1 g19808.t3 Q0IJ05 53.04 773 0.0 781.0 sp|Q0IJ05|OSBL9_XENTR Oxysterol-binding protein-related protein 9 OS=Xenopus tropicalis OX=8364 GN=osbpl9 PE=2 SV=1 g19809.t1 Q6INU7 28.027 446 8.25e-49 179.0 sp|Q6INU7|FRRS1_XENLA Putative ferric-chelate reductase 1 OS=Xenopus laevis OX=8355 GN=frrs1 PE=2 SV=1 g19811.t1 O14522 33.517 1089 5.3700000000000004e-163 541.0 sp|O14522|PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens OX=9606 GN=PTPRT PE=1 SV=6 PTPRT_HUMAN reviewed Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0031175; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893 cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886] alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19812.t1 P97318 37.011 281 5.96e-39 157.0 sp|P97318|DAB1_MOUSE Disabled homolog 1 OS=Mus musculus OX=10090 GN=Dab1 PE=1 SV=2 g19814.t1 Q8BR93 36.202 337 2.8900000000000003e-58 195.0 sp|Q8BR93|HARB1_MOUSE Putative nuclease HARBI1 OS=Mus musculus OX=10090 GN=Harbi1 PE=2 SV=1 g19816.t1 P28491 73.58 352 0.0 551.0 sp|P28491|CALR_PIG Calreticulin OS=Sus scrofa OX=9823 GN=CALR PE=1 SV=3 g19817.t1 Q6PBY7 65.594 404 0.0 524.0 sp|Q6PBY7|TPC13_DANRE Trafficking protein particle complex subunit 13 OS=Danio rerio OX=7955 GN=trappc13 PE=2 SV=2 g19817.t2 Q6PBY7 59.417 446 1.77e-176 503.0 sp|Q6PBY7|TPC13_DANRE Trafficking protein particle complex subunit 13 OS=Danio rerio OX=7955 GN=trappc13 PE=2 SV=2 g19818.t1 Q32LM2 42.727 330 2.7200000000000004e-73 233.0 sp|Q32LM2|SGTA_BOVIN Small glutamine-rich tetratricopeptide repeat-containing protein alpha OS=Bos taurus OX=9913 GN=SGTA PE=2 SV=1 SGTA_BOVIN reviewed Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) Bos taurus (Bovine) GO:0005634; GO:0006620; GO:0016020; GO:0036503; GO:0042802; GO:0060090; GO:0071816; GO:0072380; GO:1904293; GO:2000059 ERAD pathway [GO:0036503]; negative regulation of ERAD pathway [GO:1904293]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] membrane [GO:0016020]; nucleus [GO:0005634]; TRC complex [GO:0072380] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] g19819.t1 Q16740 73.611 216 1.92e-119 344.0 sp|Q16740|CLPP_HUMAN ATP-dependent Clp protease proteolytic subunit, mitochondrial OS=Homo sapiens OX=9606 GN=CLPP PE=1 SV=1 CLPP_HUMAN reviewed ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Caseinolytic mitochondrial matrix peptidase proteolytic subunit) (Endopeptidase Clp) Homo sapiens (Human) GO:0004175; GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006508; GO:0006515; GO:0008233; GO:0009368; GO:0033619; GO:0035694; GO:0042802; GO:0051117; GO:0051603 membrane protein proteolysis [GO:0033619]; mitochondrial protein catabolic process [GO:0035694]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g19820.t1 Q6GPJ5 49.503 604 0.0 570.0 sp|Q6GPJ5|LRC40_XENLA Leucine-rich repeat-containing protein 40 OS=Xenopus laevis OX=8355 GN=lrrc40 PE=2 SV=1 g19821.t1 Q96T60 40.669 359 2.0499999999999998e-91 288.0 sp|Q96T60|PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens OX=9606 GN=PNKP PE=1 SV=1 g19822.t1 Q15392 65.635 323 6.730000000000001e-160 459.0 sp|Q15392|DHC24_HUMAN Delta(24)-sterol reductase OS=Homo sapiens OX=9606 GN=DHCR24 PE=1 SV=2 g19823.t1 Q8VCH6 66.061 165 8.82e-75 235.0 sp|Q8VCH6|DHC24_MOUSE Delta(24)-sterol reductase OS=Mus musculus OX=10090 GN=Dhcr24 PE=1 SV=1 g19824.t1 Q00597 24.6 500 7.64e-28 121.0 sp|Q00597|FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens OX=9606 GN=FANCC PE=1 SV=1 FANCC_HUMAN reviewed Fanconi anemia group C protein (Protein FACC) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006289; GO:0034599; GO:0036297; GO:0043240; GO:0065003 cellular response to oxidative stress [GO:0034599]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289]; protein-containing complex assembly [GO:0065003] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g19825.t1 Q9V9S7 39.56 364 2.89e-74 257.0 sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2 g19826.t1 Q9V9S7 36.81 163 6.08e-22 104.0 sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2 g19827.t1 Q09632 39.051 274 8.31e-72 227.0 sp|Q09632|YOF5_CAEEL Uncharacterized oxidoreductase ZK1290.5 OS=Caenorhabditis elegans OX=6239 GN=ZK1290.5 PE=3 SV=3 g19827.t2 Q09632 38.168 262 2.05e-64 208.0 sp|Q09632|YOF5_CAEEL Uncharacterized oxidoreductase ZK1290.5 OS=Caenorhabditis elegans OX=6239 GN=ZK1290.5 PE=3 SV=3 g19828.t1 Q9UBS5 33.38 719 2.93e-121 390.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g19829.t1 P10079 37.931 232 2.04e-30 122.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19829.t1 P10079 35.273 275 7.54e-28 115.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19829.t1 P10079 37.975 237 1.1200000000000001e-27 114.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19829.t1 P10079 37.751 249 1.5400000000000002e-27 114.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19829.t1 P10079 37.759 241 5.7100000000000006e-27 112.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19829.t1 P10079 36.91 233 1.8199999999999997e-23 102.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19829.t1 P10079 34.599 237 3.6799999999999996e-23 101.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19829.t2 Q14517 39.103 156 6.5e-27 111.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g19829.t2 Q14517 33.962 159 9.890000000000002e-21 93.6 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g19830.t1 P10079 41.214 313 1.9e-47 174.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19830.t1 P10079 38.111 307 7.9e-43 161.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19830.t1 P10079 38.369 331 5.94e-40 153.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19830.t1 P10079 35.78 327 2.04e-38 148.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19830.t1 P10079 36.842 304 7.87e-38 147.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19830.t1 P10079 36.471 255 1.5e-30 125.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g19832.t1 Q98SV0 45.578 147 2.2400000000000002e-32 121.0 sp|Q98SV0|SELPB_DANRE Selenoprotein Pb OS=Danio rerio OX=7955 GN=sepp1b PE=2 SV=3 g19833.t1 Q15262 43.127 582 5.72e-140 481.0 sp|Q15262|PTPRK_HUMAN Receptor-type tyrosine-protein phosphatase kappa OS=Homo sapiens OX=9606 GN=PTPRK PE=1 SV=2 PTPRK_HUMAN reviewed Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005814; GO:0005886; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016020; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0045295; GO:0045786; GO:0045892; GO:0048041; GO:0120212 cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm head-tail coupling apparatus [GO:0120212] beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19833.t2 Q99M80 30.493 1115 1.5900000000000001e-143 492.0 sp|Q99M80|PTPRT_MOUSE Receptor-type tyrosine-protein phosphatase T OS=Mus musculus OX=10090 GN=Ptprt PE=1 SV=2 g19836.t1 A7MBJ4 26.528 720 7.56e-22 106.0 sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1 PTPRF_BOVIN reviewed Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) Bos taurus (Bovine) GO:0004725; GO:0007165; GO:0007399; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121 cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; nervous system development [GO:0007399]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560] membrane [GO:0016020] heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725] g19837.t1 Q3MI00 55.211 355 7.780000000000001e-123 360.0 sp|Q3MI00|DNJB1_BOVIN DnaJ homolog subfamily B member 1 OS=Bos taurus OX=9913 GN=DNAJB1 PE=2 SV=3 g19838.t1 Q9N5Y2 59.211 304 7.84e-136 390.0 sp|Q9N5Y2|TECR_CAEEL Probable very-long-chain enoyl-CoA reductase art-1 OS=Caenorhabditis elegans OX=6239 GN=art-1 PE=3 SV=1 g19839.t1 Q9NYY3 40.364 659 8.809999999999999e-172 511.0 sp|Q9NYY3|PLK2_HUMAN Serine/threonine-protein kinase PLK2 OS=Homo sapiens OX=9606 GN=PLK2 PE=1 SV=3 PLK2_HUMAN reviewed Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) Homo sapiens (Human) GO:0000082; GO:0000776; GO:0000785; GO:0000922; GO:0002862; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0007052; GO:0007265; GO:0007613; GO:0010508; GO:0016525; GO:0030330; GO:0030425; GO:0032486; GO:0043008; GO:0043066; GO:0043123; GO:0045732; GO:0046599; GO:0048167; GO:0060291; GO:0060292; GO:0071866; GO:0090050; GO:0106310; GO:2000773 DNA damage response, signal transduction by p53 class mediator [GO:0030330]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cellular senescence [GO:2000773]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of protein catabolic process [GO:0045732]; protein phosphorylation [GO:0006468]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of centriole replication [GO:0046599]; regulation of synaptic plasticity [GO:0048167] centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle pole [GO:0000922] ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19840.t1 A2VDD2 37.589 141 3.43e-25 99.8 sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1 g19841.t1 C9JJ37 40.357 280 3.2e-65 209.0 sp|C9JJ37|BTBDJ_HUMAN BTB/POZ domain-containing protein 19 OS=Homo sapiens OX=9606 GN=BTBD19 PE=1 SV=1 g19842.t1 Q8TEK3 46.132 698 2.63e-180 593.0 sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3 DOT1L_HUMAN reviewed Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Disruptor of telomeric silencing 1-like histone lysine methyltransferase) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) Homo sapiens (Human) GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006814; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677 DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; sodium ion transport [GO:0006814]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] g19843.t1 Q6P8Y1 61.244 209 7.51e-95 278.0 sp|Q6P8Y1|CAPSL_MOUSE Calcyphosin-like protein OS=Mus musculus OX=10090 GN=Capsl PE=2 SV=4 g19844.t1 Q0VCC0 44.385 187 1.05e-51 167.0 sp|Q0VCC0|CAYP1_BOVIN Calcyphosin OS=Bos taurus OX=9913 GN=CAPS PE=2 SV=1 g19846.t1 Q0VCC0 39.759 166 1.7700000000000002e-32 117.0 sp|Q0VCC0|CAYP1_BOVIN Calcyphosin OS=Bos taurus OX=9913 GN=CAPS PE=2 SV=1 g19847.t1 Q0VCC0 39.572 187 1.6e-40 139.0 sp|Q0VCC0|CAYP1_BOVIN Calcyphosin OS=Bos taurus OX=9913 GN=CAPS PE=2 SV=1 g19848.t1 Q6P8Y1 39.891 183 2.08e-34 123.0 sp|Q6P8Y1|CAPSL_MOUSE Calcyphosin-like protein OS=Mus musculus OX=10090 GN=Capsl PE=2 SV=4 g19849.t1 P54731 43.636 660 0.0 538.0 sp|P54731|FAF1_MOUSE FAS-associated factor 1 OS=Mus musculus OX=10090 GN=Faf1 PE=1 SV=2 FAF1_MOUSE reviewed FAS-associated factor 1 Mus musculus (Mouse) GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0019901; GO:0019904; GO:0030155; GO:0031072; GO:0031625; GO:0034098; GO:0036337; GO:0036503; GO:0042176; GO:0043124; GO:0043130; GO:0045732; GO:0045740; GO:0048471; GO:0051059; GO:1902043 apoptotic process [GO:0006915]; ERAD pathway [GO:0036503]; Fas signaling pathway [GO:0036337]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] g19851.t1 P18433 35.139 683 4.58e-142 459.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19851.t2 P28827 30.991 1110 7.830000000000001e-144 486.0 sp|P28827|PTPRM_HUMAN Receptor-type tyrosine-protein phosphatase mu OS=Homo sapiens OX=9606 GN=PTPRM PE=1 SV=2 PTPRM_HUMAN reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Homo sapiens (Human) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19852.t1 P28827 31.15 1130 2.45e-151 507.0 sp|P28827|PTPRM_HUMAN Receptor-type tyrosine-protein phosphatase mu OS=Homo sapiens OX=9606 GN=PTPRM PE=1 SV=2 PTPRM_HUMAN reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Homo sapiens (Human) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19853.t1 Q02858 28.842 898 5.5e-85 303.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19854.t1 Q02858 28.585 1046 8.9e-106 365.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19855.t1 P18433 35.682 667 6.73e-145 465.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19856.t1 Q06807 44.746 295 8.49e-81 286.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19858.t1 P28828 31.199 1109 5.68e-147 495.0 sp|P28828|PTPRM_MOUSE Receptor-type tyrosine-protein phosphatase mu OS=Mus musculus OX=10090 GN=Ptprm PE=1 SV=2 PTPRM_MOUSE reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Mus musculus (Mouse) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010829; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042311; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of D-glucose transmembrane transport [GO:0010829]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]; vasodilation [GO:0042311] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g19859.t1 Q06806 44.595 148 2.51e-34 146.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19859.t2 Q06806 44.595 148 2.51e-34 146.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19860.t1 Q0IHF9 41.692 331 4.7199999999999994e-67 216.0 sp|Q0IHF9|SARAF_XENLA Store-operated calcium entry-associated regulatory factor OS=Xenopus laevis OX=8355 GN=saraf PE=2 SV=2 g19861.t1 Q0MQC0 40.0 130 1.9599999999999997e-23 91.7 sp|Q0MQC0|NDUAB_PANTR NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 OS=Pan troglodytes OX=9598 GN=NDUFA11 PE=2 SV=3 g19862.t1 Q0V9D9 43.172 227 1.7600000000000003e-58 187.0 sp|Q0V9D9|COA7_XENTR Cytochrome c oxidase assembly factor 7 OS=Xenopus tropicalis OX=8364 GN=coa7 PE=2 SV=1 g19869.t1 Q9H8E8 49.656 727 0.0 651.0 sp|Q9H8E8|CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens OX=9606 GN=KAT14 PE=1 SV=3 g19870.t1 Q9QYJ1 39.608 255 4.28e-57 196.0 sp|Q9QYJ1|SIA7E_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Mus musculus OX=10090 GN=St6galnac5 PE=1 SV=1 SIA7E_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001665; GO:0006688; GO:0008373; GO:0009311; GO:0009312 ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g19871.t1 Q9H4F1 39.098 266 2.5400000000000003e-56 189.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g19874.t1 Q9H4F1 41.667 252 3.11e-62 207.0 sp|Q9H4F1|SIA7D_HUMAN Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase OS=Homo sapiens OX=9606 GN=ST6GALNAC4 PE=1 SV=2 g19878.t1 Q6AY85 53.589 209 3.95e-75 229.0 sp|Q6AY85|ALG14_RAT UDP-N-acetylglucosamine transferase subunit ALG14 OS=Rattus norvegicus OX=10116 GN=Alg14 PE=2 SV=1 g19879.t1 Q6GLX2 39.431 246 4.69e-51 171.0 sp|Q6GLX2|TLC4A_XENLA TLC domain-containing protein 4-A OS=Xenopus laevis OX=8355 GN=tlcd4-a PE=2 SV=1 g19881.t1 P56719 27.885 416 1.37e-39 151.0 sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 OX2R_RAT reviewed Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2) Rattus norvegicus (Rat) GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0040011; GO:0042593; GO:0051480 cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046] g19883.t1 P70031 25.208 361 2.2800000000000002e-29 123.0 sp|P70031|CCKAR_XENLA Cholecystokinin receptor OS=Xenopus laevis OX=8355 GN=cckar PE=2 SV=1 g19884.t1 Q02858 30.368 978 3.43e-113 387.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19884.t2 Q02763 29.626 1016 1.4e-113 389.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g19885.t1 Q9Y5R5 34.038 426 9.66e-43 162.0 sp|Q9Y5R5|DMRT2_HUMAN Doublesex- and mab-3-related transcription factor 2 OS=Homo sapiens OX=9606 GN=DMRT2 PE=1 SV=2 DMRT2_HUMAN reviewed Doublesex- and mab-3-related transcription factor 2 (Doublesex-like 2 protein) (DSXL-2) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007548; GO:0014807; GO:0042802; GO:0046872; GO:0048706; GO:0061055; GO:2000287 embryonic skeletal system development [GO:0048706]; myotome development [GO:0061055]; positive regulation of myotome development [GO:2000287]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g19886.t1 Q0MQA8 52.252 111 1.2100000000000001e-29 106.0 sp|Q0MQA8|NDUA7_PANTR NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 OS=Pan troglodytes OX=9598 GN=NDUFA7 PE=3 SV=3 g19887.t1 Q9D0D4 76.997 313 1.46e-175 490.0 sp|Q9D0D4|DIM1_MOUSE Dimethyladenosine transferase OS=Mus musculus OX=10090 GN=Dimt1 PE=2 SV=1 DIM1_MOUSE reviewed Dimethyladenosine transferase (EC 2.1.1.183) (18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (18S rRNA dimethylase) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase) Mus musculus (Mouse) GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0031167; GO:0032040; GO:0042274; GO:0052909; GO:2000234 positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179] g19888.t1 Q8N108 41.055 436 1.69e-89 288.0 sp|Q8N108|MIER1_HUMAN Mesoderm induction early response protein 1 OS=Homo sapiens OX=9606 GN=MIER1 PE=1 SV=2 MIER1_HUMAN reviewed Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (hMi-er1) Homo sapiens (Human) GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0017053; GO:0032991; GO:0042826; GO:0043123 chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; regulation of DNA-templated transcription [GO:0006355] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714] g19889.t1 Q3SZZ0 59.47 264 3.9000000000000004e-123 360.0 sp|Q3SZZ0|BRX1_BOVIN Ribosome biogenesis protein BRX1 homolog OS=Bos taurus OX=9913 GN=BRIX1 PE=2 SV=1 g19890.t1 Q5ZKE7 60.0 195 2.9399999999999997e-81 243.0 sp|Q5ZKE7|KCY_CHICK UMP-CMP kinase OS=Gallus gallus OX=9031 GN=CMPK PE=2 SV=1 KCY_CHICK reviewed UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK) Gallus gallus (Chicken) GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0033862; GO:0036430; GO:0036431; GO:0046705 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; UMP kinase activity [GO:0033862] g19891.t1 Q15468 43.506 462 3.3899999999999997e-112 390.0 sp|Q15468|STIL_HUMAN SCL-interrupting locus protein OS=Homo sapiens OX=9606 GN=STIL PE=1 SV=2 STIL_HUMAN reviewed SCL-interrupting locus protein (TAL-1-interrupting locus protein) Homo sapiens (Human) GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005938; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0031023; GO:0033504; GO:0035264; GO:0036064; GO:0042802; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905832 centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; microtubule organizing center organization [GO:0031023]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] cell cortex [GO:0005938]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; procentriole replication complex [GO:0120099] identical protein binding [GO:0042802] g19892.t1 Q8N0N3 56.105 344 1.2499999999999999e-126 375.0 sp|Q8N0N3|BGBP_PENMO Beta-1,3-glucan-binding protein OS=Penaeus monodon OX=6687 PE=2 SV=1 g19893.t1 Q8N0N3 57.102 352 7.67e-130 385.0 sp|Q8N0N3|BGBP_PENMO Beta-1,3-glucan-binding protein OS=Penaeus monodon OX=6687 PE=2 SV=1 g19893.t2 Q8N0N3 57.102 352 7.1e-130 384.0 sp|Q8N0N3|BGBP_PENMO Beta-1,3-glucan-binding protein OS=Penaeus monodon OX=6687 PE=2 SV=1 g19895.t1 Q9D531 46.309 149 1.29e-44 146.0 sp|Q9D531|NXNL2_MOUSE Nucleoredoxin-like protein 2 OS=Mus musculus OX=10090 GN=Nxnl2 PE=1 SV=1 g19896.t1 P05412 43.452 336 3.15e-72 229.0 sp|P05412|JUN_HUMAN Transcription factor Jun OS=Homo sapiens OX=9606 GN=JUN PE=1 SV=2 JUN_HUMAN reviewed Transcription factor Jun (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39) Homo sapiens (Human) GO:0000122; GO:0000228; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001774; GO:0001889; GO:0001938; GO:0003151; GO:0003677; GO:0003682; GO:0003700; GO:0003723; GO:0005096; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006915; GO:0007179; GO:0007254; GO:0008283; GO:0008285; GO:0009410; GO:0010634; GO:0017053; GO:0019046; GO:0019899; GO:0030224; GO:0031103; GO:0031625; GO:0034976; GO:0035026; GO:0035497; GO:0035976; GO:0035994; GO:0042127; GO:0042802; GO:0043392; GO:0043524; GO:0043922; GO:0043923; GO:0044389; GO:0045892; GO:0045893; GO:0045944; GO:0048146; GO:0048545; GO:0051726; GO:0060395; GO:0061029; GO:0061629; GO:0070374; GO:0070412; GO:0071277; GO:0072740; GO:0090575; GO:0140296; GO:0140467; GO:1902895; GO:1904707; GO:1990837; GO:2000144 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell population proliferation [GO:0008283]; cellular response to anisomycin [GO:0072740]; cellular response to calcium ion [GO:0071277]; eyelid development in camera-type eye [GO:0061029]; host-mediated activation of viral transcription [GO:0043923]; host-mediated suppression of viral transcription [GO:0043922]; integrated stress response signaling [GO:0140467]; JNK cascade [GO:0007254]; leading edge cell differentiation [GO:0035026]; liver development [GO:0001889]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; release from viral latency [GO:0019046]; response to endoplasmic reticulum stress [GO:0034976]; response to muscle stretch [GO:0035994]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389] g19897.t1 O43196 47.631 802 0.0 779.0 sp|O43196|MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens OX=9606 GN=MSH5 PE=1 SV=1 MSH5_HUMAN reviewed MutS protein homolog 5 (hMSH5) Homo sapiens (Human) GO:0003690; GO:0005524; GO:0005634; GO:0006298; GO:0030983; GO:0051026; GO:0140664 chiasma assembly [GO:0051026]; mismatch repair [GO:0006298] nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983] g19897.t2 O43196 46.871 815 0.0 770.0 sp|O43196|MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens OX=9606 GN=MSH5 PE=1 SV=1 MSH5_HUMAN reviewed MutS protein homolog 5 (hMSH5) Homo sapiens (Human) GO:0003690; GO:0005524; GO:0005634; GO:0006298; GO:0030983; GO:0051026; GO:0140664 chiasma assembly [GO:0051026]; mismatch repair [GO:0006298] nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983] g19898.t1 Q6DC37 27.273 297 3.11e-30 118.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g19901.t1 Q6DC37 27.946 297 5.39e-31 120.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g19902.t1 Q6DC37 29.333 300 2.23e-33 127.0 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g19903.t1 O15021 48.86 1404 0.0 1045.0 sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens OX=9606 GN=MAST4 PE=1 SV=4 g19907.t1 P98156 43.211 847 0.0 712.0 sp|P98156|VLDLR_MOUSE Very low-density lipoprotein receptor OS=Mus musculus OX=10090 GN=Vldlr PE=1 SV=1 VLDLR_MOUSE reviewed Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) Mus musculus (Mouse) GO:0005509; GO:0005615; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0008203; GO:0009986; GO:0016020; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045177; GO:0045202; GO:0048306; GO:0048471; GO:0048813; GO:0051963; GO:0071456; GO:0098978; GO:1900006 cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; positive regulation of dendrite development [GO:1900006]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; regulation of synapse assembly [GO:0051963]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] g19908.t1 Q7ZYA0 48.977 733 0.0 706.0 sp|Q7ZYA0|LMBD2_XENLA G-protein coupled receptor-associated protein LMBRD2 OS=Xenopus laevis OX=8355 GN=lmbrd2 PE=2 SV=1 g19909.t1 Q9Y3B8 64.286 196 4.81e-95 280.0 sp|Q9Y3B8|ORN_HUMAN Oligoribonuclease, mitochondrial OS=Homo sapiens OX=9606 GN=REXO2 PE=1 SV=3 ORN_HUMAN reviewed Oligoribonuclease, mitochondrial (EC 3.1.15.-) (RNA exonuclease 2 homolog) (Small fragment nuclease) Homo sapiens (Human) GO:0000175; GO:0000287; GO:0003676; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0006139; GO:0008296; GO:0008408; GO:0009117; GO:2000827 mitochondrial RNA surveillance [GO:2000827]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676] g19910.t1 Q13309 33.053 357 6.19e-55 192.0 sp|Q13309|SKP2_HUMAN S-phase kinase-associated protein 2 OS=Homo sapiens OX=9606 GN=SKP2 PE=1 SV=2 g19911.t1 Q5UR67 41.566 166 2.72e-35 125.0 sp|Q5UR67|RIBX_MIMIV N-glycosidase R617 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R617 PE=3 SV=1 g19912.t1 P35574 51.9 1553 0.0 1599.0 sp|P35574|GDE_RABIT Glycogen debranching enzyme OS=Oryctolagus cuniculus OX=9986 GN=AGL PE=1 SV=1 g19913.t1 P35573 53.376 1555 0.0 1696.0 sp|P35573|GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens OX=9606 GN=AGL PE=1 SV=3 GDE_HUMAN reviewed Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)] Homo sapiens (Human) GO:0004134; GO:0004135; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0007584; GO:0016234; GO:0016529; GO:0030247; GO:0031593; GO:0034774; GO:0043033; GO:0051384; GO:1904813 glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774] 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593] g19914.t1 Q5U243 50.328 457 4.79e-140 416.0 sp|Q5U243|CLIP3_XENLA CAP-Gly domain-containing linker protein 3 OS=Xenopus laevis OX=8355 GN=clip3 PE=2 SV=1 g19915.t1 Q8HXD5 38.875 409 1.88e-67 230.0 sp|Q8HXD5|RN220_MACFA E3 ubiquitin-protein ligase RNF220 OS=Macaca fascicularis OX=9541 GN=RNF220 PE=2 SV=1 g19916.t1 Q8BGQ6 29.395 347 5.8899999999999995e-30 126.0 sp|Q8BGQ6|EFC14_MOUSE EF-hand calcium-binding domain-containing protein 14 OS=Mus musculus OX=10090 GN=Efcab14 PE=2 SV=1 g19916.t2 Q8BGQ6 29.395 347 5.88e-30 126.0 sp|Q8BGQ6|EFC14_MOUSE EF-hand calcium-binding domain-containing protein 14 OS=Mus musculus OX=10090 GN=Efcab14 PE=2 SV=1 g19918.t1 P27986 45.733 621 1.65e-165 506.0 sp|P27986|P85A_HUMAN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Homo sapiens OX=9606 GN=PIK3R1 PE=1 SV=2 P85A_HUMAN reviewed Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha) Homo sapiens (Human) GO:0000209; GO:0001678; GO:0001784; GO:0001953; GO:0002687; GO:0005068; GO:0005096; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006366; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0016020; GO:0019209; GO:0019221; GO:0019903; GO:0030183; GO:0030217; GO:0030316; GO:0032760; GO:0032869; GO:0033120; GO:0034143; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0035655; GO:0036312; GO:0042267; GO:0042307; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0048661; GO:0050821; GO:0051491; GO:0051497; GO:0052742; GO:0060396; GO:0061470; GO:0097529; GO:0120183; GO:0140767; GO:0141038; GO:1900103; GO:1903078; GO:1990578 B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular glucose homeostasis [GO:0001678]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; T follicular helper cell differentiation [GO:0061470]; transcription by RNA polymerase II [GO:0006366] cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; GTPase activator activity [GO:0005096]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; kinase activator activity [GO:0019209]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol kinase activity [GO:0052742]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g19918.t2 P27986 45.733 621 3.7800000000000004e-166 506.0 sp|P27986|P85A_HUMAN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Homo sapiens OX=9606 GN=PIK3R1 PE=1 SV=2 P85A_HUMAN reviewed Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha) Homo sapiens (Human) GO:0000209; GO:0001678; GO:0001784; GO:0001953; GO:0002687; GO:0005068; GO:0005096; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006366; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0016020; GO:0019209; GO:0019221; GO:0019903; GO:0030183; GO:0030217; GO:0030316; GO:0032760; GO:0032869; GO:0033120; GO:0034143; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0035655; GO:0036312; GO:0042267; GO:0042307; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0048661; GO:0050821; GO:0051491; GO:0051497; GO:0052742; GO:0060396; GO:0061470; GO:0097529; GO:0120183; GO:0140767; GO:0141038; GO:1900103; GO:1903078; GO:1990578 B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular glucose homeostasis [GO:0001678]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; T follicular helper cell differentiation [GO:0061470]; transcription by RNA polymerase II [GO:0006366] cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; GTPase activator activity [GO:0005096]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; kinase activator activity [GO:0019209]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol kinase activity [GO:0052742]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g19919.t1 E3TDS3 55.096 314 4.62e-121 353.0 sp|E3TDS3|MTG1_ICTPU Mitochondrial ribosome-associated GTPase 1 OS=Ictalurus punctatus OX=7998 GN=mtg1 PE=2 SV=1 g19920.t1 P51531 64.768 1317 0.0 1604.0 sp|P51531|SMCA2_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 OS=Homo sapiens OX=9606 GN=SMARCA2 PE=1 SV=2 SMCA2_HUMAN reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SAMRCA2) (EC 3.6.4.-) (BRG1-associated factor 190B) (BAF190B) (Probable global transcription activator SNF2L2) (Protein brahma homolog) (hBRM) (SNF2-alpha) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0031507; GO:0035060; GO:0042393; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140750; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; heterochromatin formation [GO:0031507]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; nucleosome array spacer activity [GO:0140750]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g19920.t2 P51531 64.768 1317 0.0 1607.0 sp|P51531|SMCA2_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 OS=Homo sapiens OX=9606 GN=SMARCA2 PE=1 SV=2 SMCA2_HUMAN reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SAMRCA2) (EC 3.6.4.-) (BRG1-associated factor 190B) (BAF190B) (Probable global transcription activator SNF2L2) (Protein brahma homolog) (hBRM) (SNF2-alpha) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0031507; GO:0035060; GO:0042393; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140750; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; heterochromatin formation [GO:0031507]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; nucleosome array spacer activity [GO:0140750]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g19920.t3 P51531 64.692 1317 0.0 1603.0 sp|P51531|SMCA2_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 OS=Homo sapiens OX=9606 GN=SMARCA2 PE=1 SV=2 SMCA2_HUMAN reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SAMRCA2) (EC 3.6.4.-) (BRG1-associated factor 190B) (BAF190B) (Probable global transcription activator SNF2L2) (Protein brahma homolog) (hBRM) (SNF2-alpha) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0031507; GO:0035060; GO:0042393; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140750; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; heterochromatin formation [GO:0031507]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; nucleosome array spacer activity [GO:0140750]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g19921.t1 P05090 36.0 175 1.1200000000000001e-32 119.0 sp|P05090|APOD_HUMAN Apolipoprotein D OS=Homo sapiens OX=9606 GN=APOD PE=1 SV=1 APOD_HUMAN reviewed Apolipoprotein D (Apo-D) (ApoD) Homo sapiens (Human) GO:0000302; GO:0001525; GO:0005319; GO:0005576; GO:0005615; GO:0005737; GO:0006006; GO:0006629; GO:0007420; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405 angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471] cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319] g19923.t1 Q8R0I0 46.893 531 2.02e-176 521.0 sp|Q8R0I0|ACE2_MOUSE Angiotensin-converting enzyme 2 OS=Mus musculus OX=10090 GN=Ace2 PE=1 SV=1 ACE2_MOUSE reviewed Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2] Mus musculus (Mouse) GO:0000122; GO:0001618; GO:0002003; GO:0003051; GO:0003081; GO:0004175; GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005929; GO:0008237; GO:0008241; GO:0009986; GO:0015827; GO:0016324; GO:0031526; GO:0042802; GO:0046513; GO:0046718; GO:0046813; GO:0046872; GO:0048662; GO:0050727; GO:0051957; GO:0060135; GO:0060452; GO:0070373; GO:0098670; GO:0141109; GO:1903598; GO:1903779; GO:1905737 angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; ceramide biosynthetic process [GO:0046513]; entry receptor-mediated virion attachment to host cell [GO:0098670]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; symbiont entry into host cell [GO:0046718]; tryptophan transport [GO:0015827] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; transporter activator activity [GO:0141109]; virus receptor activity [GO:0001618] g19924.t1 Q5NVL7 66.556 604 0.0 895.0 sp|Q5NVL7|PPWD1_PONAB Peptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Pongo abelii OX=9601 GN=PPWD1 PE=2 SV=1 g19925.t1 Q8IWX8 44.059 202 2.96e-52 201.0 sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3 g19925.t1 Q8IWX8 61.039 77 6.7e-23 108.0 sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3 g19925.t1 Q8IWX8 70.968 62 8.57e-21 102.0 sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3 g19925.t2 Q8IWX8 44.059 202 3.4299999999999995e-52 201.0 sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3 g19925.t2 Q8IWX8 61.039 77 6.92e-23 108.0 sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3 g19925.t2 Q8IWX8 70.968 62 8.85e-21 102.0 sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3 g19926.t1 Q99570 54.558 1404 0.0 1514.0 sp|Q99570|PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PIK3R4 PE=1 SV=3 PI3R4_HUMAN reviewed Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein) Homo sapiens (Human) GO:0000425; GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005929; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016241; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036064; GO:0036092; GO:0042149; GO:0043491; GO:0045022; GO:0045171; GO:0045324; GO:0071561; GO:0097352; GO:0106310 autophagosome maturation [GO:0097352]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241] autophagosome [GO:0005776]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g19928.t1 Q6NRK1 37.665 454 1.1300000000000001e-100 323.0 sp|Q6NRK1|ADIPA_XENLA Afadin- and alpha-actinin-binding protein A OS=Xenopus laevis OX=8355 GN=ssx2ip-a PE=1 SV=1 ADIPA_XENLA reviewed Afadin- and alpha-actinin-binding protein A (ADIP-A) (Afadin DIL domain-interacting protein A) (SSX2-interacting protein A) (XSSX2IP) Xenopus laevis (African clawed frog) GO:0005874; GO:0005912; GO:0007098; GO:0007155; GO:0034451; GO:0035735; GO:0036064; GO:0051011 cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; intraciliary transport involved in cilium assembly [GO:0035735] adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; microtubule [GO:0005874] microtubule minus-end binding [GO:0051011] g19928.t2 Q6NRK1 37.445 454 1.48e-99 320.0 sp|Q6NRK1|ADIPA_XENLA Afadin- and alpha-actinin-binding protein A OS=Xenopus laevis OX=8355 GN=ssx2ip-a PE=1 SV=1 ADIPA_XENLA reviewed Afadin- and alpha-actinin-binding protein A (ADIP-A) (Afadin DIL domain-interacting protein A) (SSX2-interacting protein A) (XSSX2IP) Xenopus laevis (African clawed frog) GO:0005874; GO:0005912; GO:0007098; GO:0007155; GO:0034451; GO:0035735; GO:0036064; GO:0051011 cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; intraciliary transport involved in cilium assembly [GO:0035735] adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; microtubule [GO:0005874] microtubule minus-end binding [GO:0051011] g19929.t1 Q6GQN4 59.048 105 6.55e-31 108.0 sp|Q6GQN4|FA32A_DANRE Protein FAM32A-like OS=Danio rerio OX=7955 GN=fam32al PE=3 SV=1 g19931.t1 Q9BXS5 83.649 422 0.0 740.0 sp|Q9BXS5|AP1M1_HUMAN AP-1 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP1M1 PE=1 SV=3 AP1M1_HUMAN reviewed AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0016192; GO:0030121; GO:0030136; GO:0030659; GO:0032438; GO:0032588; GO:0035579; GO:0035615; GO:0035646; GO:0045202; GO:0060155; GO:0070062; GO:1903232 endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588] clathrin adaptor activity [GO:0035615] g19932.t1 Q9XVZ8 73.494 83 1.03e-43 139.0 sp|Q9XVZ8|ELOF1_CAEEL Transcription elongation factor 1 homolog OS=Caenorhabditis elegans OX=6239 GN=elof-1 PE=3 SV=1 g19933.t1 P54319 48.628 802 0.0 798.0 sp|P54319|PLAP_RAT Phospholipase A-2-activating protein OS=Rattus norvegicus OX=10116 GN=Plaa PE=1 SV=3 g19934.t1 Q6NY34 66.667 186 1.07e-88 262.0 sp|Q6NY34|AS1BB_DANRE Histone chaperone asf1b-B OS=Danio rerio OX=7955 GN=asf1bb PE=2 SV=1 g19936.t1 Q8IWG1 42.652 279 6.25e-58 201.0 sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1 DNAI3_HUMAN reviewed Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) Homo sapiens (Human) GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933 cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156] Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g19937.t1 Q8IWG1 42.735 468 1e-130 402.0 sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1 DNAI3_HUMAN reviewed Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) Homo sapiens (Human) GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933 cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156] Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g19937.t2 Q8IWG1 43.478 460 4.5700000000000005e-132 406.0 sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1 DNAI3_HUMAN reviewed Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) Homo sapiens (Human) GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933 cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156] Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g19938.t1 P17612 81.818 352 0.0 614.0 sp|P17612|KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PRKACA PE=1 SV=2 KAPCA_HUMAN reviewed cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) Homo sapiens (Human) GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0010881; GO:0016241; GO:0016607; GO:0019221; GO:0019870; GO:0019901; GO:0019904; GO:0021904; GO:0030007; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032703; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035694; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050850; GO:0051726; GO:0055117; GO:0061136; GO:0070062; GO:0070417; GO:0070507; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097700; GO:0098794; GO:0098978; GO:0099103; GO:0099170; GO:0106310; GO:0120186; GO:0140198; GO:0141156; GO:1903779; GO:1904262; GO:1904539; GO:1990044; GO:2000810 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] g19938.t2 P17612 83.333 336 0.0 604.0 sp|P17612|KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PRKACA PE=1 SV=2 KAPCA_HUMAN reviewed cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) Homo sapiens (Human) GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0010881; GO:0016241; GO:0016607; GO:0019221; GO:0019870; GO:0019901; GO:0019904; GO:0021904; GO:0030007; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032703; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035694; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050850; GO:0051726; GO:0055117; GO:0061136; GO:0070062; GO:0070417; GO:0070507; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097700; GO:0098794; GO:0098978; GO:0099103; GO:0099170; GO:0106310; GO:0120186; GO:0140198; GO:0141156; GO:1903779; GO:1904262; GO:1904539; GO:1990044; GO:2000810 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] g19938.t3 P17612 83.383 337 0.0 606.0 sp|P17612|KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PRKACA PE=1 SV=2 KAPCA_HUMAN reviewed cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) Homo sapiens (Human) GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006397; GO:0006611; GO:0007189; GO:0007193; GO:0010881; GO:0016241; GO:0016607; GO:0019221; GO:0019870; GO:0019901; GO:0019904; GO:0021904; GO:0030007; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032703; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035694; GO:0036126; GO:0044853; GO:0045542; GO:0045667; GO:0045722; GO:0045879; GO:0046827; GO:0048240; GO:0048471; GO:0050766; GO:0050850; GO:0051726; GO:0055117; GO:0061136; GO:0070062; GO:0070417; GO:0070507; GO:0070613; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097700; GO:0098794; GO:0098978; GO:0099103; GO:0099170; GO:0106310; GO:0120186; GO:0140198; GO:0141156; GO:1903779; GO:1904262; GO:1904539; GO:1990044; GO:2000810 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP/PKA signal transduction [GO:0141156]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; dorsal/ventral neural tube patterning [GO:0021904]; high-density lipoprotein particle assembly [GO:0034380]; intracellular potassium ion homeostasis [GO:0030007]; mesoderm formation [GO:0001707]; mitochondrial protein catabolic process [GO:0035694]; mRNA processing [GO:0006397]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein export from nucleus [GO:0006611]; protein localization to lipid droplet [GO:1990044]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; channel activator activity [GO:0099103]; histone H1-4S35 kinase activity [GO:0140198]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium channel inhibitor activity [GO:0019870]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] g19940.t1 Q9H553 60.0 400 4.46e-171 487.0 sp|Q9H553|ALG2_HUMAN Alpha-1,3/1,6-mannosyltransferase ALG2 OS=Homo sapiens OX=9606 GN=ALG2 PE=1 SV=1 ALG2_HUMAN reviewed Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase) Homo sapiens (Human) GO:0000033; GO:0004378; GO:0005789; GO:0006487; GO:0006488; GO:0009101; GO:0012505; GO:0016020; GO:0098554; GO:0102704 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; glycoprotein biosynthetic process [GO:0009101]; protein N-linked glycosylation [GO:0006487] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] alpha-1,3-mannosyltransferase activity [GO:0000033]; GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity [GO:0102704] g19941.t1 Q3TWF6 60.606 231 8.139999999999999e-90 281.0 sp|Q3TWF6|WDR70_MOUSE WD repeat-containing protein 70 OS=Mus musculus OX=10090 GN=Wdr70 PE=1 SV=1 g19942.t1 Q6GPP0 47.512 402 4.09e-119 362.0 sp|Q6GPP0|WDR70_XENLA WD repeat-containing protein 70 OS=Xenopus laevis OX=8355 GN=wdr70 PE=2 SV=2 g19943.t1 A8WFT6 31.3 377 1.67e-43 158.0 sp|A8WFT6|HYKK_DANRE Hydroxylysine kinase OS=Danio rerio OX=7955 GN=hykk PE=2 SV=1 g19944.t1 H9D1R1 56.034 116 2.51e-45 148.0 sp|H9D1R1|TXD12_EPICO Thioredoxin domain-containing protein 12 OS=Epinephelus coioides OX=94232 GN=Txndc12 PE=1 SV=1 g19948.t1 Q00PJ9 42.697 178 4.59e-47 157.0 sp|Q00PJ9|CAV1_ATEAB Caveolin-1 OS=Atelerix albiventris OX=9368 GN=CAV1 PE=3 SV=1 g19948.t2 Q00PJ9 42.935 184 9.94e-49 159.0 sp|Q00PJ9|CAV1_ATEAB Caveolin-1 OS=Atelerix albiventris OX=9368 GN=CAV1 PE=3 SV=1 g19949.t1 Q5BJ29 25.654 382 9.46e-22 101.0 sp|Q5BJ29|FBXL7_MOUSE F-box/LRR-repeat protein 7 OS=Mus musculus OX=10090 GN=Fbxl7 PE=1 SV=1 FBXL7_MOUSE reviewed F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) Mus musculus (Mouse) GO:0000086; GO:0000209; GO:0000278; GO:0005813; GO:0016567; GO:0019005; GO:0031146; GO:0051301 cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; SCF ubiquitin ligase complex [GO:0019005] g19951.t1 Q06805 36.091 834 1.2200000000000001e-133 443.0 sp|Q06805|TIE1_BOVIN Tyrosine-protein kinase receptor Tie-1 OS=Bos taurus OX=9913 GN=TIE1 PE=2 SV=1 g19951.t1 Q06805 41.129 248 4.05e-48 191.0 sp|Q06805|TIE1_BOVIN Tyrosine-protein kinase receptor Tie-1 OS=Bos taurus OX=9913 GN=TIE1 PE=2 SV=1 g19952.t1 Q54MZ3 27.968 379 9.9e-36 142.0 sp|Q54MZ3|CDC20_DICDI Anaphase-promoting complex subunit cdc20 OS=Dictyostelium discoideum OX=44689 GN=cdc20 PE=1 SV=1 g19953.t1 Q8WML3 31.195 343 7.440000000000001e-35 143.0 sp|Q8WML3|KAT6B_MACFA Histone acetyltransferase KAT6B OS=Macaca fascicularis OX=9541 GN=KAT6B PE=2 SV=1 KAT6B_MACFA reviewed Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000786; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0006334; GO:0006357; GO:0008270; GO:0036408; GO:0045892; GO:0045893; GO:0061733; GO:0070776 negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357] MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H3K14 acetyltransferase activity [GO:0036408]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g19955.t1 Q1LZA4 37.548 522 9.07e-97 304.0 sp|Q1LZA4|PIGW_BOVIN Glucosaminyl-phosphatidylinositol-acyltransferase PIGW OS=Bos taurus OX=9913 GN=PIGW PE=2 SV=1 g19956.t1 Q9CYZ6 37.063 143 5.83e-24 94.4 sp|Q9CYZ6|REX1B_MOUSE Required for excision 1-B domain-containing protein OS=Mus musculus OX=10090 GN=Rex1bd PE=1 SV=1 g19957.t1 Q64152 63.226 155 2.1700000000000002e-58 183.0 sp|Q64152|BTF3_MOUSE Transcription factor BTF3 OS=Mus musculus OX=10090 GN=Btf3 PE=1 SV=3 g19958.t1 P49321 42.169 249 4.01e-49 185.0 sp|P49321|NASP_HUMAN Nuclear autoantigenic sperm protein OS=Homo sapiens OX=9606 GN=NASP PE=1 SV=2 NASP_HUMAN reviewed Nuclear autoantigenic sperm protein (NASP) Homo sapiens (Human) GO:0000785; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0044877 blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] histone binding [GO:0042393]; protein-containing complex binding [GO:0044877] g19958.t1 P49321 47.953 171 1.23e-27 121.0 sp|P49321|NASP_HUMAN Nuclear autoantigenic sperm protein OS=Homo sapiens OX=9606 GN=NASP PE=1 SV=2 NASP_HUMAN reviewed Nuclear autoantigenic sperm protein (NASP) Homo sapiens (Human) GO:0000785; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0044877 blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] histone binding [GO:0042393]; protein-containing complex binding [GO:0044877] g19959.t1 Q96GM8 43.564 505 3.83e-131 394.0 sp|Q96GM8|TOE1_HUMAN Target of EGR1 protein 1 OS=Homo sapiens OX=9606 GN=TOE1 PE=1 SV=1 TOE1_HUMAN reviewed Target of EGR1 protein 1 Homo sapiens (Human) GO:0000175; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0008270; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472 snRNA 3'-end processing [GO:0034472] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] 3'-5'-RNA exonuclease activity [GO:0000175]; poly(A)-specific ribonuclease activity [GO:0004535]; snRNA binding [GO:0017069]; zinc ion binding [GO:0008270] g19960.t1 Q9UIF7 53.362 461 4.8999999999999995e-147 435.0 sp|Q9UIF7|MUTYH_HUMAN Adenine DNA glycosylase OS=Homo sapiens OX=9606 GN=MUTYH PE=1 SV=1 MUTYH_HUMAN reviewed Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH) Homo sapiens (Human) GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539; GO:0060546 base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701] g19963.t1 Q9UGM3 45.067 1642 0.0 1236.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19963.t1 Q9UGM3 44.505 1647 0.0 1216.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19963.t1 Q9UGM3 42.628 1811 0.0 1205.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19963.t1 Q9UGM3 44.25 1426 0.0 1030.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19963.t1 Q9UGM3 44.55 1266 0.0 938.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19963.t1 Q9UGM3 40.789 1140 0.0 723.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g19965.t1 Q99973 24.852 507 2.9e-30 129.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g19968.t1 Q3B8D7 33.6 125 8.359999999999999e-23 93.6 sp|Q3B8D7|DYL5A_XENLA Dynein light chain Tctex-type 5-A OS=Xenopus laevis OX=8355 GN=Dynlt5-a PE=2 SV=1 g19969.t1 O95801 44.103 390 2.0200000000000003e-110 332.0 sp|O95801|TTC4_HUMAN Tetratricopeptide repeat protein 4 OS=Homo sapiens OX=9606 GN=TTC4 PE=1 SV=3 CNS1_HUMAN reviewed Hsp70/Hsp90 co-chaperone CNS1 homolog (Tetratricopeptide repeat protein 4) (TPR repeat protein 4) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879] g19970.t1 G3MZR2 35.273 275 9.43e-36 138.0 sp|G3MZR2|FUT7_BOVIN Alpha-(1,3)-fucosyltransferase 7 OS=Bos taurus OX=9913 GN=FUT7 PE=1 SV=2 FUT7_BOVIN reviewed Alpha-(1,3)-fucosyltransferase 7 (bfut7) (EC 2.4.1.-) (Fucosyltransferase 7) (Fucosyltransferase VII) (Fuc-TVII) (FucT-VII) (Galactoside 3-L-fucosyltransferase) (Selectin ligand synthase) Bos taurus (Bovine) GO:0001807; GO:0002523; GO:0006954; GO:0016020; GO:0017083; GO:0022407; GO:0022409; GO:0045785; GO:0046626; GO:0046920; GO:0097022; GO:1902624; GO:1903238; GO:1904996 inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration into lymph node [GO:0097022]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; regulation of cell-cell adhesion [GO:0022407]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of type IV hypersensitivity [GO:0001807] membrane [GO:0016020] 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920] g19971.t1 G3MZR2 38.645 251 1.87e-36 139.0 sp|G3MZR2|FUT7_BOVIN Alpha-(1,3)-fucosyltransferase 7 OS=Bos taurus OX=9913 GN=FUT7 PE=1 SV=2 FUT7_BOVIN reviewed Alpha-(1,3)-fucosyltransferase 7 (bfut7) (EC 2.4.1.-) (Fucosyltransferase 7) (Fucosyltransferase VII) (Fuc-TVII) (FucT-VII) (Galactoside 3-L-fucosyltransferase) (Selectin ligand synthase) Bos taurus (Bovine) GO:0001807; GO:0002523; GO:0006954; GO:0016020; GO:0017083; GO:0022407; GO:0022409; GO:0045785; GO:0046626; GO:0046920; GO:0097022; GO:1902624; GO:1903238; GO:1904996 inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration into lymph node [GO:0097022]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; regulation of cell-cell adhesion [GO:0022407]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of type IV hypersensitivity [GO:0001807] membrane [GO:0016020] 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920] g19972.t1 Q9UKP5 47.858 1074 0.0 1058.0 sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2 ATS6_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-) Homo sapiens (Human) GO:0001822; GO:0003279; GO:0004222; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g19973.t1 Q8IUR0 63.83 188 1.78e-89 263.0 sp|Q8IUR0|TPPC5_HUMAN Trafficking protein particle complex subunit 5 OS=Homo sapiens OX=9606 GN=TRAPPC5 PE=1 SV=1 g19979.t1 A0A1L8HX76 44.828 435 3.23e-134 395.0 sp|A0A1L8HX76|WDR18_XENLA WD repeat-containing protein 18 OS=Xenopus laevis OX=8355 GN=wdr18 PE=3 SV=1 g19980.t1 Q9QYK7 65.584 154 9.86e-66 199.0 sp|Q9QYK7|RNF11_MOUSE RING finger protein 11 OS=Mus musculus OX=10090 GN=Rnf11 PE=1 SV=1 RNF11_MOUSE reviewed RING finger protein 11 (NEDD4 WW domain-binding protein 2) (Sid 1669) Mus musculus (Mouse) GO:0000151; GO:0005634; GO:0005769; GO:0006511; GO:0008270; GO:0051865; GO:0055037; GO:0061630 protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511] early endosome [GO:0005769]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g19982.t1 Q8BKE9 56.639 595 0.0 640.0 sp|Q8BKE9|IFT74_MOUSE Intraflagellar transport protein 74 homolog OS=Mus musculus OX=10090 GN=Ift74 PE=1 SV=2 IFT74_MOUSE reviewed Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2) Mus musculus (Mouse) GO:0001669; GO:0003334; GO:0003682; GO:0005634; GO:0005813; GO:0005929; GO:0007219; GO:0007368; GO:0007507; GO:0008544; GO:0030992; GO:0031514; GO:0033630; GO:0035720; GO:0035735; GO:0042073; GO:0045944; GO:0048487; GO:0050680; GO:0060271; GO:1905515 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944] acrosomal vesicle [GO:0001669]; centrosome [GO:0005813]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634] beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682] g19983.t1 Q9PTS8 35.845 491 4.5e-104 322.0 sp|Q9PTS8|ACHA9_CHICK Neuronal acetylcholine receptor subunit alpha-9 OS=Gallus gallus OX=9031 GN=CHRNA9 PE=1 SV=1 ACHA9_CHICK reviewed Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9) Gallus gallus (Chicken) GO:0005231; GO:0005262; GO:0005886; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391] neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; metal ion binding [GO:0046872]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g19984.t1 Q96N67 55.066 2181 0.0 2266.0 sp|Q96N67|DOCK7_HUMAN Dedicator of cytokinesis protein 7 OS=Homo sapiens OX=9606 GN=DOCK7 PE=1 SV=4 g19984.t2 Q96N67 55.499 2164 0.0 2275.0 sp|Q96N67|DOCK7_HUMAN Dedicator of cytokinesis protein 7 OS=Homo sapiens OX=9606 GN=DOCK7 PE=1 SV=4 g19986.t1 Q00560 24.387 693 1.11e-33 144.0 sp|Q00560|IL6RB_MOUSE Interleukin-6 receptor subunit beta OS=Mus musculus OX=10090 GN=Il6st PE=1 SV=2 g19987.t1 P97378 23.173 479 1.72e-22 106.0 sp|P97378|I12R2_MOUSE Interleukin-12 receptor subunit beta-2 OS=Mus musculus OX=10090 GN=Il12rb2 PE=1 SV=1 I12R2_MOUSE reviewed Interleukin-12 receptor subunit beta-2 (IL-12 receptor subunit beta-2) (IL-12R subunit beta-2) (IL-12R-beta-2) (IL-12RB2) Mus musculus (Mouse) GO:0004896; GO:0005886; GO:0008284; GO:0009897; GO:0015026; GO:0019221; GO:0019901; GO:0019955; GO:0032496; GO:0032729; GO:0034097; GO:0035722; GO:0043235; GO:0045063 cytokine-mediated signaling pathway [GO:0019221]; interleukin-12-mediated signaling pathway [GO:0035722]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of type II interferon production [GO:0032729]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; T-helper 1 cell differentiation [GO:0045063] external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901] g19990.t1 O54774 69.807 828 0.0 1187.0 sp|O54774|AP3D1_MOUSE AP-3 complex subunit delta-1 OS=Mus musculus OX=10090 GN=Ap3d1 PE=1 SV=1 AP3D1_MOUSE reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1) Mus musculus (Mouse) GO:0000139; GO:0005769; GO:0005802; GO:0006605; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016183; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098793; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting [GO:0006605]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802] g19990.t1 O54774 52.5 240 1.26e-70 262.0 sp|O54774|AP3D1_MOUSE AP-3 complex subunit delta-1 OS=Mus musculus OX=10090 GN=Ap3d1 PE=1 SV=1 AP3D1_MOUSE reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1) Mus musculus (Mouse) GO:0000139; GO:0005769; GO:0005802; GO:0006605; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016183; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098793; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting [GO:0006605]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802] g19990.t2 O54774 70.531 828 0.0 1204.0 sp|O54774|AP3D1_MOUSE AP-3 complex subunit delta-1 OS=Mus musculus OX=10090 GN=Ap3d1 PE=1 SV=1 AP3D1_MOUSE reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1) Mus musculus (Mouse) GO:0000139; GO:0005769; GO:0005802; GO:0006605; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016183; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098793; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting [GO:0006605]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802] g19990.t2 O54774 52.5 240 1.58e-70 262.0 sp|O54774|AP3D1_MOUSE AP-3 complex subunit delta-1 OS=Mus musculus OX=10090 GN=Ap3d1 PE=1 SV=1 AP3D1_MOUSE reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1) Mus musculus (Mouse) GO:0000139; GO:0005769; GO:0005802; GO:0006605; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016183; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098793; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting [GO:0006605]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802] g19990.t3 O54774 67.708 864 0.0 1187.0 sp|O54774|AP3D1_MOUSE AP-3 complex subunit delta-1 OS=Mus musculus OX=10090 GN=Ap3d1 PE=1 SV=1 AP3D1_MOUSE reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1) Mus musculus (Mouse) GO:0000139; GO:0005769; GO:0005802; GO:0006605; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016183; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098793; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting [GO:0006605]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802] g19990.t3 O54774 52.5 240 2.63e-70 261.0 sp|O54774|AP3D1_MOUSE AP-3 complex subunit delta-1 OS=Mus musculus OX=10090 GN=Ap3d1 PE=1 SV=1 AP3D1_MOUSE reviewed AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) (mBLVR1) Mus musculus (Mouse) GO:0000139; GO:0005769; GO:0005802; GO:0006605; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016182; GO:0016183; GO:0016192; GO:0019882; GO:0030123; GO:0030424; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0072657; GO:0098793; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:0140916; GO:1903232; GO:1904115 anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein targeting [GO:0006605]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916] AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802] g19991.t1 Q05481 41.954 174 1.51e-34 137.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 40.462 173 4.22e-32 129.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 37.931 174 8.53e-30 123.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 38.953 172 2.76e-29 121.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 37.87 169 4.07e-29 121.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 37.931 174 3.51e-28 118.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 37.576 165 6.43e-28 117.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 35.204 196 7.850000000000001e-27 114.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 33.163 196 7.850000000000001e-27 114.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 35.838 173 4.3200000000000004e-26 112.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 37.278 169 1.22e-25 110.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 32.124 193 5.1e-25 109.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 36.207 174 4.87e-24 106.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19991.t1 Q05481 34.104 173 2.33e-21 98.2 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g19993.t1 Q9H583 39.169 2239 0.0 1401.0 sp|Q9H583|HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=HEATR1 PE=1 SV=3 HEAT1_HUMAN reviewed HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed] Homo sapiens (Human) GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0016072; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0042274; GO:0045943; GO:0061351; GO:1902570; GO:2000234 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; neural precursor cell proliferation [GO:0061351]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit biogenesis [GO:0042274]; rRNA metabolic process [GO:0016072] 90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g19993.t2 Q9H583 39.125 2239 0.0 1402.0 sp|Q9H583|HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=HEATR1 PE=1 SV=3 HEAT1_HUMAN reviewed HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed] Homo sapiens (Human) GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0016072; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0042274; GO:0045943; GO:0061351; GO:1902570; GO:2000234 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; neural precursor cell proliferation [GO:0061351]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit biogenesis [GO:0042274]; rRNA metabolic process [GO:0016072] 90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g19999.t1 P43114 28.086 324 8.680000000000001e-29 122.0 sp|P43114|PE2R4_RAT Prostaglandin E2 receptor EP4 subtype OS=Rattus norvegicus OX=10116 GN=Ptger4 PE=2 SV=1 PE2R4_RAT reviewed Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor) Rattus norvegicus (Rat) GO:0000165; GO:0001818; GO:0001819; GO:0002792; GO:0004957; GO:0005886; GO:0006171; GO:0006954; GO:0006955; GO:0007188; GO:0007189; GO:0007193; GO:0007204; GO:0007254; GO:0007565; GO:0008284; GO:0009410; GO:0009612; GO:0009624; GO:0010628; GO:0010840; GO:0014911; GO:0030278; GO:0031965; GO:0032496; GO:0032570; GO:0032690; GO:0032720; GO:0032733; GO:0032757; GO:0033624; GO:0034695; GO:0035810; GO:0042093; GO:0042466; GO:0043025; GO:0043200; GO:0044306; GO:0045669; GO:0045778; GO:0045780; GO:0045785; GO:0046010; GO:0050714; GO:0050728; GO:0050729; GO:0051492; GO:0060137; GO:0060348; GO:0070257; GO:0070371; GO:0070555; GO:0071260; GO:0071333; GO:0071347; GO:0071380; GO:0090303; GO:0097070; GO:0141156; GO:1900127; GO:1902074; GO:1904336; GO:1904348; GO:1904364; GO:1904367; GO:1904460; GO:1904466; GO:1904471; GO:1904496; GO:1990785; GO:2000386; GO:2000388; GO:2000391; GO:2000420 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cAMP biosynthetic process [GO:0006171]; cAMP/PKA signal transduction [GO:0141156]; cellular response to glucose stimulus [GO:0071333]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to prostaglandin E stimulus [GO:0071380]; chemokinesis [GO:0042466]; ductus arteriosus closure [GO:0097070]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; immune response [GO:0006955]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; maternal process involved in parturition [GO:0060137]; negative regulation of cytokine production [GO:0001818]; negative regulation of ductus arteriosus closure [GO:1904336]; negative regulation of endothelin production [GO:1904471]; negative regulation of eosinophil extravasation [GO:2000420]; negative regulation of inflammatory response [GO:0050728]; negative regulation of integrin activation [GO:0033624]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of peptide secretion [GO:0002792]; negative regulation of small intestine smooth muscle contraction [GO:1904348]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of antral ovarian follicle growth [GO:2000388]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcitonin secretion [GO:1904364]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokinesis [GO:1904367]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of mucus secretion [GO:0070257]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of protein secretion [GO:0050714]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substance P secretion [GO:1904460]; positive regulation of substance P secretion, neurotransmission [GO:1904496]; positive regulation of urine volume [GO:0035810]; positive regulation of wound healing [GO:0090303]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of ossification [GO:0030278]; regulation of stress fiber assembly [GO:0051492]; response to amino acid [GO:0043200]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nematode [GO:0009624]; response to progesterone [GO:0032570]; response to prostaglandin E [GO:0034695]; response to salt [GO:1902074]; response to water-immersion restraint stress [GO:1990785]; response to xenobiotic stimulus [GO:0009410]; T-helper cell differentiation [GO:0042093] neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] prostaglandin E receptor activity [GO:0004957] g20001.t1 Q6DI40 53.684 190 2.36e-63 201.0 sp|Q6DI40|TTC33_DANRE Tetratricopeptide repeat protein 33 OS=Danio rerio OX=7955 GN=ttc33 PE=2 SV=1 g20002.t1 Q0R4F1 55.662 627 0.0 724.0 sp|Q0R4F1|PIF1_XENLA ATP-dependent DNA helicase PIF1 OS=Xenopus laevis OX=8355 GN=pif1 PE=2 SV=1 PIF1_XENLA reviewed ATP-dependent DNA helicase PIF1 (EC 5.6.2.3) (DNA 5'-3' helicase PIF1) (DNA repair and recombination helicase PIF1) Xenopus laevis (African clawed frog) GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016887; GO:0043139 DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723] mitochondrion [GO:0005739]; nucleus [GO:0005634] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677] g12416.t1 Q7ZUV7 57.561 205 8.29e-61 232.0 sp|Q7ZUV7|EMSY_DANRE BRCA2-interacting transcriptional repressor EMSY OS=Danio rerio OX=7955 GN=emsy PE=2 SV=1 g12417.t1 Q10215 44.565 92 6.86e-22 90.1 sp|Q10215|RDL_SCHPO Putative thiosulfate sulfurtransferase, mitochondrial OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC4H3.07c PE=3 SV=2 g12418.t1 A5PK71 77.376 221 5.08e-131 373.0 sp|A5PK71|PACRG_BOVIN Parkin coregulated gene protein OS=Bos taurus OX=9913 GN=PACRG PE=1 SV=1 PACRG_BOVIN reviewed Parkin coregulated gene protein Bos taurus (Bovine) GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112 flagellated sperm motility [GO:0030317]; intracellular protein localization [GO:0008104]; spermatid development [GO:0007286] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625] g12420.t1 Q5SV42 44.18 378 4.4200000000000004e-103 313.0 sp|Q5SV42|ILEUC_MOUSE Leukocyte elastase inhibitor C OS=Mus musculus OX=10090 GN=Serpinb1c PE=1 SV=1 g12421.t1 Q4R3G2 46.982 381 3.1699999999999996e-104 315.0 sp|Q4R3G2|SPB6_MACFA Serpin B6 OS=Macaca fascicularis OX=9541 GN=SERPINB6 PE=2 SV=1 g12422.t1 P46023 34.746 472 2.5900000000000003e-79 290.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g12422.t2 Q5R662 26.087 414 1.5799999999999998e-23 112.0 sp|Q5R662|LRP12_PONAB Low-density lipoprotein receptor-related protein 12 OS=Pongo abelii OX=9601 GN=LRP12 PE=2 SV=2 LRP12_PONAB reviewed Low-density lipoprotein receptor-related protein 12 (LRP-12) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001764; GO:0005178; GO:0005886; GO:0005905; GO:0006897; GO:0007155; GO:0031175; GO:0033622; GO:0097021 cell adhesion [GO:0007155]; endocytosis [GO:0006897]; integrin activation [GO:0033622]; lymphocyte migration into lymphoid organs [GO:0097021]; neuron migration [GO:0001764]; neuron projection development [GO:0031175] clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886] integrin binding [GO:0005178] g12422.t3 Q8BUJ9 25.862 464 2.88e-28 127.0 sp|Q8BUJ9|LRP12_MOUSE Low-density lipoprotein receptor-related protein 12 OS=Mus musculus OX=10090 GN=Lrp12 PE=2 SV=2 LRP12_MOUSE reviewed Low-density lipoprotein receptor-related protein 12 (LRP-12) Mus musculus (Mouse) GO:0001764; GO:0005178; GO:0005886; GO:0005905; GO:0006897; GO:0007155; GO:0016477; GO:0031175; GO:0033622; GO:0097021 cell adhesion [GO:0007155]; cell migration [GO:0016477]; endocytosis [GO:0006897]; integrin activation [GO:0033622]; lymphocyte migration into lymphoid organs [GO:0097021]; neuron migration [GO:0001764]; neuron projection development [GO:0031175] clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886] integrin binding [GO:0005178] g12424.t1 Q64514 69.772 483 0.0 726.0 sp|Q64514|TPP2_MOUSE Tripeptidyl-peptidase 2 OS=Mus musculus OX=10090 GN=Tpp2 PE=1 SV=3 TPP2_MOUSE reviewed Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II) Mus musculus (Mouse) GO:0004177; GO:0004252; GO:0005654; GO:0005783; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0030163; GO:0042277; GO:0042802; GO:0080144 intracellular amino acid homeostasis [GO:0080144]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] g12425.t1 Q64514 46.154 104 7.32e-27 106.0 sp|Q64514|TPP2_MOUSE Tripeptidyl-peptidase 2 OS=Mus musculus OX=10090 GN=Tpp2 PE=1 SV=3 TPP2_MOUSE reviewed Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II) Mus musculus (Mouse) GO:0004177; GO:0004252; GO:0005654; GO:0005783; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0030163; GO:0042277; GO:0042802; GO:0080144 intracellular amino acid homeostasis [GO:0080144]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] g12426.t1 P29144 47.5 560 8.349999999999999e-165 504.0 sp|P29144|TPP2_HUMAN Tripeptidyl-peptidase 2 OS=Homo sapiens OX=9606 GN=TPP2 PE=1 SV=4 TPP2_HUMAN reviewed Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II) Homo sapiens (Human) GO:0000209; GO:0004175; GO:0004177; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802; GO:0080144 intracellular amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] g12426.t2 P29144 46.996 566 2.43e-162 498.0 sp|P29144|TPP2_HUMAN Tripeptidyl-peptidase 2 OS=Homo sapiens OX=9606 GN=TPP2 PE=1 SV=4 TPP2_HUMAN reviewed Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II) Homo sapiens (Human) GO:0000209; GO:0004175; GO:0004177; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802; GO:0080144 intracellular amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] g12427.t1 Q14186 56.3 373 1.2100000000000002e-132 393.0 sp|Q14186|TFDP1_HUMAN Transcription factor Dp-1 OS=Homo sapiens OX=9606 GN=TFDP1 PE=1 SV=1 g12428.t1 Q27968 47.628 506 9.04e-153 447.0 sp|Q27968|DNJC3_BOVIN DnaJ homolog subfamily C member 3 OS=Bos taurus OX=9913 GN=DNAJC3 PE=1 SV=1 DNJC3_BOVIN reviewed DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58) Bos taurus (Bovine) GO:0004860; GO:0005783; GO:0005829; GO:0006986; GO:0019901; GO:0034975; GO:0036494; GO:0051087; GO:0051787; GO:0070417; GO:1903912 cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein-folding chaperone binding [GO:0051087] g12432.t1 Q14416 28.467 822 8.7e-82 286.0 sp|Q14416|GRM2_HUMAN Metabotropic glutamate receptor 2 OS=Homo sapiens OX=9606 GN=GRM2 PE=1 SV=2 GRM2_HUMAN reviewed Metabotropic glutamate receptor 2 (mGluR2) Homo sapiens (Human) GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0033554; GO:0035095; GO:0042220; GO:0042734; GO:0045211; GO:0051897; GO:0051966; GO:0060292; GO:0090461; GO:0097110; GO:0097449; GO:0098978; GO:0099171; GO:2001023 behavioral response to nicotine [GO:0035095]; cellular response to stress [GO:0033554]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate secretion [GO:0014047]; intracellular glutamate homeostasis [GO:0090461]; long-term synaptic depression [GO:0060292]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g12432.t2 P31421 28.263 835 5.2199999999999997e-82 286.0 sp|P31421|GRM2_RAT Metabotropic glutamate receptor 2 OS=Rattus norvegicus OX=10116 GN=Grm2 PE=1 SV=1 GRM2_RAT reviewed Metabotropic glutamate receptor 2 (mGluR2) Rattus norvegicus (Rat) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007215; GO:0007216; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0033554; GO:0035095; GO:0042220; GO:0042734; GO:0043005; GO:0045211; GO:0046928; GO:0051897; GO:0051966; GO:0060292; GO:0090461; GO:0097110; GO:0097449; GO:0098978; GO:0099171; GO:2001023 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; behavioral response to nicotine [GO:0035095]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate receptor signaling pathway [GO:0007215]; glutamate secretion [GO:0014047]; intracellular glutamate homeostasis [GO:0090461]; long-term synaptic depression [GO:0060292]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of neurotransmitter secretion [GO:0046928]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g12433.t1 Q0P3X8 50.505 99 1.12e-31 109.0 sp|Q0P3X8|LTOR4_DANRE Ragulator complex protein LAMTOR4 OS=Danio rerio OX=7955 GN=lamtor4 PE=3 SV=1 LTOR4_DANRE reviewed Ragulator complex protein LAMTOR4 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005764; GO:0005765; GO:0008361; GO:0032008; GO:0061462; GO:0071230; GO:0071986; GO:1904263 cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361] lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Ragulator complex [GO:0071986] g12435.t1 E7F240 29.198 661 7.15e-65 226.0 sp|E7F240|TPC14_DANRE Trafficking protein particle complex subunit 14 OS=Danio rerio OX=7955 GN=trappc14 PE=3 SV=1 g12436.t1 Q8WTR4 36.607 560 8.78e-137 415.0 sp|Q8WTR4|GDPD5_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 5 OS=Homo sapiens OX=9606 GN=GDPD5 PE=1 SV=2 GDPD5_HUMAN reviewed Glycerophosphodiester phosphodiesterase domain-containing protein 5 (Glycerophosphocholine phosphodiesterase GDPD5) (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 2) (Phosphoinositide phospholipase C GDPD5) (EC 3.1.4.11) Homo sapiens (Human) GO:0004435; GO:0005886; GO:0006629; GO:0007399; GO:0008889; GO:0012505; GO:0030426; GO:0045666; GO:0047389; GO:0048471 lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] endomembrane system [GO:0012505]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] glycerophosphocholine phosphodiesterase activity [GO:0047389]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g12436.t2 Q8WTR4 36.607 560 1.0599999999999999e-136 415.0 sp|Q8WTR4|GDPD5_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 5 OS=Homo sapiens OX=9606 GN=GDPD5 PE=1 SV=2 GDPD5_HUMAN reviewed Glycerophosphodiester phosphodiesterase domain-containing protein 5 (Glycerophosphocholine phosphodiesterase GDPD5) (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 2) (Phosphoinositide phospholipase C GDPD5) (EC 3.1.4.11) Homo sapiens (Human) GO:0004435; GO:0005886; GO:0006629; GO:0007399; GO:0008889; GO:0012505; GO:0030426; GO:0045666; GO:0047389; GO:0048471 lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] endomembrane system [GO:0012505]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] glycerophosphocholine phosphodiesterase activity [GO:0047389]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g12437.t1 O43639 40.897 379 4.08e-90 278.0 sp|O43639|NCK2_HUMAN Cytoplasmic protein NCK2 OS=Homo sapiens OX=9606 GN=NCK2 PE=1 SV=2 NCK2_HUMAN reviewed Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta) Homo sapiens (Human) GO:0000122; GO:0001771; GO:0001784; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0007165; GO:0007172; GO:0007173; GO:0008093; GO:0008285; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030159; GO:0030838; GO:0030971; GO:0035591; GO:0036491; GO:0036493; GO:0042102; GO:0042110; GO:0044877; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898 actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506] cytoskeletal anchor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159] g12439.t1 Q8BHR2 35.833 600 1.26e-96 313.0 sp|Q8BHR2|ENOX1_MOUSE Ecto-NOX disulfide-thiol exchanger 1 OS=Mus musculus OX=10090 GN=Enox1 PE=2 SV=1 g12440.t1 Q8AYS7 32.65 683 1.32e-126 397.0 sp|Q8AYS7|CENPI_CHICK Centromere protein I OS=Gallus gallus OX=9031 GN=CENPI PE=1 SV=1 g12444.t1 Q8R349 37.143 175 6.49e-28 111.0 sp|Q8R349|CDC16_MOUSE Cell division cycle protein 16 homolog OS=Mus musculus OX=10090 GN=Cdc16 PE=1 SV=1 g12445.t1 Q13042 53.312 317 4.71e-110 337.0 sp|Q13042|CDC16_HUMAN Cell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2 g12446.t1 O35817 45.07 142 2.55e-38 142.0 sp|O35817|AKA14_RAT A-kinase anchor protein 14 OS=Rattus norvegicus OX=10116 GN=Akap14 PE=2 SV=1 g12447.t1 Q80W94 48.923 325 7.9e-114 337.0 sp|Q80W94|MOGT2_MOUSE 2-acylglycerol O-acyltransferase 2 OS=Mus musculus OX=10090 GN=Mogat2 PE=1 SV=1 MOGT2_MOUSE reviewed 2-acylglycerol O-acyltransferase 2 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2) Mus musculus (Mouse) GO:0003846; GO:0004144; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578] 2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol O-acyltransferase activity [GO:0004144] g12448.t1 Q70VZ7 50.898 334 1.12e-118 348.0 sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1 MOGT1_BOVIN reviewed 2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1) Bos taurus (Bovine) GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] g12449.t1 Q2KHS5 51.307 306 7.46e-107 316.0 sp|Q2KHS5|MOG2A_XENLA 2-acylglycerol O-acyltransferase 2-A OS=Xenopus laevis OX=8355 GN=mogat2-a PE=2 SV=1 MOG2A_XENLA reviewed 2-acylglycerol O-acyltransferase 2-A (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2-A) (MGAT2-A) (Monoacylglycerol O-acyltransferase 2-A) Xenopus laevis (African clawed frog) GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006640; GO:0006651; GO:0019432; GO:1990578 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] g12450.t1 Q2KHS5 50.82 305 1.66e-114 337.0 sp|Q2KHS5|MOG2A_XENLA 2-acylglycerol O-acyltransferase 2-A OS=Xenopus laevis OX=8355 GN=mogat2-a PE=2 SV=1 MOG2A_XENLA reviewed 2-acylglycerol O-acyltransferase 2-A (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2-A) (MGAT2-A) (Monoacylglycerol O-acyltransferase 2-A) Xenopus laevis (African clawed frog) GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006640; GO:0006651; GO:0019432; GO:1990578 diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] g12452.t2 Q86YF9 30.213 609 2.09e-59 217.0 sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1 DZIP1_HUMAN reviewed Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140311; GO:0140706; GO:1903566 ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; protein sequestering activity [GO:0140311]; zinc ion binding [GO:0008270] g12452.t3 Q86YF9 33.615 473 1.1e-56 207.0 sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1 DZIP1_HUMAN reviewed Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140311; GO:0140706; GO:1903566 ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; protein sequestering activity [GO:0140311]; zinc ion binding [GO:0008270] g12452.t4 Q86YF9 33.615 473 8.620000000000001e-57 207.0 sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1 DZIP1_HUMAN reviewed Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140311; GO:0140706; GO:1903566 ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; protein sequestering activity [GO:0140311]; zinc ion binding [GO:0008270] g12452.t5 Q86YF9 34.071 452 7.56e-56 205.0 sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1 DZIP1_HUMAN reviewed Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140311; GO:0140706; GO:1903566 ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; protein sequestering activity [GO:0140311]; zinc ion binding [GO:0008270] g12455.t1 Q2TBR0 78.295 516 0.0 844.0 sp|Q2TBR0|PCCB_BOVIN Propionyl-CoA carboxylase beta chain, mitochondrial OS=Bos taurus OX=9913 GN=PCCB PE=2 SV=1 g12456.t1 A0A1D5NVS8 59.664 119 1.2399999999999999e-48 166.0 sp|A0A1D5NVS8|MSL2_CHICK E3 ubiquitin-protein ligase MSL2 OS=Gallus gallus OX=9031 GN=MSL2 PE=3 SV=1 g12458.t1 Q06190 61.276 439 0.0 568.0 sp|Q06190|P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens OX=9606 GN=PPP2R3A PE=1 SV=1 P2R3A_HUMAN reviewed Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B) Homo sapiens (Human) GO:0000159; GO:0001754; GO:0001756; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0060828; GO:0061053; GO:0090090; GO:0090249; GO:0090263 eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; somitogenesis [GO:0001756] protein phosphatase type 2A complex [GO:0000159] calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674] g12458.t2 Q06190 65.266 357 6.24e-158 477.0 sp|Q06190|P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens OX=9606 GN=PPP2R3A PE=1 SV=1 P2R3A_HUMAN reviewed Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B) Homo sapiens (Human) GO:0000159; GO:0001754; GO:0001756; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0060828; GO:0061053; GO:0090090; GO:0090249; GO:0090263 eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; somitogenesis [GO:0001756] protein phosphatase type 2A complex [GO:0000159] calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674] g12461.t1 Q4R517 70.218 413 0.0 617.0 sp|Q4R517|SUCB1_MACFA Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial OS=Macaca fascicularis OX=9541 GN=SUCLA2 PE=2 SV=1 SUCB1_MACFA reviewed Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Itaconyl--CoA ligase [ADP-forming] subunit beta) (EC 6.2.1.-) (Malyl--CoA ligase [ADP-forming] subunit beta) (EC 6.2.1.9) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000287; GO:0004775; GO:0005524; GO:0005739; GO:0006099; GO:0006104; GO:0042709 succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099] mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775] g12462.t1 Q3SZI0 53.717 417 6.200000000000001e-157 457.0 sp|Q3SZI0|MPI_BOVIN Mannose-6-phosphate isomerase OS=Bos taurus OX=9913 GN=MPI PE=2 SV=3 g12464.t1 Q3SWZ7 47.608 439 8.53e-140 417.0 sp|Q3SWZ7|TCAB1_BOVIN Telomerase Cajal body protein 1 OS=Bos taurus OX=9913 GN=WRAP53 PE=2 SV=1 TCAB1_BOVIN reviewed Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog) Bos taurus (Bovine) GO:0000781; GO:0003723; GO:0005697; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0032203; GO:0034337; GO:0035861; GO:0045739; GO:0070034; GO:0090666; GO:1904867; GO:1905168; GO:2000781; GO:2001034 Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004] Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697] RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] g12465.t1 Q8BG19 49.533 107 1.19e-28 112.0 sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1 TMTC4_MOUSE reviewed Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked glycosylation via mannose [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g12466.t1 Q8BG19 50.971 618 0.0 635.0 sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1 TMTC4_MOUSE reviewed Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked glycosylation via mannose [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g12466.t2 Q8BG19 50.487 616 0.0 631.0 sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1 TMTC4_MOUSE reviewed Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4) Mus musculus (Mouse) GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked glycosylation via mannose [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] g12467.t1 Q5ZMB2 39.487 195 2.63e-37 130.0 sp|Q5ZMB2|HEBP1_CHICK Heme-binding protein 1 OS=Gallus gallus OX=9031 GN=HEBP1 PE=2 SV=1 g12468.t1 Q8BQ48 36.101 277 6.98e-40 152.0 sp|Q8BQ48|CE295_MOUSE Centrosomal protein of 295 kDa OS=Mus musculus OX=10090 GN=Cep295 PE=1 SV=3 CE295_MOUSE reviewed Centrosomal protein of 295 kDa Mus musculus (Mouse) GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0007099; GO:0008017; GO:0010825; GO:0030030; GO:0046599; GO:1901985; GO:1903724; GO:1904951; GO:1990498 cell projection organization [GO:0030030]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498] microtubule binding [GO:0008017] g12470.t1 P14629 40.455 440 5.91e-87 311.0 sp|P14629|ERCC5_XENLA DNA excision repair protein ERCC-5 homolog OS=Xenopus laevis OX=8355 GN=ercc5 PE=2 SV=1 g12470.t1 P14629 41.368 307 4.47e-66 248.0 sp|P14629|ERCC5_XENLA DNA excision repair protein ERCC-5 homolog OS=Xenopus laevis OX=8355 GN=ercc5 PE=2 SV=1 g12470.t2 P14629 40.09 444 5.57e-85 305.0 sp|P14629|ERCC5_XENLA DNA excision repair protein ERCC-5 homolog OS=Xenopus laevis OX=8355 GN=ercc5 PE=2 SV=1 g12470.t2 P14629 41.368 307 4.63e-66 248.0 sp|P14629|ERCC5_XENLA DNA excision repair protein ERCC-5 homolog OS=Xenopus laevis OX=8355 GN=ercc5 PE=2 SV=1 g12471.t1 A2VDP6 32.231 484 1.04e-77 259.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g12471.t2 A2VDP6 32.231 484 2.0500000000000002e-77 259.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g12472.t1 P20594 42.308 234 5.04e-51 194.0 sp|P20594|ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens OX=9606 GN=NPR2 PE=1 SV=1 ANPRB_HUMAN reviewed Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) Homo sapiens (Human) GO:0000165; GO:0001549; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007283; GO:0007605; GO:0008217; GO:0016941; GO:0017046; GO:0019228; GO:0021647; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0048546; GO:0048668; GO:0048745; GO:0050872; GO:0051276; GO:0051402; GO:0051447; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537 activation of meiosis involved in egg activation [GO:0060466]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; growth plate cartilage development [GO:0003417]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; response to fibroblast growth factor [GO:0071774]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; sensory perception of sound [GO:0007605]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872] cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672] g12473.t1 O15042 51.036 917 0.0 795.0 sp|O15042|SR140_HUMAN U2 snRNP-associated SURP motif-containing protein OS=Homo sapiens OX=9606 GN=U2SURP PE=1 SV=2 g12473.t2 Q6NV83 50.698 931 0.0 795.0 sp|Q6NV83|SR140_MOUSE U2 snRNP-associated SURP motif-containing protein OS=Mus musculus OX=10090 GN=U2surp PE=1 SV=3 SR140_MOUSE reviewed U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140) Mus musculus (Mouse) GO:0003723; GO:0005634; GO:0005654; GO:0005686; GO:0006396 RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686] RNA binding [GO:0003723] g12473.t3 Q6NV83 50.698 931 0.0 795.0 sp|Q6NV83|SR140_MOUSE U2 snRNP-associated SURP motif-containing protein OS=Mus musculus OX=10090 GN=U2surp PE=1 SV=3 SR140_MOUSE reviewed U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140) Mus musculus (Mouse) GO:0003723; GO:0005634; GO:0005654; GO:0005686; GO:0006396 RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686] RNA binding [GO:0003723] g12474.t1 Q8WVM7 53.947 1140 0.0 1223.0 sp|Q8WVM7|STAG1_HUMAN Cohesin subunit SA-1 OS=Homo sapiens OX=9606 GN=STAG1 PE=1 SV=3 STAG1_HUMAN reviewed Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1) Homo sapiens (Human) GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005929; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0030892; GO:0034087; GO:0051301; GO:0090307; GO:0097431 cell division [GO:0051301]; establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682] g12475.t1 O15440 41.556 1427 0.0 1052.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g12476.t1 O15440 41.155 1402 0.0 1049.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g12476.t2 O15440 41.134 1393 0.0 1048.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g12477.t1 Q80VI1 23.824 340 5.8999999999999995e-24 107.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g12478.t1 Q8BKC5 59.543 1095 0.0 1368.0 sp|Q8BKC5|IPO5_MOUSE Importin-5 OS=Mus musculus OX=10090 GN=Ipo5 PE=1 SV=3 IPO5_MOUSE reviewed Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5) Mus musculus (Mouse) GO:0002753; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0031267; GO:0031965; GO:0042307; GO:0061608; GO:0071230 cellular response to amino acid stimulus [GO:0071230]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] g12480.t1 Q5D006 36.41 195 3.0399999999999997e-34 140.0 sp|Q5D006|UBP11_RAT Ubiquitin carboxyl-terminal hydrolase 11 OS=Rattus norvegicus OX=10116 GN=Usp11 PE=1 SV=1 UBP11_RAT reviewed Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11) Rattus norvegicus (Rat) GO:0001222; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006511; GO:0016579 protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; transcription corepressor binding [GO:0001222] g12489.t1 Q5SZT7 45.424 295 1.9899999999999998e-61 204.0 sp|Q5SZT7|NKAPL_MOUSE NKAP-like protein OS=Mus musculus OX=10090 GN=Nkapl PE=1 SV=1 g12490.t1 Q6P2D8 35.031 805 1.54e-103 340.0 sp|Q6P2D8|XRRA1_HUMAN X-ray radiation resistance-associated protein 1 OS=Homo sapiens OX=9606 GN=XRRA1 PE=1 SV=2 XRRA1_HUMAN reviewed X-ray radiation resistance-associated protein 1 Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0010165; GO:0016604 response to X-ray [GO:0010165] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g12491.t1 Q3SWY6 66.339 407 0.0 520.0 sp|Q3SWY6|STK25_BOVIN Serine/threonine-protein kinase 25 OS=Bos taurus OX=9913 GN=STK25 PE=2 SV=1 STK25_BOVIN reviewed Serine/threonine-protein kinase 25 (EC 2.7.11.1) Bos taurus (Bovine) GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0035556; GO:0046872; GO:0051645; GO:0090443; GO:0106310 Golgi localization [GO:0051645]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12492.t1 Q8BGC3 34.211 228 1.58e-35 143.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g12494.t1 Q0V9T8 54.952 313 1.29e-114 346.0 sp|Q0V9T8|BIVM_XENTR Basic immunoglobulin-like variable motif-containing protein OS=Xenopus tropicalis OX=8364 GN=bivm PE=2 SV=1 g12495.t1 A9UL78 50.314 159 2.2299999999999997e-52 167.0 sp|A9UL78|CEP19_XENTR Centrosomal protein of 19 kDa OS=Xenopus tropicalis OX=8364 GN=cep19 PE=2 SV=1 g12496.t1 Q9H5Z6 44.211 190 1.34e-44 162.0 sp|Q9H5Z6|F124B_HUMAN Protein FAM124B OS=Homo sapiens OX=9606 GN=FAM124B PE=1 SV=3 g12499.t1 Q9Y5X4 39.086 197 5.21e-32 127.0 sp|Q9Y5X4|NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens OX=9606 GN=NR2E3 PE=1 SV=1 NR2E3_HUMAN reviewed Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0007165; GO:0007601; GO:0007602; GO:0008270; GO:0008283; GO:0008285; GO:0010628; GO:0030182; GO:0042462; GO:0043565; GO:0045944; GO:0060041 cell population proliferation [GO:0008283]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g12501.t1 O88854 31.056 322 8.1e-31 122.0 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g12502.t1 O88854 30.435 299 3.0899999999999997e-24 104.0 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g12503.t1 O88854 28.758 306 5.97e-21 95.1 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g12504.t1 Q28927 29.94 334 2.48e-21 97.4 sp|Q28927|ADRB1_SHEEP Beta-1 adrenergic receptor OS=Ovis aries OX=9940 GN=ADRB1 PE=2 SV=2 g12506.t1 Q80U62 43.761 569 3.25e-149 468.0 sp|Q80U62|RUBIC_MOUSE Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Mus musculus OX=10090 GN=Rubcn PE=1 SV=2 RUBIC_MOUSE reviewed Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) Mus musculus (Mouse) GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006914; GO:0010507; GO:0045806; GO:0051898; GO:0141039; GO:1901097; GO:1901981 autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898] cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981] g12506.t2 Q80U62 45.126 554 4.54e-152 475.0 sp|Q80U62|RUBIC_MOUSE Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Mus musculus OX=10090 GN=Rubcn PE=1 SV=2 RUBIC_MOUSE reviewed Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) Mus musculus (Mouse) GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006914; GO:0010507; GO:0045806; GO:0051898; GO:0141039; GO:1901097; GO:1901981 autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898] cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981] g12507.t1 Q92622 39.759 166 1.15e-26 108.0 sp|Q92622|RUBIC_HUMAN Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Homo sapiens OX=9606 GN=RUBCN PE=1 SV=4 RUBIC_HUMAN reviewed Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron) Homo sapiens (Human) GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006909; GO:0006914; GO:0010507; GO:0045806; GO:0051898; GO:0071985; GO:0141039; GO:1901097; GO:1901981 autophagy [GO:0006914]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phagocytosis [GO:0006909] cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981] g12508.t1 A4FUB0 25.827 786 6.120000000000001e-72 251.0 sp|A4FUB0|CE034_BOVIN Uncharacterized protein C5orf34 homolog OS=Bos taurus OX=9913 PE=2 SV=1 g12510.t1 P36514 38.693 398 1.82e-94 300.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g12511.t1 P36514 40.247 405 1.4700000000000002e-103 323.0 sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1 g12512.t1 Q9WU25 30.583 206 6.579999999999999e-23 100.0 sp|Q9WU25|ADA1A_CAVPO Alpha-1A adrenergic receptor OS=Cavia porcellus OX=10141 GN=ADRA1A PE=2 SV=2 g12513.t1 Q95218 33.026 760 7.06e-82 290.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g12513.t1 Q95218 32.785 790 1.77e-78 280.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g12513.t1 Q95218 33.399 509 5.0099999999999993e-54 206.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g12514.t1 Q9H6R0 60.972 638 0.0 816.0 sp|Q9H6R0|DHX33_HUMAN ATP-dependent RNA helicase DHX33 OS=Homo sapiens OX=9606 GN=DHX33 PE=1 SV=2 DHX33_HUMAN reviewed ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33) Homo sapiens (Human) GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227 positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g12515.t1 A8MT70 29.664 327 1.85e-34 145.0 sp|A8MT70|ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZBBX PE=1 SV=3 ZBBX_HUMAN reviewed Zinc finger B-box domain-containing protein 1 Homo sapiens (Human) GO:0008270 zinc ion binding [GO:0008270] g12516.t1 A1L3P4 48.773 693 0.0 571.0 sp|A1L3P4|SL9A6_MOUSE Sodium/hydrogen exchanger 6 OS=Mus musculus OX=10090 GN=Slc9a6 PE=1 SV=1 SL9A6_MOUSE reviewed Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Sodium/hydrogen exchanger) (Solute carrier family 9 member 6) Mus musculus (Mouse) GO:0005739; GO:0005768; GO:0005769; GO:0005770; GO:0005789; GO:0005886; GO:0015385; GO:0015386; GO:0030010; GO:0030425; GO:0031410; GO:0031547; GO:0031901; GO:0031902; GO:0042802; GO:0043679; GO:0044308; GO:0045202; GO:0048675; GO:0048812; GO:0050808; GO:0051386; GO:0051453; GO:0055037; GO:0055038; GO:0060996; GO:0061900; GO:0071805; GO:0097484; GO:0098685; GO:0098719; GO:0098793; GO:0098978; GO:0099072; GO:1901546; GO:1902600 axon extension [GO:0048675]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; dendrite extension [GO:0097484]; dendritic spine development [GO:0060996]; establishment of cell polarity [GO:0030010]; glial cell activation [GO:0061900]; neuron projection morphogenesis [GO:0048812]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synaptic vesicle lumen acidification [GO:1901546]; sodium ion import across plasma membrane [GO:0098719]; synapse organization [GO:0050808] axon terminus [GO:0043679]; axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] identical protein binding [GO:0042802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g12517.t1 Q8N323 26.383 470 6.970000000000001e-36 144.0 sp|Q8N323|NXPE1_HUMAN NXPE family member 1 OS=Homo sapiens OX=9606 GN=NXPE1 PE=1 SV=2 g12523.t1 Q99J23 29.428 367 1.31e-47 172.0 sp|Q99J23|GHDC_MOUSE GH3 domain-containing protein OS=Mus musculus OX=10090 GN=Ghdc PE=2 SV=2 g12525.t1 Q64707 43.642 346 5.04e-69 235.0 sp|Q64707|U2AFL_MOUSE U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2-like OS=Mus musculus OX=10090 GN=Zrsr2-ps1 PE=1 SV=1 U2AFL_MOUSE reviewed U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2-like (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 1) (SP2) (U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 1) Mus musculus (Mouse) GO:0000398; GO:0005681; GO:0005689; GO:0008270; GO:0030628; GO:0042802; GO:0089701 mRNA splicing, via spliceosome [GO:0000398] spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701] identical protein binding [GO:0042802]; pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270] g12526.t1 Q8N137 32.613 509 5.71e-48 188.0 sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1 CNTRB_HUMAN reviewed Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8) Homo sapiens (Human) GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410 centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] protein domain specific binding [GO:0019904] g12528.t1 O15973 25.817 306 1.8100000000000002e-21 98.2 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g12529.t1 Q99J23 29.863 365 1.52e-48 177.0 sp|Q99J23|GHDC_MOUSE GH3 domain-containing protein OS=Mus musculus OX=10090 GN=Ghdc PE=2 SV=2 g12531.t1 Q0D4Z6 29.217 575 1.3e-53 196.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g12532.t1 P56377 84.076 157 1.68e-96 278.0 sp|P56377|AP1S2_HUMAN AP-1 complex subunit sigma-2 OS=Homo sapiens OX=9606 GN=AP1S2 PE=1 SV=1 AP1S2_HUMAN reviewed AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin) Homo sapiens (Human) GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0016192; GO:0030119; GO:0030121; GO:0030659; GO:0032588; GO:0035615; GO:0060155; GO:1903232 intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] clathrin adaptor activity [GO:0035615] g12534.t1 Q9IAK4 23.413 504 1.98e-35 142.0 sp|Q9IAK4|NOE1_CHICK Noelin OS=Gallus gallus OX=9031 GN=OLFM1 PE=1 SV=1 g12536.t1 Q6GP95 49.61 385 1.37e-136 403.0 sp|Q6GP95|GLPK5_XENLA Glycerol kinase 5 OS=Xenopus laevis OX=8355 GN=gk5 PE=2 SV=1 GLPK5_XENLA reviewed Glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5) Xenopus laevis (African clawed frog) GO:0004370; GO:0005524; GO:0005737; GO:0005739; GO:0006071; GO:0006641; GO:0019563; GO:0046167 glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; triglyceride metabolic process [GO:0006641] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370] g12540.t1 Q62283 35.878 262 1.1600000000000001e-57 187.0 sp|Q62283|TSN7_MOUSE Tetraspanin-7 OS=Mus musculus OX=10090 GN=Tspan7 PE=1 SV=2 g12541.t1 O15440 34.442 421 1.9e-74 257.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g12542.t1 Q9R1X5 43.295 783 0.0 602.0 sp|Q9R1X5|MRP5_MOUSE ATP-binding cassette sub-family C member 5 OS=Mus musculus OX=10090 GN=Abcc5 PE=1 SV=2 MRP5_MOUSE reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) Mus musculus (Mouse) GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359 cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g12543.t1 Q5F4B3 39.402 368 3.57e-95 293.0 sp|Q5F4B3|TMLH_CHICK Trimethyllysine dioxygenase, mitochondrial OS=Gallus gallus OX=9031 GN=TMLHE PE=2 SV=1 TMLH_CHICK reviewed Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD) Gallus gallus (Chicken) GO:0005506; GO:0005739; GO:0005759; GO:0045329; GO:0050353 carnitine biosynthetic process [GO:0045329] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] iron ion binding [GO:0005506]; trimethyllysine dioxygenase activity [GO:0050353] g12549.t1 Q9CSP9 39.247 372 2.05e-67 229.0 sp|Q9CSP9|TTC14_MOUSE Tetratricopeptide repeat protein 14 OS=Mus musculus OX=10090 GN=Ttc14 PE=1 SV=3 g12550.t1 A2VDR8 47.792 770 0.0 713.0 sp|A2VDR8|COG7_BOVIN Conserved oligomeric Golgi complex subunit 7 OS=Bos taurus OX=9913 GN=COG7 PE=2 SV=1 g12551.t1 P81134 36.415 357 2.17e-69 224.0 sp|P81134|RENR_BOVIN Renin receptor OS=Bos taurus OX=9913 GN=ATP6AP2 PE=1 SV=2 RENR_BOVIN reviewed Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor extracellular fragment; Renin receptor cytoplasmic fragment] Bos taurus (Bovine) GO:0000220; GO:0000421; GO:0005765; GO:0005789; GO:0007042; GO:0009897; GO:0010008; GO:0030177; GO:0030424; GO:0030665; GO:0030672; GO:0032591; GO:0038023; GO:0045851; GO:0090263; GO:1902600 lysosomal lumen acidification [GO:0007042]; pH reduction [GO:0045851]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600] autophagosome membrane [GO:0000421]; axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; lysosomal membrane [GO:0005765]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220] signaling receptor activity [GO:0038023] g12552.t1 Q8CGN4 35.696 395 6.47e-62 238.0 sp|Q8CGN4|BCOR_MOUSE BCL-6 corepressor OS=Mus musculus OX=10090 GN=Bcor PE=1 SV=2 BCOR_MOUSE reviewed BCL-6 corepressor (BCoR) Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0000977; GO:0001835; GO:0003714; GO:0004842; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0030502; GO:0031072; GO:0042476; GO:0042826; GO:0045892; GO:0060021; GO:0065001; GO:0070171; GO:0140261; GO:0140297 blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; negative regulation of bone mineralization [GO:0030502]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001] BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; ubiquitin-protein transferase activity [GO:0004842] g12553.t1 Q5F418 61.355 1004 0.0 1132.0 sp|Q5F418|PSMD1_CHICK 26S proteasome non-ATPase regulatory subunit 1 OS=Gallus gallus OX=9031 GN=PSMD1 PE=2 SV=1 g12556.t1 Q7ZWA3 40.724 221 9.719999999999999e-24 106.0 sp|Q7ZWA3|RBMX_DANRE RNA-binding motif protein, X chromosome OS=Danio rerio OX=7955 GN=rbmx PE=2 SV=1 RBMX_DANRE reviewed RNA-binding motif protein, X chromosome (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000381; GO:0000398; GO:0000791; GO:0000978; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0006366; GO:0006509; GO:0017069; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347 cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366] catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; snRNA binding [GO:0017069] g12560.t1 P24346 35.664 286 1.62e-25 110.0 sp|P24346|DDX3_XENLA Putative ATP-dependent RNA helicase an3 OS=Xenopus laevis OX=8355 GN=an3 PE=2 SV=1 g12561.t1 P16381 76.03 267 8.859999999999999e-139 410.0 sp|P16381|DDX3L_MOUSE Putative ATP-dependent RNA helicase Pl10 OS=Mus musculus OX=10090 GN=D1Pas1 PE=1 SV=1 g12566.t1 Q7Q1K8 68.227 705 0.0 1027.0 sp|Q7Q1K8|EFGM_ANOGA Elongation factor G, mitochondrial OS=Anopheles gambiae OX=7165 GN=AGAP009737 PE=3 SV=4 g12569.t1 A0A0R4IBK5 33.755 711 1.07e-89 326.0 sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1 R213A_DANRE reviewed E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12570.t1 Q63HN8 24.311 798 1.29e-34 149.0 sp|Q63HN8|RN213_HUMAN E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=3 RN213_HUMAN reviewed E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213) Homo sapiens (Human) GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0008270; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12574.t1 A0A0R4IBK5 30.762 1115 8.259999999999999e-128 457.0 sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1 R213A_DANRE reviewed E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12576.t1 A0A0R4IBK5 33.083 931 1.17e-122 442.0 sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1 R213A_DANRE reviewed E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12584.t1 A0A0R4IBK5 33.262 935 8.390000000000001e-124 447.0 sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1 R213A_DANRE reviewed E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12585.t1 O60706 23.695 498 2.5000000000000003e-37 149.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g12587.t1 Q09428 42.81 911 0.0 712.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g12587.t2 P70170 37.717 403 5.8700000000000005e-77 264.0 sp|P70170|ABCC9_MOUSE ATP-binding cassette sub-family C member 9 OS=Mus musculus OX=10090 GN=Abcc9 PE=1 SV=2 ABCC9_MOUSE reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Mus musculus (Mouse) GO:0000165; GO:0001508; GO:0001568; GO:0001666; GO:0001669; GO:0003007; GO:0003018; GO:0005267; GO:0005524; GO:0005737; GO:0005739; GO:0005886; GO:0006357; GO:0006813; GO:0006950; GO:0007005; GO:0007507; GO:0007519; GO:0008015; GO:0008217; GO:0008281; GO:0008282; GO:0009410; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0019905; GO:0030017; GO:0030315; GO:0032991; GO:0033198; GO:0035864; GO:0035865; GO:0036293; GO:0042311; GO:0042383; GO:0042391; GO:0042542; GO:0042626; GO:0042802; GO:0043066; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0060976; GO:0061337; GO:0062197; GO:0070482; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072359; GO:0072592; GO:0086003; GO:0097746; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:1901363; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel diameter maintenance [GO:0097746]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; circulatory system development [GO:0072359]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of blood pressure [GO:0008217]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to decreased oxygen levels [GO:0036293]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to peptide [GO:1901652]; response to potassium ion [GO:0035864]; response to stress [GO:0006950]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; vascular process in circulatory system [GO:0003018]; vasodilation [GO:0042311] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; T-tubule [GO:0030315] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325] g12588.t1 O55043 42.097 639 1.3000000000000001e-157 471.0 sp|O55043|ARHG7_RAT Rho guanine nucleotide exchange factor 7 OS=Rattus norvegicus OX=10116 GN=Arhgef7 PE=1 SV=1 ARHG7_RAT reviewed Rho guanine nucleotide exchange factor 7 (Beta-Pix) (PAK-interacting exchange factor beta) Rattus norvegicus (Rat) GO:0000322; GO:0001726; GO:0002244; GO:0005085; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007030; GO:0007264; GO:0007266; GO:0019901; GO:0030027; GO:0030032; GO:0030426; GO:0032991; GO:0043005; GO:0043008; GO:0043015; GO:0043025; GO:0043065; GO:0043615; GO:0060124; GO:0097431; GO:0098794; GO:0098974; GO:0098982; GO:0099140; GO:1905833 astrocyte cell migration [GO:0043615]; Golgi organization [GO:0007030]; hematopoietic progenitor cell differentiation [GO:0002244]; lamellipodium assembly [GO:0030032]; negative regulation of microtubule nucleation [GO:1905833]; positive regulation of apoptotic process [GO:0043065]; positive regulation of growth hormone secretion [GO:0060124]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; Rho protein signal transduction [GO:0007266]; small GTPase-mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; storage vacuole [GO:0000322] ATP-dependent protein binding [GO:0043008]; gamma-tubulin binding [GO:0043015]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901] g12589.t1 P48818 61.375 611 0.0 750.0 sp|P48818|ACADV_BOVIN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ACADVL PE=2 SV=3 ACADV_BOVIN reviewed Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9) (Long-chain specific acyl-CoA dehydrogenase, mitochondrial) (EC 1.3.8.8) Bos taurus (Bovine) GO:0000062; GO:0003995; GO:0005743; GO:0017099; GO:0033539; GO:0042802; GO:0050660 fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] mitochondrial inner membrane [GO:0005743] acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099] g12590.t1 Q6P549 39.515 949 0.0 635.0 sp|Q6P549|SHIP2_MOUSE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 OS=Mus musculus OX=10090 GN=Inppl1 PE=1 SV=1 SHIP2_MOUSE reviewed Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2) Mus musculus (Mouse) GO:0000132; GO:0000922; GO:0001958; GO:0002376; GO:0003779; GO:0004445; GO:0005547; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006006; GO:0006629; GO:0006661; GO:0006897; GO:0006915; GO:0007015; GO:0007155; GO:0008156; GO:0008285; GO:0009791; GO:0009925; GO:0010467; GO:0010629; GO:0010642; GO:0010977; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032880; GO:0032957; GO:0034485; GO:0042169; GO:0043491; GO:0043569; GO:0046627; GO:0046856; GO:0050776; GO:0070371; GO:0097178; GO:0110053 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; inositol trisphosphate metabolic process [GO:0032957]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] actin binding [GO:0003779]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124] g12593.t1 Q68EW7 53.333 90 3.8200000000000003e-29 103.0 sp|Q68EW7|MED11_XENLA Mediator of RNA polymerase II transcription subunit 11 OS=Xenopus laevis OX=8355 GN=med11 PE=3 SV=1 g12594.t1 Q5F3U0 36.646 322 9.119999999999999e-54 207.0 sp|Q5F3U0|SP130_CHICK Histone deacetylase complex subunit SAP130 OS=Gallus gallus OX=9031 GN=SAP130 PE=2 SV=1 g12594.t2 Q5F3U0 36.646 322 4.23e-54 208.0 sp|Q5F3U0|SP130_CHICK Histone deacetylase complex subunit SAP130 OS=Gallus gallus OX=9031 GN=SAP130 PE=2 SV=1 g12594.t3 Q5F3U0 36.646 322 4.2499999999999994e-54 208.0 sp|Q5F3U0|SP130_CHICK Histone deacetylase complex subunit SAP130 OS=Gallus gallus OX=9031 GN=SAP130 PE=2 SV=1 g12595.t1 Q4R562 56.553 412 1.9199999999999997e-152 441.0 sp|Q4R562|ARRB1_MACFA Beta-arrestin-1 OS=Macaca fascicularis OX=9541 GN=ARRB1 PE=2 SV=1 ARRB1_MACFA reviewed Beta-arrestin-1 (Arrestin beta-1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001934; GO:0002031; GO:0002092; GO:0005634; GO:0005829; GO:0005886; GO:0005905; GO:0006511; GO:0007165; GO:0010613; GO:0015031; GO:0019899; GO:0031143; GO:0031397; GO:0031410; GO:0031701; GO:0043161; GO:0045746; GO:0070374 G protein-coupled receptor internalization [GO:0002031]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] angiotensin receptor binding [GO:0031701]; enzyme binding [GO:0019899] g12595.t2 Q4R562 56.659 413 4.08e-153 444.0 sp|Q4R562|ARRB1_MACFA Beta-arrestin-1 OS=Macaca fascicularis OX=9541 GN=ARRB1 PE=2 SV=1 ARRB1_MACFA reviewed Beta-arrestin-1 (Arrestin beta-1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001934; GO:0002031; GO:0002092; GO:0005634; GO:0005829; GO:0005886; GO:0005905; GO:0006511; GO:0007165; GO:0010613; GO:0015031; GO:0019899; GO:0031143; GO:0031397; GO:0031410; GO:0031701; GO:0043161; GO:0045746; GO:0070374 G protein-coupled receptor internalization [GO:0002031]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] angiotensin receptor binding [GO:0031701]; enzyme binding [GO:0019899] g12596.t1 Q58HI1 34.687 591 2.24e-86 294.0 sp|Q58HI1|PELP1_XENLA Proline-, glutamic acid- and leucine-rich protein 1 OS=Xenopus laevis OX=8355 GN=pelp1 PE=1 SV=1 PELP1_XENLA reviewed Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) Xenopus laevis (African clawed frog) GO:0000791; GO:0003682; GO:0005634; GO:0005737; GO:0006364; GO:0045944; GO:0071339; GO:0071391 cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nucleus [GO:0005634] chromatin binding [GO:0003682] g12599.t1 Q5ZKC1 54.118 425 1.05e-175 506.0 sp|Q5ZKC1|EIF2A_CHICK Eukaryotic translation initiation factor 2A OS=Gallus gallus OX=9031 GN=EIF2A PE=2 SV=1 EIF2A_CHICK reviewed Eukaryotic translation initiation factor 2A (eIF-2A) Gallus gallus (Chicken) GO:0000049; GO:0003729; GO:0003743; GO:0005737; GO:0005850; GO:0006417; GO:0042255; GO:0043022 regulation of translation [GO:0006417]; ribosome assembly [GO:0042255] cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850] mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] g12603.t1 Q8CHG3 34.673 796 6.51e-112 398.0 sp|Q8CHG3|GCC2_MOUSE GRIP and coiled-coil domain-containing protein 2 OS=Mus musculus OX=10090 GN=Gcc2 PE=1 SV=3 GCC2_MOUSE reviewed GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185) Mus musculus (Mouse) GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0031023; GO:0034067; GO:0034453; GO:0034499; GO:0042147; GO:0042802; GO:0070861; GO:0071955; GO:0090161 Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] identical protein binding [GO:0042802] g12609.t1 Q80XN0 39.759 249 1.13e-57 193.0 sp|Q80XN0|BDH_MOUSE D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Bdh1 PE=1 SV=2 g12610.t1 Q93008 67.509 2533 0.0 3452.0 sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4 g12610.t2 Q93008 67.509 2533 0.0 3450.0 sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4 g12610.t3 Q93008 67.323 2540 0.0 3446.0 sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4 g12611.t1 P05165 62.358 704 0.0 899.0 sp|P05165|PCCA_HUMAN Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Homo sapiens OX=9606 GN=PCCA PE=1 SV=4 PCCA_HUMAN reviewed Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Homo sapiens (Human) GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006631; GO:0009081; GO:0009374; GO:0019626; GO:0019899; GO:0046872; GO:1902494 branched-chain amino acid metabolic process [GO:0009081]; fatty acid metabolic process [GO:0006631]; short-chain fatty acid catabolic process [GO:0019626] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; biotin binding [GO:0009374]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658] g12613.t1 P10768 69.106 246 7.980000000000001e-133 382.0 sp|P10768|ESTD_HUMAN S-formylglutathione hydrolase OS=Homo sapiens OX=9606 GN=ESD PE=1 SV=2 ESTD_HUMAN reviewed S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56) Homo sapiens (Human) GO:0005788; GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0047374; GO:0052689; GO:0070062 formaldehyde catabolic process [GO:0046294] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; S-formylglutathione hydrolase activity [GO:0018738] g12614.t1 Q8NFT8 28.345 568 9.049999999999999e-60 213.0 sp|Q8NFT8|DNER_HUMAN Delta and Notch-like epidermal growth factor-related receptor OS=Homo sapiens OX=9606 GN=DNER PE=1 SV=1 DNER_HUMAN reviewed Delta and Notch-like epidermal growth factor-related receptor Homo sapiens (Human) GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0030276; GO:0030425; GO:0043025; GO:0048741 central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416] dendrite [GO:0030425]; early endosome [GO:0005769]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888] g12616.t1 Q1T769 33.684 190 1.66e-24 99.8 sp|Q1T769|MIS12_CHICK Protein MIS12 homolog OS=Gallus gallus OX=9031 GN=MIS12 PE=2 SV=1 g12617.t1 Q54U75 25.786 318 3.32e-31 125.0 sp|Q54U75|CRLA_DICDI Cyclic AMP receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=crlA PE=2 SV=1 CRLA_DICDI reviewed Cyclic AMP receptor-like protein A Dictyostelium discoideum (Social amoeba) GO:0001646; GO:0004930; GO:0005886; GO:0007165; GO:0007189; GO:0030308; GO:0030435 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; sporulation resulting in formation of a cellular spore [GO:0030435] plasma membrane [GO:0005886] cAMP receptor activity [GO:0001646]; G protein-coupled receptor activity [GO:0004930] g12617.t2 Q54U75 25.743 303 3.06e-28 116.0 sp|Q54U75|CRLA_DICDI Cyclic AMP receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=crlA PE=2 SV=1 CRLA_DICDI reviewed Cyclic AMP receptor-like protein A Dictyostelium discoideum (Social amoeba) GO:0001646; GO:0004930; GO:0005886; GO:0007165; GO:0007189; GO:0030308; GO:0030435 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; sporulation resulting in formation of a cellular spore [GO:0030435] plasma membrane [GO:0005886] cAMP receptor activity [GO:0001646]; G protein-coupled receptor activity [GO:0004930] g12618.t1 Q6NUB2 67.1 231 5.779999999999999e-90 267.0 sp|Q6NUB2|CW15A_XENLA Protein CWC15 homolog A OS=Xenopus laevis OX=8355 GN=cwc15-a PE=2 SV=1 g12619.t1 F4HYF3 42.179 358 1.95e-91 283.0 sp|F4HYF3|DCYD1_ARATH Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=DCD PE=1 SV=1 DCYD1_ARATH reviewed Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial (EC 3.5.99.7) (EC 4.4.1.15) (1-aminocyclopropane-1-carboxylic acid deaminase 1) (AtACD1) (AtD-CDes1) (D-CDes1) (D-CDES) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0005739; GO:0005829; GO:0009507; GO:0009693; GO:0016787; GO:0019148; GO:0019447; GO:0050897; GO:1990170 D-cysteine catabolic process [GO:0019447]; ethylene biosynthetic process [GO:0009693]; stress response to cadmium ion [GO:1990170] chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; D-cysteine desulfhydrase activity [GO:0019148]; hydrolase activity [GO:0016787] g12620.t1 F4HYF3 40.327 367 2.69e-81 261.0 sp|F4HYF3|DCYD1_ARATH Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=DCD PE=1 SV=1 DCYD1_ARATH reviewed Bifunctional D-cysteine desulfhydrase/1-aminocyclopropane-1-carboxylate deaminase, mitochondrial (EC 3.5.99.7) (EC 4.4.1.15) (1-aminocyclopropane-1-carboxylic acid deaminase 1) (AtACD1) (AtD-CDes1) (D-CDes1) (D-CDES) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0005739; GO:0005829; GO:0009507; GO:0009693; GO:0016787; GO:0019148; GO:0019447; GO:0050897; GO:1990170 D-cysteine catabolic process [GO:0019447]; ethylene biosynthetic process [GO:0009693]; stress response to cadmium ion [GO:1990170] chloroplast [GO:0009507]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; D-cysteine desulfhydrase activity [GO:0019148]; hydrolase activity [GO:0016787] g12622.t1 Q4VCS5 38.567 363 6.73e-62 230.0 sp|Q4VCS5|AMOT_HUMAN Angiomotin OS=Homo sapiens OX=9606 GN=AMOT PE=1 SV=1 AMOT_HUMAN reviewed Angiomotin Homo sapiens (Human) GO:0000122; GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0007043; GO:0008104; GO:0009897; GO:0009986; GO:0014069; GO:0016020; GO:0016525; GO:0030027; GO:0030036; GO:0030139; GO:0030334; GO:0031410; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0045793; GO:0051056; GO:0051496; GO:0098978; GO:1905274 actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; intracellular protein localization [GO:0008104]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell migration [GO:0030334]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570] actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle [GO:0001726]; stress fiber [GO:0001725] angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023] g12623.t1 Q91857 54.561 570 0.0 609.0 sp|Q91857|TAF6_XENLA Transcription initiation factor TFIID subunit 6 OS=Xenopus laevis OX=8355 GN=taf6 PE=2 SV=3 g12625.t1 Q5M8Y1 60.773 181 7.55e-80 239.0 sp|Q5M8Y1|SPCS2_XENTR Signal peptidase complex subunit 2 OS=Xenopus tropicalis OX=8364 GN=spcs2 PE=2 SV=1 g12626.t1 Q9NR80 48.542 480 4.2e-143 467.0 sp|Q9NR80|ARHG4_HUMAN Rho guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=ARHGEF4 PE=1 SV=3 ARHG4_HUMAN reviewed Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0019904; GO:0030032; GO:0032587; GO:0035556; GO:0046847; GO:0051056 filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904] g12626.t2 Q9NR80 49.676 463 1.4999999999999999e-142 466.0 sp|Q9NR80|ARHG4_HUMAN Rho guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=ARHGEF4 PE=1 SV=3 ARHG4_HUMAN reviewed Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0019904; GO:0030032; GO:0032587; GO:0035556; GO:0046847; GO:0051056 filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904] g12627.t1 Q8VDR7 56.358 346 3.5199999999999997e-141 407.0 sp|Q8VDR7|TGDS_MOUSE dTDP-D-glucose 4,6-dehydratase OS=Mus musculus OX=10090 GN=Tgds PE=2 SV=2 g12627.t2 Q8VDR7 55.917 338 3.6e-139 402.0 sp|Q8VDR7|TGDS_MOUSE dTDP-D-glucose 4,6-dehydratase OS=Mus musculus OX=10090 GN=Tgds PE=2 SV=2 g12635.t2 Q28927 29.358 327 3.14e-22 99.4 sp|Q28927|ADRB1_SHEEP Beta-1 adrenergic receptor OS=Ovis aries OX=9940 GN=ADRB1 PE=2 SV=2 g12636.t1 O97827 33.544 474 1.47e-68 260.0 sp|O97827|AGRL3_BOVIN Adhesion G protein-coupled receptor L3 OS=Bos taurus OX=9913 GN=ADGRL3 PE=2 SV=1 g12638.t1 Q969Y0 26.651 439 1.2400000000000001e-37 149.0 sp|Q969Y0|NXPE3_HUMAN NXPE family member 3 OS=Homo sapiens OX=9606 GN=NXPE3 PE=1 SV=1 g12639.t1 A2VDP6 32.401 429 6.39e-69 233.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g12640.t1 Q05004 26.94 464 7.42e-33 135.0 sp|Q05004|NXPE1_RABIT NXPE family member 1 OS=Oryctolagus cuniculus OX=9986 GN=NXPE1 PE=2 SV=1 g12641.t1 Q969Y0 27.843 510 3.96e-41 159.0 sp|Q969Y0|NXPE3_HUMAN NXPE family member 3 OS=Homo sapiens OX=9606 GN=NXPE3 PE=1 SV=1 g12642.t1 A2VDP6 28.094 299 8.49e-36 140.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g12646.t1 A2VDP6 30.337 356 1.46e-47 174.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g12647.t1 Q9ESX5 73.864 440 0.0 675.0 sp|Q9ESX5|DKC1_MOUSE H/ACA ribonucleoprotein complex subunit DKC1 OS=Mus musculus OX=10090 GN=Dkc1 PE=1 SV=4 DKC1_MOUSE reviewed H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1) Mus musculus (Mouse) GO:0000454; GO:0000455; GO:0000495; GO:0001650; GO:0003720; GO:0003723; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0007004; GO:0008284; GO:0009982; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:0032212; GO:0033979; GO:0034513; GO:0070034; GO:0090661; GO:0090666; GO:0090669; GO:1904872; GO:1904874; GO:1905323; GO:1990481 box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; box H/ACA sno(s)RNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004] box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g12648.t1 P0DPB4 42.294 279 8.139999999999999e-48 181.0 sp|P0DPB4|SCHI1_MOUSE Schwannomin-interacting protein 1 OS=Mus musculus OX=10090 GN=Schip1 PE=1 SV=1 SCHI1_MOUSE reviewed Schwannomin-interacting protein 1 (SCHIP-1) Mus musculus (Mouse) GO:0001553; GO:0001822; GO:0005737; GO:0005886; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0030054; GO:0035332; GO:0042802; GO:0042803; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325 estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of hippo signaling [GO:0035332]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745] cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g12648.t2 P0DPB4 42.705 281 4e-49 184.0 sp|P0DPB4|SCHI1_MOUSE Schwannomin-interacting protein 1 OS=Mus musculus OX=10090 GN=Schip1 PE=1 SV=1 SCHI1_MOUSE reviewed Schwannomin-interacting protein 1 (SCHIP-1) Mus musculus (Mouse) GO:0001553; GO:0001822; GO:0005737; GO:0005886; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0030054; GO:0035332; GO:0042802; GO:0042803; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325 estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of hippo signaling [GO:0035332]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745] cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g12648.t3 P0DPB4 37.097 372 2.57e-49 184.0 sp|P0DPB4|SCHI1_MOUSE Schwannomin-interacting protein 1 OS=Mus musculus OX=10090 GN=Schip1 PE=1 SV=1 SCHI1_MOUSE reviewed Schwannomin-interacting protein 1 (SCHIP-1) Mus musculus (Mouse) GO:0001553; GO:0001822; GO:0005737; GO:0005886; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0030054; GO:0035332; GO:0042802; GO:0042803; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325 estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of hippo signaling [GO:0035332]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745] cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g12649.t1 P29241 38.057 247 9.84e-54 180.0 sp|P29241|NADA_APLCA ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia californica OX=6500 PE=1 SV=1 g12654.t1 P05300 28.276 435 9.409999999999999e-34 134.0 sp|P05300|LAMP1_CHICK Lysosome-associated membrane glycoprotein 1 OS=Gallus gallus OX=9031 GN=LAMP1 PE=2 SV=1 g12655.t1 Q9H2G9 36.299 281 9.51e-40 148.0 sp|Q9H2G9|GO45_HUMAN Golgin-45 OS=Homo sapiens OX=9606 GN=BLZF1 PE=1 SV=2 GO45_HUMAN reviewed Golgin-45 (Basic leucine zipper nuclear factor 1) (JEM-1) (p45 basic leucine-zipper nuclear factor) Homo sapiens (Human) GO:0000139; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005801; GO:0007030; GO:0019899; GO:0031625; GO:0043001 Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625] g12657.t1 Q498F0 66.959 342 3.87e-162 479.0 sp|Q498F0|WDR44_XENLA WD repeat-containing protein 44 OS=Xenopus laevis OX=8355 GN=wdr44 PE=2 SV=1 g12667.t1 Q9UPN9 24.625 333 9.37e-22 104.0 sp|Q9UPN9|TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens OX=9606 GN=TRIM33 PE=1 SV=3 g12668.t1 Q9R0Q9 49.593 246 1.7e-82 250.0 sp|Q9R0Q9|MPU1_MOUSE Mannose-P-dolichol utilization defect 1 protein OS=Mus musculus OX=10090 GN=Mpdu1 PE=1 SV=1 g12669.t1 Q8TF20 29.583 791 9.78e-86 295.0 sp|Q8TF20|ZN721_HUMAN Zinc finger protein 721 OS=Homo sapiens OX=9606 GN=ZNF721 PE=1 SV=2 g12669.t1 Q8TF20 27.573 787 1.91e-67 244.0 sp|Q8TF20|ZN721_HUMAN Zinc finger protein 721 OS=Homo sapiens OX=9606 GN=ZNF721 PE=1 SV=2 g12669.t1 Q8TF20 30.317 630 3.06e-62 229.0 sp|Q8TF20|ZN721_HUMAN Zinc finger protein 721 OS=Homo sapiens OX=9606 GN=ZNF721 PE=1 SV=2 g12669.t1 Q8TF20 26.884 491 1.67e-36 151.0 sp|Q8TF20|ZN721_HUMAN Zinc finger protein 721 OS=Homo sapiens OX=9606 GN=ZNF721 PE=1 SV=2 g12670.t1 Q96T23 58.163 98 7.360000000000001e-32 139.0 sp|Q96T23|RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2 RSF1_HUMAN reviewed Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0008270; GO:0031213; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0050434; GO:0140751 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213] histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; zinc ion binding [GO:0008270] g12684.t1 E9Q236 47.213 574 6.810000000000001e-163 520.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12684.t1 E9Q236 47.355 397 1.7e-107 369.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12685.t1 E9Q236 63.19 326 4.2400000000000006e-144 443.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12686.t1 E9Q236 52.245 913 0.0 953.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12686.t1 E9Q236 44.988 409 2.0100000000000002e-103 363.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12686.t2 E9Q236 52.355 913 0.0 954.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12686.t2 E9Q236 44.988 409 1.6200000000000002e-103 363.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12689.t1 P91660 39.436 1382 0.0 1003.0 sp|P91660|L259_DROME Probable multidrug resistance-associated protein lethal(2)03659 OS=Drosophila melanogaster OX=7227 GN=l(2)03659 PE=2 SV=4 g12690.t1 Q32KQ2 34.946 372 9.49e-74 236.0 sp|Q32KQ2|WDR53_BOVIN WD repeat-containing protein 53 OS=Bos taurus OX=9913 GN=WDR53 PE=2 SV=1 g12691.t1 P91660 39.337 1388 0.0 1011.0 sp|P91660|L259_DROME Probable multidrug resistance-associated protein lethal(2)03659 OS=Drosophila melanogaster OX=7227 GN=l(2)03659 PE=2 SV=4 g12698.t1 E9Q236 47.51 1225 0.0 1132.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g12699.t1 Q0IIF9 43.165 139 1.43e-29 119.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g12700.t1 O15403 24.153 443 8.230000000000001e-26 114.0 sp|O15403|MOT7_HUMAN Monocarboxylate transporter 7 OS=Homo sapiens OX=9606 GN=SLC16A6 PE=1 SV=2 g12703.t1 Q9NZ94 38.301 765 1.89e-161 495.0 sp|Q9NZ94|NLGN3_HUMAN Neuroligin-3 OS=Homo sapiens OX=9606 GN=NLGN3 PE=1 SV=2 NLGN3_HUMAN reviewed Neuroligin-3 (Gliotactin homolog) Homo sapiens (Human) GO:0002087; GO:0005886; GO:0006898; GO:0007158; GO:0007268; GO:0007416; GO:0007612; GO:0009986; GO:0016020; GO:0030139; GO:0030425; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0045211; GO:0048488; GO:0048675; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051968; GO:0060024; GO:0060076; GO:0060080; GO:0071625; GO:0097104; GO:0097105; GO:0097110; GO:0098631; GO:0098793; GO:0098983; GO:0098985; GO:0099054; GO:1900451; GO:2000463 adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625] asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202] cell adhesion mediator activity [GO:0098631]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] g12713.t1 Q8CHI9 33.838 396 4.38e-59 205.0 sp|Q8CHI9|CHSTF_RAT Carbohydrate sulfotransferase 15 OS=Rattus norvegicus OX=10116 GN=Chst15 PE=2 SV=1 CHSTF_RAT reviewed Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST) Rattus norvegicus (Rat) GO:0000139; GO:0019319; GO:0050656; GO:0050659 hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] g12715.t1 Q7LFX5 30.151 398 1.68e-49 179.0 sp|Q7LFX5|CHSTF_HUMAN Carbohydrate sulfotransferase 15 OS=Homo sapiens OX=9606 GN=CHST15 PE=1 SV=1 CHSTF_HUMAN reviewed Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST) Homo sapiens (Human) GO:0000139; GO:0016020; GO:0019319; GO:0050650; GO:0050651; GO:0050656; GO:0050659 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] g12716.t1 Q5REY7 54.908 326 1.19e-106 332.0 sp|Q5REY7|UBXN7_PONAB UBX domain-containing protein 7 OS=Pongo abelii OX=9601 GN=UBXN7 PE=2 SV=2 g12716.t1 Q5REY7 62.338 77 7.17e-26 114.0 sp|Q5REY7|UBXN7_PONAB UBX domain-containing protein 7 OS=Pongo abelii OX=9601 GN=UBXN7 PE=2 SV=2 g12717.t1 O75629 36.842 171 3.35e-31 115.0 sp|O75629|CREG1_HUMAN Protein CREG1 OS=Homo sapiens OX=9606 GN=CREG1 PE=1 SV=1 CREG1_HUMAN reviewed Protein CREG1 (Cellular repressor of E1A-stimulated genes 1) Homo sapiens (Human) GO:0003714; GO:0005159; GO:0005576; GO:0005615; GO:0005667; GO:0005764; GO:0005768; GO:0006357; GO:0006897; GO:0006914; GO:0007040; GO:0007042; GO:0035578; GO:0070062 autophagy [GO:0006914]; endocytosis [GO:0006897]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; regulation of transcription by RNA polymerase II [GO:0006357] azurophil granule lumen [GO:0035578]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; transcription regulator complex [GO:0005667] insulin-like growth factor receptor binding [GO:0005159]; transcription corepressor activity [GO:0003714] g12718.t1 Q2VPU4 36.207 232 9.969999999999999e-42 170.0 sp|Q2VPU4|MLXIP_MOUSE MLX-interacting protein OS=Mus musculus OX=10090 GN=Mlxip PE=1 SV=1 MLXIP_MOUSE reviewed MLX-interacting protein (Transcriptional activator MondoA) Mus musculus (Mouse) GO:0000977; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0005741; GO:0006913; GO:0045944; GO:0046983; GO:0090575 nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g12718.t1 Q2VPU4 34.764 233 8.9e-28 125.0 sp|Q2VPU4|MLXIP_MOUSE MLX-interacting protein OS=Mus musculus OX=10090 GN=Mlxip PE=1 SV=1 MLXIP_MOUSE reviewed MLX-interacting protein (Transcriptional activator MondoA) Mus musculus (Mouse) GO:0000977; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0005741; GO:0006913; GO:0045944; GO:0046983; GO:0090575 nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g12718.t2 Q2VPU4 36.697 218 3.52e-41 168.0 sp|Q2VPU4|MLXIP_MOUSE MLX-interacting protein OS=Mus musculus OX=10090 GN=Mlxip PE=1 SV=1 MLXIP_MOUSE reviewed MLX-interacting protein (Transcriptional activator MondoA) Mus musculus (Mouse) GO:0000977; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0005741; GO:0006913; GO:0045944; GO:0046983; GO:0090575 nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g12718.t2 Q2VPU4 34.764 233 7.05e-28 125.0 sp|Q2VPU4|MLXIP_MOUSE MLX-interacting protein OS=Mus musculus OX=10090 GN=Mlxip PE=1 SV=1 MLXIP_MOUSE reviewed MLX-interacting protein (Transcriptional activator MondoA) Mus musculus (Mouse) GO:0000977; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0005741; GO:0006913; GO:0045944; GO:0046983; GO:0090575 nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g12719.t1 Q13619 70.828 761 0.0 1111.0 sp|Q13619|CUL4A_HUMAN Cullin-4A OS=Homo sapiens OX=9606 GN=CUL4A PE=1 SV=3 CUL4A_HUMAN reviewed Cullin-4A (CUL-4A) Homo sapiens (Human) GO:0000082; GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0007283; GO:0008283; GO:0008284; GO:0016567; GO:0030097; GO:0030853; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042110; GO:0042254; GO:0043161; GO:0045732; GO:0048511; GO:0061630; GO:0080008; GO:0097193; GO:0140627; GO:0160072; GO:1900087; GO:2000001; GO:2000819 cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] g12719.t2 Q13619 71.296 756 0.0 1117.0 sp|Q13619|CUL4A_HUMAN Cullin-4A OS=Homo sapiens OX=9606 GN=CUL4A PE=1 SV=3 CUL4A_HUMAN reviewed Cullin-4A (CUL-4A) Homo sapiens (Human) GO:0000082; GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0007283; GO:0008283; GO:0008284; GO:0016567; GO:0030097; GO:0030853; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042110; GO:0042254; GO:0043161; GO:0045732; GO:0048511; GO:0061630; GO:0080008; GO:0097193; GO:0140627; GO:0160072; GO:1900087; GO:2000001; GO:2000819 cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] g12720.t1 Q6NZ03 72.0 250 4.99e-139 395.0 sp|Q6NZ03|FBSP1_DANRE F-box/SPRY domain-containing protein 1 OS=Danio rerio OX=7955 GN=fbxo45 PE=2 SV=2 g12722.t1 A6QQ21 76.744 301 3.0099999999999997e-176 493.0 sp|A6QQ21|CSN6_BOVIN COP9 signalosome complex subunit 6 OS=Bos taurus OX=9913 GN=COPS6 PE=2 SV=1 g12725.t1 Q62623 53.678 503 0.0 541.0 sp|Q62623|CDC20_RAT Cell division cycle protein 20 homolog OS=Rattus norvegicus OX=10116 GN=Cdc20 PE=1 SV=2 CDC20_RAT reviewed Cell division cycle protein 20 homolog (p55CDC) Rattus norvegicus (Rat) GO:0000086; GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008284; GO:0010997; GO:0016567; GO:0016579; GO:0031145; GO:0031146; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1904146; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein deubiquitination [GO:0016579]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922] anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g12726.t1 Q9NUN7 43.137 255 2.55e-63 202.0 sp|Q9NUN7|ACER3_HUMAN Alkaline ceramidase 3 OS=Homo sapiens OX=9606 GN=ACER3 PE=1 SV=3 ACER3_HUMAN reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC) Homo sapiens (Human) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g12727.t1 Q9D099 40.449 267 2.25e-63 202.0 sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1 ACER3_MOUSE reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g12728.t1 Q9D099 50.0 260 7.210000000000001e-85 257.0 sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1 ACER3_MOUSE reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g12729.t1 Q9DB72 30.855 269 1.5000000000000001e-31 129.0 sp|Q9DB72|BTBDH_MOUSE BTB/POZ domain-containing protein 17 OS=Mus musculus OX=10090 GN=Btbd17 PE=1 SV=1 g12730.t1 Q99805 68.252 652 0.0 941.0 sp|Q99805|TM9S2_HUMAN Transmembrane 9 superfamily member 2 OS=Homo sapiens OX=9606 GN=TM9SF2 PE=1 SV=1 g12731.t1 Q90XD2 63.205 337 2.98e-152 435.0 sp|Q90XD2|SPEB_CHICK Agmatinase, mitochondrial OS=Gallus gallus OX=9031 GN=AGMAT PE=2 SV=1 g12732.t1 Q6DDL7 49.885 435 3.7399999999999996e-147 431.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g12733.t1 A4IF63 28.121 793 8.42e-96 316.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12734.t1 Q9JLB5 36.403 467 5.67e-99 308.0 sp|Q9JLB5|ACH10_RAT Neuronal acetylcholine receptor subunit alpha-10 OS=Rattus norvegicus OX=10116 GN=Chrna10 PE=1 SV=1 ACH10_RAT reviewed Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) Rattus norvegicus (Rat) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007204; GO:0007268; GO:0007271; GO:0010996; GO:0022848; GO:0022850; GO:0030424; GO:0034220; GO:0034703; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050910; GO:0051899; GO:0070373; GO:0098878; GO:0098981; GO:0099634; GO:1902495; GO:1904315 chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; axon [GO:0030424]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g12735.t1 Q05707 36.224 196 7.78e-29 125.0 sp|Q05707|COEA1_HUMAN Collagen alpha-1(XIV) chain OS=Homo sapiens OX=9606 GN=COL14A1 PE=1 SV=3 COEA1_HUMAN reviewed Collagen alpha-1(XIV) chain (Undulin) Homo sapiens (Human) GO:0003229; GO:0003723; GO:0005201; GO:0005518; GO:0005576; GO:0005581; GO:0005596; GO:0005614; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0048873; GO:0061050; GO:0098609 cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; homeostasis of number of cells within a tissue [GO:0048873]; regulation of cell growth involved in cardiac muscle cell development [GO:0061050]; ventricular cardiac muscle tissue development [GO:0003229] collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614] collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] g12735.t1 Q05707 31.863 204 4.98e-24 110.0 sp|Q05707|COEA1_HUMAN Collagen alpha-1(XIV) chain OS=Homo sapiens OX=9606 GN=COL14A1 PE=1 SV=3 COEA1_HUMAN reviewed Collagen alpha-1(XIV) chain (Undulin) Homo sapiens (Human) GO:0003229; GO:0003723; GO:0005201; GO:0005518; GO:0005576; GO:0005581; GO:0005596; GO:0005614; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0048873; GO:0061050; GO:0098609 cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; homeostasis of number of cells within a tissue [GO:0048873]; regulation of cell growth involved in cardiac muscle cell development [GO:0061050]; ventricular cardiac muscle tissue development [GO:0003229] collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614] collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] g12737.t1 E1B9E5 26.501 766 3.21e-62 227.0 sp|E1B9E5|CTSRD_BOVIN Cation channel sperm-associated auxiliary subunit delta OS=Bos taurus OX=9913 GN=CATSPERD PE=3 SV=1 g12738.t1 Q5RF14 56.006 666 0.0 798.0 sp|Q5RF14|MIPEP_PONAB Mitochondrial intermediate peptidase OS=Pongo abelii OX=9601 GN=MIPEP PE=2 SV=1 g12740.t1 Q7M370 36.627 415 2.45e-66 219.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g12742.t1 Q8IVP5 43.262 141 1.82e-36 125.0 sp|Q8IVP5|FUND1_HUMAN FUN14 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FUNDC1 PE=1 SV=1 FUND1_HUMAN reviewed FUN14 domain-containing protein 1 Homo sapiens (Human) GO:0000422; GO:0000423; GO:0001666; GO:0005739; GO:0005741; GO:0008053 autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; mitophagy [GO:0000423]; response to hypoxia [GO:0001666] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] g12743.t1 Q8NDN9 60.3 534 0.0 689.0 sp|Q8NDN9|RCBT1_HUMAN RCC1 and BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCBTB1 PE=1 SV=1 RCBT1_HUMAN reviewed RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006325 chromatin organization [GO:0006325] cytoplasm [GO:0005737]; nucleus [GO:0005634] g12743.t2 Q8NDN9 60.3 534 0.0 689.0 sp|Q8NDN9|RCBT1_HUMAN RCC1 and BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCBTB1 PE=1 SV=1 RCBT1_HUMAN reviewed RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006325 chromatin organization [GO:0006325] cytoplasm [GO:0005737]; nucleus [GO:0005634] g12745.t1 P55202 40.488 1025 0.0 725.0 sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica OX=7937 GN=npr2 PE=2 SV=1 g12754.t1 P79382 56.338 142 7.62e-49 157.0 sp|P79382|MGST1_PIG Microsomal glutathione S-transferase 1 OS=Sus scrofa OX=9823 GN=MGST1 PE=2 SV=3 g12756.t1 O43827 42.489 233 1.0499999999999999e-54 190.0 sp|O43827|ANGL7_HUMAN Angiopoietin-related protein 7 OS=Homo sapiens OX=9606 GN=ANGPTL7 PE=1 SV=1 ANGL7_HUMAN reviewed Angiopoietin-related protein 7 (Angiopoietin-like factor) (Angiopoietin-like protein 7) (Cornea-derived transcript 6 protein) Homo sapiens (Human) GO:0005576; GO:0005615; GO:0006979; GO:0007596; GO:0042802; GO:1901346; GO:1903053 blood coagulation [GO:0007596]; negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053]; response to oxidative stress [GO:0006979] extracellular region [GO:0005576]; extracellular space [GO:0005615] identical protein binding [GO:0042802] g12758.t1 P41247 37.576 165 1.84e-39 137.0 sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3 PLPL4_HUMAN reviewed Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2) Homo sapiens (Human) GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088 lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739] acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g12760.t1 Q5I0S6 70.927 313 7.14e-157 443.0 sp|Q5I0S6|ATG3_XENTR Ubiquitin-like-conjugating enzyme ATG3 OS=Xenopus tropicalis OX=8364 GN=atg3 PE=2 SV=1 ATG3_XENTR reviewed Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006914; GO:0015031; GO:0019776; GO:0019777; GO:0043653; GO:0044804; GO:0061723; GO:0141046 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; nucleophagy [GO:0044804]; protein transport [GO:0015031] cytosol [GO:0005829]; phagophore assembly site [GO:0000407] Atg12 transferase activity [GO:0019777]; Atg8-family conjugating enzyme activity [GO:0141046]; Atg8-family ligase activity [GO:0019776] g12762.t1 Q9UI40 36.656 311 1.31e-47 183.0 sp|Q9UI40|NCKX2_HUMAN Sodium/potassium/calcium exchanger 2 OS=Homo sapiens OX=9606 GN=SLC24A2 PE=1 SV=1 g12762.t1 Q9UI40 36.181 199 4.34e-27 120.0 sp|Q9UI40|NCKX2_HUMAN Sodium/potassium/calcium exchanger 2 OS=Homo sapiens OX=9606 GN=SLC24A2 PE=1 SV=1 g12763.t1 O15266 56.989 186 5.31e-65 212.0 sp|O15266|SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens OX=9606 GN=SHOX PE=1 SV=1 SHOX_HUMAN reviewed Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein) Homo sapiens (Human) GO:0000785; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0045944; GO:1990837 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g12764.t1 Q4PZA2 34.588 691 6.97e-143 438.0 sp|Q4PZA2|ECE1_MOUSE Endothelin-converting enzyme 1 OS=Mus musculus OX=10090 GN=Ece1 PE=1 SV=1 ECE1_MOUSE reviewed Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) Mus musculus (Mouse) GO:0001666; GO:0001921; GO:0004175; GO:0004222; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0007411; GO:0007507; GO:0008217; GO:0008233; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0042447; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0045745; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0071526; GO:0097492; GO:0097746; GO:0141163 axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to hypoxia [GO:0001666]; semaphorin-plexin signaling pathway [GO:0071526]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492] cell surface [GO:0009986]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093] endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g12767.t1 A4K526 57.522 113 2.4199999999999997e-40 133.0 sp|A4K526|TM256_BUFGR Transmembrane protein 256 homolog OS=Bufo gargarizans OX=30331 PE=3 SV=1 g12768.t1 Q12908 33.628 339 1.8700000000000003e-43 160.0 sp|Q12908|NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens OX=9606 GN=SLC10A2 PE=1 SV=2 NTCP2_HUMAN reviewed Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2) Homo sapiens (Human) GO:0005886; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016324 bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] apical plasma membrane [GO:0016324]; microvillus [GO:0005902]; plasma membrane [GO:0005886] bile acid:sodium symporter activity [GO:0008508] g12770.t1 Q8BGC3 24.886 438 3.07e-27 117.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g12772.t1 O88199 34.358 358 2.1e-52 185.0 sp|O88199|CHST3_MOUSE Carbohydrate sulfotransferase 3 OS=Mus musculus OX=10090 GN=Chst3 PE=1 SV=1 CHST3_MOUSE reviewed Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0) Mus musculus (Mouse) GO:0000139; GO:0001517; GO:0005794; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0043029; GO:0045130; GO:0050650; GO:0050698 carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] chondroitin 6-sulfotransferase activity [GO:0008459]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; proteoglycan sulfotransferase activity [GO:0050698] g12773.t1 F4IF36 40.875 526 1.28e-116 400.0 sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1 FGT1_ARATH reviewed Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841 chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g12773.t1 F4IF36 45.928 442 2.11e-114 394.0 sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1 FGT1_ARATH reviewed Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841 chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g12774.t1 P48763 42.124 565 2.85e-146 451.0 sp|P48763|SL9A2_RAT Sodium/hydrogen exchanger 2 OS=Rattus norvegicus OX=10116 GN=Slc9a2 PE=1 SV=1 SL9A2_RAT reviewed Sodium/hydrogen exchanger 2 (H7) (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) Rattus norvegicus (Rat) GO:0005886; GO:0006814; GO:0006885; GO:0008104; GO:0015385; GO:0015386; GO:0016324; GO:0030855; GO:0035725; GO:0051453; GO:0071805; GO:0098719 epithelial cell differentiation [GO:0030855]; intracellular protein localization [GO:0008104]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g12777.t1 Q9VIH7 35.178 506 6.45e-93 298.0 sp|Q9VIH7|SKY_DROME GTPase-activating protein skywalker OS=Drosophila melanogaster OX=7227 GN=sky PE=1 SV=2 g12778.t1 P07768 46.818 880 0.0 789.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g12778.t1 P07768 45.036 826 0.0 698.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g12779.t1 P07768 48.646 886 0.0 821.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g12779.t1 P07768 45.652 828 0.0 708.0 sp|P07768|SUIS_RABIT Sucrase-isomaltase, intestinal OS=Oryctolagus cuniculus OX=9986 GN=SI PE=1 SV=3 g12780.t1 Q99JW4 69.536 302 6.88e-159 450.0 sp|Q99JW4|LIMS1_MOUSE LIM and senescent cell antigen-like-containing domain protein 1 OS=Mus musculus OX=10090 GN=Lims1 PE=1 SV=3 g12782.t1 G5ECX0 31.68 363 1.8e-49 194.0 sp|G5ECX0|LPLT2_CAEEL Latrophilin-like protein LAT-2 OS=Caenorhabditis elegans OX=6239 GN=lat-2 PE=2 SV=1 LPLT2_CAEEL reviewed Latrophilin-like protein LAT-2 Caenorhabditis elegans GO:0004175; GO:0004930; GO:0005886; GO:0007166; GO:0030246; GO:0097264 cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264] plasma membrane [GO:0005886] carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930] g12783.t1 P53356 34.615 468 4.6499999999999997e-82 274.0 sp|P53356|HTK16_HYDVU Tyrosine-protein kinase HTK16 OS=Hydra vulgaris OX=6087 GN=HTK16 PE=2 SV=1 g12784.t1 Q92035 35.739 568 1.42e-100 319.0 sp|Q92035|ACES_BUNFA Acetylcholinesterase OS=Bungarus fasciatus OX=8613 GN=ACHE PE=1 SV=2 g12785.t1 Q92035 34.843 574 2.26e-99 317.0 sp|Q92035|ACES_BUNFA Acetylcholinesterase OS=Bungarus fasciatus OX=8613 GN=ACHE PE=1 SV=2 g12787.t1 Q6PBM8 45.026 191 5.12e-45 150.0 sp|Q6PBM8|RBM18_DANRE Probable RNA-binding protein 18 OS=Danio rerio OX=7955 GN=rbm18 PE=2 SV=1 g12793.t1 Q9U539 33.252 412 1.91e-65 223.0 sp|Q9U539|OCT1_CAEEL Organic cation transporter 1 OS=Caenorhabditis elegans OX=6239 GN=oct-1 PE=1 SV=3 g12794.t1 Q9VCA2 30.37 540 5.49e-76 254.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g12795.t1 P0CB05 29.278 789 2.8700000000000002e-65 234.0 sp|P0CB05|CEP63_CHICK Centrosomal protein of 63 kDa OS=Gallus gallus OX=9031 GN=CEP63 PE=2 SV=1 g12796.t1 H2LBU8 39.266 545 9.08e-97 304.0 sp|H2LBU8|YAP1_ORYLA Transcriptional coactivator YAP1 OS=Oryzias latipes OX=8090 GN=yap1 PE=1 SV=2 YAP1_ORYLA reviewed Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein hirame) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944 hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g12796.t2 Q1L8J7 40.039 517 9.46e-100 310.0 sp|Q1L8J7|YAP1_DANRE Transcriptional coactivator YAP1 OS=Danio rerio OX=7955 GN=yap1 PE=2 SV=2 YAP1_DANRE reviewed Transcriptional coactivator YAP1 (Yes-associated protein 1) (zYAP) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0001570; GO:0001889; GO:0001944; GO:0003173; GO:0003406; GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0007420; GO:0007492; GO:0009950; GO:0010468; GO:0010629; GO:0031016; GO:0031101; GO:0035162; GO:0035329; GO:0039022; GO:0042593; GO:0043066; GO:0045944; GO:0046620; GO:0048514; GO:0048566; GO:0048916; GO:0051216; GO:0060271; GO:0060914; GO:0061371; GO:0070121 blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; dorsal/ventral axis specification [GO:0009950]; embryonic digestive tract development [GO:0048566]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; glucose homeostasis [GO:0042593]; heart formation [GO:0060914]; hippo signaling [GO:0035329]; Kupffer's vesicle development [GO:0070121]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of gene expression [GO:0010468]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventriculo bulbo valve development [GO:0003173] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g12797.t1 Q9H8V3 46.398 819 0.0 723.0 sp|Q9H8V3|ECT2_HUMAN Protein ECT2 OS=Homo sapiens OX=9606 GN=ECT2 PE=1 SV=4 g12798.t1 Q08623 55.752 226 6.35e-78 237.0 sp|Q08623|HDHD1_HUMAN Pseudouridine-5'-phosphatase OS=Homo sapiens OX=9606 GN=PUDP PE=1 SV=3 HDHD1_HUMAN reviewed Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase) Homo sapiens (Human) GO:0005829; GO:0009117; GO:0016791; GO:0046872; GO:1990738 nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738] g12799.t1 Q9CZR2 26.075 721 2.9299999999999997e-68 241.0 sp|Q9CZR2|NALD2_MOUSE N-acetylated-alpha-linked acidic dipeptidase 2 OS=Mus musculus OX=10090 GN=Naalad2 PE=1 SV=2 NALD2_MOUSE reviewed N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II) Mus musculus (Mouse) GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0016020; GO:0016805; GO:0046872; GO:0050129 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233] g12800.t1 O15484 47.907 645 0.0 646.0 sp|O15484|CAN5_HUMAN Calpain-5 OS=Homo sapiens OX=9606 GN=CAPN5 PE=1 SV=2 CAN5_HUMAN reviewed Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3) Homo sapiens (Human) GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062 proteolysis [GO:0006508]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202] calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g12802.t1 Q7ZV60 66.746 418 0.0 576.0 sp|Q7ZV60|BCS1_DANRE Mitochondrial chaperone BCS1 OS=Danio rerio OX=7955 GN=bcs1l PE=2 SV=2 g12808.t1 Q7Z449 31.526 498 1.43e-87 282.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g12809.t1 Q5I0R4 51.119 268 2.5599999999999998e-95 284.0 sp|Q5I0R4|CF300_XENTR Cilia- and flagella-associated protein 300 OS=Xenopus tropicalis OX=8364 GN=cfap300 PE=2 SV=1 g12810.t1 Q96HW7 45.314 971 0.0 804.0 sp|Q96HW7|INT4_HUMAN Integrator complex subunit 4 OS=Homo sapiens OX=9606 GN=INTS4 PE=1 SV=2 INT4_HUMAN reviewed Integrator complex subunit 4 (Int4) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016180; GO:0030674; GO:0032039; GO:0034243; GO:0160232; GO:0160240 regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-macromolecule adaptor activity [GO:0030674] g12813.t1 P23919 53.977 176 3e-66 204.0 sp|P23919|KTHY_HUMAN Thymidylate kinase OS=Homo sapiens OX=9606 GN=DTYMK PE=1 SV=4 KTHY_HUMAN reviewed Thymidylate kinase (EC 2.7.4.9) (dTMP kinase) Homo sapiens (Human) GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0046105; GO:0071363 cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; thymidine biosynthetic process [GO:0046105] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; dTMP kinase activity [GO:0004798]; nucleoside diphosphate kinase activity [GO:0004550] g12816.t1 Q29R99 60.829 217 9.56e-91 270.0 sp|Q29R99|LIPT2_DANRE Octanoyl-[acyl-carrier-protein]:protein N-octanoyltransferase LIPT2, mitochondrial OS=Danio rerio OX=7955 GN=lipt2 PE=2 SV=1 LIPT2_DANRE reviewed Octanoyl-[acyl-carrier-protein]:protein N-octanoyltransferase LIPT2, mitochondrial (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Lipoyltransferase 2) (EC 2.3.1.181) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005739; GO:0009249; GO:0016874; GO:0033819; GO:2000376 positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249] mitochondrion [GO:0005739] ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819] g12817.t1 Q3SZI7 61.682 642 0.0 843.0 sp|Q3SZI7|COG6_BOVIN Conserved oligomeric Golgi complex subunit 6 OS=Bos taurus OX=9913 GN=COG6 PE=2 SV=1 g12818.t1 Q3ZBG9 55.282 284 1.02e-102 308.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g12820.t1 Q7LHG5 45.223 157 1.17e-38 143.0 sp|Q7LHG5|YI31B_YEAST Transposon Ty3-I Gag-Pol polyprotein OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=TY3B-I PE=1 SV=2 YI31B_YEAST reviewed Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)] Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0006508; GO:0008270; GO:0015074; GO:0075523 DNA integration [GO:0015074]; DNA recombination [GO:0006310]; proteolysis [GO:0006508]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] g12823.t1 A0A0G2QC33 52.854 403 3.86e-149 431.0 sp|A0A0G2QC33|ATG4B_RAT Cysteine protease ATG4B OS=Rattus norvegicus OX=10116 GN=Atg4b PE=1 SV=1 ATG4B_RAT reviewed Cysteine protease ATG4B (EC 3.4.22.-) (Autophagy-related protein 4 homolog B) Rattus norvegicus (Rat) GO:0000045; GO:0000421; GO:0000423; GO:0004175; GO:0004197; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006508; GO:0006914; GO:0008233; GO:0008234; GO:0009267; GO:0015031; GO:0016237; GO:0016485; GO:0019786; GO:0031173; GO:0031410; GO:0034497; GO:0034727; GO:0035973; GO:0045732; GO:0097110 aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; microautophagy [GO:0016237]; mitophagy [GO:0000423]; otolith mineralization completed early in development [GO:0031173]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of protein catabolic process [GO:0045732]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508] autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786]; scaffold protein binding [GO:0097110] g12824.t1 A6QPI1 43.085 188 5.48e-46 160.0 sp|A6QPI1|S35A5_BOVIN UDP-sugar transporter protein SLC35A5 OS=Bos taurus OX=9913 GN=SLC35A5 PE=2 SV=1 S35A5_BOVIN reviewed UDP-sugar transporter protein SLC35A5 (Solute carrier family 35 member A5) Bos taurus (Bovine) GO:0000139; GO:0015165; GO:0015297; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] Golgi membrane [GO:0000139] antiporter activity [GO:0015297]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; transmembrane transporter activity [GO:0022857] g12825.t1 P53111 34.262 359 5.61e-45 161.0 sp|P53111|ARI1_YEAST NADPH-dependent aldehyde reductase ARI1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ARI1 PE=1 SV=1 g12833.t1 A0A7J6K629 29.684 475 7.430000000000001e-59 206.0 sp|A0A7J6K629|TGPC1_TOXGO Apicoplast pyruvate carrier 1 OS=Toxoplasma gondii OX=5811 GN=TGRH88_077530 PE=1 SV=1 TGPC1_TOXGO reviewed Apicoplast pyruvate carrier 1 (APC1) (Apicoplast monocarboxylate transporter 1) (AMT1) (Hypothetical apicoplast protein 3) (HAP3) Toxoplasma gondii GO:0003333; GO:0022857; GO:0160211; GO:1901475 amino acid transmembrane transport [GO:0003333]; pyruvate transmembrane transport [GO:1901475] apicoplast membrane [GO:0160211] transmembrane transporter activity [GO:0022857] g12833.t2 A0A7J6K629 29.684 475 7.430000000000001e-59 206.0 sp|A0A7J6K629|TGPC1_TOXGO Apicoplast pyruvate carrier 1 OS=Toxoplasma gondii OX=5811 GN=TGRH88_077530 PE=1 SV=1 TGPC1_TOXGO reviewed Apicoplast pyruvate carrier 1 (APC1) (Apicoplast monocarboxylate transporter 1) (AMT1) (Hypothetical apicoplast protein 3) (HAP3) Toxoplasma gondii GO:0003333; GO:0022857; GO:0160211; GO:1901475 amino acid transmembrane transport [GO:0003333]; pyruvate transmembrane transport [GO:1901475] apicoplast membrane [GO:0160211] transmembrane transporter activity [GO:0022857] g12833.t3 A0A7J6K629 28.261 506 3.26e-53 192.0 sp|A0A7J6K629|TGPC1_TOXGO Apicoplast pyruvate carrier 1 OS=Toxoplasma gondii OX=5811 GN=TGRH88_077530 PE=1 SV=1 TGPC1_TOXGO reviewed Apicoplast pyruvate carrier 1 (APC1) (Apicoplast monocarboxylate transporter 1) (AMT1) (Hypothetical apicoplast protein 3) (HAP3) Toxoplasma gondii GO:0003333; GO:0022857; GO:0160211; GO:1901475 amino acid transmembrane transport [GO:0003333]; pyruvate transmembrane transport [GO:1901475] apicoplast membrane [GO:0160211] transmembrane transporter activity [GO:0022857] g12843.t1 P48430 87.234 94 1.08e-53 173.0 sp|P48430|SOX2_CHICK Transcription factor SOX-2 OS=Gallus gallus OX=9031 GN=SOX2 PE=1 SV=1 g12844.t1 Q32PP9 49.801 251 8.33e-65 205.0 sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1 g12847.t1 Q0V9R4 52.609 920 0.0 909.0 sp|Q0V9R4|CCD39_XENTR Coiled-coil domain-containing protein 39 OS=Xenopus tropicalis OX=8364 GN=ccdc39 PE=2 SV=1 g12853.t1 A2VDP6 37.083 240 2.47e-43 159.0 sp|A2VDP6|NXPE3_BOVIN NXPE family member 3 OS=Bos taurus OX=9913 GN=NXPE3 PE=2 SV=1 g12854.t1 O35344 71.676 519 0.0 729.0 sp|O35344|IMA4_MOUSE Importin subunit alpha-4 OS=Mus musculus OX=10090 GN=Kpna3 PE=1 SV=1 g12855.t1 Q9VB11 29.97 1318 8.999999999999999e-152 530.0 sp|Q9VB11|UNC80_DROME Protein unc-80 homolog OS=Drosophila melanogaster OX=7227 GN=unc80 PE=1 SV=5 g12855.t1 Q9VB11 44.811 212 1.0400000000000001e-43 180.0 sp|Q9VB11|UNC80_DROME Protein unc-80 homolog OS=Drosophila melanogaster OX=7227 GN=unc80 PE=1 SV=5 g12855.t2 Q8BLN6 40.935 1605 0.0 1218.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t2 Q8BLN6 43.125 320 2.3899999999999997e-52 209.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t2 Q8BLN6 34.298 242 2.53e-31 139.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t3 Q8BLN6 40.732 1613 0.0 1211.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t3 Q8BLN6 43.125 320 2.44e-52 209.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t3 Q8BLN6 34.298 242 2.4400000000000003e-31 139.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t4 Q8BLN6 40.295 1628 0.0 1206.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t4 Q8BLN6 43.125 320 2.8099999999999997e-52 209.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12855.t4 Q8BLN6 34.298 242 2.65e-31 139.0 sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3 UNC80_MOUSE reviewed Protein unc-80 homolog (mUNC-80) Mus musculus (Mouse) GO:0005261; GO:0005886; GO:0030424; GO:0030425; GO:0034703; GO:0034706; GO:0055080 monoatomic cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] monoatomic cation channel activity [GO:0005261] g12856.t1 E7FAM5 25.287 348 1.05e-25 116.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g12857.t1 Q811Q9 65.134 261 2.52e-124 364.0 sp|Q811Q9|PCY1B_MOUSE Choline-phosphate cytidylyltransferase B OS=Mus musculus OX=10090 GN=Pcyt1b PE=1 SV=2 PCY1B_MOUSE reviewed Choline-phosphate cytidylyltransferase B (EC 2.7.7.15) (CCT-beta) (CTP:phosphocholine cytidylyltransferase B) (CCT B) (CT B) (Phosphorylcholine transferase B) Mus musculus (Mouse) GO:0001541; GO:0004105; GO:0005783; GO:0006656; GO:0006657; GO:0007283; GO:0031210; GO:0042802 CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283] endoplasmic reticulum [GO:0005783] choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210] g12858.t1 P09884 56.748 1519 0.0 1614.0 sp|P09884|DPOLA_HUMAN DNA polymerase alpha catalytic subunit OS=Homo sapiens OX=9606 GN=POLA1 PE=1 SV=2 DPOLA_HUMAN reviewed DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180) Homo sapiens (Human) GO:0000166; GO:0000731; GO:0000785; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008270; GO:0016363; GO:0019901; GO:0032479; GO:1902975 DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479] alpha DNA polymerase:primase complex [GO:0005658]; chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g12860.t1 Q26657 81.013 79 1.21e-35 133.0 sp|Q26657|ALX_STRPU Aristaless homeobox protein (Fragment) OS=Strongylocentrotus purpuratus OX=7668 GN=ALX PE=2 SV=2 g12861.t1 Q9D0P0 59.563 183 4.28e-78 235.0 sp|Q9D0P0|EBPL_MOUSE Emopamil-binding protein-like OS=Mus musculus OX=10090 GN=Ebpl PE=2 SV=1 g12862.t1 P55168 63.082 279 6.58e-135 385.0 sp|P55168|CCNC_CHICK Cyclin-C OS=Gallus gallus OX=9031 GN=CCNC PE=3 SV=1 g12863.t1 Q6NUB3 38.289 491 1.4999999999999998e-101 317.0 sp|Q6NUB3|S22AF_XENLA Solute carrier family 22 member 15 OS=Xenopus laevis OX=8355 GN=slc22a15 PE=2 SV=2 g12864.t1 O31463 42.574 303 3.63e-72 228.0 sp|O31463|HMT_BACSU Homocysteine S-methyltransferase YbgG OS=Bacillus subtilis (strain 168) OX=224308 GN=ybgG PE=4 SV=1 g12865.t1 Q5R9V0 46.823 299 8.7e-92 279.0 sp|Q5R9V0|NHLC3_PONAB NHL repeat-containing protein 3 OS=Pongo abelii OX=9601 GN=NHLRC3 PE=2 SV=1 g12869.t1 Q95R48 33.1 571 1.23e-90 293.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g12872.t1 Q6P2X9 25.591 508 2.09e-39 152.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g12873.t1 Q6P2X9 26.316 475 1.1000000000000001e-35 141.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g12874.t1 Q32TF8 56.931 743 0.0 907.0 sp|Q32TF8|EFHC2_DANRE EF-hand domain-containing family member C2 OS=Danio rerio OX=7955 GN=efhc2 PE=2 SV=2 g12878.t1 P22717 53.451 623 0.0 662.0 sp|P22717|GCYB2_RAT Guanylate cyclase soluble subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gucy1b2 PE=2 SV=1 GCYB2_RAT reviewed Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2) Rattus norvegicus (Rat) GO:0004383; GO:0005525; GO:0005829; GO:0008074; GO:0019934; GO:0020037; GO:0046872; GO:0070026; GO:0070482 cGMP-mediated signaling [GO:0019934]; response to oxygen levels [GO:0070482] cytosol [GO:0005829]; guanylate cyclase complex, soluble [GO:0008074] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026] g12878.t2 P22717 52.006 648 0.0 657.0 sp|P22717|GCYB2_RAT Guanylate cyclase soluble subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gucy1b2 PE=2 SV=1 GCYB2_RAT reviewed Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2) Rattus norvegicus (Rat) GO:0004383; GO:0005525; GO:0005829; GO:0008074; GO:0019934; GO:0020037; GO:0046872; GO:0070026; GO:0070482 cGMP-mediated signaling [GO:0019934]; response to oxygen levels [GO:0070482] cytosol [GO:0005829]; guanylate cyclase complex, soluble [GO:0008074] GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026] g12881.t1 P55205 53.333 225 6.2e-70 250.0 sp|P55205|GUC2G_RAT Guanylate cyclase 2G OS=Rattus norvegicus OX=10116 GN=Gucy2g PE=2 SV=2 g12882.t1 Q503Y7 86.275 102 1.7899999999999997e-61 187.0 sp|Q503Y7|PIN4_DANRE Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 OS=Danio rerio OX=7955 GN=pin4 PE=2 SV=1 PIN4_DANRE reviewed Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Rotamase Pin4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003677; GO:0003755; GO:0005634; GO:0005730; GO:0005737; GO:0005819; GO:0006364 rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819] DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g12885.t1 Q8IXQ4 42.7 363 1.26e-61 204.0 sp|Q8IXQ4|GPAM1_HUMAN GPALPP motifs-containing protein 1 OS=Homo sapiens OX=9606 GN=GPALPP1 PE=1 SV=1 g12892.t1 P29241 34.51 255 1.88e-49 169.0 sp|P29241|NADA_APLCA ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia californica OX=6500 PE=1 SV=1 g12893.t1 P29241 35.686 255 9.88e-50 169.0 sp|P29241|NADA_APLCA ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia californica OX=6500 PE=1 SV=1 g12894.t1 P29241 33.846 260 3.67e-46 161.0 sp|P29241|NADA_APLCA ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia californica OX=6500 PE=1 SV=1 g12895.t1 Q5FWM8 37.799 418 2.5399999999999998e-95 296.0 sp|Q5FWM8|GP180_XENLA Integral membrane protein GPR180 OS=Xenopus laevis OX=8355 GN=gpr180 PE=2 SV=1 g12902.t1 P15129 39.103 156 5.93e-24 99.4 sp|P15129|CP4B1_RAT Cytochrome P450 4B1 OS=Rattus norvegicus OX=10116 GN=Cyp4b1 PE=1 SV=3 CP4B1_RAT reviewed Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450 L-2) (Cytochrome P450 isozyme 5) Rattus norvegicus (Rat) GO:0004497; GO:0005506; GO:0005789; GO:0016712; GO:0018879; GO:0020037; GO:1901363 biphenyl metabolic process [GO:0018879] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; heterocyclic compound binding [GO:1901363]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g12909.t1 Q86YW9 50.663 1962 0.0 1758.0 sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2 MD12L_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like) Homo sapiens (Human) GO:0003713; GO:0008013; GO:0016592; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] mediator complex [GO:0016592] beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] g12909.t2 Q86YW9 50.688 1961 0.0 1758.0 sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2 MD12L_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like) Homo sapiens (Human) GO:0003713; GO:0008013; GO:0016592; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] mediator complex [GO:0016592] beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] g12910.t1 P22897 22.449 588 1.97e-22 111.0 sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1 MRC1_HUMAN reviewed Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) Homo sapiens (Human) GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] g12911.t1 Q7PCC4 34.551 301 8.78e-43 158.0 sp|Q7PCC4|ANRCH_VITVI Anthocyanidin reductase ((2S)-flavan-3-ol-forming) OS=Vitis vinifera OX=29760 GN=ANR PE=1 SV=1 g12919.t1 Q5R7V5 47.561 246 2.93e-71 237.0 sp|Q5R7V5|PFKAL_PONAB ATP-dependent 6-phosphofructokinase, liver type OS=Pongo abelii OX=9601 GN=PFKL PE=2 SV=1 PFKAL_PONAB reviewed ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003872; GO:0005524; GO:0005945; GO:0006002; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0046872; GO:0048029; GO:0061621; GO:0070095 canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glycolytic process [GO:0006096]; response to glucose [GO:0009749] 6-phosphofructokinase complex [GO:0005945]; membrane [GO:0016020] 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029] g12921.t1 Q8IZF6 30.152 461 1.92e-58 214.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g12933.t1 A2AU72 48.468 881 0.0 719.0 sp|A2AU72|ARMC3_MOUSE Armadillo repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Armc3 PE=1 SV=1 ARMC3_MOUSE reviewed Armadillo repeat-containing protein 3 Mus musculus (Mouse) GO:0007286; GO:0030317; GO:0034517 flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286] g12934.t1 Q178L7 52.0 150 3.5e-45 149.0 sp|Q178L7|SDHF2_AEDAE Succinate dehydrogenase assembly factor 2, mitochondrial OS=Aedes aegypti OX=7159 GN=AAEL005866 PE=3 SV=1 g12935.t1 A6QP05 60.265 302 9.2e-132 380.0 sp|A6QP05|DHR12_BOVIN Dehydrogenase/reductase SDR family member 12 OS=Bos taurus OX=9913 GN=DHRS12 PE=2 SV=1 g12940.t1 Q8C0L6 32.234 546 2.48e-70 247.0 sp|Q8C0L6|PAOX_MOUSE Peroxisomal N(1)-acetyl-spermine/spermidine oxidase OS=Mus musculus OX=10090 GN=Paox PE=1 SV=3 PAOX_MOUSE reviewed Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase) Mus musculus (Mouse) GO:0005737; GO:0005782; GO:0006598; GO:0009446; GO:0009447; GO:0046203; GO:0046208; GO:0046592; GO:0052903; GO:1901307 polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208] cytoplasm [GO:0005737]; peroxisomal matrix [GO:0005782] N(1)-acetylpolyamine oxidase (3-acetamidopropanal-forming) activity [GO:0052903]; polyamine oxidase activity [GO:0046592] g12940.t1 Q8C0L6 32.836 536 2.16e-68 242.0 sp|Q8C0L6|PAOX_MOUSE Peroxisomal N(1)-acetyl-spermine/spermidine oxidase OS=Mus musculus OX=10090 GN=Paox PE=1 SV=3 PAOX_MOUSE reviewed Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase) Mus musculus (Mouse) GO:0005737; GO:0005782; GO:0006598; GO:0009446; GO:0009447; GO:0046203; GO:0046208; GO:0046592; GO:0052903; GO:1901307 polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208] cytoplasm [GO:0005737]; peroxisomal matrix [GO:0005782] N(1)-acetylpolyamine oxidase (3-acetamidopropanal-forming) activity [GO:0052903]; polyamine oxidase activity [GO:0046592] g12941.t1 Q6NT55 31.719 413 1.1800000000000001e-58 202.0 sp|Q6NT55|CP4FN_HUMAN Ultra-long-chain fatty acid omega-hydroxylase OS=Homo sapiens OX=9606 GN=CYP4F22 PE=1 SV=1 CP4FN_HUMAN reviewed Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0046513 ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705] g12942.t1 P78329 31.128 514 1.97e-77 254.0 sp|P78329|CP4F2_HUMAN Cytochrome P450 4F2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1 CP4F2_HUMAN reviewed Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0055078; GO:0097258; GO:0097259; GO:0097267; GO:0102033 arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonate epoxygenase activity [GO:0008392]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g12943.t1 P78329 34.047 514 2.1600000000000001e-97 306.0 sp|P78329|CP4F2_HUMAN Cytochrome P450 4F2 OS=Homo sapiens OX=9606 GN=CYP4F2 PE=1 SV=1 CP4F2_HUMAN reviewed Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78) Homo sapiens (Human) GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0055078; GO:0097258; GO:0097259; GO:0097267; GO:0102033 arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonate epoxygenase activity [GO:0008392]; arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709] g12945.t1 Q13153 67.864 557 0.0 717.0 sp|Q13153|PAK1_HUMAN Serine/threonine-protein kinase PAK 1 OS=Homo sapiens OX=9606 GN=PAK1 PE=1 SV=2 PAK1_HUMAN reviewed Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK) Homo sapiens (Human) GO:0001666; GO:0001726; GO:0002223; GO:0004672; GO:0004674; GO:0005518; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006887; GO:0006915; GO:0006974; GO:0008284; GO:0009267; GO:0010763; GO:0014704; GO:0016477; GO:0019901; GO:0021549; GO:0030010; GO:0030018; GO:0030027; GO:0030036; GO:0030335; GO:0030424; GO:0030425; GO:0031965; GO:0032587; GO:0032869; GO:0032956; GO:0032991; GO:0033148; GO:0035556; GO:0038096; GO:0042060; GO:0042802; GO:0043015; GO:0043408; GO:0045773; GO:0046628; GO:0048012; GO:0048013; GO:0048754; GO:0048812; GO:0050770; GO:0051496; GO:0060244; GO:0061052; GO:0090063; GO:0090314; GO:0106310; GO:1903608; GO:1904707; GO:1904754 actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; response to hypoxia [GO:0001666]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060] actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018] ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g12948.t1 Q91VN0 40.171 234 7.090000000000001e-47 173.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g12948.t1 Q91VN0 41.969 193 2.08e-44 166.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g12948.t1 Q91VN0 34.241 257 9.099999999999999e-34 135.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g12948.t1 Q91VN0 36.257 171 3.38e-23 104.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g12948.t1 Q91VN0 33.906 233 3.9599999999999997e-23 104.0 sp|Q91VN0|LRP5_MOUSE Low-density lipoprotein receptor-related protein 5 OS=Mus musculus OX=10090 GN=Lrp5 PE=1 SV=3 LRP5_MOUSE reviewed Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) Mus musculus (Mouse) GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007267; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963 adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g12949.t1 O54799 29.221 308 5.63e-26 110.0 sp|O54799|NMBR_MOUSE Neuromedin-B receptor OS=Mus musculus OX=10090 GN=Nmbr PE=1 SV=1 NMBR_MOUSE reviewed Neuromedin-B receptor (NMB-R) (Neuromedin-B-preferring bombesin receptor) Mus musculus (Mouse) GO:0004946; GO:0005829; GO:0005886; GO:0007186; GO:0008188; GO:0032715; GO:0032727; GO:0090290; GO:0140374; GO:0160023; GO:1903942 antiviral innate immune response [GO:0140374]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of interleukin-6 production [GO:0032715]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; sneeze reflex [GO:0160023] cytosol [GO:0005829]; plasma membrane [GO:0005886] bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188] g12950.t1 P35249 64.088 362 5.89e-164 465.0 sp|P35249|RFC4_HUMAN Replication factor C subunit 4 OS=Homo sapiens OX=9606 GN=RFC4 PE=1 SV=2 RFC4_HUMAN reviewed Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006271; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:0031391; GO:1900264 DNA repair [GO:0006281]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899] g12951.t1 Q91514 25.751 466 1.06e-24 110.0 sp|Q91514|VACHT_TORTO Vesicular acetylcholine transporter OS=Torpedo torpedo OX=30481 PE=2 SV=1 g12952.t1 Q5RKI1 73.723 411 0.0 577.0 sp|Q5RKI1|IF4A2_RAT Eukaryotic initiation factor 4A-II OS=Rattus norvegicus OX=10116 GN=Eif4a2 PE=1 SV=1 g12954.t1 Q9Y6X6 37.571 1227 0.0 847.0 sp|Q9Y6X6|MYO16_HUMAN Unconventional myosin-XVI OS=Homo sapiens OX=9606 GN=MYO16 PE=1 SV=3 MYO16_HUMAN reviewed Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16) Homo sapiens (Human) GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0016459; GO:0019903; GO:0021549; GO:0043491; GO:0048471; GO:0048812; GO:0051015; GO:2000134 cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903] g12955.t1 O14746 36.741 313 1.33e-56 199.0 sp|O14746|TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens OX=9606 GN=TERT PE=1 SV=1 TERT_HUMAN reviewed Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2) Homo sapiens (Human) GO:0000049; GO:0000333; GO:0000722; GO:0000723; GO:0000781; GO:0000783; GO:0001172; GO:0001223; GO:0003677; GO:0003720; GO:0003723; GO:0003964; GO:0003968; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0005886; GO:0006278; GO:0006606; GO:0007004; GO:0007005; GO:0007507; GO:0016605; GO:0016607; GO:0022616; GO:0030177; GO:0030422; GO:0031379; GO:0031647; GO:0042162; GO:0042635; GO:0042645; GO:0042802; GO:0042803; GO:0043524; GO:0045766; GO:0046326; GO:0046686; GO:0046872; GO:0051087; GO:0070034; GO:0070200; GO:0071456; GO:0071897; GO:0090399; GO:0098680; GO:0140745; GO:1900087; GO:1902895; GO:1903620; GO:1904707; GO:1904751; GO:1904754; GO:1990572; GO:2000352; GO:2000648; GO:2000773; GO:2001240 cellular response to hypoxia [GO:0071456]; DNA biosynthetic process [GO:0071897]; DNA strand elongation [GO:0022616]; establishment of protein localization to telomere [GO:0070200]; heart development [GO:0007507]; mitochondrion organization [GO:0007005]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of angiogenesis [GO:0045766]; positive regulation of D-glucose import [GO:0046326]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair cycle [GO:0042635]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transdifferentiation [GO:1903620]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of Wnt signaling pathway [GO:0030177]; protein import into nucleus [GO:0006606]; regulation of protein stability [GO:0031647]; replicative senescence [GO:0090399]; response to cadmium ion [GO:0046686]; RNA-templated DNA biosynthetic process [GO:0006278]; RNA-templated transcription [GO:0001172]; siRNA processing [GO:0030422]; siRNA transcription [GO:0140745]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nuclear speck [GO:0016607]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; RNA-directed RNA polymerase complex [GO:0031379]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]; TERT-RMRP complex [GO:1990572] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-directed RNA polymerase activity [GO:0003968]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; template-free RNA nucleotidyltransferase [GO:0098680]; transcription coactivator binding [GO:0001223]; tRNA binding [GO:0000049] g12957.t1 O70372 33.005 406 2.6999999999999998e-62 228.0 sp|O70372|TERT_MOUSE Telomerase reverse transcriptase OS=Mus musculus OX=10090 GN=Tert PE=1 SV=1 TERT_MOUSE reviewed Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit) Mus musculus (Mouse) GO:0000049; GO:0000333; GO:0000722; GO:0000781; GO:0001172; GO:0001223; GO:0003677; GO:0003720; GO:0003723; GO:0003964; GO:0003968; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006278; GO:0006606; GO:0007004; GO:0007005; GO:0007507; GO:0016605; GO:0016607; GO:0022616; GO:0030177; GO:0030422; GO:0031379; GO:0031647; GO:0042162; GO:0042635; GO:0042645; GO:0042802; GO:0042803; GO:0043066; GO:0043524; GO:0045766; GO:0046326; GO:0046686; GO:0046872; GO:0051087; GO:0060253; GO:0070034; GO:0070200; GO:0071456; GO:0071897; GO:0090399; GO:0098680; GO:0140745; GO:1900087; GO:1902895; GO:1903620; GO:1904707; GO:1904751; GO:1904754; GO:1990572; GO:2000352; GO:2000648; GO:2000773; GO:2001240 cellular response to hypoxia [GO:0071456]; DNA biosynthetic process [GO:0071897]; DNA strand elongation [GO:0022616]; establishment of protein localization to telomere [GO:0070200]; heart development [GO:0007507]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of angiogenesis [GO:0045766]; positive regulation of D-glucose import [GO:0046326]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair cycle [GO:0042635]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transdifferentiation [GO:1903620]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of Wnt signaling pathway [GO:0030177]; protein import into nucleus [GO:0006606]; regulation of protein stability [GO:0031647]; replicative senescence [GO:0090399]; response to cadmium ion [GO:0046686]; RNA-templated DNA biosynthetic process [GO:0006278]; RNA-templated transcription [GO:0001172]; siRNA processing [GO:0030422]; siRNA transcription [GO:0140745]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; RNA-directed RNA polymerase complex [GO:0031379]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]; TERT-RMRP complex [GO:1990572] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-directed RNA polymerase activity [GO:0003968]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; template-free RNA nucleotidyltransferase [GO:0098680]; transcription coactivator binding [GO:0001223]; tRNA binding [GO:0000049] g12958.t1 Q16760 55.94 1271 0.0 1310.0 sp|Q16760|DGKD_HUMAN Diacylglycerol kinase delta OS=Homo sapiens OX=9606 GN=DGKD PE=1 SV=4 DGKD_HUMAN reviewed Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta) Homo sapiens (Human) GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007200; GO:0008270; GO:0015031; GO:0019900; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046340; GO:0046834; GO:0046982; GO:0160195; GO:2000370 diacylglycerol catabolic process [GO:0046340]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of phospholipase C/protein kinase C signal transduction [GO:0160195]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein transport [GO:0015031]; signal transduction [GO:0007165] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g12958.t2 Q16760 56.191 1276 0.0 1325.0 sp|Q16760|DGKD_HUMAN Diacylglycerol kinase delta OS=Homo sapiens OX=9606 GN=DGKD PE=1 SV=4 DGKD_HUMAN reviewed Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta) Homo sapiens (Human) GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007200; GO:0008270; GO:0015031; GO:0019900; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046340; GO:0046834; GO:0046982; GO:0160195; GO:2000370 diacylglycerol catabolic process [GO:0046340]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of phospholipase C/protein kinase C signal transduction [GO:0160195]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein transport [GO:0015031]; signal transduction [GO:0007165] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g12960.t1 Q93235 34.921 252 3.9300000000000005e-37 136.0 sp|Q93235|AT1B1_CAEEL Sodium/potassium-transporting ATPase subunit beta-1 OS=Caenorhabditis elegans OX=6239 GN=nkb-1 PE=1 SV=1 g12961.t1 Q93235 35.932 295 1.49e-45 159.0 sp|Q93235|AT1B1_CAEEL Sodium/potassium-transporting ATPase subunit beta-1 OS=Caenorhabditis elegans OX=6239 GN=nkb-1 PE=1 SV=1 g12962.t1 P05028 30.794 315 1.18e-34 131.0 sp|P05028|AT1B1_SHEEP Sodium/potassium-transporting ATPase subunit beta-1 OS=Ovis aries OX=9940 GN=ATP1B1 PE=2 SV=1 g12963.t1 O95490 30.137 511 5.220000000000001e-59 223.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g12963.t2 O95490 30.137 511 5.83e-59 223.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g12964.t1 Q6PBF0 85.714 252 2.49e-162 452.0 sp|Q6PBF0|RL8_XENTR Large ribosomal subunit protein uL2 OS=Xenopus tropicalis OX=8364 GN=rpl8 PE=2 SV=3 g12965.t1 P82151 39.919 248 1.1399999999999999e-40 144.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12965.t1 P82151 40.994 161 1.5400000000000001e-22 96.7 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12966.t1 P82151 39.919 248 1.8799999999999997e-40 142.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12968.t1 P82151 34.413 247 1.9600000000000002e-29 114.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12970.t1 P82151 39.024 246 7.63e-40 141.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12970.t1 P82151 39.13 161 1.7e-21 93.2 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12971.t1 P82151 40.081 247 3.07e-40 144.0 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12971.t1 P82151 42.138 159 1.22e-22 97.8 sp|P82151|LEC6_TACTR Lectin L6 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1 g12974.t1 Q14644 47.619 840 0.0 815.0 sp|Q14644|RASA3_HUMAN Ras GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=RASA3 PE=1 SV=3 RASA3_HUMAN reviewed Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein) Homo sapiens (Human) GO:0005096; GO:0005246; GO:0005829; GO:0007165; GO:0008270; GO:0009898; GO:0030168; GO:0035556; GO:0046580; GO:1902531 intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; platelet activation [GO:0030168]; regulation of intracellular signal transduction [GO:1902531]; signal transduction [GO:0007165] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829] calcium channel regulator activity [GO:0005246]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g12975.t1 Q7PCJ8 43.529 170 2.56e-41 140.0 sp|Q7PCJ8|SAT2_BOVIN Thialysine N-epsilon-acetyltransferase OS=Bos taurus OX=9913 GN=SAT2 PE=2 SV=1 g12975.t2 Q6P8J2 37.589 141 1.3299999999999998e-23 97.8 sp|Q6P8J2|SAT2_MOUSE Thialysine N-epsilon-acetyltransferase OS=Mus musculus OX=10090 GN=Sat2 PE=1 SV=1 SAT2_MOUSE reviewed Thialysine N-epsilon-acetyltransferase (EC 2.3.1.-) (Diamine acetyltransferase 2) (EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2) (SSAT-2) Mus musculus (Mouse) GO:0004145; GO:0005737; GO:0008080; GO:0008215; GO:0008216; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204 nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermidine metabolic process [GO:0008216]; spermine acetylation [GO:0032919]; spermine metabolic process [GO:0008215] cytoplasm [GO:0005737] diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080] g12976.t1 Q8BLF1 39.801 402 8.080000000000001e-72 234.0 sp|Q8BLF1|NCEH1_MOUSE Neutral cholesterol ester hydrolase 1 OS=Mus musculus OX=10090 GN=Nceh1 PE=1 SV=1 NCEH1_MOUSE reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) (Chlorpyrifos oxon-binding protein) (CPO-BP) Mus musculus (Mouse) GO:0005886; GO:0006805; GO:0016020; GO:0016042; GO:0017171; GO:0042301; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020]; plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171] g12977.t1 B2GV54 41.311 351 3.21e-71 232.0 sp|B2GV54|NCEH1_RAT Neutral cholesterol ester hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Nceh1 PE=1 SV=1 NCEH1_RAT reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) Rattus norvegicus (Rat) GO:0005886; GO:0006805; GO:0016020; GO:0016042; GO:0017171; GO:0042301; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020]; plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171] g12981.t1 Q7M370 40.206 388 8.01e-75 241.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g12982.t1 Q1JQE6 40.8 375 5.110000000000001e-72 234.0 sp|Q1JQE6|NCEH1_BOVIN Neutral cholesterol ester hydrolase 1 OS=Bos taurus OX=9913 GN=NCEH1 PE=2 SV=2 NCEH1_BOVIN reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) Bos taurus (Bovine) GO:0005886; GO:0016042; GO:0017171; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042] plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; serine hydrolase activity [GO:0017171] g12982.t2 Q1JQE6 40.8 375 5.28e-72 234.0 sp|Q1JQE6|NCEH1_BOVIN Neutral cholesterol ester hydrolase 1 OS=Bos taurus OX=9913 GN=NCEH1 PE=2 SV=2 NCEH1_BOVIN reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) Bos taurus (Bovine) GO:0005886; GO:0016042; GO:0017171; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042] plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; serine hydrolase activity [GO:0017171] g12983.t1 Q8BLF1 40.811 370 3.42e-74 239.0 sp|Q8BLF1|NCEH1_MOUSE Neutral cholesterol ester hydrolase 1 OS=Mus musculus OX=10090 GN=Nceh1 PE=1 SV=1 NCEH1_MOUSE reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) (Chlorpyrifos oxon-binding protein) (CPO-BP) Mus musculus (Mouse) GO:0005886; GO:0006805; GO:0016020; GO:0016042; GO:0017171; GO:0042301; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020]; plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171] g12985.t1 Q7M370 34.815 405 6.73e-64 214.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g12986.t1 Q7M370 36.709 395 1.64e-63 213.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g12987.t1 Q05C16 48.438 256 5.949999999999999e-67 232.0 sp|Q05C16|LRC63_HUMAN Leucine-rich repeat-containing protein 63 OS=Homo sapiens OX=9606 GN=LRRC63 PE=1 SV=3 g12994.t1 O57382 30.598 853 3.2099999999999997e-115 382.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g12994.t1 O57382 27.703 296 7.57e-25 115.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g12995.t1 Q2T9X3 60.204 196 3.46e-86 255.0 sp|Q2T9X3|SPRY7_BOVIN SPRY domain-containing protein 7 OS=Bos taurus OX=9913 GN=SPRYD7 PE=2 SV=1 g12996.t1 Q5JVF3 67.839 398 0.0 593.0 sp|Q5JVF3|PCID2_HUMAN PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2 PE=1 SV=2 PCID2_HUMAN reviewed PCI domain-containing protein 2 (CSN12-like protein) Homo sapiens (Human) GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0044615; GO:0045579; GO:0045814; GO:0048536; GO:0070390; GO:1905457 negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; spleen development [GO:0048536]; transcription elongation by RNA polymerase II [GO:0006368] cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] g12997.t1 Q9R1X5 41.889 1461 0.0 1095.0 sp|Q9R1X5|MRP5_MOUSE ATP-binding cassette sub-family C member 5 OS=Mus musculus OX=10090 GN=Abcc5 PE=1 SV=2 MRP5_MOUSE reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) Mus musculus (Mouse) GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042908; GO:0042910; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359 cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g12998.t1 F1QNX7 43.983 241 1.63e-43 167.0 sp|F1QNX7|REN3B_DANRE Regulator of nonsense transcripts 3B OS=Danio rerio OX=7955 GN=upf3b PE=2 SV=1 g12999.t1 Q8BH01 52.907 688 0.0 689.0 sp|Q8BH01|TMCO3_MOUSE Transmembrane and coiled-coil domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tmco3 PE=2 SV=1 SL9D1_MOUSE reviewed Solute carrier family 9 member D1 (Transmembrane and coiled-coil domain-containing protein 3) Mus musculus (Mouse) GO:0015386; GO:0016020 membrane [GO:0016020] potassium:proton antiporter activity [GO:0015386] g13000.t1 Q27I66 59.494 79 6.46e-21 92.0 sp|Q27I66|T22D1_BATSU TSC22 domain family protein 1 OS=Bathyergus suillus OX=10172 GN=TSC22D1 PE=2 SV=1 g13001.t1 Q9Z0J4 50.54 1112 0.0 1117.0 sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1 g13003.t1 G5E870 59.773 1852 0.0 2185.0 sp|G5E870|TRIPC_MOUSE E3 ubiquitin-protein ligase TRIP12 OS=Mus musculus OX=10090 GN=Trip12 PE=1 SV=1 TRIPC_MOUSE reviewed E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) Mus musculus (Mouse) GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g13003.t2 G5E870 59.773 1852 0.0 2185.0 sp|G5E870|TRIPC_MOUSE E3 ubiquitin-protein ligase TRIP12 OS=Mus musculus OX=10090 GN=Trip12 PE=1 SV=1 TRIPC_MOUSE reviewed E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) Mus musculus (Mouse) GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g13005.t1 Q9QYM2 36.304 303 3.53e-47 187.0 sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1 PARG_RAT reviewed Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143) Rattus norvegicus (Rat) GO:0000785; GO:0003682; GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005975; GO:0006282; GO:0006974; GO:0009225; GO:0016045; GO:0016604; GO:0045739; GO:1990966 ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; detection of bacterium [GO:0016045]; DNA damage response [GO:0006974]; nucleotide-sugar metabolic process [GO:0009225]; positive regulation of DNA repair [GO:0045739]; regulation of DNA repair [GO:0006282] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; poly(ADP-ribose) glycohydrolase activity [GO:0004649] g13006.t1 P04052 68.889 1935 0.0 2681.0 sp|P04052|RPB1_DROME DNA-directed RNA polymerase II subunit RPB1 OS=Drosophila melanogaster OX=7227 GN=Polr2A PE=1 SV=4 RPB1_DROME reviewed DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (RNA polymerase II subunit A) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0042789; GO:0046872 mRNA transcription by RNA polymerase II [GO:0042789]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872] g13006.t1 P04052 52.041 196 1.91e-36 155.0 sp|P04052|RPB1_DROME DNA-directed RNA polymerase II subunit RPB1 OS=Drosophila melanogaster OX=7227 GN=Polr2A PE=1 SV=4 RPB1_DROME reviewed DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (RNA polymerase II subunit A) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0042789; GO:0046872 mRNA transcription by RNA polymerase II [GO:0042789]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872] g13006.t1 P04052 40.717 307 2.47e-34 149.0 sp|P04052|RPB1_DROME DNA-directed RNA polymerase II subunit RPB1 OS=Drosophila melanogaster OX=7227 GN=Polr2A PE=1 SV=4 RPB1_DROME reviewed DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (RNA polymerase II subunit A) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0042789; GO:0046872 mRNA transcription by RNA polymerase II [GO:0042789]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872] g13006.t1 P04052 50.829 181 9.74e-25 117.0 sp|P04052|RPB1_DROME DNA-directed RNA polymerase II subunit RPB1 OS=Drosophila melanogaster OX=7227 GN=Polr2A PE=1 SV=4 RPB1_DROME reviewed DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (RNA polymerase II subunit A) Drosophila melanogaster (Fruit fly) GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005700; GO:0005703; GO:0006366; GO:0042789; GO:0046872 mRNA transcription by RNA polymerase II [GO:0042789]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II, core complex [GO:0005665] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872] g13007.t1 Q8N859 43.836 146 2.38e-34 139.0 sp|Q8N859|ZN713_HUMAN Zinc finger protein 713 OS=Homo sapiens OX=9606 GN=ZNF713 PE=1 SV=2 g13008.t1 Q9Y3D6 59.732 149 1.09e-58 182.0 sp|Q9Y3D6|FIS1_HUMAN Mitochondrial fission 1 protein OS=Homo sapiens OX=9606 GN=FIS1 PE=1 SV=2 g13010.t1 Q2TAF4 49.02 918 0.0 819.0 sp|Q2TAF4|INT6A_XENLA Integrator complex subunit 6-A OS=Xenopus laevis OX=8355 GN=ints6-a PE=2 SV=1 g13010.t2 Q2TAF4 48.925 930 0.0 816.0 sp|Q2TAF4|INT6A_XENLA Integrator complex subunit 6-A OS=Xenopus laevis OX=8355 GN=ints6-a PE=2 SV=1 g13011.t1 Q6NX65 52.093 215 2.43e-72 221.0 sp|Q6NX65|PDC10_RAT Programmed cell death protein 10 OS=Rattus norvegicus OX=10116 GN=Pdcd10 PE=2 SV=1 PDC10_RAT reviewed Programmed cell death protein 10 Rattus norvegicus (Rat) GO:0000139; GO:0001525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007283; GO:0007614; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0035556; GO:0036481; GO:0042803; GO:0043066; GO:0043406; GO:0044319; GO:0045747; GO:0050728; GO:0050821; GO:0051683; GO:0071454; GO:0071944; GO:0090051; GO:0090168; GO:0090316; GO:0090443; GO:1903588; GO:1990830; GO:2001055 angiogenesis [GO:0001525]; cellular response to anoxia [GO:0071454]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; short-term memory [GO:0007614]; spermatogenesis [GO:0007283]; wound healing, spreading of cells [GO:0044319] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901] g13012.t1 Q6P5L7 66.489 188 1.9199999999999998e-60 194.0 sp|Q6P5L7|ARGLA_DANRE Arginine and glutamate-rich protein 1-A OS=Danio rerio OX=7955 GN=arglu1a PE=2 SV=1 g13013.t1 Q78YY6 65.455 110 3.15e-45 146.0 sp|Q78YY6|DJC15_MOUSE DnaJ homolog subfamily C member 15 OS=Mus musculus OX=10090 GN=Dnajc15 PE=1 SV=1 DJC15_MOUSE reviewed DnaJ homolog subfamily C member 15 Mus musculus (Mouse) GO:0001405; GO:0001671; GO:0005739; GO:0005743; GO:0009267; GO:0019216; GO:0030150; GO:0031333; GO:1902957 cellular response to starvation [GO:0009267]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import into mitochondrial matrix [GO:0030150]; regulation of lipid metabolic process [GO:0019216] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405] ATPase activator activity [GO:0001671] g13014.t1 O95470 47.978 544 0.0 541.0 sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3 SGPL1_HUMAN reviewed Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase) Homo sapiens (Human) GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190 androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117] g13020.t1 Q9I8I2 35.023 217 1.0800000000000001e-27 107.0 sp|Q9I8I2|BOK_CHICK Bcl-2-related ovarian killer protein OS=Gallus gallus OX=9031 GN=BOK PE=1 SV=1 g13020.t2 Q9I8I2 34.783 207 2.35e-27 106.0 sp|Q9I8I2|BOK_CHICK Bcl-2-related ovarian killer protein OS=Gallus gallus OX=9031 GN=BOK PE=1 SV=1 g13021.t1 O75096 34.088 927 6.02e-143 499.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g13021.t1 O75096 33.37 905 1.93e-137 482.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g13021.t1 O75096 35.882 680 6.33e-103 373.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g13021.t1 O75096 31.763 573 7.55e-78 292.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g13021.t1 O75096 33.512 373 5.5899999999999994e-52 207.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g13021.t1 O75096 33.712 264 6e-33 144.0 sp|O75096|LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens OX=9606 GN=LRP4 PE=1 SV=4 LRP4_HUMAN reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Homo sapiens (Human) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g13028.t1 P39963 41.617 334 4.4500000000000005e-77 246.0 sp|P39963|CCNB3_CHICK G2/mitotic-specific cyclin-B3 OS=Gallus gallus OX=9031 GN=CCNB3 PE=2 SV=1 g13029.t1 Q8C1D8 49.086 383 3.8e-115 360.0 sp|Q8C1D8|IWS1_MOUSE Protein IWS1 homolog OS=Mus musculus OX=10090 GN=Iws1 PE=1 SV=1 IWS1_MOUSE reviewed Protein IWS1 homolog (IWS1-like protein) Mus musculus (Mouse) GO:0001701; GO:0005634; GO:0005654; GO:0006338; GO:0006397; GO:0008380; GO:0010467; GO:0010793; GO:0016973; GO:0050684; GO:0140673 chromatin remodeling [GO:0006338]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]; transcription elongation-coupled chromatin remodeling [GO:0140673] nucleoplasm [GO:0005654]; nucleus [GO:0005634] g13031.t1 Q8IZF6 28.028 578 5.87e-60 232.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g13035.t1 O64411 34.12 466 4.0599999999999996e-68 228.0 sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1 g13036.t1 P62791 55.34 103 1.72e-28 102.0 sp|P62791|H4_STYLE Histone H4 OS=Stylonychia lemnae OX=5949 PE=3 SV=2 g13037.t1 P50532 53.12 1218 0.0 1218.0 sp|P50532|SMC4_XENLA Structural maintenance of chromosomes protein 4 OS=Xenopus laevis OX=8355 GN=smc4 PE=1 SV=1 g13038.t1 Q8NBZ7 73.239 355 0.0 575.0 sp|Q8NBZ7|UXS1_HUMAN UDP-glucuronic acid decarboxylase 1 OS=Homo sapiens OX=9606 GN=UXS1 PE=1 SV=1 g13038.t2 Q5R885 67.669 399 0.0 577.0 sp|Q5R885|UXS1_PONAB UDP-glucuronic acid decarboxylase 1 OS=Pongo abelii OX=9601 GN=UXS1 PE=2 SV=1 UXS1_PONAB reviewed UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005789; GO:0006024; GO:0032580; GO:0033320; GO:0042732; GO:0048040; GO:0070403 D-xylose metabolic process [GO:0042732]; glycosaminoglycan biosynthetic process [GO:0006024]; UDP-D-xylose biosynthetic process [GO:0033320] endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040] g13041.t1 O43933 42.686 834 0.0 629.0 sp|O43933|PEX1_HUMAN Peroxisomal ATPase PEX1 OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1 g13041.t1 O43933 40.116 172 6.94e-29 130.0 sp|O43933|PEX1_HUMAN Peroxisomal ATPase PEX1 OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1 g13042.t1 Q32LC1 36.058 208 7.430000000000001e-26 108.0 sp|Q32LC1|RPP38_BOVIN Ribonuclease P protein subunit p38 OS=Bos taurus OX=9913 GN=RPP38 PE=2 SV=2 g13043.t1 Q5HZP1 42.662 293 3.59e-81 251.0 sp|Q5HZP1|RNH2B_XENLA Ribonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1 g13047.t1 P62994 58.605 215 3.64e-82 246.0 sp|P62994|GRB2_RAT Growth factor receptor-bound protein 2 OS=Rattus norvegicus OX=10116 GN=Grb2 PE=1 SV=1 GRB2_RAT reviewed Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2) Rattus norvegicus (Rat) GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007165; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019899; GO:0019901; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031295; GO:0031623; GO:0032991; GO:0035987; GO:0042059; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0044877; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0051219; GO:0060670; GO:0070436; GO:0071479; GO:0098793; GO:2000379 actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506] enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g13048.t1 B5FXE5 42.262 336 1.47e-90 280.0 sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1 g13050.t1 P10076 28.856 402 2.06e-43 173.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t1 P10076 26.256 438 6.13e-34 143.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t1 P10076 26.687 326 1.7299999999999999e-28 126.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t1 P10076 26.174 447 1.98e-28 126.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t1 P10076 26.463 393 5.2e-27 121.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t1 P10076 26.994 326 1.41e-23 110.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t2 P10076 28.856 402 1.1500000000000001e-43 173.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t2 P10076 26.256 438 3.22e-34 144.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t2 P10076 26.174 447 9.61e-29 127.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t2 P10076 26.687 326 1.06e-28 127.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t2 P10076 26.463 393 2.9200000000000002e-27 122.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13050.t2 P10076 26.994 326 8.639999999999999e-24 111.0 sp|P10076|ZFP26_MOUSE Zinc finger protein 26 OS=Mus musculus OX=10090 GN=Zfp26 PE=2 SV=2 g13051.t1 Q4R877 41.889 487 2.8200000000000003e-129 389.0 sp|Q4R877|S19A3_MACFA Thiamine transporter 2 OS=Macaca fascicularis OX=9541 GN=SLC19A3 PE=2 SV=1 S19A3_MACFA reviewed Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005886; GO:0015234; GO:0015888; GO:0031923 pyridoxine transport [GO:0031923]; thiamine transport [GO:0015888] plasma membrane [GO:0005886] thiamine transmembrane transporter activity [GO:0015234] g13052.t1 Q676U5 42.581 620 6.2e-159 470.0 sp|Q676U5|A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens OX=9606 GN=ATG16L1 PE=1 SV=2 A16L1_HUMAN reviewed Autophagy-related protein 16-1 (APG16-like 1) Homo sapiens (Human) GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0021766; GO:0022038; GO:0030424; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0043495; GO:0051020; GO:0051607; GO:0097225; GO:0098792; GO:0098930; GO:0098978; GO:0120095; GO:0140059; GO:1903860 autophagosome assembly [GO:0000045]; axonal transport [GO:0098930]; C-terminal protein lipidation [GO:0006501]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; dendrite arborization [GO:0140059]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative regulation of dendrite extension [GO:1903860]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095] GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like protein transferase activity [GO:0019787] g13053.t1 Q9CYL5 37.805 164 4.04e-25 105.0 sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3 g13055.t1 Q6DG99 53.968 126 1.21e-34 126.0 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13056.t1 Q3URF8 49.485 97 1.3399999999999999e-24 101.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13057.t1 Q3URF8 43.2 125 1.8e-24 100.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13058.t1 Q3URF8 53.608 97 2.8300000000000004e-27 108.0 sp|Q3URF8|KCD21_MOUSE BTB/POZ domain-containing protein KCTD21 OS=Mus musculus OX=10090 GN=Kctd21 PE=1 SV=1 g13060.t1 Q6DG99 49.18 122 3.75e-27 107.0 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13061.t1 Q6DG99 61.29 93 3.64e-28 110.0 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13062.t1 Q6UY01 26.984 441 1.1199999999999999e-23 110.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g13062.t1 Q6UY01 26.667 420 5.33e-21 102.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g13063.t1 P97479 51.673 1225 0.0 1209.0 sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2 g13065.t1 P49013 40.574 244 9.24e-40 156.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g13065.t1 P49013 46.104 154 1.2100000000000001e-29 126.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g13065.t1 P49013 34.101 217 7.58e-26 115.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g13070.t1 A0JC51 50.442 565 2.27e-155 457.0 sp|A0JC51|ZIC4_XENLA Zinc finger protein ZIC 4 OS=Xenopus laevis OX=8355 GN=zic4 PE=2 SV=1 g13077.t1 Q8BUP8 31.551 187 2.29e-25 106.0 sp|Q8BUP8|FA43A_MOUSE Protein FAM43A OS=Mus musculus OX=10090 GN=Fam43a PE=2 SV=1 g13078.t1 Q5PRC1 42.564 195 4.54e-53 173.0 sp|Q5PRC1|LHPL6_DANRE LHFPL tetraspan subfamily member 6 protein OS=Danio rerio OX=7955 GN=lhfpl6 PE=2 SV=1 g13079.t1 Q6DG99 68.478 92 1.6500000000000001e-37 133.0 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13080.t1 Q6DG99 60.714 84 4.05e-25 96.7 sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1 g13085.t1 Q6DHJ3 40.447 403 3.31e-94 293.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g13087.t1 S8FIE4 31.55 542 7.84e-57 205.0 sp|S8FIE4|LAC1_FOMSC Laccase-1 OS=Fomitopsis schrenkii OX=2126942 GN=LCC1 PE=1 SV=1 g13089.t1 B7ZCC9 29.145 573 8.52e-71 269.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g13092.t1 B7ZCC9 30.07 572 4.92e-70 259.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g13101.t1 Q6P2Y2 81.687 415 0.0 725.0 sp|Q6P2Y2|DAW1_XENTR Dynein assembly factor with WD repeat domains 1 OS=Xenopus tropicalis OX=8364 GN=daw1 PE=2 SV=1 g13102.t1 Q6PBU5 50.291 344 2.63e-129 377.0 sp|Q6PBU5|GRT1A_DANRE Growth hormone-regulated TBC protein 1-A OS=Danio rerio OX=7955 GN=grtp1a PE=2 SV=1 g13103.t1 Q2KHP9 51.398 465 1.3e-155 466.0 sp|Q2KHP9|FMR1B_XENLA Fragile X messenger ribonucleoprotein 1 homolog B OS=Xenopus laevis OX=8355 GN=fmr1-b PE=2 SV=1 FMR1B_XENLA reviewed Fragile X messenger ribonucleoprotein 1 homolog B (xFMR1-B) Xenopus laevis (African clawed frog) GO:0000381; GO:0000775; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006281; GO:0006397; GO:0006406; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0010629; GO:0014069; GO:0017148; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0032433; GO:0033592; GO:0034046; GO:0034063; GO:0035195; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042803; GO:0042995; GO:0043005; GO:0043197; GO:0043204; GO:0043232; GO:0043488; GO:0043679; GO:0045182; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048170; GO:0048471; GO:0048513; GO:0051028; GO:0051489; GO:0051491; GO:0060538; GO:0060965; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0097386; GO:0098793; GO:0098794; GO:0098908; GO:0099577; GO:0140006; GO:0140693; GO:0140694; GO:1900453; GO:1901386; GO:1901800; GO:1902737; GO:1990247; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766 animal organ development [GO:0048513]; DNA repair [GO:0006281]; glutamate receptor signaling pathway [GO:0007215]; membraneless organelle assembly [GO:0140694]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of receptor internalization [GO:0002092]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; RNA splicing [GO:0008380]; skeletal muscle organ development [GO:0060538]; stress granule assembly [GO:0034063] axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; histone H3 reader activity [GO:0140006]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371] g13104.t1 Q03123 47.909 263 1.62e-82 251.0 sp|Q03123|T2FB_XENLA General transcription factor IIF subunit 2 OS=Xenopus laevis OX=8355 GN=gtf2f2 PE=2 SV=1 g13106.t1 O54965 45.556 360 2.24e-94 291.0 sp|O54965|RNF13_MOUSE E3 ubiquitin-protein ligase RNF13 OS=Mus musculus OX=10090 GN=Rnf13 PE=1 SV=2 RNF13_MOUSE reviewed E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) Mus musculus (Mouse) GO:0004842; GO:0005637; GO:0005654; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008270; GO:0008432; GO:0031902; GO:0046330; GO:0051865; GO:0061630 positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654] JUN kinase binding [GO:0008432]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13106.t2 Q90972 49.836 305 2.6e-92 286.0 sp|Q90972|RNF13_CHICK E3 ubiquitin-protein ligase RNF13 OS=Gallus gallus OX=9031 GN=RNF13 PE=1 SV=1 RNF13_CHICK reviewed E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (C-RZF) (RING finger protein 13) Gallus gallus (Chicken) GO:0004842; GO:0005637; GO:0005654; GO:0005737; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008270; GO:0008432; GO:0031902; GO:0046330; GO:0051865; GO:0061630 positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654] JUN kinase binding [GO:0008432]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13106.t3 O54965 41.604 399 2.91e-87 275.0 sp|O54965|RNF13_MOUSE E3 ubiquitin-protein ligase RNF13 OS=Mus musculus OX=10090 GN=Rnf13 PE=1 SV=2 RNF13_MOUSE reviewed E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) Mus musculus (Mouse) GO:0004842; GO:0005637; GO:0005654; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008270; GO:0008432; GO:0031902; GO:0046330; GO:0051865; GO:0061630 positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654] JUN kinase binding [GO:0008432]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13107.t1 Q8BX90 40.614 1172 0.0 800.0 sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3 FND3A_MOUSE reviewed Fibronectin type-III domain-containing protein 3A Mus musculus (Mouse) GO:0000139; GO:0001669; GO:0005737; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016020; GO:0031410; GO:0060009; GO:0098609 cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; vesicle membrane [GO:0012506] g13108.t1 Q9ERU9 32.199 823 1.91e-90 334.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 27.933 716 8.590000000000001e-77 289.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 35.795 352 1.05e-52 210.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 38.019 313 1.26e-47 193.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 39.803 304 1.4400000000000002e-43 180.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 58.0 150 3.740000000000001e-43 178.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 41.126 231 8.61e-42 174.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 45.545 202 1.16e-40 170.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 49.367 158 1.7499999999999999e-40 169.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13108.t1 Q9ERU9 40.741 189 4.4e-37 158.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13109.t1 Q9ERU9 44.242 165 7.77e-34 146.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13109.t1 Q9ERU9 35.581 267 1.5000000000000001e-31 139.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13109.t1 Q9ERU9 45.522 134 8.260000000000001e-31 136.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13109.t1 Q9ERU9 41.135 141 1.66e-29 132.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13110.t1 Q9ERU9 35.282 479 2.97e-69 244.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13110.t1 Q9ERU9 49.727 183 2.31e-46 177.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13110.t1 Q9ERU9 52.258 155 3.55e-42 164.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13110.t1 Q9ERU9 50.676 148 8.38e-42 163.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13110.t1 Q9ERU9 45.714 140 5.889999999999999e-23 106.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13111.t1 Q9BRZ2 26.441 295 5.559999999999999e-23 102.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g13112.t1 Q9ERU9 31.114 826 1.5600000000000001e-86 317.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 59.286 140 9.12e-43 176.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 45.882 170 8.07e-41 169.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 37.975 316 8.7e-41 169.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 51.408 142 7.64e-40 166.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 45.05 202 7.84e-40 166.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 38.258 264 8.9e-40 166.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 52.239 134 3.01e-39 164.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 37.5 184 8.46e-36 153.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 26.714 423 3.59e-26 121.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 30.657 274 5.9899999999999996e-24 114.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 45.385 130 4.2999999999999994e-23 111.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13112.t1 Q9ERU9 39.516 124 6.6e-22 107.0 sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2 RBP2_MOUSE reviewed E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2) Mus musculus (Mouse) GO:0001975; GO:0002224; GO:0002753; GO:0003723; GO:0003755; GO:0005634; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0045824; GO:0046832; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723 centrosome localization [GO:0051642]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; mRNA transport [GO:0051028]; negative regulation of innate immune response [GO:0045824]; negative regulation of RNA export from nucleus [GO:0046832]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975]; toll-like receptor signaling pathway [GO:0002224] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO ligase complex [GO:0106068] kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g13113.t1 Q80VI1 29.874 318 4.98e-30 132.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g13114.t1 Q9BRZ2 28.288 403 4.5100000000000004e-27 120.0 sp|Q9BRZ2|TRI56_HUMAN E3 ubiquitin-protein ligase TRIM56 OS=Homo sapiens OX=9606 GN=TRIM56 PE=1 SV=3 g13115.t1 P78333 32.857 490 9.8e-72 245.0 sp|P78333|GPC5_HUMAN Glypican-5 OS=Homo sapiens OX=9606 GN=GPC5 PE=1 SV=1 GPC5_HUMAN reviewed Glypican-5 [Cleaved into: Secreted glypican-5] Homo sapiens (Human) GO:0005576; GO:0005796; GO:0005886; GO:0009986; GO:0016020; GO:0016477; GO:0043202; GO:0090263; GO:0098552; GO:1905475 cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475] cell surface [GO:0009986]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] g13117.t1 P50453 40.841 333 6.620000000000001e-73 233.0 sp|P50453|SPB9_HUMAN Serpin B9 OS=Homo sapiens OX=9606 GN=SERPINB9 PE=1 SV=1 SPB9_HUMAN reviewed Serpin B9 (Cytoplasmic antiproteinase 3) (CAP-3) (CAP3) (Peptidase inhibitor 9) (PI-9) Homo sapiens (Human) GO:0002020; GO:0002448; GO:0004867; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0016020; GO:0031012; GO:0042270; GO:0043027; GO:0043066; GO:0070062; GO:0071391 cellular response to estrogen stimulus [GO:0071391]; immune response [GO:0006955]; mast cell mediated immunity [GO:0002448]; negative regulation of apoptotic process [GO:0043066]; protection from natural killer cell mediated cytotoxicity [GO:0042270] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] g13118.t1 P83510 79.834 362 0.0 590.0 sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus OX=10090 GN=Tnik PE=1 SV=2 TNIK_MOUSE reviewed Traf2 and NCK-interacting protein kinase (EC 2.7.11.1) Mus musculus (Mouse) GO:0000165; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030036; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048471; GO:0048812; GO:0048814; GO:0050775; GO:0055037; GO:0098696; GO:0098793; GO:0098978; GO:0099092; GO:0106310; GO:1903698 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JNK cascade [GO:0046330]; positive regulation of microvillus assembly [GO:1903698]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13118.t1 P83510 65.994 347 1.02e-153 496.0 sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus OX=10090 GN=Tnik PE=1 SV=2 TNIK_MOUSE reviewed Traf2 and NCK-interacting protein kinase (EC 2.7.11.1) Mus musculus (Mouse) GO:0000165; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030036; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048471; GO:0048812; GO:0048814; GO:0050775; GO:0055037; GO:0098696; GO:0098793; GO:0098978; GO:0099092; GO:0106310; GO:1903698 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JNK cascade [GO:0046330]; positive regulation of microvillus assembly [GO:1903698]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13118.t2 P83510 79.834 362 0.0 590.0 sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus OX=10090 GN=Tnik PE=1 SV=2 TNIK_MOUSE reviewed Traf2 and NCK-interacting protein kinase (EC 2.7.11.1) Mus musculus (Mouse) GO:0000165; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030036; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048471; GO:0048812; GO:0048814; GO:0050775; GO:0055037; GO:0098696; GO:0098793; GO:0098978; GO:0099092; GO:0106310; GO:1903698 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JNK cascade [GO:0046330]; positive regulation of microvillus assembly [GO:1903698]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13118.t2 P83510 56.854 445 2.8e-155 499.0 sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus OX=10090 GN=Tnik PE=1 SV=2 TNIK_MOUSE reviewed Traf2 and NCK-interacting protein kinase (EC 2.7.11.1) Mus musculus (Mouse) GO:0000165; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030036; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048471; GO:0048812; GO:0048814; GO:0050775; GO:0055037; GO:0098696; GO:0098793; GO:0098978; GO:0099092; GO:0106310; GO:1903698 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JNK cascade [GO:0046330]; positive regulation of microvillus assembly [GO:1903698]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13118.t3 P83510 79.834 362 0.0 590.0 sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus OX=10090 GN=Tnik PE=1 SV=2 TNIK_MOUSE reviewed Traf2 and NCK-interacting protein kinase (EC 2.7.11.1) Mus musculus (Mouse) GO:0000165; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030036; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048471; GO:0048812; GO:0048814; GO:0050775; GO:0055037; GO:0098696; GO:0098793; GO:0098978; GO:0099092; GO:0106310; GO:1903698 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JNK cascade [GO:0046330]; positive regulation of microvillus assembly [GO:1903698]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13118.t3 P83510 56.854 445 2.93e-155 498.0 sp|P83510|TNIK_MOUSE Traf2 and NCK-interacting protein kinase OS=Mus musculus OX=10090 GN=Tnik PE=1 SV=2 TNIK_MOUSE reviewed Traf2 and NCK-interacting protein kinase (EC 2.7.11.1) Mus musculus (Mouse) GO:0000165; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0016055; GO:0016324; GO:0030036; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048471; GO:0048812; GO:0048814; GO:0050775; GO:0055037; GO:0098696; GO:0098793; GO:0098978; GO:0099092; GO:0106310; GO:1903698 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JNK cascade [GO:0046330]; positive regulation of microvillus assembly [GO:1903698]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13121.t1 P53356 44.819 772 0.0 655.0 sp|P53356|HTK16_HYDVU Tyrosine-protein kinase HTK16 OS=Hydra vulgaris OX=6087 GN=HTK16 PE=2 SV=1 g13122.t1 B2GV54 49.697 165 3.24e-38 138.0 sp|B2GV54|NCEH1_RAT Neutral cholesterol ester hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Nceh1 PE=1 SV=1 NCEH1_RAT reviewed Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1) Rattus norvegicus (Rat) GO:0005886; GO:0006805; GO:0016020; GO:0016042; GO:0017171; GO:0042301; GO:0046485; GO:0047378 ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020]; plasma membrane [GO:0005886] acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171] g13123.t1 Q5VUY0 49.474 95 5.7299999999999996e-24 99.4 sp|Q5VUY0|ADCL3_HUMAN Arylacetamide deacetylase-like 3 OS=Homo sapiens OX=9606 GN=AADACL3 PE=2 SV=5 g13124.t1 Q6P2X9 27.893 484 1.86e-46 171.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g13125.t1 Q8K1C7 27.579 504 4.67e-34 137.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g13126.t1 Q6P2X9 25.47 479 9.29e-41 155.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g13127.t1 Q7RTX9 29.247 465 3.89e-35 140.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g13128.t1 Q6ZSM3 29.333 375 2.71e-40 153.0 sp|Q6ZSM3|MOT12_HUMAN Monocarboxylate transporter 12 OS=Homo sapiens OX=9606 GN=SLC16A12 PE=1 SV=3 MOT12_HUMAN reviewed Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12) Homo sapiens (Human) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449; GO:0150104 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g13129.t1 Q6P2X9 25.212 472 1.14e-36 144.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g13130.t1 Q8R0M8 23.125 480 2.86e-24 108.0 sp|Q8R0M8|MOT5_MOUSE Monocarboxylate transporter 5 OS=Mus musculus OX=10090 GN=Slc16a4 PE=2 SV=1 g13132.t1 Q99056 31.786 560 3.3799999999999997e-60 213.0 sp|Q99056|LAC5_TRAVI Laccase-5 OS=Trametes villosa OX=47662 GN=LCC5 PE=3 SV=2 g13133.t1 Q9TTQ9 35.759 316 7.350000000000001e-57 193.0 sp|Q9TTQ9|GPR83_CANLF G-protein coupled receptor 83 OS=Canis lupus familiaris OX=9615 GN=GPR83 PE=2 SV=1 g13134.t1 Q84DC4 35.729 473 1.27e-71 238.0 sp|Q84DC4|MANHY_PSEPU Mandelamide hydrolase OS=Pseudomonas putida OX=303 GN=mdlY PE=1 SV=1 g13135.t1 A6QNK1 29.428 367 7e-35 137.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g13136.t1 O14936 73.667 938 0.0 1414.0 sp|O14936|CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens OX=9606 GN=CASK PE=1 SV=3 g13136.t2 O70589 73.746 937 0.0 1418.0 sp|O70589|CSKP_MOUSE Peripheral plasma membrane protein CASK OS=Mus musculus OX=10090 GN=Cask PE=1 SV=2 CSKP_MOUSE reviewed Peripheral plasma membrane protein CASK (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) Mus musculus (Mouse) GO:0001953; GO:0004674; GO:0005080; GO:0005102; GO:0005516; GO:0005524; GO:0005604; GO:0005634; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006357; GO:0008104; GO:0010839; GO:0016020; GO:0016323; GO:0016363; GO:0030165; GO:0030425; GO:0031982; GO:0032024; GO:0032991; GO:0042043; GO:0042734; GO:0043025; GO:0044877; GO:0045202; GO:0045944; GO:0046928; GO:0048471; GO:0060170; GO:0061003; GO:0061045; GO:0070509; GO:0072659; GO:0090280; GO:0090288; GO:0097060; GO:0097440; GO:0098685; GO:0098793; GO:0098794; GO:0098846; GO:0098978; GO:0099092; GO:0106310; GO:2000300 calcium ion import [GO:0070509]; intracellular protein localization [GO:0008104]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357] apical dendrite [GO:0097440]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podocyte foot [GO:0098846]; postsynapse [GO:0098794]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; vesicle [GO:0031982] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g13137.t1 Q7ZXB1 77.178 723 0.0 1144.0 sp|Q7ZXB1|MCM7B_XENLA DNA replication licensing factor mcm7-B OS=Xenopus laevis OX=8355 GN=mcm7-b PE=1 SV=1 MCM7B_XENLA reviewed DNA replication licensing factor mcm7-B (EC 3.6.4.12) (CDC47 homolog B) (CDC47-2p) (Minichromosome maintenance protein 7-B) (xMCM7-B) Xenopus laevis (African clawed frog) GO:0000727; GO:0000785; GO:0003697; GO:0005524; GO:0005634; GO:0006270; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0071162 DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174] chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270] g13138.t1 Q5U3C3 48.679 265 6.76e-83 254.0 sp|Q5U3C3|TM164_HUMAN Transmembrane protein 164 OS=Homo sapiens OX=9606 GN=TMEM164 PE=1 SV=1 g13139.t1 P35521 46.575 146 6.19e-34 125.0 sp|P35521|ICLN_CANLF Methylosome subunit pICln OS=Canis lupus familiaris OX=9615 GN=CLNS1A PE=1 SV=1 g13140.t1 Q5RDQ3 52.055 292 2.55e-99 296.0 sp|Q5RDQ3|AMERL_PONAB AMMECR1-like protein OS=Pongo abelii OX=9601 GN=AMMECR1L PE=2 SV=1 g13141.t1 A2TIL1 59.913 459 0.0 547.0 sp|A2TIL1|GSHR_CALJA Glutathione reductase, mitochondrial OS=Callithrix jacchus OX=9483 GN=GSR PE=2 SV=1 GSHR_CALJA reviewed Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7) Callithrix jacchus (White-tufted-ear marmoset) (Simia Jacchus) GO:0004362; GO:0005739; GO:0005829; GO:0006749; GO:0034599; GO:0045454; GO:0050660; GO:0050661 cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749] cytosol [GO:0005829]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase (NADPH) activity [GO:0004362]; NADP binding [GO:0050661] g13143.t1 Q6AYT4 46.701 197 2.18e-28 113.0 sp|Q6AYT4|PBIR1_RAT P2R1A-PPP2R2A-interacting phosphatase regulator 1 OS=Rattus norvegicus OX=10116 GN=Pabir1 PE=1 SV=1 PBIR1_RAT reviewed P2R1A-PPP2R2A-interacting phosphatase regulator 1 (PABIR family member 1) Rattus norvegicus (Rat) GO:0004864; GO:0004865; GO:0005634; GO:0005654; GO:0005737; GO:0016604; GO:0030307; GO:0032436; GO:0044818; GO:0051721 mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865] g13144.t1 Q01887 48.128 561 0.0 537.0 sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus OX=10090 GN=Ryk PE=1 SV=2 g13145.t1 Q9Y376 70.06 334 5.32e-159 451.0 sp|Q9Y376|CAB39_HUMAN Calcium-binding protein 39 OS=Homo sapiens OX=9606 GN=CAB39 PE=1 SV=1 CAB39_HUMAN reviewed Calcium-binding protein 39 (MO25alpha) (Protein Mo25) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005829; GO:0007165; GO:0014823; GO:0019900; GO:0030018; GO:0030295; GO:0034774; GO:0035556; GO:0043539; GO:0070062; GO:0071476; GO:0097066; GO:0120283; GO:1901380; GO:1902554; GO:1904813 cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine/threonine protein kinase complex [GO:1902554]; Z disc [GO:0030018] kinase binding [GO:0019900]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283] g13146.t1 Q8K4C0 36.217 497 1.9499999999999999e-84 274.0 sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3 FMO5_RAT reviewed Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1) Rattus norvegicus (Rat) GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016174; GO:0050660; GO:0050661; GO:0090181 lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661] g13148.t1 P02269 99.2 125 1.06e-84 246.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g13149.t1 P02286 98.361 122 1.0699999999999999e-84 245.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g13150.t1 A6BMK7 40.633 379 7.5e-88 274.0 sp|A6BMK7|NEUR1_BOVIN Sialidase-1 OS=Bos taurus OX=9913 GN=NEU1 PE=2 SV=2 NEUR1_BOVIN reviewed Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) Bos taurus (Bovine) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0030054; GO:0031410; GO:0043202 ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] exo-alpha-sialidase activity [GO:0004308] g13153.t1 Q86X83 62.121 198 2.88e-82 245.0 sp|Q86X83|COMD2_HUMAN COMM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=COMMD2 PE=1 SV=2 g13154.t1 B5X8M4 56.727 275 4.720000000000001e-109 319.0 sp|B5X8M4|BRCC3_SALSA Lys-63-specific deubiquitinase BRCC36 OS=Salmo salar OX=8030 GN=brcc3 PE=2 SV=1 BRCC3_SALSA reviewed Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36) Salmo salar (Atlantic salmon) GO:0000922; GO:0004843; GO:0005634; GO:0005737; GO:0006302; GO:0006508; GO:0007095; GO:0008237; GO:0010212; GO:0031593; GO:0045739; GO:0046872; GO:0051301; GO:0070531; GO:0070536; GO:0070552; GO:0140492; GO:0140861; GO:1900227 cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922] cysteine-type deubiquitinase activity [GO:0004843]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593] g13155.t1 Q708S7 32.609 230 5.21e-30 120.0 sp|Q708S7|ASI1A_DANRE Acid-sensing ion channel 1A OS=Danio rerio OX=7955 GN=asic1a PE=1 SV=1 ASI1A_DANRE reviewed Acid-sensing ion channel 1A (ASIC1-A) (Acid-sensing ion channel 1.2-A) (Amiloride-sensitive cation channel 2-B, neuronal-A) (ZASIC1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g13156.t1 Q708S7 31.498 454 5.98e-66 223.0 sp|Q708S7|ASI1A_DANRE Acid-sensing ion channel 1A OS=Danio rerio OX=7955 GN=asic1a PE=1 SV=1 ASI1A_DANRE reviewed Acid-sensing ion channel 1A (ASIC1-A) (Acid-sensing ion channel 1.2-A) (Amiloride-sensitive cation channel 2-B, neuronal-A) (ZASIC1.2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005261; GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128] g13160.t1 Q0P5B9 50.0 172 2.25e-50 163.0 sp|Q0P5B9|ANR39_BOVIN Ankyrin repeat domain-containing protein 39 OS=Bos taurus OX=9913 GN=ANKRD39 PE=2 SV=1 g13163.t1 Q3USZ8 45.316 395 2.9200000000000003e-124 369.0 sp|Q3USZ8|DIK2A_MOUSE Divergent protein kinase domain 2A OS=Mus musculus OX=10090 GN=Dipk2a PE=1 SV=2 g13164.t1 Q9BZ29 47.119 1076 0.0 936.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 g13164.t2 Q9BZ29 45.083 1322 0.0 1051.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 g13164.t2 Q9BZ29 47.978 890 0.0 810.0 sp|Q9BZ29|DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens OX=9606 GN=DOCK9 PE=1 SV=2 g13164.t3 Q8BIK4 49.188 862 0.0 823.0 sp|Q8BIK4|DOCK9_MOUSE Dedicator of cytokinesis protein 9 OS=Mus musculus OX=10090 GN=Dock9 PE=1 SV=2 DOCK9_MOUSE reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Mus musculus (Mouse) GO:0005085; GO:0007264; GO:0012505; GO:0031267; GO:0035023; GO:0043547 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] endomembrane system [GO:0012505] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g13164.t3 Q8BIK4 35.714 210 1.4400000000000001e-27 125.0 sp|Q8BIK4|DOCK9_MOUSE Dedicator of cytokinesis protein 9 OS=Mus musculus OX=10090 GN=Dock9 PE=1 SV=2 DOCK9_MOUSE reviewed Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1) Mus musculus (Mouse) GO:0005085; GO:0007264; GO:0012505; GO:0031267; GO:0035023; GO:0043547 positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] endomembrane system [GO:0012505] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g13164.t4 A2AF47 54.075 773 0.0 824.0 sp|A2AF47|DOC11_MOUSE Dedicator of cytokinesis protein 11 OS=Mus musculus OX=10090 GN=Dock11 PE=1 SV=1 DOC11_MOUSE reviewed Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2) Mus musculus (Mouse) GO:0001782; GO:0002315; GO:0005085; GO:0007264; GO:0031267; GO:0035023; GO:0043547; GO:0051491 B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g13164.t4 A2AF47 36.774 155 7.010000000000001e-21 103.0 sp|A2AF47|DOC11_MOUSE Dedicator of cytokinesis protein 11 OS=Mus musculus OX=10090 GN=Dock11 PE=1 SV=1 DOC11_MOUSE reviewed Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2) Mus musculus (Mouse) GO:0001782; GO:0002315; GO:0005085; GO:0007264; GO:0031267; GO:0035023; GO:0043547; GO:0051491 B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g13165.t1 Q63486 90.066 302 0.0 570.0 sp|Q63486|RRAGA_RAT Ras-related GTP-binding protein A OS=Rattus norvegicus OX=10116 GN=Rraga PE=1 SV=1 RRAGA_RAT reviewed Ras-related GTP-binding protein A (Rag A) (RagA) (EC 3.6.5.-) Rattus norvegicus (Rat) GO:0000045; GO:0002181; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0006915; GO:0008104; GO:0009267; GO:0010507; GO:0031625; GO:0031669; GO:0032008; GO:0033209; GO:0034198; GO:0035556; GO:0038202; GO:0042593; GO:0042803; GO:0043200; GO:0043495; GO:0045947; GO:0045948; GO:0046982; GO:0051219; GO:0061431; GO:0061462; GO:0071230; GO:0072657; GO:1903432; GO:1904263; GO:1990130; GO:1990131; GO:1990877 apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to methionine [GO:0061431]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; cytoplasmic translation [GO:0002181]; glucose homeostasis [GO:0042593]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; negative regulation of translational initiation [GO:0045947]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translational initiation [GO:0045948]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; TORC1 signaling [GO:0038202]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; FNIP-folliculin RagC/D GAP [GO:1990877]; GATOR1 complex [GO:1990130]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; ubiquitin protein ligase binding [GO:0031625] g13166.t1 Q9R087 54.89 317 5.4100000000000006e-129 394.0 sp|Q9R087|GPC6_MOUSE Glypican-6 OS=Mus musculus OX=10090 GN=Gpc6 PE=1 SV=1 g13166.t1 Q9R087 27.619 210 8.14e-22 103.0 sp|Q9R087|GPC6_MOUSE Glypican-6 OS=Mus musculus OX=10090 GN=Gpc6 PE=1 SV=1 g13168.t1 O18334 88.942 208 1.0399999999999999e-134 379.0 sp|O18334|RAB6_DROME Ras-related protein Rab6 OS=Drosophila melanogaster OX=7227 GN=Rab6 PE=1 SV=1 RAB6_DROME reviewed Ras-related protein Rab6 (Protein warthog) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0001745; GO:0001881; GO:0003779; GO:0003924; GO:0005525; GO:0005764; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0012505; GO:0016192; GO:0031410; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0060078; GO:0140450 axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; protein targeting to Golgi apparatus [GO:0140450]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g13168.t2 O18334 86.538 208 3.12e-130 367.0 sp|O18334|RAB6_DROME Ras-related protein Rab6 OS=Drosophila melanogaster OX=7227 GN=Rab6 PE=1 SV=1 RAB6_DROME reviewed Ras-related protein Rab6 (Protein warthog) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0001745; GO:0001881; GO:0003779; GO:0003924; GO:0005525; GO:0005764; GO:0005776; GO:0005794; GO:0005829; GO:0006886; GO:0006887; GO:0006890; GO:0006891; GO:0007293; GO:0007411; GO:0007602; GO:0008103; GO:0012505; GO:0016192; GO:0031410; GO:0032482; GO:0042147; GO:0043025; GO:0043204; GO:0045202; GO:0045451; GO:0045467; GO:0060078; GO:0140450 axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; protein targeting to Golgi apparatus [GO:0140450]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; receptor recycling [GO:0001881]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g13169.t1 O35547 48.132 696 0.0 660.0 sp|O35547|ACSL4_RAT Long-chain-fatty-acid--CoA ligase 4 OS=Rattus norvegicus OX=10116 GN=Acsl4 PE=1 SV=2 ACSL4_RAT reviewed Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4) Rattus norvegicus (Rat) GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0006636; GO:0007584; GO:0008610; GO:0015908; GO:0019432; GO:0030182; GO:0030307; GO:0031957; GO:0031966; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0036109; GO:0042759; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672; GO:0160020; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of ferroptosis [GO:0160020]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432]; unsaturated fatty acid biosynthetic process [GO:0006636] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g13170.t1 Q567G2 29.596 446 3.02e-46 167.0 sp|Q567G2|WDR73_DANRE Integrator complex assembly factor WDR73 OS=Danio rerio OX=7955 GN=wdr73 PE=2 SV=1 WDR73_DANRE reviewed Integrator complex assembly factor WDR73 (WD repeat-containing protein 73) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000922; GO:0005737; GO:0021549; GO:0021702; GO:0030674; GO:0030901; GO:0031122; GO:0032154 cerebellar Purkinje cell differentiation [GO:0021702]; cerebellum development [GO:0021549]; cytoplasmic microtubule organization [GO:0031122]; midbrain development [GO:0030901] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] protein-macromolecule adaptor activity [GO:0030674] g13171.t1 Q96PF2 34.351 262 1.1999999999999999e-39 144.0 sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=TSSK2 PE=1 SV=2 TSSK2_HUMAN reviewed Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) Homo sapiens (Human) GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007286; GO:0044877; GO:0046777; GO:0106310 protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] g13172.t1 Q9QXL7 55.128 312 3.31e-123 361.0 sp|Q9QXL7|NDK7_RAT Nucleoside diphosphate kinase homolog 7 OS=Rattus norvegicus OX=10116 GN=Nme7 PE=1 SV=2 g13174.t1 Q8BHJ5 80.739 514 0.0 843.0 sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1 TBL1R_MOUSE reviewed F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045893; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263 adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872] histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] g13179.t1 Q96GW9 57.011 542 0.0 601.0 sp|Q96GW9|SYMM_HUMAN Methionine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=MARS2 PE=1 SV=2 SYMM_HUMAN reviewed Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) Homo sapiens (Human) GO:0004825; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006431 methionyl-tRNA aminoacylation [GO:0006431]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825] g13180.t1 P62783 100.0 103 6.4e-68 201.0 sp|P62783|H4_STRPU Histone H4 OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=2 g13181.t1 P69079 100.0 136 1.3799999999999998e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g13182.t1 B2RPY5 37.632 380 1.9800000000000002e-80 260.0 sp|B2RPY5|GP161_MOUSE G-protein coupled receptor 161 OS=Mus musculus OX=10090 GN=Gpr161 PE=1 SV=1 GP161_MOUSE reviewed G-protein coupled receptor 161 Mus musculus (Mouse) GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0055037; GO:0060170; GO:1901621 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037] G protein-coupled receptor activity [GO:0004930] g13183.t1 P02286 98.361 122 1.0699999999999999e-84 245.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g13184.t1 P02286 98.361 122 1.0699999999999999e-84 245.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g13186.t1 A2BGA0 35.421 463 4.64e-93 311.0 sp|A2BGA0|RFX4_DANRE Transcription factor RFX4 OS=Danio rerio OX=7955 GN=rfx4 PE=2 SV=1 g13187.t1 Q27312 32.632 285 2.56e-50 171.0 sp|Q27312|NADA_APLKU ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia kurodai OX=6501 PE=1 SV=1 NADA_APLKU reviewed ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase) Aplysia kurodai (Kuroda's sea hare) GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0031410; GO:0061809 single fertilization [GO:0007338] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740] g13188.t1 Q6TFL4 36.219 566 1.4299999999999998e-91 304.0 sp|Q6TFL4|KLH24_HUMAN Kelch-like protein 24 OS=Homo sapiens OX=9606 GN=KLHL24 PE=1 SV=1 KLH24_HUMAN reviewed Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1) Homo sapiens (Human) GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:0045109; GO:0051865; GO:1990756 intermediate filament organization [GO:0045109]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g13189.t1 Q7L0X2 26.494 502 2.11e-45 177.0 sp|Q7L0X2|ERIP6_HUMAN Glutamate-rich protein 6 OS=Homo sapiens OX=9606 GN=ERICH6 PE=1 SV=1 g13189.t2 Q7L0X2 27.071 495 4.76e-46 179.0 sp|Q7L0X2|ERIP6_HUMAN Glutamate-rich protein 6 OS=Homo sapiens OX=9606 GN=ERICH6 PE=1 SV=1 g13190.t1 Q8CI04 52.927 837 0.0 896.0 sp|Q8CI04|COG3_MOUSE Conserved oligomeric Golgi complex subunit 3 OS=Mus musculus OX=10090 GN=Cog3 PE=1 SV=3 g13191.t1 Q2KHV4 56.835 278 9.89e-112 333.0 sp|Q2KHV4|PARL_BOVIN Presenilin-associated rhomboid-like protein, mitochondrial OS=Bos taurus OX=9913 GN=PARL PE=2 SV=1 g13192.t1 O35594 60.767 678 0.0 825.0 sp|O35594|IFT81_MOUSE Intraflagellar transport protein 81 homolog OS=Mus musculus OX=10090 GN=Ift81 PE=1 SV=4 IFT81_MOUSE reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Mus musculus (Mouse) GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0120316 cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] tubulin binding [GO:0015631] g13196.t1 Q86UY8 47.647 510 1.86e-167 488.0 sp|Q86UY8|NT5D3_HUMAN 5'-nucleotidase domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NT5DC3 PE=1 SV=1 g13197.t1 B0R0T1 59.904 1868 0.0 2271.0 sp|B0R0T1|VWA8_DANRE von Willebrand factor A domain-containing protein 8 OS=Danio rerio OX=7955 GN=vwa8 PE=3 SV=1 VWA8_DANRE reviewed von Willebrand factor A domain-containing protein 8 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005524; GO:0005737; GO:0005739; GO:0016887; GO:0030903 notochord development [GO:0030903] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g13199.t1 Q6NVD0 27.621 496 1.29e-23 110.0 sp|Q6NVD0|FREM2_MOUSE FRAS1-related extracellular matrix protein 2 OS=Mus musculus OX=10090 GN=Frem2 PE=1 SV=2 FREM2_MOUSE reviewed FRAS1-related extracellular matrix protein 2 (ECM3 homolog) (NV domain-containing protein 1) Mus musculus (Mouse) GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0031012; GO:0042733; GO:0046872; GO:0048839 anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] metal ion binding [GO:0046872] g13199.t2 Q6NVD0 27.621 496 1.61e-23 110.0 sp|Q6NVD0|FREM2_MOUSE FRAS1-related extracellular matrix protein 2 OS=Mus musculus OX=10090 GN=Frem2 PE=1 SV=2 FREM2_MOUSE reviewed FRAS1-related extracellular matrix protein 2 (ECM3 homolog) (NV domain-containing protein 1) Mus musculus (Mouse) GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0031012; GO:0042733; GO:0046872; GO:0048839 anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] metal ion binding [GO:0046872] g13201.t1 P49180 63.889 108 8.83e-49 154.0 sp|P49180|RL35A_CAEEL Large ribosomal subunit protein eL33 OS=Caenorhabditis elegans OX=6239 GN=rpl-35A PE=1 SV=3 g13202.t1 Q2T9V2 43.434 396 3.22e-89 279.0 sp|Q2T9V2|DRC9_BOVIN Dynein regulatory complex protein 9 OS=Bos taurus OX=9913 GN=IQCG PE=2 SV=1 DRC9_BOVIN reviewed Dynein regulatory complex protein 9 (IQ domain-containing protein G) Bos taurus (Bovine) GO:0002177; GO:0005516; GO:0005737; GO:0007286; GO:0007288; GO:0031514; GO:0036126; GO:0044782 cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] calmodulin binding [GO:0005516] g13203.t1 Q96II8 42.619 420 4.4999999999999995e-95 317.0 sp|Q96II8|LRCH3_HUMAN DISP complex protein LRCH3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2 g13203.t1 Q96II8 62.097 124 1.6e-36 151.0 sp|Q96II8|LRCH3_HUMAN DISP complex protein LRCH3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2 g13203.t2 Q96II8 55.085 236 8.11e-85 291.0 sp|Q96II8|LRCH3_HUMAN DISP complex protein LRCH3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2 g13203.t2 Q96II8 62.097 124 1.35e-36 152.0 sp|Q96II8|LRCH3_HUMAN DISP complex protein LRCH3 OS=Homo sapiens OX=9606 GN=LRCH3 PE=1 SV=2 g13204.t1 Q9H0J9 37.367 471 2.09e-76 272.0 sp|Q9H0J9|PAR12_HUMAN Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1 PAR12_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Homo sapiens (Human) GO:0003723; GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g13204.t1 Q9H0J9 36.062 452 5.229999999999999e-69 251.0 sp|Q9H0J9|PAR12_HUMAN Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1 PAR12_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Homo sapiens (Human) GO:0003723; GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g13205.t1 Q9H0J9 36.653 472 4.83e-71 248.0 sp|Q9H0J9|PAR12_HUMAN Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1 PAR12_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Homo sapiens (Human) GO:0003723; GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g13210.t1 Q6TLE4 48.485 99 2.59e-26 98.2 sp|Q6TLE4|EMC5_DANRE ER membrane protein complex subunit 5 OS=Danio rerio OX=7955 GN=mmgt1 PE=2 SV=1 g13211.t1 Q9CR58 66.78 295 7.819999999999999e-146 414.0 sp|Q9CR58|KMCP1_MOUSE Kidney mitochondrial carrier protein 1 OS=Mus musculus OX=10090 GN=Slc25a30 PE=1 SV=1 KMCP1_MOUSE reviewed Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30) Mus musculus (Mouse) GO:0005452; GO:0005739; GO:0005743; GO:0015698; GO:0022857 inorganic anion transport [GO:0015698] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857] g13212.t1 Q16594 53.476 187 2.69e-65 207.0 sp|Q16594|TAF9_HUMAN Transcription initiation factor TFIID subunit 9 OS=Homo sapiens OX=9606 GN=TAF9 PE=1 SV=1 TAF9_HUMAN reviewed Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Homo sapiens (Human) GO:0000124; GO:0000492; GO:0000976; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006338; GO:0006355; GO:0006357; GO:0006974; GO:0016251; GO:0032435; GO:0033276; GO:0042789; GO:0043066; GO:0043484; GO:0045893; GO:0045944; GO:0046982; GO:0050821; GO:0051117; GO:0051123; GO:0060261; GO:0060760; GO:0070555; GO:0070742; GO:0070761; GO:0071339; GO:0140297; GO:1902166 box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein stabilization [GO:0050821]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-1 [GO:0070555]; RNA polymerase II preinitiation complex assembly [GO:0051123] MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g13213.t1 Q9EP97 37.436 195 7.440000000000001e-35 144.0 sp|Q9EP97|SENP3_MOUSE Sentrin-specific protease 3 OS=Mus musculus OX=10090 GN=Senp3 PE=1 SV=1 SENP3_MOUSE reviewed Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3) (Smt3-specific isopeptidase 1) (Smt3ip1) Mus musculus (Mouse) GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006508; GO:0008234; GO:0016604; GO:0016926; GO:0016929; GO:0071339; GO:2000042 negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; deSUMOylase activity [GO:0016929] g13214.t1 B5DF89 78.039 765 0.0 1248.0 sp|B5DF89|CUL3_RAT Cullin-3 OS=Rattus norvegicus OX=10116 GN=Cul3 PE=1 SV=2 CUL3_RAT reviewed Cullin-3 Rattus norvegicus (Rat) GO:0000122; GO:0000209; GO:0000278; GO:0000902; GO:0000922; GO:0001701; GO:0001822; GO:0001831; GO:0005112; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005886; GO:0006357; GO:0006366; GO:0006368; GO:0006511; GO:0006513; GO:0006515; GO:0006888; GO:0006954; GO:0006979; GO:0007080; GO:0007229; GO:0007369; GO:0010467; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030163; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031463; GO:0031625; GO:0031648; GO:0031669; GO:0032467; GO:0032480; GO:0032481; GO:0032869; GO:0034198; GO:0034599; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0060337; GO:0061630; GO:0070294; GO:0070936; GO:0071230; GO:0071630; GO:0072576; GO:0072686; GO:0098794; GO:0098978; GO:0140252; GO:0160072; GO:0160240; GO:1900076; GO:1901992; GO:1904262; GO:1904263 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon production [GO:0032480]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of type I interferon production [GO:0032481]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation protein catabolic process at postsynapse [GO:0140252]; renal sodium ion absorption [GO:0070294]; response to oxidative stress [GO:0006979]; RNA polymerase II transcription initiation surveillance [GO:0160240]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]; trophectodermal cellular morphogenesis [GO:0001831]; type I interferon-mediated signaling pathway [GO:0060337]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] g13215.t1 Q96RQ3 59.167 720 0.0 875.0 sp|Q96RQ3|MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC1 PE=1 SV=3 MCCA_HUMAN reviewed Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha) Homo sapiens (Human) GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202 biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552] cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485] g13216.t1 Q0VA42 32.08 399 1.21e-56 202.0 sp|Q0VA42|MINY4_XENTR Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 OS=Xenopus tropicalis OX=8364 GN=mindy4 PE=2 SV=1 g13217.t1 Q9NYR8 40.728 302 7.93e-53 178.0 sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1 RDH8_HUMAN reviewed Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2) Homo sapiens (Human) GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0042572; GO:0052650 estrogen biosynthetic process [GO:0006703]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601] cytosol [GO:0005829]; plasma membrane [GO:0005886] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303] g13218.t1 Q9QXE5 38.661 463 2.21e-95 301.0 sp|Q9QXE5|TSSP_MOUSE Thymus-specific serine protease OS=Mus musculus OX=10090 GN=Prss16 PE=2 SV=1 g13219.t1 Q5M8Y7 51.406 249 9.920000000000001e-75 231.0 sp|Q5M8Y7|MED4_XENTR Mediator of RNA polymerase II transcription subunit 4 OS=Xenopus tropicalis OX=8364 GN=med4 PE=2 SV=1 g13220.t1 O60573 68.75 224 1.48e-110 320.0 sp|O60573|IF4E2_HUMAN Eukaryotic translation initiation factor 4E type 2 OS=Homo sapiens OX=9606 GN=EIF4E2 PE=1 SV=1 IF4E2_HUMAN reviewed Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3) Homo sapiens (Human) GO:0000339; GO:0000340; GO:0000932; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016281; GO:0017148; GO:0031625; GO:0035278; GO:0045947; GO:0060339; GO:0072344; GO:0098808 miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; rescue of stalled ribosome [GO:0072344]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; P-body [GO:0000932] mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625] g13222.t1 Q6QBQ4 39.462 223 5.54e-46 159.0 sp|Q6QBQ4|PLS3_RAT Phospholipid scramblase 3 OS=Rattus norvegicus OX=10116 GN=Plscr3 PE=1 SV=1 PLS3_RAT reviewed Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3) Rattus norvegicus (Rat) GO:0000287; GO:0005509; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006915; GO:0007006; GO:0017121; GO:0017124; GO:0017128; GO:0032791; GO:0042593; GO:0042632; GO:0042981; GO:0045340; GO:0048306; GO:0071222; GO:0090199 apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; mitochondrial membrane organization [GO:0007006]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124] g13231.t1 Q6P3Z3 48.344 151 9.989999999999999e-41 146.0 sp|Q6P3Z3|THAP4_MOUSE Peroxynitrite isomerase THAP4 OS=Mus musculus OX=10090 GN=Thap4 PE=1 SV=1 THAP4_MOUSE reviewed Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric nitrobindin) (Nb(III)) (THAP domain-containing protein 4) Mus musculus (Mouse) GO:0003677; GO:0005654; GO:0005829; GO:0006570; GO:0008270; GO:0020037; GO:0042126; GO:0042802; GO:0062213; GO:0070026 nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570] cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270] g13232.t1 Q6P3Z3 42.949 156 1.23e-35 132.0 sp|Q6P3Z3|THAP4_MOUSE Peroxynitrite isomerase THAP4 OS=Mus musculus OX=10090 GN=Thap4 PE=1 SV=1 THAP4_MOUSE reviewed Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric nitrobindin) (Nb(III)) (THAP domain-containing protein 4) Mus musculus (Mouse) GO:0003677; GO:0005654; GO:0005829; GO:0006570; GO:0008270; GO:0020037; GO:0042126; GO:0042802; GO:0062213; GO:0070026 nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570] cytosol [GO:0005829]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270] g13233.t1 O73787 53.077 910 0.0 906.0 sp|O73787|GCP3_XENLA Gamma-tubulin complex component 3 homolog OS=Xenopus laevis OX=8355 GN=tubgcp3 PE=1 SV=1 g13234.t1 Q9Y2G3 50.226 1107 0.0 1069.0 sp|Q9Y2G3|AT11B_HUMAN Phospholipid-transporting ATPase IF OS=Homo sapiens OX=9606 GN=ATP11B PE=1 SV=2 AT11B_HUMAN reviewed Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005794; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090556; GO:0140326; GO:1990531 aminophospholipid transport [GO:0015917]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; phospholipid translocation [GO:0045332] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; monoatomic ion transmembrane transporter activity [GO:0015075]; phosphatidylserine floppase activity [GO:0090556] g13234.t2 Q9Y2G3 49.777 1123 0.0 1070.0 sp|Q9Y2G3|AT11B_HUMAN Phospholipid-transporting ATPase IF OS=Homo sapiens OX=9606 GN=ATP11B PE=1 SV=2 AT11B_HUMAN reviewed Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B) Homo sapiens (Human) GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005794; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090556; GO:0140326; GO:1990531 aminophospholipid transport [GO:0015917]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; phospholipid translocation [GO:0045332] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; monoatomic ion transmembrane transporter activity [GO:0015075]; phosphatidylserine floppase activity [GO:0090556] g13236.t1 Q6Q2B2 48.101 316 5.31e-84 268.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13236.t1 Q6Q2B2 33.577 274 9.05e-32 129.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13236.t2 Q6Q2B2 48.101 316 6.2e-84 267.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13236.t2 Q6Q2B2 33.7 273 7.210000000000001e-32 129.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13236.t3 Q6Q2B2 43.019 265 5.84e-50 180.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13236.t3 Q6Q2B2 33.577 274 1.9300000000000002e-31 129.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13236.t4 Q6Q2B2 42.238 277 6.75e-50 180.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13236.t4 Q6Q2B2 33.216 283 2.42e-31 128.0 sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1 g13239.t1 Q9P2H3 61.799 767 0.0 1015.0 sp|Q9P2H3|IFT80_HUMAN Intraflagellar transport protein 80 homolog OS=Homo sapiens OX=9606 GN=IFT80 PE=1 SV=3 IFT80_HUMAN reviewed Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56) Homo sapiens (Human) GO:0001649; GO:0001958; GO:0003418; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0007163; GO:0007224; GO:0007249; GO:0008543; GO:0010467; GO:0010498; GO:0010839; GO:0016567; GO:0021510; GO:0030316; GO:0030991; GO:0030992; GO:0033687; GO:0035264; GO:0035567; GO:0035630; GO:0035720; GO:0036064; GO:0043491; GO:0043616; GO:0044691; GO:0048863; GO:0050821; GO:0060173; GO:0060271; GO:0061975; GO:0071895; GO:0072089; GO:0097500; GO:0097542; GO:0097731; GO:1902140; GO:1905515; GO:1990079; GO:2000051 apoptotic process [GO:0006915]; articular cartilage development [GO:0061975]; bone mineralization involved in bone maturation [GO:0035630]; canonical NF-kappaB signal transduction [GO:0007249]; cartilage homeostasis [GO:1990079]; cilium assembly [GO:0060271]; endochondral ossification [GO:0001958]; establishment or maintenance of cell polarity [GO:0007163]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; intraciliary anterograde transport [GO:0035720]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; odontoblast differentiation [GO:0071895]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; receptor localization to non-motile cilium [GO:0097500]; response to inositol [GO:1902140]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; tooth eruption [GO:0044691] 9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; intraciliary transport particle B [GO:0030992] g13240.t1 Q96LI9 45.489 266 3.06e-84 263.0 sp|Q96LI9|CX058_HUMAN Uncharacterized protein CXorf58 OS=Homo sapiens OX=9606 GN=CXorf58 PE=1 SV=2 g13241.t1 Q5RF70 42.784 194 5.46e-38 136.0 sp|Q5RF70|ZN501_PONAB Zinc finger protein 501 OS=Pongo abelii OX=9601 GN=ZNF501 PE=2 SV=3 g13241.t1 Q5RF70 38.5 200 5.35e-32 120.0 sp|Q5RF70|ZN501_PONAB Zinc finger protein 501 OS=Pongo abelii OX=9601 GN=ZNF501 PE=2 SV=3 g13241.t1 Q5RF70 44.275 131 1.02e-25 104.0 sp|Q5RF70|ZN501_PONAB Zinc finger protein 501 OS=Pongo abelii OX=9601 GN=ZNF501 PE=2 SV=3 g13241.t1 Q5RF70 43.2 125 4.8799999999999994e-24 99.8 sp|Q5RF70|ZN501_PONAB Zinc finger protein 501 OS=Pongo abelii OX=9601 GN=ZNF501 PE=2 SV=3 g13242.t1 A5PJZ2 45.82 323 3.7199999999999997e-93 285.0 sp|A5PJZ2|PPM1L_BOVIN Protein phosphatase 1L OS=Bos taurus OX=9913 GN=PPM1L PE=2 SV=1 PPM1L_BOVIN reviewed Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon) Bos taurus (Bovine) GO:0004722; GO:0007165; GO:0016020; GO:0046872 signal transduction [GO:0007165] membrane [GO:0016020] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g13243.t1 Q6AYT0 41.994 331 1.2199999999999999e-82 256.0 sp|Q6AYT0|QOR_RAT Quinone oxidoreductase OS=Rattus norvegicus OX=10116 GN=Cryz PE=2 SV=1 QOR_RAT reviewed Zeta-crystallin (NADPH:quinone reductase) (Quinone oxidoreductase) (EC 1.6.5.5) Rattus norvegicus (Rat) GO:0003730; GO:0003960; GO:0005829; GO:0008270; GO:0042178; GO:0042802; GO:0048255; GO:0051289; GO:0070402 mRNA stabilization [GO:0048255]; protein homotetramerization [GO:0051289]; xenobiotic catabolic process [GO:0042178] cytosol [GO:0005829] identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; quinone reductase (NADPH) activity [GO:0003960]; zinc ion binding [GO:0008270] g13244.t1 Q6AYT0 41.088 331 2.43e-83 258.0 sp|Q6AYT0|QOR_RAT Quinone oxidoreductase OS=Rattus norvegicus OX=10116 GN=Cryz PE=2 SV=1 QOR_RAT reviewed Zeta-crystallin (NADPH:quinone reductase) (Quinone oxidoreductase) (EC 1.6.5.5) Rattus norvegicus (Rat) GO:0003730; GO:0003960; GO:0005829; GO:0008270; GO:0042178; GO:0042802; GO:0048255; GO:0051289; GO:0070402 mRNA stabilization [GO:0048255]; protein homotetramerization [GO:0051289]; xenobiotic catabolic process [GO:0042178] cytosol [GO:0005829] identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; quinone reductase (NADPH) activity [GO:0003960]; zinc ion binding [GO:0008270] g13246.t1 Q8C0W1 47.706 327 2.47e-87 286.0 sp|Q8C0W1|ANMY1_MOUSE Ankyrin repeat and MYND domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankmy1 PE=1 SV=1 g13247.t1 Q9P2S6 31.65 515 9.620000000000001e-72 250.0 sp|Q9P2S6|ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKMY1 PE=1 SV=2 g13248.t1 P23352 31.355 657 9.5e-90 297.0 sp|P23352|KALM_HUMAN Anosmin-1 OS=Homo sapiens OX=9606 GN=ANOS1 PE=1 SV=3 KALM_HUMAN reviewed Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein) Homo sapiens (Human) GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0009986; GO:0030182; GO:0031012 axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] g13248.t2 P23352 31.882 643 1.8399999999999999e-91 301.0 sp|P23352|KALM_HUMAN Anosmin-1 OS=Homo sapiens OX=9606 GN=ANOS1 PE=1 SV=3 KALM_HUMAN reviewed Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein) Homo sapiens (Human) GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0009986; GO:0030182; GO:0031012 axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] g13249.t1 P34148 58.763 194 3.27e-83 248.0 sp|P34148|RACB_DICDI Rho-related protein racB OS=Dictyostelium discoideum OX=44689 GN=racB PE=1 SV=1 g13250.t1 Q8IXM2 48.521 169 1.6999999999999998e-42 143.0 sp|Q8IXM2|BAP18_HUMAN BPTF-associated chromatin complex component 1 OS=Homo sapiens OX=9606 GN=BACC1 PE=1 SV=1 BAP18_HUMAN reviewed BPTF-associated chromatin complex component 1 (BPTF-associated protein of 18 kDa) (Chromatin complexes subunit BAP18) Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0016589; GO:0042802; GO:0071339 chromatin organization [GO:0006325] cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589] DNA binding [GO:0003677]; identical protein binding [GO:0042802] g13251.t1 Q9JJ78 50.865 289 3.5e-93 282.0 sp|Q9JJ78|TOPK_MOUSE Lymphokine-activated killer T-cell-originated protein kinase OS=Mus musculus OX=10090 GN=Pbk PE=1 SV=1 g13252.t1 Q9DC37 57.576 429 0.0 520.0 sp|Q9DC37|MFSD1_MOUSE Lysosomal dipeptide transporter MFSD1 OS=Mus musculus OX=10090 GN=Mfsd1 PE=1 SV=1 MFSD1_MOUSE reviewed Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) Mus musculus (Mouse) GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178 dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821] lysosomal membrane [GO:0005765]; lysosome [GO:0005764] dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803] g13253.t1 P51817 61.468 327 3.3e-157 447.0 sp|P51817|PRKX_HUMAN cAMP-dependent protein kinase catalytic subunit PRKX OS=Homo sapiens OX=9606 GN=PRKX PE=1 SV=1 PRKX_HUMAN reviewed cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005952; GO:0007155; GO:0007189; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:0106310; GO:2000696 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310] g13254.t1 Q5R9E1 70.033 307 9.439999999999999e-159 449.0 sp|Q5R9E1|HMGCL_PONAB Hydroxymethylglutaryl-CoA lyase, mitochondrial OS=Pongo abelii OX=9601 GN=HMGCL PE=2 SV=1 HMGCL_PONAB reviewed Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004419; GO:0005759; GO:0005777; GO:0006552; GO:0046872; GO:0046951 ketone body biosynthetic process [GO:0046951]; L-leucine catabolic process [GO:0006552] mitochondrial matrix [GO:0005759]; peroxisome [GO:0005777] hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872] g13255.t1 P97479 62.691 2230 0.0 2903.0 sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2 g13256.t1 Q8BTM8 28.263 1111 3.5700000000000004e-97 343.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 30.54 537 2.92e-58 224.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 28.045 624 5.74e-55 213.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 26.338 710 9.95e-50 197.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 27.232 672 1.69e-48 193.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 26.73 636 1.21e-46 187.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 25.263 665 1.0400000000000001e-43 177.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 24.852 676 1.21e-39 164.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 24.846 648 1.5400000000000002e-37 157.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t1 Q8BTM8 27.845 413 2.6100000000000003e-35 150.0 sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5 FLNA_MOUSE reviewed Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) Mus musculus (Mouse) GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016479; GO:0019900; GO:0021943; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032231; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0044877; GO:0045022; GO:0045184; GO:0045216; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0071526; GO:0072659; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] g13256.t2 O75369 31.443 582 9.6e-64 237.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 29.224 657 4.04e-59 223.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 30.055 549 1.13e-58 222.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 25.26 768 1.23e-51 200.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 27.216 643 1.59e-50 197.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 26.705 689 3.31e-50 196.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 26.73 636 8.75e-48 188.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 25.476 683 2.3000000000000003e-43 174.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t2 O75369 26.415 636 1.08e-39 163.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13256.t3 O75369 42.128 235 1.26e-55 197.0 sp|O75369|FLNB_HUMAN Filamin-B OS=Homo sapiens OX=9606 GN=FLNB PE=1 SV=2 g13257.t1 Q2KMM2 64.138 145 4.51e-69 207.0 sp|Q2KMM2|TPPC1_RAT Trafficking protein particle complex subunit 1 OS=Rattus norvegicus OX=10116 GN=Trappc1 PE=2 SV=1 g13261.t1 Q91883 42.952 603 3.58e-168 500.0 sp|Q91883|BIP_XENLA Endoplasmic reticulum chaperone BiP OS=Xenopus laevis OX=8355 GN=hspa5 PE=2 SV=1 BIP_XENLA reviewed Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) Xenopus laevis (African clawed frog) GO:0005524; GO:0005634; GO:0005737; GO:0005788; GO:0016020; GO:0016887; GO:0030182; GO:0030968; GO:0031072; GO:0031333; GO:0034663; GO:0036503; GO:0042026; GO:0044183; GO:0061351; GO:0140662; GO:1903895 endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182]; protein refolding [GO:0042026] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183] g13262.t1 Q9CX98 38.272 486 4.27e-114 350.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g13263.t1 Q5HZA9 31.492 181 3.83e-25 100.0 sp|Q5HZA9|T126A_RAT Transmembrane protein 126A OS=Rattus norvegicus OX=10116 GN=Tmem126a PE=2 SV=1 g13264.t1 A0A8C0TYJ0 55.589 1011 0.0 992.0 sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1 DLG1_CANLF reviewed Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134 actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060] kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325] g13264.t2 A0A8C0TYJ0 56.313 998 0.0 1001.0 sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1 DLG1_CANLF reviewed Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134 actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060] kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325] g13267.t1 B7P877 74.648 142 8.42e-80 236.0 sp|B7P877|NCBP2_IXOSC Nuclear cap-binding protein subunit 2 OS=Ixodes scapularis OX=6945 GN=Cbp20 PE=3 SV=1 g13268.t1 Q641W3 31.928 332 2.61e-42 164.0 sp|Q641W3|NUFP1_RAT FMR1-interacting protein NUFIP1 OS=Rattus norvegicus OX=10116 GN=Nufip1 PE=1 SV=1 NUFP1_RAT reviewed FMR1-interacting protein NUFIP1 (Nuclear FMRP-interacting protein 1) Rattus norvegicus (Rat) GO:0000492; GO:0001650; GO:0003723; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0008023; GO:0008270; GO:0016363; GO:0030515; GO:0030674; GO:0032991; GO:0042802; GO:0045202; GO:0045944; GO:0048786; GO:0051117; GO:0070761 box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944] fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transcription elongation factor complex [GO:0008023] ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; zinc ion binding [GO:0008270] g13268.t2 Q641W3 31.928 332 2.6999999999999997e-42 164.0 sp|Q641W3|NUFP1_RAT FMR1-interacting protein NUFIP1 OS=Rattus norvegicus OX=10116 GN=Nufip1 PE=1 SV=1 NUFP1_RAT reviewed FMR1-interacting protein NUFIP1 (Nuclear FMRP-interacting protein 1) Rattus norvegicus (Rat) GO:0000492; GO:0001650; GO:0003723; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0008023; GO:0008270; GO:0016363; GO:0030515; GO:0030674; GO:0032991; GO:0042802; GO:0045202; GO:0045944; GO:0048786; GO:0051117; GO:0070761 box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944] fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transcription elongation factor complex [GO:0008023] ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; zinc ion binding [GO:0008270] g13271.t1 Q9D099 36.94 268 1.22e-61 199.0 sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1 ACER3_MOUSE reviewed Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016020; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602 ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020] calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] g13272.t1 Q9D0B5 45.283 106 3.8700000000000004e-21 88.6 sp|Q9D0B5|TSTD3_MOUSE Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tstd3 PE=1 SV=1 g13274.t1 Q7SZS2 53.161 348 4.74e-135 391.0 sp|Q7SZS2|PTER_XENLA N-acetyltaurine hydrolase OS=Xenopus laevis OX=8355 GN=pter PE=2 SV=1 g13276.t1 Q0D4Z6 30.545 550 1.74e-52 193.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g13277.t1 Q22460 32.472 271 2.33e-48 164.0 sp|Q22460|BCA1_CAEEL Beta carbonic anhydrase 1 OS=Caenorhabditis elegans OX=6239 GN=bca-1 PE=3 SV=1 g13278.t1 P51842 39.888 1068 0.0 716.0 sp|P51842|GUC2F_RAT Retinal guanylyl cyclase 2 OS=Rattus norvegicus OX=10116 GN=Gucy2f PE=1 SV=1 GUC2F_RAT reviewed Retinal guanylyl cyclase 2 (RETGC-2) (EC 4.6.1.2) (Guanylate cyclase 2F, retinal) (Guanylate cyclase F) (GC-F) (Rod outer segment membrane guanylate cyclase 2) (ROS-GC2) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0019934; GO:0042802; GO:0044877; GO:0050908; GO:0120200 cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; receptor guanylyl cyclase signaling pathway [GO:0007168] plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877] g13285.t1 P51589 38.972 467 2.23e-90 288.0 sp|P51589|CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens OX=9606 GN=CYP2J2 PE=1 SV=2 CP2J2_HUMAN reviewed Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301 epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate 5,6-epoxygenase activity [GO:0106301]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g13286.t1 O54750 32.99 388 2.1e-64 217.0 sp|O54750|CP2J6_MOUSE Cytochrome P450 2J6 OS=Mus musculus OX=10090 GN=Cyp2j6 PE=2 SV=2 CP2J6_MOUSE reviewed Cytochrome P450 2J6 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ6) Mus musculus (Mouse) GO:0001523; GO:0003958; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0007565; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0032760; GO:0032966; GO:0035359; GO:0043651; GO:0045722; GO:0071614; GO:1903055 epoxygenase P450 pathway [GO:0019373]; female pregnancy [GO:0007565]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; organic acid metabolic process [GO:0006082]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of tumor necrosis factor production [GO:0032760]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g13287.t1 F1R332 26.814 317 9.86e-25 107.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g13288.t1 Q3KTM2 33.072 511 1.68e-98 313.0 sp|Q3KTM2|GDPD5_CHICK Glycerophosphodiester phosphodiesterase domain-containing protein 5 OS=Gallus gallus OX=9031 GN=GDPD5 PE=1 SV=1 GDPD5_CHICK reviewed Glycerophosphodiester phosphodiesterase domain-containing protein 5 (Glycerophosphocholine phosphodiesterase GDPD5) (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 2) (Phosphoinositide phospholipase C GDPD5) (EC 3.1.4.11) Gallus gallus (Chicken) GO:0004435; GO:0005886; GO:0006629; GO:0007399; GO:0008889; GO:0012505; GO:0030426; GO:0045666; GO:0047389; GO:0048471 lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] endomembrane system [GO:0012505]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] glycerophosphocholine phosphodiesterase activity [GO:0047389]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g13289.t1 Q8VEL0 53.555 211 7.11e-77 233.0 sp|Q8VEL0|MSPD1_MOUSE Motile sperm domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mospd1 PE=1 SV=1 MSPD1_MOUSE reviewed Motile sperm domain-containing protein 1 Mus musculus (Mouse) GO:0000122; GO:0000139; GO:0005634; GO:0005737; GO:0005789; GO:0030154; GO:0045944; GO:0048471 cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] g13290.t1 Q96P53 58.897 399 0.0 525.0 sp|Q96P53|WDFY2_HUMAN WD repeat and FYVE domain-containing protein 2 OS=Homo sapiens OX=9606 GN=WDFY2 PE=1 SV=2 WDFY2_HUMAN reviewed WD repeat and FYVE domain-containing protein 2 (Propeller-FYVE protein) (Prof) (WD40- and FYVE domain-containing protein 2) (Zinc finger FYVE domain-containing protein 22) Homo sapiens (Human) GO:0001934; GO:0005769; GO:0008270; GO:0031982; GO:0045600 positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934] early endosome [GO:0005769]; vesicle [GO:0031982] zinc ion binding [GO:0008270] g13291.t1 O43704 33.688 282 3.95e-46 160.0 sp|O43704|ST1B1_HUMAN Sulfotransferase 1B1 OS=Homo sapiens OX=9606 GN=SULT1B1 PE=1 SV=2 ST1B1_HUMAN reviewed Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g13293.t1 Q8R066 40.94 149 1.0099999999999999e-24 106.0 sp|Q8R066|C1QT4_MOUSE Complement C1q tumor necrosis factor-related protein 4 OS=Mus musculus OX=10090 GN=C1qtnf4 PE=1 SV=1 g13293.t2 Q8R066 40.94 149 2.6599999999999998e-24 105.0 sp|Q8R066|C1QT4_MOUSE Complement C1q tumor necrosis factor-related protein 4 OS=Mus musculus OX=10090 GN=C1qtnf4 PE=1 SV=1 g13295.t1 Q8R066 42.336 137 1.4000000000000002e-21 99.4 sp|Q8R066|C1QT4_MOUSE Complement C1q tumor necrosis factor-related protein 4 OS=Mus musculus OX=10090 GN=C1qtnf4 PE=1 SV=1 g13296.t1 P13280 52.071 338 5.91e-121 355.0 sp|P13280|GLYG_RABIT Glycogenin-1 OS=Oryctolagus cuniculus OX=9986 GN=GYG1 PE=1 SV=3 g13297.t1 Q90600 37.095 833 1.92e-155 484.0 sp|Q90600|RB_CHICK Retinoblastoma-associated protein OS=Gallus gallus OX=9031 GN=RB1 PE=1 SV=1 g13298.t1 Q9DAN9 37.857 140 4.3400000000000003e-26 103.0 sp|Q9DAN9|CF97D_MOUSE Sperm axonemal maintenance protein CFAP97D1 OS=Mus musculus OX=10090 GN=Cfap97d1 PE=2 SV=1 g13299.t1 P46023 29.707 478 1.52e-54 206.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g13299.t2 Q90XD2 59.064 342 5.37e-136 406.0 sp|Q90XD2|SPEB_CHICK Agmatinase, mitochondrial OS=Gallus gallus OX=9031 GN=AGMAT PE=2 SV=1 g13299.t3 Q90XD2 59.064 342 1.55e-135 406.0 sp|Q90XD2|SPEB_CHICK Agmatinase, mitochondrial OS=Gallus gallus OX=9031 GN=AGMAT PE=2 SV=1 g13301.t1 F1P065 56.92 513 0.0 615.0 sp|F1P065|FARP1_CHICK FERM, ARHGEF and pleckstrin domain-containing protein 1 OS=Gallus gallus OX=9031 GN=FARP1 PE=1 SV=2 g13301.t2 F1LYQ8 55.288 539 0.0 629.0 sp|F1LYQ8|FARP1_RAT FERM, ARHGEF and pleckstrin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Farp1 PE=1 SV=2 FARP1_RAT reviewed FERM, ARHGEF and pleckstrin domain-containing protein 1 (FERM, RhoGEF and pleckstrin domain-containing protein 1) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0007167; GO:0007416; GO:0008092; GO:0009898; GO:0016601; GO:0030175; GO:0030425; GO:0031267; GO:0043197; GO:0048813; GO:0098890; GO:0098942; GO:0098974; GO:0098978; GO:1904395; GO:1905606 dendrite morphogenesis [GO:0048813]; enzyme-linked receptor protein signaling pathway [GO:0007167]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978] cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g13302.t1 Q6ZUT3 52.229 314 2.1700000000000001e-103 350.0 sp|Q6ZUT3|FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens OX=9606 GN=FRMD7 PE=1 SV=1 FRMD7_HUMAN reviewed FERM domain-containing protein 7 Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0007399; GO:0010592; GO:0010975; GO:0030426; GO:0043005; GO:0043025; GO:0051057; GO:0051497 negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975] cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g13302.t2 Q6ZUT3 52.215 316 1.51e-102 348.0 sp|Q6ZUT3|FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens OX=9606 GN=FRMD7 PE=1 SV=1 FRMD7_HUMAN reviewed FERM domain-containing protein 7 Homo sapiens (Human) GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0007399; GO:0010592; GO:0010975; GO:0030426; GO:0043005; GO:0043025; GO:0051057; GO:0051497 negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975] cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] g13303.t1 Q9D8Z1 44.658 365 5.58e-100 303.0 sp|Q9D8Z1|ASCC1_MOUSE Activating signal cointegrator 1 complex subunit 1 OS=Mus musculus OX=10090 GN=Ascc1 PE=1 SV=1 g13307.t1 Q0IP28 28.769 577 3.37e-55 206.0 sp|Q0IP28|LAC25_ORYSJ Laccase-25 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC25 PE=3 SV=1 LAC25_ORYSJ reviewed Laccase-25 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 25) (Diphenol oxidase 25) (Urishiol oxidase 25) Oryza sativa subsp. japonica (Rice) GO:0005507; GO:0016491; GO:0046274; GO:0048046; GO:0052716 lignin catabolic process [GO:0046274] apoplast [GO:0048046] copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; oxidoreductase activity [GO:0016491] g13307.t1 Q0IP28 27.022 581 1.73e-51 195.0 sp|Q0IP28|LAC25_ORYSJ Laccase-25 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC25 PE=3 SV=1 LAC25_ORYSJ reviewed Laccase-25 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 25) (Diphenol oxidase 25) (Urishiol oxidase 25) Oryza sativa subsp. japonica (Rice) GO:0005507; GO:0016491; GO:0046274; GO:0048046; GO:0052716 lignin catabolic process [GO:0046274] apoplast [GO:0048046] copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; oxidoreductase activity [GO:0016491] g13308.t1 S8FIE4 34.515 536 6.72e-70 240.0 sp|S8FIE4|LAC1_FOMSC Laccase-1 OS=Fomitopsis schrenkii OX=2126942 GN=LCC1 PE=1 SV=1 g13313.t1 Q6P5E4 51.745 1519 0.0 1556.0 sp|Q6P5E4|UGGG1_MOUSE UDP-glucose:glycoprotein glucosyltransferase 1 OS=Mus musculus OX=10090 GN=Uggt1 PE=1 SV=4 UGGG1_MOUSE reviewed UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1) Mus musculus (Mouse) GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0009306; GO:0018279; GO:0032991; GO:0051082 protein N-linked glycosylation via asparagine [GO:0018279]; protein secretion [GO:0009306] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991] UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] g13313.t2 Q6P5E4 51.715 1516 0.0 1556.0 sp|Q6P5E4|UGGG1_MOUSE UDP-glucose:glycoprotein glucosyltransferase 1 OS=Mus musculus OX=10090 GN=Uggt1 PE=1 SV=4 UGGG1_MOUSE reviewed UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1) Mus musculus (Mouse) GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0009306; GO:0018279; GO:0032991; GO:0051082 protein N-linked glycosylation via asparagine [GO:0018279]; protein secretion [GO:0009306] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991] UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] g13314.t1 Q5XGI5 64.238 302 1.42e-145 414.0 sp|Q5XGI5|WDR83_XENTR WD repeat domain-containing protein 83 OS=Xenopus tropicalis OX=8364 GN=wdr83 PE=2 SV=1 g13315.t1 Q8K245 39.961 518 1.0099999999999999e-106 348.0 sp|Q8K245|UVRAG_MOUSE UV radiation resistance-associated protein OS=Mus musculus OX=10090 GN=Uvrag PE=1 SV=2 UVRAG_MOUSE reviewed UV radiation resistance-associated protein Mus musculus (Mouse) GO:0000149; GO:0000323; GO:0000421; GO:0000775; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0010506; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035032; GO:0035493; GO:0036092; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0097352; GO:0097680 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; symbiont entry into host cell [GO:0046718] autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991] SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149] g13317.t1 Q925K9 43.258 178 1.16e-39 144.0 sp|Q925K9|TSSK6_MOUSE Testis-specific serine/threonine-protein kinase 6 OS=Mus musculus OX=10090 GN=Tssk6 PE=1 SV=1 g13318.t1 P49893 48.197 305 4.2999999999999995e-104 312.0 sp|P49893|WN11B_XENLA Protein Wnt-11b OS=Xenopus laevis OX=8355 GN=wnt11b PE=1 SV=2 g13319.t1 Q92035 41.693 319 1.02e-85 272.0 sp|Q92035|ACES_BUNFA Acetylcholinesterase OS=Bungarus fasciatus OX=8613 GN=ACHE PE=1 SV=2 g13320.t1 Q03311 49.286 140 2.44e-38 140.0 sp|Q03311|CHLE_MOUSE Cholinesterase OS=Mus musculus OX=10090 GN=Bche PE=1 SV=2 CHLE_MOUSE reviewed Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) Mus musculus (Mouse) GO:0003990; GO:0004104; GO:0005615; GO:0005641; GO:0005783; GO:0005788; GO:0005886; GO:0006581; GO:0007584; GO:0007612; GO:0008285; GO:0009410; GO:0014016; GO:0019695; GO:0033265; GO:0042802; GO:0043279; GO:0050805; GO:0051384; GO:0051593 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] acetylcholinesterase activity [GO:0003990]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; identical protein binding [GO:0042802] g13323.t1 Q8CI85 35.959 292 2.89e-45 161.0 sp|Q8CI85|CAH12_MOUSE Carbonic anhydrase 12 OS=Mus musculus OX=10090 GN=Ca12 PE=1 SV=1 CAH12_MOUSE reviewed Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) Mus musculus (Mouse) GO:0004089; GO:0005886; GO:0006885; GO:0008270; GO:0015670; GO:0016323; GO:0016324; GO:0055064 carbon dioxide transport [GO:0015670]; chloride ion homeostasis [GO:0055064]; regulation of pH [GO:0006885] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270] g13324.t1 Q92035 38.386 607 1.1000000000000001e-125 385.0 sp|Q92035|ACES_BUNFA Acetylcholinesterase OS=Bungarus fasciatus OX=8613 GN=ACHE PE=1 SV=2 g13325.t1 O62763 46.048 582 0.0 529.0 sp|O62763|ACES_FELCA Acetylcholinesterase OS=Felis catus OX=9685 GN=ACHE PE=3 SV=1 g13326.t1 Q6DC66 30.049 203 3.9500000000000003e-26 105.0 sp|Q6DC66|BOKA_DANRE Bcl-2-related ovarian killer protein homolog A OS=Danio rerio OX=7955 GN=boka PE=2 SV=1 BOKA_DANRE reviewed Bcl-2-related ovarian killer protein homolog A (zBok1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005741; GO:0006915; GO:0015267; GO:0043065 apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065] mitochondrial outer membrane [GO:0005741] channel activity [GO:0015267] g13327.t1 P61798 55.102 196 4.1200000000000006e-73 226.0 sp|P61798|APTX_CHICK Aprataxin (Fragment) OS=Gallus gallus OX=9031 GN=APTX PE=1 SV=1 APTX_CHICK reviewed Aprataxin (EC 3.6.1.71) (EC 3.6.1.72) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT) Gallus gallus (Chicken) GO:0000012; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0008270; GO:0030983; GO:0033699; GO:0120108; GO:1990165 single strand break repair [GO:0000012] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase activity [GO:0120108]; double-stranded RNA binding [GO:0003725]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g13328.t1 O15550 52.252 111 3.02e-29 113.0 sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2 KDM6A_HUMAN reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Homo sapiens (Human) GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g13329.t1 P61799 59.88 167 1.52e-68 214.0 sp|P61799|APTX_DANRE Aprataxin OS=Danio rerio OX=7955 GN=aptx PE=2 SV=1 APTX_DANRE reviewed Aprataxin (EC 3.6.1.71) (EC 3.6.1.72) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000012; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0008270; GO:0030983; GO:0033699; GO:0120108; GO:1990165 single strand break repair [GO:0000012] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase activity [GO:0120108]; double-stranded RNA binding [GO:0003725]; mismatched DNA binding [GO:0030983]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] g13330.t1 O15550 69.434 530 0.0 766.0 sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2 KDM6A_HUMAN reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Homo sapiens (Human) GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g13330.t1 O15550 67.537 268 6.37e-108 381.0 sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2 KDM6A_HUMAN reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Homo sapiens (Human) GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g13330.t2 O15550 69.434 530 0.0 766.0 sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2 KDM6A_HUMAN reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Homo sapiens (Human) GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g13330.t2 O15550 67.537 268 6e-108 381.0 sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2 KDM6A_HUMAN reviewed Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A) Homo sapiens (Human) GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g13331.t1 Q9CQ24 45.087 173 2.3e-56 179.0 sp|Q9CQ24|FBX36_MOUSE F-box only protein 36 OS=Mus musculus OX=10090 GN=Fbxo36 PE=1 SV=1 g13332.t1 P27393 51.708 644 3.3e-151 479.0 sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1 g13332.t1 P27393 43.325 397 1.7e-34 144.0 sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1 g13332.t1 P27393 38.612 461 2.95e-22 105.0 sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1 g13332.t1 P27393 40.153 391 6.6500000000000005e-22 104.0 sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1 g13332.t1 P27393 37.255 459 3.5e-21 102.0 sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1 g13333.t1 P17139 41.475 1220 2.59e-112 389.0 sp|P17139|CO4A1_CAEEL Collagen alpha-1(IV) chain OS=Caenorhabditis elegans OX=6239 GN=emb-9 PE=1 SV=5 CO4A1_CAEEL reviewed Collagen alpha-1(IV) chain Caenorhabditis elegans GO:0002119; GO:0005201; GO:0005587; GO:0005604; GO:0007517; GO:0009792; GO:0030020; GO:0030198; GO:0031012; GO:0048680; GO:0050714; GO:1904014 embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]; response to serotonin [GO:1904014] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] g13333.t1 P17139 39.553 1254 4.6999999999999995e-82 298.0 sp|P17139|CO4A1_CAEEL Collagen alpha-1(IV) chain OS=Caenorhabditis elegans OX=6239 GN=emb-9 PE=1 SV=5 CO4A1_CAEEL reviewed Collagen alpha-1(IV) chain Caenorhabditis elegans GO:0002119; GO:0005201; GO:0005587; GO:0005604; GO:0007517; GO:0009792; GO:0030020; GO:0030198; GO:0031012; GO:0048680; GO:0050714; GO:1904014 embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]; response to serotonin [GO:1904014] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] g13333.t1 P17139 38.205 958 1.75e-58 225.0 sp|P17139|CO4A1_CAEEL Collagen alpha-1(IV) chain OS=Caenorhabditis elegans OX=6239 GN=emb-9 PE=1 SV=5 CO4A1_CAEEL reviewed Collagen alpha-1(IV) chain Caenorhabditis elegans GO:0002119; GO:0005201; GO:0005587; GO:0005604; GO:0007517; GO:0009792; GO:0030020; GO:0030198; GO:0031012; GO:0048680; GO:0050714; GO:1904014 embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]; response to serotonin [GO:1904014] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] g13333.t1 P17139 37.386 765 1.81e-39 164.0 sp|P17139|CO4A1_CAEEL Collagen alpha-1(IV) chain OS=Caenorhabditis elegans OX=6239 GN=emb-9 PE=1 SV=5 CO4A1_CAEEL reviewed Collagen alpha-1(IV) chain Caenorhabditis elegans GO:0002119; GO:0005201; GO:0005587; GO:0005604; GO:0007517; GO:0009792; GO:0030020; GO:0030198; GO:0031012; GO:0048680; GO:0050714; GO:1904014 embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]; response to serotonin [GO:1904014] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] g13333.t1 P17139 40.417 527 5e-26 120.0 sp|P17139|CO4A1_CAEEL Collagen alpha-1(IV) chain OS=Caenorhabditis elegans OX=6239 GN=emb-9 PE=1 SV=5 CO4A1_CAEEL reviewed Collagen alpha-1(IV) chain Caenorhabditis elegans GO:0002119; GO:0005201; GO:0005587; GO:0005604; GO:0007517; GO:0009792; GO:0030020; GO:0030198; GO:0031012; GO:0048680; GO:0050714; GO:1904014 embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]; response to serotonin [GO:1904014] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] g13333.t1 P17139 39.388 490 5.0299999999999995e-25 117.0 sp|P17139|CO4A1_CAEEL Collagen alpha-1(IV) chain OS=Caenorhabditis elegans OX=6239 GN=emb-9 PE=1 SV=5 CO4A1_CAEEL reviewed Collagen alpha-1(IV) chain Caenorhabditis elegans GO:0002119; GO:0005201; GO:0005587; GO:0005604; GO:0007517; GO:0009792; GO:0030020; GO:0030198; GO:0031012; GO:0048680; GO:0050714; GO:1904014 embryo development ending in birth or egg hatching [GO:0009792]; extracellular matrix organization [GO:0030198]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein secretion [GO:0050714]; response to serotonin [GO:1904014] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] g13334.t1 P08120 41.979 1870 0.0 821.0 sp|P08120|CO4A1_DROME Collagen alpha-1(IV) chain OS=Drosophila melanogaster OX=7227 GN=Col4a1 PE=1 SV=3 g13335.t1 Q9QZ73 73.881 134 1.04e-71 218.0 sp|Q9QZ73|DCNL1_MOUSE DCN1-like protein 1 OS=Mus musculus OX=10090 GN=Dcun1d1 PE=1 SV=1 g13336.t1 Q5ZKU1 62.5 112 4.07e-47 154.0 sp|Q5ZKU1|DCNL1_CHICK DCN1-like protein 1 OS=Gallus gallus OX=9031 GN=DCUN1D1 PE=2 SV=1 g13339.t1 Q4V8F3 37.008 381 8.99e-59 196.0 sp|Q4V8F3|RHBL4_RAT Rhomboid-related protein 4 OS=Rattus norvegicus OX=10116 GN=Rhbdd1 PE=2 SV=1 RHBL4_RAT reviewed Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (rRHBDD1) (Rhomboid-like protein 4) Rattus norvegicus (Rat) GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0008233; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211 apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966] endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g13344.t1 Q8TEB9 56.41 78 3.94e-24 96.3 sp|Q8TEB9|RHBL4_HUMAN Rhomboid-related protein 4 OS=Homo sapiens OX=9606 GN=RHBDD1 PE=1 SV=1 RHBL4_HUMAN reviewed Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4) Homo sapiens (Human) GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211 apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966] endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] g13345.t1 Q92035 44.407 590 6.67e-171 503.0 sp|Q92035|ACES_BUNFA Acetylcholinesterase OS=Bungarus fasciatus OX=8613 GN=ACHE PE=1 SV=2 g13348.t1 P46023 33.74 492 7.85e-78 285.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g13349.t1 Q6PHY8 55.882 136 2.3899999999999997e-52 167.0 sp|Q6PHY8|SELTB_DANRE Thioredoxin reductase-like selenoprotein T1b OS=Danio rerio OX=7955 GN=selenot1b PE=2 SV=3 g13350.t1 E9Q286 29.348 368 2.85e-33 146.0 sp|E9Q286|ICE1_MOUSE Little elongation complex subunit 1 OS=Mus musculus OX=10090 GN=Ice1 PE=1 SV=1 g13351.t1 Q640R7 62.637 182 9.55e-76 228.0 sp|Q640R7|RAP1B_XENTR Ras-related protein Rap-1b OS=Xenopus tropicalis OX=8364 GN=rap1b PE=2 SV=1 g13352.t1 O60244 45.064 1489 0.0 1178.0 sp|O60244|MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2 MED14_HUMAN reviewed Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150) Homo sapiens (Human) GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] g13354.t1 Q9VUL9 38.83 188 1.17e-35 141.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g13355.t1 Q7ZX53 34.375 480 4.68e-88 281.0 sp|Q7ZX53|S22FL_XENLA Solute carrier family 22 member 15-like OS=Xenopus laevis OX=8355 GN=slc22a15b PE=2 SV=1 g13356.t1 Q8WW35 57.364 129 3.06e-51 162.0 sp|Q8WW35|DYT2B_HUMAN Dynein light chain Tctex-type protein 2B OS=Homo sapiens OX=9606 GN=DYNLT2B PE=1 SV=2 DYT2B_HUMAN reviewed Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2) Homo sapiens (Human) GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799 cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293] dynein intermediate chain binding [GO:0045505] g13358.t1 O15068 39.048 1114 0.0 753.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g13358.t2 O15068 38.687 1127 0.0 745.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g13358.t3 O15068 38.998 1118 0.0 753.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g13358.t4 O15068 39.421 1106 0.0 760.0 sp|O15068|MCF2L_HUMAN Guanine nucleotide exchange factor DBS OS=Homo sapiens OX=9606 GN=MCF2L PE=1 SV=2 g13360.t1 Q9VCA2 33.037 563 1.39e-86 282.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g13361.t1 Q9JHE4 36.158 354 4.2999999999999996e-67 222.0 sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2 G3ST1_MOUSE reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Mus musculus (Mouse) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020] galactosylceramide sulfotransferase activity [GO:0001733] g13362.t1 Q9VCA2 31.689 527 5.7e-75 250.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g13366.t1 P29241 32.812 256 5.5499999999999996e-42 150.0 sp|P29241|NADA_APLCA ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia californica OX=6500 PE=1 SV=1 g13367.t1 Q15937 45.255 137 1.46e-33 134.0 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13367.t1 Q15937 42.647 136 3.7200000000000003e-29 121.0 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13367.t1 Q15937 41.912 136 7.25e-28 117.0 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13367.t1 Q15937 41.912 136 1.11e-27 117.0 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13367.t1 Q15937 39.706 136 1.43e-27 117.0 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13367.t1 Q15937 43.902 123 6.590000000000001e-27 115.0 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13367.t1 Q15937 38.235 136 3.76e-24 107.0 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13367.t1 Q15937 40.541 111 1.92e-21 99.4 sp|Q15937|ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens OX=9606 GN=ZNF79 PE=1 SV=2 g13368.t1 Q8K2K6 56.977 172 2.05e-64 227.0 sp|Q8K2K6|AGFG1_MOUSE Arf-GAP domain and FG repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Agfg1 PE=1 SV=2 g13368.t2 P52594 39.646 396 6.25e-72 247.0 sp|P52594|AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2 AGFG1_HUMAN reviewed Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein) Homo sapiens (Human) GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0045109 acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643] DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g13369.t1 E9Q784 41.624 197 5.56e-33 144.0 sp|E9Q784|ZC3HD_MOUSE Zinc finger CCCH domain-containing protein 13 OS=Mus musculus OX=10090 GN=Zc3h13 PE=1 SV=1 ZC3HD_MOUSE reviewed Zinc finger CCCH domain-containing protein 13 Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0036396; GO:2000036 mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] zinc ion binding [GO:0008270] g13369.t2 E9Q784 41.624 197 5.47e-33 144.0 sp|E9Q784|ZC3HD_MOUSE Zinc finger CCCH domain-containing protein 13 OS=Mus musculus OX=10090 GN=Zc3h13 PE=1 SV=1 ZC3HD_MOUSE reviewed Zinc finger CCCH domain-containing protein 13 Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0036396; GO:2000036 mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] zinc ion binding [GO:0008270] g13370.t1 Q95VY2 39.106 179 1.75e-28 107.0 sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1 g13371.t1 Q8R0F5 67.532 154 6.53e-73 235.0 sp|Q8R0F5|RBMX2_MOUSE RNA-binding motif protein, X-linked 2 OS=Mus musculus OX=10090 GN=Rbmx2 PE=1 SV=1 g13372.t1 A4K526 52.83 106 1.27e-31 110.0 sp|A4K526|TM256_BUFGR Transmembrane protein 256 homolog OS=Bufo gargarizans OX=30331 PE=3 SV=1 g13373.t1 Q5ZK28 36.729 373 3.04e-50 177.0 sp|Q5ZK28|DPOD3_CHICK DNA polymerase delta subunit 3 OS=Gallus gallus OX=9031 GN=POLD3 PE=1 SV=2 DPOD3_CHICK reviewed DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66) Gallus gallus (Chicken) GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0043625; GO:0071897 DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260] cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654] g13375.t1 Q76LD0 34.204 421 2.2200000000000002e-66 222.0 sp|Q76LD0|CRDL1_RAT Chordin-like protein 1 OS=Rattus norvegicus OX=10116 GN=Chrdl1 PE=2 SV=2 CRDL1_RAT reviewed Chordin-like protein 1 (Kohjirin) (Neuralin-1) (Neurogenesin-1) (Ventroptin) Rattus norvegicus (Rat) GO:0000578; GO:0001503; GO:0001654; GO:0001709; GO:0005576; GO:0005886; GO:0030154; GO:0030182; GO:0030509; GO:0030514; GO:0036122; GO:0045202; GO:0048167; GO:0050431; GO:0060074; GO:0097113; GO:0098976 AMPA glutamate receptor clustering [GO:0097113]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; embryonic axis specification [GO:0000578]; excitatory chemical synaptic transmission [GO:0098976]; eye development [GO:0001654]; negative regulation of BMP signaling pathway [GO:0030514]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; regulation of synaptic plasticity [GO:0048167]; synapse maturation [GO:0060074] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202] BMP binding [GO:0036122]; transforming growth factor beta binding [GO:0050431] g13376.t1 O15440 42.753 683 0.0 572.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13377.t1 Q8N3Y7 39.08 261 8.19e-59 194.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g13378.t1 O15440 55.593 599 0.0 691.0 sp|O15440|MRP5_HUMAN ATP-binding cassette sub-family C member 5 OS=Homo sapiens OX=9606 GN=ABCC5 PE=1 SV=2 MRP5_HUMAN reviewed ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) Homo sapiens (Human) GO:0005524; GO:0005796; GO:0005886; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:0150104; GO:1901264; GO:1901505; GO:1990961 cAMP transport [GO:0070730]; carbohydrate derivative transport [GO:1901264]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] g13380.t1 O17482 23.554 726 6.290000000000001e-31 134.0 sp|O17482|TIM_DROVI Protein timeless OS=Drosophila virilis OX=7244 GN=tim PE=2 SV=1 g13381.t1 Q8TEB9 52.778 108 3.4700000000000003e-32 122.0 sp|Q8TEB9|RHBL4_HUMAN Rhomboid-related protein 4 OS=Homo sapiens OX=9606 GN=RHBDD1 PE=1 SV=1 RHBL4_HUMAN reviewed Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4) Homo sapiens (Human) GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211 apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966] endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] g4949.t1 A1DPK7 67.778 180 7.22e-87 255.0 sp|A1DPK7|ARC3A_XENLA Actin-related protein 2/3 complex subunit 3-A OS=Xenopus laevis OX=8355 GN=arpc3-a PE=1 SV=1 ARC3A_XENLA reviewed Actin-related protein 2/3 complex subunit 3-A Xenopus laevis (African clawed frog) GO:0003779; GO:0005634; GO:0005885; GO:0030833; GO:0034314; GO:0035861; GO:0042995 Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833] Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] actin binding [GO:0003779] g4950.t1 Q6ZM63 65.799 269 8.53e-134 383.0 sp|Q6ZM63|GPN3_DANRE GPN-loop GTPase 3 OS=Danio rerio OX=7955 GN=gpn3 PE=2 SV=2 g4951.t1 C0H8I2 38.477 499 6.61e-99 309.0 sp|C0H8I2|SETD6_SALSA N-lysine methyltransferase setd6 OS=Salmo salar OX=8030 GN=setd6 PE=2 SV=1 g4951.t2 C0H8I2 40.167 478 2.7599999999999998e-104 322.0 sp|C0H8I2|SETD6_SALSA N-lysine methyltransferase setd6 OS=Salmo salar OX=8030 GN=setd6 PE=2 SV=1 g4952.t1 Q6QEF8 38.73 488 1.6e-104 321.0 sp|Q6QEF8|CORO6_HUMAN Coronin-6 OS=Homo sapiens OX=9606 GN=CORO6 PE=1 SV=2 g4953.t1 Q05423 39.394 132 5.82e-28 103.0 sp|Q05423|FABP7_CHICK Fatty acid-binding protein, brain OS=Gallus gallus OX=9031 GN=FABP7 PE=2 SV=2 g4955.t1 Q5PXY7 34.058 138 9e-27 100.0 sp|Q5PXY7|RABP2_BOVIN Cellular retinoic acid-binding protein 2 OS=Bos taurus OX=9913 GN=CRABP2 PE=2 SV=3 g4956.t1 P13630 83.74 123 4.72e-70 209.0 sp|P13630|H2A_PARLI Histone H2A OS=Paracentrotus lividus OX=7656 PE=3 SV=2 g4957.t1 O14975 42.831 551 1.77e-151 452.0 sp|O14975|S27A2_HUMAN Long-chain fatty acid transport protein 2 OS=Homo sapiens OX=9606 GN=SLC27A2 PE=1 SV=2 S27A2_HUMAN reviewed Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Phytanate--CoA ligase) (EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase) (EC 6.2.1.7) (Very long-chain acyl-CoA synthetase) (VLACS) (VLCS) (EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase) Homo sapiens (Human) GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005778; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006635; GO:0006699; GO:0008206; GO:0019899; GO:0031957; GO:0033540; GO:0035579; GO:0042760; GO:0044539; GO:0046949; GO:0047676; GO:0047747; GO:0050197; GO:0070062; GO:0070251; GO:0097089 bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty-acyl-CoA biosynthetic process [GO:0046949]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g4958.t1 Q60HE3 76.056 213 9.99e-117 333.0 sp|Q60HE3|NDUS8_MACFA NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial OS=Macaca fascicularis OX=9541 GN=NDUFS8 PE=2 SV=1 g4959.t1 P43487 57.949 195 1.2199999999999999e-68 213.0 sp|P43487|RANG_HUMAN Ran-specific GTPase-activating protein OS=Homo sapiens OX=9606 GN=RANBP1 PE=1 SV=1 RANG_HUMAN reviewed Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1) Homo sapiens (Human) GO:0005092; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0006913; GO:0007165; GO:0031267; GO:0045296; GO:0046604 nucleocytoplasmic transport [GO:0006913]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634] cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g4960.t1 F6PHZ6 35.238 315 8.800000000000001e-59 199.0 sp|F6PHZ6|FKBP6_HORSE Inactive peptidyl-prolyl cis-trans isomerase FKBP6 OS=Equus caballus OX=9796 GN=FKBP6 PE=1 SV=2 FKBP6_HORSE reviewed Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36) Equus caballus (Horse) GO:0000795; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0051321; GO:0051879; GO:0141196 cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795] Hsp90 protein binding [GO:0051879] g4961.t1 Q0VH32 46.452 155 1.2300000000000001e-29 123.0 sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1 g4963.t1 Q8BPQ7 51.585 1136 0.0 1087.0 sp|Q8BPQ7|SGSM1_MOUSE Small G protein signaling modulator 1 OS=Mus musculus OX=10090 GN=Sgsm1 PE=1 SV=2 SGSM1_MOUSE reviewed Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2) Mus musculus (Mouse) GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0030659; GO:0031267; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g4963.t2 Q8BPQ7 51.313 1142 0.0 1080.0 sp|Q8BPQ7|SGSM1_MOUSE Small G protein signaling modulator 1 OS=Mus musculus OX=10090 GN=Sgsm1 PE=1 SV=2 SGSM1_MOUSE reviewed Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2) Mus musculus (Mouse) GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0030659; GO:0031267; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g4964.t1 P56655 36.364 473 3.86e-91 291.0 sp|P56655|CP238_MOUSE Cytochrome P450 2C38 OS=Mus musculus OX=10090 GN=Cyp2c38 PE=1 SV=2 g4966.t1 Q9X248 38.039 255 1.41e-46 159.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g4967.t1 Q5SV80 43.675 838 0.0 652.0 sp|Q5SV80|MYO19_MOUSE Unconventional myosin-XIX OS=Mus musculus OX=10090 GN=Myo19 PE=1 SV=1 MYO19_MOUSE reviewed Unconventional myosin-XIX (Myosin head domain-containing protein 1) Mus musculus (Mouse) GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006897; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0016887; GO:0032027; GO:0032465; GO:0034642; GO:0051015; GO:0060002; GO:0090140; GO:0160040 actin filament organization [GO:0007015]; endocytosis [GO:0006897]; mitochondrion migration along actin filament [GO:0034642]; mitocytosis [GO:0160040]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; plus-end directed microfilament motor activity [GO:0060002] g4968.t1 Q9D787 60.894 537 0.0 664.0 sp|Q9D787|PPIL2_MOUSE RING-type E3 ubiquitin-protein ligase PPIL2 OS=Mus musculus OX=10090 GN=Ppil2 PE=1 SV=2 PPIL2_MOUSE reviewed RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) Mus musculus (Mouse) GO:0000209; GO:0003755; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659 mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g4972.t1 Q6DJ48 33.067 375 1.1700000000000001e-65 215.0 sp|Q6DJ48|STN1_XENTR CST complex subunit STN1 OS=Xenopus tropicalis OX=8364 GN=stn1 PE=2 SV=1 STN1_XENTR reviewed CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000723; GO:0000781; GO:0005634; GO:0010833; GO:0016233; GO:0042162; GO:0043047; GO:1990879 telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833] chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; nucleus [GO:0005634] single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162] g4972.t2 Q6DJ48 33.067 375 1.1700000000000001e-65 215.0 sp|Q6DJ48|STN1_XENTR CST complex subunit STN1 OS=Xenopus tropicalis OX=8364 GN=stn1 PE=2 SV=1 STN1_XENTR reviewed CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000723; GO:0000781; GO:0005634; GO:0010833; GO:0016233; GO:0042162; GO:0043047; GO:1990879 telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833] chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; nucleus [GO:0005634] single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162] g4973.t1 Q69ZM6 39.723 1372 0.0 818.0 sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3 STK36_MOUSE reviewed Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog) Mus musculus (Mouse) GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005930; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310 axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222] g4973.t2 Q69ZM6 39.868 1367 0.0 825.0 sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3 STK36_MOUSE reviewed Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog) Mus musculus (Mouse) GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005930; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310 axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222] g4974.t1 Q2TBU3 64.228 246 5.08e-115 332.0 sp|Q2TBU3|GOSR1_BOVIN Golgi SNAP receptor complex member 1 OS=Bos taurus OX=9913 GN=GOSR1 PE=2 SV=1 GOSR1_BOVIN reviewed Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) Bos taurus (Bovine) GO:0000139; GO:0005484; GO:0005797; GO:0005801; GO:0006888; GO:0006906; GO:0015031; GO:0031201; GO:0048219 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; protein transport [GO:0015031]; vesicle fusion [GO:0006906] cis-Golgi network [GO:0005801]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484] g4976.t1 P20735 51.832 546 0.0 542.0 sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1 g4977.t1 P20735 53.073 537 0.0 554.0 sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1 g4977.t2 P20735 53.073 537 0.0 555.0 sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1 g4978.t1 Q2XWK0 53.184 534 0.0 552.0 sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1 g4979.t1 Q2XWK0 29.808 520 7.2099999999999995e-68 232.0 sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1 g4980.t1 Q5R7X9 69.039 281 6.0399999999999996e-142 403.0 sp|Q5R7X9|RAD1_PONAB Cell cycle checkpoint protein RAD1 OS=Pongo abelii OX=9601 GN=RAD1 PE=2 SV=1 g4981.t1 Q9DA08 70.548 292 3.81e-157 445.0 sp|Q9DA08|SGF29_MOUSE SAGA-associated factor 29 OS=Mus musculus OX=10090 GN=Sgf29 PE=1 SV=1 SGF29_MOUSE reviewed SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29) Mus musculus (Mouse) GO:0000122; GO:0000124; GO:0005634; GO:0006282; GO:0006355; GO:0006357; GO:0034976; GO:0043484; GO:0045815; GO:0045893; GO:0045995; GO:0051302; GO:0051726; GO:0070461; GO:0072686; GO:0140002; GO:0140003; GO:0140034; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; transcription initiation-coupled chromatin remodeling [GO:0045815] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] histone H3K36me3 reader activity [GO:0140003]; histone H3K4me3 reader activity [GO:0140002]; methylation-dependent protein binding [GO:0140034] g4981.t2 Q9DA08 68.439 301 1.47e-154 439.0 sp|Q9DA08|SGF29_MOUSE SAGA-associated factor 29 OS=Mus musculus OX=10090 GN=Sgf29 PE=1 SV=1 SGF29_MOUSE reviewed SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29) Mus musculus (Mouse) GO:0000122; GO:0000124; GO:0005634; GO:0006282; GO:0006355; GO:0006357; GO:0034976; GO:0043484; GO:0045815; GO:0045893; GO:0045995; GO:0051302; GO:0051726; GO:0070461; GO:0072686; GO:0140002; GO:0140003; GO:0140034; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; transcription initiation-coupled chromatin remodeling [GO:0045815] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] histone H3K36me3 reader activity [GO:0140003]; histone H3K4me3 reader activity [GO:0140002]; methylation-dependent protein binding [GO:0140034] g4982.t1 Q5ND56 35.955 267 4.53e-45 156.0 sp|Q5ND56|TLC3A_MOUSE TLC domain-containing protein 3A OS=Mus musculus OX=10090 GN=Tlcd3a PE=3 SV=1 g4983.t1 Q8BTK5 34.982 283 1.02e-47 187.0 sp|Q8BTK5|SMYD4_MOUSE Protein-lysine N-methyltransferase SMYD4 OS=Mus musculus OX=10090 GN=Smyd4 PE=2 SV=2 SMYD4_MOUSE reviewed Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0007507; GO:0008270; GO:0016279; GO:0032259; GO:0042826 heart development [GO:0007507]; methylation [GO:0032259] cytoplasm [GO:0005737]; nucleus [GO:0005634] histone deacetylase binding [GO:0042826]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270] g4983.t1 Q8BTK5 30.408 319 9.34e-27 121.0 sp|Q8BTK5|SMYD4_MOUSE Protein-lysine N-methyltransferase SMYD4 OS=Mus musculus OX=10090 GN=Smyd4 PE=2 SV=2 SMYD4_MOUSE reviewed Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0007507; GO:0008270; GO:0016279; GO:0032259; GO:0042826 heart development [GO:0007507]; methylation [GO:0032259] cytoplasm [GO:0005737]; nucleus [GO:0005634] histone deacetylase binding [GO:0042826]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270] g4984.t1 Q96AY4 59.519 1623 0.0 1941.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g4984.t2 Q96AY4 59.167 1560 0.0 1845.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g4985.t1 Q96AY4 50.584 257 6.87e-78 271.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g4987.t1 Q9PTE6 57.362 326 4.2099999999999996e-135 392.0 sp|Q9PTE6|TPST1_DANRE Protein-tyrosine sulfotransferase 1 OS=Danio rerio OX=7955 GN=tpst1 PE=2 SV=2 g4988.t1 Q1JQC1 30.586 461 5.55e-56 196.0 sp|Q1JQC1|MFSD1_BOVIN Lysosomal dipeptide transporter MFSD1 OS=Bos taurus OX=9913 GN=MFSD1 PE=2 SV=1 MFSD1_BOVIN reviewed Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) Bos taurus (Bovine) GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178 dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821] lysosomal membrane [GO:0005765]; lysosome [GO:0005764] dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803] g4992.t1 A4QNL8 38.605 430 9.77e-89 278.0 sp|A4QNL8|MRM3_XENTR rRNA methyltransferase 3, mitochondrial OS=Xenopus tropicalis OX=8364 GN=mrm3 PE=2 SV=1 MRM3_XENTR reviewed rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (RNA methyltransferase-like protein 1) (rRNA (guanosine-2'-O)-methyltransferase) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003723; GO:0005739; GO:0008650 mitochondrion [GO:0005739] RNA binding [GO:0003723]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650] g4993.t1 P53448 70.879 364 0.0 521.0 sp|P53448|ALDOC_CARAU Fructose-bisphosphate aldolase C OS=Carassius auratus OX=7957 GN=aldoc PE=2 SV=2 g4995.t1 D3ZAW2 47.545 387 2.69e-119 356.0 sp|D3ZAW2|PISD_RAT Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Rattus norvegicus OX=10116 GN=Pisd PE=1 SV=3 PISD_RAT reviewed Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain] Rattus norvegicus (Rat) GO:0004609; GO:0005634; GO:0005739; GO:0005743; GO:0005794; GO:0005811; GO:0005829; GO:0006646; GO:0010821; GO:0016540; GO:0035694; GO:0140042 lipid droplet formation [GO:0140042]; mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] phosphatidylserine decarboxylase activity [GO:0004609] g4995.t2 Q58DH2 52.733 311 4.95e-113 343.0 sp|Q58DH2|PISD_BOVIN Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Bos taurus OX=9913 GN=PISD PE=2 SV=1 PISD_BOVIN reviewed Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain] Bos taurus (Bovine) GO:0004609; GO:0005739; GO:0005743; GO:0005811; GO:0006646; GO:0010821; GO:0016540; GO:0035694; GO:0140042 lipid droplet formation [GO:0140042]; mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821] lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] phosphatidylserine decarboxylase activity [GO:0004609] g4997.t1 P29742 35.376 359 1.87e-66 231.0 sp|P29742|CLH_DROME Clathrin heavy chain OS=Drosophila melanogaster OX=7227 GN=Chc PE=1 SV=1 g4998.t1 A5D8M6 80.556 180 2.1499999999999997e-104 303.0 sp|A5D8M6|SBDS_XENLA Ribosome maturation protein SBDS OS=Xenopus laevis OX=8355 GN=sbds PE=2 SV=1 g5000.t1 Q60974 53.913 115 3.96e-30 130.0 sp|Q60974|NCOR1_MOUSE Nuclear receptor corepressor 1 OS=Mus musculus OX=10090 GN=Ncor1 PE=1 SV=1 NCOR1_MOUSE reviewed Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) (Retinoid X receptor-interacting protein 13) (RIP13) Mus musculus (Mouse) GO:0000118; GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0001701; GO:0002155; GO:0002361; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006325; GO:0006357; GO:0008284; GO:0008544; GO:0010467; GO:0010629; GO:0016922; GO:0017053; GO:0019904; GO:0021794; GO:0030331; GO:0032922; GO:0035033; GO:0040014; GO:0042632; GO:0042826; GO:0042974; GO:0042975; GO:0043565; GO:0045475; GO:0045820; GO:0045892; GO:0045922; GO:0046329; GO:0046965; GO:0046966; GO:0048471; GO:0050821; GO:0051225; GO:0051898; GO:0060318; GO:0060766; GO:0061436; GO:0061629; GO:0072686; GO:1902894; GO:1904017 CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; definitive erythrocyte differentiation [GO:0060318]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of gene expression [GO:0010629]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; protein stabilization [GO:0050821]; regulation of multicellular organism growth [GO:0040014]; regulation of thyroid hormone receptor signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]; thalamus development [GO:0021794] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] g5001.t1 Q4KKX4 53.493 501 3.46e-135 441.0 sp|Q4KKX4|NCOR1_XENTR Nuclear receptor corepressor 1 OS=Xenopus tropicalis OX=8364 GN=ncor1 PE=2 SV=1 g5001.t2 Q4KKX4 53.493 501 3.36e-135 441.0 sp|Q4KKX4|NCOR1_XENTR Nuclear receptor corepressor 1 OS=Xenopus tropicalis OX=8364 GN=ncor1 PE=2 SV=1 g5003.t1 Q9NXB0 37.353 340 4.02e-65 216.0 sp|Q9NXB0|MKS1_HUMAN Tectonic-like complex member MKS1 OS=Homo sapiens OX=9606 GN=MKS1 PE=1 SV=2 MKS1_HUMAN reviewed Tectonic-like complex member MKS1 (Meckel syndrome type 1 protein) Homo sapiens (Human) GO:0001843; GO:0003271; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0021904; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1905515; GO:1990403; GO:2000095 branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g5004.t1 O55230 46.894 322 1.92e-96 291.0 sp|O55230|RA51D_MOUSE DNA repair protein RAD51 homolog 4 OS=Mus musculus OX=10090 GN=Rad51d PE=1 SV=1 g5005.t1 Q9H0W9 52.98 302 3.39e-115 338.0 sp|Q9H0W9|CK054_HUMAN Ester hydrolase C11orf54 OS=Homo sapiens OX=9606 GN=C11orf54 PE=1 SV=1 g5007.t1 Q9VUL9 43.2 125 8e-31 120.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g5011.t1 Q8IVF4 67.644 4500 0.0 6358.0 sp|Q8IVF4|DYH10_HUMAN Dynein axonemal heavy chain 10 OS=Homo sapiens OX=9606 GN=DNAH10 PE=1 SV=4 DYH10_HUMAN reviewed Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10) Homo sapiens (Human) GO:0005524; GO:0005858; GO:0005874; GO:0008017; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729 cilium movement involved in cell motility [GO:0060294] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569] g5012.t1 Q9Y2E6 40.031 652 1.1e-145 439.0 sp|Q9Y2E6|DTX4_HUMAN E3 ubiquitin-protein ligase DTX4 OS=Homo sapiens OX=9606 GN=DTX4 PE=1 SV=2 DTX4_HUMAN reviewed E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4) Homo sapiens (Human) GO:0004842; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0007219; GO:0008270; GO:0010498; GO:0016567; GO:0032479; GO:0043161; GO:0045824; GO:0061630; GO:0070936 negative regulation of innate immune response [GO:0045824]; Notch signaling pathway [GO:0007219]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5012.t2 Q9Y2E6 39.032 661 6.38e-148 445.0 sp|Q9Y2E6|DTX4_HUMAN E3 ubiquitin-protein ligase DTX4 OS=Homo sapiens OX=9606 GN=DTX4 PE=1 SV=2 DTX4_HUMAN reviewed E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4) Homo sapiens (Human) GO:0004842; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0007219; GO:0008270; GO:0010498; GO:0016567; GO:0032479; GO:0043161; GO:0045824; GO:0061630; GO:0070936 negative regulation of innate immune response [GO:0045824]; Notch signaling pathway [GO:0007219]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5014.t1 Q5ZLD7 61.905 546 0.0 662.0 sp|Q5ZLD7|VPS53_CHICK Vacuolar protein sorting-associated protein 53 homolog OS=Gallus gallus OX=9031 GN=VPS53 PE=2 SV=1 VPS53_CHICK reviewed Vacuolar protein sorting-associated protein 53 homolog Gallus gallus (Chicken) GO:0000938; GO:0005829; GO:0007041; GO:0010008; GO:0015031; GO:0032456; GO:0042147; GO:0055037; GO:1990745 endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; recycling endosome [GO:0055037] g5015.t1 Q8CCB4 77.056 231 1.44e-120 367.0 sp|Q8CCB4|VPS53_MOUSE Vacuolar protein sorting-associated protein 53 homolog OS=Mus musculus OX=10090 GN=Vps53 PE=1 SV=1 g5016.t1 O46072 44.323 731 5.12e-155 481.0 sp|O46072|KZ_DROME Probable ATP-dependent RNA helicase kurz OS=Drosophila melanogaster OX=7227 GN=kz PE=1 SV=1 g5018.t1 Q9H0H0 59.184 196 9.65e-72 239.0 sp|Q9H0H0|INT2_HUMAN Integrator complex subunit 2 OS=Homo sapiens OX=9606 GN=INTS2 PE=1 SV=2 g5020.t1 Q9H0H0 50.574 959 0.0 928.0 sp|Q9H0H0|INT2_HUMAN Integrator complex subunit 2 OS=Homo sapiens OX=9606 GN=INTS2 PE=1 SV=2 g5021.t1 O44252 31.602 231 1.49e-22 96.7 sp|O44252|ROST_DROME Protein rolling stone OS=Drosophila melanogaster OX=7227 GN=rost PE=2 SV=2 g5024.t1 Q46GT9 36.855 407 7.92e-85 270.0 sp|Q46GT9|GSA_PROMT Glutamate-1-semialdehyde 2,1-aminomutase OS=Prochlorococcus marinus (strain NATL2A) OX=59920 GN=hemL PE=3 SV=1 g5025.t1 Q6DE37 53.061 294 3.67e-116 357.0 sp|Q6DE37|GXLT2_XENLA Glucoside xylosyltransferase 2 OS=Xenopus laevis OX=8355 GN=gxylt2 PE=2 SV=1 GXLT2_XENLA reviewed Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4) Xenopus laevis (African clawed frog) GO:0016020; GO:0016266; GO:0035252; GO:0140563; GO:0180059 protein O-linked glycosylation via glucose [GO:0180059]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] membrane [GO:0016020] UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252] g5026.t1 Q569B7 52.128 188 7.54e-58 182.0 sp|Q569B7|RWDD4_RAT RWD domain-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Rwdd4 PE=2 SV=1 g5027.t1 Q9D5J6 46.436 463 1.7999999999999998e-147 432.0 sp|Q9D5J6|SHPK_MOUSE Sedoheptulokinase OS=Mus musculus OX=10090 GN=Shpk PE=1 SV=1 SHPK_MOUSE reviewed Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein) Mus musculus (Mouse) GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353 carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277] g5028.t1 Q6DFQ5 49.697 165 1.61e-48 158.0 sp|Q6DFQ5|SGMR2_XENTR Sigma intracellular receptor 2 OS=Xenopus tropicalis OX=8364 GN=tmem97 PE=2 SV=1 SGMR2_XENTR reviewed Sigma intracellular receptor 2 (Sigma-2 receptor) (Sigma2 receptor) (Transmembrane protein 97) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005764; GO:0005783; GO:0005791; GO:0005886; GO:0008142; GO:0015485; GO:0030867; GO:0031965; GO:0032377; GO:0032383; GO:0042632; GO:0140077 cholesterol homeostasis [GO:0042632]; positive regulation of lipoprotein transport [GO:0140077]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of intracellular lipid transport [GO:0032377] endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142] g5029.t1 Q6R5J2 32.997 794 2.7e-134 436.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g5030.t1 Q66I67 77.273 132 7.63e-67 201.0 sp|Q66I67|IFT20_DANRE Intraflagellar transport protein 20 homolog OS=Danio rerio OX=7955 GN=ift20 PE=2 SV=1 g5031.t1 P29476 49.959 1233 0.0 1208.0 sp|P29476|NOS1_RAT Nitric oxide synthase 1 OS=Rattus norvegicus OX=10116 GN=Nos1 PE=1 SV=1 g5031.t2 Q9Z0J4 49.837 1226 0.0 1201.0 sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1 g5033.t1 Q8TBY9 47.887 568 3.38e-180 542.0 sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2 CF251_HUMAN reviewed Cilia- and flagella-associated protein 251 (WD repeat-containing protein 66) Homo sapiens (Human) GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126 cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317] axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] g5034.t1 Q8TBY9 50.446 224 1.69e-71 239.0 sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2 CF251_HUMAN reviewed Cilia- and flagella-associated protein 251 (WD repeat-containing protein 66) Homo sapiens (Human) GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126 cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317] axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] g5036.t1 Q29498 59.836 366 5.53e-145 466.0 sp|Q29498|NOS1_SHEEP Nitric oxide synthase 1 OS=Ovis aries OX=9940 GN=NOS1 PE=2 SV=3 NOS1_SHEEP reviewed Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (NNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1) Ovis aries (Sheep) GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0042383; GO:0043197; GO:0046872; GO:0050660; GO:0050661; GO:1903522 nitric oxide biosynthetic process [GO:0006809]; regulation of blood circulation [GO:1903522] dendritic spine [GO:0043197]; sarcolemma [GO:0042383] calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517] g5036.t1 Q29498 58.036 112 7.820000000000001e-31 134.0 sp|Q29498|NOS1_SHEEP Nitric oxide synthase 1 OS=Ovis aries OX=9940 GN=NOS1 PE=2 SV=3 NOS1_SHEEP reviewed Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (NNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1) Ovis aries (Sheep) GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0042383; GO:0043197; GO:0046872; GO:0050660; GO:0050661; GO:1903522 nitric oxide biosynthetic process [GO:0006809]; regulation of blood circulation [GO:1903522] dendritic spine [GO:0043197]; sarcolemma [GO:0042383] calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517] g5038.t1 P29475 53.942 241 1.7000000000000001e-77 257.0 sp|P29475|NOS1_HUMAN Nitric oxide synthase 1 OS=Homo sapiens OX=9606 GN=NOS1 PE=1 SV=2 NOS1_HUMAN reviewed Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1) Homo sapiens (Human) GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005246; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0006941; GO:0007263; GO:0007520; GO:0009408; GO:0009725; GO:0010181; GO:0010523; GO:0010882; GO:0014069; GO:0016529; GO:0017080; GO:0020037; GO:0030018; GO:0030315; GO:0032496; GO:0032991; GO:0033017; GO:0033555; GO:0034617; GO:0034618; GO:0035605; GO:0042178; GO:0042311; GO:0042383; GO:0043197; GO:0043267; GO:0043525; GO:0044305; GO:0044325; GO:0045121; GO:0045202; GO:0045454; GO:0045776; GO:0045893; GO:0045944; GO:0046870; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0050767; GO:0051612; GO:0051649; GO:0051926; GO:0055117; GO:0060078; GO:0071363; GO:0071944; GO:0097110; GO:0098735; GO:0099163; GO:0106071; GO:1902307; GO:1902514; GO:1905026 calcium ion transport [GO:0006816]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; establishment of localization in cell [GO:0051649]; L-arginine catabolic process [GO:0006527]; multicellular organismal response to stress [GO:0033555]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential [GO:1905026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transport [GO:0006813]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neurogenesis [GO:0050767]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178] calyx of Held [GO:0044305]; caveola [GO:0005901]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325] g5039.t1 P29475 55.202 346 1.4699999999999998e-119 384.0 sp|P29475|NOS1_HUMAN Nitric oxide synthase 1 OS=Homo sapiens OX=9606 GN=NOS1 PE=1 SV=2 NOS1_HUMAN reviewed Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1) Homo sapiens (Human) GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005246; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0006941; GO:0007263; GO:0007520; GO:0009408; GO:0009725; GO:0010181; GO:0010523; GO:0010882; GO:0014069; GO:0016529; GO:0017080; GO:0020037; GO:0030018; GO:0030315; GO:0032496; GO:0032991; GO:0033017; GO:0033555; GO:0034617; GO:0034618; GO:0035605; GO:0042178; GO:0042311; GO:0042383; GO:0043197; GO:0043267; GO:0043525; GO:0044305; GO:0044325; GO:0045121; GO:0045202; GO:0045454; GO:0045776; GO:0045893; GO:0045944; GO:0046870; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0050767; GO:0051612; GO:0051649; GO:0051926; GO:0055117; GO:0060078; GO:0071363; GO:0071944; GO:0097110; GO:0098735; GO:0099163; GO:0106071; GO:1902307; GO:1902514; GO:1905026 calcium ion transport [GO:0006816]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; establishment of localization in cell [GO:0051649]; L-arginine catabolic process [GO:0006527]; multicellular organismal response to stress [GO:0033555]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential [GO:1905026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transport [GO:0006813]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neurogenesis [GO:0050767]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178] calyx of Held [GO:0044305]; caveola [GO:0005901]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325] g5039.t2 P29475 55.491 346 5.38e-120 385.0 sp|P29475|NOS1_HUMAN Nitric oxide synthase 1 OS=Homo sapiens OX=9606 GN=NOS1 PE=1 SV=2 NOS1_HUMAN reviewed Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1) Homo sapiens (Human) GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005246; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0006941; GO:0007263; GO:0007520; GO:0009408; GO:0009725; GO:0010181; GO:0010523; GO:0010882; GO:0014069; GO:0016529; GO:0017080; GO:0020037; GO:0030018; GO:0030315; GO:0032496; GO:0032991; GO:0033017; GO:0033555; GO:0034617; GO:0034618; GO:0035605; GO:0042178; GO:0042311; GO:0042383; GO:0043197; GO:0043267; GO:0043525; GO:0044305; GO:0044325; GO:0045121; GO:0045202; GO:0045454; GO:0045776; GO:0045893; GO:0045944; GO:0046870; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0050767; GO:0051612; GO:0051649; GO:0051926; GO:0055117; GO:0060078; GO:0071363; GO:0071944; GO:0097110; GO:0098735; GO:0099163; GO:0106071; GO:1902307; GO:1902514; GO:1905026 calcium ion transport [GO:0006816]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; establishment of localization in cell [GO:0051649]; L-arginine catabolic process [GO:0006527]; multicellular organismal response to stress [GO:0033555]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential [GO:1905026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transport [GO:0006813]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neurogenesis [GO:0050767]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178] calyx of Held [GO:0044305]; caveola [GO:0005901]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325] g5040.t1 B0BMZ6 36.201 279 1.2699999999999999e-55 185.0 sp|B0BMZ6|CF119_RAT Cilia- and flagella-associated protein 119 OS=Rattus norvegicus OX=10116 GN=Cfap119 PE=1 SV=1 CF119_RAT reviewed Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189) (Spergen-4) Rattus norvegicus (Rat) GO:0001534; GO:0001669; GO:0005737; GO:0005930; GO:0007338; GO:0010467; GO:0097228; GO:0120316 gene expression [GO:0010467]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; radial spoke [GO:0001534]; sperm principal piece [GO:0097228] g5041.t1 Q924H5 48.476 328 9.71e-100 302.0 sp|Q924H5|RA51C_MOUSE DNA repair protein RAD51 homolog 3 OS=Mus musculus OX=10090 GN=Rad51c PE=1 SV=1 RA51C_MOUSE reviewed DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2) Mus musculus (Mouse) GO:0000400; GO:0000707; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0048471; GO:0048476; GO:0140664 DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Holliday junction resolvase complex [GO:0048476]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400] g5042.t1 Q2NKX8 46.93 456 2.03e-130 411.0 sp|Q2NKX8|ERC6L_HUMAN DNA excision repair protein ERCC-6-like OS=Homo sapiens OX=9606 GN=ERCC6L PE=1 SV=1 ERC6L_HUMAN reviewed DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15) Homo sapiens (Human) GO:0000776; GO:0003677; GO:0003678; GO:0005524; GO:0005829; GO:0006281; GO:0015616; GO:0016020; GO:0016887; GO:0051301 cell division [GO:0051301]; DNA repair [GO:0006281] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616] g5043.t1 A2BGR3 50.84 238 3.49e-66 232.0 sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1 g5045.t1 Q5SSZ7 52.459 305 1.5e-96 326.0 sp|Q5SSZ7|ZNRF3_MOUSE E3 ubiquitin-protein ligase ZNRF3 OS=Mus musculus OX=10090 GN=Znrf3 PE=1 SV=1 ZNRF3_MOUSE reviewed E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3) Mus musculus (Mouse) GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0060828; GO:0061630; GO:0072089; GO:0090090; GO:2000051; GO:2000095 limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] frizzled binding [GO:0005109]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5047.t1 A5D6V4 48.913 184 3.21e-51 166.0 sp|A5D6V4|TM17B_DANRE Transmembrane protein 17B OS=Danio rerio OX=7955 GN=Tmem17b PE=2 SV=1 g5048.t1 O00291 40.386 1035 0.0 715.0 sp|O00291|HIP1_HUMAN Huntingtin-interacting protein 1 OS=Homo sapiens OX=9606 GN=HIP1 PE=1 SV=5 HIP1_HUMAN reviewed Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I) Homo sapiens (Human) GO:0001669; GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006897; GO:0006915; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0030864; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0080025; GO:0097190; GO:0097225; GO:0097228; GO:0098685; GO:0098793; GO:0098794; GO:0098978; GO:0099149; GO:0099171; GO:0099637; GO:2000588 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of receptor-mediated endocytosis [GO:0048260]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] acrosomal vesicle [GO:0001669]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200] g5049.t1 Q99MS0 41.014 434 1.47e-120 359.0 sp|Q99MS0|S14L2_RAT SEC14-like protein 2 OS=Rattus norvegicus OX=10116 GN=Sec14l2 PE=1 SV=1 g5050.t1 A8WGS4 39.394 231 2.87e-58 189.0 sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1 g5051.t1 O00541 46.541 477 3.4700000000000002e-130 392.0 sp|O00541|PESC_HUMAN Pescadillo homolog OS=Homo sapiens OX=9606 GN=PES1 PE=1 SV=1 PESC_HUMAN reviewed Pescadillo homolog Homo sapiens (Human) GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006364; GO:0008283; GO:0016020; GO:0030687; GO:0042273; GO:0043021; GO:0051726; GO:0070545 cell population proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687] ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] g5052.t1 O00541 65.591 93 5.2600000000000004e-33 124.0 sp|O00541|PESC_HUMAN Pescadillo homolog OS=Homo sapiens OX=9606 GN=PES1 PE=1 SV=1 PESC_HUMAN reviewed Pescadillo homolog Homo sapiens (Human) GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006364; GO:0008283; GO:0016020; GO:0030687; GO:0042273; GO:0043021; GO:0051726; GO:0070545 cell population proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687] ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] g5054.t1 Q3TCV3 23.019 530 1.5600000000000002e-26 121.0 sp|Q3TCV3|GSAP_MOUSE Gamma-secretase-activating protein OS=Mus musculus OX=10090 GN=Gsap PE=2 SV=1 g5055.t1 O14735 66.825 211 2.4299999999999997e-104 303.0 sp|O14735|CDIPT_HUMAN CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Homo sapiens OX=9606 GN=CDIPT PE=1 SV=1 g5057.t1 Q0IH86 49.315 292 1.3200000000000001e-88 268.0 sp|Q0IH86|SLX1_XENLA Structure-specific endonuclease subunit slx1 OS=Xenopus laevis OX=8355 GN=slx1a PE=2 SV=1 g5058.t1 P49582 31.893 486 7.14e-75 248.0 sp|P49582|ACHA7_MOUSE Neuronal acetylcholine receptor subunit alpha-7 OS=Mus musculus OX=10090 GN=Chrna7 PE=1 SV=1 ACHA7_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Mus musculus (Mouse) GO:0001540; GO:0001988; GO:0004888; GO:0005216; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006897; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008179; GO:0008306; GO:0009409; GO:0009897; GO:0010628; GO:0014061; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043124; GO:0043197; GO:0043198; GO:0044853; GO:0045202; GO:0045211; GO:0045471; GO:0046872; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050893; GO:0051117; GO:0051247; GO:0051823; GO:0060084; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098793; GO:0098815; GO:0098878; GO:0098897; GO:0098981; GO:0099171; GO:0099634; GO:0140059; GO:1900016; GO:1900273; GO:1902004; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:1990806; GO:2000463; GO:2001023 acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; learning or memory [GO:0007611]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein metabolic process [GO:0051247]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of amyloid fibril formation [GO:1905906]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of norepinephrine secretion [GO:0014061]; regulation of response to drug [GO:2001023]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; synapse organization [GO:0050808]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110] acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; spine apparatus membrane [GO:0098897]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g5060.t1 O08662 50.142 2118 0.0 2046.0 sp|O08662|PI4KA_RAT Phosphatidylinositol 4-kinase alpha OS=Rattus norvegicus OX=10116 GN=Pi4ka PE=1 SV=2 PI4KA_RAT reviewed Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) Rattus norvegicus (Rat) GO:0004430; GO:0005524; GO:0005737; GO:0005886; GO:0022011; GO:0030036; GO:0030660; GO:0036135; GO:0044788; GO:0046854; GO:0048015; GO:0140754 actin cytoskeleton organization [GO:0030036]; host-mediated perturbation of viral process [GO:0044788]; myelination in peripheral nervous system [GO:0022011]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; reorganization of cellular membranes to establish viral sites of replication [GO:0140754]; Schwann cell migration [GO:0036135] cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; plasma membrane [GO:0005886] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] g5061.t1 Q96NI6 28.693 352 8.989999999999999e-28 124.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g5062.t1 Q14161 48.649 814 0.0 684.0 sp|Q14161|GIT2_HUMAN ARF GTPase-activating protein GIT2 OS=Homo sapiens OX=9606 GN=GIT2 PE=1 SV=2 g5062.t2 Q14161 50.704 781 0.0 701.0 sp|Q14161|GIT2_HUMAN ARF GTPase-activating protein GIT2 OS=Homo sapiens OX=9606 GN=GIT2 PE=1 SV=2 g5063.t1 Q9CQR5 38.095 189 4.2200000000000004e-35 124.0 sp|Q9CQR5|ZMAT5_MOUSE Zinc finger matrin-type protein 5 OS=Mus musculus OX=10090 GN=Zmat5 PE=2 SV=1 g5064.t1 Q8QFR2 47.259 1058 0.0 974.0 sp|Q8QFR2|HIRA_XENLA Protein HIRA OS=Xenopus laevis OX=8355 GN=hira PE=1 SV=2 g5065.t1 Q3SZP8 52.523 436 2.11e-158 457.0 sp|Q3SZP8|TAD2A_BOVIN Transcriptional adapter 2-alpha OS=Bos taurus OX=9913 GN=TADA2A PE=2 SV=1 TAD2A_BOVIN reviewed Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) Bos taurus (Bovine) GO:0000278; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0006338; GO:0006357; GO:0008270; GO:0031647; GO:0045995; GO:0051302; GO:0051726; GO:0070461; GO:0072686; GO:0140672 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA-type complex [GO:0070461] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g5066.t1 P53814 38.376 271 2.32e-44 178.0 sp|P53814|SMTN_HUMAN Smoothelin OS=Homo sapiens OX=9606 GN=SMTN PE=1 SV=7 SMTN_HUMAN reviewed Smoothelin Homo sapiens (Human) GO:0003779; GO:0005856; GO:0006939; GO:0007517; GO:0008307; GO:0015629 muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g5066.t2 P53814 38.376 271 1.7900000000000001e-44 178.0 sp|P53814|SMTN_HUMAN Smoothelin OS=Homo sapiens OX=9606 GN=SMTN PE=1 SV=7 SMTN_HUMAN reviewed Smoothelin Homo sapiens (Human) GO:0003779; GO:0005856; GO:0006939; GO:0007517; GO:0008307; GO:0015629 muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g5066.t3 P53814 38.376 271 2.72e-44 178.0 sp|P53814|SMTN_HUMAN Smoothelin OS=Homo sapiens OX=9606 GN=SMTN PE=1 SV=7 SMTN_HUMAN reviewed Smoothelin Homo sapiens (Human) GO:0003779; GO:0005856; GO:0006939; GO:0007517; GO:0008307; GO:0015629 muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g5068.t1 Q92890 61.736 311 3.1e-128 370.0 sp|Q92890|UFD1_HUMAN Ubiquitin recognition factor in ER-associated degradation protein 1 OS=Homo sapiens OX=9606 GN=UFD1 PE=1 SV=3 g5069.t1 O75419 54.657 569 0.0 646.0 sp|O75419|CDC45_HUMAN Cell division control protein 45 homolog OS=Homo sapiens OX=9606 GN=CDC45 PE=1 SV=1 CDC45_HUMAN reviewed Cell division control protein 45 homolog (PORC-PI-1) Homo sapiens (Human) GO:0000076; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0006260; GO:0006270; GO:0031261; GO:0036064; GO:0071162; GO:1902977 DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697] g5070.t1 A2PYH4 54.75 1021 0.0 1134.0 sp|A2PYH4|HFM1_HUMAN Probable ATP-dependent DNA helicase HFM1 OS=Homo sapiens OX=9606 GN=HFM1 PE=1 SV=2 HFM1_HUMAN reviewed Probable ATP-dependent DNA helicase HFM1 (EC 5.6.2.4) (DNA 3'-5' helicase HFM1) (SEC63 domain-containing protein 1) Homo sapiens (Human) GO:0000712; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0008270; GO:0016887; GO:0043138 resolution of meiotic recombination intermediates [GO:0000712] nucleus [GO:0005634] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g5071.t1 Q9DG67 56.235 818 0.0 899.0 sp|Q9DG67|RA54B_CHICK DNA repair and recombination protein RAD54B OS=Gallus gallus OX=9031 GN=RAD54B PE=2 SV=1 g5072.t1 A8WFU8 43.731 670 9.320000000000001e-173 509.0 sp|A8WFU8|KIF22_DANRE Kinesin-like protein KIF22 OS=Danio rerio OX=7955 GN=kif22 PE=2 SV=1 KIF22_DANRE reviewed Kinesin-like protein KIF22 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001756; GO:0001966; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007409; GO:0007420; GO:0008017; GO:0016887; GO:0021952; GO:0048592 axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; eye morphogenesis [GO:0048592]; microtubule-based movement [GO:0007018]; somitogenesis [GO:0001756]; thigmotaxis [GO:0001966] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g5074.t1 Q9H3F6 70.632 269 6.54e-136 390.0 sp|Q9H3F6|BACD3_HUMAN BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 OS=Homo sapiens OX=9606 GN=KCTD10 PE=1 SV=1 BACD3_HUMAN reviewed BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10) Homo sapiens (Human) GO:0005112; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260 negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; Notch binding [GO:0005112] g5078.t1 Q3V0L5 43.168 322 4.62e-66 233.0 sp|Q3V0L5|LRC43_MOUSE Leucine-rich repeat-containing protein 43 OS=Mus musculus OX=10090 GN=Lrrc43 PE=2 SV=1 g5081.t1 Q6GQ82 76.408 373 0.0 598.0 sp|Q6GQ82|SNF5_XENLA SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Xenopus laevis OX=8355 GN=smarcb1 PE=2 SV=1 g5082.t1 P21158 41.071 168 2.5199999999999998e-34 124.0 sp|P21158|CSGA_MYXXA C-signal OS=Myxococcus xanthus OX=34 GN=csgA PE=1 SV=1 g5083.t1 Q99PT0 58.754 594 0.0 690.0 sp|Q99PT0|DDX52_RAT Probable ATP-dependent RNA helicase DDX52 OS=Rattus norvegicus OX=10116 GN=Ddx52 PE=2 SV=1 g5084.t1 Q5I0D1 66.782 289 6.19e-149 422.0 sp|Q5I0D1|GLOD4_RAT Glyoxalase domain-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Glod4 PE=1 SV=1 g5085.t1 Q06846 44.366 710 0.0 566.0 sp|Q06846|RP3A_BOVIN Rabphilin-3A OS=Bos taurus OX=9913 GN=RPH3A PE=1 SV=1 g5086.t1 Q8KFK3 28.627 255 2.18e-26 117.0 sp|Q8KFK3|CRTU_CHLTE Carotenoid phi-ring synthase OS=Chlorobaculum tepidum (strain ATCC 49652 / DSM 12025 / NBRC 103806 / TLS) OX=194439 GN=crtU PE=3 SV=1 g5088.t1 Q499P8 43.072 332 2.19e-75 243.0 sp|Q499P8|RUSF1_RAT RUS family member 1 OS=Rattus norvegicus OX=10116 GN=Rusf1 PE=2 SV=1 g5089.t1 Q86K80 66.667 63 3.5e-23 99.0 sp|Q86K80|RUSF1_DICDI RUS family member 1 OS=Dictyostelium discoideum OX=44689 GN=rusf1 PE=3 SV=1 g5090.t1 Q2NKR1 67.949 78 1.31e-35 119.0 sp|Q2NKR1|TIM10_BOVIN Mitochondrial import inner membrane translocase subunit Tim10 OS=Bos taurus OX=9913 GN=TIMM10 PE=3 SV=1 TIM10_BOVIN reviewed Mitochondrial import inner membrane translocase subunit Tim10 Bos taurus (Bovine) GO:0005743; GO:0015031; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0046872; GO:0051087 protein insertion into mitochondrial inner membrane [GO:0045039]; protein transport [GO:0015031] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space chaperone complex [GO:0042719]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] membrane insertase activity [GO:0032977]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087] g5091.t1 P70259 28.682 258 1.67e-28 118.0 sp|P70259|GP143_MOUSE G-protein coupled receptor 143 OS=Mus musculus OX=10090 GN=Gpr143 PE=2 SV=1 GP143_MOUSE reviewed G-protein coupled receptor 143 (MOA1) (Ocular albinism type 1 protein homolog) Mus musculus (Mouse) GO:0004930; GO:0005654; GO:0005765; GO:0005794; GO:0005886; GO:0007186; GO:0007200; GO:0016324; GO:0016604; GO:0030054; GO:0032400; GO:0032402; GO:0032438; GO:0033162; GO:0035240; GO:0035643; GO:0042470; GO:0072544; GO:0072545; GO:1902908; GO:1903056 G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908] apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; L-tyrosine binding [GO:0072545] g5093.t1 Q8C159 27.387 555 2.49e-34 141.0 sp|Q8C159|TTC22_MOUSE Tetratricopeptide repeat protein 22 OS=Mus musculus OX=10090 GN=Ttc22 PE=2 SV=1 g5094.t1 Q9GLE4 42.68 485 4.32e-119 368.0 sp|Q9GLE4|MMP14_BOVIN Matrix metalloproteinase-14 OS=Bos taurus OX=9913 GN=MMP14 PE=2 SV=1 MMP14_BOVIN reviewed Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP) Bos taurus (Bovine) GO:0001501; GO:0004222; GO:0005615; GO:0005886; GO:0008270; GO:0010831; GO:0016477; GO:0030198; GO:0030324; GO:0030574; GO:0031012; GO:0031638; GO:0042470; GO:0045579; GO:0045746; GO:0048754 branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of myotube differentiation [GO:0010831]; skeletal system development [GO:0001501]; zymogen activation [GO:0031638] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g5095.t1 Q8N653 58.488 807 0.0 947.0 sp|Q8N653|LZTR1_HUMAN Leucine-zipper-like transcriptional regulator 1 OS=Homo sapiens OX=9606 GN=LZTR1 PE=1 SV=2 LZTR1_HUMAN reviewed Leucine-zipper-like transcriptional regulator 1 (LZTR-1) Homo sapiens (Human) GO:0005794; GO:0012505; GO:0016567; GO:0031267; GO:0031463; GO:0046580; GO:0055038 negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038] small GTPase binding [GO:0031267] g5096.t1 Q5EBP3 34.528 307 2.21e-32 140.0 sp|Q5EBP3|ARMC5_MOUSE Armadillo repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Armc5 PE=2 SV=1 ARMC5_MOUSE reviewed Armadillo repeat-containing protein 5 Mus musculus (Mouse) GO:0000785; GO:0001701; GO:0001707; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006366; GO:0006368; GO:0006633; GO:0006636; GO:0007369; GO:0009653; GO:0010467; GO:0016020; GO:0030163; GO:0031463; GO:0032933; GO:0035801; GO:0042098; GO:0043161; GO:0043367; GO:0050810; GO:0051607; GO:0061630; GO:0160240; GO:1990756 adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; fatty acid biosynthetic process [GO:0006633]; gastrulation [GO:0007369]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; regulation of steroid biosynthetic process [GO:0050810]; RNA polymerase II transcription initiation surveillance [GO:0160240]; SREBP signaling pathway [GO:0032933]; T cell proliferation [GO:0042098]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]; unsaturated fatty acid biosynthetic process [GO:0006636] chromatin [GO:0000785]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g5098.t1 O35130 71.569 204 1.0700000000000001e-109 318.0 sp|O35130|NEP1_MOUSE Ribosomal RNA small subunit methyltransferase NEP1 OS=Mus musculus OX=10090 GN=Emg1 PE=1 SV=1 NEP1_MOUSE reviewed Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1) Mus musculus (Mouse) GO:0001824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042274; GO:0042802; GO:0070037; GO:0070475 blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843] g5099.t1 Q9NP71 43.127 371 1.8100000000000002e-70 256.0 sp|Q9NP71|MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens OX=9606 GN=MLXIPL PE=1 SV=1 MLXPL_HUMAN reviewed Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) Homo sapiens (Human) GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0008610; GO:0009653; GO:0010255; GO:0035538; GO:0035774; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009; GO:0140297; GO:1901797 anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; lipid biosynthetic process [GO:0008610]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g5099.t1 Q9NP71 41.304 276 2.6399999999999997e-52 202.0 sp|Q9NP71|MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens OX=9606 GN=MLXIPL PE=1 SV=1 MLXPL_HUMAN reviewed Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) Homo sapiens (Human) GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0008610; GO:0009653; GO:0010255; GO:0035538; GO:0035774; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009; GO:0140297; GO:1901797 anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; lipid biosynthetic process [GO:0008610]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g5101.t1 Q6AYH2 57.609 92 1.7099999999999998e-23 100.0 sp|Q6AYH2|IN80E_RAT INO80 complex subunit E OS=Rattus norvegicus OX=10116 GN=Ino80e PE=2 SV=1 IN80E_RAT reviewed INO80 complex subunit E (Coiled-coil domain-containing protein 95) Rattus norvegicus (Rat) GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045893; GO:0051726; GO:0060382 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382] Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g5102.t1 G1SKF7 60.938 256 2.6100000000000002e-105 309.0 sp|G1SKF7|RL6_RABIT Large ribosomal subunit protein eL6 OS=Oryctolagus cuniculus OX=9986 GN=RPL6 PE=1 SV=1 g5103.t1 Q5SV77 47.07 512 5.66e-140 430.0 sp|Q5SV77|GGNB2_MOUSE Gametogenetin-binding protein 2 OS=Mus musculus OX=10090 GN=Ggnbp2 PE=1 SV=1 GGNB2_MOUSE reviewed Gametogenetin-binding protein 2 (Dioxin-inducible factor 3) (DIF-3) (Protein ZNF403) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0007283; GO:0008285; GO:0010629; GO:0030154; GO:0031410; GO:0060711; GO:0060716; GO:1904893 cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; labyrinthine layer development [GO:0060711]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634] g5104.t1 P68250 61.181 237 7.19e-101 296.0 sp|P68250|1433B_BOVIN 14-3-3 protein beta/alpha OS=Bos taurus OX=9913 GN=YWHAB PE=1 SV=2 g5105.t1 P62262 60.474 253 1.68e-101 298.0 sp|P62262|1433E_SHEEP 14-3-3 protein epsilon OS=Ovis aries OX=9940 GN=YWHAE PE=1 SV=1 1433E_SHEEP reviewed 14-3-3 protein epsilon (14-3-3E) (Protein kinase C inhibitor protein 1) (KCIP-1) Ovis aries (Sheep) GO:0000165; GO:0001764; GO:0002753; GO:0004864; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006605; GO:0006888; GO:0006893; GO:0015459; GO:0019855; GO:0019903; GO:0019904; GO:0021766; GO:0021987; GO:0030007; GO:0031625; GO:0034122; GO:0034123; GO:0034142; GO:0034504; GO:0034605; GO:0035329; GO:0035332; GO:0035591; GO:0042470; GO:0042802; GO:0042826; GO:0044325; GO:0046827; GO:0046982; GO:0050815; GO:0051480; GO:0060306; GO:0070972; GO:0070979; GO:0097110; GO:0140311; GO:1901379; GO:1905913 cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; hippo signaling [GO:0035329]; hippocampus development [GO:0021766]; intracellular potassium ion homeostasis [GO:0030007]; MAPK cascade [GO:0000165]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neuron migration [GO:0001764]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; protein K11-linked ubiquitination [GO:0070979]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; toll-like receptor 4 signaling pathway [GO:0034142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium channel inhibitor activity [GO:0019855]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] g5106.t1 P62262 71.654 254 4e-122 351.0 sp|P62262|1433E_SHEEP 14-3-3 protein epsilon OS=Ovis aries OX=9940 GN=YWHAE PE=1 SV=1 1433E_SHEEP reviewed 14-3-3 protein epsilon (14-3-3E) (Protein kinase C inhibitor protein 1) (KCIP-1) Ovis aries (Sheep) GO:0000165; GO:0001764; GO:0002753; GO:0004864; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006605; GO:0006888; GO:0006893; GO:0015459; GO:0019855; GO:0019903; GO:0019904; GO:0021766; GO:0021987; GO:0030007; GO:0031625; GO:0034122; GO:0034123; GO:0034142; GO:0034504; GO:0034605; GO:0035329; GO:0035332; GO:0035591; GO:0042470; GO:0042802; GO:0042826; GO:0044325; GO:0046827; GO:0046982; GO:0050815; GO:0051480; GO:0060306; GO:0070972; GO:0070979; GO:0097110; GO:0140311; GO:1901379; GO:1905913 cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; hippo signaling [GO:0035329]; hippocampus development [GO:0021766]; intracellular potassium ion homeostasis [GO:0030007]; MAPK cascade [GO:0000165]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neuron migration [GO:0001764]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; protein K11-linked ubiquitination [GO:0070979]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; toll-like receptor 4 signaling pathway [GO:0034142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium channel inhibitor activity [GO:0019855]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] g5107.t1 Q8CCN5 44.485 816 0.0 609.0 sp|Q8CCN5|BCAS3_MOUSE BCAS3 microtubule associated cell migration factor OS=Mus musculus OX=10090 GN=Bcas3 PE=1 SV=2 BCAS3_MOUSE reviewed BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3 homolog) (K20D4) (Protein rudhira) Mus musculus (Mouse) GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005096; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0010698; GO:0016922; GO:0031252; GO:0032956; GO:0035035; GO:0035091; GO:0042393; GO:0042594; GO:0043085; GO:0043627; GO:0045111; GO:0045944; GO:0048487; GO:0071391; GO:0071944 angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; response to estrogen [GO:0043627]; response to starvation [GO:0042594] cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407] acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; GTPase activator activity [GO:0005096]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear receptor binding [GO:0016922]; phosphatidylinositol binding [GO:0035091] g5107.t2 Q9H6U6 44.793 893 0.0 652.0 sp|Q9H6U6|BCAS3_HUMAN BCAS3 microtubule associated cell migration factor OS=Homo sapiens OX=9606 GN=BCAS3 PE=1 SV=3 g5108.t1 Q9Z2P6 37.264 212 1.13e-40 144.0 sp|Q9Z2P6|SNP29_RAT Synaptosomal-associated protein 29 OS=Rattus norvegicus OX=10116 GN=Snap29 PE=1 SV=1 g5110.t1 O22943 31.351 370 1.68e-49 182.0 sp|O22943|STL1_ARATH Probable glycosyltransferase STELLO1 OS=Arabidopsis thaliana OX=3702 GN=STL1 PE=1 SV=1 STL1_ARATH reviewed Probable glycosyltransferase STELLO1 (EC 2.4.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0008104; GO:0016757; GO:0042802; GO:0052324; GO:2001009 intracellular protein localization [GO:0008104]; plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802] g5111.t1 O61492 63.908 435 0.0 573.0 sp|O61492|FLOT2_DROME Flotillin-2 OS=Drosophila melanogaster OX=7227 GN=Flo2 PE=2 SV=3 g5113.t1 Q810B6 58.22 1180 0.0 1399.0 sp|Q810B6|ANFY1_MOUSE Rabankyrin-5 OS=Mus musculus OX=10090 GN=Ankfy1 PE=1 SV=2 ANFY1_MOUSE reviewed Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) (Rab5-binding and ankyrin repeats-containing protein) (Rabankyrin-5) (Rank-5) Mus musculus (Mouse) GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0008270; GO:0010008; GO:0016020; GO:0016197; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0044354; GO:0048549; GO:0090160; GO:1901981 endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904] phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g5114.t1 Q4KMP7 57.453 369 6.38e-154 469.0 sp|Q4KMP7|TB10B_HUMAN TBC1 domain family member 10B OS=Homo sapiens OX=9606 GN=TBC1D10B PE=1 SV=3 TB10B_HUMAN reviewed TBC1 domain family member 10B (Rab27A-GAP-beta) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0005886; GO:0042147; GO:0043087 regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096] g5115.t1 Q99700 34.4 250 3.86e-39 162.0 sp|Q99700|ATX2_HUMAN Ataxin-2 OS=Homo sapiens OX=9606 GN=ATXN2 PE=1 SV=2 ATX2_HUMAN reviewed Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) Homo sapiens (Human) GO:0002091; GO:0003723; GO:0003729; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006417; GO:0010494; GO:0016020; GO:0016070; GO:0033962; GO:0034063; GO:0048471; GO:0050658; GO:1990904 negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802] epidermal growth factor receptor binding [GO:0005154]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5115.t2 Q99700 34.4 250 5.12e-39 161.0 sp|Q99700|ATX2_HUMAN Ataxin-2 OS=Homo sapiens OX=9606 GN=ATXN2 PE=1 SV=2 ATX2_HUMAN reviewed Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) Homo sapiens (Human) GO:0002091; GO:0003723; GO:0003729; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006417; GO:0010494; GO:0016020; GO:0016070; GO:0033962; GO:0034063; GO:0048471; GO:0050658; GO:1990904 negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802] epidermal growth factor receptor binding [GO:0005154]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5118.t1 Q9Y3D9 48.592 142 1.0799999999999999e-30 114.0 sp|Q9Y3D9|RT23_HUMAN Small ribosomal subunit protein mS23 OS=Homo sapiens OX=9606 GN=MRPS23 PE=1 SV=2 g5119.t1 Q04678 58.833 634 0.0 744.0 sp|Q04678|SSRP1_CHICK FACT complex subunit SSRP1 OS=Gallus gallus OX=9031 GN=SSRP1 PE=2 SV=2 g5120.t1 A4IHK6 44.622 437 2.9199999999999998e-108 342.0 sp|A4IHK6|LAT4_XENTR Large neutral amino acids transporter small subunit 4 OS=Xenopus tropicalis OX=8364 GN=slc43a2 PE=2 SV=1 LAT4_XENTR reviewed Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0015188; GO:0015190; GO:0015191; GO:0015192; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0016323 isoleucine transport [GO:0015818]; L-leucine transport [GO:0015820]; methionine transport [GO:0015821]; phenylalanine transport [GO:0015823] basolateral plasma membrane [GO:0016323] L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-phenylalanine transmembrane transporter activity [GO:0015192] g5120.t1 A4IHK6 51.408 142 5.56e-38 152.0 sp|A4IHK6|LAT4_XENTR Large neutral amino acids transporter small subunit 4 OS=Xenopus tropicalis OX=8364 GN=slc43a2 PE=2 SV=1 LAT4_XENTR reviewed Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0015188; GO:0015190; GO:0015191; GO:0015192; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0016323 isoleucine transport [GO:0015818]; L-leucine transport [GO:0015820]; methionine transport [GO:0015821]; phenylalanine transport [GO:0015823] basolateral plasma membrane [GO:0016323] L-isoleucine transmembrane transporter activity [GO:0015188]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-phenylalanine transmembrane transporter activity [GO:0015192] g5121.t1 Q1JPD8 32.008 528 2.39e-70 236.0 sp|Q1JPD8|S43A3_BOVIN Equilibrative nucleobase transporter 1 OS=Bos taurus OX=9913 GN=SLC43A3 PE=2 SV=1 S43A3_BOVIN reviewed Equilibrative nucleobase transporter 1 (Solute carrier family 43 member 3) Bos taurus (Bovine) GO:0015207; GO:0015208; GO:0015245; GO:0016323; GO:0035344; GO:0042910 hypoxanthine transport [GO:0035344] basolateral plasma membrane [GO:0016323] adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910] g5122.t1 Q29RZ5 40.357 280 4.45e-63 202.0 sp|Q29RZ5|TNG2_BOVIN Transport and Golgi organization protein 2 homolog OS=Bos taurus OX=9913 GN=TANGO2 PE=2 SV=1 g5123.t1 P36537 29.333 525 7.32e-76 252.0 sp|P36537|UDB10_HUMAN UDP-glucuronosyltransferase 2B10 OS=Homo sapiens OX=9606 GN=UGT2B10 PE=1 SV=1 g5124.t1 P43125 47.41 251 1.39e-64 222.0 sp|P43125|RDGB_DROME Protein retinal degeneration B OS=Drosophila melanogaster OX=7227 GN=rdgB PE=1 SV=2 g5124.t2 P43125 55.607 214 1.23e-71 240.0 sp|P43125|RDGB_DROME Protein retinal degeneration B OS=Drosophila melanogaster OX=7227 GN=rdgB PE=1 SV=2 g5125.t1 Q3UHE1 49.412 255 4.31e-71 240.0 sp|Q3UHE1|PITM3_MOUSE Membrane-associated phosphatidylinositol transfer protein 3 OS=Mus musculus OX=10090 GN=Pitpnm3 PE=1 SV=2 g5126.t1 Q6ZPQ6 48.387 93 2.52e-22 94.0 sp|Q6ZPQ6|PITM2_MOUSE Membrane-associated phosphatidylinositol transfer protein 2 OS=Mus musculus OX=10090 GN=Pitpnm2 PE=1 SV=2 PITM2_MOUSE reviewed Membrane-associated phosphatidylinositol transfer protein 2 (Drosophila retinal degeneration B homolog 2) (RdgB2) (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3) Mus musculus (Mouse) GO:0005509; GO:0005543; GO:0005737; GO:0005856; GO:0008525; GO:0008526; GO:0012505; GO:0030971; GO:0031210; GO:0035091; GO:0044297 cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505] calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; receptor tyrosine kinase binding [GO:0030971] g5127.t1 Q5U2N3 43.96 505 6.030000000000001e-122 387.0 sp|Q5U2N3|PITM1_RAT Membrane-associated phosphatidylinositol transfer protein 1 OS=Rattus norvegicus OX=10116 GN=Pitpnm1 PE=1 SV=1 PITM1_RAT reviewed Membrane-associated phosphatidylinositol transfer protein 1 (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2) Rattus norvegicus (Rat) GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0044297; GO:0070300 phospholipid transport [GO:0015914]; protein transport [GO:0015031] cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lipid droplet [GO:0005811]; midbody [GO:0030496] calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971] g5128.t1 Q92526 75.096 261 8.13e-145 420.0 sp|Q92526|TCPW_HUMAN T-complex protein 1 subunit zeta-2 OS=Homo sapiens OX=9606 GN=CCT6B PE=1 SV=5 TCPW_HUMAN reviewed Probable T-complex protein 1 subunit zeta-2 (TCP-1-zeta-2) (EC 3.6.1.-) (CCT-zeta-2) (CCT-zeta-like) (Chaperonin containing T-complex polypeptide 1 subunit 6B) (TCP-1-zeta-like) (Testis-specific Tcp20) (Testis-specific protein TSA303) Homo sapiens (Human) GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0044183; GO:0051082; GO:0140662 protein folding [GO:0006457] chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] g5129.t1 P40227 82.573 241 1.69e-144 417.0 sp|P40227|TCPZ_HUMAN T-complex protein 1 subunit zeta OS=Homo sapiens OX=9606 GN=CCT6A PE=1 SV=3 TCPZ_HUMAN reviewed T-complex protein 1 subunit zeta (TCP-1-zeta) (EC 3.6.1.-) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (Chaperonin containing T-complex polypeptide 1 subunit 6A) (HTR3) (Tcp20) Homo sapiens (Human) GO:0003723; GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0016887; GO:0032212; GO:0044183; GO:0050821; GO:0051082; GO:0070062; GO:0071987; GO:0140662; GO:1904851; GO:1904871; GO:1904874 positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987] g5130.t1 Q3SYT8 60.0 670 0.0 870.0 sp|Q3SYT8|NCPR_BOVIN NADPH--cytochrome P450 reductase OS=Bos taurus OX=9913 GN=POR PE=2 SV=3 NCPR_BOVIN reviewed NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4) Bos taurus (Bovine) GO:0003958; GO:0005789; GO:0005829; GO:0006809; GO:0009725; GO:0010181; GO:0050660; GO:0050661 nitric oxide biosynthetic process [GO:0006809]; response to hormone [GO:0009725] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789] flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958] g5132.t1 Q66J90 49.677 155 2.9199999999999997e-40 167.0 sp|Q66J90|SET1B_XENLA Histone-lysine N-methyltransferase SETD1B OS=Xenopus laevis OX=8355 GN=setd1b PE=2 SV=1 g5134.t1 Q08D57 53.488 258 7.72e-80 265.0 sp|Q08D57|SET1B_XENTR Histone-lysine N-methyltransferase SETD1B OS=Xenopus tropicalis OX=8364 GN=setd1b PE=2 SV=1 g5137.t1 Q9Y5R2 37.695 512 3.55e-93 300.0 sp|Q9Y5R2|MMP24_HUMAN Matrix metalloproteinase-24 OS=Homo sapiens OX=9606 GN=MMP24 PE=1 SV=1 MMP24_HUMAN reviewed Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] Homo sapiens (Human) GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742 cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g5140.t1 Q9UGM3 32.999 797 7.36e-81 300.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g5140.t1 Q9UGM3 32.983 761 1.72e-76 285.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g5140.t1 Q9UGM3 32.768 766 6.62e-75 280.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g5140.t1 Q9UGM3 32.398 784 4.1e-73 275.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g5140.t1 Q9UGM3 32.134 778 1.5e-70 266.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g5140.t1 Q9UGM3 34.272 639 3.37e-69 262.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g5140.t1 Q9UGM3 38.951 267 3.14e-30 135.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g5141.t1 Q5TAA0 28.092 477 6.99e-34 140.0 sp|Q5TAA0|TTC22_HUMAN Tetratricopeptide repeat protein 22 OS=Homo sapiens OX=9606 GN=TTC22 PE=1 SV=1 g5143.t1 Q9UJ41 45.278 413 2.0100000000000002e-125 375.0 sp|Q9UJ41|RABX5_HUMAN Rab5 GDP/GTP exchange factor OS=Homo sapiens OX=9606 GN=RABGEF1 PE=1 SV=3 RABX5_HUMAN reviewed Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5) Homo sapiens (Human) GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0015031; GO:0016197; GO:0030139; GO:0030425; GO:0031267; GO:0031901; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098830; GO:0098935; GO:1900235 dendritic transport [GO:0098935]; endosomal transport [GO:0016197]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368] cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; nucleolus [GO:0005730]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g5143.t2 Q9UJ41 44.976 418 1.06e-124 374.0 sp|Q9UJ41|RABX5_HUMAN Rab5 GDP/GTP exchange factor OS=Homo sapiens OX=9606 GN=RABGEF1 PE=1 SV=3 RABX5_HUMAN reviewed Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5) Homo sapiens (Human) GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0015031; GO:0016197; GO:0030139; GO:0030425; GO:0031267; GO:0031901; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098830; GO:0098935; GO:1900235 dendritic transport [GO:0098935]; endosomal transport [GO:0016197]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368] cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; nucleolus [GO:0005730]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037] DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g5147.t1 Q9BY64 30.784 523 1.73e-76 254.0 sp|Q9BY64|UDB28_HUMAN UDP-glucuronosyltransferase 2B28 OS=Homo sapiens OX=9606 GN=UGT2B28 PE=1 SV=1 UDB28_HUMAN reviewed UDP-glucuronosyltransferase 2B28 (UDPGT 2B28) (UGT2B28) (EC 2.4.1.17) Homo sapiens (Human) GO:0005640; GO:0005783; GO:0005789; GO:0008202; GO:0008210; GO:0015020; GO:0048471 estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471] glucuronosyltransferase activity [GO:0015020] g5148.t1 F1QLY4 48.81 84 8.42e-22 100.0 sp|F1QLY4|RORAA_DANRE Nuclear receptor ROR-alpha A OS=Danio rerio OX=7955 GN=roraa PE=2 SV=2 RORAA_DANRE reviewed Nuclear receptor ROR-alpha A (Retinoid-related orphan receptor alpha 2) (Retinoid-related orphan receptor-alpha A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0008270; GO:0010468; GO:0010628; GO:0021587; GO:0048511 cerebellum morphogenesis [GO:0021587]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511] nucleus [GO:0005634] nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g5149.t1 Q04690 52.0 175 5.5600000000000004e-49 172.0 sp|Q04690|NF1_MOUSE Neurofibromin OS=Mus musculus OX=10090 GN=Nf1 PE=1 SV=1 NF1_MOUSE reviewed Neurofibromin (Neurofibromatosis-related protein NF-1) Mus musculus (Mouse) GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010976; GO:0014044; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900271; GO:1902531; GO:2001241 actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; postsynaptic signal transduction [GO:0098926]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of intracellular signal transduction [GO:1902531]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545] g5150.t1 P97526 54.475 2693 0.0 2743.0 sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1 NF1_RAT reviewed Neurofibromin (Neurofibromatosis-related protein NF-1) Rattus norvegicus (Rat) GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014037; GO:0014044; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033027; GO:0033034; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070667; GO:0071549; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1902531; GO:1904707; GO:1904753; GO:1990090; GO:2000108; GO:2000647; GO:2001241 actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of intracellular signal transduction [GO:1902531]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545] g5150.t2 P97526 54.24 2712 0.0 2744.0 sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1 NF1_RAT reviewed Neurofibromin (Neurofibromatosis-related protein NF-1) Rattus norvegicus (Rat) GO:0000165; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0007154; GO:0007265; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014037; GO:0014044; GO:0016525; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033027; GO:0033034; GO:0034605; GO:0035021; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070667; GO:0071549; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1902531; GO:1904707; GO:1904753; GO:1990090; GO:2000108; GO:2000647; GO:2001241 actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; observational learning [GO:0098597]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of intracellular signal transduction [GO:1902531]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545] g5153.t1 Q9ESG5 32.567 261 1.2300000000000001e-36 136.0 sp|Q9ESG5|HS3S1_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Hs3st1 PE=2 SV=1 g5154.t1 Q7Z449 39.511 491 5.470000000000001e-124 377.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g5158.t1 Q6ZN08 41.613 310 4.5699999999999995e-68 238.0 sp|Q6ZN08|ZNF66_HUMAN Zinc finger protein 66 OS=Homo sapiens OX=9606 GN=ZNF66 PE=1 SV=3 g5158.t1 Q6ZN08 36.39 349 2.28e-58 211.0 sp|Q6ZN08|ZNF66_HUMAN Zinc finger protein 66 OS=Homo sapiens OX=9606 GN=ZNF66 PE=1 SV=3 g5158.t1 Q6ZN08 37.5 312 2.6599999999999995e-54 199.0 sp|Q6ZN08|ZNF66_HUMAN Zinc finger protein 66 OS=Homo sapiens OX=9606 GN=ZNF66 PE=1 SV=3 g5159.t1 Q5BKL0 69.948 386 0.0 573.0 sp|Q5BKL0|HPPD_XENTR 4-hydroxyphenylpyruvate dioxygenase OS=Xenopus tropicalis OX=8364 GN=hpd PE=2 SV=1 g5160.t1 Q9JMC1 43.198 419 1.39e-104 336.0 sp|Q9JMC1|PI5PA_RAT Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A OS=Rattus norvegicus OX=10116 GN=Inpp5j PE=1 SV=1 PI5PA_RAT reviewed Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.36) (Inositol polyphosphate 5-phosphatase J) (Phosphatidylinositol 1,3,4,5-tetrakisphosphate 5-phosphatase) (EC 3.1.3.56) (Phosphatidylinositol 1,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.56) (Proline-rich inositol polyphosphate 5-phosphatase) Rattus norvegicus (Rat) GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005886; GO:0010977; GO:0017124; GO:0030426; GO:0031115; GO:0032587; GO:0034485; GO:0043005; GO:0043198; GO:0046030; GO:0046856; GO:0052658; GO:0052659 negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124] g5162.t1 P62255 65.031 163 1.75e-81 241.0 sp|P62255|UB2G1_RAT Ubiquitin-conjugating enzyme E2 G1 OS=Rattus norvegicus OX=10116 GN=Ube2g1 PE=2 SV=3 UB2G1_RAT reviewed Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Rattus norvegicus (Rat) GO:0000209; GO:0004842; GO:0005524; GO:0006511; GO:0016567; GO:0031625; GO:0043161; GO:0061631; GO:0070534; GO:0070936 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g5165.t1 P02269 98.4 125 1.13e-83 243.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g5166.t1 P02286 98.361 122 1.0699999999999999e-84 245.0 sp|P02286|H2B_ASTRU Histone H2B, gonadal OS=Asterias rubens OX=7604 PE=1 SV=2 g5168.t1 Q3T0B6 37.5 216 9.149999999999999e-42 148.0 sp|Q3T0B6|C1QBP_BOVIN Complement component 1 Q subcomponent-binding protein, mitochondrial OS=Bos taurus OX=9913 GN=C1QBP PE=2 SV=1 C1QBP_BOVIN reviewed Complement component 1 Q subcomponent-binding protein, mitochondrial Bos taurus (Bovine) GO:0000122; GO:0000724; GO:0000957; GO:0001849; GO:0003714; GO:0003729; GO:0004857; GO:0005540; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006397; GO:0006915; GO:0006958; GO:0008380; GO:0009986; GO:0030449; GO:0030984; GO:0031690; GO:0032689; GO:0032695; GO:0032991; GO:0039534; GO:0039536; GO:0042256; GO:0043065; GO:0043491; GO:0045087; GO:0045785; GO:0048025; GO:0050687; GO:0051897; GO:0060703; GO:0062153; GO:0070131; GO:0090023; GO:0097177; GO:1900026; GO:1901165; GO:2000042; GO:2000510 apoptotic process [GO:0006915]; complement activation, classical pathway [GO:0006958]; cytosolic ribosome assembly [GO:0042256]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; mitochondrial RNA catabolic process [GO:0000957]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon production [GO:0032689]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] adrenergic receptor binding [GO:0031690]; C5-methylcytidine-containing RNA reader activity [GO:0062153]; complement component C1q complex binding [GO:0001849]; deoxyribonuclease inhibitor activity [GO:0060703]; enzyme inhibitor activity [GO:0004857]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; transcription corepressor activity [GO:0003714] g5169.t1 A6QPF8 51.976 329 1.1600000000000001e-117 346.0 sp|A6QPF8|T120B_BOVIN Transmembrane protein 120B OS=Bos taurus OX=9913 GN=TMEM120B PE=2 SV=1 g5170.t1 Q5R6R6 34.766 512 2.6e-96 305.0 sp|Q5R6R6|PNDC1_PONAB Poly(A)-specific ribonuclease PNLDC1 OS=Pongo abelii OX=9601 GN=PNLDC1 PE=2 SV=1 g5171.t1 Q96J94 48.894 859 0.0 881.0 sp|Q96J94|PIWL1_HUMAN Piwi-like protein 1 OS=Homo sapiens OX=9606 GN=PIWIL1 PE=1 SV=1 g5172.t1 Q61382 30.398 477 1.2199999999999999e-74 245.0 sp|Q61382|TRAF4_MOUSE TNF receptor-associated factor 4 OS=Mus musculus OX=10090 GN=Traf4 PE=1 SV=2 TRAF4_MOUSE reviewed TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1) Mus musculus (Mouse) GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0061630 apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270] g5174.t1 Q8LB88 45.033 302 3.0299999999999997e-81 258.0 sp|Q8LB88|RGLG5_ARATH E3 ubiquitin-protein ligase RGLG5 OS=Arabidopsis thaliana OX=3702 GN=RGLG5 PE=1 SV=1 RGLG5_ARATH reviewed E3 ubiquitin-protein ligase RGLG5 (EC 2.3.2.27) (RING domain ligase 5) Arabidopsis thaliana (Mouse-ear cress) GO:0004842; GO:0005634; GO:0005886; GO:0008270; GO:0009738; GO:0009789; GO:0016567; GO:0061630 abscisic acid-activated signaling pathway [GO:0009738]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; protein ubiquitination [GO:0016567] nucleus [GO:0005634]; plasma membrane [GO:0005886] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5175.t1 P79110 70.684 307 5.2200000000000005e-160 453.0 sp|P79110|TXTP_BOVIN Tricarboxylate transport protein, mitochondrial OS=Bos taurus OX=9913 GN=SLC25A1 PE=1 SV=1 g5176.t1 Q969V4 48.872 399 3.51e-134 394.0 sp|Q969V4|TEKT1_HUMAN Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1 g5177.t1 Q9NWS8 54.849 299 1.11e-113 345.0 sp|Q9NWS8|RMND1_HUMAN Required for meiotic nuclear division protein 1 homolog OS=Homo sapiens OX=9606 GN=RMND1 PE=1 SV=2 RMND1_HUMAN reviewed Required for meiotic nuclear division protein 1 homolog Homo sapiens (Human) GO:0005739; GO:0006412; GO:0070131 positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412] mitochondrion [GO:0005739] g5178.t1 Q5ZI89 53.056 1129 0.0 1218.0 sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1 g5179.t1 G4WAW9 52.885 104 7.89e-32 113.0 sp|G4WAW9|SELM_ERISI Selenoprotein M OS=Eriocheir sinensis OX=95602 GN=Selenom PE=2 SV=1 g5180.t1 P41594 29.913 458 4.03e-61 236.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5180.t1 P41594 29.913 458 4.03e-61 236.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5180.t1 P41594 30.022 453 5.0099999999999995e-61 236.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5180.t1 P41594 29.476 458 1.74e-60 234.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5180.t1 P41594 29.476 458 1.94e-59 231.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5180.t1 P41594 23.105 831 6.12e-44 181.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5181.t1 P41594 30.247 486 2.87e-60 232.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5181.t1 P41594 29.501 461 1.24e-59 230.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5181.t1 P41594 23.225 831 2.03e-43 178.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g5182.t1 A6NFN9 36.413 368 4.15e-74 250.0 sp|A6NFN9|ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens OX=9606 GN=ANKUB1 PE=2 SV=3 g5185.t1 Q16932 75.092 273 1.28e-144 410.0 sp|Q16932|STX_APLCA Syntaxin OS=Aplysia californica OX=6500 PE=2 SV=1 g5185.t2 Q16932 75.092 273 2.2200000000000002e-144 410.0 sp|Q16932|STX_APLCA Syntaxin OS=Aplysia californica OX=6500 PE=2 SV=1 g5186.t1 P52301 82.326 215 9.16e-134 378.0 sp|P52301|RAN_XENLA GTP-binding nuclear protein Ran OS=Xenopus laevis OX=8355 GN=ran PE=1 SV=2 g5187.t1 Q9CY21 63.38 284 9.320000000000001e-129 370.0 sp|Q9CY21|BUD23_MOUSE 18S rRNA (guanine-N(7))-methyltransferase OS=Mus musculus OX=10090 GN=Bud23 PE=1 SV=1 g5188.t1 P59041 42.675 157 6.07e-29 110.0 sp|P59041|DJC30_MOUSE DnaJ homolog subfamily C member 30, mitochondrial OS=Mus musculus OX=10090 GN=Dnajc30 PE=1 SV=1 g5189.t1 Q9H9H4 41.916 167 1.49e-35 133.0 sp|Q9H9H4|VP37B_HUMAN Vacuolar protein sorting-associated protein 37B OS=Homo sapiens OX=9606 GN=VPS37B PE=1 SV=1 VP37B_HUMAN reviewed Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B) Homo sapiens (Human) GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0048306; GO:0070062; GO:0090148; GO:1903774 macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886] calcium-dependent protein binding [GO:0048306] g5190.t1 Q28BL6 67.322 661 0.0 969.0 sp|Q28BL6|AACS_XENTR Acetoacetyl-CoA synthetase OS=Xenopus tropicalis OX=8364 GN=aacs PE=2 SV=1 g5191.t1 Q8N3T6 27.203 919 1.39e-81 293.0 sp|Q8N3T6|T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens OX=9606 GN=TMEM132C PE=1 SV=3 g5195.t1 A2VDX7 31.429 315 1.16e-46 168.0 sp|A2VDX7|EXO5_BOVIN Exonuclease V OS=Bos taurus OX=9913 GN=EXO5 PE=2 SV=2 g5196.t1 P80928 41.739 115 1.0600000000000001e-29 106.0 sp|P80928|MIF_PIG Macrophage migration inhibitory factor OS=Sus scrofa OX=9823 GN=MIF PE=1 SV=3 MIF_PIG reviewed Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase) Sus scrofa (Pig) GO:0001516; GO:0002020; GO:0002906; GO:0004167; GO:0005125; GO:0005126; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0006954; GO:0007166; GO:0009986; GO:0010629; GO:0010760; GO:0030330; GO:0030890; GO:0031666; GO:0032760; GO:0033033; GO:0042056; GO:0042327; GO:0042802; GO:0043518; GO:0045087; GO:0048146; GO:0050178; GO:0051248; GO:0061078; GO:0061081; GO:0070207; GO:0070374; GO:0090238; GO:0090398; GO:0141163; GO:1902166; GO:2000343; GO:2000773 cell surface receptor signaling pathway [GO:0007166]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of protein metabolic process [GO:0051248]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020] g5197.t1 Q02960 43.86 114 1.37e-29 105.0 sp|Q02960|MIF_CHICK Macrophage migration inhibitory factor OS=Gallus gallus OX=9031 GN=MIF PE=3 SV=3 g5198.t1 Q02960 45.614 114 2.49e-31 110.0 sp|Q02960|MIF_CHICK Macrophage migration inhibitory factor OS=Gallus gallus OX=9031 GN=MIF PE=3 SV=3 g5199.t1 Q9UH36 45.226 199 2.6199999999999998e-52 181.0 sp|Q9UH36|SRR1L_HUMAN SRR1-like protein OS=Homo sapiens OX=9606 GN=SRRD PE=1 SV=1 g5200.t1 Q2KJ16 51.934 362 8.72e-138 402.0 sp|Q2KJ16|PHKG2_BOVIN Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Bos taurus OX=9913 GN=PHKG2 PE=2 SV=1 g5201.t1 P87362 58.72 453 0.0 578.0 sp|P87362|BLMH_CHICK Bleomycin hydrolase OS=Gallus gallus OX=9031 GN=BLMH PE=1 SV=1 g5202.t1 Q63615 62.397 609 0.0 785.0 sp|Q63615|VP33A_RAT Vacuolar protein sorting-associated protein 33A OS=Rattus norvegicus OX=10116 GN=Vps33a PE=1 SV=1 VP33A_RAT reviewed Vacuolar protein sorting-associated protein 33A (r-vps33a) Rattus norvegicus (Rat) GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0016192; GO:0030123; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0071439; GO:0097352 autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle-mediated transport [GO:0016192] AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin complex [GO:0071439]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] protein-containing complex binding [GO:0044877] g5203.t1 A8WGS4 28.837 215 3.89e-23 97.4 sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1 g5206.t1 A8WGS4 28.755 233 7.55e-24 99.0 sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1 g5207.t1 A8WGS4 28.972 214 1.13e-22 95.9 sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1 g5208.t1 O70279 47.131 488 4.260000000000001e-124 374.0 sp|O70279|ESS2_MOUSE Splicing factor ESS-2 homolog OS=Mus musculus OX=10090 GN=Ess2 PE=1 SV=2 g5209.t1 Q80Z30 47.745 377 2.58e-115 365.0 sp|Q80Z30|PPM1E_RAT Protein phosphatase 1E OS=Rattus norvegicus OX=10116 GN=Ppm1e PE=1 SV=1 PPM1E_RAT reviewed Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA) Rattus norvegicus (Rat) GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007165; GO:0032991; GO:0046872; GO:0051496; GO:0071222; GO:0071466 cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; positive regulation of stress fiber assembly [GO:0051496]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g5210.t1 Q1JQC6 58.537 287 9.36e-126 366.0 sp|Q1JQC6|SIR4_BOVIN NAD-dependent protein lipoamidase sirtuin-4, mitochondrial OS=Bos taurus OX=9913 GN=SIRT4 PE=2 SV=1 SIR4_BOVIN reviewed NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein biotinylase sirtuin-4) (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4) Bos taurus (Bovine) GO:0003950; GO:0004407; GO:0005739; GO:0005759; GO:0006541; GO:0006974; GO:0008270; GO:0016779; GO:0034979; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0070403; GO:0072350; GO:0106419; GO:0106420; GO:0140803; GO:0160218 DNA damage response [GO:0006974]; glutamine metabolic process [GO:0006541]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of pyruvate decarboxylation to acetyl-CoA [GO:0160218]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; tricarboxylic acid metabolic process [GO:0072350] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD-dependent protein biotinidase activity [GO:0106420]; NAD-dependent protein lipoamidase activity [GO:0106419]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270] g5211.t1 Q4V7D6 49.575 353 6.35e-116 343.0 sp|Q4V7D6|NIF3L_RAT NIF3-like protein 1 OS=Rattus norvegicus OX=10116 GN=Nif3l1 PE=1 SV=1 NIF3L_RAT reviewed NIF3-like protein 1 Rattus norvegicus (Rat) GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:0042802; GO:0045893; GO:0061629 negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g5211.t2 Q4V7D6 49.716 352 1.58e-117 347.0 sp|Q4V7D6|NIF3L_RAT NIF3-like protein 1 OS=Rattus norvegicus OX=10116 GN=Nif3l1 PE=1 SV=1 NIF3L_RAT reviewed NIF3-like protein 1 Rattus norvegicus (Rat) GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:0042802; GO:0045893; GO:0061629 negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g5212.t1 Q96DM1 24.952 525 8.26e-40 158.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g5213.t1 P49024 56.659 443 5.01e-168 491.0 sp|P49024|PAXI_CHICK Paxillin OS=Gallus gallus OX=9031 GN=PXN PE=1 SV=1 g5214.t1 Q61382 51.188 463 0.0 519.0 sp|Q61382|TRAF4_MOUSE TNF receptor-associated factor 4 OS=Mus musculus OX=10090 GN=Traf4 PE=1 SV=2 TRAF4_MOUSE reviewed TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1) Mus musculus (Mouse) GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699; GO:0061630 apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270] g5215.t1 Q9Y5R2 36.346 520 4.63e-88 286.0 sp|Q9Y5R2|MMP24_HUMAN Matrix metalloproteinase-24 OS=Homo sapiens OX=9606 GN=MMP24 PE=1 SV=1 MMP24_HUMAN reviewed Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] Homo sapiens (Human) GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742 cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g5216.t1 Q9ULZ9 35.477 482 5.1200000000000004e-86 280.0 sp|Q9ULZ9|MMP17_HUMAN Matrix metalloproteinase-17 OS=Homo sapiens OX=9606 GN=MMP17 PE=1 SV=4 MMP17_HUMAN reviewed Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP) Homo sapiens (Human) GO:0001822; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042756; GO:0070006; GO:0098552 collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g5217.t1 P51512 38.188 563 4.99e-111 346.0 sp|P51512|MMP16_HUMAN Matrix metalloproteinase-16 OS=Homo sapiens OX=9606 GN=MMP16 PE=1 SV=2 MMP16_HUMAN reviewed Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP) Homo sapiens (Human) GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094 chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g5218.t1 P51512 32.363 584 3.16e-75 254.0 sp|P51512|MMP16_HUMAN Matrix metalloproteinase-16 OS=Homo sapiens OX=9606 GN=MMP16 PE=1 SV=2 MMP16_HUMAN reviewed Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP) Homo sapiens (Human) GO:0001501; GO:0001958; GO:0004222; GO:0005615; GO:0005796; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094 chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g5219.t1 Q9JHI0 37.86 243 1.55e-39 147.0 sp|Q9JHI0|MMP19_MOUSE Matrix metalloproteinase-19 OS=Mus musculus OX=10090 GN=Mmp19 PE=2 SV=1 MMP19_MOUSE reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) Mus musculus (Mouse) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0009725; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591; GO:0098552 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g5220.t1 Q6PAY6 41.986 443 3.32e-114 348.0 sp|Q6PAY6|HYPDH_XENLA Hydroxyproline dehydrogenase OS=Xenopus laevis OX=8355 GN=prodh2 PE=2 SV=1 g5222.t1 Q8BHT6 46.488 484 2.43e-149 439.0 sp|Q8BHT6|B3GLT_MOUSE Beta-1,3-glucosyltransferase OS=Mus musculus OX=10090 GN=B3glct PE=1 SV=3 B3GLT_MOUSE reviewed Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like) Mus musculus (Mouse) GO:0001501; GO:0005789; GO:0006004; GO:0007420; GO:0008375; GO:0009306; GO:0010467; GO:0016757; GO:0036066; GO:0043010; GO:0044782; GO:0060021; GO:0060173; GO:0060271; GO:0160265; GO:1904888 brain development [GO:0007420]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; cranial skeletal system development [GO:1904888]; fucose metabolic process [GO:0006004]; gene expression [GO:0010467]; limb development [GO:0060173]; protein O-linked glycosylation via fucose [GO:0036066]; protein secretion [GO:0009306]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] endoplasmic reticulum membrane [GO:0005789] acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; O-fucosylpeptide 3-beta-glucosyltransferase activity [GO:0160265] g5223.t1 Q9D273 55.963 218 6.76e-81 245.0 sp|Q9D273|MMAB_MOUSE Corrinoid adenosyltransferase MMAB OS=Mus musculus OX=10090 GN=Mmab PE=1 SV=1 MMAB_MOUSE reviewed Corrinoid adenosyltransferase MMAB (EC 2.5.1.-) (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B homolog) Mus musculus (Mouse) GO:0005524; GO:0005739; GO:0008817; GO:0009235; GO:0016765; GO:0031419 cobalamin metabolic process [GO:0009235] mitochondrion [GO:0005739] ATP binding [GO:0005524]; cobalamin binding [GO:0031419]; corrinoid adenosyltransferase activity [GO:0008817]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765] g5224.t1 Q9P0Z9 46.702 379 3.82e-117 348.0 sp|Q9P0Z9|SOX_HUMAN Peroxisomal sarcosine oxidase OS=Homo sapiens OX=9606 GN=PIPOX PE=1 SV=2 SOX_HUMAN reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Homo sapiens (Human) GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g5225.t1 D3ZUQ0 35.34 382 4.67e-48 175.0 sp|D3ZUQ0|RIPL1_RAT RILP-like protein 1 OS=Rattus norvegicus OX=10116 GN=Rilpl1 PE=1 SV=1 RIPL1_RAT reviewed RILP-like protein 1 (GAPDH's competitor of SIAH1 protein enhances life) (GOSPEL) (Rab-interacting lysosomal-like protein 1) Rattus norvegicus (Rat) GO:0003382; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0007263; GO:0031267; GO:0036064; GO:0046983; GO:0051959; GO:0060271; GO:1903445 cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; nitric oxide mediated signal transduction [GO:0007263]; protein transport from ciliary membrane to plasma membrane [GO:1903445] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267] g5226.t1 Q8NFA0 48.077 1716 0.0 1509.0 sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1 UBP32_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32) Homo sapiens (Human) GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263 positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843] g5226.t2 Q8NFA0 46.985 1758 0.0 1493.0 sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1 UBP32_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32) Homo sapiens (Human) GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263 positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843] g5227.t1 Q5XI72 44.898 245 6.750000000000001e-43 150.0 sp|Q5XI72|IF4H_RAT Eukaryotic translation initiation factor 4H OS=Rattus norvegicus OX=10116 GN=Eif4h PE=1 SV=1 IF4H_RAT reviewed Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein homolog) Rattus norvegicus (Rat) GO:0001731; GO:0003743; GO:0033592; GO:0034057; GO:0043024; GO:0048471; GO:0048589; GO:0097010 developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731] perinuclear region of cytoplasm [GO:0048471] ribosomal small subunit binding [GO:0043024]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743] g5228.t1 Q6DRL5 27.516 1083 4.82e-97 341.0 sp|Q6DRL5|MBB1A_DANRE Myb-binding protein 1A-like protein OS=Danio rerio OX=7955 GN=mybbp1a PE=1 SV=1 MBB1A_DANRE reviewed Myb-binding protein 1A-like protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003714; GO:0005730; GO:0043565; GO:0048511 rhythmic process [GO:0048511] nucleolus [GO:0005730] sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714] g5228.t2 Q6DRL5 27.516 1083 4.39e-97 341.0 sp|Q6DRL5|MBB1A_DANRE Myb-binding protein 1A-like protein OS=Danio rerio OX=7955 GN=mybbp1a PE=1 SV=1 MBB1A_DANRE reviewed Myb-binding protein 1A-like protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003714; GO:0005730; GO:0043565; GO:0048511 rhythmic process [GO:0048511] nucleolus [GO:0005730] sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714] g5232.t1 Q8WXX7 31.971 832 2.69e-34 145.0 sp|Q8WXX7|AUTS2_HUMAN Autism susceptibility gene 2 protein OS=Homo sapiens OX=9606 GN=AUTS2 PE=1 SV=1 g5232.t2 Q8WXX7 31.205 830 1.6900000000000001e-29 130.0 sp|Q8WXX7|AUTS2_HUMAN Autism susceptibility gene 2 protein OS=Homo sapiens OX=9606 GN=AUTS2 PE=1 SV=1 g5233.t1 O17239 29.444 360 2.4700000000000002e-29 121.0 sp|O17239|NMUR2_CAEEL Neuromedin U receptor homolog nmur-2 OS=Caenorhabditis elegans OX=6239 GN=nmur-2 PE=3 SV=2 g5236.t1 Q8ITC7 26.126 333 1.29e-21 100.0 sp|Q8ITC7|CAPAR_DROME Neuropeptides capa receptor OS=Drosophila melanogaster OX=7227 GN=CapaR PE=2 SV=3 CAPAR_DROME reviewed Neuropeptides capa receptor (Cap2b receptor) (Capability receptor) Drosophila melanogaster (Fruit fly) GO:0001607; GO:0005886; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016020; GO:0016323; GO:0051928; GO:0071465 body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928] basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g5237.t1 P0C865 50.694 432 3.55e-143 454.0 sp|P0C865|MK07_RAT Mitogen-activated protein kinase 7 OS=Rattus norvegicus OX=10116 GN=Mapk7 PE=1 SV=1 MK07_RAT reviewed Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) Rattus norvegicus (Rat) GO:0000165; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016605; GO:0030154; GO:0034115; GO:0034392; GO:0035556; GO:0043066; GO:0045765; GO:0045944; GO:0051019; GO:0051247; GO:0060761; GO:0070301; GO:0070375; GO:0070377; GO:0070885; GO:0071363; GO:0071499; GO:0071560; GO:0106310; GO:1902176; GO:2000352; GO:2001240 cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ERK5 cascade [GO:0070375]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK5 cascade [GO:0070377]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5240.t1 Q8N0U8 46.746 169 1.4199999999999999e-52 168.0 sp|Q8N0U8|VKORL_HUMAN Vitamin K epoxide reductase complex subunit 1-like protein 1 OS=Homo sapiens OX=9606 GN=VKORC1L1 PE=1 SV=2 VKORL_HUMAN reviewed Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0017187; GO:0034599; GO:0042373; GO:0047057; GO:0048038 cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057] g5242.t1 O44252 28.745 247 2.97e-24 102.0 sp|O44252|ROST_DROME Protein rolling stone OS=Drosophila melanogaster OX=7227 GN=rost PE=2 SV=2 g5243.t1 O44252 28.226 248 8.53e-24 100.0 sp|O44252|ROST_DROME Protein rolling stone OS=Drosophila melanogaster OX=7227 GN=rost PE=2 SV=2 g5244.t1 Q9QXN5 56.507 292 4.670000000000001e-124 358.0 sp|Q9QXN5|MIOX_MOUSE Inositol oxygenase OS=Mus musculus OX=10090 GN=Miox PE=1 SV=2 MIOX_MOUSE reviewed Inositol oxygenase (EC 1.13.99.1) (Aldehyde reductase-like 6) (Myo-inositol oxygenase) (MI oxygenase) (Renal-specific oxidoreductase) Mus musculus (Mouse) GO:0005737; GO:0008106; GO:0008199; GO:0016234; GO:0016491; GO:0016651; GO:0019310; GO:0050113; GO:0050661 inositol catabolic process [GO:0019310] cytoplasm [GO:0005737]; inclusion body [GO:0016234] alcohol dehydrogenase (NADP+) activity [GO:0008106]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H [GO:0016651] g5245.t1 Q4V8T0 56.463 294 4.920000000000001e-125 361.0 sp|Q4V8T0|MIOX_DANRE Inositol oxygenase OS=Danio rerio OX=7955 GN=miox PE=2 SV=1 g5246.t1 P98154 30.211 331 2.98e-25 112.0 sp|P98154|IDD_MOUSE Integral membrane protein DGCR2/IDD OS=Mus musculus OX=10090 GN=Dgcr2 PE=2 SV=1 g5247.t1 Q2KHM9 35.038 391 5.05e-40 164.0 sp|Q2KHM9|MOONR_HUMAN Protein moonraker OS=Homo sapiens OX=9606 GN=KIAA0753 PE=1 SV=3 MOONR_HUMAN reviewed Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005929; GO:0007099; GO:0034451; GO:0036064; GO:0046872; GO:0051537; GO:0060271; GO:0061824; GO:0071539 centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; microtubule organizing center [GO:0005815] 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872] g5247.t2 Q2KHM9 35.038 391 5.119999999999999e-40 164.0 sp|Q2KHM9|MOONR_HUMAN Protein moonraker OS=Homo sapiens OX=9606 GN=KIAA0753 PE=1 SV=3 MOONR_HUMAN reviewed Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein) Homo sapiens (Human) GO:0005783; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005929; GO:0007099; GO:0034451; GO:0036064; GO:0046872; GO:0051537; GO:0060271; GO:0061824; GO:0071539 centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; microtubule organizing center [GO:0005815] 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872] g5248.t1 Q4V8C2 42.199 782 0.0 630.0 sp|Q4V8C2|ZW10_RAT Centromere/kinetochore protein zw10 homolog OS=Rattus norvegicus OX=10116 GN=Zw10 PE=2 SV=3 ZW10_RAT reviewed Centromere/kinetochore protein zw10 homolog Rattus norvegicus (Rat) GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0034501; GO:0051301; GO:0065003; GO:0070939; GO:1990423 cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096] cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] g5249.t1 Q8BZI6 41.126 231 1.0300000000000001e-47 160.0 sp|Q8BZI6|GUCD1_MOUSE Protein GUCD1 OS=Mus musculus OX=10090 GN=Gucd1 PE=2 SV=2 g5250.t1 Q68FD5 85.194 1675 0.0 3001.0 sp|Q68FD5|CLH1_MOUSE Clathrin heavy chain 1 OS=Mus musculus OX=10090 GN=Cltc PE=1 SV=3 CLH1_MOUSE reviewed Clathrin heavy chain 1 Mus musculus (Mouse) GO:0000278; GO:0003725; GO:0005198; GO:0005739; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0006914; GO:0007030; GO:0016020; GO:0019901; GO:0030117; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030315; GO:0030506; GO:0031072; GO:0031523; GO:0031623; GO:0032051; GO:0032991; GO:0033572; GO:0034451; GO:0042147; GO:0042277; GO:0042383; GO:0042470; GO:0043209; GO:0045334; GO:0048268; GO:0048488; GO:0050750; GO:0051301; GO:0060236; GO:0071439; GO:0072318; GO:0072583; GO:0072686; GO:0090307; GO:0097718; GO:0098684; GO:0098835; GO:0098843; GO:0098850; GO:0098978; GO:0120283; GO:0150093; GO:1900126; GO:1903077; GO:1990381; GO:1990498 amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle endocytosis [GO:0048488]; transferrin transport [GO:0033572] centriolar satellite [GO:0034451]; clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; photoreceptor ribbon synapse [GO:0098684]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; spindle [GO:0005819]; T-tubule [GO:0030315] ankyrin binding [GO:0030506]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; low-density lipoprotein particle receptor binding [GO:0050750]; peptide binding [GO:0042277]; protein kinase binding [GO:0019901]; protein serine/threonine kinase binding [GO:0120283]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381] g5251.t1 Q8IVN8 31.317 281 6.389999999999999e-34 126.0 sp|Q8IVN8|SBSPO_HUMAN Somatomedin-B and thrombospondin type-1 domain-containing protein OS=Homo sapiens OX=9606 GN=SBSPON PE=1 SV=2 g5252.t1 Q9P0Z9 45.22 387 3.0000000000000003e-117 349.0 sp|Q9P0Z9|SOX_HUMAN Peroxisomal sarcosine oxidase OS=Homo sapiens OX=9606 GN=PIPOX PE=1 SV=2 SOX_HUMAN reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Homo sapiens (Human) GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g5253.t1 Q9P0Z9 45.876 388 1.0200000000000001e-117 350.0 sp|Q9P0Z9|SOX_HUMAN Peroxisomal sarcosine oxidase OS=Homo sapiens OX=9606 GN=PIPOX PE=1 SV=2 SOX_HUMAN reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Homo sapiens (Human) GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g5254.t1 Q9R1S4 42.5 240 3.28e-38 136.0 sp|Q9R1S4|XBP1_RAT X-box-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Xbp1 PE=2 SV=1 XBP1_RAT reviewed X-box-binding protein 1 (Hepatocarcinogenesis-related transcription factor) (HTF) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form] Rattus norvegicus (Rat) GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001525; GO:0001558; GO:0001889; GO:0001935; GO:0002020; GO:0002071; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006511; GO:0007517; GO:0007584; GO:0008284; GO:0009410; GO:0010506; GO:0010508; GO:0010832; GO:0017148; GO:0019901; GO:0030335; GO:0030512; GO:0030968; GO:0031017; GO:0031490; GO:0031625; GO:0031647; GO:0031648; GO:0031670; GO:0032008; GO:0032755; GO:0032869; GO:0034599; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0036312; GO:0036498; GO:0042149; GO:0042307; GO:0042593; GO:0042632; GO:0042802; GO:0042826; GO:0043066; GO:0043161; GO:0043491; GO:0043565; GO:0044389; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0048010; GO:0048666; GO:0051602; GO:0051897; GO:0055089; GO:0055092; GO:0060096; GO:0060392; GO:0060612; GO:0060691; GO:0061629; GO:0070059; GO:0070373; GO:0071222; GO:0071230; GO:0071236; GO:0071332; GO:0071333; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:0090575; GO:0098793; GO:1900100; GO:1900102; GO:1901800; GO:1902236; GO:1903489; GO:1904294; GO:1904707; GO:1904754; GO:1990418; GO:1990830; GO:1990837; GO:2000347; GO:2000353; GO:2001243 adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid homeostasis [GO:0055089]; glandular epithelial cell maturation [GO:0002071]; glucose homeostasis [GO:0042593]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of translation [GO:0017148]; neuron development [GO:0048666]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular wound healing [GO:0035470]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; serotonin secretion, neurotransmission [GO:0060096]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; presynapse [GO:0098793]; RNA polymerase II transcription regulator complex [GO:0090575] chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389] g5256.t1 Q58DV0 72.727 385 0.0 602.0 sp|Q58DV0|PELO_BOVIN Protein pelota homolog OS=Bos taurus OX=9913 GN=PELO PE=2 SV=2 g5257.t1 Q58D20 71.338 471 0.0 741.0 sp|Q58D20|NLE1_BOVIN Notchless protein homolog 1 OS=Bos taurus OX=9913 GN=NLE1 PE=2 SV=3 g5258.t1 Q3ZBR7 43.85 187 8.36e-47 155.0 sp|Q3ZBR7|RM18_BOVIN Large ribosomal subunit protein uL18m OS=Bos taurus OX=9913 GN=MRPL18 PE=2 SV=1 g5259.t1 D3ZSZ3 78.517 391 0.0 667.0 sp|D3ZSZ3|NLK_RAT Serine/threonine-protein kinase NLK OS=Rattus norvegicus OX=10116 GN=Nlk PE=3 SV=1 NLK_RAT reviewed Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) Rattus norvegicus (Rat) GO:0000287; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0016055; GO:0030178; GO:0031625; GO:0031669; GO:0035556; GO:0038202; GO:0042169; GO:0050821; GO:0061462; GO:0071470; GO:0106310; GO:0140297; GO:1904262; GO:1904263; GO:1904894 cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; TORC1 signaling [GO:0038202]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625] g5260.t1 Q6GM71 29.304 819 7.48e-90 307.0 sp|Q6GM71|LRWD1_XENLA Leucine-rich repeat and WD repeat-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrwd1 PE=2 SV=1 LRWD1_XENLA reviewed Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein) Xenopus laevis (African clawed frog) GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005813; GO:0006260; GO:0006325; GO:0008327; GO:0061628; GO:0071169 chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169] centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] chromatin binding [GO:0003682]; histone H3K27me3 reader activity [GO:0061628]; methyl-CpG binding [GO:0008327] g5260.t2 B0R160 28.712 815 1.1999999999999999e-82 288.0 sp|B0R160|LRWD1_DANRE Leucine-rich repeat and WD repeat-containing protein 1 OS=Danio rerio OX=7955 GN=lrwd1 PE=1 SV=1 LRWD1_DANRE reviewed Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005813; GO:0006260; GO:0006325; GO:0008327; GO:0061628; GO:0071169 chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169] centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] chromatin binding [GO:0003682]; histone H3K27me3 reader activity [GO:0061628]; methyl-CpG binding [GO:0008327] g5261.t1 Q9NXW9 49.201 313 2.6600000000000004e-88 268.0 sp|Q9NXW9|ALKB4_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 OS=Homo sapiens OX=9606 GN=ALKBH4 PE=1 SV=1 ALKB4_HUMAN reviewed Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-) Homo sapiens (Human) GO:0003779; GO:0005730; GO:0005737; GO:0016706; GO:0030496; GO:0031032; GO:0032451; GO:0035516; GO:0036090; GO:0046872; GO:0070938; GO:0070988; GO:0140457; GO:0141131; GO:0141137 actomyosin structure organization [GO:0031032]; cleavage furrow ingression [GO:0036090]; demethylation [GO:0070988]; positive regulation of gene expression, epigenetic [GO:0141137] contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; broad specificity oxidative DNA demethylase activity [GO:0035516]; demethylase activity [GO:0032451]; DNA N6-methyladenine demethylase activity [GO:0141131]; metal ion binding [GO:0046872]; protein demethylase activity [GO:0140457] g5262.t1 Q9Y6J8 39.432 317 1.5e-71 226.0 sp|Q9Y6J8|STYL1_HUMAN Serine/threonine/tyrosine-interacting-like protein 1 OS=Homo sapiens OX=9606 GN=STYXL1 PE=1 SV=1 STYL1_HUMAN reviewed Serine/threonine/tyrosine-interacting-like protein 1 (Dual specificity phosphatase inhibitor MK-STYX) (Dual specificity protein phosphatase 24) (Inactive dual specificity protein phosphatase MK-STYX) (Map kinase phosphatase-like protein MK-STYX) Homo sapiens (Human) GO:0001691; GO:0005739; GO:0005759; GO:0010976; GO:0019212; GO:0019903; GO:0035556; GO:0062030; GO:2001242; GO:2001244 intracellular signal transduction [GO:0035556]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] phosphatase inhibitor activity [GO:0019212]; protein phosphatase binding [GO:0019903]; pseudophosphatase activity [GO:0001691] g5263.t1 Q5NVR2 65.373 335 6.68e-159 451.0 sp|Q5NVR2|MDHM_PONAB Malate dehydrogenase, mitochondrial OS=Pongo abelii OX=9601 GN=MDH2 PE=2 SV=1 g5264.t1 Q0IIH7 34.667 450 1.01e-61 221.0 sp|Q0IIH7|ST14_BOVIN Suppressor of tumorigenicity 14 protein homolog OS=Bos taurus OX=9913 GN=ST14 PE=2 SV=1 ST14_BOVIN reviewed Suppressor of tumorigenicity 14 protein homolog (EC 3.4.21.109) (Serine protease 14) Bos taurus (Bovine) GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0030216 keratinocyte differentiation [GO:0030216]; proteolysis [GO:0006508] plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g5266.t1 Q5EAJ7 80.19 843 0.0 1393.0 sp|Q5EAJ7|MVP_STRPU Major vault protein OS=Strongylocentrotus purpuratus OX=7668 GN=MVP PE=1 SV=1 g5267.t1 P35240 59.729 591 0.0 723.0 sp|P35240|MERL_HUMAN Merlin OS=Homo sapiens OX=9606 GN=NF2 PE=1 SV=1 MERL_HUMAN reviewed Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin) Homo sapiens (Human) GO:0000165; GO:0001707; GO:0001953; GO:0003779; GO:0005178; GO:0005634; GO:0005730; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0007398; GO:0008285; GO:0008360; GO:0010626; GO:0014010; GO:0014013; GO:0016020; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030336; GO:0030864; GO:0031527; GO:0031647; GO:0032154; GO:0032587; GO:0033687; GO:0033689; GO:0035329; GO:0035330; GO:0035591; GO:0042475; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0046426; GO:0048471; GO:0051496; GO:0051726; GO:0060243; GO:0070306; GO:0072091; GO:1900180; GO:1902115; GO:1902966; GO:2000177; GO:2000643 actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippo signaling [GO:0035329]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of Schwann cell proliferation [GO:0010626]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of organelle assembly [GO:1902115]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] actin binding [GO:0003779]; integrin binding [GO:0005178]; signaling adaptor activity [GO:0035591] g5268.t1 Q9NDJ2 54.954 868 0.0 951.0 sp|Q9NDJ2|DOM_DROME Helicase domino OS=Drosophila melanogaster OX=7227 GN=dom PE=1 SV=2 DOM_DROME reviewed Chromatin remodeling protein domino (EC 3.6.4.-) Drosophila melanogaster (Fruit fly) GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010557; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140096; GO:0140713; GO:0140849; GO:0140861 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of macromolecule biosynthetic process [GO:0010557]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222] histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent H2AZ histone chaperone activity [GO:0140849]; catalytic activity, acting on a protein [GO:0140096]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g5268.t1 Q9NDJ2 45.632 870 0.0 731.0 sp|Q9NDJ2|DOM_DROME Helicase domino OS=Drosophila melanogaster OX=7227 GN=dom PE=1 SV=2 DOM_DROME reviewed Chromatin remodeling protein domino (EC 3.6.4.-) Drosophila melanogaster (Fruit fly) GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010557; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140096; GO:0140713; GO:0140849; GO:0140861 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of macromolecule biosynthetic process [GO:0010557]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222] histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent H2AZ histone chaperone activity [GO:0140849]; catalytic activity, acting on a protein [GO:0140096]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g5268.t2 Q9NDJ2 54.828 870 0.0 950.0 sp|Q9NDJ2|DOM_DROME Helicase domino OS=Drosophila melanogaster OX=7227 GN=dom PE=1 SV=2 DOM_DROME reviewed Chromatin remodeling protein domino (EC 3.6.4.-) Drosophila melanogaster (Fruit fly) GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010557; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140096; GO:0140713; GO:0140849; GO:0140861 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of macromolecule biosynthetic process [GO:0010557]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222] histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent H2AZ histone chaperone activity [GO:0140849]; catalytic activity, acting on a protein [GO:0140096]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g5268.t2 Q9NDJ2 45.517 870 0.0 729.0 sp|Q9NDJ2|DOM_DROME Helicase domino OS=Drosophila melanogaster OX=7227 GN=dom PE=1 SV=2 DOM_DROME reviewed Chromatin remodeling protein domino (EC 3.6.4.-) Drosophila melanogaster (Fruit fly) GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010557; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140096; GO:0140713; GO:0140849; GO:0140861 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of macromolecule biosynthetic process [GO:0010557]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222] histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent H2AZ histone chaperone activity [GO:0140849]; catalytic activity, acting on a protein [GO:0140096]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g5268.t3 Q9NDJ2 54.828 870 0.0 950.0 sp|Q9NDJ2|DOM_DROME Helicase domino OS=Drosophila melanogaster OX=7227 GN=dom PE=1 SV=2 DOM_DROME reviewed Chromatin remodeling protein domino (EC 3.6.4.-) Drosophila melanogaster (Fruit fly) GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010557; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140096; GO:0140713; GO:0140849; GO:0140861 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of macromolecule biosynthetic process [GO:0010557]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222] histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent H2AZ histone chaperone activity [GO:0140849]; catalytic activity, acting on a protein [GO:0140096]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g5268.t3 Q9NDJ2 45.632 870 0.0 731.0 sp|Q9NDJ2|DOM_DROME Helicase domino OS=Drosophila melanogaster OX=7227 GN=dom PE=1 SV=2 DOM_DROME reviewed Chromatin remodeling protein domino (EC 3.6.4.-) Drosophila melanogaster (Fruit fly) GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010557; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140096; GO:0140713; GO:0140849; GO:0140861 chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; positive regulation of macromolecule biosynthetic process [GO:0010557]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222] histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent H2AZ histone chaperone activity [GO:0140849]; catalytic activity, acting on a protein [GO:0140096]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] g5270.t1 P79218 29.29 338 4.43e-25 107.0 sp|P79218|NK2R_RABIT Substance-K receptor OS=Oryctolagus cuniculus OX=9986 GN=TACR2 PE=2 SV=1 g5272.t1 A6QP05 50.175 285 1.37e-91 278.0 sp|A6QP05|DHR12_BOVIN Dehydrogenase/reductase SDR family member 12 OS=Bos taurus OX=9913 GN=DHRS12 PE=2 SV=1 g5274.t1 Q7ZVN7 40.789 304 4.7799999999999995e-61 222.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g5274.t2 Q7ZVN7 40.789 304 5.06e-61 222.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g5274.t3 Q7ZVN7 40.789 304 5.8499999999999995e-61 221.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g5274.t4 Q7ZVN7 40.789 304 4.5099999999999996e-61 221.0 sp|Q7ZVN7|MED15_DANRE Mediator of RNA polymerase II transcription subunit 15 OS=Danio rerio OX=7955 GN=med15 PE=2 SV=1 g5276.t1 Q5M819 52.423 227 8.26e-89 264.0 sp|Q5M819|SERB_RAT Phosphoserine phosphatase OS=Rattus norvegicus OX=10116 GN=Psph PE=2 SV=1 SERB_RAT reviewed Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase) Rattus norvegicus (Rat) GO:0000287; GO:0001701; GO:0005737; GO:0005829; GO:0006563; GO:0006564; GO:0009612; GO:0031667; GO:0033574; GO:0036424; GO:0042802; GO:0042803 in utero embryonic development [GO:0001701]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574] cytoplasm [GO:0005737]; cytosol [GO:0005829] identical protein binding [GO:0042802]; L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] g5277.t1 Q3TCN2 50.838 537 0.0 558.0 sp|Q3TCN2|PLBL2_MOUSE Putative phospholipase B-like 2 OS=Mus musculus OX=10090 GN=Plbd2 PE=1 SV=2 PLBL2_MOUSE reviewed Putative phospholipase B-like 2 (EC 3.4.11.-) (66.3 kDa protein) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative aminopeptidase PLBD2 28 kDa form; Putative aminopeptidase PLBD2 40 kDa form; Putative aminopeptidase PLBD2 15 kDa form] Mus musculus (Mouse) GO:0004620; GO:0005576; GO:0005764; GO:0009395; GO:0043202 phospholipid catabolic process [GO:0009395] extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] phospholipase activity [GO:0004620] g5279.t1 Q9BYK8 32.933 1667 0.0 724.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g5279.t1 Q9BYK8 31.463 1087 8.239999999999999e-106 385.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g5279.t1 Q9BYK8 33.333 300 3.6000000000000006e-27 126.0 sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7 g5280.t1 Q99MS0 46.565 393 2.18e-127 375.0 sp|Q99MS0|S14L2_RAT SEC14-like protein 2 OS=Rattus norvegicus OX=10116 GN=Sec14l2 PE=1 SV=1 g5281.t1 Q5RB71 59.438 641 0.0 752.0 sp|Q5RB71|MTO1_PONAB 5-taurinomethyluridine-[tRNA] synthase subunit MTO1, mitochondrial OS=Pongo abelii OX=9601 GN=MTO1 PE=2 SV=1 MTO1_PONAB reviewed 5-taurinomethyluridine-[tRNA] synthase subunit MTO1, mitochondrial (Mitochondrial tRNA translation optimization 1) (Protein MTO1 homolog, mitochondrial) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005739; GO:0005829; GO:0030488; GO:0050660; GO:0070899 mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488] cytosol [GO:0005829]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660] g5281.t2 Q5RB71 59.438 641 0.0 752.0 sp|Q5RB71|MTO1_PONAB 5-taurinomethyluridine-[tRNA] synthase subunit MTO1, mitochondrial OS=Pongo abelii OX=9601 GN=MTO1 PE=2 SV=1 MTO1_PONAB reviewed 5-taurinomethyluridine-[tRNA] synthase subunit MTO1, mitochondrial (Mitochondrial tRNA translation optimization 1) (Protein MTO1 homolog, mitochondrial) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005739; GO:0005829; GO:0030488; GO:0050660; GO:0070899 mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488] cytosol [GO:0005829]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660] g5282.t1 Q8BG80 54.054 111 7.689999999999999e-34 142.0 sp|Q8BG80|FBX46_MOUSE F-box only protein 46 OS=Mus musculus OX=10090 GN=Fbxo46 PE=2 SV=1 g5283.t1 P68037 79.739 153 3.09e-90 262.0 sp|P68037|UB2L3_MOUSE Ubiquitin-conjugating enzyme E2 L3 OS=Mus musculus OX=10090 GN=Ube2l3 PE=1 SV=1 UB2L3_MOUSE reviewed Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (UbcM4) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3) Mus musculus (Mouse) GO:0000209; GO:0003713; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006511; GO:0008283; GO:0016567; GO:0031398; GO:0031625; GO:0044770; GO:0061631; GO:0070979; GO:0071383; GO:0071385; GO:0097027; GO:0098793 cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein ubiquitination [GO:0031398]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA-templated transcription [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynapse [GO:0098793] ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842] g5285.t1 P51464 67.401 454 0.0 663.0 sp|P51464|ARLY_AQUCT Argininosuccinate lyase OS=Aquarana catesbeiana OX=8400 GN=ASL PE=3 SV=1 g5286.t1 Q5F3D1 32.54 630 9.73e-77 259.0 sp|Q5F3D1|ZCHC8_CHICK Zinc finger CCHC domain-containing protein 8 OS=Gallus gallus OX=9031 GN=ZCCHC8 PE=2 SV=1 g5287.t1 P07898 33.793 145 2.07e-22 97.1 sp|P07898|PGCA_CHICK Aggrecan core protein OS=Gallus gallus OX=9031 GN=ACAN PE=1 SV=2 g5290.t1 Q8WPD0 41.549 142 4.36e-26 100.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g5291.t1 P07898 33.103 145 4.95e-22 95.9 sp|P07898|PGCA_CHICK Aggrecan core protein OS=Gallus gallus OX=9031 GN=ACAN PE=1 SV=2 g5292.t1 Q8WPD0 42.029 138 3.78e-26 100.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g5296.t1 Q5F4C0 30.645 248 1.03e-33 128.0 sp|Q5F4C0|HVCN1_CHICK Voltage-gated hydrogen channel 1 OS=Gallus gallus OX=9031 GN=HVCN1 PE=2 SV=1 HVCN1_CHICK reviewed Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) Gallus gallus (Chicken) GO:0005886; GO:0009268; GO:0010043; GO:0016020; GO:0030171; GO:0030670; GO:0034702; GO:0042803; GO:0051453; GO:0071294; GO:0071467; GO:1902600; GO:1903426 cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; response to pH [GO:0009268]; response to zinc ion [GO:0010043] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] protein homodimerization activity [GO:0042803]; voltage-gated proton channel activity [GO:0030171] g5297.t1 Q9DBE9 44.544 889 0.0 667.0 sp|Q9DBE9|SPB1_MOUSE pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Mus musculus OX=10090 GN=Ftsj3 PE=1 SV=1 SPB1_MOUSE reviewed pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) Mus musculus (Mouse) GO:0000463; GO:0000466; GO:0001510; GO:0005654; GO:0005694; GO:0005730; GO:0008650; GO:0016435; GO:0030687; GO:0030688; GO:0031167; GO:0062105 maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688] RNA 2'-O-methyltransferase activity [GO:0062105]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650] g5298.t1 Q6PFQ2 69.0 400 0.0 573.0 sp|Q6PFQ2|EIF3C_DANRE Eukaryotic translation initiation factor 3 subunit C OS=Danio rerio OX=7955 GN=eif3c PE=1 SV=1 g5298.t1 Q6PFQ2 45.714 525 5.7e-110 368.0 sp|Q6PFQ2|EIF3C_DANRE Eukaryotic translation initiation factor 3 subunit C OS=Danio rerio OX=7955 GN=eif3c PE=1 SV=1 g5299.t1 Q6GR37 46.292 445 1.28e-127 390.0 sp|Q6GR37|MET16_XENLA RNA N(6)-adenosine-methyltransferase mettl16 OS=Xenopus laevis OX=8355 GN=mettl16 PE=2 SV=1 MET16_XENLA reviewed RNA N(6)-adenosine-methyltransferase mettl16 (EC 2.1.1.348) (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346) Xenopus laevis (African clawed frog) GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0120048; GO:0120049 mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049] cytoplasm [GO:0005737]; nucleus [GO:0005634] 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629] g5300.t1 C3XVT5 78.676 408 0.0 698.0 sp|C3XVT5|LIS1_BRAFL Lissencephaly-1 homolog OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_59218 PE=3 SV=1 LIS1_BRAFL reviewed Lissencephaly-1 homolog Branchiostoma floridae (Florida lancelet) (Amphioxus) GO:0000132; GO:0000776; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0007281; GO:0008090; GO:0031023; GO:0043005; GO:0043025; GO:0047496; GO:0048854; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1904115 brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635] dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010] g5301.t1 A0JMD0 61.119 1358 0.0 1662.0 sp|A0JMD0|CLU_DANRE Clustered mitochondria protein homolog OS=Danio rerio OX=7955 GN=cluh PE=2 SV=1 g5302.t1 Q80U63 54.762 756 0.0 837.0 sp|Q80U63|MFN2_MOUSE Mitofusin-2 OS=Mus musculus OX=10090 GN=Mfn2 PE=1 SV=3 MFN2_MOUSE reviewed Mitofusin-2 (EC 3.6.5.-) (Hypertension-related protein 1) (Mitochondrial assembly regulatory factor) (HSG protein) (Transmembrane GTPase MFN2) Mus musculus (Mouse) GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007005; GO:0007006; GO:0008053; GO:0008285; GO:0009060; GO:0010628; GO:0010667; GO:0010729; GO:0010918; GO:0015630; GO:0031267; GO:0031625; GO:0034497; GO:0042802; GO:0043394; GO:0045786; GO:0045792; GO:0046326; GO:0046580; GO:0046628; GO:0048312; GO:0048593; GO:0048662; GO:0051020; GO:0051560; GO:0051646; GO:0060253; GO:0060299; GO:0061003; GO:0061734; GO:0090201; GO:0090258; GO:0120162; GO:1901857; GO:1903427; GO:1903428; GO:1904706; GO:1904707; GO:1905461; GO:2000386; GO:2000866; GO:2000872 aerobic respiration [GO:0009060]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of D-glucose import [GO:0046326]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]; type 2 mitophagy [GO:0061734] cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proteoglycan binding [GO:0043394]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] g5303.t1 A4FVI0 50.746 134 2.21e-38 130.0 sp|A4FVI0|ZSWM7_DANRE Zinc finger SWIM domain-containing protein 7 OS=Danio rerio OX=7955 GN=zswim7 PE=2 SV=2 g5304.t1 P07207 35.06 1332 0.0 616.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 33.481 1356 3.5299999999999997e-165 568.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 28.992 952 3.6400000000000004e-71 270.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 35.104 433 1.23e-49 199.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 32.525 495 5.879999999999999e-48 194.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 35.872 407 3.2000000000000004e-47 191.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 34.644 407 1.32e-44 182.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 28.333 660 2.55e-44 182.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 33.005 406 1.76e-41 172.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 32.85 414 6.34e-41 171.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 33.094 417 4.01e-40 168.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 32.176 432 1.76e-38 162.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 35.0 300 2.7e-25 119.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t1 P07207 35.145 276 1.57e-24 117.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 34.85 1297 1.25e-175 598.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 33.358 1370 1.75e-169 580.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 35.18 722 1.23e-91 337.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 29.452 876 3.7499999999999996e-67 256.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 35.104 433 6.57e-50 200.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 32.525 495 3.2299999999999997e-48 194.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 35.872 407 1.7300000000000002e-47 192.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 34.644 407 7.11e-45 183.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 33.005 406 9.01e-42 173.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 32.85 414 3.9e-41 171.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 33.094 417 2.16e-40 169.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 32.176 432 8.28e-39 164.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 34.505 313 1.8e-25 120.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5304.t2 P07207 35.145 276 9.22e-25 117.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5305.t1 Q9GZN7 45.985 274 3.3999999999999997e-74 232.0 sp|Q9GZN7|ROGDI_HUMAN Protein rogdi homolog OS=Homo sapiens OX=9606 GN=ROGDI PE=1 SV=1 ROGDI_HUMAN reviewed Protein rogdi homolog Homo sapiens (Human) GO:0005635; GO:0007420; GO:0007613; GO:0008021; GO:0008284; GO:0009410; GO:0010467; GO:0022008; GO:0030097; GO:0030282; GO:0030424; GO:0030425; GO:0040011; GO:0042475; GO:0043204; GO:0043291; GO:0045475; GO:0045851; GO:0050905; GO:0070166; GO:0098686 bone mineralization [GO:0030282]; brain development [GO:0007420]; enamel mineralization [GO:0070166]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; locomotion [GO:0040011]; locomotor rhythm [GO:0045475]; memory [GO:0007613]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; odontogenesis of dentin-containing tooth [GO:0042475]; pH reduction [GO:0045851]; positive regulation of cell population proliferation [GO:0008284]; response to xenobiotic stimulus [GO:0009410] axon [GO:0030424]; dendrite [GO:0030425]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021] g5305.t2 Q9GZN7 44.853 272 2.31e-70 221.0 sp|Q9GZN7|ROGDI_HUMAN Protein rogdi homolog OS=Homo sapiens OX=9606 GN=ROGDI PE=1 SV=1 ROGDI_HUMAN reviewed Protein rogdi homolog Homo sapiens (Human) GO:0005635; GO:0007420; GO:0007613; GO:0008021; GO:0008284; GO:0009410; GO:0010467; GO:0022008; GO:0030097; GO:0030282; GO:0030424; GO:0030425; GO:0040011; GO:0042475; GO:0043204; GO:0043291; GO:0045475; GO:0045851; GO:0050905; GO:0070166; GO:0098686 bone mineralization [GO:0030282]; brain development [GO:0007420]; enamel mineralization [GO:0070166]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; locomotion [GO:0040011]; locomotor rhythm [GO:0045475]; memory [GO:0007613]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; odontogenesis of dentin-containing tooth [GO:0042475]; pH reduction [GO:0045851]; positive regulation of cell population proliferation [GO:0008284]; response to xenobiotic stimulus [GO:0009410] axon [GO:0030424]; dendrite [GO:0030425]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021] g5307.t1 Q9Y6X9 43.911 1084 0.0 835.0 sp|Q9Y6X9|MORC2_HUMAN ATPase MORC2 OS=Homo sapiens OX=9606 GN=MORC2 PE=1 SV=2 g5307.t2 Q9Y6X9 43.692 1078 0.0 833.0 sp|Q9Y6X9|MORC2_HUMAN ATPase MORC2 OS=Homo sapiens OX=9606 GN=MORC2 PE=1 SV=2 g5308.t1 Q9NWD8 34.551 301 2.66e-53 179.0 sp|Q9NWD8|TM248_HUMAN Transmembrane protein 248 OS=Homo sapiens OX=9606 GN=TMEM248 PE=1 SV=1 TM248_HUMAN reviewed Transmembrane protein 248 Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g5310.t1 P00730 41.289 419 9e-104 317.0 sp|P00730|CBPA1_BOVIN Carboxypeptidase A1 OS=Bos taurus OX=9913 GN=CPA1 PE=1 SV=3 CBPA1_BOVIN reviewed Carboxypeptidase A1 (EC 3.4.17.1) Bos taurus (Bovine) GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270 leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g5312.t1 Q9TR36 60.223 269 3.67e-114 332.0 sp|Q9TR36|PIPNB_BOVIN Phosphatidylinositol transfer protein beta isoform OS=Bos taurus OX=9913 GN=PITPNB PE=1 SV=3 PIPNB_BOVIN reviewed Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) (Phosphatidylinositol-transfer protein 36 kDa isoform) (PI-TP 36 kda isoform) Bos taurus (Bovine) GO:0000139; GO:0005737; GO:0005789; GO:0005794; GO:0006890; GO:0008525; GO:0008526; GO:0031210; GO:0035091; GO:0120019; GO:0140338 retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338] g5313.t1 A4IF93 49.138 348 2.99e-126 377.0 sp|A4IF93|TBCC1_BOVIN TBCC domain-containing protein 1 OS=Bos taurus OX=9913 GN=TBCCD1 PE=2 SV=1 g5314.t1 Q640P7 43.312 157 4.74e-32 122.0 sp|Q640P7|TBCC1_MOUSE TBCC domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tbccd1 PE=1 SV=1 g5315.t1 P55937 31.044 1092 1.2900000000000002e-124 434.0 sp|P55937|GOGA3_MOUSE Golgin subfamily A member 3 OS=Mus musculus OX=10090 GN=Golga3 PE=1 SV=3 g5316.t1 Q6NVE9 58.413 315 8.18e-125 362.0 sp|Q6NVE9|PPTC7_MOUSE Protein phosphatase PTC7 homolog OS=Mus musculus OX=10090 GN=Pptc7 PE=1 SV=1 PPTC7_MOUSE reviewed Protein phosphatase PTC7 homolog (EC 3.1.3.16) (T-cell activation protein phosphatase 2C) (TA-PP2C) Mus musculus (Mouse) GO:0000423; GO:0004722; GO:0005739; GO:0005741; GO:0005759; GO:0010795; GO:0030674; GO:0046872; GO:1901525; GO:1904775 mitophagy [GO:0000423]; negative regulation of mitophagy [GO:1901525]; positive regulation of ubiquinone biosynthetic process [GO:1904775]; regulation of ubiquinone biosynthetic process [GO:0010795] mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein-macromolecule adaptor activity [GO:0030674] g5318.t1 Q2TA16 55.533 497 2.2299999999999997e-180 518.0 sp|Q2TA16|DRC2_BOVIN Dynein regulatory complex subunit 2 OS=Bos taurus OX=9913 GN=CCDC65 PE=2 SV=1 g5319.t1 Q5FW48 50.352 284 4.75e-88 265.0 sp|Q5FW48|ASPDH_XENTR Aspartate dehydrogenase domain-containing protein OS=Xenopus tropicalis OX=8364 GN=aspdh PE=2 SV=1 g5320.t1 Q91ZQ0 65.789 342 1.8e-169 484.0 sp|Q91ZQ0|VMP1_RAT Vacuole membrane protein 1 OS=Rattus norvegicus OX=10116 GN=Vmp1 PE=1 SV=1 VMP1_RAT reviewed Vacuole membrane protein 1 Rattus norvegicus (Rat) GO:0000045; GO:0000407; GO:0000421; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0006914; GO:0007030; GO:0007566; GO:0012505; GO:0016020; GO:0016240; GO:0017128; GO:0033116; GO:0034329; GO:0042953; GO:0098609; GO:0140056; GO:1901896; GO:1990456 autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; autophagy [GO:0006914]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; embryo implantation [GO:0007566]; Golgi organization [GO:0007030]; lipoprotein transport [GO:0042953]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; organelle localization by membrane tethering [GO:0140056]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896] autophagosome membrane [GO:0000421]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; membrane [GO:0016020]; nucleolus [GO:0005730]; phagophore assembly site [GO:0000407]; plasma membrane [GO:0005886] phospholipid scramblase activity [GO:0017128] g5321.t1 Q6GM16 41.844 423 6.83e-116 348.0 sp|Q6GM16|NXN_XENLA Nucleoredoxin OS=Xenopus laevis OX=8355 GN=nxn PE=2 SV=1 NXN_XENLA reviewed Nucleoredoxin (EC 1.8.1.8) Xenopus laevis (African clawed frog) GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359 cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] thioredoxin-disulfide reductase (NADPH) activity [GO:0004791] g5322.t1 Q13615 54.224 651 0.0 726.0 sp|Q13615|MTMR3_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Homo sapiens OX=9606 GN=MTMR3 PE=1 SV=3 MTMR3_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase) (Zinc finger FYVE domain-containing protein 10) Homo sapiens (Human) GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0008270; GO:0016020; GO:0016236; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785 cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g5322.t1 Q13615 40.23 174 4.4100000000000004e-32 139.0 sp|Q13615|MTMR3_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Homo sapiens OX=9606 GN=MTMR3 PE=1 SV=3 MTMR3_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase) (Zinc finger FYVE domain-containing protein 10) Homo sapiens (Human) GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0008270; GO:0016020; GO:0016236; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785 cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g5322.t2 Q13615 54.224 651 0.0 726.0 sp|Q13615|MTMR3_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Homo sapiens OX=9606 GN=MTMR3 PE=1 SV=3 MTMR3_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase) (Zinc finger FYVE domain-containing protein 10) Homo sapiens (Human) GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0008270; GO:0016020; GO:0016236; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785 cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g5322.t2 Q13615 39.655 174 9.72e-31 135.0 sp|Q13615|MTMR3_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Homo sapiens OX=9606 GN=MTMR3 PE=1 SV=3 MTMR3_HUMAN reviewed Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase) (Zinc finger FYVE domain-containing protein 10) Homo sapiens (Human) GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0008270; GO:0016020; GO:0016236; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785 cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g5323.t1 Q7ZYJ0 50.103 485 3.35e-136 428.0 sp|Q7ZYJ0|TAO1B_XENLA Serine/threonine-protein kinase TAO1-B OS=Xenopus laevis OX=8355 GN=taok1-b PE=2 SV=1 TAO1B_XENLA reviewed Serine/threonine-protein kinase TAO1-B (EC 2.7.11.1) (Thousand and one amino acid protein 1-B) Xenopus laevis (African clawed frog) GO:0004674; GO:0005524; GO:0005737; GO:0006281; GO:0006974; GO:0007095; GO:0032874; GO:0046330; GO:0051301; GO:0051493; GO:0097194; GO:0106310 cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of JNK cascade [GO:0046330]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of cytoskeleton organization [GO:0051493] cytoplasm [GO:0005737] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5323.t2 Q7ZYJ0 50.207 484 1.18e-135 429.0 sp|Q7ZYJ0|TAO1B_XENLA Serine/threonine-protein kinase TAO1-B OS=Xenopus laevis OX=8355 GN=taok1-b PE=2 SV=1 TAO1B_XENLA reviewed Serine/threonine-protein kinase TAO1-B (EC 2.7.11.1) (Thousand and one amino acid protein 1-B) Xenopus laevis (African clawed frog) GO:0004674; GO:0005524; GO:0005737; GO:0006281; GO:0006974; GO:0007095; GO:0032874; GO:0046330; GO:0051301; GO:0051493; GO:0097194; GO:0106310 cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of JNK cascade [GO:0046330]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of cytoskeleton organization [GO:0051493] cytoplasm [GO:0005737] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5325.t1 Q53UA7 75.478 314 2.46e-176 522.0 sp|Q53UA7|TAOK3_RAT Serine/threonine-protein kinase TAO3 OS=Rattus norvegicus OX=10116 GN=Taok3 PE=1 SV=1 TAOK3_RAT reviewed Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Axotomy-related gene 357 protein) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Thousand and one amino acid protein 3) Rattus norvegicus (Rat) GO:0000165; GO:0004674; GO:0005524; GO:0005737; GO:0005811; GO:0005886; GO:0006281; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0043408; GO:0045121; GO:0046329; GO:0046330; GO:0048812; GO:0106310 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740] g5326.t1 B6NK32 63.077 65 3.67e-29 101.0 sp|B6NK32|LYRM9_BRAFL LYR motif-containing protein 9 OS=Branchiostoma floridae OX=7739 GN=LYRM9 PE=3 SV=1 g5327.t1 Q6DDL7 40.596 436 3.7500000000000004e-109 334.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g5328.t1 Q5SPL2 71.875 96 9.579999999999999e-46 162.0 sp|Q5SPL2|PHF12_MOUSE PHD finger protein 12 OS=Mus musculus OX=10090 GN=Phf12 PE=1 SV=1 PHF12_MOUSE reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Mus musculus (Mouse) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g5329.t1 Q96QT6 49.346 306 5.7e-76 271.0 sp|Q96QT6|PHF12_HUMAN PHD finger protein 12 OS=Homo sapiens OX=9606 GN=PHF12 PE=1 SV=2 PHF12_HUMAN reviewed PHD finger protein 12 (PHD factor 1) (Pf1) Homo sapiens (Human) GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g5331.t1 A0JPI9 37.307 453 5.54e-101 316.0 sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1 g5332.t1 E9PVA8 44.776 335 3.16e-84 282.0 sp|E9PVA8|GCN1_MOUSE Stalled ribosome sensor GCN1 OS=Mus musculus OX=10090 GN=Gcn1 PE=1 SV=1 GCN1_MOUSE reviewed Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0006414; GO:0006417; GO:0006511; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0055106; GO:0060090; GO:0072344; GO:0085020; GO:0140469; GO:0160127; GO:0170011 cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein K6-linked ubiquitination [GO:0085020]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626] molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; stalled ribosome sensor activity [GO:0170011]; ubiquitin-protein transferase regulator activity [GO:0055106] g5333.t1 E9PVA8 57.999 1619 0.0 1781.0 sp|E9PVA8|GCN1_MOUSE Stalled ribosome sensor GCN1 OS=Mus musculus OX=10090 GN=Gcn1 PE=1 SV=1 GCN1_MOUSE reviewed Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0006414; GO:0006417; GO:0006511; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0055106; GO:0060090; GO:0072344; GO:0085020; GO:0140469; GO:0160127; GO:0170011 cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein K6-linked ubiquitination [GO:0085020]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626] molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; stalled ribosome sensor activity [GO:0170011]; ubiquitin-protein transferase regulator activity [GO:0055106] g5334.t1 E9PVA8 42.759 145 9.569999999999999e-28 111.0 sp|E9PVA8|GCN1_MOUSE Stalled ribosome sensor GCN1 OS=Mus musculus OX=10090 GN=Gcn1 PE=1 SV=1 GCN1_MOUSE reviewed Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0006414; GO:0006417; GO:0006511; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0055106; GO:0060090; GO:0072344; GO:0085020; GO:0140469; GO:0160127; GO:0170011 cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein K6-linked ubiquitination [GO:0085020]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626] molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; stalled ribosome sensor activity [GO:0170011]; ubiquitin-protein transferase regulator activity [GO:0055106] g5335.t1 Q92616 36.627 415 1.61e-73 252.0 sp|Q92616|GCN1_HUMAN Stalled ribosome sensor GCN1 OS=Homo sapiens OX=9606 GN=GCN1 PE=1 SV=7 GCN1_HUMAN reviewed Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1) Homo sapiens (Human) GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0045296; GO:0060090; GO:0072344; GO:0140469; GO:0160127; GO:0170011 cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; ribosome [GO:0005840] cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; RNA binding [GO:0003723]; stalled ribosome sensor activity [GO:0170011]; translation factor activity, RNA binding [GO:0008135] g5336.t1 P22781 59.874 476 0.0 626.0 sp|P22781|DDC_CAVPO Aromatic-L-amino-acid decarboxylase OS=Cavia porcellus OX=10141 GN=DDC PE=2 SV=1 g5338.t1 Q6R5J2 43.799 379 7.719999999999999e-95 325.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g5338.t1 Q6R5J2 27.928 333 1.34e-28 126.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g5342.t1 Q9QZ88 90.11 182 2.7300000000000003e-122 345.0 sp|Q9QZ88|VPS29_MOUSE Vacuolar protein sorting-associated protein 29 OS=Mus musculus OX=10090 GN=Vps29 PE=1 SV=1 VPS29_MOUSE reviewed Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29) Mus musculus (Mouse) GO:0005768; GO:0005829; GO:0006886; GO:0006896; GO:0010008; GO:0030904; GO:0030906; GO:0032456; GO:0042147; GO:0046872 endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906] metal ion binding [GO:0046872] g5343.t1 Q99638 46.739 276 1.69e-78 254.0 sp|Q99638|RAD9A_HUMAN Cell cycle checkpoint control protein RAD9A OS=Homo sapiens OX=9606 GN=RAD9A PE=1 SV=1 RAD9A_HUMAN reviewed Cell cycle checkpoint control protein RAD9A (hRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A) Homo sapiens (Human) GO:0000076; GO:0000077; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0008296; GO:0008311; GO:0008630; GO:0017124; GO:0019899; GO:0019901; GO:0030896; GO:0031573; GO:0042826; GO:0071479; GO:1902231 cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231] checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 3'-5'-DNA exonuclease activity [GO:0008296]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] g5352.t1 Q3B7Z2 57.965 747 0.0 845.0 sp|Q3B7Z2|OSBP1_MOUSE Oxysterol-binding protein 1 OS=Mus musculus OX=10090 GN=Osbp PE=1 SV=3 OSBP1_MOUSE reviewed Oxysterol-binding protein 1 Mus musculus (Mouse) GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006686; GO:0006869; GO:0015914; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0035627; GO:0035774; GO:0048471; GO:0070273; GO:0097038; GO:0120013; GO:0120015; GO:1904411 ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] lipid transfer activity [GO:0120013]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015] g5352.t2 Q3B7Z2 57.965 747 0.0 844.0 sp|Q3B7Z2|OSBP1_MOUSE Oxysterol-binding protein 1 OS=Mus musculus OX=10090 GN=Osbp PE=1 SV=3 OSBP1_MOUSE reviewed Oxysterol-binding protein 1 Mus musculus (Mouse) GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006686; GO:0006869; GO:0015914; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0035627; GO:0035774; GO:0048471; GO:0070273; GO:0097038; GO:0120013; GO:0120015; GO:1904411 ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] lipid transfer activity [GO:0120013]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015] g5354.t1 Q5ZKU0 62.385 109 1e-32 117.0 sp|Q5ZKU0|PKRI1_CHICK PRKR-interacting protein 1 homolog OS=Gallus gallus OX=9031 GN=PRKRIP1 PE=2 SV=1 PKRI1_CHICK reviewed PRKR-interacting protein 1 homolog Gallus gallus (Chicken) GO:0003014; GO:0003725; GO:0004860; GO:0005681; GO:0005730; GO:0006397; GO:0008380; GO:0019901 mRNA processing [GO:0006397]; renal system process [GO:0003014]; RNA splicing [GO:0008380] nucleolus [GO:0005730]; spliceosomal complex [GO:0005681] double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] g5356.t1 O94972 60.571 700 0.0 810.0 sp|O94972|TRI37_HUMAN E3 ubiquitin-protein ligase TRIM37 OS=Homo sapiens OX=9606 GN=TRIM37 PE=1 SV=2 TRI37_HUMAN reviewed E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37) Homo sapiens (Human) GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005694; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862 aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821] aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5361.t1 Q9M2U3 28.621 290 1.09e-25 109.0 sp|Q9M2U3|ALPL_ARATH Protein ALP1-like OS=Arabidopsis thaliana OX=3702 GN=At3g55350 PE=2 SV=1 g5362.t1 Q8VDZ4 58.635 249 2.42e-99 318.0 sp|Q8VDZ4|ZDHC5_MOUSE Palmitoyltransferase ZDHHC5 OS=Mus musculus OX=10090 GN=Zdhhc5 PE=1 SV=1 ZDHC5_MOUSE reviewed Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Mus musculus (Mouse) GO:0005654; GO:0005886; GO:0015908; GO:0016409; GO:0019706; GO:0030163; GO:0030425; GO:0032495; GO:0042742; GO:0044546; GO:0045087; GO:0045335; GO:0051604; GO:0062208; GO:0070427; GO:0070431; GO:0070534; GO:0072659; GO:0098794; GO:0098978; GO:0098982; GO:0099072; GO:0099091; GO:0140639; GO:0141201; GO:1900227; GO:1903078; GO:1905171 defense response to bacterium [GO:0042742]; fatty acid transport [GO:0015908]; innate immune response [GO:0045087]; NLRP3 inflammasome complex assembly [GO:0044546]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; pyroptotic cell death [GO:0141201]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to muramyl dipeptide [GO:0032495] dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic specialization, intracellular component [GO:0099091] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] g5368.t1 Q2KIK3 54.839 93 2.6e-26 103.0 sp|Q2KIK3|SIM14_BOVIN Small integral membrane protein 14 OS=Bos taurus OX=9913 GN=SMIM14 PE=3 SV=1 g5374.t1 Q5RDN9 92.857 112 5.98e-77 225.0 sp|Q5RDN9|YPEL2_PONAB Protein yippee-like 2 OS=Pongo abelii OX=9601 GN=YPEL2 PE=3 SV=1 g5378.t1 P22304 66.667 102 8.19e-41 146.0 sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1 IDS_HUMAN reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] Homo sapiens (Human) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423] g5378.t2 P22304 49.145 468 6.88e-145 433.0 sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1 IDS_HUMAN reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] Homo sapiens (Human) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423] g5378.t3 P22304 49.145 468 6.88e-145 433.0 sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1 IDS_HUMAN reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] Homo sapiens (Human) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423] g5378.t4 P22304 49.145 468 6.88e-145 433.0 sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1 IDS_HUMAN reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] Homo sapiens (Human) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423] g5378.t5 P22304 44.475 362 1.75e-91 291.0 sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1 IDS_HUMAN reviewed Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] Homo sapiens (Human) GO:0004423; GO:0005509; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202 dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423] g5380.t1 P48727 88.415 328 0.0 617.0 sp|P48727|GLC7B_CAEEL Serine/threonine-protein phosphatase PP1-beta OS=Caenorhabditis elegans OX=6239 GN=gsp-2 PE=1 SV=1 GLC7B_CAEEL reviewed Serine/threonine-protein phosphatase PP1-beta (EC 3.1.3.16) (CeGLC-7-beta) (Glc seven-like phosphatase 2) Caenorhabditis elegans GO:0004722; GO:0005634; GO:0005694; GO:0005737; GO:0006325; GO:0031965; GO:0046872; GO:0051301; GO:0051321 cell division [GO:0051301]; chromatin organization [GO:0006325]; meiotic cell cycle [GO:0051321] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g5381.t1 Q8C4B4 61.905 231 5.0900000000000005e-105 306.0 sp|Q8C4B4|U119B_MOUSE Protein unc-119 homolog B OS=Mus musculus OX=10090 GN=Unc119b PE=1 SV=1 g5382.t1 Q4KLN4 36.138 523 1.66e-97 312.0 sp|Q4KLN4|GLE1_RAT mRNA export factor GLE1 OS=Rattus norvegicus OX=10116 GN=Gle1 PE=2 SV=1 GLE1_RAT reviewed mRNA export factor GLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1) Rattus norvegicus (Rat) GO:0000822; GO:0005543; GO:0005635; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016973; GO:0031369; GO:0031965; GO:0036064; GO:0042802; GO:0044614 poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730] identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369] g5383.t1 Q9XWZ2 46.484 583 0.0 532.0 sp|Q9XWZ2|ACD11_CAEEL Acyl-CoA dehydrogenase family member 11 OS=Caenorhabditis elegans OX=6239 GN=acdh-11 PE=1 SV=1 g5384.t1 A6H7A8 37.91 335 1.94e-59 198.0 sp|A6H7A8|TDIF1_BOVIN Deoxynucleotidyltransferase terminal-interacting protein 1 OS=Bos taurus OX=9913 GN=DNTTIP1 PE=2 SV=1 g5385.t1 Q6IN84 47.468 158 3.2999999999999996e-42 149.0 sp|Q6IN84|MRM1_HUMAN rRNA methyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=MRM1 PE=1 SV=1 MRM1_HUMAN reviewed rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase) Homo sapiens (Human) GO:0000154; GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0006364; GO:0016435; GO:0070039 rRNA 2'-O-methylation [GO:0000451]; rRNA modification [GO:0000154]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] g5386.t1 Q8C4B4 46.154 130 1.5199999999999998e-34 123.0 sp|Q8C4B4|U119B_MOUSE Protein unc-119 homolog B OS=Mus musculus OX=10090 GN=Unc119b PE=1 SV=1 g5387.t1 Q8R322 36.015 522 2.79e-96 310.0 sp|Q8R322|GLE1_MOUSE mRNA export factor GLE1 OS=Mus musculus OX=10090 GN=Gle1 PE=1 SV=2 GLE1_MOUSE reviewed mRNA export factor GLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1) Mus musculus (Mouse) GO:0000822; GO:0005543; GO:0005635; GO:0005643; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006913; GO:0015031; GO:0016973; GO:0031369; GO:0031965; GO:0036064; GO:0042802; GO:0044614 nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730] identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369] g5388.t1 Q9XWZ2 51.385 397 2.42e-145 429.0 sp|Q9XWZ2|ACD11_CAEEL Acyl-CoA dehydrogenase family member 11 OS=Caenorhabditis elegans OX=6239 GN=acdh-11 PE=1 SV=1 g5390.t1 Q91Y53 53.153 111 1.01e-32 119.0 sp|Q91Y53|TDIF1_RAT Deoxynucleotidyltransferase terminal-interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Dnttip1 PE=2 SV=1 g5391.t1 Q6IN84 39.716 282 1.47e-60 201.0 sp|Q6IN84|MRM1_HUMAN rRNA methyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=MRM1 PE=1 SV=1 MRM1_HUMAN reviewed rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase) Homo sapiens (Human) GO:0000154; GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0006364; GO:0016435; GO:0070039 rRNA 2'-O-methylation [GO:0000451]; rRNA modification [GO:0000154]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] g5392.t1 P35626 76.796 668 0.0 1090.0 sp|P35626|ARBK2_HUMAN G protein-coupled receptor kinase 3 OS=Homo sapiens OX=9606 GN=GRK3 PE=1 SV=2 ARBK2_HUMAN reviewed G protein-coupled receptor kinase 3 (EC 2.7.11.15) (Beta-adrenergic receptor kinase 2) (Beta-ARK-2) Homo sapiens (Human) GO:0001664; GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0031623; GO:0047696; GO:0098793; GO:0098794 desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672] g5393.t1 Q99MS0 43.069 404 2e-109 328.0 sp|Q99MS0|S14L2_RAT SEC14-like protein 2 OS=Rattus norvegicus OX=10116 GN=Sec14l2 PE=1 SV=1 g5399.t1 Q6IDD9 49.031 671 0.0 653.0 sp|Q6IDD9|SARM1_DROME NAD(+) hydrolase sarm1 OS=Drosophila melanogaster OX=7227 GN=Sarm PE=1 SV=1 SARM1_DROME reviewed NAD(+) hydrolase sarm1 (NADase sarm1) (EC 3.2.2.6) (Sterile alpha and TIR motif-containing protein 1) (Tir-1 homolog) Drosophila melanogaster (Fruit fly) GO:0003953; GO:0005739; GO:0005829; GO:0007165; GO:0019677; GO:0030424; GO:0030425; GO:0035591; GO:0043005; GO:0043025; GO:0048678; GO:0051607; GO:0061809; GO:0097677; GO:0140374; GO:1904894 antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; NAD+ catabolic process [GO:0019677]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; response to axon injury [GO:0048678]; signal transduction [GO:0007165] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; STAT family protein binding [GO:0097677] g5400.t1 Q5U316 81.281 203 1.48e-116 332.0 sp|Q5U316|RAB35_RAT Ras-related protein Rab-35 OS=Rattus norvegicus OX=10116 GN=Rab35 PE=1 SV=1 RAB35_RAT reviewed Ras-related protein Rab-35 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0000281; GO:0003924; GO:0003925; GO:0005525; GO:0005546; GO:0005886; GO:0005905; GO:0008104; GO:0010008; GO:0015031; GO:0016197; GO:0019003; GO:0019882; GO:0030672; GO:0031175; GO:0031253; GO:0032456; GO:0032482; GO:0036010; GO:0042470; GO:0045171; GO:0045334; GO:0046872; GO:0048227; GO:1990090 antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482] cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; endosome membrane [GO:0010008]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g5401.t1 Q8K4F5 45.238 294 1.66e-78 244.0 sp|Q8K4F5|ABHDB_MOUSE sn-1-specific diacylglycerol lipase ABHD11 OS=Mus musculus OX=10090 GN=Abhd11 PE=1 SV=1 ABHDB_MOUSE reviewed sn-1-specific diacylglycerol lipase ABHD11 (EC 3.1.1.116) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog) Mus musculus (Mouse) GO:0005739; GO:0005759; GO:0006629; GO:0016298; GO:0045252; GO:0052689 lipid metabolic process [GO:0006629] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252] carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298] g5407.t1 O14578 48.061 722 0.0 702.0 sp|O14578|CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens OX=9606 GN=CIT PE=1 SV=2 CTRO_HUMAN reviewed Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21) Homo sapiens (Human) GO:0000278; GO:0000281; GO:0001223; GO:0004674; GO:0005524; GO:0005829; GO:0008270; GO:0016020; GO:0017124; GO:0019901; GO:0030165; GO:0030291; GO:0032467; GO:0032956; GO:0035331; GO:0048699; GO:0051402; GO:0097110; GO:0106310 generation of neurons [GO:0048699]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; regulation of actin cytoskeleton organization [GO:0032956] cytosol [GO:0005829]; membrane [GO:0016020] ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g5408.t1 E9PSL7 40.86 1209 0.0 848.0 sp|E9PSL7|CTRO_RAT Citron rho-interacting kinase OS=Rattus norvegicus OX=10116 GN=Cit PE=1 SV=1 CTRO_RAT reviewed Citron rho-interacting kinase (CRIK) (EC 2.7.11.1) (Rho-interacting, serine/threonine-protein kinase 21) Rattus norvegicus (Rat) GO:0000070; GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001726; GO:0001889; GO:0004674; GO:0005524; GO:0005737; GO:0005773; GO:0005829; GO:0007030; GO:0007091; GO:0007214; GO:0007283; GO:0008064; GO:0008270; GO:0015629; GO:0016358; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0030517; GO:0031985; GO:0032154; GO:0032467; GO:0032956; GO:0035331; GO:0043025; GO:0045665; GO:0048699; GO:0050774; GO:0051402; GO:0097110; GO:0097119; GO:0098982; GO:0099092; GO:0099188; GO:0099573; GO:0106310 dendrite development [GO:0016358]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-aminobutyric acid signaling pathway [GO:0007214]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of axon extension [GO:0030517]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of hippo signaling [GO:0035331]; negative regulation of neuron differentiation [GO:0045665]; neuron apoptotic process [GO:0051402]; positive regulation of cytokinesis [GO:0032467]; postsynaptic cytoskeleton organization [GO:0099188]; postsynaptic density protein 95 clustering [GO:0097119]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glutamatergic postsynaptic density [GO:0099573]; Golgi cisterna [GO:0031985]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; postsynaptic density, intracellular component [GO:0099092]; ruffle [GO:0001726]; vacuole [GO:0005773] ATP binding [GO:0005524]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g5410.t1 Q95ND4 30.917 469 2.04e-56 206.0 sp|Q95ND4|EGF_FELCA Pro-epidermal growth factor OS=Felis catus OX=9685 GN=EGF PE=2 SV=1 EGF_FELCA reviewed Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor] Felis catus (Cat) (Felis silvestris catus) GO:0005154; GO:0005509; GO:0005615; GO:0005886; GO:0007173; GO:0008083; GO:0008284; GO:0010604; GO:0043388; GO:0043410; GO:0046425; GO:0048731; GO:0051049; GO:0080090 epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of macromolecule metabolic process [GO:0010604]; positive regulation of MAPK cascade [GO:0043410]; regulation of primary metabolic process [GO:0080090]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transport [GO:0051049]; system development [GO:0048731] extracellular space [GO:0005615]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083] g5410.t1 Q95ND4 30.493 446 9.33e-53 195.0 sp|Q95ND4|EGF_FELCA Pro-epidermal growth factor OS=Felis catus OX=9685 GN=EGF PE=2 SV=1 EGF_FELCA reviewed Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor] Felis catus (Cat) (Felis silvestris catus) GO:0005154; GO:0005509; GO:0005615; GO:0005886; GO:0007173; GO:0008083; GO:0008284; GO:0010604; GO:0043388; GO:0043410; GO:0046425; GO:0048731; GO:0051049; GO:0080090 epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of macromolecule metabolic process [GO:0010604]; positive regulation of MAPK cascade [GO:0043410]; regulation of primary metabolic process [GO:0080090]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transport [GO:0051049]; system development [GO:0048731] extracellular space [GO:0005615]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083] g5412.t1 P49013 31.395 344 1.52e-28 127.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5415.t1 Q863A2 43.503 708 7.58e-146 443.0 sp|Q863A2|TBX2_CANLF T-box transcription factor TBX2 OS=Canis lupus familiaris OX=9615 GN=TBX2 PE=3 SV=2 g5415.t2 Q863A2 43.441 709 4.8600000000000004e-144 438.0 sp|Q863A2|TBX2_CANLF T-box transcription factor TBX2 OS=Canis lupus familiaris OX=9615 GN=TBX2 PE=3 SV=2 g5418.t1 Q9BX63 47.38 916 0.0 847.0 sp|Q9BX63|FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens OX=9606 GN=BRIP1 PE=1 SV=2 FANCJ_HUMAN reviewed Fanconi anemia group J protein (EC 5.6.2.3) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1) (DNA 5'-3' helicase FANCJ) Homo sapiens (Human) GO:0000077; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006281; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0010705; GO:0016887; GO:0031965; GO:0035825; GO:0043139; GO:0046872; GO:0051026; GO:0051539; GO:0070532; GO:0072520; GO:0106300; GO:0140640; GO:1990918 chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284] BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657] 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872] g5418.t2 Q9BX63 47.38 916 0.0 847.0 sp|Q9BX63|FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens OX=9606 GN=BRIP1 PE=1 SV=2 FANCJ_HUMAN reviewed Fanconi anemia group J protein (EC 5.6.2.3) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1) (DNA 5'-3' helicase FANCJ) Homo sapiens (Human) GO:0000077; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006281; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0010705; GO:0016887; GO:0031965; GO:0035825; GO:0043139; GO:0046872; GO:0051026; GO:0051539; GO:0070532; GO:0072520; GO:0106300; GO:0140640; GO:1990918 chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284] BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657] 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872] g5420.t1 P53667 49.02 612 0.0 577.0 sp|P53667|LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens OX=9606 GN=LIMK1 PE=1 SV=3 LIMK1_HUMAN reviewed LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) Homo sapiens (Human) GO:0001673; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007165; GO:0007266; GO:0007399; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0031072; GO:0031625; GO:0032233; GO:0038096; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948 actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794] ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] g5420.t2 P53667 49.15 647 0.0 618.0 sp|P53667|LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens OX=9606 GN=LIMK1 PE=1 SV=3 LIMK1_HUMAN reviewed LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) Homo sapiens (Human) GO:0001673; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007165; GO:0007266; GO:0007399; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0031072; GO:0031625; GO:0032233; GO:0038096; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948 actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794] ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] g5421.t1 Q4QQT0 42.541 362 6.86e-84 266.0 sp|Q4QQT0|RUSD4_RAT Pseudouridylate synthase RPUSD4, mitochondrial OS=Rattus norvegicus OX=10116 GN=Rpusd4 PE=2 SV=1 RUSD4_RAT reviewed Pseudouridylate synthase RPUSD4, mitochondrial (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 4) Rattus norvegicus (Rat) GO:0000049; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031118; GO:0035770; GO:0070131; GO:0070902; GO:0106029; GO:1990400; GO:1990481 mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; RNA splicing [GO:0008380]; rRNA pseudouridine synthesis [GO:0031118] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029] g5421.t2 Q4QQT0 42.818 362 7.53e-84 266.0 sp|Q4QQT0|RUSD4_RAT Pseudouridylate synthase RPUSD4, mitochondrial OS=Rattus norvegicus OX=10116 GN=Rpusd4 PE=2 SV=1 RUSD4_RAT reviewed Pseudouridylate synthase RPUSD4, mitochondrial (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 4) Rattus norvegicus (Rat) GO:0000049; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031118; GO:0035770; GO:0070131; GO:0070902; GO:0106029; GO:1990400; GO:1990481 mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; RNA splicing [GO:0008380]; rRNA pseudouridine synthesis [GO:0031118] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029] g5421.t3 Q4QQT0 42.535 355 1.23e-83 266.0 sp|Q4QQT0|RUSD4_RAT Pseudouridylate synthase RPUSD4, mitochondrial OS=Rattus norvegicus OX=10116 GN=Rpusd4 PE=2 SV=1 RUSD4_RAT reviewed Pseudouridylate synthase RPUSD4, mitochondrial (EC 5.4.99.-) (RNA pseudouridylate synthase domain-containing protein 4) Rattus norvegicus (Rat) GO:0000049; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031118; GO:0035770; GO:0070131; GO:0070902; GO:0106029; GO:1990400; GO:1990481 mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; RNA splicing [GO:0008380]; rRNA pseudouridine synthesis [GO:0031118] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029] g5422.t1 P43690 84.384 365 0.0 630.0 sp|P43690|DRG1_XENLA Developmentally-regulated GTP-binding protein 1 OS=Xenopus laevis OX=8355 GN=drg1 PE=1 SV=1 g5423.t1 Q9EST3 29.907 535 2.17e-34 147.0 sp|Q9EST3|4ET_MOUSE Eukaryotic translation initiation factor 4E transporter OS=Mus musculus OX=10090 GN=Eif4enif1 PE=1 SV=2 4ET_MOUSE reviewed Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (CD40 ligand-activated specific transcript 4) (Eukaryotic translation initiation factor 4E nuclear import factor 1) Mus musculus (Mouse) GO:0000932; GO:0003729; GO:0005049; GO:0005634; GO:0005737; GO:0005829; GO:0006606; GO:0016605; GO:0016607; GO:0017148; GO:0019827; GO:0019900; GO:0033962; GO:0035278; GO:0045665; GO:0048255; GO:0060213; GO:0106289 miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA stabilization [GO:0048255]; negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106289]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein import into nucleus [GO:0006606]; stem cell population maintenance [GO:0019827] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605] kinase binding [GO:0019900]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049] g5424.t1 Q91YT2 65.128 195 2.42e-75 228.0 sp|Q91YT2|RN185_MOUSE E3 ubiquitin-protein ligase RNF185 OS=Mus musculus OX=10090 GN=Rnf185 PE=2 SV=1 RN185_MOUSE reviewed E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) Mus musculus (Mouse) GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0008270; GO:0036503; GO:0043130; GO:0044314; GO:0044390; GO:0044877; GO:0045087; GO:0045089; GO:0051607; GO:0051865; GO:0060340; GO:0061630; GO:0140896; GO:1904294 autophagy [GO:0006914]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of innate immune response [GO:0045089]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; zinc ion binding [GO:0008270] g5425.t1 Q9Y4D8 48.964 4152 0.0 3692.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g5425.t2 Q9Y4D8 48.988 4152 0.0 3698.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g5425.t3 Q9Y4D8 49.543 876 0.0 828.0 sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5 g5427.t1 Q9WUW9 40.455 220 3.2299999999999996e-45 155.0 sp|Q9WUW9|S1C2A_RAT Sulfotransferase 1C2A OS=Rattus norvegicus OX=10116 GN=Sult1c2a PE=1 SV=2 g5428.t1 Q9WUW9 41.919 198 1.7e-41 145.0 sp|Q9WUW9|S1C2A_RAT Sulfotransferase 1C2A OS=Rattus norvegicus OX=10116 GN=Sult1c2a PE=1 SV=2 g5432.t1 P35670 54.502 1044 0.0 1087.0 sp|P35670|ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens OX=9606 GN=ATP7B PE=1 SV=4 ATP7B_HUMAN reviewed Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa] Homo sapiens (Human) GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0051604; GO:0051649; GO:0060003; GO:0075523; GO:0140581; GO:1990961 copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; lactation [GO:0007595]; monoatomic ion transmembrane transport [GO:0034220]; protein maturation [GO:0051604]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; viral translational frameshifting [GO:0075523]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581] g5433.t1 Q9CQM5 53.448 116 2.88e-39 130.0 sp|Q9CQM5|TXD17_MOUSE Thioredoxin domain-containing protein 17 OS=Mus musculus OX=10090 GN=Txndc17 PE=1 SV=1 TXD17_MOUSE reviewed Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5) Mus musculus (Mouse) GO:0004601; GO:0005829; GO:0033209; GO:0047134 tumor necrosis factor-mediated signaling pathway [GO:0033209] cytosol [GO:0005829] peroxidase activity [GO:0004601]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134] g5434.t1 Q6NU91 42.772 505 2.84e-136 407.0 sp|Q6NU91|NOC4B_XENLA Nucleolar complex protein 4 homolog B OS=Xenopus laevis OX=8355 GN=noc4l-b PE=2 SV=1 g5435.t1 Q4KLT3 46.101 577 4.01e-170 502.0 sp|Q4KLT3|TRM44_XENLA Probable tRNA (uracil-O(2)-)-methyltransferase OS=Xenopus laevis OX=8355 GN=trmt44 PE=2 SV=1 g5437.t1 Q96DH6 52.896 259 1.3699999999999998e-89 278.0 sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1 g5437.t2 Q96DH6 55.242 248 2.5299999999999998e-92 285.0 sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1 g5438.t1 G1SE76 77.778 126 3.11e-64 197.0 sp|G1SE76|RL23A_RABIT Large ribosomal subunit protein uL23 OS=Oryctolagus cuniculus OX=9986 GN=RPL23A PE=1 SV=1 g5439.t1 Q1RM03 50.361 415 1.5600000000000002e-122 370.0 sp|Q1RM03|TCHP_DANRE Trichoplein keratin filament-binding protein OS=Danio rerio OX=7955 GN=tchp PE=2 SV=1 g5440.t1 Q96NN9 57.823 147 1.53e-54 186.0 sp|Q96NN9|AIFM3_HUMAN Apoptosis-inducing factor 3 OS=Homo sapiens OX=9606 GN=AIFM3 PE=1 SV=1 g5442.t1 Q96NN9 54.733 243 7.74e-87 272.0 sp|Q96NN9|AIFM3_HUMAN Apoptosis-inducing factor 3 OS=Homo sapiens OX=9606 GN=AIFM3 PE=1 SV=1 g5445.t1 Q8C1R0 46.667 285 8.709999999999999e-89 285.0 sp|Q8C1R0|TSSK5_MOUSE Testis-specific serine/threonine-protein kinase 5 OS=Mus musculus OX=10090 GN=Tssk5 PE=2 SV=2 TSSK5_MOUSE reviewed Testis-specific serine/threonine-protein kinase 5 (TSK-5) (TSSK-5) (Testis-specific kinase 5) (EC 2.7.11.1) Mus musculus (Mouse) GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0030154; GO:0106310 cell differentiation [GO:0030154]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5446.t1 Q8IZQ5 39.506 162 2.75e-25 97.1 sp|Q8IZQ5|SELH_HUMAN Selenoprotein H OS=Homo sapiens OX=9606 GN=SELENOH PE=1 SV=2 g5447.t1 Q5SYL3 42.308 884 0.0 635.0 sp|Q5SYL3|BLTP2_MOUSE Bridge-like lipid transfer protein family member 2 OS=Mus musculus OX=10090 GN=Bltp2 PE=1 SV=1 g5448.t1 E1BD59 30.833 240 7.39e-26 111.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g5449.t1 Q96DM1 27.436 390 5.28e-37 149.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g5452.t1 M9PH32 26.26 377 2.0900000000000002e-21 100.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5453.t1 M9PH32 26.49 302 2.57e-22 105.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5455.t1 Q14667 30.891 1392 0.0 671.0 sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3 g5455.t2 Q14667 31.03 1389 0.0 677.0 sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3 g5456.t1 Q174D3 50.893 224 6.23e-51 169.0 sp|Q174D3|MED19_AEDAE Mediator of RNA polymerase II transcription subunit 19 OS=Aedes aegypti OX=7159 GN=MED19 PE=3 SV=1 g5457.t1 Q502L2 60.088 228 2.8199999999999998e-101 300.0 sp|Q502L2|PGAM5_DANRE Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Danio rerio OX=7955 GN=pgam5 PE=2 SV=2 g5457.t2 Q502L2 59.649 228 7.750000000000001e-100 297.0 sp|Q502L2|PGAM5_DANRE Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Danio rerio OX=7955 GN=pgam5 PE=2 SV=2 g5458.t1 Q6DGR4 47.246 345 4.68e-88 271.0 sp|Q6DGR4|HGH1_DANRE Protein HGH1 homolog OS=Danio rerio OX=7955 GN=hgh1 PE=2 SV=1 g5460.t1 Q9VR07 44.556 597 0.0 578.0 sp|Q9VR07|INE_DROME Sodium- and chloride-dependent GABA transporter ine OS=Drosophila melanogaster OX=7227 GN=ine PE=1 SV=1 INE_DROME reviewed Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A) Drosophila melanogaster (Fruit fly) GO:0005034; GO:0005283; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016020; GO:0016323; GO:0019226; GO:0035725; GO:0042065; GO:0042066; GO:0047484; GO:0050891; GO:1903804 glial cell growth [GO:0042065]; glycine import across plasma membrane [GO:1903804]; multicellular organismal-level water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; sodium ion transmembrane transport [GO:0035725]; transmission of nerve impulse [GO:0019226] basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034] g5460.t2 Q9VR07 47.744 266 1.8399999999999999e-91 295.0 sp|Q9VR07|INE_DROME Sodium- and chloride-dependent GABA transporter ine OS=Drosophila melanogaster OX=7227 GN=ine PE=1 SV=1 INE_DROME reviewed Sodium- and chloride-dependent GABA transporter ine (Protein inebriated) (Protein receptor oscillation A) Drosophila melanogaster (Fruit fly) GO:0005034; GO:0005283; GO:0005328; GO:0005886; GO:0006836; GO:0009414; GO:0016020; GO:0016323; GO:0019226; GO:0035725; GO:0042065; GO:0042066; GO:0047484; GO:0050891; GO:1903804 glial cell growth [GO:0042065]; glycine import across plasma membrane [GO:1903804]; multicellular organismal-level water homeostasis [GO:0050891]; neurotransmitter transport [GO:0006836]; perineurial glial growth [GO:0042066]; regulation of response to osmotic stress [GO:0047484]; response to water deprivation [GO:0009414]; sodium ion transmembrane transport [GO:0035725]; transmission of nerve impulse [GO:0019226] basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328]; osmosensor activity [GO:0005034] g5461.t1 Q96LW2 40.663 332 6.18e-80 254.0 sp|Q96LW2|KS6R_HUMAN Ribosomal protein S6 kinase-related protein OS=Homo sapiens OX=9606 GN=RSKR PE=1 SV=3 g5462.t1 B5X5N3 30.233 258 1.95e-21 93.2 sp|B5X5N3|SKA2_SALSA SKA complex subunit 2 OS=Salmo salar OX=8030 GN=ska2 PE=2 SV=1 SKA2_SALSA reviewed SKA complex subunit 2 (Protein FAM33A) (Spindle and kinetochore-associated protein 2) Salmo salar (Atlantic salmon) GO:0000070; GO:0000940; GO:0005876; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072687 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110] meiotic spindle [GO:0072687]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876] microtubule binding [GO:0008017] g5462.t2 B5X5N3 29.07 258 2.7599999999999995e-23 97.4 sp|B5X5N3|SKA2_SALSA SKA complex subunit 2 OS=Salmo salar OX=8030 GN=ska2 PE=2 SV=1 SKA2_SALSA reviewed SKA complex subunit 2 (Protein FAM33A) (Spindle and kinetochore-associated protein 2) Salmo salar (Atlantic salmon) GO:0000070; GO:0000940; GO:0005876; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072687 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110] meiotic spindle [GO:0072687]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876] microtubule binding [GO:0008017] g5463.t1 Q6DDG2 26.524 656 5.9099999999999994e-61 217.0 sp|Q6DDG2|K2013_XENLA Uncharacterized protein KIAA2013 homolog OS=Xenopus laevis OX=8355 PE=2 SV=1 g5465.t1 O88956 34.472 322 3.0500000000000002e-49 169.0 sp|O88956|PLPP1_CAVPO Phospholipid phosphatase 1 OS=Cavia porcellus OX=10141 GN=PLPP1 PE=1 SV=1 g5467.t1 Q29J90 26.23 366 2.3e-25 111.0 sp|Q29J90|MOODY_DROPS G-protein coupled receptor moody OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=moody PE=3 SV=2 g5470.t1 Q3T0A6 77.586 58 8.43e-25 100.0 sp|Q3T0A6|BCL7B_BOVIN B-cell CLL/lymphoma 7 protein family member B OS=Bos taurus OX=9913 GN=BCL7B PE=2 SV=1 g5471.t1 Q9BQI6 23.576 1001 9.870000000000001e-58 221.0 sp|Q9BQI6|SLF1_HUMAN SMC5-SMC6 complex localization factor protein 1 OS=Homo sapiens OX=9606 GN=SLF1 PE=1 SV=2 g5471.t2 Q9BQI6 23.576 1001 9.240000000000001e-58 221.0 sp|Q9BQI6|SLF1_HUMAN SMC5-SMC6 complex localization factor protein 1 OS=Homo sapiens OX=9606 GN=SLF1 PE=1 SV=2 g5473.t1 Q7TNF8 31.492 362 4.5200000000000004e-29 128.0 sp|Q7TNF8|RIMB1_MOUSE Peripheral-type benzodiazepine receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tspoap1 PE=2 SV=2 RIMB1_MOUSE reviewed Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0046928; GO:0098978; GO:0099626 regulation of neurotransmitter secretion [GO:0046928] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g5475.t1 O15034 41.447 304 5.1999999999999995e-61 231.0 sp|O15034|RIMB2_HUMAN RIMS-binding protein 2 OS=Homo sapiens OX=9606 GN=RIMBP2 PE=1 SV=3 g5475.t1 O15034 47.549 204 1.6799999999999997e-42 173.0 sp|O15034|RIMB2_HUMAN RIMS-binding protein 2 OS=Homo sapiens OX=9606 GN=RIMBP2 PE=1 SV=3 g5475.t1 O15034 66.667 66 4.83e-21 103.0 sp|O15034|RIMB2_HUMAN RIMS-binding protein 2 OS=Homo sapiens OX=9606 GN=RIMBP2 PE=1 SV=3 g5475.t2 Q7TNF8 39.207 454 4.92e-90 323.0 sp|Q7TNF8|RIMB1_MOUSE Peripheral-type benzodiazepine receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tspoap1 PE=2 SV=2 RIMB1_MOUSE reviewed Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0046928; GO:0098978; GO:0099626 regulation of neurotransmitter secretion [GO:0046928] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g5475.t2 Q7TNF8 43.542 271 3.71e-48 192.0 sp|Q7TNF8|RIMB1_MOUSE Peripheral-type benzodiazepine receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tspoap1 PE=2 SV=2 RIMB1_MOUSE reviewed Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1) Mus musculus (Mouse) GO:0005737; GO:0005739; GO:0030156; GO:0044305; GO:0046928; GO:0098978; GO:0099626 regulation of neurotransmitter secretion [GO:0046928] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] g5478.t1 F1R332 24.781 343 7.1e-22 99.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g5479.t1 Q569L8 25.407 984 6.18e-45 181.0 sp|Q569L8|CPAP_MOUSE Centrosomal P4.1-associated protein OS=Mus musculus OX=10090 GN=Cpap PE=2 SV=2 CPAP_MOUSE reviewed Centrosomal P4.1-associated protein (Centromere protein J) (CENP-J) (Centrosome assembly and centriole elongation protein) Mus musculus (Mouse) GO:0003713; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0007099; GO:0007224; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0042802; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046601; GO:0046785; GO:0051298; GO:0060236; GO:0060271; GO:0061511; GO:0098534; GO:0120099; GO:1900087; GO:1902857; GO:1903724; GO:1904951; GO:1905515; GO:1905832 astral microtubule nucleation [GO:0030954]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; cilium assembly [GO:0060271]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centriole replication [GO:0046601]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of spindle assembly [GO:1905832]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; procentriole replication complex [GO:0120099] gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631] g5480.t1 Q9HC77 69.565 184 5.53e-91 301.0 sp|Q9HC77|CPAP_HUMAN Centrosomal P4.1-associated protein OS=Homo sapiens OX=9606 GN=CPAP PE=1 SV=2 g5495.t1 P49020 81.868 182 3.26e-115 329.0 sp|P49020|TMED2_CRIGR Transmembrane emp24 domain-containing protein 2 (Fragment) OS=Cricetulus griseus OX=10029 GN=TMED2 PE=1 SV=1 g5496.t1 Q5F371 52.917 977 0.0 865.0 sp|Q5F371|SBNO1_CHICK Protein strawberry notch homolog 1 OS=Gallus gallus OX=9031 GN=SBNO1 PE=2 SV=1 SBNO1_CHICK reviewed Protein strawberry notch homolog 1 Gallus gallus (Chicken) GO:0005634; GO:0006355; GO:0006954; GO:0016055; GO:0031490; GO:0042393; GO:0043124; GO:0043409; GO:0090263; GO:0150079; GO:2000179 inflammatory response [GO:0006954]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroinflammatory response [GO:0150079]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of DNA-templated transcription [GO:0006355]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] g5497.t1 A3KN83 60.771 441 0.0 554.0 sp|A3KN83|SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens OX=9606 GN=SBNO1 PE=1 SV=1 SBNO1_HUMAN reviewed Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) Homo sapiens (Human) GO:0005634; GO:0006355; GO:0006954; GO:0016055; GO:0031490; GO:0042393; GO:0043124; GO:0043409; GO:0090263; GO:0150079; GO:2000179 inflammatory response [GO:0006954]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroinflammatory response [GO:0150079]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of DNA-templated transcription [GO:0006355]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] g5498.t1 Q8L7W2 38.462 260 1.2800000000000001e-58 194.0 sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2 g5498.t2 Q8L7W2 36.897 290 1.9900000000000002e-59 197.0 sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2 g5499.t1 Q0V9E9 50.0 182 1.25e-56 191.0 sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1 KMT5A_XENTR reviewed N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005634; GO:0005700; GO:0006357; GO:0032259; GO:0042054; GO:0042799; GO:0043516; GO:0051301; GO:0140944 cell division [GO:0051301]; methylation [GO:0032259]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; polytene chromosome [GO:0005700] histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054] g5499.t2 Q0V9E9 50.0 182 1.39e-56 191.0 sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1 KMT5A_XENTR reviewed N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005634; GO:0005700; GO:0006357; GO:0032259; GO:0042054; GO:0042799; GO:0043516; GO:0051301; GO:0140944 cell division [GO:0051301]; methylation [GO:0032259]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; polytene chromosome [GO:0005700] histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054] g5500.t1 Q805E5 33.134 335 6.58e-50 174.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g5501.t1 Q99J08 45.078 386 1.91e-120 358.0 sp|Q99J08|S14L2_MOUSE SEC14-like protein 2 OS=Mus musculus OX=10090 GN=Sec14l2 PE=1 SV=1 g5502.t1 P15651 65.085 295 3.56e-136 392.0 sp|P15651|ACADS_RAT Short-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acads PE=1 SV=2 ACADS_RAT reviewed Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase) Rattus norvegicus (Rat) GO:0003995; GO:0005739; GO:0005759; GO:0016937; GO:0031966; GO:0033539; GO:0042594; GO:0042803; GO:0046359; GO:0050660; GO:0051384; GO:0071949 butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] acyl-CoA dehydrogenase activity [GO:0003995]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; short-chain fatty acyl-CoA dehydrogenase activity [GO:0016937] g5504.t1 P30622 30.759 1554 6.53e-161 526.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g5504.t2 O42184 31.601 1443 3.68e-160 523.0 sp|O42184|CLIP1_CHICK CAP-Gly domain-containing linker protein 1 OS=Gallus gallus OX=9031 GN=CLIP1 PE=2 SV=1 g5504.t3 P30622 30.894 1544 1.41e-162 530.0 sp|P30622|CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens OX=9606 GN=CLIP1 PE=1 SV=2 CLIP1_HUMAN reviewed CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin) Homo sapiens (Human) GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g5505.t1 Q2TA20 34.559 136 1.36e-22 100.0 sp|Q2TA20|SPT22_BOVIN Spermatogenesis-associated protein 22 OS=Bos taurus OX=9913 GN=SPATA22 PE=2 SV=1 g5505.t2 Q2TA20 34.559 136 1.4e-22 100.0 sp|Q2TA20|SPT22_BOVIN Spermatogenesis-associated protein 22 OS=Bos taurus OX=9913 GN=SPATA22 PE=2 SV=1 g5506.t1 O64411 34.914 464 9.780000000000001e-75 247.0 sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1 g5507.t1 P16354 40.152 132 9.65e-26 104.0 sp|P16354|PA23_HELSU Phospholipase A2 isozymes PA3A/PA3B/PA5 OS=Heloderma suspectum OX=8554 PE=1 SV=3 g5508.t1 P80003 38.971 136 1.9499999999999998e-30 112.0 sp|P80003|PA2A2_HELSU Acidic phospholipase A2 PA4 OS=Heloderma suspectum OX=8554 PE=1 SV=2 g5509.t1 Q6P861 92.834 307 0.0 604.0 sp|Q6P861|PP4C_XENTR Serine/threonine-protein phosphatase 4 catalytic subunit OS=Xenopus tropicalis OX=8364 GN=ppp4c PE=2 SV=1 g5510.t1 O89001 44.161 1216 0.0 989.0 sp|O89001|CBPD_MOUSE Carboxypeptidase D OS=Mus musculus OX=10090 GN=Cpd PE=1 SV=2 CBPD_MOUSE reviewed Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) Mus musculus (Mouse) GO:0004181; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006518; GO:0008270; GO:0016485; GO:0044877; GO:0048471; GO:0051721 peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270] g5510.t1 O89001 34.359 1333 0.0 686.0 sp|O89001|CBPD_MOUSE Carboxypeptidase D OS=Mus musculus OX=10090 GN=Cpd PE=1 SV=2 CBPD_MOUSE reviewed Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) Mus musculus (Mouse) GO:0004181; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006518; GO:0008270; GO:0016485; GO:0044877; GO:0048471; GO:0051721 peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270] g5510.t1 O89001 43.329 787 0.0 611.0 sp|O89001|CBPD_MOUSE Carboxypeptidase D OS=Mus musculus OX=10090 GN=Cpd PE=1 SV=2 CBPD_MOUSE reviewed Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) Mus musculus (Mouse) GO:0004181; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006518; GO:0008270; GO:0016485; GO:0044877; GO:0048471; GO:0051721 peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270] g5512.t1 P49410 60.938 448 0.0 575.0 sp|P49410|EFTU_BOVIN Elongation factor Tu, mitochondrial OS=Bos taurus OX=9913 GN=TUFM PE=1 SV=1 EFTU_BOVIN reviewed Elongation factor Tu, mitochondrial (EF-Tu) (EC 3.6.5.3) Bos taurus (Bovine) GO:0000287; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006414; GO:0032543; GO:0070125 mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; translational elongation [GO:0006414] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; translation elongation factor activity [GO:0003746] g5513.t1 O00170 45.886 316 6.629999999999999e-104 310.0 sp|O00170|AIP_HUMAN AH receptor-interacting protein OS=Homo sapiens OX=9606 GN=AIP PE=1 SV=3 AIP_HUMAN reviewed AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9) Homo sapiens (Human) GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0016020; GO:0017162; GO:0034751; GO:0036004; GO:0051082; GO:0051604 protein maturation [GO:0051604]; protein targeting to mitochondrion [GO:0006626]; xenobiotic metabolic process [GO:0006805] aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082] g5514.t1 O35207 78.947 57 5.33e-27 105.0 sp|O35207|CDKA1_MOUSE Cyclin-dependent kinase 2-associated protein 1 OS=Mus musculus OX=10090 GN=Cdk2ap1 PE=1 SV=2 CDKA1_MOUSE reviewed Cyclin-dependent kinase 2-associated protein 1 (CDK2-associated protein 1) (Deleted in oral cancer 1) (DOC-1) (Putative oral cancer suppressor) Mus musculus (Mouse) GO:0000785; GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0016581; GO:0048471; GO:0060325; GO:0070182 face morphogenesis [GO:0060325]; in utero embryonic development [GO:0001701]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; perinuclear region of cytoplasm [GO:0048471] DNA polymerase binding [GO:0070182] g5515.t1 A5WUX7 55.932 118 4.59e-41 137.0 sp|A5WUX7|MTRFR_DANRE Mitochondrial translation release factor in rescue OS=Danio rerio OX=7955 GN=mtrfr PE=3 SV=1 g5516.t1 A6H5Y1 33.071 254 2.08e-28 128.0 sp|A6H5Y1|MPP9_MOUSE M-phase phosphoprotein 9 OS=Mus musculus OX=10090 GN=Mphosph9 PE=2 SV=2 MPP9_MOUSE reviewed M-phase phosphoprotein 9 Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0005813; GO:0005814; GO:1902018 negative regulation of cilium assembly [GO:1902018] centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] g5518.t1 Q5R5S1 33.062 614 1.43e-100 321.0 sp|Q5R5S1|FBX21_PONAB F-box only protein 21 OS=Pongo abelii OX=9601 GN=FBXO21 PE=2 SV=1 g5521.t1 A5HK05 68.174 575 0.0 807.0 sp|A5HK05|APBP2_RAT Amyloid protein-binding protein 2 OS=Rattus norvegicus OX=10116 GN=Appbp2 PE=2 SV=1 g5522.t1 Q9P0Z9 40.476 378 9.300000000000001e-97 296.0 sp|Q9P0Z9|SOX_HUMAN Peroxisomal sarcosine oxidase OS=Homo sapiens OX=9606 GN=PIPOX PE=1 SV=2 SOX_HUMAN reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Homo sapiens (Human) GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g5524.t1 Q7KZ85 54.029 1303 0.0 1426.0 sp|Q7KZ85|SPT6H_HUMAN Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2 SPT6H_HUMAN reviewed Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein) Homo sapiens (Human) GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0031491; GO:0034728; GO:0042393; GO:0045191; GO:0051028; GO:0051147; GO:0140673 blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; regulation of isotype switching [GO:0045191]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673] nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723] g5524.t1 Q7KZ85 57.243 428 1.23e-92 338.0 sp|Q7KZ85|SPT6H_HUMAN Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2 SPT6H_HUMAN reviewed Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein) Homo sapiens (Human) GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0031491; GO:0034728; GO:0042393; GO:0045191; GO:0051028; GO:0051147; GO:0140673 blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; regulation of isotype switching [GO:0045191]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673] nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723] g5525.t1 Q6AY87 47.904 334 3.3900000000000003e-110 327.0 sp|Q6AY87|THOC6_RAT THO complex subunit 6 homolog OS=Rattus norvegicus OX=10116 GN=Thoc6 PE=2 SV=1 THOC6_RAT reviewed THO complex subunit 6 homolog (WD repeat-containing protein 58) Rattus norvegicus (Rat) GO:0000346; GO:0000347; GO:0000445; GO:0000781; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0006406; GO:0006915; GO:0007417; GO:0008380; GO:0016604; GO:0016607 apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] RNA binding [GO:0003723] g5526.t1 A2RUV0 32.56 1035 6.18e-96 338.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g5526.t1 A2RUV0 32.854 1044 8.58e-88 314.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g5526.t1 A2RUV0 32.625 1036 9.52e-86 308.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g5526.t1 A2RUV0 31.814 1053 4.1300000000000003e-85 306.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g5526.t1 A2RUV0 31.574 1042 7e-84 302.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g5526.t1 A2RUV0 32.812 1024 8.84e-83 299.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g5528.t1 P10079 37.624 808 8.890000000000001e-117 384.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t1 P10079 36.828 744 1.08e-101 343.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t1 P10079 35.038 665 5.29e-81 286.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t1 P10079 36.149 592 2.08e-64 238.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t1 P10079 39.186 393 3.85e-57 216.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t1 P10079 32.296 675 2.7e-51 199.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t2 P10079 37.209 817 1.61e-114 379.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t2 P10079 36.715 828 3.75e-111 370.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t2 P10079 34.76 771 9.05e-90 311.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t2 P10079 36.047 688 1.35e-89 311.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t2 P10079 31.572 757 2.43e-63 236.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5528.t2 P10079 35.657 502 6.83e-50 195.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5529.t1 P58355 29.45 309 5.55e-33 137.0 sp|P58355|S45A2_MOUSE Membrane-associated transporter protein OS=Mus musculus OX=10090 GN=Slc45a2 PE=1 SV=1 S45A2_MOUSE reviewed Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Protein underwhite) (Solute carrier family 45 member 2) Mus musculus (Mouse) GO:0005356; GO:0006583; GO:0007601; GO:0008506; GO:0015770; GO:0016020; GO:0033162; GO:0035752; GO:0048066 developmental pigmentation [GO:0048066]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process from tyrosine [GO:0006583]; sucrose transport [GO:0015770]; visual perception [GO:0007601] melanosome membrane [GO:0033162]; membrane [GO:0016020] D-glucose:proton symporter activity [GO:0005356]; sucrose:proton symporter activity [GO:0008506] g5530.t1 Q29042 46.725 229 1.09e-51 178.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 g5531.t1 Q04721 31.169 385 1.6300000000000002e-32 138.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t1 Q04721 28.198 383 6.93e-29 127.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t1 Q04721 30.0 370 3.5100000000000004e-27 122.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t1 Q04721 30.645 372 1.11e-25 117.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t1 Q04721 28.426 394 1.19e-25 117.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t1 Q04721 31.285 358 4.82e-25 115.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t1 Q04721 25.971 412 3.17e-22 106.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t1 Q04721 29.563 389 5.42e-22 105.0 sp|Q04721|NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens OX=9606 GN=NOTCH2 PE=1 SV=3 NOTC2_HUMAN reviewed Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g5531.t2 P46531 33.876 307 1.87e-31 134.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g5531.t2 P46531 32.059 340 6.61e-24 110.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g5531.t2 P46531 33.121 314 1.67e-23 109.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g5531.t2 P46531 32.343 303 1.0000000000000001e-21 103.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g5531.t2 P46531 30.421 309 3.0200000000000004e-21 102.0 sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens OX=9606 GN=NOTCH1 PE=1 SV=4 NOTC1_HUMAN reviewed Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Homo sapiens (Human) GO:0000122; GO:0000139; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g5532.t1 P07207 33.707 1160 6.570000000000001e-129 444.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5532.t1 P07207 34.771 1113 1.14e-126 437.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5532.t1 P07207 35.528 1033 7.47e-125 431.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5532.t1 P07207 33.238 1047 1.17e-112 395.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5532.t1 P07207 33.101 1006 1.94e-111 391.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5532.t1 P07207 32.163 1082 1.1999999999999999e-108 383.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5532.t1 P07207 32.875 873 9.49e-92 331.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5532.t1 P07207 34.225 374 2.76e-29 131.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g5533.t1 P10079 39.753 405 2.87e-57 213.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t1 P10079 38.015 413 1.73e-51 196.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t1 P10079 37.624 404 8.92e-49 187.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t1 P10079 37.198 414 2.85e-47 183.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t1 P10079 34.921 441 4.2399999999999995e-45 176.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t1 P10079 36.81 326 1.97e-35 147.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t1 P10079 34.835 333 8.29e-32 135.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 40.0 370 3.56e-51 194.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 37.838 370 2.7999999999999998e-45 176.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 37.113 388 6.33e-44 172.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 37.602 367 3.2100000000000004e-43 170.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 36.986 365 7.92e-41 163.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 36.42 324 1.8e-32 137.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 35.315 286 1.19e-30 132.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5533.t2 P10079 38.521 257 2.82e-27 121.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5534.t1 P34322 29.563 663 7.820000000000001e-79 268.0 sp|P34322|NCX7_CAEEL Putative sodium/calcium exchanger 7 OS=Caenorhabditis elegans OX=6239 GN=ncx-7 PE=3 SV=3 g5536.t1 Q9UQ35 53.889 180 7.08e-50 186.0 sp|Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2 SRRM2_HUMAN reviewed Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0070742; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5536.t2 Q9UQ35 53.889 180 7.72e-50 187.0 sp|Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2 SRRM2_HUMAN reviewed Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0070742; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5536.t3 Q9UQ35 53.889 180 3.64e-50 187.0 sp|Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2 SRRM2_HUMAN reviewed Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0070742; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5536.t4 Q9UQ35 53.889 180 7.2e-50 187.0 sp|Q9UQ35|SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens OX=9606 GN=SRRM2 PE=1 SV=2 SRRM2_HUMAN reviewed Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) Homo sapiens (Human) GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0070742; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5537.t1 Q07066 38.122 181 1.1099999999999999e-41 141.0 sp|Q07066|PXMP2_RAT Peroxisomal membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Pxmp2 PE=1 SV=2 g5539.t1 Q0V9P1 30.645 248 1.2000000000000001e-29 120.0 sp|Q0V9P1|HNMT_XENTR Histamine N-methyltransferase OS=Xenopus tropicalis OX=8364 GN=hnmt PE=2 SV=1 g5540.t1 Q96FN5 47.273 385 2.48e-102 338.0 sp|Q96FN5|KIF12_HUMAN Kinesin-like protein KIF12 OS=Homo sapiens OX=9606 GN=KIF12 PE=1 SV=3 g5540.t2 Q96FN5 47.273 385 2.54e-102 338.0 sp|Q96FN5|KIF12_HUMAN Kinesin-like protein KIF12 OS=Homo sapiens OX=9606 GN=KIF12 PE=1 SV=3 g5541.t1 Q01827 33.471 484 4.72e-80 260.0 sp|Q01827|VMAT2_RAT Synaptic vesicular amine transporter OS=Rattus norvegicus OX=10116 GN=Slc18a2 PE=1 SV=2 g5545.t1 Q7K4Y6 57.858 579 0.0 677.0 sp|Q7K4Y6|DAT_DROME Sodium-dependent dopamine transporter OS=Drosophila melanogaster OX=7227 GN=DAT PE=1 SV=1 DAT_DROME reviewed Sodium-dependent dopamine transporter (Protein fumin) Drosophila melanogaster (Fruit fly) GO:0005330; GO:0005886; GO:0006865; GO:0008344; GO:0015872; GO:0015874; GO:0019811; GO:0030424; GO:0030431; GO:0032809; GO:0035725; GO:0042734; GO:0042745; GO:0046872; GO:0051583; GO:0099509; GO:1990834 adult locomotory behavior [GO:0008344]; amino acid transport [GO:0006865]; circadian sleep/wake cycle [GO:0042745]; dopamine transport [GO:0015872]; dopamine uptake involved in synaptic transmission [GO:0051583]; norepinephrine transport [GO:0015874]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; sleep [GO:0030431]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] cocaine binding [GO:0019811]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872] g5553.t1 O88177 48.747 359 3.02e-110 328.0 sp|O88177|PEX12_RAT Peroxisome assembly protein 12 OS=Rattus norvegicus OX=10116 GN=Pex12 PE=2 SV=1 PEX12_RAT reviewed Peroxisome assembly protein 12 (Peroxin-12) (Peroxisome assembly factor 3) (PAF-3) Rattus norvegicus (Rat) GO:0000209; GO:0000425; GO:0004842; GO:0005777; GO:0005778; GO:0006513; GO:0007031; GO:0008270; GO:0016558; GO:0016562; GO:0034614; GO:0043335; GO:0044721; GO:1990429; GO:1990757 cellular response to reactive oxygen species [GO:0034614]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein unfolding [GO:0043335] peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ubiquitin ligase activator activity [GO:1990757]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5554.t1 P62944 75.185 947 0.0 1419.0 sp|P62944|AP2B1_RAT AP-2 complex subunit beta OS=Rattus norvegicus OX=10116 GN=Ap2b1 PE=1 SV=1 AP2B1_RAT reviewed AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit) Rattus norvegicus (Rat) GO:0001822; GO:0003279; GO:0003281; GO:0006886; GO:0007507; GO:0008021; GO:0016192; GO:0030118; GO:0030119; GO:0030122; GO:0030131; GO:0030276; GO:0035904; GO:0044877; GO:0045202; GO:0045807; GO:0048268; GO:0048488; GO:0060976; GO:0072583; GO:0098843; GO:0098884; GO:0098894; GO:0098978; GO:1905477 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin adaptor complex [GO:0030131]; clathrin coat [GO:0030118]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; glutamatergic synapse [GO:0098978]; postsynaptic endocytic zone [GO:0098843]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877] g5555.t1 Q2XWK0 53.066 473 4.69e-169 495.0 sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1 g5556.t1 P30638 60.0 135 6.509999999999999e-48 164.0 sp|P30638|SVOP_CAEEL Putative transporter svop-1 OS=Caenorhabditis elegans OX=6239 GN=svop-1 PE=3 SV=5 g5558.t1 Q2XWK0 56.277 231 8.65e-89 280.0 sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1 g5560.t1 Q5FVQ4 57.49 247 2.62e-90 273.0 sp|Q5FVQ4|MLEC_RAT Malectin OS=Rattus norvegicus OX=10116 GN=Mlec PE=2 SV=1 MLEC_RAT reviewed Malectin Rattus norvegicus (Rat) GO:0005783; GO:0008250; GO:0016020; GO:0019899; GO:0030246 endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250] carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899] g5561.t1 Q08C92 60.876 662 0.0 849.0 sp|Q08C92|TYW1_DANRE S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 OS=Danio rerio OX=7955 GN=tyw1 PE=2 SV=1 g5562.t1 Q9DB28 44.578 166 3.93e-43 144.0 sp|Q9DB28|POP5_MOUSE Ribonuclease P/MRP protein subunit POP5 OS=Mus musculus OX=10090 GN=Pop5 PE=1 SV=1 g5565.t1 E7FAM5 23.09 602 1.78e-22 106.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5567.t1 Q6GNT2 49.02 204 1.38e-61 193.0 sp|Q6GNT2|SPRNG_XENLA SREBP regulating gene protein OS=Xenopus laevis OX=8355 GN=spring1 PE=2 SV=1 g5568.t1 Q3UF64 35.659 387 8.250000000000001e-86 270.0 sp|Q3UF64|RNFT2_MOUSE RING finger and transmembrane domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rnft2 PE=2 SV=2 g5570.t1 Q9QXF7 39.92 501 9.78e-121 366.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g5571.t1 Q0IIF9 46.358 151 1.57e-42 150.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g5572.t1 Q9QXF7 35.276 326 1.43e-55 191.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g5573.t1 Q9QXF7 41.339 508 1.53e-131 394.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g5574.t1 Q9QXF7 40.945 508 7.16e-130 389.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g5576.t1 Q95078 48.387 93 1.06e-23 101.0 sp|Q95078|CP18A_DROME Cytochrome P450 18a1 OS=Drosophila melanogaster OX=7227 GN=Cyp18a1 PE=2 SV=2 CP18A_DROME reviewed Cytochrome P450 18a1 (EC 1.14.-.-) (CYPXVIIIA1) Drosophila melanogaster (Fruit fly) GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0007304; GO:0007480; GO:0007552; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0035074; GO:0035210; GO:0046344 chorion-containing eggshell formation [GO:0007304]; ecdysteroid catabolic process [GO:0046344]; imaginal disc-derived leg morphogenesis [GO:0007480]; metamorphosis [GO:0007552]; organic acid metabolic process [GO:0006082]; prepupal development [GO:0035210]; pupation [GO:0035074]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g5577.t1 Q9QXF7 36.449 535 3.6900000000000004e-116 355.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g5578.t1 Q8K1T0 42.308 260 1.56e-57 202.0 sp|Q8K1T0|TMPS3_MOUSE Transmembrane protease serine 3 OS=Mus musculus OX=10090 GN=Tmprss3 PE=1 SV=2 TMPS3_MOUSE reviewed Transmembrane protease serine 3 (EC 3.4.21.-) Mus musculus (Mouse) GO:0004252; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0008236; GO:0017080; GO:0043025 intracellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] g5579.t1 A2BGS3 29.341 334 3.6200000000000004e-21 97.1 sp|A2BGS3|TM116_DANRE Transmembrane protein 116 OS=Danio rerio OX=7955 GN=tmem116 PE=2 SV=1 g5580.t1 Q9DC11 35.281 462 2.58e-86 279.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g5580.t2 Q9DC11 35.982 453 2.44e-89 286.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g5580.t3 Q9DC11 37.705 427 8.74e-92 291.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g5580.t4 Q9DC11 34.461 473 4.84e-83 270.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g5582.t1 Q6JPI3 37.104 2369 0.0 1304.0 sp|Q6JPI3|MD13L_MOUSE Mediator of RNA polymerase II transcription subunit 13-like OS=Mus musculus OX=10090 GN=Med13l PE=1 SV=2 MD13L_MOUSE reviewed Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like) Mus musculus (Mouse) GO:0003712; GO:0005654; GO:0006357; GO:0006366; GO:0016592 regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] mediator complex [GO:0016592]; nucleoplasm [GO:0005654] transcription coregulator activity [GO:0003712] g5582.t2 Q6JPI3 37.089 2370 0.0 1304.0 sp|Q6JPI3|MD13L_MOUSE Mediator of RNA polymerase II transcription subunit 13-like OS=Mus musculus OX=10090 GN=Med13l PE=1 SV=2 MD13L_MOUSE reviewed Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like) Mus musculus (Mouse) GO:0003712; GO:0005654; GO:0006357; GO:0006366; GO:0016592 regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] mediator complex [GO:0016592]; nucleoplasm [GO:0005654] transcription coregulator activity [GO:0003712] g5584.t1 Q8IWL3 42.654 211 3.95e-50 170.0 sp|Q8IWL3|HSC20_HUMAN Iron-sulfur cluster co-chaperone protein HscB OS=Homo sapiens OX=9606 GN=HSCB PE=1 SV=3 HSC20_HUMAN reviewed Iron-sulfur cluster co-chaperone protein HscB (DnaJ homolog subfamily C member 20) [Cleaved into: Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic (C-HSC20); Iron-sulfur cluster co-chaperone protein HscB, mitochondrial] Homo sapiens (Human) GO:0001671; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016226; GO:0042802; GO:0044571; GO:0046872; GO:0051087; GO:0051259; GO:0060215; GO:0060319 [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; primitive erythrocyte differentiation [GO:0060319]; primitive hemopoiesis [GO:0060215]; protein complex oligomerization [GO:0051259] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-folding chaperone binding [GO:0051087] g5585.t1 P61752 31.525 295 7.19e-32 130.0 sp|P61752|HRH2_PONPY Histamine H2 receptor OS=Pongo pygmaeus OX=9600 GN=HRH2 PE=3 SV=1 g5586.t1 O43272 54.762 588 0.0 626.0 sp|O43272|PROD_HUMAN Proline dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PRODH PE=1 SV=4 PROD_HUMAN reviewed Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein) Homo sapiens (Human) GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0016649; GO:0019470; GO:0071949; GO:1903376 intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-proline catabolic process [GO:0006562]; L-proline catabolic process to L-glutamate [GO:0010133]; proline metabolic process [GO:0006560]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; trans-4-hydroxy-L-proline catabolic process [GO:0019470] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor [GO:0016649]; proline dehydrogenase activity [GO:0004657] g5590.t1 Q8UWA5 39.925 268 8.22e-51 171.0 sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3 g5591.t1 D4A734 26.847 406 2.86e-33 134.0 sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1 MOT12_RAT reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Rattus norvegicus (Rat) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g5592.t1 Q8R4G9 29.387 473 1.99e-71 238.0 sp|Q8R4G9|ACHA3_MOUSE Neuronal acetylcholine receptor subunit alpha-3 OS=Mus musculus OX=10090 GN=Chrna3 PE=1 SV=1 ACHA3_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-3 Mus musculus (Mouse) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g5593.t1 Q9GZZ6 39.423 312 3.92e-76 249.0 sp|Q9GZZ6|ACH10_HUMAN Neuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1 g5594.t1 Q9W3Y4 50.279 179 1.12e-47 189.0 sp|Q9W3Y4|GA2PE_DROME GAS2-like protein pickled eggs OS=Drosophila melanogaster OX=7227 GN=pigs PE=2 SV=2 g5594.t1 Q9W3Y4 68.421 95 2.1e-33 144.0 sp|Q9W3Y4|GA2PE_DROME GAS2-like protein pickled eggs OS=Drosophila melanogaster OX=7227 GN=pigs PE=2 SV=2 g5595.t1 Q9JJM9 64.578 367 1.56e-177 503.0 sp|Q9JJM9|SEPT5_RAT Septin-5 OS=Rattus norvegicus OX=10116 GN=Septin5 PE=1 SV=2 g5595.t2 Q9JJM9 66.289 353 9.94e-176 497.0 sp|Q9JJM9|SEPT5_RAT Septin-5 OS=Rattus norvegicus OX=10116 GN=Septin5 PE=1 SV=2 g5596.t1 Q9Y6I7 47.664 428 1.81e-132 392.0 sp|Q9Y6I7|WSB1_HUMAN WD repeat and SOCS box-containing protein 1 OS=Homo sapiens OX=9606 GN=WSB1 PE=1 SV=1 WSB1_HUMAN reviewed WD repeat and SOCS box-containing protein 1 (WSB-1) (SOCS box-containing WD protein SWiP-1) Homo sapiens (Human) GO:0000209; GO:0005829; GO:0035556; GO:0044314; GO:0061630; GO:0097413; GO:0140454 intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]; protein polyubiquitination [GO:0000209] cytosol [GO:0005829]; Lewy body [GO:0097413] ubiquitin protein ligase activity [GO:0061630] g5597.t1 O14495 40.602 266 1.12e-59 196.0 sp|O14495|PLPP3_HUMAN Phospholipid phosphatase 3 OS=Homo sapiens OX=9606 GN=PLPP3 PE=1 SV=1 PLPP3_HUMAN reviewed Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP) Homo sapiens (Human) GO:0000139; GO:0001568; GO:0001702; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0030111; GO:0030149; GO:0033116; GO:0033631; GO:0034112; GO:0042392; GO:0045121; GO:0045944; GO:0046839; GO:0050821; GO:0060020; GO:0070097; GO:0070971; GO:0097225; GO:0097228; GO:0098609; GO:0106235; GO:1902068; GO:1902533; GO:1904906 Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; integrin-mediated signaling pathway [GO:0007229]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; trans-Golgi network [GO:0005802] ceramide-1-phosphate phosphatase activity [GO:0106235]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392] g5597.t2 O14495 39.35 277 1.22e-61 201.0 sp|O14495|PLPP3_HUMAN Phospholipid phosphatase 3 OS=Homo sapiens OX=9606 GN=PLPP3 PE=1 SV=1 PLPP3_HUMAN reviewed Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP) Homo sapiens (Human) GO:0000139; GO:0001568; GO:0001702; GO:0005178; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005912; GO:0006644; GO:0006670; GO:0006672; GO:0006890; GO:0007165; GO:0007229; GO:0008195; GO:0010595; GO:0016020; GO:0016323; GO:0030111; GO:0030149; GO:0033116; GO:0033631; GO:0034112; GO:0042392; GO:0045121; GO:0045944; GO:0046839; GO:0050821; GO:0060020; GO:0070097; GO:0070971; GO:0097225; GO:0097228; GO:0098609; GO:0106235; GO:1902068; GO:1902533; GO:1904906 Bergmann glial cell differentiation [GO:0060020]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; ceramide metabolic process [GO:0006672]; gastrulation with mouth forming second [GO:0001702]; integrin-mediated signaling pathway [GO:0007229]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of sphingolipid mediated signaling pathway [GO:1902068]; regulation of Wnt signaling pathway [GO:0030111]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; signal transduction [GO:0007165]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; trans-Golgi network [GO:0005802] ceramide-1-phosphate phosphatase activity [GO:0106235]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392] g5599.t1 Q9H773 52.893 121 5.97e-41 147.0 sp|Q9H773|DCTP1_HUMAN dCTP pyrophosphatase 1 OS=Homo sapiens OX=9606 GN=DCTPP1 PE=1 SV=1 DCTP1_HUMAN reviewed dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein) Homo sapiens (Human) GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840 dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556] g5600.t1 Q8IZ69 46.642 551 7.499999999999999e-175 514.0 sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2 TRM2A_HUMAN reviewed tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-) Homo sapiens (Human) GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259 methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033] cytosol [GO:0005829] C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697] g5602.t1 P04069 46.535 303 8.769999999999999e-89 275.0 sp|P04069|CBPB_ASTAS Carboxypeptidase B OS=Astacus astacus OX=6715 PE=1 SV=1 g5604.t1 P27694 50.955 628 0.0 652.0 sp|P27694|RFA1_HUMAN Replication protein A 70 kDa DNA-binding subunit OS=Homo sapiens OX=9606 GN=RPA1 PE=1 SV=2 RFA1_HUMAN reviewed Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed] Homo sapiens (Human) GO:0000723; GO:0000724; GO:0000781; GO:0000800; GO:0001673; GO:0001701; GO:0003682; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0008270; GO:0008284; GO:0016605; GO:0030097; GO:0034502; GO:0035861; GO:0043047; GO:0048873; GO:0051321; GO:0090734; GO:0098505; GO:0140463; GO:1990166 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; positive regulation of cell population proliferation [GO:0008284]; protein localization to chromosome [GO:0034502]; protein localization to site of double-strand break [GO:1990166]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; zinc ion binding [GO:0008270] g5621.t1 Q810L3 35.15 734 6.86e-131 405.0 sp|Q810L3|CHFR_MOUSE E3 ubiquitin-protein ligase CHFR OS=Mus musculus OX=10090 GN=Chfr PE=1 SV=1 CHFR_MOUSE reviewed E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR) Mus musculus (Mouse) GO:0000166; GO:0000209; GO:0000278; GO:0004842; GO:0005634; GO:0006511; GO:0008270; GO:0016605; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0051301; GO:0061630 cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic cell cycle [GO:0000278]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; PML body [GO:0016605] nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5622.t1 B2RPY5 27.954 347 5.42e-34 135.0 sp|B2RPY5|GP161_MOUSE G-protein coupled receptor 161 OS=Mus musculus OX=10090 GN=Gpr161 PE=1 SV=1 GP161_MOUSE reviewed G-protein coupled receptor 161 Mus musculus (Mouse) GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0055037; GO:0060170; GO:1901621 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037] G protein-coupled receptor activity [GO:0004930] g5624.t1 Q9JJZ8 40.511 548 1.4000000000000001e-129 404.0 sp|Q9JJZ8|CNGA3_MOUSE Cyclic nucleotide-gated channel alpha-3 OS=Mus musculus OX=10090 GN=Cnga3 PE=1 SV=2 g5625.t1 O09014 51.562 128 2.5300000000000003e-32 123.0 sp|O09014|S15A4_RAT Solute carrier family 15 member 4 OS=Rattus norvegicus OX=10116 GN=Slc15a4 PE=1 SV=1 S15A4_RAT reviewed Solute carrier family 15 member 4 (Peptide/histidine transporter 1) (rPHT1) Rattus norvegicus (Rat) GO:0005290; GO:0005765; GO:0010008; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] g5626.t1 Q68F72 44.315 343 2.51e-90 286.0 sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1 S15A4_XENLA reviewed Solute carrier family 15 member 4 Xenopus laevis (African clawed frog) GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] g5630.t1 B5DE73 49.268 205 6.83e-65 209.0 sp|B5DE73|ASPH2_XENTR Aspartate beta-hydroxylase domain-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=asphd2 PE=2 SV=1 g5631.t1 Q9UMZ2 45.909 220 3.44e-52 205.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5631.t1 Q9UMZ2 39.706 136 8.4e-21 103.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5631.t2 Q9UMZ2 45.909 220 3.6e-52 205.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5631.t2 Q9UMZ2 39.706 136 8.63e-21 103.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5631.t3 Q9UMZ2 45.909 220 2.5299999999999997e-52 205.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5631.t3 Q9UMZ2 39.706 136 8.82e-21 103.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5631.t4 Q9UMZ2 45.909 220 3.0599999999999997e-52 205.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5631.t4 Q9UMZ2 39.706 136 7.8e-21 103.0 sp|Q9UMZ2|SYNRG_HUMAN Synergin gamma OS=Homo sapiens OX=9606 GN=SYNRG PE=1 SV=2 SYNRG_HUMAN reviewed Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] g5632.t1 Q64311 42.857 308 2e-76 239.0 sp|Q64311|NTAN1_MOUSE Protein N-terminal asparagine amidohydrolase OS=Mus musculus OX=10090 GN=Ntan1 PE=1 SV=3 NTAN1_MOUSE reviewed Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418 adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634] protein-N-terminal asparagine amidohydrolase activity [GO:0008418] g5633.t1 Q91618 43.432 472 2.17e-124 379.0 sp|Q91618|PMYT1_XENLA Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Xenopus laevis OX=8355 GN=pkmyt1 PE=1 SV=1 PMYT1_XENLA reviewed Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase) Xenopus laevis (African clawed frog) GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0007088; GO:0010972; GO:0046872; GO:0051321; GO:0106310; GO:0110031 meiotic cell cycle [GO:0051321]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; regulation of mitotic nuclear division [GO:0007088] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5635.t1 P56677 38.679 424 1.2e-73 253.0 sp|P56677|ST14_MOUSE Suppressor of tumorigenicity 14 protein homolog OS=Mus musculus OX=10090 GN=St14 PE=1 SV=2 ST14_MOUSE reviewed Suppressor of tumorigenicity 14 protein homolog (EC 3.4.21.109) (Epithin) (Serine protease 14) Mus musculus (Mouse) GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0009897; GO:0016323; GO:0016477; GO:0030163; GO:0030216; GO:0060672 cell migration [GO:0016477]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g5636.t1 A0A140LIJ0 25.437 629 1.37e-61 228.0 sp|A0A140LIJ0|DCST2_MOUSE DC-STAMP domain-containing protein 2 OS=Mus musculus OX=10090 GN=Dcst2 PE=1 SV=1 g5637.t1 Q9W0E3 32.624 1738 0.0 792.0 sp|Q9W0E3|IML1_DROME GATOR complex protein Iml1 OS=Drosophila melanogaster OX=7227 GN=Iml1 PE=1 SV=2 IML1_DROME reviewed GATOR complex protein Iml1 (Increased minichromosome loss 1) Drosophila melanogaster (Fruit fly) GO:0005096; GO:0005764; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859] GTPase activator activity [GO:0005096] g5637.t2 Q9W0E3 32.889 1724 0.0 792.0 sp|Q9W0E3|IML1_DROME GATOR complex protein Iml1 OS=Drosophila melanogaster OX=7227 GN=Iml1 PE=1 SV=2 IML1_DROME reviewed GATOR complex protein Iml1 (Increased minichromosome loss 1) Drosophila melanogaster (Fruit fly) GO:0005096; GO:0005764; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035859; GO:0045792; GO:0048142; GO:0051321; GO:0051729; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; germarium-derived cystoblast division [GO:0048142]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; negative regulation of cell size [GO:0045792]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Seh1-associated complex [GO:0035859] GTPase activator activity [GO:0005096] g5638.t1 Q3T0J3 54.206 214 5.2499999999999997e-76 233.0 sp|Q3T0J3|RM16_BOVIN Large ribosomal subunit protein uL16m OS=Bos taurus OX=9913 GN=MRPL16 PE=1 SV=1 g5639.t1 Q98998 30.909 220 6.7e-25 108.0 sp|Q98998|5HT1A_XENLA 5-hydroxytryptamine receptor 1A OS=Xenopus laevis OX=8355 GN=htr1a PE=2 SV=1 g5640.t1 Q98998 38.519 135 1.55e-25 103.0 sp|Q98998|5HT1A_XENLA 5-hydroxytryptamine receptor 1A OS=Xenopus laevis OX=8355 GN=htr1a PE=2 SV=1 g5642.t1 Q8BIY1 42.827 481 8.8e-109 336.0 sp|Q8BIY1|GPTC3_MOUSE G patch domain-containing protein 3 OS=Mus musculus OX=10090 GN=Gpatch3 PE=2 SV=1 g5644.t1 Q5SPX3 30.321 343 6.89e-40 147.0 sp|Q5SPX3|RN215_MOUSE RING finger protein 215 OS=Mus musculus OX=10090 GN=Rnf215 PE=2 SV=1 g5646.t1 Q32NQ8 39.977 858 2.0600000000000002e-169 513.0 sp|Q32NQ8|RNF10_XENLA E3 ubiquitin-protein ligase RNF10 OS=Xenopus laevis OX=8355 GN=rnf10 PE=2 SV=1 g5648.t1 Q6DGQ0 67.826 115 1.13e-60 184.0 sp|Q6DGQ0|SPT4H_DANRE Transcription elongation factor SPT4 OS=Danio rerio OX=7955 GN=supt4h1 PE=3 SV=1 SPT4H_DANRE reviewed Transcription elongation factor SPT4 (DRB sensitivity-inducing factor small subunit) (DSIF small subunit) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000993; GO:0006355; GO:0006368; GO:0008270; GO:0032044; GO:0140673 regulation of DNA-templated transcription [GO:0006355]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673] DSIF complex [GO:0032044] RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270] g5649.t1 Q5M782 35.398 226 1.3099999999999999e-42 147.0 sp|Q5M782|RIPB_XENLA RPA-interacting protein B OS=Xenopus laevis OX=8355 GN=rpain-b PE=2 SV=2 g5650.t1 Q9C086 40.206 291 7.15e-40 147.0 sp|Q9C086|IN80B_HUMAN INO80 complex subunit B OS=Homo sapiens OX=9606 GN=INO80B PE=1 SV=2 g5651.t1 O35551 36.268 954 9.349999999999999e-134 428.0 sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2 RABE1_MOUSE reviewed Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha) Mus musculus (Mouse) GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:0099523; GO:1903441 apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] g5651.t2 O35551 36.164 954 3.88e-134 429.0 sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2 RABE1_MOUSE reviewed Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha) Mus musculus (Mouse) GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:0099523; GO:1903441 apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] g5652.t1 Q9Y4P3 50.123 405 2.57e-139 410.0 sp|Q9Y4P3|TBL2_HUMAN Transducin beta-like protein 2 OS=Homo sapiens OX=9606 GN=TBL2 PE=1 SV=1 g5653.t1 Q9CWP8 41.441 111 2e-25 94.7 sp|Q9CWP8|DPOD4_MOUSE DNA polymerase delta subunit 4 OS=Mus musculus OX=10090 GN=Pold4 PE=1 SV=1 g5654.t1 Q5BIN4 58.108 148 1.56e-56 179.0 sp|Q5BIN4|TIM22_BOVIN Mitochondrial import inner membrane translocase subunit Tim22 OS=Bos taurus OX=9913 GN=TIMM22 PE=2 SV=1 g5655.t1 Q7PPA5 74.524 997 0.0 1531.0 sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5 g5656.t1 Q29042 38.647 207 4.49e-28 113.0 sp|Q29042|FCN1_PIG Ficolin-1 OS=Sus scrofa OX=9823 GN=FCN1 PE=1 SV=1 g5658.t1 M0R3Q7 38.895 851 0.0 591.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g5660.t1 M0R3Q7 39.6 851 0.0 597.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g5661.t1 Q9QXF7 39.721 501 9.260000000000001e-122 369.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g5662.t1 Q8WWT9 40.931 623 5.11e-148 446.0 sp|Q8WWT9|S13A3_HUMAN Na(+)/dicarboxylate cotransporter 3 OS=Homo sapiens OX=9606 GN=SLC13A3 PE=1 SV=1 g5663.t1 Q8WWT9 39.36 625 2.45e-152 456.0 sp|Q8WWT9|S13A3_HUMAN Na(+)/dicarboxylate cotransporter 3 OS=Homo sapiens OX=9606 GN=SLC13A3 PE=1 SV=1 g5664.t1 A0PJN4 53.704 162 3.16e-56 183.0 sp|A0PJN4|U2QL1_MOUSE Ubiquitin-conjugating enzyme E2Q-like protein 1 OS=Mus musculus OX=10090 GN=Ube2ql1 PE=2 SV=2 U2QL1_MOUSE reviewed Ubiquitin-conjugating enzyme E2Q-like protein 1 (EC 2.3.2.23) (E2Q-like ubiquitin-conjugating enzyme 1) Mus musculus (Mouse) GO:0000209; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0061631 protein polyubiquitination [GO:0000209] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] g5665.t1 O75845 53.061 294 1.1699999999999999e-104 310.0 sp|O75845|SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens OX=9606 GN=SC5D PE=1 SV=2 g5666.t1 A8WHP3 59.72 643 0.0 773.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g5667.t1 Q6P2X9 26.905 420 1.9000000000000002e-29 122.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g5670.t1 Q13948 52.734 256 4.5e-80 258.0 sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2 g5671.t1 Q13948 59.362 470 1.16e-168 522.0 sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2 g5672.t1 A2CEI4 39.088 724 3.1e-169 506.0 sp|A2CEI4|NUP88_DANRE Nucleoporin 88 OS=Danio rerio OX=7955 GN=nup88 PE=1 SV=1 g5672.t2 O08658 40.0 285 6.14e-60 206.0 sp|O08658|NUP88_RAT Nuclear pore complex protein Nup88 OS=Rattus norvegicus OX=10116 GN=Nup88 PE=1 SV=1 g5673.t1 Q9JLT4 60.494 486 0.0 637.0 sp|Q9JLT4|TRXR2_MOUSE Thioredoxin reductase 2, mitochondrial OS=Mus musculus OX=10090 GN=Txnrd2 PE=1 SV=4 g5676.t1 Q8WZ73 39.744 390 6.36e-70 228.0 sp|Q8WZ73|RFFL_HUMAN E3 ubiquitin-protein ligase rififylin OS=Homo sapiens OX=9606 GN=RFFL PE=1 SV=1 g5677.t1 Q28FE2 75.0 112 5.6399999999999995e-61 187.0 sp|Q28FE2|MED31_XENTR Mediator of RNA polymerase II transcription subunit 31 OS=Xenopus tropicalis OX=8364 GN=med31 PE=2 SV=2 g5678.t1 E1BD59 23.932 351 8.839999999999999e-23 107.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g5679.t1 Q08E38 70.196 510 0.0 752.0 sp|Q08E38|PRP19_BOVIN Pre-mRNA-processing factor 19 OS=Bos taurus OX=9913 GN=PRPF19 PE=2 SV=1 PRP19_BOVIN reviewed Pre-mRNA-processing factor 19 (EC 2.3.2.27) (PRP19/PSO4 homolog) (RING-type E3 ubiquitin transferase PRP19) Bos taurus (Bovine) GO:0000077; GO:0000244; GO:0000245; GO:0000398; GO:0000974; GO:0001833; GO:0004842; GO:0005634; GO:0005662; GO:0005737; GO:0005811; GO:0005819; GO:0006303; GO:0008104; GO:0008610; GO:0010498; GO:0016607; GO:0034450; GO:0035861; GO:0042802; GO:0048026; GO:0061630; GO:0070534; GO:0071006; GO:0071007 DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; inner cell mass cell proliferation [GO:0001833]; intracellular protein localization [GO:0008104]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244] cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] g5680.t1 O95294 47.714 503 8.32e-148 446.0 sp|O95294|RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens OX=9606 GN=RASAL1 PE=1 SV=3 RASL1_HUMAN reviewed RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) Homo sapiens (Human) GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0008270; GO:0030154; GO:0035556; GO:0046580; GO:0071277; GO:1902531; GO:1903861 cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of intracellular signal transduction [GO:1902531]; signal transduction [GO:0007165] cytosol [GO:0005829] GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g5680.t2 O95294 48.185 496 3.23e-148 447.0 sp|O95294|RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens OX=9606 GN=RASAL1 PE=1 SV=3 RASL1_HUMAN reviewed RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) Homo sapiens (Human) GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0008270; GO:0030154; GO:0035556; GO:0046580; GO:0071277; GO:1902531; GO:1903861 cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of intracellular signal transduction [GO:1902531]; signal transduction [GO:0007165] cytosol [GO:0005829] GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g5684.t1 O95294 48.538 342 4.09e-101 318.0 sp|O95294|RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens OX=9606 GN=RASAL1 PE=1 SV=3 RASL1_HUMAN reviewed RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) Homo sapiens (Human) GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0008270; GO:0030154; GO:0035556; GO:0046580; GO:0071277; GO:1902531; GO:1903861 cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of intracellular signal transduction [GO:1902531]; signal transduction [GO:0007165] cytosol [GO:0005829] GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] g5685.t1 Q567Y6 53.226 186 2.46e-70 214.0 sp|Q567Y6|IFT22_DANRE Intraflagellar transport protein 22 homolog OS=Danio rerio OX=7955 GN=ift22 PE=2 SV=1 g5686.t1 Q9VBY8 23.976 659 1.3699999999999998e-40 167.0 sp|Q9VBY8|UN13B_DROME Protein unc-13 homolog 4B OS=Drosophila melanogaster OX=7227 GN=stac PE=1 SV=5 UN13B_DROME reviewed Protein unc-13 homolog 4B (Protein Staccato) Drosophila melanogaster (Fruit fly) GO:0005764; GO:0005770; GO:0005856; GO:0007269; GO:0008021; GO:0016082; GO:0030175; GO:0035147; GO:0046872; GO:0099503 branch fusion, open tracheal system [GO:0035147]; neurotransmitter secretion [GO:0007269]; synaptic vesicle priming [GO:0016082] cytoskeleton [GO:0005856]; filopodium [GO:0030175]; late endosome [GO:0005770]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021] metal ion binding [GO:0046872] g5686.t2 Q9VBY8 23.976 659 7.92e-41 168.0 sp|Q9VBY8|UN13B_DROME Protein unc-13 homolog 4B OS=Drosophila melanogaster OX=7227 GN=stac PE=1 SV=5 UN13B_DROME reviewed Protein unc-13 homolog 4B (Protein Staccato) Drosophila melanogaster (Fruit fly) GO:0005764; GO:0005770; GO:0005856; GO:0007269; GO:0008021; GO:0016082; GO:0030175; GO:0035147; GO:0046872; GO:0099503 branch fusion, open tracheal system [GO:0035147]; neurotransmitter secretion [GO:0007269]; synaptic vesicle priming [GO:0016082] cytoskeleton [GO:0005856]; filopodium [GO:0030175]; late endosome [GO:0005770]; lysosome [GO:0005764]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021] metal ion binding [GO:0046872] g5687.t1 Q6R653 37.908 306 1.8299999999999999e-62 220.0 sp|Q6R653|UN5CL_MOUSE UNC5C-like protein OS=Mus musculus OX=10090 GN=Unc5cl PE=2 SV=2 g5688.t1 Q8CI85 34.752 282 9.070000000000001e-51 175.0 sp|Q8CI85|CAH12_MOUSE Carbonic anhydrase 12 OS=Mus musculus OX=10090 GN=Ca12 PE=1 SV=1 CAH12_MOUSE reviewed Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) Mus musculus (Mouse) GO:0004089; GO:0005886; GO:0006885; GO:0008270; GO:0015670; GO:0016323; GO:0016324; GO:0055064 carbon dioxide transport [GO:0015670]; chloride ion homeostasis [GO:0055064]; regulation of pH [GO:0006885] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270] g5689.t1 Q6A028 31.381 666 2.66e-61 218.0 sp|Q6A028|SWP70_MOUSE Switch-associated protein 70 OS=Mus musculus OX=10090 GN=Swap70 PE=1 SV=2 SWP70_MOUSE reviewed Switch-associated protein 70 (SWAP-70) Mus musculus (Mouse) GO:0003677; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007204; GO:0008064; GO:0015629; GO:0016444; GO:0030027; GO:0030835; GO:0032233; GO:0032880; GO:0033633; GO:0045190; GO:0051017; GO:0060754; GO:0098794 actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of protein localization [GO:0032880]; somatic cell DNA recombination [GO:0016444] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] ATP binding [GO:0005524]; DNA binding [GO:0003677] g5689.t2 Q6A028 31.355 657 7.91e-61 217.0 sp|Q6A028|SWP70_MOUSE Switch-associated protein 70 OS=Mus musculus OX=10090 GN=Swap70 PE=1 SV=2 SWP70_MOUSE reviewed Switch-associated protein 70 (SWAP-70) Mus musculus (Mouse) GO:0003677; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007204; GO:0008064; GO:0015629; GO:0016444; GO:0030027; GO:0030835; GO:0032233; GO:0032880; GO:0033633; GO:0045190; GO:0051017; GO:0060754; GO:0098794 actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of protein localization [GO:0032880]; somatic cell DNA recombination [GO:0016444] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] ATP binding [GO:0005524]; DNA binding [GO:0003677] g5690.t1 A3KP85 44.689 273 2.0800000000000002e-66 212.0 sp|A3KP85|ETKMT_DANRE Electron transfer flavoprotein beta subunit lysine methyltransferase OS=Danio rerio OX=7955 GN=etfbkmt PE=2 SV=2 g5691.t1 Q8UWA5 40.0 170 1.6999999999999998e-30 115.0 sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3 g5694.t1 Q9QZR0 45.487 277 4.05e-77 251.0 sp|Q9QZR0|RNF25_MOUSE E3 ubiquitin-protein ligase RNF25 OS=Mus musculus OX=10090 GN=Rnf25 PE=1 SV=2 RNF25_MOUSE reviewed E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7) Mus musculus (Mouse) GO:0004842; GO:0005634; GO:0005829; GO:0006414; GO:0006415; GO:0006511; GO:0008270; GO:0016567; GO:0022626; GO:0051059; GO:0051092; GO:0061630; GO:0072344; GO:0085020; GO:0160127 positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; protein-RNA covalent cross-linking repair [GO:0160127]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]; translational termination [GO:0006415]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634] NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5695.t1 Q64471 43.836 219 1.07e-62 198.0 sp|Q64471|GSTT1_MOUSE Glutathione S-transferase theta-1 OS=Mus musculus OX=10090 GN=Gstt1 PE=1 SV=4 GSTT1_MOUSE reviewed Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) Mus musculus (Mouse) GO:0004364; GO:0004602; GO:0005634; GO:0005737; GO:0005829; GO:0006304; GO:0006749; GO:0009751; GO:0010269; GO:0018900; GO:0033197; GO:0047651 dichloromethane metabolic process [GO:0018900]; DNA modification [GO:0006304]; glutathione metabolic process [GO:0006749]; response to salicylic acid [GO:0009751]; response to selenium ion [GO:0010269]; response to vitamin E [GO:0033197] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] alkylhalidase activity [GO:0047651]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] g5696.t1 Q9Z265 50.0 472 6.470000000000001e-157 461.0 sp|Q9Z265|CHK2_MOUSE Serine/threonine-protein kinase Chk2 OS=Mus musculus OX=10090 GN=Chek2 PE=1 SV=1 g5697.t1 A0JN61 60.63 127 2.53e-40 135.0 sp|A0JN61|RPC9_BOVIN DNA-directed RNA polymerase III subunit RPC9 OS=Bos taurus OX=9913 GN=CRCP PE=2 SV=1 g5698.t1 Q9Y6H1 44.578 166 2.4300000000000002e-29 108.0 sp|Q9Y6H1|CHCH2_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CHCHD2 PE=1 SV=1 CHCH2_HUMAN reviewed Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein) (NS2TP) Homo sapiens (Human) GO:0005634; GO:0005739; GO:0005758; GO:0007005; GO:0034599; GO:0043467; GO:0043565; GO:0045944; GO:0140297; GO:1900037; GO:1905448 cellular response to oxidative stress [GO:0034599]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037]; regulation of generation of precursor metabolites and energy [GO:0043467] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634] DNA-binding transcription factor binding [GO:0140297]; sequence-specific DNA binding [GO:0043565] g5699.t1 O77245 34.53 362 6.590000000000001e-57 200.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g5700.t1 Q9NQG7 30.992 242 2.9400000000000003e-31 135.0 sp|Q9NQG7|HPS4_HUMAN BLOC-3 complex member HPS4 OS=Homo sapiens OX=9606 GN=HPS4 PE=1 SV=2 HPS4_HUMAN reviewed BLOC-3 complex member HPS4 (Hermansky-Pudlak syndrome 4 protein) (Light-ear protein homolog) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006605; GO:0007040; GO:0007596; GO:0007599; GO:0016020; GO:0016192; GO:0030318; GO:0031085; GO:0031267; GO:0031410; GO:0042470; GO:0042803; GO:0042827; GO:0046983; GO:0048075; GO:0050821; GO:0060155; GO:1903232; GO:1903955 blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827] guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g5702.t1 Q9P0Z9 44.357 381 1.37e-109 330.0 sp|Q9P0Z9|SOX_HUMAN Peroxisomal sarcosine oxidase OS=Homo sapiens OX=9606 GN=PIPOX PE=1 SV=2 SOX_HUMAN reviewed Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase) Homo sapiens (Human) GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660 L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] g5703.t1 Q4R4R9 37.912 182 5.090000000000001e-37 132.0 sp|Q4R4R9|RAB3A_MACFA Ras-related protein Rab-3A OS=Macaca fascicularis OX=9541 GN=RAB3A PE=2 SV=1 RAB3A_MACFA reviewed Ras-related protein Rab-3A (EC 3.6.5.2) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003925; GO:0005525; GO:0005764; GO:0005829; GO:0005886; GO:0006887; GO:0015031; GO:0030133; GO:0030424; GO:0031489; GO:0046872; GO:0048471; GO:0048786; GO:0098793; GO:0098794 exocytosis [GO:0006887]; protein transport [GO:0015031] axon [GO:0030424]; cytosol [GO:0005829]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; transport vesicle [GO:0030133] G protein activity [GO:0003925]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g5704.t1 Q8VBT2 50.949 316 4.51e-102 305.0 sp|Q8VBT2|SDHL_MOUSE L-serine dehydratase/L-threonine deaminase OS=Mus musculus OX=10090 GN=Sds PE=1 SV=3 g5705.t1 Q6PD24 49.923 651 0.0 598.0 sp|Q6PD24|AN13D_MOUSE Ankyrin repeat domain-containing protein 13D OS=Mus musculus OX=10090 GN=Ankrd13d PE=1 SV=2 g5706.t1 A7SG73 53.952 291 4.03e-102 308.0 sp|A7SG73|NADC_NEMVE Nicotinate-nucleotide pyrophosphorylase [carboxylating] (Fragment) OS=Nematostella vectensis OX=45351 GN=qprt PE=3 SV=1 g5707.t1 Q7Z569 47.479 476 4.05e-143 435.0 sp|Q7Z569|BRAP_HUMAN BRCA1-associated protein OS=Homo sapiens OX=9606 GN=BRAP PE=1 SV=2 BRAP_HUMAN reviewed BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63) Homo sapiens (Human) GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630 MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5708.t1 P36544 29.663 445 3.6399999999999997e-60 207.0 sp|P36544|ACHA7_HUMAN Neuronal acetylcholine receptor subunit alpha-7 OS=Homo sapiens OX=9606 GN=CHRNA7 PE=1 SV=5 ACHA7_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Homo sapiens (Human) GO:0001540; GO:0001666; GO:0004888; GO:0005216; GO:0005262; GO:0005789; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007611; GO:0007613; GO:0007614; GO:0008284; GO:0015464; GO:0015643; GO:0016020; GO:0017081; GO:0022848; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043124; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045766; GO:0050808; GO:0050890; GO:0050893; GO:0051247; GO:0060079; GO:0060084; GO:0070374; GO:0095500; GO:0097061; GO:0098794; GO:0098815; GO:0140059; GO:1900016; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904645; GO:1905144; GO:1905906; GO:2000463 acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; excitatory postsynaptic potential [GO:0060079]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein metabolic process [GO:0051247]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of membrane potential [GO:0042391]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission involved in micturition [GO:0060084] acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; calcium channel activity [GO:0005262]; chloride channel regulator activity [GO:0017081]; monoatomic ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; transmembrane signaling receptor activity [GO:0004888] g5709.t1 Q05941 29.892 465 3.38e-65 221.0 sp|Q05941|ACHA7_RAT Neuronal acetylcholine receptor subunit alpha-7 OS=Rattus norvegicus OX=10116 GN=Chrna7 PE=1 SV=2 ACHA7_RAT reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Rattus norvegicus (Rat) GO:0001540; GO:0001666; GO:0001988; GO:0004888; GO:0005216; GO:0005789; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007249; GO:0007268; GO:0007271; GO:0007611; GO:0007613; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0010628; GO:0014061; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0023019; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043124; GO:0043197; GO:0043198; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045471; GO:0045766; GO:0046681; GO:0046872; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051649; GO:0051823; GO:0060079; GO:0060084; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098815; GO:0098878; GO:0098897; GO:0098981; GO:0099171; GO:0099634; GO:0140059; GO:1900016; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905869; GO:1905906; GO:1990806; GO:2000463; GO:2001023 acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; canonical NF-kappaB signal transduction [GO:0007249]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein metabolic process [GO:0051247]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of norepinephrine secretion [GO:0014061]; regulation of response to drug [GO:2001023]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to carbamate [GO:0046681]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; synapse organization [GO:0050808]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110] acetylcholine-gated channel complex [GO:0005892]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; axon [GO:0030424]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734]; spine apparatus membrane [GO:0098897]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; ATPase binding [GO:0051117]; chloride channel regulator activity [GO:0017081]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; toxic substance binding [GO:0015643]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g5711.t1 O97827 36.364 341 2.1e-56 216.0 sp|O97827|AGRL3_BOVIN Adhesion G protein-coupled receptor L3 OS=Bos taurus OX=9913 GN=ADGRL3 PE=2 SV=1 g5713.t1 Q9MYW9 26.368 402 1.1200000000000002e-21 99.4 sp|Q9MYW9|OPRM_MACMU Mu-type opioid receptor OS=Macaca mulatta OX=9544 GN=OPRM1 PE=2 SV=2 OPRM_MACMU reviewed Mu-type opioid receptor (M-OR-1) (MOR-1) Macaca mulatta (Rhesus macaque) GO:0001965; GO:0004930; GO:0004979; GO:0005245; GO:0005768; GO:0005886; GO:0007193; GO:0007197; GO:0007200; GO:0007218; GO:0019233; GO:0030424; GO:0030425; GO:0031681; GO:0038003; GO:0038047; GO:0042923; GO:0043005; GO:0043204; GO:0045019; GO:0045202; GO:0050769; GO:0051481; GO:0061358; GO:0070374; GO:2000310 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; regulation of NMDA receptor activity [GO:2000310]; sensory perception of pain [GO:0019233] axon [GO:0030424]; dendrite [GO:0030425]; endosome [GO:0005768]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202] beta-endorphin receptor activity [GO:0004979]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; neuropeptide binding [GO:0042923]; voltage-gated calcium channel activity [GO:0005245] g5715.t1 Q9Y6R7 29.818 1754 0.0 704.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 28.856 1757 0.0 691.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 30.085 1755 0.0 687.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 29.148 1760 0.0 680.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 30.09 1665 0.0 674.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 30.08 1752 0.0 666.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 30.763 1258 3.1e-158 555.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 28.916 1162 4.16e-113 409.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 27.664 1070 2.47e-93 344.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 30.065 459 3.2599999999999998e-52 209.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5715.t1 Q9Y6R7 26.074 675 3.3600000000000004e-43 179.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 31.73 3265 0.0 1430.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 30.887 3270 0.0 1388.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 30.976 3238 0.0 1379.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 30.275 3161 0.0 1282.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 31.912 2651 0.0 1224.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 30.951 2701 0.0 1142.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 30.839 2312 0.0 985.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 30.708 1498 5.66e-178 622.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 31.25 672 1.66e-76 289.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 32.933 416 1.6699999999999998e-45 187.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5716.t1 Q9Y6R7 30.97 268 5.6699999999999996e-30 135.0 sp|Q9Y6R7|FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens OX=9606 GN=FCGBP PE=1 SV=3 FCGBP_HUMAN reviewed IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0005796; GO:0031012; GO:0070062 extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] extracellular matrix structural constituent [GO:0005201] g5717.t1 P49013 46.953 279 4.44e-64 233.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5717.t1 P49013 45.5 200 1.32e-46 181.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5717.t1 P49013 47.668 193 6.88e-42 167.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5717.t1 P49013 45.581 215 7.29e-41 164.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5717.t1 P49013 40.773 233 2.0999999999999998e-40 162.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5717.t1 P49013 41.872 203 2.8799999999999997e-30 132.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5717.t1 P49013 39.779 181 1.67e-28 126.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5717.t1 P49013 41.25 160 1.4599999999999999e-24 114.0 sp|P49013|FBP3_STRPU Fibropellin-3 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF3 PE=1 SV=1 g5718.t1 Q03168 43.25 400 5.59e-101 307.0 sp|Q03168|ASPP_AEDAE Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2 g5719.t1 Q6AX44 41.558 231 1.4400000000000002e-43 158.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g5720.t1 Q53HC0 41.026 195 7.98e-31 122.0 sp|Q53HC0|CCD92_HUMAN Coiled-coil domain-containing protein 92 OS=Homo sapiens OX=9606 GN=CCDC92 PE=1 SV=2 CCD92_HUMAN reviewed Coiled-coil domain-containing protein 92 (Limkain beta-2) Homo sapiens (Human) GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0042802; GO:0045087; GO:0050688 innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802] g5721.t1 Q6P2Q9 93.165 2341 0.0 4575.0 sp|Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2 PRP8_HUMAN reviewed Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220) Homo sapiens (Human) GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157 cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244] catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070] g5723.t1 M0R3Q7 39.483 851 0.0 603.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g5725.t1 P9WET8 33.02 639 2.6499999999999997e-91 313.0 sp|P9WET8|PREU1_PREIS Highly reducing polyketide synthase Preu1 OS=Preussia isomera OX=325670 GN=Preu1 PE=2 SV=1 g5728.t1 P14686 31.66 259 1.7e-36 137.0 sp|P14686|GRST_ANEMI Gramicidin S biosynthesis protein GrsT OS=Aneurinibacillus migulanus OX=47500 GN=grsT PE=3 SV=1 g5729.t1 M0R3Q7 31.965 341 4.44e-49 179.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g5730.t1 A0A8F4S8Q3 30.173 1213 1.28e-134 478.0 sp|A0A8F4S8Q3|GKAA_PENCI Hybrid PKS-NRPS synthetase gkaA OS=Penicillium citrinum OX=5077 GN=gkaA PE=1 SV=1 GKAA_PENCI reviewed Hybrid PKS-NRPS synthetase gkaA (EC 2.3.1.-) (EC 6.3.2.-) (GKK1032 biosynthesis cluster protein A) Penicillium citrinum GO:0004312; GO:0004315; GO:0006633; GO:0008168; GO:0009403; GO:0016874; GO:0030639; GO:0031177; GO:0032259; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; methylation [GO:0032259]; polyketide biosynthetic process [GO:0030639]; toxin biosynthetic process [GO:0009403] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; ligase activity [GO:0016874]; methyltransferase activity [GO:0008168]; phosphopantetheine binding [GO:0031177] g5731.t1 M0R3Q7 31.933 238 5.37e-32 126.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g5733.t1 C8VJR7 33.305 1189 1.76e-155 542.0 sp|C8VJR7|ALNA_EMENI Highly reducing polyketide synthase alnA OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=alnA PE=1 SV=1 g5734.t1 Q70PU1 40.491 163 1.45e-38 134.0 sp|Q70PU1|PGSC2_DROSI Peptidoglycan-recognition protein SC2 OS=Drosophila simulans OX=7240 GN=PGRP-SC2 PE=3 SV=1 g5734.t2 Q70PU1 40.476 168 3.65e-41 141.0 sp|Q70PU1|PGSC2_DROSI Peptidoglycan-recognition protein SC2 OS=Drosophila simulans OX=7240 GN=PGRP-SC2 PE=3 SV=1 g5735.t1 O75594 46.328 177 1.36e-51 167.0 sp|O75594|PGRP1_HUMAN Peptidoglycan recognition protein 1 OS=Homo sapiens OX=9606 GN=PGLYRP1 PE=1 SV=1 PGRP1_HUMAN reviewed Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S) Homo sapiens (Human) GO:0005576; GO:0005615; GO:0006955; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016045; GO:0030544; GO:0031640; GO:0032689; GO:0032827; GO:0035580; GO:0042742; GO:0042834; GO:0045087; GO:0048018; GO:0050728; GO:0050830; GO:0051701; GO:0060090; GO:0061844; GO:0070062; GO:0097013; GO:1904724 antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; negative regulation of type II interferon production [GO:0032689]; peptidoglycan catabolic process [GO:0009253] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] Hsp70 protein binding [GO:0030544]; molecular adaptor activity [GO:0060090]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; receptor ligand activity [GO:0048018]; zinc ion binding [GO:0008270] g5735.t2 O75594 46.023 176 1.25e-50 165.0 sp|O75594|PGRP1_HUMAN Peptidoglycan recognition protein 1 OS=Homo sapiens OX=9606 GN=PGLYRP1 PE=1 SV=1 PGRP1_HUMAN reviewed Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S) Homo sapiens (Human) GO:0005576; GO:0005615; GO:0006955; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016045; GO:0030544; GO:0031640; GO:0032689; GO:0032827; GO:0035580; GO:0042742; GO:0042834; GO:0045087; GO:0048018; GO:0050728; GO:0050830; GO:0051701; GO:0060090; GO:0061844; GO:0070062; GO:0097013; GO:1904724 antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; negative regulation of type II interferon production [GO:0032689]; peptidoglycan catabolic process [GO:0009253] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] Hsp70 protein binding [GO:0030544]; molecular adaptor activity [GO:0060090]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; receptor ligand activity [GO:0048018]; zinc ion binding [GO:0008270] g5736.t1 Q641W4 74.566 346 0.0 558.0 sp|Q641W4|RFC2_RAT Replication factor C subunit 2 OS=Rattus norvegicus OX=10116 GN=Rfc2 PE=2 SV=1 g5739.t1 Q9Z200 33.094 556 4.18e-76 258.0 sp|Q9Z200|SH2B2_RAT SH2B adapter protein 2 OS=Rattus norvegicus OX=10116 GN=Sh2b2 PE=1 SV=1 SH2B2_RAT reviewed SH2B adapter protein 2 (Adapter protein with pleckstrin homology and Src homology 2 domains) (SH2 and PH domain-containing adapter protein APS) Rattus norvegicus (Rat) GO:0001725; GO:0001726; GO:0001922; GO:0005068; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0007399; GO:0008286; GO:0019221; GO:0030036; GO:0035556; GO:0035591; GO:0042169; GO:0042802; GO:0046578; GO:0050776; GO:0050851; GO:0050853; GO:0050873 actin cytoskeleton organization [GO:0030036]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; brown fat cell differentiation [GO:0050873]; cytokine-mediated signaling pathway [GO:0019221]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; regulation of immune response [GO:0050776]; regulation of Ras protein signal transduction [GO:0046578] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725] identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g5740.t1 O08715 38.506 348 2.37e-65 228.0 sp|O08715|AKAP1_MOUSE A-kinase anchor protein 1, mitochondrial OS=Mus musculus OX=10090 GN=Akap1 PE=1 SV=4 g5742.t1 Q8IYT8 66.084 286 9.709999999999999e-119 391.0 sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens OX=9606 GN=ULK2 PE=1 SV=3 ULK2_HUMAN reviewed Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0007411; GO:0008104; GO:0010506; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310; GO:0160038 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; collateral sprouting [GO:0048668]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]; somatic sensory system development [GO:0160038] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5742.t1 Q8IYT8 30.998 471 1.5699999999999999e-40 166.0 sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens OX=9606 GN=ULK2 PE=1 SV=3 ULK2_HUMAN reviewed Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0007411; GO:0008104; GO:0010506; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310; GO:0160038 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; collateral sprouting [GO:0048668]; intracellular protein localization [GO:0008104]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]; somatic sensory system development [GO:0160038] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5743.t1 Q5SSL4 39.256 833 0.0 569.0 sp|Q5SSL4|ABR_MOUSE Active breakpoint cluster region-related protein OS=Mus musculus OX=10090 GN=Abr PE=1 SV=1 ABR_MOUSE reviewed Active breakpoint cluster region-related protein Mus musculus (Mouse) GO:0002692; GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0006909; GO:0007420; GO:0016020; GO:0030036; GO:0030336; GO:0030424; GO:0032496; GO:0035556; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0060313; GO:0090630; GO:0098685; GO:0098978; GO:0099092; GO:1905517; GO:1905522 actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; inner ear morphogenesis [GO:0042472]; intracellular signal transduction [GO:0035556]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; regulation of vascular permeability [GO:0043114]; response to lipopolysaccharide [GO:0032496] axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g5743.t2 Q5SSL4 39.976 818 0.0 574.0 sp|Q5SSL4|ABR_MOUSE Active breakpoint cluster region-related protein OS=Mus musculus OX=10090 GN=Abr PE=1 SV=1 ABR_MOUSE reviewed Active breakpoint cluster region-related protein Mus musculus (Mouse) GO:0002692; GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0006909; GO:0007420; GO:0016020; GO:0030036; GO:0030336; GO:0030424; GO:0032496; GO:0035556; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0060313; GO:0090630; GO:0098685; GO:0098978; GO:0099092; GO:1905517; GO:1905522 actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; inner ear morphogenesis [GO:0042472]; intracellular signal transduction [GO:0035556]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; regulation of vascular permeability [GO:0043114]; response to lipopolysaccharide [GO:0032496] axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] g5745.t1 P31645 50.482 622 0.0 638.0 sp|P31645|SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens OX=9606 GN=SLC6A4 PE=1 SV=1 SC6A4_HUMAN reviewed Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4) Homo sapiens (Human) GO:0001666; GO:0005178; GO:0005261; GO:0005326; GO:0005335; GO:0005886; GO:0005925; GO:0006836; GO:0006865; GO:0007584; GO:0007613; GO:0007623; GO:0008504; GO:0009410; GO:0009636; GO:0010008; GO:0010628; GO:0012505; GO:0014064; GO:0015297; GO:0015844; GO:0017075; GO:0019811; GO:0021941; GO:0031402; GO:0032227; GO:0032355; GO:0035725; GO:0042310; GO:0042734; GO:0042802; GO:0043005; GO:0045121; GO:0045202; GO:0045211; GO:0045665; GO:0045787; GO:0046621; GO:0048148; GO:0048484; GO:0048854; GO:0050998; GO:0051015; GO:0051378; GO:0051610; GO:0051899; GO:0060179; GO:0070527; GO:0071300; GO:0071321; GO:0090067; GO:0099154; GO:1990708 amino acid transport [GO:0006865]; behavioral response to cocaine [GO:0048148]; brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; conditioned place preference [GO:1990708]; enteric nervous system development [GO:0048484]; male mating behavior [GO:0060179]; membrane depolarization [GO:0051899]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; neurotransmitter transport [GO:0006836]; platelet aggregation [GO:0070527]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; regulation of thalamus size [GO:0090067]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; serotonin uptake [GO:0051610]; sodium ion transmembrane transport [GO:0035725]; vasoconstriction [GO:0042310] endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; serotonergic synapse [GO:0099154]; synapse [GO:0045202] actin filament binding [GO:0051015]; antiporter activity [GO:0015297]; cocaine binding [GO:0019811]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; monoamine transmembrane transporter activity [GO:0008504]; monoatomic cation channel activity [GO:0005261]; neurotransmitter transmembrane transporter activity [GO:0005326]; nitric-oxide synthase binding [GO:0050998]; serotonin binding [GO:0051378]; serotonin:sodium:chloride symporter activity [GO:0005335]; sodium ion binding [GO:0031402]; syntaxin-1 binding [GO:0017075] g5746.t1 Q99542 33.471 484 1.2299999999999999e-69 235.0 sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1 MMP19_HUMAN reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18) Homo sapiens (Human) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g5753.t1 P32297 40.519 501 1.22e-126 381.0 sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4 ACHA3_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-3 Homo sapiens (Human) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0035869; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0097542; GO:0098793; GO:0098878; GO:0099171; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276] g5755.t1 P04757 39.439 535 5.969999999999999e-138 412.0 sp|P04757|ACHA3_RAT Neuronal acetylcholine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Chrna3 PE=1 SV=1 ACHA3_RAT reviewed Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007507; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034465; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; heart development [GO:0007507]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to carbon monoxide [GO:0034465]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g5755.t2 P04757 39.439 535 6.5e-138 412.0 sp|P04757|ACHA3_RAT Neuronal acetylcholine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Chrna3 PE=1 SV=1 ACHA3_RAT reviewed Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007507; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034465; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; heart development [GO:0007507]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to carbon monoxide [GO:0034465]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g5756.t1 Q5RAF1 42.319 345 3.29e-95 290.0 sp|Q5RAF1|GL1D1_PONAB Glycosyltransferase 1 domain-containing protein 1 OS=Pongo abelii OX=9601 GN=GLT1D1 PE=2 SV=1 g5758.t1 Q96RR4 65.285 386 2.9900000000000004e-160 476.0 sp|Q96RR4|KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens OX=9606 GN=CAMKK2 PE=1 SV=2 g5759.t1 Q28HL3 51.799 278 6.31e-94 282.0 sp|Q28HL3|CDIN1_XENTR CDAN1-interacting nuclease 1 OS=Xenopus tropicalis OX=8364 GN=cdin1 PE=2 SV=1 g5760.t1 Q7ZTI5 64.085 142 2.7299999999999998e-55 173.0 sp|Q7ZTI5|MED21_DANRE Mediator of RNA polymerase II transcription subunit 21 OS=Danio rerio OX=7955 GN=med21 PE=2 SV=1 g5762.t1 Q4R7T7 45.824 467 1.6999999999999998e-146 428.0 sp|Q4R7T7|TBD_MACFA Tubulin delta chain OS=Macaca fascicularis OX=9541 GN=TUBD1 PE=2 SV=1 g5763.t1 O43572 42.454 603 8.11e-143 435.0 sp|O43572|AKA10_HUMAN A-kinase anchor protein 10, mitochondrial OS=Homo sapiens OX=9606 GN=AKAP10 PE=1 SV=2 g5764.t1 Q9ES34 55.81 1093 0.0 1232.0 sp|Q9ES34|UBE3B_MOUSE Ubiquitin-protein ligase E3B OS=Mus musculus OX=10090 GN=Ube3b PE=1 SV=3 UBE3B_MOUSE reviewed Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B) Mus musculus (Mouse) GO:0000209; GO:0005739; GO:0006511; GO:0014069; GO:0061630; GO:0098794; GO:0098978; GO:0150052 protein polyubiquitination [GO:0000209]; regulation of postsynapse assembly [GO:0150052]; ubiquitin-dependent protein catabolic process [GO:0006511] glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] ubiquitin protein ligase activity [GO:0061630] g5765.t1 Q9H6F5 57.009 107 1.8700000000000002e-26 110.0 sp|Q9H6F5|CCD86_HUMAN Coiled-coil domain-containing protein 86 OS=Homo sapiens OX=9606 GN=CCDC86 PE=1 SV=1 CCD86_HUMAN reviewed Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0007059; GO:0140014 chromosome segregation [GO:0007059]; mitotic nuclear division [GO:0140014] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723] g5766.t1 Q6NWI1 47.807 228 2.99e-46 175.0 sp|Q6NWI1|RSRC2_DANRE Arginine/serine-rich coiled-coil protein 2 OS=Danio rerio OX=7955 GN=rsrc2 PE=2 SV=1 g5766.t2 Q6NWI1 47.807 228 3.7e-46 174.0 sp|Q6NWI1|RSRC2_DANRE Arginine/serine-rich coiled-coil protein 2 OS=Danio rerio OX=7955 GN=rsrc2 PE=2 SV=1 g5767.t1 Q55CD9 44.42 448 9.72e-115 347.0 sp|Q55CD9|NDH_DICDI Probable NADH dehydrogenase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0270104 PE=3 SV=2 g5770.t1 A0JNT9 38.132 257 1.8600000000000002e-37 151.0 sp|A0JNT9|BICL1_MOUSE BICD family-like cargo adapter 1 OS=Mus musculus OX=10090 GN=Bicdl1 PE=1 SV=1 BICL1_MOUSE reviewed BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A) Mus musculus (Mouse) GO:0005813; GO:0031175; GO:0031267; GO:0034452; GO:0047496; GO:0055107 Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496] centrosome [GO:0005813] dynactin binding [GO:0034452]; small GTPase binding [GO:0031267] g5770.t2 A0JNT9 38.132 257 1.11e-37 152.0 sp|A0JNT9|BICL1_MOUSE BICD family-like cargo adapter 1 OS=Mus musculus OX=10090 GN=Bicdl1 PE=1 SV=1 BICL1_MOUSE reviewed BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A) Mus musculus (Mouse) GO:0005813; GO:0031175; GO:0031267; GO:0034452; GO:0047496; GO:0055107 Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496] centrosome [GO:0005813] dynactin binding [GO:0034452]; small GTPase binding [GO:0031267] g5771.t1 Q64008 57.534 219 1.01e-85 259.0 sp|Q64008|RAB34_MOUSE Ras-related protein Rab-34 OS=Mus musculus OX=10090 GN=Rab34 PE=1 SV=2 RAB34_MOUSE reviewed Ras-related protein Rab-34 (EC 3.6.5.2) (Ras-related homolog) (Ras-related protein Rab-39) (Ras-related protein Rah) Mus musculus (Mouse) GO:0001726; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005770; GO:0005794; GO:0005795; GO:0005813; GO:0005814; GO:0005929; GO:0006897; GO:0007041; GO:0019001; GO:0019882; GO:0030670; GO:0030742; GO:0031267; GO:0031410; GO:0031982; GO:0031985; GO:0032418; GO:0043001; GO:0045335; GO:0045880; GO:0046872; GO:0048471; GO:0050714; GO:0060271; GO:0061824; GO:0071333; GO:0072659; GO:0090382; GO:0090385; GO:1900426; GO:1905171 antigen processing and presentation [GO:0019882]; cellular response to glucose stimulus [GO:0071333]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein secretion [GO:0050714]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; ruffle [GO:0001726]; vesicle [GO:0031982] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; guanyl nucleotide binding [GO:0019001]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] g5772.t1 A2BG43 34.653 202 5.629999999999999e-34 123.0 sp|A2BG43|GLTP_DANRE Glycolipid transfer protein OS=Danio rerio OX=7955 GN=gltp PE=3 SV=1 g5773.t1 P62870 66.355 107 1.4099999999999998e-45 146.0 sp|P62870|ELOB_RAT Elongin-B OS=Rattus norvegicus OX=10116 GN=Elob PE=1 SV=1 ELOB_RAT reviewed Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2) Rattus norvegicus (Rat) GO:0001222; GO:0003713; GO:0005667; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0044877; GO:0045944; GO:0070449; GO:0140958 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449]; transcription regulator complex [GO:0005667]; VCB complex [GO:0030891] protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] g5774.t1 P55266 37.25 400 6.2e-65 242.0 sp|P55266|DSRAD_RAT Double-stranded RNA-specific adenosine deaminase OS=Rattus norvegicus OX=10116 GN=Adar PE=1 SV=1 DSRAD_RAT reviewed Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) Rattus norvegicus (Rat) GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003677; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016553; GO:0016607; GO:0030218; GO:0031054; GO:0035196; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0098586; GO:1900369; GO:1903944 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA processing [GO:0035196]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251] g5776.t1 Q54BU4 52.998 617 0.0 637.0 sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1 ABCB1_DICDI reviewed ABC transporter B family member 1 (ABC transporter ABCB.1) Dictyostelium discoideum (Social amoeba) GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359 chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085] membrane [GO:0016020] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626] g5777.t1 Q9W534 25.0 388 1.6e-22 103.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g5778.t1 Q9W534 25.916 382 4.14e-24 107.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g5780.t1 Q16880 34.519 478 3.83e-82 269.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g5781.t1 Q2KIS2 45.669 254 7.859999999999999e-81 253.0 sp|Q2KIS2|RM44_BOVIN Large ribosomal subunit protein mL44 OS=Bos taurus OX=9913 GN=MRPL44 PE=2 SV=1 g5782.t1 P17035 32.609 460 1.38e-53 203.0 sp|P17035|ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens OX=9606 GN=ZNF28 PE=1 SV=5 g5782.t1 P17035 33.411 431 9.239999999999999e-52 197.0 sp|P17035|ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens OX=9606 GN=ZNF28 PE=1 SV=5 g5782.t1 P17035 34.853 373 1.61e-46 182.0 sp|P17035|ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens OX=9606 GN=ZNF28 PE=1 SV=5 g5782.t1 P17035 34.06 367 1.99e-44 176.0 sp|P17035|ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens OX=9606 GN=ZNF28 PE=1 SV=5 g5782.t1 P17035 28.365 416 1.4900000000000002e-32 139.0 sp|P17035|ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens OX=9606 GN=ZNF28 PE=1 SV=5 g5782.t1 P17035 33.708 267 6.45e-31 134.0 sp|P17035|ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens OX=9606 GN=ZNF28 PE=1 SV=5 g5783.t1 Q99676 31.789 475 3.38e-61 225.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g5783.t1 Q99676 31.176 510 6.98e-56 210.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g5783.t1 Q99676 31.365 542 1.5999999999999999e-55 209.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g5783.t1 Q99676 29.258 458 2.0099999999999999e-38 157.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g5784.t1 P51522 37.559 213 9.98e-29 125.0 sp|P51522|ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens OX=9606 GN=ZNF83 PE=1 SV=3 g5784.t1 P51522 38.743 191 6.149999999999999e-28 122.0 sp|P51522|ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens OX=9606 GN=ZNF83 PE=1 SV=3 g5785.t1 Q5RC74 76.829 246 3.27e-136 386.0 sp|Q5RC74|DERL2_PONAB Derlin-2 OS=Pongo abelii OX=9601 GN=DERL2 PE=2 SV=1 g5786.t1 A6H6W9 55.116 303 3.39e-107 319.0 sp|A6H6W9|SDS3_BOVIN Sin3 histone deacetylase corepressor complex component SDS3 OS=Bos taurus OX=9913 GN=SUDS3 PE=2 SV=1 SDS3_BOVIN reviewed Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog) Bos taurus (Bovine) GO:0000122; GO:0004407; GO:0005634; GO:0005829; GO:0006338; GO:0006915; GO:0016604; GO:0042826; GO:0070822 apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822] histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826] g5786.t2 A6H6W9 52.848 316 1.28e-105 315.0 sp|A6H6W9|SDS3_BOVIN Sin3 histone deacetylase corepressor complex component SDS3 OS=Bos taurus OX=9913 GN=SUDS3 PE=2 SV=1 SDS3_BOVIN reviewed Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog) Bos taurus (Bovine) GO:0000122; GO:0004407; GO:0005634; GO:0005829; GO:0006338; GO:0006915; GO:0016604; GO:0042826; GO:0070822 apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822] histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826] g5786.t3 A6H6W9 53.016 315 8.09e-106 316.0 sp|A6H6W9|SDS3_BOVIN Sin3 histone deacetylase corepressor complex component SDS3 OS=Bos taurus OX=9913 GN=SUDS3 PE=2 SV=1 SDS3_BOVIN reviewed Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog) Bos taurus (Bovine) GO:0000122; GO:0004407; GO:0005634; GO:0005829; GO:0006338; GO:0006915; GO:0016604; GO:0042826; GO:0070822 apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822] histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826] g5787.t1 Q5ZJK1 47.198 678 0.0 595.0 sp|Q5ZJK1|THOC5_CHICK THO complex subunit 5 homolog OS=Gallus gallus OX=9031 GN=THOC5 PE=2 SV=1 g5789.t1 Q9D920 40.838 191 4.09e-47 157.0 sp|Q9D920|BORC5_MOUSE BLOC-1-related complex subunit 5 OS=Mus musculus OX=10090 GN=Borcs5 PE=1 SV=1 BORC5_MOUSE reviewed BLOC-1-related complex subunit 5 Mus musculus (Mouse) GO:0005764; GO:0005873; GO:0005886; GO:0007005; GO:0007399; GO:0016020; GO:0030424; GO:0030672; GO:0032418; GO:0051028; GO:0051036; GO:0061564; GO:0062196; GO:0072384; GO:0098574; GO:0099078; GO:1903744 axon development [GO:0061564]; lysosome localization [GO:0032418]; mitochondrion organization [GO:0007005]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] axon [GO:0030424]; BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plus-end kinesin complex [GO:0005873]; synaptic vesicle membrane [GO:0030672] g5790.t1 Q61187 50.123 405 1.75e-126 374.0 sp|Q61187|TS101_MOUSE Tumor susceptibility gene 101 protein OS=Mus musculus OX=10090 GN=Tsg101 PE=1 SV=2 TS101_MOUSE reviewed Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101) Mus musculus (Mouse) GO:0000122; GO:0000813; GO:0001558; GO:0003714; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005813; GO:0005829; GO:0005886; GO:0006858; GO:0008285; GO:0008333; GO:0010008; GO:0015031; GO:0019076; GO:0030154; GO:0030216; GO:0031625; GO:0031901; GO:0031902; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0044877; GO:0045893; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090543; GO:1902527; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397 cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral release from host cell [GO:0019076] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790] g5791.t1 Q91755 33.208 801 1.5800000000000001e-133 424.0 sp|Q91755|GRIK2_XENLA Glutamate receptor ionotropic, kainate 2 OS=Xenopus laevis OX=8355 GN=grik2 PE=2 SV=2 GRIK2_XENLA reviewed Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) Xenopus laevis (African clawed frog) GO:0004970; GO:0005234; GO:0005886; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:0120169; GO:1904315 detection of cold stimulus involved in thermoception [GO:0120169]; modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249] kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734] extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g5792.t1 Q8BGS2 55.556 81 2.22e-27 98.2 sp|Q8BGS2|BOLA2_MOUSE BolA-like protein 2 OS=Mus musculus OX=10090 GN=Bola2 PE=1 SV=1 g5793.t1 Q5BKN4 73.789 351 0.0 551.0 sp|Q5BKN4|SEP2A_XENTR Septin-2A OS=Xenopus tropicalis OX=8364 GN=sept2-A PE=2 SV=1 SEP2A_XENTR reviewed Septin-2A Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003924; GO:0005525; GO:0005737; GO:0005819; GO:0005940; GO:0007224; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0060090; GO:0060170; GO:0060271; GO:0061640 cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; intracellular protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224] cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; synaptic vesicle [GO:0008021] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] g5794.t1 A4IFI1 35.069 653 7.24e-87 294.0 sp|A4IFI1|CC157_BOVIN Coiled-coil domain-containing protein 157 OS=Bos taurus OX=9913 GN=CCDC157 PE=2 SV=2 g5794.t2 A4IFI1 35.069 653 7.3500000000000005e-87 294.0 sp|A4IFI1|CC157_BOVIN Coiled-coil domain-containing protein 157 OS=Bos taurus OX=9913 GN=CCDC157 PE=2 SV=2 g5795.t1 Q6DFS0 44.961 258 3.94e-80 246.0 sp|Q6DFS0|TMX2_XENTR Thioredoxin-related transmembrane protein 2 OS=Xenopus tropicalis OX=8364 GN=tmx2 PE=2 SV=1 TMX2_XENTR reviewed Thioredoxin-related transmembrane protein 2 (Thioredoxin domain-containing protein 14) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005739; GO:0005789; GO:0007420; GO:0015036; GO:0031966; GO:0044233 brain development [GO:0007420] endoplasmic reticulum membrane [GO:0005789]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] disulfide oxidoreductase activity [GO:0015036] g5797.t1 K0DZA0 30.294 340 1.71e-30 120.0 sp|K0DZA0|HTYE_ASPRU 2-oxoglutarate-dependent dioxygenase htyE OS=Aspergillus rugulosus OX=41736 GN=htyE PE=1 SV=1 g5798.t1 Q28C22 54.624 346 7.18e-138 398.0 sp|Q28C22|OGFD2_XENTR 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=ogfod2 PE=2 SV=1 g5800.t1 O97524 57.423 613 0.0 723.0 sp|O97524|BGLR_FELCA Beta-glucuronidase OS=Felis catus OX=9685 GN=GUSB PE=1 SV=1 g5801.t1 Q5U263 66.465 331 5.06e-151 487.0 sp|Q5U263|KDM2A_XENTR Lysine-specific demethylase 2A OS=Xenopus tropicalis OX=8364 GN=kdm2a PE=2 SV=1 g5801.t1 Q5U263 39.754 244 2e-45 182.0 sp|Q5U263|KDM2A_XENTR Lysine-specific demethylase 2A OS=Xenopus tropicalis OX=8364 GN=kdm2a PE=2 SV=1 g5801.t1 Q5U263 40.074 272 1.0499999999999999e-41 171.0 sp|Q5U263|KDM2A_XENTR Lysine-specific demethylase 2A OS=Xenopus tropicalis OX=8364 GN=kdm2a PE=2 SV=1 g5802.t1 Q8BH10 60.386 207 1.0300000000000001e-85 256.0 sp|Q8BH10|ORAI2_MOUSE Protein orai-2 OS=Mus musculus OX=10090 GN=Orai2 PE=2 SV=1 g5803.t1 Q9MYM7 38.596 228 3.33e-48 168.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g5804.t1 Q5PPV3 63.866 238 1.83e-112 325.0 sp|Q5PPV3|MORN3_XENLA MORN repeat-containing protein 3 OS=Xenopus laevis OX=8355 GN=morn3 PE=2 SV=1 g5805.t1 Q7ZU13 46.224 437 3.75e-133 398.0 sp|Q7ZU13|SPNS1_DANRE Protein spinster homolog 1 OS=Danio rerio OX=7955 GN=spns1 PE=2 SV=1 SPNS1_DANRE reviewed Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) (Spns1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0006869; GO:0006914; GO:0016020; GO:0022857; GO:0090398; GO:0097352 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular senescence [GO:0090398]; lipid transport [GO:0006869] lysosomal membrane [GO:0005765]; membrane [GO:0016020] transmembrane transporter activity [GO:0022857] g5807.t1 Q8K370 57.967 1023 0.0 1214.0 sp|Q8K370|ACD10_MOUSE Acyl-CoA dehydrogenase family member 10 OS=Mus musculus OX=10090 GN=Acad10 PE=1 SV=1 g5808.t1 Q9UBR1 69.191 383 0.0 573.0 sp|Q9UBR1|BUP1_HUMAN Beta-ureidopropionase OS=Homo sapiens OX=9606 GN=UPB1 PE=1 SV=1 BUP1_HUMAN reviewed Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase) Homo sapiens (Human) GO:0001701; GO:0001889; GO:0003837; GO:0005829; GO:0006248; GO:0006249; GO:0033396; GO:0042803; GO:0046050; GO:0046079; GO:0046135; GO:0051260; GO:0051289; GO:0070062 beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]; UMP catabolic process [GO:0046050] cytosol [GO:0005829]; extracellular exosome [GO:0070062] beta-ureidopropionase activity [GO:0003837]; protein homodimerization activity [GO:0042803] g5809.t1 D3ZFD0 46.341 738 0.0 621.0 sp|D3ZFD0|MY18A_RAT Unconventional myosin-XVIIIa OS=Rattus norvegicus OX=10116 GN=Myo18a PE=1 SV=2 MY18A_RAT reviewed Unconventional myosin-XVIIIa Rattus norvegicus (Rat) GO:0000139; GO:0003774; GO:0005524; GO:0005737; GO:0005802; GO:0005815; GO:0005856; GO:0005903; GO:0007030; GO:0007249; GO:0016460; GO:0016477; GO:0031032; GO:0032982; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028 actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; canonical NF-kappaB signal transduction [GO:0007249]; cell migration [GO:0016477]; cellular response to type II interferon [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030] actomyosin [GO:0042641]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi membrane [GO:0000139]; microtubule organizing center [GO:0005815]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; phagocytic vesicle [GO:0045335]; trans-Golgi network [GO:0005802] actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] g5810.t1 Q92614 45.892 1059 0.0 833.0 sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3 g5811.t1 A6NHX0 45.317 331 3.75e-85 263.0 sp|A6NHX0|CAST2_HUMAN Cytosolic arginine sensor for mTORC1 subunit 2 OS=Homo sapiens OX=9606 GN=CASTOR2 PE=1 SV=3 CAST2_HUMAN reviewed Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2) Homo sapiens (Human) GO:0005829; GO:0042802; GO:1903577; GO:1904262 cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262] cytosol [GO:0005829] identical protein binding [GO:0042802] g5812.t1 P46023 31.488 578 2.8e-73 270.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g5813.t1 Q17QU7 49.505 303 6.57e-83 259.0 sp|Q17QU7|DHR13_BOVIN Dehydrogenase/reductase SDR family member 13 OS=Bos taurus OX=9913 GN=DHRS13 PE=2 SV=1 g5814.t1 Q2NL00 42.0 200 1.4799999999999999e-53 175.0 sp|Q2NL00|GSTT1_BOVIN Glutathione S-transferase theta-1 OS=Bos taurus OX=9913 GN=GSTT1 PE=2 SV=3 g5815.t1 Q2NL00 42.381 210 1.0400000000000002e-56 183.0 sp|Q2NL00|GSTT1_BOVIN Glutathione S-transferase theta-1 OS=Bos taurus OX=9913 GN=GSTT1 PE=2 SV=3 g5816.t1 Q6DDL7 32.0 450 3e-70 236.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g5818.t1 Q6DDL7 28.571 294 4.33e-33 130.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g5819.t1 O14874 66.062 386 0.0 538.0 sp|O14874|BCKD_HUMAN Branched-chain alpha-ketoacid dehydrogenase kinase OS=Homo sapiens OX=9606 GN=BCKDK PE=1 SV=2 g5820.t1 P05164 36.269 386 1.28e-57 206.0 sp|P05164|PERM_HUMAN Myeloperoxidase OS=Homo sapiens OX=9606 GN=MPO PE=1 SV=1 PERM_HUMAN reviewed Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain] Homo sapiens (Human) GO:0001878; GO:0002149; GO:0002679; GO:0003682; GO:0004601; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0006952; GO:0006979; GO:0008201; GO:0009612; GO:0019430; GO:0020037; GO:0030141; GO:0032094; GO:0032496; GO:0034374; GO:0035578; GO:0042582; GO:0042742; GO:0042744; GO:0043066; GO:0046872; GO:0050832; GO:0070062; GO:0097013; GO:1990268 defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; hydrogen peroxide catabolic process [GO:0042744]; hypochlorous acid biosynthetic process [GO:0002149]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of apoptotic process [GO:0043066]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in defense response [GO:0002679]; response to food [GO:0032094]; response to gold nanoparticle [GO:1990268]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878] azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; secretory granule [GO:0030141] chromatin binding [GO:0003682]; heme binding [GO:0020037]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] g5821.t1 Q92626 42.473 186 8.83e-39 147.0 sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2 PXDN_HUMAN reviewed Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment] Homo sapiens (Human) GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0070062; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g5822.t1 Q9XWN7 36.943 314 3.36e-45 159.0 sp|Q9XWN7|NSH1_CAEEL Nucleoside hydrolase OS=Caenorhabditis elegans OX=6239 GN=Y43F8C.13 PE=1 SV=1 g5823.t1 Q8K5A4 38.71 186 2.6e-41 142.0 sp|Q8K5A4|RSLAA_MOUSE Ras-like protein family member 10A OS=Mus musculus OX=10090 GN=Rasl10a PE=2 SV=1 g5825.t1 Q25188 29.53 447 1.48e-65 221.0 sp|Q25188|OAR_HELVI Octopamine receptor OS=Heliothis virescens OX=7102 PE=2 SV=1 g5828.t1 O64411 31.753 485 4.61e-65 224.0 sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1 g5830.t1 A7S8T5 72.99 311 3.45e-160 452.0 sp|A7S8T5|CCD42_NEMVE Coiled-coil domain-containing protein 42 homolog OS=Nematostella vectensis OX=45351 GN=v1g187067 PE=3 SV=1 g5831.t1 F6NVH9 51.064 282 4.37e-101 299.0 sp|F6NVH9|NIPS1_DANRE Protein NipSnap homolog 1 OS=Danio rerio OX=7955 GN=nipsnap1 PE=3 SV=1 g5833.t1 Q29RZ4 33.083 266 3.3000000000000004e-31 130.0 sp|Q29RZ4|ZNF2_BOVIN Zinc finger protein 2 OS=Bos taurus OX=9913 GN=ZNF2 PE=2 SV=1 g5838.t1 Q8N2Z9 52.542 118 2.61e-33 116.0 sp|Q8N2Z9|CENPS_HUMAN Centromere protein S OS=Homo sapiens OX=9606 GN=CENPS PE=1 SV=1 CENPS_HUMAN reviewed Centromere protein S (CENP-S) (Apoptosis-inducing TAF9-like domain-containing protein 1) (FANCM-associated histone fold protein 1) (FANCM-interacting histone fold protein 1) (Fanconi anemia-associated polypeptide of 16 kDa) Homo sapiens (Human) GO:0000712; GO:0000785; GO:0000939; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0007059; GO:0031297; GO:0031398; GO:0036297; GO:0043240; GO:0046982; GO:0051301; GO:0071821 cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] g5839.t1 Q9CWK3 40.256 313 4.18e-58 194.0 sp|Q9CWK3|CD2B2_MOUSE CD2 antigen cytoplasmic tail-binding protein 2 OS=Mus musculus OX=10090 GN=Cd2bp2 PE=1 SV=1 g5841.t1 O54992 54.13 460 1.32e-178 511.0 sp|O54992|MAPK5_MOUSE MAP kinase-activated protein kinase 5 OS=Mus musculus OX=10090 GN=Mapkapk5 PE=1 SV=1 MAPK5_MOUSE reviewed MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAPK-5) (EC 2.7.11.1) Mus musculus (Mouse) GO:0002039; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0007265; GO:0009931; GO:0032007; GO:0032156; GO:0032206; GO:0032991; GO:0045944; GO:0046777; GO:0051019; GO:0060999; GO:0090400; GO:0106310 negative regulation of TOR signaling [GO:0032007]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of translation [GO:0006417]; stress-induced premature senescence [GO:0090400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156] ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5842.t1 A2BGT0 31.959 291 7.340000000000001e-32 134.0 sp|A2BGT0|UBP30_DANRE Ubiquitin carboxyl-terminal hydrolase 30 OS=Danio rerio OX=7955 GN=usp30 PE=3 SV=1 g5843.t1 Q6DE94 30.676 414 2.9099999999999998e-40 158.0 sp|Q6DE94|NCBP3_XENLA Nuclear cap-binding protein subunit 3 OS=Xenopus laevis OX=8355 GN=ncbp3 PE=2 SV=1 NCBP3_XENLA reviewed Nuclear cap-binding protein subunit 3 Xenopus laevis (African clawed frog) GO:0000339; GO:0000340; GO:0003729; GO:0005634; GO:0005737; GO:0006370; GO:0051028 7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA cap binding [GO:0000339] g5843.t2 Q6DE94 30.583 412 1.85e-39 155.0 sp|Q6DE94|NCBP3_XENLA Nuclear cap-binding protein subunit 3 OS=Xenopus laevis OX=8355 GN=ncbp3 PE=2 SV=1 NCBP3_XENLA reviewed Nuclear cap-binding protein subunit 3 Xenopus laevis (African clawed frog) GO:0000339; GO:0000340; GO:0003729; GO:0005634; GO:0005737; GO:0006370; GO:0051028 7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028] cytoplasm [GO:0005737]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA cap binding [GO:0000339] g5849.t1 Q9VX98 55.97 134 3.16e-39 134.0 sp|Q9VX98|DENR_DROME Density-regulated protein homolog OS=Drosophila melanogaster OX=7227 GN=DENR PE=1 SV=3 DENR_DROME reviewed Density-regulated protein homolog Drosophila melanogaster (Fruit fly) GO:0001731; GO:0002188; GO:0003743; GO:0006417; GO:0032991; GO:0046628; GO:0048027; GO:0120142 formation of translation preinitiation complex [GO:0001731]; positive regulation of ecdysone receptor signaling pathway [GO:0120142]; positive regulation of insulin receptor signaling pathway [GO:0046628]; regulation of translation [GO:0006417]; translation reinitiation [GO:0002188] protein-containing complex [GO:0032991] mRNA 5'-UTR binding [GO:0048027]; translation initiation factor activity [GO:0003743] g5850.t1 E9PVD1 48.889 180 4.75e-46 166.0 sp|E9PVD1|CCD62_MOUSE Coiled-coil domain-containing protein 62 OS=Mus musculus OX=10090 GN=Ccdc62 PE=1 SV=1 CCD62_MOUSE reviewed Coiled-coil domain-containing protein 62 Mus musculus (Mouse) GO:0001669; GO:0001835; GO:0003713; GO:0005634; GO:0007286; GO:0030331; GO:0030520; GO:0045944; GO:0071392 blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; nucleus [GO:0005634] nuclear estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713] g5852.t1 A1A5R8 43.939 198 1.48e-39 146.0 sp|A1A5R8|SANBR_RAT SANT and BTB domain regulator of class switch recombination OS=Rattus norvegicus OX=10116 GN=Sanbr PE=2 SV=1 g5853.t1 Q08AX9 42.616 474 1.3e-100 318.0 sp|Q08AX9|SANBR_XENLA SANT and BTB domain regulator of class switch recombination OS=Xenopus laevis OX=8355 GN=sanbr PE=2 SV=1 g5855.t1 Q9EQ15 40.491 326 2.28e-75 237.0 sp|Q9EQ15|GNB1L_MOUSE Guanine nucleotide-binding protein subunit beta-like protein 1 OS=Mus musculus OX=10090 GN=Gnb1l PE=2 SV=2 g5857.t1 A7SLX5 70.091 331 6.47e-175 496.0 sp|A7SLX5|DPH1_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 OS=Nematostella vectensis OX=45351 GN=dph1 PE=3 SV=1 g5858.t1 P62323 80.769 130 4.3e-65 196.0 sp|P62323|SMD3_XENLA Small nuclear ribonucleoprotein Sm D3 OS=Xenopus laevis OX=8355 GN=snrpd3 PE=2 SV=1 g5859.t1 Q3ZBV9 47.333 150 1.3100000000000001e-43 147.0 sp|Q3ZBV9|DHR11_BOVIN Dehydrogenase/reductase SDR family member 11 OS=Bos taurus OX=9913 GN=DHRS11 PE=2 SV=1 g5861.t1 Q71R50 49.81 263 1.12e-85 259.0 sp|Q71R50|DHR11_CHICK Dehydrogenase/reductase SDR family member 11 OS=Gallus gallus OX=9031 GN=DHRS11 PE=2 SV=1 g5862.t1 Q71R50 48.221 253 1.66e-83 252.0 sp|Q71R50|DHR11_CHICK Dehydrogenase/reductase SDR family member 11 OS=Gallus gallus OX=9031 GN=DHRS11 PE=2 SV=1 g5863.t1 Q8VD76 41.077 297 6.65e-68 216.0 sp|Q8VD76|TF2H3_MOUSE General transcription factor IIH subunit 3 OS=Mus musculus OX=10090 GN=Gtf2h3 PE=1 SV=1 g5864.t1 Q0IIF2 58.824 306 1.04e-124 361.0 sp|Q0IIF2|EI2BA_BOVIN Translation initiation factor eIF2B subunit alpha OS=Bos taurus OX=9913 GN=EIF2B1 PE=2 SV=1 g5865.t1 Q5REH5 40.566 106 1.45e-22 93.2 sp|Q5REH5|RM50_PONAB Large ribosomal subunit protein mL50 OS=Pongo abelii OX=9601 GN=MRPL50 PE=2 SV=1 g5867.t1 Q9EQM6 43.419 585 2.4699999999999998e-138 426.0 sp|Q9EQM6|DGCR8_MOUSE Microprocessor complex subunit DGCR8 OS=Mus musculus OX=10090 GN=Dgcr8 PE=1 SV=2 DGCR8_MOUSE reviewed Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog) (Gy1) Mus musculus (Mouse) GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006974; GO:0014069; GO:0016604; GO:0020037; GO:0030674; GO:0031053; GO:0042802; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0072091; GO:0098978; GO:0140517; GO:2000633 DNA damage response [GO:0006974]; positive regulation of pre-miRNA processing [GO:2000633]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-RNA adaptor activity [GO:0140517] g5870.t1 Q9HA64 62.258 310 7.039999999999999e-141 402.0 sp|Q9HA64|KT3K_HUMAN Ketosamine-3-kinase OS=Homo sapiens OX=9606 GN=FN3KRP PE=1 SV=2 g5874.t1 Q14CX7 38.469 993 0.0 688.0 sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1 NAA25_HUMAN reviewed N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120) Homo sapiens (Human) GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416 cytoskeleton organization [GO:0007010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416] acetyltransferase activator activity [GO:0010698] g5875.t1 Q3ZBL5 59.887 177 6.809999999999999e-67 204.0 sp|Q3ZBL5|PTH2_BOVIN Peptidyl-tRNA hydrolase 2, mitochondrial OS=Bos taurus OX=9913 GN=PTRH2 PE=2 SV=1 g5876.t1 Q9WVM3 47.957 563 0.0 528.0 sp|Q9WVM3|APC7_MOUSE Anaphase-promoting complex subunit 7 OS=Mus musculus OX=10090 GN=Anapc7 PE=1 SV=3 APC7_MOUSE reviewed Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7) (Prediabetic NOD sera-reactive autoantigen) Mus musculus (Mouse) GO:0000792; GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0007420; GO:0015630; GO:0016567; GO:0019903; GO:0031145; GO:0045171; GO:0045842; GO:0051301; GO:0070936; GO:0070979; GO:0072686; GO:0140767; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; brain development [GO:0007420]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567] anaphase-promoting complex [GO:0005680]; heterochromatin [GO:0000792]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase binding [GO:0019903] g5877.t1 Q5M7X9 35.0 340 9.67e-67 216.0 sp|Q5M7X9|MUL1A_DANRE Mitochondrial ubiquitin ligase activator of nfkb 1-A OS=Danio rerio OX=7955 GN=mul1a PE=2 SV=1 MUL1A_DANRE reviewed Mitochondrial ubiquitin ligase activator of nfkb 1-A (EC 2.3.2.27) (E3 ubiquitin-protein ligase mul1-A) (RING-type E3 ubiquitin transferase nfkb 1-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000266; GO:0004842; GO:0005741; GO:0005777; GO:0008270; GO:0009893; GO:0016567; GO:0022603; GO:0031647; GO:0042802; GO:0043123; GO:0051094; GO:0051646; GO:0061630 mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of developmental process [GO:0051094]; positive regulation of metabolic process [GO:0009893]; protein ubiquitination [GO:0016567]; regulation of anatomical structure morphogenesis [GO:0022603]; regulation of protein stability [GO:0031647] mitochondrial outer membrane [GO:0005741]; peroxisome [GO:0005777] identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5878.t1 O02414 91.011 89 8.94e-60 180.0 sp|O02414|DYL1_HELCR Dynein light chain LC6, flagellar outer arm OS=Heliocidaris crassispina OX=1043166 PE=3 SV=1 g5879.t1 Q9D0B0 59.694 196 9.17e-76 232.0 sp|Q9D0B0|SRSF9_MOUSE Serine/arginine-rich splicing factor 9 OS=Mus musculus OX=10090 GN=Srsf9 PE=1 SV=1 g5880.t1 C3XVM1 57.333 150 1.0299999999999999e-52 167.0 sp|C3XVM1|GATC_BRAFL Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_270748 PE=3 SV=1 g5882.t1 Q5ZML3 66.351 211 5.0600000000000004e-73 226.0 sp|Q5ZML3|SRSF1_CHICK Serine/arginine-rich splicing factor 1 OS=Gallus gallus OX=9031 GN=SRSF1 PE=1 SV=3 SRSF1_CHICK reviewed Serine/arginine-rich splicing factor 1 (Splicing factor, arginine/serine-rich 1) Gallus gallus (Chicken) GO:0000381; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607 mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607] mRNA binding [GO:0003729] g5883.t1 O02414 91.011 89 8.94e-60 180.0 sp|O02414|DYL1_HELCR Dynein light chain LC6, flagellar outer arm OS=Heliocidaris crassispina OX=1043166 PE=3 SV=1 g5885.t1 Q8IXT5 36.842 228 1.0799999999999999e-23 106.0 sp|Q8IXT5|RB12B_HUMAN RNA-binding protein 12B OS=Homo sapiens OX=9606 GN=RBM12B PE=1 SV=2 g5885.t1 Q8IXT5 37.864 206 1.69e-23 106.0 sp|Q8IXT5|RB12B_HUMAN RNA-binding protein 12B OS=Homo sapiens OX=9606 GN=RBM12B PE=1 SV=2 g5887.t1 P59015 50.151 991 0.0 1003.0 sp|P59015|VPS18_DANRE Vacuolar protein sorting-associated protein 18 homolog OS=Danio rerio OX=7955 GN=vps18 PE=2 SV=2 VPS18_DANRE reviewed Vacuolar protein sorting-associated protein 18 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007040; GO:0007634; GO:0008270; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0043485; GO:0045176; GO:0048069; GO:0048284; GO:0048757; GO:0060036 apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; organelle fusion [GO:0048284]; pigment granule maturation [GO:0048757]; vesicle docking involved in exocytosis [GO:0006904] endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765] protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g5887.t2 P59015 48.019 1035 0.0 980.0 sp|P59015|VPS18_DANRE Vacuolar protein sorting-associated protein 18 homolog OS=Danio rerio OX=7955 GN=vps18 PE=2 SV=2 VPS18_DANRE reviewed Vacuolar protein sorting-associated protein 18 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007040; GO:0007634; GO:0008270; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0043485; GO:0045176; GO:0048069; GO:0048284; GO:0048757; GO:0060036 apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; organelle fusion [GO:0048284]; pigment granule maturation [GO:0048757]; vesicle docking involved in exocytosis [GO:0006904] endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765] protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g5888.t1 Q9DAN9 37.162 148 1.14e-27 105.0 sp|Q9DAN9|CF97D_MOUSE Sperm axonemal maintenance protein CFAP97D1 OS=Mus musculus OX=10090 GN=Cfap97d1 PE=2 SV=1 g5889.t1 Q8BVN3 36.752 351 2.24e-64 219.0 sp|Q8BVN3|CTSR4_MOUSE Cation channel sperm-associated protein 4 OS=Mus musculus OX=10090 GN=Catsper4 PE=1 SV=1 CTSR4_MOUSE reviewed Cation channel sperm-associated protein 4 (CatSper4) Mus musculus (Mouse) GO:0001669; GO:0005227; GO:0005245; GO:0006814; GO:0030317; GO:0036128; GO:0048240; GO:0097228 flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; sperm principal piece [GO:0097228] calcium-activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245] g5890.t1 Q5F362 50.712 351 9.33e-102 309.0 sp|Q5F362|CC50A_CHICK Cell cycle control protein 50A OS=Gallus gallus OX=9031 GN=TMEM30A PE=2 SV=1 CC50A_CHICK reviewed Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A) Gallus gallus (Chicken) GO:0001750; GO:0001917; GO:0005783; GO:0005794; GO:0005886; GO:0015247; GO:0016324; GO:0030658; GO:0045332; GO:1990531 phospholipid translocation [GO:0045332] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; phospholipid-translocating ATPase complex [GO:1990531]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] aminophospholipid flippase activity [GO:0015247] g5890.t2 Q5F362 50.571 350 1.44e-100 306.0 sp|Q5F362|CC50A_CHICK Cell cycle control protein 50A OS=Gallus gallus OX=9031 GN=TMEM30A PE=2 SV=1 CC50A_CHICK reviewed Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A) Gallus gallus (Chicken) GO:0001750; GO:0001917; GO:0005783; GO:0005794; GO:0005886; GO:0015247; GO:0016324; GO:0030658; GO:0045332; GO:1990531 phospholipid translocation [GO:0045332] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; phospholipid-translocating ATPase complex [GO:1990531]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] aminophospholipid flippase activity [GO:0015247] g5890.t3 Q5F362 50.712 351 2.89e-101 308.0 sp|Q5F362|CC50A_CHICK Cell cycle control protein 50A OS=Gallus gallus OX=9031 GN=TMEM30A PE=2 SV=1 CC50A_CHICK reviewed Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A) Gallus gallus (Chicken) GO:0001750; GO:0001917; GO:0005783; GO:0005794; GO:0005886; GO:0015247; GO:0016324; GO:0030658; GO:0045332; GO:1990531 phospholipid translocation [GO:0045332] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; phospholipid-translocating ATPase complex [GO:1990531]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] aminophospholipid flippase activity [GO:0015247] g5891.t1 Q8N4B1 49.219 128 2.9100000000000002e-43 150.0 sp|Q8N4B1|SESQ1_HUMAN Sesquipedalian-1 OS=Homo sapiens OX=9606 GN=PHETA1 PE=1 SV=1 SESQ1_HUMAN reviewed Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1) Homo sapiens (Human) GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037 endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] protein homodimerization activity [GO:0042803] g5892.t1 Q9Y5Y6 34.192 427 1.0800000000000001e-57 209.0 sp|Q9Y5Y6|ST14_HUMAN Suppressor of tumorigenicity 14 protein OS=Homo sapiens OX=9606 GN=ST14 PE=1 SV=2 ST14_HUMAN reviewed Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein) Homo sapiens (Human) GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0009897; GO:0016323; GO:0030163; GO:0030216; GO:0060672 epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g5893.t1 Q0IIH7 31.25 448 5.98e-48 183.0 sp|Q0IIH7|ST14_BOVIN Suppressor of tumorigenicity 14 protein homolog OS=Bos taurus OX=9913 GN=ST14 PE=2 SV=1 ST14_BOVIN reviewed Suppressor of tumorigenicity 14 protein homolog (EC 3.4.21.109) (Serine protease 14) Bos taurus (Bovine) GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0030216 keratinocyte differentiation [GO:0030216]; proteolysis [GO:0006508] plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g5896.t1 A4FU69 39.835 728 1.26e-168 537.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g5896.t2 A4FU69 39.218 742 8.48e-169 538.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g5896.t3 A4FU69 40.616 714 3.51e-172 546.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g5897.t1 A4FU69 28.472 288 1.17e-36 146.0 sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3 EFCB5_HUMAN reviewed EF-hand calcium-binding domain-containing protein 5 Homo sapiens (Human) GO:0005509 calcium ion binding [GO:0005509] g5898.t1 Q5SW75 54.105 475 1.25e-162 530.0 sp|Q5SW75|SSH2_MOUSE Protein phosphatase Slingshot homolog 2 OS=Mus musculus OX=10090 GN=Ssh2 PE=1 SV=2 SSH2_MOUSE reviewed Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (mSSH-2L) Mus musculus (Mouse) GO:0001669; GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005737; GO:0005856; GO:0005925; GO:0007283; GO:0030036; GO:0030154; GO:0030335; GO:0030837 actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cell migration [GO:0030335]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g5898.t2 Q5SW75 54.105 475 6.06e-163 530.0 sp|Q5SW75|SSH2_MOUSE Protein phosphatase Slingshot homolog 2 OS=Mus musculus OX=10090 GN=Ssh2 PE=1 SV=2 SSH2_MOUSE reviewed Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (mSSH-2L) Mus musculus (Mouse) GO:0001669; GO:0003779; GO:0004721; GO:0004722; GO:0004725; GO:0005737; GO:0005856; GO:0005925; GO:0007283; GO:0030036; GO:0030154; GO:0030335; GO:0030837 actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cell migration [GO:0030335]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725] g5899.t1 Q96321 28.287 502 1.63e-46 172.0 sp|Q96321|IMPA1_ARATH Importin subunit alpha-1 OS=Arabidopsis thaliana OX=3702 GN=IMPA1 PE=1 SV=2 IMPA1_ARATH reviewed Importin subunit alpha-1 (IMPa-1) (Karyopherin subunit alpha-1) (KAP-alpha-1) Arabidopsis thaliana (Mouse-ear cress) GO:0005634; GO:0005635; GO:0005730; GO:0005737; GO:0006606; GO:0006607; GO:0008139; GO:0009505; GO:0009651; GO:0061608; GO:0071555; GO:2000280 cell wall organization [GO:0071555]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; regulation of root development [GO:2000280]; response to salt stress [GO:0009651] cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plant-type cell wall [GO:0009505] nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] g5903.t1 Q5XGY9 64.39 205 8.61e-95 278.0 sp|Q5XGY9|MND1_XENLA Meiotic nuclear division protein 1 homolog OS=Xenopus laevis OX=8355 GN=mnd1 PE=2 SV=1 g5904.t1 Q9NAH6 76.0 175 1.76e-89 276.0 sp|Q9NAH6|KS6B_CAEEL Ribosomal protein S6 kinase beta OS=Caenorhabditis elegans OX=6239 GN=rsks-1 PE=1 SV=2 KS6B_CAEEL reviewed Ribosomal protein S6 kinase beta (EC 2.7.11.1) Caenorhabditis elegans GO:0002119; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0008340; GO:0030424; GO:0038202; GO:0043204; GO:0046872; GO:0106310; GO:2000786 determination of adult lifespan [GO:0008340]; nematode larval development [GO:0002119]; positive regulation of autophagosome assembly [GO:2000786]; TORC1 signaling [GO:0038202] axon [GO:0030424]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5905.t1 Q6TJY3 57.895 190 9.05e-65 211.0 sp|Q6TJY3|KS6B1_BOVIN Ribosomal protein S6 kinase beta-1 OS=Bos taurus OX=9913 GN=RPS6KB1 PE=2 SV=1 KS6B1_BOVIN reviewed Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) Bos taurus (Bovine) GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0006417; GO:0006915; GO:0018105; GO:0031929; GO:0032869; GO:0038202; GO:0043005; GO:0043066; GO:0043491; GO:0044539; GO:0045202; GO:0071363; GO:0106310; GO:1903940 apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of apoptotic process [GO:0043066]; negative regulation of TORC2 signaling [GO:1903940]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; regulation of translation [GO:0006417]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; synapse [GO:0045202] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5906.t1 Q58DM4 62.687 201 4.86e-96 286.0 sp|Q58DM4|ALKB2_BOVIN DNA oxidative demethylase ALKBH2 OS=Bos taurus OX=9913 GN=ALKBH2 PE=2 SV=1 ALKB2_BOVIN reviewed DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) Bos taurus (Bovine) GO:0000182; GO:0005654; GO:0005730; GO:0006307; GO:0008198; GO:0035516; GO:0051747 DNA alkylation repair [GO:0006307] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] broad specificity oxidative DNA demethylase activity [GO:0035516]; cytosine C-5 DNA demethylase activity [GO:0051747]; ferrous iron binding [GO:0008198]; rDNA binding [GO:0000182] g5907.t1 Q8CJB9 51.351 629 0.0 560.0 sp|Q8CJB9|BRE1B_RAT E3 ubiquitin-protein ligase BRE1B OS=Rattus norvegicus OX=10116 GN=Rnf40 PE=1 SV=1 BRE1B_RAT reviewed E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B) (Syntaxin-1-interacting RING finger protein) (Protein staring) Rattus norvegicus (Rat) GO:0000151; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0006325; GO:0006511; GO:0008270; GO:0016567; GO:0017075; GO:0031624; GO:0031625; GO:0032991; GO:0033503; GO:0042803; GO:0043434; GO:0045944; GO:0061630; GO:1901800; GO:1902916 chromatin organization [GO:0006325]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5909.t1 Q9VRP9 44.186 129 1.49e-29 116.0 sp|Q9VRP9|BRE1_DROME E3 ubiquitin-protein ligase Bre1 OS=Drosophila melanogaster OX=7227 GN=Bre1 PE=1 SV=2 BRE1_DROME reviewed E3 ubiquitin-protein ligase Bre1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Bre1) (dBre1) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0005634; GO:0006325; GO:0006513; GO:0007219; GO:0008270; GO:0031452; GO:0033503; GO:0043161; GO:0045597; GO:0045893; GO:0061630 chromatin organization [GO:0006325]; negative regulation of heterochromatin formation [GO:0031452]; Notch signaling pathway [GO:0007219]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513] chromatin [GO:0000785]; HULC complex [GO:0033503]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g5910.t1 Q96NW4 25.888 394 3.63e-21 101.0 sp|Q96NW4|ANR27_HUMAN Ankyrin repeat domain-containing protein 27 OS=Homo sapiens OX=9606 GN=ANKRD27 PE=1 SV=2 g5911.t1 Q568R1 67.368 95 4.0600000000000004e-32 127.0 sp|Q568R1|NSRP1_DANRE Nuclear speckle splicing regulatory protein 1 OS=Danio rerio OX=7955 GN=nsrp1 PE=1 SV=2 g5913.t1 P69079 100.0 136 1.3799999999999998e-95 274.0 sp|P69079|H3_STRDR Histone H3, embryonic OS=Strongylocentrotus droebachiensis OX=7671 PE=2 SV=2 g5914.t1 Q5RAK6 41.544 1295 0.0 795.0 sp|Q5RAK6|EST1A_PONAB Telomerase-binding protein EST1A OS=Pongo abelii OX=9601 GN=SMG6 PE=2 SV=1 EST1A_PONAB reviewed Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000184; GO:0000781; GO:0004521; GO:0005697; GO:0005730; GO:0005829; GO:0016787; GO:0042162; GO:0046872; GO:0070034 nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184] chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleolus [GO:0005730]; telomerase holoenzyme complex [GO:0005697] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] g5916.t1 Q9W4K2 24.197 467 2.0299999999999998e-24 110.0 sp|Q9W4K2|Y3556_DROME Uncharacterized protein CG3556 OS=Drosophila melanogaster OX=7227 GN=CG3556 PE=2 SV=1 g5916.t2 Q9W4K2 24.348 460 3.9499999999999995e-24 108.0 sp|Q9W4K2|Y3556_DROME Uncharacterized protein CG3556 OS=Drosophila melanogaster OX=7227 GN=CG3556 PE=2 SV=1 g5917.t1 Q6VAB6 33.333 1014 5.07e-141 447.0 sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2 KSR2_HUMAN reviewed Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162 calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g5917.t2 Q6VAB6 34.213 985 7.840000000000001e-144 453.0 sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2 KSR2_HUMAN reviewed Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1) Homo sapiens (Human) GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162 calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g5918.t1 Q9D0F6 71.077 325 3.11e-175 491.0 sp|Q9D0F6|RFC5_MOUSE Replication factor C subunit 5 OS=Mus musculus OX=10090 GN=Rfc5 PE=1 SV=1 g5920.t1 Q9QZ67 60.847 189 4.48e-71 230.0 sp|Q9QZ67|PPM1D_MOUSE Protein phosphatase 1D OS=Mus musculus OX=10090 GN=Ppm1d PE=2 SV=2 PPM1D_MOUSE reviewed Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1) Mus musculus (Mouse) GO:0000086; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0009267; GO:0009617; GO:0030330; GO:0045814; GO:0046872; GO:0051019; GO:1902531 cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of intracellular signal transduction [GO:1902531]; response to bacterium [GO:0009617] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine phosphatase activity [GO:0004722] g5921.t1 Q2KNA0 31.461 890 2.39e-101 341.0 sp|Q2KNA0|CYTSA_CANLF Cytospin-A OS=Canis lupus familiaris OX=9615 GN=SPECC1L PE=2 SV=1 CYTSA_CANLF reviewed Cytospin-A (SPECC1-like protein) (Sperm antigen with calponin homology and coiled-coil domains 1-like) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007026; GO:0008013; GO:0016477; GO:0030036; GO:0030835; GO:0031941; GO:0034332; GO:0036032; GO:0051301; GO:0051897; GO:0061713 actin cytoskeleton organization [GO:0030036]; adherens junction organization [GO:0034332]; anterior neural tube closure [GO:0061713]; cell division [GO:0051301]; cell migration [GO:0016477]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of microtubule depolymerization [GO:0007026]; neural crest cell delamination [GO:0036032]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819] beta-catenin binding [GO:0008013] g5922.t1 O02414 97.753 89 6.6e-62 185.0 sp|O02414|DYL1_HELCR Dynein light chain LC6, flagellar outer arm OS=Heliocidaris crassispina OX=1043166 PE=3 SV=1 g5923.t1 Q66L51 58.667 300 8.55e-122 356.0 sp|Q66L51|COQ5_DANRE 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial OS=Danio rerio OX=7955 GN=coq5 PE=2 SV=1 g5924.t1 A1EC95 35.842 505 2.5000000000000002e-70 249.0 sp|A1EC95|HEAT6_RAT HEAT repeat-containing protein 6 OS=Rattus norvegicus OX=10116 GN=Heatr6 PE=1 SV=1 g5925.t1 A9JRI0 43.085 188 2.8300000000000002e-36 136.0 sp|A9JRI0|HEAT6_DANRE HEAT repeat-containing protein 6 OS=Danio rerio OX=7955 GN=heatr6 PE=2 SV=1 g5926.t1 A9JRI0 46.753 385 1.66e-92 307.0 sp|A9JRI0|HEAT6_DANRE HEAT repeat-containing protein 6 OS=Danio rerio OX=7955 GN=heatr6 PE=2 SV=1 g5931.t1 E1BD59 28.041 296 5.86e-23 107.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g5932.t1 E7FAM5 23.698 557 2.83e-28 123.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5934.t1 E7FAM5 26.087 345 1.05e-26 119.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g5936.t1 Q91VE2 44.0 175 6.379999999999999e-40 147.0 sp|Q91VE2|P2RX5_MOUSE P2X purinoceptor 5 OS=Mus musculus OX=10090 GN=P2rx5 PE=1 SV=2 P2RX5_MOUSE reviewed P2X purinoceptor 5 (P2X5) Mus musculus (Mouse) GO:0001614; GO:0004931; GO:0005244; GO:0005524; GO:0005886; GO:0006821; GO:0009268; GO:0010043; GO:0033198; GO:0036179; GO:0042802; GO:0043416; GO:0051592; GO:0098794; GO:0099095; GO:1905665 chloride transport [GO:0006821]; osteoclast maturation [GO:0036179]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; regulation of skeletal muscle tissue regeneration [GO:0043416]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to pH [GO:0009268]; response to zinc ion [GO:0010043] plasma membrane [GO:0005886]; postsynapse [GO:0098794] ATP binding [GO:0005524]; extracellularly ATP-gated monoatomic cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated monoatomic anion channel activity [GO:0099095]; purinergic nucleotide receptor activity [GO:0001614]; voltage-gated monoatomic ion channel activity [GO:0005244] g5939.t1 P51577 51.923 156 8.91e-49 164.0 sp|P51577|P2RX4_RAT P2X purinoceptor 4 OS=Rattus norvegicus OX=10116 GN=P2rx4 PE=1 SV=1 g5943.t1 O75140 57.801 391 7.599999999999999e-135 444.0 sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2 DEPD5_HUMAN reviewed GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5) Homo sapiens (Human) GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g5943.t1 O75140 32.779 421 2.0599999999999997e-48 191.0 sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2 DEPD5_HUMAN reviewed GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5) Homo sapiens (Human) GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130 cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] g5946.t1 P21783 37.101 407 9.62e-62 226.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 36.782 435 2.47e-52 198.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 35.177 452 2.11e-47 184.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 33.333 459 4.36e-47 182.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 35.035 431 3.81e-46 180.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 34.146 410 6.9699999999999994e-46 179.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 34.286 455 2.73e-45 177.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 33.41 434 4.2399999999999995e-45 177.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 32.992 391 1.34e-44 175.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 34.845 419 1.94e-44 175.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 31.846 493 4.35e-41 164.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 31.98 394 2.04e-40 162.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 37.681 276 2.15e-35 147.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 35.077 325 2.44e-32 137.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t1 P21783 36.842 247 5.32e-22 105.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g5946.t2 P10079 38.983 354 8.97e-52 195.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5946.t2 P10079 38.719 359 2.15e-51 194.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5946.t2 P10079 38.483 356 1.7799999999999998e-48 185.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5946.t2 P10079 39.13 322 5.43e-45 175.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5946.t2 P10079 35.955 356 6.649999999999999e-45 174.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5946.t2 P10079 37.546 269 1.19e-36 149.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5946.t2 P10079 39.175 194 6.16e-26 117.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t1 P10079 41.787 761 8.33e-141 451.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t1 P10079 41.09 679 3.03e-119 393.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t1 P10079 39.469 565 9.75e-93 321.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t1 P10079 41.758 455 8.92e-74 267.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t1 P10079 40.616 357 9.830000000000001e-56 213.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t1 P10079 41.176 323 8.879999999999999e-48 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t2 P10079 37.714 875 1.17e-135 436.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t2 P10079 41.09 679 1.21e-119 393.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t2 P10079 37.483 723 5.37e-105 353.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t2 P10079 41.758 455 4.9199999999999994e-74 267.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t2 P10079 41.176 323 7.32e-48 189.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t3 P10079 39.702 738 2.38e-127 413.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t3 P10079 40.15 665 1.47e-110 368.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t3 P10079 36.705 692 2.12e-96 329.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t3 P10079 38.415 492 5.6799999999999995e-67 246.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t4 P10079 37.556 900 3.85e-142 454.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t4 P10079 39.971 683 6.83e-115 382.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t4 P10079 37.403 770 9.12e-113 376.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5947.t4 P10079 41.522 460 9.15e-74 267.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g5948.t1 P18433 43.321 277 1.04e-64 235.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g5948.t1 P18433 38.889 234 4.4e-47 184.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g5948.t2 P18433 43.321 277 3.01e-64 235.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g5948.t2 P18433 38.889 234 8.630000000000001e-47 183.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g5950.t1 Q91VA6 57.593 349 2.28e-131 381.0 sp|Q91VA6|PDIP2_MOUSE Polymerase delta-interacting protein 2 OS=Mus musculus OX=10090 GN=Poldip2 PE=1 SV=1 g5950.t2 Q91VA6 57.02 349 3.2300000000000004e-129 375.0 sp|Q91VA6|PDIP2_MOUSE Polymerase delta-interacting protein 2 OS=Mus musculus OX=10090 GN=Poldip2 PE=1 SV=1 g5951.t1 Q5BK13 36.139 202 1.7700000000000002e-35 126.0 sp|Q5BK13|VMA12_RAT Vacuolar ATPase assembly protein VMA12 OS=Rattus norvegicus OX=10116 GN=Vma12 PE=2 SV=1 g5952.t1 Q5M9B7 79.866 149 5.03e-88 256.0 sp|Q5M9B7|OSTCB_XENLA Oligosaccharyltransferase complex subunit ostc-B OS=Xenopus laevis OX=8355 GN=ostc-b PE=2 SV=1 g5953.t1 Q12872 52.397 292 5.89e-68 249.0 sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3 SFSWA_HUMAN reviewed Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog) Homo sapiens (Human) GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025 alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025] nucleus [GO:0005634] RNA binding [GO:0003723] g5953.t2 Q12872 52.397 292 5.83e-68 249.0 sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3 SFSWA_HUMAN reviewed Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog) Homo sapiens (Human) GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025 alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025] nucleus [GO:0005634] RNA binding [GO:0003723] g5954.t1 Q6ICL7 33.11 299 3.2699999999999997e-42 152.0 sp|Q6ICL7|S35E4_HUMAN Solute carrier family 35 member E4 OS=Homo sapiens OX=9606 GN=SLC35E4 PE=1 SV=1 S35E4_HUMAN reviewed Solute carrier family 35 member E4 Homo sapiens (Human) GO:0005794; GO:0015297; GO:0016020; GO:0055085 transmembrane transport [GO:0055085] Golgi apparatus [GO:0005794]; membrane [GO:0016020] antiporter activity [GO:0015297] g5956.t1 Q91739 46.036 391 2.81e-88 286.0 sp|Q91739|HNFAB_XENLA Hepatocyte nuclear factor 1-alpha-B OS=Xenopus laevis OX=8355 GN=hnf1a-b PE=2 SV=2 g5958.t1 Q9CUS9 66.923 390 0.0 516.0 sp|Q9CUS9|SPPL3_MOUSE Signal peptide peptidase-like 3 OS=Mus musculus OX=10090 GN=Sppl3 PE=1 SV=3 SPPL3_MOUSE reviewed Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Mus musculus (Mouse) GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0033116; GO:0033619; GO:0042500; GO:0042803; GO:0050852; GO:0070886; GO:0098553; GO:0098554 membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803] g5959.t1 Q7K556 55.319 376 1.81e-151 439.0 sp|Q7K556|TTD14_DROME TRPL translocation defect protein 14 OS=Drosophila melanogaster OX=7227 GN=Ttd14 PE=1 SV=1 g5960.t1 Q9X248 38.645 251 1.09e-47 161.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g5961.t1 Q9BW91 51.327 339 3.3199999999999997e-112 333.0 sp|Q9BW91|NUDT9_HUMAN ADP-ribose pyrophosphatase, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT9 PE=1 SV=1 NUDT9_HUMAN reviewed ADP-ribose pyrophosphatase (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0047631; GO:0055086; GO:0070062 ADP catabolic process [GO:0046032]; nucleobase-containing small molecule metabolic process [GO:0055086] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965] ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144] g5962.t1 Q5RJI4 28.571 231 5.72e-27 114.0 sp|Q5RJI4|PKDCC_MOUSE Extracellular tyrosine-protein kinase PKDCC OS=Mus musculus OX=10090 GN=Pkdcc PE=1 SV=2 PKDCC_MOUSE reviewed Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase) Mus musculus (Mouse) GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] g5963.t1 Q7PVQ9 75.294 85 6.17e-39 129.0 sp|Q7PVQ9|RPB11_ANOGA DNA-directed RNA polymerase II subunit RPB11 OS=Anopheles gambiae OX=7165 GN=Rpb11 PE=3 SV=2 g5964.t1 A2BIR6 40.0 265 6.3e-60 195.0 sp|A2BIR6|YDJC_DANRE Carbohydrate deacetylase OS=Danio rerio OX=7955 GN=ydjc PE=3 SV=1 g5967.t1 P61376 54.863 401 1.01e-139 409.0 sp|P61376|LHX5_RAT LIM/homeobox protein Lhx5 OS=Rattus norvegicus OX=10116 GN=Lhx5 PE=2 SV=1 g5969.t1 Q9Y4C8 47.101 983 0.0 829.0 sp|Q9Y4C8|RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3 RBM19_HUMAN reviewed Probable RNA-binding protein 19 (RNA-binding motif protein 19) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019 positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5969.t2 Q9Y4C8 46.951 984 0.0 829.0 sp|Q9Y4C8|RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3 RBM19_HUMAN reviewed Probable RNA-binding protein 19 (RNA-binding motif protein 19) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019 positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723] g5970.t1 A2BGL3 39.003 582 5.06e-124 381.0 sp|A2BGL3|WSCD2_DANRE Sialate:O-sulfotransferase 2 OS=Danio rerio OX=7955 GN=wscd2 PE=3 SV=1 g5971.t1 P00730 40.063 317 4.3e-81 255.0 sp|P00730|CBPA1_BOVIN Carboxypeptidase A1 OS=Bos taurus OX=9913 GN=CPA1 PE=1 SV=3 CBPA1_BOVIN reviewed Carboxypeptidase A1 (EC 3.4.17.1) Bos taurus (Bovine) GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270 leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g5972.t1 P48052 55.422 83 1.5500000000000001e-21 90.1 sp|P48052|CBPA2_HUMAN Carboxypeptidase A2 OS=Homo sapiens OX=9606 GN=CPA2 PE=1 SV=3 CBPA2_HUMAN reviewed Carboxypeptidase A2 (EC 3.4.17.15) Homo sapiens (Human) GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270 protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773] carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g5973.t1 P00730 32.353 170 3.84e-27 109.0 sp|P00730|CBPA1_BOVIN Carboxypeptidase A1 OS=Bos taurus OX=9913 GN=CPA1 PE=1 SV=3 CBPA1_BOVIN reviewed Carboxypeptidase A1 (EC 3.4.17.1) Bos taurus (Bovine) GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270 leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508] extracellular space [GO:0005615] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g5974.t1 P04069 45.133 226 5.469999999999999e-67 212.0 sp|P04069|CBPB_ASTAS Carboxypeptidase B OS=Astacus astacus OX=6715 PE=1 SV=1 g5975.t1 Q4V8F7 32.604 503 2.14e-69 237.0 sp|Q4V8F7|CCD63_RAT Coiled-coil domain-containing protein 63 OS=Rattus norvegicus OX=10116 GN=Ccdc63 PE=2 SV=1 g5976.t1 P46196 82.216 343 0.0 597.0 sp|P46196|MK01_BOVIN Mitogen-activated protein kinase 1 OS=Bos taurus OX=9913 GN=MAPK1 PE=2 SV=3 MK01_BOVIN reviewed Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) Bos taurus (Bovine) GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005886; GO:0005901; GO:0005925; GO:0006915; GO:0007166; GO:0035556; GO:0060341; GO:0070849; GO:0071456; GO:0072686; GO:0106310; GO:0160218; GO:1903955 apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to hypoxia [GO:0071456]; intracellular signal transduction [GO:0035556]; negative regulation of pyruvate decarboxylation to acetyl-CoA [GO:0160218]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of cellular localization [GO:0060341]; response to epidermal growth factor [GO:0070849] caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g5977.t1 Q8N9F7 46.452 310 5.53e-96 290.0 sp|Q8N9F7|GDPD1_HUMAN Lysophospholipase D GDPD1 OS=Homo sapiens OX=9606 GN=GDPD1 PE=1 SV=2 GDPD1_HUMAN reviewed Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1) Homo sapiens (Human) GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291 glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phosphoric diester hydrolase activity [GO:0008081] g5977.t2 Q8N9F7 46.774 310 1.24e-95 289.0 sp|Q8N9F7|GDPD1_HUMAN Lysophospholipase D GDPD1 OS=Homo sapiens OX=9606 GN=GDPD1 PE=1 SV=2 GDPD1_HUMAN reviewed Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1) Homo sapiens (Human) GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291 glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phosphoric diester hydrolase activity [GO:0008081] g5977.t3 Q8N9F7 44.954 109 4.57e-25 100.0 sp|Q8N9F7|GDPD1_HUMAN Lysophospholipase D GDPD1 OS=Homo sapiens OX=9606 GN=GDPD1 PE=1 SV=2 GDPD1_HUMAN reviewed Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1) Homo sapiens (Human) GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291 glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phosphoric diester hydrolase activity [GO:0008081] g5978.t1 Q5XI31 44.381 525 3.88e-130 394.0 sp|Q5XI31|PIGS_RAT GPI-anchor transamidase component PIGS OS=Rattus norvegicus OX=10116 GN=Pigs PE=2 SV=3 g5979.t1 O15254 51.599 688 0.0 744.0 sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens OX=9606 GN=ACOX3 PE=1 SV=2 ACOX3_HUMAN reviewed Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase) Homo sapiens (Human) GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0071949 fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402] g5980.t1 O15254 51.506 697 0.0 753.0 sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens OX=9606 GN=ACOX3 PE=1 SV=2 ACOX3_HUMAN reviewed Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase) Homo sapiens (Human) GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0071949 fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402] g5982.t1 P07314 38.821 577 1.2900000000000002e-125 387.0 sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4 GGT1_RAT reviewed Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain] Rattus norvegicus (Rat) GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750 amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982] aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] g5982.t2 P07314 38.821 577 4.34e-125 387.0 sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4 GGT1_RAT reviewed Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain] Rattus norvegicus (Rat) GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750 amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982] aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] g5983.t1 Q9GZT4 49.533 321 1.4000000000000001e-109 325.0 sp|Q9GZT4|SRR_HUMAN Serine racemase OS=Homo sapiens OX=9606 GN=SRR PE=1 SV=1 SRR_HUMAN reviewed Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17) Homo sapiens (Human) GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0006563; GO:0008721; GO:0009069; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0045177; GO:0070178; GO:0070179; GO:1901986 D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to ketamine [GO:1901986]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114] g5984.t1 A2CES0 49.537 216 2.51e-73 228.0 sp|A2CES0|NEUFC_DANRE Neuferricin OS=Danio rerio OX=7955 GN=cyb5d2 PE=3 SV=1 g5985.t1 Q8CG08 41.379 174 1.82e-33 122.0 sp|Q8CG08|CTHR1_RAT Collagen triple helix repeat-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Cthrc1 PE=1 SV=1 CTHR1_RAT reviewed Collagen triple helix repeat-containing protein 1 Rattus norvegicus (Rat) GO:0004666; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0019371; GO:0031012; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177 cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528] frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147] g5986.t1 Q5ZJI0 61.261 333 2.1500000000000001e-156 449.0 sp|Q5ZJI0|TPST2_CHICK Protein-tyrosine sulfotransferase 2 OS=Gallus gallus OX=9031 GN=TPST2 PE=2 SV=1 g5991.t1 Q8NBN7 43.465 329 7.69e-74 234.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g5993.t1 Q8NBN7 55.152 165 5.69e-49 165.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g5994.t1 Q8NBN7 43.657 268 6.15e-57 189.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g5995.t1 Q8BYK4 40.415 193 2.57e-35 130.0 sp|Q8BYK4|RDH12_MOUSE Retinol dehydrogenase 12 OS=Mus musculus OX=10090 GN=Rdh12 PE=2 SV=1 RDH12_MOUSE reviewed Retinol dehydrogenase 12 (EC 1.1.1.300) Mus musculus (Mouse) GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g5999.t1 Q5F2F2 38.08 323 4.86e-62 211.0 sp|Q5F2F2|ABH15_MOUSE Protein ABHD15 OS=Mus musculus OX=10090 GN=Abhd15 PE=1 SV=1 ABH15_MOUSE reviewed Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15) Mus musculus (Mouse) GO:0005576; GO:0006629; GO:0016042; GO:0034338; GO:0047372; GO:0060612 adipose tissue development [GO:0060612]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] extracellular region [GO:0005576] monoacylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338] g6014.t1 Q12718 34.608 523 5.47e-63 224.0 sp|Q12718|LAC2_TRAVE Laccase-2 OS=Trametes versicolor OX=5325 GN=LCC2 PE=1 SV=1 g6015.t1 Q9ULQ1 41.152 243 2.35e-47 174.0 sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3 g6016.t1 Q9EQJ0 46.252 547 3.68e-141 429.0 sp|Q9EQJ0|TPC1_MOUSE Two pore calcium channel protein 1 OS=Mus musculus OX=10090 GN=Tpcn1 PE=1 SV=1 TPC1_MOUSE reviewed Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1) Mus musculus (Mouse) GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0022832; GO:0031901; GO:0034702; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682 endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; sodium ion transmembrane transport [GO:0035725] early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; recycling endosome membrane [GO:0055038] identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated channel activity [GO:0022832]; voltage-gated sodium channel activity [GO:0005248] g6018.t1 F1RKB1 45.035 282 5.16e-77 245.0 sp|F1RKB1|DRC10_PIG Dynein regulatory complex protein 10 OS=Sus scrofa OX=9823 GN=IQCD PE=1 SV=2 g6019.t1 Q641X1 31.111 360 4.92e-32 129.0 sp|Q641X1|ANR61_RAT Ankyrin repeat domain-containing protein 61 OS=Rattus norvegicus OX=10116 GN=Ankrd61 PE=2 SV=1 g6023.t1 Q8AXX2 56.657 353 3.44e-122 370.0 sp|Q8AXX2|TBX1_DANRE T-box transcription factor TBX1 OS=Danio rerio OX=7955 GN=tbx1 PE=2 SV=1 TBX1_DANRE reviewed T-box transcription factor TBX1 (T-box protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001755; GO:0001947; GO:0003143; GO:0005634; GO:0006357; GO:0007507; GO:0014032; GO:0042471; GO:0042803; GO:0043282; GO:0043565; GO:0043583; GO:0045893; GO:0048538; GO:0048703; GO:0048752; GO:0055007; GO:0060017; GO:0060023; GO:0060037; GO:0060536; GO:0072513 cardiac muscle cell differentiation [GO:0055007]; cartilage morphogenesis [GO:0060536]; cell fate specification [GO:0001708]; chordate pharyngeal muscle development [GO:0043282]; ear development [GO:0043583]; ear morphogenesis [GO:0042471]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; heart looping [GO:0001947]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal morphogenesis [GO:0048752]; soft palate development [GO:0060023]; thymus development [GO:0048538] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g6023.t2 Q8AXX2 56.657 353 4.13e-122 370.0 sp|Q8AXX2|TBX1_DANRE T-box transcription factor TBX1 OS=Danio rerio OX=7955 GN=tbx1 PE=2 SV=1 TBX1_DANRE reviewed T-box transcription factor TBX1 (T-box protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001755; GO:0001947; GO:0003143; GO:0005634; GO:0006357; GO:0007507; GO:0014032; GO:0042471; GO:0042803; GO:0043282; GO:0043565; GO:0043583; GO:0045893; GO:0048538; GO:0048703; GO:0048752; GO:0055007; GO:0060017; GO:0060023; GO:0060037; GO:0060536; GO:0072513 cardiac muscle cell differentiation [GO:0055007]; cartilage morphogenesis [GO:0060536]; cell fate specification [GO:0001708]; chordate pharyngeal muscle development [GO:0043282]; ear development [GO:0043583]; ear morphogenesis [GO:0042471]; embryonic heart tube morphogenesis [GO:0003143]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; heart looping [GO:0001947]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal morphogenesis [GO:0048752]; soft palate development [GO:0060023]; thymus development [GO:0048538] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g6025.t1 B3DJT0 41.658 941 0.0 724.0 sp|B3DJT0|SART3_DANRE Spliceosome associated factor 3, U4/U6 recycling protein OS=Danio rerio OX=7955 GN=sart3 PE=2 SV=1 SART3_DANRE reviewed Spliceosome associated factor 3, U4/U6 recycling protein (Squamous cell carcinoma antigen recognized by T-cells 3) (SART-3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000245; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061484; GO:0061574; GO:0140673; GO:1902033; GO:1902253 exocrine pancreas development [GO:0031017]; hematopoietic stem cell homeostasis [GO:0061484]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]; transcription elongation-coupled chromatin remodeling [GO:0140673] ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone binding [GO:0042393]; U6 snRNA binding [GO:0017070] g6025.t2 B3DJT0 42.535 931 0.0 728.0 sp|B3DJT0|SART3_DANRE Spliceosome associated factor 3, U4/U6 recycling protein OS=Danio rerio OX=7955 GN=sart3 PE=2 SV=1 SART3_DANRE reviewed Spliceosome associated factor 3, U4/U6 recycling protein (Squamous cell carcinoma antigen recognized by T-cells 3) (SART-3) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000245; GO:0000387; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0015030; GO:0016607; GO:0017070; GO:0030098; GO:0031017; GO:0042393; GO:0048538; GO:0061484; GO:0061574; GO:0140673; GO:1902033; GO:1902253 exocrine pancreas development [GO:0031017]; hematopoietic stem cell homeostasis [GO:0061484]; lymphocyte differentiation [GO:0030098]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; thymus development [GO:0048538]; transcription elongation-coupled chromatin remodeling [GO:0140673] ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone binding [GO:0042393]; U6 snRNA binding [GO:0017070] g6026.t1 Q5XHG1 37.313 603 2.97e-104 352.0 sp|Q5XHG1|NSMA3_XENLA Sphingomyelin phosphodiesterase 4 OS=Xenopus laevis OX=8355 GN=smpd4 PE=2 SV=2 NSMA3_XENLA reviewed Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III) Xenopus laevis (African clawed frog) GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356 cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; sarcolemma [GO:0042383] metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290] g6026.t1 Q5XHG1 38.421 190 4.94e-28 125.0 sp|Q5XHG1|NSMA3_XENLA Sphingomyelin phosphodiesterase 4 OS=Xenopus laevis OX=8355 GN=smpd4 PE=2 SV=2 NSMA3_XENLA reviewed Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III) Xenopus laevis (African clawed frog) GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356 cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; sarcolemma [GO:0042383] metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290] g6027.t1 Q9R0W9 44.215 484 6.65e-144 426.0 sp|Q9R0W9|ACHA6_MOUSE Neuronal acetylcholine receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Chrna6 PE=1 SV=2 ACHA6_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-6 Mus musculus (Mouse) GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0014059; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098878; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888] g6028.t1 Q8R4G9 42.827 474 3.7099999999999996e-139 414.0 sp|Q8R4G9|ACHA3_MOUSE Neuronal acetylcholine receptor subunit alpha-3 OS=Mus musculus OX=10090 GN=Chrna3 PE=1 SV=1 ACHA3_MOUSE reviewed Neuronal acetylcholine receptor subunit alpha-3 Mus musculus (Mouse) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0045211; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g6029.t1 P09481 39.148 493 6.61e-131 393.0 sp|P09481|ACHA3_CHICK Neuronal acetylcholine receptor subunit alpha-3 OS=Gallus gallus OX=9031 GN=CHRNA3 PE=1 SV=2 g6030.t1 Q07263 42.412 481 3.8299999999999998e-140 417.0 sp|Q07263|ACHA3_BOVIN Neuronal acetylcholine receptor subunit alpha-3 OS=Bos taurus OX=9913 GN=CHRNA3 PE=2 SV=1 ACHA3_BOVIN reviewed Neuronal acetylcholine receptor subunit alpha-3 Bos taurus (Bovine) GO:0005783; GO:0005794; GO:0005886; GO:0005892; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0015464; GO:0022848; GO:0034220; GO:0035094; GO:0035095; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0051899; GO:0060084; GO:0095500; GO:0098793; GO:0099171 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202] acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; metal ion binding [GO:0046872] g6031.t1 P19440 43.934 544 4.9200000000000004e-154 457.0 sp|P19440|GGT1_HUMAN Glutathione hydrolase 1 proenzyme OS=Homo sapiens OX=9606 GN=GGT1 PE=1 SV=2 GGT1_HUMAN reviewed Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain] Homo sapiens (Human) GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0070062; GO:0103068; GO:1901750 amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] g6032.t1 Q6GM16 37.947 419 3.49e-99 305.0 sp|Q6GM16|NXN_XENLA Nucleoredoxin OS=Xenopus laevis OX=8355 GN=nxn PE=2 SV=1 NXN_XENLA reviewed Nucleoredoxin (EC 1.8.1.8) Xenopus laevis (African clawed frog) GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359 cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] thioredoxin-disulfide reductase (NADPH) activity [GO:0004791] g6033.t1 Q04336 51.064 940 0.0 920.0 sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1 g6035.t1 Q3UDK1 27.273 462 1.69e-38 155.0 sp|Q3UDK1|TRAD1_MOUSE TRAF-type zinc finger domain-containing protein 1 OS=Mus musculus OX=10090 GN=Trafd1 PE=1 SV=1 TRAD1_MOUSE reviewed TRAF-type zinc finger domain-containing protein 1 (Protein FLN29) Mus musculus (Mouse) GO:0005739; GO:0008270; GO:0045824 negative regulation of innate immune response [GO:0045824] mitochondrion [GO:0005739] zinc ion binding [GO:0008270] g6036.t1 Q9VV87 43.243 296 1.36e-72 229.0 sp|Q9VV87|ELOV6_DROME Very long chain fatty acid elongase 6 OS=Drosophila melanogaster OX=7227 GN=Baldspot PE=1 SV=2 ELOV6_DROME reviewed Very long chain fatty acid elongase 6 (ELOVL6) (EC 2.3.1.199) (Elongation of very long chain fatty acids protein 6) (Neighbor of abl) (Very-long-chain 3-oxoacyl-CoA synthase) Drosophila melanogaster (Fruit fly) GO:0005741; GO:0005789; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] fatty acid elongase activity [GO:0009922] g6037.t1 Q96UQ7 56.14 114 2.8400000000000003e-27 99.8 sp|Q96UQ7|RLA2_RHOGU Large ribosomal subunit protein P2 OS=Rhodotorula glutinis OX=5535 PE=1 SV=1 g6038.t1 Q5ZLN8 62.195 574 0.0 757.0 sp|Q5ZLN8|DDX55_CHICK ATP-dependent RNA helicase DDX55 OS=Gallus gallus OX=9031 GN=DDX55 PE=2 SV=1 DDX55_CHICK reviewed ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55) Gallus gallus (Chicken) GO:0000470; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0016887; GO:0070180 maturation of LSU-rRNA [GO:0000470] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; large ribosomal subunit rRNA binding [GO:0070180]; RNA helicase activity [GO:0003724] g6039.t1 M9PH32 25.225 333 8.37e-24 110.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6039.t2 M9PH32 25.97 335 1e-22 103.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6042.t1 Q8BYK4 47.651 298 6.19e-76 238.0 sp|Q8BYK4|RDH12_MOUSE Retinol dehydrogenase 12 OS=Mus musculus OX=10090 GN=Rdh12 PE=2 SV=1 RDH12_MOUSE reviewed Retinol dehydrogenase 12 (EC 1.1.1.300) Mus musculus (Mouse) GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g6043.t1 Q8TC12 44.918 305 4.7100000000000006e-70 223.0 sp|Q8TC12|RDH11_HUMAN Retinol dehydrogenase 11 OS=Homo sapiens OX=9606 GN=RDH11 PE=1 SV=2 RDH11_HUMAN reviewed Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1) Homo sapiens (Human) GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0016616; GO:0033721; GO:0042572; GO:0042574; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616] g6044.t1 Q8NBN7 39.628 323 4.1e-60 197.0 sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2 RDH13_HUMAN reviewed Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g6047.t1 Q17QU7 43.86 228 1.6000000000000001e-43 154.0 sp|Q17QU7|DHR13_BOVIN Dehydrogenase/reductase SDR family member 13 OS=Bos taurus OX=9913 GN=DHRS13 PE=2 SV=1 g6048.t1 Q17QU7 50.47 319 5.33e-79 249.0 sp|Q17QU7|DHR13_BOVIN Dehydrogenase/reductase SDR family member 13 OS=Bos taurus OX=9913 GN=DHRS13 PE=2 SV=1 g6050.t1 Q8BYK4 46.801 297 1.66e-78 245.0 sp|Q8BYK4|RDH12_MOUSE Retinol dehydrogenase 12 OS=Mus musculus OX=10090 GN=Rdh12 PE=2 SV=1 RDH12_MOUSE reviewed Retinol dehydrogenase 12 (EC 1.1.1.300) Mus musculus (Mouse) GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g6051.t1 Q504N0 38.186 419 2.8e-96 298.0 sp|Q504N0|CBPA2_MOUSE Carboxypeptidase A2 OS=Mus musculus OX=10090 GN=Cpa2 PE=1 SV=1 g6052.t1 Q92804 46.759 216 1.08e-42 164.0 sp|Q92804|RBP56_HUMAN TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15 PE=1 SV=1 RBP56_HUMAN reviewed TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56) Homo sapiens (Human) GO:0003677; GO:0003712; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0045893; GO:0048255 mRNA stabilization [GO:0048255]; positive regulation of DNA-templated transcription [GO:0045893]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g6052.t2 Q92804 46.759 216 8.68e-43 164.0 sp|Q92804|RBP56_HUMAN TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15 PE=1 SV=1 RBP56_HUMAN reviewed TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56) Homo sapiens (Human) GO:0003677; GO:0003712; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0045893; GO:0048255 mRNA stabilization [GO:0048255]; positive regulation of DNA-templated transcription [GO:0045893]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g6052.t3 Q92804 35.388 438 1.02e-40 158.0 sp|Q92804|RBP56_HUMAN TATA-binding protein-associated factor 2N OS=Homo sapiens OX=9606 GN=TAF15 PE=1 SV=1 RBP56_HUMAN reviewed TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56) Homo sapiens (Human) GO:0003677; GO:0003712; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0045893; GO:0048255 mRNA stabilization [GO:0048255]; positive regulation of DNA-templated transcription [GO:0045893]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g6054.t1 B5X2B8 42.52 254 1.86e-55 197.0 sp|B5X2B8|ERAL1_SALSA GTPase Era, mitochondrial OS=Salmo salar OX=8030 GN=eral1 PE=2 SV=1 g6054.t1 B5X2B8 46.259 147 6.19e-33 135.0 sp|B5X2B8|ERAL1_SALSA GTPase Era, mitochondrial OS=Salmo salar OX=8030 GN=eral1 PE=2 SV=1 g6056.t1 O73718 54.579 273 3.85e-91 279.0 sp|O73718|TBX3_CHICK T-box transcription factor TBX3 (Fragment) OS=Gallus gallus OX=9031 GN=TBX3 PE=2 SV=1 g6056.t2 O73718 54.152 277 1.82e-90 278.0 sp|O73718|TBX3_CHICK T-box transcription factor TBX3 (Fragment) OS=Gallus gallus OX=9031 GN=TBX3 PE=2 SV=1 g6056.t3 Q9PWE8 58.96 173 1.24e-66 218.0 sp|Q9PWE8|TBX5_CHICK T-box transcription factor TBX5 OS=Gallus gallus OX=9031 GN=TBX5 PE=1 SV=1 g20005.t1 O08774 34.854 548 1.22e-75 280.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g20005.t1 O08774 39.583 144 1.16e-22 109.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g20005.t2 O08774 34.854 548 1.33e-75 280.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g20005.t2 O08774 39.583 144 1.21e-22 109.0 sp|O08774|RGS12_RAT Regulator of G-protein signaling 12 OS=Rattus norvegicus OX=10116 GN=Rgs12 PE=1 SV=1 RGS12_RAT reviewed Regulator of G-protein signaling 12 (RGS12) Rattus norvegicus (Rat) GO:0001965; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008277; GO:0030425; GO:0030695; GO:0032991; GO:0038032; GO:0043025; GO:0045202; GO:0045744; GO:0097440 negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; termination of G protein-coupled receptor signaling pathway [GO:0038032] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] g20006.t1 Q5U465 29.495 495 2.96e-37 147.0 sp|Q5U465|CC125_MOUSE Coiled-coil domain-containing protein 125 OS=Mus musculus OX=10090 GN=Ccdc125 PE=2 SV=2 g20006.t2 Q5U465 29.96 494 9.66e-38 148.0 sp|Q5U465|CC125_MOUSE Coiled-coil domain-containing protein 125 OS=Mus musculus OX=10090 GN=Ccdc125 PE=2 SV=2 g20007.t1 Q95KE5 52.857 140 1.08e-46 153.0 sp|Q95KE5|RM43_BOVIN Large ribosomal subunit protein mL43 OS=Bos taurus OX=9913 GN=MRPL43 PE=2 SV=2 g20008.t1 Q6DRN3 45.007 691 0.0 572.0 sp|Q6DRN3|NOC3L_DANRE Nucleolar complex protein 3 homolog OS=Danio rerio OX=7955 GN=noc3l PE=2 SV=1 NOC3L_DANRE reviewed Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216 DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216] nucleolus [GO:0005730]; nucleus [GO:0005634] chromatin binding [GO:0003682] g20009.t1 Q19981 28.758 1304 5.31e-153 497.0 sp|Q19981|TAG53_CAEEL Putative protein tag-53 OS=Caenorhabditis elegans OX=6239 GN=tag-53 PE=1 SV=3 g20012.t1 Q6GLT8 61.873 299 2.47e-137 395.0 sp|Q6GLT8|FAHD2_XENLA Oxaloacetate tautomerase fahd2, mitochondrial OS=Xenopus laevis OX=8355 GN=fahd2 PE=2 SV=1 FAHD2_XENLA reviewed Oxaloacetate tautomerase fahd2, mitochondrial (EC 5.3.2.2) (Fumarylacetoacetate hydrolase domain-containing protein 2) Xenopus laevis (African clawed frog) GO:0005739; GO:0006107; GO:0046872; GO:0050163 oxaloacetate metabolic process [GO:0006107] mitochondrion [GO:0005739] metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163] g20012.t2 Q6GLT8 63.322 289 3.04e-136 390.0 sp|Q6GLT8|FAHD2_XENLA Oxaloacetate tautomerase fahd2, mitochondrial OS=Xenopus laevis OX=8355 GN=fahd2 PE=2 SV=1 FAHD2_XENLA reviewed Oxaloacetate tautomerase fahd2, mitochondrial (EC 5.3.2.2) (Fumarylacetoacetate hydrolase domain-containing protein 2) Xenopus laevis (African clawed frog) GO:0005739; GO:0006107; GO:0046872; GO:0050163 oxaloacetate metabolic process [GO:0006107] mitochondrion [GO:0005739] metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163] g20013.t1 Q27245 45.174 518 1.0399999999999999e-147 436.0 sp|Q27245|YH24_CAEEL Putative aminopeptidase W07G4.4 OS=Caenorhabditis elegans OX=6239 GN=lap-2 PE=3 SV=1 g20014.t1 P97718 36.188 362 9.77e-73 243.0 sp|P97718|ADA1A_MOUSE Alpha-1A adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1a PE=1 SV=3 ADA1A_MOUSE reviewed Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) Mus musculus (Mouse) GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007267; GO:0007512; GO:0008217; GO:0009410; GO:0009725; GO:0010460; GO:0010507; GO:0010613; GO:0016020; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035265; GO:0042734; GO:0043410; GO:0045211; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060452; GO:0061049; GO:0070374; GO:0071875; GO:0071880; GO:0071882; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099171; GO:0141214; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate [GO:0010460]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phospholipase C/protein kinase C signal transduction [GO:0141214]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of blood pressure [GO:0008217]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; T-tubule [GO:0030315]; Z disc [GO:0030018] alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982] g20015.t1 A7SGF0 46.491 114 6.99e-31 112.0 sp|A7SGF0|BORC8_NEMVE BLOC-1-related complex subunit 8 homolog OS=Nematostella vectensis OX=45351 GN=v1g233178 PE=3 SV=1 g20016.t1 Q24563 41.689 379 7.2999999999999995e-84 269.0 sp|Q24563|DOPR2_DROME Dopamine receptor 2 OS=Drosophila melanogaster OX=7227 GN=Dop1R2 PE=2 SV=1 DOPR2_DROME reviewed Dopamine receptor 2 (Dopamine 1-like receptor 2) Drosophila melanogaster (Fruit fly) GO:0001588; GO:0004930; GO:0004935; GO:0004952; GO:0005886; GO:0007186; GO:0007191; GO:0007212; GO:0008226; GO:0008227; GO:0016020; GO:0030672; GO:0042321; GO:0043410; GO:0071880; GO:0099509; GO:1903351; GO:1990834 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cellular response to dopamine [GO:1903351]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; positive regulation of MAPK cascade [GO:0043410]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834] membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] adrenergic receptor activity [GO:0004935]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; tyramine receptor activity [GO:0008226] g20017.t1 Q9NR45 70.0 350 0.0 541.0 sp|Q9NR45|SIAS_HUMAN N-acetylneuraminate-9-phosphate synthase OS=Homo sapiens OX=9606 GN=NANS PE=1 SV=2 SIAS_HUMAN reviewed N-acetylneuraminate-9-phosphate synthase (EC 2.5.1.57) (3-deoxy-D-glycero-D-galacto-nononate 9-phosphate synthase) (EC 2.5.1.132) (N-acetylneuraminic acid phosphate synthase) (NANS) (Sialic acid phosphate synthase) (Sialic acid synthase) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006055; GO:0016051; GO:0046380; GO:0047444; GO:0070062 carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; N-acetylneuraminate biosynthetic process [GO:0046380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] N-acylneuraminate-9-phosphate synthase activity [GO:0047444] g20018.t1 Q59990 23.516 438 1.4600000000000002e-26 114.0 sp|Q59990|CP120_SYNY3 Putative cytochrome P450 120 OS=Synechocystis sp. (strain ATCC 27184 / PCC 6803 / Kazusa) OX=1111708 GN=cyp120 PE=1 SV=1 g20019.t1 P97931 57.276 323 7.12e-122 355.0 sp|P97931|UNG_MOUSE Uracil-DNA glycosylase OS=Mus musculus OX=10090 GN=Ung PE=1 SV=3 UNG_MOUSE reviewed Uracil-DNA glycosylase (UDG) (EC 3.2.2.27) Mus musculus (Mouse) GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0016446; GO:0016447; GO:0043024; GO:0043066; GO:0045190; GO:0097510 base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844] g20020.t1 Q8CAQ8 34.67 773 1.13e-124 392.0 sp|Q8CAQ8|MIC60_MOUSE MICOS complex subunit Mic60 OS=Mus musculus OX=10090 GN=Immt PE=1 SV=1 g20021.t1 Q29J90 26.23 366 2.01e-25 111.0 sp|Q29J90|MOODY_DROPS G-protein coupled receptor moody OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=moody PE=3 SV=2 g20022.t1 Q3UAW9 24.224 322 1.94e-28 119.0 sp|Q3UAW9|BRF2_MOUSE Transcription factor IIIB 50 kDa subunit OS=Mus musculus OX=10090 GN=Brf2 PE=1 SV=1 g20024.t1 Q0VD26 55.0 140 2.63e-55 173.0 sp|Q0VD26|MORN4_BOVIN MORN repeat-containing protein 4 OS=Bos taurus OX=9913 GN=MORN4 PE=2 SV=1 g20025.t1 Q1L8Y6 66.667 69 1.0199999999999999e-23 87.8 sp|Q1L8Y6|BBIP1_DANRE BBSome-interacting protein 1 OS=Danio rerio OX=7955 GN=bbip1 PE=3 SV=1 g20038.t1 O94993 70.0 80 1.12e-26 120.0 sp|O94993|SOX30_HUMAN Transcription factor SOX-30 OS=Homo sapiens OX=9606 GN=SOX30 PE=1 SV=1 SOX30_HUMAN reviewed Transcription factor SOX-30 Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0045944; GO:0120211; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286] chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g20040.t1 Q5VV67 43.262 141 3.05e-29 128.0 sp|Q5VV67|PPRC1_HUMAN Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 OS=Homo sapiens OX=9606 GN=PPRC1 PE=1 SV=1 PPRC1_HUMAN reviewed Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC) Homo sapiens (Human) GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0045944; GO:0097009 energy homeostasis [GO:0097009]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] g20041.t1 A7Z035 43.208 530 6.53e-100 324.0 sp|A7Z035|EPN4_BOVIN Clathrin interactor 1 OS=Bos taurus OX=9913 GN=CLINT1 PE=2 SV=1 EPN4_BOVIN reviewed Clathrin interactor 1 (Epsin-4) Bos taurus (Bovine) GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0048471 endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] g20041.t2 A7Z035 42.911 529 1.4500000000000001e-99 325.0 sp|A7Z035|EPN4_BOVIN Clathrin interactor 1 OS=Bos taurus OX=9913 GN=CLINT1 PE=2 SV=1 EPN4_BOVIN reviewed Clathrin interactor 1 (Epsin-4) Bos taurus (Bovine) GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0048471 endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] g20042.t1 P24528 50.279 179 1.72e-51 167.0 sp|P24528|MGMT_RAT Methylated-DNA--protein-cysteine methyltransferase OS=Rattus norvegicus OX=10116 GN=Mgmt PE=1 SV=3 MGMT_RAT reviewed Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase) Rattus norvegicus (Rat) GO:0003677; GO:0003908; GO:0005509; GO:0005654; GO:0006281; GO:0006307; GO:0006974; GO:0008168; GO:0009410; GO:0009636; GO:0032259; GO:0034599; GO:0043066; GO:0045471; GO:0045739; GO:0051593; GO:0060644; GO:0071479; GO:2000781 cellular response to ionizing radiation [GO:0071479]; cellular response to oxidative stress [GO:0034599]; DNA alkylation repair [GO:0006307]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] nucleoplasm [GO:0005654] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168] g20043.t1 Q9EPJ3 34.518 197 3.47e-25 101.0 sp|Q9EPJ3|RT26_RAT Small ribosomal subunit protein mS26 OS=Rattus norvegicus OX=10116 GN=Mrps26 PE=1 SV=1 g20044.t1 O96028 43.769 1300 0.0 1042.0 sp|O96028|NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1 g20045.t1 Q6QD59 54.018 224 5.26e-65 204.0 sp|Q6QD59|SEC20_MOUSE Vesicle transport protein SEC20 OS=Mus musculus OX=10090 GN=Bnip1 PE=1 SV=1 g20046.t1 Q9Y227 53.646 576 0.0 619.0 sp|Q9Y227|ENTP4_HUMAN Ectonucleoside triphosphate diphosphohydrolase 4 OS=Homo sapiens OX=9606 GN=ENTPD4 PE=1 SV=1 ENTP4_HUMAN reviewed Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42) Homo sapiens (Human) GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712 CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134] g20046.t2 Q9Y227 54.419 577 0.0 631.0 sp|Q9Y227|ENTP4_HUMAN Ectonucleoside triphosphate diphosphohydrolase 4 OS=Homo sapiens OX=9606 GN=ENTPD4 PE=1 SV=1 ENTP4_HUMAN reviewed Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42) Homo sapiens (Human) GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712 CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134] g20047.t1 Q8IUR6 63.816 152 2.27e-50 186.0 sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2 g20049.t1 Q5QJC4 44.635 466 3.17e-133 434.0 sp|Q5QJC4|DCR1A_CHICK DNA cross-link repair 1A protein OS=Gallus gallus OX=9031 GN=DCLRE1A PE=1 SV=1 DCR1A_CHICK reviewed DNA cross-link repair 1A protein (Beta-lactamase MBLAC2) (EC 3.5.2.6) (SNM1 homolog A) (chSNM1A) Gallus gallus (Chicken) GO:0003684; GO:0005634; GO:0005654; GO:0006303; GO:0008270; GO:0008800; GO:0035312; GO:0036297 double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297] nucleoplasm [GO:0005654]; nucleus [GO:0005634] 5'-3' DNA exonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; zinc ion binding [GO:0008270] g20054.t1 P31401 92.181 486 0.0 932.0 sp|P31401|VATB_MANSE V-type proton ATPase subunit B OS=Manduca sexta OX=7130 GN=VHA55 PE=2 SV=1 g20055.t1 Q8BLD6 55.118 127 2.7099999999999997e-38 140.0 sp|Q8BLD6|ANR55_MOUSE Ankyrin repeat domain-containing protein 55 OS=Mus musculus OX=10090 GN=Ankrd55 PE=1 SV=2 g20056.t1 Q8BLD6 48.201 139 3.86e-32 134.0 sp|Q8BLD6|ANR55_MOUSE Ankyrin repeat domain-containing protein 55 OS=Mus musculus OX=10090 GN=Ankrd55 PE=1 SV=2 g20061.t1 Q9JID1 50.691 434 7e-114 345.0 sp|Q9JID1|PDCD4_RAT Programmed cell death protein 4 OS=Rattus norvegicus OX=10116 GN=Pdcd4 PE=1 SV=2 PDCD4_RAT reviewed Programmed cell death protein 4 (Death up-regulated gene protein) Rattus norvegicus (Rat) GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0009725; GO:0030509; GO:0034393; GO:0043066; GO:0043279; GO:0043508; GO:0045892; GO:0050729; GO:0051246; GO:0060940; GO:0071222; GO:1900016; GO:1901224; GO:1904706; GO:1904761; GO:1905064; GO:1905461; GO:2000353 apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of protein metabolic process [GO:0051246]; response to alkaloid [GO:0043279]; response to hormone [GO:0009725] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] RNA binding [GO:0003723] g20062.t1 Q9JIW4 44.318 264 7.39e-71 236.0 sp|Q9JIW4|DPOLM_MOUSE DNA-directed DNA/RNA polymerase mu OS=Mus musculus OX=10090 GN=Polm PE=1 SV=2 DPOLM_MOUSE reviewed DNA-directed DNA/RNA polymerase mu (Pol Mu) (EC 2.7.7.7) (Terminal transferase) Mus musculus (Mouse) GO:0003677; GO:0003887; GO:0005634; GO:0006303; GO:0006310; GO:0016446; GO:0030183; GO:0046872 B cell differentiation [GO:0030183]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; somatic hypermutation of immunoglobulin genes [GO:0016446] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] g20064.t1 A2VDV9 55.682 88 2.9700000000000004e-27 98.2 sp|A2VDV9|SMIM8_BOVIN Small integral membrane protein 8 OS=Bos taurus OX=9913 GN=SMIM8 PE=3 SV=1 g20066.t1 G4V4G1 36.797 231 1.81e-44 154.0 sp|G4V4G1|IGFBP_CUPSA Insulin-like growth factor-binding protein-related protein 1 OS=Cupiennius salei OX=6928 PE=2 SV=1 g20069.t1 Q61581 32.937 252 1.9100000000000002e-32 123.0 sp|Q61581|IBP7_MOUSE Insulin-like growth factor-binding protein 7 OS=Mus musculus OX=10090 GN=Igfbp7 PE=1 SV=3 IBP7_MOUSE reviewed Insulin-like growth factor-binding protein 7 (IBP-7) (IGF-binding protein 7) (IGFBP-7) (MAC25 protein) Mus musculus (Mouse) GO:0001525; GO:0001558; GO:0005520; GO:0005615; GO:0007155; GO:0009966; GO:0031012; GO:0048018; GO:0048839; GO:0050810 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; inner ear development [GO:0048839]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; regulation of steroid biosynthetic process [GO:0050810] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] insulin-like growth factor binding [GO:0005520]; receptor ligand activity [GO:0048018] g20070.t1 Q6AYK5 41.935 248 1.0699999999999999e-55 196.0 sp|Q6AYK5|LYAR_RAT Cell growth-regulating nucleolar protein OS=Rattus norvegicus OX=10116 GN=Lyar PE=1 SV=1 LYAR_RAT reviewed Cell growth-regulating nucleolar protein Rattus norvegicus (Rat) GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008270; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0048821; GO:0050766; GO:0140297; GO:0140416 erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750] DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; zinc ion binding [GO:0008270] g20072.t1 Q9PTG8 34.278 388 3.92e-51 199.0 sp|Q9PTG8|TACC3_XENLA Transforming acidic coiled-coil-containing protein 3 OS=Xenopus laevis OX=8355 GN=tacc3 PE=1 SV=2 g20072.t2 Q9PTG8 34.704 389 9.35e-53 204.0 sp|Q9PTG8|TACC3_XENLA Transforming acidic coiled-coil-containing protein 3 OS=Xenopus laevis OX=8355 GN=tacc3 PE=1 SV=2 g20072.t3 Q9PTG8 34.704 389 1.1999999999999999e-52 204.0 sp|Q9PTG8|TACC3_XENLA Transforming acidic coiled-coil-containing protein 3 OS=Xenopus laevis OX=8355 GN=tacc3 PE=1 SV=2 g20073.t1 Q2TBI1 38.732 284 4.93e-57 191.0 sp|Q2TBI1|NSE4A_BOVIN Non-structural maintenance of chromosomes element 4 homolog A OS=Bos taurus OX=9913 GN=NSMCE4A PE=2 SV=1 NSE4A_BOVIN reviewed Non-structural maintenance of chromosomes element 4 homolog A (Non-SMC element 4 homolog A) Bos taurus (Bovine) GO:0000781; GO:0005634; GO:0006281; GO:0006310; GO:0006974; GO:0016604; GO:0030915 DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915] g20076.t1 Q91783 38.503 1109 0.0 629.0 sp|Q91783|KI11A_XENLA Kinesin-like protein KIF11-A OS=Xenopus laevis OX=8355 GN=kif11-a PE=1 SV=1 g20077.t1 E1C760 37.393 468 1.32e-97 314.0 sp|E1C760|UVSSA_CHICK UV-stimulated scaffold protein A OS=Gallus gallus OX=9031 GN=UVSSA PE=3 SV=1 UVSSA_CHICK reviewed UV-stimulated scaffold protein A Gallus gallus (Chicken) GO:0000993; GO:0005634; GO:0005694; GO:0006283; GO:0008270; GO:0009411; GO:0016567; GO:0090734; GO:0140463; GO:0140870 protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283] chromosome [GO:0005694]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin-protein adaptor activity [GO:0140463]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase inhibitor activity [GO:0140870]; zinc ion binding [GO:0008270] g20078.t1 E1C760 45.175 228 4.559999999999999e-52 183.0 sp|E1C760|UVSSA_CHICK UV-stimulated scaffold protein A OS=Gallus gallus OX=9031 GN=UVSSA PE=3 SV=1 UVSSA_CHICK reviewed UV-stimulated scaffold protein A Gallus gallus (Chicken) GO:0000993; GO:0005634; GO:0005694; GO:0006283; GO:0008270; GO:0009411; GO:0016567; GO:0090734; GO:0140463; GO:0140870 protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283] chromosome [GO:0005694]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin-protein adaptor activity [GO:0140463]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase inhibitor activity [GO:0140870]; zinc ion binding [GO:0008270] g20080.t1 Q28DV7 49.01 404 6.94e-128 385.0 sp|Q28DV7|MCMBP_XENTR Mini-chromosome maintenance complex-binding protein OS=Xenopus tropicalis OX=8364 GN=mcmbp PE=2 SV=2 g20081.t1 Q5ZJV4 51.333 150 4.7999999999999996e-52 180.0 sp|Q5ZJV4|MCMBP_CHICK Mini-chromosome maintenance complex-binding protein OS=Gallus gallus OX=9031 GN=MCMBP PE=2 SV=2 g20082.t1 P41594 31.302 837 8.42e-127 414.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g20084.t1 Q9W735 28.269 803 1.08e-98 329.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g20085.t1 Q6NS60 54.118 170 6.129999999999999e-54 202.0 sp|Q6NS60|FBX41_MOUSE F-box only protein 41 OS=Mus musculus OX=10090 GN=Fbxo41 PE=1 SV=3 FBX41_MOUSE reviewed F-box only protein 41 Mus musculus (Mouse) GO:0001764; GO:0007268; GO:0010467; GO:0021542; GO:0021766; GO:0042551; GO:0045202 chemical synaptic transmission [GO:0007268]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; neuron maturation [GO:0042551]; neuron migration [GO:0001764] synapse [GO:0045202] g20086.t1 Q6NS60 40.602 133 7.74e-26 103.0 sp|Q6NS60|FBX41_MOUSE F-box only protein 41 OS=Mus musculus OX=10090 GN=Fbxo41 PE=1 SV=3 FBX41_MOUSE reviewed F-box only protein 41 Mus musculus (Mouse) GO:0001764; GO:0007268; GO:0010467; GO:0021542; GO:0021766; GO:0042551; GO:0045202 chemical synaptic transmission [GO:0007268]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; neuron maturation [GO:0042551]; neuron migration [GO:0001764] synapse [GO:0045202] g20087.t1 Q5E9Z8 71.97 132 1.7100000000000002e-59 182.0 sp|Q5E9Z8|LSM1_BOVIN U6 snRNA-associated Sm-like protein LSm1 OS=Bos taurus OX=9913 GN=LSM1 PE=2 SV=1 g20088.t1 A2PYL6 42.247 445 2.76e-103 331.0 sp|A2PYL6|HXK2_HORSE Hexokinase-2 OS=Equus caballus OX=9796 GN=HK2 PE=2 SV=1 HXK2_HORSE reviewed Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) Equus caballus (Horse) GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0008637; GO:0008865; GO:0035795; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1905091; GO:1990830; GO:2000378 apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; intracellular glucose homeostasis [GO:0001678]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of type 2 mitophagy [GO:1905091]; regulation of D-glucose import [GO:0046324] centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; hexokinase activity [GO:0004396] g20088.t1 A2PYL6 37.885 454 1.33e-95 311.0 sp|A2PYL6|HXK2_HORSE Hexokinase-2 OS=Equus caballus OX=9796 GN=HK2 PE=2 SV=1 HXK2_HORSE reviewed Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) Equus caballus (Horse) GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0008637; GO:0008865; GO:0035795; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1905091; GO:1990830; GO:2000378 apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; intracellular glucose homeostasis [GO:0001678]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of type 2 mitophagy [GO:1905091]; regulation of D-glucose import [GO:0046324] centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; hexokinase activity [GO:0004396] g20090.t1 Q6P926 40.113 177 6.14e-35 125.0 sp|Q6P926|SPA24_MOUSE Spermatogenesis-associated protein 24 OS=Mus musculus OX=10090 GN=Spata24 PE=1 SV=1 SPA24_MOUSE reviewed Spermatogenesis-associated protein 24 (TATA-binding protein-like factor-interacting protein) (TLF-interacting protein) (TRF2-interacting protein in testis) (Testis protein T6441 homolog) Mus musculus (Mouse) GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154; GO:0042802 cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; identical protein binding [GO:0042802] g20091.t1 Q9Y223 63.445 714 0.0 910.0 sp|Q9Y223|GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens OX=9606 GN=GNE PE=1 SV=1 GLCNE_HUMAN reviewed Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)] Homo sapiens (Human) GO:0004553; GO:0005524; GO:0005829; GO:0006045; GO:0006047; GO:0006055; GO:0008761; GO:0009384; GO:0046380; GO:0046872 CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829] ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761] g20091.t2 Q9Y223 63.445 714 0.0 909.0 sp|Q9Y223|GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens OX=9606 GN=GNE PE=1 SV=1 GLCNE_HUMAN reviewed Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)] Homo sapiens (Human) GO:0004553; GO:0005524; GO:0005829; GO:0006045; GO:0006047; GO:0006055; GO:0008761; GO:0009384; GO:0046380; GO:0046872 CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829] ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761] g20092.t1 Q8R0X2 44.589 231 1.7499999999999999e-68 219.0 sp|Q8R0X2|CACL1_MOUSE CDK2-associated and cullin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cacul1 PE=2 SV=1 g20094.t1 Q3C2C2 42.0 150 8.01e-26 99.4 sp|Q3C2C2|PA21_ACAPL Phospholipase A2 AP-PLA2-I OS=Acanthaster planci OX=133434 PE=1 SV=1 PA21_ACAPL reviewed Phospholipase A2 AP-PLA2-I (PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2) Acanthaster planci (Crown-of-thorns starfish) GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0031640; GO:0047498; GO:0050482; GO:0090729 arachidonate secretion [GO:0050482]; killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] extracellular region [GO:0005576] calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729] g20095.t1 Q460N5 42.529 174 1.1e-41 152.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g20096.t1 Q460N5 28.009 864 1.3e-84 301.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g20101.t1 Q8TDB6 52.261 199 3.9599999999999997e-60 209.0 sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1 DTX3L_HUMAN reviewed E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2) Homo sapiens (Human) GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646 defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20102.t1 Q5REG4 53.297 182 3.03e-63 202.0 sp|Q5REG4|DTX3_PONAB Probable E3 ubiquitin-protein ligase DTX3 OS=Pongo abelii OX=9601 GN=DTX3 PE=2 SV=1 DTX3_PONAB reviewed E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING-type E3 ubiquitin transferase DTX3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0007219; GO:0008270; GO:0008593; GO:0016567; GO:0061630 Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593] cytoplasm [GO:0005737]; nucleus [GO:0005634] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g20105.t1 Q460N5 43.719 199 2.46e-47 187.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g20109.t1 Q29RT6 44.512 492 4.08e-119 374.0 sp|Q29RT6|KI20A_BOVIN Kinesin-like protein KIF20A OS=Bos taurus OX=9913 GN=KIF20A PE=2 SV=1 KI20A_BOVIN reviewed Kinesin-like protein KIF20A Bos taurus (Bovine) GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0030496; GO:0032465; GO:0061952 microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g20109.t2 Q29RT6 39.037 602 2.55e-112 359.0 sp|Q29RT6|KI20A_BOVIN Kinesin-like protein KIF20A OS=Bos taurus OX=9913 GN=KIF20A PE=2 SV=1 KI20A_BOVIN reviewed Kinesin-like protein KIF20A Bos taurus (Bovine) GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0030496; GO:0032465; GO:0061952 microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g20110.t1 Q8CFI7 86.364 220 5.6600000000000006e-129 395.0 sp|Q8CFI7|RPB2_MOUSE DNA-directed RNA polymerase II subunit RPB2 OS=Mus musculus OX=10090 GN=Polr2b PE=1 SV=2 RPB2_MOUSE reviewed DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48) Mus musculus (Mouse) GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0008270; GO:0016787; GO:0032549 transcription by RNA polymerase II [GO:0006366] chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270] g20111.t1 A5PJW8 89.037 903 0.0 1727.0 sp|A5PJW8|RPB2_BOVIN DNA-directed RNA polymerase II subunit RPB2 OS=Bos taurus OX=9913 GN=POLR2B PE=1 SV=1 RPB2_BOVIN reviewed DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48) Bos taurus (Bovine) GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005665; GO:0006366; GO:0008270; GO:0016787; GO:0032549; GO:0071667 transcription by RNA polymerase II [GO:0006366] chromosome, telomeric region [GO:0000781]; RNA polymerase II, core complex [GO:0005665] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270] g20113.t1 Q8IYW2 36.765 272 4.79e-50 181.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g20114.t1 Q8IYW2 34.42 276 5.69e-36 139.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g20115.t1 Q8IYW2 36.161 1662 0.0 958.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g20115.t1 Q8IYW2 40.433 277 1.2699999999999999e-55 219.0 sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3 g20116.t1 Q8N7B6 56.316 190 1.69e-65 205.0 sp|Q8N7B6|PACRL_HUMAN PACRG-like protein OS=Homo sapiens OX=9606 GN=PACRGL PE=1 SV=2 g20117.t1 Q68EF4 31.971 832 8.259999999999999e-131 418.0 sp|Q68EF4|GRM4_MOUSE Metabotropic glutamate receptor 4 OS=Mus musculus OX=10090 GN=Grm4 PE=1 SV=2 GRM4_MOUSE reviewed Metabotropic glutamate receptor 4 (mGluR4) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0004930; GO:0005516; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007612; GO:0008066; GO:0031410; GO:0043005; GO:0043195; GO:0043198; GO:0043410; GO:0048306; GO:0048787; GO:0051966; GO:0098688; GO:0098978; GO:0099171; GO:0150048 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; positive regulation of MAPK cascade [GO:0043410]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g20118.t1 P08594 44.744 371 8.26e-101 312.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g20119.t1 P91685 34.975 203 7.6399999999999995e-34 137.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g20120.t1 O00222 37.5 232 4.1600000000000003e-36 149.0 sp|O00222|GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens OX=9606 GN=GRM8 PE=1 SV=2 GRM8_HUMAN reviewed Metabotropic glutamate receptor 8 (mGluR8) Homo sapiens (Human) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g20121.t1 Q9H173 41.099 455 9.080000000000001e-105 322.0 sp|Q9H173|SIL1_HUMAN Nucleotide exchange factor SIL1 OS=Homo sapiens OX=9606 GN=SIL1 PE=1 SV=1 SIL1_HUMAN reviewed Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP) Homo sapiens (Human) GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082 cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082] g20122.t1 P27652 48.797 291 4.67e-103 308.0 sp|P27652|LUCI_RENRE Coelenterazine h 2-monooxygenase OS=Renilla reniformis OX=6136 PE=1 SV=1 g20123.t1 O76093 40.625 128 2.34e-22 93.6 sp|O76093|FGF18_HUMAN Fibroblast growth factor 18 OS=Homo sapiens OX=9606 GN=FGF18 PE=1 SV=1 FGF18_HUMAN reviewed Fibroblast growth factor 18 (FGF-18) (zFGF5) Homo sapiens (Human) GO:0001525; GO:0001957; GO:0001958; GO:0002063; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008283; GO:0008284; GO:0008543; GO:0009653; GO:0022008; GO:0030324; GO:0030334; GO:0030949; GO:0032332; GO:0043406; GO:0043410; GO:0043536; GO:0045766; GO:0048010; GO:0070371; GO:0070374; GO:2000546 anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; neurogenesis [GO:0022008]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730] growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111] g20123.t2 O76093 40.625 128 2.74e-22 93.6 sp|O76093|FGF18_HUMAN Fibroblast growth factor 18 OS=Homo sapiens OX=9606 GN=FGF18 PE=1 SV=1 FGF18_HUMAN reviewed Fibroblast growth factor 18 (FGF-18) (zFGF5) Homo sapiens (Human) GO:0001525; GO:0001957; GO:0001958; GO:0002063; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008283; GO:0008284; GO:0008543; GO:0009653; GO:0022008; GO:0030324; GO:0030334; GO:0030949; GO:0032332; GO:0043406; GO:0043410; GO:0043536; GO:0045766; GO:0048010; GO:0070371; GO:0070374; GO:2000546 anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; neurogenesis [GO:0022008]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730] growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111] g20123.t3 O76093 40.625 128 2.29e-22 93.6 sp|O76093|FGF18_HUMAN Fibroblast growth factor 18 OS=Homo sapiens OX=9606 GN=FGF18 PE=1 SV=1 FGF18_HUMAN reviewed Fibroblast growth factor 18 (FGF-18) (zFGF5) Homo sapiens (Human) GO:0001525; GO:0001957; GO:0001958; GO:0002063; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008283; GO:0008284; GO:0008543; GO:0009653; GO:0022008; GO:0030324; GO:0030334; GO:0030949; GO:0032332; GO:0043406; GO:0043410; GO:0043536; GO:0045766; GO:0048010; GO:0070371; GO:0070374; GO:2000546 anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; neurogenesis [GO:0022008]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730] growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111] g20126.t1 Q9NLA3 76.571 350 1.12e-129 377.0 sp|Q9NLA3|ANO39_PATPE Nucleoplasmin-like protein ANO39 OS=Patiria pectinifera OX=7594 PE=1 SV=1 ANO39_PATPE reviewed Nucleoplasmin-like protein ANO39 (39 kDa oocyte-expressed nucleolar protein) (Nucleic acid-associated protein 36) (Nucleic acid-binding nuclear protein) (NAAP) (NAAP1) (NAAP2) Patiria pectinifera (Starfish) (Asterina pectinifera) GO:0000278; GO:0001556; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0042393 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723] g20127.t1 Q5R416 66.484 913 0.0 1218.0 sp|Q5R416|CTNA2_PONAB Catenin alpha-2 OS=Pongo abelii OX=9601 GN=CTNNA2 PE=2 SV=3 CTNA2_PONAB reviewed Catenin alpha-2 (Alpha N-catenin) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222 axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; nucleus [GO:0005634] actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198] g20133.t1 Q8MI28 23.383 1005 1.44e-40 167.0 sp|Q8MI28|LBN_BOVIN Limbin OS=Bos taurus OX=9913 GN=EVC2 PE=2 SV=1 g20134.t1 Q8R1V4 73.934 211 1.06e-119 342.0 sp|Q8R1V4|TMED4_MOUSE Transmembrane emp24 domain-containing protein 4 OS=Mus musculus OX=10090 GN=Tmed4 PE=1 SV=1 g20135.t1 Q8CAI1 26.681 476 2.7e-29 127.0 sp|Q8CAI1|CC142_MOUSE Coiled-coil domain-containing protein 142 OS=Mus musculus OX=10090 GN=Ccdc142 PE=2 SV=2 g20137.t1 Q8BJM3 47.788 226 3.43e-54 193.0 sp|Q8BJM3|R3HCL_MOUSE Coiled-coil domain-containing protein R3HCC1L OS=Mus musculus OX=10090 GN=R3hcc1l PE=1 SV=1 g20141.t1 P80146 45.238 378 1.67e-98 301.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g20142.t1 D2CLZ9 62.393 117 1.7100000000000001e-43 155.0 sp|D2CLZ9|ATOH8_DANRE Transcription factor atoh8 OS=Danio rerio OX=7955 GN=atoh8 PE=2 SV=1 ATOH8_DANRE reviewed Transcription factor atoh8 (Atonal bHLH transcription factor 8) (Protein atonal homolog 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0007507; GO:0009653; GO:0016607; GO:0030154; GO:0045944; GO:0046983; GO:0048797; GO:0061074; GO:0070888; GO:2001014 anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; heart looping [GO:0001947]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural retina development [GO:0061074]; regulation of skeletal muscle cell differentiation [GO:2001014]; swim bladder formation [GO:0048797] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983] g20144.t1 A2RSY1 60.096 416 4.0799999999999995e-174 544.0 sp|A2RSY1|KANL3_MOUSE KAT8 regulatory NSL complex subunit 3 OS=Mus musculus OX=10090 GN=Kansl3 PE=1 SV=1 KANL3_MOUSE reviewed KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) Mus musculus (Mouse) GO:0000123; GO:0000922; GO:0005654; GO:0005739; GO:0005874; GO:0006325; GO:0044545; GO:0045893; GO:0045944; GO:1903108 chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial transcription [GO:1903108] histone acetyltransferase complex [GO:0000123]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] g20146.t1 Q9W6S5 51.571 382 5.04e-150 432.0 sp|Q9W6S5|ALLC_XENLA Allantoicase OS=Xenopus laevis OX=8355 GN=allc PE=2 SV=1 g20153.t1 P13360 82.222 135 5.03e-75 251.0 sp|P13360|GLAS_DROME Protein glass OS=Drosophila melanogaster OX=7227 GN=gl PE=1 SV=2 GLAS_DROME reviewed Protein glass Drosophila melanogaster (Fruit fly) GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0008270; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045466; GO:0045944; GO:0046530; GO:0048052; GO:0060086 circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R7 cell differentiation [GO:0045466]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g20154.t1 Q9I8C7 34.783 391 2.84e-80 260.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g20155.t1 P04757 32.056 496 4.1e-84 271.0 sp|P04757|ACHA3_RAT Neuronal acetylcholine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Chrna3 PE=1 SV=1 ACHA3_RAT reviewed Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007507; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034465; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; heart development [GO:0007507]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to carbon monoxide [GO:0034465]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20155.t2 P04757 31.683 505 2.6e-81 264.0 sp|P04757|ACHA3_RAT Neuronal acetylcholine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Chrna3 PE=1 SV=1 ACHA3_RAT reviewed Neuronal acetylcholine receptor subunit alpha-3 Rattus norvegicus (Rat) GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006937; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007507; GO:0007626; GO:0009410; GO:0014056; GO:0015464; GO:0016607; GO:0022848; GO:0030425; GO:0032991; GO:0034220; GO:0034465; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0044877; GO:0045202; GO:0046872; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098691; GO:0098793; GO:0098878; GO:0098981; GO:0099171; GO:0099634; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; heart development [GO:0007507]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to carbon monoxide [GO:0034465]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cholinergic synapse [GO:0098981]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20156.t1 Q9UGM1 28.755 233 2.2799999999999997e-23 101.0 sp|Q9UGM1|ACHA9_HUMAN Neuronal acetylcholine receptor subunit alpha-9 OS=Homo sapiens OX=9606 GN=CHRNA9 PE=1 SV=2 ACHA9_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9) Homo sapiens (Human) GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007204; GO:0007268; GO:0010996; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0050910; GO:0051899; GO:0070373; GO:0095500; GO:0098981; GO:0099634; GO:1902495; GO:1904315 acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996] acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495] acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g20157.t1 P13908 37.629 194 1.59e-41 149.0 sp|P13908|ACHN2_CARAU Neuronal acetylcholine receptor subunit non-alpha-2 OS=Carassius auratus OX=7957 PE=2 SV=1 g20158.t1 Q28ID3 45.509 334 3.57e-98 295.0 sp|Q28ID3|GLRX3_XENTR Glutaredoxin-3 OS=Xenopus tropicalis OX=8364 GN=glrx3 PE=2 SV=2 g20158.t1 Q28ID3 68.627 102 3.05e-48 166.0 sp|Q28ID3|GLRX3_XENTR Glutaredoxin-3 OS=Xenopus tropicalis OX=8364 GN=glrx3 PE=2 SV=2 g20159.t1 Q7ZWF4 40.0 600 3.24e-153 459.0 sp|Q7ZWF4|RN145_DANRE RING finger protein 145 OS=Danio rerio OX=7955 GN=rnf145 PE=2 SV=1 RN145_DANRE reviewed RING finger protein 145 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0008270; GO:0012505; GO:0016020; GO:0030097; GO:0036503; GO:0043161; GO:0061515; GO:0061630 ERAD pathway [GO:0036503]; hemopoiesis [GO:0030097]; myeloid cell development [GO:0061515]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] endomembrane system [GO:0012505]; membrane [GO:0016020] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g20160.t1 Q7TMV1 32.742 620 1.48e-87 286.0 sp|Q7TMV1|RN139_MOUSE E3 ubiquitin-protein ligase RNF139 OS=Mus musculus OX=10090 GN=Rnf139 PE=1 SV=1 RN139_MOUSE reviewed E3 ubiquitin-protein ligase RNF139 (EC 2.3.2.27) (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein) Mus musculus (Mouse) GO:0002020; GO:0004842; GO:0005783; GO:0008270; GO:0008285; GO:0012505; GO:0016567; GO:0017148; GO:0019787; GO:0031648; GO:0036503; GO:0036513; GO:0043161; GO:0060628; GO:0061630; GO:0070613; GO:2000060 ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613] Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783] protease binding [GO:0002020]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20161.t1 Q8TDB6 52.308 195 4.98e-69 239.0 sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1 DTX3L_HUMAN reviewed E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2) Homo sapiens (Human) GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646 defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20162.t1 Q2EMV9 41.096 146 9.7e-28 114.0 sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3 PAR14_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14) Mus musculus (Mouse) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019677; GO:0019899; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g20170.t1 Q925F4 32.456 456 3.56e-50 182.0 sp|Q925F4|RNF37_MOUSE RING finger protein 37 OS=Mus musculus OX=10090 GN=Ubox5 PE=1 SV=2 g20171.t1 Q29RL1 67.036 361 1.41e-172 497.0 sp|Q29RL1|CF206_BOVIN Cilia- and flagella-associated protein 206 OS=Bos taurus OX=9913 GN=CFAP206 PE=2 SV=2 g20172.t1 Q6PE87 57.6 250 2.78e-99 305.0 sp|Q6PE87|CF206_MOUSE Cilia- and flagella-associated protein 206 OS=Mus musculus OX=10090 GN=Cfap206 PE=2 SV=2 CF206_MOUSE reviewed Cilia- and flagella-associated protein 206 Mus musculus (Mouse) GO:0001534; GO:0003341; GO:0003356; GO:0005930; GO:0007288; GO:0031514; GO:0035082; GO:0036064; GO:1901317 axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; radial spoke [GO:0001534] g20173.t1 F1Q8J0 44.796 538 1.26e-118 362.0 sp|F1Q8J0|RNPC3_DANRE RNA-binding region-containing protein 3 OS=Danio rerio OX=7955 GN=rnpc3 PE=2 SV=1 g20175.t1 Q8CGF7 50.145 690 0.0 592.0 sp|Q8CGF7|TCRG1_MOUSE Transcription elongation regulator 1 OS=Mus musculus OX=10090 GN=Tcerg1 PE=1 SV=2 TCRG1_MOUSE reviewed Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144) Mus musculus (Mouse) GO:0000122; GO:0003700; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0006397; GO:0008380; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063; GO:0070064 DNA-templated transcription [GO:0006351]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] g20177.t1 Q8BUR4 53.201 453 1.25e-167 520.0 sp|Q8BUR4|DOCK1_MOUSE Dedicator of cytokinesis protein 1 OS=Mus musculus OX=10090 GN=Dock1 PE=1 SV=3 g20179.t1 Q14185 46.42 1187 0.0 989.0 sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2 g20179.t2 Q14185 51.777 985 0.0 988.0 sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2 g20180.t1 P58022 35.948 765 1.36e-139 436.0 sp|P58022|LOXL2_MOUSE Lysyl oxidase homolog 2 OS=Mus musculus OX=10090 GN=Loxl2 PE=1 SV=2 g20180.t2 P58022 36.137 761 7.35e-139 434.0 sp|P58022|LOXL2_MOUSE Lysyl oxidase homolog 2 OS=Mus musculus OX=10090 GN=Loxl2 PE=1 SV=2 g20180.t2 P58022 30.672 238 1.4400000000000001e-21 104.0 sp|P58022|LOXL2_MOUSE Lysyl oxidase homolog 2 OS=Mus musculus OX=10090 GN=Loxl2 PE=1 SV=2 g20181.t1 Q5ZJJ8 64.61 308 3.23e-140 402.0 sp|Q5ZJJ8|UBCP1_CHICK Ubiquitin-like domain-containing CTD phosphatase 1 OS=Gallus gallus OX=9031 GN=UBLCP1 PE=2 SV=1 UBCP1_CHICK reviewed Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1) Gallus gallus (Chicken) GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0046872; GO:0090364; GO:1904855 regulation of proteasome assembly [GO:0090364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] metal ion binding [GO:0046872]; proteasome regulatory particle binding [GO:1904855]; protein serine/threonine phosphatase activity [GO:0004722] g20182.t1 Q0IJ33 50.556 360 6.72e-139 402.0 sp|Q0IJ33|TM129_XENTR E3 ubiquitin-protein ligase TM129 OS=Xenopus tropicalis OX=8364 GN=tmem129 PE=2 SV=1 TM129_XENTR reviewed E3 ubiquitin-protein ligase TM129 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TM129) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005783; GO:0005789; GO:0006986; GO:0008270; GO:0016567; GO:0061630 protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g20183.t1 Q19691 43.721 215 4.1e-50 185.0 sp|Q19691|TBX2_CAEEL T-box protein 2 OS=Caenorhabditis elegans OX=6239 GN=tbx-2 PE=1 SV=1 TBX2_CAEEL reviewed T-box protein 2 Caenorhabditis elegans GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001217; GO:0001708; GO:0001764; GO:0002119; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0010468; GO:0019899; GO:0032880; GO:0040011; GO:0042048; GO:0042694; GO:0045893; GO:0051402; GO:0160096 cell fate specification [GO:0001708]; locomotion [GO:0040011]; muscle cell fate specification [GO:0042694]; nematode larval development [GO:0002119]; nematode pharyngeal muscle development [GO:0160096]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; olfactory behavior [GO:0042048]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g20186.t1 Q96T55 29.502 261 1.47e-23 101.0 sp|Q96T55|KCNKG_HUMAN Potassium channel subfamily K member 16 OS=Homo sapiens OX=9606 GN=KCNK16 PE=1 SV=1 KCNKG_HUMAN reviewed Potassium channel subfamily K member 16 (2P domain potassium channel Talk-1) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1) Homo sapiens (Human) GO:0005267; GO:0005743; GO:0005789; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0032469; GO:0034702; GO:0042802; GO:0046872; GO:0046982; GO:0051279; GO:0061178; GO:0071805; GO:0086011; GO:0098900 endoplasmic reticulum calcium ion homeostasis [GO:0032469]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential [GO:0098900]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of release of sequestered calcium ion into cytosol [GO:0051279] endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982] g20187.t1 Q8BMS2 43.046 302 1.72e-75 239.0 sp|Q8BMS2|SPON2_MOUSE Spondin-2 OS=Mus musculus OX=10090 GN=Spon2 PE=2 SV=2 SPON2_MOUSE reviewed Spondin-2 (Mindin) Mus musculus (Mouse) GO:0001530; GO:0002448; GO:0003823; GO:0005102; GO:0005615; GO:0007155; GO:0008228; GO:0031012; GO:0032496; GO:0032755; GO:0032760; GO:0036120; GO:0042742; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0071222; GO:1990874 cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]; vascular associated smooth muscle cell proliferation [GO:1990874] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102] g20187.t2 Q8BMS2 42.138 318 4.24e-74 236.0 sp|Q8BMS2|SPON2_MOUSE Spondin-2 OS=Mus musculus OX=10090 GN=Spon2 PE=2 SV=2 SPON2_MOUSE reviewed Spondin-2 (Mindin) Mus musculus (Mouse) GO:0001530; GO:0002448; GO:0003823; GO:0005102; GO:0005615; GO:0007155; GO:0008228; GO:0031012; GO:0032496; GO:0032755; GO:0032760; GO:0036120; GO:0042742; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0071222; GO:1990874 cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]; vascular associated smooth muscle cell proliferation [GO:1990874] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102] g20188.t1 O43679 65.816 392 3.87e-180 509.0 sp|O43679|LDB2_HUMAN LIM domain-binding protein 2 OS=Homo sapiens OX=9606 GN=LDB2 PE=1 SV=1 g20188.t2 O43679 65.736 394 0.0 512.0 sp|O43679|LDB2_HUMAN LIM domain-binding protein 2 OS=Homo sapiens OX=9606 GN=LDB2 PE=1 SV=1 g20191.t1 Q9GPJ1 36.996 719 1.66e-121 397.0 sp|Q9GPJ1|SKEL2_DROME Protein Skeletor, isoforms D/E OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=3 g20192.t1 Q9VGY6 32.587 402 5.95e-53 197.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20192.t1 Q9VGY6 44.041 193 1.48e-35 146.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20193.t1 Q9VGY6 34.005 397 3.7399999999999995e-52 194.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20193.t1 Q9VGY6 43.299 194 7.43e-35 144.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20196.t1 P55036 59.375 384 1.1e-141 411.0 sp|P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1 PSMD4_HUMAN reviewed 26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein) Homo sapiens (Human) GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723] g20197.t1 A6NED2 41.353 133 1.3399999999999999e-25 111.0 sp|A6NED2|RCCD1_HUMAN RCC1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCCD1 PE=1 SV=1 RCCD1_HUMAN reviewed RCC1 domain-containing protein 1 Homo sapiens (Human) GO:0005694; GO:0005829; GO:0005886; GO:0006325 chromatin organization [GO:0006325] chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886] g20197.t1 A6NED2 42.063 126 6.46e-23 103.0 sp|A6NED2|RCCD1_HUMAN RCC1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RCCD1 PE=1 SV=1 RCCD1_HUMAN reviewed RCC1 domain-containing protein 1 Homo sapiens (Human) GO:0005694; GO:0005829; GO:0005886; GO:0006325 chromatin organization [GO:0006325] chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886] g20200.t1 Q9BXT4 26.903 762 3.88e-51 201.0 sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2 TDRD1_HUMAN reviewed Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1) Homo sapiens (Human) GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] zinc ion binding [GO:0008270] g20201.t1 Q58EK5 26.624 631 3.7e-47 185.0 sp|Q58EK5|TDRD1_DANRE Tudor domain-containing protein 1 OS=Danio rerio OX=7955 GN=tdrd1 PE=1 SV=2 TDRD1_DANRE reviewed Tudor domain-containing protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034584; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546] piRNA binding [GO:0034584]; zinc ion binding [GO:0008270] g20201.t1 Q58EK5 26.338 467 4.3499999999999995e-28 125.0 sp|Q58EK5|TDRD1_DANRE Tudor domain-containing protein 1 OS=Danio rerio OX=7955 GN=tdrd1 PE=1 SV=2 TDRD1_DANRE reviewed Tudor domain-containing protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034584; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196 germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196] cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546] piRNA binding [GO:0034584]; zinc ion binding [GO:0008270] g20207.t1 O54991 34.199 231 1.11e-28 129.0 sp|O54991|CNTP1_MOUSE Contactin-associated protein 1 OS=Mus musculus OX=10090 GN=Cntnap1 PE=1 SV=2 CNTP1_MOUSE reviewed Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin) Mus musculus (Mouse) GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227 axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918] SH3 domain binding [GO:0017124] g20214.t1 P30305 39.547 397 1.7499999999999998e-69 238.0 sp|P30305|MPIP2_HUMAN M-phase inducer phosphatase 2 OS=Homo sapiens OX=9606 GN=CDC25B PE=1 SV=2 MPIP2_HUMAN reviewed M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B) Homo sapiens (Human) GO:0000086; GO:0000278; GO:0000922; GO:0001556; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007144; GO:0008284; GO:0010971; GO:0019901; GO:0032467; GO:0045931; GO:0051301; GO:0110032 cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g20214.t2 P30305 39.348 399 2.21e-69 238.0 sp|P30305|MPIP2_HUMAN M-phase inducer phosphatase 2 OS=Homo sapiens OX=9606 GN=CDC25B PE=1 SV=2 MPIP2_HUMAN reviewed M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B) Homo sapiens (Human) GO:0000086; GO:0000278; GO:0000922; GO:0001556; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007144; GO:0008284; GO:0010971; GO:0019901; GO:0032467; GO:0045931; GO:0051301; GO:0110032 cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] g20215.t1 P79943 36.683 199 1.47e-28 117.0 sp|P79943|SLBP1_XENLA Histone RNA hairpin-binding protein OS=Xenopus laevis OX=8355 GN=slbp1 PE=1 SV=1 SLBP1_XENLA reviewed Histone RNA hairpin-binding protein (Histone stem-loop-binding protein 1) Xenopus laevis (African clawed frog) GO:0002191; GO:0003729; GO:0005737; GO:0006398; GO:0051028; GO:0062073; GO:0071204; GO:0071207 cap-dependent translational initiation [GO:0002191]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028] cytoplasm [GO:0005737]; histone mRNA stem-loop binding complex [GO:0062073]; histone pre-mRNA 3'end processing complex [GO:0071204] histone pre-mRNA stem-loop binding [GO:0071207]; mRNA binding [GO:0003729] g20216.t1 Q969W1 46.313 339 6.629999999999999e-106 320.0 sp|Q969W1|ZDH16_HUMAN Palmitoyltransferase ZDHHC16 OS=Homo sapiens OX=9606 GN=ZDHHC16 PE=1 SV=1 g20217.t1 D3ZX63 42.388 335 1.8600000000000001e-85 263.0 sp|D3ZX63|WDR54_RAT WD repeat domain 54 OS=Rattus norvegicus OX=10116 GN=Wdr54 PE=1 SV=1 WDR54_RAT reviewed WD repeat domain 54 Rattus norvegicus (Rat) GO:0002091; GO:0005737; GO:0005886; GO:0007338; GO:0007342; GO:0031514; GO:0031982; GO:0042058; GO:0042803; GO:0043408 fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]; single fertilization [GO:0007338] cytoplasm [GO:0005737]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; vesicle [GO:0031982] protein homodimerization activity [GO:0042803] g20218.t1 O75643 77.343 2145 0.0 3484.0 sp|O75643|U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2 g20219.t1 P18297 39.764 254 4.65e-57 186.0 sp|P18297|SPRE_RAT Sepiapterin reductase OS=Rattus norvegicus OX=10116 GN=Spr PE=1 SV=1 SPRE_RAT reviewed Sepiapterin reductase (SPR) (EC 1.1.1.153) Rattus norvegicus (Rat) GO:0004757; GO:0005654; GO:0005829; GO:0006558; GO:0006729; GO:0006809; GO:0008284; GO:0019889; GO:0040014; GO:0042415; GO:0042417; GO:0042428; GO:0042803; GO:0046146; GO:0048667; GO:0050882 cell morphogenesis involved in neuron differentiation [GO:0048667]; dopamine metabolic process [GO:0042417]; L-phenylalanine metabolic process [GO:0006558]; nitric oxide biosynthetic process [GO:0006809]; norepinephrine metabolic process [GO:0042415]; positive regulation of cell population proliferation [GO:0008284]; pteridine metabolic process [GO:0019889]; regulation of multicellular organism growth [GO:0040014]; serotonin metabolic process [GO:0042428]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrobiopterin metabolic process [GO:0046146]; voluntary musculoskeletal movement [GO:0050882] cytosol [GO:0005829]; nucleoplasm [GO:0005654] protein homodimerization activity [GO:0042803]; sepiapterin reductase (NADP+) activity [GO:0004757] g20220.t1 Q99614 55.856 222 2.96e-82 256.0 sp|Q99614|TTC1_HUMAN Tetratricopeptide repeat protein 1 OS=Homo sapiens OX=9606 GN=TTC1 PE=1 SV=1 TTC1_HUMAN reviewed Tetratricopeptide repeat protein 1 (TPR repeat protein 1) Homo sapiens (Human) GO:0005737; GO:0005778; GO:0005829; GO:0006457; GO:0030674; GO:0050729; GO:0051082; GO:0070098; GO:0150078 chemokine-mediated signaling pathway [GO:0070098]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neuroinflammatory response [GO:0150078]; protein folding [GO:0006457] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778] protein-macromolecule adaptor activity [GO:0030674]; unfolded protein binding [GO:0051082] g20221.t1 Q9WTR6 44.91 501 3.9e-153 449.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g20226.t1 Q28HT3 60.309 194 1.6999999999999997e-67 220.0 sp|Q28HT3|FOXI2_XENTR Forkhead box protein I2 OS=Xenopus tropicalis OX=8364 GN=foxi2 PE=2 SV=1 g20227.t1 Q9YHB5 42.23 296 4.8e-68 237.0 sp|Q9YHB5|CND3_XENLA Condensin complex subunit 3 OS=Xenopus laevis OX=8355 GN=ncapg PE=1 SV=1 g20228.t1 Q9YHB5 47.241 580 1.0300000000000001e-166 504.0 sp|Q9YHB5|CND3_XENLA Condensin complex subunit 3 OS=Xenopus laevis OX=8355 GN=ncapg PE=1 SV=1 g20229.t1 P00504 56.448 411 0.0 517.0 sp|P00504|AATC_CHICK Aspartate aminotransferase, cytoplasmic OS=Gallus gallus OX=9031 GN=GOT1 PE=1 SV=3 g20235.t1 Q68EF4 28.748 807 1.52e-108 357.0 sp|Q68EF4|GRM4_MOUSE Metabotropic glutamate receptor 4 OS=Mus musculus OX=10090 GN=Grm4 PE=1 SV=2 GRM4_MOUSE reviewed Metabotropic glutamate receptor 4 (mGluR4) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0004930; GO:0005516; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007612; GO:0008066; GO:0031410; GO:0043005; GO:0043195; GO:0043198; GO:0043410; GO:0048306; GO:0048787; GO:0051966; GO:0098688; GO:0098978; GO:0099171; GO:0150048 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; positive regulation of MAPK cascade [GO:0043410]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966] cerebellar granule cell to Purkinje cell synapse [GO:0150048]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g20237.t1 Q5RA50 34.586 266 4.01e-40 160.0 sp|Q5RA50|F124A_PONAB Protein FAM124A OS=Pongo abelii OX=9601 GN=FAM124A PE=2 SV=1 g20239.t1 Q05B50 63.534 266 2.5400000000000003e-125 361.0 sp|Q05B50|THG1_BOVIN Probable tRNA(His) guanylyltransferase OS=Bos taurus OX=9913 GN=THG1L PE=2 SV=1 g20240.t1 Q969Q5 71.839 174 1.24e-79 239.0 sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1 RAB24_HUMAN reviewed Ras-related protein Rab-24 (EC 3.6.5.2) Homo sapiens (Human) GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0046872; GO:0048471; GO:0140013 attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g20240.t2 Q969Q5 67.568 185 3.5e-76 231.0 sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1 RAB24_HUMAN reviewed Ras-related protein Rab-24 (EC 3.6.5.2) Homo sapiens (Human) GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0046872; GO:0048471; GO:0140013 attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g20241.t1 Q155U0 56.348 827 0.0 897.0 sp|Q155U0|VPS51_DANRE Vacuolar protein sorting-associated protein 51 homolog OS=Danio rerio OX=7955 GN=vps51 PE=2 SV=1 g20243.t1 Q6AYJ2 61.818 110 3.9e-43 158.0 sp|Q6AYJ2|BOD1_RAT Biorientation of chromosomes in cell division protein 1 OS=Rattus norvegicus OX=10116 GN=Bod1 PE=2 SV=1 g20244.t1 Q9UMX1 60.088 456 0.0 572.0 sp|Q9UMX1|SUFU_HUMAN Suppressor of fused homolog OS=Homo sapiens OX=9606 GN=SUFU PE=1 SV=2 g20246.t1 Q9WTR6 44.979 478 8.8e-149 437.0 sp|Q9WTR6|XCT_MOUSE Cystine/glutamate transporter OS=Mus musculus OX=10090 GN=Slc7a11 PE=1 SV=1 XCT_MOUSE reviewed Cystine/glutamate transporter (Amino acid transport system xc-) (Solute carrier family 7 member 11) (Subtle gray protein) (xCT) Mus musculus (Mouse) GO:0003333; GO:0005765; GO:0005886; GO:0006749; GO:0007420; GO:0008542; GO:0009636; GO:0009986; GO:0015179; GO:0015252; GO:0015327; GO:0015811; GO:0015813; GO:0016020; GO:0021591; GO:0021756; GO:0022840; GO:0030534; GO:0031526; GO:0031528; GO:0033029; GO:0033554; GO:0034599; GO:0034775; GO:0035752; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0110076; GO:0140206; GO:0140924; GO:0140926; GO:1900407; GO:1901494; GO:1902600; GO:1903786; GO:1904717; GO:2000211 adult behavior [GO:0030534]; amino acid transmembrane transport [GO:0003333]; brain development [GO:0007420]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; dipeptide import across plasma membrane [GO:0140206]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; intracellular glutamate homeostasis [GO:0090461]; L-cystine transport [GO:0015811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; L-kynurenine transmembrane transport [GO:0140924]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lysosomal lumen pH elevation [GO:0035752]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ferroptosis [GO:0110076]; platelet aggregation [GO:0070527]; proton transmembrane transport [GO:1902600]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; L-kynurenine transmembrane transporter activity [GO:0140926]; leak channel activity [GO:0022840]; proton channel activity [GO:0015252] g20247.t1 Q7Z5Q5 38.796 714 1.3399999999999999e-137 441.0 sp|Q7Z5Q5|DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens OX=9606 GN=POLN PE=1 SV=2 DPOLN_HUMAN reviewed DNA polymerase nu (EC 2.7.7.7) Homo sapiens (Human) GO:0000724; GO:0000731; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006302; GO:0019985; GO:0030332; GO:0036297 DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887] g20248.t1 Q90673 45.854 205 1.79e-56 181.0 sp|Q90673|PRLD1_CHICK PRELI domain-containing protein 1, mitochondrial OS=Gallus gallus OX=9031 GN=PRELID1 PE=2 SV=1 g20249.t1 P21274 30.805 435 2.5700000000000003e-47 171.0 sp|P21274|BMP2_MOUSE Bone morphogenetic protein 2 OS=Mus musculus OX=10090 GN=Bmp2 PE=1 SV=3 BMP2_MOUSE reviewed Bone morphogenetic protein 2 (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A) Mus musculus (Mouse) GO:0000122; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001837; GO:0002062; GO:0003007; GO:0003129; GO:0003133; GO:0003176; GO:0003181; GO:0003203; GO:0003210; GO:0003272; GO:0003331; GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0005929; GO:0006029; GO:0006355; GO:0006954; GO:0007179; GO:0007219; GO:0007507; GO:0008083; GO:0008284; GO:0008285; GO:0009617; GO:0009887; GO:0009986; GO:0010467; GO:0010628; GO:0010629; GO:0010718; GO:0010894; GO:0014898; GO:0019211; GO:0019904; GO:0021537; GO:0021978; GO:0030177; GO:0030282; GO:0030316; GO:0030335; GO:0030501; GO:0030509; GO:0030512; GO:0031648; GO:0031982; GO:0032348; GO:0032991; GO:0033690; GO:0035051; GO:0035054; GO:0035360; GO:0036305; GO:0039706; GO:0042475; GO:0042482; GO:0042487; GO:0042802; GO:0043065; GO:0043410; GO:0043539; GO:0043569; GO:0045165; GO:0045597; GO:0045599; GO:0045600; GO:0045666; GO:0045669; GO:0045778; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0048018; GO:0048662; GO:0048711; GO:0048762; GO:0048839; GO:0050769; GO:0051042; GO:0055007; GO:0055008; GO:0060039; GO:0060128; GO:0060129; GO:0060317; GO:0060348; GO:0060391; GO:0060426; GO:0060485; GO:0061036; GO:0070374; GO:0070700; GO:0070724; GO:0071363; GO:0071773; GO:0072138; GO:0090090; GO:0150005; GO:1900159; GO:1900745; GO:1901331; GO:1902895; GO:1905072; GO:1905222; GO:2000065; GO:2000726 ameloblast differentiation [GO:0036305]; animal organ morphogenesis [GO:0009887]; aortic valve development [GO:0003176]; atrioventricular canal morphogenesis [GO:1905222]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac atrium formation [GO:0003210]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte differentiation [GO:0002062]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endodermal-mesodermal cell signaling [GO:0003133]; epithelial to mesenchymal transition [GO:0001837]; gene expression [GO:0010467]; heart development [GO:0007507]; heart induction [GO:0003129]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; lung vasculature development [GO:0060426]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchyme development [GO:0060485]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of calcium-independent cell-cell adhesion [GO:0051042]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericardium development [GO:0060039]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of bone mineralization [GO:0030501]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of odontogenesis [GO:0042482]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; proteoglycan metabolic process [GO:0006029]; regulation of DNA-templated transcription [GO:0006355]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transforming growth factor beta receptor signaling pathway [GO:0007179] BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; cilium [GO:0005929]; enzyme activator complex [GO:0150005]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982] BMP receptor binding [GO:0070700]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; phosphatase activator activity [GO:0019211]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018] g20253.t1 Q5G267 32.589 448 1.91e-49 185.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g20253.t1 Q5G267 31.7 347 1.1600000000000001e-29 127.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g20253.t1 Q5G267 29.26 311 4.8500000000000006e-27 119.0 sp|Q5G267|NETR_MACMU Neurotrypsin OS=Macaca mulatta OX=9544 GN=PRSS12 PE=3 SV=1 NETR_MACMU reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Macaca mulatta (Rhesus macaque) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] serine-type endopeptidase activity [GO:0004252] g20254.t1 A9CB34 27.176 1034 1.72e-80 295.0 sp|A9CB34|SFI1_PAPAN Protein SFI1 homolog OS=Papio anubis OX=9555 GN=SFI1 PE=3 SV=2 g20258.t1 Q9QYS2 29.244 807 3.05e-106 351.0 sp|Q9QYS2|GRM3_MOUSE Metabotropic glutamate receptor 3 OS=Mus musculus OX=10090 GN=Grm3 PE=1 SV=1 GRM3_MOUSE reviewed Metabotropic glutamate receptor 3 (mGluR3) Mus musculus (Mouse) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0050804; GO:0051930; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g20259.t1 O94813 49.781 1372 0.0 1355.0 sp|O94813|SLIT2_HUMAN Slit homolog 2 protein OS=Homo sapiens OX=9606 GN=SLIT2 PE=1 SV=1 SLIT2_HUMAN reviewed Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product] Homo sapiens (Human) GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007411; GO:0008045; GO:0008201; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g20259.t1 O94813 31.341 753 1.28e-96 346.0 sp|O94813|SLIT2_HUMAN Slit homolog 2 protein OS=Homo sapiens OX=9606 GN=SLIT2 PE=1 SV=1 SLIT2_HUMAN reviewed Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product] Homo sapiens (Human) GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007411; GO:0008045; GO:0008201; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g20259.t2 O94813 48.98 1372 0.0 1319.0 sp|O94813|SLIT2_HUMAN Slit homolog 2 protein OS=Homo sapiens OX=9606 GN=SLIT2 PE=1 SV=1 SLIT2_HUMAN reviewed Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product] Homo sapiens (Human) GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007411; GO:0008045; GO:0008201; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g20259.t2 O94813 30.279 753 3.78e-90 326.0 sp|O94813|SLIT2_HUMAN Slit homolog 2 protein OS=Homo sapiens OX=9606 GN=SLIT2 PE=1 SV=1 SLIT2_HUMAN reviewed Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product] Homo sapiens (Human) GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007411; GO:0008045; GO:0008201; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288 aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] g20265.t1 Q8BZ39 29.167 336 4.25e-23 102.0 sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1 NMUR2_MOUSE reviewed Neuromedin-U receptor 2 (NMU-R2) Mus musculus (Mouse) GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930 arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g20268.t1 B2RW38 69.053 866 0.0 1168.0 sp|B2RW38|CFA58_MOUSE Cilia- and flagella-associated protein 58 OS=Mus musculus OX=10090 GN=Cfap58 PE=1 SV=1 CFA58_MOUSE reviewed Cilia- and flagella-associated protein 58 Mus musculus (Mouse) GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317 cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317] centrosome [GO:0005813]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g20269.t1 Q3SZC1 58.721 172 8.13e-63 198.0 sp|Q3SZC1|GRPE1_BOVIN GrpE protein homolog 1, mitochondrial OS=Bos taurus OX=9913 GN=GRPEL1 PE=1 SV=1 g20270.t1 Q6PCR7 52.577 582 0.0 605.0 sp|Q6PCR7|EIF3A_DANRE Eukaryotic translation initiation factor 3 subunit A OS=Danio rerio OX=7955 GN=eif3a PE=2 SV=1 EIF3A_DANRE reviewed Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0043226; GO:0043614; GO:0071540; GO:0071541 formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; organelle [GO:0043226] mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743] g20271.t1 A2VD00 82.682 179 9.37e-102 324.0 sp|A2VD00|EIF3A_XENLA Eukaryotic translation initiation factor 3 subunit A OS=Xenopus laevis OX=8355 GN=eif3a PE=2 SV=1 EIF3A_XENLA reviewed Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) Xenopus laevis (African clawed frog) GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0005852; GO:0016282; GO:0033290; GO:0043226; GO:0043614; GO:0071540; GO:0071541 formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; organelle [GO:0043226] mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743] g20272.t1 A8E7G4 43.607 305 1.99e-84 259.0 sp|A8E7G4|DEN10_DANRE DENN domain-containing protein 10 OS=Danio rerio OX=7955 GN=dennd10 PE=2 SV=1 DEN10_DANRE reviewed DENN domain-containing protein 10 (Protein FAM45) (Protein FAM45A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005085; GO:0005770; GO:0015031; GO:0031267; GO:0032509; GO:2000641 endosome transport via multivesicular body sorting pathway [GO:0032509]; protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641] late endosome [GO:0005770] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g20273.t1 Q03181 36.605 377 1.93e-64 214.0 sp|Q03181|PPARD_HUMAN Peroxisome proliferator-activated receptor delta OS=Homo sapiens OX=9606 GN=PPARD PE=1 SV=1 PPARD_HUMAN reviewed Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006006; GO:0006029; GO:0006091; GO:0006357; GO:0006629; GO:0006631; GO:0006635; GO:0006915; GO:0007507; GO:0007566; GO:0008203; GO:0008270; GO:0008283; GO:0008289; GO:0008366; GO:0008654; GO:0009062; GO:0009749; GO:0009755; GO:0010628; GO:0010887; GO:0014823; GO:0014842; GO:0014912; GO:0015908; GO:0030154; GO:0030308; GO:0030522; GO:0031589; GO:0031669; GO:0032966; GO:0033189; GO:0035774; GO:0042060; GO:0042311; GO:0043066; GO:0043415; GO:0043491; GO:0043616; GO:0045600; GO:0045662; GO:0045684; GO:0045892; GO:0045893; GO:0045923; GO:0045944; GO:0046321; GO:0046697; GO:0048662; GO:0050680; GO:0050728; GO:0051059; GO:0051546; GO:0051897; GO:0060612; GO:0070341; GO:0070346; GO:0070539; GO:0071222; GO:0071456; GO:0090575; GO:0097009; GO:0097190; GO:1902894; GO:1904659; GO:1990837; GO:2000288 adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient levels [GO:0031669]; cholesterol metabolic process [GO:0008203]; D-glucose transmembrane transport [GO:1904659]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; energy homeostasis [GO:0097009]; fat cell proliferation [GO:0070341]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phospholipid biosynthetic process [GO:0008654]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fat cell proliferation [GO:0070346]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan metabolic process [GO:0006029]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; wound healing [GO:0042060] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g20273.t2 Q03181 36.605 377 3.13e-64 214.0 sp|Q03181|PPARD_HUMAN Peroxisome proliferator-activated receptor delta OS=Homo sapiens OX=9606 GN=PPARD PE=1 SV=1 PPARD_HUMAN reviewed Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006006; GO:0006029; GO:0006091; GO:0006357; GO:0006629; GO:0006631; GO:0006635; GO:0006915; GO:0007507; GO:0007566; GO:0008203; GO:0008270; GO:0008283; GO:0008289; GO:0008366; GO:0008654; GO:0009062; GO:0009749; GO:0009755; GO:0010628; GO:0010887; GO:0014823; GO:0014842; GO:0014912; GO:0015908; GO:0030154; GO:0030308; GO:0030522; GO:0031589; GO:0031669; GO:0032966; GO:0033189; GO:0035774; GO:0042060; GO:0042311; GO:0043066; GO:0043415; GO:0043491; GO:0043616; GO:0045600; GO:0045662; GO:0045684; GO:0045892; GO:0045893; GO:0045923; GO:0045944; GO:0046321; GO:0046697; GO:0048662; GO:0050680; GO:0050728; GO:0051059; GO:0051546; GO:0051897; GO:0060612; GO:0070341; GO:0070346; GO:0070539; GO:0071222; GO:0071456; GO:0090575; GO:0097009; GO:0097190; GO:1902894; GO:1904659; GO:1990837; GO:2000288 adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient levels [GO:0031669]; cholesterol metabolic process [GO:0008203]; D-glucose transmembrane transport [GO:1904659]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; energy homeostasis [GO:0097009]; fat cell proliferation [GO:0070341]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; intracellular receptor signaling pathway [GO:0030522]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phospholipid biosynthetic process [GO:0008654]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fat cell proliferation [GO:0070346]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan metabolic process [GO:0006029]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; wound healing [GO:0042060] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g20274.t1 Q9VPH7 72.84 81 1.72e-33 121.0 sp|Q9VPH7|ERF1_DROME Eukaryotic peptide chain release factor subunit 1 OS=Drosophila melanogaster OX=7227 GN=eRF1 PE=1 SV=2 g20275.t1 Q9GR88 90.746 335 0.0 640.0 sp|Q9GR88|ERF1_POLMI Eukaryotic peptide chain release factor subunit 1 OS=Polyandrocarpa misakiensis OX=7723 GN=ERF1 PE=2 SV=1 g20278.t1 Q6PBN5 48.673 113 4.2199999999999997e-23 95.1 sp|Q6PBN5|AUP1_DANRE Lipid droplet-regulating VLDL assembly factor AUP1 OS=Danio rerio OX=7955 GN=aup1 PE=2 SV=2 g20279.t1 Q6PBN5 41.379 290 1.6799999999999997e-67 220.0 sp|Q6PBN5|AUP1_DANRE Lipid droplet-regulating VLDL assembly factor AUP1 OS=Danio rerio OX=7955 GN=aup1 PE=2 SV=2 g20280.t1 P43141 28.662 314 5.02e-25 107.0 sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 g20284.t1 Q91VN6 75.047 537 0.0 840.0 sp|Q91VN6|DDX41_MOUSE Probable ATP-dependent RNA helicase DDX41 OS=Mus musculus OX=10090 GN=Ddx41 PE=1 SV=2 DDX41_MOUSE reviewed Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) Mus musculus (Mouse) GO:0000398; GO:0003677; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005681; GO:0005783; GO:0005829; GO:0008270; GO:0008283; GO:0016887; GO:0030154; GO:0032481; GO:0035458; GO:0045944; GO:0051607; GO:0071013; GO:0140896 cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270] g20285.t1 O70469 34.94 249 3.84e-31 129.0 sp|O70469|DOK2_MOUSE Docking protein 2 OS=Mus musculus OX=10090 GN=Dok2 PE=1 SV=1 DOK2_MOUSE reviewed Docking protein 2 (Dok-related protein) (Dok-R) (Downstream of tyrosine kinase 2) (IL-four receptor-interacting protein) (FRIP) (p56(dok-2)) Mus musculus (Mouse) GO:0005068; GO:0005737; GO:0005886; GO:0007169; GO:0007265; GO:0043409 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; negative regulation of MAPK cascade [GO:0043409]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] g20293.t1 A2TLM1 66.079 227 3.5100000000000003e-109 320.0 sp|A2TLM1|RPIA_PIG Ribose-5-phosphate isomerase OS=Sus scrofa OX=9823 GN=RPIA PE=2 SV=1 g20294.t1 Q63ZH8 44.361 133 7.29e-33 115.0 sp|Q63ZH8|F136A_XENLA Protein FAM136A OS=Xenopus laevis OX=8355 GN=fam136a PE=2 SV=1 g20295.t1 Q62824 45.77 981 0.0 827.0 sp|Q62824|EXOC4_RAT Exocyst complex component 4 OS=Rattus norvegicus OX=10116 GN=Exoc4 PE=1 SV=1 EXOC4_RAT reviewed Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8) Rattus norvegicus (Rat) GO:0000145; GO:0005737; GO:0005768; GO:0005813; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030425; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0044091; GO:0044877; GO:0045202; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0071806; GO:0090522; GO:0090543; GO:0098685; GO:0098696; GO:0099092 chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; protein transmembrane transport [GO:0071806]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522] cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; endosome [GO:0005768]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877] g20295.t2 Q62824 46.146 973 0.0 832.0 sp|Q62824|EXOC4_RAT Exocyst complex component 4 OS=Rattus norvegicus OX=10116 GN=Exoc4 PE=1 SV=1 EXOC4_RAT reviewed Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8) Rattus norvegicus (Rat) GO:0000145; GO:0005737; GO:0005768; GO:0005813; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030425; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0044091; GO:0044877; GO:0045202; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0071806; GO:0090522; GO:0090543; GO:0098685; GO:0098696; GO:0099092 chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; protein transmembrane transport [GO:0071806]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522] cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; endosome [GO:0005768]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877] g20296.t1 A0JPG1 49.69 807 0.0 719.0 sp|A0JPG1|FHI2A_XENLA FHF complex subunit HOOK interacting protein 2A OS=Xenopus laevis OX=8355 GN=fhip2a PE=2 SV=1 g20296.t2 A0JPG1 49.875 798 0.0 726.0 sp|A0JPG1|FHI2A_XENLA FHF complex subunit HOOK interacting protein 2A OS=Xenopus laevis OX=8355 GN=fhip2a PE=2 SV=1 g20296.t3 A0JPG1 49.199 811 0.0 721.0 sp|A0JPG1|FHI2A_XENLA FHF complex subunit HOOK interacting protein 2A OS=Xenopus laevis OX=8355 GN=fhip2a PE=2 SV=1 g20297.t1 Q5PPZ5 38.61 259 6.94e-61 195.0 sp|Q5PPZ5|BIN3_XENLA Bridging integrator 3 homolog OS=Xenopus laevis OX=8355 GN=bin3 PE=2 SV=1 g20298.t1 Q6PDY2 38.168 262 2.4100000000000002e-49 166.0 sp|Q6PDY2|AEDO_MOUSE 2-aminoethanethiol dioxygenase OS=Mus musculus OX=10090 GN=Ado PE=1 SV=2 AEDO_MOUSE reviewed 2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase) Mus musculus (Mouse) GO:0005506; GO:0005739; GO:0047800; GO:0071456 cellular response to hypoxia [GO:0071456] mitochondrion [GO:0005739] cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506] g20299.t1 Q6NTY6 77.099 131 3.55e-64 218.0 sp|Q6NTY6|EGR1B_XENLA Early growth response protein 1-B OS=Xenopus laevis OX=8355 GN=egr1-b PE=2 SV=1 EGR1B_XENLA reviewed Early growth response protein 1-B (EGR-1-B) Xenopus laevis (African clawed frog) GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0008270; GO:0010385; GO:0032922; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:1990841 circadian regulation of gene expression [GO:0032922]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g20301.t1 Q6AZW2 55.063 316 1.8000000000000001e-121 354.0 sp|Q6AZW2|A1A1A_DANRE Aldo-keto reductase family 1 member A1-A OS=Danio rerio OX=7955 GN=akr1a1a PE=2 SV=2 A1A1A_DANRE reviewed Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0004032; GO:0005829; GO:0016324; GO:0042593; GO:0046185; GO:0110095; GO:0160163 aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; glucose homeostasis [GO:0042593]; sprouting angiogenesis [GO:0002040] apical plasma membrane [GO:0016324]; cytosol [GO:0005829] aldose reductase (NADPH) activity [GO:0004032]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163] g20302.t1 Q5REY3 70.335 209 5.19e-108 315.0 sp|Q5REY3|PRDX3_PONAB Thioredoxin-dependent peroxide reductase, mitochondrial OS=Pongo abelii OX=9601 GN=PRDX3 PE=2 SV=1 PRDX3_PONAB reviewed Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Peroxiredoxin-3) (Thioredoxin-dependent peroxiredoxin 3) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005739; GO:0005769; GO:0005829; GO:0006979; GO:0008379; GO:0033554; GO:0042744; GO:0045454 cell redox homeostasis [GO:0045454]; cellular response to stress [GO:0033554]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739] thioredoxin peroxidase activity [GO:0008379] g20303.t1 Q3ZCH0 85.374 629 0.0 1123.0 sp|Q3ZCH0|HSPA9_BOVIN Stress-70 protein, mitochondrial OS=Bos taurus OX=9913 GN=HSPA9 PE=2 SV=1 HSPA9_BOVIN reviewed Stress-70 protein, mitochondrial (EC 3.6.4.10) (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) Bos taurus (Bovine) GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0036444; GO:0042026; GO:0042645; GO:0043065; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0140662; GO:1902037; GO:1903707 calcium import into the mitochondrion [GO:0036444]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of apoptotic process [GO:0043065]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] g20304.t1 Q3T0G5 53.455 275 9.030000000000001e-103 304.0 sp|Q3T0G5|PLPHP_BOVIN Pyridoxal phosphate homeostasis protein OS=Bos taurus OX=9913 GN=PLPBP PE=2 SV=1 g20305.t1 Q7M753 64.516 372 1.0600000000000001e-167 480.0 sp|Q7M753|PANK2_MOUSE Pantothenate kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Pank2 PE=1 SV=1 PANK2_MOUSE reviewed Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2) Mus musculus (Mouse) GO:0001525; GO:0004594; GO:0005524; GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0007005; GO:0007286; GO:0009060; GO:0015937; GO:0019217; GO:0051881; GO:0090207; GO:1904251 aerobic respiration [GO:0009060]; angiogenesis [GO:0001525]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion organization [GO:0007005]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594] g20309.t1 Q63028 40.548 730 3.17e-160 484.0 sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2 ADDA_RAT reviewed Alpha-adducin (Erythrocyte adducin subunit alpha) Rattus norvegicus (Rat) GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008093; GO:0008290; GO:0014069; GO:0016020; GO:0016604; GO:0020027; GO:0030036; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393 actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; cytoskeletal anchor activity [GO:0008093]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608] g20310.t1 Q9BYZ6 41.463 738 3.9e-165 496.0 sp|Q9BYZ6|RHBT2_HUMAN Rho-related BTB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RHOBTB2 PE=1 SV=2 RHBT2_HUMAN reviewed Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83) Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0006511; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0016567; GO:0019901; GO:0030865; GO:0031410; GO:0031463; GO:0032956; GO:0042995; GO:1990756 actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; protein ubiquitination [GO:0016567]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511] cell projection [GO:0042995]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g20310.t2 Q9BYZ6 40.77 753 3.56e-161 486.0 sp|Q9BYZ6|RHBT2_HUMAN Rho-related BTB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RHOBTB2 PE=1 SV=2 RHBT2_HUMAN reviewed Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83) Homo sapiens (Human) GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0006511; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0016567; GO:0019901; GO:0030865; GO:0031410; GO:0031463; GO:0032956; GO:0042995; GO:1990756 actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; protein ubiquitination [GO:0016567]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511] cell projection [GO:0042995]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g20311.t1 Q8K4S1 30.956 659 1.74e-78 280.0 sp|Q8K4S1|PLCE1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Mus musculus OX=10090 GN=Plce1 PE=1 SV=3 PLCE1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1) Mus musculus (Mouse) GO:0000139; GO:0004435; GO:0004629; GO:0005085; GO:0005829; GO:0005886; GO:0006651; GO:0007173; GO:0007186; GO:0007200; GO:0007265; GO:0010592; GO:0016042; GO:0019899; GO:0030027; GO:0031267; GO:0032835; GO:0035556; GO:0046488; GO:0046872; GO:0048015; GO:0051209 diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerulus development [GO:0032835]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of lamellipodium assembly [GO:0010592]; Ras protein signal transduction [GO:0007265]; release of sequestered calcium ion into cytosol [GO:0051209] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267] g20311.t2 Q99P84 32.748 626 5.65e-86 300.0 sp|Q99P84|PLCE1_RAT 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Rattus norvegicus OX=10116 GN=Plce1 PE=1 SV=1 g20312.t1 Q8K4S1 37.476 1054 0.0 602.0 sp|Q8K4S1|PLCE1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Mus musculus OX=10090 GN=Plce1 PE=1 SV=3 PLCE1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1) Mus musculus (Mouse) GO:0000139; GO:0004435; GO:0004629; GO:0005085; GO:0005829; GO:0005886; GO:0006651; GO:0007173; GO:0007186; GO:0007200; GO:0007265; GO:0010592; GO:0016042; GO:0019899; GO:0030027; GO:0031267; GO:0032835; GO:0035556; GO:0046488; GO:0046872; GO:0048015; GO:0051209 diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerulus development [GO:0032835]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of lamellipodium assembly [GO:0010592]; Ras protein signal transduction [GO:0007265]; release of sequestered calcium ion into cytosol [GO:0051209] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267] g20312.t2 Q8K4S1 37.323 1061 0.0 595.0 sp|Q8K4S1|PLCE1_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 OS=Mus musculus OX=10090 GN=Plce1 PE=1 SV=3 PLCE1_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1) Mus musculus (Mouse) GO:0000139; GO:0004435; GO:0004629; GO:0005085; GO:0005829; GO:0005886; GO:0006651; GO:0007173; GO:0007186; GO:0007200; GO:0007265; GO:0010592; GO:0016042; GO:0019899; GO:0030027; GO:0031267; GO:0032835; GO:0035556; GO:0046488; GO:0046872; GO:0048015; GO:0051209 diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerulus development [GO:0032835]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of lamellipodium assembly [GO:0010592]; Ras protein signal transduction [GO:0007265]; release of sequestered calcium ion into cytosol [GO:0051209] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267] g20314.t1 Q0IHY4 51.782 477 5.32e-164 497.0 sp|Q0IHY4|TBC12_XENTR TBC1 domain family member 12 OS=Xenopus tropicalis OX=8364 GN=tbc1d12 PE=2 SV=1 TBC12_XENTR reviewed TBC1 domain family member 12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005096; GO:0005773; GO:0016192; GO:0031267; GO:0031410 vesicle-mediated transport [GO:0016192] cytoplasmic vesicle [GO:0031410]; vacuole [GO:0005773] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g20315.t1 Q0D4Z6 27.667 553 1.3e-43 169.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g20316.t1 Q0D4Z6 28.521 568 7.760000000000001e-47 177.0 sp|Q0D4Z6|GH38_ORYSJ Indole-3-acetic acid-amido synthetase GH3.8 OS=Oryza sativa subsp. japonica OX=39947 GN=GH3.8 PE=1 SV=1 GH38_ORYSJ reviewed Indole-3-acetic acid-amido synthetase GH3.8 (EC 6.3.2.-) (Auxin-responsive GH3-like protein 8) (OsGH3-8) (OsMGH3) Oryza sativa subsp. japonica (Rice) GO:0005737; GO:0006952; GO:0009555; GO:0009851; GO:0010279; GO:0016208; GO:0016881; GO:0140964; GO:1900424 auxin biosynthetic process [GO:0009851]; defense response [GO:0006952]; intracellular auxin homeostasis [GO:0140964]; pollen development [GO:0009555]; regulation of defense response to bacterium [GO:1900424] cytoplasm [GO:0005737] acid-amino acid ligase activity [GO:0016881]; AMP binding [GO:0016208]; indole-3-acetic acid amido synthetase activity [GO:0010279] g20317.t1 Q6DIS8 28.906 384 3.23e-21 103.0 sp|Q6DIS8|LZTS2_XENTR Leucine zipper putative tumor suppressor 2 homolog OS=Xenopus tropicalis OX=8364 GN=lzts2 PE=2 SV=1 LZTS2_XENTR reviewed Leucine zipper putative tumor suppressor 2 homolog (Protein lapser1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000281; GO:0005737; GO:0005813; GO:0005874; GO:0016055; GO:0030496; GO:0051013; GO:0051168; GO:0051255; GO:0090090 microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496] g20318.t1 Q5RBI7 46.825 126 3.28e-26 109.0 sp|Q5RBI7|PDZD7_PONAB PDZ domain-containing protein 7 OS=Pongo abelii OX=9601 GN=PDZD7 PE=2 SV=2 g20319.t1 Q5RBI7 47.945 219 1.04e-54 209.0 sp|Q5RBI7|PDZD7_PONAB PDZ domain-containing protein 7 OS=Pongo abelii OX=9601 GN=PDZD7 PE=2 SV=2 g20321.t1 Q5R939 50.0 108 1.6099999999999998e-24 96.7 sp|Q5R939|F204A_PONAB Protein FAM204A OS=Pongo abelii OX=9601 GN=FAM204A PE=2 SV=1 g20321.t2 Q5R939 50.0 108 1.6099999999999998e-24 96.7 sp|Q5R939|F204A_PONAB Protein FAM204A OS=Pongo abelii OX=9601 GN=FAM204A PE=2 SV=1 g20324.t1 Q9EPZ8 45.522 134 5.56e-31 123.0 sp|Q9EPZ8|RN103_RAT E3 ubiquitin-protein ligase RNF103 OS=Rattus norvegicus OX=10116 GN=Rnf103 PE=2 SV=1 g20326.t1 I6LDA6 59.949 392 5.89e-168 483.0 sp|I6LDA6|GPMI_ONCVO 2,3-bisphosphoglycerate-independent phosphoglycerate mutase OS=Onchocerca volvulus OX=6282 GN=ipgm-1 PE=1 SV=1 g20327.t1 Q4VBD2 56.046 521 0.0 587.0 sp|Q4VBD2|TAPT1_MOUSE Transmembrane anterior posterior transformation protein 1 OS=Mus musculus OX=10090 GN=Tapt1 PE=1 SV=2 TAPT1_MOUSE reviewed Transmembrane anterior posterior transformation protein 1 Mus musculus (Mouse) GO:0001503; GO:0005654; GO:0005789; GO:0005813; GO:0005829; GO:0014032; GO:0030030; GO:0036064; GO:0045724; GO:0048706; GO:0051216; GO:0061036; GO:1903012 cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654] g20328.t1 Q24K02 63.783 497 0.0 671.0 sp|Q24K02|IDE_BOVIN Insulin-degrading enzyme OS=Bos taurus OX=9913 GN=IDE PE=2 SV=1 IDE_BOVIN reviewed Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin) Bos taurus (Bovine) GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005739; GO:0005782; GO:0005829; GO:0005886; GO:0008270; GO:0010815; GO:0019885; GO:0030163; GO:0042447; GO:0042803; GO:0043171; GO:0050435; GO:0051603; GO:0097242; GO:1901143 amyloid-beta clearance [GO:0097242]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; proteolysis involved in protein catabolic process [GO:0051603] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g20329.t1 P14735 62.385 109 6.61e-42 150.0 sp|P14735|IDE_HUMAN Insulin-degrading enzyme OS=Homo sapiens OX=9606 GN=IDE PE=1 SV=4 IDE_HUMAN reviewed Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin) Homo sapiens (Human) GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044877; GO:0045732; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0150094; GO:1901142; GO:1901143; GO:1903715 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g20330.t1 P35559 57.586 290 3.57e-111 346.0 sp|P35559|IDE_RAT Insulin-degrading enzyme OS=Rattus norvegicus OX=10116 GN=Ide PE=1 SV=1 g20331.t1 Q5ZJ41 72.659 267 4.12e-153 432.0 sp|Q5ZJ41|MARH5_CHICK E3 ubiquitin-protein ligase MARCHF5 OS=Gallus gallus OX=9031 GN=MARCHF5 PE=2 SV=1 MARH5_CHICK reviewed E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCHF5) Gallus gallus (Chicken) GO:0000209; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0051865; GO:0061630; GO:0090140 protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g20332.t1 Q28CH2 54.792 626 0.0 599.0 sp|Q28CH2|CPEB3_XENTR Cytoplasmic polyadenylation element-binding protein 3 OS=Xenopus tropicalis OX=8364 GN=cpeb3 PE=2 SV=1 CPEB3_XENTR reviewed Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (CPEB-3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000122; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0007616; GO:0008135; GO:0014069; GO:0017148; GO:0030014; GO:0030154; GO:0030425; GO:0035613; GO:0035925; GO:0043005; GO:0045202; GO:0045727; GO:0048167; GO:0048793; GO:0060213; GO:0060998; GO:0060999; GO:0061158; GO:0071230; GO:0097440; GO:1900153; GO:1900248 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; pronephros development [GO:0048793]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167] apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; synapse [GO:0045202] mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135] g20334.t1 Q32LB9 38.586 495 2.83e-95 310.0 sp|Q32LB9|NOA1_BOVIN Nitric oxide-associated protein 1 OS=Bos taurus OX=9913 GN=NOA1 PE=2 SV=1 g20336.t1 Q0VD50 54.244 271 7.499999999999999e-94 281.0 sp|Q0VD50|NMNA1_BOVIN Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Bos taurus OX=9913 GN=NMNAT1 PE=2 SV=1 NMNA1_BOVIN reviewed Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1) Bos taurus (Bovine) GO:0000309; GO:0000785; GO:0004515; GO:0005524; GO:0005634; GO:0006769; GO:0009435; GO:0009611; GO:0016604; GO:0034355; GO:0042802; GO:0045892; GO:0045893; GO:0140768; GO:1904178; GO:1904179; GO:1990966 ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD+ biosynthetic process [GO:0009435]; NAD+ biosynthetic process via the salvage pathway [GO:0034355]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of DNA-templated transcription [GO:0045892]; nicotinamide metabolic process [GO:0006769]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of DNA-templated transcription [GO:0045893]; response to wounding [GO:0009611] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768] g20337.t1 Q3SYV5 40.154 259 2.14e-66 211.0 sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1 g20342.t1 Q5DTN8 30.015 673 5.03e-56 216.0 sp|Q5DTN8|JKIP3_MOUSE Janus kinase and microtubule-interacting protein 3 OS=Mus musculus OX=10090 GN=Jakmip3 PE=1 SV=2 g20342.t2 Q5DTN8 30.015 673 3.99e-56 216.0 sp|Q5DTN8|JKIP3_MOUSE Janus kinase and microtubule-interacting protein 3 OS=Mus musculus OX=10090 GN=Jakmip3 PE=1 SV=2 g20342.t3 Q5DTN8 30.015 673 4.27e-56 216.0 sp|Q5DTN8|JKIP3_MOUSE Janus kinase and microtubule-interacting protein 3 OS=Mus musculus OX=10090 GN=Jakmip3 PE=1 SV=2 g20343.t1 Q7ZYZ7 76.471 102 3.62e-53 170.0 sp|Q7ZYZ7|PCGF1_DANRE Polycomb group RING finger protein 1 OS=Danio rerio OX=7955 GN=pcgf1 PE=3 SV=1 PCGF1_DANRE reviewed Polycomb group RING finger protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000122; GO:0006338; GO:0008270; GO:0021915; GO:0031519; GO:0035102; GO:0048589; GO:1990841 chromatin remodeling [GO:0006338]; developmental growth [GO:0048589]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915] PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g20344.t1 Q08DG6 56.174 413 4.79e-152 441.0 sp|Q08DG6|COX15_BOVIN Heme A synthase COX15 OS=Bos taurus OX=9913 GN=COX15 PE=2 SV=1 g20345.t1 Q66JG3 53.265 490 0.0 524.0 sp|Q66JG3|SYEM_XENTR Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial OS=Xenopus tropicalis OX=8364 GN=ears2 PE=2 SV=1 SYEM_XENTR reviewed Nondiscriminating glutamyl-tRNA synthetase EARS2, mitochondrial (EC 6.1.1.24) (Glutamate--tRNA(Gln) ligase EARS2, mitochondrial) (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS) (Mitochondrial glutamyl-tRNA synthetase) (mtGluRS) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000049; GO:0004818; GO:0005524; GO:0005739; GO:0005759; GO:0006424; GO:0008270; GO:0050561 glutamyl-tRNA aminoacylation [GO:0006424] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamate-tRNA(Gln) ligase activity [GO:0050561]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g20346.t1 P05208 33.745 243 1.8199999999999997e-23 104.0 sp|P05208|CEL2A_MOUSE Chymotrypsin-like elastase family member 2A OS=Mus musculus OX=10090 GN=Cela2a PE=1 SV=1 g20347.t1 P04813 39.444 180 6.48e-30 119.0 sp|P04813|CTR2_CANLF Chymotrypsinogen 2 OS=Canis lupus familiaris OX=9615 GN=CTRB1 PE=2 SV=1 g20350.t1 Q5MJS3 40.227 353 3.8e-83 270.0 sp|Q5MJS3|FA20C_MOUSE Extracellular serine/threonine protein kinase FAM20C OS=Mus musculus OX=10090 GN=Fam20c PE=1 SV=1 FA20C_MOUSE reviewed Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK) Mus musculus (Mouse) GO:0000139; GO:0001501; GO:0002020; GO:0004672; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0006468; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0051174; GO:0070166; GO:0071895; GO:0097187; GO:0106310 biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20351.t1 O75063 38.725 204 1.29e-43 154.0 sp|O75063|XYLK_HUMAN Glycosaminoglycan xylosylkinase OS=Homo sapiens OX=9606 GN=FAM20B PE=1 SV=1 XYLK_HUMAN reviewed Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) Homo sapiens (Human) GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016301; GO:0016773; GO:0030166; GO:0046872; GO:1902729 negative regulation of proteoglycan biosynthetic process [GO:1902729]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773] g20353.t1 O00338 42.029 138 3.8499999999999996e-30 113.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g20354.t1 Q5MJS3 39.403 335 2.23e-71 245.0 sp|Q5MJS3|FA20C_MOUSE Extracellular serine/threonine protein kinase FAM20C OS=Mus musculus OX=10090 GN=Fam20c PE=1 SV=1 FA20C_MOUSE reviewed Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi-enriched fraction casein kinase) (GEF-CK) Mus musculus (Mouse) GO:0000139; GO:0001501; GO:0002020; GO:0004672; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0006468; GO:0030145; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0045669; GO:0051174; GO:0070166; GO:0071895; GO:0097187; GO:0106310 biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20355.t1 Q9WUW8 37.5 288 1.21e-51 175.0 sp|Q9WUW8|ST1C2_RAT Sulfotransferase 1C2 OS=Rattus norvegicus OX=10116 GN=Sult1c2 PE=1 SV=2 ST1C2_RAT reviewed Sulfotransferase 1C2 (ST1C2) (rSULT1C2) (EC 2.8.2.1) (Sulfotransferase K1) Rattus norvegicus (Rat) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0051922; GO:0051923 sulfation [GO:0051923] cytoplasm [GO:0005737]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922] g20357.t1 O35400 36.564 227 1.3000000000000001e-32 124.0 sp|O35400|ST2B1_MOUSE Sulfotransferase 2B1 OS=Mus musculus OX=10090 GN=Sult2b1 PE=1 SV=2 ST2B1_MOUSE reviewed Sulfotransferase 2B1 (EC 2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family cytosolic 2B member 1) (ST2B1) Mus musculus (Mouse) GO:0000103; GO:0003676; GO:0005634; GO:0005737; GO:0005829; GO:0008146; GO:0008202; GO:0008203; GO:0008285; GO:0015485; GO:0036094; GO:0045606; GO:0050294; GO:0050427; GO:0051922; GO:0051923; GO:1990239 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfate assimilation [GO:0000103]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cholesterol binding [GO:0015485]; cholesterol sulfotransferase activity [GO:0051922]; nucleic acid binding [GO:0003676]; small molecule binding [GO:0036094]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146] g20358.t1 O75897 34.386 285 1.6799999999999999e-46 162.0 sp|O75897|ST1C4_HUMAN Sulfotransferase 1C4 OS=Homo sapiens OX=9606 GN=SULT1C4 PE=1 SV=2 ST1C4_HUMAN reviewed Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g20359.t1 O00338 34.722 288 4.87e-50 171.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g20360.t1 Q6NS19 55.29 293 5.200000000000001e-109 320.0 sp|Q6NS19|ERGI1_XENLA Endoplasmic reticulum-Golgi intermediate compartment protein 1 OS=Xenopus laevis OX=8355 GN=ergic1 PE=2 SV=1 g20362.t1 Q9NYR8 36.913 298 1.19e-51 174.0 sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1 RDH8_HUMAN reviewed Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2) Homo sapiens (Human) GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0042572; GO:0052650 estrogen biosynthetic process [GO:0006703]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601] cytosol [GO:0005829]; plasma membrane [GO:0005886] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303] g20366.t1 Q9V477 37.87 338 6.14e-51 197.0 sp|Q9V477|TOLL8_DROME Toll-like receptor Tollo OS=Drosophila melanogaster OX=7227 GN=Tollo PE=1 SV=1 TOLL8_DROME reviewed Toll-like receptor Tollo (Toll-like receptor 8) Drosophila melanogaster (Fruit fly) GO:0003401; GO:0005886; GO:0007165; GO:0010559; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026 axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of glycoprotein biosynthetic process [GO:0010559]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] receptor ligand activity [GO:0048018] g20366.t1 Q9V477 23.941 614 6.28e-21 102.0 sp|Q9V477|TOLL8_DROME Toll-like receptor Tollo OS=Drosophila melanogaster OX=7227 GN=Tollo PE=1 SV=1 TOLL8_DROME reviewed Toll-like receptor Tollo (Toll-like receptor 8) Drosophila melanogaster (Fruit fly) GO:0003401; GO:0005886; GO:0007165; GO:0010559; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026 axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of glycoprotein biosynthetic process [GO:0010559]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] receptor ligand activity [GO:0048018] g20367.t1 Q2KIP2 48.459 357 7.23e-109 352.0 sp|Q2KIP2|HASP_BOVIN Serine/threonine-protein kinase haspin OS=Bos taurus OX=9913 GN=HASPIN PE=2 SV=1 HASP_BOVIN reviewed Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) Bos taurus (Bovine) GO:0000278; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0007064; GO:0007094; GO:0035556; GO:0071459; GO:0072354; GO:0106310 intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459] centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; histone H3T3 kinase activity [GO:0072354]; protein serine kinase activity [GO:0106310] g20368.t1 Q91085 31.677 322 1.36e-32 132.0 sp|Q91085|VIPR_MELGA Vasoactive intestinal polypeptide receptor OS=Meleagris gallopavo OX=9103 GN=VIPR1 PE=2 SV=2 VIPR_MELGA reviewed Vasoactive intestinal polypeptide receptor (VIP receptor) (VIP-R) Meleagris gallopavo (Wild turkey) GO:0004999; GO:0005886; GO:0007166; GO:0007188; GO:0008528; GO:0017046 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] g20368.t2 Q91085 33.333 279 9.110000000000001e-32 130.0 sp|Q91085|VIPR_MELGA Vasoactive intestinal polypeptide receptor OS=Meleagris gallopavo OX=9103 GN=VIPR1 PE=2 SV=2 VIPR_MELGA reviewed Vasoactive intestinal polypeptide receptor (VIP receptor) (VIP-R) Meleagris gallopavo (Wild turkey) GO:0004999; GO:0005886; GO:0007166; GO:0007188; GO:0008528; GO:0017046 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] g20369.t1 P23795 35.739 582 1.08e-102 327.0 sp|P23795|ACES_BOVIN Acetylcholinesterase OS=Bos taurus OX=9913 GN=ACHE PE=1 SV=2 ACES_BOVIN reviewed Acetylcholinesterase (AChE) (EC 3.1.1.7) Bos taurus (Bovine) GO:0001540; GO:0003990; GO:0005615; GO:0005886; GO:0006581; GO:0019695; GO:0045202; GO:0098552 acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; synapse [GO:0045202] acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540] g20371.t1 Q8K2H6 65.405 185 2.35e-88 260.0 sp|Q8K2H6|APC10_MOUSE Anaphase-promoting complex subunit 10 OS=Mus musculus OX=10090 GN=Anapc10 PE=1 SV=1 g20372.t1 Q5ZIZ2 56.627 415 2.74e-171 489.0 sp|Q5ZIZ2|SMYD5_CHICK Protein-lysine N-trimethyltransferase SMYD5 OS=Gallus gallus OX=9031 GN=SMYD5 PE=2 SV=1 SMYD5_CHICK reviewed Protein-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.-) (SET and MYND domain-containing protein 5) ([histone H3]-lysine20 N-trimethyltransferase SMYD5) (EC 2.1.1.372) ([histone H4]-lysine36 N-trimethyltransferase SMYD5) (EC 2.1.1.359) Gallus gallus (Chicken) GO:0005737; GO:0008270; GO:0016279; GO:0032259; GO:0042799; GO:0045814; GO:0140943; GO:0140955; GO:1900249; GO:2000035; GO:2000736 methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of cytoplasmic translational elongation [GO:1900249]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035] cytoplasm [GO:0005737] histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 trimethyltransferase activity [GO:0140943]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270] g20373.t1 P54886 60.135 740 0.0 926.0 sp|P54886|P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens OX=9606 GN=ALDH18A1 PE=1 SV=2 P5CS_HUMAN reviewed Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)] Homo sapiens (Human) GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006536; GO:0006592; GO:0009266; GO:0019240; GO:0042802; GO:0055129 citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; response to temperature stimulus [GO:0009266] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] g20374.t1 Q8ITC9 26.124 467 1.0099999999999999e-38 149.0 sp|Q8ITC9|PK1R_DROME Pyrokinin-1 receptor OS=Drosophila melanogaster OX=7227 GN=PK1-R PE=2 SV=1 PK1R_DROME reviewed Pyrokinin-1 receptor Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020; GO:0036401; GO:0070328; GO:0090278 G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of peptide hormone secretion [GO:0090278]; neuropeptide signaling pathway [GO:0007218]; triglyceride homeostasis [GO:0070328] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; pyrokinin receptor activity [GO:0036401] g20378.t1 Q32KR8 42.938 354 2.92e-93 285.0 sp|Q32KR8|ADPRH_BOVIN ADP-ribosylhydrolase ARH1 OS=Bos taurus OX=9913 GN=ADPRH PE=2 SV=1 ADPRH_BOVIN reviewed ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) Bos taurus (Bovine) GO:0000287; GO:0003875; GO:0030955; GO:0036211; GO:0051725 protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211] ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955] g20379.t1 Q0VBU9 55.0 200 3.25e-78 239.0 sp|Q0VBU9|PLPP4_MOUSE Phospholipid phosphatase 4 OS=Mus musculus OX=10090 GN=Plpp4 PE=2 SV=1 PLPP4_MOUSE reviewed Phospholipid phosphatase 4 (EC 3.1.3.4) (EC 3.6.1.75) Mus musculus (Mouse) GO:0000810; GO:0001835; GO:0006644; GO:0008195; GO:0016020; GO:0042802; GO:0046839; GO:0090279 blastocyst hatching [GO:0001835]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; regulation of calcium ion import [GO:0090279] membrane [GO:0016020] diacylglycerol diphosphate phosphatase activity [GO:0000810]; identical protein binding [GO:0042802]; phosphatidate phosphatase activity [GO:0008195] g20380.t1 P20905 42.636 387 1.08e-91 294.0 sp|P20905|5HT1R_DROME 5-hydroxytryptamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=5-HT7 PE=2 SV=1 g20381.t1 Q3ULA2 78.669 511 0.0 842.0 sp|Q3ULA2|FBW1A_MOUSE F-box/WD repeat-containing protein 1A OS=Mus musculus OX=10090 GN=Btrc PE=1 SV=2 FBW1A_MOUSE reviewed F-box/WD repeat-containing protein 1A (Beta-TrCP protein E3RS-IkappaB) (Beta-transducin repeat-containing protein) (Beta-TrCP) (E3RSIkappaB) (mE3RS-IkappaB) (F-box and WD repeats protein beta-TrCP) (HOS) (Ubiquitin ligase FWD1) (pIkappaB-E3 receptor subunit) Mus musculus (Mouse) GO:0000045; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006508; GO:0006511; GO:0007040; GO:0008013; GO:0010507; GO:0010508; GO:0016055; GO:0016567; GO:0019005; GO:0030163; GO:0031146; GO:0031648; GO:0031669; GO:0033598; GO:0038061; GO:0038202; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045893; GO:0046983; GO:0048511; GO:0050852; GO:0050860; GO:0050862; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070534; GO:0070936; GO:1904262; GO:1990756; GO:1990757 autophagosome assembly [GO:0000045]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to nutrient levels [GO:0031669]; lysosome organization [GO:0007040]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of autophagy [GO:0010507]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of TORC1 signaling [GO:1904262]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; T cell receptor signaling pathway [GO:0050852]; TORC1 signaling [GO:0038202]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] beta-catenin binding [GO:0008013]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] g20382.t1 Q9D0B6 59.494 158 6.83e-66 203.0 sp|Q9D0B6|PBDC1_MOUSE Protein PBDC1 OS=Mus musculus OX=10090 GN=Pbdc1 PE=1 SV=1 g20383.t1 Q3SZ21 48.4 250 3.15e-71 225.0 sp|Q3SZ21|RPP30_BOVIN Ribonuclease P protein subunit p30 OS=Bos taurus OX=9913 GN=RPP30 PE=2 SV=1 g20389.t1 P91685 29.128 872 1.0100000000000001e-103 344.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g20390.t1 Q99055 31.538 520 1.37e-63 223.0 sp|Q99055|LAC4_TRAVI Laccase-4 OS=Trametes villosa OX=47662 GN=LCC4 PE=3 SV=1 g20392.t1 Q0IH24 45.492 244 3.8700000000000004e-56 182.0 sp|Q0IH24|SPEF1_XENLA Sperm flagellar protein 1 OS=Xenopus laevis OX=8355 GN=spef1 PE=2 SV=1 SPEF1_XENLA reviewed Sperm flagellar protein 1 Xenopus laevis (African clawed frog) GO:0001578; GO:0003341; GO:0005874; GO:0005902; GO:0005930; GO:0007026; GO:0008017; GO:0016323; GO:0016324; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0046847; GO:0051493; GO:0097542; GO:0097729; GO:1904158; GO:1990716; GO:2000095 axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095] 9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902] microtubule binding [GO:0008017] g20394.t1 P70579 31.176 680 5.33e-96 319.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g20395.t1 P41594 31.196 811 1.49e-108 377.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g20395.t1 P41594 28.818 694 1.5e-81 297.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g20396.t1 P70579 29.639 830 6.57e-115 374.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g20398.t1 Q5ZK33 48.726 667 0.0 551.0 sp|Q5ZK33|LETM1_CHICK Mitochondrial proton/calcium exchanger protein OS=Gallus gallus OX=9031 GN=LETM1 PE=2 SV=1 LETM1_CHICK reviewed Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1) Gallus gallus (Chicken) GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093 calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022] g20399.t1 P57740 50.37 945 0.0 882.0 sp|P57740|NU107_HUMAN Nuclear pore complex protein Nup107 OS=Homo sapiens OX=9606 GN=NUP107 PE=1 SV=1 NU107_HUMAN reviewed Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107) Homo sapiens (Human) GO:0000776; GO:0000973; GO:0005635; GO:0005643; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0008585; GO:0016020; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006 female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] structural constituent of nuclear pore [GO:0017056] g20401.t1 Q66L33 63.88 299 6.61e-123 356.0 sp|Q66L33|MK16A_XENLA Protein MAK16 homolog A OS=Xenopus laevis OX=8355 GN=mak16-a PE=2 SV=1 g20403.t1 Q5ZK33 53.659 410 7.93e-131 396.0 sp|Q5ZK33|LETM1_CHICK Mitochondrial proton/calcium exchanger protein OS=Gallus gallus OX=9031 GN=LETM1 PE=2 SV=1 LETM1_CHICK reviewed Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1) Gallus gallus (Chicken) GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093 calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022] g20404.t1 Q1LY46 37.197 578 3.49e-94 304.0 sp|Q1LY46|LETM1_DANRE Mitochondrial proton/calcium exchanger protein OS=Danio rerio OX=7955 GN=letm1 PE=3 SV=2 LETM1_DANRE reviewed Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093 calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022] g20409.t1 Q5HZN8 63.761 218 6.17e-98 290.0 sp|Q5HZN8|SIR5A_XENLA NAD-dependent protein deacylase sirtuin-5A, mitochondrial OS=Xenopus laevis OX=8355 GN=sirt5-a PE=2 SV=1 SIR5A_XENLA reviewed NAD-dependent protein deacylase sirtuin-5A, mitochondrial (EC 2.3.1.-) (Regulatory protein SIR2 homolog 5-a) Xenopus laevis (African clawed frog) GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0008270; GO:0017136; GO:0036047; GO:0036048; GO:0036049; GO:0036054; GO:0036055; GO:0061697; GO:0070403 peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein desuccinylation [GO:0036048] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] histone deacetylase activity, NAD-dependent [GO:0017136]; NAD+ binding [GO:0070403]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270] g20410.t1 D6REC4 39.628 646 1.14e-147 446.0 sp|D6REC4|CFA99_HUMAN Cilia- and flagella-associated protein 99 OS=Homo sapiens OX=9606 GN=CFAP99 PE=1 SV=3 g20411.t1 Q2TBM9 41.507 677 3.9500000000000004e-173 513.0 sp|Q2TBM9|SRAC1_BOVIN Protein SERAC1 OS=Bos taurus OX=9913 GN=SERAC1 PE=2 SV=1 g20413.t1 Q9NWW7 52.594 559 0.0 567.0 sp|Q9NWW7|CB042_HUMAN Uncharacterized protein C2orf42 OS=Homo sapiens OX=9606 GN=C2orf42 PE=1 SV=1 g20414.t1 Q9MYU4 36.078 510 1.27e-100 319.0 sp|Q9MYU4|ENTP1_PIG Ectonucleoside triphosphate diphosphohydrolase 1 OS=Sus scrofa OX=9823 GN=ENTPD1 PE=1 SV=1 ENTP1_PIG reviewed Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39) [Cleaved into: Ectonucleoside triphosphate diphosphohydrolase 1 27 kDa subunit; Ectonucleoside triphosphate diphosphohydrolase 1 54 kDa subunit] Sus scrofa (Pig) GO:0003924; GO:0004050; GO:0004382; GO:0005524; GO:0005886; GO:0005901; GO:0009134; GO:0016616; GO:0016887; GO:0017110; GO:0017111; GO:0036384; GO:0043262; GO:0043273; GO:0045134; GO:0070527; GO:0103023; GO:1990003 nucleoside diphosphate catabolic process [GO:0009134]; platelet aggregation [GO:0070527] caveola [GO:0005901]; plasma membrane [GO:0005886] ADP phosphatase activity [GO:0043262]; apyrase activity [GO:0004050]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; IDP phosphatase activity [GO:1990003]; ITPase activity [GO:0103023]; nucleoside diphosphate phosphatase activity [GO:0017110]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134] g20415.t1 Q14865 44.009 434 4.53e-93 328.0 sp|Q14865|ARI5B_HUMAN AT-rich interactive domain-containing protein 5B OS=Homo sapiens OX=9606 GN=ARID5B PE=1 SV=3 ARI5B_HUMAN reviewed AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (MRF1-like protein) (Modulator recognition factor 2) (MRF-2) Homo sapiens (Human) GO:0000122; GO:0000976; GO:0001822; GO:0001889; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0045892; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0051091; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830 adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] g20417.t1 A4IF69 49.006 704 0.0 650.0 sp|A4IF69|NHLC2_BOVIN NHL repeat-containing protein 2 OS=Bos taurus OX=9913 GN=NHLRC2 PE=2 SV=1 g20418.t1 Q9H0F5 38.374 529 1.15e-75 250.0 sp|Q9H0F5|RNF38_HUMAN E3 ubiquitin-protein ligase RNF38 OS=Homo sapiens OX=9606 GN=RNF38 PE=1 SV=4 g20418.t2 Q9H0F5 38.158 532 1.7999999999999997e-74 251.0 sp|Q9H0F5|RNF38_HUMAN E3 ubiquitin-protein ligase RNF38 OS=Homo sapiens OX=9606 GN=RNF38 PE=1 SV=4 g20419.t1 Q5EBF1 61.985 534 0.0 676.0 sp|Q5EBF1|5NTC_XENTR Cytosolic purine 5'-nucleotidase OS=Xenopus tropicalis OX=8364 GN=nt5c2 PE=2 SV=1 5NTC_XENTR reviewed Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005829; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046085; GO:0046872; GO:0050146 adenosine metabolic process [GO:0046085]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP metabolic process [GO:0046040] cytosol [GO:0005829] 5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146] g20420.t1 Q86WI1 39.662 4266 0.0 2962.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g20420.t2 Q86WI1 39.569 4266 0.0 2954.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g20420.t3 Q86WI1 39.199 4319 0.0 2937.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g20421.t1 Q6NY64 79.864 442 0.0 753.0 sp|Q6NY64|2ABD_DANRE Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform OS=Danio rerio OX=7955 GN=ppp2r2d PE=2 SV=1 g20423.t1 A5D8N2 59.296 199 1.46e-90 267.0 sp|A5D8N2|DPCD_XENLA Protein DPCD OS=Xenopus laevis OX=8355 GN=dpcd PE=2 SV=1 g20424.t1 Q5M934 52.51 259 2.7799999999999998e-89 271.0 sp|Q5M934|TRUB1_RAT Pseudouridylate synthase TRUB1 OS=Rattus norvegicus OX=10116 GN=Trub1 PE=2 SV=1 TRUB1_RAT reviewed Pseudouridylate synthase TRUB1 (EC 5.4.99.-) (TruB pseudouridine synthase homolog 1) (tRNA pseudouridine 55 synthase TRUB1) (Psi55 synthase TRUB1) (EC 5.4.99.25) Rattus norvegicus (Rat) GO:0005634; GO:0005829; GO:0006397; GO:0006400; GO:0009982; GO:0070883; GO:0160148; GO:1990481; GO:2000633 mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of pre-miRNA processing [GO:2000633]; tRNA modification [GO:0006400] cytosol [GO:0005829]; nucleus [GO:0005634] pre-miRNA binding [GO:0070883]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine(55) synthase activity [GO:0160148] g20425.t1 Q99055 31.906 467 1.0999999999999998e-54 198.0 sp|Q99055|LAC4_TRAVI Laccase-4 OS=Trametes villosa OX=47662 GN=LCC4 PE=3 SV=1 g20426.t1 Q13324 30.193 414 4.4100000000000004e-32 130.0 sp|Q13324|CRFR2_HUMAN Corticotropin-releasing factor receptor 2 OS=Homo sapiens OX=9606 GN=CRHR2 PE=1 SV=2 g20426.t2 P47866 31.084 415 2.3100000000000002e-33 134.0 sp|P47866|CRFR2_RAT Corticotropin-releasing factor receptor 2 OS=Rattus norvegicus OX=10116 GN=Crhr2 PE=1 SV=2 CRFR2_RAT reviewed Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2) Rattus norvegicus (Rat) GO:0004930; GO:0005179; GO:0005886; GO:0007015; GO:0007166; GO:0007186; GO:0007188; GO:0007200; GO:0008528; GO:0009986; GO:0010460; GO:0010628; GO:0010629; GO:0010700; GO:0014064; GO:0015056; GO:0016525; GO:0017046; GO:0021549; GO:0021854; GO:0030424; GO:0030425; GO:0030855; GO:0032755; GO:0032811; GO:0032874; GO:0033685; GO:0035482; GO:0042423; GO:0043025; GO:0043196; GO:0043204; GO:0043404; GO:0043679; GO:0045777; GO:0046882; GO:0048630; GO:0060291; GO:0061179; GO:0070372; GO:0070852; GO:0071385; GO:0090281; GO:0106071; GO:0141163; GO:2000252; GO:2000293; GO:2000573 actin filament organization [GO:0007015]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; catecholamine biosynthetic process [GO:0042423]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; epithelial cell differentiation [GO:0030855]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric motility [GO:0035482]; hypothalamus development [GO:0021854]; long-term synaptic potentiation [GO:0060291]; negative regulation of angiogenesis [GO:0016525]; negative regulation of calcium ion import [GO:0090281]; negative regulation of defecation [GO:2000293]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of feeding behavior [GO:2000252]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of luteinizing hormone secretion [GO:0033685]; negative regulation of norepinephrine secretion [GO:0010700]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of blood pressure [GO:0045777]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate [GO:0010460]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of serotonin secretion [GO:0014064]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of ERK1 and ERK2 cascade [GO:0070372]; skeletal muscle tissue growth [GO:0048630] axon [GO:0030424]; axon terminus [GO:0043679]; cell body fiber [GO:0070852]; cell surface [GO:0009986]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; varicosity [GO:0043196] corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone activity [GO:0005179]; peptide hormone binding [GO:0017046] g20428.t1 Q95J53 35.837 466 2.35e-101 322.0 sp|Q95J53|BTBDG_MACFA BTB/POZ domain-containing protein 16 OS=Macaca fascicularis OX=9541 GN=BTBD16 PE=2 SV=1 g20431.t1 Q5R5Y7 36.212 359 8.78e-62 218.0 sp|Q5R5Y7|ZN436_PONAB Zinc finger protein 436 OS=Pongo abelii OX=9601 GN=ZNF436 PE=2 SV=1 g20431.t1 Q5R5Y7 38.652 282 1.34e-52 193.0 sp|Q5R5Y7|ZN436_PONAB Zinc finger protein 436 OS=Pongo abelii OX=9601 GN=ZNF436 PE=2 SV=1 g20431.t1 Q5R5Y7 36.364 264 9.27e-46 174.0 sp|Q5R5Y7|ZN436_PONAB Zinc finger protein 436 OS=Pongo abelii OX=9601 GN=ZNF436 PE=2 SV=1 g20431.t1 Q5R5Y7 37.5 232 1.97e-36 147.0 sp|Q5R5Y7|ZN436_PONAB Zinc finger protein 436 OS=Pongo abelii OX=9601 GN=ZNF436 PE=2 SV=1 g20432.t1 O95394 56.274 526 0.0 612.0 sp|O95394|AGM1_HUMAN Phosphoacetylglucosamine mutase OS=Homo sapiens OX=9606 GN=PGM3 PE=1 SV=1 AGM1_HUMAN reviewed Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3) Homo sapiens (Human) GO:0000287; GO:0004610; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0030097 carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytosol [GO:0005829] magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610] g20433.t1 P52789 51.23 447 4.07e-149 450.0 sp|P52789|HXK2_HUMAN Hexokinase-2 OS=Homo sapiens OX=9606 GN=HK2 PE=1 SV=2 HXK2_HUMAN reviewed Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase) Homo sapiens (Human) GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0035795; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1905091; GO:1990830; GO:2000378 apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; intracellular glucose homeostasis [GO:0001678]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of type 2 mitophagy [GO:1905091]; regulation of D-glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529] ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; hexokinase activity [GO:0004396] g20433.t1 P52789 50.905 442 1.54e-145 441.0 sp|P52789|HXK2_HUMAN Hexokinase-2 OS=Homo sapiens OX=9606 GN=HK2 PE=1 SV=2 HXK2_HUMAN reviewed Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase) Homo sapiens (Human) GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0035795; GO:0045766; GO:0046324; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1905091; GO:1990830; GO:2000378 apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; intracellular glucose homeostasis [GO:0001678]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of type 2 mitophagy [GO:1905091]; regulation of D-glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529] ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; hexokinase activity [GO:0004396] g20434.t1 Q80YQ8 59.439 392 3.03e-173 491.0 sp|Q80YQ8|RMD5A_MOUSE E3 ubiquitin-protein ligase RMND5A OS=Mus musculus OX=10090 GN=Rmnd5a PE=1 SV=2 g20436.t1 O13067 38.102 727 1.01e-143 440.0 sp|O13067|CND2_XENLA Condensin complex subunit 2 OS=Xenopus laevis OX=8355 GN=ncaph PE=1 SV=1 g20437.t1 Q8TC84 52.959 338 8.97e-124 362.0 sp|Q8TC84|FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 OS=Homo sapiens OX=9606 GN=FANK1 PE=1 SV=3 g20438.t1 Q93127 35.917 387 6.22e-69 224.0 sp|Q93127|GPR18_AMPAM Probable G-protein coupled receptor No18 OS=Amphibalanus amphitrite OX=1232801 PE=3 SV=1 g20440.t1 Q93127 38.827 358 1.88e-73 236.0 sp|Q93127|GPR18_AMPAM Probable G-protein coupled receptor No18 OS=Amphibalanus amphitrite OX=1232801 PE=3 SV=1 g20442.t1 Q9TTQ9 42.034 295 1.79e-69 230.0 sp|Q9TTQ9|GPR83_CANLF G-protein coupled receptor 83 OS=Canis lupus familiaris OX=9615 GN=GPR83 PE=2 SV=1 g20443.t1 Q6TEN6 50.847 118 1.2000000000000002e-37 142.0 sp|Q6TEN6|WDR91_DANRE WD repeat-containing protein 91 OS=Danio rerio OX=7955 GN=wdr91 PE=1 SV=2 g20444.t1 Q5NC05 45.925 773 0.0 625.0 sp|Q5NC05|TTF2_MOUSE Transcription termination factor 2 OS=Mus musculus OX=10090 GN=Ttf2 PE=1 SV=2 TTF2_MOUSE reviewed Transcription termination factor 2 (EC 3.6.4.-) (RNA polymerase II termination factor) (Transcription release factor 2) Mus musculus (Mouse) GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006281; GO:0006353; GO:0006397; GO:0008094; GO:0008270; GO:0008380; GO:0016787 DNA repair [GO:0006281]; DNA-templated transcription termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytosol [GO:0005829]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270] g20445.t1 Q6PBQ2 35.613 351 4.58e-75 244.0 sp|Q6PBQ2|CHMP7_DANRE Charged multivesicular body protein 7 OS=Danio rerio OX=7955 GN=chmp7 PE=2 SV=1 g20445.t2 Q6PBQ2 35.613 351 4.2100000000000003e-75 245.0 sp|Q6PBQ2|CHMP7_DANRE Charged multivesicular body protein 7 OS=Danio rerio OX=7955 GN=chmp7 PE=2 SV=1 g20446.t1 P78367 88.095 84 1.38e-41 150.0 sp|P78367|NKX32_HUMAN Homeobox protein Nkx-3.2 OS=Homo sapiens OX=9606 GN=NKX3-2 PE=1 SV=2 NKX32_HUMAN reviewed Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0007368; GO:0030154; GO:0031016; GO:0032331; GO:0042474; GO:0043066; GO:0048536; GO:0048645; GO:0048705; GO:0048706; GO:0060576; GO:1990837 animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g20447.t1 A6NCS4 68.657 134 1.03e-46 164.0 sp|A6NCS4|NKX26_HUMAN Homeobox protein Nkx-2.6 OS=Homo sapiens OX=9606 GN=NKX2-6 PE=1 SV=1 NKX26_HUMAN reviewed Homeobox protein Nkx-2.6 (Homeobox protein NK-2 homolog F) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008284; GO:0021854; GO:0030154; GO:0030855; GO:0035050; GO:0043066; GO:0043586; GO:0045944; GO:0048565; GO:0050673; GO:0050679; GO:0055014; GO:0055015; GO:0060037; GO:0060039; GO:1904019; GO:1904036 atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell apoptotic process [GO:1904036]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g20448.t1 Q2PYN8 62.963 135 3.67e-48 168.0 sp|Q2PYN8|LBX1_XENLA Transcription factor LBX1 OS=Xenopus laevis OX=8355 GN=lbx1 PE=2 SV=1 LBX1_XENLA reviewed Transcription factor LBX1 (Ladybird homeobox protein homolog 1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000981; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007517; GO:0030154; GO:0051450; GO:1990837 cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837] g20451.t1 P52953 93.478 92 4.48e-55 179.0 sp|P52953|MSX2_RAT Homeobox protein MSX-2 (Fragment) OS=Rattus norvegicus OX=10116 GN=Msx2 PE=3 SV=1 g20453.t1 Q9PW71 42.363 347 2.13e-85 269.0 sp|Q9PW71|DUS4_CHICK Dual specificity protein phosphatase 4 OS=Gallus gallus OX=9031 GN=DUSP4 PE=2 SV=1 g20454.t1 Q6V7V2 36.515 482 3.4099999999999996e-95 304.0 sp|Q6V7V2|RTKN_RAT Rhotekin OS=Rattus norvegicus OX=10116 GN=Rtkn PE=1 SV=1 g20454.t2 Q6V7V2 35.614 497 2.39e-91 295.0 sp|Q6V7V2|RTKN_RAT Rhotekin OS=Rattus norvegicus OX=10116 GN=Rtkn PE=1 SV=1 g20455.t1 Q5XGD7 35.125 279 2.31e-49 167.0 sp|Q5XGD7|TM45B_XENTR Transmembrane protein 45B OS=Xenopus tropicalis OX=8364 GN=tmem45b PE=2 SV=1 g20456.t1 Q6P0S3 35.135 296 1.48e-49 168.0 sp|Q6P0S3|TM45B_DANRE Transmembrane protein 45B OS=Danio rerio OX=7955 GN=tmem45b PE=2 SV=1 g20458.t1 P13360 59.494 158 3.18e-60 207.0 sp|P13360|GLAS_DROME Protein glass OS=Drosophila melanogaster OX=7227 GN=gl PE=1 SV=2 GLAS_DROME reviewed Protein glass Drosophila melanogaster (Fruit fly) GO:0000978; GO:0000981; GO:0001745; GO:0001751; GO:0001752; GO:0003677; GO:0005634; GO:0006355; GO:0006357; GO:0007601; GO:0007605; GO:0008270; GO:0009649; GO:0010114; GO:0035271; GO:0043153; GO:0045466; GO:0045944; GO:0046530; GO:0048052; GO:0060086 circadian temperature homeostasis [GO:0060086]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; compound eye photoreceptor fate commitment [GO:0001752]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R7 cell differentiation [GO:0045466]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to red light [GO:0010114]; ring gland development [GO:0035271]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g20467.t1 A5PLK2 59.091 264 1.0800000000000002e-109 320.0 sp|A5PLK2|LHPP_DANRE Phospholysine phosphohistidine inorganic pyrophosphate phosphatase OS=Danio rerio OX=7955 GN=lhpp PE=2 SV=1 g20468.t1 Q3SYX0 35.915 284 3.81e-50 175.0 sp|Q3SYX0|NDRG1_BOVIN Protein NDRG1 OS=Bos taurus OX=9913 GN=NDRG1 PE=2 SV=1 g20468.t2 Q3SYX0 35.915 284 1.57e-50 176.0 sp|Q3SYX0|NDRG1_BOVIN Protein NDRG1 OS=Bos taurus OX=9913 GN=NDRG1 PE=2 SV=1 g20469.t1 Q8K2C8 53.233 464 6.080000000000001e-166 478.0 sp|Q8K2C8|GPAT4_MOUSE Glycerol-3-phosphate acyltransferase 4 OS=Mus musculus OX=10090 GN=Gpat4 PE=1 SV=1 GPAT4_MOUSE reviewed Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) Mus musculus (Mouse) GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016024; GO:0019432; GO:0030879; GO:0040014; GO:0046339 acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glycerol-3-phosphate O-acyltransferase activity [GO:0004366] g20471.t1 Q7TT23 40.669 568 8.19e-141 439.0 sp|Q7TT23|DAAF9_MOUSE Dynein axonemal assembly factor 9 OS=Mus musculus OX=10090 GN=Dnaaf9 PE=1 SV=2 g20472.t1 Q5TEA3 42.268 582 1.79e-135 426.0 sp|Q5TEA3|DAAF9_HUMAN Dynein axonemal assembly factor 9 OS=Homo sapiens OX=9606 GN=DNAAF9 PE=1 SV=1 g20474.t1 P13832 70.175 171 8e-84 247.0 sp|P13832|MRLCA_RAT Myosin regulatory light chain RLC-A OS=Rattus norvegicus OX=10116 GN=Rlc-a PE=2 SV=2 g20475.t1 Q9W735 27.446 736 8.16e-70 251.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g20475.t2 Q9W735 27.446 736 3.1099999999999997e-68 249.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g20476.t1 Q8BG30 46.595 558 4.43e-133 400.0 sp|Q8BG30|NELFA_MOUSE Negative elongation factor A OS=Mus musculus OX=10090 GN=Nelfa PE=1 SV=1 g20478.t1 Q9VE46 60.234 513 0.0 615.0 sp|Q9VE46|SC5A7_DROME High-affinity choline transporter 1 OS=Drosophila melanogaster OX=7227 GN=ChT PE=2 SV=2 g20479.t1 Q9VE46 53.784 621 0.0 631.0 sp|Q9VE46|SC5A7_DROME High-affinity choline transporter 1 OS=Drosophila melanogaster OX=7227 GN=ChT PE=2 SV=2 g20480.t1 Q6IND7 53.595 306 2.91e-115 341.0 sp|Q6IND7|LR2BP_XENLA LRP2-binding protein OS=Xenopus laevis OX=8355 GN=lrp2bp PE=2 SV=1 g20484.t1 Q5ZI20 45.333 375 1.25e-95 295.0 sp|Q5ZI20|S39AD_CHICK Zinc transporter ZIP13 OS=Gallus gallus OX=9031 GN=SLC39A13 PE=2 SV=1 S39AD_CHICK reviewed Zinc transporter ZIP13 (Solute carrier family 39 member 13) (Zrt- and Irt-like protein 13) (ZIP-13) Gallus gallus (Chicken) GO:0000139; GO:0005385; GO:0005789; GO:0006829; GO:0006882; GO:0030659; GO:0071577 intracellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] zinc ion transmembrane transporter activity [GO:0005385] g20485.t1 Q5ZLT0 72.172 1114 0.0 1659.0 sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1 g20486.t1 Q9WV25 64.232 534 0.0 622.0 sp|Q9WV25|PUF60_RAT Poly(U)-binding-splicing factor PUF60 OS=Rattus norvegicus OX=10116 GN=Puf60 PE=2 SV=2 g20487.t1 Q5E950 60.15 133 1.05e-57 179.0 sp|Q5E950|NHP2_BOVIN H/ACA ribonucleoprotein complex subunit 2 OS=Bos taurus OX=9913 GN=NHP2 PE=2 SV=1 NHP2_BOVIN reviewed H/ACA ribonucleoprotein complex subunit 2 (Nucleolar protein family A member 2) (snoRNP protein NHP2) Bos taurus (Bovine) GO:0005697; GO:0007004; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0070034; GO:0090661 rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004] box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; telomerase holoenzyme complex [GO:0005697] box H/ACA snoRNA binding [GO:0034513]; telomerase RNA binding [GO:0070034] g20488.t1 Q9ERS5 42.424 330 1.56e-75 242.0 sp|Q9ERS5|PKHA2_MOUSE Pleckstrin homology domain-containing family A member 2 OS=Mus musculus OX=10090 GN=Plekha2 PE=1 SV=1 PKHA2_MOUSE reviewed Pleckstrin homology domain-containing family A member 2 (PH domain-containing family A member 2) (PH domain-containing adaptor PHAD47) (Tandem PH domain-containing protein 2) (TAPP-2) Mus musculus (Mouse) GO:0001954; GO:0001968; GO:0005543; GO:0005634; GO:0005737; GO:0005886; GO:0016020; GO:0030165; GO:0032991; GO:0043236; GO:0043325 positive regulation of cell-matrix adhesion [GO:0001954] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phospholipid binding [GO:0005543] g20488.t2 Q9ERS5 43.791 306 7.59e-80 252.0 sp|Q9ERS5|PKHA2_MOUSE Pleckstrin homology domain-containing family A member 2 OS=Mus musculus OX=10090 GN=Plekha2 PE=1 SV=1 PKHA2_MOUSE reviewed Pleckstrin homology domain-containing family A member 2 (PH domain-containing family A member 2) (PH domain-containing adaptor PHAD47) (Tandem PH domain-containing protein 2) (TAPP-2) Mus musculus (Mouse) GO:0001954; GO:0001968; GO:0005543; GO:0005634; GO:0005737; GO:0005886; GO:0016020; GO:0030165; GO:0032991; GO:0043236; GO:0043325 positive regulation of cell-matrix adhesion [GO:0001954] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phospholipid binding [GO:0005543] g20490.t1 Q49AM3 48.305 118 2.5999999999999997e-23 107.0 sp|Q49AM3|TTC31_HUMAN Tetratricopeptide repeat protein 31 OS=Homo sapiens OX=9606 GN=TTC31 PE=1 SV=3 g20490.t2 Q49AM3 48.305 118 2.58e-23 107.0 sp|Q49AM3|TTC31_HUMAN Tetratricopeptide repeat protein 31 OS=Homo sapiens OX=9606 GN=TTC31 PE=1 SV=3 g20491.t1 Q9JMJ2 34.25 400 6.7700000000000005e-77 246.0 sp|Q9JMJ2|FBXW4_MOUSE F-box/WD repeat-containing protein 4 OS=Mus musculus OX=10090 GN=Fbxw4 PE=1 SV=1 FBXW4_MOUSE reviewed F-box/WD repeat-containing protein 4 (F-box and WD-40 domain-containing protein 4) (Protein hagoromo) Mus musculus (Mouse) GO:0002053; GO:0016055; GO:0019005; GO:0031146; GO:0042733; GO:0051216; GO:0060173 cartilage development [GO:0051216]; embryonic digit morphogenesis [GO:0042733]; limb development [GO:0060173]; positive regulation of mesenchymal cell proliferation [GO:0002053]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055] SCF ubiquitin ligase complex [GO:0019005] g20491.t2 Q9JMJ2 32.381 315 4.8299999999999996e-52 179.0 sp|Q9JMJ2|FBXW4_MOUSE F-box/WD repeat-containing protein 4 OS=Mus musculus OX=10090 GN=Fbxw4 PE=1 SV=1 FBXW4_MOUSE reviewed F-box/WD repeat-containing protein 4 (F-box and WD-40 domain-containing protein 4) (Protein hagoromo) Mus musculus (Mouse) GO:0002053; GO:0016055; GO:0019005; GO:0031146; GO:0042733; GO:0051216; GO:0060173 cartilage development [GO:0051216]; embryonic digit morphogenesis [GO:0042733]; limb development [GO:0060173]; positive regulation of mesenchymal cell proliferation [GO:0002053]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; Wnt signaling pathway [GO:0016055] SCF ubiquitin ligase complex [GO:0019005] g20492.t1 Q3MHW7 50.0 148 3.34e-40 138.0 sp|Q3MHW7|SGMR2_BOVIN Sigma intracellular receptor 2 OS=Bos taurus OX=9913 GN=TMEM97 PE=1 SV=1 SGMR2_BOVIN reviewed Sigma intracellular receptor 2 (Sigma-2 receptor) (Sigma2 receptor) (Transmembrane protein 97) Bos taurus (Bovine) GO:0005764; GO:0005783; GO:0005791; GO:0005886; GO:0008142; GO:0015485; GO:0030867; GO:0031965; GO:0032377; GO:0032383; GO:0042632; GO:0090303; GO:0140077 cholesterol homeostasis [GO:0042632]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of wound healing [GO:0090303]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of intracellular lipid transport [GO:0032377] endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142] g20493.t1 Q9UA35 39.937 636 2.85e-149 450.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g20493.t2 Q9UA35 43.248 548 3.73e-149 450.0 sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1 g20495.t1 P41596 58.219 146 9.27e-56 187.0 sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2 DOPR1_DROME reviewed Dopamine receptor 1 (D-DOP1) (DmDop1) (dDA1) (Dopamine 1-like receptor 1) Drosophila melanogaster (Fruit fly) GO:0001588; GO:0004930; GO:0004952; GO:0004993; GO:0005886; GO:0007187; GO:0007188; GO:0007191; GO:0007212; GO:0007268; GO:0007612; GO:0007613; GO:0008306; GO:0008355; GO:0008542; GO:0009744; GO:0016020; GO:0030425; GO:0030594; GO:0040040; GO:0042048; GO:0042594; GO:0043052; GO:0071329; GO:0090328; GO:0098793; GO:0099509; GO:1990834 adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; associative learning [GO:0008306]; cellular response to sucrose stimulus [GO:0071329]; chemical synaptic transmission [GO:0007268]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; learning [GO:0007612]; memory [GO:0007613]; olfactory behavior [GO:0042048]; olfactory learning [GO:0008355]; regulation of olfactory learning [GO:0090328]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; response to odorant [GO:1990834]; response to starvation [GO:0042594]; response to sucrose [GO:0009744]; thermosensory behavior [GO:0040040]; thermotaxis [GO:0043052]; visual learning [GO:0008542] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] g20496.t1 P53454 43.147 197 2.0199999999999998e-42 154.0 sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1 g20497.t1 P53452 51.163 86 6.29e-22 94.0 sp|P53452|DRD1L_TAKRU D(1)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=d14 PE=3 SV=1 g20503.t1 P42290 45.322 342 1.0899999999999998e-89 281.0 sp|P42290|DRD5_XENLA D(1B) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd5 PE=2 SV=1 g20505.t1 Q32N55 35.693 664 2.7e-148 449.0 sp|Q32N55|PTCD3_XENLA Small ribosomal subunit protein mS39 OS=Xenopus laevis OX=8355 GN=ptcd3 PE=2 SV=1 g20507.t1 Q9VGY6 37.838 259 3.65e-51 190.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20507.t1 Q9VGY6 34.783 230 1.56e-40 159.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20507.t1 Q9VGY6 31.154 260 2.38e-28 123.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20508.t1 Q9GPJ1 50.0 176 2.36e-50 183.0 sp|Q9GPJ1|SKEL2_DROME Protein Skeletor, isoforms D/E OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=3 g20509.t1 Q9VGY6 39.56 182 1.6e-38 145.0 sp|Q9VGY6|SKEL1_DROME Protein Skeletor, isoforms B/C OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=2 SKEL1_DROME reviewed Protein Skeletor, isoforms B/C Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005700; GO:0005730; GO:0005819; GO:0005874; GO:0006997; GO:0051225; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; nucleus organization [GO:0006997]; spindle assembly [GO:0051225] microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; spindle [GO:0005819] g20510.t1 Q9GPJ1 52.663 169 4.6799999999999995e-46 172.0 sp|Q9GPJ1|SKEL2_DROME Protein Skeletor, isoforms D/E OS=Drosophila melanogaster OX=7227 GN=Skel PE=1 SV=3 g20511.t1 Q9GLD9 29.119 522 3.31e-71 240.0 sp|Q9GLD9|UDB33_MACMU UDP-glucuronosyltransferase 2B33 OS=Macaca mulatta OX=9544 GN=UGT2B33 PE=1 SV=1 g20516.t1 Q5EAE3 61.441 236 1.33e-103 302.0 sp|Q5EAE3|UBTD2_BOVIN Ubiquitin domain-containing protein 2 OS=Bos taurus OX=9913 GN=UBTD2 PE=2 SV=1 g20517.t1 Q9D071 39.494 1028 0.0 670.0 sp|Q9D071|MMS19_MOUSE MMS19 nucleotide excision repair protein homolog OS=Mus musculus OX=10090 GN=Mms19 PE=1 SV=1 MMS19_MOUSE reviewed MMS19 nucleotide excision repair protein homolog (MET18 homolog) (MMS19-like protein) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006281; GO:0007059; GO:0019899; GO:0030331; GO:0051604; GO:0071817; GO:0097361 chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; protein maturation [GO:0051604] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic [4Fe-4S] assembly targeting complex [GO:0097361]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] enzyme binding [GO:0019899]; nuclear estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713] g20518.t1 Q9H1Q7 55.598 259 4.14e-99 307.0 sp|Q9H1Q7|PED1A_HUMAN PC-esterase domain-containing protein 1A OS=Homo sapiens OX=9606 GN=PCED1A PE=1 SV=1 g20519.t1 A0A287B8J2 44.903 1334 0.0 1043.0 sp|A0A287B8J2|DCTN1_PIG Dynactin subunit 1 OS=Sus scrofa OX=9823 GN=DCTN1 PE=1 SV=2 DCTN1_PIG reviewed Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (p150-glued) Sus scrofa (Pig) GO:0000132; GO:0000776; GO:0000922; GO:0005635; GO:0005813; GO:0005814; GO:0005829; GO:0005875; GO:0005938; GO:0007097; GO:0007528; GO:0008017; GO:0010457; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0030904; GO:0031252; GO:0032402; GO:0034454; GO:0035371; GO:0036064; GO:0042147; GO:0043025; GO:0045171; GO:0050905; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0120103; GO:1904398; GO:1905515; GO:1990535 cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; establishment of mitotic spindle orientation [GO:0000132]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; motor behavior [GO:0061744]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517] axon [GO:0030424]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; retromer complex [GO:0030904]; spindle pole [GO:0000922] microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] g20519.t2 A0A287B8J2 45.413 1319 0.0 1052.0 sp|A0A287B8J2|DCTN1_PIG Dynactin subunit 1 OS=Sus scrofa OX=9823 GN=DCTN1 PE=1 SV=2 DCTN1_PIG reviewed Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (p150-glued) Sus scrofa (Pig) GO:0000132; GO:0000776; GO:0000922; GO:0005635; GO:0005813; GO:0005814; GO:0005829; GO:0005875; GO:0005938; GO:0007097; GO:0007528; GO:0008017; GO:0010457; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0030904; GO:0031252; GO:0032402; GO:0034454; GO:0035371; GO:0036064; GO:0042147; GO:0043025; GO:0045171; GO:0050905; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0120103; GO:1904398; GO:1905515; GO:1990535 cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; establishment of mitotic spindle orientation [GO:0000132]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; motor behavior [GO:0061744]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517] axon [GO:0030424]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; retromer complex [GO:0030904]; spindle pole [GO:0000922] microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] g20522.t1 P80146 50.909 385 5.09e-116 346.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g20523.t1 P80146 53.311 302 7.62e-95 289.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g20527.t1 Q28FF3 39.919 496 9.800000000000001e-116 353.0 sp|Q28FF3|S49A3_XENTR Solute carrier family 49 member A3 OS=Xenopus tropicalis OX=8364 GN=slc49a3 PE=2 SV=2 g20528.t1 Q7TT36 33.693 1205 0.0 650.0 sp|Q7TT36|AGRA3_MOUSE Adhesion G protein-coupled receptor A3 OS=Mus musculus OX=10090 GN=Adgra3 PE=2 SV=3 g20528.t2 Q7TT36 35.192 1040 0.0 620.0 sp|Q7TT36|AGRA3_MOUSE Adhesion G protein-coupled receptor A3 OS=Mus musculus OX=10090 GN=Adgra3 PE=2 SV=3 g20529.t1 Q3T0Z7 59.414 239 3.42e-97 286.0 sp|Q3T0Z7|DHPR_BOVIN Dihydropteridine reductase OS=Bos taurus OX=9913 GN=QDPR PE=2 SV=1 g20530.t1 Q9P0J7 62.791 344 7.86e-136 395.0 sp|Q9P0J7|KCMF1_HUMAN E3 ubiquitin-protein ligase KCMF1 OS=Homo sapiens OX=9606 GN=KCMF1 PE=1 SV=2 KCMF1_HUMAN reviewed E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (ZZ-type zinc finger-containing protein 1) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0008270; GO:0043161; GO:0045202; GO:0061630; GO:0070534; GO:0070936; GO:0099536; GO:0141191; GO:1904813 negative regulation of HRI-mediated signaling [GO:0141191]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; response to oxidative stress [GO:0006979]; synaptic signaling [GO:0099536]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synapse [GO:0045202] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g20531.t1 Q9NY93 58.627 539 0.0 621.0 sp|Q9NY93|DDX56_HUMAN Probable ATP-dependent RNA helicase DDX56 OS=Homo sapiens OX=9606 GN=DDX56 PE=1 SV=1 DDX56_HUMAN reviewed Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0010976; GO:0016020; GO:0016887; GO:0032480; GO:0035613; GO:0044830; GO:0051607; GO:0140311 defense response to virus [GO:0051607]; host-mediated perturbation of viral RNA genome replication [GO:0044830]; negative regulation of type I interferon production [GO:0032480]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613] g20532.t1 O35286 83.505 679 0.0 1204.0 sp|O35286|DHX15_MOUSE ATP-dependent RNA helicase DHX15 OS=Mus musculus OX=10090 GN=Dhx15 PE=1 SV=2 DHX15_MOUSE reviewed ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (DEAH box protein 15) Mus musculus (Mouse) GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0016887; GO:0042742; GO:0043123; GO:0043279; GO:0051607; GO:0071008; GO:0140374 antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type post-mRNA release spliceosomal complex [GO:0071008] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g20533.t1 Q9P287 44.195 267 6.64e-72 228.0 sp|Q9P287|BCCIP_HUMAN BRCA2 and CDKN1A-interacting protein OS=Homo sapiens OX=9606 GN=BCCIP PE=1 SV=1 BCCIP_HUMAN reviewed BRCA2 and CDKN1A-interacting protein (P21- and CDK-associated protein 1) (Protein TOK-1) Homo sapiens (Human) GO:0000079; GO:0000132; GO:0000226; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007052; GO:0015631; GO:0019207; GO:0019908; GO:0034453; GO:0042802; GO:0061101; GO:0090307; GO:0097431 DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; kinase regulator activity [GO:0019207]; RNA binding [GO:0003723]; tubulin binding [GO:0015631] g20534.t1 P10746 38.132 257 1.1899999999999999e-48 164.0 sp|P10746|HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens OX=9606 GN=Mgu PE=1 SV=1 HEM4_HUMAN reviewed Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase) Homo sapiens (Human) GO:0004852; GO:0005542; GO:0005739; GO:0005829; GO:0006780; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0070541; GO:0071243; GO:0071418 cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780] cytosol [GO:0005829]; mitochondrion [GO:0005739] folic acid binding [GO:0005542]; uroporphyrinogen-III synthase activity [GO:0004852] g20537.t1 Q8K3F2 32.619 420 1.5100000000000001e-59 209.0 sp|Q8K3F2|MMP21_MOUSE Matrix metalloproteinase-21 OS=Mus musculus OX=10090 GN=Mmp21 PE=1 SV=1 MMP21_MOUSE reviewed Matrix metalloproteinase-21 (MMP-21) (EC 3.4.24.-) Mus musculus (Mouse) GO:0002244; GO:0004222; GO:0005576; GO:0006508; GO:0007368; GO:0008237; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0060976; GO:0061371 collagen catabolic process [GO:0030574]; coronary vasculature development [GO:0060976]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g20538.t1 Q5R9R1 44.054 597 1.6e-121 413.0 sp|Q5R9R1|EDRF1_PONAB Erythroid differentiation-related factor 1 OS=Pongo abelii OX=9601 GN=EDRF1 PE=2 SV=1 g20538.t1 Q5R9R1 41.7 494 5.710000000000001e-103 360.0 sp|Q5R9R1|EDRF1_PONAB Erythroid differentiation-related factor 1 OS=Pongo abelii OX=9601 GN=EDRF1 PE=2 SV=1 g20539.t1 Q6NRH3 54.037 322 3.1699999999999996e-104 330.0 sp|Q6NRH3|CC149_XENLA Coiled-coil domain-containing protein 149 OS=Xenopus laevis OX=8355 GN=ccdc149 PE=2 SV=1 g20539.t2 Q6NRH3 54.037 322 2.7699999999999997e-104 330.0 sp|Q6NRH3|CC149_XENLA Coiled-coil domain-containing protein 149 OS=Xenopus laevis OX=8355 GN=ccdc149 PE=2 SV=1 g20541.t1 O14639 30.44 841 1.45e-112 363.0 sp|O14639|ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=3 ABLM1_HUMAN reviewed Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0007601; GO:0009887; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g20541.t2 O14639 31.334 817 1.31e-117 375.0 sp|O14639|ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=3 ABLM1_HUMAN reviewed Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0007601; GO:0009887; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g20541.t3 O14639 31.488 813 1.2e-117 375.0 sp|O14639|ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=3 ABLM1_HUMAN reviewed Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0007601; GO:0009887; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g20541.t4 O14639 32.57 786 4.71e-123 389.0 sp|O14639|ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens OX=9606 GN=ABLIM1 PE=1 SV=3 ABLM1_HUMAN reviewed Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin) Homo sapiens (Human) GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0007601; GO:0009887; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0051015; GO:0060271 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725] actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] g20542.t1 Q5E999 48.235 170 4.92e-49 172.0 sp|Q5E999|DUS11_BOVIN RNA/RNP complex-1-interacting phosphatase OS=Bos taurus OX=9913 GN=DUSP11 PE=2 SV=1 g20543.t1 Q91W96 37.781 802 3.33e-153 471.0 sp|Q91W96|APC4_MOUSE Anaphase-promoting complex subunit 4 OS=Mus musculus OX=10090 GN=Anapc4 PE=1 SV=1 g20544.t1 Q8BRH3 33.991 456 7.450000000000001e-66 226.0 sp|Q8BRH3|RHG19_MOUSE Rho GTPase-activating protein 19 OS=Mus musculus OX=10090 GN=Arhgap19 PE=1 SV=2 g20545.t1 Q6NUJ5 26.29 620 1.48e-44 170.0 sp|Q6NUJ5|PWP2B_HUMAN PWWP domain-containing protein 2B OS=Homo sapiens OX=9606 GN=PWWP2B PE=1 SV=3 PWP2B_HUMAN reviewed PWWP domain-containing protein 2B Homo sapiens (Human) GO:0005634; GO:0005654; GO:0006338; GO:0032968; GO:0120161; GO:0120325 chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161] nucleoplasm [GO:0005654]; nucleus [GO:0005634] NuRD complex binding [GO:0120325] g20546.t1 Q8IX21 26.227 591 2.53e-35 146.0 sp|Q8IX21|SLF2_HUMAN SMC5-SMC6 complex localization factor protein 2 OS=Homo sapiens OX=9606 GN=SLF2 PE=1 SV=2 SLF2_HUMAN reviewed SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1) Homo sapiens (Human) GO:0000724; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0044877; GO:0140588; GO:1990166; GO:2000781 chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] g20546.t2 Q8IX21 26.271 590 3.05e-35 146.0 sp|Q8IX21|SLF2_HUMAN SMC5-SMC6 complex localization factor protein 2 OS=Homo sapiens OX=9606 GN=SLF2 PE=1 SV=2 SLF2_HUMAN reviewed SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1) Homo sapiens (Human) GO:0000724; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0044877; GO:0140588; GO:1990166; GO:2000781 chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] g20547.t1 Q92902 28.917 785 4.6299999999999994e-82 279.0 sp|Q92902|HPS1_HUMAN BLOC-3 complex member HPS1 OS=Homo sapiens OX=9606 GN=HPS1 PE=1 SV=2 g20549.t1 Q7L273 61.153 399 1.02e-173 493.0 sp|Q7L273|KCTD9_HUMAN BTB/POZ domain-containing protein KCTD9 OS=Homo sapiens OX=9606 GN=KCTD9 PE=1 SV=1 KCTD9_HUMAN reviewed BTB/POZ domain-containing protein KCTD9 Homo sapiens (Human) GO:0016567; GO:0035556; GO:0042802; GO:0051260; GO:0097602 intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567] cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] g20571.t1 Q8VE80 77.743 319 0.0 523.0 sp|Q8VE80|THOC3_MOUSE THO complex subunit 3 OS=Mus musculus OX=10090 GN=Thoc3 PE=2 SV=1 g20574.t1 C3Y431 46.473 241 5e-45 157.0 sp|C3Y431|DDRGK_BRAFL DDRGK domain-containing protein 1 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_114851 PE=3 SV=1 g20577.t1 Q99KN2 60.059 338 6.49e-144 413.0 sp|Q99KN2|CIAO1_MOUSE Probable cytosolic iron-sulfur protein assembly protein CIAO1 OS=Mus musculus OX=10090 GN=Ciao1 PE=1 SV=1 g20577.t1 Q99KN2 32.4 250 8.82e-29 117.0 sp|Q99KN2|CIAO1_MOUSE Probable cytosolic iron-sulfur protein assembly protein CIAO1 OS=Mus musculus OX=10090 GN=Ciao1 PE=1 SV=1 g20582.t1 O75923 47.213 2099 0.0 1858.0 sp|O75923|DYSF_HUMAN Dysferlin OS=Homo sapiens OX=9606 GN=DYSF PE=1 SV=1 g20584.t1 O55127 35.0 400 3.56e-69 229.0 sp|O55127|CP26A_MOUSE Cytochrome P450 26A1 OS=Mus musculus OX=10090 GN=Cyp26a1 PE=1 SV=1 CP26A_MOUSE reviewed Cytochrome P450 26A1 (CYP26A1) (EC 1.14.13.-) (Cytochrome P450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome) Mus musculus (Mouse) GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0007417; GO:0008401; GO:0009952; GO:0014032; GO:0016709; GO:0020037; GO:0034653; GO:0042573; GO:0048384; GO:0062182; GO:0062183; GO:0071300 anterior/posterior pattern specification [GO:0009952]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; neural crest cell development [GO:0014032]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789] all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; all-trans retinoic acid 4-hydrolase activity [GO:0062182]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972] g20586.t1 B0I564 43.773 1357 0.0 1085.0 sp|B0I564|FANCI_CHICK Fanconi anemia group I protein OS=Gallus gallus OX=9031 GN=FANCI PE=1 SV=1 FANCI_CHICK reviewed Fanconi anemia group I protein Gallus gallus (Chicken) GO:0005654; GO:0006281; GO:0031398; GO:0043240 DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398] Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] g20589.t1 P04181 68.258 419 0.0 608.0 sp|P04181|OAT_HUMAN Ornithine aminotransferase, mitochondrial OS=Homo sapiens OX=9606 GN=OAT PE=1 SV=1 OAT_HUMAN reviewed Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form] Homo sapiens (Human) GO:0004587; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0007601; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0055129 L-arginine catabolic process to L-glutamate [GO:0019544]; L-arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; visual perception [GO:0007601] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] identical protein binding [GO:0042802]; ornithine aminotransferase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170] g20590.t1 O34309 27.351 925 9.59e-82 291.0 sp|O34309|RPH_BACSU Rifampicin phosphotransferase OS=Bacillus subtilis (strain 168) OX=224308 GN=rph PE=3 SV=1 g20593.t1 Q14517 38.182 165 6.16e-26 116.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20593.t1 Q14517 36.538 156 7.36e-25 113.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20593.t1 Q14517 39.37 127 3.35e-22 105.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20593.t2 Q14517 37.059 170 1.03e-25 115.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20593.t2 Q14517 36.601 153 1.81e-24 112.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20593.t2 Q14517 39.37 127 3.54e-22 105.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20598.t1 Q0P5M9 49.556 450 2.21e-127 380.0 sp|Q0P5M9|MFS10_BOVIN Major facilitator superfamily domain-containing protein 10 OS=Bos taurus OX=9913 GN=MFSD10 PE=2 SV=1 g20600.t1 D2KQB0 85.211 284 8.42e-170 472.0 sp|D2KQB0|HHEX_PATMI Hematopoietically-expressed homeobox protein HHEX homolog OS=Patiria miniata OX=46514 GN=hhex PE=2 SV=1 g20601.t1 Q26656 48.523 237 6.569999999999999e-54 184.0 sp|Q26656|HMX_STRPU Homeobox protein Hmx (Fragment) OS=Strongylocentrotus purpuratus OX=7668 GN=HMX PE=2 SV=1 g20604.t1 Q75W95 40.881 318 3.11e-50 176.0 sp|Q75W95|NKX11_DANRE NK1 transcription factor-related protein 1 OS=Danio rerio OX=7955 GN=nkx1.2lb PE=2 SV=1 g20607.t1 Q9UBV7 53.909 243 4.44e-96 290.0 sp|Q9UBV7|B4GT7_HUMAN Beta-1,4-galactosyltransferase 7 OS=Homo sapiens OX=9606 GN=B4GALT7 PE=1 SV=1 B4GT7_HUMAN reviewed Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase) Homo sapiens (Human) GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016020; GO:0030145; GO:0030166; GO:0032580; GO:0036211; GO:0046525; GO:0048147; GO:0097435; GO:0120532 carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan-protein linkage region biosynthetic process [GO:0120532]; negative regulation of fibroblast proliferation [GO:0048147]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525] g20608.t1 Q5ZKF4 38.095 126 7.39e-23 103.0 sp|Q5ZKF4|HM20A_CHICK High mobility group protein 20A OS=Gallus gallus OX=9031 GN=HMG20A PE=2 SV=1 g20610.t1 Q00945 47.143 140 4.53e-36 124.0 sp|Q00945|CONO_LYMST Conopressin/neurophysin OS=Lymnaea stagnalis OX=6523 PE=1 SV=1 g20617.t1 O76050 34.94 249 5.02e-33 128.0 sp|O76050|NEUL1_HUMAN E3 ubiquitin-protein ligase NEURL1 OS=Homo sapiens OX=9606 GN=NEURL1 PE=1 SV=1 g20618.t1 Q923S6 39.865 148 5.61e-38 145.0 sp|Q923S6|NEUL1_MOUSE E3 ubiquitin-protein ligase NEURL1 OS=Mus musculus OX=10090 GN=Neurl1 PE=1 SV=1 NEUL1_MOUSE reviewed E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (m-neu1) (m-neuralized 1) (Neuralized1) (RING-type E3 ubiquitin transferase NEURL1) Mus musculus (Mouse) GO:0004842; GO:0005737; GO:0005886; GO:0006513; GO:0007219; GO:0007288; GO:0007519; GO:0007595; GO:0008270; GO:0008285; GO:0014069; GO:0030317; GO:0043065; GO:0043197; GO:0043204; GO:0045182; GO:0045746; GO:0048170; GO:0048471; GO:0051491; GO:0060999; GO:0061630; GO:0071230; GO:0090129; GO:0097440; GO:0098978; GO:0150052 cellular response to amino acid stimulus [GO:0071230]; flagellated sperm motility [GO:0030317]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288] apical dendrite [GO:0097440]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] translation regulator activity [GO:0045182]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20619.t1 Q5BJW3 54.04 198 9.25e-66 202.0 sp|Q5BJW3|TX261_RAT Protein TEX261 OS=Rattus norvegicus OX=10116 GN=Tex261 PE=2 SV=1 g20620.t1 Q3V0J4 38.798 183 1.8800000000000002e-37 146.0 sp|Q3V0J4|ANR53_MOUSE Ankyrin repeat domain-containing protein 53 OS=Mus musculus OX=10090 GN=Ankrd53 PE=2 SV=2 g20621.t1 A9UMP7 37.259 518 3.55e-95 303.0 sp|A9UMP7|ENO4_XENLA Enolase 4 OS=Xenopus laevis OX=8355 GN=eno4 PE=2 SV=2 g20621.t2 A9UMP7 37.259 518 7.41e-95 303.0 sp|A9UMP7|ENO4_XENLA Enolase 4 OS=Xenopus laevis OX=8355 GN=eno4 PE=2 SV=2 g20622.t1 Q5RAP5 53.54 226 3.2699999999999997e-74 241.0 sp|Q5RAP5|PYRD2_PONAB Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Pongo abelii OX=9601 GN=PYROXD2 PE=2 SV=1 g20623.t1 Q8N2H3 63.481 293 7.9e-134 394.0 sp|Q8N2H3|PYRD2_HUMAN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PYROXD2 PE=1 SV=2 g20624.t1 Q8N2H3 62.218 577 0.0 742.0 sp|Q8N2H3|PYRD2_HUMAN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PYROXD2 PE=1 SV=2 g20624.t2 Q8N2H3 62.218 577 0.0 741.0 sp|Q8N2H3|PYRD2_HUMAN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PYROXD2 PE=1 SV=2 g20625.t1 G1SQH0 77.397 146 4.46e-76 226.0 sp|G1SQH0|RL26_RABIT Large ribosomal subunit protein uL24 OS=Oryctolagus cuniculus OX=9986 GN=RPL26 PE=1 SV=1 g20626.t1 Q5EAD4 55.916 431 2.97e-168 482.0 sp|Q5EAD4|ACDSB_BOVIN Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ACADSB PE=2 SV=1 ACDSB_BOVIN reviewed Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.1) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase) Bos taurus (Bovine) GO:0003853; GO:0003995; GO:0005739; GO:0005759; GO:0006550; GO:0006631; GO:0016937; GO:0042802; GO:0050660 fatty acid metabolic process [GO:0006631]; L-isoleucine catabolic process [GO:0006550] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; short-chain 2-methyl fatty acyl-CoA dehydrogenase activity [GO:0003853]; short-chain fatty acyl-CoA dehydrogenase activity [GO:0016937] g20627.t1 Q8VEB1 70.144 556 0.0 784.0 sp|Q8VEB1|GRK5_MOUSE G protein-coupled receptor kinase 5 OS=Mus musculus OX=10090 GN=Grk5 PE=1 SV=2 GRK5_MOUSE reviewed G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) Mus musculus (Mouse) GO:0002029; GO:0004672; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007217; GO:0008277; GO:0008284; GO:0008289; GO:0009966; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726; GO:0106072 apoptotic process [GO:0006915]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; fat cell differentiation [GO:0045444]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674] g20627.t2 Q8VEB1 69.573 562 0.0 786.0 sp|Q8VEB1|GRK5_MOUSE G protein-coupled receptor kinase 5 OS=Mus musculus OX=10090 GN=Grk5 PE=1 SV=2 GRK5_MOUSE reviewed G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) Mus musculus (Mouse) GO:0002029; GO:0004672; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007217; GO:0008277; GO:0008284; GO:0008289; GO:0009966; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726; GO:0106072 apoptotic process [GO:0006915]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; fat cell differentiation [GO:0045444]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674] g20628.t1 Q8N9H8 32.675 658 1.97e-102 343.0 sp|Q8N9H8|MUT7_HUMAN Exonuclease mut-7 homolog OS=Homo sapiens OX=9606 GN=EXD3 PE=1 SV=3 g20629.t1 Q179T2 28.131 519 6.03e-49 184.0 sp|Q179T2|MUT7_AEDAE Exonuclease mut-7 homolog OS=Aedes aegypti OX=7159 GN=AAEL005527 PE=1 SV=1 g20630.t1 F6NXI9 56.127 408 2.0700000000000003e-161 465.0 sp|F6NXI9|TRNT1_DANRE CCA tRNA nucleotidyltransferase 1, mitochondrial OS=Danio rerio OX=7955 GN=trnt1 PE=2 SV=1 TRNT1_DANRE reviewed CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000049; GO:0001654; GO:0001680; GO:0001966; GO:0004810; GO:0005524; GO:0005634; GO:0005739; GO:0007632; GO:0008033; GO:0046872; GO:0160016; GO:1990180 eye development [GO:0001654]; mitochondrial tRNA 3'-end processing [GO:1990180]; thigmotaxis [GO:0001966]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033]; visual behavior [GO:0007632] mitochondrion [GO:0005739]; nucleus [GO:0005634] ATP binding [GO:0005524]; CCA tRNA nucleotidyltransferase activity [GO:0004810]; CCACCA tRNA nucleotidyltransferase activity [GO:0160016]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049] g20631.t1 Q3T0S0 35.758 165 7.3e-29 108.0 sp|Q3T0S0|TM128_BOVIN Transmembrane protein 128 OS=Bos taurus OX=9913 GN=TMEM128 PE=2 SV=1 g20632.t1 Q3T000 59.391 197 4.08e-84 250.0 sp|Q3T000|YKT6_BOVIN Synaptobrevin homolog YKT6 OS=Bos taurus OX=9913 GN=YKT6 PE=2 SV=1 YKT6_BOVIN reviewed Synaptobrevin homolog YKT6 (EC 2.3.1.-) Bos taurus (Bovine) GO:0000139; GO:0005484; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030659 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484] g20633.t1 Q9WVA3 81.308 321 0.0 568.0 sp|Q9WVA3|BUB3_MOUSE Mitotic checkpoint protein BUB3 OS=Mus musculus OX=10090 GN=Bub3 PE=1 SV=2 BUB3_MOUSE reviewed Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Mus musculus (Mouse) GO:0000776; GO:0005654; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298 attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983] bub1-bub3 complex [GO:1990298]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654] ubiquitin binding [GO:0043130] g20634.t1 Q8QHI3 69.061 181 6.77e-94 273.0 sp|Q8QHI3|ARL3_XENLA ADP-ribosylation factor-like protein 3 OS=Xenopus laevis OX=8355 GN=arl3 PE=2 SV=1 g20635.t1 Q9H8M5 57.483 588 0.0 666.0 sp|Q9H8M5|CNNM2_HUMAN Metal transporter CNNM2 OS=Homo sapiens OX=9606 GN=CNNM2 PE=1 SV=2 CNNM2_HUMAN reviewed Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2) Homo sapiens (Human) GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0016323; GO:0098978 magnesium ion homeostasis [GO:0010960] basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095] g20636.t1 Q5QP82 57.927 164 2.59e-63 212.0 sp|Q5QP82|DCA10_HUMAN DDB1- and CUL4-associated factor 10 OS=Homo sapiens OX=9606 GN=DCAF10 PE=1 SV=1 DCA10_HUMAN reviewed DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32) Homo sapiens (Human) GO:0005654; GO:0016567; GO:0080008 protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] g20639.t1 Q8WXF0 43.75 96 3.8100000000000004e-21 89.7 sp|Q8WXF0|SRS12_HUMAN Serine/arginine-rich splicing factor 12 OS=Homo sapiens OX=9606 GN=SRSF12 PE=1 SV=1 SRS12_HUMAN reviewed Serine/arginine-rich splicing factor 12 (35 kDa SR repressor protein) (SRrp35) (Splicing factor, arginine/serine-rich 13B) (Splicing factor, arginine/serine-rich 19) Homo sapiens (Human) GO:0000244; GO:0000381; GO:0000395; GO:0003723; GO:0003729; GO:0005654; GO:0016607; GO:0048025; GO:0050733; GO:0051082 mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082] g20640.t1 Q8R3B7 52.821 195 7.32e-52 200.0 sp|Q8R3B7|BRD8_MOUSE Bromodomain-containing protein 8 OS=Mus musculus OX=10090 GN=Brd8 PE=1 SV=2 BRD8_MOUSE reviewed Bromodomain-containing protein 8 Mus musculus (Mouse) GO:0000786; GO:0000812; GO:0003713; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0035267; GO:0042981; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779 cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779] mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713] g20640.t1 Q8R3B7 61.635 159 6.39e-50 194.0 sp|Q8R3B7|BRD8_MOUSE Bromodomain-containing protein 8 OS=Mus musculus OX=10090 GN=Brd8 PE=1 SV=2 BRD8_MOUSE reviewed Bromodomain-containing protein 8 Mus musculus (Mouse) GO:0000786; GO:0000812; GO:0003713; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0035267; GO:0042981; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779 cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779] mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713] g20643.t1 P31424 29.803 812 4.52e-110 368.0 sp|P31424|GRM5_RAT Metabotropic glutamate receptor 5 OS=Rattus norvegicus OX=10116 GN=Grm5 PE=1 SV=2 GRM5_RAT reviewed Metabotropic glutamate receptor 5 (mGluR5) Rattus norvegicus (Rat) GO:0001639; GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005516; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0006468; GO:0007200; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0008306; GO:0030165; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0044309; GO:0045211; GO:0045471; GO:0046677; GO:0048015; GO:0048169; GO:0048170; GO:0050804; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calmodulin binding [GO:0005516]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; PLC activating G protein-coupled glutamate receptor activity [GO:0001639]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g20644.t1 P78316 42.841 887 0.0 626.0 sp|P78316|NOP14_HUMAN Nucleolar protein 14 OS=Homo sapiens OX=9606 GN=NOP14 PE=1 SV=3 NOP14_HUMAN reviewed Nucleolar protein 14 (Nucleolar complex protein 14) Homo sapiens (Human) GO:0000447; GO:0000462; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0019899; GO:0030490; GO:0030515; GO:0030686; GO:0030692; GO:0032040; GO:0042274 endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] 90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g20645.t1 P91685 28.802 868 3.78e-112 368.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g20646.t1 P97772 30.713 687 7.73e-77 271.0 sp|P97772|GRM1_MOUSE Metabotropic glutamate receptor 1 OS=Mus musculus OX=10090 GN=Grm1 PE=1 SV=2 g20647.t1 P31421 30.265 869 2.56e-103 342.0 sp|P31421|GRM2_RAT Metabotropic glutamate receptor 2 OS=Rattus norvegicus OX=10116 GN=Grm2 PE=1 SV=1 GRM2_RAT reviewed Metabotropic glutamate receptor 2 (mGluR2) Rattus norvegicus (Rat) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007215; GO:0007216; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0033554; GO:0035095; GO:0042220; GO:0042734; GO:0043005; GO:0045211; GO:0046928; GO:0051897; GO:0051966; GO:0060292; GO:0090461; GO:0097110; GO:0097449; GO:0098978; GO:0099171; GO:2001023 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; behavioral response to nicotine [GO:0035095]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate receptor signaling pathway [GO:0007215]; glutamate secretion [GO:0014047]; intracellular glutamate homeostasis [GO:0090461]; long-term synaptic depression [GO:0060292]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of neurotransmitter secretion [GO:0046928]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g20649.t1 Q5JTH9 43.359 655 2.18e-140 444.0 sp|Q5JTH9|RRP12_HUMAN RRP12-like protein OS=Homo sapiens OX=9606 GN=RRP12 PE=1 SV=2 RRP12_HUMAN reviewed RRP12-like protein Homo sapiens (Human) GO:0003723; GO:0005730; GO:0005829; GO:0005886; GO:0031965 cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] RNA binding [GO:0003723] g20651.t1 Q5ZKD5 51.702 617 0.0 647.0 sp|Q5ZKD5|RRP12_CHICK RRP12-like protein OS=Gallus gallus OX=9031 GN=RRP12 PE=2 SV=1 g20654.t1 Q9YGD2 77.0 300 4.33e-153 434.0 sp|Q9YGD2|SUCA_COLLI Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (Fragment) OS=Columba livia OX=8932 GN=SUCLG1 PE=1 SV=1 g20655.t1 A4IIZ9 46.479 142 2.92e-38 130.0 sp|A4IIZ9|MED28_XENTR Mediator of RNA polymerase II transcription subunit 28 OS=Xenopus tropicalis OX=8364 GN=med28 PE=2 SV=1 g20656.t1 Q5XGB9 56.238 521 0.0 582.0 sp|Q5XGB9|AMPL_XENTR Cytosol aminopeptidase OS=Xenopus tropicalis OX=8364 GN=lap3 PE=2 SV=1 AMPL_XENTR reviewed Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004180; GO:0005737; GO:0006508; GO:0008233; GO:0030145; GO:0070006 proteolysis [GO:0006508] cytoplasm [GO:0005737] carboxypeptidase activity [GO:0004180]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233] g20670.t1 Q9DDN6 36.0 300 9.26e-49 172.0 sp|Q9DDN6|NPY2R_CHICK Neuropeptide Y receptor type 2 OS=Gallus gallus OX=9031 GN=NPY2R PE=3 SV=1 g20673.t1 O19071 41.492 429 1.14e-130 388.0 sp|O19071|MGAT2_PIG Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Sus scrofa OX=9823 GN=MGAT2 PE=3 SV=1 g20674.t1 Q7ZXQ9 40.854 492 1.02e-93 294.0 sp|Q7ZXQ9|DBNLA_XENLA Drebrin-like protein A OS=Xenopus laevis OX=8355 GN=dbnl-a PE=2 SV=1 DBNLA_XENLA reviewed Drebrin-like protein A Xenopus laevis (African clawed frog) GO:0000139; GO:0001726; GO:0002102; GO:0005769; GO:0005829; GO:0005884; GO:0014069; GO:0030027; GO:0030425; GO:0030427; GO:0030665; GO:0030833; GO:0030864; GO:0043204; GO:0045211; GO:0045773; GO:0048812; GO:0051015; GO:0061003; GO:0098974 neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833] actin filament [GO:0005884]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; site of polarized growth [GO:0030427] actin filament binding [GO:0051015] g20675.t1 A6H5Z3 56.195 799 0.0 927.0 sp|A6H5Z3|EXC6B_MOUSE Exocyst complex component 6B OS=Mus musculus OX=10090 GN=Exoc6b PE=1 SV=1 EXC6B_MOUSE reviewed Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2) Mus musculus (Mouse) GO:0000145; GO:0000281; GO:0005886; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145]; plasma membrane [GO:0005886] g20675.t2 Q9Y2D4 55.253 809 0.0 931.0 sp|Q9Y2D4|EXC6B_HUMAN Exocyst complex component 6B OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=3 EXC6B_HUMAN reviewed Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2) Homo sapiens (Human) GO:0000145; GO:0000281; GO:0005886; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145]; plasma membrane [GO:0005886] g20677.t1 P42674 34.63 257 5.94e-45 168.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g20680.t1 P32251 39.951 408 3.23e-92 287.0 sp|P32251|ADRA2_CARAU Alpha-2 adrenergic receptor OS=Carassius auratus OX=7957 PE=3 SV=1 g20681.t1 Q01827 52.51 518 3.83e-173 501.0 sp|Q01827|VMAT2_RAT Synaptic vesicular amine transporter OS=Rattus norvegicus OX=10116 GN=Slc18a2 PE=1 SV=2 g20682.t1 Q09575 32.026 459 2.39e-63 226.0 sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1 g20684.t1 P67963 86.103 331 0.0 604.0 sp|P67963|KC1A_XENLA Casein kinase I isoform alpha OS=Xenopus laevis OX=8355 GN=csnk1a1 PE=1 SV=1 KC1A_XENLA reviewed Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) Xenopus laevis (African clawed frog) GO:0000776; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226 cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20685.t1 P67963 87.937 315 0.0 589.0 sp|P67963|KC1A_XENLA Casein kinase I isoform alpha OS=Xenopus laevis OX=8355 GN=csnk1a1 PE=1 SV=1 KC1A_XENLA reviewed Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) Xenopus laevis (African clawed frog) GO:0000776; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226 cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20687.t1 Q99KL7 69.058 223 3.82e-114 328.0 sp|Q99KL7|RAB28_MOUSE Ras-related protein Rab-28 OS=Mus musculus OX=10090 GN=Rab28 PE=1 SV=1 g20688.t1 Q0P4S0 66.897 290 3.14e-133 429.0 sp|Q0P4S0|LST2_XENTR Lateral signaling target protein 2 homolog OS=Xenopus tropicalis OX=8364 GN=zfyve28 PE=2 SV=1 g20688.t1 Q0P4S0 68.493 73 1.1e-30 134.0 sp|Q0P4S0|LST2_XENTR Lateral signaling target protein 2 homolog OS=Xenopus tropicalis OX=8364 GN=zfyve28 PE=2 SV=1 g20692.t1 P29702 60.748 321 8.51e-136 393.0 sp|P29702|FNTA_BOVIN Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha OS=Bos taurus OX=9913 GN=FNTA PE=2 SV=2 FNTA_BOVIN reviewed Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha) Bos taurus (Bovine) GO:0004660; GO:0004661; GO:0004662; GO:0005737; GO:0005953; GO:0005965; GO:0007323; GO:0018343; GO:0018344 peptide pheromone maturation [GO:0007323]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344] CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; protein farnesyltransferase complex [GO:0005965] CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661] g20696.t1 Q8K194 75.0 68 3.79e-30 110.0 sp|Q8K194|SNR27_MOUSE U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein OS=Mus musculus OX=10090 GN=Snrnp27 PE=1 SV=1 g20698.t1 P97564 34.755 774 9.02e-149 462.0 sp|P97564|GPAT1_RAT Glycerol-3-phosphate acyltransferase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Gpam PE=1 SV=3 GPAT1_RAT reviewed Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15) Rattus norvegicus (Rat) GO:0001817; GO:0004366; GO:0005739; GO:0005741; GO:0005886; GO:0006631; GO:0006637; GO:0006641; GO:0006650; GO:0006651; GO:0006654; GO:0006655; GO:0007584; GO:0009749; GO:0009750; GO:0010867; GO:0014823; GO:0016024; GO:0019432; GO:0031667; GO:0031966; GO:0032869; GO:0040018; GO:0042104; GO:0046686; GO:0051607; GO:0055089; GO:0055091; GO:0070236 acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; cellular response to insulin stimulus [GO:0032869]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cytokine production [GO:0001817]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641] mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] glycerol-3-phosphate O-acyltransferase activity [GO:0004366] g20698.t2 P97564 34.755 774 1.71e-148 462.0 sp|P97564|GPAT1_RAT Glycerol-3-phosphate acyltransferase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Gpam PE=1 SV=3 GPAT1_RAT reviewed Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15) Rattus norvegicus (Rat) GO:0001817; GO:0004366; GO:0005739; GO:0005741; GO:0005886; GO:0006631; GO:0006637; GO:0006641; GO:0006650; GO:0006651; GO:0006654; GO:0006655; GO:0007584; GO:0009749; GO:0009750; GO:0010867; GO:0014823; GO:0016024; GO:0019432; GO:0031667; GO:0031966; GO:0032869; GO:0040018; GO:0042104; GO:0046686; GO:0051607; GO:0055089; GO:0055091; GO:0070236 acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; cellular response to insulin stimulus [GO:0032869]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cytokine production [GO:0001817]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641] mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] glycerol-3-phosphate O-acyltransferase activity [GO:0004366] g20699.t1 Q9H1B5 27.273 374 4.84e-33 142.0 sp|Q9H1B5|XYLT2_HUMAN Xylosyltransferase 2 OS=Homo sapiens OX=9606 GN=XYLT2 PE=1 SV=2 g20700.t1 Q5ZKJ5 58.264 484 0.0 566.0 sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1 g20702.t1 Q61824 36.98 914 1.07e-180 552.0 sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2 g20702.t2 Q61824 37.404 909 0.0 555.0 sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2 g20702.t3 Q61824 38.02 889 0.0 560.0 sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2 g20703.t1 P36537 31.944 504 1.56e-77 257.0 sp|P36537|UDB10_HUMAN UDP-glucuronosyltransferase 2B10 OS=Homo sapiens OX=9606 GN=UGT2B10 PE=1 SV=1 g20704.t1 P36537 31.928 498 7.73e-81 265.0 sp|P36537|UDB10_HUMAN UDP-glucuronosyltransferase 2B10 OS=Homo sapiens OX=9606 GN=UGT2B10 PE=1 SV=1 g20706.t1 P36537 31.89 508 1.54e-79 262.0 sp|P36537|UDB10_HUMAN UDP-glucuronosyltransferase 2B10 OS=Homo sapiens OX=9606 GN=UGT2B10 PE=1 SV=1 g20707.t1 F6QEU4 26.735 778 9.5e-71 249.0 sp|F6QEU4|LIN41_XENTR E3 ubiquitin-protein ligase TRIM71 OS=Xenopus tropicalis OX=8364 GN=trim71 PE=3 SV=1 LIN41_XENTR reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20707.t1 F6QEU4 35.26 173 4.25e-22 105.0 sp|F6QEU4|LIN41_XENTR E3 ubiquitin-protein ligase TRIM71 OS=Xenopus tropicalis OX=8364 GN=trim71 PE=3 SV=1 LIN41_XENTR reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g20708.t1 Q3SZA9 48.76 121 2.04e-28 108.0 sp|Q3SZA9|RM35_BOVIN Large ribosomal subunit protein bL35m OS=Bos taurus OX=9913 GN=MRPL35 PE=2 SV=2 g20709.t1 Q86WZ0 28.626 1055 4.4e-113 381.0 sp|Q86WZ0|HEAT4_HUMAN HEAT repeat-containing protein 4 OS=Homo sapiens OX=9606 GN=HEATR4 PE=1 SV=2 g20711.t1 Q9NZJ5 35.808 1064 6.329999999999999e-180 560.0 sp|Q9NZJ5|E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens OX=9606 GN=EIF2AK3 PE=1 SV=3 E2AK3_HUMAN reviewed Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2) Homo sapiens (Human) GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006446; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0016020; GO:0017148; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032055; GO:0032057; GO:0034198; GO:0034976; GO:0036491; GO:0036499; GO:0042149; GO:0042802; GO:0044233; GO:0045182; GO:0045943; GO:0045947; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0070417; GO:0106310; GO:1900182; GO:1902235; GO:1990737 angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; translation regulator activity [GO:0045182] g20712.t1 Q8CDT7 35.556 225 2.07e-38 138.0 sp|Q8CDT7|CBCO1_MOUSE Ciliary-associated calcium-binding coiled-coil protein 1 OS=Mus musculus OX=10090 GN=Cabcoco1 PE=1 SV=2 g20713.t1 Q9D172 70.089 224 1.23e-118 343.0 sp|Q9D172|GAL3A_MOUSE Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial OS=Mus musculus OX=10090 GN=Gatd3 PE=1 SV=1 g20714.t1 Q5F349 51.761 284 1.83e-96 293.0 sp|Q5F349|SG196_CHICK Protein O-mannose kinase OS=Gallus gallus OX=9031 GN=POMK PE=2 SV=1 SG196_CHICK reviewed Protein O-mannose kinase (POMK) (EC 2.7.1.183) (Protein kinase-like protein SgK196) (Sugen kinase 196) Gallus gallus (Chicken) GO:0004672; GO:0005524; GO:0005789; GO:0006493; GO:0016773; GO:0019200; GO:0046835 carbohydrate phosphorylation [GO:0046835]; protein O-linked glycosylation [GO:0006493] endoplasmic reticulum membrane [GO:0005789] ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672] g20715.t1 Q91YP6 50.699 286 3.89e-96 298.0 sp|Q91YP6|ELMD3_MOUSE ELMO domain-containing protein 3 OS=Mus musculus OX=10090 GN=Elmod3 PE=1 SV=1 g20716.t1 P42859 42.019 3120 0.0 2257.0 sp|P42859|HD_MOUSE Huntingtin OS=Mus musculus OX=10090 GN=Htt PE=1 SV=2 g20718.t1 P91685 27.954 787 4.2500000000000004e-88 301.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g20719.t1 Q8C9S4 41.325 830 4.5200000000000004e-166 518.0 sp|Q8C9S4|CC186_MOUSE Coiled-coil domain-containing protein 186 OS=Mus musculus OX=10090 GN=Ccdc186 PE=1 SV=2 g20719.t2 Q8C9S4 41.276 831 6.780000000000001e-166 518.0 sp|Q8C9S4|CC186_MOUSE Coiled-coil domain-containing protein 186 OS=Mus musculus OX=10090 GN=Ccdc186 PE=1 SV=2 g20722.t1 Q91WD2 29.244 595 3.97e-64 231.0 sp|Q91WD2|TRPV6_MOUSE Transient receptor potential cation channel subfamily V member 6 OS=Mus musculus OX=10090 GN=Trpv6 PE=1 SV=2 TRPV6_MOUSE reviewed Transient receptor potential cation channel subfamily V member 6 (TrpV6) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2) Mus musculus (Mouse) GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016020; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051289; GO:0051592; GO:0055074; GO:0070509; GO:0070588; GO:0098703 calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592] calcium channel complex [GO:0034704]; membrane [GO:0016020]; plasma membrane [GO:0005886] calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g20725.t1 Q28479 66.465 331 2.45e-161 460.0 sp|Q28479|IDH3B_MACFA Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Macaca fascicularis OX=9541 GN=IDH3B PE=2 SV=2 g20726.t1 Q5EAJ7 46.759 864 0.0 796.0 sp|Q5EAJ7|MVP_STRPU Major vault protein OS=Strongylocentrotus purpuratus OX=7668 GN=MVP PE=1 SV=1 g20727.t1 B2LU20 67.937 315 4.04e-160 452.0 sp|B2LU20|SFXN1_SHEEP Sideroflexin-1 OS=Ovis aries OX=9940 GN=SFXN1 PE=2 SV=1 g20728.t1 P54803 54.531 651 0.0 704.0 sp|P54803|GALC_HUMAN Galactocerebrosidase OS=Homo sapiens OX=9606 GN=GALC PE=1 SV=3 GALC_HUMAN reviewed Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase) Homo sapiens (Human) GO:0004336; GO:0005764; GO:0006683; GO:0016020; GO:0042552; GO:0043202; GO:0046479 galactosylceramide catabolic process [GO:0006683]; glycosphingolipid catabolic process [GO:0046479]; myelination [GO:0042552] lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] galactosylceramidase activity [GO:0004336] g20728.t2 Q498K0 55.0 660 0.0 705.0 sp|Q498K0|GALC_XENLA Galactocerebrosidase OS=Xenopus laevis OX=8355 GN=galc PE=2 SV=2 g20728.t3 Q498K0 50.524 477 9.720000000000001e-157 463.0 sp|Q498K0|GALC_XENLA Galactocerebrosidase OS=Xenopus laevis OX=8355 GN=galc PE=2 SV=2 g20728.t4 P54803 49.231 715 0.0 664.0 sp|P54803|GALC_HUMAN Galactocerebrosidase OS=Homo sapiens OX=9606 GN=GALC PE=1 SV=3 GALC_HUMAN reviewed Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase) Homo sapiens (Human) GO:0004336; GO:0005764; GO:0006683; GO:0016020; GO:0042552; GO:0043202; GO:0046479 galactosylceramide catabolic process [GO:0006683]; glycosphingolipid catabolic process [GO:0046479]; myelination [GO:0042552] lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] galactosylceramidase activity [GO:0004336] g20728.t5 P54803 50.57 702 0.0 682.0 sp|P54803|GALC_HUMAN Galactocerebrosidase OS=Homo sapiens OX=9606 GN=GALC PE=1 SV=3 GALC_HUMAN reviewed Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase) Homo sapiens (Human) GO:0004336; GO:0005764; GO:0006683; GO:0016020; GO:0042552; GO:0043202; GO:0046479 galactosylceramide catabolic process [GO:0006683]; glycosphingolipid catabolic process [GO:0046479]; myelination [GO:0042552] lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] galactosylceramidase activity [GO:0004336] g20729.t1 P54803 54.729 645 0.0 697.0 sp|P54803|GALC_HUMAN Galactocerebrosidase OS=Homo sapiens OX=9606 GN=GALC PE=1 SV=3 GALC_HUMAN reviewed Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase) Homo sapiens (Human) GO:0004336; GO:0005764; GO:0006683; GO:0016020; GO:0042552; GO:0043202; GO:0046479 galactosylceramide catabolic process [GO:0006683]; glycosphingolipid catabolic process [GO:0046479]; myelination [GO:0042552] lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] galactosylceramidase activity [GO:0004336] g20730.t1 P70318 51.133 309 9.68e-100 306.0 sp|P70318|TIAR_MOUSE Nucleolysin TIAR OS=Mus musculus OX=10090 GN=Tial1 PE=1 SV=1 TIAR_MOUSE reviewed Nucleolysin TIAR (TIA-1-related protein) Mus musculus (Mouse) GO:0003677; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007281; GO:0008284; GO:0008285; GO:0010494; GO:0017145; GO:0035332; GO:0035925; GO:0044194; GO:0140517; GO:1990904; GO:2000637 apoptotic process [GO:0006915]; germ cell development [GO:0007281]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; stem cell division [GO:0017145] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517] g20730.t2 Q01085 53.082 292 2.14e-102 311.0 sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1 TIAR_HUMAN reviewed Nucleolysin TIAR (TIA-1-related protein) Homo sapiens (Human) GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637 apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723] g20730.t3 P70318 52.915 223 1.1600000000000001e-73 236.0 sp|P70318|TIAR_MOUSE Nucleolysin TIAR OS=Mus musculus OX=10090 GN=Tial1 PE=1 SV=1 TIAR_MOUSE reviewed Nucleolysin TIAR (TIA-1-related protein) Mus musculus (Mouse) GO:0003677; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007281; GO:0008284; GO:0008285; GO:0010494; GO:0017145; GO:0035332; GO:0035925; GO:0044194; GO:0140517; GO:1990904; GO:2000637 apoptotic process [GO:0006915]; germ cell development [GO:0007281]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; stem cell division [GO:0017145] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517] g20733.t1 Q8CGI1 26.27 571 4.84e-38 159.0 sp|Q8CGI1|F193A_MOUSE Protein FAM193A OS=Mus musculus OX=10090 GN=Fam193a PE=1 SV=2 g20733.t1 Q8CGI1 29.701 569 1.71e-33 145.0 sp|Q8CGI1|F193A_MOUSE Protein FAM193A OS=Mus musculus OX=10090 GN=Fam193a PE=1 SV=2 g20733.t2 Q8CGI1 26.27 571 4.81e-38 159.0 sp|Q8CGI1|F193A_MOUSE Protein FAM193A OS=Mus musculus OX=10090 GN=Fam193a PE=1 SV=2 g20733.t2 Q8CGI1 29.877 569 2.4e-35 150.0 sp|Q8CGI1|F193A_MOUSE Protein FAM193A OS=Mus musculus OX=10090 GN=Fam193a PE=1 SV=2 g20735.t1 P30937 42.169 332 1.06e-75 241.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g20737.t1 A0A1L8GXY4 40.222 1713 0.0 1197.0 sp|A0A1L8GXY4|CFA43_XENLA Cilia- and flagella-associated protein 43 OS=Xenopus laevis OX=8355 GN=cfap43 PE=2 SV=1 g20738.t1 Q8R1R3 45.016 311 1.29e-96 296.0 sp|Q8R1R3|STAR7_MOUSE StAR-related lipid transfer protein 7, mitochondrial OS=Mus musculus OX=10090 GN=Stard7 PE=1 SV=2 STAR7_MOUSE reviewed StAR-related lipid transfer protein 7, mitochondrial (START domain-containing protein 7) (StARD7) Mus musculus (Mouse) GO:0001773; GO:0005576; GO:0005737; GO:0005739; GO:0006954; GO:0008289; GO:0042092; GO:0061436; GO:0120197; GO:0140104 establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; type 2 immune response [GO:0042092] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] lipid binding [GO:0008289]; molecular carrier activity [GO:0140104] g20740.t1 Q7T2H2 58.754 337 2.6799999999999997e-137 409.0 sp|Q7T2H2|FGRL1_CHICK Fibroblast growth factor receptor-like 1 OS=Gallus gallus OX=9031 GN=FGFRL1 PE=1 SV=1 g20741.t1 Q26614 48.018 908 0.0 804.0 sp|Q26614|FGFR_STRPU Fibroblast growth factor receptor OS=Strongylocentrotus purpuratus OX=7668 GN=FGFR PE=2 SV=1 FGFR_STRPU reviewed Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005007; GO:0005524; GO:0005886; GO:0008284; GO:0008543; GO:0017134; GO:0043235; GO:0043410 fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007] g20742.t1 Q5XGR4 60.526 152 1.59e-60 190.0 sp|Q5XGR4|TM2D2_XENLA TM2 domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=tm2d2 PE=2 SV=1 g20743.t1 A4IHT0 69.779 407 0.0 560.0 sp|A4IHT0|FIGL1_XENTR Fidgetin-like protein 1 OS=Xenopus tropicalis OX=8364 GN=fignl1 PE=2 SV=1 FIGL1_XENTR reviewed Fidgetin-like protein 1 (EC 3.6.4.-) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000228; GO:0000287; GO:0005524; GO:0005634; GO:0005737; GO:0008045; GO:0008568; GO:0016787; GO:0016887; GO:0030674; GO:0046034; GO:0048471; GO:0051013; GO:2001017 ATP metabolic process [GO:0046034]; microtubule severing [GO:0051013]; motor neuron axon guidance [GO:0008045]; regulation of retrograde axon cargo transport [GO:2001017] cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568]; protein-macromolecule adaptor activity [GO:0030674] g20744.t1 E9PVX6 58.511 94 4.8899999999999994e-30 134.0 sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1 KI67_MOUSE reviewed Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog) Mus musculus (Mouse) GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072574; GO:0140693; GO:1902275; GO:1990705 cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088] chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723] g20747.t1 O08791 77.419 186 1.29e-102 310.0 sp|O08791|COE3_MOUSE Transcription factor COE3 OS=Mus musculus OX=10090 GN=Ebf3 PE=1 SV=1 g20749.t1 O08791 60.204 392 1.4e-148 437.0 sp|O08791|COE3_MOUSE Transcription factor COE3 OS=Mus musculus OX=10090 GN=Ebf3 PE=1 SV=1 g20750.t1 P80313 78.165 545 0.0 892.0 sp|P80313|TCPH_MOUSE T-complex protein 1 subunit eta OS=Mus musculus OX=10090 GN=Cct7 PE=1 SV=1 TCPH_MOUSE reviewed T-complex protein 1 subunit eta (TCP-1-eta) (EC 3.6.1.-) (CCT-eta) Mus musculus (Mouse) GO:0002199; GO:0005524; GO:0005739; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0042802; GO:0044183; GO:0044297; GO:0046872; GO:0050821; GO:0051082; GO:0140662 binding of sperm to zona pellucida [GO:0007339]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; zona pellucida receptor complex [GO:0002199] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] g20751.t1 Q5RKI3 46.167 587 8.8e-171 502.0 sp|Q5RKI3|DPOLL_RAT DNA polymerase lambda OS=Rattus norvegicus OX=10116 GN=Poll PE=2 SV=1 g20752.t1 P67963 72.973 333 0.0 520.0 sp|P67963|KC1A_XENLA Casein kinase I isoform alpha OS=Xenopus laevis OX=8355 GN=csnk1a1 PE=1 SV=1 KC1A_XENLA reviewed Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) Xenopus laevis (African clawed frog) GO:0000776; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226 cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g20753.t1 P97292 40.782 358 2.93e-86 271.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g20754.t1 Q96IZ5 46.281 121 6.02e-30 124.0 sp|Q96IZ5|RBM41_HUMAN RNA-binding protein 41 OS=Homo sapiens OX=9606 GN=RBM41 PE=1 SV=2 g20755.t1 Q8N5Y2 37.234 564 1.69e-88 285.0 sp|Q8N5Y2|MS3L1_HUMAN MSL complex subunit 3 OS=Homo sapiens OX=9606 GN=MSL3 PE=1 SV=1 g20755.t2 Q8N5Y2 36.207 580 2.59e-84 275.0 sp|Q8N5Y2|MS3L1_HUMAN MSL complex subunit 3 OS=Homo sapiens OX=9606 GN=MSL3 PE=1 SV=1 g20758.t1 Q8CDA1 49.43 789 0.0 740.0 sp|Q8CDA1|SAC2_MOUSE Phosphatidylinositide phosphatase SAC2 OS=Mus musculus OX=10090 GN=Inpp5f PE=1 SV=1 SAC2_MOUSE reviewed Phosphatidylinositide 4-phosphatase SAC2 (EC 3.1.3.-) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2) Mus musculus (Mouse) GO:0001921; GO:0005737; GO:0005769; GO:0005905; GO:0008344; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0034595; GO:0034596; GO:0042803; GO:0043025; GO:0043491; GO:0043812; GO:0045334; GO:0046856; GO:0048681; GO:0051896; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135 adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896] axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037] inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803] g20759.t1 Q6AYQ1 54.198 131 3.33e-46 150.0 sp|Q6AYQ1|GOGA7_RAT Golgin subfamily A member 7 OS=Rattus norvegicus OX=10116 GN=Golga7 PE=2 SV=1 GOGA7_RAT reviewed Golgin subfamily A member 7 Rattus norvegicus (Rat) GO:0000139; GO:0002178; GO:0005795; GO:0006612; GO:0006893; GO:0043001; GO:0043687; GO:0050821 Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; post-translational protein modification [GO:0043687]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; palmitoyltransferase complex [GO:0002178] g20761.t1 O55003 41.361 191 4.16e-28 107.0 sp|O55003|BNIP3_MOUSE BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 OS=Mus musculus OX=10090 GN=Bnip3 PE=1 SV=1 BNIP3_MOUSE reviewed BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 Mus musculus (Mouse) GO:0000423; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006915; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043068; GO:0043069; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0061709; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:0140506; GO:0140507; GO:0140580; GO:1902109; GO:1903599; GO:1990144 apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; mitophagy [GO:0000423]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; reticulophagy [GO:0061709] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; mitochondrion autophagosome adaptor activity [GO:0140580]; protein homodimerization activity [GO:0042803] g20762.t1 Q5EA43 63.175 315 6.799999999999999e-142 407.0 sp|Q5EA43|SFXN2_BOVIN Sideroflexin-2 OS=Bos taurus OX=9913 GN=SFXN2 PE=2 SV=2 g20763.t1 B5FYQ0 68.681 182 9.37e-91 266.0 sp|B5FYQ0|ARL3_TAEGU ADP-ribosylation factor-like protein 3 OS=Taeniopygia guttata OX=59729 GN=ARL3 PE=2 SV=1 ARL3_TAEGU reviewed ADP-ribosylation factor-like protein 3 Taeniopygia guttata (Zebra finch) (Poephila guttata) GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:1903441 cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017] g20764.t1 Q6GLB9 50.988 253 1.4700000000000001e-64 204.0 sp|Q6GLB9|EMX1_XENTR Homeobox protein EMX1 OS=Xenopus tropicalis OX=8364 GN=emx1 PE=2 SV=1 EMX1_XENTR reviewed Homeobox protein EMX1 (Empty spiracles homolog 1) (Empty spiracles-like protein 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007417; GO:0007420; GO:0030182 brain development [GO:0007420]; central nervous system development [GO:0007417]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g20765.t1 Q8TD22 60.39 154 2.85e-58 187.0 sp|Q8TD22|SFXN5_HUMAN Sideroflexin-5 OS=Homo sapiens OX=9606 GN=SFXN5 PE=1 SV=1 SFXN5_HUMAN reviewed Sideroflexin-5 Homo sapiens (Human) GO:0005739; GO:0005743; GO:0006865; GO:0015075; GO:0015137; GO:0015746; GO:0120162; GO:1990542 amino acid transport [GO:0006865]; citrate transport [GO:0015746]; mitochondrial transmembrane transport [GO:1990542]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] citrate transmembrane transporter activity [GO:0015137]; monoatomic ion transmembrane transporter activity [GO:0015075] g20766.t1 Q925N0 63.924 158 2.3200000000000003e-73 227.0 sp|Q925N0|SFXN5_MOUSE Sideroflexin-5 OS=Mus musculus OX=10090 GN=Sfxn5 PE=1 SV=2 g20768.t1 P50540 47.534 223 1.31e-46 155.0 sp|P50540|MXI1_MOUSE Max-interacting protein 1 OS=Mus musculus OX=10090 GN=Mxi1 PE=1 SV=1 g20770.t1 Q9PU20 53.521 142 6.38e-39 141.0 sp|Q9PU20|VAX2A_XENLA Ventral anterior homeobox 2a OS=Xenopus laevis OX=8355 GN=vax2-a PE=2 SV=1 g20771.t1 Q28G26 65.296 389 0.0 539.0 sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1 P4K2B_XENTR reviewed Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0004430; GO:0005524; GO:0005768; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0007032; GO:0031901; GO:0046854 endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] g20773.t1 O93295 36.893 515 5.12e-94 298.0 sp|O93295|ENTP8_CHICK Ectonucleoside triphosphate diphosphohydrolase 8 OS=Gallus gallus OX=9031 GN=ENTPD8 PE=1 SV=1 g20774.t1 O93295 37.597 516 2.1e-93 296.0 sp|O93295|ENTP8_CHICK Ectonucleoside triphosphate diphosphohydrolase 8 OS=Gallus gallus OX=9031 GN=ENTPD8 PE=1 SV=1 g20775.t1 Q9MYM7 33.841 328 8.14e-51 183.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g20775.t1 Q9MYM7 31.395 258 1.8500000000000002e-35 140.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g20776.t1 P12717 99.734 376 0.0 785.0 sp|P12717|ACTM_PISOC Actin, muscle OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g20778.t1 Q9N293 33.459 266 7.39e-38 146.0 sp|Q9N293|B3GT5_GORGO Beta-1,3-galactosyltransferase 5 (Fragment) OS=Gorilla gorilla gorilla OX=9595 GN=B3GALT5 PE=3 SV=2 g20779.t1 Q5ZL36 32.83 265 3.9799999999999998e-25 109.0 sp|Q5ZL36|ZFY27_CHICK Protrudin OS=Gallus gallus OX=9031 GN=ZFYVE27 PE=2 SV=1 ZFY27_CHICK reviewed Protrudin (Zinc finger FYVE domain-containing protein 27) Gallus gallus (Chicken) GO:0005783; GO:0005789; GO:0008270; GO:0016020; GO:0016192; GO:0030424; GO:0030425; GO:0031175; GO:0032584; GO:0045773; GO:0048011; GO:0055038; GO:0071782; GO:0071787; GO:0072659 endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038] zinc ion binding [GO:0008270] g20780.t1 Q5T2E6 58.576 688 0.0 824.0 sp|Q5T2E6|ARMD3_HUMAN Armadillo-like helical domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ARMH3 PE=1 SV=1 g20782.t1 Q8HYN7 66.489 188 6.92e-97 284.0 sp|Q8HYN7|KCIP4_MACFA Kv channel-interacting protein 4 OS=Macaca fascicularis OX=9541 GN=KCNIP4 PE=2 SV=1 g20785.t1 Q9QY96 34.713 314 4.6300000000000004e-36 150.0 sp|Q9QY96|CASR_MOUSE Extracellular calcium-sensing receptor OS=Mus musculus OX=10090 GN=Casr PE=1 SV=2 g20789.t1 Q99K43 41.561 628 1.83e-150 452.0 sp|Q99K43|PRC1_MOUSE Protein regulator of cytokinesis 1 OS=Mus musculus OX=10090 GN=Prc1 PE=1 SV=2 PRC1_MOUSE reviewed Protein regulator of cytokinesis 1 Mus musculus (Mouse) GO:0000226; GO:0000922; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023 cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465] contractile ring [GO:0070938]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922] identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] g20795.t1 P53621 82.419 802 0.0 1425.0 sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2 COPA_HUMAN reviewed Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin] Homo sapiens (Human) GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133] hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198] g20796.t1 P53621 62.716 405 1.2700000000000002e-167 503.0 sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2 COPA_HUMAN reviewed Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin] Homo sapiens (Human) GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133] hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198] g20797.t1 E9PTG8 53.283 396 1.12e-133 434.0 sp|E9PTG8|STK10_RAT Serine/threonine-protein kinase 10 OS=Rattus norvegicus OX=10116 GN=Stk10 PE=1 SV=1 g20797.t1 E9PTG8 34.239 552 5.49e-73 266.0 sp|E9PTG8|STK10_RAT Serine/threonine-protein kinase 10 OS=Rattus norvegicus OX=10116 GN=Stk10 PE=1 SV=1 g20798.t1 Q0KK55 46.032 189 1.2e-36 151.0 sp|Q0KK55|KNDC1_MOUSE Kinase non-catalytic C-lobe domain-containing protein 1 OS=Mus musculus OX=10090 GN=Kndc1 PE=1 SV=2 KNDC1_MOUSE reviewed Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2) Mus musculus (Mouse) GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773 cerebellar granule cell differentiation [GO:0021707]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] guanyl-nucleotide exchange factor activity [GO:0005085] g20800.t1 Q76NI1 35.559 689 3.93e-108 378.0 sp|Q76NI1|KNDC1_HUMAN Kinase non-catalytic C-lobe domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KNDC1 PE=1 SV=2 KNDC1_HUMAN reviewed Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2) Homo sapiens (Human) GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773 cerebellar granule cell differentiation [GO:0021707]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] guanyl-nucleotide exchange factor activity [GO:0005085] g20801.t1 F1QEB7 45.428 339 5.3599999999999996e-89 295.0 sp|F1QEB7|WDR11_DANRE WD repeat-containing protein 11 OS=Danio rerio OX=7955 GN=wdr11 PE=2 SV=1 WDR11_DANRE reviewed WD repeat-containing protein 11 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001755; GO:0005634; GO:0005737; GO:0005802; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; neural crest cell migration [GO:0001755]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] g20801.t2 Q9BZH6 43.646 543 1.16e-141 440.0 sp|Q9BZH6|WDR11_HUMAN WD repeat-containing protein 11 OS=Homo sapiens OX=9606 GN=WDR11 PE=1 SV=1 WDR11_HUMAN reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0097228; GO:0097229; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm principal piece [GO:0097228]; trans-Golgi network [GO:0005802] g20801.t3 Q9BZH6 43.548 186 1.3699999999999998e-48 172.0 sp|Q9BZH6|WDR11_HUMAN WD repeat-containing protein 11 OS=Homo sapiens OX=9606 GN=WDR11 PE=1 SV=1 WDR11_HUMAN reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0097228; GO:0097229; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm principal piece [GO:0097228]; trans-Golgi network [GO:0005802] g20801.t4 Q9BZH6 43.548 186 3.36e-49 173.0 sp|Q9BZH6|WDR11_HUMAN WD repeat-containing protein 11 OS=Homo sapiens OX=9606 GN=WDR11 PE=1 SV=1 WDR11_HUMAN reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0097228; GO:0097229; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm principal piece [GO:0097228]; trans-Golgi network [GO:0005802] g20802.t1 Q8K1X1 58.015 131 5.93e-46 163.0 sp|Q8K1X1|WDR11_MOUSE WD repeat-containing protein 11 OS=Mus musculus OX=10090 GN=Wdr11 PE=1 SV=1 WDR11_MOUSE reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g20803.t1 Q8K1X1 47.639 466 8.1e-139 431.0 sp|Q8K1X1|WDR11_MOUSE WD repeat-containing protein 11 OS=Mus musculus OX=10090 GN=Wdr11 PE=1 SV=1 WDR11_MOUSE reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g20803.t2 Q8K1X1 47.046 474 8.329999999999999e-138 429.0 sp|Q8K1X1|WDR11_MOUSE WD repeat-containing protein 11 OS=Mus musculus OX=10090 GN=Wdr11 PE=1 SV=1 WDR11_MOUSE reviewed WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g20805.t1 Q9NY57 57.855 401 1.79e-169 485.0 sp|Q9NY57|ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens OX=9606 GN=STK32B PE=1 SV=1 g20808.t1 O76536 33.991 659 7.89e-37 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t1 O76536 33.38 713 8.600000000000001e-37 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t1 O76536 33.037 675 1.79e-35 150.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t1 O76536 30.435 736 2.2700000000000003e-31 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t1 O76536 30.156 703 4.65e-28 126.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t2 O76536 33.991 659 7.89e-37 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t2 O76536 33.38 713 8.600000000000001e-37 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t2 O76536 33.037 675 1.79e-35 150.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t2 O76536 30.435 736 2.2700000000000003e-31 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t2 O76536 30.156 703 4.65e-28 126.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t3 O76536 34.076 628 1.32e-35 150.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t3 O76536 33.603 619 1.1e-31 138.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t3 O76536 32.998 597 2.59e-29 130.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t3 O76536 31.298 655 4.01e-28 126.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t4 O76536 34.27 534 7.599999999999999e-30 132.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t4 O76536 33.457 541 1.45e-24 114.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t4 O76536 32.673 505 3.35e-24 113.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20808.t4 O76536 32.314 523 1.5100000000000001e-22 108.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g20809.t1 Q14517 36.872 179 2.38e-28 120.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20809.t1 Q14517 35.26 173 1.84e-26 114.0 sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2 g20810.t1 Q23435 28.926 242 5.2699999999999994e-24 107.0 sp|Q23435|TWK9_CAEEL TWiK family of potassium channels protein 9 OS=Caenorhabditis elegans OX=6239 GN=twk-9 PE=2 SV=2 g20811.t1 O02464 26.822 343 4.03e-31 125.0 sp|O02464|OPS1_MANSE Opsin-1 OS=Manduca sexta OX=7130 GN=OP1 PE=1 SV=2 g20812.t1 O54782 44.604 1047 0.0 867.0 sp|O54782|MA2B2_MOUSE Epididymis-specific alpha-mannosidase OS=Mus musculus OX=10090 GN=Man2b2 PE=1 SV=2 g20818.t1 Q0P563 74.0 150 2.71e-73 219.0 sp|Q0P563|FUCM_BOVIN Fucose mutarotase OS=Bos taurus OX=9913 GN=FUOM PE=2 SV=1 FUCM_BOVIN reviewed Fucose mutarotase (EC 5.1.3.29) Bos taurus (Bovine) GO:0005829; GO:0006004; GO:0016857; GO:0036373; GO:0042806 fucose metabolic process [GO:0006004] cytosol [GO:0005829] fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857] g20819.t1 Q4VBI7 62.264 318 3.84e-133 384.0 sp|Q4VBI7|STX18_DANRE Syntaxin-18 OS=Danio rerio OX=7955 GN=stx18 PE=2 SV=1 g20820.t1 Q5FVR4 49.813 267 2.08e-96 294.0 sp|Q5FVR4|ERI1_RAT 3'-5' exoribonuclease 1 OS=Rattus norvegicus OX=10116 GN=Eri1 PE=2 SV=1 ERI1_RAT reviewed 3'-5' exoribonuclease 1 (EC 3.1.13.1) (Histone mRNA 3'-exonuclease 1) Rattus norvegicus (Rat) GO:0000175; GO:0000460; GO:0000467; GO:0005634; GO:0005730; GO:0005737; GO:0008408; GO:0008859; GO:0019843; GO:0031047; GO:0031125; GO:0043022; GO:0046872; GO:0071204; GO:0071207 exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; maturation of 5.8S rRNA [GO:0000460]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rRNA 3'-end processing [GO:0031125] cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-RNA exonuclease activity [GO:0000175]; exoribonuclease II activity [GO:0008859]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843] g20821.t1 Q5RD78 53.699 784 0.0 857.0 sp|Q5RD78|HECD2_PONAB Probable E3 ubiquitin-protein ligase HECTD2 OS=Pongo abelii OX=9601 GN=HECTD2 PE=2 SV=1 g20822.t1 D3ZZX1 48.25 400 1.6199999999999999e-136 400.0 sp|D3ZZX1|I5P1_RAT Inositol polyphosphate-5-phosphatase A OS=Rattus norvegicus OX=10116 GN=Inpp5a PE=1 SV=1 I5P1_RAT reviewed Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase) Rattus norvegicus (Rat) GO:0004445; GO:0005886; GO:0016020; GO:0030425; GO:0042731; GO:0043647; GO:0046856; GO:0050849; GO:0052658; GO:0052659; GO:1900737 inositol phosphate metabolic process [GO:0043647]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; phosphatidylinositol dephosphorylation [GO:0046856] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731] g20824.t1 P78426 72.358 123 7.7199999999999995e-53 177.0 sp|P78426|NKX61_HUMAN Homeobox protein Nkx-6.1 OS=Homo sapiens OX=9606 GN=NKX6-1 PE=1 SV=2 NKX61_HUMAN reviewed Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003310; GO:0003682; GO:0005634; GO:0006357; GO:0006366; GO:0007224; GO:0009410; GO:0009887; GO:0010255; GO:0021520; GO:0030154; GO:0030516; GO:0031016; GO:0032024; GO:0035094; GO:0044342; GO:0045666; GO:0045944; GO:0048709; GO:0048714; GO:0048715; GO:0061629; GO:0070062; GO:0071345; GO:0071375; GO:0072560; GO:2000078; GO:2001222 animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cellular response to peptide hormone stimulus [GO:0071375]; glucose mediated signaling pathway [GO:0010255]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte differentiation [GO:0048709]; pancreas development [GO:0031016]; pancreatic A cell differentiation [GO:0003310]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of axon extension [GO:0030516]; regulation of neuron migration [GO:2001222]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron cell fate specification [GO:0021520]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell maturation [GO:0072560]; type B pancreatic cell proliferation [GO:0044342] chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g20825.t1 P56407 79.688 64 1.1300000000000002e-27 110.0 sp|P56407|HM09_CAEEL Homeobox protein ceh-9 OS=Caenorhabditis elegans OX=6239 GN=ceh-9 PE=3 SV=2 g20826.t1 O93366 44.076 211 1.4e-35 132.0 sp|O93366|TLX1_CHICK T-cell leukemia homeobox protein 1 OS=Gallus gallus OX=9031 GN=TLX1 PE=2 SV=1 g20827.t1 Q5E985 36.73 422 1.05e-83 267.0 sp|Q5E985|HYAL1_BOVIN Hyaluronidase-1 OS=Bos taurus OX=9913 GN=HYAL1 PE=2 SV=1 HYAL1_BOVIN reviewed Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) Bos taurus (Bovine) GO:0000302; GO:0004415; GO:0005615; GO:0005764; GO:0005975; GO:0006954; GO:0009615; GO:0030212; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0045766; GO:0045785; GO:0046677; GO:0051216; GO:0071347; GO:0071467; GO:0071493; GO:1900106 carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to UV-B [GO:0071493]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615] cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosome [GO:0005764] hyalurononglucosaminidase activity [GO:0004415] g20828.t1 Q91ZJ9 37.164 409 8.84e-77 249.0 sp|Q91ZJ9|HYAL1_MOUSE Hyaluronidase-1 OS=Mus musculus OX=10090 GN=Hyal1 PE=1 SV=3 HYAL1_MOUSE reviewed Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) Mus musculus (Mouse) GO:0000302; GO:0004415; GO:0005615; GO:0005764; GO:0005975; GO:0006954; GO:0009615; GO:0030207; GO:0030212; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0044344; GO:0045766; GO:0045785; GO:0046677; GO:0051216; GO:0052757; GO:0060272; GO:0071347; GO:0071356; GO:0071467; GO:0071493; GO:1900106 carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; embryonic skeletal joint morphogenesis [GO:0060272]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615] cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosome [GO:0005764] chondroitin hydrolase activity [GO:0052757]; hyalurononglucosaminidase activity [GO:0004415] g20829.t1 Q91770 61.176 85 4.020000000000001e-27 110.0 sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1 g20830.t1 Q8NB25 37.05 1139 0.0 651.0 sp|Q8NB25|F184A_HUMAN Protein FAM184A OS=Homo sapiens OX=9606 GN=FAM184A PE=1 SV=3 F184A_HUMAN reviewed Protein FAM184A Homo sapiens (Human) GO:0000932; GO:0005615; GO:0005829; GO:0034451; GO:0036064 centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular space [GO:0005615]; P-body [GO:0000932] g20831.t1 A1A4R8 58.092 587 0.0 677.0 sp|A1A4R8|CDC23_BOVIN Cell division cycle protein 23 homolog OS=Bos taurus OX=9913 GN=CDC23 PE=2 SV=1 g20832.t1 B4N937 55.967 243 2.65e-75 243.0 sp|B4N937|HTRA2_DROWI Serine protease HTRA2, mitochondrial OS=Drosophila willistoni OX=7260 GN=HtrA2 PE=3 SV=1 HTRA2_DROWI reviewed Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) Drosophila willistoni (Fruit fly) GO:0004252; GO:0005758; GO:0005829; GO:0006508; GO:0006915; GO:0007005; GO:0007283; GO:0016006; GO:0031966; GO:0035234; GO:0043065 apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; mitochondrion organization [GO:0007005]; positive regulation of apoptotic process [GO:0043065]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; Nebenkern [GO:0016006] serine-type endopeptidase activity [GO:0004252] g20835.t1 Q9WTK3 37.942 651 1.04e-118 370.0 sp|Q9WTK3|GPAA1_MOUSE GPI-anchor transamidase component GPAA1 OS=Mus musculus OX=10090 GN=Gpaa1 PE=1 SV=3 GPAA1_MOUSE reviewed GPI-anchor transamidase component GPAA1 (GAA1 protein homolog) (mGAA1) (Glycosylphosphatidylinositol anchor attachment 1 protein) (GPI anchor attachment protein 1) Mus musculus (Mouse) GO:0003923; GO:0005739; GO:0005783; GO:0005813; GO:0005829; GO:0005886; GO:0006506; GO:0016255; GO:0034235; GO:0042765; GO:0046872; GO:0180046 attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046] centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GPI-anchor transamidase complex [GO:0042765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] GPI anchor binding [GO:0034235]; GPI-anchor transamidase activity [GO:0003923]; metal ion binding [GO:0046872] g20835.t2 Q9WTK3 38.71 155 1.05e-25 105.0 sp|Q9WTK3|GPAA1_MOUSE GPI-anchor transamidase component GPAA1 OS=Mus musculus OX=10090 GN=Gpaa1 PE=1 SV=3 GPAA1_MOUSE reviewed GPI-anchor transamidase component GPAA1 (GAA1 protein homolog) (mGAA1) (Glycosylphosphatidylinositol anchor attachment 1 protein) (GPI anchor attachment protein 1) Mus musculus (Mouse) GO:0003923; GO:0005739; GO:0005783; GO:0005813; GO:0005829; GO:0005886; GO:0006506; GO:0016255; GO:0034235; GO:0042765; GO:0046872; GO:0180046 attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046] centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GPI-anchor transamidase complex [GO:0042765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] GPI anchor binding [GO:0034235]; GPI-anchor transamidase activity [GO:0003923]; metal ion binding [GO:0046872] g20836.t1 Q9Y606 57.059 340 2.51e-141 418.0 sp|Q9Y606|PUS1_HUMAN Pseudouridylate synthase 1 homolog OS=Homo sapiens OX=9606 GN=PUS1 PE=1 SV=3 PUS1_HUMAN reviewed Pseudouridylate synthase 1 homolog (EC 5.4.99.-) (tRNA pseudouridine synthase 1) (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I) Homo sapiens (Human) GO:0000049; GO:0002153; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031119; GO:0045944; GO:0070902; GO:0160147; GO:0160153; GO:1990481 mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; mitochondrial tRNA pseudouridine(27/28) synthase activity [GO:0160153]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; tRNA binding [GO:0000049]; tRNA pseudouridine(38-40) synthase activity [GO:0160147] g20837.t1 Q9EQH5 68.506 435 0.0 606.0 sp|Q9EQH5|CTBP2_RAT C-terminal-binding protein 2 OS=Rattus norvegicus OX=10116 GN=Ctbp2 PE=1 SV=2 CTBP2_RAT reviewed C-terminal-binding protein 2 (CtBP2) Rattus norvegicus (Rat) GO:0001221; GO:0001222; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0016081; GO:0016616; GO:0017053; GO:0019901; GO:0042802; GO:0042974; GO:0044877; GO:0045202; GO:0045892; GO:0045944; GO:0048386; GO:0050872; GO:0051287; GO:0097470; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0099523; GO:0140297; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic vesicle docking [GO:0016081]; white fat cell differentiation [GO:0050872] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; nuclear retinoic acid receptor binding [GO:0042974]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural constituent of presynaptic active zone [GO:0098882]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] g20837.t2 Q9EQH5 68.506 435 0.0 602.0 sp|Q9EQH5|CTBP2_RAT C-terminal-binding protein 2 OS=Rattus norvegicus OX=10116 GN=Ctbp2 PE=1 SV=2 CTBP2_RAT reviewed C-terminal-binding protein 2 (CtBP2) Rattus norvegicus (Rat) GO:0001221; GO:0001222; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0016081; GO:0016616; GO:0017053; GO:0019901; GO:0042802; GO:0042974; GO:0044877; GO:0045202; GO:0045892; GO:0045944; GO:0048386; GO:0050872; GO:0051287; GO:0097470; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0099523; GO:0140297; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic vesicle docking [GO:0016081]; white fat cell differentiation [GO:0050872] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; transcription repressor complex [GO:0017053] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; nuclear retinoic acid receptor binding [GO:0042974]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural constituent of presynaptic active zone [GO:0098882]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] g20838.t1 Q7SXR3 63.472 386 1.9e-178 504.0 sp|Q7SXR3|MAEA_DANRE E3 ubiquitin-protein transferase MAEA OS=Danio rerio OX=7955 GN=maea PE=2 SV=2 g20841.t1 Q9NTM9 64.167 240 6.180000000000001e-107 312.0 sp|Q9NTM9|CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1 CUTC_HUMAN reviewed Copper homeostasis protein cutC homolog Homo sapiens (Human) GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070 copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] copper ion binding [GO:0005507] g20842.t1 O93295 39.63 487 1.52e-98 310.0 sp|O93295|ENTP8_CHICK Ectonucleoside triphosphate diphosphohydrolase 8 OS=Gallus gallus OX=9031 GN=ENTPD8 PE=1 SV=1 g20843.t1 O93295 39.05 484 5.19e-95 301.0 sp|O93295|ENTP8_CHICK Ectonucleoside triphosphate diphosphohydrolase 8 OS=Gallus gallus OX=9031 GN=ENTPD8 PE=1 SV=1 g20848.t1 Q5U4F6 42.073 492 7.19e-136 406.0 sp|Q5U4F6|DC2I2_MOUSE Cytoplasmic dynein 2 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync2i2 PE=1 SV=3 DC2I2_MOUSE reviewed Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34) Mus musculus (Mouse) GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005868; GO:0005929; GO:0005930; GO:0016604; GO:0030175; GO:0031965; GO:0035721; GO:0036064; GO:0042073; GO:0045503; GO:0045504; GO:0060271; GO:0097014 cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; filopodium [GO:0030175]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] g20849.t1 Q8R2L5 58.947 95 2.33e-33 119.0 sp|Q8R2L5|RT18C_MOUSE Small ribosomal subunit protein bS18m OS=Mus musculus OX=10090 GN=Mrps18c PE=1 SV=1 g20850.t1 C3YWU0 62.077 443 0.0 581.0 sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2 g20851.t1 P20594 36.617 1076 0.0 599.0 sp|P20594|ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens OX=9606 GN=NPR2 PE=1 SV=1 ANPRB_HUMAN reviewed Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) Homo sapiens (Human) GO:0000165; GO:0001549; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007283; GO:0007605; GO:0008217; GO:0016941; GO:0017046; GO:0019228; GO:0021647; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0048546; GO:0048668; GO:0048745; GO:0050872; GO:0051276; GO:0051402; GO:0051447; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537 activation of meiosis involved in egg activation [GO:0060466]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; growth plate cartilage development [GO:0003417]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; response to fibroblast growth factor [GO:0071774]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; sensory perception of sound [GO:0007605]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872] cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672] g20852.t1 Q8CGS4 61.883 223 1.35e-79 240.0 sp|Q8CGS4|CHMP3_RAT Charged multivesicular body protein 3 OS=Rattus norvegicus OX=10116 GN=Chmp3 PE=1 SV=3 CHMP3_RAT reviewed Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24) (rVps24p) Rattus norvegicus (Rat) GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005546; GO:0005643; GO:0005765; GO:0005769; GO:0005770; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0008333; GO:0010824; GO:0015031; GO:0030496; GO:0031210; GO:0031410; GO:0031468; GO:0032467; GO:0032509; GO:0032585; GO:0039702; GO:0042802; GO:0043162; GO:0044790; GO:0045324; GO:0046761; GO:0051036; GO:0051258; GO:0061763; GO:0061952; GO:0071985; GO:0097352; GO:0140678; GO:1901673; GO:1902774; GO:1904930; GO:1990381; GO:2000641 autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of cytokinesis [GO:0032467]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of endosome size [GO:0051036]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; phosphatidylcholine binding [GO:0031210]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin-specific protease binding [GO:1990381] g20853.t1 Q8BHJ9 59.432 599 0.0 694.0 sp|Q8BHJ9|SLU7_MOUSE Pre-mRNA-splicing factor SLU7 OS=Mus musculus OX=10090 GN=Slu7 PE=1 SV=1 SLU7_MOUSE reviewed Pre-mRNA-splicing factor SLU7 Mus musculus (Mouse) GO:0000375; GO:0000380; GO:0000386; GO:0000389; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006886; GO:0008270; GO:0008380; GO:0016607; GO:0030532; GO:0030628; GO:0034605; GO:0071013 alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681] pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270] g20854.t1 Q504G0 38.462 234 1.75e-45 156.0 sp|Q504G0|TM127_DANRE Transmembrane protein 127 OS=Danio rerio OX=7955 GN=tmem127 PE=2 SV=1 g20856.t1 Q8QHI3 44.961 129 6.33e-36 128.0 sp|Q8QHI3|ARL3_XENLA ADP-ribosylation factor-like protein 3 OS=Xenopus laevis OX=8355 GN=arl3 PE=2 SV=1 g20857.t1 Q9CQJ1 59.722 72 7.52e-25 94.0 sp|Q9CQJ1|HIG2A_MOUSE HIG1 domain family member 2A OS=Mus musculus OX=10090 GN=Higd2a PE=3 SV=1 g20858.t1 Q6NVB0 48.171 164 1.91e-40 137.0 sp|Q6NVB0|NOP16_XENTR Nucleolar protein 16 OS=Xenopus tropicalis OX=8364 GN=nop16 PE=2 SV=1 g20859.t1 P0DJG4 31.19 311 5.190000000000001e-29 119.0 sp|P0DJG4|SMA2L_HUMAN Sperm microtubule associated protein 2-like OS=Homo sapiens OX=9606 GN=SPMAP2L PE=1 SV=1 g20861.t1 O95786 35.867 750 5.22e-122 398.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g20863.t1 Q8R5F7 29.499 1078 8.36e-106 358.0 sp|Q8R5F7|IFIH1_MOUSE Interferon-induced helicase C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ifih1 PE=1 SV=1 g20869.t1 O76094 50.306 654 0.0 620.0 sp|O76094|SRP72_HUMAN Signal recognition particle subunit SRP72 OS=Homo sapiens OX=9606 GN=SRP72 PE=1 SV=3 g20870.t1 P97690 65.194 566 0.0 754.0 sp|P97690|SMC3_RAT Structural maintenance of chromosomes protein 3 OS=Rattus norvegicus OX=10116 GN=Smc3 PE=1 SV=1 g20871.t1 O93309 54.054 629 0.0 644.0 sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2 g20872.t1 A8MZ26 47.716 197 4.4099999999999997e-54 174.0 sp|A8MZ26|EFCB9_HUMAN EF-hand calcium-binding domain-containing protein 9 OS=Homo sapiens OX=9606 GN=EFCAB9 PE=1 SV=2 EFCB9_HUMAN reviewed EF-hand calcium-binding domain-containing protein 9 Homo sapiens (Human) GO:0005509; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228 flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891] g20873.t1 Q5XGL6 61.716 303 6.560000000000001e-144 412.0 sp|Q5XGL6|HOGA1_XENLA 4-hydroxy-2-oxoglutarate aldolase, mitochondrial OS=Xenopus laevis OX=8355 GN=hoga1 PE=2 SV=1 g20876.t1 O00602 43.75 224 6.84e-53 182.0 sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2 FCN1_HUMAN reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Homo sapiens (Human) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031012; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:0106139; GO:1903028; GO:1904813; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g20876.t1 O00602 48.663 187 7.68e-46 164.0 sp|O00602|FCN1_HUMAN Ficolin-1 OS=Homo sapiens OX=9606 GN=FCN1 PE=1 SV=2 FCN1_HUMAN reviewed Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) Homo sapiens (Human) GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0005886; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031012; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0097367; GO:0106139; GO:1903028; GO:1904813; GO:1905370 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated suppression of symbiont invasion [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] g20878.t1 Q6AX44 47.085 223 1.4e-57 205.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g20878.t1 Q6AX44 40.909 220 2.16e-39 154.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g20878.t2 Q6AX44 47.085 223 1.7100000000000002e-57 204.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g20878.t2 Q6AX44 40.455 220 4.93e-39 153.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g20878.t3 Q6AX44 47.085 223 1.6800000000000002e-57 204.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g20878.t3 Q6AX44 38.636 220 1.6800000000000002e-35 143.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g20879.t1 O95490 34.746 354 2.9200000000000003e-59 227.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g20879.t2 O95490 34.746 354 2.9500000000000003e-59 228.0 sp|O95490|AGRL2_HUMAN Adhesion G protein-coupled receptor L2 OS=Homo sapiens OX=9606 GN=ADGRL2 PE=1 SV=2 g20880.t1 Q13724 45.342 805 0.0 660.0 sp|Q13724|MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens OX=9606 GN=MOGS PE=1 SV=5 g20881.t1 P85515 89.096 376 0.0 717.0 sp|P85515|ACTZ_RAT Alpha-centractin OS=Rattus norvegicus OX=10116 GN=Actr1a PE=1 SV=1 g20882.t1 P62309 75.0 76 6.75e-37 121.0 sp|P62309|RUXG_MOUSE Small nuclear ribonucleoprotein G OS=Mus musculus OX=10090 GN=Snrpg PE=1 SV=1 g20883.t1 O60502 42.842 964 0.0 727.0 sp|O60502|OGA_HUMAN Protein O-GlcNAcase OS=Homo sapiens OX=9606 GN=OGA PE=1 SV=2 OGA_HUMAN reviewed Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT) Homo sapiens (Human) GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0015929; GO:0016020; GO:0042802; GO:0102571 glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; hexosaminidase activity [GO:0015929]; hyalurononglucosaminidase activity [GO:0004415]; identical protein binding [GO:0042802] g20883.t2 O60502 43.658 946 0.0 739.0 sp|O60502|OGA_HUMAN Protein O-GlcNAcase OS=Homo sapiens OX=9606 GN=OGA PE=1 SV=2 OGA_HUMAN reviewed Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT) Homo sapiens (Human) GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0015929; GO:0016020; GO:0042802; GO:0102571 glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; hexosaminidase activity [GO:0015929]; hyalurononglucosaminidase activity [GO:0004415]; identical protein binding [GO:0042802] g20884.t1 Q8VCD6 60.0 175 6.25e-64 207.0 sp|Q8VCD6|REEP2_MOUSE Receptor expression-enhancing protein 2 OS=Mus musculus OX=10090 GN=Reep2 PE=1 SV=2 g20885.t1 Q7LBC6 45.255 959 0.0 789.0 sp|Q7LBC6|KDM3B_HUMAN Lysine-specific demethylase 3B OS=Homo sapiens OX=9606 GN=KDM3B PE=1 SV=2 KDM3B_HUMAN reviewed Lysine-specific demethylase 3B (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B) Homo sapiens (Human) GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0008270; GO:0031490; GO:0032454; GO:0140683 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] chromatin DNA binding [GO:0031490]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g20885.t1 Q7LBC6 30.415 217 1.2e-25 120.0 sp|Q7LBC6|KDM3B_HUMAN Lysine-specific demethylase 3B OS=Homo sapiens OX=9606 GN=KDM3B PE=1 SV=2 KDM3B_HUMAN reviewed Lysine-specific demethylase 3B (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B) Homo sapiens (Human) GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0008270; GO:0031490; GO:0032454; GO:0140683 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] chromatin DNA binding [GO:0031490]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g20885.t2 Q7LBC6 45.255 959 0.0 791.0 sp|Q7LBC6|KDM3B_HUMAN Lysine-specific demethylase 3B OS=Homo sapiens OX=9606 GN=KDM3B PE=1 SV=2 KDM3B_HUMAN reviewed Lysine-specific demethylase 3B (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B) Homo sapiens (Human) GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0008270; GO:0031490; GO:0032454; GO:0140683 regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] chromatin DNA binding [GO:0031490]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g20889.t1 E7FDB3 52.273 88 2.7799999999999996e-23 96.7 sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1 g20890.t1 E7FDB3 55.844 77 5.7499999999999995e-24 97.4 sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1 g20894.t1 O93277 46.546 608 0.0 558.0 sp|O93277|WDR1_CHICK WD repeat-containing protein 1 OS=Gallus gallus OX=9031 GN=WDR1 PE=2 SV=1 g20895.t1 Q3TZI6 43.841 276 1.58e-66 215.0 sp|Q3TZI6|CCNJ_MOUSE Cyclin-J OS=Mus musculus OX=10090 GN=Ccnj PE=2 SV=2 g20896.t1 Q96IR7 35.955 356 2.88e-53 186.0 sp|Q96IR7|HPDL_HUMAN 4-hydroxyphenylpyruvate dioxygenase-like protein OS=Homo sapiens OX=9606 GN=HPDL PE=1 SV=1 HPDL_HUMAN reviewed 4-hydroxyphenylpyruvate dioxygenase-like protein (HPD-like protein) (HPDL) (EC 1.13.11.46) (Glyoxalase domain-containing protein 1) Homo sapiens (Human) GO:0003868; GO:0005739; GO:0005759; GO:0009072; GO:0046872; GO:0050585 aromatic amino acid metabolic process [GO:0009072] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 4-hydroxymandelate synthase activity [GO:0050585]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872] g20897.t1 Q9BYE7 44.595 222 1.92e-57 189.0 sp|Q9BYE7|PCGF6_HUMAN Polycomb group RING finger protein 6 OS=Homo sapiens OX=9606 GN=PCGF6 PE=1 SV=2 PCGF6_HUMAN reviewed Polycomb group RING finger protein 6 (Mel18 and Bmi1-like RING finger) (RING finger protein 134) Homo sapiens (Human) GO:0000122; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0008270; GO:0031519; GO:0035102; GO:0045892 chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] zinc ion binding [GO:0008270] g20898.t1 Q8BTQ0 57.261 241 4.85e-96 284.0 sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1 PCGF3_MOUSE reviewed Polycomb group RING finger protein 3 (RING finger protein 3A) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031519; GO:0035102; GO:0060816; GO:0140862 random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270] g20899.t1 O00567 72.603 438 0.0 675.0 sp|O00567|NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=4 NOP56_HUMAN reviewed Nucleolar protein 56 (Nucleolar protein 5A) Homo sapiens (Human) GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0045296; GO:0070761; GO:1990226 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] box C/D methylation guide snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g20900.t1 O96006 27.011 696 1.63e-57 214.0 sp|O96006|ZBED1_HUMAN E3 SUMO-protein ligase ZBED1 OS=Homo sapiens OX=9606 GN=ZBED1 PE=1 SV=1 ZBED1_HUMAN reviewed E3 SUMO-protein ligase ZBED1 (EC 2.3.2.-) (DNA replication-related element-binding factor) (Putative Ac-like transposable element) (Zinc finger BED domain-containing protein 1) (dREF homolog) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0008270; GO:0016605; GO:0016925; GO:0019789; GO:0031965; GO:0042802; GO:0043565; GO:0044828; GO:0045944; GO:0046983; GO:0061665; GO:1990466; GO:1990837 host-mediated suppression of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466]; protein sumoylation [GO:0016925]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g20901.t1 Q5EA50 48.495 299 5.28e-105 319.0 sp|Q5EA50|RABEK_BOVIN Rab9 effector protein with kelch motifs OS=Bos taurus OX=9913 GN=RABEPK PE=2 SV=1 g20902.t1 Q86XI6 42.105 190 3.28e-41 148.0 sp|Q86XI6|PPR3B_HUMAN Protein phosphatase 1 regulatory subunit 3B OS=Homo sapiens OX=9606 GN=PPP1R3B PE=1 SV=1 g20903.t1 Q499W2 55.238 210 1.4500000000000001e-86 258.0 sp|Q499W2|SLD5_RAT DNA replication complex GINS protein SLD5 OS=Rattus norvegicus OX=10116 GN=Gins4 PE=1 SV=1 g20904.t1 O95271 72.987 1155 0.0 1758.0 sp|O95271|TNKS1_HUMAN Poly [ADP-ribose] polymerase tankyrase-1 OS=Homo sapiens OX=9606 GN=TNKS PE=1 SV=2 TNKS1_HUMAN reviewed Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1) Homo sapiens (Human) GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0007052; GO:0008270; GO:0010521; GO:0015031; GO:0016055; GO:0016604; GO:0016779; GO:0018105; GO:0018107; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:0140806; GO:0140807; GO:1904355; GO:1904357; GO:1904358; GO:1904908; GO:1990404 cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] histone binding [GO:0042393]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; telomerase inhibitor activity [GO:0010521]; zinc ion binding [GO:0008270] g20905.t1 Q86WI1 38.691 4293 0.0 2881.0 sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2 PKHL1_HUMAN reviewed Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234 immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426] signaling receptor activity [GO:0038023] g20907.t1 Q923J1 28.231 1300 4.06e-151 505.0 sp|Q923J1|TRPM7_MOUSE Transient receptor potential cation channel subfamily M member 7 OS=Mus musculus OX=10090 GN=Trpm7 PE=1 SV=1 TRPM7_MOUSE reviewed Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7) (Transient receptor potential-phospholipase C-interacting kinase) (TRP-PLIK) [Cleaved into: TRPM7 kinase, cleaved form (M7CK); TRPM7 channel, cleaved form] Mus musculus (Mouse) GO:0001726; GO:0003779; GO:0004672; GO:0004674; GO:0005261; GO:0005262; GO:0005385; GO:0005524; GO:0005634; GO:0005886; GO:0006816; GO:0006829; GO:0007613; GO:0010960; GO:0010961; GO:0015095; GO:0015693; GO:0016301; GO:0016340; GO:0017022; GO:0030672; GO:0031032; GO:0031410; GO:0043025; GO:0043065; GO:0043196; GO:0046872; GO:0051289; GO:0070266; GO:0070588; GO:0098655; GO:0106310; GO:1903830 actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion homeostasis [GO:0010960]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; memory [GO:0007613]; monoatomic cation transmembrane transport [GO:0098655]; necroptotic process [GO:0070266]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synaptic vesicle membrane [GO:0030672]; varicosity [GO:0043196] actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; kinase activity [GO:0016301]; magnesium ion transmembrane transporter activity [GO:0015095]; metal ion binding [GO:0046872]; monoatomic cation channel activity [GO:0005261]; myosin binding [GO:0017022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion transmembrane transporter activity [GO:0005385] g20910.t1 Q460N5 27.037 1890 3.63e-171 578.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g20910.t2 Q460N5 26.589 1888 7.490000000000001e-163 553.0 sp|Q460N5|PAR14_HUMAN Protein mono-ADP-ribosyltransferase PARP14 OS=Homo sapiens OX=9606 GN=PARP14 PE=1 SV=3 PAR14_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) Homo sapiens (Human) GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019677; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140807; GO:1902216; GO:1990404 innate immune response [GO:0045087]; NAD+ catabolic process [GO:0019677]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] enzyme binding [GO:0019899]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714] g20912.t1 Q8K4T1 34.395 314 2.06e-59 200.0 sp|Q8K4T1|SIA8F_MOUSE Alpha-2,8-sialyltransferase 8F OS=Mus musculus OX=10090 GN=St8sia6 PE=1 SV=1 SIA8F_MOUSE reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g20914.t1 Q6VVW5 53.086 243 1.46e-77 270.0 sp|Q6VVW5|ANPRB_MOUSE Atrial natriuretic peptide receptor 2 OS=Mus musculus OX=10090 GN=Npr2 PE=1 SV=2 ANPRB_MOUSE reviewed Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B) Mus musculus (Mouse) GO:0000165; GO:0001541; GO:0001549; GO:0001568; GO:0001570; GO:0001945; GO:0001958; GO:0001964; GO:0001974; GO:0002062; GO:0003417; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0006182; GO:0007033; GO:0007168; GO:0007173; GO:0007268; GO:0007281; GO:0007283; GO:0007338; GO:0007409; GO:0007605; GO:0008015; GO:0009611; GO:0009725; GO:0010641; GO:0010753; GO:0016941; GO:0017046; GO:0019228; GO:0019934; GO:0021562; GO:0021647; GO:0021675; GO:0030540; GO:0034699; GO:0035108; GO:0035112; GO:0035264; GO:0035483; GO:0035988; GO:0036342; GO:0042060; GO:0042562; GO:0042802; GO:0043005; GO:0045202; GO:0046068; GO:0048546; GO:0048565; GO:0048599; GO:0048668; GO:0048745; GO:0050872; GO:0051216; GO:0051276; GO:0051402; GO:0051447; GO:0060173; GO:0060348; GO:0060385; GO:0060466; GO:0061042; GO:0061939; GO:0071321; GO:0071774; GO:0097011; GO:0097194; GO:0098868; GO:1900194; GO:1901653; GO:1902074; GO:1903537 activation of meiosis involved in egg activation [GO:0060466]; axonogenesis [GO:0007409]; axonogenesis involved in innervation [GO:0060385]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; bone growth [GO:0098868]; c-di-GMP signaling [GO:0061939]; cartilage development [GO:0051216]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to peptide [GO:1901653]; cGMP biosynthetic process [GO:0006182]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromosome organization [GO:0051276]; collateral sprouting [GO:0048668]; cumulus cell differentiation [GO:0001549]; digestive tract development [GO:0048565]; digestive tract morphogenesis [GO:0048546]; endochondral ossification [GO:0001958]; epidermal growth factor receptor signaling pathway [GO:0007173]; execution phase of apoptosis [GO:0097194]; female genitalia development [GO:0030540]; gastric emptying [GO:0035483]; genitalia morphogenesis [GO:0035112]; germ cell development [GO:0007281]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lymph vessel development [GO:0001945]; MAPK cascade [GO:0000165]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; multicellular organism growth [GO:0035264]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; post-anal tail morphogenesis [GO:0036342]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to fibroblast growth factor [GO:0071774]; response to hormone [GO:0009725]; response to luteinizing hormone [GO:0034699]; response to salt [GO:1902074]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; smooth muscle tissue development [GO:0048745]; spermatogenesis [GO:0007283]; startle response [GO:0001964]; vacuole organization [GO:0007033]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vestibulocochlear nerve development [GO:0021562]; vestibulocochlear nerve maturation [GO:0021647]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060] cilium [GO:0005929]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672] g20914.t2 P16067 53.086 243 3.4999999999999998e-74 270.0 sp|P16067|ANPRB_RAT Atrial natriuretic peptide receptor 2 OS=Rattus norvegicus OX=10116 GN=Npr2 PE=1 SV=1 g20915.t1 A7MB10 37.174 1267 0.0 691.0 sp|A7MB10|RRP5_BOVIN Protein RRP5 homolog OS=Bos taurus OX=9913 GN=PDCD11 PE=2 SV=1 g20916.t1 A7MB10 34.161 644 1.18e-116 387.0 sp|A7MB10|RRP5_BOVIN Protein RRP5 homolog OS=Bos taurus OX=9913 GN=PDCD11 PE=2 SV=1 g20917.t1 A2AAY5 38.536 519 1.68e-111 359.0 sp|A2AAY5|SPD2B_MOUSE SH3 and PX domain-containing protein 2B OS=Mus musculus OX=10090 GN=Sh3pxd2b PE=1 SV=1 SPD2B_MOUSE reviewed SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains) Mus musculus (Mouse) GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0016176; GO:0022617; GO:0032266; GO:0040018; GO:0042169; GO:0042554; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888 adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] cytoplasm [GO:0005737]; podosome [GO:0002102] phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176] g20919.t1 Q5ZJT0 61.427 757 0.0 973.0 sp|Q5ZJT0|SUV3_CHICK ATP-dependent RNA helicase SUPV3L1, mitochondrial OS=Gallus gallus OX=9031 GN=SUPV3L1 PE=2 SV=1 SUV3_CHICK reviewed ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1) Gallus gallus (Chicken) GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0007005; GO:0016887; GO:0030307; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0043066; GO:0045025; GO:2000827 DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401] mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724] g20921.t1 A7Z052 31.483 1045 1.39e-131 436.0 sp|A7Z052|WDR6_BOVIN tRNA (34-2'-O)-methyltransferase regulator WDR6 OS=Bos taurus OX=9913 GN=WDR6 PE=2 SV=1 g20922.t1 B4K9L4 54.588 861 0.0 919.0 sp|B4K9L4|PDE6_DROMO cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila mojavensis OX=7230 GN=Pde6 PE=3 SV=1 g20922.t2 B4K9L4 53.943 875 0.0 917.0 sp|B4K9L4|PDE6_DROMO cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila mojavensis OX=7230 GN=Pde6 PE=3 SV=1 g20923.t1 Q8BP78 51.376 327 2.7199999999999996e-104 311.0 sp|Q8BP78|F10C1_MOUSE Protein FRA10AC1 homolog OS=Mus musculus OX=10090 GN=Fra10ac1 PE=1 SV=3 g20924.t1 Q9QZ08 53.216 342 1.72e-127 372.0 sp|Q9QZ08|NAGK_MOUSE N-acetyl-D-glucosamine kinase OS=Mus musculus OX=10090 GN=Nagk PE=1 SV=3 g20925.t1 Q9NQW7 59.486 622 0.0 762.0 sp|Q9NQW7|XPP1_HUMAN Xaa-Pro aminopeptidase 1 OS=Homo sapiens OX=9606 GN=XPNPEP1 PE=1 SV=3 XPP1_HUMAN reviewed Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble) Homo sapiens (Human) GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0070062 bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] g20926.t1 P48441 45.642 631 0.0 546.0 sp|P48441|IDUA_MOUSE Alpha-L-iduronidase OS=Mus musculus OX=10090 GN=Idua PE=1 SV=2 IDUA_MOUSE reviewed Alpha-L-iduronidase (EC 3.2.1.76) Mus musculus (Mouse) GO:0000902; GO:0003940; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0006027; GO:0007040; GO:0007613; GO:0007626; GO:0007628; GO:0008344; GO:0008542; GO:0030198; GO:0030200; GO:0030209; GO:0030211; GO:0035108; GO:0043202; GO:0045780; GO:0048705; GO:0048878; GO:0060348; GO:0061037; GO:0090341; GO:0120158; GO:1990079 adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542] extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] L-iduronidase activity [GO:0003940]; signaling receptor binding [GO:0005102] g20928.t1 P49256 50.641 312 1.38e-107 321.0 sp|P49256|LMAN2_CANLF Vesicular integral-membrane protein VIP36 OS=Canis lupus familiaris OX=9615 GN=LMAN2 PE=1 SV=1 g20929.t1 A2VE15 51.984 252 4.3799999999999995e-89 271.0 sp|A2VE15|FADS6_BOVIN Fatty acid desaturase 6 OS=Bos taurus OX=9913 GN=FADS6 PE=2 SV=1 g20932.t1 Q28FF3 43.807 436 2.9999999999999996e-119 362.0 sp|Q28FF3|S49A3_XENTR Solute carrier family 49 member A3 OS=Xenopus tropicalis OX=8364 GN=slc49a3 PE=2 SV=2 g20933.t1 Q2TBT5 53.22 295 5.19e-111 326.0 sp|Q2TBT5|RNH2A_BOVIN Ribonuclease H2 subunit A OS=Bos taurus OX=9913 GN=RNASEH2A PE=1 SV=1 RNH2A_BOVIN reviewed Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A) Bos taurus (Bovine) GO:0003723; GO:0004523; GO:0005654; GO:0005829; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872 DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523] g20934.t1 Q9BSG0 44.828 174 5.35e-52 168.0 sp|Q9BSG0|PADC1_HUMAN Protease-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PRADC1 PE=1 SV=1 g20935.t1 Q5BJP5 56.075 107 2.3199999999999997e-41 135.0 sp|Q5BJP5|TM230_RAT Transmembrane protein 230 OS=Rattus norvegicus OX=10116 GN=Tmem230 PE=1 SV=1 TM230_RAT reviewed Transmembrane protein 230 Rattus norvegicus (Rat) GO:0005769; GO:0005770; GO:0005776; GO:0005802; GO:0008021; GO:0012505; GO:0030672; GO:0048489; GO:0055037 synaptic vesicle transport [GO:0048489] autophagosome [GO:0005776]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] g20936.t1 O43301 52.374 695 0.0 748.0 sp|O43301|HS12A_HUMAN Heat shock 70 kDa protein 12A OS=Homo sapiens OX=9606 GN=HSPA12A PE=1 SV=2 g20936.t2 O43301 52.224 697 0.0 743.0 sp|O43301|HS12A_HUMAN Heat shock 70 kDa protein 12A OS=Homo sapiens OX=9606 GN=HSPA12A PE=1 SV=2 g20937.t1 Q7M760 54.173 707 0.0 731.0 sp|Q7M760|ZRAN1_MOUSE Ubiquitin thioesterase Zranb1 OS=Mus musculus OX=10090 GN=Zranb1 PE=2 SV=1 ZRAN1_MOUSE reviewed Ubiquitin thioesterase Zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1) Mus musculus (Mouse) GO:0000045; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0008270; GO:0016055; GO:0016477; GO:0016579; GO:0022604; GO:0030177; GO:0031593; GO:0035523; GO:0046854; GO:0070530; GO:0070536; GO:0071947; GO:0101005; GO:1990168 autophagosome assembly [GO:0000045]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270] g20938.t1 Q8CG72 44.034 352 7.06e-87 269.0 sp|Q8CG72|ADPRS_MOUSE ADP-ribosylhydrolase ARH3 OS=Mus musculus OX=10090 GN=Adprs PE=1 SV=1 ADPRS_MOUSE reviewed ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-) Mus musculus (Mouse) GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006281; GO:0016604; GO:0060546; GO:0061463; GO:0071451; GO:0090734; GO:0140290; GO:0140292 cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649] g20939.t1 Q7T292 61.921 302 5.29e-132 385.0 sp|Q7T292|MFRN2_DANRE Mitoferrin-2 OS=Danio rerio OX=7955 GN=slc25a28 PE=2 SV=1 g20942.t1 Q9W735 33.333 798 1.08e-142 447.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g20942.t2 Q9W735 33.333 798 2.29e-143 447.0 sp|Q9W735|PRM1A_DANRE Prominin-1-A OS=Danio rerio OX=7955 GN=prom1a PE=2 SV=2 g13389.t1 E1BD59 25.956 366 6.8100000000000005e-31 132.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g13390.t1 Q03460 65.333 75 2.58e-21 91.3 sp|Q03460|GLSN_MEDSA Glutamate synthase [NADH], amyloplastic OS=Medicago sativa OX=3879 PE=1 SV=1 g13391.t1 E1BD59 26.575 365 2.4e-33 139.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g13396.t1 Q7TMR7 24.503 453 9.200000000000001e-31 127.0 sp|Q7TMR7|MOT7_RAT Monocarboxylate transporter 7 OS=Rattus norvegicus OX=10116 GN=Slc16a6 PE=1 SV=1 g13396.t2 Q7TMR7 24.731 465 4.95e-29 122.0 sp|Q7TMR7|MOT7_RAT Monocarboxylate transporter 7 OS=Rattus norvegicus OX=10116 GN=Slc16a6 PE=1 SV=1 g13397.t1 Q9UBU2 32.618 233 7.700000000000001e-27 110.0 sp|Q9UBU2|DKK2_HUMAN Dickkopf-related protein 2 OS=Homo sapiens OX=9606 GN=DKK2 PE=1 SV=1 DKK2_HUMAN reviewed Dickkopf-related protein 2 (Dickkopf-2) (Dkk-2) (hDkk-2) Homo sapiens (Human) GO:0005615; GO:0016055; GO:0039706; GO:0048019; GO:0090090; GO:0090263 negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615] co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019] g13399.t1 P20072 63.057 314 1.84e-148 439.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g13401.t1 Q9R229 35.405 370 7.7e-59 202.0 sp|Q9R229|BMP10_MOUSE Bone morphogenetic protein 10 OS=Mus musculus OX=10090 GN=Bmp10 PE=1 SV=2 BMP10_MOUSE reviewed Bone morphogenetic protein 10 (BMP-10) Mus musculus (Mouse) GO:0001822; GO:0005125; GO:0005179; GO:0005615; GO:0005737; GO:0007155; GO:0007507; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010628; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0045214; GO:0045893; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060391; GO:0061036; GO:1903242; GO:2000138 activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Z disc [GO:0030018] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433] g13402.t1 Q08DX6 30.068 439 1.22e-39 152.0 sp|Q08DX6|GDF10_BOVIN Growth/differentiation factor 10 OS=Bos taurus OX=9913 GN=GDF10 PE=2 SV=1 g13405.t1 Q9URT8 58.182 110 3.46e-39 129.0 sp|Q9URT8|RL34B_SCHPO Large ribosomal subunit protein eL34B OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=rpl3402 PE=1 SV=1 g13406.t1 Q96AJ9 55.046 218 7.369999999999999e-81 243.0 sp|Q96AJ9|VTI1A_HUMAN Vesicle transport through interaction with t-SNAREs homolog 1A OS=Homo sapiens OX=9606 GN=VTI1A PE=1 SV=2 VTI1A_HUMAN reviewed Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2) Homo sapiens (Human) GO:0000139; GO:0000149; GO:0005484; GO:0005768; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0006896; GO:0006914; GO:0008021; GO:0012507; GO:0016236; GO:0030136; GO:0031201; GO:0031902; GO:0032456; GO:0032588; GO:0042147; GO:0043025; GO:0044306; GO:0048280; GO:0048471; GO:0050882 autophagy [GO:0006914]; endocytic recycling [GO:0032456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g13408.t1 Q91X20 56.489 524 0.0 612.0 sp|Q91X20|ASH2L_MOUSE Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Mus musculus OX=10090 GN=Ash2l PE=1 SV=1 ASH2L_MOUSE reviewed Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein) Mus musculus (Mouse) GO:0000791; GO:0000976; GO:0005634; GO:0005654; GO:0006974; GO:0008013; GO:0008270; GO:0008284; GO:0035097; GO:0043627; GO:0044665; GO:0044666; GO:0045815; GO:0045944; GO:0048188; GO:0071339 DNA damage response [GO:0006974]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627]; transcription initiation-coupled chromatin remodeling [GO:0045815] euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] beta-catenin binding [GO:0008013]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g13409.t1 Q2M2I8 61.214 379 2.73e-151 486.0 sp|Q2M2I8|AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens OX=9606 GN=AAK1 PE=1 SV=3 AAK1_HUMAN reviewed AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) Homo sapiens (Human) GO:0004674; GO:0005112; GO:0005524; GO:0005829; GO:0005886; GO:0005905; GO:0006468; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0045747; GO:0050821; GO:0061024; GO:0098793; GO:0106310; GO:0140238; GO:2000369 membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; presynaptic endocytosis [GO:0140238]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880] cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; terminal bouton [GO:0043195] AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13410.t1 P56966 64.883 299 9.009999999999999e-149 424.0 sp|P56966|GGPPS_BOVIN Geranylgeranyl pyrophosphate synthase OS=Bos taurus OX=9913 GN=GGPS1 PE=1 SV=2 GGPPS_BOVIN reviewed Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Bos taurus (Bovine) GO:0004161; GO:0004311; GO:0004337; GO:0005654; GO:0005737; GO:0005829; GO:0006720; GO:0008299; GO:0030018; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872; GO:0048471 farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] (2E,6E)-farnesyl diphosphate synthase activity [GO:0004337]; dimethylallyltranstransferase activity [GO:0004161]; geranylgeranyl diphosphate synthase activity [GO:0004311]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g13411.t1 Q91W61 37.308 260 5.97e-54 181.0 sp|Q91W61|FXL15_MOUSE F-box/LRR-repeat protein 15 OS=Mus musculus OX=10090 GN=Fbxl15 PE=1 SV=2 g13412.t1 Q86YA3 51.508 829 0.0 818.0 sp|Q86YA3|ZGRF1_HUMAN 5'-3' DNA helicase ZGRF1 OS=Homo sapiens OX=9606 GN=ZGRF1 PE=1 SV=3 g13412.t1 Q86YA3 41.765 170 2.69e-22 110.0 sp|Q86YA3|ZGRF1_HUMAN 5'-3' DNA helicase ZGRF1 OS=Homo sapiens OX=9606 GN=ZGRF1 PE=1 SV=3 g13412.t2 Q86YA3 49.194 868 0.0 799.0 sp|Q86YA3|ZGRF1_HUMAN 5'-3' DNA helicase ZGRF1 OS=Homo sapiens OX=9606 GN=ZGRF1 PE=1 SV=3 g13412.t2 Q86YA3 41.765 170 2.87e-22 110.0 sp|Q86YA3|ZGRF1_HUMAN 5'-3' DNA helicase ZGRF1 OS=Homo sapiens OX=9606 GN=ZGRF1 PE=1 SV=3 g13416.t1 Q6B457 30.575 713 9.04e-58 218.0 sp|Q6B457|CDHR1_XENLA Cadherin-related family member 1 OS=Xenopus laevis OX=8355 GN=cdhr1 PE=2 SV=1 CDHR1_XENLA reviewed Cadherin-related family member 1 (Photoreceptor cadherin) (prCAD) (Protocadherin-21) Xenopus laevis (African clawed frog) GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0098609 cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell junction [GO:0005911]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13417.t1 Q9I927 42.105 133 4.72e-22 94.7 sp|Q9I927|FUCL5_ANGJA Fucolectin-5 OS=Anguilla japonica OX=7937 PE=2 SV=1 g13419.t1 B3EWZ5 35.227 176 1.86e-23 100.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g13419.t1 B3EWZ5 36.047 172 2.39e-22 97.8 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g13419.t1 B3EWZ5 35.028 177 1.6e-21 95.5 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g13419.t1 B3EWZ5 38.356 146 3.0700000000000002e-21 94.7 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g13420.t1 Q9H251 28.891 1831 1.85e-133 469.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g13420.t1 Q9H251 28.499 1572 5.56e-114 408.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g13420.t1 Q9H251 29.753 1499 6.61e-112 402.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g13420.t1 Q9H251 28.887 1537 1.95e-89 329.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g13420.t1 Q9H251 27.05 1427 2.9799999999999998e-84 313.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g13420.t1 Q9H251 28.758 1151 1.03e-61 239.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g13420.t1 Q9H251 28.782 952 3.08e-44 181.0 sp|Q9H251|CAD23_HUMAN Cadherin-23 OS=Homo sapiens OX=9606 GN=CDH23 PE=1 SV=2 g13422.t1 Q9I931 38.806 134 5.170000000000001e-21 93.6 sp|Q9I931|FUCL1_ANGJA Fucolectin-1 OS=Anguilla japonica OX=7937 PE=2 SV=1 g13423.t1 Q9UJM8 49.591 367 1.95e-112 335.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g13424.t1 Q5ZM16 62.055 477 0.0 562.0 sp|Q5ZM16|RBM22_CHICK Pre-mRNA-splicing factor RBM22 OS=Gallus gallus OX=9031 GN=RBM22 PE=2 SV=1 RBM22_CHICK reviewed Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) Gallus gallus (Chicken) GO:0000974; GO:0005634; GO:0005737; GO:0008270; GO:0017070; GO:0033120; GO:0036002; GO:0045292; GO:0071006; GO:0071007; GO:0071466 cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120] cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007] pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; zinc ion binding [GO:0008270] g13425.t1 P31943 42.857 462 2.65e-106 327.0 sp|P31943|HNRH1_HUMAN Heterogeneous nuclear ribonucleoprotein H OS=Homo sapiens OX=9606 GN=HNRNPH1 PE=1 SV=4 HNRH1_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed] Homo sapiens (Human) GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006396; GO:0008266; GO:0016020; GO:0042802; GO:0043484; GO:0071013; GO:1990904 mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396] catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] g13425.t2 Q5RD26 44.027 452 5.83e-106 327.0 sp|Q5RD26|HNRH2_PONAB Heterogeneous nuclear ribonucleoprotein H2 OS=Pongo abelii OX=9601 GN=HNRNPH2 PE=2 SV=1 g13427.t1 P98191 51.899 474 5.260000000000001e-164 473.0 sp|P98191|CDS1_MOUSE Phosphatidate cytidylyltransferase 1 OS=Mus musculus OX=10090 GN=Cds1 PE=1 SV=2 CDS1_MOUSE reviewed Phosphatidate cytidylyltransferase 1 (EC 2.7.7.41) (CDP-DAG synthase 1) (CDP-DG synthase 1) (CDP-diacylglycerol synthase 1) (CDS 1) (CDP-diglyceride pyrophosphorylase 1) (CDP-diglyceride synthase 1) (CTP:phosphatidate cytidylyltransferase 1) Mus musculus (Mouse) GO:0004605; GO:0005783; GO:0005789; GO:0006661; GO:0016020; GO:0016024; GO:0045600; GO:0140042 CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of fat cell differentiation [GO:0045600] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] phosphatidate cytidylyltransferase activity [GO:0004605] g13428.t1 A4IGH2 46.209 422 8.000000000000001e-129 383.0 sp|A4IGH2|RSAD1_DANRE Radical S-adenosyl methionine domain-containing protein 1, mitochondrial OS=Danio rerio OX=7955 GN=rsad1 PE=2 SV=1 RSAD1_DANRE reviewed Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004109; GO:0005737; GO:0005739; GO:0006779; GO:0046872; GO:0051539 porphyrin-containing compound biosynthetic process [GO:0006779] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872] g13429.t1 Q6P1E7 39.648 512 5.77e-116 358.0 sp|Q6P1E7|PRIPO_MOUSE DNA-directed primase/polymerase protein OS=Mus musculus OX=10090 GN=Primpol PE=1 SV=1 PRIPO_MOUSE reviewed DNA-directed primase/polymerase protein (EC 2.7.7.102) (EC 2.7.7.7) Mus musculus (Mouse) GO:0000428; GO:0003682; GO:0003887; GO:0003899; GO:0005634; GO:0005657; GO:0005759; GO:0006264; GO:0006269; GO:0008270; GO:0009411; GO:0019985; GO:0030145; GO:0031297; GO:0042276; GO:0043504; GO:0062176 DNA replication, synthesis of primer [GO:0006269]; error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop processing [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] DNA-directed RNA polymerase complex [GO:0000428]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657] chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-directed RNA polymerase activity [GO:0003899]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270] g13432.t1 P53992 56.193 993 0.0 1072.0 sp|P53992|SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3 SC24C_HUMAN reviewed Protein transport protein Sec24C (SEC24-related protein C) Homo sapiens (Human) GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] g13433.t1 P51168 32.335 334 4.5e-37 151.0 sp|P51168|SCNNB_HUMAN Epithelial sodium channel subunit beta OS=Homo sapiens OX=9606 GN=SCNN1B PE=1 SV=2 SCNNB_HUMAN reviewed Epithelial sodium channel subunit beta (Beta-ENaC) (ENaC subunit beta) (ENaCB) (Epithelial Na(+) channel subunit beta) (Amiloride-sensitive sodium channel subunit beta) (Beta-NaCH) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB) Homo sapiens (Human) GO:0002269; GO:0002283; GO:0003014; GO:0005886; GO:0006883; GO:0008217; GO:0009410; GO:0009897; GO:0010467; GO:0014824; GO:0015280; GO:0016324; GO:0030659; GO:0032094; GO:0032341; GO:0034101; GO:0034706; GO:0035264; GO:0035725; GO:0042045; GO:0048286; GO:0050699; GO:0050891; GO:0050914; GO:0050915; GO:0055075; GO:0055078; GO:0070062; GO:0070254; GO:0070944; GO:0071468; GO:0098719; GO:1904045; GO:1904117 aldosterone metabolic process [GO:0032341]; artery smooth muscle contraction [GO:0014824]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to vasopressin [GO:1904117]; epithelial fluid transport [GO:0042045]; erythrocyte homeostasis [GO:0034101]; gene expression [GO:0010467]; intracellular sodium ion homeostasis [GO:0006883]; leukocyte activation involved in inflammatory response [GO:0002269]; lung alveolus development [GO:0048286]; mucus secretion [GO:0070254]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil activation involved in immune response [GO:0002283]; neutrophil-mediated killing of bacterium [GO:0070944]; potassium ion homeostasis [GO:0055075]; regulation of blood pressure [GO:0008217]; renal system process [GO:0003014]; response to food [GO:0032094]; response to xenobiotic stimulus [GO:0009410]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699] g13434.t1 Q6P6J9 41.0 200 2.12e-37 141.0 sp|Q6P6J9|TXD15_MOUSE Thioredoxin domain-containing protein 15 OS=Mus musculus OX=10090 GN=Txndc15 PE=1 SV=1 TXD15_MOUSE reviewed Thioredoxin domain-containing protein 15 Mus musculus (Mouse) GO:0005929; GO:0045880; GO:0060170; GO:0060271 cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] ciliary membrane [GO:0060170]; cilium [GO:0005929] g13435.t1 Q6PC64 49.811 265 1.37e-78 243.0 sp|Q6PC64|ELOV6_DANRE Very long chain fatty acid elongase 6 OS=Danio rerio OX=7955 GN=elovl6 PE=2 SV=1 ELOV6_DANRE reviewed Very long chain fatty acid elongase 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Elongation of very long chain fatty acids protein 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g13436.t1 Q6PC64 46.094 256 5.57e-75 233.0 sp|Q6PC64|ELOV6_DANRE Very long chain fatty acid elongase 6 OS=Danio rerio OX=7955 GN=elovl6 PE=2 SV=1 ELOV6_DANRE reviewed Very long chain fatty acid elongase 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase elovl6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Elongation of very long chain fatty acids protein 6) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g13437.t1 Q9VV87 42.0 300 1.84e-69 221.0 sp|Q9VV87|ELOV6_DROME Very long chain fatty acid elongase 6 OS=Drosophila melanogaster OX=7227 GN=Baldspot PE=1 SV=2 ELOV6_DROME reviewed Very long chain fatty acid elongase 6 (ELOVL6) (EC 2.3.1.199) (Elongation of very long chain fatty acids protein 6) (Neighbor of abl) (Very-long-chain 3-oxoacyl-CoA synthase) Drosophila melanogaster (Fruit fly) GO:0005741; GO:0005789; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] fatty acid elongase activity [GO:0009922] g13438.t1 Q9NYP7 33.188 229 1.8200000000000002e-29 114.0 sp|Q9NYP7|ELOV5_HUMAN Very long chain fatty acid elongase 5 OS=Homo sapiens OX=9606 GN=ELOVL5 PE=1 SV=1 ELOV5_HUMAN reviewed Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0016020; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042759; GO:0042761; GO:0043025; GO:0043651; GO:0045723; GO:0097447 alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of fatty acid biosynthetic process [GO:0045723]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] dendrite [GO:0030425]; dendritic tree [GO:0097447]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuronal cell body [GO:0043025] fatty acid elongase activity [GO:0009922] g13439.t1 Q28IK8 66.055 218 1.76e-101 301.0 sp|Q28IK8|MARH8_XENTR E3 ubiquitin-protein ligase MARCHF8 OS=Xenopus tropicalis OX=8364 GN=marchf8 PE=2 SV=1 MARH8_XENTR reviewed E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING-type E3 ubiquitin transferase MARCHF8) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000209; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0042287; GO:0061630 antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g13440.t1 Q5F2N2 52.465 284 2.9999999999999996e-104 315.0 sp|Q5F2N2|OFUT4_ORYLA GDP-fucose protein O-fucosyltransferase 4 OS=Oryzias latipes OX=8090 GN=fut11 PE=2 SV=1 OFUT4_ORYLA reviewed GDP-fucose protein O-fucosyltransferase 4 (EC 2.4.1.221) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0000139; GO:0005783; GO:0005789; GO:0046920; GO:0046922; GO:0050714 positive regulation of protein secretion [GO:0050714] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; peptide-O-fucosyltransferase activity [GO:0046922] g13442.t1 A1L253 30.941 627 4.1499999999999994e-52 194.0 sp|A1L253|F149B_DANRE Protein FAM149B1 OS=Danio rerio OX=7955 GN=fam149b1 PE=2 SV=1 g13442.t2 A1L253 31.393 567 1.07e-51 193.0 sp|A1L253|F149B_DANRE Protein FAM149B1 OS=Danio rerio OX=7955 GN=fam149b1 PE=2 SV=1 g13443.t1 P00435 44.828 116 3.3800000000000003e-29 109.0 sp|P00435|GPX1_BOVIN Glutathione peroxidase 1 OS=Bos taurus OX=9913 GN=GPX1 PE=1 SV=3 GPX1_BOVIN reviewed Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) (Phospholipid-hydroperoxide glutathione peroxidase GPX1) (EC 1.11.1.12) Bos taurus (Bovine) GO:0001659; GO:0001885; GO:0002862; GO:0004602; GO:0005739; GO:0005829; GO:0006641; GO:0006749; GO:0007605; GO:0008631; GO:0009410; GO:0009609; GO:0009650; GO:0010269; GO:0010332; GO:0017124; GO:0019369; GO:0019372; GO:0032496; GO:0033194; GO:0033599; GO:0034599; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043403; GO:0043534; GO:0045444; GO:0045445; GO:0045454; GO:0047066; GO:0048144; GO:0048741; GO:0051402; GO:0051450; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0090201; GO:0097413; GO:1902042; GO:1902176; GO:1902905; GO:1990782 angiogenesis involved in wound healing [GO:0060055]; arachidonate metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; epigenetic regulation of gene expression [GO:0040029]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311] cytosol [GO:0005829]; Lewy body [GO:0097413]; mitochondrion [GO:0005739] glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; protein tyrosine kinase binding [GO:1990782]; SH3 domain binding [GO:0017124] g13444.t1 O95630 39.789 475 2.7299999999999998e-104 320.0 sp|O95630|STABP_HUMAN STAM-binding protein OS=Homo sapiens OX=9606 GN=STAMBP PE=1 SV=1 STABP_HUMAN reviewed STAM-binding protein (EC 3.4.19.-) (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase) Homo sapiens (Human) GO:0000281; GO:0005634; GO:0005654; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006508; GO:0007259; GO:0008284; GO:0016579; GO:0019904; GO:0032154; GO:0046580; GO:0046872; GO:0051898; GO:0061578; GO:0070062; GO:0070536; GO:0101005; GO:0110088; GO:0110091; GO:0140492 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; hippocampal neuron apoptotic process [GO:0110088]; mitotic cytokinesis [GO:0000281]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of cell population proliferation [GO:0008284]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508] cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] deubiquitinase activity [GO:0101005]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; protein domain specific binding [GO:0019904] g13445.t1 Q9Z2L6 31.193 436 8.09e-57 199.0 sp|Q9Z2L6|MINP1_MOUSE Multiple inositol polyphosphate phosphatase 1 OS=Mus musculus OX=10090 GN=Minpp1 PE=1 SV=3 g13446.t1 Q8HYW0 38.445 476 1.45e-75 269.0 sp|Q8HYW0|FA13A_BOVIN Protein FAM13A OS=Bos taurus OX=9913 GN=FAM13A PE=2 SV=1 g13446.t2 Q8BGI4 38.936 470 4.93e-74 264.0 sp|Q8BGI4|FA13A_MOUSE Protein FAM13A OS=Mus musculus OX=10090 GN=Fam13a PE=1 SV=1 g13451.t1 P30975 41.042 307 5.37e-84 266.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g13453.t1 P30975 36.269 386 3.07e-81 261.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g13454.t1 Q91619 29.156 391 5.9099999999999996e-40 151.0 sp|Q91619|NODAL_XENLA Nodal homolog OS=Xenopus laevis OX=8355 GN=nodal PE=1 SV=1 NODAL_XENLA reviewed Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1) Xenopus laevis (African clawed frog) GO:0003140; GO:0005125; GO:0005576; GO:0005615; GO:0007178; GO:0007368; GO:0007507; GO:0008083; GO:0016015; GO:0038092; GO:0048318; GO:0048320; GO:0048339; GO:0070986 axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; left/right axis specification [GO:0070986]; nodal signaling pathway [GO:0038092]; paraxial mesoderm development [GO:0048339] extracellular region [GO:0005576]; extracellular space [GO:0005615] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015] g13460.t1 Q920G9 51.121 446 1.5300000000000002e-166 483.0 sp|Q920G9|GMCL1_MOUSE Germ cell-less protein-like 1 OS=Mus musculus OX=10090 GN=Gmcl1 PE=1 SV=2 g13462.t1 Q7Z5K2 43.338 743 1.2799999999999999e-172 540.0 sp|Q7Z5K2|WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1 WAPL_HUMAN reviewed Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor) Homo sapiens (Human) GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0072686; GO:0140083 cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP-dependent protein-DNA unloader activity [GO:0140083] g13463.t1 P70445 51.282 117 4.6900000000000005e-31 109.0 sp|P70445|4EBP2_MOUSE Eukaryotic translation initiation factor 4E-binding protein 2 OS=Mus musculus OX=10090 GN=Eif4ebp2 PE=1 SV=1 4EBP2_MOUSE reviewed Eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2) (eIF4E-binding protein 2) (Phosphorylated heat- and acid-stable protein regulated by insulin 2) (PHAS-II) Mus musculus (Mouse) GO:0005634; GO:0006446; GO:0007613; GO:0008190; GO:0008286; GO:0030371; GO:0031929; GO:0035176; GO:0045947; GO:0048167; GO:0050804; GO:0071598; GO:0098794 insulin receptor signaling pathway [GO:0008286]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of translational initiation [GO:0045947]; regulation of synaptic plasticity [GO:0048167]; regulation of translational initiation [GO:0006446]; social behavior [GO:0035176]; TOR signaling [GO:0031929] neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; postsynapse [GO:0098794] eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371] g13464.t1 Q99NH0 74.331 635 0.0 943.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 37.931 348 1.18e-55 219.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 37.275 389 7.12e-55 217.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 36.022 372 3.5899999999999994e-52 208.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 34.492 374 4.69e-45 184.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 41.0 300 6.73e-45 184.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 36.585 328 1.56e-43 179.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 31.536 371 2.0800000000000002e-43 179.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 37.671 292 6.86e-40 167.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 36.226 265 6.080000000000001e-37 158.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 35.656 244 7.600000000000001e-29 131.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t1 Q99NH0 43.307 127 8.530000000000001e-21 105.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 74.448 634 0.0 947.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 37.931 348 1.2e-55 219.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 37.275 389 7.24e-55 217.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 36.022 372 3.61e-52 208.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 34.492 374 4.72e-45 184.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 41.0 300 7.01e-45 184.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 36.585 328 1.54e-43 179.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 31.536 371 2.1e-43 179.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 37.671 292 6.97e-40 167.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 36.226 265 6.120000000000001e-37 158.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 35.656 244 7.600000000000001e-29 131.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13464.t2 Q99NH0 43.307 127 8.52e-21 105.0 sp|Q99NH0|ANR17_MOUSE Ankyrin repeat domain-containing protein 17 OS=Mus musculus OX=10090 GN=Ankrd17 PE=1 SV=2 ANR17_MOUSE reviewed Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein) Mus musculus (Mouse) GO:0000785; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; RNA binding [GO:0003723] g13468.t1 Q5UQ13 37.764 662 5.01e-64 234.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t1 Q5UQ13 37.481 651 2.35e-61 227.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t1 Q5UQ13 35.724 725 3.34e-61 226.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t1 Q5UQ13 37.613 662 1.13e-59 222.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t1 Q5UQ13 36.297 686 2.03e-59 221.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t1 Q5UQ13 35.188 665 2.76e-57 214.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t1 Q5UQ13 37.911 517 3.94e-54 205.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t1 Q5UQ13 36.418 670 4.1199999999999996e-54 205.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t2 Q5UQ13 38.199 644 1.91e-64 236.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t2 Q5UQ13 37.615 654 2.9099999999999998e-62 229.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t2 Q5UQ13 38.245 638 1.09e-60 225.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t2 Q5UQ13 36.202 674 2.5599999999999998e-54 206.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t2 Q5UQ13 34.008 741 4.45e-54 205.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13468.t2 Q5UQ13 37.911 517 5.0199999999999997e-54 205.0 sp|Q5UQ13|COLL2_MIMIV Collagen-like protein 2 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R196 PE=4 SV=1 g13481.t1 P51589 36.017 472 2.7299999999999997e-95 301.0 sp|P51589|CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens OX=9606 GN=CYP2J2 PE=1 SV=2 CP2J2_HUMAN reviewed Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301 epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate 5,6-epoxygenase activity [GO:0106301]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g13482.t1 O54749 34.156 486 3.2899999999999996e-89 285.0 sp|O54749|CP2J5_MOUSE Cytochrome P450 2J5 OS=Mus musculus OX=10090 GN=Cyp2j5 PE=1 SV=1 CP2J5_MOUSE reviewed Cytochrome P450 2J5 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ5) Mus musculus (Mouse) GO:0001990; GO:0001998; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0071614; GO:0097254; GO:2000863 angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g13482.t2 Q7Z449 37.963 216 6.65e-56 190.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g13485.t1 O35293 30.667 225 6.550000000000001e-21 94.0 sp|O35293|CP2F2_RAT Cytochrome P450 2F2 OS=Rattus norvegicus OX=10116 GN=Cyp2f2 PE=2 SV=1 g13486.t1 Q6V0I7 24.631 1693 2.72e-50 202.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 24.188 1509 6.719999999999999e-42 174.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 28.736 696 9.64e-38 160.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 23.196 1483 8.06e-37 157.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 24.751 905 4.89e-35 152.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 25.803 872 7.449999999999999e-30 134.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 28.053 524 5.08e-26 122.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 25.028 883 5.2099999999999996e-24 115.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13486.t1 Q6V0I7 23.278 958 7.840000000000001e-21 105.0 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g13487.t1 P0DTQ2 26.331 357 3.57e-24 106.0 sp|P0DTQ2|DRDK_BACT7 5-deoxyribose kinase OS=Bacillus thuringiensis serovar kurstaki (strain ATCC 35866 / NRRL B-4488 / HD73) OX=1279365 GN=drdK PE=1 SV=1 g13489.t1 P0DTQ2 29.57 372 2e-27 115.0 sp|P0DTQ2|DRDK_BACT7 5-deoxyribose kinase OS=Bacillus thuringiensis serovar kurstaki (strain ATCC 35866 / NRRL B-4488 / HD73) OX=1279365 GN=drdK PE=1 SV=1 g13490.t1 Q8HXQ0 53.103 145 1.29e-46 154.0 sp|Q8HXQ0|SODC_MACMU Superoxide dismutase [Cu-Zn] OS=Macaca mulatta OX=9544 GN=SOD1 PE=2 SV=3 SODC_MACMU reviewed Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (EC 1.8.-.-) (Hydrogen sulfide oxidase) Macaca mulatta (Rhesus macaque) GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0002262; GO:0004784; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0007283; GO:0007566; GO:0007605; GO:0007626; GO:0008217; GO:0008270; GO:0009408; GO:0019226; GO:0019430; GO:0030346; GO:0031410; GO:0032287; GO:0032839; GO:0032991; GO:0040014; GO:0042542; GO:0043025; GO:0043410; GO:0043524; GO:0045471; GO:0046716; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0072593 auditory receptor cell stereocilium organization [GO:0060088]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular iron ion homeostasis [GO:0006879]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] copper ion binding [GO:0005507]; protein phosphatase 2B binding [GO:0030346]; protein-folding chaperone binding [GO:0051087]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270] g13497.t1 Q5REH2 47.368 399 6.46e-126 372.0 sp|Q5REH2|ZDHC6_PONAB Palmitoyltransferase ZDHHC6 OS=Pongo abelii OX=9601 GN=ZDHHC6 PE=3 SV=1 ZDHC6_PONAB reviewed Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005783; GO:0005789; GO:0016409; GO:0019706; GO:0035556; GO:0140439 intracellular signal transduction [GO:0035556] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g13499.t1 Q9DCT8 53.247 77 2.32e-21 85.9 sp|Q9DCT8|CRIP2_MOUSE Cysteine-rich protein 2 OS=Mus musculus OX=10090 GN=Crip2 PE=1 SV=1 g13499.t1 Q9DCT8 55.556 72 8.59e-21 84.3 sp|Q9DCT8|CRIP2_MOUSE Cysteine-rich protein 2 OS=Mus musculus OX=10090 GN=Crip2 PE=1 SV=1 g13502.t1 P36510 32.54 504 2.95e-83 271.0 sp|P36510|UD2A1_RAT UDP-glucuronosyltransferase 2A1 OS=Rattus norvegicus OX=10116 GN=Ugt2a1 PE=2 SV=1 UD2A1_RAT reviewed UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17) (UGT-OLF) Rattus norvegicus (Rat) GO:0006805; GO:0007606; GO:0007608; GO:0008206; GO:0009608; GO:0009636; GO:0015020; GO:0016020 bile acid metabolic process [GO:0008206]; response to symbiont [GO:0009608]; response to toxic substance [GO:0009636]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g13505.t1 P37141 34.634 205 1.25e-39 138.0 sp|P37141|GPX3_BOVIN Glutathione peroxidase 3 OS=Bos taurus OX=9913 GN=GPX3 PE=2 SV=2 g13506.t1 Q80X89 26.712 292 3.03e-25 109.0 sp|Q80X89|UD2A1_MOUSE UDP-glucuronosyltransferase 2A1 OS=Mus musculus OX=10090 GN=Ugt2a1 PE=2 SV=1 UD2A1_MOUSE reviewed UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17) Mus musculus (Mouse) GO:0006805; GO:0007606; GO:0007608; GO:0008206; GO:0009608; GO:0015020; GO:0016020 bile acid metabolic process [GO:0008206]; response to symbiont [GO:0009608]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g13507.t1 P0DTE5 45.882 170 3.2399999999999998e-46 162.0 sp|P0DTE5|UD2A2_HUMAN UDP-glucuronosyltransferase 2A2 OS=Homo sapiens OX=9606 GN=UGT2A2 PE=1 SV=1 UD2A2_HUMAN reviewed UDP-glucuronosyltransferase 2A2 (UDPGT 2A2) (EC 2.4.1.17) Homo sapiens (Human) GO:0005789; GO:0006805; GO:0008206; GO:0009608; GO:0015020 bile acid metabolic process [GO:0008206]; response to symbiont [GO:0009608]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789] glucuronosyltransferase activity [GO:0015020] g13510.t1 Q9QXF7 36.0 500 3.25e-100 312.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g13510.t2 Q9QXF7 33.2 500 5.65e-80 258.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g13511.t1 E1BD59 28.782 271 3.61e-24 112.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g13513.t1 P59723 61.493 335 1.73e-151 432.0 sp|P59723|HIF1N_DANRE Hypoxia-inducible factor 1-alpha inhibitor OS=Danio rerio OX=7955 GN=hif1an PE=2 SV=2 HIF1N_DANRE reviewed Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Hypoxia-inducible factor asparagine hydroxylase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0008198; GO:0008270; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045746; GO:0048471; GO:0062101; GO:1901343 negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of vasculature development [GO:1901343]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] [protein]-asparagine 3-dioxygenase activity [GO:0036140]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g13515.t1 Q99PF4 34.159 2825 0.0 1233.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t1 Q99PF4 29.954 3255 0.0 960.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t1 Q99PF4 31.464 3013 0.0 889.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t1 Q99PF4 30.239 1928 4.32e-143 510.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t1 Q99PF4 29.899 1679 5.02e-127 457.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t2 Q99PF4 34.159 2825 0.0 1235.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t2 Q99PF4 29.954 3255 0.0 962.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t2 Q99PF4 31.464 3013 0.0 891.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t2 Q99PF4 30.239 1928 2.11e-143 511.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t2 Q99PF4 29.899 1679 2.76e-127 458.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t3 Q99PF4 34.159 2825 0.0 1234.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t3 Q99PF4 29.954 3255 0.0 961.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t3 Q99PF4 31.464 3013 0.0 890.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t3 Q99PF4 30.239 1928 2.52e-143 511.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t3 Q99PF4 29.899 1679 3.44e-127 458.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t4 Q99PF4 34.159 2825 0.0 1233.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t4 Q99PF4 29.954 3255 0.0 961.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t4 Q99PF4 31.464 3013 0.0 890.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t4 Q99PF4 30.239 1928 4.17e-143 510.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13515.t4 Q99PF4 29.738 1678 4.77e-127 457.0 sp|Q99PF4|CAD23_MOUSE Cadherin-23 OS=Mus musculus OX=10090 GN=Cdh23 PE=1 SV=2 CAD23_MOUSE reviewed Cadherin-23 (Otocadherin) Mus musculus (Mouse) GO:0001917; GO:0005509; GO:0005813; GO:0005886; GO:0006816; GO:0007155; GO:0007156; GO:0007605; GO:0007626; GO:0008013; GO:0016339; GO:0016342; GO:0016477; GO:0031175; GO:0032420; GO:0032426; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045296; GO:0045494; GO:0048839; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0060122; GO:0090102; GO:0098683; GO:0098684; GO:0098742 auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cochlea development [GO:0090102]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; kinocilium [GO:0060091]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] g13516.t1 Q9W534 25.067 375 9.41e-23 103.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g13521.t1 Q9QYI4 42.643 401 9.72e-103 311.0 sp|Q9QYI4|DJB12_MOUSE DnaJ homolog subfamily B member 12 OS=Mus musculus OX=10090 GN=Dnajb12 PE=1 SV=2 g13522.t1 P38571 49.608 383 1.07e-128 382.0 sp|P38571|LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens OX=9606 GN=LIPA PE=1 SV=2 LICH_HUMAN reviewed Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Diacylglycerol lipase) (Lipase A) (Sterol esterase) (Triacylglycerol ester hydrolase) (Triacylglycerol lipase) Homo sapiens (Human) GO:0000278; GO:0000902; GO:0001650; GO:0001935; GO:0002021; GO:0002244; GO:0002526; GO:0002536; GO:0004771; GO:0005654; GO:0005764; GO:0005829; GO:0006006; GO:0006096; GO:0006631; GO:0006641; GO:0006695; GO:0006754; GO:0006776; GO:0006897; GO:0007005; GO:0007040; GO:0007264; GO:0008333; GO:0008340; GO:0009409; GO:0009410; GO:0010467; GO:0010878; GO:0016042; GO:0016125; GO:0016298; GO:0030099; GO:0030217; GO:0030324; GO:0030421; GO:0031929; GO:0033028; GO:0033189; GO:0033344; GO:0034383; GO:0035726; GO:0042098; GO:0042159; GO:0043202; GO:0048536; GO:0048539; GO:0048771; GO:0048873; GO:0050862; GO:0051881; GO:0055088; GO:0060612; GO:0060837; GO:0061519; GO:0070231; GO:0070341; GO:0071830; GO:0071838; GO:0072576; GO:0140354; GO:0140962; GO:1901355; GO:1903409; GO:1990845 acute inflammatory response [GO:0002526]; adaptive thermogenesis [GO:1990845]; adipose tissue development [GO:0060612]; ATP biosynthetic process [GO:0006754]; blood vessel endothelial cell differentiation [GO:0060837]; bone marrow development [GO:0048539]; cell morphogenesis [GO:0000902]; cell proliferation in bone marrow [GO:0071838]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol storage [GO:0010878]; common myeloid progenitor cell proliferation [GO:0035726]; defecation [GO:0030421]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endothelial cell proliferation [GO:0001935]; fat cell proliferation [GO:0070341]; fatty acid metabolic process [GO:0006631]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells within a tissue [GO:0048873]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; lipid import into cell [GO:0140354]; lipoprotein catabolic process [GO:0042159]; liver morphogenesis [GO:0072576]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; lysosome organization [GO:0007040]; macrophage homeostasis [GO:0061519]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organismal-level chemical homeostasis [GO:0140962]; myeloid cell apoptotic process [GO:0033028]; myeloid cell differentiation [GO:0030099]; positive regulation of T cell receptor signaling pathway [GO:0050862]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of mitochondrial membrane potential [GO:0051881]; respiratory burst involved in inflammatory response [GO:0002536]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to rapamycin [GO:1901355]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; small GTPase-mediated signal transduction [GO:0007264]; spleen development [GO:0048536]; sterol metabolic process [GO:0016125]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; tissue remodeling [GO:0048771]; TOR signaling [GO:0031929]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle clearance [GO:0071830]; vitamin A metabolic process [GO:0006776] cytosol [GO:0005829]; fibrillar center [GO:0001650]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] lipase activity [GO:0016298]; sterol ester esterase activity [GO:0004771] g13523.t1 Q5BJ65 96.875 128 6.79e-84 244.0 sp|Q5BJ65|H2AV_XENTR Histone H2A.V OS=Xenopus tropicalis OX=8364 GN=h2az2 PE=2 SV=3 g13524.t1 P10079 37.707 724 1.83e-125 407.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t1 P10079 41.105 579 1.86e-111 369.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t1 P10079 47.202 411 3.5e-108 360.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t1 P10079 39.519 582 6.28e-108 360.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t1 P10079 47.661 342 3.13e-93 320.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t1 P10079 36.866 651 2.98e-91 314.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t2 P10079 38.74 746 1.85e-132 426.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t2 P10079 49.015 406 1.06e-113 376.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t2 P10079 38.272 648 1.38e-113 376.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t2 P10079 47.981 421 4.28e-112 372.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t2 P10079 44.737 380 1.1e-93 322.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t2 P10079 46.647 343 2.2500000000000002e-86 301.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13524.t2 P10079 39.416 274 2.6e-41 167.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13525.t1 A2VDT9 32.948 173 3.5399999999999995e-24 97.8 sp|A2VDT9|DDT4L_BOVIN DNA damage-inducible transcript 4-like protein OS=Bos taurus OX=9913 GN=DDIT4L PE=2 SV=1 g13526.t1 Q920G9 35.697 423 5.85e-75 244.0 sp|Q920G9|GMCL1_MOUSE Germ cell-less protein-like 1 OS=Mus musculus OX=10090 GN=Gmcl1 PE=1 SV=2 g13527.t1 Q6N021 56.533 375 5.86e-126 445.0 sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3 TET2_HUMAN reviewed Methylcytosine dioxygenase TET2 (EC 1.14.11.80) Homo sapiens (Human) GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579 leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA 5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270] g13527.t1 Q6N021 43.902 164 8.75e-22 107.0 sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3 TET2_HUMAN reviewed Methylcytosine dioxygenase TET2 (EC 1.14.11.80) Homo sapiens (Human) GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579 leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA 5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270] g13532.t1 P12007 67.98 406 0.0 598.0 sp|P12007|IVD_RAT Isovaleryl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Ivd PE=1 SV=2 IVD_RAT reviewed Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1) Rattus norvegicus (Rat) GO:0005654; GO:0005739; GO:0005759; GO:0006551; GO:0006552; GO:0008470; GO:0009083; GO:0031966; GO:0033539; GO:0042802; GO:0050660 branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; L-leucine catabolic process [GO:0006552]; L-leucine metabolic process [GO:0006551] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 3-methylbutanoyl-CoA dehydrogenase activity [GO:0008470]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802] g13533.t1 Q96LT4 44.951 307 1.18e-85 269.0 sp|Q96LT4|SAMD8_HUMAN Sphingomyelin synthase-related protein 1 OS=Homo sapiens OX=9606 GN=SAMD8 PE=1 SV=2 SAMD8_HUMAN reviewed Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Phosphatidylethanolamine Phospholipase C) (PE-PLC) (EC 3.1.4.62) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8) Homo sapiens (Human) GO:0000139; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006686; GO:0016020; GO:0033188; GO:0046513; GO:0047493; GO:2000303 ceramide biosynthetic process [GO:0046513]; regulation of ceramide biosynthetic process [GO:2000303]; sphingomyelin biosynthetic process [GO:0006686] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188] g13536.t1 Q96LT4 53.237 417 3.01e-145 423.0 sp|Q96LT4|SAMD8_HUMAN Sphingomyelin synthase-related protein 1 OS=Homo sapiens OX=9606 GN=SAMD8 PE=1 SV=2 SAMD8_HUMAN reviewed Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Phosphatidylethanolamine Phospholipase C) (PE-PLC) (EC 3.1.4.62) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8) Homo sapiens (Human) GO:0000139; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006686; GO:0016020; GO:0033188; GO:0046513; GO:0047493; GO:2000303 ceramide biosynthetic process [GO:0046513]; regulation of ceramide biosynthetic process [GO:2000303]; sphingomyelin biosynthetic process [GO:0006686] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] ceramide cholinephosphotransferase activity [GO:0047493]; sphingomyelin synthase activity [GO:0033188] g13543.t1 O73630 44.156 231 2.53e-51 182.0 sp|O73630|NFKB2_XENLA Nuclear factor NF-kappa-B p100 subunit OS=Xenopus laevis OX=8355 GN=nfkb2 PE=2 SV=1 g13545.t1 Q63369 54.789 261 5.94e-89 289.0 sp|Q63369|NFKB1_RAT Nuclear factor NF-kappa-B p105 subunit OS=Rattus norvegicus OX=10116 GN=Nfkb1 PE=1 SV=2 NFKB1_RAT reviewed Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] Rattus norvegicus (Rat) GO:0000122; GO:0000165; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0001228; GO:0001818; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006915; GO:0006954; GO:0006979; GO:0007249; GO:0007254; GO:0009410; GO:0009617; GO:0010467; GO:0010628; GO:0010629; GO:0010744; GO:0010875; GO:0010884; GO:0010957; GO:0023019; GO:0031072; GO:0032695; GO:0032991; GO:0033209; GO:0033256; GO:0035525; GO:0035994; GO:0038061; GO:0042802; GO:0042805; GO:0043066; GO:0043565; GO:0044877; GO:0045471; GO:0045892; GO:0045893; GO:0045944; GO:0046688; GO:0050728; GO:0050729; GO:0050853; GO:0060056; GO:0060261; GO:0071222; GO:0071260; GO:0071316; GO:0071322; GO:0071345; GO:0071347; GO:0071354; GO:0071356; GO:0071359; GO:0090263; GO:0097398; GO:0098586; GO:0140311; GO:0140367; GO:1900016; GO:1900127; GO:1901653; GO:1904385; GO:1904630; GO:1904632; GO:1990416; GO:1990837; GO:2000630 antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to carbohydrate stimulus [GO:0071322]; cellular response to cytokine stimulus [GO:0071345]; cellular response to diterpene [GO:1904630]; cellular response to dsRNA [GO:0071359]; cellular response to glucoside [GO:1904632]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-17 [GO:0097398]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; mammary gland involution [GO:0060056]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; response to bacterium [GO:0009617]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to muscle stretch [GO:0035994]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I-kappaB/NF-kappaB complex [GO:0033256]; mitochondrion [GO:0005739]; NF-kappaB p50/p65 complex [GO:0035525]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] actinin binding [GO:0042805]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712] g13546.t1 G3V801 42.586 263 4.0999999999999995e-48 174.0 sp|G3V801|NETR_RAT Neurotrypsin OS=Rattus norvegicus OX=10116 GN=Prss12 PE=1 SV=1 NETR_RAT reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Rattus norvegicus (Rat) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g13547.t1 O54749 36.686 507 3.19e-103 320.0 sp|O54749|CP2J5_MOUSE Cytochrome P450 2J5 OS=Mus musculus OX=10090 GN=Cyp2j5 PE=1 SV=1 CP2J5_MOUSE reviewed Cytochrome P450 2J5 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ5) Mus musculus (Mouse) GO:0001990; GO:0001998; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0071614; GO:0097254; GO:2000863 angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g13549.t1 Q6DKC0 71.383 311 7.2e-169 475.0 sp|Q6DKC0|ERL2B_XENLA Erlin-2-B OS=Xenopus laevis OX=8355 GN=erlin2-b PE=2 SV=1 g13550.t1 P63245 81.09 312 0.0 536.0 sp|P63245|RACK1_RAT Small ribosomal subunit protein RACK1 OS=Rattus norvegicus OX=10116 GN=Rack1 PE=1 SV=3 RACK1_RAT reviewed Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) (Receptor for activated C kinase) (Receptor of activated protein C kinase 1) (Receptor of activated protein kinase C 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Receptor of activated protein C kinase 1, N-terminally processed)] Rattus norvegicus (Rat) GO:0001649; GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006412; GO:0007200; GO:0007369; GO:0008047; GO:0008200; GO:0008656; GO:0010629; GO:0015935; GO:0016020; GO:0016567; GO:0017148; GO:0019899; GO:0019903; GO:0030178; GO:0030291; GO:0030292; GO:0030308; GO:0030332; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0035591; GO:0042169; GO:0042802; GO:0042803; GO:0042998; GO:0043005; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043473; GO:0043547; GO:0044297; GO:0045182; GO:0045879; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051434; GO:0051726; GO:0051898; GO:0051901; GO:0071333; GO:0071363; GO:0072344; GO:0106070; GO:1903076; GO:1903751; GO:1990630; GO:2000114; GO:2000543; GO:2001125; GO:2001244 cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translation [GO:0017148]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; protein ubiquitination [GO:0016567]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511]; translation [GO:0006412] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; IRE1-RACK1-PP2A complex [GO:1990630]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935] BH3 domain binding [GO:0051434]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ion channel inhibitor activity [GO:0008200]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; translation regulator activity [GO:0045182] g13551.t1 P11611 94.463 307 0.0 621.0 sp|P11611|PP2AB_RABIT Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform OS=Oryctolagus cuniculus OX=9986 GN=PPP2CB PE=1 SV=1 g13552.t1 Q96FV3 45.66 265 1.04e-72 230.0 sp|Q96FV3|TSN17_HUMAN Tetraspanin-17 OS=Homo sapiens OX=9606 GN=TSPAN17 PE=2 SV=2 g13553.t1 Q9UBI4 40.346 347 1.97e-77 248.0 sp|Q9UBI4|STML1_HUMAN Stomatin-like protein 1 OS=Homo sapiens OX=9606 GN=STOML1 PE=1 SV=1 g13554.t1 P00367 76.265 514 0.0 853.0 sp|P00367|DHE3_HUMAN Glutamate dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=GLUD1 PE=1 SV=2 DHE3_HUMAN reviewed Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) Homo sapiens (Human) GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0021762; GO:0032024; GO:0042803; GO:0043531; GO:0070403; GO:0070728; GO:0072350 glutamate biosynthetic process [GO:0006537]; glutamine metabolic process [GO:0006541]; L-glutamate catabolic process [GO:0006538]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; L-leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g13554.t2 P00367 75.439 513 0.0 842.0 sp|P00367|DHE3_HUMAN Glutamate dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=GLUD1 PE=1 SV=2 DHE3_HUMAN reviewed Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) Homo sapiens (Human) GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0021762; GO:0032024; GO:0042803; GO:0043531; GO:0070403; GO:0070728; GO:0072350 glutamate biosynthetic process [GO:0006537]; glutamine metabolic process [GO:0006541]; L-glutamate catabolic process [GO:0006538]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; L-leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g13555.t1 Q5W4S4 42.075 530 3.49e-112 382.0 sp|Q5W4S4|FNIP1_CHICK Folliculin-interacting protein 1 OS=Gallus gallus OX=9031 GN=FNIP1 PE=3 SV=1 g13555.t1 Q5W4S4 47.716 197 5.49e-41 168.0 sp|Q5W4S4|FNIP1_CHICK Folliculin-interacting protein 1 OS=Gallus gallus OX=9031 GN=FNIP1 PE=3 SV=1 g13561.t1 Q9ULJ6 75.789 95 1.18e-44 157.0 sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3 g13562.t1 Q9ULJ6 56.15 748 0.0 633.0 sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3 g13563.t1 Q569Z5 66.272 845 0.0 1087.0 sp|Q569Z5|DDX46_MOUSE Probable ATP-dependent RNA helicase DDX46 OS=Mus musculus OX=10090 GN=Ddx46 PE=1 SV=2 DDX46_MOUSE reviewed Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) Mus musculus (Mouse) GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005684; GO:0015030; GO:0016607; GO:0016887; GO:1903241 mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type spliceosomal complex [GO:0005684] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g13565.t1 O15072 34.278 1129 0.0 628.0 sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4 ATS3_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme) Homo sapiens (Human) GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g13565.t1 O15072 32.948 173 1.7100000000000003e-21 105.0 sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4 ATS3_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme) Homo sapiens (Human) GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g13567.t1 Q8VI56 36.585 205 4.0600000000000004e-32 130.0 sp|Q8VI56|LRP4_MOUSE Low-density lipoprotein receptor-related protein 4 OS=Mus musculus OX=10090 GN=Lrp4 PE=1 SV=3 LRP4_MOUSE reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan) Mus musculus (Mouse) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g13568.t1 Q9BEA0 29.879 579 3.69e-73 265.0 sp|Q9BEA0|EGF_CANLF Pro-epidermal growth factor OS=Canis lupus familiaris OX=9615 GN=EGF PE=2 SV=1 g13568.t1 Q9BEA0 25.852 352 2.0099999999999999e-28 127.0 sp|Q9BEA0|EGF_CANLF Pro-epidermal growth factor OS=Canis lupus familiaris OX=9615 GN=EGF PE=2 SV=1 g13569.t1 Q5D016 52.419 124 7.84e-40 132.0 sp|Q5D016|PFD1_DANRE Prefoldin subunit 1 OS=Danio rerio OX=7955 GN=pfdn1 PE=2 SV=1 g13571.t1 Q6IVV8 50.937 854 0.0 835.0 sp|Q6IVV8|PKD2_DANRE Polycystin-2 OS=Danio rerio OX=7955 GN=pkd2 PE=1 SV=1 PKD2_DANRE reviewed Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0003173; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005886; GO:0005929; GO:0007166; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0060271; GO:0060972; GO:0061371; GO:0065003; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662 atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; cilium assembly [GO:0060271]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; lymphangiogenesis [GO:0001946]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; release of sequestered calcium ion into cytosol [GO:0051209]; ventriculo bulbo valve development [GO:0003173] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248] g13576.t1 P10079 43.629 777 0.0 620.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13576.t1 P10079 41.205 830 0.0 615.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13576.t1 P10079 49.004 502 1.76e-135 459.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13576.t1 P10079 43.64 511 1.99e-121 417.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13579.t1 P0C6B8 29.523 1216 5.27e-131 469.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g13579.t1 P0C6B8 26.829 533 1.38e-32 144.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g13579.t1 P0C6B8 23.679 549 7.57e-25 119.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g13579.t1 P0C6B8 22.201 1072 1.86e-24 117.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g13579.t1 P0C6B8 27.674 430 4.62e-22 109.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g13579.t1 P0C6B8 25.282 443 1.7700000000000003e-21 107.0 sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1 SVEP1_RAT reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 Rattus norvegicus (Rat) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0031012; GO:0031099; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193 epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; regeneration [GO:0031099]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g13581.t1 Q9EQW8 47.931 870 0.0 868.0 sp|Q9EQW8|NDST4_MOUSE Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Mus musculus OX=10090 GN=Ndst4 PE=2 SV=2 NDST4_MOUSE reviewed Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 4) (NDST-4) (N-heparan sulfate sulfotransferase 4) (N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 4 (EC 2.8.2.-)] Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0008146; GO:0015012; GO:0015016; GO:0019213; GO:0030210; GO:0050119 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] deacetylase activity [GO:0019213]; heparan sulfate N-sulfotransferase activity [GO:0015016]; N-acetylglucosamine deacetylase activity [GO:0050119]; sulfotransferase activity [GO:0008146] g13584.t1 P10079 42.443 794 8.79e-177 579.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13584.t1 P10079 47.906 597 2.6400000000000003e-163 540.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13584.t1 P10079 45.631 206 1.16e-47 192.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13584.t1 P10079 48.276 145 1.4099999999999999e-30 137.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13584.t2 P10079 42.443 794 5.28e-177 580.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13584.t2 P10079 47.906 597 1.4800000000000003e-163 541.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13584.t2 P10079 45.631 206 8.809999999999999e-48 192.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13584.t2 P10079 48.276 145 1.25e-30 137.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g13586.t1 Q9Y4G8 48.263 1065 0.0 971.0 sp|Q9Y4G8|RPGF2_HUMAN Rap guanine nucleotide exchange factor 2 OS=Homo sapiens OX=9606 GN=RAPGEF2 PE=1 SV=1 g13586.t2 Q9Y4G8 48.499 1066 0.0 974.0 sp|Q9Y4G8|RPGF2_HUMAN Rap guanine nucleotide exchange factor 2 OS=Homo sapiens OX=9606 GN=RAPGEF2 PE=1 SV=1 g13586.t3 Q8TEU7 45.447 1230 0.0 1010.0 sp|Q8TEU7|RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens OX=9606 GN=RAPGEF6 PE=1 SV=2 RPGF6_HUMAN reviewed Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2) (PDZ-GEF2) (RA-GEF-2) Homo sapiens (Human) GO:0005085; GO:0005813; GO:0005829; GO:0005886; GO:0007265; GO:0016324; GO:0030033; GO:0030139; GO:0030742; GO:0031267; GO:0043087; GO:0070300; GO:0072659; GO:1903698 microvillus assembly [GO:0030033]; positive regulation of microvillus assembly [GO:1903698]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886] GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267] g13587.t1 Q9DDT2 28.767 511 3.3499999999999997e-38 155.0 sp|Q9DDT2|BCAP_CHICK Phosphoinositide 3-kinase adapter protein 1 OS=Gallus gallus OX=9031 GN=PIK3AP1 PE=1 SV=1 g13587.t2 Q9DDT2 28.244 524 1.37e-38 157.0 sp|Q9DDT2|BCAP_CHICK Phosphoinositide 3-kinase adapter protein 1 OS=Gallus gallus OX=9031 GN=PIK3AP1 PE=1 SV=1 g13589.t1 Q9CZP0 45.238 210 3.43e-57 183.0 sp|Q9CZP0|UFSP1_MOUSE Ufm1-specific protease 1 OS=Mus musculus OX=10090 GN=Ufsp1 PE=1 SV=1 g13590.t1 P69478 28.782 271 1.02e-25 108.0 sp|P69478|CHSTB_RAT Carbohydrate sulfotransferase 11 OS=Rattus norvegicus OX=10116 GN=Chst11 PE=1 SV=1 CHSTB_RAT reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Rattus norvegicus (Rat) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g13591.t1 Q805E5 28.772 285 1.2800000000000001e-26 112.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g13592.t1 O14802 75.298 336 9.91e-171 516.0 sp|O14802|RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens OX=9606 GN=POLR3A PE=1 SV=2 RPC1_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160) Homo sapiens (Human) GO:0000287; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005737; GO:0005829; GO:0006351; GO:0008270; GO:0016020; GO:0032728; GO:0042797; GO:0045087; GO:0051607; GO:0071667 defense response to virus [GO:0051607]; DNA-templated transcription [GO:0006351]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] g13593.t1 A4IF62 59.067 193 1.73e-68 229.0 sp|A4IF62|RPC1_BOVIN DNA-directed RNA polymerase III subunit RPC1 OS=Bos taurus OX=9913 GN=POLR3A PE=2 SV=1 RPC1_BOVIN reviewed DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A) Bos taurus (Bovine) GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0032728; GO:0042797; GO:0045087; GO:0046872; GO:0051607 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872] g13595.t1 O14802 81.102 127 1.4999999999999998e-67 223.0 sp|O14802|RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens OX=9606 GN=POLR3A PE=1 SV=2 RPC1_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160) Homo sapiens (Human) GO:0000287; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005737; GO:0005829; GO:0006351; GO:0008270; GO:0016020; GO:0032728; GO:0042797; GO:0045087; GO:0051607; GO:0071667 defense response to virus [GO:0051607]; DNA-templated transcription [GO:0006351]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] g13596.t1 Q5ZL98 75.802 686 0.0 1108.0 sp|Q5ZL98|RPC1_CHICK DNA-directed RNA polymerase III subunit RPC1 OS=Gallus gallus OX=9031 GN=POLR3A PE=2 SV=1 g13597.t1 Q91ZW1 29.469 207 2.5200000000000004e-21 92.8 sp|Q91ZW1|TFAM_RAT Transcription factor A, mitochondrial OS=Rattus norvegicus OX=10116 GN=Tfam PE=2 SV=1 TFAM_RAT reviewed Transcription factor A, mitochondrial (mtTFA) Rattus norvegicus (Rat) GO:0001018; GO:0001223; GO:0001666; GO:0003682; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006390; GO:0006391; GO:0007584; GO:0031072; GO:0032991; GO:0033108; GO:0034246; GO:0042645; GO:0043565 mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial transcription [GO:0006390]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; transcription initiation at mitochondrial promoter [GO:0006391] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; mitochondrial transcription factor activity [GO:0034246]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223] g13598.t1 O73888 39.024 205 9.83e-35 125.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g13599.t1 P23653 32.895 380 2.04e-40 150.0 sp|P23653|PRTR_PARAQ Proteinase R OS=Parengyodontium album OX=37998 GN=PROR PE=1 SV=1 g13599.t2 P23653 37.297 185 9.67e-33 125.0 sp|P23653|PRTR_PARAQ Proteinase R OS=Parengyodontium album OX=37998 GN=PROR PE=1 SV=1 g13601.t1 P46023 33.167 802 7.13e-115 392.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g13601.t1 P46023 30.182 275 1.5499999999999998e-24 115.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g13604.t1 P28026 53.231 325 1.6200000000000002e-117 347.0 sp|P28026|WNT8_XENLA Protein Wnt-8 OS=Xenopus laevis OX=8355 GN=wnt8 PE=1 SV=2 g13605.t1 X6R8R1 50.165 303 1.43e-101 317.0 sp|X6R8R1|ST15B_HUMAN Synaptotagmin-15B OS=Homo sapiens OX=9606 GN=SYT15B PE=3 SV=1 ST15B_HUMAN reviewed Synaptotagmin-15B Homo sapiens (Human) GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0061891; GO:0070382 regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149] g13607.t1 P24507 31.476 359 2.0400000000000002e-35 140.0 sp|P24507|SY63_DIPOM Synaptotagmin-C OS=Diplobatis ommata OX=1870830 GN=P65-C PE=2 SV=1 g13609.t1 Q5U4T7 59.375 416 4.75e-148 472.0 sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1 g13609.t1 Q5U4T7 45.769 260 1.7699999999999998e-45 182.0 sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1 g13609.t2 Q5U4T7 59.604 505 0.0 577.0 sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1 g13609.t2 Q5U4T7 45.769 260 2.4399999999999998e-45 182.0 sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1 g13610.t1 Q08209 78.512 484 0.0 820.0 sp|Q08209|PP2BA_HUMAN Protein phosphatase 3 catalytic subunit alpha OS=Homo sapiens OX=9606 GN=PPP3CA PE=1 SV=1 PP2BA_HUMAN reviewed Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) Homo sapiens (Human) GO:0000082; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0016311; GO:0019897; GO:0019899; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042060; GO:0042104; GO:0042110; GO:0042383; GO:0043197; GO:0043403; GO:0045669; GO:0045672; GO:0045785; GO:0045807; GO:0045944; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070262; GO:0070886; GO:0090193; GO:0097205; GO:0097720; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903235; GO:1903244; GO:1905205; GO:1905665; GO:1905949 calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; dephosphorylation [GO:0016311]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; T cell activation [GO:0042110]; transition between fast and slow fiber [GO:0014883]; wound healing [GO:0042060] calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018] ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein serine/threonine phosphatase activity [GO:0004722] g13611.t1 Q9H3K2 51.447 311 6.76e-100 301.0 sp|Q9H3K2|GHITM_HUMAN Growth hormone-inducible transmembrane protein OS=Homo sapiens OX=9606 GN=GHITM PE=1 SV=2 GHITM_HUMAN reviewed Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5) Homo sapiens (Human) GO:0005262; GO:0005739; GO:0005743; GO:0005789; GO:0006816; GO:0006851; GO:0006915; GO:0007007; GO:0015369; GO:0031966; GO:0070062; GO:0090201; GO:0099093; GO:0140141; GO:1905448 apoptotic process [GO:0006915]; calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial potassium ion transmembrane transport [GO:0140141]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] calcium channel activity [GO:0005262]; calcium:proton antiporter activity [GO:0015369] g13613.t1 O15973 35.154 293 3.2e-50 176.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g13617.t1 Q96HR8 39.163 263 2.84e-49 181.0 sp|Q96HR8|NAF1_HUMAN H/ACA ribonucleoprotein complex non-core subunit NAF1 OS=Homo sapiens OX=9606 GN=NAF1 PE=1 SV=2 NAF1_HUMAN reviewed H/ACA ribonucleoprotein complex non-core subunit NAF1 (hNAF1) Homo sapiens (Human) GO:0000454; GO:0000493; GO:0003723; GO:0005634; GO:0005654; GO:0005732; GO:0005737; GO:0032212; GO:0042254; GO:0042802; GO:0043489; GO:0070034; GO:0090669; GO:0090671; GO:1904358; GO:1905323 box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA localization to Cajal body [GO:0090671]; telomerase RNA stabilization [GO:0090669] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] g13617.t2 Q96HR8 40.244 246 8.66e-49 177.0 sp|Q96HR8|NAF1_HUMAN H/ACA ribonucleoprotein complex non-core subunit NAF1 OS=Homo sapiens OX=9606 GN=NAF1 PE=1 SV=2 NAF1_HUMAN reviewed H/ACA ribonucleoprotein complex non-core subunit NAF1 (hNAF1) Homo sapiens (Human) GO:0000454; GO:0000493; GO:0003723; GO:0005634; GO:0005654; GO:0005732; GO:0005737; GO:0032212; GO:0042254; GO:0042802; GO:0043489; GO:0070034; GO:0090669; GO:0090671; GO:1904358; GO:1905323 box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA localization to Cajal body [GO:0090671]; telomerase RNA stabilization [GO:0090669] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] g13618.t1 Q91ZW2 36.87 377 1.42e-77 248.0 sp|Q91ZW2|OFUT1_MOUSE GDP-fucose protein O-fucosyltransferase 1 OS=Mus musculus OX=10090 GN=Pofut1 PE=1 SV=1 OFUT1_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Mus musculus (Mouse) GO:0001525; GO:0001756; GO:0005783; GO:0006004; GO:0007219; GO:0007399; GO:0007507; GO:0008417; GO:0008593; GO:0016020; GO:0036066; GO:0046922 angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g13618.t2 Q91ZW2 33.495 412 9.42e-71 231.0 sp|Q91ZW2|OFUT1_MOUSE GDP-fucose protein O-fucosyltransferase 1 OS=Mus musculus OX=10090 GN=Pofut1 PE=1 SV=1 OFUT1_MOUSE reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Mus musculus (Mouse) GO:0001525; GO:0001756; GO:0005783; GO:0006004; GO:0007219; GO:0007399; GO:0007507; GO:0008417; GO:0008593; GO:0016020; GO:0036066; GO:0046922 angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g13619.t1 Q8TCT9 65.289 363 5.31e-176 498.0 sp|Q8TCT9|SPP_HUMAN Signal peptide peptidase OS=Homo sapiens OX=9606 GN=HM13 PE=1 SV=1 SPP_HUMAN reviewed Signal peptide peptidase (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Minor histocompatibility antigen H13) (Presenilin-like protein 3) (Signal peptide peptidase-like 1) Homo sapiens (Human) GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0016020; GO:0031625; GO:0033619; GO:0034599; GO:0036513; GO:0042500; GO:0042803; GO:0098553; GO:0098554; GO:1904211 cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465] cell surface [GO:0009986]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625] g13620.t1 Q7T2P6 50.0 168 6.709999999999999e-52 169.0 sp|Q7T2P6|TIM23_DANRE Mitochondrial import inner membrane translocase subunit Tim23 OS=Danio rerio OX=7955 GN=timm23 PE=2 SV=1 TIM23_DANRE reviewed Mitochondrial import inner membrane translocase subunit Tim23 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005744; GO:0006886; GO:0008320; GO:0015450; GO:0016020; GO:0030150; GO:0042719; GO:0045039 intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039] membrane [GO:0016020]; mitochondrial intermembrane space chaperone complex [GO:0042719]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] protein transmembrane transporter activity [GO:0008320]; protein-transporting ATPase activity [GO:0015450] g13621.t1 O15973 39.084 371 4.8e-84 270.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g13622.t1 Q6TH22 59.494 395 1.27e-149 434.0 sp|Q6TH22|DDI2_DANRE Protein DDI1 homolog 2 OS=Danio rerio OX=7955 GN=ddi2 PE=2 SV=1 g13623.t1 Q14831 28.279 831 4.15e-104 346.0 sp|Q14831|GRM7_HUMAN Metabotropic glutamate receptor 7 OS=Homo sapiens OX=9606 GN=GRM7 PE=1 SV=1 g13625.t1 Q7JQD3 54.648 355 8.76e-131 382.0 sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1 g13626.t1 Q8MPM1 55.342 365 9.35e-142 409.0 sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1 g13627.t1 Q7JQD3 46.809 376 2.34e-115 342.0 sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1 g13631.t1 Q4QRK0 69.713 383 0.0 570.0 sp|Q4QRK0|MAP11_DANRE Methionine aminopeptidase 1 OS=Danio rerio OX=7955 GN=metap1 PE=2 SV=2 g13632.t1 P81601 73.797 374 0.0 590.0 sp|P81601|ADHL_GADMO Alcohol dehydrogenase class-3 chain L OS=Gadus morhua OX=8049 PE=1 SV=1 g13633.t1 P16260 51.351 296 1.5600000000000001e-99 298.0 sp|P16260|GDC_HUMAN Solute carrier family 25 member 16 OS=Homo sapiens OX=9606 GN=SLC25A16 PE=1 SV=3 g13634.t1 Q16204 62.437 394 3.19e-144 421.0 sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2 CCDC6_HUMAN reviewed Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) Homo sapiens (Human) GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 cytoskeleton [GO:0005856]; cytosol [GO:0005829] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] g13634.t2 Q16204 60.837 406 5.97e-144 421.0 sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2 CCDC6_HUMAN reviewed Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) Homo sapiens (Human) GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 cytoskeleton [GO:0005856]; cytosol [GO:0005829] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] g13634.t3 Q16204 59.848 396 8.160000000000001e-144 421.0 sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2 CCDC6_HUMAN reviewed Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) Homo sapiens (Human) GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 cytoskeleton [GO:0005856]; cytosol [GO:0005829] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] g13634.t4 Q16204 59.233 417 6.38e-142 416.0 sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2 CCDC6_HUMAN reviewed Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) Homo sapiens (Human) GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 cytoskeleton [GO:0005856]; cytosol [GO:0005829] identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] g13635.t1 Q8BXN7 50.508 295 3.53e-100 301.0 sp|Q8BXN7|PPM1K_MOUSE Protein phosphatase Mn(2+)-dependent 1K OS=Mus musculus OX=10090 GN=Ppm1k PE=1 SV=1 PPM1K_MOUSE reviewed Protein phosphatase Mn(2+)-dependent 1K (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (BCKDH) (BDP) (EC 3.1.3.16) (Protein phosphatase 2C family member) (Protein phosphatase 2C isoform kappa) (PP2C-kappa) ([3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)]-phosphatase) (EC 3.1.3.52) Mus musculus (Mouse) GO:0004722; GO:0005739; GO:0005759; GO:0009083; GO:0030145; GO:0047385; GO:1902108; GO:1902531 branched-chain amino acid catabolic process [GO:0009083]; regulation of intracellular signal transduction [GO:1902531]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity [GO:0047385]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722] g13638.t1 P47743 31.938 454 1.1099999999999999e-61 233.0 sp|P47743|GRM8_MOUSE Metabotropic glutamate receptor 8 OS=Mus musculus OX=10090 GN=Grm8 PE=1 SV=2 GRM8_MOUSE reviewed Metabotropic glutamate receptor 8 (mGluR8) Mus musculus (Mouse) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0035249; GO:0042734; GO:0043025; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g13638.t1 P47743 28.288 403 1.14e-38 160.0 sp|P47743|GRM8_MOUSE Metabotropic glutamate receptor 8 OS=Mus musculus OX=10090 GN=Grm8 PE=1 SV=2 GRM8_MOUSE reviewed Metabotropic glutamate receptor 8 (mGluR8) Mus musculus (Mouse) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0035249; GO:0042734; GO:0043025; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g13638.t1 P47743 23.864 440 7.89e-29 129.0 sp|P47743|GRM8_MOUSE Metabotropic glutamate receptor 8 OS=Mus musculus OX=10090 GN=Grm8 PE=1 SV=2 GRM8_MOUSE reviewed Metabotropic glutamate receptor 8 (mGluR8) Mus musculus (Mouse) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0035249; GO:0042734; GO:0043025; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g13649.t1 Q9D8I1 37.931 145 1.3800000000000002e-27 106.0 sp|Q9D8I1|MZB1_MOUSE Marginal zone B- and B1-cell-specific protein OS=Mus musculus OX=10090 GN=Mzb1 PE=1 SV=2 MZB1_MOUSE reviewed Marginal zone B- and B1-cell-specific protein (Plasma cell-induced resident endoplasmic reticulum protein) (Plasma cell-induced resident ER protein) (pERp1) (Proapoptotic caspase adapter protein) Mus musculus (Mouse) GO:0002639; GO:0005576; GO:0005737; GO:0005788; GO:0008284; GO:0030888; GO:0033622; GO:0034663; GO:0042127; GO:0046626 integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] g13650.t1 Q5VYX0 40.933 386 9.259999999999999e-104 313.0 sp|Q5VYX0|RNLS_HUMAN Renalase OS=Homo sapiens OX=9606 GN=RNLS PE=1 SV=1 RNLS_HUMAN reviewed Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C) Homo sapiens (Human) GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0045776; GO:0051379; GO:0070404; GO:0071869; GO:0071871; GO:0097621; GO:1902074 negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; response to catecholamine [GO:0071869]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074] extracellular region [GO:0005576]; extracellular space [GO:0005615] epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651] g13653.t1 Q5XHC1 56.954 302 1.55e-110 326.0 sp|Q5XHC1|CFA96_XENLA Cilia-and flagella-associated protein 96 OS=Xenopus laevis OX=8355 GN=cfap96.L PE=2 SV=1 g13655.t1 Q8CI70 38.608 158 8.359999999999999e-23 92.8 sp|Q8CI70|LRC20_MOUSE Leucine-rich repeat-containing protein 20 OS=Mus musculus OX=10090 GN=Lrrc20 PE=1 SV=1 g13656.t1 Q9EPZ7 30.197 659 1.11e-79 273.0 sp|Q9EPZ7|SO1C1_RAT Solute carrier organic anion transporter family member 1C1 OS=Rattus norvegicus OX=10116 GN=Slco1c1 PE=1 SV=1 SO1C1_RAT reviewed Solute carrier organic anion transporter family member 1C1 (BBB-specific anion transporter type 1) (BAST1) (Blood-brain barrier-specific anion transporter 1) (Organic anion transporter 1C1) (OATP1C1) (Organic anion-transporting polypeptide 14) (OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter) Rattus norvegicus (Rat) GO:0005886; GO:0006811; GO:0008514; GO:0015125; GO:0015347; GO:0015349; GO:0015721; GO:0016323; GO:0043252; GO:0055085; GO:0070327; GO:2000611 bile acid and bile salt transport [GO:0015721]; monoatomic ion transport [GO:0006811]; positive regulation of thyroid hormone generation [GO:2000611]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] g13661.t1 Q8N6G5 54.0 250 2.34e-98 308.0 sp|Q8N6G5|CGAT2_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 2 OS=Homo sapiens OX=9606 GN=CSGALNACT2 PE=1 SV=1 CGAT2_HUMAN reviewed Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2) Homo sapiens (Human) GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0032580; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; proteoglycan biosynthetic process [GO:0030166] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872] g13662.t1 P04836 48.235 425 1.2999999999999999e-134 399.0 sp|P04836|CBPE_BOVIN Carboxypeptidase E OS=Bos taurus OX=9913 GN=CPE PE=1 SV=2 CBPE_BOVIN reviewed Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase) Bos taurus (Bovine) GO:0003214; GO:0004181; GO:0005615; GO:0005794; GO:0006518; GO:0008270; GO:0016055; GO:0016485; GO:0030070; GO:0030072; GO:0030658; GO:0030667; GO:0033366; GO:0042043; GO:0050839; GO:0072657 cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270] g13663.t1 P18426 36.649 191 3.9099999999999997e-41 141.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g13665.t1 Q9HD45 77.562 566 0.0 916.0 sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2 g13668.t1 Q62798 40.141 284 1.6199999999999998e-40 144.0 sp|Q62798|DRGX_RAT Dorsal root ganglia homeobox protein OS=Rattus norvegicus OX=10116 GN=Drgx PE=2 SV=1 DRGX_RAT reviewed Dorsal root ganglia homeobox protein (Dorsal root ganglion 11) (Homeobox protein DRG11) (Paired-related homeobox protein-like 1) Rattus norvegicus (Rat) GO:0000977; GO:0000981; GO:0001764; GO:0003677; GO:0005634; GO:0006357; GO:0007399; GO:0007409; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0030182; GO:0048666; GO:0050954; GO:1990837 axon guidance [GO:0007411]; axonogenesis [GO:0007409]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g13670.t1 Q3B7D5 30.303 330 9.710000000000001e-36 135.0 sp|Q3B7D5|RASF2_RAT Ras association domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Rassf2 PE=2 SV=1 RASF2_RAT reviewed Ras association domain-containing protein 2 Rattus norvegicus (Rat) GO:0000776; GO:0001501; GO:0001503; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007173; GO:0007249; GO:0032991; GO:0043065; GO:0045667; GO:0045670; GO:0046330; GO:0046849; GO:0048872; GO:0050821; GO:1901222; GO:1901223 bone remodeling [GO:0046849]; canonical NF-kappaB signal transduction [GO:0007249]; epidermal growth factor receptor signaling pathway [GO:0007173]; homeostasis of number of cells [GO:0048872]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; protein stabilization [GO:0050821]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; signal transduction [GO:0007165]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] protein kinase activity [GO:0004672] g13671.t1 Q6IE24 57.851 363 2.6e-142 478.0 sp|Q6IE24|UBP54_RAT Ubiquitin carboxyl-terminal hydrolase 54 OS=Rattus norvegicus OX=10116 GN=Usp54 PE=1 SV=2 UBP54_RAT reviewed Ubiquitin carboxyl-terminal hydrolase 54 (EC 3.4.19.12) (Ubiquitin-specific peptidase 54) Rattus norvegicus (Rat) GO:0004843; GO:0006508; GO:0016579; GO:0046872; GO:0061578 protein deubiquitination [GO:0016579]; proteolysis [GO:0006508] cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872] g13673.t1 Q9VJ79 55.753 730 0.0 847.0 sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4 g13675.t1 Q80W99 36.975 357 1.69e-75 242.0 sp|Q80W99|CTSR3_MOUSE Cation channel sperm-associated protein 3 OS=Mus musculus OX=10090 GN=Catsper3 PE=1 SV=2 CTSR3_MOUSE reviewed Cation channel sperm-associated protein 3 (CatSper3) Mus musculus (Mouse) GO:0001669; GO:0005245; GO:0005783; GO:0006814; GO:0030317; GO:0036128; GO:0048240 flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783] voltage-gated calcium channel activity [GO:0005245] g13676.t1 Q5E9Z7 38.902 419 9.659999999999999e-67 220.0 sp|Q5E9Z7|RPC4_BOVIN DNA-directed RNA polymerase III subunit RPC4 OS=Bos taurus OX=9913 GN=POLR3D PE=2 SV=1 RPC4_BOVIN reviewed DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) Bos taurus (Bovine) GO:0003677; GO:0005666; GO:0032728; GO:0042797; GO:0045087; GO:0045089; GO:0051607 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797] RNA polymerase III complex [GO:0005666] DNA binding [GO:0003677] g13677.t1 Q805E5 37.344 241 1.01e-41 152.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g13678.t1 O75899 31.536 742 1.23e-118 384.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g13680.t1 O73853 34.255 470 9.43e-95 300.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g13681.t1 Q95MI7 54.955 333 4.45e-131 382.0 sp|Q95MI7|SCD_CAPHI Stearoyl-CoA desaturase OS=Capra hircus OX=9925 GN=SCD PE=2 SV=1 SCD_CAPHI reviewed Stearoyl-CoA desaturase (EC 1.14.19.1) (Acyl-CoA desaturase) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) Capra hircus (Goat) GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016020; GO:0016491; GO:0032896; GO:0070542; GO:1903966 monounsaturated fatty acid biosynthetic process [GO:1903966]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768] g13682.t1 P30975 31.414 382 6.34e-53 189.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g13683.t1 P41216 49.319 661 0.0 653.0 sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2 g13684.t1 O16025 29.555 697 9.449999999999999e-89 301.0 sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1 AOSL_PLEHO reviewed Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)] Plexaura homomalla (Black sea rod) GO:0005506; GO:0005737; GO:0006633; GO:0016020; GO:0016829; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677 arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408] cytoplasm [GO:0005737]; membrane [GO:0016020] arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829] g13688.t1 P13214 57.778 90 1.4399999999999998e-30 112.0 sp|P13214|ANXA4_BOVIN Annexin A4 OS=Bos taurus OX=9913 GN=ANXA4 PE=1 SV=2 ANXA4_BOVIN reviewed Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II) Bos taurus (Bovine) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0008201; GO:0012506; GO:0016020; GO:0016324; GO:0030246; GO:0035374; GO:0042584; GO:0042589 apical plasma membrane [GO:0016324]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; zymogen granule membrane [GO:0042589] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; carbohydrate binding [GO:0030246]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; phosphatidylserine binding [GO:0001786] g13689.t1 Q4R5L5 53.361 238 6.06e-69 229.0 sp|Q4R5L5|ANXA7_MACFA Annexin A7 OS=Macaca fascicularis OX=9541 GN=ANXA7 PE=2 SV=1 ANXA7_MACFA reviewed Annexin A7 (Annexin VII) (Annexin-7) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506 cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] g13689.t2 Q4R5L5 53.361 238 1.46e-68 228.0 sp|Q4R5L5|ANXA7_MACFA Annexin A7 OS=Macaca fascicularis OX=9541 GN=ANXA7 PE=2 SV=1 ANXA7_MACFA reviewed Annexin A7 (Annexin VII) (Annexin-7) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506 cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] g13690.t1 P36898 53.333 495 0.0 536.0 sp|P36898|BMR1B_MOUSE Bone morphogenetic protein receptor type-1B OS=Mus musculus OX=10090 GN=Bmpr1b PE=1 SV=1 BMR1B_MOUSE reviewed Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (Activin receptor-like kinase 6) (ALK-6) (Serine/threonine-protein kinase receptor R6) (SKR6) (CD antigen CDw293) Mus musculus (Mouse) GO:0001502; GO:0001550; GO:0001649; GO:0001654; GO:0002062; GO:0002063; GO:0004674; GO:0004675; GO:0004888; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0006703; GO:0006954; GO:0007178; GO:0007179; GO:0009953; GO:0010628; GO:0030154; GO:0030166; GO:0030425; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0036122; GO:0042698; GO:0043010; GO:0043025; GO:0043235; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060348; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:0098821; GO:1902043; GO:1902731 BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; estrogen biosynthetic process [GO:0006703]; eye development [GO:0001654]; inflammatory response [GO:0006954]; negative regulation of chondrocyte proliferation [GO:1902731]; osteoblast differentiation [GO:0001649]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; transforming growth factor beta receptor signaling pathway [GO:0007179] dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; transmembrane signaling receptor activity [GO:0004888] g13693.t1 Q923E4 45.317 331 1.78e-80 266.0 sp|Q923E4|SIR1_MOUSE NAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2 SIR1_MOUSE reviewed NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)] Mus musculus (Mouse) GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000781; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0004857; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006094; GO:0006325; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008047; GO:0008284; GO:0008630; GO:0009267; GO:0010460; GO:0010629; GO:0010659; GO:0010667; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0010976; GO:0014858; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019432; GO:0019899; GO:0019904; GO:0030225; GO:0030424; GO:0030426; GO:0030512; GO:0030968; GO:0031393; GO:0031507; GO:0031509; GO:0031648; GO:0032007; GO:0032041; GO:0032071; GO:0032088; GO:0032436; GO:0032720; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035329; GO:0035331; GO:0035356; GO:0035358; GO:0035774; GO:0042127; GO:0042149; GO:0042311; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043422; GO:0043425; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045471; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051315; GO:0051402; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060125; GO:0060766; GO:0060907; GO:0061051; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0071356; GO:0071456; GO:0071479; GO:0072331; GO:0072350; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0140416; GO:0140861; GO:0140937; GO:0141050; GO:0141208; GO:0160012; GO:1900181; GO:1901797; GO:1902166; GO:1902176; GO:1902237; GO:1902424; GO:1903427; GO:1904179; GO:1904639; GO:1904646; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000270; GO:2000481; GO:2000614; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781 angiogenesis [GO:0001525]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; behavioral response to starvation [GO:0042595]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to resveratrol [GO:1904639]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; endoplasmic reticulum unfolded protein response [GO:0030968]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; heterochromatin formation [GO:0031507]; hippo signaling [GO:0035329]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902424]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron apoptotic process [GO:0051402]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; signal transduction by p53 class mediator [GO:0072331]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; subtelomeric heterochromatin formation [GO:0031509]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricarboxylic acid metabolic process [GO:0072350]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; vasodilation [GO:0042311]; white fat cell differentiation [GO:0050872] axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; ESC/E(Z) complex [GO:0035098]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; rDNA heterochromatin [GO:0033553] bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, NAD-dependent [GO:0017136]; histone decrotonylase activity, NAD-dependent [GO:0160012]; histone H3K deacetylase activity [GO:0141050]; histone H3K14 deacetylase activity, NAD-dependent [GO:0032041]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; histone H4K12 deacetylase activity, hydrolytic mechanism [GO:0140937]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein lysine delactylase activity [GO:0141208]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g13693.t2 Q923E4 54.723 307 3.65e-102 322.0 sp|Q923E4|SIR1_MOUSE NAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2 SIR1_MOUSE reviewed NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)] Mus musculus (Mouse) GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000781; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0004857; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006094; GO:0006325; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008047; GO:0008284; GO:0008630; GO:0009267; GO:0010460; GO:0010629; GO:0010659; GO:0010667; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0010976; GO:0014858; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019432; GO:0019899; GO:0019904; GO:0030225; GO:0030424; GO:0030426; GO:0030512; GO:0030968; GO:0031393; GO:0031507; GO:0031509; GO:0031648; GO:0032007; GO:0032041; GO:0032071; GO:0032088; GO:0032436; GO:0032720; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035329; GO:0035331; GO:0035356; GO:0035358; GO:0035774; GO:0042127; GO:0042149; GO:0042311; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043422; GO:0043425; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045471; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051315; GO:0051402; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060125; GO:0060766; GO:0060907; GO:0061051; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0071356; GO:0071456; GO:0071479; GO:0072331; GO:0072350; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0140416; GO:0140861; GO:0140937; GO:0141050; GO:0141208; GO:0160012; GO:1900181; GO:1901797; GO:1902166; GO:1902176; GO:1902237; GO:1902424; GO:1903427; GO:1904179; GO:1904639; GO:1904646; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000270; GO:2000481; GO:2000614; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781 angiogenesis [GO:0001525]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; behavioral response to starvation [GO:0042595]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to resveratrol [GO:1904639]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; endoplasmic reticulum unfolded protein response [GO:0030968]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; heterochromatin formation [GO:0031507]; hippo signaling [GO:0035329]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902424]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron apoptotic process [GO:0051402]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; signal transduction by p53 class mediator [GO:0072331]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; subtelomeric heterochromatin formation [GO:0031509]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricarboxylic acid metabolic process [GO:0072350]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; vasodilation [GO:0042311]; white fat cell differentiation [GO:0050872] axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; ESC/E(Z) complex [GO:0035098]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; rDNA heterochromatin [GO:0033553] bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, NAD-dependent [GO:0017136]; histone decrotonylase activity, NAD-dependent [GO:0160012]; histone H3K deacetylase activity [GO:0141050]; histone H3K14 deacetylase activity, NAD-dependent [GO:0032041]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; histone H4K12 deacetylase activity, hydrolytic mechanism [GO:0140937]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein lysine delactylase activity [GO:0141208]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] g13694.t1 Q9UKB3 37.374 198 1.2899999999999999e-38 133.0 sp|Q9UKB3|DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens OX=9606 GN=DNAJC12 PE=1 SV=1 g13696.t1 Q99N96 32.411 253 7.95e-37 138.0 sp|Q99N96|RM01_MOUSE Large ribosomal subunit protein uL1m OS=Mus musculus OX=10090 GN=Mrpl1 PE=1 SV=2 g13697.t1 Q8VEG6 58.318 535 0.0 624.0 sp|Q8VEG6|CNO6L_MOUSE CCR4-NOT transcription complex subunit 6-like OS=Mus musculus OX=10090 GN=Cnot6l PE=1 SV=2 CNO6L_MOUSE reviewed CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4) Mus musculus (Mouse) GO:0000175; GO:0000288; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872; GO:0061157 mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] 3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535] g13698.t1 Q86X67 41.697 271 1.0100000000000001e-70 225.0 sp|Q86X67|NUD13_HUMAN NAD(P)H pyrophosphatase NUDT13, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT13 PE=1 SV=3 g13699.t1 Q28DZ1 40.323 682 4.3e-172 515.0 sp|Q28DZ1|IKKA_XENTR Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Xenopus tropicalis OX=8364 GN=chuk PE=2 SV=1 IKKA_XENTR reviewed Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0008384; GO:0008385; GO:0033209; GO:0042803; GO:0043123; GO:0045944; GO:0046982; GO:0071356 cellular response to tumor necrosis factor [GO:0071356]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; nucleus [GO:0005634] ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674] g13700.t1 Q5G268 35.22 318 2.84e-45 171.0 sp|Q5G268|NETR_NOMLE Neurotrypsin OS=Nomascus leucogenys OX=61853 GN=PRSS12 PE=3 SV=1 NETR_NOMLE reviewed Neurotrypsin (EC 3.4.21.-) (Serine protease 12) Nomascus leucogenys (Northern white-cheeked gibbon) (Hylobates leucogenys) GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793] serine-type endopeptidase activity [GO:0004252] g13706.t1 P51958 76.094 297 1.9e-173 484.0 sp|P51958|CDK1_CARAU Cyclin-dependent kinase 1 OS=Carassius auratus OX=7957 GN=cdk1 PE=1 SV=1 g13707.t1 Q7ZWE3 33.498 203 6.83e-25 108.0 sp|Q7ZWE3|LARP7_DANRE La-related protein 7 OS=Danio rerio OX=7955 GN=larp7 PE=2 SV=1 LARP7_DANRE reviewed La-related protein 7 (La ribonucleoprotein domain family member 7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0048024; GO:0060043; GO:0061026; GO:0097322; GO:1904871; GO:1905382; GO:1990438; GO:1990904 box C/D sno(s)RNA 3'-end processing [GO:0000494]; cardiac muscle tissue regeneration [GO:0061026]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] g13708.t1 Q28G87 48.691 191 2.03e-60 203.0 sp|Q28G87|LARP7_XENTR La-related protein 7 OS=Xenopus tropicalis OX=8364 GN=larp7 PE=2 SV=1 LARP7_XENTR reviewed La-related protein 7 (La ribonucleoprotein domain family member 7) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0048024; GO:0097322; GO:1904871; GO:1905382; GO:1990438; GO:1990904 box C/D sno(s)RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] g13717.t1 P79385 43.114 167 4.16e-33 126.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g13732.t1 P79385 40.789 152 8.040000000000001e-27 106.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g13733.t1 Q95114 40.12 167 3.0800000000000003e-31 121.0 sp|Q95114|MFGM_BOVIN Lactadherin OS=Bos taurus OX=9913 GN=MFGE8 PE=1 SV=2 MFGM_BOVIN reviewed Lactadherin (BP47) (Components 15/16) (MFGM) (MGP57/53) (Milk fat globule-EGF factor 8) (MFG-E8) (PAS-6/PAS-7 glycoprotein) (SED1) (Sperm surface protein SP47) Bos taurus (Bovine) GO:0001525; GO:0001786; GO:0002080; GO:0005615; GO:0007155; GO:0007338 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; extracellular space [GO:0005615] phosphatidylserine binding [GO:0001786] g13733.t2 Q95114 40.964 166 3.8000000000000004e-31 121.0 sp|Q95114|MFGM_BOVIN Lactadherin OS=Bos taurus OX=9913 GN=MFGE8 PE=1 SV=2 MFGM_BOVIN reviewed Lactadherin (BP47) (Components 15/16) (MFGM) (MGP57/53) (Milk fat globule-EGF factor 8) (MFG-E8) (PAS-6/PAS-7 glycoprotein) (SED1) (Sperm surface protein SP47) Bos taurus (Bovine) GO:0001525; GO:0001786; GO:0002080; GO:0005615; GO:0007155; GO:0007338 angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; extracellular space [GO:0005615] phosphatidylserine binding [GO:0001786] g13735.t1 P70490 36.145 166 2.02e-22 98.6 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g13737.t1 Q68CP4 38.462 624 1.47e-139 424.0 sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2 HGNAT_HUMAN reviewed Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76) Homo sapiens (Human) GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821 heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259] lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019] g13738.t1 Q9H7Z6 75.545 413 0.0 671.0 sp|Q9H7Z6|KAT8_HUMAN Histone acetyltransferase KAT8 OS=Homo sapiens OX=9606 GN=KAT8 PE=1 SV=2 KAT8_HUMAN reviewed Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (hMOF) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-) Homo sapiens (Human) GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010485; GO:0010506; GO:0010719; GO:0016363; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0035267; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841 dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815] chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] enzyme binding [GO:0019899]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g13739.t1 Q9DBW0 49.016 508 3.93e-170 493.0 sp|Q9DBW0|CP4V2_MOUSE Cytochrome P450 4V2 OS=Mus musculus OX=10090 GN=Cyp4v2 PE=1 SV=1 g13740.t1 O42231 34.631 488 2.26e-92 294.0 sp|O42231|CP1A1_CHEAU Cytochrome P450 1A1 OS=Chelon auratus OX=48191 GN=cyp1a1 PE=2 SV=1 g13741.t1 O15072 32.609 828 4.67e-137 441.0 sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4 ATS3_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme) Homo sapiens (Human) GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g13742.t1 Q566X8 51.852 243 1.7e-57 196.0 sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1 DMX1B_DANRE reviewed Diencephalon/mesencephalon homeobox protein 1-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074 midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g13744.t1 Q566X8 67.626 139 1.6199999999999998e-48 174.0 sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1 DMX1B_DANRE reviewed Diencephalon/mesencephalon homeobox protein 1-B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074 midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g13745.t1 P82808 69.737 684 0.0 997.0 sp|P82808|GFPT1_RAT Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Rattus norvegicus OX=10116 GN=Gfpt1 PE=1 SV=3 GFPT1_RAT reviewed Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1) Rattus norvegicus (Rat) GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0009744; GO:0016597; GO:0030246; GO:0032868; GO:0032869; GO:0032922; GO:0042802; GO:0045719; GO:0097367 cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; identical protein binding [GO:0042802] g13746.t1 Q71U00 84.663 163 6.53e-88 256.0 sp|Q71U00|SKP1_XENLA S-phase kinase-associated protein 1 OS=Xenopus laevis OX=8355 GN=skp1 PE=1 SV=3 g13747.t1 Q9JHW5 37.912 182 1.78e-36 130.0 sp|Q9JHW5|VAMP7_RAT Vesicle-associated membrane protein 7 OS=Rattus norvegicus OX=10116 GN=Vamp7 PE=1 SV=1 VAMP7_RAT reviewed Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1) Rattus norvegicus (Rat) GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008333; GO:0009986; GO:0016020; GO:0016079; GO:0016192; GO:0017156; GO:0019905; GO:0030027; GO:0030133; GO:0030141; GO:0030175; GO:0030667; GO:0030670; GO:0030672; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0034197; GO:0035493; GO:0035577; GO:0043001; GO:0043005; GO:0043308; GO:0043312; GO:0043320; GO:0045177; GO:0045335; GO:0047496; GO:0048280; GO:0048471; GO:0050775; GO:0098686; GO:1900483; GO:1903595 calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; synaptic vesicle exocytosis [GO:0016079]; triglyceride transport [GO:0034197]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192] apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] g13748.t1 Q3UPL0 43.287 1296 0.0 963.0 sp|Q3UPL0|SC31A_MOUSE Protein transport protein Sec31A OS=Mus musculus OX=10090 GN=Sec31a PE=1 SV=2 SC31A_MOUSE reviewed Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A) Mus musculus (Mouse) GO:0005198; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0007029; GO:0015031; GO:0030120; GO:0030127; GO:0030134; GO:0048306; GO:0048471; GO:0051592; GO:0070971; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; protein transport [GO:0015031]; response to calcium ion [GO:0051592] COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; vesicle coat [GO:0030120] calcium-dependent protein binding [GO:0048306]; structural molecule activity [GO:0005198] g13748.t2 Q5F3X8 43.231 1300 0.0 974.0 sp|Q5F3X8|SC31A_CHICK Protein transport protein Sec31A OS=Gallus gallus OX=9031 GN=SEC31A PE=2 SV=1 SC31A_CHICK reviewed Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A) Gallus gallus (Chicken) GO:0005198; GO:0005789; GO:0007029; GO:0015031; GO:0030127; GO:0030134; GO:0070971; GO:0090110 COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; protein transport [GO:0015031] COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789] structural molecule activity [GO:0005198] g13750.t1 Q9JID6 48.029 685 0.0 663.0 sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1 g13751.t1 Q91821 44.618 706 0.0 558.0 sp|Q91821|MELK_XENLA Maternal embryonic leucine zipper kinase OS=Xenopus laevis OX=8355 GN=melk PE=1 SV=2 MELK_XENLA reviewed Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) Xenopus laevis (African clawed frog) GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005737; GO:0005886; GO:0005938; GO:0006915; GO:0008283; GO:0008289; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0061351; GO:0106310 apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13752.t1 P32114 76.8 125 1.3900000000000001e-58 209.0 sp|P32114|PAX2_MOUSE Paired box protein Pax-2 OS=Mus musculus OX=10090 GN=Pax2 PE=1 SV=2 PAX2_MOUSE reviewed Paired box protein Pax-2 Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001655; GO:0001656; GO:0001657; GO:0001658; GO:0001709; GO:0001822; GO:0001823; GO:0001843; GO:0002072; GO:0003337; GO:0003406; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005815; GO:0006357; GO:0007399; GO:0007417; GO:0007423; GO:0007501; GO:0008284; GO:0010001; GO:0021554; GO:0021631; GO:0021633; GO:0021650; GO:0031016; GO:0032991; GO:0032993; GO:0034451; GO:0035566; GO:0035799; GO:0039003; GO:0042472; GO:0042981; GO:0043010; GO:0043066; GO:0043067; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0048793; GO:0048854; GO:0048863; GO:0050679; GO:0060231; GO:0061205; GO:0061360; GO:0070742; GO:0071260; GO:0071300; GO:0071333; GO:0071542; GO:0072075; GO:0072108; GO:0072162; GO:0072164; GO:0072172; GO:0072177; GO:0072179; GO:0072189; GO:0072197; GO:0072205; GO:0072207; GO:0072221; GO:0072289; GO:0072300; GO:0072305; GO:0072307; GO:0090102; GO:0090103; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000378; GO:2000594; GO:2000597 brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to glucose stimulus [GO:0071333]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; mesonephric tubule formation [GO:0072172]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; pancreas development [GO:0031016]; paramesonephric duct development [GO:0061205]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of programmed cell death [GO:0043067]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650] centriolar satellite [GO:0034451]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] C2H2 zinc finger domain binding [GO:0070742]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g13752.t2 P32114 76.8 125 1.46e-58 209.0 sp|P32114|PAX2_MOUSE Paired box protein Pax-2 OS=Mus musculus OX=10090 GN=Pax2 PE=1 SV=2 PAX2_MOUSE reviewed Paired box protein Pax-2 Mus musculus (Mouse) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001655; GO:0001656; GO:0001657; GO:0001658; GO:0001709; GO:0001822; GO:0001823; GO:0001843; GO:0002072; GO:0003337; GO:0003406; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005815; GO:0006357; GO:0007399; GO:0007417; GO:0007423; GO:0007501; GO:0008284; GO:0010001; GO:0021554; GO:0021631; GO:0021633; GO:0021650; GO:0031016; GO:0032991; GO:0032993; GO:0034451; GO:0035566; GO:0035799; GO:0039003; GO:0042472; GO:0042981; GO:0043010; GO:0043066; GO:0043067; GO:0043069; GO:0045892; GO:0045893; GO:0045944; GO:0048793; GO:0048854; GO:0048863; GO:0050679; GO:0060231; GO:0061205; GO:0061360; GO:0070742; GO:0071260; GO:0071300; GO:0071333; GO:0071542; GO:0072075; GO:0072108; GO:0072162; GO:0072164; GO:0072172; GO:0072177; GO:0072179; GO:0072189; GO:0072197; GO:0072205; GO:0072207; GO:0072221; GO:0072289; GO:0072300; GO:0072305; GO:0072307; GO:0090102; GO:0090103; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000378; GO:2000594; GO:2000597 brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to glucose stimulus [GO:0071333]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; central nervous system development [GO:0007417]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; dopaminergic neuron differentiation [GO:0071542]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; mesonephric tubule formation [GO:0072172]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; metanephros development [GO:0001656]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct formation [GO:0072179]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; pancreas development [GO:0031016]; paramesonephric duct development [GO:0061205]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of programmed cell death [GO:0043067]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal pigment epithelium development [GO:0003406]; sensory organ development [GO:0007423]; stem cell differentiation [GO:0048863]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650] centriolar satellite [GO:0034451]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] C2H2 zinc finger domain binding [GO:0070742]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g13756.t1 O57682 41.071 504 1.16e-95 299.0 sp|O57682|PAX2B_XENLA Paired box protein Pax-2-B OS=Xenopus laevis OX=8355 GN=pax2-b PE=2 SV=2 g13756.t2 O57682 41.6 500 1.4e-96 301.0 sp|O57682|PAX2B_XENLA Paired box protein Pax-2-B OS=Xenopus laevis OX=8355 GN=pax2-b PE=2 SV=2 g13758.t1 Q9CZ52 41.649 461 3.59e-94 299.0 sp|Q9CZ52|ANTR1_MOUSE Anthrax toxin receptor 1 OS=Mus musculus OX=10090 GN=Antxr1 PE=1 SV=2 ANTR1_MOUSE reviewed Anthrax toxin receptor 1 (Tumor endothelial marker 8) Mus musculus (Mouse) GO:0001568; GO:0004888; GO:0005518; GO:0005886; GO:0007173; GO:0009897; GO:0009986; GO:0030036; GO:0031258; GO:0031527; GO:0034446; GO:0038023; GO:0045742; GO:0046872; GO:0051015; GO:1901202 actin cytoskeleton organization [GO:0030036]; blood vessel development [GO:0001568]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of extracellular matrix assembly [GO:1901202]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; substrate adhesion-dependent cell spreading [GO:0034446] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] g13759.t1 Q8C4U2 38.679 424 2.64e-95 312.0 sp|Q8C4U2|TM145_MOUSE Transmembrane protein 145 OS=Mus musculus OX=10090 GN=Tmem145 PE=1 SV=1 g13761.t1 Q8C4U2 39.183 416 4.5399999999999994e-95 311.0 sp|Q8C4U2|TM145_MOUSE Transmembrane protein 145 OS=Mus musculus OX=10090 GN=Tmem145 PE=1 SV=1 g13763.t1 Q8C4U2 39.183 416 3.03e-95 312.0 sp|Q8C4U2|TM145_MOUSE Transmembrane protein 145 OS=Mus musculus OX=10090 GN=Tmem145 PE=1 SV=1 g13765.t1 Q5PQ44 78.879 232 9.78e-137 386.0 sp|Q5PQ44|CF299_XENLA Cilia- and flagella-associated protein 299 OS=Xenopus laevis OX=8355 GN=cfap299 PE=2 SV=1 g13767.t1 Q9NYR8 40.69 290 5.27e-59 193.0 sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1 RDH8_HUMAN reviewed Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2) Homo sapiens (Human) GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0042572; GO:0052650 estrogen biosynthetic process [GO:0006703]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601] cytosol [GO:0005829]; plasma membrane [GO:0005886] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303] g13768.t1 Q86XX4 45.506 4050 0.0 3616.0 sp|Q86XX4|FRAS1_HUMAN Extracellular matrix organizing protein FRAS1 OS=Homo sapiens OX=9606 GN=FRAS1 PE=1 SV=2 g13769.t1 Q91X83 69.792 384 0.0 565.0 sp|Q91X83|METK1_MOUSE S-adenosylmethionine synthase isoform type-1 OS=Mus musculus OX=10090 GN=Mat1a PE=1 SV=1 METK1_MOUSE reviewed S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) Mus musculus (Mouse) GO:0000287; GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0009087; GO:0016363; GO:0016597; GO:0042802; GO:0043531; GO:0048269; GO:0051289; GO:0065003 L-methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein-containing complex assembly [GO:0065003]; S-adenosylmethionine biosynthetic process [GO:0006556] cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; nuclear matrix [GO:0016363] ADP binding [GO:0043531]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; methionine adenosyltransferase activity [GO:0004478] g13770.t1 O00124 39.216 204 7.07e-36 132.0 sp|O00124|UBXN8_HUMAN UBX domain-containing protein 8 OS=Homo sapiens OX=9606 GN=UBXN8 PE=1 SV=2 UBXN8_HUMAN reviewed UBX domain-containing protein 8 (Reproduction 8 protein) (Rep-8 protein) (UBX domain-containing protein 6) Homo sapiens (Human) GO:0000151; GO:0005654; GO:0005730; GO:0005783; GO:0005789; GO:0007338; GO:0030674; GO:0036503; GO:0043130 ERAD pathway [GO:0036503]; single fertilization [GO:0007338] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130] g13771.t1 Q95RA8 85.514 214 8.44e-139 390.0 sp|Q95RA8|MOB1_DROME MOB kinase activator-like 1 OS=Drosophila melanogaster OX=7227 GN=mats PE=1 SV=1 MOB1_DROME reviewed MOB kinase activator-like 1 (Mob as tumor suppressor protein 1) (Dmob1) (Mps one binder kinase activator-like 1) Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006915; GO:0007059; GO:0007165; GO:0008285; GO:0019901; GO:0030295; GO:0030707; GO:0035329; GO:0046872 apoptotic process [GO:0006915]; chromosome segregation [GO:0007059]; follicle cell of egg chamber development [GO:0030707]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] g13773.t1 P61258 61.154 260 5.560000000000001e-117 338.0 sp|P61258|PCNA_MACFA Proliferating cell nuclear antigen OS=Macaca fascicularis OX=9541 GN=PCNA PE=2 SV=1 PCNA_MACFA reviewed DNA sliding clamp PCNA (Proliferating cell nuclear antigen) (PCNA) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000122; GO:0000307; GO:0000701; GO:0000785; GO:0001673; GO:0003682; GO:0003684; GO:0005652; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0006325; GO:0016604; GO:0019985; GO:0030337; GO:0030855; GO:0030971; GO:0031297; GO:0032139; GO:0032405; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0045739; GO:0045740; GO:0070182; GO:0070557; GO:0071466; GO:1902990 base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; epithelial cell differentiation [GO:0030855]; leading strand elongation [GO:0006272]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; replication fork processing [GO:0031297]; translesion synthesis [GO:0019985] centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557] chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971] g13774.t1 Q8CDG1 44.287 849 0.0 766.0 sp|Q8CDG1|PIWL2_MOUSE Piwi-like protein 2 OS=Mus musculus OX=10090 GN=Piwil2 PE=1 SV=2 PIWL2_MOUSE reviewed Piwi-like protein 2 (EC 3.1.26.-) Mus musculus (Mouse) GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0010370; GO:0016787; GO:0030718; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0042754; GO:0043186; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060903; GO:0071546; GO:0097433; GO:0140965; GO:0140991; GO:0141005; GO:0141006; GO:0141008; GO:0141196; GO:1990923; GO:2000767 germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of meiosis I [GO:0060903]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rhythmic process [GO:0048511]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by heterochromatin formation [GO:0141005]; transposable element silencing by mRNA destabilization [GO:0141008]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; RNA endonuclease activity [GO:0004521] g13775.t1 Q3UMR5 54.828 290 2.54e-114 338.0 sp|Q3UMR5|MCU_MOUSE Calcium uniporter protein, mitochondrial OS=Mus musculus OX=10090 GN=Mcu PE=1 SV=2 MCU_MOUSE reviewed Calcium uniporter protein, mitochondrial Mus musculus (Mouse) GO:0005262; GO:0005739; GO:0005743; GO:0006091; GO:0006851; GO:0008283; GO:0015292; GO:0016477; GO:0019722; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0046872; GO:0051259; GO:0051560; GO:0051561; GO:0072732; GO:0090023; GO:0090141; GO:1990246 calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to calcium ion starvation [GO:0072732]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein complex oligomerization [GO:0051259] calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; uniporter activity [GO:0015292] g13776.t1 B1H2N3 51.765 425 1.22e-149 436.0 sp|B1H2N3|MICU1_XENTR Calcium uptake protein 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=micu1 PE=2 SV=2 MICU1_XENTR reviewed Calcium uptake protein 1, mitochondrial (Calcium-binding atopy-related autoantigen 1 homolog) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005509; GO:0005743; GO:0005758; GO:0006851; GO:0031966; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0061891; GO:0070509; GO:1903852; GO:1990246 calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of cristae formation [GO:1903852]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; uniplex complex [GO:1990246] calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982] g13777.t1 Q5U2Z7 37.356 348 5.45e-64 230.0 sp|Q5U2Z7|RHG24_RAT Rho GTPase-activating protein 24 OS=Rattus norvegicus OX=10116 GN=Arhgap24 PE=1 SV=2 RHG24_RAT reviewed Rho GTPase-activating protein 24 (Down-regulated in nephrectomized rat kidney #2) (Rho-type GTPase-activating protein 24) Rattus norvegicus (Rat) GO:0001525; GO:0005096; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:1900028 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313] adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] GTPase activator activity [GO:0005096] g13778.t1 P49187 74.317 366 0.0 590.0 sp|P49187|MK10_RAT Mitogen-activated protein kinase 10 OS=Rattus norvegicus OX=10116 GN=Mapk10 PE=1 SV=3 MK10_RAT reviewed Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) Rattus norvegicus (Rat) GO:0000122; GO:0004705; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0007254; GO:0009416; GO:0014069; GO:0042752; GO:0043204; GO:0045475; GO:0071474; GO:0098969; GO:0098978; GO:0106310; GO:0150051 cellular hyperosmotic response [GO:0071474]; JNK cascade [GO:0007254]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; regulation of circadian rhythm [GO:0042752]; response to light stimulus [GO:0009416] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic Golgi apparatus [GO:0150051] ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein serine kinase activity [GO:0106310] g13779.t1 Q8N264 50.151 331 7.21e-112 357.0 sp|Q8N264|RHG24_HUMAN Rho GTPase-activating protein 24 OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=2 g13780.t1 Q12923 46.631 371 4.95e-86 320.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t1 Q12923 44.706 340 7.87e-86 320.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t1 Q12923 39.153 189 6.29e-29 132.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t1 Q12923 56.863 102 4.6399999999999995e-28 129.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t1 Q12923 60.215 93 2.89e-27 127.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t2 Q12923 35.642 592 6.0799999999999995e-89 330.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t2 Q12923 46.631 371 4.46e-86 320.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t2 Q12923 39.153 189 5.7e-29 132.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t2 Q12923 56.863 102 4.53e-28 129.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t2 Q12923 60.215 93 2.6900000000000003e-27 127.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t3 Q12923 46.631 371 3.32e-86 321.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t3 Q12923 44.706 340 5.78e-86 320.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t3 Q12923 39.153 189 5.89e-29 132.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t3 Q12923 56.863 102 5.1e-28 129.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13780.t3 Q12923 60.215 93 2.71e-27 127.0 sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2 g13781.t1 B4PZ52 62.791 258 1.9e-113 331.0 sp|B4PZ52|NFU1_DROYA NFU1 iron-sulfur cluster scaffold homolog, mitochondrial OS=Drosophila yakuba OX=7245 GN=GE15286 PE=3 SV=1 g13784.t1 B6LS00 69.565 92 7.6100000000000005e-44 140.0 sp|B6LS00|U728_BRAFL UPF0728 protein OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_270831 PE=3 SV=1 g13785.t1 Q9NQB0 57.003 307 6.45e-92 296.0 sp|Q9NQB0|TF7L2_HUMAN Transcription factor 7-like 2 OS=Homo sapiens OX=9606 GN=TCF7L2 PE=1 SV=2 g13787.t1 F6QV99 62.108 351 6.68e-168 476.0 sp|F6QV99|ATAD1_BOVIN Outer mitochondrial transmembrane helix translocase OS=Bos taurus OX=9913 GN=ATAD1 PE=2 SV=2 ATAD1_BOVIN reviewed Outer mitochondrial transmembrane helix translocase (EC 7.4.2.-) (ATPase family AAA domain-containing protein 1) (Thorase) Bos taurus (Bovine) GO:0002092; GO:0005524; GO:0005741; GO:0005778; GO:0007612; GO:0007613; GO:0016887; GO:0045211; GO:0051967; GO:0140567; GO:0140570 extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092] mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; membrane protein dislocase activity [GO:0140567] g13788.t1 P41777 62.5 96 5.6400000000000004e-33 140.0 sp|P41777|NOLC1_RAT Nucleolar and coiled-body phosphoprotein 1 OS=Rattus norvegicus OX=10116 GN=Nolc1 PE=1 SV=2 NOLC1_RAT reviewed Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130) Rattus norvegicus (Rat) GO:0001093; GO:0001650; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006417; GO:0007000; GO:0007409; GO:0008139; GO:0008284; GO:0014029; GO:0014032; GO:0015030; GO:0019904; GO:0030674; GO:0031428; GO:0031429; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893; GO:0046982; GO:0048167; GO:0062064; GO:0062065; GO:0140678 axonogenesis [GO:0007409]; box H/ACA sno(s)RNA metabolic process [GO:0033979]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of synaptic plasticity [GO:0048167]; regulation of translation [GO:0006417] box C/D methylation guide snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; box C/D methylation guide snoRNP complex binding [GO:0062064]; box C/D sno(s)RNA binding [GO:0034512]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; GTP binding [GO:0005525]; molecular function inhibitor activity [GO:0140678]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; TFIIB-class transcription factor binding [GO:0001093] g13789.t1 O54857 55.524 353 1.4999999999999999e-142 414.0 sp|O54857|PTEN_RAT Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Rattus norvegicus OX=10116 GN=Pten PE=1 SV=1 PTEN_RAT reviewed Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Inositol polyphosphate 3-phosphatase) (EC 3.1.3.-) (Phosphatase and tensin homolog) Rattus norvegicus (Rat) GO:0001525; GO:0001649; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005161; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007056; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008013; GO:0008138; GO:0008284; GO:0008285; GO:0009410; GO:0009749; GO:0009898; GO:0010043; GO:0010467; GO:0010628; GO:0010666; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014069; GO:0014823; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030351; GO:0030534; GO:0030889; GO:0031175; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0032755; GO:0032760; GO:0032869; GO:0033198; GO:0033555; GO:0035176; GO:0035255; GO:0035749; GO:0036294; GO:0042130; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043065; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0044320; GO:0045211; GO:0045471; GO:0045475; GO:0045666; GO:0045668; GO:0045786; GO:0045792; GO:0045944; GO:0046621; GO:0046685; GO:0046856; GO:0048008; GO:0048679; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0048870; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0051548; GO:0051717; GO:0051726; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0052866; GO:0060024; GO:0060044; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060341; GO:0060368; GO:0060736; GO:0060766; GO:0060997; GO:0061002; GO:0070374; GO:0071257; GO:0071361; GO:0071456; GO:0071545; GO:0072709; GO:0090071; GO:0090394; GO:0097105; GO:0097107; GO:0099524; GO:0140678; GO:1900425; GO:1902533; GO:1902807; GO:1903690; GO:1903860; GO:1904262; GO:1904706; GO:1905235; GO:1990090; GO:1990314; GO:1990381; GO:1990757; GO:1990782; GO:2000060; GO:2000109; GO:2000134; GO:2000463; GO:2000773; GO:2000808; GO:2001235 adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to sorbitol [GO:0072709]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; heart development [GO:0007507]; inositol phosphate catabolic process [GO:0071545]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cellular senescence [GO:2000773]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron projection development [GO:0031175]; neuron-neuron synaptic transmission [GO:0007270]; osteoblast differentiation [GO:0001649]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of macrophage apoptotic process [GO:2000109]; regulation of neuron projection development [GO:0010975]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to quercetin [GO:1905235]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; spindle assembly involved in female meiosis [GO:0007056]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074] apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220] anaphase-promoting complex binding [GO:0010997]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; molecular function inhibitor activity [GO:0140678]; PDZ domain binding [GO:0030165]; phosphatidylinositol phosphate phosphatase activity [GO:0052866]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-specific protease binding [GO:1990381] g13790.t1 O54857 54.987 391 4.7799999999999995e-149 430.0 sp|O54857|PTEN_RAT Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Rattus norvegicus OX=10116 GN=Pten PE=1 SV=1 PTEN_RAT reviewed Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Inositol polyphosphate 3-phosphatase) (EC 3.1.3.-) (Phosphatase and tensin homolog) Rattus norvegicus (Rat) GO:0001525; GO:0001649; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005161; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007056; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007584; GO:0007611; GO:0007613; GO:0007626; GO:0008013; GO:0008138; GO:0008284; GO:0008285; GO:0009410; GO:0009749; GO:0009898; GO:0010043; GO:0010467; GO:0010628; GO:0010666; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014069; GO:0014823; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030351; GO:0030534; GO:0030889; GO:0031175; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032355; GO:0032535; GO:0032755; GO:0032760; GO:0032869; GO:0033198; GO:0033555; GO:0035176; GO:0035255; GO:0035749; GO:0036294; GO:0042130; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043065; GO:0043066; GO:0043197; GO:0043220; GO:0043491; GO:0043542; GO:0044320; GO:0045211; GO:0045471; GO:0045475; GO:0045666; GO:0045668; GO:0045786; GO:0045792; GO:0045944; GO:0046621; GO:0046685; GO:0046856; GO:0048008; GO:0048679; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0048870; GO:0050680; GO:0050765; GO:0050771; GO:0050821; GO:0051548; GO:0051717; GO:0051726; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0052866; GO:0060024; GO:0060044; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060292; GO:0060341; GO:0060368; GO:0060736; GO:0060766; GO:0060997; GO:0061002; GO:0070374; GO:0071257; GO:0071361; GO:0071456; GO:0071545; GO:0072709; GO:0090071; GO:0090394; GO:0097105; GO:0097107; GO:0099524; GO:0140678; GO:1900425; GO:1902533; GO:1902807; GO:1903690; GO:1903860; GO:1904262; GO:1904706; GO:1905235; GO:1990090; GO:1990314; GO:1990381; GO:1990757; GO:1990782; GO:2000060; GO:2000109; GO:2000134; GO:2000463; GO:2000773; GO:2000808; GO:2001235 adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to sorbitol [GO:0072709]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; heart development [GO:0007507]; inositol phosphate catabolic process [GO:0071545]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cellular senescence [GO:2000773]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron projection development [GO:0031175]; neuron-neuron synaptic transmission [GO:0007270]; osteoblast differentiation [GO:0001649]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein stabilization [GO:0050821]; regulation of axon regeneration [GO:0048679]; regulation of B cell apoptotic process [GO:0002902]; regulation of cell cycle [GO:0051726]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of macrophage apoptotic process [GO:2000109]; regulation of neuron projection development [GO:0010975]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to quercetin [GO:1905235]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; spindle assembly involved in female meiosis [GO:0007056]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074] apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220] anaphase-promoting complex binding [GO:0010997]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; molecular function inhibitor activity [GO:0140678]; PDZ domain binding [GO:0030165]; phosphatidylinositol phosphate phosphatase activity [GO:0052866]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-specific protease binding [GO:1990381] g13791.t1 F1MBP6 66.667 558 0.0 797.0 sp|F1MBP6|KLHL3_BOVIN Kelch-like protein 3 OS=Bos taurus OX=9913 GN=KLHL3 PE=3 SV=3 g13792.t1 P25867 94.558 147 2.7e-102 292.0 sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1 g13793.t1 Q9HAR2 25.434 692 6.17e-33 143.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g13796.t1 Q6DEB1 63.049 387 0.0 530.0 sp|Q6DEB1|AT2L1_XENLA Ethanolamine-phosphate phospho-lyase OS=Xenopus laevis OX=8355 GN=etnppl PE=2 SV=1 AT2L1_XENLA reviewed Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1) Xenopus laevis (African clawed frog) GO:0005739; GO:0008483; GO:0030170; GO:0050459 mitochondrion [GO:0005739] ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] g13798.t1 Q8C1Z8 43.439 221 2.3699999999999998e-60 196.0 sp|Q8C1Z8|TM10A_MOUSE tRNA methyltransferase 10 homolog A OS=Mus musculus OX=10090 GN=Trmt10a PE=2 SV=2 TM10A_MOUSE reviewed tRNA methyltransferase 10 homolog A (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A) Mus musculus (Mouse) GO:0000049; GO:0002939; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0010960; GO:0015629; GO:0030488; GO:0052905 magnesium ion homeostasis [GO:0010960]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049] g13800.t1 P0C605 63.947 674 0.0 869.0 sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Prkg1 PE=1 SV=1 KGP1_MOUSE reviewed cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) Mus musculus (Mouse) GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0014912; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042311; GO:0042383; GO:0042753; GO:0042802; GO:0043114; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224 cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of testosterone biosynthetic process [GO:2000224]; regulation of vascular permeability [GO:0043114]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; vasodilation [GO:0042311] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g13802.t1 Q556Y8 36.216 185 7.630000000000001e-31 125.0 sp|Q556Y8|DUSPR_DICDI Probable rhodanese domain-containing dual specificity protein phosphatase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0273199 PE=3 SV=1 DUSPR_DICDI reviewed Probable rhodanese domain-containing dual specificity protein phosphatase (EC 3.1.3.16) (EC 3.1.3.48) Dictyostelium discoideum (Social amoeba) GO:0004721; GO:0004722; GO:0005737; GO:0007165; GO:0008330; GO:0017017; GO:0030587; GO:0033550; GO:0043409; GO:0072718 negative regulation of MAPK cascade [GO:0043409]; response to cisplatin [GO:0072718]; signal transduction [GO:0007165]; sorocarp development [GO:0030587] cytoplasm [GO:0005737] MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330] g13804.t1 Q5ZKA5 58.844 294 1.19e-123 361.0 sp|Q5ZKA5|MTDC_CHICK Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial OS=Gallus gallus OX=9031 GN=MTHFD2 PE=2 SV=1 g13805.t1 Q3TIX9 67.921 505 0.0 703.0 sp|Q3TIX9|UBP39_MOUSE Ubiquitin carboxyl-terminal hydrolase 39 OS=Mus musculus OX=10090 GN=Usp39 PE=1 SV=2 UBP39_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) Mus musculus (Mouse) GO:0000245; GO:0000398; GO:0004843; GO:0005634; GO:0005654; GO:0005681; GO:0008270; GO:0016579; GO:0046540; GO:0051301 cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540] cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270] g13808.t1 D3Z3C6 71.287 202 6.61e-92 300.0 sp|D3Z3C6|ZFAN4_MOUSE AN1-type zinc finger protein 4 OS=Mus musculus OX=10090 GN=Zfand4 PE=1 SV=2 g13808.t1 D3Z3C6 40.909 198 5.51e-31 131.0 sp|D3Z3C6|ZFAN4_MOUSE AN1-type zinc finger protein 4 OS=Mus musculus OX=10090 GN=Zfand4 PE=1 SV=2 g13809.t1 Q86UD5 52.35 468 1.62e-152 454.0 sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2 SL9B2_HUMAN reviewed Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206 clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672] identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385] g13810.t1 Q86UD5 45.72 514 3.65e-136 413.0 sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2 SL9B2_HUMAN reviewed Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206 clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672] identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385] g13812.t1 Q91WS0 50.538 93 1.12e-30 109.0 sp|Q91WS0|CISD1_MOUSE CDGSH iron-sulfur domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cisd1 PE=1 SV=1 CISD1_MOUSE reviewed CDGSH iron-sulfur domain-containing protein 1 (Cysteine transaminase CISD1) (EC 2.6.1.3) (MitoNEET) Mus musculus (Mouse) GO:0005506; GO:0005739; GO:0005741; GO:0006879; GO:0010506; GO:0030170; GO:0032473; GO:0042802; GO:0042803; GO:0043457; GO:0047801; GO:0051537; GO:0051604 intracellular iron ion homeostasis [GO:0006879]; protein maturation [GO:0051604]; regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457] cytoplasmic side of mitochondrial outer membrane [GO:0032473]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] 2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-cysteine transaminase activity [GO:0047801]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] g13813.t1 P35129 80.137 146 1.25e-87 254.0 sp|P35129|UBC2_CAEEL Ubiquitin-conjugating enzyme E2 2 OS=Caenorhabditis elegans OX=6239 GN=let-70 PE=1 SV=1 UBC2_CAEEL reviewed Ubiquitin-conjugating enzyme E2 2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme 2) (Lethal protein 70) (Ubiquitin carrier protein 2) (Ubiquitin-protein ligase 2) Caenorhabditis elegans GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006511; GO:0010623; GO:0016567; GO:0031625; GO:0061631 programmed cell death involved in cell development [GO:0010623]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g13814.t1 Q5R4J5 35.943 281 1.18e-51 185.0 sp|Q5R4J5|SYT1_PONAB Synaptotagmin-1 OS=Pongo abelii OX=9601 GN=SYT1 PE=2 SV=1 SYT1_PONAB reviewed Synaptotagmin-1 (Synaptotagmin I) (SytI) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0030154; GO:0030276; GO:0030424; GO:0030669; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:1903235; GO:1903861 calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of dendrite extension [GO:1903861]; synaptic vesicle endocytosis [GO:0048488] axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g13815.t1 Q3T0P5 47.766 291 1.52e-90 275.0 sp|Q3T0P5|CASP6_BOVIN Caspase-6 OS=Bos taurus OX=9913 GN=CASP6 PE=2 SV=1 CASP6_BOVIN reviewed Caspase-6 (CASP-6) (EC 3.4.22.59) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11] Bos taurus (Bovine) GO:0002218; GO:0004197; GO:0005634; GO:0005737; GO:0006915; GO:0016540; GO:0043065; GO:0043525; GO:0060545; GO:0070269; GO:0072332; GO:0097284 activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; hepatocyte apoptotic process [GO:0097284]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; protein autoprocessing [GO:0016540]; pyroptotic inflammatory response [GO:0070269] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type endopeptidase activity [GO:0004197] g13816.t1 Q9UBQ7 56.386 321 3.32e-130 377.0 sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1 GRHPR_HUMAN reviewed Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494 carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] g13817.t1 Q0ZM14 31.872 1437 2.6000000000000002e-157 534.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g13817.t2 Q0ZM14 31.872 1437 2.63e-157 534.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g13817.t3 Q0ZM14 31.872 1437 2.6900000000000003e-157 534.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g13817.t4 Q0ZM14 31.872 1437 1.61e-157 535.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g13817.t5 Q0ZM14 31.872 1437 1.79e-157 534.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g13817.t6 Q0ZM14 31.872 1437 4.65e-157 534.0 sp|Q0ZM14|PCD15_CHICK Protocadherin-15 OS=Gallus gallus OX=9031 GN=Pcdh15 PE=1 SV=1 PCD15_CHICK reviewed Protocadherin-15 Gallus gallus (Chicken) GO:0001750; GO:0005509; GO:0005886; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0048839; GO:0050839; GO:0050953; GO:0050957 cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] g13819.t1 Q8WML3 67.178 326 3.63e-136 476.0 sp|Q8WML3|KAT6B_MACFA Histone acetyltransferase KAT6B OS=Macaca fascicularis OX=9541 GN=KAT6B PE=2 SV=1 KAT6B_MACFA reviewed Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000786; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0006334; GO:0006357; GO:0008270; GO:0036408; GO:0045892; GO:0045893; GO:0061733; GO:0070776 negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357] MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H3K14 acetyltransferase activity [GO:0036408]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g13819.t1 Q8WML3 42.623 366 4.199999999999999e-68 260.0 sp|Q8WML3|KAT6B_MACFA Histone acetyltransferase KAT6B OS=Macaca fascicularis OX=9541 GN=KAT6B PE=2 SV=1 KAT6B_MACFA reviewed Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000786; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0006334; GO:0006357; GO:0008270; GO:0036408; GO:0045892; GO:0045893; GO:0061733; GO:0070776 negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357] MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H3K14 acetyltransferase activity [GO:0036408]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g13819.t2 Q5TKR9 67.093 313 2.45e-137 483.0 sp|Q5TKR9|KAT6A_RAT Histone acetyltransferase KAT6A OS=Rattus norvegicus OX=10116 GN=Kat6a PE=1 SV=2 KAT6A_RAT reviewed Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger homolog) (Monocytic leukemia zinc finger protein) (MOZ) Rattus norvegicus (Rat) GO:0000785; GO:0000786; GO:0003007; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006355; GO:0006357; GO:0006473; GO:0008270; GO:0010484; GO:0010628; GO:0016605; GO:0016607; GO:0030099; GO:0035019; GO:0035162; GO:0035909; GO:0036408; GO:0043992; GO:0043995; GO:0043996; GO:0043997; GO:0045892; GO:0045893; GO:0046972; GO:0060325; GO:0070776; GO:0090398; GO:0140297 aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein acetylation [GO:0006473]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019] chromatin [GO:0000785]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K9 acetyltransferase activity [GO:0043992]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g13819.t2 Q5TKR9 44.142 367 6.800000000000001e-72 273.0 sp|Q5TKR9|KAT6A_RAT Histone acetyltransferase KAT6A OS=Rattus norvegicus OX=10116 GN=Kat6a PE=1 SV=2 KAT6A_RAT reviewed Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger homolog) (Monocytic leukemia zinc finger protein) (MOZ) Rattus norvegicus (Rat) GO:0000785; GO:0000786; GO:0003007; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0006355; GO:0006357; GO:0006473; GO:0008270; GO:0010484; GO:0010628; GO:0016605; GO:0016607; GO:0030099; GO:0035019; GO:0035162; GO:0035909; GO:0036408; GO:0043992; GO:0043995; GO:0043996; GO:0043997; GO:0045892; GO:0045893; GO:0046972; GO:0060325; GO:0070776; GO:0090398; GO:0140297 aorta morphogenesis [GO:0035909]; cellular senescence [GO:0090398]; embryonic hemopoiesis [GO:0035162]; face morphogenesis [GO:0060325]; heart morphogenesis [GO:0003007]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein acetylation [GO:0006473]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019] chromatin [GO:0000785]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K9 acetyltransferase activity [GO:0043992]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] g13820.t1 O49923 56.725 342 3.9900000000000002e-143 411.0 sp|O49923|ADK_PHYPA Adenosine kinase OS=Physcomitrium patens OX=3218 GN=ADK PE=2 SV=1 g13821.t1 Q9Z210 34.118 255 1.15e-40 143.0 sp|Q9Z210|PX11B_MOUSE Peroxisomal membrane protein 11B OS=Mus musculus OX=10090 GN=Pex11b PE=1 SV=1 g13822.t1 Q3MQ24 60.517 271 4.38e-119 345.0 sp|Q3MQ24|ATG5_BOVIN Autophagy protein 5 OS=Bos taurus OX=9913 GN=ATG5 PE=2 SV=2 ATG5_BOVIN reviewed Autophagy protein 5 Bos taurus (Bovine) GO:0000045; GO:0000423; GO:0002376; GO:0005776; GO:0005930; GO:0006914; GO:0006915; GO:0006995; GO:0034045; GO:0034274; GO:0034727; GO:0035973; GO:0043069; GO:0061908; GO:1902017 aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; immune system process [GO:0002376]; mitophagy [GO:0000423]; negative regulation of programmed cell death [GO:0043069]; piecemeal microautophagy of the nucleus [GO:0034727]; regulation of cilium assembly [GO:1902017] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axoneme [GO:0005930]; phagophore [GO:0061908]; phagophore assembly site membrane [GO:0034045] g13823.t1 A4ILL2 30.874 366 8.519999999999999e-39 146.0 sp|A4ILL2|MTNK_GEOTN Methylthioribose kinase OS=Geobacillus thermodenitrificans (strain NG80-2) OX=420246 GN=mtnK PE=3 SV=1 g13824.t1 Q6P161 44.545 110 8.12e-26 98.2 sp|Q6P161|RM54_HUMAN Large ribosomal subunit protein mL54 OS=Homo sapiens OX=9606 GN=MRPL54 PE=1 SV=1 g13825.t1 Q9BVQ7 44.728 588 2.14e-155 477.0 sp|Q9BVQ7|AFG2B_HUMAN ATPase family gene 2 protein homolog B OS=Homo sapiens OX=9606 GN=AFG2B PE=1 SV=2 g13826.t1 Q6DIR8 39.703 874 0.0 625.0 sp|Q6DIR8|PALD_XENTR Paladin OS=Xenopus tropicalis OX=8364 GN=pald1 PE=2 SV=1 g13828.t1 Q5RFS2 66.827 416 0.0 583.0 sp|Q5RFS2|CSN3_PONAB COP9 signalosome complex subunit 3 OS=Pongo abelii OX=9601 GN=COPS3 PE=2 SV=1 g13828.t2 Q5RFS2 59.236 471 0.0 554.0 sp|Q5RFS2|CSN3_PONAB COP9 signalosome complex subunit 3 OS=Pongo abelii OX=9601 GN=COPS3 PE=2 SV=1 g13829.t1 Q8N5R6 27.454 652 1.24e-55 213.0 sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3 CCD33_HUMAN reviewed Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61) (CT61) Homo sapiens (Human) GO:0005777 peroxisome [GO:0005777] g13829.t1 Q8N5R6 30.389 283 8.02e-21 102.0 sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3 CCD33_HUMAN reviewed Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61) (CT61) Homo sapiens (Human) GO:0005777 peroxisome [GO:0005777] g13830.t1 O42606 61.702 94 8.170000000000001e-33 122.0 sp|O42606|NGN1_DANRE Neurogenin-1 OS=Danio rerio OX=7955 GN=neurog1 PE=2 SV=1 g13831.t1 Q13257 63.429 175 6.23e-81 243.0 sp|Q13257|MD2L1_HUMAN Mitotic spindle assembly checkpoint protein MAD2A OS=Homo sapiens OX=9606 GN=MAD2L1 PE=1 SV=1 g13832.t1 Q9NR71 44.54 696 0.0 580.0 sp|Q9NR71|ASAH2_HUMAN Neutral ceramidase OS=Homo sapiens OX=9606 GN=ASAH2 PE=1 SV=2 g13833.t1 Q55G11 50.725 690 0.0 657.0 sp|Q55G11|NCSEB_DICDI Neutral ceramidase B OS=Dictyostelium discoideum OX=44689 GN=dcd2B PE=3 SV=1 g13834.t1 Q5RAG8 50.462 541 0.0 540.0 sp|Q5RAG8|P4HA1_PONAB Prolyl 4-hydroxylase subunit alpha-1 OS=Pongo abelii OX=9601 GN=P4HA1 PE=2 SV=1 P4HA1_PONAB reviewed Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004656; GO:0005506; GO:0005739; GO:0005788; GO:0031418; GO:0042802 endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656] g13834.t2 Q5RAG8 49.168 541 3.3800000000000004e-179 518.0 sp|Q5RAG8|P4HA1_PONAB Prolyl 4-hydroxylase subunit alpha-1 OS=Pongo abelii OX=9601 GN=P4HA1 PE=2 SV=1 P4HA1_PONAB reviewed Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004656; GO:0005506; GO:0005739; GO:0005788; GO:0031418; GO:0042802 endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656] g13834.t3 Q5RAG8 48.925 558 0.0 529.0 sp|Q5RAG8|P4HA1_PONAB Prolyl 4-hydroxylase subunit alpha-1 OS=Pongo abelii OX=9601 GN=P4HA1 PE=2 SV=1 P4HA1_PONAB reviewed Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004656; GO:0005506; GO:0005739; GO:0005788; GO:0031418; GO:0042802 endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739] identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656] g13835.t1 Q7TSV9 39.344 305 6.67e-48 167.0 sp|Q7TSV9|ENKD1_MOUSE Enkurin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Enkd1 PE=1 SV=1 g13836.t1 Q6AXP4 44.03 134 7.080000000000001e-29 124.0 sp|Q6AXP4|CB081_RAT Uncharacterized protein C2orf81 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1 g13836.t2 Q6AXP4 44.03 134 6.75e-29 124.0 sp|Q6AXP4|CB081_RAT Uncharacterized protein C2orf81 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1 g13837.t1 O73853 31.368 475 9.049999999999999e-67 227.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g13838.t1 Q9JHI0 34.709 533 3.6299999999999997e-81 265.0 sp|Q9JHI0|MMP19_MOUSE Matrix metalloproteinase-19 OS=Mus musculus OX=10090 GN=Mmp19 PE=2 SV=1 MMP19_MOUSE reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) Mus musculus (Mouse) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0009725; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591; GO:0098552 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g13839.t1 P91953 40.323 434 6.59e-82 268.0 sp|P91953|HE_HEMPU 50 kDa hatching enzyme OS=Hemicentrotus pulcherrimus OX=7650 PE=1 SV=1 HE_HEMPU reviewed 50 kDa hatching enzyme (HE) (HEZ) (EC 3.4.24.12) (Envelysin) (Sea-urchin-hatching proteinase) [Cleaved into: 38 kDa hatching enzyme; 32 kDa hatching enzyme non-specific; 15 kDa peptide] Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus) GO:0004222; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012 collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g13841.t1 Q99NF1 44.181 507 1.7099999999999998e-147 437.0 sp|Q99NF1|BCDO2_MOUSE Carotenoid-cleaving dioxygenase, mitochondrial OS=Mus musculus OX=10090 GN=Bco2 PE=1 SV=1 BCDO2_MOUSE reviewed Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (B-diox-II) (Beta,beta-carotene 9',10'-oxygenase) (Beta-carotene dioxygenase 2) Mus musculus (Mouse) GO:0003834; GO:0005739; GO:0010436; GO:0010437; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016124; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0062172; GO:0102076; GO:1901176; GO:1901826; GO:2000377 carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll catabolic process [GO:0016124]; xanthophyll metabolic process [GO:0016122]; zeaxanthin catabolic process [GO:1901826] mitochondrion [GO:0005739] 9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702] g13843.t1 Q99NF1 42.607 514 2.64e-141 421.0 sp|Q99NF1|BCDO2_MOUSE Carotenoid-cleaving dioxygenase, mitochondrial OS=Mus musculus OX=10090 GN=Bco2 PE=1 SV=1 BCDO2_MOUSE reviewed Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (B-diox-II) (Beta,beta-carotene 9',10'-oxygenase) (Beta-carotene dioxygenase 2) Mus musculus (Mouse) GO:0003834; GO:0005739; GO:0010436; GO:0010437; GO:0016116; GO:0016119; GO:0016121; GO:0016122; GO:0016124; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0062172; GO:0102076; GO:1901176; GO:1901826; GO:2000377 carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll catabolic process [GO:0016124]; xanthophyll metabolic process [GO:0016122]; zeaxanthin catabolic process [GO:1901826] mitochondrion [GO:0005739] 9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702] g13844.t1 Q16836 64.217 313 6.24e-143 408.0 sp|Q16836|HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HADH PE=1 SV=3 g13845.t1 Q8K2X8 55.882 68 3.12e-24 89.0 sp|Q8K2X8|TF2H5_MOUSE General transcription factor IIH subunit 5 OS=Mus musculus OX=10090 GN=Gtf2h5 PE=1 SV=1 g13852.t1 Q5RFQ8 27.441 379 6.9e-23 105.0 sp|Q5RFQ8|ATS4_PONAB A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Pongo abelii OX=9601 GN=ADAMTS4 PE=2 SV=1 ATS4_PONAB reviewed A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAM-TS 4) (ADAM-TS4) (ADAMTS-4) (EC 3.4.24.82) (Aggrecanase-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004222; GO:0006508; GO:0008233; GO:0008237; GO:0030198; GO:0031012; GO:0046872 extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233] g13853.t1 P58459 28.224 411 3.41e-22 103.0 sp|P58459|ATS10_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 10 OS=Mus musculus OX=10090 GN=Adamts10 PE=2 SV=3 g13854.t1 Q9UKP5 27.441 379 8.550000000000001e-21 99.0 sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2 ATS6_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-) Homo sapiens (Human) GO:0001822; GO:0003279; GO:0004222; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g13855.t1 Q03059 50.744 605 0.0 612.0 sp|Q03059|CLAT_MOUSE Choline O-acetyltransferase OS=Mus musculus OX=10090 GN=Chat PE=2 SV=2 CLAT_MOUSE reviewed Choline O-acetyltransferase (CHOACTase) (ChAT) (Choline acetylase) (EC 2.3.1.6) Mus musculus (Mouse) GO:0004102; GO:0005737; GO:0005739; GO:0007268; GO:0007274; GO:0007517; GO:0007529; GO:0007613; GO:0007622; GO:0007628; GO:0008292; GO:0016358; GO:0030182; GO:0030424; GO:0033265; GO:0043005; GO:0043025; GO:0043179; GO:0045202 acetylcholine biosynthetic process [GO:0008292]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; memory [GO:0007613]; muscle organ development [GO:0007517]; neuromuscular synaptic transmission [GO:0007274]; neuron differentiation [GO:0030182]; rhythmic behavior [GO:0007622]; rhythmic excitation [GO:0043179] axon [GO:0030424]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202] choline binding [GO:0033265]; choline O-acetyltransferase activity [GO:0004102] g13856.t1 Q08C75 61.517 356 2.2800000000000002e-154 448.0 sp|Q08C75|VACHA_DANRE Probable vesicular acetylcholine transporter-A OS=Danio rerio OX=7955 GN=slc18a3a PE=2 SV=1 g13857.t1 O17444 58.333 120 5.11e-37 135.0 sp|O17444|VACHT_DROME Vesicular acetylcholine transporter OS=Drosophila melanogaster OX=7227 GN=VAChT PE=2 SV=2 g13860.t1 Q02218 66.33 989 0.0 1393.0 sp|Q02218|ODO1_HUMAN 2-oxoglutarate dehydrogenase complex component E1 OS=Homo sapiens OX=9606 GN=OGDH PE=1 SV=3 ODO1_HUMAN reviewed 2-oxoglutarate dehydrogenase complex component E1 (E1o) (HsOGDH) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase) Homo sapiens (Human) GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0120551 2-oxoglutarate decarboxylation to succinyl-CoA [GO:0120551]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; protein-folding chaperone binding [GO:0051087]; thiamine pyrophosphate binding [GO:0030976] g13860.t2 Q02218 65.064 1019 0.0 1402.0 sp|Q02218|ODO1_HUMAN 2-oxoglutarate dehydrogenase complex component E1 OS=Homo sapiens OX=9606 GN=OGDH PE=1 SV=3 ODO1_HUMAN reviewed 2-oxoglutarate dehydrogenase complex component E1 (E1o) (HsOGDH) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase) Homo sapiens (Human) GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0120551 2-oxoglutarate decarboxylation to succinyl-CoA [GO:0120551]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; protein-folding chaperone binding [GO:0051087]; thiamine pyrophosphate binding [GO:0030976] g13860.t3 Q02218 67.647 884 0.0 1291.0 sp|Q02218|ODO1_HUMAN 2-oxoglutarate dehydrogenase complex component E1 OS=Homo sapiens OX=9606 GN=OGDH PE=1 SV=3 ODO1_HUMAN reviewed 2-oxoglutarate dehydrogenase complex component E1 (E1o) (HsOGDH) (OGDC-E1) (OGDH-E1) (EC 1.2.4.2) (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase) (Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase) Homo sapiens (Human) GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0120551 2-oxoglutarate decarboxylation to succinyl-CoA [GO:0120551]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; protein-folding chaperone binding [GO:0051087]; thiamine pyrophosphate binding [GO:0030976] g13860.t4 Q148N0 45.455 176 4.01e-38 142.0 sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1 g13862.t1 Q68F72 37.714 525 6.81e-104 328.0 sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1 S15A4_XENLA reviewed Solute carrier family 15 member 4 Xenopus laevis (African clawed frog) GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] g13863.t1 Q9W6R5 36.31 168 8.45e-21 92.0 sp|Q9W6R5|XLRS1_TAKRU Retinoschisin OS=Takifugu rubripes OX=31033 GN=xlrs1 PE=3 SV=1 g13863.t2 Q9W6R5 36.31 168 8.11e-21 92.0 sp|Q9W6R5|XLRS1_TAKRU Retinoschisin OS=Takifugu rubripes OX=31033 GN=xlrs1 PE=3 SV=1 g13865.t1 O60706 33.656 1548 0.0 779.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g13867.t1 P79385 37.87 169 2.88e-28 113.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g13867.t1 P79385 36.076 158 4.11e-24 102.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g13869.t1 Q7ZVE0 68.627 102 3.22e-48 160.0 sp|Q7ZVE0|GAR1_DANRE H/ACA ribonucleoprotein complex subunit 1 OS=Danio rerio OX=7955 GN=gar1 PE=2 SV=1 g13870.t1 Q8NB16 31.164 292 1.58e-35 140.0 sp|Q8NB16|MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens OX=9606 GN=MLKL PE=1 SV=1 MLKL_HUMAN reviewed Mixed lineage kinase domain-like protein (hMLKL) Homo sapiens (Human) GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0019901; GO:0030054; GO:0042802; GO:0044877; GO:0051607; GO:0070207; GO:0070266; GO:0097527; GO:0097528 cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] g13871.t1 A0A0R4IVV0 29.075 908 1.2600000000000001e-116 379.0 sp|A0A0R4IVV0|MTP_DANRE Microsomal triglyceride transfer protein large subunit OS=Danio rerio OX=7955 GN=mttp PE=1 SV=1 MTP_DANRE reviewed Microsomal triglyceride transfer protein large subunit Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001579; GO:0002040; GO:0005319; GO:0005548; GO:0005783; GO:0005794; GO:0006629; GO:0006869; GO:0007586; GO:0008289; GO:0009306; GO:0015909; GO:0016323; GO:0034377; GO:0042157; GO:0042158; GO:0042632; GO:0042953; GO:0120013; GO:1904121 cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; plasma lipoprotein particle assembly [GO:0034377]; protein secretion [GO:0009306]; sprouting angiogenesis [GO:0002040] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794] lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; lipid transporter activity [GO:0005319]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transporter activity [GO:0005548] g13880.t1 C3ZQF9 43.7 373 2.4499999999999997e-95 292.0 sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1 g13883.t1 Q6DHJ3 42.708 384 5.91e-102 315.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g13884.t1 Q6DHJ3 41.985 393 5.33e-103 317.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g13885.t1 Q6DHJ3 42.347 392 2.41e-97 303.0 sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1 NVD_DANRE reviewed Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056 cholesterol metabolic process [GO:0008203] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase [NAD(P)H] activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] g13887.t1 Q27128 74.172 604 0.0 967.0 sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1 g13888.t1 O35217 25.587 426 3.87e-41 157.0 sp|O35217|MINP1_RAT Multiple inositol polyphosphate phosphatase 1 OS=Rattus norvegicus OX=10116 GN=Minpp1 PE=1 SV=3 MINP1_RAT reviewed Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase) Rattus norvegicus (Rat) GO:0003993; GO:0004446; GO:0005615; GO:0005788; GO:0005886; GO:0008707; GO:0016158; GO:0016312; GO:0030003; GO:0030351; GO:0030352; GO:0034417; GO:0046030; GO:0048015; GO:0052745; GO:0052827 intracellular monoatomic cation homeostasis [GO:0030003]; phosphatidylinositol-mediated signaling [GO:0048015] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol hexakisphosphate 3-phosphatase activity [GO:0016158]; inositol hexakisphosphate 4-phosphatase activity [GO:0008707]; inositol hexakisphosphate phosphatase activity [GO:0004446]; inositol pentakisphosphate phosphatase activity [GO:0052827]; inositol phosphate phosphatase activity [GO:0052745]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity [GO:0030352] g13889.t1 Q7ZW78 48.734 158 2.2799999999999998e-45 148.0 sp|Q7ZW78|RN181_DANRE E3 ubiquitin-protein ligase RNF181 OS=Danio rerio OX=7955 GN=rnf181 PE=2 SV=2 g13890.t1 Q66KB9 60.833 120 1.23e-44 146.0 sp|Q66KB9|BL1S2_XENTR Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Xenopus tropicalis OX=8364 GN=bloc1s2 PE=2 SV=1 g13894.t1 P98068 35.244 349 1.49e-50 181.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g13895.t1 P42674 41.176 204 2.23e-41 152.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g13896.t1 P98068 34.263 502 6.68e-69 234.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g13897.t1 P42674 36.893 618 1.77e-103 328.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g13897.t2 P42674 36.893 618 2.4400000000000002e-103 327.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g13899.t1 P34714 38.197 233 1.37e-44 154.0 sp|P34714|SPRC_CAEEL SPARC OS=Caenorhabditis elegans OX=6239 GN=ost-1 PE=1 SV=1 g13902.t1 B2RVL6 85.333 150 1.84e-93 280.0 sp|B2RVL6|ZCH24_MOUSE Zinc finger CCHC domain-containing protein 24 OS=Mus musculus OX=10090 GN=Zcchc24 PE=1 SV=1 g13903.t1 Q6PAV2 48.264 576 0.0 543.0 sp|Q6PAV2|HERC4_MOUSE Probable E3 ubiquitin-protein ligase HERC4 OS=Mus musculus OX=10090 GN=Herc4 PE=1 SV=2 HERC4_MOUSE reviewed Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) Mus musculus (Mouse) GO:0001650; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] g13904.t1 Q80TP3 85.938 64 1.56e-31 130.0 sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2 UBR5_MOUSE reviewed E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) Mus musculus (Mouse) GO:0000209; GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0006979; GO:0008270; GO:0010498; GO:0010628; GO:0016567; GO:0019904; GO:0030520; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0034450; GO:0035519; GO:0042307; GO:0043130; GO:0043161; GO:0045879; GO:0048384; GO:0048471; GO:0050847; GO:0061630; GO:0070561; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0071630; GO:0090263; GO:0140455; GO:0140861; GO:0141198 cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; estrogen receptor signaling pathway [GO:0030520]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; response to oxidative stress [GO:0006979]; retinoic acid receptor signaling pathway [GO:0048384]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]; vitamin D receptor signaling pathway [GO:0070561] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g13906.t1 Q5PQN1 54.277 339 4.0999999999999996e-108 352.0 sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1 HERC4_RAT reviewed Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) Rattus norvegicus (Rat) GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] ubiquitin protein ligase activity [GO:0061630] g13906.t2 Q5PQN1 54.277 339 4.0999999999999996e-108 352.0 sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1 HERC4_RAT reviewed Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4) Rattus norvegicus (Rat) GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] ubiquitin protein ligase activity [GO:0061630] g13907.t1 A6X942 41.473 258 3.55e-47 173.0 sp|A6X942|SH24B_MOUSE SH2 domain-containing protein 4B OS=Mus musculus OX=10090 GN=Sh2d4b PE=2 SV=1 g13907.t1 A6X942 41.053 190 2.4600000000000002e-26 115.0 sp|A6X942|SH24B_MOUSE SH2 domain-containing protein 4B OS=Mus musculus OX=10090 GN=Sh2d4b PE=2 SV=1 g13908.t1 Q9QUK0 46.84 617 9.599999999999999e-176 513.0 sp|Q9QUK0|CDKL2_MOUSE Cyclin-dependent kinase-like 2 OS=Mus musculus OX=10090 GN=Cdkl2 PE=2 SV=1 g13910.t1 Q13283 43.973 448 1.82e-84 271.0 sp|Q13283|G3BP1_HUMAN Ras GTPase-activating protein-binding protein 1 OS=Homo sapiens OX=9606 GN=G3BP1 PE=1 SV=1 G3BP1_HUMAN reviewed Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1) Homo sapiens (Human) GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0004519; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0007265; GO:0010494; GO:0016887; GO:0032481; GO:0033677; GO:0034063; GO:0043024; GO:0043204; GO:0045087; GO:0051607; GO:0090090; GO:0140693 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of type I interferon production [GO:0032481]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/RNA helicase activity [GO:0033677]; endonuclease activity [GO:0004519]; molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g13914.t1 Q8TB73 39.17 554 1.79e-135 409.0 sp|Q8TB73|NDNF_HUMAN Protein NDNF OS=Homo sapiens OX=9606 GN=NDNF PE=1 SV=2 NDNF_HUMAN reviewed Protein NDNF (Neuron-derived neurotrophic factor) Homo sapiens (Human) GO:0001525; GO:0001764; GO:0002931; GO:0005539; GO:0005576; GO:0005615; GO:0007263; GO:0008201; GO:0010811; GO:0010976; GO:0021828; GO:0030198; GO:0031012; GO:0043524; GO:0044344; GO:0061042; GO:0071456; GO:2000352 angiogenesis [GO:0001525]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hypoxia [GO:0071456]; extracellular matrix organization [GO:0030198]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron projection development [GO:0010976]; response to ischemia [GO:0002931]; vascular wound healing [GO:0061042] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201] g13917.t1 O14718 28.244 262 8.76e-34 128.0 sp|O14718|OPSX_HUMAN Visual pigment-like receptor peropsin OS=Homo sapiens OX=9606 GN=RRH PE=1 SV=1 g13918.t1 Q6DGQ8 66.346 208 7.729999999999999e-104 301.0 sp|Q6DGQ8|NDK5_DANRE Nucleoside diphosphate kinase homolog 5 OS=Danio rerio OX=7955 GN=nme5 PE=2 SV=2 NDK5_DANRE reviewed Nucleoside diphosphate kinase 5 (NDK5) (Putative 3'-5'-DNA exonuclease NDK5) (EC 3.1.11.-) (Radial spoke head protein 23 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003341; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0006308; GO:0008296; GO:1902176 cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; DNA catabolic process [GO:0006308]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; UTP biosynthetic process [GO:0006228] cilium [GO:0005929] 3'-5'-DNA exonuclease activity [GO:0008296] g13919.t1 Q0IHV2 51.129 487 9.76e-132 410.0 sp|Q0IHV2|LIN54_XENTR Protein lin-54 homolog OS=Xenopus tropicalis OX=8364 GN=lin54 PE=2 SV=1 g13920.t1 O88544 75.802 405 0.0 657.0 sp|O88544|CSN4_MOUSE COP9 signalosome complex subunit 4 OS=Mus musculus OX=10090 GN=Cops4 PE=1 SV=1 g13921.t1 O88544 64.444 405 0.0 529.0 sp|O88544|CSN4_MOUSE COP9 signalosome complex subunit 4 OS=Mus musculus OX=10090 GN=Cops4 PE=1 SV=1 g13922.t1 Q0IHV2 45.248 484 9.06e-100 317.0 sp|Q0IHV2|LIN54_XENTR Protein lin-54 homolog OS=Xenopus tropicalis OX=8364 GN=lin54 PE=2 SV=1 g13923.t1 O13035 27.292 469 2.86e-42 167.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t1 O13035 26.471 442 3.6e-31 134.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t1 O13035 26.303 422 2.2e-28 125.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t1 O13035 25.942 451 1.2e-26 120.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t1 O13035 23.667 469 3.57e-21 103.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t2 O13035 27.292 469 2.7999999999999997e-42 167.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t2 O13035 26.471 442 3.6e-31 134.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t2 O13035 26.303 422 2.21e-28 125.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t2 O13035 25.942 451 1.2e-26 120.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13923.t2 O13035 23.667 469 3.7300000000000006e-21 103.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13924.t1 O13035 26.226 469 1.62e-39 153.0 sp|O13035|SAP_CHICK Prosaposin OS=Gallus gallus OX=9031 GN=PSAP PE=1 SV=1 g13927.t1 Q9MYM7 47.826 276 9.499999999999999e-89 275.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g13929.t1 P21452 39.577 331 1.76e-70 229.0 sp|P21452|NK2R_HUMAN Substance-K receptor OS=Homo sapiens OX=9606 GN=TACR2 PE=1 SV=3 NK2R_HUMAN reviewed Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2) Homo sapiens (Human) GO:0004995; GO:0005886; GO:0006936; GO:0007189; GO:0007209; GO:0007217; GO:0014057; GO:0014827; GO:0016497; GO:0033685; GO:0035106; GO:0036126; GO:0043117; GO:0043270; GO:0045987; GO:0051602; GO:0061827; GO:0070459; GO:0070474; GO:0097225; GO:1902093 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; intestine smooth muscle contraction [GO:0014827]; muscle contraction [GO:0006936]; negative regulation of luteinizing hormone secretion [GO:0033685]; operant conditioning [GO:0035106]; phospholipase C-activating tachykinin receptor signaling pathway [GO:0007209]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of monoatomic ion transport [GO:0043270]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; prolactin secretion [GO:0070459]; response to electrical stimulus [GO:0051602]; tachykinin receptor signaling pathway [GO:0007217] plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225] substance K receptor activity [GO:0016497]; tachykinin receptor activity [GO:0004995] g13930.t1 G3V9H8 37.83 719 2.1299999999999998e-134 435.0 sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1 RET_RAT reviewed Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] Rattus norvegicus (Rat) GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144; GO:1904894; GO:2001241 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657] axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g13934.t1 Q9MYM7 45.455 275 1.07e-78 244.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g13935.t1 Q9MYM7 51.095 274 4.880000000000001e-100 304.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g13936.t1 Q8BR93 36.825 315 6.12e-59 196.0 sp|Q8BR93|HARB1_MOUSE Putative nuclease HARBI1 OS=Mus musculus OX=10090 GN=Harbi1 PE=2 SV=1 g13937.t1 Q7TMR7 24.678 466 1.23e-28 121.0 sp|Q7TMR7|MOT7_RAT Monocarboxylate transporter 7 OS=Rattus norvegicus OX=10116 GN=Slc16a6 PE=1 SV=1 g13938.t1 O88854 28.71 310 4.6900000000000004e-21 95.9 sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2 g13939.t1 P30533 33.828 337 2.4899999999999998e-39 145.0 sp|P30533|AMRP_HUMAN Alpha-2-macroglobulin receptor-associated protein OS=Homo sapiens OX=9606 GN=LRPAP1 PE=1 SV=1 AMRP_HUMAN reviewed Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP) Homo sapiens (Human) GO:0001540; GO:0002091; GO:0005102; GO:0005576; GO:0005768; GO:0005783; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0007165; GO:0008201; GO:0009986; GO:0010916; GO:0012505; GO:0031904; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0070326; GO:0150093; GO:1900116; GO:1900222; GO:1900223 amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165] cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237] amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326] g13940.t1 Q9D9B4 51.965 229 3.54e-80 244.0 sp|Q9D9B4|LRMDA_MOUSE Leucine-rich melanocyte differentiation-associated protein OS=Mus musculus OX=10090 GN=Lrmda PE=1 SV=1 g13941.t1 P36544 32.4 500 1.6900000000000002e-86 278.0 sp|P36544|ACHA7_HUMAN Neuronal acetylcholine receptor subunit alpha-7 OS=Homo sapiens OX=9606 GN=CHRNA7 PE=1 SV=5 ACHA7_HUMAN reviewed Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7) Homo sapiens (Human) GO:0001540; GO:0001666; GO:0004888; GO:0005216; GO:0005262; GO:0005789; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0007165; GO:0007268; GO:0007611; GO:0007613; GO:0007614; GO:0008284; GO:0015464; GO:0015643; GO:0016020; GO:0017081; GO:0022848; GO:0030425; GO:0032720; GO:0034220; GO:0035094; GO:0042166; GO:0042391; GO:0042803; GO:0043005; GO:0043124; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045766; GO:0050808; GO:0050890; GO:0050893; GO:0051247; GO:0060079; GO:0060084; GO:0070374; GO:0095500; GO:0097061; GO:0098794; GO:0098815; GO:0140059; GO:1900016; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904645; GO:1905144; GO:1905906; GO:2000463 acetylcholine receptor signaling pathway [GO:0095500]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; excitatory postsynaptic potential [GO:0060079]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein metabolic process [GO:0051247]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of membrane potential [GO:0042391]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission involved in micturition [GO:0060084] acetylcholine-gated channel complex [GO:0005892]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; amyloid-beta binding [GO:0001540]; calcium channel activity [GO:0005262]; chloride channel regulator activity [GO:0017081]; monoatomic ion channel activity [GO:0005216]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; transmembrane signaling receptor activity [GO:0004888] g13942.t1 Q9MYW0 25.375 867 4.9000000000000005e-65 241.0 sp|Q9MYW0|TRPC6_BOVIN Short transient receptor potential channel 6 OS=Bos taurus OX=9913 GN=TRPC6 PE=2 SV=2 g13943.t1 Q9VJJ7 26.364 770 1.9000000000000002e-70 262.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g13944.t1 Q9Y210 27.162 740 2.41e-72 264.0 sp|Q9Y210|TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens OX=9606 GN=TRPC6 PE=1 SV=1 g13948.t1 Q29451 49.95 999 0.0 965.0 sp|Q29451|MA2B1_BOVIN Lysosomal alpha-mannosidase OS=Bos taurus OX=9913 GN=MAN2B1 PE=1 SV=4 MA2B1_BOVIN reviewed Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide] Bos taurus (Bovine) GO:0004559; GO:0005764; GO:0006013; GO:0008270; GO:0030246 mannose metabolic process [GO:0006013] lysosome [GO:0005764] alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; zinc ion binding [GO:0008270] g13949.t1 Q03650 14.286 427 1.25e-25 117.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13949.t1 Q03650 14.286 427 1.37e-25 117.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13949.t1 Q03650 14.286 427 2.91e-25 116.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13949.t1 Q03650 14.286 427 3.2e-25 115.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13949.t1 Q03650 14.286 427 3.2e-25 115.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13949.t1 Q03650 14.286 427 3.2e-25 115.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13949.t1 Q03650 14.286 427 3.68e-25 115.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13949.t1 Q03650 14.286 427 7.48e-25 114.0 sp|Q03650|CRAM_TRYBB Cysteine-rich, acidic integral membrane protein OS=Trypanosoma brucei brucei OX=5702 GN=CRAM PE=2 SV=1 g13951.t1 Q5M8T2 35.47 234 4.34e-28 113.0 sp|Q5M8T2|S35D3_HUMAN Solute carrier family 35 member D3 OS=Homo sapiens OX=9606 GN=SLC35D3 PE=1 SV=1 S35D3_HUMAN reviewed Solute carrier family 35 member D3 (Fringe connection-like protein 1) Homo sapiens (Human) GO:0005460; GO:0005783; GO:0005789; GO:0005794; GO:0010508; GO:0015297; GO:0015786; GO:0030672; GO:0030674; GO:0031901; GO:0032527; GO:0055085; GO:0060155; GO:0070863; GO:0097009 energy homeostasis [GO:0097009]; platelet dense granule organization [GO:0060155]; positive regulation of autophagy [GO:0010508]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; transmembrane transport [GO:0055085]; UDP-glucose transmembrane transport [GO:0015786] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; synaptic vesicle membrane [GO:0030672] antiporter activity [GO:0015297]; protein-macromolecule adaptor activity [GO:0030674]; UDP-glucose transmembrane transporter activity [GO:0005460] g13953.t1 P30975 41.642 341 1.6e-74 242.0 sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 g13955.t1 Q5ZI72 41.398 186 2.72e-35 134.0 sp|Q5ZI72|HNRDL_CHICK Heterogeneous nuclear ribonucleoprotein D-like OS=Gallus gallus OX=9031 GN=HNRNPDL PE=2 SV=1 g13956.t1 Q68VK5 45.556 270 1.09e-66 216.0 sp|Q68VK5|TSN5_RAT Tetraspanin-5 OS=Rattus norvegicus OX=10116 GN=Tspan5 PE=2 SV=2 g13957.t1 Q9UQC9 31.366 915 8.120000000000001e-117 386.0 sp|Q9UQC9|CLCA2_HUMAN Calcium-activated chloride channel regulator 2 OS=Homo sapiens OX=9606 GN=CLCA2 PE=1 SV=2 g13958.t1 P54281 32.993 979 2.17e-145 459.0 sp|P54281|CLCA1_BOVIN Calcium-activated chloride channel regulator 1 OS=Bos taurus OX=9913 PE=1 SV=1 g13959.t1 Q9QUQ5 27.626 771 8.22e-73 267.0 sp|Q9QUQ5|TRPC4_MOUSE Short transient receptor potential channel 4 OS=Mus musculus OX=10090 GN=Trpc4 PE=1 SV=1 TRPC4_MOUSE reviewed Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel Trp4) (Receptor-activated cation channel TRP4) Mus musculus (Mouse) GO:0005262; GO:0005886; GO:0005901; GO:0005911; GO:0006816; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0032991; GO:0034703; GO:0034704; GO:0045121; GO:0045296; GO:0046872; GO:0048709; GO:0051480; GO:0051924; GO:0070509; GO:0070588; GO:0070679; GO:0099605; GO:0106129 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; oligodendrocyte differentiation [GO:0048709]; positive regulation of store-operated calcium entry [GO:0106129]; regulation of action potential firing rate [GO:0099605]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; metal ion binding [GO:0046872]; store-operated calcium channel activity [GO:0015279] g13960.t1 Q6Q473 34.413 988 2.79e-149 471.0 sp|Q6Q473|CLA4A_MOUSE Calcium-activated chloride channel regulator 4A OS=Mus musculus OX=10090 GN=Clca4a PE=1 SV=2 CLA4A_MOUSE reviewed Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form] Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872 chloride transport [GO:0006821]; proteolysis [GO:0006508] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; ligand-gated monoatomic ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g13961.t1 Q6Q473 33.814 970 7.380000000000001e-144 456.0 sp|Q6Q473|CLA4A_MOUSE Calcium-activated chloride channel regulator 4A OS=Mus musculus OX=10090 GN=Clca4a PE=1 SV=2 CLA4A_MOUSE reviewed Calcium-activated chloride channel regulator 4A (EC 3.4.-.-) (Calcium-activated chloride channel regulator 6) (mClca6) [Cleaved into: Calcium-activated chloride channel regulator 4A, 110 kDa form; Calcium-activated chloride channel regulator 4A, 30 kDa form] Mus musculus (Mouse) GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0015276; GO:0016324; GO:0046872 chloride transport [GO:0006821]; proteolysis [GO:0006508] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; ligand-gated monoatomic ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g13963.t1 Q9QX15 29.553 917 8.77e-106 356.0 sp|Q9QX15|CA3A1_MOUSE Calcium-activated chloride channel regulator 3A-1 OS=Mus musculus OX=10090 GN=Clca3a1 PE=1 SV=1 CA3A1_MOUSE reviewed Calcium-activated chloride channel regulator 3A-1 (EC 3.4.-.-) Mus musculus (Mouse) GO:0005229; GO:0005886; GO:0006508; GO:0006821; GO:0008237; GO:0046872 chloride transport [GO:0006821]; proteolysis [GO:0006508] plasma membrane [GO:0005886] intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] g13966.t1 P23359 26.981 467 1.5299999999999998e-42 159.0 sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2 BMP7_MOUSE reviewed Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1) Mus musculus (Mouse) GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0007507; GO:0008083; GO:0008201; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030902; GO:0031012; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045597; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1905069; GO:1905312 allantois development [GO:1905069]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cellular response to BMP stimulus [GO:0071773]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart development [GO:0007507]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell differentiation [GO:0045597]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; vesicle [GO:0031982] BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539] g13968.t1 Q6NU56 57.701 461 0.0 527.0 sp|Q6NU56|MET14_XENLA N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 OS=Xenopus laevis OX=8355 GN=mettl14 PE=2 SV=1 g13970.t1 Q8WXA3 52.475 606 0.0 628.0 sp|Q8WXA3|RUFY2_HUMAN RUN and FYVE domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RUFY2 PE=1 SV=3 RUFY2_HUMAN reviewed RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005768; GO:0008270; GO:0017124; GO:0030100 regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634] SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270] g13973.t1 A1L2T6 38.65 163 3.44e-27 120.0 sp|A1L2T6|ZCHC7_XENLA Zinc finger CCHC domain-containing protein 7 OS=Xenopus laevis OX=8355 GN=zcchc7 PE=2 SV=2 g13973.t2 A1L2T6 38.65 163 4.06e-27 120.0 sp|A1L2T6|ZCHC7_XENLA Zinc finger CCHC domain-containing protein 7 OS=Xenopus laevis OX=8355 GN=zcchc7 PE=2 SV=2 g13973.t3 A1L2T6 38.65 163 3.8200000000000005e-27 120.0 sp|A1L2T6|ZCHC7_XENLA Zinc finger CCHC domain-containing protein 7 OS=Xenopus laevis OX=8355 GN=zcchc7 PE=2 SV=2 g13974.t1 Q18PD9 32.292 192 3.79e-26 117.0 sp|Q18PD9|DOK7_TAKRU Protein Dok-7 OS=Takifugu rubripes OX=31033 GN=dok7 PE=2 SV=1 g13974.t2 Q18PE0 30.151 199 1.3999999999999999e-24 112.0 sp|Q18PE0|DOK7_MOUSE Protein Dok-7 OS=Mus musculus OX=10090 GN=Dok7 PE=1 SV=1 DOK7_MOUSE reviewed Protein Dok-7 (Downstream of tyrosine kinase 7) Mus musculus (Mouse) GO:0005654; GO:0005739; GO:0007167; GO:0007528; GO:0019901; GO:0031594; GO:0035022; GO:0035091; GO:0035591; GO:0043113; GO:0045211; GO:0061098 enzyme-linked receptor protein signaling pathway [GO:0007167]; neuromuscular junction development [GO:0007528]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rac protein signal transduction [GO:0035022]; receptor clustering [GO:0043113] mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211] phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591] g13976.t1 P24470 36.913 149 6.370000000000001e-21 92.0 sp|P24470|CP2CN_RAT Cytochrome P450 2C23 OS=Rattus norvegicus OX=10116 GN=Cyp2c23 PE=1 SV=2 CP2CN_RAT reviewed Cytochrome P450 2C23 (EC 1.14.14.-) (Arachidonic acid epoxygenase) (CYPIIC23) Rattus norvegicus (Rat) GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0019369; GO:0019373; GO:0020037; GO:0033574; GO:0042178; GO:0046456 arachidonate metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; icosanoid biosynthetic process [GO:0046456]; response to testosterone [GO:0033574]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g13977.t1 Q9QXF7 53.03 198 8.7e-71 226.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g13981.t1 Q62417 40.059 337 5.64e-64 227.0 sp|Q62417|SRBS1_MOUSE Sorbin and SH3 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sorbs1 PE=1 SV=2 g13988.t1 Q2HJF4 50.512 293 1.45e-96 289.0 sp|Q2HJF4|PBLD_BOVIN Phenazine biosynthesis-like domain-containing protein OS=Bos taurus OX=9913 GN=PBLD PE=2 SV=1 g13988.t2 Q2HJF4 51.027 292 1.73e-97 291.0 sp|Q2HJF4|PBLD_BOVIN Phenazine biosynthesis-like domain-containing protein OS=Bos taurus OX=9913 GN=PBLD PE=2 SV=1 g13988.t3 Q9DCG6 50.588 170 2.37e-51 169.0 sp|Q9DCG6|PBLD1_MOUSE Phenazine biosynthesis-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pbld1 PE=1 SV=2 PBLD1_MOUSE reviewed Phenazine biosynthesis-like domain-containing protein 1 Mus musculus (Mouse) GO:0002230; GO:0005737; GO:0006915; GO:0016853; GO:0030277; GO:0030512; GO:0032728; GO:0042802; GO:0043122; GO:0140374 antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; regulation of canonical NF-kappaB signal transduction [GO:0043122] cytoplasm [GO:0005737] identical protein binding [GO:0042802]; isomerase activity [GO:0016853] g13988.t4 Q2HJF4 50.318 157 3.6499999999999995e-46 155.0 sp|Q2HJF4|PBLD_BOVIN Phenazine biosynthesis-like domain-containing protein OS=Bos taurus OX=9913 GN=PBLD PE=2 SV=1 g13989.t1 P06766 68.155 336 1.19e-172 485.0 sp|P06766|DPOLB_RAT DNA polymerase beta OS=Rattus norvegicus OX=10116 GN=Polb PE=1 SV=4 DPOLB_RAT reviewed DNA polymerase beta (EC 2.7.7.7) (5'-deoxyribose-phosphate lyase) (5'-dRP lyase) (EC 4.2.99.-) (AP lyase) (EC 4.2.99.18) Rattus norvegicus (Rat) GO:0001701; GO:0003677; GO:0003684; GO:0003887; GO:0005634; GO:0005737; GO:0005874; GO:0005876; GO:0006260; GO:0006284; GO:0006287; GO:0006290; GO:0006303; GO:0006915; GO:0006954; GO:0006974; GO:0007435; GO:0008017; GO:0008630; GO:0010332; GO:0016445; GO:0016446; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0051575; GO:0055093; GO:0071707; GO:0140078 apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017] g13990.t1 Q5R548 70.681 191 2.38e-101 293.0 sp|Q5R548|SAR1A_PONAB Small COPII coat GTPase SAR1A OS=Pongo abelii OX=9601 GN=SAR1A PE=2 SV=1 SAR1A_PONAB reviewed Small COPII coat GTPase SAR1A (EC 3.6.5.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003925; GO:0005525; GO:0005765; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0030127; GO:0032580; GO:0046872; GO:0048208; GO:0070971; GO:0090110; GO:0140785; GO:1904262; GO:1990253 cellular response to leucine starvation [GO:1990253]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of TORC1 signaling [GO:1904262] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765] amino acid sensor activity [GO:0140785]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] g13991.t1 A6QNT8 59.24 763 0.0 978.0 sp|A6QNT8|SC24A_BOVIN Protein transport protein Sec24A OS=Bos taurus OX=9913 GN=SEC24A PE=2 SV=1 g13992.t1 Q8K1C7 34.404 218 5.73e-35 138.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g13994.t1 O15403 25.591 465 7.94e-43 162.0 sp|O15403|MOT7_HUMAN Monocarboxylate transporter 7 OS=Homo sapiens OX=9606 GN=SLC16A6 PE=1 SV=2 g13995.t1 Q8BGC3 28.035 453 7.829999999999999e-46 170.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g13996.t1 Q9Z1Z0 55.754 782 0.0 824.0 sp|Q9Z1Z0|USO1_MOUSE General vesicular transport factor p115 OS=Mus musculus OX=10090 GN=Uso1 PE=1 SV=2 USO1_MOUSE reviewed General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein) Mus musculus (Mouse) GO:0000139; GO:0001650; GO:0005783; GO:0005794; GO:0005795; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0007264; GO:0012507; GO:0032252; GO:0045056; GO:0048211; GO:0048280; GO:0048471; GO:0061025; GO:1900076 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase-mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471] g14000.t1 P08761 44.737 190 4.2499999999999996e-48 162.0 sp|P08761|MSRA_DROME Peptide methionine sulfoxide reductase OS=Drosophila melanogaster OX=7227 GN=MsrA PE=1 SV=2 g14001.t1 O77460 57.343 286 2.2500000000000003e-123 360.0 sp|O77460|IPYR_DROME Inorganic pyrophosphatase OS=Drosophila melanogaster OX=7227 GN=Nurf-38 PE=1 SV=3 g14002.t1 O95858 40.075 267 3.68e-71 223.0 sp|O95858|TSN15_HUMAN Tetraspanin-15 OS=Homo sapiens OX=9606 GN=TSPAN15 PE=1 SV=1 TSN15_HUMAN reviewed Tetraspanin-15 (Tspan-15) (Tetraspan NET-7) (Transmembrane 4 superfamily member 15) Homo sapiens (Human) GO:0005788; GO:0005829; GO:0005886; GO:0009986; GO:0016604; GO:0019899; GO:0030054; GO:0031902; GO:0045746; GO:0051043; GO:0051604; GO:0072659; GO:0097197 negative regulation of Notch signaling pathway [GO:0045746]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; regulation of membrane protein ectodomain proteolysis [GO:0051043] cell junction [GO:0030054]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; late endosome membrane [GO:0031902]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] enzyme binding [GO:0019899] g14005.t1 Q5PPZ9 39.046 566 1.87e-115 360.0 sp|Q5PPZ9|GDS1B_XENLA Rap1 GTPase-GDP dissociation stimulator 1-B OS=Xenopus laevis OX=8355 GN=rap1gds1-b PE=2 SV=1 g14007.t1 P79385 37.952 166 7.32e-26 107.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g14008.t1 P79385 40.719 167 3.59e-27 110.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g14010.t1 P79385 39.521 167 1.02e-28 114.0 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g14010.t1 P79385 33.333 174 1.1e-21 95.5 sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2 g14012.t1 Q3SZP0 48.855 131 5.5e-38 144.0 sp|Q3SZP0|IRF1_BOVIN Interferon regulatory factor 1 OS=Bos taurus OX=9913 GN=IRF1 PE=2 SV=1 IRF1_BOVIN reviewed Interferon regulatory factor 1 (IRF-1) Bos taurus (Bovine) GO:0000976; GO:0000978; GO:0000981; GO:0002376; GO:0005634; GO:0005737; GO:0006357; GO:0006915; GO:0032481; GO:0032728; GO:0034124; GO:0045590; GO:0045892; GO:0045893; GO:0045944; GO:0051607; GO:0051726; GO:0060333; GO:2000564 apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of regulatory T cell differentiation [GO:0045590]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of cell cycle [GO:0051726]; regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034124]; regulation of transcription by RNA polymerase II [GO:0006357]; type II interferon-mediated signaling pathway [GO:0060333] cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976] g14013.t1 Q3B8Q1 48.62 652 0.0 586.0 sp|Q3B8Q1|DDX21_RAT Nucleolar RNA helicase 2 OS=Rattus norvegicus OX=10116 GN=Ddx21 PE=2 SV=1 DDX21_RAT reviewed Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu) Rattus norvegicus (Rat) GO:0002735; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005654; GO:0005694; GO:0005730; GO:0005739; GO:0005829; GO:0006364; GO:0006366; GO:0009615; GO:0016887; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop processing [GO:0062176]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366] B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515] g14014.t1 Q99NI4 44.681 235 9.3e-64 216.0 sp|Q99NI4|IPMK_RAT Inositol polyphosphate multikinase OS=Rattus norvegicus OX=10116 GN=Ipmk PE=1 SV=1 IPMK_RAT reviewed Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase) Rattus norvegicus (Rat) GO:0000823; GO:0000824; GO:0000825; GO:0001841; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008440; GO:0032957; GO:0032958; GO:0036064; GO:0046488; GO:0046872; GO:0046934; GO:0047326; GO:0051765; GO:0070266; GO:0097243 inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube formation [GO:0001841]; phosphatidylinositol metabolic process [GO:0046488] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4,6-tetrakisphosphate 5-kinase activity [GO:0047326]; inositol-1,4,5,6-tetrakisphosphate 3-kinase activity [GO:0000824]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; metal ion binding [GO:0046872] g14016.t1 Q5MB13 51.491 637 0.0 650.0 sp|Q5MB13|ABCG2_MACMU Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Macaca mulatta OX=9544 GN=ABCG2 PE=2 SV=1 ABCG2_MACMU reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338) Macaca mulatta (Rhesus macaque) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0046983; GO:0055085; GO:0097744 biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; protein dimerization activity [GO:0046983]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143] g14017.t1 Q5MB13 52.484 644 0.0 667.0 sp|Q5MB13|ABCG2_MACMU Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Macaca mulatta OX=9544 GN=ABCG2 PE=2 SV=1 ABCG2_MACMU reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338) Macaca mulatta (Rhesus macaque) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0046983; GO:0055085; GO:0097744 biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; protein dimerization activity [GO:0046983]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143] g14017.t2 Q5MB13 51.863 644 0.0 668.0 sp|Q5MB13|ABCG2_MACMU Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Macaca mulatta OX=9544 GN=ABCG2 PE=2 SV=1 ABCG2_MACMU reviewed Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338) Macaca mulatta (Rhesus macaque) GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0046983; GO:0055085; GO:0097744 biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; protein dimerization activity [GO:0046983]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143] g14019.t1 P48597 56.667 210 7.6e-88 261.0 sp|P48597|IF4E_XENLA Eukaryotic translation initiation factor 4E OS=Xenopus laevis OX=8355 GN=eif4e PE=1 SV=1 g14021.t1 Q8VC74 46.875 288 5.3e-85 266.0 sp|Q8VC74|COX18_MOUSE Cytochrome c oxidase assembly protein COX18, mitochondrial OS=Mus musculus OX=10090 GN=Cox18 PE=1 SV=5 g14022.t1 O18783 47.26 146 8.530000000000001e-35 143.0 sp|O18783|PLMN_NOTEU Plasminogen OS=Notamacropus eugenii OX=9315 GN=PLG PE=2 SV=1 g14022.t1 O18783 43.902 164 5.39e-32 134.0 sp|O18783|PLMN_NOTEU Plasminogen OS=Notamacropus eugenii OX=9315 GN=PLG PE=2 SV=1 g14022.t1 O18783 42.593 162 2.28e-28 124.0 sp|O18783|PLMN_NOTEU Plasminogen OS=Notamacropus eugenii OX=9315 GN=PLG PE=2 SV=1 g14022.t1 O18783 39.409 203 1.4600000000000001e-27 121.0 sp|O18783|PLMN_NOTEU Plasminogen OS=Notamacropus eugenii OX=9315 GN=PLG PE=2 SV=1 g14023.t1 O08762 35.219 389 7.31e-55 204.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g14023.t1 O08762 36.614 254 1.63e-36 150.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g14024.t1 Q8K1T0 52.0 125 8.959999999999999e-40 141.0 sp|Q8K1T0|TMPS3_MOUSE Transmembrane protease serine 3 OS=Mus musculus OX=10090 GN=Tmprss3 PE=1 SV=2 TMPS3_MOUSE reviewed Transmembrane protease serine 3 (EC 3.4.21.-) Mus musculus (Mouse) GO:0004252; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0008236; GO:0017080; GO:0043025 intracellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] g14025.t1 A7E305 45.581 645 2.18e-140 473.0 sp|A7E305|ZSWM8_BOVIN Zinc finger SWIM domain-containing protein 8 OS=Bos taurus OX=9913 GN=ZSWIM8 PE=2 SV=1 g14025.t1 A7E305 52.79 233 3.1199999999999997e-60 232.0 sp|A7E305|ZSWM8_BOVIN Zinc finger SWIM domain-containing protein 8 OS=Bos taurus OX=9913 GN=ZSWIM8 PE=2 SV=1 g14025.t1 A7E305 71.028 107 4.09e-40 167.0 sp|A7E305|ZSWM8_BOVIN Zinc finger SWIM domain-containing protein 8 OS=Bos taurus OX=9913 GN=ZSWIM8 PE=2 SV=1 g14026.t1 A7E305 62.222 225 8.4e-90 292.0 sp|A7E305|ZSWM8_BOVIN Zinc finger SWIM domain-containing protein 8 OS=Bos taurus OX=9913 GN=ZSWIM8 PE=2 SV=1 g14027.t1 C0HKA1 92.857 140 1.86e-91 265.0 sp|C0HKA1|RS14B_DROME Small ribosomal subunit protein uS11B OS=Drosophila melanogaster OX=7227 GN=RpS14b PE=2 SV=1 RS14B_DROME reviewed Small ribosomal subunit protein uS11B (40S ribosomal protein S14b) Drosophila melanogaster (Fruit fly) GO:0000028; GO:0002181; GO:0003735; GO:0006412; GO:0022626; GO:0022627 cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627] structural constituent of ribosome [GO:0003735] g14028.t1 O08762 40.152 264 9.28e-45 167.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g14029.t1 P00766 38.189 254 2.17e-48 166.0 sp|P00766|CTRA_BOVIN Chymotrypsinogen A OS=Bos taurus OX=9913 PE=1 SV=1 g14030.t1 Q6GPI1 37.449 243 4.52e-37 137.0 sp|Q6GPI1|CTRB2_HUMAN Chymotrypsinogen B2 OS=Homo sapiens OX=9606 GN=CTRB2 PE=1 SV=2 CTRB2_HUMAN reviewed Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin B2 chain A; Chymotrypsin B2 chain B; Chymotrypsin B2 chain C] Homo sapiens (Human) GO:0004252; GO:0005576; GO:0006508; GO:0007586 digestion [GO:0007586]; proteolysis [GO:0006508] extracellular region [GO:0005576] serine-type endopeptidase activity [GO:0004252] g14033.t1 Q8JI28 54.822 985 0.0 1122.0 sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1 g14034.t1 O95470 54.137 556 0.0 613.0 sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3 SGPL1_HUMAN reviewed Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase) Homo sapiens (Human) GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190 androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117] g14035.t1 O73888 40.299 201 9.939999999999999e-45 150.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g14036.t1 P18426 39.32 206 6.6700000000000004e-49 161.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14037.t1 P18426 40.777 206 4.21e-45 151.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14039.t1 Q6DFZ1 51.579 475 1.47e-141 450.0 sp|Q6DFZ1|GBF1_MOUSE Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Mus musculus OX=10090 GN=Gbf1 PE=1 SV=1 GBF1_MOUSE reviewed Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1) Mus musculus (Mouse) GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005777; GO:0005788; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006890; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008 cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g14041.t1 Q6DFZ1 49.046 524 1.57e-131 439.0 sp|Q6DFZ1|GBF1_MOUSE Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Mus musculus OX=10090 GN=Gbf1 PE=1 SV=1 GBF1_MOUSE reviewed Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1) Mus musculus (Mouse) GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005777; GO:0005788; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006890; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008 cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g14041.t1 Q6DFZ1 52.459 305 1.8499999999999998e-68 253.0 sp|Q6DFZ1|GBF1_MOUSE Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Mus musculus OX=10090 GN=Gbf1 PE=1 SV=1 GBF1_MOUSE reviewed Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1) Mus musculus (Mouse) GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005777; GO:0005788; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006890; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008 cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g14041.t2 Q9R1D7 53.211 872 0.0 837.0 sp|Q9R1D7|GBF1_CRIGR Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Cricetulus griseus OX=10029 GN=GBF1 PE=1 SV=1 g14041.t2 Q9R1D7 49.811 528 2.83e-127 440.0 sp|Q9R1D7|GBF1_CRIGR Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Cricetulus griseus OX=10029 GN=GBF1 PE=1 SV=1 g14051.t1 O88496 47.995 748 0.0 709.0 sp|O88496|VKGC_RAT Vitamin K-dependent gamma-carboxylase OS=Rattus norvegicus OX=10116 GN=Ggcx PE=1 SV=1 VKGC_RAT reviewed Vitamin K-dependent gamma-carboxylase (VKGC) (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase) Rattus norvegicus (Rat) GO:0005788; GO:0005789; GO:0008488; GO:0010042; GO:0019842; GO:0032571; GO:0032869; GO:0033280; GO:0042277; GO:0042373; GO:0042593; GO:0044342; GO:0046929; GO:0051604; GO:0060437; GO:0070482; GO:0071107; GO:0071548; GO:1903011; GO:1904016; GO:2000225 cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; lung growth [GO:0060437]; negative regulation of bone development [GO:1903011]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of testosterone biosynthetic process [GO:2000225]; protein maturation [GO:0051604]; response to dexamethasone [GO:0071548]; response to manganese ion [GO:0010042]; response to oxygen levels [GO:0070482]; response to parathyroid hormone [GO:0071107]; response to Thyroglobulin triiodothyronine [GO:1904016]; response to vitamin D [GO:0033280]; response to vitamin K [GO:0032571]; type B pancreatic cell proliferation [GO:0044342]; vitamin K metabolic process [GO:0042373] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789] gamma-glutamyl carboxylase activity [GO:0008488]; peptide binding [GO:0042277]; vitamin binding [GO:0019842] g14052.t1 O62471 25.909 1127 1.81e-111 393.0 sp|O62471|QUI1_CAEEL Protein qui-1 OS=Caenorhabditis elegans OX=6239 GN=qui-1 PE=1 SV=2 g14052.t2 O62471 25.786 1113 3.68e-111 392.0 sp|O62471|QUI1_CAEEL Protein qui-1 OS=Caenorhabditis elegans OX=6239 GN=qui-1 PE=1 SV=2 g14053.t1 B2RQL2 37.056 197 2.76e-35 149.0 sp|B2RQL2|STOX1_MOUSE Storkhead-box protein 1 OS=Mus musculus OX=10090 GN=Stox1 PE=1 SV=1 STOX1_MOUSE reviewed Storkhead-box protein 1 Mus musculus (Mouse) GO:0000977; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0007346; GO:0010468; GO:0010628; GO:0010629; GO:0010821; GO:0010971; GO:0045787; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904120 cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of mitotic cell cycle [GO:0007346]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g14054.t1 Q5F2L1 47.269 476 3.17e-155 452.0 sp|Q5F2L1|OFUT3_RAT GDP-fucose protein O-fucosyltransferase 3 OS=Rattus norvegicus OX=10116 GN=Fut10 PE=2 SV=1 OFUT3_RAT reviewed GDP-fucose protein O-fucosyltransferase 3 (EC 2.4.1.221) (Alpha-(1,3)-fucosyltransferase 10) (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10) Rattus norvegicus (Rat) GO:0000139; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0006491; GO:0008417; GO:0021799; GO:0036445; GO:0046920; GO:0046922; GO:0050714; GO:0097150; GO:0097402 cerebral cortex radially oriented cell migration [GO:0021799]; N-glycan processing [GO:0006491]; neuroblast migration [GO:0097402]; neuronal stem cell division [GO:0036445]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of protein secretion [GO:0050714] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] g14056.t1 Q8IZQ1 50.626 2238 0.0 2133.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g14056.t2 Q8IZQ1 50.785 2229 0.0 2135.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g14057.t1 Q8IZQ1 45.192 208 5.6799999999999996e-42 155.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g14058.t1 Q8IZQ1 56.17 940 0.0 1036.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g14058.t1 Q8IZQ1 65.693 137 1.63e-55 216.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g14061.t1 Q8IZQ1 58.491 106 2.35e-39 147.0 sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2 WDFY3_HUMAN reviewed WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy) Homo sapiens (Human) GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204 aggrephagy [GO:0035973] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] g14062.t1 O14718 35.915 284 5.43e-60 197.0 sp|O14718|OPSX_HUMAN Visual pigment-like receptor peropsin OS=Homo sapiens OX=9606 GN=RRH PE=1 SV=1 g14064.t1 O02776 55.631 444 2.2799999999999998e-174 528.0 sp|O02776|PARG_BOVIN Poly(ADP-ribose) glycohydrolase OS=Bos taurus OX=9913 GN=PARG PE=1 SV=1 g14064.t2 O02776 55.631 444 5.099999999999999e-175 528.0 sp|O02776|PARG_BOVIN Poly(ADP-ribose) glycohydrolase OS=Bos taurus OX=9913 GN=PARG PE=1 SV=1 g14066.t1 Q5VNW5 32.0 275 1.13e-34 132.0 sp|Q5VNW5|IMCL2_ORYSJ Probable isoprenylcysteine alpha-carbonyl methylesterase ICMEL2 OS=Oryza sativa subsp. japonica OX=39947 GN=IMCEL2 PE=2 SV=1 g14066.t2 Q5VNW5 31.769 277 1.57e-34 132.0 sp|Q5VNW5|IMCL2_ORYSJ Probable isoprenylcysteine alpha-carbonyl methylesterase ICMEL2 OS=Oryza sativa subsp. japonica OX=39947 GN=IMCEL2 PE=2 SV=1 g14068.t1 Q5RC04 62.87 439 0.0 606.0 sp|Q5RC04|RGF1B_PONAB Ras-GEF domain-containing family member 1B OS=Pongo abelii OX=9601 GN=RASGEF1B PE=2 SV=2 g14068.t2 Q5RC04 62.929 437 0.0 606.0 sp|Q5RC04|RGF1B_PONAB Ras-GEF domain-containing family member 1B OS=Pongo abelii OX=9601 GN=RASGEF1B PE=2 SV=2 g14068.t3 Q5RC04 62.302 443 0.0 605.0 sp|Q5RC04|RGF1B_PONAB Ras-GEF domain-containing family member 1B OS=Pongo abelii OX=9601 GN=RASGEF1B PE=2 SV=2 g14069.t1 Q9D8S9 52.381 126 7.18e-39 131.0 sp|Q9D8S9|BOLA1_MOUSE BolA-like protein 1 OS=Mus musculus OX=10090 GN=Bola1 PE=1 SV=1 g14070.t1 Q02874 58.824 374 2.1e-148 426.0 sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5 g14071.t1 Q8BYK4 53.793 290 4.5600000000000004e-97 291.0 sp|Q8BYK4|RDH12_MOUSE Retinol dehydrogenase 12 OS=Mus musculus OX=10090 GN=Rdh12 PE=2 SV=1 RDH12_MOUSE reviewed Retinol dehydrogenase 12 (EC 1.1.1.300) Mus musculus (Mouse) GO:0001917; GO:0004745; GO:0007601; GO:0042572; GO:0052650; GO:0102354; GO:0110095 cellular detoxification of aldehyde [GO:0110095]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] photoreceptor inner segment [GO:0001917] 11-cis-retinol dehydrogenase (NADP+) activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650] g14074.t1 P18426 38.537 205 1.48e-37 132.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14075.t1 O42387 78.462 130 1.83e-70 210.0 sp|O42387|RS24_TAKRU Small ribosomal subunit protein eS24 OS=Takifugu rubripes OX=31033 GN=rps24 PE=3 SV=1 g14076.t1 P27012 36.744 215 6.26e-44 149.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g14077.t1 P27012 36.279 215 2.04e-42 145.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g14078.t1 P27012 32.877 219 7.4e-36 128.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g14079.t1 P18426 40.097 207 1.45e-43 147.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14080.t1 P18426 40.58 207 6.69e-43 145.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14081.t1 P18426 35.122 205 3.5e-34 122.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14082.t1 P27012 35.648 216 1.06e-47 158.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g14083.t1 P18426 40.865 208 6.36e-47 156.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14085.t1 P27011 36.697 218 1.17e-45 153.0 sp|P27011|SCRY3_ENTDO S-crystallin 3 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g14086.t1 O73888 40.777 206 7.58e-44 148.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g14087.t1 P27012 32.386 176 1.16e-26 104.0 sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1 g14088.t1 O73888 38.235 204 9.36e-39 135.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g14089.t1 P18426 33.838 198 5.94e-35 125.0 sp|P18426|SCR11_NOTSL S-crystallin SL11 OS=Nototodarus sloanii OX=215440 PE=2 SV=1 g14090.t1 O73888 39.234 209 8.85e-41 140.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g14092.t1 O73888 35.149 202 3.33e-29 110.0 sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3 g14099.t1 Q14191 43.517 887 0.0 754.0 sp|Q14191|WRN_HUMAN Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN OS=Homo sapiens OX=9606 GN=WRN PE=1 SV=2 WRN_HUMAN reviewed Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)] Homo sapiens (Human) GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006284; GO:0006298; GO:0006302; GO:0006974; GO:0006979; GO:0008340; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032392; GO:0032405; GO:0040009; GO:0042803; GO:0043138; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773 base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA geometric change [GO:0032392]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820] centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657] 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403] g14101.t1 Q4V7N4 43.353 173 4.06e-49 160.0 sp|Q4V7N4|TMA16_XENLA Translation machinery-associated protein 16 OS=Xenopus laevis OX=8355 GN=tma16 PE=2 SV=1 g14102.t1 Q03042 57.962 628 0.0 772.0 sp|Q03042|KGP1_DROME cGMP-dependent protein kinase, isozyme 1 OS=Drosophila melanogaster OX=7227 GN=Pkg21D PE=1 SV=2 g14103.t1 Q5ZKY0 28.858 499 6.01e-52 187.0 sp|Q5ZKY0|TM175_CHICK Endosomal/lysosomal proton channel TMEM175 OS=Gallus gallus OX=9031 GN=TMEM175 PE=2 SV=2 TM175_CHICK reviewed Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175) Gallus gallus (Chicken) GO:0005267; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0015252; GO:0022841; GO:0035751; GO:0035752; GO:0050544; GO:0070050; GO:0071805; GO:0090385; GO:1902600 lysosomal lumen pH elevation [GO:0035752]; neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of lysosomal lumen pH [GO:0035751] endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] arachidonate binding [GO:0050544]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; proton channel activity [GO:0015252] g14104.t1 Q99MW1 23.856 1027 3.72e-52 203.0 sp|Q99MW1|STK31_MOUSE Serine/threonine-protein kinase 31 OS=Mus musculus OX=10090 GN=Stk31 PE=1 SV=2 g14105.t1 Q9QZS6 37.857 280 7.689999999999999e-52 179.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g14106.t1 Q9QZS6 37.5 280 7.88e-51 177.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g14107.t1 Q9QZS6 37.722 281 5.14e-52 180.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g14108.t1 Q9QZS6 37.722 281 4.48e-52 180.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g14109.t1 Q9QZS6 37.857 280 1.33e-51 179.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g14110.t1 Q9QZS6 37.722 281 5.14e-52 180.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g14111.t1 Q9QZS6 37.118 229 5.269999999999999e-34 138.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g14115.t1 O73853 28.75 480 6.68e-57 201.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g14118.t1 P30372 28.571 483 8.84e-58 203.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g14120.t1 Q2PFD7 47.772 404 3.57e-121 388.0 sp|Q2PFD7|PSD3_MOUSE PH and SEC7 domain-containing protein 3 OS=Mus musculus OX=10090 GN=Psd3 PE=1 SV=2 PSD3_MOUSE reviewed PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Pleckstrin homology and SEC7 domain-containing protein 3) Mus musculus (Mouse) GO:0005085; GO:0014069; GO:0016020; GO:0032011; GO:0032012; GO:0032587; GO:0098794; GO:0098978 ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012] glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085] g14120.t2 Q2PFD7 49.869 383 2.2800000000000002e-125 399.0 sp|Q2PFD7|PSD3_MOUSE PH and SEC7 domain-containing protein 3 OS=Mus musculus OX=10090 GN=Psd3 PE=1 SV=2 PSD3_MOUSE reviewed PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Pleckstrin homology and SEC7 domain-containing protein 3) Mus musculus (Mouse) GO:0005085; GO:0014069; GO:0016020; GO:0032011; GO:0032012; GO:0032587; GO:0098794; GO:0098978 ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012] glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085] g14120.t3 Q2PFD7 50.0 382 4.4800000000000004e-125 399.0 sp|Q2PFD7|PSD3_MOUSE PH and SEC7 domain-containing protein 3 OS=Mus musculus OX=10090 GN=Psd3 PE=1 SV=2 PSD3_MOUSE reviewed PH and SEC7 domain-containing protein 3 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Pleckstrin homology and SEC7 domain-containing protein 3) Mus musculus (Mouse) GO:0005085; GO:0014069; GO:0016020; GO:0032011; GO:0032012; GO:0032587; GO:0098794; GO:0098978 ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012] glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] guanyl-nucleotide exchange factor activity [GO:0005085] g14121.t1 Q8N8Q8 32.154 311 3.0400000000000002e-56 191.0 sp|Q8N8Q8|COX18_HUMAN Cytochrome c oxidase assembly protein COX18, mitochondrial OS=Homo sapiens OX=9606 GN=COX18 PE=1 SV=1 COX18_HUMAN reviewed Cytochrome c oxidase assembly protein COX18, mitochondrial (COX18Hs) (Cytochrome c oxidase assembly protein 18) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0008535; GO:0032977; GO:0032979; GO:0033617; GO:0051204 mitochondrial respiratory chain complex IV assembly [GO:0033617]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]; respiratory chain complex IV assembly [GO:0008535] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] membrane insertase activity [GO:0032977] g14123.t1 B7ZC96 54.767 451 6.58e-156 474.0 sp|B7ZC96|KCMA1_DANRE Calcium-activated potassium channel subunit alpha-1a OS=Danio rerio OX=7955 GN=kcnma1a PE=1 SV=1 KCMA1_DANRE reviewed Calcium-activated potassium channel subunit alpha-1a (BK channel) (Potassium large conductance calcium-activated channel, subfamily M, alpha member 1a) (Slo1a) (Slowpoke homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0015269; GO:0016020; GO:0034702; GO:0045211; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072] g14123.t2 B7ZC96 51.224 490 3.13e-151 464.0 sp|B7ZC96|KCMA1_DANRE Calcium-activated potassium channel subunit alpha-1a OS=Danio rerio OX=7955 GN=kcnma1a PE=1 SV=1 KCMA1_DANRE reviewed Calcium-activated potassium channel subunit alpha-1a (BK channel) (Potassium large conductance calcium-activated channel, subfamily M, alpha member 1a) (Slo1a) (Slowpoke homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0015269; GO:0016020; GO:0034702; GO:0045211; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072] g14124.t1 B7ZC96 58.896 652 0.0 811.0 sp|B7ZC96|KCMA1_DANRE Calcium-activated potassium channel subunit alpha-1a OS=Danio rerio OX=7955 GN=kcnma1a PE=1 SV=1 KCMA1_DANRE reviewed Calcium-activated potassium channel subunit alpha-1a (BK channel) (Potassium large conductance calcium-activated channel, subfamily M, alpha member 1a) (Slo1a) (Slowpoke homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0015269; GO:0016020; GO:0034702; GO:0045211; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072] g14124.t2 B7ZC96 57.059 680 0.0 801.0 sp|B7ZC96|KCMA1_DANRE Calcium-activated potassium channel subunit alpha-1a OS=Danio rerio OX=7955 GN=kcnma1a PE=1 SV=1 KCMA1_DANRE reviewed Calcium-activated potassium channel subunit alpha-1a (BK channel) (Potassium large conductance calcium-activated channel, subfamily M, alpha member 1a) (Slo1a) (Slowpoke homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005509; GO:0015269; GO:0016020; GO:0034702; GO:0045211; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072] g14124.t3 Q8AYS8 62.648 506 0.0 669.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t3 Q8AYS8 49.296 142 8.79e-37 153.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t4 Q8AYS8 60.377 636 0.0 804.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t5 Q8AYS8 63.043 506 0.0 670.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t5 Q8AYS8 60.185 108 4.08e-36 151.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t6 Q8AYS8 62.648 506 0.0 669.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t6 Q8AYS8 60.185 108 3.85e-36 151.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t7 Q8AYS8 62.648 506 0.0 670.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t7 Q8AYS8 60.185 108 3.84e-36 151.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t8 Q8AYS8 62.402 508 0.0 666.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t8 Q8AYS8 60.185 108 3.97e-36 151.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t9 Q8AYS8 62.648 506 0.0 669.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14124.t9 Q8AYS8 53.846 130 6.72e-38 155.0 sp|Q8AYS8|KCMA1_CHICK Calcium-activated potassium channel subunit alpha-1 OS=Gallus gallus OX=9031 GN=KCNMA1 PE=1 SV=2 KCMA1_CHICK reviewed Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (cSlo) Gallus gallus (Chicken) GO:0005249; GO:0015269; GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805 potassium ion transmembrane transport [GO:0071805] monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211] calcium-activated potassium channel activity [GO:0015269]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] g14125.t1 O93403 32.845 341 1.0600000000000001e-44 164.0 sp|O93403|CHST3_TETCF Carbohydrate sulfotransferase 3 OS=Tetronarce californica OX=7787 GN=CHST3 PE=1 SV=1 g14126.t1 O93403 35.174 344 1.05e-50 179.0 sp|O93403|CHST3_TETCF Carbohydrate sulfotransferase 3 OS=Tetronarce californica OX=7787 GN=CHST3 PE=1 SV=1 g14130.t1 P82013 70.671 283 2.2800000000000002e-154 435.0 sp|P82013|VDAC2_MELGA Non-selective voltage-gated ion channel VDAC2 OS=Meleagris gallopavo OX=9103 GN=VDAC2 PE=1 SV=2 VDAC2_MELGA reviewed Non-selective voltage-gated ion channel VDAC2 (VDAC-2) (Outer mitochondrial membrane protein porin 2) Meleagris gallopavo (Wild turkey) GO:0001669; GO:0005244; GO:0005524; GO:0005741; GO:0006820; GO:0007339; GO:0008142; GO:0008308; GO:0015288; GO:0015485; GO:0017128; GO:0031210; GO:0042645; GO:0046930; GO:0097001; GO:0097345; GO:1990542 binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial transmembrane transport [GO:1990542]; monoatomic anion transport [GO:0006820] acrosomal vesicle [GO:0001669]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930] ATP binding [GO:0005524]; ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142]; phosphatidylcholine binding [GO:0031210]; phospholipid scramblase activity [GO:0017128]; porin activity [GO:0015288]; voltage-gated monoatomic anion channel activity [GO:0008308]; voltage-gated monoatomic ion channel activity [GO:0005244] g14132.t1 P30974 25.0 308 1.9599999999999997e-23 103.0 sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2 g14133.t1 Q95266 78.074 488 0.0 800.0 sp|Q95266|KCC2D_PIG Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Sus scrofa OX=9823 GN=CAMK2D PE=2 SV=1 KCC2D_PIG reviewed Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) Sus scrofa (Pig) GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0006468; GO:0010613; GO:0014069; GO:0033017; GO:0042383; GO:0043005; GO:0048168; GO:0060341; GO:0106310; GO:1903076 positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein phosphorylation [GO:0006468]; regulation of cellular localization [GO:0060341]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein localization to plasma membrane [GO:1903076] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017] ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310] g14134.t1 Q08BC4 37.432 553 1.92e-102 321.0 sp|Q08BC4|STPG2_DANRE Sperm-tail PG-rich repeat-containing protein 2 OS=Danio rerio OX=7955 GN=stpg2 PE=2 SV=1 g14139.t1 Q7T2Z5 37.995 429 3.01e-85 282.0 sp|Q7T2Z5|UNC5C_CHICK Netrin receptor UNC5C OS=Gallus gallus OX=9031 GN=UNC5C PE=2 SV=1 g14140.t1 C5IAW9 43.032 409 1.3500000000000002e-110 352.0 sp|C5IAW9|UN5BB_XENLA Netrin receptor UNC5B-b OS=Xenopus laevis OX=8355 GN=unc5b-b PE=1 SV=1 g14141.t1 Q9EQC0 32.861 353 2.75e-40 150.0 sp|Q9EQC0|CHST1_MOUSE Carbohydrate sulfotransferase 1 OS=Mus musculus OX=10090 GN=Chst1 PE=1 SV=1 CHST1_MOUSE reviewed Carbohydrate sulfotransferase 1 (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST) (EC 2.8.2.21) Mus musculus (Mouse) GO:0000139; GO:0001517; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0018146; GO:0042339; GO:0045130 galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate proteoglycan biosynthetic process [GO:0018146]; keratan sulfate proteoglycan metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139] keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] g14142.t1 Q7LGC8 31.378 341 5.84e-38 148.0 sp|Q7LGC8|CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens OX=9606 GN=CHST3 PE=1 SV=3 CHST3_HUMAN reviewed Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0) Homo sapiens (Human) GO:0000139; GO:0001517; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0018146; GO:0043029; GO:0045130; GO:0050650 carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; keratan sulfate proteoglycan biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029] Golgi membrane [GO:0000139] chondroitin 6-sulfotransferase activity [GO:0008459]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517] g14143.t1 Q8IX12 40.181 1217 0.0 594.0 sp|Q8IX12|CCAR1_HUMAN Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens OX=9606 GN=CCAR1 PE=1 SV=2 CCAR1_HUMAN reviewed Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain) Homo sapiens (Human) GO:0000978; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005641; GO:0005654; GO:0006511; GO:0006915; GO:0008284; GO:0016567; GO:0030335; GO:0043065; GO:0048471; GO:0061630 apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630] g14144.t1 Q924H0 34.473 351 3.05e-58 198.0 sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2 g14148.t1 Q68F72 29.511 532 2.2300000000000003e-56 203.0 sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1 S15A4_XENLA reviewed Solute carrier family 15 member 4 Xenopus laevis (African clawed frog) GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206 dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] g14151.t1 O70209 39.319 323 7.78e-71 226.0 sp|O70209|PDLI3_MOUSE PDZ and LIM domain protein 3 OS=Mus musculus OX=10090 GN=Pdlim3 PE=1 SV=1 g14151.t2 O70209 39.181 342 3.7200000000000003e-66 224.0 sp|O70209|PDLI3_MOUSE PDZ and LIM domain protein 3 OS=Mus musculus OX=10090 GN=Pdlim3 PE=1 SV=1 g14152.t1 Q8TDM6 40.432 648 9.38e-129 454.0 sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4 DLG5_HUMAN reviewed Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) Homo sapiens (Human) GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0010001; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060563; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609; GO:0098978; GO:0099173 apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; glial cell differentiation [GO:0010001]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; neuroepithelial cell differentiation [GO:0060563]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; postsynapse organization [GO:0099173]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186] adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159] g14152.t1 Q8TDM6 32.429 848 8.66e-108 388.0 sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4 DLG5_HUMAN reviewed Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) Homo sapiens (Human) GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0010001; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060563; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609; GO:0098978; GO:0099173 apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; glial cell differentiation [GO:0010001]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; neuroepithelial cell differentiation [GO:0060563]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; postsynapse organization [GO:0099173]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186] adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159] g14153.t1 P91791 75.152 165 7.289999999999999e-90 262.0 sp|P91791|PPIA_HEMPU Peptidyl-prolyl cis-trans isomerase OS=Hemicentrotus pulcherrimus OX=7650 PE=2 SV=1 g14154.t1 Q9QUR2 50.429 466 1.1399999999999999e-174 501.0 sp|Q9QUR2|DCTN4_RAT Dynactin subunit 4 OS=Rattus norvegicus OX=10116 GN=Dctn4 PE=1 SV=1 DCTN4_RAT reviewed Dynactin subunit 4 (Dynactin subunit p62) Rattus norvegicus (Rat) GO:0000776; GO:0000922; GO:0001725; GO:0005813; GO:0005868; GO:0005869; GO:0005925; GO:0005938; GO:0030017 cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725] g14156.t1 Q9UJM8 49.189 370 1.11e-118 351.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g14158.t1 Q6TCH7 44.286 280 1.68e-86 265.0 sp|Q6TCH7|PAQR3_HUMAN Progestin and adipoQ receptor family member 3 OS=Homo sapiens OX=9606 GN=PAQR3 PE=1 SV=2 PAQR3_HUMAN reviewed Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) Homo sapiens (Human) GO:0000139; GO:0001933; GO:0005794; GO:0010977; GO:0032436; GO:0033137; GO:0034067; GO:0035359; GO:0043407; GO:0043495; GO:0045542; GO:1990756; GO:2000640 negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of SREBP signaling pathway [GO:2000640]; protein localization to Golgi apparatus [GO:0034067] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g14159.t1 Q502C1 54.545 143 5.21e-62 191.0 sp|Q502C1|RT24_DANRE Small ribosomal subunit protein uS3m OS=Danio rerio OX=7955 GN=mrps24 PE=2 SV=1 g14160.t1 Q8C8R3 60.721 1497 0.0 1902.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t1 Q8C8R3 35.109 732 2.5200000000000002e-129 465.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t1 Q8C8R3 34.05 558 3.3e-87 325.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t2 Q8C8R3 61.212 1485 0.0 1910.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t2 Q8C8R3 35.417 720 1.5700000000000001e-130 469.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t2 Q8C8R3 34.05 558 3.37e-87 325.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t3 Q8C8R3 61.253 1484 0.0 1910.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t3 Q8C8R3 34.05 558 3.34e-87 325.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t3 Q8C8R3 35.069 288 3.49e-49 200.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t4 Q8C8R3 61.212 1485 0.0 1911.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t4 Q8C8R3 35.417 720 1.77e-130 468.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t4 Q8C8R3 34.05 558 3.5e-87 325.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t5 Q8C8R3 61.212 1485 0.0 1911.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t5 Q8C8R3 35.417 720 1.72e-130 468.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t5 Q8C8R3 34.05 558 3.49e-87 325.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t6 Q8C8R3 61.402 1469 0.0 1908.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t6 Q8C8R3 35.417 720 2.5000000000000002e-130 468.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t6 Q8C8R3 34.05 558 4.21e-87 325.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t7 Q8C8R3 61.212 1485 0.0 1911.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t7 Q8C8R3 35.417 720 1.9e-130 468.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14160.t7 Q8C8R3 34.05 558 3.87e-87 325.0 sp|Q8C8R3|ANK2_MOUSE Ankyrin-2 OS=Mus musculus OX=10090 GN=Ank2 PE=1 SV=2 ANK2_MOUSE reviewed Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) Mus musculus (Mouse) GO:0002027; GO:0003283; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0016323; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051279; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0060307; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:0099103; GO:0099104; GO:0140031; GO:1903288 atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; paranodal junction [GO:0033010]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] ATPase binding [GO:0051117]; channel activator activity [GO:0099103]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14161.t1 D3UW23 43.355 918 0.0 766.0 sp|D3UW23|AMPE_BITRH Glutamyl aminopeptidase OS=Bitis rhinoceros OX=715877 PE=1 SV=1 AMPE_BITRH reviewed Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A) Bitis rhinoceros (West African gaboon viper) (Vipera rhinoceros) GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006 peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g14163.t1 Q9U637 59.144 257 2.61e-80 250.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g14165.t1 Q9U637 56.677 337 5.58e-99 297.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g14165.t2 Q9U637 65.737 251 2.98e-93 286.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g14166.t1 Q9U637 58.333 156 1.67e-36 130.0 sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1 g14167.t1 Q99697 44.444 117 1.6200000000000002e-21 94.0 sp|Q99697|PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens OX=9606 GN=PITX2 PE=1 SV=2 PITX2_HUMAN reviewed Pituitary homeobox 2 (ALL1-responsive protein ARP1) (Homeobox protein PITX2) (Paired-like homeodomain transcription factor 2) (RIEG bicoid-related homeobox transcription factor) (Solurshin) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001569; GO:0001570; GO:0001701; GO:0001764; GO:0002074; GO:0003151; GO:0003171; GO:0003253; GO:0003350; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007368; GO:0008284; GO:0009653; GO:0016055; GO:0021763; GO:0021855; GO:0030334; GO:0031076; GO:0031490; GO:0035116; GO:0035315; GO:0035886; GO:0035993; GO:0042476; GO:0042802; GO:0042803; GO:0043010; GO:0043021; GO:0045944; GO:0048536; GO:0048557; GO:0051219; GO:0055009; GO:0055015; GO:0060126; GO:0060127; GO:0060412; GO:0060460; GO:0060577; GO:0060578; GO:0060971; GO:0061031; GO:0061072; GO:0061325; GO:0061629; GO:0070986; GO:0140297; GO:1990837 anatomical structure morphogenesis [GO:0009653]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; atrioventricular valve development [GO:0003171]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye development [GO:0043010]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in outflow tract morphogenesis [GO:0061325]; deltoid tuberosity development [GO:0035993]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic hindlimb morphogenesis [GO:0035116]; endodermal digestive tract morphogenesis [GO:0061031]; extraocular skeletal muscle development [GO:0002074]; hair cell differentiation [GO:0035315]; hypothalamus cell migration [GO:0021855]; in utero embryonic development [GO:0001701]; iris morphogenesis [GO:0061072]; left lung morphogenesis [GO:0060460]; left/right axis specification [GO:0070986]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prolactin secreting cell differentiation [GO:0060127]; pulmonary myocardium development [GO:0003350]; pulmonary vein morphogenesis [GO:0060577]; regulation of cell migration [GO:0030334]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatotropin secreting cell differentiation [GO:0060126]; spleen development [GO:0048536]; subthalamic nucleus development [GO:0021763]; superior vena cava morphogenesis [GO:0060578]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell development [GO:0055015]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g16286.t1 Q7ZYD5 59.041 459 0.0 580.0 sp|Q7ZYD5|SCMC2_XENLA Calcium-binding mitochondrial carrier protein SCaMC-2 OS=Xenopus laevis OX=8355 GN=slc25a25 PE=2 SV=1 SCMC2_XENLA reviewed Mitochondrial adenyl nucleotide antiporter SLC25A25 (Calcium-binding mitochondrial carrier protein SCaMC-2) (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25) Xenopus laevis (African clawed frog) GO:0005347; GO:0005509; GO:0005743; GO:0015866; GO:0015867 ADP transport [GO:0015866]; ATP transport [GO:0015867] mitochondrial inner membrane [GO:0005743] ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] g16286.t2 Q7ZYD5 56.133 481 0.0 564.0 sp|Q7ZYD5|SCMC2_XENLA Calcium-binding mitochondrial carrier protein SCaMC-2 OS=Xenopus laevis OX=8355 GN=slc25a25 PE=2 SV=1 SCMC2_XENLA reviewed Mitochondrial adenyl nucleotide antiporter SLC25A25 (Calcium-binding mitochondrial carrier protein SCaMC-2) (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25) Xenopus laevis (African clawed frog) GO:0005347; GO:0005509; GO:0005743; GO:0015866; GO:0015867 ADP transport [GO:0015866]; ATP transport [GO:0015867] mitochondrial inner membrane [GO:0005743] ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] g16287.t1 Q08DF4 69.49 862 0.0 1231.0 sp|Q08DF4|DYN1_BOVIN Dynamin-1 OS=Bos taurus OX=9913 GN=DNM1 PE=1 SV=1 DYN1_BOVIN reviewed Dynamin-1 (EC 3.6.5.5) (Dynamin) Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0005905; GO:0008017; GO:0016185; GO:0042584; GO:0045202; GO:0045920; GO:0098793 negative regulation of exocytosis [GO:0045920]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185] chromaffin granule membrane [GO:0042584]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017] g16287.t2 Q08DF4 69.965 859 0.0 1239.0 sp|Q08DF4|DYN1_BOVIN Dynamin-1 OS=Bos taurus OX=9913 GN=DNM1 PE=1 SV=1 DYN1_BOVIN reviewed Dynamin-1 (EC 3.6.5.5) (Dynamin) Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0005905; GO:0008017; GO:0016185; GO:0042584; GO:0045202; GO:0045920; GO:0098793 negative regulation of exocytosis [GO:0045920]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185] chromaffin granule membrane [GO:0042584]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017] g16287.t3 Q08DF4 69.026 862 0.0 1232.0 sp|Q08DF4|DYN1_BOVIN Dynamin-1 OS=Bos taurus OX=9913 GN=DNM1 PE=1 SV=1 DYN1_BOVIN reviewed Dynamin-1 (EC 3.6.5.5) (Dynamin) Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0005905; GO:0008017; GO:0016185; GO:0042584; GO:0045202; GO:0045920; GO:0098793 negative regulation of exocytosis [GO:0045920]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185] chromaffin granule membrane [GO:0042584]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017] g16290.t1 Q8BP86 33.92 398 1.3200000000000001e-73 276.0 sp|Q8BP86|SNPC4_MOUSE snRNA-activating protein complex subunit 4 OS=Mus musculus OX=10090 GN=Snapc4 PE=1 SV=2 g16290.t2 Q8BP86 33.92 398 1.3100000000000001e-73 276.0 sp|Q8BP86|SNPC4_MOUSE snRNA-activating protein complex subunit 4 OS=Mus musculus OX=10090 GN=Snapc4 PE=1 SV=2 g16291.t1 A7MBH5 28.938 546 9.37e-48 179.0 sp|A7MBH5|ODAD3_BOVIN Outer dynein arm-docking complex subunit 3 OS=Bos taurus OX=9913 GN=ODAD3 PE=1 SV=1 ODAD3_BOVIN reviewed Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151) Bos taurus (Bovine) GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0035253; GO:0036064; GO:0036158; GO:0097542; GO:0120228; GO:1902017 cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; outer dynein arm docking complex [GO:0120228] g16293.t1 Q8R4K8 36.902 1569 0.0 1006.0 sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2 PAPP1_MOUSE reviewed Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0008237; GO:0030163; GO:0046872; GO:0071548 cell surface receptor signaling pathway [GO:0007166]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548] extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g16293.t2 Q8R4K8 36.879 1570 0.0 1007.0 sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2 PAPP1_MOUSE reviewed Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0008237; GO:0030163; GO:0046872; GO:0071548 cell surface receptor signaling pathway [GO:0007166]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548] extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g16295.t1 Q9H7Z7 52.613 287 3.18e-103 312.0 sp|Q9H7Z7|PGES2_HUMAN Prostaglandin E synthase 2 OS=Homo sapiens OX=9606 GN=PTGES2 PE=1 SV=1 PGES2_HUMAN reviewed Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) (Prostaglandin-H(2) E-isomerase) [Cleaved into: Prostaglandin E synthase 2 truncated form] Homo sapiens (Human) GO:0000139; GO:0003677; GO:0005576; GO:0005634; GO:0005739; GO:0005829; GO:0006629; GO:0016829; GO:0019371; GO:0020037; GO:0035578; GO:0036134; GO:0043295; GO:0045893; GO:0046457; GO:0046903; GO:0048471; GO:0050220 cyclooxygenase pathway [GO:0019371]; lipid metabolic process [GO:0006629]; positive regulation of DNA-templated transcription [GO:0045893]; prostanoid biosynthetic process [GO:0046457]; secretion [GO:0046903] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220] g16296.t1 Q9ESR9 50.339 2211 0.0 2151.0 sp|Q9ESR9|ABCA2_RAT ATP-binding cassette sub-family A member 2 OS=Rattus norvegicus OX=10116 GN=Abca2 PE=1 SV=1 ABCA2_RAT reviewed ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2) Rattus norvegicus (Rat) GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0010008; GO:0016020; GO:0016887; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905601; GO:2000008 central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085] cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319] g16296.t1 Q9ESR9 41.294 201 1.14e-37 160.0 sp|Q9ESR9|ABCA2_RAT ATP-binding cassette sub-family A member 2 OS=Rattus norvegicus OX=10116 GN=Abca2 PE=1 SV=1 ABCA2_RAT reviewed ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2) Rattus norvegicus (Rat) GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0010008; GO:0016020; GO:0016887; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905601; GO:2000008 central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085] cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319] g16297.t1 D3ZWZ9 45.12 543 3.51e-158 466.0 sp|D3ZWZ9|GP107_RAT Protein GPR107 OS=Rattus norvegicus OX=10116 GN=Gpr107 PE=1 SV=1 GP107_RAT reviewed Protein GPR107 Rattus norvegicus (Rat) GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0030136; GO:0032050; GO:0072583 clathrin-dependent endocytosis [GO:0072583] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] clathrin heavy chain binding [GO:0032050] g16297.t2 Q5VW38 43.952 587 2.93e-155 462.0 sp|Q5VW38|GP107_HUMAN Protein GPR107 OS=Homo sapiens OX=9606 GN=GPR107 PE=1 SV=1 GP107_HUMAN reviewed Protein GPR107 (Lung seven transmembrane receptor 1) Homo sapiens (Human) GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0030136; GO:0032050; GO:0072583 clathrin-dependent endocytosis [GO:0072583] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] clathrin heavy chain binding [GO:0032050] g16298.t1 Q9VJJ7 37.856 457 2.8e-86 303.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g16298.t1 Q9VJJ7 40.823 316 2.03e-64 239.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g16300.t1 Q9NRR4 58.573 729 0.0 867.0 sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2 g16300.t2 Q9NRR4 58.573 729 0.0 866.0 sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2 g16300.t3 Q9NRR4 56.258 759 0.0 851.0 sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2 g16304.t1 Q3T197 65.0 220 7.27e-86 256.0 sp|Q3T197|STEEP_BOVIN STING ER exit protein OS=Bos taurus OX=9913 GN=STEEP1 PE=2 SV=1 g16305.t1 Q13905 36.497 1159 3.93e-179 554.0 sp|Q13905|RPGF1_HUMAN Rap guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=RAPGEF1 PE=1 SV=3 g16307.t1 Q5R4W3 72.381 105 8.77e-55 174.0 sp|Q5R4W3|DPOE3_PONAB DNA polymerase epsilon subunit 3 OS=Pongo abelii OX=9601 GN=POLE3 PE=2 SV=1 g16308.t1 P68370 98.004 451 0.0 934.0 sp|P68370|TBA1A_RAT Tubulin alpha-1A chain OS=Rattus norvegicus OX=10116 GN=Tuba1a PE=1 SV=1 TBA1A_RAT reviewed Tubulin alpha-1A chain (EC 3.6.5.-) (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain] Rattus norvegicus (Rat) GO:0000226; GO:0000278; GO:0000793; GO:0001764; GO:0001964; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0005879; GO:0005881; GO:0005886; GO:0005929; GO:0006886; GO:0007017; GO:0007098; GO:0007224; GO:0007613; GO:0007626; GO:0008344; GO:0008542; GO:0009612; GO:0010001; GO:0010467; GO:0015630; GO:0016787; GO:0019904; GO:0021542; GO:0021696; GO:0021766; GO:0021859; GO:0021987; GO:0022008; GO:0030182; GO:0030317; GO:0030534; GO:0031594; GO:0034612; GO:0035641; GO:0036126; GO:0036464; GO:0042802; GO:0043209; GO:0044877; GO:0045121; GO:0045202; GO:0046785; GO:0046872; GO:0046982; GO:0048853; GO:0048873; GO:0050807; GO:0050808; GO:0051402; GO:0055037; GO:0061744; GO:0071277; GO:0072384; GO:0140058; GO:1902065 adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; cellular response to calcium ion [GO:0071277]; centrosome cycle [GO:0007098]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; dentate gyrus development [GO:0021542]; flagellated sperm motility [GO:0030317]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; locomotory exploration behavior [GO:0035641]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection arborization [GO:0140058]; organelle transport along microtubule [GO:0072384]; pyramidal neuron differentiation [GO:0021859]; regulation of synapse organization [GO:0050807]; response to L-glutamate [GO:1902065]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; smoothened signaling pathway [GO:0007224]; startle response [GO:0001964]; synapse organization [GO:0050808]; visual learning [GO:0008542] axonemal microtubule [GO:0005879]; cilium [GO:0005929]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; sperm flagellum [GO:0036126]; synapse [GO:0045202] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200] g16309.t1 F6RRD7 29.112 608 1.8899999999999997e-48 181.0 sp|F6RRD7|RPAP2_BOVIN Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Bos taurus OX=9913 GN=RPAP2 PE=2 SV=1 RPAP2_BOVIN reviewed Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 (EC 3.1.3.16) (RNA polymerase II-associated protein 2) Bos taurus (Bovine) GO:0004722; GO:0005634; GO:0005737; GO:0008270; GO:0008420; GO:0009301; GO:0036499; GO:0043175; GO:0097550 PERK-mediated unfolded protein response [GO:0036499]; snRNA transcription [GO:0009301] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription preinitiation complex [GO:0097550] protein serine/threonine phosphatase activity [GO:0004722]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; zinc ion binding [GO:0008270] g16311.t1 Q07120 85.03 167 1.4099999999999999e-101 311.0 sp|Q07120|GFI1_RAT Zinc finger protein Gfi-1 OS=Rattus norvegicus OX=10116 GN=Gfi1 PE=1 SV=1 GFI1_RAT reviewed Zinc finger protein Gfi-1 (Growth factor independent protein 1) Rattus norvegicus (Rat) GO:0000122; GO:0000724; GO:0000976; GO:0000978; GO:0001217; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0006974; GO:0007638; GO:0008270; GO:0009996; GO:0010957; GO:0010977; GO:0016363; GO:0016604; GO:0017053; GO:0034121; GO:0042472; GO:0042491; GO:0042660; GO:0045165; GO:0045892; GO:0070105; GO:0071222; GO:0140767; GO:1990837; GO:2000042 cell fate commitment [GO:0045165]; cellular response to lipopolysaccharide [GO:0071222]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; mechanosensory behavior [GO:0007638]; negative regulation of cell fate specification [GO:0009996]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of cell fate specification [GO:0042660]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme-substrate adaptor activity [GO:0140767]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g16312.t1 B3EWZ3 46.778 419 7.96e-102 362.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16312.t1 B3EWZ3 46.961 181 1.13e-36 155.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16315.t1 P21783 39.599 1346 0.0 896.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g16315.t1 P21783 40.074 1088 0.0 711.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g16315.t1 P21783 36.087 1283 0.0 701.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g16315.t1 P21783 38.618 1085 0.0 662.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g16315.t1 P21783 36.6 847 2.21e-129 457.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g16315.t1 P21783 36.881 404 1.49e-50 202.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g16315.t1 P21783 32.982 285 1.9700000000000002e-31 139.0 sp|P21783|NOTC1_XENLA Neurogenic locus notch homolog protein 1 OS=Xenopus laevis OX=8355 GN=notch1 PE=1 SV=3 g16315.t2 P07207 38.505 1244 0.0 823.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16315.t2 P07207 37.291 1255 0.0 740.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16315.t2 P07207 35.935 1294 0.0 664.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16315.t2 P07207 35.176 597 4.95e-83 308.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16315.t2 P07207 37.295 488 7.07e-65 249.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g16317.t1 P10079 39.274 634 6.1900000000000006e-117 385.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16317.t1 P10079 39.494 633 1.0400000000000001e-109 366.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16317.t1 P10079 36.676 698 4.310000000000001e-109 364.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16317.t1 P10079 38.077 520 4.79e-82 290.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16319.t1 P18130 30.53 321 2.22e-27 115.0 sp|P18130|ADA1A_BOVIN Alpha-1A adrenergic receptor OS=Bos taurus OX=9913 GN=ADRA1A PE=2 SV=1 ADA1A_BOVIN reviewed Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) Bos taurus (Bovine) GO:0001994; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007267; GO:0010613; GO:0019229; GO:0031965; GO:0043410; GO:0046982; GO:0055117; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229] caveola [GO:0005901]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982] g16320.t1 Q75WF2 57.073 205 5.720000000000001e-79 245.0 sp|Q75WF2|DNA2_ACAPL Plancitoxin-1 OS=Acanthaster planci OX=133434 PE=1 SV=1 g16321.t1 P59083 48.8 125 3.3e-35 122.0 sp|P59083|PHP14_PIG 14 kDa phosphohistidine phosphatase OS=Sus scrofa OX=9823 GN=PHPT1 PE=1 SV=2 g16322.t1 Q5BIM1 35.429 350 1.81e-74 244.0 sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1 g16323.t1 Q5BIM1 57.0 100 6.5e-35 133.0 sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1 g16324.t1 Q9H9B1 41.696 566 1.0300000000000001e-133 442.0 sp|Q9H9B1|EHMT1_HUMAN Histone-lysine N-methyltransferase EHMT1 OS=Homo sapiens OX=9606 GN=EHMT1 PE=1 SV=4 g16324.t2 Q9H9B1 41.696 566 8.19e-134 442.0 sp|Q9H9B1|EHMT1_HUMAN Histone-lysine N-methyltransferase EHMT1 OS=Homo sapiens OX=9606 GN=EHMT1 PE=1 SV=4 g16325.t1 Q9Z148 72.775 191 3.65e-94 317.0 sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2 EHMT2_MOUSE reviewed Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007281; GO:0007286; GO:0007616; GO:0008270; GO:0009267; GO:0009566; GO:0010467; GO:0016279; GO:0016607; GO:0018027; GO:0031399; GO:0035265; GO:0036166; GO:0040029; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140948; GO:1902902; GO:1990841 behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; gene expression [GO:0010467]; germ cell development [GO:0007281]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of protein modification process [GO:0031399]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g16326.t1 Q01815 44.332 1676 0.0 1310.0 sp|Q01815|CAC1C_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1C OS=Mus musculus OX=10090 GN=Cacna1c PE=1 SV=1 CAC1C_MOUSE reviewed Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2) Mus musculus (Mouse) GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005654; GO:0005737; GO:0005886; GO:0005891; GO:0005929; GO:0006816; GO:0006874; GO:0006887; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0009986; GO:0010881; GO:0014069; GO:0016020; GO:0017156; GO:0019229; GO:0019899; GO:0019904; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0030424; GO:0030425; GO:0031369; GO:0032024; GO:0032991; GO:0035115; GO:0042383; GO:0042593; GO:0042734; GO:0043010; GO:0043025; GO:0043198; GO:0043204; GO:0044325; GO:0045211; GO:0045762; GO:0045933; GO:0046620; GO:0046872; GO:0051393; GO:0051721; GO:0060083; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086065; GO:0086091; GO:0098703; GO:0098839; GO:0098911; GO:0098912; GO:0098978; GO:1904181; GO:1904879; GO:1990454 adult walking behavior [GO:0007628]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-ion regulated exocytosis [GO:0017156]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication involved in cardiac conduction [GO:0086065]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane depolarization [GO:1904181]; positive regulation of muscle contraction [GO:0045933]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542] axon [GO:0030424]; caveolar macromolecular signaling complex [GO:0002095]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] g16326.t2 Q02485 43.971 1667 0.0 1307.0 sp|Q02485|CAC1S_RAT Voltage-dependent L-type calcium channel subunit alpha-1S OS=Rattus norvegicus OX=10116 GN=Cacna1s PE=1 SV=2 CAC1S_RAT reviewed Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (ROB1) (Voltage-gated calcium channel subunit alpha Cav1.1) Rattus norvegicus (Rat) GO:0001501; GO:0001503; GO:0002074; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006936; GO:0006941; GO:0007029; GO:0007519; GO:0007520; GO:0007528; GO:0008331; GO:0016529; GO:0030315; GO:0031674; GO:0036094; GO:0042383; GO:0043501; GO:0044327; GO:0046872; GO:0048741; GO:0051209; GO:0055001; GO:0061771; GO:0071313; GO:0098703; GO:0140677; GO:1990454 calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extraocular skeletal muscle development [GO:0002074]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; ossification [GO:0001503]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caloric restriction [GO:0061771]; skeletal muscle adaptation [GO:0043501]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]; skeletal system development [GO:0001501]; striated muscle contraction [GO:0006941] cytoplasm [GO:0005737]; dendritic spine head [GO:0044327]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891] calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; small molecule binding [GO:0036094]; voltage-gated calcium channel activity [GO:0005245] g16326.t3 Q01815 44.033 1676 0.0 1304.0 sp|Q01815|CAC1C_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1C OS=Mus musculus OX=10090 GN=Cacna1c PE=1 SV=1 CAC1C_MOUSE reviewed Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2) Mus musculus (Mouse) GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005654; GO:0005737; GO:0005886; GO:0005891; GO:0005929; GO:0006816; GO:0006874; GO:0006887; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0009986; GO:0010881; GO:0014069; GO:0016020; GO:0017156; GO:0019229; GO:0019899; GO:0019904; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0030424; GO:0030425; GO:0031369; GO:0032024; GO:0032991; GO:0035115; GO:0042383; GO:0042593; GO:0042734; GO:0043010; GO:0043025; GO:0043198; GO:0043204; GO:0044325; GO:0045211; GO:0045762; GO:0045933; GO:0046620; GO:0046872; GO:0051393; GO:0051721; GO:0060083; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086065; GO:0086091; GO:0098703; GO:0098839; GO:0098911; GO:0098912; GO:0098978; GO:1904181; GO:1904879; GO:1990454 adult walking behavior [GO:0007628]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-ion regulated exocytosis [GO:0017156]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication involved in cardiac conduction [GO:0086065]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane depolarization [GO:1904181]; positive regulation of muscle contraction [GO:0045933]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542] axon [GO:0030424]; caveolar macromolecular signaling complex [GO:0002095]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] g16326.t4 Q01815 44.033 1676 0.0 1303.0 sp|Q01815|CAC1C_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1C OS=Mus musculus OX=10090 GN=Cacna1c PE=1 SV=1 CAC1C_MOUSE reviewed Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2) Mus musculus (Mouse) GO:0002095; GO:0002520; GO:0005245; GO:0005516; GO:0005654; GO:0005737; GO:0005886; GO:0005891; GO:0005929; GO:0006816; GO:0006874; GO:0006887; GO:0006939; GO:0007204; GO:0007268; GO:0007507; GO:0007628; GO:0008217; GO:0008331; GO:0008542; GO:0009986; GO:0010881; GO:0014069; GO:0016020; GO:0017156; GO:0019229; GO:0019899; GO:0019904; GO:0030018; GO:0030073; GO:0030252; GO:0030315; GO:0030424; GO:0030425; GO:0031369; GO:0032024; GO:0032991; GO:0035115; GO:0042383; GO:0042593; GO:0042734; GO:0043010; GO:0043025; GO:0043198; GO:0043204; GO:0044325; GO:0045211; GO:0045762; GO:0045933; GO:0046620; GO:0046872; GO:0051393; GO:0051721; GO:0060083; GO:0060402; GO:0061337; GO:0061577; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086065; GO:0086091; GO:0098703; GO:0098839; GO:0098911; GO:0098912; GO:0098978; GO:1904181; GO:1904879; GO:1990454 adult walking behavior [GO:0007628]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-ion regulated exocytosis [GO:0017156]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication involved in cardiac conduction [GO:0086065]; chemical synaptic transmission [GO:0007268]; embryonic forelimb morphogenesis [GO:0035115]; exocytosis [GO:0006887]; glucose homeostasis [GO:0042593]; growth hormone secretion [GO:0030252]; heart development [GO:0007507]; immune system development [GO:0002520]; insulin secretion [GO:0030073]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane depolarization [GO:1904181]; positive regulation of muscle contraction [GO:0045933]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of organ growth [GO:0046620]; regulation of vasoconstriction [GO:0019229]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; smooth muscle contraction [GO:0006939]; smooth muscle contraction involved in micturition [GO:0060083]; visual learning [GO:0008542] axon [GO:0030424]; caveolar macromolecular signaling complex [GO:0002095]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein phosphatase 2A binding [GO:0051721]; translation initiation factor binding [GO:0031369]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] g16326.t5 Q02485 44.37 1643 0.0 1306.0 sp|Q02485|CAC1S_RAT Voltage-dependent L-type calcium channel subunit alpha-1S OS=Rattus norvegicus OX=10116 GN=Cacna1s PE=1 SV=2 CAC1S_RAT reviewed Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (ROB1) (Voltage-gated calcium channel subunit alpha Cav1.1) Rattus norvegicus (Rat) GO:0001501; GO:0001503; GO:0002074; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006936; GO:0006941; GO:0007029; GO:0007519; GO:0007520; GO:0007528; GO:0008331; GO:0016529; GO:0030315; GO:0031674; GO:0036094; GO:0042383; GO:0043501; GO:0044327; GO:0046872; GO:0048741; GO:0051209; GO:0055001; GO:0061771; GO:0071313; GO:0098703; GO:0140677; GO:1990454 calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extraocular skeletal muscle development [GO:0002074]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; ossification [GO:0001503]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caloric restriction [GO:0061771]; skeletal muscle adaptation [GO:0043501]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]; skeletal system development [GO:0001501]; striated muscle contraction [GO:0006941] cytoplasm [GO:0005737]; dendritic spine head [GO:0044327]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891] calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; small molecule binding [GO:0036094]; voltage-gated calcium channel activity [GO:0005245] g16326.t6 C9D7C2 57.238 1644 0.0 1778.0 sp|C9D7C2|CAC1A_APIME Voltage-dependent calcium channel type A subunit alpha-1 OS=Apis mellifera OX=7460 GN=CAC PE=2 SV=1 g16326.t7 O35505 44.162 1653 0.0 1288.0 sp|O35505|CAC1C_CAVPO Voltage-dependent L-type calcium channel subunit alpha-1C OS=Cavia porcellus OX=10141 GN=CACNA1C PE=1 SV=2 CAC1C_CAVPO reviewed Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) Cavia porcellus (Guinea pig) GO:0005245; GO:0005516; GO:0005886; GO:0008331; GO:0010881; GO:0030315; GO:0030425; GO:0042383; GO:0043204; GO:0045762; GO:0046872; GO:0060402; GO:0061337; GO:0061577; GO:0070588; GO:0098703; GO:0098839; GO:1990454 calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport into cytosol [GO:0060402]; cardiac conduction [GO:0061337]; positive regulation of adenylate cyclase activity [GO:0045762]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881] dendrite [GO:0030425]; L-type voltage-gated calcium channel complex [GO:1990454]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; T-tubule [GO:0030315] calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g16326.t8 Q13936 44.088 1683 0.0 1295.0 sp|Q13936|CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens OX=9606 GN=CACNA1C PE=1 SV=4 g16328.t1 D3YXG0 34.478 4339 0.0 2392.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g16328.t1 D3YXG0 34.597 3668 0.0 1928.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g16328.t2 D3YXG0 34.432 4339 0.0 2395.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g16328.t2 D3YXG0 34.99 3641 0.0 1950.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g16328.t3 D3YXG0 33.794 4338 0.0 2278.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g16328.t3 D3YXG0 34.99 3641 0.0 1946.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g16328.t3 D3YXG0 27.476 626 2.47e-60 237.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g16331.t1 Q3UHC7 49.748 595 0.0 619.0 sp|Q3UHC7|DAB2P_MOUSE Disabled homolog 2-interacting protein OS=Mus musculus OX=10090 GN=Dab2ip PE=1 SV=1 DAB2P_MOUSE reviewed Disabled homolog 2-interacting protein (DAB2-interacting protein) (ASK-interacting protein 1) (DOC-2/DAB-2 interactive protein) Mus musculus (Mouse) GO:0000122; GO:0001525; GO:0005096; GO:0005123; GO:0005737; GO:0005886; GO:0006954; GO:0006986; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0016020; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032266; GO:0032809; GO:0033209; GO:0034144; GO:0034260; GO:0035148; GO:0035556; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0042059; GO:0042177; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043123; GO:0043124; GO:0043184; GO:0043254; GO:0043409; GO:0043410; GO:0043539; GO:0043548; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050679; GO:0050680; GO:0051721; GO:0051726; GO:0051898; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0090090; GO:0090129; GO:0140042; GO:1900006; GO:1900744; GO:1900747; GO:1901223; GO:1901800; GO:1902531; GO:1990032; GO:1990597; GO:2001224; GO:2001235 angiogenesis [GO:0001525]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; lipid droplet formation [GO:0140042]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cell cycle [GO:0051726]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324] AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886] 14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g16331.t1 Q3UHC7 43.787 169 1.28e-25 119.0 sp|Q3UHC7|DAB2P_MOUSE Disabled homolog 2-interacting protein OS=Mus musculus OX=10090 GN=Dab2ip PE=1 SV=1 DAB2P_MOUSE reviewed Disabled homolog 2-interacting protein (DAB2-interacting protein) (ASK-interacting protein 1) (DOC-2/DAB-2 interactive protein) Mus musculus (Mouse) GO:0000122; GO:0001525; GO:0005096; GO:0005123; GO:0005737; GO:0005886; GO:0006954; GO:0006986; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0016020; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032266; GO:0032809; GO:0033209; GO:0034144; GO:0034260; GO:0035148; GO:0035556; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0042059; GO:0042177; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043123; GO:0043124; GO:0043184; GO:0043254; GO:0043409; GO:0043410; GO:0043539; GO:0043548; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050679; GO:0050680; GO:0051721; GO:0051726; GO:0051898; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0090090; GO:0090129; GO:0140042; GO:1900006; GO:1900744; GO:1900747; GO:1901223; GO:1901800; GO:1902531; GO:1990032; GO:1990597; GO:2001224; GO:2001235 angiogenesis [GO:0001525]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; lipid droplet formation [GO:0140042]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cell cycle [GO:0051726]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324] AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886] 14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184] g16333.t1 A5A8Y8 34.5 200 6.87e-26 108.0 sp|A5A8Y8|EGFL8_PIG Epidermal growth factor-like protein 8 OS=Sus scrofa OX=9823 GN=EGFL8 PE=3 SV=1 g16335.t1 Q9CXT6 46.651 433 8.89e-133 391.0 sp|Q9CXT6|KDM8_MOUSE Bifunctional peptidase and arginyl-hydroxylase JMJD5 OS=Mus musculus OX=10090 GN=Kdm8 PE=1 SV=1 KDM8_MOUSE reviewed Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8) (Lysine-specific demethylase 8) Mus musculus (Mouse) GO:0000086; GO:0001701; GO:0002039; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006508; GO:0031648; GO:0032922; GO:0045892; GO:0045893; GO:0046872; GO:0048144; GO:0051864; GO:0106157; GO:1901796 circadian regulation of gene expression [GO:0032922]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3K36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; peptidyl-arginine 3-dioxygenase activity [GO:0106157] g16336.t1 P37892 52.732 421 2.79e-150 439.0 sp|P37892|CBPE_LOPAM Carboxypeptidase E OS=Lophius americanus OX=8073 GN=cpe PE=2 SV=1 g16337.t1 E9Q236 50.0 1036 0.0 996.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g16338.t1 E9Q236 43.798 258 5.82e-68 231.0 sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1 MRP4_MOUSE reviewed ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4) Mus musculus (Mouse) GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006568; GO:0006855; GO:0008559; GO:0009410; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022857; GO:0031088; GO:0032310; GO:0034275; GO:0034634; GO:0042626; GO:0042908; GO:0042910; GO:0048661; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359 bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; kynurenic acid metabolic process [GO:0034275]; L-tryptophan metabolic process [GO:0006568]; leukotriene transport [GO:0071716]; positive regulation of smooth muscle cell proliferation [GO:0048661]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] g16339.t1 Q55E72 31.693 1057 1.19e-157 528.0 sp|Q55E72|PKS1_DICDI Probable polyketide synthase 1 OS=Dictyostelium discoideum OX=44689 GN=stlA PE=1 SV=1 PKS1_DICDI reviewed Probable polyketide synthase 1 (dipks1) [Includes: Polyketide synthase stlA (EC 2.3.1.-); Chalcone synthase stlA (EC 2.3.1.74) (Steely1)] Dictyostelium discoideum (Social amoeba) GO:0004312; GO:0004315; GO:0006633; GO:0007165; GO:0009813; GO:0010628; GO:0010629; GO:0016210; GO:0016491; GO:0019505; GO:0030639; GO:0031149; GO:0031152; GO:0043327; GO:0044671; GO:0048837; GO:0106070 aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; fatty acid biosynthetic process [GO:0006633]; flavonoid biosynthetic process [GO:0009813]; negative regulation of gene expression [GO:0010629]; polyketide biosynthetic process [GO:0030639]; positive regulation of gene expression [GO:0010628]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; resorcinol metabolic process [GO:0019505]; signal transduction [GO:0007165]; sorocarp sorus development [GO:0048837]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk cell differentiation [GO:0031149] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; naringenin-chalcone synthase activity [GO:0016210]; oxidoreductase activity [GO:0016491] g16340.t1 P96202 34.326 571 2.62e-88 315.0 sp|P96202|PPSC_MYCTU Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=ppsC PE=1 SV=2 PPSC_MYCTU reviewed Phenolphthiocerol/phthiocerol polyketide synthase subunit C (EC 2.3.1.292) ((Phenol)carboxyphthiodiolenone synthase subunit C) (Beta-ketoacyl-acyl-carrier-protein synthase I) (Phthiocerol synthesis polyketide synthase type I PpsC) Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) GO:0004312; GO:0004315; GO:0005737; GO:0005829; GO:0005886; GO:0006633; GO:0016491; GO:0031177; GO:0034081; GO:0071766; GO:0071770; GO:0097040; GO:0097041 Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177] g16341.t1 Q27433 78.516 256 2.81e-136 398.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g16341.t2 Q27433 77.186 263 4.98e-137 400.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g16343.t1 P10079 46.405 459 1.62e-108 357.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 40.784 510 7.29e-107 352.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 39.474 494 4.39e-91 310.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t1 P10079 37.818 550 3.87e-89 304.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t2 P10079 46.405 459 4.8e-109 357.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t2 P10079 44.372 462 4.71e-106 349.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t2 P10079 41.558 462 1.05e-100 334.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t2 P10079 44.444 387 7.42e-89 302.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t2 P10079 37.938 485 5.33e-84 289.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16343.t2 P10079 47.755 245 8.15e-55 206.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16344.t1 Q6V0I7 54.286 70 9.939999999999999e-24 96.7 sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2 FAT4_HUMAN reviewed Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) Homo sapiens (Human) GO:0005509; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0007409; GO:0021987; GO:0022008; GO:0030855; GO:0035329; GO:0044331; GO:0070062 axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; epithelial cell differentiation [GO:0030855]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509] g16346.t1 P82279 28.455 492 3.18e-55 202.0 sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2 CRUM1_HUMAN reviewed Protein crumbs homolog 1 Homo sapiens (Human) GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0062139; GO:0071482; GO:0097386 blood vessel remodeling [GO:0001974]; camera-type eye photoreceptor cell development [GO:0062139]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; intracellular protein localization [GO:0008104]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003] calcium ion binding [GO:0005509] g16346.t1 P82279 24.557 395 6.240000000000001e-21 100.0 sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2 CRUM1_HUMAN reviewed Protein crumbs homolog 1 Homo sapiens (Human) GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0062139; GO:0071482; GO:0097386 blood vessel remodeling [GO:0001974]; camera-type eye photoreceptor cell development [GO:0062139]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; intracellular protein localization [GO:0008104]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003] calcium ion binding [GO:0005509] g16347.t1 P10079 43.519 432 4.19e-85 288.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 38.745 462 4.31e-80 274.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 40.045 447 1.67e-79 272.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 35.341 498 1.22e-76 265.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 38.562 459 3.11e-73 255.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 41.995 381 2.16e-70 247.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 39.747 395 1.28e-65 233.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 31.197 468 1.0399999999999998e-42 167.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16347.t1 P10079 39.545 220 1.1800000000000001e-32 136.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16348.t1 Q8WX92 56.131 579 0.0 641.0 sp|Q8WX92|NELFB_HUMAN Negative elongation factor B OS=Homo sapiens OX=9606 GN=NELFB PE=1 SV=1 g16351.t1 Q7L4E1 40.135 446 2.14e-89 289.0 sp|Q7L4E1|MIGA2_HUMAN Mitoguardin 2 OS=Homo sapiens OX=9606 GN=MIGA2 PE=1 SV=1 MIGA2_HUMAN reviewed Mitoguardin 2 (Protein FAM73B) Homo sapiens (Human) GO:0005739; GO:0005741; GO:0005886; GO:0008053; GO:0042803; GO:0046982; GO:0060348 bone development [GO:0060348]; mitochondrial fusion [GO:0008053] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g16352.t1 Q86UD0 39.45 218 2.76e-29 122.0 sp|Q86UD0|SAPC2_HUMAN Suppressor APC domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SAPCD2 PE=1 SV=2 SAPC2_HUMAN reviewed Suppressor APC domain-containing protein 2 (Tumor specificity and mitosis phase-dependent expression protein) (TS/MDEP) (p42.3) Homo sapiens (Human) GO:0000132; GO:0005654; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777 establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725] apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g16353.t1 O15213 45.791 594 1.77e-180 525.0 sp|O15213|WDR46_HUMAN WD repeat-containing protein 46 OS=Homo sapiens OX=9606 GN=WDR46 PE=1 SV=3 WDR46_HUMAN reviewed WD repeat-containing protein 46 (WD repeat-containing protein BING4) Homo sapiens (Human) GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0032040; GO:0042274 maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g16354.t1 Q9Z0H0 42.351 536 1.08e-122 375.0 sp|Q9Z0H0|CDC7_MOUSE Cell division cycle 7-related protein kinase OS=Mus musculus OX=10090 GN=Cdc7 PE=1 SV=2 g16355.t1 O88393 25.871 402 1.3700000000000002e-21 104.0 sp|O88393|TGBR3_MOUSE Transforming growth factor beta receptor type 3 OS=Mus musculus OX=10090 GN=Tgfbr3 PE=1 SV=1 TGBR3_MOUSE reviewed Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III) Mus musculus (Mouse) GO:0001568; GO:0001570; GO:0001649; GO:0001701; GO:0001824; GO:0001837; GO:0001889; GO:0001974; GO:0003150; GO:0003151; GO:0003223; GO:0003347; GO:0004888; GO:0005024; GO:0005114; GO:0005160; GO:0005539; GO:0005615; GO:0005737; GO:0005783; GO:0005886; GO:0006955; GO:0007179; GO:0007181; GO:0008201; GO:0008284; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010633; GO:0010719; GO:0015026; GO:0016020; GO:0016477; GO:0017015; GO:0017134; GO:0030165; GO:0030336; GO:0030509; GO:0030511; GO:0030512; GO:0030513; GO:0032354; GO:0032963; GO:0034673; GO:0034695; GO:0034699; GO:0035556; GO:0036122; GO:0043124; GO:0043235; GO:0046332; GO:0048185; GO:0050431; GO:0050680; GO:0055010; GO:0060021; GO:0060038; GO:0060045; GO:0060216; GO:0060317; GO:0060318; GO:0060347; GO:0060391; GO:0060392; GO:0060412; GO:0060939; GO:0060976; GO:0060977; GO:0060979; GO:0061032; GO:0061384; GO:0062009; GO:0065003; GO:0070123; GO:0090050; GO:0097746; GO:1901202; GO:1902338 blastocyst development [GO:0001824]; blood vessel development [GO:0001568]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; collagen metabolic process [GO:0032963]; coronary vasculature development [GO:0060976]; coronary vasculature morphogenesis [GO:0060977]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardial cell to mesenchymal cell transition [GO:0003347]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of apoptotic process involved in morphogenesis [GO:1902338]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extracellular matrix assembly [GO:1901202]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein-containing complex assembly [GO:0065003]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; roof of mouth development [GO:0060021]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; visceral serous pericardium development [GO:0061032] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] activin binding [GO:0048185]; BMP binding [GO:0036122]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; transmembrane signaling receptor activity [GO:0004888]; type II transforming growth factor beta receptor binding [GO:0005114] g16359.t1 Q5R8Z8 90.233 215 5.84e-147 410.0 sp|Q5R8Z8|RAB14_PONAB Ras-related protein Rab-14 OS=Pongo abelii OX=9601 GN=RAB14 PE=2 SV=3 RAB14_PONAB reviewed Ras-related protein Rab-14 (EC 3.6.5.2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005802; GO:0005829; GO:0006895; GO:0008543; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0046872; GO:0055037; GO:0090382 defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g16360.t1 Q92574 34.492 374 3.38e-51 191.0 sp|Q92574|TSC1_HUMAN Hamartin OS=Homo sapiens OX=9606 GN=TSC1 PE=1 SV=2 TSC1_HUMAN reviewed Hamartin (Tuberous sclerosis 1 protein) Homo sapiens (Human) GO:0001822; GO:0001843; GO:0001952; GO:0002250; GO:0005634; GO:0005737; GO:0005765; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006813; GO:0007160; GO:0008283; GO:0008285; GO:0008306; GO:0008344; GO:0009267; GO:0014069; GO:0016020; GO:0016242; GO:0021766; GO:0021987; GO:0030027; GO:0030030; GO:0030544; GO:0032007; GO:0032780; GO:0032868; GO:0032991; GO:0033596; GO:0035869; GO:0036064; GO:0036294; GO:0042030; GO:0042552; GO:0043379; GO:0044183; GO:0045792; GO:0046323; GO:0048471; GO:0050808; GO:0050821; GO:0051087; GO:0051492; GO:0051726; GO:0051879; GO:0051894; GO:0055007; GO:0090630; GO:0101031; GO:1904262 activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; cardiac muscle cell differentiation [GO:0055007]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to starvation [GO:0009267]; cerebral cortex development [GO:0021987]; D-glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of stress fiber assembly [GO:0051492]; response to insulin [GO:0032868]; synapse organization [GO:0050808] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596] ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087] g16361.t1 Q92574 31.51 384 5.25e-35 142.0 sp|Q92574|TSC1_HUMAN Hamartin OS=Homo sapiens OX=9606 GN=TSC1 PE=1 SV=2 TSC1_HUMAN reviewed Hamartin (Tuberous sclerosis 1 protein) Homo sapiens (Human) GO:0001822; GO:0001843; GO:0001952; GO:0002250; GO:0005634; GO:0005737; GO:0005765; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006813; GO:0007160; GO:0008283; GO:0008285; GO:0008306; GO:0008344; GO:0009267; GO:0014069; GO:0016020; GO:0016242; GO:0021766; GO:0021987; GO:0030027; GO:0030030; GO:0030544; GO:0032007; GO:0032780; GO:0032868; GO:0032991; GO:0033596; GO:0035869; GO:0036064; GO:0036294; GO:0042030; GO:0042552; GO:0043379; GO:0044183; GO:0045792; GO:0046323; GO:0048471; GO:0050808; GO:0050821; GO:0051087; GO:0051492; GO:0051726; GO:0051879; GO:0051894; GO:0055007; GO:0090630; GO:0101031; GO:1904262 activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; cardiac muscle cell differentiation [GO:0055007]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to starvation [GO:0009267]; cerebral cortex development [GO:0021987]; D-glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of stress fiber assembly [GO:0051492]; response to insulin [GO:0032868]; synapse organization [GO:0050808] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596] ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087] g16363.t1 Q9PUB8 46.632 193 1.94e-38 140.0 sp|Q9PUB8|S39A7_DANRE Zinc transporter Slc39a7 OS=Danio rerio OX=7955 GN=slc39a7 PE=2 SV=2 S39A7_DANRE reviewed Zinc transporter Slc39a7 (Histidine-rich membrane protein Ke4) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005385; GO:0005789; GO:0005794; GO:0006829; GO:0006882; GO:0030183; GO:0071577; GO:0098773; GO:0110075 B cell differentiation [GO:0030183]; intracellular zinc ion homeostasis [GO:0006882]; regulation of ferroptosis [GO:0110075]; skin epidermis development [GO:0098773]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] zinc ion transmembrane transporter activity [GO:0005385] g16365.t1 Q5ZLM0 63.853 545 0.0 672.0 sp|Q5ZLM0|CDC73_CHICK Parafibromin OS=Gallus gallus OX=9031 GN=CDC73 PE=2 SV=1 g16366.t1 P10155 52.142 537 0.0 581.0 sp|P10155|RO60_HUMAN RNA-binding protein RO60 OS=Homo sapiens OX=9606 GN=RO60 PE=1 SV=2 RO60_HUMAN reviewed RNA-binding protein RO60 (60 kDa SS-A/Ro ribonucleoprotein) (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (Ro 60 kDa autoantigen) (Ro60 autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2) Homo sapiens (Human) GO:0002520; GO:0003723; GO:0005654; GO:0005829; GO:0005929; GO:0006383; GO:0007224; GO:0009411; GO:0010468; GO:0016604; GO:0030620; GO:0035457; GO:0046872; GO:0060271; GO:1990904 cellular response to interferon-alpha [GO:0035457]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; regulation of gene expression [GO:0010468]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383] cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620] g16367.t1 Q64620 86.452 310 0.0 572.0 sp|Q64620|PPP6_RAT Serine/threonine-protein phosphatase 6 catalytic subunit OS=Rattus norvegicus OX=10116 GN=Ppp6c PE=2 SV=2 PPP6_RAT reviewed Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) (Protein phosphatase V) (PP-V) Rattus norvegicus (Rat) GO:0000082; GO:0004722; GO:0005737; GO:0005739; GO:0005829; GO:0045087; GO:0046872; GO:0140896; GO:0160049 cGAS/STING signaling pathway [GO:0140896]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; negative regulation of cGAS/STING signaling pathway [GO:0160049] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g16368.t1 Q64620 80.656 305 0.0 533.0 sp|Q64620|PPP6_RAT Serine/threonine-protein phosphatase 6 catalytic subunit OS=Rattus norvegicus OX=10116 GN=Ppp6c PE=2 SV=2 PPP6_RAT reviewed Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) (Protein phosphatase V) (PP-V) Rattus norvegicus (Rat) GO:0000082; GO:0004722; GO:0005737; GO:0005739; GO:0005829; GO:0045087; GO:0046872; GO:0140896; GO:0160049 cGAS/STING signaling pathway [GO:0140896]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; negative regulation of cGAS/STING signaling pathway [GO:0160049] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] g16370.t1 O70249 42.782 381 1.15e-100 305.0 sp|O70249|OGG1_RAT N-glycosylase/DNA lyase OS=Rattus norvegicus OX=10116 GN=Ogg1 PE=2 SV=1 OGG1_RAT reviewed N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)] Rattus norvegicus (Rat) GO:0000978; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006289; GO:0006355; GO:0006974; GO:0006979; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0019899; GO:0032355; GO:0032357; GO:0032991; GO:0034039; GO:0034614; GO:0043066; GO:0044029; GO:0045471; GO:0045944; GO:0051593; GO:0071276; GO:0140078; GO:1901291 base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair [GO:0006289]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410] mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; enzyme binding [GO:0019899]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16371.t1 A6PVS8 41.463 205 3.67e-50 190.0 sp|A6PVS8|LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens OX=9606 GN=LRRIQ3 PE=1 SV=1 LRIQ3_HUMAN reviewed Leucine-rich repeat and IQ domain-containing protein 3 (Leucine-rich repeat-containing protein 44) Homo sapiens (Human) g16372.t1 Q9UKP5 36.452 310 4.07e-49 182.0 sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2 ATS6_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-) Homo sapiens (Human) GO:0001822; GO:0003279; GO:0004222; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g16373.t1 Q9Y399 54.31 232 6.18e-89 268.0 sp|Q9Y399|RT02_HUMAN Small ribosomal subunit protein uS2m OS=Homo sapiens OX=9606 GN=MRPS2 PE=1 SV=1 RT02_HUMAN reviewed Small ribosomal subunit protein uS2m (28S ribosomal protein S2, mitochondrial) (MRP-S2) (S2mt) Homo sapiens (Human) GO:0003735; GO:0005739; GO:0005743; GO:0005759; GO:0005763; GO:0032543; GO:0061668 mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] structural constituent of ribosome [GO:0003735] g16374.t1 Q96AY4 28.425 292 4.66e-26 121.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g16374.t1 Q96AY4 27.419 310 1.43e-21 106.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g16374.t1 Q96AY4 24.26 507 2.7800000000000003e-21 105.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g16375.t1 Q5M936 28.425 292 2.6499999999999996e-23 105.0 sp|Q5M936|TOR3A_RAT Torsin-3A OS=Rattus norvegicus OX=10116 GN=Tor3a PE=2 SV=1 g16376.t1 Q62904 45.625 320 7.6e-103 308.0 sp|Q62904|DHB7_RAT 3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 OS=Rattus norvegicus OX=10116 GN=Hsd17b7 PE=1 SV=1 g16378.t1 P09172 41.794 591 4.29e-148 444.0 sp|P09172|DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens OX=9606 GN=DBH PE=1 SV=3 DOPO_HUMAN reviewed Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase] Homo sapiens (Human) GO:0001974; GO:0001975; GO:0002443; GO:0003824; GO:0004500; GO:0005507; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006589; GO:0007268; GO:0007613; GO:0007626; GO:0008542; GO:0016020; GO:0030658; GO:0030667; GO:0031418; GO:0034451; GO:0034466; GO:0034774; GO:0042309; GO:0042310; GO:0042420; GO:0042421; GO:0042584; GO:0042593; GO:0042596; GO:0042711; GO:0045202; GO:0045907; GO:0048149; GO:0048265; GO:0050900; GO:0120162; GO:1904705; GO:1905562; GO:2001236 behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; chemical synaptic transmission [GO:0007268]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of vascular associated smooth muscle cell proliferation [GO:1904705]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; vasoconstriction [GO:0042310]; visual learning [GO:0008542] centriolar satellite [GO:0034451]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] catalytic activity [GO:0003824]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418] g16379.t1 Q5EGZ1 48.322 596 0.0 599.0 sp|Q5EGZ1|ACE2_RAT Angiotensin-converting enzyme 2 OS=Rattus norvegicus OX=10116 GN=Ace2 PE=1 SV=1 ACE2_RAT reviewed Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2] Rattus norvegicus (Rat) GO:0000122; GO:0001618; GO:0002003; GO:0003051; GO:0003081; GO:0004175; GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005929; GO:0008237; GO:0008241; GO:0009986; GO:0015827; GO:0016324; GO:0031526; GO:0042802; GO:0046513; GO:0046718; GO:0046813; GO:0046872; GO:0048662; GO:0050727; GO:0051957; GO:0060135; GO:0060452; GO:0070373; GO:0098670; GO:0141109; GO:1903598; GO:1903779; GO:1905737 angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; ceramide biosynthetic process [GO:0046513]; entry receptor-mediated virion attachment to host cell [GO:0098670]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; symbiont entry into host cell [GO:0046718]; tryptophan transport [GO:0015827] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; transporter activator activity [GO:0141109]; virus receptor activity [GO:0001618] g16380.t1 Q92990 29.805 614 2.67e-70 243.0 sp|Q92990|GLMN_HUMAN Glomulin OS=Homo sapiens OX=9606 GN=GLMN PE=1 SV=2 g16382.t1 Q9H7B4 30.045 446 1.2900000000000001e-59 206.0 sp|Q9H7B4|SMYD3_HUMAN Histone-lysine N-methyltransferase SMYD3 OS=Homo sapiens OX=9606 GN=SMYD3 PE=1 SV=4 SMYD3_HUMAN reviewed Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1) Homo sapiens (Human) GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0008270; GO:0014904; GO:0032259; GO:0045184; GO:0045944; GO:0071549; GO:0140939; GO:0140954; GO:0140999 cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; methylation [GO:0032259]; myotube cell development [GO:0014904]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H4 methyltransferase activity [GO:0140939]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; zinc ion binding [GO:0008270] g16386.t1 Q9D0T2 43.26 319 1.7e-86 266.0 sp|Q9D0T2|DUS12_MOUSE Dual specificity protein phosphatase 12 OS=Mus musculus OX=10090 GN=Dusp12 PE=2 SV=1 DUS12_MOUSE reviewed Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase T-DSP4) (Dual specificity phosphatase VH1) Mus musculus (Mouse) GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016791; GO:0019900 cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] g16387.t1 P42674 32.274 409 8.55e-52 187.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g16388.t1 P42674 25.482 467 2.1200000000000001e-32 132.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g16388.t2 P98068 27.92 351 1.3600000000000001e-31 130.0 sp|P98068|SPAN_STRPU Protein SpAN OS=Strongylocentrotus purpuratus OX=7668 GN=SPAN PE=2 SV=1 g16389.t1 Q8NE28 25.654 612 9.760000000000001e-47 178.0 sp|Q8NE28|STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 OS=Homo sapiens OX=9606 GN=STKLD1 PE=1 SV=5 g16390.t1 Q03958 49.153 118 8.210000000000001e-35 119.0 sp|Q03958|PFD6_MOUSE Prefoldin subunit 6 OS=Mus musculus OX=10090 GN=Pfdn6 PE=1 SV=1 g16391.t1 P61765 62.458 594 0.0 775.0 sp|P61765|STXB1_RAT Syntaxin-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Stxbp1 PE=1 SV=1 STXB1_RAT reviewed Syntaxin-binding protein 1 (N-Sec1) (Protein unc-18 homolog 1) (Unc18-1) (Protein unc-18 homolog A) (Unc-18A) (p67) (rbSec1) Rattus norvegicus (Rat) GO:0000149; GO:0002576; GO:0003006; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006904; GO:0007269; GO:0007274; GO:0007412; GO:0010807; GO:0010808; GO:0016082; GO:0016188; GO:0017075; GO:0019901; GO:0019904; GO:0019905; GO:0030141; GO:0030424; GO:0031091; GO:0031333; GO:0031338; GO:0031340; GO:0032229; GO:0032355; GO:0032991; GO:0035493; GO:0035544; GO:0042802; GO:0043195; GO:0043274; GO:0043306; GO:0043524; GO:0045335; GO:0045921; GO:0045956; GO:0048471; GO:0050821; GO:0051402; GO:0051649; GO:0060090; GO:0060292; GO:0061670; GO:0070527; GO:0071346; GO:0072659; GO:0098688; GO:0098793; GO:0098794; GO:0098831; GO:0098888; GO:0098978; GO:0099523; GO:0099525; GO:0106022; GO:1903296; GO:2000367 axon target recognition [GO:0007412]; cellular response to type II interferon [GO:0071346]; developmental process involved in reproduction [GO:0003006]; establishment of localization in cell [GO:0051649]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of SNARE complex assembly [GO:0035544]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of synaptic vesicle priming [GO:0010808]; positive regulation of vesicle docking [GO:0106022]; positive regulation of vesicle fusion [GO:0031340]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of synaptic vesicle priming [GO:0010807]; regulation of vesicle fusion [GO:0031338]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; terminal bouton [GO:0043195] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g16392.t1 B3M611 62.745 102 8.3e-41 133.0 sp|B3M611|URM1_DROAN Ubiquitin-related modifier 1 homolog OS=Drosophila ananassae OX=7217 GN=Urm1 PE=3 SV=1 g16393.t1 Q6NWX7 55.556 216 2.57e-86 258.0 sp|Q6NWX7|NTM1A_DANRE N-terminal Xaa-Pro-Lys N-methyltransferase 1 OS=Danio rerio OX=7955 GN=ntmt1 PE=2 SV=1 NTM1A_DANRE reviewed N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0007051; GO:0007059; GO:0008276; GO:0018013; GO:0018016; GO:0035572; GO:0035573; GO:0042054; GO:0071885 chromosome segregation [GO:0007059]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051] cytoplasm [GO:0005737]; nucleus [GO:0005634] histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276] g16394.t1 Q9Y305 50.127 395 4.4200000000000004e-133 393.0 sp|Q9Y305|ACOT9_HUMAN Acyl-coenzyme A thioesterase 9, mitochondrial OS=Homo sapiens OX=9606 GN=ACOT9 PE=1 SV=2 g16394.t2 Q9Y305 50.128 391 5.15e-134 395.0 sp|Q9Y305|ACOT9_HUMAN Acyl-coenzyme A thioesterase 9, mitochondrial OS=Homo sapiens OX=9606 GN=ACOT9 PE=1 SV=2 g16397.t1 Q26626 81.499 827 0.0 1349.0 sp|Q26626|KIFA3_STRPU Kinesin-associated protein 3 OS=Strongylocentrotus purpuratus OX=7668 GN=KAP115 PE=1 SV=1 g16398.t1 Q6AXY7 71.503 193 3.14e-101 313.0 sp|Q6AXY7|PR38B_RAT Pre-mRNA-splicing factor 38B OS=Rattus norvegicus OX=10116 GN=Prpf38b PE=1 SV=1 g16399.t1 B2KI79 54.274 234 4.06e-95 281.0 sp|B2KI79|DOPP1_RHIFE Dolichyldiphosphatase 1 OS=Rhinolophus ferrumequinum OX=59479 GN=DOLPP1 PE=3 SV=1 g16400.t1 Q28HC6 65.578 398 0.0 562.0 sp|Q28HC6|TGT_XENTR Queuine tRNA-ribosyltransferase catalytic subunit 1 OS=Xenopus tropicalis OX=8364 GN=qtrt1 PE=2 SV=2 TGT_XENTR reviewed Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.64) (Guanine insertion enzyme) (tRNA-guanine transglycosylase) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005741; GO:0006400; GO:0008479; GO:0046872 tRNA modification [GO:0006400] mitochondrial outer membrane [GO:0005741] metal ion binding [GO:0046872]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479] g16401.t1 Q6X4W1 34.132 334 1.87e-50 180.0 sp|Q6X4W1|NSMF_HUMAN NMDA receptor synaptonuclear signaling and neuronal migration factor OS=Homo sapiens OX=9606 GN=NSMF PE=1 SV=1 NSMF_HUMAN reviewed NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor) Homo sapiens (Human) GO:0000791; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005886; GO:0014069; GO:0016020; GO:0016363; GO:0030425; GO:0030863; GO:0031965; GO:0043005; GO:0043204; GO:0043523; GO:0045202; GO:0048168; GO:0048306; GO:0048814; GO:0071230; GO:0071257; GO:0071371; GO:0097440; GO:2001224 cellular response to amino acid stimulus [GO:0071230]; cellular response to electrical stimulus [GO:0071257]; cellular response to gonadotropin stimulus [GO:0071371]; positive regulation of neuron migration [GO:2001224]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuronal synaptic plasticity [GO:0048168] apical dendrite [GO:0097440]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; euchromatin [GO:0000791]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] calcium-dependent protein binding [GO:0048306] g16402.t1 P30041 62.385 218 8.009999999999999e-89 263.0 sp|P30041|PRDX6_HUMAN Peroxiredoxin-6 OS=Homo sapiens OX=9606 GN=PRDX6 PE=1 SV=3 PRDX6_HUMAN reviewed Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12) Homo sapiens (Human) GO:0004601; GO:0004602; GO:0004623; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006979; GO:0016020; GO:0031625; GO:0035578; GO:0042744; GO:0042802; GO:0045296; GO:0045454; GO:0046475; GO:0047184; GO:0047499; GO:0048026; GO:0048471; GO:0051920; GO:0070062; GO:0098869 cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623]; ubiquitin protein ligase binding [GO:0031625] g16403.t1 Q9D4F2 41.667 108 4.4099999999999993e-23 94.7 sp|Q9D4F2|PLPP6_MOUSE Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 OS=Mus musculus OX=10090 GN=Plpp6 PE=1 SV=1 PLPP6_MOUSE reviewed Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 (EC 3.1.3.-) (EC 3.6.1.-) (EC 3.6.1.68) (Phospholipid phosphatase 6) Mus musculus (Mouse) GO:0005637; GO:0005789; GO:0006720; GO:0008195; GO:0016020; GO:0016787; GO:0018342; GO:0031965; GO:0033383; GO:0042392; GO:0042577; GO:0042632; GO:0045087; GO:0045339; GO:0046839; GO:0052642; GO:0098554; GO:0106405; GO:0120557; GO:1902247; GO:1902565 cholesterol homeostasis [GO:0042632]; farnesyl diphosphate catabolic process [GO:0045339]; geranyl diphosphate metabolic process [GO:0033383]; geranylgeranyl diphosphate catabolic process [GO:1902247]; innate immune response [GO:0045087]; isoprenoid metabolic process [GO:0006720]; phospholipid dephosphorylation [GO:0046839]; positive regulation of neutrophil activation [GO:1902565]; protein prenylation [GO:0018342] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] farnesyl diphosphatase activity [GO:0120557]; hydrolase activity [GO:0016787]; isoprenoid diphosphate phosphatase activity [GO:0106405]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392] g16404.t1 Q8BQN5 52.29 262 8.77e-91 283.0 sp|Q8BQN5|FA78B_MOUSE Protein FAM78B OS=Mus musculus OX=10090 GN=Fam78b PE=2 SV=2 g16405.t1 P35658 39.43 421 1.84e-88 327.0 sp|P35658|NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2 NU214_HUMAN reviewed Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) Homo sapiens (Human) GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] g16405.t1 P35658 31.519 349 6.08e-40 167.0 sp|P35658|NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2 NU214_HUMAN reviewed Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) Homo sapiens (Human) GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] g16405.t2 P35658 35.608 469 4.6599999999999995e-82 306.0 sp|P35658|NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2 NU214_HUMAN reviewed Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) Homo sapiens (Human) GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] g16405.t2 P35658 31.519 349 1.14e-39 167.0 sp|P35658|NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2 NU214_HUMAN reviewed Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) Homo sapiens (Human) GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] g16406.t1 O75379 39.062 128 7.100000000000001e-21 85.9 sp|O75379|VAMP4_HUMAN Vesicle-associated membrane protein 4 OS=Homo sapiens OX=9606 GN=VAMP4 PE=1 SV=2 VAMP4_HUMAN reviewed Vesicle-associated membrane protein 4 (VAMP-4) Homo sapiens (Human) GO:0000139; GO:0005764; GO:0005768; GO:0005794; GO:0005802; GO:0005886; GO:0009986; GO:0016189; GO:0030133; GO:0030669; GO:0031201; GO:0032456; GO:0032588; GO:0035493; GO:0042996; GO:0043001; GO:0045335; GO:0071346; GO:0090161; GO:0098887; GO:0098954; GO:0098978; GO:0099003; GO:1900242 cellular response to type II interferon [GO:0071346]; endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of Golgi to plasma membrane protein transport [GO:0042996]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle-mediated transport in synapse [GO:0099003] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; presynaptic endosome membrane [GO:0098954]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] g16407.t1 Q5I0H4 69.655 145 6.86e-59 184.0 sp|Q5I0H4|TMCO1_RAT Calcium load-activated calcium channel OS=Rattus norvegicus OX=10116 GN=Tmco1 PE=2 SV=1 TMCO1_RAT reviewed Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Meg-2-like protein) (Transmembrane and coiled-coil domain-containing protein 1) Rattus norvegicus (Rat) GO:0000139; GO:0001503; GO:0005262; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006983; GO:0031966; GO:0032469; GO:0043022; GO:0070588; GO:0160063; GO:0160064 calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; ossification [GO:0001503] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; multi-pass translocon complex [GO:0160064] calcium channel activity [GO:0005262]; ribosome binding [GO:0043022] g16408.t1 A2T929 67.841 454 0.0 598.0 sp|A2T929|RXRAA_DANRE Retinoic acid receptor RXR-alpha-A OS=Danio rerio OX=7955 GN=rxraa PE=2 SV=2 RXRAA_DANRE reviewed Retinoic acid receptor RXR-alpha-A (Nuclear receptor subfamily 2 group B member 1-A) (RXRalpha-B) (Retinoid X receptor alpha-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045944; GO:0048384; GO:0090575 cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384] RNA polymerase II transcription regulator complex [GO:0090575] nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270] g16408.t2 A2T929 68.597 449 0.0 604.0 sp|A2T929|RXRAA_DANRE Retinoic acid receptor RXR-alpha-A OS=Danio rerio OX=7955 GN=rxraa PE=2 SV=2 RXRAA_DANRE reviewed Retinoic acid receptor RXR-alpha-A (Nuclear receptor subfamily 2 group B member 1-A) (RXRalpha-B) (Retinoid X receptor alpha-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045944; GO:0048384; GO:0090575 cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384] RNA polymerase II transcription regulator complex [GO:0090575] nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270] g16409.t1 Q9QX29 39.819 442 1.53e-91 317.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g16409.t1 Q9QX29 41.042 307 2.2e-66 245.0 sp|Q9QX29|TRPC5_MOUSE Short transient receptor potential channel 5 OS=Mus musculus OX=10090 GN=Trpc5 PE=1 SV=2 g16410.t1 F1QGD2 37.407 270 2.6999999999999997e-52 176.0 sp|F1QGD2|ZDH24_DANRE Probable palmitoyltransferase ZDHHC24 OS=Danio rerio OX=7955 GN=zdhhc24 PE=2 SV=1 g16411.t1 Q5ZLV2 78.125 160 2.72e-94 273.0 sp|Q5ZLV2|PPIL3_CHICK Peptidyl-prolyl cis-trans isomerase-like 3 OS=Gallus gallus OX=9031 GN=PPIL3 PE=2 SV=1 PPIL3_CHICK reviewed Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3) Gallus gallus (Chicken) GO:0003755; GO:0006457; GO:0071013 protein folding [GO:0006457] catalytic step 2 spliceosome [GO:0071013] peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g16412.t1 Q4V9P0 59.533 257 2.27e-101 299.0 sp|Q4V9P0|SAMC_DANRE Mitochondrial S-adenosylmethionine carrier protein OS=Danio rerio OX=7955 GN=slc25a26 PE=2 SV=1 SAMC_DANRE reviewed Mitochondrial S-adenosylmethionine carrier protein (SAM carrier) (Solute carrier family 25 member 26) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000095; GO:0005739; GO:0005743; GO:0015805; GO:0180003; GO:1990543 mitochondrial S-adenosyl-L-methionine transmembrane transport [GO:1990543]; S-adenosyl-L-methionine transport [GO:0015805] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]; S-adenosyl-L-methionine:S-adenosyl-L-homocysteine antiporter activity [GO:0180003] g16415.t1 A2AV25 46.637 223 1.1699999999999999e-55 191.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g16417.t1 Q9TST5 26.121 379 1.09e-24 107.0 sp|Q9TST5|ADRB2_FELCA Beta-2 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB2 PE=3 SV=1 g16418.t1 Q2WGJ8 29.592 196 2.9400000000000003e-21 91.3 sp|Q2WGJ8|TM249_HUMAN Cation channel sperm-associated auxiliary subunit TMEM249 OS=Homo sapiens OX=9606 GN=TMEM249 PE=1 SV=1 CTSRQ_HUMAN reviewed Cation channel sperm-associated auxiliary subunit theta (Cation channel sperm-associated auxiliary subunit TMEM249) (Catsper channel auxiliary subunit theta) (Transmembrane protein 249) Homo sapiens (Human) GO:0036128; GO:0097228 CatSper complex [GO:0036128]; sperm principal piece [GO:0097228] g16419.t1 Q5RC90 67.568 185 7.56e-88 258.0 sp|Q5RC90|NCS1_PONAB Neuronal calcium sensor 1 OS=Pongo abelii OX=9601 GN=NCS1 PE=2 SV=3 NCS1_PONAB reviewed Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005245; GO:0005509; GO:0005794; GO:0005886; GO:0008048; GO:0010975; GO:0014069; GO:0048471 regulation of neuron projection development [GO:0010975] Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; voltage-gated calcium channel activity [GO:0005245] g16420.t1 Q60HH9 63.975 322 2.12e-163 461.0 sp|Q60HH9|HEM2_MACFA Delta-aminolevulinic acid dehydratase OS=Macaca fascicularis OX=9541 GN=ALAD PE=2 SV=2 g16421.t1 Q8C8N2 59.494 553 0.0 682.0 sp|Q8C8N2|SCAI_MOUSE Protein SCAI OS=Mus musculus OX=10090 GN=Scai PE=1 SV=2 SCAI_MOUSE reviewed Protein SCAI (Suppressor of cancer cell invasion protein) Mus musculus (Mouse) GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0030336; GO:0031965; GO:0035024 DNA-templated transcription [GO:0006351]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription corepressor activity [GO:0003714] g16422.t1 Q8NHY2 61.424 674 0.0 826.0 sp|Q8NHY2|COP1_HUMAN E3 ubiquitin-protein ligase COP1 OS=Homo sapiens OX=9606 GN=COP1 PE=1 SV=1 COP1_HUMAN reviewed E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2) Homo sapiens (Human) GO:0000139; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0045717; GO:0061630 negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g16423.t1 Q5T1M5 34.043 1081 1.09e-164 531.0 sp|Q5T1M5|FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15 PE=1 SV=2 FKB15_HUMAN reviewed FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL) Homo sapiens (Human) GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g16423.t2 Q5T1M5 34.043 1081 1.0500000000000001e-164 531.0 sp|Q5T1M5|FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15 PE=1 SV=2 FKB15_HUMAN reviewed FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL) Homo sapiens (Human) GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g16423.t3 Q5T1M5 35.543 1041 5.11e-170 544.0 sp|Q5T1M5|FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15 PE=1 SV=2 FKB15_HUMAN reviewed FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL) Homo sapiens (Human) GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g16424.t1 P00742 31.494 308 1.49e-34 141.0 sp|P00742|FA10_HUMAN Coagulation factor X OS=Homo sapiens OX=9606 GN=F10 PE=1 SV=2 FA10_HUMAN reviewed Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain] Homo sapiens (Human) GO:0004252; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0007596; GO:0009897; GO:0030335; GO:0032008 blood coagulation [GO:0007596]; positive regulation of cell migration [GO:0030335]; positive regulation of TOR signaling [GO:0032008]; proteolysis [GO:0006508] endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; serine-type endopeptidase activity [GO:0004252] g16426.t1 Q8K211 38.776 147 1.16e-27 104.0 sp|Q8K211|COPT1_MOUSE High affinity copper uptake protein 1 OS=Mus musculus OX=10090 GN=Slc31a1 PE=1 SV=1 COPT1_MOUSE reviewed High affinity copper uptake protein 1 (Copper transporter 1) (CTR1) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form] Mus musculus (Mouse) GO:0001525; GO:0005375; GO:0005507; GO:0005770; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0043025; GO:0051259; GO:0055037; GO:0055038; GO:0055085; GO:0072719; GO:0098705; GO:1902601 angiogenesis [GO:0001525]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; transmembrane transport [GO:0055085]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910] g16428.t1 Q9JK41 48.634 183 1.85e-56 179.0 sp|Q9JK41|COPT1_RAT High affinity copper uptake protein 1 OS=Rattus norvegicus OX=10116 GN=Slc31a1 PE=2 SV=1 g16430.t1 Q8WU76 38.416 682 5.45e-147 445.0 sp|Q8WU76|SCFD2_HUMAN Sec1 family domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCFD2 PE=1 SV=2 g16431.t1 P0DME0 70.391 179 8.030000000000001e-85 258.0 sp|P0DME0|SETLP_HUMAN Protein SETSIP OS=Homo sapiens OX=9606 GN=SETSIP PE=1 SV=2 SETLP_HUMAN reviewed Protein SETSIP (SET pseudogene protein 18) (SET similar protein) (Similar to SET translocation protein) Homo sapiens (Human) GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005811; GO:0006334; GO:0042393; GO:0045446; GO:0045944 endothelial cell differentiation [GO:0045446]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393] g16432.t1 P04758 27.988 343 6.98e-38 147.0 sp|P04758|ACHB_BOVIN Acetylcholine receptor subunit beta OS=Bos taurus OX=9913 GN=CHRNB1 PE=1 SV=1 ACHB_BOVIN reviewed Acetylcholine receptor subunit beta Bos taurus (Bovine) GO:0001941; GO:0003009; GO:0005231; GO:0005886; GO:0005892; GO:0006812; GO:0006936; GO:0007165; GO:0007271; GO:0007274; GO:0015267; GO:0015464; GO:0022848; GO:0034220; GO:0035095; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:0055001; GO:0095500; GO:1904315 acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271] acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g16434.t1 Q8CBH5 27.635 351 5.07e-37 146.0 sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1 g16436.t1 A0P8Z4 45.958 433 1.79e-130 390.0 sp|A0P8Z4|NR6A1_PIG Nuclear receptor subfamily 6 group A member 1 OS=Sus scrofa OX=9823 GN=NR6A1 PE=1 SV=2 NR6A1_PIG reviewed Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor) (GCNF) Sus scrofa (Pig) GO:0000785; GO:0004879; GO:0005634; GO:0006357; GO:0007283; GO:0008270; GO:0030154; GO:0034056; GO:2000741 cell differentiation [GO:0030154]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; nucleus [GO:0005634] estrogen response element binding [GO:0034056]; nuclear receptor activity [GO:0004879]; zinc ion binding [GO:0008270] g16437.t1 O42101 44.163 514 1.38e-136 406.0 sp|O42101|NR5A2_CHICK Nuclear receptor subfamily 5 group A member 2 OS=Gallus gallus OX=9031 GN=NR5A2 PE=2 SV=1 g16437.t2 O00482 46.203 474 6.19e-136 405.0 sp|O00482|NR5A2_HUMAN Nuclear receptor subfamily 5 group A member 2 OS=Homo sapiens OX=9606 GN=NR5A2 PE=1 SV=2 NR5A2_HUMAN reviewed Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor) (hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1) (LRH-1) Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0001545; GO:0001826; GO:0002669; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007283; GO:0008206; GO:0008270; GO:0009755; GO:0009792; GO:0009888; GO:0022008; GO:0031017; GO:0031948; GO:0032331; GO:0035019; GO:0040016; GO:0042102; GO:0042592; GO:0042632; GO:0043565; GO:0045070; GO:0045893; GO:0045944; GO:0050728; GO:0050870; GO:0051216; GO:0060009; GO:0061113; GO:0090425; GO:0090575; GO:0097720; GO:0140001; GO:0141064; GO:1990830; GO:1990837; GO:2000738; GO:2001051 acinar cell differentiation [GO:0090425]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cartilage development [GO:0051216]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; chromatin remodeling [GO:0006338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic cleavage [GO:0040016]; exocrine pancreas development [GO:0031017]; homeostatic process [GO:0042592]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell differentiation [GO:0001826]; morula formation [GO:0140001]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of inflammatory response [GO:0050728]; neurogenesis [GO:0022008]; pancreas morphogenesis [GO:0061113]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glucocorticoid biosynthetic process [GO:0031948]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; primary ovarian follicle growth [GO:0001545]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; tissue development [GO:0009888]; zygotic genome activation [GO:0141064] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g16437.t3 O00482 46.203 474 3.1499999999999998e-136 406.0 sp|O00482|NR5A2_HUMAN Nuclear receptor subfamily 5 group A member 2 OS=Homo sapiens OX=9606 GN=NR5A2 PE=1 SV=2 NR5A2_HUMAN reviewed Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor) (hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1) (LRH-1) Homo sapiens (Human) GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0001545; GO:0001826; GO:0002669; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007283; GO:0008206; GO:0008270; GO:0009755; GO:0009792; GO:0009888; GO:0022008; GO:0031017; GO:0031948; GO:0032331; GO:0035019; GO:0040016; GO:0042102; GO:0042592; GO:0042632; GO:0043565; GO:0045070; GO:0045893; GO:0045944; GO:0050728; GO:0050870; GO:0051216; GO:0060009; GO:0061113; GO:0090425; GO:0090575; GO:0097720; GO:0140001; GO:0141064; GO:1990830; GO:1990837; GO:2000738; GO:2001051 acinar cell differentiation [GO:0090425]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cartilage development [GO:0051216]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; chromatin remodeling [GO:0006338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic cleavage [GO:0040016]; exocrine pancreas development [GO:0031017]; homeostatic process [GO:0042592]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell differentiation [GO:0001826]; morula formation [GO:0140001]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of inflammatory response [GO:0050728]; neurogenesis [GO:0022008]; pancreas morphogenesis [GO:0061113]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glucocorticoid biosynthetic process [GO:0031948]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; primary ovarian follicle growth [GO:0001545]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; tissue development [GO:0009888]; zygotic genome activation [GO:0141064] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] g16438.t1 Q6AYK6 44.0 225 6.090000000000001e-56 181.0 sp|Q6AYK6|CYBP_RAT Calcyclin-binding protein OS=Rattus norvegicus OX=10116 GN=Cacybp PE=1 SV=1 CYBP_RAT reviewed Calcyclin-binding protein (CacyBP) Rattus norvegicus (Rat) GO:0005634; GO:0005641; GO:0005654; GO:0005737; GO:0005829; GO:0007507; GO:0015631; GO:0019005; GO:0019904; GO:0030877; GO:0031625; GO:0042803; GO:0044297; GO:0044548; GO:0045740; GO:0055007; GO:0060090; GO:0060416; GO:0071277; GO:1990830 cardiac muscle cell differentiation [GO:0055007]; cellular response to calcium ion [GO:0071277]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507]; positive regulation of DNA replication [GO:0045740]; response to growth hormone [GO:0060416] beta-catenin destruction complex [GO:0030877]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625] g16439.t1 P40821 30.918 207 8.75e-28 112.0 sp|P40821|CRJ1C_TRICY Crystallin J1C OS=Tripedalia cystophora OX=6141 PE=1 SV=1 g16440.t1 Q1RMP0 43.103 116 1.2e-26 99.0 sp|Q1RMP0|RPA12_BOVIN DNA-directed RNA polymerase I subunit RPA12 OS=Bos taurus OX=9913 GN=POLR1H PE=2 SV=1 RPA12_BOVIN reviewed DNA-directed RNA polymerase I subunit RPA12 (DNA-directed RNA polymerase I subunit H) Bos taurus (Bovine) GO:0003676; GO:0003899; GO:0005654; GO:0005736; GO:0006363; GO:0008270 termination of RNA polymerase I transcription [GO:0006363] nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g16442.t1 Q8NE71 69.686 541 0.0 677.0 sp|Q8NE71|ABCF1_HUMAN ATP-binding cassette sub-family F member 1 OS=Homo sapiens OX=9606 GN=ABCF1 PE=1 SV=2 ABCF1_HUMAN reviewed ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein) Homo sapiens (Human) GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0016887; GO:0043022; GO:0045727 inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135] g16444.t1 A5WUL3 66.423 137 2.91e-59 184.0 sp|A5WUL3|MED22_DANRE Mediator of RNA polymerase II transcription subunit 22 OS=Danio rerio OX=7955 GN=med22 PE=2 SV=1 g16445.t1 O57592 69.88 249 3.1600000000000004e-125 358.0 sp|O57592|RL7A_TAKRU Large ribosomal subunit protein eL8 OS=Takifugu rubripes OX=31033 GN=rpl7a PE=3 SV=3 g16446.t1 P97443 27.597 308 8.130000000000001e-32 130.0 sp|P97443|SMYD1_MOUSE Histone-lysine N-methyltransferase Smyd1 OS=Mus musculus OX=10090 GN=Smyd1 PE=1 SV=3 SMYD1_MOUSE reviewed Histone-lysine N-methyltransferase Smyd1 (EC 2.1.1.354) (CD8b-opposite) (SET and MYND domain-containing protein 1) (Zinc finger protein BOP) (m-BOP) Mus musculus (Mouse) GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0007507; GO:0008270; GO:0010831; GO:0032259; GO:0035914; GO:0045663; GO:0045892; GO:0140999 chromatin remodeling [GO:0006338]; heart development [GO:0007507]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; skeletal muscle cell differentiation [GO:0035914] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone H3K4 trimethyltransferase activity [GO:0140999]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g16448.t1 Q6GQB9 57.831 249 2.57e-91 291.0 sp|Q6GQB9|EDEM3_XENLA ER degradation-enhancing alpha-mannosidase-like protein 3 OS=Xenopus laevis OX=8355 GN=edem3 PE=2 SV=2 EDEM3_XENLA reviewed ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3) Xenopus laevis (African clawed frog) GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0016020; GO:0030968; GO:0044322; GO:0097466; GO:1904380 carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571] g16449.t1 Q2HXL6 55.508 472 1.88e-168 520.0 sp|Q2HXL6|EDEM3_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 3 OS=Mus musculus OX=10090 GN=Edem3 PE=1 SV=2 EDEM3_MOUSE reviewed ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3) Mus musculus (Mouse) GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006516; GO:0016020; GO:0030968; GO:0036503; GO:0043161; GO:0044322; GO:0097466; GO:1904380 carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571] g16452.t1 Q3TRM4 47.701 1392 0.0 1211.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g16452.t2 Q3TRM4 48.739 1348 0.0 1222.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g16452.t3 Q3TRM4 55.452 862 0.0 992.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g16452.t3 Q3TRM4 48.288 292 3.23e-65 247.0 sp|Q3TRM4|PLPL6_MOUSE Patatin-like phospholipase domain-containing protein 6 OS=Mus musculus OX=10090 GN=Pnpla6 PE=1 SV=2 PLPL6_MOUSE reviewed Patatin-like phospholipase domain-containing protein 6 (Neuropathy target esterase) (EC 3.1.1.5) Mus musculus (Mouse) GO:0001525; GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0009887; GO:0016020; GO:0016042; GO:0046470; GO:0052689 angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] carboxylic ester hydrolase activity [GO:0052689]; phosphatidylcholine lysophospholipase activity [GO:0004622] g16453.t1 Q3TQI7 56.803 294 5.52e-99 295.0 sp|Q3TQI7|TLS1_MOUSE Splicing factor C9orf78 homolog OS=Mus musculus OX=10090 PE=1 SV=2 g16453.t2 Q3TQI7 56.61 295 9.14e-99 295.0 sp|Q3TQI7|TLS1_MOUSE Splicing factor C9orf78 homolog OS=Mus musculus OX=10090 PE=1 SV=2 g16454.t1 Q9Z0U4 29.691 421 4.16e-50 186.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 g16455.t1 O75899 34.604 341 3.54e-53 193.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g16457.t1 Q6NRG5 62.088 182 4.16e-78 246.0 sp|Q6NRG5|NDOR1_XENLA NADPH-dependent diflavin oxidoreductase 1 OS=Xenopus laevis OX=8355 GN=ndor1 PE=2 SV=1 NDOR1_XENLA reviewed NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) Xenopus laevis (African clawed frog) GO:0005634; GO:0005829; GO:0009055; GO:0010181; GO:0016226; GO:0016491; GO:0016653; GO:0048471; GO:0050660; GO:0050661; GO:0160246 iron-sulfur cluster assembly [GO:0016226] cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-iron-sulfur [2Fe-2S] protein oxidoreductase activity [GO:0160246]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653] g16458.t1 Q9UHB4 56.522 115 3.95e-35 130.0 sp|Q9UHB4|NDOR1_HUMAN NADPH-dependent diflavin oxidoreductase 1 OS=Homo sapiens OX=9606 GN=NDOR1 PE=1 SV=1 g16459.t1 Q6PFP6 49.425 174 1.77e-49 170.0 sp|Q6PFP6|NDOR1_DANRE NADPH-dependent diflavin oxidoreductase 1 OS=Danio rerio OX=7955 GN=ndor1 PE=2 SV=1 NDOR1_DANRE reviewed NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005829; GO:0009055; GO:0010181; GO:0016226; GO:0016491; GO:0016653; GO:0048471; GO:0050660; GO:0050661; GO:0160246 iron-sulfur cluster assembly [GO:0016226] cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-iron-sulfur [2Fe-2S] protein oxidoreductase activity [GO:0160246]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653] g16460.t1 Q1LWV4 53.221 357 2.29e-115 348.0 sp|Q1LWV4|LHX9_DANRE LIM/homeobox protein Lhx9 OS=Danio rerio OX=7955 GN=lhx9 PE=2 SV=1 g16461.t1 Q5TM62 48.428 159 9e-45 153.0 sp|Q5TM62|RT18B_MACMU Small ribosomal subunit protein mS40 OS=Macaca mulatta OX=9544 GN=MRPS18B PE=3 SV=1 g16463.t1 Q6GLQ4 32.168 572 2.39e-39 160.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 PP1RA_XENLA reviewed Serine/threonine-protein phosphatase 1 regulatory subunit 10 Xenopus laevis (African clawed frog) GO:0000785; GO:0001111; GO:0005634; GO:0008157; GO:0008270; GO:0019888; GO:0032968; GO:0034244; GO:0072357; GO:0140767; GO:2000806 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; zinc ion binding [GO:0008270] g16463.t1 Q6GLQ4 40.789 152 2.29e-27 123.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 PP1RA_XENLA reviewed Serine/threonine-protein phosphatase 1 regulatory subunit 10 Xenopus laevis (African clawed frog) GO:0000785; GO:0001111; GO:0005634; GO:0008157; GO:0008270; GO:0019888; GO:0032968; GO:0034244; GO:0072357; GO:0140767; GO:2000806 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; zinc ion binding [GO:0008270] g16463.t2 Q6GLQ4 31.919 589 2.48e-39 160.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 PP1RA_XENLA reviewed Serine/threonine-protein phosphatase 1 regulatory subunit 10 Xenopus laevis (African clawed frog) GO:0000785; GO:0001111; GO:0005634; GO:0008157; GO:0008270; GO:0019888; GO:0032968; GO:0034244; GO:0072357; GO:0140767; GO:2000806 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; zinc ion binding [GO:0008270] g16463.t2 Q6GLQ4 43.357 143 8.339999999999999e-30 130.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 PP1RA_XENLA reviewed Serine/threonine-protein phosphatase 1 regulatory subunit 10 Xenopus laevis (African clawed frog) GO:0000785; GO:0001111; GO:0005634; GO:0008157; GO:0008270; GO:0019888; GO:0032968; GO:0034244; GO:0072357; GO:0140767; GO:2000806 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; zinc ion binding [GO:0008270] g16463.t3 Q6GLQ4 32.168 572 2.3099999999999998e-39 160.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 PP1RA_XENLA reviewed Serine/threonine-protein phosphatase 1 regulatory subunit 10 Xenopus laevis (African clawed frog) GO:0000785; GO:0001111; GO:0005634; GO:0008157; GO:0008270; GO:0019888; GO:0032968; GO:0034244; GO:0072357; GO:0140767; GO:2000806 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; zinc ion binding [GO:0008270] g16463.t3 Q6GLQ4 43.357 143 7.289999999999999e-30 130.0 sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1 PP1RA_XENLA reviewed Serine/threonine-protein phosphatase 1 regulatory subunit 10 Xenopus laevis (African clawed frog) GO:0000785; GO:0001111; GO:0005634; GO:0008157; GO:0008270; GO:0019888; GO:0032968; GO:0034244; GO:0072357; GO:0140767; GO:2000806 negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA polymerase II promoter clearance [GO:0001111] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; zinc ion binding [GO:0008270] g16464.t1 A1IH00 38.252 1064 2.7900000000000002e-164 513.0 sp|A1IH00|GOGA2_DANRE Golgin subfamily A member 2 OS=Danio rerio OX=7955 GN=golga2 PE=2 SV=1 GOGA2_DANRE reviewed Golgin subfamily A member 2 (Golgin A2) (cis-Golgi matrix protein GM130) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000137; GO:0000922; GO:0001966; GO:0005801; GO:0005874; GO:0007030; GO:0007420; GO:0007519; GO:0015031; GO:0032580; GO:0033116; GO:0051301 brain development [GO:0007420]; cell division [GO:0051301]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; skeletal muscle tissue development [GO:0007519]; thigmotaxis [GO:0001966] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; microtubule [GO:0005874]; spindle pole [GO:0000922] g16465.t1 Q7YR39 65.134 1044 0.0 1399.0 sp|Q7YR39|DHX16_PANTR Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Pan troglodytes OX=9598 GN=DHX16 PE=3 SV=1 g16466.t1 O43805 66.972 109 2.2199999999999997e-48 153.0 sp|O43805|SSNA1_HUMAN Microtubule nucleation factor SSNA1 OS=Homo sapiens OX=9606 GN=SSNA1 PE=1 SV=2 SSNA1_HUMAN reviewed Microtubule nucleation factor SSNA1 (Nuclear autoantigen of 14 kDa) (Sjoegren syndrome nuclear autoantigen 1) Homo sapiens (Human) GO:0000226; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005930; GO:0007020; GO:0007224; GO:0007409; GO:0008017; GO:0030424; GO:0030496; GO:0036064; GO:0042073; GO:0042802; GO:0043113; GO:0048675; GO:0051301; GO:0099512; GO:0140060 axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; receptor clustering [GO:0043113]; smoothened signaling pathway [GO:0007224] axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; supramolecular fiber [GO:0099512] identical protein binding [GO:0042802]; microtubule binding [GO:0008017] g16471.t1 Q3KRD0 53.5 600 0.0 656.0 sp|Q3KRD0|SYDM_RAT Aspartate--tRNA ligase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Dars2 PE=1 SV=1 SYDM_RAT reviewed Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) Rattus norvegicus (Rat) GO:0003676; GO:0004815; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006422; GO:0031966; GO:0042803; GO:0043039; GO:0050560; GO:0070145 aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803] g16472.t1 Q3YEC7 41.864 633 4.88e-125 394.0 sp|Q3YEC7|RABL6_HUMAN Rab-like protein 6 OS=Homo sapiens OX=9606 GN=RABL6 PE=1 SV=2 RABL6_HUMAN reviewed Rab-like protein 6 (EC 3.6.5.2) (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1) Homo sapiens (Human) GO:0003925; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0034451; GO:0036064 centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] G protein activity [GO:0003925]; GTP binding [GO:0005525] g16473.t1 P48508 37.687 268 1.2799999999999999e-54 181.0 sp|P48508|GSH0_RAT Glutamate--cysteine ligase regulatory subunit OS=Rattus norvegicus OX=10116 GN=Gclm PE=1 SV=1 GSH0_RAT reviewed Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit) Rattus norvegicus (Rat) GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0008637; GO:0009410; GO:0014823; GO:0017109; GO:0035226; GO:0035729; GO:0035733; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990609; GO:1990830; GO:2001237 apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410] glutamate-cysteine ligase complex [GO:0017109] glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; glutamate-cysteine ligase regulator activity [GO:1990609]; protein-containing complex binding [GO:0044877] g16474.t1 P49696 51.927 986 0.0 1079.0 sp|P49696|SYVC_TAKRU Valine--tRNA ligase OS=Takifugu rubripes OX=31033 GN=vars1 PE=3 SV=1 g16475.t1 Q99941 39.461 408 9.55e-71 245.0 sp|Q99941|ATF6B_HUMAN Cyclic AMP-dependent transcription factor ATF-6 beta OS=Homo sapiens OX=9606 GN=ATF6B PE=1 SV=2 ATF6B_HUMAN reviewed Cyclic AMP-dependent transcription factor ATF-6 beta (cAMP-dependent transcription factor ATF-6 beta) (Activating transcription factor 6 beta) (ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein) (Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta] Homo sapiens (Human) GO:0000139; GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0007165; GO:0030968; GO:0032993; GO:0034976; GO:0036500; GO:0045944; GO:0090575; GO:1903892; GO:1990837 ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g16475.t2 Q99941 39.461 408 6.68e-71 246.0 sp|Q99941|ATF6B_HUMAN Cyclic AMP-dependent transcription factor ATF-6 beta OS=Homo sapiens OX=9606 GN=ATF6B PE=1 SV=2 ATF6B_HUMAN reviewed Cyclic AMP-dependent transcription factor ATF-6 beta (cAMP-dependent transcription factor ATF-6 beta) (Activating transcription factor 6 beta) (ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein) (Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta] Homo sapiens (Human) GO:0000139; GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0007165; GO:0030968; GO:0032993; GO:0034976; GO:0036500; GO:0045944; GO:0090575; GO:1903892; GO:1990837 ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976] g16476.t1 Q5ZIR1 56.111 360 1.7900000000000002e-144 416.0 sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1 g16476.t2 Q5ZIR1 54.155 373 6.17e-142 410.0 sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1 g16478.t1 P21398 31.809 481 1.58e-65 225.0 sp|P21398|AOFA_BOVIN Amine oxidase [flavin-containing] A OS=Bos taurus OX=9913 GN=MAOA PE=2 SV=2 AOFA_BOVIN reviewed Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) Bos taurus (Bovine) GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0050660; GO:0097621 catecholamine metabolic process [GO:0006584] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131] g16479.t1 Q8NEE8 40.798 451 4.2e-115 380.0 sp|Q8NEE8|TTC16_HUMAN Tetratricopeptide repeat protein 16 OS=Homo sapiens OX=9606 GN=TTC16 PE=1 SV=2 g16481.t1 P55008 47.183 142 3.9699999999999996e-42 140.0 sp|P55008|AIF1_HUMAN Allograft inflammatory factor 1 OS=Homo sapiens OX=9606 GN=AIF1 PE=1 SV=1 AIF1_HUMAN reviewed Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1) Homo sapiens (Human) GO:0001726; GO:0001774; GO:0001891; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0016601; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0032587; GO:0032722; GO:0032755; GO:0034599; GO:0042102; GO:0048471; GO:0048661; GO:0048662; GO:0050921; GO:0051015; GO:0051017; GO:0051764; GO:0071346; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406 actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; ruffle assembly [GO:0097178] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509] g16483.t1 Q62371 39.663 890 0.0 619.0 sp|Q62371|DDR2_MOUSE Discoidin domain-containing receptor 2 OS=Mus musculus OX=10090 GN=Ddr2 PE=1 SV=2 DDR2_MOUSE reviewed Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) Mus musculus (Mouse) GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0007169; GO:0008284; GO:0010763; GO:0010976; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0048146; GO:0051091; GO:0051897; GO:0070374; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491 biomineral tissue development [GO:0031214]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of neuron projection development [GO:0010976]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; regulation of bone mineralization [GO:0030500]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g16484.t1 Q5FWM1 55.556 189 1.67e-65 220.0 sp|Q5FWM1|ATAT_XENLA Alpha-tubulin N-acetyltransferase 1 OS=Xenopus laevis OX=8355 GN=atat1 PE=2 SV=1 ATAT_XENLA reviewed Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog) Xenopus laevis (African clawed frog) GO:0000226; GO:0004468; GO:0005737; GO:0005819; GO:0005874; GO:0005905; GO:0005925; GO:0019799; GO:0030424; GO:0048666; GO:0070507; GO:0071929 alpha-tubulin acetylation [GO:0071929]; microtubule cytoskeleton organization [GO:0000226]; neuron development [GO:0048666]; regulation of microtubule cytoskeleton organization [GO:0070507] axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; spindle [GO:0005819] L-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799] g16485.t1 Q7YR35 55.694 562 0.0 579.0 sp|Q7YR35|GNL1_PANTR Guanine nucleotide-binding protein-like 1 OS=Pan troglodytes OX=9598 GN=GNL1 PE=3 SV=3 g16485.t2 Q7YR35 55.496 564 0.0 578.0 sp|Q7YR35|GNL1_PANTR Guanine nucleotide-binding protein-like 1 OS=Pan troglodytes OX=9598 GN=GNL1 PE=3 SV=3 g16486.t1 Q923I8 58.522 487 0.0 638.0 sp|Q923I8|CRY2_RAT Cryptochrome-2 OS=Rattus norvegicus OX=10116 GN=Cry2 PE=1 SV=1 CRY2_RAT reviewed Cryptochrome-2 Rattus norvegicus (Rat) GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0004864; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006606; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0016607; GO:0016922; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0032868; GO:0032922; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:1990512; GO:2000118; GO:2000323; GO:2000850 circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein import into nucleus [GO:0006606]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416] Cry-Per complex [GO:1990512]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634] damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; kinase binding [GO:0019900]; nuclear receptor binding [GO:0016922]; phosphatase binding [GO:0019902]; photoreceptor activity [GO:0009881]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864]; single-stranded DNA binding [GO:0003697]; transcription cis-regulatory region binding [GO:0000976] g16487.t1 Q9Y345 44.708 633 0.0 558.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g16488.t1 Q5RAY7 33.534 832 8.74e-131 413.0 sp|Q5RAY7|CMTR2_PONAB Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 OS=Pongo abelii OX=9601 GN=CMTR2 PE=2 SV=1 CMTR2_PONAB reviewed Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0032259; GO:0120550 7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259] cytoplasm [GO:0005737]; nucleus [GO:0005634] methyltransferase cap1 activity [GO:0004483]; methyltransferase cap2 activity [GO:0120550] g16489.t1 Q8BW00 47.778 180 9.59e-57 180.0 sp|Q8BW00|PTH_MOUSE Probable peptidyl-tRNA hydrolase OS=Mus musculus OX=10090 GN=Ptrh1 PE=2 SV=1 g16490.t1 Q92506 51.908 262 2.95e-85 258.0 sp|Q92506|DHB8_HUMAN (3R)-3-hydroxyacyl-CoA dehydrogenase OS=Homo sapiens OX=9606 GN=HSD17B8 PE=1 SV=2 DHB8_HUMAN reviewed (3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (HSD17B8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (Estradiol 17-beta-dehydrogenase 8) (EC 1.1.1.62) (Protein Ke6) (Ke6) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239) Homo sapiens (Human) GO:0004303; GO:0005739; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0047035; GO:0048038; GO:0051290; GO:0070404; GO:0106386; GO:1990204 androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290] mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]; plasma membrane [GO:0005886] (3R)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; NADH binding [GO:0070404]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035] g16491.t1 Q6ZPR4 52.598 1097 0.0 1148.0 sp|Q6ZPR4|KCNT1_MOUSE Potassium channel subfamily T member 1 OS=Mus musculus OX=10090 GN=Kcnt1 PE=1 SV=2 KCNT1_MOUSE reviewed Potassium channel subfamily T member 1 Mus musculus (Mouse) GO:0005228; GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0046872; GO:0051289; GO:0060078; GO:0070089; GO:0071805; GO:0098839 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of postsynaptic membrane potential [GO:0060078] plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] chloride-activated potassium channel activity [GO:0070089]; intracellular sodium-activated potassium channel activity [GO:0005228]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267] g16491.t2 Q6ZPR4 52.646 1096 0.0 1146.0 sp|Q6ZPR4|KCNT1_MOUSE Potassium channel subfamily T member 1 OS=Mus musculus OX=10090 GN=Kcnt1 PE=1 SV=2 KCNT1_MOUSE reviewed Potassium channel subfamily T member 1 Mus musculus (Mouse) GO:0005228; GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0046872; GO:0051289; GO:0060078; GO:0070089; GO:0071805; GO:0098839 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of postsynaptic membrane potential [GO:0060078] plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] chloride-activated potassium channel activity [GO:0070089]; intracellular sodium-activated potassium channel activity [GO:0005228]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267] g16491.t3 Q6ZPR4 52.646 1096 0.0 1146.0 sp|Q6ZPR4|KCNT1_MOUSE Potassium channel subfamily T member 1 OS=Mus musculus OX=10090 GN=Kcnt1 PE=1 SV=2 KCNT1_MOUSE reviewed Potassium channel subfamily T member 1 Mus musculus (Mouse) GO:0005228; GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0046872; GO:0051289; GO:0060078; GO:0070089; GO:0071805; GO:0098839 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of postsynaptic membrane potential [GO:0060078] plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] chloride-activated potassium channel activity [GO:0070089]; intracellular sodium-activated potassium channel activity [GO:0005228]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267] g16491.t4 Q5JUK3 53.099 1081 0.0 1156.0 sp|Q5JUK3|KCNT1_HUMAN Potassium channel subfamily T member 1 OS=Homo sapiens OX=9606 GN=KCNT1 PE=1 SV=2 KCNT1_HUMAN reviewed Potassium channel subfamily T member 1 (KCa4.1) (KNa1.1) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.2) Homo sapiens (Human) GO:0005228; GO:0005886; GO:0015271; GO:0046872; GO:0051289; GO:0071805 potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289] plasma membrane [GO:0005886] intracellular sodium-activated potassium channel activity [GO:0005228]; metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271] g16492.t1 Q64459 34.749 518 1e-91 292.0 sp|Q64459|CP3AB_MOUSE Cytochrome P450 3A11 OS=Mus musculus OX=10090 GN=Cyp3a11 PE=1 SV=1 CP3AB_MOUSE reviewed Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT) Mus musculus (Mouse) GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0008210; GO:0008401; GO:0009617; GO:0009822; GO:0016491; GO:0020037; GO:0032451; GO:0042178; GO:0042573; GO:0050649; GO:0070989; GO:0101020 alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; response to bacterium [GO:0009617]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178] endoplasmic reticulum membrane [GO:0005789] demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; testosterone 6-beta-hydroxylase activity [GO:0050649] g16493.t1 Q9UHL4 45.695 453 1.64e-143 423.0 sp|Q9UHL4|DPP2_HUMAN Dipeptidyl peptidase 2 OS=Homo sapiens OX=9606 GN=DPP7 PE=1 SV=3 DPP2_HUMAN reviewed Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) Homo sapiens (Human) GO:0004177; GO:0005576; GO:0005794; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0070008; GO:0070062; GO:1905146 lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236] g16494.t1 Q9UHL4 48.38 463 3.4099999999999996e-146 430.0 sp|Q9UHL4|DPP2_HUMAN Dipeptidyl peptidase 2 OS=Homo sapiens OX=9606 GN=DPP7 PE=1 SV=3 DPP2_HUMAN reviewed Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) Homo sapiens (Human) GO:0004177; GO:0005576; GO:0005794; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0070008; GO:0070062; GO:1905146 lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982] aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236] g16495.t1 Q9Z2H4 23.747 459 3.4e-21 104.0 sp|Q9Z2H4|LGR4_RAT Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Rattus norvegicus OX=10116 GN=Lgr4 PE=2 SV=2 LGR4_RAT reviewed Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48) Rattus norvegicus (Rat) GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0005886; GO:0007186; GO:0007283; GO:0007411; GO:0007623; GO:0008201; GO:0016055; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0035239; GO:0036335; GO:0045087; GO:0046849; GO:0048495; GO:0048565; GO:0050673; GO:0050919; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013 axon guidance [GO:0007411]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestive tract development [GO:0048565]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative chemotaxis [GO:0050919]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; spermatogenesis [GO:0007283]; tube morphogenesis [GO:0035239]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888] g16495.t2 Q9Z2H4 23.747 459 3.3700000000000004e-21 104.0 sp|Q9Z2H4|LGR4_RAT Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Rattus norvegicus OX=10116 GN=Lgr4 PE=2 SV=2 LGR4_RAT reviewed Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48) Rattus norvegicus (Rat) GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0005886; GO:0007186; GO:0007283; GO:0007411; GO:0007623; GO:0008201; GO:0016055; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0035239; GO:0036335; GO:0045087; GO:0046849; GO:0048495; GO:0048565; GO:0050673; GO:0050919; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013 axon guidance [GO:0007411]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; digestive tract development [GO:0048565]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative chemotaxis [GO:0050919]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; spermatogenesis [GO:0007283]; tube morphogenesis [GO:0035239]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888] g16496.t1 P11645 45.13 308 1.55e-98 306.0 sp|P11645|URIC_RABIT Uricase OS=Oryctolagus cuniculus OX=9986 GN=UOX PE=2 SV=1 g16496.t1 P11645 42.907 289 7.2e-88 278.0 sp|P11645|URIC_RABIT Uricase OS=Oryctolagus cuniculus OX=9986 GN=UOX PE=2 SV=1 g16496.t2 P11645 45.13 308 6.61e-99 306.0 sp|P11645|URIC_RABIT Uricase OS=Oryctolagus cuniculus OX=9986 GN=UOX PE=2 SV=1 g16496.t2 P11645 42.958 284 9.880000000000001e-88 277.0 sp|P11645|URIC_RABIT Uricase OS=Oryctolagus cuniculus OX=9986 GN=UOX PE=2 SV=1 g16497.t1 O95295 42.188 128 2.8000000000000003e-31 112.0 sp|O95295|SNAPN_HUMAN SNARE-associated protein Snapin OS=Homo sapiens OX=9606 GN=SNAPIN PE=1 SV=1 g16497.t2 O95295 42.748 131 2.77e-33 116.0 sp|O95295|SNAPN_HUMAN SNARE-associated protein Snapin OS=Homo sapiens OX=9606 GN=SNAPIN PE=1 SV=1 g16498.t1 A2AV25 41.852 270 4.09e-54 192.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g16498.t1 A2AV25 36.0 300 1.5199999999999999e-46 172.0 sp|A2AV25|FBCD1_MOUSE Fibrinogen C domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fibcd1 PE=2 SV=1 g16499.t1 P55918 43.096 239 2.9799999999999998e-52 176.0 sp|P55918|MFAP4_BOVIN Microfibril-associated glycoprotein 4 OS=Bos taurus OX=9913 GN=MFAP4 PE=1 SV=2 g16500.t1 Q9D6J3 50.974 308 7.16e-93 285.0 sp|Q9D6J3|YJU2_MOUSE Splicing factor YJU2 OS=Mus musculus OX=10090 GN=Yju2 PE=1 SV=1 g16501.t1 P70195 71.119 277 8.41e-149 420.0 sp|P70195|PSB7_MOUSE Proteasome subunit beta type-7 OS=Mus musculus OX=10090 GN=Psmb7 PE=1 SV=1 g16503.t1 A0MSJ1 38.114 1241 2.03e-139 466.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16503.t1 A0MSJ1 42.925 424 5.63e-43 175.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16503.t1 A0MSJ1 38.449 632 1.2e-40 168.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16503.t1 A0MSJ1 42.705 281 3.12e-24 114.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16504.t1 Q27746 63.033 1642 0.0 2006.0 sp|Q27746|DNMT1_PARLI DNA (cytosine-5)-methyltransferase PliMCI OS=Paracentrotus lividus OX=7656 GN=DNMT PE=2 SV=1 g16505.t1 Q9NSG2 30.726 895 9.48e-123 396.0 sp|Q9NSG2|FIRRM_HUMAN FIGNL1-interacting regulator of recombination and mitosis OS=Homo sapiens OX=9606 GN=FIRRM PE=1 SV=1 g16506.t1 P62294 31.543 3687 0.0 1602.0 sp|P62294|ASPM_PONPY Abnormal spindle-like microcephaly-associated protein homolog OS=Pongo pygmaeus OX=9600 GN=ASPM PE=2 SV=1 g16507.t1 Q27546 36.842 285 7.570000000000001e-47 163.0 sp|Q27546|IUNH_CRIFA Inosine-uridine preferring nucleoside hydrolase OS=Crithidia fasciculata OX=5656 GN=IUNH PE=1 SV=3 IUNH_CRIFA reviewed Inosine-uridine preferring nucleoside hydrolase (IU-NH) (IU-nucleoside hydrolase) (EC 3.2.2.2) (EC 3.2.2.3) (Non-specific nucleoside hydrolase) Crithidia fasciculata GO:0005829; GO:0006152; GO:0009117; GO:0045437; GO:0046872; GO:0047724 nucleotide metabolic process [GO:0009117]; purine nucleoside catabolic process [GO:0006152] cytosol [GO:0005829] inosine nucleosidase activity [GO:0047724]; metal ion binding [GO:0046872]; uridine nucleosidase activity [GO:0045437] g16508.t1 P83851 38.929 280 5.5400000000000006e-43 153.0 sp|P83851|IUNH_LEIMA Inosine-uridine preferring nucleoside hydrolase OS=Leishmania major OX=5664 GN=NSNH PE=1 SV=3 IUNH_LEIMA reviewed Inosine-uridine preferring nucleoside hydrolase (IU-NH) (IU-nucleoside hydrolase) (EC 3.2.2.2) (EC 3.2.2.3) (Non-specific nucleoside hydrolase) Leishmania major GO:0005509; GO:0008477; GO:0009117; GO:0043101; GO:0045437; GO:0047724 nucleotide metabolic process [GO:0009117]; purine-containing compound salvage [GO:0043101] calcium ion binding [GO:0005509]; inosine nucleosidase activity [GO:0047724]; purine nucleosidase activity [GO:0008477]; uridine nucleosidase activity [GO:0045437] g16509.t1 A8AJF8 38.214 280 4.22e-44 156.0 sp|A8AJF8|RIHA_CITK8 Pyrimidine-specific ribonucleoside hydrolase RihA OS=Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) OX=290338 GN=rihA PE=3 SV=1 g16510.t1 Q2TBS2 49.219 128 2.96e-31 115.0 sp|Q2TBS2|RM21_BOVIN Large ribosomal subunit protein bL21m OS=Bos taurus OX=9913 GN=MRPL21 PE=1 SV=1 g16511.t1 Q8K0E3 48.671 715 0.0 648.0 sp|Q8K0E3|SC5AB_MOUSE Sodium/myo-inositol cotransporter 2 OS=Mus musculus OX=10090 GN=Slc5a11 PE=1 SV=1 g16512.t1 Q9CXF4 51.294 425 1.01e-146 451.0 sp|Q9CXF4|TBC15_MOUSE TBC1 domain family member 15 OS=Mus musculus OX=10090 GN=Tbc1d15 PE=1 SV=1 g16513.t1 Q9HA65 31.884 207 1.1300000000000001e-29 118.0 sp|Q9HA65|TBC17_HUMAN TBC1 domain family member 17 OS=Homo sapiens OX=9606 GN=TBC1D17 PE=1 SV=3 TBC17_HUMAN reviewed TBC1 domain family member 17 Homo sapiens (Human) GO:0005096; GO:0005776; GO:0005829; GO:0006914; GO:0015031; GO:0042147; GO:0055037 autophagy [GO:0006914]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147] autophagosome [GO:0005776]; cytosol [GO:0005829]; recycling endosome [GO:0055037] GTPase activator activity [GO:0005096] g16514.t1 Q3TXU5 65.819 354 0.0 513.0 sp|Q3TXU5|DHYS_MOUSE Deoxyhypusine synthase OS=Mus musculus OX=10090 GN=Dhps PE=1 SV=2 g16515.t1 Q91WL8 36.877 301 3.63e-51 177.0 sp|Q91WL8|WWOX_MOUSE WW domain-containing oxidoreductase OS=Mus musculus OX=10090 GN=Wwox PE=1 SV=1 WWOX_MOUSE reviewed WW domain-containing oxidoreductase (EC 1.1.1.-) Mus musculus (Mouse) GO:0001649; GO:0005634; GO:0005737; GO:0005739; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0042802; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241 cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491] g16516.t1 Q9Z0U4 50.432 811 0.0 809.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 g16517.t1 Q3UFB2 45.614 228 1.13e-62 209.0 sp|Q3UFB2|BCD1_MOUSE Box C/D snoRNA protein 1 OS=Mus musculus OX=10090 GN=Znhit6 PE=1 SV=2 g16518.t1 Q5QJE6 52.778 180 8.16e-59 207.0 sp|Q5QJE6|TDIF2_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens OX=9606 GN=DNTTIP2 PE=1 SV=2 TDIF2_HUMAN reviewed Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2) Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006396; GO:0032040; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g16519.t1 Q8C6M1 47.231 957 0.0 844.0 sp|Q8C6M1|UBP20_MOUSE Ubiquitin carboxyl-terminal hydrolase 20 OS=Mus musculus OX=10090 GN=Usp20 PE=1 SV=1 UBP20_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) Mus musculus (Mouse) GO:0001664; GO:0004197; GO:0004843; GO:0005783; GO:0005813; GO:0006508; GO:0006897; GO:0007249; GO:0007399; GO:0008270; GO:0008277; GO:0010508; GO:0016579; GO:0043124; GO:0048471; GO:0070536; GO:0071108; GO:0140374 antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; endocytosis [GO:0006897]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] centrosome [GO:0005813]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; zinc ion binding [GO:0008270] g16519.t2 Q8C6M1 46.855 954 0.0 844.0 sp|Q8C6M1|UBP20_MOUSE Ubiquitin carboxyl-terminal hydrolase 20 OS=Mus musculus OX=10090 GN=Usp20 PE=1 SV=1 UBP20_MOUSE reviewed Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) Mus musculus (Mouse) GO:0001664; GO:0004197; GO:0004843; GO:0005783; GO:0005813; GO:0006508; GO:0006897; GO:0007249; GO:0007399; GO:0008270; GO:0008277; GO:0010508; GO:0016579; GO:0043124; GO:0048471; GO:0070536; GO:0071108; GO:0140374 antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; endocytosis [GO:0006897]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; nervous system development [GO:0007399]; positive regulation of autophagy [GO:0010508]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] centrosome [GO:0005813]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; zinc ion binding [GO:0008270] g16520.t1 P02269 82.171 129 1.13e-71 213.0 sp|P02269|H2A_ASTRU Histone H2A OS=Asterias rubens OX=7604 PE=1 SV=2 g16521.t1 Q1JPS6 29.032 341 5.56e-27 114.0 sp|Q1JPS6|OPN4L_DANRE Melanopsin-like OS=Danio rerio OX=7955 GN=opn4l PE=2 SV=1 OPN4L_DANRE reviewed Melanopsin-like (Melanopsin) (Opsin-4-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009881; GO:0030265; GO:0042752; GO:0071482; GO:1904059 cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating opsin-mediated signaling pathway [GO:0030265]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; visual perception [GO:0007601] plasma membrane [GO:0005886] G protein-coupled photoreceptor activity [GO:0008020]; photoreceptor activity [GO:0009881] g16525.t1 P00520 68.127 502 0.0 746.0 sp|P00520|ABL1_MOUSE Tyrosine-protein kinase ABL1 OS=Mus musculus OX=10090 GN=Abl1 PE=1 SV=3 g16527.t1 H3ZPL1 30.25 400 5.22e-50 179.0 sp|H3ZPL1|ARAT1_THELN Aromatic-amino-acid aminotransferase 1 OS=Thermococcus litoralis (strain ATCC 51850 / DSM 5473 / JCM 8560 / NS-C) OX=523849 GN=OCC_04335 PE=1 SV=1 g16530.t1 Q9PU65 30.261 499 9.8e-46 171.0 sp|Q9PU65|GCNFA_DANRE Nuclear receptor subfamily 6 group A member 1-A OS=Danio rerio OX=7955 GN=nr6a1a PE=2 SV=2 GCNFA_DANRE reviewed Nuclear receptor subfamily 6 group A member 1-A (Germ cell nuclear factor A) (GCNF-A) (zfGCNF) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0004879; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0009952; GO:0016477; GO:0022008; GO:0030917; GO:0033993; GO:0034056; GO:0042562; GO:0042803; GO:0043565; GO:0048513 animal organ development [GO:0048513]; anterior/posterior pattern specification [GO:0009952]; cell migration [GO:0016477]; midbrain-hindbrain boundary development [GO:0030917]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipid [GO:0033993] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] estrogen response element binding [GO:0034056]; hormone binding [GO:0042562]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g16532.t1 Q1LVF3 38.235 714 2.1899999999999998e-128 431.0 sp|Q1LVF3|SMG7_DANRE Nonsense-mediated mRNA decay factor SMG7 OS=Danio rerio OX=7955 GN=smg7 PE=2 SV=2 SMG7_DANRE reviewed Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000184; GO:0005697; GO:0005737; GO:0042162; GO:0043009; GO:0070034 chordate embryonic development [GO:0043009]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184] cytoplasm [GO:0005737]; telomerase holoenzyme complex [GO:0005697] telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] g16533.t1 Q6DD44 55.653 681 0.0 729.0 sp|Q6DD44|XPR1_XENLA Xenotropic and polytropic retrovirus receptor 1 homolog OS=Xenopus laevis OX=8355 GN=xpr1 PE=2 SV=1 S53A1_XENLA reviewed Solute carrier family 53 member 1 (Xenotropic and polytropic retrovirus receptor 1 homolog) Xenopus laevis (African clawed frog) GO:0000822; GO:0005315; GO:0005794; GO:0005886; GO:0006817; GO:0015562; GO:0016036; GO:0030643; GO:0035435 cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817] Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315] g16534.t1 Q5T9S5 29.838 1545 4.2800000000000003e-144 486.0 sp|Q5T9S5|CCD18_HUMAN Coiled-coil domain-containing protein 18 OS=Homo sapiens OX=9606 GN=CCDC18 PE=1 SV=1 g16535.t1 Q26481 76.027 292 8.57e-162 454.0 sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3 g16536.t1 Q9DBQ7 44.494 445 3.9999999999999998e-115 369.0 sp|Q9DBQ7|PACE1_MOUSE Protein-associating with the carboxyl-terminal domain of ezrin OS=Mus musculus OX=10090 GN=Scyl3 PE=1 SV=3 PACE1_MOUSE reviewed Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3) Mus musculus (Mouse) GO:0000139; GO:0004672; GO:0005524; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0008104; GO:0021522; GO:0030027; GO:0042802; GO:0048666 inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; neuron development [GO:0048666]; spinal cord motor neuron differentiation [GO:0021522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672] g16537.t1 P97461 88.5 200 3.17e-132 372.0 sp|P97461|RS5_MOUSE Small ribosomal subunit protein uS7 OS=Mus musculus OX=10090 GN=Rps5 PE=1 SV=4 RS5_MOUSE reviewed Small ribosomal subunit protein uS7 (40S ribosomal protein S5) [Cleaved into: Small ribosomal subunit protein uS7, N-terminally processed] Mus musculus (Mouse) GO:0002181; GO:0003729; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006450; GO:0019843; GO:0022626; GO:0022627; GO:0032040; GO:0042274; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990904 cytoplasmic translation [GO:0002181]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202] mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] g16538.t1 Q8K4H1 34.286 140 2.27e-28 108.0 sp|Q8K4H1|KFA_MOUSE Kynurenine formamidase OS=Mus musculus OX=10090 GN=Afmid PE=1 SV=1 KFA_MOUSE reviewed Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) Mus musculus (Mouse) GO:0004061; GO:0005634; GO:0005737; GO:0005829; GO:0019441; GO:0034354 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; L-tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] arylformamidase activity [GO:0004061] g16540.t1 P49288 28.387 310 9.510000000000002e-21 94.7 sp|P49288|MTR1C_CHICK Melatonin receptor type 1C OS=Gallus gallus OX=9031 PE=2 SV=1 g16541.t1 P49286 25.974 308 1.35e-23 103.0 sp|P49286|MTR1B_HUMAN Melatonin receptor type 1B OS=Homo sapiens OX=9606 GN=MTNR1B PE=1 SV=1 MTR1B_HUMAN reviewed Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007268; GO:0008502; GO:0010754; GO:0042593; GO:0043010; GO:0043524; GO:0045202; GO:0045906; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0098908 camera-type eye development [GO:0043010]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908] plasma membrane [GO:0005886]; synapse [GO:0045202] G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502] g16542.t1 P49288 28.571 308 1.9e-25 107.0 sp|P49288|MTR1C_CHICK Melatonin receptor type 1C OS=Gallus gallus OX=9031 PE=2 SV=1 g16546.t1 B5XB27 41.611 149 2.6000000000000003e-32 119.0 sp|B5XB27|KFA_SALSA Kynurenine formamidase OS=Salmo salar OX=8030 GN=afmid PE=2 SV=1 g16546.t2 B5XB27 42.581 155 1e-35 128.0 sp|B5XB27|KFA_SALSA Kynurenine formamidase OS=Salmo salar OX=8030 GN=afmid PE=2 SV=1 g16547.t1 Q14CW9 41.783 359 3.44e-71 229.0 sp|Q14CW9|AT7L3_HUMAN Ataxin-7-like protein 3 OS=Homo sapiens OX=9606 GN=ATXN7L3 PE=1 SV=1 g16549.t1 Q76KB1 52.975 353 9.869999999999999e-138 398.0 sp|Q76KB1|HS2ST_CHICK Heparan sulfate 2-O-sulfotransferase 1 OS=Gallus gallus OX=9031 GN=HS2ST1 PE=1 SV=1 g16552.t1 Q920Q8 38.059 649 1.1000000000000001e-156 471.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16552.t1 Q920Q8 35.5 200 1.7000000000000001e-29 128.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16552.t1 Q920Q8 29.249 253 2.1899999999999998e-25 115.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16552.t2 Q920Q8 38.059 649 7.54e-157 471.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16552.t2 Q920Q8 35.5 200 1.59e-29 128.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16552.t2 Q920Q8 29.249 253 1.72e-25 115.0 sp|Q920Q8|NS1BP_MOUSE Influenza virus NS1A-binding protein homolog OS=Mus musculus OX=10090 GN=Ivns1abp PE=1 SV=2 NS1BP_MOUSE reviewed Influenza virus NS1A-binding protein homolog (NS1-BP) (NS1-binding protein homolog) (Kelch family protein Nd1-L) (ND1-L2) (Nd1-S) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:1990756; GO:2001243 mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g16553.t1 Q6DCZ7 32.677 609 2.68e-92 296.0 sp|Q6DCZ7|FBP1L_XENLA Formin-binding protein 1-like OS=Xenopus laevis OX=8355 GN=fnbp1l PE=1 SV=1 FBP1L_XENLA reviewed Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) Xenopus laevis (African clawed frog) GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0006914; GO:0007165; GO:0008289; GO:0031410 autophagy [GO:0006914]; endocytosis [GO:0006897]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] lipid binding [GO:0008289] g16553.t2 Q96RU3 33.019 636 2.14e-93 301.0 sp|Q96RU3|FNBP1_HUMAN Formin-binding protein 1 OS=Homo sapiens OX=9606 GN=FNBP1 PE=1 SV=2 FNBP1_HUMAN reviewed Formin-binding protein 1 (Formin-binding protein 17) (hFBP17) Homo sapiens (Human) GO:0005764; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005938; GO:0006897; GO:0007165; GO:0008289; GO:0031410; GO:0042802 endocytosis [GO:0006897]; signal transduction [GO:0007165] cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; lipid binding [GO:0008289] g16553.t3 Q6GUF4 34.965 572 7.499999999999999e-94 299.0 sp|Q6GUF4|FBP1L_XENTR Formin-binding protein 1-like OS=Xenopus tropicalis OX=8364 GN=fnbp1l PE=1 SV=1 FBP1L_XENTR reviewed Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0006914; GO:0007165; GO:0008289; GO:0031410 autophagy [GO:0006914]; endocytosis [GO:0006897]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] lipid binding [GO:0008289] g16554.t1 P51688 63.039 487 0.0 648.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g16554.t2 P51688 66.154 390 0.0 546.0 sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1 SPHM_HUMAN reviewed N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase) Homo sapiens (Human) GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062 determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484] g16558.t1 Q9JHA8 28.788 858 1.59e-77 276.0 sp|Q9JHA8|VWA7_MOUSE von Willebrand factor A domain-containing protein 7 OS=Mus musculus OX=10090 GN=Vwa7 PE=2 SV=1 g16559.t1 Q9JII1 54.822 394 4.87e-145 429.0 sp|Q9JII1|INP5E_MOUSE Phosphatidylinositol polyphosphate 5-phosphatase type IV OS=Mus musculus OX=10090 GN=Inpp5e PE=1 SV=1 INP5E_MOUSE reviewed Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86) Mus musculus (Mouse) GO:0000139; GO:0001726; GO:0004439; GO:0004445; GO:0005634; GO:0005794; GO:0005886; GO:0005929; GO:0005930; GO:0016314; GO:0017148; GO:0032580; GO:0034485; GO:0043813; GO:0046488; GO:0046856; GO:0051898; GO:0060271; GO:0106019; GO:1902140; GO:1903565 cilium assembly [GO:0060271]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; response to inositol [GO:1902140] axoneme [GO:0005930]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4,5-bisphosphate phosphatase activity [GO:0106019] g16564.t1 Q9DAW6 61.538 507 0.0 637.0 sp|Q9DAW6|PRP4_MOUSE U4/U6 small nuclear ribonucleoprotein Prp4 OS=Mus musculus OX=10090 GN=Prpf4 PE=1 SV=1 g16569.t1 Q5SKU3 33.036 224 5.78e-27 108.0 sp|Q5SKU3|ECH_THET8 Putative enoyl-CoA hydratase OS=Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) OX=300852 GN=TTHA0550 PE=1 SV=1 g16569.t2 A4YI89 32.627 236 3.44e-33 125.0 sp|A4YI89|HPCD_METS5 3-hydroxypropionyl-coenzyme A dehydratase OS=Metallosphaera sedula (strain ATCC 51363 / DSM 5348 / JCM 9185 / NBRC 15509 / TH2) OX=399549 GN=Msed_2001 PE=1 SV=1 g16570.t1 B0S5D5 37.193 285 1.8199999999999997e-54 181.0 sp|B0S5D5|ZD12A_DANRE Palmitoyltransferase ZDHHC12-A OS=Danio rerio OX=7955 GN=zdhhc12a PE=3 SV=1 g16571.t2 Q4PJX1 34.451 328 3.46e-44 160.0 sp|Q4PJX1|ODR4_MOUSE Protein odr-4 homolog OS=Mus musculus OX=10090 GN=Odr4 PE=1 SV=2 ODR4_MOUSE reviewed Protein odr-4 homolog (mODR-4) Mus musculus (Mouse) GO:0008104; GO:0016020 intracellular protein localization [GO:0008104] membrane [GO:0016020] g16571.t3 Q4PJX1 31.712 473 1.1799999999999998e-67 227.0 sp|Q4PJX1|ODR4_MOUSE Protein odr-4 homolog OS=Mus musculus OX=10090 GN=Odr4 PE=1 SV=2 ODR4_MOUSE reviewed Protein odr-4 homolog (mODR-4) Mus musculus (Mouse) GO:0008104; GO:0016020 intracellular protein localization [GO:0008104] membrane [GO:0016020] g16573.t1 P17702 61.194 134 2.41e-52 165.0 sp|P17702|RL28_RAT Large ribosomal subunit protein eL28 OS=Rattus norvegicus OX=10116 GN=Rpl28 PE=1 SV=4 g16574.t1 Q8TB37 71.374 262 1.3600000000000002e-132 382.0 sp|Q8TB37|NUBPL_HUMAN Iron-sulfur cluster transfer protein NUBPL OS=Homo sapiens OX=9606 GN=NUBPL PE=1 SV=3 NUBPL_HUMAN reviewed Iron-sulfur cluster transfer protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1) Homo sapiens (Human) GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0007005; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0140663 iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; metal ion binding [GO:0046872] g16575.t1 O61491 73.668 319 3.95e-176 499.0 sp|O61491|FLOT1_DROME Flotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1 g16576.t1 Q9WUP7 65.165 333 7.470000000000001e-166 468.0 sp|Q9WUP7|UCHL5_MOUSE Ubiquitin carboxyl-terminal hydrolase isozyme L5 OS=Mus musculus OX=10090 GN=Uchl5 PE=1 SV=2 g16579.t1 Q9Y5Z4 38.037 163 9.62e-37 130.0 sp|Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens OX=9606 GN=HEBP2 PE=1 SV=1 HEBP2_HUMAN reviewed Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062 azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] heme binding [GO:0020037] g16580.t1 Q659K0 24.274 964 2.42e-31 139.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 24.662 888 7.7e-31 137.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 24.72 894 1.0600000000000001e-29 134.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 24.444 945 5.24e-28 128.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 24.867 941 4.68e-26 122.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 23.397 936 3.9899999999999997e-25 119.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 23.652 909 7.59e-25 118.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 24.341 949 2.76e-24 116.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 23.045 959 2.76e-24 116.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 23.45 968 2.72e-23 113.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 24.012 962 5.47e-23 112.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 22.866 984 1.5500000000000001e-21 107.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16580.t1 Q659K0 22.94 898 4.01e-21 105.0 sp|Q659K0|CCNB3_CANLF G2/mitotic-specific cyclin-B3 OS=Canis lupus familiaris OX=9615 GN=CCNB3 PE=2 SV=1 g16581.t1 P97347 26.829 492 3.2000000000000003e-27 119.0 sp|P97347|RPTN_MOUSE Repetin OS=Mus musculus OX=10090 GN=Rptn PE=2 SV=2 g16581.t1 P97347 25.394 508 4.37e-23 107.0 sp|P97347|RPTN_MOUSE Repetin OS=Mus musculus OX=10090 GN=Rptn PE=2 SV=2 g16582.t1 P97347 25.391 512 2.2e-31 137.0 sp|P97347|RPTN_MOUSE Repetin OS=Mus musculus OX=10090 GN=Rptn PE=2 SV=2 g16582.t1 P97347 25.849 530 2.0400000000000002e-29 130.0 sp|P97347|RPTN_MOUSE Repetin OS=Mus musculus OX=10090 GN=Rptn PE=2 SV=2 g16582.t1 P97347 25.577 563 6.47e-29 129.0 sp|P97347|RPTN_MOUSE Repetin OS=Mus musculus OX=10090 GN=Rptn PE=2 SV=2 g16582.t1 P97347 25.0 536 8.58e-29 129.0 sp|P97347|RPTN_MOUSE Repetin OS=Mus musculus OX=10090 GN=Rptn PE=2 SV=2 g16585.t1 P98133 31.591 1684 2.74e-139 495.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 33.287 1454 1.12e-135 483.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 32.262 1463 6.79e-125 448.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 32.847 1507 4.37e-123 442.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 33.242 1453 2.1100000000000002e-122 440.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 32.6 1500 1.77e-120 433.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 33.721 1118 2.32e-103 377.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 34.391 599 1.13e-48 197.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 34.375 448 3.8e-45 186.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 30.803 685 7.02e-41 171.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 32.781 543 7.14e-41 171.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 33.656 517 2.25e-40 170.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 31.217 567 2.98e-38 163.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 33.207 527 4.800000000000001e-37 159.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 30.088 565 1.03e-34 151.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 32.909 471 1.02e-33 148.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 33.763 388 5.4400000000000005e-31 139.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 29.01 586 7.000000000000001e-31 138.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 32.091 483 1.11e-27 128.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 32.456 342 1.79e-27 127.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 28.793 646 2.22e-26 124.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 29.813 587 5.07e-25 119.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t1 P98133 46.269 134 5.6399999999999995e-24 115.0 sp|P98133|FBN1_BOVIN Fibrillin-1 OS=Bos taurus OX=9913 GN=FBN1 PE=1 SV=2 g16585.t2 P35555 31.851 1686 2.71e-139 495.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 32.768 1474 8.39e-133 474.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 32.872 1518 6.04e-121 435.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 33.219 1463 5.18e-120 432.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 32.561 1511 2.93e-118 426.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 31.462 1443 5.08e-112 406.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 33.946 598 1.83e-47 193.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 34.598 448 2.02e-44 183.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 30.855 538 2.8e-40 169.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 32.721 544 6.86e-40 168.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 33.141 519 2.36e-39 166.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 30.603 696 3.11e-39 166.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 33.889 540 4.23e-38 162.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 31.041 567 6.02e-38 162.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 29.912 565 2.51e-34 150.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 30.939 543 2.2900000000000002e-32 143.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 32.696 471 2.35e-32 143.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 30.0 540 5.52e-31 139.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 33.247 388 3.49e-29 133.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 33.041 342 4.32e-28 129.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 32.505 483 4.380000000000001e-27 126.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 29.167 648 3.25e-26 123.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 29.642 587 3.02e-24 117.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 46.269 134 3.26e-24 116.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16585.t2 P35555 47.899 119 7.320000000000001e-21 105.0 sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4 FBN1_HUMAN reviewed Fibrillin-1 [Cleaved into: Asprosin] Homo sapiens (Human) GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010467; GO:0030023; GO:0031012; GO:0033627; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0048286; GO:0071560; GO:1990314; GO:2001205 camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; lung alveolus development [GO:0048286]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] g16588.t1 Q07008 40.0 260 5.73e-30 129.0 sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3 NOTC1_RAT reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Rattus norvegicus (Rat) GO:0000122; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003266; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g16588.t1 Q07008 33.333 297 6.129999999999999e-23 107.0 sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3 NOTC1_RAT reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Rattus norvegicus (Rat) GO:0000122; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003266; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g16588.t1 Q07008 36.187 257 1.1700000000000001e-21 103.0 sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3 NOTC1_RAT reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Rattus norvegicus (Rat) GO:0000122; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003266; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888] g16591.t1 Q5RDY4 47.377 591 0.0 593.0 sp|Q5RDY4|S27A4_PONAB Long-chain fatty acid transport protein 4 OS=Pongo abelii OX=9601 GN=SLC27A4 PE=2 SV=1 S27A4_PONAB reviewed Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000166; GO:0001579; GO:0005324; GO:0005789; GO:0005886; GO:0031957; GO:0044539; GO:0047676; GO:0090434; GO:1990379 lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; medium-chain fatty acid transport [GO:0001579] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; oleoyl-CoA ligase activity [GO:0090434]; very long-chain fatty acid-CoA ligase activity [GO:0031957] g16593.t1 Q6PCJ9 49.064 267 5.17e-91 274.0 sp|Q6PCJ9|PPT2A_XENLA Lysosomal thioesterase PPT2-A OS=Xenopus laevis OX=8355 GN=ppt2-a PE=2 SV=1 g16594.t1 Q5ZJT1 45.833 360 3.77e-93 288.0 sp|Q5ZJT1|HMCES_CHICK Abasic site processing protein HMCES OS=Gallus gallus OX=9031 GN=HMCES PE=2 SV=1 HMCES_CHICK reviewed Abasic site processing protein HMCES (EC 4.-.-.-) (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (SRAP domain-containing protein 1) Gallus gallus (Chicken) GO:0003697; GO:0005657; GO:0006508; GO:0006974; GO:0008233; GO:0016446; GO:0036297; GO:0045830; GO:0097681; GO:0106300; GO:0140431; GO:0160129 DNA damage response [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; interstrand cross-link repair [GO:0036297]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; somatic hypermutation of immunoglobulin genes [GO:0016446] replication fork [GO:0005657] DNA-(abasic site) binding [GO:0140431]; peptidase activity [GO:0008233]; protein-DNA covalent cross-linking activity [GO:0160129]; single-stranded DNA binding [GO:0003697] g16595.t1 Q16513 56.83 1003 0.0 1046.0 sp|Q16513|PKN2_HUMAN Serine/threonine-protein kinase N2 OS=Homo sapiens OX=9606 GN=PKN2 PE=1 SV=1 g16599.t1 B3EWY9 29.793 1064 1.71e-106 381.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16602.t1 Q2KIN1 51.852 81 2.4400000000000003e-27 97.8 sp|Q2KIN1|DPM2_BOVIN Dolichol phosphate-mannose biosynthesis regulatory protein OS=Bos taurus OX=9913 GN=DPM2 PE=3 SV=3 g16603.t1 Q17QS4 38.551 345 1.01e-66 226.0 sp|Q17QS4|PI5L1_BOVIN Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 OS=Bos taurus OX=9913 GN=PIP5KL1 PE=2 SV=1 g16604.t1 A2RUV0 39.977 2584 0.0 1680.0 sp|A2RUV0|NOTC1_XENTR Neurogenic locus notch homolog protein 1 OS=Xenopus tropicalis OX=8364 GN=notch1 PE=1 SV=2 NOTC1_XENTR reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001525; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007411; GO:0009986; GO:0038023; GO:0043235; GO:0050793; GO:0060271; GO:0061314 angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355] cell surface [GO:0009986]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023] g16609.t1 Q5WR10 84.527 433 0.0 759.0 sp|Q5WR10|DX39B_CANLF Spliceosome RNA helicase DDX39B OS=Canis lupus familiaris OX=9615 GN=DDX39B PE=3 SV=1 DX39B_CANLF reviewed Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (DEAD box protein UAP56) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000245; GO:0000346; GO:0000398; GO:0003724; GO:0003729; GO:0005524; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006406; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0042802; GO:0043008 mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070] g16610.t1 Q9UL12 59.427 838 0.0 1066.0 sp|Q9UL12|SARDH_HUMAN Sarcosine dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=SARDH PE=1 SV=1 SARDH_HUMAN reviewed Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:1901053 sarcosine catabolic process [GO:1901053] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] sarcosine dehydrogenase activity [GO:0008480] g16611.t1 Q6GNM6 46.939 392 2.5400000000000003e-97 296.0 sp|Q6GNM6|EEIG1_XENLA Early estrogen-induced gene 1 protein OS=Xenopus laevis OX=8355 GN=eeig1 PE=2 SV=1 g16615.t1 Q6INP9 33.052 711 1.46e-109 358.0 sp|Q6INP9|BCAR3_XENLA Breast cancer anti-estrogen resistance protein 3 homolog OS=Xenopus laevis OX=8355 GN=bcar3 PE=2 SV=1 g16615.t2 Q6INP9 33.052 711 1.68e-109 357.0 sp|Q6INP9|BCAR3_XENLA Breast cancer anti-estrogen resistance protein 3 homolog OS=Xenopus laevis OX=8355 GN=bcar3 PE=2 SV=1 g16616.t1 Q4V8X4 44.358 257 2.48e-73 228.0 sp|Q4V8X4|ACBD6_DANRE Acyl-CoA-binding domain-containing protein 6 OS=Danio rerio OX=7955 GN=acbd6 PE=2 SV=1 ACBD6_DANRE reviewed Acyl-CoA-binding domain-containing protein 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000062; GO:0005634; GO:0005737; GO:0008289 cytoplasm [GO:0005737]; nucleus [GO:0005634] fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289] g16617.t1 Q05192 29.691 421 3.81e-51 197.0 sp|Q05192|FTF1B_DROME Nuclear hormone receptor FTZ-F1 beta OS=Drosophila melanogaster OX=7227 GN=Hr39 PE=1 SV=3 FTF1B_DROME reviewed Nuclear hormone receptor FTZ-F1 beta (Nuclear hormone receptor HR39) (dHR39) (Nuclear receptor subfamily 5 group B member 1) Drosophila melanogaster (Fruit fly) GO:0000978; GO:0004879; GO:0005634; GO:0006355; GO:0008270; GO:0035211 regulation of DNA-templated transcription [GO:0006355]; spermathecum morphogenesis [GO:0035211] nucleus [GO:0005634] nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g16618.t1 Q5R6L8 64.986 357 4.08e-175 496.0 sp|Q5R6L8|GPI8_PONAB GPI-anchor transamidase OS=Pongo abelii OX=9601 GN=PIGK PE=2 SV=1 GPI8_PONAB reviewed GPI-anchor transamidase (EC 2.6.1.-) (GPI-anchor transamidase component PIGK) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003923; GO:0006506; GO:0006508; GO:0016255; GO:0042765; GO:0046872 attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; proteolysis [GO:0006508] GPI-anchor transamidase complex [GO:0042765] GPI-anchor transamidase activity [GO:0003923]; metal ion binding [GO:0046872] g16619.t1 Q9WUV2 48.594 249 1.05e-77 246.0 sp|Q9WUV2|SIA7C_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 OS=Mus musculus OX=10090 GN=St6galnac3 PE=1 SV=2 SIA7C_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (EC 2.4.3.7) (GalNAc alpha-2,6-sialyltransferase III) (ST6GalNAc III) (ST6GalNAcIII) (STY) (Sialyltransferase 7C) (SIAT7-C) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001665; GO:0005654; GO:0006677; GO:0006687; GO:0008373; GO:0009100; GO:0009311; GO:0047290 ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [GO:0047290]; sialyltransferase activity [GO:0008373] g16620.t1 B2GUY0 53.374 652 0.0 674.0 sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2 MA1B1_RAT reviewed Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1) Rattus norvegicus (Rat) GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0016020; GO:0031410; GO:0036503; GO:0044322 carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571] g16620.t2 B2GUY0 51.245 683 0.0 668.0 sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2 MA1B1_RAT reviewed Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1) Rattus norvegicus (Rat) GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0016020; GO:0031410; GO:0036503; GO:0044322 carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571] g16621.t1 Q9BG99 40.092 217 4.71e-40 141.0 sp|Q9BG99|TREX1_BOVIN Three-prime repair exonuclease 1 OS=Bos taurus OX=9913 GN=TREX1 PE=1 SV=1 g16622.t1 Q9BG99 38.249 217 3.41e-36 131.0 sp|Q9BG99|TREX1_BOVIN Three-prime repair exonuclease 1 OS=Bos taurus OX=9913 GN=TREX1 PE=1 SV=1 g16623.t1 Q9BQ50 38.028 213 2.62e-36 130.0 sp|Q9BQ50|TREX2_HUMAN Three prime repair exonuclease 2 OS=Homo sapiens OX=9606 GN=TREX2 PE=1 SV=2 TREX2_HUMAN reviewed Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2) Homo sapiens (Human) GO:0000287; GO:0003677; GO:0005634; GO:0005737; GO:0006259; GO:0006281; GO:0006308; GO:0008296; GO:0008311; GO:0042803; GO:0060090 DNA catabolic process [GO:0006308]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281] cytoplasm [GO:0005737]; nucleus [GO:0005634] 3'-5'-DNA exonuclease activity [GO:0008296]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803] g16624.t1 Q9BG99 39.631 217 1.79e-39 140.0 sp|Q9BG99|TREX1_BOVIN Three-prime repair exonuclease 1 OS=Bos taurus OX=9913 GN=TREX1 PE=1 SV=1 g16625.t1 Q9BG99 39.827 231 1.21e-43 152.0 sp|Q9BG99|TREX1_BOVIN Three-prime repair exonuclease 1 OS=Bos taurus OX=9913 GN=TREX1 PE=1 SV=1 g16626.t1 P16086 63.556 2486 0.0 3184.0 sp|P16086|SPTN1_RAT Spectrin alpha chain, non-erythrocytic 1 OS=Rattus norvegicus OX=10116 GN=Sptan1 PE=1 SV=2 SPTN1_RAT reviewed Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Rattus norvegicus (Rat) GO:0005509; GO:0005516; GO:0005829; GO:0005886; GO:0005916; GO:0008091; GO:0015630; GO:0016020; GO:0016328; GO:0030018; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030864; GO:0032437; GO:0032991; GO:0033010; GO:0033270; GO:0042995; GO:0044877; GO:0051015; GO:0051693; GO:0098794; GO:0098978 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; Z disc [GO:0030018] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507] g16626.t2 P16086 63.556 2486 0.0 3185.0 sp|P16086|SPTN1_RAT Spectrin alpha chain, non-erythrocytic 1 OS=Rattus norvegicus OX=10116 GN=Sptan1 PE=1 SV=2 SPTN1_RAT reviewed Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Rattus norvegicus (Rat) GO:0005509; GO:0005516; GO:0005829; GO:0005886; GO:0005916; GO:0008091; GO:0015630; GO:0016020; GO:0016328; GO:0030018; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030864; GO:0032437; GO:0032991; GO:0033010; GO:0033270; GO:0042995; GO:0044877; GO:0051015; GO:0051693; GO:0098794; GO:0098978 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; Z disc [GO:0030018] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507] g16626.t3 P16086 63.916 2472 0.0 3196.0 sp|P16086|SPTN1_RAT Spectrin alpha chain, non-erythrocytic 1 OS=Rattus norvegicus OX=10116 GN=Sptan1 PE=1 SV=2 SPTN1_RAT reviewed Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Rattus norvegicus (Rat) GO:0005509; GO:0005516; GO:0005829; GO:0005886; GO:0005916; GO:0008091; GO:0015630; GO:0016020; GO:0016328; GO:0030018; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030864; GO:0032437; GO:0032991; GO:0033010; GO:0033270; GO:0042995; GO:0044877; GO:0051015; GO:0051693; GO:0098794; GO:0098978 actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; Z disc [GO:0030018] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; spectrin binding [GO:0030507] g16627.t1 A8E5W8 39.073 302 5.2e-64 207.0 sp|A8E5W8|CMI2B_XENTR Ciliary microtubule inner protein 2B OS=Xenopus tropicalis OX=8364 GN=cimip2b PE=2 SV=1 g16629.t1 Q9EPE9 60.657 1187 0.0 1431.0 sp|Q9EPE9|AT131_MOUSE Endoplasmic reticulum transmembrane helix translocase OS=Mus musculus OX=10090 GN=Atp13a1 PE=1 SV=2 AT131_MOUSE reviewed Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase) Mus musculus (Mouse) GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015662; GO:0016887; GO:0019829; GO:0046872; GO:0055085; GO:0140567; GO:0140569 extraction of mislocalized protein from ER membrane [GO:0140569]; intracellular calcium ion homeostasis [GO:0006874]; protein transport [GO:0015031]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; membrane protein dislocase activity [GO:0140567]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662] g16630.t1 Q9BSY4 40.659 91 2.11e-24 93.2 sp|Q9BSY4|CHCH5_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 5 OS=Homo sapiens OX=9606 GN=CHCHD5 PE=1 SV=1 g16631.t1 B3EWY9 29.54 1151 4.91e-121 427.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16631.t1 B3EWY9 35.082 305 3.8199999999999995e-30 136.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16631.t1 B3EWY9 33.01 309 1.2000000000000001e-29 134.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16631.t1 B3EWY9 33.119 311 2.09e-28 130.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16631.t1 B3EWY9 29.94 334 2.36e-27 127.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16631.t1 B3EWY9 33.333 255 2.35e-21 107.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16633.t1 Q91YU8 44.397 464 2.73e-134 400.0 sp|Q91YU8|SSF1_MOUSE Suppressor of SWI4 1 homolog OS=Mus musculus OX=10090 GN=Ppan PE=1 SV=2 g16634.t1 Q90593 84.985 646 0.0 1114.0 sp|Q90593|BIP_CHICK Endoplasmic reticulum chaperone BiP OS=Gallus gallus OX=9031 GN=HSPA5 PE=1 SV=1 g16635.t1 B3EWY9 29.589 1095 3.1e-116 412.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16635.t1 B3EWY9 38.281 256 1.18e-27 127.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16635.t1 B3EWY9 32.075 318 2.8899999999999995e-23 112.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16635.t1 B3EWY9 34.848 264 4.84e-21 105.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16637.t1 Q02395 44.162 591 1.11e-164 489.0 sp|Q02395|MTF2_MOUSE Metal-response element-binding transcription factor 2 OS=Mus musculus OX=10090 GN=Mtf2 PE=1 SV=2 MTF2_MOUSE reviewed Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2) (mPCl2) (Zinc-regulated factor 1) (ZiRF1) Mus musculus (Mouse) GO:0000977; GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0007379; GO:0008270; GO:0019827; GO:0040029; GO:0045814; GO:0048863; GO:0140003; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of gene expression, epigenetic [GO:0045814]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K36me3 reader activity [GO:0140003]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] g16638.t1 Q9V6X7 45.363 399 8.1e-123 364.0 sp|Q9V6X7|OFUT1_DROME GDP-fucose protein O-fucosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=O-fut1 PE=1 SV=1 OFUT1_DROME reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Drosophila melanogaster (Fruit fly) GO:0005112; GO:0005783; GO:0005788; GO:0006004; GO:0007219; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922 cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922] g16641.t1 Q7ZYH1 45.681 521 2.62e-151 446.0 sp|Q7ZYH1|SIN1_XENLA Target of rapamycin complex 2 subunit MAPKAP1 OS=Xenopus laevis OX=8355 GN=mapkap1 PE=2 SV=1 SIN1_XENLA reviewed Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1) Xenopus laevis (African clawed frog) GO:0000139; GO:0005546; GO:0005547; GO:0005634; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005886; GO:0031901; GO:0031902; GO:0031932; GO:0038203; GO:0048471; GO:0140767 TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932] enzyme-substrate adaptor activity [GO:0140767]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546] g16642.t1 P40426 66.381 467 0.0 546.0 sp|P40426|PBX3_HUMAN Pre-B-cell leukemia transcription factor 3 OS=Homo sapiens OX=9606 GN=PBX3 PE=1 SV=1 PBX3_HUMAN reviewed Pre-B-cell leukemia transcription factor 3 (Homeobox protein PBX3) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0002087; GO:0005634; GO:0005667; GO:0007387; GO:0007388; GO:0007420; GO:0007585; GO:0008344; GO:0009887; GO:0021516; GO:0048568; GO:0048666 adult locomotory behavior [GO:0008344]; animal organ morphogenesis [GO:0009887]; anterior compartment pattern formation [GO:0007387]; brain development [GO:0007420]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; posterior compartment specification [GO:0007388]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16642.t2 P40426 66.239 468 0.0 542.0 sp|P40426|PBX3_HUMAN Pre-B-cell leukemia transcription factor 3 OS=Homo sapiens OX=9606 GN=PBX3 PE=1 SV=1 PBX3_HUMAN reviewed Pre-B-cell leukemia transcription factor 3 (Homeobox protein PBX3) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0002087; GO:0005634; GO:0005667; GO:0007387; GO:0007388; GO:0007420; GO:0007585; GO:0008344; GO:0009887; GO:0021516; GO:0048568; GO:0048666 adult locomotory behavior [GO:0008344]; animal organ morphogenesis [GO:0009887]; anterior compartment pattern formation [GO:0007387]; brain development [GO:0007420]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; posterior compartment specification [GO:0007388]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g16646.t1 Q8VDM1 37.458 590 7.529999999999999e-104 326.0 sp|Q8VDM1|ZGPAT_MOUSE Zinc finger CCCH-type with G patch domain-containing protein OS=Mus musculus OX=10090 GN=Zgpat PE=1 SV=1 g16647.t1 Q5ZJW4 71.163 215 1.95e-115 330.0 sp|Q5ZJW4|SC22B_CHICK Vesicle-trafficking protein SEC22b OS=Gallus gallus OX=9031 GN=SEC22B PE=2 SV=1 SC22B_CHICK reviewed Vesicle-trafficking protein SEC22b (SEC22 vesicle-trafficking protein homolog B) Gallus gallus (Chicken) GO:0000139; GO:0005484; GO:0005789; GO:0006888; GO:0006890; GO:0012507; GO:0015031; GO:0031201; GO:0033116; GO:0042470; GO:0045732; GO:0048280; GO:1902902 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of autophagosome assembly [GO:1902902]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; SNARE complex [GO:0031201] SNAP receptor activity [GO:0005484] g16648.t1 P27463 63.843 484 0.0 644.0 sp|P27463|AL1A1_CHICK Aldehyde dehydrogenase 1A1 OS=Gallus gallus OX=9031 GN=ALDH1A1 PE=2 SV=1 g16649.t1 E9QAT4 39.69 839 4.3400000000000003e-157 545.0 sp|E9QAT4|SC16A_MOUSE Protein transport protein Sec16A OS=Mus musculus OX=10090 GN=Sec16a PE=1 SV=1 SC16A_MOUSE reviewed Protein transport protein Sec16A (SEC16 homolog A) (p250) Mus musculus (Mouse) GO:0000139; GO:0003400; GO:0005789; GO:0005829; GO:0006888; GO:0006893; GO:0007029; GO:0007030; GO:0012507; GO:0031090; GO:0032527; GO:0034976; GO:0048471; GO:0050821; GO:0070971; GO:0070973; GO:0072659 endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane transport [GO:0006893]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of COPII vesicle coating [GO:0003400]; response to endoplasmic reticulum stress [GO:0034976] cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471] g16650.t1 Q8JG30 29.963 267 3.14e-32 123.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g16651.t1 Q8JG30 31.731 208 1.37e-26 106.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g16653.t1 Q9Y5Q8 35.123 447 1.3e-90 291.0 sp|Q9Y5Q8|TF3C5_HUMAN General transcription factor 3C polypeptide 5 OS=Homo sapiens OX=9606 GN=GTF3C5 PE=1 SV=2 TF3C5_HUMAN reviewed General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon) Homo sapiens (Human) GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0006383; GO:0006384; GO:0035914; GO:0042791; GO:0042797 5S class rRNA transcription by RNA polymerase III [GO:0042791]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] g16654.t1 A6BMK7 47.772 404 8.09e-124 367.0 sp|A6BMK7|NEUR1_BOVIN Sialidase-1 OS=Bos taurus OX=9913 GN=NEU1 PE=2 SV=2 NEUR1_BOVIN reviewed Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) Bos taurus (Bovine) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0030054; GO:0031410; GO:0043202 ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] exo-alpha-sialidase activity [GO:0004308] g16656.t1 A6BMK7 45.455 396 2.69e-111 335.0 sp|A6BMK7|NEUR1_BOVIN Sialidase-1 OS=Bos taurus OX=9913 GN=NEU1 PE=2 SV=2 NEUR1_BOVIN reviewed Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) Bos taurus (Bovine) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0030054; GO:0031410; GO:0043202 ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] exo-alpha-sialidase activity [GO:0004308] g16657.t1 Q6DJ06 63.636 143 9.639999999999999e-61 189.0 sp|Q6DJ06|LMO42_XENTR LIM domain transcription factor LMO4.2 OS=Xenopus tropicalis OX=8364 GN=lmo4.2 PE=2 SV=1 g16658.t1 Q6PAR5 40.278 792 2.92e-158 526.0 sp|Q6PAR5|GAPD1_MOUSE GTPase-activating protein and VPS9 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gapvd1 PE=1 SV=2 GAPD1_MOUSE reviewed GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6) Mus musculus (Mouse) GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0030139; GO:0031267; GO:0032794; GO:0051223 endocytosis [GO:0006897]; regulation of protein transport [GO:0051223] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g16658.t1 Q6PAR5 54.185 454 1.81e-141 479.0 sp|Q6PAR5|GAPD1_MOUSE GTPase-activating protein and VPS9 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gapvd1 PE=1 SV=2 GAPD1_MOUSE reviewed GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6) Mus musculus (Mouse) GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0030139; GO:0031267; GO:0032794; GO:0051223 endocytosis [GO:0006897]; regulation of protein transport [GO:0051223] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886] GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] g16660.t1 Q91VF2 25.43 291 2.45e-21 94.7 sp|Q91VF2|HNMT_MOUSE Histamine N-methyltransferase OS=Mus musculus OX=10090 GN=Hnmt PE=1 SV=1 HNMT_MOUSE reviewed Histamine N-methyltransferase (HMT) (EC 2.1.1.8) Mus musculus (Mouse) GO:0001692; GO:0001695; GO:0002347; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006972; GO:0008170; GO:0014075; GO:0032259; GO:0035902; GO:0042220; GO:0046500; GO:0046539; GO:0051384; GO:0070555 histamine catabolic process [GO:0001695]; histamine metabolic process [GO:0001692]; hyperosmotic response [GO:0006972]; methylation [GO:0032259]; response to amine [GO:0014075]; response to cocaine [GO:0042220]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to interleukin-1 [GO:0070555]; response to tumor cell [GO:0002347]; S-adenosylmethionine metabolic process [GO:0046500] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] histamine N-methyltransferase activity [GO:0046539]; N-methyltransferase activity [GO:0008170] g16661.t1 P53690 37.448 478 8.01e-90 289.0 sp|P53690|MMP14_MOUSE Matrix metalloproteinase-14 OS=Mus musculus OX=10090 GN=Mmp14 PE=1 SV=3 MMP14_MOUSE reviewed Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (MT-MMP) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP) Mus musculus (Mouse) GO:0000139; GO:0001501; GO:0001503; GO:0001525; GO:0001541; GO:0001666; GO:0001935; GO:0001958; GO:0004175; GO:0004222; GO:0005178; GO:0005615; GO:0005634; GO:0005829; GO:0005886; GO:0006508; GO:0006979; GO:0008270; GO:0008584; GO:0009612; GO:0009725; GO:0010831; GO:0010954; GO:0016477; GO:0030163; GO:0030198; GO:0030307; GO:0030324; GO:0030335; GO:0030574; GO:0031012; GO:0031410; GO:0031638; GO:0035987; GO:0035988; GO:0042470; GO:0043615; GO:0043627; GO:0044354; GO:0045111; GO:0045579; GO:0045746; GO:0048701; GO:0048754; GO:0048771; GO:0051895; GO:0060322; GO:0060348; GO:0070006; GO:0071412; GO:0097094; GO:0160144; GO:0160145; GO:1903076; GO:1905523; GO:1990834 angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; bone development [GO:0060348]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to genistein [GO:0071412]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; GDF15-GFRAL signaling pathway [GO:0160144]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GDF15-GFRAL signaling pathway [GO:0160145]; negative regulation of Notch signaling pathway [GO:0045746]; ossification [GO:0001503]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g16662.t1 Q9UBS9 45.775 284 7.2e-66 249.0 sp|Q9UBS9|SUCO_HUMAN SUN domain-containing ossification factor OS=Homo sapiens OX=9606 GN=SUCO PE=1 SV=1 SUCO_HUMAN reviewed SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1) Homo sapiens (Human) GO:0001503; GO:0005737; GO:0005791; GO:0016020; GO:0030867; GO:0032967; GO:0045669; GO:0046850 ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850] cytoplasm [GO:0005737]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] g16662.t1 Q9UBS9 53.125 128 7.38e-30 133.0 sp|Q9UBS9|SUCO_HUMAN SUN domain-containing ossification factor OS=Homo sapiens OX=9606 GN=SUCO PE=1 SV=1 SUCO_HUMAN reviewed SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1) Homo sapiens (Human) GO:0001503; GO:0005737; GO:0005791; GO:0016020; GO:0030867; GO:0032967; GO:0045669; GO:0046850 ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850] cytoplasm [GO:0005737]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] g16663.t1 P42674 30.673 401 5.16e-49 179.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g16666.t1 Q5R5W2 50.0 274 1.0599999999999999e-89 277.0 sp|Q5R5W2|TADBP_PONAB TAR DNA-binding protein 43 OS=Pongo abelii OX=9601 GN=TARDBP PE=2 SV=1 TADBP_PONAB reviewed TAR DNA-binding protein 43 (TDP-43) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000785; GO:0003690; GO:0003723; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0010468; GO:0016607; GO:0031647; GO:0042752 mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] g16666.t2 Q5R5W2 50.0 274 2.1699999999999997e-89 276.0 sp|Q5R5W2|TADBP_PONAB TAR DNA-binding protein 43 OS=Pongo abelii OX=9601 GN=TARDBP PE=2 SV=1 TADBP_PONAB reviewed TAR DNA-binding protein 43 (TDP-43) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000785; GO:0003690; GO:0003723; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0010468; GO:0016607; GO:0031647; GO:0042752 mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] g16669.t1 Q6DF96 49.763 422 1.69e-144 421.0 sp|Q6DF96|QTRT2_XENLA Queuine tRNA-ribosyltransferase accessory subunit 2 OS=Xenopus laevis OX=8355 GN=qtrt2 PE=2 SV=1 QTRT2_XENLA reviewed Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1) Xenopus laevis (African clawed frog) GO:0005737; GO:0005739; GO:0005741; GO:0006400; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0140767 tRNA modification [GO:0006400] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] enzyme-substrate adaptor activity [GO:0140767]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479] g16670.t1 Q7Z442 32.552 1109 1.34e-130 465.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g16670.t1 Q7Z442 28.837 645 7.6e-73 276.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g16672.t1 Q3ZBX1 55.036 278 2.0100000000000002e-107 316.0 sp|Q3ZBX1|PIGC_BOVIN Phosphatidylinositol N-acetylglucosaminyltransferase subunit C OS=Bos taurus OX=9913 GN=PIGC PE=2 SV=1 g16673.t1 Q5K651 26.283 1267 4.12e-96 349.0 sp|Q5K651|SAMD9_HUMAN Sterile alpha motif domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SAMD9 PE=1 SV=1 SAMD9_HUMAN reviewed Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0034058; GO:0045087 endosomal vesicle fusion [GO:0034058]; innate immune response [GO:0045087] cytoplasm [GO:0005737]; cytosol [GO:0005829] g16673.t2 Q5K651 26.361 1267 1.92e-96 350.0 sp|Q5K651|SAMD9_HUMAN Sterile alpha motif domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SAMD9 PE=1 SV=1 SAMD9_HUMAN reviewed Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0034058; GO:0045087 endosomal vesicle fusion [GO:0034058]; innate immune response [GO:0045087] cytoplasm [GO:0005737]; cytosol [GO:0005829] g16674.t1 Q0VFN8 48.155 515 6.21e-130 392.0 sp|Q0VFN8|CF157_XENTR Cilia- and flagella-associated protein 157 OS=Xenopus tropicalis OX=8364 GN=cfap157 PE=2 SV=1 g16675.t1 Q5ZID0 37.037 297 1.38e-56 187.0 sp|Q5ZID0|NMRL1_CHICK NmrA-like family domain-containing protein 1 OS=Gallus gallus OX=9031 GN=NMRAL1 PE=2 SV=1 g16677.t1 A1A619 39.357 249 4.95e-46 158.0 sp|A1A619|OCAD1_XENLA OCIA domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=ociad1 PE=2 SV=3 g16678.t1 Q9P1Z9 33.946 925 6.75e-136 464.0 sp|Q9P1Z9|CC180_HUMAN Coiled-coil domain-containing protein 180 OS=Homo sapiens OX=9606 GN=CCDC180 PE=1 SV=3 g16678.t1 Q9P1Z9 32.615 650 4.47e-101 362.0 sp|Q9P1Z9|CC180_HUMAN Coiled-coil domain-containing protein 180 OS=Homo sapiens OX=9606 GN=CCDC180 PE=1 SV=3 g16679.t1 Q96RW7 27.712 848 4.8e-62 239.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 27.657 781 4.4699999999999994e-54 213.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 27.842 783 1.99e-52 208.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 25.32 782 2.1499999999999998e-52 208.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.288 757 5.86e-52 206.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.814 813 1.06e-50 202.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.551 806 1.13e-49 199.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.099 751 1.82e-49 198.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.24 766 1.67e-48 195.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.418 723 1.6999999999999998e-48 195.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.194 775 2.07e-44 182.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.719 771 8.66e-40 166.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 26.523 558 1.19e-33 146.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16679.t1 Q96RW7 25.415 602 4.47e-28 128.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g16682.t1 J3S9D9 38.676 287 2.69e-54 182.0 sp|J3S9D9|RCN2V_CROAD Reticulocalbin-2 OS=Crotalus adamanteus OX=8729 PE=1 SV=1 g16683.t1 Q7ZVB2 60.656 488 0.0 636.0 sp|Q7ZVB2|A9A1A_DANRE 4-trimethylaminobutyraldehyde dehydrogenase A OS=Danio rerio OX=7955 GN=aldh9a1a PE=2 SV=1 g16687.t1 Q6KAU4 32.979 282 1.29e-32 125.0 sp|Q6KAU4|MB12B_MOUSE Multivesicular body subunit 12B OS=Mus musculus OX=10090 GN=Mvb12b PE=1 SV=2 MB12B_MOUSE reviewed Multivesicular body subunit 12B (ESCRT-I complex subunit MVB12B) (Protein FAM125B) Mus musculus (Mouse) GO:0000813; GO:0005634; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0008289; GO:0015031; GO:0019075; GO:0031902; GO:0031982; GO:0042058; GO:0046755 protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; viral budding [GO:0046755]; virus maturation [GO:0019075] cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT I complex [GO:0000813]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982] lipid binding [GO:0008289] g16688.t1 A6BMK7 47.688 346 2.92e-102 318.0 sp|A6BMK7|NEUR1_BOVIN Sialidase-1 OS=Bos taurus OX=9913 GN=NEU1 PE=2 SV=2 NEUR1_BOVIN reviewed Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) Bos taurus (Bovine) GO:0004308; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0030054; GO:0031410; GO:0043202 ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] exo-alpha-sialidase activity [GO:0004308] g16693.t1 B3EWY9 27.342 1057 4.67e-94 342.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16693.t2 B3EWY9 27.342 1057 6.37e-94 342.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16694.t1 Q98930 34.783 207 4.9499999999999994e-23 105.0 sp|Q98930|SORL_CHICK Sortilin-related receptor (Fragment) OS=Gallus gallus OX=9031 GN=SORL1 PE=2 SV=1 g16694.t2 Q98930 34.783 207 4.9499999999999994e-23 105.0 sp|Q98930|SORL_CHICK Sortilin-related receptor (Fragment) OS=Gallus gallus OX=9031 GN=SORL1 PE=2 SV=1 g16700.t1 P07942 32.639 1008 1.2e-130 457.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16700.t1 P07942 24.773 993 1.4300000000000001e-70 267.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16700.t1 P07942 30.537 298 7.240000000000001e-29 130.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16700.t1 P07942 31.071 280 2.6e-21 106.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16700.t2 P07942 32.223 1021 6.61e-128 449.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16700.t2 P07942 24.773 993 1.14e-70 268.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16700.t2 P07942 27.34 406 7.06e-29 130.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16700.t2 P07942 31.071 280 2.6200000000000003e-21 106.0 sp|P07942|LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens OX=9606 GN=LAMB1 PE=1 SV=2 LAMB1_HUMAN reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Homo sapiens (Human) GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0005788; GO:0007155; GO:0007162; GO:0007165; GO:0007566; GO:0019899; GO:0021812; GO:0030155; GO:0030334; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043257; GO:0043259; GO:0045785; GO:0045995; GO:0048471; GO:0050679; GO:0051149; GO:0070062; GO:0098637; GO:0110011; GO:2001046 cell adhesion [GO:0007155]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] g16701.t1 Q0P5M8 60.624 513 0.0 611.0 sp|Q0P5M8|MPPA_BOVIN Mitochondrial-processing peptidase subunit alpha OS=Bos taurus OX=9913 GN=PMPCA PE=2 SV=1 MPPA_BOVIN reviewed Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) Bos taurus (Bovine) GO:0004222; GO:0005739; GO:0005743; GO:0005759; GO:0006627; GO:0016485; GO:0046872 protein processing [GO:0016485]; protein processing involved in protein targeting to mitochondrion [GO:0006627] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g16701.t2 Q0P5M8 60.624 513 0.0 610.0 sp|Q0P5M8|MPPA_BOVIN Mitochondrial-processing peptidase subunit alpha OS=Bos taurus OX=9913 GN=PMPCA PE=2 SV=1 MPPA_BOVIN reviewed Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) Bos taurus (Bovine) GO:0004222; GO:0005739; GO:0005743; GO:0005759; GO:0006627; GO:0016485; GO:0046872 protein processing [GO:0016485]; protein processing involved in protein targeting to mitochondrion [GO:0006627] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g16702.t1 P02469 30.242 992 1.57e-105 379.0 sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3 LAMB1_MOUSE reviewed Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) Mus musculus (Mouse) GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007411; GO:0007566; GO:0007611; GO:0009887; GO:0009888; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048018; GO:0048471; GO:0051149; GO:0070831; GO:0098637; GO:0110011; GO:1904395; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018] g16703.t1 A0MSJ1 37.108 1245 3.8e-114 402.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16703.t1 A0MSJ1 41.026 975 6.25e-95 343.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16703.t1 A0MSJ1 41.31 840 4.3299999999999997e-82 303.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16703.t1 A0MSJ1 40.682 821 8.58e-78 289.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16703.t1 A0MSJ1 38.371 847 8.81e-71 267.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16703.t1 A0MSJ1 41.049 648 2.6e-66 252.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16703.t1 A0MSJ1 40.693 462 1.48e-44 181.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16705.t1 Q9JHB4 43.529 340 1.0599999999999999e-91 281.0 sp|Q9JHB4|WDR31_MOUSE WD repeat-containing protein 31 OS=Mus musculus OX=10090 GN=Wdr31 PE=2 SV=1 g16706.t1 Q9Y3A0 55.357 224 2.69e-89 270.0 sp|Q9Y3A0|COQ4_HUMAN Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=COQ4 PE=1 SV=3 COQ4_HUMAN reviewed Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase) (EC 4.1.1.130) (Coenzyme Q biosynthesis protein 4 homolog) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0006744; GO:0008270; GO:0031314; GO:0032991; GO:0110142; GO:0120539 ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142] 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity [GO:0120539]; zinc ion binding [GO:0008270] g16707.t1 Q9ES74 86.667 270 4.41e-178 496.0 sp|Q9ES74|NEK7_MOUSE Serine/threonine-protein kinase Nek7 OS=Mus musculus OX=10090 GN=Nek7 PE=1 SV=1 NEK7_MOUSE reviewed Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) Mus musculus (Mouse) GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0006468; GO:0007346; GO:0009306; GO:0032206; GO:0032731; GO:0032741; GO:0035655; GO:0035865; GO:0044546; GO:0046872; GO:0050729; GO:0051604; GO:0070269; GO:0070498; GO:0106310; GO:0140677; GO:1900227 cellular response to potassium ion [GO:0035865]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-18-mediated signaling pathway [GO:0035655]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein maturation [GO:0051604]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16707.t2 Q9ES74 80.37 270 6.25e-165 462.0 sp|Q9ES74|NEK7_MOUSE Serine/threonine-protein kinase Nek7 OS=Mus musculus OX=10090 GN=Nek7 PE=1 SV=1 NEK7_MOUSE reviewed Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) Mus musculus (Mouse) GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0006468; GO:0007346; GO:0009306; GO:0032206; GO:0032731; GO:0032741; GO:0035655; GO:0035865; GO:0044546; GO:0046872; GO:0050729; GO:0051604; GO:0070269; GO:0070498; GO:0106310; GO:0140677; GO:1900227 cellular response to potassium ion [GO:0035865]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-18-mediated signaling pathway [GO:0035655]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein maturation [GO:0051604]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16707.t3 Q9ES74 76.221 307 2.3700000000000002e-169 475.0 sp|Q9ES74|NEK7_MOUSE Serine/threonine-protein kinase Nek7 OS=Mus musculus OX=10090 GN=Nek7 PE=1 SV=1 NEK7_MOUSE reviewed Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) Mus musculus (Mouse) GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0006468; GO:0007346; GO:0009306; GO:0032206; GO:0032731; GO:0032741; GO:0035655; GO:0035865; GO:0044546; GO:0046872; GO:0050729; GO:0051604; GO:0070269; GO:0070498; GO:0106310; GO:0140677; GO:1900227 cellular response to potassium ion [GO:0035865]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-18-mediated signaling pathway [GO:0035655]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein maturation [GO:0051604]; protein phosphorylation [GO:0006468]; protein secretion [GO:0009306]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16712.t1 Q95ZE9 34.237 295 1.45e-28 114.0 sp|Q95ZE9|NELFE_DROVI Negative elongation factor E OS=Drosophila virilis OX=7244 GN=Nelf-E PE=3 SV=1 g16713.t1 Q91614 73.684 190 3.6500000000000004e-103 297.0 sp|Q91614|NCS1_XENLA Neuronal calcium sensor 1 OS=Xenopus laevis OX=8355 GN=ncs1 PE=2 SV=2 g16714.t1 Q5M7G4 50.313 479 0.0 529.0 sp|Q5M7G4|KAD8_XENLA Adenylate kinase 8 OS=Xenopus laevis OX=8355 GN=ak8 PE=2 SV=1 g16715.t1 Q66HG1 35.316 269 3.2400000000000004e-36 150.0 sp|Q66HG1|DMTF1_RAT Cyclin-D-binding Myb-like transcription factor 1 OS=Rattus norvegicus OX=10116 GN=Dmtf1 PE=2 SV=2 g16716.t1 Q9H8H2 50.079 631 0.0 625.0 sp|Q9H8H2|DDX31_HUMAN ATP-dependent DNA helicase DDX31 OS=Homo sapiens OX=9606 GN=DDX31 PE=1 SV=2 g16717.t1 P63156 72.297 148 1.15e-62 200.0 sp|P63156|BARH1_RAT BarH-like 1 homeobox protein OS=Rattus norvegicus OX=10116 GN=Barhl1 PE=2 SV=1 g16721.t1 Q5SRE5 38.398 362 1.64e-73 252.0 sp|Q5SRE5|NU188_HUMAN Nucleoporin NUP188 OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1 NU188_HUMAN reviewed Nucleoporin NUP188 (hNup188) Homo sapiens (Human) GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0044611; GO:0051028 mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] structural constituent of nuclear pore [GO:0017056] g16723.t1 F6WXT2 33.604 1476 0.0 697.0 sp|F6WXT2|NU188_XENTR Nucleoporin NUP188 OS=Xenopus tropicalis OX=8364 GN=nup188 PE=2 SV=1 g16725.t1 P56965 46.786 280 3.36e-71 224.0 sp|P56965|DDAH1_BOVIN N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 OS=Bos taurus OX=9913 GN=DDAH1 PE=1 SV=3 DDAH1_BOVIN reviewed N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1) Bos taurus (Bovine) GO:0000052; GO:0006525; GO:0006809; GO:0008270; GO:0016403; GO:0016597; GO:0017014; GO:0045429 arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein nitrosylation [GO:0017014] amino acid binding [GO:0016597]; dimethylargininase activity [GO:0016403]; zinc ion binding [GO:0008270] g16726.t1 Q9QXW2 61.074 149 4.09e-59 197.0 sp|Q9QXW2|FBXW5_MOUSE F-box/WD repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Fbxw5 PE=1 SV=1 FBXW5_MOUSE reviewed F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5) Mus musculus (Mouse) GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005] protein kinase binding [GO:0019901] g16727.t1 Q969U6 54.98 251 8.79e-84 279.0 sp|Q969U6|FBXW5_HUMAN F-box/WD repeat-containing protein 5 OS=Homo sapiens OX=9606 GN=FBXW5 PE=1 SV=1 FBXW5_HUMAN reviewed F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] protein kinase binding [GO:0019901] g16728.t1 P69736 71.631 141 9.73e-70 209.0 sp|P69736|EDF1_RAT Endothelial differentiation-related factor 1 OS=Rattus norvegicus OX=10116 GN=Edf1 PE=1 SV=1 EDF1_RAT reviewed Endothelial differentiation-related factor 1 (EDF-1) (Calmodulin-associated peptide 19) (CAP-19) (Multiprotein-bridging factor 1) (MBF1) Rattus norvegicus (Rat) GO:0001094; GO:0003677; GO:0003713; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0030154 cell differentiation [GO:0030154] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713] g16728.t2 P69736 71.631 141 1.62e-69 209.0 sp|P69736|EDF1_RAT Endothelial differentiation-related factor 1 OS=Rattus norvegicus OX=10116 GN=Edf1 PE=1 SV=1 EDF1_RAT reviewed Endothelial differentiation-related factor 1 (EDF-1) (Calmodulin-associated peptide 19) (CAP-19) (Multiprotein-bridging factor 1) (MBF1) Rattus norvegicus (Rat) GO:0001094; GO:0003677; GO:0003713; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0030154 cell differentiation [GO:0030154] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713] g16729.t1 O77775 36.123 227 3e-41 162.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g16729.t1 O77775 35.023 217 2.2100000000000002e-37 151.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g16729.t2 O77775 36.123 227 2.57e-41 162.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g16729.t2 O77775 35.023 217 1.9e-37 151.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g16729.t3 O77775 36.123 227 2.5e-41 162.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g16729.t3 O77775 35.023 217 2.0500000000000003e-37 151.0 sp|O77775|NCF2_BOVIN Neutrophil cytosol factor 2 OS=Bos taurus OX=9913 GN=NCF2 PE=2 SV=1 g16730.t1 Q5XGG2 42.414 290 2.33e-78 244.0 sp|Q5XGG2|TRUB2_XENTR Pseudouridylate synthase TRUB2, mitochondrial OS=Xenopus tropicalis OX=8364 GN=Trub2 PE=2 SV=1 g16731.t1 Q25532 59.483 116 7.289999999999999e-42 137.0 sp|Q25532|VATG_MANSE V-type proton ATPase subunit G OS=Manduca sexta OX=7130 PE=3 SV=1 g16732.t1 Q66I24 66.501 403 0.0 585.0 sp|Q66I24|ASSY_DANRE Argininosuccinate synthase OS=Danio rerio OX=7955 GN=ass1 PE=2 SV=1 g16733.t1 A5PK19 44.733 655 0.0 563.0 sp|A5PK19|EFNMT_BOVIN eEF1A lysine and N-terminal methyltransferase OS=Bos taurus OX=9913 GN=METTL13 PE=2 SV=1 EFNMT_BOVIN reviewed eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)] Bos taurus (Bovine) GO:0005634; GO:0005737; GO:0005739; GO:0016279; GO:0032259 methylation [GO:0032259] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] protein-lysine N-methyltransferase activity [GO:0016279] g16734.t1 A2AL36 31.075 1358 1.29e-137 486.0 sp|A2AL36|CNTRL_MOUSE Centriolin OS=Mus musculus OX=10090 GN=Cntrl PE=1 SV=2 CNTRL_MOUSE reviewed Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110) Mus musculus (Mouse) GO:0001822; GO:0003279; GO:0003281; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0034451; GO:0035904; GO:0036064; GO:0048132; GO:0048471; GO:0060976; GO:0072687; GO:0090543; GO:0090619; GO:0097431; GO:0120103 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; meiotic spindle pole [GO:0090619]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] g16734.t1 A2AL36 26.65 1182 1.11e-68 262.0 sp|A2AL36|CNTRL_MOUSE Centriolin OS=Mus musculus OX=10090 GN=Cntrl PE=1 SV=2 CNTRL_MOUSE reviewed Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110) Mus musculus (Mouse) GO:0001822; GO:0003279; GO:0003281; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0034451; GO:0035904; GO:0036064; GO:0048132; GO:0048471; GO:0060976; GO:0072687; GO:0090543; GO:0090619; GO:0097431; GO:0120103 aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; female germ-line stem cell asymmetric division [GO:0048132]; kidney development [GO:0001822]; ventricular septum development [GO:0003281] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; meiotic spindle pole [GO:0090619]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] g16737.t1 Q9DBA6 31.613 620 5.43e-80 266.0 sp|Q9DBA6|TYSD1_MOUSE Peroxisomal leader peptide-processing protease OS=Mus musculus OX=10090 GN=Tysnd1 PE=1 SV=1 TYSD1_MOUSE reviewed Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 10 kDa form; Peroxisomal leader peptide-processing protease, 49 kDa form] Mus musculus (Mouse) GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0006508; GO:0016485; GO:0031998; GO:0042802 protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252] g16738.t1 Q8N531 36.721 433 4.8e-63 219.0 sp|Q8N531|FBXL6_HUMAN F-box/LRR-repeat protein 6 OS=Homo sapiens OX=9606 GN=FBXL6 PE=1 SV=2 g16739.t1 A0A087WRI3 41.667 240 2.0699999999999998e-54 179.0 sp|A0A087WRI3|CFA77_MOUSE Cilia- and flagella-associated protein 77 OS=Mus musculus OX=10090 GN=Cfap77 PE=1 SV=1 g16740.t1 Q3TLH4 33.386 638 6.26e-56 220.0 sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3 PRC2C_MOUSE reviewed Protein PRRC2C (BAT2 domain-containing protein 1) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) Mus musculus (Mouse) GO:0002244; GO:0005829; GO:0010494; GO:0034063 hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829] g16745.t1 Q9NYQ6 31.927 877 8.410000000000001e-125 420.0 sp|Q9NYQ6|CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens OX=9606 GN=CELSR1 PE=1 SV=1 CELR1_HUMAN reviewed Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2) Homo sapiens (Human) GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007266; GO:0007409; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0044331; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251 apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g16745.t1 Q9NYQ6 28.169 355 3.25e-24 114.0 sp|Q9NYQ6|CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens OX=9606 GN=CELSR1 PE=1 SV=1 CELR1_HUMAN reviewed Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2) Homo sapiens (Human) GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007156; GO:0007266; GO:0007409; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0044331; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251 apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell-cell adhesion mediated by cadherin [GO:0044331]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071] adherens junction [GO:0005912]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] g16748.t1 A0A1D3PCM3 61.092 293 1.53e-130 387.0 sp|A0A1D3PCM3|SST_EMEND Serine O-succinyltransferase OS=Emericella nidulans OX=162425 GN=CysA PE=1 SV=1 g16749.t1 Q8BZQ7 46.675 782 0.0 701.0 sp|Q8BZQ7|ANC2_MOUSE Anaphase-promoting complex subunit 2 OS=Mus musculus OX=10090 GN=Anapc2 PE=1 SV=2 ANC2_MOUSE reviewed Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2) Mus musculus (Mouse) GO:0005680; GO:0007091; GO:0007399; GO:0010629; GO:0030154; GO:0031145; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0070936; GO:0070979; GO:0090129; GO:0141198 anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936] anaphase-promoting complex [GO:0005680] ubiquitin protein ligase binding [GO:0031625] g16750.t1 Q641B9 54.217 166 1.3299999999999997e-54 172.0 sp|Q641B9|APC5C_XENLA Actin-related protein 2/3 complex subunit 5-C OS=Xenopus laevis OX=8355 GN=arpc5-c PE=2 SV=1 g16751.t1 Q3MHM7 77.049 122 7.569999999999999e-54 167.0 sp|Q3MHM7|RL35_BOVIN Large ribosomal subunit protein uL29 OS=Bos taurus OX=9913 GN=RPL35 PE=2 SV=3 g16752.t1 Q9LGZ2 30.588 425 5.97e-40 152.0 sp|Q9LGZ2|LCYD1_ORYSJ Putative L-cysteine desulfhydrase 1 OS=Oryza sativa subsp. japonica OX=39947 GN=Os01g0290100 PE=2 SV=1 g16755.t1 Q9VCA2 33.883 546 9.77e-85 278.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g16756.t1 B3EWY9 26.524 886 4.670000000000001e-56 219.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16757.t1 Q8BG21 35.616 146 4.2e-21 87.8 sp|Q8BG21|FLOWR_MOUSE Calcium channel flower homolog OS=Mus musculus OX=10090 GN=Cacfd1 PE=1 SV=1 FLOWR_MOUSE reviewed Calcium channel flower homolog (Calcium channel flower domain-containing protein 1) Mus musculus (Mouse) GO:0005886; GO:0006897; GO:0016192; GO:0031982; GO:0045202 endocytosis [GO:0006897]; vesicle-mediated transport [GO:0016192] plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle [GO:0031982] g16759.t1 P0C090 63.903 579 0.0 705.0 sp|P0C090|RC3H2_MOUSE Roquin-2 OS=Mus musculus OX=10090 GN=Rc3h2 PE=1 SV=1 RC3H2_MOUSE reviewed Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING-type E3 ubiquitin transferase Roquin-2) Mus musculus (Mouse) GO:0000209; GO:0000288; GO:0000932; GO:0001782; GO:0003677; GO:0003725; GO:0003729; GO:0006511; GO:0008270; GO:0009791; GO:0009986; GO:0010468; GO:0010494; GO:0010608; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:0061630; GO:1901224; GO:2000320; GO:2000628 B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-embryonic development [GO:0009791]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511] cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; P-body [GO:0000932] DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g16759.t2 P0C090 63.731 579 0.0 707.0 sp|P0C090|RC3H2_MOUSE Roquin-2 OS=Mus musculus OX=10090 GN=Rc3h2 PE=1 SV=1 RC3H2_MOUSE reviewed Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING-type E3 ubiquitin transferase Roquin-2) Mus musculus (Mouse) GO:0000209; GO:0000288; GO:0000932; GO:0001782; GO:0003677; GO:0003725; GO:0003729; GO:0006511; GO:0008270; GO:0009791; GO:0009986; GO:0010468; GO:0010494; GO:0010608; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:0061630; GO:1901224; GO:2000320; GO:2000628 B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-embryonic development [GO:0009791]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511] cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; P-body [GO:0000932] DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g16760.t1 Q6PFL0 46.732 306 4.66e-93 281.0 sp|Q6PFL0|MED27_DANRE Mediator of RNA polymerase II transcription subunit 27 OS=Danio rerio OX=7955 GN=med27 PE=2 SV=1 g16761.t1 A5PK45 48.561 556 0.0 563.0 sp|A5PK45|GT251_BOVIN Procollagen galactosyltransferase 1 OS=Bos taurus OX=9913 GN=COLGALT1 PE=2 SV=1 g16763.t1 P53412 49.096 387 2.51e-118 352.0 sp|P53412|LHX3_CHICK LIM/homeobox protein Lhx3 OS=Gallus gallus OX=9031 GN=LHX3 PE=2 SV=1 g16763.t2 P53412 49.344 381 9.52e-118 350.0 sp|P53412|LHX3_CHICK LIM/homeobox protein Lhx3 OS=Gallus gallus OX=9031 GN=LHX3 PE=2 SV=1 g16763.t3 P53412 49.344 381 2.3800000000000002e-117 350.0 sp|P53412|LHX3_CHICK LIM/homeobox protein Lhx3 OS=Gallus gallus OX=9031 GN=LHX3 PE=2 SV=1 g16764.t1 Q498M4 85.174 344 0.0 594.0 sp|Q498M4|WDR5_RAT WD repeat-containing protein 5 OS=Rattus norvegicus OX=10116 GN=Wdr5 PE=1 SV=1 WDR5_RAT reviewed WD repeat-containing protein 5 Rattus norvegicus (Rat) GO:0000122; GO:0000123; GO:0001501; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0031175; GO:0035097; GO:0042393; GO:0042800; GO:0044545; GO:0044665; GO:0044666; GO:0045722; GO:0045815; GO:0045995; GO:0048188; GO:0051302; GO:0051726; GO:0071339; GO:0140004; GO:0140109; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; positive regulation of gluconeogenesis [GO:0045722]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription initiation-coupled chromatin remodeling [GO:0045815] ATAC complex [GO:0140672]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] histone binding [GO:0042393]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4me1 reader activity [GO:0140109]; histone H3Q5ser reader activity [GO:0140004] g16767.t1 Q8BND5 33.945 327 4.35e-44 166.0 sp|Q8BND5|QSOX1_MOUSE Sulfhydryl oxidase 1 OS=Mus musculus OX=10090 GN=Qsox1 PE=1 SV=1 QSOX1_MOUSE reviewed Sulfhydryl oxidase 1 (mSOx) (EC 1.8.3.2) (Quiescin Q6) (Skin sulfhydryl oxidase) Mus musculus (Mouse) GO:0000139; GO:0003756; GO:0005615; GO:0005783; GO:0005794; GO:0006457; GO:0016242; GO:0016971; GO:0070062; GO:0071949; GO:0085029 extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]; protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] FAD binding [GO:0071949]; flavin-dependent sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756] g16768.t1 H2N4I1 48.413 126 2.8799999999999997e-34 138.0 sp|H2N4I1|QSOX1_PONAB Sulfhydryl oxidase 1 OS=Pongo abelii OX=9601 GN=QSOX1 PE=3 SV=2 g16769.t1 Q6AZW2 60.0 95 2.55e-35 126.0 sp|Q6AZW2|A1A1A_DANRE Aldo-keto reductase family 1 member A1-A OS=Danio rerio OX=7955 GN=akr1a1a PE=2 SV=2 A1A1A_DANRE reviewed Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0004032; GO:0005829; GO:0016324; GO:0042593; GO:0046185; GO:0110095; GO:0160163 aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; glucose homeostasis [GO:0042593]; sprouting angiogenesis [GO:0002040] apical plasma membrane [GO:0016324]; cytosol [GO:0005829] aldose reductase (NADPH) activity [GO:0004032]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163] g16777.t1 Q68FK8 55.483 1222 0.0 1335.0 sp|Q68FK8|DHX9_XENLA ATP-dependent RNA helicase A protein OS=Xenopus laevis OX=8355 GN=dhx9 PE=2 SV=1 DHX9_XENLA reviewed ATP-dependent RNA helicase A protein (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II) Xenopus laevis (African clawed frog) GO:0000380; GO:0000978; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0006353; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0033679; GO:0034458; GO:0035195; GO:0035613; GO:0036464; GO:0043022; GO:0043138; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050684; GO:0051028; GO:0051092; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0097165; GO:0140640; GO:1905172; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000765; GO:2000767 alternative mRNA splicing, via spliceosome [GO:0000380]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RISC complex assembly [GO:0070922] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside triphosphate diphosphatase activity [GO:0047429]; promoter-specific chromatin binding [GO:1990841]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosome binding [GO:0043022]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142] g16777.t2 Q5R874 53.659 574 0.0 616.0 sp|Q5R874|DHX9_PONAB ATP-dependent RNA helicase A OS=Pongo abelii OX=9601 GN=DHX9 PE=2 SV=1 DHX9_PONAB reviewed ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0006260; GO:0006325; GO:0006353; GO:0006954; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0033679; GO:0034458; GO:0035195; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0043022; GO:0043138; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061629; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071360; GO:0097165; GO:0140640; GO:1900152; GO:1903608; GO:1905172; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000765; GO:2000767 alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; chromatin organization [GO:0006325]; CRD-mediated mRNA stabilization [GO:0070934]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RISC complex assembly [GO:0070922] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside triphosphate diphosphatase activity [GO:0047429]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosome binding [GO:0043022]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142] g16779.t1 A0JP86 44.173 1596 0.0 1352.0 sp|A0JP86|LAMC1_XENTR Laminin subunit gamma-1 OS=Xenopus tropicalis OX=8364 GN=lamc1 PE=2 SV=1 g16780.t1 A6QP05 44.086 279 2.4200000000000002e-79 246.0 sp|A6QP05|DHR12_BOVIN Dehydrogenase/reductase SDR family member 12 OS=Bos taurus OX=9913 GN=DHRS12 PE=2 SV=1 g16780.t2 A6QP05 44.086 279 2.4200000000000002e-79 246.0 sp|A6QP05|DHR12_BOVIN Dehydrogenase/reductase SDR family member 12 OS=Bos taurus OX=9913 GN=DHRS12 PE=2 SV=1 g16780.t3 A6QP05 44.086 279 2.4200000000000002e-79 246.0 sp|A6QP05|DHR12_BOVIN Dehydrogenase/reductase SDR family member 12 OS=Bos taurus OX=9913 GN=DHRS12 PE=2 SV=1 g16781.t1 Q91VS7 51.402 107 1.03e-32 114.0 sp|Q91VS7|MGST1_MOUSE Microsomal glutathione S-transferase 1 OS=Mus musculus OX=10090 GN=Mgst1 PE=1 SV=3 MGST1_MOUSE reviewed Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mus musculus (Mouse) GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005743; GO:0005778; GO:0005783; GO:0005789; GO:0006749; GO:0009410; GO:0016020; GO:0032496; GO:0034635; GO:0042802; GO:0043295; GO:0045177; GO:0071449 cellular response to lipid hydroperoxide [GO:0071449]; glutathione metabolic process [GO:0006749]; glutathione transport [GO:0034635]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410] apical part of cell [GO:0045177]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778] glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802] g16782.t1 Q7Z591 32.7 263 2.35e-25 118.0 sp|Q7Z591|AKNA_HUMAN Microtubule organization protein AKNA OS=Homo sapiens OX=9606 GN=AKNA PE=1 SV=2 AKNA_HUMAN reviewed Microtubule organization protein AKNA (AT-hook-containing transcription factor) Homo sapiens (Human) GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0045944; GO:0050727; GO:0060232; GO:0060234 delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] DNA binding [GO:0003677] g16784.t1 Q80VW5 47.535 568 6.12e-153 482.0 sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3 WHRN_MOUSE reviewed Whirlin Mus musculus (Mouse) GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0019904; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042802; GO:0043025; GO:0043198; GO:0044303; GO:0045184; GO:0048471; GO:0050910; GO:0050953; GO:0060088; GO:0060113; GO:0060122; GO:0097440; GO:0098793; GO:0098794; GO:1990075; GO:1990227; GO:1990696 auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; apical dendrite [GO:0097440]; axon collateral [GO:0044303]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; periciliary membrane compartment [GO:1990075]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696] identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] g16784.t1 Q80VW5 57.303 89 4.22e-24 113.0 sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3 WHRN_MOUSE reviewed Whirlin Mus musculus (Mouse) GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0019904; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042802; GO:0043025; GO:0043198; GO:0044303; GO:0045184; GO:0048471; GO:0050910; GO:0050953; GO:0060088; GO:0060113; GO:0060122; GO:0097440; GO:0098793; GO:0098794; GO:1990075; GO:1990227; GO:1990696 auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; apical dendrite [GO:0097440]; axon collateral [GO:0044303]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; periciliary membrane compartment [GO:1990075]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696] identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] g16785.t1 P70052 43.839 422 7.46e-102 311.0 sp|P70052|NR2E1_XENLA Nuclear receptor subfamily 2 group E member 1 OS=Xenopus laevis OX=8355 GN=nr2e1 PE=2 SV=1 g16785.t2 P70052 43.839 422 6.99e-102 311.0 sp|P70052|NR2E1_XENLA Nuclear receptor subfamily 2 group E member 1 OS=Xenopus laevis OX=8355 GN=nr2e1 PE=2 SV=1 g16786.t1 A0MSJ1 36.191 1108 1.95e-113 388.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16786.t1 A0MSJ1 42.954 738 3.13e-78 285.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16786.t1 A0MSJ1 41.577 647 5.659999999999999e-60 228.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16786.t1 A0MSJ1 38.975 644 8.869999999999999e-48 190.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16786.t1 A0MSJ1 41.339 433 2.9700000000000002e-33 143.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16787.t1 Q64739 38.789 776 3.41e-90 313.0 sp|Q64739|COBA2_MOUSE Collagen alpha-2(XI) chain OS=Mus musculus OX=10090 GN=Col11a2 PE=2 SV=3 COBA2_MOUSE reviewed Collagen alpha-2(XI) chain Mus musculus (Mouse) GO:0001501; GO:0001894; GO:0002062; GO:0005201; GO:0005581; GO:0005592; GO:0007605; GO:0030020; GO:0030199; GO:0031012; GO:0046872; GO:0048705; GO:0051216; GO:0060021; GO:0060023 cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; soft palate development [GO:0060023]; tissue homeostasis [GO:0001894] collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16787.t1 Q64739 40.342 409 3.5599999999999996e-23 109.0 sp|Q64739|COBA2_MOUSE Collagen alpha-2(XI) chain OS=Mus musculus OX=10090 GN=Col11a2 PE=2 SV=3 COBA2_MOUSE reviewed Collagen alpha-2(XI) chain Mus musculus (Mouse) GO:0001501; GO:0001894; GO:0002062; GO:0005201; GO:0005581; GO:0005592; GO:0007605; GO:0030020; GO:0030199; GO:0031012; GO:0046872; GO:0048705; GO:0051216; GO:0060021; GO:0060023 cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; soft palate development [GO:0060023]; tissue homeostasis [GO:0001894] collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; extracellular matrix [GO:0031012] extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g16788.t1 Q5E9D6 37.339 233 7.11e-51 169.0 sp|Q5E9D6|HDHD3_BOVIN Haloacid dehalogenase-like hydrolase domain-containing protein 3 OS=Bos taurus OX=9913 GN=HDHD3 PE=2 SV=1 g16789.t1 Q27433 77.992 259 2.61e-139 405.0 sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1 MEC2_CAEEL reviewed Mechanosensory protein 2 Caenorhabditis elegans GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0008200; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792 detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612] neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; ion channel inhibitor activity [GO:0008200]; sodium channel activity [GO:0005272] g16792.t1 Q9CX98 43.947 380 1.4200000000000001e-105 329.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g16794.t1 Q9CX98 40.121 496 9.270000000000001e-123 372.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g16798.t1 Q9CX98 40.323 496 1.9300000000000002e-125 379.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g16799.t1 Q9CX98 40.4 500 1.08e-126 382.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g16809.t1 B3EWY9 32.865 712 8.3e-84 311.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16809.t1 B3EWY9 34.155 284 4.270000000000001e-27 126.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16809.t1 B3EWY9 33.216 283 1.95e-24 117.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16810.t1 P10079 39.269 438 4.2100000000000004e-79 271.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t1 P10079 37.757 437 5.75e-79 271.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t1 P10079 37.838 444 2.08e-77 266.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t1 P10079 38.249 434 6.65e-77 265.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t1 P10079 37.24 384 9.95e-65 231.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t1 P10079 38.507 335 2.03e-54 201.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t1 P10079 39.228 311 7.02e-53 197.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t2 P10079 39.269 438 4.2700000000000006e-79 271.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t2 P10079 37.757 437 5.94e-79 271.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t2 P10079 37.838 444 2.13e-77 266.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t2 P10079 38.249 434 6.7300000000000004e-77 265.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t2 P10079 37.24 384 1.02e-64 231.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t2 P10079 38.507 335 2.02e-54 201.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16810.t2 P10079 39.228 311 7e-53 197.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g16812.t1 D3Z8N4 82.837 571 0.0 1013.0 sp|D3Z8N4|KLH20_RAT Kelch-like protein 20 OS=Rattus norvegicus OX=10116 GN=Klhl20 PE=3 SV=1 KLH20_RAT reviewed Kelch-like protein 20 Rattus norvegicus (Rat) GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756 Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802] actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] g16813.t1 B0S794 36.19 210 6.18e-38 135.0 sp|B0S794|ANR45_DANRE Ankyrin repeat domain-containing protein 45 OS=Danio rerio OX=7955 GN=ankrd45 PE=2 SV=1 ANR45_DANRE reviewed Ankyrin repeat domain-containing protein 45 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005737; GO:0008283; GO:0030496; GO:0032154; GO:0090543 cell population proliferation [GO:0008283] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496] g16815.t1 Q9Y345 50.82 610 0.0 624.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g16816.t1 Q9Y345 52.195 615 0.0 644.0 sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3 SC6A5_HUMAN reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Homo sapiens (Human) GO:0005768; GO:0005886; GO:0006836; GO:0007268; GO:0015375; GO:0016020; GO:0031045; GO:0035725; GO:0045202; GO:0046872; GO:0060012; GO:1903804 chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g16817.t1 Q5XKL5 33.333 363 6.9499999999999995e-62 228.0 sp|Q5XKL5|BTBD8_HUMAN BTB/POZ domain-containing protein 8 OS=Homo sapiens OX=9606 GN=BTBD8 PE=1 SV=3 BTBD8_HUMAN reviewed BTB/POZ domain-containing protein 8 (AP2-interacting clathrin-endocytosis) (APache) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0016182; GO:0030122; GO:0030424; GO:0044306; GO:0048488; GO:0098850 synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; axon [GO:0030424]; extrinsic component of synaptic vesicle membrane [GO:0098850]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g16818.t1 Q5JS13 49.341 531 2.58e-155 459.0 sp|Q5JS13|RGPS1_HUMAN Ras-specific guanine nucleotide-releasing factor RalGPS1 OS=Homo sapiens OX=9606 GN=RALGPS1 PE=1 SV=1 RGPS1_HUMAN reviewed Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2) (RalGEF 2) (RalA exchange factor RalGPS1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005886; GO:0007265; GO:0032485; GO:0035556 intracellular signal transduction [GO:0035556]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g16818.t2 Q5JS13 49.156 533 2.66e-155 459.0 sp|Q5JS13|RGPS1_HUMAN Ras-specific guanine nucleotide-releasing factor RalGPS1 OS=Homo sapiens OX=9606 GN=RALGPS1 PE=1 SV=1 RGPS1_HUMAN reviewed Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2) (RalGEF 2) (RalA exchange factor RalGPS1) Homo sapiens (Human) GO:0005085; GO:0005737; GO:0005886; GO:0007265; GO:0032485; GO:0035556 intracellular signal transduction [GO:0035556]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor activity [GO:0005085] g16819.t1 Q5ZKN1 75.526 380 0.0 584.0 sp|Q5ZKN1|CDK9_CHICK Cyclin-dependent kinase 9 OS=Gallus gallus OX=9031 GN=CDK9 PE=2 SV=1 CDK9_CHICK reviewed Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) Gallus gallus (Chicken) GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0008353; GO:0032968; GO:0045944; GO:0070691; GO:0106310; GO:0120187 positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634]; P-TEFb complex [GO:0070691] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] g16824.t1 Q17CS8 54.369 412 5.299999999999999e-165 475.0 sp|Q17CS8|KAT_AEDAE Kynurenine aminotransferase OS=Aedes aegypti OX=7159 GN=KAT PE=1 SV=1 KAT_AEDAE reviewed Kynurenine aminotransferase (EC 2.6.1.-) (EC 2.6.1.63) (EC 2.6.1.7) (AeKAT) Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0005739; GO:0016212; GO:0030170; GO:0047315; GO:0097053 L-kynurenine catabolic process [GO:0097053] mitochondrion [GO:0005739] kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170] g16825.t1 P81274 56.875 640 0.0 699.0 sp|P81274|GPSM2_HUMAN G-protein-signaling modulator 2 OS=Homo sapiens OX=9606 GN=GPSM2 PE=1 SV=3 GPSM2_HUMAN reviewed G-protein-signaling modulator 2 (Mosaic protein LGN) Homo sapiens (Human) GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0009642; GO:0014069; GO:0016328; GO:0019904; GO:0032991; GO:0042802; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099645; GO:0099738; GO:1904778; GO:1905832 cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236]; response to light intensity [GO:0009642] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991] dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904] g16826.t1 Q9HCS7 60.0 315 2.2499999999999999e-119 365.0 sp|Q9HCS7|SYF1_HUMAN Pre-mRNA-splicing factor SYF1 OS=Homo sapiens OX=9606 GN=XAB2 PE=1 SV=2 SYF1_HUMAN reviewed Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2) Homo sapiens (Human) GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0071007; GO:0071013; GO:0071014 blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; DNA-templated transcription [GO:0006351]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283] catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007] g16827.t1 Q9DCD2 70.47 149 6.19e-68 224.0 sp|Q9DCD2|SYF1_MOUSE Pre-mRNA-splicing factor SYF1 OS=Mus musculus OX=10090 GN=Xab2 PE=1 SV=1 g16828.t1 Q9DCD2 66.867 332 1.65e-158 467.0 sp|Q9DCD2|SYF1_MOUSE Pre-mRNA-splicing factor SYF1 OS=Mus musculus OX=10090 GN=Xab2 PE=1 SV=1 g16830.t1 Q8IYH5 43.013 458 2.37e-102 345.0 sp|Q8IYH5|ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 OS=Homo sapiens OX=9606 GN=ZZZ3 PE=1 SV=1 ZZZ3_HUMAN reviewed ZZ-type zinc finger-containing protein 3 Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672 chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] g16830.t2 Q8IYH5 42.919 459 3.69e-102 345.0 sp|Q8IYH5|ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 OS=Homo sapiens OX=9606 GN=ZZZ3 PE=1 SV=1 ZZZ3_HUMAN reviewed ZZ-type zinc finger-containing protein 3 Homo sapiens (Human) GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672 chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357] ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] g16831.t1 P53611 76.807 332 0.0 555.0 sp|P53611|PGTB2_HUMAN Geranylgeranyl transferase type-2 subunit beta OS=Homo sapiens OX=9606 GN=RABGGTB PE=1 SV=2 PGTB2_HUMAN reviewed Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta) Homo sapiens (Human) GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006888; GO:0007601; GO:0008270; GO:0018344; GO:0031267; GO:0036211 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601] cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968] Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g16832.t1 Q60803 36.742 577 3.9100000000000003e-109 341.0 sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2 g16833.t1 Q96AE4 37.275 499 1.63e-75 258.0 sp|Q96AE4|FUBP1_HUMAN Far upstream element-binding protein 1 OS=Homo sapiens OX=9606 GN=FUBP1 PE=1 SV=3 g16833.t2 Q96AE4 37.275 499 9.49e-76 258.0 sp|Q96AE4|FUBP1_HUMAN Far upstream element-binding protein 1 OS=Homo sapiens OX=9606 GN=FUBP1 PE=1 SV=3 g16834.t1 Q5R634 37.656 401 4.36e-107 325.0 sp|Q5R634|DIK1A_PONAB Divergent protein kinase domain 1A OS=Pongo abelii OX=9601 GN=DIPK1A PE=2 SV=1 g16836.t1 Q5RF15 47.7 413 1e-131 395.0 sp|Q5RF15|TNI3K_PONAB Serine/threonine-protein kinase TNNI3K OS=Pongo abelii OX=9601 GN=TNNI3K PE=2 SV=3 TNI3K_PONAB reviewed Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (TNNI3-interacting kinase) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0046872; GO:0106310 cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g16837.t1 Q8HZ57 30.812 714 1.42e-68 244.0 sp|Q8HZ57|CCHCR_PANPA Coiled-coil alpha-helical rod protein 1 OS=Pan paniscus OX=9597 GN=CCHCR1 PE=3 SV=1 g16839.t1 Q9CX98 41.851 497 3.1499999999999995e-126 381.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g16841.t1 Q8K458 40.667 300 3.6700000000000004e-71 232.0 sp|Q8K458|PKR2_MOUSE Prokineticin receptor 2 OS=Mus musculus OX=10090 GN=Prokr2 PE=2 SV=1 g16842.t1 O14733 60.584 411 8.82e-171 487.0 sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2 g16843.t1 Q924L9 42.071 618 2.9099999999999997e-147 442.0 sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1 g16843.t2 Q924L9 43.5 600 3.2899999999999996e-150 449.0 sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1 g16846.t1 Q5ZKK5 39.016 833 6.48e-171 517.0 sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1 g16846.t2 Q5ZKK5 39.538 822 5.6e-174 525.0 sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1 g16847.t1 Q2KID0 73.575 193 6.77e-96 285.0 sp|Q2KID0|EXOS2_BOVIN Exosome complex component RRP4 OS=Bos taurus OX=9913 GN=EXOSC2 PE=2 SV=1 EXOS2_BOVIN reviewed Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Bos taurus (Bovine) GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0000956; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0030307; GO:0034475; GO:0071034; GO:0071035; GO:0071038; GO:0071051 CUT catabolic process [GO:0071034]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U4 snRNA 3'-end processing [GO:0034475] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] RNA binding [GO:0003723] g16848.t1 Q04462 62.188 1042 0.0 1333.0 sp|Q04462|SYVC_RAT Valine--tRNA ligase OS=Rattus norvegicus OX=10116 GN=Vars1 PE=2 SV=2 g16849.t1 Q9D3A8 53.109 386 2.2499999999999998e-94 305.0 sp|Q9D3A8|CAPON_MOUSE Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein OS=Mus musculus OX=10090 GN=Nos1ap PE=1 SV=3 CAPON_MOUSE reviewed Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein) Mus musculus (Mouse) GO:0002020; GO:0002102; GO:0003062; GO:0005634; GO:0005739; GO:0005829; GO:0030018; GO:0030165; GO:0030175; GO:0031434; GO:0031965; GO:0033017; GO:0035591; GO:0050998; GO:0060307; GO:0098793; GO:0098794; GO:0098974; GO:0098978 postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of heart rate by chemical signal [GO:0003062]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; podosome [GO:0002102]; postsynapse [GO:0098794]; presynapse [GO:0098793]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] mitogen-activated protein kinase kinase binding [GO:0031434]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; protease binding [GO:0002020]; signaling adaptor activity [GO:0035591] g16850.t1 Q9H4G4 52.74 146 8.55e-43 156.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g16850.t1 Q9H4G4 47.097 155 8.399999999999999e-38 142.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g16850.t1 Q9H4G4 46.405 153 1.38e-35 135.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g16850.t1 Q9H4G4 44.966 149 6.04e-34 131.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g16850.t1 Q9H4G4 40.523 153 1.11e-27 113.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g16850.t1 Q9H4G4 40.559 143 7.910000000000001e-27 110.0 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g16851.t1 Q925C0 36.585 369 2.21e-69 231.0 sp|Q925C0|SYT9_RAT Synaptotagmin-9 OS=Rattus norvegicus OX=10116 GN=Syt9 PE=1 SV=1 SYT9_RAT reviewed Synaptotagmin-9 (Synaptotagmin 5) (Synaptotagmin IX) (SytIX) (Synaptotagmin V) Rattus norvegicus (Rat) GO:0000149; GO:0001786; GO:0005513; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0016192; GO:0017158; GO:0030141; GO:0030672; GO:0031045; GO:0031340; GO:0042802; GO:0045956; GO:0046872; GO:0050796; GO:0061891; GO:0070382; GO:0098686; GO:0099502 calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; chemical synaptic transmission [GO:0007268]; detection of calcium ion [GO:0005513]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192] dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672] calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] g16852.t1 Q9H4G4 31.788 151 1.08e-21 88.2 sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3 GAPR1_HUMAN reviewed Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2) Homo sapiens (Human) GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374 positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] protein homodimerization activity [GO:0042803] g16853.t1 A7X5R6 32.292 384 1.86e-40 166.0 sp|A7X5R6|BAG6_ORNAN Large proline-rich protein BAG6 OS=Ornithorhynchus anatinus OX=9258 GN=BAG6 PE=3 SV=1 BAG6_ORNAN reviewed Large proline-rich protein BAG6 (BCL2-associated athanogene 6) (HLA-B-associated transcript 3) Ornithorhynchus anatinus (Duckbill platypus) GO:0001822; GO:0002376; GO:0005576; GO:0005634; GO:0005829; GO:0006325; GO:0006511; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0018393; GO:0030154; GO:0030324; GO:0031593; GO:0032435; GO:0036503; GO:0042771; GO:0042981; GO:0043022; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070628; GO:0071816; GO:0071818 brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune system process [GO:0002376]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022] g16854.t1 Q0VCQ4 54.639 194 3.6199999999999996e-68 214.0 sp|Q0VCQ4|RRFM_BOVIN Ribosome-recycling factor, mitochondrial OS=Bos taurus OX=9913 GN=MRRF PE=2 SV=1 g16856.t1 Q5T5J6 32.604 457 1.41e-48 190.0 sp|Q5T5J6|SWT1_HUMAN Transcriptional protein SWT1 OS=Homo sapiens OX=9606 GN=SWT1 PE=1 SV=1 g16861.t1 Q60992 39.374 927 0.0 581.0 sp|Q60992|VAV2_MOUSE Guanine nucleotide exchange factor VAV2 OS=Mus musculus OX=10090 GN=Vav2 PE=1 SV=1 VAV2_MOUSE reviewed Guanine nucleotide exchange factor VAV2 (VAV-2) Mus musculus (Mouse) GO:0001525; GO:0001784; GO:0002768; GO:0005085; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0008270; GO:0016477; GO:0030031; GO:0030032; GO:0051897 angiogenesis [GO:0001525]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; lamellipodium assembly [GO:0030032]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; zinc ion binding [GO:0008270] g16862.t1 Q3UHX9 58.177 373 6.91e-148 427.0 sp|Q3UHX9|SPOUT_MOUSE 28S rRNA (uridine-N(3))-methyltransferase OS=Mus musculus OX=10090 GN=Spout1 PE=1 SV=1 SPOUT_MOUSE reviewed 28S rRNA (uridine-N(3))-methyltransferase (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (Methyltransferase C9orf114 homolog) (SPOUT domain-containing methyltransferase 1) Mus musculus (Mouse) GO:0000776; GO:0008168; GO:0010608; GO:0031616; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0070042; GO:0070475; GO:0072686; GO:1904047 cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]; rRNA base methylation [GO:0070475] kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616] methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; S-adenosyl-L-methionine binding [GO:1904047] g16865.t1 Q3U0J8 28.498 586 5.2e-65 243.0 sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2 g16865.t2 Q3U0J8 28.498 586 5.02e-65 243.0 sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2 g16865.t3 Q3U0J8 28.498 586 5.06e-65 243.0 sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2 g16866.t1 A6QLU6 41.441 333 1.05e-62 229.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g16866.t2 Q9HAR2 34.366 355 1.36e-58 220.0 sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2 g16867.t1 F1QGD2 36.546 249 1.9300000000000002e-47 163.0 sp|F1QGD2|ZDH24_DANRE Probable palmitoyltransferase ZDHHC24 OS=Danio rerio OX=7955 GN=zdhhc24 PE=2 SV=1 g16868.t1 B3EWY9 29.508 1159 8.57e-105 377.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16868.t1 B3EWY9 34.296 277 2.11e-28 130.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16868.t1 B3EWY9 31.609 348 3.0099999999999997e-28 130.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16868.t1 B3EWY9 33.462 260 3.7500000000000003e-26 123.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16870.t1 Q8TF66 27.151 372 8.32e-24 111.0 sp|Q8TF66|LRC15_HUMAN Leucine-rich repeat-containing protein 15 OS=Homo sapiens OX=9606 GN=LRRC15 PE=1 SV=2 LRC15_HUMAN reviewed Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib) Homo sapiens (Human) GO:0001968; GO:0005518; GO:0005886; GO:0016324; GO:0030335; GO:0038023; GO:0043236; GO:0046597; GO:0046813; GO:0051965; GO:0070062; GO:0140311; GO:1903077 host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; positive regulation of synapse assembly [GO:0051965]; receptor-mediated virion attachment to host cell [GO:0046813] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; protein sequestering activity [GO:0140311]; signaling receptor activity [GO:0038023] g16870.t2 Q8TF66 26.455 378 4.94e-25 115.0 sp|Q8TF66|LRC15_HUMAN Leucine-rich repeat-containing protein 15 OS=Homo sapiens OX=9606 GN=LRRC15 PE=1 SV=2 LRC15_HUMAN reviewed Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib) Homo sapiens (Human) GO:0001968; GO:0005518; GO:0005886; GO:0016324; GO:0030335; GO:0038023; GO:0043236; GO:0046597; GO:0046813; GO:0051965; GO:0070062; GO:0140311; GO:1903077 host-mediated suppression of symbiont invasion [GO:0046597]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; positive regulation of synapse assembly [GO:0051965]; receptor-mediated virion attachment to host cell [GO:0046813] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; protein sequestering activity [GO:0140311]; signaling receptor activity [GO:0038023] g16871.t1 B3EWY9 27.281 1129 1.7699999999999998e-94 343.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g16874.t1 Q00685 28.125 1792 0.0 605.0 sp|Q00685|CO3_LETCA Complement C3 (Fragment) OS=Lethenteron camtschaticum OX=980415 GN=C3 PE=2 SV=1 g16876.t1 P09926 42.564 195 1.6800000000000002e-43 150.0 sp|P09926|SURF2_MOUSE Surfeit locus protein 2 OS=Mus musculus OX=10090 GN=Surf2 PE=1 SV=1 g16877.t1 P04186 27.392 763 1.7699999999999998e-61 227.0 sp|P04186|CFAB_MOUSE Complement factor B OS=Mus musculus OX=10090 GN=Cfb PE=1 SV=2 g16878.t1 A2AVA0 24.364 1022 1.72e-44 181.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g16878.t1 A2AVA0 23.662 1065 3.1199999999999997e-38 161.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g16878.t1 A2AVA0 25.744 773 3.9800000000000004e-36 154.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g16878.t1 A2AVA0 23.203 1099 1.16e-33 146.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g16878.t1 A2AVA0 21.262 1030 8.810000000000001e-33 143.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g16878.t1 A2AVA0 21.409 1093 7.73e-27 124.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g16878.t1 A2AVA0 24.818 411 4.13e-25 118.0 sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1 SVEP1_MOUSE reviewed Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom) Mus musculus (Mouse) GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193 cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640] g16879.t1 Q9ES87 30.0 260 2.59e-31 129.0 sp|Q9ES87|PRSS8_RAT Prostasin OS=Rattus norvegicus OX=10116 GN=Prss8 PE=2 SV=3 PRSS8_RAT reviewed Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain] Rattus norvegicus (Rat) GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0009410; GO:0009897; GO:0010765; GO:0017080; GO:0043434; GO:0045121; GO:0051385; GO:0070633; GO:1902307 positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; transepithelial transport [GO:0070633] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] g16880.t1 Q22328 29.391 558 3.82e-59 219.0 sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3 LEV9_CAEEL reviewed Protein lev-9 Caenorhabditis elegans GO:0005615; GO:0030414; GO:0045202 extracellular space [GO:0005615]; synapse [GO:0045202] peptidase inhibitor activity [GO:0030414] g16880.t1 Q22328 25.054 459 6.949999999999999e-23 109.0 sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3 LEV9_CAEEL reviewed Protein lev-9 Caenorhabditis elegans GO:0005615; GO:0030414; GO:0045202 extracellular space [GO:0005615]; synapse [GO:0045202] peptidase inhibitor activity [GO:0030414] g16880.t2 Q22328 29.391 558 4.05e-59 219.0 sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3 LEV9_CAEEL reviewed Protein lev-9 Caenorhabditis elegans GO:0005615; GO:0030414; GO:0045202 extracellular space [GO:0005615]; synapse [GO:0045202] peptidase inhibitor activity [GO:0030414] g16880.t2 Q22328 25.054 459 6.89e-23 109.0 sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3 LEV9_CAEEL reviewed Protein lev-9 Caenorhabditis elegans GO:0005615; GO:0030414; GO:0045202 extracellular space [GO:0005615]; synapse [GO:0045202] peptidase inhibitor activity [GO:0030414] g16886.t1 P14272 34.276 283 3.88e-38 157.0 sp|P14272|KLKB1_RAT Plasma kallikrein OS=Rattus norvegicus OX=10116 GN=Klkb1 PE=1 SV=1 KLKB1_RAT reviewed Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain] Rattus norvegicus (Rat) GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0008236; GO:0031639; GO:0042730; GO:0051919; GO:0097421 blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919] extracellular space [GO:0005615] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g16887.t1 P21180 27.222 720 5.07e-51 196.0 sp|P21180|CO2_MOUSE Complement C2 OS=Mus musculus OX=10090 GN=C2 PE=1 SV=2 g16889.t1 Q99102 27.303 912 2.63e-60 230.0 sp|Q99102|MUC4_HUMAN Mucin-4 OS=Homo sapiens OX=9606 GN=MUC4 PE=1 SV=5 g16890.t1 Q6AX44 44.796 221 4.06e-51 176.0 sp|Q6AX44|FBCDA_XENLA Fibrinogen C domain-containing protein 1-A OS=Xenopus laevis OX=8355 GN=fibcd1-a PE=2 SV=1 g16891.t1 Q00546 44.397 232 1.56e-51 187.0 sp|Q00546|TENR_CHICK Tenascin-R OS=Gallus gallus OX=9031 GN=TNR PE=1 SV=1 g16892.t1 Q9N126 42.553 188 1.0899999999999999e-41 149.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g16894.t1 Q8K458 38.066 331 8.34e-65 217.0 sp|Q8K458|PKR2_MOUSE Prokineticin receptor 2 OS=Mus musculus OX=10090 GN=Prokr2 PE=2 SV=1 g16895.t1 P01024 30.629 1319 5.14e-164 536.0 sp|P01024|CO3_HUMAN Complement C3 OS=Homo sapiens OX=9606 GN=C3 PE=1 SV=2 CO3_HUMAN reviewed Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2] Homo sapiens (Human) GO:0001798; GO:0001934; GO:0001970; GO:0002430; GO:0004866; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006631; GO:0006954; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0007165; GO:0007186; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0031715; GO:0032991; GO:0034774; GO:0035578; GO:0035846; GO:0042113; GO:0045745; GO:0045766; GO:0048018; GO:0048260; GO:0060100; GO:0070062; GO:0072562; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:0160257; GO:2000427 amyloid-beta clearance [GO:0097242]; B cell activation [GO:0042113]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement activation, GZMK pathway [GO:0160257]; complement receptor mediated signaling pathway [GO:0002430]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of lipid storage [GO:0010884]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; vertebrate eye-specific patterning [GO:0150064] azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774] C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102] g16901.t1 Q99542 34.442 511 2.3e-79 259.0 sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1 MMP19_HUMAN reviewed Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18) Homo sapiens (Human) GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591 angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] g16904.t1 O02833 27.841 352 2.98e-21 99.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g16906.t1 Q6UY01 26.158 367 1.94e-23 109.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g16906.t1 Q6UY01 25.255 392 1.9599999999999997e-23 109.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g16907.t1 Q6UY01 23.788 433 4.23e-25 113.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g16907.t1 Q6UY01 24.0 425 1.8e-23 108.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g16907.t1 Q6UY01 25.071 351 4.76e-22 104.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g16907.t1 Q6UY01 23.256 430 1.1400000000000001e-21 103.0 sp|Q6UY01|LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens OX=9606 GN=LRRC31 PE=1 SV=1 g16912.t1 Q92805 32.551 341 4.27e-35 138.0 sp|Q92805|GOGA1_HUMAN Golgin subfamily A member 1 OS=Homo sapiens OX=9606 GN=GOLGA1 PE=1 SV=3 GOGA1_HUMAN reviewed Golgin subfamily A member 1 (Golgin-97) Homo sapiens (Human) GO:0000139; GO:0001669; GO:0005794; GO:0005802; GO:0005829; GO:0048471; GO:0070633; GO:0140104 transepithelial transport [GO:0070633] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] molecular carrier activity [GO:0140104] g16913.t1 Q38931 28.479 309 3.1500000000000004e-27 114.0 sp|Q38931|FKB62_ARATH Peptidyl-prolyl cis-trans isomerase FKBP62 OS=Arabidopsis thaliana OX=3702 GN=FKBP62 PE=1 SV=2 FKB62_ARATH reviewed Peptidyl-prolyl cis-trans isomerase FKBP62 (PPIase FKBP62) (EC 5.2.1.8) (70 kDa peptidyl-prolyl isomerase) (FK506-binding protein 62) (AtFKBP62) (Immunophilin FKBP62) (Peptidylprolyl isomerase ROF1) (Protein ROTAMASE FKBP 1) (Rotamase) Arabidopsis thaliana (Mouse-ear cress) GO:0003755; GO:0005516; GO:0005634; GO:0005737; GO:0005829; GO:0006970; GO:0009408; GO:0009611; GO:0009644; GO:0009845; GO:0032266; GO:0070370; GO:0071944; GO:0080025 cellular heat acclimation [GO:0070370]; response to heat [GO:0009408]; response to high light intensity [GO:0009644]; response to osmotic stress [GO:0006970]; response to wounding [GO:0009611]; seed germination [GO:0009845] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266] g16915.t1 Q9BE52 31.746 567 3.9e-51 200.0 sp|Q9BE52|CK5P2_MACFA CDK5 regulatory subunit-associated protein 2 OS=Macaca fascicularis OX=9541 GN=CDK5RAP2 PE=2 SV=1 g16924.t1 Q5R5W2 52.555 274 2.8899999999999997e-95 297.0 sp|Q5R5W2|TADBP_PONAB TAR DNA-binding protein 43 OS=Pongo abelii OX=9601 GN=TARDBP PE=2 SV=1 TADBP_PONAB reviewed TAR DNA-binding protein 43 (TDP-43) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000785; GO:0003690; GO:0003723; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0010468; GO:0016607; GO:0031647; GO:0042752 mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] g16927.t1 O75063 60.059 338 2.37e-155 444.0 sp|O75063|XYLK_HUMAN Glycosaminoglycan xylosylkinase OS=Homo sapiens OX=9606 GN=FAM20B PE=1 SV=1 XYLK_HUMAN reviewed Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) Homo sapiens (Human) GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016301; GO:0016773; GO:0030166; GO:0046872; GO:1902729 negative regulation of proteoglycan biosynthetic process [GO:1902729]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773] g16929.t1 Q5R6S0 46.619 562 0.0 550.0 sp|Q5R6S0|ABHGA_PONAB Phosphatidylserine lipase ABHD16A OS=Pongo abelii OX=9601 GN=ABHD16A PE=2 SV=1 ABHGA_PONAB reviewed Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0004620; GO:0006660; GO:0012505; GO:0016020; GO:0047372; GO:0052651 monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] endomembrane system [GO:0012505]; membrane [GO:0016020] monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620] g16930.t1 Q761V0 44.532 631 3.72e-173 516.0 sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1 SC6A5_MOUSE reviewed Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5) Mus musculus (Mouse) GO:0001504; GO:0005768; GO:0005886; GO:0015187; GO:0015375; GO:0015816; GO:0031045; GO:0035725; GO:0042734; GO:0046872; GO:0060012; GO:0098690; GO:0098810; GO:1903804 glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012] dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] g16931.t1 Q32L67 48.936 94 1.8899999999999999e-28 104.0 sp|Q32L67|GLRX2_BOVIN Glutaredoxin-2, mitochondrial OS=Bos taurus OX=9913 GN=GLRX2 PE=2 SV=1 g16932.t1 Q568K2 51.25 80 2.82e-23 89.7 sp|Q568K2|PP1RB_DANRE E3 ubiquitin-protein ligase PPP1R11 OS=Danio rerio OX=7955 GN=ppp1r11 PE=1 SV=1 g16933.t1 P60027 62.192 447 0.0 591.0 sp|P60027|TF2H4_PANTR General transcription factor IIH subunit 4 OS=Pan troglodytes OX=9598 GN=GTF2H4 PE=3 SV=1 g16934.t1 Q8RWT8 26.848 514 7.93e-46 171.0 sp|Q8RWT8|SYSM_ARATH Serine--tRNA ligase, chloroplastic/mitochondrial OS=Arabidopsis thaliana OX=3702 GN=OVA7 PE=2 SV=1 g16935.t1 A6QR06 40.0 335 1.72e-78 246.0 sp|A6QR06|TADA1_BOVIN Transcriptional adapter 1 OS=Bos taurus OX=9913 GN=TADA1 PE=2 SV=1 g16935.t2 A6QR06 39.583 336 2.49e-78 245.0 sp|A6QR06|TADA1_BOVIN Transcriptional adapter 1 OS=Bos taurus OX=9913 GN=TADA1 PE=2 SV=1 g16936.t1 Q9IB83 69.725 218 5.8399999999999995e-115 331.0 sp|Q9IB83|PSB1B_CARAU Proteasome subunit beta type-1-B OS=Carassius auratus OX=7957 GN=psmb1-B PE=2 SV=1 g16937.t1 O35900 94.737 95 1.59e-62 187.0 sp|O35900|LSM2_MOUSE U6 snRNA-associated Sm-like protein LSm2 OS=Mus musculus OX=10090 GN=Lsm2 PE=1 SV=1 g16938.t1 Q0IH40 63.077 65 1.1e-21 85.9 sp|Q0IH40|DNLZ_XENLA DNL-type zinc finger protein OS=Xenopus laevis OX=8355 GN=dnlz PE=2 SV=1 g16940.t1 P08482 27.907 430 1.65e-45 167.0 sp|P08482|ACM1_RAT Muscarinic acetylcholine receptor M1 OS=Rattus norvegicus OX=10116 GN=Chrm1 PE=1 SV=1 ACM1_RAT reviewed Muscarinic acetylcholine receptor M1 Rattus norvegicus (Rat) GO:0005886; GO:0007187; GO:0007197; GO:0007213; GO:0007268; GO:0007274; GO:0007603; GO:0009649; GO:0016907; GO:0030425; GO:0032279; GO:0040012; GO:0042734; GO:0043270; GO:0043679; GO:0045202; GO:0045211; GO:0046541; GO:0050890; GO:0060078; GO:0090316; GO:0098685; GO:0098839; GO:0098978; GO:0098981; GO:0099170 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; neuromuscular synaptic transmission [GO:0007274]; phototransduction, visible light [GO:0007603]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of monoatomic ion transport [GO:0043270]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of locomotion [GO:0040012]; regulation of postsynaptic membrane potential [GO:0060078]; saliva secretion [GO:0046541] asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] G protein-coupled acetylcholine receptor activity [GO:0016907] g16941.t1 Q7TSV3 60.256 234 1.8300000000000001e-97 286.0 sp|Q7TSV3|ZMY19_RAT Zinc finger MYND domain-containing protein 19 OS=Rattus norvegicus OX=10116 GN=Zmynd19 PE=2 SV=1 g16942.t1 O18405 66.667 270 6.4899999999999996e-139 394.0 sp|O18405|SURF4_DROME Surfeit locus protein 4 homolog OS=Drosophila melanogaster OX=7227 GN=Surf4 PE=2 SV=1 g16944.t1 Q9H7T0 30.5 400 8.77e-60 223.0 sp|Q9H7T0|CTSRB_HUMAN Cation channel sperm-associated auxiliary subunit beta OS=Homo sapiens OX=9606 GN=CATSPERB PE=1 SV=2 g16945.t1 O70497 44.783 230 5.64e-58 192.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g16946.t1 Q9H7T0 23.704 405 2.3000000000000004e-21 100.0 sp|Q9H7T0|CTSRB_HUMAN Cation channel sperm-associated auxiliary subunit beta OS=Homo sapiens OX=9606 GN=CATSPERB PE=1 SV=2 g16947.t1 Q6UWL6 29.316 307 7.83e-22 105.0 sp|Q6UWL6|KIRR2_HUMAN Kin of IRRE-like protein 2 OS=Homo sapiens OX=9606 GN=KIRREL2 PE=1 SV=3 KIRR2_HUMAN reviewed Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3) Homo sapiens (Human) GO:0005886; GO:0005911; GO:0007155; GO:0016020; GO:0036057; GO:0042802; GO:0050839; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609] cell-cell junction [GO:0005911]; membrane [GO:0016020]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057] cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802] g16948.t1 Q6DRC4 55.369 298 1.2199999999999999e-106 315.0 sp|Q6DRC4|EIF3G_DANRE Eukaryotic translation initiation factor 3 subunit G OS=Danio rerio OX=7955 GN=eif3g PE=1 SV=1 EIF3G_DANRE reviewed Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290 formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] g16949.t1 Q28717 53.355 313 1.96e-124 362.0 sp|Q28717|PTPA_RABIT Serine/threonine-protein phosphatase 2A activator OS=Oryctolagus cuniculus OX=9986 GN=PTPA PE=1 SV=1 PTPA_RABIT reviewed Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B') Oryctolagus cuniculus (Rabbit) GO:0000159; GO:0003755; GO:0005524; GO:0005634; GO:0005737; GO:0007052; GO:0008160; GO:0019888; GO:0042803; GO:0046872; GO:0051721; GO:1904949 mitotic spindle organization [GO:0007052] ATPase complex [GO:1904949]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160] g16950.t1 P47934 53.947 608 0.0 668.0 sp|P47934|CACP_MOUSE Carnitine O-acetyltransferase OS=Mus musculus OX=10090 GN=Crat PE=1 SV=3 CACP_MOUSE reviewed Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.137) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT) Mus musculus (Mouse) GO:0003997; GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005783; GO:0006631; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791 carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459] endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458] g16953.t1 Q5TAA0 27.778 414 3.71e-25 114.0 sp|Q5TAA0|TTC22_HUMAN Tetratricopeptide repeat protein 22 OS=Homo sapiens OX=9606 GN=TTC22 PE=1 SV=1 g16956.t1 Q5TAA0 28.571 504 4.48e-30 129.0 sp|Q5TAA0|TTC22_HUMAN Tetratricopeptide repeat protein 22 OS=Homo sapiens OX=9606 GN=TTC22 PE=1 SV=1 g16960.t1 Q5VVW2 55.644 877 0.0 971.0 sp|Q5VVW2|GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Homo sapiens OX=9606 GN=GARNL3 PE=1 SV=2 g16960.t2 Q5VVW2 55.721 874 0.0 967.0 sp|Q5VVW2|GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Homo sapiens OX=9606 GN=GARNL3 PE=1 SV=2 g16961.t1 Q99943 36.22 254 4.28e-51 172.0 sp|Q99943|PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2 PLCA_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15) Homo sapiens (Human) GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] g16965.t1 Q9NQX5 48.819 127 8.31e-33 128.0 sp|Q9NQX5|NPDC1_HUMAN Neural proliferation differentiation and control protein 1 OS=Homo sapiens OX=9606 GN=NPDC1 PE=1 SV=2 NPDC1_HUMAN reviewed Neural proliferation differentiation and control protein 1 (NPDC-1) Homo sapiens (Human) GO:0005886 plasma membrane [GO:0005886] g16965.t2 Q9NQX5 48.819 127 2.7900000000000002e-33 128.0 sp|Q9NQX5|NPDC1_HUMAN Neural proliferation differentiation and control protein 1 OS=Homo sapiens OX=9606 GN=NPDC1 PE=1 SV=2 NPDC1_HUMAN reviewed Neural proliferation differentiation and control protein 1 (NPDC-1) Homo sapiens (Human) GO:0005886 plasma membrane [GO:0005886] g16965.t3 Q9NQX5 44.961 129 8.74e-28 108.0 sp|Q9NQX5|NPDC1_HUMAN Neural proliferation differentiation and control protein 1 OS=Homo sapiens OX=9606 GN=NPDC1 PE=1 SV=2 NPDC1_HUMAN reviewed Neural proliferation differentiation and control protein 1 (NPDC-1) Homo sapiens (Human) GO:0005886 plasma membrane [GO:0005886] g16966.t1 Q7M370 33.58 405 1.43e-56 194.0 sp|Q7M370|AAAD_RABIT Arylacetamide deacetylase OS=Oryctolagus cuniculus OX=9986 GN=AADAC PE=1 SV=1 AAAD_RABIT reviewed Arylacetamide deacetylase (EC 3.1.1.3) (50 kDa microsomal esterase/N-deacetylase) Oryctolagus cuniculus (Rabbit) GO:0004806; GO:0005789; GO:0006629; GO:0019213 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789] deacetylase activity [GO:0019213]; triacylglycerol lipase activity [GO:0004806] g16967.t1 P29054 76.238 303 2.17e-177 495.0 sp|P29054|TF2B_XENLA Transcription initiation factor IIB OS=Xenopus laevis OX=8355 GN=gtf2b PE=2 SV=1 g16968.t1 Q8MJU1 28.667 300 6.1399999999999995e-30 120.0 sp|Q8MJU1|CASP3_FELCA Caspase-3 OS=Felis catus OX=9685 GN=CASP3 PE=2 SV=1 g16970.t1 Q5TJE1 41.152 243 9.4e-53 201.0 sp|Q5TJE1|DAXX_CANLF Death domain-associated protein 6 OS=Canis lupus familiaris OX=9615 GN=DAXX PE=3 SV=1 DAXX_CANLF reviewed Death domain-associated protein 6 (Daxx) Canis lupus familiaris (Dog) (Canis familiaris) GO:0000775; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005730; GO:0005829; GO:0006334; GO:0007254; GO:0008625; GO:0010629; GO:0016605; GO:0019901; GO:0030295; GO:0030521; GO:0031396; GO:0031625; GO:0034605; GO:0034620; GO:0036480; GO:0042393; GO:0042803; GO:0042981; GO:0045892; GO:0050681; GO:0061629; GO:0071276; GO:0071280; GO:0072738; GO:0140416; GO:1903936 androgen receptor signaling pathway [GO:0030521]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; JNK cascade [GO:0007254]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; neuron intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0036480]; nucleosome assembly [GO:0006334]; regulation of apoptotic process [GO:0042981]; regulation of protein ubiquitination [GO:0031396] chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605] histone binding [GO:0042393]; nuclear androgen receptor binding [GO:0050681]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin protein ligase binding [GO:0031625] g16971.t1 A4II29 61.818 110 2.16e-40 132.0 sp|A4II29|NRARP_XENTR Notch-regulated ankyrin repeat-containing protein OS=Xenopus tropicalis OX=8364 GN=nrarp PE=3 SV=1 g16972.t1 Q5U3U0 52.431 288 1.0200000000000001e-103 306.0 sp|Q5U3U0|PHYD1_DANRE Phytanoyl-CoA dioxygenase domain-containing protein 1 OS=Danio rerio OX=7955 GN=phyhd1 PE=2 SV=1 g16973.t1 Q8UVR3 46.561 378 1.15e-98 301.0 sp|Q8UVR3|LMX1B_XENLA LIM homeobox transcription factor 1-beta.1 OS=Xenopus laevis OX=8355 GN=lmx1b.1 PE=2 SV=1 g16978.t1 Q9D994 45.775 284 2.48e-81 252.0 sp|Q9D994|WDR38_MOUSE WD repeat-containing protein 38 OS=Mus musculus OX=10090 GN=Wdr38 PE=2 SV=1 g16979.t1 O35127 57.724 123 1.2e-40 134.0 sp|O35127|C10_MOUSE Protein C10 OS=Mus musculus OX=10090 GN=Grcc10 PE=1 SV=1 g16980.t1 Q1LZD0 32.344 337 5.48e-38 144.0 sp|Q1LZD0|AA2BR_BOVIN Adenosine receptor A2b OS=Bos taurus OX=9913 GN=ADORA2B PE=2 SV=1 g16982.t1 C3KJF2 45.69 116 1.07e-22 93.2 sp|C3KJF2|SWI5_ANOFI DNA repair protein SWI5 homolog OS=Anoplopoma fimbria OX=229290 GN=swi5 PE=2 SV=1 g16985.t1 A7MBH5 39.82 555 3.64e-109 342.0 sp|A7MBH5|ODAD3_BOVIN Outer dynein arm-docking complex subunit 3 OS=Bos taurus OX=9913 GN=ODAD3 PE=1 SV=1 ODAD3_BOVIN reviewed Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151) Bos taurus (Bovine) GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0035253; GO:0036064; GO:0036158; GO:0097542; GO:0120228; GO:1902017 cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; outer dynein arm docking complex [GO:0120228] g16987.t1 P49253 29.31 464 2.3099999999999997e-52 187.0 sp|P49253|AOF_ONCMY Amine oxidase [flavin-containing] OS=Oncorhynchus mykiss OX=8022 GN=mao PE=2 SV=2 g16988.t1 O13055 47.989 348 4.68e-120 354.0 sp|O13055|GNAI2_ORYLA Guanine nucleotide-binding protein G(i) subunit alpha-2 OS=Oryzias latipes OX=8090 GN=gnai2 PE=2 SV=3 g16989.t1 Q8TEH3 39.452 621 1.2e-132 425.0 sp|Q8TEH3|DEN1A_HUMAN DENN domain-containing protein 1A OS=Homo sapiens OX=9606 GN=DENND1A PE=1 SV=2 DEN1A_HUMAN reviewed DENN domain-containing protein 1A (Connecdenn 1) (Connecdenn) (Protein FAM31A) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0006897; GO:0015031; GO:0030136; GO:0030665; GO:0032266; GO:0032456; GO:0032483; GO:0042734; GO:1901981 endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; presynaptic membrane [GO:0042734] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266] g16989.t2 Q8TEH3 38.766 632 2.6699999999999997e-131 422.0 sp|Q8TEH3|DEN1A_HUMAN DENN domain-containing protein 1A OS=Homo sapiens OX=9606 GN=DENND1A PE=1 SV=2 DEN1A_HUMAN reviewed DENN domain-containing protein 1A (Connecdenn 1) (Connecdenn) (Protein FAM31A) Homo sapiens (Human) GO:0005085; GO:0005829; GO:0006897; GO:0015031; GO:0030136; GO:0030665; GO:0032266; GO:0032456; GO:0032483; GO:0042734; GO:1901981 endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; presynaptic membrane [GO:0042734] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266] g16990.t1 Q5VUE5 58.974 78 1.29e-24 94.7 sp|Q5VUE5|CA053_HUMAN Uncharacterized protein C1orf53 OS=Homo sapiens OX=9606 GN=C1orf53 PE=1 SV=1 g16991.t1 P57678 25.367 682 1.65e-40 166.0 sp|P57678|GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens OX=9606 GN=GEMIN4 PE=1 SV=2 GEMI4_HUMAN reviewed Gem-associated protein 4 (Gemin-4) (Component of gems 4) (p97) Homo sapiens (Human) GO:0000387; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0016604; GO:0030532; GO:0032797; GO:0034719; GO:0043021; GO:0070062; GO:0097504 rRNA processing [GO:0006364]; spliceosomal snRNP assembly [GO:0000387] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Gemini of Cajal bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] ribonucleoprotein complex binding [GO:0043021] g16992.t1 Q5T1B0 35.615 862 3.8199999999999995e-172 537.0 sp|Q5T1B0|AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens OX=9606 GN=AXDND1 PE=1 SV=1 AXDN1_HUMAN reviewed Axonemal dynein light chain domain-containing protein 1 Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0036064; GO:1905198 manchette assembly [GO:1905198]; spermatogenesis [GO:0007283] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] g16994.t1 Q8NHH1 46.073 573 6.58e-177 525.0 sp|Q8NHH1|TTL11_HUMAN Tubulin polyglutamylase TTLL11 OS=Homo sapiens OX=9606 GN=TTLL11 PE=1 SV=3 TTL11_HUMAN reviewed Tubulin polyglutamylase TTLL11 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 11) Homo sapiens (Human) GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0015631; GO:0036064; GO:0046872; GO:0051013; GO:0070740; GO:0106437; GO:0106438 microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g16995.t1 Q8CHT3 37.988 1024 1.72e-177 546.0 sp|Q8CHT3|INT5_MOUSE Integrator complex subunit 5 OS=Mus musculus OX=10090 GN=Ints5 PE=2 SV=1 g16999.t1 P53676 75.359 418 0.0 686.0 sp|P53676|AP3M1_RAT AP-3 complex subunit mu-1 OS=Rattus norvegicus OX=10116 GN=Ap3m1 PE=1 SV=1 g17000.t1 Q5T4S7 58.78 4032 0.0 4733.0 sp|Q5T4S7|UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4 PE=1 SV=1 UBR4_HUMAN reviewed E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) Homo sapiens (Human) GO:0004842; GO:0005516; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006511; GO:0006515; GO:0006979; GO:0007032; GO:0008270; GO:0010508; GO:0016020; GO:0035579; GO:0043161; GO:0044314; GO:0045717; GO:0050821; GO:0061630; GO:0070821; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0101003; GO:0140455; GO:0141191; GO:0141198; GO:1990756 cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of HRI-mediated signaling [GO:0141191]; positive regulation of autophagy [GO:0010508]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17000.t2 Q2TL32 46.837 3256 0.0 2692.0 sp|Q2TL32|UBR4_RAT E3 ubiquitin-protein ligase UBR4 OS=Rattus norvegicus OX=10116 GN=Ubr4 PE=1 SV=2 UBR4_RAT reviewed E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (N-recognin-4) (Zinc finger UBR1-type protein 1) Rattus norvegicus (Rat) GO:0004842; GO:0005516; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0006413; GO:0006511; GO:0006515; GO:0006633; GO:0006979; GO:0007032; GO:0008270; GO:0010498; GO:0010508; GO:0030163; GO:0033554; GO:0043161; GO:0044314; GO:0045717; GO:0050821; GO:0060337; GO:0061630; GO:0070936; GO:0070979; GO:0071211; GO:0071596; GO:0071629; GO:0140455; GO:0140468; GO:0141191; GO:0141198; GO:1990756 cellular response to stress [GO:0033554]; cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; fatty acid biosynthetic process [GO:0006633]; HRI-mediated signaling [GO:0140468]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of HRI-mediated signaling [GO:0141191]; positive regulation of autophagy [GO:0010508]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein catabolic process [GO:0030163]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; protein targeting to vacuole involved in autophagy [GO:0071211]; response to oxidative stress [GO:0006979]; translational initiation [GO:0006413]; type I interferon-mediated signaling pathway [GO:0060337]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17000.t3 Q2TL32 36.81 1304 0.0 727.0 sp|Q2TL32|UBR4_RAT E3 ubiquitin-protein ligase UBR4 OS=Rattus norvegicus OX=10116 GN=Ubr4 PE=1 SV=2 UBR4_RAT reviewed E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (N-recognin-4) (Zinc finger UBR1-type protein 1) Rattus norvegicus (Rat) GO:0004842; GO:0005516; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0006413; GO:0006511; GO:0006515; GO:0006633; GO:0006979; GO:0007032; GO:0008270; GO:0010498; GO:0010508; GO:0030163; GO:0033554; GO:0043161; GO:0044314; GO:0045717; GO:0050821; GO:0060337; GO:0061630; GO:0070936; GO:0070979; GO:0071211; GO:0071596; GO:0071629; GO:0140455; GO:0140468; GO:0141191; GO:0141198; GO:1990756 cellular response to stress [GO:0033554]; cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; fatty acid biosynthetic process [GO:0006633]; HRI-mediated signaling [GO:0140468]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of HRI-mediated signaling [GO:0141191]; positive regulation of autophagy [GO:0010508]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein catabolic process [GO:0030163]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; protein targeting to vacuole involved in autophagy [GO:0071211]; response to oxidative stress [GO:0006979]; translational initiation [GO:0006413]; type I interferon-mediated signaling pathway [GO:0060337]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634] calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17002.t1 Q99943 45.02 251 4.8e-69 218.0 sp|Q99943|PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2 PLCA_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15) Homo sapiens (Human) GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024 CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] g17004.t1 P0DN75 69.173 133 1.24e-63 193.0 sp|P0DN75|ISCA1_COLLI Iron-sulfur cluster assembly 1 homolog, mitochondrial OS=Columba livia OX=8932 GN=ISCA1 PE=1 SV=1 g17005.t1 P97343 33.949 433 4.5200000000000004e-66 220.0 sp|P97343|UHMK1_MOUSE Serine/threonine-protein kinase Kist OS=Mus musculus OX=10090 GN=Uhmk1 PE=1 SV=3 UHMK1_MOUSE reviewed Serine/threonine-protein kinase Kist (EC 2.7.11.1) (Kinase interacting with stathmin) (PAM COOH-terminal interactor protein 2) (P-CIP2) (U2AF homology motif kinase 1) Mus musculus (Mouse) GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0018105; GO:0019899; GO:0030424; GO:0031175; GO:0032839; GO:0043021; GO:0045948; GO:0046825; GO:0051726; GO:0071598; GO:0106310; GO:1990935 neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; regulation of cell cycle [GO:0051726]; regulation of protein export from nucleus [GO:0046825] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935] g17006.t1 Q8BY89 48.252 715 0.0 654.0 sp|Q8BY89|CTL2_MOUSE Choline transporter-like protein 2 OS=Mus musculus OX=10090 GN=Slc44a2 PE=1 SV=2 CTL2_MOUSE reviewed Choline transporter-like protein 2 (Solute carrier family 44 member 2) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0022857; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228]; transmembrane transporter activity [GO:0022857] g17006.t2 Q8BY89 48.319 714 0.0 654.0 sp|Q8BY89|CTL2_MOUSE Choline transporter-like protein 2 OS=Mus musculus OX=10090 GN=Slc44a2 PE=1 SV=2 CTL2_MOUSE reviewed Choline transporter-like protein 2 (Solute carrier family 44 member 2) Mus musculus (Mouse) GO:0005739; GO:0005741; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0022857; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228]; transmembrane transporter activity [GO:0022857] g17007.t1 Q6IP59 40.584 754 1.1299999999999999e-176 525.0 sp|Q6IP59|CTL2_XENLA Choline transporter-like protein 2 OS=Xenopus laevis OX=8355 GN=slc44a2 PE=2 SV=1 CTL2_XENLA reviewed Choline transporter-like protein 2 (Solute carrier family 44 member 2) Xenopus laevis (African clawed frog) GO:0005741; GO:0005886; GO:0015220; GO:0015297; GO:0015871; GO:0016020; GO:0022857; GO:0034228; GO:0034229; GO:0055085 choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; transmembrane transport [GO:0055085] membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228]; transmembrane transporter activity [GO:0022857] g17008.t1 Q9ER39 41.424 309 1.58e-81 254.0 sp|Q9ER39|TOR1A_MOUSE Torsin-1A OS=Mus musculus OX=10090 GN=Tor1a PE=1 SV=1 TOR1A_MOUSE reviewed Torsin-1A (Dystonia 1 protein) (Torsin ATPase 1) (EC 3.6.4.-) (Torsin family 1 member A) Mus musculus (Mouse) GO:0000338; GO:0005524; GO:0005634; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005856; GO:0006457; GO:0006979; GO:0006996; GO:0006998; GO:0007155; GO:0008021; GO:0008092; GO:0016020; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0036503; GO:0042802; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051584; GO:0051787; GO:0071763; GO:0140662; GO:1900244; GO:2000008 cell adhesion [GO:0007155]; ERAD pathway [GO:0036503]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; misfolded protein binding [GO:0051787] g17010.t1 E9Q309 31.077 1123 1.08e-84 316.0 sp|E9Q309|CE350_MOUSE Centrosome-associated protein 350 OS=Mus musculus OX=10090 GN=Cep350 PE=1 SV=1 g17010.t1 E9Q309 28.0 500 3.42e-39 166.0 sp|E9Q309|CE350_MOUSE Centrosome-associated protein 350 OS=Mus musculus OX=10090 GN=Cep350 PE=1 SV=1 g17011.t1 Q8N1B4 63.45 684 0.0 975.0 sp|Q8N1B4|VPS52_HUMAN Vacuolar protein sorting-associated protein 52 homolog OS=Homo sapiens OX=9606 GN=VPS52 PE=1 SV=1 VPS52_HUMAN reviewed Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein) Homo sapiens (Human) GO:0000938; GO:0005794; GO:0005829; GO:0006605; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:0090119; GO:0098793; GO:0098794; GO:1990745 ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein targeting [GO:0006605]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated cholesterol transport [GO:0090119] cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] syntaxin binding [GO:0019905] g17012.t1 Q8ISP0 88.816 152 1.33e-100 288.0 sp|Q8ISP0|RS18_BRABE Small ribosomal subunit protein uS13 OS=Branchiostoma belcheri OX=7741 GN=RPS18 PE=2 SV=1 g17013.t1 Q6DCP1 55.269 465 2.75e-173 499.0 sp|Q6DCP1|FXRD1_XENLA FAD-dependent oxidoreductase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=foxred1 PE=2 SV=1 g17014.t1 Q921T2 36.564 227 7.98e-30 124.0 sp|Q921T2|TOIP1_MOUSE Torsin-1A-interacting protein 1 OS=Mus musculus OX=10090 GN=Tor1aip1 PE=1 SV=3 g17018.t1 Q28FE4 76.608 171 3.02e-98 284.0 sp|Q28FE4|MORN5_XENTR MORN repeat-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=morn5 PE=2 SV=1 g17019.t1 Q15477 54.798 1261 0.0 1322.0 sp|Q15477|SKI2_HUMAN Superkiller complex protein 2 OS=Homo sapiens OX=9606 GN=SKIC2 PE=1 SV=3 g17019.t2 Q15477 52.788 1309 0.0 1299.0 sp|Q15477|SKI2_HUMAN Superkiller complex protein 2 OS=Homo sapiens OX=9606 GN=SKIC2 PE=1 SV=3 g17019.t3 Q15477 60.756 767 0.0 913.0 sp|Q15477|SKI2_HUMAN Superkiller complex protein 2 OS=Homo sapiens OX=9606 GN=SKIC2 PE=1 SV=3 g17019.t3 Q15477 46.704 531 1.14e-135 451.0 sp|Q15477|SKI2_HUMAN Superkiller complex protein 2 OS=Homo sapiens OX=9606 GN=SKIC2 PE=1 SV=3 g17020.t1 P32456 29.799 349 5.740000000000001e-32 135.0 sp|P32456|GBP2_HUMAN Guanylate-binding protein 2 OS=Homo sapiens OX=9606 GN=GBP2 PE=1 SV=3 GBP2_HUMAN reviewed Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2) Homo sapiens (Human) GO:0000139; GO:0002218; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0030659; GO:0031410; GO:0034504; GO:0042742; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0140639; GO:0140678; GO:0140973 activation of innate immune response [GO:0002218]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; positive regulation of AIM2 inflammasome complex assembly [GO:0140973]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; protein homodimerization activity [GO:0042803] g17021.t1 Q9NZL6 37.154 759 2.13e-135 421.0 sp|Q9NZL6|RGL1_HUMAN Ral guanine nucleotide dissociation stimulator-like 1 OS=Homo sapiens OX=9606 GN=RGL1 PE=1 SV=1 g17021.t2 Q9NZL6 37.383 749 3.8199999999999997e-134 417.0 sp|Q9NZL6|RGL1_HUMAN Ral guanine nucleotide dissociation stimulator-like 1 OS=Homo sapiens OX=9606 GN=RGL1 PE=1 SV=1 g17022.t1 A7RWC9 73.37 184 1.33e-97 284.0 sp|A7RWC9|ITPA_NEMVE Inosine triphosphate pyrophosphatase OS=Nematostella vectensis OX=45351 GN=v1g163483 PE=3 SV=1 ITPA_NEMVE reviewed Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.66) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (XTP/dITP diphosphatase) Nematostella vectensis (Starlet sea anemone) GO:0000166; GO:0005737; GO:0009117; GO:0009143; GO:0009204; GO:0035870; GO:0036220; GO:0036222; GO:0046872; GO:0047429 deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117] cytoplasm [GO:0005737] dITP diphosphatase activity [GO:0035870]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222] g17023.t1 Q5XI68 69.014 142 5.2299999999999994e-67 206.0 sp|Q5XI68|NC2B_RAT Protein Dr1 OS=Rattus norvegicus OX=10116 GN=Dr1 PE=2 SV=1 NC2B_RAT reviewed Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Rattus norvegicus (Rat) GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0016251; GO:0017025; GO:0017054; GO:0045995; GO:0046982; GO:0051123; GO:0051302; GO:0051726; GO:0090575; GO:0140672 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] ATAC complex [GO:0140672]; negative cofactor 2 complex [GO:0017054]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025] g17024.t1 Q8BRM2 33.518 361 4.8799999999999997e-42 156.0 sp|Q8BRM2|GORAB_MOUSE RAB6-interacting golgin OS=Mus musculus OX=10090 GN=Gorab PE=1 SV=1 GORAB_MOUSE reviewed RAB6-interacting golgin (N-terminal kinase-like-binding protein 1) (NTKL-BP1) (NTKL-binding protein 1) (mNTKL-BP1) (SCY1-like 1-binding protein 1) (SCYL1-BP1) (SCYL1-binding protein 1) Mus musculus (Mouse) GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0031069; GO:0045880; GO:1905515 hair follicle morphogenesis [GO:0031069]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g17025.t1 Q641F8 53.571 196 9.8e-69 218.0 sp|Q641F8|TYW3_XENLA tRNA wybutosine-synthesizing protein 3 homolog OS=Xenopus laevis OX=8355 GN=tyw3 PE=2 SV=1 g17026.t1 Q15058 46.35 1096 0.0 905.0 sp|Q15058|KIF14_HUMAN Kinesin-like protein KIF14 OS=Homo sapiens OX=9606 GN=KIF14 PE=1 SV=1 g17027.t1 Q05437 43.515 239 3.71e-47 160.0 sp|Q05437|PRRX1_CHICK Paired mesoderm homeobox protein 1 OS=Gallus gallus OX=9031 GN=PRRX1 PE=1 SV=2 PRRX1_CHICK reviewed Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) Gallus gallus (Chicken) GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002053; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007224; GO:0010463; GO:0016251; GO:0030326; GO:0042472; GO:0042474; GO:0045880; GO:0048664; GO:0048701; GO:0048844; GO:0051216; GO:0060021; GO:0061629; GO:0070570; GO:0071837; GO:0072089; GO:0097150; GO:2000648 artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; mesenchymal cell proliferation [GO:0010463]; middle ear morphogenesis [GO:0042474]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron projection regeneration [GO:0070570]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] g17028.t1 P49796 31.225 253 6.35e-23 109.0 sp|P49796|RGS3_HUMAN Regulator of G-protein signaling 3 OS=Homo sapiens OX=9606 GN=RGS3 PE=1 SV=2 g17029.t1 P49797 48.555 173 9.66e-43 158.0 sp|P49797|RGS3_RAT Regulator of G-protein signaling 3 OS=Rattus norvegicus OX=10116 GN=Rgs3 PE=1 SV=2 g17030.t1 P41320 71.788 358 0.0 568.0 sp|P41320|GLNA_SQUAC Glutamine synthetase, mitochondrial OS=Squalus acanthias OX=7797 PE=2 SV=1 g17031.t1 Q5RE52 38.797 665 1.47e-151 465.0 sp|Q5RE52|APC5_PONAB Anaphase-promoting complex subunit 5 OS=Pongo abelii OX=9601 GN=ANAPC5 PE=2 SV=1 g17032.t1 Q8TER0 40.496 242 4.56e-44 177.0 sp|Q8TER0|SNED1_HUMAN Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNED1 PE=1 SV=2 SNED1_HUMAN reviewed Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1) Homo sapiens (Human) GO:0005112; GO:0005509; GO:0007160; GO:0031012 cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g17032.t1 Q8TER0 36.207 290 1.27e-33 144.0 sp|Q8TER0|SNED1_HUMAN Sushi, nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SNED1 PE=1 SV=2 SNED1_HUMAN reviewed Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1) Homo sapiens (Human) GO:0005112; GO:0005509; GO:0007160; GO:0031012 cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012] calcium ion binding [GO:0005509]; Notch binding [GO:0005112] g17034.t1 Q8TDY2 25.31 1047 8.02e-57 221.0 sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3 RBCC1_HUMAN reviewed RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005764; GO:0005789; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g17034.t1 Q8TDY2 40.777 206 5.24e-44 179.0 sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3 RBCC1_HUMAN reviewed RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005764; GO:0005789; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g17034.t1 Q8TDY2 27.903 620 9.7e-36 152.0 sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3 RBCC1_HUMAN reviewed RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005764; GO:0005789; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g17034.t2 Q8TDY2 25.288 1040 3.6599999999999995e-55 214.0 sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3 RBCC1_HUMAN reviewed RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005764; GO:0005789; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g17034.t2 Q8TDY2 27.994 618 1.74e-35 151.0 sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3 RBCC1_HUMAN reviewed RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005764; GO:0005789; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g17034.t3 Q8TDY2 40.777 206 1.0400000000000001e-47 173.0 sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3 RBCC1_HUMAN reviewed RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0000425; GO:0001889; GO:0005764; GO:0005789; GO:0005829; GO:0006914; GO:0007507; GO:0008285; GO:0010508; GO:0019901; GO:0031965; GO:0034045; GO:0034517; GO:0034727; GO:0043495; GO:0045087; GO:0045793; GO:0046330; GO:0051607; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1990316; GO:2001237 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; innate immune response [GO:0045087]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; reticulophagy [GO:0061709]; ribophagy [GO:0034517] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-membrane adaptor activity [GO:0043495] g17035.t1 Q7TSK7 32.399 321 6.7e-36 147.0 sp|Q7TSK7|ATL2_MOUSE ADAMTS-like protein 2 OS=Mus musculus OX=10090 GN=Adamtsl2 PE=1 SV=1 g17036.t1 Q86TH1 33.874 493 3.6700000000000004e-73 251.0 sp|Q86TH1|ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens OX=9606 GN=ADAMTSL2 PE=1 SV=1 ATL2_HUMAN reviewed ADAMTS-like protein 2 (ADAMTSL-2) Homo sapiens (Human) GO:0005576; GO:0030198; GO:0030512; GO:0031012; GO:0050436; GO:0060481 extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] microfibril binding [GO:0050436] g17037.t1 C9J069 42.675 314 1.2199999999999999e-74 273.0 sp|C9J069|AJM1_HUMAN Apical junction component 1 homolog OS=Homo sapiens OX=9606 GN=AJM1 PE=1 SV=1 g17038.t1 Q7Z7L7 35.351 826 1.9599999999999998e-146 452.0 sp|Q7Z7L7|ZER1_HUMAN Protein zer-1 homolog OS=Homo sapiens OX=9606 GN=ZER1 PE=1 SV=1 ZER1_HUMAN reviewed Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein) (Zyg11b-like protein) Homo sapiens (Human) GO:0006515; GO:0031462; GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] Cul2-RING ubiquitin ligase complex [GO:0031462] g17039.t1 Q9NVG8 57.042 284 1.07e-115 342.0 sp|Q9NVG8|TBC13_HUMAN TBC1 domain family member 13 OS=Homo sapiens OX=9606 GN=TBC1D13 PE=1 SV=3 g17040.t1 F1R5H6 73.0 100 1.92e-48 176.0 sp|F1R5H6|BRD4_DANRE Bromodomain-containing protein 4 OS=Danio rerio OX=7955 GN=brd4 PE=1 SV=1 BRD4_DANRE reviewed Bromodomain-containing protein 4 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000785; GO:0000793; GO:0002039; GO:0002574; GO:0005634; GO:0006338; GO:0006355; GO:0032968; GO:0042393; GO:0043123; GO:0045944; GO:0050727; GO:2000330 chromatin remodeling [GO:0006338]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of DNA-templated transcription [GO:0006355]; regulation of inflammatory response [GO:0050727]; thrombocyte differentiation [GO:0002574] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nucleus [GO:0005634] histone binding [GO:0042393]; p53 binding [GO:0002039] g17041.t1 Q4R8Y1 47.071 495 2.5099999999999998e-113 377.0 sp|Q4R8Y1|BRDT_MACFA Bromodomain testis-specific protein OS=Macaca fascicularis OX=9541 GN=BRDT PE=2 SV=3 BRDT_MACFA reviewed Bromodomain testis-specific protein Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000785; GO:0005634; GO:0006338; GO:0006355; GO:0006397; GO:0007140; GO:0007141; GO:0008380; GO:0010628; GO:0035092; GO:0043484; GO:0140008 chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092] chromatin [GO:0000785]; nucleus [GO:0005634] histone H4 reader activity [GO:0140008] g17041.t2 Q4R8Y1 47.071 495 2.1299999999999998e-113 377.0 sp|Q4R8Y1|BRDT_MACFA Bromodomain testis-specific protein OS=Macaca fascicularis OX=9541 GN=BRDT PE=2 SV=3 BRDT_MACFA reviewed Bromodomain testis-specific protein Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000785; GO:0005634; GO:0006338; GO:0006355; GO:0006397; GO:0007140; GO:0007141; GO:0008380; GO:0010628; GO:0035092; GO:0043484; GO:0140008 chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092] chromatin [GO:0000785]; nucleus [GO:0005634] histone H4 reader activity [GO:0140008] g17043.t1 A2AWA9 54.873 472 0.0 549.0 sp|A2AWA9|RBGP1_MOUSE Rab GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Rabgap1 PE=1 SV=1 g17045.t1 A6QLE7 34.653 303 6.72e-48 167.0 sp|A6QLE7|GPR52_BOVIN G-protein coupled receptor 52 OS=Bos taurus OX=9913 GN=GPR52 PE=2 SV=1 GPR52_BOVIN reviewed G-protein coupled receptor 52 Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007186; GO:0007626; GO:0009410 G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; response to xenobiotic stimulus [GO:0009410] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g17046.t1 Q5R372 54.167 96 4.23e-28 110.0 sp|Q5R372|RBG1L_HUMAN Rab GTPase-activating protein 1-like OS=Homo sapiens OX=9606 GN=RABGAP1L PE=1 SV=1 RBG1L_HUMAN reviewed Rab GTPase-activating protein 1-like Homo sapiens (Human) GO:0005096; GO:0005634; GO:0005769; GO:0005794; GO:0006897; GO:0015031; GO:0031267; GO:0032880 endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g17047.t1 Q5RAN1 40.202 495 2.2e-99 325.0 sp|Q5RAN1|RBGP1_PONAB Rab GTPase-activating protein 1 OS=Pongo abelii OX=9601 GN=RABGAP1 PE=2 SV=1 g17047.t2 A2AWA9 42.283 473 2.2000000000000001e-100 326.0 sp|A2AWA9|RBGP1_MOUSE Rab GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Rabgap1 PE=1 SV=1 g17048.t1 Q5ZJA4 47.682 604 0.0 533.0 sp|Q5ZJA4|ARP5_CHICK Actin-related protein 5 OS=Gallus gallus OX=9031 GN=ACTR5 PE=2 SV=1 g17048.t2 Q5ZJA4 47.769 605 0.0 530.0 sp|Q5ZJA4|ARP5_CHICK Actin-related protein 5 OS=Gallus gallus OX=9031 GN=ACTR5 PE=2 SV=1 g17049.t1 B1H116 62.857 105 8.15e-38 130.0 sp|B1H116|UCK2_XENTR Uridine-cytidine kinase 2 OS=Xenopus tropicalis OX=8364 GN=uck2 PE=2 SV=1 g17050.t1 Q7ZV79 57.419 155 1.0699999999999999e-53 173.0 sp|Q7ZV79|UCK2B_DANRE Uridine-cytidine kinase 2-B OS=Danio rerio OX=7955 GN=uck2b PE=2 SV=1 g17054.t1 Q9R0Y5 66.304 184 2.0000000000000003e-79 258.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t1 Q9R0Y5 33.333 189 1.48e-30 122.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t1 Q9R0Y5 30.526 190 1.76e-22 99.4 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t2 Q9R0Y5 66.304 184 2.13e-79 258.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t2 Q9R0Y5 33.333 189 1.52e-30 122.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t2 Q9R0Y5 30.526 190 1.79e-22 99.4 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t3 Q9R0Y5 66.304 184 2.08e-79 258.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t3 Q9R0Y5 33.333 189 1.4099999999999999e-30 122.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t3 Q9R0Y5 30.526 190 1.73e-22 99.4 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t4 Q9R0Y5 66.304 184 2.08e-79 258.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t4 Q9R0Y5 33.333 189 1.4099999999999999e-30 122.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t4 Q9R0Y5 30.526 190 1.73e-22 99.4 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t5 Q9R0Y5 66.304 184 2.08e-79 258.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t5 Q9R0Y5 33.333 189 1.45e-30 122.0 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17054.t5 Q9R0Y5 30.526 190 1.73e-22 99.4 sp|Q9R0Y5|KAD1_MOUSE Adenylate kinase isoenzyme 1 OS=Mus musculus OX=10090 GN=Ak1 PE=1 SV=1 KAD1_MOUSE reviewed Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.4) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Mus musculus (Mouse) GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006172; GO:0009142; GO:0010828; GO:0030017; GO:0036126; GO:0046033; GO:0046034; GO:0046103; GO:0047506; GO:0048471; GO:2000045 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; inosine biosynthetic process [GO:0046103]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of D-glucose transmembrane transport [GO:0010828]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; outer dense fiber [GO:0001520]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; sperm flagellum [GO:0036126] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; dAMP kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550] g17055.t1 Q921Y2 65.363 179 2.06e-88 259.0 sp|Q921Y2|IMP3_MOUSE U3 small nucleolar ribonucleoprotein protein IMP3 OS=Mus musculus OX=10090 GN=Imp3 PE=2 SV=1 g17057.t1 Q9P2N4 28.66 806 3.11e-70 268.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g17057.t1 Q9P2N4 28.829 777 1.82e-65 252.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g17057.t1 Q9P2N4 29.255 752 4.49e-65 251.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g17057.t1 Q9P2N4 27.197 603 1.31e-40 170.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g17057.t1 Q9P2N4 30.818 318 1.69e-34 150.0 sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4 ATS9_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) Homo sapiens (Human) GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671 aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g17058.t1 Q9BYN0 57.6 125 1.5e-44 147.0 sp|Q9BYN0|SRXN1_HUMAN Sulfiredoxin-1 OS=Homo sapiens OX=9606 GN=SRXN1 PE=1 SV=2 g17059.t1 P41367 73.697 403 0.0 635.0 sp|P41367|ACADM_PIG Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Sus scrofa OX=9823 GN=ACADM PE=1 SV=3 g17060.t1 Q6MG12 41.139 158 5.87e-32 124.0 sp|Q6MG12|CF136_RAT Uncharacterized protein C6orf136 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1 g17063.t1 A4IHH4 45.848 277 1.67e-75 236.0 sp|A4IHH4|SURF1_XENTR Surfeit locus protein 1 OS=Xenopus tropicalis OX=8364 GN=surf1 PE=2 SV=1 g17064.t1 Q28J59 69.307 202 1.99e-107 313.0 sp|Q28J59|F221A_XENTR Protein FAM221A OS=Xenopus tropicalis OX=8364 GN=fam221a PE=2 SV=1 g17067.t1 Q16TM5 48.339 271 6.7000000000000005e-77 236.0 sp|Q16TM5|BND7A_AEDAE Band 7 protein AAEL010189 OS=Aedes aegypti OX=7159 GN=AAEL010189 PE=3 SV=1 g17068.t1 Q5R6Q2 58.403 238 5.41e-98 290.0 sp|Q5R6Q2|STX6_PONAB Syntaxin-6 OS=Pongo abelii OX=9601 GN=STX6 PE=2 SV=1 STX6_PONAB reviewed Syntaxin-6 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0005484; GO:0005654; GO:0005769; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0019905; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048471; GO:0055037; GO:0055038 endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906] cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; trans-Golgi network membrane [GO:0032588] SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905] g17069.t1 O94967 37.856 597 1.08e-93 319.0 sp|O94967|WDR47_HUMAN WD repeat-containing protein 47 OS=Homo sapiens OX=9606 GN=WDR47 PE=1 SV=1 WDR47_HUMAN reviewed WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin) Homo sapiens (Human) GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0008344; GO:0021801; GO:0021960; GO:0022038; GO:0030425; GO:0030426; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168 adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuronal stem cell population maintenance [GO:0097150] cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuronal cell body [GO:0043025] protein-containing complex binding [GO:0044877] g17069.t1 O94967 46.199 342 3.7e-83 290.0 sp|O94967|WDR47_HUMAN WD repeat-containing protein 47 OS=Homo sapiens OX=9606 GN=WDR47 PE=1 SV=1 WDR47_HUMAN reviewed WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin) Homo sapiens (Human) GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0008344; GO:0021801; GO:0021960; GO:0022038; GO:0030425; GO:0030426; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168 adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuronal stem cell population maintenance [GO:0097150] cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuronal cell body [GO:0043025] protein-containing complex binding [GO:0044877] g17070.t1 O08600 51.759 199 5.1099999999999995e-67 213.0 sp|O08600|NUCG_MOUSE Endonuclease G, mitochondrial OS=Mus musculus OX=10090 GN=Endog PE=1 SV=1 NUCG_MOUSE reviewed Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-) Mus musculus (Mouse) GO:0000014; GO:0000287; GO:0001701; GO:0003676; GO:0004520; GO:0004521; GO:0004536; GO:0005634; GO:0005739; GO:0005743; GO:0006308; GO:0006309; GO:0006974; GO:0009612; GO:0010508; GO:0032007; GO:0032043; GO:0032355; GO:0034599; GO:0034612; GO:0042803; GO:0043065; GO:0043204; GO:0046677; GO:0048471; GO:0071277; GO:0071333; GO:0071456; GO:0090297; GO:1901300; GO:1902512 apoptotic DNA fragmentation [GO:0006309]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; mitochondrial DNA catabolic process [GO:0032043]; negative regulation of TOR signaling [GO:0032007]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitochondrial DNA replication [GO:0090297]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] DNA endonuclease activity [GO:0004520]; DNA nuclease activity [GO:0004536]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; RNA endonuclease activity [GO:0004521]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] g17072.t1 O75445 29.71 276 3.25e-23 111.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g17072.t2 O75445 29.71 276 3.38e-23 111.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g17072.t3 O75445 29.71 276 3.6999999999999997e-23 110.0 sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3 USH2A_HUMAN reviewed Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) Homo sapiens (Human) GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] g17073.t1 Q5R4S7 54.93 142 3.69e-47 158.0 sp|Q5R4S7|QOR_PONAB Quinone oxidoreductase OS=Pongo abelii OX=9601 GN=CRYZ PE=2 SV=1 g17074.t1 P11415 59.06 149 2.67e-57 185.0 sp|P11415|QOR_CAVPO Quinone oxidoreductase OS=Cavia porcellus OX=10141 GN=CRYZ PE=1 SV=1 g17075.t1 Q91398 91.262 206 1.4e-145 407.0 sp|Q91398|CSK2B_DANRE Casein kinase II subunit beta OS=Danio rerio OX=7955 GN=csnk2b PE=2 SV=1 g17076.t1 Q13526 57.317 164 2.3200000000000002e-57 179.0 sp|Q13526|PIN1_HUMAN Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 OS=Homo sapiens OX=9606 GN=PIN1 PE=1 SV=1 PIN1_HUMAN reviewed Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) Homo sapiens (Human) GO:0000413; GO:0001666; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0007088; GO:0007266; GO:0008013; GO:0010468; GO:0016607; GO:0016859; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0031647; GO:0031648; GO:0032465; GO:0032794; GO:0036064; GO:0042177; GO:0045944; GO:0048156; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0060392; GO:0070373; GO:0071456; GO:0090263; GO:0098978; GO:0099524; GO:1900180; GO:1902430; GO:1903444; GO:1990757; GO:2000146 cellular response to hypoxia [GO:0071456]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; protein targeting to mitochondrion [GO:0006626]; regulation of cytokinesis [GO:0032465]; regulation of gene expression [GO:0010468]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; Rho protein signal transduction [GO:0007266]; synapse organization [GO:0050808] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524] beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; cytoskeletal motor activity [GO:0003774]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; tau protein binding [GO:0048156]; ubiquitin ligase activator activity [GO:1990757] g17077.t1 Q96CN4 49.651 717 0.0 652.0 sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1 EVI5L_HUMAN reviewed EVI5-like protein (Ecotropic viral integration site 5-like protein) Homo sapiens (Human) GO:0005096; GO:0031267; GO:0043547; GO:1902018 negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] g17079.t1 P19615 34.451 1402 0.0 773.0 sp|P19615|MYP_STRPU Major yolk protein OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=2 g17080.t1 Q6UWE0 36.153 733 1.22e-143 441.0 sp|Q6UWE0|LRSM1_HUMAN E3 ubiquitin-protein ligase LRSAM1 OS=Homo sapiens OX=9606 GN=LRSAM1 PE=1 SV=1 LRSM1_HUMAN reviewed E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL) Homo sapiens (Human) GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786 autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g17081.t1 Q6UWE0 34.188 585 3.1000000000000003e-99 320.0 sp|Q6UWE0|LRSM1_HUMAN E3 ubiquitin-protein ligase LRSAM1 OS=Homo sapiens OX=9606 GN=LRSAM1 PE=1 SV=1 LRSM1_HUMAN reviewed E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL) Homo sapiens (Human) GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786 autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18266.t1 P57760 43.345 293 6.92e-87 265.0 sp|P57760|STK16_RAT Serine/threonine-protein kinase 16 OS=Rattus norvegicus OX=10116 GN=Stk16 PE=2 SV=2 STK16_RAT reviewed Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2) Rattus norvegicus (Rat) GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0016604; GO:0045944; GO:0048471; GO:0071560; GO:0106310 cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g18267.t1 Q1MTN8 29.966 297 7.58e-30 121.0 sp|Q1MTN8|ACL4_SCHPO Probable assembly chaperone of rpl4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC16D10.01c PE=3 SV=2 g18268.t1 P58557 42.236 161 2.9600000000000004e-43 144.0 sp|P58557|YBEY_HUMAN Endoribonuclease YbeY OS=Homo sapiens OX=9606 GN=YBEY PE=1 SV=2 g18269.t2 P35978 52.147 163 7.689999999999999e-30 117.0 sp|P35978|KINH_STRPU Kinesin heavy chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g18270.t1 P35978 74.365 866 0.0 1204.0 sp|P35978|KINH_STRPU Kinesin heavy chain OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g18271.t1 Q5FW42 48.418 411 4.699999999999999e-128 377.0 sp|Q5FW42|DCTN2_XENTR Dynactin subunit 2 OS=Xenopus tropicalis OX=8364 GN=dctn2 PE=2 SV=1 g18272.t1 Q7ZV82 75.735 136 1.62e-73 218.0 sp|Q7ZV82|RL27_DANRE Large ribosomal subunit protein eL27 OS=Danio rerio OX=7955 GN=rpl27 PE=1 SV=3 g18273.t1 Q6ZMG9 46.608 339 5.5e-116 345.0 sp|Q6ZMG9|CERS6_HUMAN Ceramide synthase 6 OS=Homo sapiens OX=9606 GN=CERS6 PE=1 SV=1 CERS6_HUMAN reviewed Ceramide synthase 6 (CerS6) (EC 2.3.1.-) (LAG1 longevity assurance homolog 6) (Sphingoid base N-palmitoyltransferase CERS6) (EC 2.3.1.291) Homo sapiens (Human) GO:0003677; GO:0005789; GO:0006954; GO:0014003; GO:0016020; GO:0030148; GO:0046513; GO:0050291; GO:1900143 ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; oligodendrocyte development [GO:0014003]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291] g18274.t1 O15973 24.857 350 1.1399999999999999e-23 105.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18274.t2 O15973 24.857 350 7.48e-24 106.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18275.t1 Q0VA42 39.875 800 2.7500000000000003e-177 529.0 sp|Q0VA42|MINY4_XENTR Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 OS=Xenopus tropicalis OX=8364 GN=mindy4 PE=2 SV=1 g18277.t1 O15973 28.319 339 9.97e-28 116.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18279.t1 Q0V9P1 30.0 230 3.0099999999999995e-23 100.0 sp|Q0V9P1|HNMT_XENTR Histamine N-methyltransferase OS=Xenopus tropicalis OX=8364 GN=hnmt PE=2 SV=1 g18281.t1 Q1LZF7 41.053 380 2.49e-84 278.0 sp|Q1LZF7|PTH1R_BOVIN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Bos taurus OX=9913 GN=PTH1R PE=2 SV=1 PTH1R_BOVIN reviewed Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) Bos taurus (Bovine) GO:0004991; GO:0005886; GO:0006874; GO:0007166; GO:0007188; GO:0007189; GO:0007200; GO:0008528; GO:0017046; GO:0042803 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; intracellular calcium ion homeostasis [GO:0006874]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803] g18281.t2 Q1LZF7 41.316 380 1.04e-85 282.0 sp|Q1LZF7|PTH1R_BOVIN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Bos taurus OX=9913 GN=PTH1R PE=2 SV=1 PTH1R_BOVIN reviewed Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) Bos taurus (Bovine) GO:0004991; GO:0005886; GO:0006874; GO:0007166; GO:0007188; GO:0007189; GO:0007200; GO:0008528; GO:0017046; GO:0042803 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; intracellular calcium ion homeostasis [GO:0006874]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803] g18286.t1 Q9P0K1 31.976 663 5.57e-75 271.0 sp|Q9P0K1|ADA22_HUMAN Disintegrin and metalloproteinase domain-containing protein 22 OS=Homo sapiens OX=9606 GN=ADAM22 PE=1 SV=1 g18289.t1 Q8N9W6 45.494 233 2.2099999999999998e-48 169.0 sp|Q8N9W6|BOLL_HUMAN Protein boule-like OS=Homo sapiens OX=9606 GN=BOLL PE=1 SV=2 g18290.t1 D3Z2X2 26.46 291 8.35e-23 108.0 sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3 DNHD1_MOUSE reviewed Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein) Mus musculus (Mouse) GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0120316 flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316] inner dynein arm [GO:0036156]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18292.t1 Q9C0G6 26.0 700 2.43e-64 243.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g18292.t2 Q9C0G6 26.0 700 9.57e-65 244.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g18293.t1 E7FAM5 21.033 794 2.4600000000000002e-29 129.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18294.t1 Q9C0G6 24.414 938 4.92e-70 262.0 sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3 g18296.t1 D3Z2X2 23.598 856 1.47e-61 232.0 sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3 DNHD1_MOUSE reviewed Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein) Mus musculus (Mouse) GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0120316 flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316] inner dynein arm [GO:0036156]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18297.t1 Q96M86 30.556 288 1.1400000000000001e-29 128.0 sp|Q96M86|DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DNHD1 PE=1 SV=2 DNHD1_HUMAN reviewed Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein) Homo sapiens (Human) GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0070062; GO:0120316 flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316] extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156]; sperm flagellum [GO:0036126] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g18299.t1 Q60756 61.765 102 7.93e-32 118.0 sp|Q60756|TCF15_MOUSE Transcription factor 15 OS=Mus musculus OX=10090 GN=Tcf15 PE=1 SV=2 TCF15_MOUSE reviewed Transcription factor 15 (TCF-15) (Meso1) (Paraxis) (Protein bHLH-EC2) Mus musculus (Mouse) GO:0000977; GO:0000981; GO:0001756; GO:0003016; GO:0005634; GO:0006357; GO:0007517; GO:0009952; GO:0010468; GO:0019827; GO:0032502; GO:0036342; GO:0043425; GO:0043583; GO:0045198; GO:0045944; GO:0046983; GO:0048339; GO:0048644; GO:0048705; GO:0050884; GO:0060231; GO:0070888; GO:0090575; GO:1902037; GO:1903053; GO:2000738 anterior/posterior pattern specification [GO:0009952]; developmental process [GO:0032502]; ear development [GO:0043583]; establishment of epithelial cell apical/basal polarity [GO:0045198]; mesenchymal to epithelial transition [GO:0060231]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular process controlling posture [GO:0050884]; paraxial mesoderm development [GO:0048339]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; regulation of extracellular matrix organization [GO:1903053]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g18301.t1 P97831 67.808 146 1.2e-57 186.0 sp|P97831|TWST2_RAT Twist-related protein 2 OS=Rattus norvegicus OX=10116 GN=Twist2 PE=2 SV=2 g18303.t1 Q5ZML5 46.667 165 1.54e-40 138.0 sp|Q5ZML5|LSM12_CHICK Protein LSM12 OS=Gallus gallus OX=9031 GN=LSM12 PE=2 SV=1 g18305.t1 O01635 28.857 350 1.77e-36 152.0 sp|O01635|ASIC1_CAEEL Degenerin-like protein asic-1 OS=Caenorhabditis elegans OX=6239 GN=asic-1 PE=3 SV=2 g18307.t1 Q15485 49.074 216 1.48e-65 209.0 sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2 FCN2_HUMAN reviewed Ficolin-2 (37 kDa elastin-binding protein) (EBP-37) (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) Homo sapiens (Human) GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0038187; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0070062; GO:0070892; GO:0072562; GO:0097367; GO:0106139; GO:1903028; GO:1905370; GO:2001065 cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654] blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] g18308.t1 Q95LU3 49.099 222 2.23e-61 202.0 sp|Q95LU3|FBCD1_MACFA Fibrinogen C domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=FIBCD1 PE=2 SV=1 g18309.t1 Q95LU3 50.0 222 2.88e-65 213.0 sp|Q95LU3|FBCD1_MACFA Fibrinogen C domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=FIBCD1 PE=2 SV=1 g18310.t1 O70497 49.533 214 1.78e-62 205.0 sp|O70497|FCN2_MOUSE Ficolin-2 OS=Mus musculus OX=10090 GN=Fcn2 PE=2 SV=2 g18311.t1 P33534 28.75 320 5.92e-32 126.0 sp|P33534|OPRK_MOUSE Kappa-type opioid receptor OS=Mus musculus OX=10090 GN=Oprk1 PE=1 SV=1 OPRK_MOUSE reviewed Kappa-type opioid receptor (K-OR-1) (KOR-1) (MSL-1) Mus musculus (Mouse) GO:0004985; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006955; GO:0007200; GO:0007218; GO:0007626; GO:0016020; GO:0016529; GO:0019233; GO:0030315; GO:0030425; GO:0030672; GO:0031635; GO:0032868; GO:0033603; GO:0033612; GO:0033685; GO:0035094; GO:0038003; GO:0038048; GO:0042383; GO:0042711; GO:0042734; GO:0042755; GO:0042923; GO:0043005; GO:0043025; GO:0043204; GO:0043627; GO:0043679; GO:0044849; GO:0045211; GO:0045471; GO:0046877; GO:0048148; GO:0050951; GO:0051607; GO:0071222; GO:0071333; GO:1900745; GO:1901381; GO:1903937; GO:1904000; GO:1990708 adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; response to acrylamide [GO:1903937]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951] axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synaptic vesicle membrane [GO:0030672]; T-tubule [GO:0030315] dynorphin receptor activity [GO:0038048]; G protein-coupled opioid receptor activity [GO:0004985]; neuropeptide binding [GO:0042923]; receptor serine/threonine kinase binding [GO:0033612] g18312.t1 F1R332 29.085 306 8.159999999999999e-24 104.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g18314.t1 Q9DAP0 47.799 159 4.41e-35 133.0 sp|Q9DAP0|LRC46_MOUSE Leucine-rich repeat-containing protein 46 OS=Mus musculus OX=10090 GN=Lrrc46 PE=1 SV=2 LRC46_MOUSE reviewed Leucine-rich repeat-containing protein 46 Mus musculus (Mouse) GO:0007283; GO:0007286; GO:0007338; GO:0035082; GO:0036126; GO:0097225; GO:0098727; GO:0120316; GO:0120317 axoneme assembly [GO:0035082]; maintenance of cell number [GO:0098727]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] g18315.t1 Q9JJ06 35.371 229 6.91e-39 144.0 sp|Q9JJ06|C1GLT_MOUSE Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Mus musculus OX=10090 GN=C1galt1 PE=1 SV=1 C1GLT_MOUSE reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (T-syn) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Mus musculus (Mouse) GO:0000166; GO:0001525; GO:0001822; GO:0006493; GO:0008378; GO:0016020; GO:0016263; GO:0016266; GO:0046872; GO:0060576 angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] membrane [GO:0016020] galactosyltransferase activity [GO:0008378]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g18316.t1 Q7K237 50.336 298 5.22e-100 302.0 sp|Q7K237|C1GLT_DROME Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=C1GalTA PE=1 SV=1 C1GLT_DROME reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0000166; GO:0007528; GO:0009247; GO:0016020; GO:0016263; GO:0016266; GO:0021551; GO:0030145; GO:0042803; GO:0048531; GO:0051489; GO:0055001; GO:1902037 central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; regulation of filopodium assembly [GO:0051489] Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] g18317.t1 Q7K237 48.185 303 1.88e-100 303.0 sp|Q7K237|C1GLT_DROME Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=C1GalTA PE=1 SV=1 C1GLT_DROME reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Drosophila melanogaster (Fruit fly) GO:0000139; GO:0000166; GO:0007528; GO:0009247; GO:0016020; GO:0016263; GO:0016266; GO:0021551; GO:0030145; GO:0042803; GO:0048531; GO:0051489; GO:0055001; GO:1902037 central nervous system morphogenesis [GO:0021551]; glycolipid biosynthetic process [GO:0009247]; muscle cell development [GO:0055001]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular junction development [GO:0007528]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; regulation of filopodium assembly [GO:0051489] Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-1,3-galactosyltransferase activity [GO:0048531]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] g18318.t1 Q18515 53.875 271 3.2199999999999998e-111 335.0 sp|Q18515|C1GLT_CAEEL Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Caenorhabditis elegans OX=6239 GN=C38H2.2 PE=1 SV=2 C1GLT_CAEEL reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) Caenorhabditis elegans GO:0000166; GO:0016020; GO:0016263; GO:0030145 membrane [GO:0016020] glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166] g18319.t1 Q99NH2 32.477 1207 1.45e-139 471.0 sp|Q99NH2|PARD3_MOUSE Partitioning defective 3 homolog OS=Mus musculus OX=10090 GN=Pard3 PE=1 SV=2 g18321.t1 A8WG43 40.934 364 2.0100000000000002e-73 234.0 sp|A8WG43|CCD89_DANRE Coiled-coil domain-containing protein 89 OS=Danio rerio OX=7955 GN=ccdc89 PE=2 SV=1 g18322.t1 Q9WYG0 35.135 259 1.17e-31 120.0 sp|Q9WYG0|Y325_THEMA Uncharacterized oxidoreductase TM_0325 OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0325 PE=3 SV=1 g18323.t1 Q9VGJ5 74.648 71 7.57e-30 115.0 sp|Q9VGJ5|FER3_DROME Protein Fer3 OS=Drosophila melanogaster OX=7227 GN=fer3 PE=2 SV=2 g18325.t1 Q6P819 89.236 288 0.0 528.0 sp|Q6P819|CNOT9_XENTR CCR4-NOT transcription complex subunit 9 OS=Xenopus tropicalis OX=8364 GN=cnot9 PE=2 SV=1 g18327.t1 Q5ZKI4 65.62 605 0.0 798.0 sp|Q5ZKI4|CCD93_CHICK Coiled-coil domain-containing protein 93 OS=Gallus gallus OX=9031 GN=CCDC93 PE=2 SV=1 g18328.t1 Q3SZ76 40.206 194 1.29e-46 154.0 sp|Q3SZ76|COMD3_BOVIN COMM domain-containing protein 3 OS=Bos taurus OX=9913 GN=COMMD3 PE=2 SV=1 g18329.t1 Q9UJ83 57.325 314 7.05e-131 387.0 sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2 HACL1_HUMAN reviewed 2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2) Homo sapiens (Human) GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0097089; GO:0106359; GO:0106376; GO:1903512 fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] 2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] g18331.t1 Q9UJ83 62.745 255 2.05e-112 337.0 sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2 HACL1_HUMAN reviewed 2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2) Homo sapiens (Human) GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0097089; GO:0106359; GO:0106376; GO:1903512 fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] 2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] g18332.t1 Q29121 39.321 501 1.8e-125 383.0 sp|Q29121|GALT1_PIG Polypeptide N-acetylgalactosaminyltransferase 1 OS=Sus scrofa OX=9823 GN=GALNT1 PE=1 SV=1 GALT1_PIG reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Sus scrofa (Pig) GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580 protein O-linked glycosylation [GO:0006493] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18333.t1 Q80UA9 67.961 206 1.22e-102 298.0 sp|Q80UA9|INSI2_RAT Insulin-induced gene 2 protein OS=Rattus norvegicus OX=10116 GN=Insig2 PE=2 SV=1 INSI2_RAT reviewed Insulin-induced gene 2 protein (INSIG-2) Rattus norvegicus (Rat) GO:0005783; GO:0005789; GO:0006607; GO:0006641; GO:0006695; GO:0006991; GO:0008142; GO:0008203; GO:0010894; GO:0016126; GO:0032868; GO:0032869; GO:0032933; GO:0032937; GO:0033993; GO:0036316; GO:0042472; GO:0042474; GO:0045542; GO:0045717; GO:0051604; GO:0060021; GO:0060363; GO:0070542; GO:0140311 cellular response to insulin stimulus [GO:0032869]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; cranial suture morphogenesis [GO:0060363]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of steroid biosynthetic process [GO:0010894]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cholesterol biosynthetic process [GO:0045542]; protein maturation [GO:0051604]; response to fatty acid [GO:0070542]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; response to sterol depletion [GO:0006991]; roof of mouth development [GO:0060021]; SREBP signaling pathway [GO:0032933]; SREBP-SCAP complex retention in endoplasmic reticulum [GO:0036316]; sterol biosynthetic process [GO:0016126]; triglyceride metabolic process [GO:0006641] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SREBP-SCAP-Insig complex [GO:0032937] oxysterol binding [GO:0008142]; protein sequestering activity [GO:0140311] g18334.t1 P29074 53.135 941 0.0 940.0 sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1 PTN4_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1) Homo sapiens (Human) GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254 protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] g18334.t2 P29074 53.483 933 0.0 941.0 sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1 PTN4_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1) Homo sapiens (Human) GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254 protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] g18335.t1 Q53S58 34.926 272 2.08e-37 138.0 sp|Q53S58|TM177_HUMAN Transmembrane protein 177 OS=Homo sapiens OX=9606 GN=TMEM177 PE=1 SV=1 TM177_HUMAN reviewed Transmembrane protein 177 Homo sapiens (Human) GO:0005739; GO:0005743; GO:0016020 membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] g18336.t1 Q8BGS1 62.434 378 1.4199999999999998e-170 517.0 sp|Q8BGS1|E41L5_MOUSE Band 4.1-like protein 5 OS=Mus musculus OX=10090 GN=Epb41l5 PE=1 SV=1 E41L5_MOUSE reviewed Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5) Mus musculus (Mouse) GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826] adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904] g18336.t2 Q8BGS1 62.434 378 2.51e-170 516.0 sp|Q8BGS1|E41L5_MOUSE Band 4.1-like protein 5 OS=Mus musculus OX=10090 GN=Epb41l5 PE=1 SV=1 E41L5_MOUSE reviewed Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5) Mus musculus (Mouse) GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826] adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904] g18336.t3 Q8BGS1 62.434 378 1.2799999999999999e-170 517.0 sp|Q8BGS1|E41L5_MOUSE Band 4.1-like protein 5 OS=Mus musculus OX=10090 GN=Epb41l5 PE=1 SV=1 E41L5_MOUSE reviewed Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5) Mus musculus (Mouse) GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826] adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904] g18337.t1 Q5ZI03 46.154 234 1.61e-65 220.0 sp|Q5ZI03|CIR1_CHICK Corepressor interacting with RBPJ 1 OS=Gallus gallus OX=9031 GN=CIR1 PE=2 SV=1 g18338.t1 Q9CQV4 38.934 244 2.6799999999999996e-54 193.0 sp|Q9CQV4|RETR3_MOUSE Reticulophagy regulator 3 OS=Mus musculus OX=10090 GN=Retreg3 PE=1 SV=1 RETR3_MOUSE reviewed Reticulophagy regulator 3 Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0007029; GO:0010976; GO:0030574; GO:0032991; GO:0061709; GO:0071782; GO:0071786; GO:0140506 collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of neuron projection development [GO:0010976]; reticulophagy [GO:0061709] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; protein-containing complex [GO:0032991] endoplasmic reticulum-autophagosome adaptor activity [GO:0140506] g18339.t1 O61462 84.783 92 4.11e-51 158.0 sp|O61462|RL37A_CRYST Large ribosomal subunit protein eL43 OS=Cryptochiton stelleri OX=6655 GN=RPL37A PE=3 SV=3 g18340.t1 Q91VY9 48.659 261 5.400000000000001e-75 244.0 sp|Q91VY9|ZN622_MOUSE Cytoplasmic 60S subunit biogenesis factor ZNF622 OS=Mus musculus OX=10090 GN=Znf622 PE=1 SV=1 g18340.t1 Q91VY9 46.98 149 7.420000000000001e-36 140.0 sp|Q91VY9|ZN622_MOUSE Cytoplasmic 60S subunit biogenesis factor ZNF622 OS=Mus musculus OX=10090 GN=Znf622 PE=1 SV=1 g18341.t1 Q0P4U8 51.242 644 0.0 647.0 sp|Q0P4U8|SMAL1_XENTR SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Xenopus tropicalis OX=8364 GN=smarcal1 PE=2 SV=1 SMAL1_XENTR reviewed SNF2 related chromatin remodeling annealing helicase 1 (EC 3.6.4.-) (EC 5.6.2.-) (HepA-related protein) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1) (Sucrose nonfermenting protein 2-like 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005524; GO:0005634; GO:0006281; GO:0006357; GO:0016887; GO:0031297; GO:0036310; GO:0043596 DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297] nuclear replication fork [GO:0043596]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA/DNA annealing activity [GO:0036310] g18342.t1 Q63ZL2 58.685 213 4.61e-82 246.0 sp|Q63ZL2|HOP2_XENLA Homologous-pairing protein 2 homolog OS=Xenopus laevis OX=8355 GN=psmc3ip PE=2 SV=1 g18343.t1 A0A1D5PUP4 44.041 965 0.0 817.0 sp|A0A1D5PUP4|RECK_CHICK Reversion-inducing cysteine-rich protein with Kazal motifs OS=Gallus gallus OX=9031 GN=RECK PE=1 SV=1 RECK_CHICK reviewed Reversion-inducing cysteine-rich protein with Kazal motifs Gallus gallus (Chicken) GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005615; GO:0005886; GO:0008191; GO:0015026; GO:0030198; GO:0045765; GO:0060070; GO:0060828; GO:0090210; GO:0098552; GO:1903053; GO:1990909 blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; extracellular matrix organization [GO:0030198]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of establishment of blood-brain barrier [GO:0090210]; regulation of extracellular matrix organization [GO:1903053]; sprouting angiogenesis [GO:0002040] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909] coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867] g18344.t1 P70193 33.158 190 2.4000000000000003e-21 103.0 sp|P70193|LRIG1_MOUSE Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Mus musculus OX=10090 GN=Lrig1 PE=1 SV=2 g18345.t1 Q9PRL8 68.182 66 1.44e-28 100.0 sp|Q9PRL8|ACBP_CHICK Acyl-CoA-binding protein OS=Gallus gallus OX=9031 GN=DBI PE=1 SV=1 g18346.t1 A0JPH4 33.631 1454 0.0 753.0 sp|A0JPH4|SCAP_XENLA Sterol regulatory element-binding protein cleavage-activating protein OS=Xenopus laevis OX=8355 GN=scap PE=2 SV=1 SCAP_XENLA reviewed Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein) Xenopus laevis (African clawed frog) GO:0000139; GO:0005789; GO:0008203; GO:0012507; GO:0032933; GO:0032934; GO:0032936; GO:0045540; GO:0090110 cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933] endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SREBP-SCAP complex [GO:0032936] sterol binding [GO:0032934] g18348.t1 O60551 61.746 481 0.0 619.0 sp|O60551|NMT2_HUMAN Glycylpeptide N-tetradecanoyltransferase 2 OS=Homo sapiens OX=9606 GN=NMT2 PE=1 SV=1 NMT2_HUMAN reviewed Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Protein-lysine myristoyltransferase NMT2) (EC 2.3.1.-) (Type II N-myristoyltransferase) Homo sapiens (Human) GO:0004379; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0018008; GO:0018030; GO:0022400; GO:0043657; GO:0072657; GO:0075733 intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; protein localization to membrane [GO:0072657]; regulation of opsin-mediated signaling pathway [GO:0022400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886] glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030] g18349.t1 Q3KQ77 52.514 179 6.26e-63 196.0 sp|Q3KQ77|CLXN_XENLA Calaxin OS=Xenopus laevis OX=8355 GN=clxn PE=2 SV=1 g18349.t2 Q3KQ77 53.073 179 4.42e-63 197.0 sp|Q3KQ77|CLXN_XENLA Calaxin OS=Xenopus laevis OX=8355 GN=clxn PE=2 SV=1 g18350.t1 Q5RBS7 56.198 121 4.22e-46 148.0 sp|Q5RBS7|CB076_PONAB UPF0538 protein C2orf76 homolog OS=Pongo abelii OX=9601 PE=2 SV=1 g18351.t1 Q9W683 28.44 327 8.520000000000001e-31 127.0 sp|Q9W683|CP1A1_CHESA Cytochrome P450 1A1 OS=Chelon saliens OX=48192 GN=cyp1a1 PE=2 SV=1 g18352.t1 O73853 33.745 486 1.37e-92 293.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g18353.t1 Q61466 74.388 449 0.0 675.0 sp|Q61466|SMRD1_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 OS=Mus musculus OX=10090 GN=Smarcd1 PE=1 SV=3 g18353.t2 Q61466 73.478 460 0.0 680.0 sp|Q61466|SMRD1_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 OS=Mus musculus OX=10090 GN=Smarcd1 PE=1 SV=3 g18354.t1 Q5R4U2 56.934 137 1.46e-50 180.0 sp|Q5R4U2|RBM48_PONAB RNA-binding protein 48 OS=Pongo abelii OX=9601 GN=RBM48 PE=2 SV=1 g18354.t2 Q5R4U2 56.934 137 1.41e-50 180.0 sp|Q5R4U2|RBM48_PONAB RNA-binding protein 48 OS=Pongo abelii OX=9601 GN=RBM48 PE=2 SV=1 g18355.t1 Q0P4C4 53.917 217 3.6400000000000006e-79 240.0 sp|Q0P4C4|DCAKD_DANRE Dephospho-CoA kinase domain-containing protein OS=Danio rerio OX=7955 GN=dcakd PE=2 SV=1 g18358.t1 Q6IQX7 37.463 678 9.93e-155 472.0 sp|Q6IQX7|CHSS2_MOUSE Chondroitin sulfate synthase 2 OS=Mus musculus OX=10090 GN=Chpf PE=1 SV=1 CHSS2_MOUSE reviewed Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2) Mus musculus (Mouse) GO:0005759; GO:0005794; GO:0005829; GO:0016757; GO:0032580; GO:0046872; GO:0047238; GO:0050510; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; mitochondrial matrix [GO:0005759] glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] g18359.t1 P54814 91.422 408 0.0 761.0 sp|P54814|PRS8_MANSE 26S proteasome regulatory subunit 8 OS=Manduca sexta OX=7130 PE=2 SV=1 g18359.t2 P54814 87.15 428 0.0 749.0 sp|P54814|PRS8_MANSE 26S proteasome regulatory subunit 8 OS=Manduca sexta OX=7130 PE=2 SV=1 g18360.t1 Q95245 32.719 217 3.81e-26 106.0 sp|Q95245|CY561_PIG Transmembrane ascorbate-dependent reductase CYB561 OS=Sus scrofa OX=9823 GN=CYB561 PE=2 SV=1 g18361.t1 B0FYY4 41.244 788 0.0 595.0 sp|B0FYY4|ITB1_SHEEP Integrin beta-1 OS=Ovis aries OX=9940 GN=ITGB1 PE=2 SV=1 ITB1_SHEEP reviewed Integrin beta-1 (Fibronectin receptor subunit beta) (Integrin subunit beta-1) (VLA-4 subunit beta) (CD antigen CD29) Ovis aries (Sheep) GO:0001968; GO:0005925; GO:0007229; GO:0007517; GO:0007520; GO:0009986; GO:0010710; GO:0016020; GO:0016477; GO:0019901; GO:0019960; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0034679; GO:0042470; GO:0043236; GO:0045202; GO:0045445; GO:0045906; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0098609; GO:0098639; GO:0098640; GO:1903078 cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin alpha9-beta1 complex [GO:0034679]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; synapse [GO:0045202] C-X3-C chemokine binding [GO:0019960]; collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g18364.t1 P29558 55.215 326 8.99e-96 296.0 sp|P29558|RBMS1_HUMAN RNA-binding motif, single-stranded-interacting protein 1 OS=Homo sapiens OX=9606 GN=RBMS1 PE=1 SV=3 RBMS1_HUMAN reviewed RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2) Homo sapiens (Human) GO:0003690; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006260; GO:0006396; GO:0008143; GO:0008266; GO:1990904 DNA replication [GO:0006260]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g18364.t2 Q3ZBP3 51.613 372 2.7500000000000003e-97 300.0 sp|Q3ZBP3|RBMS1_BOVIN RNA-binding motif, single-stranded-interacting protein 1 OS=Bos taurus OX=9913 GN=RBMS1 PE=2 SV=1 g18364.t3 P29558 55.215 326 3.51e-96 297.0 sp|P29558|RBMS1_HUMAN RNA-binding motif, single-stranded-interacting protein 1 OS=Homo sapiens OX=9606 GN=RBMS1 PE=1 SV=3 RBMS1_HUMAN reviewed RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2) Homo sapiens (Human) GO:0003690; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006260; GO:0006396; GO:0008143; GO:0008266; GO:1990904 DNA replication [GO:0006260]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] g18370.t1 O42602 35.484 372 4.5700000000000005e-59 203.0 sp|O42602|CRFR1_XENLA Corticotropin-releasing factor receptor 1 OS=Xenopus laevis OX=8355 GN=crhr1 PE=2 SV=1 g18372.t1 Q8R143 40.58 138 8.34e-22 90.5 sp|Q8R143|PTTG_MOUSE Pituitary tumor-transforming gene 1 protein-interacting protein OS=Mus musculus OX=10090 GN=Pttg1ip PE=1 SV=1 g18372.t2 Q5NVI6 43.165 139 1.02e-22 92.8 sp|Q5NVI6|PTTG_PONAB Pituitary tumor-transforming gene 1 protein-interacting protein OS=Pongo abelii OX=9601 GN=PTTG1IP PE=2 SV=2 g18372.t3 Q8R143 41.667 132 3.29e-22 91.3 sp|Q8R143|PTTG_MOUSE Pituitary tumor-transforming gene 1 protein-interacting protein OS=Mus musculus OX=10090 GN=Pttg1ip PE=1 SV=1 g18373.t1 Q80UG8 52.99 602 0.0 656.0 sp|Q80UG8|TTLL4_MOUSE Tubulin monoglutamylase TTLL4 OS=Mus musculus OX=10090 GN=Ttll4 PE=1 SV=3 TTLL4_MOUSE reviewed Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4) Mus musculus (Mouse) GO:0000226; GO:0005524; GO:0005737; GO:0005874; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0106437; GO:0120222 microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g18374.t1 P53603 58.627 539 0.0 651.0 sp|P53603|FTCD_PIG Formimidoyltransferase-cyclodeaminase OS=Sus scrofa OX=9823 GN=FTCD PE=1 SV=1 g18375.t1 Q1LWC2 32.42 219 3.24e-30 118.0 sp|Q1LWC2|T106B_DANRE Transmembrane protein 106B OS=Danio rerio OX=7955 GN=tmem106b PE=3 SV=1 g18376.t1 O54826 78.723 188 2.14e-106 361.0 sp|O54826|AF10_MOUSE Protein AF-10 OS=Mus musculus OX=10090 GN=Mllt10 PE=1 SV=2 g18378.t1 Q61712 39.187 541 2.71e-103 323.0 sp|Q61712|DNJC1_MOUSE DnaJ homolog subfamily C member 1 OS=Mus musculus OX=10090 GN=Dnajc1 PE=1 SV=1 g18379.t1 O02695 59.274 496 0.0 569.0 sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1 g18380.t1 A4IIW9 28.875 471 2.21e-44 173.0 sp|A4IIW9|LIGO1_XENTR Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Xenopus tropicalis OX=8364 GN=lingo1 PE=2 SV=1 g18383.t1 Q8IVI9 26.744 258 1.11e-24 105.0 sp|Q8IVI9|NOSTN_HUMAN Nostrin OS=Homo sapiens OX=9606 GN=NOSTRIN PE=1 SV=2 NOSTN_HUMAN reviewed Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030666; GO:0045892 endocytosis [GO:0006897]; negative regulation of DNA-templated transcription [GO:0045892]; signal transduction [GO:0007165] cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677] g18387.t1 Q8WPA2 29.758 289 1.79e-26 111.0 sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori OX=7091 GN=AR PE=2 SV=1 g18389.t1 Q8WPA2 29.47 302 2.04e-28 117.0 sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori OX=7091 GN=AR PE=2 SV=1 g18390.t1 Q8WPA2 30.69 290 3.15e-29 119.0 sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori OX=7091 GN=AR PE=2 SV=1 g18391.t1 Q7TNE1 59.747 395 2.6600000000000003e-179 511.0 sp|Q7TNE1|SUCHY_MOUSE Succinyl-CoA:glutarate CoA-transferase OS=Mus musculus OX=10090 GN=Sugct PE=1 SV=2 SUCHY_MOUSE reviewed Succinyl-CoA:glutarate CoA-transferase (EC 2.8.3.-) (Dicarboxyl-CoA:dicarboxylic acid coenzyme A transferase SUGCT) (Succinate--hydroxymethylglutarate CoA-transferase) (EC 2.8.3.13) Mus musculus (Mouse) GO:0005739; GO:0047369 mitochondrion [GO:0005739] succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369] g18392.t1 P40692 60.766 757 0.0 943.0 sp|P40692|MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens OX=9606 GN=MLH1 PE=1 SV=1 MLH1_HUMAN reviewed DNA mismatch repair protein Mlh1 (MutL protein homolog 1) Homo sapiens (Human) GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008047; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0140664 double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283] chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137] g18393.t1 F4KGU4 31.912 1548 0.0 688.0 sp|F4KGU4|DEAHC_ARATH ATP-dependent RNA helicase DEAH12, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g10370 PE=3 SV=1 DEAHC_ARATH reviewed ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13) Arabidopsis thaliana (Mouse-ear cress) GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005768; GO:0006605; GO:0008270; GO:0009507; GO:0016740; GO:0016887 protein targeting [GO:0006605] chloroplast [GO:0009507]; endosome [GO:0005768] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270] g18394.t1 Q9BUQ8 68.393 753 0.0 989.0 sp|Q9BUQ8|DDX23_HUMAN Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3 g18395.t1 Q8HZY8 33.943 601 3.91e-103 328.0 sp|Q8HZY8|CC148_MACFA Coiled-coil domain-containing protein 148 OS=Macaca fascicularis OX=9541 GN=CCDC148 PE=2 SV=1 g18397.t1 P49442 46.04 404 3.87e-116 347.0 sp|P49442|INPP_MOUSE Inositol polyphosphate 1-phosphatase OS=Mus musculus OX=10090 GN=Inpp1 PE=1 SV=2 g18398.t1 Q5ZM41 30.074 951 2.81e-94 321.0 sp|Q5ZM41|TEX10_CHICK Testis-expressed protein 10 homolog OS=Gallus gallus OX=9031 GN=TEX10 PE=2 SV=1 g18399.t1 Q7ZY47 63.679 647 0.0 829.0 sp|Q7ZY47|DDX42_XENLA ATP-dependent RNA helicase DDX42 OS=Xenopus laevis OX=8355 GN=ddx42 PE=2 SV=1 g18400.t1 Q58D55 55.911 626 0.0 724.0 sp|Q58D55|BGAL_BOVIN Beta-galactosidase OS=Bos taurus OX=9913 GN=GLB1 PE=2 SV=1 BGAL_BOVIN reviewed Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) Bos taurus (Bovine) GO:0004565; GO:0005576; GO:0005764; GO:0005773; GO:0006689; GO:0016020; GO:0019388; GO:0042340 galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; keratan sulfate proteoglycan catabolic process [GO:0042340] extracellular region [GO:0005576]; lysosome [GO:0005764]; membrane [GO:0016020]; vacuole [GO:0005773] beta-galactosidase activity [GO:0004565] g18401.t1 Q4SBY6 33.784 296 4.8e-45 157.0 sp|Q4SBY6|HNMT_TETNG Histamine N-methyltransferase OS=Tetraodon nigroviridis OX=99883 GN=hnmt PE=3 SV=1 g18403.t1 A2RT91 42.302 1364 0.0 1115.0 sp|A2RT91|ANKAR_MOUSE Ankyrin and armadillo repeat-containing protein OS=Mus musculus OX=10090 GN=Ankar PE=2 SV=1 g18403.t2 Q7Z5J8 43.675 1328 0.0 1123.0 sp|Q7Z5J8|ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein OS=Homo sapiens OX=9606 GN=ANKAR PE=1 SV=3 g18404.t1 Q6PEB4 54.233 378 4.51e-141 413.0 sp|Q6PEB4|OSGL1_MOUSE tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial OS=Mus musculus OX=10090 GN=Osgepl1 PE=1 SV=2 OSGL1_MOUSE reviewed tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein Osgepl1) (tRNA threonylcarbamoyladenosine biosynthesis protein Osgepl1) Mus musculus (Mouse) GO:0002949; GO:0005739; GO:0046872; GO:0061711 tRNA threonylcarbamoyladenosine modification [GO:0002949] mitochondrion [GO:0005739] metal ion binding [GO:0046872]; tRNA N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711] g18405.t1 Q6INX1 52.459 244 1.5600000000000002e-72 224.0 sp|Q6INX1|TMM98_XENLA Transmembrane protein 98 OS=Xenopus laevis OX=8355 GN=tmem98 PE=2 SV=1 g18407.t1 Q8BRU6 40.106 379 7.94e-93 296.0 sp|Q8BRU6|VMAT2_MOUSE Synaptic vesicular amine transporter OS=Mus musculus OX=10090 GN=Slc18a2 PE=1 SV=1 VMAT2_MOUSE reviewed Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2) (Vesicular monoamine transporter 2) Mus musculus (Mouse) GO:0001975; GO:0002552; GO:0002553; GO:0005275; GO:0005335; GO:0005813; GO:0006836; GO:0007626; GO:0008021; GO:0009636; GO:0009791; GO:0015311; GO:0015842; GO:0015844; GO:0019899; GO:0030073; GO:0030424; GO:0030425; GO:0030667; GO:0030672; GO:0031045; GO:0031072; GO:0042910; GO:0042995; GO:0043025; GO:0043195; GO:0043679; GO:0044297; GO:0051589; GO:0051610; GO:0051615; GO:0071466; GO:0098691; GO:0098700; GO:0098794; GO:0098992; GO:0099012; GO:0099123; GO:1901363 aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular response to xenobiotic stimulus [GO:0071466]; histamine secretion by mast cell [GO:0002553]; histamine uptake [GO:0051615]; insulin secretion [GO:0030073]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of neurotransmitter transport [GO:0051589]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]; serotonin secretion by mast cell [GO:0002552]; serotonin uptake [GO:0051610]; somato-dendritic dopamine secretion [GO:0099123] axon [GO:0030424]; axon terminus [GO:0043679]; cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; dendrite [GO:0030425]; dense core granule [GO:0031045]; dopaminergic synapse [GO:0098691]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; neuronal dense core vesicle membrane [GO:0099012]; postsynapse [GO:0098794]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] amine transmembrane transporter activity [GO:0005275]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; heterocyclic compound binding [GO:1901363]; monoamine:proton antiporter activity [GO:0015311]; serotonin:sodium:chloride symporter activity [GO:0005335]; xenobiotic transmembrane transporter activity [GO:0042910] g18410.t1 Q2PC93 31.725 1264 6.84e-162 562.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18410.t2 Q2PC93 31.725 1264 6.84e-162 562.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18410.t3 Q2PC93 31.671 1263 4.44e-161 560.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18410.t4 Q2PC93 31.725 1264 1.6500000000000001e-161 561.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18410.t5 Q2PC93 31.903 1235 8.38e-162 562.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18410.t5 Q2PC93 28.495 372 4.98e-37 158.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18410.t5 Q2PC93 31.421 366 8.43e-32 141.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18411.t1 Q7LGC8 31.988 347 6.41e-45 165.0 sp|Q7LGC8|CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens OX=9606 GN=CHST3 PE=1 SV=3 CHST3_HUMAN reviewed Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0) Homo sapiens (Human) GO:0000139; GO:0001517; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0018146; GO:0043029; GO:0045130; GO:0050650 carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; keratan sulfate proteoglycan biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029] Golgi membrane [GO:0000139] chondroitin 6-sulfotransferase activity [GO:0008459]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517] g18412.t1 P12606 44.541 806 0.0 680.0 sp|P12606|ITB1A_XENLA Integrin beta-1-A OS=Xenopus laevis OX=8355 GN=itgb1-a PE=2 SV=1 g18412.t2 P12607 45.689 777 0.0 679.0 sp|P12607|ITB1B_XENLA Integrin beta-1-B OS=Xenopus laevis OX=8355 GN=itgb1-b PE=2 SV=1 ITB1B_XENLA reviewed Integrin beta-1-B (Integrin beta-1*) Xenopus laevis (African clawed frog) GO:0001968; GO:0002164; GO:0005178; GO:0005925; GO:0007160; GO:0007229; GO:0007517; GO:0007520; GO:0008305; GO:0009986; GO:0016328; GO:0016477; GO:0019901; GO:0019960; GO:0030016; GO:0030027; GO:0032154; GO:0032587; GO:0033627; GO:0036477; GO:0040012; GO:0042470; GO:0042592; GO:0043005; GO:0043236; GO:0045202; GO:0045445; GO:0046872; GO:0051094; GO:0051130; GO:0055002; GO:0098609; GO:0098639; GO:0110020; GO:1902903 cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; homeostatic process [GO:0042592]; integrin-mediated signaling pathway [GO:0007229]; larval development [GO:0002164]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520]; positive regulation of cellular component organization [GO:0051130]; positive regulation of developmental process [GO:0051094]; regulation of actomyosin structure organization [GO:0110020]; regulation of locomotion [GO:0040012]; regulation of supramolecular fiber organization [GO:1902903]; striated muscle cell development [GO:0055002] cell surface [GO:0009986]; cleavage furrow [GO:0032154]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; myofibril [GO:0030016]; neuron projection [GO:0043005]; ruffle membrane [GO:0032587]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202] C-X3-C chemokine binding [GO:0019960]; collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901] g18413.t1 Q00651 31.813 811 1.27e-109 369.0 sp|Q00651|ITA4_MOUSE Integrin alpha-4 OS=Mus musculus OX=10090 GN=Itga4 PE=1 SV=1 g18414.t1 Q8HXX1 73.92 648 0.0 997.0 sp|Q8HXX1|MUTA_MACFA Methylmalonyl-CoA mutase, mitochondrial OS=Macaca fascicularis OX=9541 GN=MMUT PE=2 SV=1 g18416.t1 P00038 73.585 106 4.15e-55 170.0 sp|P00038|CYC_APIME Cytochrome c OS=Apis mellifera OX=7460 GN=cytC PE=1 SV=2 g18421.t1 Q9NSC7 36.111 324 4.49e-39 150.0 sp|Q9NSC7|SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 OS=Homo sapiens OX=9606 GN=ST6GALNAC1 PE=1 SV=1 SIA7A_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAc-I) (ST6GalNAcI) (hST6GalNAc-I) (Sialyltransferase 7A) (SIAT7-A) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0008373; GO:0009101; GO:0009312; GO:0048874 glycoprotein biosynthetic process [GO:0009101]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; oligosaccharide biosynthetic process [GO:0009312] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g18422.t1 Q9NSC7 32.312 359 2.83e-38 149.0 sp|Q9NSC7|SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 OS=Homo sapiens OX=9606 GN=ST6GALNAC1 PE=1 SV=1 SIA7A_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAc-I) (ST6GalNAcI) (hST6GalNAc-I) (Sialyltransferase 7A) (SIAT7-A) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0008373; GO:0009101; GO:0009312; GO:0048874 glycoprotein biosynthetic process [GO:0009101]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; oligosaccharide biosynthetic process [GO:0009312] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g18423.t1 Q92184 37.975 237 1.01e-33 132.0 sp|Q92184|SIA7B_CHICK Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 OS=Gallus gallus OX=9031 GN=ST6GALNAC2 PE=1 SV=1 g18425.t1 Q9QZ39 34.494 316 1.89e-36 142.0 sp|Q9QZ39|SIA7A_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 OS=Mus musculus OX=10090 GN=St6galnac1 PE=1 SV=2 SIA7A_MOUSE reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAcI) (Sialyltransferase 7A) (SIAT7-A) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001665; GO:0009101; GO:0009312; GO:0048874; GO:0051851 ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; host-mediated perturbation of symbiont process [GO:0051851]; oligosaccharide biosynthetic process [GO:0009312] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665] g18426.t1 Q9NSC7 34.568 324 1.12e-39 150.0 sp|Q9NSC7|SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 OS=Homo sapiens OX=9606 GN=ST6GALNAC1 PE=1 SV=1 SIA7A_HUMAN reviewed Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.3.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAc-I) (ST6GalNAcI) (hST6GalNAc-I) (Sialyltransferase 7A) (SIAT7-A) Homo sapiens (Human) GO:0000139; GO:0001665; GO:0008373; GO:0009101; GO:0009312; GO:0048874 glycoprotein biosynthetic process [GO:0009101]; host-mediated modulation of intestinal microbiota composition [GO:0048874]; oligosaccharide biosynthetic process [GO:0009312] Golgi membrane [GO:0000139] alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373] g18431.t1 Q6J6I9 37.963 216 3.08e-45 182.0 sp|Q6J6I9|BRCA1_MACMU Breast cancer type 1 susceptibility protein homolog OS=Macaca mulatta OX=9544 GN=BRCA1 PE=3 SV=1 BRCA1_MACMU reviewed Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1) Macaca mulatta (Rhesus macaque) GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0006633; GO:0007095; GO:0008270; GO:0031436; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0061630; GO:0070013; GO:0070063; GO:0070531; GO:0085020 chordate embryonic development [GO:0043009]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357] BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular organelle lumen [GO:0070013]; nucleus [GO:0005634] DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18432.t1 Q6SA80 50.0 188 4.819999999999999e-68 213.0 sp|Q6SA80|RND3_RAT Rho-related GTP-binding protein RhoE OS=Rattus norvegicus OX=10116 GN=Rnd3 PE=2 SV=1 g18435.t1 P23785 43.662 213 1.26e-49 173.0 sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3 GRN_RAT reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Rattus norvegicus (Rat) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g18435.t1 P23785 45.699 186 2.9800000000000002e-43 156.0 sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3 GRN_RAT reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Rattus norvegicus (Rat) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g18435.t1 P23785 41.451 193 3.31e-40 147.0 sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3 GRN_RAT reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Rattus norvegicus (Rat) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g18435.t1 P23785 40.284 211 2.3800000000000003e-37 140.0 sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3 GRN_RAT reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Rattus norvegicus (Rat) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g18435.t1 P23785 36.702 188 5.540000000000001e-32 125.0 sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3 GRN_RAT reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Rattus norvegicus (Rat) GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488] cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087] g18436.t1 P28799 39.789 568 1.62e-114 372.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g18436.t1 P28799 38.704 571 9.63e-108 354.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g18436.t1 P28799 39.011 546 3.0399999999999997e-106 350.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g18436.t1 P28799 42.348 477 1.5300000000000001e-105 348.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g18436.t1 P28799 38.104 538 4e-104 344.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g18436.t1 P28799 40.291 206 8.97e-29 127.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g18439.t1 Q9H3L0 45.13 308 3.52e-80 249.0 sp|Q9H3L0|MMAD_HUMAN Cobalamin trafficking protein CblD OS=Homo sapiens OX=9606 GN=MMADHC PE=1 SV=2 MMAD_HUMAN reviewed Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005829; GO:0009235; GO:0140104 cobalamin metabolic process [GO:0009235] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] molecular carrier activity [GO:0140104] g18440.t1 D2GXS7 26.139 505 1.53e-25 115.0 sp|D2GXS7|TRIM2_AILME Tripartite motif-containing protein 2 OS=Ailuropoda melanoleuca OX=9646 GN=TRIM2 PE=3 SV=1 g18440.t1 D2GXS7 25.651 269 5.27e-22 104.0 sp|D2GXS7|TRIM2_AILME Tripartite motif-containing protein 2 OS=Ailuropoda melanoleuca OX=9646 GN=TRIM2 PE=3 SV=1 g18442.t1 B2GV72 45.387 271 4.35e-81 248.0 sp|B2GV72|CRB3_RAT Carbonyl reductase [NADPH] 3 OS=Rattus norvegicus OX=10116 GN=Cbr3 PE=1 SV=1 CRB3_RAT reviewed Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (Monomeric carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) Rattus norvegicus (Rat) GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0008753; GO:0042376; GO:0050890; GO:0070402 cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753] g18443.t1 B2GV72 48.519 270 5.72e-86 261.0 sp|B2GV72|CRB3_RAT Carbonyl reductase [NADPH] 3 OS=Rattus norvegicus OX=10116 GN=Cbr3 PE=1 SV=1 CRB3_RAT reviewed Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (Monomeric carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) Rattus norvegicus (Rat) GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0008753; GO:0042376; GO:0050890; GO:0070402 cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753] g18444.t1 B2GV72 48.175 274 1.54e-88 267.0 sp|B2GV72|CRB3_RAT Carbonyl reductase [NADPH] 3 OS=Rattus norvegicus OX=10116 GN=Cbr3 PE=1 SV=1 CRB3_RAT reviewed Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (Monomeric carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) Rattus norvegicus (Rat) GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0008753; GO:0042376; GO:0050890; GO:0070402 cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753] g18445.t1 B2GV72 49.635 274 6.07e-92 276.0 sp|B2GV72|CRB3_RAT Carbonyl reductase [NADPH] 3 OS=Rattus norvegicus OX=10116 GN=Cbr3 PE=1 SV=1 CRB3_RAT reviewed Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (Monomeric carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) Rattus norvegicus (Rat) GO:0000253; GO:0004090; GO:0005654; GO:0005829; GO:0008753; GO:0042376; GO:0050890; GO:0070402 cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753] g18446.t1 Q14562 80.943 997 0.0 1684.0 sp|Q14562|DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1 g18447.t1 Q6JEL2 51.993 577 0.0 630.0 sp|Q6JEL2|KLH10_HUMAN Kelch-like protein 10 OS=Homo sapiens OX=9606 GN=KLHL10 PE=1 SV=1 KLH10_HUMAN reviewed Kelch-like protein 10 Homo sapiens (Human) GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0031463; GO:0043161; GO:0048808; GO:0048873; GO:1990756 cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g18450.t1 B5DE93 59.032 537 0.0 630.0 sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis OX=8364 GN=cdk12 PE=2 SV=1 CDK12_XENTR reviewed Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004693; GO:0005524; GO:0005634; GO:0006397; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0045944; GO:0106310 mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of MAP kinase activity [GO:0043405]; RNA splicing [GO:0008380] cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] g18450.t2 B5DE93 59.032 537 0.0 630.0 sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis OX=8364 GN=cdk12 PE=2 SV=1 CDK12_XENTR reviewed Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 12) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004693; GO:0005524; GO:0005634; GO:0006397; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0045944; GO:0106310 mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of MAP kinase activity [GO:0043405]; RNA splicing [GO:0008380] cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] g18451.t1 Q7ZX22 45.875 800 0.0 673.0 sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1 WDR24_XENLA reviewed GATOR2 complex protein WDR24 (EC 2.3.2.27) Xenopus laevis (African clawed frog) GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263 autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g18452.t1 Q9Z2J0 46.805 579 5.4600000000000005e-177 519.0 sp|Q9Z2J0|S23A1_MOUSE Solute carrier family 23 member 1 OS=Mus musculus OX=10090 GN=Slc23a1 PE=1 SV=2 S23A1_MOUSE reviewed Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3) Mus musculus (Mouse) GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015143; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837 brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; urate transmembrane transporter activity [GO:0015143] g18452.t2 Q9Z2J0 46.805 579 1.03e-176 519.0 sp|Q9Z2J0|S23A1_MOUSE Solute carrier family 23 member 1 OS=Mus musculus OX=10090 GN=Slc23a1 PE=1 SV=2 S23A1_MOUSE reviewed Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3) Mus musculus (Mouse) GO:0005737; GO:0005886; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015143; GO:0015229; GO:0015882; GO:0016324; GO:0030324; GO:0033300; GO:0043229; GO:0070837 brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; sodium ion transmembrane transporter activity [GO:0015081]; urate transmembrane transporter activity [GO:0015143] g18453.t1 Q8WZA2 59.755 1061 0.0 1293.0 sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1 RPGF4_HUMAN reviewed Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) Homo sapiens (Human) GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0098686; GO:0098693 adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886] cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g18453.t2 Q8WZA2 60.49 858 0.0 1080.0 sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1 RPGF4_HUMAN reviewed Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) Homo sapiens (Human) GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0098686; GO:0098693 adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886] cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g18453.t2 Q8WZA2 73.723 137 8.31e-58 221.0 sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1 RPGF4_HUMAN reviewed Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) Homo sapiens (Human) GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0098686; GO:0098693 adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886] cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] g18454.t1 Q6PHS6 44.898 196 6.77e-44 161.0 sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1 g18455.t1 Q6PHS6 39.22 821 0.0 575.0 sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1 g18455.t2 Q6PHS6 40.351 798 0.0 584.0 sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1 g18456.t1 Q0MQB7 46.497 314 1.6099999999999998e-95 291.0 sp|Q0MQB7|NDUAA_PANTR NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial OS=Pan troglodytes OX=9598 GN=NDUFA10 PE=2 SV=1 g18457.t1 P79145 53.401 294 6.55e-78 244.0 sp|P79145|CREM_CANLF cAMP-responsive element modulator OS=Canis lupus familiaris OX=9615 GN=CREM PE=2 SV=2 g18458.t1 Q8BM96 24.822 701 5.95e-45 178.0 sp|Q8BM96|AGRG7_MOUSE Adhesion G-protein coupled receptor G7 OS=Mus musculus OX=10090 GN=Adgrg7 PE=1 SV=2 g18459.t1 O89029 40.513 195 3.3499999999999997e-34 142.0 sp|O89029|MATN4_MOUSE Matrilin-4 OS=Mus musculus OX=10090 GN=Matn4 PE=1 SV=1 g18459.t1 O89029 36.318 201 9.500000000000001e-26 116.0 sp|O89029|MATN4_MOUSE Matrilin-4 OS=Mus musculus OX=10090 GN=Matn4 PE=1 SV=1 g18463.t1 Q9QW30 31.659 458 5.489999999999999e-48 189.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 30.818 477 4.27e-44 177.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 31.685 445 1.79e-42 172.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 31.765 425 1.61e-39 163.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 30.986 426 3.49e-39 162.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 31.463 410 2.51e-37 155.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 27.837 467 1.23e-35 150.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 30.097 412 9.53e-34 144.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 28.922 408 2.5600000000000004e-32 140.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t1 Q9QW30 30.245 367 2.54e-30 133.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 31.659 458 5.0699999999999996e-48 189.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 30.818 477 3.94e-44 177.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 31.685 445 1.7299999999999997e-42 172.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 31.765 425 1.51e-39 163.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 30.986 426 3.28e-39 162.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 31.463 410 2.16e-37 156.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 27.837 467 1.1400000000000001e-35 150.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 30.097 412 8.82e-34 144.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 28.922 408 2.39e-32 140.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18463.t2 Q9QW30 30.245 367 2.39e-30 133.0 sp|Q9QW30|NOTC2_RAT Neurogenic locus notch homolog protein 2 OS=Rattus norvegicus OX=10116 GN=Notch2 PE=1 SV=1 NOTC2_RAT reviewed Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain] Rattus norvegicus (Rat) GO:0000122; GO:0001701; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003184; GO:0003713; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0007420; GO:0008284; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204 animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; brain development [GO:0007420]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; transcription coactivator activity [GO:0003713] g18464.t1 Q8BM96 28.81 420 1.03e-39 155.0 sp|Q8BM96|AGRG7_MOUSE Adhesion G-protein coupled receptor G7 OS=Mus musculus OX=10090 GN=Adgrg7 PE=1 SV=2 g18465.t1 Q9W4Y2 37.302 378 1.82e-69 235.0 sp|Q9W4Y2|PDFR_DROME PDF receptor OS=Drosophila melanogaster OX=7227 GN=Pdfr PE=1 SV=2 PDFR_DROME reviewed PDF receptor (Pigment-dispersing factor receptor) (Protein groom-of-PDF) Drosophila melanogaster (Fruit fly) GO:0004948; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007218; GO:0007623; GO:0008188; GO:0008528; GO:0016020; GO:0042332; GO:0042745; GO:0042749; GO:0042752; GO:0043005; GO:0043025; GO:0045475; GO:0048512; GO:0050850; GO:0055070; GO:0060086; GO:1901562 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; response to paraquat [GO:1901562] membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188] g18467.t1 Q9W4Y2 36.524 397 4.11e-71 239.0 sp|Q9W4Y2|PDFR_DROME PDF receptor OS=Drosophila melanogaster OX=7227 GN=Pdfr PE=1 SV=2 PDFR_DROME reviewed PDF receptor (Pigment-dispersing factor receptor) (Protein groom-of-PDF) Drosophila melanogaster (Fruit fly) GO:0004948; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007218; GO:0007623; GO:0008188; GO:0008528; GO:0016020; GO:0042332; GO:0042745; GO:0042749; GO:0042752; GO:0043005; GO:0043025; GO:0045475; GO:0048512; GO:0050850; GO:0055070; GO:0060086; GO:1901562 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; circadian temperature homeostasis [GO:0060086]; copper ion homeostasis [GO:0055070]; G protein-coupled receptor signaling pathway [GO:0007186]; gravitaxis [GO:0042332]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; response to paraquat [GO:1901562] membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188] g18468.t1 Q7Z3C6 47.694 824 0.0 755.0 sp|Q7Z3C6|ATG9A_HUMAN Autophagy-related protein 9A OS=Homo sapiens OX=9606 GN=ATG9A PE=1 SV=3 ATG9A_HUMAN reviewed Autophagy-related protein 9A (APG9-like 1) (mATG9) Homo sapiens (Human) GO:0000045; GO:0000139; GO:0000407; GO:0000423; GO:0005739; GO:0005768; GO:0005770; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0010936; GO:0016020; GO:0017128; GO:0031902; GO:0031966; GO:0032688; GO:0034045; GO:0034067; GO:0034497; GO:0034727; GO:0045087; GO:0055037; GO:0055038; GO:0060349; GO:0061709; GO:0097060; GO:0097300 autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; innate immune response [GO:0045087]; mitophagy [GO:0000423]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of macrophage cytokine production [GO:0010936]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to Golgi apparatus [GO:0034067]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; trans-Golgi network [GO:0005802] phospholipid scramblase activity [GO:0017128] g18469.t1 O89029 38.342 193 4.48e-34 140.0 sp|O89029|MATN4_MOUSE Matrilin-4 OS=Mus musculus OX=10090 GN=Matn4 PE=1 SV=1 g18469.t1 O89029 33.679 193 4.4300000000000005e-27 119.0 sp|O89029|MATN4_MOUSE Matrilin-4 OS=Mus musculus OX=10090 GN=Matn4 PE=1 SV=1 g18470.t1 O35701 40.526 190 1.04e-37 152.0 sp|O35701|MATN3_MOUSE Matrilin-3 OS=Mus musculus OX=10090 GN=Matn3 PE=1 SV=2 MATN3_MOUSE reviewed Matrilin-3 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0051216; GO:0120216 cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216] calcium ion binding [GO:0005509] g18470.t1 O35701 34.375 192 4.91e-28 122.0 sp|O35701|MATN3_MOUSE Matrilin-3 OS=Mus musculus OX=10090 GN=Matn3 PE=1 SV=2 MATN3_MOUSE reviewed Matrilin-3 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0051216; GO:0120216 cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216] calcium ion binding [GO:0005509] g18471.t1 O35701 41.053 190 4.91e-38 149.0 sp|O35701|MATN3_MOUSE Matrilin-3 OS=Mus musculus OX=10090 GN=Matn3 PE=1 SV=2 MATN3_MOUSE reviewed Matrilin-3 Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0051216; GO:0120216 cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216] calcium ion binding [GO:0005509] g18473.t1 C0HL13 35.746 456 1.1e-60 226.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 34.529 446 3.64e-50 194.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 33.409 440 1.65e-45 180.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 34.375 416 5.03e-43 172.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 34.988 423 1.8299999999999997e-42 171.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 33.246 382 1.9199999999999998e-40 164.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 34.118 425 3.45e-40 164.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 37.346 324 6.02e-38 157.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 33.796 432 1.2400000000000001e-37 155.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 37.5 280 1.32e-37 155.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 35.168 327 1.47e-36 152.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 37.676 284 7.510000000000001e-36 150.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 38.225 293 7.88e-35 147.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 39.437 284 2.1e-33 142.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 36.928 306 3.8600000000000003e-31 135.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 35.636 275 9.83e-27 121.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 34.266 286 1.04e-26 121.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 31.977 344 2.7899999999999997e-23 110.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 37.438 203 5.449999999999999e-23 109.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 35.27 241 6.469999999999999e-23 109.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18473.t1 C0HL13 36.321 212 6.929999999999999e-23 108.0 sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1 LRP2_PIG reviewed Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Sus scrofa (Pig) GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167 coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124] g18474.t1 Q9JI18 35.728 529 1.07e-63 244.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 35.306 507 6.86e-57 222.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 36.419 497 2.6099999999999996e-52 207.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 35.876 485 4.61e-52 206.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 34.118 510 1e-50 202.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 34.156 486 3.63e-50 200.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 33.874 493 7.479999999999999e-48 192.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 33.333 489 9.21e-45 182.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 37.634 372 1.22e-38 162.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 33.051 472 1.95e-38 162.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 34.048 420 7.79e-38 160.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 34.135 416 2.5899999999999997e-34 148.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 36.735 343 8.16e-34 146.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 35.522 335 2.19e-33 145.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 32.452 416 3.7800000000000003e-31 138.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 35.873 315 8.010000000000001e-31 137.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 36.391 327 2.2e-30 135.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 32.483 431 2.73e-28 128.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 37.0 300 5.18e-28 127.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 30.238 420 1.5200000000000002e-27 126.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 29.792 480 1.16e-25 120.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 33.429 350 2.62e-25 119.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 35.366 328 1.17e-22 110.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18474.t1 Q9JI18 32.162 370 5.08e-22 108.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g18475.t1 Q6NYL3 48.494 697 0.0 675.0 sp|Q6NYL3|ECHP_DANRE Peroxisomal bifunctional enzyme OS=Danio rerio OX=7955 GN=ehhadh PE=2 SV=1 ECHP_DANRE reviewed Peroxisomal bifunctional enzyme (PBE) (PBFE) (Multifunctional enzyme 1) (MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0006635; GO:0016509; GO:0016863; GO:0018812; GO:0070403 fatty acid beta-oxidation [GO:0006635] peroxisome [GO:0005777] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0016509]; NAD+ binding [GO:0070403] g18476.t1 P10090 41.667 636 1.0300000000000001e-166 497.0 sp|P10090|WHITE_DROME Protein white OS=Drosophila melanogaster OX=7227 GN=w PE=1 SV=2 WHITE_DROME reviewed Protein white (EC 7.6.2.-) (EC 7.6.2.6) (ATP-binding cassette transporter sub-family G member white) (Broad substrate specificity ATP-binding cassette transporter white) Drosophila melanogaster (Fruit fly) GO:0005275; GO:0005524; GO:0005886; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015208; GO:0015827; GO:0015842; GO:0015854; GO:0016887; GO:0022857; GO:0030659; GO:0031409; GO:0031410; GO:0032217; GO:0032218; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0042906; GO:0042907; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090741; GO:0098793; GO:1905948 aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; guanine transport [GO:0015854]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085]; tryptophan transport [GO:0015827]; xanthine transport [GO:0042906] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; pigment granule [GO:0048770]; pigment granule membrane [GO:0090741]; plasma membrane [GO:0005886]; presynapse [GO:0098793] ABC-type 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ABC-type guanine transporter activity [GO:0008558]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; guanine transmembrane transporter activity [GO:0015208]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; riboflavin transmembrane transporter activity [GO:0032217]; transmembrane transporter activity [GO:0022857]; xanthine transmembrane transporter activity [GO:0042907] g18476.t2 P10090 41.667 636 1.01e-166 496.0 sp|P10090|WHITE_DROME Protein white OS=Drosophila melanogaster OX=7227 GN=w PE=1 SV=2 WHITE_DROME reviewed Protein white (EC 7.6.2.-) (EC 7.6.2.6) (ATP-binding cassette transporter sub-family G member white) (Broad substrate specificity ATP-binding cassette transporter white) Drosophila melanogaster (Fruit fly) GO:0005275; GO:0005524; GO:0005886; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015208; GO:0015827; GO:0015842; GO:0015854; GO:0016887; GO:0022857; GO:0030659; GO:0031409; GO:0031410; GO:0032217; GO:0032218; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0042906; GO:0042907; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090741; GO:0098793; GO:1905948 aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; guanine transport [GO:0015854]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085]; tryptophan transport [GO:0015827]; xanthine transport [GO:0042906] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; pigment granule [GO:0048770]; pigment granule membrane [GO:0090741]; plasma membrane [GO:0005886]; presynapse [GO:0098793] ABC-type 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ABC-type guanine transporter activity [GO:0008558]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; guanine transmembrane transporter activity [GO:0015208]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; riboflavin transmembrane transporter activity [GO:0032217]; transmembrane transporter activity [GO:0022857]; xanthine transmembrane transporter activity [GO:0042907] g18481.t1 Q7ZWB7 76.765 340 0.0 561.0 sp|Q7ZWB7|BBS5_DANRE BBSome complex member BBS5 OS=Danio rerio OX=7955 GN=bbs5 PE=2 SV=1 BBS5_DANRE reviewed BBSome complex member BBS5 (Bardet-Biedl syndrome 5 protein homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0007369; GO:0032266; GO:0032402; GO:0034451; GO:0034464; GO:0036064; GO:0043010; GO:0051877; GO:0060170; GO:0060271; GO:0062139; GO:0070121; GO:0072116 camera-type eye development [GO:0043010]; camera-type eye photoreceptor cell development [GO:0062139]; cilium assembly [GO:0060271]; gastrulation [GO:0007369]; heart looping [GO:0001947]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170] phosphatidylinositol-3-phosphate binding [GO:0032266] g18484.t1 Q2PW47 35.782 1062 0.0 607.0 sp|Q2PW47|MED24_DANRE Mediator of RNA polymerase II transcription subunit 24 OS=Danio rerio OX=7955 GN=med24 PE=2 SV=2 MED24_DANRE reviewed Mediator of RNA polymerase II transcription subunit 24 (Mediator complex subunit 24) (Protein lessen) (Thyroid hormone receptor-associated protein 4 homolog) (Trap100 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003712; GO:0016592; GO:0046549; GO:0048484; GO:0048538; GO:0060261; GO:0061453 enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538] mediator complex [GO:0016592] transcription coregulator activity [GO:0003712] g18487.t1 Q5F3J5 56.379 243 5.46e-97 286.0 sp|Q5F3J5|PSME3_CHICK Proteasome activator complex subunit 3 OS=Gallus gallus OX=9031 GN=PSME3 PE=1 SV=1 g18488.t1 Q8NEG5 40.583 446 7.03e-116 368.0 sp|Q8NEG5|ZSWM2_HUMAN E3 ubiquitin-protein ligase ZSWIM2 OS=Homo sapiens OX=9606 GN=ZSWIM2 PE=1 SV=2 g18489.t1 Q5T5U3 38.491 517 2.8499999999999998e-95 347.0 sp|Q5T5U3|RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens OX=9606 GN=ARHGAP21 PE=1 SV=2 RHG21_HUMAN reviewed Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21) Homo sapiens (Human) GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030659; GO:0051056; GO:0051645; GO:0051683; GO:0051684; GO:0070161; GO:0072384 establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096] g18489.t1 Q5T5U3 52.023 173 7.27e-39 164.0 sp|Q5T5U3|RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens OX=9606 GN=ARHGAP21 PE=1 SV=2 RHG21_HUMAN reviewed Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21) Homo sapiens (Human) GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030659; GO:0051056; GO:0051645; GO:0051683; GO:0051684; GO:0070161; GO:0072384 establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096] g18490.t1 O14807 68.657 201 1.53e-85 254.0 sp|O14807|RASM_HUMAN Ras-related protein M-Ras OS=Homo sapiens OX=9606 GN=MRAS PE=1 SV=2 RASM_HUMAN reviewed Ras-related protein M-Ras (EC 3.6.5.2) (Ras-related protein R-Ras3) Homo sapiens (Human) GO:0000164; GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003; GO:0030036; GO:0030742; GO:1990830 actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] g18491.t1 P13667 56.537 589 0.0 681.0 sp|P13667|PDIA4_HUMAN Protein disulfide-isomerase A4 OS=Homo sapiens OX=9606 GN=PDIA4 PE=1 SV=2 PDIA4_HUMAN reviewed Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72) Homo sapiens (Human) GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015035; GO:0034976; GO:0042470 protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470] protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723] g18491.t2 P13667 56.537 589 0.0 681.0 sp|P13667|PDIA4_HUMAN Protein disulfide-isomerase A4 OS=Homo sapiens OX=9606 GN=PDIA4 PE=1 SV=2 PDIA4_HUMAN reviewed Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72) Homo sapiens (Human) GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015035; GO:0034976; GO:0042470 protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470] protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723] g18492.t1 P49615 80.412 291 0.0 504.0 sp|P49615|CDK5_MOUSE Cyclin-dependent kinase 5 OS=Mus musculus OX=10090 GN=Cdk5 PE=1 SV=1 CDK5_MOUSE reviewed Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) Mus musculus (Mouse) GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006886; GO:0006887; GO:0006913; GO:0006915; GO:0006936; GO:0006974; GO:0007005; GO:0007160; GO:0007409; GO:0007416; GO:0007519; GO:0007528; GO:0008045; GO:0008092; GO:0008306; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016301; GO:0016477; GO:0016533; GO:0019233; GO:0019901; GO:0021537; GO:0021549; GO:0021695; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0021987; GO:0022038; GO:0030027; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030547; GO:0030549; GO:0030866; GO:0030900; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032801; GO:0034352; GO:0035173; GO:0035249; GO:0035255; GO:0035418; GO:0042220; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045055; GO:0045786; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0046875; GO:0048148; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048709; GO:0048812; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051879; GO:0051966; GO:0060078; GO:0060079; GO:0060537; GO:0061001; GO:0070509; GO:0090314; GO:0098685; GO:0098793; GO:0098794; GO:0098978; GO:0099509; GO:0099533; GO:0106310; GO:1901987; GO:1903076; GO:1903234; GO:1904646; GO:1905806 apoptotic process [GO:0006915]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex development [GO:0021695]; cerebellar cortex formation [GO:0021697]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; DNA damage response [GO:0006974]; excitatory postsynaptic potential [GO:0060079]; exocytosis [GO:0006887]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; muscle contraction [GO:0006936]; muscle tissue development [GO:0060537]; negative regulation of axon extension [GO:0030517]; negative regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903234]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulated exocytosis [GO:0045055]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synapse pruning [GO:1905806]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; telencephalon development [GO:0021537]; visual learning [GO:0008542] axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685] acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; histone kinase activity [GO:0035173]; Hsp90 protein binding [GO:0051879]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor inhibitor activity [GO:0030547]; tau-protein kinase activity [GO:0050321] g18496.t1 Q02284 27.778 360 5.92e-22 99.0 sp|Q02284|5HT1F_MOUSE 5-hydroxytryptamine receptor 1F OS=Mus musculus OX=10090 GN=Htr1f PE=2 SV=1 g18502.t1 Q9W534 24.518 363 1.91e-22 102.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g18503.t1 Q9W534 25.556 360 1.68e-23 105.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g18504.t1 Q62758 26.567 335 8.31e-30 122.0 sp|Q62758|5HT4R_RAT 5-hydroxytryptamine receptor 4 OS=Rattus norvegicus OX=10116 GN=Htr4 PE=2 SV=1 g18506.t1 O15973 29.464 336 1.66e-28 119.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18507.t1 O15973 30.031 323 9.479999999999999e-30 122.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18509.t1 E1B836 58.0 250 4.26e-97 288.0 sp|E1B836|ENKUR_BOVIN Enkurin OS=Bos taurus OX=9913 GN=ENKUR PE=1 SV=2 ENKUR_BOVIN reviewed Enkurin Bos taurus (Bovine) GO:0001669; GO:0005516; GO:0005879; GO:0017124; GO:0030317; GO:0036126; GO:0061966; GO:0097228; GO:0097728; GO:0160112 establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] 9+0 motile cilium [GO:0097728]; acrosomal vesicle [GO:0001669]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124] g18510.t1 Q45FY6 70.335 209 1.3000000000000001e-110 318.0 sp|Q45FY6|HPRT_PIG Hypoxanthine-guanine phosphoribosyltransferase OS=Sus scrofa OX=9823 GN=HPRT1 PE=2 SV=3 HPRT_PIG reviewed Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8) Sus scrofa (Pig) GO:0000166; GO:0000287; GO:0004422; GO:0005737; GO:0005829; GO:0006164; GO:0006166; GO:0006178; GO:0032263; GO:0032264; GO:0042802; GO:0043103; GO:0045964; GO:0046038; GO:0046040; GO:0046100; GO:0052657 GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166] cytoplasm [GO:0005737]; cytosol [GO:0005829] guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166] g18517.t1 Q14527 50.075 667 0.0 657.0 sp|Q14527|HLTF_HUMAN Helicase-like transcription factor OS=Homo sapiens OX=9606 GN=HLTF PE=1 SV=2 g18517.t1 Q14527 50.725 276 4.15e-82 293.0 sp|Q14527|HLTF_HUMAN Helicase-like transcription factor OS=Homo sapiens OX=9606 GN=HLTF PE=1 SV=2 g18518.t1 Q95R48 30.329 577 2.36e-75 253.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g18519.t1 O08966 29.483 580 3.05e-63 219.0 sp|O08966|S22A1_MOUSE Solute carrier family 22 member 1 OS=Mus musculus OX=10090 GN=Slc22a1 PE=1 SV=2 g18520.t1 Q95R48 32.804 567 2.0100000000000002e-85 279.0 sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2 g18525.t1 Q9UL51 43.612 587 1.84e-152 464.0 sp|Q9UL51|HCN2_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 OS=Homo sapiens OX=9606 GN=HCN2 PE=1 SV=3 HCN2_HUMAN reviewed Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2) Homo sapiens (Human) GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0007267; GO:0008076; GO:0009410; GO:0030165; GO:0030424; GO:0030425; GO:0030552; GO:0032590; GO:0035725; GO:0042391; GO:0042802; GO:0043025; GO:0043198; GO:0044877; GO:0060090; GO:0071320; GO:0071321; GO:0071805; GO:0072488; GO:0086012; GO:0098719; GO:0098855; GO:1904045; GO:1990573 ammonium transmembrane transport [GO:0072488]; cell-cell signaling [GO:0007267]; cellular response to aldosterone [GO:1904045]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; HCN channel complex [GO:0098855]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] g18529.t1 Q95ZJ1 42.885 506 4.18e-142 425.0 sp|Q95ZJ1|GALT5_CAEEL Polypeptide N-acetylgalactosaminyltransferase 5 OS=Caenorhabditis elegans OX=6239 GN=gly-5 PE=2 SV=2 GALT5_CAEEL reviewed Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5) Caenorhabditis elegans GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0030246; GO:0036498; GO:0046872 IRE1-mediated unfolded protein response [GO:0036498]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18531.t1 Q8K4T5 55.714 140 3.0999999999999996e-48 159.0 sp|Q8K4T5|DUS19_MOUSE Dual specificity protein phosphatase 19 OS=Mus musculus OX=10090 GN=Dusp19 PE=2 SV=1 DUS19_MOUSE reviewed Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1) Mus musculus (Mouse) GO:0004722; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043409; GO:0043410; GO:0046328; GO:0046329; GO:0046330 JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; regulation of JNK cascade [GO:0046328] cytoplasm [GO:0005737] JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] g18532.t1 Q8BHA0 69.118 68 1.8299999999999999e-25 99.8 sp|Q8BHA0|IN80C_MOUSE INO80 complex subunit C OS=Mus musculus OX=10090 GN=Ino80c PE=1 SV=1 IN80C_MOUSE reviewed INO80 complex subunit C Mus musculus (Mouse) GO:0000723; GO:0001650; GO:0005654; GO:0005829; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0071339; GO:1904507 chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723] cytosol [GO:0005829]; fibrillar center [GO:0001650]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654] g18533.t1 Q10472 48.743 517 2.62e-172 507.0 sp|Q10472|GALT1_HUMAN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=GALNT1 PE=1 SV=1 GALT1_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005576; GO:0005789; GO:0006493; GO:0016020; GO:0016266; GO:0019082; GO:0030145; GO:0030246; GO:0032580; GO:0033116; GO:0048471 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; viral protein processing [GO:0019082] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18534.t1 Q10472 64.912 570 0.0 781.0 sp|Q10472|GALT1_HUMAN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=GALNT1 PE=1 SV=1 GALT1_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005576; GO:0005789; GO:0006493; GO:0016020; GO:0016266; GO:0019082; GO:0030145; GO:0030246; GO:0032580; GO:0033116; GO:0048471 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; viral protein processing [GO:0019082] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18535.t1 Q6UW02 35.897 468 2.37e-107 329.0 sp|Q6UW02|CP20A_HUMAN Cytochrome P450 20A1 OS=Homo sapiens OX=9606 GN=CYP20A1 PE=1 SV=1 g18536.t1 Q09274 28.161 348 1.3000000000000001e-37 156.0 sp|Q09274|UN105_CAEEL Degenerin-like protein unc-105 OS=Caenorhabditis elegans OX=6239 GN=unc-105 PE=1 SV=3 UN105_CAEEL reviewed Degenerin-like protein unc-105 (Uncoordinated protein 105) Caenorhabditis elegans GO:0005216; GO:0005886; GO:0006816; GO:0007517; GO:0015280; GO:0015693; GO:0016020; GO:0030154; GO:0035725 calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; magnesium ion transport [GO:0015693]; muscle organ development [GO:0007517]; sodium ion transmembrane transport [GO:0035725] membrane [GO:0016020]; plasma membrane [GO:0005886] ligand-gated sodium channel activity [GO:0015280]; monoatomic ion channel activity [GO:0005216] g18538.t1 O35474 32.692 208 3.08e-21 100.0 sp|O35474|EDIL3_MOUSE EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Mus musculus OX=10090 GN=Edil3 PE=1 SV=2 g18540.t1 Q08D69 40.749 854 0.0 657.0 sp|Q08D69|MED16_XENTR Mediator of RNA polymerase II transcription subunit 16 OS=Xenopus tropicalis OX=8364 GN=med16 PE=2 SV=1 g18541.t1 O43543 32.787 183 1.48e-25 108.0 sp|O43543|XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens OX=9606 GN=XRCC2 PE=1 SV=1 XRCC2_HUMAN reviewed DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2) Homo sapiens (Human) GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269 centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756] centrosome [GO:0005813]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677] g18544.t1 Q2KIJ2 38.333 300 5.8100000000000005e-58 193.0 sp|Q2KIJ2|MET18_BOVIN Histidine protein methyltransferase 1 homolog OS=Bos taurus OX=9913 GN=METTL18 PE=2 SV=1 MET18_BOVIN reviewed Histidine protein methyltransferase 1 homolog (EC 2.1.1.85) (Methyltransferase-like protein 18) Bos taurus (Bovine) GO:0005634; GO:0005730; GO:0005829; GO:0006417; GO:0006448; GO:0018026; GO:0018064; GO:0090069; GO:2000232 peptidyl-lysine monomethylation [GO:0018026]; regulation of ribosome biogenesis [GO:0090069]; regulation of rRNA processing [GO:2000232]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] protein-L-histidine N-tele-methyltransferase activity [GO:0018064] g18545.t1 Q9NVS9 54.098 244 1.56e-93 280.0 sp|Q9NVS9|PNPO_HUMAN Pyridoxine-5'-phosphate oxidase OS=Homo sapiens OX=9606 GN=PNPO PE=1 SV=1 g18546.t1 Q7KW14 54.762 126 1.83e-34 148.0 sp|Q7KW14|CCDCX_DROME Coiled-coil domain-containing protein CG32809 OS=Drosophila melanogaster OX=7227 GN=CG32809 PE=2 SV=1 g18546.t1 Q7KW14 37.097 186 3.6999999999999996e-30 134.0 sp|Q7KW14|CCDCX_DROME Coiled-coil domain-containing protein CG32809 OS=Drosophila melanogaster OX=7227 GN=CG32809 PE=2 SV=1 g18548.t1 Q54KA7 35.533 197 1.17e-22 108.0 sp|Q54KA7|SECG_DICDI Ankyrin repeat, PH and SEC7 domain containing protein secG OS=Dictyostelium discoideum OX=44689 GN=secG PE=2 SV=1 SECG_DICDI reviewed Ankyrin repeat, PH and SEC7 domain containing protein secG Dictyostelium discoideum (Social amoeba) GO:0005085; GO:0005764; GO:0005829; GO:0006935; GO:0030036; GO:0031154; GO:0031589; GO:0032012; GO:0043327 actin cytoskeleton organization [GO:0030036]; cell-substrate adhesion [GO:0031589]; chemotaxis [GO:0006935]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; regulation of ARF protein signal transduction [GO:0032012] cytosol [GO:0005829]; lysosome [GO:0005764] guanyl-nucleotide exchange factor activity [GO:0005085] g18550.t1 Q1ECX4 55.322 714 0.0 702.0 sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio OX=7955 GN=tlk2 PE=2 SV=2 TLK2_DANRE reviewed Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0035556; GO:0048471; GO:0106310 chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556] cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g18551.t1 Q5I0G4 66.815 675 0.0 982.0 sp|Q5I0G4|GARS_RAT Glycine--tRNA ligase OS=Rattus norvegicus OX=10116 GN=Gars1 PE=1 SV=2 GARS_RAT reviewed Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1) Rattus norvegicus (Rat) GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150; GO:0141192 diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; secretory granule [GO:0030141] ATP binding [GO:0005524]; ATP:ATP adenylyltransferase activity [GO:0141192]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983] g18552.t1 Q9H3G5 54.375 480 0.0 524.0 sp|Q9H3G5|CPVL_HUMAN Probable serine carboxypeptidase CPVL OS=Homo sapiens OX=9606 GN=CPVL PE=1 SV=2 g18553.t1 Q3USY0 42.89 436 9.41e-120 361.0 sp|Q3USY0|S38AB_MOUSE Putative sodium-coupled neutral amino acid transporter 11 OS=Mus musculus OX=10090 GN=Slc38a11 PE=2 SV=2 g18554.t1 Q5UIP0 36.301 1168 0.0 708.0 sp|Q5UIP0|RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens OX=9606 GN=RIF1 PE=1 SV=2 RIF1_HUMAN reviewed Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) Homo sapiens (Human) GO:0000122; GO:0000723; GO:0000785; GO:0000793; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006974; GO:0031509; GO:0031965; GO:0035019; GO:0035861; GO:0043247; GO:0045814; GO:0045830; GO:0051233; GO:0140445; GO:1990830; GO:2000042; GO:2001034 cellular response to leukemia inhibitory factor [GO:1990830]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic stem cell population maintenance [GO:0035019]; subtelomeric heterochromatin formation [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247] chromatin [GO:0000785]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233] g18556.t1 E7F590 56.695 829 0.0 984.0 sp|E7F590|VPS41_DANRE Vacuolar protein sorting-associated protein 41 homolog OS=Danio rerio OX=7955 GN=vps41 PE=1 SV=1 VPS41_DANRE reviewed Vacuolar protein sorting-associated protein 41 homolog Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0005770; GO:0005794; GO:0005829; GO:0006623; GO:0008270; GO:0008333; GO:0009267; GO:0016192; GO:0016236; GO:0030136; GO:0030897; GO:0031901; GO:0031902; GO:0034058 cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765] zinc ion binding [GO:0008270] g18557.t1 P78424 68.367 196 6.09e-87 288.0 sp|P78424|PO6F2_HUMAN POU domain, class 6, transcription factor 2 OS=Homo sapiens OX=9606 GN=POU6F2 PE=1 SV=3 PO6F2_HUMAN reviewed POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g18557.t2 P78424 68.367 196 6.68e-87 288.0 sp|P78424|PO6F2_HUMAN POU domain, class 6, transcription factor 2 OS=Homo sapiens OX=9606 GN=POU6F2 PE=1 SV=3 PO6F2_HUMAN reviewed POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g18557.t3 P78424 68.367 196 5.63e-87 289.0 sp|P78424|PO6F2_HUMAN POU domain, class 6, transcription factor 2 OS=Homo sapiens OX=9606 GN=POU6F2 PE=1 SV=3 PO6F2_HUMAN reviewed POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g18557.t4 P78424 68.02 197 3.56e-85 284.0 sp|P78424|PO6F2_HUMAN POU domain, class 6, transcription factor 2 OS=Homo sapiens OX=9606 GN=POU6F2 PE=1 SV=3 PO6F2_HUMAN reviewed POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g18558.t1 O76536 33.42 1158 9.05e-99 350.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g18558.t1 O76536 32.14 1145 3.1499999999999996e-94 336.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g18558.t1 O76536 33.333 1134 1.76e-93 334.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g18558.t1 O76536 31.333 1200 2.68e-80 294.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g18558.t1 O76536 31.138 835 1.96e-62 238.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g18559.t1 Q95245 36.694 248 7.51e-51 169.0 sp|Q95245|CY561_PIG Transmembrane ascorbate-dependent reductase CYB561 OS=Sus scrofa OX=9823 GN=CYB561 PE=2 SV=1 g18560.t1 P10897 37.917 240 3.14e-45 154.0 sp|P10897|CY561_BOVIN Transmembrane ascorbate-dependent reductase CYB561 OS=Bos taurus OX=9913 GN=CYB561 PE=1 SV=2 CY561_BOVIN reviewed Transmembrane ascorbate-dependent reductase CYB561 (EC 7.2.1.3) (Chromomembrin B) (Cytochrome b-561) (Cytochrome b561) Bos taurus (Bovine) GO:0005765; GO:0016491; GO:0042584; GO:0046872; GO:0140575; GO:0140576 ascorbate homeostasis [GO:0140576] chromaffin granule membrane [GO:0042584]; lysosomal membrane [GO:0005765] metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane monodehydroascorbate reductase activity [GO:0140575] g18561.t1 Q6DFQ7 41.667 312 2.23e-76 242.0 sp|Q6DFQ7|TM198_XENTR Transmembrane protein 198 OS=Xenopus tropicalis OX=8364 GN=tmem198 PE=1 SV=1 TM198_XENTR reviewed Transmembrane protein 198 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005886; GO:0012506; GO:0016055; GO:0031410 Wnt signaling pathway [GO:0016055] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] g18564.t1 O54749 41.667 492 3.35e-129 387.0 sp|O54749|CP2J5_MOUSE Cytochrome P450 2J5 OS=Mus musculus OX=10090 GN=Cyp2j5 PE=1 SV=1 CP2J5_MOUSE reviewed Cytochrome P450 2J5 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ5) Mus musculus (Mouse) GO:0001990; GO:0001998; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0071614; GO:0097254; GO:2000863 angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g18566.t1 Q96K80 34.634 410 3.4500000000000003e-56 192.0 sp|Q96K80|ZC3HA_HUMAN Zinc finger CCCH domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ZC3H10 PE=1 SV=1 ZC3HA_HUMAN reviewed Zinc finger CCCH domain-containing protein 10 Homo sapiens (Human) GO:0003723; GO:0005634; GO:0008270; GO:0010608; GO:0035198; GO:0043484; GO:1903799 negative regulation of miRNA processing [GO:1903799]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of RNA splicing [GO:0043484] nucleus [GO:0005634] miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g18569.t1 Q96PC2 34.761 397 1.77e-74 240.0 sp|Q96PC2|IP6K3_HUMAN Inositol hexakisphosphate kinase 3 OS=Homo sapiens OX=9606 GN=IP6K3 PE=1 SV=2 IP6K3_HUMAN reviewed Inositol hexakisphosphate kinase 3 (InsP6 kinase 3) (EC 2.7.4.21) (Inositol hexaphosphate kinase 3) Homo sapiens (Human) GO:0000827; GO:0000828; GO:0000829; GO:0000831; GO:0000832; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0032958; GO:0040011; GO:0043647; GO:0046488; GO:0046854; GO:0052836; GO:0052839 inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; locomotion [GO:0040011]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; diphosphoinositol pentakisphosphate kinase activity [GO:0000829]; diphosphoinositol tetrakisphosphate kinase activity [GO:0052839]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate 6-kinase activity [GO:0000831]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827] g18570.t1 P70345 34.975 203 1.4e-26 105.0 sp|P70345|B2CL2_MOUSE Bcl-2-like protein 2 OS=Mus musculus OX=10090 GN=Bcl2l2 PE=1 SV=1 g18571.t1 Q99JH1 46.847 111 4.45e-34 121.0 sp|Q99JH1|RP25L_MOUSE Ribonuclease P protein subunit p25-like protein OS=Mus musculus OX=10090 GN=Rpp25l PE=1 SV=1 g18572.t1 F1QVR8 71.498 207 1.28e-107 311.0 sp|F1QVR8|METL5_DANRE rRNA N(6)-adenosine-methyltransferase METTL5 OS=Danio rerio OX=7955 GN=mettl5 PE=2 SV=1 g18573.t1 A0A0R4IXF6 64.106 833 0.0 1100.0 sp|A0A0R4IXF6|KAT2A_DANRE Histone acetyltransferase KAT2A OS=Danio rerio OX=7955 GN=kat2a PE=2 SV=1 KAT2A_DANRE reviewed Histone acetyltransferase KAT2A (EC 2.3.1.48) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000123; GO:0001819; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005813; GO:0006338; GO:0007507; GO:0007616; GO:0010484; GO:0018393; GO:0040029; GO:0043992; GO:0045589; GO:0045893; GO:0045944; GO:0048167; GO:0050863; GO:0060173; GO:0060349; GO:0061035; GO:0061733; GO:0106078; GO:0106227; GO:0106229; GO:0140187; GO:0140672; GO:1903010 bone morphogenesis [GO:0060349]; chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heart development [GO:0007507]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; long-term memory [GO:0007616]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863] ATAC complex [GO:0140672]; centrosome [GO:0005813]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone glutaryltransferase activity [GO:0106229]; histone H1-4K34 acetyltransferase activity [GO:0140187]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K9 acetyltransferase activity [GO:0043992]; histone succinyltransferase activity [GO:0106078]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713] g18579.t1 O54902 61.896 559 0.0 649.0 sp|O54902|NRAM2_RAT Natural resistance-associated macrophage protein 2 OS=Rattus norvegicus OX=10116 GN=Slc11a2 PE=1 SV=1 NRAM2_RAT reviewed Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2) Rattus norvegicus (Rat) GO:0000041; GO:0001666; GO:0003032; GO:0005375; GO:0005381; GO:0005384; GO:0005385; GO:0005506; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005773; GO:0005802; GO:0005886; GO:0005903; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006825; GO:0006826; GO:0006828; GO:0006879; GO:0007611; GO:0008270; GO:0009986; GO:0010008; GO:0010039; GO:0010042; GO:0010288; GO:0012505; GO:0015078; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015100; GO:0015295; GO:0015675; GO:0015676; GO:0015692; GO:0016151; GO:0016324; GO:0022890; GO:0030026; GO:0030145; GO:0031410; GO:0031526; GO:0031901; GO:0031902; GO:0033212; GO:0034599; GO:0034755; GO:0045177; GO:0045178; GO:0046686; GO:0046870; GO:0046915; GO:0048471; GO:0048813; GO:0048821; GO:0050897; GO:0051649; GO:0055037; GO:0055038; GO:0060586; GO:0070574; GO:0070826; GO:0071281; GO:0071356; GO:0071456; GO:0098705; GO:1902600; GO:1903561; GO:1905394 cadmium ion transmembrane transport [GO:0070574]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cobalt ion transport [GO:0006824]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; establishment of localization in cell [GO:0051649]; heme biosynthetic process [GO:0006783]; intracellular iron ion homeostasis [GO:0006879]; intracellular manganese ion homeostasis [GO:0030026]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; proton transmembrane transport [GO:1902600]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; transition metal ion transport [GO:0000041]; vanadium ion transport [GO:0015676] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular vesicle [GO:1903561]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion binding [GO:0050897]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion binding [GO:0005506]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion binding [GO:0030145]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation binding [GO:0016151]; nickel cation transmembrane transporter activity [GO:0015099]; proton transmembrane transporter activity [GO:0015078]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385] g18579.t2 O54902 63.72 543 0.0 659.0 sp|O54902|NRAM2_RAT Natural resistance-associated macrophage protein 2 OS=Rattus norvegicus OX=10116 GN=Slc11a2 PE=1 SV=1 NRAM2_RAT reviewed Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2) Rattus norvegicus (Rat) GO:0000041; GO:0001666; GO:0003032; GO:0005375; GO:0005381; GO:0005384; GO:0005385; GO:0005506; GO:0005507; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005773; GO:0005802; GO:0005886; GO:0005903; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006825; GO:0006826; GO:0006828; GO:0006879; GO:0007611; GO:0008270; GO:0009986; GO:0010008; GO:0010039; GO:0010042; GO:0010288; GO:0012505; GO:0015078; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015100; GO:0015295; GO:0015675; GO:0015676; GO:0015692; GO:0016151; GO:0016324; GO:0022890; GO:0030026; GO:0030145; GO:0031410; GO:0031526; GO:0031901; GO:0031902; GO:0033212; GO:0034599; GO:0034755; GO:0045177; GO:0045178; GO:0046686; GO:0046870; GO:0046915; GO:0048471; GO:0048813; GO:0048821; GO:0050897; GO:0051649; GO:0055037; GO:0055038; GO:0060586; GO:0070574; GO:0070826; GO:0071281; GO:0071356; GO:0071456; GO:0098705; GO:1902600; GO:1903561; GO:1905394 cadmium ion transmembrane transport [GO:0070574]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cobalt ion transport [GO:0006824]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; establishment of localization in cell [GO:0051649]; heme biosynthetic process [GO:0006783]; intracellular iron ion homeostasis [GO:0006879]; intracellular manganese ion homeostasis [GO:0030026]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; proton transmembrane transport [GO:1902600]; response to cadmium ion [GO:0046686]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; transition metal ion transport [GO:0000041]; vanadium ion transport [GO:0015676] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular vesicle [GO:1903561]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion binding [GO:0050897]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion binding [GO:0005506]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion binding [GO:0030145]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation binding [GO:0016151]; nickel cation transmembrane transporter activity [GO:0015099]; proton transmembrane transporter activity [GO:0015078]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385] g18580.t1 Q8BGC3 24.153 443 1.43e-22 103.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g18581.t1 Q640E9 46.907 194 2.39e-44 149.0 sp|Q640E9|PYM1_XENLA Partner of Y14 and mago OS=Xenopus laevis OX=8355 GN=pym1 PE=2 SV=1 g18582.t1 A1Z9S1 59.829 117 9.38e-44 142.0 sp|A1Z9S1|BL1S1_DROME Biogenesis of lysosome-related organelles complex 1 subunit 1 OS=Drosophila melanogaster OX=7227 GN=Blos1 PE=1 SV=2 BL1S1_DROME reviewed Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) Drosophila melanogaster (Fruit fly) GO:0007274; GO:0008057; GO:0008355; GO:0016197; GO:0031083; GO:0031594; GO:0036466; GO:0048489; GO:0050808; GO:0061909; GO:0098693; GO:0098793 autophagosome-lysosome fusion [GO:0061909]; endosomal transport [GO:0016197]; eye pigment granule organization [GO:0008057]; neuromuscular synaptic transmission [GO:0007274]; olfactory learning [GO:0008355]; regulation of synaptic vesicle cycle [GO:0098693]; synapse organization [GO:0050808]; synaptic vesicle recycling via endosome [GO:0036466]; synaptic vesicle transport [GO:0048489] BLOC-1 complex [GO:0031083]; neuromuscular junction [GO:0031594]; presynapse [GO:0098793] g18583.t1 P26007 31.5 1127 1.12e-149 479.0 sp|P26007|ITA6_CHICK Integrin alpha-6 OS=Gallus gallus OX=9031 GN=ITGA6 PE=2 SV=1 g18584.t1 Q7ZWG6 30.66 424 1.51e-47 174.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g18585.t1 Q9Z100 39.877 163 7.6299999999999995e-25 106.0 sp|Q9Z100|CPXM1_MOUSE Probable carboxypeptidase X1 OS=Mus musculus OX=10090 GN=Cpxm1 PE=2 SV=2 g18586.t1 Q96SM3 39.011 182 9.44e-24 103.0 sp|Q96SM3|CPXM1_HUMAN Probable carboxypeptidase X1 OS=Homo sapiens OX=9606 GN=CPXM1 PE=1 SV=2 g18588.t1 Q96SM3 39.011 182 1.37e-23 102.0 sp|Q96SM3|CPXM1_HUMAN Probable carboxypeptidase X1 OS=Homo sapiens OX=9606 GN=CPXM1 PE=1 SV=2 g18589.t1 P30803 54.918 1098 0.0 1189.0 sp|P30803|ADCY5_CANLF Adenylate cyclase type 5 OS=Canis lupus familiaris OX=9615 GN=ADCY5 PE=1 SV=2 g18591.t1 Q9CZ28 65.021 243 6.269999999999999e-115 332.0 sp|Q9CZ28|SNF8_MOUSE Vacuolar-sorting protein SNF8 OS=Mus musculus OX=10090 GN=Snf8 PE=1 SV=1 SNF8_MOUSE reviewed Vacuolar-sorting protein SNF8 (ESCRT-II complex subunit VPS22) Mus musculus (Mouse) GO:0000814; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0008289; GO:0010008; GO:0010628; GO:0016020; GO:0016236; GO:0016247; GO:0031902; GO:0032456; GO:0036258; GO:0042176; GO:0042803; GO:0043328; GO:0045022; GO:0045732; GO:0048471; GO:0055037; GO:0061635; GO:0071985; GO:1903543 early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667] channel regulator activity [GO:0016247]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803] g18592.t1 Q5F450 53.624 1145 0.0 1225.0 sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1 PAN2_CHICK reviewed PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2) Gallus gallus (Chicken) GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872 mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251] 3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535] g18593.t1 Q95V11 84.298 605 0.0 1109.0 sp|Q95V11|CMAH_ASTRU Cytidine monophosphate-N-acetylneuraminic acid hydroxylase OS=Asterias rubens OX=7604 GN=cnh PE=1 SV=1 CMAH_ASTRU reviewed Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminic acid hydroxylase) (EC 1.14.18.2) (CMP-N-acetylneuraminate monooxygenase) (CMP-Neu5Ac hydroxylase) (CMP-NeuAc hydroxylase) Asterias rubens (Common European starfish) (Asterias vulgaris) GO:0005737; GO:0006054; GO:0016020; GO:0030338; GO:0046381; GO:0046872; GO:0051537 CMP-N-acetylneuraminate metabolic process [GO:0046381]; N-acetylneuraminate metabolic process [GO:0006054] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; CMP-N-acetylneuraminate monooxygenase activity [GO:0030338]; metal ion binding [GO:0046872] g18594.t1 Q15326 40.25 641 4.4299999999999997e-159 473.0 sp|Q15326|ZMY11_HUMAN Zinc finger MYND domain-containing protein 11 OS=Homo sapiens OX=9606 GN=ZMYND11 PE=1 SV=2 ZMY11_HUMAN reviewed Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69) Homo sapiens (Human) GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0008270; GO:0009966; GO:0034243; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:0140003; GO:2001237 defense response to virus [GO:0051607]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of JNK cascade [GO:0046329]; regulation of signal transduction [GO:0009966]; regulation of transcription elongation by RNA polymerase II [GO:0034243] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; histone H3K36me3 reader activity [GO:0140003]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g18596.t1 Q0II24 37.956 274 3.3299999999999997e-40 145.0 sp|Q0II24|C1QT9_BOVIN Complement C1q and tumor necrosis factor-related protein 9 OS=Bos taurus OX=9913 GN=C1QTNF9 PE=2 SV=1 g18597.t1 Q4R6W9 45.255 137 9.74e-32 120.0 sp|Q4R6W9|SNPC1_MACFA snRNA-activating protein complex subunit 1 OS=Macaca fascicularis OX=9541 GN=SNAPC1 PE=2 SV=1 SNPC1_MACFA reviewed snRNA-activating protein complex subunit 1 (SNAPc subunit 1) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit) (SNAPc 43 kDa subunit) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005654; GO:0005730; GO:0019185; GO:0042795; GO:0042796; GO:0043565 snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185] sequence-specific DNA binding [GO:0043565] g18605.t1 Q2PC93 33.696 1288 0.0 634.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18608.t1 Q99LX5 53.0 100 3.86e-27 107.0 sp|Q99LX5|MMTA2_MOUSE Multiple myeloma tumor-associated protein 2 homolog OS=Mus musculus OX=10090 GN=Mmtag2 PE=2 SV=1 g18609.t1 F6P3G4 72.967 418 0.0 645.0 sp|F6P3G4|PS11A_DANRE 26S proteasome non-ATPase regulatory subunit 11A OS=Danio rerio OX=7955 GN=psmd11a PE=2 SV=1 g18610.t1 Q28199 40.346 347 9.43e-72 228.0 sp|Q28199|CD5R1_BOVIN Cyclin-dependent kinase 5 activator 1 OS=Bos taurus OX=9913 GN=CDK5R1 PE=1 SV=1 CD5R1_BOVIN reviewed Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] Bos taurus (Bovine) GO:0000307; GO:0001764; GO:0002020; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016301; GO:0016533; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030182; GO:0030424; GO:0030425; GO:0030426; GO:0031116; GO:0031175; GO:0031594; GO:0032956; GO:0035235; GO:0035255; GO:0043005; GO:0043014; GO:0043025; GO:0043197; GO:0043204; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045892; GO:0048013; GO:0048471; GO:0048487; GO:0048511; GO:0051015; GO:0061001; GO:0061575; GO:0070315; GO:0090314 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; negative regulation of DNA-templated transcription [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; rhythmic process [GO:0048511]; superior olivary nucleus maturation [GO:0021722] axon [GO:0030424]; contractile muscle fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein kinase 5 complex [GO:0016533] actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] g18612.t1 O94832 58.631 1008 0.0 1211.0 sp|O94832|MYO1D_HUMAN Unconventional myosin-Id OS=Homo sapiens OX=9606 GN=MYO1D PE=1 SV=2 MYO1D_HUMAN reviewed Unconventional myosin-Id Homo sapiens (Human) GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030048; GO:0030424; GO:0030673; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0070062; GO:0097440 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; protein transport [GO:0015031] actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904] g18613.t1 Q08D64 57.282 824 0.0 924.0 sp|Q08D64|ABCB6_XENTR ATP-binding cassette sub-family B member 6 OS=Xenopus tropicalis OX=8364 GN=abcb6 PE=2 SV=1 ABCB6_XENTR reviewed ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0005524; GO:0005739; GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0006778; GO:0006878; GO:0015439; GO:0016887; GO:0031901; GO:0031902; GO:0032585; GO:0033013; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0046906; GO:0070062; GO:0098849; GO:0140359; GO:1903232 cellular detoxification of cadmium ion [GO:0098849]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; intracellular copper ion homeostasis [GO:0006878]; melanosome assembly [GO:1903232]; porphyrin-containing compound metabolic process [GO:0006778]; tetrapyrrole metabolic process [GO:0033013] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; tetrapyrrole binding [GO:0046906] g18615.t1 Q2PC93 33.071 1273 4.73e-175 617.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18616.t1 A2VEC9 33.046 1274 0.0 627.0 sp|A2VEC9|SSPO_HUMAN SCO-spondin OS=Homo sapiens OX=9606 GN=SSPOP PE=2 SV=2 SSPO_HUMAN reviewed SCO-spondin (SCO-spondin pseudogene) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0007155; GO:0030414; GO:0031012 cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414] g18616.t1 A2VEC9 25.244 614 1.15e-40 170.0 sp|A2VEC9|SSPO_HUMAN SCO-spondin OS=Homo sapiens OX=9606 GN=SSPOP PE=2 SV=2 SSPO_HUMAN reviewed SCO-spondin (SCO-spondin pseudogene) Homo sapiens (Human) GO:0005201; GO:0005615; GO:0007155; GO:0030414; GO:0031012 cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414] g18619.t1 Q805E5 31.359 287 7.63e-37 139.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g18621.t1 Q2PC93 34.144 1274 7.5300000000000004e-177 622.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18621.t2 Q2PC93 34.144 1274 4.5e-177 623.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18621.t3 Q2PC93 33.805 1272 1.01e-178 627.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18621.t3 Q2PC93 26.699 412 8.49e-31 139.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g18623.t1 Q805E5 31.119 286 6.73e-38 143.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g18624.t1 Q9TV66 44.381 525 5.839999999999999e-146 453.0 sp|Q9TV66|HCN4_RABIT Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Oryctolagus cuniculus OX=9986 GN=HCN4 PE=1 SV=1 g18625.t1 Q0MQG2 74.377 722 0.0 1132.0 sp|Q0MQG2|NDUS1_PANTR NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Pan troglodytes OX=9598 GN=NDUFS1 PE=2 SV=1 NDUS1_PANTR reviewed NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD) Pan troglodytes (Chimpanzee) GO:0005739; GO:0005743; GO:0005758; GO:0006120; GO:0008137; GO:0016651; GO:0032981; GO:0045271; GO:0046872; GO:0051537; GO:0051539 mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity, acting on NAD(P)H [GO:0016651] g18626.t1 P30151 64.912 228 1.52e-99 291.0 sp|P30151|EF1B_XENLA Elongation factor 1-beta OS=Xenopus laevis OX=8355 GN=eef1b PE=1 SV=3 g18628.t1 Q9UKA2 43.989 366 6.17e-89 283.0 sp|Q9UKA2|FBXL4_HUMAN F-box/LRR-repeat protein 4 OS=Homo sapiens OX=9606 GN=FBXL4 PE=1 SV=2 g18629.t1 D3ZVM4 31.987 297 2.76e-28 124.0 sp|D3ZVM4|LIN41_RAT E3 ubiquitin-protein ligase TRIM71 OS=Rattus norvegicus OX=10116 GN=Trim71 PE=3 SV=1 LIN41_RAT reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Rattus norvegicus (Rat) GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18630.t1 Q8BH70 36.364 220 1.93e-37 140.0 sp|Q8BH70|FBXL4_MOUSE F-box/LRR-repeat protein 4 OS=Mus musculus OX=10090 GN=Fbxl4 PE=1 SV=1 g18640.t1 Q13057 42.424 561 3.0899999999999997e-136 410.0 sp|Q13057|COASY_HUMAN Bifunctional coenzyme A synthase OS=Homo sapiens OX=9606 GN=COASY PE=1 SV=4 COASY_HUMAN reviewed Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)] Homo sapiens (Human) GO:0004140; GO:0004595; GO:0005524; GO:0005739; GO:0005741; GO:0005759; GO:0015937; GO:0070062; GO:0120212 coenzyme A biosynthetic process [GO:0015937] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm head-tail coupling apparatus [GO:0120212] ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595] g18640.t2 Q13057 42.424 561 4.43e-136 410.0 sp|Q13057|COASY_HUMAN Bifunctional coenzyme A synthase OS=Homo sapiens OX=9606 GN=COASY PE=1 SV=4 COASY_HUMAN reviewed Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)] Homo sapiens (Human) GO:0004140; GO:0004595; GO:0005524; GO:0005739; GO:0005741; GO:0005759; GO:0015937; GO:0070062; GO:0120212 coenzyme A biosynthetic process [GO:0015937] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm head-tail coupling apparatus [GO:0120212] ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595] g18643.t1 Q505D1 53.486 1090 0.0 1128.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t1 Q505D1 31.062 866 6.75e-85 300.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t2 Q505D1 54.132 1077 0.0 1133.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t2 Q505D1 31.034 870 1.9600000000000002e-85 301.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t3 Q505D1 54.393 1070 0.0 1135.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t3 Q505D1 30.974 862 6.2400000000000004e-86 303.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t4 Q505D1 54.443 1069 0.0 1138.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t4 Q505D1 31.206 862 7.94e-87 305.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t5 Q505D1 55.261 1055 0.0 1145.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18643.t5 Q505D1 30.974 862 5.84e-87 305.0 sp|Q505D1|ANR28_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A OS=Mus musculus OX=10090 GN=Ankrd28 PE=1 SV=1 g18644.t1 P10922 63.333 90 3.3300000000000003e-32 118.0 sp|P10922|H10_MOUSE Histone H1.0 OS=Mus musculus OX=10090 GN=H1-0 PE=2 SV=4 H10_MOUSE reviewed Histone H1.0 (Histone H1') (Histone H1(0)) (MyD196) [Cleaved into: Histone H1.0, N-terminally processed] Mus musculus (Mouse) GO:0000785; GO:0000786; GO:0000791; GO:0003677; GO:0003680; GO:0003690; GO:0005634; GO:0005654; GO:0005794; GO:0006334; GO:0015629; GO:0016604; GO:0017053; GO:0030261; GO:0030527; GO:0031490; GO:0031491; GO:0031492; GO:0031507; GO:0045910 chromosome condensation [GO:0030261]; heterochromatin formation [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; structural constituent of chromatin [GO:0030527] g18645.t1 P25100 30.12 332 9.499999999999999e-23 103.0 sp|P25100|ADA1D_HUMAN Alpha-1D adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1D PE=1 SV=2 ADA1D_HUMAN reviewed Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a) Homo sapiens (Human) GO:0004937; GO:0005886; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0008284; GO:0042802; GO:0043410; GO:0045907; GO:0071880; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802] g18647.t1 P97288 27.515 338 1.75e-22 101.0 sp|P97288|5HT4R_MOUSE 5-hydroxytryptamine receptor 4 OS=Mus musculus OX=10090 GN=Htr4 PE=1 SV=3 5HT4R_MOUSE reviewed 5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4) Mus musculus (Mouse) GO:0004993; GO:0005737; GO:0005886; GO:0007186; GO:0007187; GO:0007189; GO:0007192; GO:0007198; GO:0007214; GO:0007268; GO:0010008; GO:0016020; GO:0030277; GO:0030425; GO:0030594; GO:0032098; GO:0051378; GO:0070254; GO:0098794; GO:0098978; GO:0099589; GO:0120056; GO:0150052 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-activating serotonin receptor signaling pathway [GO:0007192]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; large intestinal transit [GO:0120056]; maintenance of gastrointestinal epithelium [GO:0030277]; mucus secretion [GO:0070254]; regulation of appetite [GO:0032098]; regulation of postsynapse assembly [GO:0150052] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589] g18648.t1 Q9NDM2 29.18 305 1.95e-21 98.2 sp|Q9NDM2|GUTR1_DROME Protein trapped in endoderm-1 OS=Drosophila melanogaster OX=7227 GN=Tre1 PE=1 SV=1 GUTR1_DROME reviewed Protein trapped in endoderm-1 Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007281; GO:0008354; GO:0016020; GO:0035234 ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354] cell cortex [GO:0005938]; membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g18649.t1 Q5XIA3 37.931 203 1.98e-28 120.0 sp|Q5XIA3|TYW4_RAT tRNA wybutosine-synthesizing protein 4 OS=Rattus norvegicus OX=10116 GN=Lcmt2 PE=2 SV=1 TYW4_RAT reviewed tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) Rattus norvegicus (Rat) GO:0008175; GO:0030488; GO:0031591 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] tRNA methyltransferase activity [GO:0008175] g18651.t1 Q8BYR1 49.412 85 8.419999999999999e-24 97.8 sp|Q8BYR1|TYW4_MOUSE tRNA wybutosine-synthesizing protein 4 OS=Mus musculus OX=10090 GN=Lcmt2 PE=2 SV=4 TYW4_MOUSE reviewed tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) Mus musculus (Mouse) GO:0003880; GO:0008175; GO:0030488; GO:0031591 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175] g18653.t1 Q9NDM2 28.402 338 2.0600000000000002e-21 98.2 sp|Q9NDM2|GUTR1_DROME Protein trapped in endoderm-1 OS=Drosophila melanogaster OX=7227 GN=Tre1 PE=1 SV=1 GUTR1_DROME reviewed Protein trapped in endoderm-1 Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007281; GO:0008354; GO:0016020; GO:0035234 ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354] cell cortex [GO:0005938]; membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g18655.t1 Q8BYR1 45.729 199 2.01e-51 179.0 sp|Q8BYR1|TYW4_MOUSE tRNA wybutosine-synthesizing protein 4 OS=Mus musculus OX=10090 GN=Lcmt2 PE=2 SV=4 TYW4_MOUSE reviewed tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) Mus musculus (Mouse) GO:0003880; GO:0008175; GO:0030488; GO:0031591 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175] g18657.t1 Q9NDM2 28.402 338 2.0600000000000002e-21 98.2 sp|Q9NDM2|GUTR1_DROME Protein trapped in endoderm-1 OS=Drosophila melanogaster OX=7227 GN=Tre1 PE=1 SV=1 GUTR1_DROME reviewed Protein trapped in endoderm-1 Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005938; GO:0007186; GO:0007281; GO:0008354; GO:0016020; GO:0035234 ectopic germ cell programmed cell death [GO:0035234]; G protein-coupled receptor signaling pathway [GO:0007186]; germ cell development [GO:0007281]; germ cell migration [GO:0008354] cell cortex [GO:0005938]; membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g18658.t1 Q5XIA3 38.916 203 6.2800000000000005e-31 122.0 sp|Q5XIA3|TYW4_RAT tRNA wybutosine-synthesizing protein 4 OS=Rattus norvegicus OX=10116 GN=Lcmt2 PE=2 SV=1 TYW4_RAT reviewed tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) Rattus norvegicus (Rat) GO:0008175; GO:0030488; GO:0031591 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] tRNA methyltransferase activity [GO:0008175] g18659.t1 Q8BYR1 40.055 362 7.479999999999999e-68 238.0 sp|Q8BYR1|TYW4_MOUSE tRNA wybutosine-synthesizing protein 4 OS=Mus musculus OX=10090 GN=Lcmt2 PE=2 SV=4 TYW4_MOUSE reviewed tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) Mus musculus (Mouse) GO:0003880; GO:0008175; GO:0030488; GO:0031591 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175] g18659.t1 Q8BYR1 46.763 139 2.94e-25 114.0 sp|Q8BYR1|TYW4_MOUSE tRNA wybutosine-synthesizing protein 4 OS=Mus musculus OX=10090 GN=Lcmt2 PE=2 SV=4 TYW4_MOUSE reviewed tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (p21WAF1/CIP1 promoter-interacting protein) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase) Mus musculus (Mouse) GO:0003880; GO:0008175; GO:0030488; GO:0031591 tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591] protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; tRNA methyltransferase activity [GO:0008175] g18660.t1 Q6GNX5 48.529 136 3.9900000000000003e-35 121.0 sp|Q6GNX5|TM203_XENLA Transmembrane protein 203 OS=Xenopus laevis OX=8355 GN=tmem203 PE=2 SV=1 g18661.t1 P62997 72.65 117 6.03e-57 187.0 sp|P62997|TRA2B_RAT Transformer-2 protein homolog beta OS=Rattus norvegicus OX=10116 GN=Tra2b PE=1 SV=1 TRA2B_RAT reviewed Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Rattus norvegicus (Rat) GO:0000302; GO:0000381; GO:0000398; GO:0001673; GO:0003723; GO:0003729; GO:0005634; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0048471; GO:0070717; GO:0071333; GO:1990403 cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to reactive oxygen species [GO:0000302] male germ cell nucleus [GO:0001673]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681] identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly-purine tract binding [GO:0070717]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] g18661.t2 P62997 72.65 117 3.67e-55 184.0 sp|P62997|TRA2B_RAT Transformer-2 protein homolog beta OS=Rattus norvegicus OX=10116 GN=Tra2b PE=1 SV=1 TRA2B_RAT reviewed Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Rattus norvegicus (Rat) GO:0000302; GO:0000381; GO:0000398; GO:0001673; GO:0003723; GO:0003729; GO:0005634; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0048471; GO:0070717; GO:0071333; GO:1990403 cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to reactive oxygen species [GO:0000302] male germ cell nucleus [GO:0001673]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681] identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly-purine tract binding [GO:0070717]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] g18662.t1 Q0VCQ7 34.599 237 1.1900000000000001e-26 122.0 sp|Q0VCQ7|ICE2_BOVIN Little elongation complex subunit 2 OS=Bos taurus OX=9913 GN=ICE2 PE=2 SV=1 g18662.t1 Q0VCQ7 25.208 361 1.84e-22 108.0 sp|Q0VCQ7|ICE2_BOVIN Little elongation complex subunit 2 OS=Bos taurus OX=9913 GN=ICE2 PE=2 SV=1 g18663.t1 Q5R9A7 35.646 836 4.73e-159 488.0 sp|Q5R9A7|LYCHS_PONAB Lysosomal cholesterol signaling protein OS=Pongo abelii OX=9601 GN=GPR155 PE=2 SV=1 LYCHS_PONAB reviewed Lysosomal cholesterol signaling protein (LYCHOS) (Integral membrane protein GPR155) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005765; GO:0015485; GO:0030514; GO:0034198; GO:0035556; GO:0055085; GO:0071397; GO:1904263 cellular response to amino acid starvation [GO:0034198]; cellular response to cholesterol [GO:0071397]; intracellular signal transduction [GO:0035556]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of TORC1 signaling [GO:1904263]; transmembrane transport [GO:0055085] lysosomal membrane [GO:0005765] cholesterol binding [GO:0015485] g18664.t1 Q4G0U5 39.024 820 0.0 577.0 sp|Q4G0U5|PCDP1_HUMAN Cilia- and flagella-associated protein 221 OS=Homo sapiens OX=9606 GN=CFAP221 PE=1 SV=2 PCDP1_HUMAN reviewed Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1) Homo sapiens (Human) GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0044458; GO:0051649; GO:0060271; GO:0090660; GO:0097386; GO:0097729; GO:0120197; GO:0120316 cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; manchette [GO:0002177]; sperm flagellum [GO:0036126] calmodulin binding [GO:0005516] g18665.t1 P23330 87.168 452 0.0 842.0 sp|P23330|TBG1_XENLA Tubulin gamma-1 chain OS=Xenopus laevis OX=8355 GN=tubg1 PE=1 SV=1 g18666.t1 Q9JLI7 84.418 507 0.0 890.0 sp|Q9JLI7|SPAG6_MOUSE Sperm-associated antigen 6 OS=Mus musculus OX=10090 GN=Spag6 PE=1 SV=1 SPAG6_MOUSE reviewed Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog) Mus musculus (Mouse) GO:0001669; GO:0001771; GO:0002177; GO:0002467; GO:0003351; GO:0003356; GO:0005576; GO:0005813; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0015630; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716 cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; germinal center formation [GO:0002467]; immunological synapse formation [GO:0001771]; intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lateral wall of outer hair cell [GO:0120249]; manchette [GO:0002177]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm principal piece [GO:0097228] microtubule binding [GO:0008017] g18668.t1 Q1RMT1 72.02 797 0.0 1207.0 sp|Q1RMT1|ERCC3_BOVIN General transcription and DNA repair factor IIH helicase/translocase subunit XPB OS=Bos taurus OX=9913 GN=ERCC3 PE=2 SV=1 ERCC3_BOVIN reviewed General transcription and DNA repair factor IIH helicase/translocase subunit XPB (TFIIH subunit XPB) (EC 5.6.2.4) (DNA 3'-5' helicase/translocase XPB) (DNA excision repair protein ERCC-3) Bos taurus (Bovine) GO:0000112; GO:0000439; GO:0003677; GO:0005524; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0035315; GO:0043065; GO:0043138; GO:0048568; GO:0097550; GO:1901990; GO:1990841 apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; intracellular protein localization [GO:0008104]; nucleotide-excision repair [GO:0006289]; positive regulation of apoptotic process [GO:0043065]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650] nucleotide-excision repair factor 3 complex [GO:0000112]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841] g18676.t1 P10394 26.506 249 1.5100000000000002e-21 97.1 sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1 g18679.t1 Q93075 36.491 285 3.07e-51 192.0 sp|Q93075|TATD2_HUMAN 3'-5' RNA nuclease TATDN2 OS=Homo sapiens OX=9606 GN=TATDN2 PE=1 SV=2 g18683.t1 Q8R519 69.345 336 0.0 524.0 sp|Q8R519|ACMSD_MOUSE 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase OS=Mus musculus OX=10090 GN=Acmsd PE=1 SV=2 g18684.t1 A4D1E9 53.082 292 8.69e-102 306.0 sp|A4D1E9|GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens OX=9606 GN=GTPBP10 PE=1 SV=1 GTPBA_HUMAN reviewed GTP-binding protein 10 (Protein obg homolog 2) (ObgH2) Homo sapiens (Human) GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0005759; GO:0019843; GO:0140978; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775] chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; mitochondrial large ribosomal subunit binding [GO:0140978]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] g18686.t1 Q8CI71 60.572 979 0.0 1165.0 sp|Q8CI71|VPS50_MOUSE Syndetin OS=Mus musculus OX=10090 GN=Vps50 PE=1 SV=2 VPS50_MOUSE reviewed Syndetin (Bcl2-like protein blm) (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50) Mus musculus (Mouse) GO:0000149; GO:0015031; GO:0016020; GO:0032456; GO:0048471; GO:0055037; GO:1990745 endocytic recycling [GO:0032456]; protein transport [GO:0015031] EARP complex [GO:1990745]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] SNARE binding [GO:0000149] g18687.t1 Q8VCH0 87.037 108 5.83e-63 199.0 sp|Q8VCH0|THIKB_MOUSE 3-ketoacyl-CoA thiolase B, peroxisomal OS=Mus musculus OX=10090 GN=Acaa1b PE=1 SV=1 THIKB_MOUSE reviewed 3-ketoacyl-CoA thiolase B, peroxisomal (EC 2.3.1.155) (EC 2.3.1.16) (EC 2.3.1.9) (Acetyl-CoA acyltransferase B) (Beta-ketothiolase B) (Peroxisomal 3-oxoacyl-CoA thiolase B) Mus musculus (Mouse) GO:0000038; GO:0003985; GO:0003988; GO:0005739; GO:0005777; GO:0005782; GO:0006633; GO:0006635; GO:0006636; GO:0008206; GO:0008775; GO:0010124; GO:0033540; GO:0036109; GO:0042759; GO:0050633; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid biosynthetic process [GO:0006633]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; phenylacetate catabolic process [GO:0010124]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038] mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633] g18688.t1 Q8VCH0 51.292 271 7.78e-85 263.0 sp|Q8VCH0|THIKB_MOUSE 3-ketoacyl-CoA thiolase B, peroxisomal OS=Mus musculus OX=10090 GN=Acaa1b PE=1 SV=1 THIKB_MOUSE reviewed 3-ketoacyl-CoA thiolase B, peroxisomal (EC 2.3.1.155) (EC 2.3.1.16) (EC 2.3.1.9) (Acetyl-CoA acyltransferase B) (Beta-ketothiolase B) (Peroxisomal 3-oxoacyl-CoA thiolase B) Mus musculus (Mouse) GO:0000038; GO:0003985; GO:0003988; GO:0005739; GO:0005777; GO:0005782; GO:0006633; GO:0006635; GO:0006636; GO:0008206; GO:0008775; GO:0010124; GO:0033540; GO:0036109; GO:0042759; GO:0050633; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid biosynthetic process [GO:0006633]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; phenylacetate catabolic process [GO:0010124]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038] mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633] g18691.t1 Q9R1S8 43.357 143 6.05e-26 114.0 sp|Q9R1S8|CAN7_MOUSE Calpain-7 OS=Mus musculus OX=10090 GN=Capn7 PE=2 SV=1 g18692.t1 Q9R1S8 69.279 319 2.02e-161 476.0 sp|Q9R1S8|CAN7_MOUSE Calpain-7 OS=Mus musculus OX=10090 GN=Capn7 PE=2 SV=1 g18693.t1 Q9R1S8 55.16 281 3.4100000000000003e-105 326.0 sp|Q9R1S8|CAN7_MOUSE Calpain-7 OS=Mus musculus OX=10090 GN=Capn7 PE=2 SV=1 g18694.t1 Q66IA6 34.682 173 1.4e-28 107.0 sp|Q66IA6|LYPD6_DANRE Ly6/PLAUR domain-containing protein 6 OS=Danio rerio OX=7955 GN=lypd6 PE=1 SV=1 LYPD6_DANRE reviewed Ly6/PLAUR domain-containing protein 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0030111; GO:0030550; GO:0045121; GO:0060061; GO:0060828; GO:0090263; GO:0098552 positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway [GO:0030111]; Spemann organizer formation [GO:0060061] membrane raft [GO:0045121]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] acetylcholine receptor inhibitor activity [GO:0030550] g18697.t1 Q08CH6 50.737 339 1.05e-119 353.0 sp|Q08CH6|CATIP_DANRE Ciliogenesis-associated TTC17-interacting protein OS=Danio rerio OX=7955 GN=catip PE=1 SV=1 CATIP_DANRE reviewed Ciliogenesis-associated TTC17-interacting protein Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371 actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] g18698.t1 Q5F3X4 86.861 685 0.0 1258.0 sp|Q5F3X4|U5S1_CHICK 116 kDa U5 small nuclear ribonucleoprotein component OS=Gallus gallus OX=9031 GN=EFTUD2 PE=2 SV=1 g18699.t1 O08810 69.88 249 5.1699999999999996e-108 336.0 sp|O08810|U5S1_MOUSE 116 kDa U5 small nuclear ribonucleoprotein component OS=Mus musculus OX=10090 GN=Eftud2 PE=1 SV=1 U5S1_MOUSE reviewed 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) Mus musculus (Mouse) GO:0000398; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0015030; GO:0016607; GO:0030623; GO:0046540; GO:0071005; GO:0071007; GO:0071013 mRNA splicing, via spliceosome [GO:0000398] Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; U5 snRNA binding [GO:0030623] g18702.t1 P50227 40.767 287 1.92e-67 216.0 sp|P50227|ST1A1_BOVIN Sulfotransferase 1A1 OS=Bos taurus OX=9913 GN=SULT1A1 PE=1 SV=2 g18706.t1 Q9D9H8 39.185 319 1.77e-70 225.0 sp|Q9D9H8|CB069_MOUSE Mitochondrial protein C2orf69 homolog OS=Mus musculus OX=10090 PE=2 SV=3 g18711.t1 Q5ICW4 39.889 539 8.66e-124 382.0 sp|Q5ICW4|GRB14_BOVIN Growth factor receptor-bound protein 14 OS=Bos taurus OX=9913 GN=GRB14 PE=1 SV=1 g18711.t2 Q5ICW4 39.889 539 5.0800000000000005e-124 382.0 sp|Q5ICW4|GRB14_BOVIN Growth factor receptor-bound protein 14 OS=Bos taurus OX=9913 GN=GRB14 PE=1 SV=1 g18712.t1 P27169 36.813 364 4.26e-64 210.0 sp|P27169|PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens OX=9606 GN=PON1 PE=1 SV=3 PON1_HUMAN reviewed Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1) Homo sapiens (Human) GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005789; GO:0008203; GO:0009636; GO:0010875; GO:0034364; GO:0034366; GO:0042803; GO:0046395; GO:0046434; GO:0046470; GO:0070062; GO:0072562; GO:0102007; GO:1901335 carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lactone catabolic process [GO:1901335]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to toxic substance [GO:0009636] blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366] acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] g18719.t1 Q8JFV8 52.011 348 8.120000000000001e-133 391.0 sp|Q8JFV8|VAT1_DANRE Synaptic vesicle membrane protein VAT-1 homolog OS=Danio rerio OX=7955 GN=vat1 PE=2 SV=1 g18720.t1 Q6P1L5 39.747 395 2.24e-43 164.0 sp|Q6P1L5|F117B_HUMAN Protein FAM117B OS=Homo sapiens OX=9606 GN=FAM117B PE=1 SV=2 F117B_HUMAN reviewed Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein) Homo sapiens (Human) g18723.t1 Q9NXC5 38.803 902 0.0 615.0 sp|Q9NXC5|MIOS_HUMAN GATOR2 complex protein MIOS OS=Homo sapiens OX=9606 GN=MIOS PE=1 SV=2 g18724.t1 Q9W0M3 39.844 128 3.8e-22 96.3 sp|Q9W0M3|KDM8_DROME Jumonji C domain-containing protein 5 OS=Drosophila melanogaster OX=7227 GN=JMJD5 PE=2 SV=2 KDM8_DROME reviewed Jumonji C domain-containing protein 5 (EC 1.14.11.73) (EC 3.4.-.-) (Lysine-specific demethylase 8) Drosophila melanogaster (Fruit fly) GO:0000086; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0045892; GO:0046872; GO:0048512; GO:0051864; GO:0106157 circadian behavior [GO:0048512]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of DNA-templated transcription [GO:0045892] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H3K36 demethylase activity [GO:0051864]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; peptidyl-arginine 3-dioxygenase activity [GO:0106157] g18726.t1 Q9D4H8 59.517 746 0.0 941.0 sp|Q9D4H8|CUL2_MOUSE Cullin-2 OS=Mus musculus OX=10090 GN=Cul2 PE=1 SV=2 CUL2_MOUSE reviewed Cullin-2 (CUL-2) Mus musculus (Mouse) GO:0005654; GO:0005730; GO:0016567; GO:0019005; GO:0030163; GO:0030674; GO:0030891; GO:0031146; GO:0031462; GO:0031625; GO:0044877; GO:0140627; GO:0160072 protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891] protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625] g18727.t1 Q9UGJ0 64.013 314 3.86e-145 431.0 sp|Q9UGJ0|AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens OX=9606 GN=PRKAG2 PE=1 SV=1 AAKG2_HUMAN reviewed 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) Homo sapiens (Human) GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0006754; GO:0008603; GO:0008607; GO:0016126; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0043531; GO:0043609; GO:0045722; GO:0046320; GO:0046324; GO:0051726 ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; positive regulation of gluconeogenesis [GO:0045722]; regulation of carbon utilization [GO:0043609]; regulation of cell cycle [GO:0051726]; regulation of D-glucose import [GO:0046324]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] g18727.t2 Q9UGJ0 64.013 314 2.42e-145 430.0 sp|Q9UGJ0|AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens OX=9606 GN=PRKAG2 PE=1 SV=1 AAKG2_HUMAN reviewed 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) Homo sapiens (Human) GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0006754; GO:0008603; GO:0008607; GO:0016126; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0043531; GO:0043609; GO:0045722; GO:0046320; GO:0046324; GO:0051726 ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; positive regulation of gluconeogenesis [GO:0045722]; regulation of carbon utilization [GO:0043609]; regulation of cell cycle [GO:0051726]; regulation of D-glucose import [GO:0046324]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] g18727.t3 Q9UGJ0 46.468 538 7.95e-145 431.0 sp|Q9UGJ0|AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens OX=9606 GN=PRKAG2 PE=1 SV=1 AAKG2_HUMAN reviewed 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) Homo sapiens (Human) GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0006754; GO:0008603; GO:0008607; GO:0016126; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0043531; GO:0043609; GO:0045722; GO:0046320; GO:0046324; GO:0051726 ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; positive regulation of gluconeogenesis [GO:0045722]; regulation of carbon utilization [GO:0043609]; regulation of cell cycle [GO:0051726]; regulation of D-glucose import [GO:0046324]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] g18729.t1 G5CTG8 27.984 243 2.19e-23 99.4 sp|G5CTG8|AQP11_MILTA Aquaporin-11 OS=Milnesium tardigradum OX=46460 GN=AQP11 PE=2 SV=2 g18730.t1 Q9NRG9 47.325 486 1.37e-149 442.0 sp|Q9NRG9|AAAS_HUMAN Aladin OS=Homo sapiens OX=9606 GN=AAAS PE=1 SV=1 AAAS_HUMAN reviewed Aladin (Adracalin) Homo sapiens (Human) GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006749; GO:0006913; GO:0006979; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0035264; GO:0046822; GO:0051028; GO:0072686; GO:0090307; GO:0097229 fertilization [GO:0009566]; glutathione metabolic process [GO:0006749]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822]; response to oxidative stress [GO:0006979] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm end piece [GO:0097229]; spindle pole [GO:0000922] g18732.t1 Q17QR8 34.831 178 1e-25 104.0 sp|Q17QR8|HARB1_BOVIN Putative nuclease HARBI1 OS=Bos taurus OX=9913 GN=HARBI1 PE=2 SV=1 g18734.t1 Q5R4U9 64.072 167 2.66e-79 237.0 sp|Q5R4U9|SORCN_PONAB Sorcin OS=Pongo abelii OX=9601 GN=SRI PE=2 SV=1 SORCN_PONAB reviewed Sorcin Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002020; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006816; GO:0010459; GO:0010880; GO:0030018; GO:0033017; GO:0042584; GO:0046982; GO:0051281; GO:0055118; GO:0061178; GO:0070062; GO:0086004; GO:0140297; GO:0140311; GO:0140416; GO:1901077; GO:1901844 calcium ion transport [GO:0006816]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; transcription regulator inhibitor activity [GO:0140416] g18735.t1 Q6P6V1 50.586 597 0.0 610.0 sp|Q6P6V1|GLT11_RAT Polypeptide N-acetylgalactosaminyltransferase 11 OS=Rattus norvegicus OX=10116 GN=Galnt11 PE=1 SV=1 GLT11_RAT reviewed Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11) Rattus norvegicus (Rat) GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0006493; GO:0007220; GO:0007368; GO:0008593; GO:0030246; GO:0046872; GO:0060271; GO:0061314 cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18736.t1 Q9DC11 46.691 272 2.3800000000000003e-73 244.0 sp|Q9DC11|PXDC2_MOUSE Plexin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Plxdc2 PE=1 SV=1 PXDC2_MOUSE reviewed Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) Mus musculus (Mouse) GO:0005886; GO:0031012 extracellular matrix [GO:0031012]; plasma membrane [GO:0005886] g18737.t1 A0A0R4ITC5 60.982 3993 0.0 4944.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 g18737.t2 A0A0R4ITC5 61.332 3980 0.0 4970.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 g18737.t3 A0A0R4ITC5 61.347 3979 0.0 4971.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 g18737.t4 A0A0R4ITC5 61.316 3981 0.0 4965.0 sp|A0A0R4ITC5|TRRAP_DANRE Transformation/transcription domain-associated protein OS=Danio rerio OX=7955 GN=trrap PE=3 SV=1 g18739.t1 Q91VF2 28.904 301 2.6999999999999997e-42 150.0 sp|Q91VF2|HNMT_MOUSE Histamine N-methyltransferase OS=Mus musculus OX=10090 GN=Hnmt PE=1 SV=1 HNMT_MOUSE reviewed Histamine N-methyltransferase (HMT) (EC 2.1.1.8) Mus musculus (Mouse) GO:0001692; GO:0001695; GO:0002347; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006972; GO:0008170; GO:0014075; GO:0032259; GO:0035902; GO:0042220; GO:0046500; GO:0046539; GO:0051384; GO:0070555 histamine catabolic process [GO:0001695]; histamine metabolic process [GO:0001692]; hyperosmotic response [GO:0006972]; methylation [GO:0032259]; response to amine [GO:0014075]; response to cocaine [GO:0042220]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to interleukin-1 [GO:0070555]; response to tumor cell [GO:0002347]; S-adenosylmethionine metabolic process [GO:0046500] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] histamine N-methyltransferase activity [GO:0046539]; N-methyltransferase activity [GO:0008170] g18740.t1 Q91VF2 28.814 295 4.91e-37 136.0 sp|Q91VF2|HNMT_MOUSE Histamine N-methyltransferase OS=Mus musculus OX=10090 GN=Hnmt PE=1 SV=1 HNMT_MOUSE reviewed Histamine N-methyltransferase (HMT) (EC 2.1.1.8) Mus musculus (Mouse) GO:0001692; GO:0001695; GO:0002347; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006972; GO:0008170; GO:0014075; GO:0032259; GO:0035902; GO:0042220; GO:0046500; GO:0046539; GO:0051384; GO:0070555 histamine catabolic process [GO:0001695]; histamine metabolic process [GO:0001692]; hyperosmotic response [GO:0006972]; methylation [GO:0032259]; response to amine [GO:0014075]; response to cocaine [GO:0042220]; response to glucocorticoid [GO:0051384]; response to immobilization stress [GO:0035902]; response to interleukin-1 [GO:0070555]; response to tumor cell [GO:0002347]; S-adenosylmethionine metabolic process [GO:0046500] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] histamine N-methyltransferase activity [GO:0046539]; N-methyltransferase activity [GO:0008170] g18743.t1 Q5ZL72 75.488 563 0.0 869.0 sp|Q5ZL72|CH60_CHICK 60 kDa heat shock protein, mitochondrial OS=Gallus gallus OX=9031 GN=HSPD1 PE=1 SV=1 CH60_CHICK reviewed 60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) Gallus gallus (Chicken) GO:0001530; GO:0002039; GO:0002755; GO:0002842; GO:0003725; GO:0005524; GO:0005737; GO:0005743; GO:0005759; GO:0005769; GO:0005829; GO:0005905; GO:0006457; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0016853; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0034186; GO:0034514; GO:0042026; GO:0042100; GO:0042110; GO:0043025; GO:0043032; GO:0045041; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051087; GO:0051702; GO:0070062; GO:0097225; GO:0097524; GO:0098761; GO:0140494; GO:0140608; GO:0140662; GO:1900118; GO:1900119 apoptotic mitochondrial changes [GO:0008637]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to interleukin-7 [GO:0098761]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of type II interferon production [GO:0032729]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; T cell activation [GO:0042110] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lipopolysaccharide receptor complex [GO:0046696]; migrasome [GO:0140494]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524] apolipoprotein A-I binding [GO:0034186]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; cysteine-type endopeptidase activator activity [GO:0140608]; double-stranded RNA binding [GO:0003725]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625] g18744.t1 Q5DC69 65.979 97 2.1199999999999998e-42 137.0 sp|Q5DC69|CH10_SCHJA 10 kDa heat shock protein, mitochondrial OS=Schistosoma japonicum OX=6182 GN=SJCHGC01960 PE=3 SV=2 g18745.t1 Q7ZVY5 76.18 445 0.0 737.0 sp|Q7ZVY5|CISY_DANRE Citrate synthase, mitochondrial OS=Danio rerio OX=7955 GN=cs PE=2 SV=1 g18746.t1 O73817 78.537 205 8.770000000000001e-124 351.0 sp|O73817|PSB3_ONCMY Proteasome subunit beta type-3 OS=Oncorhynchus mykiss OX=8022 GN=psmb3 PE=2 SV=1 g18747.t1 Q7TS68 45.816 478 4.52e-139 411.0 sp|Q7TS68|NSUN6_MOUSE tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 OS=Mus musculus OX=10090 GN=Nsun6 PE=2 SV=2 g18749.t1 Q5R4U9 56.627 166 3.26e-69 212.0 sp|Q5R4U9|SORCN_PONAB Sorcin OS=Pongo abelii OX=9601 GN=SRI PE=2 SV=1 SORCN_PONAB reviewed Sorcin Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0002020; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006816; GO:0010459; GO:0010880; GO:0030018; GO:0033017; GO:0042584; GO:0046982; GO:0051281; GO:0055118; GO:0061178; GO:0070062; GO:0086004; GO:0140297; GO:0140311; GO:0140416; GO:1901077; GO:1901844 calcium ion transport [GO:0006816]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; transcription regulator inhibitor activity [GO:0140416] g18750.t1 Q9NS40 53.425 876 0.0 838.0 sp|Q9NS40|KCNH7_HUMAN Voltage-gated inwardly rectifying potassium channel KCNH7 OS=Homo sapiens OX=9606 GN=KCNH7 PE=1 SV=2 KCNH7_HUMAN reviewed Voltage-gated inwardly rectifying potassium channel KCNH7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Potassium voltage-gated channel subfamily H member 7) (Voltage-gated potassium channel subunit Kv11.3) Homo sapiens (Human) GO:0005242; GO:0005886; GO:0006813; GO:0020037; GO:0034702; GO:0042391; GO:0071805 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] heme binding [GO:0020037]; inward rectifier potassium channel activity [GO:0005242] g18750.t2 Q9NS40 64.341 645 0.0 820.0 sp|Q9NS40|KCNH7_HUMAN Voltage-gated inwardly rectifying potassium channel KCNH7 OS=Homo sapiens OX=9606 GN=KCNH7 PE=1 SV=2 KCNH7_HUMAN reviewed Voltage-gated inwardly rectifying potassium channel KCNH7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Potassium voltage-gated channel subfamily H member 7) (Voltage-gated potassium channel subunit Kv11.3) Homo sapiens (Human) GO:0005242; GO:0005886; GO:0006813; GO:0020037; GO:0034702; GO:0042391; GO:0071805 potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] heme binding [GO:0020037]; inward rectifier potassium channel activity [GO:0005242] g18752.t1 O35219 69.608 102 2.2700000000000003e-43 154.0 sp|O35219|KCNH2_MOUSE Voltage-gated inwardly rectifying potassium channel KCNH2 OS=Mus musculus OX=10090 GN=Kcnh2 PE=1 SV=2 KCNH2_MOUSE reviewed Voltage-gated inwardly rectifying potassium channel KCNH2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (MERG) (Potassium voltage-gated channel subfamily H member 2) (Voltage-gated potassium channel subunit Kv11.1) Mus musculus (Mouse) GO:0000976; GO:0005216; GO:0005242; GO:0005249; GO:0005251; GO:0005267; GO:0005635; GO:0005737; GO:0005886; GO:0006813; GO:0008076; GO:0009986; GO:0031625; GO:0042391; GO:0042802; GO:0042803; GO:0044877; GO:0045893; GO:0048471; GO:0055075; GO:0060048; GO:0060306; GO:0060307; GO:0071466; GO:0071805; GO:0086005; GO:0086009; GO:0086010; GO:0086011; GO:0086013; GO:0086091; GO:0097110; GO:0097623; GO:0098915; GO:1901379; GO:1901380; GO:1901381; GO:1902282; GO:1902937; GO:1903765; GO:1990573 cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005] cell surface [GO:0009986]; cytoplasm [GO:0005737]; inward rectifier potassium channel complex [GO:1902937]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; monoatomic ion channel activity [GO:0005216]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282] g18755.t2 Q8IWW6 29.153 885 2.02e-85 291.0 sp|Q8IWW6|RHG12_HUMAN Rho GTPase-activating protein 12 OS=Homo sapiens OX=9606 GN=ARHGAP12 PE=1 SV=1 RHG12_HUMAN reviewed Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12) Homo sapiens (Human) GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0005886; GO:0006911; GO:0007015; GO:0007264; GO:0051058; GO:0098794; GO:0098978; GO:0150052 actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of postsynapse assembly [GO:0150052]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] GTPase activator activity [GO:0005096] g18755.t3 Q6AYC5 36.219 439 1.78e-81 262.0 sp|Q6AYC5|RHG15_RAT Rho GTPase-activating protein 15 OS=Rattus norvegicus OX=10116 GN=Arhgap15 PE=1 SV=1 RHG15_RAT reviewed Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15) Rattus norvegicus (Rat) GO:0005096; GO:0005654; GO:0005737; GO:0005886; GO:0007264; GO:0008360 regulation of cell shape [GO:0008360]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096] g18756.t1 Q9D4C5 58.407 113 6.53e-38 136.0 sp|Q9D4C5|EAF1_MOUSE ELL-associated factor 1 OS=Mus musculus OX=10090 GN=Eaf1 PE=1 SV=2 g18757.t1 Q8TCB7 61.538 273 1.26e-124 360.0 sp|Q8TCB7|METL6_HUMAN tRNA N(3)-cytidine methyltransferase METTL6 OS=Homo sapiens OX=9606 GN=METTL6 PE=1 SV=2 METL6_HUMAN reviewed tRNA N(3)-cytidine methyltransferase METTL6 (EC 2.1.1.-) (Methyltransferase-like protein 6) (hMETTL6) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006400; GO:0019899; GO:0030488; GO:0052735 tRNA methylation [GO:0030488]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] enzyme binding [GO:0019899]; tRNA (cytidine-3-)-methyltransferase activity [GO:0052735] g18758.t1 Q9JJA4 50.633 316 4.0299999999999994e-104 315.0 sp|Q9JJA4|WDR12_MOUSE Ribosome biogenesis protein WDR12 OS=Mus musculus OX=10090 GN=Wdr12 PE=1 SV=1 g18759.t1 Q8BGD4 28.375 437 5.13e-50 187.0 sp|Q8BGD4|SO4C1_MOUSE Solute carrier organic anion transporter family member 4C1 OS=Mus musculus OX=10090 GN=Slco4c1 PE=1 SV=1 SO4C1_MOUSE reviewed Solute carrier organic anion transporter family member 4C1 (Slco4c1) (Oatp-R) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20) Mus musculus (Mouse) GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0030154; GO:0043252 cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g18761.t1 Q8BGD4 26.984 630 3.58e-65 231.0 sp|Q8BGD4|SO4C1_MOUSE Solute carrier organic anion transporter family member 4C1 OS=Mus musculus OX=10090 GN=Slco4c1 PE=1 SV=1 SO4C1_MOUSE reviewed Solute carrier organic anion transporter family member 4C1 (Slco4c1) (Oatp-R) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20) Mus musculus (Mouse) GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0030154; GO:0043252 cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g18762.t1 Q9X248 38.735 253 2.33e-47 160.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g18763.t1 Q3U821 37.662 847 7.15e-173 524.0 sp|Q3U821|WDR75_MOUSE WD repeat-containing protein 75 OS=Mus musculus OX=10090 GN=Wdr75 PE=1 SV=1 g18764.t1 Q29041 53.302 212 1.76e-71 230.0 sp|Q29041|FCN2_PIG Ficolin-2 OS=Sus scrofa OX=9823 GN=FCN2 PE=1 SV=1 FCN2_PIG reviewed Ficolin-2 (Collagen/fibrinogen domain-containing protein 2) (Ficolin-B) (Ficolin-beta) (L-ficolin) Sus scrofa (Pig) GO:0001867; GO:0003823; GO:0005102; GO:0005581; GO:0005615; GO:0030246; GO:0038187; GO:0046872; GO:0070892; GO:0097367; GO:0106139 complement activation, lectin pathway [GO:0001867] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; symbiont cell surface [GO:0106139] antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; lipoteichoic acid immune receptor activity [GO:0070892]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; signaling receptor binding [GO:0005102] g18768.t1 Q8BKE6 31.613 465 1.0700000000000001e-79 258.0 sp|Q8BKE6|CP20A_MOUSE Cytochrome P450 20A1 OS=Mus musculus OX=10090 GN=Cyp20a1 PE=1 SV=1 g18769.t1 Q8BKE6 31.33 466 1.27e-77 252.0 sp|Q8BKE6|CP20A_MOUSE Cytochrome P450 20A1 OS=Mus musculus OX=10090 GN=Cyp20a1 PE=1 SV=1 g18771.t1 Q6ZT12 45.011 922 0.0 778.0 sp|Q6ZT12|UBR3_HUMAN E3 ubiquitin-protein ligase UBR3 OS=Homo sapiens OX=9606 GN=UBR3 PE=1 SV=2 UBR3_HUMAN reviewed E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650) Homo sapiens (Human) GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016020; GO:0016567; GO:0042048; GO:0045732; GO:0061630; GO:0071596; GO:1904878 embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18771.t1 Q6ZT12 35.2 875 1.69e-148 509.0 sp|Q6ZT12|UBR3_HUMAN E3 ubiquitin-protein ligase UBR3 OS=Homo sapiens OX=9606 GN=UBR3 PE=1 SV=2 UBR3_HUMAN reviewed E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650) Homo sapiens (Human) GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016020; GO:0016567; GO:0042048; GO:0045732; GO:0061630; GO:0071596; GO:1904878 embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18772.t1 Q8ITC7 29.693 293 5.8900000000000004e-21 97.4 sp|Q8ITC7|CAPAR_DROME Neuropeptides capa receptor OS=Drosophila melanogaster OX=7227 GN=CapaR PE=2 SV=3 CAPAR_DROME reviewed Neuropeptides capa receptor (Cap2b receptor) (Capability receptor) Drosophila melanogaster (Fruit fly) GO:0001607; GO:0005886; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016020; GO:0016323; GO:0051928; GO:0071465 body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928] basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g18774.t1 A3KP77 47.253 273 7.680000000000001e-79 243.0 sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1 g18774.t2 A3KP77 45.788 273 2.63e-76 237.0 sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1 g18774.t3 Q8VE38 47.009 117 1.49e-29 113.0 sp|Q8VE38|OXND1_MOUSE Oxidoreductase NAD-binding domain-containing protein 1 OS=Mus musculus OX=10090 GN=Oxnad1 PE=1 SV=2 g18774.t4 A3KP77 45.55 191 1.51e-49 164.0 sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1 g18785.t1 D4AD75 52.656 659 0.0 719.0 sp|D4AD75|D19L1_RAT Protein C-mannosyl-transferase DPY19L1 OS=Rattus norvegicus OX=10116 GN=Dpy19l1 PE=3 SV=1 g18786.t1 A4D263 28.995 438 1.41e-43 161.0 sp|A4D263|SMIP7_HUMAN Protein SPMIP7 OS=Homo sapiens OX=9606 GN=SPMIP7 PE=1 SV=2 g18787.t1 Q504Y3 44.03 134 6.84e-28 119.0 sp|Q504Y3|ZCPW2_HUMAN Zinc finger CW-type PWWP domain protein 2 OS=Homo sapiens OX=9606 GN=ZCWPW2 PE=1 SV=1 ZCPW2_HUMAN reviewed Zinc finger CW-type PWWP domain protein 2 Homo sapiens (Human) GO:0005634; GO:0008270; GO:0140002 nucleus [GO:0005634] histone H3K4me3 reader activity [GO:0140002]; zinc ion binding [GO:0008270] g18788.t1 P11466 43.954 612 0.0 531.0 sp|P11466|OCTC_RAT Peroxisomal carnitine O-octanoyltransferase OS=Rattus norvegicus OX=10116 GN=Crot PE=1 SV=3 OCTC_RAT reviewed Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137) Rattus norvegicus (Rat) GO:0001579; GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009410; GO:0009437; GO:0015908; GO:0015909; GO:0015936; GO:0051791; GO:0071874 carnitine metabolic process [GO:0009437]; cellular response to norepinephrine stimulus [GO:0071874]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid metabolic process [GO:0051791]; medium-chain fatty acid transport [GO:0001579]; response to xenobiotic stimulus [GO:0009410] peroxisome [GO:0005777] carnitine O-octanoyltransferase activity [GO:0008458] g18788.t2 Q9UKG9 43.443 610 0.0 528.0 sp|Q9UKG9|OCTC_HUMAN Peroxisomal carnitine O-octanoyltransferase OS=Homo sapiens OX=9606 GN=CROT PE=1 SV=2 g18788.t3 P11466 44.243 608 3.07e-178 523.0 sp|P11466|OCTC_RAT Peroxisomal carnitine O-octanoyltransferase OS=Rattus norvegicus OX=10116 GN=Crot PE=1 SV=3 OCTC_RAT reviewed Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137) Rattus norvegicus (Rat) GO:0001579; GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009410; GO:0009437; GO:0015908; GO:0015909; GO:0015936; GO:0051791; GO:0071874 carnitine metabolic process [GO:0009437]; cellular response to norepinephrine stimulus [GO:0071874]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid metabolic process [GO:0051791]; medium-chain fatty acid transport [GO:0001579]; response to xenobiotic stimulus [GO:0009410] peroxisome [GO:0005777] carnitine O-octanoyltransferase activity [GO:0008458] g18789.t1 Q1GNW5 38.538 301 9.07e-67 216.0 sp|Q1GNW5|ECTD_SPHAL Ectoine dioxygenase OS=Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) OX=317655 GN=ectD PE=1 SV=1 ECTD_SPHAL reviewed Ectoine dioxygenase (EC 1.14.11.55) (Ectoine hydroxylase) Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) (Sphingomonas alaskensis) GO:0005506; GO:0016706 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506] g18792.t1 P11889 29.139 302 2.59e-24 105.0 sp|P11889|PHL2_BACCE Sphingomyelinase C OS=Bacillus cereus OX=1396 GN=sph PE=1 SV=1 g18793.t1 Q09428 33.213 277 3.35e-40 152.0 sp|Q09428|ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens OX=9606 GN=ABCC8 PE=1 SV=6 ABCC8_HUMAN reviewed ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) Homo sapiens (Human) GO:0001508; GO:0001678; GO:0005267; GO:0005524; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016525; GO:0016887; GO:0019829; GO:0030672; GO:0031004; GO:0031669; GO:0032496; GO:0032760; GO:0032868; GO:0035774; GO:0042383; GO:0042734; GO:0043268; GO:0043531; GO:0044325; GO:0046676; GO:0046872; GO:0050796; GO:0050905; GO:0055085; GO:0060253; GO:0061535; GO:0061855; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1905075; GO:1905604; GO:1990573 action potential [GO:0001508]; cellular response to nutrient levels [GO:0031669]; female pregnancy [GO:0007565]; glutamate secretion, neurotransmission [GO:0061535]; inorganic cation transmembrane transport [GO:0098662]; intracellular glucose homeostasis [GO:0001678]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; neuromuscular process [GO:0050905]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of insulin secretion [GO:0050796]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] ABC-type transporter activity [GO:0140359]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g18795.t1 Q96J66 67.857 84 2.21e-31 119.0 sp|Q96J66|MRP8_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens OX=9606 GN=ABCC11 PE=1 SV=1 g18796.t1 P82451 48.025 481 1.33e-154 480.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g18797.t1 O60706 38.167 1593 0.0 1079.0 sp|O60706|ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens OX=9606 GN=ABCC9 PE=1 SV=2 ABCC9_HUMAN reviewed ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) Homo sapiens (Human) GO:0000165; GO:0001508; GO:0001666; GO:0003007; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006357; GO:0007005; GO:0007519; GO:0008281; GO:0008282; GO:0010467; GO:0014823; GO:0015459; GO:0016887; GO:0019395; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0035865; GO:0042311; GO:0042383; GO:0042542; GO:0042626; GO:0043066; GO:0043225; GO:0043627; GO:0044325; GO:0044877; GO:0045333; GO:0045776; GO:0046034; GO:0048144; GO:0051607; GO:0055085; GO:0060976; GO:0061337; GO:0062197; GO:0071277; GO:0071318; GO:0071466; GO:0071805; GO:0072592; GO:0086003; GO:0098655; GO:0098662; GO:0099104; GO:0140359; GO:0150104; GO:1901379; GO:1901652; GO:1903409; GO:1904880; GO:1990573 action potential [GO:0001508]; ATP metabolic process [GO:0046034]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cellular respiration [GO:0045333]; cellular response to ATP [GO:0071318]; cellular response to calcium ion [GO:0071277]; cellular response to chemical stress [GO:0062197]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; coronary vasculature development [GO:0060976]; defense response to virus [GO:0051607]; fatty acid oxidation [GO:0019395]; fibroblast proliferation [GO:0048144]; gene expression [GO:0010467]; heart morphogenesis [GO:0003007]; inorganic cation transmembrane transport [GO:0098662]; MAPK cascade [GO:0000165]; mitochondrion organization [GO:0007005]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; oxygen metabolic process [GO:0072592]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to ATP [GO:0033198]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hydrogen sulfide [GO:1904880]; response to hypoxia [GO:0001666]; response to peptide [GO:1901652]; skeletal muscle tissue development [GO:0007519]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; vasodilation [GO:0042311] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; sarcomere [GO:0030017] ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activator activity [GO:0099104]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; protein-containing complex binding [GO:0044877]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] g18798.t1 Q8ITC7 27.874 348 2.4600000000000003e-21 99.0 sp|Q8ITC7|CAPAR_DROME Neuropeptides capa receptor OS=Drosophila melanogaster OX=7227 GN=CapaR PE=2 SV=3 CAPAR_DROME reviewed Neuropeptides capa receptor (Cap2b receptor) (Capability receptor) Drosophila melanogaster (Fruit fly) GO:0001607; GO:0005886; GO:0007186; GO:0007218; GO:0007589; GO:0008188; GO:0016020; GO:0016323; GO:0051928; GO:0071465 body fluid secretion [GO:0007589]; cellular response to desiccation [GO:0071465]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928] basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886] neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g18799.t1 A0A2C9JXL4 50.397 252 1.04e-84 265.0 sp|A0A2C9JXL4|C1GLT_BIOGL Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Biomphalaria glabrata OX=6526 PE=1 SV=1 C1GLT_BIOGL reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Glycoprotein-N-acetylgalactosamine beta-1,3-galactosyltransferase) (Beta-1,3-galactosyltransferase) (T-synthase) Biomphalaria glabrata (Bloodfluke planorb) (Freshwater snail) GO:0000166; GO:0009101; GO:0016020; GO:0016263; GO:0030145 glycoprotein biosynthetic process [GO:0009101] membrane [GO:0016020] glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166] g18801.t1 E7FDW2 35.862 145 9.510000000000002e-21 92.8 sp|E7FDW2|PZR3B_DANRE E3 ubiquitin-protein ligase PDZRN3-B OS=Danio rerio OX=7955 GN=pdzrn3b PE=1 SV=1 g18802.t1 Q6NX27 46.05 443 3.8e-133 394.0 sp|Q6NX27|MINY3_XENTR Ubiquitin carboxyl-terminal hydrolase MINDY-3 OS=Xenopus tropicalis OX=8364 GN=mindy3 PE=2 SV=1 g18806.t1 Q6BD04 43.322 307 2.83e-78 247.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g18807.t1 Q6BD04 32.53 332 2.79e-63 209.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g18809.t1 Q6I6G8 62.703 799 0.0 1032.0 sp|Q6I6G8|HECW2_MOUSE E3 ubiquitin-protein ligase HECW2 OS=Mus musculus OX=10090 GN=Hecw2 PE=1 SV=1 HECW2_MOUSE reviewed E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2) Mus musculus (Mouse) GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0048814; GO:0061630; GO:0072686 protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686] ubiquitin protein ligase activity [GO:0061630] g18809.t1 Q6I6G8 48.837 301 4.52e-79 293.0 sp|Q6I6G8|HECW2_MOUSE E3 ubiquitin-protein ligase HECW2 OS=Mus musculus OX=10090 GN=Hecw2 PE=1 SV=1 HECW2_MOUSE reviewed E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2) Mus musculus (Mouse) GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0048814; GO:0061630; GO:0072686 protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686] ubiquitin protein ligase activity [GO:0061630] g18810.t1 Q9GM70 62.946 224 4.14e-99 304.0 sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus OX=9986 GN=STK17A PE=2 SV=1 g18811.t1 P80146 44.236 373 7.18e-95 292.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g18812.t1 P80146 47.439 371 1.34e-106 322.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g18813.t1 O95786 30.496 705 1e-73 266.0 sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2 RIGI_HUMAN reviewed Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) Homo sapiens (Human) GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g18814.t1 Q99J87 29.0 700 1.63e-66 241.0 sp|Q99J87|DHX58_MOUSE ATP-dependent RNA helicase DHX58 OS=Mus musculus OX=10090 GN=Dhx58 PE=1 SV=2 g18816.t1 Q70E73 48.806 377 1.73e-102 357.0 sp|Q70E73|RAPH1_HUMAN Ras-associated and pleckstrin homology domains-containing protein 1 OS=Homo sapiens OX=9606 GN=RAPH1 PE=1 SV=3 RAPH1_HUMAN reviewed Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1) Homo sapiens (Human) GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0016604; GO:0030027; GO:0030175; GO:0048675 axon extension [GO:0048675]; signal transduction [GO:0007165] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] g18817.t1 Q3ZBK3 34.459 148 5.34e-21 90.9 sp|Q3ZBK3|SPC25_BOVIN Kinetochore protein Spc25 OS=Bos taurus OX=9913 GN=SPC25 PE=2 SV=1 g18818.t1 Q5EB77 78.261 207 6.15e-116 331.0 sp|Q5EB77|RAB18_RAT Ras-related protein Rab-18 OS=Rattus norvegicus OX=10116 GN=Rab18 PE=2 SV=1 RAB18_RAT reviewed Ras-related protein Rab-18 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0001654; GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0019003; GO:0033106; GO:0034389; GO:0045202; GO:0046872; GO:0051170; GO:0071782; GO:0071786 brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389] apical plasma membrane [GO:0016324]; cis-Golgi network membrane [GO:0033106]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; synapse [GO:0045202] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g18819.t1 P12716 98.138 376 0.0 776.0 sp|P12716|ACTC_PISOC Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g18820.t1 P53470 40.374 374 1.37e-91 282.0 sp|P53470|ACT1_SCHMA Actin-1 OS=Schistosoma mansoni OX=6183 PE=2 SV=1 g18821.t1 Q964E1 74.933 375 0.0 579.0 sp|Q964E1|ACTC_BIOOB Actin, cytoplasmic OS=Biomphalaria obstructa OX=153466 PE=3 SV=1 g18822.t1 P10982 72.5 120 3.18e-66 199.0 sp|P10982|ACT1_ABSGL Actin-1 (Fragment) OS=Absidia glauca OX=4829 GN=ACT1 PE=3 SV=1 g18824.t1 P12716 69.674 399 0.0 555.0 sp|P12716|ACTC_PISOC Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g18825.t1 P53467 66.31 374 8.94e-176 494.0 sp|P53467|ACTM_MOLOC Actin, larval muscle-type OS=Molgula oculata OX=27575 PE=3 SV=1 g18826.t1 P12716 99.202 376 0.0 783.0 sp|P12716|ACTC_PISOC Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1 g18827.t1 Q9X248 34.263 251 2.27e-40 142.0 sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1 g18830.t1 Q96G46 51.911 628 0.0 672.0 sp|Q96G46|DUS3L_HUMAN tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Homo sapiens OX=9606 GN=DUS3L PE=1 SV=2 DUS3L_HUMAN reviewed tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like) Homo sapiens (Human) GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414 mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943] flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270] g18831.t1 Q8VCK5 42.029 552 1.61e-150 449.0 sp|Q8VCK5|KLH20_MOUSE Kelch-like protein 20 OS=Mus musculus OX=10090 GN=Klhl20 PE=2 SV=2 KLH20_MOUSE reviewed Kelch-like protein 20 (Kelch-like ECT2-interacting protein) Mus musculus (Mouse) GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756 Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802] actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] g18831.t1 Q8VCK5 33.195 241 4.58e-30 128.0 sp|Q8VCK5|KLH20_MOUSE Kelch-like protein 20 OS=Mus musculus OX=10090 GN=Klhl20 PE=2 SV=2 KLH20_MOUSE reviewed Kelch-like protein 20 (Kelch-like ECT2-interacting protein) Mus musculus (Mouse) GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756 Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802] actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] g18832.t1 Q21974 31.481 324 8.26e-34 144.0 sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1 UNC8_CAEEL reviewed Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8) Caenorhabditis elegans GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025 locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725] neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261] g18833.t1 P07700 26.608 342 6.6e-25 108.0 sp|P07700|ADRB1_MELGA Beta-1 adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB1 PE=1 SV=1 g18834.t1 Q804Q2 28.286 350 2.7800000000000003e-21 99.0 sp|Q804Q2|OPN4B_GADMO Melanopsin-B OS=Gadus morhua OX=8049 GN=opn4b PE=2 SV=1 g18835.t1 Q8K4Z4 27.829 327 6.58e-25 107.0 sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1 ADRB2_CAVPO reviewed Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) Cavia porcellus (Guinea pig) GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0004941; GO:0005634; GO:0005769; GO:0005794; GO:0006366; GO:0006898; GO:0006939; GO:0008179; GO:0009409; GO:0010666; GO:0010667; GO:0015459; GO:0016324; GO:0030501; GO:0031649; GO:0036064; GO:0040015; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045171; GO:0045453; GO:0045744; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071880; GO:0071881; GO:0072686; GO:0098990; GO:0098992; GO:0106134; GO:0120162; GO:0141163; GO:1901098; GO:1904504; GO:1904646 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; AMPA selective glutamate receptor signaling pathway [GO:0098990]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cellular response to amyloid-beta [GO:1904646]; diet induced thermogenesis [GO:0002024]; heat generation [GO:0031649]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366] apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; receptor complex [GO:0043235] adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] g18837.t1 O15973 27.747 364 5.79e-26 112.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18838.t1 O15973 28.72 289 8.989999999999999e-23 102.0 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18839.t1 O57422 29.524 315 3.96e-25 109.0 sp|O57422|OPN4B_XENLA Melanopsin-B OS=Xenopus laevis OX=8355 GN=opn4b PE=2 SV=1 g18840.t1 Q6XL69 32.508 323 1.0100000000000001e-29 122.0 sp|Q6XL69|OPN4_RUTRU Melanopsin OS=Rutilus rutilus OX=48668 GN=opn4 PE=2 SV=1 g18843.t1 P18130 27.869 366 3.0900000000000003e-21 98.2 sp|P18130|ADA1A_BOVIN Alpha-1A adrenergic receptor OS=Bos taurus OX=9913 GN=ADRA1A PE=2 SV=1 ADA1A_BOVIN reviewed Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) Bos taurus (Bovine) GO:0001994; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007267; GO:0010613; GO:0019229; GO:0031965; GO:0043410; GO:0046982; GO:0055117; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229] caveola [GO:0005901]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982] g18845.t1 Q2KNE5 28.097 331 3.66e-22 101.0 sp|Q2KNE5|OPN4A_DANRE Melanopsin-A OS=Danio rerio OX=7955 GN=opn4a PE=2 SV=3 OPN4A_DANRE reviewed Melanopsin-A (Mammalian-like melanopsin) (Melanopsin-M) (Opsin-4-A) (Opsin-4M) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009881; GO:0042752; GO:0071482 cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; visual perception [GO:0007601] plasma membrane [GO:0005886] G protein-coupled photoreceptor activity [GO:0008020]; photoreceptor activity [GO:0009881] g18848.t1 O15973 29.553 291 2.91e-22 99.8 sp|O15973|OPSD1_MIZYE Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 g18851.t1 Q5XXP2 27.795 331 8.32e-21 96.7 sp|Q5XXP2|OPN4_PHOSU Melanopsin OS=Phodopus sungorus OX=10044 GN=OPN4 PE=2 SV=1 OPN4_PHOSU reviewed Melanopsin (Opsin-4) Phodopus sungorus (Striped hairy-footed hamster) (Djungarian hamster) GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:1990384 hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601] axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020] g18853.t1 Q0P496 29.515 227 7.61e-27 112.0 sp|Q0P496|MARH4_DANRE E3 ubiquitin-protein ligase MARCHF4 OS=Danio rerio OX=7955 GN=marchf4 PE=2 SV=1 MARH4_DANRE reviewed E3 ubiquitin-protein ligase MARCHF4 (EC 2.3.2.27) (Membrane-associated RING finger protein 4) (Membrane-associated RING-CH protein IV) (MARCH-IV) (RING-type E3 ubiquitin transferase MARCHF4) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004842; GO:0005795; GO:0005802; GO:0008270; GO:0016567; GO:0061630 protein ubiquitination [GO:0016567] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; trans-Golgi network [GO:0005802] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18854.t1 Q13439 36.535 583 1.11e-68 259.0 sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1 g18855.t1 Q5U4E6 28.838 482 1.04e-25 119.0 sp|Q5U4E6|GOGA4_RAT Golgin subfamily A member 4 OS=Rattus norvegicus OX=10116 GN=Golga4 PE=1 SV=2 GOGA4_RAT reviewed Golgin subfamily A member 4 Rattus norvegicus (Rat) GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020 Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654] GTPase binding [GO:0051020]; small GTPase binding [GO:0031267] g18857.t1 Q6NYU3 66.667 147 5.1e-58 195.0 sp|Q6NYU3|NDF6A_DANRE Neurogenic differentiation factor 6-A OS=Danio rerio OX=7955 GN=neurod6a PE=2 SV=1 NDF6A_DANRE reviewed Neurogenic differentiation factor 6-A (NeuroD6-A) (Protein atonal homolog 2-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000981; GO:0005634; GO:0007423; GO:0045944; GO:0046983; GO:0050769; GO:0061564; GO:0070888 axon development [GO:0061564]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory organ development [GO:0007423] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983] g18860.t1 Q6BD04 39.766 342 5.2400000000000004e-73 238.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g18861.t1 Q6BD04 46.226 318 6.05e-92 285.0 sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1 g18862.t1 P78356 62.629 388 1.3300000000000001e-163 468.0 sp|P78356|PI42B_HUMAN Phosphatidylinositol 5-phosphate 4-kinase type-2 beta OS=Homo sapiens OX=9606 GN=PIP4K2B PE=1 SV=1 PI42B_HUMAN reviewed Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta) Homo sapiens (Human) GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0007166; GO:0010506; GO:0016308; GO:0016309; GO:0042803; GO:0046627; GO:0046854; GO:0061909; GO:1902635; GO:2000786 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; autophagosome-lysosome fusion [GO:0061909]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506] autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803] g18863.t1 A9JRX0 30.606 330 1.2099999999999999e-24 109.0 sp|A9JRX0|MSL1_DANRE Male-specific lethal 1-like 1 OS=Danio rerio OX=7955 GN=msl1l1 PE=2 SV=1 g18864.t1 Q9MZD5 46.789 109 8.27e-25 93.2 sp|Q9MZD5|SUMO1_CERNI Small ubiquitin-related modifier 1 OS=Cervus nippon OX=9863 GN=SUMO1 PE=3 SV=1 g18865.t1 Q91V92 72.192 1104 0.0 1654.0 sp|Q91V92|ACLY_MOUSE ATP-citrate synthase OS=Mus musculus OX=10090 GN=Acly PE=1 SV=1 ACLY_MOUSE reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme) Mus musculus (Mouse) GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0036064; GO:0046872; GO:0071616; GO:0110076; GO:2001295 acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; acyl-CoA biosynthetic process [GO:0071616]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g18865.t2 Q91V92 72.578 1094 0.0 1656.0 sp|Q91V92|ACLY_MOUSE ATP-citrate synthase OS=Mus musculus OX=10090 GN=Acly PE=1 SV=1 ACLY_MOUSE reviewed ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme) Mus musculus (Mouse) GO:0003878; GO:0005524; GO:0005654; GO:0005739; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0036064; GO:0046872; GO:0071616; GO:0110076; GO:2001295 acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; acyl-CoA biosynthetic process [GO:0071616]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of ferroptosis [GO:0110076]; oxaloacetate metabolic process [GO:0006107] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] g18874.t1 P17948 23.639 643 2.69e-32 139.0 sp|P17948|VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens OX=9606 GN=FLT1 PE=1 SV=2 VGFR1_HUMAN reviewed Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) Homo sapiens (Human) GO:0002040; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005829; GO:0005886; GO:0005925; GO:0007169; GO:0008284; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030154; GO:0030335; GO:0035924; GO:0036323; GO:0036332; GO:0043235; GO:0043406; GO:0043410; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:0051897; GO:1905563; GO:1990384 blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021] g18876.t1 P52583 48.75 400 1.2e-120 383.0 sp|P52583|VGFR2_COTJA Vascular endothelial growth factor receptor 2 OS=Coturnix japonica OX=93934 GN=KDR PE=1 SV=1 g18879.t1 Q68FV2 44.681 94 2.95e-21 91.3 sp|Q68FV2|AR6P6_RAT ADP-ribosylation factor-like protein 6-interacting protein 6 OS=Rattus norvegicus OX=10116 GN=Arl6ip6 PE=1 SV=1 g18880.t1 O75400 52.849 702 0.0 646.0 sp|O75400|PR40A_HUMAN Pre-mRNA-processing factor 40 homolog A OS=Homo sapiens OX=9606 GN=PRPF40A PE=1 SV=2 g18883.t1 D3YXS5 43.028 502 3.05e-113 361.0 sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1 g18886.t1 Q99728 35.0 340 5.15e-49 189.0 sp|Q99728|BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens OX=9606 GN=BARD1 PE=1 SV=2 BARD1_HUMAN reviewed BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1) Homo sapiens (Human) GO:0000151; GO:0000152; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006282; GO:0006338; GO:0006357; GO:0006974; GO:0008270; GO:0016567; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0035825; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0044818; GO:0045732; GO:0045786; GO:0046826; GO:0046982; GO:0051726; GO:0061649; GO:0070531; GO:0070532; GO:0070533; GO:0071479; GO:0085020; GO:0110025; GO:0140863; GO:0140864; GO:2000001 cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue homeostasis [GO:0001894] BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] histone H2AK127 ubiquitin ligase activity [GO:0140863]; histone H2AK129 ubiquitin ligase activity [GO:0140864]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-modified histone reader activity [GO:0061649]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g18887.t1 Q05AM5 49.351 385 1.67e-112 351.0 sp|Q05AM5|ELP2_DANRE Elongator complex protein 2 OS=Danio rerio OX=7955 GN=elp2 PE=2 SV=1 g18888.t1 Q05AM5 43.609 399 4.69e-84 274.0 sp|Q05AM5|ELP2_DANRE Elongator complex protein 2 OS=Danio rerio OX=7955 GN=elp2 PE=2 SV=1 g18889.t1 P41279 32.381 315 3.6900000000000005e-43 168.0 sp|P41279|M3K8_HUMAN Mitogen-activated protein kinase kinase kinase 8 OS=Homo sapiens OX=9606 GN=MAP3K8 PE=1 SV=2 M3K8_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2) Homo sapiens (Human) GO:0000165; GO:0000287; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0031295; GO:0050729; GO:0106310 MAPK cascade [GO:0000165]; positive regulation of inflammatory response [GO:0050729]; protein phosphorylation [GO:0006468]; T cell costimulation [GO:0031295] cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g18890.t1 P08635 40.928 237 5.16e-58 188.0 sp|P08635|SAST_RAT S-acyl fatty acid synthase thioesterase, medium chain OS=Rattus norvegicus OX=10116 GN=Olah PE=1 SV=1 SAST_RAT reviewed S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Medium-chain S-acyl fatty acid synthetase thioester hydrolase) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1) Rattus norvegicus (Rat) GO:0005829; GO:0008610; GO:0016297; GO:0051792 lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792] cytosol [GO:0005829] fatty acyl-[ACP] hydrolase activity [GO:0016297] g18892.t1 Q9JLG4 33.69 187 4.7099999999999995e-23 107.0 sp|Q9JLG4|PK2L2_MOUSE Polycystin-2-like protein 2 OS=Mus musculus OX=10090 GN=Pkd2l2 PE=2 SV=2 g18895.t1 Q7Z442 28.536 403 3.31e-41 162.0 sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5 PK1L2_HUMAN reviewed Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2) Homo sapiens (Human) GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982 detection of mechanical stimulus [GO:0050982] membrane [GO:0016020] calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] g18896.t1 Q8TDX9 26.029 1045 1.64e-88 328.0 sp|Q8TDX9|PK1L1_HUMAN Polycystin-1-like protein 1 OS=Homo sapiens OX=9606 GN=PKD1L1 PE=1 SV=1 PK1L1_HUMAN reviewed Polycystin-1-like protein 1 (Polycystin-1L1) (PC1-like 1 protein) (Polycystic kidney disease protein 1-like 1) Homo sapiens (Human) GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730; GO:0098609 cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986] calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730] calcium channel activity [GO:0005262] g18896.t1 Q8TDX9 29.049 568 4.31e-49 198.0 sp|Q8TDX9|PK1L1_HUMAN Polycystin-1-like protein 1 OS=Homo sapiens OX=9606 GN=PKD1L1 PE=1 SV=1 PK1L1_HUMAN reviewed Polycystin-1-like protein 1 (Polycystin-1L1) (PC1-like 1 protein) (Polycystic kidney disease protein 1-like 1) Homo sapiens (Human) GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730; GO:0098609 cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986] calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730] calcium channel activity [GO:0005262] g18898.t1 Q60457 52.862 297 8.090000000000001e-100 317.0 sp|Q60457|SOAT1_CRIGR Sterol O-acyltransferase 1 OS=Cricetulus griseus OX=10029 GN=SOAT1 PE=2 SV=1 g18898.t1 Q60457 37.931 232 1.2e-36 147.0 sp|Q60457|SOAT1_CRIGR Sterol O-acyltransferase 1 OS=Cricetulus griseus OX=10029 GN=SOAT1 PE=2 SV=1 g18899.t1 Q9Y238 33.855 511 2.22e-70 246.0 sp|Q9Y238|DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens OX=9606 GN=DLEC1 PE=1 SV=2 DLEC1_HUMAN reviewed Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1) Homo sapiens (Human) GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487 cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631] g18900.t1 Q9Y238 29.298 570 5.19e-55 204.0 sp|Q9Y238|DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens OX=9606 GN=DLEC1 PE=1 SV=2 DLEC1_HUMAN reviewed Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1) Homo sapiens (Human) GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487 cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631] g18901.t1 Q9Y238 35.87 552 1.08e-90 307.0 sp|Q9Y238|DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens OX=9606 GN=DLEC1 PE=1 SV=2 DLEC1_HUMAN reviewed Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1) Homo sapiens (Human) GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487 cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631] g18904.t1 Q5ZJU3 62.62 313 8.969999999999999e-136 399.0 sp|Q5ZJU3|ASNS_CHICK Asparagine synthetase [glutamine-hydrolyzing] OS=Gallus gallus OX=9031 GN=ASNS PE=2 SV=3 g18905.t1 Q5ZJU3 60.377 212 1.3e-89 277.0 sp|Q5ZJU3|ASNS_CHICK Asparagine synthetase [glutamine-hydrolyzing] OS=Gallus gallus OX=9031 GN=ASNS PE=2 SV=3 g18906.t1 Q5ZJU3 62.278 562 0.0 731.0 sp|Q5ZJU3|ASNS_CHICK Asparagine synthetase [glutamine-hydrolyzing] OS=Gallus gallus OX=9031 GN=ASNS PE=2 SV=3 g18907.t1 Q9NVE5 50.346 433 1.87e-127 429.0 sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3 UBP40_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0016579; GO:0031647; GO:0043066 negative regulation of apoptotic process [GO:0043066]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g18907.t1 Q9NVE5 31.851 832 1.3100000000000002e-97 345.0 sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3 UBP40_HUMAN reviewed Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0016579; GO:0031647; GO:0043066 negative regulation of apoptotic process [GO:0043066]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g18908.t1 Q9PW80 40.506 395 1.2800000000000001e-80 261.0 sp|Q9PW80|IF2B3_DANRE Insulin-like growth factor 2 mRNA-binding protein 3 OS=Danio rerio OX=7955 GN=igf2bp3 PE=1 SV=1 IF2B3_DANRE reviewed Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247 CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g18908.t2 Q9PW80 40.1 399 4.96e-80 260.0 sp|Q9PW80|IF2B3_DANRE Insulin-like growth factor 2 mRNA-binding protein 3 OS=Danio rerio OX=7955 GN=igf2bp3 PE=1 SV=1 IF2B3_DANRE reviewed Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247 CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g18908.t3 Q9PW80 39.9 401 4.06e-78 255.0 sp|Q9PW80|IF2B3_DANRE Insulin-like growth factor 2 mRNA-binding protein 3 OS=Danio rerio OX=7955 GN=igf2bp3 PE=1 SV=1 IF2B3_DANRE reviewed Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (Decapentaplegic and Vg-related 1 RNA-binding protein) (IGF-II mRNA-binding protein 3) (VICKZ family member 3) (Vg1 RNA-binding protein) (Vg1-RBP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0007281; GO:0007399; GO:0007530; GO:0008354; GO:0010494; GO:0045995; GO:0051028; GO:0070934; GO:1990247 CRD-mediated mRNA stabilization [GO:0070934]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of embryonic development [GO:0045995]; regulation of translation [GO:0006417]; sex determination [GO:0007530] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g18909.t1 Q8CGX0 40.0 155 6.27e-22 95.5 sp|Q8CGX0|IF2B1_RAT Insulin-like growth factor 2 mRNA-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Igf2bp1 PE=1 SV=1 IF2B1_RAT reviewed Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (B-actin zipcode-binding protein 1) (ZBP1) (rZBP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) Rattus norvegicus (Rat) GO:0000932; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006403; GO:0007399; GO:0008284; GO:0010494; GO:0010610; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030424; GO:0030425; GO:0030426; GO:0043025; GO:0043197; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150; GO:0140059; GO:1900152; GO:1990247; GO:1990904; GO:2000767 CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of mRNA stability involved in response to stress [GO:0010610]; RNA localization [GO:0006403] axon [GO:0030424]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; translation regulator activity [GO:0045182] g18911.t1 Q9HD67 59.47 264 9.49e-104 334.0 sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3 MYO10_HUMAN reviewed Unconventional myosin-X (Unconventional myosin-10) Homo sapiens (Human) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002 cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507] g18912.t1 P79114 49.293 919 0.0 891.0 sp|P79114|MYO10_BOVIN Unconventional myosin-X OS=Bos taurus OX=9913 GN=MYO10 PE=1 SV=1 g18912.t1 P79114 50.577 607 2.6600000000000002e-167 558.0 sp|P79114|MYO10_BOVIN Unconventional myosin-X OS=Bos taurus OX=9913 GN=MYO10 PE=1 SV=1 g18912.t2 F8VQB6 48.568 943 0.0 891.0 sp|F8VQB6|MYO10_MOUSE Unconventional myosin-X OS=Mus musculus OX=10090 GN=Myo10 PE=1 SV=1 MYO10_MOUSE reviewed Unconventional myosin-X (Unconventional myosin-10) Mus musculus (Mouse) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0048870; GO:0051015; GO:0051489; GO:0060002 cell motility [GO:0048870]; cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489] cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507] g18912.t2 F8VQB6 47.519 665 3.72e-168 561.0 sp|F8VQB6|MYO10_MOUSE Unconventional myosin-X OS=Mus musculus OX=10090 GN=Myo10 PE=1 SV=1 MYO10_MOUSE reviewed Unconventional myosin-X (Unconventional myosin-10) Mus musculus (Mouse) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0048870; GO:0051015; GO:0051489; GO:0060002 cell motility [GO:0048870]; cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489] cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507] g18912.t3 P79114 49.747 593 1.91e-174 583.0 sp|P79114|MYO10_BOVIN Unconventional myosin-X OS=Bos taurus OX=9913 GN=MYO10 PE=1 SV=1 g18912.t3 P79114 50.577 607 1.5400000000000002e-166 561.0 sp|P79114|MYO10_BOVIN Unconventional myosin-X OS=Bos taurus OX=9913 GN=MYO10 PE=1 SV=1 g18912.t3 P79114 48.624 327 3.2e-85 314.0 sp|P79114|MYO10_BOVIN Unconventional myosin-X OS=Bos taurus OX=9913 GN=MYO10 PE=1 SV=1 g18919.t1 Q6GX86 50.5 200 1.46e-50 184.0 sp|Q6GX86|HROB_RAT Homologous recombination OB-fold protein OS=Rattus norvegicus OX=10116 GN=Hrob PE=2 SV=1 HROB_RAT reviewed Homologous recombination OB-fold protein Rattus norvegicus (Rat) GO:0000725; GO:0000731; GO:0003697; GO:0005634; GO:0006974; GO:0007292; GO:0036297; GO:0048232; GO:0090734 DNA damage response [GO:0006974]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725] nucleus [GO:0005634]; site of DNA damage [GO:0090734] single-stranded DNA binding [GO:0003697] g18920.t1 F1R332 29.042 334 7.93e-34 132.0 sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2 g18923.t1 Q5BLE8 48.099 605 0.0 615.0 sp|Q5BLE8|RETST_DANRE All-trans-retinol 13,14-reductase OS=Danio rerio OX=7955 GN=retsat PE=1 SV=1 g18923.t2 Q5BLE8 47.565 616 0.0 608.0 sp|Q5BLE8|RETST_DANRE All-trans-retinol 13,14-reductase OS=Danio rerio OX=7955 GN=retsat PE=1 SV=1 g18924.t1 Q503Y4 54.867 226 5.11e-76 232.0 sp|Q503Y4|OVCA2_DANRE Esterase OVCA2 OS=Danio rerio OX=7955 GN=ovca2 PE=2 SV=1 g18925.t1 Q5E9J7 57.396 169 3.8099999999999996e-69 212.0 sp|Q5E9J7|ADAT2_BOVIN tRNA-specific adenosine deaminase 2 OS=Bos taurus OX=9913 GN=DEADC1 PE=2 SV=1 g18926.t1 Q9D4P0 76.705 176 3.22e-101 291.0 sp|Q9D4P0|ARL5B_MOUSE ADP-ribosylation factor-like protein 5B OS=Mus musculus OX=10090 GN=Arl5b PE=2 SV=3 g18927.t1 Q9H0H5 45.74 446 9.61e-111 351.0 sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1 RGAP1_HUMAN reviewed Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) Homo sapiens (Human) GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358 actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358] acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g18927.t1 Q9H0H5 39.506 162 3.57e-26 117.0 sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1 RGAP1_HUMAN reviewed Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) Homo sapiens (Human) GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358 actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358] acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g18927.t2 Q9H0H5 48.341 422 7.26e-116 363.0 sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1 RGAP1_HUMAN reviewed Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) Homo sapiens (Human) GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358 actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358] acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g18927.t2 Q9H0H5 39.506 162 3.3300000000000003e-26 117.0 sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1 RGAP1_HUMAN reviewed Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) Homo sapiens (Human) GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358 actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358] acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233] alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270] g18928.t1 Q25117 88.71 496 0.0 895.0 sp|Q25117|ATPB_HEMPU ATP synthase subunit beta, mitochondrial OS=Hemicentrotus pulcherrimus OX=7650 PE=2 SV=1 g18929.t1 Q8IYJ2 27.912 455 3.49e-28 122.0 sp|Q8IYJ2|CJ067_HUMAN Uncharacterized protein C10orf67, mitochondrial OS=Homo sapiens OX=9606 GN=C10orf67 PE=1 SV=3 CJ067_HUMAN reviewed Uncharacterized protein C10orf67, mitochondrial Homo sapiens (Human) GO:0005739 mitochondrion [GO:0005739] g18929.t2 Q8IYJ2 27.397 438 2.8300000000000004e-27 119.0 sp|Q8IYJ2|CJ067_HUMAN Uncharacterized protein C10orf67, mitochondrial OS=Homo sapiens OX=9606 GN=C10orf67 PE=1 SV=3 CJ067_HUMAN reviewed Uncharacterized protein C10orf67, mitochondrial Homo sapiens (Human) GO:0005739 mitochondrion [GO:0005739] g18930.t1 P21447 54.668 1264 0.0 1367.0 sp|P21447|MDR1A_MOUSE ATP-dependent translocase ABCB1 OS=Mus musculus OX=10090 GN=Abcb1a PE=1 SV=3 MDR1A_MOUSE reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1) Mus musculus (Mouse) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0007173; GO:0007507; GO:0007512; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0008585; GO:0009410; GO:0009636; GO:0009986; GO:0010467; GO:0010498; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022008; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0035640; GO:0035932; GO:0036146; GO:0042626; GO:0042908; GO:0042910; GO:0043215; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055007; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0097719; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 adult heart development [GO:0007512]; aldosterone secretion [GO:0035932]; carboxylic acid transmembrane transport [GO:1905039]; cardiac muscle cell differentiation [GO:0055007]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; exploration behavior [GO:0035640]; export across plasma membrane [GO:0140115]; female gonad development [GO:0008585]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; gene expression [GO:0010467]; heart development [GO:0007507]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; neural tissue regeneration [GO:0097719]; neurogenesis [GO:0022008]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; proteasomal protein catabolic process [GO:0010498]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g18931.t1 P21447 53.597 1265 0.0 1337.0 sp|P21447|MDR1A_MOUSE ATP-dependent translocase ABCB1 OS=Mus musculus OX=10090 GN=Abcb1a PE=1 SV=3 MDR1A_MOUSE reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1) Mus musculus (Mouse) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0007173; GO:0007507; GO:0007512; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0008585; GO:0009410; GO:0009636; GO:0009986; GO:0010467; GO:0010498; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022008; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0035640; GO:0035932; GO:0036146; GO:0042626; GO:0042908; GO:0042910; GO:0043215; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055007; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0097719; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 adult heart development [GO:0007512]; aldosterone secretion [GO:0035932]; carboxylic acid transmembrane transport [GO:1905039]; cardiac muscle cell differentiation [GO:0055007]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; exploration behavior [GO:0035640]; export across plasma membrane [GO:0140115]; female gonad development [GO:0008585]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; gene expression [GO:0010467]; heart development [GO:0007507]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; neural tissue regeneration [GO:0097719]; neurogenesis [GO:0022008]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; proteasomal protein catabolic process [GO:0010498]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g18932.t1 O81884 47.188 320 3.3899999999999997e-93 293.0 sp|O81884|GALDH_ARATH L-galactose dehydrogenase OS=Arabidopsis thaliana OX=3702 GN=LGALDH PE=1 SV=1 g18935.t1 P21447 52.43 1255 0.0 1305.0 sp|P21447|MDR1A_MOUSE ATP-dependent translocase ABCB1 OS=Mus musculus OX=10090 GN=Abcb1a PE=1 SV=3 MDR1A_MOUSE reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1) Mus musculus (Mouse) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0007173; GO:0007507; GO:0007512; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0008585; GO:0009410; GO:0009636; GO:0009986; GO:0010467; GO:0010498; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022008; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0035640; GO:0035932; GO:0036146; GO:0042626; GO:0042908; GO:0042910; GO:0043215; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055007; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0097719; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 adult heart development [GO:0007512]; aldosterone secretion [GO:0035932]; carboxylic acid transmembrane transport [GO:1905039]; cardiac muscle cell differentiation [GO:0055007]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; exploration behavior [GO:0035640]; export across plasma membrane [GO:0140115]; female gonad development [GO:0008585]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; gene expression [GO:0010467]; heart development [GO:0007507]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; neural tissue regeneration [GO:0097719]; neurogenesis [GO:0022008]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; proteasomal protein catabolic process [GO:0010498]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g18935.t1 P21447 38.462 585 1.35e-117 400.0 sp|P21447|MDR1A_MOUSE ATP-dependent translocase ABCB1 OS=Mus musculus OX=10090 GN=Abcb1a PE=1 SV=3 MDR1A_MOUSE reviewed ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1A) (MDR1A) (Multidrug resistance protein 1A) (EC 7.6.2.2) (Multidrug resistance protein 3) (P-glycoprotein 3) (Phospholipid transporter ABCB1) (EC 7.6.2.1) Mus musculus (Mouse) GO:0000086; GO:0001666; GO:0001890; GO:0005524; GO:0005737; GO:0005886; GO:0007173; GO:0007507; GO:0007512; GO:0007565; GO:0007595; GO:0007623; GO:0008559; GO:0008585; GO:0009410; GO:0009636; GO:0009986; GO:0010467; GO:0010498; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022008; GO:0022857; GO:0031526; GO:0031625; GO:0032570; GO:0033189; GO:0033280; GO:0033762; GO:0035633; GO:0035640; GO:0035932; GO:0036146; GO:0042626; GO:0042908; GO:0042910; GO:0043215; GO:0045332; GO:0046581; GO:0046686; GO:0046865; GO:0046943; GO:0050892; GO:0055007; GO:0060856; GO:0070633; GO:0071217; GO:0071222; GO:0071236; GO:0071312; GO:0071356; GO:0071392; GO:0071475; GO:0071549; GO:0072089; GO:0090554; GO:0090555; GO:0097068; GO:0097305; GO:0097327; GO:0097719; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1902396; GO:1903416; GO:1904057; GO:1904148; GO:1904446; GO:1904478; GO:1905039; GO:1905231; GO:1905232; GO:1905233; GO:1905235; GO:1905237; GO:1990961; GO:1990962; GO:1990963; GO:2001025; GO:2001225 adult heart development [GO:0007512]; aldosterone secretion [GO:0035932]; carboxylic acid transmembrane transport [GO:1905039]; cardiac muscle cell differentiation [GO:0055007]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to alkaloid [GO:0071312]; cellular response to antibiotic [GO:0071236]; cellular response to borneol [GO:1905231]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to external biotic stimulus [GO:0071217]; cellular response to L-glutamate [GO:1905232]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mycotoxin [GO:0036146]; cellular response to nonylphenol [GO:1904148]; cellular response to tumor necrosis factor [GO:0071356]; ceramide translocation [GO:0099040]; circadian rhythm [GO:0007623]; daunorubicin transport [GO:0043215]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; exploration behavior [GO:0035640]; export across plasma membrane [GO:0140115]; female gonad development [GO:0008585]; female pregnancy [GO:0007565]; G2/M transition of mitotic cell cycle [GO:0000086]; gene expression [GO:0010467]; heart development [GO:0007507]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of sensory perception of pain [GO:1904057]; neural tissue regeneration [GO:0097719]; neurogenesis [GO:0022008]; phospholipid translocation [GO:0045332]; placenta development [GO:0001890]; positive regulation of establishment of Sertoli cell barrier [GO:1904446]; positive regulation of response to drug [GO:2001025]; proteasomal protein catabolic process [GO:0010498]; protein localization to bicellular tight junction [GO:1902396]; regulation of chloride transport [GO:2001225]; regulation of intestinal absorption [GO:1904478]; response to alcohol [GO:0097305]; response to antineoplastic agent [GO:0097327]; response to cadmium ion [GO:0046686]; response to codeine [GO:1905233]; response to cyclosporin A [GO:1905237]; response to glucagon [GO:0033762]; response to glycoside [GO:1903416]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to quercetin [GO:1905235]; response to thyroxine [GO:0097068]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886] ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] g18938.t1 P53708 37.984 1032 0.0 608.0 sp|P53708|ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens OX=9606 GN=ITGA8 PE=1 SV=3 ITA8_HUMAN reviewed Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain] Homo sapiens (Human) GO:0001656; GO:0001822; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007399; GO:0007613; GO:0008305; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0034446; GO:0034678; GO:0038023; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978 cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g18939.t1 Q66H85 40.779 385 1.8700000000000002e-72 255.0 sp|Q66H85|ANKZ1_RAT tRNA endonuclease ANKZF1 OS=Rattus norvegicus OX=10116 GN=Ankzf1 PE=2 SV=1 g18939.t1 Q66H85 39.906 213 1.67e-30 132.0 sp|Q66H85|ANKZ1_RAT tRNA endonuclease ANKZF1 OS=Rattus norvegicus OX=10116 GN=Ankzf1 PE=2 SV=1 g18940.t1 Q1LZ95 57.589 224 4.6799999999999997e-94 280.0 sp|Q1LZ95|IDI1_BOVIN Isopentenyl-diphosphate Delta-isomerase 1 OS=Bos taurus OX=9913 GN=IDI1 PE=2 SV=2 IDI1_BOVIN reviewed Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1) Bos taurus (Bovine) GO:0004452; GO:0005737; GO:0005777; GO:0006695; GO:0009240; GO:0046872; GO:0050992 cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240] cytoplasm [GO:0005737]; peroxisome [GO:0005777] isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872] g18941.t1 Q642F4 40.823 316 1.42e-71 226.0 sp|Q642F4|SC22A_RAT Vesicle-trafficking protein SEC22a OS=Rattus norvegicus OX=10116 GN=Sec22a PE=2 SV=1 g18944.t1 Q96IZ6 51.079 417 1.54e-140 410.0 sp|Q96IZ6|MET2A_HUMAN tRNA N(3)-cytidine methyltransferase METTL2A OS=Homo sapiens OX=9606 GN=METTL2A PE=1 SV=5 g18944.t2 Q96IZ6 47.865 445 3.5399999999999996e-134 395.0 sp|Q96IZ6|MET2A_HUMAN tRNA N(3)-cytidine methyltransferase METTL2A OS=Homo sapiens OX=9606 GN=METTL2A PE=1 SV=5 g18945.t1 Q8IUH3 40.612 490 8.13e-111 340.0 sp|Q8IUH3|RBM45_HUMAN RNA-binding protein 45 OS=Homo sapiens OX=9606 GN=RBM45 PE=1 SV=1 RBM45_HUMAN reviewed RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0007399; GO:0030154; GO:0042802; GO:1990904 cell differentiation [GO:0030154]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] identical protein binding [GO:0042802]; RNA binding [GO:0003723] g18946.t1 P83038 47.83 1037 0.0 791.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g18946.t2 P83038 47.596 1040 0.0 785.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g18946.t3 P83038 47.596 1040 0.0 787.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g18946.t4 P83038 46.064 1029 0.0 753.0 sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1 HDAC4_CHICK reviewed Histone deacetylase 4 (HD4) (EC 3.5.1.98) Gallus gallus (Chicken) GO:0000118; GO:0000122; GO:0004407; GO:0005737; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221 B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872] g18947.t1 Q7ZSX3 61.25 160 8.66e-56 181.0 sp|Q7ZSX3|PTF1A_DANRE Pancreas transcription factor 1 subunit alpha OS=Danio rerio OX=7955 GN=ptf1a PE=2 SV=1 PTF1A_DANRE reviewed Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048666; GO:0048699 amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; neuron development [GO:0048666]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565] g18949.t1 Q9NS86 57.825 377 8.390000000000001e-156 450.0 sp|Q9NS86|LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1 LANC2_HUMAN reviewed LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) Homo sapiens (Human) GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0031179; GO:0032266; GO:0045892; GO:0070273 carbohydrate metabolic process [GO:0005975]; negative regulation of DNA-templated transcription [GO:0045892]; peptide modification [GO:0031179]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789] cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] g18950.t1 Q06194 39.264 163 5.27e-26 107.0 sp|Q06194|FA8_MOUSE Coagulation factor VIII OS=Mus musculus OX=10090 GN=F8 PE=2 SV=2 FA8_MOUSE reviewed Coagulation factor VIII (Procoagulant component) Mus musculus (Mouse) GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491; GO:0031091 acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597] extracellular space [GO:0005615]; platelet alpha granule [GO:0031091] copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] g18951.t1 Q96PY5 47.716 1029 0.0 854.0 sp|Q96PY5|FMNL2_HUMAN Formin-like protein 2 OS=Homo sapiens OX=9606 GN=FMNL2 PE=1 SV=3 FMNL2_HUMAN reviewed Formin-like protein 2 (Formin homology 2 domain-containing protein 2) Homo sapiens (Human) GO:0005829; GO:0007010; GO:0008360; GO:0016477; GO:0022604; GO:0030866; GO:0031267; GO:0045296; GO:0051015 cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360] cytosol [GO:0005829] actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267] g18951.t2 Q6ZPF4 48.115 1008 0.0 880.0 sp|Q6ZPF4|FMNL3_MOUSE Formin-like protein 3 OS=Mus musculus OX=10090 GN=Fmnl3 PE=1 SV=2 FMNL3_MOUSE reviewed Formin-like protein 3 Mus musculus (Mouse) GO:0001525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0008360; GO:0016477; GO:0030036; GO:0030866; GO:0031267; GO:0032794; GO:0046847; GO:0051015 actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267] g18952.t1 Q10472 54.947 566 0.0 660.0 sp|Q10472|GALT1_HUMAN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=GALNT1 PE=1 SV=1 GALT1_HUMAN reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Homo sapiens (Human) GO:0000139; GO:0004653; GO:0005576; GO:0005789; GO:0006493; GO:0016020; GO:0016266; GO:0019082; GO:0030145; GO:0030246; GO:0032580; GO:0033116; GO:0048471 protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266]; viral protein processing [GO:0019082] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g18953.t1 Q3UGM2 46.088 1176 0.0 898.0 sp|Q3UGM2|NEK10_MOUSE Serine/threonine-protein kinase Nek10 OS=Mus musculus OX=10090 GN=Nek10 PE=2 SV=2 NEK10_MOUSE reviewed Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911 mucociliary clearance [GO:0120197]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] extracellular region [GO:0005576]; protein kinase complex [GO:1902911] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g18954.t1 P59110 45.066 304 1.02e-89 282.0 sp|P59110|SENP1_MOUSE Sentrin-specific protease 1 OS=Mus musculus OX=10090 GN=Senp1 PE=1 SV=1 SENP1_MOUSE reviewed Sentrin-specific protease 1 (EC 3.4.22.-) (SUMO-1 protease 2) (SuPr-2) (Sentrin/SUMO-specific protease SENP1) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005925; GO:0006508; GO:0010724; GO:0016925; GO:0016926; GO:0016929; GO:0031965; GO:0032435; GO:0043488; GO:0045944; GO:0061157; GO:0070139; GO:0098978; GO:0099523; GO:0099524; GO:0150052 mRNA destabilization [GO:0061157]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; protein sumoylation [GO:0016925]; proteolysis [GO:0006508]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of mRNA stability [GO:0043488]; regulation of postsynapse assembly [GO:0150052] focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139] g18956.t1 A2RU49 26.382 398 3.7699999999999996e-42 154.0 sp|A2RU49|HYKK_HUMAN Hydroxylysine kinase OS=Homo sapiens OX=9606 GN=HYKK PE=1 SV=2 HYKK_HUMAN reviewed Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1) Homo sapiens (Human) GO:0005759; GO:0006554; GO:0019202; GO:0047992 lysine catabolic process [GO:0006554] mitochondrial matrix [GO:0005759] amino acid kinase activity [GO:0019202]; hydroxylysine kinase activity [GO:0047992] g18957.t1 Q5U5V2 27.536 276 2.68e-22 98.2 sp|Q5U5V2|HYKK_MOUSE Hydroxylysine kinase OS=Mus musculus OX=10090 GN=Hykk PE=1 SV=2 g18960.t1 O95613 29.63 1107 1.61e-78 296.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18960.t1 O95613 26.881 1183 2.04e-33 147.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18960.t2 O95613 29.63 1107 1.25e-78 297.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18960.t2 O95613 26.78 1180 4.2600000000000004e-33 146.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18960.t3 O95613 29.545 1100 6.0800000000000005e-80 301.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18960.t3 O95613 26.78 1180 3.82e-33 147.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18960.t4 O95613 29.63 1107 1.28e-78 297.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18960.t4 O95613 26.78 1180 4.38e-33 146.0 sp|O95613|PCNT_HUMAN Pericentrin OS=Homo sapiens OX=9606 GN=PCNT PE=1 SV=4 PCNT_HUMAN reviewed Pericentrin (Kendrin) (Pericentrin-B) Homo sapiens (Human) GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316; GO:0097225 cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm midpiece [GO:0097225] calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] g18961.t1 Q8BLN5 64.435 717 0.0 993.0 sp|Q8BLN5|LSS_MOUSE Lanosterol synthase OS=Mus musculus OX=10090 GN=Lss PE=1 SV=2 LSS_MOUSE reviewed Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) Mus musculus (Mouse) GO:0000250; GO:0005789; GO:0005811; GO:0006694; GO:0006695; GO:0016104; GO:0016125; GO:0031647; GO:0033489; GO:0033490; GO:0036197; GO:0098554 cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; triterpenoid biosynthetic process [GO:0016104]; zymosterol biosynthetic process [GO:0036197] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] lanosterol synthase activity [GO:0000250] g18961.t2 P48449 64.549 488 0.0 701.0 sp|P48449|LSS_HUMAN Lanosterol synthase OS=Homo sapiens OX=9606 GN=LSS PE=1 SV=1 LSS_HUMAN reviewed Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC) Homo sapiens (Human) GO:0000250; GO:0005789; GO:0005811; GO:0006694; GO:0006695; GO:0016020; GO:0016104; GO:0031647 cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020] lanosterol synthase activity [GO:0000250] g18962.t1 Q4PJW3 64.99 497 0.0 683.0 sp|Q4PJW3|CP51A_BOVIN Lanosterol 14-alpha demethylase OS=Bos taurus OX=9913 GN=CYP51A1 PE=2 SV=1 CP51A_BOVIN reviewed Lanosterol 14-alpha demethylase (LDM) (EC 1.14.14.154) (CYPLI) (Cytochrome P450 51A1) (CYP51) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase) Bos taurus (Bovine) GO:0005506; GO:0005789; GO:0006694; GO:0008398; GO:0016491; GO:0020037; GO:0033488 cholesterol biosynthetic process via 24,25-dihydrolanosterol [GO:0033488]; steroid biosynthetic process [GO:0006694] endoplasmic reticulum membrane [GO:0005789] heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; sterol 14-demethylase activity [GO:0008398] g18963.t1 Q9D1J3 36.33 267 5.55e-30 114.0 sp|Q9D1J3|SARNP_MOUSE SAP domain-containing ribonucleoprotein OS=Mus musculus OX=10090 GN=Sarnp PE=1 SV=3 SARNP_MOUSE reviewed SAP domain-containing ribonucleoprotein (Nuclear protein Hcc-1) Mus musculus (Mouse) GO:0000122; GO:0000346; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0006406; GO:0006417; GO:0016607; GO:0016973; GO:0036464 mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723] g18963.t2 Q9D1J3 32.986 288 1.94e-28 111.0 sp|Q9D1J3|SARNP_MOUSE SAP domain-containing ribonucleoprotein OS=Mus musculus OX=10090 GN=Sarnp PE=1 SV=3 SARNP_MOUSE reviewed SAP domain-containing ribonucleoprotein (Nuclear protein Hcc-1) Mus musculus (Mouse) GO:0000122; GO:0000346; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0006406; GO:0006417; GO:0016607; GO:0016973; GO:0036464 mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723] g18964.t1 Q8C163 42.182 275 7.550000000000001e-71 228.0 sp|Q8C163|EXOG_MOUSE Nuclease EXOG, mitochondrial OS=Mus musculus OX=10090 GN=Exog PE=1 SV=1 EXOG_MOUSE reviewed Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1) Mus musculus (Mouse) GO:0000014; GO:0003676; GO:0004519; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0006309; GO:0008409; GO:0032991; GO:0046872 apoptotic DNA fragmentation [GO:0006309] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] 5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA endonuclease activity [GO:0004521]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] g18965.t1 Q502K1 43.681 364 2.19e-104 314.0 sp|Q502K1|EXOG_DANRE Nuclease EXOG, mitochondrial OS=Danio rerio OX=7955 GN=exog PE=2 SV=2 g18967.t1 B0FYY4 40.842 808 0.0 598.0 sp|B0FYY4|ITB1_SHEEP Integrin beta-1 OS=Ovis aries OX=9940 GN=ITGB1 PE=2 SV=1 ITB1_SHEEP reviewed Integrin beta-1 (Fibronectin receptor subunit beta) (Integrin subunit beta-1) (VLA-4 subunit beta) (CD antigen CD29) Ovis aries (Sheep) GO:0001968; GO:0005925; GO:0007229; GO:0007517; GO:0007520; GO:0009986; GO:0010710; GO:0016020; GO:0016477; GO:0019901; GO:0019960; GO:0030027; GO:0030335; GO:0031623; GO:0032587; GO:0033627; GO:0034679; GO:0042470; GO:0043236; GO:0045202; GO:0045445; GO:0045906; GO:0046872; GO:0046982; GO:0055037; GO:0071404; GO:0098609; GO:0098639; GO:0098640; GO:1903078 cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fusion [GO:0007520]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin alpha9-beta1 complex [GO:0034679]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; synapse [GO:0045202] C-X3-C chemokine binding [GO:0019960]; collagen binding involved in cell-matrix adhesion [GO:0098639]; fibronectin binding [GO:0001968]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g18969.t1 Q13797 32.682 1074 1.45e-156 496.0 sp|Q13797|ITA9_HUMAN Integrin alpha-9 OS=Homo sapiens OX=9606 GN=ITGA9 PE=1 SV=2 ITA9_HUMAN reviewed Integrin alpha-9 (Integrin alpha-RLC) Homo sapiens (Human) GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009925; GO:0009986; GO:0030593; GO:0034679; GO:0038023; GO:0045906; GO:0046872; GO:0098609; GO:0098640 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] integrin binding involved in cell-matrix adhesion [GO:0098640]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g18969.t2 Q13797 32.369 1072 1.8400000000000002e-157 498.0 sp|Q13797|ITA9_HUMAN Integrin alpha-9 OS=Homo sapiens OX=9606 GN=ITGA9 PE=1 SV=2 ITA9_HUMAN reviewed Integrin alpha-9 (Integrin alpha-RLC) Homo sapiens (Human) GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009925; GO:0009986; GO:0030593; GO:0034679; GO:0038023; GO:0045906; GO:0046872; GO:0098609; GO:0098640 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] integrin binding involved in cell-matrix adhesion [GO:0098640]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g18970.t1 D3ZH22 33.816 207 1.03e-36 131.0 sp|D3ZH22|SWET1_RAT Sugar transporter SWEET1 OS=Rattus norvegicus OX=10116 GN=Slc50a1 PE=1 SV=1 SWET1_RAT reviewed Sugar transporter SWEET1 (RAG1-activating protein 1) (Solute carrier family 50 member 1) Rattus norvegicus (Rat) GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0012505; GO:0016020; GO:0042947; GO:0051119 carbohydrate transport [GO:0008643] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] glucoside transmembrane transporter activity [GO:0042947]; sugar transmembrane transporter activity [GO:0051119] g18971.t1 Q8TCT0 27.634 579 1.58e-59 210.0 sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1 CERK1_HUMAN reviewed Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4) Homo sapiens (Human) GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020 ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287] g18972.t1 Q13797 29.352 1080 2.63e-115 385.0 sp|Q13797|ITA9_HUMAN Integrin alpha-9 OS=Homo sapiens OX=9606 GN=ITGA9 PE=1 SV=2 ITA9_HUMAN reviewed Integrin alpha-9 (Integrin alpha-RLC) Homo sapiens (Human) GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009925; GO:0009986; GO:0030593; GO:0034679; GO:0038023; GO:0045906; GO:0046872; GO:0098609; GO:0098640 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integrin alpha9-beta1 complex [GO:0034679]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] integrin binding involved in cell-matrix adhesion [GO:0098640]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g18973.t1 O61366 52.025 321 1.6400000000000002e-103 346.0 sp|O61366|GPRS_DROME Serine-enriched protein OS=Drosophila melanogaster OX=7227 GN=gprs PE=4 SV=3 g18973.t2 O61366 52.025 321 9.150000000000001e-103 345.0 sp|O61366|GPRS_DROME Serine-enriched protein OS=Drosophila melanogaster OX=7227 GN=gprs PE=4 SV=3 g18974.t1 Q8K1C7 23.913 460 1.13e-33 135.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g18975.t1 Q8BGC3 24.146 410 2.1200000000000003e-27 117.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g18977.t1 P61210 87.931 174 1.27e-112 321.0 sp|P61210|ARF1_LOCMI ADP-ribosylation factor 1 OS=Locusta migratoria OX=7004 GN=ARF1 PE=2 SV=2 g18978.t1 P61210 93.22 177 5.66e-122 344.0 sp|P61210|ARF1_LOCMI ADP-ribosylation factor 1 OS=Locusta migratoria OX=7004 GN=ARF1 PE=2 SV=2 g18979.t1 P61210 90.11 182 4.4e-120 340.0 sp|P61210|ARF1_LOCMI ADP-ribosylation factor 1 OS=Locusta migratoria OX=7004 GN=ARF1 PE=2 SV=2 g18980.t1 Q9JHI9 37.138 622 5.62e-119 370.0 sp|Q9JHI9|S40A1_MOUSE Ferroportin OS=Mus musculus OX=10090 GN=Slc40a1 PE=1 SV=1 S40A1_MOUSE reviewed Ferroportin (Ferroportin-1) (Iron-regulated transporter 1) (Metal transporter protein 1) (MTP1) (Solute carrier family 40 member 1) Mus musculus (Mouse) GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005829; GO:0005886; GO:0006826; GO:0006879; GO:0008021; GO:0015093; GO:0016323; GO:0017046; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0046872; GO:0048536; GO:0060345; GO:0060586; GO:1903988 endothelium development [GO:0003158]; intracellular iron ion homeostasis [GO:0006879]; iron ion export across plasma membrane [GO:1903988]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046] g18981.t1 Q5R5Z5 74.074 297 1.27e-166 467.0 sp|Q5R5Z5|ARPC2_PONAB Actin-related protein 2/3 complex subunit 2 OS=Pongo abelii OX=9601 GN=ARPC2 PE=2 SV=1 ARPC2_PONAB reviewed Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005200; GO:0005634; GO:0005654; GO:0005768; GO:0005885; GO:0005925; GO:0010592; GO:0030027; GO:0030041; GO:0030672; GO:0030838; GO:0034314; GO:0035861; GO:0036195; GO:0043005; GO:0051015; GO:0098794; GO:0098978; GO:1900026 actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] Arp2/3 protein complex [GO:0005885]; endosome [GO:0005768]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; site of double-strand break [GO:0035861]; synaptic vesicle membrane [GO:0030672] actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200] g18982.t1 Q91Y80 44.4 250 1.64e-57 203.0 sp|Q91Y80|3BP5_RAT SH3 domain-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Sh3bp5 PE=1 SV=2 3BP5_RAT reviewed SH3 domain-binding protein 5 (SH3BP-5) (Vascular endothelial cell-specific protein 18) Rattus norvegicus (Rat) GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0005739; GO:0007254; GO:0016604; GO:0017124; GO:0030659; GO:0035556 intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124] g18984.t2 P51400 38.166 338 7.18e-63 214.0 sp|P51400|RED1_RAT Double-stranded RNA-specific editase 1 OS=Rattus norvegicus OX=10116 GN=Adarb1 PE=1 SV=1 g18985.t1 Q91836 34.364 291 2.93e-51 172.0 sp|Q91836|PRKAB_XENLA Interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog B OS=Xenopus laevis OX=8355 GN=prkra-b PE=1 SV=1 g18987.t1 Q9BSH4 35.784 204 4.71e-33 122.0 sp|Q9BSH4|TACO1_HUMAN Translational activator of cytochrome c oxidase 1 OS=Homo sapiens OX=9606 GN=TACO1 PE=1 SV=1 TACO1_HUMAN reviewed Translational activator of cytochrome c oxidase 1 (Coiled-coil domain-containing protein 44) (Translational activator of mitochondrially-encoded cytochrome c oxidase I) Homo sapiens (Human) GO:0003729; GO:0005739; GO:0019843; GO:0033617; GO:0061743; GO:0070129; GO:0097177 mitochondrial respiratory chain complex IV assembly [GO:0033617]; motor learning [GO:0061743]; regulation of mitochondrial translation [GO:0070129] mitochondrion [GO:0005739] mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843] g18990.t1 Q13324 41.489 376 1.51e-84 276.0 sp|Q13324|CRFR2_HUMAN Corticotropin-releasing factor receptor 2 OS=Homo sapiens OX=9606 GN=CRHR2 PE=1 SV=2 g18990.t2 Q60748 41.489 376 1.9499999999999999e-84 276.0 sp|Q60748|CRFR2_MOUSE Corticotropin-releasing factor receptor 2 OS=Mus musculus OX=10090 GN=Crhr2 PE=1 SV=2 CRFR2_MOUSE reviewed Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (CRF-RB) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2) (Heart and muscle corticotropin-releasing factor receptor) (HM-CRF) Mus musculus (Mouse) GO:0005179; GO:0005886; GO:0007015; GO:0007166; GO:0007186; GO:0007188; GO:0007200; GO:0008528; GO:0009986; GO:0010460; GO:0010628; GO:0010629; GO:0010700; GO:0014064; GO:0015056; GO:0016525; GO:0017046; GO:0030424; GO:0030425; GO:0030855; GO:0032755; GO:0032811; GO:0032874; GO:0033685; GO:0035482; GO:0042423; GO:0043025; GO:0043196; GO:0043204; GO:0043404; GO:0043679; GO:0045777; GO:0046882; GO:0048630; GO:0060291; GO:0061179; GO:0070372; GO:0070852; GO:0090281; GO:0106071; GO:0141163; GO:2000252; GO:2000293; GO:2000573 actin filament organization [GO:0007015]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; catecholamine biosynthetic process [GO:0042423]; cell surface receptor signaling pathway [GO:0007166]; epithelial cell differentiation [GO:0030855]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric motility [GO:0035482]; long-term synaptic potentiation [GO:0060291]; negative regulation of angiogenesis [GO:0016525]; negative regulation of calcium ion import [GO:0090281]; negative regulation of defecation [GO:2000293]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of feeding behavior [GO:2000252]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of luteinizing hormone secretion [GO:0033685]; negative regulation of norepinephrine secretion [GO:0010700]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of blood pressure [GO:0045777]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate [GO:0010460]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of serotonin secretion [GO:0014064]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of ERK1 and ERK2 cascade [GO:0070372]; skeletal muscle tissue growth [GO:0048630] axon [GO:0030424]; axon terminus [GO:0043679]; cell body fiber [GO:0070852]; cell surface [GO:0009986]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; varicosity [GO:0043196] corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone activity [GO:0005179]; peptide hormone binding [GO:0017046] g18991.t1 O42602 36.119 371 1.31e-59 206.0 sp|O42602|CRFR1_XENLA Corticotropin-releasing factor receptor 1 OS=Xenopus laevis OX=8355 GN=crhr1 PE=2 SV=1 g18991.t2 O42602 36.119 371 1.2900000000000001e-59 206.0 sp|O42602|CRFR1_XENLA Corticotropin-releasing factor receptor 1 OS=Xenopus laevis OX=8355 GN=crhr1 PE=2 SV=1 g18992.t1 Q9QYP1 36.445 557 4.8e-92 322.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g18992.t1 Q9QYP1 34.766 535 9.34e-88 309.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g18992.t1 Q9QYP1 34.709 533 7.52e-85 300.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g18992.t1 Q9QYP1 33.333 297 2.23e-41 168.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g18992.t1 Q9QYP1 30.345 290 1.1200000000000001e-29 131.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g18994.t1 Q2T9W6 47.697 304 6.6e-58 195.0 sp|Q2T9W6|LRRF2_BOVIN Leucine-rich repeat flightless-interacting protein 2 OS=Bos taurus OX=9913 GN=LRRFIP2 PE=2 SV=1 g18994.t2 Q2T9W6 48.973 292 1.81e-60 201.0 sp|Q2T9W6|LRRF2_BOVIN Leucine-rich repeat flightless-interacting protein 2 OS=Bos taurus OX=9913 GN=LRRFIP2 PE=2 SV=1 g18996.t1 P22045 41.135 282 2.4e-66 211.0 sp|P22045|PGFS_LEIMA 9,11-endoperoxide prostaglandin H2 reductase OS=Leishmania major OX=5664 GN=P100/11E PE=1 SV=3 g18997.t1 Q9UBN4 31.99 769 5.07e-102 341.0 sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1 g18999.t1 Q9H9Y6 57.381 1138 0.0 1370.0 sp|Q9H9Y6|RPA2_HUMAN DNA-directed RNA polymerase I subunit RPA2 OS=Homo sapiens OX=9606 GN=POLR1B PE=1 SV=2 RPA2_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135) Homo sapiens (Human) GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005829; GO:0007566; GO:0008270; GO:0009303; GO:0014029; GO:0017126; GO:0032549; GO:0071667 embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270] g19002.t1 P48999 31.503 692 1.93e-107 344.0 sp|P48999|LOX5_MOUSE Polyunsaturated fatty acid 5-lipoxygenase OS=Mus musculus OX=10090 GN=Alox5 PE=1 SV=3 LOX5_MOUSE reviewed Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34) Mus musculus (Mouse) GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005654; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030425; GO:0030501; GO:0031965; GO:0034440; GO:0036336; GO:0036403; GO:0042383; GO:0042593; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904999; GO:2001301 arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383] arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506] g19002.t2 P48999 30.769 689 9.85e-106 338.0 sp|P48999|LOX5_MOUSE Polyunsaturated fatty acid 5-lipoxygenase OS=Mus musculus OX=10090 GN=Alox5 PE=1 SV=3 LOX5_MOUSE reviewed Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34) Mus musculus (Mouse) GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005654; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030425; GO:0030501; GO:0031965; GO:0034440; GO:0036336; GO:0036403; GO:0042383; GO:0042593; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904999; GO:2001301 arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383] arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506] g19004.t1 P68370 97.339 451 0.0 932.0 sp|P68370|TBA1A_RAT Tubulin alpha-1A chain OS=Rattus norvegicus OX=10116 GN=Tuba1a PE=1 SV=1 TBA1A_RAT reviewed Tubulin alpha-1A chain (EC 3.6.5.-) (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain] Rattus norvegicus (Rat) GO:0000226; GO:0000278; GO:0000793; GO:0001764; GO:0001964; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0005879; GO:0005881; GO:0005886; GO:0005929; GO:0006886; GO:0007017; GO:0007098; GO:0007224; GO:0007613; GO:0007626; GO:0008344; GO:0008542; GO:0009612; GO:0010001; GO:0010467; GO:0015630; GO:0016787; GO:0019904; GO:0021542; GO:0021696; GO:0021766; GO:0021859; GO:0021987; GO:0022008; GO:0030182; GO:0030317; GO:0030534; GO:0031594; GO:0034612; GO:0035641; GO:0036126; GO:0036464; GO:0042802; GO:0043209; GO:0044877; GO:0045121; GO:0045202; GO:0046785; GO:0046872; GO:0046982; GO:0048853; GO:0048873; GO:0050807; GO:0050808; GO:0051402; GO:0055037; GO:0061744; GO:0071277; GO:0072384; GO:0140058; GO:1902065 adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; cellular response to calcium ion [GO:0071277]; centrosome cycle [GO:0007098]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; dentate gyrus development [GO:0021542]; flagellated sperm motility [GO:0030317]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; locomotory exploration behavior [GO:0035641]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection arborization [GO:0140058]; organelle transport along microtubule [GO:0072384]; pyramidal neuron differentiation [GO:0021859]; regulation of synapse organization [GO:0050807]; response to L-glutamate [GO:1902065]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; smoothened signaling pathway [GO:0007224]; startle response [GO:0001964]; synapse organization [GO:0050808]; visual learning [GO:0008542] axonemal microtubule [GO:0005879]; cilium [GO:0005929]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; sperm flagellum [GO:0036126]; synapse [GO:0045202] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200] g19005.t1 P25916 52.013 298 4.790000000000001e-97 305.0 sp|P25916|BMI1_MOUSE Polycomb complex protein BMI-1 OS=Mus musculus OX=10090 GN=Bmi1 PE=1 SV=1 g19006.t1 Q32KX7 47.39 249 1.4500000000000001e-77 242.0 sp|Q32KX7|BMI1_BOVIN Polycomb complex protein BMI-1 OS=Bos taurus OX=9913 GN=BMI1 PE=2 SV=1 BMI1_BOVIN reviewed Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) Bos taurus (Bovine) GO:0000122; GO:0000151; GO:0000792; GO:0001701; GO:0005829; GO:0006338; GO:0006346; GO:0006959; GO:0007420; GO:0008270; GO:0016604; GO:0021903; GO:0030097; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0045814; GO:0048103; GO:0048146; GO:0048704; GO:0051443; GO:0071535; GO:0097027; GO:0097190; GO:1990841; GO:2000011; GO:2001234 apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; rostrocaudal neural tube patterning [GO:0021903]; somatic stem cell division [GO:0048103] cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151] promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270] g19007.t1 Q6NZC7 46.23 1008 0.0 803.0 sp|Q6NZC7|S23IP_MOUSE SEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2 S23IP_MOUSE reviewed SEC23-interacting protein Mus musculus (Mouse) GO:0001675; GO:0004620; GO:0005737; GO:0005794; GO:0005801; GO:0007286; GO:0007338; GO:0012507; GO:0030134; GO:0046872; GO:0048471; GO:0070971; GO:0097038 acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatid development [GO:0007286] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; phospholipase activity [GO:0004620] g19008.t1 Q5F495 89.32 206 9.77e-140 393.0 sp|Q5F495|PHOCN_CHICK MOB-like protein phocein OS=Gallus gallus OX=9031 GN=MOB4 PE=2 SV=1 g19009.t1 Q27256 34.505 626 7.17e-113 357.0 sp|Q27256|WHITE_ANOGA Protein white OS=Anopheles gambiae OX=7165 GN=w PE=2 SV=1 g19010.t1 Q98TB4 38.108 370 3.98e-78 250.0 sp|Q98TB4|GDF8_OREMO Growth/differentiation factor 8 OS=Oreochromis mossambicus OX=8127 GN=gdf-8 PE=2 SV=1 g19011.t1 Q1LU93 49.068 161 8.1e-59 186.0 sp|Q1LU93|ABITM_DANRE Protein Abitram OS=Danio rerio OX=7955 GN=abitram PE=2 SV=1 g19012.t1 Q9Y6A2 39.789 475 5.79e-116 354.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g19014.t1 Q5ZJL4 65.258 426 0.0 621.0 sp|Q5ZJL4|CLP1_CHICK Polyribonucleotide 5'-hydroxyl-kinase Clp1 OS=Gallus gallus OX=9031 GN=CLP1 PE=2 SV=2 CLP1_CHICK reviewed Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1) Gallus gallus (Chicken) GO:0000214; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005849; GO:0006388; GO:0021695; GO:0031124; GO:0046404; GO:0051731; GO:0051736; GO:0070922; GO:0098795 cerebellar cortex development [GO:0021695]; global gene silencing by mRNA cleavage [GO:0098795]; mRNA 3'-end processing [GO:0031124]; RISC complex assembly [GO:0070922]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214] ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731] g19014.t2 Q5ZJL4 66.344 413 0.0 619.0 sp|Q5ZJL4|CLP1_CHICK Polyribonucleotide 5'-hydroxyl-kinase Clp1 OS=Gallus gallus OX=9031 GN=CLP1 PE=2 SV=2 CLP1_CHICK reviewed Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1) Gallus gallus (Chicken) GO:0000214; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005849; GO:0006388; GO:0021695; GO:0031124; GO:0046404; GO:0051731; GO:0051736; GO:0070922; GO:0098795 cerebellar cortex development [GO:0021695]; global gene silencing by mRNA cleavage [GO:0098795]; mRNA 3'-end processing [GO:0031124]; RISC complex assembly [GO:0070922]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388] cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214] ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731] g19015.t1 Q4R7Y5 50.562 267 3.66e-64 204.0 sp|Q4R7Y5|DNJB6_MACFA DnaJ homolog subfamily B member 6 OS=Macaca fascicularis OX=9541 GN=DNAJB6 PE=2 SV=1 g19015.t2 Q4R7Y5 52.734 256 2.5900000000000004e-66 208.0 sp|Q4R7Y5|DNJB6_MACFA DnaJ homolog subfamily B member 6 OS=Macaca fascicularis OX=9541 GN=DNAJB6 PE=2 SV=1 g19019.t1 Q8IZF6 33.333 285 1.84e-35 147.0 sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2 AGRG4_HUMAN reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g19020.t1 Q9TU53 25.303 660 4.4500000000000004e-36 152.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 25.0 600 5.23e-31 135.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 24.0 700 1.63e-29 130.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 24.457 552 1.8e-28 127.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 24.324 555 4.38e-28 126.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 24.365 591 2.38e-24 114.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 24.205 566 2.76e-24 114.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 22.928 567 3.11e-23 110.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 23.717 565 9.249999999999999e-23 108.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19020.t1 Q9TU53 22.38 706 5.66e-21 103.0 sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1 g19021.t1 O57382 25.831 391 4.21e-28 124.0 sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1 g19022.t1 P93732 53.822 314 7.790000000000001e-124 363.0 sp|P93732|PIP_ARATH Proline iminopeptidase OS=Arabidopsis thaliana OX=3702 GN=PIP PE=2 SV=3 g19023.t1 Q5RC62 25.068 367 5.9500000000000004e-27 122.0 sp|Q5RC62|BBS12_PONAB Chaperonin-containing T-complex member BBS12 OS=Pongo abelii OX=9601 GN=BBS12 PE=2 SV=2 g19023.t2 Q5RC62 25.068 367 1.4700000000000002e-27 123.0 sp|Q5RC62|BBS12_PONAB Chaperonin-containing T-complex member BBS12 OS=Pongo abelii OX=9601 GN=BBS12 PE=2 SV=2 g19024.t1 Q8CC21 41.569 255 1.12e-53 188.0 sp|Q8CC21|TTC19_MOUSE Tetratricopeptide repeat protein 19, mitochondrial OS=Mus musculus OX=10090 GN=Ttc19 PE=1 SV=1 g19025.t1 Q99MN1 72.007 568 0.0 867.0 sp|Q99MN1|SYK_MOUSE Lysine--tRNA ligase OS=Mus musculus OX=10090 GN=Kars1 PE=1 SV=1 SYK_MOUSE reviewed Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS) Mus musculus (Mouse) GO:0000049; GO:0002276; GO:0002863; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0010165; GO:0015966; GO:0016597; GO:0017101; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0097110 basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of macrophage activation [GO:0043032]; response to X-ray [GO:0010165] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; ATP binding [GO:0005524]; ATP:ADP adenylyltransferase activity [GO:0003877]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049] g19025.t2 Q99MN1 71.75 577 0.0 877.0 sp|Q99MN1|SYK_MOUSE Lysine--tRNA ligase OS=Mus musculus OX=10090 GN=Kars1 PE=1 SV=1 SYK_MOUSE reviewed Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS) Mus musculus (Mouse) GO:0000049; GO:0002276; GO:0002863; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006430; GO:0010165; GO:0015966; GO:0016597; GO:0017101; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371; GO:0097110 basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of macrophage activation [GO:0043032]; response to X-ray [GO:0010165] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] amino acid binding [GO:0016597]; ATP binding [GO:0005524]; ATP:ADP adenylyltransferase activity [GO:0003877]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049] g19026.t1 Q28614 40.65 369 2.36e-88 276.0 sp|Q28614|UT2_RABIT Urea transporter 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC14A2 PE=2 SV=1 g19027.t1 Q9QUQ5 39.416 137 8.46e-25 102.0 sp|Q9QUQ5|TRPC4_MOUSE Short transient receptor potential channel 4 OS=Mus musculus OX=10090 GN=Trpc4 PE=1 SV=1 TRPC4_MOUSE reviewed Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel Trp4) (Receptor-activated cation channel TRP4) Mus musculus (Mouse) GO:0005262; GO:0005886; GO:0005901; GO:0005911; GO:0006816; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0032991; GO:0034703; GO:0034704; GO:0045121; GO:0045296; GO:0046872; GO:0048709; GO:0051480; GO:0051924; GO:0070509; GO:0070588; GO:0070679; GO:0099605; GO:0106129 calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; oligodendrocyte differentiation [GO:0048709]; positive regulation of store-operated calcium entry [GO:0106129]; regulation of action potential firing rate [GO:0099605]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; metal ion binding [GO:0046872]; store-operated calcium channel activity [GO:0015279] g19028.t1 Q9VJJ7 27.262 829 1.66e-86 301.0 sp|Q9VJJ7|TRPG_DROME Transient receptor potential-gamma protein OS=Drosophila melanogaster OX=7227 GN=Trpgamma PE=1 SV=2 TRPG_DROME reviewed Transient receptor potential-gamma protein (TRPgamma) (Transient receptor potential cation channel gamma) Drosophila melanogaster (Fruit fly) GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0006816; GO:0007628; GO:0008381; GO:0009416; GO:0015279; GO:0016028; GO:0033583; GO:0034703; GO:0043025; GO:0050884; GO:0050908; GO:0051480; GO:0070588; GO:0070679; GO:1990635 adult walking behavior [GO:0007628]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; detection of light stimulus involved in visual perception [GO:0050908]; monoatomic cation transport [GO:0006812]; neuromuscular process controlling posture [GO:0050884]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to light stimulus [GO:0009416] cation channel complex [GO:0034703]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; proximal dendrite [GO:1990635]; rhabdomere [GO:0016028]; rhabdomere membrane [GO:0033583] calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261]; store-operated calcium channel activity [GO:0015279] g19029.t1 Q6P2X9 25.114 438 1.58e-32 132.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g19030.t1 P53811 47.015 268 2.43e-74 231.0 sp|P53811|PIPNB_MOUSE Phosphatidylinositol transfer protein beta isoform OS=Mus musculus OX=10090 GN=Pitpnb PE=1 SV=2 PIPNB_MOUSE reviewed Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta) Mus musculus (Mouse) GO:0000139; GO:0001701; GO:0005543; GO:0005737; GO:0005789; GO:0005794; GO:0006890; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0120019; GO:0140338 in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid binding [GO:0005543]; sphingomyelin transfer activity [GO:0140338] g19031.t1 Q6P2X9 24.706 425 6.22e-29 121.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g19032.t1 O75600 65.679 405 0.0 561.0 sp|O75600|KBL_HUMAN 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial OS=Homo sapiens OX=9606 GN=GCAT PE=1 SV=1 KBL_HUMAN reviewed 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005739; GO:0006520; GO:0006567; GO:0008890; GO:0016607; GO:0030170 amino acid metabolic process [GO:0006520]; L-threonine catabolic process [GO:0006567] mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170] g19033.t1 P53708 35.441 759 4.71e-125 404.0 sp|P53708|ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens OX=9606 GN=ITGA8 PE=1 SV=3 ITA8_HUMAN reviewed Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain] Homo sapiens (Human) GO:0001656; GO:0001822; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007399; GO:0007613; GO:0008305; GO:0009986; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0034446; GO:0034678; GO:0038023; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609; GO:0098839; GO:0098978 cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] g19035.t1 A0A2C9JXL4 51.587 252 5.37e-83 259.0 sp|A0A2C9JXL4|C1GLT_BIOGL Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Biomphalaria glabrata OX=6526 PE=1 SV=1 C1GLT_BIOGL reviewed Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Glycoprotein-N-acetylgalactosamine beta-1,3-galactosyltransferase) (Beta-1,3-galactosyltransferase) (T-synthase) Biomphalaria glabrata (Bloodfluke planorb) (Freshwater snail) GO:0000166; GO:0009101; GO:0016020; GO:0016263; GO:0030145 glycoprotein biosynthetic process [GO:0009101] membrane [GO:0016020] glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166] g19038.t1 Q9UG63 70.408 588 0.0 858.0 sp|Q9UG63|ABCF2_HUMAN ATP-binding cassette sub-family F member 2 OS=Homo sapiens OX=9606 GN=ABCF2 PE=1 SV=2 g19040.t1 A7YY46 50.0 316 8.75e-109 325.0 sp|A7YY46|PNKD_BOVIN Probable thioesterase PNKD OS=Bos taurus OX=9913 GN=PNKD PE=2 SV=1 PNKD_BOVIN reviewed Probable thioesterase PNKD (EC 3.1.2.-) Bos taurus (Bovine) GO:0004416; GO:0005739; GO:0005886; GO:0019243; GO:0046872; GO:0046929 methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929] mitochondrion [GO:0005739]; plasma membrane [GO:0005886] hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] g19041.t1 Q863I2 59.962 522 0.0 601.0 sp|Q863I2|OXSR1_PIG Serine/threonine-protein kinase OSR1 OS=Sus scrofa OX=9823 GN=OXSR1 PE=2 SV=1 g19043.t1 Q9EP75 33.922 510 5.1e-94 298.0 sp|Q9EP75|CP4FE_MOUSE Leukotriene-B4 omega-hydroxylase 3 OS=Mus musculus OX=10090 GN=Cyp4f14 PE=1 SV=1 g19044.t1 P51871 37.313 469 1.19e-97 308.0 sp|P51871|CP4F6_RAT Cytochrome P450 4F6 OS=Rattus norvegicus OX=10116 GN=Cyp4f6 PE=2 SV=1 g19045.t1 Q29121 46.337 505 1.14e-160 479.0 sp|Q29121|GALT1_PIG Polypeptide N-acetylgalactosaminyltransferase 1 OS=Sus scrofa OX=9823 GN=GALNT1 PE=1 SV=1 GALT1_PIG reviewed Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form] Sus scrofa (Pig) GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580 protein O-linked glycosylation [GO:0006493] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] g19046.t1 Q8BGC3 28.191 376 2.66e-34 137.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g19047.t1 P48999 31.095 685 6.32e-109 347.0 sp|P48999|LOX5_MOUSE Polyunsaturated fatty acid 5-lipoxygenase OS=Mus musculus OX=10090 GN=Alox5 PE=1 SV=3 LOX5_MOUSE reviewed Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34) Mus musculus (Mouse) GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005654; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030425; GO:0030501; GO:0031965; GO:0034440; GO:0036336; GO:0036403; GO:0042383; GO:0042593; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904999; GO:2001301 arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383] arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506] g19048.t1 P09917 31.479 683 1.62e-102 330.0 sp|P09917|LOX5_HUMAN Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2 LOX5_HUMAN reviewed Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34) Homo sapiens (Human) GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016491; GO:0016525; GO:0016701; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301 arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774] arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701] g19051.t1 P97292 27.744 328 6.34e-24 104.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g19052.t1 P46336 31.09 312 3.8900000000000005e-37 138.0 sp|P46336|IOLS_BACSU Aldo-keto reductase IolS OS=Bacillus subtilis (strain 168) OX=224308 GN=iolS PE=1 SV=1 g19053.t1 B0VXE6 47.291 886 0.0 849.0 sp|B0VXE6|CFA69_CALJA Cilia- and flagella-associated protein 69 OS=Callithrix jacchus OX=9483 GN=CFAP69 PE=3 SV=1 g19055.t1 Q2PC93 40.576 1459 0.0 1074.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 31.215 724 1.43e-64 251.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 39.257 377 5.509999999999999e-60 236.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 32.95 695 2.7900000000000003e-56 224.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 37.594 399 4.54e-50 203.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 32.987 385 1.32e-38 165.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 32.687 361 2.8099999999999998e-34 151.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 32.124 386 2.85e-33 147.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 32.134 389 9.510000000000001e-33 146.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 35.599 309 2.8099999999999998e-30 137.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t1 Q2PC93 32.986 288 6.46e-26 123.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 38.133 1660 0.0 1079.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 31.215 724 1.0800000000000001e-64 251.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 39.257 377 4.5699999999999997e-60 236.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 32.95 695 1.54e-56 224.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 37.594 399 3.19e-50 204.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 32.687 361 2.18e-34 151.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 32.124 386 2.4500000000000002e-33 148.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 32.134 389 7.83e-33 146.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 35.599 309 2.28e-30 138.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19055.t2 Q2PC93 32.986 288 5.1000000000000005e-26 124.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19056.t1 P25100 29.747 316 4.6599999999999993e-23 103.0 sp|P25100|ADA1D_HUMAN Alpha-1D adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1D PE=1 SV=2 ADA1D_HUMAN reviewed Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a) Homo sapiens (Human) GO:0004937; GO:0005886; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0008284; GO:0042802; GO:0043410; GO:0045907; GO:0071880; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907] plasma membrane [GO:0005886] alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802] g19057.t1 Q2PC93 38.512 1667 0.0 1056.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19057.t1 Q2PC93 35.604 323 2.64e-35 154.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19057.t2 Q2PC93 40.671 1431 0.0 1000.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19057.t2 Q2PC93 35.604 323 2.7700000000000003e-35 154.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19057.t2 Q2PC93 28.61 367 1.05e-31 142.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19057.t2 Q2PC93 26.359 368 1.72e-22 111.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19057.t3 Q2PC93 37.395 1666 0.0 1009.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19057.t3 Q2PC93 31.464 321 5.400000000000001e-26 123.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 30.211 1420 4.0700000000000005e-110 401.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 31.161 844 9.58e-88 327.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 29.597 794 7.76e-61 238.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 35.604 455 2.39e-56 223.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 33.591 518 6.99e-54 215.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 34.146 451 6.390000000000001e-43 179.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 32.614 417 9.46e-36 155.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 30.425 447 6.440000000000001e-35 152.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 30.019 533 9.459999999999999e-34 149.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 36.555 238 3.13e-32 144.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 32.282 412 5.96e-31 139.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 30.753 478 1.6499999999999999e-28 131.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 33.069 378 1.8600000000000002e-26 124.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19058.t1 Q2PC93 34.058 276 2.61e-21 107.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 33.575 551 1.8299999999999999e-62 227.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 32.028 434 7.52e-39 157.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 33.634 333 6.41e-38 154.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 36.806 288 6.06e-37 151.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 31.928 332 4.22e-34 142.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 32.18 289 2.08e-33 140.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 28.635 447 1.03e-31 135.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 29.333 300 4.03e-21 102.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19060.t1 Q2PC93 30.034 293 5.670000000000001e-21 101.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g19062.t1 Q91XN4 38.693 199 2.47e-32 122.0 sp|Q91XN4|BAMBI_RAT BMP and activin membrane-bound inhibitor homolog OS=Rattus norvegicus OX=10116 GN=Bambi PE=2 SV=1 g19063.t1 Q9ET66 33.696 184 2.15e-22 97.8 sp|Q9ET66|PI16_MOUSE Peptidase inhibitor 16 OS=Mus musculus OX=10090 GN=Pi16 PE=1 SV=2 PI16_MOUSE reviewed Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364) Mus musculus (Mouse) GO:0005615; GO:0030414; GO:0061052 negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052] extracellular space [GO:0005615] peptidase inhibitor activity [GO:0030414] g19064.t1 P54277 52.339 342 3.24e-115 381.0 sp|P54277|PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens OX=9606 GN=PMS1 PE=1 SV=1 PMS1_HUMAN reviewed PMS1 protein homolog 1 (DNA mismatch repair protein PMS1) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032389; GO:0140664 mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410] MutLalpha complex [GO:0032389]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] g19064.t1 P54277 32.549 510 4.2e-61 229.0 sp|P54277|PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens OX=9606 GN=PMS1 PE=1 SV=1 PMS1_HUMAN reviewed PMS1 protein homolog 1 (DNA mismatch repair protein PMS1) Homo sapiens (Human) GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032389; GO:0140664 mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410] MutLalpha complex [GO:0032389]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] g19065.t1 Q5XJR6 50.0 150 8.79e-51 162.0 sp|Q5XJR6|ORML3_DANRE ORM1-like protein 3 OS=Danio rerio OX=7955 GN=ormdl3 PE=2 SV=1 g19066.t1 Q9D9M5 38.115 244 2.37e-59 191.0 sp|Q9D9M5|PHOP2_MOUSE Pyridoxal phosphate phosphatase PHOSPHO2 OS=Mus musculus OX=10090 GN=Phospho2 PE=1 SV=1 g19067.t1 Q9FHN8 44.194 577 5.2300000000000005e-121 416.0 sp|Q9FHN8|KN14E_ARATH Kinesin-like protein KIN-14E OS=Arabidopsis thaliana OX=3702 GN=KIN14E PE=1 SV=1 g19068.t1 E1BJL9 37.456 566 5.97e-86 280.0 sp|E1BJL9|CF210_BOVIN Cilia- and flagella- associated protein 210 OS=Bos taurus OX=9913 GN=CFAP210 PE=1 SV=3 g19069.t1 Q0VFE3 42.14 299 3.26e-79 247.0 sp|Q0VFE3|PGAP3_XENTR GPI-specific phospholipase A2-like PGAP3 OS=Xenopus tropicalis OX=8364 GN=pgap3 PE=2 SV=1 g19070.t1 Q80U56 59.336 241 8.18e-100 315.0 sp|Q80U56|AVL9_MOUSE Late secretory pathway protein AVL9 homolog OS=Mus musculus OX=10090 GN=Avl9 PE=1 SV=2 g19071.t1 Q80U56 51.538 260 9.79e-93 289.0 sp|Q80U56|AVL9_MOUSE Late secretory pathway protein AVL9 homolog OS=Mus musculus OX=10090 GN=Avl9 PE=1 SV=2 g19072.t1 O08651 50.562 534 1.09e-180 521.0 sp|O08651|SERA_RAT D-3-phosphoglycerate dehydrogenase OS=Rattus norvegicus OX=10116 GN=Phgdh PE=1 SV=3 SERA_RAT reviewed D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) Rattus norvegicus (Rat) GO:0004617; GO:0006541; GO:0006544; GO:0006563; GO:0006564; GO:0006566; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0022008; GO:0031175; GO:0051287; GO:0070314 G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566] NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617] g19077.t1 O57683 80.558 1327 0.0 2144.0 sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1 g19077.t2 O57683 80.604 1325 0.0 2144.0 sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1 g19078.t1 Q5I0I9 64.088 181 8.890000000000001e-80 242.0 sp|Q5I0I9|CQ10B_RAT Coenzyme Q-binding protein COQ10 homolog B, mitochondrial OS=Rattus norvegicus OX=10116 GN=Coq10b PE=2 SV=2 g19082.t1 Q5C9Z4 45.167 538 5.969999999999999e-172 523.0 sp|Q5C9Z4|NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NOM1 PE=1 SV=1 NOM1_HUMAN reviewed Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) Homo sapiens (Human) GO:0003723; GO:0005730; GO:0042274; GO:0048820 hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274] nucleolus [GO:0005730] RNA binding [GO:0003723] g3021.t1 B4F7A7 39.468 489 1.92e-80 261.0 sp|B4F7A7|CEP57_RAT Centrosomal protein of 57 kDa OS=Rattus norvegicus OX=10116 GN=Cep57 PE=1 SV=2 CEP57_RAT reviewed Centrosomal protein of 57 kDa (Cep57) (Translokin) Rattus norvegicus (Rat) GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260 fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634] fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] g3022.t1 Q6PAM1 54.447 371 3.95e-120 362.0 sp|Q6PAM1|TXLNA_MOUSE Alpha-taxilin OS=Mus musculus OX=10090 GN=Txlna PE=1 SV=1 g3023.t1 Q07243 59.779 271 1.9400000000000002e-107 338.0 sp|Q07243|MTF1_MOUSE Metal regulatory transcription factor 1 OS=Mus musculus OX=10090 GN=Mtf1 PE=1 SV=2 MTF1_MOUSE reviewed Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mus musculus (Mouse) GO:0000978; GO:0000987; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006979; GO:0007417; GO:0008270; GO:0035035; GO:0045893; GO:0045944; GO:0046686; GO:0071294; GO:1990079; GO:1990837 cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; DNA-templated transcription [GO:0006351]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone acetyltransferase binding [GO:0035035]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g3024.t1 Q5ZJ65 59.032 310 7.66e-120 350.0 sp|Q5ZJ65|FA76A_CHICK Protein FAM76A OS=Gallus gallus OX=9031 GN=FAM76A PE=2 SV=1 g3025.t1 A0A1L8HCK2 62.021 287 2.96e-139 397.0 sp|A0A1L8HCK2|C298A_XENLA Cilia- and flagella-associated protein 298-A OS=Xenopus laevis OX=8355 GN=cfap298-a PE=2 SV=1 g3026.t1 P58659 29.446 343 5.109999999999999e-38 146.0 sp|P58659|EVA1C_MOUSE Protein eva-1 homolog C OS=Mus musculus OX=10090 GN=Eva1c PE=2 SV=2 g3026.t2 P58659 30.464 302 2.16e-39 149.0 sp|P58659|EVA1C_MOUSE Protein eva-1 homolog C OS=Mus musculus OX=10090 GN=Eva1c PE=2 SV=2 g3026.t3 P58659 34.928 209 4.23e-36 141.0 sp|P58659|EVA1C_MOUSE Protein eva-1 homolog C OS=Mus musculus OX=10090 GN=Eva1c PE=2 SV=2 g3027.t1 Q8N2I9 64.428 402 2.2500000000000003e-179 517.0 sp|Q8N2I9|STK40_HUMAN Serine/threonine-protein kinase 40 OS=Homo sapiens OX=9606 GN=STK40 PE=1 SV=2 g3029.t1 Q2HJI0 49.573 234 7.630000000000001e-75 233.0 sp|Q2HJI0|RM19_BOVIN Large ribosomal subunit protein bL19m OS=Bos taurus OX=9913 GN=MRPL19 PE=1 SV=1 g3030.t1 Q9QZQ1 43.188 1035 0.0 800.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g3030.t1 Q9QZQ1 42.654 211 8.28e-34 147.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g3030.t2 Q9QZQ1 44.478 996 0.0 809.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g3030.t2 Q9QZQ1 42.654 211 6.49e-34 147.0 sp|Q9QZQ1|AFAD_MOUSE Afadin OS=Mus musculus OX=10090 GN=Afdn PE=1 SV=3 AFAD_MOUSE reviewed Afadin (Afadin adherens junction formation factor) (Protein Af-6) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0016607; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049 adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; axon [GO:0030424]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; LIM domain binding [GO:0030274]; small GTPase binding [GO:0031267] g3031.t1 A1ZAY1 35.014 357 9.030000000000001e-58 191.0 sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1 DLISH_DROME reviewed SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains) Drosophila melanogaster (Fruit fly) GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219 establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251] apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219] cadherin binding [GO:0045296] g3032.t1 Q8BL99 51.813 579 7.790000000000001e-173 579.0 sp|Q8BL99|DOP1A_MOUSE Protein DOP1A OS=Mus musculus OX=10090 GN=Dop1a PE=1 SV=2 g3032.t1 Q8BL99 39.711 277 3.53e-47 190.0 sp|Q8BL99|DOP1A_MOUSE Protein DOP1A OS=Mus musculus OX=10090 GN=Dop1a PE=1 SV=2 g3033.t1 Q5JWR5 43.166 1017 0.0 787.0 sp|Q5JWR5|DOP1A_HUMAN Protein DOP1A OS=Homo sapiens OX=9606 GN=DOP1A PE=1 SV=1 DOP1A_HUMAN reviewed Protein DOP1A Homo sapiens (Human) GO:0000139; GO:0005768; GO:0005798; GO:0005802; GO:0005829; GO:0006895; GO:0015031 Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; trans-Golgi network [GO:0005802] g3035.t1 Q8IYF3 33.225 921 1.09e-153 480.0 sp|Q8IYF3|TEX11_HUMAN Testis-expressed protein 11 OS=Homo sapiens OX=9606 GN=TEX11 PE=1 SV=3 TEX11_HUMAN reviewed Testis-expressed protein 11 (Protein ZIP4 homolog) (ZIP4H) Homo sapiens (Human) GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0006915; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0035234; GO:0043066; GO:0051026; GO:0051093; GO:2000242 apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694] g3035.t2 Q8IYF3 32.15 958 6.04e-147 463.0 sp|Q8IYF3|TEX11_HUMAN Testis-expressed protein 11 OS=Homo sapiens OX=9606 GN=TEX11 PE=1 SV=3 TEX11_HUMAN reviewed Testis-expressed protein 11 (Protein ZIP4 homolog) (ZIP4H) Homo sapiens (Human) GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0006915; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0035234; GO:0043066; GO:0051026; GO:0051093; GO:2000242 apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694] g3041.t1 A1YFX9 54.217 83 8.300000000000001e-26 98.2 sp|A1YFX9|HTAI2_PANPA Protein HTATIP2 OS=Pan paniscus OX=9597 GN=HTATIP2 PE=3 SV=1 g3058.t1 Q4R367 48.306 797 0.0 782.0 sp|Q4R367|UFL1_MACFA E3 UFM1-protein ligase 1 OS=Macaca fascicularis OX=9541 GN=UFL1 PE=2 SV=1 UFL1_MACFA reviewed E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000077; GO:0002841; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0010508; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032790; GO:0033146; GO:0034976; GO:0035861; GO:0043122; GO:0050727; GO:0050868; GO:0060218; GO:0061666; GO:0061709; GO:0071569; GO:0072344; GO:0140501; GO:1903895; GO:1990592 DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of autophagy [GO:0010508]; positive regulation of reticulophagy [GO:0140501]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; rescue of stalled ribosome [GO:0072344]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] UFM1 ligase activity [GO:0061666] g3059.t1 Q8IXY8 49.306 288 1.2e-102 305.0 sp|Q8IXY8|PPIL6_HUMAN Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 OS=Homo sapiens OX=9606 GN=PPIL6 PE=1 SV=1 g3060.t1 Q9UMY4 76.101 159 6.35e-92 267.0 sp|Q9UMY4|SNX12_HUMAN Sorting nexin-12 OS=Homo sapiens OX=9606 GN=SNX12 PE=1 SV=4 g3061.t1 Q3V384 54.126 412 1.1e-158 462.0 sp|Q3V384|AFG1L_MOUSE AFG1-like ATPase OS=Mus musculus OX=10090 GN=Afg1l PE=1 SV=1 g3062.t1 Q9Y466 56.477 386 2.89e-148 428.0 sp|Q9Y466|NR2E1_HUMAN Nuclear receptor subfamily 2 group E member 1 OS=Homo sapiens OX=9606 GN=NR2E1 PE=1 SV=1 g3063.t1 P82925 33.333 405 1e-50 177.0 sp|P82925|RT31_BOVIN Small ribosomal subunit protein mS31 OS=Bos taurus OX=9913 GN=MRPS31 PE=1 SV=3 g3064.t1 Q8BGT0 32.669 251 1.6000000000000002e-35 135.0 sp|Q8BGT0|OSTM1_MOUSE Osteopetrosis-associated transmembrane protein 1 OS=Mus musculus OX=10090 GN=Ostm1 PE=1 SV=1 OSTM1_MOUSE reviewed Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit) (Grey-lethal protein) Mus musculus (Mouse) GO:0005765; GO:0005829; GO:0030316; GO:0030321; GO:0034707 osteoclast differentiation [GO:0030316]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765] g3065.t1 Q52KD8 44.681 235 5.7e-47 157.0 sp|Q52KD8|EAF6_XENLA Chromatin modification-related protein MEAF6 OS=Xenopus laevis OX=8355 GN=meaf6 PE=2 SV=1 g3066.t1 Q8BQJ6 47.653 426 3.03e-137 408.0 sp|Q8BQJ6|TRM2B_MOUSE tRNA (uracil-5-)-methyltransferase homolog B OS=Mus musculus OX=10090 GN=Trmt2b PE=1 SV=1 g3067.t1 Q9YGL3 44.499 409 1.73e-112 338.0 sp|Q9YGL3|NR2E1_ORYLA Nuclear receptor subfamily 2 group E member 1 OS=Oryzias latipes OX=8090 GN=nr2e1 PE=2 SV=1 g3067.t2 Q9YGL3 44.581 406 2.4e-112 337.0 sp|Q9YGL3|NR2E1_ORYLA Nuclear receptor subfamily 2 group E member 1 OS=Oryzias latipes OX=8090 GN=nr2e1 PE=2 SV=1 g3068.t1 Q9DC48 58.434 498 0.0 568.0 sp|Q9DC48|PRP17_MOUSE Pre-mRNA-processing factor 17 OS=Mus musculus OX=10090 GN=Cdc40 PE=1 SV=1 g3068.t2 Q9DC48 58.98 490 0.0 564.0 sp|Q9DC48|PRP17_MOUSE Pre-mRNA-processing factor 17 OS=Mus musculus OX=10090 GN=Cdc40 PE=1 SV=1 g3069.t1 Q9Z2A5 47.544 509 6.22e-151 442.0 sp|Q9Z2A5|ATE1_MOUSE Arginyl-tRNA--protein transferase 1 OS=Mus musculus OX=10090 GN=Ate1 PE=1 SV=2 g3069.t2 O95260 44.587 545 8.540000000000001e-144 426.0 sp|O95260|ATE1_HUMAN Arginyl-tRNA--protein transferase 1 OS=Homo sapiens OX=9606 GN=ATE1 PE=1 SV=2 ATE1_HUMAN reviewed Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1) Homo sapiens (Human) GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0006979; GO:0010498; GO:0016598; GO:0071596 proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; nucleus [GO:0005634] arginyl-tRNA--protein transferase activity [GO:0004057] g3070.t1 Q01196 40.438 502 2.09e-83 269.0 sp|Q01196|RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3 RUNX1_HUMAN reviewed Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203 cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222] g3071.t1 O75486 42.803 264 7.7e-66 211.0 sp|O75486|SUPT3_HUMAN Transcription initiation protein SPT3 homolog OS=Homo sapiens OX=9606 GN=SUPT3H PE=1 SV=3 g3071.t2 O75486 42.803 264 7.71e-66 211.0 sp|O75486|SUPT3_HUMAN Transcription initiation protein SPT3 homolog OS=Homo sapiens OX=9606 GN=SUPT3H PE=1 SV=3 g3073.t1 Q6ZTR5 36.954 1648 0.0 1104.0 sp|Q6ZTR5|CFA47_HUMAN Cilia- and flagella-associated protein 47 OS=Homo sapiens OX=9606 GN=CFAP47 PE=1 SV=5 CFA47_HUMAN reviewed Cilia- and flagella-associated protein 47 Homo sapiens (Human) GO:0005929; GO:0007288; GO:0060271; GO:0120212 cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288] cilium [GO:0005929]; sperm head-tail coupling apparatus [GO:0120212] g3073.t2 Q6ZTR5 37.179 1638 0.0 1110.0 sp|Q6ZTR5|CFA47_HUMAN Cilia- and flagella-associated protein 47 OS=Homo sapiens OX=9606 GN=CFAP47 PE=1 SV=5 CFA47_HUMAN reviewed Cilia- and flagella-associated protein 47 Homo sapiens (Human) GO:0005929; GO:0007288; GO:0060271; GO:0120212 cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288] cilium [GO:0005929]; sperm head-tail coupling apparatus [GO:0120212] g3074.t1 A0A0G2JEB6 33.046 1625 0.0 872.0 sp|A0A0G2JEB6|CFA47_MOUSE Cilia and flagella-associated protein 47 OS=Mus musculus OX=10090 GN=Cfap47 PE=1 SV=2 g3075.t1 Q80Y75 60.635 315 1.66e-134 386.0 sp|Q80Y75|DJB13_MOUSE DnaJ homolog subfamily B member 13 OS=Mus musculus OX=10090 GN=Dnajb13 PE=1 SV=1 DJB13_MOUSE reviewed DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein) Mus musculus (Mouse) GO:0001534; GO:0003351; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006457; GO:0007618; GO:0030317; GO:0031514; GO:0036126; GO:0051082; GO:0051087; GO:0097729; GO:0120212; GO:1904158 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; protein folding [GO:0006457] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212] protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] g3079.t1 Q9QX47 45.413 218 7.77e-51 191.0 sp|Q9QX47|SON_MOUSE Protein SON OS=Mus musculus OX=10090 GN=Son PE=1 SV=2 SON_MOUSE reviewed Protein SON (Negative regulatory element-binding protein) (NRE-binding protein) Mus musculus (Mouse) GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0050733; GO:0051726 microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] nuclear speck [GO:0016607] DNA binding [GO:0003677]; RNA binding [GO:0003723]; RS domain binding [GO:0050733] g3080.t1 Q9QXP4 33.443 610 4.34e-90 293.0 sp|Q9QXP4|DONS_MOUSE Protein downstream neighbor of Son OS=Mus musculus OX=10090 GN=Donson PE=1 SV=2 g3081.t1 Q7RTX9 27.347 490 2.04e-37 147.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g3083.t1 Q90632 33.182 220 2.3600000000000002e-32 133.0 sp|Q90632|MOT3_CHICK Monocarboxylate transporter 3 OS=Gallus gallus OX=9031 GN=SLC16A8 PE=1 SV=3 g3084.t1 Q9WVS6 47.863 468 4.36e-149 435.0 sp|Q9WVS6|PRKN_MOUSE E3 ubiquitin-protein ligase parkin OS=Mus musculus OX=10090 GN=Prkn PE=1 SV=1 g3085.t1 Q80YA9 38.276 290 1.0899999999999999e-55 214.0 sp|Q80YA9|CNKR2_MOUSE Connector enhancer of kinase suppressor of ras 2 OS=Mus musculus OX=10090 GN=Cnksr2 PE=1 SV=1 CNKR2_MOUSE reviewed Connector enhancer of kinase suppressor of ras 2 (Connector enhancer of KSR 2) (CNK homolog protein 2) (CNK2) Mus musculus (Mouse) GO:0005737; GO:0005886; GO:0009966; GO:0014069; GO:0019901; GO:0035556; GO:0042802; GO:0043025; GO:0045211; GO:0098978; GO:0099084; GO:0099147; GO:0099173 intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; postsynaptic specialization organization [GO:0099084]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901] g3085.t1 Q80YA9 44.262 122 6.55e-29 129.0 sp|Q80YA9|CNKR2_MOUSE Connector enhancer of kinase suppressor of ras 2 OS=Mus musculus OX=10090 GN=Cnksr2 PE=1 SV=1 CNKR2_MOUSE reviewed Connector enhancer of kinase suppressor of ras 2 (Connector enhancer of KSR 2) (CNK homolog protein 2) (CNK2) Mus musculus (Mouse) GO:0005737; GO:0005886; GO:0009966; GO:0014069; GO:0019901; GO:0035556; GO:0042802; GO:0043025; GO:0045211; GO:0098978; GO:0099084; GO:0099147; GO:0099173 intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; postsynaptic specialization organization [GO:0099084]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] identical protein binding [GO:0042802]; protein kinase binding [GO:0019901] g3086.t1 Q5ZI57 70.556 180 1.19e-97 283.0 sp|Q5ZI57|TPPC3_CHICK Trafficking protein particle complex subunit 3 OS=Gallus gallus OX=9031 GN=TRAPPC3 PE=2 SV=1 g3087.t1 Q9CYK1 55.442 294 5.92e-117 345.0 sp|Q9CYK1|SYWM_MOUSE Tryptophan--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Wars2 PE=1 SV=2 g3087.t2 Q9CYK1 55.442 294 1.46e-116 345.0 sp|Q9CYK1|SYWM_MOUSE Tryptophan--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Wars2 PE=1 SV=2 g3088.t1 Q9Y6R4 59.655 290 2.11e-110 353.0 sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2 M3K4_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Homo sapiens (Human) GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745 chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] g3089.t1 Q9Y6R4 33.86 1267 2.69e-177 573.0 sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2 M3K4_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Homo sapiens (Human) GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745 chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] g3093.t1 Q5FW12 56.452 248 5.74e-101 298.0 sp|Q5FW12|TIPRL_XENTR TIP41-like protein OS=Xenopus tropicalis OX=8364 GN=tiprl PE=2 SV=1 g3094.t1 Q68EV5 35.417 288 7.81e-42 147.0 sp|Q68EV5|CMS1_XENLA Protein CMSS1 OS=Xenopus laevis OX=8355 GN=cmss1 PE=2 SV=1 g3095.t1 O09173 71.889 434 0.0 672.0 sp|O09173|HGD_MOUSE Homogentisate 1,2-dioxygenase OS=Mus musculus OX=10090 GN=Hgd PE=1 SV=2 HGD_MOUSE reviewed Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase) Mus musculus (Mouse) GO:0004411; GO:0006520; GO:0006559; GO:0006572; GO:0042802; GO:0046872 amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; L-tyrosine catabolic process [GO:0006572] homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g3097.t1 Q6P988 48.469 392 8.56e-133 394.0 sp|Q6P988|NOTUM_HUMAN Palmitoleoyl-protein carboxylesterase NOTUM OS=Homo sapiens OX=9606 GN=NOTUM PE=1 SV=2 NOTUM_HUMAN reviewed Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (hNOTUM) Homo sapiens (Human) GO:0004629; GO:0005576; GO:0005788; GO:0016055; GO:0030178; GO:0030500; GO:0060348; GO:0090090; GO:0140776; GO:1990697; GO:1990699 bone development [GO:0060348]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; regulation of bone mineralization [GO:0030500]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] palmitoleyl hydrolase activity [GO:1990699]; phospholipase C activity [GO:0004629]; protein-containing complex destabilizing activity [GO:0140776] g3097.t2 Q6P988 49.604 379 9.160000000000001e-132 393.0 sp|Q6P988|NOTUM_HUMAN Palmitoleoyl-protein carboxylesterase NOTUM OS=Homo sapiens OX=9606 GN=NOTUM PE=1 SV=2 NOTUM_HUMAN reviewed Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (hNOTUM) Homo sapiens (Human) GO:0004629; GO:0005576; GO:0005788; GO:0016055; GO:0030178; GO:0030500; GO:0060348; GO:0090090; GO:0140776; GO:1990697; GO:1990699 bone development [GO:0060348]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; regulation of bone mineralization [GO:0030500]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] palmitoleyl hydrolase activity [GO:1990699]; phospholipase C activity [GO:0004629]; protein-containing complex destabilizing activity [GO:0140776] g3100.t1 Q9V3D2 69.88 166 3.7000000000000004e-85 258.0 sp|Q9V3D2|HEM6_DROME Oxygen-dependent coproporphyrinogen-III oxidase OS=Drosophila melanogaster OX=7227 GN=Coprox PE=2 SV=1 g3104.t1 Q9V3D2 63.441 93 1.25e-36 130.0 sp|Q9V3D2|HEM6_DROME Oxygen-dependent coproporphyrinogen-III oxidase OS=Drosophila melanogaster OX=7227 GN=Coprox PE=2 SV=1 g3106.t1 Q1JPJ2 34.971 692 2.5800000000000003e-123 386.0 sp|Q1JPJ2|XPP1_BOVIN Xaa-Pro aminopeptidase 1 OS=Bos taurus OX=9913 GN=XPNPEP1 PE=2 SV=1 g3108.t1 Q6P1B1 42.573 653 1.92e-164 491.0 sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1 g3108.t2 Q6P1B1 41.871 652 1.72e-158 475.0 sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1 g3108.t3 Q6P1B1 41.742 666 4.2900000000000004e-161 483.0 sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1 g3109.t1 F1NV61 43.662 284 2.37e-77 243.0 sp|F1NV61|CASP7_CHICK Caspase-7 OS=Gallus gallus OX=9031 GN=CASP7 PE=3 SV=2 CASP7_CHICK reviewed Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] Gallus gallus (Chicken) GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0043525; GO:0070227; GO:0097194; GO:1905686 apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723] g3110.t1 F1NV61 46.4 250 1.0199999999999999e-74 236.0 sp|F1NV61|CASP7_CHICK Caspase-7 OS=Gallus gallus OX=9031 GN=CASP7 PE=3 SV=2 CASP7_CHICK reviewed Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] Gallus gallus (Chicken) GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0043525; GO:0070227; GO:0097194; GO:1905686 apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723] g3111.t1 C9WPN6 86.652 457 0.0 817.0 sp|C9WPN6|IF2H_RAT Eukaryotic translation initiation factor 2 subunit 3, Y-linked OS=Rattus norvegicus OX=10116 GN=Eif2s3y PE=2 SV=2 IF2H_RAT reviewed Eukaryotic translation initiation factor 2 subunit 3, Y-linked (EC 3.6.5.3) (Eukaryotic translation initiation factor 2 subunit gamma, Y-linked) (eIF-2-gamma Y) Rattus norvegicus (Rat) GO:0000049; GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005850; GO:0007283; GO:2000020 formation of translation preinitiation complex [GO:0001731]; positive regulation of male gonad development [GO:2000020]; spermatogenesis [GO:0007283] eukaryotic translation initiation factor 2 complex [GO:0005850] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] g3112.t1 Q9VCA2 41.446 567 3.1599999999999998e-136 410.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3112.t2 Q9VCA2 42.329 541 2.06e-134 404.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3113.t1 Q68FG0 54.795 219 1.69e-75 230.0 sp|Q68FG0|ZC4H2_MOUSE Zinc finger C4H2 domain-containing protein OS=Mus musculus OX=10090 GN=Zc4h2 PE=2 SV=1 ZC4H2_MOUSE reviewed Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127 homolog) Mus musculus (Mouse) GO:0003358; GO:0005634; GO:0005737; GO:0006513; GO:0007399; GO:0007528; GO:0008270; GO:0021522; GO:0032991; GO:0043025; GO:0045211; GO:0045666 nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; noradrenergic neuron development [GO:0003358]; positive regulation of neuron differentiation [GO:0045666]; protein monoubiquitination [GO:0006513]; spinal cord motor neuron differentiation [GO:0021522] cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991] zinc ion binding [GO:0008270] g3116.t1 Q5U5R9 31.716 804 7.06e-106 346.0 sp|Q5U5R9|HECD2_HUMAN Probable E3 ubiquitin-protein ligase HECTD2 OS=Homo sapiens OX=9606 GN=HECTD2 PE=1 SV=2 HECD2_HUMAN reviewed Probable E3 ubiquitin-protein ligase HECTD2 (EC 2.3.2.26) (HECT domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECTD2) Homo sapiens (Human) GO:0000209; GO:0005829; GO:0061630 protein polyubiquitination [GO:0000209] cytosol [GO:0005829] ubiquitin protein ligase activity [GO:0061630] g3117.t1 Q99ND9 46.835 237 1.32e-51 169.0 sp|Q99ND9|RWDD1_RAT RWD domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Rwdd1 PE=2 SV=1 g3118.t1 O61577 66.344 517 0.0 676.0 sp|O61577|KTNA1_STRPU Katanin p60 ATPase-containing subunit A1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNA1 PE=1 SV=1 g3119.t1 Q95LD9 45.393 445 1.4100000000000002e-122 403.0 sp|Q95LD9|AHR_DELLE Aryl hydrocarbon receptor OS=Delphinapterus leucas OX=9749 GN=AHR PE=2 SV=1 AHR_DELLE reviewed Aryl hydrocarbon receptor (Ah receptor) (AhR) Delphinapterus leucas (Beluga whale) GO:0001094; GO:0001223; GO:0002819; GO:0002841; GO:0004879; GO:0005634; GO:0005737; GO:0005829; GO:0006805; GO:0009410; GO:0009636; GO:0017025; GO:0030888; GO:0032922; GO:0034753; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0060729; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837 cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; intestinal epithelial structure maintenance [GO:0060729]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleus [GO:0005634] E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator binding [GO:0001223] g3121.t1 Q9C102 53.263 2084 0.0 2177.0 sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1 GLT1_SCHPO reviewed Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT) Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) GO:0005506; GO:0005759; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054 ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759] 3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639] g3123.t1 O94885 43.919 148 1.4099999999999999e-24 115.0 sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3 SASH1_HUMAN reviewed SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) Homo sapiens (Human) GO:0000209; GO:0001965; GO:0005654; GO:0005737; GO:0005829; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] g3123.t2 O94885 43.919 148 1.8899999999999998e-24 115.0 sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3 SASH1_HUMAN reviewed SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) Homo sapiens (Human) GO:0000209; GO:0001965; GO:0005654; GO:0005737; GO:0005829; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] g3123.t3 O94885 43.919 148 1.84e-24 115.0 sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3 SASH1_HUMAN reviewed SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) Homo sapiens (Human) GO:0000209; GO:0001965; GO:0005654; GO:0005737; GO:0005829; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] g3123.t4 O94885 43.919 148 1.84e-24 115.0 sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3 SASH1_HUMAN reviewed SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) Homo sapiens (Human) GO:0000209; GO:0001965; GO:0005654; GO:0005737; GO:0005829; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] g3123.t5 O94885 43.919 148 1.3e-24 115.0 sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3 SASH1_HUMAN reviewed SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) Homo sapiens (Human) GO:0000209; GO:0001965; GO:0005654; GO:0005737; GO:0005829; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] g3123.t6 O94885 43.919 148 1.3399999999999999e-24 115.0 sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3 SASH1_HUMAN reviewed SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) Homo sapiens (Human) GO:0000209; GO:0001965; GO:0005654; GO:0005737; GO:0005829; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] g3123.t7 O94885 43.919 148 1.84e-24 115.0 sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3 SASH1_HUMAN reviewed SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) Homo sapiens (Human) GO:0000209; GO:0001965; GO:0005654; GO:0005737; GO:0005829; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] g3124.t1 Q6ZN17 47.159 176 1.08e-42 147.0 sp|Q6ZN17|LN28B_HUMAN Protein lin-28 homolog B OS=Homo sapiens OX=9606 GN=LIN28B PE=1 SV=1 LN28B_HUMAN reviewed Protein lin-28 homolog B (Lin-28B) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010587; GO:0031054; GO:0031123; GO:0050779; GO:1990837; GO:2000627; GO:2000632; GO:2000635 miRNA catabolic process [GO:0010587]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of primary miRNA processing [GO:2000635]; positive regulation of miRNA catabolic process [GO:2000627]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA destabilization [GO:0050779] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g3128.t1 P11717 38.162 2340 0.0 1410.0 sp|P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3 MPRI_HUMAN reviewed Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) Homo sapiens (Human) GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated activation of viral process [GO:0044794]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] g3128.t1 P11717 28.037 1391 1.94e-112 405.0 sp|P11717|MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens OX=9606 GN=IGF2R PE=1 SV=3 MPRI_HUMAN reviewed Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) Homo sapiens (Human) GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated activation of viral process [GO:0044794]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] g3129.t1 Q5TH69 37.553 1651 0.0 982.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3129.t1 Q5TH69 42.171 479 1.25e-84 314.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3129.t2 Q5TH69 37.553 1651 0.0 983.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3129.t2 Q5TH69 40.619 517 7.72e-83 308.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3129.t3 Q5TH69 37.553 1651 0.0 982.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3129.t3 Q5TH69 40.668 509 8.68e-83 308.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3129.t4 Q5TH69 37.553 1651 0.0 983.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3129.t4 Q5TH69 40.619 517 8.289999999999999e-82 305.0 sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3 BIG3_HUMAN reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) Homo sapiens (Human) GO:0005085; GO:0030658; GO:0032012 regulation of ARF protein signal transduction [GO:0032012] transport vesicle membrane [GO:0030658] guanyl-nucleotide exchange factor activity [GO:0005085] g3130.t1 Q80ZK9 51.857 700 0.0 692.0 sp|Q80ZK9|WDTC1_MOUSE WD and tetratricopeptide repeats protein 1 OS=Mus musculus OX=10090 GN=Wdtc1 PE=1 SV=1 WDTC1_MOUSE reviewed WD and tetratricopeptide repeats protein 1 Mus musculus (Mouse) GO:0000122; GO:0001701; GO:0004857; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082; GO:0080008 cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; intracellular chemical homeostasis [GO:0055082]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826] g3131.t1 Q5ZK69 49.361 391 1.38e-144 419.0 sp|Q5ZK69|PAAF1_CHICK Proteasomal ATPase-associated factor 1 OS=Gallus gallus OX=9031 GN=PAAF1 PE=2 SV=1 g3134.t1 Q9BG94 41.026 117 2.41e-22 94.0 sp|Q9BG94|NR0B1_CALJA Nuclear receptor subfamily 0 group B member 1 OS=Callithrix jacchus OX=9483 GN=NR0B1 PE=2 SV=1 g3135.t1 Q80Y44 61.63 503 0.0 678.0 sp|Q80Y44|DDX10_MOUSE Probable ATP-dependent RNA helicase DDX10 OS=Mus musculus OX=10090 GN=Ddx10 PE=1 SV=2 g3135.t1 Q80Y44 32.331 266 3.1700000000000002e-27 123.0 sp|Q80Y44|DDX10_MOUSE Probable ATP-dependent RNA helicase DDX10 OS=Mus musculus OX=10090 GN=Ddx10 PE=1 SV=2 g3136.t1 P42674 43.556 225 1.13e-48 179.0 sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1 g3137.t1 B3DLF3 54.651 86 3.95e-28 100.0 sp|B3DLF3|LYRM2_XENTR LYR motif-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=lyrm2 PE=3 SV=1 g3138.t1 Q17QU4 57.547 212 7.339999999999999e-89 264.0 sp|Q17QU4|RB39B_BOVIN Ras-related protein Rab-39B OS=Bos taurus OX=9913 GN=RAB39B PE=2 SV=1 RB39B_BOVIN reviewed Ras-related protein Rab-39B (EC 3.6.5.2) Bos taurus (Bovine) GO:0000421; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0032482; GO:0043005; GO:0046872; GO:0050808; GO:0120281 autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192] autolysosome membrane [GO:0120281]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g3139.t1 Q8IXU6 54.799 323 2.97e-114 341.0 sp|Q8IXU6|S35F2_HUMAN Solute carrier family 35 member F2 OS=Homo sapiens OX=9606 GN=SLC35F2 PE=1 SV=1 S35F2_HUMAN reviewed Queuine/queuosine transporter SLC35F2 (Solute carrier family 35 member F2) Homo sapiens (Human) GO:0005886; GO:0022857; GO:0160254; GO:0160255 tRNA queuosine(34) biosynthetic process from salvaged queuine [GO:0160255]; tRNA queuosine(34) biosynthetic process from salvaged queuosine or its precursors [GO:0160254] plasma membrane [GO:0005886] transmembrane transporter activity [GO:0022857] g3140.t1 Q6IRN2 51.143 350 7.649999999999999e-104 314.0 sp|Q6IRN2|QKIB_XENLA KH domain-containing RNA-binding protein qki.L OS=Xenopus laevis OX=8355 GN=qki.L PE=1 SV=1 g3140.t2 Q6IRN2 51.143 350 9.83e-104 314.0 sp|Q6IRN2|QKIB_XENLA KH domain-containing RNA-binding protein qki.L OS=Xenopus laevis OX=8355 GN=qki.L PE=1 SV=1 g3140.t3 Q6IRN2 52.802 339 8.21e-106 319.0 sp|Q6IRN2|QKIB_XENLA KH domain-containing RNA-binding protein qki.L OS=Xenopus laevis OX=8355 GN=qki.L PE=1 SV=1 g3141.t1 Q9DAK2 51.98 202 8.2e-64 199.0 sp|Q9DAK2|PACRG_MOUSE Parkin coregulated gene protein homolog OS=Mus musculus OX=10090 GN=Pacrg PE=1 SV=1 PACRG_MOUSE reviewed Parkin coregulated gene protein homolog (Hypertension-related protein 1-like protein) (PARK2 coregulated gene protein) Mus musculus (Mouse) GO:0001664; GO:0002177; GO:0003779; GO:0005739; GO:0005829; GO:0005879; GO:0005929; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0036126; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0097225; GO:0160112 cellular response to unfolded protein [GO:0034620]; flagellated sperm motility [GO:0030317]; intracellular protein localization [GO:0008104]; spermatid development [GO:0007286] axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; manchette [GO:0002177]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625] g3142.t1 Q6NRS1 45.455 99 5.23e-22 92.8 sp|Q6NRS1|IBTK_XENLA Inhibitor of Bruton tyrosine kinase OS=Xenopus laevis OX=8355 GN=ibtk PE=2 SV=1 g3144.t1 Q9P2D0 35.158 1169 0.0 631.0 sp|Q9P2D0|IBTK_HUMAN Inhibitor of Bruton tyrosine kinase OS=Homo sapiens OX=9606 GN=IBTK PE=1 SV=3 IBTK_HUMAN reviewed Inhibitor of Bruton tyrosine kinase (IBtk) Homo sapiens (Human) GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209 negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292] g3144.t2 Q9P2D0 35.319 1175 0.0 637.0 sp|Q9P2D0|IBTK_HUMAN Inhibitor of Bruton tyrosine kinase OS=Homo sapiens OX=9606 GN=IBTK PE=1 SV=3 IBTK_HUMAN reviewed Inhibitor of Bruton tyrosine kinase (IBtk) Homo sapiens (Human) GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209 negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292] g3148.t1 O00338 37.778 270 1.71e-53 179.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g3149.t1 Q9H9A7 35.593 236 1.7500000000000001e-31 134.0 sp|Q9H9A7|RMI1_HUMAN RecQ-mediated genome instability protein 1 OS=Homo sapiens OX=9606 GN=RMI1 PE=1 SV=3 RMI1_HUMAN reviewed RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa) (BLAP75) (FAAP75) Homo sapiens (Human) GO:0000166; GO:0000712; GO:0000724; GO:0002023; GO:0005634; GO:0005654; GO:0006260; GO:0009749; GO:0016604; GO:0031422; GO:0035264; GO:0042593; GO:0071139 DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of DNA recombination intermediates [GO:0071139]; resolution of meiotic recombination intermediates [GO:0000712]; response to glucose [GO:0009749] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422] nucleotide binding [GO:0000166] g3149.t1 Q9H9A7 44.361 133 7.24e-23 107.0 sp|Q9H9A7|RMI1_HUMAN RecQ-mediated genome instability protein 1 OS=Homo sapiens OX=9606 GN=RMI1 PE=1 SV=3 RMI1_HUMAN reviewed RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa) (BLAP75) (FAAP75) Homo sapiens (Human) GO:0000166; GO:0000712; GO:0000724; GO:0002023; GO:0005634; GO:0005654; GO:0006260; GO:0009749; GO:0016604; GO:0031422; GO:0035264; GO:0042593; GO:0071139 DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of DNA recombination intermediates [GO:0071139]; resolution of meiotic recombination intermediates [GO:0000712]; response to glucose [GO:0009749] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422] nucleotide binding [GO:0000166] g3149.t2 Q7ZVM9 28.514 498 7.68e-47 172.0 sp|Q7ZVM9|RMI1_DANRE RecQ-mediated genome instability protein 1 OS=Danio rerio OX=7955 GN=rmi1 PE=2 SV=1 g3150.t1 Q6PUR6 68.121 298 1.8e-153 434.0 sp|Q6PUR6|GPN2_DANRE GPN-loop GTPase 2 OS=Danio rerio OX=7955 GN=gpn2 PE=2 SV=1 g3151.t1 O88866 46.957 345 7.93e-93 308.0 sp|O88866|HUNK_MOUSE Hormonally up-regulated neu tumor-associated kinase OS=Mus musculus OX=10090 GN=Hunk PE=2 SV=1 g3152.t1 Q9P2C4 52.654 471 8.61e-169 488.0 sp|Q9P2C4|TM181_HUMAN Transmembrane protein 181 OS=Homo sapiens OX=9606 GN=TMEM181 PE=1 SV=3 g3152.t2 Q9P2C4 52.411 477 4.46e-170 493.0 sp|Q9P2C4|TM181_HUMAN Transmembrane protein 181 OS=Homo sapiens OX=9606 GN=TMEM181 PE=1 SV=3 g3153.t1 Q9Y493 33.092 414 1.26e-54 217.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 28.222 450 7.119999999999999e-48 195.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 30.542 406 4.47e-46 189.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 32.512 406 1.71e-44 184.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 31.266 387 1.39e-41 174.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 26.637 443 1.1500000000000001e-31 141.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 27.005 374 8.789999999999999e-30 135.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 25.0 420 3.1899999999999998e-24 117.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3153.t1 Q9Y493 24.939 413 2.83e-22 110.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3154.t1 Q80V03 42.518 548 2.3999999999999999e-150 448.0 sp|Q80V03|ADCK5_MOUSE Uncharacterized aarF domain-containing protein kinase 5 OS=Mus musculus OX=10090 GN=Adck5 PE=2 SV=2 g3155.t1 Q9NU22 54.761 2405 0.0 2612.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g3155.t2 Q9NU22 54.738 2406 0.0 2612.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g3156.t1 M9PH32 26.284 331 1.65e-24 112.0 sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1 MEI26_DROME reviewed Protein meiotic P26 Drosophila melanogaster (Fruit fly) GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0036464 protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464] ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3157.t1 Q9NU22 38.193 2490 0.0 1407.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g3157.t1 Q9NU22 24.913 859 1.94e-44 183.0 sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2 MDN1_HUMAN reviewed Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) Homo sapiens (Human) GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0045111 ribosomal large subunit assembly [GO:0000027] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] g3158.t1 Q642C0 57.143 238 3.98e-86 259.0 sp|Q642C0|DNJC8_RAT DnaJ homolog subfamily C member 8 OS=Rattus norvegicus OX=10116 GN=Dnajc8 PE=2 SV=1 g3159.t1 Q9JHI8 44.983 578 8.75e-172 503.0 sp|Q9JHI8|NOX4_MOUSE NADPH oxidase 4 OS=Mus musculus OX=10090 GN=Nox4 PE=1 SV=1 NOX4_MOUSE reviewed NADPH oxidase 4 (EC 1.6.3.1) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase) (Superoxide-generating NADPH oxidase 4) Mus musculus (Mouse) GO:0000902; GO:0001725; GO:0003015; GO:0005634; GO:0005730; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0008285; GO:0010467; GO:0010729; GO:0014911; GO:0016174; GO:0016175; GO:0016324; GO:0016529; GO:0020037; GO:0035556; GO:0042554; GO:0043020; GO:0043065; GO:0043406; GO:0045453; GO:0048471; GO:0050664; GO:0050667; GO:0051496; GO:0051897; GO:0055007; GO:0070374; GO:0071944; GO:0072341; GO:0072593; GO:0097038; GO:0106292; GO:1990782; GO:2000379; GO:2000573 bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell morphogenesis [GO:0000902]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; stress fiber [GO:0001725] heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO:0050664]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activity [GO:0106292] g3164.t1 Q7TPQ3 49.862 1089 0.0 1081.0 sp|Q7TPQ3|SHPRH_MOUSE E3 ubiquitin-protein ligase SHPRH OS=Mus musculus OX=10090 GN=Shprh PE=1 SV=1 SHPRH_MOUSE reviewed E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase) Mus musculus (Mouse) GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006334; GO:0006974; GO:0008270; GO:0016787; GO:0031625; GO:0061630 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209] nucleosome [GO:0000786]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3168.t1 Q8R326 59.531 341 1.3e-112 351.0 sp|Q8R326|PSPC1_MOUSE Paraspeckle component 1 OS=Mus musculus OX=10090 GN=Pspc1 PE=1 SV=1 g3168.t2 Q1JPY8 47.505 461 2.81e-113 351.0 sp|Q1JPY8|PSPC1_DANRE Paraspeckle component 1 OS=Danio rerio OX=7955 GN=pspc1 PE=2 SV=1 PSPC1_DANRE reviewed Paraspeckle component 1 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0005634; GO:0006355; GO:0016607; GO:0042382; GO:0042752 regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355] nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382] RNA binding [GO:0003723] g3169.t1 Q9CQ66 38.849 139 3.06e-26 101.0 sp|Q9CQ66|DYT2B_MOUSE Dynein light chain Tctex-type protein 2B OS=Mus musculus OX=10090 GN=Dynlt2b PE=1 SV=1 g3170.t1 Q6GN98 56.279 215 1.6599999999999999e-84 252.0 sp|Q6GN98|EFMT1_XENLA EEF1A lysine methyltransferase 1 OS=Xenopus laevis OX=8355 GN=eef1akmt1 PE=2 SV=1 EFMT1_XENLA reviewed EEF1A lysine methyltransferase 1 (EC 2.1.1.-) (N(6)-adenine-specific DNA methyltransferase 2) (Protein-lysine N-methyltransferase n6amt2) Xenopus laevis (African clawed frog) GO:0003676; GO:0005737; GO:0008168; GO:0016279; GO:0018022 peptidyl-lysine methylation [GO:0018022] cytoplasm [GO:0005737] methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279] g3172.t1 Q810A5 32.845 341 2.6199999999999998e-48 177.0 sp|Q810A5|MACA1_MOUSE Microtubule-associated tyrosine carboxypeptidase 1 OS=Mus musculus OX=10090 GN=Matcap1 PE=2 SV=1 g3173.t1 P15145 35.408 980 0.0 594.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g3175.t1 P0DPD7 43.83 235 6.14e-65 206.0 sp|P0DPD7|EFMT4_HUMAN EEF1A lysine methyltransferase 4 OS=Homo sapiens OX=9606 GN=EEF1AKMT4 PE=1 SV=1 EFMT4_HUMAN reviewed EEF1A lysine methyltransferase 4 (EC 2.1.1.-) Homo sapiens (Human) GO:0008168; GO:0016279; GO:0032259 methylation [GO:0032259] methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279] g3176.t1 P15684 41.603 923 0.0 677.0 sp|P15684|AMPN_RAT Aminopeptidase N OS=Rattus norvegicus OX=10116 GN=Anpep PE=1 SV=2 AMPN_RAT reviewed Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13) Rattus norvegicus (Rat) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g3176.t1 P15684 40.453 927 0.0 664.0 sp|P15684|AMPN_RAT Aminopeptidase N OS=Rattus norvegicus OX=10116 GN=Anpep PE=1 SV=2 AMPN_RAT reviewed Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13) Rattus norvegicus (Rat) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g3176.t1 P15684 39.149 917 0.0 632.0 sp|P15684|AMPN_RAT Aminopeptidase N OS=Rattus norvegicus OX=10116 GN=Anpep PE=1 SV=2 AMPN_RAT reviewed Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13) Rattus norvegicus (Rat) GO:0001525; GO:0002003; GO:0004177; GO:0005615; GO:0005793; GO:0005886; GO:0008237; GO:0008270; GO:0009897; GO:0016285; GO:0016485; GO:0030154; GO:0031526; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0072237 angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell differentiation [GO:0030154]; metanephric proximal tubule development [GO:0072237]; peptide catabolic process [GO:0043171]; protein processing [GO:0016485] brush border membrane [GO:0031526]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] g3177.t1 P15145 39.301 916 0.0 621.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g3177.t1 P15145 35.621 918 3.32e-163 527.0 sp|P15145|AMPN_PIG Aminopeptidase N OS=Sus scrofa OX=9823 GN=ANPEP PE=1 SV=4 g3178.t1 O57579 33.991 912 4.989999999999999e-168 521.0 sp|O57579|AMPN_CHICK Aminopeptidase Ey OS=Gallus gallus OX=9031 GN=ANPEP PE=1 SV=2 g3179.t1 Q6DRM0 37.013 154 1.1500000000000001e-35 125.0 sp|Q6DRM0|GET1_DANRE Guided entry of tail-anchored proteins factor 1 OS=Danio rerio OX=7955 GN=get1 PE=2 SV=1 GET1_DANRE reviewed Guided entry of tail-anchored proteins factor 1 (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001964; GO:0005783; GO:0005789; GO:0007507; GO:0007605; GO:0010996; GO:0043495; GO:0043529; GO:0060041; GO:0071816 heart development [GO:0007507]; response to auditory stimulus [GO:0010996]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529] protein-membrane adaptor activity [GO:0043495] g3182.t1 Q69Z37 26.299 308 3.9399999999999998e-28 126.0 sp|Q69Z37|SAM9L_MOUSE Sterile alpha motif domain-containing protein 9-like OS=Mus musculus OX=10090 GN=Samd9l PE=1 SV=2 SAM9L_MOUSE reviewed Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like) Mus musculus (Mouse) GO:0002244; GO:0005737; GO:0005739; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536 common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145] cytoplasm [GO:0005737]; early endosome [GO:0005769]; mitochondrion [GO:0005739] g3182.t2 Q69Z37 26.299 308 4.0199999999999998e-28 126.0 sp|Q69Z37|SAM9L_MOUSE Sterile alpha motif domain-containing protein 9-like OS=Mus musculus OX=10090 GN=Samd9l PE=1 SV=2 SAM9L_MOUSE reviewed Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like) Mus musculus (Mouse) GO:0002244; GO:0005737; GO:0005739; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536 common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145] cytoplasm [GO:0005737]; early endosome [GO:0005769]; mitochondrion [GO:0005739] g3183.t1 Q69Z37 28.238 386 4.93e-38 157.0 sp|Q69Z37|SAM9L_MOUSE Sterile alpha motif domain-containing protein 9-like OS=Mus musculus OX=10090 GN=Samd9l PE=1 SV=2 SAM9L_MOUSE reviewed Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like) Mus musculus (Mouse) GO:0002244; GO:0005737; GO:0005739; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536 common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145] cytoplasm [GO:0005737]; early endosome [GO:0005769]; mitochondrion [GO:0005739] g3187.t1 A0MTA1 59.058 276 5.99e-117 342.0 sp|A0MTA1|APEX1_DANRE DNA repair nuclease APEX1 OS=Danio rerio OX=7955 GN=apex1 PE=1 SV=1 APEX1_DANRE reviewed DNA repair nuclease APEX1 (EC 3.1.11.2) (EC 3.1.21.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (zAP1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0003723; GO:0003906; GO:0005634; GO:0005730; GO:0005739; GO:0005783; GO:0006284; GO:0008081; GO:0008311; GO:0010628; GO:0016607; GO:0043066; GO:0044029; GO:0046872; GO:0052720; GO:0060047; GO:0140431 base-excision repair [GO:0006284]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; positive regulation of gene expression [GO:0010628]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; RNA binding [GO:0003723] g3188.t1 Q8NG11 40.927 259 3.77e-58 189.0 sp|Q8NG11|TSN14_HUMAN Tetraspanin-14 OS=Homo sapiens OX=9606 GN=TSPAN14 PE=1 SV=1 TSN14_HUMAN reviewed Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14) Homo sapiens (Human) GO:0005788; GO:0005886; GO:0009986; GO:0019899; GO:0035579; GO:0045747; GO:0051604; GO:0070821; GO:0072659; GO:0097197 positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197] enzyme binding [GO:0019899] g3189.t1 Q86SQ9 56.646 316 2.47e-128 374.0 sp|Q86SQ9|DHDDS_HUMAN Dehydrodolichyl diphosphate synthase complex subunit DHDDS OS=Homo sapiens OX=9606 GN=DHDDS PE=1 SV=3 DHDDS_HUMAN reviewed Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0043048; GO:0045547; GO:0046872; GO:1904423 dolichyl diphosphate biosynthetic process [GO:0006489]; dolichyl monophosphate biosynthetic process [GO:0043048]; polyprenol biosynthetic process [GO:0016094] dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] ditrans,polycis-polyprenyl diphosphate synthase [(2E,6E)-farnesyl diphosphate specific] activity [GO:0045547]; metal ion binding [GO:0046872] g3190.t1 Q9NSI6 47.368 209 3.93e-53 187.0 sp|Q9NSI6|BRWD1_HUMAN Bromodomain and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=BRWD1 PE=1 SV=4 BRWD1_HUMAN reviewed Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514; GO:0060170 cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g3191.t1 Q8VDD9 40.638 1661 0.0 1102.0 sp|Q8VDD9|PHIP_MOUSE PH-interacting protein OS=Mus musculus OX=10090 GN=Phip PE=1 SV=2 PHIP_MOUSE reviewed PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (Neuronal differentiation-related protein) (NDRP) (WD repeat-containing protein 11) Mus musculus (Mouse) GO:0001932; GO:0005634; GO:0006357; GO:0006606; GO:0007010; GO:0008284; GO:0008286; GO:0008360; GO:0022604; GO:0040008; GO:0043066; GO:0043568; GO:0045840; GO:0045893; GO:0045944; GO:0140566; GO:2001237 cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of growth [GO:0040008]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] histone reader activity [GO:0140566] g3191.t2 Q6RI45 45.875 1103 0.0 898.0 sp|Q6RI45|BRWD3_HUMAN Bromodomain and WD repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=BRWD3 PE=1 SV=2 BRWD3_HUMAN reviewed Bromodomain and WD repeat-containing protein 3 Homo sapiens (Human) GO:0005634; GO:0006357; GO:0007010; GO:0008360 cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] g3193.t1 Q8K418 34.831 356 8.08e-66 217.0 sp|Q8K418|BRS3_RAT Bombesin receptor subtype-3 OS=Rattus norvegicus OX=10116 GN=Brs3 PE=2 SV=1 g3195.t1 Q99MV7 25.499 702 8.95e-38 155.0 sp|Q99MV7|RNF17_MOUSE RING finger protein 17 OS=Mus musculus OX=10090 GN=Rnf17 PE=1 SV=2 g3196.t1 Q4R3G4 30.864 486 1.86e-50 192.0 sp|Q4R3G4|RNF17_MACFA RING finger protein 17 OS=Macaca fascicularis OX=9541 GN=RNF17 PE=2 SV=2 g3198.t1 Q6ZN84 39.224 696 1.88e-149 451.0 sp|Q6ZN84|CCD81_HUMAN Coiled-coil domain-containing protein 81 OS=Homo sapiens OX=9606 GN=CCDC81 PE=1 SV=2 g3200.t1 Q5ZMJ9 70.395 152 5.27e-65 240.0 sp|Q5ZMJ9|SRRM1_CHICK Serine/arginine repetitive matrix protein 1 OS=Gallus gallus OX=9031 GN=SRRM1 PE=2 SV=1 g3200.t2 Q5ZMJ9 70.395 152 5.47e-65 239.0 sp|Q5ZMJ9|SRRM1_CHICK Serine/arginine repetitive matrix protein 1 OS=Gallus gallus OX=9031 GN=SRRM1 PE=2 SV=1 g3201.t1 Q7TMK9 46.712 441 4.24e-94 298.0 sp|Q7TMK9|HNRPQ_MOUSE Heterogeneous nuclear ribonucleoprotein Q OS=Mus musculus OX=10090 GN=Syncrip PE=1 SV=2 HNRPQ_MOUSE reviewed Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Mus musculus (Mouse) GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0014069; GO:0016556; GO:0017148; GO:0043025; GO:0045293; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0090367; GO:0097452; GO:0098978; GO:0106002; GO:0141166; GO:1900152; GO:1990635; GO:1990904; GO:2000623; GO:2000767 cellular response to type II interferon [GO:0071346]; chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380] catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; glutamatergic synapse [GO:0098978]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; mRNA editing complex [GO:0045293]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; proximal dendrite [GO:1990635]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; poly(A) binding [GO:0008143] g3202.t1 O60506 53.093 194 7.870000000000001e-59 197.0 sp|O60506|HNRPQ_HUMAN Heterogeneous nuclear ribonucleoprotein Q OS=Homo sapiens OX=9606 GN=SYNCRIP PE=1 SV=2 g3203.t1 P70031 26.0 350 8.26e-23 102.0 sp|P70031|CCKAR_XENLA Cholecystokinin receptor OS=Xenopus laevis OX=8355 GN=cckar PE=2 SV=1 g3204.t1 Q9JJ80 57.705 305 1.2699999999999998e-128 372.0 sp|Q9JJ80|RPF2_MOUSE Ribosome production factor 2 homolog OS=Mus musculus OX=10090 GN=Rpf2 PE=2 SV=2 g3205.t1 Q6GQB5 55.682 88 1.71e-26 99.4 sp|Q6GQB5|AKIR2_XENLA Akirin-2 OS=Xenopus laevis OX=8355 GN=akirin2.S PE=1 SV=1 g3211.t1 Q8C0T7 38.537 410 1.8299999999999998e-82 263.0 sp|Q8C0T7|MFSD9_MOUSE Major facilitator superfamily domain-containing protein 9 OS=Mus musculus OX=10090 GN=Mfsd9 PE=2 SV=1 g3212.t1 Q8NBP5 36.092 435 3.66e-67 223.0 sp|Q8NBP5|MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens OX=9606 GN=MFSD9 PE=1 SV=2 g3214.t1 B3LYS5 55.336 253 5e-78 250.0 sp|B3LYS5|FOXO_DROAN Forkhead box protein O OS=Drosophila ananassae OX=7217 GN=foxo PE=3 SV=2 g3217.t1 Q8BGC3 26.637 443 3.61e-41 155.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g3218.t1 Q8CE94 29.351 385 2.42e-27 115.0 sp|Q8CE94|MOT13_MOUSE Monocarboxylate transporter 13 OS=Mus musculus OX=10090 GN=Slc16a13 PE=2 SV=1 g3220.t1 Q91ZV2 35.897 195 2.2699999999999997e-23 103.0 sp|Q91ZV2|DCBD2_RAT Discoidin, CUB and LCCL domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Dcbld2 PE=2 SV=1 g3221.t1 O95084 36.813 364 4.43e-79 251.0 sp|O95084|PRS23_HUMAN Serine protease 23 OS=Homo sapiens OX=9606 GN=PRSS23 PE=1 SV=1 g3223.t1 P28227 64.428 551 0.0 758.0 sp|P28227|MAOX_ANAPL NADP-dependent malic enzyme OS=Anas platyrhynchos OX=8839 GN=ME1 PE=1 SV=1 g3224.t1 Q9BQE3 95.973 447 0.0 884.0 sp|Q9BQE3|TBA1C_HUMAN Tubulin alpha-1C chain OS=Homo sapiens OX=9606 GN=TUBA1C PE=1 SV=1 TBA1C_HUMAN reviewed Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain] Homo sapiens (Human) GO:0000226; GO:0000278; GO:0005198; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0005929; GO:0007017; GO:0015630; GO:0016787; GO:0030705; GO:0031982; GO:0046872; GO:0051301 cell division [GO:0051301]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; vesicle [GO:0031982] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] g3225.t1 P06603 94.533 439 0.0 858.0 sp|P06603|TBA1_DROME Tubulin alpha-1 chain OS=Drosophila melanogaster OX=7227 GN=alphaTub84B PE=1 SV=1 TBA1_DROME reviewed Tubulin alpha-1 chain (EC 3.6.5.-) Drosophila melanogaster (Fruit fly) GO:0000226; GO:0000235; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0016787; GO:0032418; GO:0046872; GO:0048471 lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g3226.t1 Q8CA95 50.364 687 0.0 715.0 sp|Q8CA95|PDE10_MOUSE cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A OS=Mus musculus OX=10090 GN=Pde10a PE=1 SV=2 PDE10_MOUSE reviewed cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) Mus musculus (Mouse) GO:0004112; GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0007165; GO:0010754; GO:0030552; GO:0030553; GO:0043025; GO:0043204; GO:0045202; GO:0046069; GO:0046872; GO:0047555; GO:0098978; GO:0099147; GO:0106070; GO:0141161; GO:0141162 cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cAMP/PKA signal transduction [GO:0141161]; signal transduction [GO:0007165] cytosol [GO:0005829]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872] g3228.t1 Q6UWM5 35.429 175 8.209999999999999e-24 102.0 sp|Q6UWM5|GPRL1_HUMAN GLIPR1-like protein 1 OS=Homo sapiens OX=9606 GN=GLIPR1L1 PE=1 SV=2 g3229.t1 Q3SB03 31.602 231 4.8400000000000004e-29 116.0 sp|Q3SB03|CRVP_HOPST Cysteine-rich venom protein pseudechetoxin-like OS=Hoplocephalus stephensii OX=196418 PE=2 SV=1 g3230.t1 P19213 62.283 403 0.0 531.0 sp|P19213|CREA_FLASU Creatinase OS=Flavobacterium sp. (strain U-188) OX=242 PE=1 SV=2 g3231.t1 Q9Z0W7 31.837 245 1.36e-24 103.0 sp|Q9Z0W7|CLIC4_RAT Chloride intracellular channel protein 4 OS=Rattus norvegicus OX=10116 GN=Clic4 PE=1 SV=3 g3232.t1 Q2NKT1 42.105 114 5.81e-31 111.0 sp|Q2NKT1|PROF4_BOVIN Profilin-4 OS=Bos taurus OX=9913 GN=PFN4 PE=2 SV=1 g3233.t1 P0C875 30.841 214 6.08e-30 119.0 sp|P0C875|F228B_HUMAN Protein FAM228B OS=Homo sapiens OX=9606 GN=FAM228B PE=1 SV=2 g3234.t1 Q64104 52.068 411 1.0499999999999999e-140 409.0 sp|Q64104|NR2E1_MOUSE Nuclear receptor subfamily 2 group E member 1 OS=Mus musculus OX=10090 GN=Nr2e1 PE=1 SV=1 NR2E1_MOUSE reviewed Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (mTll) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0001662; GO:0002118; GO:0004879; GO:0005634; GO:0005654; GO:0007420; GO:0007601; GO:0008270; GO:0008284; GO:0008347; GO:0019899; GO:0021542; GO:0021764; GO:0021772; GO:0021819; GO:0021872; GO:0021895; GO:0021960; GO:0021987; GO:0030154; GO:0030198; GO:0035019; GO:0035176; GO:0042826; GO:0043010; GO:0043066; GO:0045165; GO:0045665; GO:0045766; GO:0045787; GO:0048712; GO:0048814; GO:0060041; GO:0060164; GO:0060291; GO:0090049; GO:1990837; GO:2000178; GO:2000179; GO:2000648 aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anterior commissure morphogenesis [GO:0021960]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex development [GO:0021987]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; glial cell migration [GO:0008347]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g3235.t1 P11009 70.896 402 0.0 591.0 sp|P11009|KCRS_CHICK Creatine kinase S-type, mitochondrial OS=Gallus gallus OX=9031 GN=CKMT2 PE=1 SV=2 g3236.t1 Q61093 49.915 589 0.0 558.0 sp|Q61093|CY24B_MOUSE NADPH oxidase 2 OS=Mus musculus OX=10090 GN=Cybb PE=1 SV=1 g3237.t1 Q21828 67.5 80 4.97e-37 126.0 sp|Q21828|MPC1_CAEEL Probable mitochondrial pyruvate carrier 1 OS=Caenorhabditis elegans OX=6239 GN=mpc-1 PE=3 SV=2 g3238.t1 P52649 48.532 579 0.0 555.0 sp|P52649|CY24B_PIG NADPH oxidase 2 OS=Sus scrofa OX=9823 GN=CYBB PE=2 SV=3 g3239.t1 Q8HXM1 48.336 571 4.71e-121 367.0 sp|Q8HXM1|CSTF2_BOVIN Cleavage stimulation factor subunit 2 OS=Bos taurus OX=9913 GN=CSTF2 PE=2 SV=1 g3242.t1 P68373 85.714 448 0.0 815.0 sp|P68373|TBA1C_MOUSE Tubulin alpha-1C chain OS=Mus musculus OX=10090 GN=Tuba1c PE=1 SV=1 TBA1C_MOUSE reviewed Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Alpha-tubulin isotype M-alpha-6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain] Mus musculus (Mouse) GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0005929; GO:0015630; GO:0016787; GO:0045121; GO:0046872 microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g3243.t1 P08537 93.764 449 0.0 873.0 sp|P08537|TBA_XENLA Tubulin alpha chain OS=Xenopus laevis OX=8355 GN=tuba PE=2 SV=2 g3244.t1 P68373 94.932 296 0.0 592.0 sp|P68373|TBA1C_MOUSE Tubulin alpha-1C chain OS=Mus musculus OX=10090 GN=Tuba1c PE=1 SV=1 TBA1C_MOUSE reviewed Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Alpha-tubulin isotype M-alpha-6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain] Mus musculus (Mouse) GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0005929; GO:0015630; GO:0016787; GO:0045121; GO:0046872 microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g3245.t1 P08537 85.969 449 0.0 795.0 sp|P08537|TBA_XENLA Tubulin alpha chain OS=Xenopus laevis OX=8355 GN=tuba PE=2 SV=2 g3246.t1 P68373 91.131 451 0.0 849.0 sp|P68373|TBA1C_MOUSE Tubulin alpha-1C chain OS=Mus musculus OX=10090 GN=Tuba1c PE=1 SV=1 TBA1C_MOUSE reviewed Tubulin alpha-1C chain (EC 3.6.5.-) (Alpha-tubulin 6) (Alpha-tubulin isotype M-alpha-6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain] Mus musculus (Mouse) GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0005929; GO:0015630; GO:0016787; GO:0045121; GO:0046872 microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g3248.t1 P08537 94.382 445 0.0 861.0 sp|P08537|TBA_XENLA Tubulin alpha chain OS=Xenopus laevis OX=8355 GN=tuba PE=2 SV=2 g3248.t1 P08537 83.851 161 8.3e-83 270.0 sp|P08537|TBA_XENLA Tubulin alpha chain OS=Xenopus laevis OX=8355 GN=tuba PE=2 SV=2 g3249.t1 P18258 98.009 452 0.0 931.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g3250.t1 P68370 97.118 451 0.0 930.0 sp|P68370|TBA1A_RAT Tubulin alpha-1A chain OS=Rattus norvegicus OX=10116 GN=Tuba1a PE=1 SV=1 TBA1A_RAT reviewed Tubulin alpha-1A chain (EC 3.6.5.-) (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain] Rattus norvegicus (Rat) GO:0000226; GO:0000278; GO:0000793; GO:0001764; GO:0001964; GO:0005200; GO:0005525; GO:0005737; GO:0005829; GO:0005874; GO:0005879; GO:0005881; GO:0005886; GO:0005929; GO:0006886; GO:0007017; GO:0007098; GO:0007224; GO:0007613; GO:0007626; GO:0008344; GO:0008542; GO:0009612; GO:0010001; GO:0010467; GO:0015630; GO:0016787; GO:0019904; GO:0021542; GO:0021696; GO:0021766; GO:0021859; GO:0021987; GO:0022008; GO:0030182; GO:0030317; GO:0030534; GO:0031594; GO:0034612; GO:0035641; GO:0036126; GO:0036464; GO:0042802; GO:0043209; GO:0044877; GO:0045121; GO:0045202; GO:0046785; GO:0046872; GO:0046982; GO:0048853; GO:0048873; GO:0050807; GO:0050808; GO:0051402; GO:0055037; GO:0061744; GO:0071277; GO:0072384; GO:0140058; GO:1902065 adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; cellular response to calcium ion [GO:0071277]; centrosome cycle [GO:0007098]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; dentate gyrus development [GO:0021542]; flagellated sperm motility [GO:0030317]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; locomotory exploration behavior [GO:0035641]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection arborization [GO:0140058]; organelle transport along microtubule [GO:0072384]; pyramidal neuron differentiation [GO:0021859]; regulation of synapse organization [GO:0050807]; response to L-glutamate [GO:1902065]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612]; smoothened signaling pathway [GO:0007224]; startle response [GO:0001964]; synapse organization [GO:0050808]; visual learning [GO:0008542] axonemal microtubule [GO:0005879]; cilium [GO:0005929]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; sperm flagellum [GO:0036126]; synapse [GO:0045202] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200] g3251.t1 P18258 97.345 452 0.0 924.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g3252.t1 P18258 96.825 441 0.0 900.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g3253.t1 P18258 96.583 439 0.0 872.0 sp|P18258|TBA1_PARLI Tubulin alpha-1 chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g3254.t1 Q91060 83.413 416 0.0 709.0 sp|Q91060|TBA_NOTVI Tubulin alpha chain OS=Notophthalmus viridescens OX=8316 PE=2 SV=1 TBA_NOTVI reviewed Tubulin alpha chain (EC 3.6.5.-) [Cleaved into: Detyrosinated tubulin alpha chain] Notophthalmus viridescens (Eastern newt) (Triturus viridescens) GO:0005200; GO:0005525; GO:0005874; GO:0007017; GO:0016787; GO:0046872 microtubule-based process [GO:0007017] microtubule [GO:0005874] GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200] g3255.t1 Q5DTV4 48.837 215 5.3e-50 190.0 sp|Q5DTV4|ZC12C_MOUSE Probable ribonuclease ZC3H12C OS=Mus musculus OX=10090 GN=Zc3h12c PE=1 SV=2 ZC12C_MOUSE reviewed Probable ribonuclease ZC3H12C (EC 3.1.-.-) (Zinc finger CCCH domain-containing protein 12C) Mus musculus (Mouse) GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0016787; GO:0036464 cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634] hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270] g3256.t1 Q9C0D7 69.048 84 8.28e-30 127.0 sp|Q9C0D7|ZC12C_HUMAN Probable ribonuclease ZC3H12C OS=Homo sapiens OX=9606 GN=ZC3H12C PE=1 SV=2 g3257.t1 Q59A28 42.136 337 3.4e-93 285.0 sp|Q59A28|QORL1_BOVIN Quinone oxidoreductase-like protein 1 OS=Bos taurus OX=9913 GN=CRYZL1 PE=2 SV=1 g3258.t1 O42287 47.695 1063 0.0 960.0 sp|O42287|ITSN1_XENLA Intersectin-1 OS=Xenopus laevis OX=8355 GN=itsn1 PE=1 SV=2 ITSN1_XENLA reviewed Intersectin-1 Xenopus laevis (African clawed frog) GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0030027; GO:0035025; GO:0035556; GO:0043005; GO:0045202; GO:0055037 endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; protein transport [GO:0015031] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085] g3258.t1 O42287 37.224 771 3.3000000000000004e-103 372.0 sp|O42287|ITSN1_XENLA Intersectin-1 OS=Xenopus laevis OX=8355 GN=itsn1 PE=1 SV=2 ITSN1_XENLA reviewed Intersectin-1 Xenopus laevis (African clawed frog) GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0030027; GO:0035025; GO:0035556; GO:0043005; GO:0045202; GO:0055037 endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; protein transport [GO:0015031] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085] g3258.t1 O42287 37.383 535 6.6e-81 300.0 sp|O42287|ITSN1_XENLA Intersectin-1 OS=Xenopus laevis OX=8355 GN=itsn1 PE=1 SV=2 ITSN1_XENLA reviewed Intersectin-1 Xenopus laevis (African clawed frog) GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0015031; GO:0030027; GO:0035025; GO:0035556; GO:0043005; GO:0045202; GO:0055037 endocytosis [GO:0006897]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; protein transport [GO:0015031] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synapse [GO:0045202] calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085] g3259.t1 Q24439 48.039 204 6.789999999999999e-68 209.0 sp|Q24439|ATPO_DROME ATP synthase subunit O, mitochondrial OS=Drosophila melanogaster OX=7227 GN=ATPsynO PE=2 SV=2 g3260.t1 P82931 49.474 95 1.31e-31 112.0 sp|P82931|RT06_BOVIN Small ribosomal subunit protein bS6m OS=Bos taurus OX=9913 GN=MRPS6 PE=1 SV=4 g3261.t1 Q9NRZ7 36.745 381 7.92e-84 263.0 sp|Q9NRZ7|PLCC_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma OS=Homo sapiens OX=9606 GN=AGPAT3 PE=1 SV=1 g3262.t1 P80146 40.379 317 1.4200000000000001e-66 219.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g3263.t1 P31729 56.627 166 4.21e-62 194.0 sp|P31729|OV16_ONCVO OV-16 antigen OS=Onchocerca volvulus OX=6282 GN=OV16 PE=2 SV=2 g3264.t1 Q499R4 54.902 204 5.55e-75 231.0 sp|Q499R4|YRDC_RAT Threonylcarbamoyl-AMP synthase OS=Rattus norvegicus OX=10116 GN=Yrdc PE=2 SV=1 YRDC_RAT reviewed Threonylcarbamoyl-AMP synthase (EC 2.7.7.87) Rattus norvegicus (Rat) GO:0000049; GO:0002949; GO:0003725; GO:0005737; GO:0005739; GO:0005886; GO:0006450; GO:0016020; GO:0016779; GO:0051051; GO:0061710 negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949] cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049] g3265.t1 P08941 32.049 2309 0.0 998.0 sp|P08941|ROS1_CHICK Proto-oncogene tyrosine-protein kinase ROS OS=Gallus gallus OX=9031 GN=ROS1 PE=1 SV=3 g3266.t1 Q8BUB6 31.618 272 1.28e-31 126.0 sp|Q8BUB6|UST_MOUSE Uronyl 2-sulfotransferase OS=Mus musculus OX=10090 GN=Ust PE=2 SV=3 g3267.t1 Q8BUB6 34.848 198 4.97e-26 109.0 sp|Q8BUB6|UST_MOUSE Uronyl 2-sulfotransferase OS=Mus musculus OX=10090 GN=Ust PE=2 SV=3 g3268.t1 P08537 94.457 451 0.0 878.0 sp|P08537|TBA_XENLA Tubulin alpha chain OS=Xenopus laevis OX=8355 GN=tuba PE=2 SV=2 g3273.t1 Q9UPY6 50.917 218 2.3400000000000002e-65 223.0 sp|Q9UPY6|WASF3_HUMAN Actin-binding protein WASF3 OS=Homo sapiens OX=9606 GN=WASF3 PE=1 SV=2 WASF3_HUMAN reviewed Actin-binding protein WASF3 (Protein WAVE-3) (Verprolin homology domain-containing protein 3) (Wiskott-Aldrich syndrome protein family member 3) (WASP family protein member 3) Homo sapiens (Human) GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0031209; GO:0031643; GO:0034237; GO:0065003; GO:0070062; GO:0071933; GO:0097386; GO:0098794; GO:0098885; GO:0098978; GO:2000601 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237] g3273.t2 Q9UPY6 58.257 218 6.31e-80 261.0 sp|Q9UPY6|WASF3_HUMAN Actin-binding protein WASF3 OS=Homo sapiens OX=9606 GN=WASF3 PE=1 SV=2 WASF3_HUMAN reviewed Actin-binding protein WASF3 (Protein WAVE-3) (Verprolin homology domain-containing protein 3) (Wiskott-Aldrich syndrome protein family member 3) (WASP family protein member 3) Homo sapiens (Human) GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0031209; GO:0031643; GO:0034237; GO:0065003; GO:0070062; GO:0071933; GO:0097386; GO:0098794; GO:0098885; GO:0098978; GO:2000601 actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237] g3273.t3 Q9Y6W5 47.899 119 1.4599999999999999e-24 109.0 sp|Q9Y6W5|WASF2_HUMAN Actin-binding protein WASF2 OS=Homo sapiens OX=9606 GN=WASF2 PE=1 SV=3 WASF2_HUMAN reviewed Actin-binding protein WASF2 (Protein WAVE-2) (Verprolin homology domain-containing protein 2) (Wiskott-Aldrich syndrome protein family member 2) (WASP family protein member 2) Homo sapiens (Human) GO:0001525; GO:0001667; GO:0001726; GO:0001764; GO:0003779; GO:0005769; GO:0005829; GO:0005911; GO:0006897; GO:0007188; GO:0010592; GO:0015629; GO:0016323; GO:0016601; GO:0017124; GO:0030027; GO:0030032; GO:0030036; GO:0030048; GO:0031209; GO:0032991; GO:0034237; GO:0035855; GO:0045202; GO:0045296; GO:0051018; GO:0051497; GO:0070062; GO:0071933; GO:0072673; GO:0098974; GO:2000601 actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; neuron migration [GO:0001764]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601] actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124] g3274.t1 Q0VFI5 58.366 514 0.0 627.0 sp|Q0VFI5|GATA_XENTR Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial OS=Xenopus tropicalis OX=8364 GN=qrsl1 PE=2 SV=1 g3275.t1 Q2KJC1 66.334 802 0.0 1061.0 sp|Q2KJC1|CDC5L_BOVIN Cell division cycle 5-like protein OS=Bos taurus OX=9913 GN=CDC5L PE=2 SV=1 CDC5L_BOVIN reviewed Cell division cycle 5-like protein (Cdc5-like protein) Bos taurus (Bovine) GO:0000077; GO:0000398; GO:0000974; GO:0000977; GO:0000981; GO:0001228; GO:0003723; GO:0005634; GO:0005662; GO:0005681; GO:0005737; GO:0006281; GO:0006357; GO:0016607; GO:0042802; GO:0071007; GO:0071987 DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987] g3276.t1 Q6DGP2 61.364 220 1.16e-95 283.0 sp|Q6DGP2|SYF2_DANRE Pre-mRNA-splicing factor syf2 OS=Danio rerio OX=7955 GN=syf2 PE=2 SV=1 g3277.t1 Q3T174 56.41 156 2.7100000000000002e-58 186.0 sp|Q3T174|TAF12_BOVIN Transcription initiation factor TFIID subunit 12 OS=Bos taurus OX=9913 GN=TAF12 PE=2 SV=1 g3279.t1 P52292 59.091 506 0.0 596.0 sp|P52292|IMA1_HUMAN Importin subunit alpha-1 OS=Homo sapiens OX=9606 GN=KPNA2 PE=1 SV=1 IMA1_HUMAN reviewed Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha) Homo sapiens (Human) GO:0000018; GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006259; GO:0006606; GO:0006607; GO:0008139; GO:0016020; GO:0031965; GO:0032481; GO:0042564; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:1903902 DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral life cycle [GO:1903902]; protein import into nucleus [GO:0006606]; regulation of DNA recombination [GO:0000018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723] g3280.t1 Q9BY27 50.273 183 4.86e-53 172.0 sp|Q9BY27|DGC6L_HUMAN Protein DGCR6L OS=Homo sapiens OX=9606 GN=DGCR6L PE=1 SV=2 DGC6L_HUMAN reviewed Protein DGCR6L (DiGeorge syndrome critical region 6-like protein) Homo sapiens (Human) GO:0005634 nucleus [GO:0005634] g3281.t1 P42620 56.698 321 4.33e-123 359.0 sp|P42620|YQJG_ECOLI Glutathionyl-hydroquinone reductase YqjG OS=Escherichia coli (strain K12) OX=83333 GN=yqjG PE=1 SV=1 YQJG_ECOLI reviewed Glutathionyl-hydroquinone reductase YqjG (GS-HQR) (EC 1.8.5.7) Escherichia coli (strain K12) GO:0004364; GO:0005737; GO:0016672; GO:0042803 cytoplasm [GO:0005737] glutathione transferase activity [GO:0004364]; oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor [GO:0016672]; protein homodimerization activity [GO:0042803] g3286.t1 Q5PQS7 40.315 444 1.71e-80 261.0 sp|Q5PQS7|CC174_RAT Coiled-coil domain-containing protein 174 OS=Rattus norvegicus OX=10116 GN=Ccdc174 PE=2 SV=2 g3287.t1 Q6ZPD9 48.613 685 0.0 646.0 sp|Q6ZPD9|D19L3_HUMAN Protein C-mannosyl-transferase DPY19L3 OS=Homo sapiens OX=9606 GN=DPY19L3 PE=1 SV=1 D19L3_HUMAN reviewed Protein C-mannosyl-transferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3) Homo sapiens (Human) GO:0000030; GO:0005789 endoplasmic reticulum membrane [GO:0005789] mannosyltransferase activity [GO:0000030] g3287.t2 Q6ZPD9 48.748 679 0.0 644.0 sp|Q6ZPD9|D19L3_HUMAN Protein C-mannosyl-transferase DPY19L3 OS=Homo sapiens OX=9606 GN=DPY19L3 PE=1 SV=1 D19L3_HUMAN reviewed Protein C-mannosyl-transferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3) Homo sapiens (Human) GO:0000030; GO:0005789 endoplasmic reticulum membrane [GO:0005789] mannosyltransferase activity [GO:0000030] g3290.t1 P0C6R2 34.85 901 1.9600000000000002e-163 500.0 sp|P0C6R2|ARMC2_BOVIN Armadillo repeat-containing protein 2 OS=Bos taurus OX=9913 GN=ARMC2 PE=3 SV=1 g3291.t1 P02256 56.303 119 2.17e-28 111.0 sp|P02256|H1_PARAN Histone H1, gonadal OS=Parechinus angulosus OX=7658 PE=1 SV=1 g3293.t1 G3UZ78 34.326 1142 0.0 602.0 sp|G3UZ78|ADGB_MOUSE Androglobin OS=Mus musculus OX=10090 GN=Adgb PE=1 SV=1 ADGB_MOUSE reviewed Androglobin Mus musculus (Mouse) GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g3293.t1 G3UZ78 41.463 574 1.9700000000000002e-110 392.0 sp|G3UZ78|ADGB_MOUSE Androglobin OS=Mus musculus OX=10090 GN=Adgb PE=1 SV=1 ADGB_MOUSE reviewed Androglobin Mus musculus (Mouse) GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g3293.t2 G3UZ78 34.629 1132 0.0 608.0 sp|G3UZ78|ADGB_MOUSE Androglobin OS=Mus musculus OX=10090 GN=Adgb PE=1 SV=1 ADGB_MOUSE reviewed Androglobin Mus musculus (Mouse) GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g3293.t2 G3UZ78 41.463 574 1.2500000000000001e-110 393.0 sp|G3UZ78|ADGB_MOUSE Androglobin OS=Mus musculus OX=10090 GN=Adgb PE=1 SV=1 ADGB_MOUSE reviewed Androglobin Mus musculus (Mouse) GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g3293.t3 G3UZ78 34.507 1136 0.0 607.0 sp|G3UZ78|ADGB_MOUSE Androglobin OS=Mus musculus OX=10090 GN=Adgb PE=1 SV=1 ADGB_MOUSE reviewed Androglobin Mus musculus (Mouse) GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g3293.t3 G3UZ78 41.463 574 1.38e-110 392.0 sp|G3UZ78|ADGB_MOUSE Androglobin OS=Mus musculus OX=10090 GN=Adgb PE=1 SV=1 ADGB_MOUSE reviewed Androglobin Mus musculus (Mouse) GO:0004198; GO:0006508; GO:0007283; GO:0007286; GO:0019825; GO:0020037; GO:0036126; GO:0046872; GO:0097225; GO:0097227 proteolysis [GO:0006508]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] sperm annulus [GO:0097227]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825] g3295.t1 P02256 54.31 116 6.67e-28 110.0 sp|P02256|H1_PARAN Histone H1, gonadal OS=Parechinus angulosus OX=7658 PE=1 SV=1 g3298.t1 Q5R5W5 48.485 297 4.77e-86 263.0 sp|Q5R5W5|VTA1_PONAB Vacuolar protein sorting-associated protein VTA1 homolog OS=Pongo abelii OX=9601 GN=VTA1 PE=2 SV=1 g3299.t1 Q6ZMT9 30.139 647 2.83e-71 258.0 sp|Q6ZMT9|DTHD1_HUMAN Death domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DTHD1 PE=1 SV=3 g3301.t1 Q96GD3 40.832 649 8.41e-153 456.0 sp|Q96GD3|SCMH1_HUMAN Polycomb protein SCMH1 OS=Homo sapiens OX=9606 GN=SCMH1 PE=1 SV=1 SCMH1_HUMAN reviewed Polycomb protein SCMH1 (Sex comb on midleg homolog 1) Homo sapiens (Human) GO:0003682; GO:0005634; GO:0005654; GO:0031507; GO:0042393; GO:0045892 heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393] g3302.t1 A1L1W9 42.266 459 7.450000000000001e-122 372.0 sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1 MOT10_DANRE reviewed Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327 aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857] g3311.t1 Q60769 28.638 646 7.33e-63 233.0 sp|Q60769|TNAP3_MOUSE Tumor necrosis factor alpha-induced protein 3 OS=Mus musculus OX=10090 GN=Tnfaip3 PE=1 SV=2 g3312.t1 Q53FA7 57.879 330 5.78e-134 387.0 sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2 QORX_HUMAN reviewed Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein) Homo sapiens (Human) GO:0003960; GO:0005829; GO:0006915; GO:0048038; GO:0070402; GO:1903409 apoptotic process [GO:0006915]; reactive oxygen species biosynthetic process [GO:1903409] cytosol [GO:0005829] NADPH binding [GO:0070402]; quinone binding [GO:0048038]; quinone reductase (NADPH) activity [GO:0003960] g3313.t1 Q53FA7 53.614 332 2.03e-126 368.0 sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2 QORX_HUMAN reviewed Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein) Homo sapiens (Human) GO:0003960; GO:0005829; GO:0006915; GO:0048038; GO:0070402; GO:1903409 apoptotic process [GO:0006915]; reactive oxygen species biosynthetic process [GO:1903409] cytosol [GO:0005829] NADPH binding [GO:0070402]; quinone binding [GO:0048038]; quinone reductase (NADPH) activity [GO:0003960] g3314.t1 Q5U2R1 50.279 358 6.41e-110 336.0 sp|Q5U2R1|DLP1_RAT All trans-polyprenyl-diphosphate synthase PDSS2 OS=Rattus norvegicus OX=10116 GN=Pdss2 PE=2 SV=1 g3317.t1 P52899 65.435 379 0.0 526.0 sp|P52899|ODPA_CAEEL Probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=pdha-1 PE=3 SV=1 g3318.t1 Q99683 45.795 1308 0.0 1091.0 sp|Q99683|M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens OX=9606 GN=MAP3K5 PE=1 SV=1 M3K5_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) Homo sapiens (Human) GO:0000165; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0007254; GO:0008631; GO:0009897; GO:0010666; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0036480; GO:0038066; GO:0042802; GO:0042803; GO:0043065; GO:0045087; GO:0045663; GO:0045893; GO:0046330; GO:0051402; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0090398; GO:0097190; GO:0097300; GO:0106310; GO:1900745; GO:1902170; GO:1902911; GO:1904707; GO:1990604 apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron apoptotic process [GO:0051402]; neuron intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0036480]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3318.t2 Q99683 45.888 1301 0.0 1092.0 sp|Q99683|M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens OX=9606 GN=MAP3K5 PE=1 SV=1 M3K5_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) Homo sapiens (Human) GO:0000165; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0007254; GO:0008631; GO:0009897; GO:0010666; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0036480; GO:0038066; GO:0042802; GO:0042803; GO:0043065; GO:0045087; GO:0045663; GO:0045893; GO:0046330; GO:0051402; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0090398; GO:0097190; GO:0097300; GO:0106310; GO:1900745; GO:1902170; GO:1902911; GO:1904707; GO:1990604 apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron apoptotic process [GO:0051402]; neuron intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0036480]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3318.t3 Q99683 46.006 1302 0.0 1093.0 sp|Q99683|M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens OX=9606 GN=MAP3K5 PE=1 SV=1 M3K5_HUMAN reviewed Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) Homo sapiens (Human) GO:0000165; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0007254; GO:0008631; GO:0009897; GO:0010666; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0036480; GO:0038066; GO:0042802; GO:0042803; GO:0043065; GO:0045087; GO:0045663; GO:0045893; GO:0046330; GO:0051402; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0090398; GO:0097190; GO:0097300; GO:0106310; GO:1900745; GO:1902170; GO:1902911; GO:1904707; GO:1990604 apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron apoptotic process [GO:0051402]; neuron intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0036480]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3319.t1 Q920F5 47.153 439 4.92e-136 406.0 sp|Q920F5|DCMC_RAT Malonyl-CoA decarboxylase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Mlycd PE=1 SV=1 DCMC_RAT reviewed Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9) Rattus norvegicus (Rat) GO:0002931; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0006085; GO:0006633; GO:0007584; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046320; GO:0046321; GO:0050080; GO:2001294 acetyl-CoA biosynthetic process [GO:0006085]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]; response to nutrient [GO:0007584] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080] g3320.t1 D4A4T9 51.057 331 4.33e-117 344.0 sp|D4A4T9|CHRD1_RAT Cysteine and histidine-rich domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Chordc1 PE=3 SV=1 g3321.t1 B9ENE7 87.075 147 1.48e-94 272.0 sp|B9ENE7|MGN_SALSA Protein mago nashi homolog OS=Salmo salar OX=8030 GN=magoh PE=2 SV=1 g3322.t1 P63172 84.956 113 2.87e-71 211.0 sp|P63172|DYLT1_HUMAN Dynein light chain Tctex-type 1 OS=Homo sapiens OX=9606 GN=DYNLT1 PE=1 SV=1 DYLT1_HUMAN reviewed Dynein light chain Tctex-type 1 (Protein CW-1) (T-complex testis-specific protein 1 homolog) Homo sapiens (Human) GO:0000132; GO:0005576; GO:0005737; GO:0005794; GO:0005819; GO:0005868; GO:0005881; GO:0007018; GO:0007399; GO:0008277; GO:0019060; GO:0032388; GO:0034774; GO:0042802; GO:0043657; GO:0045505; GO:0046718; GO:0050768; GO:0051301; GO:0075521; GO:0099503; GO:1904813 cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; intracellular transport of viral protein in host cell [GO:0019060]; microtubule-based movement [GO:0007018]; microtubule-dependent intracellular transport of viral material towards nucleus [GO:0075521]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; positive regulation of intracellular transport [GO:0032388]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; symbiont entry into host cell [GO:0046718] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; secretory granule lumen [GO:0034774]; secretory vesicle [GO:0099503]; spindle [GO:0005819] dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802] g3323.t1 Q8TE73 63.855 4612 0.0 6080.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g3323.t2 Q8TE73 63.855 4612 0.0 6080.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g3323.t3 Q8TE73 63.855 4612 0.0 6080.0 sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3 DYH5_HUMAN reviewed Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) Homo sapiens (Human) GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729 cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g3324.t1 Q6GPY0 68.687 99 6.059999999999999e-45 143.0 sp|Q6GPY0|TI13A_XENLA Mitochondrial import inner membrane translocase subunit Tim13-A OS=Xenopus laevis OX=8355 GN=timm13-a PE=3 SV=2 g3325.t1 Q96B97 34.75 541 2.6699999999999997e-68 238.0 sp|Q96B97|SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2 SH3K1_HUMAN reviewed SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0014069; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0050871; GO:0098978; GO:0098982 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] g3325.t2 Q96B97 35.548 557 1.6599999999999999e-68 239.0 sp|Q96B97|SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2 SH3K1_HUMAN reviewed SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0014069; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0050871; GO:0098978; GO:0098982 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] g3325.t3 Q96B97 35.778 559 8.739999999999999e-68 237.0 sp|Q96B97|SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2 SH3K1_HUMAN reviewed SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0014069; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0050871; GO:0098978; GO:0098982 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] g3325.t4 Q96B97 34.637 537 1.16e-68 239.0 sp|Q96B97|SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2 SH3K1_HUMAN reviewed SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0014069; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0050871; GO:0098978; GO:0098982 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] g3325.t5 Q96B97 34.256 578 2.38e-62 222.0 sp|Q96B97|SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2 SH3K1_HUMAN reviewed SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0014069; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0050871; GO:0098978; GO:0098982 actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] g3326.t1 Q9U903 90.652 460 0.0 842.0 sp|Q9U903|TBXT_PATPE T-box transcription factor T homolog OS=Patiria pectinifera OX=7594 GN=TBXT PE=2 SV=1 g3334.t1 Q9H299 43.333 90 1.8299999999999997e-23 88.6 sp|Q9H299|SH3L3_HUMAN SH3 domain-binding glutamic acid-rich-like protein 3 OS=Homo sapiens OX=9606 GN=SH3BGRL3 PE=1 SV=1 g3335.t1 P30549 28.981 314 4.6e-28 116.0 sp|P30549|NK2R_MOUSE Substance-K receptor OS=Mus musculus OX=10090 GN=Tacr2 PE=2 SV=1 g3336.t1 Q92734 59.5 200 4.2900000000000005e-70 229.0 sp|Q92734|TFG_HUMAN Protein TFG OS=Homo sapiens OX=9606 GN=TFG PE=1 SV=2 TFG_HUMAN reviewed Protein TFG (TRK-fused gene protein) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0048208; GO:0070971 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971] identical protein binding [GO:0042802] g3336.t2 Q92734 58.639 191 5.69e-69 225.0 sp|Q92734|TFG_HUMAN Protein TFG OS=Homo sapiens OX=9606 GN=TFG PE=1 SV=2 TFG_HUMAN reviewed Protein TFG (TRK-fused gene protein) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0048208; GO:0070971 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971] identical protein binding [GO:0042802] g3337.t1 A2ACJ2 23.152 717 2.95e-22 107.0 sp|A2ACJ2|FP100_MOUSE Fanconi anemia core complex-associated protein 100 OS=Mus musculus OX=10090 GN=Faap100 PE=2 SV=1 g3338.t1 Q5M9G6 73.077 156 6.8e-83 261.0 sp|Q5M9G6|SNIP1_RAT Smad nuclear interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Snip1 PE=1 SV=1 SNIP1_RAT reviewed Smad nuclear interacting protein 1 Rattus norvegicus (Rat) GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0035196; GO:0043124; GO:0045944; GO:0071005; GO:0140416 miRNA processing [GO:0035196]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005] mRNA binding [GO:0003729]; transcription regulator inhibitor activity [GO:0140416] g3339.t1 E1BNG3 62.919 2206 0.0 2823.0 sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1 ASCC3_BOVIN reviewed Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4) Bos taurus (Bovine) GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:0180022; GO:1990116 DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022] 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676] g3347.t1 Q8JH47 68.016 494 0.0 674.0 sp|Q8JH47|CDK8_DANRE Cyclin-dependent kinase 8 OS=Danio rerio OX=7955 GN=cdk8 PE=2 SV=1 g3347.t2 Q6P3N6 69.979 483 0.0 678.0 sp|Q6P3N6|CDK8_XENTR Cyclin-dependent kinase 8 OS=Xenopus tropicalis OX=8364 GN=cdk8 PE=2 SV=1 g3347.t3 Q6P3N6 69.485 485 0.0 674.0 sp|Q6P3N6|CDK8_XENTR Cyclin-dependent kinase 8 OS=Xenopus tropicalis OX=8364 GN=cdk8 PE=2 SV=1 g3348.t1 P79888 51.07 327 3.81e-108 322.0 sp|P79888|DCAM_XENLA S-adenosylmethionine decarboxylase proenzyme OS=Xenopus laevis OX=8355 GN=amd1 PE=2 SV=1 g3350.t1 Q8C0X0 34.842 221 1.44e-32 139.0 sp|Q8C0X0|LCA5L_MOUSE Lebercilin-like protein OS=Mus musculus OX=10090 GN=Lca5l PE=2 SV=3 g3350.t2 Q8C0X0 34.842 221 1.69e-32 139.0 sp|Q8C0X0|LCA5L_MOUSE Lebercilin-like protein OS=Mus musculus OX=10090 GN=Lca5l PE=2 SV=3 g3354.t1 P35738 77.035 344 0.0 572.0 sp|P35738|ODBB_RAT 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bckdhb PE=1 SV=3 g3355.t1 Q7ZUP1 64.263 319 7.069999999999999e-150 433.0 sp|Q7ZUP1|TET5C_DANRE Terminal nucleotidyltransferase 5C OS=Danio rerio OX=7955 GN=tent5c PE=2 SV=1 g3356.t1 A7T167 48.509 503 1.54e-177 511.0 sp|A7T167|GDAP2_NEMVE Protein GDAP2 homolog OS=Nematostella vectensis OX=45351 GN=gdap2 PE=3 SV=1 g3357.t1 P91620 41.421 1084 0.0 790.0 sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2 SIF2_DROME reviewed Protein still life, isoforms C/SIF type 2 Drosophila melanogaster (Fruit fly) GO:0005085; GO:0007264; GO:0030036; GO:0045202; GO:0050770; GO:0050803; GO:0051491 actin cytoskeleton organization [GO:0030036]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264] synapse [GO:0045202] guanyl-nucleotide exchange factor activity [GO:0005085] g3357.t2 P91620 41.23 1089 0.0 785.0 sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2 SIF2_DROME reviewed Protein still life, isoforms C/SIF type 2 Drosophila melanogaster (Fruit fly) GO:0005085; GO:0007264; GO:0030036; GO:0045202; GO:0050770; GO:0050803; GO:0051491 actin cytoskeleton organization [GO:0030036]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264] synapse [GO:0045202] guanyl-nucleotide exchange factor activity [GO:0005085] g3357.t3 P91620 41.042 1094 0.0 784.0 sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2 SIF2_DROME reviewed Protein still life, isoforms C/SIF type 2 Drosophila melanogaster (Fruit fly) GO:0005085; GO:0007264; GO:0030036; GO:0045202; GO:0050770; GO:0050803; GO:0051491 actin cytoskeleton organization [GO:0030036]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264] synapse [GO:0045202] guanyl-nucleotide exchange factor activity [GO:0005085] g3358.t1 O88848 67.582 182 2.8e-92 270.0 sp|O88848|ARL6_MOUSE ADP-ribosylation factor-like protein 6 OS=Mus musculus OX=10090 GN=Arl6 PE=1 SV=1 ARL6_MOUSE reviewed ADP-ribosylation factor-like protein 6 Mus musculus (Mouse) GO:0003924; GO:0005525; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005879; GO:0005929; GO:0005930; GO:0006612; GO:0006886; GO:0007265; GO:0007420; GO:0008589; GO:0010842; GO:0015630; GO:0016020; GO:0016055; GO:0016192; GO:0030117; GO:0045444; GO:0046872; GO:0051258; GO:0060170; GO:0060271; GO:0061512; GO:0097499; GO:1903445; GO:1990404 brain development [GO:0007420]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; intracellular protein transport [GO:0006886]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; Ras protein signal transduction [GO:0007265]; regulation of smoothened signaling pathway [GO:0008589]; retina layer formation [GO:0010842]; vesicle-mediated transport [GO:0016192]; Wnt signaling pathway [GO:0016055] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; phospholipid binding [GO:0005543] g3359.t1 Q28HM1 64.984 317 2.83e-152 433.0 sp|Q28HM1|TFB1M_XENTR Dimethyladenosine transferase 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=tfb1m PE=2 SV=1 TFB1M_XENTR reviewed Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000179; GO:0003677; GO:0003723; GO:0005739; GO:0031167; GO:1904047 rRNA methylation [GO:0031167] mitochondrion [GO:0005739] DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; S-adenosyl-L-methionine binding [GO:1904047] g3362.t1 Q7Z449 35.642 491 3.84e-97 306.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g3363.t1 Q6PQD5 38.106 3178 0.0 2017.0 sp|Q6PQD5|ATM_PIG Serine-protein kinase ATM OS=Sus scrofa OX=9823 GN=ATM PE=3 SV=2 g3365.t1 P80146 38.192 343 2.79e-54 189.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g3366.t1 Q5T5N4 24.675 462 1.59e-32 132.0 sp|Q5T5N4|CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens OX=9606 GN=C6orf118 PE=1 SV=1 g3366.t2 Q5T5N4 24.051 474 1.29e-29 124.0 sp|Q5T5N4|CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens OX=9606 GN=C6orf118 PE=1 SV=1 g3367.t1 Q5R9W6 81.25 96 9.199999999999999e-55 170.0 sp|Q5R9W6|TAF13_PONAB Transcription initiation factor TFIID subunit 13 OS=Pongo abelii OX=9601 GN=TAF13 PE=2 SV=1 TAF13_PONAB reviewed Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003677; GO:0005669; GO:0005730; GO:0017025; GO:0042789; GO:0046982; GO:0051123; GO:0060261 mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] nucleolus [GO:0005730]; transcription factor TFIID complex [GO:0005669] DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025] g3368.t1 Q6J3Q7 67.925 53 1.57e-21 81.6 sp|Q6J3Q7|COX17_CANLF Cytochrome c oxidase copper chaperone OS=Canis lupus familiaris OX=9615 GN=COX17 PE=3 SV=3 g3370.t1 P08594 29.902 408 1.15e-49 179.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g3371.t1 P08594 34.808 339 3.48e-43 161.0 sp|P08594|AQL1_THEAQ Aqualysin-1 OS=Thermus aquaticus OX=271 GN=pstI PE=1 SV=2 g3372.t1 Q9Y385 63.333 240 1.52e-101 306.0 sp|Q9Y385|UB2J1_HUMAN Ubiquitin-conjugating enzyme E2 J1 OS=Homo sapiens OX=9606 GN=UBE2J1 PE=1 SV=2 UB2J1_HUMAN reviewed Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e) Homo sapiens (Human) GO:0000209; GO:0000836; GO:0005524; GO:0005634; GO:0005789; GO:0007286; GO:0010935; GO:0018279; GO:0031625; GO:0032680; GO:0036503; GO:0061631; GO:1904153 ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286] endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625] g3373.t1 Q9CZ57 49.662 296 6.170000000000001e-85 270.0 sp|Q9CZ57|NSUN4_MOUSE 5-cytosine rRNA methyltransferase NSUN4 OS=Mus musculus OX=10090 GN=Nsun4 PE=1 SV=1 NSUN4_MOUSE reviewed 5-cytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (5-cytosine tRNA methyltransferase NSUN4) (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4) (Sperm head and tail associated protein) Mus musculus (Mouse) GO:0000957; GO:0005759; GO:0009383; GO:0031167; GO:0062152; GO:0070181; GO:0180026; GO:1902775 mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial small ribosomal subunit assembly [GO:0180026]; rRNA methylation [GO:0031167] mitochondrial matrix [GO:0005759] mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; small ribosomal subunit rRNA binding [GO:0070181] g3375.t1 Q2KJ09 42.438 443 1.2e-85 297.0 sp|Q2KJ09|UBP16_RAT Ubiquitin carboxyl-terminal hydrolase 16 OS=Rattus norvegicus OX=10116 GN=Usp16 PE=1 SV=2 UBP16_RAT reviewed Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16) Rattus norvegicus (Rat) GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006357; GO:0006508; GO:0006974; GO:0008270; GO:0035520; GO:0042393; GO:0043024; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0090070; GO:0140014; GO:0140950 cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic nuclear division [GO:0140014]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; ribosomal small subunit binding [GO:0043024]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g3375.t1 Q2KJ09 41.016 256 2.34e-49 192.0 sp|Q2KJ09|UBP16_RAT Ubiquitin carboxyl-terminal hydrolase 16 OS=Rattus norvegicus OX=10116 GN=Usp16 PE=1 SV=2 UBP16_RAT reviewed Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-specific-processing protease 16) Rattus norvegicus (Rat) GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006357; GO:0006508; GO:0006974; GO:0008270; GO:0035520; GO:0042393; GO:0043024; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0090070; GO:0140014; GO:0140950 cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic nuclear division [GO:0140014]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ribosome biogenesis [GO:0090070]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; ribosomal small subunit binding [GO:0043024]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g3376.t1 Q91XQ0 29.249 2342 0.0 1051.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t1 Q91XQ0 25.762 1378 7.48e-112 407.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t1 Q91XQ0 27.642 369 1.0400000000000001e-43 182.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t1 Q91XQ0 26.385 379 9.25e-34 149.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t2 Q39575 29.851 2278 0.0 1100.0 sp|Q39575|DYHG_CHLRE Dynein gamma chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA2 PE=1 SV=1 DYHG_CHLRE reviewed Dynein gamma chain, flagellar outer arm Chlamydomonas reinhardtii (Chlamydomonas smithii) GO:0005524; GO:0005874; GO:0008569; GO:0030286; GO:0031514; GO:0036158; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t2 Q39575 25.487 1334 3.29e-96 355.0 sp|Q39575|DYHG_CHLRE Dynein gamma chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA2 PE=1 SV=1 DYHG_CHLRE reviewed Dynein gamma chain, flagellar outer arm Chlamydomonas reinhardtii (Chlamydomonas smithii) GO:0005524; GO:0005874; GO:0008569; GO:0030286; GO:0031514; GO:0036158; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t2 Q39575 30.385 441 3.56e-60 236.0 sp|Q39575|DYHG_CHLRE Dynein gamma chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA2 PE=1 SV=1 DYHG_CHLRE reviewed Dynein gamma chain, flagellar outer arm Chlamydomonas reinhardtii (Chlamydomonas smithii) GO:0005524; GO:0005874; GO:0008569; GO:0030286; GO:0031514; GO:0036158; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t2 Q39575 29.278 485 6.489999999999999e-42 176.0 sp|Q39575|DYHG_CHLRE Dynein gamma chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA2 PE=1 SV=1 DYHG_CHLRE reviewed Dynein gamma chain, flagellar outer arm Chlamydomonas reinhardtii (Chlamydomonas smithii) GO:0005524; GO:0005874; GO:0008569; GO:0030286; GO:0031514; GO:0036158; GO:0045505; GO:0051959; GO:0060294 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t3 Q91XQ0 29.163 2342 0.0 1050.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t3 Q91XQ0 25.762 1378 8.29e-112 407.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t3 Q91XQ0 27.642 369 1.1300000000000001e-43 182.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t3 Q91XQ0 27.1 369 1.61e-34 151.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t4 Q91XQ0 29.163 2342 0.0 1050.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t4 Q91XQ0 25.762 1378 8.38e-112 407.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t4 Q91XQ0 27.642 369 1.14e-43 182.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t4 Q91XQ0 26.385 379 9.84e-34 149.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t5 Q91XQ0 29.163 2342 0.0 1051.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t5 Q91XQ0 25.632 1385 5.94e-110 401.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t5 Q91XQ0 27.642 369 9.65e-44 182.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t5 Q91XQ0 26.385 379 8.41e-34 149.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t6 Q91XQ0 29.163 2342 0.0 1051.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t6 Q91XQ0 25.303 1403 2.8100000000000003e-109 399.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t6 Q91XQ0 27.642 369 1.0400000000000001e-43 182.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3376.t6 Q91XQ0 26.385 379 9.409999999999999e-34 149.0 sp|Q91XQ0|DYH8_MOUSE Dynein axonemal heavy chain 8 OS=Mus musculus OX=10090 GN=Dnah8 PE=1 SV=2 DYH8_MOUSE reviewed Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) Mus musculus (Mouse) GO:0003777; GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060294; GO:0097228 cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] g3377.t1 P14942 47.297 222 2.67e-58 187.0 sp|P14942|GSTA4_RAT Glutathione S-transferase alpha-4 OS=Rattus norvegicus OX=10116 GN=Gsta4 PE=1 SV=2 GSTA4_RAT reviewed Glutathione S-transferase alpha-4 (EC 2.5.1.18) (GST 8-8) (GST A4-4) (GST K) (Glutathione S-transferase Yk) (GST Yk) Rattus norvegicus (Rat) GO:0004364; GO:0005739; GO:0005829; GO:0006749; GO:0006805; GO:0009635; GO:0010043; GO:0015643; GO:0035094; GO:0042802; GO:0042803; GO:0061771; GO:0071285 cellular response to lithium ion [GO:0071285]; glutathione metabolic process [GO:0006749]; response to caloric restriction [GO:0061771]; response to herbicide [GO:0009635]; response to nicotine [GO:0035094]; response to zinc ion [GO:0010043]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; mitochondrion [GO:0005739] glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] g3377.t2 P14942 47.297 222 1.85e-58 187.0 sp|P14942|GSTA4_RAT Glutathione S-transferase alpha-4 OS=Rattus norvegicus OX=10116 GN=Gsta4 PE=1 SV=2 GSTA4_RAT reviewed Glutathione S-transferase alpha-4 (EC 2.5.1.18) (GST 8-8) (GST A4-4) (GST K) (Glutathione S-transferase Yk) (GST Yk) Rattus norvegicus (Rat) GO:0004364; GO:0005739; GO:0005829; GO:0006749; GO:0006805; GO:0009635; GO:0010043; GO:0015643; GO:0035094; GO:0042802; GO:0042803; GO:0061771; GO:0071285 cellular response to lithium ion [GO:0071285]; glutathione metabolic process [GO:0006749]; response to caloric restriction [GO:0061771]; response to herbicide [GO:0009635]; response to nicotine [GO:0035094]; response to zinc ion [GO:0010043]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; mitochondrion [GO:0005739] glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] g3378.t1 Q9NVP1 65.224 624 0.0 811.0 sp|Q9NVP1|DDX18_HUMAN ATP-dependent RNA helicase DDX18 OS=Homo sapiens OX=9606 GN=DDX18 PE=1 SV=2 DDX18_HUMAN reviewed ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb) Homo sapiens (Human) GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0016887; GO:0071392 cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463] chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g3379.t1 Q9JIL5 47.546 713 0.0 633.0 sp|Q9JIL5|TULP4_MOUSE Tubby-related protein 4 OS=Mus musculus OX=10090 GN=Tulp4 PE=1 SV=1 g3379.t1 Q9JIL5 50.568 176 3.66e-37 156.0 sp|Q9JIL5|TULP4_MOUSE Tubby-related protein 4 OS=Mus musculus OX=10090 GN=Tulp4 PE=1 SV=1 g3380.t1 Q5U2V9 46.296 486 1.29e-138 411.0 sp|Q5U2V9|TM39A_RAT Transmembrane protein 39A OS=Rattus norvegicus OX=10116 GN=Tmem39a PE=2 SV=1 g3381.t1 Q99417 61.053 95 1.84e-38 127.0 sp|Q99417|MYCBP_HUMAN c-Myc-binding protein OS=Homo sapiens OX=9606 GN=MYCBP PE=1 SV=3 MYCBP_HUMAN reviewed c-Myc-binding protein (Associate of Myc 1) (AMY-1) Homo sapiens (Human) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006355; GO:0007283 regulation of DNA-templated transcription [GO:0006355]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] transcription coactivator activity [GO:0003713] g3382.t1 O88828 80.952 105 1.4999999999999999e-55 172.0 sp|O88828|RPAB2_RAT DNA-directed RNA polymerases I, II, and III subunit RPABC2 OS=Rattus norvegicus OX=10116 GN=Polr2f PE=1 SV=1 g3383.t1 A4IF63 30.213 235 6.04e-24 110.0 sp|A4IF63|TRIM2_BOVIN Tripartite motif-containing protein 2 OS=Bos taurus OX=9913 GN=TRIM2 PE=2 SV=1 TRIM2_BOVIN reviewed Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING-type E3 ubiquitin transferase TRIM2) Bos taurus (Bovine) GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3387.t1 Q7TP40 52.083 96 1.1799999999999999e-25 101.0 sp|Q7TP40|PCNP_RAT PEST proteolytic signal-containing nuclear protein OS=Rattus norvegicus OX=10116 GN=Pcnp PE=1 SV=1 g3388.t1 Q8K183 55.34 309 8.42e-117 342.0 sp|Q8K183|PDXK_MOUSE Pyridoxal kinase OS=Mus musculus OX=10090 GN=Pdxk PE=1 SV=1 PDXK_MOUSE reviewed Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) Mus musculus (Mouse) GO:0000287; GO:0005524; GO:0005654; GO:0005829; GO:0008270; GO:0008478; GO:0009443; GO:0016773; GO:0030170; GO:0030955; GO:0031402; GO:0031403; GO:0042803; GO:0042816; GO:0070280 pyridoxal 5'-phosphate salvage [GO:0009443]; vitamin B6 metabolic process [GO:0042816] cytosol [GO:0005829]; nucleoplasm [GO:0005654] ATP binding [GO:0005524]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal kinase activity [GO:0008478]; pyridoxal phosphate binding [GO:0030170]; sodium ion binding [GO:0031402]; zinc ion binding [GO:0008270] g3389.t1 D4A1J4 65.164 244 2.96e-119 343.0 sp|D4A1J4|DHRS6_RAT Dehydrogenase/reductase SDR family member 6 OS=Rattus norvegicus OX=10116 GN=Bdh2 PE=1 SV=2 DHRS6_RAT reviewed Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.-) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (EC 1.1.1.30) (4-oxo-L-proline reductase) (EC 1.1.1.104) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1) Rattus norvegicus (Rat) GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0016617; GO:0016628; GO:0019290; GO:0030855; GO:0042168; GO:0051287 epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; siderophore biosynthetic process [GO:0019290] cytoplasm [GO:0005737]; cytosol [GO:0005829] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; 4-oxoproline reductase activity [GO:0016617]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628] g3390.t1 Q3BCU4 40.336 238 1.3899999999999998e-54 188.0 sp|Q3BCU4|POPD1_RAT Popeye domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Popdc1 PE=1 SV=2 POPD1_RAT reviewed Popeye domain-containing protein 1 (Popeye protein 1) (Blood vessel epicardial substance) Rattus norvegicus (Rat) GO:0001921; GO:0002027; GO:0002244; GO:0002931; GO:0005198; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007519; GO:0008360; GO:0016020; GO:0016192; GO:0016328; GO:0030054; GO:0030552; GO:0031253; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0048278; GO:0051146; GO:0060931; GO:0060973; GO:0090136; GO:2001135 cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] cAMP binding [GO:0030552]; structural molecule activity [GO:0005198] g3391.t1 Q9DG23 36.677 319 6.400000000000001e-59 197.0 sp|Q9DG23|POPD1_CHICK Popeye domain-containing protein 1 OS=Gallus gallus OX=9031 GN=POPDC1 PE=1 SV=1 g3394.t1 Q6P5U7 29.412 884 4.07e-80 297.0 sp|Q6P5U7|NWD2_MOUSE NACHT and WD repeat domain-containing protein 2 OS=Mus musculus OX=10090 GN=Nwd2 PE=1 SV=2 g3395.t1 O35115 44.097 288 1.32e-87 275.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g3395.t1 O35115 31.655 278 2.23e-35 137.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g3395.t1 O35115 27.679 224 1.4100000000000001e-22 101.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g3395.t2 O35115 44.097 288 2.11e-87 275.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g3395.t2 O35115 31.655 278 3.21e-35 137.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g3395.t2 O35115 27.679 224 2.13e-22 100.0 sp|O35115|FHL2_RAT Four and a half LIM domains protein 2 OS=Rattus norvegicus OX=10116 GN=Fhl2 PE=1 SV=1 FHL2_RAT reviewed Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) Rattus norvegicus (Rat) GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0006357; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0031430; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885 atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018] bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270] g3399.t1 Q6Q759 33.736 2072 0.0 959.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3399.t1 Q6Q759 46.047 215 7.27e-44 181.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3399.t2 Q6Q759 35.377 1142 2.75e-178 608.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3399.t2 Q6Q759 32.843 883 5.12e-103 374.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3399.t2 Q6Q759 46.047 215 6.91e-44 181.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3399.t3 Q6Q759 35.197 1145 3.27e-177 605.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3399.t3 Q6Q759 32.874 870 6.05e-103 374.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3399.t3 Q6Q759 46.047 215 7.38e-44 181.0 sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1 SPG17_HUMAN reviewed Sperm-associated antigen 17 (Projection protein PF6 homolog) Homo sapiens (Human) GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874] g3410.t1 Q499Y0 48.384 1145 0.0 1118.0 sp|Q499Y0|XPO4_XENLA Exportin-4 OS=Xenopus laevis OX=8355 GN=xpo4 PE=2 SV=1 g3411.t1 Q6GQ39 39.318 440 1.06e-103 320.0 sp|Q6GQ39|TM135_XENLA Transmembrane protein 135 OS=Xenopus laevis OX=8355 GN=tmem135 PE=2 SV=1 g3413.t1 Q9QZH0 61.468 327 1.82e-142 418.0 sp|Q9QZH0|FZD4_RAT Frizzled-4 OS=Rattus norvegicus OX=10116 GN=Fzd4 PE=2 SV=1 g3414.t1 Q61088 66.049 162 2.83e-64 208.0 sp|Q61088|FZD4_MOUSE Frizzled-4 OS=Mus musculus OX=10090 GN=Fzd4 PE=1 SV=1 FZD4_MOUSE reviewed Frizzled-4 (Fz-4) (mFz4) (CD antigen CD344) Mus musculus (Mouse) GO:0001525; GO:0001540; GO:0001553; GO:0001568; GO:0001570; GO:0001666; GO:0004896; GO:0004930; GO:0005654; GO:0005886; GO:0005911; GO:0005929; GO:0007223; GO:0007605; GO:0008283; GO:0009986; GO:0010812; GO:0016055; GO:0017147; GO:0019955; GO:0030165; GO:0030335; GO:0030425; GO:0030947; GO:0031625; GO:0031987; GO:0034446; GO:0035426; GO:0035567; GO:0038023; GO:0042701; GO:0042803; GO:0042813; GO:0044877; GO:0045202; GO:0045446; GO:0045893; GO:0045944; GO:0046982; GO:0050775; GO:0060070; GO:0060856; GO:0061298; GO:0061299; GO:0061301; GO:0061304; GO:0098978; GO:0110135; GO:0150012; GO:1990830 angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cell population proliferation [GO:0008283]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum vasculature morphogenesis [GO:0061301]; endothelial cell differentiation [GO:0045446]; establishment of blood-brain barrier [GO:0060856]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; luteinization [GO:0001553]; negative regulation of cell-substrate adhesion [GO:0010812]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g3414.t2 Q61088 67.241 174 3.01e-72 229.0 sp|Q61088|FZD4_MOUSE Frizzled-4 OS=Mus musculus OX=10090 GN=Fzd4 PE=1 SV=1 FZD4_MOUSE reviewed Frizzled-4 (Fz-4) (mFz4) (CD antigen CD344) Mus musculus (Mouse) GO:0001525; GO:0001540; GO:0001553; GO:0001568; GO:0001570; GO:0001666; GO:0004896; GO:0004930; GO:0005654; GO:0005886; GO:0005911; GO:0005929; GO:0007223; GO:0007605; GO:0008283; GO:0009986; GO:0010812; GO:0016055; GO:0017147; GO:0019955; GO:0030165; GO:0030335; GO:0030425; GO:0030947; GO:0031625; GO:0031987; GO:0034446; GO:0035426; GO:0035567; GO:0038023; GO:0042701; GO:0042803; GO:0042813; GO:0044877; GO:0045202; GO:0045446; GO:0045893; GO:0045944; GO:0046982; GO:0050775; GO:0060070; GO:0060856; GO:0061298; GO:0061299; GO:0061301; GO:0061304; GO:0098978; GO:0110135; GO:0150012; GO:1990830 angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cell population proliferation [GO:0008283]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum vasculature morphogenesis [GO:0061301]; endothelial cell differentiation [GO:0045446]; establishment of blood-brain barrier [GO:0060856]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; luteinization [GO:0001553]; negative regulation of cell-substrate adhesion [GO:0010812]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g3416.t1 Q32LJ6 54.852 237 6.67e-86 257.0 sp|Q32LJ6|RABL3_BOVIN Rab-like protein 3 OS=Bos taurus OX=9913 GN=RABL3 PE=2 SV=2 RABL3_BOVIN reviewed Rab-like protein 3 (EC 3.6.5.2) Bos taurus (Bovine) GO:0001779; GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030183; GO:0033077; GO:0042803; GO:0045724; GO:0046578; GO:0050821; GO:1903059 B cell differentiation [GO:0030183]; intracellular protein transport [GO:0006886]; natural killer cell differentiation [GO:0001779]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077] endomembrane system [GO:0012505] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803] g3416.t2 Q32LJ6 51.181 254 2.0699999999999998e-81 247.0 sp|Q32LJ6|RABL3_BOVIN Rab-like protein 3 OS=Bos taurus OX=9913 GN=RABL3 PE=2 SV=2 RABL3_BOVIN reviewed Rab-like protein 3 (EC 3.6.5.2) Bos taurus (Bovine) GO:0001779; GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030183; GO:0033077; GO:0042803; GO:0045724; GO:0046578; GO:0050821; GO:1903059 B cell differentiation [GO:0030183]; intracellular protein transport [GO:0006886]; natural killer cell differentiation [GO:0001779]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077] endomembrane system [GO:0012505] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803] g3417.t1 Q5R8H5 42.308 442 3.8499999999999995e-104 318.0 sp|Q5R8H5|T2EA_PONAB General transcription factor IIE subunit 1 OS=Pongo abelii OX=9601 GN=GTF2E1 PE=2 SV=1 g3418.t1 Q6EE31 66.667 546 0.0 739.0 sp|Q6EE31|TCPQ_CHICK T-complex protein 1 subunit theta OS=Gallus gallus OX=9031 GN=CCT8 PE=1 SV=3 TCPQ_CHICK reviewed T-complex protein 1 subunit theta (TCP-1-theta) (EC 3.6.1.-) (CCT-theta) Gallus gallus (Chicken) GO:0005524; GO:0005813; GO:0005832; GO:0006457; GO:0016887; GO:0046872; GO:0051082; GO:0140662 protein folding [GO:0006457] centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] g3419.t1 Q9Y5Y3 50.0 352 1.7e-124 366.0 sp|Q9Y5Y3|GPR45_HUMAN Probable G-protein coupled receptor 45 OS=Homo sapiens OX=9606 GN=GPR45 PE=1 SV=2 g3421.t1 Q24799 45.312 192 7.6e-50 162.0 sp|Q24799|MYPH_ECHGR Myophilin OS=Echinococcus granulosus OX=6210 PE=2 SV=1 g3421.t2 Q24799 44.271 192 1.1799999999999999e-48 159.0 sp|Q24799|MYPH_ECHGR Myophilin OS=Echinococcus granulosus OX=6210 PE=2 SV=1 g3422.t1 Q8NCR3 44.643 280 2.2899999999999998e-82 262.0 sp|Q8NCR3|MFI_HUMAN Protein MFI OS=Homo sapiens OX=9606 GN=MFI PE=1 SV=1 g3424.t1 Q14202 33.391 1150 0.0 583.0 sp|Q14202|ZMYM3_HUMAN Zinc finger MYM-type protein 3 OS=Homo sapiens OX=9606 GN=ZMYM3 PE=1 SV=2 g3424.t2 Q14202 33.42 1152 0.0 585.0 sp|Q14202|ZMYM3_HUMAN Zinc finger MYM-type protein 3 OS=Homo sapiens OX=9606 GN=ZMYM3 PE=1 SV=2 g3424.t3 Q14202 33.42 1152 0.0 585.0 sp|Q14202|ZMYM3_HUMAN Zinc finger MYM-type protein 3 OS=Homo sapiens OX=9606 GN=ZMYM3 PE=1 SV=2 g3425.t1 Q9UBI9 44.0 150 7.689999999999999e-34 130.0 sp|Q9UBI9|HDC_HUMAN Headcase protein homolog OS=Homo sapiens OX=9606 GN=HECA PE=1 SV=1 g3426.t1 P58467 35.753 372 1.6e-69 229.0 sp|P58467|SETD4_MOUSE SET domain-containing protein 4 OS=Mus musculus OX=10090 GN=Setd4 PE=1 SV=2 SETD4_MOUSE reviewed SET domain-containing protein 4 (EC 2.1.1.-) (EC 2.1.1.364) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005829; GO:0006338; GO:0006954; GO:0032259; GO:0032755; GO:0032760; GO:0042799; GO:0042800; GO:0045944; GO:0046975; GO:0050729; GO:0071863; GO:0140941; GO:0140944; GO:0140945 chromatin remodeling [GO:0006338]; inflammatory response [GO:0006954]; methylation [GO:0032259]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863] cytosol [GO:0005829]; nucleus [GO:0005634] histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; transcription coactivator activity [GO:0003713] g3440.t1 P16423 33.725 255 5.3399999999999995e-30 127.0 sp|P16423|POLR_DROME Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g3442.t1 P18654 70.013 747 0.0 1069.0 sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2 g3447.t1 Q5TFE4 35.776 464 7.17e-89 281.0 sp|Q5TFE4|NT5D1_HUMAN 5'-nucleotidase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NT5DC1 PE=1 SV=1 g3448.t1 Q5FWR0 47.971 838 0.0 770.0 sp|Q5FWR0|SMRCD_XENTR SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Xenopus tropicalis OX=8364 GN=smarcad1 PE=2 SV=1 SMRCD_XENTR reviewed SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.-) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000729; GO:0000785; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0016887; GO:0031507; GO:0035861; GO:0043130; GO:0045944; GO:0140658; GO:0140750 DNA double-strand break processing [GO:0000729]; heterochromatin formation [GO:0031507]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome array spacer activity [GO:0140750]; ubiquitin binding [GO:0043130] g3450.t1 Q8NFD5 50.712 351 3.34e-105 381.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t1 Q8NFD5 35.39 308 6.1900000000000005e-37 157.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t1 Q8NFD5 30.25 400 1.6700000000000002e-26 123.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t1 Q8NFD5 37.545 277 3.7e-21 105.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t2 O14497 39.776 714 2.46e-127 451.0 sp|O14497|ARI1A_HUMAN AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3 ARI1A_HUMAN reviewed AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713] g3450.t3 Q8NFD5 50.712 351 3.33e-105 381.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t3 Q8NFD5 35.39 308 6.13e-37 157.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t3 Q8NFD5 30.25 400 1.64e-26 123.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t3 Q8NFD5 37.545 277 3.69e-21 105.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t4 Q8NFD5 50.712 351 3.4900000000000004e-105 381.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t4 Q8NFD5 35.39 308 6.740000000000001e-37 157.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t4 Q8NFD5 30.25 400 1.8500000000000002e-26 123.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t5 Q8NFD5 50.712 351 4.15e-105 380.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t5 Q8NFD5 35.39 308 6.740000000000001e-37 157.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t5 Q8NFD5 30.0 400 3.7000000000000004e-26 122.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t5 Q8NFD5 37.545 277 3.6700000000000006e-21 105.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t6 Q8NFD5 50.712 351 3.33e-105 380.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t6 Q8NFD5 35.39 308 6.88e-37 157.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t6 Q8NFD5 30.25 400 1.4e-26 123.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3450.t6 Q8NFD5 37.545 277 3.6700000000000006e-21 105.0 sp|Q8NFD5|ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ARID1B PE=1 SV=3 ARI1B_HUMAN reviewed AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] g3451.t1 P22102 59.764 1019 0.0 1204.0 sp|P22102|PUR2_HUMAN Trifunctional purine biosynthetic protein adenosine-3 OS=Homo sapiens OX=9606 GN=GART PE=1 SV=1 PUR2_HUMAN reviewed Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)] Homo sapiens (Human) GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0009168; GO:0021549; GO:0021987; GO:0044208; GO:0046084; GO:0046872; GO:0070062; GO:0097294 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168] cytosol [GO:0005829]; extracellular exosome [GO:0070062] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644] g3453.t1 Q8BMS4 47.5 280 9.840000000000001e-88 268.0 sp|Q8BMS4|COQ3_MOUSE Ubiquinone biosynthesis O-methyltransferase, mitochondrial OS=Mus musculus OX=10090 GN=Coq3 PE=1 SV=1 COQ3_MOUSE reviewed Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.-) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0005759; GO:0006071; GO:0006744; GO:0008171; GO:0010420; GO:0031314; GO:0032259; GO:0046872; GO:0061542; GO:0110142; GO:0120537 glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142] 3-demethylubiquinol 3-O-methyltransferase activity [GO:0061542]; 3-demethylubiquinone 3-O-methyltransferase activity [GO:0120537]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; polyprenyldihydroxybenzoate methyltransferase activity [GO:0010420] g3455.t1 Q3T0Q8 42.138 318 1.2700000000000001e-64 232.0 sp|Q3T0Q8|UT14A_BOVIN U3 small nucleolar RNA-associated protein 14 homolog A OS=Bos taurus OX=9913 GN=UTP14A PE=2 SV=1 g3455.t1 Q3T0Q8 38.208 212 3.65e-36 149.0 sp|Q3T0Q8|UT14A_BOVIN U3 small nucleolar RNA-associated protein 14 homolog A OS=Bos taurus OX=9913 GN=UTP14A PE=2 SV=1 g3459.t1 F1NZI4 39.046 671 2.13e-179 531.0 sp|F1NZI4|PGGHG_CHICK Protein-glucosylgalactosylhydroxylysine glucosidase OS=Gallus gallus OX=9031 GN=PGGHG PE=1 SV=3 g3460.t1 Q8AYG3 50.862 348 4.2e-102 345.0 sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio OX=7955 GN=ttk PE=1 SV=2 TTK_DANRE reviewed Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000776; GO:0001100; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0007059; GO:0007060; GO:0007094; GO:0016321; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0060249; GO:0106310 anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of exit from mitosis [GO:0001100]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246] kinetochore [GO:0000776]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g3462.t1 Q68UT7 48.864 352 1.17e-106 348.0 sp|Q68UT7|HUNK_PANTR Hormonally up-regulated neu tumor-associated kinase OS=Pan troglodytes OX=9598 GN=HUNK PE=3 SV=1 g3466.t1 Q80VI1 26.861 309 8.99e-25 113.0 sp|Q80VI1|TRI56_MOUSE E3 ubiquitin-protein ligase TRIM56 OS=Mus musculus OX=10090 GN=Trim56 PE=1 SV=1 TRI56_MOUSE reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0044790; GO:0045087; GO:0045089; GO:0046597; GO:0051607; GO:0060340; GO:0061630; GO:0070534; GO:0140896; GO:1901224 cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; host-mediated suppression of symbiont invasion [GO:0046597]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g3467.t1 Q7ZTY4 92.019 426 0.0 808.0 sp|Q7ZTY4|RBBP7_DANRE Histone-binding protein RBBP7 OS=Danio rerio OX=7955 GN=rbbp7 PE=2 SV=1 g3468.t1 Q96D71 43.75 192 2.4100000000000003e-31 135.0 sp|Q96D71|REPS1_HUMAN RalBP1-associated Eps domain-containing protein 1 OS=Homo sapiens OX=9606 GN=REPS1 PE=1 SV=3 g3473.t1 O75417 65.672 67 1.82e-22 92.0 sp|O75417|DPOLQ_HUMAN DNA polymerase theta OS=Homo sapiens OX=9606 GN=POLQ PE=1 SV=2 DPOLQ_HUMAN reviewed DNA polymerase theta (DNA polymerase eta) [Includes: Helicase POLQ (EC 3.6.4.12); DNA polymerase POLQ (EC 2.7.7.7) (RNA-directed DNA polymerase POLQ) (EC 2.7.7.49)] Homo sapiens (Human) GO:0000287; GO:0000731; GO:0003678; GO:0003682; GO:0003684; GO:0003887; GO:0003964; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0016887; GO:0017116; GO:0031297; GO:0035861; GO:0042276; GO:0042645; GO:0042802; GO:0051260; GO:0051575; GO:0090734; GO:0097681; GO:2000042 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; error-prone translesion synthesis [GO:0042276]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; replication fork processing [GO:0031297]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; single-stranded DNA helicase activity [GO:0017116] g3474.t1 Q8CGS6 46.97 132 2.44e-35 131.0 sp|Q8CGS6|DPOLQ_MOUSE DNA polymerase theta OS=Mus musculus OX=10090 GN=Polq PE=1 SV=2 g3475.t1 O75417 51.197 543 2.7200000000000004e-166 528.0 sp|O75417|DPOLQ_HUMAN DNA polymerase theta OS=Homo sapiens OX=9606 GN=POLQ PE=1 SV=2 DPOLQ_HUMAN reviewed DNA polymerase theta (DNA polymerase eta) [Includes: Helicase POLQ (EC 3.6.4.12); DNA polymerase POLQ (EC 2.7.7.7) (RNA-directed DNA polymerase POLQ) (EC 2.7.7.49)] Homo sapiens (Human) GO:0000287; GO:0000731; GO:0003678; GO:0003682; GO:0003684; GO:0003887; GO:0003964; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0016887; GO:0017116; GO:0031297; GO:0035861; GO:0042276; GO:0042645; GO:0042802; GO:0051260; GO:0051575; GO:0090734; GO:0097681; GO:2000042 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; error-prone translesion synthesis [GO:0042276]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; replication fork processing [GO:0031297]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; single-stranded DNA helicase activity [GO:0017116] g3479.t1 O75417 71.277 94 9.15e-36 140.0 sp|O75417|DPOLQ_HUMAN DNA polymerase theta OS=Homo sapiens OX=9606 GN=POLQ PE=1 SV=2 DPOLQ_HUMAN reviewed DNA polymerase theta (DNA polymerase eta) [Includes: Helicase POLQ (EC 3.6.4.12); DNA polymerase POLQ (EC 2.7.7.7) (RNA-directed DNA polymerase POLQ) (EC 2.7.7.49)] Homo sapiens (Human) GO:0000287; GO:0000731; GO:0003678; GO:0003682; GO:0003684; GO:0003887; GO:0003964; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0016887; GO:0017116; GO:0031297; GO:0035861; GO:0042276; GO:0042645; GO:0042802; GO:0051260; GO:0051575; GO:0090734; GO:0097681; GO:2000042 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; error-prone translesion synthesis [GO:0042276]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; replication fork processing [GO:0031297]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; single-stranded DNA helicase activity [GO:0017116] g3483.t1 B3EWY9 30.33 1121 3.36e-114 406.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g3483.t1 B3EWY9 32.024 331 5.9399999999999995e-30 135.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g3483.t1 B3EWY9 31.875 320 7.810000000000001e-27 124.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g3483.t1 B3EWY9 28.371 356 4.570000000000001e-22 109.0 sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g3485.t1 Q6DE40 36.62 142 1.1499999999999999e-23 98.6 sp|Q6DE40|MANEA_XENLA Glycoprotein endo-alpha-1,2-mannosidase OS=Xenopus laevis OX=8355 GN=manea PE=2 SV=1 g3487.t1 Q9VCA2 40.406 542 1.43e-131 399.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3490.t1 Q6DGL8 35.294 170 1.2099999999999999e-23 100.0 sp|Q6DGL8|RT15_DANRE Small ribosomal subunit protein uS15m OS=Danio rerio OX=7955 GN=mrps15 PE=2 SV=1 g3491.t1 P0C8E4 44.919 679 1.8400000000000002e-169 500.0 sp|P0C8E4|M3K7_RAT Mitogen-activated protein kinase kinase kinase 7 OS=Rattus norvegicus OX=10116 GN=Map3k7 PE=1 SV=1 M3K7_RAT reviewed Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) Rattus norvegicus (Rat) GO:0000165; GO:0000287; GO:0001223; GO:0001525; GO:0001649; GO:0001666; GO:0001841; GO:0002726; GO:0004674; GO:0004707; GO:0004708; GO:0004709; GO:0005114; GO:0005524; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010508; GO:0010629; GO:0014069; GO:0016239; GO:0023019; GO:0030971; GO:0031146; GO:0031625; GO:0032481; GO:0032527; GO:0032743; GO:0034142; GO:0035173; GO:0038061; GO:0038066; GO:0038172; GO:0038173; GO:0042742; GO:0042770; GO:0042802; GO:0043123; GO:0043124; GO:0043276; GO:0043410; GO:0043507; GO:0045787; GO:0045793; GO:0046330; GO:0051403; GO:0060348; GO:0060546; GO:0070498; GO:0071356; GO:0071456; GO:0071560; GO:0097110; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:0140896; GO:0141111; GO:1900016; GO:1901224; GO:1902443; GO:1904385; GO:1904707; GO:1904754; GO:1990450; GO:1990776; GO:2000377; GO:2000378; GO:2001234 angiogenesis [GO:0001525]; anoikis [GO:0043276]; bone development [GO:0060348]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cGAS/STING signaling pathway [GO:0140896]; defense response to bacterium [GO:0042742]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of gene expression [GO:0010629]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; non-canonical NF-kappaB signal transduction [GO:0038061]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of type I interferon production [GO:0032481]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein exit from endoplasmic reticulum [GO:0032527]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to angiotensin [GO:1990776]; response to hypoxia [GO:0001666]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in regulation of gene expression [GO:0023019]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179] ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625] g3492.t1 Q61371 62.514 867 0.0 1105.0 sp|Q61371|IFT88_MOUSE Intraflagellar transport protein 88 homolog OS=Mus musculus OX=10090 GN=Ift88 PE=1 SV=2 g3492.t2 Q61371 64.142 845 0.0 1113.0 sp|Q61371|IFT88_MOUSE Intraflagellar transport protein 88 homolog OS=Mus musculus OX=10090 GN=Ift88 PE=1 SV=2 g3494.t1 Q9VHK6 76.623 154 1.75e-79 235.0 sp|Q9VHK6|ISCU_DROME Iron-sulfur cluster assembly enzyme IscU OS=Drosophila melanogaster OX=7227 GN=IscU PE=1 SV=1 g3495.t1 Q4R8Z2 61.224 196 3.38e-89 263.0 sp|Q4R8Z2|RL13A_MACFA Large ribosomal subunit protein uL13 OS=Macaca fascicularis OX=9541 GN=RPL13A PE=2 SV=3 RL13A_MACFA reviewed Large ribosomal subunit protein uL13 (60S ribosomal protein L13a) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0003729; GO:0003735; GO:0006412; GO:0017148; GO:0022625; GO:0097452; GO:1901194 negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412] cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452] mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735] g3500.t1 Q9CZJ1 48.819 254 1.65e-68 214.0 sp|Q9CZJ1|UTP11_MOUSE Probable U3 small nucleolar RNA-associated protein 11 OS=Mus musculus OX=10090 GN=Utp11 PE=2 SV=1 g3504.t1 P79746 86.982 169 7.84e-99 303.0 sp|P79746|PO3F2_DANRE POU domain, class 3, transcription factor 2 OS=Danio rerio OX=7955 GN=pou3f2 PE=1 SV=1 PO3F2_DANRE reviewed POU domain, class 3, transcription factor 2 (POU domain protein 47) (ZP-47) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000978; GO:0000981; GO:0001885; GO:0005634; GO:0006357; GO:0007420 brain development [GO:0007420]; endothelial cell development [GO:0001885]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g3506.t1 P29145 46.018 565 1.78e-166 501.0 sp|P29145|NECB_HYDVU PC3-like endoprotease variant B OS=Hydra vulgaris OX=6087 PE=2 SV=1 g3509.t1 P29240 42.308 208 9.69e-41 151.0 sp|P29240|5NTD_DIPOM 5'-nucleotidase OS=Diplobatis ommata OX=1870830 PE=2 SV=1 g3510.t1 Q9JHE4 30.841 321 3.04e-50 178.0 sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2 G3ST1_MOUSE reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Mus musculus (Mouse) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020] galactosylceramide sulfotransferase activity [GO:0001733] g3511.t1 Q05927 38.511 309 2.1800000000000003e-64 219.0 sp|Q05927|5NTD_BOVIN 5'-nucleotidase OS=Bos taurus OX=9913 GN=NT5E PE=1 SV=2 5NTD_BOVIN reviewed 5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73) Bos taurus (Bovine) GO:0000166; GO:0002953; GO:0005886; GO:0006196; GO:0008253; GO:0016020; GO:0042802; GO:0046872; GO:0098552 AMP catabolic process [GO:0006196] membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] 5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] g3512.t1 Q9JHE4 30.841 321 3.04e-50 178.0 sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2 G3ST1_MOUSE reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Mus musculus (Mouse) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; membrane [GO:0016020] galactosylceramide sulfotransferase activity [GO:0001733] g3513.t1 Q61503 54.468 235 8.600000000000001e-72 233.0 sp|Q61503|5NTD_MOUSE 5'-nucleotidase OS=Mus musculus OX=10090 GN=Nt5e PE=1 SV=2 5NTD_MOUSE reviewed 5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73) Mus musculus (Mouse) GO:0000166; GO:0002953; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008198; GO:0008253; GO:0008270; GO:0009897; GO:0009986; GO:0016020; GO:0033198; GO:0042802; GO:0046032; GO:0046034; GO:0046085; GO:0046086; GO:0050728; GO:0055074; GO:0097060; GO:0140928 adenosine biosynthetic process [GO:0046086]; adenosine metabolic process [GO:0046085]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198] cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060] 5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g3514.t1 A6QNK1 35.35 314 9.499999999999999e-45 162.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g3516.t1 Q9JL70 29.658 789 1.74e-81 288.0 sp|Q9JL70|FANCA_MOUSE Fanconi anemia group A protein homolog OS=Mus musculus OX=10090 GN=Fanca PE=2 SV=2 g3517.t1 Q64331 58.769 1283 0.0 1452.0 sp|Q64331|MYO6_MOUSE Unconventional myosin-VI OS=Mus musculus OX=10090 GN=Myo6 PE=1 SV=2 MYO6_MOUSE reviewed Unconventional myosin-VI (Protein twist) (Unconventional myosin-6) Mus musculus (Mouse) GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005905; GO:0006605; GO:0006897; GO:0007015; GO:0007268; GO:0007416; GO:0007605; GO:0007626; GO:0008104; GO:0009410; GO:0012506; GO:0014047; GO:0014069; GO:0015031; GO:0015629; GO:0016358; GO:0016459; GO:0030048; GO:0030136; GO:0030139; GO:0030175; GO:0030330; GO:0030424; GO:0031410; GO:0031941; GO:0031965; GO:0032587; GO:0032991; GO:0042472; GO:0042491; GO:0042802; GO:0043025; GO:0045177; GO:0045202; GO:0048167; GO:0048471; GO:0048839; GO:0051015; GO:0051046; GO:0071257; GO:0098683; GO:0098685; GO:0098833; GO:0098871; GO:0098884; GO:0098978; GO:0099171 actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; glutamate secretion [GO:0014047]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; intracellular protein localization [GO:0008104]; locomotory behavior [GO:0007626]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of secretion [GO:0051046]; regulation of synaptic plasticity [GO:0048167]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; synapse assembly [GO:0007416] actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; axon [GO:0030424]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cochlear hair cell ribbon synapse [GO:0098683]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; presynaptic endocytic zone [GO:0098833]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; vesicle membrane [GO:0012506] actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146] g3518.t1 Q4R6P7 52.632 456 1.4200000000000002e-169 493.0 sp|Q4R6P7|SESN1_MACFA Sestrin-1 OS=Macaca fascicularis OX=9541 GN=SESN1 PE=2 SV=1 SESN1_MACFA reviewed Sestrin-1 (EC 1.11.1.-) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0034198; GO:0042149; GO:0070728; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253 cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of response to reactive oxygen species [GO:1901031] cytoplasm [GO:0005737]; nucleus [GO:0005634] L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684] g3518.t2 Q4R6P7 52.516 457 2e-170 492.0 sp|Q4R6P7|SESN1_MACFA Sestrin-1 OS=Macaca fascicularis OX=9541 GN=SESN1 PE=2 SV=1 SESN1_MACFA reviewed Sestrin-1 (EC 1.11.1.-) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0034198; GO:0042149; GO:0070728; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253 cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of response to reactive oxygen species [GO:1901031] cytoplasm [GO:0005737]; nucleus [GO:0005634] L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684] g3521.t1 Q3SXY8 49.669 302 2.1899999999999998e-91 280.0 sp|Q3SXY8|AR13B_HUMAN ADP-ribosylation factor-like protein 13B OS=Homo sapiens OX=9606 GN=ARL13B PE=1 SV=1 AR13B_HUMAN reviewed ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) Homo sapiens (Human) GO:0001669; GO:0001947; GO:0003924; GO:0005525; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0009953; GO:0015630; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035869; GO:0036064; GO:0045171; GO:0060170; GO:0060271; GO:0070986; GO:0097225; GO:0097228; GO:0097229; GO:0097500; GO:0097730; GO:1905515 cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g3524.t1 A7XYQ1 38.148 270 2.71e-45 177.0 sp|A7XYQ1|SOBP_HUMAN Sine oculis-binding protein homolog OS=Homo sapiens OX=9606 GN=SOBP PE=1 SV=2 SOBP_HUMAN reviewed Sine oculis-binding protein homolog (Jackson circler protein 1) Homo sapiens (Human) GO:0005634; GO:0007605; GO:0007626; GO:0008270; GO:0032184; GO:0042472; GO:0048513; GO:0050890; GO:0090102 animal organ development [GO:0048513]; cochlea development [GO:0090102]; cognition [GO:0050890]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605] nucleus [GO:0005634] SUMO polymer binding [GO:0032184]; zinc ion binding [GO:0008270] g3526.t1 Q99K90 41.341 179 5.38e-34 136.0 sp|Q99K90|TAB2_MOUSE TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 OS=Mus musculus OX=10090 GN=Tab2 PE=1 SV=1 TAB2_MOUSE reviewed TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2) (TAB-2) (TGF-beta-activated kinase 1-binding protein 2) Mus musculus (Mouse) GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0006954; GO:0007249; GO:0007507; GO:0008270; GO:0010008; GO:0032496; GO:0038061; GO:0038066; GO:0042742; GO:0043123; GO:0043124; GO:0043130; GO:0045860; GO:0060090; GO:0070530; GO:0070534 canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; heart development [GO:0007507]; inflammatory response [GO:0006954]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; non-canonical NF-kappaB signal transduction [GO:0038061]; p38MAPK cascade [GO:0038066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; protein K63-linked ubiquitination [GO:0070534]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654] K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular adaptor activity [GO:0060090]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] g3527.t1 O08807 81.532 222 4.3e-133 379.0 sp|O08807|PRDX4_MOUSE Peroxiredoxin-4 OS=Mus musculus OX=10090 GN=Prdx4 PE=1 SV=1 PRDX4_MOUSE reviewed Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4) Mus musculus (Mouse) GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0030198; GO:0042744; GO:0042802; GO:0045454; GO:0051604; GO:0060090; GO:0072593; GO:0140313; GO:2000255 cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; protein maturation [GO:0051604]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790] identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular sequestering activity [GO:0140313]; thioredoxin peroxidase activity [GO:0008379] g3528.t1 Q2LD37 37.907 1166 0.0 839.0 sp|Q2LD37|BLTP1_HUMAN Bridge-like lipid transfer protein family member 1 OS=Homo sapiens OX=9606 GN=BLTP1 PE=1 SV=2 BLTP1_HUMAN reviewed Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein) Homo sapiens (Human) GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006909; GO:0016020; GO:0016197; GO:0030856; GO:0031966; GO:0032456; GO:0048488; GO:0098793; GO:0120009; GO:0140268; GO:1904121 endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] phosphatidylethanolamine transfer activity [GO:1904121] g3529.t1 A0A0R4IES7 36.273 601 2.53e-96 324.0 sp|A0A0R4IES7|BLTP1_DANRE Bridge-like lipid transfer protein family member 1 OS=Danio rerio OX=7955 GN=bltp1 PE=3 SV=1 g3529.t2 A0A0R4IES7 32.289 1468 8.6e-158 557.0 sp|A0A0R4IES7|BLTP1_DANRE Bridge-like lipid transfer protein family member 1 OS=Danio rerio OX=7955 GN=bltp1 PE=3 SV=1 g3529.t2 A0A0R4IES7 34.41 805 6.69e-110 400.0 sp|A0A0R4IES7|BLTP1_DANRE Bridge-like lipid transfer protein family member 1 OS=Danio rerio OX=7955 GN=bltp1 PE=3 SV=1 g3529.t2 A0A0R4IES7 24.957 577 8.059999999999999e-23 112.0 sp|A0A0R4IES7|BLTP1_DANRE Bridge-like lipid transfer protein family member 1 OS=Danio rerio OX=7955 GN=bltp1 PE=3 SV=1 g3530.t1 Q66II8 62.869 237 1.82e-68 226.0 sp|Q66II8|RU17_XENTR U1 small nuclear ribonucleoprotein 70 kDa OS=Xenopus tropicalis OX=8364 GN=snrnp70 PE=2 SV=1 g3530.t2 P17133 63.203 231 1.39e-69 232.0 sp|P17133|RU17_DROME U1 small nuclear ribonucleoprotein 70 kDa OS=Drosophila melanogaster OX=7227 GN=snRNP-U1-70K PE=1 SV=2 RU17_DROME reviewed U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70) Drosophila melanogaster (Fruit fly) GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0016607; GO:0030619; GO:0043484; GO:0048025; GO:0048477; GO:0071004; GO:0071011; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619] g3535.t1 B2GV36 33.943 383 7.470000000000001e-66 228.0 sp|B2GV36|S22AD_RAT Solute carrier family 22 member 13 OS=Rattus norvegicus OX=10116 GN=Slc22a13 PE=2 SV=1 S22AD_RAT reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) Rattus norvegicus (Rat) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0045922; GO:0090416; GO:2001142 negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g3536.t1 Q9U539 30.072 552 1.94e-79 273.0 sp|Q9U539|OCT1_CAEEL Organic cation transporter 1 OS=Caenorhabditis elegans OX=6239 GN=oct-1 PE=1 SV=3 g3537.t1 Q8R242 39.118 340 1.6800000000000001e-80 253.0 sp|Q8R242|DIAC_MOUSE Di-N-acetylchitobiase OS=Mus musculus OX=10090 GN=Ctbs PE=1 SV=2 DIAC_MOUSE reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Mus musculus (Mouse) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568] g3538.t1 Q9VCA2 31.335 517 3.1999999999999998e-62 216.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3539.t1 Q9VCA2 37.616 537 8.79e-106 333.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3540.t1 Q9VCA2 37.708 541 2.63e-109 342.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3541.t1 Q6DG91 34.572 269 1.02e-40 145.0 sp|Q6DG91|PSMG1_DANRE Proteasome assembly chaperone 1 OS=Danio rerio OX=7955 GN=psmg1 PE=2 SV=1 g3546.t1 Q803X1 68.21 324 1.9000000000000002e-160 454.0 sp|Q803X1|CTU1_DANRE Cytoplasmic tRNA 2-thiolation protein 1 OS=Danio rerio OX=7955 GN=ctu1 PE=2 SV=1 g3548.t1 Q6PFG8 42.795 229 1.32e-39 144.0 sp|Q6PFG8|OLIG3_MOUSE Oligodendrocyte transcription factor 3 OS=Mus musculus OX=10090 GN=Olig3 PE=2 SV=1 OLIG3_MOUSE reviewed Oligodendrocyte transcription factor 3 (Oligo3) (Class B basic helix-loop-helix protein 7) (bHLHb7) (Oligodendrocyte-specific bHLH transcription factor 3) Mus musculus (Mouse) GO:0000122; GO:0000981; GO:0005634; GO:0007423; GO:0010468; GO:0021520; GO:0021522; GO:0045944; GO:0046983; GO:0061564; GO:0070888; GO:0097476; GO:1990837 axon development [GO:0061564]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; sensory organ development [GO:0007423]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord motor neuron migration [GO:0097476] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; sequence-specific double-stranded DNA binding [GO:1990837] g3549.t1 Q8IUF8 44.818 357 5.19e-96 298.0 sp|Q8IUF8|RIOX2_HUMAN Ribosomal oxygenase 2 OS=Homo sapiens OX=9606 GN=RIOX2 PE=1 SV=1 g3552.t1 Q95K40 39.865 148 6.14e-23 97.4 sp|Q95K40|CCD83_MACFA Coiled-coil domain-containing protein 83 OS=Macaca fascicularis OX=9541 GN=CCDC83 PE=2 SV=1 g3553.t1 Q8WUA2 69.565 368 1.36e-173 500.0 sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1 g3553.t2 Q8WUA2 69.565 368 7.35e-174 500.0 sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1 g3554.t1 Q9Y2C2 43.561 264 9.43e-67 223.0 sp|Q9Y2C2|UST_HUMAN Uronyl 2-sulfotransferase OS=Homo sapiens OX=9606 GN=UST PE=1 SV=1 UST_HUMAN reviewed Uronyl 2-sulfotransferase (EC 2.8.2.-) (Chondroitin sulfate 2-O-sulfotransferase) (CS-2OST) Homo sapiens (Human) GO:0000139; GO:0008146; GO:0016020; GO:0030010; GO:0034482; GO:0050650; GO:0050651; GO:0050656; GO:0050770; GO:0102142 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; establishment of cell polarity [GO:0030010]; regulation of axonogenesis [GO:0050770] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 2-sulfotransferase activity [GO:0034482]; dermatan 2-sulfotransferase activity [GO:0102142]; sulfotransferase activity [GO:0008146] g3557.t1 Q9JKK0 44.809 183 1.62e-45 155.0 sp|Q9JKK0|RCAN3_MOUSE Calcipressin-3 OS=Mus musculus OX=10090 GN=Rcan3 PE=2 SV=1 g3558.t1 Q7SXL7 55.319 235 2.01e-78 260.0 sp|Q7SXL7|FL2D_DANRE Pre-mRNA-splicing regulator WTAP OS=Danio rerio OX=7955 GN=wtap PE=2 SV=1 FL2D_DANRE reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000381; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0016556; GO:0016607; GO:0036396; GO:0042981 mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] g3559.t1 Q4V3C7 45.455 429 1.53e-112 343.0 sp|Q4V3C7|Y4423_ARATH DUF21 domain-containing protein At4g14230 OS=Arabidopsis thaliana OX=3702 GN=CBSDUF2 PE=2 SV=1 Y4423_ARATH reviewed DUF21 domain-containing protein At4g14230 (CBS domain-containing protein CBSDUF2) Arabidopsis thaliana (Mouse-ear cress) GO:0005739; GO:0005774; GO:0005829; GO:0010960; GO:0022857 magnesium ion homeostasis [GO:0010960] cytosol [GO:0005829]; mitochondrion [GO:0005739]; vacuolar membrane [GO:0005774] transmembrane transporter activity [GO:0022857] g3560.t1 Q13489 29.076 595 3.03e-64 227.0 sp|Q13489|BIRC3_HUMAN Baculoviral IAP repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=BIRC3 PE=1 SV=2 BIRC3_HUMAN reviewed Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0007283; GO:0008270; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0044877; GO:0045088; GO:0050727; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070424 apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3560.t1 Q13489 31.599 269 6.33e-29 125.0 sp|Q13489|BIRC3_HUMAN Baculoviral IAP repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=BIRC3 PE=1 SV=2 BIRC3_HUMAN reviewed Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1) Homo sapiens (Human) GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0007249; GO:0007283; GO:0008270; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0044877; GO:0045088; GO:0050727; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070424 apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g3562.t1 Q80W54 63.034 468 0.0 622.0 sp|Q80W54|FACE1_MOUSE CAAX prenyl protease 1 homolog OS=Mus musculus OX=10090 GN=Zmpste24 PE=1 SV=2 FACE1_MOUSE reviewed CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) Mus musculus (Mouse) GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005635; GO:0005637; GO:0005789; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0006925; GO:0006974; GO:0006997; GO:0006998; GO:0007346; GO:0007628; GO:0008016; GO:0008340; GO:0008360; GO:0008544; GO:0010506; GO:0010628; GO:0010629; GO:0010906; GO:0016020; GO:0016485; GO:0019216; GO:0030282; GO:0030327; GO:0030500; GO:0031901; GO:0031902; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0040029; GO:0043007; GO:0043516; GO:0044029; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0051276; GO:0051604; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903463; GO:1903522; GO:1903799; GO:1990036; GO:2000730; GO:2000772 adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; epigenetic regulation of gene expression [GO:0040029]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g3562.t2 Q80W54 62.821 468 0.0 620.0 sp|Q80W54|FACE1_MOUSE CAAX prenyl protease 1 homolog OS=Mus musculus OX=10090 GN=Zmpste24 PE=1 SV=2 FACE1_MOUSE reviewed CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) Mus musculus (Mouse) GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005635; GO:0005637; GO:0005789; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0006925; GO:0006974; GO:0006997; GO:0006998; GO:0007346; GO:0007628; GO:0008016; GO:0008340; GO:0008360; GO:0008544; GO:0010506; GO:0010628; GO:0010629; GO:0010906; GO:0016020; GO:0016485; GO:0019216; GO:0030282; GO:0030327; GO:0030500; GO:0031901; GO:0031902; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0040029; GO:0043007; GO:0043516; GO:0044029; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0051276; GO:0051604; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903463; GO:1903522; GO:1903799; GO:1990036; GO:2000730; GO:2000772 adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; epigenetic regulation of gene expression [GO:0040029]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991] double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g3563.t1 O94822 30.039 1528 0.0 663.0 sp|O94822|LTN1_HUMAN E3 ubiquitin-protein ligase listerin OS=Homo sapiens OX=9606 GN=LTN1 PE=1 SV=6 g3571.t1 A0JM49 50.273 366 4.72e-123 392.0 sp|A0JM49|LTN1_XENTR E3 ubiquitin-protein ligase listerin OS=Xenopus tropicalis OX=8364 GN=ltn1 PE=2 SV=1 g3573.t1 Q9CPU4 53.846 130 2.1499999999999997e-42 140.0 sp|Q9CPU4|MGST3_MOUSE Glutathione S-transferase 3, mitochondrial OS=Mus musculus OX=10090 GN=Mgst3 PE=1 SV=1 MGST3_MOUSE reviewed Glutathione S-transferase 3, mitochondrial (EC 2.5.1.-) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20) Mus musculus (Mouse) GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005741; GO:0005783; GO:0006629; GO:0006692; GO:0016020; GO:0019369; GO:0019370; GO:0042802 arachidonate metabolic process [GO:0019369]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; prostanoid metabolic process [GO:0006692] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635] glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464] g3576.t1 H0VCJ6 43.452 336 8.16e-89 274.0 sp|H0VCJ6|NAAA_CAVPO N-acylethanolamine-hydrolyzing acid amidase OS=Cavia porcellus OX=10141 GN=NAAA PE=1 SV=3 NAAA_CAVPO reviewed N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.60) (Acylsphingosine deacylase NAAA) (EC 3.5.1.23) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta] Cavia porcellus (Guinea pig) GO:0005764; GO:0006631; GO:0006670; GO:0016020; GO:0016042; GO:0017040; GO:0017064; GO:0047412; GO:0070291; GO:0070292 fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; sphingosine metabolic process [GO:0006670] lysosome [GO:0005764]; membrane [GO:0016020] fatty acid amide hydrolase activity [GO:0017064]; N-(long-chain-acyl)ethanolamine deacylase activity [GO:0047412]; N-acylsphingosine amidohydrolase activity [GO:0017040] g3577.t1 Q5KTC7 44.242 330 3.77e-89 275.0 sp|Q5KTC7|NAAA_RAT N-acylethanolamine-hydrolyzing acid amidase OS=Rattus norvegicus OX=10116 GN=Naaa PE=1 SV=1 NAAA_RAT reviewed N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.60) (Acylsphingosine deacylase NAAA) (EC 3.5.1.23) (N-acylsphingosine amidohydrolase-like) (ASAH-like protein) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta] Rattus norvegicus (Rat) GO:0005737; GO:0005764; GO:0006631; GO:0006670; GO:0016020; GO:0016042; GO:0016810; GO:0017040; GO:0017064; GO:0047412; GO:0070291; GO:0070292; GO:0140297 fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; sphingosine metabolic process [GO:0006670] cytoplasm [GO:0005737]; lysosome [GO:0005764]; membrane [GO:0016020] DNA-binding transcription factor binding [GO:0140297]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-(long-chain-acyl)ethanolamine deacylase activity [GO:0047412]; N-acylsphingosine amidohydrolase activity [GO:0017040] g3579.t1 P10791 67.974 153 6.950000000000001e-64 195.0 sp|P10791|SODC_DROVI Superoxide dismutase [Cu-Zn] OS=Drosophila virilis OX=7244 GN=Sod1 PE=3 SV=2 g3580.t1 Q6DID3 60.488 205 4.05e-62 238.0 sp|Q6DID3|SCAF8_MOUSE SR-related and CTD-associated factor 8 OS=Mus musculus OX=10090 GN=Scaf8 PE=1 SV=1 SCAF8_MOUSE reviewed SR-related and CTD-associated factor 8 (RNA-binding motif protein 16) Mus musculus (Mouse) GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006366; GO:0006369; GO:0006397; GO:0016363; GO:0019904; GO:0032786; GO:0043175; GO:0070063; GO:1990269; GO:2000805 mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993] g3581.t1 Q8CD19 45.349 430 2.29e-121 362.0 sp|Q8CD19|LANC3_MOUSE LanC-like protein 3 OS=Mus musculus OX=10090 GN=Lancl3 PE=2 SV=2 g3582.t1 Q6GMR7 49.605 506 6.87e-164 478.0 sp|Q6GMR7|FAAH2_HUMAN Fatty-acid amide hydrolase 2 OS=Homo sapiens OX=9606 GN=FAAH2 PE=1 SV=1 FAAH2_HUMAN reviewed Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2) Homo sapiens (Human) GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369 arachidonate metabolic process [GO:0019369]; lipid catabolic process [GO:0016042] lipid droplet [GO:0005811]; membrane [GO:0016020] fatty acid amide hydrolase activity [GO:0017064] g3585.t1 Q8IW35 45.714 315 6.73e-64 236.0 sp|Q8IW35|CEP97_HUMAN Centrosomal protein of 97 kDa OS=Homo sapiens OX=9606 GN=CEP97 PE=1 SV=1 g3585.t2 Q8IW35 45.714 315 1.76e-63 237.0 sp|Q8IW35|CEP97_HUMAN Centrosomal protein of 97 kDa OS=Homo sapiens OX=9606 GN=CEP97 PE=1 SV=1 g3587.t1 Q9DFQ7 66.242 157 1.4400000000000001e-64 197.0 sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2 g3589.t1 P48180 39.608 255 9.55e-59 199.0 sp|P48180|ACH1_CAEEL Acetylcholine receptor subunit alpha-type acr-16 OS=Caenorhabditis elegans OX=6239 GN=acr-16 PE=2 SV=1 g3590.t1 Q9Y2S2 50.943 318 3.82e-118 346.0 sp|Q9Y2S2|CRYL1_HUMAN Lambda-crystallin homolog OS=Homo sapiens OX=9606 GN=CRYL1 PE=1 SV=3 CRYL1_HUMAN reviewed Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) Homo sapiens (Human) GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403 D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; extracellular exosome [GO:0070062] L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g3591.t1 Q9Y2S2 50.459 327 6.63e-116 340.0 sp|Q9Y2S2|CRYL1_HUMAN Lambda-crystallin homolog OS=Homo sapiens OX=9606 GN=CRYL1 PE=1 SV=3 CRYL1_HUMAN reviewed Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) Homo sapiens (Human) GO:0005829; GO:0006631; GO:0019640; GO:0042803; GO:0050104; GO:0070062; GO:0070403 D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; extracellular exosome [GO:0070062] L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803] g3594.t1 P52757 51.556 450 2.3400000000000002e-163 474.0 sp|P52757|CHIO_HUMAN Beta-chimaerin OS=Homo sapiens OX=9606 GN=CHN2 PE=1 SV=2 CHIO_HUMAN reviewed Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3) Homo sapiens (Human) GO:0001675; GO:0005096; GO:0005829; GO:0007165; GO:0008270; GO:0016020; GO:0045202; GO:0051056 acrosome assembly [GO:0001675]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202] GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g3596.t1 Q5TCS8 42.616 1957 0.0 1440.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g3596.t2 Q5TCS8 42.602 1960 0.0 1441.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g3596.t3 Q5TCS8 42.674 1952 0.0 1441.0 sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2 KAD9_HUMAN reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2) Homo sapiens (Human) GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145; GO:0120238 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm glycocalyx [GO:0120238] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dAMP kinase activity [GO:0047506]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g3596.t4 G3UYQ4 41.244 2010 0.0 1380.0 sp|G3UYQ4|KAD9_MOUSE Adenylate kinase 9 OS=Mus musculus OX=10090 GN=Ak9 PE=2 SV=2 KAD9_MOUSE reviewed Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) Mus musculus (Mouse) GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0031514; GO:0031965; GO:0033862; GO:0046705; GO:0050145 CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862] g3597.t1 P11533 34.31 1501 0.0 863.0 sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1 g3598.t1 P11533 34.225 374 4.52e-38 157.0 sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1 g3604.t1 P11530 40.032 1851 0.0 1313.0 sp|P11530|DMD_RAT Dystrophin OS=Rattus norvegicus OX=10116 GN=Dmd PE=1 SV=2 DMD_RAT reviewed Dystrophin Rattus norvegicus (Rat) GO:0001954; GO:0002027; GO:0002162; GO:0003779; GO:0005178; GO:0005521; GO:0005634; GO:0005741; GO:0005840; GO:0005883; GO:0005886; GO:0006355; GO:0006915; GO:0006941; GO:0006954; GO:0007271; GO:0007517; GO:0007519; GO:0008065; GO:0008104; GO:0008270; GO:0008284; GO:0008307; GO:0008340; GO:0009410; GO:0009986; GO:0010467; GO:0010468; GO:0010880; GO:0010881; GO:0010976; GO:0014069; GO:0014809; GO:0014819; GO:0014894; GO:0014904; GO:0016010; GO:0017022; GO:0017166; GO:0021629; GO:0021987; GO:0030016; GO:0030018; GO:0030027; GO:0030054; GO:0030055; GO:0030141; GO:0030154; GO:0030165; GO:0030175; GO:0030182; GO:0030424; GO:0030672; GO:0031527; GO:0032991; GO:0035264; GO:0035994; GO:0042383; GO:0042391; GO:0042692; GO:0042995; GO:0043025; GO:0043034; GO:0043043; GO:0043403; GO:0044306; GO:0044877; GO:0045121; GO:0045202; GO:0045211; GO:0045665; GO:0045666; GO:0046716; GO:0048471; GO:0048666; GO:0048812; GO:0050998; GO:0051647; GO:0055001; GO:0055002; GO:0060048; GO:0060173; GO:0060348; GO:0060857; GO:0061448; GO:0065003; GO:0070373; GO:0086001; GO:0090257; GO:0090287; GO:0090659; GO:0097449; GO:0098794; GO:0098982; GO:0099536; GO:0099572; GO:0099617; GO:1902305; GO:1903169; GO:1903409 apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cell differentiation [GO:0030154]; cerebral cortex development [GO:0021987]; connective tissue development [GO:0061448]; determination of adult lifespan [GO:0008340]; establishment of blood-nerve barrier [GO:0008065]; establishment of glial blood-brain barrier [GO:0060857]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; myotube cell development [GO:0014904]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; nucleus localization [GO:0051647]; olfactory nerve structural organization [GO:0021629]; peptide biosynthetic process [GO:0043043]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex assembly [GO:0065003]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of sodium ion transmembrane transport [GO:1902305]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536]; synaptic transmission, cholinergic [GO:0007271]; walking behavior [GO:0090659] astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; lamellipodium [GO:0030027]; matrix side of mitochondrial inner membrane [GO:0099617]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; myofibril [GO:0030016]; neurofilament [GO:0005883]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; Z disc [GO:0030018] actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; integrin binding [GO:0005178]; lamin binding [GO:0005521]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] g3604.t2 P11530 39.269 1887 0.0 1297.0 sp|P11530|DMD_RAT Dystrophin OS=Rattus norvegicus OX=10116 GN=Dmd PE=1 SV=2 DMD_RAT reviewed Dystrophin Rattus norvegicus (Rat) GO:0001954; GO:0002027; GO:0002162; GO:0003779; GO:0005178; GO:0005521; GO:0005634; GO:0005741; GO:0005840; GO:0005883; GO:0005886; GO:0006355; GO:0006915; GO:0006941; GO:0006954; GO:0007271; GO:0007517; GO:0007519; GO:0008065; GO:0008104; GO:0008270; GO:0008284; GO:0008307; GO:0008340; GO:0009410; GO:0009986; GO:0010467; GO:0010468; GO:0010880; GO:0010881; GO:0010976; GO:0014069; GO:0014809; GO:0014819; GO:0014894; GO:0014904; GO:0016010; GO:0017022; GO:0017166; GO:0021629; GO:0021987; GO:0030016; GO:0030018; GO:0030027; GO:0030054; GO:0030055; GO:0030141; GO:0030154; GO:0030165; GO:0030175; GO:0030182; GO:0030424; GO:0030672; GO:0031527; GO:0032991; GO:0035264; GO:0035994; GO:0042383; GO:0042391; GO:0042692; GO:0042995; GO:0043025; GO:0043034; GO:0043043; GO:0043403; GO:0044306; GO:0044877; GO:0045121; GO:0045202; GO:0045211; GO:0045665; GO:0045666; GO:0046716; GO:0048471; GO:0048666; GO:0048812; GO:0050998; GO:0051647; GO:0055001; GO:0055002; GO:0060048; GO:0060173; GO:0060348; GO:0060857; GO:0061448; GO:0065003; GO:0070373; GO:0086001; GO:0090257; GO:0090287; GO:0090659; GO:0097449; GO:0098794; GO:0098982; GO:0099536; GO:0099572; GO:0099617; GO:1902305; GO:1903169; GO:1903409 apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; cell differentiation [GO:0030154]; cerebral cortex development [GO:0021987]; connective tissue development [GO:0061448]; determination of adult lifespan [GO:0008340]; establishment of blood-nerve barrier [GO:0008065]; establishment of glial blood-brain barrier [GO:0060857]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular protein localization [GO:0008104]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; myotube cell development [GO:0014904]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; nucleus localization [GO:0051647]; olfactory nerve structural organization [GO:0021629]; peptide biosynthetic process [GO:0043043]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; protein-containing complex assembly [GO:0065003]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of sodium ion transmembrane transport [GO:1902305]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to muscle stretch [GO:0035994]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536]; synaptic transmission, cholinergic [GO:0007271]; walking behavior [GO:0090659] astrocyte projection [GO:0097449]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; GABA-ergic synapse [GO:0098982]; lamellipodium [GO:0030027]; matrix side of mitochondrial inner membrane [GO:0099617]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; myofibril [GO:0030016]; neurofilament [GO:0005883]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; Z disc [GO:0030018] actin binding [GO:0003779]; dystroglycan binding [GO:0002162]; integrin binding [GO:0005178]; lamin binding [GO:0005521]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] g3606.t1 Q2TLZ3 57.627 118 1.6399999999999999e-34 132.0 sp|Q2TLZ3|MACOI_BOVIN Macoilin OS=Bos taurus OX=9913 GN=MACO1 PE=2 SV=1 g3607.t1 Q8N5G2 49.485 485 8.3e-158 466.0 sp|Q8N5G2|MACOI_HUMAN Macoilin OS=Homo sapiens OX=9606 GN=MACO1 PE=1 SV=1 MACOI_HUMAN reviewed Macoilin (Macoilin-1) (Transmembrane protein 57) Homo sapiens (Human) GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0044306; GO:0045202 brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041] axon [GO:0030424]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202] microtubule binding [GO:0008017] g3608.t1 Q5ZKH3 58.864 440 0.0 516.0 sp|Q5ZKH3|EED_CHICK Polycomb protein EED OS=Gallus gallus OX=9031 GN=EED PE=2 SV=1 g3609.t1 O14602 85.606 132 7.36e-78 229.0 sp|O14602|IF1AY_HUMAN Eukaryotic translation initiation factor 1A, Y-chromosomal OS=Homo sapiens OX=9606 GN=EIF1AY PE=1 SV=4 g3610.t1 Q66HE2 32.187 407 1.18e-46 169.0 sp|Q66HE2|MOT13_RAT Monocarboxylate transporter 13 OS=Rattus norvegicus OX=10116 GN=Slc16a13 PE=2 SV=1 g3611.t1 Q66HE2 31.746 315 9e-33 129.0 sp|Q66HE2|MOT13_RAT Monocarboxylate transporter 13 OS=Rattus norvegicus OX=10116 GN=Slc16a13 PE=2 SV=1 g3617.t1 Q5R8X9 49.802 253 3.79e-85 257.0 sp|Q5R8X9|AMN1_PONAB Protein AMN1 homolog OS=Pongo abelii OX=9601 GN=AMN1 PE=2 SV=1 g3618.t1 Q7ZWY2 49.147 293 4.68e-102 304.0 sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1 g3618.t2 Q7ZWY2 46.835 237 1.22e-72 227.0 sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1 g3621.t1 Q8IZP9 37.895 380 4.41e-71 262.0 sp|Q8IZP9|AGRG2_HUMAN Adhesion G-protein coupled receptor G2 OS=Homo sapiens OX=9606 GN=ADGRG2 PE=1 SV=2 g3622.t1 B7ZCC9 30.804 672 1.2400000000000001e-75 279.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g3623.t1 Q8JG30 33.333 270 8.09e-50 169.0 sp|Q8JG30|ST1B1_CHICK Sulfotransferase 1B1 OS=Gallus gallus OX=9031 GN=SULT1B1 PE=1 SV=1 g3624.t1 Q9W534 24.451 364 8.86e-25 108.0 sp|Q9W534|MOODY_DROME G-protein coupled receptor moody OS=Drosophila melanogaster OX=7227 GN=moody PE=2 SV=2 MOODY_DROME reviewed G-protein coupled receptor moody Drosophila melanogaster (Fruit fly) GO:0004930; GO:0005886; GO:0005919; GO:0007186; GO:0007419; GO:0008366; GO:0016020; GO:0019991; GO:0030866; GO:0035095; GO:0048148; GO:0048149; GO:0060857 axon ensheathment [GO:0008366]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; cortical actin cytoskeleton organization [GO:0030866]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419] membrane [GO:0016020]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919] G protein-coupled receptor activity [GO:0004930] g3625.t1 O00222 32.536 836 5.2099999999999995e-136 432.0 sp|O00222|GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens OX=9606 GN=GRM8 PE=1 SV=2 GRM8_HUMAN reviewed Metabotropic glutamate receptor 8 (mGluR8) Homo sapiens (Human) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g3626.t1 P70579 28.538 855 5.4400000000000004e-99 335.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g3628.t1 Q29476 35.254 295 4.2e-52 176.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g3629.t1 Q29476 36.644 292 2.2e-53 179.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g3631.t1 A2BE28 25.147 509 2.03e-36 148.0 sp|A2BE28|LAS1L_MOUSE Ribosomal biogenesis protein LAS1L OS=Mus musculus OX=10090 GN=Las1l PE=1 SV=1 LAS1L_MOUSE reviewed Ribosomal biogenesis protein LAS1L (Endoribonuclease LAS1L) (EC 3.1.-.-) (Protein LAS1 homolog) Mus musculus (Mouse) GO:0000460; GO:0000470; GO:0004519; GO:0005634; GO:0005730; GO:0006364; GO:0016787; GO:0071339; GO:0090730 maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364] Las1 complex [GO:0090730]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleus [GO:0005634] endonuclease activity [GO:0004519]; hydrolase activity [GO:0016787] g3632.t1 Q99973 27.479 353 2.8199999999999997e-30 129.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g3634.t1 Q8BTW8 54.265 551 0.0 574.0 sp|Q8BTW8|CK5P1_MOUSE Mitochondrial tRNA methylthiotransferase CDK5RAP1 OS=Mus musculus OX=10090 GN=Cdk5rap1 PE=1 SV=2 CK5P1_MOUSE reviewed Mitochondrial tRNA methylthiotransferase CDK5RAP1 (EC 2.8.4.3) (CDK5 activator-binding protein C42) (CDK5 regulatory subunit-associated protein 1) (mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase) (mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase) Mus musculus (Mouse) GO:0000079; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0009451; GO:0035597; GO:0044877; GO:0045736; GO:0045903; GO:0046872; GO:0051539; GO:0070131; GO:0070900 mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; RNA modification [GO:0009451] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; tRNA-2-methylthio-N(6)-dimethylallyladenosine(37) synthase activity [GO:0035597] g3635.t1 P31422 34.637 895 2.99e-159 494.0 sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1 GRM3_RAT reviewed Metabotropic glutamate receptor 3 (mGluR3) Rattus norvegicus (Rat) GO:0001641; GO:0005246; GO:0005886; GO:0007193; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g3636.t1 Q14832 38.488 291 2.8999999999999998e-52 189.0 sp|Q14832|GRM3_HUMAN Metabotropic glutamate receptor 3 OS=Homo sapiens OX=9606 GN=GRM3 PE=1 SV=2 GRM3_HUMAN reviewed Metabotropic glutamate receptor 3 (mGluR3) Homo sapiens (Human) GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0033554; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 cellular response to stress [GO:0033554]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g3640.t1 Q3TDX8 37.171 304 1.33e-59 202.0 sp|Q3TDX8|NB5R4_MOUSE Cytochrome b5 reductase 4 OS=Mus musculus OX=10090 GN=Cyb5r4 PE=2 SV=3 NB5R4_MOUSE reviewed Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R) Mus musculus (Mouse) GO:0003958; GO:0004128; GO:0005737; GO:0005783; GO:0006739; GO:0006801; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042168; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0050660; GO:0072593; GO:0090524 cell development [GO:0048468]; glucose homeostasis [GO:0042593]; heme metabolic process [GO:0042168]; insulin secretion [GO:0030073]; NADP+ metabolic process [GO:0006739]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; cytochrome-b5 reductase activity, acting on NADH [GO:0090524]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653] g3641.t1 Q502I6 35.426 223 6.23e-36 134.0 sp|Q502I6|NB5R4_DANRE Cytochrome b5 reductase 4 OS=Danio rerio OX=7955 GN=cyb5r4 PE=2 SV=1 NB5R4_DANRE reviewed Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (cb5/cb5R) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004128; GO:0005737; GO:0005783; GO:0006801; GO:0020037; GO:0046872; GO:0090524 superoxide metabolic process [GO:0006801] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783] cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; cytochrome-b5 reductase activity, acting on NADH [GO:0090524]; heme binding [GO:0020037]; metal ion binding [GO:0046872] g3643.t1 Q6DDL7 36.119 371 5.8e-72 234.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g3644.t1 O46503 37.638 271 9.41e-51 172.0 sp|O46503|ST1C2_RABIT Sulfotransferase 1C2 OS=Oryctolagus cuniculus OX=9986 GN=SULT1C2 PE=1 SV=1 g3645.t1 O46503 39.033 269 9.32e-53 177.0 sp|O46503|ST1C2_RABIT Sulfotransferase 1C2 OS=Oryctolagus cuniculus OX=9986 GN=SULT1C2 PE=1 SV=1 g3646.t1 O00338 38.849 278 1.09e-51 175.0 sp|O00338|ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens OX=9606 GN=SULT1C2 PE=1 SV=1 ST1C2_HUMAN reviewed Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051922; GO:0051923 amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; mitochondrion [GO:0005739] aryl sulfotransferase activity [GO:0004062]; cholesterol sulfotransferase activity [GO:0051922]; sulfotransferase activity [GO:0008146] g3647.t1 O70277 28.829 222 1.82e-21 100.0 sp|O70277|TRIM3_RAT Tripartite motif-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Trim3 PE=1 SV=1 g3649.t1 Q96P65 29.126 309 3.7e-33 131.0 sp|Q96P65|QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor OS=Homo sapiens OX=9606 GN=QRFPR PE=1 SV=2 QRFPR_HUMAN reviewed Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155) Homo sapiens (Human) GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0016020; GO:0032870 cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983] g3650.t1 Q5XHA8 64.204 609 0.0 806.0 sp|Q5XHA8|PYG1A_XENLA CTP synthase 1-A OS=Xenopus laevis OX=8355 GN=ctps1-a PE=2 SV=1 PYG1A_XENLA reviewed CTP synthase 1-A (EC 6.3.4.2) (CTP synthetase 1-A) (Protein-asparagine deamidase CTPS1-A) (EC 3.5.1.-) (UTP--ammonia ligase 1-A) Xenopus laevis (African clawed frog) GO:0000785; GO:0003883; GO:0005524; GO:0005634; GO:0005737; GO:0006241; GO:0019856; GO:0032480; GO:0042802; GO:0044210; GO:0097268; GO:0140861; GO:0160260; GO:0160264; GO:1902340 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; DNA repair-dependent chromatin remodeling [GO:0140861]; negative regulation of chromosome condensation [GO:1902340]; negative regulation of type I interferon production [GO:0032480]; pyrimidine nucleobase biosynthetic process [GO:0019856] chromatin [GO:0000785]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; histone H1N76/N77 asparagine deamidase activity [GO:0160264]; identical protein binding [GO:0042802]; protein asparagine deamidase activity [GO:0160260] g3651.t1 B1H369 55.22 364 1.63e-153 448.0 sp|B1H369|HDAC8_XENTR Histone deacetylase 8 OS=Xenopus tropicalis OX=8364 GN=hdac8 PE=2 SV=1 HDAC8_XENTR reviewed Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000118; GO:0004407; GO:0005694; GO:0005737; GO:0031507; GO:0046872; GO:0141221; GO:0160009 heterochromatin formation [GO:0031507] chromosome [GO:0005694]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118] histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; metal ion binding [GO:0046872] g3652.t1 P58501 47.059 374 2.55e-121 376.0 sp|P58501|PAXB1_MOUSE PAX3- and PAX7-binding protein 1 OS=Mus musculus OX=10090 GN=Paxbp1 PE=1 SV=3 g3655.t1 P32019 49.788 707 0.0 686.0 sp|P32019|I5P2_HUMAN Type II inositol 1,4,5-trisphosphate 5-phosphatase OS=Homo sapiens OX=9606 GN=INPP5B PE=1 SV=4 I5P2_HUMAN reviewed Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (EC 3.1.3.56) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase) Homo sapiens (Human) GO:0001701; GO:0004439; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007283; GO:0016020; GO:0030317; GO:0030670; GO:0031901; GO:0043005; GO:0043647; GO:0046856; GO:0046872; GO:0052658; GO:0052659; GO:0070613; GO:0097542 flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuron projection [GO:0043005]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439] g3656.t1 Q5T5C0 54.015 1183 0.0 1261.0 sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1 STXB5_HUMAN reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g3656.t2 Q5T5C0 53.808 1195 0.0 1264.0 sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1 STXB5_HUMAN reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g3656.t3 Q5T5C0 52.273 1232 0.0 1237.0 sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1 STXB5_HUMAN reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g3656.t4 Q5T5C0 52.354 1232 0.0 1248.0 sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1 STXB5_HUMAN reviewed Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300 exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] g3657.t1 Q8BGC0 47.277 404 3.65e-105 331.0 sp|Q8BGC0|HTSF1_MOUSE 17S U2 SnRNP complex component HTATSF1 OS=Mus musculus OX=10090 GN=Htatsf1 PE=1 SV=1 g3658.t1 Q8BGW8 30.925 346 2.08e-21 96.7 sp|Q8BGW8|VGLL2_MOUSE Transcription cofactor vestigial-like protein 2 OS=Mus musculus OX=10090 GN=Vgll2 PE=1 SV=1 VGLL2_MOUSE reviewed Transcription cofactor vestigial-like protein 2 (Vgl-2) (Protein VITO1) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005737; GO:0006357; GO:0007519; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519] cytoplasm [GO:0005737]; nucleus [GO:0005634] transcription coactivator activity [GO:0003713] g3659.t1 Q8BH60 67.03 367 9.85e-175 503.0 sp|Q8BH60|GOPC_MOUSE Golgi-associated PDZ and coiled-coil motif-containing protein OS=Mus musculus OX=10090 GN=Gopc PE=1 SV=1 GOPC_MOUSE reviewed Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (PDZ protein interacting specifically with TC10) (PIST) Mus musculus (Mouse) GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0010467; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030140; GO:0030165; GO:0030425; GO:0030695; GO:0032991; GO:0042802; GO:0042803; GO:0044325; GO:0045202; GO:0140313; GO:2000009 autophagy [GO:0006914]; gene expression [GO:0010467]; negative regulation of protein localization to cell surface [GO:2000009]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289] cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140] frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; molecular sequestering activity [GO:0140313]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; transmembrane transporter binding [GO:0044325] g3661.t1 Q8R242 41.86 344 1.7099999999999997e-89 277.0 sp|Q8R242|DIAC_MOUSE Di-N-acetylchitobiase OS=Mus musculus OX=10090 GN=Ctbs PE=1 SV=2 DIAC_MOUSE reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Mus musculus (Mouse) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568] g3662.t1 Q8R242 43.642 346 9.409999999999999e-95 290.0 sp|Q8R242|DIAC_MOUSE Di-N-acetylchitobiase OS=Mus musculus OX=10090 GN=Ctbs PE=1 SV=2 DIAC_MOUSE reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Mus musculus (Mouse) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568] g3663.t1 Q71SG7 42.473 372 7.82e-97 301.0 sp|Q71SG7|GCNT4_DANRE Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 OS=Danio rerio OX=7955 GN=gcnt4 PE=2 SV=2 g3664.t1 P41594 54.854 855 0.0 974.0 sp|P41594|GRM5_HUMAN Metabotropic glutamate receptor 5 OS=Homo sapiens OX=9606 GN=GRM5 PE=1 SV=2 GRM5_HUMAN reviewed Metabotropic glutamate receptor 5 (mGluR5) Homo sapiens (Human) GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007626; GO:0008066; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0045471; GO:0046677; GO:0048170; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g3665.t1 Q8CEG5 41.818 110 8.1e-22 93.6 sp|Q8CEG5|CC28B_MOUSE Coiled-coil domain-containing protein 28B OS=Mus musculus OX=10090 GN=Ccdc28b PE=1 SV=3 g3665.t2 Q9BUN5 36.416 173 7.77e-22 92.4 sp|Q9BUN5|CC28B_HUMAN Coiled-coil domain-containing protein 28B OS=Homo sapiens OX=9606 GN=CCDC28B PE=1 SV=2 CC28B_HUMAN reviewed Coiled-coil domain-containing protein 28B Homo sapiens (Human) GO:0005813; GO:0060271 cilium assembly [GO:0060271] centrosome [GO:0005813] g3667.t1 Q9D5V6 51.803 305 1.3599999999999999e-95 292.0 sp|Q9D5V6|SYAP1_MOUSE Synapse-associated protein 1 OS=Mus musculus OX=10090 GN=Syap1 PE=1 SV=1 SYAP1_MOUSE reviewed Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009898; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0032869; GO:0036120; GO:0038203; GO:0042734; GO:0043204; GO:0045202; GO:0045211; GO:0045600; GO:0048172; GO:0048471; GO:0071364; GO:0071902; GO:1990314 cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] g3668.t1 P47836 70.0 260 6.59e-134 379.0 sp|P47836|RS4_CHICK Small ribosomal subunit protein eS4 OS=Gallus gallus OX=9031 GN=RPS4 PE=1 SV=2 g3669.t1 Q6NYU7 71.163 215 2.09e-114 330.0 sp|Q6NYU7|UPP_DANRE Uracil phosphoribosyltransferase homolog OS=Danio rerio OX=7955 GN=uprt PE=2 SV=1 g3669.t2 Q6NYU7 71.163 215 1.36e-114 330.0 sp|Q6NYU7|UPP_DANRE Uracil phosphoribosyltransferase homolog OS=Danio rerio OX=7955 GN=uprt PE=2 SV=1 g3670.t1 H2LNR5 64.364 550 0.0 745.0 sp|H2LNR5|ABCB7_ORYLA Iron-sulfur clusters transporter ABCB7, mitochondrial OS=Oryzias latipes OX=8090 GN=abcb7 PE=1 SV=2 ABCB7_ORYLA reviewed Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) Oryzias latipes (Japanese rice fish) (Japanese killifish) GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0010312; GO:0016226; GO:0016887; GO:0042626; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903427; GO:1990748 cellular detoxification [GO:1990748]; detoxification of zinc ion [GO:0010312]; intracellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; transmembrane transport [GO:0055085] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626] g3672.t1 P97355 44.318 352 4.95e-86 266.0 sp|P97355|SPSY_MOUSE Spermine synthase OS=Mus musculus OX=10090 GN=Sms PE=1 SV=1 g3673.t1 Q6AXW7 45.304 181 5.78e-50 163.0 sp|Q6AXW7|DUS18_RAT Dual specificity protein phosphatase 18 OS=Rattus norvegicus OX=10116 GN=Dusp18 PE=2 SV=1 DUS18_RAT reviewed Dual specificity protein phosphatase 18 (EC 3.1.3.16) (EC 3.1.3.48) Rattus norvegicus (Rat) GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005743; GO:0008138; GO:0016311; GO:0016791; GO:0017017; GO:0035335; GO:0035970 dephosphorylation [GO:0016311]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] g3675.t1 Q99LJ8 47.368 171 1.17e-50 167.0 sp|Q99LJ8|NGBR_MOUSE Dehydrodolichyl diphosphate synthase complex subunit Nus1 OS=Mus musculus OX=10090 GN=Nus1 PE=2 SV=1 g3677.t1 Q8BYR2 58.321 679 0.0 766.0 sp|Q8BYR2|LATS1_MOUSE Serine/threonine-protein kinase LATS1 OS=Mus musculus OX=10090 GN=Lats1 PE=1 SV=3 LATS1_MOUSE reviewed Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) Mus musculus (Mouse) GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005815; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0035332; GO:0043065; GO:0043254; GO:0044546; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058 cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular protein localization [GO:0008104]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819] centrosome [GO:0005813]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; postsynapse [GO:0098794]; spindle pole [GO:0000922] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g3678.t1 P59235 40.842 404 3.37e-103 313.0 sp|P59235|NUP43_MOUSE Nucleoporin Nup43 OS=Mus musculus OX=10090 GN=Nup43 PE=1 SV=2 g3680.t1 Q9VUL9 39.623 212 1.14e-38 145.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g3681.t1 Q9VUL9 41.53 183 9.46e-37 144.0 sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2 FUCTA_DROME reviewed Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase) Drosophila melanogaster (Fruit fly) GO:0005797; GO:0006491; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0046920 N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; protein N-linked glycosylation via asparagine [GO:0018279] Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797] alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392] g3682.t1 A8WHP3 52.227 651 0.0 657.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g3683.t1 A8WHP3 51.852 648 0.0 656.0 sp|A8WHP3|SC5A9_DANRE Sodium/glucose cotransporter 4 OS=Danio rerio OX=7955 GN=slc5a9 PE=2 SV=1 g3685.t1 Q3SX42 46.753 231 2.5800000000000003e-59 189.0 sp|Q3SX42|CHM2B_BOVIN Charged multivesicular body protein 2b OS=Bos taurus OX=9913 GN=CHMP2B PE=2 SV=1 CHM2B_BOVIN reviewed Charged multivesicular body protein 2b (Chromatin-modifying protein 2b) (CHMP2b) Bos taurus (Bovine) GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324 endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031] cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771] g3686.t1 Q1XA76 32.237 456 5.95e-72 241.0 sp|Q1XA76|ASIC1_CHICK Acid-sensing ion channel 1 OS=Gallus gallus OX=9031 GN=ASIC1 PE=1 SV=1 ASIC1_CHICK reviewed Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) Gallus gallus (Chicken) GO:0005886; GO:0007269; GO:0015280; GO:0030425; GO:0035725; GO:0042802; GO:0045211; GO:0071467; GO:0098793; GO:0098978; GO:0160128 cellular response to pH [GO:0071467]; neurotransmitter secretion [GO:0007269]; sodium ion transmembrane transport [GO:0035725] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793] identical protein binding [GO:0042802]; ligand-gated sodium channel activity [GO:0015280]; pH-gated monoatomic ion channel activity [GO:0160128] g3689.t1 O75626 78.74 127 1.33e-61 226.0 sp|O75626|PRDM1_HUMAN PR domain zinc finger protein 1 OS=Homo sapiens OX=9606 GN=PRDM1 PE=1 SV=2 g3689.t1 O75626 50.532 188 4.1999999999999994e-54 205.0 sp|O75626|PRDM1_HUMAN PR domain zinc finger protein 1 OS=Homo sapiens OX=9606 GN=PRDM1 PE=1 SV=2 g3691.t1 Q67FQ3 44.878 205 2.02e-47 163.0 sp|Q67FQ3|ARHB_XENLA Low density lipoprotein receptor adapter protein 1-B OS=Xenopus laevis OX=8355 GN=ldlrap1-b PE=1 SV=1 g3693.t1 Q9Y493 30.923 401 2.83e-46 189.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3693.t1 Q9Y493 27.105 380 6.080000000000001e-37 159.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3693.t1 Q9Y493 31.378 392 9.48e-37 158.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3693.t1 Q9Y493 27.225 382 2.4500000000000002e-27 127.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3693.t1 Q9Y493 26.984 378 3.63e-25 120.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3693.t1 Q9Y493 27.92 351 1.0199999999999999e-23 115.0 sp|Q9Y493|ZAN_HUMAN Zonadhesin OS=Homo sapiens OX=9606 GN=ZAN PE=2 SV=5 g3694.t1 Q7ZVB1 70.202 198 5.4e-83 247.0 sp|Q7ZVB1|CHM1B_DANRE Charged multivesicular body protein 1b OS=Danio rerio OX=7955 GN=chmp1b PE=2 SV=1 g3695.t1 Q5RDT5 66.438 146 2.92e-62 191.0 sp|Q5RDT5|SAP18_PONAB Histone deacetylase complex subunit SAP18 OS=Pongo abelii OX=9601 GN=SAP18 PE=2 SV=1 SAP18_PONAB reviewed Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p18) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000381; GO:0003714; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0043065; GO:0048025; GO:0061574 mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607] transcription corepressor activity [GO:0003714] g3696.t1 Q9BWD1 66.24 391 0.0 524.0 sp|Q9BWD1|THIC_HUMAN Acetyl-CoA acetyltransferase, cytosolic OS=Homo sapiens OX=9606 GN=ACAT2 PE=1 SV=2 g3697.t1 Q923I7 38.124 661 6.78e-147 445.0 sp|Q923I7|SC5A2_MOUSE Sodium/glucose cotransporter 2 OS=Mus musculus OX=10090 GN=Slc5a2 PE=1 SV=1 SC5A2_MOUSE reviewed Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2) Mus musculus (Mouse) GO:0000017; GO:0005412; GO:0005886; GO:0006814; GO:0015151; GO:0016324; GO:0031526; GO:0035623; GO:0035811; GO:0036359; GO:0046872; GO:0055056; GO:0098708; GO:0098719; GO:1904659 alpha-glucoside transport [GO:0000017]; D-glucose import across plasma membrane [GO:0098708]; D-glucose transmembrane transport [GO:1904659]; negative regulation of urine volume [GO:0035811]; renal D-glucose absorption [GO:0035623]; renal potassium excretion [GO:0036359]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] alpha-glucoside transmembrane transporter activity [GO:0015151]; D-glucose transmembrane transporter activity [GO:0055056]; D-glucose:sodium symporter activity [GO:0005412]; metal ion binding [GO:0046872] g3698.t1 Q5RCG9 62.791 172 1.45e-79 238.0 sp|Q5RCG9|PFD3_PONAB Prefoldin subunit 3 OS=Pongo abelii OX=9601 GN=VBP1 PE=2 SV=1 PFD3_PONAB reviewed Prefoldin subunit 3 (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001540; GO:0005634; GO:0005829; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0051082; GO:1905907 microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] cytosol [GO:0005829]; nucleus [GO:0005634]; prefoldin complex [GO:0016272] amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082] g3699.t1 Q93034 75.096 783 0.0 1221.0 sp|Q93034|CUL5_HUMAN Cullin-5 OS=Homo sapiens OX=9606 GN=CUL5 PE=1 SV=4 CUL5_HUMAN reviewed Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1) Homo sapiens (Human) GO:0000082; GO:0004842; GO:0005262; GO:0005634; GO:0005737; GO:0005829; GO:0016477; GO:0016567; GO:0019005; GO:0030335; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038023; GO:0038026; GO:0038128; GO:0043161; GO:0051895; GO:0070979; GO:0090734; GO:0097193; GO:0120184; GO:0160072; GO:2001222 cell migration [GO:0016477]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of focal adhesion disassembly [GO:0120184]; positive regulation of cell migration [GO:0030335]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734] calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g3700.t1 Q4R630 34.403 561 8.05e-97 313.0 sp|Q4R630|NDC80_MACFA Kinetochore protein NDC80 homolog OS=Macaca fascicularis OX=9541 GN=NDC80 PE=2 SV=1 NDC80_MACFA reviewed Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000776; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0007059; GO:0008017; GO:0031262; GO:0051301; GO:0051310; GO:0051315; GO:0090267; GO:0140483 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; metaphase chromosome alignment [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267] centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; nucleus [GO:0005634] kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017] g3701.t1 Q3E6S9 33.333 393 1.9599999999999998e-61 209.0 sp|Q3E6S9|CNIF3_ARATH Probable L-cysteine desulfhydrase, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=CpNIFS3 PE=1 SV=1 g3702.t1 B2GV36 33.645 535 2.15e-93 299.0 sp|B2GV36|S22AD_RAT Solute carrier family 22 member 13 OS=Rattus norvegicus OX=10116 GN=Slc22a13 PE=2 SV=1 S22AD_RAT reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) Rattus norvegicus (Rat) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0045922; GO:0090416; GO:2001142 negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g3703.t1 Q9VCA2 35.211 568 5.11e-92 296.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3704.t1 Q9U539 40.541 259 1.08e-56 201.0 sp|Q9U539|OCT1_CAEEL Organic cation transporter 1 OS=Caenorhabditis elegans OX=6239 GN=oct-1 PE=1 SV=3 g3705.t1 Q9Y226 33.333 534 1.4299999999999999e-89 290.0 sp|Q9Y226|S22AD_HUMAN Solute carrier family 22 member 13 OS=Homo sapiens OX=9606 GN=SLC22A13 PE=1 SV=2 S22AD_HUMAN reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) (ORCTL3) Homo sapiens (Human) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0034355; GO:0045922; GO:0070062; GO:0090416; GO:2001142 NAD+ biosynthetic process via the salvage pathway [GO:0034355]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g3706.t1 Q6A4L0 32.983 476 5.5900000000000004e-70 237.0 sp|Q6A4L0|S22AD_MOUSE Solute carrier family 22 member 13 OS=Mus musculus OX=10090 GN=Slc22a13 PE=1 SV=3 S22AD_MOUSE reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) Mus musculus (Mouse) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0045922; GO:0090416; GO:2001142 negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g3707.t1 Q9Y226 31.616 563 1.24e-88 288.0 sp|Q9Y226|S22AD_HUMAN Solute carrier family 22 member 13 OS=Homo sapiens OX=9606 GN=SLC22A13 PE=1 SV=2 S22AD_HUMAN reviewed Solute carrier family 22 member 13 (Organic anion transporter 10) (OAT10) (Organic cation transporter-like 3) (ORCTL-3) (ORCTL3) Homo sapiens (Human) GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015143; GO:0015747; GO:0016324; GO:0034355; GO:0045922; GO:0070062; GO:0090416; GO:2001142 NAD+ biosynthetic process via the salvage pathway [GO:0034355]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] nicotinate transmembrane transporter activity [GO:0090416]; urate transmembrane transporter activity [GO:0015143] g3708.t1 P97402 46.584 322 4.27e-101 311.0 sp|P97402|GCNT2_MOUSE N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase OS=Mus musculus OX=10090 GN=Gcnt2 PE=2 SV=2 GCNT2_MOUSE reviewed N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) (Large I antigen-forming beta-1,6-N-acetylglucosaminyltransferase) Mus musculus (Mouse) GO:0000139; GO:0007179; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374 maintenance of lens transparency [GO:0036438]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi membrane [GO:0000139] acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109] g3709.t1 Q17RP2 29.708 377 1.8799999999999998e-38 149.0 sp|Q17RP2|TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens OX=9606 GN=TIGD6 PE=1 SV=2 g3709.t2 Q17RP2 29.894 378 2.0199999999999998e-38 149.0 sp|Q17RP2|TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens OX=9606 GN=TIGD6 PE=1 SV=2 g3711.t1 Q9CXL1 63.125 160 1.5499999999999998e-67 205.0 sp|Q9CXL1|TM50A_MOUSE Transmembrane protein 50A OS=Mus musculus OX=10090 GN=Tmem50a PE=1 SV=1 g3712.t1 Q99973 26.426 719 4.81e-56 216.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g3712.t2 Q99973 25.301 747 2.04e-45 183.0 sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2 TEP1_HUMAN reviewed Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog) Homo sapiens (Human) GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697] ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] g3714.t1 Q32NQ7 46.217 489 1e-147 434.0 sp|Q32NQ7|DAAF3_XENLA Dynein axonemal assembly factor 3 OS=Xenopus laevis OX=8355 GN=dnaaf3 PE=2 SV=1 g3715.t1 P46023 37.604 718 8.459999999999999e-139 444.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g3717.t1 P70490 33.333 330 1.1199999999999999e-38 154.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g3717.t1 P70490 28.53 347 5.2e-31 131.0 sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1 MFGM_RAT reviewed Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (O-acetyl GD3 ganglioside synthase) (AGS) (SED1) Rattus norvegicus (Rat) GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008284; GO:0008429; GO:0009897; GO:0043277; GO:0043627; GO:0050766 angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phagocytosis [GO:0050766]; response to estrogen [GO:0043627]; single fertilization [GO:0007338] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615] integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] g3718.t1 P39098 50.297 674 0.0 674.0 sp|P39098|MA1A2_MOUSE Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB OS=Mus musculus OX=10090 GN=Man1a2 PE=1 SV=1 MA1A2_MOUSE reviewed Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB) Mus musculus (Mouse) GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0007585; GO:0009100; GO:0036503; GO:0048286 carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; glycoprotein metabolic process [GO:0009100]; lung alveolus development [GO:0048286]; respiratory gaseous exchange by respiratory system [GO:0007585] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571] g3719.t1 Q8BMK0 27.215 790 6.66e-56 208.0 sp|Q8BMK0|CEP85_MOUSE Centrosomal protein of 85 kDa OS=Mus musculus OX=10090 GN=Cep85 PE=1 SV=2 g3719.t2 Q8BMK0 26.585 820 1.13e-56 211.0 sp|Q8BMK0|CEP85_MOUSE Centrosomal protein of 85 kDa OS=Mus musculus OX=10090 GN=Cep85 PE=1 SV=2 g3720.t1 O54862 43.713 501 1.02e-131 394.0 sp|O54862|MBTP2_CRIGR Membrane-bound transcription factor site-2 protease OS=Cricetulus griseus OX=10029 GN=MBTPS2 PE=2 SV=1 g3723.t1 Q6PBT5 57.404 493 0.0 597.0 sp|Q6PBT5|PYRD1_DANRE Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 OS=Danio rerio OX=7955 GN=pyroxd1 PE=2 SV=1 PYRD1_DANRE reviewed tRNA ligase complex-associated NAD(P)H dehydrogenase PYROXD1 (EC 1.6.99.1) (Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005634; GO:0016491; GO:0030017 nucleus [GO:0005634]; sarcomere [GO:0030017] oxidoreductase activity [GO:0016491] g3724.t1 Q5VVH5 45.238 252 3.78e-67 211.0 sp|Q5VVH5|IKBP1_HUMAN Interleukin-1 receptor-associated kinase 1-binding protein 1 OS=Homo sapiens OX=9606 GN=IRAK1BP1 PE=1 SV=1 IKBP1_HUMAN reviewed Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0006955; GO:0035591; GO:0043123 immune response [GO:0006955]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123] cytoplasm [GO:0005737]; nucleus [GO:0005634] signaling adaptor activity [GO:0035591] g3725.t1 Q5M7C7 33.149 181 1.3299999999999999e-24 97.4 sp|Q5M7C7|JAGN1_XENLA Protein jagunal homolog 1 OS=Xenopus laevis OX=8355 GN=jagn1 PE=2 SV=1 g3739.t1 Q4R7V3 61.364 132 4.55e-48 173.0 sp|Q4R7V3|CEP43_MACFA Centrosomal protein 43 OS=Macaca fascicularis OX=9541 GN=CEP43 PE=2 SV=1 CEP43_MACFA reviewed Centrosomal protein 43 (FGFR1 oncogene partner) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005813; GO:0005814; GO:0030030; GO:0034453 cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453] centriole [GO:0005814]; centrosome [GO:0005813] g3739.t2 O95684 56.463 147 5.17e-48 174.0 sp|O95684|CEP43_HUMAN Centrosomal protein 43 OS=Homo sapiens OX=9606 GN=CEP43 PE=1 SV=1 g3740.t1 Q9EQG7 40.042 477 5.169999999999999e-119 361.0 sp|Q9EQG7|ENPP5_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Mus musculus OX=10090 GN=Enpp5 PE=1 SV=3 ENPP5_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-) Mus musculus (Mouse) GO:0000210; GO:0004551; GO:0005576; GO:0005886; GO:0007154; GO:0008270; GO:0009166; GO:0016787 cell communication [GO:0007154]; nucleotide catabolic process [GO:0009166] extracellular region [GO:0005576]; plasma membrane [GO:0005886] dinucleotide phosphatase activity [GO:0004551]; hydrolase activity [GO:0016787]; NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270] g3741.t1 Q9TZM3 30.769 819 5.47e-95 349.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g3741.t1 Q9TZM3 29.558 927 6.38e-90 332.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g3741.t1 Q9TZM3 26.234 709 2.11e-34 150.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g3741.t2 Q9TZM3 30.769 819 4.9099999999999996e-95 349.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g3741.t2 Q9TZM3 29.558 927 6.07e-90 332.0 sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6 g3742.t1 Q5XXB5 65.208 937 0.0 1239.0 sp|Q5XXB5|MSH2_CHLAE DNA mismatch repair protein Msh2 OS=Chlorocebus aethiops OX=9534 GN=MSH2 PE=2 SV=1 g3745.t1 Q9ESL4 47.015 536 1.63e-151 466.0 sp|Q9ESL4|M3K20_MOUSE Mitogen-activated protein kinase kinase kinase 20 OS=Mus musculus OX=10090 GN=Map3k20 PE=1 SV=1 g3746.t1 Q4R918 43.095 601 2.53e-139 422.0 sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1 KIF25_MACFA reviewed Kinesin-like protein KIF25 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647 establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289] centrosome [GO:0005813]; microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569] g3746.t2 Q4R918 43.095 601 9.31e-140 423.0 sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1 KIF25_MACFA reviewed Kinesin-like protein KIF25 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647 establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289] centrosome [GO:0005813]; microtubule [GO:0005874] ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569] g3749.t1 Q14BI2 29.647 850 3.77e-99 333.0 sp|Q14BI2|GRM2_MOUSE Metabotropic glutamate receptor 2 OS=Mus musculus OX=10090 GN=Grm2 PE=1 SV=2 g3751.t1 Q9UNX4 58.61 935 0.0 1089.0 sp|Q9UNX4|WDR3_HUMAN WD repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=WDR3 PE=1 SV=1 WDR3_HUMAN reviewed WD repeat-containing protein 3 Homo sapiens (Human) GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388; GO:0042274 maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] RNA binding [GO:0003723]; snoRNA binding [GO:0030515] g3757.t1 Q61493 57.838 555 0.0 697.0 sp|Q61493|REV3L_MOUSE DNA polymerase zeta catalytic subunit OS=Mus musculus OX=10090 GN=Rev3l PE=1 SV=3 g3758.t1 Q61493 49.186 307 6.15e-87 314.0 sp|Q61493|REV3L_MOUSE DNA polymerase zeta catalytic subunit OS=Mus musculus OX=10090 GN=Rev3l PE=1 SV=3 g3762.t1 O60673 39.488 547 2.58e-94 320.0 sp|O60673|REV3L_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens OX=9606 GN=REV3L PE=1 SV=2 REV3L_HUMAN reviewed DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (hREV3) Homo sapiens (Human) GO:0000166; GO:0000724; GO:0000731; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0006261; GO:0008270; GO:0016035; GO:0019985; GO:0042276; GO:0051539; GO:0071897; GO:0090734 DNA biosynthetic process [GO:0071897]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; zeta DNA polymerase complex [GO:0016035] 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g3764.t1 E9PYK3 43.898 1057 0.0 822.0 sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1 PARP4_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0140806; GO:0140807; GO:1990404; GO:1990904 inflammatory response [GO:0006954] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876] enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779] g3764.t2 E9PYK3 43.898 1057 0.0 822.0 sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1 PARP4_MOUSE reviewed Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp) Mus musculus (Mouse) GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0140806; GO:0140807; GO:1990404; GO:1990904 inflammatory response [GO:0006954] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876] enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779] g3768.t1 Q58DQ5 47.917 336 7.84e-110 330.0 sp|Q58DQ5|RT09_BOVIN Small ribosomal subunit protein uS9m OS=Bos taurus OX=9913 GN=MRPS9 PE=1 SV=3 g3769.t1 P50747 37.383 749 2.19e-143 445.0 sp|P50747|BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens OX=9606 GN=HLCS PE=1 SV=1 BPL1_HUMAN reviewed Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)] Homo sapiens (Human) GO:0000785; GO:0004077; GO:0005524; GO:0005652; GO:0005737; GO:0005739; GO:0005829; GO:0006768; GO:0009374; GO:0016363; GO:0019899; GO:0042802; GO:0043687; GO:0070781 biotin metabolic process [GO:0006768]; post-translational protein modification [GO:0043687]; response to biotin [GO:0070781] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363] ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin--[biotin carboxyl-carrier protein] ligase activity [GO:0004077]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802] g3770.t1 Q8WPD0 33.526 173 2.76e-21 88.2 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g3771.t1 Q8WPD0 36.723 177 8.28e-23 92.4 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g3774.t1 P82451 47.856 583 0.0 556.0 sp|P82451|ABCC9_RABIT ATP-binding cassette sub-family C member 9 OS=Oryctolagus cuniculus OX=9986 GN=ABCC9 PE=2 SV=1 g3775.t1 Q09427 34.486 983 1.77e-170 540.0 sp|Q09427|ABCC8_CRICR ATP-binding cassette sub-family C member 8 OS=Cricetus cricetus OX=10034 GN=ABCC8 PE=1 SV=3 g3776.t1 A2T6X9 79.888 358 0.0 617.0 sp|A2T6X9|SIM1_PANTR Single-minded homolog 1 OS=Pan troglodytes OX=9598 GN=SIM1 PE=3 SV=1 g3777.t1 Q8BX13 28.412 447 8.29e-51 179.0 sp|Q8BX13|UBE3D_MOUSE E3 ubiquitin-protein ligase E3D OS=Mus musculus OX=10090 GN=Ube3d PE=2 SV=1 g3779.t1 A0A2R8QF68 34.45 209 4.4e-32 127.0 sp|A0A2R8QF68|GRIK2_DANRE Glutamate receptor ionotropic, kainate 2 OS=Danio rerio OX=7955 GN=grik2 PE=3 SV=1 GRIK2_DANRE reviewed Glutamate receptor ionotropic, kainate 2 (GluK2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005886; GO:0009409; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:0120169; GO:1904315 detection of cold stimulus involved in thermoception [GO:0120169]; modulation of chemical synaptic transmission [GO:0050804]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249] kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734] glutamate-gated calcium ion channel activity [GO:0022849]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g3780.t1 Q13002 53.195 579 0.0 608.0 sp|Q13002|GRIK2_HUMAN Glutamate receptor ionotropic, kainate 2 OS=Homo sapiens OX=9606 GN=GRIK2 PE=1 SV=1 g3781.t1 P39087 46.462 848 0.0 753.0 sp|P39087|GRIK2_MOUSE Glutamate receptor ionotropic, kainate 2 OS=Mus musculus OX=10090 GN=Grik2 PE=1 SV=4 GRIK2_MOUSE reviewed Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) (Glutamate receptor beta-2) (GluR beta-2) Mus musculus (Mouse) GO:0000149; GO:0001662; GO:0004970; GO:0005234; GO:0005886; GO:0006874; GO:0006886; GO:0007268; GO:0008066; GO:0008328; GO:0014069; GO:0015277; GO:0016020; GO:0019228; GO:0022849; GO:0030165; GO:0030424; GO:0030425; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042391; GO:0042734; GO:0042802; GO:0043025; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045202; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060079; GO:0060080; GO:0097110; GO:0097471; GO:0098686; GO:0098794; GO:0098815; GO:0098839; GO:0098978; GO:0099507; GO:0120169; GO:1904315 behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; intracellular calcium ion homeostasis [GO:0006874]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of membrane potential [GO:0042391]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249] axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; ionotropic glutamate receptor complex [GO:0008328]; kainate selective glutamate receptor complex [GO:0032983]; membrane [GO:0016020]; mossy fiber rosette [GO:0097471]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195] extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; glutamate-gated calcium ion channel activity [GO:0022849]; glutamate-gated receptor activity [GO:0004970]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; SNARE binding [GO:0000149]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625] g3782.t1 Q5TB80 30.759 1554 3.98e-149 495.0 sp|Q5TB80|CE162_HUMAN Centrosomal protein of 162 kDa OS=Homo sapiens OX=9606 GN=CEP162 PE=1 SV=2 CE162_HUMAN reviewed Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog) Homo sapiens (Human) GO:0005654; GO:0005794; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0036064; GO:0060271; GO:0097225; GO:0097228; GO:0120212 cilium assembly [GO:0060271] axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; sperm head-tail coupling apparatus [GO:0120212]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle [GO:0005819] g3783.t1 E1C2Z0 32.231 937 1.72e-127 417.0 sp|E1C2Z0|MMS22_CHICK Protein MMS22-like OS=Gallus gallus OX=9031 GN=MMS22L PE=3 SV=1 g3786.t1 E1C2Z0 33.441 311 2.31e-42 159.0 sp|E1C2Z0|MMS22_CHICK Protein MMS22-like OS=Gallus gallus OX=9031 GN=MMS22L PE=3 SV=1 g3786.t2 E1C2Z0 32.578 353 8.559999999999999e-46 171.0 sp|E1C2Z0|MMS22_CHICK Protein MMS22-like OS=Gallus gallus OX=9031 GN=MMS22L PE=3 SV=1 g3787.t1 Q8N0X4 55.629 302 3.3e-115 340.0 sp|Q8N0X4|CLYBL_HUMAN Citramalyl-CoA lyase, mitochondrial OS=Homo sapiens OX=9606 GN=CLYBL PE=1 SV=2 CLYBL_HUMAN reviewed Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9) Homo sapiens (Human) GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121 positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064] mitochondrion [GO:0005739] (S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474] g3788.t1 O55012 53.812 446 9.04e-158 477.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g3788.t2 O55012 51.812 469 2.42e-154 469.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g3788.t3 O55012 52.941 459 7.59e-158 478.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g3788.t4 O55012 51.812 469 1.46e-154 469.0 sp|O55012|PICAL_RAT Phosphatidylinositol-binding clathrin assembly protein OS=Rattus norvegicus OX=10116 GN=Picalm PE=1 SV=1 PICAL_RAT reviewed Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) (rCALM) Rattus norvegicus (Rat) GO:0000149; GO:0005545; GO:0005546; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005905; GO:0006879; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0014069; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0017124; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0042802; GO:0043025; GO:0045211; GO:0045893; GO:0046579; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048488; GO:0048813; GO:0050750; GO:0050772; GO:0051223; GO:0060586; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098685; GO:0098688; GO:0098794; GO:0098843; GO:0098894; GO:0150093; GO:1900242; GO:1900244; GO:1902004; GO:1902803; GO:1902991; GO:1902993; GO:1903077; GO:1903861; GO:2000009; GO:2000331; GO:2000809 amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of axonogenesis [GO:0050772]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of protein transport [GO:0051223]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle transport [GO:1902803]; regulation of terminal button organization [GO:2000331]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] 1-phosphatidylinositol binding [GO:0005545]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156] g3790.t1 Q8CIQ6 31.119 286 3.04e-24 104.0 sp|Q8CIQ6|MTR1B_MOUSE Melatonin receptor type 1B OS=Mus musculus OX=10090 GN=Mtnr1b PE=2 SV=1 MTR1B_MOUSE reviewed Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor) Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007186; GO:0007623; GO:0008502; GO:0010754; GO:0042593; GO:0042753; GO:0043524; GO:0045906; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0098908 circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502] g3791.t1 P48039 27.931 290 9.41e-22 97.4 sp|P48039|MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens OX=9606 GN=MTNR1A PE=1 SV=1 MTR1A_HUMAN reviewed Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) Homo sapiens (Human) GO:0004930; GO:0005886; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617] plasma membrane [GO:0005886]; receptor complex [GO:0043235] G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502] g3792.t1 Q5T160 46.404 584 0.0 551.0 sp|Q5T160|SYRM_HUMAN Probable arginine--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=RARS2 PE=1 SV=1 SYRM_HUMAN reviewed Probable arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS) Homo sapiens (Human) GO:0003723; GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006420; GO:0031966; GO:0032543 arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723] g3793.t1 Q5XJN2 42.975 242 3.2199999999999997e-69 216.0 sp|Q5XJN2|GILT_DANRE Gamma-interferon-inducible lysosomal thiol reductase OS=Danio rerio OX=7955 GN=ifi30 PE=1 SV=1 GILT_DANRE reviewed Gamma-interferon-inducible lysosomal thiol reductase (zGILT) (EC 1.8.4.-) (Gamma-interferon-inducible protein IP-30) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002376; GO:0005576; GO:0005764; GO:0016667; GO:0016671; GO:0045454; GO:0047134; GO:0071425 cell redox homeostasis [GO:0045454]; hematopoietic stem cell proliferation [GO:0071425]; immune system process [GO:0002376] extracellular region [GO:0005576]; lysosome [GO:0005764] oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134] g3794.t1 Q5GF25 57.735 362 3.57e-157 456.0 sp|Q5GF25|MANEA_RAT Glycoprotein endo-alpha-1,2-mannosidase OS=Rattus norvegicus OX=10116 GN=Manea PE=1 SV=1 g3796.t1 O75417 57.026 854 0.0 996.0 sp|O75417|DPOLQ_HUMAN DNA polymerase theta OS=Homo sapiens OX=9606 GN=POLQ PE=1 SV=2 DPOLQ_HUMAN reviewed DNA polymerase theta (DNA polymerase eta) [Includes: Helicase POLQ (EC 3.6.4.12); DNA polymerase POLQ (EC 2.7.7.7) (RNA-directed DNA polymerase POLQ) (EC 2.7.7.49)] Homo sapiens (Human) GO:0000287; GO:0000731; GO:0003678; GO:0003682; GO:0003684; GO:0003887; GO:0003964; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0016887; GO:0017116; GO:0031297; GO:0035861; GO:0042276; GO:0042645; GO:0042802; GO:0051260; GO:0051575; GO:0090734; GO:0097681; GO:2000042 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; error-prone translesion synthesis [GO:0042276]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; replication fork processing [GO:0031297]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; single-stranded DNA helicase activity [GO:0017116] g3796.t1 O75417 47.074 786 0.0 723.0 sp|O75417|DPOLQ_HUMAN DNA polymerase theta OS=Homo sapiens OX=9606 GN=POLQ PE=1 SV=2 DPOLQ_HUMAN reviewed DNA polymerase theta (DNA polymerase eta) [Includes: Helicase POLQ (EC 3.6.4.12); DNA polymerase POLQ (EC 2.7.7.7) (RNA-directed DNA polymerase POLQ) (EC 2.7.7.49)] Homo sapiens (Human) GO:0000287; GO:0000731; GO:0003678; GO:0003682; GO:0003684; GO:0003887; GO:0003964; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0016887; GO:0017116; GO:0031297; GO:0035861; GO:0042276; GO:0042645; GO:0042802; GO:0051260; GO:0051575; GO:0090734; GO:0097681; GO:2000042 base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; error-prone translesion synthesis [GO:0042276]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; replication fork processing [GO:0031297]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; single-stranded DNA helicase activity [GO:0017116] g3797.t1 O60341 74.232 749 0.0 1130.0 sp|O60341|KDM1A_HUMAN Lysine-specific histone demethylase 1A OS=Homo sapiens OX=9606 GN=KDM1A PE=1 SV=2 KDM1A_HUMAN reviewed Lysine-specific histone demethylase 1A (EC 1.14.11.-) (EC 1.14.11.65) (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A) Homo sapiens (Human) GO:0000122; GO:0000781; GO:0000785; GO:0002039; GO:0002052; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0010569; GO:0010718; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0031398; GO:0032452; GO:0032453; GO:0032454; GO:0032880; GO:0032991; GO:0034644; GO:0035097; GO:0035575; GO:0040029; GO:0042551; GO:0042802; GO:0043426; GO:0043518; GO:0045793; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0055001; GO:0060765; GO:0060992; GO:0061629; GO:0061752; GO:0071320; GO:0071480; GO:0120162; GO:0140297; GO:0140457; GO:0140682; GO:0140861; GO:0160217; GO:1902166; GO:1902254; GO:1990391; GO:1990841; GO:2000179; GO:2000648 cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; DNA repair-dependent chromatin remodeling [GO:0140861]; epigenetic regulation of gene expression [GO:0040029]; guanine metabolic process [GO:0046098]; muscle cell development [GO:0055001]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA repair complex [GO:1990391]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K9 demethylase activity [GO:0032454]; histone H4K20 demethylase activity [GO:0035575]; identical protein binding [GO:0042802]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein demethylase activity [GO:0140457]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric repeat-containing RNA binding [GO:0061752]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] g3799.t1 Q99549 37.584 298 3.66e-48 189.0 sp|Q99549|MPP8_HUMAN M-phase phosphoprotein 8 OS=Homo sapiens OX=9606 GN=MPHOSPH8 PE=1 SV=2 MPP8_HUMAN reviewed M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) Homo sapiens (Human) GO:0000785; GO:0000786; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0032480; GO:0044027; GO:0045814; GO:0062072; GO:0140283; GO:0140286; GO:0140719; GO:0141005 constitutive heterochromatin formation [GO:0140719]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of type I interferon production [GO:0032480]; transposable element silencing by heterochromatin formation [GO:0141005] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; HUSH complex [GO:0140283]; HUSH2 complex [GO:0140286]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886] chromatin binding [GO:0003682]; histone H3K9me2/3 reader activity [GO:0062072] g3800.t1 Q9P2F6 33.563 727 1.23e-106 374.0 sp|Q9P2F6|RHG20_HUMAN Rho GTPase-activating protein 20 OS=Homo sapiens OX=9606 GN=ARHGAP20 PE=1 SV=2 RHG20_HUMAN reviewed Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0007165; GO:0035023; GO:0051056 regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] GTPase activator activity [GO:0005096] g3800.t2 Q9P2F6 33.425 727 2.87e-108 375.0 sp|Q9P2F6|RHG20_HUMAN Rho GTPase-activating protein 20 OS=Homo sapiens OX=9606 GN=ARHGAP20 PE=1 SV=2 RHG20_HUMAN reviewed Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20) Homo sapiens (Human) GO:0005096; GO:0005829; GO:0007165; GO:0035023; GO:0051056 regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] GTPase activator activity [GO:0005096] g3803.t1 Q9UBD5 37.449 737 4.25e-149 451.0 sp|Q9UBD5|ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens OX=9606 GN=ORC3 PE=1 SV=1 ORC3_HUMAN reviewed Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo) Homo sapiens (Human) GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005634; GO:0005654; GO:0005656; GO:0005664; GO:0006260; GO:0006270; GO:0006275; GO:0014009; GO:0016604; GO:0031261; GO:0061351 DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; glial cell proliferation [GO:0014009]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808] DNA replication origin binding [GO:0003688] g3804.t1 Q5ZIN1 58.551 345 3.09e-138 399.0 sp|Q5ZIN1|NUDC_CHICK Nuclear migration protein nudC OS=Gallus gallus OX=9031 GN=NUDC PE=2 SV=1 NUDC_CHICK reviewed Nuclear migration protein nudC (Nuclear distribution protein C homolog) Gallus gallus (Chicken) GO:0005737; GO:0005874; GO:0006457; GO:0007052; GO:0007080; GO:0030496; GO:0051082; GO:0051301; GO:0051656; GO:0072686 cell division [GO:0051301]; establishment of organelle localization [GO:0051656]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; protein folding [GO:0006457] cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] unfolded protein binding [GO:0051082] g3805.t1 Q9NX36 42.042 333 2.75e-74 240.0 sp|Q9NX36|DJC28_HUMAN DnaJ homolog subfamily C member 28 OS=Homo sapiens OX=9606 GN=DNAJC28 PE=1 SV=2 g3806.t1 Q8R512 34.334 533 3.65e-91 290.0 sp|Q8R512|UBX11_RAT UBX domain-containing protein 11 OS=Rattus norvegicus OX=10116 GN=Ubxn11 PE=1 SV=1 g3808.t1 Q9VCA2 31.809 481 1.0299999999999999e-55 199.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g3810.t1 Q4R4A2 33.333 243 1.3599999999999999e-30 128.0 sp|Q4R4A2|ZUP1_MACFA Zinc finger-containing ubiquitin peptidase 1 OS=Macaca fascicularis OX=9541 GN=ZUP1 PE=2 SV=1 ZUP1_MACFA reviewed Zinc finger-containing ubiquitin peptidase 1 (EC 3.4.19.12) (Lys-63-specific deubiquitinase ZUFSP) (DUB) (Ubiquitin carboxyl-terminal hydrolase ZUFSP) (EC 3.4.19.12) (Zinc finger with UFM1-specific peptidase domain protein) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0004843; GO:0005634; GO:0005737; GO:0008270 cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270] g3812.t1 Q5RBV0 69.136 324 1.45e-156 451.0 sp|Q5RBV0|IMA7_PONAB Importin subunit alpha-7 OS=Pongo abelii OX=9601 GN=KPNA6 PE=2 SV=1 g3813.t1 Q503E9 61.739 115 9.640000000000001e-35 128.0 sp|Q503E9|IMA6_DANRE Importin subunit alpha-6 OS=Danio rerio OX=7955 GN=kpna5 PE=2 SV=3 g3814.t1 Q6PBK1 58.333 132 2.6999999999999997e-52 165.0 sp|Q6PBK1|MIX23_DANRE Protein MIX23 OS=Danio rerio OX=7955 GN=mix23 PE=2 SV=2 g3815.t1 Q9D0N7 45.983 585 3.06e-167 494.0 sp|Q9D0N7|CAF1B_MOUSE Chromatin assembly factor 1 subunit B OS=Mus musculus OX=10090 GN=Chaf1b PE=1 SV=1 g3817.t1 Q9H4Q3 52.239 201 3.18e-47 182.0 sp|Q9H4Q3|PRD13_HUMAN PR domain zinc finger protein 13 OS=Homo sapiens OX=9606 GN=PRDM13 PE=1 SV=2 PRD13_HUMAN reviewed PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010468; GO:0021979; GO:0032259; GO:0042054; GO:0061629; GO:0097154 GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270] g3817.t1 Q9H4Q3 35.256 156 2.06e-24 112.0 sp|Q9H4Q3|PRD13_HUMAN PR domain zinc finger protein 13 OS=Homo sapiens OX=9606 GN=PRDM13 PE=1 SV=2 PRD13_HUMAN reviewed PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010468; GO:0021979; GO:0032259; GO:0042054; GO:0061629; GO:0097154 GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270] g3818.t1 Q86UC2 64.62 342 5.71e-133 395.0 sp|Q86UC2|RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens OX=9606 GN=RSPH3 PE=1 SV=1 RSPH3_HUMAN reviewed Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2) Homo sapiens (Human) GO:0001535; GO:0005929; GO:0097729 9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; radial spoke head [GO:0001535] g3819.t1 P13216 59.231 130 1.4699999999999998e-52 169.0 sp|P13216|ADX_CHICK Adrenodoxin, mitochondrial (Fragment) OS=Gallus gallus OX=9031 GN=FDX1 PE=1 SV=1 g3820.t1 P26044 60.892 583 0.0 676.0 sp|P26044|RADI_PIG Radixin OS=Sus scrofa OX=9823 GN=RDX PE=2 SV=1 g3822.t1 P04179 70.776 219 3.29e-112 323.0 sp|P04179|SODM_HUMAN Superoxide dismutase [Mn], mitochondrial OS=Homo sapiens OX=9606 GN=SOD2 PE=1 SV=3 SODM_HUMAN reviewed Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) Homo sapiens (Human) GO:0000303; GO:0001666; GO:0001836; GO:0001889; GO:0003032; GO:0003069; GO:0003677; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006749; GO:0006801; GO:0007507; GO:0007626; GO:0008217; GO:0008285; GO:0008630; GO:0008631; GO:0009410; GO:0009791; GO:0010042; GO:0010043; GO:0010269; GO:0010332; GO:0010729; GO:0014823; GO:0019430; GO:0019825; GO:0019899; GO:0022904; GO:0030097; GO:0030145; GO:0030335; GO:0032364; GO:0032496; GO:0033591; GO:0034021; GO:0034599; GO:0035900; GO:0035902; GO:0042542; GO:0042554; GO:0042645; GO:0042802; GO:0043524; GO:0045429; GO:0045599; GO:0046686; GO:0048147; GO:0048666; GO:0048678; GO:0048773; GO:0050665; GO:0051289; GO:0051602; GO:0051881; GO:0055093; GO:0060586; GO:0070062; GO:0071000; GO:0071361; GO:1902176; GO:1902631; GO:1904706; GO:1905461; GO:1905932 acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; cellular response to ethanol [GO:0071361]; cellular response to oxidative stress [GO:0034599]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular oxygen homeostasis [GO:0032364]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784] g3823.t1 Q9D554 73.108 502 0.0 739.0 sp|Q9D554|SF3A3_MOUSE Splicing factor 3A subunit 3 OS=Mus musculus OX=10090 GN=Sf3a3 PE=1 SV=2 SF3A3_MOUSE reviewed Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Mus musculus (Mouse) GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0016607; GO:0071005; GO:0071013; GO:1903241 mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g3824.t1 P48553 36.716 1340 0.0 792.0 sp|P48553|TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens OX=9606 GN=TRAPPC10 PE=1 SV=2 TPC10_HUMAN reviewed Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071 early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] g3825.t1 Q6AZA0 70.504 417 0.0 609.0 sp|Q6AZA0|THIL_DANRE Acetyl-CoA acetyltransferase, mitochondrial OS=Danio rerio OX=7955 GN=acat1 PE=2 SV=1 g3826.t1 Q9Y2G4 48.289 263 7.4e-70 250.0 sp|Q9Y2G4|ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 OS=Homo sapiens OX=9606 GN=ANKRD6 PE=1 SV=3 g3829.t1 Q9W742 56.562 541 0.0 623.0 sp|Q9W742|FZ10B_XENLA Frizzled-10-B OS=Xenopus laevis OX=8355 GN=fzd10-b PE=2 SV=1 g3832.t1 P06027 36.17 141 4.68e-25 97.1 sp|P06027|LECE_HELCR Echinoidin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1 g3833.t1 A7X3Z0 39.521 167 1.62e-22 90.9 sp|A7X3Z0|LECM_THRJA C-type lectin lectoxin-Thr1 OS=Thrasops jacksonii OX=186611 PE=2 SV=1 g3836.t1 O75897 35.548 301 2.6e-43 152.0 sp|O75897|ST1C4_HUMAN Sulfotransferase 1C4 OS=Homo sapiens OX=9606 GN=SULT1C4 PE=1 SV=2 ST1C4_HUMAN reviewed Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2) Homo sapiens (Human) GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g3837.t1 Q5U3Y5 58.282 163 1.25e-60 187.0 sp|Q5U3Y5|SFT2A_RAT Vesicle transport protein SFT2A OS=Rattus norvegicus OX=10116 GN=Sft2d1 PE=2 SV=1 g3837.t2 Q5U3Y5 56.886 167 2.86e-58 182.0 sp|Q5U3Y5|SFT2A_RAT Vesicle transport protein SFT2A OS=Rattus norvegicus OX=10116 GN=Sft2d1 PE=2 SV=1 g3838.t1 Q8VHE0 44.286 770 0.0 595.0 sp|Q8VHE0|SEC63_MOUSE Translocation protein SEC63 homolog OS=Mus musculus OX=10090 GN=Sec63 PE=1 SV=4 SEC63_MOUSE reviewed Translocation protein SEC63 homolog (DnaJ homolog subfamily C member 23) Mus musculus (Mouse) GO:0001889; GO:0005783; GO:0006614; GO:0006620; GO:0008320; GO:0016020; GO:0031204; GO:0031207; GO:0071941 liver development [GO:0001889]; nitrogen cycle metabolic process [GO:0071941]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207] protein transmembrane transporter activity [GO:0008320] g3840.t1 Q18297 31.514 1209 2.6300000000000003e-173 552.0 sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5 TRPA1_CAEEL reviewed Transient receptor potential cation channel subfamily A member 1 homolog Caenorhabditis elegans GO:0005216; GO:0005886; GO:0043025; GO:0097730 neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] monoatomic ion channel activity [GO:0005216] g3840.t1 Q18297 23.97 534 1.22e-35 151.0 sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5 TRPA1_CAEEL reviewed Transient receptor potential cation channel subfamily A member 1 homolog Caenorhabditis elegans GO:0005216; GO:0005886; GO:0043025; GO:0097730 neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] monoatomic ion channel activity [GO:0005216] g3841.t1 P29147 49.492 295 1.44e-101 305.0 sp|P29147|BDH_RAT D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bdh1 PE=1 SV=2 BDH_RAT reviewed D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) Rattus norvegicus (Rat) GO:0001889; GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0007584; GO:0008202; GO:0009410; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617 adipose tissue development [GO:0060612]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543] g3842.t1 Q8WPD0 36.691 139 6.86e-28 105.0 sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1 g3843.t1 Q9H2M3 33.994 353 1.9499999999999997e-52 180.0 sp|Q9H2M3|BHMT2_HUMAN S-methylmethionine--homocysteine S-methyltransferase BHMT2 OS=Homo sapiens OX=9606 GN=BHMT2 PE=1 SV=1 g3846.t1 Q96RL7 30.717 1325 1.12e-165 582.0 sp|Q96RL7|VP13A_HUMAN Intermembrane lipid transfer protein VPS13A OS=Homo sapiens OX=9606 GN=VPS13A PE=1 SV=2 g3846.t1 Q96RL7 24.301 1967 4.81e-144 511.0 sp|Q96RL7|VP13A_HUMAN Intermembrane lipid transfer protein VPS13A OS=Homo sapiens OX=9606 GN=VPS13A PE=1 SV=2 g3846.t2 Q96RL7 31.048 1298 4.79e-165 580.0 sp|Q96RL7|VP13A_HUMAN Intermembrane lipid transfer protein VPS13A OS=Homo sapiens OX=9606 GN=VPS13A PE=1 SV=2 g3846.t2 Q96RL7 24.301 1967 4.04e-144 511.0 sp|Q96RL7|VP13A_HUMAN Intermembrane lipid transfer protein VPS13A OS=Homo sapiens OX=9606 GN=VPS13A PE=1 SV=2 g3847.t1 Q5XM32 38.765 405 2.76e-90 293.0 sp|Q5XM32|RXFP2_CANLF Relaxin receptor 2 OS=Canis lupus familiaris OX=9615 GN=RXFP2 PE=2 SV=1 RXFP2_CANLF reviewed Relaxin receptor 2 (INSL3 receptor) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2) Canis lupus familiaris (Dog) (Canis familiaris) GO:0005886; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0016500 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584] plasma membrane [GO:0005886] G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500] g3849.t1 O88279 32.955 176 1.1399999999999999e-24 111.0 sp|O88279|SLIT1_RAT Slit homolog 1 protein OS=Rattus norvegicus OX=10116 GN=Slit1 PE=1 SV=1 SLIT1_RAT reviewed Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4) Rattus norvegicus (Rat) GO:0005509; GO:0005615; GO:0007097; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0021510; GO:0021772; GO:0022028; GO:0022029; GO:0031290; GO:0033563; GO:0043395; GO:0048495; GO:0048812; GO:0048843; GO:0048846; GO:0050919; GO:0051964 axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dorsal/ventral axon guidance [GO:0033563]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; neuron projection morphogenesis [GO:0048812]; nuclear migration [GO:0007097]; olfactory bulb development [GO:0021772]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; telencephalon cell migration [GO:0022029] extracellular space [GO:0005615] calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495] g3850.t1 Q8TEV9 35.522 335 8.23e-46 181.0 sp|Q8TEV9|SMCR8_HUMAN Guanine nucleotide exchange protein SMCR8 OS=Homo sapiens OX=9606 GN=SMCR8 PE=1 SV=2 SMCR8_HUMAN reviewed Guanine nucleotide exchange protein SMCR8 (Smith-Magenis syndrome chromosomal region candidate gene 8 protein) Homo sapiens (Human) GO:0000785; GO:0004860; GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0006914; GO:0010506; GO:0010629; GO:0016242; GO:0019901; GO:0032008; GO:0032045; GO:0045920; GO:0050777; GO:0098793; GO:0098794; GO:1901098; GO:1902902; GO:1903432; GO:1990316 autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432] Atg1/ULK1 kinase complex [GO:1990316]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] g3850.t2 Q8TEV9 35.435 333 9.24e-46 181.0 sp|Q8TEV9|SMCR8_HUMAN Guanine nucleotide exchange protein SMCR8 OS=Homo sapiens OX=9606 GN=SMCR8 PE=1 SV=2 SMCR8_HUMAN reviewed Guanine nucleotide exchange protein SMCR8 (Smith-Magenis syndrome chromosomal region candidate gene 8 protein) Homo sapiens (Human) GO:0000785; GO:0004860; GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0006914; GO:0010506; GO:0010629; GO:0016242; GO:0019901; GO:0032008; GO:0032045; GO:0045920; GO:0050777; GO:0098793; GO:0098794; GO:1901098; GO:1902902; GO:1903432; GO:1990316 autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432] Atg1/ULK1 kinase complex [GO:1990316]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] g3853.t1 P29147 49.558 226 5.4199999999999995e-74 233.0 sp|P29147|BDH_RAT D-beta-hydroxybutyrate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Bdh1 PE=1 SV=2 BDH_RAT reviewed D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) Rattus norvegicus (Rat) GO:0001889; GO:0003858; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0007584; GO:0008202; GO:0009410; GO:0009636; GO:0009725; GO:0032355; GO:0032868; GO:0042594; GO:0045471; GO:0046686; GO:0051412; GO:0060416; GO:0060612; GO:0099617 adipose tissue development [GO:0060612]; liver development [GO:0001889]; response to cadmium ion [GO:0046686]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to growth hormone [GO:0060416]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; phospholipid binding [GO:0005543] g3854.t1 A0A2I4HXH5 49.719 533 8.29e-170 496.0 sp|A0A2I4HXH5|V5NTD_NAJAT Snake venom 5'-nucleotidase (Fragment) OS=Naja atra OX=8656 PE=1 SV=1 g3855.t1 Q9QXA6 42.95 461 5.960000000000001e-124 374.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g3856.t1 P82251 40.486 494 2.7199999999999996e-128 387.0 sp|P82251|BAT1_HUMAN b(0,+)-type amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A9 PE=1 SV=1 BAT1_HUMAN reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0065003; GO:0180009 amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g3857.t1 P82251 42.285 499 5.59e-133 397.0 sp|P82251|BAT1_HUMAN b(0,+)-type amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A9 PE=1 SV=1 BAT1_HUMAN reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0065003; GO:0180009 amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g3859.t1 Q29S00 62.141 383 4.48e-167 475.0 sp|Q29S00|OSCP1_BOVIN Protein OSCP1 OS=Bos taurus OX=9913 GN=OSCP1 PE=2 SV=1 g3860.t1 Q92562 49.138 928 0.0 852.0 sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1 FIG4_HUMAN reviewed Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16) Homo sapiens (Human) GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037 locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037] phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722] g3861.t1 O00628 59.547 309 1.73e-143 410.0 sp|O00628|PEX7_HUMAN Peroxisomal targeting signal 2 receptor OS=Homo sapiens OX=9606 GN=PEX7 PE=1 SV=1 PEX7_HUMAN reviewed Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7) Homo sapiens (Human) GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803 endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803] g3863.t1 Q6TGS6 72.34 517 0.0 771.0 sp|Q6TGS6|SYYC_DANRE Tyrosine--tRNA ligase, cytoplasmic OS=Danio rerio OX=7955 GN=yars1 PE=2 SV=2 g3864.t1 B5XF11 28.571 252 3.51e-21 97.1 sp|B5XF11|KDM8_SALSA Lysine-specific demethylase 8 OS=Salmo salar OX=8030 GN=kdm8 PE=2 SV=1 g3865.t1 Q8VHQ7 42.254 142 1.9e-26 119.0 sp|Q8VHQ7|SYTL4_RAT Synaptotagmin-like protein 4 OS=Rattus norvegicus OX=10116 GN=Sytl4 PE=1 SV=1 SYTL4_RAT reviewed Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin) Rattus norvegicus (Rat) GO:0001778; GO:0005543; GO:0005768; GO:0005886; GO:0006886; GO:0006887; GO:0008270; GO:0016324; GO:0030141; GO:0030658; GO:0031267; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0050714; GO:0070382; GO:0071985; GO:1905684 exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684] apical plasma membrane [GO:0016324]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658] neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g3865.t2 Q8VHQ7 41.781 146 4.86e-25 115.0 sp|Q8VHQ7|SYTL4_RAT Synaptotagmin-like protein 4 OS=Rattus norvegicus OX=10116 GN=Sytl4 PE=1 SV=1 SYTL4_RAT reviewed Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin) Rattus norvegicus (Rat) GO:0001778; GO:0005543; GO:0005768; GO:0005886; GO:0006886; GO:0006887; GO:0008270; GO:0016324; GO:0030141; GO:0030658; GO:0031267; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0050714; GO:0070382; GO:0071985; GO:1905684 exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684] apical plasma membrane [GO:0016324]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658] neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g3866.t1 Q812E4 45.69 348 5.87e-88 290.0 sp|Q812E4|SYTL5_RAT Synaptotagmin-like protein 5 OS=Rattus norvegicus OX=10116 GN=Sytl5 PE=2 SV=1 g3868.t1 Q4V8S3 40.984 122 5.3e-25 96.7 sp|Q4V8S3|TM242_DANRE Transmembrane protein 242 OS=Danio rerio OX=7955 GN=tmem242 PE=2 SV=2 g3870.t1 Q8BQQ1 53.319 467 1.39e-159 466.0 sp|Q8BQQ1|ZDH14_MOUSE Palmitoyltransferase ZDHHC14 OS=Mus musculus OX=10090 GN=Zdhhc14 PE=1 SV=1 g3870.t2 Q8BQQ1 67.732 313 2.67e-159 461.0 sp|Q8BQQ1|ZDH14_MOUSE Palmitoyltransferase ZDHHC14 OS=Mus musculus OX=10090 GN=Zdhhc14 PE=1 SV=1 g3871.t1 Q9N1T2 43.973 448 4.17e-111 367.0 sp|Q9N1T2|RPGR_CANLF X-linked retinitis pigmentosa GTPase regulator OS=Canis lupus familiaris OX=9615 GN=RPGR PE=2 SV=1 RPGR_CANLF reviewed X-linked retinitis pigmentosa GTPase regulator Canis lupus familiaris (Dog) (Canis familiaris) GO:0005085; GO:0005794; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0010508; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0097499 cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; visual perception [GO:0007601] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126] guanyl-nucleotide exchange factor activity [GO:0005085] g3871.t2 Q9N1T2 43.973 448 3.7e-111 365.0 sp|Q9N1T2|RPGR_CANLF X-linked retinitis pigmentosa GTPase regulator OS=Canis lupus familiaris OX=9615 GN=RPGR PE=2 SV=1 RPGR_CANLF reviewed X-linked retinitis pigmentosa GTPase regulator Canis lupus familiaris (Dog) (Canis familiaris) GO:0005085; GO:0005794; GO:0005813; GO:0005929; GO:0005930; GO:0007601; GO:0010508; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0097499 cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; visual perception [GO:0007601] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126] guanyl-nucleotide exchange factor activity [GO:0005085] g3872.t1 O19072 63.924 316 8.2e-154 439.0 sp|O19072|OTC_PIG Ornithine transcarbamylase, mitochondrial (Fragment) OS=Sus scrofa OX=9823 GN=OTC PE=2 SV=1 g3873.t1 O95563 51.908 131 1.2e-40 135.0 sp|O95563|MPC2_HUMAN Mitochondrial pyruvate carrier 2 OS=Homo sapiens OX=9606 GN=MPC2 PE=1 SV=1 MPC2_HUMAN reviewed Mitochondrial pyruvate carrier 2 (Brain protein 44) Homo sapiens (Human) GO:0005634; GO:0005739; GO:0005743; GO:0006086; GO:0006850; GO:0035774; GO:0042802; GO:0050833; GO:0098800; GO:7770001 positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; pyruvate decarboxylation to acetyl-CoA [GO:0006086]; pyruvate import into mitochondria [GO:0006850] inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial pyruvate carrier complex [GO:7770001]; mitochondrion [GO:0005739]; nucleus [GO:0005634] identical protein binding [GO:0042802]; pyruvate transmembrane transporter activity [GO:0050833] g3874.t1 Q5R9B8 46.958 526 2.35e-142 452.0 sp|Q5R9B8|DCAF6_PONAB DDB1- and CUL4-associated factor 6 OS=Pongo abelii OX=9601 GN=DCAF6 PE=2 SV=2 DCAF6_PONAB reviewed DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0016567; GO:0045944; GO:0080008 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634] g3874.t1 Q5R9B8 64.072 167 1.3199999999999998e-61 230.0 sp|Q5R9B8|DCAF6_PONAB DDB1- and CUL4-associated factor 6 OS=Pongo abelii OX=9601 GN=DCAF6 PE=2 SV=2 DCAF6_PONAB reviewed DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005737; GO:0016567; GO:0045944; GO:0080008 positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634] g10605.t1 Q68EX9 51.015 394 1.25e-138 404.0 sp|Q68EX9|CHID1_XENLA Chitinase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=chid1 PE=2 SV=1 g10606.t1 Q9V3H2 85.852 311 0.0 561.0 sp|Q9V3H2|PSDE_DROME 26S proteasome non-ATPase regulatory subunit 14 OS=Drosophila melanogaster OX=7227 GN=Rpn11 PE=1 SV=1 PSDE_DROME reviewed 26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory complex subunit p37B) (26S proteasome regulatory subunit rpn11) (Yippee-interacting protein 5) Drosophila melanogaster (Fruit fly) GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0043161; GO:0046872; GO:0070628; GO:0140492 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541] metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; proteasome binding [GO:0070628] g10607.t1 Q9NVH0 40.171 351 5.3e-75 247.0 sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2 EXD2_HUMAN reviewed Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2) Homo sapiens (Human) GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734 DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] 3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310] g10610.t1 P35601 42.752 1083 0.0 744.0 sp|P35601|RFC1_MOUSE Replication factor C subunit 1 OS=Mus musculus OX=10090 GN=Rfc1 PE=1 SV=2 RFC1_MOUSE reviewed Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit) Mus musculus (Mouse) GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019904; GO:0031391; GO:0032991; GO:0043565; GO:0045892; GO:0045893; GO:0061860; GO:0140297 DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893] DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565] g10611.t1 Q8CEE6 49.265 408 1.3799999999999999e-119 409.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10611.t1 Q8CEE6 44.66 309 3.69e-71 266.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10611.t2 Q8CEE6 49.265 408 2.32e-119 409.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10611.t2 Q8CEE6 44.66 309 3.89e-71 266.0 sp|Q8CEE6|PASK_MOUSE PAS domain-containing serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Pask PE=1 SV=3 PASK_MOUSE reviewed PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0046777; GO:0070092; GO:0097009; GO:0106310 energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10613.t1 Q5ZID2 32.794 433 1.45e-62 211.0 sp|Q5ZID2|PDD2L_CHICK Programmed cell death protein 2-like OS=Gallus gallus OX=9031 GN=PDCD2L PE=2 SV=1 g10616.t1 P17405 44.129 528 7.4e-140 421.0 sp|P17405|ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens OX=9606 GN=SMPD1 PE=1 SV=5 ASM_HUMAN reviewed Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase) [Cleaved into: Sphingomyelin phosphodiesterase, processed form] Homo sapiens (Human) GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006684; GO:0006685; GO:0007165; GO:0007399; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034480; GO:0034612; GO:0034644; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043409; GO:0045807; GO:0046479; GO:0046513; GO:0046598; GO:0046718; GO:0061750; GO:0070062; GO:0070555; GO:0071277 cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid catabolic process [GO:0046479]; negative regulation of MAPK cascade [GO:0043409]; nervous system development [GO:0007399]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of viral entry into host cell [GO:0046598]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; symbiont entry into host cell [GO:0046718]; termination of signal transduction [GO:0023021]; wound healing [GO:0042060] endolysosome [GO:0036019]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886] acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphatidylcholine phospholipase C activity [GO:0034480]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g10617.t1 Q5U4S8 50.0 384 4.64e-137 400.0 sp|Q5U4S8|CEGTB_XENLA Ceramide glucosyltransferase-B OS=Xenopus laevis OX=8355 GN=ugcg-b PE=2 SV=1 g10618.t1 Q6PE01 48.734 158 3.3199999999999997e-40 141.0 sp|Q6PE01|SNR40_MOUSE U5 small nuclear ribonucleoprotein 40 kDa protein OS=Mus musculus OX=10090 GN=Snrnp40 PE=1 SV=1 g10619.t1 Q3UME2 38.235 272 1.2699999999999999e-45 159.0 sp|Q3UME2|TM241_MOUSE UDP-N-acetylglucosamine transporter TMEM241 OS=Mus musculus OX=10090 GN=Tmem241 PE=2 SV=2 g10621.t1 Q5XJA0 38.71 372 2.5399999999999998e-82 259.0 sp|Q5XJA0|TYDP2_DANRE Tyrosyl-DNA phosphodiesterase 2 OS=Danio rerio OX=7955 GN=tdp2 PE=1 SV=3 TYDP2_DANRE reviewed Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (TRAF and TNF receptor-associated protein homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0003677; GO:0003697; GO:0004518; GO:0005737; GO:0006302; GO:0007368; GO:0007369; GO:0016605; GO:0030145; GO:0030512; GO:0060027; GO:0070259; GO:0070260 convergent extension involved in gastrulation [GO:0060027]; determination of left/right symmetry [GO:0007368]; double-strand break repair [GO:0006302]; gastrulation [GO:0007369]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] cytoplasm [GO:0005737]; PML body [GO:0016605] 5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; tyrosyl-DNA phosphodiesterase activity [GO:0070259] g10622.t1 Q803H4 53.012 166 1.2800000000000002e-47 155.0 sp|Q803H4|CENPA_DANRE Histone H3-like centromeric protein A OS=Danio rerio OX=7955 GN=cenpa PE=1 SV=1 g10624.t1 Q5ZKP6 49.422 346 1.57e-115 342.0 sp|Q5ZKP6|ADA_CHICK Adenosine deaminase OS=Gallus gallus OX=9031 GN=ADA PE=2 SV=1 ADA_CHICK reviewed Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase) Gallus gallus (Chicken) GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0045187; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161 adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; T cell activation [GO:0042110] anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764] 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270] g10625.t1 O76536 32.746 1191 4.39e-113 396.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 31.728 1204 1.39e-102 365.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 32.924 1221 3.89e-101 360.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 34.169 1197 3.86e-98 351.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 33.667 1200 5.57e-97 348.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 32.479 1170 5.77e-97 347.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 32.82 1103 1.59e-96 346.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 33.473 1192 3.52e-96 345.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 31.721 1220 6.03e-96 344.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 31.443 1199 1.17e-93 337.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 30.986 1136 2.25e-93 337.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 31.707 1189 1.51e-91 331.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 33.013 1145 2.1199999999999998e-91 330.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 32.442 1122 2.57e-90 327.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 31.494 1051 9.030000000000001e-73 273.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 33.148 718 1.75e-53 212.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10625.t1 O76536 33.333 561 2.42e-35 153.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g10626.t2 Q70E20 30.061 326 9.760000000000001e-21 100.0 sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2 g10633.t1 Q7RTY7 26.15 891 2.16e-60 232.0 sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3 OVCH1_HUMAN reviewed Ovochymase-1 (EC 3.4.21.-) Homo sapiens (Human) GO:0004252; GO:0005576; GO:0006508; GO:0009566; GO:0046872 fertilization [GO:0009566]; proteolysis [GO:0006508] extracellular region [GO:0005576] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] g10633.t1 Q7RTY7 23.589 886 2.5999999999999998e-46 187.0 sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3 OVCH1_HUMAN reviewed Ovochymase-1 (EC 3.4.21.-) Homo sapiens (Human) GO:0004252; GO:0005576; GO:0006508; GO:0009566; GO:0046872 fertilization [GO:0009566]; proteolysis [GO:0006508] extracellular region [GO:0005576] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] g10633.t1 Q7RTY7 33.197 244 6.440000000000001e-33 144.0 sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3 OVCH1_HUMAN reviewed Ovochymase-1 (EC 3.4.21.-) Homo sapiens (Human) GO:0004252; GO:0005576; GO:0006508; GO:0009566; GO:0046872 fertilization [GO:0009566]; proteolysis [GO:0006508] extracellular region [GO:0005576] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] g10633.t1 Q7RTY7 29.932 294 6.82e-30 134.0 sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3 OVCH1_HUMAN reviewed Ovochymase-1 (EC 3.4.21.-) Homo sapiens (Human) GO:0004252; GO:0005576; GO:0006508; GO:0009566; GO:0046872 fertilization [GO:0009566]; proteolysis [GO:0006508] extracellular region [GO:0005576] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] g10633.t1 Q7RTY7 34.746 236 9.42e-30 133.0 sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3 OVCH1_HUMAN reviewed Ovochymase-1 (EC 3.4.21.-) Homo sapiens (Human) GO:0004252; GO:0005576; GO:0006508; GO:0009566; GO:0046872 fertilization [GO:0009566]; proteolysis [GO:0006508] extracellular region [GO:0005576] metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] g10634.t1 P98073 34.602 289 3.8999999999999995e-46 183.0 sp|P98073|ENTK_HUMAN Enteropeptidase OS=Homo sapiens OX=9606 GN=TMPRSS15 PE=1 SV=3 ENTK_HUMAN reviewed Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain] Homo sapiens (Human) GO:0004252; GO:0005903; GO:0006508; GO:0008236; GO:0016020 proteolysis [GO:0006508] brush border [GO:0005903]; membrane [GO:0016020] serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g10636.t1 Q6P5D8 47.977 1953 0.0 1883.0 sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2 SMHD1_MOUSE reviewed Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-) Mus musculus (Mouse) GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0005654; GO:0006302; GO:0009048; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034 chromosome organization [GO:0051276]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034] Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803] g10637.t1 P09496 44.538 238 4.77e-53 173.0 sp|P09496|CLCA_HUMAN Clathrin light chain A OS=Homo sapiens OX=9606 GN=CLTA PE=1 SV=1 CLCA_HUMAN reviewed Clathrin light chain A (Lca) Homo sapiens (Human) GO:0005198; GO:0005764; GO:0005768; GO:0005794; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030672; GO:0031410; GO:0032050; GO:0032588; GO:0036020; GO:0042277; GO:0044877; GO:0045334; GO:0048268; GO:0048488; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843 cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488] clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network membrane [GO:0032588] clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] g10637.t2 P09496 44.351 239 6.84e-53 173.0 sp|P09496|CLCA_HUMAN Clathrin light chain A OS=Homo sapiens OX=9606 GN=CLTA PE=1 SV=1 CLCA_HUMAN reviewed Clathrin light chain A (Lca) Homo sapiens (Human) GO:0005198; GO:0005764; GO:0005768; GO:0005794; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030672; GO:0031410; GO:0032050; GO:0032588; GO:0036020; GO:0042277; GO:0044877; GO:0045334; GO:0048268; GO:0048488; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843 cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488] clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network membrane [GO:0032588] clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] g10638.t1 Q9BSV6 44.361 133 5.49e-32 128.0 sp|Q9BSV6|SEN34_HUMAN tRNA-splicing endonuclease subunit Sen34 OS=Homo sapiens OX=9606 GN=TSEN34 PE=1 SV=1 SEN34_HUMAN reviewed tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34) Homo sapiens (Human) GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0006397 mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] nucleic acid binding [GO:0003676]; tRNA-intron lyase activity [GO:0000213] g10641.t1 Q5RBM1 39.375 640 7.43e-139 423.0 sp|Q5RBM1|RPN2_PONAB Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Pongo abelii OX=9601 GN=RPN2 PE=2 SV=1 g10644.t1 Q9NV88 58.806 670 0.0 833.0 sp|Q9NV88|INT9_HUMAN Integrator complex subunit 9 OS=Homo sapiens OX=9606 GN=INTS9 PE=1 SV=2 g10645.t1 Q6DC37 24.913 289 2.58e-21 94.7 sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1 g10646.t1 O35261 48.299 147 9.920000000000001e-29 112.0 sp|O35261|E2F3_MOUSE Transcription factor E2F3 OS=Mus musculus OX=10090 GN=E2f3 PE=1 SV=2 E2F3_MOUSE reviewed Transcription factor E2F3 (E2F-3) Mus musculus (Mouse) GO:0000082; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0006606; GO:0008284; GO:0043565; GO:0045893; GO:0045944; GO:0046983; GO:0070345; GO:0090575; GO:1905461; GO:1990837 G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g10647.t1 O00716 51.934 181 4.61e-46 164.0 sp|O00716|E2F3_HUMAN Transcription factor E2F3 OS=Homo sapiens OX=9606 GN=E2F3 PE=1 SV=1 E2F3_HUMAN reviewed Transcription factor E2F3 (E2F-3) Homo sapiens (Human) GO:0000082; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006367; GO:0006606; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0070345; GO:0090575; GO:1905461; GO:1990837 G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation at RNA polymerase II promoter [GO:0006367] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g10648.t1 Q7Z7G8 32.638 4363 0.0 2047.0 sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2 VP13B_HUMAN reviewed Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) Homo sapiens (Human) GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168 acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol-3-phosphate binding [GO:0032266] g10649.t1 Q8NB78 53.641 824 0.0 896.0 sp|Q8NB78|KDM1B_HUMAN Lysine-specific histone demethylase 2 OS=Homo sapiens OX=9606 GN=KDM1B PE=1 SV=3 g10653.t1 P45436 33.455 275 1.09e-38 153.0 sp|P45436|CED3_CAERE Cell death protein 3 OS=Caenorhabditis remanei OX=31234 GN=ced-3 PE=3 SV=2 g10654.t1 Q9TST4 29.091 330 3.8299999999999997e-28 116.0 sp|Q9TST4|ADRB3_FELCA Beta-3 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB3 PE=3 SV=1 g10655.t1 P07146 50.207 241 4.4899999999999997e-69 216.0 sp|P07146|TRY2_MOUSE Anionic trypsin-2 OS=Mus musculus OX=10090 GN=Prss2 PE=1 SV=1 TRY2_MOUSE reviewed Anionic trypsin-2 (EC 3.4.21.4) (Anionic trypsin II) (Pretrypsinogen II) (Serine protease 2) Mus musculus (Mouse) GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007584; GO:0007586; GO:0008236; GO:0030574; GO:0031000; GO:0031012; GO:0035094; GO:1905640 collagen catabolic process [GO:0030574]; digestion [GO:0007586]; proteolysis [GO:0006508]; response to acetaldehyde [GO:1905640]; response to caffeine [GO:0031000]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g10656.t1 Q9H2Y9 24.173 695 3.36e-52 197.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g10657.t1 Q8K078 35.849 689 5.94e-141 433.0 sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2 SO4A1_MOUSE reviewed Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12) Mus musculus (Mouse) GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0015711; GO:0016323; GO:0042403; GO:0043252 monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] g10658.t1 Q8N695 35.072 556 2.2000000000000001e-100 322.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g10660.t1 C3KBV5 45.578 147 1.64e-28 112.0 sp|C3KBV5|SELO_PSEFS Protein nucleotidyltransferase YdiU OS=Pseudomonas fluorescens (strain SBW25) OX=216595 GN=ydiU PE=3 SV=1 SELO_PSEFS reviewed Protein nucleotidyltransferase YdiU (EC 2.7.7.-) (Protein adenylyltransferase YdiU) (EC 2.7.7.108) (Protein uridylyltransferase YdiU) (EC 2.7.7.-) Pseudomonas fluorescens (strain SBW25) GO:0000287; GO:0005524; GO:0030145; GO:0070733 AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g10661.t1 C1AED7 52.364 275 1.18e-90 284.0 sp|C1AED7|SELO_GEMAT Protein nucleotidyltransferase YdiU OS=Gemmatimonas aurantiaca (strain DSM 14586 / JCM 11422 / NBRC 100505 / T-27) OX=379066 GN=ydiU PE=3 SV=1 SELO_GEMAT reviewed Protein nucleotidyltransferase YdiU (EC 2.7.7.-) (Protein adenylyltransferase YdiU) (EC 2.7.7.108) (Protein uridylyltransferase YdiU) (EC 2.7.7.-) Gemmatimonas aurantiaca (strain DSM 14586 / JCM 11422 / NBRC 100505 / T-27) GO:0000287; GO:0005524; GO:0030145; GO:0070733 AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g10662.t1 P07687 48.246 456 2.55e-151 441.0 sp|P07687|HYEP_RAT Epoxide hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Ephx1 PE=1 SV=1 HYEP_RAT reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Rattus norvegicus (Rat) GO:0001889; GO:0004301; GO:0005789; GO:0008142; GO:0009636; GO:0016020; GO:0019369; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; liver development [GO:0001889]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g10663.t1 P07687 48.478 427 1.1100000000000001e-144 424.0 sp|P07687|HYEP_RAT Epoxide hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Ephx1 PE=1 SV=1 HYEP_RAT reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Rattus norvegicus (Rat) GO:0001889; GO:0004301; GO:0005789; GO:0008142; GO:0009636; GO:0016020; GO:0019369; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; liver development [GO:0001889]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g10664.t1 P07687 46.171 457 1.28e-139 411.0 sp|P07687|HYEP_RAT Epoxide hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Ephx1 PE=1 SV=1 HYEP_RAT reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Rattus norvegicus (Rat) GO:0001889; GO:0004301; GO:0005789; GO:0008142; GO:0009636; GO:0016020; GO:0019369; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; liver development [GO:0001889]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g10665.t1 P07687 47.3 463 2.98e-144 423.0 sp|P07687|HYEP_RAT Epoxide hydrolase 1 OS=Rattus norvegicus OX=10116 GN=Ephx1 PE=1 SV=1 HYEP_RAT reviewed Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) Rattus norvegicus (Rat) GO:0001889; GO:0004301; GO:0005789; GO:0008142; GO:0009636; GO:0016020; GO:0019369; GO:0019899; GO:0033961; GO:0034312; GO:0043231; GO:0071385; GO:0097176; GO:0120253 arachidonate metabolic process [GO:0019369]; cellular response to glucocorticoid stimulus [GO:0071385]; diol biosynthetic process [GO:0034312]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; liver development [GO:0001889]; response to toxic substance [GO:0009636] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cis-stilbene-oxide hydrolase activity [GO:0033961]; enzyme binding [GO:0019899]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142] g10666.t1 O60266 45.321 1090 0.0 920.0 sp|O60266|ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens OX=9606 GN=ADCY3 PE=1 SV=3 ADCY3_HUMAN reviewed Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3) Homo sapiens (Human) GO:0003091; GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:0071377; GO:0097700; GO:1904322 acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; renal water homeostasis [GO:0003091]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886] adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] g10668.t1 Q5EAD8 50.307 163 3.68e-48 159.0 sp|Q5EAD8|LRC51_BOVIN Leucine-rich repeat-containing protein 51 OS=Bos taurus OX=9913 GN=LRRC51 PE=2 SV=1 g10670.t1 Q91W90 50.765 392 2.61e-139 407.0 sp|Q91W90|TXND5_MOUSE Thioredoxin domain-containing protein 5 OS=Mus musculus OX=10090 GN=Txndc5 PE=1 SV=2 TXND5_MOUSE reviewed Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46) Mus musculus (Mouse) GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0015035 protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] g10670.t1 Q91W90 38.636 264 1.18e-57 197.0 sp|Q91W90|TXND5_MOUSE Thioredoxin domain-containing protein 5 OS=Mus musculus OX=10090 GN=Txndc5 PE=1 SV=2 TXND5_MOUSE reviewed Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Plasma cell-specific thioredoxin-related protein) (PC-TRP) (Thioredoxin-like protein p46) Mus musculus (Mouse) GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0015035 protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] g10674.t1 Q9W6I0 50.515 194 8.57e-71 221.0 sp|Q9W6I0|UQCC1_XENLA Ubiquinol-cytochrome-c reductase complex assembly factor 1 OS=Xenopus laevis OX=8355 GN=uqcc1 PE=2 SV=1 g10675.t1 Q5F477 42.532 308 2.62e-81 252.0 sp|Q5F477|LDAH_CHICK Lipid droplet-associated hydrolase OS=Gallus gallus OX=9031 GN=LDAH PE=2 SV=2 LDAH_CHICK reviewed Lipid droplet-associated hydrolase (EC 3.1.1.13) (Lipid droplet-associated serine hydrolase) Gallus gallus (Chicken) GO:0004771; GO:0005783; GO:0005811; GO:0019915; GO:0035356; GO:0042632; GO:0160077 cholesterol homeostasis [GO:0042632]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet fusion [GO:0160077]; lipid storage [GO:0019915] endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] sterol ester esterase activity [GO:0004771] g10676.t1 Q8BQ86 36.918 279 2.52e-57 195.0 sp|Q8BQ86|CHST8_MOUSE Carbohydrate sulfotransferase 8 OS=Mus musculus OX=10090 GN=Chst8 PE=2 SV=1 CHST8_MOUSE reviewed Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016051; GO:0016486; GO:0030166; GO:0042446 carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g10677.t1 Q8BQ86 36.071 280 7.52e-55 188.0 sp|Q8BQ86|CHST8_MOUSE Carbohydrate sulfotransferase 8 OS=Mus musculus OX=10090 GN=Chst8 PE=2 SV=1 CHST8_MOUSE reviewed Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016051; GO:0016486; GO:0030166; GO:0042446 carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g10679.t1 Q8NET6 37.367 281 1.1800000000000001e-59 199.0 sp|Q8NET6|CHSTD_HUMAN Carbohydrate sulfotransferase 13 OS=Homo sapiens OX=9606 GN=CHST13 PE=1 SV=1 CHSTD_HUMAN reviewed Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g10680.t1 Q6B860 66.346 104 1.74e-42 140.0 sp|Q6B860|RT14_BOVIN Small ribosomal subunit protein uS14m OS=Bos taurus OX=9913 GN=MRPS14 PE=1 SV=1 RT14_BOVIN reviewed Small ribosomal subunit protein uS14m (28S ribosomal protein S14, mitochondrial) (MRP-S14) (S14mt) Bos taurus (Bovine) GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543 mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] structural constituent of ribosome [GO:0003735] g10682.t1 Q9NY64 41.85 454 3.71e-100 313.0 sp|Q9NY64|SL2A8_HUMAN Solute carrier family 2, facilitated glucose transporter member 8 OS=Homo sapiens OX=9606 GN=SLC2A8 PE=1 SV=3 SL2A8_HUMAN reviewed Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1) Homo sapiens (Human) GO:0001666; GO:0005353; GO:0005536; GO:0005765; GO:0005886; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0016020; GO:0030669; GO:0033300; GO:0055056; GO:0070837; GO:1904659 carbohydrate metabolic process [GO:0005975]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666] clathrin-coated endocytic vesicle membrane [GO:0030669]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353] g10683.t1 Q92005 83.404 470 0.0 811.0 sp|Q92005|EF1A_DANRE Elongation factor 1-alpha OS=Danio rerio OX=7955 GN=eef1a PE=2 SV=1 g10684.t1 Q66GV0 47.159 176 1.01e-52 169.0 sp|Q66GV0|MPV17_XENLA Mitochondrial inner membrane protein Mpv17 OS=Xenopus laevis OX=8355 GN=mpv17 PE=2 SV=2 g10685.t1 Q58D00 50.87 460 7.06e-163 471.0 sp|Q58D00|FBXW2_BOVIN F-box/WD repeat-containing protein 2 OS=Bos taurus OX=9913 GN=FBXW2 PE=2 SV=1 g10686.t1 Q9XGA1 51.93 285 1.06e-101 306.0 sp|Q9XGA1|KPRS4_SPIOL Ribose-phosphate pyrophosphokinase 4 OS=Spinacia oleracea OX=3562 GN=PRS4 PE=2 SV=1 g10687.t1 B4QCR6 37.302 1075 1.26e-177 544.0 sp|B4QCR6|SRRT_DROSI Serrate RNA effector molecule homolog OS=Drosophila simulans OX=7240 GN=Ars2 PE=3 SV=1 g10688.t1 Q9GZV8 48.807 545 1.88e-160 474.0 sp|Q9GZV8|PRD14_HUMAN PR domain zinc finger protein 14 OS=Homo sapiens OX=9606 GN=PRDM14 PE=1 SV=1 PRD14_HUMAN reviewed PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14) Homo sapiens (Human) GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0030718; GO:0031490; GO:0032259; GO:0040037; GO:0045814; GO:0048873; GO:0141107; GO:1902093; GO:1902459; GO:1990226 cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin DNA binding [GO:0031490]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g10690.t1 Q8BZK4 38.764 356 7.62e-68 226.0 sp|Q8BZK4|S35F4_MOUSE Solute carrier family 35 member F4 OS=Mus musculus OX=10090 GN=Slc35f4 PE=2 SV=1 g10694.t1 O97967 29.211 380 1.53e-32 129.0 sp|O97967|BRS3_SHEEP Bombesin receptor subtype-3 OS=Ovis aries OX=9940 GN=BRS3 PE=2 SV=1 g10697.t1 O75899 36.387 764 5.930000000000001e-157 484.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g10698.t1 Q9N126 35.106 282 1.2e-43 154.0 sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1 g10699.t1 P85521 38.835 206 5.47e-34 145.0 sp|P85521|C163A_BOVIN Scavenger receptor cysteine-rich type 1 protein M130 OS=Bos taurus OX=9913 GN=CD163 PE=1 SV=2 g10699.t1 P85521 31.304 230 7.54e-25 116.0 sp|P85521|C163A_BOVIN Scavenger receptor cysteine-rich type 1 protein M130 OS=Bos taurus OX=9913 GN=CD163 PE=1 SV=2 g10699.t1 P85521 30.769 260 1.71e-24 115.0 sp|P85521|C163A_BOVIN Scavenger receptor cysteine-rich type 1 protein M130 OS=Bos taurus OX=9913 GN=CD163 PE=1 SV=2 g10699.t1 P85521 35.407 209 2.61e-21 104.0 sp|P85521|C163A_BOVIN Scavenger receptor cysteine-rich type 1 protein M130 OS=Bos taurus OX=9913 GN=CD163 PE=1 SV=2 g10700.t1 F7J220 39.556 225 4.0200000000000005e-32 139.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g10700.t1 F7J220 33.559 295 3.57e-30 133.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g10700.t1 F7J220 34.653 202 1.57e-22 108.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g10700.t1 F7J220 34.466 206 5.8800000000000005e-21 103.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g10702.t1 Q2VLH6 33.333 696 9.54e-87 311.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g10702.t1 Q2VLH6 31.365 542 1.44e-53 209.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g10702.t1 Q2VLH6 37.318 343 1.9199999999999999e-53 209.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g10702.t1 Q2VLH6 27.681 690 7.489999999999999e-48 191.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g10702.t1 Q2VLH6 36.449 214 1.59e-26 122.0 sp|Q2VLH6|C163A_MOUSE Scavenger receptor cysteine-rich type 1 protein M130 OS=Mus musculus OX=10090 GN=Cd163 PE=1 SV=2 C163A_MOUSE reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Mus musculus (Mouse) GO:0005044; GO:0005576; GO:0005737; GO:0005886; GO:0006953; GO:0009897; GO:0009986; GO:0097110 acute-phase response [GO:0006953] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] g10703.t1 P70117 47.414 116 9.58e-26 104.0 sp|P70117|LG3BP_MESAU Galectin-3-binding protein OS=Mesocricetus auratus OX=10036 GN=LGALS3BP PE=2 SV=1 g10706.t1 Q9Z173 27.974 311 2.61e-21 104.0 sp|Q9Z173|AGRL3_RAT Adhesion G protein-coupled receptor L3 OS=Rattus norvegicus OX=10116 GN=Adgrl3 PE=1 SV=1 g10708.t1 Q8N695 34.003 597 1.52e-103 330.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g10710.t1 Q9H2A2 61.746 481 0.0 647.0 sp|Q9H2A2|AL8A1_HUMAN 2-aminomuconic semialdehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH8A1 PE=1 SV=1 AL8A1_HUMAN reviewed 2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase 12) (Aldehyde dehydrogenase family 8 member A1) Homo sapiens (Human) GO:0001758; GO:0005829; GO:0042573; GO:0042574; GO:0042904; GO:0047102; GO:0070062; GO:0097053 9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573] cytosol [GO:0005829]; extracellular exosome [GO:0070062] aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase (NAD+) activity [GO:0001758] g10712.t1 Q8L7C8 43.371 445 1.93e-109 342.0 sp|Q8L7C8|RWA1_ARATH Protein REDUCED WALL ACETYLATION 1 OS=Arabidopsis thaliana OX=3702 GN=RWA1 PE=2 SV=1 RWA1_ARATH reviewed Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-) Arabidopsis thaliana (Mouse-ear cress) GO:0000139; GO:0005794; GO:0009834; GO:0010411; GO:0016407; GO:0016491; GO:0045491; GO:0045492 plant-type secondary cell wall biogenesis [GO:0009834]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] acetyltransferase activity [GO:0016407]; oxidoreductase activity [GO:0016491] g10713.t1 Q80TP3 41.754 1425 0.0 846.0 sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2 UBR5_MOUSE reviewed E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) Mus musculus (Mouse) GO:0000209; GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0006979; GO:0008270; GO:0010498; GO:0010628; GO:0016567; GO:0019904; GO:0030520; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0034450; GO:0035519; GO:0042307; GO:0043130; GO:0043161; GO:0045879; GO:0048384; GO:0048471; GO:0050847; GO:0061630; GO:0070561; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0071630; GO:0090263; GO:0140455; GO:0140861; GO:0141198 cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; estrogen receptor signaling pathway [GO:0030520]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; response to oxidative stress [GO:0006979]; retinoic acid receptor signaling pathway [GO:0048384]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]; vitamin D receptor signaling pathway [GO:0070561] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g10713.t1 Q80TP3 60.475 673 0.0 783.0 sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2 UBR5_MOUSE reviewed E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) Mus musculus (Mouse) GO:0000209; GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0006979; GO:0008270; GO:0010498; GO:0010628; GO:0016567; GO:0019904; GO:0030520; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0034450; GO:0035519; GO:0042307; GO:0043130; GO:0043161; GO:0045879; GO:0048384; GO:0048471; GO:0050847; GO:0061630; GO:0070561; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0071630; GO:0090263; GO:0140455; GO:0140861; GO:0141198 cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; estrogen receptor signaling pathway [GO:0030520]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; response to oxidative stress [GO:0006979]; retinoic acid receptor signaling pathway [GO:0048384]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]; vitamin D receptor signaling pathway [GO:0070561] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g10719.t1 Q80TP3 48.636 843 0.0 700.0 sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2 UBR5_MOUSE reviewed E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) Mus musculus (Mouse) GO:0000209; GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0006979; GO:0008270; GO:0010498; GO:0010628; GO:0016567; GO:0019904; GO:0030520; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0034450; GO:0035519; GO:0042307; GO:0043130; GO:0043161; GO:0045879; GO:0048384; GO:0048471; GO:0050847; GO:0061630; GO:0070561; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0071630; GO:0090263; GO:0140455; GO:0140861; GO:0141198 cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; estrogen receptor signaling pathway [GO:0030520]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; response to oxidative stress [GO:0006979]; retinoic acid receptor signaling pathway [GO:0048384]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]; vitamin D receptor signaling pathway [GO:0070561] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g10721.t1 Q9VQX4 62.243 535 0.0 684.0 sp|Q9VQX4|PNCB_DROME Nicotinate phosphoribosyltransferase OS=Drosophila melanogaster OX=7227 GN=Naprt PE=2 SV=2 g10722.t1 Q62941 40.125 319 1.25e-83 261.0 sp|Q62941|ZNT2_RAT Proton-coupled zinc antiporter SLC30A2 OS=Rattus norvegicus OX=10116 GN=Slc30a2 PE=1 SV=1 ZNT2_RAT reviewed Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2) Rattus norvegicus (Rat) GO:0005385; GO:0005737; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006829; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0046872; GO:0062111; GO:0071577; GO:0099503; GO:0140826; GO:0140882; GO:0140914; GO:0140915; GO:0140916; GO:0140917 intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc export across plasma membrane [GO:0140882]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into organelle [GO:0062111]; zinc ion import into secretory vesicle [GO:0140914]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589] identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826] g10724.t1 Q9Y2Y1 81.481 108 7.999999999999999e-68 201.0 sp|Q9Y2Y1|RPC10_HUMAN DNA-directed RNA polymerase III subunit RPC10 OS=Homo sapiens OX=9606 GN=POLR3K PE=1 SV=3 RPC10_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11) Homo sapiens (Human) GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0008270; GO:0045087; GO:0051607 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] g10725.t1 Q9BV90 60.606 132 1.9500000000000001e-47 152.0 sp|Q9BV90|SNR25_HUMAN U11/U12 small nuclear ribonucleoprotein 25 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP25 PE=1 SV=1 SNR25_HUMAN reviewed U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) Homo sapiens (Human) GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0005829; GO:0008380; GO:0045171 mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689] g10726.t1 Q8C5W3 35.545 211 2.4799999999999998e-28 121.0 sp|Q8C5W3|TBCEL_MOUSE Tubulin-specific chaperone cofactor E-like protein OS=Mus musculus OX=10090 GN=Tbcel PE=1 SV=1 g10727.t1 D7REX8 45.415 927 0.0 815.0 sp|D7REX8|UN45B_XENTR Protein unc-45 homolog B OS=Xenopus tropicalis OX=8364 GN=unc45b PE=1 SV=1 g10732.t1 E1BD59 25.172 290 2.5000000000000002e-29 127.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g10733.t1 E7FAM5 22.727 682 3.5800000000000003e-29 127.0 sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1 LIN41_DANRE reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g10734.t1 Q9Z0U4 35.387 763 1.7499999999999998e-152 473.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 g10735.t1 Q54MC6 26.642 274 1.1200000000000002e-21 100.0 sp|Q54MC6|LRLA_DICDI Latrophilin receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=lrlA PE=3 SV=1 g10738.t1 O88871 43.701 254 4.81e-63 215.0 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g10739.t1 Q9UBS5 35.185 756 5.72e-146 455.0 sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1 GABR1_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Homo sapiens (Human) GO:0001649; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0098685; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g10742.t1 O75581 34.992 623 3.41e-92 335.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10742.t1 O75581 30.641 718 1.4000000000000001e-70 266.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10742.t1 O75581 38.621 290 7.21e-45 183.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10742.t1 O75581 32.676 355 6.17e-41 170.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10742.t1 O75581 31.034 377 3.88e-30 134.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10743.t1 Q15067 42.763 152 1.64e-36 138.0 sp|Q15067|ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens OX=9606 GN=ACOX1 PE=1 SV=3 ACOX1_HUMAN reviewed Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] Homo sapiens (Human) GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006091; GO:0006629; GO:0006636; GO:0006693; GO:0007283; GO:0009062; GO:0016020; GO:0016559; GO:0019395; GO:0030165; GO:0033540; GO:0036109; GO:0042632; GO:0042759; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0120524; GO:0140493; GO:1901570 alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid derivative biosynthetic process [GO:1901570]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; long-chain fatty acyl-CoA oxidase activity [GO:0120524]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803] g10744.t1 Q8HYL8 51.573 572 0.0 610.0 sp|Q8HYL8|ACOX1_PHACI Peroxisomal acyl-coenzyme A oxidase 1 OS=Phascolarctos cinereus OX=38626 GN=ACOX1 PE=1 SV=2 ACOX1_PHACI reviewed Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) Phascolarctos cinereus (Koala) GO:0003997; GO:0005504; GO:0005777; GO:0006091; GO:0006629; GO:0006693; GO:0009062; GO:0019395; GO:0042803; GO:0050665; GO:0055088; GO:0071949; GO:0140493 fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid beta-oxidation [GO:0140493] peroxisome [GO:0005777] acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; protein homodimerization activity [GO:0042803] g10745.t1 Q5RCT1 54.615 130 3.740000000000001e-43 150.0 sp|Q5RCT1|TPD54_PONAB Tumor protein D54 OS=Pongo abelii OX=9601 GN=TPD52L2 PE=2 SV=1 g10745.t2 O54818 48.299 147 1.2800000000000001e-37 135.0 sp|O54818|TPD53_MOUSE Tumor protein D53 OS=Mus musculus OX=10090 GN=Tpd52l1 PE=1 SV=1 g10746.t1 P59708 79.339 121 1.2999999999999998e-69 207.0 sp|P59708|SF3B6_MOUSE Splicing factor 3B subunit 6 OS=Mus musculus OX=10090 GN=Sf3b6 PE=1 SV=1 g10747.t1 B7ZCC9 30.89 382 2.9999999999999995e-54 212.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10747.t2 B7ZCC9 26.994 652 2.01e-58 226.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10748.t1 B7ZCC9 27.921 659 2.7999999999999998e-67 255.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10749.t1 O75581 30.388 928 9.19e-97 343.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10749.t1 O75581 28.947 988 5.64e-95 338.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10749.t1 O75581 32.401 679 8.62e-82 298.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10749.t1 O75581 27.534 592 1.4000000000000001e-43 177.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10749.t1 O75581 33.216 283 9.300000000000001e-35 149.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10749.t1 O75581 37.443 219 1.36e-33 145.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10749.t1 O75581 32.215 298 3.520000000000001e-27 124.0 sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2 LRP6_HUMAN reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Homo sapiens (Human) GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909 canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10750.t1 B7ZCC9 27.119 649 1.63e-64 245.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10751.t1 B7ZCC9 27.152 604 2.7999999999999997e-60 232.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10752.t1 B7ZCC9 29.801 453 2.58e-60 224.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10753.t1 B7ZCC9 26.638 702 2.01e-64 247.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10753.t1 B7ZCC9 26.254 678 1.01e-56 222.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10754.t1 Q9NX57 35.95 242 1.81e-43 149.0 sp|Q9NX57|RAB20_HUMAN Ras-related protein Rab-20 OS=Homo sapiens OX=9606 GN=RAB20 PE=1 SV=1 g10755.t1 Q78KK3 37.43 358 4.1e-63 213.0 sp|Q78KK3|S67A1_MOUSE Solute carrier family 22 member 18 OS=Mus musculus OX=10090 GN=Slc67a1 PE=1 SV=2 S67A1_MOUSE reviewed Solute carrier family 22 member 18 (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Multi-membrane-spanning polyspecific transporter) (Organic cation transporter-like protein 2) (ORCTL-2) Mus musculus (Mouse) GO:0005635; GO:0005737; GO:0005886; GO:0006820; GO:0008514; GO:0015293; GO:0016324; GO:0031625; GO:0042908; GO:1990961 monoatomic anion transport [GO:0006820]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; symporter activity [GO:0015293]; ubiquitin protein ligase binding [GO:0031625] g10756.t1 Q5RHP9 39.636 439 5.08e-83 305.0 sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1 ERIC3_HUMAN reviewed Glutamate-rich protein 3 Homo sapiens (Human) GO:0005737; GO:0005929; GO:0005930; GO:0060271; GO:0097730 cilium assembly [GO:0060271] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730] g10756.t2 Q5RHP9 39.261 433 8.4e-81 298.0 sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1 ERIC3_HUMAN reviewed Glutamate-rich protein 3 Homo sapiens (Human) GO:0005737; GO:0005929; GO:0005930; GO:0060271; GO:0097730 cilium assembly [GO:0060271] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730] g10757.t1 Q5E9N0 63.747 411 0.0 527.0 sp|Q5E9N0|BYST_BOVIN Bystin OS=Bos taurus OX=9913 GN=BYSL PE=2 SV=1 g10758.t1 Q9H2Y9 32.727 660 1.0800000000000001e-97 324.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g10759.t1 Q9NPD5 29.099 677 1.25e-94 312.0 sp|Q9NPD5|SO1B3_HUMAN Solute carrier organic anion transporter family member 1B3 OS=Homo sapiens OX=9606 GN=SLCO1B3 PE=1 SV=1 SO1B3_HUMAN reviewed Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (OATP1B3) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) Homo sapiens (Human) GO:0004867; GO:0005886; GO:0006805; GO:0006811; GO:0008514; GO:0009925; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016323; GO:0042167; GO:0043252 bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; xenobiotic metabolic process [GO:0006805] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; serine-type endopeptidase inhibitor activity [GO:0004867]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g10760.t1 Q9H2Y9 30.269 707 1.52e-98 326.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g10760.t2 Q9H2Y9 28.326 699 1.3e-80 276.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g10761.t1 Q9H2Y9 29.571 700 4.07e-85 287.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g10763.t1 Q9H2Y9 30.551 635 5.9499999999999996e-83 281.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g10764.t1 Q9H2Y9 28.68 659 1.08e-77 267.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g10766.t1 Q99N02 31.847 628 9.7e-99 323.0 sp|Q99N02|SO3A1_RAT Solute carrier organic anion transporter family member 3A1 OS=Rattus norvegicus OX=10116 GN=Slco3a1 PE=1 SV=1 SO3A1_RAT reviewed Solute carrier organic anion transporter family member 3A1 (Organic anion-transporting polypeptide D) (OATP-D) (Prostaglandin transporter subtype 2) (Sodium-independent organic anion transporter D) (Solute carrier family 21 member 11) Rattus norvegicus (Rat) GO:0005886; GO:0006811; GO:0008514; GO:0009925; GO:0015132; GO:0015347; GO:0015732; GO:0015823; GO:0015827; GO:0015828; GO:0016323; GO:0016324; GO:0043123; GO:0043252; GO:0043410 monoatomic ion transport [GO:0006811]; phenylalanine transport [GO:0015823]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g10767.t1 Q38936 44.0 125 2.5e-27 105.0 sp|Q38936|FK152_ARATH Peptidyl-prolyl cis-trans isomerase FKBP15-2 OS=Arabidopsis thaliana OX=3702 GN=FKBP15-2 PE=2 SV=2 FK152_ARATH reviewed Peptidyl-prolyl cis-trans isomerase FKBP15-2 (PPIase FKBP15-2) (EC 5.2.1.8) (15 kDa FK506-binding protein) (15 kDa FKBP) (FK506-binding protein 15-2) (AtFKBP15-2) (FK506-binding protein 2-2) (Immunophilin FKBP15-2) (Rotamase) Arabidopsis thaliana (Mouse-ear cress) GO:0000325; GO:0003755; GO:0005783; GO:0005788; GO:0005794; GO:0009536; GO:0009620; GO:0034976 response to endoplasmic reticulum stress [GO:0034976]; response to fungus [GO:0009620] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; plant-type vacuole [GO:0000325]; plastid [GO:0009536] peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g10768.t1 Q6CGG3 51.538 130 2.94e-35 124.0 sp|Q6CGG3|FKBP2_YARLI FK506-binding protein 2 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=FPR2 PE=3 SV=1 g10769.t1 Q6P5E8 37.167 939 0.0 665.0 sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1 DGKQ_MOUSE reviewed Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta) Mus musculus (Mouse) GO:0004143; GO:0004697; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007186; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016020; GO:0016363; GO:0016607; GO:0019900; GO:0030297; GO:0030971; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506] alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270] g10769.t2 Q6P5E8 38.162 925 0.0 676.0 sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1 DGKQ_MOUSE reviewed Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta) Mus musculus (Mouse) GO:0004143; GO:0004697; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007186; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016020; GO:0016363; GO:0016607; GO:0019900; GO:0030297; GO:0030971; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506] alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270] g10770.t1 D3Z5L6 31.026 419 4.77e-53 187.0 sp|D3Z5L6|S18B1_MOUSE MFS-type transporter SLC18B1 OS=Mus musculus OX=10090 GN=Slc18b1 PE=1 SV=2 S18B1_MOUSE reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Mus musculus (Mouse) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g10772.t1 Q9BTC0 36.28 543 3.08e-84 311.0 sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5 DIDO1_HUMAN reviewed Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0006357; GO:0008270; GO:0097190 apoptotic signaling pathway [GO:0097190]; DNA-templated transcription [GO:0006351]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g10772.t1 Q9BTC0 38.503 187 1.41e-31 139.0 sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5 DIDO1_HUMAN reviewed Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0006357; GO:0008270; GO:0097190 apoptotic signaling pathway [GO:0097190]; DNA-templated transcription [GO:0006351]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g10773.t1 Q5RFR6 45.187 748 0.0 655.0 sp|Q5RFR6|K319L_PONAB Dyslexia-associated protein KIAA0319-like protein OS=Pongo abelii OX=9601 GN=Kiaa0319l PE=2 SV=1 K319L_PONAB reviewed Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0001764; GO:0005730; GO:0005802; GO:0005886; GO:0010996; GO:0019065; GO:0030317; GO:0031410; GO:0120211 flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996] cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g10773.t2 Q5RFR6 44.709 756 0.0 653.0 sp|Q5RFR6|K319L_PONAB Dyslexia-associated protein KIAA0319-like protein OS=Pongo abelii OX=9601 GN=Kiaa0319l PE=2 SV=1 K319L_PONAB reviewed Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0001764; GO:0005730; GO:0005802; GO:0005886; GO:0010996; GO:0019065; GO:0030317; GO:0031410; GO:0120211 flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996] cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g10773.t3 Q5RFR6 45.187 748 0.0 655.0 sp|Q5RFR6|K319L_PONAB Dyslexia-associated protein KIAA0319-like protein OS=Pongo abelii OX=9601 GN=Kiaa0319l PE=2 SV=1 K319L_PONAB reviewed Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000139; GO:0001764; GO:0005730; GO:0005802; GO:0005886; GO:0010996; GO:0019065; GO:0030317; GO:0031410; GO:0120211 flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996] cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] g10774.t1 A6H8T7 46.429 532 5.65e-149 479.0 sp|A6H8T7|CBPC2_DANRE Cytosolic carboxypeptidase 2 OS=Danio rerio OX=7955 GN=zte25 PE=2 SV=1 CBPC2_DANRE reviewed Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) (Testis-expressed protein 25) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064 protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g10774.t2 A6H8T7 46.429 532 5.99e-149 479.0 sp|A6H8T7|CBPC2_DANRE Cytosolic carboxypeptidase 2 OS=Danio rerio OX=7955 GN=zte25 PE=2 SV=1 CBPC2_DANRE reviewed Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) (Testis-expressed protein 25) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064 protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g10782.t1 O54748 58.462 585 0.0 618.0 sp|O54748|STK3_RAT Serine/threonine-protein kinase 3 OS=Rattus norvegicus OX=10116 GN=Stk3 PE=1 SV=1 STK3_RAT reviewed Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] Rattus norvegicus (Rat) GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006606; GO:0007417; GO:0008285; GO:0008625; GO:0032991; GO:0035265; GO:0035329; GO:0035332; GO:0035556; GO:0042802; GO:0043065; GO:0043408; GO:0045600; GO:0046330; GO:0046621; GO:0050673; GO:0050680; GO:0050821; GO:0051262; GO:0051299; GO:0051897; GO:0060070; GO:0060215; GO:0060706; GO:0060800; GO:0071539; GO:0090090; GO:0097284; GO:0106310; GO:0140537; GO:1902043 canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; centrosome separation [GO:0051299]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hippo signaling [GO:0035332]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein localization to centrosome [GO:0071539]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription regulator activator activity [GO:0140537] g10782.t2 O54748 59.375 576 0.0 628.0 sp|O54748|STK3_RAT Serine/threonine-protein kinase 3 OS=Rattus norvegicus OX=10116 GN=Stk3 PE=1 SV=1 STK3_RAT reviewed Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] Rattus norvegicus (Rat) GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006606; GO:0007417; GO:0008285; GO:0008625; GO:0032991; GO:0035265; GO:0035329; GO:0035332; GO:0035556; GO:0042802; GO:0043065; GO:0043408; GO:0045600; GO:0046330; GO:0046621; GO:0050673; GO:0050680; GO:0050821; GO:0051262; GO:0051299; GO:0051897; GO:0060070; GO:0060215; GO:0060706; GO:0060800; GO:0071539; GO:0090090; GO:0097284; GO:0106310; GO:0140537; GO:1902043 canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; centrosome separation [GO:0051299]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hippo signaling [GO:0035332]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein localization to centrosome [GO:0071539]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription regulator activator activity [GO:0140537] g10783.t1 Q4QQW3 64.0 475 0.0 634.0 sp|Q4QQW3|HOT_RAT Hydroxyacid-oxoacid transhydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Adhfe1 PE=1 SV=1 HOT_RAT reviewed Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1) Rattus norvegicus (Rat) GO:0004022; GO:0005739; GO:0019552; GO:0046872; GO:0046952; GO:0047988 ketone body catabolic process [GO:0046952]; L-glutamate catabolic process via 2-hydroxyglutarate [GO:0019552] mitochondrion [GO:0005739] alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872] g10784.t1 Q7ZW47 37.881 689 7.92e-113 357.0 sp|Q7ZW47|STAU2_DANRE Double-stranded RNA-binding protein Staufen homolog 2 OS=Danio rerio OX=7955 GN=stau2 PE=2 SV=2 STAU2_DANRE reviewed Double-stranded RNA-binding protein Staufen homolog 2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003725; GO:0003729; GO:0005874; GO:0005886; GO:0007281; GO:0008298; GO:0008354; GO:0010494; GO:0032839; GO:0035418; GO:0043005; GO:0043025; GO:0098964 anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular mRNA localization [GO:0008298]; protein localization to synapse [GO:0035418] cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729] g10785.t1 Q9QZM9 43.701 254 1.0999999999999999e-67 219.0 sp|Q9QZM9|FBX16_MOUSE F-box only protein 16 OS=Mus musculus OX=10090 GN=Fbxo16 PE=2 SV=1 g10786.t1 E1BYJ2 53.952 1303 0.0 1393.0 sp|E1BYJ2|MSH6_CHICK DNA mismatch repair protein Msh6 OS=Gallus gallus OX=9031 GN=MSH6 PE=3 SV=2 MSH6_CHICK reviewed DNA mismatch repair protein Msh6 Gallus gallus (Chicken) GO:0005524; GO:0005634; GO:0006298; GO:0007095; GO:0030890; GO:0030983; GO:0032301; GO:0032876; GO:0140664 mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; positive regulation of B cell proliferation [GO:0030890] MutSalpha complex [GO:0032301]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; mismatched DNA binding [GO:0030983] g10786.t2 E1BYJ2 53.952 1303 0.0 1392.0 sp|E1BYJ2|MSH6_CHICK DNA mismatch repair protein Msh6 OS=Gallus gallus OX=9031 GN=MSH6 PE=3 SV=2 MSH6_CHICK reviewed DNA mismatch repair protein Msh6 Gallus gallus (Chicken) GO:0005524; GO:0005634; GO:0006298; GO:0007095; GO:0030890; GO:0030983; GO:0032301; GO:0032876; GO:0140664 mismatch repair [GO:0006298]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of DNA endoreduplication [GO:0032876]; positive regulation of B cell proliferation [GO:0030890] MutSalpha complex [GO:0032301]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; mismatched DNA binding [GO:0030983] g10787.t1 Q9EQW7 60.102 1366 0.0 1596.0 sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1 KI13A_MOUSE reviewed Kinesin-like protein KIF13A Mus musculus (Mouse) GO:0000139; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383 cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] centrosome [GO:0005813]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g10787.t2 Q9EQW7 60.147 1365 0.0 1596.0 sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1 KI13A_MOUSE reviewed Kinesin-like protein KIF13A Mus musculus (Mouse) GO:0000139; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383 cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] centrosome [GO:0005813]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g10787.t3 Q9H1H9 59.14 1395 0.0 1595.0 sp|Q9H1H9|KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens OX=9606 GN=KIF13A PE=1 SV=2 g10787.t4 Q9EQW7 59.479 1382 0.0 1590.0 sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1 KI13A_MOUSE reviewed Kinesin-like protein KIF13A Mus musculus (Mouse) GO:0000139; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383 cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] centrosome [GO:0005813]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g10787.t5 Q9EQW7 58.769 1397 0.0 1578.0 sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1 KI13A_MOUSE reviewed Kinesin-like protein KIF13A Mus musculus (Mouse) GO:0000139; GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383 cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] centrosome [GO:0005813]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g10788.t1 Q6UXS0 35.294 170 1.4900000000000002e-27 110.0 sp|Q6UXS0|CL19A_HUMAN C-type lectin domain family 19 member A OS=Homo sapiens OX=9606 GN=CLEC19A PE=1 SV=2 g10788.t1 Q6UXS0 34.118 170 1.6200000000000003e-27 110.0 sp|Q6UXS0|CL19A_HUMAN C-type lectin domain family 19 member A OS=Homo sapiens OX=9606 GN=CLEC19A PE=1 SV=2 g10789.t1 Q5ZMN2 68.069 808 0.0 1102.0 sp|Q5ZMN2|MCM3_CHICK DNA replication licensing factor MCM3 OS=Gallus gallus OX=9031 GN=MCM3 PE=2 SV=1 MCM3_CHICK reviewed DNA replication licensing factor MCM3 (EC 3.6.4.12) Gallus gallus (Chicken) GO:0000727; GO:0003678; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0016887; GO:0042555; GO:0071162; GO:1902975 DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975] CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] g10791.t1 P23416 31.081 444 4.41e-56 196.0 sp|P23416|GLRA2_HUMAN Glycine receptor subunit alpha-2 OS=Homo sapiens OX=9606 GN=GLRA2 PE=1 SV=1 GLRA2_HUMAN reviewed Glycine receptor subunit alpha-2 Homo sapiens (Human) GO:0004888; GO:0005231; GO:0005886; GO:0007218; GO:0016594; GO:0016934; GO:0022852; GO:0034220; GO:0034707; GO:0042995; GO:0046872; GO:0050804; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0098982; GO:0099634; GO:1902476; GO:1904315 cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic ion transmembrane transport [GO:0034220]; neuropeptide signaling pathway [GO:0007218] cell projection [GO:0042995]; chloride channel complex [GO:0034707]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634] excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] g10793.t1 Q8K0Q5 38.523 623 9.130000000000001e-122 380.0 sp|Q8K0Q5|RHG18_MOUSE Rho GTPase-activating protein 18 OS=Mus musculus OX=10090 GN=Arhgap18 PE=1 SV=1 g10796.t1 Q9QXF7 38.477 512 2.69e-117 358.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g10798.t1 Q8MR62 56.904 239 9.49e-96 283.0 sp|Q8MR62|PHLP2_DROME Phosducin-like protein 2 OS=Drosophila melanogaster OX=7227 GN=PhLP2 PE=1 SV=1 g10799.t1 Q27972 26.284 331 1.53e-25 112.0 sp|Q27972|CHAD_BOVIN Chondroadherin OS=Bos taurus OX=9913 GN=CHAD PE=1 SV=1 CHAD_BOVIN reviewed Chondroadherin (38 kDa bone protein) (Cartilage leucine-rich protein) [Cleaved into: Chondroadherin minor form] Bos taurus (Bovine) g10802.t1 Q8BKN5 36.963 698 2.5400000000000002e-129 410.0 sp|Q8BKN5|GCP5_MOUSE Gamma-tubulin complex component 5 OS=Mus musculus OX=10090 GN=Tubgcp5 PE=2 SV=2 g10803.t1 Q8BKN5 36.778 329 7.89e-53 191.0 sp|Q8BKN5|GCP5_MOUSE Gamma-tubulin complex component 5 OS=Mus musculus OX=10090 GN=Tubgcp5 PE=2 SV=2 g10804.t1 Q8WQI5 75.481 208 2.29e-118 337.0 sp|Q8WQI5|RS8_SPOFR Small ribosomal subunit protein eS8 OS=Spodoptera frugiperda OX=7108 GN=RpS8 PE=2 SV=1 g10805.t1 Q9UJM8 49.128 344 5.82e-107 320.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g10806.t1 Q9UJM8 40.462 173 9.569999999999999e-40 144.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g10808.t1 B7ZCC9 31.421 366 2.69e-53 206.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10809.t1 Q9UJM8 49.587 363 2.53e-115 342.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g10810.t1 Q9UGM3 34.632 1155 8.3099999999999995e-140 488.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g10810.t1 Q9UGM3 34.775 1156 2.89e-137 480.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g10810.t1 Q9UGM3 34.669 1148 6.889999999999999e-137 479.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g10810.t1 Q9UGM3 41.688 770 3.95e-126 446.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g10810.t1 Q9UGM3 45.136 514 4.45e-98 357.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g10810.t1 Q9UGM3 29.703 505 9.21e-32 140.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g10810.t2 Q2VLG6 30.435 782 3.71e-60 230.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10810.t2 Q2VLG6 27.337 706 1.0699999999999999e-41 171.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10810.t2 Q2VLG6 27.008 722 1.06e-39 165.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10810.t2 Q2VLG6 36.245 229 2.79e-26 121.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10810.t3 Q2VLG6 29.872 780 1.66e-59 228.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10810.t3 Q2VLG6 27.468 699 3.1999999999999996e-42 173.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10810.t3 Q2VLG6 27.182 699 7.199999999999999e-40 165.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10810.t3 Q2VLG6 36.245 229 3.46e-26 121.0 sp|Q2VLG6|C163A_CANLF Scavenger receptor cysteine-rich type 1 protein M130 OS=Canis lupus familiaris OX=9615 GN=CD163 PE=2 SV=1 C163A_CANLF reviewed Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)] Canis lupus familiaris (Dog) (Canis familiaris) GO:0005576; GO:0005737; GO:0006953; GO:0009897 acute-phase response [GO:0006953] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] g10811.t1 Q91YT7 43.994 666 2.02e-148 445.0 sp|Q91YT7|YTHD2_MOUSE YTH domain-containing family protein 2 OS=Mus musculus OX=10090 GN=Ythdf2 PE=1 SV=1 YTHD2_MOUSE reviewed YTH domain-containing family protein 2 Mus musculus (Mouse) GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007276; GO:0007284; GO:0010494; GO:0030155; GO:0034063; GO:0034451; GO:0036464; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0062153; GO:0070925; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247; GO:2000232; GO:2000737 embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] C5-methylcytidine-containing RNA reader activity [GO:0062153]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247] g10812.t1 Q5XGF7 39.016 305 3.97e-66 213.0 sp|Q5XGF7|RDH10_XENTR Retinol dehydrogenase 10 OS=Xenopus tropicalis OX=8364 GN=rdh10 PE=2 SV=1 g10813.t1 Q8N3Y7 42.4 250 1.5899999999999998e-67 216.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g10814.t1 Q8N3Y7 50.345 290 2.98e-97 294.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g10821.t1 E3WDQ9 48.59 1206 0.0 834.0 sp|E3WDQ9|PUM2_XENLA Pumilio homolog 2 OS=Xenopus laevis OX=8355 GN=pum2 PE=1 SV=1 PUM2_XENLA reviewed Pumilio homolog 2 (Pumilio-2) Xenopus laevis (African clawed frog) GO:0000932; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0035196; GO:0043488 miRNA processing [GO:0035196]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932] mRNA 3'-UTR binding [GO:0003730] g10826.t1 Q5RFZ7 33.01 206 1.45e-25 101.0 sp|Q5RFZ7|F167A_DANRE Protein FAM167A OS=Danio rerio OX=7955 GN=fam167a PE=2 SV=1 g10829.t1 O60216 57.619 420 8.529999999999999e-152 454.0 sp|O60216|RAD21_HUMAN Double-strand-break repair protein rad21 homolog OS=Homo sapiens OX=9606 GN=RAD21 PE=1 SV=2 RAD21_HUMAN reviewed Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product)] Homo sapiens (Human) GO:0000775; GO:0000785; GO:0000794; GO:0000922; GO:0000987; GO:0001666; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006302; GO:0006310; GO:0006357; GO:0006915; GO:0007059; GO:0007062; GO:0007131; GO:0008278; GO:0010972; GO:0016020; GO:0016363; GO:0030496; GO:0030892; GO:0030893; GO:0032691; GO:0032720; GO:0032733; GO:0034087; GO:0034089; GO:0034351; GO:0043524; GO:0045841; GO:0045876; GO:0051301; GO:0071168; GO:0106222; GO:0140297; GO:0140588; GO:1990414 apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; establishment of meiotic sister chromatid cohesion [GO:0034089]; establishment of mitotic sister chromatid cohesion [GO:0034087]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; reciprocal meiotic recombination [GO:0007131]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to hypoxia [GO:0001666]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; meiotic cohesin complex [GO:0030893]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic cohesin complex [GO:0030892]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor binding [GO:0140297]; lncRNA binding [GO:0106222] g10831.t1 Q3SZ85 56.897 116 6.52e-35 120.0 sp|Q3SZ85|PTRD1_BOVIN Putative peptidyl-tRNA hydrolase PTRHD1 OS=Bos taurus OX=9913 GN=PTRHD1 PE=2 SV=2 g10833.t1 Q6IZB5 59.06 298 9.780000000000001e-124 360.0 sp|Q6IZB5|S2532_CRIGR Solute carrier family 25 member 32 OS=Cricetulus griseus OX=10029 GN=SLC25A32 PE=1 SV=1 S2532_CRIGR reviewed Solute carrier family 25 member 32 (Mitochondrial FAD transporter) Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) GO:0005739; GO:0005743; GO:0015230; GO:1904947; GO:1990548 folate import into mitochondrion [GO:1904947]; mitochondrial FAD transmembrane transport [GO:1990548] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] FAD transmembrane transporter activity [GO:0015230] g10834.t1 Q5IGR8 56.504 738 0.0 852.0 sp|Q5IGR8|EXT1A_DANRE Exostosin-1a OS=Danio rerio OX=7955 GN=ext1a PE=2 SV=1 EXT1A_DANRE reviewed Exostosin-1a (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase 1a) (Multiple exostoses protein 1 homolog a) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001503; GO:0005789; GO:0005794; GO:0008375; GO:0015012; GO:0015020; GO:0046872; GO:0050508; GO:0050509 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification [GO:0001503] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509] g10835.t1 Q9DG68 70.794 315 1.26e-148 423.0 sp|Q9DG68|RLA0_LITSY Large ribosomal subunit protein uL10 OS=Lithobates sylvaticus OX=45438 GN=RPLP0 PE=2 SV=1 g10836.t1 Q5R6L5 72.142 1242 0.0 1845.0 sp|Q5R6L5|CAND1_PONAB Cullin-associated NEDD8-dissociated protein 1 OS=Pongo abelii OX=9601 GN=CAND1 PE=2 SV=1 g10837.t1 P50053 46.102 295 6.1e-91 276.0 sp|P50053|KHK_HUMAN Ketohexokinase OS=Homo sapiens OX=9606 GN=KHK PE=1 SV=2 KHK_HUMAN reviewed Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase) Homo sapiens (Human) GO:0004454; GO:0005524; GO:0005737; GO:0005829; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0032868; GO:0042802; GO:0042803; GO:0070061; GO:0070062; GO:0070873 fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] ATP binding [GO:0005524]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; ketohexokinase activity [GO:0004454]; protein homodimerization activity [GO:0042803] g10839.t1 Q9QYL7 39.444 180 3.44e-42 147.0 sp|Q9QYL7|ABT1_MOUSE Activator of basal transcription 1 OS=Mus musculus OX=10090 GN=Abt1 PE=2 SV=1 g10840.t1 Q84K35 55.298 302 1.21e-101 317.0 sp|Q84K35|PUMY_ARATH Pseudouridine-5'-phosphate glycosidase OS=Arabidopsis thaliana OX=3702 GN=PUMY PE=1 SV=1 g10841.t1 Q6DDS9 39.867 750 2.6800000000000003e-163 491.0 sp|Q6DDS9|XRCC5_XENLA X-ray repair cross-complementing protein 5 OS=Xenopus laevis OX=8355 GN=xrcc5.L PE=1 SV=1 XRCC5_XENLA reviewed DNA repair protein Ku80 (EC 4.2.99.18) (EC 5.6.2.4) (Ku80) Xenopus laevis (African clawed frog) GO:0000723; GO:0003678; GO:0003684; GO:0003690; GO:0005524; GO:0005737; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564 DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723] cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564] ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; hydrolase activity [GO:0016787]; telomeric DNA binding [GO:0042162] g10843.t1 O55236 54.817 602 0.0 696.0 sp|O55236|MCE1_MOUSE mRNA-capping enzyme OS=Mus musculus OX=10090 GN=Rngtt PE=1 SV=1 MCE1_MOUSE reviewed mRNA-capping enzyme (HCE) (MCE1) [Includes: mRNA 5'-triphosphate monophosphatase (EC 3.6.1.74) (mRNA 5'-phosphatase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)] Mus musculus (Mouse) GO:0004484; GO:0004721; GO:0005524; GO:0005525; GO:0005634; GO:0006370; GO:0006396; GO:0008192; GO:0050355; GO:0140818 7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396] nucleus [GO:0005634] ATP binding [GO:0005524]; GTP binding [GO:0005525]; inorganic triphosphate phosphatase activity [GO:0050355]; mRNA 5'-triphosphate monophosphatase activity [GO:0140818]; mRNA guanylyltransferase activity [GO:0004484]; phosphoprotein phosphatase activity [GO:0004721]; RNA guanylyltransferase activity [GO:0008192] g10844.t1 O75346 51.628 215 5.53e-69 236.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g10844.t1 O75346 47.234 235 3.5600000000000004e-64 223.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g10844.t1 O75346 49.091 220 4.5500000000000005e-64 223.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g10844.t1 O75346 42.188 192 7.0100000000000005e-43 165.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g10844.t1 O75346 41.916 167 1.29e-33 138.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g10844.t1 O75346 41.844 141 1.88e-24 110.0 sp|O75346|ZN253_HUMAN Zinc finger protein 253 OS=Homo sapiens OX=9606 GN=ZNF253 PE=1 SV=2 g10845.t1 P48969 51.02 441 3.35e-136 402.0 sp|P48969|DVR1_STRPU Protein DVR-1 homolog OS=Strongylocentrotus purpuratus OX=7668 GN=DVR1 PE=2 SV=1 g10846.t1 Q8BL74 27.414 642 2.18e-48 191.0 sp|Q8BL74|TF3C2_MOUSE General transcription factor 3C polypeptide 2 OS=Mus musculus OX=10090 GN=Gtf3c2 PE=2 SV=2 g10848.t1 B0BNF9 48.227 282 9.72e-83 256.0 sp|B0BNF9|HAOX1_RAT 2-Hydroxyacid oxidase 1 OS=Rattus norvegicus OX=10116 GN=Hao1 PE=1 SV=1 HAOX1_RAT reviewed 2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5) Rattus norvegicus (Rat) GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] g10849.t1 Q9CQI9 43.478 184 1.91e-42 143.0 sp|Q9CQI9|MED30_MOUSE Mediator of RNA polymerase II transcription subunit 30 OS=Mus musculus OX=10090 GN=Med30 PE=1 SV=1 MED30_MOUSE reviewed Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30) (Thyroid hormone receptor-associated protein 6) (Thyroid hormone receptor-associated protein complex 25 kDa component) (Trap25) Mus musculus (Mouse) GO:0000151; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0016567; GO:0016592; GO:0019827; GO:0032968; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0061630; GO:0070847 positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein ubiquitination [GO:0016567]; RNA polymerase II preinitiation complex assembly [GO:0051123]; stem cell population maintenance [GO:0019827] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] g10851.t1 Q6GQ69 54.709 446 9.28e-165 474.0 sp|Q6GQ69|FAF2B_XENLA FAS-associated factor 2-B OS=Xenopus laevis OX=8355 GN=faf2-b PE=2 SV=1 g10852.t1 Q9WVC5 38.328 634 1.94e-130 414.0 sp|Q9WVC5|TRPC7_MOUSE Short transient receptor potential channel 7 OS=Mus musculus OX=10090 GN=Trpc7 PE=2 SV=1 g10854.t1 P15848 55.04 496 0.0 540.0 sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1 ARSB_HUMAN reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Homo sapiens (Human) GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484] g10855.t1 P15848 45.098 153 1.55e-28 112.0 sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1 ARSB_HUMAN reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Homo sapiens (Human) GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484] g10856.t1 P15848 54.032 496 0.0 533.0 sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1 ARSB_HUMAN reviewed Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S) Homo sapiens (Human) GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 autophagy [GO:0006914]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484] g10872.t1 P70712 48.171 492 5.59e-169 489.0 sp|P70712|KYNU_RAT Kynureninase OS=Rattus norvegicus OX=10116 GN=Kynu PE=1 SV=2 KYNU_RAT reviewed Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase) Rattus norvegicus (Rat) GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006569; GO:0009435; GO:0019441; GO:0019442; GO:0019805; GO:0030170; GO:0030429; GO:0034341; GO:0034354; GO:0034516; GO:0042803; GO:0043420; GO:0097053 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; L-tryptophan catabolic process [GO:0006569]; L-tryptophan catabolic process to acetyl-CoA [GO:0019442]; L-tryptophan catabolic process to kynurenine [GO:0019441]; NAD+ biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to type II interferon [GO:0034341]; response to vitamin B6 [GO:0034516] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] g10872.t2 P70712 50.533 469 1.11e-174 503.0 sp|P70712|KYNU_RAT Kynureninase OS=Rattus norvegicus OX=10116 GN=Kynu PE=1 SV=2 KYNU_RAT reviewed Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase) Rattus norvegicus (Rat) GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006569; GO:0009435; GO:0019441; GO:0019442; GO:0019805; GO:0030170; GO:0030429; GO:0034341; GO:0034354; GO:0034516; GO:0042803; GO:0043420; GO:0097053 'de novo' NAD+ biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; L-tryptophan catabolic process [GO:0006569]; L-tryptophan catabolic process to acetyl-CoA [GO:0019442]; L-tryptophan catabolic process to kynurenine [GO:0019441]; NAD+ biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to type II interferon [GO:0034341]; response to vitamin B6 [GO:0034516] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] g10873.t1 P46978 84.892 695 0.0 1235.0 sp|P46978|STT3A_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Mus musculus OX=10090 GN=Stt3a PE=1 SV=1 g10874.t1 Q5PQ50 39.189 370 1.08e-89 278.0 sp|Q5PQ50|NUD19_XENLA Acyl-coenzyme A diphosphatase NUDT19 OS=Xenopus laevis OX=8355 GN=nudt19 PE=2 SV=1 NUD19_XENLA reviewed Acyl-coenzyme A diphosphatase NUDT19 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 19) (Nudix motif 19) Xenopus laevis (African clawed frog) GO:0000287; GO:0005739; GO:0005777; GO:0010945; GO:0015938; GO:0036114; GO:0044580; GO:1901289; GO:1902858; GO:2001294 butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] mitochondrion [GO:0005739]; peroxisome [GO:0005777] coenzyme A diphosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287] g10875.t1 Q29496 37.259 518 1.2900000000000002e-123 374.0 sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1 g10876.t1 P79401 38.536 519 8.369999999999999e-126 380.0 sp|P79401|CP3AT_PIG Cytochrome P450 3A29 OS=Sus scrofa OX=9823 GN=CYP3A29 PE=2 SV=1 g10877.t1 P61645 35.017 297 7.78e-46 166.0 sp|P61645|SIA8D_PANTR CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Pan troglodytes OX=9598 GN=ST8SIA4 PE=2 SV=1 g10878.t1 Q9QXF7 36.731 520 2.08e-96 304.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g10880.t1 Q09225 34.505 455 1.27e-67 244.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g10881.t1 Q6AZB8 27.852 298 5.08e-27 112.0 sp|Q6AZB8|HARB1_DANRE Putative nuclease HARBI1 OS=Danio rerio OX=7955 GN=harbi1 PE=2 SV=1 g10883.t1 Q09225 33.48 454 2.4100000000000003e-66 240.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g10884.t1 Q09225 33.263 472 4.81e-65 236.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g10886.t1 Q8CDM4 28.679 265 2.36e-24 114.0 sp|Q8CDM4|CCD73_MOUSE Coiled-coil domain-containing protein 73 OS=Mus musculus OX=10090 GN=Ccdc73 PE=2 SV=2 g10887.t1 Q9ER04 31.833 311 1.5100000000000002e-31 131.0 sp|Q9ER04|TMPS5_MOUSE Transmembrane protease serine 5 OS=Mus musculus OX=10090 GN=Tmprss5 PE=2 SV=3 g10888.t1 Q91YR7 71.933 962 0.0 1400.0 sp|Q91YR7|PRP6_MOUSE Pre-mRNA-processing factor 6 OS=Mus musculus OX=10090 GN=Prpf6 PE=1 SV=1 PRP6_MOUSE reviewed Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein) Mus musculus (Mouse) GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005813; GO:0005829; GO:0006403; GO:0016607; GO:0030674; GO:0036064; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244] catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] g10889.t1 Q9ESQ4 26.433 314 1.49e-21 98.6 sp|Q9ESQ4|NMUR2_RAT Neuromedin-U receptor 2 OS=Rattus norvegicus OX=10116 GN=Nmur2 PE=1 SV=2 NMUR2_RAT reviewed Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4) Rattus norvegicus (Rat) GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930 arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g10894.t1 Q09225 34.423 459 6.3e-68 248.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g10895.t1 D3Z5L6 36.667 240 3.82e-46 165.0 sp|D3Z5L6|S18B1_MOUSE MFS-type transporter SLC18B1 OS=Mus musculus OX=10090 GN=Slc18b1 PE=1 SV=2 S18B1_MOUSE reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Mus musculus (Mouse) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g10896.t1 D3Z5L6 33.973 365 8.54e-61 207.0 sp|D3Z5L6|S18B1_MOUSE MFS-type transporter SLC18B1 OS=Mus musculus OX=10090 GN=Slc18b1 PE=1 SV=2 S18B1_MOUSE reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Mus musculus (Mouse) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g10896.t2 D3Z5L6 33.485 439 1.8500000000000002e-71 237.0 sp|D3Z5L6|S18B1_MOUSE MFS-type transporter SLC18B1 OS=Mus musculus OX=10090 GN=Slc18b1 PE=1 SV=2 S18B1_MOUSE reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Mus musculus (Mouse) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g10897.t1 Q09225 33.769 459 3.48e-64 238.0 sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3 NRF6_CAEEL reviewed Nose resistant to fluoxetine protein 6 (Protein nrf-6) Caenorhabditis elegans GO:0006869; GO:0008289; GO:0016020; GO:0016747 lipid transport [GO:0006869] membrane [GO:0016020] acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289] g10898.t1 P10605 43.26 319 2.09e-82 256.0 sp|P10605|CATB_MOUSE Cathepsin B OS=Mus musculus OX=10090 GN=Ctsb PE=1 SV=2 CATB_MOUSE reviewed Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Mus musculus (Mouse) GO:0004175; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005901; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0009986; GO:0016324; GO:0030163; GO:0030574; GO:0030855; GO:0030984; GO:0031012; GO:0042277; GO:0042383; GO:0042470; GO:0042802; GO:0043394; GO:0044877; GO:0046697; GO:0046718; GO:0048471; GO:0051402; GO:0051603; GO:0097067; GO:1904090 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neuron apoptotic process [GO:0051402]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; caveola [GO:0005901]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394] g10901.t1 Q7SXT7 35.197 304 4.87e-44 158.0 sp|Q7SXT7|ZC21A_DANRE Zinc finger C2HC domain-containing protein 1A OS=Danio rerio OX=7955 GN=zc2hc1a PE=2 SV=1 g10901.t2 Q7SXT7 37.079 356 9.290000000000001e-58 192.0 sp|Q7SXT7|ZC21A_DANRE Zinc finger C2HC domain-containing protein 1A OS=Danio rerio OX=7955 GN=zc2hc1a PE=2 SV=1 g10902.t1 Q9Z2D0 66.79 542 0.0 786.0 sp|Q9Z2D0|MTMR9_MOUSE Myotubularin-related protein 9 OS=Mus musculus OX=10090 GN=Mtmr9 PE=1 SV=2 MTMR9_MOUSE reviewed Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9) Mus musculus (Mouse) GO:0005737; GO:0005783; GO:0005829; GO:0006897; GO:0010507; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304 endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903] g10904.t1 D3ZR10 32.979 376 1.8899999999999997e-48 183.0 sp|D3ZR10|DCDC2_RAT Doublecortin domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Dcdc2 PE=1 SV=1 DCDC2_RAT reviewed Doublecortin domain-containing protein 2 Rattus norvegicus (Rat) GO:0001764; GO:0005737; GO:0005815; GO:0005874; GO:0005929; GO:0005930; GO:0007605; GO:0008542; GO:0019228; GO:0019894; GO:0030111; GO:0035249; GO:0035556; GO:0045202; GO:0045880; GO:0048813; GO:0060091; GO:0060271; GO:1902017 cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; neuronal action potential [GO:0019228]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; synapse [GO:0045202] kinesin binding [GO:0019894] g10904.t2 Q5DU00 30.657 411 3.4399999999999997e-45 173.0 sp|Q5DU00|DCDC2_MOUSE Doublecortin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Dcdc2 PE=1 SV=2 DCDC2_MOUSE reviewed Doublecortin domain-containing protein 2 Mus musculus (Mouse) GO:0001764; GO:0005737; GO:0005815; GO:0005874; GO:0005929; GO:0005930; GO:0007605; GO:0008542; GO:0019228; GO:0019894; GO:0030111; GO:0035249; GO:0035556; GO:0045202; GO:0048813; GO:0060091; GO:0060271; GO:1902017 cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; neuronal action potential [GO:0019228]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; synapse [GO:0045202] kinesin binding [GO:0019894] g10905.t1 Q8K078 41.768 656 4.09e-172 514.0 sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2 SO4A1_MOUSE reviewed Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12) Mus musculus (Mouse) GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0015711; GO:0016323; GO:0042403; GO:0043252 monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] g10906.t1 Q9DBU3 50.196 510 4.29e-165 482.0 sp|Q9DBU3|RIOK3_MOUSE Serine/threonine-protein kinase RIO3 OS=Mus musculus OX=10090 GN=Riok3 PE=1 SV=3 RIOK3_MOUSE reviewed Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) Mus musculus (Mouse) GO:0004674; GO:0005524; GO:0005829; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786 cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728] cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688] ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10908.t1 Q8BGD4 39.286 700 3.26e-155 470.0 sp|Q8BGD4|SO4C1_MOUSE Solute carrier organic anion transporter family member 4C1 OS=Mus musculus OX=10090 GN=Slco4c1 PE=1 SV=1 SO4C1_MOUSE reviewed Solute carrier organic anion transporter family member 4C1 (Slco4c1) (Oatp-R) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20) Mus musculus (Mouse) GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0015711; GO:0016323; GO:0030154; GO:0043252 cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] basolateral plasma membrane [GO:0016323] organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] g10913.t1 Q6SKR2 43.981 216 8.19e-57 182.0 sp|Q6SKR2|HEMK2_MOUSE Methyltransferase HEMK2 OS=Mus musculus OX=10090 GN=Hemk2 PE=1 SV=1 HEMK2_MOUSE reviewed Methyltransferase HEMK2 (HemK methyltransferase family member 2) (M.HsaHemK2P) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Methyltransferase N6AMT1) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-) Mus musculus (Mouse) GO:0003676; GO:0005634; GO:0008276; GO:0008757; GO:0009007; GO:0009404; GO:0018364; GO:0018872; GO:0030307; GO:0030791; GO:0032259; GO:0032991; GO:0035657; GO:0036009; GO:0045814; GO:0045815; GO:0140984; GO:1904047 arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]; transcription initiation-coupled chromatin remodeling [GO:0045815] eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] arsenite methyltransferase activity [GO:0030791]; histone H4K12 methyltransferase activity [GO:0140984]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007] g10917.t1 E1BD59 27.698 278 6.73e-28 123.0 sp|E1BD59|TRI56_BOVIN E3 ubiquitin-protein ligase TRIM56 OS=Bos taurus OX=9913 GN=TRIM56 PE=2 SV=1 TRI56_BOVIN reviewed E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (Tripartite motif-containing protein 56) Bos taurus (Bovine) GO:0005654; GO:0005737; GO:0006513; GO:0008270; GO:0032728; GO:0034340; GO:0045087; GO:0051607; GO:0060340; GO:0061630; GO:0070534 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; response to type I interferon [GO:0034340] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g10918.t1 Q6QNK2 36.919 344 8.38e-55 197.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10919.t1 B7Z0W9 27.572 486 8.84e-39 157.0 sp|B7Z0W9|OTOP_DROME Proton channel OtopLc OS=Drosophila melanogaster OX=7227 GN=OtopLc PE=3 SV=2 OTOP_DROME reviewed Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc) Drosophila melanogaster (Fruit fly) GO:0005886; GO:0015252; GO:1902600 proton transmembrane transport [GO:1902600] plasma membrane [GO:0005886] proton channel activity [GO:0015252] g10920.t1 Q7TNK0 52.155 464 1.73e-154 449.0 sp|Q7TNK0|SERC1_RAT Serine incorporator 1 OS=Rattus norvegicus OX=10116 GN=Serinc1 PE=1 SV=1 SERC1_RAT reviewed Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2) Rattus norvegicus (Rat) GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0010698; GO:0016020; GO:0019899; GO:0030674; GO:0044091 membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674] g10920.t2 Q7TNK0 52.735 457 1.9600000000000002e-155 451.0 sp|Q7TNK0|SERC1_RAT Serine incorporator 1 OS=Rattus norvegicus OX=10116 GN=Serinc1 PE=1 SV=1 SERC1_RAT reviewed Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2) Rattus norvegicus (Rat) GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0010698; GO:0016020; GO:0019899; GO:0030674; GO:0044091 membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; sphingolipid metabolic process [GO:0006665] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674] g10921.t1 Q8IWA6 25.107 466 6.54e-29 125.0 sp|Q8IWA6|CCD60_HUMAN Coiled-coil domain-containing protein 60 OS=Homo sapiens OX=9606 GN=CCDC60 PE=1 SV=2 g10922.t1 P62914 85.876 177 2.96e-113 322.0 sp|P62914|RL11_RAT Large ribosomal subunit protein uL5 OS=Rattus norvegicus OX=10116 GN=Rpl11 PE=1 SV=2 RL11_RAT reviewed Large ribosomal subunit protein uL5 (60S ribosomal protein L11) Rattus norvegicus (Rat) GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005840; GO:0006364; GO:0006412; GO:0006605; GO:0008097; GO:0010628; GO:0015934; GO:0022625; GO:0022626; GO:0031625; GO:0032435; GO:0032991; GO:0034504; GO:0042273; GO:0042975; GO:0045202; GO:0050821; GO:0098556; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1901796; GO:1901798; GO:1990948; GO:2000059; GO:2000435 cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202] 5S rRNA binding [GO:0008097]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] g10923.t1 Q3USS3 49.161 775 0.0 680.0 sp|Q3USS3|DRC1_MOUSE Dynein regulatory complex protein 1 OS=Mus musculus OX=10090 GN=Drc1 PE=1 SV=1 DRC1_MOUSE reviewed Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164) Mus musculus (Mouse) GO:0003352; GO:0005829; GO:0005858; GO:0005929; GO:0005930; GO:0007338; GO:0007368; GO:0007507; GO:0035082; GO:0036126; GO:0044782; GO:0060285; GO:0065003; GO:0070286; GO:0120316 axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium organization [GO:0044782]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein-containing complex assembly [GO:0065003]; regulation of cilium movement [GO:0003352]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; sperm flagellum [GO:0036126] g10924.t1 Q9NV58 53.125 672 0.0 642.0 sp|Q9NV58|RN19A_HUMAN E3 ubiquitin-protein ligase RNF19A OS=Homo sapiens OX=9606 GN=RNF19A PE=1 SV=3 RN19A_HUMAN reviewed E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38) Homo sapiens (Human) GO:0000151; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016020; GO:0016567; GO:0031624; GO:0061630 microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g10925.t1 P0CT24 37.736 159 2.5200000000000004e-21 97.8 sp|P0CT24|GLU2B_MYCMD Glucosidase 2 subunit beta OS=Mycosarcoma maydis OX=5270 GN=UMAG_12045 PE=3 SV=1 g10928.t1 Q9YHT1 77.638 635 0.0 1034.0 sp|Q9YHT1|SDHA_CHICK Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial OS=Gallus gallus OX=9031 GN=SDHA PE=1 SV=2 g10930.t1 Q95V11 77.368 623 0.0 1028.0 sp|Q95V11|CMAH_ASTRU Cytidine monophosphate-N-acetylneuraminic acid hydroxylase OS=Asterias rubens OX=7604 GN=cnh PE=1 SV=1 CMAH_ASTRU reviewed Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminic acid hydroxylase) (EC 1.14.18.2) (CMP-N-acetylneuraminate monooxygenase) (CMP-Neu5Ac hydroxylase) (CMP-NeuAc hydroxylase) Asterias rubens (Common European starfish) (Asterias vulgaris) GO:0005737; GO:0006054; GO:0016020; GO:0030338; GO:0046381; GO:0046872; GO:0051537 CMP-N-acetylneuraminate metabolic process [GO:0046381]; N-acetylneuraminate metabolic process [GO:0006054] cytoplasm [GO:0005737]; membrane [GO:0016020] 2 iron, 2 sulfur cluster binding [GO:0051537]; CMP-N-acetylneuraminate monooxygenase activity [GO:0030338]; metal ion binding [GO:0046872] g10935.t1 Q8BK06 46.073 382 8.360000000000001e-110 337.0 sp|Q8BK06|FBX9_MOUSE F-box only protein 9 OS=Mus musculus OX=10090 GN=Fbxo9 PE=1 SV=1 FBX9_MOUSE reviewed F-box only protein 9 Mus musculus (Mouse) GO:0005737; GO:0006915; GO:0016567; GO:0019005; GO:0031146; GO:0032006; GO:0043161; GO:0045087; GO:0045444; GO:0070936; GO:1904037; GO:1990756 apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; positive regulation of epithelial cell apoptotic process [GO:1904037]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g10937.t1 P36241 77.551 196 4.85e-100 290.0 sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2 g10940.t1 Q58D08 38.636 264 1.06e-65 210.0 sp|Q58D08|P5CR3_BOVIN Pyrroline-5-carboxylate reductase 3 OS=Bos taurus OX=9913 GN=PYCR3 PE=2 SV=1 g10941.t1 Q9JKP8 53.333 90 3.3100000000000004e-26 97.1 sp|Q9JKP8|CHRC1_MOUSE Chromatin accessibility complex protein 1 OS=Mus musculus OX=10090 GN=Chrac1 PE=1 SV=1 g10942.t1 Q3U0M1 40.325 1168 0.0 833.0 sp|Q3U0M1|TPPC9_MOUSE Trafficking protein particle complex subunit 9 OS=Mus musculus OX=10090 GN=Trappc9 PE=1 SV=2 g10943.t1 Q63187 45.238 210 2.8e-48 186.0 sp|Q63187|ELOA1_RAT Elongin-A OS=Rattus norvegicus OX=10116 GN=Eloa PE=1 SV=1 ELOA1_RAT reviewed Elongin-A (EloA) (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3) Rattus norvegicus (Rat) GO:0003690; GO:0006357; GO:0006367; GO:0006368; GO:0008023; GO:0070449; GO:0090734 regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367] elongin complex [GO:0070449]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023] double-stranded DNA binding [GO:0003690] g10944.t1 Q9DBU0 66.047 592 0.0 805.0 sp|Q9DBU0|TM9S1_MOUSE Transmembrane 9 superfamily member 1 OS=Mus musculus OX=10090 GN=Tm9sf1 PE=2 SV=2 g10945.t1 Q5ZJX4 38.636 176 1.3299999999999998e-23 97.4 sp|Q5ZJX4|RBM38_CHICK RNA-binding protein 38 OS=Gallus gallus OX=9031 GN=RBM38 PE=2 SV=1 g10946.t1 Q01518 40.919 479 8.81e-111 339.0 sp|Q01518|CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens OX=9606 GN=CAP1 PE=1 SV=5 CAP1_HUMAN reviewed Adenylyl cyclase-associated protein 1 (CAP 1) Homo sapiens (Human) GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005737; GO:0005886; GO:0005925; GO:0006898; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0019933; GO:0030864; GO:0035578; GO:0070062; GO:0098793; GO:0098794; GO:0098885; GO:0098978 actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; modification of postsynaptic actin cytoskeleton [GO:0098885]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179] g10947.t1 P52784 60.0 765 0.0 957.0 sp|P52784|PFKAM_CANLF ATP-dependent 6-phosphofructokinase, muscle type OS=Canis lupus familiaris OX=9615 GN=PFKM PE=2 SV=2 g10947.t2 P52034 63.612 753 0.0 966.0 sp|P52034|PFKA_DROME ATP-dependent 6-phosphofructokinase OS=Drosophila melanogaster OX=7227 GN=Pfk PE=2 SV=2 g10947.t2 P52034 32.692 312 2.11e-26 119.0 sp|P52034|PFKA_DROME ATP-dependent 6-phosphofructokinase OS=Drosophila melanogaster OX=7227 GN=Pfk PE=2 SV=2 g10948.t1 Q5W0Q7 27.93 512 1.7699999999999998e-41 169.0 sp|Q5W0Q7|USPL1_HUMAN SUMO-specific isopeptidase USPL1 OS=Homo sapiens OX=9606 GN=USPL1 PE=1 SV=1 USPL1_HUMAN reviewed SUMO-specific isopeptidase USPL1 (EC 3.4.22.-) (Ubiquitin-specific peptidase-like protein 1) (USP-like 1) Homo sapiens (Human) GO:0005615; GO:0006508; GO:0008283; GO:0009301; GO:0015030; GO:0016926; GO:0016929; GO:0030576; GO:0032183 Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508]; snRNA transcription [GO:0009301] Cajal body [GO:0015030]; extracellular space [GO:0005615] deSUMOylase activity [GO:0016929]; SUMO binding [GO:0032183] g10949.t1 Q8BI55 51.977 531 0.0 576.0 sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus OX=10090 GN=Dyrk4 PE=2 SV=1 DYRK4_MOUSE reviewed Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1) Mus musculus (Mouse) GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0046872; GO:0106310 cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g10949.t2 Q8BI55 56.739 460 0.0 575.0 sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus OX=10090 GN=Dyrk4 PE=2 SV=1 DYRK4_MOUSE reviewed Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1) Mus musculus (Mouse) GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0046872; GO:0106310 cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g10950.t1 P07858 53.799 329 9.57e-123 358.0 sp|P07858|CATB_HUMAN Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3 CATB_HUMAN reviewed Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Homo sapiens (Human) GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0031012; GO:0036021; GO:0042470; GO:0042981; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0070062; GO:0097067; GO:1904090; GO:1904813 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394] g10952.t1 P28480 70.872 539 0.0 769.0 sp|P28480|TCPA_RAT T-complex protein 1 subunit alpha OS=Rattus norvegicus OX=10116 GN=Tcp1 PE=1 SV=1 TCPA_RAT reviewed T-complex protein 1 subunit alpha (TCP-1-alpha) (EC 3.6.1.-) (CCT-alpha) Rattus norvegicus (Rat) GO:0000242; GO:0000792; GO:0001669; GO:0002199; GO:0005524; GO:0005794; GO:0005813; GO:0005815; GO:0005832; GO:0005874; GO:0006457; GO:0007286; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044183; GO:0044297; GO:0046872; GO:0050821; GO:0051082; GO:0090666; GO:0140662; GO:1904851; GO:1904874 binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] g10953.t1 O53561 34.118 255 1.04e-35 132.0 sp|O53561|ECH19_MYCTU Enoyl-CoA hydratase EchA19 OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=echA19 PE=1 SV=2 g10954.t1 A4IH82 55.118 254 1.54e-83 265.0 sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1 g10955.t1 A2VE56 44.776 134 1.75e-37 147.0 sp|A2VE56|P20L1_BOVIN PHD finger protein 20-like protein 1 OS=Bos taurus OX=9913 GN=PHF20L1 PE=2 SV=1 g10955.t2 A2VE56 44.776 134 1.71e-37 147.0 sp|A2VE56|P20L1_BOVIN PHD finger protein 20-like protein 1 OS=Bos taurus OX=9913 GN=PHF20L1 PE=2 SV=1 g10958.t1 Q12797 54.028 422 1.0099999999999999e-165 511.0 sp|Q12797|ASPH_HUMAN Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens OX=9606 GN=ASPH PE=1 SV=3 g10959.t1 Q8K430 39.324 562 7.98e-135 409.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g10960.t1 D3YYI7 38.567 293 7.43e-74 246.0 sp|D3YYI7|RN217_MOUSE E3 ubiquitin-protein ligase RNF217 OS=Mus musculus OX=10090 GN=Rnf217 PE=1 SV=2 RN217_MOUSE reviewed E3 ubiquitin-protein ligase RNF217 (EC 2.3.2.31) (IBR domain-containing protein 1) (RING finger protein 217) Mus musculus (Mouse) GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016020; GO:0016567; GO:0031624; GO:0061630 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g10962.t1 Q9M0G0 35.752 565 1.71e-98 317.0 sp|Q9M0G0|GAGT3_ARATH Glutathione hydrolase 3 OS=Arabidopsis thaliana OX=3702 GN=GGT3 PE=2 SV=1 GAGT3_ARATH reviewed Glutathione hydrolase 3 (EC 3.4.19.13) (Gamma-glutamyltransferase 3) (Gamma-glutamyltranspeptidase 3) (EC 2.3.2.2) (Gamma-glutamyltranspeptidase 4) Arabidopsis thaliana (Mouse-ear cress) GO:0005773; GO:0005774; GO:0005886; GO:0006751; GO:0006805; GO:0009636; GO:0016756; GO:0036374; GO:0103068 glutathione catabolic process [GO:0006751]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773] glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068] g10962.t2 Q9M0G0 35.752 565 1.15e-98 317.0 sp|Q9M0G0|GAGT3_ARATH Glutathione hydrolase 3 OS=Arabidopsis thaliana OX=3702 GN=GGT3 PE=2 SV=1 GAGT3_ARATH reviewed Glutathione hydrolase 3 (EC 3.4.19.13) (Gamma-glutamyltransferase 3) (Gamma-glutamyltranspeptidase 3) (EC 2.3.2.2) (Gamma-glutamyltranspeptidase 4) Arabidopsis thaliana (Mouse-ear cress) GO:0005773; GO:0005774; GO:0005886; GO:0006751; GO:0006805; GO:0009636; GO:0016756; GO:0036374; GO:0103068 glutathione catabolic process [GO:0006751]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773] glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068] g10964.t1 P25977 32.862 636 2.5000000000000002e-107 350.0 sp|P25977|UBF1_RAT Nucleolar transcription factor 1 OS=Rattus norvegicus OX=10116 GN=Ubtf PE=1 SV=1 g10965.t1 Q1L8F9 42.5 440 2.91e-108 331.0 sp|Q1L8F9|KICS2_DANRE KICSTOR subunit 2 OS=Danio rerio OX=7955 GN=kics2 PE=2 SV=2 KICS2_DANRE reviewed KICSTOR subunit 2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0034198; GO:0042149; GO:0044782; GO:0061462; GO:0140007; GO:1903432; GO:1904262 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cilium organization [GO:0044782]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]; regulation of TORC1 signaling [GO:1903432] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765] g10965.t2 Q1L8F9 41.834 447 1.89e-105 324.0 sp|Q1L8F9|KICS2_DANRE KICSTOR subunit 2 OS=Danio rerio OX=7955 GN=kics2 PE=2 SV=2 KICS2_DANRE reviewed KICSTOR subunit 2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005765; GO:0034198; GO:0042149; GO:0044782; GO:0061462; GO:0140007; GO:1903432; GO:1904262 cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cilium organization [GO:0044782]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462]; regulation of TORC1 signaling [GO:1903432] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765] g10966.t1 Q6PAC3 70.112 445 0.0 690.0 sp|Q6PAC3|DCA13_MOUSE DDB1- and CUL4-associated factor 13 OS=Mus musculus OX=10090 GN=Dcaf13 PE=1 SV=2 DCA13_MOUSE reviewed DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1) Mus musculus (Mouse) GO:0000462; GO:0001555; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006364; GO:0007056; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0043161; GO:0044725; GO:0046697; GO:0051898; GO:0080008; GO:1990756 decidualization [GO:0046697]; epigenetic programming in the zygotic pronuclei [GO:0044725]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; oocyte growth [GO:0001555]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]; spindle assembly involved in female meiosis [GO:0007056] cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] nuclear estrogen receptor binding [GO:0030331]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g10967.t1 Q9EQZ7 46.316 665 1.06e-141 484.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t1 Q9EQZ7 50.673 446 1.14e-100 362.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t1 Q9EQZ7 41.753 194 3.53e-32 141.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t2 Q9EQZ7 47.489 657 2.03e-143 488.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t2 Q9EQZ7 50.673 446 8.36e-101 362.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t2 Q9EQZ7 44.505 182 5.43e-35 150.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t3 Q9EQZ7 46.316 665 1.17e-141 483.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t3 Q9EQZ7 50.673 446 1.21e-100 361.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t3 Q9EQZ7 44.505 182 7.670000000000001e-35 150.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t4 Q9EQZ7 46.316 665 9.27e-142 484.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t4 Q9EQZ7 50.673 446 1.16e-100 362.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t4 Q9EQZ7 44.505 182 7.63e-35 150.0 sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1 RIMS2_MOUSE reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 2) Mus musculus (Mouse) GO:0006886; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0043005; GO:0044325; GO:0044877; GO:0048791; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10967.t5 Q9JIS1 56.09 312 4.7e-98 319.0 sp|Q9JIS1|RIMS2_RAT Regulating synaptic membrane exocytosis protein 2 OS=Rattus norvegicus OX=10116 GN=Rims2 PE=1 SV=1 RIMS2_RAT reviewed Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) Rattus norvegicus (Rat) GO:0006886; GO:0006887; GO:0007188; GO:0007269; GO:0008270; GO:0010628; GO:0016081; GO:0016082; GO:0017156; GO:0017157; GO:0019904; GO:0030073; GO:0030154; GO:0030674; GO:0031267; GO:0032991; GO:0042391; GO:0042734; GO:0044325; GO:0044877; GO:0048791; GO:0051649; GO:0060077; GO:0061669; GO:0097151; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0150037; GO:1903861; GO:2000300; GO:2000463 adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g10968.t1 Q99470 62.147 177 3.5e-81 244.0 sp|Q99470|SDF2_HUMAN Stromal cell-derived factor 2 OS=Homo sapiens OX=9606 GN=SDF2 PE=1 SV=2 g10969.t1 Q8N0Z2 49.333 150 1.9e-33 124.0 sp|Q8N0Z2|ABRA_HUMAN Actin-binding Rho-activating protein OS=Homo sapiens OX=9606 GN=ABRA PE=1 SV=1 g10970.t1 Q6IRN6 35.992 489 9.83e-85 312.0 sp|Q6IRN6|CAMP1_XENLA Calmodulin-regulated spectrin-associated protein 1 OS=Xenopus laevis OX=8355 GN=camsap1 PE=2 SV=1 g10970.t1 Q6IRN6 56.618 136 3.37e-41 171.0 sp|Q6IRN6|CAMP1_XENLA Calmodulin-regulated spectrin-associated protein 1 OS=Xenopus laevis OX=8355 GN=camsap1 PE=2 SV=1 g10970.t2 Q6IRN6 35.992 489 8.34e-85 312.0 sp|Q6IRN6|CAMP1_XENLA Calmodulin-regulated spectrin-associated protein 1 OS=Xenopus laevis OX=8355 GN=camsap1 PE=2 SV=1 g10970.t2 Q6IRN6 56.618 136 3.19e-41 171.0 sp|Q6IRN6|CAMP1_XENLA Calmodulin-regulated spectrin-associated protein 1 OS=Xenopus laevis OX=8355 GN=camsap1 PE=2 SV=1 g10971.t1 O01761 26.667 495 7.22e-34 140.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 25.447 503 1.2600000000000001e-29 127.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 24.701 502 2.25e-28 123.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 24.66 515 4.5100000000000004e-26 116.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 23.819 487 1.48e-23 108.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 24.242 462 6.89e-23 106.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 24.458 507 9.43e-23 106.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 26.004 473 3.23e-22 104.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10971.t1 O01761 23.504 468 9.23e-21 100.0 sp|O01761|UNC89_CAEEL Muscle M-line assembly protein unc-89 OS=Caenorhabditis elegans OX=6239 GN=unc-89 PE=1 SV=3 g10972.t1 Q23551 36.511 3577 0.0 2140.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 37.287 1231 0.0 741.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 32.116 1588 0.0 734.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 39.05 1137 0.0 731.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 31.755 1499 3.94e-165 583.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 35.663 830 3.15e-124 448.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 36.051 785 2.53e-120 435.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 34.691 614 1.1100000000000001e-85 320.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 23.878 2006 7.33e-83 311.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 27.482 1128 1.89e-72 277.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 29.236 838 4.8299999999999995e-68 262.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 25.919 1007 3.63e-65 253.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 28.065 677 3.0400000000000004e-57 226.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 27.509 538 1.34e-36 158.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 26.85 581 3.82e-36 157.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 28.659 492 7.75e-34 149.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t1 Q23551 26.426 526 3.0800000000000004e-32 144.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 35.395 3848 0.0 2145.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 37.287 1231 0.0 741.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 32.116 1588 0.0 733.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 39.05 1137 0.0 731.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 31.755 1499 4.92e-165 583.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 35.663 830 5.6600000000000005e-124 447.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 36.051 785 3.63e-120 435.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 34.691 614 1.78e-85 320.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 23.878 2006 1.5799999999999998e-82 310.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 27.577 1135 3.56e-72 276.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 29.236 838 9.25e-68 261.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 25.919 1007 1.04e-64 251.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 28.065 677 6.69e-57 225.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 27.509 538 1.3e-36 158.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 26.85 581 6.07e-36 156.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 28.659 492 6.53e-34 149.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t2 Q23551 26.426 526 5.03e-32 143.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 35.395 3848 0.0 2145.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 37.287 1231 0.0 741.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 32.116 1588 0.0 733.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 39.05 1137 0.0 731.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 31.755 1499 6.33e-165 583.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 35.663 830 5.94e-124 447.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 36.051 785 3.71e-120 435.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 34.691 614 1.82e-85 320.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 23.878 2006 1.5799999999999998e-82 310.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 27.482 1128 4.3400000000000004e-72 276.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 29.236 838 1.0699999999999999e-67 261.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 25.919 1007 1.06e-64 251.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 28.065 677 7.06e-57 225.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 27.509 538 1.35e-36 158.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 26.85 581 6.2e-36 156.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 28.659 492 6.45e-34 149.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t3 Q23551 26.426 526 5.49e-32 143.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 36.838 3529 0.0 2143.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 37.287 1231 0.0 741.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 32.116 1588 0.0 733.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 39.05 1137 0.0 731.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 31.755 1499 9.71e-165 582.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 35.663 830 8.850000000000001e-124 447.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 36.051 785 5.17e-120 434.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 34.691 614 2.41e-85 320.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 23.713 2020 6.36e-81 305.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 27.482 1128 6.460000000000001e-72 275.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 29.236 838 1.3799999999999999e-67 261.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 25.919 1007 1.4600000000000001e-64 251.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 28.065 677 8.17e-57 225.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 27.509 538 1.7e-36 158.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 26.85 581 7.420000000000001e-36 155.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 28.659 492 7.91e-34 149.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10972.t4 Q23551 26.426 526 6.56e-32 142.0 sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans OX=6239 GN=unc-22 PE=1 SV=3 UNC22_CAEEL reviewed Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) Caenorhabditis elegans GO:0004674; GO:0005516; GO:0005524; GO:0008344; GO:0019899; GO:0031430; GO:0031672; GO:0040017; GO:0045214; GO:0045989; GO:0046872; GO:0051782; GO:0060298; GO:0106310 adult locomotory behavior [GO:0008344]; negative regulation of cell division [GO:0051782]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214] A band [GO:0031672]; M band [GO:0031430] ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10973.t1 Q9NQL2 73.171 369 0.0 555.0 sp|Q9NQL2|RRAGD_HUMAN Ras-related GTP-binding protein D OS=Homo sapiens OX=9606 GN=RRAGD PE=1 SV=1 g10974.t1 Q69ZZ6 40.033 602 1.5599999999999999e-108 345.0 sp|Q69ZZ6|TMCC1_MOUSE Transmembrane and coiled-coil domains protein 1 OS=Mus musculus OX=10090 GN=Tmcc1 PE=1 SV=2 TMCC1_MOUSE reviewed Transmembrane and coiled-coil domains protein 1 Mus musculus (Mouse) GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285 endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; rough endoplasmic reticulum [GO:0005791] identical protein binding [GO:0042802] g10974.t2 O94876 38.387 620 1.75e-108 345.0 sp|O94876|TMCC1_HUMAN Transmembrane and coiled-coil domains protein 1 OS=Homo sapiens OX=9606 GN=TMCC1 PE=1 SV=3 TMCC1_HUMAN reviewed Transmembrane and coiled-coil domains protein 1 Homo sapiens (Human) GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285 endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; rough endoplasmic reticulum [GO:0005791] identical protein binding [GO:0042802] g10974.t3 O94876 38.843 605 2.18e-101 325.0 sp|O94876|TMCC1_HUMAN Transmembrane and coiled-coil domains protein 1 OS=Homo sapiens OX=9606 GN=TMCC1 PE=1 SV=3 TMCC1_HUMAN reviewed Transmembrane and coiled-coil domains protein 1 Homo sapiens (Human) GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285 endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; rough endoplasmic reticulum [GO:0005791] identical protein binding [GO:0042802] g10976.t1 O43909 42.363 838 0.0 667.0 sp|O43909|EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens OX=9606 GN=EXTL3 PE=1 SV=1 EXTL3_HUMAN reviewed Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3) Homo sapiens (Human) GO:0000139; GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0010838; GO:0015012; GO:0016500; GO:0016757; GO:0019805; GO:0030307; GO:0032496; GO:0045617; GO:0051897; GO:0106015; GO:1900016; GO:2000972 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; quinolinate biosynthetic process [GO:0019805]; response to lipopolysaccharide [GO:0032496] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886] glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500] g10977.t1 O43909 51.429 945 0.0 924.0 sp|O43909|EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens OX=9606 GN=EXTL3 PE=1 SV=1 EXTL3_HUMAN reviewed Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3) Homo sapiens (Human) GO:0000139; GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0010838; GO:0015012; GO:0016500; GO:0016757; GO:0019805; GO:0030307; GO:0032496; GO:0045617; GO:0051897; GO:0106015; GO:1900016; GO:2000972 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; quinolinate biosynthetic process [GO:0019805]; response to lipopolysaccharide [GO:0032496] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886] glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500] g10978.t1 B7ZCC9 27.642 738 5.22e-60 232.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10979.t1 Q9Z0U4 36.521 753 1.6299999999999999e-152 473.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 g10982.t1 Q91W86 58.997 917 0.0 1112.0 sp|Q91W86|VPS11_MOUSE Vacuolar protein sorting-associated protein 11 homolog OS=Mus musculus OX=10090 GN=Vps11 PE=1 SV=3 VPS11_MOUSE reviewed Vacuolar protein sorting-associated protein 11 homolog Mus musculus (Mouse) GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008270; GO:0008333; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0045732; GO:0048284; GO:0048786; GO:0061630; GO:1902115; GO:2000643 autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904] actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynaptic active zone [GO:0048786] nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g10984.t1 A9JS71 64.94 251 8.330000000000001e-123 357.0 sp|A9JS71|ECHD3_XENLA Enoyl-CoA hydratase domain-containing protein 3, mitochondrial OS=Xenopus laevis OX=8355 GN=echdc3 PE=2 SV=1 g10984.t2 A9JS71 64.94 251 7.110000000000001e-123 357.0 sp|A9JS71|ECHD3_XENLA Enoyl-CoA hydratase domain-containing protein 3, mitochondrial OS=Xenopus laevis OX=8355 GN=echdc3 PE=2 SV=1 g10986.t1 O35491 69.591 342 1.73e-180 521.0 sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus OX=10090 GN=Clk2 PE=1 SV=2 CLK2_MOUSE reviewed Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) Mus musculus (Mouse) GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0032526; GO:0042802; GO:0043484; GO:0045721; GO:0046777; GO:0106310 negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] g10987.t1 Q2YDE7 62.937 143 7.01e-61 190.0 sp|Q2YDE7|ARCH_BOVIN Protein archease OS=Bos taurus OX=9913 GN=ZBTB8OS PE=2 SV=2 g10993.t1 P46023 43.853 1090 0.0 831.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g10995.t1 P30372 29.605 456 7.76e-64 217.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g10996.t1 Q9QXF7 37.5 504 4.3799999999999996e-114 348.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g10997.t1 A2RT67 30.74 1324 0.0 584.0 sp|A2RT67|DEND3_MOUSE DENN domain-containing protein 3 OS=Mus musculus OX=10090 GN=Dennd3 PE=1 SV=2 DEND3_MOUSE reviewed DENN domain-containing protein 3 Mus musculus (Mouse) GO:0005085; GO:0008333; GO:0030163; GO:0031410; GO:0032483 endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410] guanyl-nucleotide exchange factor activity [GO:0005085] g11000.t1 P44849 26.546 388 1.8199999999999999e-34 139.0 sp|P44849|Y736_HAEIN Uncharacterized sodium-dependent transporter HI_0736 OS=Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) OX=71421 GN=HI_0736 PE=3 SV=1 g11001.t1 Q8NIW7 47.633 338 3.8099999999999996e-94 310.0 sp|Q8NIW7|BBP_NEUCR Branchpoint-bridging protein OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=bbp-1 PE=3 SV=1 g11001.t2 Q8NIW7 47.633 338 1.4e-94 310.0 sp|Q8NIW7|BBP_NEUCR Branchpoint-bridging protein OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=bbp-1 PE=3 SV=1 g11002.t1 Q6ZMS4 31.412 347 9.52e-49 181.0 sp|Q6ZMS4|ZN852_HUMAN Zinc finger protein 852 OS=Homo sapiens OX=9606 GN=ZNF852 PE=1 SV=4 g11002.t1 Q6ZMS4 32.883 222 6.569999999999999e-34 139.0 sp|Q6ZMS4|ZN852_HUMAN Zinc finger protein 852 OS=Homo sapiens OX=9606 GN=ZNF852 PE=1 SV=4 g11002.t1 Q6ZMS4 33.333 195 1.0400000000000002e-27 120.0 sp|Q6ZMS4|ZN852_HUMAN Zinc finger protein 852 OS=Homo sapiens OX=9606 GN=ZNF852 PE=1 SV=4 g11003.t1 Q7Z7K0 63.265 98 1.73e-38 128.0 sp|Q7Z7K0|COXM1_HUMAN COX assembly mitochondrial protein homolog OS=Homo sapiens OX=9606 GN=CMC1 PE=1 SV=1 COXM1_HUMAN reviewed COX assembly mitochondrial protein homolog (Cmc1p) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0046872 mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] metal ion binding [GO:0046872] g11004.t1 Q92783 46.796 515 2.0000000000000001e-143 428.0 sp|Q92783|STAM1_HUMAN Signal transducing adapter molecule 1 OS=Homo sapiens OX=9606 GN=STAM PE=1 SV=3 STAM1_HUMAN reviewed Signal transducing adapter molecule 1 (STAM-1) Homo sapiens (Human) GO:0005829; GO:0007165; GO:0016236; GO:0031901; GO:0033565; GO:0035091; GO:0036258; GO:0043130; GO:0043328; GO:0044389; GO:0090148; GO:1903543; GO:1903551 macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565] phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389] g11005.t1 Q7ZV80 49.789 237 4.6200000000000005e-65 205.0 sp|Q7ZV80|SPF30_DANRE Survival of motor neuron-related-splicing factor 30 OS=Danio rerio OX=7955 GN=smndc1 PE=2 SV=1 g11006.t1 Q9CZE3 67.757 214 2.37e-106 308.0 sp|Q9CZE3|RAB32_MOUSE Ras-related protein Rab-32 OS=Mus musculus OX=10090 GN=Rab32 PE=1 SV=3 RAB32_MOUSE reviewed Ras-related protein Rab-32 (EC 3.6.5.2) Mus musculus (Mouse) GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0006886; GO:0007005; GO:0012505; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0046872; GO:0072657; GO:0090382; GO:1903232 antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192] early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802] AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g11007.t1 Q9D3B1 59.735 226 5.06e-98 289.0 sp|Q9D3B1|HACD2_MOUSE Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 OS=Mus musculus OX=10090 GN=Hacd2 PE=1 SV=1 HACD2_MOUSE reviewed Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0042761; GO:0102158 fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158] g11008.t1 Q6A4L1 46.866 702 0.0 605.0 sp|Q6A4L1|S12A8_XENLA Solute carrier family 12 member 8 OS=Xenopus laevis OX=8355 GN=slc12a8 PE=2 SV=1 g11008.t2 Q6A4L1 47.571 700 0.0 609.0 sp|Q6A4L1|S12A8_XENLA Solute carrier family 12 member 8 OS=Xenopus laevis OX=8355 GN=slc12a8 PE=2 SV=1 g11009.t1 Q4H4B6 60.795 528 0.0 593.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g11009.t1 Q4H4B6 48.998 549 6.75e-148 501.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g11009.t2 Q4H4B6 60.795 528 0.0 594.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g11009.t2 Q4H4B6 49.346 535 4.44e-146 495.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g11009.t3 Q4H4B6 60.795 528 0.0 593.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g11009.t3 Q4H4B6 48.998 549 2.28e-148 501.0 sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1 SCRIB_DANRE reviewed Protein scribble homolog (Scribble1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887 activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901] g11010.t1 J9VHE9 41.325 317 1.62e-65 214.0 sp|J9VHE9|UHRF1_CRYNH UHRF1-like protein OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=UHF1 PE=3 SV=2 g11012.t1 O60318 27.183 1214 6.049999999999999e-98 346.0 sp|O60318|GANP_HUMAN Germinal-center associated nuclear protein OS=Homo sapiens OX=9606 GN=MCM3AP PE=1 SV=2 g11012.t2 O60318 27.325 1215 2.05e-98 347.0 sp|O60318|GANP_HUMAN Germinal-center associated nuclear protein OS=Homo sapiens OX=9606 GN=MCM3AP PE=1 SV=2 g11013.t1 E9Q7T7 28.107 338 4.3699999999999995e-30 126.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g11013.t1 E9Q7T7 26.647 334 4.7399999999999997e-23 105.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g11014.t1 E9Q7T7 32.258 217 1.24e-24 108.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g11014.t2 Q6NUI6 32.719 217 3.23e-25 108.0 sp|Q6NUI6|CHADL_HUMAN Chondroadherin-like protein OS=Homo sapiens OX=9606 GN=CHADL PE=1 SV=2 CHADL_HUMAN reviewed Chondroadherin-like protein Homo sapiens (Human) GO:0005518; GO:0005576; GO:0030021; GO:0031012; GO:0032331; GO:0038023; GO:0098633; GO:1904027 negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of collagen fibril organization [GO:1904027] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; signaling receptor activity [GO:0038023] g11014.t3 E9Q7T7 32.258 217 1.81e-23 108.0 sp|E9Q7T7|CHADL_MOUSE Chondroadherin-like protein OS=Mus musculus OX=10090 GN=Chadl PE=1 SV=1 g11015.t1 O94898 31.164 292 3.15e-29 127.0 sp|O94898|LRIG2_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 2 OS=Homo sapiens OX=9606 GN=LRIG2 PE=1 SV=3 LRIG2_HUMAN reviewed Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2) Homo sapiens (Human) GO:0005102; GO:0005737; GO:0005886; GO:0006509; GO:0007605; GO:0010640; GO:0030426; GO:0034394; GO:0038023; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222 innervation [GO:0060384]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886] signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102] g11016.t1 Q9WUU9 43.25 400 4.57e-88 313.0 sp|Q9WUU9|GANP_MOUSE Germinal-center associated nuclear protein OS=Mus musculus OX=10090 GN=Mcm3ap PE=1 SV=2 GANP_MOUSE reviewed Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase) Mus musculus (Mouse) GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390 mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H3 acetyltransferase activity [GO:0010484]; nucleic acid binding [GO:0003676] g11017.t1 B0JZG0 48.739 595 0.0 582.0 sp|B0JZG0|S23A2_XENTR Solute carrier family 23 member 2 OS=Xenopus tropicalis OX=8364 GN=slc23a2 PE=2 SV=1 g11018.t1 P22124 66.834 199 1.76e-89 263.0 sp|P22124|RAL_DIPOM Ras-related protein O-RAL OS=Diplobatis ommata OX=1870830 PE=2 SV=1 g11019.t1 Q99PI5 39.511 696 1.3300000000000001e-132 425.0 sp|Q99PI5|LPIN2_MOUSE Phosphatidate phosphatase LPIN2 OS=Mus musculus OX=10090 GN=Lpin2 PE=1 SV=2 LPIN2_MOUSE reviewed Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944 cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] g11019.t1 Q99PI5 62.963 108 2.52e-32 139.0 sp|Q99PI5|LPIN2_MOUSE Phosphatidate phosphatase LPIN2 OS=Mus musculus OX=10090 GN=Lpin2 PE=1 SV=2 LPIN2_MOUSE reviewed Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944 cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] g11019.t2 Q99PI5 44.712 539 4.43e-131 421.0 sp|Q99PI5|LPIN2_MOUSE Phosphatidate phosphatase LPIN2 OS=Mus musculus OX=10090 GN=Lpin2 PE=1 SV=2 LPIN2_MOUSE reviewed Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944 cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] g11019.t2 Q99PI5 62.963 108 2.78e-32 139.0 sp|Q99PI5|LPIN2_MOUSE Phosphatidate phosphatase LPIN2 OS=Mus musculus OX=10090 GN=Lpin2 PE=1 SV=2 LPIN2_MOUSE reviewed Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2) Mus musculus (Mouse) GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944 cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] g11023.t1 Q6NV12 37.52 629 7.440000000000001e-124 382.0 sp|Q6NV12|S20AA_DANRE Sodium-dependent phosphate transporter 1-A OS=Danio rerio OX=7955 GN=slc20a1a PE=2 SV=1 g11024.t1 Q9JJP0 37.838 666 7.98e-138 418.0 sp|Q9JJP0|S20A1_RAT Sodium-dependent phosphate transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc20a1 PE=1 SV=1 g11025.t1 Q9NL40 71.337 778 0.0 1065.0 sp|Q9NL40|TBR1_PATPE T-box protein 1 OS=Patiria pectinifera OX=7594 GN=tbr1 PE=2 SV=1 g11027.t1 P0C862 32.4 250 3.04e-25 105.0 sp|P0C862|C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A OS=Homo sapiens OX=9606 GN=C1QTNF9 PE=1 SV=1 g11029.t1 Q5I0X7 42.742 124 6.57e-23 90.9 sp|Q5I0X7|TTC32_HUMAN Tetratricopeptide repeat protein 32 OS=Homo sapiens OX=9606 GN=TTC32 PE=1 SV=1 g11035.t1 Q96LR7 39.456 147 2.04e-26 100.0 sp|Q96LR7|CMIP5_HUMAN Ciliary microtubule inner protein 5 OS=Homo sapiens OX=9606 GN=CIMIP5 PE=1 SV=1 g11038.t1 A6N6J5 70.524 1184 0.0 1782.0 sp|A6N6J5|WDR35_RAT WD repeat-containing protein 35 OS=Rattus norvegicus OX=10116 GN=Wdr35 PE=1 SV=1 WDR35_RAT reviewed WD repeat-containing protein 35 (Naofen) Rattus norvegicus (Rat) GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0045019; GO:0045907; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0071466; GO:0090200; GO:0097421; GO:1990830; GO:2001238 cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; intraciliary transport particle A [GO:0030991] g11039.t1 P67884 86.239 109 3.34e-66 198.0 sp|P67884|RL30_OPHHA Large ribosomal subunit protein eL30 OS=Ophiophagus hannah OX=8665 GN=RPL30 PE=3 SV=2 g11040.t1 Q9UJT0 64.682 487 0.0 641.0 sp|Q9UJT0|TBE_HUMAN Tubulin epsilon chain OS=Homo sapiens OX=9606 GN=TUBE1 PE=1 SV=1 g11041.t1 Q6IMK3 65.0 260 3.14e-131 375.0 sp|Q6IMK3|DJC27_DANRE DnaJ homolog subfamily C member 27 OS=Danio rerio OX=7955 GN=dnajc27 PE=2 SV=1 g11042.t1 Q0V9A9 59.233 287 1.45e-126 365.0 sp|Q0V9A9|LACB2_XENTR Endoribonuclease LACTB2 OS=Xenopus tropicalis OX=8364 GN=lactb2 PE=2 SV=1 g11043.t1 Q9NY99 42.659 504 2.44e-140 417.0 sp|Q9NY99|SNTG2_HUMAN Gamma-2-syntrophin OS=Homo sapiens OX=9606 GN=SNTG2 PE=1 SV=2 SNTG2_HUMAN reviewed Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005654; GO:0005856; GO:0005886; GO:0007417; GO:0016010; GO:0016013; GO:0030165; GO:0042383; GO:0097109 central nervous system development [GO:0007417] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013] actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] g11046.t1 Q641M3 42.647 136 6.07e-40 134.0 sp|Q641M3|TMM18_DANRE Transmembrane protein 18 OS=Danio rerio OX=7955 GN=tmem18 PE=2 SV=1 g11047.t1 Q9Z1J2 44.074 270 1.4799999999999999e-74 254.0 sp|Q9Z1J2|NEK4_MOUSE Serine/threonine-protein kinase Nek4 OS=Mus musculus OX=10090 GN=Nek4 PE=1 SV=1 NEK4_MOUSE reviewed Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) Mus musculus (Mouse) GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0030145; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:0106310; GO:2000772 cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772] ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829] ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11048.t1 P48147 70.496 705 0.0 1091.0 sp|P48147|PPCE_HUMAN Prolyl endopeptidase OS=Homo sapiens OX=9606 GN=PREP PE=1 SV=2 PPCE_HUMAN reviewed Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Homo sapiens (Human) GO:0002003; GO:0004181; GO:0004252; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012 angiotensin maturation [GO:0002003]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] g11051.t1 Q32P51 36.139 202 2.5600000000000004e-32 125.0 sp|Q32P51|RA1L2_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 2 OS=Homo sapiens OX=9606 GN=HNRNPA1L2 PE=1 SV=2 RA1L2_HUMAN reviewed Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2) Homo sapiens (Human) GO:0000398; GO:0003730; GO:0005737; GO:0051028; GO:0071013 mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737] mRNA 3'-UTR binding [GO:0003730] g11052.t1 A0A2R8Y4L2 40.437 183 2.5599999999999997e-40 146.0 sp|A0A2R8Y4L2|RA1L3_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 3 OS=Homo sapiens OX=9606 GN=HNRNPA1L3 PE=1 SV=2 g11053.t1 P48810 39.894 188 3.1e-29 117.0 sp|P48810|RB87F_DROME Heterogeneous nuclear ribonucleoprotein 87F OS=Drosophila melanogaster OX=7227 GN=Hrb87F PE=2 SV=2 RB87F_DROME reviewed Heterogeneous nuclear ribonucleoprotein 87F (HRP36.1 protein) (Protein P11) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0000381; GO:0000785; GO:0000792; GO:0001745; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0008585; GO:0009408; GO:0034046; GO:0035062; GO:0042594; GO:0043565; GO:0048026; GO:1990904 compound eye morphogenesis [GO:0001745]; female gonad development [GO:0008585]; mitotic cell cycle [GO:0000278]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to heat [GO:0009408]; response to starvation [GO:0042594] chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; sequence-specific DNA binding [GO:0043565] g11053.t2 P48810 40.212 189 7.289999999999999e-30 119.0 sp|P48810|RB87F_DROME Heterogeneous nuclear ribonucleoprotein 87F OS=Drosophila melanogaster OX=7227 GN=Hrb87F PE=2 SV=2 RB87F_DROME reviewed Heterogeneous nuclear ribonucleoprotein 87F (HRP36.1 protein) (Protein P11) Drosophila melanogaster (Fruit fly) GO:0000278; GO:0000381; GO:0000785; GO:0000792; GO:0001745; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0008585; GO:0009408; GO:0034046; GO:0035062; GO:0042594; GO:0043565; GO:0048026; GO:1990904 compound eye morphogenesis [GO:0001745]; female gonad development [GO:0008585]; mitotic cell cycle [GO:0000278]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to heat [GO:0009408]; response to starvation [GO:0042594] chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; omega speckle [GO:0035062]; polytene chromosome puff [GO:0005703]; ribonucleoprotein complex [GO:1990904] mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; sequence-specific DNA binding [GO:0043565] g11054.t1 Q13151 40.11 182 1.4900000000000002e-32 126.0 sp|Q13151|ROA0_HUMAN Heterogeneous nuclear ribonucleoprotein A0 OS=Homo sapiens OX=9606 GN=HNRNPA0 PE=1 SV=1 g11056.t1 Q5RFR0 37.313 268 8.03e-63 207.0 sp|Q5RFR0|TTPAL_PONAB Alpha-tocopherol transfer protein-like OS=Pongo abelii OX=9601 GN=TTPAL PE=2 SV=1 g11057.t1 Q9QZS6 31.963 219 4.93e-31 120.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g11058.t1 Q9QZS6 33.798 287 4.34e-41 152.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g11059.t1 Q9QZS6 33.798 287 1.0699999999999999e-41 154.0 sp|Q9QZS6|HS3SB_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 OS=Mus musculus OX=10090 GN=Hs3st3b1 PE=2 SV=2 g11060.t1 Q9ESG5 32.27 282 8.67e-52 180.0 sp|Q9ESG5|HS3S1_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Hs3st1 PE=2 SV=1 g11061.t1 Q8IZT8 35.274 292 2.85e-53 185.0 sp|Q8IZT8|HS3S5_HUMAN Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Homo sapiens OX=9606 GN=HS3ST5 PE=1 SV=1 HS3S5_HUMAN reviewed Heparan sulfate glucosamine 3-O-sulfotransferase 5 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5) (3-OST-5) (Heparan sulfate 3-O-sulfotransferase 5) (h3-OST-5) Homo sapiens (Human) GO:0000139; GO:0006477; GO:0008467; GO:0015012; GO:0016020; GO:0046596; GO:0050656; GO:0050819 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase activity [GO:0008467] g11062.t1 Q9ESG5 32.168 286 6.52e-53 185.0 sp|Q9ESG5|HS3S1_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Hs3st1 PE=2 SV=1 g11063.t1 Q8BSL4 37.979 287 4.980000000000001e-56 189.0 sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1 g11064.t1 Q91YT0 83.521 443 0.0 786.0 sp|Q91YT0|NDUV1_MOUSE NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Mus musculus OX=10090 GN=Ndufv1 PE=1 SV=1 NDUV1_MOUSE reviewed NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (NDUFV1) (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0010181; GO:0016491; GO:0042775; GO:0042776; GO:0045271; GO:0046872; GO:0051287; GO:0051539 aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271] 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity [GO:0016491] g11065.t1 Q9JKZ2 46.87 687 0.0 637.0 sp|Q9JKZ2|SC5A3_MOUSE Sodium/myo-inositol cotransporter OS=Mus musculus OX=10090 GN=Slc5a3 PE=1 SV=2 SC5A3_MOUSE reviewed Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) Mus musculus (Mouse) GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0008076; GO:0015459; GO:0015798; GO:0016323; GO:0016324; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1905477 inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] D-glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325] g11065.t2 Q9JKZ2 45.816 729 0.0 647.0 sp|Q9JKZ2|SC5A3_MOUSE Sodium/myo-inositol cotransporter OS=Mus musculus OX=10090 GN=Slc5a3 PE=1 SV=2 SC5A3_MOUSE reviewed Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3) Mus musculus (Mouse) GO:0005367; GO:0005412; GO:0005886; GO:0006020; GO:0007422; GO:0008076; GO:0015459; GO:0015798; GO:0016323; GO:0016324; GO:0043576; GO:0044325; GO:0048471; GO:1903428; GO:1905477 inositol metabolic process [GO:0006020]; myo-inositol transport [GO:0015798]; peripheral nervous system development [GO:0007422]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] D-glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325] g11066.t1 Q66L17 55.978 184 4.1700000000000004e-72 219.0 sp|Q66L17|HDDC2_XENLA 5'-deoxynucleotidase HDDC2 OS=Xenopus laevis OX=8355 GN=hddc2 PE=2 SV=1 g11067.t1 P82928 56.25 128 6.67e-46 152.0 sp|P82928|RT28_BOVIN Small ribosomal subunit protein bS1m OS=Bos taurus OX=9913 GN=MRPS28 PE=1 SV=2 g11070.t1 Q2KIN4 46.959 296 4.58e-72 228.0 sp|Q2KIN4|HEY1_BOVIN Hairy/enhancer-of-split related with YRPW motif protein 1 OS=Bos taurus OX=9913 GN=HEY1 PE=2 SV=1 g11070.t2 Q2KIN4 46.622 296 1.86e-71 226.0 sp|Q2KIN4|HEY1_BOVIN Hairy/enhancer-of-split related with YRPW motif protein 1 OS=Bos taurus OX=9913 GN=HEY1 PE=2 SV=1 g11071.t1 Q6NZL0 31.429 455 6.26e-37 157.0 sp|Q6NZL0|MTCL3_MOUSE Microtubule cross-linking factor 3 OS=Mus musculus OX=10090 GN=Mtcl3 PE=1 SV=2 g11071.t2 Q6NZL0 31.778 450 7.72e-38 159.0 sp|Q6NZL0|MTCL3_MOUSE Microtubule cross-linking factor 3 OS=Mus musculus OX=10090 GN=Mtcl3 PE=1 SV=2 g11071.t3 Q6NZL0 31.778 450 1.41e-37 159.0 sp|Q6NZL0|MTCL3_MOUSE Microtubule cross-linking factor 3 OS=Mus musculus OX=10090 GN=Mtcl3 PE=1 SV=2 g11073.t1 Q9NR82 48.187 579 2.13e-168 514.0 sp|Q9NR82|KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 OS=Homo sapiens OX=9606 GN=KCNQ5 PE=1 SV=3 g11073.t2 Q9NR82 48.168 573 7.48e-168 513.0 sp|Q9NR82|KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 OS=Homo sapiens OX=9606 GN=KCNQ5 PE=1 SV=3 g11073.t3 Q9NR82 48.084 574 2.9e-167 511.0 sp|Q9NR82|KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 OS=Homo sapiens OX=9606 GN=KCNQ5 PE=1 SV=3 g11074.t1 P97494 60.979 633 0.0 804.0 sp|P97494|GSH1_MOUSE Glutamate--cysteine ligase catalytic subunit OS=Mus musculus OX=10090 GN=Gclc PE=1 SV=4 GSH1_MOUSE reviewed Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase) Mus musculus (Mouse) GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237 blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739] ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877] g11075.t1 Q9D361 35.366 246 1.39e-33 131.0 sp|Q9D361|SNR48_MOUSE U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Mus musculus OX=10090 GN=Snrnp48 PE=2 SV=2 g11076.t1 Q8BVE3 59.737 457 0.0 570.0 sp|Q8BVE3|VATH_MOUSE V-type proton ATPase subunit H OS=Mus musculus OX=10090 GN=Atp6v1h PE=1 SV=1 g11077.t1 Q7TQA3 38.462 299 2.12e-69 221.0 sp|Q7TQA3|RDHE2_MOUSE Epidermal retinol dehydrogenase 2 OS=Mus musculus OX=10090 GN=Sdr16c5 PE=2 SV=1 RDHE2_MOUSE reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase reductase 9) (Short-chain dehydrogenase/reductase family 16C member 5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0005886; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g11078.t1 Q8CIC2 30.126 478 2.0200000000000002e-35 139.0 sp|Q8CIC2|NUP42_MOUSE Nucleoporin NUP42 OS=Mus musculus OX=10090 GN=Nup42 PE=2 SV=1 NUP42_MOUSE reviewed Nucleoporin NUP42 (NLP-1) (Nucleoporin-like protein 2) Mus musculus (Mouse) GO:0001750; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0008270; GO:0015031; GO:0031965; GO:0051028 mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; photoreceptor outer segment [GO:0001750] nuclear export signal receptor activity [GO:0005049]; zinc ion binding [GO:0008270] g11079.t1 Q8BK75 46.691 272 4.27e-72 224.0 sp|Q8BK75|ELP6_MOUSE Elongator complex protein 6 OS=Mus musculus OX=10090 GN=Elp6 PE=1 SV=1 ELP6_MOUSE reviewed Elongator complex protein 6 (Protein TMEM103) Mus musculus (Mouse) GO:0002098; GO:0005634; GO:0005829; GO:0006412; GO:0006457; GO:0006914; GO:0006915; GO:0006986; GO:0007626; GO:0010992; GO:0030335; GO:0033554; GO:0033588; GO:0046530; GO:0048877; GO:0050885; GO:0050905; GO:0051402; GO:0060041; GO:0061744; GO:0097352; GO:0141084 apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to stress [GO:0033554]; homeostasis of number of retina cells [GO:0048877]; inflammasome-mediated signaling pathway [GO:0141084]; locomotory behavior [GO:0007626]; motor behavior [GO:0061744]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; photoreceptor cell differentiation [GO:0046530]; positive regulation of cell migration [GO:0030335]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986]; retina development in camera-type eye [GO:0060041]; translation [GO:0006412]; tRNA wobble uridine modification [GO:0002098]; ubiquitin recycling [GO:0010992] cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634] g11080.t1 O76536 28.321 798 3.2300000000000003e-47 188.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 28.656 848 3.2800000000000003e-43 176.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 29.68 657 2.4999999999999997e-42 172.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 28.492 716 1.6e-38 160.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 28.82 746 2.8300000000000003e-37 156.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 28.487 674 1.5300000000000002e-36 154.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 29.091 550 3.2200000000000003e-31 137.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 30.162 494 8.5e-27 122.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11080.t1 O76536 27.215 474 3.28e-25 117.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11081.t1 A4IGK3 63.462 104 5.569999999999999e-38 127.0 sp|A4IGK3|CRBL2_XENTR cAMP-responsive element-binding protein-like 2 OS=Xenopus tropicalis OX=8364 GN=crebl2 PE=3 SV=1 CRBL2_XENTR reviewed cAMP-responsive element-binding protein-like 2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0030154; GO:0045600; GO:0045893; GO:0046326; GO:0046889 cell differentiation [GO:0030154]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] g11082.t1 Q32PP1 47.656 128 1.7500000000000002e-26 114.0 sp|Q32PP1|MRNIP_DANRE MRN complex-interacting protein OS=Danio rerio OX=7955 GN=mrnip PE=2 SV=1 MRNIP_DANRE reviewed MRN complex-interacting protein (MRN-interacting protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682] g11083.t1 Q4R8M9 53.425 73 1.0600000000000001e-21 93.6 sp|Q4R8M9|GTSF1_MACFA Gametocyte-specific factor 1 OS=Macaca fascicularis OX=9541 GN=GTSF1 PE=2 SV=1 g11085.t1 Q8NCE0 45.894 207 5.98e-57 200.0 sp|Q8NCE0|SEN2_HUMAN tRNA-splicing endonuclease subunit Sen2 OS=Homo sapiens OX=9606 GN=TSEN2 PE=1 SV=2 SEN2_HUMAN reviewed tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2) (HsSen2) Homo sapiens (Human) GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006397; GO:0008033 mRNA processing [GO:0006397]; tRNA processing [GO:0008033]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] nucleic acid binding [GO:0003676]; tRNA-intron lyase activity [GO:0000213] g11085.t2 Q8NCE0 32.438 484 7.81e-69 228.0 sp|Q8NCE0|SEN2_HUMAN tRNA-splicing endonuclease subunit Sen2 OS=Homo sapiens OX=9606 GN=TSEN2 PE=1 SV=2 SEN2_HUMAN reviewed tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2) (HsSen2) Homo sapiens (Human) GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006397; GO:0008033 mRNA processing [GO:0006397]; tRNA processing [GO:0008033]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] nucleic acid binding [GO:0003676]; tRNA-intron lyase activity [GO:0000213] g11086.t1 Q9BXW6 45.624 1017 0.0 837.0 sp|Q9BXW6|OSBL1_HUMAN Oxysterol-binding protein-related protein 1 OS=Homo sapiens OX=9606 GN=OSBPL1A PE=1 SV=2 g11087.t1 Q5F3K4 69.175 691 0.0 953.0 sp|Q5F3K4|WDR48_CHICK WD repeat-containing protein 48 OS=Gallus gallus OX=9031 GN=WDR48 PE=2 SV=1 WDR48_CHICK reviewed WD repeat-containing protein 48 (USP1-associated factor 1) Gallus gallus (Chicken) GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007259; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168 cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283] late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634] deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130] g11088.t1 O42224 54.915 590 0.0 686.0 sp|O42224|SMO_CHICK Protein smoothened (Fragment) OS=Gallus gallus OX=9031 GN=SMO PE=2 SV=1 g11089.t1 P69478 36.678 289 4.8799999999999995e-54 184.0 sp|P69478|CHSTB_RAT Carbohydrate sulfotransferase 11 OS=Rattus norvegicus OX=10116 GN=Chst11 PE=1 SV=1 CHSTB_RAT reviewed Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1) Rattus norvegicus (Rat) GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216 carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585] Golgi membrane [GO:0000139] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] g11090.t1 A1ZAX0 29.805 359 2.55e-34 135.0 sp|A1ZAX0|CCH1R_DROME Neuropeptide CCHamide-1 receptor OS=Drosophila melanogaster OX=7227 GN=CCHa1-R PE=2 SV=2 CCH1R_DROME reviewed Neuropeptide CCHamide-1 receptor Drosophila melanogaster (Fruit fly) GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008261; GO:0016020 G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] membrane [GO:0016020]; plasma membrane [GO:0005886] allatostatin receptor activity [GO:0008261]; neuropeptide receptor activity [GO:0008188] g11091.t1 Q9ULU4 54.469 358 1.76e-134 452.0 sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2 g11091.t1 Q9ULU4 37.895 190 1.13e-31 139.0 sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2 g11091.t2 Q9ULU4 54.469 358 2.4e-134 451.0 sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2 g11091.t2 Q9ULU4 37.895 190 1.07e-31 139.0 sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2 g11093.t1 Q6DED0 50.136 369 1.7800000000000002e-124 367.0 sp|Q6DED0|TR1L1_XENLA Translocating chain-associated membrane protein 1-like 1 OS=Xenopus laevis OX=8355 GN=tram1l1 PE=2 SV=1 g11093.t2 Q6DED0 51.397 358 1.47e-125 370.0 sp|Q6DED0|TR1L1_XENLA Translocating chain-associated membrane protein 1-like 1 OS=Xenopus laevis OX=8355 GN=tram1l1 PE=2 SV=1 g11094.t1 Q6PFL6 39.545 220 2.94e-35 127.0 sp|Q6PFL6|CCD43_DANRE Coiled-coil domain-containing protein 43 OS=Danio rerio OX=7955 GN=ccdc43 PE=2 SV=1 g11095.t1 Q5RFZ7 38.095 189 2.09e-26 107.0 sp|Q5RFZ7|F167A_DANRE Protein FAM167A OS=Danio rerio OX=7955 GN=fam167a PE=2 SV=1 g11096.t1 Q91677 51.368 329 3.56e-78 258.0 sp|Q91677|GATA4_XENLA Transcription factor GATA-4 OS=Xenopus laevis OX=8355 GN=gata4 PE=2 SV=1 g11096.t2 Q91677 57.288 295 4.94e-83 270.0 sp|Q91677|GATA4_XENLA Transcription factor GATA-4 OS=Xenopus laevis OX=8355 GN=gata4 PE=2 SV=1 g11096.t3 Q91677 56.902 297 1.76e-83 271.0 sp|Q91677|GATA4_XENLA Transcription factor GATA-4 OS=Xenopus laevis OX=8355 GN=gata4 PE=2 SV=1 g11097.t1 Q32KR6 60.345 406 0.0 518.0 sp|Q32KR6|FDFT_BOVIN Squalene synthase OS=Bos taurus OX=9913 GN=FDFT1 PE=2 SV=1 FDFT_BOVIN reviewed Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase) Bos taurus (Bovine) GO:0005789; GO:0006695; GO:0008299; GO:0045338; GO:0046872; GO:0051996 cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; isoprenoid biosynthetic process [GO:0008299] endoplasmic reticulum membrane [GO:0005789] metal ion binding [GO:0046872]; squalene synthase [NAD(P)H] activity [GO:0051996] g11098.t1 P07858 59.459 74 5.19e-25 98.6 sp|P07858|CATB_HUMAN Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3 CATB_HUMAN reviewed Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Homo sapiens (Human) GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0031012; GO:0036021; GO:0042470; GO:0042981; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0070062; GO:0097067; GO:1904090; GO:1904813 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394] g11099.t1 P07858 45.038 262 2.9400000000000003e-64 208.0 sp|P07858|CATB_HUMAN Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3 CATB_HUMAN reviewed Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Homo sapiens (Human) GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0031012; GO:0036021; GO:0042470; GO:0042981; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0070062; GO:0097067; GO:1904090; GO:1904813 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394] g11100.t1 P07858 43.939 264 3.9600000000000005e-64 207.0 sp|P07858|CATB_HUMAN Cathepsin B OS=Homo sapiens OX=9606 GN=CTSB PE=1 SV=3 CATB_HUMAN reviewed Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Homo sapiens (Human) GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0031012; GO:0036021; GO:0042470; GO:0042981; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0070062; GO:0097067; GO:1904090; GO:1904813 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394] g11102.t1 Q19749 51.619 494 7.600000000000001e-166 482.0 sp|Q19749|ODP2_CAEEL Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=dlat-1 PE=1 SV=1 g11103.t1 Q6AXX1 50.955 157 2.25e-46 167.0 sp|Q6AXX1|SLNL1_RAT Schlafen-like protein 1 OS=Rattus norvegicus OX=10116 GN=Slfnl1 PE=2 SV=1 g11104.t1 A9X1A0 57.613 729 0.0 839.0 sp|A9X1A0|PI4KB_PAPAN Phosphatidylinositol 4-kinase beta OS=Papio anubis OX=9555 GN=PI4KB PE=3 SV=2 PI4KB_PAPAN reviewed Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) Papio anubis (Olive baboon) GO:0000139; GO:0004430; GO:0005524; GO:0005741; GO:0030867; GO:0046854; GO:0048015; GO:0048839; GO:0071889 inner ear development [GO:0048839]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015] Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867] 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524] g11107.t1 Q8IUQ0 45.26 327 1.21e-99 300.0 sp|Q8IUQ0|CLVS1_HUMAN Clavesin-1 OS=Homo sapiens OX=9606 GN=CLVS1 PE=1 SV=1 CLVS1_HUMAN reviewed Clavesin-1 (Cellular retinaldehyde-binding protein-like) (Retinaldehyde-binding protein 1-like 1) (clathrin vesicle-associated Sec14 protein 1) Homo sapiens (Human) GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0032588; GO:0080025; GO:1902936 lysosome organization [GO:0007040] clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025] g11108.t1 Q32NX4 43.333 210 6.1e-60 190.0 sp|Q32NX4|NKAI4_XENLA Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 OS=Xenopus laevis OX=8355 GN=nkain4 PE=2 SV=1 g11110.t1 A1L3H4 38.255 149 6.17e-28 105.0 sp|A1L3H4|BL1S5_XENLA Biogenesis of lysosome-related organelles complex 1 subunit 5 OS=Xenopus laevis OX=8355 GN=bloc1s5 PE=2 SV=1 g11111.t1 Q63081 58.05 441 4.26e-175 500.0 sp|Q63081|PDIA6_RAT Protein disulfide-isomerase A6 OS=Rattus norvegicus OX=10116 GN=Pdia6 PE=1 SV=2 PDIA6_RAT reviewed Protein disulfide-isomerase A6 (EC 5.3.4.1) (Calcium-binding protein 1) (CaBP1) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7) Rattus norvegicus (Rat) GO:0003756; GO:0005509; GO:0005615; GO:0005783; GO:0005788; GO:0005790; GO:0005793; GO:0005886; GO:0005929; GO:0006457; GO:0015035; GO:0030168; GO:0034451; GO:0034663; GO:0034976; GO:0036064; GO:0036498; GO:0042470; GO:0070527; GO:1903895 IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] g11112.t1 B5DFN3 50.42 119 1.84e-42 139.0 sp|B5DFN3|UQCC2_RAT Ubiquinol-cytochrome-c reductase complex assembly factor 2 OS=Rattus norvegicus OX=10116 GN=Uqcc2 PE=2 SV=1 g11114.t1 P00766 38.34 253 9.370000000000001e-47 172.0 sp|P00766|CTRA_BOVIN Chymotrypsinogen A OS=Bos taurus OX=9913 PE=1 SV=1 g11116.t1 P40313 37.5 248 2.93e-44 166.0 sp|P40313|CTRL_HUMAN Chymotrypsin-like protease CTRL-1 OS=Homo sapiens OX=9606 GN=CTRL PE=1 SV=1 g11116.t1 P40313 35.743 249 7.8e-40 152.0 sp|P40313|CTRL_HUMAN Chymotrypsin-like protease CTRL-1 OS=Homo sapiens OX=9606 GN=CTRL PE=1 SV=1 g11117.t1 P97435 28.471 569 8.23e-49 191.0 sp|P97435|ENTK_MOUSE Enteropeptidase OS=Mus musculus OX=10090 GN=Tmprss15 PE=2 SV=1 g11121.t1 Q9WV18 33.615 711 1.67e-136 427.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g11122.t1 Q6P0I8 44.762 105 2.88e-24 96.3 sp|Q6P0I8|EXOS6_DANRE Exosome complex component MTR3 OS=Danio rerio OX=7955 GN=exosc6 PE=2 SV=2 g11123.t1 Q6P0I8 48.023 177 6.79e-55 178.0 sp|Q6P0I8|EXOS6_DANRE Exosome complex component MTR3 OS=Danio rerio OX=7955 GN=exosc6 PE=2 SV=2 g11124.t1 Q8NEV4 39.542 918 0.0 611.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11124.t2 Q8NEV4 39.542 918 0.0 611.0 sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2 MYO3A_HUMAN reviewed Myosin-IIIa (EC 2.7.11.1) Homo sapiens (Human) GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310 cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g11125.t1 Q9CYF5 57.275 433 0.0 515.0 sp|Q9CYF5|RCC1L_MOUSE RCC1-like G exchanging factor-like protein OS=Mus musculus OX=10090 GN=Rcc1l PE=1 SV=1 g11126.t1 Q5ZMM5 71.053 76 5.0899999999999995e-28 99.0 sp|Q5ZMM5|ZN706_CHICK Zinc finger protein 706 OS=Gallus gallus OX=9031 GN=ZNF706 PE=3 SV=1 g11127.t1 F1RBN2 49.342 152 1.02e-38 152.0 sp|F1RBN2|SPAG1_DANRE Sperm-associated antigen 1A OS=Danio rerio OX=7955 GN=spag1a PE=2 SV=1 g11127.t1 F1RBN2 45.312 128 4.02e-25 112.0 sp|F1RBN2|SPAG1_DANRE Sperm-associated antigen 1A OS=Danio rerio OX=7955 GN=spag1a PE=2 SV=1 g11128.t1 Q5U2X2 47.619 189 2.7300000000000002e-43 160.0 sp|Q5U2X2|SPAG1_RAT Sperm-associated antigen 1 OS=Rattus norvegicus OX=10116 GN=Spag1 PE=1 SV=1 SPAG1_RAT reviewed Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1) Rattus norvegicus (Rat) GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0007338; GO:0016787; GO:0070286; GO:0101031; GO:0120293 axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; nucleoplasm [GO:0005654]; protein folding chaperone complex [GO:0101031] GTP binding [GO:0005525]; hydrolase activity [GO:0016787] g11129.t1 Q9QZ81 72.146 876 0.0 1306.0 sp|Q9QZ81|AGO2_RAT Protein argonaute-2 OS=Rattus norvegicus OX=10116 GN=Ago2 PE=1 SV=2 g11131.t1 Q9P2E3 37.01 1532 0.0 893.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g11131.t1 Q9P2E3 28.635 447 1.15e-30 137.0 sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2 ZNFX1_HUMAN reviewed NFX1-type zinc finger-containing protein 1 Homo sapiens (Human) GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g11140.t1 P22105 33.384 653 2.5600000000000003e-64 252.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11140.t1 P22105 33.088 680 9.04e-64 250.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11140.t1 P22105 32.822 652 3.17e-63 248.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11140.t1 P22105 29.404 789 3.74e-62 245.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11140.t1 P22105 31.352 673 8.29e-62 244.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11140.t1 P22105 30.198 808 7.419999999999999e-61 241.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11140.t1 P22105 32.179 491 6.5e-45 187.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11140.t1 P22105 34.848 264 1.35e-21 110.0 sp|P22105|TENX_HUMAN Tenascin-X OS=Homo sapiens OX=9606 GN=TNXB PE=1 SV=5 TENX_HUMAN reviewed Tenascin-X (TN-X) (Hexabrachion-like protein) Homo sapiens (Human) GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0045595; GO:0046328; GO:0048251; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935 actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; regulation of JNK cascade [GO:0046328]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; tenascin complex [GO:0090733] collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] g11141.t1 Q99JT9 64.912 171 3.58e-82 243.0 sp|Q99JT9|MTND_MOUSE Acireductone dioxygenase OS=Mus musculus OX=10090 GN=Adi1 PE=1 SV=1 MTND_MOUSE reviewed Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53) (Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1) (MTCBP-1) Mus musculus (Mouse) GO:0005506; GO:0005634; GO:0005737; GO:0005886; GO:0006555; GO:0010308; GO:0010309; GO:0016151; GO:0016491; GO:0019509 L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] acireductone dioxygenase (Ni2+-requiring) activity [GO:0010308]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; nickel cation binding [GO:0016151]; oxidoreductase activity [GO:0016491] g11142.t1 B7PRF6 60.432 139 9.72e-62 191.0 sp|B7PRF6|MTND_IXOSC Acireductone dioxygenase OS=Ixodes scapularis OX=6945 GN=IscW_ISCW007295 PE=3 SV=1 g11143.t1 Q6R5J2 32.992 976 3.68e-159 508.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g11144.t1 Q8K4L0 50.115 866 0.0 813.0 sp|Q8K4L0|DDX54_MOUSE ATP-dependent RNA helicase DDX54 OS=Mus musculus OX=10090 GN=Ddx54 PE=1 SV=1 DDX54_MOUSE reviewed ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (DEAD box protein 54) Mus musculus (Mouse) GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016070; GO:0016887; GO:0030331 RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] g11145.t1 Q8N3S3 36.023 855 2.38e-128 406.0 sp|Q8N3S3|PHTF2_HUMAN Protein PHTF2 OS=Homo sapiens OX=9606 GN=PHTF2 PE=1 SV=2 g11145.t2 Q8N3S3 36.023 855 5.41e-128 406.0 sp|Q8N3S3|PHTF2_HUMAN Protein PHTF2 OS=Homo sapiens OX=9606 GN=PHTF2 PE=1 SV=2 g11146.t1 Q9H2L4 40.164 122 2.2e-24 93.6 sp|Q9H2L4|TMM60_HUMAN Transmembrane protein 60 OS=Homo sapiens OX=9606 GN=TMEM60 PE=1 SV=1 TMM60_HUMAN reviewed Transmembrane protein 60 Homo sapiens (Human) GO:0016020 membrane [GO:0016020] g11150.t1 Q6P4Y6 46.595 279 3.1400000000000004e-72 256.0 sp|Q6P4Y6|IRS1_XENTR Insulin receptor substrate 1 OS=Xenopus tropicalis OX=8364 GN=irs1 PE=2 SV=1 g11150.t2 Q6P4Y6 46.595 279 1.21e-72 256.0 sp|Q6P4Y6|IRS1_XENTR Insulin receptor substrate 1 OS=Xenopus tropicalis OX=8364 GN=irs1 PE=2 SV=1 g11150.t3 Q6P4Y6 46.595 279 6.39e-73 256.0 sp|Q6P4Y6|IRS1_XENTR Insulin receptor substrate 1 OS=Xenopus tropicalis OX=8364 GN=irs1 PE=2 SV=1 g11155.t1 Q9H2Y9 34.615 728 1.14e-114 372.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g11157.t1 B7ZCC9 28.488 688 4.35e-64 244.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g11158.t1 P11617 29.338 317 7.98e-29 118.0 sp|P11617|AA2AR_CANLF Adenosine receptor A2a OS=Canis lupus familiaris OX=9615 GN=ADORA2A PE=2 SV=1 g11160.t1 Q91ZD1 75.758 198 2.5799999999999998e-101 305.0 sp|Q91ZD1|OSR2_MOUSE Protein odd-skipped-related 2 OS=Mus musculus OX=10090 GN=Osr2 PE=1 SV=1 OSR2_MOUSE reviewed Protein odd-skipped-related 2 Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001655; GO:0001656; GO:0001823; GO:0002062; GO:0005634; GO:0007389; GO:0008270; GO:0008284; GO:0009792; GO:0010628; GO:0030154; GO:0030501; GO:0033687; GO:0035115; GO:0035116; GO:0036023; GO:0042474; GO:0042476; GO:0042733; GO:0043565; GO:0045893; GO:0045944; GO:0048704; GO:0048793; GO:0050679; GO:0060021; GO:0060272; GO:0060322; GO:0060349; GO:0061029; GO:0072498; GO:1990837; GO:2000543 bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; head development [GO:0060322]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; osteoblast proliferation [GO:0033687]; pattern specification process [GO:0007389]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; roof of mouth development [GO:0060021]; urogenital system development [GO:0001655] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g11160.t2 Q91ZD1 75.758 198 3.52e-101 305.0 sp|Q91ZD1|OSR2_MOUSE Protein odd-skipped-related 2 OS=Mus musculus OX=10090 GN=Osr2 PE=1 SV=1 OSR2_MOUSE reviewed Protein odd-skipped-related 2 Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001655; GO:0001656; GO:0001823; GO:0002062; GO:0005634; GO:0007389; GO:0008270; GO:0008284; GO:0009792; GO:0010628; GO:0030154; GO:0030501; GO:0033687; GO:0035115; GO:0035116; GO:0036023; GO:0042474; GO:0042476; GO:0042733; GO:0043565; GO:0045893; GO:0045944; GO:0048704; GO:0048793; GO:0050679; GO:0060021; GO:0060272; GO:0060322; GO:0060349; GO:0061029; GO:0072498; GO:1990837; GO:2000543 bone morphogenesis [GO:0060349]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; head development [GO:0060322]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; osteoblast proliferation [GO:0033687]; pattern specification process [GO:0007389]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephros development [GO:0048793]; roof of mouth development [GO:0060021]; urogenital system development [GO:0001655] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g11161.t1 O94925 53.819 563 0.0 633.0 sp|O94925|GLSK_HUMAN Glutaminase kidney isoform, mitochondrial OS=Homo sapiens OX=9606 GN=GLS PE=1 SV=1 g11162.t1 Q96C36 47.101 276 3.94e-86 263.0 sp|Q96C36|P5CR2_HUMAN Pyrroline-5-carboxylate reductase 2 OS=Homo sapiens OX=9606 GN=PYCR2 PE=1 SV=1 g11163.t1 Q11205 43.945 289 3.7299999999999996e-82 257.0 sp|Q11205|SIA4B_RAT CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 OS=Rattus norvegicus OX=10116 GN=St3gal2 PE=1 SV=1 SIA4B_RAT reviewed CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B) Rattus norvegicus (Rat) GO:0000139; GO:0001574; GO:0001576; GO:0003836; GO:0005576; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0032580; GO:0042803; GO:0047288; GO:0097503 ganglioside biosynthetic process [GO:0001574]; globoside biosynthetic process [GO:0001576]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; oligosaccharide biosynthetic process [GO:0009312]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020] beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373] g11165.t1 Q6NT16 35.165 455 6.47e-72 239.0 sp|Q6NT16|S18B1_HUMAN MFS-type transporter SLC18B1 OS=Homo sapiens OX=9606 GN=SLC18B1 PE=1 SV=1 S18B1_HUMAN reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Homo sapiens (Human) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g11169.t1 Q9UHI8 26.933 401 1.7899999999999998e-38 151.0 sp|Q9UHI8|ATS1_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 1 OS=Homo sapiens OX=9606 GN=ADAMTS1 PE=1 SV=4 ATS1_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-) (METH-1) Homo sapiens (Human) GO:0001542; GO:0001822; GO:0004222; GO:0005604; GO:0006508; GO:0007229; GO:0008201; GO:0008237; GO:0008270; GO:0008285; GO:0016525; GO:0030198; GO:0031012; GO:0031410; GO:0060347; GO:1900087; GO:1904707; GO:1904754 extracellular matrix organization [GO:0030198]; heart trabecula formation [GO:0060347]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; ovulation from ovarian follicle [GO:0001542]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508] basement membrane [GO:0005604]; cytoplasmic vesicle [GO:0031410]; extracellular matrix [GO:0031012] heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] g11170.t1 D3Z5L6 31.25 416 1.46e-53 189.0 sp|D3Z5L6|S18B1_MOUSE MFS-type transporter SLC18B1 OS=Mus musculus OX=10090 GN=Slc18b1 PE=1 SV=2 S18B1_MOUSE reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Mus musculus (Mouse) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g11172.t1 Q5PQ53 48.98 196 5.77e-64 206.0 sp|Q5PQ53|PEF1_XENLA Peflin OS=Xenopus laevis OX=8355 GN=pef1 PE=1 SV=1 PEF1_XENLA reviewed Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1) Xenopus laevis (African clawed frog) GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0048208; GO:0048306; GO:1902527; GO:1990756 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; endoplasmic reticulum [GO:0005783] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g11173.t1 P83205 54.848 330 3.9400000000000004e-123 360.0 sp|P83205|CATB_SHEEP Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2 CATB_SHEEP reviewed Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Ovis aries (Sheep) GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394] g11174.t1 Q803C9 51.957 460 4.2300000000000003e-169 486.0 sp|Q803C9|PTSS1_DANRE Phosphatidylserine synthase 1 OS=Danio rerio OX=7955 GN=ptdss1 PE=2 SV=2 g11175.t1 Q5ZJC8 40.263 380 2.76e-91 287.0 sp|Q5ZJC8|MTEF3_CHICK Transcription termination factor 3, mitochondrial OS=Gallus gallus OX=9031 GN=MTERF3 PE=2 SV=1 g11176.t1 P10605 49.375 320 2.9299999999999998e-108 323.0 sp|P10605|CATB_MOUSE Cathepsin B OS=Mus musculus OX=10090 GN=Ctsb PE=1 SV=2 CATB_MOUSE reviewed Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] Mus musculus (Mouse) GO:0004175; GO:0004197; GO:0005518; GO:0005576; GO:0005615; GO:0005739; GO:0005764; GO:0005901; GO:0006508; GO:0006590; GO:0008233; GO:0008234; GO:0009897; GO:0009986; GO:0016324; GO:0030163; GO:0030574; GO:0030855; GO:0030984; GO:0031012; GO:0042277; GO:0042383; GO:0042470; GO:0042802; GO:0043394; GO:0044877; GO:0046697; GO:0046718; GO:0048471; GO:0051402; GO:0051603; GO:0097067; GO:1904090 cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neuron apoptotic process [GO:0051402]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; caveola [GO:0005901]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383] collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kininogen binding [GO:0030984]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; proteoglycan binding [GO:0043394] g11178.t1 Q5JVL4 54.121 643 0.0 696.0 sp|Q5JVL4|EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=EFHC1 PE=1 SV=1 EFHC1_HUMAN reviewed EF-hand domain-containing protein 1 (Myoclonin-1) Homo sapiens (Human) GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005879; GO:0005930; GO:0007052; GO:0021795; GO:0030317; GO:0036126; GO:0043014; GO:0043025; GO:0051302; GO:0060285; GO:0072686; GO:0160111 cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922] alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509] g11179.t1 Q61026 37.157 401 9.26e-65 248.0 sp|Q61026|NCOA2_MOUSE Nuclear receptor coactivator 2 OS=Mus musculus OX=10090 GN=Ncoa2 PE=1 SV=3 NCOA2_MOUSE reviewed Nuclear receptor coactivator 2 (NCoA-2) (Glucocorticoid receptor-interacting protein 1) (GRIP-1) (Steroid receptor coactivator 2) (SRC-2) (Transcriptional intermediary factor 2) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0007623; GO:0010468; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019216; GO:0019904; GO:0030331; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035259; GO:0035357; GO:0042789; GO:0042974; GO:0043197; GO:0044877; GO:0045475; GO:0045879; GO:0045892; GO:0045925; GO:0045944; GO:0046965; GO:0046966; GO:0046983; GO:0061629; GO:0070182; GO:0090575; GO:0140416; GO:1900076; GO:1904017; GO:1904179; GO:2000324 cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of female receptivity [GO:0045925]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]; response to progesterone [GO:0032570] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription regulator inhibitor activity [GO:0140416] g11179.t2 Q15596 37.965 403 2.63e-64 246.0 sp|Q15596|NCOA2_HUMAN Nuclear receptor coactivator 2 OS=Homo sapiens OX=9606 GN=NCOA2 PE=1 SV=2 NCOA2_HUMAN reviewed Nuclear receptor coactivator 2 (NCoA-2) (Class E basic helix-loop-helix protein 75) (bHLHe75) (Transcriptional intermediary factor 2) (hTIF2) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019216; GO:0019904; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035357; GO:0042789; GO:0045475; GO:0045879; GO:0045944; GO:0046983; GO:0090575; GO:0140416; GO:1900076; GO:1904017; GO:1904179 cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]; response to progesterone [GO:0032570] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription coactivator activity [GO:0003713]; transcription regulator inhibitor activity [GO:0140416] g11179.t3 Q61026 37.157 401 8.680000000000001e-65 248.0 sp|Q61026|NCOA2_MOUSE Nuclear receptor coactivator 2 OS=Mus musculus OX=10090 GN=Ncoa2 PE=1 SV=3 NCOA2_MOUSE reviewed Nuclear receptor coactivator 2 (NCoA-2) (Glucocorticoid receptor-interacting protein 1) (GRIP-1) (Steroid receptor coactivator 2) (SRC-2) (Transcriptional intermediary factor 2) Mus musculus (Mouse) GO:0000122; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0007623; GO:0010468; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019216; GO:0019904; GO:0030331; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035259; GO:0035357; GO:0042789; GO:0042974; GO:0043197; GO:0044877; GO:0045475; GO:0045879; GO:0045892; GO:0045925; GO:0045944; GO:0046965; GO:0046966; GO:0046983; GO:0061629; GO:0070182; GO:0090575; GO:0140416; GO:1900076; GO:1904017; GO:1904179; GO:2000324 cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of female receptivity [GO:0045925]; positive regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000324]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]; response to progesterone [GO:0032570] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription regulator inhibitor activity [GO:0140416] g11181.t1 Q96D46 63.439 506 0.0 671.0 sp|Q96D46|NMD3_HUMAN 60S ribosomal export protein NMD3 OS=Homo sapiens OX=9606 GN=NMD3 PE=1 SV=1 NMD3_HUMAN reviewed 60S ribosomal export protein NMD3 (hNMD3) Homo sapiens (Human) GO:0000055; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0015031; GO:0016020; GO:0030674; GO:0043023; GO:1902680; GO:1904751 positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; protein transport [GO:0015031]; ribosomal large subunit export from nucleus [GO:0000055] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723] g11183.t1 Q9VAC5 42.318 716 0.0 558.0 sp|Q9VAC5|ADA17_DROME ADAM 17-like protease OS=Drosophila melanogaster OX=7227 GN=Tace PE=2 SV=2 ADA17_DROME reviewed ADAM 17-like protease (EC 3.4.24.-) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016020; GO:0033209; GO:0040015; GO:0043068; GO:0046872; GO:0071679; GO:1903427 commissural neuron axon guidance [GO:0071679]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of programmed cell death [GO:0043068]; tumor necrosis factor-mediated signaling pathway [GO:0033209] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g11183.t2 Q9VAC5 42.318 716 0.0 559.0 sp|Q9VAC5|ADA17_DROME ADAM 17-like protease OS=Drosophila melanogaster OX=7227 GN=Tace PE=2 SV=2 ADA17_DROME reviewed ADAM 17-like protease (EC 3.4.24.-) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016020; GO:0033209; GO:0040015; GO:0043068; GO:0046872; GO:0071679; GO:1903427 commissural neuron axon guidance [GO:0071679]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of programmed cell death [GO:0043068]; tumor necrosis factor-mediated signaling pathway [GO:0033209] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] g11187.t1 Q8K007 39.227 854 0.0 599.0 sp|Q8K007|SULF1_MOUSE Extracellular sulfatase Sulf-1 OS=Mus musculus OX=10090 GN=Sulf1 PE=1 SV=1 g11187.t2 Q8K007 39.227 854 0.0 599.0 sp|Q8K007|SULF1_MOUSE Extracellular sulfatase Sulf-1 OS=Mus musculus OX=10090 GN=Sulf1 PE=1 SV=1 g11189.t1 Q9VCZ3 26.1 341 2.01e-26 112.0 sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1 OCTB1_DROME reviewed Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R) Drosophila melanogaster (Fruit fly) GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410] membrane [GO:0016020]; plasma membrane [GO:0005886] adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989] g11192.t1 Q4WVW4 42.938 531 2.64e-119 367.0 sp|Q4WVW4|VAC8_ASPFU Vacuolar protein 8 OS=Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) OX=330879 GN=vac8 PE=3 SV=1 VAC8_ASPFU reviewed Vacuolar protein 8 Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) (Neosartorya fumigata) GO:0000011; GO:0000045; GO:0000329; GO:0000407; GO:0000425; GO:0031503; GO:0031965; GO:0034497; GO:0034517; GO:0034727; GO:0042144; GO:0042802; GO:0043495; GO:0045121; GO:0051656; GO:0061724; GO:0071561; GO:0071562; GO:0071563; GO:1903044 autophagosome assembly [GO:0000045]; establishment of organelle localization [GO:0051656]; lipophagy [GO:0061724]; nucleus-vacuole junction assembly [GO:0071562]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; protein localization to membrane raft [GO:1903044]; protein localization to phagophore assembly site [GO:0034497]; protein-containing complex localization [GO:0031503]; ribophagy [GO:0034517]; vacuole fusion, non-autophagic [GO:0042144]; vacuole inheritance [GO:0000011] fungal-type vacuole membrane [GO:0000329]; membrane raft [GO:0045121]; Myo2p-Vac17p-Vac8p transport complex [GO:0071563]; nuclear membrane [GO:0031965]; nucleus-vacuole junction [GO:0071561]; phagophore assembly site [GO:0000407] identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495] g11194.t1 Q0V8C2 46.132 711 0.0 635.0 sp|Q0V8C2|EXOC3_BOVIN Exocyst complex component 3 OS=Bos taurus OX=9913 GN=EXOC3 PE=2 SV=1 EXOC3_BOVIN reviewed Exocyst complex component 3 (Exocyst complex component Sec6) Bos taurus (Bovine) GO:0000145; GO:0000149; GO:0005794; GO:0006887; GO:0015031; GO:0016020; GO:0030426; GO:0030496; GO:0048471; GO:0051601 exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031] exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471] SNARE binding [GO:0000149] g11196.t1 Q9CWH4 34.263 251 8.22e-34 124.0 sp|Q9CWH4|RE114_MOUSE Meiotic recombination protein REC114 OS=Mus musculus OX=10090 GN=Rec114 PE=1 SV=1 RE114_MOUSE reviewed Meiotic recombination protein REC114 Mus musculus (Mouse) GO:0005694; GO:0006310; GO:0007283; GO:0042138; GO:0048477 DNA recombination [GO:0006310]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] chromosome [GO:0005694] g11197.t1 Q6DFC8 33.522 531 1.8299999999999997e-54 194.0 sp|Q6DFC8|ZN395_XENLA Zinc finger protein 395 OS=Xenopus laevis OX=8355 GN=znf395 PE=2 SV=1 g11197.t2 Q6DFC8 33.585 530 1.2899999999999998e-54 194.0 sp|Q6DFC8|ZN395_XENLA Zinc finger protein 395 OS=Xenopus laevis OX=8355 GN=znf395 PE=2 SV=1 g11198.t1 Q6IRP4 44.816 299 7.270000000000001e-97 296.0 sp|Q6IRP4|ABHDD_XENLA Protein ABHD13 OS=Xenopus laevis OX=8355 GN=abhd13 PE=2 SV=1 g11199.t1 Q9DBB9 35.294 255 1.61e-29 127.0 sp|Q9DBB9|CPN2_MOUSE Carboxypeptidase N subunit 2 OS=Mus musculus OX=10090 GN=Cpn2 PE=1 SV=2 g11200.t1 Q5ZJ56 63.008 246 1.39e-112 326.0 sp|Q5ZJ56|RL7_CHICK Large ribosomal subunit protein uL30 OS=Gallus gallus OX=9031 GN=RPL7 PE=1 SV=1 g11201.t1 Q7T2D1 39.815 324 1.58e-86 265.0 sp|Q7T2D1|RD10B_DANRE Retinol dehydrogenase 10-B OS=Danio rerio OX=7955 GN=rdh10b PE=2 SV=2 g11202.t1 Q9JMB5 54.869 421 2.15e-133 392.0 sp|Q9JMB5|ADRM1_RAT Proteasomal ubiquitin receptor ADRM1 OS=Rattus norvegicus OX=10116 GN=Adrm1 PE=1 SV=2 ADRM1_RAT reviewed Proteasomal ubiquitin receptor ADRM1 (110 kDa cell membrane glycoprotein) (Gp110) (Adhesion-regulating molecule 1) (ARM-1) (Rpn13 homolog) Rattus norvegicus (Rat) GO:0000502; GO:0001541; GO:0002020; GO:0005654; GO:0005829; GO:0005886; GO:0006368; GO:0007286; GO:0008541; GO:0033081; GO:0042699; GO:0043248; GO:0048477; GO:0048538; GO:0060009; GO:0060399; GO:0060612; GO:0061133; GO:0070628; GO:0072520; GO:0140678 adipose tissue development [GO:0060612]; follicle-stimulating hormone signaling pathway [GO:0042699]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; proteasome assembly [GO:0043248]; regulation of T cell differentiation in thymus [GO:0033081]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286]; thymus development [GO:0048538]; transcription elongation by RNA polymerase II [GO:0006368] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541] endopeptidase activator activity [GO:0061133]; molecular function inhibitor activity [GO:0140678]; protease binding [GO:0002020]; proteasome binding [GO:0070628] g11203.t1 Q8WU67 48.649 370 2.56e-133 391.0 sp|Q8WU67|ABHD3_HUMAN Phospholipase ABHD3 OS=Homo sapiens OX=9606 GN=ABHD3 PE=1 SV=2 ABHD3_HUMAN reviewed Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) Homo sapiens (Human) GO:0004623; GO:0005886; GO:0006656; GO:0008126; GO:0008970; GO:0046470; GO:0047372; GO:0051792; GO:0051793 medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470] plasma membrane [GO:0005886] acetylesterase activity [GO:0008126]; monoacylglycerol lipase activity [GO:0047372]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] g11204.t1 Q8N584 47.603 584 0.0 556.0 sp|Q8N584|TT39C_HUMAN Tetratricopeptide repeat protein 39C OS=Homo sapiens OX=9606 GN=TTC39C PE=1 SV=2 g11208.t1 Q9D855 61.165 103 7.28e-39 128.0 sp|Q9D855|QCR7_MOUSE Cytochrome b-c1 complex subunit 7 OS=Mus musculus OX=10090 GN=Uqcrb PE=1 SV=3 QCR7_MOUSE reviewed Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (Ubiquinol-cytochrome c reductase complex 14 kDa protein) Mus musculus (Mouse) GO:0005739; GO:0005743; GO:0006122; GO:0044877; GO:0045275; GO:0045333 cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex III [GO:0045275] protein-containing complex binding [GO:0044877] g11209.t1 Q7ZXH2 32.489 237 7.76e-30 114.0 sp|Q7ZXH2|NSE2_XENLA E3 SUMO-protein ligase NSE2 OS=Xenopus laevis OX=8355 GN=nsmce2 PE=2 SV=1 NSE2_XENLA reviewed E3 SUMO-protein ligase NSE2 (EC 2.3.2.-) (E3 SUMO-protein transferase NSE2) (MMS21 homolog) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog) Xenopus laevis (African clawed frog) GO:0000722; GO:0000724; GO:0000781; GO:0005634; GO:0008270; GO:0016605; GO:0016925; GO:0019789; GO:0030915; GO:0034184; GO:0045842; GO:0051301; GO:0061665; GO:0090398 cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; telomere maintenance via recombination [GO:0000722] chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915] SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] g11210.t1 O97902 49.812 799 0.0 746.0 sp|O97902|ASAP1_BOVIN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Bos taurus OX=9913 GN=ASAP1 PE=1 SV=1 g11210.t1 O97902 61.039 77 4.5899999999999996e-23 110.0 sp|O97902|ASAP1_BOVIN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Bos taurus OX=9913 GN=ASAP1 PE=1 SV=1 g11210.t2 O97902 49.812 799 0.0 746.0 sp|O97902|ASAP1_BOVIN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Bos taurus OX=9913 GN=ASAP1 PE=1 SV=1 g11210.t2 O97902 61.039 77 4.5599999999999994e-23 110.0 sp|O97902|ASAP1_BOVIN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Bos taurus OX=9913 GN=ASAP1 PE=1 SV=1 g11211.t1 Q78EG7 61.85 173 5.82e-77 230.0 sp|Q78EG7|TP4A1_RAT Protein tyrosine phosphatase type IVA 1 OS=Rattus norvegicus OX=10116 GN=Ptp4a1 PE=1 SV=1 TP4A1_RAT reviewed Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1) Rattus norvegicus (Rat) GO:0004725; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005819; GO:0009898; GO:0030335 positive regulation of cell migration [GO:0030335] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spindle [GO:0005819] protein tyrosine phosphatase activity [GO:0004725] g11213.t1 Q5RDN3 38.144 291 8.07e-62 199.0 sp|Q5RDN3|PSMF1_PONAB Proteasome inhibitor PI31 subunit OS=Pongo abelii OX=9601 GN=PSMF1 PE=2 SV=1 PSMF1_PONAB reviewed Proteasome inhibitor PI31 subunit Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000502; GO:0004866; GO:0005783; GO:0005829; GO:0006511; GO:0042803; GO:0043161; GO:0046982; GO:0048471; GO:0070628; GO:1901799 negative regulation of proteasomal protein catabolic process [GO:1901799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502] endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g11214.t1 Q9NHW7 39.726 219 2.7000000000000003e-43 151.0 sp|Q9NHW7|AQP_AEDAE Aquaporin AQPAe.a OS=Aedes aegypti OX=7159 GN=AAEL003512 PE=2 SV=2 g11215.t1 Q9UBU6 36.145 332 1.8e-50 176.0 sp|Q9UBU6|FA8A1_HUMAN Protein FAM8A1 OS=Homo sapiens OX=9606 GN=FAM8A1 PE=1 SV=1 g11216.t1 Q05B63 52.632 456 1.81e-162 470.0 sp|Q05B63|TRM11_BOVIN tRNA (guanine(10)-N(2))-methyltransferase TRMT11 OS=Bos taurus OX=9913 GN=TRMT11 PE=2 SV=1 g11217.t1 Q6TGY8 53.103 290 1.01e-112 330.0 sp|Q6TGY8|EMC2_DANRE ER membrane protein complex subunit 2 OS=Danio rerio OX=7955 GN=emc2 PE=2 SV=1 g11218.t1 Q26630 93.822 259 2.94e-179 496.0 sp|Q26630|IDLC_STRPU 33 kDa inner dynein arm light chain, axonemal OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g11219.t1 P47800 28.205 351 9.53e-22 98.6 sp|P47800|DRD1L_OREMO D(1)-like dopamine receptor OS=Oreochromis mossambicus OX=8127 PE=2 SV=1 g11222.t1 Q52KK3 47.569 288 6.820000000000001e-97 291.0 sp|Q52KK3|S2551_RAT Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 OS=Rattus norvegicus OX=10116 GN=Slc25a51 PE=2 SV=1 g11223.t1 Q8NI08 51.133 309 1.5900000000000002e-85 298.0 sp|Q8NI08|NCOA7_HUMAN Nuclear receptor coactivator 7 OS=Homo sapiens OX=9606 GN=NCOA7 PE=1 SV=2 g11223.t1 Q8NI08 35.178 253 3.98e-32 139.0 sp|Q8NI08|NCOA7_HUMAN Nuclear receptor coactivator 7 OS=Homo sapiens OX=9606 GN=NCOA7 PE=1 SV=2 g11224.t1 Q2PC93 33.101 1290 0.0 632.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g11224.t1 Q2PC93 33.264 478 7.1000000000000005e-59 231.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g11224.t1 Q2PC93 27.957 372 2.01e-36 157.0 sp|Q2PC93|SSPO_CHICK SCO-spondin OS=Gallus gallus OX=9031 GN=SSPO PE=2 SV=1 g11226.t1 Q6AYF5 62.136 103 1.24e-35 135.0 sp|Q6AYF5|DTWD1_RAT tRNA-uridine aminocarboxypropyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Dtwd1 PE=2 SV=1 g11226.t1 Q6AYF5 42.282 149 2.54e-30 121.0 sp|Q6AYF5|DTWD1_RAT tRNA-uridine aminocarboxypropyltransferase 1 OS=Rattus norvegicus OX=10116 GN=Dtwd1 PE=2 SV=1 g11227.t1 Q13310 62.293 663 0.0 763.0 sp|Q13310|PABP4_HUMAN Polyadenylate-binding protein 4 OS=Homo sapiens OX=9606 GN=PABPC4 PE=1 SV=1 g11228.t1 Q9UKD2 64.679 218 1.0499999999999999e-101 298.0 sp|Q9UKD2|MRT4_HUMAN mRNA turnover protein 4 homolog OS=Homo sapiens OX=9606 GN=MRTO4 PE=1 SV=2 g11229.t1 Q2F637 73.577 246 2.4000000000000003e-124 356.0 sp|Q2F637|1433Z_BOMMO 14-3-3 protein zeta OS=Bombyx mori OX=7091 GN=14-3-3zeta PE=2 SV=2 g11230.t1 H3BPM6 31.088 193 1.42e-34 125.0 sp|H3BPM6|MKROS_HUMAN MKRN2 opposite strand protein OS=Homo sapiens OX=9606 GN=MKRN2OS PE=1 SV=1 g11231.t1 Q15036 45.639 493 2.61e-146 429.0 sp|Q15036|SNX17_HUMAN Sorting nexin-17 OS=Homo sapiens OX=9606 GN=SNX17 PE=1 SV=1 g11232.t1 Q9WTP6 66.667 234 2.21e-117 338.0 sp|Q9WTP6|KAD2_MOUSE Adenylate kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Ak2 PE=1 SV=5 KAD2_MOUSE reviewed Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) Mus musculus (Mouse) GO:0004017; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0006172; GO:0036126; GO:0046033; GO:0046034; GO:0097226 ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226] AMP kinase activity [GO:0004017]; ATP binding [GO:0005524] g11233.t1 Q63186 53.896 462 1.38e-169 492.0 sp|Q63186|EI2BD_RAT Translation initiation factor eIF2B subunit delta OS=Rattus norvegicus OX=10116 GN=Eif2b4 PE=2 SV=1 EI2BD_RAT reviewed Translation initiation factor eIF2B subunit delta (eIF2B GDP-GTP exchange factor subunit delta) Rattus norvegicus (Rat) GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0021766; GO:0031369; GO:0042552; GO:0043434; GO:0050852 cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851] guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g11237.t1 Q9NRA2 50.54 463 4.829999999999999e-159 464.0 sp|Q9NRA2|S17A5_HUMAN Sialin OS=Homo sapiens OX=9606 GN=SLC17A5 PE=1 SV=2 g11238.t1 O76536 25.537 791 2.02e-26 120.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11238.t1 O76536 28.255 722 5.1e-25 115.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11238.t1 O76536 26.158 734 8e-22 105.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 32.164 1197 7.24e-98 348.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 31.297 1195 1.4399999999999999e-95 342.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 31.174 1158 6.929999999999999e-94 337.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 31.92 1156 3.47e-93 334.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 31.298 1163 2.02e-87 317.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 30.801 1211 7.5e-86 312.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 32.243 1101 1.49e-83 305.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 30.033 1212 2.6800000000000003e-79 292.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 30.452 1018 7.46e-72 269.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 30.324 587 1.53e-38 162.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11239.t1 O76536 32.961 358 8.17e-25 117.0 sp|O76536|HYAL_STRPU Hyalin (Fragment) OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g11240.t1 A4QNF3 70.886 79 1.73e-30 105.0 sp|A4QNF3|ROMO1_XENTR Reactive oxygen species modulator 1 OS=Xenopus tropicalis OX=8364 GN=romo1 PE=3 SV=1 g11241.t1 Q803I2 65.641 390 0.0 546.0 sp|Q803I2|ERGI3_DANRE Endoplasmic reticulum-Golgi intermediate compartment protein 3 OS=Danio rerio OX=7955 GN=ergic3 PE=2 SV=1 g11242.t1 Q3TC93 39.552 134 4.35e-29 115.0 sp|Q3TC93|H1BP3_MOUSE HCLS1-binding protein 3 OS=Mus musculus OX=10090 GN=Hs1bp3 PE=1 SV=2 H1BP3_MOUSE reviewed HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3) Mus musculus (Mouse) GO:0005739; GO:0005783; GO:0007166; GO:0030217; GO:0035091; GO:0042981 cell surface receptor signaling pathway [GO:0007166]; regulation of apoptotic process [GO:0042981]; T cell differentiation [GO:0030217] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] phosphatidylinositol binding [GO:0035091] g11244.t1 Q8BZ39 34.911 338 1.29e-51 181.0 sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1 NMUR2_MOUSE reviewed Neuromedin-U receptor 2 (NMU-R2) Mus musculus (Mouse) GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930 arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265] membrane [GO:0016020]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] g11247.t1 Q66H59 40.984 305 7.740000000000001e-70 232.0 sp|Q66H59|NPL_RAT N-acetylneuraminate lyase OS=Rattus norvegicus OX=10116 GN=Npl PE=2 SV=1 g11248.t1 F1R983 50.962 104 6.77e-27 120.0 sp|F1R983|CTIP_DANRE DNA endonuclease RBBP8 OS=Danio rerio OX=7955 GN=rbbp8 PE=2 SV=1 g11249.t1 Q8K4K3 57.391 345 6.75e-132 382.0 sp|Q8K4K3|TRIB2_MOUSE Tribbles homolog 2 OS=Mus musculus OX=10090 GN=Trib2 PE=2 SV=2 g11250.t1 Q9WVT6 34.539 304 1.87e-40 147.0 sp|Q9WVT6|CAH14_MOUSE Carbonic anhydrase 14 OS=Mus musculus OX=10090 GN=Ca14 PE=1 SV=1 g11253.t1 Q8JFQ4 32.997 297 2.88e-39 142.0 sp|Q8JFQ4|RDM1_CHICK RAD52 motif-containing protein 1 OS=Gallus gallus OX=9031 GN=RDM1 PE=1 SV=1 g11254.t1 Q6UL01 59.74 77 8.22e-27 99.0 sp|Q6UL01|MORN2_MOUSE MORN repeat-containing protein 2 OS=Mus musculus OX=10090 GN=Morn2 PE=1 SV=1 g11255.t1 Q8C436 46.729 214 9.680000000000001e-59 187.0 sp|Q8C436|MT21D_MOUSE Protein N-lysine methyltransferase METTL21D OS=Mus musculus OX=10090 GN=Vcpkmt PE=1 SV=2 MT21D_MOUSE reviewed Protein N-lysine methyltransferase METTL21D (EC 2.1.1.-) (Methyltransferase-like protein 21D) (VCP lysine methyltransferase) (VCP-KMT) (Valosin-containing protein lysine methyltransferase) Mus musculus (Mouse) GO:0005737; GO:0005829; GO:0008276; GO:0016279; GO:0018023; GO:0032991; GO:0051117 peptidyl-lysine trimethylation [GO:0018023] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] ATPase binding [GO:0051117]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] g11256.t1 P56941 48.447 1288 0.0 1207.0 sp|P56941|NPC1_PIG NPC intracellular cholesterol transporter 1 OS=Sus scrofa OX=9823 GN=NPC1 PE=2 SV=1 g11259.t1 P49219 29.129 333 1.1800000000000001e-36 140.0 sp|P49219|MTR1C_XENLA Melatonin receptor type 1C OS=Xenopus laevis OX=8355 GN=mtnr1c PE=2 SV=1 g11260.t1 Q9D8B1 41.398 186 1.38e-49 164.0 sp|Q9D8B1|AIG1_MOUSE Androgen-induced gene 1 protein OS=Mus musculus OX=10090 GN=Aig1 PE=2 SV=2 AIG1_MOUSE reviewed Androgen-induced gene 1 protein (AIG-1) (Fatty acid esters of hydroxy fatty acids hydrolase AIG1) (FAHFA hydrolase AIG1) (EC 3.1.-.-) Mus musculus (Mouse) GO:0005886; GO:0012505; GO:0016020; GO:0016787; GO:0042758 long-chain fatty acid catabolic process [GO:0042758] endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886] hydrolase activity [GO:0016787] g11262.t1 Q03172 45.038 262 6.04e-55 217.0 sp|Q03172|ZEP1_MOUSE Zinc finger protein 40 OS=Mus musculus OX=10090 GN=Hivep1 PE=1 SV=1 g11262.t1 Q03172 73.846 65 1.2799999999999999e-24 117.0 sp|Q03172|ZEP1_MOUSE Zinc finger protein 40 OS=Mus musculus OX=10090 GN=Hivep1 PE=1 SV=1 g11265.t1 Q63ZI0 47.557 307 1.91e-95 291.0 sp|Q63ZI0|KCNK9_XENLA Potassium channel subfamily K member 9 OS=Xenopus laevis OX=8355 GN=kcnk9 PE=2 SV=1 g11266.t1 Q5ZKL6 37.525 493 2.11e-118 361.0 sp|Q5ZKL6|MBOA2_CHICK Membrane-bound glycerophospholipid O-acyltransferase 2 OS=Gallus gallus OX=9031 GN=mboat2 PE=2 SV=1 MBOA2_CHICK reviewed Membrane-bound glycerophospholipid O-acyltransferase 2 (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (Lysophospholipid acyltransferase 2) (LPLAT 2) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2) Gallus gallus (Chicken) GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047184; GO:0106262; GO:0106263 lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; acyltransferase activity [GO:0016746] g6062.t1 Q6P3S6 34.685 444 6.82e-79 265.0 sp|Q6P3S6|FBX42_HUMAN F-box only protein 42 OS=Homo sapiens OX=9606 GN=FBXO42 PE=1 SV=1 FBX42_HUMAN reviewed F-box only protein 42 (Just one F-box and Kelch domain-containing protein) Homo sapiens (Human) GO:0019005; GO:1990756 SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g6063.t1 A2A825 45.749 247 3.5199999999999995e-82 251.0 sp|A2A825|CPLN2_MOUSE Ciliogenesis and planar polarity effector 2 OS=Mus musculus OX=10090 GN=Cplane2 PE=1 SV=1 CPLN2_MOUSE reviewed Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1) Mus musculus (Mouse) GO:0003274; GO:0003924; GO:0005525; GO:0005814; GO:0006887; GO:0007224; GO:0008104; GO:0008589; GO:0015031; GO:0016485; GO:0017157; GO:0031338; GO:0035082; GO:0035869; GO:0036064; GO:0060173; GO:0060271; GO:0097546; GO:1904888 axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cranial skeletal system development [GO:1904888]; endocardial cushion fusion [GO:0003274]; exocytosis [GO:0006887]; intracellular protein localization [GO:0008104]; limb development [GO:0060173]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of smoothened signaling pathway [GO:0008589]; regulation of vesicle fusion [GO:0031338]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g6064.t1 P84850 57.374 495 0.0 608.0 sp|P84850|D2HDH_RAT D-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=D2hgdh PE=1 SV=1 D2HDH_RAT reviewed D-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.39) Rattus norvegicus (Rat) GO:0005739; GO:0006089; GO:0006108; GO:0008270; GO:0010042; GO:0010043; GO:0032025; GO:0051990; GO:0071949; GO:1901275 lactate metabolic process [GO:0006089]; malate metabolic process [GO:0006108]; response to cobalt ion [GO:0032025]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; tartrate metabolic process [GO:1901275] mitochondrion [GO:0005739] (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; FAD binding [GO:0071949]; zinc ion binding [GO:0008270] g6065.t1 Q6NZ13 50.962 104 1.74e-33 119.0 sp|Q6NZ13|NBL1_DANRE Neuroblastoma suppressor of tumorigenicity 1 OS=Danio rerio OX=7955 GN=nbl1 PE=2 SV=1 g6068.t1 Q2KIP7 56.931 202 8.67e-79 238.0 sp|Q2KIP7|MD2L2_BOVIN Mitotic spindle assembly checkpoint protein MAD2B OS=Bos taurus OX=9913 GN=MAD2L2 PE=2 SV=1 g6069.t1 Q8H1F7 38.246 285 1.51e-47 164.0 sp|Q8H1F7|IPK_ARATH Isopentenyl phosphate kinase OS=Arabidopsis thaliana OX=3702 GN=IPK PE=1 SV=1 IPK_ARATH reviewed Isopentenyl phosphate kinase (AtIPK) (IPK) (EC 2.7.4.26) Arabidopsis thaliana (Mouse-ear cress) GO:0005524; GO:0005829; GO:0016114; GO:0016301; GO:0102043 terpenoid biosynthetic process [GO:0016114] cytosol [GO:0005829] ATP binding [GO:0005524]; isopentenyl phosphate kinase activity [GO:0102043]; kinase activity [GO:0016301] g6070.t1 Q7M456 36.087 230 1.18e-43 150.0 sp|Q7M456|RNOY_MAGGI Ribonuclease Oy OS=Magallana gigas OX=29159 PE=1 SV=1 g6072.t1 Q8BTI9 44.6 1074 0.0 907.0 sp|Q8BTI9|PK3CB_MOUSE Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Mus musculus OX=10090 GN=Pik3cb PE=1 SV=2 PK3CB_MOUSE reviewed Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1) Mus musculus (Mouse) GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0016303; GO:0016477; GO:0030168; GO:0030496; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0042267; GO:0043409; GO:0043491; GO:0043560; GO:0045429; GO:0046854; GO:0046934; GO:0048015; GO:0051898; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671 angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g6075.t1 P82649 47.337 338 1.82e-111 332.0 sp|P82649|RT22_BOVIN Small ribosomal subunit protein mS22 OS=Bos taurus OX=9913 GN=MRPS22 PE=1 SV=2 g6076.t1 A1A5V9 34.106 302 1.62e-42 151.0 sp|A1A5V9|ELP5_DANRE Elongator complex protein 5 OS=Danio rerio OX=7955 GN=elp5 PE=2 SV=1 g6078.t1 Q2TA11 37.563 197 3.04e-31 117.0 sp|Q2TA11|CF107_BOVIN Cilia- and flagella-associated protein 107 OS=Bos taurus OX=9913 GN=CFAP107 PE=1 SV=1 g6079.t1 Q9CR24 43.299 194 1.18e-42 147.0 sp|Q9CR24|NUDT8_MOUSE Mitochondrial coenzyme A diphosphatase NUDT8 OS=Mus musculus OX=10090 GN=Nudt8 PE=1 SV=1 NUDT8_MOUSE reviewed Mitochondrial coenzyme A diphosphatase NUDT8 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 8) (Nudix motif 8) Mus musculus (Mouse) GO:0000287; GO:0005739; GO:0005759; GO:0010945; GO:0015938; GO:0030145; GO:0036114; GO:0044580; GO:0046356; GO:1901289; GO:1902859; GO:2001294 acetyl-CoA catabolic process [GO:0046356]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA catabolic process [GO:1902859]; succinyl-CoA catabolic process [GO:1901289] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] coenzyme A diphosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] g6080.t1 Q8K430 62.651 581 0.0 768.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g6081.t1 Q5U247 48.198 666 0.0 636.0 sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1 g6083.t1 Q7SY23 57.838 555 0.0 718.0 sp|Q7SY23|AL4A1_DANRE Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=aldh4a1 PE=2 SV=1 g6084.t1 Q9Y6Y1 52.159 301 1.6e-89 327.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t1 Q9Y6Y1 52.83 212 3.97e-61 235.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t1 Q9Y6Y1 43.243 259 2.25e-46 187.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t2 Q9Y6Y1 52.159 301 1.4099999999999998e-89 327.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t2 Q9Y6Y1 52.83 212 3.72e-61 236.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t2 Q9Y6Y1 43.243 259 2.49e-46 187.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t3 Q9Y6Y1 52.159 301 1.5199999999999999e-89 327.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t3 Q9Y6Y1 52.83 212 3.84e-61 235.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6084.t3 Q9Y6Y1 43.243 259 2.4599999999999997e-46 187.0 sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4 CMTA1_HUMAN reviewed Calmodulin-binding transcription activator 1 Homo sapiens (Human) GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886 neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] g6085.t1 Q5PQ76 62.712 177 1.44e-79 238.0 sp|Q5PQ76|CA050_XENLA Uncharacterized protein C1orf50 homolog OS=Xenopus laevis OX=8355 PE=2 SV=1 g6086.t1 P10079 48.103 659 0.0 620.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g6086.t1 P10079 47.259 675 0.0 619.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g6086.t1 P10079 46.856 668 0.0 598.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g6086.t1 P10079 48.627 619 0.0 578.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g6086.t1 P10079 41.258 795 6.08e-180 556.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g6086.t1 P10079 27.407 405 4.0699999999999996e-23 110.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g6087.t1 P46530 38.731 1056 0.0 708.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t1 P46530 40.881 976 0.0 687.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t1 P46530 36.81 1141 0.0 677.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t1 P46530 40.491 936 0.0 663.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t1 P46530 37.539 967 1.0200000000000002e-179 592.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t1 P46530 37.983 595 1.46e-119 416.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t2 P46530 38.731 1056 0.0 708.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t2 P46530 40.881 976 0.0 687.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t2 P46530 36.81 1141 0.0 677.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t2 P46530 40.491 936 0.0 663.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t2 P46530 37.539 967 9.289999999999999e-180 592.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6087.t2 P46530 37.983 595 1.4099999999999998e-119 416.0 sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio OX=7955 GN=notch1a PE=2 SV=1 NOTC1_DANRE reviewed Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001525; GO:0001756; GO:0001840; GO:0002244; GO:0005112; GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007368; GO:0009952; GO:0021514; GO:0021523; GO:0021531; GO:0021986; GO:0031016; GO:0031017; GO:0035907; GO:0038023; GO:0042663; GO:0048259; GO:0048337; GO:0048699; GO:0048936; GO:0050768; GO:0055016; GO:0060218; GO:0060271; GO:0061314; GO:1901222 angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal aorta development [GO:0035907]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; habenula development [GO:0021986]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hypochord development [GO:0055016]; negative regulation of neurogenesis [GO:0050768]; neural plate development [GO:0001840]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; positive regulation of mesodermal cell fate specification [GO:0048337]; regulation of DNA-templated transcription [GO:0006355]; regulation of endodermal cell fate specification [GO:0042663]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of receptor-mediated endocytosis [GO:0048259]; somatic motor neuron differentiation [GO:0021523]; somitogenesis [GO:0001756]; spinal cord radial glial cell differentiation [GO:0021531]; ventral spinal cord interneuron differentiation [GO:0021514] nucleus [GO:0005634]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] g6091.t1 Q5R629 56.406 640 0.0 701.0 sp|Q5R629|ARMC9_PONAB LisH domain-containing protein ARMC9 OS=Pongo abelii OX=9601 GN=ARMC9 PE=2 SV=1 ARMC9_PONAB reviewed LisH domain-containing protein ARMC9 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542 cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929] g6091.t2 Q5R629 56.447 636 0.0 695.0 sp|Q5R629|ARMC9_PONAB LisH domain-containing protein ARMC9 OS=Pongo abelii OX=9601 GN=ARMC9 PE=2 SV=1 ARMC9_PONAB reviewed LisH domain-containing protein ARMC9 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542 cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929] g6091.t3 Q5R629 56.447 636 0.0 694.0 sp|Q5R629|ARMC9_PONAB LisH domain-containing protein ARMC9 OS=Pongo abelii OX=9601 GN=ARMC9 PE=2 SV=1 ARMC9_PONAB reviewed LisH domain-containing protein ARMC9 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542 cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929] g6091.t4 Q5R629 56.447 636 0.0 695.0 sp|Q5R629|ARMC9_PONAB LisH domain-containing protein ARMC9 OS=Pongo abelii OX=9601 GN=ARMC9 PE=2 SV=1 ARMC9_PONAB reviewed LisH domain-containing protein ARMC9 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542 cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929] g6092.t1 O43447 78.531 177 2.16e-100 290.0 sp|O43447|PPIH_HUMAN Peptidyl-prolyl cis-trans isomerase H OS=Homo sapiens OX=9606 GN=PPIH PE=1 SV=1 PPIH_HUMAN reviewed Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP) Homo sapiens (Human) GO:0000398; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006457; GO:0016018; GO:0016607; GO:0043021; GO:0045070; GO:0046540; GO:0065003; GO:0071001 mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein-containing complex assembly [GO:0065003] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540] cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021] g6093.t1 P41824 56.571 175 1.97e-50 169.0 sp|P41824|YBOXH_APLCA Y-box factor homolog OS=Aplysia californica OX=6500 PE=2 SV=1 g6094.t1 P10160 74.51 153 4.0199999999999995e-82 241.0 sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2 g6095.t1 P10160 61.745 149 3.8100000000000005e-70 212.0 sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2 g6096.t1 Q17QM6 41.243 177 2.39e-34 125.0 sp|Q17QM6|EFHD1_BOVIN EF-hand domain-containing protein D1 OS=Bos taurus OX=9913 GN=EFHD1 PE=2 SV=1 g6097.t1 Q4R1I4 32.035 231 1.38e-21 102.0 sp|Q4R1I4|OPN4_BRABE Melanopsin OS=Branchiostoma belcheri OX=7741 GN=OPN4 PE=1 SV=1 OPN4_BRABE reviewed Melanopsin (Opsin-4) (amphi-MOP) Branchiostoma belcheri (Amphioxus) GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016020 G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; visual perception [GO:0007601] membrane [GO:0016020]; plasma membrane [GO:0005886] G protein-coupled photoreceptor activity [GO:0008020] g6099.t1 Q92685 62.899 407 2.4800000000000004e-163 469.0 sp|Q92685|ALG3_HUMAN Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG3 PE=1 SV=1 ALG3_HUMAN reviewed Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein) Homo sapiens (Human) GO:0000033; GO:0005783; GO:0005789; GO:0006487; GO:0006488; GO:0052925; GO:0098553 dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925] g6100.t1 Q5TIE3 41.952 584 9.32e-136 450.0 sp|Q5TIE3|VW5B1_HUMAN von Willebrand factor A domain-containing protein 5B1 OS=Homo sapiens OX=9606 GN=VWA5B1 PE=1 SV=2 g6101.t1 Q8IWE5 43.537 441 7.49e-114 381.0 sp|Q8IWE5|PKHM2_HUMAN Pleckstrin homology domain-containing family M member 2 OS=Homo sapiens OX=9606 GN=PLEKHM2 PE=1 SV=2 g6101.t1 Q8IWE5 42.683 164 1.0299999999999999e-38 160.0 sp|Q8IWE5|PKHM2_HUMAN Pleckstrin homology domain-containing family M member 2 OS=Homo sapiens OX=9606 GN=PLEKHM2 PE=1 SV=2 g6102.t1 Q13029 36.777 242 3.9200000000000004e-33 145.0 sp|Q13029|PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens OX=9606 GN=PRDM2 PE=1 SV=3 PRDM2_HUMAN reviewed PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0032259; GO:0043565; GO:0045944; GO:0140949 determination of adult lifespan [GO:0008340]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone H3K9 trimethyltransferase activity [GO:0140949]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6102.t1 Q13029 39.706 136 2.5599999999999997e-24 116.0 sp|Q13029|PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens OX=9606 GN=PRDM2 PE=1 SV=3 PRDM2_HUMAN reviewed PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0032259; GO:0043565; GO:0045944; GO:0140949 determination of adult lifespan [GO:0008340]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone H3K9 trimethyltransferase activity [GO:0140949]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6102.t2 Q13029 36.777 242 5.09e-33 144.0 sp|Q13029|PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens OX=9606 GN=PRDM2 PE=1 SV=3 PRDM2_HUMAN reviewed PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0032259; GO:0043565; GO:0045944; GO:0140949 determination of adult lifespan [GO:0008340]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone H3K9 trimethyltransferase activity [GO:0140949]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6102.t2 Q13029 39.706 136 1.7599999999999998e-24 116.0 sp|Q13029|PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens OX=9606 GN=PRDM2 PE=1 SV=3 PRDM2_HUMAN reviewed PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ) Homo sapiens (Human) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0032259; GO:0043565; GO:0045944; GO:0140949 determination of adult lifespan [GO:0008340]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone H3K9 trimethyltransferase activity [GO:0140949]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g6103.t1 O00461 35.169 236 5.1299999999999997e-23 108.0 sp|O00461|GOLI4_HUMAN Golgi integral membrane protein 4 OS=Homo sapiens OX=9606 GN=GOLIM4 PE=1 SV=1 GOLI4_HUMAN reviewed Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa) Homo sapiens (Human) GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0030133; GO:0030139; GO:0032580 cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133] g6103.t2 O00461 35.169 236 4.76e-23 108.0 sp|O00461|GOLI4_HUMAN Golgi integral membrane protein 4 OS=Homo sapiens OX=9606 GN=GOLIM4 PE=1 SV=1 GOLI4_HUMAN reviewed Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa) Homo sapiens (Human) GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0030133; GO:0030139; GO:0032580 cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133] g6103.t3 O00461 33.778 225 2.39e-23 109.0 sp|O00461|GOLI4_HUMAN Golgi integral membrane protein 4 OS=Homo sapiens OX=9606 GN=GOLIM4 PE=1 SV=1 GOLI4_HUMAN reviewed Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa) Homo sapiens (Human) GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0030133; GO:0030139; GO:0032580 cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133] g6104.t1 P21127 76.276 392 0.0 662.0 sp|P21127|CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens OX=9606 GN=CDK11B PE=1 SV=4 CD11B_HUMAN reviewed Cyclin-dependent kinase 11B (EC 2.7.11.22) (EC 2.7.11.23) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1) Homo sapiens (Human) GO:0000278; GO:0000307; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0042981; GO:0043484; GO:0046605; GO:0050684; GO:0051726; GO:0071962; GO:0106310 apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of DNA-templated transcription [GO:0006355]; regulation of mRNA processing [GO:0050684]; regulation of RNA splicing [GO:0043484] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g6104.t2 P21127 76.276 392 0.0 662.0 sp|P21127|CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens OX=9606 GN=CDK11B PE=1 SV=4 CD11B_HUMAN reviewed Cyclin-dependent kinase 11B (EC 2.7.11.22) (EC 2.7.11.23) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1) Homo sapiens (Human) GO:0000278; GO:0000307; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0042981; GO:0043484; GO:0046605; GO:0050684; GO:0051726; GO:0071962; GO:0106310 apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of DNA-templated transcription [GO:0006355]; regulation of mRNA processing [GO:0050684]; regulation of RNA splicing [GO:0043484] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] g6105.t1 Q5T0D9 37.674 215 1.2e-49 169.0 sp|Q5T0D9|TPRGL_HUMAN Tumor protein p63-regulated gene 1-like protein OS=Homo sapiens OX=9606 GN=TPRG1L PE=1 SV=1 g6117.t1 Q8BLQ7 39.832 595 4.7599999999999996e-126 389.0 sp|Q8BLQ7|CTR4_MOUSE Cationic amino acid transporter 4 OS=Mus musculus OX=10090 GN=Slc7a4 PE=1 SV=1 g6118.t1 P24392 45.752 306 2.62e-87 266.0 sp|P24392|PEX2_RAT Peroxisome biogenesis factor 2 OS=Rattus norvegicus OX=10116 GN=Pex2 PE=2 SV=1 PEX2_RAT reviewed Peroxisome biogenesis factor 2 (EC 2.3.2.27) (EC 2.3.2.36) (Peroxin-2) (Peroxisomal membrane protein 3) (Peroxisome assembly factor 1) (PAF-1) Rattus norvegicus (Rat) GO:0000038; GO:0000425; GO:0001764; GO:0005654; GO:0005777; GO:0005778; GO:0006513; GO:0006635; GO:0006699; GO:0007031; GO:0007399; GO:0008270; GO:0016558; GO:0016562; GO:0016593; GO:0031648; GO:0034614; GO:0042632; GO:0043335; GO:0044721; GO:0045540; GO:0048147; GO:0050680; GO:0061630; GO:1990928 bile acid biosynthetic process [GO:0006699]; cellular response to reactive oxygen species [GO:0034614]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein monoubiquitination [GO:0006513]; protein unfolding [GO:0043335]; regulation of cholesterol biosynthetic process [GO:0045540]; response to amino acid starvation [GO:1990928]; very long-chain fatty acid metabolic process [GO:0000038] Cdc73/Paf1 complex [GO:0016593]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g6120.t1 Q5TZA2 43.921 2122 0.0 1410.0 sp|Q5TZA2|CROCC_HUMAN Rootletin OS=Homo sapiens OX=9606 GN=CROCC PE=1 SV=2 CROCC_HUMAN reviewed Rootletin (Ciliary rootlet coiled-coil protein) Homo sapiens (Human) GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019725; GO:0019894; GO:0032053; GO:0035253; GO:0035869; GO:0036064; GO:0045494; GO:0045724; GO:0051649; GO:0051656; GO:0070062; GO:0097225; GO:0097386; GO:0120219; GO:1903566 cellular homeostasis [GO:0019725]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; establishment of organelle localization [GO:0051656]; intracellular protein localization [GO:0008104]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566] actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; subapical part of cell [GO:0120219] actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] g6120.t2 Q5TZA2 43.957 2118 0.0 1417.0 sp|Q5TZA2|CROCC_HUMAN Rootletin OS=Homo sapiens OX=9606 GN=CROCC PE=1 SV=2 CROCC_HUMAN reviewed Rootletin (Ciliary rootlet coiled-coil protein) Homo sapiens (Human) GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019725; GO:0019894; GO:0032053; GO:0035253; GO:0035869; GO:0036064; GO:0045494; GO:0045724; GO:0051649; GO:0051656; GO:0070062; GO:0097225; GO:0097386; GO:0120219; GO:1903566 cellular homeostasis [GO:0019725]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; establishment of organelle localization [GO:0051656]; intracellular protein localization [GO:0008104]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566] actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; subapical part of cell [GO:0120219] actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] g6121.t1 Q95JN5 43.152 1161 0.0 920.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g6122.t1 Q8BLQ7 41.46 644 9.919999999999999e-147 442.0 sp|Q8BLQ7|CTR4_MOUSE Cationic amino acid transporter 4 OS=Mus musculus OX=10090 GN=Slc7a4 PE=1 SV=1 g6123.t1 Q9V477 26.54 844 1.3500000000000001e-58 223.0 sp|Q9V477|TOLL8_DROME Toll-like receptor Tollo OS=Drosophila melanogaster OX=7227 GN=Tollo PE=1 SV=1 TOLL8_DROME reviewed Toll-like receptor Tollo (Toll-like receptor 8) Drosophila melanogaster (Fruit fly) GO:0003401; GO:0005886; GO:0007165; GO:0010559; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026 axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of glycoprotein biosynthetic process [GO:0010559]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886] receptor ligand activity [GO:0048018] g6126.t1 O94923 62.5 96 9.18e-36 130.0 sp|O94923|GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3 GLCE_HUMAN reviewed D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase) Homo sapiens (Human) GO:0000139; GO:0005509; GO:0005794; GO:0008284; GO:0015012; GO:0016857; GO:0030210; GO:0031345; GO:0042803; GO:0047464; GO:0060391 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857] g6127.t1 Q9EPS3 67.769 121 5.609999999999999e-54 181.0 sp|Q9EPS3|GLCE_MOUSE D-glucuronyl C5-epimerase OS=Mus musculus OX=10090 GN=Glce PE=1 SV=2 GLCE_MOUSE reviewed D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin sulfate C5-epimerase) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase) Mus musculus (Mouse) GO:0000139; GO:0005509; GO:0005794; GO:0008284; GO:0015012; GO:0016857; GO:0030210; GO:0031345; GO:0042803; GO:0047464; GO:0050379; GO:0060391 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; UDP-glucuronate 5'-epimerase activity [GO:0050379] g6128.t1 F1QR43 52.033 246 1.66e-78 254.0 sp|F1QR43|GLCEB_DANRE D-glucuronyl C5-epimerase B OS=Danio rerio OX=7955 GN=glceb PE=1 SV=1 GLCEB_DANRE reviewed D-glucuronyl C5-epimerase B (EC 5.1.3.17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005794; GO:0015012; GO:0030210; GO:0042802; GO:0046872; GO:0047464 heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] g6129.t1 Q5R4Q3 44.386 383 2.39e-85 267.0 sp|Q5R4Q3|SEC62_PONAB Translocation protein SEC62 OS=Pongo abelii OX=9601 GN=SEC62 PE=2 SV=1 g6130.t1 Q95JN5 42.416 1167 0.0 899.0 sp|Q95JN5|AT133_MACFA Polyamine-transporting ATPase 13A3 OS=Macaca fascicularis OX=9541 GN=ATP13A3 PE=2 SV=3 AT133_MACFA reviewed Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0005524; GO:0006874; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358 intracellular calcium ion homeostasis [GO:0006874] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358] g6132.t1 P70627 33.582 670 1.63e-120 383.0 sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1 g6133.t1 O95619 77.477 222 3.1099999999999997e-119 341.0 sp|O95619|YETS4_HUMAN YEATS domain-containing protein 4 OS=Homo sapiens OX=9606 GN=YEATS4 PE=1 SV=1 YETS4_HUMAN reviewed YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1) Homo sapiens (Human) GO:0000278; GO:0000786; GO:0005200; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0016363; GO:0031965; GO:0035267; GO:0042393; GO:0042981; GO:0045893; GO:0051726; GO:0140044; GO:0140119; GO:1905168; GO:2000779 chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357] NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; structural constituent of cytoskeleton [GO:0005200] g6135.t1 Q3B7T6 68.201 239 5.8000000000000005e-118 339.0 sp|Q3B7T6|CNEP1_RAT CTD nuclear envelope phosphatase 1 OS=Rattus norvegicus OX=10116 GN=Ctdnep1 PE=2 SV=2 CNEP1_RAT reviewed CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard) Rattus norvegicus (Rat) GO:0004721; GO:0004722; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005811; GO:0006998; GO:0007276; GO:0007498; GO:0010867; GO:0031965; GO:0034504; GO:0071595; GO:0090263 gamete generation [GO:0007276]; mesoderm development [GO:0007498]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722] g6147.t1 P18910 63.134 217 9.349999999999999e-82 283.0 sp|P18910|ANPRA_RAT Atrial natriuretic peptide receptor 1 OS=Rattus norvegicus OX=10116 GN=Npr1 PE=1 SV=1 ANPRA_RAT reviewed Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) Rattus norvegicus (Rat) GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0035556; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114] ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] g6151.t1 Q6PAX2 65.7 586 0.0 775.0 sp|Q6PAX2|ATD3B_XENLA ATPase family AAA domain-containing protein 3-B OS=Xenopus laevis OX=8355 GN=atad3-b PE=2 SV=1 ATD3B_XENLA reviewed ATPase family AAA domain-containing protein 3-B (EC 3.6.1.-) Xenopus laevis (African clawed frog) GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0008270; GO:0016887; GO:0030291; GO:0042645; GO:1903898 mitochondrion organization [GO:0007005]; negative regulation of PERK-mediated unfolded protein response [GO:1903898] mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein serine/threonine kinase inhibitor activity [GO:0030291]; zinc ion binding [GO:0008270] g6159.t1 A8E7I5 51.63 184 1.4600000000000002e-59 187.0 sp|A8E7I5|TTC36_DANRE Tetratricopeptide repeat protein 36 OS=Danio rerio OX=7955 GN=ttc36 PE=2 SV=1 g6166.t1 Q0E908 29.225 503 3.0400000000000002e-58 220.0 sp|Q0E908|HIL_DROME Hillarin OS=Drosophila melanogaster OX=7227 GN=Hil PE=1 SV=1 HIL_DROME reviewed Hillarin (D-Hillarin) (D-hil) Drosophila melanogaster (Fruit fly) GO:0005737; GO:0005938; GO:0032154; GO:0046872 cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737] metal ion binding [GO:0046872] g6167.t1 Q5THJ4 46.739 368 3.17e-102 334.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g6168.t1 Q5THJ4 34.622 1863 0.0 946.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g6168.t1 Q5THJ4 39.231 780 2.23e-147 520.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g6169.t1 Q5THJ4 43.187 1343 0.0 1045.0 sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2 VP13D_HUMAN reviewed Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) Homo sapiens (Human) GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526 lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] g6170.t1 Q9CQA3 73.646 277 8.03e-153 431.0 sp|Q9CQA3|SDHB_MOUSE Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Mus musculus OX=10090 GN=Sdhb PE=1 SV=1 SDHB_MOUSE reviewed Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) (Malate dehydrogenase [quinone] iron-sulfur subunit) (EC 1.1.5.-) Mus musculus (Mouse) GO:0005654; GO:0005739; GO:0005743; GO:0005886; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0042776; GO:0045273; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539 aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; respiratory chain complex II (succinate dehydrogenase) [GO:0045273] 2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (quinone) activity [GO:0008177]; ubiquinone binding [GO:0048039] g6171.t1 Q8BGC3 28.155 412 5.159999999999999e-38 146.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g6172.t1 Q7RTX9 27.579 475 3.34e-46 170.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g6174.t1 Q6NRV0 32.495 477 6.11e-63 213.0 sp|Q6NRV0|TRAIP_XENLA E3 ubiquitin-protein ligase TRAIP OS=Xenopus laevis OX=8355 GN=traip PE=1 SV=2 TRAIP_XENLA reviewed E3 ubiquitin-protein ligase TRAIP (EC 2.3.2.27) (TRAF-interacting protein) Xenopus laevis (African clawed frog) GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0006974; GO:0008270; GO:0016567; GO:0031297; GO:0036297; GO:0061630; GO:0090734; GO:0106300; GO:1904931 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] MCM complex binding [GO:1904931]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6176.t1 P33534 27.077 325 8.36e-24 103.0 sp|P33534|OPRK_MOUSE Kappa-type opioid receptor OS=Mus musculus OX=10090 GN=Oprk1 PE=1 SV=1 OPRK_MOUSE reviewed Kappa-type opioid receptor (K-OR-1) (KOR-1) (MSL-1) Mus musculus (Mouse) GO:0004985; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006955; GO:0007200; GO:0007218; GO:0007626; GO:0016020; GO:0016529; GO:0019233; GO:0030315; GO:0030425; GO:0030672; GO:0031635; GO:0032868; GO:0033603; GO:0033612; GO:0033685; GO:0035094; GO:0038003; GO:0038048; GO:0042383; GO:0042711; GO:0042734; GO:0042755; GO:0042923; GO:0043005; GO:0043025; GO:0043204; GO:0043627; GO:0043679; GO:0044849; GO:0045211; GO:0045471; GO:0046877; GO:0048148; GO:0050951; GO:0051607; GO:0071222; GO:0071333; GO:1900745; GO:1901381; GO:1903937; GO:1904000; GO:1990708 adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; response to acrylamide [GO:1903937]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951] axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synaptic vesicle membrane [GO:0030672]; T-tubule [GO:0030315] dynorphin receptor activity [GO:0038048]; G protein-coupled opioid receptor activity [GO:0004985]; neuropeptide binding [GO:0042923]; receptor serine/threonine kinase binding [GO:0033612] g6182.t1 Q9I7S6 54.798 396 2.29e-143 453.0 sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2 g6185.t1 Q8JZW5 38.514 148 6.429999999999999e-23 106.0 sp|Q8JZW5|SH2D5_MOUSE SH2 domain-containing protein 5 OS=Mus musculus OX=10090 GN=Sh2d5 PE=1 SV=3 g6187.t1 P30937 27.795 331 8.69e-24 105.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g6188.t1 P30937 27.147 361 1.99e-22 101.0 sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 SSR4_RAT reviewed Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R) Rattus norvegicus (Rat) GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] neuron projection [GO:0043005]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994] g6190.t1 Q9PVK2 78.241 432 0.0 711.0 sp|Q9PVK2|ENOA_ALLMI Alpha-enolase OS=Alligator mississippiensis OX=8496 PE=2 SV=3 g6191.t1 A5PJ65 72.581 186 4.25e-101 293.0 sp|A5PJ65|RER1_BOVIN Protein RER1 OS=Bos taurus OX=9913 GN=RER1 PE=2 SV=2 g6192.t1 Q8N357 56.233 361 3.22e-130 383.0 sp|Q8N357|S35F6_HUMAN Solute carrier family 35 member F6 OS=Homo sapiens OX=9606 GN=SLC35F6 PE=1 SV=1 S35F6_HUMAN reviewed Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog) Homo sapiens (Human) GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0022857; GO:0070062; GO:1901029 negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] transmembrane transporter activity [GO:0022857] g6193.t1 P54714 67.339 248 1.62e-126 361.0 sp|P54714|TPIS_CANLF Triosephosphate isomerase OS=Canis lupus familiaris OX=9615 GN=TPI1 PE=1 SV=3 g6194.t1 Q66JG1 48.861 395 1e-130 392.0 sp|Q66JG1|DDB2_XENTR DNA damage-binding protein 2 OS=Xenopus tropicalis OX=8364 GN=ddb2 PE=2 SV=1 g6195.t1 Q9JJS6 40.267 524 1.27e-130 394.0 sp|Q9JJS6|BCDO1_MOUSE Beta,beta-carotene 15,15'-dioxygenase OS=Mus musculus OX=10090 GN=Bco1 PE=1 SV=2 BCDO1_MOUSE reviewed Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1) Mus musculus (Mouse) GO:0001523; GO:0003834; GO:0005829; GO:0010436; GO:0016121; GO:0042572; GO:0042574; GO:0046872; GO:1901810 beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] cytosol [GO:0005829] beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872] g6197.t1 Q6VFT5 84.848 99 1.31e-54 187.0 sp|Q6VFT5|FOXL2_RABIT Forkhead box protein L2 OS=Oryctolagus cuniculus OX=9986 GN=FOXL2 PE=3 SV=1 g6198.t1 O55029 65.076 461 0.0 615.0 sp|O55029|COPB2_MOUSE Coatomer subunit beta' OS=Mus musculus OX=10090 GN=Copb2 PE=1 SV=2 COPB2_MOUSE reviewed Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102) Mus musculus (Mouse) GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198] g6199.t1 O55029 82.275 378 0.0 686.0 sp|O55029|COPB2_MOUSE Coatomer subunit beta' OS=Mus musculus OX=10090 GN=Copb2 PE=1 SV=2 COPB2_MOUSE reviewed Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102) Mus musculus (Mouse) GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198] g6200.t1 D3ZFW5 51.908 131 1.84e-46 150.0 sp|D3ZFW5|TM107_RAT Transmembrane protein 107 OS=Rattus norvegicus OX=10116 GN=Tmem107 PE=3 SV=1 g6201.t1 Q9CWL2 46.638 461 3.75e-118 417.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g6201.t1 Q9CWL2 53.03 198 2.1000000000000002e-58 227.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g6201.t1 Q9CWL2 33.523 176 8.789999999999999e-25 117.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g6201.t1 Q9CWL2 32.184 174 1.35e-23 113.0 sp|Q9CWL2|CASZ1_MOUSE Zinc finger protein castor homolog 1 OS=Mus musculus OX=10090 GN=Casz1 PE=1 SV=3 CASZ1_MOUSE reviewed Zinc finger protein castor homolog 1 (Castor-related protein) Mus musculus (Mouse) GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0045596; GO:0045664; GO:0045665; GO:0045893; GO:0045944; GO:0060040; GO:0060223; GO:0060226; GO:1902870 negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neuron differentiation [GO:0045664]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270] g6202.t1 Q32KP2 53.795 303 1.19e-99 299.0 sp|Q32KP2|LRC23_BOVIN Leucine-rich repeat-containing protein 23 OS=Bos taurus OX=9913 GN=LRRC23 PE=2 SV=1 g6204.t1 P58058 58.793 381 2.77e-148 434.0 sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2 g6204.t2 P58058 58.639 382 1.88e-147 433.0 sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2 g6205.t1 Q8WYP5 32.617 1257 1.7700000000000002e-161 551.0 sp|Q8WYP5|ELYS_HUMAN Protein ELYS OS=Homo sapiens OX=9606 GN=AHCTF1 PE=1 SV=3 g6208.t1 Q8TBB6 25.038 659 2.62e-53 200.0 sp|Q8TBB6|S7A14_HUMAN Solute carrier family 7 member 14 OS=Homo sapiens OX=9606 GN=SLC7A14 PE=1 SV=3 S7A14_HUMAN reviewed Solute carrier family 7 member 14 (Gamma-aminobutyric acid transporter SLC7A14) Homo sapiens (Human) GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0015171; GO:0015185; GO:0051939 amino acid transport [GO:0006865]; gamma-aminobutyric acid import [GO:0051939] cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185] g6209.t1 Q8TBB6 56.714 633 0.0 674.0 sp|Q8TBB6|S7A14_HUMAN Solute carrier family 7 member 14 OS=Homo sapiens OX=9606 GN=SLC7A14 PE=1 SV=3 S7A14_HUMAN reviewed Solute carrier family 7 member 14 (Gamma-aminobutyric acid transporter SLC7A14) Homo sapiens (Human) GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0015171; GO:0015185; GO:0051939 amino acid transport [GO:0006865]; gamma-aminobutyric acid import [GO:0051939] cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185] g6210.t1 Q1JQ91 54.861 144 8.76e-42 137.0 sp|Q1JQ91|RPB4_BOVIN DNA-directed RNA polymerase II subunit RPB4 OS=Bos taurus OX=9913 GN=POLR2D PE=1 SV=1 g6211.t1 O75391 56.279 215 1.8199999999999998e-81 246.0 sp|O75391|SPAG7_HUMAN Sperm-associated antigen 7 OS=Homo sapiens OX=9606 GN=SPAG7 PE=1 SV=2 g6212.t1 Q8J0F5 27.566 1179 1.7499999999999999e-115 401.0 sp|Q8J0F5|MLCB_PENCI Compactin diketide synthase mlcB OS=Penicillium citrinum OX=5077 GN=mlcB PE=1 SV=1 g6213.t1 A0A6S5ZY48 29.637 496 1.88e-49 189.0 sp|A0A6S5ZY48|G433_FUSSX Highly reducing polyketide synthase g433 OS=Fusarium sp. OX=29916 GN=g433 PE=2 SV=1 G433_FUSSX reviewed Highly reducing polyketide synthase g433 (HR-PKS g433) (EC 2.3.1.-) (1233A biosynthesis cluster protein g433) Fusarium sp GO:0004312; GO:0004315; GO:0006633; GO:0008168; GO:0016491; GO:0031177; GO:0032259; GO:0044550 fatty acid biosynthetic process [GO:0006633]; methylation [GO:0032259]; secondary metabolite biosynthetic process [GO:0044550] 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid synthase activity [GO:0004312]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177] g6214.t1 A0A0L1JG62 40.956 481 4.01e-108 357.0 sp|A0A0L1JG62|RSTN3_ASPN3 Highly reducing polyketide synthase rstn3 OS=Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 / M93) OX=1509407 GN=rstn3 PE=3 SV=1 g6215.t1 Q5AY39 26.274 2630 0.0 768.0 sp|Q5AY39|PKS91_EMENI Highly reducing polyketide synthase AN6791 OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=AN6791 PE=2 SV=1 PKS91_EMENI reviewed Highly reducing polyketide synthase AN6791 (HR-PKS) (EC 2.3.1.-) Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans) GO:0004312; GO:0006633; GO:0008168; GO:0008270; GO:0016491; GO:0019748; GO:0030639; GO:0031177; GO:0032259; GO:0044550; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; methylation [GO:0032259]; polyketide biosynthetic process [GO:0030639]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] fatty acid synthase activity [GO:0004312]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; zinc ion binding [GO:0008270] g6216.t1 Q5AY39 27.3 2619 0.0 845.0 sp|Q5AY39|PKS91_EMENI Highly reducing polyketide synthase AN6791 OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=AN6791 PE=2 SV=1 PKS91_EMENI reviewed Highly reducing polyketide synthase AN6791 (HR-PKS) (EC 2.3.1.-) Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans) GO:0004312; GO:0006633; GO:0008168; GO:0008270; GO:0016491; GO:0019748; GO:0030639; GO:0031177; GO:0032259; GO:0044550; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; methylation [GO:0032259]; polyketide biosynthetic process [GO:0030639]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] fatty acid synthase activity [GO:0004312]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; zinc ion binding [GO:0008270] g6217.t1 Q5AY39 27.353 2614 0.0 840.0 sp|Q5AY39|PKS91_EMENI Highly reducing polyketide synthase AN6791 OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=AN6791 PE=2 SV=1 PKS91_EMENI reviewed Highly reducing polyketide synthase AN6791 (HR-PKS) (EC 2.3.1.-) Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans) GO:0004312; GO:0006633; GO:0008168; GO:0008270; GO:0016491; GO:0019748; GO:0030639; GO:0031177; GO:0032259; GO:0044550; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; methylation [GO:0032259]; polyketide biosynthetic process [GO:0030639]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] fatty acid synthase activity [GO:0004312]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; zinc ion binding [GO:0008270] g6218.t1 Q28505 39.811 530 3.1499999999999996e-138 413.0 sp|Q28505|FMO2_MACMU Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Macaca mulatta OX=9544 GN=FMO2 PE=1 SV=2 g6227.t1 P46087 60.297 471 0.0 583.0 sp|P46087|NOP2_HUMAN 28S rRNA (cytosine(4447)-C(5))-methyltransferase OS=Homo sapiens OX=9606 GN=NOP2 PE=1 SV=2 NOP2_HUMAN reviewed 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120) Homo sapiens (Human) GO:0000027; GO:0000470; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0008284; GO:0009383; GO:0042273; GO:0070475; GO:1901796 maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383] g6229.t1 Q505F5 41.133 406 6.06e-83 267.0 sp|Q505F5|LRC47_MOUSE Leucine-rich repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Lrrc47 PE=1 SV=1 g6231.t1 D4A1X2 42.208 924 0.0 672.0 sp|D4A1X2|EXOSX_RAT Exosome complex component 10 OS=Rattus norvegicus OX=10116 GN=Exosc10 PE=1 SV=2 EXOSX_RAT reviewed Exosome complex component 10 (EC 3.1.13.-) Rattus norvegicus (Rat) GO:0000166; GO:0000175; GO:0000176; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006396; GO:0006401; GO:0032040; GO:0032211; GO:0042274; GO:0046872; GO:0060816; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:1904872; GO:1905746 CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; random inactivation of X chromosome [GO:0060816]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; TRAMP-dependent tRNA surveillance pathway [GO:0071038] cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] 3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA exonuclease activity [GO:0004532]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034] g6232.t1 P38166 31.915 188 1.1e-28 110.0 sp|P38166|SFT2_YEAST Protein transport protein SFT2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=SFT2 PE=1 SV=1 g6234.t1 O60645 23.817 634 2.35e-39 158.0 sp|O60645|EXOC3_HUMAN Exocyst complex component 3 OS=Homo sapiens OX=9606 GN=EXOC3 PE=1 SV=3 EXOC3_HUMAN reviewed Exocyst complex component 3 (Exocyst complex component Sec6) Homo sapiens (Human) GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0005829; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0045296; GO:0048471; GO:0051601; GO:0090148; GO:0090522 exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667] cadherin binding [GO:0045296]; SNARE binding [GO:0000149] g6235.t1 Q5T089 63.0 100 1.1e-34 129.0 sp|Q5T089|MORN1_HUMAN MORN repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=MORN1 PE=1 SV=2 g6237.t1 Q5BKL9 39.157 332 1.78e-68 222.0 sp|Q5BKL9|CAB45_XENTR 45 kDa calcium-binding protein OS=Xenopus tropicalis OX=8364 GN=sdf4 PE=2 SV=1 g6238.t1 Q91Z92 53.546 282 8.19e-107 318.0 sp|Q91Z92|B3GT6_MOUSE Beta-1,3-galactosyltransferase 6 OS=Mus musculus OX=10090 GN=B3galt6 PE=2 SV=1 B3GT6_MOUSE reviewed Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6) Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006493; GO:0015012; GO:0030166; GO:0032580; GO:0035250; GO:0047220; GO:0050650; GO:0050651 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked glycosylation [GO:0006493]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactosyltransferase activity [GO:0035250] g6239.t1 Q91Z92 46.296 324 1.05e-106 318.0 sp|Q91Z92|B3GT6_MOUSE Beta-1,3-galactosyltransferase 6 OS=Mus musculus OX=10090 GN=B3galt6 PE=2 SV=1 B3GT6_MOUSE reviewed Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6) Mus musculus (Mouse) GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006493; GO:0015012; GO:0030166; GO:0032580; GO:0035250; GO:0047220; GO:0050650; GO:0050651 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked glycosylation [GO:0006493]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139] galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactosyltransferase activity [GO:0035250] g6244.t1 Q5FVM7 32.044 827 4.55e-120 384.0 sp|Q5FVM7|DJC16_RAT DnaJ homolog subfamily C member 16 OS=Rattus norvegicus OX=10116 GN=Dnajc16 PE=2 SV=1 DJC16_RAT reviewed DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8) Rattus norvegicus (Rat) GO:0005789; GO:0016243 regulation of autophagosome size [GO:0016243] endoplasmic reticulum membrane [GO:0005789] g6245.t1 Q7L2J0 42.561 531 1.7599999999999998e-119 373.0 sp|Q7L2J0|MEPCE_HUMAN 7SK snRNA methylphosphate capping enzyme OS=Homo sapiens OX=9606 GN=MEPCE PE=1 SV=1 MEPCE_HUMAN reviewed 7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) Homo sapiens (Human) GO:0000122; GO:0001510; GO:0003723; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:0097322; GO:0120259; GO:1900087; GO:1904871; GO:1905382; GO:1990276; GO:1990904 negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031] 7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-gamma-phosphate methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069] g6246.t1 P70059 42.248 258 9.19e-58 187.0 sp|P70059|TRY2_XENLA Trypsin OS=Xenopus laevis OX=8355 PE=2 SV=1 g6247.t1 A0A0R4IB93 38.462 338 1.59e-63 219.0 sp|A0A0R4IB93|UBP48_DANRE Ubiquitin carboxyl-terminal hydrolase 48 OS=Danio rerio OX=7955 GN=usp48 PE=3 SV=1 UBP48_DANRE reviewed Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001966; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0010975; GO:0010996; GO:0016579; GO:0031647; GO:1904888 cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; response to auditory stimulus [GO:0010996]; thigmotaxis [GO:0001966] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g6248.t1 A0A0R4IB93 55.644 629 0.0 731.0 sp|A0A0R4IB93|UBP48_DANRE Ubiquitin carboxyl-terminal hydrolase 48 OS=Danio rerio OX=7955 GN=usp48 PE=3 SV=1 UBP48_DANRE reviewed Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001966; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0010975; GO:0010996; GO:0016579; GO:0031647; GO:1904888 cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; response to auditory stimulus [GO:0010996]; thigmotaxis [GO:0001966] cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] g6249.t1 P39675 42.537 268 2.3999999999999998e-54 179.0 sp|P39675|DERP3_DERPT Mite allergen Der p 3 OS=Dermatophagoides pteronyssinus OX=6956 GN=DERP3 PE=1 SV=1 g6250.t1 P70059 44.815 270 2.03e-61 197.0 sp|P70059|TRY2_XENLA Trypsin OS=Xenopus laevis OX=8355 PE=2 SV=1 g6251.t1 P00760 44.867 263 1.75e-54 179.0 sp|P00760|TRY1_BOVIN Serine protease 1 OS=Bos taurus OX=9913 GN=PRSS1 PE=1 SV=3 TRY1_BOVIN reviewed Serine protease 1 (EC 3.4.21.4) (Anionic trypsin I) (Anionic trypsin-I) (Beta-trypsin) (Cationic trypsin) (Pretrypsinogen I) (Trypsin I) (Trypsin-I) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2] Bos taurus (Bovine) GO:0004175; GO:0004252; GO:0005615; GO:0006508; GO:0007586; GO:0046872; GO:0097180; GO:0097655 digestion [GO:0007586]; proteolysis [GO:0006508] extracellular space [GO:0005615]; serine protease inhibitor complex [GO:0097180] endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; serpin family protein binding [GO:0097655] g6253.t1 Q9Y4G2 38.333 180 5.22e-37 144.0 sp|Q9Y4G2|PKHM1_HUMAN Pleckstrin homology domain-containing family M member 1 OS=Homo sapiens OX=9606 GN=PLEKHM1 PE=1 SV=3 PKHM1_HUMAN reviewed Pleckstrin homology domain-containing family M member 1 (PH domain-containing family M member 1) (162 kDa adapter protein) (AP162) Homo sapiens (Human) GO:0005654; GO:0005730; GO:0005764; GO:0008270; GO:0015031; GO:0031902; GO:0032418; GO:0044754; GO:0045780; GO:0061909; GO:0120281; GO:1900029; GO:1902774 autophagosome-lysosome fusion [GO:0061909]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031] autolysosome [GO:0044754]; autolysosome membrane [GO:0120281]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] zinc ion binding [GO:0008270] g6254.t1 Q08AW4 42.126 254 3.35e-58 202.0 sp|Q08AW4|PKHM3_XENLA Pleckstrin homology domain-containing family M member 3 OS=Xenopus laevis OX=8355 GN=plekhm3 PE=2 SV=1 g6254.t2 Q08AW4 42.126 254 3.01e-58 203.0 sp|Q08AW4|PKHM3_XENLA Pleckstrin homology domain-containing family M member 3 OS=Xenopus laevis OX=8355 GN=plekhm3 PE=2 SV=1 g6254.t3 Q08AW4 37.621 311 1.87e-58 202.0 sp|Q08AW4|PKHM3_XENLA Pleckstrin homology domain-containing family M member 3 OS=Xenopus laevis OX=8355 GN=plekhm3 PE=2 SV=1 g6257.t1 Q9I7F7 47.967 369 2.55e-91 324.0 sp|Q9I7F7|ACKL_DROME Activated Cdc42 kinase-like OS=Drosophila melanogaster OX=7227 GN=Ack-like PE=1 SV=3 ACKL_DROME reviewed Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004715; GO:0005524; GO:0005886; GO:0006468; GO:0008258; GO:0031034; GO:0046664 dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468] plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] g6261.t1 Q8WZA0 67.914 187 1.28e-88 261.0 sp|Q8WZA0|LZIC_HUMAN Protein LZIC OS=Homo sapiens OX=9606 GN=LZIC PE=1 SV=1 g6262.t1 B0S5G3 42.525 602 2.75e-147 451.0 sp|B0S5G3|CSTN2_DANRE Calsyntenin-2 OS=Danio rerio OX=7955 GN=clstn2a PE=1 SV=1 CSTN2_DANRE reviewed Calsyntenin-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0030425; GO:0045211; GO:0050806; GO:0051965 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806] cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509] g6262.t2 B0S5G3 41.83 612 1.99e-144 444.0 sp|B0S5G3|CSTN2_DANRE Calsyntenin-2 OS=Danio rerio OX=7955 GN=clstn2a PE=1 SV=1 CSTN2_DANRE reviewed Calsyntenin-2 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0030425; GO:0045211; GO:0050806; GO:0051965 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806] cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; postsynaptic membrane [GO:0045211] calcium ion binding [GO:0005509] g6263.t1 O94985 34.796 319 1.33e-34 137.0 sp|O94985|CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens OX=9606 GN=CLSTN1 PE=1 SV=1 CSTN1_HUMAN reviewed Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)] Homo sapiens (Human) GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0014069; GO:0019894; GO:0042988; GO:0043005; GO:0045211; GO:0050806; GO:0051965; GO:0090128; GO:0098845; GO:0098969; GO:0098978; GO:0099003 cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988] g6264.t1 Q0IHQ9 33.189 461 6.47e-53 191.0 sp|Q0IHQ9|PXYP1_XENTR 2-phosphoxylose phosphatase 1 OS=Xenopus tropicalis OX=8364 GN=pxylp1 PE=2 SV=1 PXYP1_XENTR reviewed 2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016791; GO:0050650 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] phosphatase activity [GO:0016791] g6265.t1 Q6DG32 59.295 312 8.76e-123 358.0 sp|Q6DG32|S2536_DANRE Solute carrier family 25 member 36-A OS=Danio rerio OX=7955 GN=slc25a36a PE=2 SV=1 g6266.t1 Q4FZY0 65.969 191 1.51e-73 224.0 sp|Q4FZY0|EFHD2_RAT EF-hand domain-containing protein D2 OS=Rattus norvegicus OX=10116 GN=Efhd2 PE=1 SV=1 g6267.t1 A6PWD2 26.309 1452 2e-106 373.0 sp|A6PWD2|FHAD1_MOUSE Forkhead-associated domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fhad1 PE=1 SV=1 FHAD1_MOUSE reviewed Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1) Mus musculus (Mouse) GO:0006915; GO:0007283; GO:0030154; GO:0036126; GO:0051321 apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283] sperm flagellum [GO:0036126] g6267.t2 A6PWD2 25.311 1529 6.160000000000001e-97 346.0 sp|A6PWD2|FHAD1_MOUSE Forkhead-associated domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fhad1 PE=1 SV=1 FHAD1_MOUSE reviewed Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1) Mus musculus (Mouse) GO:0006915; GO:0007283; GO:0030154; GO:0036126; GO:0051321 apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283] sperm flagellum [GO:0036126] g6267.t3 A6PWD2 25.733 1500 1.63e-100 357.0 sp|A6PWD2|FHAD1_MOUSE Forkhead-associated domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fhad1 PE=1 SV=1 FHAD1_MOUSE reviewed Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1) Mus musculus (Mouse) GO:0006915; GO:0007283; GO:0030154; GO:0036126; GO:0051321 apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283] sperm flagellum [GO:0036126] g6267.t4 A6PWD2 25.682 1503 5.96e-99 352.0 sp|A6PWD2|FHAD1_MOUSE Forkhead-associated domain-containing protein 1 OS=Mus musculus OX=10090 GN=Fhad1 PE=1 SV=1 FHAD1_MOUSE reviewed Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1) Mus musculus (Mouse) GO:0006915; GO:0007283; GO:0030154; GO:0036126; GO:0051321 apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283] sperm flagellum [GO:0036126] g6268.t1 Q5XJ36 62.842 183 6.27e-77 231.0 sp|Q5XJ36|PARK7_DANRE Parkinson disease protein 7 homolog OS=Danio rerio OX=7955 GN=park7 PE=2 SV=1 PARK7_DANRE reviewed Parkinson disease protein 7 homolog (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1zDJ-1) (zDJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001895; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005886; GO:0006281; GO:0006508; GO:0006914; GO:0006954; GO:0006979; GO:0007338; GO:0008233; GO:0016684; GO:0030073; GO:0034599; GO:0036269; GO:0042593; GO:0042803; GO:0043523; GO:0045121; GO:0046295; GO:0050821; GO:0061691; GO:0071542; GO:0106044; GO:0106045; GO:0106046; GO:1903189; GO:1903427; GO:1990422; GO:2000277 autophagy [GO:0006914]; cellular response to oxidative stress [GO:0034599]; detoxification of hydrogen peroxide [GO:0061691]; DNA repair [GO:0006281]; dopaminergic neuron differentiation [GO:0071542]; glucose homeostasis [GO:0042593]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]; single fertilization [GO:0007338]; swimming behavior [GO:0036269] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] glyoxalase (glycolic acid-forming) activity [GO:1990422]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803] g6269.t1 A1Z6E0 61.151 278 7.43e-118 343.0 sp|A1Z6E0|GUS_DROME Protein gustavus OS=Drosophila melanogaster OX=7227 GN=gus PE=1 SV=2 GUS_DROME reviewed Protein gustavus Drosophila melanogaster (Fruit fly) GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449 cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular protein localization [GO:0008104]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; wing disc morphogenesis [GO:0007472] cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005] g6270.t1 Q8C3Q9 32.67 352 6.76e-45 162.0 sp|Q8C3Q9|CASP9_MOUSE Caspase-9 OS=Mus musculus OX=10090 GN=Casp9 PE=1 SV=1 CASP9_MOUSE reviewed Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10] Mus musculus (Mouse) GO:0001666; GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006974; GO:0008233; GO:0008234; GO:0008303; GO:0008630; GO:0009411; GO:0016485; GO:0019901; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0045471; GO:0051604; GO:0070059; GO:0071549; GO:0071680; GO:0071887; GO:0072347; GO:0097193; GO:1900119 apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; positive regulation of apoptotic process [GO:0043065]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron apoptotic process [GO:0043525]; protein maturation [GO:0051604]; protein processing [GO:0016485]; response to anesthetic [GO:0072347]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to indole-3-methanol [GO:0071680]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to UV [GO:0009411]; signal transduction in response to DNA damage [GO:0042770] apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901] g6271.t1 P97864 44.643 112 1.53e-26 102.0 sp|P97864|CASP7_MOUSE Caspase-7 OS=Mus musculus OX=10090 GN=Casp7 PE=1 SV=2 CASP7_MOUSE reviewed Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] Mus musculus (Mouse) GO:0000122; GO:0001650; GO:0001778; GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006508; GO:0006915; GO:0007507; GO:0008233; GO:0008234; GO:0009411; GO:0016485; GO:0030163; GO:0042742; GO:0043123; GO:0043525; GO:0044346; GO:0046513; GO:0051146; GO:0051402; GO:0051604; GO:0070212; GO:0070227; GO:0070269; GO:0071222; GO:0072734; GO:0097194; GO:1905686 apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to staurosporine [GO:0072734]; ceramide biosynthetic process [GO:0046513]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; heart development [GO:0007507]; lymphocyte apoptotic process [GO:0070227]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; plasma membrane repair [GO:0001778]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein poly-ADP-ribosylation [GO:0070212]; protein processing [GO:0016485]; proteolysis [GO:0006508]; pyroptotic inflammatory response [GO:0070269]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; RNA binding [GO:0003723] g6273.t1 Q9H7F0 42.174 1233 0.0 949.0 sp|Q9H7F0|AT133_HUMAN Polyamine-transporting ATPase 13A3 OS=Homo sapiens OX=9606 GN=ATP13A3 PE=1 SV=4 g6273.t2 Q9H7F0 42.174 1233 0.0 949.0 sp|Q9H7F0|AT133_HUMAN Polyamine-transporting ATPase 13A3 OS=Homo sapiens OX=9606 GN=ATP13A3 PE=1 SV=4 g6274.t1 P52569 38.534 641 3.4e-130 400.0 sp|P52569|CTR2_HUMAN Cationic amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC7A2 PE=1 SV=2 CTR2_HUMAN reviewed Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2) Homo sapiens (Human) GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] cell junction [GO:0030054]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g6278.t1 Q0V9R3 57.663 659 0.0 808.0 sp|Q0V9R3|DI3L2_XENTR DIS3-like exonuclease 2 OS=Xenopus tropicalis OX=8364 GN=dis3l2 PE=2 SV=2 g6279.t1 P32138 48.777 654 0.0 666.0 sp|P32138|SQASE_ECOLI Sulfoquinovosidase OS=Escherichia coli (strain K12) OX=83333 GN=yihQ PE=1 SV=3 SQASE_ECOLI reviewed Sulfoquinovosidase (SQase) (EC 3.2.1.199) Escherichia coli (strain K12) GO:0004553; GO:0005975; GO:0030246; GO:0061720; GO:1990929 6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975] carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; sulfoquinovosidase activity [GO:1990929] g6280.t1 P42898 63.608 632 0.0 827.0 sp|P42898|MTHR_HUMAN Methylenetetrahydrofolate reductase (NADPH) OS=Homo sapiens OX=9606 GN=MTHFR PE=1 SV=3 MTHR_HUMAN reviewed Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53) Homo sapiens (Human) GO:0001666; GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0009086; GO:0009410; GO:0033274; GO:0035999; GO:0043200; GO:0044877; GO:0046500; GO:0050660; GO:0050661; GO:0050667; GO:0051593; GO:0070555; GO:0070828; GO:0071949; GO:0072341; GO:0106313 heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; response to amino acid [GO:0043200]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; response to xenobiotic stimulus [GO:0009410]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999] cytosol [GO:0005829] FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NADPH) activity [GO:0106313]; methylenetetrahydrofolate reductase [NAD(P)H] activity [GO:0004489]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877] g6281.t1 A1A4J8 61.086 221 1.48e-96 290.0 sp|A1A4J8|SCO1_BOVIN Protein SCO1 homolog, mitochondrial OS=Bos taurus OX=9913 GN=SCO1 PE=2 SV=1 SCO1_BOVIN reviewed Cytochrome c oxidase assembly factor SCO1 Bos taurus (Bovine) GO:0005743; GO:0033617; GO:0046872 mitochondrial respiratory chain complex IV assembly [GO:0033617] mitochondrial inner membrane [GO:0005743] metal ion binding [GO:0046872] g6282.t1 Q4FZX7 49.606 254 9.03e-77 236.0 sp|Q4FZX7|SRPRB_RAT Signal recognition particle receptor subunit beta OS=Rattus norvegicus OX=10116 GN=Srprb PE=2 SV=1 g6284.t1 Q9WYP5 31.195 343 1.1299999999999998e-54 186.0 sp|Q9WYP5|IOLG_THEMA Myo-inositol 2-dehydrogenase OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=iolG PE=1 SV=1 g6285.t1 P56389 56.818 132 1.73e-51 163.0 sp|P56389|CDD_MOUSE Cytidine deaminase OS=Mus musculus OX=10090 GN=Cda PE=1 SV=2 CDD_MOUSE reviewed Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase) Mus musculus (Mouse) GO:0001882; GO:0004126; GO:0005829; GO:0006248; GO:0006249; GO:0008270; GO:0019239; GO:0042802; GO:0042803; GO:0044206; GO:0071217 cellular response to external biotic stimulus [GO:0071217]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; UMP salvage [GO:0044206] cytosol [GO:0005829] cytidine deaminase activity [GO:0004126]; deaminase activity [GO:0019239]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g6286.t1 P56389 56.25 128 1.08e-47 153.0 sp|P56389|CDD_MOUSE Cytidine deaminase OS=Mus musculus OX=10090 GN=Cda PE=1 SV=2 CDD_MOUSE reviewed Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase) Mus musculus (Mouse) GO:0001882; GO:0004126; GO:0005829; GO:0006248; GO:0006249; GO:0008270; GO:0019239; GO:0042802; GO:0042803; GO:0044206; GO:0071217 cellular response to external biotic stimulus [GO:0071217]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; UMP salvage [GO:0044206] cytosol [GO:0005829] cytidine deaminase activity [GO:0004126]; deaminase activity [GO:0019239]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] g6287.t1 Q8VCC1 40.323 248 1.02e-51 172.0 sp|Q8VCC1|PGDH_MOUSE 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Mus musculus OX=10090 GN=Hpgd PE=1 SV=1 PGDH_MOUSE reviewed 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) Mus musculus (Mouse) GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0047034; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828 ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] 15-hydroxyicosatetraenoate dehydrogenase activity [GO:0047034]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957] g6288.t1 Q8MJY8 38.306 248 1.58e-48 172.0 sp|Q8MJY8|PGDH_MACFA 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Macaca fascicularis OX=9541 GN=HPGD PE=2 SV=1 g6288.t1 Q8MJY8 36.759 253 1.6700000000000002e-47 170.0 sp|Q8MJY8|PGDH_MACFA 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Macaca fascicularis OX=9541 GN=HPGD PE=2 SV=1 g6289.t1 P15428 35.458 251 4.49e-48 163.0 sp|P15428|PGDH_HUMAN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Homo sapiens OX=9606 GN=HPGD PE=1 SV=1 PGDH_HUMAN reviewed 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) Homo sapiens (Human) GO:0001822; GO:0004957; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0019372; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0047034; GO:0051287; GO:0070062; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828 ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] 15-hydroxyicosatetraenoate dehydrogenase activity [GO:0047034]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957] g6290.t1 Q9JJ00 47.651 149 2.1700000000000002e-37 133.0 sp|Q9JJ00|PLS1_MOUSE Phospholipid scramblase 1 OS=Mus musculus OX=10090 GN=Plscr1 PE=1 SV=1 PLS1_MOUSE reviewed Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (Transplantability-associated protein 1) (NOR1) (TRA1) Mus musculus (Mouse) GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006659; GO:0006915; GO:0006953; GO:0006955; GO:0008270; GO:0010288; GO:0010628; GO:0016787; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032791; GO:0033003; GO:0035455; GO:0035456; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:1905820; GO:2000373 acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; hydrolase activity [GO:0016787]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g6291.t1 O15162 49.08 163 3.38e-37 133.0 sp|O15162|PLS1_HUMAN Phospholipid scramblase 1 OS=Homo sapiens OX=9606 GN=PLSCR1 PE=1 SV=1 PLS1_HUMAN reviewed Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b) Homo sapiens (Human) GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006659; GO:0006915; GO:0006953; GO:0008270; GO:0010288; GO:0010628; GO:0016020; GO:0016787; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030168; GO:0032791; GO:0033003; GO:0035456; GO:0042609; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0070062; GO:0070782; GO:1905820; GO:2000373 acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; hydrolase activity [GO:0016787]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g6292.t1 Q3ZBG9 47.719 285 2.38e-81 251.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6294.t1 Q3ZBG9 50.82 305 3.27e-96 289.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6295.t1 Q9BXM7 37.029 478 9.91e-75 254.0 sp|Q9BXM7|PINK1_HUMAN Serine/threonine-protein kinase PINK1, mitochondrial OS=Homo sapiens OX=9606 GN=PINK1 PE=1 SV=1 g6296.t1 Q9ES00 50.234 1069 0.0 1073.0 sp|Q9ES00|UBE4B_MOUSE Ubiquitin conjugation factor E4 B OS=Mus musculus OX=10090 GN=Ube4b PE=1 SV=3 UBE4B_MOUSE reviewed Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2) Mus musculus (Mouse) GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051117; GO:0051865; GO:0061630 ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082] g6297.t1 O00462 48.968 872 0.0 842.0 sp|O00462|MANBA_HUMAN Beta-mannosidase OS=Homo sapiens OX=9606 GN=MANBA PE=1 SV=3 MANBA_HUMAN reviewed Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase) Homo sapiens (Human) GO:0004567; GO:0005886; GO:0006516; GO:0009313; GO:0035577; GO:0036211; GO:0043202 glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211] azurophil granule membrane [GO:0035577]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886] beta-mannosidase activity [GO:0004567] g6298.t1 Q5F464 63.948 233 6.53e-107 332.0 sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1 LPP_CHICK reviewed Lipoma-preferred partner homolog Gallus gallus (Chicken) GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609 cell-cell adhesion [GO:0098609] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725] metal ion binding [GO:0046872] g6299.t1 P58355 35.805 553 8.2e-112 348.0 sp|P58355|S45A2_MOUSE Membrane-associated transporter protein OS=Mus musculus OX=10090 GN=Slc45a2 PE=1 SV=1 S45A2_MOUSE reviewed Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Protein underwhite) (Solute carrier family 45 member 2) Mus musculus (Mouse) GO:0005356; GO:0006583; GO:0007601; GO:0008506; GO:0015770; GO:0016020; GO:0033162; GO:0035752; GO:0048066 developmental pigmentation [GO:0048066]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process from tyrosine [GO:0006583]; sucrose transport [GO:0015770]; visual perception [GO:0007601] melanosome membrane [GO:0033162]; membrane [GO:0016020] D-glucose:proton symporter activity [GO:0005356]; sucrose:proton symporter activity [GO:0008506] g6300.t1 O60683 46.012 326 6.58e-87 266.0 sp|O60683|PEX10_HUMAN Peroxisome biogenesis factor 10 OS=Homo sapiens OX=9606 GN=PEX10 PE=1 SV=1 g6301.t1 Q5F499 61.272 896 0.0 1099.0 sp|Q5F499|OPA1_CHICK Dynamin-like GTPase OPA1, mitochondrial OS=Gallus gallus OX=9031 GN=OPA1 PE=2 SV=1 OPA1_CHICK reviewed Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)] Gallus gallus (Chicken) GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0005874; GO:0006915; GO:0008017; GO:0008053; GO:0016559; GO:0031966; GO:0032740; GO:0046039; GO:0046872; GO:0070300; GO:0097749; GO:0140523; GO:0180020; GO:1901612; GO:1990627; GO:2000330 apoptotic process [GO:0006915]; GTP metabolic process [GO:0046039]; membrane tubulation [GO:0097749]; mitochondrial fusion [GO:0008053]; mitochondrial inner membrane fusion [GO:1990627]; peroxisome fission [GO:0016559]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330] cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966] cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; membrane bending activity [GO:0180020]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300] g6301.t2 Q5F499 60.951 904 0.0 1101.0 sp|Q5F499|OPA1_CHICK Dynamin-like GTPase OPA1, mitochondrial OS=Gallus gallus OX=9031 GN=OPA1 PE=2 SV=1 OPA1_CHICK reviewed Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)] Gallus gallus (Chicken) GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0005874; GO:0006915; GO:0008017; GO:0008053; GO:0016559; GO:0031966; GO:0032740; GO:0046039; GO:0046872; GO:0070300; GO:0097749; GO:0140523; GO:0180020; GO:1901612; GO:1990627; GO:2000330 apoptotic process [GO:0006915]; GTP metabolic process [GO:0046039]; membrane tubulation [GO:0097749]; mitochondrial fusion [GO:0008053]; mitochondrial inner membrane fusion [GO:1990627]; peroxisome fission [GO:0016559]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330] cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966] cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; membrane bending activity [GO:0180020]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300] g6303.t1 Q8AVU4 67.742 124 2.16e-53 182.0 sp|Q8AVU4|HES1B_XENLA Transcription factor HES-1-B OS=Xenopus laevis OX=8355 GN=hes1-b PE=2 SV=1 g6306.t1 Q04666 59.843 127 2.4299999999999998e-45 162.0 sp|Q04666|HES1_RAT Transcription factor HES-1 OS=Rattus norvegicus OX=10116 GN=Hes1 PE=1 SV=1 HES1_RAT reviewed Transcription factor HES-1 (Hairy and enhancer of split 1) (Hairy-like protein) (RHL) Rattus norvegicus (Rat) GO:0000122; GO:0000785; GO:0000981; GO:0001217; GO:0001222; GO:0001227; GO:0001701; GO:0001709; GO:0001889; GO:0002085; GO:0003143; GO:0003151; GO:0003266; GO:0003281; GO:0003310; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007389; GO:0008284; GO:0008432; GO:0009615; GO:0009952; GO:0010628; GO:0010629; GO:0010977; GO:0016363; GO:0016477; GO:0021537; GO:0021555; GO:0021557; GO:0021558; GO:0021575; GO:0021861; GO:0021870; GO:0021915; GO:0021953; GO:0021983; GO:0021984; GO:0030182; GO:0030324; GO:0030509; GO:0030513; GO:0030901; GO:0031016; GO:0032991; GO:0035019; GO:0035315; GO:0035881; GO:0035909; GO:0035910; GO:0042098; GO:0042102; GO:0042491; GO:0042531; GO:0042802; GO:0042803; GO:0042826; GO:0043254; GO:0043279; GO:0043388; GO:0043398; GO:0043565; GO:0044877; GO:0045165; GO:0045596; GO:0045598; GO:0045608; GO:0045664; GO:0045665; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045977; GO:0046331; GO:0046425; GO:0046427; GO:0048469; GO:0048505; GO:0048538; GO:0048667; GO:0048711; GO:0048715; GO:0048844; GO:0050678; GO:0050767; GO:0050768; GO:0051087; GO:0060122; GO:0060164; GO:0060253; GO:0060412; GO:0060675; GO:0060716; GO:0061009; GO:0061101; GO:0061102; GO:0061106; GO:0061309; GO:0061626; GO:0061629; GO:0065003; GO:0070888; GO:0071347; GO:0071356; GO:0071398; GO:0071820; GO:0072012; GO:0072049; GO:0072050; GO:0072141; GO:0072282; GO:0090102; GO:0090162; GO:0090281; GO:0097066; GO:0097084; GO:0097150; GO:1902870; GO:1904010; GO:1905934; GO:1990090; GO:1990837; GO:2000227; GO:2000737; GO:2000974; GO:2000978; GO:2000981 adenohypophysis development [GO:0021984]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; BMP signaling pathway [GO:0030509]; Cajal-Retzius cell differentiation [GO:0021870]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system neuron differentiation [GO:0021953]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hair cell differentiation [GO:0035315]; hindbrain morphogenesis [GO:0021575]; in utero embryonic development [GO:0001701]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of inner ear receptor cell differentiation [GO:2000981]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreas development [GO:0031016]; pancreatic A cell differentiation [GO:0003310]; pattern specification process [GO:0007389]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of neuron differentiation [GO:0045664]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of cell differentiation [GO:0048505]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to Aroclor 1254 [GO:1904010]; response to thyroid hormone [GO:0097066]; response to virus [GO:0009615]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; stomach neuroendocrine cell differentiation [GO:0061102]; T cell proliferation [GO:0042098]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222] g6308.t1 Q4V8C3 41.088 662 1.7399999999999999e-171 531.0 sp|Q4V8C3|EMAL1_RAT Echinoderm microtubule-associated protein-like 1 OS=Rattus norvegicus OX=10116 GN=Eml1 PE=1 SV=2 EMAL1_RAT reviewed Echinoderm microtubule-associated protein-like 1 (EMAP-1) Rattus norvegicus (Rat) GO:0000226; GO:0002244; GO:0005829; GO:0005874; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015630; GO:0015631; GO:0048471; GO:0097431; GO:1990023 brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471] microtubule binding [GO:0008017]; tubulin binding [GO:0015631] g6309.t1 Q6AYL5 93.365 211 8.13e-142 412.0 sp|Q6AYL5|SF3B4_RAT Splicing factor 3B subunit 4 OS=Rattus norvegicus OX=10116 GN=Sf3b4 PE=2 SV=1 g6310.t1 Q96T58 34.626 722 5.16e-94 348.0 sp|Q96T58|MINT_HUMAN Msx2-interacting protein OS=Homo sapiens OX=9606 GN=SPEN PE=1 SV=1 MINT_HUMAN reviewed Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0031048; GO:0045892; GO:0050769; GO:0060816; GO:0061629; GO:0070062 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g6310.t1 Q96T58 55.208 192 1.25e-57 228.0 sp|Q96T58|MINT_HUMAN Msx2-interacting protein OS=Homo sapiens OX=9606 GN=SPEN PE=1 SV=1 MINT_HUMAN reviewed Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) Homo sapiens (Human) GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0031048; GO:0045892; GO:0050769; GO:0060816; GO:0061629; GO:0070062 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g6315.t1 P47736 41.809 586 1.67e-134 416.0 sp|P47736|RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=2 RPGP1_HUMAN reviewed Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) Homo sapiens (Human) GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006909; GO:0007165; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:0051649; GO:0098609; GO:1903697; GO:1904442; GO:1990792 adaptive immune response [GO:0002250]; cell-cell adhesion [GO:0098609]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; establishment of localization in cell [GO:0051649]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; phagocytosis [GO:0006909]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g6315.t2 P47736 41.809 586 1.7e-134 416.0 sp|P47736|RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=2 RPGP1_HUMAN reviewed Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) Homo sapiens (Human) GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006909; GO:0007165; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:0051649; GO:0098609; GO:1903697; GO:1904442; GO:1990792 adaptive immune response [GO:0002250]; cell-cell adhesion [GO:0098609]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; establishment of localization in cell [GO:0051649]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; phagocytosis [GO:0006909]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g6315.t3 P47736 41.809 586 2.34e-134 415.0 sp|P47736|RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=2 RPGP1_HUMAN reviewed Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) Homo sapiens (Human) GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006909; GO:0007165; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:0051649; GO:0098609; GO:1903697; GO:1904442; GO:1990792 adaptive immune response [GO:0002250]; cell-cell adhesion [GO:0098609]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; establishment of localization in cell [GO:0051649]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; phagocytosis [GO:0006909]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g6315.t4 P47736 41.126 586 1.94e-129 402.0 sp|P47736|RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=2 RPGP1_HUMAN reviewed Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) Homo sapiens (Human) GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006909; GO:0007165; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:0051649; GO:0098609; GO:1903697; GO:1904442; GO:1990792 adaptive immune response [GO:0002250]; cell-cell adhesion [GO:0098609]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; establishment of localization in cell [GO:0051649]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; phagocytosis [GO:0006909]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g6315.t5 P47736 41.809 586 3.14e-133 416.0 sp|P47736|RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=2 RPGP1_HUMAN reviewed Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1) Homo sapiens (Human) GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006909; GO:0007165; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:0051649; GO:0098609; GO:1903697; GO:1904442; GO:1990792 adaptive immune response [GO:0002250]; cell-cell adhesion [GO:0098609]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; establishment of localization in cell [GO:0051649]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; phagocytosis [GO:0006909]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] g6338.t1 Q6Q7X9 36.655 562 5.38e-136 413.0 sp|Q6Q7X9|KLH31_DANRE Kelch-like protein 31 OS=Danio rerio OX=7955 GN=klhl31 PE=2 SV=1 g6339.t1 Q9D287 60.68 206 3.72e-87 261.0 sp|Q9D287|SPF27_MOUSE Pre-mRNA-splicing factor SPF27 OS=Mus musculus OX=10090 GN=Bcas2 PE=1 SV=1 SPF27_MOUSE reviewed Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2 homolog) (DNA amplified in mammary carcinoma 1 protein) Mus musculus (Mouse) GO:0000380; GO:0000398; GO:0000974; GO:0001541; GO:0005634; GO:0005662; GO:0005681; GO:0005730; GO:0005813; GO:0007611; GO:0016358; GO:0016607; GO:0021542; GO:0030163; GO:0048477; GO:0048599; GO:0048813; GO:0051225; GO:0071007; GO:0071013; GO:0097061 alternative mRNA splicing, via spliceosome [GO:0000380]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendritic spine organization [GO:0097061]; dentate gyrus development [GO:0021542]; learning or memory [GO:0007611]; mRNA splicing, via spliceosome [GO:0000398]; oocyte development [GO:0048599]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein catabolic process [GO:0030163]; spindle assembly [GO:0051225] catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] g6340.t1 Q645J3 58.252 206 5.42e-88 261.0 sp|Q645J3|SGMR1_TARGR Sigma non-opioid intracellular receptor 1 OS=Taricha granulosa OX=8321 GN=SIGMAR1 PE=2 SV=1 g6343.t1 Q9W436 36.428 711 1.66e-160 490.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g6348.t1 Q07929 33.52 179 2.1399999999999997e-23 99.8 sp|Q07929|SP63_STRPU 63 kDa sperm flagellar membrane protein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g6350.t1 Q5VY43 34.627 335 1.01e-40 160.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6350.t1 Q5VY43 34.1 261 8.57e-27 118.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6350.t1 Q5VY43 33.712 264 1.2900000000000001e-26 117.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6350.t2 Q5VY43 33.238 349 2.21e-39 156.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6350.t2 Q5VY43 34.182 275 6.22e-29 125.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6350.t2 Q5VY43 33.7 273 1.8400000000000002e-27 120.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6351.t1 Q5VY43 34.627 335 1.01e-40 160.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6351.t1 Q5VY43 34.1 261 8.57e-27 118.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6351.t1 Q5VY43 33.712 264 1.2900000000000001e-26 117.0 sp|Q5VY43|PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens OX=9606 GN=PEAR1 PE=1 SV=1 PEAR1_HUMAN reviewed Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12) Homo sapiens (Human) GO:0001891; GO:0010572; GO:0016020; GO:0030027; GO:0038023; GO:0043491; GO:0043654; GO:0070527 phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet aggregation [GO:0070527]; positive regulation of platelet activation [GO:0010572]; recognition of apoptotic cell [GO:0043654] lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891] signaling receptor activity [GO:0038023] g6352.t1 O75095 39.464 261 1.16e-37 153.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 35.452 299 1.12e-33 140.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 39.823 226 2.44e-32 136.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 35.714 266 5.32e-29 126.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 36.364 253 7.94e-27 119.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 34.529 223 4.7100000000000004e-26 117.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 36.255 251 1.44e-24 112.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 34.387 253 2.36e-24 112.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 30.769 299 3.58e-24 111.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 32.881 295 4.14e-23 108.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6352.t1 O75095 33.67 297 2.95e-22 105.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6354.t1 O75095 45.385 130 2.16e-21 100.0 sp|O75095|MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens OX=9606 GN=MEGF6 PE=1 SV=4 g6356.t1 Q5R630 53.185 314 1.6199999999999998e-90 273.0 sp|Q5R630|NECP1_PONAB Adaptin ear-binding coat-associated protein 1 OS=Pongo abelii OX=9601 GN=NECAP1 PE=2 SV=1 NECP1_PONAB reviewed Adaptin ear-binding coat-associated protein 1 (NECAP endocytosis-associated protein 1) (NECAP-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005886; GO:0006897; GO:0015031; GO:0030125 endocytosis [GO:0006897]; protein transport [GO:0015031] clathrin vesicle coat [GO:0030125]; plasma membrane [GO:0005886] g6357.t1 Q8VCC1 37.984 258 3.55e-53 176.0 sp|Q8VCC1|PGDH_MOUSE 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Mus musculus OX=10090 GN=Hpgd PE=1 SV=1 PGDH_MOUSE reviewed 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) Mus musculus (Mouse) GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0047034; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828 ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] 15-hydroxyicosatetraenoate dehydrogenase activity [GO:0047034]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957] g6359.t1 Q6NYS8 67.991 428 0.0 610.0 sp|Q6NYS8|OST48_DANRE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Danio rerio OX=7955 GN=ddost PE=2 SV=2 g6360.t1 Q9H0J9 31.221 647 1.26e-78 271.0 sp|Q9H0J9|PAR12_HUMAN Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1 PAR12_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Homo sapiens (Human) GO:0003723; GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g6360.t2 Q9H0J9 31.269 646 5.13e-78 269.0 sp|Q9H0J9|PAR12_HUMAN Protein mono-ADP-ribosyltransferase PARP12 OS=Homo sapiens OX=9606 GN=PARP12 PE=1 SV=1 PAR12_HUMAN reviewed Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1) Homo sapiens (Human) GO:0003723; GO:0003950; GO:0005634; GO:0005802; GO:0008270; GO:0010494; GO:0016779; GO:0070213; GO:0070633; GO:0140803; GO:0140806; GO:1990404 protein auto-ADP-ribosylation [GO:0070213]; transepithelial transport [GO:0070633] cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g6362.t1 Q6GQ53 45.638 298 2.35e-85 261.0 sp|Q6GQ53|PUSL1_XENLA tRNA pseudouridine synthase-like 1 OS=Xenopus laevis OX=8355 GN=pusl1 PE=2 SV=1 g6363.t1 Q5ZLD3 31.952 579 2.58e-85 283.0 sp|Q5ZLD3|KLH13_CHICK Kelch-like protein 13 OS=Gallus gallus OX=9031 GN=KLHL13 PE=2 SV=1 g6364.t1 P98160 37.457 2603 0.0 1696.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g6364.t1 P98160 32.783 1937 0.0 980.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g6364.t2 P98160 37.457 2603 0.0 1695.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g6364.t2 P98160 32.783 1937 0.0 979.0 sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4 PGBM_HUMAN reviewed Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide] Homo sapiens (Human) GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031012; GO:0031100; GO:0031594; GO:0032223; GO:0035418; GO:0043005; GO:0043202; GO:0050750; GO:0060090; GO:0070052; GO:0070062; GO:0072359; GO:0098797 angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization to synapse [GO:0035418]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750]; molecular adaptor activity [GO:0060090] g6365.t1 Q2TBV5 58.808 386 1.36e-173 493.0 sp|Q2TBV5|TF2H2_BOVIN General transcription factor IIH subunit 2 OS=Bos taurus OX=9913 GN=GTF2H2 PE=2 SV=1 g6366.t1 B1WAP7 57.945 730 0.0 694.0 sp|B1WAP7|DVL3_XENTR Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus tropicalis OX=8364 GN=dvl3 PE=2 SV=1 g6366.t2 Q6DKE2 58.086 742 0.0 704.0 sp|Q6DKE2|DVL3_XENLA Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus laevis OX=8355 GN=dvl3 PE=2 SV=1 g6366.t3 Q6DKE2 57.895 741 0.0 699.0 sp|Q6DKE2|DVL3_XENLA Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus laevis OX=8355 GN=dvl3 PE=2 SV=1 g6366.t4 Q6DKE2 56.348 575 1.9199999999999999e-168 500.0 sp|Q6DKE2|DVL3_XENLA Segment polarity protein dishevelled homolog DVL-3 OS=Xenopus laevis OX=8355 GN=dvl3 PE=2 SV=1 g6367.t1 Q02978 75.497 302 3.23e-171 480.0 sp|Q02978|M2OM_HUMAN Mitochondrial 2-oxoglutarate/malate carrier protein OS=Homo sapiens OX=9606 GN=SLC25A11 PE=1 SV=3 M2OM_HUMAN reviewed Mitochondrial 2-oxoglutarate/malate carrier protein (Alpha-oxoglutarate carrier) (OGCP) (Solute carrier family 25 member 11) (SLC25A11) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005886; GO:0006094; GO:0006869; GO:0015367; GO:0022857; GO:0043490 gluconeogenesis [GO:0006094]; lipid transport [GO:0006869]; malate-aspartate shuttle [GO:0043490] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; transmembrane transporter activity [GO:0022857] g6368.t1 Q8NA47 33.206 524 8.960000000000001e-79 261.0 sp|Q8NA47|CCD63_HUMAN Coiled-coil domain-containing protein 63 OS=Homo sapiens OX=9606 GN=CCDC63 PE=1 SV=1 g6369.t1 Q9H0C8 60.064 313 5.24e-137 397.0 sp|Q9H0C8|ILKAP_HUMAN Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Homo sapiens OX=9606 GN=ILKAP PE=1 SV=1 g6370.t1 Q14832 40.095 843 0.0 622.0 sp|Q14832|GRM3_HUMAN Metabotropic glutamate receptor 3 OS=Homo sapiens OX=9606 GN=GRM3 PE=1 SV=2 GRM3_HUMAN reviewed Metabotropic glutamate receptor 3 (mGluR3) Homo sapiens (Human) GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0033554; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 cellular response to stress [GO:0033554]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g6371.t1 Q9YHY6 43.139 1421 0.0 1132.0 sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1 g6373.t1 Q9R1Q2 64.706 323 2.74e-142 422.0 sp|Q9R1Q2|CCNL1_RAT Cyclin-L1 OS=Rattus norvegicus OX=10116 GN=Ccnl1 PE=1 SV=1 g6374.t1 Q9CQL4 45.455 132 5.47e-36 125.0 sp|Q9CQL4|RM20_MOUSE Large ribosomal subunit protein bL20m OS=Mus musculus OX=10090 GN=Mrpl20 PE=1 SV=1 g6375.t1 O12947 48.097 289 3.02e-93 280.0 sp|O12947|ICMT_XENLA Protein-S-isoprenylcysteine O-methyltransferase OS=Xenopus laevis OX=8355 GN=icmt PE=1 SV=1 g6378.t1 P46471 91.244 434 0.0 820.0 sp|P46471|PRS7_MOUSE 26S proteasome regulatory subunit 7 OS=Mus musculus OX=10090 GN=Psmc2 PE=1 SV=5 PRS7_MOUSE reviewed 26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) Mus musculus (Mouse) GO:0000502; GO:0000932; GO:0005524; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0036464; GO:0043161; GO:0140296 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; general transcription initiation factor binding [GO:0140296]; proteasome-activating activity [GO:0036402]; TBP-class protein binding [GO:0017025] g6379.t1 B8DKP2 40.647 278 7.580000000000001e-72 225.0 sp|B8DKP2|PHNX_NITV9 Phosphonoacetaldehyde hydrolase OS=Nitratidesulfovibrio vulgaris (strain DSM 19637 / Miyazaki F) OX=883 GN=phnX PE=3 SV=1 PHNX_NITV9 reviewed Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase) Nitratidesulfovibrio vulgaris (strain DSM 19637 / Miyazaki F) (Desulfovibrio vulgaris) GO:0005829; GO:0006281; GO:0008967; GO:0019700; GO:0046872; GO:0050194 DNA repair [GO:0006281]; organic phosphonate catabolic process [GO:0019700] cytosol [GO:0005829] metal ion binding [GO:0046872]; phosphoglycolate phosphatase activity [GO:0008967]; phosphonoacetaldehyde hydrolase activity [GO:0050194] g6379.t2 B8DKP2 40.647 278 6.29e-72 225.0 sp|B8DKP2|PHNX_NITV9 Phosphonoacetaldehyde hydrolase OS=Nitratidesulfovibrio vulgaris (strain DSM 19637 / Miyazaki F) OX=883 GN=phnX PE=3 SV=1 PHNX_NITV9 reviewed Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase) Nitratidesulfovibrio vulgaris (strain DSM 19637 / Miyazaki F) (Desulfovibrio vulgaris) GO:0005829; GO:0006281; GO:0008967; GO:0019700; GO:0046872; GO:0050194 DNA repair [GO:0006281]; organic phosphonate catabolic process [GO:0019700] cytosol [GO:0005829] metal ion binding [GO:0046872]; phosphoglycolate phosphatase activity [GO:0008967]; phosphonoacetaldehyde hydrolase activity [GO:0050194] g6380.t1 Q9NZN8 50.647 541 2.8900000000000003e-160 471.0 sp|Q9NZN8|CNOT2_HUMAN CCR4-NOT transcription complex subunit 2 OS=Homo sapiens OX=9606 GN=CNOT2 PE=1 SV=1 g6380.t2 Q9NZN8 51.184 549 1.08e-166 488.0 sp|Q9NZN8|CNOT2_HUMAN CCR4-NOT transcription complex subunit 2 OS=Homo sapiens OX=9606 GN=CNOT2 PE=1 SV=1 g6383.t1 Q4KME6 35.105 715 1.07e-69 261.0 sp|Q4KME6|GGYF2_DANRE GRB10-interacting GYF protein 2 OS=Danio rerio OX=7955 GN=gigyf2 PE=2 SV=2 GGYF2_DANRE reviewed GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0016020; GO:0031982; GO:0043204; GO:0048009; GO:1990635 insulin-like growth factor receptor signaling pathway [GO:0048009] cytosol [GO:0005829]; membrane [GO:0016020]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; vesicle [GO:0031982] g6383.t1 Q4KME6 36.261 444 8.610000000000001e-32 139.0 sp|Q4KME6|GGYF2_DANRE GRB10-interacting GYF protein 2 OS=Danio rerio OX=7955 GN=gigyf2 PE=2 SV=2 GGYF2_DANRE reviewed GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0016020; GO:0031982; GO:0043204; GO:0048009; GO:1990635 insulin-like growth factor receptor signaling pathway [GO:0048009] cytosol [GO:0005829]; membrane [GO:0016020]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; vesicle [GO:0031982] g6383.t2 Q4KME6 35.105 715 1.7e-69 261.0 sp|Q4KME6|GGYF2_DANRE GRB10-interacting GYF protein 2 OS=Danio rerio OX=7955 GN=gigyf2 PE=2 SV=2 GGYF2_DANRE reviewed GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0016020; GO:0031982; GO:0043204; GO:0048009; GO:1990635 insulin-like growth factor receptor signaling pathway [GO:0048009] cytosol [GO:0005829]; membrane [GO:0016020]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; vesicle [GO:0031982] g6383.t2 Q4KME6 35.938 448 6.8e-31 136.0 sp|Q4KME6|GGYF2_DANRE GRB10-interacting GYF protein 2 OS=Danio rerio OX=7955 GN=gigyf2 PE=2 SV=2 GGYF2_DANRE reviewed GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005829; GO:0016020; GO:0031982; GO:0043204; GO:0048009; GO:1990635 insulin-like growth factor receptor signaling pathway [GO:0048009] cytosol [GO:0005829]; membrane [GO:0016020]; perikaryon [GO:0043204]; proximal dendrite [GO:1990635]; vesicle [GO:0031982] g6384.t1 Q9W436 41.496 682 0.0 589.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g6384.t2 Q9W436 41.496 682 0.0 588.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g6385.t1 Q9W436 38.512 766 0.0 582.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g6389.t1 Q9SAL0 42.593 270 1.99e-63 208.0 sp|Q9SAL0|RGLG4_ARATH E3 ubiquitin-protein ligase RGLG4 OS=Arabidopsis thaliana OX=3702 GN=RGLG4 PE=1 SV=1 g6390.t1 Q9N0C5 48.78 205 1.47e-73 229.0 sp|Q9N0C5|KITM_MACFA Thymidine kinase 2, mitochondrial OS=Macaca fascicularis OX=9541 GN=TK2 PE=2 SV=1 g6391.t1 Q9ET47 45.732 328 5.310000000000001e-85 283.0 sp|Q9ET47|ESPN_MOUSE Espin OS=Mus musculus OX=10090 GN=Espn PE=1 SV=2 g6393.t1 Q8K0H5 73.913 115 1.13e-56 179.0 sp|Q8K0H5|TAF10_MOUSE Transcription initiation factor TFIID subunit 10 OS=Mus musculus OX=10090 GN=Taf10 PE=1 SV=1 TAF10_MOUSE reviewed Transcription initiation factor TFIID subunit 10 (Transcription initiation factor TFIID 30 kDa subunit) (TAF(II)30) (TAFII-30) (TAFII30) (mTAFII30) Mus musculus (Mouse) GO:0000082; GO:0000124; GO:0001701; GO:0001756; GO:0001889; GO:0001892; GO:0003677; GO:0004402; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006282; GO:0006352; GO:0006355; GO:0006357; GO:0006367; GO:0006915; GO:0010467; GO:0010468; GO:0016251; GO:0019899; GO:0030331; GO:0033276; GO:0035264; GO:0036285; GO:0042789; GO:0042802; GO:0043484; GO:0045893; GO:0048371; GO:0048471; GO:0051123; GO:0060173; GO:0060261; GO:0065003; GO:0070063; GO:0070365; GO:0097550; GO:1905069; GO:1990841 allantois development [GO:1905069]; apoptotic process [GO:0006915]; DNA-templated transcription initiation [GO:0006352]; embryonic placenta development [GO:0001892]; G1/S transition of mitotic cell cycle [GO:0000082]; gene expression [GO:0010467]; hepatocyte differentiation [GO:0070365]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; limb development [GO:0060173]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein-containing complex assembly [GO:0065003]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; SAGA complex assembly [GO:0036285]; somitogenesis [GO:0001756]; transcription initiation at RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription preinitiation complex [GO:0097550] DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251] g6394.t1 Q64674 48.993 298 6.629999999999999e-104 309.0 sp|Q64674|SPEE_MOUSE Spermidine synthase OS=Mus musculus OX=10090 GN=Srm PE=1 SV=1 g6394.t2 Q64674 48.993 298 7.019999999999999e-104 308.0 sp|Q64674|SPEE_MOUSE Spermidine synthase OS=Mus musculus OX=10090 GN=Srm PE=1 SV=1 g6395.t1 Q64674 69.718 284 9.78e-154 436.0 sp|Q64674|SPEE_MOUSE Spermidine synthase OS=Mus musculus OX=10090 GN=Srm PE=1 SV=1 g6396.t1 P42345 82.852 589 0.0 1036.0 sp|P42345|MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1 MTOR_HUMAN reviewed Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) (Tyrosine-protein kinase mTOR) (EC 2.7.10.2) Homo sapiens (Human) GO:0000139; GO:0000822; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006112; GO:0006207; GO:0006954; GO:0006974; GO:0007010; GO:0007281; GO:0008361; GO:0009267; GO:0009408; GO:0009615; GO:0009791; GO:0010507; GO:0010592; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016605; GO:0019228; GO:0030030; GO:0030307; GO:0030425; GO:0030838; GO:0031295; GO:0031641; GO:0031648; GO:0031667; GO:0031669; GO:0031670; GO:0031929; GO:0031931; GO:0031932; GO:0032869; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0038203; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043200; GO:0043276; GO:0044325; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0045948; GO:0046627; GO:0046889; GO:0048266; GO:0048709; GO:0048714; GO:0050821; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0061431; GO:0062027; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0097700; GO:0106310; GO:1900029; GO:1900034; GO:1900181; GO:1901796; GO:1901838; GO:1903691; GO:1904059; GO:1904690; GO:1905671; GO:1905672; GO:1905857; GO:1990253; GO:2000060; GO:2000785 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell projection organization [GO:0030030]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062027]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; transmembrane transporter binding [GO:0044325] g6396.t2 P42345 81.293 588 0.0 1010.0 sp|P42345|MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1 MTOR_HUMAN reviewed Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) (Tyrosine-protein kinase mTOR) (EC 2.7.10.2) Homo sapiens (Human) GO:0000139; GO:0000822; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006112; GO:0006207; GO:0006954; GO:0006974; GO:0007010; GO:0007281; GO:0008361; GO:0009267; GO:0009408; GO:0009615; GO:0009791; GO:0010507; GO:0010592; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016605; GO:0019228; GO:0030030; GO:0030307; GO:0030425; GO:0030838; GO:0031295; GO:0031641; GO:0031648; GO:0031667; GO:0031669; GO:0031670; GO:0031929; GO:0031931; GO:0031932; GO:0032869; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0038203; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043200; GO:0043276; GO:0044325; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0045948; GO:0046627; GO:0046889; GO:0048266; GO:0048709; GO:0048714; GO:0050821; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0061431; GO:0062027; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0097700; GO:0106310; GO:1900029; GO:1900034; GO:1900181; GO:1901796; GO:1901838; GO:1903691; GO:1904059; GO:1904690; GO:1905671; GO:1905672; GO:1905857; GO:1990253; GO:2000060; GO:2000785 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell projection organization [GO:0030030]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062027]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; transmembrane transporter binding [GO:0044325] g6400.t1 P42345 62.864 1955 0.0 2402.0 sp|P42345|MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1 MTOR_HUMAN reviewed Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) (Tyrosine-protein kinase mTOR) (EC 2.7.10.2) Homo sapiens (Human) GO:0000139; GO:0000822; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006112; GO:0006207; GO:0006954; GO:0006974; GO:0007010; GO:0007281; GO:0008361; GO:0009267; GO:0009408; GO:0009615; GO:0009791; GO:0010507; GO:0010592; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016605; GO:0019228; GO:0030030; GO:0030307; GO:0030425; GO:0030838; GO:0031295; GO:0031641; GO:0031648; GO:0031667; GO:0031669; GO:0031670; GO:0031929; GO:0031931; GO:0031932; GO:0032869; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0038203; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043200; GO:0043276; GO:0044325; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0045948; GO:0046627; GO:0046889; GO:0048266; GO:0048709; GO:0048714; GO:0050821; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0061431; GO:0062027; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0097700; GO:0106310; GO:1900029; GO:1900034; GO:1900181; GO:1901796; GO:1901838; GO:1903691; GO:1904059; GO:1904690; GO:1905671; GO:1905672; GO:1905857; GO:1990253; GO:2000060; GO:2000785 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell projection organization [GO:0030030]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062027]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; transmembrane transporter binding [GO:0044325] g6400.t2 Q9JLN9 63.294 1937 0.0 2414.0 sp|Q9JLN9|MTOR_MOUSE Serine/threonine-protein kinase mTOR OS=Mus musculus OX=10090 GN=Mtor PE=1 SV=2 g6401.t1 Q9Y5Z9 61.981 313 1.89e-135 391.0 sp|Q9Y5Z9|UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBIAD1 PE=1 SV=1 UBIA1_HUMAN reviewed UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (EC 2.5.1.39) (Transitional epithelial response protein 1) Homo sapiens (Human) GO:0000139; GO:0004659; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006744; GO:0008412; GO:0009234; GO:0016020; GO:0016209; GO:0031966; GO:0042371; GO:0042373; GO:0120566 menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; vitamin K biosynthetic process [GO:0042371]; vitamin K metabolic process [GO:0042373] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634] 4-hydroxybenzoate polyprenyltransferase activity [GO:0008412]; antioxidant activity [GO:0016209]; menadiol geranylgeranyltransferase activity [GO:0120566]; prenyltransferase activity [GO:0004659] g6405.t1 Q58CP2 57.143 280 1.47e-113 335.0 sp|Q58CP2|SUMF2_BOVIN Inactive C-alpha-formylglycine-generating enzyme 2 OS=Bos taurus OX=9913 GN=SUMF2 PE=2 SV=1 g6406.t1 Q9DCJ9 43.369 279 6.47e-78 243.0 sp|Q9DCJ9|NPL_MOUSE N-acetylneuraminate lyase OS=Mus musculus OX=10090 GN=Npl PE=1 SV=1 NPL_MOUSE reviewed N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase) Mus musculus (Mouse) GO:0005737; GO:0008747; GO:0019262; GO:0042802 N-acetylneuraminate catabolic process [GO:0019262] cytoplasm [GO:0005737] identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747] g6407.t1 Q64692 34.754 305 1.13e-45 166.0 sp|Q64692|SIA8D_MOUSE CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase OS=Mus musculus OX=10090 GN=St8sia4 PE=1 SV=1 SIA8D_MOUSE reviewed CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (EC 2.4.3.-) (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D) (SIAT8-D) (Sialyltransferase St8Sia IV) (ST8SiaIV) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0003828; GO:0005576; GO:0005794; GO:0006491; GO:0008373; GO:0009311; GO:0097503 ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; sialylation [GO:0097503] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g6416.t1 P08472 34.646 381 3.4900000000000002e-59 214.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g6417.t1 P11833 97.321 448 0.0 916.0 sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1 g6418.t1 P08472 34.974 386 1.24e-59 214.0 sp|P08472|M130_STRPU Mesenchyme-specific cell surface glycoprotein OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2 g6419.t1 Q8VI93 30.671 313 1.65e-35 140.0 sp|Q8VI93|OAS3_MOUSE 2'-5'-oligoadenylate synthase 3 OS=Mus musculus OX=10090 GN=Oas3 PE=1 SV=1 OAS3_MOUSE reviewed 2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0046872; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071650; GO:0071659; GO:0140374; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6419.t1 Q8VI93 27.554 323 5.95e-26 112.0 sp|Q8VI93|OAS3_MOUSE 2'-5'-oligoadenylate synthase 3 OS=Mus musculus OX=10090 GN=Oas3 PE=1 SV=1 OAS3_MOUSE reviewed 2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0046872; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071650; GO:0071659; GO:0140374; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6419.t1 Q8VI93 27.835 291 1.24e-21 100.0 sp|Q8VI93|OAS3_MOUSE 2'-5'-oligoadenylate synthase 3 OS=Mus musculus OX=10090 GN=Oas3 PE=1 SV=1 OAS3_MOUSE reviewed 2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0046872; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071650; GO:0071659; GO:0140374; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6420.t1 P11928 30.897 301 3.7300000000000003e-26 111.0 sp|P11928|OAS1A_MOUSE 2'-5'-oligoadenylate synthase 1A OS=Mus musculus OX=10090 GN=Oas1a PE=1 SV=2 OAS1A_MOUSE reviewed 2'-5'-oligoadenylate synthase 1A ((2-5')oligo(A) synthase 1A) (2-5A synthase 1A) (EC 2.7.7.84) (p42 OAS) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0006164; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0048525; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071659; GO:0140374; GO:1901857; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; purine nucleotide biosynthetic process [GO:0006164]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6421.t1 P11928 31.333 300 3.57e-28 115.0 sp|P11928|OAS1A_MOUSE 2'-5'-oligoadenylate synthase 1A OS=Mus musculus OX=10090 GN=Oas1a PE=1 SV=2 OAS1A_MOUSE reviewed 2'-5'-oligoadenylate synthase 1A ((2-5')oligo(A) synthase 1A) (2-5A synthase 1A) (EC 2.7.7.84) (p42 OAS) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0006164; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0048525; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071659; GO:0140374; GO:1901857; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; purine nucleotide biosynthetic process [GO:0006164]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6422.t1 P11928 29.63 297 2.32e-27 113.0 sp|P11928|OAS1A_MOUSE 2'-5'-oligoadenylate synthase 1A OS=Mus musculus OX=10090 GN=Oas1a PE=1 SV=2 OAS1A_MOUSE reviewed 2'-5'-oligoadenylate synthase 1A ((2-5')oligo(A) synthase 1A) (2-5A synthase 1A) (EC 2.7.7.84) (p42 OAS) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0006164; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0048525; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071659; GO:0140374; GO:1901857; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; purine nucleotide biosynthetic process [GO:0006164]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6423.t1 Q8VI93 29.341 334 7.02e-32 131.0 sp|Q8VI93|OAS3_MOUSE 2'-5'-oligoadenylate synthase 3 OS=Mus musculus OX=10090 GN=Oas3 PE=1 SV=1 OAS3_MOUSE reviewed 2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0046872; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071650; GO:0071659; GO:0140374; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6423.t1 Q8VI93 27.551 294 9.26e-24 107.0 sp|Q8VI93|OAS3_MOUSE 2'-5'-oligoadenylate synthase 3 OS=Mus musculus OX=10090 GN=Oas3 PE=1 SV=1 OAS3_MOUSE reviewed 2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0046872; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071650; GO:0071659; GO:0140374; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6423.t1 Q8VI93 25.664 339 1.8700000000000002e-21 100.0 sp|Q8VI93|OAS3_MOUSE 2'-5'-oligoadenylate synthase 3 OS=Mus musculus OX=10090 GN=Oas3 PE=1 SV=1 OAS3_MOUSE reviewed 2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (2',5'-oligoadenylate synthetase-like 10) Mus musculus (Mouse) GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0045071; GO:0046872; GO:0051607; GO:0060337; GO:0060339; GO:0070106; GO:0071360; GO:0071639; GO:0071650; GO:0071659; GO:0140374; GO:2000342 antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; type I interferon-mediated signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] g6426.t1 Q09621 35.149 404 2.4e-74 243.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g6427.t1 Q09621 30.816 331 2.25e-44 160.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g6428.t1 Q09621 35.784 408 3.76e-77 250.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g6429.t1 Q09621 36.881 404 1.92e-77 251.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g6430.t1 Q09621 34.491 403 9.55e-67 224.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g6431.t1 Q8BLQ7 33.548 620 3.9e-96 310.0 sp|Q8BLQ7|CTR4_MOUSE Cationic amino acid transporter 4 OS=Mus musculus OX=10090 GN=Slc7a4 PE=1 SV=1 g6432.t1 A1A5X5 44.404 277 2.2100000000000002e-66 216.0 sp|A1A5X5|ADIPL_DANRE Adipolin OS=Danio rerio OX=7955 GN=c1qtnf12 PE=2 SV=1 ADIPL_DANRE reviewed Adipolin (Adipose-derived insulin-sensitizing factor) (Complement C1q tumor necrosis factor-related protein 12) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005179; GO:0005576; GO:0005615; GO:0046324 regulation of D-glucose import [GO:0046324] extracellular region [GO:0005576]; extracellular space [GO:0005615] hormone activity [GO:0005179] g6433.t1 Q6NYE2 55.31 452 1.58e-175 510.0 sp|Q6NYE2|RCC2_DANRE Protein RCC2 homolog OS=Danio rerio OX=7955 GN=rcc2 PE=2 SV=1 g6434.t1 Q5M888 43.921 403 8.95e-112 338.0 sp|Q5M888|CG025_RAT UPF0415 protein C7orf25 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1 g6435.t1 A1A535 42.317 423 2.99e-97 327.0 sp|A1A535|MELT_MOUSE Ventricular zone-expressed PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Veph1 PE=2 SV=2 MELT_MOUSE reviewed Ventricular zone-expressed PH domain-containing protein 1 (Protein melted homolog) Mus musculus (Mouse) GO:0005886; GO:0009966; GO:0010314; GO:0030512; GO:0060392 negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966] plasma membrane [GO:0005886] phosphatidylinositol-5-phosphate binding [GO:0010314] g6435.t1 A1A535 43.369 279 1.4999999999999998e-67 245.0 sp|A1A535|MELT_MOUSE Ventricular zone-expressed PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Veph1 PE=2 SV=2 MELT_MOUSE reviewed Ventricular zone-expressed PH domain-containing protein 1 (Protein melted homolog) Mus musculus (Mouse) GO:0005886; GO:0009966; GO:0010314; GO:0030512; GO:0060392 negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966] plasma membrane [GO:0005886] phosphatidylinositol-5-phosphate binding [GO:0010314] g6436.t1 P63045 90.667 75 1.59e-43 140.0 sp|P63045|VAMP2_RAT Vesicle-associated membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Vamp2 PE=1 SV=2 VAMP2_RAT reviewed Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2) Rattus norvegicus (Rat) GO:0000149; GO:0000322; GO:0005484; GO:0005516; GO:0005543; GO:0005737; GO:0005802; GO:0005886; GO:0006906; GO:0008021; GO:0008289; GO:0009749; GO:0014069; GO:0015031; GO:0016020; GO:0016079; GO:0016081; GO:0016192; GO:0017022; GO:0017075; GO:0017156; GO:0017157; GO:0019905; GO:0030136; GO:0030141; GO:0030659; GO:0030672; GO:0031201; GO:0031410; GO:0031982; GO:0032869; GO:0035493; GO:0042589; GO:0042802; GO:0043001; GO:0043195; GO:0043308; GO:0044306; GO:0044325; GO:0044877; GO:0045055; GO:0045202; GO:0046879; GO:0048306; GO:0048471; GO:0048488; GO:0051649; GO:0060090; GO:0060291; GO:0060627; GO:0061025; GO:0065003; GO:0070032; GO:0070033; GO:0070044; GO:0070723; GO:0090316; GO:0098967; GO:0098978; GO:0099003; GO:0099524; GO:1902259; GO:1903421 calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; eosinophil degranulation [GO:0043308]; establishment of localization in cell [GO:0051649]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; Golgi to plasma membrane protein transport [GO:0043001]; hormone secretion [GO:0046879]; long-term synaptic potentiation [GO:0060291]; membrane fusion [GO:0061025]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of vesicle-mediated transport [GO:0060627]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; SNARE complex assembly [GO:0035493]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; storage vacuole [GO:0000322]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; molecular adaptor activity [GO:0060090]; myosin binding [GO:0017022]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325] g6436.t2 P63045 90.667 75 8.06e-44 141.0 sp|P63045|VAMP2_RAT Vesicle-associated membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Vamp2 PE=1 SV=2 VAMP2_RAT reviewed Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2) Rattus norvegicus (Rat) GO:0000149; GO:0000322; GO:0005484; GO:0005516; GO:0005543; GO:0005737; GO:0005802; GO:0005886; GO:0006906; GO:0008021; GO:0008289; GO:0009749; GO:0014069; GO:0015031; GO:0016020; GO:0016079; GO:0016081; GO:0016192; GO:0017022; GO:0017075; GO:0017156; GO:0017157; GO:0019905; GO:0030136; GO:0030141; GO:0030659; GO:0030672; GO:0031201; GO:0031410; GO:0031982; GO:0032869; GO:0035493; GO:0042589; GO:0042802; GO:0043001; GO:0043195; GO:0043308; GO:0044306; GO:0044325; GO:0044877; GO:0045055; GO:0045202; GO:0046879; GO:0048306; GO:0048471; GO:0048488; GO:0051649; GO:0060090; GO:0060291; GO:0060627; GO:0061025; GO:0065003; GO:0070032; GO:0070033; GO:0070044; GO:0070723; GO:0090316; GO:0098967; GO:0098978; GO:0099003; GO:0099524; GO:1902259; GO:1903421 calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; eosinophil degranulation [GO:0043308]; establishment of localization in cell [GO:0051649]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; Golgi to plasma membrane protein transport [GO:0043001]; hormone secretion [GO:0046879]; long-term synaptic potentiation [GO:0060291]; membrane fusion [GO:0061025]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of vesicle-mediated transport [GO:0060627]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; SNARE complex assembly [GO:0035493]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; storage vacuole [GO:0000322]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; zymogen granule membrane [GO:0042589] calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; molecular adaptor activity [GO:0060090]; myosin binding [GO:0017022]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325] g6437.t1 Q9TT16 57.541 862 0.0 942.0 sp|Q9TT16|CLCN6_RABIT H(+)/Cl(-) exchange transporter 6 OS=Oryctolagus cuniculus OX=9986 GN=CLCN6 PE=2 SV=1 g6438.t1 P32871 60.264 1062 0.0 1299.0 sp|P32871|PK3CA_BOVIN Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Bos taurus OX=9913 GN=PIK3CA PE=1 SV=1 g6439.t1 Q91845 43.883 1030 0.0 780.0 sp|Q91845|EPA4A_XENLA Ephrin type-A receptor 4-A OS=Xenopus laevis OX=8355 GN=epha4-a PE=2 SV=1 g6439.t2 Q91845 44.109 1027 0.0 785.0 sp|Q91845|EPA4A_XENLA Ephrin type-A receptor 4-A OS=Xenopus laevis OX=8355 GN=epha4-a PE=2 SV=1 g6441.t1 Q5JXC2 34.874 238 5.39e-31 128.0 sp|Q5JXC2|MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens OX=9606 GN=MIIP PE=1 SV=3 MIIP_HUMAN reviewed Migration and invasion-inhibitory protein (IGFBP2-binding protein) (Invasion-inhibitory protein 45) (IIp45) Homo sapiens (Human) GO:0010972; GO:0030336 negative regulation of cell migration [GO:0030336]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] g6442.t1 Q3U4G3 45.791 297 5.39e-87 279.0 sp|Q3U4G3|XXLT1_MOUSE Xyloside xylosyltransferase 1 OS=Mus musculus OX=10090 GN=Xxylt1 PE=1 SV=2 XXLT1_MOUSE reviewed Xyloside xylosyltransferase 1 (EC 2.4.2.62) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase) Mus musculus (Mouse) GO:0000287; GO:0005789; GO:0016266; GO:0030145; GO:0035252; GO:0140560; GO:0180059 protein O-linked glycosylation via glucose [GO:0180059]; protein O-linked glycosylation via N-acetyl-galactosamine [GO:0016266] endoplasmic reticulum membrane [GO:0005789] magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560] g6443.t1 Q3MHN0 68.75 208 2.04e-109 317.0 sp|Q3MHN0|PSB6_BOVIN Proteasome subunit beta type-6 OS=Bos taurus OX=9913 GN=PSMB6 PE=1 SV=1 PSB6_BOVIN reviewed Proteasome subunit beta type-6 (EC 3.4.25.1) Bos taurus (Bovine) GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0019774; GO:0043161 proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774] endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298] g6444.t1 Q60821 30.556 360 2.6300000000000004e-32 139.0 sp|Q60821|ZBT17_MOUSE Zinc finger and BTB domain-containing protein 17 OS=Mus musculus OX=10090 GN=Zbtb17 PE=1 SV=2 ZBT17_MOUSE reviewed Zinc finger and BTB domain-containing protein 17 (LP-1) (Polyomavirus late initiator promoter-binding protein) (Zinc finger protein 100) (Zfp-100) (Zinc finger protein 151) (Zinc finger protein Z13) Mus musculus (Mouse) GO:0000977; GO:0000978; GO:0000981; GO:0001046; GO:0001223; GO:0001228; GO:0001702; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007398; GO:0008270; GO:0008285; GO:0032991; GO:0032993; GO:0045893; GO:0045944; GO:0070314; GO:0140297 ectoderm development [GO:0007398]; G1 to G0 transition [GO:0070314]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993] core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270] g6445.t1 Q3ZBG9 47.154 246 1.05e-74 231.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6448.t1 Q8K0Z9 27.815 302 5.680000000000001e-35 145.0 sp|Q8K0Z9|GP153_MOUSE Probable G-protein coupled receptor 153 OS=Mus musculus OX=10090 GN=Gpr153 PE=2 SV=2 g6450.t1 Q5ZIJ9 33.219 581 6.479999999999999e-68 251.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g6450.t1 Q5ZIJ9 35.224 335 1.31e-45 182.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g6452.t1 Q8IUB2 35.681 213 6.5800000000000004e-21 96.7 sp|Q8IUB2|WFDC3_HUMAN WAP four-disulfide core domain protein 3 OS=Homo sapiens OX=9606 GN=WFDC3 PE=1 SV=1 g6453.t1 Q5W8W0 25.472 318 5.98e-22 97.8 sp|Q5W8W0|TAAR6_PANTR Trace amine-associated receptor 6 OS=Pan troglodytes OX=9598 GN=TAAR6 PE=3 SV=1 g6454.t1 P98064 36.695 714 2.4599999999999998e-146 446.0 sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2 g6455.t1 P48740 36.338 721 1.14e-152 462.0 sp|P48740|MASP1_HUMAN Mannan-binding lectin serine protease 1 OS=Homo sapiens OX=9606 GN=MASP1 PE=1 SV=3 MASP1_HUMAN reviewed Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain] Homo sapiens (Human) GO:0001867; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0006957; GO:0008233; GO:0031638; GO:0042802; GO:0042803; GO:0045916; GO:0048306; GO:0051604; GO:0106139 complement activation, alternative pathway [GO:0006957]; complement activation, lectin pathway [GO:0001867]; negative regulation of complement activation [GO:0045916]; protein maturation [GO:0051604]; zymogen activation [GO:0031638] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; symbiont cell surface [GO:0106139] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252] g6456.t1 P98064 36.164 730 6.89e-158 476.0 sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2 g6457.t1 P98064 36.6 653 2.07e-134 430.0 sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2 g6458.t1 Q8BQ86 36.749 283 2.96e-44 158.0 sp|Q8BQ86|CHST8_MOUSE Carbohydrate sulfotransferase 8 OS=Mus musculus OX=10090 GN=Chst8 PE=2 SV=1 CHST8_MOUSE reviewed Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1) Mus musculus (Mouse) GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016051; GO:0016486; GO:0030166; GO:0042446 carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139] dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g6458.t2 Q7L1S5 34.058 276 4.28e-43 162.0 sp|Q7L1S5|CHST9_HUMAN Carbohydrate sulfotransferase 9 OS=Homo sapiens OX=9606 GN=CHST9 PE=1 SV=2 CHST9_HUMAN reviewed Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030203; GO:0042446; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g6458.t2 Q7L1S5 34.902 255 7.37e-35 139.0 sp|Q7L1S5|CHST9_HUMAN Carbohydrate sulfotransferase 9 OS=Homo sapiens OX=9606 GN=CHST9 PE=1 SV=2 CHST9_HUMAN reviewed Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030203; GO:0042446; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g6465.t1 Q9NZR2 28.571 469 6.08e-26 116.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g6465.t1 Q9NZR2 28.409 440 3.61e-25 114.0 sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2 LRP1B_HUMAN reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Homo sapiens (Human) GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0043235 protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g6469.t1 Q9R0A0 42.083 240 9.409999999999999e-55 187.0 sp|Q9R0A0|PEX14_MOUSE Peroxisomal membrane protein PEX14 OS=Mus musculus OX=10090 GN=Pex14 PE=1 SV=1 PEX14_MOUSE reviewed Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14) Mus musculus (Mouse) GO:0001650; GO:0003714; GO:0005102; GO:0005777; GO:0005778; GO:0007031; GO:0008017; GO:0008320; GO:0016558; GO:0016560; GO:0016561; GO:0016562; GO:0030674; GO:0032991; GO:0034453; GO:0034614; GO:0036250; GO:0042802; GO:0043335; GO:0044721; GO:0045892; GO:0048487; GO:0065003; GO:1990429 cellular response to reactive oxygen species [GO:0034614]; microtubule anchoring [GO:0034453]; negative regulation of DNA-templated transcription [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein unfolding [GO:0043335]; protein-containing complex assembly [GO:0065003] fibrillar center [GO:0001650]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] g6469.t2 Q9R0A0 42.083 240 1.1099999999999999e-54 186.0 sp|Q9R0A0|PEX14_MOUSE Peroxisomal membrane protein PEX14 OS=Mus musculus OX=10090 GN=Pex14 PE=1 SV=1 PEX14_MOUSE reviewed Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14) Mus musculus (Mouse) GO:0001650; GO:0003714; GO:0005102; GO:0005777; GO:0005778; GO:0007031; GO:0008017; GO:0008320; GO:0016558; GO:0016560; GO:0016561; GO:0016562; GO:0030674; GO:0032991; GO:0034453; GO:0034614; GO:0036250; GO:0042802; GO:0043335; GO:0044721; GO:0045892; GO:0048487; GO:0065003; GO:1990429 cellular response to reactive oxygen species [GO:0034614]; microtubule anchoring [GO:0034453]; negative regulation of DNA-templated transcription [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein unfolding [GO:0043335]; protein-containing complex assembly [GO:0065003] fibrillar center [GO:0001650]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] g6470.t1 Q9H0R3 63.354 161 7.580000000000001e-77 232.0 sp|Q9H0R3|TM222_HUMAN Transmembrane protein 222 OS=Homo sapiens OX=9606 GN=TMEM222 PE=1 SV=2 TM222_HUMAN reviewed Transmembrane protein 222 Homo sapiens (Human) GO:0016020; GO:0030425 dendrite [GO:0030425]; membrane [GO:0016020] g6471.t1 Q8K4F6 44.789 451 1.2900000000000001e-117 357.0 sp|Q8K4F6|NSUN5_MOUSE 28S rRNA (cytosine-C(5))-methyltransferase OS=Mus musculus OX=10090 GN=Nsun5 PE=1 SV=2 NSUN5_MOUSE reviewed 28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein homolog) Mus musculus (Mouse) GO:0003723; GO:0005654; GO:0005730; GO:0009383; GO:0014003; GO:0021987; GO:0022038; GO:0031641; GO:0045727; GO:0050890; GO:0070475 cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; rRNA base methylation [GO:0070475] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383] g6472.t1 Q9CXR1 47.396 192 2.4499999999999997e-52 175.0 sp|Q9CXR1|DHRS7_MOUSE Dehydrogenase/reductase SDR family member 7 OS=Mus musculus OX=10090 GN=Dhrs7 PE=1 SV=2 g6475.t1 Q12756 60.323 1734 0.0 2022.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 g6475.t2 Q12756 59.505 1736 0.0 1982.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 g6475.t3 Q12756 59.334 1741 0.0 1977.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 g6475.t4 Q12756 59.63 1729 0.0 1980.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 g6475.t5 Q12756 59.631 1734 0.0 1982.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 g6475.t6 Q12756 59.163 1768 0.0 2004.0 sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2 g6477.t1 Q99N34 33.934 333 3.1e-49 169.0 sp|Q99N34|DFFB_RAT DNA fragmentation factor subunit beta OS=Rattus norvegicus OX=10116 GN=Dffb PE=1 SV=1 DFFB_RAT reviewed DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (DNA fragmentation factor 40 kDa subunit) (DFF-40) Rattus norvegicus (Rat) GO:0000785; GO:0003677; GO:0004518; GO:0004520; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0016787; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718; GO:1902511 apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; negative regulation of apoptotic DNA fragmentation [GO:1902511] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA endonuclease activity [GO:0004520]; DNA nuclease activity [GO:0004536]; enzyme binding [GO:0019899]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; nuclease activity [GO:0004518]; protein domain specific binding [GO:0019904] g6482.t1 O15072 25.486 463 2.32e-21 100.0 sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4 ATS3_HUMAN reviewed A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme) Homo sapiens (Human) GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g6483.t1 Q9C0B2 33.495 1654 0.0 780.0 sp|Q9C0B2|CFA74_HUMAN Cilia- and flagella-associated protein 74 OS=Homo sapiens OX=9606 GN=CFAP74 PE=1 SV=3 CFA74_HUMAN reviewed Cilia- and flagella-associated protein 74 Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005930; GO:0035082; GO:0036126 axoneme assembly [GO:0035082] axoneme [GO:0005930]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] g6484.t1 Q6P2X9 26.817 399 6.71e-31 127.0 sp|Q6P2X9|MOT12_XENTR Monocarboxylate transporter 12 OS=Xenopus tropicalis OX=8364 GN=slc16a12 PE=2 SV=1 g6490.t1 Q4T2X8 75.978 179 2.7399999999999998e-108 310.0 sp|Q4T2X8|NIP7_TETNG 60S ribosome subunit biogenesis protein NIP7 homolog OS=Tetraodon nigroviridis OX=99883 GN=nip7 PE=3 SV=1 g6491.t1 P04058 35.149 569 4.18e-101 322.0 sp|P04058|ACES_TETCF Acetylcholinesterase OS=Tetronarce californica OX=7787 GN=ache PE=1 SV=2 g6492.t1 C0HM36 42.593 216 2.04e-47 162.0 sp|C0HM36|LEC1_ECHLU Echinolectin 1 OS=Echinometra lucunter OX=105361 PE=1 SV=1 g6493.t1 C0HM36 39.336 211 2.8000000000000002e-43 150.0 sp|C0HM36|LEC1_ECHLU Echinolectin 1 OS=Echinometra lucunter OX=105361 PE=1 SV=1 g6495.t1 Q8CDI7 30.877 1072 5.58e-127 421.0 sp|Q8CDI7|CC150_MOUSE Coiled-coil domain-containing protein 150 OS=Mus musculus OX=10090 GN=Ccdc150 PE=2 SV=2 g6495.t2 Q8CDI7 30.877 1072 7.92e-127 421.0 sp|Q8CDI7|CC150_MOUSE Coiled-coil domain-containing protein 150 OS=Mus musculus OX=10090 GN=Ccdc150 PE=2 SV=2 g6497.t1 Q8IZH2 51.981 1262 0.0 1272.0 sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1 XRN1_HUMAN reviewed 5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog) Homo sapiens (Human) GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795 cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075] cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886] 5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] g6499.t1 Q99KX1 42.797 236 1.24e-49 167.0 sp|Q99KX1|MLF2_MOUSE Myeloid leukemia factor 2 OS=Mus musculus OX=10090 GN=Mlf2 PE=1 SV=1 g6499.t2 Q15773 41.667 228 7.1e-49 165.0 sp|Q15773|MLF2_HUMAN Myeloid leukemia factor 2 OS=Homo sapiens OX=9606 GN=MLF2 PE=1 SV=1 g6502.t1 Q9JJ00 51.584 221 7.6e-75 233.0 sp|Q9JJ00|PLS1_MOUSE Phospholipid scramblase 1 OS=Mus musculus OX=10090 GN=Plscr1 PE=1 SV=1 PLS1_MOUSE reviewed Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (Transplantability-associated protein 1) (NOR1) (TRA1) Mus musculus (Mouse) GO:0000287; GO:0001228; GO:0001618; GO:0003677; GO:0004518; GO:0005154; GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006659; GO:0006915; GO:0006953; GO:0006955; GO:0008270; GO:0010288; GO:0010628; GO:0016787; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0030099; GO:0032791; GO:0033003; GO:0035455; GO:0035456; GO:0042609; GO:0043065; GO:0045071; GO:0045089; GO:0045121; GO:0045340; GO:0045944; GO:0048471; GO:0050765; GO:0051607; GO:0060368; GO:0070782; GO:0071222; GO:0071345; GO:0097193; GO:1902231; GO:1905820; GO:2000373 acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; defense response to virus [GO:0051607]; immune response [GO:0006955]; intrinsic apoptotic signaling pathway [GO:0097193]; myeloid cell differentiation [GO:0030099]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; hydrolase activity [GO:0016787]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] g6503.t1 Q3ZBG9 52.814 231 8.15e-77 237.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6505.t1 Q3ZBG9 50.403 248 1.72e-77 239.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6506.t1 Q9UBZ9 39.92 749 2.6e-159 516.0 sp|Q9UBZ9|REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens OX=9606 GN=REV1 PE=1 SV=1 REV1_HUMAN reviewed Translesion synthesis protein REV1 (Alpha integrin-binding protein 80) (AIBP80) (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Homo sapiens (Human) GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006281; GO:0016446; GO:0017125; GO:0019985; GO:0030674; GO:0042276; GO:0043130; GO:0043596; GO:0046872; GO:0070987; GO:0071897; GO:0090734; GO:0140431 DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130] g6506.t1 Q9UBZ9 59.459 148 2e-45 183.0 sp|Q9UBZ9|REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens OX=9606 GN=REV1 PE=1 SV=1 REV1_HUMAN reviewed Translesion synthesis protein REV1 (Alpha integrin-binding protein 80) (AIBP80) (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Homo sapiens (Human) GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006281; GO:0016446; GO:0017125; GO:0019985; GO:0030674; GO:0042276; GO:0043130; GO:0043596; GO:0046872; GO:0070987; GO:0071897; GO:0090734; GO:0140431 DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130] g6506.t1 Q9UBZ9 27.763 371 7.02e-21 103.0 sp|Q9UBZ9|REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens OX=9606 GN=REV1 PE=1 SV=1 REV1_HUMAN reviewed Translesion synthesis protein REV1 (Alpha integrin-binding protein 80) (AIBP80) (Molecular adapter protein REV1) (Rev1-like terminal deoxycytidyl transferase) (Reversionless protein 1 homolog) (REV1 homolog) (Template-dependent deoxycytidyl transferase REV1) (EC 2.7.7.-) Homo sapiens (Human) GO:0003677; GO:0003684; GO:0003887; GO:0005654; GO:0006281; GO:0016446; GO:0017125; GO:0019985; GO:0030674; GO:0042276; GO:0043130; GO:0043596; GO:0046872; GO:0070987; GO:0071897; GO:0090734; GO:0140431 DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; somatic hypermutation of immunoglobulin genes [GO:0016446]; translesion synthesis [GO:0019985] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734] damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130] g6510.t1 Q14832 28.966 832 5.110000000000001e-103 342.0 sp|Q14832|GRM3_HUMAN Metabotropic glutamate receptor 3 OS=Homo sapiens OX=9606 GN=GRM3 PE=1 SV=2 GRM3_HUMAN reviewed Metabotropic glutamate receptor 3 (mGluR3) Homo sapiens (Human) GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0033554; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170 cellular response to stress [GO:0033554]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966] astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] g6511.t1 P51788 50.699 858 0.0 783.0 sp|P51788|CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens OX=9606 GN=CLCN2 PE=1 SV=2 CLCN2_HUMAN reviewed Chloride channel protein 2 (ClC-2) Homo sapiens (Human) GO:0005247; GO:0005886; GO:0006821; GO:0006911; GO:0016323; GO:0017081; GO:0030322; GO:0030324; GO:0032347; GO:0032591; GO:0034707; GO:0043194; GO:0043204; GO:0043209; GO:0048714; GO:0060041; GO:0060075; GO:0060689; GO:0071476; GO:0072320; GO:0090425; GO:0097450; GO:0098902 acinar cell differentiation [GO:0090425]; cell differentiation involved in salivary gland development [GO:0060689]; cellular hypotonic response [GO:0071476]; chloride transport [GO:0006821]; lung development [GO:0030324]; phagocytosis, engulfment [GO:0006911]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of resting membrane potential [GO:0060075]; retina development in camera-type eye [GO:0060041]; stabilization of membrane potential [GO:0030322] astrocyte end-foot [GO:0097450]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; dendritic spine membrane [GO:0032591]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] chloride channel regulator activity [GO:0017081]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320] g6512.t1 Q9H3D4 34.682 692 3.07e-88 293.0 sp|Q9H3D4|P63_HUMAN Tumor protein 63 OS=Homo sapiens OX=9606 GN=TP63 PE=1 SV=1 g6512.t2 Q9H3D4 34.732 691 4.75e-90 297.0 sp|Q9H3D4|P63_HUMAN Tumor protein 63 OS=Homo sapiens OX=9606 GN=TP63 PE=1 SV=1 g6512.t3 Q9JJP2 43.522 301 1.32e-67 229.0 sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1 g6514.t1 Q5ZMP6 85.417 432 0.0 793.0 sp|Q5ZMP6|AP2M1_CHICK AP-2 complex subunit mu OS=Gallus gallus OX=9031 GN=AP2M1 PE=2 SV=1 g6515.t1 Q9JHG1 51.969 127 3.35e-44 144.0 sp|Q9JHG1|PIGP_MOUSE Phosphatidylinositol N-acetylglucosaminyltransferase subunit P OS=Mus musculus OX=10090 GN=Pigp PE=2 SV=1 g6524.t1 Q9UGM3 35.032 1393 0.0 699.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t1 Q9UGM3 35.213 1383 0.0 698.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t1 Q9UGM3 34.56 1386 0.0 691.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t1 Q9UGM3 35.994 1278 0.0 681.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t1 Q9UGM3 34.692 908 4.2200000000000005e-133 459.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t1 Q9UGM3 33.171 615 1.0100000000000001e-72 273.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t1 Q9UGM3 44.118 136 3.19e-22 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t2 Q9UGM3 35.032 1393 0.0 698.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t2 Q9UGM3 35.213 1383 0.0 697.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t2 Q9UGM3 34.56 1386 0.0 690.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t2 Q9UGM3 35.994 1278 0.0 680.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t2 Q9UGM3 34.692 908 6.44e-133 458.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t2 Q9UGM3 33.171 615 1.32e-72 272.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6524.t2 Q9UGM3 44.118 136 3.4e-22 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6535.t1 O57472 34.718 939 0.0 588.0 sp|O57472|CHRD_DANRE Chordin OS=Danio rerio OX=7955 GN=chd PE=2 SV=1 CHRD_DANRE reviewed Chordin (Protein chordino) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001756; GO:0001947; GO:0003143; GO:0005615; GO:0007368; GO:0009948; GO:0009953; GO:0010159; GO:0030510; GO:0030514; GO:0035143; GO:0035162; GO:0036122; GO:0043049; GO:0048264; GO:0060030; GO:0061371; GO:0070121 anterior/posterior axis specification [GO:0009948]; caudal fin morphogenesis [GO:0035143]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; determination of ventral identity [GO:0048264]; dorsal convergence [GO:0060030]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; embryonic hemopoiesis [GO:0035162]; heart looping [GO:0001947]; Kupffer's vesicle development [GO:0070121]; negative regulation of BMP signaling pathway [GO:0030514]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway [GO:0030510]; somitogenesis [GO:0001756]; specification of animal organ position [GO:0010159] extracellular space [GO:0005615] BMP binding [GO:0036122] g6536.t1 Q9XTY1 51.739 230 5.82e-75 263.0 sp|Q9XTY1|GCY22_CAEEL Receptor-type guanylate cyclase gcy-22 OS=Caenorhabditis elegans OX=6239 GN=gcy-22 PE=1 SV=2 g6536.t2 P55205 57.647 85 3.63e-29 113.0 sp|P55205|GUC2G_RAT Guanylate cyclase 2G OS=Rattus norvegicus OX=10116 GN=Gucy2g PE=2 SV=2 g6537.t1 O16118 51.414 389 4.45e-137 399.0 sp|O16118|GNAS_HOMAM Guanine nucleotide-binding protein G(s) subunit alpha OS=Homarus americanus OX=6706 PE=2 SV=1 g6538.t1 Q5H9S7 29.905 525 4.49e-60 210.0 sp|Q5H9S7|DCA17_HUMAN DDB1- and CUL4-associated factor 17 OS=Homo sapiens OX=9606 GN=DCAF17 PE=1 SV=1 DCA17_HUMAN reviewed DDB1- and CUL4-associated factor 17 Homo sapiens (Human) GO:0000902; GO:0001675; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016567; GO:0080008 acrosome assembly [GO:0001675]; cell morphogenesis [GO:0000902]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] g6539.t1 O60308 42.505 934 0.0 701.0 sp|O60308|CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens OX=9606 GN=CEP104 PE=1 SV=1 CE104_HUMAN reviewed Centrosomal protein of 104 kDa (Cep104) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0005814; GO:0005929 centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; spindle pole [GO:0000922] g6539.t2 O60308 42.291 934 0.0 701.0 sp|O60308|CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens OX=9606 GN=CEP104 PE=1 SV=1 CE104_HUMAN reviewed Centrosomal protein of 104 kDa (Cep104) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0005814; GO:0005929 centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; spindle pole [GO:0000922] g6541.t1 P16858 75.904 332 0.0 522.0 sp|P16858|G3P_MOUSE Glyceraldehyde-3-phosphate dehydrogenase OS=Mus musculus OX=10090 GN=Gapdh PE=1 SV=2 G3P_MOUSE reviewed Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-) Mus musculus (Mouse) GO:0000226; GO:0001819; GO:0004365; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0008017; GO:0015630; GO:0017148; GO:0019828; GO:0019899; GO:0031640; GO:0031906; GO:0031965; GO:0032481; GO:0035605; GO:0035606; GO:0042802; GO:0043123; GO:0043209; GO:0046166; GO:0050661; GO:0050821; GO:0050832; GO:0051287; GO:0051402; GO:0051873; GO:0061621; GO:0061844; GO:0071346; GO:0097452; GO:0097718; GO:0098978; GO:0099092; GO:1990904 antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; canonical glycolysis [GO:0061621]; cellular response to type II interferon [GO:0071346]; defense response to fungus [GO:0050832]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production [GO:0001819]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; glutamatergic synapse [GO:0098978]; late endosome lumen [GO:0031906]; lipid droplet [GO:0005811]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; ribonucleoprotein complex [GO:1990904] aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605] g6542.t1 B0DOB4 41.467 1500 0.0 1115.0 sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1 g6543.t1 O54967 54.819 498 0.0 569.0 sp|O54967|ACK1_MOUSE Activated CDC42 kinase 1 OS=Mus musculus OX=10090 GN=Tnk2 PE=1 SV=2 ACK1_MOUSE reviewed Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2) Mus musculus (Mouse) GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007165; GO:0007286; GO:0016310; GO:0030136; GO:0030424; GO:0030425; GO:0030426; GO:0030659; GO:0031625; GO:0042802; GO:0043025; GO:0046872; GO:0050699; GO:0070436; GO:0097268; GO:0099523; GO:0099524; GO:0106310; GO:2000369 endocytosis [GO:0006897]; phosphorylation [GO:0016310]; regulation of clathrin-dependent endocytosis [GO:2000369]; signal transduction [GO:0007165]; spermatid development [GO:0007286] adherens junction [GO:0005912]; axon [GO:0030424]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endosome [GO:0005768]; Grb2-EGFR complex [GO:0070436]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523] ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699] g6550.t1 Q69ZS8 41.63 675 7.34e-153 469.0 sp|Q69ZS8|KAZRN_MOUSE Kazrin OS=Mus musculus OX=10090 GN=Kazn PE=1 SV=2 KAZRN_MOUSE reviewed Kazrin Mus musculus (Mouse) GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424 keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] g6553.t1 O00154 51.652 333 2.73e-112 335.0 sp|O00154|BACH_HUMAN Cytosolic acyl coenzyme A thioester hydrolase OS=Homo sapiens OX=9606 GN=ACOT7 PE=1 SV=3 BACH_HUMAN reviewed Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (hBACH) (CTE-IIa) (CTE-II) (Long chain acyl-CoA thioester hydrolase) Homo sapiens (Human) GO:0000062; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006637; GO:0009062; GO:0015937; GO:0036042; GO:0036114; GO:0036116; GO:0042803; GO:0051792; GO:0052689; GO:0052816; GO:0070062; GO:1900535 acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid catabolic process [GO:0009062]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; protein homodimerization activity [GO:0042803] g6554.t1 Q3T0W4 57.012 328 1.0400000000000001e-123 362.0 sp|Q3T0W4|PP1R7_BOVIN Protein phosphatase 1 regulatory subunit 7 OS=Bos taurus OX=9913 GN=PPP1R7 PE=1 SV=1 g6555.t1 P49915 68.018 666 0.0 955.0 sp|P49915|GUAA_HUMAN GMP synthase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=GMPS PE=1 SV=1 GUAA_HUMAN reviewed GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) Homo sapiens (Human) GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0009113; GO:0009168 GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168] cytosol [GO:0005829] ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921] g6556.t1 C6EUD4 59.041 459 0.0 550.0 sp|C6EUD4|APSCT_FASHE Succinyl-CoA:acetate/propanoyl-CoA:succinate CoA transferase OS=Fasciola hepatica OX=6192 PE=1 SV=1 g6557.t1 O02751 38.503 187 1.11e-40 150.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g6557.t2 O02751 36.81 163 4.84e-34 130.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g6560.t1 Q5AY39 27.376 2462 0.0 754.0 sp|Q5AY39|PKS91_EMENI Highly reducing polyketide synthase AN6791 OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=AN6791 PE=2 SV=1 PKS91_EMENI reviewed Highly reducing polyketide synthase AN6791 (HR-PKS) (EC 2.3.1.-) Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans) GO:0004312; GO:0006633; GO:0008168; GO:0008270; GO:0016491; GO:0019748; GO:0030639; GO:0031177; GO:0032259; GO:0044550; GO:1901336 fatty acid biosynthetic process [GO:0006633]; lactone biosynthetic process [GO:1901336]; methylation [GO:0032259]; polyketide biosynthetic process [GO:0030639]; secondary metabolic process [GO:0019748]; secondary metabolite biosynthetic process [GO:0044550] fatty acid synthase activity [GO:0004312]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; zinc ion binding [GO:0008270] g6575.t1 Q5RC70 54.77 566 0.0 600.0 sp|Q5RC70|DJC11_PONAB DnaJ homolog subfamily C member 11 OS=Pongo abelii OX=9601 GN=DNAJC11 PE=2 SV=1 g6577.t1 Q9P2S5 60.619 452 0.0 592.0 sp|Q9P2S5|WRP73_HUMAN WD repeat-containing protein WRAP73 OS=Homo sapiens OX=9606 GN=WRAP73 PE=1 SV=1 WRP73_HUMAN reviewed WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene) Homo sapiens (Human) GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0034451; GO:0036064; GO:0090307; GO:1902857; GO:1990810; GO:1990811 cell projection organization [GO:0030030]; microtubule anchoring at mitotic spindle pole body [GO:1990810]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; MWP complex [GO:1990811] g6580.t1 Q96DM1 41.026 156 3.18e-25 107.0 sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3 g6583.t2 P20825 38.318 214 2.89e-35 149.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g6585.t1 O88281 43.995 1557 0.0 1239.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g6585.t1 O88281 41.17 923 0.0 627.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g6585.t1 O88281 36.254 1244 0.0 619.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g6585.t2 O88281 43.297 1559 0.0 1207.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g6585.t2 O88281 40.665 782 2.78e-165 545.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g6585.t2 O88281 38.889 648 6.1400000000000005e-117 408.0 sp|O88281|MEGF6_RAT Multiple epidermal growth factor-like domains protein 6 OS=Rattus norvegicus OX=10116 GN=Megf6 PE=1 SV=1 g6587.t1 P56705 64.873 353 1.6100000000000001e-173 489.0 sp|P56705|WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens OX=9606 GN=WNT4 PE=1 SV=4 WNT4_HUMAN reviewed Protein Wnt-4 Homo sapiens (Human) GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0046580; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234 adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714] g6588.t1 O94827 34.807 701 4.8200000000000005e-99 339.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6588.t2 O94827 34.195 696 1.69e-97 334.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6589.t1 O94827 37.826 230 3.77e-39 163.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6589.t1 O94827 37.778 225 8.17e-39 162.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6589.t1 O94827 34.409 279 1.49e-38 161.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6589.t1 O94827 34.074 270 1.07e-36 155.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6589.t1 O94827 33.574 277 1.3500000000000001e-35 152.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6589.t1 O94827 39.07 215 9.75e-35 149.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6589.t1 O94827 32.453 265 6.17e-31 137.0 sp|O94827|PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens OX=9606 GN=PLEKHG5 PE=1 SV=4 g6590.t1 Q9WUA2 61.864 590 0.0 772.0 sp|Q9WUA2|SYFB_MOUSE Phenylalanine--tRNA ligase beta subunit OS=Mus musculus OX=10090 GN=Farsb PE=1 SV=2 g6591.t1 Q5ZK62 45.791 784 0.0 686.0 sp|Q5ZK62|ACAP2_CHICK Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ACAP2 PE=2 SV=1 g6592.t1 P40757 59.021 388 1.08e-146 430.0 sp|P40757|ALN_AQUCT Allantoinase, mitochondrial OS=Aquarana catesbeiana OX=8400 GN=ALN PE=1 SV=1 g6593.t1 P17343 66.765 340 6.66e-158 445.0 sp|P17343|GBB1_CAEEL Guanine nucleotide-binding protein subunit beta-1 OS=Caenorhabditis elegans OX=6239 GN=gpb-1 PE=1 SV=2 g6594.t1 Q811A3 48.974 731 0.0 750.0 sp|Q811A3|PLOD2_RAT Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 OS=Rattus norvegicus OX=10116 GN=Plod2 PE=2 SV=1 g6595.t1 Q96NI6 30.994 342 9.43e-34 140.0 sp|Q96NI6|LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 OS=Homo sapiens OX=9606 GN=LRFN5 PE=1 SV=2 LRFN5_HUMAN reviewed Leucine-rich repeat and fibronectin type-III domain-containing protein 5 Homo sapiens (Human) GO:0009986; GO:0043031; GO:0050728; GO:0098839; GO:0098978; GO:0098982; GO:0099560; GO:1905606 negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839] g6597.t1 P30875 36.304 303 7.5e-55 186.0 sp|P30875|SSR2_MOUSE Somatostatin receptor type 2 OS=Mus musculus OX=10090 GN=Sstr2 PE=2 SV=1 SSR2_MOUSE reviewed Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1) Mus musculus (Mouse) GO:0004994; GO:0005654; GO:0005829; GO:0005886; GO:0007186; GO:0007193; GO:0007218; GO:0016020; GO:0030165; GO:0030432; GO:0042923; GO:0043005; GO:0071385; GO:0071392 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432] cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994] g6598.t1 Q5XF89 47.191 890 0.0 743.0 sp|Q5XF89|AT133_MOUSE Polyamine-transporting ATPase 13A3 OS=Mus musculus OX=10090 GN=Atp13a3 PE=1 SV=1 AT133_MOUSE reviewed Polyamine-transporting ATPase 13A3 (Putrescine transporting ATPase) (EC 7.6.2.16) Mus musculus (Mouse) GO:0005524; GO:0006874; GO:0015203; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358; GO:1902047 intracellular calcium ion homeostasis [GO:0006874]; polyamine transmembrane transport [GO:1902047] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358]; polyamine transmembrane transporter activity [GO:0015203] g6598.t2 Q5XF89 46.452 902 0.0 740.0 sp|Q5XF89|AT133_MOUSE Polyamine-transporting ATPase 13A3 OS=Mus musculus OX=10090 GN=Atp13a3 PE=1 SV=1 AT133_MOUSE reviewed Polyamine-transporting ATPase 13A3 (Putrescine transporting ATPase) (EC 7.6.2.16) Mus musculus (Mouse) GO:0005524; GO:0006874; GO:0015203; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358; GO:1902047 intracellular calcium ion homeostasis [GO:0006874]; polyamine transmembrane transport [GO:1902047] early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358]; polyamine transmembrane transporter activity [GO:0015203] g6599.t1 Q9CTG6 50.943 318 1.14e-85 283.0 sp|Q9CTG6|AT132_MOUSE Polyamine-transporting ATPase 13A2 OS=Mus musculus OX=10090 GN=Atp13a2 PE=2 SV=3 AT132_MOUSE reviewed Polyamine-transporting ATPase 13A2 (EC 7.6.2.-) Mus musculus (Mouse) GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0010628; GO:0010821; GO:0012506; GO:0015203; GO:0015417; GO:0015662; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030133; GO:0031902; GO:0031982; GO:0032585; GO:0033157; GO:0034599; GO:0043005; GO:0043025; GO:0046872; GO:0050714; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0080025; GO:0097734; GO:1900180; GO:1902047; GO:1903543; GO:1903710; GO:1905037; GO:1905165 autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; extracellular exosome biogenesis [GO:0097734]; intracellular calcium ion homeostasis [GO:0006874]; intracellular iron ion homeostasis [GO:0006879]; intracellular zinc ion homeostasis [GO:0006882]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; spermine transmembrane transport [GO:1903710] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; vesicle membrane [GO:0012506] ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; polyamine transmembrane transporter activity [GO:0015203] g6601.t1 P16067 60.811 222 8.57e-84 286.0 sp|P16067|ANPRB_RAT Atrial natriuretic peptide receptor 2 OS=Rattus norvegicus OX=10116 GN=Npr2 PE=1 SV=1 g6602.t1 C0HM36 45.872 218 2.86e-60 195.0 sp|C0HM36|LEC1_ECHLU Echinolectin 1 OS=Echinometra lucunter OX=105361 PE=1 SV=1 g6603.t1 P54186 36.601 153 4.9199999999999993e-23 94.0 sp|P54186|D1_ONCVO Protein D1 (Fragment) OS=Onchocerca volvulus OX=6282 GN=D1 PE=2 SV=1 g6608.t1 P49916 49.694 980 0.0 941.0 sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2 DNLI3_HUMAN reviewed DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) Homo sapiens (Human) GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298] DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] g6609.t1 Q5XI32 81.413 269 6.64e-166 463.0 sp|Q5XI32|CAPZB_RAT F-actin-capping protein subunit beta OS=Rattus norvegicus OX=10116 GN=Capzb PE=1 SV=1 CAPZB_RAT reviewed F-actin-capping protein subunit beta (CapZ beta) Rattus norvegicus (Rat) GO:0000902; GO:0003779; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0010591; GO:0014069; GO:0014704; GO:0016020; GO:0022604; GO:0030018; GO:0030027; GO:0030030; GO:0030032; GO:0030863; GO:0031115; GO:0031175; GO:0032279; GO:0043025; GO:0043197; GO:0048487; GO:0051015; GO:0051016; GO:0051490; GO:0055001; GO:0061827; GO:0071203; GO:0090036; GO:0098685; GO:0098686; GO:0120212 actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; muscle cell development [GO:0055001]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591]; regulation of protein kinase C signaling [GO:0090036] asymmetric synapse [GO:0032279]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm head [GO:0061827]; sperm head-tail coupling apparatus [GO:0120212]; WASH complex [GO:0071203]; Z disc [GO:0030018] actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487] g6610.t1 O15013 40.153 914 0.0 659.0 sp|O15013|ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 OS=Homo sapiens OX=9606 GN=ARHGEF10 PE=1 SV=4 g6610.t2 O15013 40.153 914 0.0 660.0 sp|O15013|ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 OS=Homo sapiens OX=9606 GN=ARHGEF10 PE=1 SV=4 g6610.t3 O15013 40.153 914 0.0 659.0 sp|O15013|ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 OS=Homo sapiens OX=9606 GN=ARHGEF10 PE=1 SV=4 g6610.t4 O15013 39.677 930 0.0 660.0 sp|O15013|ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 OS=Homo sapiens OX=9606 GN=ARHGEF10 PE=1 SV=4 g6612.t1 P12755 37.042 710 2.69e-101 326.0 sp|P12755|SKI_HUMAN Ski oncogene OS=Homo sapiens OX=9606 GN=SKI PE=1 SV=1 SKI_HUMAN reviewed Ski oncogene (Proto-oncogene c-Ski) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001843; GO:0002089; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0007179; GO:0008270; GO:0008285; GO:0009948; GO:0010626; GO:0014902; GO:0016604; GO:0016605; GO:0017053; GO:0019901; GO:0019904; GO:0021772; GO:0022011; GO:0030177; GO:0030326; GO:0030512; GO:0030514; GO:0031625; GO:0032926; GO:0032991; GO:0035019; GO:0042802; GO:0043010; GO:0043388; GO:0043585; GO:0045668; GO:0045944; GO:0046332; GO:0046811; GO:0048147; GO:0048593; GO:0048741; GO:0048870; GO:0060021; GO:0060038; GO:0060041; GO:0060325; GO:0060349; GO:0060392; GO:0140297 anterior/posterior axis specification [GO:0009948]; bone morphogenesis [GO:0060349]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell proliferation [GO:0060038]; cell motility [GO:0048870]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; lens morphogenesis in camera-type eye [GO:0002089]; myelination in peripheral nervous system [GO:0022011]; myotube differentiation [GO:0014902]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neural tube closure [GO:0001843]; nose morphogenesis [GO:0043585]; olfactory bulb development [GO:0021772]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; retina development in camera-type eye [GO:0060041]; roof of mouth development [GO:0060021]; skeletal muscle fiber development [GO:0048741]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway [GO:0007179] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase inhibitor activity [GO:0046811]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] g6613.t1 Q9P2K9 36.329 779 1.19e-128 436.0 sp|Q9P2K9|DISP3_HUMAN Protein dispatched homolog 3 OS=Homo sapiens OX=9606 GN=DISP3 PE=1 SV=2 DISP3_HUMAN reviewed Protein dispatched homolog 3 (Patched domain-containing protein 2) Homo sapiens (Human) GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179 cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965] g6613.t1 Q9P2K9 47.573 412 1.55e-94 338.0 sp|Q9P2K9|DISP3_HUMAN Protein dispatched homolog 3 OS=Homo sapiens OX=9606 GN=DISP3 PE=1 SV=2 DISP3_HUMAN reviewed Protein dispatched homolog 3 (Patched domain-containing protein 2) Homo sapiens (Human) GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179 cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965] g6616.t1 Q96RW7 30.508 413 3.06e-40 166.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g6624.t1 P0DPD9 46.827 583 0.0 599.0 sp|P0DPD9|EFCE2_MOUSE EEF1AKMT4-ECE2 readthrough transcript protein OS=Mus musculus OX=10090 GN=Eef1akmt4-Ece2 PE=1 SV=1 g6625.t1 Q3ZBG9 46.595 279 6.61e-82 251.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6628.t1 Q3ZBG9 45.965 285 2.81e-80 248.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6629.t1 Q3ZBG9 48.905 274 4.75e-82 252.0 sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1 g6631.t1 G5E8K6 28.693 352 9.950000000000001e-21 96.7 sp|G5E8K6|MOT6_MOUSE Monocarboxylate transporter 6 OS=Mus musculus OX=10090 GN=Slc16a5 PE=3 SV=1 g6632.t1 O15466 29.167 288 7.309999999999999e-42 155.0 sp|O15466|SIA8E_HUMAN Alpha-2,8-sialyltransferase 8E OS=Homo sapiens OX=9606 GN=ST8SIA5 PE=1 SV=2 SIA8E_HUMAN reviewed Alpha-2,8-sialyltransferase 8E (EC 2.4.99.-) (Sialyltransferase 8E) (SIAT8-E) (Sialyltransferase St8Sia V) (ST8SiaV) Homo sapiens (Human) GO:0000139; GO:0003828; GO:0005975; GO:0006491; GO:0006688; GO:0008373; GO:0009311 carbohydrate metabolic process [GO:0005975]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g6632.t2 O15466 29.167 288 2.0699999999999998e-42 156.0 sp|O15466|SIA8E_HUMAN Alpha-2,8-sialyltransferase 8E OS=Homo sapiens OX=9606 GN=ST8SIA5 PE=1 SV=2 SIA8E_HUMAN reviewed Alpha-2,8-sialyltransferase 8E (EC 2.4.99.-) (Sialyltransferase 8E) (SIAT8-E) (Sialyltransferase St8Sia V) (ST8SiaV) Homo sapiens (Human) GO:0000139; GO:0003828; GO:0005975; GO:0006491; GO:0006688; GO:0008373; GO:0009311 carbohydrate metabolic process [GO:0005975]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g6633.t1 A7T1N0 28.274 1008 1.64e-120 409.0 sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1 TMP2L_NEMVE reviewed Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2) Nematostella vectensis (Starlet sea anemone) GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604 calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886] ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872] g6634.t1 Q14AT5 49.702 839 0.0 810.0 sp|Q14AT5|ANO7_MOUSE Anoctamin-7 OS=Mus musculus OX=10090 GN=Ano7 PE=1 SV=2 g6634.t2 Q14AT5 50.431 813 0.0 808.0 sp|Q14AT5|ANO7_MOUSE Anoctamin-7 OS=Mus musculus OX=10090 GN=Ano7 PE=1 SV=2 g6635.t1 Q8VDJ3 51.888 1245 0.0 1265.0 sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1 g6636.t1 G5EDR5 34.375 256 1.0999999999999999e-38 149.0 sp|G5EDR5|FUTA_CAEEL Alpha-(1,3)-fucosyltransferase fut-1 OS=Caenorhabditis elegans OX=6239 GN=fut-1 PE=1 SV=1 FUTA_CAEEL reviewed Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1) Caenorhabditis elegans GO:0000139; GO:0006487; GO:0006491; GO:0008417; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0046872; GO:0046920; GO:1901137 carbohydrate biosynthetic process [GO:0016051]; carbohydrate derivative biosynthetic process [GO:1901137]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872] g6637.t1 G5EDR5 37.131 237 4.66e-39 150.0 sp|G5EDR5|FUTA_CAEEL Alpha-(1,3)-fucosyltransferase fut-1 OS=Caenorhabditis elegans OX=6239 GN=fut-1 PE=1 SV=1 FUTA_CAEEL reviewed Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1) Caenorhabditis elegans GO:0000139; GO:0006487; GO:0006491; GO:0008417; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0046872; GO:0046920; GO:1901137 carbohydrate biosynthetic process [GO:0016051]; carbohydrate derivative biosynthetic process [GO:1901137]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139] 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872] g6639.t1 Q5EA33 47.549 204 5.6300000000000005e-59 192.0 sp|Q5EA33|ANR49_BOVIN Ankyrin repeat domain-containing protein 49 OS=Bos taurus OX=9913 GN=ANKRD49 PE=2 SV=1 g6641.t1 Q13546 25.0 732 1.0400000000000001e-36 150.0 sp|Q13546|RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens OX=9606 GN=RIPK1 PE=1 SV=3 g6642.t1 P30825 31.325 664 1.31e-100 325.0 sp|P30825|CTR1_HUMAN High affinity cationic amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A1 PE=1 SV=1 CTR1_HUMAN reviewed High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter) Homo sapiens (Human) GO:0000064; GO:0001618; GO:0005290; GO:0005886; GO:0006865; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:0098655; GO:0150104; GO:1903352; GO:1903401; GO:1903810; GO:1903826 amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-lysine transmembrane transport [GO:1903401]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; monoatomic cation transmembrane transport [GO:0098655]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618] g6643.t1 B3TP03 42.288 577 1.38e-147 444.0 sp|B3TP03|CTR2_CHICK Cationic amino acid transporter 2 OS=Gallus gallus OX=9031 GN=SLC7A2 PE=2 SV=1 CTR2_CHICK reviewed Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2) Gallus gallus (Chicken) GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352 L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] g6645.t1 Q03112 36.652 1326 0.0 676.0 sp|Q03112|MECOM_HUMAN Histone-lysine N-methyltransferase MECOM OS=Homo sapiens OX=9606 GN=MECOM PE=1 SV=3 MECOM_HUMAN reviewed Histone-lysine N-methyltransferase MECOM (EC 2.1.1.367) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0008270; GO:0016607; GO:0032259; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046974; GO:0051604; GO:0051726; GO:0070828; GO:0071425; GO:0140938; GO:0140948 apoptotic process [GO:0006915]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone H3 methyltransferase activity [GO:0140938]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g6645.t2 Q03112 37.399 1238 0.0 671.0 sp|Q03112|MECOM_HUMAN Histone-lysine N-methyltransferase MECOM OS=Homo sapiens OX=9606 GN=MECOM PE=1 SV=3 MECOM_HUMAN reviewed Histone-lysine N-methyltransferase MECOM (EC 2.1.1.367) (Ecotropic virus integration site 1 protein homolog) (EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0008270; GO:0016607; GO:0032259; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046974; GO:0051604; GO:0051726; GO:0070828; GO:0071425; GO:0140938; GO:0140948 apoptotic process [GO:0006915]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone H3 methyltransferase activity [GO:0140938]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g6646.t1 P41743 70.728 591 0.0 873.0 sp|P41743|KPCI_HUMAN Protein kinase C iota type OS=Homo sapiens OX=9606 GN=PRKCI PE=1 SV=2 KPCI_HUMAN reviewed Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) Homo sapiens (Human) GO:0000139; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005903; GO:0005923; GO:0005929; GO:0006468; GO:0006612; GO:0007010; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016192; GO:0016324; GO:0016477; GO:0030010; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0035556; GO:0042462; GO:0043066; GO:0043220; GO:0043524; GO:0045171; GO:0045197; GO:0045216; GO:0045747; GO:0046326; GO:0046903; GO:0048194; GO:0051092; GO:0060252; GO:0061024; GO:0062197; GO:0070062; GO:0070160; GO:0070555; GO:0072659; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353 actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to chemical stress [GO:0062197]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160] ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] g6647.t1 Q5BKC9 37.815 476 1.27e-92 320.0 sp|Q5BKC9|NGEF_RAT Ephexin-1 OS=Rattus norvegicus OX=10116 GN=Ngef PE=1 SV=2 NGEF_RAT reviewed Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor) Rattus norvegicus (Rat) GO:0005085; GO:0005737; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0032956; GO:0043087; GO:0046875; GO:0048013; GO:0061002; GO:0098794; GO:0098978; GO:1905806 cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of synapse pruning [GO:1905806] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; postsynapse [GO:0098794] ephrin receptor binding [GO:0046875]; guanyl-nucleotide exchange factor activity [GO:0005085] g6649.t1 Q0VGW6 46.491 912 0.0 769.0 sp|Q0VGW6|S12A9_XENLA Solute carrier family 12 member 9 OS=Xenopus laevis OX=8355 GN=slc12a9 PE=2 SV=1 g6654.t1 Q8K4T1 32.986 288 7.09e-41 152.0 sp|Q8K4T1|SIA8F_MOUSE Alpha-2,8-sialyltransferase 8F OS=Mus musculus OX=10090 GN=St8sia6 PE=1 SV=1 SIA8F_MOUSE reviewed Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) Mus musculus (Mouse) GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016051 blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139] alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373] g6656.t1 Q5ZIJ9 33.21 810 2.9e-114 370.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g6656.t2 Q5ZIJ9 31.076 753 9.39e-96 323.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g6656.t2 Q5ZIJ9 55.725 131 1.47e-33 142.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g6657.t1 Q80SY4 34.325 807 4.85e-133 421.0 sp|Q80SY4|MIB1_MOUSE E3 ubiquitin-protein ligase MIB1 OS=Mus musculus OX=10090 GN=Mib1 PE=1 SV=1 MIB1_MOUSE reviewed E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) Mus musculus (Mouse) GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0005737; GO:0005813; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0007507; GO:0008270; GO:0014069; GO:0016567; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978 blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g6658.t1 Q86YT6 34.645 788 4.45e-132 419.0 sp|Q86YT6|MIB1_HUMAN E3 ubiquitin-protein ligase MIB1 OS=Homo sapiens OX=9606 GN=MIB1 PE=1 SV=1 MIB1_HUMAN reviewed E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2) Homo sapiens (Human) GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0021953; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978 blood vessel development [GO:0001568]; central nervous system neuron differentiation [GO:0021953]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6659.t1 P31029 54.545 385 1.4400000000000001e-157 452.0 sp|P31029|AGT1_CALJA Alanine--glyoxylate aminotransferase OS=Callithrix jacchus OX=9483 GN=AGXT PE=2 SV=1 g6660.t1 P56399 56.052 851 0.0 959.0 sp|P56399|UBP5_MOUSE Ubiquitin carboxyl-terminal hydrolase 5 OS=Mus musculus OX=10090 GN=Usp5 PE=1 SV=1 g6664.t1 P0AC33 67.286 538 0.0 778.0 sp|P0AC33|FUMA_ECOLI Fumarate hydratase class I, aerobic OS=Escherichia coli (strain K12) OX=83333 GN=fumA PE=1 SV=2 FUMA_ECOLI reviewed Fumarate hydratase class I, aerobic (EC 4.2.1.2) (Fumarase A) (Oxaloacetate keto--enol-isomerase) (OAAKE isomerase) (Oxaloacetate tautomerase) (EC 5.3.2.2) Escherichia coli (strain K12) GO:0004333; GO:0005829; GO:0006099; GO:0042802; GO:0042803; GO:0046872; GO:0050163; GO:0051539 tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829] 4 iron, 4 sulfur cluster binding [GO:0051539]; fumarate hydratase activity [GO:0004333]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxaloacetate tautomerase activity [GO:0050163]; protein homodimerization activity [GO:0042803] g6665.t1 I6V1W0 40.394 406 1.21e-97 315.0 sp|I6V1W0|BMBL_DANRE Protein brambleberry OS=Danio rerio OX=7955 GN=bmb PE=2 SV=1 g6667.t1 Q8R481 37.824 579 2.8999999999999995e-104 338.0 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 g6667.t2 Q8R481 37.824 579 1.8699999999999997e-104 338.0 sp|Q8R481|PERL_MESAU Lactoperoxidase OS=Mesocricetus auratus OX=10036 GN=LPO PE=1 SV=1 g6668.t1 P50430 54.635 507 0.0 548.0 sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2 g6668.t2 P33727 47.452 569 2.3e-171 500.0 sp|P33727|ARSB_FELCA Arylsulfatase B OS=Felis catus OX=9685 GN=ARSB PE=2 SV=1 g6670.t1 P50430 52.079 505 1.7099999999999998e-180 521.0 sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2 g6671.t1 Q5FYB0 53.861 505 1.26e-180 523.0 sp|Q5FYB0|ARSJ_HUMAN Arylsulfatase J OS=Homo sapiens OX=9606 GN=ARSJ PE=1 SV=1 ARSJ_HUMAN reviewed Arylsulfatase J (ASJ) (EC 3.1.6.-) Homo sapiens (Human) GO:0004065; GO:0005576; GO:0005788; GO:0008484; GO:0015629; GO:0046872 actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484] g6673.t1 Q02380 49.032 155 4.22e-46 152.0 sp|Q02380|NDUB5_BOVIN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial OS=Bos taurus OX=9913 GN=NDUFB5 PE=1 SV=1 g6674.t1 Q9XT54 84.722 144 8.75e-90 260.0 sp|Q9XT54|PDE6D_CANLF Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta OS=Canis lupus familiaris OX=9615 GN=PDE6D PE=2 SV=1 g6675.t1 O09012 52.719 662 0.0 639.0 sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2 g6676.t1 Q8K2Y7 48.108 185 1.03e-46 160.0 sp|Q8K2Y7|RM47_MOUSE Large ribosomal subunit protein uL29m OS=Mus musculus OX=10090 GN=Mrpl47 PE=1 SV=2 g6679.t1 Q8IXK0 38.746 351 2.5900000000000003e-57 214.0 sp|Q8IXK0|PHC2_HUMAN Polyhomeotic-like protein 2 OS=Homo sapiens OX=9606 GN=PHC2 PE=1 SV=1 g6679.t2 Q8IXK0 38.746 351 3.45e-57 214.0 sp|Q8IXK0|PHC2_HUMAN Polyhomeotic-like protein 2 OS=Homo sapiens OX=9606 GN=PHC2 PE=1 SV=1 g6680.t1 Q14692 55.373 670 0.0 719.0 sp|Q14692|BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1 BMS1_HUMAN reviewed Ribosome biogenesis protein BMS1 homolog (EC 3.6.5.-) (Ribosome assembly protein BMS1 homolog) Homo sapiens (Human) GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0032040; GO:0034511; GO:0042274 endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] g6680.t1 Q14692 60.078 511 0.0 601.0 sp|Q14692|BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1 BMS1_HUMAN reviewed Ribosome biogenesis protein BMS1 homolog (EC 3.6.5.-) (Ribosome assembly protein BMS1 homolog) Homo sapiens (Human) GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0032040; GO:0034511; GO:0042274 endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] g6681.t1 Q9UJW7 36.036 555 2.35e-107 358.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g6681.t1 Q9UJW7 29.268 287 3.12e-29 129.0 sp|Q9UJW7|ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens OX=9606 GN=ZNF229 PE=1 SV=4 g6683.t1 Q6AY20 41.016 256 2.46e-62 200.0 sp|Q6AY20|MPRD_RAT Cation-dependent mannose-6-phosphate receptor OS=Rattus norvegicus OX=10116 GN=M6pr PE=1 SV=1 MPRD_RAT reviewed Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) Rattus norvegicus (Rat) GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0006622; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394 lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299] endosome [GO:0005768]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394] g6684.t1 Q9BZE2 50.901 444 1.47e-152 445.0 sp|Q9BZE2|PUS3_HUMAN tRNA pseudouridine(38/39) synthase OS=Homo sapiens OX=9606 GN=PUS3 PE=1 SV=3 PUS3_HUMAN reviewed tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3) Homo sapiens (Human) GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0009982; GO:0031119; GO:0160154; GO:1990481 mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(38/39) synthase activity [GO:0160154] g6685.t1 P43646 48.322 149 1.2700000000000001e-37 130.0 sp|P43646|CATR_TETST Caltractin (Fragment) OS=Tetraselmis striata OX=3165 PE=2 SV=1 g6686.t1 P10077 27.872 531 6.429999999999999e-23 107.0 sp|P10077|ZFP27_MOUSE Zinc finger protein 27 OS=Mus musculus OX=10090 GN=Zfp27 PE=2 SV=2 g6687.t1 Q9UGM3 46.047 2011 0.0 1466.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 46.127 2014 0.0 1466.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 50.615 1707 0.0 1419.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 50.559 1699 0.0 1414.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 50.477 1678 0.0 1405.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 50.118 1692 0.0 1403.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 49.704 1692 0.0 1397.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 48.817 1649 0.0 1303.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 41.018 2004 0.0 1196.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 41.106 1591 0.0 974.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 46.231 1300 0.0 950.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 38.811 858 1.5599999999999998e-134 479.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 36.261 444 2.76e-51 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 46.309 149 6.51e-23 113.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 55.556 108 1.5500000000000001e-21 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 55.556 108 1.5500000000000001e-21 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t1 Q9UGM3 54.63 108 4.46e-21 107.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 46.047 2011 0.0 1464.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 46.127 2014 0.0 1464.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 50.615 1707 0.0 1417.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 50.559 1699 0.0 1412.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 50.477 1678 0.0 1404.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 50.118 1692 0.0 1401.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 49.704 1692 0.0 1395.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 48.817 1649 0.0 1301.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 41.088 2003 0.0 1197.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 41.195 1590 0.0 975.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 46.231 1300 0.0 949.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 38.856 857 4.8e-133 474.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 36.261 444 3.55e-51 206.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 46.309 149 7.13e-23 112.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 55.556 108 1.6700000000000002e-21 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 55.556 108 1.6700000000000002e-21 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6687.t2 Q9UGM3 54.63 108 4.8100000000000005e-21 106.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6691.t1 O75529 46.543 593 0.0 559.0 sp|O75529|TAF5L_HUMAN TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L OS=Homo sapiens OX=9606 GN=TAF5L PE=1 SV=1 g6692.t1 Q8K268 59.097 709 0.0 875.0 sp|Q8K268|ABCF3_MOUSE ATP-binding cassette sub-family F member 3 OS=Mus musculus OX=10090 GN=Abcf3 PE=1 SV=1 g6694.t1 Q8CBC7 73.288 292 2.26e-149 426.0 sp|Q8CBC7|TRM7_MOUSE tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase OS=Mus musculus OX=10090 GN=Ftsj1 PE=1 SV=1 TRM7_MOUSE reviewed tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1) Mus musculus (Mouse) GO:0002128; GO:0002130; GO:0002181; GO:0005634; GO:0005737; GO:0005829; GO:0008175; GO:0016423; GO:0022008; GO:0030488; GO:0106050; GO:0106340; GO:1904047 cytoplasmic translation [GO:0002181]; neurogenesis [GO:0022008]; tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128]; wobble position ribose methylation [GO:0002130] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] S-adenosyl-L-methionine binding [GO:1904047]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA (guanosine(34)-2'-O)-methyltransferase activity [GO:0106340]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175] g6696.t1 Q9QXF7 39.264 489 2.45e-115 352.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g6697.t1 P52209 76.605 483 0.0 767.0 sp|P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=PGD PE=1 SV=3 6PGD_HUMAN reviewed 6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44) Homo sapiens (Human) GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0050661; GO:0070062 D-gluconate metabolic process [GO:0019521]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616] g6698.t1 Q68FT9 59.048 420 4.6299999999999995e-180 511.0 sp|Q68FT9|SCLY_RAT Selenocysteine lyase OS=Rattus norvegicus OX=10116 GN=Scly PE=1 SV=1 SCLY_RAT reviewed Selenocysteine lyase (EC 4.4.1.16) Rattus norvegicus (Rat) GO:0001887; GO:0005794; GO:0005829; GO:0006629; GO:0009000; GO:0016261; GO:0016597; GO:0016740; GO:0032868; GO:0042803; GO:0070279; GO:1900408; GO:1902494 lipid metabolic process [GO:0006629]; negative regulation of cellular response to oxidative stress [GO:1900408]; response to insulin [GO:0032868]; selenium compound metabolic process [GO:0001887]; selenocysteine catabolic process [GO:0016261] catalytic complex [GO:1902494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]; vitamin B6 binding [GO:0070279] g6700.t1 Q9UMR2 68.483 422 0.0 615.0 sp|Q9UMR2|DD19B_HUMAN ATP-dependent RNA helicase DDX19B OS=Homo sapiens OX=9606 GN=DDX19B PE=1 SV=1 DD19B_HUMAN reviewed ATP-dependent RNA helicase DDX19B (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (DEAD box protein 19B) Homo sapiens (Human) GO:0003723; GO:0003724; GO:0003729; GO:0004386; GO:0005524; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0006406; GO:0010494; GO:0016020; GO:0016887; GO:0016973; GO:0070062 mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g6702.t1 Q96NU1 68.571 70 8.96e-24 110.0 sp|Q96NU1|SAM11_HUMAN Sterile alpha motif domain-containing protein 11 OS=Homo sapiens OX=9606 GN=SAMD11 PE=1 SV=3 g6703.t1 P43427 42.084 499 1.96e-130 391.0 sp|P43427|GTR5_RAT Solute carrier family 2, facilitated glucose transporter member 5 OS=Rattus norvegicus OX=10116 GN=Slc2a5 PE=1 SV=1 GTR5_RAT reviewed Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) (GLUT-5) Rattus norvegicus (Rat) GO:0003044; GO:0005353; GO:0005886; GO:0009750; GO:0015755; GO:0016324; GO:0042383; GO:0046323; GO:0055056; GO:0070061; GO:0070837; GO:0071332; GO:0072237; GO:1904659; GO:1990539 cellular response to fructose stimulus [GO:0071332]; D-glucose import [GO:0046323]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; metanephric proximal tubule development [GO:0072237]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] D-glucose transmembrane transporter activity [GO:0055056]; fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353] g6704.t1 P28568 51.168 471 2.51e-165 481.0 sp|P28568|GTR3_CHICK Solute carrier family 2, facilitated glucose transporter member 3 OS=Gallus gallus OX=9031 GN=SLC2A3 PE=2 SV=1 g6709.t1 Q3SZ87 72.222 180 7.48e-98 283.0 sp|Q3SZ87|SSRG_BOVIN Translocon-associated protein subunit gamma OS=Bos taurus OX=9913 GN=SSR3 PE=2 SV=1 g6710.t1 A2A8L1 57.152 1594 0.0 1691.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t1 A2A8L1 83.099 213 1.92e-102 371.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t2 A2A8L1 57.152 1594 0.0 1691.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t2 A2A8L1 83.099 213 1.92e-102 371.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t3 A2A8L1 57.152 1594 0.0 1691.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t3 A2A8L1 83.099 213 1.96e-102 371.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t4 A2A8L1 57.152 1594 0.0 1691.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t4 A2A8L1 82.71 214 5.39e-101 366.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t5 A2A8L1 56.611 1611 0.0 1685.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6710.t5 A2A8L1 83.099 213 1.3e-102 372.0 sp|A2A8L1|CHD5_MOUSE Chromodomain-helicase-DNA-binding protein 5 OS=Mus musculus OX=10090 GN=Chd5 PE=1 SV=1 CHD5_MOUSE reviewed ATP-dependent chromatin remodeler CHD5 (EC 3.6.4.-) (Chromo domain-containing protein 5) (CHD-5) Mus musculus (Mouse) GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798 cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270] g6711.t1 Q5ZJD3 55.205 317 1.71e-101 328.0 sp|Q5ZJD3|LSG1_CHICK Large subunit GTPase 1 homolog OS=Gallus gallus OX=9031 GN=LSG1 PE=2 SV=1 LSG1_CHICK reviewed Large subunit GTPase 1 homolog (EC 3.6.5.-) Gallus gallus (Chicken) GO:0000054; GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0051168 nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g6711.t1 Q5ZJD3 54.231 260 1.02e-79 271.0 sp|Q5ZJD3|LSG1_CHICK Large subunit GTPase 1 homolog OS=Gallus gallus OX=9031 GN=LSG1 PE=2 SV=1 LSG1_CHICK reviewed Large subunit GTPase 1 homolog (EC 3.6.5.-) Gallus gallus (Chicken) GO:0000054; GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0051168 nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g6712.t1 Q09621 36.01 411 2.49e-74 243.0 sp|Q09621|LACT2_CAEEL Beta-lactamase domain-containing protein 2 OS=Caenorhabditis elegans OX=6239 GN=lact-2 PE=4 SV=1 g6713.t1 Q6P1A2 36.304 460 1.33e-109 337.0 sp|Q6P1A2|MBOA5_HUMAN Lysophospholipid acyltransferase 5 OS=Homo sapiens OX=9606 GN=LPCAT3 PE=1 SV=1 MBOA5_HUMAN reviewed Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) Homo sapiens (Human) GO:0003841; GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047144; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0106262; GO:0106263; GO:1903573; GO:1905885 chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617] g6713.t2 Q6P1A2 36.304 460 1.33e-109 337.0 sp|Q6P1A2|MBOA5_HUMAN Lysophospholipid acyltransferase 5 OS=Homo sapiens OX=9606 GN=LPCAT3 PE=1 SV=1 MBOA5_HUMAN reviewed Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) Homo sapiens (Human) GO:0003841; GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047144; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0106262; GO:0106263; GO:1903573; GO:1905885 chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617] g6714.t1 Q91V01 34.783 161 5.72e-26 106.0 sp|Q91V01|MBOA5_MOUSE Lysophospholipid acyltransferase 5 OS=Mus musculus OX=10090 GN=Lpcat3 PE=1 SV=1 MBOA5_MOUSE reviewed Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (mLPCAT3) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) Mus musculus (Mouse) GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0097006; GO:0106262; GO:0106263; GO:1903573; GO:1905885 chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617] g6715.t1 Q9VVX5 38.863 211 1.64e-41 152.0 sp|Q9VVX5|MBOA5_DROME Lysophospholipid acyltransferase 5 OS=Drosophila melanogaster OX=7227 GN=nes PE=1 SV=1 MBOA5_DROME reviewed Lysophospholipid acyltransferase 5 (LPLAT 5) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5) (Protein nessy) (Nes) Drosophila melanogaster (Fruit fly) GO:0005783; GO:0006656; GO:0007009; GO:0007291; GO:0008354; GO:0016020; GO:0030258; GO:0036152; GO:0047184; GO:0071617; GO:0106263 germ cell migration [GO:0008354]; lipid modification [GO:0030258]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; plasma membrane organization [GO:0007009]; sperm individualization [GO:0007291] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; lysophospholipid acyltransferase activity [GO:0071617] g6716.t1 Q90Z12 47.244 127 5.21e-28 115.0 sp|Q90Z12|HES4A_XENLA Transcription factor HES-4-A OS=Xenopus laevis OX=8355 GN=hes4-a PE=1 SV=2 HES4A_XENLA reviewed Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0000981; GO:0002088; GO:0005634; GO:0006357; GO:0009952; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983; GO:0050767 anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g6717.t1 Q6IRB2 34.109 258 1.6e-36 133.0 sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1 HES1A_XENLA reviewed Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1) Xenopus laevis (African clawed frog) GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007219; GO:0009952; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767 anterior/posterior pattern specification [GO:0009952]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] g6718.t1 Q5ZIJ9 49.387 978 0.0 945.0 sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1 g6720.t1 Q80WG7 32.419 802 5.8e-125 394.0 sp|Q80WG7|TRI36_MOUSE E3 ubiquitin-protein ligase Trim36 OS=Mus musculus OX=10090 GN=Trim36 PE=1 SV=2 TRI36_MOUSE reviewed E3 ubiquitin-protein ligase Trim36 (EC 2.3.2.27) (Acrosome RBCC protein) (Haprin) (RING-type E3 ubiquitin transferase TRIM36) (Tripartite motif-containing protein 36) Mus musculus (Mouse) GO:0000281; GO:0001669; GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007051; GO:0007340; GO:0008270; GO:0043014; GO:0051726; GO:0061630; GO:0070507 acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] alpha-tubulin binding [GO:0043014]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g6722.t1 Q9MYW9 26.347 334 1.6499999999999998e-23 104.0 sp|Q9MYW9|OPRM_MACMU Mu-type opioid receptor OS=Macaca mulatta OX=9544 GN=OPRM1 PE=2 SV=2 OPRM_MACMU reviewed Mu-type opioid receptor (M-OR-1) (MOR-1) Macaca mulatta (Rhesus macaque) GO:0001965; GO:0004930; GO:0004979; GO:0005245; GO:0005768; GO:0005886; GO:0007193; GO:0007197; GO:0007200; GO:0007218; GO:0019233; GO:0030424; GO:0030425; GO:0031681; GO:0038003; GO:0038047; GO:0042923; GO:0043005; GO:0043204; GO:0045019; GO:0045202; GO:0050769; GO:0051481; GO:0061358; GO:0070374; GO:2000310 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of Wnt protein secretion [GO:0061358]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neurogenesis [GO:0050769]; regulation of NMDA receptor activity [GO:2000310]; sensory perception of pain [GO:0019233] axon [GO:0030424]; dendrite [GO:0030425]; endosome [GO:0005768]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202] beta-endorphin receptor activity [GO:0004979]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; morphine receptor activity [GO:0038047]; neuropeptide binding [GO:0042923]; voltage-gated calcium channel activity [GO:0005245] g6723.t1 Q923V4 41.502 253 2.45e-60 197.0 sp|Q923V4|FBX6_RAT F-box only protein 6 OS=Rattus norvegicus OX=10116 GN=Fbxo6 PE=1 SV=1 g6724.t1 Q923V4 31.148 244 1.38e-26 108.0 sp|Q923V4|FBX6_RAT F-box only protein 6 OS=Rattus norvegicus OX=10116 GN=Fbxo6 PE=1 SV=1 g6725.t1 P41144 24.8 375 5.2600000000000005e-27 114.0 sp|P41144|OPRK_CAVPO Kappa-type opioid receptor OS=Cavia porcellus OX=10141 GN=OPRK1 PE=2 SV=1 g6726.t1 Q6ZUK4 31.233 365 6.33e-41 152.0 sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1 g6727.t1 Q04637 38.87 1150 0.0 661.0 sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4 IF4G1_HUMAN reviewed Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) Homo sapiens (Human) GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606 behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840] ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g6727.t2 Q04637 38.87 1150 0.0 662.0 sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4 IF4G1_HUMAN reviewed Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) Homo sapiens (Human) GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606 behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840] ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] g6728.t1 Q95XZ6 34.049 326 1.8100000000000002e-47 166.0 sp|Q95XZ6|LAAT1_CAEEL Lysosomal amino acid transporter 1 OS=Caenorhabditis elegans OX=6239 GN=laat-1 PE=1 SV=2 LAAT1_CAEEL reviewed Lysosomal amino acid transporter 1 Caenorhabditis elegans GO:0005765; GO:0010508; GO:0015174; GO:0015189; GO:0015819; GO:0016020; GO:0031090; GO:0061459; GO:0080144; GO:1903826 intracellular amino acid homeostasis [GO:0080144]; L-arginine transmembrane transport [GO:1903826]; lysine transport [GO:0015819]; positive regulation of autophagy [GO:0010508] lysosomal membrane [GO:0005765]; membrane [GO:0016020]; organelle membrane [GO:0031090] basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189] g6729.t1 O43156 39.57 1117 0.0 702.0 sp|O43156|TTI1_HUMAN TELO2-interacting protein 1 homolog OS=Homo sapiens OX=9606 GN=TTI1 PE=1 SV=3 TTI1_HUMAN reviewed TELO2-interacting protein 1 homolog (Protein SMG10) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0019900; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0110078; GO:0140777; GO:2000003 positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006] cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT Hsp90 cochaperone complex [GO:0110078] kinase binding [GO:0019900]; protein-containing complex stabilizing activity [GO:0140777] g6730.t1 Q95ZS2 62.963 108 1.67e-44 157.0 sp|Q95ZS2|TDC1_CAEEL Tyrosine decarboxylase OS=Caenorhabditis elegans OX=6239 GN=tdc-1 PE=2 SV=1 TDC1_CAEEL reviewed Tyrosine decarboxylase (EC 4.1.1.25) Caenorhabditis elegans GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0016831; GO:0019752; GO:0030170; GO:0030424; GO:0043025; GO:0043204 amino acid metabolic process [GO:0006520]; carboxylic acid metabolic process [GO:0019752]; octopamine biosynthetic process [GO:0006589] axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837] g6731.t1 Q95ZS2 54.098 305 5.05e-113 344.0 sp|Q95ZS2|TDC1_CAEEL Tyrosine decarboxylase OS=Caenorhabditis elegans OX=6239 GN=tdc-1 PE=2 SV=1 TDC1_CAEEL reviewed Tyrosine decarboxylase (EC 4.1.1.25) Caenorhabditis elegans GO:0004837; GO:0005737; GO:0006520; GO:0006589; GO:0016831; GO:0019752; GO:0030170; GO:0030424; GO:0043025; GO:0043204 amino acid metabolic process [GO:0006520]; carboxylic acid metabolic process [GO:0019752]; octopamine biosynthetic process [GO:0006589] axon [GO:0030424]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; tyrosine decarboxylase activity [GO:0004837] g6742.t1 Q7TNS2 53.425 73 2.43e-27 98.6 sp|Q7TNS2|MIC10_MOUSE MICOS complex subunit Mic10 OS=Mus musculus OX=10090 GN=Micos10 PE=1 SV=1 g6743.t1 Q9JLI3 38.03 731 1.6799999999999997e-170 512.0 sp|Q9JLI3|MMEL1_MOUSE Membrane metallo-endopeptidase-like 1 OS=Mus musculus OX=10090 GN=Mmel1 PE=1 SV=1 MMEL1_MOUSE reviewed Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) (Neprilysin-like 1) (NL-1) (Neprilysin-like peptidase) (NEPLP) (Soluble secreted endopeptidase) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))] Mus musculus (Mouse) GO:0004175; GO:0004222; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0006508; GO:0008270; GO:0016020; GO:0016485 protein processing [GO:0016485]; proteolysis [GO:0006508] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886] endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] g6744.t1 Q9W436 38.171 689 2.7200000000000004e-166 504.0 sp|Q9W436|NEP_DROME Neprilysin-1 OS=Drosophila melanogaster OX=7227 GN=Nep1 PE=2 SV=2 NEP_DROME reviewed Neprilysin-1 (EC 3.4.24.11) Drosophila melanogaster (Fruit fly) GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0046872 proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] g6745.t1 Q9I8C7 37.405 393 3.2100000000000002e-86 277.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g6745.t2 Q9I8C7 38.649 370 7.91e-87 277.0 sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1 g6746.t1 F1MNN4 32.973 185 3.1800000000000004e-21 101.0 sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3 FBXW7_BOVIN reviewed F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) Bos taurus (Bovine) GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0007346; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045944; GO:0050816; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000059; GO:2000060; GO:2001205 DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; regulation of mitotic cell cycle [GO:0007346]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005] cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027] g6747.t1 Q2KI56 59.69 258 3.58e-106 312.0 sp|Q2KI56|CSN7B_BOVIN COP9 signalosome complex subunit 7b OS=Bos taurus OX=9913 GN=COPS7B PE=2 SV=1 CSN7B_BOVIN reviewed COP9 signalosome complex subunit 7b (SGN7b) (Signalosome subunit 7b) Bos taurus (Bovine) GO:0005829; GO:0008180; GO:0010387 COP9 signalosome assembly [GO:0010387] COP9 signalosome [GO:0008180]; cytosol [GO:0005829] g6748.t1 Q9NRZ9 56.334 671 0.0 782.0 sp|Q9NRZ9|HELLS_HUMAN Lymphoid-specific helicase OS=Homo sapiens OX=9606 GN=HELLS PE=1 SV=1 g6752.t1 A3KPP4 62.034 295 2.03e-126 365.0 sp|A3KPP4|S2535_DANRE Solute carrier family 25 member 35 OS=Danio rerio OX=7955 GN=slc25a35 PE=2 SV=1 g6754.t1 P09487 51.4 500 1.3299999999999998e-165 483.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g6755.t1 P09487 46.362 481 3.18e-144 430.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g6756.t1 P09487 47.755 490 2.18e-145 430.0 sp|P09487|PPBT_BOVIN Alkaline phosphatase, tissue-nonspecific isozyme OS=Bos taurus OX=9913 GN=ALPL PE=1 SV=2 PPBT_BOVIN reviewed Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1) Bos taurus (Bovine) GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0030282; GO:0031214; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0065010; GO:0098552; GO:0120162 biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular membrane-bounded organelle [GO:0065010]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] g6758.t1 Q3SYU1 43.544 728 0.0 569.0 sp|Q3SYU1|NOC2L_BOVIN Nucleolar complex protein 2 homolog OS=Bos taurus OX=9913 GN=NOC2L PE=2 SV=1 NOC2L_BOVIN reviewed Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor) Bos taurus (Bovine) GO:0000122; GO:0003714; GO:0005654; GO:0005730; GO:0006915; GO:0030690; GO:0030691; GO:0042273; GO:0042393 apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273] Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] histone binding [GO:0042393]; transcription corepressor activity [GO:0003714] g6758.t2 Q3SYU1 43.544 728 0.0 569.0 sp|Q3SYU1|NOC2L_BOVIN Nucleolar complex protein 2 homolog OS=Bos taurus OX=9913 GN=NOC2L PE=2 SV=1 NOC2L_BOVIN reviewed Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor) Bos taurus (Bovine) GO:0000122; GO:0003714; GO:0005654; GO:0005730; GO:0006915; GO:0030690; GO:0030691; GO:0042273; GO:0042393 apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273] Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] histone binding [GO:0042393]; transcription corepressor activity [GO:0003714] g6759.t1 Q91WI7 47.758 446 3.2e-130 386.0 sp|Q91WI7|ITFG2_MOUSE KICSTOR complex protein ITFG2 OS=Mus musculus OX=10090 GN=Itfg2 PE=2 SV=1 g6759.t2 Q91WI7 47.191 445 1.72e-127 379.0 sp|Q91WI7|ITFG2_MOUSE KICSTOR complex protein ITFG2 OS=Mus musculus OX=10090 GN=Itfg2 PE=2 SV=1 g6760.t1 Q8C811 64.091 220 2.2199999999999998e-94 290.0 sp|Q8C811|S35E2_MOUSE Solute carrier family 35 member E2A OS=Mus musculus OX=10090 GN=Slc35e2a PE=2 SV=1 g6762.t1 Q5XIH7 73.649 296 3.56e-163 458.0 sp|Q5XIH7|PHB2_RAT Prohibitin-2 OS=Rattus norvegicus OX=10116 GN=Phb2 PE=1 SV=1 PHB2_RAT reviewed Prohibitin-2 (B-cell receptor-associated protein BAP37) (BAP-37) Rattus norvegicus (Rat) GO:0000423; GO:0002639; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005886; GO:0006606; GO:0007005; GO:0007062; GO:0009986; GO:0014069; GO:0016363; GO:0016477; GO:0030424; GO:0032991; GO:0033147; GO:0033218; GO:0033600; GO:0035632; GO:0039529; GO:0042113; GO:0042802; GO:0042803; GO:0043066; GO:0045892; GO:0046625; GO:0046982; GO:0048786; GO:0050821; GO:0060744; GO:0060749; GO:0060762; GO:0070374; GO:0071300; GO:0071456; GO:0071944; GO:0098800; GO:0098978; GO:0098982; GO:0140374; GO:1900208; GO:1901224; GO:1904959 antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062] axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inner mitochondrial membrane protein complex [GO:0098800]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991] amide binding [GO:0033218]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625] g6766.t1 O75038 53.073 716 0.0 743.0 sp|O75038|PLCH2_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Homo sapiens OX=9606 GN=PLCH2 PE=1 SV=3 PLCH2_HUMAN reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2) Homo sapiens (Human) GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209 lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g6767.t1 A2AP18 32.948 173 4.1100000000000004e-26 110.0 sp|A2AP18|PLCH2_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Mus musculus OX=10090 GN=Plch2 PE=1 SV=2 PLCH2_MOUSE reviewed 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2) Mus musculus (Mouse) GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209 lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629] g6769.t1 Q0VA04 44.404 277 6.51e-60 208.0 sp|Q0VA04|SMG8_XENTR Nonsense-mediated mRNA decay factor SMG8 OS=Xenopus tropicalis OX=8364 GN=smg8 PE=2 SV=1 g6770.t1 A1A4J7 40.756 238 1.5499999999999998e-48 175.0 sp|A1A4J7|SMG8_BOVIN Nonsense-mediated mRNA decay factor SMG8 OS=Bos taurus OX=9913 GN=SMG8 PE=2 SV=2 g6771.t1 Q0VA04 39.111 225 2.09e-43 159.0 sp|Q0VA04|SMG8_XENTR Nonsense-mediated mRNA decay factor SMG8 OS=Xenopus tropicalis OX=8364 GN=smg8 PE=2 SV=1 g6772.t1 Q5T2D3 43.094 362 3.6999999999999997e-90 279.0 sp|Q5T2D3|OTUD3_HUMAN OTU domain-containing protein 3 OS=Homo sapiens OX=9606 GN=OTUD3 PE=1 SV=1 OTUD3_HUMAN reviewed OTU domain-containing protein 3 (EC 3.4.19.12) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0016579; GO:0031669; GO:0035871; GO:0044313; GO:0050821; GO:0051898; GO:0071108; GO:1990167 cellular response to nutrient levels [GO:0031669]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g6774.t1 Q3UVX5 28.325 812 2.6e-93 321.0 sp|Q3UVX5|GRM5_MOUSE Metabotropic glutamate receptor 5 OS=Mus musculus OX=10090 GN=Grm5 PE=1 SV=2 GRM5_MOUSE reviewed Metabotropic glutamate receptor 5 (mGluR5) Mus musculus (Mouse) GO:0001639; GO:0001640; GO:0001659; GO:0001975; GO:0002029; GO:0004930; GO:0005637; GO:0005737; GO:0005886; GO:0006355; GO:0007204; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0008306; GO:0030296; GO:0030425; GO:0031687; GO:0033603; GO:0035106; GO:0036228; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043278; GO:0043410; GO:0044309; GO:0045211; GO:0045471; GO:0046677; GO:0048169; GO:0048170; GO:0050804; GO:0050808; GO:0050850; GO:0050890; GO:0051412; GO:0051966; GO:0061002; GO:0062036; GO:0090394; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099530; GO:0099583; GO:1900039; GO:1900452; GO:1904058; GO:1904646; GO:1990708; GO:1990782; GO:2000179 associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; conditioned place preference [GO:1990708]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cellular response to hypoxia [GO:1900039]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sensory perception of pain [GO:1904058]; protein localization to nuclear inner membrane [GO:0036228]; regulation of DNA-templated transcription [GO:0006355]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic depression [GO:1900452]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to morphine [GO:0043278]; sensory perception of hot stimulus [GO:0062036]; synapse organization [GO:0050808]; temperature homeostasis [GO:0001659] astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PLC activating G protein-coupled glutamate receptor activity [GO:0001639]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] g6776.t1 A2BIG9 67.606 71 7.3e-31 107.0 sp|A2BIG9|NAA38_DANRE N-alpha-acetyltransferase 38, NatC auxiliary subunit OS=Danio rerio OX=7955 GN=naa38 PE=3 SV=1 g6777.t1 Q567I9 68.396 212 5.63e-106 306.0 sp|Q567I9|CB5D1_DANRE Cytochrome b5 domain-containing protein 1 OS=Danio rerio OX=7955 GN=cyb5d1 PE=2 SV=1 g6779.t1 Q8K4P0 60.368 598 0.0 725.0 sp|Q8K4P0|WDR33_MOUSE pre-mRNA 3' end processing protein WDR33 OS=Mus musculus OX=10090 GN=Wdr33 PE=1 SV=1 g6780.t1 Q5ZJQ7 67.708 192 5.96e-98 285.0 sp|Q5ZJQ7|SSU72_CHICK RNA polymerase II subunit A C-terminal domain phosphatase SSU72 OS=Gallus gallus OX=9031 GN=SSU72 PE=2 SV=1 SSU72_CHICK reviewed RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16) Gallus gallus (Chicken) GO:0005737; GO:0005847; GO:0006369; GO:0008420; GO:0031124 mRNA 3'-end processing [GO:0031124]; termination of RNA polymerase II transcription [GO:0006369] cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847] RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] g6782.t1 Q9R0N8 28.371 356 3.75e-33 133.0 sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2 g6786.t1 Q3T134 54.902 102 2.16e-38 127.0 sp|Q3T134|SPCS1_BOVIN Signal peptidase complex subunit 1 OS=Bos taurus OX=9913 GN=SPCS1 PE=3 SV=1 g6787.t1 Q68CQ7 45.541 314 3.22e-98 300.0 sp|Q68CQ7|GL8D1_HUMAN Glycosyltransferase 8 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GLT8D1 PE=1 SV=2 GL8D1_HUMAN reviewed Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-) Homo sapiens (Human) GO:0005794; GO:0008194; GO:0016020 Golgi apparatus [GO:0005794]; membrane [GO:0016020] UDP-glycosyltransferase activity [GO:0008194] g6788.t1 P60517 93.966 116 9.51e-77 225.0 sp|P60517|GBRAP_RAT Gamma-aminobutyric acid receptor-associated protein OS=Rattus norvegicus OX=10116 GN=Gabarap PE=1 SV=1 GBRAP_RAT reviewed Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein) Rattus norvegicus (Rat) GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000423; GO:0005764; GO:0005776; GO:0005790; GO:0005794; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008429; GO:0008625; GO:0015031; GO:0015629; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0044297; GO:0048471; GO:0048487; GO:0050811; GO:0097225; GO:0097352; GO:0098696; GO:0098982; GO:0099091; GO:1902524 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; mitophagy [GO:0000423]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein transport [GO:0015031]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020] actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225] beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625] g6789.t1 P30372 23.571 420 7.56e-33 132.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g6790.t1 P30372 27.115 461 2.18e-34 135.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g6791.t1 P30372 24.894 470 2.79e-43 161.0 sp|P30372|ACM2_CHICK Muscarinic acetylcholine receptor M2 OS=Gallus gallus OX=9031 GN=CHRM2 PE=3 SV=1 g6792.t1 P42288 27.966 354 2.16e-28 118.0 sp|P42288|DRD1_DIDVI D(1A) dopamine receptor OS=Didelphis virginiana OX=9267 GN=DRD1 PE=2 SV=1 g6793.t1 P08482 25.952 420 6.2e-41 154.0 sp|P08482|ACM1_RAT Muscarinic acetylcholine receptor M1 OS=Rattus norvegicus OX=10116 GN=Chrm1 PE=1 SV=1 ACM1_RAT reviewed Muscarinic acetylcholine receptor M1 Rattus norvegicus (Rat) GO:0005886; GO:0007187; GO:0007197; GO:0007213; GO:0007268; GO:0007274; GO:0007603; GO:0009649; GO:0016907; GO:0030425; GO:0032279; GO:0040012; GO:0042734; GO:0043270; GO:0043679; GO:0045202; GO:0045211; GO:0046541; GO:0050890; GO:0060078; GO:0090316; GO:0098685; GO:0098839; GO:0098978; GO:0098981; GO:0099170 adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; neuromuscular synaptic transmission [GO:0007274]; phototransduction, visible light [GO:0007603]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of monoatomic ion transport [GO:0043270]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of locomotion [GO:0040012]; regulation of postsynaptic membrane potential [GO:0060078]; saliva secretion [GO:0046541] asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] G protein-coupled acetylcholine receptor activity [GO:0016907] g6794.t1 Q8BLD9 29.351 385 8.750000000000001e-35 137.0 sp|Q8BLD9|DRD5_MOUSE D(1B) dopamine receptor OS=Mus musculus OX=10090 GN=Drd5 PE=2 SV=1 DRD5_MOUSE reviewed D(1B) dopamine receptor (D(5) dopamine receptor) (Dopamine D5 receptor) Mus musculus (Mouse) GO:0001588; GO:0001965; GO:0001975; GO:0001992; GO:0001994; GO:0004930; GO:0004952; GO:0005886; GO:0005929; GO:0007189; GO:0007191; GO:0007212; GO:0007617; GO:0008306; GO:0008542; GO:0019226; GO:0030336; GO:0030424; GO:0030425; GO:0031526; GO:0035240; GO:0042060; GO:0042220; GO:0043025; GO:0043197; GO:0043410; GO:0045776; GO:0045924; GO:0046960; GO:0060170; GO:0060292; GO:0071870; GO:0071880; GO:0072593; GO:0097730; GO:0097731; GO:0098839; GO:0098978; GO:0099072 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular response to catecholamine stimulus [GO:0071870]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; mating behavior [GO:0007617]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; positive regulation of MAPK cascade [GO:0043410]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; transmission of nerve impulse [GO:0019226]; visual learning [GO:0008542]; wound healing [GO:0042060] 9+0 non-motile cilium [GO:0097731]; axon [GO:0030424]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965] g6795.t1 P42290 30.363 303 2.6799999999999997e-34 135.0 sp|P42290|DRD5_XENLA D(1B) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd5 PE=2 SV=1 g6800.t1 Q9P2R6 56.579 456 7.329999999999999e-165 506.0 sp|Q9P2R6|RERE_HUMAN Arginine-glutamic acid dipeptide repeats protein OS=Homo sapiens OX=9606 GN=RERE PE=1 SV=2 RERE_HUMAN reviewed Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) Homo sapiens (Human) GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016604; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813 branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942] histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] g6801.t1 Q9MYM7 38.655 238 3.14e-50 179.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g6802.t1 P04058 35.387 568 2.35e-103 327.0 sp|P04058|ACES_TETCF Acetylcholinesterase OS=Tetronarce californica OX=7787 GN=ache PE=1 SV=2 g6803.t1 Q499U8 48.794 539 4.08e-151 459.0 sp|Q499U8|TMCO4_RAT Transmembrane and coiled-coil domain-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Tmco4 PE=2 SV=1 g6803.t2 Q499U8 49.248 532 9.78e-153 463.0 sp|Q499U8|TMCO4_RAT Transmembrane and coiled-coil domain-containing protein 4 OS=Rattus norvegicus OX=10116 GN=Tmco4 PE=2 SV=1 g6804.t1 Q9UGM3 35.762 755 3.87e-99 337.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 35.582 756 1.17e-97 333.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 35.095 738 1.25e-96 330.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 34.967 755 1.9e-95 327.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 35.484 744 5.77e-95 325.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 34.959 738 1.06e-94 325.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 34.759 748 1.76e-92 318.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 35.423 638 1.69e-80 283.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 35.284 598 4.51e-76 270.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 38.462 507 5.500000000000001e-73 261.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 32.824 524 2.84e-51 196.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6804.t1 Q9UGM3 35.23 369 2.0299999999999997e-42 169.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 39.459 555 2.15e-97 333.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 40.782 537 5.71e-97 332.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 39.488 547 7.88e-96 329.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 39.318 557 8.11e-96 329.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 38.959 557 1.07e-95 328.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 39.046 566 3.6199999999999995e-95 327.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 39.961 508 5.0599999999999996e-92 318.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 47.883 307 1.77e-67 245.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 31.862 521 1.01e-52 201.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 35.813 363 1.44e-51 197.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6805.t1 Q9UGM3 46.154 195 1.23e-34 145.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 40.879 1639 0.0 1027.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 40.277 1589 0.0 996.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 39.666 1558 0.0 912.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 41.691 1372 0.0 889.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 48.575 702 5.2e-179 602.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 37.544 855 9e-135 472.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 32.368 587 1.26e-53 212.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 53.509 114 4.5400000000000005e-27 125.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 52.066 121 1.59e-26 123.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 49.206 126 8.43e-26 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 51.261 119 9.810000000000001e-26 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t1 Q9UGM3 45.161 124 5.090000000000001e-22 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 40.2 1597 0.0 954.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 40.751 1465 0.0 923.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 41.172 1399 0.0 887.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 39.31 1450 0.0 857.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 40.61 1278 0.0 790.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 35.561 748 1.72e-101 367.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 32.68 612 8.04e-59 229.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 53.509 114 4.130000000000001e-27 125.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 52.066 121 1.33e-26 123.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 49.206 126 7.010000000000001e-26 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 51.261 119 8.230000000000001e-26 120.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6807.t2 Q9UGM3 45.161 124 4.61e-22 108.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g6808.t1 Q55EX9 33.624 229 5.269999999999999e-34 126.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g6808.t2 Q55EX9 32.171 258 2.48e-34 128.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g6809.t1 Q55EX9 31.923 260 1.9600000000000001e-35 131.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g6810.t1 Q55EX9 30.385 260 7.82e-34 126.0 sp|Q55EX9|Y8948_DICDI Putative methyltransferase DDB_G0268948 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0268948 PE=1 SV=2 g6812.t1 Q16880 34.535 527 4.77e-100 315.0 sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2 CGT_HUMAN reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Homo sapiens (Human) GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812; GO:0098553 central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g6813.t1 O00468 37.549 1012 3.95e-176 595.0 sp|O00468|AGRIN_HUMAN Agrin OS=Homo sapiens OX=9606 GN=AGRN PE=1 SV=6 AGRIN_HUMAN reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Homo sapiens (Human) GO:0002062; GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007166; GO:0007213; GO:0007528; GO:0031012; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050808; GO:0070062 cell surface receptor signaling pathway [GO:0007166]; chondrocyte differentiation [GO:0002062]; clustering of voltage-gated sodium channels [GO:0045162]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202] calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200] g6813.t1 O00468 37.817 788 2.87e-147 511.0 sp|O00468|AGRIN_HUMAN Agrin OS=Homo sapiens OX=9606 GN=AGRN PE=1 SV=6 AGRIN_HUMAN reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Homo sapiens (Human) GO:0002062; GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007166; GO:0007213; GO:0007528; GO:0031012; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050808; GO:0070062 cell surface receptor signaling pathway [GO:0007166]; chondrocyte differentiation [GO:0002062]; clustering of voltage-gated sodium channels [GO:0045162]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202] calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200] g6813.t2 P25304 35.918 1019 9.04e-162 550.0 sp|P25304|AGRIN_RAT Agrin OS=Rattus norvegicus OX=10116 GN=Agrn PE=1 SV=2 AGRIN_RAT reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Rattus norvegicus (Rat) GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0031012; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043113; GO:0043395; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050431; GO:0050807; GO:0055117; GO:0060025; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:0099645; GO:0141110; GO:1902667; GO:1903277; GO:1904395; GO:2000673 cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; filopodium assembly [GO:0046847]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; plasma membrane organization [GO:0007009]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416] axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; sarcolemma [GO:0042383]; synapse [GO:0045202] acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; transmembrane transporter binding [GO:0044325]; transporter inhibitor activity [GO:0141110] g6813.t2 P25304 37.097 744 2.28e-139 484.0 sp|P25304|AGRIN_RAT Agrin OS=Rattus norvegicus OX=10116 GN=Agrn PE=1 SV=2 AGRIN_RAT reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Rattus norvegicus (Rat) GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0031012; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043113; GO:0043395; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050431; GO:0050807; GO:0055117; GO:0060025; GO:0070507; GO:0071340; GO:0086036; GO:0098978; GO:0099645; GO:0141110; GO:1902667; GO:1903277; GO:1904395; GO:2000673 cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; filopodium assembly [GO:0046847]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; plasma membrane organization [GO:0007009]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416] axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; sarcolemma [GO:0042383]; synapse [GO:0045202] acetylcholine receptor regulator activity [GO:0030548]; ATPase inhibitor activity [GO:0042030]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; transmembrane transporter binding [GO:0044325]; transporter inhibitor activity [GO:0141110] g6813.t3 O00468 37.549 1012 1.89e-176 596.0 sp|O00468|AGRIN_HUMAN Agrin OS=Homo sapiens OX=9606 GN=AGRN PE=1 SV=6 AGRIN_HUMAN reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Homo sapiens (Human) GO:0002062; GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007166; GO:0007213; GO:0007528; GO:0031012; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050808; GO:0070062 cell surface receptor signaling pathway [GO:0007166]; chondrocyte differentiation [GO:0002062]; clustering of voltage-gated sodium channels [GO:0045162]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202] calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200] g6813.t3 O00468 37.531 794 4.35e-145 504.0 sp|O00468|AGRIN_HUMAN Agrin OS=Homo sapiens OX=9606 GN=AGRN PE=1 SV=6 AGRIN_HUMAN reviewed Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] Homo sapiens (Human) GO:0002062; GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007166; GO:0007213; GO:0007528; GO:0031012; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0046847; GO:0048018; GO:0050808; GO:0070062 cell surface receptor signaling pathway [GO:0007166]; chondrocyte differentiation [GO:0002062]; clustering of voltage-gated sodium channels [GO:0045162]; filopodium assembly [GO:0046847]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808] basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202] calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; receptor ligand activity [GO:0048018]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200] g6814.t1 Q921N8 62.162 111 3.51e-24 105.0 sp|Q921N8|GPS2_MOUSE G protein pathway suppressor 2 OS=Mus musculus OX=10090 GN=Gps2 PE=1 SV=1 GPS2_MOUSE reviewed G protein pathway suppressor 2 (GPS-2) Mus musculus (Mouse) GO:0000122; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0010804; GO:0010875; GO:0017053; GO:0019216; GO:0030183; GO:0030332; GO:0034122; GO:0035360; GO:0045598; GO:0045599; GO:0045944; GO:0046329; GO:0050728; GO:0050859; GO:0098780; GO:1900045 B cell differentiation [GO:0030183]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] cyclin binding [GO:0030332]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] g6815.t1 P67985 73.171 123 1.29e-48 155.0 sp|P67985|RL22_PIG Large ribosomal subunit protein eL22 OS=Sus scrofa OX=9823 GN=RPL22 PE=1 SV=2 g6816.t1 Q5ZKY4 62.205 254 1.96e-107 313.0 sp|Q5ZKY4|ING4_CHICK Inhibitor of growth protein 4 OS=Gallus gallus OX=9031 GN=ING4 PE=2 SV=1 ING4_CHICK reviewed Inhibitor of growth protein 4 (p29ING4) Gallus gallus (Chicken) GO:0005634; GO:0006355; GO:0008270; GO:0043065; GO:0140889 DNA replication-dependent chromatin disassembly [GO:0140889]; positive regulation of apoptotic process [GO:0043065]; regulation of DNA-templated transcription [GO:0006355] nucleus [GO:0005634] zinc ion binding [GO:0008270] g6817.t1 A1L0Y2 47.629 1497 0.0 1333.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g6817.t1 A1L0Y2 33.441 619 9.24e-93 334.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g6817.t1 A1L0Y2 31.579 399 2.4099999999999998e-46 187.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g6817.t1 A1L0Y2 33.051 236 2.59e-28 128.0 sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1 g6821.t1 P20397 29.63 405 1.97e-34 142.0 sp|P20397|NUCL_XENLA Nucleolin OS=Xenopus laevis OX=8355 GN=ncl PE=2 SV=3 g6822.t1 Q9H0C1 51.744 344 1.63e-120 356.0 sp|Q9H0C1|ZMY12_HUMAN Zinc finger MYND domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ZMYND12 PE=1 SV=3 ZMY12_HUMAN reviewed Zinc finger MYND domain-containing protein 12 Homo sapiens (Human) GO:0007288; GO:0008270; GO:0030317; GO:0036126 flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288] sperm flagellum [GO:0036126] zinc ion binding [GO:0008270] g6823.t1 Q0VC81 29.179 329 3.45e-36 136.0 sp|Q0VC81|AA3R_BOVIN Adenosine receptor A3 OS=Bos taurus OX=9913 GN=ADORA3 PE=2 SV=1 AA3R_BOVIN reviewed Adenosine receptor A3 Bos taurus (Bovine) GO:0001609; GO:0001973; GO:0005886; GO:0030425; GO:0045202 G protein-coupled adenosine receptor signaling pathway [GO:0001973] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] G protein-coupled adenosine receptor activity [GO:0001609] g6824.t1 O00400 54.604 467 4.22e-170 493.0 sp|O00400|ACATN_HUMAN Acetyl-coenzyme A transporter 1 OS=Homo sapiens OX=9606 GN=SLC33A1 PE=1 SV=1 ACATN_HUMAN reviewed Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1) Homo sapiens (Human) GO:0000139; GO:0005789; GO:0005886; GO:0008521; GO:0016020; GO:0035348; GO:0042803; GO:0055085 acetyl-CoA transmembrane transport [GO:0035348]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] acetyl-CoA transmembrane transporter activity [GO:0008521]; protein homodimerization activity [GO:0042803] g6825.t1 Q8N2K1 66.797 256 2.18e-118 341.0 sp|Q8N2K1|UB2J2_HUMAN Ubiquitin-conjugating enzyme E2 J2 OS=Homo sapiens OX=9606 GN=UBE2J2 PE=1 SV=3 g6827.t1 Q9UPW0 45.748 341 5.85e-73 245.0 sp|Q9UPW0|FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens OX=9606 GN=FOXJ3 PE=1 SV=2 FOXJ3_HUMAN reviewed Forkhead box protein J3 Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837 cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g6828.t1 Q8BKF1 42.568 1036 0.0 852.0 sp|Q8BKF1|RPOM_MOUSE DNA-directed RNA polymerase, mitochondrial OS=Mus musculus OX=10090 GN=Polrmt PE=1 SV=1 g6830.t1 Q90687 57.305 616 0.0 669.0 sp|Q90687|PTN11_CHICK Tyrosine-protein phosphatase non-receptor type 11 OS=Gallus gallus OX=9031 GN=PTPN11 PE=2 SV=1 PTN11_CHICK reviewed Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2) Gallus gallus (Chicken) GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0030971; GO:0032331; GO:0038127; GO:0045778; GO:0050839; GO:0070374; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB signaling pathway [GO:0038127]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ossification [GO:0045778] cytoplasm [GO:0005737]; nucleus [GO:0005634] cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971] g6830.t2 Q90687 57.305 616 0.0 669.0 sp|Q90687|PTN11_CHICK Tyrosine-protein phosphatase non-receptor type 11 OS=Gallus gallus OX=9031 GN=PTPN11 PE=2 SV=1 PTN11_CHICK reviewed Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2) Gallus gallus (Chicken) GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0030971; GO:0032331; GO:0038127; GO:0045778; GO:0050839; GO:0070374; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB signaling pathway [GO:0038127]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ossification [GO:0045778] cytoplasm [GO:0005737]; nucleus [GO:0005634] cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971] g6830.t3 Q06124 58.416 606 0.0 674.0 sp|Q06124|PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens OX=9606 GN=PTPN11 PE=1 SV=3 PTN11_HUMAN reviewed Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3) Homo sapiens (Human) GO:0000077; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0031295; GO:0031666; GO:0032331; GO:0032480; GO:0032528; GO:0032728; GO:0032760; GO:0032991; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042130; GO:0042311; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048806; GO:0048839; GO:0048873; GO:0050839; GO:0050860; GO:0050868; GO:0051428; GO:0051463; GO:0051897; GO:0060020; GO:0060090; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070374; GO:0071260; GO:0071364; GO:1902533; GO:1902564; GO:1990782 atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to mechanical stimulus [GO:0071260]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of type I interferon production [GO:0032480]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of D-glucose import [GO:0046326]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; molecular adaptor activity [GO:0060090]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159] g6830.t4 Q90687 56.39 626 0.0 665.0 sp|Q90687|PTN11_CHICK Tyrosine-protein phosphatase non-receptor type 11 OS=Gallus gallus OX=9031 GN=PTPN11 PE=2 SV=1 PTN11_CHICK reviewed Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2) Gallus gallus (Chicken) GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0030971; GO:0032331; GO:0038127; GO:0045778; GO:0050839; GO:0070374; GO:0071364 cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB signaling pathway [GO:0038127]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ossification [GO:0045778] cytoplasm [GO:0005737]; nucleus [GO:0005634] cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971] g6831.t1 A4Q9F3 52.85 386 8.55e-138 430.0 sp|A4Q9F3|TTL10_MOUSE Protein polyglycylase TTLL10 OS=Mus musculus OX=10090 GN=Ttll10 PE=1 SV=1 TTL10_MOUSE reviewed Protein polyglycylase TTLL10 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 10) Mus musculus (Mouse) GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0046872; GO:0070735; GO:0070737 protein polyglycylation [GO:0018094] axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737] g6833.t1 Q5ZL00 40.159 1006 0.0 720.0 sp|Q5ZL00|EMC1_CHICK ER membrane protein complex subunit 1 OS=Gallus gallus OX=9031 GN=EMC1 PE=2 SV=1 EMC1_CHICK reviewed ER membrane protein complex subunit 1 Gallus gallus (Chicken) GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546 protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] g6834.t1 Q8IZF0 55.028 1790 0.0 1905.0 sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1 NALCN_HUMAN reviewed Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Homo sapiens (Human) GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248] g6834.t2 Q8IZF0 54.835 1789 0.0 1907.0 sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1 NALCN_HUMAN reviewed Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) Homo sapiens (Human) GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805 calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725] monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886] leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248] g6835.t1 Q5T0B9 52.885 208 7.520000000000001e-71 234.0 sp|Q5T0B9|ZN362_HUMAN Zinc finger protein 362 OS=Homo sapiens OX=9606 GN=ZNF362 PE=1 SV=1 g6835.t2 Q5T0B9 52.885 208 9.56e-71 234.0 sp|Q5T0B9|ZN362_HUMAN Zinc finger protein 362 OS=Homo sapiens OX=9606 GN=ZNF362 PE=1 SV=1 g6837.t1 Q6P8M1 63.481 293 2.9099999999999997e-147 418.0 sp|Q6P8M1|TATD1_MOUSE Deoxyribonuclease TATDN1 OS=Mus musculus OX=10090 GN=Tatdn1 PE=1 SV=1 g6838.t1 Q9FT51 49.802 253 3.7900000000000003e-72 253.0 sp|Q9FT51|AB27G_ARATH ABC transporter G family member 27 OS=Arabidopsis thaliana OX=3702 GN=ABCG27 PE=2 SV=1 g6838.t1 Q9FT51 30.901 233 3.24e-35 146.0 sp|Q9FT51|AB27G_ARATH ABC transporter G family member 27 OS=Arabidopsis thaliana OX=3702 GN=ABCG27 PE=2 SV=1 g6839.t1 Q16YG0 77.487 191 2.26e-101 291.0 sp|Q16YG0|CDC42_AEDAE Cdc42 homolog OS=Aedes aegypti OX=7159 GN=Cdc42 PE=3 SV=1 CDC42_AEDAE reviewed Cdc42 homolog Aedes aegypti (Yellowfever mosquito) (Culex aegypti) GO:0001667; GO:0003006; GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0005912; GO:0007264; GO:0009653; GO:0022412; GO:0035006; GO:0035099; GO:0045185; GO:0045860; GO:0051130 ameboidal-type cell migration [GO:0001667]; anatomical structure morphogenesis [GO:0009653]; cellular process involved in reproduction in multicellular organism [GO:0022412]; developmental process involved in reproduction [GO:0003006]; hemocyte migration [GO:0035099]; maintenance of protein location [GO:0045185]; melanization defense response [GO:0035006]; positive regulation of cellular component organization [GO:0051130]; positive regulation of protein kinase activity [GO:0045860]; small GTPase-mediated signal transduction [GO:0007264] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g6842.t1 Q5BJQ6 59.318 381 2.96e-172 490.0 sp|Q5BJQ6|CSTF1_RAT Cleavage stimulation factor subunit 1 OS=Rattus norvegicus OX=10116 GN=Cstf1 PE=2 SV=1 g6844.t1 O53532 36.798 356 1.1700000000000001e-64 212.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g14182.t1 P70102 41.071 168 2.9200000000000002e-36 127.0 sp|P70102|MCA3_CRIGR Eukaryotic translation elongation factor 1 epsilon-1 OS=Cricetulus griseus OX=10029 GN=EEF1E1 PE=2 SV=1 g14184.t1 P0DQQ4 33.766 154 1.01e-26 108.0 sp|P0DQQ4|PDE_CRODO Venom phosphodiesterase CdcPDE OS=Crotalus durissus collilineatus OX=221569 PE=1 SV=1 g14185.t1 J3SBP3 27.215 474 1.5e-50 186.0 sp|J3SBP3|PDE2_CROAD Venom phosphodiesterase 2 OS=Crotalus adamanteus OX=8729 PE=1 SV=1 g14186.t1 Q8NE09 42.268 582 6.16e-143 476.0 sp|Q8NE09|RGS22_HUMAN Regulator of G-protein signaling 22 OS=Homo sapiens OX=9606 GN=RGS22 PE=1 SV=3 RGS22_HUMAN reviewed Regulator of G-protein signaling 22 (RGS22) Homo sapiens (Human) GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629 negative regulation of signal transduction [GO:0009968] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] G-protein alpha-subunit binding [GO:0001965] g14186.t1 Q8NE09 40.773 233 5.98e-47 189.0 sp|Q8NE09|RGS22_HUMAN Regulator of G-protein signaling 22 OS=Homo sapiens OX=9606 GN=RGS22 PE=1 SV=3 RGS22_HUMAN reviewed Regulator of G-protein signaling 22 (RGS22) Homo sapiens (Human) GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629 negative regulation of signal transduction [GO:0009968] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] G-protein alpha-subunit binding [GO:0001965] g14187.t1 Q11002 41.754 479 5.510000000000001e-122 383.0 sp|Q11002|CANA_DROME Calpain-A OS=Drosophila melanogaster OX=7227 GN=CalpA PE=1 SV=2 CANA_DROME reviewed Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit] Drosophila melanogaster (Fruit fly) GO:0004198; GO:0005509; GO:0005737; GO:0005783; GO:0005794; GO:0006508; GO:0007520; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832 cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025] calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] g14188.t1 Q8R5F3 57.353 136 5.49e-57 180.0 sp|Q8R5F3|OARD1_MOUSE ADP-ribose glycohydrolase OARD1 OS=Mus musculus OX=10090 GN=Oard1 PE=1 SV=2 OARD1_MOUSE reviewed ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-) Mus musculus (Mouse) GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0047407; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293 DNA damage response [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734] ADP-ribosyl-[dinitrogen reductase] hydrolase activity [GO:0047407]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883] g14189.t1 Q28147 57.386 352 1.19e-134 390.0 sp|Q28147|PP1R8_BOVIN Nuclear inhibitor of protein phosphatase 1 OS=Bos taurus OX=9913 GN=PPP1R8 PE=1 SV=1 PP1R8_BOVIN reviewed Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8) Bos taurus (Bovine) GO:0003677; GO:0003729; GO:0004865; GO:0005681; GO:0006397; GO:0008380; GO:0016607 mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681] DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein serine/threonine phosphatase inhibitor activity [GO:0004865] g14190.t1 Q15560 48.875 311 1.56e-95 286.0 sp|Q15560|TCEA2_HUMAN Transcription elongation factor A protein 2 OS=Homo sapiens OX=9606 GN=TCEA2 PE=1 SV=1 TCEA2_HUMAN reviewed Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l) Homo sapiens (Human) GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006354; GO:0006357; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0036064 DNA-templated transcription elongation [GO:0006354]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g14192.t1 Q60675 35.434 2808 0.0 1685.0 sp|Q60675|LAMA2_MOUSE Laminin subunit alpha-2 OS=Mus musculus OX=10090 GN=Lama2 PE=1 SV=2 LAMA2_MOUSE reviewed Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) Mus musculus (Mouse) GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0009887; GO:0009888; GO:0014037; GO:0030334; GO:0031012; GO:0031594; GO:0032224; GO:0042383; GO:0043083; GO:0043197; GO:0045785; GO:0045995; GO:0051149; GO:0098637; GO:0110011; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]; tissue development [GO:0009888] basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083] extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] g14192.t2 Q60675 35.382 2815 0.0 1686.0 sp|Q60675|LAMA2_MOUSE Laminin subunit alpha-2 OS=Mus musculus OX=10090 GN=Lama2 PE=1 SV=2 LAMA2_MOUSE reviewed Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) Mus musculus (Mouse) GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0009887; GO:0009888; GO:0014037; GO:0030334; GO:0031012; GO:0031594; GO:0032224; GO:0042383; GO:0043083; GO:0043197; GO:0045785; GO:0045995; GO:0051149; GO:0098637; GO:0110011; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]; tissue development [GO:0009888] basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083] extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] g14194.t1 Q0EAB6 39.803 407 2.11e-101 313.0 sp|Q0EAB6|5HT1A_HORSE 5-hydroxytryptamine receptor 1A OS=Equus caballus OX=9796 GN=HTR1A PE=2 SV=1 5HT1A_HORSE reviewed 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A) Equus caballus (Horse) GO:0001586; GO:0001662; GO:0004993; GO:0005886; GO:0007187; GO:0007198; GO:0007210; GO:0007214; GO:0007268; GO:0014062; GO:0019229; GO:0030425; GO:0030534; GO:0030594; GO:0035640; GO:0042053; GO:0042428; GO:0045202; GO:0046883; GO:0050795; GO:0051378; GO:0090722; GO:0099589 adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; adult behavior [GO:0030534]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of behavior [GO:0050795]; regulation of dopamine metabolic process [GO:0042053]; regulation of hormone secretion [GO:0046883]; regulation of serotonin secretion [GO:0014062]; regulation of vasoconstriction [GO:0019229]; serotonin metabolic process [GO:0042428]; serotonin receptor signaling pathway [GO:0007210] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; receptor-receptor interaction [GO:0090722]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589] g14195.t1 Q60675 29.085 306 6.14e-34 134.0 sp|Q60675|LAMA2_MOUSE Laminin subunit alpha-2 OS=Mus musculus OX=10090 GN=Lama2 PE=1 SV=2 LAMA2_MOUSE reviewed Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) Mus musculus (Mouse) GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0009887; GO:0009888; GO:0014037; GO:0030334; GO:0031012; GO:0031594; GO:0032224; GO:0042383; GO:0043083; GO:0043197; GO:0045785; GO:0045995; GO:0051149; GO:0098637; GO:0110011; GO:2001046 animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]; tissue development [GO:0009888] basement membrane [GO:0005604]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083] extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] g14196.t1 Q9P0M2 36.139 202 5.94e-38 148.0 sp|Q9P0M2|AKA7G_HUMAN A-kinase anchor protein 7 isoform gamma OS=Homo sapiens OX=9606 GN=AKAP7 PE=1 SV=2 AKA7G_HUMAN reviewed A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma) Homo sapiens (Human) GO:0000166; GO:0005634; GO:0005829; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686 modulation of chemical synaptic transmission [GO:0050804] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901] g14196.t2 Q9P0M2 36.139 202 5.109999999999999e-38 149.0 sp|Q9P0M2|AKA7G_HUMAN A-kinase anchor protein 7 isoform gamma OS=Homo sapiens OX=9606 GN=AKAP7 PE=1 SV=2 AKA7G_HUMAN reviewed A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma) Homo sapiens (Human) GO:0000166; GO:0005634; GO:0005829; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686 modulation of chemical synaptic transmission [GO:0050804] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901] g14197.t1 Q6PAF4 35.271 258 1.94e-58 189.0 sp|Q6PAF4|NSE1_XENLA Non-structural maintenance of chromosomes element 1 homolog OS=Xenopus laevis OX=8355 GN=nsmce1 PE=1 SV=1 g14198.t1 Q9CQN6 56.842 95 9.790000000000001e-26 95.5 sp|Q9CQN6|TM14C_MOUSE Transmembrane protein 14C OS=Mus musculus OX=10090 GN=Tmem14c PE=1 SV=1 g14202.t1 Q8N157 42.219 739 0.0 642.0 sp|Q8N157|AHI1_HUMAN Jouberin OS=Homo sapiens OX=9606 GN=AHI1 PE=1 SV=1 AHI1_HUMAN reviewed Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1) Homo sapiens (Human) GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0008104; GO:0016192; GO:0035845; GO:0036038; GO:0036064; GO:0042802; GO:0043066; GO:0044458; GO:0045944; GO:0050795; GO:0060271; GO:0097730 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium assembly [GO:0060271]; intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730] identical protein binding [GO:0042802] g14202.t2 Q8N157 43.631 683 0.0 640.0 sp|Q8N157|AHI1_HUMAN Jouberin OS=Homo sapiens OX=9606 GN=AHI1 PE=1 SV=1 AHI1_HUMAN reviewed Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1) Homo sapiens (Human) GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0008104; GO:0016192; GO:0035845; GO:0036038; GO:0036064; GO:0042802; GO:0043066; GO:0044458; GO:0045944; GO:0050795; GO:0060271; GO:0097730 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium assembly [GO:0060271]; intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730] identical protein binding [GO:0042802] g14202.t3 Q8K3E5 40.909 858 0.0 686.0 sp|Q8K3E5|AHI1_MOUSE Jouberin OS=Mus musculus OX=10090 GN=Ahi1 PE=1 SV=2 AHI1_MOUSE reviewed Jouberin (Abelson helper integration site 1 protein) (AHI-1) Mus musculus (Mouse) GO:0001750; GO:0002092; GO:0005813; GO:0005814; GO:0005911; GO:0005912; GO:0005929; GO:0006903; GO:0007169; GO:0008104; GO:0010628; GO:0010976; GO:0016192; GO:0034329; GO:0035845; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043066; GO:0044458; GO:0045927; GO:0045944; GO:0046325; GO:0046548; GO:0046549; GO:0050708; GO:0050795; GO:0060041; GO:0060271; GO:0097730; GO:0120206; GO:1905515 cell junction assembly [GO:0034329]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intracellular protein localization [GO:0008104]; motile cilium assembly [GO:0044458]; negative regulation of apoptotic process [GO:0043066]; negative regulation of D-glucose import [GO:0046325]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of protein secretion [GO:0050708]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; vesicle targeting [GO:0006903]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750] identical protein binding [GO:0042802] g14203.t1 Q5PPX0 53.906 256 3.88e-97 297.0 sp|Q5PPX0|PPR42_XENLA Protein phosphatase 1 regulatory subunit 42 OS=Xenopus laevis OX=8355 GN=ppp1r42 PE=2 SV=1 g14204.t1 Q9HCU5 33.258 445 2.07e-66 221.0 sp|Q9HCU5|SEC12_HUMAN Guanine nucleotide-exchange factor SEC12 OS=Homo sapiens OX=9606 GN=PREB PE=1 SV=2 SEC12_HUMAN reviewed Guanine nucleotide-exchange factor SEC12 (Prolactin regulatory element-binding protein) Homo sapiens (Human) GO:0003400; GO:0003677; GO:0005085; GO:0005634; GO:0005789; GO:0006888; GO:0016020; GO:0042953; GO:0048208; GO:0051020; GO:0070971 COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; regulation of COPII vesicle coating [GO:0003400] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634] DNA binding [GO:0003677]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085] g14209.t1 Q865K9 38.024 334 2.8400000000000003e-66 215.0 sp|Q865K9|MPRB_PIG Membrane progestin receptor beta OS=Sus scrofa OX=9823 GN=PAQR8 PE=2 SV=1 g14210.t1 Q9QXG4 64.425 669 0.0 921.0 sp|Q9QXG4|ACSA_MOUSE Acetyl-coenzyme A synthetase, cytoplasmic OS=Mus musculus OX=10090 GN=Acss2 PE=1 SV=2 ACSA_MOUSE reviewed Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17) Mus musculus (Mouse) GO:0003682; GO:0003713; GO:0003987; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0007616; GO:0008610; GO:0019413; GO:0019542; GO:0050218 acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; lipid biosynthetic process [GO:0008610]; long-term memory [GO:0007616]; propionate biosynthetic process [GO:0019542] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; propionate-CoA ligase activity [GO:0050218]; transcription coactivator activity [GO:0003713] g14211.t1 Q62193 45.545 303 1.1100000000000001e-80 247.0 sp|Q62193|RFA2_MOUSE Replication protein A 32 kDa subunit OS=Mus musculus OX=10090 GN=Rpa2 PE=1 SV=2 RFA2_MOUSE reviewed Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) Mus musculus (Mouse) GO:0000723; GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0010569; GO:0016604; GO:0016605; GO:0019899; GO:0019903; GO:0031571; GO:0031625; GO:0034502; GO:0035861; GO:0042162; GO:0098505; GO:2000001 base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723] chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861] damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein phosphatase binding [GO:0019903]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625] g14212.t1 Q5HZQ8 47.232 271 2.33e-84 260.0 sp|Q5HZQ8|ECHD1_XENLA Ethylmalonyl-CoA decarboxylase OS=Xenopus laevis OX=8355 GN=echdc1 PE=2 SV=1 g14213.t1 Q8N6T3 49.563 343 6.36e-107 327.0 sp|Q8N6T3|ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2 g14213.t2 Q8N6T3 49.563 343 2.79e-106 326.0 sp|Q8N6T3|ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2 g14219.t1 Q90655 62.366 93 3.76e-36 136.0 sp|Q90655|AKR_CHICK Homeobox protein AKR OS=Gallus gallus OX=9031 PE=2 SV=1 g14224.t1 P49790 29.534 1439 1.1100000000000001e-85 313.0 sp|P49790|NU153_HUMAN Nuclear pore complex protein Nup153 OS=Homo sapiens OX=9606 GN=NUP153 PE=1 SV=2 NU153_HUMAN reviewed Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) Homo sapiens (Human) GO:0003677; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0008139; GO:0008270; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0042405; GO:0042802; GO:0043495; GO:0043657; GO:0044615; GO:0046718; GO:0046832; GO:0051028; GO:0051292; GO:0075732; GO:0140693; GO:1990000 amyloid fibril formation [GO:1990000]; mRNA transport [GO:0051028]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; symbiont entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732] cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; molecular condensate scaffold activity [GO:0140693]; nuclear localization sequence binding [GO:0008139]; protein-membrane adaptor activity [GO:0043495]; structural constituent of nuclear pore [GO:0017056]; zinc ion binding [GO:0008270] g14225.t1 Q7SZC2 62.925 971 0.0 1228.0 sp|Q7SZC2|XPO2_DANRE Exportin-2 OS=Danio rerio OX=7955 GN=cse1l PE=1 SV=2 XPO2_DANRE reviewed Exportin-2 (Exp2) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005049; GO:0005635; GO:0005829; GO:0006606; GO:0006611; GO:0007589; GO:0009925; GO:0016324; GO:0016328; GO:0031267 body fluid secretion [GO:0007589]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear envelope [GO:0005635] nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] g14227.t1 P60954 48.729 236 6.26e-62 207.0 sp|P60954|NOL4_MOUSE Nucleolar protein 4 OS=Mus musculus OX=10090 GN=Nol4 PE=2 SV=2 g14227.t2 P60954 46.774 248 9.65e-61 203.0 sp|P60954|NOL4_MOUSE Nucleolar protein 4 OS=Mus musculus OX=10090 GN=Nol4 PE=2 SV=2 g14228.t1 Q6DIB4 50.445 337 3.5600000000000003e-75 248.0 sp|Q6DIB4|NOL4L_MOUSE Nucleolar protein 4-like OS=Mus musculus OX=10090 GN=Nol4l PE=2 SV=1 g14228.t2 Q6DIB4 51.205 332 4.41e-76 250.0 sp|Q6DIB4|NOL4L_MOUSE Nucleolar protein 4-like OS=Mus musculus OX=10090 GN=Nol4l PE=2 SV=1 g14229.t1 Q9BV79 56.522 299 8.44e-110 326.0 sp|Q9BV79|MECR_HUMAN Enoyl-[acyl-carrier-protein] reductase, mitochondrial OS=Homo sapiens OX=9606 GN=MECR PE=1 SV=2 MECR_HUMAN reviewed Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase) (Nuclear receptor-binding factor 1) (HsNrbf-1) (NRBF-1) Homo sapiens (Human) GO:0005634; GO:0005739; GO:0005759; GO:0006631; GO:0006633; GO:0006879; GO:0016020; GO:0046513; GO:0141148 ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; intracellular iron ion homeostasis [GO:0006879] membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] enoyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0141148] g14230.t1 P33610 59.957 467 0.0 565.0 sp|P33610|PRI2_MOUSE DNA primase large subunit OS=Mus musculus OX=10090 GN=Prim2 PE=1 SV=1 g14231.t1 F6QEU4 36.822 258 4.6299999999999994e-48 175.0 sp|F6QEU4|LIN41_XENTR E3 ubiquitin-protein ligase TRIM71 OS=Xenopus tropicalis OX=8364 GN=trim71 PE=3 SV=1 LIN41_XENTR reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14231.t1 F6QEU4 38.428 229 5.2e-44 163.0 sp|F6QEU4|LIN41_XENTR E3 ubiquitin-protein ligase TRIM71 OS=Xenopus tropicalis OX=8364 GN=trim71 PE=3 SV=1 LIN41_XENTR reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14231.t1 F6QEU4 35.185 216 4.84e-39 149.0 sp|F6QEU4|LIN41_XENTR E3 ubiquitin-protein ligase TRIM71 OS=Xenopus tropicalis OX=8364 GN=trim71 PE=3 SV=1 LIN41_XENTR reviewed E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177 fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14234.t1 O13019 55.0 80 2.3999999999999997e-23 90.9 sp|O13019|RS12_ORENI Small ribosomal subunit protein eS12 OS=Oreochromis niloticus OX=8128 GN=rps12 PE=2 SV=3 g14235.t1 Q969P5 34.085 399 3.39e-60 201.0 sp|Q969P5|FBX32_HUMAN F-box only protein 32 OS=Homo sapiens OX=9606 GN=FBXO32 PE=1 SV=1 FBX32_HUMAN reviewed F-box only protein 32 (Atrogin-1) (Muscle atrophy F-box protein) (MAFbx) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0014894; GO:0016567; GO:0019005; GO:0030018; GO:0062026; GO:0071549; GO:1990756 cellular response to dexamethasone stimulus [GO:0071549]; negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process [GO:0062026]; protein ubiquitination [GO:0016567]; response to denervation involved in regulation of muscle adaptation [GO:0014894] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g14237.t1 Q4R4I5 31.416 226 1.42e-33 124.0 sp|Q4R4I5|LAP4A_MACFA Lysosomal-associated transmembrane protein 4A OS=Macaca fascicularis OX=9541 GN=LAPTM4A PE=2 SV=1 g14238.t1 Q62725 54.941 253 9e-72 228.0 sp|Q62725|NFYC_RAT Nuclear transcription factor Y subunit gamma OS=Rattus norvegicus OX=10116 GN=Nfyc PE=2 SV=1 g14239.t1 Q9D1F3 47.682 151 2e-46 154.0 sp|Q9D1F3|EOLA1_MOUSE Protein EOLA1 OS=Mus musculus OX=10090 GN=Eola1 PE=1 SV=1 g14243.t1 Q29476 39.446 289 6.66e-69 219.0 sp|Q29476|ST1A1_CANLF Sulfotransferase 1A1 OS=Canis lupus familiaris OX=9615 GN=SULT1A1 PE=1 SV=1 ST1A1_CANLF reviewed Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase) (Phenol sulfotransferase) (Phenol-sulfating phenol sulfotransferase) (P-PST) Canis lupus familiaris (Dog) (Canis familiaris) GO:0004062; GO:0005737; GO:0008146; GO:0008202; GO:0042403; GO:0042420; GO:0050656; GO:0051923 dopamine catabolic process [GO:0042420]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403] cytoplasm [GO:0005737] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] g14247.t1 P90850 44.595 444 4.93e-122 365.0 sp|P90850|YCF2E_CAEEL Uncharacterized peptidase C1-like protein F26E4.3 OS=Caenorhabditis elegans OX=6239 GN=F26E4.3 PE=1 SV=3 g14248.t1 P90850 46.698 424 1.46e-122 367.0 sp|P90850|YCF2E_CAEEL Uncharacterized peptidase C1-like protein F26E4.3 OS=Caenorhabditis elegans OX=6239 GN=F26E4.3 PE=1 SV=3 g14249.t1 Q80T41 31.946 745 6.66e-119 384.0 sp|Q80T41|GABR2_MOUSE Gamma-aminobutyric acid type B receptor subunit 2 OS=Mus musculus OX=10090 GN=Gabbr2 PE=1 SV=2 GABR2_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Mus musculus (Mouse) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0038039; GO:0042734; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g14250.t1 P90850 48.879 446 2.03e-134 397.0 sp|P90850|YCF2E_CAEEL Uncharacterized peptidase C1-like protein F26E4.3 OS=Caenorhabditis elegans OX=6239 GN=F26E4.3 PE=1 SV=3 g14253.t1 P20794 48.26 661 0.0 550.0 sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens OX=9606 GN=MAK PE=1 SV=2 MAK_HUMAN reviewed Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) Homo sapiens (Human) GO:0001750; GO:0001917; GO:0003713; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0005930; GO:0006468; GO:0007283; GO:0030154; GO:0030496; GO:0032391; GO:0035556; GO:0036064; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0097228; GO:0097229; GO:0106310; GO:0120212; GO:1902856; GO:1905515 cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sperm end piece [GO:0097229]; sperm head-tail coupling apparatus [GO:0120212]; sperm principal piece [GO:0097228] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713] g14255.t1 Q5ZIT5 67.488 203 9.39e-96 280.0 sp|Q5ZIT5|RAB10_CHICK Ras-related protein Rab-10 OS=Gallus gallus OX=9031 GN=RAB10 PE=2 SV=1 RAB10_CHICK reviewed Ras-related protein Rab-10 (EC 3.6.5.2) Gallus gallus (Chicken) GO:0003925; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005929; GO:0006887; GO:0006893; GO:0007409; GO:0010008; GO:0016020; GO:0016192; GO:0016197; GO:0019003; GO:0030670; GO:0030859; GO:0031489; GO:0032593; GO:0032869; GO:0043001; GO:0045200; GO:0046872; GO:0048471; GO:0055037; GO:0055038; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:0099503; GO:1903361 axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g14256.t1 Q2HJI8 45.856 181 6.8e-53 177.0 sp|Q2HJI8|RAB8B_BOVIN Ras-related protein Rab-8B OS=Bos taurus OX=9913 GN=RAB8B PE=2 SV=1 RAB8B_BOVIN reviewed Ras-related protein Rab-8B (EC 3.6.5.2) Bos taurus (Bovine) GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0010008; GO:0015031; GO:0019003; GO:0030140; GO:0030670; GO:0032456; GO:0045335; GO:0046872 endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; protein transport [GO:0015031] endosome [GO:0005768]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g14257.t1 Q96E17 39.286 224 9.08e-59 189.0 sp|Q96E17|RAB3C_HUMAN Ras-related protein Rab-3C OS=Homo sapiens OX=9606 GN=RAB3C PE=1 SV=1 RAB3C_HUMAN reviewed Ras-related protein Rab-3C (EC 3.6.5.2) Homo sapiens (Human) GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0015031; GO:0017157; GO:0019882; GO:0030742; GO:0031489; GO:0031982; GO:0046872; GO:0048471 antigen processing and presentation [GO:0019882]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157] endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; myosin V binding [GO:0031489] g14262.t1 O70439 45.283 265 9.180000000000001e-72 224.0 sp|O70439|STX7_MOUSE Syntaxin-7 OS=Mus musculus OX=10090 GN=Stx7 PE=1 SV=3 g14263.t1 Q923L3 29.499 339 2.5599999999999997e-40 167.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g14263.t1 Q923L3 27.536 345 4.81e-31 136.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g14263.t1 Q923L3 28.097 331 9.01e-29 129.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g14263.t1 Q923L3 22.556 399 7.240000000000001e-21 103.0 sp|Q923L3|CSMD1_MOUSE CUB and sushi domain-containing protein 1 OS=Mus musculus OX=10090 GN=Csmd1 PE=1 SV=2 g14265.t1 Q99732 38.835 103 8.01e-22 89.7 sp|Q99732|LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens OX=9606 GN=LITAF PE=1 SV=2 LITAF_HUMAN reviewed Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LPS-induced TNF-alpha factor) (Small integral membrane protein of lysosome/late endosome) (p53-induced gene 7 protein) Homo sapiens (Human) GO:0000139; GO:0000978; GO:0001228; GO:0001817; GO:0005634; GO:0005654; GO:0005765; GO:0005794; GO:0005886; GO:0008270; GO:0009898; GO:0010935; GO:0042802; GO:0043123; GO:0045944; GO:0050699; GO:0071222; GO:0098559; GO:0098560; GO:0098574; GO:1901223 cellular response to lipopolysaccharide [GO:0071222]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]; regulation of macrophage cytokine production [GO:0010935] cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270] g14266.t1 Q6GMG8 41.463 123 5.5999999999999996e-24 93.6 sp|Q6GMG8|LITAF_DANRE Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog OS=Danio rerio OX=7955 GN=litaf PE=2 SV=1 LITAF_DANRE reviewed Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0003677; GO:0005634; GO:0008270; GO:0009898; GO:0098559; GO:0098560; GO:0098574 cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g14267.t1 Q8QGW7 47.273 110 3.09e-25 95.9 sp|Q8QGW7|LITAF_CHICK Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog OS=Gallus gallus OX=9031 GN=LITAF PE=2 SV=1 g14268.t1 Q5U3U7 34.82 471 2.25e-101 318.0 sp|Q5U3U7|NLS1A_DANRE Sodium-dependent lysophosphatidylcholine symporter 1-A OS=Danio rerio OX=7955 GN=mfsd2aa PE=2 SV=1 NLS1A_DANRE reviewed Sodium-dependent lysophosphatidylcholine symporter 1-A (NLS1-A) (Sodium-dependent LPC symporter 1-A) (Major facilitator superfamily domain-containing protein 2A-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005789; GO:0005886; GO:0008643; GO:0015245; GO:0015293; GO:0015908; GO:0035633; GO:0045056; GO:0051977; GO:0051978; GO:0055085; GO:0060856; GO:0140329; GO:1990379 carbohydrate transport [GO:0008643]; establishment of blood-brain barrier [GO:0060856]; fatty acid transport [GO:0015908]; lipid transport across blood-brain barrier [GO:1990379]; lysophospholipid translocation [GO:0140329]; lysophospholipid transport [GO:0051977]; maintenance of blood-brain barrier [GO:0035633]; transcytosis [GO:0045056]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] fatty acid transmembrane transporter activity [GO:0015245]; lysophospholipid:sodium symporter activity [GO:0051978]; symporter activity [GO:0015293] g14269.t1 Q9VML9 38.261 230 6.25e-36 145.0 sp|Q9VML9|TRISR_DROME Trissin receptor OS=Drosophila melanogaster OX=7227 GN=TrissinR PE=2 SV=4 g14271.t1 Q924H0 33.198 247 1.21e-33 136.0 sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2 g14279.t1 O97490 41.079 723 4.65e-164 493.0 sp|O97490|TRFM_RABIT Melanotransferrin OS=Oryctolagus cuniculus OX=9986 GN=MELTF PE=2 SV=1 g14280.t1 D4A2K4 35.862 580 3.34e-94 305.0 sp|D4A2K4|KLH21_RAT Kelch-like protein 21 OS=Rattus norvegicus OX=10116 GN=Klhl21 PE=3 SV=1 g14281.t1 P0C928 48.004 1052 0.0 968.0 sp|P0C928|RTEL1_DANRE Regulator of telomere elongation helicase 1 OS=Danio rerio OX=7955 GN=rtel1 PE=3 SV=1 g14283.t1 Q7ZWF0 71.123 374 0.0 558.0 sp|Q7ZWF0|RAE1L_DANRE mRNA export factor OS=Danio rerio OX=7955 GN=rae1 PE=2 SV=2 RAE1L_DANRE reviewed mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000972; GO:0003723; GO:0005643; GO:0005737; GO:0006405; GO:0043130; GO:0051301; GO:0060236; GO:0097431 cell division [GO:0051301]; regulation of mitotic spindle organization [GO:0060236]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643] RNA binding [GO:0003723]; ubiquitin binding [GO:0043130] g14284.t1 Q5ZLX2 72.403 308 7.360000000000001e-163 459.0 sp|Q5ZLX2|IF2A_CHICK Eukaryotic translation initiation factor 2 subunit 1 OS=Gallus gallus OX=9031 GN=EIF2S1 PE=2 SV=2 IF2A_CHICK reviewed Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha) (eIF2-alpha) Gallus gallus (Chicken) GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0010494; GO:0032057; GO:0033290; GO:0034198; GO:0034644; GO:0034976; GO:0036499; GO:0043022 cellular response to amino acid starvation [GO:0034198]; cellular response to UV [GO:0034644]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; response to endoplasmic reticulum stress [GO:0034976]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850] ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] g14285.t1 Q7T3C7 38.873 355 4.35e-82 261.0 sp|Q7T3C7|RT4I1_DANRE NAD(P)H oxidoreductase RTN4IP1, mitochondrial OS=Danio rerio OX=7955 GN=rtn4ip1 PE=2 SV=2 RT4I1_DANRE reviewed NAD(P)H oxidoreductase RTN4IP1, mitochondrial (EC 1.6.5.-) (Reticulon-4-interacting protein 1 homolog) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000166; GO:0005739; GO:0005741; GO:0005759; GO:0006744; GO:0010842; GO:0016491; GO:0042462; GO:0050773 eye photoreceptor cell development [GO:0042462]; regulation of dendrite development [GO:0050773]; retina layer formation [GO:0010842]; ubiquinone biosynthetic process [GO:0006744] mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491] g14286.t1 P62083 80.412 194 2.38e-112 321.0 sp|P62083|RS7_RAT Small ribosomal subunit protein eS7 OS=Rattus norvegicus OX=10116 GN=Rps7 PE=1 SV=1 RS7_RAT reviewed Small ribosomal subunit protein eS7 (40S ribosomal protein S7) (S8) Rattus norvegicus (Rat) GO:0001843; GO:0003730; GO:0003735; GO:0005634; GO:0005730; GO:0005783; GO:0005813; GO:0005829; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0014033; GO:0019901; GO:0022626; GO:0022627; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1990904; GO:1990948; GO:2000059 negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural crest cell differentiation [GO:0014033]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] centrosome [GO:0005813]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040]; synapse [GO:0045202] mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; poly(U) RNA binding [GO:0008266]; protein kinase binding [GO:0019901]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] g14287.t1 O70338 41.641 329 1.26e-75 237.0 sp|O70338|RNH1_MOUSE Ribonuclease H1 OS=Mus musculus OX=10090 GN=Rnaseh1 PE=2 SV=1 g14288.t1 P83941 89.286 112 2.9799999999999997e-69 206.0 sp|P83941|ELOC_RAT Elongin-C OS=Rattus norvegicus OX=10116 GN=Eloc PE=1 SV=1 g14289.t1 P35659 38.636 176 2.37e-32 130.0 sp|P35659|DEK_HUMAN Protein DEK OS=Homo sapiens OX=9606 GN=DEK PE=1 SV=1 DEK_HUMAN reviewed Protein DEK Homo sapiens (Human) GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006357; GO:0006366; GO:0007165; GO:0019079; GO:0042393; GO:0043292; GO:0045943; GO:0045944; GO:0045945; GO:0110016; GO:2000779; GO:2001032 chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079] B-WICH complex [GO:0110016]; contractile muscle fiber [GO:0043292]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723] g14290.t1 O08876 60.843 166 4.7e-65 221.0 sp|O08876|KLF10_RAT Krueppel-like factor 10 OS=Rattus norvegicus OX=10116 GN=Klf10 PE=2 SV=1 KLF10_RAT reviewed Krueppel-like factor 10 (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1) (Zinc finger transcription factor homolog CPG20) Rattus norvegicus (Rat) GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0005634; GO:0006355; GO:0006357; GO:0007623; GO:0008270; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:1990837; GO:1990859 bone mineralization [GO:0030282]; cellular response to endothelin [GO:1990859]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019] nucleus [GO:0005634] core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g14291.t1 P27117 57.246 414 1.62e-166 481.0 sp|P27117|DCOR_BOVIN Ornithine decarboxylase OS=Bos taurus OX=9913 GN=ODC1 PE=2 SV=1 g14292.t1 Q54P77 42.164 536 6.39e-142 423.0 sp|Q54P77|4CL1_DICDI Probable 4-coumarate--CoA ligase 1 OS=Dictyostelium discoideum OX=44689 GN=4cl1 PE=3 SV=1 g14293.t1 Q54P77 38.848 538 2.64e-137 411.0 sp|Q54P77|4CL1_DICDI Probable 4-coumarate--CoA ligase 1 OS=Dictyostelium discoideum OX=44689 GN=4cl1 PE=3 SV=1 g14300.t1 Q28EM3 34.069 317 9.92e-32 134.0 sp|Q28EM3|PARI_XENTR PCNA-interacting partner OS=Xenopus tropicalis OX=8364 GN=parpbp PE=2 SV=2 PARI_XENTR reviewed PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:2000042 DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677] g14301.t1 Q9QZI7 38.721 297 1.15e-52 177.0 sp|Q9QZI7|TSAP1_RAT tRNA selenocysteine 1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Trnau1ap PE=1 SV=1 g14302.t1 Q6TNS2 43.234 303 1.44e-87 270.0 sp|Q6TNS2|PK1IP_DANRE p21-activated protein kinase-interacting protein 1-like OS=Danio rerio OX=7955 GN=pak1ip1 PE=2 SV=1 g14303.t1 Q8BSL4 48.905 137 7.489999999999999e-45 152.0 sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1 g14304.t1 B1A8Z2 53.927 191 1.05e-61 192.0 sp|B1A8Z2|CIB1_SHEEP Calcium and integrin-binding protein 1 OS=Ovis aries OX=9940 GN=CIB1 PE=2 SV=1 CIB1_SHEEP reviewed Calcium and integrin-binding protein 1 (Calmyrin) Ovis aries (Sheep) GO:0000287; GO:0001525; GO:0005509; GO:0005634; GO:0005813; GO:0006915; GO:0007155; GO:0007229; GO:0007283; GO:0016324; GO:0030027; GO:0030154; GO:0030426; GO:0032433; GO:0032587; GO:0042383; GO:0043204; GO:0043495; GO:0048471; GO:0051301; GO:0070886; GO:0071363; GO:1903078 angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein localization to plasma membrane [GO:1903078]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383] calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein-membrane adaptor activity [GO:0043495] g14307.t1 P18754 52.368 359 7.48e-121 358.0 sp|P18754|RCC1_HUMAN Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1 RCC1_HUMAN reviewed Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) Homo sapiens (Human) GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0007346; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:0090068; GO:1901673 cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; positive regulation of cell cycle process [GO:0090068]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032] chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199] g14308.t1 Q9BWJ5 82.353 85 5.78e-53 162.0 sp|Q9BWJ5|SF3B5_HUMAN Splicing factor 3B subunit 5 OS=Homo sapiens OX=9606 GN=SF3B5 PE=1 SV=1 g14310.t1 Q6UXP7 38.735 253 3.63e-51 181.0 sp|Q6UXP7|F151B_HUMAN Protein FAM151B OS=Homo sapiens OX=9606 GN=FAM151B PE=1 SV=2 g14312.t1 Q52KP5 27.039 466 2.9200000000000002e-36 145.0 sp|Q52KP5|NXPE4_MOUSE NXPE family member 4 OS=Mus musculus OX=10090 GN=Nxpe4 PE=2 SV=1 g14313.t1 Q05004 26.304 460 4.42e-36 145.0 sp|Q05004|NXPE1_RABIT NXPE family member 1 OS=Oryctolagus cuniculus OX=9986 GN=NXPE1 PE=2 SV=1 g14313.t2 Q05004 26.304 460 9.25e-36 144.0 sp|Q05004|NXPE1_RABIT NXPE family member 1 OS=Oryctolagus cuniculus OX=9986 GN=NXPE1 PE=2 SV=1 g14314.t1 Q28BZ2 43.609 133 7.68e-36 125.0 sp|Q28BZ2|HINT3_XENTR Adenosine 5'-monophosphoramidase HINT3 OS=Xenopus tropicalis OX=8364 GN=hint3 PE=2 SV=1 HINT3_XENTR reviewed Adenosine 5'-monophosphoramidase HINT3 (EC 3.9.1.-) (Histidine triad nucleotide-binding protein 3) (HINT-3) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000166; GO:0005634; GO:0005737; GO:0043530 cytoplasm [GO:0005737]; nucleus [GO:0005634] adenosine 5'-monophosphoramidase activity [GO:0043530]; nucleotide binding [GO:0000166] g14317.t1 G3M4F8 26.257 358 1.81e-38 145.0 sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 OCTB2_CHISP reviewed Octopamine receptor beta-2R (CsOA2B2) Chilo suppressalis (Asiatic rice borer moth) GO:0004989; GO:0005886; GO:0007189; GO:0008226; GO:0016020; GO:0043410; GO:0071418; GO:0071880; GO:0071927; GO:0071928 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to amine stimulus [GO:0071418]; octopamine signaling pathway [GO:0071927]; positive regulation of MAPK cascade [GO:0043410]; tyramine signaling pathway [GO:0071928] membrane [GO:0016020]; plasma membrane [GO:0005886] octopamine receptor activity [GO:0004989]; tyramine receptor activity [GO:0008226] g14318.t1 P09324 52.183 504 0.0 525.0 sp|P09324|YES_CHICK Tyrosine-protein kinase Yes OS=Gallus gallus OX=9031 GN=YES1 PE=1 SV=3 g14322.t1 Q9WYG0 39.286 252 3.0900000000000002e-43 150.0 sp|Q9WYG0|Y325_THEMA Uncharacterized oxidoreductase TM_0325 OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0325 PE=3 SV=1 g14323.t1 Q9H3H1 49.818 275 7.13e-74 248.0 sp|Q9H3H1|MOD5_HUMAN tRNA dimethylallyltransferase OS=Homo sapiens OX=9606 GN=TRIT1 PE=1 SV=1 g14323.t1 Q9H3H1 61.719 128 1.89e-45 171.0 sp|Q9H3H1|MOD5_HUMAN tRNA dimethylallyltransferase OS=Homo sapiens OX=9606 GN=TRIT1 PE=1 SV=1 g14324.t1 Q17103 60.584 411 3.99e-141 411.0 sp|Q17103|MYC_ASTRU Myc protein (Fragment) OS=Asterias rubens OX=7604 GN=MYC PE=2 SV=1 g14326.t1 Q921M7 59.633 327 5.64e-140 402.0 sp|Q921M7|CYRIB_MOUSE CYFIP-related Rac1 interactor B OS=Mus musculus OX=10090 GN=Cyrib PE=1 SV=1 CYRIB_MOUSE reviewed CYFIP-related Rac1 interactor B (Protein FAM49B) Mus musculus (Mouse) GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568 cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140] cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739] MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267] g14331.t1 Q5RIW8 60.233 1373 0.0 1697.0 sp|Q5RIW8|MED23_DANRE Mediator of RNA polymerase II transcription subunit 23 OS=Danio rerio OX=7955 GN=med23 PE=2 SV=2 g14333.t1 O08992 52.716 313 1.37e-112 330.0 sp|O08992|SDCB1_MOUSE Syntenin-1 OS=Mus musculus OX=10090 GN=Sdcbp PE=1 SV=1 SDCB1_MOUSE reviewed Syntenin-1 (Scaffold protein Pbp1) (Syndecan-binding protein 1) Mus musculus (Mouse) GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0007265; GO:0007346; GO:0008284; GO:0010718; GO:0019838; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0035255; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0044877; GO:0045121; GO:0045545; GO:0046875; GO:0046982; GO:0050839; GO:0070062; GO:0098793; GO:0099054; GO:0140311; GO:1903543; GO:1903553 negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793] cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; ionotropic glutamate receptor binding [GO:0035255]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545] g14334.t1 O35276 27.346 373 1.59e-26 121.0 sp|O35276|NRP2_RAT Neuropilin-2 OS=Rattus norvegicus OX=10116 GN=Nrp2 PE=2 SV=1 NRP2_RAT reviewed Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2) Rattus norvegicus (Rat) GO:0001525; GO:0001764; GO:0003148; GO:0005021; GO:0005886; GO:0007411; GO:0007507; GO:0008201; GO:0017154; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036484; GO:0036486; GO:0042802; GO:0045211; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0071526; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1903375; GO:1904835; GO:1990830 angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trunk neural crest cell migration [GO:0036484]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor receptor activity [GO:0005021] g14335.t1 P97846 36.923 195 3.49e-26 120.0 sp|P97846|CNTP1_RAT Contactin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Cntnap1 PE=1 SV=1 CNTP1_RAT reviewed Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (Paranodin) (p190) Rattus norvegicus (Rat) GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227 axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone [GO:0048786] SH3 domain binding [GO:0017124] g14338.t1 O70585 52.99 485 1.0799999999999999e-159 475.0 sp|O70585|DTNB_MOUSE Dystrobrevin beta OS=Mus musculus OX=10090 GN=Dtnb PE=1 SV=3 DTNB_MOUSE reviewed Dystrobrevin beta (DTN-B) (mDTN-BDTN-B) (Beta-dystrobrevin) Mus musculus (Mouse) GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0019902; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0098794; GO:0098982; GO:0099536 neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202] DNA binding [GO:0003677]; phosphatase binding [GO:0019902]; zinc ion binding [GO:0008270] g14338.t2 O70585 52.577 485 3.39e-159 474.0 sp|O70585|DTNB_MOUSE Dystrobrevin beta OS=Mus musculus OX=10090 GN=Dtnb PE=1 SV=3 DTNB_MOUSE reviewed Dystrobrevin beta (DTN-B) (mDTN-BDTN-B) (Beta-dystrobrevin) Mus musculus (Mouse) GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0019902; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0098794; GO:0098982; GO:0099536 neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202] DNA binding [GO:0003677]; phosphatase binding [GO:0019902]; zinc ion binding [GO:0008270] g14340.t1 P84060 66.216 148 6.8e-69 223.0 sp|P84060|DTNB_RAT Dystrobrevin beta OS=Rattus norvegicus OX=10116 GN=Dtnb PE=1 SV=2 DTNB_RAT reviewed Dystrobrevin beta (DTN-B) (Beta-dystrobrevin) Rattus norvegicus (Rat) GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0019902; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0098794; GO:0098982; GO:0099536 neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202] DNA binding [GO:0003677]; phosphatase binding [GO:0019902]; zinc ion binding [GO:0008270] g14341.t1 A7RM45 46.168 548 7.95e-174 504.0 sp|A7RM45|LMBD1_NEMVE Probable lysosomal cobalamin transporter OS=Nematostella vectensis OX=45351 GN=v1g160387 PE=3 SV=1 g14346.t1 O54749 36.16 401 2.16e-90 286.0 sp|O54749|CP2J5_MOUSE Cytochrome P450 2J5 OS=Mus musculus OX=10090 GN=Cyp2j5 PE=1 SV=1 CP2J5_MOUSE reviewed Cytochrome P450 2J5 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ5) Mus musculus (Mouse) GO:0001990; GO:0001998; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006690; GO:0006805; GO:0008392; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043651; GO:0071614; GO:0097254; GO:2000863 angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; positive regulation of estrogen secretion [GO:2000863]; regulation of systemic arterial blood pressure by hormone [GO:0001990]; renal tubular secretion [GO:0097254]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] arachidonate 11,12-epoxygenase activity [GO:0008405]; arachidonate 14,15-epoxygenase activity [GO:0008404]; arachidonate epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712] g14347.t1 Q95L11 65.01 483 0.0 687.0 sp|Q95L11|KCNB2_RABIT Potassium voltage-gated channel subfamily B member 2 OS=Oryctolagus cuniculus OX=9986 GN=KCNB2 PE=2 SV=1 KCNB2_RABIT reviewed Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2) Oryctolagus cuniculus (Rabbit) GO:0001508; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0030425; GO:0032809; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659 action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659] dendrite [GO:0030425]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982] g14349.t1 P09324 65.417 480 0.0 650.0 sp|P09324|YES_CHICK Tyrosine-protein kinase Yes OS=Gallus gallus OX=9031 GN=YES1 PE=1 SV=3 g14350.t1 Q7RTX9 26.173 405 1.0700000000000001e-33 135.0 sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1 g14351.t1 Q9PTU6 35.878 393 6.59e-69 224.0 sp|Q9PTU6|ENDOU_PAROL Uridylate-specific endoribonuclease OS=Paralichthys olivaceus OX=8255 GN=endou PE=2 SV=1 g14352.t1 Q3YL68 42.963 135 1.3800000000000002e-27 108.0 sp|Q3YL68|B4GT5_DANRE Beta-1,4-galactosyltransferase 5 OS=Danio rerio OX=7955 GN=b4galt5 PE=2 SV=2 B4GT5_DANRE reviewed Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001574; GO:0005794; GO:0005975; GO:0008489; GO:0009101; GO:0009950; GO:0030166; GO:0030513; GO:0032580; GO:0046872; GO:0048840 carbohydrate metabolic process [GO:0005975]; dorsal/ventral axis specification [GO:0009950]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; otolith development [GO:0048840]; positive regulation of BMP signaling pathway [GO:0030513]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g14353.t1 A0A1S6M251 61.111 90 6.2e-36 134.0 sp|A0A1S6M251|B4GT5_PIG Beta-1,4-galactosyltransferase 5 OS=Sus scrofa OX=9823 GN=B4GALT5 PE=1 SV=2 B4GT5_PIG reviewed Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5) Sus scrofa (Pig) GO:0001574; GO:0003945; GO:0005794; GO:0005975; GO:0008489; GO:0009101; GO:0021955; GO:0022010; GO:0030311; GO:0031647; GO:0032580; GO:0040019; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycoprotein biosynthetic process [GO:0009101]; neuron maturation [GO:0042551]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; regulation of protein stability [GO:0031647] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g14354.t1 Q8TB45 29.512 410 6.84e-42 155.0 sp|Q8TB45|DPTOR_HUMAN DEP domain-containing mTOR-interacting protein OS=Homo sapiens OX=9606 GN=DEPTOR PE=1 SV=2 DPTOR_HUMAN reviewed DEP domain-containing mTOR-interacting protein (hDEPTOR) (DEP domain-containing protein 6) Homo sapiens (Human) GO:0004860; GO:0005085; GO:0005096; GO:0005765; GO:0005886; GO:0006469; GO:0007186; GO:0010508; GO:0030291; GO:0032007; GO:0035556; GO:0045792; GO:0070300; GO:1903940; GO:1904262; GO:2001236 G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of autophagy [GO:0010508]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase inhibitor activity [GO:0030291] g14355.t1 Q66I84 47.194 392 8.930000000000001e-125 368.0 sp|Q66I84|DCC1_DANRE Sister chromatid cohesion protein DCC1 OS=Danio rerio OX=7955 GN=dscc1 PE=2 SV=1 g14356.t1 Q8R059 60.388 361 3.18e-159 453.0 sp|Q8R059|GALE_MOUSE UDP-glucose 4-epimerase OS=Mus musculus OX=10090 GN=Gale PE=1 SV=1 g14356.t2 Q8R059 63.557 343 3.87e-164 465.0 sp|Q8R059|GALE_MOUSE UDP-glucose 4-epimerase OS=Mus musculus OX=10090 GN=Gale PE=1 SV=1 g14358.t1 Q80X89 28.685 502 5.26e-62 225.0 sp|Q80X89|UD2A1_MOUSE UDP-glucuronosyltransferase 2A1 OS=Mus musculus OX=10090 GN=Ugt2a1 PE=2 SV=1 UD2A1_MOUSE reviewed UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17) Mus musculus (Mouse) GO:0006805; GO:0007606; GO:0007608; GO:0008206; GO:0009608; GO:0015020; GO:0016020 bile acid metabolic process [GO:0008206]; response to symbiont [GO:0009608]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g14358.t1 Q80X89 27.689 502 1.5900000000000001e-58 215.0 sp|Q80X89|UD2A1_MOUSE UDP-glucuronosyltransferase 2A1 OS=Mus musculus OX=10090 GN=Ugt2a1 PE=2 SV=1 UD2A1_MOUSE reviewed UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17) Mus musculus (Mouse) GO:0006805; GO:0007606; GO:0007608; GO:0008206; GO:0009608; GO:0015020; GO:0016020 bile acid metabolic process [GO:0008206]; response to symbiont [GO:0009608]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g14358.t1 Q80X89 27.95 483 1.0899999999999999e-55 206.0 sp|Q80X89|UD2A1_MOUSE UDP-glucuronosyltransferase 2A1 OS=Mus musculus OX=10090 GN=Ugt2a1 PE=2 SV=1 UD2A1_MOUSE reviewed UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17) Mus musculus (Mouse) GO:0006805; GO:0007606; GO:0007608; GO:0008206; GO:0009608; GO:0015020; GO:0016020 bile acid metabolic process [GO:0008206]; response to symbiont [GO:0009608]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]; xenobiotic metabolic process [GO:0006805] membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g14359.t1 A6QLQ8 34.058 414 1.7599999999999998e-74 239.0 sp|A6QLQ8|ENDOU_BOVIN Uridylate-specific endoribonuclease OS=Bos taurus OX=9913 GN=ENDOU PE=2 SV=1 ENDOU_BOVIN reviewed Uridylate-specific endoribonuclease (EC 3.1.-.-) (EC 4.6.1.-) (Protein endoU) Bos taurus (Bovine) GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0006955; GO:0016787; GO:0016829; GO:0030247; GO:0046872 immune response [GO:0006955] extracellular region [GO:0005576] hydrolase activity [GO:0016787]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; scavenger receptor activity [GO:0005044] g14366.t1 Q02858 36.725 403 8.22e-81 276.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g14366.t2 Q02858 36.725 403 8.22e-81 276.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g14366.t3 Q06807 44.333 300 2.92e-80 268.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g14366.t4 Q02858 36.725 403 4.27e-81 277.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g14370.t1 Q9JKU3 64.465 1756 0.0 2404.0 sp|Q9JKU3|IF172_RAT Intraflagellar transport protein 172 homolog OS=Rattus norvegicus OX=10116 GN=Ift172 PE=1 SV=1 IF172_RAT reviewed Intraflagellar transport protein 172 homolog (Selective LIM-binding factor) Rattus norvegicus (Rat) GO:0000122; GO:0001841; GO:0001843; GO:0001947; GO:0005634; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007368; GO:0007420; GO:0007507; GO:0008544; GO:0008589; GO:0009953; GO:0010839; GO:0016485; GO:0021522; GO:0021915; GO:0030992; GO:0031122; GO:0036064; GO:0042073; GO:0045879; GO:0045880; GO:0048596; GO:0050680; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097598; GO:1905515 bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epidermis development [GO:0008544]; heart development [GO:0007507]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary transport [GO:0042073]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] g14371.t1 Q5GH73 37.995 429 3.8e-87 284.0 sp|Q5GH73|XKR6_HUMAN XK-related protein 6 OS=Homo sapiens OX=9606 GN=XKR6 PE=1 SV=1 g14372.t1 Q2KIR8 63.836 318 4.54e-145 419.0 sp|Q2KIR8|TDH_BOVIN L-threonine 3-dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=TDH PE=2 SV=1 g14373.t1 Q9Z1L5 24.242 990 1.95e-51 201.0 sp|Q9Z1L5|CA2D3_MOUSE Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Mus musculus OX=10090 GN=Cacna2d3 PE=1 SV=1 CA2D3_MOUSE reviewed Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3] Mus musculus (Mouse) GO:0005245; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314 calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174] GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891] metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] g14374.t1 P83852 44.444 378 2.88e-107 325.0 sp|P83852|CBPD_LOPSP Carboxypeptidase D (Fragment) OS=Lophonetta specularioides OX=75873 GN=CPD PE=1 SV=1 CBPD_LOPSP reviewed Carboxypeptidase D (EC 3.4.17.22) (CPD-2) (Metallocarboxypeptidase D) Lophonetta specularioides (Crested duck) (Anas specularioides) GO:0004181; GO:0005615; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485 peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508] extracellular space [GO:0005615]; membrane [GO:0016020] metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] g14375.t1 Q8NCW0 31.698 265 8.17e-24 108.0 sp|Q8NCW0|KREM2_HUMAN Kremen protein 2 OS=Homo sapiens OX=9606 GN=KREMEN2 PE=1 SV=1 g14376.t1 O97490 34.129 712 4.19e-108 346.0 sp|O97490|TRFM_RABIT Melanotransferrin OS=Oryctolagus cuniculus OX=9986 GN=MELTF PE=2 SV=1 g14376.t1 O97490 32.507 363 3.04e-40 160.0 sp|O97490|TRFM_RABIT Melanotransferrin OS=Oryctolagus cuniculus OX=9986 GN=MELTF PE=2 SV=1 g14377.t1 Q8R0M8 25.771 551 4.0899999999999996e-48 178.0 sp|Q8R0M8|MOT5_MOUSE Monocarboxylate transporter 5 OS=Mus musculus OX=10090 GN=Slc16a4 PE=2 SV=1 g14380.t1 Q6DJI5 63.452 197 9.479999999999999e-89 263.0 sp|Q6DJI5|PITH1_XENLA PITH domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pithd1 PE=2 SV=1 g14381.t1 Q6AZN4 59.459 296 7.040000000000001e-124 358.0 sp|Q6AZN4|RM15_XENLA Large ribosomal subunit protein uL15m OS=Xenopus laevis OX=8355 GN=mrpl15 PE=2 SV=1 g14382.t1 Q9BRU9 40.179 224 1.33e-55 181.0 sp|Q9BRU9|UTP23_HUMAN rRNA-processing protein UTP23 homolog OS=Homo sapiens OX=9606 GN=UTP23 PE=1 SV=2 g14383.t1 Q92481 50.636 472 2.3599999999999997e-128 383.0 sp|Q92481|AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens OX=9606 GN=TFAP2B PE=1 SV=2 AP2B_HUMAN reviewed Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001822; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006006; GO:0006366; GO:0007399; GO:0008284; GO:0008285; GO:0009410; GO:0010842; GO:0030510; GO:0035136; GO:0035137; GO:0035909; GO:0042127; GO:0042803; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0048485; GO:0048745; GO:0050796; GO:0051402; GO:0072017; GO:0072044; GO:0072210; GO:0097070; GO:1990837 aorta morphogenesis [GO:0035909]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of insulin secretion [GO:0050796]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; skin development [GO:0043588]; smooth muscle tissue development [GO:0048745]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g14383.t2 Q92481 50.743 471 6.5e-130 387.0 sp|Q92481|AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens OX=9606 GN=TFAP2B PE=1 SV=2 AP2B_HUMAN reviewed Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001822; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006006; GO:0006366; GO:0007399; GO:0008284; GO:0008285; GO:0009410; GO:0010842; GO:0030510; GO:0035136; GO:0035137; GO:0035909; GO:0042127; GO:0042803; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0048485; GO:0048745; GO:0050796; GO:0051402; GO:0072017; GO:0072044; GO:0072210; GO:0097070; GO:1990837 aorta morphogenesis [GO:0035909]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of insulin secretion [GO:0050796]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; skin development [GO:0043588]; smooth muscle tissue development [GO:0048745]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g14384.t1 B5RI54 60.55 327 8.82e-139 399.0 sp|B5RI54|EIF3H_SALSA Eukaryotic translation initiation factor 3 subunit H OS=Salmo salar OX=8030 GN=eif3h PE=2 SV=1 EIF3H_SALSA reviewed Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit) Salmo salar (Atlantic salmon) GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0008237; GO:0016282; GO:0033290 formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] metallopeptidase activity [GO:0008237]; translation initiation factor activity [GO:0003743] g14385.t1 Q571F5 41.739 115 9.410000000000001e-21 89.4 sp|Q571F5|SPSB3_MOUSE SPRY domain-containing SOCS box protein 3 OS=Mus musculus OX=10090 GN=Spsb3 PE=2 SV=2 SPSB3_MOUSE reviewed SPRY domain-containing SOCS box protein 3 (SSB-3) Mus musculus (Mouse) GO:0001837; GO:0005634; GO:0010719; GO:0019005; GO:0031466; GO:0043161; GO:0070936; GO:0140896; GO:0160049; GO:1990756 cGAS/STING signaling pathway [GO:0140896]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] Cul5-RING ubiquitin ligase complex [GO:0031466]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g14388.t1 Q15691 54.406 261 3.38e-96 286.0 sp|Q15691|MARE1_HUMAN Microtubule-associated protein RP/EB family member 1 OS=Homo sapiens OX=9606 GN=MAPRE1 PE=1 SV=3 MARE1_HUMAN reviewed Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1) Homo sapiens (Human) GO:0000132; GO:0001578; GO:0003723; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005874; GO:0005881; GO:0005925; GO:0008104; GO:0016477; GO:0030981; GO:0031110; GO:0031115; GO:0031116; GO:0031253; GO:0035371; GO:0035372; GO:0036064; GO:0042802; GO:0045296; GO:0046785; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0051315; GO:0071539; GO:0097431; GO:0120283; GO:1902480; GO:1902888; GO:1905515; GO:1905721; GO:1990498 attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein localization [GO:0008104]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; negative regulation of microtubule polymerization [GO:0031115]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]; protein localization to astral microtubule [GO:1902888]; protein localization to centrosome [GO:0071539]; protein localization to microtubule [GO:0035372]; protein localization to mitotic spindle [GO:1902480]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225] cell projection membrane [GO:0031253]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; mitotic spindle microtubule [GO:1990498]; mitotic spindle pole [GO:0097431]; spindle midzone [GO:0051233] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protein serine/threonine kinase binding [GO:0120283]; RNA binding [GO:0003723] g14389.t1 P62024 35.113 487 4.52e-63 217.0 sp|P62024|PHAR1_RAT Phosphatase and actin regulator 1 OS=Rattus norvegicus OX=10116 GN=Phactr1 PE=1 SV=1 PHAR1_RAT reviewed Phosphatase and actin regulator 1 Rattus norvegicus (Rat) GO:0003779; GO:0004864; GO:0005634; GO:0005737; GO:0005829; GO:0008157; GO:0010628; GO:0021987; GO:0030036; GO:0031032; GO:0043149; GO:0048870; GO:0071260; GO:0098794; GO:0098978; GO:0099159; GO:0140059; GO:2001222 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; positive regulation of gene expression [GO:0010628]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794] actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864] g14389.t2 P62024 35.174 489 3.69e-64 221.0 sp|P62024|PHAR1_RAT Phosphatase and actin regulator 1 OS=Rattus norvegicus OX=10116 GN=Phactr1 PE=1 SV=1 PHAR1_RAT reviewed Phosphatase and actin regulator 1 Rattus norvegicus (Rat) GO:0003779; GO:0004864; GO:0005634; GO:0005737; GO:0005829; GO:0008157; GO:0010628; GO:0021987; GO:0030036; GO:0031032; GO:0043149; GO:0048870; GO:0071260; GO:0098794; GO:0098978; GO:0099159; GO:0140059; GO:2001222 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; positive regulation of gene expression [GO:0010628]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794] actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864] g14390.t1 Q8R059 49.448 362 5.69e-113 333.0 sp|Q8R059|GALE_MOUSE UDP-glucose 4-epimerase OS=Mus musculus OX=10090 GN=Gale PE=1 SV=1 g14395.t1 Q4R594 43.548 310 4.72e-78 243.0 sp|Q4R594|RTF2_MACFA Replication termination factor 2 OS=Macaca fascicularis OX=9541 GN=RTF2 PE=2 SV=1 g14396.t1 Q8IYB5 65.289 121 5.33e-57 190.0 sp|Q8IYB5|SMAP1_HUMAN Stromal membrane-associated protein 1 OS=Homo sapiens OX=9606 GN=SMAP1 PE=1 SV=2 SMAP1_HUMAN reviewed Stromal membrane-associated protein 1 Homo sapiens (Human) GO:0005096; GO:0005737; GO:0005886; GO:0008270; GO:0030276; GO:0045648; GO:2000369 positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] g14399.t1 P80146 49.02 357 5.07e-107 323.0 sp|P80146|SEPR_THESR Extracellular serine proteinase OS=Thermus sp. (strain Rt41A) OX=32063 PE=1 SV=3 g14400.t1 Q6NSQ7 38.681 455 5.0699999999999997e-76 247.0 sp|Q6NSQ7|LTV1_MOUSE Protein LTV1 homolog OS=Mus musculus OX=10090 GN=Ltv1 PE=1 SV=2 LTV1_MOUSE reviewed Protein LTV1 homolog Mus musculus (Mouse) GO:0000056; GO:0005634; GO:0005654; GO:0005829; GO:0030688; GO:0042254; GO:0042274 ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome biogenesis [GO:0042254] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688] g14401.t1 Q8VCL5 38.528 231 1.93e-46 164.0 sp|Q8VCL5|S17A9_MOUSE Voltage-gated purine nucleotide uniporter SLC17A9 OS=Mus musculus OX=10090 GN=Slc17a9 PE=1 SV=3 g14402.t1 Q8VCL5 38.69 168 7.140000000000001e-33 124.0 sp|Q8VCL5|S17A9_MOUSE Voltage-gated purine nucleotide uniporter SLC17A9 OS=Mus musculus OX=10090 GN=Slc17a9 PE=1 SV=3 g14403.t1 O35864 87.462 327 0.0 589.0 sp|O35864|CSN5_MOUSE COP9 signalosome complex subunit 5 OS=Mus musculus OX=10090 GN=Cops5 PE=1 SV=3 CSN5_MOUSE reviewed COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (EC 3.4.-.-) (Jun activation domain-binding protein 1) (Kip1 C-terminus-interacting protein 2) Mus musculus (Mouse) GO:0000338; GO:0000785; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006508; GO:0008021; GO:0008180; GO:0008237; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0140492; GO:1903894; GO:1990182 exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deneddylation [GO:0000338]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328] chromatin [GO:0000785]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; transcription regulator complex [GO:0005667] deNEDDylase activity [GO:0019784]; enzyme binding [GO:0019899]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; transcription coactivator activity [GO:0003713] g14405.t1 O88419 50.644 233 5.25e-80 256.0 sp|O88419|B4GT6_RAT Beta-1,4-galactosyltransferase 6 OS=Rattus norvegicus OX=10116 GN=B4galt6 PE=1 SV=1 B4GT6_RAT reviewed Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (EC 2.4.1.-) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) Rattus norvegicus (Rat) GO:0001572; GO:0001574; GO:0005794; GO:0005975; GO:0006688; GO:0008378; GO:0008489; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872 carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580] galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g14407.t1 B3DH20 79.661 59 1.23e-25 100.0 sp|B3DH20|DAA11_DANRE Dynein axonemal assembly factor 11 OS=Danio rerio OX=7955 GN=dnaaf11 PE=1 SV=1 DAA11_DANRE reviewed Dynein axonemal assembly factor 11 (DNAAF11) (Leucine-rich repeat-containing 6-like protein) (Leucine-rich repeat-containing protein 6) (Protein tilB homolog) (Seahorse) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001947; GO:0003143; GO:0003146; GO:0003351; GO:0005576; GO:0005737; GO:0005829; GO:0005929; GO:0007368; GO:0009953; GO:0030317; GO:0036158; GO:0044458; GO:0048793; GO:0060027; GO:0060271; GO:0060287; GO:0060294; GO:0061512; GO:0070286; GO:0090660; GO:0120229; GO:0120293 axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; convergent extension involved in gastrulation [GO:0060027]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; pronephros development [GO:0048793]; protein localization to cilium [GO:0061512]; protein localization to motile cilium [GO:0120229] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576] g14408.t1 Q28FY0 40.931 408 1.13e-86 273.0 sp|Q28FY0|DAA11_XENTR Dynein axonemal assembly factor 11 OS=Xenopus tropicalis OX=8364 GN=dnaaf11 PE=2 SV=1 DAA11_XENTR reviewed Dynein axonemal assembly factor 11 (DNAAF11) (Leucine-rich repeat-containing protein 6) (Protein tilB homolog) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003351; GO:0005576; GO:0005737; GO:0005829; GO:0030317; GO:0031514; GO:0036158; GO:0060287; GO:0061512; GO:0070286; GO:0090660; GO:0120229; GO:0120293 axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; outer dynein arm assembly [GO:0036158]; protein localization to cilium [GO:0061512]; protein localization to motile cilium [GO:0120229] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; motile cilium [GO:0031514] g14409.t1 Q26648 80.27 370 0.0 611.0 sp|Q26648|TKB1_STRPU Tektin-B1 OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1 g14410.t1 Q3KQ80 51.786 112 5.0399999999999994e-30 113.0 sp|Q3KQ80|STPG1_XENLA O(6)-methylguanine-induced apoptosis 2 OS=Xenopus laevis OX=8355 GN=stpg1 PE=2 SV=1 g14412.t1 P11157 65.586 401 0.0 521.0 sp|P11157|RIR2_MOUSE Ribonucleoside-diphosphate reductase subunit M2 OS=Mus musculus OX=10090 GN=Rrm2 PE=1 SV=1 RIR2_MOUSE reviewed Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit) Mus musculus (Mouse) GO:0004748; GO:0005635; GO:0005654; GO:0005829; GO:0005971; GO:0008199; GO:0008284; GO:0009185; GO:0009262; GO:0009263; GO:0009265; GO:0042802; GO:0042803; GO:0051290; GO:1900087 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleotide biosynthetic process [GO:0009263]; deoxyribonucleotide metabolic process [GO:0009262]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; ribonucleoside-diphosphate reductase complex [GO:0005971] ferric iron binding [GO:0008199]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748] g14413.t1 Q6DH94 77.311 119 2.87e-59 188.0 sp|Q6DH94|R1442_DANRE Probable E3 ubiquitin-protein ligase RNF144A-B OS=Danio rerio OX=7955 GN=rnf144ab PE=2 SV=1 R1442_DANRE reviewed Probable E3 ubiquitin-protein ligase RNF144A-B (EC 2.3.2.31) (RING finger protein 144A-B) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000151; GO:0005737; GO:0005794; GO:0006511; GO:0008270; GO:0016567; GO:0031090; GO:0031624; GO:0061630 protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; organelle membrane [GO:0031090]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g14414.t1 A5PK27 46.763 139 2.74e-39 137.0 sp|A5PK27|R144B_BOVIN E3 ubiquitin-protein ligase RNF144B OS=Bos taurus OX=9913 GN=RNF144B PE=2 SV=1 R144B_BOVIN reviewed E3 ubiquitin-protein ligase RNF144B (EC 2.3.2.31) (RING finger protein 144B) Bos taurus (Bovine) GO:0000151; GO:0005737; GO:0006511; GO:0006915; GO:0008270; GO:0016567; GO:0031624; GO:0031966; GO:0043066; GO:0061630 apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; ubiquitin ligase complex [GO:0000151] ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g14415.t1 Q0EEE2 36.441 708 3.67e-152 473.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g14415.t2 Q0EEE2 36.441 708 2.7399999999999998e-152 473.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g14417.t1 Q0P8I7 42.628 312 6.62e-81 251.0 sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1 GMHD_CAMJE reviewed GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-) Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404 capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289] GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491] g14418.t1 Q3T178 62.162 222 1.08e-104 304.0 sp|Q3T178|VPS28_BOVIN Vacuolar protein sorting-associated protein 28 homolog OS=Bos taurus OX=9913 GN=VPS28 PE=2 SV=1 g14419.t1 P10982 84.483 58 1.7500000000000002e-32 112.0 sp|P10982|ACT1_ABSGL Actin-1 (Fragment) OS=Absidia glauca OX=4829 GN=ACT1 PE=3 SV=1 g14420.t1 O17320 76.654 257 5.1100000000000003e-144 410.0 sp|O17320|ACT_MAGGI Actin OS=Magallana gigas OX=29159 PE=2 SV=1 g14421.t1 Q9Y5K1 53.258 353 6.23e-143 415.0 sp|Q9Y5K1|SPO11_HUMAN Meiotic recombination protein SPO11 OS=Homo sapiens OX=9606 GN=SPO11 PE=1 SV=1 g14421.t2 Q9Y5K1 52.975 353 7.35e-146 423.0 sp|Q9Y5K1|SPO11_HUMAN Meiotic recombination protein SPO11 OS=Homo sapiens OX=9606 GN=SPO11 PE=1 SV=1 g14422.t1 Q7RTU0 60.714 112 1.73e-36 129.0 sp|Q7RTU0|TCF24_HUMAN Transcription factor 24 OS=Homo sapiens OX=9606 GN=TCF24 PE=1 SV=3 g14426.t1 Q5GH73 34.596 396 2.12e-59 206.0 sp|Q5GH73|XKR6_HUMAN XK-related protein 6 OS=Homo sapiens OX=9606 GN=XKR6 PE=1 SV=1 g14427.t1 Q8NET6 36.0 250 5.44e-40 145.0 sp|Q8NET6|CHSTD_HUMAN Carbohydrate sulfotransferase 13 OS=Homo sapiens OX=9606 GN=CHST13 PE=1 SV=1 CHSTD_HUMAN reviewed Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3) Homo sapiens (Human) GO:0000139; GO:0001537; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0047756; GO:0050650 carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139]; membrane [GO:0016020] chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] g14429.t1 Q6R5J2 34.817 764 2.65e-146 469.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g14435.t1 Q27403 55.556 135 7.77e-46 175.0 sp|Q27403|GCM_DROME Transcription factor glial cells missing OS=Drosophila melanogaster OX=7227 GN=gcm PE=1 SV=2 GCM_DROME reviewed Transcription factor glial cells missing (Protein glide) Drosophila melanogaster (Fruit fly) GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0007403; GO:0007516; GO:0010001; GO:0010468; GO:0010628; GO:0021782; GO:0030182; GO:0031290; GO:0035165; GO:0035289; GO:0042063; GO:0042387; GO:0042690; GO:0045610; GO:0045687; GO:0045893; GO:0045944; GO:0048813; GO:0050764; GO:0060252; GO:0060857 dendrite morphogenesis [GO:0048813]; embryonic crystal cell differentiation [GO:0035165]; establishment of glial blood-brain barrier [GO:0060857]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; gliogenesis [GO:0042063]; hemocyte development [GO:0007516]; negative regulation of crystal cell differentiation [GO:0042690]; neuron differentiation [GO:0030182]; plasmatocyte differentiation [GO:0042387]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of hemocyte differentiation [GO:0045610]; regulation of phagocytosis [GO:0050764]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g14437.t1 Q9NUQ2 44.504 373 2.32e-122 360.0 sp|Q9NUQ2|PLCE_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3 PLCE_HUMAN reviewed 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon) Homo sapiens (Human) GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016024; GO:0016746; GO:0036149 acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730] 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] g14438.t1 P40939 65.217 736 0.0 1018.0 sp|P40939|ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2 ECHA_HUMAN reviewed Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (MLCL AT) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)] Homo sapiens (Human) GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016509; GO:0018812; GO:0032868; GO:0035965; GO:0042645; GO:0052816; GO:0070403 cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868] mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0016509]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; NAD+ binding [GO:0070403] g14438.t2 P40939 65.217 736 0.0 1019.0 sp|P40939|ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2 ECHA_HUMAN reviewed Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (MLCL AT) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)] Homo sapiens (Human) GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016509; GO:0018812; GO:0032868; GO:0035965; GO:0042645; GO:0052816; GO:0070403 cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868] mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0003857]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0016509]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; NAD+ binding [GO:0070403] g14440.t1 Q99JY0 67.223 479 0.0 665.0 sp|Q99JY0|ECHB_MOUSE Trifunctional enzyme subunit beta, mitochondrial OS=Mus musculus OX=10090 GN=Hadhb PE=1 SV=1 g14441.t1 Q8IVV2 30.43 953 1.09e-109 397.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 27.572 1244 6.54e-99 363.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 26.814 951 2.48e-86 322.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 26.337 972 1.24e-83 313.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 27.033 947 3.79e-81 305.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 25.714 980 5.47e-74 281.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 24.561 1026 1.2e-73 280.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 33.269 517 7.42e-73 277.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 28.427 693 3.47e-71 272.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 33.948 542 1.08e-65 254.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 32.952 525 9.64e-63 244.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 25.422 830 1.3800000000000001e-58 230.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 27.2 625 1.79e-57 227.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 30.051 589 2.4e-55 220.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 28.991 545 3.15e-48 196.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 27.799 518 3.87e-45 186.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 29.468 526 9.52e-44 181.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 26.69 562 4.43e-41 173.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 23.765 749 3.25e-40 170.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 24.843 636 4.77e-37 159.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 25.801 562 1.16e-36 158.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 24.207 599 4.68e-36 156.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 31.538 260 8.930000000000001e-35 152.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 22.376 724 7.36e-34 149.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 25.417 539 1.87e-33 147.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 38.645 251 1.31e-32 145.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 25.813 523 8.820000000000001e-32 142.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 36.803 269 1.52e-31 141.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 25.91 467 1.6800000000000001e-31 141.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 31.97 269 2.6100000000000002e-31 140.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 33.333 273 8.44e-31 139.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 27.68 513 7.82e-30 135.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 24.701 502 3.4000000000000003e-29 134.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 31.734 271 3.6600000000000003e-29 134.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 31.179 263 3.61e-26 124.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 22.75 589 2.92e-25 120.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t1 Q8IVV2 32.422 256 2.48e-24 117.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 30.43 953 1.43e-109 397.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 27.572 1244 1.27e-98 362.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 26.814 951 3.36e-86 321.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 26.44 972 1.58e-83 312.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 27.033 947 5.5e-81 304.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 25.714 980 8.27e-74 280.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 24.561 1026 1.77e-73 280.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 33.269 517 8.71e-73 277.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 28.427 693 4.91e-71 271.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 33.948 542 1.46e-65 253.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 32.952 525 1.04e-62 244.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 25.422 830 2.38e-58 229.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 27.2 625 2.87e-57 226.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 30.051 589 2.5699999999999998e-55 219.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 28.991 545 3.6099999999999995e-48 196.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 27.799 518 5.11e-45 186.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 29.468 526 1.18e-43 181.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 26.69 562 5.95e-41 172.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 23.765 749 4.01e-40 169.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 23.753 762 1.85e-37 161.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 25.96 547 1.31e-36 158.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 24.333 600 5.88e-36 156.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 32.171 258 9.33e-35 152.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 22.376 724 1.05e-33 148.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 25.417 539 2.51e-33 147.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 38.645 251 1.31e-32 145.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 25.813 523 1.23e-31 142.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 36.803 269 1.6e-31 141.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 25.91 467 1.91e-31 141.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 31.97 269 2.7700000000000004e-31 140.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 33.594 256 8.75e-31 139.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 33.333 273 9.92e-31 139.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 27.68 513 1.0300000000000001e-29 135.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 31.734 271 3.7000000000000003e-29 133.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 24.701 502 5.4e-29 133.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 31.349 252 4.24e-26 123.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 22.75 589 4.3e-25 120.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t2 Q8IVV2 32.422 256 2.47e-24 117.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 30.43 953 1.59e-109 397.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 27.572 1244 9.23e-99 362.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 26.814 951 3.07e-86 321.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 26.44 972 1.8e-83 312.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 27.033 947 5.61e-81 304.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 25.714 980 7.829999999999999e-74 281.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 24.561 1026 1.64e-73 280.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 33.269 517 8.310000000000001e-73 277.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 28.427 693 4.3e-71 271.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 33.948 542 1.16e-65 254.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 33.133 498 1.96e-62 243.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 25.422 830 1.7600000000000003e-58 230.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 27.097 620 2.13e-57 226.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 30.051 589 2.6199999999999997e-55 219.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 28.47 562 2.6599999999999997e-48 196.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 27.799 518 4.02e-45 186.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 29.468 526 1.0600000000000001e-43 181.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 32.275 378 3.15e-43 180.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 26.69 562 4.57e-41 172.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 23.765 749 3.4599999999999997e-40 170.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 24.843 636 5.48e-37 159.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 25.96 547 1.3200000000000001e-36 158.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 24.207 599 5.6600000000000004e-36 156.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 31.538 260 9.13e-35 152.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 22.376 724 9.43e-34 149.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 25.417 539 1.98e-33 147.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 38.645 251 1.33e-32 145.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 25.813 523 1.06e-31 142.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 36.803 269 1.5700000000000001e-31 141.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 25.91 467 1.81e-31 141.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 31.97 269 2.78e-31 140.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 33.333 273 8.28e-31 139.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 27.68 513 8.91e-30 135.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 31.734 271 3.5600000000000003e-29 134.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 24.701 502 3.9400000000000003e-29 133.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 31.349 252 3.9500000000000003e-26 124.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 22.75 589 3.25e-25 120.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14441.t3 Q8IVV2 32.422 256 2.35e-24 117.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g14448.t1 Q6IR74 41.265 664 2.6800000000000003e-163 486.0 sp|Q6IR74|CTL1_XENLA Choline transporter-like protein 1 OS=Xenopus laevis OX=8355 GN=slc44a1 PE=2 SV=2 g14451.t1 Q0VCR6 53.425 292 1.06e-112 333.0 sp|Q0VCR6|DIESL_BOVIN DGAT1/2-independent enzyme synthesizing storage lipids OS=Bos taurus OX=9913 GN=TMEM68 PE=2 SV=1 DIESL_BOVIN reviewed DGAT1/2-independent enzyme synthesizing storage lipids (DIESL) (EC 2.3.1.-) (2-acylglycerol/1,2-diacylglycerol O-acyltransferase) (Monoacylglycerol/Diacylglycerol O-acyltransferase) (MGAT/DGAT) (EC 2.3.1.20, EC 2.3.1.22) (Transmembrane protein 68) Bos taurus (Bovine) GO:0003846; GO:0004144; GO:0005789; GO:0016020; GO:0019432; GO:0046027 triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; phospholipid:diacylglycerol acyltransferase activity [GO:0046027] g14452.t1 Q6DRP4 37.019 416 8.36e-80 257.0 sp|Q6DRP4|CCM2_DANRE Cerebral cavernous malformations protein 2 homolog OS=Danio rerio OX=7955 GN=ccm2 PE=1 SV=1 CCM2_DANRE reviewed Cerebral cavernous malformations protein 2 homolog (Malcavernin) (Valentine) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001570; GO:0005737; GO:0007043; GO:0007507; GO:0009948; GO:0048845; GO:0060047; GO:1904018; GO:1905072 anterior/posterior axis specification [GO:0009948]; cardiac jelly development [GO:1905072]; cell-cell junction assembly [GO:0007043]; heart contraction [GO:0060047]; heart development [GO:0007507]; positive regulation of vasculature development [GO:1904018]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845] cytoplasm [GO:0005737] g14458.t1 Q9QXF7 44.091 220 2.16e-65 213.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g14461.t1 O75414 55.03 169 1.23e-64 200.0 sp|O75414|NDK6_HUMAN Nucleoside diphosphate kinase 6 OS=Homo sapiens OX=9606 GN=NME6 PE=1 SV=3 g14462.t1 Q9QXF7 39.431 492 1.87e-114 350.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g14463.t1 P12270 38.565 1924 0.0 1037.0 sp|P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3 TPR_HUMAN reviewed Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) Homo sapiens (Human) GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] g14463.t1 P12270 37.662 231 4.1499999999999993e-23 112.0 sp|P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3 TPR_HUMAN reviewed Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) Homo sapiens (Human) GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] g14463.t2 P12270 38.565 1924 0.0 1036.0 sp|P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3 TPR_HUMAN reviewed Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) Homo sapiens (Human) GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] g14463.t2 P12270 37.662 231 4.3199999999999995e-23 112.0 sp|P12270|TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens OX=9606 GN=TPR PE=1 SV=3 TPR_HUMAN reviewed Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) Homo sapiens (Human) GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] g14465.t1 Q9QXF7 39.212 533 1.1200000000000001e-117 359.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g14465.t2 Q9QXF7 38.837 533 2.34e-118 360.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g14466.t1 Q5RA75 63.863 321 8.589999999999999e-126 419.0 sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1 g14466.t1 Q5RA75 40.087 459 1.1999999999999999e-95 335.0 sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1 g14468.t1 Q9VBW3 41.693 319 6.47e-77 274.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g14473.t1 P27216 49.669 302 1.11e-102 307.0 sp|P27216|ANX13_HUMAN Annexin A13 OS=Homo sapiens OX=9606 GN=ANXA13 PE=1 SV=3 ANX13_HUMAN reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Homo sapiens (Human) GO:0001786; GO:0005509; GO:0005544; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0012506; GO:0016020; GO:0016323; GO:0016324; GO:0030154; GO:0031410; GO:0042997; GO:0042998; GO:0045121; GO:0070062; GO:0070382; GO:1901611 cell differentiation [GO:0030154]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylglycerol binding [GO:1901611]; phosphatidylserine binding [GO:0001786] g14474.t1 P33477 48.867 309 1.43e-96 297.0 sp|P33477|ANX11_RABIT Annexin A11 OS=Oryctolagus cuniculus OX=9986 GN=ANXA11 PE=1 SV=1 g14475.t1 P50995 52.412 311 1.17e-106 323.0 sp|P50995|ANX11_HUMAN Annexin A11 OS=Homo sapiens OX=9606 GN=ANXA11 PE=1 SV=1 ANX11_HUMAN reviewed Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50) Homo sapiens (Human) GO:0001786; GO:0003723; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005886; GO:0006909; GO:0008429; GO:0012506; GO:0016020; GO:0023026; GO:0030496; GO:0031012; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0070062 cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592] azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; specific granule [GO:0042581]; spindle [GO:0005819]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548] g14476.t1 P27216 48.571 315 3.8499999999999995e-104 310.0 sp|P27216|ANX13_HUMAN Annexin A13 OS=Homo sapiens OX=9606 GN=ANXA13 PE=1 SV=3 ANX13_HUMAN reviewed Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) Homo sapiens (Human) GO:0001786; GO:0005509; GO:0005544; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0012506; GO:0016020; GO:0016323; GO:0016324; GO:0030154; GO:0031410; GO:0042997; GO:0042998; GO:0045121; GO:0070062; GO:0070382; GO:1901611 cell differentiation [GO:0030154]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylglycerol binding [GO:1901611]; phosphatidylserine binding [GO:0001786] g14478.t1 P26256 41.693 319 4.2599999999999996e-67 216.0 sp|P26256|ANX12_HYDVU Annexin-B12 OS=Hydra vulgaris OX=6087 GN=ANXB12 PE=1 SV=1 g14479.t1 O60293 34.0 850 6.36e-146 504.0 sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3 g14479.t1 O60293 30.172 464 1.99e-23 113.0 sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3 g14481.t1 Q6AXX4 38.623 523 4.4299999999999994e-95 300.0 sp|Q6AXX4|SAS10_RAT Something about silencing protein 10 OS=Rattus norvegicus OX=10116 GN=Utp3 PE=1 SV=1 g14482.t1 Q4V8D9 48.354 395 2.87e-128 379.0 sp|Q4V8D9|LRC34_RAT Leucine-rich repeat-containing protein 34 OS=Rattus norvegicus OX=10116 GN=Lrrc34 PE=2 SV=1 g14483.t1 Q96DM3 55.828 652 0.0 736.0 sp|Q96DM3|RMC1_HUMAN Regulator of MON1-CCZ1 complex OS=Homo sapiens OX=9606 GN=RMC1 PE=1 SV=2 g14484.t1 D2HSA6 40.71 479 1.73e-103 320.0 sp|D2HSA6|S52A3_AILME Solute carrier family 52, riboflavin transporter, member 3 OS=Ailuropoda melanoleuca OX=9646 GN=SLC52A3 PE=3 SV=1 g14485.t1 P00428 44.792 96 2.69e-25 95.5 sp|P00428|COX5B_BOVIN Cytochrome c oxidase subunit 5B, mitochondrial OS=Bos taurus OX=9913 GN=COX5B PE=1 SV=2 g14486.t1 Q5R833 41.791 134 2.35e-30 110.0 sp|Q5R833|ACO13_PONAB Acyl-coenzyme A thioesterase 13 OS=Pongo abelii OX=9601 GN=ACOT13 PE=2 SV=1 ACO13_PONAB reviewed Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Thioesterase superfamily member 2) (THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0006629; GO:0047617 lipid metabolic process [GO:0006629] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819] fatty acyl-CoA hydrolase activity [GO:0047617] g14487.t1 Q5R833 43.262 141 2.82e-38 130.0 sp|Q5R833|ACO13_PONAB Acyl-coenzyme A thioesterase 13 OS=Pongo abelii OX=9601 GN=ACOT13 PE=2 SV=1 ACO13_PONAB reviewed Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Thioesterase superfamily member 2) (THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0006629; GO:0047617 lipid metabolic process [GO:0006629] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819] fatty acyl-CoA hydrolase activity [GO:0047617] g14489.t1 Q5R833 45.926 135 2.12e-40 135.0 sp|Q5R833|ACO13_PONAB Acyl-coenzyme A thioesterase 13 OS=Pongo abelii OX=9601 GN=ACOT13 PE=2 SV=1 ACO13_PONAB reviewed Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Thioesterase superfamily member 2) (THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed] Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005634; GO:0005739; GO:0005819; GO:0005829; GO:0006629; GO:0047617 lipid metabolic process [GO:0006629] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819] fatty acyl-CoA hydrolase activity [GO:0047617] g14491.t1 Q2WGJ9 42.516 1924 0.0 1472.0 sp|Q2WGJ9|FR1L6_HUMAN Fer-1-like protein 6 OS=Homo sapiens OX=9606 GN=FER1L6 PE=1 SV=2 FR1L6_HUMAN reviewed Fer-1-like protein 6 Homo sapiens (Human) GO:0005544; GO:0005802; GO:0005886; GO:0007519; GO:0009617; GO:0010628; GO:0046872; GO:0048471; GO:0048738; GO:0055037 cardiac muscle tissue development [GO:0048738]; positive regulation of gene expression [GO:0010628]; response to bacterium [GO:0009617]; skeletal muscle tissue development [GO:0007519] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] g14491.t2 Q2WGJ9 41.904 1933 0.0 1460.0 sp|Q2WGJ9|FR1L6_HUMAN Fer-1-like protein 6 OS=Homo sapiens OX=9606 GN=FER1L6 PE=1 SV=2 FR1L6_HUMAN reviewed Fer-1-like protein 6 Homo sapiens (Human) GO:0005544; GO:0005802; GO:0005886; GO:0007519; GO:0009617; GO:0010628; GO:0046872; GO:0048471; GO:0048738; GO:0055037 cardiac muscle tissue development [GO:0048738]; positive regulation of gene expression [GO:0010628]; response to bacterium [GO:0009617]; skeletal muscle tissue development [GO:0007519] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] g14491.t3 Q2WGJ9 42.706 1892 0.0 1477.0 sp|Q2WGJ9|FR1L6_HUMAN Fer-1-like protein 6 OS=Homo sapiens OX=9606 GN=FER1L6 PE=1 SV=2 FR1L6_HUMAN reviewed Fer-1-like protein 6 Homo sapiens (Human) GO:0005544; GO:0005802; GO:0005886; GO:0007519; GO:0009617; GO:0010628; GO:0046872; GO:0048471; GO:0048738; GO:0055037 cardiac muscle tissue development [GO:0048738]; positive regulation of gene expression [GO:0010628]; response to bacterium [GO:0009617]; skeletal muscle tissue development [GO:0007519] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] g14491.t4 Q2WGJ9 42.721 1889 0.0 1479.0 sp|Q2WGJ9|FR1L6_HUMAN Fer-1-like protein 6 OS=Homo sapiens OX=9606 GN=FER1L6 PE=1 SV=2 FR1L6_HUMAN reviewed Fer-1-like protein 6 Homo sapiens (Human) GO:0005544; GO:0005802; GO:0005886; GO:0007519; GO:0009617; GO:0010628; GO:0046872; GO:0048471; GO:0048738; GO:0055037 cardiac muscle tissue development [GO:0048738]; positive regulation of gene expression [GO:0010628]; response to bacterium [GO:0009617]; skeletal muscle tissue development [GO:0007519] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] g14491.t5 Q2WGJ9 42.32 1914 0.0 1473.0 sp|Q2WGJ9|FR1L6_HUMAN Fer-1-like protein 6 OS=Homo sapiens OX=9606 GN=FER1L6 PE=1 SV=2 FR1L6_HUMAN reviewed Fer-1-like protein 6 Homo sapiens (Human) GO:0005544; GO:0005802; GO:0005886; GO:0007519; GO:0009617; GO:0010628; GO:0046872; GO:0048471; GO:0048738; GO:0055037 cardiac muscle tissue development [GO:0048738]; positive regulation of gene expression [GO:0010628]; response to bacterium [GO:0009617]; skeletal muscle tissue development [GO:0007519] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] g14492.t1 Q9GKT2 44.582 323 6.740000000000001e-97 293.0 sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1 g14493.t1 Q6QNK2 47.785 316 2.4699999999999998e-82 294.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g14493.t2 Q6QNK2 47.785 316 2.97e-82 294.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g14499.t1 Q6DIY4 61.364 176 2.32e-75 231.0 sp|Q6DIY4|TBPL1_XENTR TATA box-binding protein-like 1 OS=Xenopus tropicalis OX=8364 GN=tbpl1 PE=2 SV=1 g14500.t1 B0JZV4 49.877 812 0.0 746.0 sp|B0JZV4|CBPC5_XENTR Cytosolic carboxypeptidase-like protein 5 OS=Xenopus tropicalis OX=8364 GN=agbl5 PE=2 SV=1 CBPC5_XENTR reviewed Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686 C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g14500.t2 B0JZV4 49.877 812 0.0 745.0 sp|B0JZV4|CBPC5_XENTR Cytosolic carboxypeptidase-like protein 5 OS=Xenopus tropicalis OX=8364 GN=agbl5 PE=2 SV=1 CBPC5_XENTR reviewed Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686 C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] g14501.t1 D4A631 57.106 767 0.0 766.0 sp|D4A631|BIG1_RAT Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Rattus norvegicus OX=10116 GN=Arfgef1 PE=1 SV=1 BIG1_RAT reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) Rattus norvegicus (Rat) GO:0000139; GO:0005085; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0007030; GO:0009101; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0031175; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0051897; GO:0090303; GO:2000114 endomembrane system organization [GO:0010256]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] g14502.t1 G3X9K3 71.648 455 0.0 664.0 sp|G3X9K3|BIG1_MOUSE Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Mus musculus OX=10090 GN=Arfgef1 PE=1 SV=1 BIG1_MOUSE reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) Mus musculus (Mouse) GO:0000139; GO:0005085; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0007030; GO:0009101; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0031175; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0051897; GO:0090303; GO:2000114 endomembrane system organization [GO:0010256]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] g14503.t1 D4A631 61.661 626 0.0 763.0 sp|D4A631|BIG1_RAT Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Rattus norvegicus OX=10116 GN=Arfgef1 PE=1 SV=1 BIG1_RAT reviewed Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) Rattus norvegicus (Rat) GO:0000139; GO:0005085; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0007030; GO:0009101; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0031175; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0051897; GO:0090303; GO:2000114 endomembrane system organization [GO:0010256]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802] guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] g14505.t1 P07207 37.64 1424 0.0 708.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 36.195 1456 0.0 701.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 35.424 1451 0.0 686.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 35.971 1390 0.0 646.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 34.309 1504 0.0 641.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 36.461 1311 0.0 631.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 33.775 1510 2.15e-178 614.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 34.491 1267 2.2e-163 568.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 32.92 1452 1.0200000000000001e-154 541.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 35.107 1071 3e-137 486.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 33.451 1130 1.5899999999999998e-113 409.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14505.t1 P07207 32.378 349 3.6200000000000004e-21 106.0 sp|P07207|NOTCH_DROME Neurogenic locus Notch protein OS=Drosophila melanogaster OX=7227 GN=N PE=1 SV=3 NOTCH_DROME reviewed Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein] Drosophila melanogaster (Fruit fly) GO:0001745; GO:0002052; GO:0002213; GO:0003682; GO:0003713; GO:0004888; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005788; GO:0005796; GO:0005829; GO:0005886; GO:0005912; GO:0006110; GO:0007015; GO:0007219; GO:0007293; GO:0007297; GO:0007298; GO:0007346; GO:0007391; GO:0007400; GO:0007403; GO:0007405; GO:0007411; GO:0007422; GO:0007423; GO:0007440; GO:0007455; GO:0007474; GO:0007476; GO:0007478; GO:0007480; GO:0007498; GO:0007521; GO:0007616; GO:0008045; GO:0008284; GO:0008340; GO:0008347; GO:0008356; GO:0008407; GO:0008587; GO:0009608; GO:0009950; GO:0009986; GO:0010001; GO:0010628; GO:0010629; GO:0014018; GO:0014019; GO:0016020; GO:0016318; GO:0016324; GO:0016330; GO:0016348; GO:0016360; GO:0022416; GO:0030139; GO:0030154; GO:0030707; GO:0030713; GO:0030718; GO:0030720; GO:0032991; GO:0035035; GO:0035153; GO:0035162; GO:0035167; GO:0035171; GO:0035172; GO:0035204; GO:0035214; GO:0035222; GO:0036011; GO:0036099; GO:0036335; GO:0040008; GO:0042686; GO:0042688; GO:0042691; GO:0043525; GO:0043697; GO:0045165; GO:0045316; GO:0045466; GO:0045595; GO:0045893; GO:0045944; GO:0046331; GO:0046666; GO:0046667; GO:0046716; GO:0046843; GO:0048052; GO:0048056; GO:0048190; GO:0048477; GO:0048542; GO:0048627; GO:0048664; GO:0048665; GO:0048749; GO:0048803; GO:0048863; GO:0050699; GO:0050767; GO:0050768; GO:0050877; GO:0051489; GO:0060250; GO:0060288; GO:0060289; GO:0060571; GO:0061331; GO:0061382; GO:0097150; GO:1900087; GO:1902692; GO:1990433; GO:2000035; GO:2000048 actin filament organization [GO:0007015]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification, open tracheal system [GO:0035153]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber migration [GO:0007297]; follicle cell of egg chamber stalk formation [GO:0030713]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; motor neuron axon guidance [GO:0008045]; muscle cell cellular homeostasis [GO:0046716]; muscle cell fate determination [GO:0007521]; myoblast development [GO:0048627]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast fate specification [GO:0014018]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; ommatidial rotation [GO:0016318]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell differentiation [GO:0048056]; R7 cell differentiation [GO:0045466]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; stem cell differentiation [GO:0048863]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; CSL-Notch-Mastermind transcription factor complex [GO:1990433]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; WW domain binding [GO:0050699] g14506.t1 Q80T74 31.1 582 3.83e-86 296.0 sp|Q80T74|KLH29_MOUSE Kelch-like protein 29 OS=Mus musculus OX=10090 GN=Klhl29 PE=2 SV=3 g14507.t1 P20107 41.866 418 1.88e-95 296.0 sp|P20107|ZRC1_YEAST Vacuolar zinc transporter ZRC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ZRC1 PE=1 SV=2 g14508.t1 P20107 42.056 321 7.15e-70 228.0 sp|P20107|ZRC1_YEAST Vacuolar zinc transporter ZRC1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ZRC1 PE=1 SV=2 g14513.t1 Q96RW7 29.014 355 1.56e-23 113.0 sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2 HMCN1_HUMAN reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Homo sapiens (Human) GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0031012; GO:0032154; GO:0051301; GO:0070062; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631]; extracellular matrix structural constituent [GO:0005201] g14515.t1 B3EWZ3 39.34 394 4.48e-69 263.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g14515.t1 B3EWZ3 35.345 348 9.52e-49 197.0 sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g14516.t1 Q86YS7 49.071 1023 0.0 922.0 sp|Q86YS7|C2CD5_HUMAN C2 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=C2CD5 PE=1 SV=1 C2CD5_HUMAN reviewed C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa) Homo sapiens (Human) GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0008286; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0034451; GO:0065002; GO:0072659; GO:0090314 insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] g14516.t2 Q86YS7 49.343 989 0.0 890.0 sp|Q86YS7|C2CD5_HUMAN C2 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=C2CD5 PE=1 SV=1 C2CD5_HUMAN reviewed C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa) Homo sapiens (Human) GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0008286; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0034451; GO:0065002; GO:0072659; GO:0090314 insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] g14521.t1 P62749 87.435 191 9.21e-127 357.0 sp|P62749|HPCL1_RAT Hippocalcin-like protein 1 OS=Rattus norvegicus OX=10116 GN=Hpcal1 PE=1 SV=2 g14523.t1 Q8C6U2 30.851 188 2.37e-22 93.2 sp|Q8C6U2|S66A3_MOUSE Solute carrier family 66 member 3 OS=Mus musculus OX=10090 GN=Slc66a3 PE=1 SV=1 g14525.t1 F1R237 23.529 1003 2.81e-50 202.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 25.187 802 1.4000000000000001e-43 180.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 24.59 915 2.07e-39 166.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 22.938 1055 1.81e-37 160.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 28.8 375 1.0200000000000001e-35 154.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 22.143 840 1.33e-26 124.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 28.431 408 3.6499999999999996e-24 116.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 26.923 338 1.68e-22 110.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 28.729 362 5.28e-22 108.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14525.t1 F1R237 22.757 602 3.71e-21 106.0 sp|F1R237|TDRD6_DANRE Tudor domain-containing 6 OS=Danio rerio OX=7955 GN=tdrd6 PE=1 SV=2 TDRD6_DANRE reviewed Tudor domain-containing 6 Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007281; GO:0007283; GO:0030719; GO:0032019; GO:0033391; GO:0034587; GO:0043186; GO:0060293; GO:1903863; GO:1905879 germ cell development [GO:0007281]; P granule assembly [GO:1903863]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; regulation of oogenesis [GO:1905879]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; germ plasm [GO:0060293]; mitochondrial cloud [GO:0032019]; P granule [GO:0043186] g14527.t1 Q13823 52.474 768 0.0 741.0 sp|Q13823|NOG2_HUMAN Nucleolar GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GNL2 PE=1 SV=1 NOG2_HUMAN reviewed Nucleolar GTP-binding protein 2 (Autoantigen NGP-1) Homo sapiens (Human) GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0016020; GO:0042254 ribosome biogenesis [GO:0042254] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723] g14528.t1 Q91437 68.449 2263 0.0 3188.0 sp|Q91437|PYR1_SQUAC Multifunctional protein CAD OS=Squalus acanthias OX=7797 GN=CAD PE=2 SV=1 PYR1_SQUAC reviewed Multifunctional protein CAD (Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Glutamine amidotransferase (GATase) (GLNase) (EC 3.5.1.2); Ammonium-dependent carbamoyl phosphate synthase (CPS) (CPSase) (EC 6.3.4.16); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] Squalus acanthias (Spiny dogfish) GO:0004070; GO:0004087; GO:0004088; GO:0004151; GO:0004359; GO:0005524; GO:0005634; GO:0005951; GO:0006207; GO:0006526; GO:0006541; GO:0008270; GO:0016597; GO:0044205 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; L-arginine biosynthetic process [GO:0006526] carbamoyl-phosphate synthase complex [GO:0005951]; nucleus [GO:0005634] amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutaminase activity [GO:0004359]; zinc ion binding [GO:0008270] g14530.t1 O35437 60.331 121 5.81e-45 150.0 sp|O35437|TCF21_MOUSE Transcription factor 21 OS=Mus musculus OX=10090 GN=Tcf21 PE=2 SV=1 TCF21_MOUSE reviewed Transcription factor 21 (TCF-21) (Capsulin) (Epicardin) (Podocyte-expressed 1) (Pod-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001822; GO:0001944; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007530; GO:0007548; GO:0009887; GO:0014707; GO:0030855; GO:0032502; GO:0032835; GO:0042826; GO:0043425; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0050681; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0070888; GO:0072162; GO:0072277; GO:1990837 animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nuclear androgen receptor binding [GO:0050681]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837] g14531.t1 Q9Y4C4 35.193 233 1.04e-25 111.0 sp|Q9Y4C4|MFHA1_HUMAN Malignant fibrous histiocytoma-amplified sequence 1 OS=Homo sapiens OX=9606 GN=MFHAS1 PE=1 SV=2 MFHA1_HUMAN reviewed Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1) Homo sapiens (Human) GO:0005525; GO:0005737; GO:0006954; GO:0030218; GO:0031625; GO:0034121; GO:0034136; GO:0034137; GO:0034144; GO:0035556; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745 erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030]; regulation of toll-like receptor signaling pathway [GO:0034121] cytoplasm [GO:0005737] GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625] g14532.t1 Q9D1P0 61.765 170 4.0799999999999996e-74 223.0 sp|Q9D1P0|RM13_MOUSE Large ribosomal subunit protein uL13m OS=Mus musculus OX=10090 GN=Mrpl13 PE=1 SV=1 g14533.t1 B5DEI4 73.973 146 6.31e-83 243.0 sp|B5DEI4|UBE2W_RAT Ubiquitin-conjugating enzyme E2 W OS=Rattus norvegicus OX=10116 GN=Ube2w PE=2 SV=1 UBE2W_RAT reviewed Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.25) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.23) (N-terminus-conjugating E2) (Ubiquitin carrier protein W) (Ubiquitin-protein ligase W) Rattus norvegicus (Rat) GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0031625; GO:0031669; GO:0038202; GO:0043161; GO:0061631; GO:0070979; GO:0071218; GO:0140374; GO:1904262 antiviral innate immune response [GO:0140374]; cellular response to misfolded protein [GO:0071218]; cellular response to nutrient levels [GO:0031669]; DNA repair [GO:0006281]; negative regulation of TORC1 signaling [GO:1904262]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; TORC1 signaling [GO:0038202] nucleus [GO:0005634] ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] g14534.t1 Q9VKJ9 35.042 839 8.849999999999999e-134 425.0 sp|Q9VKJ9|C2D1_DROME Coiled-coil and C2 domain-containing protein 1-like OS=Drosophila melanogaster OX=7227 GN=l(2)gd1 PE=1 SV=1 C2D1_DROME reviewed Coiled-coil and C2 domain-containing protein 1-like (Lethal (2) giant discs 1 protein) Drosophila melanogaster (Fruit fly) GO:0000281; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006357; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0010008; GO:0016197; GO:0016327; GO:0032509; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592; GO:1901981; GO:1905367 compound eye development [GO:0048749]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of intralumenal vesicle formation [GO:1905367]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472] apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidylinositol phosphate binding [GO:1901981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g14535.t1 Q922Z0 40.413 339 9.110000000000001e-86 265.0 sp|Q922Z0|OXDD_MOUSE D-aspartate oxidase OS=Mus musculus OX=10090 GN=Ddo PE=1 SV=1 g14535.t2 Q922Z0 39.535 344 6.34e-81 253.0 sp|Q922Z0|OXDD_MOUSE D-aspartate oxidase OS=Mus musculus OX=10090 GN=Ddo PE=1 SV=1 g14536.t1 P16065 58.208 1060 0.0 1269.0 sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1 g14538.t1 Q60HE1 51.958 383 2.2700000000000002e-129 380.0 sp|Q60HE1|PEX3_MACFA Peroxisomal biogenesis factor 3 OS=Macaca fascicularis OX=9541 GN=PEX3 PE=2 SV=1 g14539.t1 Q6R5J2 35.583 1037 0.0 624.0 sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1 DISP1_DANRE reviewed Protein dispatched homolog 1 (Protein chameleon) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839 adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224] membrane [GO:0016020] g14542.t1 P40826 62.677 493 0.0 637.0 sp|P40826|UBP14_RABIT Ubiquitin carboxyl-terminal hydrolase 14 OS=Oryctolagus cuniculus OX=9986 GN=USP14 PE=1 SV=3 g14543.t1 O95816 35.976 164 3.61e-27 107.0 sp|O95816|BAG2_HUMAN BAG family molecular chaperone regulator 2 OS=Homo sapiens OX=9606 GN=BAG2 PE=1 SV=1 BAG2_HUMAN reviewed BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2) Homo sapiens (Human) GO:0000774; GO:0005829; GO:0006457; GO:0010954; GO:0019538; GO:0030424; GO:0030425; GO:0031072; GO:0031397; GO:0031625; GO:0042802; GO:0044325; GO:0048156; GO:0050821; GO:0051087; GO:0101031; GO:1901588; GO:1901800 negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588]; protein folding chaperone complex [GO:0101031] adenyl-nucleotide exchange factor activity [GO:0000774]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein-folding chaperone binding [GO:0051087]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] g14544.t1 Q9ULC3 72.489 229 2.62e-112 324.0 sp|Q9ULC3|RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens OX=9606 GN=RAB23 PE=1 SV=1 RAB23_HUMAN reviewed Ras-related protein Rab-23 (EC 3.6.5.2) Homo sapiens (Human) GO:0000045; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0006968; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0036064; GO:0042308; GO:0045335; GO:0046039; GO:0046872; GO:0060271; GO:0097094 autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308] autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] g14546.t1 P57071 37.344 241 2.1800000000000002e-36 145.0 sp|P57071|PRD15_HUMAN PR domain zinc finger protein 15 OS=Homo sapiens OX=9606 GN=PRDM15 PE=1 SV=5 PRD15_HUMAN reviewed PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298) Homo sapiens (Human) GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008168; GO:0008270; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0090263; GO:1990841; GO:2000035 methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g14550.t1 Q3MHR0 51.709 234 2.1e-80 243.0 sp|Q3MHR0|LYPA1_BOVIN Acyl-protein thioesterase 1 OS=Bos taurus OX=9913 GN=LYPLA1 PE=2 SV=1 LYPA1_BOVIN reviewed Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I) (Palmitoyl-protein hydrolase) (EC 3.1.2.22) Bos taurus (Bovine) GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005886; GO:0006631; GO:0008474; GO:0031965; GO:0042997 fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] palmitoyl-(protein) hydrolase activity [GO:0008474]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620] g14550.t2 Q3MHR0 51.961 102 1.3500000000000002e-26 101.0 sp|Q3MHR0|LYPA1_BOVIN Acyl-protein thioesterase 1 OS=Bos taurus OX=9913 GN=LYPLA1 PE=2 SV=1 LYPA1_BOVIN reviewed Acyl-protein thioesterase 1 (APT-1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I) (Palmitoyl-protein hydrolase) (EC 3.1.2.22) Bos taurus (Bovine) GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005886; GO:0006631; GO:0008474; GO:0031965; GO:0042997 fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] palmitoyl-(protein) hydrolase activity [GO:0008474]; phosphatidylcholine lysophospholipase activity [GO:0004622]; phospholipase activity [GO:0004620] g14552.t1 P56518 79.545 572 0.0 886.0 sp|P56518|HDAC1_STRPU Histone deacetylase 1 OS=Strongylocentrotus purpuratus OX=7668 GN=HDAC1 PE=2 SV=1 g14553.t1 Q9V9J3 64.272 529 0.0 703.0 sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1 SRC42_DROME reviewed Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0009611; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136 actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] g14554.t1 Q91754 34.756 656 2.31e-133 408.0 sp|Q91754|GCKR_XENLA Glucokinase regulatory protein OS=Xenopus laevis OX=8355 GN=gckr PE=1 SV=1 GCKR_XENLA reviewed Glucokinase regulatory protein (GKRP) (Glucokinase regulator) Xenopus laevis (African clawed frog) GO:0001678; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0009750; GO:0019210; GO:0019899; GO:0030246; GO:0033132; GO:0034504; GO:0070095; GO:0141089; GO:1901135 carbohydrate derivative metabolic process [GO:1901135]; intracellular glucose homeostasis [GO:0001678]; negative regulation of glucokinase activity [GO:0033132]; protein localization to nucleus [GO:0034504]; response to fructose [GO:0009750] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; fructose-6-phosphate binding [GO:0070095]; glucose sensor activity [GO:0141089]; kinase inhibitor activity [GO:0019210] g14556.t1 O08762 47.863 117 3.4800000000000006e-21 100.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g14556.t1 O08762 50.962 104 8.02e-21 99.8 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g14556.t2 O08762 48.031 127 7.45e-22 103.0 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g14556.t2 O08762 50.962 104 9.650000000000001e-21 99.8 sp|O08762|NETR_MOUSE Neurotrypsin OS=Mus musculus OX=10090 GN=Prss12 PE=1 SV=1 NETR_MOUSE reviewed Neurotrypsin (EC 3.4.21.-) (Brain-specific serine protease 3) (BSSP-3) (Motopsin) (Serine protease 12) Mus musculus (Mouse) GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0008233; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195; GO:0045202; GO:0098685; GO:0098793; GO:0098978 exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] g14558.t1 Q7T0Q5 57.971 690 0.0 832.0 sp|Q7T0Q5|NOL10_XENLA Nucleolar protein 10 OS=Xenopus laevis OX=8355 GN=nol10 PE=2 SV=1 g14561.t1 Q9PWA1 57.711 201 1.3700000000000001e-64 202.0 sp|Q9PWA1|RGS20_CHICK Regulator of G-protein signaling 20 OS=Gallus gallus OX=9031 GN=RGS20 PE=2 SV=1 g14561.t2 Q9PWA1 56.442 163 2.01e-64 200.0 sp|Q9PWA1|RGS20_CHICK Regulator of G-protein signaling 20 OS=Gallus gallus OX=9031 GN=RGS20 PE=2 SV=1 g14562.t1 A0JMW6 34.783 575 4.04e-114 361.0 sp|A0JMW6|T214A_XENLA Transmembrane protein 214-A OS=Xenopus laevis OX=8355 GN=tmem214-a PE=2 SV=1 g14563.t1 P45479 68.966 58 3.74e-25 98.2 sp|P45479|PPT1_RAT Palmitoyl-protein thioesterase 1 OS=Rattus norvegicus OX=10116 GN=Ppt1 PE=1 SV=1 PPT1_RAT reviewed Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.2) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1) Rattus norvegicus (Rat) GO:0002084; GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0006897; GO:0006898; GO:0006907; GO:0007040; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016042; GO:0019834; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030672; GO:0031579; GO:0034164; GO:0035727; GO:0043025; GO:0043066; GO:0043524; GO:0045121; GO:0048167; GO:0048260; GO:0048549; GO:0052816; GO:0099523; GO:0120146 adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; endocytosis [GO:0006897]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; nervous system development [GO:0007399]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of synaptic plasticity [GO:0048167]; visual perception [GO:0007601] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase A2 inhibitor activity [GO:0019834]; sulfatide binding [GO:0120146] g14564.t1 P45478 51.282 195 1.4999999999999999e-61 194.0 sp|P45478|PPT1_BOVIN Palmitoyl-protein thioesterase 1 OS=Bos taurus OX=9913 GN=PPT1 PE=1 SV=1 PPT1_BOVIN reviewed Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.2) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1) Bos taurus (Bovine) GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0006897; GO:0006898; GO:0006907; GO:0007042; GO:0007399; GO:0007420; GO:0008021; GO:0008474; GO:0015031; GO:0016042; GO:0030308; GO:0030424; GO:0031579; GO:0043066; GO:0043524; GO:0045121; GO:0048260; GO:0048549; GO:0052816; GO:0120146 brain development [GO:0007420]; endocytosis [GO:0006897]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] axon [GO:0030424]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021] long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; palmitoyl-(protein) hydrolase activity [GO:0008474]; sulfatide binding [GO:0120146] g14565.t1 Q2NL11 31.461 267 3.16e-32 124.0 sp|Q2NL11|CH074_BOVIN Uncharacterized protein C8orf74 homolog OS=Bos taurus OX=9913 PE=2 SV=1 g14566.t1 D2H0Y8 54.545 176 9.04e-69 224.0 sp|D2H0Y8|RN146_AILME E3 ubiquitin-protein ligase RNF146 OS=Ailuropoda melanoleuca OX=9646 GN=RNF146 PE=3 SV=1 g14567.t1 Q05AY2 71.396 444 0.0 681.0 sp|Q05AY2|EI3EA_XENLA Eukaryotic translation initiation factor 3 subunit E-A OS=Xenopus laevis OX=8355 GN=eif3e-a PE=2 SV=1 g14568.t1 Q91ZU6 50.0 168 8.53e-41 152.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g14570.t1 Q9QXS1 30.816 821 3.62e-120 433.0 sp|Q9QXS1|PLEC_MOUSE Plectin OS=Mus musculus OX=10090 GN=Plec PE=1 SV=3 g14571.t1 Q9UPN3 23.158 475 4.07e-29 125.0 sp|Q9UPN3|MACF1_HUMAN Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 OS=Homo sapiens OX=9606 GN=MACF1 PE=1 SV=4 MACF1_HUMAN reviewed Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha) Homo sapiens (Human) GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] g14572.t1 Q03001 20.148 1623 3.76e-57 227.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 23.94 731 1.26e-53 216.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 19.097 1262 2.36e-41 175.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 21.751 1462 6.23e-41 174.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 21.823 834 1.06e-39 169.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 19.798 1389 1.1199999999999999e-38 166.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 19.585 2701 1.43e-38 166.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 20.431 1625 5.17e-38 164.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 20.325 1353 5.35e-38 164.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 21.516 976 6.34e-32 144.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 20.595 1243 4.230000000000001e-31 141.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 19.832 1664 7.34e-26 124.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14572.t1 Q03001 20.093 1294 5.88e-25 120.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14573.t1 Q03001 25.138 1086 3.8e-97 344.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14573.t1 Q03001 22.009 936 4.04e-43 176.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14573.t1 Q03001 21.429 812 6.6400000000000005e-37 156.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14573.t1 Q03001 24.933 373 2.5100000000000004e-27 124.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14573.t1 Q03001 19.159 856 8.42e-26 119.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14574.t1 Q91ZU6 32.454 379 7.619999999999999e-61 216.0 sp|Q91ZU6|DYST_MOUSE Dystonin OS=Mus musculus OX=10090 GN=Dst PE=1 SV=2 g14576.t1 Q03001 25.608 617 4.4199999999999995e-68 247.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14576.t1 Q03001 23.129 588 3.49e-28 125.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14576.t1 Q03001 22.292 637 5.79e-28 125.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14576.t1 Q03001 18.77 618 1.4599999999999999e-24 114.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14576.t1 Q03001 20.607 626 8.28e-21 102.0 sp|Q03001|DYST_HUMAN Dystonin OS=Homo sapiens OX=9606 GN=DST PE=1 SV=4 DYST_HUMAN reviewed Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) Homo sapiens (Human) GO:0000226; GO:0001725; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] g14577.t1 D3ZHV2 44.719 1174 0.0 1004.0 sp|D3ZHV2|MACF1_RAT Microtubule-actin cross-linking factor 1 OS=Rattus norvegicus OX=10116 GN=Macf1 PE=1 SV=1 MACF1_RAT reviewed Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7) Rattus norvegicus (Rat) GO:0001707; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006620; GO:0007163; GO:0008017; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030054; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0036064; GO:0042060; GO:0043001; GO:0045104; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198] g14577.t1 D3ZHV2 22.549 612 3.2800000000000003e-37 157.0 sp|D3ZHV2|MACF1_RAT Microtubule-actin cross-linking factor 1 OS=Rattus norvegicus OX=10116 GN=Macf1 PE=1 SV=1 MACF1_RAT reviewed Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7) Rattus norvegicus (Rat) GO:0001707; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006620; GO:0007163; GO:0008017; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030054; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0036064; GO:0042060; GO:0043001; GO:0045104; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198] g14577.t1 D3ZHV2 21.196 769 2.5e-24 115.0 sp|D3ZHV2|MACF1_RAT Microtubule-actin cross-linking factor 1 OS=Rattus norvegicus OX=10116 GN=Macf1 PE=1 SV=1 MACF1_RAT reviewed Microtubule-actin cross-linking factor 1 (Actin cross-linking family 7) Rattus norvegicus (Rat) GO:0001707; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006620; GO:0007163; GO:0008017; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030054; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0036064; GO:0042060; GO:0043001; GO:0045104; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; structural molecule activity [GO:0005198] g14578.t1 Q9WV18 33.444 604 2.86e-97 332.0 sp|Q9WV18|GABR1_MOUSE Gamma-aminobutyric acid type B receptor subunit 1 OS=Mus musculus OX=10090 GN=Gabbr1 PE=1 SV=1 GABR1_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) Mus musculus (Mouse) GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932] axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982] g14585.t1 Q767L8 43.842 203 6.2699999999999996e-40 166.0 sp|Q767L8|MDC1_PIG Mediator of DNA damage checkpoint protein 1 OS=Sus scrofa OX=9823 GN=MDC1 PE=3 SV=1 g14586.t1 Q5RBH9 61.426 477 0.0 581.0 sp|Q5RBH9|NRBP_PONAB Nuclear receptor-binding protein OS=Pongo abelii OX=9601 GN=NRBP1 PE=2 SV=1 g14587.t1 P79126 65.714 210 2.95e-88 285.0 sp|P79126|PPM1G_BOVIN Protein phosphatase 1G OS=Bos taurus OX=9913 GN=PPM1G PE=2 SV=2 g14587.t2 P79126 64.762 210 3.42e-87 282.0 sp|P79126|PPM1G_BOVIN Protein phosphatase 1G OS=Bos taurus OX=9913 GN=PPM1G PE=2 SV=2 g14588.t1 Q54TR1 34.116 554 5.279999999999999e-89 287.0 sp|Q54TR1|CFAD_DICDI Counting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1 CFAD_DICDI reviewed Counting factor associated protein D Dictyostelium discoideum (Social amoeba) GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0008656; GO:0031288; GO:0031410; GO:0042742; GO:0072659; GO:0140986; GO:1903665; GO:2001235 defense response to bacterium [GO:0042742]; G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656] g14589.t1 Q32NG5 45.119 379 4.66e-96 317.0 sp|Q32NG5|GTR12_XENLA Solute carrier family 2, facilitated glucose transporter member 12 OS=Xenopus laevis OX=8355 GN=slc2a12 PE=2 SV=1 g14589.t1 Q32NG5 43.636 110 3.1000000000000002e-21 102.0 sp|Q32NG5|GTR12_XENLA Solute carrier family 2, facilitated glucose transporter member 12 OS=Xenopus laevis OX=8355 GN=slc2a12 PE=2 SV=1 g14590.t1 P34152 47.802 1069 0.0 974.0 sp|P34152|FAK1_MOUSE Focal adhesion kinase 1 OS=Mus musculus OX=10090 GN=Ptk2 PE=1 SV=4 FAK1_MOUSE reviewed Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) Mus musculus (Mouse) GO:0000165; GO:0000226; GO:0001525; GO:0001568; GO:0001570; GO:0001725; GO:0001764; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005178; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0005938; GO:0007097; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007254; GO:0008284; GO:0008360; GO:0008432; GO:0010507; GO:0010613; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0014704; GO:0014911; GO:0016323; GO:0016324; GO:0016477; GO:0016604; GO:0019901; GO:0019902; GO:0019903; GO:0021955; GO:0022408; GO:0030027; GO:0030155; GO:0030198; GO:0030307; GO:0030335; GO:0030336; GO:0030644; GO:0033628; GO:0033629; GO:0036064; GO:0042127; GO:0042169; GO:0042311; GO:0042383; GO:0042802; GO:0043066; GO:0043542; GO:0043548; GO:0044877; GO:0045667; GO:0045785; GO:0046621; GO:0048013; GO:0048471; GO:0048661; GO:0050766; GO:0050771; GO:0050806; GO:0051893; GO:0051897; GO:0051964; GO:0060252; GO:0060396; GO:0071560; GO:0090303; GO:0098794; GO:0098978; GO:0120041; GO:0140677; GO:1900024; GO:1905274; GO:2000060; GO:2000811 angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix organization [GO:0030198]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; intracellular chloride ion homeostasis [GO:0030644]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of osteoblast differentiation [GO:0045667]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vasodilation [GO:0042311] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; molecular function activator activity [GO:0140677]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169] g14590.t2 P34152 48.433 1053 0.0 981.0 sp|P34152|FAK1_MOUSE Focal adhesion kinase 1 OS=Mus musculus OX=10090 GN=Ptk2 PE=1 SV=4 FAK1_MOUSE reviewed Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) Mus musculus (Mouse) GO:0000165; GO:0000226; GO:0001525; GO:0001568; GO:0001570; GO:0001725; GO:0001764; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005178; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0005938; GO:0007097; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007254; GO:0008284; GO:0008360; GO:0008432; GO:0010507; GO:0010613; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0014704; GO:0014911; GO:0016323; GO:0016324; GO:0016477; GO:0016604; GO:0019901; GO:0019902; GO:0019903; GO:0021955; GO:0022408; GO:0030027; GO:0030155; GO:0030198; GO:0030307; GO:0030335; GO:0030336; GO:0030644; GO:0033628; GO:0033629; GO:0036064; GO:0042127; GO:0042169; GO:0042311; GO:0042383; GO:0042802; GO:0043066; GO:0043542; GO:0043548; GO:0044877; GO:0045667; GO:0045785; GO:0046621; GO:0048013; GO:0048471; GO:0048661; GO:0050766; GO:0050771; GO:0050806; GO:0051893; GO:0051897; GO:0051964; GO:0060252; GO:0060396; GO:0071560; GO:0090303; GO:0098794; GO:0098978; GO:0120041; GO:0140677; GO:1900024; GO:1905274; GO:2000060; GO:2000811 angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix organization [GO:0030198]; growth hormone receptor signaling pathway [GO:0060396]; integrin-mediated signaling pathway [GO:0007229]; intracellular chloride ion homeostasis [GO:0030644]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of osteoblast differentiation [GO:0045667]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vasodilation [GO:0042311] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; sarcolemma [GO:0042383]; stress fiber [GO:0001725] actin binding [GO:0003779]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; molecular function activator activity [GO:0140677]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169] g14590.t3 Q91738 46.757 1110 0.0 955.0 sp|Q91738|FAK1_XENLA Focal adhesion kinase 1 OS=Xenopus laevis OX=8355 GN=ptk2 PE=2 SV=2 FAK1_XENLA reviewed Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Protein-tyrosine kinase 2) (pp125FAK) Xenopus laevis (African clawed frog) GO:0004715; GO:0005524; GO:0005886; GO:0005925; GO:0007172; GO:0008284; GO:0030154; GO:0036064 cell differentiation [GO:0030154]; positive regulation of cell population proliferation [GO:0008284]; signal complex assembly [GO:0007172] ciliary basal body [GO:0036064]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715] g14592.t1 Q9IB61 65.789 76 3.98e-26 94.7 sp|Q9IB61|BLCAP_DANRE Apoptosis inducing factor BLCAP OS=Danio rerio OX=7955 GN=blcap PE=3 SV=1 g14593.t1 Q6GLE1 52.404 208 1.18e-66 205.0 sp|Q6GLE1|CCD25_XENTR Coiled-coil domain-containing protein 25 OS=Xenopus tropicalis OX=8364 GN=ccdc25 PE=2 SV=1 CCD25_XENTR reviewed Coiled-coil domain-containing protein 25 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003677; GO:0005886; GO:0012505; GO:2000147 positive regulation of cell motility [GO:2000147] endomembrane system [GO:0012505]; plasma membrane [GO:0005886] DNA binding [GO:0003677] g14594.t1 O42123 75.789 95 5.68e-51 159.0 sp|O42123|FKB1A_XENLA Peptidyl-prolyl cis-trans isomerase FKBP1A OS=Xenopus laevis OX=8355 GN=fkbp1a PE=3 SV=3 FKB1A_XENLA reviewed Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) Xenopus laevis (African clawed frog) GO:0000413; GO:0001933; GO:0003007; GO:0003755; GO:0005528; GO:0005737; GO:0005829; GO:0006936; GO:0010881; GO:0014802; GO:0016020; GO:0019221; GO:0019855; GO:0030018; GO:0031398; GO:0032092; GO:0032880; GO:0032925; GO:0033017; GO:0042098; GO:0042803; GO:0043123; GO:0044325; GO:0046332; GO:0048185; GO:0050776; GO:0051209; GO:0051280; GO:0055010; GO:0060314; GO:0060315; GO:0060347; GO:0070062; GO:0097435; GO:0098562; GO:1902991; GO:1990000; GO:1990425 amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018] activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; transmembrane transporter binding [GO:0044325] g14595.t1 Q9NXZ2 50.95 579 0.0 587.0 sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2 g14595.t2 Q9NXZ2 50.78 577 0.0 586.0 sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2 g14596.t1 Q86YT6 78.869 1008 0.0 1638.0 sp|Q86YT6|MIB1_HUMAN E3 ubiquitin-protein ligase MIB1 OS=Homo sapiens OX=9606 GN=MIB1 PE=1 SV=1 MIB1_HUMAN reviewed E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2) Homo sapiens (Human) GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0021953; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978 blood vessel development [GO:0001568]; central nervous system neuron differentiation [GO:0021953]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g14597.t1 Q8JFY9 46.758 293 6.96e-84 256.0 sp|Q8JFY9|ENDUA_XENLA Poly(U)-specific endoribonuclease-A OS=Xenopus laevis OX=8355 GN=endou-a PE=1 SV=1 g14598.t1 Q8TDN4 43.344 323 1.0300000000000001e-79 265.0 sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2 CABL1_HUMAN reviewed CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726 cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726] cytosol [GO:0005829]; nucleus [GO:0005634] g14598.t2 Q8TDN4 44.805 308 3.63e-78 258.0 sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2 CABL1_HUMAN reviewed CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1) Homo sapiens (Human) GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726 cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726] cytosol [GO:0005829]; nucleus [GO:0005634] g14604.t2 P23074 33.152 184 3.48e-27 115.0 sp|P23074|POL_SFV1 Pro-Pol polyprotein OS=Simian foamy virus type 1 OX=338478 GN=pol PE=1 SV=3 g14605.t1 P20825 41.86 258 1.44e-65 223.0 sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1 g14608.t1 Q7Z020 36.445 1114 0.0 735.0 sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4 g14609.t1 O73853 36.207 464 1.26e-100 314.0 sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1 g14610.t1 P26221 42.539 449 1.91e-92 302.0 sp|P26221|GUN4_THEFU Endoglucanase E-4 OS=Thermobifida fusca OX=2021 GN=celD PE=1 SV=2 g14612.t1 Q5FWF5 57.576 231 4.25e-96 317.0 sp|Q5FWF5|ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens OX=9606 GN=ESCO1 PE=1 SV=3 ESCO1_HUMAN reviewed N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1) Homo sapiens (Human) GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0007064; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733 mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; protein-lysine-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270] g14613.t1 Q9C0D9 47.208 394 1.39e-115 345.0 sp|Q9C0D9|EPT1_HUMAN Ethanolaminephosphotransferase 1 OS=Homo sapiens OX=9606 GN=SELENOI PE=1 SV=3 EPT1_HUMAN reviewed Ethanolaminephosphotransferase 1 (hEPT1) (EC 2.7.8.1) (Selenoprotein I) (SelI) Homo sapiens (Human) GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0008611; GO:0042552; GO:0046872 ether lipid biosynthetic process [GO:0008611]; myelination [GO:0042552]; phosphatidylethanolamine biosynthetic process [GO:0006646] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872] g14617.t1 P91119 46.357 796 0.0 690.0 sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3 PDE5_CAEEL reviewed Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17) Caenorhabditis elegans GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555; GO:0141162 chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g14617.t2 P91119 46.388 789 0.0 678.0 sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3 PDE5_CAEEL reviewed Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17) Caenorhabditis elegans GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555; GO:0141162 chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g14617.t3 P91119 46.895 789 0.0 691.0 sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3 PDE5_CAEEL reviewed Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17) Caenorhabditis elegans GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555; GO:0141162 chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g14617.t4 P91119 42.399 842 0.0 623.0 sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3 PDE5_CAEEL reviewed Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17) Caenorhabditis elegans GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0032528; GO:0042542; GO:0046872; GO:0047555; GO:0141162 chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542] 3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g14618.t1 Q80Y55 46.759 216 7.94e-58 199.0 sp|Q80Y55|BSDC1_MOUSE BSD domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bsdc1 PE=1 SV=1 g14627.t1 Q9BUK0 50.685 73 7.33e-23 95.9 sp|Q9BUK0|CHCH7_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 OS=Homo sapiens OX=9606 GN=CHCHD7 PE=1 SV=1 g14629.t1 Q9Y6N9 39.789 284 1.26e-61 212.0 sp|Q9Y6N9|USH1C_HUMAN Harmonin OS=Homo sapiens OX=9606 GN=USH1C PE=1 SV=3 g14629.t1 Q9Y6N9 45.763 118 2.9499999999999997e-24 108.0 sp|Q9Y6N9|USH1C_HUMAN Harmonin OS=Homo sapiens OX=9606 GN=USH1C PE=1 SV=3 g14630.t1 Q9DAT2 62.766 94 9.680000000000001e-37 131.0 sp|Q9DAT2|MRGBP_MOUSE MRG/MORF4L-binding protein OS=Mus musculus OX=10090 GN=Mrgbp PE=1 SV=2 g14631.t1 Q5R723 75.241 311 2.04e-170 477.0 sp|Q5R723|PPIE_PONAB Peptidyl-prolyl cis-trans isomerase E OS=Pongo abelii OX=9601 GN=PPIE PE=2 SV=1 g14632.t1 Q6P9I7 50.584 257 4.9500000000000003e-79 270.0 sp|Q6P9I7|SMC6_XENLA Structural maintenance of chromosomes protein 6 OS=Xenopus laevis OX=8355 GN=smc6 PE=2 SV=1 g14633.t1 Q6P9I7 33.905 525 2.01e-87 297.0 sp|Q6P9I7|SMC6_XENLA Structural maintenance of chromosomes protein 6 OS=Xenopus laevis OX=8355 GN=smc6 PE=2 SV=1 g14633.t2 Q96SB8 33.208 533 1.11e-79 280.0 sp|Q96SB8|SMC6_HUMAN Structural maintenance of chromosomes protein 6 OS=Homo sapiens OX=9606 GN=SMC6 PE=1 SV=2 SMC6_HUMAN reviewed Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (hSMC6) Homo sapiens (Human) GO:0000217; GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016607; GO:0016887; GO:0016925; GO:0030915; GO:0031625; GO:0032204; GO:0035061; GO:0035861; GO:0044828; GO:0051984; GO:0090398; GO:0097431; GO:0140588 cellular senescence [GO:0090398]; chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722] chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA secondary structure binding [GO:0000217]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] g14633.t2 Q96SB8 40.541 259 3.31e-53 203.0 sp|Q96SB8|SMC6_HUMAN Structural maintenance of chromosomes protein 6 OS=Homo sapiens OX=9606 GN=SMC6 PE=1 SV=2 SMC6_HUMAN reviewed Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (hSMC6) Homo sapiens (Human) GO:0000217; GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016607; GO:0016887; GO:0016925; GO:0030915; GO:0031625; GO:0032204; GO:0035061; GO:0035861; GO:0044828; GO:0051984; GO:0090398; GO:0097431; GO:0140588 cellular senescence [GO:0090398]; chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722] chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA secondary structure binding [GO:0000217]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] g14634.t1 M9PE65 27.414 580 4.25e-53 199.0 sp|M9PE65|AXO_DROME Axotactin OS=Drosophila melanogaster OX=7227 GN=axo PE=1 SV=1 AXO_DROME reviewed Axotactin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0016020; GO:0019226; GO:0030424 transmission of nerve impulse [GO:0019226] axon [GO:0030424]; membrane [GO:0016020] serine-type endopeptidase inhibitor activity [GO:0004867] g14637.t1 M9PE65 24.512 563 1.33e-42 174.0 sp|M9PE65|AXO_DROME Axotactin OS=Drosophila melanogaster OX=7227 GN=axo PE=1 SV=1 AXO_DROME reviewed Axotactin Drosophila melanogaster (Fruit fly) GO:0004867; GO:0016020; GO:0019226; GO:0030424 transmission of nerve impulse [GO:0019226] axon [GO:0030424]; membrane [GO:0016020] serine-type endopeptidase inhibitor activity [GO:0004867] g14638.t1 Q94K49 29.375 320 4.6000000000000003e-35 135.0 sp|Q94K49|ALP1_ARATH Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1 ALP1_ARATH reviewed Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 (EC 3.1.-.-) Arabidopsis thaliana (Mouse-ear cress) GO:0003682; GO:0004518; GO:0005634; GO:0016787; GO:0035098; GO:0035102; GO:0040029; GO:0046872 epigenetic regulation of gene expression [GO:0040029] ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; PRC1 complex [GO:0035102] chromatin binding [GO:0003682]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] g14639.t1 Q9NBX4 34.104 173 7.690000000000001e-27 113.0 sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1 g14655.t1 Q05585 51.087 92 1.02e-21 102.0 sp|Q05585|MSRE_RABIT Macrophage scavenger receptor types I and II OS=Oryctolagus cuniculus OX=9986 GN=MSR1 PE=2 SV=1 g14656.t1 Q8NCW0 30.98 255 7.95e-21 98.2 sp|Q8NCW0|KREM2_HUMAN Kremen protein 2 OS=Homo sapiens OX=9606 GN=KREMEN2 PE=1 SV=1 g14658.t1 Q80T79 29.064 609 5.0800000000000003e-57 216.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g14658.t1 Q80T79 28.939 622 7.36e-53 204.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g14658.t1 Q80T79 27.553 519 3.95e-34 145.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g14658.t1 Q80T79 24.609 447 1.23e-22 108.0 sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3 CSMD3_MOUSE reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Mus musculus (Mouse) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g14661.t1 Q05B79 54.942 941 0.0 1043.0 sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1 DHX36_BOVIN reviewed ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein) Bos taurus (Bovine) GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669] axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034] g14662.t1 Q0D289 35.897 156 2.3300000000000004e-27 103.0 sp|Q0D289|MOSMO_DANRE Modulator of smoothened protein OS=Danio rerio OX=7955 GN=mosmob PE=2 SV=1 g14664.t1 Q99575 42.593 216 1.6800000000000002e-47 179.0 sp|Q99575|POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens OX=9606 GN=POP1 PE=1 SV=2 POP1_HUMAN reviewed Ribonucleases P/MRP protein subunit POP1 (hPOP1) Homo sapiens (Human) GO:0000172; GO:0001682; GO:0003723; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204 tRNA 5'-leader removal [GO:0001682]; tRNA decay [GO:0016078]; tRNA processing [GO:0008033] extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172] ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] g14665.t1 E1C2V1 43.135 772 0.0 604.0 sp|E1C2V1|LMBL1_CHICK Lethal(3)malignant brain tumor-like protein 1 OS=Gallus gallus OX=9031 GN=L3MBTL1 PE=3 SV=1 g14665.t2 E1C2V1 43.613 775 0.0 607.0 sp|E1C2V1|LMBL1_CHICK Lethal(3)malignant brain tumor-like protein 1 OS=Gallus gallus OX=9031 GN=L3MBTL1 PE=3 SV=1 g14665.t3 E1C2V1 43.653 772 0.0 612.0 sp|E1C2V1|LMBL1_CHICK Lethal(3)malignant brain tumor-like protein 1 OS=Gallus gallus OX=9031 GN=L3MBTL1 PE=3 SV=1 g14667.t1 P59913 64.875 279 6.84e-129 387.0 sp|P59913|PCMD1_MOUSE Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pcmtd1 PE=1 SV=1 g14669.t1 P97500 35.006 837 7.62e-117 400.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14669.t1 P97500 44.8 125 8.57e-22 107.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14669.t2 P97500 35.167 836 6.52e-119 406.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14669.t2 P97500 44.8 125 8.2e-22 107.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14669.t3 P97500 35.575 818 1.59e-121 414.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14669.t3 P97500 55.435 92 5.6300000000000005e-21 104.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14669.t4 P97500 35.741 817 3.84e-118 404.0 sp|P97500|MYT1L_MOUSE Myelin transcription factor 1-like protein OS=Mus musculus OX=10090 GN=Myt1l PE=1 SV=3 MYT1L_MOUSE reviewed Myelin transcription factor 1-like protein (MyT1-L) (MyT1L) (Neural zinc finger factor 1) (NZF-1) (Postmitotic neural gene 1 protein) (Zinc finger protein Png-1) Mus musculus (Mouse) GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0003713; GO:0005634; GO:0005694; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0044323; GO:0045944; GO:0048663; GO:0048665; GO:0048666; GO:0050897; GO:0140487 negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion sequestering activity [GO:0140487]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] g14670.t1 Q6DUZ9 66.838 389 0.0 553.0 sp|Q6DUZ9|EIPR1_GEKJA EARP-interacting protein homolog OS=Gekko japonicus OX=146911 GN=eipr1 PE=2 SV=1 g14671.t1 Q8K2L8 50.851 470 4.42e-151 466.0 sp|Q8K2L8|TPC12_MOUSE Trafficking protein particle complex subunit 12 OS=Mus musculus OX=10090 GN=Trappc12 PE=1 SV=2 g14672.t1 Q8BGC3 25.056 443 1.94e-24 108.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g14674.t1 Q8BGC3 25.056 443 5.22e-25 110.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g14675.t1 Q8R0M8 24.797 492 1.1300000000000002e-27 118.0 sp|Q8R0M8|MOT5_MOUSE Monocarboxylate transporter 5 OS=Mus musculus OX=10090 GN=Slc16a4 PE=2 SV=1 g14677.t1 Q00174 36.506 3331 0.0 2117.0 sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2 g14677.t1 Q00174 26.225 408 3.6800000000000003e-32 143.0 sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2 g14678.t1 Q5ZIT8 56.359 1093 0.0 1264.0 sp|Q5ZIT8|TAF2_CHICK Transcription initiation factor TFIID subunit 2 OS=Gallus gallus OX=9031 GN=TAF2 PE=2 SV=1 g14678.t2 Q6P1X5 58.451 994 0.0 1230.0 sp|Q6P1X5|TAF2_HUMAN Transcription initiation factor TFIID subunit 2 OS=Homo sapiens OX=9606 GN=TAF2 PE=1 SV=3 TAF2_HUMAN reviewed Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150) Homo sapiens (Human) GO:0000086; GO:0000976; GO:0003682; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006357; GO:0006367; GO:0016251; GO:0033276; GO:0042789; GO:0045893; GO:0051123; GO:0060261; GO:1901562 G2/M transition of mitotic cell cycle [GO:0000086]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to paraquat [GO:1901562]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976] g14679.t1 Q9CQR2 73.494 83 1.2e-43 139.0 sp|Q9CQR2|RS21_MOUSE Small ribosomal subunit protein eS21 OS=Mus musculus OX=10090 GN=Rps21 PE=1 SV=1 RS21_MOUSE reviewed Small ribosomal subunit protein eS21 (40S ribosomal protein S21) Mus musculus (Mouse) GO:0000447; GO:0000461; GO:0001701; GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005791; GO:0005829; GO:0005840; GO:0022626; GO:0022627; GO:0043022; GO:0045202; GO:0098794 cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]; in utero embryonic development [GO:0001701] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202] ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735] g14683.t1 Q63530 50.432 347 6.19e-123 360.0 sp|Q63530|PTER_RAT N-acetyltaurine hydrolase OS=Rattus norvegicus OX=10116 GN=Pter PE=2 SV=2 g14684.t1 Q96BW5 56.923 195 1.12e-84 256.0 sp|Q96BW5|PTER_HUMAN N-acetyltaurine hydrolase OS=Homo sapiens OX=9606 GN=PTER PE=1 SV=1 g14686.t1 Q9CUU3 28.756 386 1.03e-50 202.0 sp|Q9CUU3|SYCP2_MOUSE Synaptonemal complex protein 2 OS=Mus musculus OX=10090 GN=Sycp2 PE=1 SV=2 SYCP2_MOUSE reviewed Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein) Mus musculus (Mouse) GO:0000779; GO:0000795; GO:0000800; GO:0003677; GO:0005654; GO:0007140; GO:0007143; GO:0009566; GO:0009887; GO:0043066; GO:0048808; GO:0051301 animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066] condensed chromosome, centromeric region [GO:0000779]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795] DNA binding [GO:0003677] g14687.t1 Q9GRC0 91.369 336 0.0 646.0 sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1 g14688.t1 Q5RBW6 34.657 277 1.15e-39 142.0 sp|Q5RBW6|STX12_PONAB Syntaxin-12 OS=Pongo abelii OX=9601 GN=STX12 PE=2 SV=1 STX12_PONAB reviewed Syntaxin-12 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000045; GO:0000139; GO:0000149; GO:0005484; GO:0006886; GO:0006906; GO:0030672; GO:0031201; GO:0031901; GO:0032456; GO:0048278; GO:0055037; GO:0055038; GO:0098837 autophagosome assembly [GO:0000045]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g14689.t1 Q5VTT2 44.34 212 7.94e-46 154.0 sp|Q5VTT2|CFA95_HUMAN Cilia- and flagella-associated protein 95 OS=Homo sapiens OX=9606 GN=CFAP95 PE=1 SV=1 CFA95_HUMAN reviewed Cilia- and flagella-associated protein 95 Homo sapiens (Human) GO:0005737; GO:0005879; GO:0005886; GO:0030317; GO:0036126; GO:0160111 flagellated sperm motility [GO:0030317] axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126] g14692.t1 Q8BYH0 35.622 233 8.62e-30 115.0 sp|Q8BYH0|DRGX_MOUSE Dorsal root ganglia homeobox protein OS=Mus musculus OX=10090 GN=Drgx PE=1 SV=2 g14697.t1 Q8BGW3 65.686 102 4.14e-38 137.0 sp|Q8BGW3|BHE23_MOUSE Class E basic helix-loop-helix protein 23 OS=Mus musculus OX=10090 GN=Bhlhe23 PE=2 SV=1 BHE23_MOUSE reviewed Class E basic helix-loop-helix protein 23 (bHLHe23) (Class B basic helix-loop-helix protein 4) (bHLHb4) Mus musculus (Mouse) GO:0000981; GO:0005634; GO:0007423; GO:0045944; GO:0046548; GO:0046671; GO:0046983; GO:0048050; GO:0061564; GO:0070888; GO:1990837 axon development [GO:0061564]; negative regulation of retinal cell programmed cell death [GO:0046671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic eye morphogenesis [GO:0048050]; retinal rod cell development [GO:0046548]; sensory organ development [GO:0007423] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; sequence-specific double-stranded DNA binding [GO:1990837] g14699.t1 Q17QQ2 42.667 225 2.3699999999999998e-61 199.0 sp|Q17QQ2|TPMT_BOVIN Thiopurine S-methyltransferase OS=Bos taurus OX=9913 GN=TPMT PE=2 SV=1 TPMT_BOVIN reviewed Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase) Bos taurus (Bovine) GO:0005737; GO:0006805; GO:0008119; GO:0032259; GO:1904047 methylation [GO:0032259]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737] S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119] g14700.t1 Q6INX4 66.667 441 0.0 644.0 sp|Q6INX4|ENOF1_XENLA Mitochondrial enolase superfamily member 1 OS=Xenopus laevis OX=8355 GN=enosf1 PE=2 SV=1 g14701.t1 P08519 32.506 443 1.5e-38 155.0 sp|P08519|APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens OX=9606 GN=LPA PE=1 SV=2 APOA_HUMAN reviewed Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) Homo sapiens (Human) GO:0001968; GO:0004252; GO:0004866; GO:0005576; GO:0006508; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0034185; GO:0034358 blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358] apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252] g14701.t1 P08519 30.243 453 9.79e-35 144.0 sp|P08519|APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens OX=9606 GN=LPA PE=1 SV=2 APOA_HUMAN reviewed Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) Homo sapiens (Human) GO:0001968; GO:0004252; GO:0004866; GO:0005576; GO:0006508; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0034185; GO:0034358 blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358] apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252] g14701.t1 P08519 28.313 498 3.51e-32 136.0 sp|P08519|APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens OX=9606 GN=LPA PE=1 SV=2 APOA_HUMAN reviewed Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) Homo sapiens (Human) GO:0001968; GO:0004252; GO:0004866; GO:0005576; GO:0006508; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0034185; GO:0034358 blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358] apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252] g14701.t1 P08519 30.531 452 1.1900000000000002e-31 134.0 sp|P08519|APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens OX=9606 GN=LPA PE=1 SV=2 APOA_HUMAN reviewed Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) Homo sapiens (Human) GO:0001968; GO:0004252; GO:0004866; GO:0005576; GO:0006508; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0034185; GO:0034358 blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358] apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252] g14701.t1 P08519 30.065 459 3.31e-31 133.0 sp|P08519|APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens OX=9606 GN=LPA PE=1 SV=2 APOA_HUMAN reviewed Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) Homo sapiens (Human) GO:0001968; GO:0004252; GO:0004866; GO:0005576; GO:0006508; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0034185; GO:0034358 blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358] apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252] g14701.t1 P08519 29.63 459 2.3e-30 130.0 sp|P08519|APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens OX=9606 GN=LPA PE=1 SV=2 APOA_HUMAN reviewed Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-) Homo sapiens (Human) GO:0001968; GO:0004252; GO:0004866; GO:0005576; GO:0006508; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0034185; GO:0034358 blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma lipoprotein particle [GO:0034358] apolipoprotein binding [GO:0034185]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252] g14702.t1 B4E2M5 44.444 189 5.32e-47 156.0 sp|B4E2M5|ANR66_HUMAN Ankyrin repeat domain-containing protein 66 OS=Homo sapiens OX=9606 GN=ANKRD66 PE=1 SV=3 g14703.t1 Q9Y450 59.704 541 0.0 661.0 sp|Q9Y450|HBS1L_HUMAN HBS1-like protein OS=Homo sapiens OX=9606 GN=HBS1L PE=1 SV=1 HBS1L_HUMAN reviewed HBS1-like protein (EC 3.6.5.-) (ERFS) Homo sapiens (Human) GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006417; GO:0007165; GO:0016020; GO:0022626; GO:0032790; GO:0070062; GO:0070966; GO:0072344; GO:1990533 nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; signal transduction [GO:0007165]; translation [GO:0006412] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Dom34-Hbs1 complex [GO:1990533]; extracellular exosome [GO:0070062]; membrane [GO:0016020] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746] g14703.t1 Q9Y450 33.649 211 9.069999999999999e-23 108.0 sp|Q9Y450|HBS1L_HUMAN HBS1-like protein OS=Homo sapiens OX=9606 GN=HBS1L PE=1 SV=1 HBS1L_HUMAN reviewed HBS1-like protein (EC 3.6.5.-) (ERFS) Homo sapiens (Human) GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0006417; GO:0007165; GO:0016020; GO:0022626; GO:0032790; GO:0070062; GO:0070966; GO:0072344; GO:1990533 nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; signal transduction [GO:0007165]; translation [GO:0006412] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; Dom34-Hbs1 complex [GO:1990533]; extracellular exosome [GO:0070062]; membrane [GO:0016020] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746] g14704.t1 Q502M6 48.754 281 5.89e-84 257.0 sp|Q502M6|ANR29_DANRE Ankyrin repeat domain-containing protein 29 OS=Danio rerio OX=7955 GN=ankrd29 PE=2 SV=1 g14705.t1 Q5RDW0 62.136 206 1.85e-94 278.0 sp|Q5RDW0|FAHD1_PONAB Oxaloacetate tautomerase FAHD1, mitochondrial OS=Pongo abelii OX=9601 GN=FAHD1 PE=2 SV=2 FAHD1_PONAB reviewed Oxaloacetate tautomerase FAHD1, mitochondrial (EC 5.3.2.2) (Acylpyruvase FAHD1) (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005739; GO:0005829; GO:0006107; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621; GO:0050163 oxaloacetate metabolic process [GO:0006107] cytosol [GO:0005829]; mitochondrion [GO:0005739] acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; oxaloacetate tautomerase activity [GO:0050163] g14706.t1 P11926 44.557 395 3.2299999999999997e-115 348.0 sp|P11926|DCOR_HUMAN Ornithine decarboxylase OS=Homo sapiens OX=9606 GN=ODC1 PE=1 SV=2 DCOR_HUMAN reviewed Ornithine decarboxylase (ODC) (EC 4.1.1.17) Homo sapiens (Human) GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803 cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829] ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803] g14707.t1 P27117 44.986 349 8.54e-101 308.0 sp|P27117|DCOR_BOVIN Ornithine decarboxylase OS=Bos taurus OX=9913 GN=ODC1 PE=2 SV=1 g14710.t1 Q8BYF6 47.849 558 0.0 535.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g14711.t1 Q8N695 47.176 602 0.0 541.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g14712.t1 Q8BYF6 48.479 559 0.0 543.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g14712.t2 Q8N695 45.861 604 0.0 550.0 sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2 SC5A8_HUMAN reviewed Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) Homo sapiens (Human) GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0090416; GO:0140161; GO:0160081; GO:1901847; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate metabolic process [GO:1901847]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886] iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552] g14714.t1 F7J220 84.039 1134 0.0 1942.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g14715.t1 P05480 56.167 527 0.0 598.0 sp|P05480|SRC_MOUSE Proto-oncogene tyrosine-protein kinase Src OS=Mus musculus OX=10090 GN=Src PE=1 SV=5 g14716.t1 Q7Z020 40.62 1162 0.0 805.0 sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4 g14717.t1 Q0VCH8 54.802 177 4.03e-59 190.0 sp|Q0VCH8|TMM65_BOVIN Transmembrane protein 65 OS=Bos taurus OX=9913 GN=TMEM65 PE=2 SV=1 g14718.t1 A8WYE4 34.694 196 1.32e-27 124.0 sp|A8WYE4|PAR1_CAEBR Serine/threonine-protein kinase par-1 OS=Caenorhabditis briggsae OX=6238 GN=par-1 PE=3 SV=1 g14720.t1 Q9Y2K2 44.118 136 1.94e-30 117.0 sp|Q9Y2K2|SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens OX=9606 GN=SIK3 PE=1 SV=4 g14722.t1 P40650 38.786 379 4.91e-56 191.0 sp|P40650|SX11B_XENLA Transcription factor Sox-11-B OS=Xenopus laevis OX=8355 GN=sox11-b PE=1 SV=2 g14727.t1 Q9D0K1 50.765 327 9.529999999999999e-104 318.0 sp|Q9D0K1|PEX13_MOUSE Peroxisomal membrane protein PEX13 OS=Mus musculus OX=10090 GN=Pex13 PE=1 SV=1 PEX13_MOUSE reviewed Peroxisomal membrane protein PEX13 (Peroxin-13) Mus musculus (Mouse) GO:0000268; GO:0001561; GO:0001764; GO:0001967; GO:0005777; GO:0005778; GO:0007626; GO:0008320; GO:0016558; GO:0016560; GO:0016561; GO:0016562; GO:0021795; GO:0034614; GO:0043335; GO:0060152; GO:1990429 cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, translocation [GO:0016561]; protein unfolding [GO:0043335]; suckling behavior [GO:0001967] peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] peroxisome targeting sequence binding [GO:0000268]; protein transmembrane transporter activity [GO:0008320] g14729.t1 Q64680 34.2 500 1.15e-91 291.0 sp|Q64680|CP2D4_RAT Cytochrome P450 2D4 OS=Rattus norvegicus OX=10116 GN=Cyp2d4 PE=2 SV=1 CP2D4_RAT reviewed Cytochrome P450 2D4 (EC 1.14.14.1) (CYPIID18) (CYPIID4) (Cytochrome P450 2D-29) (Cytochrome P450 2D-35) (Cytochrome P450 2D18) (Cytochrome P450-CMF3) (Cytochrome P450-DB4) (Debrisoquine 4-hydroxylase) Rattus norvegicus (Rat) GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005789; GO:0006587; GO:0006805; GO:0007565; GO:0008202; GO:0008207; GO:0008210; GO:0008391; GO:0009804; GO:0009820; GO:0009822; GO:0016098; GO:0016491; GO:0016712; GO:0019369; GO:0020037; GO:0033076; GO:0042178; GO:0042416; GO:0042417; GO:0042572; GO:0062187; GO:0062188; GO:0062189; GO:0070989; GO:0090350; GO:0106309; GO:1901424 alkaloid catabolic process [GO:0009822]; alkaloid metabolic process [GO:0009820]; arachidonate metabolic process [GO:0019369]; C21-steroid hormone metabolic process [GO:0008207]; coumarin metabolic process [GO:0009804]; dopamine biosynthetic process [GO:0042416]; dopamine metabolic process [GO:0042417]; estrogen metabolic process [GO:0008210]; female pregnancy [GO:0007565]; isoquinoline alkaloid metabolic process [GO:0033076]; monoterpenoid metabolic process [GO:0016098]; negative regulation of organofluorine metabolic process [GO:0090350]; oxidative demethylation [GO:0070989]; response to toluene [GO:1901424]; retinol metabolic process [GO:0042572]; serotonin biosynthetic process from tryptophan [GO:0006587]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739] anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonate monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; progesterone 21-hydroxylase activity [GO:0106309] g14730.t1 P97292 30.62 258 3.99e-23 102.0 sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 HRH2_MOUSE reviewed Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I) Mus musculus (Mouse) GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:1900139; GO:1901363 chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] g14731.t1 Q9P2K1 44.629 1685 0.0 1339.0 sp|Q9P2K1|C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens OX=9606 GN=CC2D2A PE=1 SV=3 C2D2A_HUMAN reviewed Coiled-coil and C2 domain-containing protein 2A Homo sapiens (Human) GO:0001822; GO:0001843; GO:0005829; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403 axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; MKS complex [GO:0036038] g14732.t1 B1AT66 23.956 455 9.24e-24 108.0 sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1 g14734.t1 Q3TYL0 38.621 145 4.82e-26 107.0 sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3 g14735.t1 Q9NZJ4 26.119 536 5.51e-37 150.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t1 Q9NZJ4 29.712 3443 0.0 1315.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t1 Q9NZJ4 33.333 246 2.9400000000000004e-27 127.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t2 Q9NZJ4 28.239 2840 0.0 971.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t2 Q9NZJ4 39.754 488 3.18e-89 331.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t2 Q9NZJ4 31.524 479 7.63e-44 181.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t2 Q9NZJ4 29.58 524 2.21e-39 167.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t2 Q9NZJ4 29.454 421 1.0099999999999999e-38 164.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14737.t2 Q9NZJ4 36.905 168 7.32e-22 108.0 sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2 g14738.t1 Q3TYL0 44.872 546 2.3599999999999997e-140 421.0 sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3 g14738.t2 Q3TYL0 44.587 545 3.87e-141 422.0 sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3 g14739.t1 Q08BL9 32.99 582 5.65e-96 309.0 sp|Q08BL9|KL24A_DANRE Kelch-like protein 24a OS=Danio rerio OX=7955 GN=klhl24a PE=2 SV=1 g14740.t1 Q3TIW9 37.727 440 1.36e-94 295.0 sp|Q3TIW9|ENPP7_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Mus musculus OX=10090 GN=Enpp7 PE=1 SV=1 ENPP7_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Mus musculus (Mouse) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0006685; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g14741.t1 Q3TIW9 38.164 414 3.82e-83 266.0 sp|Q3TIW9|ENPP7_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Mus musculus OX=10090 GN=Enpp7 PE=1 SV=1 ENPP7_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Mus musculus (Mouse) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0006685; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g14742.t1 Q80ZW0 32.895 228 8.87e-29 120.0 sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3 STK35_MOUSE reviewed Serine/threonine-protein kinase 35 (Serine/threonine-protein kinase 35 L1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0010972; GO:0016604; GO:0106310; GO:0110031 negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g14743.t1 Q8QZR7 35.321 218 1.52e-33 129.0 sp|Q8QZR7|PDK1L_MOUSE Serine/threonine-protein kinase PDIK1L OS=Mus musculus OX=10090 GN=Pdik1l PE=2 SV=1 g14747.t1 Q80ZW0 30.655 336 5.88e-37 143.0 sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3 STK35_MOUSE reviewed Serine/threonine-protein kinase 35 (Serine/threonine-protein kinase 35 L1) (EC 2.7.11.1) Mus musculus (Mouse) GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0010972; GO:0016604; GO:0106310; GO:0110031 negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g14748.t1 Q3TIW9 37.387 444 3.16e-90 283.0 sp|Q3TIW9|ENPP7_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Mus musculus OX=10090 GN=Enpp7 PE=1 SV=1 ENPP7_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Mus musculus (Mouse) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0006685; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g14750.t1 Q3TIW9 47.059 102 6.55e-23 95.5 sp|Q3TIW9|ENPP7_MOUSE Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Mus musculus OX=10090 GN=Enpp7 PE=1 SV=1 ENPP7_MOUSE reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Mus musculus (Mouse) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0006685; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g14751.t1 Q6UWV6 37.791 172 4.52e-31 120.0 sp|Q6UWV6|ENPP7_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Homo sapiens OX=9606 GN=ENPP7 PE=1 SV=4 ENPP7_HUMAN reviewed Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase) Homo sapiens (Human) GO:0004767; GO:0005794; GO:0005886; GO:0005902; GO:0006684; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0016020; GO:0044241; GO:0045797; GO:0046479; GO:0055089; GO:1904729; GO:2000304; GO:2000755 fatty acid homeostasis [GO:0055089]; glycosphingolipid catabolic process [GO:0046479]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] g14752.t1 P24032 82.558 172 5.31e-100 288.0 sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2 g14753.t1 Q13946 48.347 484 2.6e-147 447.0 sp|Q13946|PDE7A_HUMAN High affinity 3',5'-cyclic-AMP phosphodiesterase 7A OS=Homo sapiens OX=9606 GN=PDE7A PE=1 SV=2 PDE7A_HUMAN reviewed High affinity 3',5'-cyclic-AMP phosphodiesterase 7A (EC 3.1.4.53) (HCP1) (TM22) (cAMP-specific phosphodiesterase 7A) Homo sapiens (Human) GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0046872; GO:0047555; GO:0141162 cAMP catabolic process [GO:0006198]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; signal transduction [GO:0007165] cytosol [GO:0005829] 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872] g14753.t2 P70453 47.26 438 4.28e-131 402.0 sp|P70453|PDE7A_MOUSE High affinity 3',5'-cyclic-AMP phosphodiesterase 7A OS=Mus musculus OX=10090 GN=Pde7a PE=1 SV=2 g14755.t1 Q08BD8 34.656 378 5.27e-31 124.0 sp|Q08BD8|MTRF2_DANRE Mitochondrial fission regulator 2 OS=Danio rerio OX=7955 GN=mtfr2 PE=2 SV=1 g14756.t1 Q9D7A8 46.043 278 1.63e-82 252.0 sp|Q9D7A8|ARMC1_MOUSE Armadillo repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Armc1 PE=1 SV=1 g14757.t1 Q13347 65.123 324 1.53e-162 459.0 sp|Q13347|EIF3I_HUMAN Eukaryotic translation initiation factor 3 subunit I OS=Homo sapiens OX=9606 GN=EIF3I PE=1 SV=1 g14759.t1 B9EJV3 40.406 1871 0.0 1266.0 sp|B9EJV3|GRB1L_MOUSE GREB1-like protein OS=Mus musculus OX=10090 GN=Greb1l PE=2 SV=1 GRB1L_MOUSE reviewed GREB1-like protein Mus musculus (Mouse) GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0060562; GO:0061205; GO:0072177 branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; epithelial tube morphogenesis [GO:0060562]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065] membrane [GO:0016020] g14760.t1 P09669 52.857 70 2.51e-21 82.4 sp|P09669|COX6C_HUMAN Cytochrome c oxidase subunit 6C OS=Homo sapiens OX=9606 GN=COX6C PE=1 SV=2 COX6C_HUMAN reviewed Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide VIc) Homo sapiens (Human) GO:0005739; GO:0005743; GO:0005758; GO:0006091; GO:0006123; GO:0031966; GO:0045277; GO:0045333 cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277] g14761.t1 P85107 41.065 526 1.16e-106 345.0 sp|P85107|TGS1_RAT Trimethylguanosine synthase OS=Rattus norvegicus OX=10116 GN=Tgs1 PE=1 SV=1 TGS1_RAT reviewed Trimethylguanosine synthase (EC 2.1.1.-) (Cap-specific guanine-N(2) methyltransferase) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT) Rattus norvegicus (Rat) GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0015030; GO:0036261; GO:0042308; GO:0061178; GO:0071164; GO:0071333; GO:0071398 7-methylguanosine cap hypermethylation [GO:0036261]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; negative regulation of protein import into nucleus [GO:0042308]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] RNA cap trimethylguanosine synthase activity [GO:0071164] g14767.t1 Q8AWH3 70.435 115 7.98e-49 175.0 sp|Q8AWH3|SX17A_XENTR Transcription factor Sox-17-alpha OS=Xenopus tropicalis OX=8364 GN=sox17a PE=2 SV=1 g14768.t1 Q5IFK1 35.959 292 2.73e-41 167.0 sp|Q5IFK1|MCPH1_MACFA Microcephalin OS=Macaca fascicularis OX=9541 GN=MCPH1 PE=2 SV=1 g14768.t2 Q5IFK1 35.959 292 6.23e-41 166.0 sp|Q5IFK1|MCPH1_MACFA Microcephalin OS=Macaca fascicularis OX=9541 GN=MCPH1 PE=2 SV=1 g14769.t1 Q9Y6A2 39.787 470 1.64e-117 358.0 sp|Q9Y6A2|CP46A_HUMAN Cholesterol 24-hydroxylase OS=Homo sapiens OX=9606 GN=CYP46A1 PE=1 SV=1 CP46A_HUMAN reviewed Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1) Homo sapiens (Human) GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044 bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793] cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649] g14770.t1 O43491 69.972 353 0.0 553.0 sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1 E41L2_HUMAN reviewed Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778 actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091] actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198] g14770.t2 Q6Q7P4 50.238 629 0.0 576.0 sp|Q6Q7P4|EPB41_CANLF Protein 4.1 OS=Canis lupus familiaris OX=9615 GN=EPB41 PE=2 SV=1 g14770.t3 O43491 69.972 353 0.0 553.0 sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1 E41L2_HUMAN reviewed Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778 actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091] actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198] g14770.t4 O43491 69.972 353 0.0 553.0 sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1 E41L2_HUMAN reviewed Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778 actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091] actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198] g14770.t5 O43491 69.972 353 0.0 553.0 sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1 E41L2_HUMAN reviewed Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G) Homo sapiens (Human) GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778 actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091] actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198] g14771.t1 O70511 31.652 793 3.9e-88 324.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t1 O70511 29.8 802 6.960000000000001e-80 297.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t1 O70511 29.06 819 6.66e-78 291.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t1 O70511 30.486 761 8.93e-74 277.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t1 O70511 28.793 837 1.93e-72 273.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t1 O70511 29.803 557 2.8199999999999996e-45 184.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t2 O70511 31.652 793 2.56e-88 324.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t2 O70511 29.06 819 3.5e-78 291.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t2 O70511 29.899 796 2.75e-77 288.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t2 O70511 28.793 837 9.060000000000001e-73 274.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14771.t2 O70511 29.803 557 1.94e-45 185.0 sp|O70511|ANK3_RAT Ankyrin-3 OS=Rattus norvegicus OX=10116 GN=Ank3 PE=1 SV=3 ANK3_RAT reviewed Ankyrin-3 (ANK-3) (Ankyrin-G) Rattus norvegicus (Rat) GO:0000281; GO:0005200; GO:0005634; GO:0005764; GO:0005856; GO:0005886; GO:0005923; GO:0006357; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0035902; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0061629; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0098794; GO:0098978; GO:0099103; GO:0099159; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1903784; GO:1904115 anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment of protein localization [GO:0045184]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion import across plasma membrane [GO:1903784]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; regulation of transcription by RNA polymerase II [GO:0006357]; response to immobilization stress [GO:0035902]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; phosphorylation-dependent protein binding [GO:0140031]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] g14772.t1 Q8N3Y7 51.77 226 4.7400000000000005e-79 243.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g14773.t1 Q8N3Y7 47.619 294 2.67e-91 276.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g14774.t1 Q8N3Y7 46.599 294 1.9899999999999997e-89 271.0 sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2 RDHE2_HUMAN reviewed Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297 keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] g14775.t1 Q6NTW5 43.195 169 3.5200000000000003e-29 114.0 sp|Q6NTW5|IMPA3_XENLA Inositol monophosphatase 3 OS=Xenopus laevis OX=8355 GN=bpnt2 PE=2 SV=1 g14778.t1 R9UTQ8 29.508 244 6.02e-24 100.0 sp|R9UTQ8|PROHY_STRGD L-proline trans-4-hydroxylase OS=Streptomyces griseoviridis OX=45398 PE=1 SV=1 g14780.t1 Q9UGT4 31.325 332 1.0599999999999999e-34 138.0 sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1 SUSD2_HUMAN reviewed Sushi domain-containing protein 2 Homo sapiens (Human) GO:0005615; GO:0005886; GO:0051782; GO:0070062; GO:1902807 negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] g14781.t1 Q9UGT4 28.917 785 1.91e-72 262.0 sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1 SUSD2_HUMAN reviewed Sushi domain-containing protein 2 Homo sapiens (Human) GO:0005615; GO:0005886; GO:0051782; GO:0070062; GO:1902807 negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] g14782.t1 A6QLU6 36.957 368 3.7300000000000004e-64 239.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g14782.t2 A6QLU6 36.856 369 4.98e-64 239.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g14784.t1 Q17QQ2 41.096 219 7.860000000000001e-58 186.0 sp|Q17QQ2|TPMT_BOVIN Thiopurine S-methyltransferase OS=Bos taurus OX=9913 GN=TPMT PE=2 SV=1 TPMT_BOVIN reviewed Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase) Bos taurus (Bovine) GO:0005737; GO:0006805; GO:0008119; GO:0032259; GO:1904047 methylation [GO:0032259]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737] S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119] g14785.t1 Q17QQ2 42.466 219 9.87e-59 190.0 sp|Q17QQ2|TPMT_BOVIN Thiopurine S-methyltransferase OS=Bos taurus OX=9913 GN=TPMT PE=2 SV=1 TPMT_BOVIN reviewed Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase) Bos taurus (Bovine) GO:0005737; GO:0006805; GO:0008119; GO:0032259; GO:1904047 methylation [GO:0032259]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737] S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119] g14786.t1 Q66HE2 24.099 444 2.5000000000000002e-29 124.0 sp|Q66HE2|MOT13_RAT Monocarboxylate transporter 13 OS=Rattus norvegicus OX=10116 GN=Slc16a13 PE=2 SV=1 g14787.t1 Q7ZU90 52.78 1025 0.0 1004.0 sp|Q7ZU90|CHD1L_DANRE Chromodomain-helicase-DNA-binding protein 1-like OS=Danio rerio OX=7955 GN=chd1l PE=2 SV=1 CHD1L_DANRE reviewed ATP-dependent chromatin remodeler CHD1l (EC 3.6.4.-) (Chromo domain-containing protein 1-like) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0006281; GO:0006338; GO:0006974; GO:0007420; GO:0016887; GO:0031491; GO:0035861; GO:0140566; GO:0140658; GO:0160004 brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281] nucleus [GO:0005634]; site of double-strand break [GO:0035861] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; histone reader activity [GO:0140566]; nucleosome binding [GO:0031491]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004] g14788.t1 Q9I922 48.649 296 6.72e-101 300.0 sp|Q9I922|RGN_XENLA Regucalcin OS=Xenopus laevis OX=8355 GN=rgn PE=2 SV=1 g14789.t1 Q9I922 43.098 297 4.02e-86 263.0 sp|Q9I922|RGN_XENLA Regucalcin OS=Xenopus laevis OX=8355 GN=rgn PE=2 SV=1 g14790.t1 Q3UVG3 60.256 858 0.0 1011.0 sp|Q3UVG3|F91A1_MOUSE Protein FAM91A1 OS=Mus musculus OX=10090 GN=Fam91a1 PE=1 SV=1 g14790.t2 Q3UVG3 60.824 850 0.0 1017.0 sp|Q3UVG3|F91A1_MOUSE Protein FAM91A1 OS=Mus musculus OX=10090 GN=Fam91a1 PE=1 SV=1 g14791.t1 Q9VR81 29.213 356 2.96e-23 103.0 sp|Q9VR81|NAGA_DROME N-acetylglucosamine-6-phosphate deacetylase OS=Drosophila melanogaster OX=7227 GN=CG17065 PE=2 SV=1 g14792.t1 Q92113 35.363 509 9.39e-104 323.0 sp|Q92113|CP17A_SQUAC Steroid 17-alpha-hydroxylase/17,20 lyase OS=Squalus acanthias OX=7797 GN=CYP17A1 PE=2 SV=1 g14793.t1 Q5RDY2 59.815 647 0.0 801.0 sp|Q5RDY2|TM9S4_PONAB Transmembrane 9 superfamily member 4 OS=Pongo abelii OX=9601 GN=TM9SF4 PE=2 SV=1 g14794.t1 P23403 87.179 117 6.19e-70 208.0 sp|P23403|RS20_XENLA Small ribosomal subunit protein uS10 OS=Xenopus laevis OX=8355 GN=rps20 PE=1 SV=1 g14795.t1 Q8BJA3 32.713 376 4.68e-44 162.0 sp|Q8BJA3|HMBX1_MOUSE Homeobox-containing protein 1 OS=Mus musculus OX=10090 GN=Hmbox1 PE=1 SV=1 HMBX1_MOUSE reviewed Homeobox-containing protein 1 Mus musculus (Mouse) GO:0000122; GO:0000781; GO:0003691; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0007004; GO:0015030; GO:0016604; GO:0016605; GO:0042162; GO:0042802; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:1905324; GO:1990837 negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; telomere maintenance via telomerase [GO:0007004]; telomere-telomerase complex assembly [GO:1905324] Cajal body [GO:0015030]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; telomeric DNA binding [GO:0042162] g14796.t1 Q9NWZ5 69.087 482 0.0 690.0 sp|Q9NWZ5|UCKL1_HUMAN Uridine-cytidine kinase-like 1 OS=Homo sapiens OX=9606 GN=UCKL1 PE=1 SV=2 g14797.t1 Q40082 54.751 442 2.71e-177 508.0 sp|Q40082|XYLA_HORVU Xylose isomerase OS=Hordeum vulgare OX=4513 GN=XYLA PE=1 SV=1 g14799.t1 Q922Q5 61.696 342 9.76e-143 412.0 sp|Q922Q5|S35B3_MOUSE Adenosine 3'-phospho 5'-phosphosulfate transporter 2 OS=Mus musculus OX=10090 GN=Slc35b3 PE=2 SV=1 g14800.t1 Q14534 62.741 467 0.0 630.0 sp|Q14534|ERG1_HUMAN Squalene monooxygenase OS=Homo sapiens OX=9606 GN=SQLE PE=1 SV=3 ERG1_HUMAN reviewed Squalene monooxygenase (EC 1.14.14.17) (Squalene epoxidase) (SE) Homo sapiens (Human) GO:0004506; GO:0005783; GO:0005789; GO:0006695; GO:0016020; GO:0016126; GO:0042127; GO:0043231; GO:0071949; GO:0140042; GO:1904614 cholesterol biosynthetic process [GO:0006695]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to biphenyl [GO:1904614]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506] g14801.t1 Q5ZHS1 86.314 548 0.0 1009.0 sp|Q5ZHS1|ELP3_CHICK Elongator complex protein 3 OS=Gallus gallus OX=9031 GN=ELP3 PE=2 SV=1 ELP3_CHICK reviewed Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase) Gallus gallus (Chicken) GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0006357; GO:0033588; GO:0046872; GO:0051539; GO:0106261 regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634] 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261] g14803.t1 Q9BXY4 46.471 170 5.8800000000000005e-56 186.0 sp|Q9BXY4|RSPO3_HUMAN R-spondin-3 OS=Homo sapiens OX=9606 GN=RSPO3 PE=1 SV=1 RSPO3_HUMAN reviewed R-spondin-3 (Protein with TSP type-1 repeat) (hPWTSR) (Roof plate-specific spondin-3) (hRspo3) (Thrombospondin type-1 domain-containing protein 2) Homo sapiens (Human) GO:0001974; GO:0002040; GO:0005102; GO:0005109; GO:0005576; GO:0005615; GO:0008201; GO:0030177; GO:0060070; GO:0060670; GO:0090263; GO:2000052; GO:2000096 blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040] extracellular region [GO:0005576]; extracellular space [GO:0005615] frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] g14804.t1 Q6DIV6 46.293 499 1.33e-152 448.0 sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1 VIAAT_XENTR reviewed Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0001762; GO:0003333; GO:0005774; GO:0006836; GO:0008021; GO:0015179; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0051939; GO:0060077; GO:0098793; GO:0140799; GO:0140800 amino acid transmembrane transport [GO:0003333]; beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836] cytoplasmic vesicle membrane [GO:0030659]; inhibitory synapse [GO:0060077]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774] gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799]; L-amino acid transmembrane transporter activity [GO:0015179] g14806.t1 P34024 31.01 287 3.02e-33 126.0 sp|P34024|PLC_LISMO 1-phosphatidylinositol phosphodiesterase OS=Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) OX=169963 GN=plcA PE=1 SV=1 g14807.t1 Q8BGC3 24.138 435 2.4299999999999997e-24 109.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g14809.t1 P56719 42.391 368 3.0899999999999996e-95 296.0 sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 OX2R_RAT reviewed Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2) Rattus norvegicus (Rat) GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0040011; GO:0042593; GO:0051480 cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046] g14809.t2 P56719 41.713 362 2.6e-89 282.0 sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 OX2R_RAT reviewed Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2) Rattus norvegicus (Rat) GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0040011; GO:0042593; GO:0051480 cellular response to hormone stimulus [GO:0032870]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046] g14810.t1 Q1MSJ5 28.62 884 1.93e-49 196.0 sp|Q1MSJ5|CSPP1_HUMAN Centrosome and spindle pole-associated protein 1 OS=Homo sapiens OX=9606 GN=CSPP1 PE=1 SV=4 CSPP1_HUMAN reviewed Centrosome and spindle pole-associated protein 1 Homo sapiens (Human) GO:0000922; GO:0005654; GO:0005813; GO:0005819; GO:0005874; GO:0005929; GO:0032467; GO:0034451; GO:0036064; GO:0051781 positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922] g14810.t2 Q1MSJ5 28.733 884 2.37e-50 196.0 sp|Q1MSJ5|CSPP1_HUMAN Centrosome and spindle pole-associated protein 1 OS=Homo sapiens OX=9606 GN=CSPP1 PE=1 SV=4 CSPP1_HUMAN reviewed Centrosome and spindle pole-associated protein 1 Homo sapiens (Human) GO:0000922; GO:0005654; GO:0005813; GO:0005819; GO:0005874; GO:0005929; GO:0032467; GO:0034451; GO:0036064; GO:0051781 positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922] g14810.t3 Q1MSJ5 28.636 887 3.24e-50 195.0 sp|Q1MSJ5|CSPP1_HUMAN Centrosome and spindle pole-associated protein 1 OS=Homo sapiens OX=9606 GN=CSPP1 PE=1 SV=4 CSPP1_HUMAN reviewed Centrosome and spindle pole-associated protein 1 Homo sapiens (Human) GO:0000922; GO:0005654; GO:0005813; GO:0005819; GO:0005874; GO:0005929; GO:0032467; GO:0034451; GO:0036064; GO:0051781 positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922] g14813.t1 Q6UPE0 66.547 556 0.0 772.0 sp|Q6UPE0|CHDH_RAT Choline dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Chdh PE=1 SV=1 g14814.t1 Q8BGC3 24.886 438 2.69e-23 105.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g14816.t1 A0MSJ1 40.582 722 6.68e-74 270.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14816.t1 A0MSJ1 39.286 812 6.94e-71 261.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14816.t1 A0MSJ1 40.574 732 1.99e-65 244.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14816.t1 A0MSJ1 40.0 700 1.2600000000000001e-64 242.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14816.t1 A0MSJ1 39.911 674 1.32e-62 235.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14816.t1 A0MSJ1 39.696 592 5.76e-44 177.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14816.t1 A0MSJ1 35.874 761 1.12e-43 176.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14816.t1 A0MSJ1 39.122 501 2.02e-37 156.0 sp|A0MSJ1|CRA1B_DANRE Collagen alpha-1(XXVII) chain B OS=Danio rerio OX=7955 GN=col27a1b PE=2 SV=1 CRA1B_DANRE reviewed Collagen alpha-1(XXVII) chain B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0001501; GO:0005594; GO:0030020; GO:0030282; GO:0031012; GO:0046872; GO:0048570 bone mineralization [GO:0030282]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; extracellular matrix [GO:0031012] extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] g14817.t1 Q501Q9 50.997 602 0.0 563.0 sp|Q501Q9|MK15_XENLA Mitogen-activated protein kinase 15 OS=Xenopus laevis OX=8355 GN=mapk15 PE=1 SV=1 MK15_XENLA reviewed Mitogen-activated protein kinase 15 (EC 2.7.11.24) Xenopus laevis (African clawed frog) GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005911; GO:0005929; GO:0035253; GO:0035556; GO:0036064; GO:0106310; GO:1902017 intracellular signal transduction [GO:0035556]; regulation of cilium assembly [GO:1902017] cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g14817.t2 Q501Q9 52.332 579 0.0 568.0 sp|Q501Q9|MK15_XENLA Mitogen-activated protein kinase 15 OS=Xenopus laevis OX=8355 GN=mapk15 PE=1 SV=1 MK15_XENLA reviewed Mitogen-activated protein kinase 15 (EC 2.7.11.24) Xenopus laevis (African clawed frog) GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005911; GO:0005929; GO:0035253; GO:0035556; GO:0036064; GO:0106310; GO:1902017 intracellular signal transduction [GO:0035556]; regulation of cilium assembly [GO:1902017] cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g14818.t1 O95677 51.351 703 0.0 616.0 sp|O95677|EYA4_HUMAN Protein phosphatase EYA4 OS=Homo sapiens OX=9606 GN=EYA4 PE=1 SV=2 EYA4_HUMAN reviewed Protein phosphatase EYA4 (EC 3.1.3.48) (Eyes absent homolog 4) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005737; GO:0006281; GO:0006325; GO:0007601; GO:0009653; GO:0030154; GO:0045739; GO:0046872; GO:0048839; GO:2001240 anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; inner ear development [GO:0048839]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; visual perception [GO:0007601] cytoplasm [GO:0005737]; nucleus [GO:0005634] metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] g14818.t2 O95677 51.868 696 0.0 620.0 sp|O95677|EYA4_HUMAN Protein phosphatase EYA4 OS=Homo sapiens OX=9606 GN=EYA4 PE=1 SV=2 EYA4_HUMAN reviewed Protein phosphatase EYA4 (EC 3.1.3.48) (Eyes absent homolog 4) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005737; GO:0006281; GO:0006325; GO:0007601; GO:0009653; GO:0030154; GO:0045739; GO:0046872; GO:0048839; GO:2001240 anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; inner ear development [GO:0048839]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; visual perception [GO:0007601] cytoplasm [GO:0005737]; nucleus [GO:0005634] metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] g14818.t3 O95677 51.942 695 0.0 624.0 sp|O95677|EYA4_HUMAN Protein phosphatase EYA4 OS=Homo sapiens OX=9606 GN=EYA4 PE=1 SV=2 EYA4_HUMAN reviewed Protein phosphatase EYA4 (EC 3.1.3.48) (Eyes absent homolog 4) Homo sapiens (Human) GO:0004725; GO:0005634; GO:0005737; GO:0006281; GO:0006325; GO:0007601; GO:0009653; GO:0030154; GO:0045739; GO:0046872; GO:0048839; GO:2001240 anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; inner ear development [GO:0048839]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; visual perception [GO:0007601] cytoplasm [GO:0005737]; nucleus [GO:0005634] metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] g14818.t4 P97767 54.89 634 0.0 626.0 sp|P97767|EYA1_MOUSE Protein phosphatase EYA1 OS=Mus musculus OX=10090 GN=Eya1 PE=1 SV=3 EYA1_MOUSE reviewed Protein phosphatase EYA1 (EC 3.1.3.16) (EC 3.1.3.48) (Eyes absent homolog 1) Mus musculus (Mouse) GO:0001656; GO:0001657; GO:0001658; GO:0003151; GO:0003723; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0007389; GO:0007501; GO:0009887; GO:0010212; GO:0014706; GO:0016604; GO:0016925; GO:0030154; GO:0032991; GO:0032993; GO:0035909; GO:0042472; GO:0042473; GO:0042474; GO:0045165; GO:0045664; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0048665; GO:0048704; GO:0048752; GO:0050679; GO:0060037; GO:0071599; GO:0071600; GO:0072513; GO:0090103; GO:0140793; GO:2001240 animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; inner ear morphogenesis [GO:0042472]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle development [GO:0071599]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; striated muscle tissue development [GO:0014706]; ureteric bud development [GO:0001657] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993] histone H2AXY142 phosphatase activity [GO:0140793]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723] g14822.t1 Q66HB5 41.787 828 0.0 637.0 sp|Q66HB5|RS10B_RAT Radial spoke head 10 homolog B OS=Rattus norvegicus OX=10116 GN=Rsph10b PE=2 SV=1 g14823.t1 Q5M7F8 48.201 139 2.21e-47 155.0 sp|Q5M7F8|CM2CA_XENLA Ciliary microtubule inner protein 2C OS=Xenopus laevis OX=8355 GN=cimip2ca PE=2 SV=1 g14827.t1 Q91287 47.945 292 3.32e-83 280.0 sp|Q91287|FGFR3_PLEWA Fibroblast growth factor receptor 3 OS=Pleurodeles waltl OX=8319 GN=FGFR3 PE=2 SV=1 FGFR3_PLEWA reviewed Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (PFR3) Pleurodeles waltl (Iberian ribbed newt) GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0017134; GO:0043235; GO:0043410 apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007] g14827.t2 Q91287 47.945 292 3.53e-83 280.0 sp|Q91287|FGFR3_PLEWA Fibroblast growth factor receptor 3 OS=Pleurodeles waltl OX=8319 GN=FGFR3 PE=2 SV=1 FGFR3_PLEWA reviewed Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (PFR3) Pleurodeles waltl (Iberian ribbed newt) GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0017134; GO:0043235; GO:0043410 apoptotic process [GO:0006915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410] plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007] g14830.t1 P27117 41.626 406 1.8399999999999998e-104 320.0 sp|P27117|DCOR_BOVIN Ornithine decarboxylase OS=Bos taurus OX=9913 GN=ODC1 PE=2 SV=1 g14831.t1 Q5SPP5 48.329 838 0.0 761.0 sp|Q5SPP5|EFR3B_DANRE Protein EFR3 homolog B OS=Danio rerio OX=7955 GN=efr3b PE=3 SV=2 g14834.t1 M0R3Q7 42.405 158 1.2e-34 134.0 sp|M0R3Q7|PTHD3_RAT Patched domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Ptchd3 PE=1 SV=1 g14835.t1 Q0EEE2 35.018 277 1e-52 189.0 sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1 PTHD3_MOUSE reviewed Patched domain-containing protein 3 (RND-type protein RNDEu-3) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0016020; GO:0097225 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; sperm midpiece [GO:0097225] g14836.t1 Q8K4R9 30.075 532 8.62e-40 162.0 sp|Q8K4R9|DLGP5_MOUSE Disks large-associated protein 5 OS=Mus musculus OX=10090 GN=Dlgap5 PE=1 SV=2 DLGP5_MOUSE reviewed Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein homolog) (HURP) Mus musculus (Mouse) GO:0005634; GO:0005737; GO:0005829; GO:0007052; GO:0007059; GO:0007346; GO:0008017; GO:0023052; GO:0031616; GO:0051382; GO:0051642; GO:0072686 centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616] microtubule binding [GO:0008017] g14837.t1 Q8R3N6 49.462 651 0.0 576.0 sp|Q8R3N6|THOC1_MOUSE THO complex subunit 1 OS=Mus musculus OX=10090 GN=Thoc1 PE=1 SV=1 THOC1_MOUSE reviewed THO complex subunit 1 (Nuclear matrix protein p84) Mus musculus (Mouse) GO:0000346; GO:0000347; GO:0000445; GO:0000781; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0042802 apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; signal transduction [GO:0007165] chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] g14838.t1 Q9BZC7 50.882 340 3.13e-105 343.0 sp|Q9BZC7|ABCA2_HUMAN ATP-binding cassette sub-family A member 2 OS=Homo sapiens OX=9606 GN=ABCA2 PE=1 SV=4 g14838.t1 Q9BZC7 32.576 264 9.7e-41 157.0 sp|Q9BZC7|ABCA2_HUMAN ATP-binding cassette sub-family A member 2 OS=Homo sapiens OX=9606 GN=ABCA2 PE=1 SV=4 g14839.t1 P41233 32.386 1760 0.0 802.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g14839.t1 P41233 24.538 758 8.65e-44 181.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g14839.t2 P41233 32.386 1760 0.0 802.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g14839.t2 P41233 24.967 761 4.02e-44 182.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g14839.t3 P41233 31.899 1790 0.0 788.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g14839.t3 P41233 33.144 353 7.48e-44 181.0 sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4 ABCA1_MOUSE reviewed Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Mus musculus (Mouse) GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030139; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; high-density lipoprotein particle binding [GO:0008035]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] g14842.t1 Q9BRS2 53.533 467 3.63e-171 500.0 sp|Q9BRS2|RIOK1_HUMAN Serine/threonine-protein kinase RIO1 OS=Homo sapiens OX=9606 GN=RIOK1 PE=1 SV=2 RIOK1_HUMAN reviewed Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.1.-) (RIO kinase 1) Homo sapiens (Human) GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234 maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274] cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g14849.t1 B3EWZ9 45.324 1112 0.0 992.0 sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1 g14850.t1 Q62559 65.848 448 0.0 610.0 sp|Q62559|IFT52_MOUSE Intraflagellar transport protein 52 homolog OS=Mus musculus OX=10090 GN=Ift52 PE=1 SV=2 g14850.t2 Q62559 69.976 423 0.0 622.0 sp|Q62559|IFT52_MOUSE Intraflagellar transport protein 52 homolog OS=Mus musculus OX=10090 GN=Ift52 PE=1 SV=2 g14851.t1 Q8R4V0 65.083 484 0.0 634.0 sp|Q8R4V0|SGK3_RAT Serine/threonine-protein kinase Sgk3 OS=Rattus norvegicus OX=10116 GN=Sgk3 PE=1 SV=2 SGK3_RAT reviewed Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) Rattus norvegicus (Rat) GO:0004674; GO:0005524; GO:0005769; GO:0015459; GO:0031410; GO:0035091; GO:0035556; GO:0055037; GO:0060090; GO:0106310; GO:2001240 intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240] cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; recycling endosome [GO:0055037] ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g14852.t1 Q923Y0 25.22 341 1.48e-22 99.8 sp|Q923Y0|TAA8C_RAT Trace amine-associated receptor 8c OS=Rattus norvegicus OX=10116 GN=Taar8c PE=3 SV=1 g14855.t1 O75116 48.699 1384 0.0 1211.0 sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4 ROCK2_HUMAN reviewed Rho-associated protein kinase 2 (EC 2.7.11.39) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) Homo sapiens (Human) GO:0000281; GO:0001837; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; host-mediated perturbation of viral process [GO:0044788]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270] g14855.t2 O75116 48.947 1377 0.0 1217.0 sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4 ROCK2_HUMAN reviewed Rho-associated protein kinase 2 (EC 2.7.11.39) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) Homo sapiens (Human) GO:0000281; GO:0001837; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145 actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; host-mediated perturbation of viral process [GO:0044788]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270] g14856.t1 P52758 56.818 132 2e-51 162.0 sp|P52758|RIDA_HUMAN 2-iminobutanoate/2-iminopropanoate deaminase OS=Homo sapiens OX=9606 GN=RIDA PE=1 SV=1 RIDA_HUMAN reviewed 2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.5 kDa translational inhibitor protein) (hp14.5) (p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog) Homo sapiens (Human) GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0006629; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0061157; GO:0070062; GO:0120242; GO:0120243 L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777] 2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA endonuclease activity producing 3'-phosphomonoesters, hydrolytic mechanism [GO:0016892] g14857.t1 Q3ZMH1 34.11 601 3.18e-111 349.0 sp|Q3ZMH1|SC5A8_DANRE Sodium-coupled monocarboxylate transporter 1 OS=Danio rerio OX=7955 GN=slc5a8 PE=1 SV=1 SC5A8_DANRE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0015355; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0140161; GO:2001142 acetate transport [GO:0006846]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324] monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355] g14858.t1 Q5I047 58.73 189 4.33e-74 226.0 sp|Q5I047|ACKMT_XENLA ATP synthase subunit C lysine N-methyltransferase OS=Xenopus laevis OX=8355 GN=atpsckmt PE=2 SV=1 g14860.t1 Q3ZMH1 31.264 451 1.47e-69 235.0 sp|Q3ZMH1|SC5A8_DANRE Sodium-coupled monocarboxylate transporter 1 OS=Danio rerio OX=7955 GN=slc5a8 PE=1 SV=1 SC5A8_DANRE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (zSMCTe) (Sodium solute symporter family 5 member 8 protein) (Solute carrier family 5 member 8) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0015355; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0140161; GO:2001142 acetate transport [GO:0006846]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324] monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; secondary active monocarboxylate transmembrane transporter activity [GO:0015355] g14865.t1 Q6GL62 59.42 69 3.5400000000000006e-21 87.4 sp|Q6GL62|ID4_XENTR DNA-binding protein inhibitor ID-4 OS=Xenopus tropicalis OX=8364 GN=id4 PE=2 SV=1 g14868.t1 Q8IYS1 44.828 406 5.53e-102 312.0 sp|Q8IYS1|P20D2_HUMAN Xaa-Arg dipeptidase OS=Homo sapiens OX=9606 GN=PM20D2 PE=1 SV=2 P20D2_HUMAN reviewed Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246 proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246] nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] g14869.t1 Q32LJ2 65.347 202 2.64e-100 291.0 sp|Q32LJ2|ARFRP_BOVIN ADP-ribosylation factor-related protein 1 OS=Bos taurus OX=9913 GN=ARFRP1 PE=2 SV=1 ARFRP_BOVIN reviewed ADP-ribosylation factor-related protein 1 (ARF-related protein 1) Bos taurus (Bovine) GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0016020; GO:0034067; GO:0043001 Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067] Golgi apparatus [GO:0005794]; membrane [GO:0016020] GTP binding [GO:0005525]; GTPase activity [GO:0003924] g14870.t1 D3ZVR7 34.375 192 2.0200000000000003e-31 115.0 sp|D3ZVR7|PXL2B_RAT Prostamide/prostaglandin F synthase OS=Rattus norvegicus OX=10116 GN=Prxl2b PE=3 SV=1 g14871.t1 Q9H841 41.935 341 1.88e-76 245.0 sp|Q9H841|NPAL2_HUMAN NIPA-like protein 2 OS=Homo sapiens OX=9606 GN=NIPAL2 PE=1 SV=2 g14872.t1 Q54TR1 34.644 534 1.07e-92 297.0 sp|Q54TR1|CFAD_DICDI Counting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1 CFAD_DICDI reviewed Counting factor associated protein D Dictyostelium discoideum (Social amoeba) GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0008656; GO:0031288; GO:0031410; GO:0042742; GO:0072659; GO:0140986; GO:1903665; GO:2001235 defense response to bacterium [GO:0042742]; G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656] g14873.t1 Q9GZR7 49.474 475 2.32e-151 475.0 sp|Q9GZR7|DDX24_HUMAN ATP-dependent RNA helicase DDX24 OS=Homo sapiens OX=9606 GN=DDX24 PE=1 SV=1 g14874.t1 Q92626 62.931 116 2.52e-33 126.0 sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2 PXDN_HUMAN reviewed Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment] Homo sapiens (Human) GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0070062; GO:0070207; GO:0070831; GO:0071711 angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601] g14876.t1 Q9V727 50.296 169 2.1200000000000001e-44 180.0 sp|Q9V727|ASX_DROME Polycomb group protein Asx OS=Drosophila melanogaster OX=7227 GN=Asx PE=1 SV=1 ASX_DROME reviewed Polycomb group protein Asx (Protein additional sex combs) Drosophila melanogaster (Fruit fly) GO:0000785; GO:0001709; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007469; GO:0007475; GO:0008270; GO:0009887; GO:0009948; GO:0010468; GO:0035186; GO:0035517; GO:0035800; GO:0040029; GO:0045498; GO:0045892; GO:0045893; GO:0045944 animal organ morphogenesis [GO:0009887]; antennal development [GO:0007469]; anterior/posterior axis specification [GO:0009948]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; cell fate determination [GO:0001709]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]; syncytial blastoderm mitotic cell cycle [GO:0035186] chromatin [GO:0000785]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517] chromatin binding [GO:0003682]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g14877.t1 J3SBP3 37.599 758 1.13e-160 491.0 sp|J3SBP3|PDE2_CROAD Venom phosphodiesterase 2 OS=Crotalus adamanteus OX=8729 PE=1 SV=1 g14878.t1 A0A2D0TC04 41.833 753 6.339999999999999e-180 541.0 sp|A0A2D0TC04|PDE_NAJAT Venom phosphodiesterase OS=Naja atra OX=8656 PE=1 SV=1 PDE_NAJAT reviewed Venom phosphodiesterase (PDE) (EC 3.6.1.-) Naja atra (Chinese cobra) GO:0003676; GO:0005576; GO:0009143; GO:0043262; GO:0046872; GO:0047429; GO:0090729 nucleoside triphosphate catabolic process [GO:0009143] extracellular region [GO:0005576] ADP phosphatase activity [GO:0043262]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; toxin activity [GO:0090729] g14879.t1 Q5R5P0 67.845 1160 0.0 1678.0 sp|Q5R5P0|WASC5_PONAB WASH complex subunit 5 OS=Pongo abelii OX=9601 GN=WASHC5 PE=2 SV=1 WASC5_PONAB reviewed WASH complex subunit 5 (WASH complex subunit strumpellin) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0005769; GO:0005783; GO:0005829; GO:0007032; GO:0015031; GO:0030041; GO:0051125; GO:0071203; GO:0140285 actin filament polymerization [GO:0030041]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125] cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; WASH complex [GO:0071203] g14881.t1 Q6PL18 50.707 1132 0.0 1041.0 sp|Q6PL18|ATAD2_HUMAN ATPase family AAA domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ATAD2 PE=1 SV=1 ATAD2_HUMAN reviewed ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA) Homo sapiens (Human) GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0045893; GO:0070062 nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription [GO:0045893]; transcription initiation-coupled chromatin remodeling [GO:0045815] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393] g14883.t1 Q08BJ2 48.649 259 9.939999999999998e-68 221.0 sp|Q08BJ2|KHDR2_DANRE KH domain-containing, RNA-binding, signal transduction-associated protein 2 OS=Danio rerio OX=7955 GN=khdrbs2 PE=2 SV=1 g9890.t1 B6CJY5 44.737 228 1.3999999999999999e-61 217.0 sp|B6CJY5|TRAF6_MACMU TNF receptor-associated factor 6 OS=Macaca mulatta OX=9544 GN=TRAF6 PE=2 SV=1 TRAF6_MACMU reviewed TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6) Macaca mulatta (Rhesus macaque) GO:0000045; GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009299; GO:0009898; GO:0019886; GO:0023035; GO:0030316; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042742; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043124; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070936; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996 antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mRNA transcription [GO:0009299]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g9890.t1 B6CJY5 37.615 218 1.9e-35 144.0 sp|B6CJY5|TRAF6_MACMU TNF receptor-associated factor 6 OS=Macaca mulatta OX=9544 GN=TRAF6 PE=2 SV=1 TRAF6_MACMU reviewed TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6) Macaca mulatta (Rhesus macaque) GO:0000045; GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009299; GO:0009898; GO:0019886; GO:0023035; GO:0030316; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042742; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043124; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070936; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996 antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mRNA transcription [GO:0009299]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] g9891.t1 Q9HAP6 74.02 204 1.68e-106 307.0 sp|Q9HAP6|LIN7B_HUMAN Protein lin-7 homolog B OS=Homo sapiens OX=9606 GN=LIN7B PE=1 SV=1 LIN7B_HUMAN reviewed Protein lin-7 homolog B (Lin-7B) (hLin7B) (Mammalian lin-seven protein 2) (MALS-2) (Vertebrate lin-7 homolog 2) (Veli-2) (hVeli2) Homo sapiens (Human) GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0019904; GO:0030674; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839 exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202] protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674] g9892.t1 Q8IYG6 39.295 397 2.24e-72 246.0 sp|Q8IYG6|LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens OX=9606 GN=LRRC56 PE=1 SV=1 LRC56_HUMAN reviewed Leucine-rich repeat-containing protein 56 Homo sapiens (Human) GO:0005929; GO:0030030 cell projection organization [GO:0030030] cilium [GO:0005929] g9893.t1 Q8CDK2 51.878 719 0.0 728.0 sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1 g9893.t2 Q8CDK2 51.878 719 0.0 729.0 sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1 g9893.t3 Q8CDK2 51.878 719 0.0 728.0 sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1 g9893.t4 Q8CDK2 51.644 730 0.0 730.0 sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1 g9894.t1 Q8BGC4 53.143 350 7.670000000000001e-122 359.0 sp|Q8BGC4|PTGR3_MOUSE Prostaglandin reductase-3 OS=Mus musculus OX=10090 GN=Ptgr3 PE=1 SV=1 PTGR3_MOUSE reviewed Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2) Mus musculus (Mouse) GO:0005739; GO:0005777; GO:0006629; GO:0008270; GO:0045599; GO:0047522 lipid metabolic process [GO:0006629]; negative regulation of fat cell differentiation [GO:0045599] mitochondrion [GO:0005739]; peroxisome [GO:0005777] 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; zinc ion binding [GO:0008270] g9895.t1 Q8BGC4 46.821 346 3.74e-99 300.0 sp|Q8BGC4|PTGR3_MOUSE Prostaglandin reductase-3 OS=Mus musculus OX=10090 GN=Ptgr3 PE=1 SV=1 PTGR3_MOUSE reviewed Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2) Mus musculus (Mouse) GO:0005739; GO:0005777; GO:0006629; GO:0008270; GO:0045599; GO:0047522 lipid metabolic process [GO:0006629]; negative regulation of fat cell differentiation [GO:0045599] mitochondrion [GO:0005739]; peroxisome [GO:0005777] 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; zinc ion binding [GO:0008270] g9898.t1 Q803G5 50.104 479 5.780000000000001e-156 454.0 sp|Q803G5|SAM5A_DANRE Sorting and assembly machinery component 50 homolog A OS=Danio rerio OX=7955 GN=samm50a PE=2 SV=1 g9899.t1 Q99P31 38.291 316 1.3e-52 180.0 sp|Q99P31|HPBP1_MOUSE Hsp70-binding protein 1 OS=Mus musculus OX=10090 GN=Hspbp1 PE=1 SV=1 g9900.t1 P50430 41.276 533 8.92e-130 391.0 sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2 g9901.t1 O14095 35.294 204 7.990000000000001e-37 132.0 sp|O14095|PLP1_SCHPO Thioredoxin domain-containing protein plp1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=plp1 PE=1 SV=2 g9902.t1 Q9VU77 27.852 298 1.8499999999999999e-28 115.0 sp|Q9VU77|JMJD7_DROME Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 OS=Drosophila melanogaster OX=7227 GN=JMJD7 PE=1 SV=1 JMJD7_DROME reviewed Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 (EC 1.14.11.63) (EC 3.4.-.-) (Jumonji domain containing protein 7) Drosophila melanogaster (Fruit fly) GO:0004175; GO:0005634; GO:0005737; GO:0005829; GO:0008198; GO:0016706; GO:0042802; GO:0048512; GO:0106155 circadian behavior [GO:0048512] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; endopeptidase activity [GO:0004175]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; peptidyl-lysine 3-dioxygenase activity [GO:0106155] g9903.t1 Q5F3N9 58.163 196 5.11e-87 265.0 sp|Q5F3N9|ILRUN_CHICK Protein ILRUN OS=Gallus gallus OX=9031 GN=ILRUN PE=2 SV=1 g9904.t1 Q924D0 46.575 365 6.43e-112 338.0 sp|Q924D0|RT4I1_MOUSE NAD(P)H oxidoreductase RTN4IP1, mitochondrial OS=Mus musculus OX=10090 GN=Rtn4ip1 PE=1 SV=2 RT4I1_MOUSE reviewed NAD(P)H oxidoreductase RTN4IP1, mitochondrial (EC 1.6.5.-) (NOGO-interacting mitochondrial protein) (Reticulon-4-interacting protein 1) Mus musculus (Mouse) GO:0000166; GO:0005739; GO:0005741; GO:0005759; GO:0006744; GO:0007399; GO:0008270; GO:0008753; GO:0050773 nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773]; ubiquinone biosynthetic process [GO:0006744] mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] NADPH dehydrogenase (quinone) activity [GO:0008753]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g9905.t1 Q9Y484 67.797 354 3.25e-179 503.0 sp|Q9Y484|WIPI4_HUMAN WD repeat domain phosphoinositide-interacting protein 4 OS=Homo sapiens OX=9606 GN=WDR45 PE=1 SV=1 WIPI4_HUMAN reviewed WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45) Homo sapiens (Human) GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005829; GO:0006914; GO:0009267; GO:0019901; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025; GO:1901981; GO:2000786 autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; positive regulation of autophagosome assembly [GO:2000786]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] g9906.t1 E7EY42 54.897 439 5.7399999999999995e-180 514.0 sp|E7EY42|PTSS2_DANRE Phosphatidylserine synthase 2 OS=Danio rerio OX=7955 GN=ptdss2 PE=3 SV=1 g9907.t1 P61082 80.978 184 2.4500000000000002e-110 315.0 sp|P61082|UBC12_MOUSE NEDD8-conjugating enzyme Ubc12 OS=Mus musculus OX=10090 GN=Ube2m PE=1 SV=1 UBC12_MOUSE reviewed NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M) Mus musculus (Mouse) GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0043525; GO:0045116; GO:0061654; GO:0098793; GO:0098794; GO:0098978; GO:0150052 positive regulation of neuron apoptotic process [GO:0043525]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; regulation of postsynapse assembly [GO:0150052] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842] g9908.t1 P62250 86.301 146 1.46e-90 262.0 sp|P62250|RS16_RAT Small ribosomal subunit protein uS9 OS=Rattus norvegicus OX=10116 GN=Rps16 PE=1 SV=2 g9909.t1 P04818 69.333 300 2.88e-158 448.0 sp|P04818|TYSY_HUMAN Thymidylate synthase OS=Homo sapiens OX=9606 GN=TYMS PE=1 SV=3 TYSY_HUMAN reviewed Thymidylate synthase (TS) (TSase) (EC 2.1.1.45) Homo sapiens (Human) GO:0000900; GO:0004799; GO:0005542; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0017148; GO:0032259; GO:0035999; GO:0071897; GO:1990825 DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; methylation [GO:0032259]; negative regulation of translation [GO:0017148]; tetrahydrofolate interconversion [GO:0035999] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] folic acid binding [GO:0005542]; mRNA regulatory element binding translation repressor activity [GO:0000900]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799] g9910.t1 X1WHY6 44.59 305 2.88e-71 266.0 sp|X1WHY6|AMR1B_DANRE Activating molecule in BECN1-regulated autophagy protein 1B OS=Danio rerio OX=7955 GN=ambra1b PE=2 SV=1 AMR1B_DANRE reviewed Activating molecule in BECN1-regulated autophagy protein 1B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0007281; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045 autophagosome assembly [GO:0000045]; chordate embryonic development [GO:0043009]; germ cell development [GO:0007281]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741] autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleus [GO:0005634] protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g9910.t1 X1WHY6 46.919 211 1.46e-51 203.0 sp|X1WHY6|AMR1B_DANRE Activating molecule in BECN1-regulated autophagy protein 1B OS=Danio rerio OX=7955 GN=ambra1b PE=2 SV=1 AMR1B_DANRE reviewed Activating molecule in BECN1-regulated autophagy protein 1B Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0007281; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045 autophagosome assembly [GO:0000045]; chordate embryonic development [GO:0043009]; germ cell development [GO:0007281]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741] autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleus [GO:0005634] protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g9911.t1 Q08DY8 38.211 492 1.79e-80 260.0 sp|Q08DY8|ATG13_BOVIN Autophagy-related protein 13 OS=Bos taurus OX=9913 GN=ATG13 PE=2 SV=1 g9912.t1 D4A770 46.306 555 1.28e-178 518.0 sp|D4A770|FERY3_RAT FERRY endosomal RAB5 effector complex subunit 3 OS=Rattus norvegicus OX=10116 GN=Ferry3 PE=1 SV=1 g9912.t2 D4A770 46.14 557 2.24e-176 512.0 sp|D4A770|FERY3_RAT FERRY endosomal RAB5 effector complex subunit 3 OS=Rattus norvegicus OX=10116 GN=Ferry3 PE=1 SV=1 g9913.t1 O53532 32.967 364 1.18e-56 191.0 sp|O53532|Y2258_MYCTU S-adenosylmethionine-dependent methyltransferase Rv2258c OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=Rv2258c PE=1 SV=1 g9914.t1 Q7T3H7 56.614 189 3.45e-76 231.0 sp|Q7T3H7|MED18_DANRE Mediator of RNA polymerase II transcription subunit 18 OS=Danio rerio OX=7955 GN=med18 PE=2 SV=1 g9915.t1 Q9Y234 38.611 360 5.87e-91 281.0 sp|Q9Y234|LIPT_HUMAN Lipoyl amidotransferase LIPT1, mitochondrial OS=Homo sapiens OX=9606 GN=LIPT1 PE=1 SV=1 LIPT_HUMAN reviewed Lipoyl amidotransferase LIPT1, mitochondrial (EC 2.3.1.200) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase) (Lipoyltransferase 1) (EC 2.3.1.-) Homo sapiens (Human) GO:0005737; GO:0005739; GO:0005759; GO:0006629; GO:0009249; GO:0016410; GO:0017118; GO:0036211 lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]; protein modification process [GO:0036211] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] lipoyltransferase activity [GO:0017118]; N-acyltransferase activity [GO:0016410] g9916.t1 Q5RAK7 63.522 477 0.0 657.0 sp|Q5RAK7|SPCS_PONAB O-phosphoseryl-tRNA(Sec) selenium transferase OS=Pongo abelii OX=9601 GN=SEPSECS PE=2 SV=1 g9918.t1 P58355 24.908 542 1.2e-45 171.0 sp|P58355|S45A2_MOUSE Membrane-associated transporter protein OS=Mus musculus OX=10090 GN=Slc45a2 PE=1 SV=1 S45A2_MOUSE reviewed Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Protein underwhite) (Solute carrier family 45 member 2) Mus musculus (Mouse) GO:0005356; GO:0006583; GO:0007601; GO:0008506; GO:0015770; GO:0016020; GO:0033162; GO:0035752; GO:0048066 developmental pigmentation [GO:0048066]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process from tyrosine [GO:0006583]; sucrose transport [GO:0015770]; visual perception [GO:0007601] melanosome membrane [GO:0033162]; membrane [GO:0016020] D-glucose:proton symporter activity [GO:0005356]; sucrose:proton symporter activity [GO:0008506] g9919.t1 Q9D4H2 36.727 776 2.81e-138 428.0 sp|Q9D4H2|GCC1_MOUSE GRIP and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gcc1 PE=1 SV=2 g9921.t1 Q9CRG1 33.015 524 5.69e-77 256.0 sp|Q9CRG1|TM7S3_MOUSE Transmembrane 7 superfamily member 3 OS=Mus musculus OX=10090 GN=Tm7sf3 PE=2 SV=2 g9922.t1 Q5R561 61.413 184 8.76e-70 219.0 sp|Q5R561|FGOP2_PONAB FGFR1 oncogene partner 2 homolog OS=Pongo abelii OX=9601 GN=FGFR1OP2 PE=2 SV=1 g9924.t1 Q3ZCD0 34.568 243 1.41e-39 140.0 sp|Q3ZCD0|CD81_BOVIN CD81 antigen OS=Bos taurus OX=9913 GN=CD81 PE=2 SV=1 CD81_BOVIN reviewed CD81 antigen (CD antigen CD81) Bos taurus (Bovine) GO:0001771; GO:0001772; GO:0002455; GO:0002863; GO:0005178; GO:0005886; GO:0014905; GO:0015485; GO:0016020; GO:0016323; GO:0031623; GO:0034238; GO:0035783; GO:0050861; GO:0050862; GO:0050871; GO:0070863; GO:0071404; GO:0072659; GO:0072675; GO:0097197; GO:1903911; GO:1905521; GO:2000553; GO:2000563; GO:2001190 CD4-positive, alpha-beta T cell costimulation [GO:0035783]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; immunological synapse formation [GO:0001771]; macrophage fusion [GO:0034238]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; osteoclast fusion [GO:0072675]; positive regulation of B cell activation [GO:0050871]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of receptor clustering [GO:1903911]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521] basolateral plasma membrane [GO:0016323]; immunological synapse [GO:0001772]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] cholesterol binding [GO:0015485]; integrin binding [GO:0005178] g9928.t1 Q6GMK6 29.958 237 1.42e-31 119.0 sp|Q6GMK6|TSN9_DANRE Tetraspanin-9 OS=Danio rerio OX=7955 GN=tspan9 PE=2 SV=1 g9929.t1 Q6GMK6 39.474 228 5.41e-45 154.0 sp|Q6GMK6|TSN9_DANRE Tetraspanin-9 OS=Danio rerio OX=7955 GN=tspan9 PE=2 SV=1 g9930.t1 Q6GMK6 42.128 235 2.28e-57 185.0 sp|Q6GMK6|TSN9_DANRE Tetraspanin-9 OS=Danio rerio OX=7955 GN=tspan9 PE=2 SV=1 g9931.t1 P62876 94.03 67 6.970000000000001e-43 135.0 sp|P62876|RPAB5_MOUSE DNA-directed RNA polymerases I, II, and III subunit RPABC5 OS=Mus musculus OX=10090 GN=Polr2l PE=3 SV=1 g9932.t1 Q32KQ7 47.038 287 7.5e-89 270.0 sp|Q32KQ7|CSTP1_BOVIN Centriolar satellite-associated tubulin polyglutamylase complex regulator 1 OS=Bos taurus OX=9913 GN=CSTPP1 PE=2 SV=1 g9935.t1 Q9QYP1 55.831 1818 0.0 2041.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9935.t2 Q9QYP1 55.831 1818 0.0 2041.0 sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2 LRP4_RAT reviewed Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Rattus norvegicus (Rat) GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0016601; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395 amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; intracellular protein localization [GO:0008104]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; Rac protein signal transduction [GO:0016601]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060] apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] g9941.t1 Q3B726 43.165 139 2.7200000000000004e-27 115.0 sp|Q3B726|RPA43_HUMAN DNA-directed RNA polymerase I subunit RPA43 OS=Homo sapiens OX=9606 GN=POLR1F PE=1 SV=1 RPA43_HUMAN reviewed DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein) Homo sapiens (Human) GO:0005654; GO:0005736; GO:0006352; GO:0006362; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription initiation [GO:0006352]; transcription elongation by RNA polymerase I [GO:0006362] nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] g9942.t1 Q5ZMW3 47.432 331 4.88e-79 254.0 sp|Q5ZMW3|API5_CHICK Apoptosis inhibitor 5 OS=Gallus gallus OX=9031 GN=API5 PE=2 SV=1 g9944.t1 Q9D5T7 46.725 229 5.339999999999999e-69 233.0 sp|Q9D5T7|HORM1_MOUSE HORMA domain-containing protein 1 OS=Mus musculus OX=10090 GN=Hormad1 PE=1 SV=1 HORM1_MOUSE reviewed HORMA domain-containing protein 1 (Newborn ovary HORMA protein) Mus musculus (Mouse) GO:0000794; GO:0000795; GO:0001824; GO:0005634; GO:0005694; GO:0005737; GO:0007129; GO:0007130; GO:0007283; GO:0042138; GO:0048477; GO:0051177; GO:0051321; GO:0051598; GO:0060629 blastocyst development [GO:0001824]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] g9945.t1 Q4V7T8 64.319 213 9.8e-102 296.0 sp|Q4V7T8|ROP1L_XENLA Ropporin-1-like protein OS=Xenopus laevis OX=8355 GN=ropn1l PE=2 SV=1 g9946.t1 Q9P016 61.692 201 1.5199999999999999e-89 266.0 sp|Q9P016|THYN1_HUMAN Thymocyte nuclear protein 1 OS=Homo sapiens OX=9606 GN=THYN1 PE=1 SV=1 g9947.t1 Q9D0K0 41.281 281 9.16e-75 233.0 sp|Q9D0K0|TBCD7_MOUSE TBC1 domain family member 7 OS=Mus musculus OX=10090 GN=Tbc1d7 PE=1 SV=1 g9951.t1 P20070 68.015 272 1.4500000000000001e-145 414.0 sp|P20070|NB5R3_RAT NADH-cytochrome b5 reductase 3 OS=Rattus norvegicus OX=10116 GN=Cyb5r3 PE=1 SV=2 g9953.t1 Q16629 59.504 121 1.64e-38 135.0 sp|Q16629|SRSF7_HUMAN Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7 PE=1 SV=1 SRSF7_HUMAN reviewed Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:0070062; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g9954.t1 Q3T106 52.174 115 2.15e-31 117.0 sp|Q3T106|SRSF7_BOVIN Serine/arginine-rich splicing factor 7 OS=Bos taurus OX=9913 GN=SRSF7 PE=2 SV=1 SRSF7_BOVIN reviewed Serine/arginine-rich splicing factor 7 (Splicing factor, arginine/serine-rich 7) Bos taurus (Bovine) GO:0000381; GO:0003729; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0048025; GO:0051028 mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607] mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] g9955.t1 P13834 63.293 662 0.0 878.0 sp|P13834|GYS1_RABIT Glycogen [starch] synthase, muscle OS=Oryctolagus cuniculus OX=9986 GN=GYS1 PE=1 SV=4 g9956.t1 P62278 91.391 151 1.31e-99 285.0 sp|P62278|RS13_RAT Small ribosomal subunit protein uS15 OS=Rattus norvegicus OX=10116 GN=Rps13 PE=1 SV=2 RS13_RAT reviewed Small ribosomal subunit protein uS15 (40S ribosomal protein S13) Rattus norvegicus (Rat) GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005840; GO:0014069; GO:0022626; GO:0022627; GO:0032040; GO:0033119; GO:0042274; GO:0045202; GO:0048027; GO:0070181; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990932 negative regulation of RNA splicing [GO:0033119]; ribosomal small subunit biogenesis [GO:0042274]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236] cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202] 5.8S rRNA binding [GO:1990932]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735] g9957.t1 A0A8V0ZLT4 32.472 271 8.43e-33 123.0 sp|A0A8V0ZLT4|TSN18_CHICK Tetraspanin-18 OS=Gallus gallus OX=9031 GN=TSPAN18 PE=2 SV=1 g9958.t1 Q6DDW4 52.0 225 2.31e-63 226.0 sp|Q6DDW4|CPSF6_XENLA Cleavage and polyadenylation specificity factor subunit 6 OS=Xenopus laevis OX=8355 GN=cpsf6 PE=2 SV=1 g9958.t1 Q6DDW4 63.699 146 3.45e-36 148.0 sp|Q6DDW4|CPSF6_XENLA Cleavage and polyadenylation specificity factor subunit 6 OS=Xenopus laevis OX=8355 GN=cpsf6 PE=2 SV=1 g9959.t1 Q9H2Y9 33.384 659 3.0599999999999997e-115 372.0 sp|Q9H2Y9|SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens OX=9606 GN=SLCO5A1 PE=1 SV=2 g9960.t1 O93428 54.135 399 2.4e-156 449.0 sp|O93428|CATD_CHIHA Cathepsin D OS=Chionodraco hamatus OX=36188 GN=ctsd PE=1 SV=2 g9961.t1 Q6ING7 51.546 485 1.77e-180 520.0 sp|Q6ING7|FLAD1_XENLA FAD synthase OS=Xenopus laevis OX=8355 GN=flad1 PE=2 SV=1 FLAD1_XENLA reviewed Bifunctional FAD diphosphatase/FAD synthase [Includes: FAD diphosphatase (EC 3.6.1.18) (EC 3.6.1.22) (FAD pyrophosphatase) (FADPPase) (FADHy) (NADH diphosphatase); FAD synthase (FADSy) (EC 2.7.7.2) (FMN adenylyltransferase) (FMNAT) (Flavin adenine dinucleotide synthase)] Xenopus laevis (African clawed frog) GO:0003919; GO:0005524; GO:0005829; GO:0006747; GO:0006771 FAD biosynthetic process [GO:0006747]; riboflavin metabolic process [GO:0006771] cytosol [GO:0005829] ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919] g9962.t1 P80109 40.6 867 0.0 650.0 sp|P80109|PHLD_BOVIN Phosphatidylinositol-glycan-specific phospholipase D OS=Bos taurus OX=9913 GN=GPLD1 PE=1 SV=1 PHLD_BOVIN reviewed Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D) Bos taurus (Bovine) GO:0001503; GO:0002042; GO:0002062; GO:0002430; GO:0004621; GO:0005615; GO:0005737; GO:0008285; GO:0008286; GO:0009306; GO:0009749; GO:0010595; GO:0010694; GO:0010867; GO:0010897; GO:0010907; GO:0010983; GO:0017080; GO:0031012; GO:0032869; GO:0034364; GO:0035774; GO:0043065; GO:0043231; GO:0046470; GO:0051044; GO:0070633; GO:0071397; GO:0071401; GO:0071466; GO:0071467; GO:1900076 cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein secretion [GO:0009306]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231] glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080] g9965.t1 Q7ZW02 55.228 373 5.58e-144 418.0 sp|Q7ZW02|CHPT1_DANRE Cholinephosphotransferase 1 OS=Danio rerio OX=7955 GN=chpt1 PE=2 SV=1 CHPT1_DANRE reviewed Cholinephosphotransferase 1 (EC 2.7.8.2) (Diacylglycerol cholinephosphotransferase 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0004142; GO:0005789; GO:0005794; GO:0046872 endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872] g9966.t1 Q6DDL7 28.195 493 2.11e-64 219.0 sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1 g9970.t1 P40616 79.641 167 2.48e-98 285.0 sp|P40616|ARL1_HUMAN ADP-ribosylation factor-like protein 1 OS=Homo sapiens OX=9606 GN=ARL1 PE=1 SV=1 ARL1_HUMAN reviewed ADP-ribosylation factor-like protein 1 Homo sapiens (Human) GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007030; GO:0008047; GO:0009404; GO:0016192; GO:0019904; GO:0032588; GO:0034067; GO:0042147; GO:0046872; GO:1990583 Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipase D activator activity [GO:1990583]; protein domain specific binding [GO:0019904] g9972.t1 Q96KP4 67.442 473 0.0 690.0 sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2 CNDP2_HUMAN reviewed Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573 proteolysis [GO:0006508] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573] g9973.t1 Q96KP4 66.525 472 0.0 681.0 sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2 CNDP2_HUMAN reviewed Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase) Homo sapiens (Human) GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573 proteolysis [GO:0006508] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573] g9975.t1 Q9D2C2 34.87 347 6.859999999999999e-52 183.0 sp|Q9D2C2|SAAL1_MOUSE Protein SAAL1 OS=Mus musculus OX=10090 GN=Saal1 PE=1 SV=1 g9975.t2 Q9D2C2 34.87 347 6.469999999999999e-52 184.0 sp|Q9D2C2|SAAL1_MOUSE Protein SAAL1 OS=Mus musculus OX=10090 GN=Saal1 PE=1 SV=1 g9978.t1 Q90953 40.237 169 9.24e-34 135.0 sp|Q90953|CSPG2_CHICK Versican core protein OS=Gallus gallus OX=9031 GN=VCAN PE=2 SV=1 CSPG2_CHICK reviewed Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Large fibroblast proteoglycan) (PG-M) Gallus gallus (Chicken) GO:0001501; GO:0001750; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0030246; GO:0033165; GO:0045202; GO:0072534 cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501] extracellular space [GO:0005615]; interphotoreceptor matrix [GO:0033165]; perineuronal net [GO:0072534]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202] calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540] g9980.t1 Q0VBY7 42.222 135 1.3000000000000001e-32 116.0 sp|Q0VBY7|DJC24_BOVIN DnaJ homolog subfamily C member 24 OS=Bos taurus OX=9913 GN=DNAJC24 PE=2 SV=3 DJC24_BOVIN reviewed DnaJ homolog subfamily C member 24 (CSL-type zinc finger-containing protein 3) (Diphthamide biosynthesis protein 4) Bos taurus (Bovine) GO:0001671; GO:0005856; GO:0008198; GO:0008270; GO:0017183; GO:0032781 positive regulation of ATP-dependent activity [GO:0032781]; protein histidyl modification to diphthamide [GO:0017183] cytoskeleton [GO:0005856] ATPase activator activity [GO:0001671]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270] g9981.t1 O88879 36.421 1263 0.0 808.0 sp|O88879|APAF_MOUSE Apoptotic protease-activating factor 1 OS=Mus musculus OX=10090 GN=Apaf1 PE=1 SV=3 APAF_MOUSE reviewed Apoptotic protease-activating factor 1 (APAF-1) Mus musculus (Mouse) GO:0001666; GO:0001822; GO:0001843; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007420; GO:0007584; GO:0008656; GO:0010659; GO:0030154; GO:0030900; GO:0031072; GO:0032991; GO:0042802; GO:0043065; GO:0043293; GO:0043531; GO:0051402; GO:0070059; GO:0071560; GO:0097193; GO:1902510; GO:2001235 brain development [GO:0007420]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584] apoptosome [GO:0043293]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802] g9982.t1 Q9CR89 56.0 375 8.82e-156 447.0 sp|Q9CR89|ERGI2_MOUSE Endoplasmic reticulum-Golgi intermediate compartment protein 2 OS=Mus musculus OX=10090 GN=Ergic2 PE=1 SV=1 ERGI2_MOUSE reviewed Endoplasmic reticulum-Golgi intermediate compartment protein 2 Mus musculus (Mouse) GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0033116; GO:0061852; GO:1990351 endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890] COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; retrograde transporter complex, Golgi to ER [GO:0061852]; transporter complex [GO:1990351] g9991.t1 Q02858 47.917 288 2.89e-85 290.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g9993.t1 Q06807 39.793 387 4.62e-80 288.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g9996.t1 Q9JM95 41.322 242 4.1800000000000003e-57 191.0 sp|Q9JM95|SIA7F_MOUSE Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 OS=Mus musculus OX=10090 GN=St6galnac6 PE=1 SV=1 g9998.t1 O00750 42.516 1423 0.0 1065.0 sp|O00750|P3C2B_HUMAN Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta OS=Homo sapiens OX=9606 GN=PIK3C2B PE=1 SV=2 P3C2B_HUMAN reviewed Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) Homo sapiens (Human) GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0009267; GO:0016303; GO:0016477; GO:0030139; GO:0031965; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037 autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091] g9998.t2 O00750 42.847 1412 0.0 1073.0 sp|O00750|P3C2B_HUMAN Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta OS=Homo sapiens OX=9606 GN=PIK3C2B PE=1 SV=2 P3C2B_HUMAN reviewed Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) Homo sapiens (Human) GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0009267; GO:0016303; GO:0016477; GO:0030139; GO:0031965; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037 autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091] g9998.t3 O00750 43.051 1403 0.0 1077.0 sp|O00750|P3C2B_HUMAN Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta OS=Homo sapiens OX=9606 GN=PIK3C2B PE=1 SV=2 P3C2B_HUMAN reviewed Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) Homo sapiens (Human) GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0009267; GO:0016303; GO:0016477; GO:0030139; GO:0031965; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037 autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091] g9999.t1 Q9JI85 42.01 388 1.25e-74 249.0 sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1 NUCB2_RAT reviewed Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1] Rattus norvegicus (Rat) GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845 insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164] g9999.t2 Q9JI85 41.753 388 4.63e-76 253.0 sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1 NUCB2_RAT reviewed Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1] Rattus norvegicus (Rat) GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845 insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164] g9999.t3 Q9JI85 38.517 418 2.29e-69 236.0 sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1 NUCB2_RAT reviewed Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1] Rattus norvegicus (Rat) GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845 insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164] g9999.t4 Q9JI85 41.753 388 2.23e-76 253.0 sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1 NUCB2_RAT reviewed Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1] Rattus norvegicus (Rat) GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845 insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634] calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164] g10002.t1 D3YXG0 27.41 529 1.87e-38 158.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 27.358 530 5.92e-36 150.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 26.239 545 1.3399999999999998e-34 146.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 24.953 529 7.17e-33 141.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 27.505 549 7.25e-32 137.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 26.103 544 1.03e-31 137.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 27.178 574 2.96e-29 129.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 24.954 545 3.09e-29 129.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 27.342 523 4.6800000000000004e-29 129.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 25.15 501 8.3e-29 128.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 24.901 506 1.43e-28 127.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 28.571 469 4.3e-28 125.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 26.957 460 1.1300000000000002e-27 124.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 26.923 520 1.27e-27 124.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 26.087 552 3.36e-27 123.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 26.7 397 1.0300000000000001e-26 121.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 25.858 437 1.87e-25 117.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 24.47 519 8.01e-25 115.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 24.861 539 1.6499999999999998e-23 111.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t1 D3YXG0 24.535 538 6.669999999999999e-23 109.0 sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1 HMCN1_MOUSE reviewed Hemicentin-1 (Fibulin-6) (FIBL-6) Mus musculus (Mouse) GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005886; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0031012; GO:0032154; GO:0051301; GO:0071711; GO:0098631 actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; cell adhesion mediator activity [GO:0098631] g10002.t2 Q8NDA2 30.479 397 1.46e-31 135.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 26.747 415 2.3599999999999998e-30 132.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 28.814 413 4.45e-28 125.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 28.211 436 6.85e-28 124.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 26.824 425 2.7700000000000003e-27 122.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 26.829 410 7.34e-26 117.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 26.316 342 1.95e-24 113.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 26.147 436 9.87e-24 111.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 24.839 467 3.5099999999999994e-23 109.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 26.629 353 1.1200000000000001e-22 107.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 24.021 562 4.66e-22 105.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10002.t2 Q8NDA2 27.865 445 6.5900000000000005e-22 105.0 sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4 g10004.t1 Q9VGL8 30.719 306 2.82e-35 140.0 sp|Q9VGL8|TBWKD_DROME TBC1 domain family member whacked OS=Drosophila melanogaster OX=7227 GN=wkd PE=1 SV=1 TBWKD_DROME reviewed TBC1 domain family member whacked Drosophila melanogaster (Fruit fly) GO:0005096; GO:0005737; GO:0005829; GO:0010085; GO:0030175; GO:0031410; GO:0035149; GO:0042147; GO:0098592 lumen formation, open tracheal system [GO:0035149]; polarity specification of proximal/distal axis [GO:0010085]; retrograde transport, endosome to Golgi [GO:0042147] cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; filopodium [GO:0030175] GTPase activator activity [GO:0005096] g10007.t1 Q8IWY4 47.764 984 0.0 929.0 sp|Q8IWY4|SCUB1_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SCUBE1 PE=1 SV=3 SCUB1_HUMAN reviewed Signal peptide, CUB and EGF-like domain-containing protein 1 Homo sapiens (Human) GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0042802; GO:0045446; GO:0045880 adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g10007.t2 Q8IWY4 47.716 985 0.0 925.0 sp|Q8IWY4|SCUB1_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SCUBE1 PE=1 SV=3 SCUB1_HUMAN reviewed Signal peptide, CUB and EGF-like domain-containing protein 1 Homo sapiens (Human) GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0042802; GO:0045446; GO:0045880 adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g10007.t3 Q8IWY4 48.057 978 0.0 935.0 sp|Q8IWY4|SCUB1_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SCUBE1 PE=1 SV=3 SCUB1_HUMAN reviewed Signal peptide, CUB and EGF-like domain-containing protein 1 Homo sapiens (Human) GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0042802; GO:0045446; GO:0045880 adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] g10009.t1 Q9D4C1 35.644 303 1.96e-44 166.0 sp|Q9D4C1|LMTD1_MOUSE Lamin tail domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lmntd1 PE=2 SV=1 g10012.t1 Q9JJB9 28.409 352 2.4700000000000002e-33 133.0 sp|Q9JJB9|TM183_MOUSE Transmembrane protein 183 OS=Mus musculus OX=10090 GN=Tmem183 PE=2 SV=1 g10024.t1 Q80T41 40.909 220 1.34e-44 163.0 sp|Q80T41|GABR2_MOUSE Gamma-aminobutyric acid type B receptor subunit 2 OS=Mus musculus OX=10090 GN=Gabbr2 PE=1 SV=2 GABR2_MOUSE reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Mus musculus (Mouse) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0038039; GO:0042734; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g10025.t1 Q9Z0U4 32.571 350 2.72e-56 201.0 sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2 g10026.t1 Q8CHP8 44.56 193 3.09e-45 161.0 sp|Q8CHP8|PGP_MOUSE Glycerol-3-phosphate phosphatase OS=Mus musculus OX=10090 GN=Pgp PE=1 SV=1 PGP_MOUSE reviewed Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP) Mus musculus (Mouse) GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0043262; GO:0045721 glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721] cytoplasm [GO:0005737] ADP phosphatase activity [GO:0043262]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; sn-glycerol 1-phosphatase activity [GO:0000121]; sn-glycerol 3-phosphatase activity [GO:0043136] g10026.t1 Q8CHP8 45.455 154 9.7e-39 144.0 sp|Q8CHP8|PGP_MOUSE Glycerol-3-phosphate phosphatase OS=Mus musculus OX=10090 GN=Pgp PE=1 SV=1 PGP_MOUSE reviewed Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP) Mus musculus (Mouse) GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0043262; GO:0045721 glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721] cytoplasm [GO:0005737] ADP phosphatase activity [GO:0043262]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; sn-glycerol 1-phosphatase activity [GO:0000121]; sn-glycerol 3-phosphatase activity [GO:0043136] g10026.t2 Q8CHP8 43.322 307 1.48e-82 255.0 sp|Q8CHP8|PGP_MOUSE Glycerol-3-phosphate phosphatase OS=Mus musculus OX=10090 GN=Pgp PE=1 SV=1 PGP_MOUSE reviewed Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP) Mus musculus (Mouse) GO:0000121; GO:0000287; GO:0004725; GO:0005737; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0043262; GO:0045721 glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721] cytoplasm [GO:0005737] ADP phosphatase activity [GO:0043262]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; sn-glycerol 1-phosphatase activity [GO:0000121]; sn-glycerol 3-phosphatase activity [GO:0043136] g10031.t1 Q801S4 42.755 421 6.08e-100 306.0 sp|Q801S4|K0930_XENLA Uncharacterized protein KIAA0930 homolog OS=Xenopus laevis OX=8355 PE=2 SV=2 g10031.t2 Q801S4 42.927 410 5.79e-100 306.0 sp|Q801S4|K0930_XENLA Uncharacterized protein KIAA0930 homolog OS=Xenopus laevis OX=8355 PE=2 SV=2 g10033.t1 Q6ZN57 46.269 335 2.04e-101 310.0 sp|Q6ZN57|ZFP2_HUMAN Zinc finger protein ZFP2 OS=Homo sapiens OX=9606 GN=ZFP2 PE=1 SV=1 ZFP2_HUMAN reviewed Zinc finger protein ZFP2 (Zfp-2) (Zinc finger protein 751) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10033.t1 Q6ZN57 44.412 340 5.9e-95 293.0 sp|Q6ZN57|ZFP2_HUMAN Zinc finger protein ZFP2 OS=Homo sapiens OX=9606 GN=ZFP2 PE=1 SV=1 ZFP2_HUMAN reviewed Zinc finger protein ZFP2 (Zfp-2) (Zinc finger protein 751) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10033.t1 Q6ZN57 46.254 307 1.66e-90 282.0 sp|Q6ZN57|ZFP2_HUMAN Zinc finger protein ZFP2 OS=Homo sapiens OX=9606 GN=ZFP2 PE=1 SV=1 ZFP2_HUMAN reviewed Zinc finger protein ZFP2 (Zfp-2) (Zinc finger protein 751) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10033.t1 Q6ZN57 41.158 311 2.5400000000000004e-72 235.0 sp|Q6ZN57|ZFP2_HUMAN Zinc finger protein ZFP2 OS=Homo sapiens OX=9606 GN=ZFP2 PE=1 SV=1 ZFP2_HUMAN reviewed Zinc finger protein ZFP2 (Zfp-2) (Zinc finger protein 751) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10033.t1 Q6ZN57 42.424 297 2.94e-69 227.0 sp|Q6ZN57|ZFP2_HUMAN Zinc finger protein ZFP2 OS=Homo sapiens OX=9606 GN=ZFP2 PE=1 SV=1 ZFP2_HUMAN reviewed Zinc finger protein ZFP2 (Zfp-2) (Zinc finger protein 751) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10033.t1 Q6ZN57 43.961 207 4.74e-55 190.0 sp|Q6ZN57|ZFP2_HUMAN Zinc finger protein ZFP2 OS=Homo sapiens OX=9606 GN=ZFP2 PE=1 SV=1 ZFP2_HUMAN reviewed Zinc finger protein ZFP2 (Zfp-2) (Zinc finger protein 751) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0045892 negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10041.t1 P46023 30.802 948 1.17e-97 347.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g10042.t1 Q6QNK2 36.97 330 9.07e-62 232.0 sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1 AGRD1_HUMAN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Homo sapiens (Human) GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g10043.t1 P24288 60.519 385 5.21e-174 493.0 sp|P24288|BCAT1_MOUSE Branched-chain-amino-acid aminotransferase, cytosolic OS=Mus musculus OX=10090 GN=Bcat1 PE=1 SV=2 BCAT1_MOUSE reviewed Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) Mus musculus (Mouse) GO:0004084; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0009083; GO:0009098; GO:0009099; GO:0042802; GO:0052654; GO:0052655; GO:0052656 branched-chain amino acid catabolic process [GO:0009083]; L-leucine biosynthetic process [GO:0009098]; L-valine biosynthetic process [GO:0009099]; lipid metabolic process [GO:0006629] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] branched-chain-amino-acid transaminase activity [GO:0004084]; identical protein binding [GO:0042802]; L-isoleucine-2-oxoglutarate transaminase activity [GO:0052656]; L-leucine-2-oxoglutarate transaminase activity [GO:0052654]; L-valine-2-oxoglutarate transaminase activity [GO:0052655] g10044.t1 Q4R684 28.626 262 2.4399999999999997e-24 105.0 sp|Q4R684|AMZ2_MACFA Archaemetzincin-2 OS=Macaca fascicularis OX=9541 GN=AMZ2 PE=2 SV=2 g10045.t1 Q5E9H2 37.164 409 9.529999999999999e-91 286.0 sp|Q5E9H2|1A1L1_BOVIN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Bos taurus OX=9913 GN=ACCS PE=2 SV=1 g10046.t1 Q5E9H2 40.299 402 7.27e-99 308.0 sp|Q5E9H2|1A1L1_BOVIN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Bos taurus OX=9913 GN=ACCS PE=2 SV=1 g10047.t1 Q9V0D5 42.32 319 6.88e-71 228.0 sp|Q9V0D5|MDH_PYRAB Malate dehydrogenase OS=Pyrococcus abyssi (strain GE5 / Orsay) OX=272844 GN=mdh PE=3 SV=1 g10050.t1 Q8BXB6 30.178 676 3.49e-92 306.0 sp|Q8BXB6|SO2B1_MOUSE Solute carrier organic anion transporter family member 2B1 OS=Mus musculus OX=10090 GN=Slco2b1 PE=1 SV=1 SO2B1_MOUSE reviewed Solute carrier organic anion transporter family member 2B1 (Organic anion transporting polypeptide 2B1) (OATP2B1) (Solute carrier family 21 member 9) Mus musculus (Mouse) GO:0005886; GO:0006879; GO:0008283; GO:0008514; GO:0009925; GO:0010106; GO:0010496; GO:0015125; GO:0015132; GO:0015347; GO:0015711; GO:0015721; GO:0016323; GO:0016324; GO:0022857; GO:0042908; GO:0043252; GO:0055085; GO:0071718; GO:0140420 bile acid and bile salt transport [GO:0015721]; cell population proliferation [GO:0008283]; cellular response to iron ion starvation [GO:0010106]; heme import into cell [GO:0140420]; intercellular transport [GO:0010496]; intracellular iron ion homeostasis [GO:0006879]; organic anion transport [GO:0015711]; sodium-independent icosanoid transport [GO:0071718]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; transmembrane transporter activity [GO:0022857] g10051.t1 Q00910 31.424 681 1.9199999999999998e-95 313.0 sp|Q00910|SO2A1_RAT Solute carrier organic anion transporter family member 2A1 OS=Rattus norvegicus OX=10116 GN=Slco2a1 PE=1 SV=3 g10052.t1 Q5W8I8 52.265 574 0.0 572.0 sp|Q5W8I8|VGL2A_DANRE Vesicular glutamate transporter 2.1 OS=Danio rerio OX=7955 GN=slc17a6b PE=2 SV=2 VGL2A_DANRE reviewed Vesicular glutamate transporter 2.1 (Protein blumenkohl) (Solute carrier family 17 member 6-B) (Vesicular glutamate transporter 2-A) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006817; GO:0007268; GO:0007601; GO:0008021; GO:0015386; GO:0015813; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788 chemical synaptic transmission [GO:0007268]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]; visual perception [GO:0007601] chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436] g10056.t2 Q8K1C7 31.111 270 7.12e-26 111.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g10060.t1 Q9ER72 63.562 730 0.0 971.0 sp|Q9ER72|SYCC_MOUSE Cysteine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Cars1 PE=1 SV=2 g10066.t1 Q06806 47.697 304 6.92e-88 298.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10068.t1 Q86PM4 49.55 111 1.57e-27 112.0 sp|Q86PM4|FGFR_HYDVU Fibroblast growth factor receptor OS=Hydra vulgaris OX=6087 GN=FGFR PE=2 SV=1 g10071.t1 Q02858 39.948 383 4.71e-80 291.0 sp|Q02858|TIE2_MOUSE Angiopoietin-1 receptor OS=Mus musculus OX=10090 GN=Tek PE=1 SV=2 TIE2_MOUSE reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b) Mus musculus (Mouse) GO:0001525; GO:0001569; GO:0001570; GO:0001666; GO:0001935; GO:0001936; GO:0002040; GO:0002720; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007160; GO:0007166; GO:0007169; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016020; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0019838; GO:0030097; GO:0030334; GO:0030949; GO:0032526; GO:0032878; GO:0034446; GO:0036064; GO:0038023; GO:0042307; GO:0042802; GO:0043066; GO:0043235; GO:0043410; GO:0043627; GO:0045121; GO:0045765; GO:0045766; GO:0045785; GO:0048014; GO:0048471; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:0098609; GO:1901222; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to mechanical stimulus [GO:0071260]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to retinoic acid [GO:0032526]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; vasculogenesis [GO:0001570] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10079.t1 O35137 42.248 258 2.52e-51 176.0 sp|O35137|ALX4_MOUSE Homeobox protein aristaless-like 4 OS=Mus musculus OX=10090 GN=Alx4 PE=1 SV=1 ALX4_MOUSE reviewed Homeobox protein aristaless-like 4 (ALX-4) Mus musculus (Mouse) GO:0000977; GO:0001228; GO:0001942; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007389; GO:0007517; GO:0009791; GO:0009952; GO:0035108; GO:0035115; GO:0035116; GO:0042733; GO:0042981; GO:0043565; GO:0045944; GO:0048565; GO:0048666; GO:0048704; GO:0048705; GO:0060021; GO:0071837; GO:1990837 anterior/posterior pattern specification [GO:0009952]; digestive tract development [GO:0048565]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal system morphogenesis [GO:0048704]; hair follicle development [GO:0001942]; limb morphogenesis [GO:0035108]; muscle organ development [GO:0007517]; neuron development [GO:0048666]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; HMG box domain binding [GO:0071837]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g10085.t1 Q1LVQ7 41.791 268 7.58e-49 174.0 sp|Q1LVQ7|ALX1_DANRE ALX homeobox protein 1 OS=Danio rerio OX=7955 GN=alx1 PE=2 SV=1 ALX1_DANRE reviewed ALX homeobox protein 1 (Cartilage homeoprotein 1) (CART-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0001228; GO:0001755; GO:0005634; GO:0010718; GO:0045892; GO:0045893; GO:0045944; GO:0048593; GO:0048666; GO:0048701; GO:0048702; GO:0048704 camera-type eye morphogenesis [GO:0048593]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of DNA-templated transcription [GO:0045892]; neural crest cell migration [GO:0001755]; neuron development [GO:0048666]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g10085.t2 Q1LVQ7 41.791 268 3.35e-49 172.0 sp|Q1LVQ7|ALX1_DANRE ALX homeobox protein 1 OS=Danio rerio OX=7955 GN=alx1 PE=2 SV=1 ALX1_DANRE reviewed ALX homeobox protein 1 (Cartilage homeoprotein 1) (CART-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000977; GO:0001228; GO:0001755; GO:0005634; GO:0010718; GO:0045892; GO:0045893; GO:0045944; GO:0048593; GO:0048666; GO:0048701; GO:0048702; GO:0048704 camera-type eye morphogenesis [GO:0048593]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of DNA-templated transcription [GO:0045892]; neural crest cell migration [GO:0001755]; neuron development [GO:0048666]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g10086.t1 Q2TBF2 32.493 357 1.46e-49 180.0 sp|Q2TBF2|WSCD2_HUMAN Sialate:O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=WSCD2 PE=1 SV=2 WSCD2_HUMAN reviewed Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) Homo sapiens (Human) GO:0000139; GO:0008146 Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g10087.t1 Q2TBF2 31.728 353 1.02e-51 185.0 sp|Q2TBF2|WSCD2_HUMAN Sialate:O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=WSCD2 PE=1 SV=2 WSCD2_HUMAN reviewed Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) Homo sapiens (Human) GO:0000139; GO:0008146 Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g10088.t1 Q2TBF2 32.295 353 3.1999999999999997e-52 187.0 sp|Q2TBF2|WSCD2_HUMAN Sialate:O-sulfotransferase 2 OS=Homo sapiens OX=9606 GN=WSCD2 PE=1 SV=2 WSCD2_HUMAN reviewed Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) Homo sapiens (Human) GO:0000139; GO:0008146 Golgi membrane [GO:0000139] sulfotransferase activity [GO:0008146] g10092.t1 Q32KI9 52.273 484 1.18e-176 511.0 sp|Q32KI9|ARSI_MOUSE Arylsulfatase I OS=Mus musculus OX=10090 GN=Arsi PE=2 SV=1 ARSI_MOUSE reviewed Arylsulfatase I (ASI) (EC 3.1.6.-) Mus musculus (Mouse) GO:0005576; GO:0005783; GO:0008484; GO:0046872 endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576] metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484] g10093.t1 B1A193 27.953 508 2.21e-31 129.0 sp|B1A193|RASFA_XENLA Ras association domain-containing protein 10 OS=Xenopus laevis OX=8355 GN=rassf10 PE=2 SV=1 g10097.t1 A0A1B0GTJ6 31.908 304 1.09e-27 113.0 sp|A0A1B0GTJ6|SAXO3_HUMAN Stabilizer of axonemal microtubules 3 OS=Homo sapiens OX=9606 GN=SAXO3 PE=1 SV=1 g10102.t1 Q7TQI7 48.921 973 0.0 923.0 sp|Q7TQI7|ABTB2_MOUSE Ankyrin repeat and BTB/POZ domain-containing protein 2 OS=Mus musculus OX=10090 GN=Abtb2 PE=1 SV=1 g10103.t1 P42577 65.089 169 3.09e-81 241.0 sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2 g10104.t1 P42577 50.602 166 1.51e-56 178.0 sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2 g10105.t1 Q92035 32.264 561 4.18e-72 251.0 sp|Q92035|ACES_BUNFA Acetylcholinesterase OS=Bungarus fasciatus OX=8613 GN=ACHE PE=1 SV=2 g10108.t1 P41247 34.122 296 1.03e-45 158.0 sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3 PLPL4_HUMAN reviewed Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2) Homo sapiens (Human) GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088 lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739] acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g10109.t1 P41247 28.92 287 2.1300000000000002e-33 126.0 sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3 PLPL4_HUMAN reviewed Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2) Homo sapiens (Human) GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088 lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739] acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g10110.t1 Q6NTN5 47.496 1358 0.0 1209.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t1 Q6NTN5 45.137 401 6.51e-97 353.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t1 Q6NTN5 57.391 115 4.51e-34 148.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t2 Q6NTN5 47.952 1343 0.0 1216.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t2 Q6NTN5 45.137 401 6.07e-97 353.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t2 Q6NTN5 57.391 115 4.54e-34 148.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t3 Q6NTN5 48.101 1343 0.0 1215.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t3 Q6NTN5 45.137 401 6.110000000000001e-97 353.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t3 Q6NTN5 57.391 115 4.65e-34 148.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t4 Q6NTN5 48.414 1324 0.0 1225.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t4 Q6NTN5 45.137 401 4.96e-97 353.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10110.t4 Q6NTN5 57.391 115 4.18e-34 148.0 sp|Q6NTN5|MTMRD_XENLA Myotubularin-related protein 13 OS=Xenopus laevis OX=8355 GN=sbf2 PE=2 SV=1 g10111.t1 M0R2J8 34.426 671 4.36e-109 370.0 sp|M0R2J8|DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DCDC1 PE=1 SV=1 DCDC1_HUMAN reviewed Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein) Homo sapiens (Human) GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412 cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017] g10112.t1 M0R2J8 36.1 241 4e-45 166.0 sp|M0R2J8|DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DCDC1 PE=1 SV=1 DCDC1_HUMAN reviewed Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein) Homo sapiens (Human) GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412 cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017] g10114.t1 M0R2J8 30.745 631 7.57e-77 270.0 sp|M0R2J8|DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DCDC1 PE=1 SV=1 DCDC1_HUMAN reviewed Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein) Homo sapiens (Human) GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412 cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017] g10118.t1 Q5ZEQ8 33.433 335 4.2400000000000003e-44 166.0 sp|Q5ZEQ8|FJX1_XIPMA Four-jointed box protein 1 OS=Xiphophorus maculatus OX=8083 GN=fjx1 PE=2 SV=1 g10122.t1 Q9H0X9 47.239 815 0.0 723.0 sp|Q9H0X9|OSBL5_HUMAN Oxysterol-binding protein-related protein 5 OS=Homo sapiens OX=9606 GN=OSBPL5 PE=1 SV=1 OSBL5_HUMAN reviewed Oxysterol-binding protein-related protein 5 (ORP-5) (OSBP-related protein 5) (Oxysterol-binding protein homolog 1) Homo sapiens (Human) GO:0001786; GO:0005548; GO:0005789; GO:0005829; GO:0006893; GO:0008142; GO:0008203; GO:0015485; GO:0015914; GO:0016020; GO:0030301; GO:0036150; GO:0070273; GO:0140268; GO:0140343 cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020] cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548] g10124.t1 Q6GNM0 34.0 250 3.87e-38 138.0 sp|Q6GNM0|NRM_XENLA Nurim OS=Xenopus laevis OX=8355 GN=nrm PE=2 SV=1 g10125.t1 Q8IWQ3 61.897 643 0.0 761.0 sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3 g10128.t1 Q8BSS9 60.56 464 0.0 555.0 sp|Q8BSS9|LIPA2_MOUSE Liprin-alpha-2 OS=Mus musculus OX=10090 GN=Ppfia2 PE=1 SV=2 LIPA2_MOUSE reviewed Liprin-alpha-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2) (PTPRF-interacting protein alpha-2) Mus musculus (Mouse) GO:0008021; GO:0009986; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0044877; GO:0045202; GO:0048786; GO:0050808; GO:0060998; GO:0061001; GO:0098919; GO:0098978; GO:0099181; GO:0099519; GO:0099523; GO:0099572; GO:2000300 dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse organization [GO:0050808] axon [GO:0030424]; cell surface [GO:0009986]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; presynaptic active zone [GO:0048786]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] protein-containing complex binding [GO:0044877]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of presynapse [GO:0099181] g10129.t1 Q13136 59.629 701 0.0 719.0 sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1 LIPA1_HUMAN reviewed Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077 cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444] g10129.t2 Q13136 59.544 702 0.0 714.0 sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1 LIPA1_HUMAN reviewed Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077 cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444] g10129.t3 Q13136 61.401 614 0.0 652.0 sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1 LIPA1_HUMAN reviewed Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077 cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444] g10129.t4 Q13136 58.956 709 0.0 712.0 sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1 LIPA1_HUMAN reviewed Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1) Homo sapiens (Human) GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077 cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444] g10131.t1 Q8K2Q0 51.042 192 1.17e-61 193.0 sp|Q8K2Q0|COMD9_MOUSE COMM domain-containing protein 9 OS=Mus musculus OX=10090 GN=Commd9 PE=1 SV=3 g10133.t1 Q6GP17 53.846 78 2.22e-22 94.0 sp|Q6GP17|KT5BA_XENLA Histone-lysine N-methyltransferase KMT5B-A OS=Xenopus laevis OX=8355 GN=kmt5b-a PE=2 SV=1 KT5BA_XENLA reviewed Histone-lysine N-methyltransferase KMT5B-A (Lysine-specific methyltransferase 5B-A) (Suppressor of variegation 4-20 homolog 1-A) (Su(var)4-20 homolog 1-A) (Suv4-20h1-A) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) Xenopus laevis (African clawed frog) GO:0003682; GO:0005634; GO:0005694; GO:0006281; GO:0007517; GO:0032259; GO:0042799; GO:0045830; GO:0046872; GO:0140941; GO:0140944; GO:1904047; GO:2001034 DNA repair [GO:0006281]; methylation [GO:0032259]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830] chromosome [GO:0005694]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] g10134.t1 Q29RP8 75.472 106 4.49e-53 173.0 sp|Q29RP8|KMT5B_BOVIN Histone-lysine N-methyltransferase KMT5B OS=Bos taurus OX=9913 GN=KMT5B PE=2 SV=1 KMT5B_BOVIN reviewed Histone-lysine N-methyltransferase KMT5B (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) Bos taurus (Bovine) GO:0003682; GO:0005634; GO:0005694; GO:0006281; GO:0007517; GO:0032259; GO:0042054; GO:0042799; GO:0045830; GO:0046872; GO:0140941; GO:0140944; GO:1904047; GO:2001034 DNA repair [GO:0006281]; methylation [GO:0032259]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830] chromosome [GO:0005694]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] g10136.t1 Q60865 30.704 355 3.06e-38 155.0 sp|Q60865|CAPR1_MOUSE Caprin-1 OS=Mus musculus OX=10090 GN=Caprin1 PE=1 SV=2 CAPR1_MOUSE reviewed Caprin-1 (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105) Mus musculus (Mouse) GO:0000290; GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007399; GO:0007416; GO:0008298; GO:0010494; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0034063; GO:0035591; GO:0045202; GO:0045947; GO:0048699; GO:0050775; GO:0050808; GO:0061003; GO:0062029; GO:0098794; GO:0098978; GO:0106288; GO:0140677; GO:0140693; GO:0140694 deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; membraneless organelle assembly [GO:0140694]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; nervous system development [GO:0007399]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; stress granule assembly [GO:0034063]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; P-body [GO:0000932]; postsynapse [GO:0098794]; synapse [GO:0045202] ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591] g10139.t1 Q8N682 33.198 247 1.2099999999999999e-42 148.0 sp|Q8N682|DRAM1_HUMAN DNA damage-regulated autophagy modulator protein 1 OS=Homo sapiens OX=9606 GN=DRAM1 PE=1 SV=1 g10140.t1 Q6UX65 41.35 237 1.14e-51 172.0 sp|Q6UX65|DRAM2_HUMAN DNA damage-regulated autophagy modulator protein 2 OS=Homo sapiens OX=9606 GN=DRAM2 PE=1 SV=1 DRAM2_HUMAN reviewed DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77) Homo sapiens (Human) GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0008283; GO:0010506; GO:0016324; GO:0045494; GO:0060041 apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917] g10141.t1 Q5BK09 32.075 265 2.55e-33 125.0 sp|Q5BK09|DRAM2_RAT DNA damage-regulated autophagy modulator protein 2 OS=Rattus norvegicus OX=10116 GN=Dram2 PE=2 SV=1 g10142.t1 Q6UX65 35.874 223 2.07e-34 128.0 sp|Q6UX65|DRAM2_HUMAN DNA damage-regulated autophagy modulator protein 2 OS=Homo sapiens OX=9606 GN=DRAM2 PE=1 SV=1 DRAM2_HUMAN reviewed DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77) Homo sapiens (Human) GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0008283; GO:0010506; GO:0016324; GO:0045494; GO:0060041 apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917] g10143.t1 Q3T906 40.445 764 0.0 594.0 sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1 GNPTA_HUMAN reviewed N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta] Homo sapiens (Human) GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835 carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] g10143.t1 Q3T906 55.135 370 1.6100000000000001e-121 419.0 sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1 GNPTA_HUMAN reviewed N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta] Homo sapiens (Human) GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835 carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] g10146.t1 Q01134 40.0 395 7.33e-96 297.0 sp|Q01134|CHKA_RAT Choline kinase alpha OS=Rattus norvegicus OX=10116 GN=Chka PE=1 SV=2 g10146.t2 Q01134 41.885 382 4.59e-103 314.0 sp|Q01134|CHKA_RAT Choline kinase alpha OS=Rattus norvegicus OX=10116 GN=Chka PE=1 SV=2 g10147.t1 Q924W7 43.34 503 2.77e-118 397.0 sp|Q924W7|DEN2B_MOUSE DENN domain-containing protein 2B OS=Mus musculus OX=10090 GN=Dennd2b PE=1 SV=1 g10147.t2 Q924W7 45.223 471 4.06e-121 387.0 sp|Q924W7|DEN2B_MOUSE DENN domain-containing protein 2B OS=Mus musculus OX=10090 GN=Dennd2b PE=1 SV=1 g10151.t1 Q06806 46.948 213 4.7500000000000004e-58 220.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10151.t2 Q06806 46.948 213 5.98e-58 220.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10151.t3 Q06806 46.948 213 5.9200000000000006e-58 220.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10153.t1 E7F7V7 25.439 342 1.1300000000000002e-27 114.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g10154.t1 E7F7V7 29.221 308 1.56e-22 101.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g10157.t1 O75899 33.287 721 1.4e-130 414.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g10159.t1 O08587 34.109 516 4.98e-65 219.0 sp|O08587|NUP50_RAT Nuclear pore complex protein Nup50 OS=Rattus norvegicus OX=10116 GN=Nup50 PE=2 SV=2 g10160.t1 P24399 53.901 141 9.969999999999999e-48 162.0 sp|P24399|ZN239_MOUSE Zinc finger protein 239 OS=Mus musculus OX=10090 GN=Znf239 PE=2 SV=2 g10160.t1 P24399 56.061 132 9.28e-45 154.0 sp|P24399|ZN239_MOUSE Zinc finger protein 239 OS=Mus musculus OX=10090 GN=Znf239 PE=2 SV=2 g10160.t1 P24399 46.108 167 3.25e-44 153.0 sp|P24399|ZN239_MOUSE Zinc finger protein 239 OS=Mus musculus OX=10090 GN=Znf239 PE=2 SV=2 g10160.t1 P24399 46.259 147 6.51e-37 134.0 sp|P24399|ZN239_MOUSE Zinc finger protein 239 OS=Mus musculus OX=10090 GN=Znf239 PE=2 SV=2 g10161.t1 P49109 44.444 540 6.2000000000000005e-161 471.0 sp|P49109|FMO5_CAVPO Flavin-containing monooxygenase 5 OS=Cavia porcellus OX=10141 GN=FMO5 PE=1 SV=2 g10166.t1 Q9WVQ5 67.907 215 1.45e-106 309.0 sp|Q9WVQ5|MTNB_MOUSE Methylthioribulose-1-phosphate dehydratase OS=Mus musculus OX=10090 GN=Apip PE=1 SV=1 MTNB_MOUSE reviewed Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein) (Monocyte/macrophage protein 19) Mus musculus (Mouse) GO:0005737; GO:0006915; GO:0008270; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372 apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptotic inflammatory response [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasm [GO:0005737] identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270] g10166.t2 Q9WVQ5 65.581 215 1.44e-101 296.0 sp|Q9WVQ5|MTNB_MOUSE Methylthioribulose-1-phosphate dehydratase OS=Mus musculus OX=10090 GN=Apip PE=1 SV=1 MTNB_MOUSE reviewed Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein) (Monocyte/macrophage protein 19) Mus musculus (Mouse) GO:0005737; GO:0006915; GO:0008270; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372 apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptotic inflammatory response [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasm [GO:0005737] identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270] g10167.t1 O00330 49.785 466 3.18e-139 411.0 sp|O00330|ODPX_HUMAN Pyruvate dehydrogenase protein X component, mitochondrial OS=Homo sapiens OX=9606 GN=PDHX PE=1 SV=3 ODPX_HUMAN reviewed Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein) (E3BP) (Lipoyl-containing pyruvate dehydrogenase complex component X) (proX) Homo sapiens (Human) GO:0004742; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0006086; GO:0045254 pyruvate decarboxylation to acetyl-CoA [GO:0006086] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254] dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742] g10170.t1 Q9UPZ3 32.042 284 9.71e-33 134.0 sp|Q9UPZ3|HPS5_HUMAN BLOC-2 complex member HPS5 OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2 g10171.t1 Q9UPZ3 45.669 127 7.57e-27 108.0 sp|Q9UPZ3|HPS5_HUMAN BLOC-2 complex member HPS5 OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2 g10173.t1 B2RNN3 36.237 287 6.87e-29 115.0 sp|B2RNN3|C1T9B_HUMAN Complement C1q and tumor necrosis factor-related protein 9B OS=Homo sapiens OX=9606 GN=C1QTNF9B PE=1 SV=1 C1T9B_HUMAN reviewed Complement C1q and tumor necrosis factor-related protein 9B (C1q/TNF-related protein 9B) (CTRP9B) (Complement C1q and tumor necrosis factor-related protein 9-like) Homo sapiens (Human) GO:0005576; GO:0005581 collagen trimer [GO:0005581]; extracellular region [GO:0005576] g10174.t1 B2RNN3 34.286 280 5.88e-26 107.0 sp|B2RNN3|C1T9B_HUMAN Complement C1q and tumor necrosis factor-related protein 9B OS=Homo sapiens OX=9606 GN=C1QTNF9B PE=1 SV=1 C1T9B_HUMAN reviewed Complement C1q and tumor necrosis factor-related protein 9B (C1q/TNF-related protein 9B) (CTRP9B) (Complement C1q and tumor necrosis factor-related protein 9-like) Homo sapiens (Human) GO:0005576; GO:0005581 collagen trimer [GO:0005581]; extracellular region [GO:0005576] g10177.t1 Q4R764 54.07 172 3.1199999999999997e-60 193.0 sp|Q4R764|SYCP3_MACFA Synaptonemal complex protein 3 OS=Macaca fascicularis OX=9541 GN=SYCP3 PE=2 SV=1 SYCP3_MACFA reviewed Synaptonemal complex protein 3 (SCP-3) Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) GO:0000775; GO:0000800; GO:0003677; GO:0005694; GO:0035092; GO:0051301; GO:0051321 cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; sperm DNA condensation [GO:0035092] chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800] DNA binding [GO:0003677] g10178.t1 O95238 50.593 253 1.86e-79 249.0 sp|O95238|SPDEF_HUMAN SAM pointed domain-containing Ets transcription factor OS=Homo sapiens OX=9606 GN=SPDEF PE=1 SV=1 SPDEF_HUMAN reviewed SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor) (Prostate-specific Ets) (Prostate-derived Ets factor) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000981; GO:0002068; GO:0005634; GO:0006357; GO:0006366; GO:0010454; GO:0010455; GO:0030154; GO:0043065; GO:0043565; GO:0045944; GO:0060480; GO:0060576; GO:0072148; GO:1990837 cell differentiation [GO:0030154]; epithelial cell fate commitment [GO:0072148]; glandular epithelial cell development [GO:0002068]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g10180.t1 Q4V920 30.897 301 6.68e-44 167.0 sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1 PACN1_DANRE reviewed Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006 actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202] phospholipid binding [GO:0005543] g10181.t1 Q6ZQ03 36.073 219 4.6200000000000003e-35 144.0 sp|Q6ZQ03|FNBP4_MOUSE Formin-binding protein 4 OS=Mus musculus OX=10090 GN=Fnbp4 PE=1 SV=2 g10184.t1 Q5ZL77 43.385 325 4.5e-75 242.0 sp|Q5ZL77|RIC8A_CHICK Chaperone Ric-8A OS=Gallus gallus OX=9031 GN=RIC8A PE=2 SV=1 g10185.t1 Q9NTG7 61.481 270 3.6400000000000003e-118 359.0 sp|Q9NTG7|SIR3_HUMAN NAD-dependent protein deacetylase sirtuin-3, mitochondrial OS=Homo sapiens OX=9606 GN=SIRT3 PE=1 SV=2 g10192.t1 Q9Y3E0 71.014 138 6.68e-48 154.0 sp|Q9Y3E0|GOT1B_HUMAN Vesicle transport protein GOT1B OS=Homo sapiens OX=9606 GN=GOLT1B PE=1 SV=1 g10194.t1 P16390 60.521 499 0.0 592.0 sp|P16390|KCNA3_MOUSE Potassium voltage-gated channel subfamily A member 3 OS=Mus musculus OX=10090 GN=Kcna3 PE=1 SV=3 g10196.t1 Q8N682 29.386 228 2.58e-23 99.0 sp|Q8N682|DRAM1_HUMAN DNA damage-regulated autophagy modulator protein 1 OS=Homo sapiens OX=9606 GN=DRAM1 PE=1 SV=1 g10198.t1 P61082 32.941 170 1.19e-25 104.0 sp|P61082|UBC12_MOUSE NEDD8-conjugating enzyme Ubc12 OS=Mus musculus OX=10090 GN=Ube2m PE=1 SV=1 UBC12_MOUSE reviewed NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M) Mus musculus (Mouse) GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0043525; GO:0045116; GO:0061654; GO:0098793; GO:0098794; GO:0098978; GO:0150052 positive regulation of neuron apoptotic process [GO:0043525]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; regulation of postsynapse assembly [GO:0150052] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842] g10199.t1 Q99JX1 71.963 107 3.25e-49 164.0 sp|Q99JX1|TAF11_MOUSE Transcription initiation factor TFIID subunit 11 OS=Mus musculus OX=10090 GN=Taf11 PE=1 SV=1 g10200.t1 Q15256 45.54 426 2.9799999999999997e-115 355.0 sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2 g10201.t1 O75795 31.237 493 3.45e-69 235.0 sp|O75795|UDB17_HUMAN UDP-glucuronosyltransferase 2B17 OS=Homo sapiens OX=9606 GN=UGT2B17 PE=1 SV=1 UDB17_HUMAN reviewed UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT) Homo sapiens (Human) GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0015020; GO:0016020 estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucuronosyltransferase activity [GO:0015020] g10202.t1 A7MBI7 40.084 237 2.7999999999999996e-54 179.0 sp|A7MBI7|COMT_BOVIN Catechol O-methyltransferase OS=Bos taurus OX=9913 GN=COMT PE=2 SV=1 COMT_BOVIN reviewed Catechol O-methyltransferase (EC 2.1.1.6) Bos taurus (Bovine) GO:0000287; GO:0005829; GO:0005886; GO:0006629; GO:0016020; GO:0016206; GO:0030424; GO:0030425; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g10203.t1 A7MBI7 43.578 218 6.650000000000001e-58 188.0 sp|A7MBI7|COMT_BOVIN Catechol O-methyltransferase OS=Bos taurus OX=9913 GN=COMT PE=2 SV=1 COMT_BOVIN reviewed Catechol O-methyltransferase (EC 2.1.1.6) Bos taurus (Bovine) GO:0000287; GO:0005829; GO:0005886; GO:0006629; GO:0016020; GO:0016206; GO:0030424; GO:0030425; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g10204.t1 Q3UR85 51.82 577 0.0 599.0 sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2 MYRF_MOUSE reviewed Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal] Mus musculus (Mouse) GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0042802; GO:0043565; GO:0045893; GO:0048709; GO:0048714 central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565] g10204.t2 Q3UR85 51.82 577 0.0 599.0 sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2 MYRF_MOUSE reviewed Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal] Mus musculus (Mouse) GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0042802; GO:0043565; GO:0045893; GO:0048709; GO:0048714 central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565] g10205.t1 Q9QZU7 32.804 378 1.58e-74 239.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g10208.t1 P15823 25.21 357 6.15e-21 98.2 sp|P15823|ADA1B_RAT Alpha-1B adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1b PE=2 SV=2 ADA1B_RAT reviewed Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor) Rattus norvegicus (Rat) GO:0001974; GO:0001975; GO:0001987; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005901; GO:0007200; GO:0007204; GO:0007267; GO:0007512; GO:0007626; GO:0008217; GO:0008542; GO:0009410; GO:0009725; GO:0014704; GO:0016020; GO:0019229; GO:0030315; GO:0031965; GO:0035024; GO:0035265; GO:0042593; GO:0043278; GO:0043410; GO:0043627; GO:0045818; GO:0045819; GO:0046982; GO:0048148; GO:0048545; GO:0055117; GO:0061049; GO:0071880; GO:0150099 adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; behavioral response to cocaine [GO:0048148]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; locomotory behavior [GO:0007626]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229]; response to amphetamine [GO:0001975]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]; response to morphine [GO:0043278]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [GO:0001987]; visual learning [GO:0008542] caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982] g10209.t1 Q7TM99 24.319 477 1.3299999999999998e-23 107.0 sp|Q7TM99|MOT9_MOUSE Monocarboxylate transporter 9 OS=Mus musculus OX=10090 GN=Slc16a9 PE=2 SV=1 g10210.t1 Q61121 48.361 366 1.25e-114 343.0 sp|Q61121|GPR19_MOUSE Probable G-protein coupled receptor 19 OS=Mus musculus OX=10090 GN=Gpr19 PE=2 SV=2 g10212.t1 P10079 41.087 589 2.3300000000000004e-129 440.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g10212.t1 P10079 40.833 600 1.31e-126 432.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g10212.t1 P10079 40.657 578 3.2000000000000005e-123 422.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g10212.t1 P10079 40.933 579 1.34e-119 411.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g10212.t1 P10079 44.332 397 1.6000000000000001e-87 315.0 sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus OX=7668 GN=EGF1 PE=1 SV=2 g10217.t1 Q8C8U0 41.526 1009 0.0 637.0 sp|Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus OX=10090 GN=Ppfibp1 PE=1 SV=3 LIPB1_MOUSE reviewed Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) Mus musculus (Mouse) GO:0005829; GO:0005886; GO:0005938; GO:0007528; GO:0043622; GO:0048786 cortical microtubule organization [GO:0043622]; neuromuscular junction development [GO:0007528] cell cortex [GO:0005938]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] g10217.t2 Q8C8U0 40.976 1025 0.0 632.0 sp|Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus OX=10090 GN=Ppfibp1 PE=1 SV=3 LIPB1_MOUSE reviewed Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) Mus musculus (Mouse) GO:0005829; GO:0005886; GO:0005938; GO:0007528; GO:0043622; GO:0048786 cortical microtubule organization [GO:0043622]; neuromuscular junction development [GO:0007528] cell cortex [GO:0005938]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] g10217.t3 Q8ND30 37.775 908 1.0900000000000001e-167 515.0 sp|Q8ND30|LIPB2_HUMAN Liprin-beta-2 OS=Homo sapiens OX=9606 GN=PPFIBP2 PE=1 SV=3 LIPB2_HUMAN reviewed Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2) (PTPRF-interacting protein-binding protein 2) Homo sapiens (Human) GO:0005615; GO:0005829; GO:0007528; GO:0042802; GO:0048786 neuromuscular junction development [GO:0007528] cytosol [GO:0005829]; extracellular space [GO:0005615]; presynaptic active zone [GO:0048786] identical protein binding [GO:0042802] g10218.t1 A6NJ78 52.212 339 2.61e-117 349.0 sp|A6NJ78|MET15_HUMAN 12S rRNA N(4)-cytidine methyltransferase METTL15 OS=Homo sapiens OX=9606 GN=METTL15 PE=1 SV=1 MET15_HUMAN reviewed 12S rRNA N(4)-cytidine methyltransferase METTL15 (12S rRNA m4C methyltransferase) (EC 2.1.1.-) (Methyltransferase 5 domain-containing protein 1) (Methyltransferase-like protein 15) Homo sapiens (Human) GO:0005739; GO:0005759; GO:0070475; GO:0071424; GO:0180026 mitochondrial small ribosomal subunit assembly [GO:0180026]; rRNA base methylation [GO:0070475] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424] g10219.t1 Q8NI77 49.433 617 0.0 594.0 sp|Q8NI77|KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens OX=9606 GN=KIF18A PE=1 SV=2 KI18A_HUMAN reviewed Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A) Homo sapiens (Human) GO:0000070; GO:0000776; GO:0001726; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005828; GO:0005829; GO:0005871; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023 cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520] caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726] actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463] g10221.t1 Q922J9 54.297 512 0.0 612.0 sp|Q922J9|FACR1_MOUSE Fatty acyl-CoA reductase 1 OS=Mus musculus OX=10090 GN=Far1 PE=1 SV=1 g10221.t2 Q922J9 54.297 512 0.0 611.0 sp|Q922J9|FACR1_MOUSE Fatty acyl-CoA reductase 1 OS=Mus musculus OX=10090 GN=Far1 PE=1 SV=1 g10222.t1 Q6AY97 32.863 496 2.8200000000000003e-47 174.0 sp|Q6AY97|CCD91_RAT Coiled-coil domain-containing protein 91 OS=Rattus norvegicus OX=10116 GN=Ccdc91 PE=1 SV=1 g10223.t1 P40240 32.52 246 5.8e-38 135.0 sp|P40240|CD9_MOUSE CD9 antigen OS=Mus musculus OX=10090 GN=Cd9 PE=1 SV=2 CD9_MOUSE reviewed CD9 antigen (CD antigen CD9) Mus musculus (Mouse) GO:0005178; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0008285; GO:0008347; GO:0009897; GO:0009986; GO:0014003; GO:0014905; GO:0016020; GO:0016324; GO:0030913; GO:0031623; GO:0032991; GO:0035036; GO:0070062; GO:0071404; GO:0090331; GO:1905521 cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet aggregation [GO:0090331]; oligodendrocyte development [GO:0014003]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] integrin binding [GO:0005178] g10223.t2 P40240 34.694 245 6.82e-49 163.0 sp|P40240|CD9_MOUSE CD9 antigen OS=Mus musculus OX=10090 GN=Cd9 PE=1 SV=2 CD9_MOUSE reviewed CD9 antigen (CD antigen CD9) Mus musculus (Mouse) GO:0005178; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0008285; GO:0008347; GO:0009897; GO:0009986; GO:0014003; GO:0014905; GO:0016020; GO:0016324; GO:0030913; GO:0031623; GO:0032991; GO:0035036; GO:0070062; GO:0071404; GO:0090331; GO:1905521 cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet aggregation [GO:0090331]; oligodendrocyte development [GO:0014003]; paranodal junction assembly [GO:0030913]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] integrin binding [GO:0005178] g10224.t1 Q9D1D1 32.129 249 2.3399999999999998e-34 127.0 sp|Q9D1D1|TSN11_MOUSE Tetraspanin-11 OS=Mus musculus OX=10090 GN=Tspan11 PE=2 SV=1 g10227.t1 Q96AE7 32.883 1183 1.5100000000000002e-179 560.0 sp|Q96AE7|TTC17_HUMAN Tetratricopeptide repeat protein 17 OS=Homo sapiens OX=9606 GN=TTC17 PE=1 SV=1 g10228.t1 Q7TSE6 72.009 468 0.0 699.0 sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus OX=10090 GN=Stk38l PE=1 SV=2 ST38L_MOUSE reviewed Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2) Mus musculus (Mouse) GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0010508; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0098978; GO:0099173; GO:0106310 intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; positive regulation of autophagy [GO:0010508]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020] actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g10229.t1 Q9D8N3 41.379 232 3.73e-44 158.0 sp|Q9D8N3|TM86A_MOUSE Lysoplasmalogenase TMEM86A OS=Mus musculus OX=10090 GN=Tmem86a PE=1 SV=1 TM86A_MOUSE reviewed Lysoplasmalogenase TMEM86A (EC 3.3.2.2) (Transmembrane protein 86A) Mus musculus (Mouse) GO:0005789; GO:0006629; GO:0016020; GO:0016787; GO:0047408 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] alkenylglycerophosphocholine hydrolase activity [GO:0047408]; hydrolase activity [GO:0016787] g10229.t1 Q9D8N3 35.47 234 9.77e-27 111.0 sp|Q9D8N3|TM86A_MOUSE Lysoplasmalogenase TMEM86A OS=Mus musculus OX=10090 GN=Tmem86a PE=1 SV=1 TM86A_MOUSE reviewed Lysoplasmalogenase TMEM86A (EC 3.3.2.2) (Transmembrane protein 86A) Mus musculus (Mouse) GO:0005789; GO:0006629; GO:0016020; GO:0016787; GO:0047408 lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] alkenylglycerophosphocholine hydrolase activity [GO:0047408]; hydrolase activity [GO:0016787] g10230.t1 O77302 72.436 156 3.89e-74 221.0 sp|O77302|RS10_LUMRU Small ribosomal subunit protein eS10 OS=Lumbricus rubellus OX=35632 GN=RPS10 PE=2 SV=1 g10231.t1 Q7T2B9 48.673 113 9.39e-32 111.0 sp|Q7T2B9|MTPN_DANRE Myotrophin OS=Danio rerio OX=7955 GN=mtpn PE=3 SV=1 g10233.t1 O13154 46.56 436 6.57e-135 398.0 sp|O13154|PACN2_CHICK Protein kinase C and casein kinase substrate in neurons protein 2 OS=Gallus gallus OX=9031 GN=PACSIN2 PE=1 SV=1 g10233.t2 Q4V920 44.719 445 2.84e-133 393.0 sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1 PACN1_DANRE reviewed Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006 actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202] phospholipid binding [GO:0005543] g10234.t1 Q6P7K5 48.131 214 2.32e-58 189.0 sp|Q6P7K5|EMC10_XENTR ER membrane protein complex subunit 10 OS=Xenopus tropicalis OX=8364 GN=emc10 PE=2 SV=1 g10235.t1 P30932 28.692 237 4.05e-25 102.0 sp|P30932|CD9_BOVIN CD9 antigen OS=Bos taurus OX=9913 GN=CD9 PE=2 SV=2 g10236.t1 A0A8V0ZLT4 31.621 253 2.2300000000000002e-29 114.0 sp|A0A8V0ZLT4|TSN18_CHICK Tetraspanin-18 OS=Gallus gallus OX=9031 GN=TSPAN18 PE=2 SV=1 g10237.t1 Q9D1D1 41.079 241 1.1900000000000001e-57 187.0 sp|Q9D1D1|TSN11_MOUSE Tetraspanin-11 OS=Mus musculus OX=10090 GN=Tspan11 PE=2 SV=1 g10238.t1 Q28F07 77.946 331 0.0 556.0 sp|Q28F07|ANM1_XENTR Protein arginine N-methyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=prmt1 PE=2 SV=1 ANM1_XENTR reviewed Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007552; GO:0008170; GO:0008276; GO:0008284; GO:0008380; GO:0016274; GO:0018216; GO:0022008; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0044020; GO:0045652; GO:0045653; GO:0045893; GO:0048738; GO:0051260; GO:0061431; GO:0106080; GO:1904047; GO:1904263; GO:1905168 cardiac muscle tissue development [GO:0048738]; cellular response to methionine [GO:0061431]; chromatin remodeling [GO:0006338]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of TORC1 signaling [GO:1904263]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of DNA-templated transcription [GO:0006355]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GATOR1 complex binding [GO:0106080]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713] g10239.t1 Q76B49 33.735 249 5.66e-33 123.0 sp|Q76B49|CD63_FELCA CD63 antigen OS=Felis catus OX=9685 GN=CD63 PE=2 SV=3 g10240.t1 Q568Y5 31.967 244 3.16e-38 137.0 sp|Q568Y5|TSN11_RAT Tetraspanin-11 OS=Rattus norvegicus OX=10116 GN=Tspan11 PE=2 SV=1 g10241.t1 A1L157 29.956 227 8.91e-24 99.8 sp|A1L157|TSN11_HUMAN Tetraspanin-11 OS=Homo sapiens OX=9606 GN=TSPAN11 PE=1 SV=2 g10242.t1 Q8INF0 51.815 606 0.0 636.0 sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4 GCY8E_DROME reviewed Soluble guanylate cyclase 88E (EC 4.6.1.2) Drosophila melanogaster (Fruit fly) GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482 nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302] guanylate cyclase complex, soluble [GO:0008074] carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g10242.t2 Q8INF0 50.643 622 0.0 629.0 sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4 GCY8E_DROME reviewed Soluble guanylate cyclase 88E (EC 4.6.1.2) Drosophila melanogaster (Fruit fly) GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482 nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302] guanylate cyclase complex, soluble [GO:0008074] carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g10242.t3 Q8INF0 49.842 634 0.0 627.0 sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4 GCY8E_DROME reviewed Soluble guanylate cyclase 88E (EC 4.6.1.2) Drosophila melanogaster (Fruit fly) GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482 nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302] guanylate cyclase complex, soluble [GO:0008074] carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] g10243.t1 Q16629 46.903 113 3.34e-27 105.0 sp|Q16629|SRSF7_HUMAN Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7 PE=1 SV=1 SRSF7_HUMAN reviewed Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:0070062; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g10244.t1 Q16629 50.725 138 3.3499999999999997e-34 123.0 sp|Q16629|SRSF7_HUMAN Serine/arginine-rich splicing factor 7 OS=Homo sapiens OX=9606 GN=SRSF7 PE=1 SV=1 SRSF7_HUMAN reviewed Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7) Homo sapiens (Human) GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:0070062; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g10245.t1 Q6K1J1 30.261 499 1.4399999999999999e-68 233.0 sp|Q6K1J1|UDB31_CANLF UDP-glucuronosyltransferase 2B31 OS=Canis lupus familiaris OX=9615 GN=UGT2B31 PE=1 SV=1 g10246.t1 P70691 30.739 501 3.07e-68 232.0 sp|P70691|UD12_MOUSE UDP-glucuronosyltransferase 1-2 OS=Mus musculus OX=10090 GN=Ugt1a2 PE=1 SV=1 g10247.t1 A7MBI7 45.455 198 2.8299999999999995e-54 178.0 sp|A7MBI7|COMT_BOVIN Catechol O-methyltransferase OS=Bos taurus OX=9913 GN=COMT PE=2 SV=1 COMT_BOVIN reviewed Catechol O-methyltransferase (EC 2.1.1.6) Bos taurus (Bovine) GO:0000287; GO:0005829; GO:0005886; GO:0006629; GO:0016020; GO:0016206; GO:0030424; GO:0030425; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g10248.t1 P22734 46.354 192 1.97e-54 178.0 sp|P22734|COMT_RAT Catechol O-methyltransferase OS=Rattus norvegicus OX=10116 GN=Comt PE=1 SV=2 COMT_RAT reviewed Catechol O-methyltransferase (EC 2.1.1.6) Rattus norvegicus (Rat) GO:0000287; GO:0001662; GO:0001666; GO:0001822; GO:0001963; GO:0001964; GO:0001975; GO:0002001; GO:0005615; GO:0005829; GO:0005977; GO:0006584; GO:0006693; GO:0006950; GO:0006979; GO:0007565; GO:0007611; GO:0007612; GO:0007613; GO:0007614; GO:0008210; GO:0008217; GO:0008542; GO:0009266; GO:0009410; GO:0009611; GO:0009636; GO:0009712; GO:0010467; GO:0014046; GO:0016020; GO:0016036; GO:0016206; GO:0021696; GO:0030424; GO:0030425; GO:0031982; GO:0032094; GO:0032259; GO:0032496; GO:0032502; GO:0032835; GO:0033344; GO:0033555; GO:0034097; GO:0035264; GO:0035640; GO:0035812; GO:0042415; GO:0042417; GO:0042420; GO:0042424; GO:0042596; GO:0043197; GO:0043627; GO:0044297; GO:0045211; GO:0045963; GO:0046498; GO:0046500; GO:0046959; GO:0048243; GO:0048265; GO:0048662; GO:0050668; GO:0050890; GO:0050965; GO:0051412; GO:0060840; GO:0071314; GO:0071626; GO:0097018; GO:0097205; GO:0097333; GO:0097336; GO:0097386; GO:0098794; GO:0098978; GO:1902074; GO:1903350; GO:1903489; GO:1990776 artery development [GO:0060840]; behavioral fear response [GO:0001662]; catechol-containing compound metabolic process [GO:0009712]; catecholamine catabolic process [GO:0042424]; catecholamine metabolic process [GO:0006584]; cellular response to cocaine [GO:0071314]; cellular response to phosphate starvation [GO:0016036]; cerebellar cortex morphogenesis [GO:0021696]; cholesterol efflux [GO:0033344]; cognition [GO:0050890]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; dopamine secretion [GO:0014046]; estrogen metabolic process [GO:0008210]; exploration behavior [GO:0035640]; fear response [GO:0042596]; female pregnancy [GO:0007565]; gene expression [GO:0010467]; glomerulus development [GO:0032835]; glycogen metabolic process [GO:0005977]; habituation [GO:0046959]; kidney development [GO:0001822]; learning [GO:0007612]; learning or memory [GO:0007611]; mastication [GO:0071626]; memory [GO:0007613]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; multicellular organismal response to stress [GO:0033555]; negative regulation of dopamine metabolic process [GO:0045963]; negative regulation of smooth muscle cell proliferation [GO:0048662]; norepinephrine metabolic process [GO:0042415]; norepinephrine secretion [GO:0048243]; positive regulation of homocysteine metabolic process [GO:0050668]; positive regulation of lactation [GO:1903489]; prostaglandin metabolic process [GO:0006693]; regulation of blood pressure [GO:0008217]; renal albumin absorption [GO:0097018]; renal filtration [GO:0097205]; renal sodium excretion [GO:0035812]; renin secretion into blood stream [GO:0002001]; response to amphetamine [GO:0001975]; response to angiotensin [GO:1990776]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to dopamine [GO:1903350]; response to estrogen [GO:0043627]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to olanzapine [GO:0097333]; response to oxidative stress [GO:0006979]; response to pain [GO:0048265]; response to risperidone [GO:0097336]; response to salt [GO:1902074]; response to stress [GO:0006950]; response to temperature stimulus [GO:0009266]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; short-term memory [GO:0007614]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; visual learning [GO:0008542] axon [GO:0030424]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; vesicle [GO:0031982] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g10249.t1 A7MBI7 45.238 168 1.94e-46 155.0 sp|A7MBI7|COMT_BOVIN Catechol O-methyltransferase OS=Bos taurus OX=9913 GN=COMT PE=2 SV=1 COMT_BOVIN reviewed Catechol O-methyltransferase (EC 2.1.1.6) Bos taurus (Bovine) GO:0000287; GO:0005829; GO:0005886; GO:0006629; GO:0016020; GO:0016206; GO:0030424; GO:0030425; GO:0032259; GO:0032502; GO:0042417; GO:0042424 catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287] g10252.t1 Q924Y0 36.243 378 5.97e-89 280.0 sp|Q924Y0|BODG_MOUSE Gamma-butyrobetaine dioxygenase OS=Mus musculus OX=10090 GN=Bbox1 PE=1 SV=1 g10253.t1 O75936 35.0 360 2.13e-77 247.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g10255.t1 Q924Y0 38.813 219 4.3699999999999997e-45 158.0 sp|Q924Y0|BODG_MOUSE Gamma-butyrobetaine dioxygenase OS=Mus musculus OX=10090 GN=Bbox1 PE=1 SV=1 g10258.t1 Q8CJ96 31.066 441 1.62e-35 138.0 sp|Q8CJ96|RASF8_MOUSE Ras association domain-containing protein 8 OS=Mus musculus OX=10090 GN=Rassf8 PE=2 SV=1 g10259.t1 Q6NRZ1 29.084 1616 0.0 640.0 sp|Q6NRZ1|BLT3B_XENLA Bridge-like lipid transfer protein family member 3B OS=Xenopus laevis OX=8355 GN=bltp3b PE=2 SV=1 g10262.t1 Q9QZU7 33.245 379 3.66e-71 231.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g10265.t1 O75936 36.99 392 5.1599999999999995e-82 259.0 sp|O75936|BODG_HUMAN Gamma-butyrobetaine dioxygenase OS=Homo sapiens OX=9606 GN=BBOX1 PE=1 SV=1 BODG_HUMAN reviewed Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase) Homo sapiens (Human) GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] g10270.t1 D4A734 23.982 442 7.000000000000001e-32 130.0 sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1 MOT12_RAT reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Rattus norvegicus (Rat) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g10271.t1 Q9QZU7 35.884 379 3.39e-80 254.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g10279.t1 Q9QZU7 35.696 381 6.12e-80 253.0 sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1 g10282.t1 D3Z5L6 31.461 445 2.17e-63 216.0 sp|D3Z5L6|S18B1_MOUSE MFS-type transporter SLC18B1 OS=Mus musculus OX=10090 GN=Slc18b1 PE=1 SV=2 S18B1_MOUSE reviewed MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT) Mus musculus (Mouse) GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610 serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296] secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857] g10283.t1 O09158 32.806 506 4.67e-90 287.0 sp|O09158|CP3AP_MOUSE Cytochrome P450 3A25 OS=Mus musculus OX=10090 GN=Cyp3a25 PE=1 SV=1 g10293.t1 Q6ZV73 31.105 389 9.53e-38 152.0 sp|Q6ZV73|FGD6_HUMAN FYVE, RhoGEF and PH domain-containing protein 6 OS=Homo sapiens OX=9606 GN=FGD6 PE=1 SV=2 FGD6_HUMAN reviewed FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24) Homo sapiens (Human) GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008270; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847 actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] g10295.t1 P28656 62.881 361 1.37e-143 416.0 sp|P28656|NP1L1_MOUSE Nucleosome assembly protein 1-like 1 OS=Mus musculus OX=10090 GN=Nap1l1 PE=1 SV=2 NP1L1_MOUSE reviewed Nucleosome assembly protein 1-like 1 (Brain protein DN38) (Histone H2A-H2B chaperone NAP1L1) (NAP-1-related protein) Mus musculus (Mouse) GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007399; GO:0019900; GO:0042393; GO:0042470; GO:0050769; GO:0140713; GO:2000179 nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769] chromatin [GO:0000785]; cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; kinase binding [GO:0019900] g10295.t2 P28656 62.022 366 7.81e-143 415.0 sp|P28656|NP1L1_MOUSE Nucleosome assembly protein 1-like 1 OS=Mus musculus OX=10090 GN=Nap1l1 PE=1 SV=2 NP1L1_MOUSE reviewed Nucleosome assembly protein 1-like 1 (Brain protein DN38) (Histone H2A-H2B chaperone NAP1L1) (NAP-1-related protein) Mus musculus (Mouse) GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007399; GO:0019900; GO:0042393; GO:0042470; GO:0050769; GO:0140713; GO:2000179 nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769] chromatin [GO:0000785]; cytoplasm [GO:0005737]; melanosome [GO:0042470]; nucleus [GO:0005634] chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; kinase binding [GO:0019900] g10301.t1 Q63ZU0 45.763 354 1.32e-112 335.0 sp|Q63ZU0|ADA_XENTR Adenosine deaminase OS=Xenopus tropicalis OX=8364 GN=ada PE=2 SV=1 g10303.t1 Q8BJ56 38.353 425 2.4e-84 273.0 sp|Q8BJ56|PLPL2_MOUSE Patatin-like phospholipase domain-containing protein 2 OS=Mus musculus OX=10090 GN=Pnpla2 PE=1 SV=1 PLPL2_MOUSE reviewed Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2-zeta) (iPLA2-zeta) (EC 3.1.1.4) (Desnutrin) Mus musculus (Mouse) GO:0001523; GO:0004623; GO:0004806; GO:0005654; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0006651; GO:0010891; GO:0010898; GO:0016020; GO:0016042; GO:0016411; GO:0019433; GO:0019915; GO:0034389; GO:0035356; GO:0050253; GO:0051264; GO:0051265; GO:0055088; GO:0160077; GO:1905691 diacylglycerol biosynthetic process [GO:0006651]; intracellular triglyceride homeostasis [GO:0035356]; lipid catabolic process [GO:0016042]; lipid droplet disassembly [GO:1905691]; lipid droplet fusion [GO:0160077]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of triglyceride storage [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] acylglycerol O-acyltransferase activity [GO:0016411]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806] g10304.t1 Q8T880 39.862 725 1.26e-151 462.0 sp|Q8T880|DNAI7_CIOIN Dynein axonemal intermediate chain 7 homolog OS=Ciona intestinalis OX=7719 GN=AXP83.9 PE=2 SV=1 g10306.t1 B5FXA0 71.084 83 2.14e-35 118.0 sp|B5FXA0|ETFR1_TAEGU Electron transfer flavoprotein regulatory factor 1 OS=Taeniopygia guttata OX=59729 GN=etfrf1 PE=3 SV=1 g10307.t1 Q9C0I9 29.719 498 2.93e-44 165.0 sp|Q9C0I9|LRC27_HUMAN Leucine-rich repeat-containing protein 27 OS=Homo sapiens OX=9606 GN=LRRC27 PE=1 SV=2 g10309.t1 Q4QQM4 41.765 170 4.01e-40 138.0 sp|Q4QQM4|P5I11_MOUSE Tumor protein p53-inducible protein 11 OS=Mus musculus OX=10090 GN=Trp53i11 PE=1 SV=1 g10309.t2 Q4QQM4 41.765 170 4.9199999999999996e-40 138.0 sp|Q4QQM4|P5I11_MOUSE Tumor protein p53-inducible protein 11 OS=Mus musculus OX=10090 GN=Trp53i11 PE=1 SV=1 g10310.t1 Q0P5X1 29.686 987 1.46e-88 323.0 sp|Q0P5X1|LRIQ1_MOUSE Leucine-rich repeat- and IQ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrriq1 PE=2 SV=2 g10311.t1 Q4R5Y0 47.244 127 2.6300000000000002e-33 117.0 sp|Q4R5Y0|CFA68_MACFA Cilia- and flagella-associated protein 68 OS=Macaca fascicularis OX=9541 GN=CFAP68 PE=2 SV=1 g10312.t1 Q2VQV9 43.802 484 6.84e-141 423.0 sp|Q2VQV9|ADA2_XENLA Adenosine deaminase 2 OS=Xenopus laevis OX=8355 GN=ada2 PE=1 SV=1 ADA2_XENLA reviewed Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1) Xenopus laevis (African clawed frog) GO:0004000; GO:0005615; GO:0006154; GO:0008270; GO:0031685; GO:0043394; GO:0046103 adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103] extracellular space [GO:0005615] adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270] g10313.t1 Q9BXF3 47.222 216 2.44e-50 198.0 sp|Q9BXF3|CECR2_HUMAN Chromatin remodeling regulator CECR2 OS=Homo sapiens OX=9606 GN=CECR2 PE=1 SV=2 CECR2_HUMAN reviewed Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2) Homo sapiens (Human) GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006309; GO:0006338; GO:0007010; GO:0007338; GO:0016192; GO:0060122; GO:0061640; GO:0090102; GO:0090537; GO:0097194; GO:0140658 apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192] CERF complex [GO:0090537]; euchromatin [GO:0000791]; nucleus [GO:0005634] ATP-dependent chromatin remodeler activity [GO:0140658] g10313.t1 Q9BXF3 30.503 318 1.4200000000000002e-35 151.0 sp|Q9BXF3|CECR2_HUMAN Chromatin remodeling regulator CECR2 OS=Homo sapiens OX=9606 GN=CECR2 PE=1 SV=2 CECR2_HUMAN reviewed Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2) Homo sapiens (Human) GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006309; GO:0006338; GO:0007010; GO:0007338; GO:0016192; GO:0060122; GO:0061640; GO:0090102; GO:0090537; GO:0097194; GO:0140658 apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192] CERF complex [GO:0090537]; euchromatin [GO:0000791]; nucleus [GO:0005634] ATP-dependent chromatin remodeler activity [GO:0140658] g10314.t1 O08873 45.761 1663 0.0 1287.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g10314.t2 O08873 44.953 1159 0.0 836.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g10314.t2 O08873 52.318 453 1.4199999999999999e-142 484.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g10314.t3 O08873 45.265 1151 0.0 839.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g10314.t3 O08873 52.318 453 1.56e-142 483.0 sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1 MADD_RAT reviewed MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP) Rattus norvegicus (Rat) GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236 anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] guanyl-nucleotide exchange factor activity [GO:0005085] g10316.t1 Q54F25 28.472 432 3.57e-46 168.0 sp|Q54F25|CLN3_DICDI Battenin OS=Dictyostelium discoideum OX=44689 GN=cln3 PE=3 SV=1 CLN3_DICDI reviewed Battenin (Protein CLN3 homolog) Dictyostelium discoideum (Social amoeba) GO:0000281; GO:0000331; GO:0005765; GO:0005794; GO:0006907; GO:0006971; GO:0006972; GO:0008285; GO:0009992; GO:0030139; GO:0031152; GO:0031156; GO:0031589; GO:0050708; GO:0050709; GO:0050714; GO:0098609 aggregation involved in sorocarp development [GO:0031152]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; hyperosmotic response [GO:0006972]; hypotonic response [GO:0006971]; intracellular water homeostasis [GO:0009992]; mitotic cytokinesis [GO:0000281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein secretion [GO:0050709]; pinocytosis [GO:0006907]; positive regulation of protein secretion [GO:0050714]; regulation of protein secretion [GO:0050708]; regulation of sorocarp development [GO:0031156] contractile vacuole [GO:0000331]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765] g10317.t1 Q08CL3 29.724 508 1.79e-63 223.0 sp|Q08CL3|KBTB8_DANRE Kelch repeat and BTB domain-containing protein 8 OS=Danio rerio OX=7955 GN=kbtbd8 PE=2 SV=1 g10325.t1 Q15047 37.106 698 7.21e-122 395.0 sp|Q15047|SETB1_HUMAN Histone-lysine N-methyltransferase SETDB1 OS=Homo sapiens OX=9606 GN=SETDB1 PE=1 SV=1 SETB1_HUMAN reviewed Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006346; GO:0008270; GO:0010629; GO:0032259; GO:0046974; GO:0062072; GO:0070828; GO:0140015; GO:0140938; GO:0140942; GO:0140947; GO:0140948; GO:0140949; GO:0141005; GO:1990841 DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629]; transposable element silencing by heterochromatin formation [GO:0141005] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K14ac reader activity [GO:0140015]; histone H3K9 dimethyltransferase activity [GO:0140942]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H3K9me2 methyltransferase activity [GO:0140947]; histone H3K9me2/3 reader activity [GO:0062072]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g10325.t2 Q15047 38.496 678 1.0600000000000001e-122 397.0 sp|Q15047|SETB1_HUMAN Histone-lysine N-methyltransferase SETDB1 OS=Homo sapiens OX=9606 GN=SETDB1 PE=1 SV=1 SETB1_HUMAN reviewed Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1) Homo sapiens (Human) GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006346; GO:0008270; GO:0010629; GO:0032259; GO:0046974; GO:0062072; GO:0070828; GO:0140015; GO:0140938; GO:0140942; GO:0140947; GO:0140948; GO:0140949; GO:0141005; GO:1990841 DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629]; transposable element silencing by heterochromatin formation [GO:0141005] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K14ac reader activity [GO:0140015]; histone H3K9 dimethyltransferase activity [GO:0140942]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H3K9me2 methyltransferase activity [GO:0140947]; histone H3K9me2/3 reader activity [GO:0062072]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g10326.t1 Q6INA9 52.683 205 2.6099999999999998e-54 211.0 sp|Q6INA9|SETB1_XENLA Histone-lysine N-methyltransferase SETDB1 OS=Xenopus laevis OX=8355 GN=setdb1 PE=2 SV=1 SETB1_XENLA reviewed Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (SET domain bifurcated 1) Xenopus laevis (African clawed frog) GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006346; GO:0008270; GO:0010629; GO:0032259; GO:0046974; GO:0062072; GO:0070828; GO:0140015; GO:0140942; GO:0140947; GO:0140948; GO:1990841 DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone H3K14ac reader activity [GO:0140015]; histone H3K9 dimethyltransferase activity [GO:0140942]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9me2 methyltransferase activity [GO:0140947]; histone H3K9me2/3 reader activity [GO:0062072]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g10326.t2 Q6INA9 52.683 205 2.35e-54 211.0 sp|Q6INA9|SETB1_XENLA Histone-lysine N-methyltransferase SETDB1 OS=Xenopus laevis OX=8355 GN=setdb1 PE=2 SV=1 SETB1_XENLA reviewed Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (SET domain bifurcated 1) Xenopus laevis (African clawed frog) GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006346; GO:0008270; GO:0010629; GO:0032259; GO:0046974; GO:0062072; GO:0070828; GO:0140015; GO:0140942; GO:0140947; GO:0140948; GO:1990841 DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] DNA binding [GO:0003677]; histone H3K14ac reader activity [GO:0140015]; histone H3K9 dimethyltransferase activity [GO:0140942]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9me2 methyltransferase activity [GO:0140947]; histone H3K9me2/3 reader activity [GO:0062072]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] g10328.t1 Q8BFQ8 57.407 216 1.8999999999999997e-89 265.0 sp|Q8BFQ8|GALD1_MOUSE Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Gatd1 PE=1 SV=1 g10328.t2 Q32NG4 55.45 211 3.7e-76 231.0 sp|Q32NG4|GALD1_XENLA Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gatd1 PE=2 SV=1 g10329.t1 Q9H0A0 58.571 490 0.0 572.0 sp|Q9H0A0|NAT10_HUMAN RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2 g10330.t1 Q9H0A0 77.21 509 0.0 801.0 sp|Q9H0A0|NAT10_HUMAN RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2 g10334.t1 Q06807 47.405 289 9.2e-85 295.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10337.t1 Q06807 39.733 375 5.2e-80 281.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10343.t1 G3V9H8 56.075 107 9.04e-37 142.0 sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1 RET_RAT reviewed Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] Rattus norvegicus (Rat) GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144; GO:1904894; GO:2001241 cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657] axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10348.t1 Q09426 35.03 334 1.81e-53 186.0 sp|Q09426|CGT_RAT 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Rattus norvegicus OX=10116 GN=Ugt8 PE=1 SV=1 CGT_RAT reviewed 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (CGalT) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase) Rattus norvegicus (Rat) GO:0002175; GO:0003851; GO:0005783; GO:0006682; GO:0006688; GO:0007010; GO:0008489; GO:0016020; GO:0030913; GO:0035902; GO:0042552; GO:0048812 cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489] g10351.t1 Q641G4 37.75 649 2.5100000000000003e-117 366.0 sp|Q641G4|CNDH2_XENLA Condensin-2 complex subunit H2 OS=Xenopus laevis OX=8355 GN=ncaph2 PE=1 SV=1 g10353.t1 Q8VI63 47.826 230 3.15e-76 233.0 sp|Q8VI63|MOB2_MOUSE MOB kinase activator 2 OS=Mus musculus OX=10090 GN=Mob2 PE=1 SV=1 MOB2_MOUSE reviewed MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein) Mus musculus (Mouse) GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007165; GO:0010976; GO:0030036; GO:0030295; GO:0044306; GO:0046872; GO:0048471 actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] g10354.t1 Q5ZIW1 49.403 670 0.0 623.0 sp|Q5ZIW1|PEO1_CHICK Twinkle mtDNA helicase OS=Gallus gallus OX=9031 GN=TWNK PE=2 SV=1 PEO1_CHICK reviewed Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein homolog) (Twinkle protein, mitochondrial) Gallus gallus (Chicken) GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0006264; GO:0008289; GO:0016887; GO:0042645; GO:0043139 mitochondrial DNA replication [GO:0006264] mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; lipid binding [GO:0008289]; single-stranded DNA binding [GO:0003697] g10354.t2 Q5ZIW1 53.754 586 0.0 615.0 sp|Q5ZIW1|PEO1_CHICK Twinkle mtDNA helicase OS=Gallus gallus OX=9031 GN=TWNK PE=2 SV=1 PEO1_CHICK reviewed Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein homolog) (Twinkle protein, mitochondrial) Gallus gallus (Chicken) GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0006264; GO:0008289; GO:0016887; GO:0042645; GO:0043139 mitochondrial DNA replication [GO:0006264] mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; lipid binding [GO:0008289]; single-stranded DNA binding [GO:0003697] g10360.t1 P11369 24.694 409 5.97e-25 113.0 sp|P11369|LORF2_MOUSE LINE-1 retrotransposable element ORF2 protein OS=Mus musculus OX=10090 GN=Pol PE=1 SV=2 g10361.t2 O02751 30.508 236 6.76e-31 127.0 sp|O02751|CFDP2_BOVIN Craniofacial development protein 2 OS=Bos taurus OX=9913 GN=CFDP2 PE=1 SV=2 g10362.t1 D4A734 25.472 424 2.82e-25 111.0 sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1 MOT12_RAT reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Rattus norvegicus (Rat) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g10363.t1 Q84DC4 46.626 163 5.35e-28 112.0 sp|Q84DC4|MANHY_PSEPU Mandelamide hydrolase OS=Pseudomonas putida OX=303 GN=mdlY PE=1 SV=1 g10366.t1 O08696 42.763 152 1.0100000000000001e-27 124.0 sp|O08696|FOXM1_MOUSE Forkhead box protein M1 OS=Mus musculus OX=10090 GN=Foxm1 PE=1 SV=2 g10367.t1 Q5E9S2 59.868 152 4.2999999999999994e-54 184.0 sp|Q5E9S2|NFYA_BOVIN Nuclear transcription factor Y subunit alpha OS=Bos taurus OX=9913 GN=NFYA PE=2 SV=1 g10368.t1 Q80YD6 41.05 419 5.56e-87 275.0 sp|Q80YD6|SRGEF_MOUSE Secretion-regulating guanine nucleotide exchange factor OS=Mus musculus OX=10090 GN=Sergef PE=2 SV=2 g10369.t1 Q95333 42.325 671 1.7200000000000002e-160 483.0 sp|Q95333|XPP2_PIG Xaa-Pro aminopeptidase 2 OS=Sus scrofa OX=9823 GN=XPNPEP2 PE=1 SV=1 XPP2_PIG reviewed Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2) Sus scrofa (Pig) GO:0005886; GO:0006508; GO:0046872; GO:0070006; GO:0070062; GO:0098552 proteolysis [GO:0006508] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; side of membrane [GO:0098552] metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006] g10371.t1 Q9JLB4 29.061 554 4.11e-54 213.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 25.386 906 1.3e-48 195.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 23.62 906 2.77e-44 181.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 28.0 550 4.45e-44 180.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 24.106 643 2.3e-38 162.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 24.156 948 3.3000000000000002e-37 158.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 25.865 607 1.39e-36 156.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 24.652 933 1.04e-35 153.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 23.872 997 2.3000000000000002e-35 152.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 23.851 914 2.35e-35 152.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 23.028 938 3.33e-35 151.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 26.91 576 6.310000000000001e-35 150.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 26.0 550 3.42e-32 141.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 24.228 615 7.23e-31 137.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10371.t1 Q9JLB4 21.512 1283 4.66e-28 128.0 sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3 CUBN_MOUSE reviewed Cubilin (Intrinsic factor-cobalamin receptor) Mus musculus (Mouse) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038023; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] g10375.t1 P49109 43.727 542 2.7300000000000003e-164 479.0 sp|P49109|FMO5_CAVPO Flavin-containing monooxygenase 5 OS=Cavia porcellus OX=10141 GN=FMO5 PE=1 SV=2 g10376.t1 Q9EPL8 57.763 1037 0.0 1228.0 sp|Q9EPL8|IPO7_MOUSE Importin-7 OS=Mus musculus OX=10090 GN=Ipo7 PE=1 SV=2 IPO7_MOUSE reviewed Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Mus musculus (Mouse) GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0045668; GO:0046332; GO:1900182; GO:1901331 innate immune response [GO:0045087]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267] g10382.t1 A3RL54 63.993 1197 0.0 1494.0 sp|A3RL54|SL9C1_STRPU Sperm-specific sodium:proton exchanger OS=Strongylocentrotus purpuratus OX=7668 GN=SLC9C1 PE=1 SV=1 SL9C1_STRPU reviewed Sperm-specific sodium:proton exchanger (Solute carrier family 9 member C1) (Voltage-gated Na(+)/H(+) exchanger) Strongylocentrotus purpuratus (Purple sea urchin) GO:0005886; GO:0007338; GO:0015385; GO:0015386; GO:0030552; GO:0030553; GO:0036126; GO:0042803; GO:0051453; GO:0061827; GO:0071805; GO:0098719 potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion import across plasma membrane [GO:0098719] plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827] cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; potassium:proton antiporter activity [GO:0015386]; protein homodimerization activity [GO:0042803]; sodium:proton antiporter activity [GO:0015385] g10383.t1 Q3SZJ4 55.12 332 1.44e-128 373.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g10384.t1 Q3SZJ4 54.268 328 3.36e-129 374.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g10385.t1 Q3SZJ4 55.183 328 9.38e-129 373.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g10386.t1 Q3SZJ4 53.963 328 9.3e-128 371.0 sp|Q3SZJ4|PTGR1_BOVIN Prostaglandin reductase 1 OS=Bos taurus OX=9913 GN=PTGR1 PE=2 SV=1 PTGR1_BOVIN reviewed Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74) Bos taurus (Bovine) GO:0005737; GO:0006693; GO:0035798; GO:0036102; GO:0036185; GO:0047522; GO:0097257; GO:2001302 leukotriene B4 metabolic process [GO:0036102]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] 13-lipoxin reductase activity [GO:0036185]; 15-oxoprostaglandin 13-reductase [NAD(P)+] activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] g10394.t1 Q7Z6G8 49.485 291 4.07e-74 275.0 sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2 ANS1B_HUMAN reviewed Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1) Homo sapiens (Human) GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013 ephrin receptor signaling pathway [GO:0048013] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ephrin receptor binding [GO:0046875] g10394.t1 Q7Z6G8 51.744 172 1.54e-44 181.0 sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2 ANS1B_HUMAN reviewed Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1) Homo sapiens (Human) GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013 ephrin receptor signaling pathway [GO:0048013] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ephrin receptor binding [GO:0046875] g10394.t1 Q7Z6G8 45.055 182 3.4999999999999996e-42 173.0 sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2 ANS1B_HUMAN reviewed Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1) Homo sapiens (Human) GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013 ephrin receptor signaling pathway [GO:0048013] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] ephrin receptor binding [GO:0046875] g10395.t1 Q8N682 31.579 247 1.03e-37 136.0 sp|Q8N682|DRAM1_HUMAN DNA damage-regulated autophagy modulator protein 1 OS=Homo sapiens OX=9606 GN=DRAM1 PE=1 SV=1 g10396.t1 Q9BXB1 32.147 843 7.700000000000001e-123 406.0 sp|Q9BXB1|LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Homo sapiens OX=9606 GN=LGR4 PE=1 SV=2 g10397.t1 Q4R8N2 54.27 562 0.0 580.0 sp|Q4R8N2|LIN9_MACFA Protein lin-9 homolog OS=Macaca fascicularis OX=9541 GN=LIN9 PE=2 SV=1 g10397.t2 Q4R8N2 44.409 626 1.8599999999999999e-152 453.0 sp|Q4R8N2|LIN9_MACFA Protein lin-9 homolog OS=Macaca fascicularis OX=9541 GN=LIN9 PE=2 SV=1 g10399.t1 B2RNN3 35.347 331 6.83e-35 133.0 sp|B2RNN3|C1T9B_HUMAN Complement C1q and tumor necrosis factor-related protein 9B OS=Homo sapiens OX=9606 GN=C1QTNF9B PE=1 SV=1 C1T9B_HUMAN reviewed Complement C1q and tumor necrosis factor-related protein 9B (C1q/TNF-related protein 9B) (CTRP9B) (Complement C1q and tumor necrosis factor-related protein 9-like) Homo sapiens (Human) GO:0005576; GO:0005581 collagen trimer [GO:0005581]; extracellular region [GO:0005576] g10400.t1 Q14008 47.932 2103 0.0 1856.0 sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3 g10400.t2 Q14008 47.884 2103 0.0 1853.0 sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3 g10400.t3 Q14008 48.289 2075 0.0 1851.0 sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3 g10401.t1 Q5EB73 27.885 416 4.03e-35 137.0 sp|Q5EB73|PGAP4_RAT GPI-N-acetylgalactosamine transferase PGAP4 OS=Rattus norvegicus OX=10116 GN=Pgap4 PE=2 SV=1 g10402.t1 P83877 88.732 142 6.690000000000001e-97 278.0 sp|P83877|TXN4A_MOUSE Thioredoxin-like protein 4A OS=Mus musculus OX=10090 GN=Txnl4a PE=1 SV=1 g10403.t1 P34943 51.576 349 4.43e-133 388.0 sp|P34943|NDUA9_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial OS=Bos taurus OX=9913 GN=NDUFA9 PE=1 SV=1 g10404.t1 Q8BGA5 65.635 323 6.08e-162 461.0 sp|Q8BGA5|KRR1_MOUSE KRR1 small subunit processome component homolog OS=Mus musculus OX=10090 GN=Krr1 PE=2 SV=1 KRR1_MOUSE reviewed KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2 homolog) (KRR-R motif-containing protein 1) Mus musculus (Mouse) GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0032040; GO:0042274; GO:0045171 ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364] chromosome [GO:0005694]; intercellular bridge [GO:0045171]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] RNA binding [GO:0003723] g10406.t1 B6RSP1 51.613 124 2.6300000000000004e-32 137.0 sp|B6RSP1|PKHA7_DANRE Pleckstrin homology domain-containing family A member 7 OS=Danio rerio OX=7955 GN=plekha7 PE=2 SV=2 PKHA7_DANRE reviewed Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7) (Heart adapter protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005813; GO:0005915; GO:0045218; GO:0070097; GO:0090136 epithelial cell-cell adhesion [GO:0090136]; zonula adherens maintenance [GO:0045218] centrosome [GO:0005813]; zonula adherens [GO:0005915] delta-catenin binding [GO:0070097] g10409.t1 B6RSP1 59.722 72 7.81e-25 99.0 sp|B6RSP1|PKHA7_DANRE Pleckstrin homology domain-containing family A member 7 OS=Danio rerio OX=7955 GN=plekha7 PE=2 SV=2 PKHA7_DANRE reviewed Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7) (Heart adapter protein 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005813; GO:0005915; GO:0045218; GO:0070097; GO:0090136 epithelial cell-cell adhesion [GO:0090136]; zonula adherens maintenance [GO:0045218] centrosome [GO:0005813]; zonula adherens [GO:0005915] delta-catenin binding [GO:0070097] g10410.t1 Q64732 39.713 209 1.05e-33 131.0 sp|Q64732|FOXB1_MOUSE Forkhead box protein B1 OS=Mus musculus OX=10090 GN=Foxb1 PE=2 SV=2 FOXB1_MOUSE reviewed Forkhead box protein B1 (Transcription factor FKH-5) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001655; GO:0001756; GO:0005634; GO:0006357; GO:0007412; GO:0007595; GO:0008542; GO:0009653; GO:0021510; GO:0021767; GO:0021794; GO:0021855; GO:0022029; GO:0030154; GO:0030901; GO:0033504; GO:0043524; GO:0043565; GO:0061030; GO:0061374; GO:0061377; GO:0061379; GO:0061381; GO:1990837 anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837] g10414.t1 P52950 46.853 286 1.1599999999999999e-67 223.0 sp|P52950|DBX1_MOUSE Homeobox protein DBX1 OS=Mus musculus OX=10090 GN=Dbx1 PE=2 SV=1 g10415.t1 Q5M8V8 60.432 139 1.1999999999999999e-60 187.0 sp|Q5M8V8|RBTN2_XENTR Rhombotin-2 OS=Xenopus tropicalis OX=8364 GN=lmo2 PE=2 SV=1 g10418.t1 P42839 29.315 730 1.59e-81 283.0 sp|P42839|VNX1_YEAST Low affinity vacuolar monovalent cation/H(+) antiporter OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=VNX1 PE=1 SV=1 VNX1_YEAST reviewed Low affinity vacuolar monovalent cation/H(+) antiporter (Vacuolar Na(+)/H(+) exchanger) Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0000324; GO:0000329; GO:0005789; GO:0006813; GO:0006814; GO:0006874; GO:0012505; GO:0015369; GO:0015385; GO:0015386; GO:0070588; GO:1902600; GO:1990816 calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; sodium ion transport [GO:0006814] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; vacuole-mitochondrion membrane contact site [GO:1990816] calcium:proton antiporter activity [GO:0015369]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g10418.t2 P42839 28.904 730 3.52e-79 276.0 sp|P42839|VNX1_YEAST Low affinity vacuolar monovalent cation/H(+) antiporter OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=VNX1 PE=1 SV=1 VNX1_YEAST reviewed Low affinity vacuolar monovalent cation/H(+) antiporter (Vacuolar Na(+)/H(+) exchanger) Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) GO:0000324; GO:0000329; GO:0005789; GO:0006813; GO:0006814; GO:0006874; GO:0012505; GO:0015369; GO:0015385; GO:0015386; GO:0070588; GO:1902600; GO:1990816 calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; sodium ion transport [GO:0006814] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; fungal-type vacuole [GO:0000324]; fungal-type vacuole membrane [GO:0000329]; vacuole-mitochondrion membrane contact site [GO:1990816] calcium:proton antiporter activity [GO:0015369]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] g10420.t1 Q4QR29 66.094 1165 0.0 1517.0 sp|Q4QR29|CTR9_XENLA RNA polymerase-associated protein CTR9 homolog OS=Xenopus laevis OX=8355 GN=ctr9 PE=2 SV=1 g10421.t1 Q91YA9 49.596 619 0.0 544.0 sp|Q91YA9|BMAL1_NANGA Basic helix-loop-helix ARNT-like protein 1 OS=Nannospalax galili OX=1026970 GN=Bmal1 PE=1 SV=1 g10422.t1 Q4UMH6 24.681 470 7.169999999999999e-23 109.0 sp|Q4UMH6|Y381_RICFE Putative ankyrin repeat protein RF_0381 OS=Rickettsia felis (strain ATCC VR-1525 / URRWXCal2) OX=315456 GN=RF_0381 PE=4 SV=1 g10424.t1 Q84DC4 35.307 456 8.91e-66 222.0 sp|Q84DC4|MANHY_PSEPU Mandelamide hydrolase OS=Pseudomonas putida OX=303 GN=mdlY PE=1 SV=1 g10432.t1 Q9DE27 89.394 462 0.0 853.0 sp|Q9DE27|RUVB2_XENLA RuvB-like 2 OS=Xenopus laevis OX=8355 GN=ruvbl2 PE=2 SV=1 g10433.t1 P37059 39.181 342 3.7900000000000005e-64 214.0 sp|P37059|DHB2_HUMAN 17-beta-hydroxysteroid dehydrogenase type 2 OS=Homo sapiens OX=9606 GN=HSD17B2 PE=1 SV=1 DHB2_HUMAN reviewed 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 2) (EC 1.1.1.62) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) Homo sapiens (Human) GO:0001701; GO:0001890; GO:0004303; GO:0005789; GO:0006703; GO:0008202; GO:0008209; GO:0032526; GO:0047006; GO:0047035 androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789] 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase [NAD(P)+] activity [GO:0047006]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; testosterone dehydrogenase (NAD+) activity [GO:0047035] g10434.t1 O77245 35.878 393 1.34e-53 192.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g10434.t2 O77245 36.317 391 5.33e-56 199.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g10434.t3 O77245 35.696 395 3.28e-53 191.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g10434.t4 O77245 36.317 391 8.610000000000001e-56 198.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g10435.t1 O77245 38.028 355 1.6000000000000002e-70 239.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g10436.t1 P79955 42.219 694 7.23e-153 459.0 sp|P79955|CTK2_XENLA Carboxy-terminal kinesin 2 OS=Xenopus laevis OX=8355 PE=2 SV=1 g10438.t1 Q6P829 54.859 319 6.35e-121 352.0 sp|Q6P829|NOSIP_XENTR Nitric oxide synthase-interacting protein OS=Xenopus tropicalis OX=8364 GN=nosip PE=2 SV=1 g10439.t1 O77245 31.956 363 1.34e-55 199.0 sp|O77245|E75_METEN Nuclear hormone receptor E75 OS=Metapenaeus ensis OX=32278 GN=E75 PE=2 SV=1 g10440.t1 Q7ZWN0 53.003 383 3.09e-125 379.0 sp|Q7ZWN0|LMF2_XENLA Lipase maturation factor 2 OS=Xenopus laevis OX=8355 GN=lmf2 PE=2 SV=1 g10441.t1 Q7ZWN0 44.8 250 2.03e-63 214.0 sp|Q7ZWN0|LMF2_XENLA Lipase maturation factor 2 OS=Xenopus laevis OX=8355 GN=lmf2 PE=2 SV=1 g10442.t1 Q0IIF9 34.394 503 3.24e-93 296.0 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g10443.t1 O88871 32.383 596 3.04e-86 291.0 sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2 GABR2_RAT reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) Rattus norvegicus (Rat) GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982] g10444.t1 O75899 45.652 92 6.389999999999999e-23 95.9 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g10447.t1 P23475 30.976 410 5.96e-48 175.0 sp|P23475|XRCC6_MOUSE X-ray repair cross-complementing protein 6 OS=Mus musculus OX=10090 GN=Xrcc6 PE=1 SV=5 XRCC6_MOUSE reviewed DNA repair protein Ku70 (EC 4.2.99.18) (EC 5.6.2.4) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70) (X-ray repair cross-complementing protein 6) Mus musculus (Mouse) GO:0000723; GO:0000725; GO:0000976; GO:0002218; GO:0003678; GO:0003684; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005730; GO:0005737; GO:0005958; GO:0006302; GO:0006303; GO:0006974; GO:0008094; GO:0010212; GO:0016887; GO:0030332; GO:0032991; GO:0032993; GO:0033151; GO:0042162; GO:0043564; GO:0044877; GO:0045087; GO:0045621; GO:0045892; GO:0045893; GO:0045944; GO:0048660; GO:0050769; GO:0051575; GO:0070418; GO:0070419; GO:0071475; GO:0071480; GO:0071481; GO:0097110; GO:0097680 activation of innate immune response [GO:0002218]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]; V(D)J recombination [GO:0033151] chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin binding [GO:0030332]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976] g10448.t1 P46720 27.97 665 2.4300000000000002e-85 285.0 sp|P46720|SO1A1_RAT Solute carrier organic anion transporter family member 1A1 OS=Rattus norvegicus OX=10116 GN=Slco1a1 PE=1 SV=1 g10453.t1 Q9FXA7 25.83 271 2.74e-22 98.6 sp|Q9FXA7|RGXT3_ARATH UDP-D-xylose:L-fucose alpha-1,3-D-xylosyltransferase 3 OS=Arabidopsis thaliana OX=3702 GN=RGXT3 PE=1 SV=1 g10454.t1 O02703 32.787 183 1.01e-25 101.0 sp|O02703|BAX_BOVIN Apoptosis regulator BAX OS=Bos taurus OX=9913 GN=BAX PE=2 SV=1 g10455.t1 P18484 58.659 179 1.07e-66 222.0 sp|P18484|AP2A2_RAT AP-2 complex subunit alpha-2 OS=Rattus norvegicus OX=10116 GN=Ap2a2 PE=1 SV=3 AP2A2_RAT reviewed AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit) Rattus norvegicus (Rat) GO:0005886; GO:0006886; GO:0008021; GO:0019900; GO:0019901; GO:0019904; GO:0030117; GO:0030122; GO:0031410; GO:0035091; GO:0035615; GO:0044877; GO:0045202; GO:0048488; GO:0072583; GO:0097718; GO:0120283 clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; kinase binding [GO:0019900]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877] g10456.t1 P18484 37.736 212 1.7500000000000002e-32 127.0 sp|P18484|AP2A2_RAT AP-2 complex subunit alpha-2 OS=Rattus norvegicus OX=10116 GN=Ap2a2 PE=1 SV=3 AP2A2_RAT reviewed AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit) Rattus norvegicus (Rat) GO:0005886; GO:0006886; GO:0008021; GO:0019900; GO:0019901; GO:0019904; GO:0030117; GO:0030122; GO:0031410; GO:0035091; GO:0035615; GO:0044877; GO:0045202; GO:0048488; GO:0072583; GO:0097718; GO:0120283 clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488] AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021] clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; kinase binding [GO:0019900]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877] g10457.t1 Q7QG73 84.266 572 0.0 1002.0 sp|Q7QG73|AP2A_ANOGA AP-2 complex subunit alpha OS=Anopheles gambiae OX=7165 GN=alpha-Adaptin PE=3 SV=4 g10458.t1 Q9PVX0 36.279 215 1.1499999999999999e-24 108.0 sp|Q9PVX0|RX2_CHICK Retinal homeobox protein Rx2 OS=Gallus gallus OX=9031 GN=RX2 PE=2 SV=1 g10459.t1 Q4ZJN1 35.531 273 1.2200000000000002e-27 112.0 sp|Q4ZJN1|C1QT9_MOUSE Complement C1q and tumor necrosis factor-related protein 9 OS=Mus musculus OX=10090 GN=C1qtnf9 PE=1 SV=1 C1QT9_MOUSE reviewed Complement C1q and tumor necrosis factor-related protein 9 Mus musculus (Mouse) GO:0005179; GO:0005581; GO:0005615; GO:0019395; GO:0042802; GO:0045792; GO:0097009; GO:1900078 energy homeostasis [GO:0097009]; fatty acid oxidation [GO:0019395]; negative regulation of cell size [GO:0045792]; positive regulation of cellular response to insulin stimulus [GO:1900078] collagen trimer [GO:0005581]; extracellular space [GO:0005615] hormone activity [GO:0005179]; identical protein binding [GO:0042802] g10465.t1 Q7T3B0 54.011 374 3.4e-141 409.0 sp|Q7T3B0|EIF3M_DANRE Eukaryotic translation initiation factor 3 subunit M OS=Danio rerio OX=7955 GN=eif3m PE=2 SV=2 g10466.t1 Q2TBS4 35.897 195 2.87e-24 97.8 sp|Q2TBS4|CMAP3_BOVIN Ciliary microtubule-associated protein 3 OS=Bos taurus OX=9913 GN=CIMAP3 PE=2 SV=1 CMAP3_BOVIN reviewed Ciliary microtubule-associated protein 3 (Protein pitchfork) Bos taurus (Bovine) GO:0005802; GO:0008092; GO:0030030; GO:0031344; GO:0031410; GO:0033674; GO:0036064 cell projection organization [GO:0030030]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344] ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802] cytoskeletal protein binding [GO:0008092] g10467.t1 P32780 49.551 557 0.0 555.0 sp|P32780|TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1 TF2H1_HUMAN reviewed General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit) Homo sapiens (Human) GO:0000079; GO:0000439; GO:0003682; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009755; GO:0045893; GO:0046966 DNA repair [GO:0006281]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367] nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966] g10470.t1 A0A0G2K047 57.717 622 0.0 795.0 sp|A0A0G2K047|ACSS3_RAT Acyl-CoA synthetase short-chain family member 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acss3 PE=1 SV=1 ACSS3_RAT reviewed Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase) (EC 6.2.1.17) Rattus norvegicus (Rat) GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006629; GO:0031956; GO:0050218 lipid metabolic process [GO:0006629] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; propionate-CoA ligase activity [GO:0050218] g10471.t1 Q6P3W7 49.52 937 0.0 870.0 sp|Q6P3W7|SCYL2_HUMAN SCY1-like protein 2 OS=Homo sapiens OX=9606 GN=SCYL2 PE=1 SV=1 SCYL2_HUMAN reviewed SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa) Homo sapiens (Human) GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0031623; GO:0072583; GO:0090090 brain development [GO:0007420]; clathrin-dependent endocytosis [GO:0072583]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; pyramidal neuron development [GO:0021860]; receptor internalization [GO:0031623] clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102] g10472.t1 P52747 56.476 471 2.87e-169 499.0 sp|P52747|ZN143_HUMAN Zinc finger protein 143 OS=Homo sapiens OX=9606 GN=ZNF143 PE=1 SV=2 ZN143_HUMAN reviewed Zinc finger protein 143 (SPH-binding factor) (Selenocysteine tRNA gene transcription-activating factor) (hStaf) Homo sapiens (Human) GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0005654; GO:0006355; GO:0006357; GO:0006359; GO:0008270; GO:0045944 positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359] nucleoplasm [GO:0005654] core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] g10478.t1 Q9ES30 37.427 171 2.5499999999999998e-24 98.6 sp|Q9ES30|C1QT3_MOUSE Complement C1q tumor necrosis factor-related protein 3 OS=Mus musculus OX=10090 GN=C1qtnf3 PE=2 SV=1 g10481.t1 Q4QRH7 43.662 355 1.44e-89 276.0 sp|Q4QRH7|PEX16_DANRE Peroxisomal membrane protein PEX16 OS=Danio rerio OX=7955 GN=pex16 PE=2 SV=1 g10482.t1 Q99PP7 40.26 385 2.53e-77 278.0 sp|Q99PP7|TRI33_MOUSE E3 ubiquitin-protein ligase TRIM33 OS=Mus musculus OX=10090 GN=Trim33 PE=1 SV=2 g10482.t1 Q99PP7 38.537 205 3.06e-41 168.0 sp|Q99PP7|TRI33_MOUSE E3 ubiquitin-protein ligase TRIM33 OS=Mus musculus OX=10090 GN=Trim33 PE=1 SV=2 g10483.t1 G1SNY0 79.021 143 1.72e-78 232.0 sp|G1SNY0|RL27A_RABIT Large ribosomal subunit protein uL15 OS=Oryctolagus cuniculus OX=9986 GN=RPL27A PE=1 SV=2 g10487.t1 A5WVX9 46.791 592 0.0 577.0 sp|A5WVX9|ZDH17_DANRE Palmitoyltransferase ZDHHC17 OS=Danio rerio OX=7955 GN=zdhhc17 PE=2 SV=1 ZDH17_DANRE reviewed Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (Zinc finger DHHC domain-containing protein 17) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000139; GO:0007409; GO:0019705; GO:0019706; GO:0030659; GO:0042734; GO:0046959; GO:0051386; GO:0070372; GO:0140439 axonogenesis [GO:0007409]; habituation [GO:0046959]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386] cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; presynaptic membrane [GO:0042734] protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] g10488.t1 Q62908 56.995 193 2.87e-69 211.0 sp|Q62908|CSRP2_RAT Cysteine and glycine-rich protein 2 OS=Rattus norvegicus OX=10116 GN=Csrp2 PE=1 SV=3 g10489.t1 Q9V6X7 36.997 373 3.67e-76 246.0 sp|Q9V6X7|OFUT1_DROME GDP-fucose protein O-fucosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=O-fut1 PE=1 SV=1 OFUT1_DROME reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Drosophila melanogaster (Fruit fly) GO:0005112; GO:0005783; GO:0005788; GO:0006004; GO:0007219; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922 cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation via fucose [GO:0036066] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922] g10490.t1 Q6EV69 44.598 361 8.69e-102 311.0 sp|Q6EV69|OFUT1_PANTR GDP-fucose protein O-fucosyltransferase 1 OS=Pan troglodytes OX=9598 GN=POFUT1 PE=2 SV=1 OFUT1_PANTR reviewed GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Pan troglodytes (Chimpanzee) GO:0001525; GO:0001756; GO:0005783; GO:0006004; GO:0007219; GO:0007399; GO:0007507; GO:0008593; GO:0016020; GO:0036066; GO:0046922 angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation via fucose [GO:0036066]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756] endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] peptide-O-fucosyltransferase activity [GO:0046922] g10491.t1 Q05158 49.223 193 3.8e-56 179.0 sp|Q05158|CSRP2_COTJA Cysteine and glycine-rich protein 2 OS=Coturnix japonica OX=93934 GN=CSRP2 PE=1 SV=2 g10492.t1 Q9R9J1 37.025 632 6.21e-111 404.0 sp|Q9R9J1|MYCA_BACIU Mycosubtilin synthase subunit A OS=Bacillus subtilis OX=1423 GN=mycA PE=1 SV=1 g10492.t1 Q9R9J1 43.38 355 7.21e-71 272.0 sp|Q9R9J1|MYCA_BACIU Mycosubtilin synthase subunit A OS=Bacillus subtilis OX=1423 GN=mycA PE=1 SV=1 g10492.t1 Q9R9J1 23.103 1160 1.62e-58 231.0 sp|Q9R9J1|MYCA_BACIU Mycosubtilin synthase subunit A OS=Bacillus subtilis OX=1423 GN=mycA PE=1 SV=1 g10492.t1 Q9R9J1 25.275 728 1.22e-51 208.0 sp|Q9R9J1|MYCA_BACIU Mycosubtilin synthase subunit A OS=Bacillus subtilis OX=1423 GN=mycA PE=1 SV=1 g10492.t1 Q9R9J1 25.475 895 1.44e-51 208.0 sp|Q9R9J1|MYCA_BACIU Mycosubtilin synthase subunit A OS=Bacillus subtilis OX=1423 GN=mycA PE=1 SV=1 g10492.t1 Q9R9J1 23.864 528 2.34e-39 167.0 sp|Q9R9J1|MYCA_BACIU Mycosubtilin synthase subunit A OS=Bacillus subtilis OX=1423 GN=mycA PE=1 SV=1 g10492.t1 Q9R9J1 22.122 443 2.0299999999999998e-23 115.0 sp|Q9R9J1|MYCA_BACIU Mycosubtilin synthase subunit A OS=Bacillus subtilis OX=1423 GN=mycA PE=1 SV=1 g10493.t1 Q8C966 30.369 461 5.54e-46 169.0 sp|Q8C966|PF21B_MOUSE PHD finger protein 21B OS=Mus musculus OX=10090 GN=Phf21b PE=2 SV=1 g10494.t1 P48053 33.533 1002 3.6e-180 553.0 sp|P48053|YPD1_CAEEL Uncharacterized protein C05D11.1 OS=Caenorhabditis elegans OX=6239 GN=C05D11.1 PE=4 SV=2 g10496.t1 P35710 38.333 540 7.07e-75 259.0 sp|P35710|SOX5_MOUSE Transcription factor SOX-5 OS=Mus musculus OX=10090 GN=Sox5 PE=1 SV=2 g10496.t2 B1H349 39.033 538 4.34e-77 266.0 sp|B1H349|SOX6_XENTR Transcription factor Sox-6 OS=Xenopus tropicalis OX=8364 GN=sox6 PE=2 SV=1 g10497.t1 P17972 51.708 439 1.03e-154 457.0 sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1 KCNAW_DROME reviewed Potassium voltage-gated channel protein Shaw (Shaw2) Drosophila melanogaster (Fruit fly) GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805 action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431] axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076] delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249] g10498.t1 Q9BXJ4 37.066 259 2.0700000000000002e-29 114.0 sp|Q9BXJ4|C1QT3_HUMAN Complement C1q tumor necrosis factor-related protein 3 OS=Homo sapiens OX=9606 GN=C1QTNF3 PE=1 SV=1 C1QT3_HUMAN reviewed Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26) Homo sapiens (Human) GO:0001819; GO:0005581; GO:0010629; GO:0016020; GO:0032715; GO:0035356; GO:0042802; GO:0045444; GO:0045721; GO:0050728; GO:0070062; GO:0070165; GO:0071638; GO:1901223 fat cell differentiation [GO:0045444]; intracellular triglyceride homeostasis [GO:0035356]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine production [GO:0001819] collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; membrane [GO:0016020] identical protein binding [GO:0042802] g10500.t1 P28340 62.208 1114 0.0 1451.0 sp|P28340|DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens OX=9606 GN=POLD1 PE=1 SV=2 DPOD1_HUMAN reviewed DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125) Homo sapiens (Human) GO:0000109; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006287; GO:0006297; GO:0008270; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0051539; GO:0055089; GO:0070987; GO:0071897 base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]; response to UV [GO:0009411] aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634] 3'-5'-DNA exonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] g10501.t1 P78545 56.25 144 3.2800000000000003e-43 159.0 sp|P78545|ELF3_HUMAN ETS-related transcription factor Elf-3 OS=Homo sapiens OX=9606 GN=ELF3 PE=1 SV=1 ELF3_HUMAN reviewed ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001824; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006357; GO:0006954; GO:0030154; GO:0030198; GO:0045892; GO:0045944; GO:0060056; GO:1990837 blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g10501.t2 P78545 56.25 144 3.12e-43 159.0 sp|P78545|ELF3_HUMAN ETS-related transcription factor Elf-3 OS=Homo sapiens OX=9606 GN=ELF3 PE=1 SV=1 ELF3_HUMAN reviewed ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001824; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006357; GO:0006954; GO:0030154; GO:0030198; GO:0045892; GO:0045944; GO:0060056; GO:1990837 blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g10503.t1 Q9VBW3 42.32 319 3.69e-75 258.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10504.t1 Q9VBW3 40.256 313 9.27e-67 234.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10504.t2 Q9VBW3 39.936 313 2.1899999999999998e-67 236.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10508.t1 Q9VBW3 42.804 271 3.19e-65 231.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10510.t1 Q8BGC3 25.298 419 2.34e-28 120.0 sp|Q8BGC3|MOT12_MOUSE Monocarboxylate transporter 12 OS=Mus musculus OX=10090 GN=Slc16a12 PE=1 SV=1 MOT12_MOUSE reviewed Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12) Mus musculus (Mouse) GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449 creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886] creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292] g10511.t1 P54145 44.213 527 2.53e-136 407.0 sp|P54145|AMT1_CAEEL Putative ammonium transporter 1 OS=Caenorhabditis elegans OX=6239 GN=amt-1 PE=3 SV=1 g10514.t1 O70244 25.185 405 3.33e-21 101.0 sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2 CUBN_RAT reviewed Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) Rattus norvegicus (Rat) GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062 cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] g10517.t1 F1RWC3 23.997 1246 3.47e-62 238.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 24.374 878 1.24e-53 210.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 23.975 951 4.89e-50 199.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 22.357 1154 9.38e-50 198.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 23.064 1149 7.209999999999999e-48 192.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 24.951 1014 3.94e-46 186.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 22.749 1266 7.95e-45 182.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 23.085 914 6.860000000000001e-43 176.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 22.285 1243 5.33e-40 166.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 24.522 628 1.5e-38 161.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10517.t1 F1RWC3 23.917 623 1.07e-28 129.0 sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3 CUBN_PIG reviewed Cubilin (Intrinsic factor-cobalamin receptor) Sus scrofa (Pig) GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419 cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031] apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765] calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252] g10518.t1 Q9D4V0 40.286 350 1.66e-94 287.0 sp|Q9D4V0|EKI1_MOUSE Ethanolamine kinase 1 OS=Mus musculus OX=10090 GN=Etnk1 PE=1 SV=2 g10522.t1 Q9VBW3 39.498 319 1.5800000000000001e-77 264.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10524.t1 Q9VBW3 40.719 334 6.78e-77 265.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10524.t2 Q9VBW3 40.719 334 1.27e-76 266.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10526.t1 Q9VBW3 37.41 278 2.4300000000000003e-58 208.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10529.t1 Q9VBW3 39.159 309 5.2e-71 241.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10531.t1 Q8N5I4 35.274 292 2e-39 143.0 sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2 DHRSX_HUMAN reviewed Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase) Homo sapiens (Human) GO:0005576; GO:0005789; GO:0005811; GO:0008106; GO:0010508; GO:0043048; GO:0160196; GO:0160197 dolichyl monophosphate biosynthetic process [GO:0043048]; positive regulation of autophagy [GO:0010508] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; lipid droplet [GO:0005811] alcohol dehydrogenase (NADP+) activity [GO:0008106]; dolichal reductase (NADPH) activity [GO:0160197]; polyprenol dehydrogenase (NAD+) activity [GO:0160196] g10532.t1 Q8N5I4 34.615 286 1.33e-33 127.0 sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2 DHRSX_HUMAN reviewed Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase) Homo sapiens (Human) GO:0005576; GO:0005789; GO:0005811; GO:0008106; GO:0010508; GO:0043048; GO:0160196; GO:0160197 dolichyl monophosphate biosynthetic process [GO:0043048]; positive regulation of autophagy [GO:0010508] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; lipid droplet [GO:0005811] alcohol dehydrogenase (NADP+) activity [GO:0008106]; dolichal reductase (NADPH) activity [GO:0160197]; polyprenol dehydrogenase (NAD+) activity [GO:0160196] g10541.t1 O88572 54.582 1506 0.0 1667.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10541.t1 O88572 39.014 933 0.0 662.0 sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1 LRP6_MOUSE reviewed Low-density lipoprotein receptor-related protein 6 (LRP-6) Mus musculus (Mouse) GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003344; GO:0003401; GO:0005041; GO:0005102; GO:0005109; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0009986; GO:0010976; GO:0014029; GO:0014033; GO:0015026; GO:0016020; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021915; GO:0021943; GO:0021987; GO:0030291; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0031410; GO:0034185; GO:0034392; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042127; GO:0042475; GO:0042733; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045599; GO:0045778; GO:0045780; GO:0045787; GO:0045893; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050680; GO:0051593; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071397; GO:0071542; GO:0072659; GO:0090009; GO:0090118; GO:0090245; GO:0098609; GO:0110135; GO:1990851; GO:1990909; GO:1990963; GO:2000051 anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] apolipoprotein binding [GO:0034185]; coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] g10542.t1 O93257 49.654 578 0.0 596.0 sp|O93257|XRCC6_CHICK X-ray repair cross-complementing protein 5 OS=Gallus gallus OX=9031 GN=XRCC6 PE=2 SV=1 g10543.t1 Q8TC57 34.442 511 1.2899999999999999e-82 270.0 sp|Q8TC57|M1AP_HUMAN Meiosis 1 arrest protein OS=Homo sapiens OX=9606 GN=M1AP PE=1 SV=1 M1AP_HUMAN reviewed Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37) Homo sapiens (Human) GO:0005737; GO:0006325; GO:0006396; GO:0007127; GO:0007283; GO:0007292; GO:0016020; GO:0030154; GO:0042802; GO:0051308 cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; membrane [GO:0016020] identical protein binding [GO:0042802] g10544.t1 Q805F9 75.744 1142 0.0 1825.0 sp|Q805F9|DDB1_CHICK DNA damage-binding protein 1 OS=Gallus gallus OX=9031 GN=DDB1 PE=1 SV=1 g10545.t1 Q95NI4 52.229 157 5.12e-51 163.0 sp|Q95NI4|CALM_HALOK Calmodulin OS=Halichondria okadai OX=163232 PE=2 SV=3 g10546.t1 O02833 29.735 565 1.28e-46 181.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g10546.t1 O02833 29.815 379 2.1100000000000002e-29 128.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g10546.t2 O02833 29.735 565 1.9599999999999998e-46 180.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g10546.t2 O02833 29.815 379 3.26e-29 127.0 sp|O02833|ALS_PAPHA Insulin-like growth factor-binding protein complex acid labile subunit OS=Papio hamadryas OX=9557 GN=IGFALS PE=2 SV=1 g10547.t1 Q1LZF1 64.222 450 0.0 518.0 sp|Q1LZF1|PAX6_BOVIN Paired box protein Pax-6 OS=Bos taurus OX=9913 GN=PAX6 PE=2 SV=1 PAX6_BOVIN reviewed Paired box protein Pax-6 (Oculorhombin) Bos taurus (Bovine) GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003322; GO:0004842; GO:0005634; GO:0006357; GO:0007420; GO:0007423; GO:0009653; GO:0010628; GO:0030900; GO:0045893; GO:0045944; GO:0050768; GO:0050877; GO:0060041 anatomical structure morphogenesis [GO:0009653]; brain development [GO:0007420]; forebrain development [GO:0030900]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; pancreatic A cell development [GO:0003322]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; sensory organ development [GO:0007423]; type B pancreatic cell differentiation [GO:0003309] chromatin [GO:0000785]; nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-protein transferase activity [GO:0004842] g10549.t1 Q28I39 46.875 160 1.0399999999999999e-45 150.0 sp|Q28I39|IMP1L_XENTR Mitochondrial inner membrane protease subunit 1 OS=Xenopus tropicalis OX=8364 GN=immp1l PE=2 SV=1 g10550.t1 P41212 50.0 116 1.8e-31 132.0 sp|P41212|ETV6_HUMAN Transcription factor ETV6 OS=Homo sapiens OX=9606 GN=ETV6 PE=1 SV=1 ETV6_HUMAN reviewed Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0071425; GO:0097152 cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; vitellogenesis [GO:0007296] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g10550.t2 P41212 50.0 116 1.38e-31 132.0 sp|P41212|ETV6_HUMAN Transcription factor ETV6 OS=Homo sapiens OX=9606 GN=ETV6 PE=1 SV=1 ETV6_HUMAN reviewed Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0071425; GO:0097152 cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; vitellogenesis [GO:0007296] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] g10551.t1 Q9GZR5 50.0 306 7.910000000000001e-103 306.0 sp|Q9GZR5|ELOV4_HUMAN Very long chain fatty acid elongase 4 OS=Homo sapiens OX=9606 GN=ELOVL4 PE=1 SV=1 ELOV4_HUMAN reviewed Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761 fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020] g10552.t1 Q9EQC4 46.853 286 6.1e-92 278.0 sp|Q9EQC4|ELOV4_MOUSE Very long chain fatty acid elongase 4 OS=Mus musculus OX=10090 GN=Elovl4 PE=1 SV=2 ELOV4_MOUSE reviewed Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) Mus musculus (Mouse) GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0061886; GO:0097151; GO:1990926 fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; short-term synaptic potentiation [GO:1990926]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] fatty acid elongase activity [GO:0009922] g10553.t1 Q3T0K1 53.438 320 1.02e-110 327.0 sp|Q3T0K1|CALU_BOVIN Calumenin OS=Bos taurus OX=9913 GN=CALU PE=2 SV=1 CALU_BOVIN reviewed Calumenin Bos taurus (Bovine) GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018] calcium ion binding [GO:0005509] g10553.t2 Q3T0K1 53.727 322 1.16e-114 337.0 sp|Q3T0K1|CALU_BOVIN Calumenin OS=Bos taurus OX=9913 GN=CALU PE=2 SV=1 CALU_BOVIN reviewed Calumenin Bos taurus (Bovine) GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018] calcium ion binding [GO:0005509] g10553.t3 Q28BT4 48.76 363 2.8e-106 318.0 sp|Q28BT4|CALU_XENTR Calumenin OS=Xenopus tropicalis OX=8364 GN=calu PE=2 SV=1 CALU_XENTR reviewed Calumenin Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0005509; GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0033018; GO:0042470 endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018] calcium ion binding [GO:0005509] g10554.t1 Q5MNV8 34.914 464 6.2e-75 244.0 sp|Q5MNV8|FBX47_HUMAN F-box only protein 47 OS=Homo sapiens OX=9606 GN=FBXO47 PE=2 SV=2 g10559.t1 Q9VBW3 41.391 302 4.78e-76 263.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g10569.t1 Q96QU6 39.278 443 3.4e-111 343.0 sp|Q96QU6|1A1L1_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Homo sapiens OX=9606 GN=ACCS PE=1 SV=1 g10570.t1 Q5R7J9 47.322 915 0.0 766.0 sp|Q5R7J9|IF4G2_PONAB Eukaryotic translation initiation factor 4 gamma 2 OS=Pongo abelii OX=9601 GN=EIF4G2 PE=2 SV=2 g10572.t1 Q3TTI8 35.533 197 3.2999999999999997e-28 113.0 sp|Q3TTI8|TEX52_MOUSE Testis-expressed protein 52 OS=Mus musculus OX=10090 GN=Tex52 PE=2 SV=1 g10573.t1 Q6GP15 53.302 212 7.620000000000001e-72 260.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10573.t1 Q6GP15 47.647 170 2.35e-41 168.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10573.t2 Q6GP15 53.302 212 8.260000000000001e-72 260.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10573.t2 Q6GP15 47.647 170 2.36e-41 168.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10573.t3 Q6GP15 53.302 212 7.810000000000001e-72 260.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10573.t3 Q6GP15 50.0 148 1.67e-40 165.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10573.t4 Q6GP15 53.302 212 8.55e-72 260.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10573.t4 Q6GP15 47.647 170 2.41e-41 168.0 sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1 g10574.t1 Q566Y1 49.118 397 2.28e-126 372.0 sp|Q566Y1|ELP4_DANRE Elongator complex protein 4 OS=Danio rerio OX=7955 GN=elp4 PE=2 SV=2 g10577.t1 E7F7V7 26.22 328 7.2e-24 104.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g10578.t1 E7F7V7 27.844 334 1.86e-25 108.0 sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1 g10579.t1 Q9Z321 70.07 862 0.0 1280.0 sp|Q9Z321|TOP3B_MOUSE DNA topoisomerase 3-beta-1 OS=Mus musculus OX=10090 GN=Top3b PE=1 SV=1 g10583.t1 Q02790 51.294 425 3.2e-154 449.0 sp|Q02790|FKBP4_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Homo sapiens OX=9606 GN=FKBP4 PE=1 SV=3 FKBP4_HUMAN reviewed Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed] Homo sapiens (Human) GO:0003723; GO:0003755; GO:0005524; GO:0005525; GO:0005528; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0006457; GO:0006463; GO:0006825; GO:0007566; GO:0010977; GO:0030521; GO:0030674; GO:0030850; GO:0031072; GO:0031111; GO:0031115; GO:0031503; GO:0032767; GO:0032991; GO:0035259; GO:0043025; GO:0044295; GO:0046661; GO:0048156; GO:0048471; GO:0051219; GO:0070062 androgen receptor signaling pathway [GO:0030521]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein-containing complex localization [GO:0031503]; steroid hormone receptor complex assembly [GO:0006463] axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; nuclear glucocorticoid receptor binding [GO:0035259]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156] g10584.t1 Q5U4K5 66.265 249 1.42e-116 339.0 sp|Q5U4K5|TM41B_XENLA Transmembrane protein 41B OS=Xenopus laevis OX=8355 GN=tmem41b PE=2 SV=1 g10585.t1 Q0VC71 73.709 426 0.0 669.0 sp|Q0VC71|TTLL1_BOVIN Polyglutamylase complex subunit TTLL1 OS=Bos taurus OX=9913 GN=TTLL1 PE=2 SV=1 TTLL1_BOVIN reviewed Polyglutamylase complex subunit TTLL1 (EC 6.3.2.-) (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1) Bos taurus (Bovine) GO:0005524; GO:0005874; GO:0005930; GO:0007288; GO:0015631; GO:0031514; GO:0036064; GO:0046872; GO:0070740; GO:0106438 sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; microtubule [GO:0005874]; motile cilium [GO:0031514] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] g10587.t1 A6H619 36.673 559 6.81e-78 291.0 sp|A6H619|PHRF1_MOUSE PHD and RING finger domain-containing protein 1 OS=Mus musculus OX=10090 GN=Phrf1 PE=1 SV=2 g10587.t1 A6H619 59.524 84 4.19e-25 119.0 sp|A6H619|PHRF1_MOUSE PHD and RING finger domain-containing protein 1 OS=Mus musculus OX=10090 GN=Phrf1 PE=1 SV=2 g10599.t1 Q9QZR5 48.106 1056 0.0 804.0 sp|Q9QZR5|HIPK2_MOUSE Homeodomain-interacting protein kinase 2 OS=Mus musculus OX=10090 GN=Hipk2 PE=1 SV=2 g10601.t1 Q0VCJ7 64.677 201 1.13e-94 277.0 sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1 g10602.t1 A6QLU6 39.946 368 3.3e-74 259.0 sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1 AGRD1_BOVIN reviewed Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)] Bos taurus (Bovine) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g1107.t1 Q9Y6I8 48.634 183 6.730000000000001e-56 177.0 sp|Q9Y6I8|PXMP4_HUMAN Peroxisomal membrane protein 4 OS=Homo sapiens OX=9606 GN=PXMP4 PE=1 SV=3 g1108.t1 Q805E5 31.667 300 4.05e-35 135.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g1109.t1 Q8BWT1 70.202 396 0.0 580.0 sp|Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitochondrial OS=Mus musculus OX=10090 GN=Acaa2 PE=1 SV=3 THIM_MOUSE reviewed 3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) Mus musculus (Mouse) GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005743; GO:0005759; GO:0006084; GO:0006635; GO:0016604; GO:0036064; GO:0047617; GO:0071456; GO:1901029; GO:1902109 acetyl-CoA metabolic process [GO:0006084]; cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] ciliary basal body [GO:0036064]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; fatty acyl-CoA hydrolase activity [GO:0047617] g1111.t1 Q805E5 34.921 252 3.84e-36 143.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g1112.t1 A4IGP0 53.5 200 1.0700000000000001e-72 221.0 sp|A4IGP0|HIKES_XENTR Protein Hikeshi OS=Xenopus tropicalis OX=8364 GN=hikeshi PE=2 SV=1 g1113.t1 B1WAR9 59.641 223 4.03e-82 286.0 sp|B1WAR9|GWL_XENTR Serine/threonine-protein kinase greatwall OS=Xenopus tropicalis OX=8364 GN=mastl PE=2 SV=1 GWL_XENTR reviewed Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0006974; GO:0032154; GO:0051301; GO:0051721; GO:0106310 cell division [GO:0051301]; DNA damage response [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1113.t1 B1WAR9 63.636 176 3.88e-65 238.0 sp|B1WAR9|GWL_XENTR Serine/threonine-protein kinase greatwall OS=Xenopus tropicalis OX=8364 GN=mastl PE=2 SV=1 GWL_XENTR reviewed Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0006974; GO:0032154; GO:0051301; GO:0051721; GO:0106310 cell division [GO:0051301]; DNA damage response [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; nucleus [GO:0005634] ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1115.t1 E9Q3S4 62.963 270 2.5000000000000003e-103 368.0 sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus OX=10090 GN=Map3k19 PE=3 SV=1 g1115.t2 E9Q3S4 62.963 270 2.2200000000000002e-103 368.0 sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus OX=10090 GN=Map3k19 PE=3 SV=1 g1115.t3 E9Q3S4 62.963 270 2.42e-103 368.0 sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus OX=10090 GN=Map3k19 PE=3 SV=1 g1120.t1 Q8K3C0 50.0 92 9.920000000000001e-26 94.7 sp|Q8K3C0|RNK_MOUSE Ribonuclease kappa OS=Mus musculus OX=10090 GN=Rnasek PE=1 SV=1 g1121.t1 Q5ZLY5 67.686 229 7.29e-118 340.0 sp|Q5ZLY5|PKHF2_CHICK Pleckstrin homology domain-containing family F member 2 OS=Gallus gallus OX=9031 GN=PLEKHF2 PE=2 SV=1 g1122.t1 P62282 83.019 159 3.34e-86 252.0 sp|P62282|RS11_RAT Small ribosomal subunit protein uS17 OS=Rattus norvegicus OX=10116 GN=Rps11 PE=1 SV=3 g1130.t1 Q8R242 50.145 345 1.5000000000000002e-124 366.0 sp|Q8R242|DIAC_MOUSE Di-N-acetylchitobiase OS=Mus musculus OX=10090 GN=Ctbs PE=1 SV=2 DIAC_MOUSE reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Mus musculus (Mouse) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568] g1131.t1 Q8R242 54.971 342 5.75e-130 380.0 sp|Q8R242|DIAC_MOUSE Di-N-acetylchitobiase OS=Mus musculus OX=10090 GN=Ctbs PE=1 SV=2 DIAC_MOUSE reviewed Di-N-acetylchitobiase (EC 3.2.1.-) Mus musculus (Mouse) GO:0004568; GO:0005764; GO:0006032; GO:0008061; GO:0009313 chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] lysosome [GO:0005764] chitin binding [GO:0008061]; chitinase activity [GO:0004568] g1132.t1 Q5RI75 46.535 202 6.64e-51 186.0 sp|Q5RI75|RASEF_MOUSE Ras and EF-hand domain-containing protein homolog OS=Mus musculus OX=10090 GN=Rasef PE=1 SV=1 RASEF_MOUSE reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Mus musculus (Mouse) GO:0003924; GO:0005525; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g1132.t2 Q5RI75 46.535 202 7.95e-51 186.0 sp|Q5RI75|RASEF_MOUSE Ras and EF-hand domain-containing protein homolog OS=Mus musculus OX=10090 GN=Rasef PE=1 SV=1 RASEF_MOUSE reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Mus musculus (Mouse) GO:0003924; GO:0005525; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g1134.t1 Q29RK9 68.868 212 1.18e-112 323.0 sp|Q29RK9|MOB3B_BOVIN MOB kinase activator 3B OS=Bos taurus OX=9913 GN=MOB3B PE=2 SV=1 g1136.t1 Q9Y2A7 58.563 1127 0.0 1379.0 sp|Q9Y2A7|NCKP1_HUMAN Nck-associated protein 1 OS=Homo sapiens OX=9606 GN=NCKAP1 PE=1 SV=1 NCKP1_HUMAN reviewed Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1) Homo sapiens (Human) GO:0000902; GO:0001701; GO:0001726; GO:0001756; GO:0001843; GO:0005829; GO:0005925; GO:0006915; GO:0007354; GO:0007417; GO:0007492; GO:0008078; GO:0010172; GO:0010592; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030838; GO:0030866; GO:0030950; GO:0031209; GO:0031258; GO:0031941; GO:0032880; GO:0035050; GO:0042074; GO:0045175; GO:0045176; GO:0048340; GO:0048570; GO:0048617; GO:0048812; GO:0050821; GO:0070062; GO:0098794; GO:2000601 apical protein localization [GO:0045176]; apoptotic process [GO:0006915]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord morphogenesis [GO:0048570]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis, embryo [GO:0007354] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209] g1137.t1 Q9UGC7 49.622 397 5.98e-128 377.0 sp|Q9UGC7|RF1ML_HUMAN Peptide chain release factor 1-like, mitochondrial OS=Homo sapiens OX=9606 GN=MTRF1L PE=1 SV=1 RF1ML_HUMAN reviewed Peptide chain release factor 1-like, mitochondrial (Mitochondrial translational release factor 1-like) (mtRF1a) Homo sapiens (Human) GO:0003747; GO:0005739; GO:0005759; GO:0016149; GO:0070126 mitochondrial translational termination [GO:0070126] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149] g1138.t1 E7F1U2 35.294 697 6.1e-121 424.0 sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1 g1138.t1 E7F1U2 30.435 322 1.0700000000000001e-33 146.0 sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1 g1139.t1 Q9QXA6 43.093 485 9.27e-130 389.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g1140.t1 Q9QXA6 42.828 495 6.610000000000001e-132 395.0 sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1 BAT1_MOUSE reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Mus musculus (Mouse) GO:0003333; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009 amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g1141.t1 P82251 45.182 467 9.86e-136 404.0 sp|P82251|BAT1_HUMAN b(0,+)-type amino acid transporter 1 OS=Homo sapiens OX=9606 GN=SLC7A9 PE=1 SV=1 BAT1_HUMAN reviewed b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9) Homo sapiens (Human) GO:0003333; GO:0005886; GO:0015175; GO:0015184; GO:0015297; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0065003; GO:0180009 amino acid transmembrane transport [GO:0003333]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886] antiporter activity [GO:0015297]; broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982] g1142.t1 O60669 25.431 464 1.22e-35 141.0 sp|O60669|MOT2_HUMAN Monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC16A7 PE=1 SV=2 MOT2_HUMAN reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Homo sapiens (Human) GO:0005477; GO:0005654; GO:0005829; GO:0005886; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:0150104; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g1145.t1 Q924T3 29.927 274 2.5699999999999998e-23 102.0 sp|Q924T3|XRCC4_MOUSE DNA repair protein XRCC4 OS=Mus musculus OX=10090 GN=Xrcc4 PE=1 SV=1 g1146.t1 P56701 75.196 891 0.0 1394.0 sp|P56701|PSMD2_BOVIN 26S proteasome non-ATPase regulatory subunit 2 OS=Bos taurus OX=9913 GN=PSMD2 PE=1 SV=2 g1147.t1 Q7T385 68.074 379 0.0 558.0 sp|Q7T385|VTC1A_DANRE V-type proton ATPase subunit C 1-A OS=Danio rerio OX=7955 GN=atp6v1c1a PE=2 SV=1 g1148.t1 P62332 92.0 175 5.02e-122 344.0 sp|P62332|ARF6_RAT ADP-ribosylation factor 6 OS=Rattus norvegicus OX=10116 GN=Arf6 PE=1 SV=2 ARF6_RAT reviewed ADP-ribosylation factor 6 (EC 3.6.5.2) Rattus norvegicus (Rat) GO:0001726; GO:0001889; GO:0003925; GO:0005525; GO:0005737; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0007399; GO:0010975; GO:0010976; GO:0016020; GO:0016192; GO:0019003; GO:0030036; GO:0030139; GO:0030154; GO:0030496; GO:0030838; GO:0030866; GO:0031527; GO:0031901; GO:0031996; GO:0032154; GO:0032456; GO:0034394; GO:0035020; GO:0035591; GO:0036010; GO:0048488; GO:0050714; GO:0051489; GO:0051549; GO:0055037; GO:0055038; GO:0060998; GO:0070382; GO:0072659; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0098793; GO:0098794; GO:0098978; GO:0099562; GO:0120183; GO:1902217; GO:1903078; GO:1903438; GO:1905345; GO:1905606; GO:1990090; GO:2000009; GO:2000171 actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; erythrocyte apoptotic process [GO:1902217]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to cleavage furrow [GO:1905345]; protein localization to endosome [GO:0036010]; protein localization to plasma membrane [GO:0072659]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726] G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996] g1150.t1 Q6AYH9 43.271 483 1.51e-111 351.0 sp|Q6AYH9|DAAF1_RAT Dynein axonemal assembly factor 1 OS=Rattus norvegicus OX=10116 GN=Dnaaf1 PE=1 SV=1 DAAF1_RAT reviewed Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50) Rattus norvegicus (Rat) GO:0001947; GO:0003341; GO:0003356; GO:0005930; GO:0030324; GO:0035082; GO:0035469; GO:0036158; GO:0036159; GO:0044458; GO:0060271; GO:0060972; GO:0070286; GO:0070840; GO:0071907; GO:0071910 axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; left/right pattern formation [GO:0060972]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930] dynein complex binding [GO:0070840] g1151.t1 Q9BSW2 34.349 722 6.68e-116 368.0 sp|Q9BSW2|EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens OX=9606 GN=CRACR2A PE=1 SV=2 EFC4B_HUMAN reviewed EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) (EC 3.6.5.2) Homo sapiens (Human) GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005576; GO:0005737; GO:0005815; GO:0005886; GO:0008104; GO:0016020; GO:0016192; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0035580; GO:0045063; GO:0046330; GO:0051928 activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; intracellular protein localization [GO:0008104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] g1151.t2 Q8IZ41 28.225 783 1.17e-70 249.0 sp|Q8IZ41|RASEF_HUMAN Ras and EF-hand domain-containing protein OS=Homo sapiens OX=9606 GN=RASEF PE=1 SV=1 RASEF_HUMAN reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Homo sapiens (Human) GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g1152.t1 Q5ZII6 87.143 70 2.45e-40 129.0 sp|Q5ZII6|KISHA_CHICK Protein kish-A OS=Gallus gallus OX=9031 GN=TMEM167A PE=3 SV=1 g1153.t1 Q2KI24 63.745 251 1.83e-120 352.0 sp|Q2KI24|MTHSD_BOVIN Methenyltetrahydrofolate synthase domain-containing protein OS=Bos taurus OX=9913 GN=MTHFSD PE=2 SV=1 g1156.t1 B3EWZ6 40.681 2790 0.0 1954.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 35.489 3649 0.0 1895.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 37.785 3197 0.0 1886.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 39.986 2771 0.0 1879.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 39.45 2834 0.0 1865.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 38.853 2911 0.0 1839.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 38.928 2818 0.0 1816.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 37.842 2928 0.0 1772.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 38.202 2903 0.0 1758.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 31.819 4161 0.0 1736.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 38.014 2649 0.0 1686.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 36.748 2860 0.0 1633.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 36.062 2859 0.0 1611.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 30.464 4136 0.0 1543.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 29.163 4348 0.0 1524.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 30.274 4162 0.0 1521.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 32.263 2771 0.0 1200.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 29.332 3307 0.0 1192.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 31.663 2694 0.0 1127.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 30.12 2905 0.0 1034.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 29.911 2591 0.0 868.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 28.513 2462 0.0 776.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 31.226 1582 0.0 675.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 30.793 1640 1.3099999999999999e-180 636.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 31.322 1475 2.5100000000000003e-163 579.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 28.394 1687 1.9600000000000002e-156 556.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 29.196 1716 3.17e-153 546.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 28.469 1672 6.27e-143 511.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 27.12 1722 3.62e-137 493.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 26.908 1271 9.11e-98 362.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 30.897 780 3.6900000000000005e-70 270.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 26.736 864 4.8999999999999995e-62 243.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 31.313 594 1.9099999999999997e-55 222.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 31.783 516 6.64e-53 213.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 29.401 568 1.3e-47 196.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 25.287 609 1.47e-35 155.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1156.t1 B3EWZ6 32.031 384 6.07e-32 144.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1159.t1 P46023 32.047 674 5.81e-77 283.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1163.t1 B0BNA9 65.556 450 0.0 597.0 sp|B0BNA9|CNO11_RAT CCR4-NOT transcription complex subunit 11 OS=Rattus norvegicus OX=10116 GN=Cnot11 PE=2 SV=1 g1166.t1 Q9UKF6 69.927 685 0.0 1041.0 sp|Q9UKF6|CPSF3_HUMAN Cleavage and polyadenylation specificity factor subunit 3 OS=Homo sapiens OX=9606 GN=CPSF3 PE=1 SV=1 CPSF3_HUMAN reviewed Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Homo sapiens (Human) GO:0003723; GO:0004521; GO:0004534; GO:0005654; GO:0005847; GO:0006398; GO:0031124; GO:0046872; GO:0180010; GO:1900087; GO:1990904 co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] 5'-3' RNA exonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521] g1167.t1 P83509 36.951 774 9.45e-148 498.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t1 P83509 33.862 189 3.08e-33 144.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t2 P83509 36.951 774 2.64e-148 499.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t2 P83509 33.862 189 2.6500000000000002e-33 145.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t3 P83509 36.951 774 2.35e-148 499.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t3 P83509 33.862 189 2.57e-33 145.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t4 P83509 36.951 774 1.68e-148 499.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t4 P83509 33.862 189 2.61e-33 145.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t5 P83509 36.951 774 1.7e-148 499.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t5 P83509 33.862 189 2.58e-33 145.0 sp|P83509|RHG35_CANLF Rho GTPase-activating protein 35 OS=Canis lupus familiaris OX=9615 GN=ARHGAP35 PE=2 SV=1 RHG35_CANLF reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Rho GAP p190A) (p190-A) Canis lupus familiaris (Dog) (Canis familiaris) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0042478; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0045724; GO:0050770; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of eye photoreceptor cell development [GO:0042478]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t6 Q9NRY4 37.08 774 7.09e-149 499.0 sp|Q9NRY4|RHG35_HUMAN Rho GTPase-activating protein 35 OS=Homo sapiens OX=9606 GN=ARHGAP35 PE=1 SV=3 RHG35_HUMAN reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A) Homo sapiens (Human) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0043010; GO:0043116; GO:0044319; GO:0045724; GO:0050770; GO:0051056; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t6 Q9NRY4 33.862 189 2.5e-33 145.0 sp|Q9NRY4|RHG35_HUMAN Rho GTPase-activating protein 35 OS=Homo sapiens OX=9606 GN=ARHGAP35 PE=1 SV=3 RHG35_HUMAN reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A) Homo sapiens (Human) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0043010; GO:0043116; GO:0044319; GO:0045724; GO:0050770; GO:0051056; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t7 Q9NRY4 37.08 774 2.65e-148 499.0 sp|Q9NRY4|RHG35_HUMAN Rho GTPase-activating protein 35 OS=Homo sapiens OX=9606 GN=ARHGAP35 PE=1 SV=3 RHG35_HUMAN reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A) Homo sapiens (Human) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0043010; GO:0043116; GO:0044319; GO:0045724; GO:0050770; GO:0051056; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1167.t7 Q9NRY4 33.862 189 3.01e-33 144.0 sp|Q9NRY4|RHG35_HUMAN Rho GTPase-activating protein 35 OS=Homo sapiens OX=9606 GN=ARHGAP35 PE=1 SV=3 RHG35_HUMAN reviewed Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A) Homo sapiens (Human) GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0032956; GO:0035024; GO:0036064; GO:0043010; GO:0043116; GO:0044319; GO:0045724; GO:0050770; GO:0051056; GO:0097485 axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319] actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543] g1169.t1 Q6AXN3 41.126 231 1.88e-51 169.0 sp|Q6AXN3|TMED5_RAT Transmembrane emp24 domain-containing protein 5 OS=Rattus norvegicus OX=10116 GN=Tmed5 PE=2 SV=1 g1170.t1 Q2KIR1 61.071 280 1.62e-106 312.0 sp|Q2KIR1|SNRPA_BOVIN U1 small nuclear ribonucleoprotein A OS=Bos taurus OX=9913 GN=SNRPA PE=2 SV=1 g1171.t1 Q5RJA1 46.838 506 8.92e-155 476.0 sp|Q5RJA1|RFX6_DANRE DNA-binding protein RFX6 OS=Danio rerio OX=7955 GN=rfx6 PE=2 SV=2 g1173.t1 Q6DH23 76.873 307 0.0 508.0 sp|Q6DH23|V26BL_DANRE Vacuolar protein sorting-associated protein 26B-like OS=Danio rerio OX=7955 GN=vps26bl PE=2 SV=1 g1174.t1 Q9Z120 64.0 250 1.2800000000000001e-124 357.0 sp|Q9Z120|TRMB_MOUSE tRNA (guanine-N(7)-)-methyltransferase OS=Mus musculus OX=10090 GN=Mettl1 PE=1 SV=1 g1177.t1 Q9UPR0 54.448 1023 0.0 1163.0 sp|Q9UPR0|PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens OX=9606 GN=PLCL2 PE=1 SV=2 PLCL2_HUMAN reviewed Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2) Homo sapiens (Human) GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0007214; GO:0032228; GO:0046488; GO:0048015; GO:0050811; GO:0050859; GO:0051209; GO:0070679; GO:0120163 B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737] GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g1177.t2 Q9UPR0 55.533 1003 0.0 1176.0 sp|Q9UPR0|PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens OX=9606 GN=PLCL2 PE=1 SV=2 PLCL2_HUMAN reviewed Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2) Homo sapiens (Human) GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0007214; GO:0032228; GO:0046488; GO:0048015; GO:0050811; GO:0050859; GO:0051209; GO:0070679; GO:0120163 B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737] GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435] g1178.t1 Q9NWU2 65.0 220 2.74e-96 283.0 sp|Q9NWU2|GID8_HUMAN Glucose-induced degradation protein 8 homolog OS=Homo sapiens OX=9606 GN=GID8 PE=1 SV=1 GID8_HUMAN reviewed Glucose-induced degradation protein 8 homolog (Two hybrid-associated protein 1 with RanBPM) (Twa1) Homo sapiens (Human) GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0016055; GO:0030054; GO:0042803; GO:0043161; GO:0090263 positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] protein homodimerization activity [GO:0042803] g1180.t1 O75718 34.0 350 2.2e-58 200.0 sp|O75718|CRTAP_HUMAN Cartilage-associated protein OS=Homo sapiens OX=9606 GN=CRTAP PE=1 SV=1 CRTAP_HUMAN reviewed Cartilage-associated protein Homo sapiens (Human) GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0007283; GO:0030199; GO:0032991; GO:0050821; GO:1901874 collagen fibril organization [GO:0030199]; negative regulation of post-translational protein modification [GO:1901874]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] g1181.t1 Q8IVL5 44.937 316 3.8199999999999996e-74 252.0 sp|Q8IVL5|P3H2_HUMAN Prolyl 3-hydroxylase 2 OS=Homo sapiens OX=9606 GN=P3H2 PE=1 SV=1 P3H2_HUMAN reviewed Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) (Myxoid liposarcoma-associated protein 4) Homo sapiens (Human) GO:0005506; GO:0005604; GO:0005654; GO:0005783; GO:0005788; GO:0005794; GO:0005829; GO:0008285; GO:0016529; GO:0019511; GO:0019797; GO:0031418; GO:0032963 collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511] basement membrane [GO:0005604]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529] iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797] g1182.t1 P18433 37.605 593 4.88e-128 423.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1183.t1 P18433 45.486 288 2.97e-71 259.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1183.t1 P18433 33.559 295 1.9799999999999997e-48 190.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1184.t1 Q03348 39.024 287 8.32e-55 209.0 sp|Q03348|PTPRA_RAT Receptor-type tyrosine-protein phosphatase alpha OS=Rattus norvegicus OX=10116 GN=Ptpra PE=1 SV=1 g1185.t1 P18433 37.38 313 1.4899999999999999e-53 205.0 sp|P18433|PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens OX=9606 GN=PTPRA PE=1 SV=3 PTPRA_HUMAN reviewed Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) Homo sapiens (Human) GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007165; GO:0007229; GO:0016020; GO:0043235; GO:0051893; GO:0070062 integrin-mediated signaling pathway [GO:0007229]; regulation of focal adhesion assembly [GO:0051893]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g1186.t1 Q91880 83.41 434 0.0 777.0 sp|Q91880|SUH_XENLA Suppressor of hairless protein homolog OS=Xenopus laevis OX=8355 GN=rbpj PE=1 SV=1 g1187.t1 A3KQS4 48.953 382 6.29e-113 345.0 sp|A3KQS4|MINY1_DANRE Ubiquitin carboxyl-terminal hydrolase MINDY-1 OS=Danio rerio OX=7955 GN=mindy1 PE=3 SV=1 g1188.t1 Q86YI8 71.831 71 1.9199999999999999e-34 125.0 sp|Q86YI8|PHF13_HUMAN PHD finger protein 13 OS=Homo sapiens OX=9606 GN=PHF13 PE=1 SV=2 PHF13_HUMAN reviewed PHD finger protein 13 (Survival time-associated PHD finger protein in ovarian cancer 1) (SPOC1) Homo sapiens (Human) GO:0000278; GO:0003682; GO:0005634; GO:0005654; GO:0006974; GO:0007059; GO:0007076; GO:0008270; GO:0051301; GO:0062072; GO:0140463 cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076] nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; histone H3K9me2/3 reader activity [GO:0062072]; zinc ion binding [GO:0008270] g1190.t1 Q9C0H5 55.961 411 4.86e-162 517.0 sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2 g1190.t1 Q9C0H5 67.045 88 6.01e-33 142.0 sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2 g1190.t2 Q9C0H5 53.725 443 9.570000000000002e-163 518.0 sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2 g1190.t2 Q9C0H5 67.045 88 5.8e-33 142.0 sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2 g1191.t1 Q28IU1 50.658 304 2.56e-101 303.0 sp|Q28IU1|DHB12_XENTR Very-long-chain 3-oxoacyl-CoA reductase OS=Xenopus tropicalis OX=8364 GN=hsd17b12 PE=2 SV=1 DHB12_XENTR reviewed Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62) Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) GO:0004303; GO:0005783; GO:0005789; GO:0006633; GO:0006703; GO:0016491; GO:0141040 estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; oxidoreductase activity [GO:0016491]; very-long-chain 3-oxoacyl-CoA reductase activity [GO:0141040] g1193.t1 Q3SXM5 50.769 325 6.84e-118 346.0 sp|Q3SXM5|HSDL1_HUMAN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Homo sapiens OX=9606 GN=HSDL1 PE=1 SV=3 HSDL1_HUMAN reviewed Inactive hydroxysteroid dehydrogenase-like protein 1 (Short chain dehydrogenase/reductase family 12C member 3) Homo sapiens (Human) GO:0005739; GO:0045111 intermediate filament cytoskeleton [GO:0045111]; mitochondrion [GO:0005739] g1194.t1 Q5FWH7 32.295 706 8.89e-99 323.0 sp|Q5FWH7|S39AC_MOUSE Zinc transporter ZIP12 OS=Mus musculus OX=10090 GN=Slc39a12 PE=1 SV=1 S39AC_MOUSE reviewed Zinc transporter ZIP12 (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12) Mus musculus (Mouse) GO:0001841; GO:0005385; GO:0005886; GO:0007165; GO:0010975; GO:0030003; GO:0031113; GO:0048471; GO:0071578; GO:0140410; GO:1903672; GO:1990138 intracellular monoatomic cation homeostasis [GO:0030003]; neural tube formation [GO:0001841]; neuron projection extension [GO:1990138]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578] perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g1195.t1 Q9D7X3 49.39 164 9.48e-56 177.0 sp|Q9D7X3|DUS3_MOUSE Dual specificity protein phosphatase 3 OS=Mus musculus OX=10090 GN=Dusp3 PE=1 SV=1 DUS3_MOUSE reviewed Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (T-DSP11) (Vaccinia H1-related phosphatase) (VHR) Mus musculus (Mouse) GO:0001701; GO:0001772; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008092; GO:0008138; GO:0016791; GO:0019901; GO:0030294; GO:0030317; GO:0030336; GO:0030971; GO:0033549; GO:0036126; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:0160110; GO:1990782 cellular response to epidermal growth factor stimulus [GO:0071364]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893] axonemal microtubule doublet inner sheath [GO:0160110]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor signaling protein tyrosine kinase inhibitor activity [GO:0030294]; receptor tyrosine kinase binding [GO:0030971] g1196.t1 P46871 75.558 761 0.0 1107.0 sp|P46871|KRP95_STRPU Kinesin-II 95 kDa subunit OS=Strongylocentrotus purpuratus OX=7668 GN=KRP95 PE=1 SV=1 g1197.t1 Q5RBK0 24.752 303 2.03e-31 132.0 sp|Q5RBK0|GIN1_PONAB Gypsy retrotransposon integrase-like protein 1 OS=Pongo abelii OX=9601 GN=GIN1 PE=2 SV=1 g1200.t1 Q9VCA2 38.561 542 5.62e-118 363.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g1201.t1 Q9VCA2 38.632 541 2.95e-118 364.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g1202.t1 Q08509 36.228 806 1.34e-131 419.0 sp|Q08509|EPS8_MOUSE Epidermal growth factor receptor kinase substrate 8 OS=Mus musculus OX=10090 GN=Eps8 PE=1 SV=2 EPS8_MOUSE reviewed Epidermal growth factor receptor kinase substrate 8 Mus musculus (Mouse) GO:0003779; GO:0005829; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830 actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202] actin binding [GO:0003779]; small GTPase binding [GO:0031267] g1202.t2 Q5RC07 32.197 792 3.76e-122 390.0 sp|Q5RC07|ES8L2_PONAB Epidermal growth factor receptor kinase substrate 8-like protein 2 OS=Pongo abelii OX=9601 GN=EPS8L2 PE=2 SV=1 ES8L2_PONAB reviewed Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003779; GO:0005829; GO:0007266; GO:0007605; GO:0031982; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:1900029 positive regulation of ruffle assembly [GO:1900029]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] actin binding [GO:0003779] g1203.t1 Q5RGJ5 54.937 557 0.0 599.0 sp|Q5RGJ5|C19L1_DANRE CWF19-like protein 1 OS=Danio rerio OX=7955 GN=cwf19l1 PE=2 SV=1 g1204.t1 Q5EA98 53.712 458 3.5700000000000003e-122 366.0 sp|Q5EA98|MFAP1_BOVIN Microfibrillar-associated protein 1 OS=Bos taurus OX=9913 GN=MFAP1 PE=2 SV=1 MFAP1_BOVIN reviewed Microfibrillar-associated protein 1 (Spliceosome B complex protein MFAP1) Bos taurus (Bovine) GO:0000398; GO:0001527; GO:0005634; GO:0005654; GO:0005684; GO:0005813; GO:0071005 mRNA splicing, via spliceosome [GO:0000398] centrosome [GO:0005813]; microfibril [GO:0001527]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] g1207.t1 Q15428 84.722 216 1.97e-121 362.0 sp|Q15428|SF3A2_HUMAN Splicing factor 3A subunit 2 OS=Homo sapiens OX=9606 GN=SF3A2 PE=1 SV=2 SF3A2_HUMAN reviewed Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62) Homo sapiens (Human) GO:0000245; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241 mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g1208.t1 Q96IG2 27.861 402 6.67e-28 122.0 sp|Q96IG2|FXL20_HUMAN F-box/LRR-repeat protein 20 OS=Homo sapiens OX=9606 GN=FBXL20 PE=1 SV=2 g1211.t1 Q62910 56.877 1127 0.0 1305.0 sp|Q62910|SYNJ1_RAT Synaptojanin-1 OS=Rattus norvegicus OX=10116 GN=Synj1 PE=1 SV=3 g1212.t1 Q641W2 61.111 324 3.03e-139 404.0 sp|Q641W2|MYG1_RAT MYG1 exonuclease OS=Rattus norvegicus OX=10116 GN=Myg1 PE=1 SV=1 g1213.t1 Q9UIG0 41.784 998 0.0 653.0 sp|Q9UIG0|BAZ1B_HUMAN Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2 g1213.t1 Q9UIG0 33.333 318 2.67e-37 157.0 sp|Q9UIG0|BAZ1B_HUMAN Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2 g1213.t2 Q9UIG0 41.784 998 0.0 654.0 sp|Q9UIG0|BAZ1B_HUMAN Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2 g1213.t2 Q9UIG0 34.304 309 1.09e-38 162.0 sp|Q9UIG0|BAZ1B_HUMAN Tyrosine-protein kinase BAZ1B OS=Homo sapiens OX=9606 GN=BAZ1B PE=1 SV=2 g1214.t1 Q8BMI4 39.363 597 2.14e-128 408.0 sp|Q8BMI4|GEN_MOUSE Flap endonuclease GEN homolog 1 OS=Mus musculus OX=10090 GN=Gen1 PE=1 SV=2 g1215.t1 A6H603 29.227 893 1.94e-73 276.0 sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2 NWD1_MOUSE reviewed NACHT domain- and WD repeat-containing protein 1 Mus musculus (Mouse) GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088 negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628] cytosol [GO:0005829]; nucleolus [GO:0005730] ATP binding [GO:0005524] g1218.t1 Q6DCX5 30.549 419 1.03e-58 203.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g1219.t1 P18320 71.223 139 6.520000000000001e-70 211.0 sp|P18320|PROF_HELCR Profilin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=2 g1222.t1 Q6DCX5 28.176 433 4.95e-38 149.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g1226.t1 Q9Z0W3 41.148 1429 0.0 1068.0 sp|Q9Z0W3|NU160_MOUSE Nuclear pore complex protein Nup160 OS=Mus musculus OX=10090 GN=Nup160 PE=1 SV=2 g1227.t1 A1L314 39.68 688 5.72e-164 493.0 sp|A1L314|MPEG1_MOUSE Macrophage-expressed gene 1 protein OS=Mus musculus OX=10090 GN=Mpeg1 PE=1 SV=1 MPEG1_MOUSE reviewed Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2) (PFN2) (mPFN2) (Protein MPS1) [Cleaved into: Macrophage-expressed gene 1 protein, processed form] Mus musculus (Mouse) GO:0002250; GO:0002468; GO:0002478; GO:0002479; GO:0022829; GO:0030670; GO:0031410; GO:0036019; GO:0042590; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0061474; GO:0140367; GO:0140911 adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; antigen processing and presentation of exogenous peptide antigen [GO:0002478]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell antigen processing and presentation [GO:0002468] cytoplasmic vesicle [GO:0031410]; endolysosome [GO:0036019]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagolysosome membrane [GO:0061474] pore-forming activity [GO:0140911]; wide pore channel activity [GO:0022829] g1228.t1 P0CJ79 34.646 508 6.09e-84 284.0 sp|P0CJ79|ZN888_HUMAN Zinc finger protein 888 OS=Homo sapiens OX=9606 GN=ZNF888 PE=1 SV=2 g1228.t1 P0CJ79 33.639 327 2.5e-46 179.0 sp|P0CJ79|ZN888_HUMAN Zinc finger protein 888 OS=Homo sapiens OX=9606 GN=ZNF888 PE=1 SV=2 g1228.t1 P0CJ79 33.449 287 2.14e-38 155.0 sp|P0CJ79|ZN888_HUMAN Zinc finger protein 888 OS=Homo sapiens OX=9606 GN=ZNF888 PE=1 SV=2 g1228.t1 P0CJ79 30.714 280 2.28e-30 131.0 sp|P0CJ79|ZN888_HUMAN Zinc finger protein 888 OS=Homo sapiens OX=9606 GN=ZNF888 PE=1 SV=2 g1234.t1 Q6NV04 68.812 606 0.0 891.0 sp|Q6NV04|HACL2_DANRE 2-hydroxyacyl-CoA lyase 2 OS=Danio rerio OX=7955 GN=ilvbl PE=2 SV=1 HACL2_DANRE reviewed 2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016829; GO:0030976; GO:0048701; GO:0050660 embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; L-valine biosynthetic process [GO:0009099] acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789] acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] g1237.t1 Q8K3Q3 35.417 384 1.85e-56 200.0 sp|Q8K3Q3|FOXN4_MOUSE Forkhead box protein N4 OS=Mus musculus OX=10090 GN=Foxn4 PE=1 SV=1 FOXN4_MOUSE reviewed Forkhead box protein N4 Mus musculus (Mouse) GO:0000981; GO:0000987; GO:0001947; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0021514; GO:0030154; GO:0035881; GO:0036302; GO:0045944; GO:0048663; GO:0060579 amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; cell differentiation [GO:0030154]; heart looping [GO:0001947]; neuron fate commitment [GO:0048663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of heart contraction [GO:0008016]; retina layer formation [GO:0010842]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron fate commitment [GO:0060579] nucleus [GO:0005634] chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981] g1238.t1 Q2KJC3 38.27 682 3.7400000000000003e-157 476.0 sp|Q2KJC3|MPEG1_BOVIN Macrophage-expressed gene 1 protein OS=Bos taurus OX=9913 GN=MPEG1 PE=2 SV=2 MPEG1_BOVIN reviewed Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2) [Cleaved into: Macrophage-expressed gene 1 protein, processed form] Bos taurus (Bovine) GO:0002250; GO:0002468; GO:0002478; GO:0002479; GO:0022829; GO:0030670; GO:0031410; GO:0042590; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0061474; GO:0140367 adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; antigen processing and presentation of exogenous peptide antigen [GO:0002478]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell antigen processing and presentation [GO:0002468] cytoplasmic vesicle [GO:0031410]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagolysosome membrane [GO:0061474] wide pore channel activity [GO:0022829] g1240.t1 Q8R2Q6 28.947 608 4.57e-53 196.0 sp|Q8R2Q6|TECT3_MOUSE Tectonic-3 OS=Mus musculus OX=10090 GN=Tctn3 PE=1 SV=1 g1243.t1 Q9SR22 34.824 425 1.17e-73 240.0 sp|Q9SR22|PAE5_ARATH Pectin acetylesterase 5 OS=Arabidopsis thaliana OX=3702 GN=PAE5 PE=2 SV=1 g1244.t1 P46023 32.103 623 2.67e-75 276.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1246.t1 Q7Z407 24.341 493 7.33e-21 104.0 sp|Q7Z407|CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens OX=9606 GN=CSMD3 PE=1 SV=3 CSMD3_HUMAN reviewed CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) Homo sapiens (Human) GO:0005886; GO:0050773 regulation of dendrite development [GO:0050773] plasma membrane [GO:0005886] g1247.t1 Q9SR22 35.446 426 9.939999999999999e-81 259.0 sp|Q9SR22|PAE5_ARATH Pectin acetylesterase 5 OS=Arabidopsis thaliana OX=3702 GN=PAE5 PE=2 SV=1 g1248.t1 P46023 31.01 416 3.41e-34 147.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1248.t2 P46023 31.01 416 4.97e-34 146.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1249.t1 Q61830 27.885 416 2.2e-40 158.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g1249.t1 Q61830 28.228 457 1.0400000000000001e-36 147.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g1249.t1 Q61830 25.714 455 9.570000000000001e-36 144.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g1249.t1 Q61830 30.855 269 2.85e-30 128.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g1249.t1 Q61830 25.346 434 6.54e-30 127.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g1249.t1 Q61830 27.078 421 8.32e-30 126.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g1249.t1 Q61830 25.221 452 9.53e-26 114.0 sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2 g1250.t1 P46023 31.707 615 3.05e-73 271.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1252.t1 Q9NXS3 31.072 457 6.97e-50 185.0 sp|Q9NXS3|KLH28_HUMAN Kelch-like protein 28 OS=Homo sapiens OX=9606 GN=KLHL28 PE=1 SV=2 g1253.t1 Q6DDT1 68.739 547 0.0 786.0 sp|Q6DDT1|INO1B_XENLA Inositol-3-phosphate synthase 1-B OS=Xenopus laevis OX=8355 GN=isyna1-b PE=2 SV=2 INO1B_XENLA reviewed Inositol-3-phosphate synthase 1-B (IPS 1-B) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase B) (MI-1-P synthase B) (MIP synthase B) Xenopus laevis (African clawed frog) GO:0004512; GO:0005737; GO:0006021; GO:0008654 inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654] cytoplasm [GO:0005737] inositol-3-phosphate synthase activity [GO:0004512] g1256.t1 O55055 61.905 168 2.54e-70 235.0 sp|O55055|TRDMT_MOUSE tRNA (cytosine(38)-C(5))-methyltransferase OS=Mus musculus OX=10090 GN=Trdmt1 PE=1 SV=2 TRDMT_MOUSE reviewed tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2) (DNA methyltransferase homolog MmuIIP) (DNA MTase homolog MmuIIP) (M.MmuIIP) (Met-2) Mus musculus (Mouse) GO:0003723; GO:0005634; GO:0005737; GO:0006400; GO:0008175; GO:0016428; GO:0030488; GO:0036416 tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] cytoplasm [GO:0005737]; nucleus [GO:0005634] RNA binding [GO:0003723]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA methyltransferase activity [GO:0008175] g1256.t1 O55055 48.299 147 1.0800000000000001e-26 115.0 sp|O55055|TRDMT_MOUSE tRNA (cytosine(38)-C(5))-methyltransferase OS=Mus musculus OX=10090 GN=Trdmt1 PE=1 SV=2 TRDMT_MOUSE reviewed tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2) (DNA methyltransferase homolog MmuIIP) (DNA MTase homolog MmuIIP) (M.MmuIIP) (Met-2) Mus musculus (Mouse) GO:0003723; GO:0005634; GO:0005737; GO:0006400; GO:0008175; GO:0016428; GO:0030488; GO:0036416 tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] cytoplasm [GO:0005737]; nucleus [GO:0005634] RNA binding [GO:0003723]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA methyltransferase activity [GO:0008175] g1257.t1 Q6ZT07 46.035 1425 0.0 1140.0 sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2 g1257.t2 Q6ZT07 46.322 1414 0.0 1142.0 sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2 g1257.t3 Q6ZT07 47.046 1388 0.0 1149.0 sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2 g1258.t1 Q91VP7 32.218 239 1.27e-36 133.0 sp|Q91VP7|TM101_MOUSE Transmembrane protein 101 OS=Mus musculus OX=10090 GN=Tmem101 PE=2 SV=1 g1259.t1 Q6GN08 36.443 1608 0.0 918.0 sp|Q6GN08|CND3L_XENLA Condensin-2 complex subunit D3-L OS=Xenopus laevis OX=8355 GN=ncapd3.L PE=1 SV=1 CND3L_XENLA reviewed Condensin-2 complex subunit D3-L Xenopus laevis (African clawed frog) GO:0000779; GO:0000796; GO:0007076; GO:0010032; GO:0031981; GO:0042393; GO:0051301 cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076] condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; nuclear lumen [GO:0031981] histone binding [GO:0042393] g1260.t1 Q6AI39 44.828 116 1.89e-21 106.0 sp|Q6AI39|BICRL_HUMAN BRD4-interacting chromatin-remodeling complex-associated protein-like OS=Homo sapiens OX=9606 GN=BICRAL PE=1 SV=2 BICRL_HUMAN reviewed BRD4-interacting chromatin-remodeling complex-associated protein-like (Glioma tumor suppressor candidate region gene 1 protein-like) Homo sapiens (Human) GO:0000785; GO:0005654; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:1902459 chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514] g1261.t1 O95948 52.727 385 1.89e-107 331.0 sp|O95948|ONEC2_HUMAN One cut domain family member 2 OS=Homo sapiens OX=9606 GN=ONECUT2 PE=1 SV=2 ONEC2_HUMAN reviewed One cut domain family member 2 (Hepatocyte nuclear factor 6-beta) (HNF-6-beta) (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2) Homo sapiens (Human) GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0005634; GO:0005654; GO:0006357; GO:0007179; GO:0009887; GO:0015629; GO:0030512; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271; GO:1905319; GO:1905322; GO:1990837 animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; mesenchymal stem cell migration [GO:1905319]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; transforming growth factor beta receptor signaling pathway [GO:0007179] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g1262.t1 Q9UGM3 27.856 1059 2.02e-85 306.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1262.t1 Q9UGM3 27.155 1079 3.38e-83 299.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1262.t1 Q9UGM3 27.032 1095 9.32e-81 292.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1262.t1 Q9UGM3 26.362 918 3.2600000000000005e-58 223.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1262.t1 Q9UGM3 31.408 277 1.25e-27 125.0 sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2 g1266.t1 P62912 77.444 133 1.5500000000000002e-73 218.0 sp|P62912|RL32_RAT Large ribosomal subunit protein eL32 OS=Rattus norvegicus OX=10116 GN=Rpl32 PE=1 SV=2 g1267.t1 O42587 86.967 422 0.0 759.0 sp|O42587|PR6AA_XENLA 26S proteasome regulatory subunit 6A-A OS=Xenopus laevis OX=8355 GN=psmc3-a PE=2 SV=2 g1268.t1 Q3ZC33 53.333 435 5.59e-174 497.0 sp|Q3ZC33|GGLO_BOVIN L-gulonolactone oxidase OS=Bos taurus OX=9913 GN=GULO PE=2 SV=3 g1269.t1 Q9VCA2 36.531 542 2.9599999999999997e-115 356.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g1270.t1 Q9VCA2 48.322 149 4.46e-39 147.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g1271.t1 B3EWZ6 33.766 4392 0.0 2082.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 39.083 2858 0.0 1872.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 38.554 2822 0.0 1843.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 37.994 2911 0.0 1799.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 31.008 4244 0.0 1712.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 37.907 2675 0.0 1658.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 36.43 2885 0.0 1608.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 35.527 2857 0.0 1569.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 30.062 4188 0.0 1551.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 35.506 2884 0.0 1545.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 34.786 2915 0.0 1505.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 29.957 4196 0.0 1494.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 29.201 4219 0.0 1479.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 29.237 4207 0.0 1460.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 27.972 4551 0.0 1393.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 39.014 2130 0.0 1354.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 30.72 3112 0.0 1236.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 37.5 1848 0.0 1117.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 32.343 2322 0.0 1097.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 38.366 1616 0.0 1022.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 28.257 3224 0.0 934.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 34.258 1766 0.0 841.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 30.54 1945 0.0 699.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 32.252 1541 3.11e-177 625.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 30.308 1752 3.43e-177 625.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t1 B3EWZ6 29.005 1548 2.23e-137 493.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 33.766 4392 0.0 2081.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 38.841 2881 0.0 1862.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 38.243 2845 0.0 1834.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 37.994 2911 0.0 1798.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 31.008 4244 0.0 1712.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 37.907 2675 0.0 1657.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 36.43 2885 0.0 1607.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 35.407 2878 0.0 1560.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 30.038 4188 0.0 1547.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 35.294 2907 0.0 1536.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 34.786 2915 0.0 1504.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 29.9 4214 0.0 1489.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 29.05 4241 0.0 1469.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 29.237 4207 0.0 1459.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 27.972 4551 0.0 1392.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 39.014 2130 0.0 1353.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 30.501 3131 0.0 1226.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 37.5 1848 0.0 1117.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 32.343 2322 0.0 1096.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 38.366 1616 0.0 1021.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 28.257 3224 0.0 934.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 34.258 1766 0.0 841.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 30.54 1945 0.0 699.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 32.252 1541 3.84e-177 625.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 30.308 1752 4.51e-177 625.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1271.t2 B3EWZ6 29.005 1548 2.8799999999999997e-137 493.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1272.t1 P60905 48.718 195 8.110000000000001e-47 157.0 sp|P60905|DNJC5_RAT DnaJ homolog subfamily C member 5 OS=Rattus norvegicus OX=10116 GN=Dnajc5 PE=1 SV=1 DNJC5_RAT reviewed DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP) Rattus norvegicus (Rat) GO:0005829; GO:0005886; GO:0006457; GO:0007268; GO:0008021; GO:0016020; GO:0030672; GO:0031594; GO:0042470; GO:0042584; GO:0043008; GO:0043195; GO:0043524; GO:0051402; GO:0098693; GO:0098793 chemical synaptic transmission [GO:0007268]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; protein folding [GO:0006457]; regulation of synaptic vesicle cycle [GO:0098693] chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; melanosome [GO:0042470]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] ATP-dependent protein binding [GO:0043008] g1273.t1 Q4V8B8 50.872 344 4.34e-109 336.0 sp|Q4V8B8|TYW2_RAT tRNA wybutosine-synthesizing protein 2 homolog OS=Rattus norvegicus OX=10116 GN=Trmt12 PE=2 SV=2 g1274.t1 Q15599 55.66 106 2.42e-31 125.0 sp|Q15599|NHRF2_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=NHERF2 PE=1 SV=2 g1274.t1 Q15599 50.877 114 2.38e-23 103.0 sp|Q15599|NHRF2_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF2 OS=Homo sapiens OX=9606 GN=NHERF2 PE=1 SV=2 g1275.t1 A7MB11 50.058 855 0.0 907.0 sp|A7MB11|TGFA1_BOVIN Transforming growth factor-beta receptor-associated protein 1 OS=Bos taurus OX=9913 GN=TGFBRAP1 PE=2 SV=1 g1276.t1 P08836 56.342 339 5.56e-148 427.0 sp|P08836|FPPS_CHICK Farnesyl pyrophosphate synthase OS=Gallus gallus OX=9031 GN=FDPS PE=1 SV=2 g1276.t2 P08836 56.012 341 2.4e-149 428.0 sp|P08836|FPPS_CHICK Farnesyl pyrophosphate synthase OS=Gallus gallus OX=9031 GN=FDPS PE=1 SV=2 g1277.t1 Q0VAW7 35.741 263 8.27e-35 147.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g1277.t1 Q0VAW7 33.077 260 3.5499999999999996e-30 132.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g1277.t1 Q0VAW7 33.202 253 2.67e-28 126.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g1277.t1 Q0VAW7 34.896 192 1.37e-22 107.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g1277.t1 Q0VAW7 28.84 319 1.83e-22 107.0 sp|Q0VAW7|ZN112_MOUSE Zinc finger protein 112 OS=Mus musculus OX=10090 GN=Znf112 PE=2 SV=2 ZN112_MOUSE reviewed Zinc finger protein 112 (Zfp-112) Mus musculus (Mouse) GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0043565 regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] g1280.t1 Q805E5 31.449 283 9.140000000000001e-31 122.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g1281.t1 Q805E5 32.852 277 1.3e-31 128.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g1282.t1 Q805E5 32.734 278 1.38e-36 140.0 sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1 g1286.t1 Q5RF67 42.561 289 9.82e-72 229.0 sp|Q5RF67|SFRP3_PONAB Secreted frizzled-related protein 3 OS=Pongo abelii OX=9601 GN=FRZB PE=2 SV=1 SFRP3_PONAB reviewed Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0001501; GO:0002064; GO:0005615; GO:0005737; GO:0008285; GO:0010721; GO:0014033; GO:0017147; GO:0030308; GO:0035567; GO:0043065; GO:0045600; GO:0060029; GO:0060070; GO:0061037; GO:0061053; GO:0070365; GO:0070367; GO:0090090; GO:0090103 canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; epithelial cell development [GO:0002064]; hepatocyte differentiation [GO:0070365]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; neural crest cell differentiation [GO:0014033]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053] cytoplasm [GO:0005737]; extracellular space [GO:0005615] Wnt-protein binding [GO:0017147] g1287.t1 Q9XSC1 39.932 293 3.48e-68 221.0 sp|Q9XSC1|SFRP5_BOVIN Secreted frizzled-related protein 5 OS=Bos taurus OX=9913 GN=SFRP5 PE=2 SV=1 g1289.t1 Q8BYF6 35.072 556 2.4e-102 326.0 sp|Q8BYF6|SC5A8_MOUSE Sodium-coupled monocarboxylate transporter 1 OS=Mus musculus OX=10090 GN=Slc5a8 PE=1 SV=1 SC5A8_MOUSE reviewed Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8) Mus musculus (Mouse) GO:0000811; GO:0005343; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0015129; GO:0015552; GO:0015636; GO:0015705; GO:0015706; GO:0015718; GO:0015727; GO:0015730; GO:0015913; GO:0016324; GO:0031526; GO:0090416; GO:0140161; GO:2001142 acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; short-chain fatty acid transmembrane transport [GO:0015913]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; GINS complex [GO:0000811] lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; nicotinate transmembrane transporter activity [GO:0090416]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552]; short-chain fatty acid transmembrane transporter activity [GO:0015636] g1290.t1 P51523 53.073 179 8.809999999999999e-55 189.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 51.955 179 1.0299999999999999e-54 188.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 50.0 176 5.939999999999999e-52 181.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 52.727 165 8.14e-50 175.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 49.162 179 1.22e-48 172.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 47.486 179 1.49e-48 171.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 50.279 179 4.15e-48 170.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 47.486 179 5.0799999999999996e-48 170.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 49.162 179 6.27e-48 170.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 49.162 179 1.66e-47 169.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 48.603 179 4.06e-47 167.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 46.629 178 2.13e-43 157.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1290.t1 P51523 44.643 168 2.2199999999999998e-39 146.0 sp|P51523|ZNF84_HUMAN Zinc finger protein 84 OS=Homo sapiens OX=9606 GN=ZNF84 PE=1 SV=2 g1291.t1 Q05481 46.816 534 1.06e-160 492.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 44.484 562 1.7000000000000002e-157 483.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 46.516 531 1.27e-156 481.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 47.148 526 2.7200000000000003e-156 480.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 45.506 534 7.59e-155 476.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 46.809 517 7.1e-154 474.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 43.95 562 5.76e-152 469.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 45.318 534 6.46e-150 464.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 43.06 562 2.06e-146 454.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 45.261 517 2.14e-146 454.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 45.833 504 2.9400000000000002e-145 451.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 44.401 509 1.08e-141 442.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 45.773 485 1.08e-138 434.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 42.857 504 2.3199999999999997e-126 401.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 42.925 424 1.48e-98 327.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1291.t1 Q05481 44.586 314 4.6e-77 267.0 sp|Q05481|ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens OX=9606 GN=ZNF91 PE=1 SV=2 ZNF91_HUMAN reviewed Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) Homo sapiens (Human) GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0010526 regulation of transcription by RNA polymerase II [GO:0006357]; transposable element silencing [GO:0010526] nucleus [GO:0005634] DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; zinc ion binding [GO:0008270] g1292.t1 P51960 35.864 764 9.5e-121 380.0 sp|P51960|MYBA_MOUSE Myb-related protein A OS=Mus musculus OX=10090 GN=Mybl1 PE=1 SV=2 MYBA_MOUSE reviewed Myb-related protein A (A-Myb) (Myb-like protein 1) Mus musculus (Mouse) GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0007141; GO:0007283; GO:0030154; GO:0045944; GO:0140543; GO:1990841 cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; positive regulation of piRNA transcription [GO:0140543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283] nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] g1293.t1 Q9Y6J0 41.194 1005 0.0 736.0 sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1 g1293.t1 Q9Y6J0 49.836 305 2.31e-76 287.0 sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1 g1293.t1 Q9Y6J0 51.813 193 1.3999999999999998e-54 216.0 sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1 g1298.t1 O35623 51.695 118 5.87e-36 121.0 sp|O35623|BET1_MOUSE BET1 homolog OS=Mus musculus OX=10090 GN=Bet1 PE=1 SV=1 g1299.t1 Q5ZIM6 38.721 594 2.38e-90 292.0 sp|Q5ZIM6|AATF_CHICK Protein AATF OS=Gallus gallus OX=9031 GN=AATF PE=2 SV=1 g1300.t1 Q9Z2K9 75.426 411 0.0 672.0 sp|Q9Z2K9|IDHC_MICME Isocitrate dehydrogenase [NADP] cytoplasmic OS=Microtus mexicanus OX=79689 GN=IDH1 PE=2 SV=1 g1302.t1 O95628 77.021 235 6.020000000000001e-122 380.0 sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3 CNOT4_HUMAN reviewed CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4) Homo sapiens (Human) GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865; GO:0061630 nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g1302.t2 O95628 77.021 235 5.86e-122 380.0 sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3 CNOT4_HUMAN reviewed CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4) Homo sapiens (Human) GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865; GO:0061630 nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g1305.t1 P20072 41.158 311 1.8499999999999998e-82 261.0 sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2 g1306.t1 Q8VE52 51.456 103 1.79e-28 111.0 sp|Q8VE52|OGRL1_MOUSE Opioid growth factor receptor-like protein 1 OS=Mus musculus OX=10090 GN=Ogfrl1 PE=1 SV=2 g1313.t1 Q68ED2 27.356 870 2.1e-97 327.0 sp|Q68ED2|GRM7_MOUSE Metabotropic glutamate receptor 7 OS=Mus musculus OX=10090 GN=Grm7 PE=1 SV=1 GRM7_MOUSE reviewed Metabotropic glutamate receptor 7 (mGluR7) Mus musculus (Mouse) GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005509; GO:0005516; GO:0005886; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045211; GO:0046983; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0061564; GO:0070905; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axon development [GO:0061564]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226] asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245] g1314.t1 P91685 27.357 859 2.3399999999999998e-101 339.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g1316.t1 P91685 33.862 189 2.59e-28 114.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g1317.t1 P31423 28.281 541 7.52e-57 207.0 sp|P31423|GRM4_RAT Metabotropic glutamate receptor 4 OS=Rattus norvegicus OX=10116 GN=Grm4 PE=1 SV=1 g1319.t1 P35400 33.175 211 1.48e-29 118.0 sp|P35400|GRM7_RAT Metabotropic glutamate receptor 7 OS=Rattus norvegicus OX=10116 GN=Grm7 PE=1 SV=1 g1320.t1 P91685 27.273 858 3.79e-101 338.0 sp|P91685|GRM_DROME Metabotropic glutamate receptor OS=Drosophila melanogaster OX=7227 GN=mGluR PE=1 SV=2 GRM_DROME reviewed Metabotropic glutamate receptor (DmGluRA) Drosophila melanogaster (Fruit fly) GO:0001641; GO:0004930; GO:0005886; GO:0007216; GO:0007528; GO:0007612; GO:0007614; GO:0007616; GO:0008049; GO:0008066; GO:0015485; GO:0016020; GO:0016595; GO:0038038; GO:0045121; GO:0051966; GO:0072553 G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; neuromuscular junction development [GO:0007528]; regulation of synaptic transmission, glutamatergic [GO:0051966]; short-term memory [GO:0007614]; terminal button organization [GO:0072553] G protein-coupled receptor homodimeric complex [GO:0038038]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cholesterol binding [GO:0015485]; G protein-coupled receptor activity [GO:0004930]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641] g1321.t1 P35400 33.175 211 1.48e-29 118.0 sp|P35400|GRM7_RAT Metabotropic glutamate receptor 7 OS=Rattus norvegicus OX=10116 GN=Grm7 PE=1 SV=1 g1322.t1 P31423 27.9 681 7.43e-79 274.0 sp|P31423|GRM4_RAT Metabotropic glutamate receptor 4 OS=Rattus norvegicus OX=10116 GN=Grm4 PE=1 SV=1 g1323.t1 P35400 33.175 211 1.48e-29 118.0 sp|P35400|GRM7_RAT Metabotropic glutamate receptor 7 OS=Rattus norvegicus OX=10116 GN=Grm7 PE=1 SV=1 g1324.t1 P31423 28.235 680 1.24e-79 276.0 sp|P31423|GRM4_RAT Metabotropic glutamate receptor 4 OS=Rattus norvegicus OX=10116 GN=Grm4 PE=1 SV=1 g1325.t1 P70579 29.172 833 2.33e-103 343.0 sp|P70579|GRM8_RAT Metabotropic glutamate receptor 8 OS=Rattus norvegicus OX=10116 GN=Grm8 PE=1 SV=1 GRM8_RAT reviewed Metabotropic glutamate receptor 8 (mGluR8) Rattus norvegicus (Rat) GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0008066; GO:0019233; GO:0035249; GO:0042734; GO:0043025; GO:0045211; GO:0046928; GO:0048787; GO:0050966; GO:0051966; GO:0098978; GO:0098982; GO:0099171 adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734] G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] g1329.t1 Q9Y5Z4 41.139 158 9.150000000000001e-37 130.0 sp|Q9Y5Z4|HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens OX=9606 GN=HEBP2 PE=1 SV=1 HEBP2_HUMAN reviewed Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL) Homo sapiens (Human) GO:0005576; GO:0005737; GO:0005739; GO:0020037; GO:0035578; GO:0070062 azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739] heme binding [GO:0020037] g1330.t1 Q15459 56.044 819 0.0 741.0 sp|Q15459|SF3A1_HUMAN Splicing factor 3A subunit 1 OS=Homo sapiens OX=9606 GN=SF3A1 PE=1 SV=1 SF3A1_HUMAN reviewed Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114) Homo sapiens (Human) GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241 mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241] catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] RNA binding [GO:0003723] g1331.t1 Q5PQ71 63.402 194 5.07e-83 247.0 sp|Q5PQ71|ISOC2_XENLA Isochorismatase domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=isoc2 PE=2 SV=1 g1333.t1 P56201 44.458 803 0.0 692.0 sp|P56201|G6PE_RABIT GDH/6PGL endoplasmic bifunctional protein OS=Oryctolagus cuniculus OX=9986 GN=H6PD PE=1 SV=3 g1334.t1 Q58E03 51.852 324 3.5599999999999997e-106 316.0 sp|Q58E03|DJC25_XENLA DnaJ homolog subfamily C member 25 OS=Xenopus laevis OX=8355 GN=dnajc25 PE=2 SV=1 g1336.t1 Q8NCJ5 49.405 336 1.5500000000000001e-99 306.0 sp|Q8NCJ5|SPRY3_HUMAN SPRY domain-containing protein 3 OS=Homo sapiens OX=9606 GN=SPRYD3 PE=1 SV=2 g1336.t2 Q8NCJ5 49.405 336 3.08e-99 306.0 sp|Q8NCJ5|SPRY3_HUMAN SPRY domain-containing protein 3 OS=Homo sapiens OX=9606 GN=SPRYD3 PE=1 SV=2 g1336.t3 Q8NCJ5 49.405 336 1.99e-99 305.0 sp|Q8NCJ5|SPRY3_HUMAN SPRY domain-containing protein 3 OS=Homo sapiens OX=9606 GN=SPRYD3 PE=1 SV=2 g1337.t1 P23358 80.368 163 7.22e-95 275.0 sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1 g1338.t1 P50411 38.953 172 3.36e-27 105.0 sp|P50411|IPP2_RAT Protein phosphatase inhibitor 2 OS=Rattus norvegicus OX=10116 GN=Ppp1r2 PE=1 SV=2 g1339.t1 Q96JH7 46.547 1115 0.0 1004.0 sp|Q96JH7|VCIP1_HUMAN Deubiquitinating protein VCPIP1 OS=Homo sapiens OX=9606 GN=VCPIP1 PE=1 SV=2 VCIP1_HUMAN reviewed Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein) Homo sapiens (Human) GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006508; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634 DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843] g1340.t1 Q91YN5 57.812 512 0.0 623.0 sp|Q91YN5|UAP1_MOUSE UDP-N-acetylhexosamine pyrophosphorylase OS=Mus musculus OX=10090 GN=Uap1 PE=1 SV=1 UAP1_MOUSE reviewed UDP-N-acetylhexosamine pyrophosphorylase (Protein-pyrophosphorylation enzyme) (EC 2.7.4.-) (UDP-N-acetylgalactosamine pyrophosphorylase) (EC 2.7.7.83) (UDP-N-acetylglucosamine pyrophosphorylase) (EC 2.7.7.23) Mus musculus (Mouse) GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006047; GO:0006048; GO:0030246; GO:0032481; GO:0042802; GO:0052630; GO:0140374; GO:0141090 antiviral innate immune response [GO:0140374]; positive regulation of type I interferon production [GO:0032481]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; protein serine pyrophosphorylase activity [GO:0141090]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977] g1342.t1 Q8WV41 42.082 461 2.99e-121 377.0 sp|Q8WV41|SNX33_HUMAN Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1 SNX33_HUMAN reviewed Sorting nexin-33 (SH3 and PX domain-containing protein 3) Homo sapiens (Human) GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010 cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] g1342.t2 Q8WV41 42.082 461 2.2e-120 376.0 sp|Q8WV41|SNX33_HUMAN Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1 SNX33_HUMAN reviewed Sorting nexin-33 (SH3 and PX domain-containing protein 3) Homo sapiens (Human) GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010 cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] g1342.t3 Q8WV41 42.082 461 2.2e-120 376.0 sp|Q8WV41|SNX33_HUMAN Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1 SNX33_HUMAN reviewed Sorting nexin-33 (SH3 and PX domain-containing protein 3) Homo sapiens (Human) GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010 cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] g1342.t4 Q8WV41 42.572 451 1.02e-120 377.0 sp|Q8WV41|SNX33_HUMAN Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1 SNX33_HUMAN reviewed Sorting nexin-33 (SH3 and PX domain-containing protein 3) Homo sapiens (Human) GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010 cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] g1343.t1 O35153 52.041 98 2.37e-31 110.0 sp|O35153|BET1L_MOUSE BET1-like protein OS=Mus musculus OX=10090 GN=Bet1l PE=3 SV=1 BET1L_MOUSE reviewed BET1-like protein (Golgi SNARE with a size of 15 kDa) (GOS-15) (GS15) (Vesicle transport protein GOS15) Mus musculus (Mouse) GO:0000139; GO:0005484; GO:0005768; GO:0005794; GO:0005795; GO:0005798; GO:0005802; GO:0005829; GO:0015031; GO:0031201; GO:0042147; GO:2000156 protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi-associated vesicle [GO:0005798]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802] SNAP receptor activity [GO:0005484] g1344.t1 Q9UPZ6 29.138 1462 5.9e-158 525.0 sp|Q9UPZ6|THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens OX=9606 GN=THSD7A PE=1 SV=4 g1345.t1 Q5R405 65.191 994 0.0 1285.0 sp|Q5R405|SPT5H_PONAB Transcription elongation factor SPT5 OS=Pongo abelii OX=9601 GN=SUPT5H PE=2 SV=1 SPT5H_PONAB reviewed Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0003729; GO:0006357; GO:0006368; GO:0032044; GO:0032784 regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368] DSIF complex [GO:0032044] mRNA binding [GO:0003729] g1346.t1 Q8BYK8 41.436 181 2.4099999999999997e-34 147.0 sp|Q8BYK8|ZC3H6_MOUSE Zinc finger CCCH domain-containing protein 6 OS=Mus musculus OX=10090 GN=Zc3h6 PE=2 SV=2 g1347.t1 Q9VV87 39.041 292 3.45e-62 202.0 sp|Q9VV87|ELOV6_DROME Very long chain fatty acid elongase 6 OS=Drosophila melanogaster OX=7227 GN=Baldspot PE=1 SV=2 ELOV6_DROME reviewed Very long chain fatty acid elongase 6 (ELOVL6) (EC 2.3.1.199) (Elongation of very long chain fatty acids protein 6) (Neighbor of abl) (Very-long-chain 3-oxoacyl-CoA synthase) Drosophila melanogaster (Fruit fly) GO:0005741; GO:0005789; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] fatty acid elongase activity [GO:0009922] g1348.t1 Q9VV87 40.268 298 2.97e-64 208.0 sp|Q9VV87|ELOV6_DROME Very long chain fatty acid elongase 6 OS=Drosophila melanogaster OX=7227 GN=Baldspot PE=1 SV=2 ELOV6_DROME reviewed Very long chain fatty acid elongase 6 (ELOVL6) (EC 2.3.1.199) (Elongation of very long chain fatty acids protein 6) (Neighbor of abl) (Very-long-chain 3-oxoacyl-CoA synthase) Drosophila melanogaster (Fruit fly) GO:0005741; GO:0005789; GO:0009922; GO:0019367; GO:0030148; GO:0030497; GO:0034625; GO:0034626; GO:0042759; GO:0042761 fatty acid elongation [GO:0030497]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741] fatty acid elongase activity [GO:0009922] g1352.t1 Q7ZWG6 32.569 436 2.4999999999999997e-42 159.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g1352.t2 Q7ZWG6 31.21 471 3.62e-42 159.0 sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1 PCFT_DANRE reviewed Proton-coupled folate transporter (Solute carrier family 46 member 1) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g1353.t1 Q6DCX5 26.786 448 1.87e-41 157.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g1354.t1 Q6DCX5 27.315 432 5.44e-40 153.0 sp|Q6DCX5|PCFT_XENLA Proton-coupled folate transporter OS=Xenopus laevis OX=8355 GN=slc46a1 PE=2 SV=1 PCFT_XENLA reviewed Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1) Xenopus laevis (African clawed frog) GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085 transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] g1355.t1 Q9BXB4 52.924 684 0.0 677.0 sp|Q9BXB4|OSB11_HUMAN Oxysterol-binding protein-related protein 11 OS=Homo sapiens OX=9606 GN=OSBPL11 PE=1 SV=2 g1356.t1 P47941 41.311 305 1.5499999999999998e-67 216.0 sp|P47941|CRKL_MOUSE Crk-like protein OS=Mus musculus OX=10090 GN=Crkl PE=1 SV=2 CRKL_MOUSE reviewed Crk-like protein Mus musculus (Mouse) GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404 acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202] identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591] g1357.t1 Q5XI67 46.108 167 1.8e-39 160.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 FBX30_RAT reviewed F-box only protein 30 Rattus norvegicus (Rat) GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630 chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1357.t1 Q5XI67 42.045 176 7.17e-33 139.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 FBX30_RAT reviewed F-box only protein 30 Rattus norvegicus (Rat) GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630 chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1357.t1 Q5XI67 49.107 112 4.85e-25 115.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 FBX30_RAT reviewed F-box only protein 30 Rattus norvegicus (Rat) GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630 chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1357.t2 Q5XI67 46.108 167 1.88e-39 160.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 FBX30_RAT reviewed F-box only protein 30 Rattus norvegicus (Rat) GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630 chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1357.t2 Q5XI67 42.045 176 7.39e-33 139.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 FBX30_RAT reviewed F-box only protein 30 Rattus norvegicus (Rat) GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630 chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1357.t2 Q5XI67 49.107 112 4.82e-25 115.0 sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1 FBX30_RAT reviewed F-box only protein 30 Rattus norvegicus (Rat) GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630 chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1358.t1 Q7TNK1 60.667 450 0.0 577.0 sp|Q7TNK1|RFX4_MOUSE Transcription factor RFX4 OS=Mus musculus OX=10090 GN=Rfx4 PE=1 SV=1 RFX4_MOUSE reviewed Transcription factor RFX4 (Regulatory factor X 4) Mus musculus (Mouse) GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0006357; GO:0021516; GO:0021537; GO:0021696; GO:0030900; GO:0030901; GO:0045879; GO:0045944; GO:0060271; GO:0070613; GO:1990837 cerebellar cortex morphogenesis [GO:0021696]; cilium assembly [GO:0060271]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; midbrain development [GO:0030901]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537] nucleus [GO:0005634] chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g1359.t1 Q7TQN3 33.083 266 2.87e-33 138.0 sp|Q7TQN3|WFKN2_MOUSE WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 OS=Mus musculus OX=10090 GN=Wfikkn2 PE=1 SV=2 WFKN2_MOUSE reviewed WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 (Growth and differentiation factor-associated serum protein 1) (GASP-1) (mGASP-1) Mus musculus (Mouse) GO:0001501; GO:0004867; GO:0005576; GO:0005615; GO:0007179; GO:0030512; GO:0048019; GO:0050431; GO:0055001; GO:0060021 muscle cell development [GO:0055001]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular region [GO:0005576]; extracellular space [GO:0005615] receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431] g1361.t1 P11654 37.049 1911 0.0 1207.0 sp|P11654|PO210_RAT Nuclear pore membrane glycoprotein 210 OS=Rattus norvegicus OX=10116 GN=Nup210 PE=1 SV=1 PO210_RAT reviewed Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa) Rattus norvegicus (Rat) GO:0005635; GO:0005643; GO:0005789; GO:0015031; GO:0017056; GO:0031965; GO:0051028; GO:0065003 mRNA transport [GO:0051028]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003] endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643] structural constituent of nuclear pore [GO:0017056] g1361.t2 P11654 36.565 1939 0.0 1196.0 sp|P11654|PO210_RAT Nuclear pore membrane glycoprotein 210 OS=Rattus norvegicus OX=10116 GN=Nup210 PE=1 SV=1 PO210_RAT reviewed Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa) Rattus norvegicus (Rat) GO:0005635; GO:0005643; GO:0005789; GO:0015031; GO:0017056; GO:0031965; GO:0051028; GO:0065003 mRNA transport [GO:0051028]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003] endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643] structural constituent of nuclear pore [GO:0017056] g1362.t1 P55266 44.38 516 4.89e-135 444.0 sp|P55266|DSRAD_RAT Double-stranded RNA-specific adenosine deaminase OS=Rattus norvegicus OX=10116 GN=Adar PE=1 SV=1 DSRAD_RAT reviewed Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) Rattus norvegicus (Rat) GO:0001649; GO:0001701; GO:0002244; GO:0002566; GO:0003677; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016553; GO:0016607; GO:0030218; GO:0031054; GO:0035196; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0098586; GO:1900369; GO:1903944 adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA processing [GO:0035196]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251] g1363.t1 Q4KLQ5 43.205 493 2.3e-121 375.0 sp|Q4KLQ5|WDR76_XENLA WD repeat-containing protein 76 OS=Xenopus laevis OX=8355 GN=wdr76 PE=2 SV=1 g1366.t1 Q8IZ41 36.061 782 7.2e-135 419.0 sp|Q8IZ41|RASEF_HUMAN Ras and EF-hand domain-containing protein OS=Homo sapiens OX=9606 GN=RASEF PE=1 SV=1 RASEF_HUMAN reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Homo sapiens (Human) GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g1366.t2 Q8IZ41 37.888 644 5.87e-116 367.0 sp|Q8IZ41|RASEF_HUMAN Ras and EF-hand domain-containing protein OS=Homo sapiens OX=9606 GN=RASEF PE=1 SV=1 RASEF_HUMAN reviewed Ras and EF-hand domain-containing protein (EC 3.6.5.2) (Ras-related protein Rab-45) Homo sapiens (Human) GO:0003924; GO:0003925; GO:0005509; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0016192; GO:0019003; GO:0036019; GO:0042802; GO:0048471; GO:0070625 vesicle-mediated transport [GO:0016192]; zymogen granule exocytosis [GO:0070625] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endolysosome [GO:0036019]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] calcium ion binding [GO:0005509]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] g1379.t1 G3V928 38.073 218 1.85e-32 129.0 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1379.t1 G3V928 37.736 212 3.5200000000000003e-29 120.0 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1379.t1 G3V928 35.586 222 1.93e-23 103.0 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1379.t1 G3V928 37.674 215 3.46e-23 102.0 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1379.t1 G3V928 36.287 237 5.2499999999999996e-23 102.0 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1379.t1 G3V928 29.63 270 3.29e-22 100.0 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1379.t1 G3V928 36.323 223 1.2800000000000001e-21 98.2 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1379.t1 G3V928 32.51 243 1.3900000000000001e-21 98.2 sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1 LRP1_RAT reviewed Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] Rattus norvegicus (Rat) GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005730; GO:0005768; GO:0005769; GO:0005815; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0070495; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903053; GO:1903064; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587 amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of reverse cholesterol transport [GO:1903064]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235] alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] g1380.t1 P35953 30.822 292 4.9699999999999995e-23 102.0 sp|P35953|VLDLR_RABIT Very low-density lipoprotein receptor OS=Oryctolagus cuniculus OX=9986 GN=VLDLR PE=2 SV=1 g1380.t1 P35953 32.411 253 6.37e-22 99.0 sp|P35953|VLDLR_RABIT Very low-density lipoprotein receptor OS=Oryctolagus cuniculus OX=9986 GN=VLDLR PE=2 SV=1 g1382.t1 P46023 30.29 690 8.03e-78 286.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1383.t1 P46023 30.548 694 2.66e-76 281.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1393.t1 Q7LFX5 33.956 321 1e-44 165.0 sp|Q7LFX5|CHSTF_HUMAN Carbohydrate sulfotransferase 15 OS=Homo sapiens OX=9606 GN=CHST15 PE=1 SV=1 CHSTF_HUMAN reviewed Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST) Homo sapiens (Human) GO:0000139; GO:0016020; GO:0019319; GO:0050650; GO:0050651; GO:0050656; GO:0050659 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] g1394.t1 Q7LFX5 32.11 327 2.4799999999999996e-42 163.0 sp|Q7LFX5|CHSTF_HUMAN Carbohydrate sulfotransferase 15 OS=Homo sapiens OX=9606 GN=CHST15 PE=1 SV=1 CHSTF_HUMAN reviewed Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST) Homo sapiens (Human) GO:0000139; GO:0016020; GO:0019319; GO:0050650; GO:0050651; GO:0050656; GO:0050659 chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139]; membrane [GO:0016020] 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] g1402.t1 Q8BS90 34.395 314 5.97e-29 122.0 sp|Q8BS90|BORA_MOUSE Protein aurora borealis OS=Mus musculus OX=10090 GN=Bora PE=1 SV=1 g1406.t1 Q5HYC2 40.921 391 6.2700000000000005e-86 318.0 sp|Q5HYC2|BRD10_HUMAN Uncharacterized bromodomain-containing protein 10 OS=Homo sapiens OX=9606 GN=BRD10 PE=1 SV=2 g1407.t1 Q9MYM7 38.516 283 1.9499999999999997e-55 188.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g1408.t1 Q9MYM7 37.456 283 5.9899999999999995e-52 179.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g1409.t1 Q9MYM7 36.957 276 2.67e-53 183.0 sp|Q9MYM7|B3GT1_PONPY Beta-1,3-galactosyltransferase 1 OS=Pongo pygmaeus OX=9600 GN=B3GALT1 PE=3 SV=1 g1412.t1 Q96CB8 37.817 394 9.14e-58 198.0 sp|Q96CB8|INT12_HUMAN Integrator complex subunit 12 OS=Homo sapiens OX=9606 GN=INTS12 PE=1 SV=1 INT12_HUMAN reviewed Integrator complex subunit 12 (Int12) (PHD finger protein 22) Homo sapiens (Human) GO:0005634; GO:0005654; GO:0008270; GO:0016180; GO:0032039; GO:0034243; GO:0034472; GO:0160232; GO:0160240 regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] zinc ion binding [GO:0008270] g1413.t1 A6QNK1 35.821 268 5.7399999999999995e-40 148.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g1415.t1 P24666 49.682 157 7.49e-44 145.0 sp|P24666|PPAC_HUMAN Low molecular weight phosphotyrosine protein phosphatase OS=Homo sapiens OX=9606 GN=ACP1 PE=1 SV=3 PPAC_HUMAN reviewed Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1) Homo sapiens (Human) GO:0003993; GO:0004725; GO:0004726; GO:0005737; GO:0005829; GO:0007268; GO:0009898; GO:0017124; GO:0042383; GO:0045202; GO:0070062 chemical synaptic transmission [GO:0007268] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; sarcolemma [GO:0042383]; synapse [GO:0045202] acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] g1415.t2 P81693 45.57 158 6.399999999999999e-42 140.0 sp|P81693|PPAC_PIG Low molecular weight phosphotyrosine protein phosphatase OS=Sus scrofa OX=9823 GN=ACP1 PE=1 SV=2 g1415.t3 Q5ZKG5 45.833 144 7.16e-35 124.0 sp|Q5ZKG5|PPAC_CHICK Low molecular weight phosphotyrosine protein phosphatase OS=Gallus gallus OX=9031 GN=ACP1 PE=2 SV=3 g1416.t1 O43826 46.637 223 5.24e-64 207.0 sp|O43826|G6PT1_HUMAN Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=1 G6PT1_HUMAN reviewed Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0015152; GO:0015760; GO:0016020; GO:0035435; GO:0042593; GO:0061513 gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152] g1417.t1 O43826 37.297 185 5.67e-37 135.0 sp|O43826|G6PT1_HUMAN Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=1 G6PT1_HUMAN reviewed Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19) Homo sapiens (Human) GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0015152; GO:0015760; GO:0016020; GO:0035435; GO:0042593; GO:0061513 gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152] g1422.t1 Q91XL2 40.896 670 1.75e-151 455.0 sp|Q91XL2|LNX2_MOUSE Ligand of Numb protein X 2 OS=Mus musculus OX=10090 GN=Lnx2 PE=1 SV=2 g1424.t1 P61315 35.22 318 8.959999999999999e-38 149.0 sp|P61315|G3ST3_MOUSE Galactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1 g1424.t1 P61315 39.048 210 1.1e-28 122.0 sp|P61315|G3ST3_MOUSE Galactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1 g1427.t1 Q8BYI9 47.642 212 5.46e-57 200.0 sp|Q8BYI9|TENR_MOUSE Tenascin-R OS=Mus musculus OX=10090 GN=Tnr PE=1 SV=2 TENR_MOUSE reviewed Tenascin-R (TN-R) (Janusin) (Neural recognition molecule J1-160/180) (Restrictin) Mus musculus (Mouse) GO:0005178; GO:0005615; GO:0007158; GO:0007162; GO:0007399; GO:0008306; GO:0009986; GO:0010977; GO:0022029; GO:0022408; GO:0030155; GO:0030198; GO:0030334; GO:0030517; GO:0031012; GO:0031103; GO:0035641; GO:0045121; GO:0045595; GO:0046625; GO:0048692; GO:0050804; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0072534; GO:0090733; GO:0098685; GO:0098686; GO:0098966; GO:0098978 associative learning [GO:0008306]; axon regeneration [GO:0031103]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic transmission [GO:0050805]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; telencephalon cell migration [GO:0022029] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; perisynaptic extracellular matrix [GO:0098966]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733] integrin binding [GO:0005178]; sphingolipid binding [GO:0046625] g1432.t1 Q9D3W1 47.214 341 2.7900000000000003e-97 293.0 sp|Q9D3W1|RSP14_MOUSE Radial spoke head 14 homolog OS=Mus musculus OX=10090 GN=Rsph14 PE=1 SV=1 RSP14_MOUSE reviewed Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1) Mus musculus (Mouse) GO:0001534; GO:0003351; GO:0005576; GO:0007618; GO:0030317; GO:0036126; GO:0097729 epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618] 9+2 motile cilium [GO:0097729]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126] g1433.t1 A4IH75 65.753 219 6.1e-110 317.0 sp|A4IH75|ATGA1_XENTR Autophagy-related protein 101 OS=Xenopus tropicalis OX=8364 GN=atg101 PE=2 SV=1 g1434.t1 Q5R9H4 60.421 523 0.0 617.0 sp|Q5R9H4|A1CF_PONAB APOBEC1 complementation factor OS=Pongo abelii OX=9601 GN=A1CF PE=2 SV=1 g1434.t2 Q5R9H4 60.612 523 0.0 620.0 sp|Q5R9H4|A1CF_PONAB APOBEC1 complementation factor OS=Pongo abelii OX=9601 GN=A1CF PE=2 SV=1 g1435.t1 Q63850 60.811 222 4.64e-97 296.0 sp|Q63850|NUP62_MOUSE Nuclear pore glycoprotein p62 OS=Mus musculus OX=10090 GN=Nup62 PE=1 SV=2 NUP62_MOUSE reviewed Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62) Mus musculus (Mouse) GO:0000922; GO:0005543; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005813; GO:0006405; GO:0006606; GO:0006913; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0008285; GO:0016477; GO:0017056; GO:0019894; GO:0030159; GO:0030544; GO:0031965; GO:0032991; GO:0042059; GO:0042169; GO:0042306; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0043407; GO:0044613; GO:0044877; GO:0045840; GO:0045893; GO:0046580; GO:0046601; GO:0046966; GO:0051028; GO:0051425; GO:0051879; GO:0060236; GO:0072686; GO:0090398; GO:0090543; GO:0098534; GO:1903438; GO:1904781; GO:1990904 cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cellular senescence [GO:0090398]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; nucleocytoplasmic transport [GO:0006913]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of centriole replication [GO:0046601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; RNA export from nucleus [GO:0006405] annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922] Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; nuclear thyroid hormone receptor binding [GO:0046966]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; structural constituent of nuclear pore [GO:0017056]; ubiquitin binding [GO:0043130] g1437.t1 Q503E1 69.95 599 0.0 890.0 sp|Q503E1|INT11_DANRE Integrator complex subunit 11 OS=Danio rerio OX=7955 GN=cpsf3l PE=2 SV=1 INT11_DANRE reviewed Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0004521; GO:0005634; GO:0005737; GO:0016180; GO:0016787; GO:0032039; GO:0034472; GO:0043484; GO:0046872; GO:0160232; GO:0160240 regulation of RNA splicing [GO:0043484]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634] hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA endonuclease activity [GO:0004521] g1438.t1 Q6DBQ8 38.647 207 1.9199999999999998e-45 152.0 sp|Q6DBQ8|CPTP_DANRE Ceramide-1-phosphate transfer protein OS=Danio rerio OX=7955 GN=cptp PE=2 SV=1 CPTP_DANRE reviewed Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0010507; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389 ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886] ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; phospholipid binding [GO:0005543] g1439.t1 Q0VCQ0 37.356 174 1.1699999999999999e-34 127.0 sp|Q0VCQ0|CPTP_BOVIN Ceramide-1-phosphate transfer protein OS=Bos taurus OX=9913 GN=CPTP PE=2 SV=1 CPTP_BOVIN reviewed Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP) Bos taurus (Bovine) GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0010507; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389 ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886] ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; phospholipid binding [GO:0005543] g1440.t1 Q9UQB3 48.041 587 5.23e-164 520.0 sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3 CTND2_HUMAN reviewed Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] g1440.t2 Q9UQB3 48.041 587 5.13e-164 521.0 sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3 CTND2_HUMAN reviewed Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin) Homo sapiens (Human) GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] g1444.t1 Q5RBG3 48.223 394 2.46e-111 333.0 sp|Q5RBG3|NSF1C_PONAB NSFL1 cofactor p47 OS=Pongo abelii OX=9601 GN=NSFL1C PE=2 SV=1 NSF1C_PONAB reviewed NSFL1 cofactor p47 (p97 cofactor p47) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000045; GO:0000132; GO:0005634; GO:0005694; GO:0005795; GO:0005813; GO:0005829; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0046604; GO:0061025; GO:1904780; GO:1990730 autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] centrosome [GO:0005813]; chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730] lipid binding [GO:0008289]; ubiquitin binding [GO:0043130] g1445.t1 Q921Y4 51.715 379 7.98e-125 373.0 sp|Q921Y4|MFSD5_MOUSE Molybdate-anion transporter OS=Mus musculus OX=10090 GN=Mfsd5 PE=2 SV=1 g1446.t1 P61314 82.424 165 1.0500000000000001e-99 289.0 sp|P61314|RL15_RAT Large ribosomal subunit protein eL15 OS=Rattus norvegicus OX=10116 GN=Rpl15 PE=1 SV=2 g1455.t1 Q9EPK2 47.414 348 1.4e-122 359.0 sp|Q9EPK2|XRP2_MOUSE Protein XRP2 OS=Mus musculus OX=10090 GN=Rp2 PE=1 SV=3 XRP2_MOUSE reviewed Protein XRP2 Mus musculus (Mouse) GO:0000287; GO:0005096; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006892; GO:0015031; GO:0016604; GO:0031410; GO:0036064; GO:1990075 post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886] GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287] g1459.t1 B3EWZ6 36.177 1805 0.0 988.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 33.642 1837 0.0 936.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 33.354 1646 0.0 801.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 28.885 1866 0.0 613.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 27.293 1832 3.31e-159 547.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 28.333 1680 2.79e-155 535.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 28.659 1476 2.1200000000000003e-144 502.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 27.179 1744 3.45e-141 492.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 26.991 1645 5.37e-141 491.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 27.119 1298 2.98e-126 446.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 25.901 1193 1.49e-91 336.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 29.294 850 3.0800000000000003e-86 319.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 28.086 883 2.58e-85 316.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1459.t1 B3EWZ6 28.111 900 3.09e-81 303.0 sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1460.t1 Q96AY4 29.81 369 1.18e-28 122.0 sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4 TTC28_HUMAN reviewed Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio) Homo sapiens (Human) GO:0000922; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301 cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] centrosome [GO:0005813]; midbody [GO:0030496]; spindle pole [GO:0000922] kinase binding [GO:0019900] g1463.t1 Q99PW8 48.966 435 3.84e-120 390.0 sp|Q99PW8|KIF17_MOUSE Kinesin-like protein KIF17 OS=Mus musculus OX=10090 GN=Kif17 PE=1 SV=1 KIF17_MOUSE reviewed Kinesin-like protein KIF17 (MmKIF17) Mus musculus (Mouse) GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075 anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] g1463.t1 Q99PW8 38.462 351 7.179999999999999e-54 206.0 sp|Q99PW8|KIF17_MOUSE Kinesin-like protein KIF17 OS=Mus musculus OX=10090 GN=Kif17 PE=1 SV=1 KIF17_MOUSE reviewed Kinesin-like protein KIF17 (MmKIF17) Mus musculus (Mouse) GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005737; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075 anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] g1464.t1 Q9MYP6 53.077 130 7.700000000000001e-47 158.0 sp|Q9MYP6|DHB14_BOVIN L-fucose dehydrogenase OS=Bos taurus OX=9913 GN=HSD17B14 PE=2 SV=1 DHB14_BOVIN reviewed L-fucose dehydrogenase (EC 1.1.1.122) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3) Bos taurus (Bovine) GO:0005829; GO:0008202; GO:0042355; GO:0047834 L-fucose catabolic process [GO:0042355]; steroid metabolic process [GO:0008202] cytosol [GO:0005829] D-threo-aldose 1-dehydrogenase activity [GO:0047834] g1465.t1 C8YR32 42.717 1325 0.0 1038.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 31.894 1621 0.0 728.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 33.308 1333 0.0 660.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 30.534 1274 3.5399999999999998e-158 536.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 28.15 1357 1.3899999999999999e-136 473.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 30.762 1115 2.92e-130 454.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 32.058 967 4.48e-130 454.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 30.704 824 5.070000000000001e-103 371.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 35.411 401 3.69e-60 233.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 33.108 444 1.44e-53 211.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 35.027 374 2.09e-49 197.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 30.751 413 5.91e-43 177.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 38.4 250 3.26e-36 154.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 29.524 315 7.96e-32 140.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1465.t1 C8YR32 28.082 292 3.7400000000000005e-21 105.0 sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1 g1466.t1 Q8IVV2 48.956 431 9.59e-130 428.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 34.56 625 1.28e-93 323.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 34.465 589 1.33e-90 315.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 35.273 567 1.66e-88 308.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 33.439 631 2.02e-83 293.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 35.512 566 1.06e-82 291.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 30.58 569 8.87e-70 253.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 29.813 587 2.76e-63 234.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 30.684 541 1.53e-58 219.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1466.t1 Q8IVV2 30.0 280 3.4600000000000005e-27 122.0 sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4 g1468.t1 Q5JVG2 30.672 238 1.32e-26 119.0 sp|Q5JVG2|ZN484_HUMAN Zinc finger protein 484 OS=Homo sapiens OX=9606 GN=ZNF484 PE=1 SV=1 ZN484_HUMAN reviewed Zinc finger protein 484 Homo sapiens (Human) GO:0003677; GO:0005634; GO:0006357; GO:0008270 regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA binding [GO:0003677]; zinc ion binding [GO:0008270] g1469.t1 Q298E0 73.913 92 3.34e-43 143.0 sp|Q298E0|RU1C_DROPS U1 small nuclear ribonucleoprotein C OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=snRNP-U1-C PE=3 SV=1 g1470.t1 P40694 44.995 1029 0.0 790.0 sp|P40694|SMBP2_MOUSE DNA-binding protein SMUBP-2 OS=Mus musculus OX=10090 GN=Ighmbp2 PE=1 SV=1 SMBP2_MOUSE reviewed DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Cardiac transcription factor 1) (CATF1) (Immunoglobulin mu-binding protein 2) Mus musculus (Mouse) GO:0000049; GO:0000122; GO:0003677; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0008094; GO:0008186; GO:0008270; GO:0016604; GO:0016887; GO:0021522; GO:0030424; GO:0030426; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043025; GO:0043139; GO:0048471; GO:0050905; GO:0140296; GO:1990904; GO:1990955 negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process [GO:0050905]; spinal cord motor neuron differentiation [GO:0021522]; translation [GO:0006412] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904] 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; double-stranded DNA helicase activity [GO:0036121]; G-rich single-stranded DNA binding [GO:1990955]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] g1476.t1 Q9VBW3 34.703 438 9.83e-70 238.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1478.t1 Q9VBW3 43.793 290 8.54e-66 241.0 sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2 CAD96_DROME reviewed Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14) Drosophila melanogaster (Fruit fly) GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060] apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g1479.t1 Q9VCA2 37.064 545 3.57e-108 338.0 sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1 g1481.t1 P46023 38.509 322 3.75e-58 204.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1482.t1 O75899 44.147 709 0.0 607.0 sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1 GABR2_HUMAN reviewed Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20) Homo sapiens (Human) GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932] cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] g1490.t1 Q9WVR6 48.907 503 2.75e-156 458.0 sp|Q9WVR6|LAT2_RAT Large neutral amino acids transporter small subunit 2 OS=Rattus norvegicus OX=10116 GN=Slc7a8 PE=1 SV=1 LAT2_RAT reviewed Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (Solute carrier family 7 member 8) Rattus norvegicus (Rat) GO:0003333; GO:0005886; GO:0006865; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015297; GO:0015349; GO:0015804; GO:0015807; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0046982; GO:0070327; GO:0089718; GO:1903801; GO:1904273 amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-amino acid transport [GO:0015807]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; valine transport [GO:0015829] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534] g1493.t1 Q63150 67.944 496 0.0 711.0 sp|Q63150|DPYS_RAT Dihydropyrimidinase OS=Rattus norvegicus OX=10116 GN=Dpys PE=1 SV=2 DPYS_RAT reviewed Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase) Rattus norvegicus (Rat) GO:0002058; GO:0002059; GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0016597; GO:0019482; GO:0019860; GO:0032991; GO:0042802; GO:0046050; GO:0046074; GO:0046079; GO:0051219 beta-alanine metabolic process [GO:0019482]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860] cytosol [GO:0005829]; protein-containing complex [GO:0032991] amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270] g1493.t2 Q5R9Y6 57.143 350 4.6899999999999997e-138 407.0 sp|Q5R9Y6|DPYL2_PONAB Dihydropyrimidinase-related protein 2 OS=Pongo abelii OX=9601 GN=DPYSL2 PE=2 SV=1 g1496.t1 P82920 61.905 84 5.15e-33 112.0 sp|P82920|RT21_BOVIN Small ribosomal subunit protein bS21m OS=Bos taurus OX=9913 GN=MRPS21 PE=1 SV=3 g1497.t1 P46023 35.391 486 1.49e-92 317.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1498.t1 P46023 29.485 641 1.4500000000000001e-65 248.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1499.t1 Q9JI18 32.742 620 4.2e-62 234.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 32.315 622 3.81e-60 228.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 32.613 555 9.74e-55 211.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 31.827 509 2.12e-46 185.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 33.237 346 1.02e-36 154.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 29.259 499 1.9600000000000002e-33 144.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 33.162 389 9.950000000000001e-31 135.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 26.643 563 4.8699999999999996e-30 133.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 28.983 521 4.91e-30 133.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 28.708 418 4.4900000000000006e-27 123.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 31.807 393 1.2199999999999999e-24 115.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 30.337 356 1.4099999999999999e-24 115.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1499.t1 Q9JI18 30.886 395 2.2699999999999997e-23 111.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1500.t1 P98157 31.978 369 1.3e-27 119.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g1500.t1 P98157 30.682 352 1.6e-22 104.0 sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1 g1500.t2 Q9JI18 29.151 518 8.57e-33 137.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1500.t2 Q9JI18 30.0 400 1.47e-22 106.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1500.t2 Q9JI18 28.755 466 1.5100000000000001e-22 106.0 sp|Q9JI18|LRP1B_MOUSE Low-density lipoprotein receptor-related protein 1B OS=Mus musculus OX=10090 GN=Lrp1b PE=1 SV=1 LRP1B_MOUSE reviewed Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT) Mus musculus (Mouse) GO:0001701; GO:0005041; GO:0005509; GO:0005886; GO:0006897; GO:0016020; GO:0043235 endocytosis [GO:0006897]; in utero embryonic development [GO:0001701] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] g1502.t1 Q803Z2 59.292 226 3.8399999999999996e-91 281.0 sp|Q803Z2|YIPF3_DANRE Protein YIPF3 OS=Danio rerio OX=7955 GN=yipf3 PE=2 SV=1 g1503.t1 A0A974CYQ5 47.4 500 2.81e-165 504.0 sp|A0A974CYQ5|RFW3S_XENLA E3 ubiquitin-protein ligase rfwd3.S OS=Xenopus laevis OX=8355 GN=rfwd3.S PE=1 SV=1 RFW3S_XENLA reviewed E3 ubiquitin-protein ligase rfwd3.S (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3.S) Xenopus laevis (African clawed frog) GO:0005737; GO:0008270; GO:0016567; GO:0016605; GO:0036297; GO:0061630 interstrand cross-link repair [GO:0036297]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; PML body [GO:0016605] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g1506.t1 Q9UJM8 48.883 358 7.740000000000001e-117 346.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g1507.t1 Q9UJM8 48.219 365 6.2300000000000004e-117 346.0 sp|Q9UJM8|HAOX1_HUMAN 2-Hydroxyacid oxidase 1 OS=Homo sapiens OX=9606 GN=HAO1 PE=1 SV=1 g1508.t1 Q6DRI7 48.752 521 6.92e-160 488.0 sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1 DDX51_DANRE reviewed ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887 rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleus [GO:0005634] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] g1509.t1 Q9BVA6 58.496 359 3.8e-145 425.0 sp|Q9BVA6|FICD_HUMAN Protein adenylyltransferase FICD OS=Homo sapiens OX=9606 GN=FICD PE=1 SV=2 FICD_HUMAN reviewed Protein adenylyltransferase FICD (EC 2.7.7.108) (AMPylator FICD) (De-AMPylase FICD) (EC 3.1.4.-) (FIC domain-containing protein) (Huntingtin yeast partner E) (Huntingtin-interacting protein 13) (HIP-13) (Huntingtin-interacting protein E) Homo sapiens (Human) GO:0005524; GO:0005783; GO:0005789; GO:0006986; GO:0018117; GO:0030544; GO:0034260; GO:0034976; GO:0042802; GO:0042803; GO:0044602; GO:0044603; GO:0051087; GO:0070733; GO:1903894 negative regulation of GTPase activity [GO:0034260]; protein adenylylation [GO:0018117]; protein deadenylylation [GO:0044602]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein adenylylhydrolase activity [GO:0044603]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087] g1510.t1 Q7ZYA2 47.751 289 6.350000000000001e-85 259.0 sp|Q7ZYA2|TAF8_XENLA Transcription initiation factor TFIID subunit 8 OS=Xenopus laevis OX=8355 GN=taf8 PE=2 SV=1 g1514.t1 A6QNK1 33.446 296 2.54e-38 148.0 sp|A6QNK1|G3ST1_BOVIN Galactosylceramide sulfotransferase OS=Bos taurus OX=9913 GN=GAL3ST1 PE=2 SV=1 G3ST1_BOVIN reviewed Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase) Bos taurus (Bovine) GO:0000139; GO:0001733; GO:0006665; GO:0006681; GO:0006682; GO:0042552; GO:0046486 galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139] galactosylceramide sulfotransferase activity [GO:0001733] g1518.t1 Q99676 31.195 452 6.49e-61 227.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g1518.t1 Q99676 32.68 459 4.1599999999999996e-60 224.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g1518.t1 Q99676 30.635 457 4e-56 213.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g1518.t1 Q99676 29.803 406 1.2099999999999999e-42 171.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g1518.t1 Q99676 32.258 341 2.66e-42 170.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g1518.t1 Q99676 31.429 280 2.4700000000000002e-31 136.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g1518.t1 Q99676 27.219 338 1.71e-22 108.0 sp|Q99676|ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens OX=9606 GN=ZNF184 PE=1 SV=4 g1529.t1 Q5XGZ2 46.345 684 0.0 563.0 sp|Q5XGZ2|UP44B_XENLA Ubiquitin carboxyl-terminal hydrolase 44-B OS=Xenopus laevis OX=8355 GN=usp44-b PE=2 SV=1 UP44B_XENLA reviewed Ubiquitin carboxyl-terminal hydrolase 44-B (EC 3.4.19.12) (Deubiquitinating enzyme 44-B) (Ubiquitin thioesterase 44-B) (Ubiquitin-specific-processing protease 44-B) Xenopus laevis (African clawed frog) GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0008270; GO:0010564; GO:0016579; GO:0051301; GO:1904667 cell division [GO:0051301]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of cell cycle process [GO:0010564] cytoplasm [GO:0005737]; nucleus [GO:0005634] cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270] g1533.t1 Q06441 47.068 648 4.34e-162 532.0 sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1 TSP4_XENLA reviewed Thrombospondin-4 Xenopus laevis (African clawed frog) GO:0005509; GO:0005615; GO:0005783; GO:0006986; GO:0007155; GO:0008083; GO:0016529; GO:0031012; GO:0034976; GO:0051781 cell adhesion [GO:0007155]; positive regulation of cell division [GO:0051781]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529] calcium ion binding [GO:0005509]; growth factor activity [GO:0008083] g1533.t2 Q06441 46.349 671 2.04e-162 533.0 sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1 TSP4_XENLA reviewed Thrombospondin-4 Xenopus laevis (African clawed frog) GO:0005509; GO:0005615; GO:0005783; GO:0006986; GO:0007155; GO:0008083; GO:0016529; GO:0031012; GO:0034976; GO:0051781 cell adhesion [GO:0007155]; positive regulation of cell division [GO:0051781]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529] calcium ion binding [GO:0005509]; growth factor activity [GO:0008083] g1533.t3 Q06441 46.97 660 4.82e-164 538.0 sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1 TSP4_XENLA reviewed Thrombospondin-4 Xenopus laevis (African clawed frog) GO:0005509; GO:0005615; GO:0005783; GO:0006986; GO:0007155; GO:0008083; GO:0016529; GO:0031012; GO:0034976; GO:0051781 cell adhesion [GO:0007155]; positive regulation of cell division [GO:0051781]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529] calcium ion binding [GO:0005509]; growth factor activity [GO:0008083] g1539.t1 P46023 31.557 732 7.18e-89 309.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1540.t1 P55006 45.848 277 9.7e-71 224.0 sp|P55006|RDH7_RAT Retinol dehydrogenase 7 OS=Rattus norvegicus OX=10116 GN=Rdh7 PE=1 SV=1 g1541.t1 Q8NEX9 49.117 283 8.75e-82 253.0 sp|Q8NEX9|DR9C7_HUMAN Short-chain dehydrogenase/reductase family 9C member 7 OS=Homo sapiens OX=9606 GN=SDR9C7 PE=1 SV=1 DR9C7_HUMAN reviewed Short-chain dehydrogenase/reductase family 9C member 7 (SDR9C7) (EC 1.1.1.-) (O-acylceramide dehydrogenase) (Orphan short-chain dehydrogenase/reductase) (SDR-O) (RDH-S) Homo sapiens (Human) GO:0004745; GO:0005737; GO:0008202; GO:0042572 retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] cytoplasm [GO:0005737] all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745] g1542.t1 Q95218 38.514 592 5.49e-98 342.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1542.t1 Q95218 37.195 492 4.02e-76 277.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1542.t1 Q95218 40.86 465 2.71e-75 275.0 sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2 DMBT1_RABIT reviewed Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin) Oryctolagus cuniculus (Rabbit) GO:0005576; GO:0015031; GO:0030154; GO:0031012; GO:0035375; GO:0042589; GO:0045217; GO:0050829; GO:0050830 cell differentiation [GO:0030154]; cell-cell junction maintenance [GO:0045217]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; zymogen granule membrane [GO:0042589] zymogen binding [GO:0035375] g1543.t1 Q3ZCX4 41.253 383 5.48e-88 294.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g1543.t1 Q3ZCX4 39.005 382 2.01e-84 285.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g1543.t1 Q3ZCX4 36.364 341 1.13e-60 220.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g1543.t1 Q3ZCX4 45.098 204 1.54e-44 174.0 sp|Q3ZCX4|ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens OX=9606 GN=ZNF568 PE=1 SV=2 ZN568_HUMAN reviewed Zinc finger protein 568 Homo sapiens (Human) GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0060669 embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] g1545.t1 Q8VCC1 39.024 246 6.3e-53 176.0 sp|Q8VCC1|PGDH_MOUSE 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Mus musculus OX=10090 GN=Hpgd PE=1 SV=1 PGDH_MOUSE reviewed 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1) Mus musculus (Mouse) GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0047034; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828 ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] 15-hydroxyicosatetraenoate dehydrogenase activity [GO:0047034]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957] g1546.t1 Q9QXF7 37.323 493 2.99e-113 347.0 sp|Q9QXF7|CP2J4_RAT Cytochrome P450 2J4 OS=Rattus norvegicus OX=10116 GN=CYP2J4 PE=1 SV=1 g1547.t1 Q90805 29.487 468 2.74e-53 205.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1547.t1 Q90805 27.778 468 6.48e-52 201.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1547.t1 Q90805 28.448 464 1.65e-45 181.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1547.t1 Q90805 26.316 437 1.58e-44 178.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1547.t2 Q90805 29.487 468 2.27e-53 205.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1547.t2 Q90805 27.778 468 5.279999999999999e-52 201.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1547.t2 Q90805 28.448 464 1.53e-45 181.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1547.t2 Q90805 26.24 484 3.55e-45 180.0 sp|Q90805|CNG1_CHICK Cyclic nucleotide-gated channel cone photoreceptor subunit alpha OS=Gallus gallus OX=9031 PE=2 SV=1 g1548.t1 Q86VH2 41.685 1365 0.0 937.0 sp|Q86VH2|KIF27_HUMAN Kinesin-like protein KIF27 OS=Homo sapiens OX=9606 GN=KIF27 PE=1 SV=1 KIF27_HUMAN reviewed Kinesin-like protein KIF27 Homo sapiens (Human) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0051649; GO:0060271 cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g1548.t2 Q86VH2 43.3 1291 0.0 954.0 sp|Q86VH2|KIF27_HUMAN Kinesin-like protein KIF27 OS=Homo sapiens OX=9606 GN=KIF27 PE=1 SV=1 KIF27_HUMAN reviewed Kinesin-like protein KIF27 Homo sapiens (Human) GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0051649; GO:0060271 cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874] ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] g1550.t1 Q9UHR5 35.227 264 5.02e-34 130.0 sp|Q9UHR5|S30BP_HUMAN SAP30-binding protein OS=Homo sapiens OX=9606 GN=SAP30BP PE=1 SV=1 g1551.t1 Q9NW08 81.534 1121 0.0 1956.0 sp|Q9NW08|RPC2_HUMAN DNA-directed RNA polymerase III subunit RPC2 OS=Homo sapiens OX=9606 GN=POLR3B PE=1 SV=2 RPC2_HUMAN reviewed DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B) Homo sapiens (Human) GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005737; GO:0005829; GO:0008270; GO:0032549; GO:0032728; GO:0042796; GO:0045087; GO:0045089; GO:0051607; GO:0055029; GO:0071667 defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; snRNA transcription by RNA polymerase III [GO:0042796] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear DNA-directed RNA polymerase complex [GO:0055029]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270] g1553.t1 Q4FZP2 62.606 353 4.89e-153 437.0 sp|Q4FZP2|MTNA_XENLA Methylthioribose-1-phosphate isomerase OS=Xenopus laevis OX=8355 GN=mri1 PE=2 SV=1 g1554.t1 A4L691 46.288 229 1.63e-57 192.0 sp|A4L691|PINX1_RAT PIN2/TERF1-interacting telomerase inhibitor 1 OS=Rattus norvegicus OX=10116 GN=Pinx1 PE=1 SV=1 PINX1_RAT reviewed PIN2/TERF1-interacting telomerase inhibitor 1 (Pin2-interacting protein X1) Rattus norvegicus (Rat) GO:0000228; GO:0000776; GO:0000781; GO:0005654; GO:0005730; GO:0005739; GO:0005819; GO:0007004; GO:0007080; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0070034; GO:0070198; GO:1902570; GO:1904751 mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819] protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034] g1554.t2 Q96BK5 40.659 273 1.84e-55 186.0 sp|Q96BK5|PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens OX=9606 GN=PINX1 PE=1 SV=2 PINX1_HUMAN reviewed PIN2/TERF1-interacting telomerase inhibitor 1 (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (Protein 67-11-3) (TRF1-interacting protein 1) Homo sapiens (Human) GO:0000228; GO:0000776; GO:0000781; GO:0005654; GO:0005730; GO:0005739; GO:0005819; GO:0007004; GO:0007080; GO:0008285; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0070034; GO:0070198; GO:1902570; GO:1904357; GO:1904751 mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004] chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819] protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034] g1555.t1 Q07832 60.672 595 0.0 761.0 sp|Q07832|PLK1_MOUSE Serine/threonine-protein kinase PLK1 OS=Mus musculus OX=10090 GN=Plk1 PE=1 SV=2 PLK1_MOUSE reviewed Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) Mus musculus (Mouse) GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000724; GO:0000775; GO:0000776; GO:0000779; GO:0000785; GO:0000795; GO:0000922; GO:0000940; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005876; GO:0006302; GO:0006468; GO:0007052; GO:0007094; GO:0007095; GO:0007098; GO:0007346; GO:0008017; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0040038; GO:0042802; GO:0043066; GO:0045143; GO:0045184; GO:0045842; GO:0045862; GO:0051081; GO:0051233; GO:0051299; GO:0070194; GO:0071168; GO:0071539; GO:0090435; GO:0097431; GO:0097681; GO:0106310; GO:1901673; GO:1903673; GO:1904776; GO:1990166; GO:2000042 centrosome cycle [GO:0007098]; centrosome separation [GO:0051299]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cleavage furrow formation [GO:1903673]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis [GO:0045862]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein localization to site of double-strand break [GO:1990166]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization to cell cortex [GO:1904776]; synaptonemal complex disassembly [GO:0070194] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795] anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] g1556.t1 Q7TPN3 36.264 273 3.77e-40 149.0 sp|Q7TPN3|PIGV_MOUSE GPI alpha-1,6-mannosyltransferase 2 OS=Mus musculus OX=10090 GN=Pigv PE=2 SV=2 PIGV_MOUSE reviewed GPI alpha-1,6-mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V) Mus musculus (Mouse) GO:0000009; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0031501 GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; mannosyltransferase complex [GO:0031501] alpha-1,6-mannosyltransferase activity [GO:0000009]; GPI mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030] g1557.t1 Q66IZ5 53.879 464 7.47e-155 449.0 sp|Q66IZ5|TAD3B_XENLA Transcriptional adapter 3-B OS=Xenopus laevis OX=8355 GN=tada3-b PE=2 SV=1 g1557.t2 Q66IZ5 55.292 463 7.56e-155 449.0 sp|Q66IZ5|TAD3B_XENLA Transcriptional adapter 3-B OS=Xenopus laevis OX=8355 GN=tada3-b PE=2 SV=1 g1558.t1 P97306 30.383 339 1.2300000000000001e-33 137.0 sp|P97306|STAC_MOUSE SH3 and cysteine-rich domain-containing protein OS=Mus musculus OX=10090 GN=Stac PE=1 SV=1 STAC_MOUSE reviewed SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein) Mus musculus (Mouse) GO:0003009; GO:0005829; GO:0006936; GO:0008270; GO:0009898; GO:0030315; GO:0034605; GO:0044325; GO:1901387; GO:1903078; GO:2001259 cellular response to heat [GO:0034605]; muscle contraction [GO:0006936]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; T-tubule [GO:0030315] transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g1558.t2 P97306 30.294 340 1.7e-33 136.0 sp|P97306|STAC_MOUSE SH3 and cysteine-rich domain-containing protein OS=Mus musculus OX=10090 GN=Stac PE=1 SV=1 STAC_MOUSE reviewed SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein) Mus musculus (Mouse) GO:0003009; GO:0005829; GO:0006936; GO:0008270; GO:0009898; GO:0030315; GO:0034605; GO:0044325; GO:1901387; GO:1903078; GO:2001259 cellular response to heat [GO:0034605]; muscle contraction [GO:0006936]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009] cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; T-tubule [GO:0030315] transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] g1559.t1 O46037 43.563 971 0.0 755.0 sp|O46037|VINC_DROME Vinculin OS=Drosophila melanogaster OX=7227 GN=Vinc PE=1 SV=1 g1559.t2 O46037 40.247 728 7.400000000000001e-179 540.0 sp|O46037|VINC_DROME Vinculin OS=Drosophila melanogaster OX=7227 GN=Vinc PE=1 SV=1 g1559.t3 Q04615 64.571 175 6.13e-75 229.0 sp|Q04615|VINC_XENLA Vinculin (Fragment) OS=Xenopus laevis OX=8355 GN=vcl PE=2 SV=1 g1563.t1 Q6EAS5 63.609 676 0.0 927.0 sp|Q6EAS5|GLGB_HORSE 1,4-alpha-glucan-branching enzyme OS=Equus caballus OX=9796 GN=GBE1 PE=1 SV=1 GLGB_HORSE reviewed 1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme) Equus caballus (Horse) GO:0003844; GO:0004553; GO:0005737; GO:0005829; GO:0005978; GO:0043169 glycogen biosynthetic process [GO:0005978] cytoplasm [GO:0005737]; cytosol [GO:0005829] 1,4-alpha-glucan branching enzyme activity [GO:0003844]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553] g1564.t1 Q2HJ23 71.667 120 7.23e-60 182.0 sp|Q2HJ23|MLP3A_BOVIN Microtubule-associated protein 1 light chain 3 alpha OS=Bos taurus OX=9913 GN=MAP1LC3A PE=2 SV=1 MLP3A_BOVIN reviewed Microtubule-associated protein 1 light chain 3 alpha (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (Microtubule-associated proteins 1A/1B light chain 3A) (MAP1A/MAP1B LC3 A) (MAP1A/MAP1B light chain 3 A) Bos taurus (Bovine) GO:0000045; GO:0000421; GO:0000423; GO:0005543; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0008429; GO:0012505; GO:0031090; GO:0031410; GO:0031625; GO:0044754; GO:0097352 autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; mitophagy [GO:0000423] autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090] microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625] g1565.t1 A6NJI9 32.384 281 1.07e-39 142.0 sp|A6NJI9|LRC72_HUMAN Leucine-rich repeat-containing protein 72 OS=Homo sapiens OX=9606 GN=LRRC72 PE=1 SV=2 g1571.t1 Q08BH7 63.433 134 1.7400000000000002e-59 187.0 sp|Q08BH7|UBE2T_DANRE Ubiquitin-conjugating enzyme E2 T OS=Danio rerio OX=7955 GN=ube2t PE=2 SV=1 g1572.t1 Q6ZW49 44.266 497 6.35e-139 444.0 sp|Q6ZW49|PAXI1_HUMAN PAX-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAXIP1 PE=1 SV=2 PAXI1_HUMAN reviewed PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) Homo sapiens (Human) GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006338; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0060261; GO:0060612; GO:0060717; GO:1902749 adipose tissue development [GO:0060612]; chorion development [GO:0060717]; chromatin remodeling [GO:0006338]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570] chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g1572.t1 Q6ZW49 42.982 228 2.6e-48 190.0 sp|Q6ZW49|PAXI1_HUMAN PAX-interacting protein 1 OS=Homo sapiens OX=9606 GN=PAXIP1 PE=1 SV=2 PAXI1_HUMAN reviewed PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) Homo sapiens (Human) GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006338; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0060261; GO:0060612; GO:0060717; GO:1902749 adipose tissue development [GO:0060612]; chorion development [GO:0060717]; chromatin remodeling [GO:0006338]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570] chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] g1573.t1 Q9BUP3 46.053 228 2.7e-77 240.0 sp|Q9BUP3|HTAI2_HUMAN Protein HTATIP2 OS=Homo sapiens OX=9606 GN=HTATIP2 PE=1 SV=2 HTAI2_HUMAN reviewed Protein HTATIP2 (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2) Homo sapiens (Human) GO:0004674; GO:0005737; GO:0005739; GO:0005829; GO:0006417; GO:0043068; GO:0045944; GO:0046777 positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] protein serine/threonine kinase activity [GO:0004674] g1583.t1 B3EWZ5 30.643 607 2.26e-76 268.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 30.378 609 1.14e-72 257.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 31.086 608 6.27e-71 252.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 30.478 607 2.3e-68 244.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 29.45 618 2.64e-65 236.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 31.54 539 3.63e-65 235.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 29.489 607 4.55e-65 235.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 30.396 556 8.64e-65 234.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 30.508 649 2.9e-62 227.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 29.593 615 4.6299999999999997e-60 220.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 29.058 616 1.2100000000000002e-59 219.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 28.054 663 5.180000000000001e-57 211.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 25.674 705 8.340000000000001e-51 193.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 29.847 459 1.66e-50 192.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 26.063 729 2.05e-47 182.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 29.245 424 2.37e-44 173.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 30.1 402 1.41e-43 171.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 31.755 359 6.37e-36 148.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1583.t1 B3EWZ5 30.514 331 4.67e-29 127.0 sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1 g1587.t1 Q9Z2N8 66.59 437 0.0 611.0 sp|Q9Z2N8|ACL6A_MOUSE Actin-like protein 6A OS=Mus musculus OX=10090 GN=Actl6a PE=1 SV=2 g1588.t1 Q0VDN7 43.973 589 2.18e-148 444.0 sp|Q0VDN7|RUND1_MOUSE RUN domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rundc1 PE=1 SV=1 g1589.t1 Q6DCC6 51.402 428 5.6900000000000007e-157 458.0 sp|Q6DCC6|GTPB6_XENLA Putative GTP-binding protein 6 OS=Xenopus laevis OX=8355 GN=gtpbp6 PE=2 SV=1 g1590.t1 P46023 31.183 651 2.38e-76 281.0 sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1 g1594.t1 A0A0G2KQY6 38.205 479 5.14e-93 294.0 sp|A0A0G2KQY6|S39AE_DANRE Metal cation symporter ZIP14 OS=Danio rerio OX=7955 GN=slc39a14 PE=2 SV=1 S39AE_DANRE reviewed Metal cation symporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0006829; GO:0006882; GO:0015086; GO:0015296; GO:0016323; GO:0016324; GO:0030003; GO:0031901; GO:0031902; GO:0032869; GO:0033212; GO:0034755; GO:0045745; GO:0055071; GO:0071333; GO:0071421; GO:0071577; GO:0071578; GO:0098662; GO:0098739; GO:0140410 cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; monoatomic anion:monoatomic cation symporter activity [GO:0015296]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385] g1601.t1 P0DX17 34.409 186 3.41e-28 111.0 sp|P0DX17|S39A5_DANRE Zinc transporter ZIP5 OS=Danio rerio OX=7955 GN=slc39a5 PE=2 SV=1 g1602.t1 Q3U0J8 28.87 575 9.89e-51 193.0 sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2 g1602.t2 Q3U0J8 34.851 1010 5.21e-165 532.0 sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2 g1604.t1 O16305 53.378 148 3.85e-50 160.0 sp|O16305|CALM_CAEEL Calmodulin OS=Caenorhabditis elegans OX=6239 GN=cmd-1 PE=1 SV=3 CALM_CAEEL reviewed Calmodulin (CaM) Caenorhabditis elegans GO:0000226; GO:0005509; GO:0005737; GO:0005813; GO:0005955; GO:0009792; GO:0010629; GO:0016477; GO:0030234; GO:0031965; GO:0032880; GO:0042981; GO:0043277; GO:0050918; GO:0051296; GO:0051726; GO:0071944; GO:0072686 apoptotic cell clearance [GO:0043277]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of gene expression [GO:0010629]; positive chemotaxis [GO:0050918]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880] calcineurin complex [GO:0005955]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965] calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234] g1608.t1 O93512 32.653 196 2.2100000000000003e-21 100.0 sp|O93512|GFRA4_CHICK GDNF family receptor alpha-4 OS=Gallus gallus OX=9031 GN=GFRA4 PE=2 SV=1 g1609.t1 Q5RJA1 67.014 576 0.0 788.0 sp|Q5RJA1|RFX6_DANRE DNA-binding protein RFX6 OS=Danio rerio OX=7955 GN=rfx6 PE=2 SV=2 g1609.t2 Q5RJA1 66.494 579 0.0 785.0 sp|Q5RJA1|RFX6_DANRE DNA-binding protein RFX6 OS=Danio rerio OX=7955 GN=rfx6 PE=2 SV=2 g1617.t1 Q4KMD3 64.881 168 1.98e-67 211.0 sp|Q4KMD3|U1SBP_DANRE U11/U12 small nuclear ribonucleoprotein 35 kDa protein OS=Danio rerio OX=7955 GN=snrnp35 PE=2 SV=1 g1619.t1 Q9ESG5 36.293 259 6.89e-44 159.0 sp|Q9ESG5|HS3S1_RAT Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Rattus norvegicus OX=10116 GN=Hs3st1 PE=2 SV=1 g1620.t1 Q8K1C7 25.833 480 4.6900000000000004e-32 132.0 sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1 g1621.t1 G5E8K6 34.375 192 1.32e-27 116.0 sp|G5E8K6|MOT6_MOUSE Monocarboxylate transporter 6 OS=Mus musculus OX=10090 GN=Slc16a5 PE=3 SV=1 g1625.t1 Q59I64 45.259 464 3.57e-130 389.0 sp|Q59I64|YLAT2_DANRE Y+L amino acid transporter 2 OS=Danio rerio OX=7955 GN=slc7a6 PE=2 SV=1 YLAT2_DANRE reviewed Y+L amino acid transporter 2 (Solute carrier family 7 member 6) (zfSlc7a6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0003333; GO:0005886; GO:0006809; GO:0015179; GO:0015804; GO:0031460; GO:0034618; GO:0061459; GO:0106439; GO:1903826 amino acid transmembrane transport [GO:0003333]; glycine betaine transport [GO:0031460]; L-arginine transmembrane transport [GO:1903826]; neutral amino acid transport [GO:0015804]; nitric oxide biosynthetic process [GO:0006809] plasma membrane [GO:0005886] arginine binding [GO:0034618]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine:L-arginine antiporter activity [GO:0106439] g1626.t1 Q9Y3Q0 45.43 755 0.0 642.0 sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1 NALD2_HUMAN reviewed N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II) Homo sapiens (Human) GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129 carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508] membrane [GO:0016020]; plasma membrane [GO:0005886] carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236] g1648.t1 Q9QXL2 41.22 1230 0.0 813.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g1648.t2 Q9QXL2 41.138 1230 0.0 815.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g1648.t3 Q9QXL2 40.6 1234 0.0 818.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g1648.t4 Q7Z4S6 39.072 668 5.98e-121 399.0 sp|Q7Z4S6|KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens OX=9606 GN=KIF21A PE=1 SV=2 KI21A_HUMAN reviewed Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62) Homo sapiens (Human) GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005938; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0016887; GO:0030425; GO:0031113; GO:0031114; GO:0043622; GO:0044295; GO:0071532; GO:0098793; GO:1902667; GO:1904115 anterograde axonal transport [GO:0008089]; cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; regulation of axon guidance [GO:1902667]; regulation of microtubule depolymerization [GO:0031114]; regulation of microtubule polymerization [GO:0031113] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; presynapse [GO:0098793] ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] g1649.t1 Q9QXL2 67.14 493 0.0 709.0 sp|Q9QXL2|KI21A_MOUSE Kinesin-like protein KIF21A OS=Mus musculus OX=10090 GN=Kif21a PE=1 SV=2 g1651.t1 Q63344 24.578 415 6.25e-27 115.0 sp|Q63344|MOT2_RAT Monocarboxylate transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc16a7 PE=1 SV=2 MOT2_RAT reviewed Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) Rattus norvegicus (Rat) GO:0005654; GO:0005829; GO:0005886; GO:0008028; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:1901475 lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475] basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] g1652.t1 Q6PFM0 63.797 395 7.0699999999999995e-180 510.0 sp|Q6PFM0|JMJD6_DANRE Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 OS=Danio rerio OX=7955 GN=jmjd6 PE=2 SV=2 JMJD6_DANRE reviewed Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr) Danio rerio (Zebrafish) (Brachydanio rerio) GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070815; GO:0106140 cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone demethylase activity [GO:0032452]; histone H3R2 demethylase activity [GO:0033746]; histone H4R3 demethylase activity [GO:0033749]; metal ion binding [GO:0046872]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727] g1655.t1 Q61233 54.221 616 0.0 632.0 sp|Q61233|PLSL_MOUSE Plastin-2 OS=Mus musculus OX=10090 GN=Lcp1 PE=1 SV=4 PLSL_MOUSE reviewed Plastin-2 (65 kDa macrophage protein) (L-plastin) (Lymphocyte cytosolic protein 1) (LCP-1) (pp65) Mus musculus (Mouse) GO:0001725; GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0005178; GO:0005509; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0009611; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030175; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0042802; GO:0048471; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0071803 actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; response to wounding [GO:0009611]; T cell activation involved in immune response [GO:0002286] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725] actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; integrin binding [GO:0005178] g1661.t1 Q9NP64 55.063 158 4.809999999999999e-52 179.0 sp|Q9NP64|ZCC17_HUMAN Zinc finger CCHC domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ZCCHC17 PE=1 SV=1 ZCC17_HUMAN reviewed Zinc finger CCHC domain-containing protein 17 (Nucleolar protein of 40 kDa) (pNO40) (Pnn-interacting nucleolar protein) (Putative S1 RNA-binding domain protein) (PS1D protein) Homo sapiens (Human) GO:0003723; GO:0005730; GO:0008270; GO:0022625; GO:0042802; GO:0043489 RNA stabilization [GO:0043489] cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730] identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] g1662.t1 Q8NFH5 43.333 360 1.8e-83 259.0 sp|Q8NFH5|NUP35_HUMAN Nucleoporin NUP35 OS=Homo sapiens OX=9606 GN=NUP35 PE=1 SV=1 NUP35_HUMAN reviewed Nucleoporin NUP35 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53) Homo sapiens (Human) GO:0003676; GO:0005543; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0005886; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0042802; GO:0044613; GO:0044615; GO:0051028; GO:1990830 cellular response to leukemia inhibitory factor [GO:1990830]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phospholipid binding [GO:0005543]; structural constituent of nuclear pore [GO:0017056] g1677.t1 Q4FZU8 39.514 329 1.41e-63 237.0 sp|Q4FZU8|RIPR1_RAT Rho family-interacting cell polarization regulator 1 OS=Rattus norvegicus OX=10116 GN=Ripor1 PE=1 SV=2 RIPR1_RAT reviewed Rho family-interacting cell polarization regulator 1 Rattus norvegicus (Rat) GO:0005737; GO:0005794; GO:0005829; GO:0007266; GO:0009267; GO:0009611; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0071889; GO:0090316; GO:1990869 cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] 14-3-3 protein binding [GO:0071889] g1677.t1 Q4FZU8 30.0 320 3.9000000000000003e-35 148.0 sp|Q4FZU8|RIPR1_RAT Rho family-interacting cell polarization regulator 1 OS=Rattus norvegicus OX=10116 GN=Ripor1 PE=1 SV=2 RIPR1_RAT reviewed Rho family-interacting cell polarization regulator 1 Rattus norvegicus (Rat) GO:0005737; GO:0005794; GO:0005829; GO:0007266; GO:0009267; GO:0009611; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0071889; GO:0090316; GO:1990869 cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] 14-3-3 protein binding [GO:0071889] g1677.t2 Q4FZU8 38.906 329 4.0900000000000004e-64 238.0 sp|Q4FZU8|RIPR1_RAT Rho family-interacting cell polarization regulator 1 OS=Rattus norvegicus OX=10116 GN=Ripor1 PE=1 SV=2 RIPR1_RAT reviewed Rho family-interacting cell polarization regulator 1 Rattus norvegicus (Rat) GO:0005737; GO:0005794; GO:0005829; GO:0007266; GO:0009267; GO:0009611; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0071889; GO:0090316; GO:1990869 cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] 14-3-3 protein binding [GO:0071889] g1677.t2 Q4FZU8 30.0 320 3.19e-35 148.0 sp|Q4FZU8|RIPR1_RAT Rho family-interacting cell polarization regulator 1 OS=Rattus norvegicus OX=10116 GN=Ripor1 PE=1 SV=2 RIPR1_RAT reviewed Rho family-interacting cell polarization regulator 1 Rattus norvegicus (Rat) GO:0005737; GO:0005794; GO:0005829; GO:0007266; GO:0009267; GO:0009611; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0071889; GO:0090316; GO:1990869 cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] 14-3-3 protein binding [GO:0071889] g1680.t1 P35445 46.349 671 7.79e-166 536.0 sp|P35445|COMP_BOVIN Cartilage oligomeric matrix protein OS=Bos taurus OX=9913 GN=COMP PE=1 SV=2 COMP_BOVIN reviewed Cartilage oligomeric matrix protein (COMP) Bos taurus (Bovine) GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0051260; GO:0060173; GO:0070527; GO:0090398; GO:0097084; GO:1900047; GO:1902732; GO:1990079 apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020] g1680.t2 P35445 46.832 647 1.93e-162 526.0 sp|P35445|COMP_BOVIN Cartilage oligomeric matrix protein OS=Bos taurus OX=9913 GN=COMP PE=1 SV=2 COMP_BOVIN reviewed Cartilage oligomeric matrix protein (COMP) Bos taurus (Bovine) GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0051260; GO:0060173; GO:0070527; GO:0090398; GO:0097084; GO:1900047; GO:1902732; GO:1990079 apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020] g1680.t3 P35445 46.349 671 2.36e-165 534.0 sp|P35445|COMP_BOVIN Cartilage oligomeric matrix protein OS=Bos taurus OX=9913 GN=COMP PE=1 SV=2 COMP_BOVIN reviewed Cartilage oligomeric matrix protein (COMP) Bos taurus (Bovine) GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0051260; GO:0060173; GO:0070527; GO:0090398; GO:0097084; GO:1900047; GO:1902732; GO:1990079 apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020] g1681.t1 B7ZCC9 28.0 650 1.83e-70 265.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g1681.t2 B7ZCC9 28.397 655 2.63e-70 262.0 sp|B7ZCC9|AGRG4_MOUSE Adhesion G-protein coupled receptor G4 OS=Mus musculus OX=10090 GN=Adgrg4 PE=3 SV=1 AGRG4_MOUSE reviewed Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)] Mus musculus (Mouse) GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] plasma membrane [GO:0005886] G protein-coupled receptor activity [GO:0004930] g1686.t1 Q14585 39.554 359 2.26e-75 255.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g1686.t1 Q14585 39.674 368 1.73e-72 248.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g1686.t1 Q14585 40.317 315 3.92e-60 214.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g1686.t1 Q14585 36.306 314 5.8399999999999996e-55 200.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g1686.t1 Q14585 33.19 232 7.27e-31 130.0 sp|Q14585|ZN345_HUMAN Zinc finger protein 345 OS=Homo sapiens OX=9606 GN=ZNF345 PE=1 SV=1 ZN345_HUMAN reviewed Zinc finger protein 345 (Zinc finger protein HZF10) Homo sapiens (Human) GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0008270; GO:1990837 negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] g1687.t1 P61963 90.909 341 0.0 664.0 sp|P61963|DCAF7_MOUSE DDB1- and CUL4-associated factor 7 OS=Mus musculus OX=10090 GN=Dcaf7 PE=1 SV=1 g1692.t1 Q8BQ89 77.255 255 3.02e-149 425.0 sp|Q8BQ89|LIX1L_MOUSE LIX1-like protein OS=Mus musculus OX=10090 GN=Lix1l PE=2 SV=2 g1693.t1 Q5REM7 42.105 152 4.9300000000000004e-33 117.0 sp|Q5REM7|PPAC_PONAB Low molecular weight phosphotyrosine protein phosphatase OS=Pongo abelii OX=9601 GN=ACP1 PE=2 SV=3 g1695.t1 Q8AVI4 66.294 537 0.0 701.0 sp|Q8AVI4|SHOC2_XENLA Leucine-rich repeat protein SHOC-2 OS=Xenopus laevis OX=8355 GN=shoc2 PE=2 SV=1 g1701.t1 Q6PHK6 49.815 271 1.09e-80 247.0 sp|Q6PHK6|PURB_DANRE Transcriptional regulator protein Pur-beta OS=Danio rerio OX=7955 GN=purb PE=2 SV=3 g14884.t1 Q7Z449 38.865 458 2.0200000000000002e-103 323.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g14887.t1 Q9CX98 38.124 501 2.1e-110 340.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g14888.t1 Q9CX98 44.715 123 1.29e-25 108.0 sp|Q9CX98|CP2U1_MOUSE Cytochrome P450 2U1 OS=Mus musculus OX=10090 GN=Cyp2u1 PE=2 SV=2 CP2U1_MOUSE reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Mus musculus (Mouse) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033 omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g14889.t1 Q0IIF9 48.387 93 7.7e-24 97.4 sp|Q0IIF9|CP2U1_BOVIN Cytochrome P450 2U1 OS=Bos taurus OX=9913 GN=CYP2U1 PE=2 SV=1 CP2U1_BOVIN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Bos taurus (Bovine) GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0102033 organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g14893.t1 Q7Z449 38.865 458 7.219999999999999e-104 324.0 sp|Q7Z449|CP2U1_HUMAN Cytochrome P450 2U1 OS=Homo sapiens OX=9606 GN=CYP2U1 PE=1 SV=1 CP2U1_HUMAN reviewed Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) Homo sapiens (Human) GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008395; GO:0016712; GO:0020037; GO:0052869; GO:0097267; GO:0102033; GO:1903604 cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743] arachidonate omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395] g11267.t1 Q06807 32.203 413 5.479999999999999e-60 221.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g11268.t1 Q06807 30.547 311 5.6500000000000004e-33 132.0 sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1 TIE2_BOVIN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b) Bos taurus (Bovine) GO:0001525; GO:0001935; GO:0001936; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030097; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of endothelial cell proliferation [GO:0001936]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g11269.t1 Q06806 44.702 302 1.6499999999999998e-82 285.0 sp|Q06806|TIE1_MOUSE Tyrosine-protein kinase receptor Tie-1 OS=Mus musculus OX=10090 GN=Tie1 PE=1 SV=3 TIE1_MOUSE reviewed Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Mus musculus (Mouse) GO:0001525; GO:0001568; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0016020; GO:0016525; GO:0030336; GO:0032526; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood vessel development [GO:0001568]; branching involved in lymph vessel morphogenesis [GO:0060854]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; tissue remodeling [GO:0048771]; vasculogenesis [GO:0001570] membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g11270.t1 Q02763 29.706 340 4.93e-29 124.0 sp|Q02763|TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens OX=9606 GN=TEK PE=1 SV=2 TIE2_HUMAN reviewed Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) Homo sapiens (Human) GO:0001525; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005813; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007166; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019199; GO:0032878; GO:0034446; GO:0035022; GO:0035025; GO:0036064; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0071260; GO:0072012; GO:1902533; GO:2000351; GO:2000352 angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to mechanical stimulus [GO:0071260]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; transmembrane receptor protein kinase activity [GO:0019199]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] g11272.t1 P28827 36.771 737 2.3699999999999998e-138 452.0 sp|P28827|PTPRM_HUMAN Receptor-type tyrosine-protein phosphatase mu OS=Homo sapiens OX=9606 GN=PTPRM PE=1 SV=2 PTPRM_HUMAN reviewed Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) Homo sapiens (Human) GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010828; GO:0010842; GO:0016525; GO:0016791; GO:0030027; GO:0031175; GO:0031290; GO:0042802; GO:0045296; GO:0048471 homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of D-glucose transmembrane transport [GO:0010828]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] g22098.t1 Q63530 57.798 109 3.89e-40 139.0 sp|Q63530|PTER_RAT N-acetyltaurine hydrolase OS=Rattus norvegicus OX=10116 GN=Pter PE=2 SV=2 g22099.t1 Q63530 50.0 346 2.5700000000000003e-123 361.0 sp|Q63530|PTER_RAT N-acetyltaurine hydrolase OS=Rattus norvegicus OX=10116 GN=Pter PE=2 SV=2 g22100.t1 Q63530 57.798 109 3.89e-40 139.0 sp|Q63530|PTER_RAT N-acetyltaurine hydrolase OS=Rattus norvegicus OX=10116 GN=Pter PE=2 SV=2 g22101.t1 Q96BW5 50.0 270 5.3e-99 300.0 sp|Q96BW5|PTER_HUMAN N-acetyltaurine hydrolase OS=Homo sapiens OX=9606 GN=PTER PE=1 SV=1 g22103.t1 Q9UL42 36.842 171 1.37e-23 106.0 sp|Q9UL42|PNMA2_HUMAN Paraneoplastic antigen Ma2 OS=Homo sapiens OX=9606 GN=PNMA2 PE=1 SV=2 g22107.t1 Q96BW5 48.555 173 3.6600000000000003e-56 183.0 sp|Q96BW5|PTER_HUMAN N-acetyltaurine hydrolase OS=Homo sapiens OX=9606 GN=PTER PE=1 SV=1 g22109.t1 Q96BW5 51.056 284 4.780000000000001e-109 326.0 sp|Q96BW5|PTER_HUMAN N-acetyltaurine hydrolase OS=Homo sapiens OX=9606 GN=PTER PE=1 SV=1 g22111.t1 Q63530 50.867 173 8.18e-57 185.0 sp|Q63530|PTER_RAT N-acetyltaurine hydrolase OS=Rattus norvegicus OX=10116 GN=Pter PE=2 SV=2 g11278.t1 Q9R1S8 62.838 148 1.08e-52 197.0 sp|Q9R1S8|CAN7_MOUSE Calpain-7 OS=Mus musculus OX=10090 GN=Capn7 PE=2 SV=1 g11278.t1 Q9R1S8 43.357 143 1.21e-25 116.0 sp|Q9R1S8|CAN7_MOUSE Calpain-7 OS=Mus musculus OX=10090 GN=Capn7 PE=2 SV=1 g22117.t1 P28799 42.533 529 4.64e-122 387.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 41.856 528 6.84e-118 376.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 40.943 530 5.96e-116 371.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 41.288 528 1.39e-112 362.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 41.331 496 3.51e-103 337.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 42.484 459 9.34e-101 331.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 42.553 423 4.13e-95 316.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 43.122 378 8.1399999999999995e-84 285.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22117.t1 P28799 42.566 343 3.5199999999999997e-74 259.0 sp|P28799|GRN_HUMAN Progranulin OS=Homo sapiens OX=9606 GN=GRN PE=1 SV=2 GRN_HUMAN reviewed Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] Homo sapiens (Human) GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0007566; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0035641; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060041; GO:0060266; GO:0070062; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905673 astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; trophectodermal cell proliferation [GO:0001834] azurophil granule lumen [GO:0035578]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723] g22119.t1 Q6SA80 50.0 188 4.819999999999999e-68 213.0 sp|Q6SA80|RND3_RAT Rho-related GTP-binding protein RhoE OS=Rattus norvegicus OX=10116 GN=Rnd3 PE=2 SV=1 g22120.t1 Q6J6I9 48.235 85 6.29e-22 91.3 sp|Q6J6I9|BRCA1_MACMU Breast cancer type 1 susceptibility protein homolog OS=Macaca mulatta OX=9544 GN=BRCA1 PE=3 SV=1 BRCA1_MACMU reviewed Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1) Macaca mulatta (Rhesus macaque) GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0006633; GO:0007095; GO:0008270; GO:0031436; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0061630; GO:0070013; GO:0070063; GO:0070531; GO:0085020 chordate embryonic development [GO:0043009]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357] BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular organelle lumen [GO:0070013]; nucleus [GO:0005634] DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g22122.t1 Q864U1 37.696 191 1.49e-37 143.0 sp|Q864U1|BRCA1_BOVIN Breast cancer type 1 susceptibility protein homolog OS=Bos taurus OX=9913 GN=BRCA1 PE=1 SV=1 BRCA1_BOVIN reviewed Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1) Bos taurus (Bovine) GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0006633; GO:0007095; GO:0008270; GO:0031436; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0061630; GO:0070013; GO:0070063; GO:0070531; GO:0085020 chordate embryonic development [GO:0043009]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357] BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular organelle lumen [GO:0070013]; nucleus [GO:0005634] DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g22123.t1 Q6SA80 38.356 146 7.03e-30 111.0 sp|Q6SA80|RND3_RAT Rho-related GTP-binding protein RhoE OS=Rattus norvegicus OX=10116 GN=Rnd3 PE=2 SV=1 g14902.t1 Q9D1D1 32.129 249 2.3399999999999998e-34 127.0 sp|Q9D1D1|TSN11_MOUSE Tetraspanin-11 OS=Mus musculus OX=10090 GN=Tspan11 PE=2 SV=1 g12411.t1 Q61555 40.957 376 3.35e-50 199.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t1 Q61555 29.536 711 2.07e-43 177.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t1 Q61555 27.546 766 3.09e-34 147.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t1 Q61555 39.262 298 3.43e-28 127.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t1 Q61555 32.36 411 7.86e-28 126.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t1 Q61555 33.504 391 1.7499999999999999e-25 119.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t1 Q61555 36.0 250 2.4299999999999998e-23 112.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t1 Q61555 26.145 830 7.94e-21 103.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 40.957 376 3.71e-50 199.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 29.536 711 2.46e-43 177.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 27.546 766 3.7999999999999997e-34 147.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 39.262 298 4.76e-28 127.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 32.36 411 1.11e-27 126.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 33.504 391 2.08e-25 119.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 36.0 250 3.0499999999999997e-23 111.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t2 Q61555 26.082 832 5.96e-21 104.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 39.573 422 8.419999999999999e-55 215.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 34.426 427 1.65e-44 181.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 28.933 712 3.05e-44 180.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 27.034 762 1.2600000000000002e-43 178.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 33.043 460 9.57e-38 159.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 27.284 788 1.4e-35 152.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 31.209 455 2.32e-32 141.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 28.958 518 1.87e-31 139.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 26.413 867 3.92e-24 114.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 29.112 529 3.8900000000000003e-22 108.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12411.t3 Q61555 28.352 522 4.97e-21 104.0 sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2 FBN2_MOUSE reviewed Fibrillin-2 [Cleaved into: Placensin] Mus musculus (Mouse) GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0030326; GO:0030501; GO:0031012; GO:0035108; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:1901163 bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; limb morphogenesis [GO:0035108]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] g12412.t1 Q7SY23 57.297 555 0.0 707.0 sp|Q7SY23|AL4A1_DANRE Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=aldh4a1 PE=2 SV=1 g12414.t1 Q5U247 47.337 676 0.0 629.0 sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1 g12414.t2 Q5U247 48.198 666 0.0 636.0 sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1 g12415.t1 Q8K430 63.095 420 0.0 556.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g12415.t1 Q8K430 48.78 123 9.520000000000001e-27 116.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g12415.t1 Q8K430 40.0 125 1.5399999999999999e-24 110.0 sp|Q8K430|KLH17_RAT Kelch-like protein 17 OS=Rattus norvegicus OX=10116 GN=Klhl17 PE=1 SV=1 KLH17_RAT reviewed Kelch-like protein 17 (Actinfilin) Rattus norvegicus (Rat) GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0031463; GO:0032839; GO:0043025; GO:0043161; GO:0051015; GO:0060090; GO:0098794; GO:0098978; GO:0140252; GO:1990756 actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756] g1730.t1 P53782 62.162 74 1.0899999999999999e-23 93.6 sp|P53782|CCND2_XENLA G1/S-specific cyclin-D2 OS=Xenopus laevis OX=8355 GN=ccnd2 PE=2 SV=1 g1731.t1 Q13263 25.071 351 1.5600000000000002e-21 104.0 sp|Q13263|TIF1B_HUMAN Transcription intermediary factor 1-beta OS=Homo sapiens OX=9606 GN=TRIM28 PE=1 SV=5 TIF1B_HUMAN reviewed Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28) Homo sapiens (Human) GO:0000122; GO:0000791; GO:0000792; GO:0001837; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006346; GO:0007566; GO:0008270; GO:0016925; GO:0019789; GO:0031625; GO:0032991; GO:0035851; GO:0042307; GO:0043161; GO:0044790; GO:0045087; GO:0045739; GO:0045869; GO:0045892; GO:0045893; GO:0060028; GO:0060669; GO:0061630; GO:0070087; GO:0071514; GO:0090575; GO:1990841 chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; genomic imprinting [GO:0071514]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein sumoylation [GO:0016925]; suppression of viral release by host [GO:0044790] euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575] chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] g4946.t1 Q9NWZ5 67.647 136 2.72e-56 188.0 sp|Q9NWZ5|UCKL1_HUMAN Uridine-cytidine kinase-like 1 OS=Homo sapiens OX=9606 GN=UCKL1 PE=1 SV=2 g4947.t1 Q9NWZ5 60.933 343 1.33e-136 401.0 sp|Q9NWZ5|UCKL1_HUMAN Uridine-cytidine kinase-like 1 OS=Homo sapiens OX=9606 GN=UCKL1 PE=1 SV=2 g4948.t1 Q40082 54.751 442 2.71e-177 508.0 sp|Q40082|XYLA_HORVU Xylose isomerase OS=Hordeum vulgare OX=4513 GN=XYLA PE=1 SV=1 g14.t1 Q8BRT1 49.942 863 0.0 740.0 sp|Q8BRT1|CLAP2_MOUSE CLIP-associating protein 2 OS=Mus musculus OX=10090 GN=Clasp2 PE=1 SV=1 CLAP2_MOUSE reviewed CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) Mus musculus (Mouse) GO:0000226; GO:0000776; GO:0000922; GO:0002162; GO:0005794; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010634; GO:0015630; GO:0016477; GO:0030010; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051321; GO:0051497; GO:0051895; GO:0071711; GO:0072686; GO:0090091; GO:0090307; GO:0098978; GO:0099187; GO:1903690; GO:1903754; GO:1905477; GO:1990782 basement membrane organization [GO:0071711]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of protein localization to membrane [GO:1905477]; presynaptic cytoskeleton organization [GO:0099187]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903] axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cortical microtubule plus-end [GO:1903754]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782] g14.t2 Q8BRT1 50.118 850 0.0 740.0 sp|Q8BRT1|CLAP2_MOUSE CLIP-associating protein 2 OS=Mus musculus OX=10090 GN=Clasp2 PE=1 SV=1 CLAP2_MOUSE reviewed CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) Mus musculus (Mouse) GO:0000226; GO:0000776; GO:0000922; GO:0002162; GO:0005794; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010634; GO:0015630; GO:0016477; GO:0030010; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051321; GO:0051497; GO:0051895; GO:0071711; GO:0072686; GO:0090091; GO:0090307; GO:0098978; GO:0099187; GO:1903690; GO:1903754; GO:1905477; GO:1990782 basement membrane organization [GO:0071711]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of protein localization to membrane [GO:1905477]; presynaptic cytoskeleton organization [GO:0099187]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903] axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cortical microtubule plus-end [GO:1903754]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782] g14.t3 Q8BRT1 48.808 881 0.0 733.0 sp|Q8BRT1|CLAP2_MOUSE CLIP-associating protein 2 OS=Mus musculus OX=10090 GN=Clasp2 PE=1 SV=1 CLAP2_MOUSE reviewed CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) Mus musculus (Mouse) GO:0000226; GO:0000776; GO:0000922; GO:0002162; GO:0005794; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010634; GO:0015630; GO:0016477; GO:0030010; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051321; GO:0051497; GO:0051895; GO:0071711; GO:0072686; GO:0090091; GO:0090307; GO:0098978; GO:0099187; GO:1903690; GO:1903754; GO:1905477; GO:1990782 basement membrane organization [GO:0071711]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of protein localization to membrane [GO:1905477]; presynaptic cytoskeleton organization [GO:0099187]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903] axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cortical microtubule plus-end [GO:1903754]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782] g15.t1 Q9NZI6 44.595 222 3.12e-51 175.0 sp|Q9NZI6|TF2L1_HUMAN Transcription factor CP2-like protein 1 OS=Homo sapiens OX=9606 GN=TFCP2L1 PE=1 SV=1 TF2L1_HUMAN reviewed Transcription factor CP2-like protein 1 (CP2-related transcriptional repressor 1) (CRTR-1) (Transcription factor LBP-9) Homo sapiens (Human) GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0001228; GO:0002070; GO:0005634; GO:0005737; GO:0006357; GO:0007028; GO:0007431; GO:0008340; GO:0016020; GO:0045927; GO:1990837 cell morphogenesis [GO:0000902]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; epithelial cell maturation [GO:0002070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of growth [GO:0045927]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] g4943.t1 A1A5Q7 43.659 552 7.17e-153 457.0 sp|A1A5Q7|VWA3A_RAT von Willebrand factor A domain-containing protein 3A OS=Rattus norvegicus OX=10116 GN=Vwa3a PE=2 SV=1 g4944.t1 Q2NL21 56.226 265 1.63e-86 271.0 sp|Q2NL21|DJC11_BOVIN DnaJ homolog subfamily C member 11 OS=Bos taurus OX=9913 GN=DNAJC11 PE=2 SV=1 DJC11_BOVIN reviewed DnaJ homolog subfamily C member 11 Bos taurus (Bovine) GO:0001401; GO:0016607; GO:0042407; GO:0061617 cristae formation [GO:0042407] MICOS complex [GO:0061617]; nuclear speck [GO:0016607]; SAM complex [GO:0001401] g12.t1 Q8C2E4 41.784 213 2.6499999999999997e-48 173.0 sp|Q8C2E4|PTCD1_MOUSE Pentatricopeptide repeat-containing protein 1, mitochondrial OS=Mus musculus OX=10090 GN=Ptcd1 PE=2 SV=2 g3018.t1 Q8WZ42 24.511 767 5.61e-50 195.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 22.265 777 6.839999999999999e-48 189.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 24.938 802 1.08e-47 188.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 24.208 789 7.35e-46 182.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 22.711 841 1.05e-39 163.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 23.641 791 4.0900000000000004e-37 155.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 21.597 764 4.7200000000000004e-32 139.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 24.309 543 9.26e-28 125.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 24.453 503 3.92e-27 123.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 29.242 277 9.48e-24 112.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t1 Q8WZ42 24.668 527 6e-22 106.0 sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4 g3018.t2 Q9I7U4 27.254 477 4.47e-33 142.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g3018.t2 Q9I7U4 27.273 374 2.0900000000000002e-29 130.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g3018.t2 Q9I7U4 27.968 379 2.9000000000000004e-26 120.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g3018.t2 Q9I7U4 25.097 518 1.21e-25 118.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g3018.t2 Q9I7U4 24.306 576 8.94e-22 106.0 sp|Q9I7U4|TITIN_DROME Titin OS=Drosophila melanogaster OX=7227 GN=sls PE=1 SV=3 TITIN_DROME reviewed Titin (D-Titin) (Kettin) Drosophila melanogaster (Fruit fly) GO:0000794; GO:0003779; GO:0005863; GO:0007062; GO:0007076; GO:0007498; GO:0007520; GO:0007522; GO:0007525; GO:0008307; GO:0030017; GO:0030018; GO:0031674; GO:0035206; GO:0045214; GO:0051301 cell division [GO:0051301]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522] condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018] actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] g3019.t1 Q9D6R2 79.618 157 2.73e-85 257.0 sp|Q9D6R2|IDH3A_MOUSE Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial OS=Mus musculus OX=10090 GN=Idh3a PE=1 SV=1 IDH3A_MOUSE reviewed Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha) Mus musculus (Mouse) GO:0000287; GO:0004449; GO:0005739; GO:0005759; GO:0006099; GO:0006102; GO:0043209; GO:0045242; GO:0051287 isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] isocitrate dehydrogenase complex (NAD+) [GO:0045242]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209] isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] g3020.t1 Q9NJ15 32.847 411 8.62e-49 181.0 sp|Q9NJ15|PCSK5_BRACL Proprotein convertase subtilisin/kexin type 5 OS=Branchiostoma californiense OX=7738 GN=PC6 PE=2 SV=1 PCSK5_BRACL reviewed Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase PC6-like) (aPC6) Branchiostoma californiense (California lancelet) (Amphioxus) GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0016486 peptide hormone processing [GO:0016486] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] serine-type endopeptidase activity [GO:0004252] g3020.t1 Q9NJ15 29.412 255 6.100000000000001e-21 98.6 sp|Q9NJ15|PCSK5_BRACL Proprotein convertase subtilisin/kexin type 5 OS=Branchiostoma californiense OX=7738 GN=PC6 PE=2 SV=1 PCSK5_BRACL reviewed Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase PC6-like) (aPC6) Branchiostoma californiense (California lancelet) (Amphioxus) GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0016486 peptide hormone processing [GO:0016486] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] serine-type endopeptidase activity [GO:0004252] g12368.t1 Q0BYM3 65.657 297 1.0400000000000001e-144 432.0 sp|Q0BYM3|SYA_HYPNA Alanine--tRNA ligase OS=Hyphomonas neptunium (strain ATCC 15444) OX=228405 GN=alaS PE=3 SV=1 g12370.t1 B3PPU4 73.239 142 3.71e-68 214.0 sp|B3PPU4|RECA_RHIE6 Protein RecA OS=Rhizobium etli (strain CIAT 652) OX=491916 GN=recA PE=3 SV=1 g12371.t1 P0DOA0 46.154 416 2.2099999999999998e-108 358.0 sp|P0DOA0|CCKA_BRUA2 Sensor kinase CckA OS=Brucella abortus (strain 2308) OX=359391 GN=cckA PE=1 SV=1 g12372.t1 O54243 36.12 299 9.82e-56 187.0 sp|O54243|FLHB_RHIME Flagellar biosynthetic protein FlhB OS=Rhizobium meliloti (strain 1021) OX=266834 GN=flhB PE=3 SV=2 g12373.t1 Q45975 48.98 98 1.52e-25 99.8 sp|Q45975|FLIR_CAUVC Flagellar biosynthetic protein FliR OS=Caulobacter vibrioides (strain ATCC 19089 / CIP 103742 / CB 15) OX=190650 GN=fliR PE=3 SV=1 g12378.t1 C9DQ21 46.748 246 2.78e-65 227.0 sp|C9DQ21|DMFAB_PARAH N,N-dimethylformamidase beta subunit OS=Paracoccus aminophilus OX=34003 GN=dmfA2 PE=2 SV=1 g12378.t1 C9DQ21 37.838 222 5.07e-34 139.0 sp|C9DQ21|DMFAB_PARAH N,N-dimethylformamidase beta subunit OS=Paracoccus aminophilus OX=34003 GN=dmfA2 PE=2 SV=1 g12382.t1 P21629 33.878 245 3.34e-42 147.0 sp|P21629|BRAF_PSEAE High-affinity branched-chain amino acid transport ATP-binding protein BraF OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=braF PE=3 SV=1 g12389.t1 O54478 55.391 742 0.0 792.0 sp|O54478|PARC_CAUVC DNA topoisomerase 4 subunit A OS=Caulobacter vibrioides (strain ATCC 19089 / CIP 103742 / CB 15) OX=190650 GN=parC PE=3 SV=2 g12397.t1 P55702 36.883 385 1.33e-59 209.0 sp|P55702|Y4XJ_SINFN Uncharacterized protein y4xJ OS=Sinorhizobium fredii (strain NBRC 101917 / NGR234) OX=394 GN=NGR_a00790 PE=3 SV=1 g12404.t1 O33915 75.318 393 0.0 635.0 sp|O33915|CISY_RHIME Citrate synthase OS=Rhizobium meliloti (strain 1021) OX=266834 GN=gltA PE=3 SV=2 g12406.t1 O31584 34.416 308 2.71e-52 181.0 sp|O31584|MUTY_BACSU Adenine DNA glycosylase OS=Bacillus subtilis (strain 168) OX=224308 GN=mutY PE=2 SV=1 MUTY_BACSU reviewed Adenine DNA glycosylase (EC 3.2.2.31) Bacillus subtilis (strain 168) GO:0000701; GO:0006284; GO:0006298; GO:0032357; GO:0034039; GO:0035485; GO:0046872; GO:0051539 base-excision repair [GO:0006284]; mismatch repair [GO:0006298] 4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; metal ion binding [GO:0046872]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701] g6061.t1 B2RR83 35.036 274 1.1199999999999999e-38 147.0 sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1 YTDC2_MOUSE reviewed 3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2) Mus musculus (Mouse) GO:0003723; GO:0004386; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0008186; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247 germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; host-mediated activation of viral genome replication [GO:0044829]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770] 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; helicase activity [GO:0004386]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063] g11280.t1 Q0BYA8 71.591 88 7.0500000000000004e-37 134.0 sp|Q0BYA8|RPOC_HYPNA DNA-directed RNA polymerase subunit beta' OS=Hyphomonas neptunium (strain ATCC 15444) OX=228405 GN=rpoC PE=3 SV=1 g11281.t1 Q0BYA8 77.229 830 0.0 1344.0 sp|Q0BYA8|RPOC_HYPNA DNA-directed RNA polymerase subunit beta' OS=Hyphomonas neptunium (strain ATCC 15444) OX=228405 GN=rpoC PE=3 SV=1 g11282.t1 Q0BYA7 74.771 547 0.0 857.0 sp|Q0BYA7|RPOB_HYPNA DNA-directed RNA polymerase subunit beta OS=Hyphomonas neptunium (strain ATCC 15444) OX=228405 GN=rpoB PE=3 SV=1 g11283.t1 B0SUP7 79.389 131 7.03e-63 210.0 sp|B0SUP7|RPOB_CAUSK DNA-directed RNA polymerase subunit beta OS=Caulobacter sp. (strain K31) OX=366602 GN=rpoB PE=3 SV=1 g11284.t1 Q0BYA7 78.903 237 4.52e-128 397.0 sp|Q0BYA7|RPOB_HYPNA DNA-directed RNA polymerase subunit beta OS=Hyphomonas neptunium (strain ATCC 15444) OX=228405 GN=rpoB PE=3 SV=1 g11285.t1 Q0ANP3 55.072 345 1.77e-132 412.0 sp|Q0ANP3|RPOB_MARMM DNA-directed RNA polymerase subunit beta OS=Maricaulis maris (strain MCS10) OX=394221 GN=rpoB PE=3 SV=1 g11286.t1 Q9ZE21 42.623 122 1.99e-22 90.1 sp|Q9ZE21|RL7_RICPR Large ribosomal subunit protein bL12 OS=Rickettsia prowazekii (strain Madrid E) OX=272947 GN=rplL PE=3 SV=1 g11287.t1 B4R8K3 54.819 166 8.169999999999999e-62 192.0 sp|B4R8K3|RL10_PHEZH Large ribosomal subunit protein uL10 OS=Phenylobacterium zucineum (strain HLK1) OX=450851 GN=rplJ PE=3 SV=1 g11288.t1 Q0ANP0 67.773 211 7e-106 307.0 sp|Q0ANP0|RL1_MARMM Large ribosomal subunit protein uL1 OS=Maricaulis maris (strain MCS10) OX=394221 GN=rplA PE=3 SV=1 g11289.t1 A7HWQ0 63.248 117 1.45e-49 159.0 sp|A7HWQ0|RL11_PARL1 Large ribosomal subunit protein uL11 OS=Parvibaculum lavamentivorans (strain DS-1 / DSM 13023 / NCIMB 13966) OX=402881 GN=rplK PE=3 SV=1 g11290.t1 Q9KV35 52.027 148 2.48e-46 151.0 sp|Q9KV35|NUSG_VIBCH Transcription termination/antitermination protein NusG OS=Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) OX=243277 GN=nusG PE=3 SV=3 g11291.t1 A1L258 38.07 373 1.41e-74 246.0 sp|A1L258|D2HDH_DANRE D-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=d2hgdh PE=2 SV=1 g11294.t1 Q982V5 83.493 418 0.0 721.0 sp|Q982V5|CLPX_RHILO ATP-dependent Clp protease ATP-binding subunit ClpX OS=Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) OX=266835 GN=clpX PE=3 SV=1 g11295.t1 Q0AQ07 72.77 213 3.4599999999999998e-115 330.0 sp|Q0AQ07|CLPP_MARMM ATP-dependent Clp protease proteolytic subunit OS=Maricaulis maris (strain MCS10) OX=394221 GN=clpP PE=3 SV=1 g11296.t1 Q0C0H6 32.967 455 2.58e-67 225.0 sp|Q0C0H6|TIG_HYPNA Trigger factor OS=Hyphomonas neptunium (strain ATCC 15444) OX=228405 GN=tig PE=3 SV=1 TIG_HYPNA reviewed Trigger factor (TF) (EC 5.2.1.8) (PPIase) Hyphomonas neptunium (strain ATCC 15444) GO:0003755; GO:0005737; GO:0015031; GO:0043022; GO:0043335; GO:0044183; GO:0051083; GO:0051301 'de novo' cotranslational protein folding [GO:0051083]; cell division [GO:0051301]; protein transport [GO:0015031]; protein unfolding [GO:0043335] cytoplasm [GO:0005737] peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022] g11301.t1 Q2LVL0 43.027 337 1.02e-87 278.0 sp|Q2LVL0|MSBA_SYNAS ATP-dependent lipid A-core flippase OS=Syntrophus aciditrophicus (strain SB) OX=56780 GN=msbA PE=3 SV=1 g11303.t1 P0AFK0 30.67 388 1.33e-47 173.0 sp|P0AFK0|PMBA_ECOLI Metalloprotease PmbA OS=Escherichia coli (strain K12) OX=83333 GN=pmbA PE=1 SV=1 g11306.t1 Q45972 68.75 112 1.5599999999999998e-54 170.0 sp|Q45972|FER1_CAUVC Ferredoxin-1 OS=Caulobacter vibrioides (strain ATCC 19089 / CIP 103742 / CB 15) OX=190650 GN=fdxA PE=3 SV=3 g11312.t1 P37908 35.423 319 4.16e-52 180.0 sp|P37908|YFJD_ECOLI UPF0053 inner membrane protein YfjD OS=Escherichia coli (strain K12) OX=83333 GN=yfjD PE=1 SV=5 g11314.t1 B4RG33 50.423 355 1.57e-102 315.0 sp|B4RG33|AROB_PHEZH 3-dehydroquinate synthase OS=Phenylobacterium zucineum (strain HLK1) OX=450851 GN=aroB PE=3 SV=1 g11315.t1 Q9A437 50.336 298 1.36e-79 250.0 sp|Q9A437|XERD_CAUVC Tyrosine recombinase XerD OS=Caulobacter vibrioides (strain ATCC 19089 / CIP 103742 / CB 15) OX=190650 GN=xerD PE=3 SV=1 g11317.t1 P52878 41.979 374 5.64e-102 308.0 sp|P52878|SERC_METBF Phosphoserine aminotransferase OS=Methanosarcina barkeri (strain Fusaro / DSM 804) OX=269797 GN=serC PE=1 SV=1 g11318.t1 P73821 39.848 527 3.44e-124 377.0 sp|P73821|SERA_SYNY3 D-3-phosphoglycerate dehydrogenase OS=Synechocystis sp. (strain ATCC 27184 / PCC 6803 / Kazusa) OX=1111708 GN=serA PE=3 SV=1 g22112.t1 B0TQU4 45.89 146 2.37e-25 103.0 sp|B0TQU4|PLSX_SHEHH Phosphate acyltransferase OS=Shewanella halifaxensis (strain HAW-EB4) OX=458817 GN=plsX PE=3 SV=1 g22113.t1 Q9K0K9 38.378 370 1.09e-33 136.0 sp|Q9K0K9|FRPA_NEIMB Iron-regulated protein FrpA OS=Neisseria meningitidis serogroup B (strain ATCC BAA-335 / MC58) OX=122586 GN=frpA PE=3 SV=1 g22114.t2 Q9KQR9 69.048 84 2.13e-36 135.0 sp|Q9KQR9|DCTP_VIBCH C4-dicarboxylate-binding periplasmic protein DctP OS=Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) OX=243277 GN=dctP PE=3 SV=1 g22115.t1 P16462 54.128 109 9.67e-22 101.0 sp|P16462|LTXA_AGGAC Leukotoxin OS=Aggregatibacter actinomycetemcomitans OX=714 GN=ltxA PE=1 SV=2 g22116.t1 Q60295 24.052 686 7.89e-38 155.0 sp|Q60295|T1RH_METJA Putative type I restriction enzyme MjaIXP endonuclease subunit OS=Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) OX=243232 GN=MJECL40 PE=3 SV=1 g7939.t1 O54478 67.532 77 1.44e-31 119.0 sp|O54478|PARC_CAUVC DNA topoisomerase 4 subunit A OS=Caulobacter vibrioides (strain ATCC 19089 / CIP 103742 / CB 15) OX=190650 GN=parC PE=3 SV=2 g7940.t1 P43873 55.83 446 1.2200000000000002e-179 512.0 sp|P43873|ACCC_HAEIN Biotin carboxylase OS=Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) OX=71421 GN=accC PE=1 SV=1 g4942.t1 Q9BX51 38.428 229 3.17e-41 142.0 sp|Q9BX51|GGTL1_HUMAN Glutathione hydrolase light chain 1 OS=Homo sapiens OX=9606 GN=GGTLC1 PE=1 SV=2 g7.t1 Q6P0C6 41.434 251 1.37e-53 176.0 sp|Q6P0C6|LHPL2_DANRE LHFPL tetraspan subfamily member 2a protein OS=Danio rerio OX=7955 GN=lhfpl2a PE=2 SV=1 g22089.t1 Q9NU19 54.297 512 0.0 544.0 sp|Q9NU19|TB22B_HUMAN TBC1 domain family member 22B OS=Homo sapiens OX=9606 GN=TBC1D22B PE=1 SV=3 TB22B_HUMAN reviewed TBC1 domain family member 22B Homo sapiens (Human) GO:0005096; GO:0005794; GO:0071889 Golgi apparatus [GO:0005794] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096] g22090.t1 Q55C17 29.492 295 3.12e-28 113.0 sp|Q55C17|TECR_DICDI Very-long-chain enoyl-CoA reductase OS=Dictyostelium discoideum OX=44689 GN=gpsn2 PE=3 SV=1 g22091.t1 Q8TCT0 42.434 304 1.37e-84 270.0 sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1 CERK1_HUMAN reviewed Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4) Homo sapiens (Human) GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020 ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287] g6850.t1 P0DTK4 28.571 728 2.97e-50 192.0 sp|P0DTK4|DPOLA_BPPM6 DNA-directed DNA polymerase OS=Pseudomonas phage M6 OX=2911432 GN=gp62 PE=1 SV=1 g6852.t1 Q5UPG5 35.294 187 4.0599999999999995e-24 100.0 sp|Q5UPG5|YL093_MIMIV Putative ankyrin repeat protein L93 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_L93 PE=4 SV=1 g6852.t1 Q5UPG5 37.43 179 1.18e-21 94.4 sp|Q5UPG5|YL093_MIMIV Putative ankyrin repeat protein L93 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_L93 PE=4 SV=1 g6859.t1 P0DTK4 28.918 619 4.5599999999999997e-48 185.0 sp|P0DTK4|DPOLA_BPPM6 DNA-directed DNA polymerase OS=Pseudomonas phage M6 OX=2911432 GN=gp62 PE=1 SV=1 g6861.t1 Q5UPG5 35.294 187 4.0599999999999995e-24 100.0 sp|Q5UPG5|YL093_MIMIV Putative ankyrin repeat protein L93 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_L93 PE=4 SV=1 g6861.t1 Q5UPG5 37.43 179 1.18e-21 94.4 sp|Q5UPG5|YL093_MIMIV Putative ankyrin repeat protein L93 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_L93 PE=4 SV=1 g2.t1 Q5T1M5 36.364 176 9.09e-24 101.0 sp|Q5T1M5|FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens OX=9606 GN=FKBP15 PE=1 SV=2 FKB15_HUMAN reviewed FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP- and FKBP-like protein) (WAFL) Homo sapiens (Human) GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] g4.t1 Q9R1A8 65.217 506 0.0 673.0 sp|Q9R1A8|COP1_MOUSE E3 ubiquitin-protein ligase COP1 OS=Mus musculus OX=10090 GN=Cop1 PE=1 SV=2 COP1_MOUSE reviewed E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2) Mus musculus (Mouse) GO:0000139; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0061630 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607] ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] g20004.t1 Q5RBW6 34.657 277 1.15e-39 142.0 sp|Q5RBW6|STX12_PONAB Syntaxin-12 OS=Pongo abelii OX=9601 GN=STX12 PE=2 SV=1 STX12_PONAB reviewed Syntaxin-12 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) GO:0000045; GO:0000139; GO:0000149; GO:0005484; GO:0006886; GO:0006906; GO:0030672; GO:0031201; GO:0031901; GO:0032456; GO:0048278; GO:0055037; GO:0055038; GO:0098837 autophagosome assembly [GO:0000045]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672] SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] g11.t1 F7J220 73.125 160 6.49e-72 236.0 sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1 g11273.t1 P94437 45.989 187 5.8699999999999994e-52 182.0 sp|P94437|YFII_BACSU Uncharacterized oxidoreductase YfiI OS=Bacillus subtilis (strain 168) OX=224308 GN=yfiI PE=3 SV=1